Name

Label

Description

DataType

Groups

120 Sample Arm

Phase 2 data. Arm from which 120 minute blood sample was taken.

Text

120 Sample by

Phase 2 data. Initials/ID of staff member 120 minute blood sample was taken by

Text

120 Sample Site

Phase 2 data. Site of 120 minute sample blood sample taken

Text

whether there was 35 hrs of good quality daytime d

35 daytime hours

None

Phase 2 data. 35 daytime hours for Phase 2? (frist wear of Actiheart only). Used for Study cooridination purposes not for analysis. Use wear varibles in main AH dataset for analysis. 0 = no; 1 = yes;

Categorical

Eat when lonely

When I feel lonely I console myself by eating.

Categorical

Feeling lonely console by eating

Phase 2 data. When I feel lonely; I console myself by eating. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Eat when lonely_rescored

New in R8. derived by re-scoring item 3FEQ_10lonelyconsoleeating; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810). When I feel lonely; I console myself by eating.

Categorical

Re-scored item 3FEQ_10lonelyconsoleeating_P2

Phase 2 data. Derived by re-scoring item 3FEQ_10lonelyconsoleeating_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810). When I feel lonely; I console myself by eating. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Hold back on meals so not to gain weight

I consciously hold back at meals in order not to gain weight.

Categorical

Hold back on eating control weight

Phase 2 data. I consciously hold back at meals in order not to gain weight. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Hold back on meals so not to gain weight_rescored

New in R8. derived by re-scoring item 3FEQ_11holdbackatmeals; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).I consciously hold back at meals in order not to gain weight.

Categorical

Re-scored item 3FEQ_11holdbackatmeals

Phase 2 data. Derived by re-scoring item 3FEQ_11holdbackatmeals_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).I consciously hold back at meals in order not to gain weight. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Avoid foods that make me fat

I do not eat some foods because they make me fat.

Categorical

Do not eat some food make me fat

Phase 2 data. I do not eat some foods because they make me fat. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Avoid foods that make me fat_rescored

New in R8. derived by re-scoring item 3FEQfeq_12foodmakemefat; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).I do not eat some foods because they make me fat.

Categorical

Re-scored item 3FEQfeq_12foodmakemefat_P2

Phase 2 data. Derived by re-scoring item 3FEQfeq_12foodmakemefat_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).I do not eat some foods because they make me fat. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Hungry enough to eat any time

I am always hungry enough to eat at any time.

Categorical

Always hungry to eat any time

Phase 2 data. I am always hungry enough to eat at any time. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Hungry enough to eat any time_rescored

New in R8. derived by re-scoring item 3FEQ_13hungryeatanytime; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).I am always hungry enough to eat at any time.

Categorical

Re-scored item 3FEQ_13hungryeatanytime_P2

Phase 2 data. Derived by re-scoring item 3FEQ_13hungryeatanytime_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).I am always hungry enough to eat at any time. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

How often hungry

How often do you feel hungry?

Categorical

Often feel hungry frequency

Phase 2 data. How often do you feel hungry? 1 = Only at meal times; 2 = Sometimes between meals; 3 = Often between meals; 4 = Almost always;

Categorical

How often hungry_rescored

New in R8. derived from item 3FEQ_14oftenfeelhungry (assessed and cleaned only in the subset n=4810). Note all scores were left the same apart from -1 scores which were removed. How often do you feel hungry? Please note that rarely and never have been recoded as 1.

Categorical

Derived from 3FEQ_14oftenfeelhungry_P2

Phase 2 data. Derived from item 3FEQ_14oftenfeelhungry_P2 (assessed and cleaned only in the subset n = 4810). Note all scores were left the same apart from -1 scores which were removed. How often do you feel hungry? Please note that rarely and never have been recoded as 1. 1 = Only at meal times; 2 = Sometimes between meals; 3 = Often between meals; 4 = Almost always; -1 = missing data; -9 = questionnaire not completed;

Categorical

Avoid stocking up on tempting foods

Phase 2 data. How frequently do you avoid stocking up on tempting foods? 1 = Almost never; 2 = Seldom; 3 = Usually; 4 = Almost always;

Categorical

Avoid stocking up on tempting foods

How frequently do you avoid -stocking up?½ on tempting foods?

Categorical

Avoid stocking up on tempting foods_rescored

New in R8. derived from item 3FEQ_15stockinguptemptingfoods (assessed and cleaned only in the subset n=4810). Note all scores were left the same apart from -1 scores which were removed. How frequently do you avoid stocking up?½ on tempting foods?

Categorical

Derived from 3FEQ_15stockinguptemptingfoods_P2

Phase 2 data. Derived from item 3FEQ_15stockinguptemptingfoods_P2 (assessed and cleaned only in the subset n = 4810). Note all scores were left the same apart from -1 scores which were removed. How frequently do you avoid stocking up® on tempting foods? 1 = Almost never; 2 = Seldom; 3 = Usually; 4 = Almost always; -9 = questionnaire not completed;

Categorical

Conciously eat less than want

How likely are you to consciously eat less than you want?

Categorical

Consciously eat less food

Phase 2 data. How likely are you to consciously eat less than you want? 1 = Unlikely; 2 = Slightly likely; 3 = Moderately likely; 4 = Very likely;

Categorical

Conciously eat less than want_rescored

New in R8. derived from item 3FEQ_16consciouslyeatless (assessed and cleaned only in the subset n=4810). Note all scores were left the same apart from -1 scores which were removed.

Categorical

Derived from 3FEQ_16consciouslyeatless_P2

Phase 2 data. Derived from item 3FEQ_16consciouslyeatless_P2 (assessed and cleaned only in the subset n = 4810). Note all scores were left the same apart from -1 scores which were removed. 1 = Unlikely; 2 = Slightly likely; 3 = Moderately likely; 4 = Very likely; -9 = questionnaire not completed;

Categorical

Binge eating

Phase 2 data. Do you go on eating binges though you are not hungry? 1 = Never; 2 = Rarely; 3 = Sometimes; 4 = At least once a week;

Categorical

Eating binges when not hungry

Do you go on eating binges though you are not hungry?

Categorical

Eating binges when not hungry_rescored

New in R8. derived from item 3FEQ_17eatingbingeswhennothungry (assessed and cleaned only in the subset n=4810). Note all scores were left the same apart from -1 scores which were removed. Do you go on eating binges though you are not hungry?

Categorical

Derived from 3FEQ_17eatingbingeswhennothungry_P2

Phase 2 data. Derived from item 3FEQ_17eatingbingeswhennothungry_P2 (assessed and cleaned only in the subset n = 4810). Note all scores were left the same apart from -1 scores which were removed. Do you go on eating binges though you are not hungry? 1 = Never; 2 = Rarely; 3 = Sometimes; 4 = At least once a week; -1 = missing data; -9 = questionnaire not completed;

Categorical

How restrained when eating

On a scale of 1 to 8 with regards to restraint in eating what number would you give yourself? Where 1 means no restraint in eating and 8 means total restraint.

Categorical

Scale of restraint on eating

Phase 2 data. On a scale of 1 to 8 where 1 means no restraint in eating (eating whatever you want whenever you want it) and 8 means total restraint (constantly limiting food intake and never giving in); what number would you give yourself? 1 = 1 (no restraint in eating ie eating whatever you want and whenever you want it); 2 = 2; 3 = 34 = 4; 5 = 5; 6 = 6; 7 = 7; 8 = 8 (total restraint ie constantly limiting food and never giving in);

Categorical

How restrained when eating_rescored

New in R8. derived by re-scoring item 3FEQ_ 18scaleofrestraint; score of 1 or 2 as 1; 3 or 4 as 2; 5 or 6 as 3 and 7 or 8 as 4 (assessed and cleaned only in the subset n=4810). On a scale of 1 to 4 with regards to restraint in eating what number would you give yourself? Where 1 means no restraint in eating and 4 means total restraint.

Categorical

Re-scored item 3FEQ_ 18scaleofrestraint_P2

Phase 2 data. Derived by re-scoring item 3FEQ_ 18scaleofrestraint_P2; score of 1 or 2 as 1; 3 or 4 as 2; 5 or 6 as 3 and 7 or 8 as 4 (assessed and cleaned only in the subset n = 4810). On a scale of 1 to 4 with regards to restraint in eating what number would you give yourself? Where 1 means no restraint in eating and 4 means total restraint. 1 = 1; 2 = 2; 3 = 3; 4 = 4; -9 = questionnaire not completed; -1 = missing data (this also includes answers which were not consecutive);

Categorical

Smell of meat dfficult to keep from eating even after a meal

When I smell a sizzling steak or juicy piece of meat I find it very difficult to keep from eating even if I have just finished a meal.

Categorical

Smell of meat makes eating more

Phase 2 data. When I smell a sizzling steak or juicy piece of meat I find it very difficult to keep from eating even if I have just finished a meal. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = definitely false; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Smell of meat dfficult to keep from eating even after a meal_rescored

New in R8. Derived by re-scoring item 3FEQ_1smellofmeat score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810). When I smell a sizzling steak or juicy piece of meat I find it very difficult to keep from eating even if I have just finished a meal.

Categorical

Re-scored item 3FEQ_1smellofmeat_P2

Phase 2 data. Derived by re-scoring item 3FEQ_1smellofmeat_P2 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810). When I smell a sizzling steak or juicy piece of meat I find it very difficult to keep from eating even if I have just finished a meal. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Small helpings to control weight

I deliberately take small helpings as a means of controlling my weight.

Categorical

Small helpings to control weight

Phase 2 data. I deliberately take small helpings as a means of controlling my weight. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Small helpings to control weight_rescored

New in R8. derived by re-scoring item 3FEQ_2smallhelpings score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).I deliberately take small helpings as a means of controlling my weight.

Categorical

Re-scored item 3FEQ_2smallhelpings_P2

Phase 2 data. Derived by re-scoring item 3FEQ_2smallhelpings_P2 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).I deliberately take small helpings as a means of controlling my weight. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Eat when anxious

When I feel anxious I find myself eating.

Categorical

Eating when anxious

Phase 2 data. When I feel anxious; I find myself eating. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Eat when anxious_rescored

New in R8. derived by re-scoring item 3FEQ_3anxiousandeating score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).When I feel anxious I find myself eating.

Categorical

Re-scored item 3FEQ_3anxiousandeating_P2

Phase 2 data. Derived by re-scoring item 3FEQ_3anxiousandeating_P2 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).When I feel anxious I find myself eating. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Can't stop eating when started

Sometimes when I start eating I just can-t seem to stop.

Categorical

Cant stop eating

Phase 2 data. Sometimes when I start eating; I just can't seem to stop. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Can't stop eating when started_rescored

New in R8. derived by re-scoring item 3FEQ_4startedeatingcantstop score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).Sometimes when I start eating I just cannot seem to stop.

Categorical

Re-scored item 3FEQ_4startedeatingcantstop_P2

Phase 2 data. Derived by re-scoring item 3FEQ_4startedeatingcantstop_P2 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).Sometimes when I start eating I just cannot seem to stop. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Hungry enough to eat when with someone who is eating

Being with someone who is eating often makes me hungry enough to eat also.

Categorical

When with someone eat more

Phase 2 data. Being with someone who is eating often makes me hungry enough to eat also. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Hungry enough to eat when with someone who is eating_rescored

New in R8. derived by re-scoring item 3FEQ_5withsomeoneeating score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).Being with someone who is eating often makes me hungry enough to eat also.

Categorical

Re-scored item 3FEQ_5withsomeoneeating_P2

Phase 2 data. Derived by re-scoring item 3FEQ_5withsomeoneeating_P2 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).Being with someone who is eating often makes me hungry enough to eat also. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Overeat when feeling blue

When I feel blue I often overeat.

Categorical

Overeat when feeling down

Phase 2 data. When I feel blue; I often overeat. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Overeat when feeling blue_rescored

New in R8. derived by re-scoring item 3FEQ_6blueandovereating score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).When I feel blue I often overeat.

Categorical

Re-scored item 3FEQ_6blueandovereating_P2

Phase 2 data. Derived by re-scoring item 3FEQ_6blueandovereating_P2 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).When I feel blue I often overeat. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Eat delicacy straight away

When I see a real delicacy I often get so hungry that I have to eat right away.

Categorical

Delicacy eat right away

Phase 2 data. When I see a real delicacy; I often get so hungry that I have to eat right away. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Eat delicacy straight away_rescored

New in R8. derived by re-scoring item 3FEQ_7delicacyandeatingrightaway; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).When I see a real delicacy I often get so hungry that I have to eat right away.

Categorical

Re-scored item 3FEQ_7delicacyandeatingrightaway_P2

Phase 2 data. Derived by re-scoring item 3FEQ_7delicacyandeatingrightaway_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).When I see a real delicacy I often get so hungry that I have to eat right away. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Stomach feels like bottomless pit

I get so hungry that my stomach often seems like a bottomless pit.

Categorical

Hungry bottomless pit

Phase 2 data. I get so hungry that my stomach often seems like a bottomless pit. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Stomach feels like bottomless pit_rescored

New in R8. derived by re-scoring item 3FEQ_8hungrybottomlesspit; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).I get so hungry that my stomach often seems like a bottomless pit.

Categorical

Re-scored item 3FEQ_8hungrybottomlesspit_P2

Phase 2 data. Derived by re-scoring item 3FEQ_8hungrybottomlesspit_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).I get so hungry that my stomach often seems like a bottomless pit. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Stop eating before finished food on plate

I am always hungry so it is hard for me to stop eating before I finish the food on my plate.

Categorical

Hunger stops finish food on plate

Phase 2 data. I am always hungry so it is hard for me to stop eating before I finish the food on my plate. 1 = Definitely true; 2 = Mostly true; 3 = Mostly false; 4 = Definitely false;

Categorical

Stop eating before finished food on plate_rescored

New in R8. derived by re-scoring item 3FEQ_9finishfoodonplate; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).I am always hungry so it is hard for me to stop eating before I finish the food on my plate.

Categorical

Re-scored item 3FEQ_9finishfoodonplate_P2

Phase 2 data. Derived by re-scoring item 3FEQ_9finishfoodonplate_P2; score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n = 4810).I am always hungry so it is hard for me to stop eating before I finish the food on my plate. 1 = Definitely false; 2 = Mostly false; 3 = Mostly true; 4 = Definitely true (a decimal value was allowed for answers with a range); -1 = missing data; -9 = questionnaire not completed;

Categorical

Date finished to fill in e3FEQ qnr

Phase 2 data. Date the participant finished filling in the Electronic Online 3FEQ questionnaire.

Date

Date started to fill in e3FEQ qnr

Phase 2 data. Date the participant started to fill in the Electronic Online 3FEQ questionnaire.

Date

None

Phase 2 data. Data status variable to log user progress. Has the volunteer started filling in the eForm? 0 = no; 1 = yes;

Categorical

None

Phase 2 data. Data status variable to log user progress. Has the volunteer finished filling in the eForm? 0 = no; 1 = yes;

Categorical

e3FEQ questionnaire participant ID

Phase 2 data. Electronic 3FEQ questionnaire-specicifc participant ID number.

Text

e3FEQ questionnaire ID number

Phase 2 data. Electronic 3FEQ questionnaire ID number for version control.

Text

e3FEQ questionnaire ID name

Phase 2 data. Electronic 3FEQ questionnaire ID name for version control.

Text

Study phase e3FEQ questionnaire

Phase 2 data. Study phase the Electronic 3FEQ questionnaire was used for.

Text

Time finished to fill in e3FEQ qnr

Phase 2 data. Time the participant finished filling in the Electronic Online3FEQ questionnaire.

Time

Time started to fill in e3FEQ qnr

Phase 2 data. Time the participant started to fill in the Electronic Online 3FEQ questionnaire.

Time

None

Phase 2 data. Please enter your 3-digit pin (on electronic form).

Integer

e3FEQ questionnaire version date

Phase 2 data. Electronic 3FEQ questionnaire version date for version control.

Text

e3FEQ questionnaire version no

Phase 2 data. Electronic 3FEQ questionnaire version number for version control.

Integer

e3FEQ qnr web form version no

Phase 2 data. Electronic 3FEQ questionnaire web form version number for version control.

Text

Emotional eating

New in R8. raw score for Emotional Eating subscale of TFEQ-18 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).Data derived by calculating (mean of 3FEQ_Z_Rescored items where Z=3; 6 or10)*3.

Real

None

Phase 2 data.

Categorical

Emotional eating

New in R8. Score for Emotional Eating subscale of 3FEQ_EmotionalRAW on a scale of 0-100 [(raw score - lowest possible raw score)/possible raw score range) * 100] (assessed and cleaned only in the subset n=4810).Derived by calculating ((3FEQ_EmotionalRAW-3)/9)*100.

Categorical

Score for emotional eating

Phase 2 data. Score for Emotional Eating subscale of 3FEQ_EmotionalRAW_P2 on a scale of 0-100 (raw score - lowest possible raw score)/possible raw score range) * 100 (assessed and cleaned only in the subset n = 4810).Derived by calculating ((3FEQ_EmotionalRAW-3)/9)*100. -1 = missing data; number = score; -9 = questionnaire not completed;

Categorical

Three-Factor Eating Questionnaire version

Three-Factor Eating Questionnaire version number.

Categorical

Restrained eating

New in R8. Score for Restrained Eating subscale of 3FEQ_RestraintRAW on a scale of 0-100 (assessed and cleaned only in the subset n=4810).Derived by calculating [(raw score - lowest possible raw score)/possible raw score range) * 100] ((3FEQ_RestraintRAW-6)/18)*100.

Real

Score for restrained eating

Phase 2 data. Score for Restrained Eating subscale of 3FEQ_RestraintRAW_P2 on a scale of 0-100 (assessed and cleaned only in the subset n = 4810).Derived by calculating (raw score - lowest possible raw score)/possible raw score range) * 100 ((3FEQ_RestraintRAW-6)/18)*100. -1 = missing data; -9 = questionnaire not completed;

Categorical

Restrained eating

New in R8. raw score for Restrained Eating subscale of TFEQ-18 (assessed and cleaned only in the subset n=4810).Data derived by calculating (mean of 3FEQ_X_Rescored items where X=2; 11; 12; 15; 16 or 18)*6.

Real

None

Phase 2 data.

Categorical

Uncontrolled eating

New in R8. raw score Uncontrolled Eating subscale of TFEQ-18 score of 1 as 4; 2 as 3; 3 as 2 and 4 as 1 (assessed and cleaned only in the subset n=4810).Data derived by calculating (mean of 3FEQ_Y_Rescored items where Y = 1; 4; 5; 7; 8; 9; 13; 14 or 17)*9.

Real

None

Phase 2 data.

Categorical

Uncontrolled eating

New in R8. Score for Uncontrolled Eating subscale of 3FEQ_UncontrolledRAW on a scale of 0-100 [(raw score - lowest possible raw score)/possible raw score range) * 100] (assessed and cleaned only in the subset n=4810).Derived by calculating ((3FEQ_UncontrolledRAW-9)/27)*100.

Categorical

Score for uncontrolled eating

Phase 2 data. Score for Uncontrolled Eating subscale of 3FEQ_UncontrolledRAW on a scale of 0-100 (raw score - lowest possible raw score)/possible raw score range) * 100 (assessed and cleaned only in the subset n = 4810).Derived by calculating ((3FEQ_UncontrolledRAW-9)/27)*100. -1 = missing data; number = score; -9 = questionnaire not completed;

Categorical

Visible fat

What did you do with the visible fat on your meat? After cleaning this variable is renamed as VISIBLE_FAT which is then used by the FETA program for analysis.

Categorical

Visible fat ERROR CODES CLEANED

What did you do with the visible fat on your meat? After cleaning this variable is renamed as VISIBLE_FAT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding down to previous whole number. This question asks about the consumption of visible fat on meat (beef pork lamb etc). Variable name prior to Release 7 is A10VisibleFat_ADWN.

Categorical

Visible fat

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads What did you do with the visible fat on your meat? 1 = Ate most of the fat; 2 = Ate some of the fat; 3 = Ate as little as possible; 4 = Did not eat meat; -1 = left blank; -5 = more than one selected;

Categorical

Grilled frequency

How often did you eat grilled or roast meat? If a decimal was provided Data entry has been told to round down if it is < 0.5 or up if it is >= 0.5. Not mapped to FETA variable since not used by FETA.

Categorical

Grilled frequency ERROR CODES CLEANED

How often did you eat grilled or roast meat? If a decimal was provided Data entry has been told to round down if it is < 0.5 or up if it is >= 0.5. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up where values are >/0.5 and down if value is <0.5. Variable name prior to Release 7 is A11GrilledFreq_ANAT.

Categorical

Grilled frequency

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How often did you eat grilled or roast meat

Categorical

Cooked

How well cooked did you usually have grilled or roast meat? Not mapped to FETA variable since not used by FETA.

Categorical

Cooked ERROR CODES CLEANED

How well cooked did you usually have grilled or roast meat? Not mapped to FETA variable since not used by FETA. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding down to previous whole number. Variable name prior to Release 7 is A12Cooked_ADWN.

Categorical

None

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How well cooked did you usually have grilled or roast meat? 1 = Well done/dark brown; 2 = Medium; 3 = Lightly cooked/rare; 4 = Did not eat meat; -1 = left blank; -5 = more than one selected;

Categorical

Cooking salt use

How often did you add salt to food while cooking? Not mapped to FETA variable since not used by FETA.

Categorical

Cooking salt use ERROR CODES CLEANED

How often did you add salt to food while cooking? Not mapped to FETA variable since not used by FETA. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding down to previous whole number. Variable name prior to Release 7 is A13CookingSalt_ADWN.

Categorical

Cooking salt use

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How often did you add salt to food while cooking? 1 = Always; 2 = Usually; 3 = Sometimes; 4 = Rarely; -1 = left blank; -5 = more than one selected;

Categorical

Table salt use

How often did you add salt to any food at the table? Not mapped to FETA variable since not used by FETA.

Categorical

Table salt use ERROR CODES CLEANED

How often did you add salt to any food at the table? Not mapped to FETA variable since not used by FETA. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding down to previous whole number. Variable name prior to Release 7 is A14TableSalt_ADWN.

Categorical

Table salt use

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How often did you add salt to any food at the table? 5 = Never; -1 = left blank; -5 = more than one selected;

Categorical

Salt substitute use

Did you regularly use a salt substitute? Not mapped to FETA variable since not used by FETA.

Categorical

Salt substitute used

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Did you regularly use a salt substitute? 2 = Yes; 3 = No; -1 = left blank; -5 = more than one selected;

Categorical

Brand of salt substitute used

Did you regularly use a salt substitute? Not mapped to FETA variable since not used by FETA. If yes (regularly use salt substitute) which brand of salt substitute? Not mapped to FETA variable since not used by FETA

Text

Brand of salt subsitute

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Brand of salt substitute

Text

Supplements use

Have you taken any vitamins minerals fish oils fibre or other food supplements during the past year? Not mapped to FETA variable since not used by FETA.

Categorical

Supplements use

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Have you taken any vitamins during the past year? 2 = Yes; 3 = No; -1 = left blank; -5 = more than one selected;

Categorical

Brand of vitamin supplement 1

If yes list name and Brand of vitamin supplement 1. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 1

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 1

If yes list Frequency of vitamin supplement 1. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 1

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 2

If yes list name and Brand of vitamin supplement 2. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 2

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 2

If yes list Frequency of vitamin supplement 2. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 2

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 3

If yes list name and Brand of vitamin supplement 3. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 3

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 3

If yes list Frequency of vitamin supplement 3. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 3

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 4

If yes list name and Brand of vitamin supplement 4. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 4

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 4

If yes list Frequency of vitamin supplement 4. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 4

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 5

If yes list name and Brand of vitamin supplement 5. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 5

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 5

If yes list Frequency of vitamin supplement 5. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 5

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 6

If yes list name and Brand of vitamin supplement 6. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 6

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 6

If yes list Frequency of vitamin supplement 6. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 6

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 7

If yes list name and Brand of vitamin supplement 7. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 7

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 7

If yes list Frequency of vitamin supplement 7. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 7

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Brand of vitamin supplement 8

If yes list name and Brand of vitamin supplement 8. Not mapped to FETA variable since not used by FETA

Text

Brand of vitamin supplement 8

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Name and brand of supplements

Text

Frequency of vitamin supplement 8

If yes list Frequency of vitamin supplement 8. Not mapped to FETA variable since not used by FETA

Text

Frequency of vitamin supplement 8

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Frequency of supplements

Text

Name of other food 1 eaten more than once per week

If yes please list Name of other food 1 eaten more than once per week. Not mapped to FETA variable since not used by FETA.

Categorical

Name of other food 1 eaten more than once per week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Text

Number of times food 1 eaten each week

If yes please list Number of times food 1 eaten each week. Not mapped to FETA variable since not used by FETA.

Categorical

Number of times food 1 eaten each week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Usual serving size for food 1

If yes please list Usual serving size for food 1. Not mapped to FETA variable since not used by FETA.

Categorical

Usual serving size for food 1

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Name of other food 2 eaten

If yes please list Name of other food 2 eaten more than once per week. Not mapped to FETA variable since not used by FETA.

Categorical

Name of other food 2 eaten more than once per week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Text

Number of times food 2 eaten each week

If yes please list Number of times food 2 eaten each week. Not mapped to FETA variable since not used by FETA.

Categorical

Number of times food 2 eaten each week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Usual serving size for food 2

If yes please list Usual serving size for food 2. Not mapped to FETA variable since not used by FETA.

Categorical

Usual serving size for food 2

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Name of other food 3 eaten

If yes please list Name of other food 3 eaten more than once per week. Not mapped to FETA variable since not used by FETA.

Categorical

Name of other food 3 eaten more than once per week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Text

Number of times food 3 eaten each week

If yes please list Number of times food 3 eaten each week. Not mapped to FETA variable since not used by FETA.

Categorical

Number of times food 3 eaten each week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Usual serving size for food 3

If yes please list Usual serving size for food 3. Not mapped to FETA variable since not used by FETA.

Categorical

Usual serving size for food 3

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Name of other food 4 eaten

If yes please list Name of other food 4 eaten more than once per week. Not mapped to FETA variable since not used by FETA.

Categorical

Name of other food 4 eaten

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Text

Number of times food 4 eaten each week

If yes please list Number of times food 4 eaten each week. Not mapped to FETA variable since not used by FETA.

Categorical

Number of times food 4 eaten each week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Usual serving size for food 4

If yes please list Usual serving size for food 4. Not mapped to FETA variable since not used by FETA.

Categorical

Usual serving size for food 4

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Name of other food 5 eaten

If yes please list Name of other food 5 eaten more than once per week. Not mapped to FETA variable since not used by FETA.

Categorical

Name of other food 5 eaten

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Text

Number of times food 5 eaten each week

If yes please list Number of times food 5 eaten each week. Not mapped to FETA variable since not used by FETA.

Categorical

Number of times food 5 eaten each week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Usual serving size for food 5

If yes please list Usual serving size for food 5. Not mapped to FETA variable since not used by FETA.

Categorical

Usual serving size for food 5

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Name of other food 6 eaten

If yes please list Name of other food 6 eaten more than once per week. Not mapped to FETA variable since not used by FETA.

Categorical

Name of other food 6 eaten

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Text

Number of times food 6 eaten each week

If yes please list Number of times food 6 eaten each week. Not mapped to FETA variable since not used by FETA.

Categorical

Number of times food 6 eaten each week

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Usual serving size for food 6

If yes please list Usual serving size for food 6. Not mapped to FETA variable since not used by FETA.

Categorical

Usual serving size for food 6

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Other foods eaten

Categorical

Other foods eaten >1 per week

Are there any other foods which you ate more than once a week in the last year? Not mapped to FETA variable since not used by FETA.

Categorical

Other foods eaten >1 per week

Phase 2 data.

Text

Milk used

What type of milk did you most often use? Data translated manually into new variable MILK_FOOD using the milk_Lookuplist_161111. This new variable was then used by FETA.

Categorical

Other milk used

What type of milk did you most often use? - Other Milks in the last year. Data translated manually into new variable MILK_FOOD using the milk_Lookuplist_161111. This new variable was then used by FETA.

Text

Other milk used

Phase 2 data.

Text

Milk amount

How much milk did you drink each day including milk with tea coffee cereals etc in the last year? Data translated manually into new variable MILK_FREQUENCY which was then used by FETA.

Categorical

Milk amount

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How much milk did you drink each day including milk with tea coffee cereals etc? 1 = None; 2 = Quarter of a pint; 3 = Half a pint; 4 = Three quarters of a pint; 5 = One pint; 6 = More than one pint; -1 = left blank; -5 = more than one selected;

Categorical

Breakfast Cereal

Did you usually eat breakfast cereal (excluding porridge and ready break mentioned earlier) in the last year? Data translated manually into new variable CEREAL_FOOD using the cereal_Lookuplist_130812. This new variable was then used by FETA.

Categorical

Breakfast Cereal

Phase 2 data.

Text

Brand breakfast cereal 1

If yes which type of breakfast cereal inclusing muesli did you usually eat? Brand of breakfast cereal 1. Data translated manually into new variable CEREAL_FOOD using the cereal_Lookuplist_130812. This new variable was then used by FETA.

Text

Brand breakfast cereal 1

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Brand of breakfast cereal.

Text

Type breakfast cereal 1

If yes which type of breakfast cereal inclusing muesli did you usually eat? Type of breakfast cereal 1. Data translated manually into new variable CEREAL_FOOD using the cereal_Lookuplist_130812. This new variable was then used by FETA.

Text

Type breakfast cereal 1

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Type of breakfast cereal.

Text

Brand breakfast cereal 2

If yes which type of breakfast cereal inclusing muesli did you usually eat? Brand of breakfast cereal 2. Data translated manually into new variable CEREAL_FOOD using the cereal_Lookuplist_130812. This new variable was then used by FETA.

Text

Brand breakfast cereal 2

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Brand of breakfast cereal.

Text

Type breakfast cereal 2

If yes which type of breakfast cereal inclusing muesli did you usually eat? Type of breakfast cereal 2. Data translated manually into new variable CEREAL_FOOD using the cereal_Lookuplist_130812. This new variable was then used by FETA.

Text

Type breakfast cereal 2

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Type of breakfast cereal.

Text

Fat used for frying

What kind of fat did you most often use for frying roasting grilling etc in the last year? Select one only. Data translated manually into new variable FAT_FRYING_FOOD using the fats_Lookuplist_161111. This new variable was then used by FETA.

Categorical

Fat used for frying

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads What kind of fat did you most often use for frying roasting grilling etc

Categorical

Other frying fat

If you used vegetable oil please give type eg. Corn sunflower. Data translated manually into new variable FAT_FRYING_FOOD using the fats_Lookuplist_161111. This new variable was then used by FETA.

Text

Other frying fat

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads If you used vegetable oil please give type eg. corn sun?ower

Text

Fat used for baking

What kind of fat did you most often use for baking cakes etc? select one only. Data translated manually into new variable FAT_BAKING_FOOD using the fats_Lookuplist_161111. This new variable was then used by FETA.

Categorical

Fat used for baking

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads What kind of fat did you most often use for baking cakes etc

Categorical

Other baking fat

If you used margarine please give name or type eg Flora Stork. Data translated manually into new variable FAT_BAKING_FOOD using the fats_Lookuplist_161111. This new variable was then used by FETA.

Text

Other baking fat

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads If you used vegetable oil please give type eg. corn sun?ower

Text

Eat home fried food

How often did you eat food that was fried at home? Not mapped to FETA variable since not used by FETA.

Categorical

Eat home fried food ERROR CODES CLEANED

How often did you eat food that was fried at home? Not mapped to FETA variable since not used by FETA. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding down to previous whole number. Variable name for release prior to Release 7 is A8HomeFried_ADWN.

Categorical

Eat home fried food

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How often did you eat food that was fried at home

Categorical

Eat away fried food

How often did you eat fried food away from home? Not mapped to FETA variable since not used by FETA.

Categorical

Eat away fried food ERROR CODES CLEANED

How often did you eat fried food away from home? Not mapped to FETA variable since not used by FETA. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding down to previous whole number. Variable name for release prior to Release 7 is A9AwayFried_ADWN.

Categorical

Eat away fried food

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads How often did you eat food that was fried at home

Categorical

OLINK assay AARSD1

Phase 1 OLINK assay data for target AARSD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ABHD14B

Phase 1 OLINK assay data for target ABHD14B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ABL1

Phase 1 OLINK assay data for target ABL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ACAN

Phase 1 OLINK assay data for target ACAN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Acc_No

Accelerometer serial number

Text

General cmnts wrist acc day1

Phase 2 data. General comments (wrist accelerometer) on day 1 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

General cmnts wrist acc day2

Phase 2 data. General comments (wrist accelerometer) on day 2 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

General cmnts wrist acc day3

Phase 2 data. General comments (wrist accelerometer) on day 3 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

General cmnts wrist acc day4

Phase 2 data. General comments (wrist accelerometer) on day 4 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

General cmnts wrist acc day5

Phase 2 data. General comments (wrist accelerometer) on day 5 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

General cmnts wrist acc day6

Phase 2 data. General comments (wrist accelerometer) on day 6 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

General cmnts wrist acc day7

Phase 2 data. General comments (wrist accelerometer) on day 7 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -2 = no data entered AND wrist acc column header crossed through; -8 = text illegible

Text

Reason take off wrist acc day1

Phase 2 data. Reason for taking off (wrist accelerometer) on day 1 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off wrist acc day2

Phase 2 data. Reason for taking off (wrist accelerometer) on day 2 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off wrist acc day3

Phase 2 data. Reason for taking off (wrist accelerometer) on day 3 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off wrist acc day4

Phase 2 data. Reason for taking off (wrist accelerometer) on day 4 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off wrist acc day5

Phase 2 data. Reason for taking off (wrist accelerometer) on day 5 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off wrist acc day6

Phase 2 data. Reason for taking off (wrist accelerometer) on day 6 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off wrist acc day7

Phase 2 data. Reason for taking off (wrist accelerometer) on day 7 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Time wrist acc taken off day1

Phase 2 data. What time did you take off the wrist accelerometer on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc taken off day2

Phase 2 data. What time did you take off the wrist accelerometer on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc taken off day3

Phase 2 data. What time did you take off the wrist accelerometer on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc taken off day4

Phase 2 data. What time did you take off the wrist accelerometer on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc taken off day5

Phase 2 data. What time did you take off the wrist accelerometer on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc taken off day6

Phase 2 data. What time did you take off the wrist accelerometer on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc taken off day7

Phase 2 data. What time did you take off the wrist accelerometer on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Final date Wrist monitor taken off

Phase 2 data. Date of Final time taken off wrist accelerometer monitor dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Final time Wrist monitor taken off

Phase 2 data. Date of Final time taken off wrist accelerometer monitor (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Date

Time wrist acc put back on day1

Phase 2 data. What time did you put the wrist accelerometer back on on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc put back on day2

Phase 2 data. What time did you put the wrist accelerometer back on on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc put back on day3

Phase 2 data. What time did you put the wrist accelerometer back on on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc put back on day4

Phase 2 data. What time did you put the wrist accelerometer back on on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc put back on day5

Phase 2 data. What time did you put the wrist accelerometer back on on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc put back on day6

Phase 2 data. What time did you put the wrist accelerometer back on on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time wrist acc put back on day7

Phase 2 data. What time did you put the wrist accelerometer back on on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

OLINK assay ACE2

Phase 1 OLINK assay data for target ACE2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

ace_inhibitor

Phase 2 data. Binary variable indicating whether a drug from the ace inhibitor class was prescribed. 0: No 1: Yes

Categorical

AcOrn_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable AcOrn_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_023.

Real

OLINK assay ACP6

Phase 1 OLINK assay data for target ACP6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cln variable: Active comp games hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Active computer games. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Active computer games hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Active computer games. -1 = left blank. DO NOT USE THIS VARIABLE. Use ActiveComputerHr_CLEAN_P2 instead.

Real

Cln variable: Active comp games min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Active computer games. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Active computer games min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Active computer games. -1 = left blank. DO NOT USE THIS VARIABLE. Use ActiveComputerMin_CLEAN_P2 instead.

Real

Cln variable: Active computer games

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Active computer games. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed;

Categorical

Active computer games

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Active computer games. PAPER FORMS ONLY: Data entered using data entry template with 1-3-4-5-6-7-8 codes. 1 = none; 3 = once in last 4 wks; 4 = 2-3 times in last 4 wks; 5 = once a week; 6 = 2-3 times a wk; 7 = 4-5 times a week; 8 = every day; -1 = left blank; -5 = more than 1 selected; ELECTRONIC FORMS: 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; DO NOT USE THIS VARIABLE. Use ActiveComputer_CLEAN_P2 instead.

Real

Active computer games

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Active computer games. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

ActivPALPosition

Position on body where ActivPAL was placed to perform the measurement

Text

ActivPAL_No

Serial number of the ActivPAL

Text

ACTMETS

Total activity energy expenditure discounting resting [net METhrs/d]

Real

Total AEE discounting resting

Phase 2 data. Derived with method 2. Total activity energy expenditure discounting resting net METhrs/d

Real

ACTMETS_w_UNACCtime

Activity EE incl AEE for unaccounted time for active getting about [net METhrs/d]

Real

ACTMETS inc of unaccounted hrs

Phase 2 data. Derived with method 2. Activity EE inc AEE for unaccounted time for active getting about net METhrs/d

Real

Cln variable: Other activity 1 hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other activity 1. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other activity 1 hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other activity 1. -1 = left blank. DO NOT USE THIS VARIABLE. Use Act_Other1Hr_CLEAN_P2 instead.

Real

Cln variable: Other activity 1 min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other activity 1. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other activity 1 min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other activity 1. -1 = left blank. DO NOT USE THIS VARIABLE. Use Act_Other1Min_CLEAN_P2 instead.

Real

Name of other acitivity

Phase 2 data. Name of Other activity 1. -1 = left blank;

Text

Cln variable: Other activity 1

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other activity 1 (with no similarity to any listed). Error codes cleaned by DMT; -10 error codes cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank;

Categorical

Other activity 1

Phase 2 data. Questionnaire reads D14. You should try and classify all the activities you do in the list above. If however you do activities which have no similarity with any of those listed above please mention here. Other activity 1. PAPER FORMS ONLY: Data entered using data entry template with 1-3-4-5-6-7-8 codes. 1 = none; 3 = once in last 4 wks; 4 = 2-3 times in last 4 wks; 5 = once a week; 6 = 2-3 times a wk; 7 = 4-5 times a week; 8 = every day; -1 = left blank; -5 = more than 1 selected; ELECTRONIC FORMS: 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; DO NOT USE THIS VARIABLE. Use Act_Other1_CLEAN_P2 instead.

Categorical

Other activity 1

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other activity 1 (with no similarity to any listed). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Cln variable: Other activity 2 hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other activity 2. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other activity 2 hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other activity 2. -1 = left blank. DO NOT USE THIS VARIABLE. Use Act_Other2Hr_CLEAN_P2 instead.

Real

Cln variable: Other activity 2 min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other activity 2. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other activity 2 min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other activity 2. -1 = left blank. DO NOT USE THIS VARIABLE. Use Act_Other2Min_CLEAN_P2 instead.

Real

Name of other acitivity

Phase 2 data. Name of Other activity 2. -1 = left blank;

Text

Cln variable: Other activity 2

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other activity 1 (with no similarity to any listed). Error codes cleaned by DMT; -10 error codes cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank;

Categorical

Other activity 2

Phase 2 data. Questionnaire reads D14. You should try and classify all the activities you do in the list above. If however you do activities which have no similarity with any of those listed above please mention here. Other activity 2. PAPER FORMS ONLY: Data entered using data entry template with 1-3-4-5-6-7-8 codes. 1 = none; 3 = once in last 4 wks; 4 = 2-3 times in last 4 wks; 5 = once a week; 6 = 2-3 times a wk; 7 = 4-5 times a week; 8 = every day; -1 = left blank; -5 = more than 1 selected; ELECTRONIC FORMS: 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; DO NOT USE THIS VARIABLE. Use Act_Other2_CLEAN_P2 instead.

Categorical

Other activity 2

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other activity 2 (with no similarity to any listed). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Other Sports

Phase 2 data. Asked on electronic form only. Hence where left blank data could still exist for Act_Other1Text_P2 and Act_Other2Text_P2 as it has come from the paper questionnaire. 1 = yes; 2 = no; blank or = data not collected so instead use Act_Other1Text_P2 and Act_Other2Text_P2;

Categorical

Date of scan

Date of test/scan

Date

DEXA operator

DEXA operator. Entered by operator before DEXA scan

Categorical

Overall total bone mineral content in grams

New in R7. Overall total bone mass (bone mineral content) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Overall total bone mineral content

Phase 2 data. Overall total bone mass (bone mineral content) in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall total bone mineral content in grams

Overall total bone mass (bone mineral content) in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall total bone mineral content

Phase 2 data. Overall total bone mass (bone mineral content) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD04i_iDEXA_Total_bone_mass_P2); -9 = Missing data;

Real

Overall total tissue fat mass in grams

New in R7. Overall total fat mass (tissue fat mass) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Overall total tissue fat mass

Phase 2 data. Overall total fat mass (tissue fat mass) in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall total tissue fat mass in grams

Overall total fat mass(tissue fat mass) in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall total tissue fat mass

Phase 2 data. Overall total fat mass(tissue fat mass) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD05i_iDEXA_Total_fat_mass_P2AD05i_iDEXA_Total_fat_mass_P2); -9 = Missing data;

Real

Overall total tissue lean mass in grams

New in R7. Overall total lean mass (tissue lean mass) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Overall total tissue lean mass

Phase 2 data. Overall total lean mass (tissue lean mass) in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall total tissue lean mass in grams

Overall total lean mass(tissue lean mass) in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall total tissue lean mass

Phase 2 data. Overall total lean mass (tissue lean mass) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD06i_iDEXA_Total_lean_mass_P2); -9 = Missing data;

Real

Overall left bone mineral content in grams

New in R7. Overall left bone mineral content in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Overall left bone mineral content

Phase 2 data. Overall left bone mineral content in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall left bone mineral content in grams

Overall left bone mineral content in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall left bone mineral content

Phase 2 data. Overall left bone mineral content in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD07i_iDEXA_Left_total_bone_mass_P2); -9 = Missing data;

Real

Overall left tissue fat mass in grams

New in R7. Overall left tissue fat mass in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Overall left tissue fat mass

Phase 2 data. Overall left tissue fat mass in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall left tissue fat mass in grams

Overall left tissue fat mass in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall left tissue fat mass

Phase 2 data. Overall left tissue fat mass in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD08i_iDEXA_Left_total_fat_mass_P2); -9 = Missing data;

Real

Overall left tissue lean mass in grams

New in R7. Overall left tissue lean mass in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Overall left tissue lean mass

Phase 2 data. Overall left tissue lean mass in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall left tissue lean mass in grams

Overall left tissue lean mass in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall left tissue lean mass

Phase 2 data. Overall left tissue lean mass in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD09i_iDEXA_Left_total_lean_mass_P2); -9 = Missing data;

Real

Overall right bone mineral content in grams

New in R7. Overall right bone mineral content in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Overall right bone mineral content

Phase 2 data. Overall right bone mineral content in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall right bone mineral content in grams

Overall right bone mineral content in grams. Raw data from DEXA Lunar Prodigy

Real

Overall right bone mineral content

Phase 2 data. Overall right bone mineral content in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD10i_iDEXA_Right_total_bone_mass_P2); -9 = Missing data;

Real

Overall right tissue fat mass in grams

New in R7. Overall right tissue fat mass in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Overall right tissue fat mass

Phase 2 data. Overall right tissue fat mass in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall right tissue fat mass in grams

Overall right tissue fat mass in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall right tissue fat mass

Phase 2 data. Overall right tissue fat mass in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD11i_iDEXA_Right_total_fat_mass_P2); -9 = Missing data;

Real

Overall right tissue lean mass in grams

New in R7. Overall right tissue lean mass in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Overall right tissue lean mass

Phase 2 data. Overall right tissue lean mass in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Overall right tissue lean mass in grams

Overall right tissue lean mass in grams. Raw data from DEXA Lunar Prodigy.

Real

Overall right tissue lean mass

Phase 2 data. Overall right tissue lean mass in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD12i_iDEXA_Right_total_lean_mass_P2); -9 = Missing data;

Real

Total bone mineral content of two arms in grams

New in R7. Total bone mineral content of two arms in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Total bone mineral content of 2 arms

Phase 2 data. Total bone mineral content of two arms in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Total bone mineral content of two arms in grams

Total bone mineral content of two arms in grams. Raw data from DEXA Lunar Prodigy.

Real

Total bone mineral content of 2arms

Phase 2 data. Total bone mineral content of two arms in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD13i_iDEXA_arms_bone_mass_P2); -9 = Missing data;

Real

Total tissue fat mass of two arms in grams

New in R7. Total tissue fat mass of two arms in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Total tissue fat mass of 2 arms

Phase 2 data. Total tissue fat mass of two arms in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Total tissue fat mass of two arms in grams

Total tissue fat mass of two arms in grams. Raw data from DEXA Lunar Prodigy.

Real

Total tissue fat mass of two arms

Phase 2 data. Total tissue fat mass of two arms in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD14i_iDEXA_arms_fat_mass_P2); -9 = Missing data;

Real

Total tissue lean mass of two arms in grams

New in R7. Total tissue lean mass of two arms in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Total tissue lean mass of 2 arms

Phase 2 data. Total tissue lean mass of two arms in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Total tissue lean mass of two arms in grams

Total tissue lean mass of two arms in grams. Raw data from DEXA Lunar Prodigy.

Real

Total tissue lean mass of two arms

Phase 2 data. Total tissue lean mass of two arms in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD15i_iDEXA_arms_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content in left arm in grams

New in R7. Bone mineral content in left arm in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Bone mineral content in left arm

Phase 2 data. Bone mineral content in left arm in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content in left arm in grams

Bone mineral content in left arm in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content in left arm

Phase 2 data. Bone mineral content in left arm in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD16i_iDEXA_Left_arm_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass in left arm in grams

New in R7. Tissue fat mass in left arm in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Tissue fat mass in left arm

Phase 2 data. Tissue fat mass in left arm in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass in left arm in grams

tissue fat mass in left arm in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass in left arm

Phase 2 data. tissue fat mass in left arm in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD17i_iDEXA_Left_arm_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass in left arm in grams

New in R7. Tissue lean mass in left arm in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Indirectly with sum of mass. Total mass.

Real

Tissue lean mass in left arm

Phase 2 data. Tissue lean mass in left arm in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass in left arm in grams

tissue lean mass in left arm in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass in left arm

Phase 2 data. tissue lean mass in left arm in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD18i_iDEXA_Left_arm_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content in right arm in grams

New in R7. Bone mineral content in right arm in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content in right arm

Phase 2 data. Bone mineral content in right arm in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content in right arm in grams

bone mineral content in right arm in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content in right arm

Phase 2 data. bone mineral content in right arm in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD19i_iDEXA_Right_arm_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass in right arm in grams

New in R7. Tissue fat mass in right arm in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass in right arm

Phase 2 data. Tissue fat mass in right arm in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass in right arm in grams

tissue fat mass in right arm in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass in right arm

Phase 2 data. tissue fat mass in right arm in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD20i_iDEXA_Right_arm_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass in right arm in grams

New in R7. Tissue lean mass in right arm in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass in right arm

Phase 2 data. Tissue lean mass in right arm in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass in right arm in grams

tissue lean mass in right arm in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass in right arm

Phase 2 data. tissue lean mass in right arm in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD21i_iDEXA_Right_arm_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content of trunk torso & pelvis in grams

New in R7. Bone mineral content of trunk (torso & pelvis) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content trunk torso pelvis

Phase 2 data. Bone mineral content of trunk (torso and pelvis) in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content of trunk in grams

Bone mineral content of trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content of trunk

Phase 2 data. Bone mineral content of trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD22i_iDEXA_Trunk_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of trunk torso & pelvis in grams

New in R7. Tissue fat mass of trunk (torso & pelvis) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass trunk torso pelvis

Phase 2 data. Tissue fat mass of trunk (torso and pelvis) in grams for Phase 2 data. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of trunk

Tissue fat mass of trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of trunk

Phase 2 data. Tissue fat mass of trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD23i_iDEXA_Trunk_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of trunk torso & pelvis in grams

New in R7. Tissue lean mass of trunk (torso & pelvis) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass trunk torso pelvis

Phase 2 data. Tissue lean mass of trunk (torso and pelvis) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of trunk

Tissue lean mass of trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of trunk

Phase 2 data. Tissue lean mass of trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD24i_iDEXA_Trunk_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content of left trunk in grams

New in R7. Bone mineral content of left trunk in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content left trunk

Phase 2 data. Bone mineral content of left trunk in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content of left trunk

bone mineral content of left trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content of left trunk

Phase 2 data. bone mineral content of left trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD25i_iDEXA_Left_trunk_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of left trunk in grams

New in R7. Tissue fat mass of left trunk in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass left trunk

Phase 2 data. Tissue fat mass of left trunk in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of left trunk

Tissue fat mass of left trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of left trunk

Phase 2 data. Tissue fat mass of left trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD26i_iDEXA_Left_trunk_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of left trunk in grams

New in R7. Tissue lean mass of left trunk in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass of left trunk

Phase 2 data. Tissue lean mass of left trunk in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of left trunk

Tissue lean mass of left trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of left trunk

Phase 2 data. Tissue lean mass of left trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD27i_iDEXA_Left_trunk_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content of right trunk in grams

New in R7. Bone mineral content of right trunk in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content right trunk

Phase 2 data. Bone mineral content of right trunk in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content of right trunk

Bone mineral content of right trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content of right trunk

Phase 2 data. Bone mineral content of right trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD28i_iDEXA_Right_trunk_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of right trunk in grams

New in R7. Tissue fat mass of right trunk in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass of right trunk

Phase 2 data. Tissue fat mass of right trunk in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of right trunk

Tissue fat mass of right trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of right trunk

Phase 2 data. Tissue fat mass of right trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD29i_iDEXA_Right_trunk_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of right trunk in grams

New in R7. Tissue lean mass of right trunk in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass of right trunk

Phase 2 data. Tissue lean mass of right trunk in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of right trunk

Tissue lean mass of right trunk in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of right trunk

Phase 2 data. Tissue lean mass of right trunk in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD30i_iDEXA_Right_trunk_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content of android waist area in grams

New in R7. Bone mineral content of android (waist area) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content android waist area

Phase 2 data. Bone mineral content of android (waist area) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content of android area

Bone mineral content of android(waist area) in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content android area

Phase 2 data. Bone mineral content of android(waist area) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD31i_iDEXA_Android_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of android waist area in grams

New in R7. tissue fat mass of android (waist area) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass android waist area

Phase 2 data. tissue fat mass of android (waist area) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral mass of android area

bone mineral mass of android(waist area) in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral mass of android area

Phase 2 data. bone mineral mass of android(waist area) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD32i_iDEXA_Android_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of android waist area in grams

New in R7. Tissue lean mass of android (waist area) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass android waist area

Phase 2 data. Tissue lean mass of android (waist area) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of android area

tissue lean mass of android(waist area) in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of android area

Phase 2 data. tissue lean mass of android(waist area) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD33i_iDEXA_Android_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content of gynoid Hip area in grams

New in R7. Bone mineral content of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content gynoid Hip area

Phase 2 data. Bone mineral content of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content of gynoid area

Bone mineral content of gynoid(Hip area) in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content of gynoid area

Phase 2 data. Bone mineral content of gynoid(Hip area) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD34i_iDEXA_Gynoid_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of gynoid Hip area in grams

New in R7. tissue fat mass of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass of gynoid Hip area

Phase 2 data. tissue fat mass of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of gynoid area

Tissue fat mass of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of gynoid area

Phase 2 data. Tissue fat mass of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD35i_iDEXA_Gynoid_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of gynoid Hip area in grams

New in R7. Tissue lean mass of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass of gynoid Hip area

Phase 2 data. Tissue lean mass of gynoid (Hip area) in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of gynoid area

Tissue lean mass of gynoid(Hip area) in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of gynoid area

Phase 2 data. Tissue lean mass of gynoid(Hip area) in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD36i_iDEXA_Gynoid_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content of two legs in grams

New in R7. Bone mineral content of two legs in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content of two legs

Phase 2 data. Bone mineral content of two legs in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content of two legs

Bone mineral content of two legs in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content of two legs

Phase 2 data. Bone mineral content of two legs in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD37i_iDEXA_legs_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of two legs in grams

New in R7. Tissue fat mass of two legs in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass of two legs

Phase 2 data. Tissue fat mass of two legs in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of two legs

Tissue fat mass of two legs in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of two legs

Phase 2 data. Tissue fat mass of two legs in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD38i_iDEXA_legs_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of two legs in grams

New in R7. Tissue lean mass of two legs in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass of two legs

Phase 2 data. Tissue lean mass of two legs in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of two legs

Tissue lean mass of two legs in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of two legs

Phase 2 data. Tissue lean mass of two legs in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD39i_iDEXA_legs_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content left leg in grams

New in R7. Bone mineral content left leg in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content left leg

Phase 2 data. Bone mineral content left leg in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content left leg

Bone mineral content left leg in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content left leg

Phase 2 data. Bone mineral content left leg in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD40i_iDEXA_Left_leg_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of left leg in grams

New in R7. Tissue fat mass of left leg in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass of left leg

Phase 2 data. Tissue fat mass of left leg in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of left leg

Tissue fat mass of left leg in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of left leg

Phase 2 data. Tissue fat mass of left leg in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD41i_iDEXA_Left_leg_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of left leg in grams

New in R7. Tissue lean mass of left leg in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass of left leg

Phase 2 data. Tissue lean mass of left leg in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of left leg in grams

Tissue lean mass of left leg in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of left leg

Phase 2 data. Tissue lean mass of left leg in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD42i_iDEXA_Left_leg_lean_mass_P2); -9 = Missing data;

Real

Bone mineral content right leg in grams

New in R7. Bone mineral content right leg in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Bone mineral content right leg

Phase 2 data. Bone mineral content right leg in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Bone mineral content right leg in grams

Bone mineral content right leg in grams. Raw data from DEXA Lunar Prodigy.

Real

Bone mineral content right leg

Phase 2 data. Bone mineral content right leg in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD43i_iDEXA_Right_leg_bone_mass_P2); -9 = Missing data;

Real

Tissue fat mass of right leg in grams

New in R7. Tissue fat mass of right leg in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue fat mass of right leg

Phase 2 data. Tissue fat mass of right leg in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue fat mass of right leg in grams

Tissue fat mass of right leg in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue fat mass of right leg

Phase 2 data. Tissue fat mass of right leg in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD44i_iDEXA_Right_leg_fat_mass_P2); -9 = Missing data;

Real

Tissue lean mass of right leg in grams

New in R7. Tissue lean mass of right leg in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software.

Real

Tissue lean mass of right leg

Phase 2 data. Tissue lean mass of right leg in grams. Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Tissue lean mass of right leg in grams

Tissue lean mass of right leg in grams. Raw data from DEXA Lunar Prodigy.

Real

Tissue lean mass of right leg

Phase 2 data. Tissue lean mass of right leg in grams. Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD45i_iDEXA_Right_leg_lean_mass_P2); -9 = Missing data;

Real

Total mass in kilograms

Regenerated mass (fat mass(grams) + fat free mass(grams) + bone mineral mass(grams))/1000.

Real

Percent overall body fat from DEXA

New in R7. Percent overall body fat from DEXA. Regenerated percentage body fat (overall fat) using a 3 compartment model (fat mass; fat free mass; bone mineral mass). Calculated as (100* fat mass / (total mass * 1000). Calculation and or check: % of total fat mass from total mass. Comparison with study support data.

Real

Percent overall body fat from DEXA

Phase 2 data. Percent overall body fat from DEXA. Regenerated percentage body fat (overall fat) using a 3 compartment model (fat mass; fat free; mass bone mineral mass). Calculated as (100* fat mass / (total mass * 1000). Raw data from DEXA Lunar Prodigy processed with enhanced analysis. -9 = Missing data;

Real

Body fat percent DEXA

Regenerated percentage body fat (overall fat) using a 3 compartment model (fat mass; fat free mass; bone mineral mass). Calculated as (100* fat mass / (total mass * 1000).

Real

Body fat percent DEXA

Phase 2 data. Regenerated percentage body fat (overall fat) using a 3 compartment model (fat mass; fat free mass; bone mineral mass). Calculated as (100* fat mass / (total mass * 1000). Raw data from DEXA Lunar Prodigy processed with basic analysis. DO NOT USE THIS VARIABLE. Use iDEXA equivalent instead (AD47i_iDEXA_body_fat_percent_P2); -9 = Missing data;

Real

Which symmetry method was applied

New in R7. If symmetry method was applied it is indicated whether it was left or right. Where symmetry method was used arm was omitted from scan as volunteer was too broad for the scanner. Therefore the values of the arm within the scanner was used to recalculate overall Body composition. Calculation and or check: Identified by Fenland_Symmetry_Calculations.xls and iDEXA estimate.

Text

Symmetry method applied

Phase 2 data. If symmetry method was applied it is indicated whether it was left or right. Where symmetry method was used arm was omitted from scan as volunteer was too broad for the scanner. Therefore the values of the arm within the scanner was used to recalculate overall Body composition. Calculation and or check: Identified by Fenland_Symmetry_Calculations.xls and iDEXA estimate.

Text

Was symmetry method applied

Was symmetry method used yes or no. Where symmetry method was used arm was omitted from scan as volunteer was too broad for the scanner. Therefore the values of the arm within the scanner was used to recalculate overall Body Composition.

Categorical

DEXA comments

Comments for when there are artefacts or missing tissue from the scanning area. Do not analyse any DEXA data without reviewing these comments. Please also request variable AD58i_iDEXA_Comments.

Text

Categories of DEXA scan

Background data information code generated by Anthropometry team (scans without code should be considered to have followed standard protocol). Request with AD50_DEXA_Coding for further clarification.

Categorical

Visceral Adipose Tissue within the Android region in cm3

New in R7. Visceral Adipose Tissue (VAT) within the Android region in cm3. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. The iDEXA algorithm did not work in volunteers who were too broad or had too little fat around the abdomen so it produced an output of 0. These were changed to -7 afterwards by the Data Man team.

Real

VAT within Android region in cm3

Phase 2 data. Visceral Adipose Tissue (VAT) within the Android region in cm3. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. The iDEXA algorithm did not work in volunteers who were too broad or had too little fat around the abdomen so it produced an output of 0. These were changed to -7 afterwards by the Data Man team.

Real

Visceral Adipose Tissue within the Android region in grams

New in R7. Visceral Adipose Tissue (VAT) within the Android region in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. The iDEXA algorithm did not work in volunteers who were too broad or had too little fat around the abdomen so it produced an output of 0. These were changed to -7 afterwards by the Data Man team.

Real

VAT within Android region in grams

Phase 2 data. Visceral Adipose Tissue (VAT) within the Android region in grams. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. The iDEXA algorithm did not work in volunteers who were too broad or had too little fat around the abdomen so it produced an output of 0. These were changed to -7 afterwards by the Data Man team.

Real

Subcutaneous Adipose Tissue within the Android region in grams

New in R7. Subcutaneous Adipose Tissue within the Android region in grams. generated by the anthro team = iDEXA Android fat mass g - iDEXA VAT g. Calculation and or check: iDEXA Android fat mass - iDEXA VAT g.

Real

SCAT within Android region in grams

Phase 2 data. Subcutaneous Adipose Tissue within the Android region in grams. generated by the anthro team = iDEXA Android fat mass g - iDEXA VAT g. Calculation and or check: iDEXA Android fat mass - iDEXA VAT g.

Real

Total fat mass of leg and head areas in grams

New in R7. Total fat mass of leg and head areas in grams. Generated by the anthro team iDEXA Total fat mass g - (iDEXA Trunk fat mass g + iDEXA arms fat mass g). Calculation and or check: Total fat mass - (Trunk fat mass + Arms fat mass).

Real

Total fat mass leg and head areas

Phase 2 data. Total fat mass of leg and head areas in grams. Generated by the anthro team iDEXA Total fat mass g - (iDEXA Trunk fat mass g + iDEXA arms fat mass g). Calculation and or check: Total fat mass - (Trunk fat mass + Arms fat mass).

Real

Total bone mineral density

New in R7. Total bone mineral density. regenerated by the anthro team iDEXA total bone mineral content/iDEXA area. Calculation and or check: checked against BMD generated by the DEXA - it was recalculated where the symmetry method was applied.

Real

Total bone mineral density

Phase 2 data. Total bone mineral density. Regenerated by the anthro team iDEXA total bone mineral content/iDEXA area. Calculation and or check: checked against BMD generated by the DEXA - it was recalculated where the symmetry method was applied.

Real

Total Mass regenerated from DEXA

New in R7. Total Mass regenerated from DEXA. Regenerated mass by the anthro team (fat mass(grams) + fat free mass(grams) + bone mineral mass(grams))/1000. Calculation and or check: Sum of total bone; lean; fat masses. comparison with weight.

Real

Total Mass regenerated from DEXA

Phase 2 data. Total Mass regenerated from DEXA. Regenerated mass by the anthro team (fat mass(grams) + fat free mass(grams) + bone mineral mass(grams))/1000. Calculation and or check: Sum of total bone; lean; fat masses. comparison with weight.

Real

Categories of iDEXA scan

New in R7. Background data information code generated by Anthropometry team. Request with AD58i_DEXA_Comments for further clarification.

Categorical

Categories of iDEXA scan

Phase 2 data.  Background data information code generated by Anthropometry team. Request with AD58i_DEXA_Comments for further clarification.

Categorical

iDEXA Comments

New in R7. Comments provided by Anthropometry team regarding processing the data. Variable AD49_DEXA_Comments should be requested too.

Text

iDEXA Comments

Phase 2 data.  Comments provided by Anthropometry team regarding processing the data. Variable AD49_DEXA_Comments should be requested too.

Text

OLINK assay ADAM15

Phase 1 OLINK assay data for target ADAM15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADAM 22

Phase 1 OLINK assay data for target ADAM 22 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADAM 23

Phase 1 OLINK assay data for target ADAM 23 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADAM 8

Phase 1 OLINK assay data for target ADAM 8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADAM-TS13

Phase 1 OLINK assay data for target ADAM-TS13 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADAM-TS 15

Phase 1 OLINK assay data for target ADAM-TS 15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADA

Phase 1 OLINK assay data for target ADA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADGRE2

Phase 1 OLINK assay data for target ADGRE2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADGRG1

Phase 1 OLINK assay data for target ADGRG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ADGRG2

Phase 1 OLINK assay data for target ADGRG2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum Adiponectin RAW

Serum biomarker Adiponectin RAW in ug/ml. Raw data; cleaned data provided in variable G_Adiponectin with x_Threshold and x_Com variables provided for clarification.

Real

Any comments which are relevant to admin data or b

General comments provided on study participation study samples tests etc.

Text

Comments relevant to admin data

Phase 2 data. General comments provided on phase 2 study participation study samples tests etc.

Text

OLINK assay ADM

Phase 1 OLINK assay data for target ADM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of High impact or step aerobics

Please indicate the average length of time (in hours) you spent doing the activity per episode. High impact or step aerobics.

Integer

Hours of High impact or step aerobics CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. High impact or step aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable:Highimpactaerobics hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. High impact or step aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

High impact or step aerobics hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. High impact or step aerobics. -1 = left blank. DO NOT USE THIS VARIABLE. Use AerobicsHighHr_CLEAN_P2 instead.

Real

Minutes of High impact or step aerobics

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. High impact or step aerobics.

Integer

Minutes of High impact or step aerobics CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. High impact or step aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable:Highimpactaerobics min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. High impact or step aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

High impact or step aerobics min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. High impact or step aerobics. -1 = left blank. DO NOT USE THIS VARIABLE. Use AerobicsHighMin_CLEAN_P2 instead.

Real

Frequency of High impact or step aerobics CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. High impact or step aerobics. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

None

New in R8. Cleaned translated frequency (per week) for High impact or step aerobics

Real

Cln variable: High impact aerobics

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. High impact or step aerobics. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

AerobicsHigh_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. High impact or step aerobics. Data normalised to DE template 1 data.

Categorical

High impact or step aerobics

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. High impact or step aerobics. DO NOT USE THIS VARIABLE. Use AerobicsHigh_CLEAN_P2 instead.

Real

High impact or step aerobics

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. High impact or step aerobics. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of High impact or step aerobics DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. High impact or step aerobics. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in AerobicsHigh_T2. Instead use AerobicsHigh_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of High impact or step aerobics DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. High impact or step aerobics. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in AerobicsHigh_T1. Instead use AerobicsHigh_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Hours of other types of aerobics

Please indicate the average length of time (in hours) you spent doing the activity per episode. Other types of aerobics.

Integer

Hours ofother types of aerobics CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Other types of aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Other aerobics hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other types of aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other types of aerobics hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other types of aerobics. -1 = left blank. DO NOT USE THIS VARIABLE. Use aerobicsOtherHr_CLEAN_P2 instead.

Real

Minutes of other types of aerobics

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other types of aerobics.

Integer

Minutes of other types of aerobics CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other types of aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Other aerobics min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other types of aerobics. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other types of aerobics min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other types of aerobics. -1 = left blank. DO NOT USE THIS VARIABLE. Use aerobicsOtherMin_CLEAN_P2 instead.

Real

Frequency of other types of aerobics CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other types of aerobics. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

aerobicsOther_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for other types of aerobics

Real

Cln variable: Other erobics

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other types of aerobics. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

aerobicsOther_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other types of aerobics. Data normalised to DE template 1 data.

Categorical

Other types of aerobics

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other types of aerobics. DO NOT USE THIS VARIABLE. Use aerobicsOther_CLEAN_P2 instead.

Real

Other types of aerobics

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other types of aerobics. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of other types of aerobics DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other types of aerobics. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in aerobicsOther_T2. Instead use aerobicsOther_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of other types of aerobics DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other types of aerobics. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in aerobicsOther_T1. Instead use aerobicsOther_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

AES Comments on sheet

ActiHeart Evaluation Sheet. Any other comments made on Actiheart evaluation sheet not in Q9 by either study staff of participant. Potentailly provides additional explanation for any answers given so should be included in EAS data releases.

Text

AES DM batch

ActiHeart Evaluation Sheet. Data Management batch number.

AES Think Measure

ActiHeart Evaluation Sheet. Q1. What do you think the ActiHeart was measuring?

Text

AES Tell from Info

ActiHeart Evaluation Sheet. Q2. What do you think the research team will be able to tell from the information stored in your ActiHeart?

Text

AES PA wearingAH

ActiHeart Evaluation Sheet. Q3. While you were wearing the ActiHeart do you think you were

Categorical

AES Change 3

ActiHeart Evaluation Sheet. Q4iii. If you were more or less physically active than usual while you were wearing the ActHeart what did you do (or not do) that was different from usual? 3rd answer.

Text

AES Change 2

ActiHeart Evaluation Sheet. Q4ii. If you were more or less physically active than usual while you were wearing the ActHeart what did you do (or not do) that was different from usual? 2nd answer.

Text

AES Change 1

ActiHeart Evaluation Sheet. Q4i. If you were more or less physically active than usual while you were wearing the ActHeart what did you do (or not do) that was different from usual? 1st answer.

Text

AES Reason change 3

ActiHeart Evaluation Sheet. Q5iii. If you were more or less physically active than usual while you were wearing the ActHeart what were the main reasons for this? 3rd answer.

Text

AES Reason change 2

ActiHeart Evaluation Sheet. Q5ii. If you were more or less physically active than usual while you were wearing the ActHeart what were the main reasons for this? 2nd answer.

Text

AES Reason change 1

ActiHeart Evaluation Sheet. Q5i. If you were more or less physically active than usual while you were wearing the ActHeart what were the main reasons for this? 1st answer. (Note to data entry: If the answer to Q3 is 3 (about the same) and as expected Q4 and 5 have not been answered do not code these as -9 leave them blank).

Text

AES Should up PA comment

ActiHeart Evaluation Sheet. Q6c. While you were wearing the ActiHeart did you feel you should increase your physical activity - please explain.

Text

AES Should up PA

ActiHeart Evaluation Sheet. Q6. While you were wearing the ActiHeart did you feel you should increase your physical activity?

Categorical

AES More aware of PA comment

ActiHeart Evaluation Sheet. Q7c. Did wearing the ActiHeart make you more aware of how physically active you are - please explain.

Text

AES More aware of PA

ActiHeart Evaluation Sheet. Q7. Did wearing the ActiHeart make you more aware of how physically active you are?

Categorical

AES Reminded to be PA comment

ActiHeart Evaluation Sheet. Q8c. Did wearing the ActiHeart remind you to be more physically active - please explain.

Text

AES Reminded to be PA

ActiHeart Evaluation Sheet. Q8. Did wearing the ActiHeart remind you to be more physically active?

Categorical

AES Other comments

ActiHeart Evaluation Sheet. Q9. If you have any other comments about the ActiHeart please write them here.

Text

AES WD Batch

ActiHeart Evaluation Sheet. Data entry company processing batch number.

Age at Test

Data as entered on Study database. Age at test as reported by participant during site visit.

AgeAtTest_DM_Attended

New in R8. Derived age at test in decimals to reflect true age (eg 35.9 instead of 35) at first visit in years and decimals. This variable replaces AgeAtTest_DM because that was calculated using AppDate. Since AppDate is the date the first visit is scheduled which is not always the date the visit took place. For AgeAtTest_DM_Attended the variable AppDate_Attended is used which is the actual date of the first visit. Please note that this is a decimal number which does not reflect months.

Real

Age at test derived

Phase 2 data. Derived age at test in decimals to reflect true age (eg 35.9 instead of 35) at phase 2 visit in years and decimals ( the actual date of the phase 2 visit). Please note that this is a decimal number which does not reflect months.

Real

Age at test as reported by pt

Phase 2 data. Data as entered on Study database. Age at test as reported by participant during phase 2 site visit.

Real

None

Phase 1 data. Age of phase 1 volunteer (a volunteer who has a phase 1 visit date) on 01 Aug 2014. This allows for coss-study population ages comparison

Real

None

Phase 2 data. Age of phase 2 volunteer (a volunteer who has a phase 2 visit date) on 01 Aug 2020. This allows for coss-study population ages comparison. age provided only if volunteer took part in phase 2

Real

OLINK assay AGR2

Phase 1 OLINK assay data for target AGR2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AGR3

Phase 1 OLINK assay data for target AGR3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AGRP

Phase 1 OLINK assay data for target AGRP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

AH comments

AH comments. Contains comments on treadmill test fasting information

Text

AH comments

Phase 2 data. AH comments for Phase 2 data. Contains comments on treadmill test fasting information. Cleaned information held in main AH dataset for analysis. This has not been checked for identifaible information.

Text

OLINK assay AHCY

Phase 1 OLINK assay data for target AHCY in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Actiheart serial number

ActiHeart monitor serial Number

Text

Cmnts diary sheet AH Wrist Mon

Phase 2 data. General comments left on Diary sheet for actiheart and Wrist accelerometer monitor. The name of the variable the comment relates to has been provided where possible. -1 = no comments provided; -8 = text illegible

Text

Date day 1 of AhAccMon Worn

Phase 2 data. Date of day 1 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Day Name of day 1 of AhAccMon Worn

Phase 2 data. Name of day of day 1 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Date day 2 of AhAccMon Worn

Phase 2 data. Date of day 2 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Day Name of day 2 of AhAccMon Worn

Phase 2 data. Name of day of day 2 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Date day 3 of AhAccMon Worn

Phase 2 data. Date of day 3 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Day Name of day 3 of AhAccMon Worn

Phase 2 data. Name of day of day 3 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Date day 4 of AhAccMon Worn

Phase 2 data. Date of day 4 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Day Name of day 4 of AhAccMon Worn

Phase 2 data. Name of day of day 4 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Date day 5 of AhAccMon Worn

Phase 2 data. Date of day 5 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Day Name of day 5 of AhAccMon Worn

Phase 2 data. Name of day of day 5 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Date day 6 of AhAccMon Worn

Phase 2 data. Date of day 6 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Name of day6 Ah Acc Mon Worn

Phase 2 data. Name of day of day 6 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Date day 7 of AhAccMon Worn

Phase 2 data. Date of day 7 of wearing Actiheart and wrist accelerometer dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Name of day7 Ah Acc Mon Worn

Phase 2 data. Name of day of day 7 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

No of times AH Wrist Mon worn

Phase 2 data. Number Of times actiheart and wrist worn accelerometer diary sheets have been completed. For each time the date of completion has been entered. -1 = only one copy completed

Real

General cmnts actiheart mon on day1

Phase 2 data. General comments (actiheart monitor) on day 1 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

General cmnts actiheart mon on day2

Phase 2 data. General comments (actiheart monitor) on day 2 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

General cmnts actiheart mon on day3

Phase 2 data. General comments (actiheart monitor) on day 3 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

General cmnts actiheart mon on day4

Phase 2 data. General comments (actiheart monitor) on day 4 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

General cmnts actiheart mon on day5

Phase 2 data. General comments (actiheart monitor) on day 5 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

General cmnts actiheart mon on day6

Phase 2 data. General comments (actiheart monitor) on day 6 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

General cmnts actiheart mon on day7

Phase 2 data. General comments (actiheart monitor) on day 7 of wearing Actiheart and wrist accelerometer. -1 = left blank or crossed through; -8 = text illegible

Text

Time actiheart mon taken off day1

Phase 2 data. What time did you take off the actiheart monitor on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon taken off day2

Phase 2 data. What time did you take off the actiheart monitor on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon taken off day3

Phase 2 data. What time did you take off the actiheart monitor on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon taken off day4

Phase 2 data. What time did you take off the actiheart monitor on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon taken off day5

Phase 2 data. What time did you take off the actiheart monitor on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon taken off day6

Phase 2 data. What time did you take off the actiheart monitor on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon taken off day7

Phase 2 data. What time did you take off the actiheart monitor on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Final date AH monitor taken off

Phase 2 data. Date of Final time taken off Actiheart monitor dd/mm/yyyy. -1 = left blank or crossed through; -8 = text illegible

Date

Final time AH monitor taken off

Phase 2 data. Date of Final time taken off Actiheart monitor (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Date

Time actiheart mon put back on day1

Phase 2 data. What time did you put the actiheart monitor back on on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon put back on day2

Phase 2 data. What time did you put the actiheart monitor back on on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon put back on day3

Phase 2 data. What time did you put the actiheart monitor back on on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon put back on day4

Phase 2 data. What time did you put the actiheart monitor back on on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon put back on day5

Phase 2 data. What time did you put the actiheart monitor back on on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon put back on day6

Phase 2 data. What time did you put the actiheart monitor back on on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time actiheart mon put back on day7

Phase 2 data. What time did you put the actiheart monitor back on on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Reason take off actiheart mon day1

Phase 2 data. Reason for taking off (actiheart monitor) on day 1 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off actiheart mon day2

Phase 2 data. Reason for taking off (actiheart monitor) on day 2 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off actiheart mon day3

Phase 2 data. Reason for taking off (actiheart monitor) on day 3 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off actiheart mon day4

Phase 2 data. Reason for taking off (actiheart monitor) on day 4 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off actiheart mon day5

Phase 2 data. Reason for taking off (actiheart monitor) on day 5 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off actiheart mon day6

Phase 2 data. Reason for taking off (actiheart monitor) on day 6 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Reason take off actiheart mon day7

Phase 2 data. Reason for taking off (actiheart monitor) on day 7 of wearing Actiheart and wrist accelerometer; example provided on form is CHANGE ELECTRODES. -1 = left blank or crossed through; -8 = text illegible

Text

Barcode error comments

Phase 2 data. Actiheart and wrist accelerometer diary sheet barcode scanning error comment. -1 = no issues to report

Text

Time finish wrk day1 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time finish wrk day2 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time finish wrk day3 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time finish wrk day4 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time finish wrk day5 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time finish wrk day6 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time finish wrk day7 AhAcc Mon Worn

Phase 2 data. What time did you finish work on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Get up time day2 Ah Acc Mon Worn

Phase 2 data. What time did you get up on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Get up time day3 Ah Acc Mon Worn

Phase 2 data. What time did you get up on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Get up time day4 Ah Acc Mon Worn

Phase 2 data. What time did you get up on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Get up time day5 Ah Acc Mon Worn

Phase 2 data. What time did you get up on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Get up time day6 Ah Acc Mon Worn

Phase 2 data. What time did you get up on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Get up time day7 Ah Acc Mon Worn

Phase 2 data. What time did you get up on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time went sleep day1 AhAcc Mon Worn

Phase 2 data. What time did you go to sleep on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time went sleep day2 AhAcc Mon Worn

Phase 2 data. What time did you go to sleep on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time went sleep day3 AhAcc Mon Worn

Phase 2 data. What time did you go to sleep on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time went sleep day4 AhAcc Mon Worn

Phase 2 data. What time did you go to sleep on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time went sleep day5 AhAcc Mon Worn

Phase 2 data. What time did you go to sleep on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time went sleep day6 AhAcc Mon Worn

Phase 2 data. What time did you go to sleep on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Not wrk day1 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 1 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

Not wrk day2 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 2 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

Not wrk day3 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 3 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

Not wrk day4 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 4 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

Not wrk day5 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 5 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

Not wrk day6 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 6 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

Not wrk day7 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 7 of wearing Actiheart and wrist accelerometer (24 hr format)? 1 = did not work (box ticked); -1 = not ticked (worked)

Categorical

AH wrist acc qnr version date

Phase 2 data. Actiheart and wrist accelerometer diary sheet questionnaire version date.

Date

AH wrist acc qnr version no

Phase 2 data. Actiheart and wrist accelerometer diary sheet questionnaire version number.

Real

Time start wrk day1 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 1 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time start wrk day2 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 2 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time start wrk day3 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 3 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time start wrk day4 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 4 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time start wrk day5 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 5 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time start wrk day6 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 6 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

Time start wrk day7 Ah Acc Mon Worn

Phase 2 data. What time did you start work on day 7 of wearing Actiheart and wrist accelerometer (24 hr format). -1 = left blank or crossed through; -8 = text illegible

Time

OLINK assay AIFM1

Phase 1 OLINK assay data for target AIFM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. the CV of calculated concentration between intraplate duplicates - this is calculated by the MSD software (where applicable)

Real

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. the individual calculated concentration for each intra plate duplicate in pg/mL - this is calculated by the MSD software

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. Date of MSD aKlotho experiment

Date

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. number of times the sample was thawed

Real

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. Plate specific Lower limit of detection for aKlotho measurements.

Real

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. barcode label by MSD - each plate is unique

Text

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. number of the plate assigned by the lab team

Real

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. well position within a 96-well plate

Text

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. The comment of wether the calculated concentration of the sample is within or outside the detection range of the assay; as assigned by the MSD software

Text

None

New for R9. Phase 1 plasma fluoride sample data for aKlotho. Plate specific Upper limit of detection for aKlotho measurements.

Real

OLINK assay AKT1S1

Phase 1 OLINK assay data for target AKT1S1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Investigation Date

When was Subject Measured?

Date

Investigation Date

Phase 2 data. When was Subject Measured?

Date

RT longitudinal sweep made: Quality

What was the quality of the RT Longitudinal Sweep that was Made?

Categorical

RT longitudinal sweep made: Quality

Phase 2 data. What was the quality of the RT Longitudinal Sweep that was Made? -1 = Unable to be determined; -9 = Missing data; 1 = A(highest); 2 = B; 3 = C(lowest);

Categorical

R transverse sweep made: Quality

What was the quality of the RT transverse Sweep that was Made?

Categorical

RT transverse sweep made: Quality

Phase 2 data. What was the quality of the RT transverse Sweep that was Made? -1 = Unable to be determined; -9 = Missing data; 1 = A(highest); 2 = B; 3 = C(lowest);

Categorical

LT longitudinal sweep made: Quality

What was the quality of the LT longitudinal sweep that was Made?

Categorical

LT longitudinal sweep made: Quality

Phase 2 data. What was the quality of the LT longitudinal sweep that was Made? -1 = Unable to be determined; -9 = Missing data; 1 = A(highest); 2 = B; 3 = C(lowest);

Categorical

LT transverse sweep made: Quality

What was the quality of the LT transverse sweep that was Made?

Categorical

LT transverse sweep made: Quality

Phase 2 data. What was the quality of the LT transverse sweep that was Made? -1 = Unable to be determined; -9 = Missing data; 1 = A(highest); 2 = B; 3 = C(lowest);

Categorical

Repeat sweep representative segment : Quality

What was the quality of the Repeat sweep (representative segment) that was Made?

Categorical

Quality of Repeat sweep

Phase 2 data. What was the quality of the Repeat sweep (representative segment) that was Made? -1 = Unable to be determined; -9 = Missing data; 1 = A(highest); 2 = B; 3 = C(lowest);

Categorical

Increased echo reflectivity liver parenchyma in comparison with kidney

What was the (Increased) echo reflectivity liver parenchyma (in comparison with kidney) score? Scored from 1 (highest quality) to 4 (lowest quality).

Categorical

Scoring criteria 1

Phase 2 data. What was the (Increased) echo reflectivity liver parenchyma (in comparison with kidney) score? Scored from 1 (highest quality) to 4 (lowest quality).

Categorical

Decreased visualization of intra-hepatic vascula

What was the (Decreased) visualization of intra-hepatic vasculature score? Scored from 1 (highest quality) to 4 (lowest quality).

Categorical

Scoring criteria 2

Phase 2 data. What was the (Decreased) visualization of intra-hepatic vasculature score? Scored from 1 (highest quality) to 4 (lowest quality). -1 = Unable to be determined; -9 = Missing data; 1 = Normal; 2 = Mild; 3 = Moderate; 4 = Severe;

Categorical

Attenuation of ultrasound beam impaired penetrati

What was the Attenuation of ultrasound beam impaired penetration score? Scored from 1 (highest quality) to 4 (lowest quality).

Categorical

Scoring criteria 3

Phase 2 data. What was the Attenuation of ultrasound beam impaired penetration score? Scored from 1 (highest quality) to 4 (lowest quality). -1 = Unable to be determined; -9 = Missing data; 1 = Normal; 2 = Mild; 3 = Moderate; 4 = Severe;

Categorical

Total liver score

This is the score for AL09_scoring_criteria_1 AL10_scoring_criteria_2 and AL11_scoring_criteria_3 all added. Values from a minimum of 3 to a maximum of 12. 16 data items with a value of 41275 in some Fenland R6 or earlier data releases were corrected to 10 in later R6 data releases. Error was due to data incorrectly being labelled as a date.

Real

Total liver score

Phase 2 data.

Real

Total score Category

Provides the Assessed Category from total score. Normal = 4 or less; Mild = 5 to 7; Moderate = 8 to 10; Severe = 11 or more;

Categorical

Total score Category

Phase 2 data. Provides the Assessed Category from total score. Normal = 4 or less; Mild = 5 to 7; Moderate = 8 to 10; Severe = 11 or more;

Categorical

Liver ultrasound comments

The comment made on theTotal score Category was

Text

Liver ultrasound comments

Phase 2 data. The comment made on theTotal score Category

Text

Liver DM comment

Liver data Data management comment

Text

Repeat sweep representative segment : Quality

What was the quality of the Repeat sweep (representative segment) that was Made?

Categorical

Inter frozen quality

Phase 2 data. What was the quality of the Repeat sweep (representative segment) that was Made? -1 = Unable to be determined; -9 = Missing data; 1 = A(highest); 2 = B; 3 = C(lowest);

Categorical

Image format used

Image format that was used by the liver reviewer to assess the liver

Categorical

Sonographer

Identification of sonographer who carried out the ultrasound.

Categorical

Liver reviewer

Identification of liver reviewer who determined the score

Categorical

Ala_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Ala_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_001.

Real

Albumin 0 minutes

Serum Albumin measurement taken at 0 minutes in g/L

Integer

Albumin 0 minutes

Phase 2 data. Serum Albumin measurement taken at 0 minutes in g/L

Real

OLINK assay ALCAM

Phase 1 OLINK assay data for target ALCAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

number of units of alcohol consumed per week

Alcohol Units Per Week

Units of alcohol consumed per week

Phase 2 data. Alcohol Units Per Week in Phase 2 data. Phase 2 unit definition: 1 unit is equivalent to 1/2 pint of beer ; 1/2 glass of wine; 1 single measure of spirits; 1 glass of sherry; This is different from phase 1 unit definition. Used for participant feedback only. Not for analysis. Used set of alcohol consumption variables derived from general questionnaire instead.

Real

ALCOHOL_EPI

Current alcohol consumption History / Status as requested by Ruth Loos. Derived from GenQ Qs by DM team JAVA script. Pls request G_Alcohol variable as well. 0 = never;

Categorical

Alcohol_EPI_weekend

Phase 2 data. Current alcohol consumption on fri-sat-sun History / Status. Derived from GenQ Qs by DM team JAVA script. Pls request G_Alcohol variable as well. Codes of 1; 3 and 9 for G_ALCOHOL are recoded as 9 in this variable. 0 = never; 1 = ex; 2 = current; 9 = not known;

Categorical

Alcohol consumption weekday

Phase 2 data. Current alcohol consumption on mon-tue-wed-thu History / Status. Derived from GenQ Qs by DM team JAVA script. Pls request G_Alcohol variable as well. Codes of 1; 3 and 9 for G_ALCOHOL are recoded as 9 in this variable. 0 = never; 1 = ex; 2 = current; 9 = not known;

Categorical

OLINK assay ALDH1A1

Phase 1 OLINK assay data for target ALDH1A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ALDH3A1

Phase 1 OLINK assay data for target ALDH3A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

AlkPhos 0 minutes

Serum Alkaline Phosphatase measurement taken at 0 minutes in U/L

Integer

AlkPhos 0 minutes

Phase 2 data. Serum Alkaline Phosphatase measurement taken at 0 minutes in U/L

Integer

alphaAAA_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable alphaAAA_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_025.

Real

OLINK assay Alpha-2-MRAP

Phase 1 OLINK assay data for target Alpha-2-MRAP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Alt 0 minutes

Serum Alt measurement taken at 0 minutes in U/L

Integer

Alt 0 minutes

Phase 2 data. Serum Alt measurement taken at 0 minutes in U/L

Integer

OLINK assay AMBP

Phase 1 OLINK assay data for target AMBP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AMIGO2

Phase 1 OLINK assay data for target AMIGO2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AMN

Phase 1 OLINK assay data for target AMN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

aneamia

Phase 2 data. Binary variable indicating whether a drug from the anemia medication class was prescribed. 0 = No; 1 = Yes;

Categorical

OLINK assay ANGPT2

Phase 1 OLINK assay data for target ANGPT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANGPTL1

Phase 1 OLINK assay data for target ANGPTL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANGPTL3

Phase 1 OLINK assay data for target ANGPTL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANGPTL4

Phase 1 OLINK assay data for target ANGPTL4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANGPTL7

Phase 1 OLINK assay data for target ANGPTL7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANG-1

Phase 1 OLINK assay data for target ANG-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANG

Phase 1 OLINK assay data for target ANG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

ANML signal normalization scale factor (0.005percent mix)

Real

None

Phase 2 data. ANML signal normalization scale factor (0.005% mix)

Real

None

ANML signal normalization scale factor (0.5percent mix)

Real

None

Phase 2 data. ANML signal normalization scale factor (0.5% mix)

Real

None

ANML signal normalization scale factor (20percent mix)

Real

None

Phase 2 data. ANML signal normalization scale factor (20% mix)

Real

Anno tool complete

Phase 2 data. Annotation tool completed? 1 = yes;

Categorical

Anno tool email sent date

Phase 2 data. Date Annotation tool email sent off.

Date

Anno tool invite sent date

Phase 2 data. Date Annotation tool invite sent off.

Date

Anthro DoB

Phase 2 data.

Date

Anthro data sourec

Phase 2 data. Tracker variable created by DMT. 1 = paper; 2 = electronic; 3 = private network study db; 9 = paper and electronic;

Real

antidepressants

Phase 2 data. Binary variable indicating whether a drug from the antidepressant class was prescribed. 0 = No; 1 = Yes;

Categorical

OLINK assay ANXA10

Phase 1 OLINK assay data for target ANXA10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANXA11

Phase 1 OLINK assay data for target ANXA11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANXA1

Phase 1 OLINK assay data for target ANXA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ANXA4

Phase 1 OLINK assay data for target ANXA4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AOC1

Phase 1 OLINK assay data for target AOC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AOC3

Phase 1 OLINK assay data for target AOC3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay APBB1IP

Phase 1 OLINK assay data for target APBB1IP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay APEX1

Phase 1 OLINK assay data for target APEX1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay APLP1

Phase 1 OLINK assay data for target APLP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum Apo_A1 RAW

Serum biomarker Apo A1 measurement RAW in g/L. Raw data; cleaned data provided in variable G_ApoA1 with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

Serum Apo_B RAW

Serum biomarker Apo B measurement RAW in g/L. Raw data; cleaned data provided in variable G_ApoB with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

Apo_E

ApoE data produced by UCL from blood samples.

Real

OLINK assay APOM

Phase 1 OLINK assay data for target APOM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

AppDate_Attended

New for R8 and replaces AppDate. Date of the apppointment which the participant ACTUALLY attended so appointment status = 2. Where participant had 2 or more appointments with status 2 the most recent date has been entered here. This is different from the data in AppDate since this is the actual date and Appdate is the date is should have been had it not been cancelled. The AppDate variable should no longer be used in R8.

Date

None

Phase 2 data. Date of the apppointment which the participant ACTUALLY attended so appointment status = 2. Where participant had 2 or more appointments with status 2 the most recent date has been entered here.

Date

OLINK assay APP

Phase 1 OLINK assay data for target APP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AP-N

Phase 1 OLINK assay data for target AP-N in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AREG

Phase 1 OLINK assay data for target AREG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AREG

Phase 1 OLINK assay data for target AREG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ARG1

Phase 1 OLINK assay data for target ARG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Arg_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Arg_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_002.

Real

OLINK assay ARHGAP1

Phase 1 OLINK assay data for target ARHGAP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ARHGEF12

Phase 1 OLINK assay data for target ARHGEF12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ARNT

Phase 1 OLINK assay data for target ARNT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Arrival Time

Phase 2 data. Clinical visit arrival time

Time

OLINK assay ARSA

Phase 1 OLINK assay data for target ARSA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ARSB

Phase 1 OLINK assay data for target ARSB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Phase 2 data. Self reported

Real

OLINK assay ARTN

Phase 1 OLINK assay data for target ARTN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ASGR1

Phase 1 OLINK assay data for target ASGR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Asn_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Asn_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_003.

Real

Asp_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Asp_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_004.

Real

None

Assay team run observation

Real

Assay team run observation

Phase 2 data. Assay team run observation

Text

asthma_BA

Phase 2 data. Binary variable indicating whether a drug from the asthma: beta agonist class was prescribed. 0 = No; 1 = Yes;

Categorical

asthma_other

Phase 2 data. Binary variable indicating whether a drug from the asthma: other class was prescribed. 0 = No; 1 = Yes;

Categorical

asthma_steroids

Phase 2 data. Binary variable indicating whether a drug from the asthma: steroid class was prescribed. 0 = No; 1 = Yes;

Categorical

OLINK assay ATG4A

Phase 1 OLINK assay data for target ATG4A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ATP6AP2

Phase 1 OLINK assay data for target ATP6AP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ATP6V1F

Phase 1 OLINK assay data for target ATP6V1F in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

The average data lost during free living

The average data lost during free living (1st wear of ActiHeart only) Manual scoring for Q purposes.

Categorical

OLINK assay AXIN1

Phase 1 OLINK assay data for target AXIN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AXL

Phase 1 OLINK assay data for target AXL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay AZU1

Phase 1 OLINK assay data for target AZU1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay B4GALT1

Phase 1 OLINK assay data for target B4GALT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay B4GAT1

Phase 1 OLINK assay data for target B4GAT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BACH1

Phase 1 OLINK assay data for target BACH1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Backpacking Or Mountain Climbing

Please indicate the average length of time (in hours) you spent doing the activity per episode. Backpacking Or Mountain Climbing.

Integer

Hours of Backpacking Or Mountain Climbing CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Backpacking Or Mountain Climbing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Backpack Mountain hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Backpacking Or Mountain Climbing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Backpacking Mountain Climbing hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Backpacking Or Mountain Climbing. -1 = left blank. DO NOT USE THIS VARIABLE. Use BackPackMountainClimbHr_CLEAN_P2 instead.

Real

Minutes of Backpacking Or Mountain Climbing

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Backpacking Or Mountain Climbing.

Integer

Minutes of Backpacking Or Mountain Climbing CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Backpacking Or Mountain Climbing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Backpack Mountain min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Backpacking Or Mountain Climbing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Backpacking Mountain Climbing min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Backpacking Or Mountain Climbing. -1 = left blank. DO NOT USE THIS VARIABLE. Use BackPackMountainClimbMin_CLEAN_P2 instead.

Real

Frequency of Backpacking Or Mountain Climbing CLEANED

Frequency of Backpacking Or Mountain Climbing CLEANED

Categorical

backPackMountainClimb_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Backpacking Or Mountain Climbing

Real

Cln variable: Backpack Mountain

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Backpacking Or Mountain Climbing. CLEANED. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

BackPackMountainClimb_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Backpacking Or Mountain Climbing. Data normalised to DE template 1 data.

Categorical

Backpacking or Mountain Climbing

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Backpacking Or Mountain Climbing. DO NOT USE THIS VARIABLE. Use BackPackMountainClimb_CLEAN_P2 instead.

Real

Backpacking or Mountain Climbing

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Backpacking Or Mountain Climbing. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Backpacking Or Mountain Climbing DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Backpacking Or Mountain Climbing. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in BackPackMountainClimb_T2. Instead use BackPackMountainClimb_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Backpacking Or Mountain Climbing DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Backpacking Or Mountain Climbing. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in BackPackMountainClimb_T1. Instead use BackPackMountainClimb_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay BAG6

Phase 1 OLINK assay data for target BAG6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BAMBI

Phase 1 OLINK assay data for target BAMBI in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BANK1

Phase 1 OLINK assay data for target BANK1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

2D Barcode of aliquot

Real

2D Barcode of aliquot

Phase 2 data. 2D Barcode of aliquot

Text

Basophil count

Basophils play a role in the immune system; particularly in allergic reactions and inflammation. A high basophil count (basophilia) can indicate various conditions; including allergies; chronic inflammation; and certain blood disorders. A normal basophil count is generally between 0.02 to 0.10 x 10^9/L. 

Real

Branch chain amino acid alanine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) alanine peak area compared against peak area of known internal standard

Real

Branch chain amino acid arginine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) arginine peak area compared against peak area of known internal standard

Real

Branch chain amino acid asparagine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) asparagine peak area compared against peak area of known internal standard

Real

Branch chain amino acid aspartic acid

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) aspartic acid peak area compared against peak area of known internal standard

Real

Branch chain amino acid betaine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) betaine peak area compared against peak area of known internal standard

Real

BCAA box number

New in R7. Number of BCAA box assigned by MRC Epi lab.

Integer

Branch chain amino acid citrulline

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) citrulline peak area compared against peak area of known internal standard

Real

Branch chain amino acid cystine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) cystine peak area compared against peak area of known internal standard

Real

Branch chain amino acid glutamic acid

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) glutamic acid peak area compared against peak area of known internal standard

Real

Branch chain amino acid glutamine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) glutamine peak area compared against peak area of known internal standard

Real

Branch chain amino acid glycine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) glycine peak area compared against peak area of known internal standard

Real

Branch chain amino acid histidine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) histidine peak area compared against peak area of known internal standard

Real

Branch chain amino acid isoleucine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) isoleucine peak area compared against peak area of known internal standard

Real

Branch chain amino acid leucine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) leucine peak area compared against peak area of known internal standard

Real

Branch chain amino acid lysine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) lysine peak area compared against peak area of known internal standard

Real

Branch chain amino acid methionine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) methionine peak area compared against peak area of known internal standard

Real

Branch chain amino acid methylhistidine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) methylhistidine peak area compared against peak area of known internal standard

Real

Branch chain amino acid ornithine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) ornithine peak area compared against peak area of known internal standard

Real

Branch chain amino acid phenylalanine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) phenylalanine peak area compared against peak area of known internal standard

Real

Branch chain amino acid proline

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) proline peak area compared against peak area of known internal standard

Real

BCAA sample ID

New in R7. ID number for BCAA sample assigned by MRC Epi lab.

Integer

Branch chain amino acid serine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) serine peak area compared against peak area of known internal standard

Real

Branch chain amino acid threonine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) threonine peak area compared against peak area of known internal standard

Real

Branch chain amino acid tryptophan

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) tryptophan peak area compared against peak area of known internal standard

Real

Branch chain amino acid tyrosine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) tyrosine peak area compared against peak area of known internal standard

Real

Branch chain amino acid valine

New in R7. Relative concentration of Plasma Heparin BCAA (branch Chain Amino Acid) valine peak area compared against peak area of known internal standard

Real

OLINK assay BCAM

Phase 1 OLINK assay data for target BCAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BCAN

Phase 1 OLINK assay data for target BCAN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BCL2L11

Phase 1 OLINK assay data for target BCL2L11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BCR

Phase 1 OLINK assay data for target BCR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OnBetablockers

New in R8. Is the volunteer on betablockers? As indicated by nurse at the time of doing treadmill test. Volunteer's affermative answer is recorded as yes. The data is then reviewed by the PA team and corrected where additional information (eg notes on form) indicates betablocker useage. This is a much more accurate indication of betablocker useage then BNF_Betablocker variable.

Categorical

beta_blocker

Phase 2 data. Binary variable indicating whether a drug from the beta blocker class was prescribed. 0 = No; 1 = Yes;

Categorical

OLINK assay Beta-NGF

Phase 1 OLINK assay data for target Beta-NGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Beta-NGF

Phase 1 OLINK assay data for target Beta-NGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BGN

Phase 1 OLINK assay data for target BGN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BID

Phase 1 OLINK assay data for target BID in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Bilirubin 0 minutes

Serum Total Bili (Bilirubin) measurement taken at 0 minutes in umol/L

Integer

Bilirubin 0 minutes

Phase 2 data. Serum Total Bili (Bilirubin) measurement taken at 0 minutes in umol/L

Integer

None

Metabolomics Biocrates assay N of repeats (1 to 3). Most samples were assayed only once but some were assayed multiple times.

Integer

Ala_QCstep2 valid=1 LoD=1

New in R8. QCd metabolomics data (final) for alanine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable ala. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Ala_raw and QCstep1 var is Ala

Real

Arg_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for arginine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable arg. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Arg_raw and QCstep1 var is Arg_i

Real

Asn_QCstep2 valid=1 LoD=15

New in R8. QCd metabolomics data (final) for asparagine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable asn. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Asn_raw and QCstep1 var is Asn_i

Real

Asp_QCstep2 valid=0 LoD=15

New in R8. QCd metabolomics data (final) for aspartate - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=1.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable asp. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Asp_raw and QCstep1 var is Asp_i

Real

Cit_QCstep2 valid=0 LoD=1

New in R8. QCd metabolomics data (final) for citrulline - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable cit. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Cit_raw and QCstep1 var is Cit_i

Real

Gln_QCstep2 valid=1 LoD=15

New in R8. QCd metabolomics data (final) for glutamine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable gln. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Gln_raw and QCstep1 var is Gln_i

Real

Glu_QCstep2 valid=1 LoD=2

New in R8. QCd metabolomics data (final) for glutamate - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=2 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable glu. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Glu_raw and QCstep1 var is Glu_i

Real

Gly_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for glycine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable gly. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Gly_raw and QCstep1 var is Gly_i

Real

His_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for histidine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable his. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is His_raw and QCstep1 var is His

Real

Ile_QCstep2 valid=1 LoD=15

New in R8. QCd metabolomics data (final) for isoleucine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable ile. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Ile_raw and QCstep1 var is Ile

Real

Leu_QCstep2 valid=1 LoD=15

New in R8. QCd metabolomics data (final) for leucine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable leu. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Leu_raw and QCstep1 var is Leu

Real

Lys_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for lysine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lys. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Lys_raw and QCstep1 var is Lys

Real

Met_QCstep2 valid=1 LoD=01

New in R8. QCd metabolomics data (final) for methionine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable met. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Met_raw and QCstep1 var is Met_i

Real

Orn_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for ornithine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable orn. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Orn_raw and QCstep1 var is Orn_i

Real

PEA_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phenylethylamine - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=0.03 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pea. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PEA_raw and QCstep1 var is PEA_i

Real

Phe_QCstep2 valid=1 LoD=01

New in R8. QCd metabolomics data (final) for phenylalanine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable phe. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Phe_raw and QCstep1 var is Phe

Real

Pro_QCstep2 valid=1 LoD=1

New in R8. QCd metabolomics data (final) for proline - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pro. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Pro_raw and QCstep1 var is Pro_i

Real

Ser_QCstep2 valid=1 LoD=1

New in R8. QCd metabolomics data (final) for serine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable ser. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Ser_raw and QCstep1 var is Ser_i

Real

Thr_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for threonine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable thr. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Thr_raw and QCstep1 var is Thr_i

Real

Trp_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for tryptophan - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable trp. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Trp_raw and QCstep1 var is Trp_i

Real

Tyr_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for tyrosine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable tyr. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Tyr_raw and QCstep1 var is Tyr

Real

Val_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for valine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable val. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Val_raw and QCstep1 var is Val

Real

AcOrn_QCstep2 valid=0 LoD=015

New in R8. QCd metabolomics data (final) for acetylornithine - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=0.15 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable acorn. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is AcOrn_raw and QCstep1 var is AcOrn_i

Real

SDMA_QCstep2 valid=1 LoD=03

New in R8. QCd metabolomics data (final) for symmetric dimethylarginine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.3 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable sdma. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SDMA_raw and QCstep1 var is SDMA_i

Real

alphaAAA_QCstep2 valid=0 LoD=03

New in R8. QCd metabolomics data (final) for alpha-aminoadipic acid - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=0.3 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable alphaaaa. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is alphaAAA_raw and QCstep1 var is alphaAAA_i

Real

Creatinine_QCstep2 valid=1 LoD=1

New in R8. QCd metabolomics data (final) for creatinine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable creatinine. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Creatinine_raw and QCstep1 var is Creatinine

Real

Kynurenine_QCstep2 valid=0 LoD=03

New in R8. QCd metabolomics data (final) for kynurenine - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=0.3 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable kynurenine. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Kynurenine_raw and QCstep1 var is Kynurenine_i

Real

MetSO_QCstep2 valid=0 LoD=03

New in R8. QCd metabolomics data (final) for methioninesulfoxide - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=0.3 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable metso. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is MetSO_raw and QCstep1 var is MetSO_i

Real

c4OHPro_QCstep2 valid=1 LoD=01

New in R8. QCd metabolomics data (final) for cis-hydroxyproline - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c4ohpro. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is c4OHPro_raw and QCstep1 var is c4OHPro_i

Real

t4OHPro_QCstep2 valid=1 LoD=01

New in R8. QCd metabolomics data (final) for trans-hydroxyproline - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.1 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable t4ohpro. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is t4OHPro_raw and QCstep1 var is t4OHPro

Real

Sarcosine_QCstep2 valid=1 LoD=03

New in R8. QCd metabolomics data (final) for sarcosine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.3 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable sarcosine. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Sarcosine_raw and QCstep1 var is Sarcosine_i

Real

Serotonin_QCstep2 valid=1 LoD=003

New in R8. QCd metabolomics data (final) for serotonin - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.03 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable serotonin. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Serotonin_raw and QCstep1 var is Serotonin_i

Real

Spermidine_QCstep2 valid=0 LoD=008

New in R8. QCd metabolomics data (final) for spermidine - Metabolomics measures in an absolute scale (uM) - validity=0 and LoD=0.08 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable spermidine. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Spermidine_raw and QCstep1 var is Spermidine_i

Real

Taurine_QCstep2 valid=1 LoD=05

New in R8. QCd metabolomics data (final) for taurine - Metabolomics measures in an absolute scale (uM) - validity=1 and LoD=0.5 uM based on the Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable taurine. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Taurine_raw and QCstep1 var is Taurine_i

Real

Biochem Comments

Comments from lab related to BioChem samples.

Text

BioChemFormRec

New in R7. Has the Biochemistry form been received

Categorical

None

Has Biochemistry data been imported into Study access database?

Categorical

Biochem Imported

Phase 2 data. Biochemistry Imported? Data from study database. 0 = No; 1 = Yes;

Categorical

None

Variable present in Fenland study database which indicates if there are any issues with biochemistry data collected.

Biochem Manual Edit Warning

Phase 2 data. Variable present in Fenland study database which indicates if there are any issues with biochemistry data collected. 0 = No; 1 = Yes;

Categorical

None

Biochemistry test results received date from test laboratory.

Date

Biochem Received Date

Phase 2 data. Date Phase 2 biochem sample was received in lab.

Date

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Integer

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Text

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Integer

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Text

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Date

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Integer

None

Phase 2 data. BioChemistry Import variable (leptin results only?). Fields with Data

Integer

None

Metabolomics Biocrates assay date (DD/MM/YYYY)

Date

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IFNg at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IFNg at T000 timepoint (fasting). Results for plates 1a to 41 were bridged with rest of the plates using a bridging factor of 1.645 to calculate Calc Conc Mean.

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used for IFNg at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IFNg at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IFNg at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IFNg at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IFNg at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IFNg at T120 timepoint (fasting). Results for plates 1a to 41 were bridged with rest of the plates using a bridging factor of 1.645 to calculate Calc Conc Mean. EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIFNg at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IFNg at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IFNg at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IFNg at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IL1b at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IL1b at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIL1b at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IL1b at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IL1b at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IL1b at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IL1b at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IL1b at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIL1b at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IL1b at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IL1b at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IL1b at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IL6 at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IL6 at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIL6 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IL6 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IL6 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IL6 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IL6 at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IL6 at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIL6 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IL6 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IL6 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IL6 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IL8 at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IL8 at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIL8 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IL8 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IL8 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IL8 at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for IL8 at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for IL8 at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forIL8 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for IL8 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for IL8 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For IL8 at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for TNFa at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for TNFa at T000 timepoint (fasting). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forTNFa at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for TNFa at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for TNFa at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For TNFa at T000 timepoint (fasting).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The CV of calculated concentation between intraplate (within plate) duplicates (where applicable) calculated by the MSD software for TNFa at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. The mean of calculated concentration in pg/mL calculated by the MSD software for TNFa at T120 timepoint (2hrs post glucose drink). EX = technical error; ALD = above upper limit of detectio; BLD = below lower limit of detection; PD = poor duplicate - CalcConcCV of within plate (intra-plate) duplicates higher than 20percent;

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate Barcode number of plate used forTNFa at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Random plate number (asigned by lab team) of plate used for TNFa at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Plate well in 96-well plate used for TNFa at T120 timepoint (2hrs post glucose drink).

Text

None

New for R8a. MSD Proinflammatory Cytokines Project 0139 measuring phase 1 serum samples for proinflammatory biomarkers using the MSD V-Plex Human proinflammatory panel I (4-plex) kits. Indication where measurement was in relation to detection range. Above Detection Range (above the calculated high). Or In Detection Range (between calculated high and calculated low. Or Below Detection Range and Below Fit Curve Range (below calculated low). For TNFa at T120 timepoint (2hrs post glucose drink).

Text

None

Metabolomics assay plate number as assigned by MRC Epi lab team

Integer

None

Metabolomics Random plate number as assigned by the data management team to be used to de-identify the results

Integer

C0_QCstep2 valid=1 LoD=4

New in R8. QCd metabolomics data (final) for carnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=4 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c0. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C0_raw and QCstep1 var is C0

Real

C2_QCstep2 valid=1 LoD=015

New in R8. QCd metabolomics data (final) for acetylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.15 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c2. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C2_raw and QCstep1 var is C2

Real

C3_QCstep2 valid=1 LoD=008

New in R8. QCd metabolomics data (final) for propionylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.08 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c3. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C3_raw and QCstep1 var is C3

Real

C31_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for propenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c31. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C31_raw and QCstep1 var is C31

Real

C3OH_QCstep2 valid=0 LoD=005

New in R8. QCd metabolomics data (final) for hydroxypropionylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.05 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c3oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C3OH_raw and QCstep1 var is C3OH

Real

C4_QCstep2 valid=1 LoD=003

New in R8. QCd metabolomics data (final) for butyrylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c4. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C4_raw and QCstep1 var is C4

Real

C41_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for butenylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c41. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C41_raw and QCstep1 var is C41

Real

C3DCMC5OH_QCstep2 valid=0 LoD=01

New in R8. QCd metabolomics data (final) for hydroxybutyrylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.1 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c3dcmc5oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C3DCMC5OH_raw and QCstep1 var is C3DCMC5OH

Real

C5_QCstep2 valid=1 LoD=004

New in R8. QCd metabolomics data (final) for valerylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c5. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C5_raw and QCstep1 var is C5

Real

C51_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for tiglylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c51. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C51_raw and QCstep1 var is C51

Real

C51DC_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for glutaconylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c51dc. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C51DC_raw and QCstep1 var is C51DC

Real

C5DCC6OH_QCstep2 valid=0 LoD=0035

New in R8. QCd metabolomics data (final) for glutarylcarnitine (hydroxihexanoylcarnitine) - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.035 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c5dcc6oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C5DCC6OH_raw and QCstep1 var is C5DCC6OH

Real

C5MDC_QCstep2 valid=0 LoD=006

New in R8. QCd metabolomics data (final) for methylglutarylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.06 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c5mdc. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C5MDC_raw and QCstep1 var is C5MDC

Real

C3DCC4OH_QCstep2 valid=0 LoD=009

New in R8. QCd metabolomics data (final) for hydroxyvalerylcarnitine (methylmalonlcarnitine) - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.09 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c3dcc4oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C3DCC4OH_raw and QCstep1 var is C3DCC4OH

Real

C6C41DC_QCstep2 valid=1 LoD=008

New in R8. QCd metabolomics data (final) for hexanoylcarnitine (fumarylcarnitine) - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.08 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c6c41dc. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C6C41DC_raw and QCstep1 var is C6C41DC

Real

C61_QCstep2 valid=0 LoD=0035

New in R8. QCd metabolomics data (final) for hexenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.035 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c61. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C61_raw and QCstep1 var is C61

Real

C7DC_QCstep2 valid=0 LoD=0035

New in R8. QCd metabolomics data (final) for pimelylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.035 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c7dc. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C7DC_raw and QCstep1 var is C7DC

Real

C8_QCstep2 valid=1 LoD=017

New in R8. QCd metabolomics data (final) for octanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.17 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c8. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C8_raw and QCstep1 var is C8

Real

C9_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for nonaylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c9. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C9_raw and QCstep1 var is C9

Real

C10_QCstep2 valid=1 LoD=016

New in R8. QCd metabolomics data (final) for decanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.16 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c10. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C10_raw and QCstep1 var is C10

Real

C101_QCstep2 valid=0 LoD=012

New in R8. QCd metabolomics data (final) for decenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.12 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c101. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C101_raw and QCstep1 var is C101

Real

C102_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for decadienylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c102. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C102_raw and QCstep1 var is C102

Real

C12_QCstep2 valid=1 LoD=0057

New in R8. QCd metabolomics data (final) for dodecanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.057 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c12. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C12_raw and QCstep1 var is C12

Real

C12DC_QCstep2 valid=0 LoD=02

New in R8. QCd metabolomics data (final) for dodecaenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c12dc. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C12DC_raw and QCstep1 var is C12DC

Real

C121_QCstep2 valid=0 LoD=02

New in R8. QCd metabolomics data (final) for dodecanedioylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c121. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C121_raw and QCstep1 var is C121

Real

C14_QCstep2 valid=1 LoD=003

New in R8. QCd metabolomics data (final) for tetradecanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c14. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C14_raw and QCstep1 var is C14

Real

C141_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for tetradecenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c141. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C141_raw and QCstep1 var is C141

Real

C141OH_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for hydroxytetradecenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c141oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C141OH_raw and QCstep1 var is C141OH

Real

C142_QCstep2 valid=0 LoD=0012

New in R8. QCd metabolomics data (final) for tetradecadienylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.012 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c142. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C142_raw and QCstep1 var is C142

Real

C142OH_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for hydroxytetradecadienylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c142oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C142OH_raw and QCstep1 var is C142OH

Real

C16_QCstep2 valid=1 LoD=0018

New in R8. QCd metabolomics data (final) for hexadecanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.018 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c16. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C16_raw and QCstep1 var is C16

Real

C161_QCstep2 valid=0 LoD=006

New in R8. QCd metabolomics data (final) for hexadecenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.06 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c161. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C161_raw and QCstep1 var is C161

Real

C161OH_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for hydroxyhexadecenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c161oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C161OH_raw and QCstep1 var is C161OH

Real

C162_QCstep2 valid=0 LoD=0008

New in R8. QCd metabolomics data (final) for hexadecadienylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.008 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c162. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C162_raw and QCstep1 var is C162

Real

C162OH_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for hydroxyhexadecadienylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c162oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C162OH_raw and QCstep1 var is C162OH

Real

C16OH_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for hydroxyhexadecanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c16oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C16OH_raw and QCstep1 var is C16OH

Real

C18_QCstep2 valid=1 LoD=002

New in R8. QCd metabolomics data (final) for octadecanoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c18. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C18_raw and QCstep1 var is C18_i

Real

C181_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for octadecenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c181. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C181_raw and QCstep1 var is C181_i

Real

C181OH_QCstep2 valid=0 LoD=0023

New in R8. QCd metabolomics data (final) for hydroxyoctadecenoylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.023 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c181oh. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C181OH_raw and QCstep1 var is C181OH_i

Real

C182_QCstep2 valid=0 LoD=0009

New in R8. QCd metabolomics data (final) for octadecadienylcarnitine - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.009 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable c182. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is C182_raw and QCstep1 var is C182_i

Real

PCaaC240_QCstep2 valid=0 LoD=01

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C240 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.1 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac240. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC240_raw and QCstep1 var is PCaaC240_i

Real

lysoPCaC140_QCstep2 valid=0 LoD=5

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C140 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=5 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac140. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC140_raw and QCstep1 var is lysoPCaC140

Real

lysoPCaC161_QCstep2 valid=0 LoD=007

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C161 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.07 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac161. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC161_raw and QCstep1 var is lysoPCaC161

Real

lysoPCaC170_QCstep2 valid=0 LoD=005

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C170 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.05 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac170. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC170_raw and QCstep1 var is lysoPCaC170

Real

lysoPCaC180_QCstep2 valid=0 LoD=005

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C180 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.05 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac180. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC180_raw and QCstep1 var is lysoPCaC180

Real

lysoPCaC182_QCstep2 valid=0 LoD=01

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C182 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.1 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac182. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC182_raw and QCstep1 var is lysoPCaC182

Real

lysoPCaC204_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C204 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac204. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC204_raw and QCstep1 var is lysoPCaC204

Real

PCaaC260_QCstep2 valid=0 LoD=14

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C260 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=1.4 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac260. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC260_raw and QCstep1 var is PCaaC260_i

Real

PCaaC281_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C281 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac281. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC281_raw and QCstep1 var is PCaaC281_i

Real

PCaaC300_QCstep2 valid=0 LoD=02

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C300 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac300. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC300_raw and QCstep1 var is PCaaC300_i

Real

lysoPCaC261_QCstep2 valid=0 LoD=4

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C261 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=4 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac261. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC261_raw and QCstep1 var is lysoPCaC261

Real

lysoPCaC160_QCstep2 valid=0 LoD=012

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C160 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.12 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac160. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC160_raw and QCstep1 var is lysoPCaC160_i

Real

lysoPCaC181_QCstep2 valid=0 LoD=01

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C181 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.1 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac181. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC181_raw and QCstep1 var is lysoPCaC181_i

Real

lysoPCaC203_QCstep2 valid=0 LoD=02

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C203 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac203. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC203_raw and QCstep1 var is lysoPCaC203_i

Real

lysoPCaC240_QCstep2 valid=0 LoD=13

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C240 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=1.3 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac240. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC240_raw and QCstep1 var is lysoPCaC240_i

Real

lysoPCaC260_QCstep2 valid=0 LoD=05

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C260 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.5 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac260. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC260_raw and QCstep1 var is lysoPCaC260_i

Real

PCaaC320_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C320 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac320. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC320_raw and QCstep1 var is PCaaC320_i

Real

PCaaC321_QCstep2 valid=0 LoD=006

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C321 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.06 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac321. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC321_raw and QCstep1 var is PCaaC321_i

Real

PCaaC322_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C322 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac322. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC322_raw and QCstep1 var is PCaaC322_i

Real

lysoPCaC280_QCstep2 valid=0 LoD=033

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C280 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.33 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac280. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC280_raw and QCstep1 var is lysoPCaC280_i

Real

lysoPCaC281_QCstep2 valid=0 LoD=015

New in R8. QCd metabolomics data (final) for lysoPhosphatidylcholine acyl C281 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.15 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable lysopcac281. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is lysoPCaC281_raw and QCstep1 var is lysoPCaC281_i

Real

PCaaC323_QCstep2 valid=0 LoD=0008

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C323 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.008 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac323. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC323_raw and QCstep1 var is PCaaC323_i

Real

PCaaC341_QCstep2 valid=0 LoD=006

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C341 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.06 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac341. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC341_raw and QCstep1 var is PCaaC341_i

Real

PCaaC342_QCstep2 valid=0 LoD=01

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C342 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.1 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac342. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC342_raw and QCstep1 var is PCaaC342_i

Real

PCaaC343_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C343 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac343. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC343_raw and QCstep1 var is PCaaC343_i

Real

PCaaC344_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C344 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac344. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC344_raw and QCstep1 var is PCaaC344_i

Real

PCaaC360_QCstep2 valid=0 LoD=02

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C360 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac360. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC360_raw and QCstep1 var is PCaaC360_i

Real

PCaaC361_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C361 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac361. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC361_raw and QCstep1 var is PCaaC361_i

Real

PCaaC362_QCstep2 valid=0 LoD=015

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C362 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.15 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac362. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC362_raw and QCstep1 var is PCaaC362_i

Real

PCaaC363_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C363 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac363. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC363_raw and QCstep1 var is PCaaC363_i

Real

PCaaC364_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C364 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac364. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC364_raw and QCstep1 var is PCaaC364_i

Real

PCaaC365_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C365 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac365. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC365_raw and QCstep1 var is PCaaC365_i

Real

PCaaC366_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C366 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac366. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC366_raw and QCstep1 var is PCaaC366_i

Real

PCaaC380_QCstep2 valid=0 LoD=02

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C380 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac380. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC380_raw and QCstep1 var is PCaaC380_i

Real

PCaaC381_QCstep2 valid=0 LoD=008

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C381 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.08 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac381. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC381_raw and QCstep1 var is PCaaC381_i

Real

PCaaC383_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C383 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac383. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC383_raw and QCstep1 var is PCaaC383_i

Real

PCaaC384_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C384 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac384. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC384_raw and QCstep1 var is PCaaC384_i

Real

PCaaC385_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C385 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac385. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC385_raw and QCstep1 var is PCaaC385_i

Real

PCaaC386_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C386 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac386. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC386_raw and QCstep1 var is PCaaC386_i

Real

PCaaC401_QCstep2 valid=0 LoD=04

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C401 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.4 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac401. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC401_raw and QCstep1 var is PCaaC401_i

Real

PCaaC402_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C402 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac402. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC402_raw and QCstep1 var is PCaaC402_i

Real

PCaaC403_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C403 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac403. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC403_raw and QCstep1 var is PCaaC403_i

Real

PCaaC404_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C404 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac404. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC404_raw and QCstep1 var is PCaaC404_i

Real

PCaaC405_QCstep2 valid=0 LoD=004

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C405 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.04 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac405. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC405_raw and QCstep1 var is PCaaC405_i

Real

PCaaC406_QCstep2 valid=0 LoD=12

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C406 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=1.2 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac406. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC406_raw and QCstep1 var is PCaaC406_i

Real

PCaaC420_QCstep2 valid=0 LoD=005

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C420 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.05 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac420. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC420_raw and QCstep1 var is PCaaC420_i

Real

PCaaC421_QCstep2 valid=0 LoD=0008

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C421 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.008 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac421. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC421_raw and QCstep1 var is PCaaC421_i

Real

PCaaC422_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C422 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac422. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC422_raw and QCstep1 var is PCaaC422_i

Real

PCaaC424_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C424 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac424. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC424_raw and QCstep1 var is PCaaC424_i

Real

PCaaC425_QCstep2 valid=0 LoD=005

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C425 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.05 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac425. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC425_raw and QCstep1 var is PCaaC425_i

Real

PCaaC426_QCstep2 valid=0 LoD=03

New in R8. QCd metabolomics data (final) for phosphatidylcholine diacyl C426 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.3 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaac426. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaaC426_raw and QCstep1 var is PCaaC426_i

Real

PCaeC300_QCstep2 valid=0 LoD=015

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C300 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.15 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec300. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC300_raw and QCstep1 var is PCaeC300_i

Real

PCaeC301_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C301 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec301. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC301_raw and QCstep1 var is PCaeC301_i

Real

PCaeC302_QCstep2 valid=0 LoD=057

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C302 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.57 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec302. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC302_raw and QCstep1 var is PCaeC302_i

Real

PCaeC321_QCstep2 valid=0 LoD=0009

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C321 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.009 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec321. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC321_raw and QCstep1 var is PCaeC321_i

Real

PCaeC322_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C322 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec322. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC322_raw and QCstep1 var is PCaeC322_i

Real

PCaeC340_QCstep2 valid=0 LoD=0017

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C340 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.017 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec340. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC340_raw and QCstep1 var is PCaeC340_i

Real

PCaeC341_QCstep2 valid=0 LoD=0012

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C341 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.012 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec341. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC341_raw and QCstep1 var is PCaeC341_i

Real

PCaeC342_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C342 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec342. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC342_raw and QCstep1 var is PCaeC342_i

Real

PCaeC343_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C343 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec343. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC343_raw and QCstep1 var is PCaeC343_i

Real

PCaeC360_QCstep2 valid=0 LoD=012

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C360 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.12 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec360. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC360_raw and QCstep1 var is PCaeC360_i

Real

PCaeC361_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C361 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec361. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC361_raw and QCstep1 var is PCaeC361_i

Real

PCaeC362_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C362 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec362. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC362_raw and QCstep1 var is PCaeC362_i

Real

PCaeC363_QCstep2 valid=0 LoD=0007

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C363 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.007 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec363. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC363_raw and QCstep1 var is PCaeC363_i

Real

PCaeC364_QCstep2 valid=0 LoD=0013

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C364 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.013 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec364. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC364_raw and QCstep1 var is PCaeC364_i

Real

PCaeC365_QCstep2 valid=0 LoD=0012

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C365 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.012 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec365. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC365_raw and QCstep1 var is PCaeC365_i

Real

PCaeC380_QCstep2 valid=0 LoD=0066

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C380 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.066 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec380. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC380_raw and QCstep1 var is PCaeC380_i

Real

PCaeC381_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C381 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec381. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC381_raw and QCstep1 var is PCaeC381_i

Real

PCaeC382_QCstep2 valid=0 LoD=0018

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C382 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.018 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec382. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC382_raw and QCstep1 var is PCaeC382_i

Real

PCaeC383_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C383 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec383. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC383_raw and QCstep1 var is PCaeC383_i

Real

PCaeC384_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C384 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec384. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC384_raw and QCstep1 var is PCaeC384_i

Real

PCaeC385_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C385 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec385. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC385_raw and QCstep1 var is PCaeC385_i

Real

PCaeC386_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C386 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec386. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC386_raw and QCstep1 var is PCaeC386_i

Real

PCaeC401_QCstep2 valid=0 LoD=006

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C401 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.06 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec401. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC401_raw and QCstep1 var is PCaeC401_i

Real

PCaeC402_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C402 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec402. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC402_raw and QCstep1 var is PCaeC402_i

Real

PCaeC403_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C403 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec403. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC403_raw and QCstep1 var is PCaeC403_i

Real

PCaeC404_QCstep2 valid=0 LoD=01

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C404 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.1 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec404. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC404_raw and QCstep1 var is PCaeC404_i

Real

PCaeC405_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C405 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec405. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC405_raw and QCstep1 var is PCaeC405_i

Real

PCaeC406_QCstep2 valid=0 LoD=0025

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C406 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.025 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec406. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC406_raw and QCstep1 var is PCaeC406_i

Real

PCaeC420_QCstep2 valid=0 LoD=04

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C420 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.4 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec420. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC420_raw and QCstep1 var is PCaeC420_i

Real

PCaeC421_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C421 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec421. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC421_raw and QCstep1 var is PCaeC421_i

Real

PCaeC422_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C422 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec422. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC422_raw and QCstep1 var is PCaeC422_i

Real

PCaeC423_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C423 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec423. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC423_raw and QCstep1 var is PCaeC423_i

Real

PCaeC424_QCstep2 valid=0 LoD=03

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C424 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.3 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec424. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC424_raw and QCstep1 var is PCaeC424_i

Real

PCaeC425_QCstep2 valid=0 LoD=13

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C425 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=1.3 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec425. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC425_raw and QCstep1 var is PCaeC425_i

Real

PCaeC443_QCstep2 valid=0 LoD=0006

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C443 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.006 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec443. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC443_raw and QCstep1 var is PCaeC443_i

Real

PCaeC445_QCstep2 valid=0 LoD=002

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C445 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.02 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec445. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC445_raw and QCstep1 var is PCaeC445_i

Real

PCaeC446_QCstep2 valid=0 LoD=009

New in R8. QCd metabolomics data (final) for phosphatidylcholine acyl-alkyl C446 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.09 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable pcaec446. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is PCaeC446_raw and QCstep1 var is PCaeC446_i

Real

SMC160_QCstep2 valid=0 LoD=003

New in R8. QCd metabolomics data (final) for shpingomyeline C160 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.03 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc160. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC160_raw and QCstep1 var is SMC160_i

Real

SMC161_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for shpingomyeline C161 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc161. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC161_raw and QCstep1 var is SMC161_i

Real

SMC180_QCstep2 valid=0 LoD=007

New in R8. QCd metabolomics data (final) for shpingomyeline C180 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.07 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc180. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC180_raw and QCstep1 var is SMC180_i

Real

SMC181_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for shpingomyeline C181 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc181. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC181_raw and QCstep1 var is SMC181_i

Real

SMC202_QCstep2 valid=0 LoD=0005

New in R8. QCd metabolomics data (final) for shpingomyeline C202 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.005 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc202. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC202_raw and QCstep1 var is SMC202_i

Real

SMC240_QCstep2 valid=0 LoD=013

New in R8. QCd metabolomics data (final) for shpingomyeline C240 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.13 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc240. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC240_raw and QCstep1 var is SMC240_i

Real

SMC241_QCstep2 valid=0 LoD=0035

New in R8. QCd metabolomics data (final) for shpingomyeline C241 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.035 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smc241. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMC241_raw and QCstep1 var is SMC241_i

Real

SMOHC141_QCstep2 valid=0 LoD=0025

New in R8. QCd metabolomics data (final) for hydroxysphingomyeline C141 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.025 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smohc141. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMOHC141_raw and QCstep1 var is SMOHC141_i

Real

SMOHC161_QCstep2 valid=0 LoD=0012

New in R8. QCd metabolomics data (final) for hydroxysphingomyeline C161 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.012 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smohc161. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMOHC161_raw and QCstep1 var is SMOHC161_i

Real

SMOHC221_QCstep2 valid=0 LoD=0015

New in R8. QCd metabolomics data (final) for hydroxysphingomyeline C221 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.015 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smohc221. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMOHC221_raw and QCstep1 var is SMOHC221_i

Real

SMOHC222_QCstep2 valid=0 LoD=001

New in R8. QCd metabolomics data (final) for hydroxysphingomyeline C222 - Metabolomics measures in a relative scale (uM) - validity=0 and LoD=0.01 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable smohc222. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is SMOHC222_raw and QCstep1 var is SMOHC222_i

Real

Hexose_QCstep2 valid=1 LoD=20

New in R8. QCd metabolomics data (final) for hexose - Metabolomics measures in a relative scale (uM) - validity=1 and LoD=20 based on Biocrates report - processed for analysis use -derived by 2-step QC process from raw variable hexose. Assayed in MRC HNR lab on plasma using Liquid Chromatography Mass Spec with batch correction via location-scale method after 1) normalisation of a Box-Cox type and 2) winsorisation based on overall mean +/- 5 x batch-specific standard deviation - see the Fenland document on metabolomics for more details) Raw var is Hexose_raw and QCstep1 var is Hexose_i

Real

None

Metabolomics Biocrates assay well position(s)

Text

OLINK assay BIRC2

Phase 1 OLINK assay data for target BIRC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Year of birth of participant.

OLINK assay BLM hydrolase

Phase 1 OLINK assay data for target BLM hydrolase in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BLVRB

Phase 1 OLINK assay data for target BLVRB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BMP-4

Phase 1 OLINK assay data for target BMP-4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BMP-6

Phase 1 OLINK assay data for target BMP-6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

BNF_BetaBlocker

Has the volunteer reported usage of Beta blockers on the general questionnaire as defined by the following BNF code: 2.4 or 2.12 or 6.1.2 This does not imply that the volunteer is not on betablockers if the code here is 0 since there are more BNF codes for betablocker. Please use variable BNF_Betablocker_Pateam instead as an accurate indication of betablocker use.

Categorical

BNF_LipidLowering

Has the participant reported usage of Lipid lowering agents as defined by the following BNF code: 2.12

Categorical

OralAntidiabetic

Has the participant reported usage of Oral antidiabetic agents as defined by the following BNF code: 6.1.2

Categorical

OLINK assay BNP

Phase 1 OLINK assay data for target BNP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BOC

Phase 1 OLINK assay data for target BOC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BOC

Phase 1 OLINK assay data for target BOC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Body fat percent consolidated

Derived variable from Anthro data. This is AD47_DEXA_body_fat_percent data if it is available (since this is better data) if not it is E_TANITA_BodyFatPcnt data.

Real

Body fat percent device

Derived variable from Anthro data. To clarify whether BodyFatPercent_Cons data is DEXA data (AD47_DEXA_body_fat_percent) or Tanita data (E_TANITA_BodyFatPcnt). (Indicates the type of device that was used for reporting body fat percent for BodyFatPercent_Cons).

Text

Body Fat Percent Cons Device

Phase 2 data. Derived variable from Anthro data. To clarify whether BodyFatPercent_Cons data is DEXA data (AD47_DEXA_body_fat_percent_P2) or Tanita data (E_TANITA_BodyFatPcnt_P2). (Indicates the type of device that was used for reporting body fat percent for BodyFatPercent_Cons_P2).

Real

Body Fat Percent Cons

Phase 2 data. Derived variable from Anthro data. This is AD47_DEXA_body_fat_percent_P2 data if it is available (since this is better data) if not it is E_TANITA_BodyFatPcnt_P2 data.

Real

None

Fenland phase 1 serum sample Beta Hydroxy Butyrate measurement in umol/L. Only 24 samples were analysed for a small substudy.

Real

Hours of bowling

Please indicate the average length of time (in hours) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin).

Integer

Hours of bowling hrs CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Bowling hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Bowling hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin). -1 = left blank. DO NOT USE THIS VARIABLE. Use bowlingHr_CLEAN_P2 instead.

Real

Minutes of bowling

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin).

Integer

Minutes of bowling mins CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Bowling min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Bowling min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Avg duration of bowling (indoor lawn or 10-pin). -1 = left blank. DO NOT USE THIS VARIABLE. Use bowlingMin_CLEAN_P2 instead.

Real

Frequency of bowling CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Bowling (indoor lawn or 10-pin). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

bowling_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for bowling (mins)

Real

Cln variable: Bowling

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Bowling (indoor lawn or 10-pin). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

bowling_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Bowling (indoor lawn or 10-pin). Data normalised to DE template 1 data.

Categorical

Bowling

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks.Bowling. DO NOT USE THIS VARIABLE. Use bowling_CLEAN_P2 instead.

Real

Bowling

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Bowling (indoor lawn or 10-pin). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of bowling DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Bowling (indoor lawn or 10-pin). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in bowling_T2. Instead use bowling_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of bowling DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Bowling (indoor lawn or 10-pin). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in bowling_T1. Instead use bowling_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

First Diastolic Blood Pressure Measurement

First Diastolic Blood Pressure Measurement - BPDia1 in mmHg/min

Integer

First Diastolic Blood Pressure

Phase 2 data. First Diastolic Blood Pressure Measurement - BPDia1 in mmHg/min

Real

Second Diastolic Blood Pressure Measurement

Second Diastolic Blood Pressure Measurement - BPDia2 in mmHg/min

Integer

Second Diastolic Blood Pressure

Phase 2 data. Second Diastolic Blood Pressure Measurement - BPDia2 in mmHg/min

Real

Third Diastolic Blood Pressure Measurement

Third Diastolic Blood Pressure Measurement -BPDia3 in mmHg/min

Integer

Third Diastolic Blood Pressure

Phase 2 data. Third Diastolic Blood Pressure Measurement -BPDia3 in mmHg/min

Real

First Pulse Rate Measurement

First Pulse Rate Measurement - BPPR1 in beats/min bpm

Integer

First Pulse Rate Measurement

Phase 2 data. First Pulse Rate Measurement - BPPR1 in beats/min bpm

Real

Second Pulse Rate Measurement

Second Pulse Rate Measuremen - BPPR2 in beats/min bpm

Integer

Second Pulse Rate Measurement

Phase 2 data. Second Pulse Rate Measuremen - BPPR2 in beats/min bpm

Real

Third Pulse Rate Measurement

Third Pulse Rate Measurement - BPPR3 in beats/min bpm

Integer

Third Pulse Rate Measurement

Phase 2 data. Third Pulse Rate Measurement - BPPR3 in beats/min bpm

Real

First Systolic Blood Pressure Measurement

First Systolic Blood Pressure Measurement - BPSys1 in mmHg/min

Integer

First Systolic Blood Pressure

Phase 2 data. First Systolic Blood Pressure Measurement - BPSys1 in mmHg/min

Real

Second Systolic Blood Pressure Measurement

Second Systolic Blood Pressure Measurement - BPSys2 in mmHg/min

Integer

Second Systolic Blood Pressure

Phase 2 data. Second Systolic Blood Pressure Measurement - BPSys2 in mmHg/min

Real

Third Systolic Blood Pressure Measurement

Third Systolic Blood Pressure Measuremen - BPSys3 in mmHg/min

Integer

Third Systolic Blood Pressure

Phase 2 data. Third Systolic Blood Pressure Measuremen - BPSys3 in mmHg/min

Real

White bread and rolls ERROR CODES CLEANED

Average use last year of White bread and rolls After cleaning this variable is renamed as WHITE_BREAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Brown bread and rolls ERROR CODES CLEANED

Average use last year of Brown bread and rolls After cleaning this variable is renamed as BROWN_BREAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Wholemeal bread and rolls ERROR CODES CLEANED

Average use last year of Wholemeal bread and rolls After cleaning this variable is renamed as WHOLEMEAL_BREAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cream crackers cheese biscuits ERROR CODES CLEANED

Average use last year of Cream crackers cheese biscuits After cleaning this variable is renamed as CRACKERS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Crispbread eg Ryvita ERROR CODES CLEANED

Average use last year of Crispbread eg Ryvita After cleaning this variable is renamed as CRISPBREAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

White bread and rolls

Average use last year of White bread and rolls. After cleaning this variable is renamed as WHITE_BREAD which is then used by the FETA program for analysis.

Categorical

White bread and rolls

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Brown bread and rolls

Average use last year of Brown bread and rolls. After cleaning this variable is renamed as BROWN_BREAD which is then used by the FETA program for analysis.

Categorical

Brown bread and rolls

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Wholemeal bread and rolls

Average use last year of Wholemeal bread and rolls. After cleaning this variable is renamed as WHOLEMEAL_BREAD which is then used by the FETA program for analysis.

Categorical

Wholemeal bread and rolls

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cream crackers; cheese biscuits

Average use last year of Cream crackers cheese biscuits. After cleaning this variable is renamed as CRACKERS which is then used by the FETA program for analysis.

Categorical

Cream crackers; cheese biscuits

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Crispbread eg Ryvita

Average use last year of Crispbread eg Ryvita. After cleaning this variable is renamed as CRISPBREAD which is then used by the FETA program for analysis.

Categorical

Crispbread eg Ryvita

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay BST1

Phase 1 OLINK assay data for target BST1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BST2

Phase 1 OLINK assay data for target BST2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BTC

Phase 1 OLINK assay data for target BTC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay BTN3A2

Phase 1 OLINK assay data for target BTN3A2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

C0_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C0_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=4. 2nd and final QC step on this var created new and final var BIOR_001.

Real

C10_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C10_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.16. 2nd and final QC step on this var created new and final var BIOR_020.

Real

C101_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C101_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.12. 2nd and final QC step on this var created new and final var BIOR_021.

Real

C102_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C102_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_022.

Real

C12_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C12_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.057. 2nd and final QC step on this var created new and final var BIOR_023.

Real

C121_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C121_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.2. 2nd and final QC step on this var created new and final var BIOR_025.

Real

C12DC_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C12DC_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.2. 2nd and final QC step on this var created new and final var BIOR_024.

Real

C14_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C14_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_026.

Real

C141_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C141_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_027.

Real

C141OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C141OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_028.

Real

C142_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C142_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.012. 2nd and final QC step on this var created new and final var BIOR_029.

Real

C142OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C142OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_030.

Real

C16_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C16_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.018. 2nd and final QC step on this var created new and final var BIOR_031.

Real

C161_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C161_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.06. 2nd and final QC step on this var created new and final var BIOR_032.

Real

C161OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C161OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_033.

Real

C162_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C162_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.008. 2nd and final QC step on this var created new and final var BIOR_034.

Real

C162OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C162OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_035.

Real

C16OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C16OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_036.

Real

C181OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C181OH_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.023. 2nd and final QC step on this var created new and final var BIOR_039.

Real

C181_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C181_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_038.

Real

C182_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C182_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.009. 2nd and final QC step on this var created new and final var BIOR_040.

Real

C18_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C18_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=1 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_037.

Real

OLINK assay C1QTNF1

Phase 1 OLINK assay data for target C1QTNF1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

C2_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C2_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.15. 2nd and final QC step on this var created new and final var BIOR_002.

Real

OLINK assay C2

Phase 1 OLINK assay data for target C2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

C3_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C3_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.08. 2nd and final QC step on this var created new and final var BIOR_003.

Real

C31_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C31_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_004.

Real

C3DCC4OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C3DCC4OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.09. 2nd and final QC step on this var created new and final var BIOR_014.

Real

C3DCMC5OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C3DCMC5OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.1. 2nd and final QC step on this var created new and final var BIOR_008.

Real

C3OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C3OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.05. 2nd and final QC step on this var created new and final var BIOR_005.

Real

C4_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C4_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_006.

Real

C41_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C41_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_007.

Real

c4OHPro_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable c4OHPro_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_029.

Real

C5_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C5_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_009.

Real

C51_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C51_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_010.

Real

C51DC_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C51DC_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_011.

Real

C5DCC6OH_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C5DCC6OH_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.035. 2nd and final QC step on this var created new and final var BIOR_012.

Real

C5MDC_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C5MDC_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.06. 2nd and final QC step on this var created new and final var BIOR_013.

Real

C61_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C61_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.035. 2nd and final QC step on this var created new and final var BIOR_016.

Real

C6C41DC_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C6C41DC_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.08. 2nd and final QC step on this var created new and final var BIOR_015.

Real

C7DC_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C7DC_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.035. 2nd and final QC step on this var created new and final var BIOR_017.

Real

C8_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C8_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=1 LoD=0.17. 2nd and final QC step on this var created new and final var BIOR_018.

Real

C9_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable C9_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_019.

Real

OLINK assay CA12

Phase 1 OLINK assay data for target CA12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA13

Phase 1 OLINK assay data for target CA13 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA14

Phase 1 OLINK assay data for target CA14 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA1

Phase 1 OLINK assay data for target CA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA2

Phase 1 OLINK assay data for target CA2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA3

Phase 1 OLINK assay data for target CA3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA4

Phase 1 OLINK assay data for target CA4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA5A

Phase 1 OLINK assay data for target CA5A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CA6

Phase 1 OLINK assay data for target CA6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CADM3

Phase 1 OLINK assay data for target CADM3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CAIX

Phase 1 OLINK assay data for target CAIX in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CALCA

Phase 1 OLINK assay data for target CALCA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Calcium 0 minutes

Serum Calcium measurement taken at 0 minutes in mmol/l

Real

Calcium 0 minutes

Phase 2 data. Serum Calcium measurement taken at 0 minutes in mmol/l

Real

calcium_channel_blocker

Phase 2 data. Binary variable indicating whether a drug from the calcium channel blocker class was prescribed. 0 = No; 1 = Yes;

Categorical

Calibn Quality

The quality of the AH treadmill trace:

Categorical

Quality of the AH treadmill trace

Phase 2 data. The quality of the AH treadmill trace: 1 = pass; 0 = fail;

Categorical

OLINK assay CALR

Phase 1 OLINK assay data for target CALR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CAMKK1

Phase 1 OLINK assay data for target CAMKK1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CANT1

Phase 1 OLINK assay data for target CANT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CAPG

Phase 1 OLINK assay data for target CAPG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

CARadj

CARadj. Derived Intermediate not for general release. Data can be provided if necessary.

Real

OLINK assay CARHSP1

Phase 1 OLINK assay data for target CARHSP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

CARMILES

CARMILES. Derived Intermediate not for general release. Data can be provided if necessary.

Real

OLINK assay CASP-3

Phase 1 OLINK assay data for target CASP-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CASP-8

Phase 1 OLINK assay data for target CASP-8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CBL

Phase 1 OLINK assay data for target CBL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCDC80

Phase 1 OLINK assay data for target CCDC80 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL11

Phase 1 OLINK assay data for target CCL11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL11

Phase 1 OLINK assay data for target CCL11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL14

Phase 1 OLINK assay data for target CCL14 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL15

Phase 1 OLINK assay data for target CCL15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL16

Phase 1 OLINK assay data for target CCL16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL17

Phase 1 OLINK assay data for target CCL17 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL18

Phase 1 OLINK assay data for target CCL18 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL19

Phase 1 OLINK assay data for target CCL19 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL20

Phase 1 OLINK assay data for target CCL20 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL21

Phase 1 OLINK assay data for target CCL21 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL23

Phase 1 OLINK assay data for target CCL23 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL24

Phase 1 OLINK assay data for target CCL24 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL25

Phase 1 OLINK assay data for target CCL25 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL27

Phase 1 OLINK assay data for target CCL27 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL28

Phase 1 OLINK assay data for target CCL28 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL3

Phase 1 OLINK assay data for target CCL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL3

Phase 1 OLINK assay data for target CCL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL4

Phase 1 OLINK assay data for target CCL4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CCL5

Phase 1 OLINK assay data for target CCL5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD109

Phase 1 OLINK assay data for target CD109 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD160

Phase 1 OLINK assay data for target CD160 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD163

Phase 1 OLINK assay data for target CD163 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD164

Phase 1 OLINK assay data for target CD164 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD177

Phase 1 OLINK assay data for target CD177 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD1C

Phase 1 OLINK assay data for target CD1C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD200R1

Phase 1 OLINK assay data for target CD200R1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD200

Phase 1 OLINK assay data for target CD200 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD207

Phase 1 OLINK assay data for target CD207 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD209

Phase 1 OLINK assay data for target CD209 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD244

Phase 1 OLINK assay data for target CD244 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD27

Phase 1 OLINK assay data for target CD27 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD28

Phase 1 OLINK assay data for target CD28 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD2AP

Phase 1 OLINK assay data for target CD2AP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD300LG

Phase 1 OLINK assay data for target CD300LG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD302

Phase 1 OLINK assay data for target CD302 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD33

Phase 1 OLINK assay data for target CD33 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD38

Phase 1 OLINK assay data for target CD38 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD40

Phase 1 OLINK assay data for target CD40 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD40-L

Phase 1 OLINK assay data for target CD40-L in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD46

Phase 1 OLINK assay data for target CD46 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD48

Phase 1 OLINK assay data for target CD48 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD4

Phase 1 OLINK assay data for target CD4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD58

Phase 1 OLINK assay data for target CD58 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD59

Phase 1 OLINK assay data for target CD59 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD5

Phase 1 OLINK assay data for target CD5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD63

Phase 1 OLINK assay data for target CD63 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD69

Phase 1 OLINK assay data for target CD69 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD6

Phase 1 OLINK assay data for target CD6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD70

Phase 1 OLINK assay data for target CD70 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD74

Phase 1 OLINK assay data for target CD74 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD79B

Phase 1 OLINK assay data for target CD79B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD83

Phase 1 OLINK assay data for target CD83 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD84

Phase 1 OLINK assay data for target CD84 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD8A

Phase 1 OLINK assay data for target CD8A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD93

Phase 1 OLINK assay data for target CD93 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD97

Phase 1 OLINK assay data for target CD97 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CD99L2

Phase 1 OLINK assay data for target CD99L2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDCP1

Phase 1 OLINK assay data for target CDCP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH15

Phase 1 OLINK assay data for target CDH15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH17

Phase 1 OLINK assay data for target CDH17 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH1

Phase 1 OLINK assay data for target CDH1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH2

Phase 1 OLINK assay data for target CDH2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH3

Phase 1 OLINK assay data for target CDH3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH5

Phase 1 OLINK assay data for target CDH5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDH6

Phase 1 OLINK assay data for target CDH6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDHR5

Phase 1 OLINK assay data for target CDHR5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDKN1A

Phase 1 OLINK assay data for target CDKN1A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDNF

Phase 1 OLINK assay data for target CDNF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDON

Phase 1 OLINK assay data for target CDON in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CDSN

Phase 1 OLINK assay data for target CDSN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CEACAM1

Phase 1 OLINK assay data for target CEACAM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CEACAM3

Phase 1 OLINK assay data for target CEACAM3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CEACAM5

Phase 1 OLINK assay data for target CEACAM5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CEACAM8

Phase 1 OLINK assay data for target CEACAM8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Porridge; Readybrek ERROR CODES CLEANED

How often did you eat Porridge/ readybrek (one bowl) on average last year After cleaning this variable is renamed as PORRIDGE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Breakfast cereal ERROR CODES CLEANED

How often did you eatbreakfast cereal (one bowl) on average last year After cleaning this variable is renamed as CEREAL which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Porridge; Readybrek

How often did you eat Porridge/ readybrek (one bowl) on average last year. After cleaning this variable is renamed as PORRIDGE which is then used by the FETA program for analysis.

Categorical

Porridge; Readybrek

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Breakfast cereal

How often did you eatbreakfast cereal (one bowl) on average last year. After cleaning this variable is renamed as CEREAL which is then used by the FETA program for analysis.

Categorical

Breakfast cereal

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

The text given must be translated into food code s using the cereal lookup list You can list up t

Variable derived by study staff from raw FFQ data for A5bCereal1Brand A5bCereal1Type A5bCereal2Brand and A5bCereal2Type.

Categorical

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay CES1

Phase 1 OLINK assay data for target CES1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CES2

Phase 1 OLINK assay data for target CES2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CETN2

Phase 1 OLINK assay data for target CETN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CFC1

Phase 1 OLINK assay data for target CFC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CFHR5

Phase 1 OLINK assay data for target CFHR5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CGA

Phase 1 OLINK assay data for target CGA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CHI3L1

Phase 1 OLINK assay data for target CHI3L1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CHIT1

Phase 1 OLINK assay data for target CHIT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CHL1

Phase 1 OLINK assay data for target CHL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cholesterol 0 minutes

Serum Cholesterol measurement taken at 0 minutes in mmol/l

Real

Cholestrol 0 minutes

Phase 2 data. Serum Cholesterol measurement taken at 0 minutes in mmol/l

Real

Total cholesterol to HDL cholesterol ratio 0 minutes

Total cholesterol to HDL cholesterol ratio measurement taken at 0 minutes

Real

Total Chol to HDLChol ratio 0 min

Phase 2 data. Total cholestrol to HDL cholestrol ratio measurement taken at 0 minutes

Real

OLINK assay CHRDL2

Phase 1 OLINK assay data for target CHRDL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cit_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Cit_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_005.

Real

OLINK assay CKAP4

Phase 1 OLINK assay data for target CKAP4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC10A

Phase 1 OLINK assay data for target CLEC10A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC11A

Phase 1 OLINK assay data for target CLEC11A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC14A

Phase 1 OLINK assay data for target CLEC14A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC1A

Phase 1 OLINK assay data for target CLEC1A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC1B

Phase 1 OLINK assay data for target CLEC1B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC4A

Phase 1 OLINK assay data for target CLEC4A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC4C

Phase 1 OLINK assay data for target CLEC4C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC4D

Phase 1 OLINK assay data for target CLEC4D in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC4G

Phase 1 OLINK assay data for target CLEC4G in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC5A

Phase 1 OLINK assay data for target CLEC5A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC6A

Phase 1 OLINK assay data for target CLEC6A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLEC7A

Phase 1 OLINK assay data for target CLEC7A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLMP

Phase 1 OLINK assay data for target CLMP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLM-1

Phase 1 OLINK assay data for target CLM-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLM-6

Phase 1 OLINK assay data for target CLM-6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLSPN

Phase 1 OLINK assay data for target CLSPN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLSTN1

Phase 1 OLINK assay data for target CLSTN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLSTN2

Phase 1 OLINK assay data for target CLSTN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLSTN3

Phase 1 OLINK assay data for target CLSTN3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CLUL1

Phase 1 OLINK assay data for target CLUL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Cleaned BMI calculated as weight in kilograms divided by height in meters squared from CL_HeightCM_P1 and CL_WeightKG_P1

Real

Cln variable: BMI

Phase 2 data. Cleaned BMI calculated as weight in kilograms divided by height in meters squared from CL_HeightCM_P2 and CL_WeightKG_P2. Recommended BMI Varible

Real

None

Cleaned Height in centimetres (if E_HeightCM_P1 not = to ALT_Height_P1

Real

None

Cleaned Height code 1=No measures; 2=DEXA height measurement from DEXA image

Real

Cln variable: Height code

Phase 2 data. Cleaned Height code 1 = No measures; 2 = DEXA height measurement from DEXA image

Categorical

Cln variable: Height

Phase 2 data. Cleaned Height in centimetres (if E_HeightCM_P2 not = to ALT_Height_P2

Real

None

Cleaned Weight in centimetres (if E_WeightCM_P1 not = to ALT_Weight_P1

Real

None

Cleaned Weight code 1=No measures; 2=DEXA Weight measurement from DEXA

Real

Cln variable: Weight code

Phase 2 data. Cleaned Weight code 1 = No measures; 2 = DEXA Weight measurement from DEXA

Categorical

Cln variable: Weight

Phase 2 data. Cleaned Weight in centimetres (if E_WeightCM_P2 not = to ALT_Weight_P2

Real

OLINK assay CNDP1

Phase 1 OLINK assay data for target CNDP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CNTN1

Phase 1 OLINK assay data for target CNTN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CNTN2

Phase 1 OLINK assay data for target CNTN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CNTN4

Phase 1 OLINK assay data for target CNTN4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CNTN5

Phase 1 OLINK assay data for target CNTN5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CNTNAP2

Phase 1 OLINK assay data for target CNTNAP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COCH

Phase 1 OLINK assay data for target COCH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COL18A1

Phase 1 OLINK assay data for target COL18A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COL1A1

Phase 1 OLINK assay data for target COL1A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COL4A1

Phase 1 OLINK assay data for target COL4A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COL4A3BP

Phase 1 OLINK assay data for target COL4A3BP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COLEC12

Phase 1 OLINK assay data for target COLEC12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Combat sports

Please indicate the average length of time (in hours) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling).

Integer

Hours of Combat sports CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Combat sports hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Combat sports hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling). -1 = left blank. DO NOT USE THIS VARIABLE. Use CombatsSportsHr_CLEAN_P2 instead.

Real

Minutes of Combat sports

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling).

Integer

Minutes of Combat sports CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Combat sports min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Combat sports min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Combat sports (martial arts boxing or wrestling). -1 = left blank. DO NOT USE THIS VARIABLE. Use CombatsSportsMin_CLEAN_P2 instead.

Real

Frequency of Combat sports CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Combat sports (martial arts boxing or wrestling). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

combatsSports_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Combat sports

Real

Cln variable: Combat sports

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Combat sports (martial arts boxing or wrestling). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

CombatsSports_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Combat sports (martial arts boxing or wrestling). Data normalised to DE template 1 data.

Categorical

Combat sports

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Martial arts boxing or wrestling. DO NOT USE THIS VARIABLE. Use CombatsSports_CLEAN_P2 instead.

Real

Combat sports

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Combat sports (martial arts boxing or wrestling). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Combat sports DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Combat sports (martial arts boxing or wrestling). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in CombatsSports_T2. Instead use CombatsSports_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Combat sports DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Combat sports (martial arts boxing or wrestling). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in CombatsSports_T1. Instead use CombatsSports_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Insulin NEFA comments

Phase 2 data. Lab comments relating to heparin samples used for insulin and NEFA analysis for phase 2

Text

Cmnt geocodeing Cln work postcode

Phase 2 data. Comment related to geocodeing of phase 2 cleaned work postcode

Text

COMMUTEtime

COMMUTEtime. Derived Intermediate not for general release. Data can be provided if necessary.

Real

COMMUTE_ACTMETS

Commute domain activity energy expenditure [net METhrs/d]

Real

Commute domain AEE

Phase 2 data. Derived with method 2. Commute domain activity energy expenditure net METhrs/d

Real

COMMUTE_METS

Commute domain energy expenditure [METhrs/d]

Real

Commute domain energy expenditure

Phase 2 data. Derived with method 2. Commute domain energy expenditure METhrs/d

Real

COMMUTE_PAEE

Commute domain activity energy expenditure [kJ/kg/d]

Real

Commute domain PAEE

Phase 2 data. Derived with method 2. Commute domain activity energy expenditure kJ/kg/d

Real

COMPadj

COMPadj. Derived Intermediate not for general release. Data can be provided if necessary.

Real

COMPDUR1

COMPDUR1. Derived Intermediate not for general release. Data can be provided if necessary.

Real

COMPDUR2

COMPDUR2. Derived Intermediate not for general release. Data can be provided if necessary.

Real

COMPDUR3

COMPDUR3. Derived Intermediate not for general release. Data can be provided if necessary.

Real

COMPDUR4

COMPDUR4. Derived Intermediate not for general release. Data can be provided if necessary.

Real

Hours of Competitive Running

Please indicate the average length of time (in hours) you spent doing the activity per episode. Competitive Running.

Integer

Hours of Competitive Running CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Competitive Running. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Competitive running hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Competitive Running. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Competitive Running hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Competitive Running. -1 = left blank. DO NOT USE THIS VARIABLE. Use compRunHr_CLEAN_P2 instead.

Real

Minutes of Competitive Running

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Competitive Running.

Integer

Minutes of Competitive Running CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Competitive Running. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Competitive running min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Competitive Running. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Competitive Running min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Competitive Running. -1 = left blank. DO NOT USE THIS VARIABLE. Use compRunMin_CLEAN_P2 instead.

Real

Frequency of Competitive Running CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

compRun_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Competitive Running

Real

Cln variable: Competitive running

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

compRun_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. Data normalised to DE template 1 data.

Categorical

Competitive Running

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. DO NOT USE THIS VARIABLE. Use compRun_CLEAN_P2 instead.

Real

Competitive Running

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Competitive Running DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in compRun_T2. Instead use compRun_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Competitive Running DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Competitive Running. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in compRun_T1. Instead use compRun_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Computer use at weekday after 6pm

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use per day on a weekday after 6 pm. Average over the last 4 weeks

Categorical

Cln variable: Computer wkday post6pm

Phase 2 data. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use per day on a weekday after 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekdaypost6pm. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day; -1 = left blank;

Categorical

Hrs homecomputer use wkday post 6pm

Phase 2 data. Questionnaire reads D3. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use per day on a weekday after 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekdaypost6pm. DO NOT USE THIS VARIABLE. Use Computerweekdaypost6pmDiff_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Computer use at weekday after 6pm CLEANED

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use per day on a weekday after 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team.

Categorical

Computer use at weekday before 6pm

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use per day on a weekday before 6 pm. Average over the last 4 weeks.

Categorical

Cln variable: Computer wkday pre6pm

Phase 2 data. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use per day on a weekday before 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekdaypre6pm. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day; -1 = left blank;

Categorical

Hrs home computer use wkday pre 6pm

Phase 2 data. Questionnaire reads D3. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use per day on a weekday before 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekdaypre6pm. DO NOT USE THIS VARIABLE. Use Computerweekdaypre6pmDiff_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Computer use at weekday before 6pm CLEANED

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use per day on a weekday before 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team.

Categorical

Computer use at weekend after 6pm

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use on a weekend after 6 pm. Average over the last 4 weeks.

Categorical

Cln variable: Computer wknd post6pm

Phase 2 data. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use on a weekend after 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekendpost6pm. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day; -1 = left blank;

Categorical

Hrs homecomputer use wknday post6pm

Phase 2 data. Questionnaire reads D3. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use on a weekend after 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekendpost6pm. DO NOT USE THIS VARIABLE. Use Computerweekendpost6pmDiff_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Computer use at weekend after 6pm CLEANED

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use on a weekend after 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team.

Categorical

Computer use at weekend before 6pm

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use per day on a weekend before 6 pm. Average over the last 4 weeks.

Categorical

Cln variable: Computer wknd pre6pm

Phase 2 data. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use per day on a weekend before 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekendpre6pm. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day; -1 = left blank;

Categorical

Hrs homecomputer use wknday pre 6pm

Phase 2 data. Questionnaire reads D3. Computer use at home but not at work (eg internet email playstation Xbox Gameboy and Wii; non-active games only). Hours of home computer use per day on a weekend before 6 pm. Average over the last 4 weeks. Data not quite the same as phase 1 data for Computerweekendpre6pm. DO NOT USE THIS VARIABLE. Use Computerweekendpre6pmDiff_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Computer use at weekend before 6pm CLEANED

Computer use at home but not at work (eg internet email playstation Xbox Gameboy etc). Hours of home computer use per day on a weekend before 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 error codes cleaned by PA team.

Categorical

OLINK assay COMP

Phase 1 OLINK assay data for target COMP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay COMT

Phase 1 OLINK assay data for target COMT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Conditioning Exercises

Please indicate the average length of time (in hours) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine).

Integer

Hours of Conditioning Exercises CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Conditioning exercise hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Conditioning Exercises hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). -1 = left blank. DO NOT USE THIS VARIABLE. Use conditionExerciseHr_CLEAN_P2 instead.

Real

Minutes of Conditioning Exercises

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine).

Integer

Minutes of Conditioning Exercises CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Conditioning exercise min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Conditioning Exercises min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). -1 = left blank. DO NOT USE THIS VARIABLE. Use conditionExerciseMin_CLEAN_P2 instead.

Real

Frequency of Conditioning Exercises CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Conditioning Exercises (eg using a bike or rowing machine). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

conditionExercise_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Conditioning Exercises

Real

Cln variable: Conditioning exercise

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Conditioning Exercises (eg using a bike or rowing machine). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

conditionExercise_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Conditioning Exercises (eg using a bike or rowing machine). Data normalised to DE template 1 data.

Categorical

Conditioning Exercises

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Conditioning Exercises (eg using a bike or rowing machine). DO NOT USE THIS VARIABLE. Use conditionExercise_CLEAN_P2 instead.

Real

Conditioning Exercises

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Conditioning Exercises (eg using a bike or rowing machine). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Conditioning Exercises DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Conditioning Exercises (eg using a bike or rowing machine). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in conditionExercise_T2. Instead use conditionExercise_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Conditioning Exercises DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Conditioning Exercises (eg using a bike or rowing machine). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in conditionExercise_T1. Instead use conditionExercise_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Consent Form version

Consent Form version of the main consent form (all versions) not the restrospective consent form.

Text

Consent Form version date

Consent Form version date (as written) of the main consent form (all versions) not the restrospective consent form.

Date

Statement 1 consented

Statement 1 consented V1.2 I confirm that I have read and understood the information sheet for the above study version dated (x/y/z) and have had the opprtunity to ask questions. Other form versions: I confirm that I have read and understood the information sheet for the above study version (nr) dated (x/y/z) and have had the opprtunity to ask questions.

Categorical

Statements 1 to 5 consented

Statements 1 to 5 consented derived variable where a 1 has been assigned if statements 1-5 have all been initialled a 0 if not.

Categorical

Statements 1 to 9 consented

Statements 1 to 9 consented derived variable where a 1 has been assigned if statements 1-9 have all been initialled a 0 if not.

Categorical

Statement 2 consented

Statement 2 consented all consent form versions: I agree to having a physical examination and giving a sample of blood and urine for research in the Fenland Study.

Categorical

Statement 3 consented

Statement 3 consented all consent form versions: I understand that future research will only be undertaken on anonymous samples and will include genetic studies aimed at investigating the cause of diabetes and related diseases but that the results of these investigations are unlikely to have any implications for me pesonally. I understand that I will not benefit financially if this research leads to the development of a new treatment or medical test.

Categorical

Statement 4 consented

Statement 4 consented all consent form versions: I understand that my participation is voluntary and that I am free to withdraw at any time without giving any reason and without my medical care or legal rights being affected.

Categorical

Statement 5 consented

Statement 5 consented: consent form V1.2 and 2: I agree that samples I have given and the information gathered about me can be looked after and stored at the MRC Epidemiology Unit for use in future projects aimed at identifying the cause of diabetes obesity and their complications. Consent form V: at replaced by (the MRC Epi Unit) consent form V4: at the MRC Epidemiology Unit replaced by the MRC Epidemiology Unit University of Cambridge

Categorical

Statement 6 consented

Statement 6 consented all consent form versions I agree to be reapproached to consider participating in possible future studies on the basis of information gained from the Fenland study. I note that I will be provided with full information about these additional studies when and if I am reapproached.

Categorical

Statement 7 consented

Statement 7 consented all consent form versions I agree that my test results can be forwarded to my general practitioner.

Categorical

Statement 8 consented

Statement 8 consented: not present on consent form V1.2 covered by retrospective consent form V3. Consent form version 2 onwards: I understand that information held by the NHS and records maintained by the General Register office may be used to kep in touch with me and follow up on my health status.

Categorical

Statement 9 consented

Statement 9 consented: not present on consent form V1.2 covered by retrospective consent form V3. Consent form version 2 and 3 I am willing to allow access to my medical records and information from them to be analysed in strict confidence by researchers from the MRC Epidemiology Unit. Consent form version 4: statement changed to researchers from the MRC Epidemiology Unit University of Cambridge

Categorical

None

Consent data management comments

Data Entry comments

Data Entry comments

Text

None

Has Consent form been completed fully.

Categorical

Participant's signature present

Participant's signature (present) on the main consent form (all versions) not the restrospective consent form.

Categorical

Participant's signature date as written

Participant's signature date (as written) on the main consent form (all versions) not the restrospective consent form.

Date

Researcher's signature present

Researcher's signature (present) on the main consent form (all versions) not the restrospective consent form.

Categorical

Researcher's signature comments

Researcher's signature comments on the main consent form (all versions) not the restrospective consent form.

Text

Retrospective Participant's signature

Retrospective consent Participant's signature. A retrospective consent form was only sent out to any participant who'd signed Consent form version 1.2 since that only contained 7 statements not 9.

Categorical

Retrospective Participant's signature date

Retrospective consent Participant's signature date. A retrospective consent form was only sent out to any participant who'd signed Consent form version 1.2 since that only contained 7 statements not 9.

Date

Retrospective witness signature date

Retrospective consent witness signature date. A retrospective consent form was only sent out to any participant who'd signed Consent form version 1.2 since that only contained 7 statements not 9.

Date

Retrospective witness signature

Retrospective consent witness signature. A retrospective consent form was only sent out to any participant who'd signed Consent form version 1.2 since that only contained 7 statements not 9.

Categorical

None

Researcher's signature date (as written) on the main consent form (all versions) not the restrospective consent form.

Text

Participant's signature comments

Participant's signature comments on the main consent form (all versions) not the restrospective consent form.

Text

Consent form signed and dated

Consent form signed and dated? Related to the main consent form (all versions) not the restrospective consent form.

Categorical

None

Unique random ID number assigned to samples on InfiniumCoreExome-24v1 chip for genetic SNP analysis.

None

Comments left by data analyst performing core exome data QC.

None

Indication if Core Exome data can be included in the dataset or not due to potential relatedness of participants

Corrected calcium 0 minutes

Corrected calcium measurement taken at 0 minutes in mmol/l

Real

Corrected calcium 0 minutes

Phase 2 data. Corrected calcium measurement taken at 0 minutes in mmol/l

Real

None

Phase 2 data.

Integer

Supermarket count around home 1km buffer p1

Number of supermarkets around participants home postcode unit within a 1 kilometer Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around home 1km buffer p2

Number of supermarkets around participants home postcode unit within a 1 kilometer Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around home 1km buffer p1

Number of takeaway outlets around participants home postcode unit within a 1 kilometer Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around home 1km buffer p2

Number of takeaway outlets around participants home postcode unit within a 1 kilometer Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around home 1mile buffer p1

Number of supermarkets around participants home postcode unit within a 1 mile Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around home 1mile buffer p2

Number of supermarkets around participants home postcode unit within a 1 mile Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around home 1mile buffer p1

Number of takeaway outlets around participants home postcode unit within a 1 mile Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around home 1mile buffer p2

Number of takeaway outlets around participants home postcode unit within a 1 mile Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around home 400m buffer p1

Number of supermarket outlets around participants home postcode unit within a 400 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around home 400m buffer p2

Number of supermarket outlets around participants home postcode unit within a 400 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around home 400m buffer p1

Number of takeaway outlets around participants home postcode unit within a 400 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around home 400m buffer p2

Number of takeaway outlets around participants home postcode unit within a 400 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around home 800m buffer p1

Number of supermarkets around participants home postcode unit within a 800 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around home 800m buffer p2

Number of supermarkets around participants home postcode unit within a 800 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around home 800m buffer p1

Number of takeaway outlets around participants home postcode unit within a 800 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around home 800m buffer p2

Number of takeaway outlets around participants home postcode unit within a 800 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around work 1km buffer p1

Number of supermarkets around participants work postcode unit within a 1 kilometer Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around work 1km buffer p2

Number of supermarkets around participants work postcode unit within a 1 kilometer Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around work 1km buffer p1

Number of takeaway outlets around participants work postcode unit within a 1 kilometer Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around work 1km buffer p2

Number of takeaway outlets around participants work postcode unit within a 1 kilometer Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around work 1mile buffer p1

Number of supermarkets around participants work postcode unit within a 1 mile Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around work 1mile buffer p2

Number of supermarkets around participants work postcode unit within a 1 mile Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around work 1mile buffer p1

Number of takeaway outlets around participants work postcode unit within a 1 mile Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around work 1mile buffer p2

Number of takeaway outlets around participants work postcode unit within a 1 mile Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around work 400m buffer p1

Number of supermarket outlets around participants work postcode unit within a 400 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around work 400m buffer p2

Number of supermarket outlets around participants work postcode unit within a 400 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around work 400m buffer p1

Number of takeaway outlets around participants work postcode unit within a 400 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around work 400m buffer p2

Number of takeaway outlets around participants work postcode unit within a 400 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Supermarket count around work 800m buffer p1

Number of supermarkets around participants work postcode unit within a 800 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Supermarket count around work 800m buffer p2

Number of supermarkets around participants work postcode unit within a 800 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

Takeaway count around work 800m buffer p1

Number of takeaway outlets around participants work postcode unit within a 800 meter Euclidean buffer in phase 1. Variable for analyses relating to the food environment.

Real

Takeaway count around work 800m buffer p2

Number of takeaway outlets around participants work postcode unit within a 800 meter Euclidean buffer in phase 2. Variable for analyses relating to the food environment.

Real

OLINK assay CPA1

Phase 1 OLINK assay data for target CPA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CPA2

Phase 1 OLINK assay data for target CPA2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CPB1

Phase 1 OLINK assay data for target CPB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CPE

Phase 1 OLINK assay data for target CPE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CPM

Phase 1 OLINK assay data for target CPM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CPXM1

Phase 1 OLINK assay data for target CPXM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CR2

Phase 1 OLINK assay data for target CR2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRADD

Phase 1 OLINK assay data for target CRADD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Creatinine_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Creatinine_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_026.

Real

Creatinine 0 minutes

Serum Creatinine measurement taken at 0 minutes in umol/l

Real

Creatinine 0 minutes

Phase 2 data. Serum Creatinine measurement taken at 0 minutes in umol/l

Real

OLINK assay CRELD2

Phase 1 OLINK assay data for target CRELD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRHBP

Phase 1 OLINK assay data for target CRHBP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRH

Phase 1 OLINK assay data for target CRH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Cricket

Please indicate the average length of time (in hours) you spent doing the activity per episode. Cricket.

Integer

Hours of Cricket CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Cricket. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Cricket hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Cricket. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Cricket hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Cricket. -1 = left blank. DO NOT USE THIS VARIABLE. Use cricketHr_CLEAN_P2 instead.

Real

Minutes of Cricket

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cricket.

Integer

Minutes of Cricket CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cricket. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Cricket min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cricket. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Cricket min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cricket. -1 = left blank. DO NOT USE THIS VARIABLE. Use cricketMin_CLEAN_P2 instead.

Real

Frequency of Cricket CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

cricket_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Cricket

Real

Cln variable: Cricket

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

cricket_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. Data normalised to DE template 1 data.

Categorical

Cricket

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. DO NOT USE THIS VARIABLE. Use cricket_CLEAN_P2 instead.

Real

Cricket

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Cricket DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in cricket_T2. Instead use cricket_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Cricket DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cricket. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in cricket_T1. Instead use cricket_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay CRIM1

Phase 1 OLINK assay data for target CRIM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRIP2

Phase 1 OLINK assay data for target CRIP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRISP2

Phase 1 OLINK assay data for target CRISP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRKL

Phase 1 OLINK assay data for target CRKL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRNN

Phase 1 OLINK assay data for target CRNN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRTAC1

Phase 1 OLINK assay data for target CRTAC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRTAM

Phase 1 OLINK assay data for target CRTAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CRX

Phase 1 OLINK assay data for target CRX in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CSF-1

Phase 1 OLINK assay data for target CSF-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CSNK1D

Phase 1 OLINK assay data for target CSNK1D in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CST3

Phase 1 OLINK assay data for target CST3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CST5

Phase 1 OLINK assay data for target CST5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CST6

Phase 1 OLINK assay data for target CST6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CSTB

Phase 1 OLINK assay data for target CSTB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTF1

Phase 1 OLINK assay data for target CTF1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTRC

Phase 1 OLINK assay data for target CTRC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSC

Phase 1 OLINK assay data for target CTSC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSD

Phase 1 OLINK assay data for target CTSD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSF

Phase 1 OLINK assay data for target CTSF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSH

Phase 1 OLINK assay data for target CTSH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSL1

Phase 1 OLINK assay data for target CTSL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSO

Phase 1 OLINK assay data for target CTSO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSS

Phase 1 OLINK assay data for target CTSS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSV

Phase 1 OLINK assay data for target CTSV in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CTSZ

Phase 1 OLINK assay data for target CTSZ in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Status within FAB study

Status within FAB study - CurrFABStatus

OLINK assay CX3CL1

Phase 1 OLINK assay data for target CX3CL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXADR

Phase 1 OLINK assay data for target CXADR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL10

Phase 1 OLINK assay data for target CXCL10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL11

Phase 1 OLINK assay data for target CXCL11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL12

Phase 1 OLINK assay data for target CXCL12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL13

Phase 1 OLINK assay data for target CXCL13 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL16

Phase 1 OLINK assay data for target CXCL16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL1

Phase 1 OLINK assay data for target CXCL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL1

Phase 1 OLINK assay data for target CXCL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL5

Phase 1 OLINK assay data for target CXCL5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL6

Phase 1 OLINK assay data for target CXCL6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXCL9

Phase 1 OLINK assay data for target CXCL9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay CXL17

Phase 1 OLINK assay data for target CXL17 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

CYCLEadj

CYCLEadj. Derived Intermediate not for general release. Data can be provided if necessary.

Real

CYCLEMILES

CYCLEMILES. Derived Intermediate not for general release. Data can be provided if necessary.

Real

Hours of Cycling For Pleasure

Please indicate the average length of time (in hours) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport).

Integer

Hours of Cycling For Pleasure CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Cycling pleasure hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Real

Cycling for Pleasure hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). -1 = left blank. DO NOT USE THIS VARIABLE. Use cyclePleasureHr_CLEAN_P2 instead.

Real

Minutes of Cycling For Pleasure

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport).

Integer

Minutes of Cycling For Pleasure CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Cycling pleasure min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Cycling for Pleasure min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). -1 = left blank. DO NOT USE THIS VARIABLE. Use cyclePleasureMin_CLEAN_P2 instead.

Real

Frequency of Cycling For Pleasure CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cycling For Pleasure (not as a means of transport). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

cyclePleasure_CLEAN_FRQ

New in R8.Cleaned translated frequency (per week) for Cycling For Pleasure

Real

Cln variable: Cycling pleasure

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cycling For Pleasure (not as a means of transport). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

cyclePleasure_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cycling For Pleasure (not as a means of transport). Data normalised to DE template 1 data.

Categorical

Cycling for Pleasure

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Cycling For Pleasure (not as a means of transport). DO NOT USE THIS VARIABLE. Use cyclePleasure_CLEAN_P2 instead.

Real

Cycling for Pleasure

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cycling For Pleasure (not as a means of transport). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Cycling For Pleasure DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cycling For Pleasure (not as a means of transport). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in cyclePleasure_T2. Instead use cyclePleasure_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Cycling For Pleasure DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Cycling For Pleasure (not as a means of transport). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in cyclePleasure_T1. Instead use cyclePleasure_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Hours of Racing Or Rough Terrain Cycling

Please indicate the average length of time (in hours) you spent doing the activity per episode. Racing Or Rough Terrain Cycling.

Integer

Hours of Racing Or Rough Terrain Cycling CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Racing hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Racing or Rough Terrain Cycling hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. -1 = left blank. DO NOT USE THIS VARIABLE. Use cyclingRacingRoughHr_CLEAN_P2 instead.

Real

Minutes of Racing Or Rough Terrain Cycling

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Racing Or Rough Terrain Cycling.

Integer

Minutes of Racing Or Rough Terrain Cycling CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Racing min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Racing or Rough Terrain Cycling min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. -1 = left blank. DO NOT USE THIS VARIABLE. Use cyclingRacingRoughMin_CLEAN_P2 instead.

Real

Frequency of Racing Or Rough Terrain Cycling CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Racing Or Rough Terrain Cycling. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

cyclingRacingRough_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Racing Or Rough Terrain Cycling

Real

Cln variable: Racing

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Racing Or Rough Terrain Cycling. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

cyclingRacingRough_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Racing Or Rough Terrain Cycling. Data normalised to DE template 1 data.

Categorical

Racing or Rough Terrain Cycling

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Racing Or Rough Terrain Cycling. DO NOT USE THIS VARIABLE. Use cyclingRacingRough_CLEAN_P2 instead.

Real

Racing or Rough Terrain Cycling

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Racing Or Rough Terrain Cycling. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Racing Or Rough Terrain Cycling DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Racing Or Rough Terrain Cycling. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in cyclingRacingRough_T2. Instead use cyclingRacingRough_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Racing Or Rough Terrain Cycling DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Racing Or Rough Terrain Cycling. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in cyclingRacingRough_T1. Instead use cyclingRacingRough_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay CYR61

Phase 1 OLINK assay data for target CYR61 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

C_Peptide

C_Peptide measurement in pmol/L. Raw data; cleaned data provided in variable G_C_Peptide with x_Threshold and x_Com variables provided for clarification.

Real

OLINK assay DAB2

Phase 1 OLINK assay data for target DAB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DAG1

Phase 1 OLINK assay data for target DAG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Single or sour cream (tablespoon) ERROR CODES CLEANED

Average use last year of Single or sour cream (tablespoon) After cleaning this variable is renamed as SINGLE_CREAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Double or clotted cream (tablespoon) ERROR CODES CLEANED

Average use last year of Low calorie low fat salad cream (tablespoon) After cleaning this variable is renamed as LOWCAL_SALAD_CREAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Low fat yogurt fromage frais (125g carton) ERROR CODES CLEANED

Average use last year of Salad Cream Mayonnaise (tablespoon) After cleaning this variable is renamed as SALAD_CREAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Full fat or Greek yogurt (125g carton) ERROR CODES CLEANED

Average use last year of French Dressing (tablespoon) After cleaning this variable is renamed as FRENCH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Dairy desserts (125g carton) ERROR CODES CLEANED

Average use last year of Other Salad Dressing (tablespoon) After cleaning this variable is renamed as OTHER_DRESSING which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cheese eg Cheddar Brie Edam(medium serving) ERROR CODES CLEANED

Average use last year on bread or vegetables of Butter (teaspoon) After cleaning this variable is renamed as BUTTER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cottage cheese low fat soft cheese(medium serving) ERROR CODES CLEANED

Average use last year on bread or vegetables of Hard margarine eg Stork Krona (teaspoon) After cleaning this variable is renamed as HARD_MARGARINE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Eggs as boiled fried scrambled etc (one) ERROR CODES CLEANED

Average use last year on bread or vegetables of Polyunsaturated margarine eg Flora sunflower (teaspoon) After cleaning this variable is renamed as POLYUNSATURATED_MARGARINE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Quiche (medium serving) ERROR CODES CLEANED

Average use last year on bread or vegetables of Other soft margarine eg Blue Band Stork SB (teaspoon) After cleaning this variable is renamed as OTHER_MARGARINE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Low calorie low fat salad cream tablespoon

Average use last year of Low calorie low fat salad cream (tablespoon). After cleaning this variable is renamed as LOWCAL_SALAD_CREAM which is then used by the FETA program for analysis.

Categorical

Low calorie low fat salad cream (tablespoon) ERROR CODES CLEANED

Average use last year on bread or vegetables of Low fat spread eg Outline Gold After cleaning this variable is renamed as LOWFAT_SPREAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Low calorie low fat salad cream tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Salad Cream Mayonnaise tablespoon

Average use last year of Salad Cream Mayonnaise (tablespoon). After cleaning this variable is renamed as SALAD_CREAM which is then used by the FETA program for analysis.

Categorical

Salad Cream; Mayonnaise (tablespoon) ERROR CODES CLEANED

Average use last year on bread or vegetables of Very low fat spread (teaspoon) After cleaning this variable is renamed as VERY_LOWFAT_SPREAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Salad Cream Mayonnaise tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

French Dressing tablespoon

Average use last year of French Dressing (tablespoon). After cleaning this variable is renamed as FRENCH which is then used by the FETA program for analysis.

Categorical

French Dressing (tablespoon) ERROR CODES CLEANED

Average use last year of Double or clotted cream (tablespoon) After cleaning this variable is renamed as DOUBLE_CREAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

French Dressing tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Other Salad Dressing tablespoon

Average use last year of Other Salad Dressing (tablespoon). After cleaning this variable is renamed as OTHER_DRESSING which is then used by the FETA program for analysis.

Categorical

Other Salad Dressing (tablespoon) ERROR CODES CLEANED

Average use last year of Quiche (medium serving) After cleaning this variable is renamed as QUICHE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Other Salad Dressing tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Butter teaspoon

Average use last year on bread or vegetables of Butter (teaspoon). After cleaning this variable is renamed as BUTTER which is then used by the FETA program for analysis.

Categorical

Butter (teaspoon) ERROR CODES CLEANED

Average use last year of Low fat yogurt fromage frais (125g carton) After cleaning this variable is renamed as LOWFAT_YOGURT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Butter teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Hard margarine eg Stork Krona teaspoon

Average use last year on bread or vegetables of Hard margarine eg. Stork Krona (teaspoon). After cleaning this variable is renamed as HARD_MARGARINE which is then used by the FETA program for analysis.

Categorical

Hard margarine eg Stork Krona (teaspoon) ERROR CODES CLEANED

Average use last year of Full fat or Greek yogurt (125g carton) After cleaning this variable is renamed as FULLFAT_YOGURT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Hard margarine eg Stork Krona teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Polyunsaturated margarine eg Flora sunflower teaspoon

Average use last year on bread or vegetables of Polyunsaturated margarine eg. Flora sunflower (teaspoon). After cleaning this variable is renamed as POLYUNSATURATED_MARGARINE which is then used by the FETA program for analys.

Categorical

Polyunsaturated margarine eg Flora sunflower (teaspoon) ERROR CODES CLEANED

Average use last year of Dairy desserts (125g carton) After cleaning this variable is renamed as DAIRY_DESSERT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Polyunsaturated margarine eg Flora sunflower teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Other soft margarine eg Blue Band Stork SB. teaspoon

Average use last year on bread or vegetables of Other soft margarine eg. Blue Band Stork S.B. (teaspoon). After cleaning this variable is renamed as OTHER_MARGARINE which is then used by the FETA program for analysis.

Categorical

Other soft margarine eg Blue Band Stork S.B. (teaspoon) ERROR CODES CLEANED

Average use last year of Cheese eg Cheddar Brie Edam (medium serving) After cleaning this variable is renamed as CHEESE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Other soft margarine eg Blue Band Stork teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Low fat spread; eg Outline; Gold

Average use last year on bread or vegetables of Low fat spread eg. Outline Gold. After cleaning this variable is renamed as LOWFAT_SPREAD which is then used by the FETA program for analysis.

Categorical

Low fat spread eg Outline Gold ERROR CODES CLEANED

Average use last year of Cottage cheese; low fat soft cheese (medium serving) Average use last year of Cottage cheese low fat soft cheese (medium serving) After cleaning this variable is renamed as COTTAGE_CHEESE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Low fat spread; eg Outline; Gold

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Very low fat spread teaspoon

Average use last year on bread or vegetables of Very low fat spread (teaspoon). After cleaning this variable is renamed as VERY_LOWFAT_SPREAD which is then used by the FETA program for analysis.

Categorical

Very low fat spread (teaspoon) ERROR CODES CLEANED

Average use last year of Eggs as boiled fried scrambled etc (one) After cleaning this variable is renamed as EGGS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Very low fat spread teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Single or sour cream tablespoon

Average use last year of Single or sour cream (tablespoon). After cleaning this variable is renamed as SINGLE_CREAM which is then used by the FETA program for analysis.

Categorical

Single or sour cream tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Double or clotted cream tablespoon

Average use last year of Double or clotted cream (tablespoon). After cleaning this variable is renamed as DOUBLE_CREAM which is then used by the FETA program for analysis.

Categorical

Double or clotted cream tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Low fat yogurt fromage frais 125g carton

Average use last year of Low fat yogurt fromage frais (125g carton). After cleaning this variable is renamed as LOWFAT_YOGURT which is then used by the FETA program for analysis.

Categorical

Low fat yogurt fromage frais 125g carton

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Full fat or Greek yogurt 125g carton

Average use last year of Full fat or Greek yogurt (125g carton). After cleaning this variable is renamed as FULLFAT_YOGURT which is then used by the FETA program for analysis.

Categorical

Full fat or Greek yogurt 125g carton

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Dairy desserts 125g carton

Average use last year of Dairy desserts (125g carton). After cleaning this variable is renamed as DAIRY_DESSERT which is then used by the FETA program for analysis.

Categorical

Dairy desserts 125g carton

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cheese eg Cheddar Brie Edam medium serving

Average use last year of Cheese eg. Cheddar Brie Edam (medium serving). After cleaning this variable is renamed as CHEESE which is then used by the FETA program for analysis.

Categorical

Cheese eg Cheddar Brie Edam medium serving

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cottage cheese

Average use last year of Cottage cheese; low fat soft cheese (medium serving). Average use last year of Cottage cheese low fat soft cheese (medium serving). After cleaning this variable is renamed as COTTAGE_CHEESE which is then used by the FETA program for analysis.

Categorical

Cottage cheese

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Eggs as boiled; fried; scrambled etc one

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Eggs as boiled; fried; scrambled etc one

Average use last year of Eggs as boiled fried scrambled etc (one). After cleaning this variable is renamed as EGGS which is then used by the FETA program for analysis.

Categorical

Quiche medium serving

Average use last year of Quiche (medium serving). After cleaning this variable is renamed as QUICHE which is then used by the FETA program for analysis.

Categorical

Quiche medium serving

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Hours of Dancing

Please indicate the average length of time (in hours) you spent doing the activity per episode. Dancing (eg ballroom or disco).

Integer

Hours of Dancing CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Dancing (eg ballroom or disco). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Dancing hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Dancing (eg ballroom or disco). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Dancing hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Dancing (eg ballroom or disco). -1 = left blank. DO NOT USE THIS VARIABLE. Use dancingHr_CLEAN_P2 instead.

Real

Minutes of Dancing

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Dancing (eg ballroom or disco).

Integer

Minutes of Dancing CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Dancing (eg ballroom or disco). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Dancing min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Dancing (eg ballroom or disco). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Dancing min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Dancing (eg ballroom or disco). -1 = left blank. DO NOT USE THIS VARIABLE. Use dancingMin_CLEAN_P2 instead.

Real

Frequency of Dancing CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

dancing_CLEAN_FRQ

New in R8.Cleaned translated frequency (per week) for Dancing

Real

Cln variable: Dancing

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

dancing_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). Data normalised to DE template 1 data.

Categorical

Dancing

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). DO NOT USE THIS VARIABLE. Use dancing_CLEAN_P2 instead.

Real

Dancing

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Dancing DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in dancing_T2. Instead use dancing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Dancing DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Dancing (eg ballroom or disco). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in dancing_T1. Instead use dancing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay DAPP1

Phase 1 OLINK assay data for target DAPP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Date report sent off.

Date

Date Report Sent

Phase 2 data. Date participant feedback Report was sent

Date

Days AH worn

Number of days ActiHeart monitor was worn during free living (first wear of Actiheart only)

Integer

Days AH monitor worn free living

Phase 2 data. Number of days ActiHeart monitor was worn during free living (first wear of Actiheart only). Used for Study cooridination purposes not for analysis. Use wear varibles in main AH dataset for analysis.

Integer

OLINK assay DCBLD2

Phase 1 OLINK assay data for target DCBLD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DCBLD2

Phase 1 OLINK assay data for target DCBLD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DCN

Phase 1 OLINK assay data for target DCN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DCTN1

Phase 1 OLINK assay data for target DCTN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DCTN2

Phase 1 OLINK assay data for target DCTN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DDAH1

Phase 1 OLINK assay data for target DDAH1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DDC

Phase 1 OLINK assay data for target DDC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DDR1

Phase 1 OLINK assay data for target DDR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DDX58

Phase 1 OLINK assay data for target DDX58 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DECR1

Phase 1 OLINK assay data for target DECR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DEFA1

Phase 1 OLINK assay data for target DEFA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DEFB4A

Phase 1 OLINK assay data for target DEFB4A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Departure Time

Phase 2 data. Clinical visit departure time

Time

DEXA Bone Density

Manually entered Bone Density as measured by the DEXA in grams per centimetre cubed [NOT RELEASED]

Real

M_DEXAEnt

M_DEXAEnt [NOT RELEASED]

M_DEXAEnt

Phase 2 data. M_DEXAEnt NOT RELEASED

Categorical

DEXA method

Phase 2 data. DEXA method used for positioning of volunteer. No DEXA; Normal; Symmetry; 1/2 body;

Text

DEXA TScore

Manually entered T Score as measured by the DEXA [NOT RELEASED]

M_DEXAUsed

M_DEXAUsed [NOT RELEASED]

M_DEXAUsed

Phase 2 data. M_DEXAUsed NOT RELEASED

Categorical

DEXA ZScore

Manually entered Z Score as measured by the DEXA [NOT RELEASED]

DEXA App lean mass

New in R7. Data derived by data management team by adding up data for AD15_DEXA_arms_lean_mass and AD39_DEXA_legs_lean_mass and rounding to 2 decimals.

Integer

DEXA App lean mass

Phase 2 data. Data derived by data management team by adding up data for AD15_DEXA_arms_lean_mass and AD39_DEXA_legs_lean_mass and rounding to 2 decimals.

Real

DEXA Sample Check

Phase 2 data. DEXA CRF Check done? 0 = no; 1 = yes;

Categorical

Ethnicity used fo DEXA

Phase 2 data. Ethnicity used fo DEXA. For Dexa dataset only. Should not be used to indicate participant ethnicity. Use variables derived from general questionniare instead

Text

DEXA ethnicity

Phase 2 data. DEXA ethnicity enterd by operator. White; Asian; Black; Hispanic; Other; -9 = Missing data; -1 = Unable to be determined;

Real

DEXA ethnicity

Phase 2 data. DEXA ethnicity enterd at phase 2 by operator. White; Asian; Black; Hispanic; Other; -9 = Missing data; -1 = Unable to be determined;

Real

None

Phase 2 data. Name of DEXA scanner file

Text

None

Phase 2 data. Name of DEXA scanner image

Text

DEXA method

DEXA method used for positioning of volunteer. No DEXA; Normal; Symmetry; 1/2 body;

DEXA Periph fat mass

New in R7. Data derived by data management team by adding up data for AD14_DEXA_arms_fat_mass and AD38_DEXA_legs_fat_mass and rounding to 2 decimals.

Integer

DEXA Periph fat mass

Phase 2 data. Data derived by data management team by adding up data for AD14_DEXA_arms_fat_mass and AD38_DEXA_legs_fat_mass and rounding to 2 decimals.

Real

M_DEXAQCFail

M_DEXAQCFail [NOT RELEASED]

M_DEXAQCFail

Phase 2 data. M_DEXAQCFail NOT RELEASED

Categorical

M_DEXARevReq

M_DEXARevReq [NOT RELEASED]

M_DEXARevReq

Phase 2 data. M_DEXARevReq NOT RELEASED

Categorical

M_DEXAReviewed

M_DEXAReviewed [NOT RELEASED]

M_DEXAReviewed

Phase 2 data. M_DEXAReviewed NOT RELEASED

Categorical

None

Phase 2 data. ID of DEXA scanner

Text

OLINK assay DFFA

Phase 1 OLINK assay data for target DFFA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DGKZ

Phase 1 OLINK assay data for target DGKZ in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Diabetes Diagnosed

Phase 2 data. Particpant reported. Phase 2 participants were asked over the phone; when booking their clinical visits; if they had been diagnosed with diabetes since their phase 1 visit. For recruitment at baseline it was not asked because one of the exclusion criteria for recruitment was a diabetes diagnosis. 1 = Has been diagnosed with diabetes since baseline; 0 = not diagnosed with diabetes since baseline

Integer

Diabetes Status

Record of participants diabetes status at time of site visit.

Categorical

Diabetes Status

Phase 2 data. Diabetes status of participant. This was used for study coordiniation purposes and participant feedback. It should NOT be used for analysis. The definition of raised and normal was based on WHO guidlines at the time of the visit and would have changed part way through the study. Use Glucose and HBA1c results to derive diabetes staus for analysis. 1 = HbA1C and OGTT normal; 2 = HbA1C and OGTT Raised; 3 = HbA1C raised and OGTT normal; 4 = HbA1C normal and OGTT raised;

Categorical

OLINK assay DIABLO

Phase 1 OLINK assay data for target DIABLO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Avg dist to closest 5 supermarkets home p1

Average distance to the closest 5 supermarkets from participants home postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 supermarkets home p2

Average distance to the closest 5 supermarkets from participants home postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 takeaways home p1

Average distance to the closest 5 takeaway food outlets from participants home postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 takeaways home p2

Average distance to the closest 5 takeaway food outlets from participants home postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Dist to closest supermarket home p1

Distance to the nearest supermarket from participants home postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Dist to closest supermarket home p2

Distance to the nearest supermarket from participants home postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Dist to closest takeaway home p1

Distance to the nearest takeaway food outlet from participants home postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Dist to closest takeaway home p2

Distance to the nearest takeaway food outlet from participants home postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Dist to closest supermarket work p1

Distance to the nearest supermarket from participants work postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Dist to closest supermarket work p2

Distance to the nearest supermarket from participants work postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Dist to closest takeaway work p1

Distance to the nearest takeaway food outlet from participants work postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Dist to closest takeaway work p2

Distance to the nearest takeaway food outlet from participants work postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 supermarkets work p1

Average distance to the closest 5 supermarkets from participants work postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 supermarkets work p2

Average distance to the closest 5 supermarkets from participants work postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 takeaways work p1

Average distance to the closest 5 takeaway food outlets from participants work postcode unit in phase 1. Variable for analyses relating to the food environment.

Real

Avg dist to closest 5 takeaways work p2

Average distance to the closest 5 takeaway food outlets from participants work postcode unit in phase 2. Variable for analyses relating to the food environment.

Real

DISTFACTOR

DISTFACTOR. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DISTWORKMILES

DISTWORKMILES. Derived Intermediate not for general release. Data can be provided if necessary.

Real

diuretic

Phase 2 data. Binary variable indicating whether a drug from the diuretic class was prescribed. 0: No 1: Yes

Categorical

Hours of DIY

Please indicate the average length of time (in hours) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance).

Integer

Hours of DIY CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: DIY hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

DIY hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). -1 = left blank. DO NOT USE THIS VARIABLE. Use dIYHr_CLEAN_P2 instead.

Real

Minutes of DIY

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance).

Integer

Minutes of DIY CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: DIY min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

DIY min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). -1 = left blank. DO NOT USE THIS VARIABLE. Use dIYMin_CLEAN_P2 instead.

Real

Frequency of DIY CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. DIY (eg carpentry home or car maintenance). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

dIY_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for DIY

Real

Cln variable: DIY

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. DIY (eg carpentry home or car maintenance). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

dIY_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. DIY (eg carpentry home or car maintenance). Data normalised to DE template 1 data.

Categorical

DIY

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. DIY (eg carpentry home or car maintenance). DO NOT USE THIS VARIABLE. Use dIY_CLEAN_P2 instead.

Real

DIY

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. DIY (eg carpentry home or car maintenance). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of DIY DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. DIY (eg carpentry home or car maintenance). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in dIY_T2. Instead use dIY_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of DIY DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. DIY (eg carpentry home or car maintenance). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in dIY_T1. Instead use dIY_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay DKK3

Phase 1 OLINK assay data for target DKK3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DKKL1

Phase 1 OLINK assay data for target DKKL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Dkk-1

Phase 1 OLINK assay data for target Dkk-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Dkk-4

Phase 1 OLINK assay data for target Dkk-4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DLK-1

Phase 1 OLINK assay data for target DLK-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DLL1

Phase 1 OLINK assay data for target DLL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DNAJB1

Phase 1 OLINK assay data for target DNAJB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DNER

Phase 1 OLINK assay data for target DNER in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Dominant hand grip strength 1st

Phase 2 data. Dominant hand grip strength 1st measurement

Real

Dominant hand grip strength 2nd

Phase 2 data. Dominant hand grip strength 2nd measurement

Real

Dominant hand

Phase 2 data. Dominant hand. Left or right.

Text

OLINK assay DPEP1

Phase 1 OLINK assay data for target DPEP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DPEP2

Phase 1 OLINK assay data for target DPEP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DPP10

Phase 1 OLINK assay data for target DPP10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DPP4

Phase 1 OLINK assay data for target DPP4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DPP6

Phase 1 OLINK assay data for target DPP6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DPP7

Phase 1 OLINK assay data for target DPP7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DRAXIN

Phase 1 OLINK assay data for target DRAXIN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Tea (cup) ERROR CODES CLEANED

Average use last year of Tea (cup) After cleaning this variable is renamed as TEA which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Coffee instant or ground (cup) ERROR CODES CLEANED

Average use last year of Coffee instant or ground (cup) After cleaning this variable is renamed as INSTANT_COFFEE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Coffee decaffeinated (cup) ERROR CODES CLEANED

Average use last year of Coffee decaffeinated (cup) After cleaning this variable is renamed as DECAFF_COFFEE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Coffee whitener eg Coffee-mate (teaspoon) ERROR CODES CLEANED

Average use last year of Coffee whitener eg Coffee-mate (teaspoon) After cleaning this variable is renamed as COFFEE_WHITENER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cocoa hot chocolate (cup) ERROR CODES CLEANED

Average use last year of Cocoa hot chocolate (cup) After cleaning this variable is renamed as COCOA which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Horlicks Ovaltine (cup) ERROR CODES CLEANED

Average use last year of Horlicks Ovaltine (cup) After cleaning this variable is renamed as HORLICKS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Wine (glass) ERROR CODES CLEANED

Average use last year of Wine (glass) After cleaning this variable is renamed as WINE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Beer lager or cider (half pint) ERROR CODES CLEANED

Average use last year of Beer lager or cider (half pint) After cleaning this variable is renamed as BEER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Port sherry vermouth liqueurs (glass) ERROR CODES CLEANED

Average use last year of Port sherry vermouth liqueurs (glass) After cleaning this variable is renamed as PORT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Spirits; eg gin; brandy; whisky; vodka single

Average use last year of Spirits eg. gin brandy whisky vodka (single). After cleaning this variable is renamed as SPIRITS which is then used by the FETA program for analysis.

Categorical

Spirits eg gin brandy whisky vodka (single) ERROR CODES CLEANED

Average use last year of Spirits eg gin brandy whisky vodka (single) After cleaning this variable is renamed as SPIRITS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Spirits; eg gin brandy whisky vodka single

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Low calorie or diet fizzy soft drinks glass

Average use last year of Low calorie or diet fizzy soft drinks (glass). After cleaning this variable is renamed as LOWCAL_FIZZY_DRINKS which is then used by the FETA program for analysis.

Categorical

Low calorie or diet fizzy soft drinks (glass) ERROR CODES CLEANED

Average use last year of Low calorie or diet fizzy soft drinks (glass) After cleaning this variable is renamed as LOWCAL_FIZZY_DRINKS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Low calorie or diet fizzy soft drinks glass

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fizzy soft drinks

Average use last year of Fizzy soft drinks eg. Coca cola lemonade (glass). After cleaning this variable is renamed as FIZZY_DRINKS which is then used by the FETA program for analysis.

Categorical

Fizzy soft drinks eg Coca cola lemonade(glass) ERROR CODES CLEANED

Average use last year of Fizzy soft drinks eg Coca cola lemonade (glass) After cleaning this variable is renamed as FIZZY_DRINKS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fizzy soft drinks

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Pure fruit juice 100% eg orange applejuice glass

Average use last year of Pure fruit juice (100%) eg. orange applejuice (glass). After cleaning this variable is renamed as FRUIT_JUICE which is then used by the FETA program for analysis.

Categorical

Pure fruit juice (100%) eg orange applejuice (glass) ERROR CODES CLEANED

Average use last year of Pure fruit juice (100%) eg orange applejuice (glass) After cleaning this variable is renamed as FRUIT_JUICE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Pure fruit juice 100% orange juice glass

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fruit squash or cordial glass

Average use last year of Fruit squash or cordial (glass). After cleaning this variable is renamed as FRUIT_SQUASH which is then used by the FETA program for analysis.

Categorical

Fruit squash or cordial (glass) ERROR CODES CLEANED

Average use last year of Fruit squash or cordial (glass) After cleaning this variable is renamed as FRUIT_SQUASH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fruit squash or cordial glass

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Tea cup

Average use last year of Tea (cup). After cleaning this variable is renamed as TEA which is then used by the FETA program for analysis.

Categorical

Tea cup

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Coffee instant or ground cup

Average use last year of Coffee instant or ground (cup). After cleaning this variable is renamed as INSTANT_COFFEE which is then used by the FETA program for analysis.

Categorical

Coffee instant or ground cup

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Coffee decaffeinated cup

Average use last year of Coffee decaffeinated (cup). After cleaning this variable is renamed as DECAFF_COFFEE which is then used by the FETA program for analysis.

Categorical

Coffee decaffeinated cup

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Coffee whitener eg Coffee-mate teaspoon

Average use last year of Coffee whitener eg Coffee-mate (teaspoon). After cleaning this variable is renamed as COFFEE_WHITENER which is then used by the FETA program for analysis.

Categorical

Coffee whitener

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cocoa hot chocolate cup

Average use last year of Cocoa hot chocolate (cup). After cleaning this variable is renamed as COCOA which is then used by the FETA program for analysis.

Categorical

Cocoa hot chocolate cup

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Horlicks Ovaltine cup

Average use last year of Horlicks Ovaltine (cup). After cleaning this variable is renamed as HORLICKS which is then used by the FETA program for analysis.

Categorical

Horlicks Ovaltine cup

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Wine glass

Average use last year of Wine (glass). After cleaning this variable is renamed as WINE which is then used by the FETA program for analysis.

Categorical

Wine glass

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Beer lager or cider half pint

Average use last year of Beer lager or cider (half pint). After cleaning this variable is renamed as BEER which is then used by the FETA program for analysis.

Categorical

Beer lager or cider half pint

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Port sherry vermouth liqueurs glass

Average use last year of Port sherry vermouth liqueurs (glass). After cleaning this variable is renamed as PORT which is then used by the FETA program for analysis.

Categorical

Port sherry vermouth liqueurs glass

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay DSC2

Phase 1 OLINK assay data for target DSC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DSG3

Phase 1 OLINK assay data for target DSG3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay DSG4

Phase 1 OLINK assay data for target DSG4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

DURATIONINI

DURATIONINI. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURATIONJOB

DURATIONJOB. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURATIONJOB1

DURATIONJOB1. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURATIONJOB2

DURATIONJOB2. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURATIONJOB3

DURATIONJOB3. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURATIONJOB4

DURATIONJOB4. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURATIONLEIS

DURATIONLEIS. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURCAR

DURCAR. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURCOMP

DURCOMP. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURCYCLE

DURCYCLE. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURJOB

DURJOB. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURPUBLIC

DURPUBLIC. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURSTAIRFLIGHT

DURSTAIRFLIGHT. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURTV

DURTV. Derived Intermediate not for general release. Data can be provided if necessary.

Real

DURWALK

DURWALK. Derived Intermediate not for general release. Data can be provided if necessary.

Real

OLINK assay DUSP3

Phase 1 OLINK assay data for target DUSP3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ECE1

Phase 1 OLINK assay data for target ECE1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Date of the ECG scan a

Date

None

Name of the original ECG a file. This will be the same for 90percent the files. Some will have had the scan date added to the pdf file at a later date (but not to the txt or tif files).

Text

None

Name of folder where ECG scans a were stored. This probably is (but might not always be) the same as the foldername where they were moved to. Files could be just a pdf file or a pdf; a tif and a text file.

Text

None

Date of the ECG scan b

Date

None

Name of the original ECG b file. This will be the same for 90percent the files. Some will have had the scan date added to the pdf file at a later date (but not to the txt or tif files).

Text

None

Name of folder where ECG scans b were stored. This probably is (but might not always be) the same as the foldername where they were moved to. Files could be just a pdf file or a pdf; a tif and a text file.

Text

None

Date of the ECG scan c

Date

None

Name of the original ECG c file. This will be the same for 90percent the files. Some will have had the scan date added to the pdf file at a later date (but not to the txt or tif files).

Text

None

Name of folder where ECG scans c were stored. This probably is (but might not always be) the same as the foldername where they were moved to. Files could be just a pdf file or a pdf; a tif and a text file.

Text

None

Any comments regarding the ECG scans provided by the DM team

Text

None

Indication whether ECG paper outputfor phase 1 analysis has been scanned into an electronic file. Data entered is the name of the file. Since this contains the study ID number this variable should not be released. If left blank it hasn't been scanned yet.

None

Indication which team scanned the ECG paper output for phase 1 analysis.

OLINK assay EDA2R

Phase 1 OLINK assay data for target EDA2R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EDAR

Phase 1 OLINK assay data for target EDAR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EDIL3

Phase 1 OLINK assay data for target EDIL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EFEMP1

Phase 1 OLINK assay data for target EFEMP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EFNA4

Phase 1 OLINK assay data for target EFNA4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

EFT In house Complete

Phase 2 data. In House Executive Function test completed? 1 = yes;

Categorical

EFT Online Complete

Phase 2 data. Online Executive Function test completed? 0 = no; 1 = yes;

Categorical

OLINK assay EGFL7

Phase 1 OLINK assay data for target EGFL7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EGFR

Phase 1 OLINK assay data for target EGFR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EGF

Phase 1 OLINK assay data for target EGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EGLN1

Phase 1 OLINK assay data for target EGLN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EIF4B

Phase 1 OLINK assay data for target EIF4B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EIF4G1

Phase 1 OLINK assay data for target EIF4G1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EIF5A

Phase 1 OLINK assay data for target EIF5A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Electrodes

Data as entered on Study database. Electrodes used Arbo or Red dot

Text

Electrodes used Arbo or Red dot

Phase 2 data. Data as entered on Study database. Electrodes used Arbo or Red dot For study coordination purposes and QC only.

Text

EMPLOYED

EMPLOYED. Derived Intermediate not for general release. Data can be provided if necessary.

Categorical

OLINK assay ENAH

Phase 1 OLINK assay data for target ENAH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENG

Phase 1 OLINK assay data for target ENG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENO2

Phase 1 OLINK assay data for target ENO2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENPP2

Phase 1 OLINK assay data for target ENPP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENPP7

Phase 1 OLINK assay data for target ENPP7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENTPD2

Phase 1 OLINK assay data for target ENTPD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENTPD5

Phase 1 OLINK assay data for target ENTPD5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENTPD6

Phase 1 OLINK assay data for target ENTPD6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ENTPD6

Phase 1 OLINK assay data for target ENTPD6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EN-RAGE

Phase 1 OLINK assay data for target EN-RAGE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Eosinophil count

An eosinophil count is a blood test that measures the number of eosinophils; a type of white blood cell; in your bloodstream. These cells are part of your immune system and help fight off infections; especially parasitic infections and allergic reactions. A normal eosinophil count is 0.1 - 0.4 x10^9/L

Real

OLINK assay EPHA10

Phase 1 OLINK assay data for target EPHA10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EPHA2

Phase 1 OLINK assay data for target EPHA2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EPHB4

Phase 1 OLINK assay data for target EPHB4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EPHB6

Phase 1 OLINK assay data for target EPHB6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EPO

Phase 1 OLINK assay data for target EPO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Ep-CAM

Phase 1 OLINK assay data for target Ep-CAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ERBB2IP

Phase 1 OLINK assay data for target ERBB2IP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ERBB2

Phase 1 OLINK assay data for target ERBB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ERBB3

Phase 1 OLINK assay data for target ERBB3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ERBB4

Phase 1 OLINK assay data for target ERBB4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay EREG

Phase 1 OLINK assay data for target EREG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ESAM

Phase 1 OLINK assay data for target ESAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ESM-1

Phase 1 OLINK assay data for target ESM-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

EventsBookEntry

EventsBookEntry

Events Book Entry

Phase 2 data. Was there an entry in the Adverse Events books related to the Phase 2 Clinical visit? 0 = no; 1 = yes;

Categorical

Hours of Exercise With Weights

Please indicate the average length of time (in hours) you spent doing the activity per episode. Exercise With Weights.

Integer

Hours of Exercise With Weights CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Exercise With Weights. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Exercise Weights hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Exercise With Weights. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Exercise With Weights hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Exercise With Weights. -1 = left blank. DO NOT USE THIS VARIABLE. Use exerciseWeightsHr_CLEAN_P2 instead.

Real

Minutes of Exercise With Weights

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Exercise With Weights.

Integer

Minutes of Exercise With Weights CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Exercise With Weights. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Exercise Weights min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Exercise With Weights. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Exercise With Weights min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Exercise With Weights. -1 = left blank. DO NOT USE THIS VARIABLE. Use exerciseWeightsMin_CLEAN_P2 instead.

Real

Frequency of Exercise With Weights CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Exercise With Weights. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

exerciseWeights_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Exercise With Weights

Real

Cln variable: Exercise Weights

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Exercise With Weights. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

exerciseWeights_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Exercise With Weights. Data normalised to DE template 1 data.

Categorical

Exercise With Weights

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Exercise With Weights. DO NOT USE THIS VARIABLE. Use exerciseWeights_CLEAN_P2 instead.

Real

Exercise With Weights

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Exercise With Weights. CLEANED. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Exercise With Weights DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Exercise With Weights. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in exerciseWeights_T2. Instead use exerciseWeights_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Exercise With Weights DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Exercise With Weights. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in exerciseWeights_T1. Instead use exerciseWeights_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

ExomeID

Exome ID number. All samples on the Illumina exome chip have a exomeid. Having an exomeid does not guarantee having exome data. Only those marked as HasExomeData - 1 have exome data.

Expenses

Total amount of expenses incurred.

OLINK assay EZR

Phase 1 OLINK assay data for target EZR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Anthro code

Coding of anthropometry team data. Request with E_AnthroComment for further information.

Anthro code

Phase 2 data. Coding of anthropometry team data. Request with E_AnthroComment for further information. 8 = Correct extreme value; 9 = poor quality data;

Real

Anthro Team Comment

Data provided by Anthropometry team. Comments provided by Anthro team on the data they have derived. Not available in release 1-5. Request with E_AnthroCode.

Text

Anthro Team Comment

Phase 2 data. Data provided by Anthropometry team. Comments provided by Anthro team on the data they have derived. Not available in release 1-5. Request with E_AnthroCode.

Text

Average of all hip measurements

Data provided by Anthropometry team. Average of all hip measurements. If 2 measurements were taken: (hip1+hip2)/2 and (hip1+hip2+hip3)/3 if a third measurement was taken.

Real

Average of all hip measurements

Phase 2 data. Data provided by Anthropometry team. Average of all hip measurements. If 2 measurements were taken: (hip1+hip2)/2 and (hip1+hip2+hip3)/3 if a third measurement was taken. -1 = Unable to be determined; -9 = Missing data;

Real

Average of all waist measurements

Data provided by Anthropometry team. Average of all waist measurements. If 2 measurements were taken: (waist1+waist2)/2 and (waist1+waist2+waist3)/3 if a third measurement was taken.

Real

Average of all Waist measurements

Phase 2 data. Data provided by Anthropometry team. Average of all waist measurements. If 2 measurements were taken: (waist1+waist2)/2 and (waist1+waist2+waist3)/3 if a third measurement was taken. -1 = Unable to be determined; -9 = Missing data;

Real

Body Mass Index

Data provided by Anthropometry team. BMI (E_Weight / E_Height Squared).

Real

Body Mass Index

Phase 2 data. Data provided by Anthropometry team. BMI (E_Weight / E_Height Squared). -1 = Unable to be determined;

Real

Height in cm

Data provided by Anthropometry team. Height measurement in centimetres. This is data from the study database which has been QCd by the Anthropometry team. Any data issues have been corrected by the study team. Data checking is performed by comparing data from the DEXA machine and the study db. Any discrepancies are flagged and resolved.

Real

Comment for Cln E_Height Data

Phase 2 data. Comment for phase 2 cleaned E_Height Data (in E_Height_Cl_P2) Provided by Anthropometry team.

Text

Body Fat percentage

New in R7. Data provided by Anthropometry team. Body Fat % derived by in house prediction equations based on impedance and anthropometry values which were validated against DEXA values. We used the following equations in men: 16.34649+(Ht2Im*0.6493159)+( Weight*0.1334669)-(AgeAtTest *0.0801411) ; and in women: 13.09247+(Ht2Im*0.6587483)+( Weight*0.0914326)-(AgeAtTest *0.0660596) to firstly generate fat free mass then fat mass was derived as follows : weight - fat free mass and % derived: fat mass / (weight/100) ; further information on the validity can be found by requesting the BIARegeneratedBodyFatPcnt document.pdf. (Ht2Im = height2/Impedance)

Real

Body Fat percentage

Phase 2 data. Data provided by Anthropometry team. Body Fat percent derived by in house prediction equations based on impedance and anthropometry values which were validated against DEXA values. The following equations were used in men: 16.34649+(Ht2Im*0.6493159)+( Weight*0.1334669)-(AgeAtTest *0.0801411) and in women: 13.09247+(Ht2Im*0.6587483)+( Weight*0.0914326)-(AgeAtTest *0.0660596) to generate fat free mass (Ht2Im = height2/Impedance). Fat mass (weight - fat free mass) then percentage body fat (fat mass / (weight/100)) were derived. Further information on the validity can be provided by requesting the BIARegeneratedBodyFatPcnt document. -1 = unable to be determined; -7 = 0 values replaced; -9 = Missing data;

Real

Cln variable: height data

Phase 2 data. Replaces data for E_Height_P2. Cleaned phase 2 data provided by Anthropometry team. Height measurement in centimetres (data source: either from E_Height_P2 or where missing or incorrect a height estimate was taken from the phase 2 DEXA scan). -9 = Missing data;

Real

Height measurement in centimetres

Phase 2 data. Data provided by Anthropometry team. Height measurement in centimetres. This is data from the study database which has been QCd by the Anthropometry team. Any data issues have been corrected by the study team. Data checking is performed by comparing data from the DEXA machine and the study db. Any discrepancies are flagged and resolved. -9 = Missing data; Replaced by E_Height_Cl_P2

Real

Hip 1

Data provided by Anthropometry team. First Hip Measurement in centimetres.

Real

First Hip Measurement

Phase 2 data. Data provided by Anthropometry team. First Hip Measurement in centimetres. -1 = Unable to be determined; -9 = Missing data;

Real

Hip 2

Data provided by Anthropometry team. Second Hip Measurement in centimetres.

Real

Second Hip Measurement

Phase 2 data. Data provided by Anthropometry team. Second Hip Measurement in centimetres. -1 = Unable to be determined; -9 = Missing data;

Real

Hip 3

Data provided by Anthropometry team. Third Hip Measurement in centimetres.

Real

Third Hip Measurement

Phase 2 data. Data provided by Anthropometry team. Third Hip Measurement in centimetres. -1 = Unable to be determined; -9 = Missing data;

Real

Anthro comment

Anthropometry team comment on the data.

Text

None

Phase 2 data. Info on DEXA scanner used for volunteer. 1 = Prodigy; 2 = Prodigy Advanced; 3 = iDEXA; -9 = No DEXA scan performed;

Categorical

Sex

Participants gender checked and cleaned by Anthropometry team. Available for participants with Anthro data only.

Categorical

Sex

Phase 2 data. Participants gender checked and cleaned by Anthropometry team. Available for participants with Anthro data only. M = male; F = female; -9 = Missing data;

Categorical

Body fat percent Tanita

Data provided by Anthropometry team. Body Fat% by BIA (Bioelectrical Impedance Analysis) devise.

Real

Body fat percent Tanita

Phase 2 data. Data provided by Anthropometry team. Body Fat% by BIA (Bioelectrical Impedance Analysis) devise. -1 = Unable to be determined; -9 = Missing data;

Real

Tanita Impedance

Data provided by Anthropometry team. Bioelectrical Impedance for the whole body (right foot to right hand) in Ohm.

Integer

Tanita Impedance

Phase 2 data. Data provided by Anthropometry team. Bioelectrical Impedance for the whole body (right foot to right hand) in Ohm. -1 = Unable to be determined; -9 = Missing data;

Integer

Tanita left arm impedance

Data provided by Anthropometry team. Bioelectrical Impedance for the left arm in Ohm.

Integer

Tanita left arm Impedance

Phase 2 data. Data provided by Anthropometry team. Bioelectrical Impedance for the left arm in Ohm. -1 = Unable to be determined; -9 = Missing data;

Integer

Tanita left leg impedance

Data provided by Anthropometry team. Bioelectrical Impedance for the left leg in Ohm. -1 = Unable to be determined; -9 = Missing data;

Integer

Tanita left leg Impedance

Phase 2 data. Data provided by Anthropometry team. Bioelectrical Impedance for the left leg in Ohm. -1 = Unable to be determined; -9 = Missing data;

Integer

Tanita right arm impedance

Data provided by Anthropometry team. Bioelectrical Impedance for the right arm in Ohm.

Integer

Tanita right arm Impedance

Phase 2 data. Data provided by Anthropometry team. Bioelectrical Impedance for the right arm in Ohm. -1 = Unable to be determined; -9 = Missing data;

Integer

Tanita right leg impedance

Data provided by Anthropometry team. Bioelectrical Impedance for the right leg in Ohm.

Integer

Tanita right leg Impedance

Phase 2 data. Data provided by Anthropometry team. Bioelectrical Impedance for the right leg in Ohm. -1 = Unable to be determined; -9 = Missing data;

Integer

Test date

Data provided by Anthropometry team. Date of Test (DOT).

Date

Test date

Phase 2 data. Data provided by Anthropometry team. Date of Test (DOT). -9 = Missing data;

Date

None

E_TestDate rounded to 0.1 years. E_TestDate: Data provided by Anthropometry team. Date of Test (DOT). -9 = Missing data;

Date

US left lateral

Data provided by Anthropometry team. Left lateral ultrasound measurement in centimetres (no longer in the updated protocol).

Real

US Right lateral

Data provided by Anthropometry team. Right lateral ultrasound measurement in centimetres (no longer in the updated protocol).

Real

Ultrasound Medial

Data provided by Anthropometry team. Medial (depth of visceral abdominal tissue) ultrasound measurement in centimetres.

Real

Ultrasound Medial

Phase 2 data. Data provided by Anthropometry team. Medial (depth of visceral abdominal tissue) ultrasound measurement in centimetres.

Real

Ultrasound Sub Cut

Data provided by Anthropometry team. Subcutaneous (Depth of abdominal subcutaneous tissue) ultrasound measurement in centimetres.

Real

Ultrasound Subcutaneous

Phase 2 data. Data provided by Anthropometry team. Subcutaneous (Depth of abdominal subcutaneous tissue) ultrasound measurement in centimetres.

Real

Waist 1

Data provided by Anthropometry team. First Waist Measurement in centimetres.

Real

First Waist Measurement

Phase 2 data. Data provided by Anthropometry team. First Waist Measurement in centimetres. -1 = Unable to be determined; -9 = Missing data;

Real

Waist 2

Data provided by Anthropometry team. Second Waist Measurement in centimetres.

Real

Second Waist Measurement

Phase 2 data. Data provided by Anthropometry team. Second Waist Measurement in centimetres. -1 = Unable to be determined; -9 = Missing data;

Real

Waist 3

Data provided by Anthropometry team. Third Waist Measurement in centimetres (appended only if waist 1 and 2 differed by greater than 3 cm).

Real

Third Waist Measurement

Phase 2 data. Data provided by Anthropometry team. Third Waist Measurement in centimetres (appended only if waist 1 and 2 differed by greater than 3 cm). -1 = Unable to be determined; -9 = Missing data;

Real

Waist to hip ratio

Phase 2 data. Waist to hip ratio. Data provided by Anthropometry team.

Real

Weight

Data provided by Anthropometry team. Weight measurement in kilograms. This is data from the study database which has been QCd by the Anthropometry team. Any data issues have been corrected by the study team. Data checking is performed by comparing data from the DEXA machine and the study db. Any discrepancies are flagged and resolved.

Real

Weight Device

Data provided by Anthropometry team. Equipment used to measure weight. No data available for participants not included in R6 or earlier.

Categorical

Weight measurement in kilograms

Phase 2 data. Data provided by Anthropometry team. Weight measurement in kilograms. -9 = Missing data;

Real

OLINK assay F11

Phase 1 OLINK assay data for target F11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay F7

Phase 1 OLINK assay data for target F7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FABP2

Phase 1 OLINK assay data for target FABP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FABP4

Phase 1 OLINK assay data for target FABP4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FABP9

Phase 1 OLINK assay data for target FABP9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

FAB ID number

FAB ID number identical to study number so will not be released

Text

OLINK assay FADD

Phase 1 OLINK assay data for target FADD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay FAM19A5

Phase 1 OLINK assay data for target FAM19A5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FAM3B

Phase 1 OLINK assay data for target FAM3B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FAM3C

Phase 1 OLINK assay data for target FAM3C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FAP

Phase 1 OLINK assay data for target FAP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FASLG

Phase 1 OLINK assay data for target FASLG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Fasted status for rest and treadmill test

Fasting status for rest and treadmill test.

Categorical

Fasting Sample Arm

Phase 2 data. Arm from which fasting blood sample was taken.

Text

Fasting Sample by

Phase 2 data. Initials/ID of staff member fasting blood sample was taken by

Text

Fasting Sample Site

Phase 2 data. Site of fasting sample blood sample taken

Text

OLINK assay FAS

Phase 1 OLINK assay data for target FAS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

This question asks about the type of fat used most often for baking cakes etc There is a fats look-

Variable derived by study staff from raw FFQ data for A7aBakingFat and A7bOtherfat.

Categorical

This question asks about the type of fat used most often for frying roasting grilling etc There i

Variable derived by study staff from raw FFQ data for A6aFryingFat and A6bOtherfat.

Categorical

C10:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Capric (C10:0). This variable contains the data from FA_C10_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C11:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Undecylic (C11:0). This variable contains the data from FA_C11_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C12:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Lauric (C12:0). This variable contains the data from FA_C12_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C13:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Tridecylic (C13:0). This variable contains the data from FA_C13_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C14:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Myristic (C14:0). This variable contains the data from FA_C14_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C14:1 QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: Myristoleic (C14:1). This variable contains the data from FA_C14_1 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C15:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Pentadecanoic (C15:0). This variable contains the data from FA_C15_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C15:1 QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: No name (C15:1). This variable contains the data from FA_C15_1 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C16:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Palmitic (C16:0). This variable contains the data from FA_C16_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C16:1c QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: Palmitoleic (C16:1c). This variable contains the data from FA_C16_1c which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C16:1t QCd

QCd Plasma phospholipid Trans Fatty Acid: Trans Palmitoleic Acid (C16:1t). This variable contains the data from FA_C16_1t which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C17:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Heptadecanoic (C17:0). This variable contains the data from FA_C17_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C17:1 QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: no name (C17:1). This variable contains the data from FA_C17_1 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C18:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Stearic (C18:0). This variable contains the data from FA_C18_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C18:1n9c QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: Oleic (C18:1n9c). This variable contains the data from FA_C18_1n9c which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C18:1n9t QCd

QCd Plasma phospholipid Trans Fatty Acid: ElaidicAcid (C18:1n9t). This variable contains the data from FA_C18_1n9t which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C18:2n6c QCd

QCd Plasma phospholipid Omega-6 Polyunsaturated Fatty Acid: Linoleic (C18:2n6c). This variable contains the data from FA_C18_2n6c which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C18:2n6t QCd

QCd Plasma phospholipid Trans Fatty Acid: ConjugatedLinoleic (C18:2n6t). This variable contains the data from FA_C18_2n6t which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C18:3n3 QCd

QCd Plasma phospholipid Omega-3 Polyunsaturated Fatty Acid: AlphaLinolenic (C18:3n3). This variable contains the data from FA_C18_3n3 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C18:3n6 QCd

QCd Plasma phospholipid Omega-6 Polyunsaturated Fatty Acid: GammaLinolenic (C18:3n6). This variable contains the data from FA_C18_3n6 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C20:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Arachidic (C20:0). This variable contains the data from FA_C20_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

New for R8a. Data from phase 1 samples. c20:1n-9 gondoic acid - percent total phospholipid fatty acids; The raw un-QCd data is stored in FA_C20_1. The result is the percent of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in molpercent. -9 if the assay was attempted but the sample was insufficient

Real

None

New for R8a. Data from phase 1 samples. c20:2n-6 eicosadienoic acid - percent total phospholipid fatty acids;The raw un-QCd data is stored in FA_C20_2. The result is the percent of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in molpercent. -9 if the assay was attempted but the sample was insufficient

Real

C20:3n6 QCd

QCd Plasma phospholipid Omega-6 Polyunsaturated Fatty Acid: DihomoGammaLinolenic (C20:3n6). This variable contains the data from FA_C20_3n6 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C20:4n6_plus_C20:3n3 QCd

QCd Plasma phospholipid Omega-6 Polyunsaturated Fatty Acid: Arachidonic acid(20_4n6). + Eicosatrienoic Acid(20_3n3). (C20:4n6_plus_C20:3n3). This variable contains the data from FA_C20_4n6_C20_3n3 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C20:5n3 QCd

QCd Plasma phospholipid Omega-3 Polyunsaturated Fatty Acid: Eicosapentaenoic (C20:5n3). This variable contains the data from FA_C20_5n3 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C21:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Heneicosanoic (C21:0). This variable contains the data from FA_C21_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C22:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Behenic (C22:0). This variable contains the data from FA_C22_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C22:1n9 QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: Erucic (C22:1n9). This variable contains the data from FA_C22_1n9 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

New for R8a. Data from phase 1 samples. c22:2n-6 docosadienoic acid - percent total phospholipid fatty acids; The raw un-QCd data is stored in FA_C22_2. The result is the percent of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in molpercent. -9 if the assay was attempted but the sample was insufficient

Real

None

New for R8a. Data from phase 1 samples. c22:4n-6 adrenic acid - percent total phospholipid fatty acids; The raw un-QCd data is stored in FA_C21_0. The result is the percent of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in molpercent. -9 if the assay was attempted but the sample was insufficient

Real

C22:5n3 QCd

QCd Plasma phospholipid Omega-3 Polyunsaturated Fatty Acid: Docosapenteanoic (C22:5n3). This variable contains the data from FA_C22_5n3 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C22:5n6 QCd

QCd Plasma phospholipid Omega-6 Polyunsaturated Fatty Acid: Docosapentenoic (C22:5n6). This variable contains the data from FA_C22_5n6 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C22:6n3 QCd

QCd Plasma phospholipid Omega-3 Polyunsaturated Fatty Acid: Docosahexaenoic (C22:6n3). This variable contains the data from FA_C22_6n3 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C23:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Tricosanoic (C23:0). This variable contains the data from FA_C23_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C24:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Lignoceric (C24:0). This variable contains the data from FA_C24_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

C24:1 QCd

QCd Plasma phospholipid Monounsaturated Fatty Acid: Nervonic (C24:1). This variable contains the data from FA_C24_1 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

C8:0 QCd

QCd Plasma phospholipid Saturated Fatty Acid: Caprylic (C8:0). This variable contains the data from FA_C8_0 which passed our QC steps. The result is the % of the peak area for this fatty acid of the total peak area for all 38 fatty acids measured in mol%

Real

fatty acid date

Date of analysis for fatty acids

Date

OLINK assay FBP1

Phase 1 OLINK assay data for target FBP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCAR

Phase 1 OLINK assay data for target FCAR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCER2

Phase 1 OLINK assay data for target FCER2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCGR2A

Phase 1 OLINK assay data for target FCGR2A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCGR3B

Phase 1 OLINK assay data for target FCGR3B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCN2

Phase 1 OLINK assay data for target FCN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCRL1

Phase 1 OLINK assay data for target FCRL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FcRL2

Phase 1 OLINK assay data for target FcRL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCRL3

Phase 1 OLINK assay data for target FCRL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCRL5

Phase 1 OLINK assay data for target FCRL5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCRL6

Phase 1 OLINK assay data for target FCRL6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FCRLB

Phase 1 OLINK assay data for target FCRLB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Ferritin

Ferritin measurement data in ug/l

Real

Ferritin_Comment

Comment provided by lab on ferritin lab measurement data

Ferritin_Date_Analysed

Date sample was analysed for ferritin

OLINK assay FES

Phase 1 OLINK assay data for target FES in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FETUB

Phase 1 OLINK assay data for target FETUB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

General comments

Comments entered on FFQ form. Not mapped to FETA variable since not used by FETA.

Text

General comments

Phase 2 data. General Comments

Text

FFQ Q version number

Version number of the FFQ completed by the participant.

Text

None

Fenland phase 1 serum sample Fibroblast Growth Factor 21 measurement in pg/ml. Only 24 samples were analysed for a small substudy.

Real

OLINK assay FGF2

Phase 1 OLINK assay data for target FGF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGFR2

Phase 1 OLINK assay data for target FGFR2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-19

Phase 1 OLINK assay data for target FGF-19 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-21

Phase 1 OLINK assay data for target FGF-21 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-21

Phase 1 OLINK assay data for target FGF-21 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-21

Phase 1 OLINK assay data for target FGF-21 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-23

Phase 1 OLINK assay data for target FGF-23 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-23

Phase 1 OLINK assay data for target FGF-23 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-5

Phase 1 OLINK assay data for target FGF-5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGF-BP1

Phase 1 OLINK assay data for target FGF-BP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FGR

Phase 1 OLINK assay data for target FGR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

factor H

Complement Factor H. Data produced by UCL from blood samples.

Real

SiblingTotalText

How many brothers and sisters do or did you have (Please do not include any adopted family members or step-brothers/sisters/parents). For data entry: enter all text as is and where ? used = female ? = male

Text

No of brothers and sisters

Phase 2 data. How many brothers and sisters do or did you have (Please do not include any adopted family members or step-brothers/sisters/parents). For data entry: enter all text as is and where ? used = female ? = male

Text

SisterTotal

Total number of sisters. Please do not include step-sisters. For data entry: Enter number as is. NB this number should be interpreted based on the full text in the previous variable - SiblingTotaltext.

Integer

No of sisters

Phase 2 data. Total number of sisters. Please do not include step-sisters. For data entry: Enter number as is. NB this number should be interpreted based on the full text in the previous variable - SiblingTotaltext. -1 = no number of sister or brother given

Real

BrotherTotal

Total number of brothers. Please do not include step-brothers. For data entry: Enter number as is. NB this number should be interpreted based on the full text in the previous variable - SiblingTotaltext.

Integer

No of brothers

Phase 2 data. Total number of brothers. Please do not include step-brothers. For data entry: Enter number as is. NB this number should be interpreted based on the full text in the previous variable - SiblingTotaltext.-1 = no number of sister or brother given

Real

MotherDiabetic

Mother has/had diabetes. Please do not include step-mother. Please do not include gestational diabetes.

Categorical

Mother diabetes has/had

Phase 2 data. Mother has/had diabetes. Please do not include step-mother. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

MotherAge

Approximate age at diabetes diagnosis of mother.

Categorical

Age mother at diabetes diagnosis

Phase 2 data. Approximate age at diabetes diagnosis of mother. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

FatherDiabetic

Father has/had diabetes. Please do not include step-father. Please do not include gestational diabetes.

Categorical

Father diabetes has/had

Phase 2 data. Father has/had diabetes. Please do not include step-father. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

FatherAge

Approximate age at diabetes diagnosis of father.

Categorical

Age father at diabetes diagnosis

Phase 2 data. Approximate age at diabetes diagnosis of father. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling01Type

Type of sibling 01.

Categorical

Type of sibling 01

Phase 2 data. Type of sibling 01. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling01Diabetic

Sibling 10 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 01 has/had diabetes

Phase 2 data. Sibling 01 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling01Age

Approximate age at diabetes diagnosis of sibling 01.

Categorical

Age Sibling 01 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 01. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling02Type

Type of sibling 02.

Categorical

Type of sibling 02

Phase 2 data. Type of sibling 02. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling02Diabetic

Sibling 02 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 02 has/had diabetes

Phase 2 data. Sibling 02 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling02 Age

Approximate age at diabetes diagnosis of sibling 02.

Categorical

Age Sibling 02 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 02. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling03Type

Type of sibling 03

Categorical

Type of sibling 03

Phase 2 data. Type of sibling 03. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling03Diabetic

Sibling 03 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 03 has/had diabetes

Phase 2 data. Sibling 03 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling03Age

Approximate age at diabetes diagnosis of sibling 03.

Categorical

Age Sibling 03 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 03. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling04Type

Type of sibling 04

Categorical

Type of sibling 04

Phase 2 data. Type of sibling 04. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling04Diabetic

Sibling 04 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 04 has/had diabetes

Phase 2 data. Sibling 04 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling04Age

Approximate age at diabetes diagnosis of sibling 04.

Categorical

Age Sibling 04 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 04. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling05Type

Type of sibling 05

Categorical

Type of sibling 05

Phase 2 data. Type of sibling 05. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling05Diabetic

Sibling 05 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 05 has/had diabetes

Phase 2 data. Sibling 05 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling05Age

Approximate age at diabetes diagnosis of sibling 05.

Categorical

Age Sibling 05 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 05. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling06Type

Type of sibling 06

Categorical

Type of sibling 06

Phase 2 data. Type of sibling 06. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling06Diabetic

Sibling 06 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 06 has/had diabetes

Phase 2 data. Sibling 06 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling06Age

Approximate age at diabetes diagnosis of sibling 06.

Categorical

Age Sibling 06 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 06. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling07Type

Type of sibling 07

Categorical

Type of sibling 07

Phase 2 data. Type of sibling 07. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling07Diabetic

Sibling 07 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 07 has/had diabetes

Phase 2 data. Sibling 07 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling07Age

Approximate age at diabetes diagnosis of sibling 07.

Categorical

Age Sibling 07 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 07. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling08Type

Type of sibling 08

Categorical

Type of sibling 08

Phase 2 data. Type of sibling 08. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling08Diabetic

Sibling 08 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 08 has/had diabetes

Phase 2 data. Sibling 08 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling08Age

Approximate age at diabetes diagnosis of sibling 08.

Categorical

Age Sibling 08 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 08. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling09Type

Type of sibling 09

Categorical

Type of sibling 09

Phase 2 data. Type of sibling 09. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling09Diabetic

Sibling 09 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 09 has/had diabetes

Phase 2 data. Sibling 09 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling09Age

Approximate age at diabetes diagnosis of sibling 09.

Categorical

Age Sibling 09 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 09. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

Sibling10Type

Type of sibling 10

Categorical

Type of sibling 10

Phase 2 data. Type of sibling 10. 1 = sister; 2 = brother; 3 = half sister; 4 = half brother; -1 = left blank; -7 = sibling type not on questionnaire; -10 = answer plus additional text;

Categorical

Sibling10Diabetic

Sibling 10 has/had diabetes. Please do not include gestational diabetes.

Categorical

Sibling 10 has/had diabetes

Phase 2 data. Sibling 10 has/had diabetes. Please do not include gestational diabetes. 2 = yes; 3 = No; 4 = Not known; -1 = left blank; -10 = answer plus additional text;

Categorical

Sibling10Age

Approximate age at diabetes diagnosis of sibling 10.

Categorical

Age Sibling 10 at diabetes diag

Phase 2 data. Approximate age at diabetes diagnosis of sibling 10. 1 = <10; 2 = 10-19; 3 = 20-29; 4 = 30-39; 5 = 40-49; 6 = 50-59; 7 = 60-69; 8 = 70+; 9 = Not known; -1 = left blank; -5 = more than one selected;

Categorical

FamilyHistoryEntryComments

Any additional text written on the questionnaire

Text

Family History entry comments

Phase 2 data. Any additional text written on the questionnaire

Text

OLINK assay FHIT

Phase 1 OLINK assay data for target FHIT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Date finished eFamHist qnr

Phase 2 data. Date the participant finished filling in the Electronic Online FamHist questionnaire.

Date

Date started eFamHist qnr

Phase 2 data. Date the participant started to fill in the Electronic Online FamHist questionnaire.

Date

eFamHist qnr pt ID no

Phase 2 data. Electronic FamHist questionnaire-specicifc participant ID number.

Text

None

Phase 2 data. Please enter your 3-digit pin (on electronic form).

Text

eFamHist qnr ID no

Phase 2 data. Electronic FamHist questionnaire ID number for version control.

Text

eFamHist qnr ID name

Phase 2 data. Electronic FamHist questionnaire ID name for version control.

Text

Study phase eFamHist qnr

Phase 2 data. Study phase the Electronic FamHist questionnaire was used for.

Text

Time finished eFamHist qnr

Phase 2 data. Time the participant finished filling in the Electronic Online FamHist questionnaire.

Text

Time started eFamHist qnr

Phase 2 data. Time the participant started to fill in the Electronic Online FamHist questionnaire.

Text

eFamHist qnr version date

Phase 2 data. Electronic FamHist questionnaire version date for version control.

Text

eFamHist qnr version no

Phase 2 data. Electronic FamHist questionnaire version number for version control.

Text

eFamHist qnr web form version no

Phase 2 data. Electronic FamHist questionnaire web form version number for version control.

Text

None

To be used for clustering particpants in age groups of 5 year blocks. Useful when data of birth can not be released.

Five Year Age Group

Phase 2 data. Age group the volunteer belonged to at the time of their phase 2 clinical appointment where age groups have been split up into groups of 5 years. Derived by data management team based on AgeAtTest_DM_Attended_P2. Can be used where precise age cannot be released or in not required.

Text

OLINK assay FKBP1B

Phase 1 OLINK assay data for target FKBP1B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FKBP4

Phase 1 OLINK assay data for target FKBP4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FKBP5

Phase 1 OLINK assay data for target FKBP5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FKBP7

Phase 1 OLINK assay data for target FKBP7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Flag incomplete questionnaire

Phase 2 data. Derived with method 2. Flag those that did not complete questionnaire (1 = Not complete)

Categorical

Flag shift worker

Phase 2 data. 1=Noted as shift worker 2=Multiple sleep times reported (but not ticked shift)

Categorical

OLINK assay FLI1

Phase 1 OLINK assay data for target FLI1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Floor Exercises

Please indicate the average length of time (in hours) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga).

Integer

Hours of Floor Exercises CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Floor exercises hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Floor Exercises hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). -1 = left blank. DO NOT USE THIS VARIABLE. Use floorExerciseHr_CLEAN_P2 instead.

Real

Minutes of Floor Exercises

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga).

Integer

Minutes of Floor Exercises CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Floor exercises min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Floor Exercises min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). -1 = left blank. DO NOT USE THIS VARIABLE. Use floorExerciseMin_CLEAN_P2 instead.

Real

Frequency of Floor Exercises CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Floor Exercises (eg stretching bending keep fit or yoga). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

floorExercise_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Floor Exercises

Real

Cln variable: Floor exercises

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Floor Exercises (eg stretching bending keep fit or yoga). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

floorExercise_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Floor Exercises (eg stretching bending keep fit or yoga). Data normalised to DE template 1 data.

Categorical

Floor Exercises

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Floor Exercises(eg stretching bending keep fit or yoga). DO NOT USE THIS VARIABLE. Use floorExercise_CLEAN_P2 instead.

Real

Floor Exercises

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Floor Exercises (eg stretching bending keep fit or yoga). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Floor Exercises DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Floor Exercises (eg stretching bending keep fit or yoga). Data entered using data entry template with 1-2-3-4-5-6-7 codes . This data cannot be compared with data in floorExercise_T2. Instead use floorExercise_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Floor Exercises DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Floor Exercises (eg stretching bending keep fit or yoga). Data entered using data entry template with 1-3-4-5-6-7-8 codes . This data cannot be compared with data in floorExercise_T1. Instead use floorExercise_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay FLRT2

Phase 1 OLINK assay data for target FLRT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Flt3L

Phase 1 OLINK assay data for target Flt3L in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

FMR group

Indication wether the participant was allocated to FMR group A or B. People in group A were only told that the monitor they had to wear for 6 days and nights was a heart rate monitor. People in group B were also told it monitors movement and that by analysing the information stored in the monitor we will be able to tell exactly how active you have been during these six days.

Categorical

FMR Info date

Version date of the Information sheet provided to FMR participants.

Date

FMR Info version

Version number of the Information sheet provided to FMR participants.

Text

FMR participant

Is the participant part of the FMR study. Data generated by the data management team based on list provided by study coordination.

Categorical

FMR test date

Date FMR participant attended research unit to undergo FMR health checks and to hand over monitor.

Date

OLINK assay FOLR2

Phase 1 OLINK assay data for target FOLR2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

No. of correctly identified targets (target=food image)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on the food picture; in the Rapid Serial Visualisation Task.

Integer

No. of correctly identified targets (food distractor 1 image before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a distractor food picture shown 1 image before the target (i.e.; the distractor immediately preceded the target); in the Rapid Serial Visualisation Task.

Integer

No. of correctly identified targets (food distractor 2 images before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a distractor food picture shown 2 images before the target (i.e.; there was 1 neutral image between the distractor and the target); in the Rapid Serial Visualisation Task.

Integer

No. of correctly identified targets (food distractor 3 images before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a distractor food picture shown 3 images before the target (i.e.; there were 2 neutral image between the distractor and the target); in the Rapid Serial Visualisation Task.

Integer

No. of correctly identified targets (food distractor 4 images before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a distractor food picture shown 4 images before the target (i.e.; there were 3 neutral image between the distractor and the target); in the Rapid Serial Visualisation Task.

Integer

No. of errors in go trials (food)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of errors across all Go Trials for food stimuli in the Food Go/No-Go with Affective Shifting task.

Integer

No. of inhibition errors (food)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of inhibition errors across all food stimuli. Inhibition errors = responses that should have been inhibited as a distractor was presented. Number of times the participant is instructed not to respond to blue-outlined or green-outlined images; but responds when these are food images.

Integer

Hours of Football Rugby Or Hockey

Please indicate the average length of time (in hours) you spent doing the activity per episode. Football Rugby Or Hockey.

Integer

Hours of Football Rugby Or Hockey CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Football Rugby Or Hockey. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Football Hockey hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Football Rugby Or Hockey. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Football Rugby or Hockey hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Football Rugby Or Hockey. -1 = left blank. DO NOT USE THIS VARIABLE. Use footballRugbyHockeyHr_CLEAN_P2 instead.

Real

Minutes of Football Rugby Or Hockey

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Football Rugby Or Hockey.

Integer

Minutes of Football Rugby Or Hockey CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Football Rugby Or Hockey. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Football Hockey min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Football Rugby Or Hockey. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Football Rugby or Hockey mins

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Football Rugby Or Hockey. -1 = left blank. DO NOT USE THIS VARIABLE. Use footballRugbyHockeyMin_CLEAN_P2 instead.

Real

Frequency of Football Rugby Or Hockey CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

footballRugbyHockey_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Football Rugby Or Hockey

Real

Cln variable: Football Hockey

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

footballRugbyHockey_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. Data normalised to DE template 1 data.

Categorical

Football Rugby or Hockey

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. DO NOT USE THIS VARIABLE. Use footballRugbyHockey_CLEAN_P2 instead.

Real

Football Rugby or Hockey

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Football Rugby Or Hockey DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in footballRugbyHockey_T2. Instead use footballRugbyHockey_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Football Rugby Or Hockey DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Football Rugby Or Hockey. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in footballRugbyHockey_T1. Instead use footballRugbyHockey_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay FOSB

Phase 1 OLINK assay data for target FOSB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FOXO1

Phase 1 OLINK assay data for target FOXO1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

FL_Data

Data as entered on Study database. Is free living data available? Yes-tick or no-left blank

FL_DataQuality

Data as entered on Study database. Has Free Living data quality been reviewed? yes-tick or no-left blank

Free Living data quality reviewed

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. Has Free Living data quality been reviewed? 0 = no; 1 = yes;

Categorical

Free living data

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. Is free living data available? 0 = no; 1 = yes;

Categorical

FL_DateMatch

Data as entered on Study database. Is the 1st date of the free living data the same as the test date? Yes or no

Test-Free living date match

Phase 2 data. Data as entered on Study database. For study coordination and QC purposes only. Is the 1st date of the free living data the same as the test date? Yes or blank

Text

FL_MismatchReason

Data as entered on Study database. If the 1st date of the free living data is not the same as the test date provide a reason why not.

Test-Free living date not match

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. If the 1st date of the free living data is not the same as the test date provide a reason why not.

Text

FREQCARINI

FREQCARINI. Derived Intermediate not for general release. Data can be provided if necessary.

Real

FREQCYCLEINI

FREQCYCLEINI. Derived Intermediate not for general release. Data can be provided if necessary.

Real

FREQPUBLICINI

FREQPUBLICINI. Derived Intermediate not for general release. Data can be provided if necessary.

Real

FREQTOTAL

FREQTOTAL. Derived Intermediate not for general release. Data can be provided if necessary.

Real

FREQWALKINI

FREQWALKINI. Derived Intermediate not for general release. Data can be provided if necessary.

Real

None

Name of file data was transferred with.

Apples (1 fruit) ERROR CODES CLEANED

Average use last year of Apples (1 fruit) After cleaning this variable is renamed as APPLES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Pears (1 fruit) ERROR CODES CLEANED

Average use last year of Pears (1 fruit) After cleaning this variable is renamed as PEARS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Oranges satsumas mandarins 1 fruit

Average use last year of Oranges satsumas mandarins (1 fruit). After cleaning this variable is renamed as ORANGES which is then used by the FETA program for analysis.

Categorical

Oranges satsumas mandarins (1 fruit) ERROR CODES CLEANED

Average use last year of Oranges satsumas mandarins (1 fruit) After cleaning this variable is renamed as ORANGES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Grapefruit (half) ERROR CODES CLEANED

Average use last year of Grapefruit (half) After cleaning this variable is renamed as GRAPEFRUIT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Bananas (1 fruit) ERROR CODES CLEANED

Average use last year of Bananas (1 fruit) After cleaning this variable is renamed as BANANAS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Grapes (medium serving) ERROR CODES CLEANED

Average use last year of Grapes (medium serving) After cleaning this variable is renamed as GRAPES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Melon (1 slice) ERROR CODES CLEANED

Average use last year of Melon (1 slice) After cleaning this variable is renamed as MELONS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Peaches Plums Apricots (1 fruit). Seasonal. ERROR CODES CLEANED

Average use last year of Peaches Plums Apricots (1 fruit) Seasonal For seasonal fruits please estimate your average use when the fruit is in season After cleaning this variable is renamed as PEACHES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Strawberries Raspberries Kiwi Fruit medium serving Seasonal.

Average use last year of Strawberries Raspberries Kiwi Fruit (medium serving). Seasonal. For seasonal fruits please estimate your average use when the fruit is in season. After cleaning this variable is renamed as STRAWBERRIES which is then used by the FETA program for analysis.

Categorical

Strawberries; Raspberries; Kiwi Fruit (medium serving). Seasonal. ERROR CODES CLEANED

Average use last year of Strawberries Raspberries Kiwi Fruit (medium serving) Seasonal For seasonal fruits please estimate your average use when the fruit is in season After cleaning this variable is renamed as STRAWBERRIES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Tinned Fruit

Average use last year of Tinned Fruit. After cleaning this variable is renamed as TINNED_FRUIT which is then used by the FETA program for analysis.

Categorical

Tinned Fruit ERROR CODES CLEANED

Average use last year of Tinned Fruit After cleaning this variable is renamed as TINNED_FRUIT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Tinned Fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Dried Fruit

Average use last year of Dried Fruit. After cleaning this variable is renamed as DRIED_FRUIT which is then used by the FETA program for analysis.

Categorical

Dried Fruit ERROR CODES CLEANED

Average use last year of Dried Fruit After cleaning this variable is renamed as DRIED_FRUIT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Dried Fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Apples 1 fruit

Average use last year of Apples (1 fruit). After cleaning this variable is renamed as APPLES which is then used by the FETA program for analysis.

Categorical

Apples 1 fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Pears 1 fruit

Average use last year of Pears (1 fruit). After cleaning this variable is renamed as PEARS which is then used by the FETA program for analysis.

Categorical

Pears 1 fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Oranges satsumas mandarins 1 fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Grapefruit half

Average use last year of Grapefruit (half). After cleaning this variable is renamed as GRAPEFRUIT which is then used by the FETA program for analysis.

Categorical

Grapefruit half

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Bananas 1 fruit

Average use last year of Bananas (1 fruit). After cleaning this variable is renamed as BANANAS which is then used by the FETA program for analysis.

Categorical

Bananas 1 fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Grapes medium serving

Average use last year of Grapes (medium serving). After cleaning this variable is renamed as GRAPES which is then used by the FETA program for analysis.

Categorical

Grapes medium serving

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Melon 1 slice

Average use last year of Melon (1 slice). After cleaning this variable is renamed as MELONS which is then used by the FETA program for analysis.

Categorical

Melon 1 slice

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Peaches Plums Apricots 1 fruit Seasonal.

Average use last year of Peaches Plums Apricots (1 fruit). Seasonal. For seasonal fruits please estimate your average use when the fruit is in season. After cleaning this variable is renamed as PEACHES which is then used by the FETA program for analysis.

Categorical

Peaches Plums Apricots 1 fruit

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Strawberries Raspberries Kiwi Fruit medium serving

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay FR-alpha

Phase 1 OLINK assay data for target FR-alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FR-gamma

Phase 1 OLINK assay data for target FR-gamma in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FSTL3

Phase 1 OLINK assay data for target FSTL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FS

Phase 1 OLINK assay data for target FS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Thyroid Function Test (TFT) analaysis on T120 blood sample. Fenland phase 1. Triidothyronine (T3). Sample used is T120 plasma Heparin sample as that was being shipped off for Insulin_T120 measurement already.

Real

None

Thyroid Function Test (TFT) analaysis on T120 blood sample. Fenland phase 1. Thyroxine (T4). Sample used is T120 plasma Heparin sample as that was being shipped off for Insulin_T120 measurement already.

Real

OLINK assay FUCA1

Phase 1 OLINK assay data for target FUCA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Full aliquot sample set collected

Aliquot & Biochemistry sample set fully collected according to form (TRUE/FALSE) (Default=FALSE) TRUE = completed fully;

Categorical

OLINK assay FURIN

Phase 1 OLINK assay data for target FURIN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FUT3/FUT5

Phase 1 OLINK assay data for target FUT3/FUT5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FUT8

Phase 1 OLINK assay data for target FUT8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay FXYD5

Phase 1 OLINK assay data for target FXYD5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GALNT10

Phase 1 OLINK assay data for target GALNT10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GALNT2

Phase 1 OLINK assay data for target GALNT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GALNT3

Phase 1 OLINK assay data for target GALNT3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Gal-1

Phase 1 OLINK assay data for target Gal-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Gal-3

Phase 1 OLINK assay data for target Gal-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Gal-4

Phase 1 OLINK assay data for target Gal-4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay gal-8

Phase 1 OLINK assay data for target gal-8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Gal-9

Phase 1 OLINK assay data for target Gal-9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GAL

Phase 1 OLINK assay data for target GAL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

GammaGT 0 minutes

Serum GGT (Gamma GT) measurement taken at 0 minutes in U/l

Integer

GammaGT 0 minutes

Phase 2 data. Serum GGT (Gamma GT) measurement taken at 0 minutes in U/l

Integer

OLINK assay GAS6

Phase 1 OLINK assay data for target GAS6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

calibration method applied

Phase 2 data. Calibration method applied to data file. Offset and scale with temperature (which uses both an offset and scaling factor for each axis) or offset only with temperature (which uses just the offsets).

Text

calibration type

Phase 2 data. Calibration type used. Single file; multi file or fail. Single file calibration uses the calibration factors from the file itself. Multi-file calibration uses calibration factors from all files in the processing database (all datasets) that have used the same device. Fail indicates that the file has failed calibration and therefore the results are unusable and have been set to missing.

Text

Device serial number

Phase 2 data. Device serial number of monitor used for data collection.

Integer

Proportion time spent >= 0 milli-g

Phase 2 data. Proportion of time spent above >=0 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 0 milli-g

Phase 2 data. Proportion of time spent above >=0 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 0 milli-g consolidated

Phase 2 data. Proportion of time spent above >=0 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 1000 milli-g

Phase 2 data. Proportion of time spent above >=1000 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 1000 milli-g

Phase 2 data. Proportion of time spent above >=1000 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Proportion timespent >= 1000 milli-g

Phase 2 data. Proportion of time spent above >=1000 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 100 milli-g

Phase 2 data. Proportion of time spent above >=100 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 100 milli-g

Phase 2 data. Proportion of time spent above >=100 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 100 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=100 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 105 milli-g

Phase 2 data. Proportion of time spent above >=105 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 105 milli-g

Phase 2 data. Proportion of time spent above >=105 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 105 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=105 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 10 milli-g

Phase 2 data. Proportion of time spent above >=10 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 10 milli-g

Phase 2 data. Proportion of time spent above >=10 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 10 milli-g consolidated

Phase 2 data. Proportion of time spent above >=10 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 110 milli-g

Phase 2 data. Proportion of time spent above >=110 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 110 milli-g

Phase 2 data. Proportion of time spent above >=110 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 110 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=110 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 115 milli-g

Phase 2 data. Proportion of time spent above >=115 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 115 milli-g

Phase 2 data. Proportion of time spent above >=115 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 115 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=115 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 120 milli-g

Phase 2 data. Proportion of time spent above >=120 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 120 milli-g

Phase 2 data. Proportion of time spent above >=120 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 120 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=120 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 125 milli-g

Phase 2 data. Proportion of time spent above >=125 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 125 milli-g

Phase 2 data. Proportion of time spent above >=125 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 125 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=125 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 130 milli-g

Phase 2 data. Proportion of time spent above >=130 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 130 milli-g

Phase 2 data. Proportion of time spent above >=130 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 130 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=130 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 135 milli-g

Phase 2 data. Proportion of time spent above >=135 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 135 milli-g

Phase 2 data. Proportion of time spent above >=135 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 135 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=135 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 140 milli-g

Phase 2 data. Proportion of time spent above >=140 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 140 milli-g

Phase 2 data. Proportion of time spent above >=140 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 140 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=140 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 145 milli-g

Phase 2 data. Proportion of time spent above >=145 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 145 milli-g

Phase 2 data. Proportion of time spent above >=145 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 145 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=145 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 150 milli-g

Phase 2 data. Proportion of time spent above >=150 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 150 milli-g

Phase 2 data. Proportion of time spent above >=150 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 150 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=150 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 15 milli-g

Phase 2 data. Proportion of time spent above >=15 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 15 milli-g

Phase 2 data. Proportion of time spent above >=15 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 15 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=15 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 160 milli-g

Phase 2 data. Proportion of time spent above >=160 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 160 milli-g

Phase 2 data. Proportion of time spent above >=160 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 160 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=160 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 170 milli-g

Phase 2 data. Proportion of time spent above >=170 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 170 milli-g

Phase 2 data. Proportion of time spent above >=170 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 170 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=170 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 180 milli-g

Phase 2 data. Proportion of time spent above >=180 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 180 milli-g

Phase 2 data. Proportion of time spent above >=180 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 180 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=180 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 190 milli-g

Phase 2 data. Proportion of time spent above >=190 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 190 milli-g

Phase 2 data. Proportion of time spent above >=190 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 190 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=190 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 1 milli-g

Phase 2 data. Proportion of time spent above >=1 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 1 milli-g

Phase 2 data. Proportion of time spent above >=1 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 1 milli-g consolidated

Phase 2 data. Proportion of time spent above >=1 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 2000 milli-g

Phase 2 data. Proportion of time spent above >=2000 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 2000 milli-g

Phase 2 data. Proportion of time spent above >=2000 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Proportion timespent >= 2000 milli-g

Phase 2 data. Proportion of time spent above >=2000 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 200 milli-g

Phase 2 data. Proportion of time spent above >=200 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 200 milli-g

Phase 2 data. Proportion of time spent above >=200 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 200 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=200 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 20 milli-g

Phase 2 data. Proportion of time spent above >=20 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 20 milli-g

Phase 2 data. Proportion of time spent above >=20 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 20 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=20 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 210 milli-g

Phase 2 data. Proportion of time spent above >=210 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 210 milli-g

Phase 2 data. Proportion of time spent above >=210 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 210 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=210 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 220 milli-g

Phase 2 data. Proportion of time spent above >=220 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 220 milli-g

Phase 2 data. Proportion of time spent above >=220 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 220 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=220 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 230 milli-g

Phase 2 data. Proportion of time spent above >=230 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 230 milli-g

Phase 2 data. Proportion of time spent above >=230 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 230 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=230 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 240 milli-g

Phase 2 data. Proportion of time spent above >=240 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 240 milli-g

Phase 2 data. Proportion of time spent above >=240 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 240 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=240 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 250 milli-g

Phase 2 data. Proportion of time spent above >=250 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 250 milli-g

Phase 2 data. Proportion of time spent above >=250 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 250 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=250 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 25 milli-g

Phase 2 data. Proportion of time spent above >=25 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 25 milli-g

Phase 2 data. Proportion of time spent above >=25 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 25 milli-g consolidated

Phase 2 data. Proportion of time spent above >=25 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 260 milli-g

Phase 2 data. Proportion of time spent above >=260 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 260 milli-g

Phase 2 data. Proportion of time spent above >=260 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 260 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=260 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 270 milli-g

Phase 2 data. Proportion of time spent above >=270 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 270 milli-g

Phase 2 data. Proportion of time spent above >=270 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 270 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=270 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 280 milli-g

Phase 2 data. Proportion of time spent above >=280 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 280 milli-g

Phase 2 data. Proportion of time spent above >=280 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 280 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=280 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 290 milli-g

Phase 2 data. Proportion of time spent above >=290 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 290 milli-g

Phase 2 data. Proportion of time spent above >=290 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 290 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=290 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 2 milli-g

Phase 2 data. Proportion of time spent above >=2 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 2 milli-g

Phase 2 data. Proportion of time spent above >=2 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 2 milli-g consolidated

Phase 2 data. Proportion of time spent above >=2 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 3000 milli-g

Phase 2 data. Proportion of time spent above >=3000 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 3000 milli-g

Phase 2 data. Proportion of time spent above >=3000 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Proportion timespent >= 3000 milli-g

Phase 2 data. Proportion of time spent above >=3000 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 300 milli-g

Phase 2 data. Proportion of time spent above >=300 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 300 milli-g

Phase 2 data. Proportion of time spent above >=300 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 300 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=300 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 30 milli-g

Phase 2 data. Proportion of time spent above >=30 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 30 milli-g

Phase 2 data. Proportion of time spent above >=30 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 30 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=30 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 35 milli-g

Phase 2 data. Proportion of time spent above >=35 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 35 milli-g

Phase 2 data. Proportion of time spent above >=35 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 35 milli-g consolidated

Phase 2 data. Proportion of time spent above >=35 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 3 milli-g

Phase 2 data. Proportion of time spent above >=3 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 3 milli-g

Phase 2 data. Proportion of time spent above >=3 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 3 milli-g consolidated

Phase 2 data. Proportion of time spent above >=3 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 4000 milli-g

Phase 2 data. Proportion of time spent above >=4000 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 4000 milli-g

Phase 2 data. Proportion of time spent above >=4000 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Proportion timespent >= 4000 milli-g

Phase 2 data. Proportion of time spent above >=4000 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 400 milli-g

Phase 2 data. Proportion of time spent above >=400 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 400 milli-g

Phase 2 data. Proportion of time spent above >=400 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 400 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=400 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 40 milli-g

Phase 2 data. Proportion of time spent above >=40 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 40 milli-g

Phase 2 data. Proportion of time spent above >=40 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 40 milli-g consolidated

Phase 2 data. Proportion of time spent above >=40 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 45 milli-g

Phase 2 data. Proportion of time spent above >=45 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 45 milli-g

Phase 2 data. Proportion of time spent above >=45 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 45 milli-g consolidated

Phase 2 data. Proportion of time spent above >=45 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 4 milli-g

Phase 2 data. Proportion of time spent above >=4 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 4 milli-g

Phase 2 data. Proportion of time spent above >=4 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 4 milli-g consolidated

Phase 2 data. Proportion of time spent above >=4 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 500 milli-g

Phase 2 data. Proportion of time spent above >=500 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 500 milli-g

Phase 2 data. Proportion of time spent above >=500 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 500 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=500 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 50 milli-g

Phase 2 data. Proportion of time spent above >=50 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 50 milli-g

Phase 2 data. Proportion of time spent above >=50 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 50 milli-g consolidated

Phase 2 data. Proportion of time spent above >=50 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 55 milli-g

Phase 2 data. Proportion of time spent above >=55 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 55 milli-g

Phase 2 data. Proportion of time spent above >=55 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 55 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=55 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 5 milli-g

Phase 2 data. Proportion of time spent above >=5 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 5 milli-g

Phase 2 data. Proportion of time spent above >=5 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 5 milli-g consolidated

Phase 2 data. Proportion of time spent above >=5 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 600 milli-g

Phase 2 data. Proportion of time spent above >=600 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 600 milli-g

Phase 2 data. Proportion of time spent above >=600 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 600 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=600 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 60 milli-g

Phase 2 data. Proportion of time spent above >=60 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 60 milli-g

Phase 2 data. Proportion of time spent above >=60 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 60 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=60 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 65 milli-g

Phase 2 data. Proportion of time spent above >=65 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 65 milli-g

Phase 2 data. Proportion of time spent above >=65 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 65 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=65 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 700 milli-g

Phase 2 data. Proportion of time spent above >=700 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 700 milli-g

Phase 2 data. Proportion of time spent above >=700 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 700 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=700 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 70 milli-g

Phase 2 data. Proportion of time spent above >=70 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 70 milli-g

Phase 2 data. Proportion of time spent above >=70 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 70 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=70 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 75 milli-g

Phase 2 data. Proportion of time spent above >=75 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 75 milli-g

Phase 2 data. Proportion of time spent above >=75 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 75 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=75 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 800 milli-g

Phase 2 data. Proportion of time spent above >=800 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 800 milli-g

Phase 2 data. Proportion of time spent above >=800 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Proportion time spent >= 800 milli-g

Phase 2 data. Proportion of time spent above >=800 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 80 milli-g

Phase 2 data. Proportion of time spent above >=80 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 80 milli-g

Phase 2 data. Proportion of time spent above >=80 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 80 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=80 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 85 milli-g

Phase 2 data. Proportion of time spent above >=85 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 85 milli-g

Phase 2 data. Proportion of time spent above >=85 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 85 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=85 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 900 milli-g

Phase 2 data. Proportion of time spent above >=900 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 900 milli-g

Phase 2 data. Proportion of time spent above >=900 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Proportion time spent >= 900 milli-g

Phase 2 data. Proportion of time spent above >=900 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 90 milli-g

Phase 2 data. Proportion of time spent above >=90 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 90 milli-g

Phase 2 data. Proportion of time spent above >=90 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 90 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=90 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Proportion time spent >= 95 milli-g

Phase 2 data. Proportion of time spent above >=95 milli-g (sleep imputed). The acceleration value is calculated as ENMO (euclidean norm minus one). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Proportion time spent >= 95 milli-g

Phase 2 data. Proportion of time spent above >=95 milli-g (no sleep imputed / standard output). The acceleration value is calculated as ENMO (euclidean norm minus one). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Time spent >= 95 milli-gconsolidated

Phase 2 data. Proportion of time spent above >=95 milli-g (consolidated). The acceleration value is calculated as ENMO (euclidean norm minus one). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Average acceleration ENMO Friday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Friday) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 10

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 10) (9:00-10:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 11

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 11) (10:00-11:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 12

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 12) (11:00-12:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 13

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 13) (12:00-13:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 14

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 14) (13:00-14:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 15

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 15) (14:00-15:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 16

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 16) (15:00-16:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 17

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 17) (16:00-17:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 18

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 18) (17:00-18:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 19

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 19) (18:00-19:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 1

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 1) (0:00-1:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 20

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 20) (19:00-20:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 21

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 21) (20:00-21:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 22

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 22) (21:00-22:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 23

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 23) (22:00-23:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 24

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 24) (23:00-00:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 2

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 2) (1:00-2:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 3

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 3) (2:00-3:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 4

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 4) (3:00-4:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 5

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 5) (4:00-5:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 6

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 6) (5:00-6:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 7

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 7) (6:00-7:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 8

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 8) (7:00-8:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg acceleration by hr of day hr 9

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by hour of day (hr 9) (8:00-9:00) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Average acceleration imputed

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) in milli-g; (sleep imputed). This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn.

Real

Average acceleration ENMO Monday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Monday) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Average acceleration non-imputed

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) in milli-g; (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Avg accel milli-g consolidated

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) in milli-g; (consolidated). Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1).

Real

Average acceleration ENMO Saturday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Saturday) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Average acceleration ENMO Sunday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Sunday) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Average acceleration ENMO Thursday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Thursday) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Average acceleration ENMO Tuesday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Tuesday) across the full data file (mg) (no sleep imputed / standard output) . This is the standard output (original) variable meaning no sleep imputation has been done.

Real

Average acceleration ENMO Wednesday

Phase 2 data. Average acceleration (euclidean norm minus one (ENMO)) by day of week (Wednesday) across the full data file (mg) (no sleep imputed / standard output). This is the standard output (original) variable meaning no sleep imputation has been done.

Real

File error after calibration single file

Phase 2 data. The absolute difference between 1g and the Euclidean Norm of the values of the three axes; averaged per file; after calibration (mg). Single file calibration.

Real

File error before calibration single file

Phase 2 data. The absolute difference between 1g and the Euclidean Norm of the values of the three axes; averaged per file; before calibration (mg). Single file calibration.

Real

First date timestamp

Phase 2 data. First date timestamp of hdf5 file (Stata formatted).

DateTime

Flag to indicate anomaly

Phase 2 data. Binary flag to indicate file had anomaly (1=anomaly present). Anomaly detected and fixed during processing.

Categorical

Flag to indicate axis issue

Phase 2 data. Binary flag to indicate there was an issue with one of the axis during the recording (1 = file had technical axis issue affecting integrity of data). Data set to missing.

Categorical

Flag to indicate = <1 hr valid data

Phase 2 data. Binary flag to indicate file had less than 1 hour of valid data (1= <1hour of data).

Categorical

Flag for data missing Pwear

Phase 2 data. Flag variable that can be used to condition the data on to protect against potential bias caused by data missing at certain times of day (i.e. missing in certain Pwear quadrants). It is advisable to ensure that data are distributed across the 24-hour period and use an inclusion criteria relating to compliance. This variable indicates: 0 = Insufficient wear time (Pwear <48 hours and three Pwear_quads <9 hours wear); 1 = Pwear >=48 hours and all four Pwear_quads >=9 hours; 2 = Pwear >=48 hours and three Pwear_quads >=9 hours (<9 hours in morning quad (midnight-6am)).

Categorical

Flag to indicate imputed data used

Phase 2 data. Binary flag (imputed=1) indicates if the imputed data has been used in the consolidated variables for this dataset. In some instances where data is likely to be excluded non-randomly; imputation may be required. Most commonly this is observed with night recording with systematic non-adherence to wearing a monitor during sleep in a 24-hr protocol. The Pwear variable has been set to 1 during the night (midnight-6am); to impute sleep when the monitor was flagged as non-wear during those times. These data are imputed proportional to the amount of days the monitor was worn so as not to inflate wear-time over the recording period. During the creation of the consolidated variables; the standard output variables (means and intensity categories) have been updated with the imputed data if certain criteria are met (limited night data i.e. include=2). These variables are indicated in the label with consolidated.

Categorical

Last date timestamp

Phase 2 data. Last date timestamp of hdf5 file (Stata formatted).

DateTime

File error after calibration multi-file

Phase 2 data. The absolute difference between 1g and the Euclidean Norm of the values of the three axes; averaged per file; after calibration (mg). Multi-file calibration.

Real

File error before calibration multi-file

Phase 2 data. The absolute difference between 1g and the Euclidean Norm of the values of the three axes; averaged per file; before calibration (mg). Multi-file calibration.

Real

Threshold set still bout detection

Phase 2 data. Threshold set for still bout detection (milli-g). Still bouts are flagged during processing as periods of time where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) fall below this threshold.

Integer

Processing epoch (seconds)

Phase 2 data. Frequency at which the data has been processed; in seconds. This may not reflect the raw frequency the monitor recorded in; instead is the level the data were collapsed to for the processing.

Integer

Pwear afternoon imputed

Phase 2 data. Number of valid hours worn during free-living in the afternoon quadrant (between 12:00-18:00); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 12:00-18:00; across the whole data file; in hours.

Real

Pwear afternoon total time

Phase 2 data. Number of valid hours worn during free-living in the afternoon quadrant (between 12:00-18:00); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 12:00-18:00; across the whole data file; in hours.

Real

No of hrs during free-living 12-18

Phase 2 data. Number of valid hours worn during free-living in the afternoon quadrant (between 12:00-18:00); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 12:00-18:00; across the whole data file; in hours.

Real

Pwear Friday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Friday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Friday; across the whole data file; in hours.

Real

Pwear by hr of day hr10 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 09:00-10:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 09:00-10:00; across the whole data file; in hours.

Real

Pwear by hr of day hr11 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 10:00-11:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 10:00-11:00; across the whole data file; in hours.

Real

Wkday afternoon pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 12:00-18:00) on weekdays (Monday-Friday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 12:00-18:00 on weekdays; across the whole data file; in hours.

Real

Wkday Pwear afternoon total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 12:00-18:00) on weekdays (Monday-Friday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 12:00-18:00 on weekdays; across the whole data file; in hours.

Real

Pwear wkday 12-18

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 12:00-18:00) on weekdays (Monday-Friday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 12:00-18:00 on weekdays; across the whole data file; in hours.

Real

Wkend afternoon pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 12:00-18:00) on weekend days (Saturday and Sunday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 12:00-18:00 on weekend days; across the whole data file; in hours.

Real

Wkend Pwear afternoon total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 12:00-18:00) on weekend days (Saturday and Sunday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 12:00-18:00 on weekend days; across the whole data file; in hours.

Real

Pwear wkend 12-18

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 12:00-18:00) on weekend days (Saturday and Sunday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 12:00-18:00 on weekend days; across the whole data file; in hours.

Real

Pwear by hr of day hr12 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 11:00-12:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 11:00-12:00; across the whole data file; in hours.

Real

Pwear by hr of day hr13 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 12:00-13:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 12:00-13:00; across the whole data file; in hours.

Real

Pwear by hr of day hr14 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 13:00-14:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 13:00-14:00; across the whole data file; in hours.

Real

Pwear by hr of day hr15 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 14:00-15:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 14:00-15:00; across the whole data file; in hours.

Real

Pwear by hr of day hr16 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 15:00-16:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 15:00-16:00; across the whole data file; in hours.

Real

Pwear by hr of day hr17 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 16:00-17:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 16:00-17:00; across the whole data file; in hours.

Real

Pwear by hr of day hr18 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 17:00-18:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 17:00-18:00; across the whole data file; in hours.

Real

Pwear by hr of day hr19 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 18:00-19:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 18:00-19:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 1 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 00:00-01:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 00:00-01:00; across the whole data file; in hours.

Real

Pwear by hr of day hr20 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 19:00-20:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 19:00-20:00; across the whole data file; in hours.

Real

Pwear by hr of day hr21 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 20:00-21:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 20:00-21:00; across the whole data file; in hours.

Real

Pwear by hr of day hr22 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 21:00-22:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 21:00-22:00; across the whole data file; in hours.

Real

Pwear by hr of day hr23 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 22:00-23:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 22:00-23:00; across the whole data file; in hours.

Real

Pwear by hr of day hr24 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 23:00-00:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 23:00-00:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 2 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 01:00-02:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 01:00-02:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 3 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 02:00-03:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 02:00-03:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 4 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 03:00-04:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 03:00-04:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 5 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 04:00-05:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 04:00-05:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 6 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 05:00-06:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 05:00-06:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 7 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 06:00-07:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 06:00-07:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 8 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 07:00-08:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 07:00-08:00; across the whole data file; in hours.

Real

Pwear by hr of day hr 9 non-imputed

Phase 2 data. Number of valid hours worn during free-living between 08:00-09:00; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 08:00-09:00; across the whole data file; in hours.

Real

Pwear Monday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Monday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Monday; across the whole data file; in hours.

Real

Pwear imputed

Phase 2 data. Time integral of wear probability based on accelerometry (number of hours considered worn during free-living) (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time across the whole data file in hours.

Real

Pwear morning imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 00:00-06:00; across the whole data file; in hours.

Real

Pwear morning total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 00:00-06:00; across the whole data file; in hours.

Real

No of hrs during free-living 00-06

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 00:00-06:00; across the whole data file; in hours.

Real

Wkday morning pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00) on weekdays (Monday-Friday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 00:00-06:00 on weekdays; across the whole data file; in hours.

Real

Wkday Pwear morning total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00) on weekdays (Monday-Friday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 00:00-06:00 on weekdays; across the whole data file; in hours.

Real

Pwear night total time

Phase 2 data. Number of valid hours worn during free-living in the night quadrant (between 18:00-00:00); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 18:00-00:00; across the whole data file; in hours.

Real

Pwear noon total time

Phase 2 data. Number of valid hours worn during free-living in the noon quadrant (between 06:00-12:00); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 06:00-12:00; across the whole data file; in hours.

Real

Pwear total time

Phase 2 data. Time integral of wear probability based on accelerometry (number of hours considered worn during free-living) (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time across the whole data file; in hours.

Real

Pwear wkday 00-06

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00) on weekdays (Monday-Friday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 00:00-06:00 on weekdays; across the whole data file; in hours.

Real

Wkend morning pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00) on weekend days (Saturday and Sunday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 00:00-06:00 on weekend days; across the whole data file; in hours.

Real

Wkend Pwear morning total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00) on weekend days (Saturday and Sunday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 00:00-06:00 on weekend days; across the whole data file; in hours.

Real

Pwear wkend 00-06

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 00:00-06:00) on weekend days (Saturday and Sunday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 00:00-06:00 on weekend days; across the whole data file; in hours.

Real

Pwear night imputed

Phase 2 data. Number of valid hours worn during free-living in the night quadrant (between 18:00-00:00); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 18:00-00:00; across the whole data file; in hours.

Real

No of hrs during free-living 18-00

Phase 2 data. Number of valid hours worn during free-living in the night quadrant (between 18:00-00:00); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 18:00-00:00; across the whole data file; in hours.

Real

Pwear Saturday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Saturday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Saturday; across the whole data file; in hours.

Real

Pwear Sunday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Sunday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Sunday; across the whole data file; in hours.

Real

Wkday night pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 18:00-00:00) on weekdays (Monday-Friday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 18:00-00:00 on weekdays; across the whole data file; in hours.

Real

Wkday Pwear night total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 18:00-00:00) on weekdays (Monday-Friday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 18:00-00:00 on weekdays; across the whole data file; in hours.

Real

Pwear wkday 18-00

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 18:00-00:00) on weekdays (Monday-Friday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 18:00-00:00 on weekdays; across the whole data file; in hours.

Real

Wkend night pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 18:00-00:00) on weekend days (Saturday and Sunday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 18:00-00:00 on weekend days; across the whole data file; in hours.

Real

Wkend Pwear night total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 18:00-00:00) on weekend days (Saturday and Sunday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 18:00-00:00 on weekend days; across the whole data file; in hours.

Real

Pwear wkend 18-00

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 18:00-00:00) on weekend days (Saturday and Sunday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 18:00-00:00 on weekend days; across the whole data file; in hours.

Real

Pwear Thursday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Thursday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Thursday; across the whole data file; in hours.

Real

Pwear Tuesday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Tuesday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Tuesday; across the whole data file; in hours.

Real

Pwear Wednesday hrs non-imputed

Phase 2 data. Number of valid hours worn during free-living on a Wednesday; across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on a Wednesday; across the whole data file; in hours.

Real

Pwear noon imputed

Phase 2 data. Number of valid hours worn during free-living in the noon quadrant (between 06:00-12:00); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 06:00-12:00; across the whole data file; in hours.

Real

No of hrs during free-living 06-12

Phase 2 data. Number of valid hours worn during free-living in the noon quadrant (between 06:00-12:00); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 06:00-12:00; across the whole data file; in hours.

Real

Wkday noon pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 06:00-12:00) on weekdays (Monday-Friday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 06:00-12:00 on weekdays; across the whole data file; in hours.

Real

Wkday Pwear noon total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 06:00-12:00) on weekdays (Monday-Friday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 06:00-12:00 on weekdays; across the whole data file; in hours.

Real

Pwear wkday 06-12

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 06:00-12:00) on weekdays (Monday-Friday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 06:00-12:00 on weekdays; across the whole data file; in hours.

Real

Wkend noon pwear imputed

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 06:00-12:00) on weekend days (Saturday and Sunday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time between 06:00-12:00 on weekend days; across the whole data file; in hours.

Real

Wkday Pwear total time

Phase 2 data. Number of valid hours worn during free-living over weekdays (Monday-Friday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on weekdays; across the whole data file; in hours.

Real

Wkend Pwear total time

Phase 2 data. Number of valid hours worn during free-living over weekend days (Saturday and Sunday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time on weekend days; across the whole data file; in hours.

Real

No of hours file was recording for

Phase 2 data. Number of hours file was recording for. The is the whole length of the file itself; regardless of whether it is being worn.

Real

Wkend Pwear noon total time

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 06:00-12:00) on weekend days (Saturday and Sunday); across the full data file (no sleep imputed / standard output). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This is the standard output (original) variable meaning no sleep imputation has been done. This variable indicates the total wear time between 06:00-12:00 on weekend days; across the whole data file; in hours.

Real

Pwear wkend 06-12

Phase 2 data. Number of valid hours worn during free-living in the morning quadrant (between 06:00-12:00) on weekend days (Saturday and Sunday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time between 06:00-12:00 on weekend days; across the whole data file; in hours.

Real

Total wear time

Phase 2 data. Time integral of wear probability based on accelerometry (number of hours considered worn during free-living) (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time across the whole data file; in hours.

Real

Wkday pwear imputed

Phase 2 data. Number of valid hours worn during free-living over weekdays (Monday-Friday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time on weekdays; across the whole data file; in hours.

Real

Wkday valid hrs during free-living

Phase 2 data. Number of valid hours worn during free-living over weekdays (Monday-Friday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time on weekdays; across the whole data file; in hours.

Real

Wkend pwear imputed

Phase 2 data. Number of valid hours worn during free-living over weekend days (Saturday and Sunday); across the full data file (sleep imputed). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. This imputed variable is derived from imputing sleep data if certain criteria of limited night data are met (i.e. not worn between 00:00-06:00). Pwear is set to 1 during these hours to impute sleep if not worn. This variable indicates the total wear time on weekend days; across the whole data file; in hours.

Real

Start date of free-living recording

Phase 2 data. Date of first day of free-living recording (Stata formatted). This date is regardless of whether the monitor was actually being worn; it is simply when the monitor started recording.

Date

Time resolution of processed data

Phase 2 data. The time resolution of the processed data outputted from accelerometry processing pipeline (pampro) and used by the post-processing scripts (minutes).

Integer

Location of GENEActiv wrist monitor

Phase 2 data. Location of the GENEActiv wrist monitor when worn for free-living (left/right). If wrist location was unknown; variable left as missing.

Text

OLINK assay GBP2

Phase 1 OLINK assay data for target GBP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GCG

Phase 1 OLINK assay data for target GCG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GCNT1

Phase 1 OLINK assay data for target GCNT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Wkend valid hrs during free-living

Phase 2 data. Number of valid hours worn during free-living over weekend days (Saturday and Sunday); across the full data file (consolidated). Non-wear periods are calculated as periods of time >=60 mins where the standard devigorous intensity activitytion of each of the three axes (x; y and z of the raw; triaxial accelerometry data) is <13mg. Both of these criteria are used to determine wear probability. Consolidated variable derived from either the original data (i.e. non-imputed) or imputed data where sleep has been imputed if certain criteria of limited night data are met (i.e. where inclusion criteria include= 2 (for details of inclusion criteria; see include variable)). In instances when the imputed data has been used in the consolidated variable; this will have a binary flag (imputed = 1). This variable indicates the total wear time on weekend days; across the whole data file; in hours.

Real

OLINK assay GCP5

Phase 1 OLINK assay data for target GCP5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GDF-15

Phase 1 OLINK assay data for target GDF-15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GDF-2

Phase 1 OLINK assay data for target GDF-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GDF-8

Phase 1 OLINK assay data for target GDF-8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GDNFR-alpha-3

Phase 1 OLINK assay data for target GDNFR-alpha-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GDNF

Phase 1 OLINK assay data for target GDNF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GDNF

Phase 1 OLINK assay data for target GDNF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

GETABOUT

GETABOUT. Derived Intermediate not for general release. Data can be provided if necessary.

Categorical

Getting About

Which form of transport have you used MOST OFTEN in the last 4 weeks apart from your journey to and from work. Please tick one only.

Categorical

Getting About CLEANED

Getting About Error codes cleaned by DM team with this rule: CASE_TEXT. And then -10 errors cleaned by PA team.

Categorical

Cln variable: Mode of transport

Phase 2 data. Which form of transport have you used MOST OFTEN in the last 4 weeks apart from your journey to and from work. Please tick one only. 1 = car - motor vehicle; 2 = walking; 3 = public transport; 4 = cycling; -1 = left blank; Error codes cleaned by DM team with this rule: CASE_TEXT. And then -10 errors cleaned by PA team.

Categorical

Mode of transport

Phase 2 data. Questionnaire reads D1. Getting about. Which form of transport have you used MOST OFTEN in the last 4 weeks apart from your journey to and from work. Please tick one box only. DO NOT USE THIS VARIABLE. Use Gettingabout_CLEAN_P2 instead. 1 = car - motor vehicle; 2 = walking; 3 = public transport; 4 = cycling;

Categorical

OLINK assay GFRA2

Phase 1 OLINK assay data for target GFRA2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GFR-alpha-1

Phase 1 OLINK assay data for target GFR-alpha-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GGT5

Phase 1 OLINK assay data for target GGT5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GH2

Phase 1 OLINK assay data for target GH2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GHRL

Phase 1 OLINK assay data for target GHRL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GH

Phase 1 OLINK assay data for target GH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GIF

Phase 1 OLINK assay data for target GIF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GKN1

Phase 1 OLINK assay data for target GKN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GLB1

Phase 1 OLINK assay data for target GLB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Gln_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Gln_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_006.

Real

OLINK assay GLO1

Phase 1 OLINK assay data for target GLO1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GLRX

Phase 1 OLINK assay data for target GLRX in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Glucose 0 minutes

Fasting Serum Glucose measurement taken at 0 minutes in mmol/l

Real

Glucose 0 minutes

Phase 2 data. Fasting Serum Glucose measurement taken at 0 minutes in mmol/l

Real

Glucose 120 minutes

2 hour Glucose measurement taken at 120 minutes in mmol/l

Real

Glucose 120 minutes

Phase 2 data. 3 hour Glucose measurement taken at 120 minutes in mmol/l

Real

Time of glucose drink

Time glucose drink was drunk by participant.

Time

Glucose drink time

Phase 2 data. Time glucose drink was drunk by participant. For QC and filed team use. Not for analysis

Time

Glu_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Glu_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_007.

Real

Gly_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Gly_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_008.

Real

OLINK assay GM-CSF-R-alpha

Phase 1 OLINK assay data for target GM-CSF-R-alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GNLY

Phase 1 OLINK assay data for target GNLY in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Golf

Please indicate the average length of time (in hours) you spent doing the activity per episode. Golf.

Integer

Hours of Golf CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Golf. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Golf hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Golf. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Golf hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Golf. -1 = left blank. DO NOT USE THIS VARIABLE. Use golfHr_CLEAN_P2 instead.

Real

Minutes of Golf

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Golf.

Integer

Minutes of Golf CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Golf. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Golf min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Golf. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Golf min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Golf. -1 = left blank. DO NOT USE THIS VARIABLE. Use golfMin_CLEAN_P2 instead.

Real

Frequency of Golf CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

golf_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Golf

Real

Cln variable: Golf

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

golf_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. Data normalised to DE template 1 data.

Categorical

Golf

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. DO NOT USE THIS VARIABLE. Use golf_CLEAN_P2 instead.

Real

Golf

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Golf DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in golf_T2. Instead use golf_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Golf DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Golf. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in golf_T1. Instead use golf_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay GP1BA

Phase 1 OLINK assay data for target GP1BA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GP6

Phase 1 OLINK assay data for target GP6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GPC1

Phase 1 OLINK assay data for target GPC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

GP ID

General Practitioner ID number. Replaces GP name variable from Release 5.

GP Letter Sent

GP Letter Sent

GP Letter Sent

Phase 2 data. Date GP Letter Sent

Date

OLINK assay GPNMB

Phase 1 OLINK assay data for target GPNMB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GPNMB

Phase 1 OLINK assay data for target GPNMB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

GPS_Accepted

Has GPS data been accepted by field team yes or no. Data to be found on the GPS data log form in column with header Comments (Field Staff) lower half: Accepted?

Categorical

GPS_ExtraComment

Any additional comments provided on the GPS form on the form.

Text

DaysOfData

Total number of days over which the GPS data was collected. Data to be found on the GPS data log form in column with header Days of data.

Real

DeviceNr

Barcode number of GPS device used by volunteer. Data to be found on the GPS data log form in column with header GPS Device #.

Text

FieldStaffComments

Any comments the field staff have made about the GPS data. Data to be found on the GPS data log form in column with header Comments (Field Staff) top half.

Text

FileSize

Size of file containing the GPS data. Number entered as written omitting commas. Unit (KB) not entered if it was written. Data to be found on GPS data log form in column with header File Size.

Text

GPSissued

Data as entered on Study database. Has GPS been issued to participant? Yes-tick or no-left blank

GPS issued to participants

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. Has GPS been issued to participant? 0 = no; 1 = yes;

Categorical

LogSheetNumber

Number of the GPS Data Log Sheet completed. Data located at the top of the GPS data log form in the section Sheet number.

Integer

LogSheetversion

Version number of GPS log sheet used. Data found on GPS data log form in the footer of the log sheet.

Real

GPS number

GPS number (barcode number)

Text

StudySite

Study site where volunteer is registered. Data to be found on GPS data log form at the section Site at the top of the document next to the sheet number.

Text

DayofVisit

Date of 1st GPS visit - day. Data to be found on the GPS data log form in column with header Date.

Integer

MonthOfVisit

Date of 1st GPS visit - Month. Data to be found on the GPS data log form in column with header Date.

Integer

YearOfVisit

Date of 1st GPS visit - Year. Data to be found on the GPS data log form in column with header Date.

Integer

VolunteerComment

Any comments provided by the volunteer about wearing the GPS. Data to be found on the GPS data log form in column with header Comments from Volunteers.

Text

On medication

Are you taking any tablets or medicines at the moment? This data is also captured with GQV3_A1OnMedication and GQV4_A1OnMedication. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Meds and data derived into: gq_meds_DER. Please request those variables instead.

Categorical

Current Medication a BNF Code

BNF Code for medication a added by research team This data is also captured with GQV3_A2aCurrentMedicationBNFCode and GQV4_A2aCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds a

Dose of drug a. This data is also captured with GQV3_A2aCurrentMedicationDose and GQV4_A2aCurrentMedicationDose. You should request that data too.

Text

Name meds a

Name of drug a. This data is also captured with GQV3_A2aCurrentMedicationName and GQV4_A2aCurrentMedicationName. You should request that data too.

Text

Reason Meds a

Reason for taking the drug a. This data is also captured with GQV3_A2aCurrentMedicationReason and GQV4_A2aCurrentMedicationReason. You should request that data too.

Text

Current Medication b BNF Code

BNF Code for medication b added by research team. This data is also captured with GQV3_A2bCurrentMedicationBNFCode and GQV4_A2bCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds b

Dose of drug b. This data is also captured with GQV3_A2bCurrentMedicationDose and GQV4_A2bCurrentMedicationDose. You should request that data too.

Text

Name meds b

Name of drug b. This data is also captured with GQV3_A2bCurrentMedicationName and GQV4_A2bCurrentMedicationName. You should request that data too.

Text

Reason Meds b

Reason for taking the drug b. This data is also captured with GQV3_A2bCurrentMedicationReason and GQV4_A2bCurrentMedicationReason. You should request that data too.

Text

Current Medication c BNF Code

BNF Code for medication c added by research team. This data is also captured with GQV3_A2cCurrentMedicationBNFCode and GQV4_A2cCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds c

Dose of drug c. This data is also captured with GQV3_A2cCurrentMedicationDose and GQV4_A2cCurrentMedicationDose. You should request that data too.

Text

Name meds c

Name of drug c. This data is also captured with GQV3_A2cCurrentMedicationName and GQV4_A2cCurrentMedicationName. You should request that data too.

Text

reason Meds c

Reason for taking the drug c. This data is also captured with GQV3_A2cCurrentMedicationReason and GQV4_A2cCurrentMedicationReason. You should request that data too.

Text

Current Medication d BNF Code

BNF Code for medication d added by research team. This data is also captured with GQV3_A2dCurrentMedicationBNFCode and GQV4_A2dCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds d

Dose of drug d. This data is also captured with GQV3_A2dCurrentMedicationDose and GQV4_A2dCurrentMedicationDose. You should request that data too.

Text

Name meds d

Name of drug d. This data is also captured with GQV3_A2dCurrentMedicationName and GQV4_A2dCurrentMedicationName. You should request that data too.

Text

Reason Meds d

Reason for taking the drug d. This data is also captured with GQV3_A2dCurrentMedicationReason and GQV4_A2dCurrentMedicationReason. You should request that data too.

Text

Current Medication e BNF Code

BNF Code for medication e added by research team. This data is also captured with GQV3_A2eCurrentMedicationBNFCode and GQV4_A2eCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds e

Dose of drug e. This data is also captured with GQV3_A2eCurrentMedicationDose and GQV4_A2eCurrentMedicationDose. You should request that data too.

Text

Name meds e

Name of drug e. This data is also captured with GQV3_A2eCurrentMedicationName and GQV4_A2eCurrentMedicationName. You should request that data too.

Text

Reason Meds e

Reason for taking the drug e. This data is also captured with GQV3_A2eCurrentMedicationReason and GQV4_A2eCurrentMedicationReason. You should request that data too.

Text

Current Medication f BNF Code

BNF Code for medication f added by research team. This data is also captured with GQV3_A2fCurrentMedicationBNFCode and GQV4_A2fCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds f

Dose of drug f. This data is also captured with GQV3_A2fCurrentMedicationDose and GQV4_A2fCurrentMedicationDose. You should request that data too.

Text

Name meds f

Name of drug f. This data is also captured with GQV3_A2fCurrentMedicationName and GQV4_A2fCurrentMedicationName. You should request that data too.

Text

Reason Meds f

Reason for taking the drug f. This data is also captured with GQV3_A2fCurrentMedicationReason and GQV4_A2fCurrentMedicationReason. You should request that data too.

Text

Current Medication g BNF Code

BNF Code for medication g added by research team. This data is also captured with GQV3_A2gCurrentMedicationBNFCode and GQV4_A2gCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds g

Dose of drug g. This data is also captured with GQV3_A2gCurrentMedicationDose and GQV4_A2gCurrentMedicationDose. You should request that data too.

Text

Name meds g

Name of drug g. This data is also captured with GQV3_A2gCurrentMedicationName and GQV4_A2gCurrentMedicationName. You should request that data too.

Text

Reason Meds g

Reason for taking the drug g. This data is also captured with GQV3_A2gCurrentMedicationReason and GQV4_A2gCurrentMedicationReason. You should request that data too.

Text

Current Medication h BNF Code

BNF Code for medication h added by research team. This data is also captured with GQV3_A2hCurrentMedicationBNFCode and GQV4_A2hCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds h

Dose of drug h. This data is also captured with GQV3_A2hCurrentMedicationDose and GQV4_A2hCurrentMedicationDose. You should request that data too.

Text

Name meds h

Name of drug h. This data is also captured with GQV3_A2hCurrentMedicationName and GQV4_A2hCurrentMedicationName. You should request that data too.

Text

Reason Meds h

Reason for taking the drug h. This data is also captured with GQV3_A2hCurrentMedicationReason and GQV4_A2hCurrentMedicationReason. You should request that data too.

Text

On HRT

For women only. Are you on Hormone replacement therapy? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. From R8 phase 1 variable placed into variable: GQ_Med_hrt_v1 . Please request those variables instead.

Categorical

Birth weight value

What was your weight at birth value entered only. This data is also captured with GQV3_A3aBirthWeightImperial or GQV3_A3bBirthWeightMetric and GQV4_A3aBirthWeightImperial or GQV4_A3bBirthWeightMetric. You should request that data too.

Real

Birth weight unit

What was your weight at birth units only. This data is also captured with GQV3_A3aBirthWeightImperial or GQV3_A3bBirthWeightMetric and GQV4_A3aBirthWeightImperial or GQV4_A3bBirthWeightMetric. You should request that data too. From R8 phase 1 variable placed into variable: GQ_BWt_unit . Please request those variables instead.

Categorical

Birth weight unknown

Tick if you are not able to give your birth weight. This data is also captured with GQV3_A3cBirthWeightUnknown and GQV4_A3cBirthWeightUnknown. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_BWt_unknown . Please request those variables instead. -1 = left blank;

Categorical

Term of birth

When were you born (pre post or at term). This data is also captured with GQV3_A4aBorn and GQV4_A4aBorn. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Bterm and data derived into: gq_bterm_DER. Please request those variables instead.

Categorical

Dr report heart trouble

Has your doctor ever told you that you have heart trouble? This data is also captured with GQV3_A5aDrReportHeartTrouble and GQV4_A5aDrReportHeartTrouble. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Htn_dr and data derived into: gq_htn_dr_DER. Please request those variables. Instead.

Categorical

Chest pain ever

Have you ever had any pain or discomfort in your chest? If no proceed to question 7. If yes please answer the next question. This data is also captured with GQV3_A5bChestPain and GQV4_A5bChestPain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_dr and data derived into: gq_chestpain_dr_DER. Please request those variables instead.

Categorical

Chest pain uphill

Do you experience pain or chest discomfort when you walk uphill or hurry? This data is also captured with GQV3_A5cChestPainUphill and GQV4_A5cChestPainUphill. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_uphill and data derived into: gq_chestpain_uphill_DER. Please request those variables instead.

Categorical

Chest pain normal pace

Do you experience pain or chest discomfort when you walk at an ordinary pace on the level? This data is also captured with GQV3_A5dChestPainNormalPace and GQV4_A5dChestPainNormalPace. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_normal and data derived into: gq_chestpain_normal_DER. Please request those variables instead.

Categorical

Action when chest discomfort

What do you do if you experience pain or chest discomfort while walking? This data is also captured with GQV3_A5eActionWhenChestDiscomfort and GQV4_A5eActionWhenChestDiscomfort. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_action and data derived into: gq_chestpain_action_DER. Please request those variables instead.

Categorical

Chest discomfort after stopping

If you stand still what happens to pain or chest discomfort? This data is also captured with GQV3_A5fChestDiscomfortAfterStopping and GQV4_A5fChestDiscomfortAfterStopping. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_stop and data derived into: gq_chestpain_stop_DER. Please request those variables instead.

Categorical

Feel faint or dizzy

Do you often feel faint or have spells of severe dizziness? This data is also captured with GQV3_A5gFeelFaint and GQV4_A5gFeelFaint. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_FeelFaint and data derived into: gq_feelfaint_DER. Please request those variables instead.

Categorical

Dr report high BP

Has a doctor ever told you that your blood pressure was too high? Yes or No. This data is also captured with GQV3_A5hDrReportBPHigh and GQV4_A5hDrReportBPHigh. You should request that data too.

Categorical

Treatment for high blood pressure

If you have been told that your blood pressure was too high are you now on treatment? This data is also captured with GQV3_A5iTreatmentHighBP and GQV4_A5iTreatmentHighBP. You should request that data too.

Categorical

Bone problems worse by exercise

Has your doctor ever told you that you have a bone or joint problem such as arthritis that has been aggravated by exercise or might be made worse by exercise? This data is also captured with GQV3_A5jBoneProblemsAggravatedByExercise and GQV4_A5jBoneProblem All phase 1 data from all 3 GenQs was merged into new variable: GQ_Bone_exercise and data derived into: gq_bone_exercise_DER. Please request those variables instead.

Categorical

Pregnancy status

Are you pregnant? This data is also captured with GQV3_A5kPregnant and GQV4_A5kPregnant. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Preg and data derived into: gq_preg_DER. Please request those variables instead.

Categorical

Any reason not to do PA

Is there any reason you know of that means you should not follow an activity programme even if you wanted to? This data is also captured with GQV3_A5lReasonNotToDoPA and GQV4_A5lReasonNotToDoPA. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_PA_reason and data derived into: gq_pa_reason_DER. Please request those variables instead.

Categorical

Smoke daily

Do you smoke daily? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. All phase 1 data from 1 GenQ was placed into variable: GQ_Sm_daily . Please request those variables instead.

Categorical

Smoke occasionally

Do you smoke occasionally? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. All phase 1 data from 1 GenQ was placed into variable: GQ_Sm_occasion . Please request those variables instead.

Categorical

Ever smoked

Have you ever smoked? This data is also captured with GQV3_B1aEverSmoked and GQV4_B1aEverSmoked. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_ever and data derived into: gq_sm_ever_DER. Please request those variables instead.

Categorical

Ever smoked year quit

If you have ever smoked please add the year in which you quit. This data is also captured with GQV3_B1dYearQuit and GQV4_B1dYearQuit. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_yearstop and data derived into: gq_sm_yearstop_DER. Please request those variables instead.

Text

Number of cigarettes per day

How many cigarettes did you or do you smoke a day on average? This data is also captured with GQV3_B1eNumberCigarettesPerDay and GQV4_B1eNumberCigarettesPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5 All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_Ncig and data derived into: gq_sm_ncig_DER. Please request those variables instead.

Integer

Number of cheroots smoked per day

How many cheroots did you or do you smoke a day on average? This data is also captured with GQV3_B1fNumberCherootsPerDay and GQV4_B1fNumberCherootsPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5 All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_Ncheroots and data derived into: gq_sm_ncheroots_DER. Please request those variables instead.

Integer

How many cigars smoked per day

How many cigars did you or do you smoke a day on average? This data is also captured with GQV3_B1gNumberCigarsPerDay and GQV4_B1gNumberCigarsPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5 All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_Ncigars and data derived into: gq_sm_ncigars_DER. Please request those variables instead.

Integer

Grams of tobacco per week

How much did you or do you smoke a day on average? Amount in grams of tobacco in a week. This data is also captured with GQV3_B1hTobaccoPerWeek and GQV4_B1hTobaccoPerWeek. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Real

Units of beer lager or cider per week

How many units of Beer lager or cider do you consume in an average week? This data is also captured with GQV3_B3aUnitsBeerPerWk and GQV4_B3aUnitsBeerPerWk. You should request that data too.

Categorical

Units of wine per week

How many units of wine do you consume in an average week? This data is also captured with GQV3_B3bUnitsWinePerWk and GQV4_B3bUnitsWinePerWk. You should request that data too.

Categorical

Units of spirit per week

How many units of spirits do you consume in an average week? This data is also captured with GQV3_B3cUnitsSpiritsPerWk and GQV4_B3cUnitsSpiritsPerWk. You should request that data too.

Categorical

Units of fortified wine per week

How many units of Fortified wine (sherry Cinzano Campari) do you consume in an average week? This data is also captured with GQV3_B4dUnitsFortWinePerWk and GQV4_B4dUnitsFortWinePerWk. You should request that data too.

Categorical

Alcoholic drink frequency

How often do you usually have an alcoholic drink of any kind? This question was only asked in GenQ version 1 (25/11/2004) so not all participants will have this data. All phase 1 data from 2 GenQs was placed into variable: GQ_Alc_f ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Eat breakfast

How often do you usually eat breakfast? Please tick the box which is most true. This data is also captured with GQV3_D1EatBreakfast and GQV4_D1EatBreakfast. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Breakfast and data derived into: gq_breakfast_DER. Please request those variables instead.

Categorical

Eat take-aways

When eating your main meal at home how often do you usually eat Home delivery or take-away meals. This data is also captured with GQV3_D2aEatTakeaways and GQV4_D2aEatTakeaways. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Takeaway and data derived into: gq_takeaway_DER. Please request those variables instead.

Categorical

Eat ready meals

When eating your main meal at home how often do you usually eat Ready-made meals/prepared foods. This data is also captured with GQV3_D2bEatReadyMeals and GQV4_D2bEatReadyMeals. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Readymeals and data derived into: gq_readymeals_DER. Please request those variables instead.

Categorical

Eat home cooked meals

When eating your main meal at home how often do you usually eat Home cooked meals. This data is also captured with GQV3_D2cEatHomeCookedMeals and GQV4_D2cEatHomeCookedMeals. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Homecooked and data derived into: gq_homecooked_DER. Please request those variables instead.

Categorical

Eat out

On average how often do you eat a meal outside of the home (restaurants pubs fast-food outlets etc)? This data is also captured with GQV3_D3EatOut and GQV4_D3EatOut. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eatout and data derived into: gq_eatout_DER. Please request those variables instead.

Categorical

Eat and watch TV

How often do you eat your meal while watching television or video? This data is also captured with GQV3_D4EatAndWatchTV and GQV4_D4EatAndWatchTV. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_eat and data derived into: gq_tv_eat_DER. Please request those variables instead.

Categorical

Snack and watch TV

Apart from meals how often do you eat snack foods while watching television? This data is also captured with GQV3_D5SnackAndWatchTV and GQV4_D5SnackAndWatchTV. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_snack and data derived into: gq_tv_snack_DER. Please request those variables instead.

Categorical

Main meal 6am - 7:59am

Had a main meal between 6am - 7:59am E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D601aMain and GQV4_D701aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0204 and data derived into: gq_eat_main0204_DER. Please request those variables instead.

Categorical

Light meal 6-8am

Had a light meal between 6am - 7:59am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV3_D601bLight and GQV4_D701bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0204 and data derived into: gq_eat_light0204_DER. Please request those variables instead.

Categorical

Snack 6-8am

Had a snack between 6am - 7:59am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D601cSnack and GQV4_D701cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0204 and data derived into: gq_eat_snack0204_DER. Please request those variables instead.

Categorical

Drink only snack 6-8am

Had a drink only snack between 6am - 7:59am E.g. e.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV3_D601dDrink and GQV4_D701dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0204 and data derived into: gq_eat_drink0204_DER. Please request those variables instead.

Categorical

Main meal 8am - 9:59am

Had a main meal between 8am - 9:59am E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D602aMain and GQV4_D702aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0406 and data derived into: gq_eat_main0406_DER. Please request those variables instead.

Categorical

Light meal 8-10am

Had a light meal between 8am - 9:59am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV3_D602bLight and GQV4_D702bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0406 and data derived into: gq_eat_light0406_DER. Please request those variables instead.

Categorical

Snack 8-10am

Had a snack between 8am - 9:59am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D602cSnack and GQV4_D702cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0406 and data derived into: gq_eat_snack0406_DER. Please request those variables instead.

Categorical

Drink only snack 8-10am

Had a drink only snack between 8am - 9:59am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV3_D602dDrink and GQV4_D702dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0406 and data derived into: gq_eat_drink0406_DER. Please request those variables instead.

Categorical

Main meal 10am - 11:59am

Had a main meal between 10am - 11:59am E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D603aMain and GQV4_D703aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0608 and data derived into: gq_eat_main0608_DER. Please request those variables instead.

Categorical

Light meal 10am-12pm

Had a light meal between 10am - 11:59pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV3_D603bLight and GQV4_D703bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0608 and data derived into: gq_eat_light0608_DER. Please request those variables instead.

Categorical

Snack 10am-11:59 pm

Had a snack between 10am - 11:59pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D603cSnack and GQV4_D703cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0608 and data derived into: gq_eat_snack0608_DER. Please request those variables instead.

Categorical

Drink only snack 10am-12pm

Had a drink only snack between 10am - 11:59pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV3_D603dDrink and GQV4_D703dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0608 and data derived into: gq_eat_drink0608_DER. Please request those variables instead.

Categorical

Main meal 12am - 1:59pm

Had a main meal between 12am - 1:59pm E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D604aMain and GQV4_D704aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0810 and data derived into: gq_eat_main0810_DER. Please request those variables instead.

Categorical

Light meal 12-1:59 pm

Had a light meal between 12pm - 1:59pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV3_D604bLight and GQV4_D704bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0810 and data derived into: gq_eat_light0810_DER. Please request those variables instead.

Categorical

Snack 12-2pm

Had a snack between 12pm - 1:59pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D604cSnack and GQV4_D704cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0810 and data derived into: gq_eat_snack0810_DER. Please request those variables instead.

Categorical

Drink only snack 12-2pm

Had a drink only snack between 12pm - 1:59pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV3_D604dDrink and GQV4_D704dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0810 and data derived into: gq_eat_drink0810_DER. Please request those variables instead.

Categorical

Main meal 2-3:59pm

Had a main meal between 2pm - 3:59pm E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D605aMain and GQV4_D705aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1012 and data derived into: gq_eat_main1012_DER. Please request those variables instead.

Categorical

Light meal 2-3:59 pm

Had a light meal between 2pm - 3:59pm E.g. porridge cereal toast sandwiches soup salad omelette. This data is also captured with GQV3_D605bLight and GQV4_D705bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1012 and data derived into: gq_eat_light1012_DER. Please request those variables instead.

Categorical

Snack 2-3:59 pm

Had a snack between 2pm - 3:59pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. This data is also captured with GQV3_D605cSnack and GQV4_D705cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1012 and data derived into: gq_eat_snack1012_DER. Please request those variables instead.

Categorical

Drink only snack 2-3:59pm

Had a drink only snack between 2pm - 3:59pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D605dDrink and GQV4_D705dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1012 and data derived into: gq_eat_drink1012_DER. Please request those variables instead.

Categorical

Main meal 4pm - 5:59pm

Had a main meal between 4pm - 5:59pm E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D606aMain and GQV4_D706aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1214 and data derived into: gq_eat_main1214_DER. Please request those variables instead.

Categorical

Light meal 4-6pm

Had a light meal between 4pm - 5:59pm E.g. porridge cereal toast sandwiches soup salad omelette. This data is also captured with GQV3_D606bLight and GQV4_D706bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1214 and data derived into: gq_eat_light1214_DER. Please request those variables instead.

Categorical

Snack 4-6pm

Had a snack between 4pm - 5:59pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. This data is also captured with GQV3_D606cSnack and GQV4_D706cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1214 and data derived into: gq_eat_snack1214_DER. Please request those variables instead.

Categorical

Drink only snack 4-6pm

Had a drink only snack between 4pm - 5:59pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D606dDrink and GQV4_D706dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1214 and data derived into: gq_eat_drink1214_DER. Please request those variables instead.

Categorical

Main meal 6-8pm

Had a main meal between 6pm - 7:59pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D607aMain and GQV4_D707aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1416 and data derived into: gq_eat_main1416_DER. Please request those variables instead.

Categorical

Light meal 6-8pm

Had a light meal between 6pm - 7:59pm E.g. porridge cereal toast sandwiches soup salad omelette. This data is also captured with GQV3_D607bLight and GQV4_D707bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1416 and data derived into: gq_eat_light1416_DER. Please request those variables instead.

Categorical

Snack 6-8pm

Had a snack between 6pm - 7:59pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. This data is also captured with GQV3_D607cSnack and GQV4_D707cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1416 and data derived into: gq_eat_snack1416_DER. Please request those variables instead.

Categorical

Drink only snack 6-8pm

Had a drink only snack between 6pm - 7:59pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D607dDrink and GQV4_D707dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1416 and data derived into: gq_eat_drink1416_DER. Please request those variables instead.

Categorical

Main meal 8pm - 9:59 pm

Had a main meal between 8pm - 9:59pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D608aMain and GQV4_D708aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1618 and data derived into: gq_eat_main1618_DER. Please request those variables instead.

Categorical

Light meal 8-9:59 pm

Had a light meal between 8pm - 9:59pm E.g. porridge cereal toast sandwiches soup salad omelette. This data is also captured with GQV3_D608bLight and GQV4_D708bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1618 and data derived into: gq_eat_light1618_DER. Please request those variables instead.

Categorical

Snack 8-9:59 pm

Had a snack between 8pm - 9:59pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D608cSnack and GQV4_D708cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1618 and data derived into: gq_eat_snack1618_DER. Please request those variables instead.

Categorical

Drink only snack 8-9:59pm

Had a drink only snack between 8pm - 9:59pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D608dDrink and GQV4_D708dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1618 and data derived into: gq_eat_drink1618_DER. Please request those variables instead.

Categorical

Main meal 10pm-12am

Had a main meal between 10pm - 11:59am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D609aMain and GQV4_D709aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1820 and data derived into: gq_eat_main1820_DER. Please request those variables instead.

Categorical

Light meal 10pm-12am

Had a light meal between 10pm - 11:59am E.g. porridge cereal toast sandwiches soup salad omelette. This data is also captured with GQV3_D609bLight and GQV4_D709bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1820 and data derived into: gq_eat_light1820_DER. Please request those variables instead.

Categorical

Snack 10-11:59 pm

Had a snack between 10pm - 11:59am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. This data is also captured with GQV3_D609cSnack and GQV4_D709cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1820 and data derived into: gq_eat_snack1820_DER. Please request those variables instead.

Categorical

Drink only snack 10-11:59pm

Had a drink only snack between 10pm - 11:59am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D609dDrink and GQV4_D709dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1820 and data derived into: gq_eat_drink1820_DER. Please request those variables instead.

Categorical

Main meal 12 am - 1:59 am

Had a main meal between 12am - 1:59am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D610aMain and GQV4_D710aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2022 and data derived into: gq_eat_main2022_DER. Please request those variables instead.

Categorical

Light meal 12 am - 1:59 am

Had a light meal between 12am - 1:59am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV3_D610bLight and GQV4_D710bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2022 and data derived into: gq_eat_light2022_DER. Please request those variables instead.

Categorical

Snack 12 am - 1:59 am

Had a snack between 12am - 1:59am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D610cSnack and GQV4_D710cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2022 and data derived into: gq_eat_snack2022_DER. Please request those variables instead.

Categorical

Drink only snack 12-1:59am

Had a drink only snack between 12am - 1:59am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D610dDrink and GQV4_D710dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2022 and data derived into: gq_eat_drink2022_DER. Please request those variables instead.

Categorical

Main meal 2-3:59 am

Had a main meal between 2am - 3:59am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV3_D611aMain and GQV4_D711aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2224 and data derived into: gq_eat_main2224_DER. Please request those variables instead.

Categorical

Light meal 2-3:59 am

Had a light meal between 2am - 3:59am E.g. porridge cereal toast sandwiches soup salad omelette. This data is also captured with GQV3_D611bLight and GQV4_D711bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2224 and data derived into: gq_eat_light2224_DER. Please request those variables instead.

Categorical

Snack 2-4am

Had a snack between 2am - 3:59am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D611cSnack and GQV4_D711cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2224 and data derived into: gq_eat_snack2224_DER. Please request those variables instead.

Categorical

Drink only snack 2-3:59am

Had a drink only snack between 2am - 3:59am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV3_D611dDrink and GQV4_D711dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2224 and data derived into: gq_eat_drink2224_DER. Please request those variables instead.

Categorical

Main meal 4am - 6am

Had a main meal between 4am - 5:59am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV3_D612aMain and GQV4_D712aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2402 and data derived into: gq_eat_main2402_DER. Please request those variables instead.

Categorical

Light meal 4-6am

Had a light meal between 4am - 5:59am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV3_D612bLight and GQV4_D712bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2402 and data derived into: gq_eat_light2402_DER. Please request those variables instead.

Categorical

Snack 4-6am

Had a snack between 4am - 5:59am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV3_D612cSnack and GQV4_D712cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2402 and data derived into: gq_eat_snack2402_DER. Please request those variables instead.

Categorical

Drink only snack 4-6am

Had a drink only snack between 4am - 5:59am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV3_D612dDrink and GQV4_D712dDrink. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2402 and data derived into: gq_eat_drink2402_DER. Please request those variables instead.

Categorical

Frequency of eating Vegetables

During the course of last year how many times a week did you eat Medium serving of Vegetables (not including potatoes). This data is also captured with GQV3_D7aVeg. You should request that data too. Not asked in GQV4. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_veg and data derived into: gq_eat_veg_DER. Please request those variables instead.

Categorical

Frequency of eating salads

During the course of last year how many times a week did you eat Medium serving of Salads. This data is also captured with GQV3_D7bSalad. You should request that data too. This data is not captured in GQV4. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_salads and data derived into: gq_eat_salads_DER. Please request those variables instead.

Categorical

Frequency of eating fruit

During the course of last year how many times a week did you eatMedium serving or 1 fruit of Fruit and fruit products (not including fruit juice). This data is also captured with GQV3_D7cFruit. You should request that data too. This data is not captured i All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_fruit and data derived into: gq_eat_fruit_DER. Please request those variables instead.

Categorical

Frequency of eating Fish

During the course of last year how many times a week did you eat medium serving of Fish and fish products. This data is also captured with GQV3_D7dFish. You should request that data too. Not asked in GQV4. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_fish and data derived into: gq_eat_fish_DER. Please request those variables instead.

Categorical

Frequency of eating Meat

During the course of last year how many times a week did you eat Medium serving of Meat meat products and meat dishes (including bacon ham or chicken). This data is also captured with GQV3_D7eMeat. You should request that data too. This data is not capt All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_meat and data derived into: gq_eat_meat_DER. Please request those variables instead.

Categorical

Weight Watchers' diet

Currently on a 'Weight Watchers' diet. This data is also captured with GQV3_D8aWW and GQV4_D8aWW. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_ww and data derived into: gq_diet_ww_DER. Please request those variables instead.

Categorical

Slimmers World' diet

Currently on a 'Slimmers World' diet. This data is also captured with GQV3_D8bSW and GQV4_D8bSW. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_slim and data derived into: gq_diet_slim_DER. Please request those variables instead. nstead.

Categorical

Low fat diet

Currently on a low fat diet. This data is also captured with GQV3_D8cLFD and GQV4_D8cLFD. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_lowf and data derived into: gq_diet_lowf_DER. Please request those variables instead. nstead.

Categorical

Low carbohydrate diet

Currently on a low carbohydrate diet eg Atkins Diet. This data is also captured with GQV3_D8dLCD and GQV4_D8dLCD. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_lowc and data derived into: gq_diet_lowc_DER. Please request those variables instead. nstead.

Categorical

Vegetarian diet

Currently on a vegetarian diet. This data is also captured with GQV3_D8eVegetarian and GQV4_D8eVegetarian. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_veg and data derived into: gq_diet_veg_DER. Please request those variables instead.

Categorical

Vegan diet

Currently on a vegan diet. This data is also captured with GQV3_D8fVegan and GQV4_D8fVegan. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_vegan and data derived into: gq_diet_vegan_DER. Please request those variables instead. nstead.

Categorical

Kosher diet

Currently on a Kosher diet. This data is also captured with GQV3_D8gKosher and GQV4_D8gKosher. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_kosh and data derived into: gq_diet_kosh_DER. Please request those variables instead. nstead.

Categorical

Halal diet

Currently on a Halal diet. This data is also captured with GQV3_D8hHalal and GQV4_D8hHalal. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_halal and data derived into: gq_diet_halal_DER. Please request those variables instead. nstead.

Categorical

Other diet

Currently on an other diet. Please describe. This data is also captured with GQV3_D8iOther and GQV4_D8iOther. You should request that data too.

Text

Full time work status

What is your current work status? In work - full time i.e. more than 30 hours per week. This data is also captured with GQV3_C1aFullTime and GQV4_C1aFullTime. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_full and data derived into: gq_job_full_DER. Please request those variables instead.

Categorical

Part time work status

What is your current work status? Part time work i.e. less than 30 hours per week. This data is also captured with GQV3_C1bPartTime and GQV4_C1bPartTime. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_part and data derived into: gq_job_part_DER. Please request those variables instead.

Categorical

Keeping house work status

What is your current work status? Keeping house. This data is also captured with GQV3_C1cKeepingHouse and GQV4_C1cKeepingHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_house and data derived into: gq_job_house_DER. Please request those variables instead.

Categorical

Retired work status

What is your current work status? Wholly retired from work. This data is also captured with GQV3_C1dRetired and GQV4_C1dRetired. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_retired and data derived into: gq_job_retired_DER. Please request those variables instead.

Categorical

Obtained new job work status

What is your current work status? Waiting to start a new job already obtained. This data is also captured with GQV3_C1eObtainedNewJob and GQV4_C1eObtainedNewJob. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_newjob and data derived into: gq_job_newjob_DER. Please request those variables instead.

Categorical

Unemployed work status

What is your current work status? Unemployed and looking for work. This data is also captured with GQV3_C1fUnemployed and GQV4_C1fUnemployed. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_unempl and data derived into: gq_job_unempl_DER. Please request those variables instead.

Categorical

Temporarily sick work status

What is your current work status? Out of work as temporarily sick. This data is also captured with GQV3_C1gTempSick and GQV4_C1gTempSick. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_tempsick and data derived into: gq_job_tempsick_DER. Please request those variables instead.

Categorical

Permanently sick work status

What is your current work status? Permanently sick or disabled. This data is also captured with GQV3_C1hPermSick and GQV4_C1hPermSick. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_sick and data derived into: gq_job_sick_DER. Please request those variables instead.

Categorical

Work status other

What is your current work status? If other please specify. This data is also captured with GQV3_C1iOther and GQV4_C1iOther. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_oth and data derived into: gq_job_oth_DER. Please request those variables instead.

Text

Last job title

Please could you give us some details about your present or last job. What is (was) the title of your job ? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data.

Text

Kind of work

What kind of work do (did) you do in your job ? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_type . Please request those variables instead.

Text

Training or qualifications for job

What training or qualifications are (were) needed for your job ? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_qual . Please request those variables instead.

Text

Employment type without employee data

Are (were) you working as an employee / as self-employed. This data is captured slightly differently with GQV3_C2EmployeeType and GQV4_C2EmployeeType. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_type and data derived into: gq_emp_type_DER. Please request those variables instead.

Categorical

Supervisory status with numbers

Present or your last job: Do (did) you supervise or have management responsibility for the work of other people and if so for up to 24 or more than 24? This data is captured (without numbers) with GQV3_C4SupervisoryStatus and GQV4_C4SupervisoryStatus. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_supervise and data derived into: gq_emp_supervise_DER. Please request those variables instead.

Categorical

Number of employees

Present or your last job: If you are (were) a supervisor or manager how many people are (were) employed in the firm company or establishment. This data is captured slightly differently with GQV3_C3NumberPeopleEmployed and GQV4_C3NumberPeopleEmployed. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_n and data derived into: gq_emp_n_DER. Please request those variables instead.

Categorical

Household Income

Please can you indicate what your household income is. This data is also captured with GQV3_C8HouseholdIncome and GQV4_C8HouseholdIncome (with slightly different wording). You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Income and data derived into: gq_income_DER. Please request those variables instead.

Categorical

Age finished full time education

At what age did you finish full time education? (in years). This data is also captured with GQV3_C7AgeEndFTE and GQV4_C7AgeEndFTE. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_age and data derived into: gq_edu_age_DER. Please request those variables instead.

Real

School leaving certificate

Do you have any of the following qualifications? (tick all applicable). School Leaving certificate. This data is also captured with GQV3_C6aSLC and GQV4_C6aSLC. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_SLC and data derived into: gq_edu_slc_DER. Please request those variables instead.

Categorical

CSE qualification

Do you have any of the following qualifications? (tick all applicable). CSE. This data is also captured with GQV3_C6bCSE and GQV4_C6bCSE. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_CSE and data derived into: gq_edu_cse_DER. Please request those variables instead.

Categorical

O level or GCSE qualification

Do you have any of the following qualifications? (tick all applicable). GCE O level or GCSE. This data is also captured with GQV3_C6cGCSE and GQV4_C6cGCSE. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_GCSE and data derived into: gq_edu_gcse_DER. Please request those variables instead.

Categorical

Matriculation qualification

Do you have any of the following qualifications? (tick all applicable). Matriculation. This data is also captured with GQV3_C6dMatriculation and GQV4_C6dMatriculation. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_matricul and data derived into: gq_edu_matricul_DER. Please request those variables instead.

Categorical

A level qualification

Do you have any of the following qualifications? (tick all applicable). GCE A Level AS level Highers This data is also captured with GQV3_C6eALevels and GQV4_C6eALevels. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_Alev and data derived into: gq_edu_alev_DER. Please request those variables instead.

Categorical

Technical or C&G qualification

Do you have any of the following qualifications? (tick all applicable). Technical College exams City & Guilds. This data is also captured with GQV3_C6fC_G and GQV4_C6fC_G. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_TechCG and data derived into: gq_edu_techcg_DER. Please request those variables instead.

Categorical

HND or GNVQ qualification

Do you have any of the following qualifications? (tick all applicable). HND or GNVQ. This data is also captured with GQV3_C6gHND_GNVQ and GQV4_C6gHND_GNVQ. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HND_NVQ and data derived into: gq_edu_hnd_nvq_DER. Please request those variables instead.

Categorical

Completed apprenticeship

Do you have any of the following qualifications? (tick all applicable). Completed Apprenticeship. This data is also captured with GQV3_C6hApprenticeship and GQV4_C6hApprenticeship. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_apprentice and data derived into: gq_edu_apprentice_DER. Please request those variables instead.

Categorical

Secretarial College qualification

Do you have any of the following qualifications? (tick all applicable). Secretarial College Exams. This data is also captured with GQV3_C6iSecretarial and GQV4_C6iSecretarial. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_secret and data derived into: gq_edu_secret_DER. Please request those variables instead.

Categorical

HNC or NVQ qualification

Do you have any of the following qualifications? (tick all applicable). Teaching Diploma HNC NVQ. This data is also captured with GQV3_C6jHNC and GQV4_C6jHNC. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HNC and data derived into: gq_edu_hnc_DER. Please request those variables instead.

Categorical

University degree qualification

Do you have any of the following qualifications? (tick all applicable). University Degree. This data is also captured with GQV3_C6kDegree and GQV4_C6kDegree. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_degree and data derived into: gq_edu_degree_DER. Please request those variables instead.

Categorical

Trade certificate qualification

Do you have any of the following qualifications? (tick all applicable). Trade Certificates. This data is also captured with GQV3_C6lTradeCertificate and GQV4_C6lTradeCertificate. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_trade and data derived into: gq_edu_trade_DER. Please request those variables instead.

Categorical

Other qualifications

Do you have any of the following qualifications? (tick all applicable). Other please describe. This data is also captured with GQV3_C6mOther and GQV4_C6mOther. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_others and data derived into: gq_edu_others_DER. Please request those variables instead.

Text

No Qualifications

Do you have any of the following qualifications? (tick all applicable). None. This data is also captured with GQV3_C6nNone and GQV4_C6nNone. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_none and data derived into: gq_edu_none_DER. Please request those variables instead.

Categorical

Can use car or van

Does your household have any cars or vans normally available for its use? This data is also captured with GQV3_C10Cars and GQV4_C10Cars (with slightly different wording). You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Owncars and data derived into: gq_owncars_DER. Please request those variables instead.

Categorical

Own or buying house

Do you own your own (or are you buying) home? This data is also captured with GQV3_C11aOwnHouse and GQV4_C11aOwnHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Ownhouse and data derived into: gq_ownhouse_DER. Please request those variables instead.

Categorical

Rent house

Do you rent your own home? This data is also captured with GQV3_C11bRentHouse and GQV4_C11bRentHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Renthouse and data derived into: gq_renthouse_DER. Please request those variables instead.

Categorical

Partners job details

Only for women who currently live with their partner. Please could you give us some details about your husband/partner's present or last job. What kind of work does (did) he do in his job? What training or qualifications are (were) needed for his job? Only asked in version 1 of the questionnaire. The data was put into new variable: GQ_Job_partner . Please request that variable instead.

Text

Partners employment status

Is (was) he working as an employee or self-employed. This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_others_txt . Please request those variables instead.

Categorical

Partners management status

Does (did) he supervise or have management responsibility for the work of other people? This question was only asked in GenQ version 1 (25/11/2004 and 26/01/2005) so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_partnermanage. Please request those variables instead.

Categorical

Additional comments on gen questionnaire version 1

GQV1 additional comments made on any page with page number and text. This data is also captured with GQV3_FSGQComments and GQV4_FSGQComments. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: FSGQComments_Updated . Please request those variables instead.

Text

On medication

Are you taking any tablets or medicines at the moment? This data is also captured with GQV1_A1OnMedication or GQV4_A1OnMedication. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Meds and data derived into: gq_meds_DER. Please request those variables instead.

Categorical

Current Medication a BNF Code

BNF Code for medication a added by research team This data is also captured with GQV1_A2aCurrentMedicationBNFCode or GQV4_A2aCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds a

Dose of drug a. This data is also captured with GQV1_A2aCurrentMedicationDose or GQV4_A2aCurrentMedicationDose. You should be given that data too.

Text

Name meds a

Name of drug a. This data is also captured with GQV1_A2aCurrentMedicationName or GQV4_A2aCurrentMedicationName. You should be given that data too.

Text

Reason Meds a

Reason for taking the drug a. This data is also captured with GQV1_A2aCurrentMedicationReason or GQV4_A2aCurrentMedicationReason. You should be given that data too.

Text

Current Medication b BNF Code

BNF Code for medication b added by research team. This data is also captured with GQV1_A2bCurrentMedicationBNFCode or GQV4_A2bCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds b

Dose of drug b. This data is also captured with GQV1_A2bCurrentMedicationDose or GQV4_A2bCurrentMedicationDose. You should be given that data too.

Text

Name meds b

Name of drug b. This data is also captured with GQV1_A2bCurrentMedicationName or GQV4_A2bCurrentMedicationName. You should request that data too.

Text

Reason Meds b

Reason for taking the drug b. This data is also captured with GQV1_A2bCurrentMedicationReason or GQV4_A2bCurrentMedicationReason. You should be given that data too.

Text

Current Medication c BNF Code

BNF Code for medication c added by research team. This data is also captured with GQV1_A2cCurrentMedicationBNFCode or GQV4_A2cCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds c

Dose of drug c. This data is also captured with GQV1_A2cCurrentMedicationDose or GQV4_A2cCurrentMedicationDose. You should be given that data too.

Text

Name meds c

Name of drug c. This data is also captured with GQV1_A2cCurrentMedicationName or GQV4_A2cCurrentMedicationName. You should be given that data too.

Text

Reason Meds c

Reason for taking the drug c. This data is also captured with GQV1_A2cCurrentMedicationReason or GQV4_A2cCurrentMedicationReason. You should be given that data too.

Text

Current Medication d BNF Code

BNF Code for medication d added by research team. This data is also captured with GQV1_A2dCurrentMedicationBNFCode or GQV4_A2dCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds d

Dose of drug d. This data is also captured with GQV1_A2dCurrentMedicationDose or GQV4_A2dCurrentMedicationDose. You should be given that data too.

Text

Name meds d

Name of drug d. This data is also captured with GQV1_A2dCurrentMedicationName or GQV4_A2dCurrentMedicationName. You should be given that data too.

Text

Reason Meds d

Reason for taking the drug d. This data is also captured with GQV1_A2dCurrentMedicationReason or GQV4_A2dCurrentMedicationReason. You should be given that data too.

Text

Current Medication e BNF Code

BNF Code for medication e added by research team. This data is also captured with GQV1_A2eCurrentMedicationBNFCode or GQV4_A2eCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds e

Dose of drug e. This data is also captured with GQV1_A2eCurrentMedicationDose or GQV4_A2eCurrentMedicationDose. You should be given that data too.

Text

Name meds e

Name of drug e. This data is also captured with GQV1_A2eCurrentMedicationName or GQV4_A2eCurrentMedicationName. You should be given that data too.

Text

Reason Meds e

Reason for taking the drug e. This data is also captured with GQV1_A2eCurrentMedicationReason or GQV4_A2eCurrentMedicationReason. You should be given that data too.

Text

Current Medication f BNF Code

BNF Code for medication f added by research team. This data is also captured with GQV1_A2fCurrentMedicationBNFCode or GQV4_A2fCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds f

Dose of drug f. This data is also captured with GQV1_A2fCurrentMedicationDose or GQV4_A2fCurrentMedicationDose. You should be given that data too.

Text

Name meds f

Name of drug f. This data is also captured with GQV1_A2fCurrentMedicationName or GQV4_A2fCurrentMedicationName. You should be given that data too.

Text

Reason Meds f

Reason for taking the drug f. This data is also captured with GQV1_A2fCurrentMedicationReason or GQV4_A2fCurrentMedicationReason. You should be given that data too.

Text

Current Medication g BNF Code

BNF Code for medication g added by research team. This data is also captured with GQV1_A2gCurrentMedicationBNFCode or GQV4_A2gCurrentMedicationBNFCode. You should request that data too.

Text

Dose Meds g

Dose of drug g. This data is also captured with GQV1_A2gCurrentMedicationDose or GQV4_A2gCurrentMedicationDose. You should be given that data too.

Text

Name meds g

Name of drug b. This data is also captured with GQV1_A2gCurrentMedicationName or GQV4_A2gCurrentMedicationName. You should request that data too.

Text

Reason Meds g

Reason for taking the drug g. This data is also captured with GQV1_A2gCurrentMedicationReason or GQV4_A2gCurrentMedicationReason. You should be given that data too.

Text

Current Medication h BNF Code

BNF Code for medication h added by research team. This data is also captured with GQV1_A2hCurrentMedicationBNFCode or GQV4_A2hCurrentMedicationBNFCode. You should be given that data too.

Text

Dose Meds h

Dose of drug h. This data is also captured with GQV1_A2hCurrentMedicationDose or GQV4_A2hCurrentMedicationDose. You should be given that data too.

Text

Name meds h

Name of drug h. This data is also captured with GQV1_A2hCurrentMedicationName or GQV4_A2hCurrentMedicationName. You should be given that data too.

Text

Reason Meds h

Reason for taking the drug h. This data is also captured with GQV1_A2hCurrentMedicationReason or GQV4_A2hCurrentMedicationReason. You should be given that data too.

Text

Birth weight imperial

What was your weight at birth in pounds and ounces. This data is also captured with GQV1_A4aBirthWeight and GQV1_A4bBirthWeightUnits or GQV4_A3aBirthWeightImperial. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_BWt_imperial . Please request those variables instead.

Real

Birth weight metric

What was your weight at birth in kilograms. This data is also captured with GQV1_A4aBirthWeight and GQV1_A4bBirthWeightUnits or GQV4_A3bBirthWeightMetric. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_BWt_metric . Please request those variables instead.

Real

Birth weight unknown

Tick if you are not able to give your birth weight. This data is also captured with GQV1_A4cBirthWeightUnknown and GQV4_A3cBirthWeightUnknown. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_BWt_unknown . Please request those variables instead.

Categorical

Term of birth

When were you born (pre post or at term). This data is also captured with GQV1_A4dBorn or GQV4_A4aBorn. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Bterm and data derived into: gq_bterm_DER. Please request those variables instead.

Categorical

Dr report heart trouble

Has your doctor ever told you that you have heart trouble? This data is also captured with GQV1_A5aDrReportHeartTrouble or GQV4_A5aDrReportHeartTrouble. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Htn_dr and data derived into: gq_htn_dr_DER. Please request those variables instead.

Categorical

Chest pain ever

Have you ever had any pain or discomfort in your chest? If no proceed to question 7. If yes please answer the next question. This data is also captured with GQV1_A5bChestPain or GQV4_A5bChestPain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_dr and data derived into: gq_chestpain_dr_DER. Please request those variables instead.

Categorical

Chest pain uphill

Do you experience pain or chest discomfort when you walk uphill or hurry? This data is also captured with GQV1_A5cChestPainUphill or GQV4_A5cChestPainUphill. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_uphill and data derived into: gq_chestpain_uphill_DER. Please request those variables instead.

Categorical

Chest pain normal pace

Do you experience pain or chest discomfort when you walk at an ordinary pace on the level? This data is also captured with GQV1_A5dChestPainNormalPace or GQV4_A5dChestPainNormalPace. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_normal and data derived into: gq_chestpain_normal_DER. Please request those variables instead.

Categorical

Action taken when experience chest discomfort from walking

What do you do if you experience pain or chest discomfort while walking? This data is also captured with GQV1_A5eActionWhenChestDiscomfort or GQV4_A5eActionWhenChestDiscomfort. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_action and data derived into: gq_chestpain_action_DER. Please request those variables instead.

Categorical

Chest discomfort after stopping

If you stand still what happens to pain or chest discomfort? This data is also captured with GQV1_A5fChestDiscomfortAfterStopping or GQV4_A5fChestDiscomfortAfterStopping. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_stop and data derived into: gq_chestpain_stop_DER. Please request those variables instead.

Categorical

Feel faint or dizzy

Do you often feel faint or have spells of severe dizziness? This data is also captured with GQV1_A5gFeelFaint or GQV4_A5gFeelFaint. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_FeelFaint and data derived into: gq_feelfaint_DER. Please request those variables instead.

Categorical

Dr report high BP

Has a doctor ever told you that your blood pressure was too high? This data is also captured with GQV1_A5hDrReportBPHigh or GQV4_A5hDrReportBPHigh. You should be given that data too.

Categorical

Treatment for high blood pressure

If you have been told that your blood pressure was too high are you now on treatment? This data is also captured with GQV1_A5iTreatmentHighBP or GQV4_A5iTreatmentHighBP. You should be given that data too.

Categorical

Bone problems worse by exercise

Has your doctor ever told you that you have a bone or joint problem such as arthritis that has been aggravated by exercise or might be made worse by exercise? This data is also captured with GQV1_A5jBoneProblemsAggravatedByExercise or GQV4_A5jBoneProblems. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Bone_exercise and data derived into: gq_bone_exercise_DER. Please request those variables instead.

Categorical

Pregnancy status

Are you pregnant? This data is also captured with GQV1_A5kPregnant or GQV4_A5kPregnant. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Preg and data derived into: gq_preg_DER. Please request those variables instead.

Categorical

Any reason not to do PA

Is there any reason you know of that means you should not follow an activity programme even if you wanted to? Yes / No. This data is also captured with GQV1_A5lReasonNotToDoPA or GQV4_A5lReasonNotToDoPA. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_PA_reason and data derived into: gq_pa_reason_DER. Please request those variables instead.

Categorical

Age first menstruation

How old were you when you had your first menstrual period (in years)? This data is also captured with GQV4_A6AgeFirstMenstralPeriod. You should be given that data too. This data is not collected in GQV1. All phase 1 data from 2 GenQs was merged into new variable: GQ_Menstr_age and data derived into: gq_menstr_age_DER. Please request those variables instead.

Real

Still menstruating

Are you still having menstrual periods? This data is also captured with GQV4_A7aStillHaveMenstrualPeriods. You should be given that data too. This data is not collected in GQV1. All phase 1 data from 2 GenQs was merged into new variable: GQ_Menstr_still and data derived into: gq_menstr_still_DER. Please request those variables instead.

Categorical

Age menstruation stopped

If NO how old were you when you stopped having your periods (i.e. your age at menopause in years old)? This data is also captured with GQV4_A7bAgePeriodsStopped. You should be given that data too. This data is not collected in GQV1.

Real

Ever smoked

Have you ever smoked? If no please go to B2 on the next page. This data is also captured with GQV1_B1cEverSmoked or GQV4_B1aEverSmoked. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_ever and data derived into: gq_sm_ever_DER. Please request those variables instead.

Categorical

Smoke now

Do you smoke now? This data is also captured with GQV4_B1bCurrentlySmoke. You should request that data too. Not asked in GQV1. All phase 1 data from 2 GenQs was merged into new variable: GQ_Sm_cur and data derived into: gq_sm_cur_DER. Please request those variables instead.

Categorical

Age start smoking

At what age did you start smoking? Please enter age in years. This data is also captured with GQV4_B1cAgeStartSmoking. You should request that data too. Data not requested in GQV1. All phase 1 data from 2 GenQs was merged into new variable: GQ_Sm_agestart and data derived into: gq_sm_agestart_DER. Please request those variables instead.

Real

Year stopped smoking

If you have stopped smoking in which year did you quit. This data is also captured with GQV1_B1dEverSmokedYearQuit and GQV4_B1dYearQuit. You shouldrequest that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_yearstop and data derived into: gq_sm_yearstop_DER. Please request those variables instead.

Text

Number of cigarettes per day

How many cigarettes do you or did you smoke a day on average? This data is also captured with GQV1_B1eNumberCigarettesPerDay or GQV4_B1eNumberCigarettesPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Integer

Number of cheroots smoked per day

How many cheroots do you or did you smoke a day on average? This data is also captured with GQV1_B1fNumberCherootsPerDay or GQV4_B1fNumberCherootsPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Integer

How many cigars smoked per day

How many cigars do you or did you smoke a day on average? This data is also captured with GQV1_B1gNumberCigarsPerDay or GQV4_B1gNumberCigarsPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Integer

Grams of tobacco per week

How much do you or did you smoke a day on average? Amount in grams of tobacco in a week. This data is also captured with GQV1_B1hTobaccoPerWeek or GQV4_B1hTobaccoPerWeek. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Real

Never drink

Do you never drink alcohol? If you are a non drinker please go to section C on the next page. This question was only asked in GenQ version 3. GQV4 asks the question the other way around (Do you ever drink). All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_ever and data derived into: gq_alc_ever_DER; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink every day

Do you usually drink every day? This data is also captured with GQV4_B2bDrinkDaily and is covered in a different format in GQV1_B3aDrinkFrequency. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_everyday ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink almost every day

Do you usually drink almost every day? This data is also captured with GQV4_B2cDrinkMostDays and is covered in a different format in GQV1_B3aDrinkFrequency. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_almostday ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink 3-4 times per week

Do you usually drink 3-4 times per week This data is also captured with GQV4_B2dDrink3-4TimesPerWeek and is covered in a different format in GQV1_B3aDrinkFrequency. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_3to4perwk ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink 1-2 times per week

Do you usually drink 1-2 times per week? This data is also captured with GQV4_B2eDrink1-2TimesPerWeek and is covered in a different format in GQV1_B3aDrinkFrequency. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_1to2perwk ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink once per fortnight

Do you usually drink once per fortnight? This data is also captured with GQV4_B2fDrinkPerFortnight. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_1per14days ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink 1 times per month

Do you usually drink once per month? This data is also captured with GQV4_B2gDrinkPerMonth and is covered in a different format in GQV1_B3aDrinkFrequency. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_1permth ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink less then 1 times per month

Do you usually drink less often than once a month. This data is also captured with GQV4_B2hDrinkLessOncePerMonth and is covered in a different format in GQV1_B3aDrinkFrequency. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_less1permth ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Units of beer lager or cider per week

How many units of beer lager or cider do you consume in an average week? This data is also captured with GQV1_B2aUnitsBeerPerWk or GQV4_B3aUnitsBeerPerWk. You should request that data too.

Categorical

Units of wine per week

How many units of wine do you consume in an average week? This data is also captured with GQV1_B2bUnitsWinePerWk or GQV4_B3bUnitsWinePerWk. You should request that data too.

Categorical

Units of spirit per week

How many units of spirits do you consume in an average week? This data is also captured with GQV1_B2cUnitsSpiritsPerWk or GQV4_B3cUnitsSpiritsPerWk. You should request that data too.

Categorical

Units of fortified wine per week

How many units of Fortified wine (sherry Cinzano Campari) do you consume in an average week? This data is also captured with GQV1_B2dUnitsFortWinePerWk or GQV4_B4dUnitsFortWinePerWk. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Alc_units_fortwine and data derived into: gq_alc_units_fortwine_DER; gq_alc_units_DER and gq_alc_g_DER. Please request those variables instead.

Categorical

Own a car or van

Do you own a car or van ? This data is also captured with GQV1_DMC5aCars or GQV4_C10Cars (with slightly different wording). You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Owncars and data derived into: gq_owncars_DER. Please request those variables instead.

Categorical

Own or buying house

Do you own or are you buying your own home? This data is also captured with GQV1_DMC5bOwnHouse or GQV4_C11aOwnHouse. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Ownhouse and data derived into: gq_ownhouse_DER. Please request those variables instead.

Categorical

Rent house

Do you rent your home? This data is also captured with GQV1_DMC5cRenHouse or GQV4_C11bRentHouse. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Renthouse and data derived into: gq_renthouse_DER. Please request those variables instead.

Categorical

Marital status

What is your marital status? This data is also captured with GQV4_C12MaritalStatus. You should request that data too. Not asked in GQV1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Marit and data derived into: gq_marit_DER. Please request those variables instead.

Categorical

Full time work status

What is your current work status? In work full time i.e. more than 30 hours per week. This data is also captured with GQV1_DMC1aFullTime or GQV4_C1aFullTime. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_full and data derived into: gq_job_full_DER. Please request those variables instead.

Categorical

Part time work status

What is your current work status? Part time work i.e. less than 30 hours per week. This data is also captured with GQV1_DMC1bPartTime or GQV4_C1bPartTime. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_part and data derived into: gq_job_part_DER. Please request those variables instead.

Categorical

Keeping house work status

What is your current work status? Keeping house. This data is also captured with GQV1_DMC1cKeepingHouse or GQV4_C1cKeepingHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_house and data derived into: gq_job_house_DER. Please request those variables instead.

Categorical

Retired work status

What is your current work status? Wholly retired from work. This data is also captured with GQV1_DMC1dRetired or GQV4_C1dRetired. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_retired and data derived into: gq_job_retired_DER. Please request those variables instead.

Categorical

Obtained new job work status

What is your current work status? Waiting to start a new job already obtained. This data is also captured with GQV1_DMC1eObtainedNewJob or GQV4_C1eObtainedNewJob. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_newjob and data derived into: gq_job_newjob_DER. Please request those variables instead.

Categorical

Unemployed work status

What is your current work status? Unemployed and looking for work. This data is also captured with GQV1_DMC1fUnemployed or GQV4_C1fUnemployed. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_unempl and data derived into: gq_job_unempl_DER. Please request those variables instead.

Categorical

Temporarily sick work status

What is your current work status? Out of work as temporarily sick. This data is also captured with GQV1_DMC1gTempSick or GQV4_C1gTempSick. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_tempsick and data derived into: gq_job_tempsick_DER. Please request those variables instead.

Categorical

Permanently sick work status

What is your current work status? Permanently sick or disabled. This data is also captured with GQV1_DMC1hPermSick or GQV4_C1hPermSick. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_sick and data derived into: gq_job_sick_DER. Please request those variables instead.

Categorical

Work status other

What is your current work status? If other please specify. This data is also captured with GQV1_DMC1iOther or GQV4_C1iOther. You should request that data too.

Text

Employment type with employee data

Present or your last job: Do (did) you work as an employee or are (were) you self-employed? This data is also captured with GQV1_DMC2dEmployeeType (though answers mean different things) or GQV4_C2EmployeeType. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_type and data derived into: gq_emp_type_DER. Please request those variables instead.

Categorical

Number of people employed

Present or your last job: Number of employees. For employees: indicate below how many people work (worked) for your employer at the place where you work (worked). For self-employed: indicate below how many people you employ(ed). This data is also captured with GQV4_C3NumberPeopleEmployed. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_n and data derived into: gq_emp_n_DER. Please request those variables instead.

Categorical

Supervisory status without numbers

Present or your last job: Supervisory status: Do (did) you supervise any other employees (A supervisor or foreman is responsible for overseeing the work of other employees on a day to day basis).This data is captured slightly differently with GQV1_DMC2eSupervisoryStatus (that captures numbers too) and identically with GQV4_C4SupervisoryStatus. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_supervise and data derived into: gq_emp_supervise_DER. Please request those variables instead.

Categorical

Occupation type

Occupation type: Current work or last job.This data is also captured with GQV4_C5Occupation (but not in GQV1). You should request that data too.

Categorical

School leaving certificate

Do you have any of the following qualifications? (tick all applicable). School Leaving certificate. This data is also captured with GQV1_DMC4aSLC or GQV4_C6aSLC. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_SLC and data derived into: gq_edu_slc_DER. Please request those variables instead.

Categorical

CSE qualification

Do you have any of the following qualifications? (tick all applicable). CSE. This data is also captured with GQV1_DMC4bCSE or GQV4_C6bCSE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_CSE and data derived into: gq_edu_cse_DER. Please request those variables instead.

Categorical

O level or GCSE qualification

Do you have any of the following qualifications? (tick all applicable). GCE O level or GCSE. This data is also captured with GQV1_DMC4cGCSE or GQV4_C6cGCSE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_GCSE and data derived into: gq_edu_gcse_DER. Please request those variables instead.

Categorical

Matriculation qualification

Do you have any of the following qualifications? (tick all applicable). Matriculation. This data is also captured with GQV1_DMC4dMatriculation or GQV4_C6dMatriculation. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_matricul and data derived into: gq_edu_matricul_DER. Please request those variables instead.

Categorical

A level qualification

Do you have any of the following qualifications? (tick all applicable). GCE A Level AS level Highers This data is also captured with GQV1_DMc4eALevels or GQV4_C6eALevels. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_Alev and data derived into: gq_edu_alev_DER. Please request those variables instead.

Categorical

Technical or C&G qualification

Do you have any of the following qualifications? (tick all applicable). Technical College exams City & Guilds. This data is also captured with GQV1_DMC4fC_G or GQV4_C6fC_G. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_TechCG and data derived into: gq_edu_techcg_DER. Please request those variables instead.

Categorical

HND or GNVQ qualification

Do you have any of the following qualifications? (tick all applicable). HND or GNVQ. This data is also captured with GQV1_DMC4gHND or GQV4_C6gHND_NVQ. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HND_NVQ and data derived into: gq_edu_hnd_nvq_DER. Please request those variables instead.

Categorical

Completed apprenticeship

Do you have any of the following qualifications? (tick all applicable). Completed Apprenticeship. This data is also captured with GQV1_DMC4hApprenticeship or GQV4_C6hApprenticeship. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_apprentice and data derived into: gq_edu_apprentice_DER. Please request those variables instead.

Categorical

Secretarial College qualification

Do you have any of the following qualifications? (tick all applicable). Secretarial College Exams. This data is also captured with GQV1_DMC4iSecretarial or GQV4_C6iSecretarial. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_secret and data derived into: gq_edu_secret_DER. Please request those variables instead.

Categorical

HNC or NVQ qualification

Do you have any of the following qualifications? (tick all applicable). Teaching Diploma HNC NVQ. This data is also captured with GQV1_DMC4jHMC or GQV4_C6jHNC. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HNC and data derived into: gq_edu_hnc_DER. Please request those variables instead.

Categorical

University degree qualification

Do you have any of the following qualifications? (tick all applicable). University Degree. This data is also captured with GQV1_DMC4kDegree or GQV4_C6kDegree. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_degree and data derived into: gq_edu_degree_DER. Please request those variables instead.

Categorical

Trade certificate qualification

Do you have any of the following qualifications? (tick all applicable). Trade Certificates. This data is also captured with GQV1_DMC4lTradeCertificate or GQV4_C6lTradeCertificate. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_trade and data derived into: gq_edu_trade_DER. Please request those variables instead.

Categorical

Other qualifications

Do you have any of the following qualifications? (tick all applicable). Other please describe. This data is also captured with GQV1_DMC4mOther or GQV4_C6mOther. You should be given that data too.

Text

No Qualifications

Do you have any of the following qualifications? (tick all applicable). None. This data is also captured with GQV1_DMC4nNone or GQV4_C6nNone. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_none and data derived into: gq_edu_none_DER. Please request those variables instead.

Categorical

Age finished full time education

At what age did you finish full time education (in years)? This data is also captured with GQV1_DMC42aAgeEndFTE or GQV4_C7AgeEndFTE. You should be given that data too.

Real

Household income

What is your total combined household income? This data is also captured with GQV1_DMC3HouseholdIncome or GQV4_C8HouseholdIncome (with slightly different wording). You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Income and data derived into: gq_income_DER. Please request those variables instead

Categorical

Number of people in household

How many people are there in your household? (including children). This data is also captured with GQV4_C9NumberInHouse. You should be given that data too. Data not collected in GQV1.

Real

How often do you eat breakfast?

How often do you usually eat breakfast? Please tick the box which is most true. This data is also captured with GQV1_D1EatBreakfast or GQV4_D1EatBreakfast. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Breakfast and data derived into: gq_breakfast_DER. Please request those variables instead.

Categorical

How often do you takeaway meals

When eating your main meal at home how often do you usually eat Home delivery or take-away meals. This data is also captured with GQV1_D2aEatTakeaways or GQV4_D2aEatTakeaways. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Takeaway and data derived into: gq_takeaway_DER. Please request those variables instead.

Categorical

How often do you eat ready meals

When eating your main meal at home how often do you usually eat Ready-made meals/prepared foods. This data is also captured with GQV1_D2bEatReadyMeals or GQV4_D2bEatReadyMeals. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Readymeals and data derived into: gq_readymeals_DER. Please request those variables instead.

Categorical

How often do you eat home-cooked meals

When eating your main meal at home how often do you usually eat Home cooked meals. This data is also captured with GQV1_D2cEatHomeCookedMeals or GQV4_D2cEatHomeCookedMeals. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Homecooked and data derived into: gq_homecooked_DER. Please request those variables instead.

Categorical

How often do you a have a meal out?

On average how often do you eat a meal outside of the home (restaurants pubs fast-food outlets etc)? This data is also captured with GQV1_D3EatOut or GQV4_D3EatOut. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eatout and data derived into: gq_eatout_DER. Please request those variables instead.

Categorical

Meal while watching TV

How often do you eat your meal while watching television or video? This data is also captured with GQV1_D4EatAndWatchTV or GQV4_D4EatAndWatchTV. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_eat and data derived into: gq_tv_eat_DER. Please request those variables instead.

Categorical

Snack foods while watching TV

Apart from meals how often do you snack foods while watching television? This data is also captured with GQV1_D5SnackAndWatchTV or GQV4_D5SnackAndWatchTV. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_snack and data derived into: gq_tv_snack_DER. Please request those variables instead.

Categorical

Eating patterns: 6-8am 01

Had a main meal between 6am - 8am E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV1_D601aMain or GQV4_D701aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0204 and data derived into: gq_eat_main0204_DER. Please request those variables instead.

Categorical

Eating patterns: 6-8am 01

Had a light meal between 6am - 8am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D601bLight or GQV4_D701bLight. You should be given that data too.All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0204 and data derived into: gq_eat_light0204_DER. Please request those variables instead.

Categorical

Snack 6-8am 01

Had a snack between 6am - 8am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D601cSnack or GQV4_D701cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0204 and data derived into: gq_eat_snack0204_DER. Please request those variables instead.

Categorical

Drink only snack 6-8am

Had a drink only snack between 6am - 8am E.g. e.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D601dDrink or GQV4_D701dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0204 and data derived into: gq_eat_drink0204_DER. Please request those variables instead.

Categorical

Eating patterns: 8-10am 02

Had a main meal between 8am - 10am E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV1_D602aMain or GQV4_D702aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0406 and data derived into: gq_eat_main0406_DER. Please request those variables instead.

Categorical

Eating patterns: 8-10am 02

Had a light meal between 8am - 10am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D602bLight or GQV4_D702bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0406 and data derived into: gq_eat_light0406_DER. Please request those variables instead.

Categorical

Snack 8-10am 02

Had a snack between 8am - 10am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D602cSnack or GQV4_D702cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0406 and data derived into: gq_eat_snack0406_DER. Please request those variables instead.

Categorical

Drink only snack 8-10am

Had a drink only snack between 8am - 10am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D602dDrink or GQV4_D702dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0406 and data derived into: gq_eat_drink0406_DER. Please request those variables instead.

Categorical

Eating patterns: 10-12am 03

Had a main meal between 10am - 12am E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV1_D603aMain or GQV4_D703aMain. You should be given that data too.All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0608 and data derived into: gq_eat_main0608_DER. Please request those variables instead.

Categorical

Eating patterns: 10-12am 03

Had a light meal between 10am - 12pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D603bLight or GQV4_D703bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0608 and data derived into: gq_eat_light0608_DER. Please request those variables instead.

Categorical

Snack 10-12am 03

Had a snack between 10am - 12pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D603cSnack or GQV4_D703cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0608 and data derived into: gq_eat_snack0608_DER. Please request those variables instead.

Categorical

Drink only snack 10-12am

Had a drink only snack between 10am - 12pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D603dDrink or GQV4_D703dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0608 and data derived into: gq_eat_drink0608_DER. Please request those variables instead.

Categorical

Eating patterns: 12-2pm 04

Had a main meal between 12am - 2pm E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV1_D604aMain or GQV4_D704aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0810 and data derived into: gq_eat_main0810_DER. Please request those variables instead. -1 = left blank;

Categorical

Eating patterns: 12-2pm 04

Had a light meal between 12pm -2pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D604bLight or GQV4_D704bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0810 and data derived into: gq_eat_light0810_DER. Please request those variables instead.

Categorical

Snack 12-2pm 04

Had a snack between 12pm - 2pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D604cSnack or GQV4_D704cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0810 and data derived into: gq_eat_snack0810_DER. Please request those variables instead.

Categorical

Drink only snack 12-2pm

Had a drink only snack between 12pm - 2pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D604dDrink or GQV4_D704dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0810 and data derived into: gq_eat_drink0810_DER. Please request those variables instead.

Categorical

Eating patterns: 2-4pm 05

Had a main meal between 2pm - 4pm E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV1_D605aMain or GQV4_D705aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1012 and data derived into: gq_eat_main1012_DER. Please request those variables instead.

Categorical

Eating patterns: 2-4pm 05

Had a light meal between 2pm - 4pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D605bLight or GQV4_D705bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1012 and data derived into: gq_eat_light1012_DER. Please request those variables instead.

Categorical

Snack 2-4pm 05

Had a snack between 2pm - 4pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D605cSnack or GQV4_D705cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1012 and data derived into: gq_eat_snack1012_DER. Please request those variables instead.

Categorical

Drink only snack 2-4pm

Had a drink only snack between 2pm - 4pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D605dDrink or GQV4_D705dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1012 and data derived into: gq_eat_drink1012_DER. Please request those variables instead.

Categorical

Eating patterns: 4-6pm 06

Had a main meal between 4pm - 6pm E.g. cooked dish e.g. meat with potatoes pizza lasagne fish and chips burgers fried breakfast. This data is also captured with GQV1_D606aMain or GQV4_D706aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1214 and data derived into: gq_eat_main1214_DER. Please request those variables instead.

Categorical

Eating patterns: 4-6pm 06

Had a light meal between 4pm - 6pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D606bLight or GQV4_D706bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1214 and data derived into: gq_eat_light1214_DER. Please request those variables instead.

Categorical

Snack 4-6pm 06

Had a snack between 4pm - 6pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D606cSnack or GQV4_D706cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1214 and data derived into: gq_eat_snack1214_DER. Please request those variables instead.

Categorical

Drink only snack 4-6pm

Had a drink only snack between 4pm - 6pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D606dDrink or GQV4_D706dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1214 and data derived into: gq_eat_drink1214_DER. Please request those variables instead.

Categorical

Eating patterns: 6-8pm 07

Had a main meal between 6pm - 8pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D607aMain or GQV4_D707aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1416 and data derived into: gq_eat_main1416_DER. Please request those variables instead.

Categorical

Eating patterns: 6-8pm 07

Had a light meal between 6pm - 8pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D607bLight or GQV4_D707bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1416 and data derived into: gq_eat_light1416_DER. Please request those variables instead.

Categorical

Snack 6-8pm 07

Had a snack between 6pm - 8pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D607cSnack or GQV4_D707cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1416 and data derived into: gq_eat_snack1416_DER. Please request those variables instead.

Categorical

Drink only snack 6-8pm

Had a drink only snack between 6pm - 8pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D607dDrink or GQV4_D707dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1416 and data derived into: gq_eat_drink1416_DER. Please request those variables instead.

Categorical

Eating patterns: 8-10pm 08

Had a main meal between 8pm - 10pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D608aMain or GQV4_D708aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1618 and data derived into: gq_eat_main1618_DER. Please request those variables instead.

Categorical

Eating patterns: 8-10pm 08

Had a light meal between 8pm - 10pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D608bLight or GQV4_D708bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1618 and data derived into: gq_eat_light1618_DER. Please request those variables instead.

Categorical

Snack 8-10pm 08

Had a snack between 8pm - 10pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D608cSnack or GQV4_D708cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1618 and data derived into: gq_eat_snack1618_DER. Please request those variables instead.

Categorical

Drink only snack 8-10pm

Had a drink only snack between 8pm - 10pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D608dDrink or GQV4_D708dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1618 and data derived into: gq_eat_drink1618_DER. Please request those variables instead.

Categorical

Eating patterns: 10-12pm 09

Had a main meal between 10pm - 12am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D609aMain or GQV4_D709aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1820 and data derived into: gq_eat_main1820_DER. Please request those variables instead.

Categorical

Eating patterns: 10-12pm 09

Had a light meal between 10pm - 12am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D609bLight or GQV4_D709bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1820 and data derived into: gq_eat_light1820_DER. Please request those variables instead.

Categorical

Snack 10-12pm 09

Had a snack between 10pm - 12am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D609cSnack or GQV4_D709cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1820 and data derived into: gq_eat_snack1820_DER. Please request those variables instead.

Categorical

Drink only snack 10-12pm

Had a drink only snack between 10pm - 12am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D609dDrink or GQV4_D709dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1820 and data derived into: gq_eat_drink1820_DER. Please request those variables instead.

Categorical

Eating patterns: 0-2am 10

Had a main meal between 12am - 2am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D610aMain or GQV4_D710aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2022 and data derived into: gq_eat_main2022_DER. Please request those variables instead.

Categorical

Eating patterns: 0-2am 10

Had a light meal between 12am - 2am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D610bLight or GQV4_D710bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2022 and data derived into: gq_eat_light2022_DER. Please request those variables instead.

Categorical

Snack 0-2am 10

Had a snack between 12am - 2am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D610cSnack or GQV4_D710cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2022 and data derived into: gq_eat_snack2022_DER. Please request those variables instead.

Categorical

Drink only snack 0-2am

Had a drink only snack between 12am - 2am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D610dDrink or GQV4_D710dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2022 and data derived into: gq_eat_drink2022_DER. Please request those variables instead.

Categorical

Eating patterns: 2-4am 11

Had a main meal between 2am - 4am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D611aMain or GQV4_D711aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2224 and data derived into: gq_eat_main2224_DER. Please request those variables instead.

Categorical

Eating patterns: 2-4am 11

Had a light meal between 2am - 4am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D611bLight or GQV4_D711bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2224 and data derived into: gq_eat_light2224_DER. Please request those variables instead.

Categorical

Snack 2-4am 11

Had a snack between 2am - 4am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D611cSnack or GQV4_D711cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2224 and data derived into: gq_eat_snack2224_DER. Please request those variables instead.

Categorical

Drink only snack 2-4am

Had a drink only snack between 2am - 4am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D611dDrink or GQV4_D711dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2224 and data derived into: gq_eat_drink2224_DER. Please request those variables instead.

Categorical

Eating patterns: 4-6am 12

Had a main meal between 4am - 6am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D612aMain or GQV4_D712aMain. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2402 and data derived into: gq_eat_main2402_DER. Please request those variables instead.

Categorical

Eating patterns: 4-6am 12

Had a light meal between 4am - 6am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D612bLight or GQV4_D712bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2402 and data derived into: gq_eat_light2402_DER. Please request those variables instead.

Categorical

Snack 4-6am 12

Had a snack between 4am - 6am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D612cSnack or GQV4_D712cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2402 and data derived into: gq_eat_snack2402_DER. Please request those variables instead.

Categorical

Drink only snack 4-6am

Had a drink only snack between 4am - 6am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D612dDrink or GQV4_D712dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2402 and data derived into: gq_eat_drink2402_DER. Please request those variables instead.

Categorical

Frequency of eating Vegetables

During the course of last year how many times a week did you eat Medium serving of Vegetables (not including potatoes). This data is also captured with GQV1_D7aVeg. You should be given that data too. This data is not captured with GQV4.

Categorical

Frequency of eating Salad

During the course of last year how many times a week did you eat Medium serving of Salads. This data is also captured with GQV1_D7bSalad. You should request that data too. This data is not captured in GQV4.

Categorical

Frequency of eating Fruit

During the course of last year how many times a week did you eat Medium serving or 1 fruit of Fruit and fruit products (not including fruit juice). This data is also captured with GQV1_D7cFruit. You should request that data too. This data is not captured with GQV4.

Categorical

Frequency of eating Fish

During the course of last year how many times a week did you eat Medium serving of Fish and fish products. This data is also captured with GQV1_D7dFish. You should request that data too. This data is not captured in GQV4.

Categorical

Frequency of eating Meat

During the course of last year how many times a week did you eat Medium serving of Meat meat products and meat dishes (including bacon ham or chicken). This data is also captured with GQV1_D7eMeat. You should request that data too. This data is not captured with GQV4.

Categorical

Currently participating in special diets: Weight Watchers

Please tick to show if you are currently on a 'Weight Watchers' diet. This data is also captured with GQV1_D8aWW or GQV4_D8aWW. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_ww and data derived into: gq_diet_ww_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Slimmers world

Please tick to show if you are currently on a 'Slimmers World' diet. This data is also captured with GQV1_d8bSW or GQV4_D8bSW. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_slim and data derived into: gq_diet_slim_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Low fat

Please tick to show if you are currently on a low fat diet. This data is also captured with GQV1_D8cLFD or GQV4_D8cLFD. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_lowf and data derived into: gq_diet_lowf_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Low carb

Please tick to show if you are currently on a low carbohydrate diet eg Atkins Diet. This data is also captured with GQV1_D8dLCD or GQV4_D8dLCD. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_lowc and data derived into: gq_diet_lowc_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Vegetarian

Please tick to show if you are currently on a vegetarian diet. This data is also captured with GQV1_D8eVegetarian or GQV4_D8eVegetarian. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_veg and data derived into: gq_diet_veg_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Vegan

Please tick to show if you are currently on a a vegan diet. This data is also captured with GQV1_D8fVegan or GQV4_D8fVegan. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_vegan and data derived into: gq_diet_vegan_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Kosher

Please tick to show if you are currently on a Kosher diet. This data is also captured with GQV1_D8gKosher or GQV4_D8gKosher. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_kosh and data derived into: gq_diet_kosh_DER. Please request those variables instead.

Categorical

Currently participating in special diets: Halal

Please tick to show if you are currently on a Halal diet. This data is also captured with GQV1_D8hHalal or GQV4_D8hHalal. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_halal and data derived into: gq_diet_halal_DER. Please request those variables instead.

Categorical

Other diet

Currently on an other diet. Please describe. This data is also captured with GQV1_D8iOther or GQV4_D8iOther. You should request that data too.

Text

Health in last 4 weeks

Self perceived health status. Overall how would you rate your health during the past 4 weeks? This data is also captured with GQV4_E1SRHealth. You should be given that data too. This data is not captured in Gen Q V1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_health and data derived into: gq_selfr_health_DER. Please request those variables instead.

Categorical

Physical problems

Self perceived health status. During the past 4 weeks how much did physical health problems limit your usual physycal activities (walking climbing stairs)? This data is also captured with GQV4_E2SRPhysicalProblems. You should be given that data too. This data is not captured in GQV1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_pa and data derived into: gq_selfr_pa_DER. Please request those variables instead.

Categorical

Physical daily work

Self perceived health status. During the past 4 weeks how much difficulty did you have doing your daily work both inside and outside the home because of your physical health? This data is also captured with GQV4_E3SRPhysicalDailyWork. You should request that data too. This data is not captured in GQV1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_work and data derived into: gq_selfr_work_DER. Please request those variables instead.

Categorical

Bodily pain

Self perceived health status. How much bodily pain have you had during the past 4 weeks? This data is also captured with GQV4_E4SRBodilyPain. You should request that data too. This data is not captured in Gen Q V1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_pain and data derived into: gq_selfr_pain_DER. Please request those variables instead.

Categorical

Energy levels

Self perceived health status. During the past 4 weeks how much energy did you have? This data is also captured with GQV4_E5SREnergy. You should request that data too. This data is not captured in Gen Q V1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_energy and data derived into: gq_selfr_energy_DER. Please request those variables instead.

Categorical

Emotional social

Self perceived health status. During the past 4 weeks how much did your physical health or emotional problems limit your social activities with family or friends? This data is also captured with GQV4_E6SREmotionalSocial. You should request that data too All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_social and data derived into: gq_selfr_social_DER. Please request those variables instead.

Categorical

Emotional problems

Self perceived health status. During the past 4 weeks how much have you been bothered by emotional problems (such as feeling anxious depressed or irritable)? This data is also captured with GQV4_E7SREmotional. You should request that data too. This data is not captured on GQV1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_emot and data derived into: gq_selfr_emot_DER. Please request those variables instead.

Categorical

Emotional daily work

Self perceived health status. During the past 4 weeks how much did personal or emotional problems keep you from doing your usual work studies or other daily activities? This data is also captured with GQV4_E8SREmotionalDailyWork. You should request that data too. This data is not captured with GQV1. All phase 1 data from all 2 GenQs was merged into new variable: GQ_SelfR_emotwork and data derived into: gq_selfr_emotwork_DER. Please request those variables instead.

Categorical

Ethnic origin

Ethnic origin (from the UK Government 2001 census ethnicity classification). This data is also captured with GQV4_F1Ethnicity. You should request that data too. This data is not collected in GQV1 so not all people with have this data. All phase 1 data from all 2 GenQs was merged into new variable: GQ_eth and data derived into: gq_eth_DER. Please request those variables instead.

Categorical

Additional comments on gen questionnaire version2/3

GQV3 additional comments made on any page with page number and text. This data is also captured with GQV1_FSGQComments or GQV4_FSGQComments. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: FSGQComments_Updated . Please request those variables instead.

Text

Questionnaire version number

Version number of the questionnaire completed by participant. This data is also captured with GQV4_QVersion. You should be given that data too. This data is not captured in Gen Q V1. All phase 1 data from all GenQs was merged into new variable: GQ_v . Please request that variable instead.

Text

On medication

Are you taking any tablets or medicines at the moment? This data is also captured with GQV1_A1OnMedication or GQV3_A1OnMedication. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Meds and data derived into: gq_meds_DER. Please request those variables instead.

Categorical

Current Medication a BNF Code

BNF Code for medication a added by research team. This data is also captured with GQV1_A2aCurrentMedicationBNFCode or GQV3_A2aCurrentMedicationBNFCode. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_bnf_a . Please request those variables instead.

Text

Current Medication Dose

Dose of drug a. This data is also captured with GQV1_A2aCurrentMedicationDose or GQV3_A2aCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug a. This data is also captured with GQV1_A2aCurrentMedicationName or GQV3_A2aCurrentMedicationName. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_a and data derived into: gq_v_DER and into gq_med_?_DER where ? is asp; statin; lipid; acei; arb; betab; diuret; nitr; cardio; dm; depr; slp; can; gastro; bowel; nsaid; pain; painany; autoimm; inflamany; hrt; oc; infect; nutr; herb or any. Please request those variables instead.

Text

Current Medication Reason

Reason for taking the drug a. This data is also captured with GQV1_A2aCurrentMedicationReason or GQV3_A2aCurrentMedicationReason. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_why_a . Please request those variables instead.

Text

Current Medication b BNF Code

BNF Code for medication b added by research team. This data is also captured with GQV1_A2bCurrentMedicationBNFCode or GQV3_A2bCurrentMedicationBNFCode. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_bnf_b . Please request those variables instead.

Text

Current Medication Dose

Dose of drug b. This data is also captured with GQV1_A2bCurrentMedicationDose or GQV3_A2bCurrentMedicationDose. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_dose_b . Please request those variables instead.

Text

Current Medication Name

Name of drug b. This data is also captured with GQV1_A2bCurrentMedicationName or GQV3_A2bCurrentMedicationName. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_b . Please request those variables instead.

Text

Current Medication Reason

Reason for taking the drug b. This data is also captured with GQV1_A2bCurrentMedicationReason or GQV3_A2bCurrentMedicationReason. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Med_why_b . Please request those variables instead.

Text

Current Medication c BNF Code

BNF Code for medication c added by research team. This data is also captured with GQV1_A2cCurrentMedicationBNFCode or GQV3_A2cCurrentMedicationBNFCode. You should be given that data too.

Text

Current Medication Dose

Dose of drug c. This data is also captured with GQV1_A2cCurrentMedicationDose or GQV3_A2cCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug c. This data is also captured with GQV1_A2cCurrentMedicationName or GQV3_A2cCurrentMedicationName. You should be given that data too.

Text

Current Medication Reason

Reason for taking the drug c. This data is also captured with GQV1_A2cCurrentMedicationReason or GQV3_A2cCurrentMedicationReason. You should be given that data too.

Text

Current Medication d BNF Code

BNF Code for medication d added by research team. This data is also captured with GQV1_A2dCurrentMedicationBNFCode or GQV3_A2dCurrentMedicationBNFCode. You should be given that data too.

Text

Current Medication Dose

Dose of drug d. This data is also captured with GQV1_A2dCurrentMedicationDose or GQV3_A2dCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug d. This data is also captured with GQV1_A2dCurrentMedicationName or GQV3_A2dCurrentMedicationName. You should be given that data too.

Text

Current Medication Reason

Reason for taking the drug d. This data is also captured with GQV1_A2dCurrentMedicationReason or GQV3_A2dCurrentMedicationReason. You should be given that data too.

Text

Current Medication e BNF Code

BNF Code for medication e added by research team. This data is also captured with GQV1_A2eCurrentMedicationBNFCode or GQV3_A2eCurrentMedicationBNFCode. You should be given that data too.

Text

Current Medication Dose

Dose of drug e. This data is also captured with GQV1_A2eCurrentMedicationDose or GQV3_A2eCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug e. This data is also captured with GQV1_A2eCurrentMedicationName or GQV3_A2eCurrentMedicationName. You should be given that data too.

Text

Current Medication Reason

Reason for taking the drug e. This data is also captured with GQV1_A2eCurrentMedicationReason or GQV3_A2eCurrentMedicationReason. You should be given that data too.

Text

Current Medication f BNF Code

BNF Code for medication f added by research team. This data is also captured with GQV1_A2fCurrentMedicationBNFCode or GQV3_A2fCurrentMedicationBNFCode. You should be given that data too.

Text

Current Medication Dose

Dose of drug f. This data is also captured with GQV1_A2fCurrentMedicationDose or GQV3_A2fCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug f. This data is also captured with GQV1_A2fCurrentMedicationName or GQV3_A2fCurrentMedicationName. You should be given that data too.

Text

Current Medication Reason

Reason for taking the drug f. This data is also captured with GQV1_A2fCurrentMedicationReason or GQV3_A2fCurrentMedicationReason. You should be given that data too.

Text

Current Medication g BNF Code

BNF Code for medication g added by research team. This data is also captured with GQV1_A2gCurrentMedicationBNFCode or GQV3_A2gCurrentMedicationBNFCode. You should be given that data too.

Text

Current Medication Dose

Dose of drug g. This data is also captured with GQV1_A2gCurrentMedicationDose or GQV3_A2gCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug g. This data is also captured with GQV1_A2gCurrentMedicationName or GQV3_A2gCurrentMedicationName. You should be given that data too.

Text

Current Medication Reason

Reason for taking the drug g. This data is also captured with GQV1_A2gCurrentMedicationReason or GQV3_A2gCurrentMedicationReason. You should be given that data too.

Text

Current Medication h BNF Code

BNF Code for medication h added by research team. This data is also captured with GQV1_A2hCurrentMedicationBNFCode or GQV3_A2hCurrentMedicationBNFCode. You should be given that data too.

Text

Current Medication Dose

Dose of drug h. This data is also captured with GQV1_A2hCurrentMedicationDose or GQV3_A2hCurrentMedicationDose. You should be given that data too.

Text

Current Medication Name

Name of drug h. This data is also captured with GQV1_A2hCurrentMedicationName or GQV3_A2hCurrentMedicationName. You should be given that data too.

Text

Current Medication Reason

Reason for taking the drug h. This data is also captured with GQV1_A2hCurrentMedicationReason or GQV3_A2hCurrentMedicationReason. You should be given that data too.

Text

Birth weight imperial

What was your weight at birth in pounds and ounces. This data is also captured with GQV1_A4aBirthWeight and GQV1_A4bBirthWeightUnits and GQV3_A3aBirthWeightImperial. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_BWt_imperial . Please request those variables instead.

Real

Birth weight metric

What was your weight at birth? Birth weight in kilograms. This data is also captured with GQV1_A4aBirthWeight and GQV1_A4bBirthWeightUnits and GQV3_A3bBirthWeightMetric. You should request that data too.All phase 1 data from 2 GenQs was merged into new variable: GQ_BWt_metric . Please request those variables instead.

Real

Unknown birth weight

Tick if you are not able to give your birth weight. This data is also captured with GQV1_A4cBirthWeightUnknown or GQV3_A3cBirthWeightUnknown. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_BWt_unknown. Please request those variables instead.

Categorical

Term of birth

When were you born (pre post or at term). This data is also captured with GQV1_A4dBorn or GQV3_A4aBorn. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Bterm and data derived into: gq_bterm_DER. Please request those variables instead.

Categorical

Dr reported heart trouble

Has your doctor ever told you that you have heart trouble? This data is also captured with GQV1_A5aDrReportHeartTrouble or GQV3_A5aDrReportHeartTrouble. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Htn_dr and data derived into: gq_htn_dr_DER. Please request those variables instead.

Categorical

Chest pain ever

Have you ever had any pain or discomfort in your chest? If no proceed to question 7. If yes please answer the next question. This data is also captured with GQV1_A5bChestPain or GQV3_A5bChestPain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_dr and data derived into: gq_chestpain_dr_DER. Please request those variables instead.

Categorical

Chest discomfort from walking uphill

Do you experience pain or chest discomfort when you walk uphill or hurry? This data is also captured with GQV1_A5cChestPainUphill or GQV3_A5cChestPainUphill. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_uphill and data derived into: gq_chestpain_uphill_DER. Please request those variables instead.

Categorical

Chest discomfort from walking

Do you experience pain or chest discomfort when you walk at an ordinary pace on the level? This data is also captured with GQV1_A5dChestPainNormalPace or GQV3_A5dChestPainNormalPace. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_normal and data derived into: gq_chestpain_normal_DER. Please request those variables instead.

Categorical

Action taken when experience chest discomfort from walking

What do you do if you experience pain or chest discomfort while walking? This data is also captured with GQV1_A5eActionWhenChestDiscomfort or GQV3_A5eActionWhenChestDiscomfort. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_action and data derived into: gq_chestpain_action_DER. Please request those variables instead.

Categorical

Chest discomfort after stopping

If you stand still what happens to pain or chest discomfort? This data is also captured with GQV1_A5fChestDiscomfortAfterStopping or GQV3_A5fChestDiscomfortAfterStopping. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_ChestPain_stop and data derived into: gq_chestpain_stop_DER. Please request those variables instead.

Categorical

Feel faint or dizzy

Do you often feel faint or have spells of severe dizziness? This data is also captured with GQV1_A5gFeelFaint or GQV3_A5gFeelFaint. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_FeelFaint and data derived into: gq_feelfaint_DER. Please request those variables instead.

Categorical

Dr reported high blood pressure

Has a doctor ever told you that your blood pressure was too high? This data is also captured with GQV1_A5hDrReportBPHigh or GQV3_A5hDrReportBPHigh. You should be given that data too.

Categorical

Treatment for high blood pressure

If you have been told that your blood pressure was too high are you now on treatment? This data is also captured with GQV1_A5iTreatmentHighBP or GQV3_A5iTreatmentHighBP. You should be given that data too.

Categorical

Bone problems worse by exercise

Has your doctor ever told you that you have a bone or joint problem such as arthritis that has been aggravated by exercise or might be made worse by exercise? This data is also captured with GQV1_A5jBoneProblemsAggravatedByExercise or GQV3_A5jBoneProblems All phase 1 data from all 3 GenQs was merged into new variable: GQ_Bone_exercise and data derived into: gq_bone_exercise_DER. Please request those variables instead.

Categorical

Pregnancy status

Are you pregnant? This data is also captured with GQV1_A5kPregnant or GQV3_A5kPregnant. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Preg and data derived into: gq_preg_DER. Please request those variables instead.

Categorical

Any reason not to do PA

Is there any reason you know of that means you should not follow an activity programme even if you wanted to? Yes / No. This data is also captured with GQV1_A5lReasonNotToDoPA or GQV3_A5lReasonNotToDoPA. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_PA_reason and data derived into: gq_pa_reason_DER. Please request those variables instead.

Categorical

Age first menstruation

How old were you when you had your first menstrual period (in years)? This data is also captured with GQV3_A6AgeFirstMenstralPeriod. You should be given that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Menstr_age and data derived into: gq_menstr_age_DER. Please request those variables instead.

Real

Still menstruating

Are you still having menstrual periods? This data is also captured with GQV3_A7aStillHaveMenstrualPeriods. You should be given that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Menstr_still and data derived into: gq_menstr_still_DER. Please request those variables instead.

Categorical

Age menstruation stopped

If NO how old were you when you stopped having your periods (i.e. your age at menopause in years old)? This data is also captured with GQV3_A7bAgePeriodsStopped. You should be given that data too. All phase 1 data from2 GenQs was merged into new variable: GQ_Meno_age and data derived into: gq_meno_age_DER. Please request those variables instead.

Real

Ever smoked

Have you ever smoked? If no please go to B2 on the next page. This data is also captured with GQV1_B1cEverSmoked or GQV3_B1aEverSmoked. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_ever and data derived into: gq_sm_ever_DER. Please request those variables instead.

Categorical

Smoke now

Do you smoke now? This data is also captured with GQV3_B1bCurrentlySmoke. You should be given that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Sm_cur and data derived into: gq_sm_cur_DER. Please request those variables instead.

Categorical

Age started smoking

At what age did you start smoking? Please enter age in years. This data is also captured with GQV3_B1cAgeStartSmoking. You should be given that data too. Data not collected in GQV1. All phase 1 data from 2 GenQs was merged into new variable: GQ_Sm_agestart and data derived into: gq_sm_agestart_DER. Please request those variables instead.

Real

Year stopped smoking

If you have stopped smoking in which year did you quit. This data is also captured with GQV1_B1dEverSmokedYearQuit or GQV3_B1dYearQuit. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_yearstop and data derived into: gq_sm_yearstop_DER. Please request those variables instead.

Text

Number of cigarettes per day

How many cigarettes do you or did you smoke a day on average? This data is also captured with GQV1_B1eNumberCigarettesPerDay or GQV3_B1eNumberCigarettesPerDay. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Integer

Number of cheroots smoked per day

How many cheroots do you or did you smoke a day on average? This data is also captured with GQV1_B1fNumberCherootsPerDay or GQV3_B1fNumberCherootsPerDay. You should be given that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5 All phase 1 data from all 3 GenQs was merged into new variable: GQ_Sm_Ncheroots and data derived into: gq_sm_ncheroots_DER. Please request those variables instead.

Categorical

How many cigars smoked per day

How many cigars do you or did you smoke a day on average? This data is also captured with GQV1_B1gNumberCigarsPerDay or GQV3_B1gNumberCigarsPerDay. You should be given that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Integer

Grams of tobacco per week

How much do you or did you smoke a day on average? Amount of tobacco in grams in a week. This data is also captured with GQV1_B1hTobaccoPerWeek or GQV3_B1hTobaccoPerWeek. You should request that data too. Note that if a decimal was provided by the participant data entry was asked to round it down if <0.5 and round up if >=0.5

Real

Ever drink alcohol

Do you EVER drink alcohol? If you answered no please go to section C on the next page. This question was only asked in GenQ version 4. Therefore not all participants will have this data. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_ever and data derived into: gq_alc_ever_DER; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink every day

Do you usually drink every day? This data is also captured with GQV3_B2bDrinkDaily. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_everyday ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink almost every day

Do you usually drink almost every day? This data is also captured with GQV3_B2cDrinkMostDays. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_almostday ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink 3-4 times per week

Do you usually drink 3-4 times per week This data is also captured with GQV3_B2dDrink3-4TimesPerWeek. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_3to4perwk ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink 1-2 times per week

Do you usually drink 1-2 times per week This data is also captured with GQV3_B2eDrink1-2TimesPerWeek. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_1to2perwk ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink once per fortnight

Do you usually drink once per fortnight? This data is also captured with GQV3_B2fDrinkPerFortnight. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_1per14days ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink 1 times per month

Do you usually drink once per month? This data is also captured with GQV3_B2gDrinkPerMonth. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_1permth ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Drink less then 1 times per month

Do you usually drink less often This data is also captured with GQV3_B2hDrinkLessOncePerMonth. You should request that data too. All phase 1 data from 2 GenQs was merged into new variable: GQ_Alc_less1permth ; gq_alc_freq_DER and gq_alc_freqc_DER. Please request those variables instead.

Categorical

Units of beer per week

How many units of beer lager or cider do you consume in an average week? This data is also captured with GQV1_B2aUnitsBeerPerWk or GQV3_B3aUnitsBeerPerWk. You should request that data too.

Categorical

Units of wine per week

How many units of wine do you consume in an average week? This data is also captured with GQV1_B2bUnitsWinePerWk or GQV3_B3bUnitsWinePerWk. You should request that data too.

Categorical

Units of spirits per week

How many units of spirits do you consume in an average week? This data is also captured with GQV1_B2cUnitsSpiritsPerWk or GQV3_B3cUnitsSpiritsPerWk. You should request that data too.

Categorical

Units of fortified wine per week

How many units of Fortified wine (sherry Cinzano Campari) do you consume in an average week? This data is also captured with GQV1_B2dUnitsFortWinePerWk or GQV3_B4dUnitsFortWinePerWk. You should request that data too.

Categorical

Own a car or van

Do you own a car or van ? This data is also captured with GQV1_DMC5aCars or GQV3_C10Cars (with slightly different wording). You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Owncars and data derived into: gq_owncars_DER. Please request those variables instead.

Categorical

Own house

Do you own or are you buying your own home? This data is also captured with GQV1_DMC5bOwnHouse or GQV3_C11aOwnHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Ownhouse and data derived into: gq_ownhouse_DER. Please request those variables instead.

Categorical

Rent house

Do you rent your home? This data is also captured with GQV1_DMC5cRenHouse or GQV3_C11bRentHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Renthouse and data derived into: gq_renthouse_DER. Please request those variables instead.

Categorical

Marital status

What is your marital status? This data is also captured with GQV3_C12MaritalStatus. You should request that data too. Not asked in GQV1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Marit and data derived into: gq_marit_DER. Please request those variables instead.

Categorical

Full time work status

What is your current work status? In work full time i.e. more than 30 hours per week. This data is also captured with GQV1_DMC1aFullTime or GQV3_C1aFullTime. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_full and data derived into: gq_job_full_DER. Please request those variables instead.2 = yes

Categorical

Part time work status

What is your current work status? Part time work i.e. less than 30 hours per week. This data is also captured with GQV1_DMC1bPartTime or GQV3_C1bPartTime. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_part and data derived into: gq_job_part_DER. Please request those variables instead.2 = yes

Categorical

Keeping house work status

What is your current work status? Keeping house. This data is also captured with GQV1_DMC1cKeepingHouse or GQV3_C1cKeepingHouse. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_house and data derived into: gq_job_house_DER. Please request those variables instead.2 = yes

Categorical

Retired work status

What is your current work status? Wholly retired from work. This data is also captured with GQV1_DMC1dRetired or GQV3_C1dRetired. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_retired and data derived into: gq_job_retired_DER. Please request those variables instead.2 = yes

Categorical

Obtained new job work status

What is your current work status? Waiting to start a new job already obtained. This data is also captured with GQV1_DMC1eObtainedNewJob or GQV3_C1eObtainedNewJob. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_newjob and data derived into: gq_job_newjob_DER. Please request those variables instead.2 = yes

Categorical

Unemployed work status

What is your current work status? Unemployed and looking for work. This data is also captured with GQV1_DMC1fUnemployed or GQV3_C1fUnemployed. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_unempl and data derived into: gq_job_unempl_DER. Please request those variables instead.2 = yes

Categorical

Temporarily sick work status

What is your current work status? Out of work as temporarily sick. This data is also captured with GQV1_DMC1gTempSick or GQV3_C1gTempSick. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_tempsick and data derived into: gq_job_tempsick_DER. Please request those variables instead.2 = yes

Categorical

Permanently sick work status

What is your current work status? Permanently sick or disabled. This data is also captured with GQV1_DMC1hPermSick or GQV3_C1hPermSick. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_sick and data derived into: gq_job_sick_DER. Please request those variables instead.2 = yes

Categorical

Work status other

What is your current work status? If other please specify. This data is also captured with GQV1_DMC1iOther or GQV3_C1iOther. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Job_oth and data derived into: gq_job_oth_DER. Please request those variables instead.

Text

Employment type with employee data

Present or your last job: Employee or self-employed - Do (did) you work as an employee or are (were) you self-employed? This data is also captured with GQV1_DMC2dEmployeeType (though answers mean different things) or GQV3_C2EmployeeType. You should reques All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_type and data derived into: gq_emp_type_DER. Please request those variables instead.

Categorical

Number of people employed

Present or your last job: Number of employees. For employees: indicate below how many people work (worked) for your employer at the place where you work (worked). For self-employed: indicate below how many people you employ(ed). This data is also captured with GQV3_C3NumberPeopleEmployed. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_n and data derived into: gq_emp_n_DER. Please request those variables instead.

Categorical

Supervisory status without numbers

Present or your last job: Supervisory status: Do (did) you supervise any other employees. This data is is also captured with GQV1_DMC2eSupervisoryStatus (though that captures numbers too) and GQV3_C4SupervisoryStatus. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Emp_supervise and data derived into: gq_emp_supervise_DER. Please request those variables instead.

Categorical

Occupation type

Occupation type: Current work or last job.This data is also captured with GQV3_C5Occupation (but not in GQV1). You should request that data too.

Categorical

School Leaving Certificate

Do you have any of the following qualifications? (tick all applicable). School Leaving certificate. This data is also captured with GQV1_DMC4aSLC or GQV3_C6aSLC. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_SLC and data derived into: gq_edu_slc_DER. Please request those variables instead.

Categorical

CSE qualification

Do you have any of the following qualifications? (tick all applicable). CSE. This data is also captured with GQV1_DMC4bCSE or GQV3_C6bCSE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_CSE and data derived into: gq_edu_cse_DER. Please request those variables instead.

Categorical

O level or GCSE qualification

Do you have any of the following qualifications? (tick all applicable). GCE O level or GCSE. This data is also captured with GQV1_DMC4cGCSE or GQV3_C6cGCSE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_GCSE and data derived into: gq_edu_gcse_DER. Please request those variables instead.

Categorical

Matriculation qualification

Do you have any of the following qualifications? (tick all applicable). Matriculation. This data is also captured with GQV1_DMC4dMatriculation or GQV3_C6dMatriculation. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_matricul and data derived into: gq_edu_matricul_DER. Please request those variables instead.

Categorical

A level qualification

Do you have any of the following qualifications? (tick all applicable). GCE A Level AS level Highers This data is also captured with GQV1_DMc4eALevels or GQV3_C6eALevels. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_Alev and data derived into: gq_edu_alev_DER. Please request those variables instead.

Categorical

Technical or C&G qualification

Do you have any of the following qualifications? (tick all applicable). Technical College exams City & Guilds. This data is also captured with GQV1_DMC4fC_G or GQV3_C6fC_G. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_TechCG and data derived into: gq_edu_techcg_DER. Please request those variables instead.

Categorical

HND or GNVQ qualification

Do you have any of the following qualifications? (tick all applicable). HND or GNVQ. This data is also captured with GQV1_DMC4gHND or GQV3_C6gHND_NVQ. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HND_NVQ and data derived into: gq_edu_hnd_nvq_DER. Please request those variables instead.

Categorical

Completed apprenticeship

Do you have any of the following qualifications? (tick all applicable). Completed Apprenticeship. This data is also captured with GQV1_DMC4hApprenticeship or GQV3_C6hApprenticeship. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_apprentice and data derived into: gq_edu_apprentice_DER. Please request those variables instead.

Categorical

Secretarial College qualification

Do you have any of the following qualifications? (tick all applicable). Secretarial College Exams. This data is also captured with GQV1_DMC4iSecretarial or GQV3_C6iSecretarial. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_secret and data derived into: gq_edu_secret_DER. Please request those variables instead.

Categorical

HNC or NVQ qualification

Do you have any of the following qualifications? (tick all applicable). Teaching Diploma HNC NVQ. This data is also captured with GQV1_DMC4jHMC or GQV3_C6jHNC. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HNC and data derived into: gq_edu_hnc_DER. Please request those variables instead.

Categorical

University degree qualification

Do you have any of the following qualifications? (tick all applicable). University Degree. This data is also captured with GQV1_DMC4kDegree or GQV3_C6kDegree. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_degree and data derived into: gq_edu_degree_DER. Please request those variables instead.

Categorical

Trade certificate qualification

Do you have any of the following qualifications? (tick all applicable). Trade Certificates. This data is also captured with GQV1_DMC4lTradeCertificate or GQV3_C6lTradeCertificate. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_trade and data derived into: gq_edu_trade_DER. Please request those variables instead.

Categorical

Other qualifications

Do you have any of the following qualifications? (tick all applicable). Other please describe. This data is also captured with GQV1_DMC4mOther or GQV3_C6mOther. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_others and data derived into: gq_edu_others_DER. Please request those variables instead.

Text

No Qualifications

Do you have any of the following qualifications? (tick all applicable). None. This data is also captured with GQV1_DMC4nNone or GQV3_C6nNone. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_none and data derived into: gq_edu_none_DER. Please request those variables instead.

Categorical

Age finished full time education

At what age did you finish full time education (in years)? This data is also captured with GQV1_DMC42aAgeEndFTE or GQV3_C7AgeEndFTE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_age and data derived into: gq_edu_age_DER. Please request those variables instead.

Real

Household income

What is your total combined household income? This data is also captured with GQV1_DMC3HouseholdIncome (slightly different wording) or GQV3_C8HouseholdIncome. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Income and data derived into: gq_income_DER. Please request those variables instead.

Categorical

Number of people in household

How many people are there in your household? (including children). This data is also captured with GQV3_C9NumberInHouse. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Nhouse and data derived into: gq_nhouse_DER. Please request those variables instead.

Integer

How often eat breakfast

How often do you usually eat breakfast? Please tick the box which is most true. This data is also captured with GQV1_D1EatBreakfast or GQV3_D1EatBreakfast. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Breakfast and data derived into: gq_breakfast_DER. Please request those variables instead.

Categorical

How often eat take-away

When eating your main meal at home how often do you usually eat Home delivery or take-away meals. This data is also captured with GQV1_D2aEatTakeaways or GQV3_D2aEatTakeaways. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Takeaway and data derived into: gq_takeaway_DER. Please request those variables instead.

Categorical

How often eat ready meals

When eating your main meal at home how often do you usually eat Ready-made meals/prepared foods. This data is also captured with GQV1_D2bEatReadyMeals or GQV3_D2bEatReadyMeals. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Readymeals and data derived into: gq_readymeals_DER. Please request those variables instead.

Categorical

How often eat home cooked meals

When eating your main meal at home how often do you usually eat Home cooked meals. This data is also captured with GQV1_D2cEatHomeCookedMeals or GQV3_D2cEatHomeCookedMeals. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Homecooked and data derived into: gq_homecooked_DER. Please request those variables instead.

Categorical

How often eat out

On average how often do you eat a meal outside of the home (restaurants pubs fast-food outlets etc)? This data is also captured with GQV1_D3EatOut or GQV3_D3EatOut. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eatout and data derived into: gq_eatout_DER. Please request those variables instead.

Categorical

Meal while watching TV

How often do you eat your meal while watching television or video? This data is also captured with GQV1_D4EatAndWatchTV or GQV3_D4EatAndWatchTV. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_eat and data derived into: gq_tv_eat_DER. Please request those variables instead.

Categorical

Snack foods while watching TV

Apart from meals how often do you snack foods while watching television? This data is also captured with GQV1_D5SnackAndWatchTV or GQV3_D5SnackAndWatchTV. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_snack and data derived into: gq_tv_snack_DER. Please request those variables instead.

Categorical

Savoury snacks while watching TV

How often did you have savoury snacks (crisps salted nuts -) while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_savory and data derived into: gq_tv_savory_DER. Please request those variables instead.

Categorical

Sweets while watching TV

How often did you have Sweets chocolate(s) (bars) cakes biscuits while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_swts and data derived into: gq_tv_swts_DER. Please request those variables instead.

Categorical

Ice cream while watching TV

How often did you have Ice cream chocolate mousse while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_icecream and data derived into: gq_tv_icecream_DER. Please request those variables instead.

Categorical

Yoghurt while watching TV

How often did you have Yoghurt rice pudding while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_yoghurt and data derived into: gq_tv_yoghurt_DER. Please request those variables instead.

Categorical

Soda or coke while watching TV

How often did you have Soda (coke -) while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_soda and data derived into: gq_tv_soda_DER. Please request those variables instead.

Categorical

How often drink alcohol while watching TV

How often drink alcohol while watching TV (last 4 weeks) All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_alc and data derived into: gq_tv_alc_DER. Please request those variables instead.

Categorical

Fruit juice while watching TV

How often did you have Fruit juice while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_frjuice and data derived into: gq_tv_frjuice_DER. Please request those variables instead.

Categorical

Squash while watching TV

How often did you have squash while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_squash and data derived into: gq_tv_squash_DER. Please request those variables instead.

Categorical

Milk while watching TV

How often did you have Milk milkshake hot chocolate while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_milk and data derived into: gq_tv_milk_DER. Please request those variables instead.

Categorical

Tea or coffee while watching TV

How often did you have tea or coffeewhile watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_teacoffee and data derived into: gq_tv_teacoffee_DER. Please request those variables instead.

Categorical

Other snacks while watching TV

How often did you have other (please list) snacks while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_TV_others and data derived into: gq_tv_others_DER. Please request those variables instead.

Categorical

Other snacks while watching TV text

Which other (please list) snacks did you have while watching TV in addition to breakfast lunch or dinner (last 4 weeks) . This question was only asked in GQV4 so not all participants will have this data. New variable GQ_TV_others_txt now available which should be requested instead.

Text

Main meal 6-8am

Had a main meal between 6am - 8am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D601aMain or GQV3_D601aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0204 and data derived into: gq_eat_main0204_DER. Please request those variables instead.

Categorical

Light meal 6-8am

Had a light meal between 6am - 8am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D601bLight or GQV3_D601bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0204 and data derived into: gq_eat_light0204_DER. Please request those variables instead.

Categorical

Snack 6-8am

Had a snack between 6am - 8am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D601cSnack or GQV3_D601cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0204 and data derived into: gq_eat_snack0204_DER. Please request those variables instead.

Categorical

Drink only snack 6-8am

Had a drink only snack between 6am - 8am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D601dDrink or GQV3_D601dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0204 and data derived into: gq_eat_drink0204_DER. Please request those variables instead.

Categorical

Main meal 8-10am

Had a main meal between 8am - 10am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D602aMain or GQV3_D602aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0406 and data derived into: gq_eat_main0406_DER. Please request those variables instead.

Categorical

Light meal 8-10am

Had a light meal between 8am - 10am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D602bLight or GQV3_D602bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0406 and data derived into: gq_eat_light0406_DER. Please request those variables instead.

Categorical

Snack 8-10am

Had a snack between 8am - 10am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D602cSnack or GQV3_D602cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0406 and data derived into: gq_eat_snack0406_DER. Please request those variables instead.

Categorical

Drink only snack 8-10am

Had a drink only snack between 8am - 10am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D602dDrink or GQV3_D602dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0406 and data derived into: gq_eat_drink0406_DER. Please request those variables instead.

Categorical

Main meal 10am-12pm

Had a main meal between 10am - 12pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D603aMain or GQV3_D603aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0608 and data derived into: gq_eat_main0608_DER. Please request those variables instead.

Categorical

Light meal 10am-12pm

Had a light meal between 10am - 12pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D603bLight or GQV3_D603bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0608 and data derived into: gq_eat_light0608_DER. Please request those variables instead.

Categorical

Snack 10am-12pm

Had a snack between 10am - 12pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D603cSnack or GQV3_D603cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0608 and data derived into: gq_eat_snack0608_DER. Please request those variables instead.

Categorical

Drink only snack 10am-12pm

Had a drink only snack between 10am - 12pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D603dDrink or GQV3_D603dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0608 and data derived into: gq_eat_drink0608_DER. Please request those variables instead.

Categorical

Main meal 12-2pm

Had a main meal between 12pm - 2pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D604aMain or GQV3_D604aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0810 and data derived into: gq_eat_main0810_DER. Please request those variables instead.

Categorical

Light meal 12-2pm

Had a light meal between 12pm -2pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D604bLight or GQV3_D604bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0810 and data derived into: gq_eat_light0810_DER. Please request those variables instead.

Categorical

Snack 12-2pm

Had a snack between 12pm - 2pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D604cSnack or GQV3_D604cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0810 and data derived into: gq_eat_snack0810_DER. Please request those variables instead.

Categorical

Drink only snack 12-2pm

Had a drink only snack between 12pm - 2pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D604dDrink or GQV3_D604dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0810 and data derived into: gq_eat_drink0810_DER. Please request those variables instead.

Categorical

Main meal 2-4pm

Had a main meal between 2pm - 4pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D605aMain or GQV3_D605aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1012 and data derived into: gq_eat_main1012_DER. Please request those variables instead.

Categorical

Light meal 2-4pm

Had a light meal between 2pm - 4pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D605bLight or GQV3_D605bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1012 and data derived into: gq_eat_light1012_DER. Please request those variables instead.

Categorical

Snack 2-4pm

Had a snack between 2pm - 4pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D605cSnack or GQV3_D605cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1012 and data derived into: gq_eat_snack1012_DER. Please request those variables instead.

Categorical

Drink only snack 2-4pm

Had a drink only snack between 2pm - 4pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D605dDrink or GQV3_D605dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1012 and data derived into: gq_eat_drink1012_DER. Please request those variables instead.

Categorical

Main meal 4-6pm

Had a main meal between 4pm - 6pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D606aMain or GQV3_D606aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1214 and data derived into: gq_eat_main1214_DER. Please request those variables instead.

Categorical

Light meal 4-6pm

Had a light meal between 4pm - 6pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D606bLight or GQV3_D606bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1214 and data derived into: gq_eat_light1214_DER. Please request those variables instead.

Categorical

Snack 4-6pm

Had a snack between 4pm - 6pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D606cSnack or GQV3_D606cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1214 and data derived into: gq_eat_snack1214_DER. Please request those variables instead.

Categorical

Drink only snack 4-6pm

Had a drink only snack between 4pm - 6pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D606dDrink or GQV3_D606dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1214 and data derived into: gq_eat_drink1214_DER. Please request those variables instead.

Categorical

Main meal 6-8pm

Had a main meal between 6pm - 8pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D607aMain or GQV3_D607aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1416 and data derived into: gq_eat_main1416_DER. Please request those variables instead.

Categorical

Light meal 6-8pm

Had a light meal between 6pm - 8pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D607bLight or GQV3_D607bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1416 and data derived into: gq_eat_light1416_DER. Please request those variables instead.

Categorical

Snack 6-8pm

Had a snack between 6pm - 8pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D607cSnack or GQV3_D607cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1416 and data derived into: gq_eat_snack1416_DER. Please request those variables instead.

Categorical

Drink only snack 6-8pm

Had a drink only snack between 6pm - 8pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D607dDrink or GQV3_D607dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1416 and data derived into: gq_eat_drink1416_DER. Please request those variables instead.

Categorical

Main meal 8-10pm

Had a main meal between 8pm - 10pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D608aMain or GQV3_D608aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1618 and data derived into: gq_eat_main1618_DER. Please request those variables instead.

Categorical

Light meal 8-10pm

Had a light meal between 8pm - 10pm E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D608bLight or GQV3_D608bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1618 and data derived into: gq_eat_light1618_DER. Please request those variables instead.

Categorical

Snack 8-10pm

Had a snack between 8pm - 10pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D608cSnack or GQV3_D608cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1618 and data derived into: gq_eat_snack1618_DER. Please request those variables instead.

Categorical

Drink only snack 8-10pm

Had a drink only snack between 8pm - 10pm E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D608dDrink or GQV3_D608dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1618 and data derived into: gq_eat_drink1618_DER. Please request those variables instead.

Categorical

Main meal 10pm-12am

Had a main meal between 10pm - 12am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D609aMain or GQV3_D609aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1820 and data derived into: gq_eat_main1820_DER. Please request those variables instead.

Categorical

Light meal 10pm-12am

Had a light meal between 10pm - 12am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D609bLight or GQV3_D609bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1820 and data derived into: gq_eat_light1820_DER. Please request those variables instead.

Categorical

Snack 10pm-12am

Had a snack between 10pm - 12am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D609cSnack or GQV3_D609cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1820 and data derived into: gq_eat_snack1820_DER. Please request those variables instead.

Categorical

Drink only snack 10pm-12am

Had a drink only snack between 10pm - 12am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D609dDrink or GQV3_D609dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1820 and data derived into: gq_eat_drink1820_DER. Please request those variables instead.

Categorical

Main meal 0-2am

Had a main meal between 12am - 2am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D610aMain or GQV3_D610aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2022 and data derived into: gq_eat_main2022_DER. Please request those variables instead.

Categorical

Light meal 0-2am

Had a light meal between 12am - 2am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D610bLight or GQV3_D610bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2022 and data derived into: gq_eat_light2022_DER. Please request those variables instead.

Categorical

Snack 0-2am

Had a snack between 12am - 2am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D610cSnack or GQV3_D610cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2022 and data derived into: gq_eat_snack2022_DER. Please request those variables instead.

Categorical

Drink only snack 0-2am

Had a drink only snack between 12am - 2am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D610dDrink or GQV3_D610dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2022 and data derived into: gq_eat_drink2022_DER. Please request those variables instead.

Categorical

Main meal 2-4am

Had a main meal between 2am - 4am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D611aMain or GQV3_D611aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2224 and data derived into: gq_eat_main2224_DER. Please request those variables instead.

Categorical

Light meal 2-4am

Had a light meal between 2am - 4am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D611bLight or GQV3_D611bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2224 and data derived into: gq_eat_light2224_DER. Please request those variables instead.

Categorical

Snack 2-4am

Had a snack between 2am - 4am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D611cSnack or GQV3_D611cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2224 and data derived into: gq_eat_snack2224_DER. Please request those variables instead.

Categorical

Drink only snack 2-4am

Had a drink only snack between 2am - 4am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D611dDrink or GQV3_D611dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2224 and data derived into: gq_eat_drink2224_DER. Please request those variables instead.

Categorical

Main meal 4-6am

Had a main meal between 4am - 6am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast This data is also captured with GQV1_D612aMain or GQV3_D612aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2402 and data derived into: gq_eat_main2402_DER. Please request those variables instead.

Categorical

Light meal 4-6am

Had a light meal between 4am - 6am E.g. porridge cereal toast sandwiches soup salad omelette This data is also captured with GQV1_D612bLight or GQV3_D612bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2402 and data derived into: gq_eat_light2402_DER. Please request those variables instead.

Categorical

Snack 4-6am

Had a snack between 4am - 6am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream This data is also captured with GQV1_D612cSnack or GQV3_D612cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2402 and data derived into: gq_eat_snack2402_DER. Please request those variables instead.

Categorical

Drink only snack 4-6am

Had a drink only snack between 4am - 6am E.g. drinks with some milk or sugar in; not low calorie drinks or water This data is also captured with GQV1_D612dDrink or GQV3_D612dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2402 and data derived into: gq_eat_drink2402_DER. Please request those variables instead.

Categorical

Weight Watchers' diet

Currently on a 'Weight Watchers' diet. This data is also captured with GQV1_D8aWW or GQV3_D8aWW. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_ww and data derived into: gq_diet_ww_DER. Please request those variables instead.

Categorical

Slimmers World' diet

Currently on a 'Slimmers World' diet. This data is also captured with GQV1_d8bSW or GQV3_D8bSW. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_slim and data derived into: gq_diet_slim_DER. Please request those variables instead.

Categorical

Low fat diet

Currently on a low fat diet. This data is also captured with GQV1_D8cLFD or GQV3_D8cLFD. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_lowf and data derived into: gq_diet_lowf_DER. Please request those variables instead.

Categorical

Low carbohydrate diet

Currently on a low carbohydrate diet eg Atkins Diet. This data is also captured with GQV1_D8dLCD or GQV3_D8dLCD. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_lowc and data derived into: gq_diet_lowc_DER. Please request those variables instead.

Categorical

Vegetarian diet

Currently on a vegetarian diet. This data is also captured with GQV1_D8eVegetarian or GQV3_D8eVegetarian. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_veg and data derived into: gq_diet_veg_DER. Please request those variables instead.

Categorical

Vegan diet

Currently on a vegan diet. This data is also captured with GQV1_D8fVegan or GQV3_D8fVegan. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_vegan and data derived into: gq_diet_vegan_DER. Please request those variables instead.

Categorical

Kosher diet

Currently on a Kosher diet. This data is also captured with GQV1_D8gKosher or GQV3_D8gKosher. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_kosh and data derived into: gq_diet_kosh_DER. Please request those variables instead.

Categorical

Halal diet

Currently on a Halal diet. This data is also captured with GQV1_D8hHalal or GQV3_D8hHalal. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Diet_halal and data derived into: gq_diet_halal_DER. Please request those variables instead.

Categorical

Other diet

Currently on an other diet. Please describe. This data is also captured with GQV1_D8iOther or GQV3_D8iOther. You should request that data too.

Text

articipant body outline at age 10

Nine diagrams depicting participant body outline at age 10. Tick best matching one. This question was only asked in GenQ version 4. Therefore not all participants will have this data. Data was merged into new variable: GQ_BodImg_y10 and data derived into: gq_bodimg_y10_DER. Please request those variables instead.

Categorical

Participant body outline at age 20

Nine diagrams depicting participant body outline at age 20. Tick best matching one. This question was only asked in GenQ version 4. Therefore not all participants will have this data. Data was merged into new variable: GQ_BodImg_y20 and data derived into: gq_bodimg_y20_DER. Please request those variables instead.

Categorical

Participant body outline at age 30

Nine diagrams depicting participant body outline at age 30. Tick best matching one. This question was only asked in GenQ version 4. Therefore not all participants will have this data. Data was merged into new variable: GQ_BodImg_y30 and data derived into: gq_bodimg_y30_DER. Please request those variables instead.

Categorical

Participant body outline at age 40

Nine diagrams depicting participant body outline at age 40. Tick best matching one. This question was only asked in GenQ version 4. Therefore not all participants will have this data. Data was merged into new variable: GQ_BodImg_y40 and data derived into: gq_bodimg_y40_DER. Please request those variables instead.

Categorical

Participant body outline currently

Nine diagrams depicting participant body outline you currently. Tick best matching one. This question was only asked in GenQ version 4. Therefore not all participants will have this data. Data was merged into new variable: GQ_BodImg_cur and data derived into: gq_bodimg_cur_DER. Please request those variables instead.

Categorical

Fathers body outline in middle age

Nine diagrams depicting father's body outline in middle age. Tick best matching one. This question was only asked in GenQ version 4. Therefore not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_BodImg_fath and data derived into: gq_bodimg_fath_DER. Please request those variables instead.

Categorical

Weight at age 20

Approximately how much did you weigh when you were about 20 years old? This question was only asked in GenQ version 4. Therefore not all participants will have this data. All phase 1 data from all 3 GenQs was merged into new variable: GQ_BodWt_y20 and data derived into: gq_bodwt_y20_DER. Please request those variables instead.

Text

Mother's body outline in middle age

Nine diagrams depicting mother's body outline in middle age. Tick one best matching. This question was only asked in GenQ version 4. Therefore not all participants will have this data. Data wasmerged into new variable: GQ_BodImg_moth and data derived into: gq_bodimg_moth_DER. Please request those variables instead.

Categorical

Self recorded health

Self perceived health status. Overall how would you rate your health during the past 4 weeks? This data is also captured with GQV3_E1SRHealth. You should request that data too. This data is not captured in Gen Q V1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_health and data derived into: gq_selfr_health_DER. Please request those variables instead.

Categorical

Physical Activity limited by health problems

Self perceived health status. During the past 4 weeks how much did physical health problems limit your usual physycal activities (walking climbing stairs)? This data is also captured with GQV3_E2SRPhysicalProblems. You should request that data too. This All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_pa and data derived into: gq_selfr_pa_DER. Please request those variables instead.

Categorical

Difficulty doing daily work due to health problems

Self perceived health status. During the past 4 weeks how much difficulty did you have doing your daily work both inside and outside the home because of your physical health? This data is also captured with GQV3_E3SRPhysicalDailyWork. You should reques All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_work and data derived into: gq_selfr_work_DER. Please request those variables instead.

Categorical

Bodily pain

Self perceived health status. How much bodily pain have you had during the past 4 weeks? This data is also captured with GQV3_E4SRBodilyPain. You should request that data too. This data is not captured in Gen Q V1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_pain and data derived into: gq_selfr_pain_DER. Please request those variables instead.

Categorical

Energy level

Self perceived health status. During the past 4 weeks how much energy did you have? This data is also captured with GQV3_E5SREnergy. You should request that data too. This data is not captured in Gen Q V1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_energy and data derived into: gq_selfr_energy_DER. Please request those variables instead.

Categorical

Health and emotional problems affecting social activity

Self perceived health status. During the past 4 weeks how much did your physical health or emotional problems limit your social activities with family or friends? This data is also captured with GQV3_E6SREmotionalSocial. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_social and data derived into: gq_selfr_social_DER. Please request those variables instead.

Categorical

Emotional problems

Self perceived health status. During the past 4 weeks how much have you been bothered by emotional problems (such as feeling anxious depressed or irritable)? This data is also captured with GQV3_E7SREmotional. You should request that data too. This dat All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_emot and data derived into: gq_selfr_emot_DER. Please request those variables instead.

Categorical

Emotional problems limiting daily work and activities

Self perceived health status. During the past 4 weeks how much did personal or emotional problems keep you from doing your usual work studies or other daily activities? This data is also captured with GQV3_E8SREmotionalDailyWork. You should request thi All phase 1 data from all 3 GenQs was merged into new variable: GQ_SelfR_emotwork and data derived into: gq_selfr_emotwork_DER. Please request those variables instead.

Categorical

Time went to sleep on a week day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you went to bed and got up on weekdays and on weekend days. At what time did you go to sleep on a weekday? This question was only asked in GQV4. Therefore not all participants will have this data. Cleaned data available in GQV4_SleepingPatternsWeekDaySleep_CL.

Text

Went to sleep am or pm on a week day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you went to sleep; am or pm on a week day? This question was only asked in GQV4. Therefore not all participants will have this data.

Categorical

Time got up on a week day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you get up on a week day. This question was only asked in GQV4. Therefore not all participants will have this data. Cleaned data available in GQV4_SleepingPatternsWeekDayUP_CL.

Text

Got up am or pm on a week day

Got up am or pm on a week day? This question was only asked in GQV4. Therefore not all participants will have this data.

Categorical

Time went to sleep on a weekend day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you went to sleep on a weekend day. This question was only asked in GQV4. Therefore not all participants will have this data. Cleaned data available in GQV4_SleepingPatternsWeekendDaySleep_CL.

Text

Went to sleep am or pm on a weekend day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you went to sleep am or pm on a weekend day. This question was only asked in GQV4. Therefore not all participants will have this data.

Categorical

Time got up on a weekend day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you get up on a weekend day. This question was only asked in GQV4. Therefore not all participants will have this data. Cleaned data available in GQV4_SleepingPatternsWeekendDayUP_CL.

Text

Got up am or pm on a weekend day

In the last 4 weeks. If you had variable sleeping patterns please record the average time you got up: am or pm on a weekend day. This question was only asked in GQV4. Therefore not all participants will have this data.

Categorical

Ethnic origin

Ethnic origin. This data is also captured with GQV3_F1Ethnicity but not in GQV1. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_eth and data derived into: gq_eth_DER. Please request those variables instead.

Categorical

Additional comments on gen questionnaire version 4

GQV4 additional comments made on any page with page number and text. This data is also captured with GQV1_FSGQComments or GQV3_FSGQComments. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: FSGQComments_Updated . Please request those variables instead.

Text

Questionnaire version

Questionnaire version. This data is also captured with GQV3_Qversion but not in GQV1. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_v . Please request those variables instead.

Categorical

Time went to sleep on a week day_CLEANED

New in R7. In the last 4 weeks. If you had variable sleeping patterns please record the average time you went to bed and got up on weekdays and on weekend days. At what time did you go to sleep on a weekday? CLEANED data using data in GQV4_E9SRSleepingPatternsWeekDaySleepAMPM. This question was only asked in GQV4. Therefore not all participants will have this data.

Time

Time got up on a week day_CLEANED

New in R7. In the last 4 weeks. If you had variable sleeping patterns please record the average time you get up on a week day. CLEANED data using data in GQV4_E9SRSleepingPatternsWeekDayUPAMPM. This question was only asked in GQV4. Therefore not all participants will have this data.

Time

Time went to sleep on a weekend day_CLEANED

New in R7. In the last 4 weeks. If you had variable sleeping patterns please record the average time you went to sleep on a weekend day. CLEANED data using data in GQV4_E9SRSleepingPatternsWeekendDaySleepAMPM. This question was only asked in GQV4. Therefore not all participants will have this data.

Time

Time got up on a weekend day_CLEANED

New in R7. In the last 4 weeks. If you had variable sleeping patterns please record the average time you get up on a weekend day. CLEANED data using data in GQV4_E9SRSleepingPatternsWeekendDayUPAMPM. This question was only asked in GQV4. Therefore not all participants will have this data.

Time

Body outline yourself age 30

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Yourself at Age 30. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

Pt taking any tablets or medicines

Phase 2 data. Questionnaire reads: Are you taking any tablets or medicines at the moment? 2 = yes; 3 = No;

Categorical

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Text

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Real

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Real

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Real

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Text

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Real

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Text

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Text

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

BNF code

Phase 2 data. Questionnaire reads: Which drugs and reasons? BNF Code

Text

Dosage of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Name of the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Reason for taking the drugs

Phase 2 data. Questionnaire reads: Which drugs and reasons?

Text

Heart problems

Phase 2 data. Questionnaire reads A3. 1. Has your doctor ever told you that you have heart trouble? 2 = yes; 3 = no;

Categorical

Chest pain or discomfort

Phase 2 data. Questionnaire reads A3. 2. Have you ever had any pain or discomfort in your chest? If no proceed to question 7. If yes please answer also the next 4 questions. 2 = yes; 3 = no;

Categorical

Dicomfort when walking uphill

Phase 2 data. Questionnaire reads A3. 3. Do you experience this discomfort when you walk uphill or hurry? (from GQV1_A5cChestPainUphill GQV3_A5cChestPainUphill GQV4_A5cChestPainUphill) (raw info of gq_chestpain_uphill). 2 = yes; 3 = no;

Categorical

Discomfort in wlking ordinary pace

Phase 2 data. Questionnaire reads A3. 4. Do you experience this discomfort when you walk at an ordinary pace on the level? (from GQV1_A5dChestPainNormalPace GQV3_A5dChestPainNormalPace GQV4_A5dChestPainNormalPace) (raw info of gq_chestpain_normal). 2 = yes; 3 = no;

Categorical

Disomfort while walking

Phase 2 data. Questionnaire reads A3. 5. What do you do if you experience this discomfort while walking? 1 = Stop or slow down; 2 = Carry on

Categorical

Disomfort when standing still

Phase 2 data. Questionnaire reads A3. 6. If you stand still; what happens to this discomfort? 1 = It goes away; 2 = It remains the same or gets worse

Categorical

Feel faint or spells of dizziness

Phase 2 data. Questionnaire reads A3. 7. Do you often feel faint or have spells of severe dizziness? 2 - yes; 3 = no;

Categorical

Blood pressure too high

Phase 2 data. Questionnaire reads A3. 8. Has a doctor ever told you that your blood pressure was too high? 2 - yes; 3 = no;

Categorical

Taking treatment for high BP

Phase 2 data. Questionnaire reads A3. 9. If you have been told that your blood pressure was too high; are you now on treatment? 2 - yes; 3 = no;

Categorical

Bone or joint problem

Phase 2 data. Questionnaire reads A3. 10. Has your doctor ever told you that you have a bone or joint problem such as arthritis that has been aggravated by exercise or might be made worse by exercise? 2 - yes; 3 = no;

Categorical

Pregnant

Phase 2 data. Questionnaire reads A3. 11. Are you pregant? 2 = yes; 3 = no;

Categorical

Reason not following acitivity prog

Phase 2 data. Questionnaire reads A3. 12. Is there any reason you know of that means you should not follow an activity programme even if you wanted to? 2 - yes; 3 = no;

Categorical

Walk unaided 10 minutes

Phase 2 data. Questionnaire reads A3. 13. Can you walk unaided for 10 minutes at a moderate pace? 2 - yes; 3 = no;

Categorical

Ever smoked

Phase 2 data. Questionnaire reads A4. Smoking. Have you ever smoked? 2 = yes; 3 = no;

Categorical

Smoke now

Phase 2 data. Questionnaire reads A4. Smoking. Do you smoke now? 2 = yes; 3 = No;

Categorical

Age smoking started

Phase 2 data. Questionnaire reads A4. Smoking. At what age did you start smoking? Please enter age in years.

Real

Year smoking quitted

Phase 2 data. Questionnaire reads A4. Smoking. If you have stopped smoking in which year did you quit.

Real

Number of cigarettes a day

Phase 2 data. Questionnaire reads A4. Smoking. How much do you or did you smoke a day on average? Number of cigarettes a day

Real

Number of cheroots a day

Phase 2 data. Questionnaire reads A4. Smoking. How much do you or did you smoke a day on average? Number of cheroots a day

Real

Number of cigars a day

Phase 2 data. Questionnaire reads A4. Smoking. How much do you or did you smoke a day on average? Number of cigars a day

Real

Tobacco in a week

Phase 2 data. Questionnaire reads A4. Smoking. How much do you or did you smoke a day on average? Amount in grams of tobacco in a week

Real

Age of first menstrual period

Phase 2 data. Questionnaire reads A5.1. How old were you when you had your first menstrual period? 2 = I Dont Know; 3 = I have never had a period;

Categorical

Still having menstrual period

Phase 2 data. Questionnaire reads A5.2. Are you still having menstrual periods? 2 = yes; 3 = No;

Categorical

Date 1st day of last menstrual period

Phase 2 data. Questionnaire reads A6.1. On what date was the first day of your last menstrual period?

Real

Days between menstrual periods

Phase 2 data. Questionnaire reads A6.2. About how many days are there usually from the first day of one menstrual period to the first day of the next?

Real

Irregular cycles

Phase 2 data. Questionnaire reads A6.3. Do you have irregular cycles? (i.e. you cannot predict within 5 days in either direction when your next period will start) 2 = yes; 3 = No;

Categorical

Reached menopause

Phase 2 data. Questionnaire reads A7.1. Have you reached the menopause? (i.e. your periods have now stopped completely and you believe permanently; and your last period was at least six months ago) 2 = Yes; 3 = No; 4 = Dont Know because I am taking HRT and therefore am unsure whether I have reached natural menopause;

Categorical

Age when periods stopped

Phase 2 data. Questionnaire reads A7.2. How old were you when your periods stopped completely and permanently? YEARS of age

Real

Age unkown when periods stopped

Phase 2 data. Questionnaire reads A7.2. How old were you when your periods stopped completely and permanently? Dont Know

Categorical

Reason for periods stopping

Phase 2 data. Questionnaire reads A7.3. What was the reason for your periods stopping? 1 = Natural menopause; 3 = Natural menopause while on HRT or contraception; 2 = Surgery (e.g.hysterectomy/removal of ovaries); 4 = Dont know

Categorical

Other reasons for periods stopping

Phase 2 data. Questionnaire reads IF NO A7c. What was the reason for your periods stopping? Other; specify

Text

Mother's age of Menopause

Phase 2 data. Questionnaire reads IF NO A7d. What was your mother’s age of natural menopause? (see exclusions above) YEARS of age

Real

Mother's age of natural menopause

Phase 2 data. Questionnaire reads IF NO A7d. What was your mother’s age of natural menopause? (see exclusions above) Dont know

Real

When voice break

Phase 2 data. Questionnaire reads A8a. When did your voice break? 1 = Younger than average; 2 = About average age; 3 = Older than average; 4 = Dont know;

Categorical

Age of voice break

Phase 2 data. Questionnaire reads A8b. If known; at what age did your voice break? YEARS of age

Real

Age of voice break not known

Phase 2 data. Questionnaire reads A8b. If known; at what age did your voice break? Dont know

Real

When facial hair started to grow

Phase 2 data. Questionnaire reads A9a. When did you start to grow facial hair? 1 = Younger than average; 2 = About average age; 3 = Older than average; 4 = Dont know;

Categorical

Age of facial hair

Phase 2 data. Questionnaire reads A9b. If known; at what age did you grow facial hair? YEARS of age

Real

Age of facial hair not known

Phase 2 data. Questionnaire reads A9b. If known; at what age did you grow facial hair? Dont know

Real

GQ_Alc_1per14days

New in R8. B2. Do you usually drink once per fortnight? (a single variable Alc_f in GQv1) (from GQV3_B2fDrinkPerFortnight GQV4_B2fDrinkPerFortnight) (raw info of gq_alc_1per14days).

Categorical

GQ_Alc_1permth

New in R8. B2. Do you usually drink once per month? (a single variable Alc_f in GQv1) (from GQV3_B2gDrinkPerMonth GQV4_B2gDrinkPerMonth) (raw info of gq_alc_1permth).

Categorical

GQ_Alc_1to2perwk

New in R8. B2. Do you usually drink 1-(not asked in GQv1) 2 times per week? (a single variable Alc_f in GQv1) (from GQV3_B2eDrink1-2TimesPerWeek GQV4_B2eDrink12TimesPerWeek) (raw info of gq_alc_1to2perwk).

Categorical

GQ_Alc_3to4perwk

New in R8. B2. Do you usually drink 3-4 times per week? (a single variable Alc_f in GQv1) (from GQV3_B2dDrink3-4TimesPerWeek GQV4_B2dDrink34TimesPerWeek) (raw info of gq_alc_3to4perwk).

Categorical

GQ_Alc_almostday

New in R8. B2. Do you usually drink almost every day? (a single variable Alc_f in GQv1) (from GQV3_B2cDrinkMostDays GQV4_B2cDrinkMostDays) (raw info of gq_alc_almostday).

Categorical

C2. Change in alcohol consumption

C2. Has your current alcohol consumption changed significantly compared with that of some years ago? Please only tick one box. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank;1=My consumption has increased a lot;2=My consumption has slightly increased;3=I currently consume a similar amount as before;4=My consumption has slightly decreased;5=My consumption has decreased a lot;6=In the past and at present I have been consuming little or no alcohol

Categorical

GQ_Alc_ever

New in R8. B2. Do you EVER drink alcohol? If never drinkers please go to section C on the next page. (a single variable Alc_f in GQv1) Asked differently in GQv3 (never drinkers?) and GQv4 (ever drinkers?). (from GQV3_B2aNeverDrink GQV4_B2aEverDrink) (raw info of gq_alc_ever).

Categorical

GQ_Alc_everyday

New in R8. B2. Do you usually drink every day? (a single variable Alc_f in GQv1) (from GQV3_B2bDrinkDaily GQV4_B2bDrinkDaily) (raw info of gq_alc_everyday).

Categorical

B2. Alc drink ever or never (check GQ version)

B2. Alc drink ever or never (check GQ version): 2=Yes; 3=No; -7=not applicable/answered but undetermined; -1=left blank

Categorical

GQ_Alc_f

New in R8. B3. How often do you usually have an alcoholic drink of any kind? (compiled in 8 different variables in GQv3 and GQv4) (from GQV1_B3aDrinkFrequency ) (raw info of gq_alc_f).

Categorical

B2. Alc frequency categories

B2. Alc frequency categories: 1=never/rare; 2= <1/wk; 3=1-2/wk; 4=3-4/wk; 5=almost daily; -7=not applicable/answered but undetermined

Categorical

C1. Alc frequency categories

C1. Alcohol consumption in categories of frequency consumption (5 categories) based on gq_alc_freq derived from GQ_V3.0_24/04: 1=never/rare;2= <1/wk;3=1-2/wk;4=3-4/wk;5=almost daily

Categorical

B2. Alc frequency/week

B2. Alc frequency/week: -7=not applicable/answered but undetermined; -1=left blank

Real

C1. Alc frequency/week

C1. Alcohol consumption in frequency (servings/week) based on frequency variables asked differently across the versions of the general questionnaire derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank;1=Never or rarely;2=About once a month;3=1-2 times per week;4=3-4 times per week;5=Almost every day;6=Every day

Categorical

B2. Alc exposure (grams of ethanol/week)

B2. Alc exposure (grams of ethanol/week): -7=not applicable/answered but undetermined

Real

C3. Alc exposure (grams of ethanol/week)

C3. Alcohol consumption in amounts (grams of ethanol/week) derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined

Real

GQ_Alc_less1permth

New in R8. B2. Do you usually drink less than once a month? (a single variable Alc_f in GQv1) (from GQV3_B2hDrinkLessOncePerMonth GQV4_B2hDrinkLessOncePerMonth) (raw info of gq_alc_less1permth).

Categorical

GQ_Alc_units_beer

New in R8. B3. How many units of beer lager or cider do you consume in an average week? (units/week)(from GQV1_B2aUnitsBeerPerWk GQV3_B3aUnitsBeerPerWk GQV4_B3aUnitsBeerPerWk) (raw info of gq_alc_units_beer).

Categorical

B3. Alc units of beer per week

B3. Alc units of beer per week: -7=not applicable/answered but undetermined; -1=left blank

Real

C3. Beer in weekdays (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Beer in weekdays. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

C3. Beer in weekends (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Beer in weekends. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

B2. Alc exposure (UK units/week)

B2. Alc exposure (UK units/week): -7=not applicable/answered but undetermined

Real

C3. Alc exposure (UK units/week)

C3. Alcohol consumption in amounts (UK units/week) derived from GQ_V3.0_24/04: beer x1.4 wine x2.1 spirits x1.0 fortified wine x0.9x3.5) after cleaning/harmonisation (see variables with the prefix of GQ_Alc_units_): -7=not applicable/answered but undetermined

Real

GQ_Alc_units_fortwine

New in R8. B4. How many units of Fortified wine (sherry Cinzano Campari) do you consume in an average week? (units/week) (from GQV1_B2dUnitsFortWinePerWk GQV3_B4dUnitsFortWinePerWk GQV4_B4dUnitsFortWinePerWk) (raw info of gq_alc_units_fortwine).

Categorical

B4. Alc units of fortified wine per week

B4. Alc units of fortified wine per week: -7=not applicable/answered but undetermined; -1=left blank

Real

C3. Fortified wine in weekdays (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Fortified wine in weekdays. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

C3. Fortified wine in weekends (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Fortified wine in weekdays. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

GQ_Alc_units_spirits

New in R8. B3. How many units of spirits do you consume in an average week? (units/week) (from GQV1_B2cUnitsSpiritsPerWk GQV3_B3cUnitsSpiritsPerWk GQV4_B3cUnitsSpiritsPerWk) (raw info of gq_alc_units_spirits).

Categorical

B3. Alc units of spirits per week

B3. Alc units of spirits per week: -7=not applicable/answered but undetermined; -1=left blank

Real

C3. Spirits in weekdays (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Spirits in weekdays. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

C3. Spirits in weekends (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Spirits in weekends. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

GQ_Alc_units_wine

New in R8. B3. How many units of wine do you consume in an average week? (units/week) (from GQV1_B2bUnitsWinePerWk GQV3_B3bUnitsWinePerWk GQV4_B3bUnitsWinePerWk) (raw info of gq_alc_units_wine).

Categorical

B3. Alc units of wine per week

B3. Alc units of wine per week: -7=not applicable/answered but undetermined; -1=left blank

Real

C3. Wine in weekdays (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Wine in weekdays. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

C3. Wine in weekends (UK unites).

C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Wine in weekends. UK Units. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

C3. Alc exposure weekday (grams of ethanol/week)

C3. Alc exposure weekday (grams of ethanol/week) derived from GQ_V3.0_24/04

Real

C3. Alc exposure weekday (UK units/week)

C3. Alc exposure weekday (UK units/week) derived from GQ_V3.0_24/04

Real

C3. Alc exposure weekend (grams of ethanol/week)

C3. Alc exposure weekend (grams of ethanol/week)

Real

C3. Alc exposure weekend (UK units/week)

C3. Alc exposure weekend (UK units/week) derived from GQ_V3.0_24/04

Real

Own a car or van

Phase 2 data. Questionnaire reads B10. Do you own a car or van? 2 = yes; 3 = no;

Categorical

Tv or computer in bedroom

Phase 2 data. Questionnaire reads B11. Do you have a TV or computer in your bedroom?

Categorical

Own house

Phase 2 data. Questionnaire reads B12. Do you own or rent the home where you live? Own it/buying it   2 = yes; 3 = no; -1 = left blank; -5 = more than one selected;

Categorical

Rent house

Phase 2 data. Questionnaire reads B12. Do you own or rent the home where you live? Rent it.   2 = yes; 3 = no; -1 = left blank; -5 = more than one selected;

Categorical

Marital status

Phase 2 data. Questionnaire reads B13. What is your marital status? This data is also captured with GQV3_C12MaritalStatus. You should request that data too. Not asked in GQV1. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Marit and data derived into: gq_marit_DER. Please request those variables instead. 1 = single; 2 = married or living as married; 3 = widowed; 4 = separated; 5 = divorced;

Categorical

Work full time

Phase 2 data. Questionnaire reads B1. What is your current work status? In work full time i.e. more than 30 hours per week. 2 = yes; 3 = no;

Categorical

Work part time

Phase 2 data. Questionnaire reads B1. What is your current work status? Part time work i.e. less than 30 hours per week. 2 = yes; 3 = no;

Categorical

Work keeping house

Phase 2 data. Questionnaire reads B1. What is your current work status? Keeping house. 2 = yes; 3 = no;

Categorical

Retired

Phase 2 data. Questionnaire reads B1. What is your current work status? Wholly retired from work. 2 = yes; 3 = no;

Categorical

Starting a new job

Phase 2 data. Questionnaire reads B1. What is your current work status? Waiting to start a new job already obtained. 2 = yes; 3 = no;

Categorical

Unemployed

Phase 2 data. Questionnaire reads B1. What is your current work status? Unemployed and looking for work. 2 = yes; 3 = no;

Categorical

Temporary out of work

Phase 2 data. Questionnaire reads B1. What is your current work status? Out of work as temporarily sick. 2 = yes; 3 = no;

Categorical

Sick or disabled

Phase 2 data. Questionnaire reads B1. What is your current work status? Permanently sick or disabled. 2 = yes; 3 = no;

Categorical

Work other

Phase 2 data. Questionnaire reads B1. What is your current work status? If other please specify.

Real

Self employed

Phase 2 data. Questionnaire reads B2. Employee or self employed; Do (did) you work as an employee or are (were) you self-employed? 1 = Employee; 2 = Self employed with employees; 3 = Self employed without employees;

Categorical

No of employees at work

Phase 2 data. Questionnaire reads B3. Number of employees; For employees: indicate below how many people work (worked) for your employer at the place where you work (worked). For self-employed: indicate below how many people you employ (employed). 1 = 1 to 24 people; 2 = 25 or more people;

Categorical

Supervise other employees

Phase 2 data. Questionnaire reads B4. Supervisory status; Do (did) you supervise any other employees? A supervisor or foreman is responsible for overseeing the work of other employees on a day to day basis. 2 = yes; 3 = no;

Categorical

Occupation type

Phase 2 data. Questionnaire reads B5. Occupation type; Please tick one box which best describes the sort of work you do. If you are not working now; please tick a box to show what you did in your last job. This data is also captured with GQV3_C5Occupation (but not in GQV1). You should request that data too. 1 = Modern professional ; 2 = Clerical; 3 = Senior manager; 4 = Technical; 5 = Semi-routine; 6 = Routine; 7 = Middle management; 8 = Traditional professional;

Categorical

School leaving certificate

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). School Leaving certificate. This data is also captured with GQV1_DMC4aSLC or GQV3_C6aSLC. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_SLC and data derived into: gq_edu_slc_DER. Please request those variables instead. 2 = yes

Categorical

CSE qualification

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). CSE. This data is also captured with GQV1_DMC4bCSE or GQV3_C6bCSE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_CSE and data derived into: gq_edu_cse_DER. Please request those variables instead. 2 = yes

Categorical

GCE qualification

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). GCE O level or GCSE. This data is also captured with GQV1_DMC4cGCSE or GQV3_C6cGCSE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_GCSE and data derived into: gq_edu_gcse_DER. Please request those variables instead. 2 = yes

Categorical

Matriculation

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Matriculation. This data is also captured with GQV1_DMC4dMatriculation or GQV3_C6dMatriculation. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_matricul and data derived into: gq_edu_matricul_DER. Please request those variables instead. 2 = yes

Categorical

A levels

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). GCE A Level AS level Highers This data is also captured with GQV1_DMc4eALevels or GQV3_C6eALevels. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_Alev and data derived into: gq_edu_alev_DER. Please request those variables instead. 2 = yes

Categorical

Technical qualifications

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Technical College exams City and Guilds. This data is also captured with GQV1_DMC4fC_G or GQV3_C6fC_G. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_TechCG and data derived into: gq_edu_techcg_DER. Please request those variables instead. 2 = yes

Categorical

HND or GNVQ

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). HND or GNVQ. This data is also captured with GQV1_DMC4gHND or GQV3_C6gHND_NVQ. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HND_NVQ and data derived into: gq_edu_hnd_nvq_DER. Please request those variables instead. 2 = yes

Categorical

Apprenticeship

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Completed Apprenticeship. This data is also captured with GQV1_DMC4hApprenticeship or GQV3_C6hApprenticeship. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_apprentice and data derived into: gq_edu_apprentice_DER. Please request those variables instead. 2 = yes

Categorical

Secretarial

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Secretarial College Exams. This data is also captured with GQV1_DMC4iSecretarial or GQV3_C6iSecretarial. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_secret and data derived into: gq_edu_secret_DER. Please request those variables instead. 2 = yes

Categorical

Teaching Diploma

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Teaching Diploma HNC NVQ. This data is also captured with GQV1_DMC4jHMC or GQV3_C6jHNC. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_HNC and data derived into: gq_edu_hnc_DER. Please request those variables instead. 2 = yes

Categorical

University degree

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). University Degree. This data is also captured with GQV1_DMC4kDegree or GQV3_C6kDegree. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_degree and data derived into: gq_edu_degree_DER. Please request those variables instead. 2 = yes

Categorical

Trade certificates

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Trade Certificates. This data is also captured with GQV1_DMC4lTradeCertificate or GQV3_C6lTradeCertificate. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_trade and data derived into: gq_edu_trade_DER. Please request those variables instead. 2 = yes

Categorical

Other qualifications

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). Other please describe. This data is also captured with GQV1_DMC4mOther or GQV3_C6mOther. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_others and data derived into: gq_edu_others_DER. Please request those variables instead.

Text

No qualifications

Phase 2 data. Questionnaire reads B6. Do you have any of the following qualifications? (tick all applicable). None. This data is also captured with GQV1_DMC4nNone or GQV3_C6nNone. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_none and data derived into: gq_edu_none_DER. Please request those variables instead. 2 = yes

Categorical

Age full time education finished

Phase 2 data. Questionnaire reads B7. At what age did you finish full time education (in years)? This data is also captured with GQV1_DMC42aAgeEndFTE or GQV3_C7AgeEndFTE. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Edu_age and data derived into: gq_edu_age_DER. Please request those variables instead.

Real

Household Income

Phase 2 data. Questionnaire reads B8. Please can you indicate what your household income is. 1 = < £2000; 2 = £20000 - <£40000; 3 = > £40000 - <£60000; 4 = £60000 - <£80000; 5 = £80000 and above;

Categorical

No of people in household

Phase 2 data. Questionnaire reads B9. How many people are there in your household? (including children)

Real

GQ_BodImg_cur

New in R8. E10. Nine diagrams depicting participant body outline currently. Tick best matching one. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10fYC) (raw info of gq_bodimg_cur).

Categorical

E10. Participant current body outline

E10. Participant current body outline : -8=not asked (GQ version difference); -1=left blank

Categorical

E9. Participant current body outline

E9. Nine diagrams depicting participant body outline currently. Tick best matching one. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodImg_fath

New in R8. E10. Nine diagrams depicting fathers body outline in middle age. Tick best matching one. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10gFIMA) (raw info of gq_bodimg_fath).

Categorical

E10. Father's body outline in middle age

E10. Father's body outline in middle age: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Categorical

E9. Father's body outline in middle age

E9. Nine diagrams depicting fathers body outline in middle age. Tick best matching one. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodImg_moth

New in R8. E10. Nine diagrams depicting mothers body outline in middle age. Tick one best matching. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10MIMA) (raw info of gq_bodimg_moth).

Categorical

E10. Mother's body outline in middle age

E10. Mother's body outline in middle age: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Categorical

E9. Mother's body outline in middle age

E9. Nine diagrams depicting mothers body outline in middle age. Tick one best matching. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodImg_y10

New in R8. E10. Nine diagrams depicting participant body outline at age 10. Tick best matching one. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10bYA10) (raw info of gq_bodimg_y10).

Categorical

E10. Participant body outline at age 10

E10. Participant body outline at age 10: -8=not asked (GQ version difference); -1=left blank

Categorical

E9. Participant body outline at age 10

E9. Nine diagrams depicting participant body outline at age 10. Tick best matching one. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodImg_y20

New in R8. E10. Nine diagrams depicting participant body outline at age 20. Tick best matching one. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10cYA20) (raw info of gq_bodimg_y20).

Categorical

E10. Participant body outline at age 20

E10. Participant body outline at age 20: -8=not asked (GQ version difference); -1=left blank

Categorical

E9. Participant body outline at age 20

E9. Nine diagrams depicting participant body outline at age 20. Tick best matching one. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodImg_y30

New in R8. E10. Nine diagrams depicting participant body outline at age 30. Tick best matching one. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10dYA30) (raw info of gq_bodimg_y30).

Categorical

E10. Participant body outline at age 30

E10. Participant body outline at age 30: -8=not asked (GQ version difference); -1=left blank

Categorical

E9. Participant body outline at age 30

E9. Nine diagrams depicting participant body outline at age 30. Tick best matching one. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodImg_y40

New in R8. E10. Nine diagrams depicting participant body outline at age 40. Tick best matching one. (asked only in GQv4) (integers 1 to 9) (from GQV4_E10eYA40) (raw info of gq_bodimg_y40).

Categorical

E10. Participant body outline at age 40

E10. Participant body outline at age 40: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Categorical

E9. Participant body outline at age 40

E9. Nine diagrams depicting participant body outline at age 40. Tick best matching one. (integers 1 to 9) derived from GQ_V3.0_24/04: -1=left blank

Categorical

GQ_BodWt_y20

New in R8. E10. Approximately how much did you weigh (kg) when you were about 20 years old? Imperial or metric unit (asked only in GQv4)

Real

E10. Participant body weight at age 20

E10. Participant body weight at age 20: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Real

E10. Participant body weight at age 20

E10. Approximately how much did you weigh (kg) when you were about 20 years old? Imperial or metric unit derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

gq_bodwt_y20_kg_DER_p2

Data derived from Fenland Phase 2 General Questionnaire data. Data Dictionary entry not available - please contact Data management for more details.

Real

GQ_Bone_exercise

New in R8. A5. Has your doctor ever told you that you have a bone or joint problem such as arthritis that has been aggravated by exercise or might be made worse by exercise? (from GQV1_A5jBoneProblemsAggravatedByExercise GQV3_A5jBoneProblemsAggravatedByExercise GQV4_A5jBoneProblemsAggravatedByExercise) (raw info of gq_bone_exercise).

Categorical

A5. Bone problems worse by exercise

A5. Bone problems worse by exercise: 2=Yes; 3=No; -1=left blank

Categorical

A3. Bone problems worse by exercise

A3. Has your doctor ever told you that you have a bone or joint problem such as arthritis that has been aggravated by exercise or might be made worse by exercise? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Breakfast

New in R8. D1. How often do you usually eat breakfast? Please tick the box which is most true. (from GQV1_D1EatBreakfast GQV3_D1EatBreakfast GQV4_D1EatBreakfast) (raw info of gq_breakfast).

Categorical

D1. How often eat breakfast

D1. How often eat breakfast: 1=never or rarely; 2=1-2 times/wk; 3=3-5 times/wk; 4=>5 times/wk; -1=left blank

Categorical

C4. How often eat breakfast

C4. How often do you usually eat breakfast? Please tick the box which is most true. derived from GQ_V3.0_24/04: 1=never or rarely;2=1-2 times/wk;3=3-5 times/wk;4=>5 times/wk;-1=left blank

Categorical

GQ_Bterm

New in R8. A4. When were you born (pre post or at term). (from GQV1_A4dBorn GQV3_A4aBorn GQV4_A4aBorn) (raw info of gq_bterm).

Categorical

A4. Term of birth

A4. Term of birth: 1=very pre-term; 2=pre-term; 3=at term; 4=post term; 5=not known; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Birth weight in grams

A3. Birth weight in grams: -7=not applicable/answered but undetermined; -1=left blank

Real

Derived Birth weight imperial weight

New for R8. A3. What was your weight at birth in pounds and ounces. Asked differently in GQv1. (from GQV3_A3aBirthWeightImperial GQV4_A3aBirthWeightImperial) (raw info of gq_bwt_imperial).

Real

GQ_BWt_metric

New in R8. A3. What was your weight at birth? Birth weight in kilograms. Asked differently in GQv1. (from GQV3_A3bBirthWeightMetric GQV4_A3bBirthWeightMetric) (raw info of gq_bwt_metric).

Categorical

GQ_BWt_unit

New in R8. A4. What was your weight at birth units only. Asked differently in GQv3 and GQv4. (from GQV1_A4bBirthWeightUnits ) (raw info of gq_bwt_unit).

Categorical

GQ_BWt_unknown

New in R8. A3. Tick if you are not able to give your birth weight. (from GQV1_A4cBirthWeightUnknown GQV3_A3cBirthWeightUnknown GQV4_A3cBirthWeightUnknown) (raw info of gq_bwt_unknown).

Categorical

GQ_BWt_value

New in R8. A4. What was your weight at birth value entered only. Asked differently in GQv3 and GQv4.

Real

Eat snack foods using PC

Phase 2 data. Questionnaire reads C10. Apart from meals how often do you eat snack foods while using PC; tablet; smartphone or similar electronic device? 1 = Never or rarely; 2 = Occasionally; 3 = Usually; 4 = Always;

Categorical

Main meal between 6am - 8am

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal: between 6am - 8am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D601aMain or GQV3_D601aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0204 and data derived into: gq_eat_main0204_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 6am - 8am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 6am - 8am E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D601bLight or GQV3_D601bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0204 and data derived into: gq_eat_light0204_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 6am - 8am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 6am - 8am E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D601cSnack or GQV3_D601cSnack. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0204 and data derived into: gq_eat_snack0204_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 6am - 8am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 6am - 8am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D601dDrink or GQV3_D601dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0204 and data derived into: gq_eat_drink0204_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 8am - 10am

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 8am - 10am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D602aMain or GQV3_D602aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0406 and data derived into: gq_eat_main0406_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 8am - 10am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 8am - 10am E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D602bLight or GQV3_D602bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0406 and data derived into: gq_eat_light0406_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 8am - 10am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 8am - 10am E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D602cSnack or GQV3_D602cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0406 and data derived into: gq_eat_snack0406_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 8am - 10am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 8am - 10am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D602dDrink or GQV3_D602dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0406 and data derived into: gq_eat_drink0406_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 10am - 12am

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 10am - 12am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D603aMain or GQV3_D603aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0608 and data derived into: gq_eat_main0608_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 10am - 12pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 10am - 12pm E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D603bLight or GQV3_D603bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0608 and data derived into: gq_eat_light0608_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 10am - 12pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 10am - 12pm E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D603cSnack or GQV3_D603cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0608 and data derived into: gq_eat_snack0608_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack btwn 10am - 12pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 10am - 12pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D603dDrink or GQV3_D603dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0608 and data derived into: gq_eat_drink0608_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 12pm - 2pm

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 12pm - 2pm cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D604aMain or GQV3_D604aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main0810 and data derived into: gq_eat_main0810_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 12pm - 2pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 12pm -2pm E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D604bLight or GQV3_D604bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light0810 and data derived into: gq_eat_light0810_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 12pm - 2pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 12pm - 2pm E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D604cSnack or GQV3_D604cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack0810 and data derived into: gq_eat_snack0810_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 12pm - 2pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 12pm - 2pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D604dDrink or GQV3_D604dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink0810 and data derived into: gq_eat_drink0810_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 2pm - 4pm

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 2pm - 4pm cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D605aMain or GQV3_D605aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1012 and data derived into: gq_eat_main1012_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 2pm - 4pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 2pm - 4pm E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D605bLight or GQV3_D605bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1012 and data derived into: gq_eat_light1012_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 2pm - 4pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 2pm - 4pm E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D605cSnack or GQV3_D605cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1012 and data derived into: gq_eat_snack1012_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 2pm - 4pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 2pm - 4pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D605dDrink or GQV3_D605dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1012 and data derived into: gq_eat_drink1012_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 4pm - 6pm

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 4pm - 6pm cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D606aMain or GQV3_D606aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1214 and data derived into: gq_eat_main1214_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 4pm - 6pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 4pm - 6pm E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D606bLight or GQV3_D606bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1214 and data derived into: gq_eat_light1214_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 4pm -6pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 4pm - 6pm E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D606cSnack or GQV3_D606cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1214 and data derived into: gq_eat_snack1214_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 4pm - 6pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 4pm - 6pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D606dDrink or GQV3_D606dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1214 and data derived into: gq_eat_drink1214_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 6pm - 8pm

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 6pm - 8pm cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D607aMain or GQV3_D607aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1416 and data derived into: gq_eat_main1416_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 6pm - 8pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 6pm - 8pm E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D607bLight or GQV3_D607bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1416 and data derived into: gq_eat_light1416_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 6pm -8pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 6pm - 8pm E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D607cSnack or GQV3_D607cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1416 and data derived into: gq_eat_snack1416_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 6pm - 8pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 6pm - 8pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D607dDrink or GQV3_D607dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1416 and data derived into: gq_eat_drink1416_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 8pm - 10pm

Phase 2 data. Questionnaire reads Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 8pm - 10pm cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D608aMain or GQV3_D608aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1618 and data derived into: gq_eat_main1618_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 8pm - 10pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 8pm - 10pm E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D608bLight or GQV3_D608bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1618 and data derived into: gq_eat_light1618_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 8pm -10pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 8pm - 10pm E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D608cSnack or GQV3_D608cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1618 and data derived into: gq_eat_snack1618_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 8pm - 10pm

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 8pm - 10pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D608dDrink or GQV3_D608dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1618 and data derived into: gq_eat_drink1618_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 10pm - 12am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 10pm - 12am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D609aMain or GQV3_D609aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main1820 and data derived into: gq_eat_main1820_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 10pm - 12am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 10pm - 12am E.g.porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D609bLight or GQV3_D609bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light1820 and data derived into: gq_eat_light1820_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 10pm -12am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 10pm - 12am E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D609cSnack or GQV3_D609cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack1820 and data derived into: gq_eat_snack1820_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack btwn 10pm - 12am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 10pm - 12am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D609dDrink or GQV3_D609dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink1820 and data derived into: gq_eat_drink1820_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 12am - 2am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 12am - 2am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D610aMain or GQV3_D610aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2022 and data derived into: gq_eat_main2022_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 12am - 2am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 12am - 2am E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D610bLight or GQV3_D610bLight. You should request that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2022 and data derived into: gq_eat_light2022_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 12am - 2am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 12am - 2am E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D610cSnack or GQV3_D610cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2022 and data derived into: gq_eat_snack2022_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 12am - 2am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 12am - 2am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D610dDrink or GQV3_D610dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2022 and data derived into: gq_eat_drink2022_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 2am - 4am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 2am - 4am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D611aMain or GQV3_D611aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2224 and data derived into: gq_eat_main2224_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 2am - 4am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 2am - 4am E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D611bLight or GQV3_D611bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2224 and data derived into: gq_eat_light2224_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 2am - 4am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 2am - 4am E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D611cSnack or GQV3_D611cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2224 and data derived into: gq_eat_snack2224_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 2am - 4am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 2am - 4am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D611dDrink or GQV3_D611dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2224 and data derived into: gq_eat_drink2224_DER. Please request those variables instead. 2 = yes

Categorical

Main meal between 4am - 6am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a main meal between: 4am - 6am cooked dish e.g. meat with potatoes; pizza; lasagne; fish and chips; burgers; fried breakfast. This data is also captured with GQV1_D612aMain or GQV3_D612aMain. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Main2402 and data derived into: gq_eat_main2402_DER. Please request those variables instead. 2 = yes

Categorical

Light meal between 4am - 6am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a light meal between: 4am - 6am E.g. porridge; cereal; toast; sandwiches; soup; salad; omelette. This data is also captured with GQV1_D612bLight or GQV3_D612bLight. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Light2402 and data derived into: gq_eat_light2402_DER. Please request those variables instead. 2 = yes

Categorical

Snack between 4am - 6am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a snack between: 4am - 6am E.g. biscuit; cake; fruit; sweets; chocolate; crisps; nuts; ice cream. This data is also captured with GQV1_D612cSnack or GQV3_D612cSnack. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Snack2402 and data derived into: gq_eat_snack2402_DER. Please request those variables instead. 2 = yes

Categorical

Drink only snack between 4am - 6am

Phase 2 data. Questionnaire reads C11. Eating patterns: In the table below; describe the meals or snacks you usually eat during a 24hour period. Tick the boxes that best describe what you eat and when. You may tick more than one box per line. Had a drink only snack between: 4am - 6am E.g. drinks with some milk or sugar in; not low calorie drinks or water. This data is also captured with GQV1_D612dDrink or GQV3_D612dDrink. You should be given that data too. All phase 1 data from all 3 GenQs was merged into new variable: GQ_Eat_Drink2402 and data derived into: gq_eat_drink2402_DER. Please request those variables instead. 2 = yes

Categorical

Savoury snacks plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Savoury snacks(crisps;salted nuts) 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Sweets cakes bisct plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Sweets; chocolate bars; cakes; biscuits. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Icecream chocolate plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Ice cream; chocolate mousse. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Yoghurt rice pudd plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Yoghurt; rice pudding. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Soda in addition to usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Soda. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Alcoholic drinks plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Alcoholic drinks. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Fruit juice plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Fruit juice. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Squash plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Squash. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Milk shake plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Milk; milkshake; hot chocolate. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Tea or coffee plus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Tea or coffee. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Other snack splus usual meals

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Other. 1 = None; 2 = 1-2 times a week; 3 = 3-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = 2 times a day; 7 = 3 times a day; 8 = 4 times a day; 9 = 5 times a day; 10 = More than 5 a day;

Categorical

Name of the other text

Phase 2 data. Questionnaire reads C12. We are interested in how often you had snacks or drinks while watching TV in the last 4 weeks in addition to your usual meals. Only think of snacks in addition to your breakfast; lunch or dinner. Please tick one box only per line. In the last 4 weeks on average how often did you have the following snacks or drinks while watching TV in addition to your breakfast; lunch or dinner? Other (text)

Text

Special diets: Weight watchers

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Weight watchers. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Special diets: Slimming world

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Slimming world. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Low fat diet

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Low fat diet. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Low carbohydrate diet

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Low carbohydrate diet eg Atkins diet.

Categorical

Vegetarian diet

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Vegetarian. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Vegan diet

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Vegan. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Kosher diet

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Kosher. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Halal

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Halal. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Other diet

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Other. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Special diets: Jenny Craig

Phase 2 data. Questionnaire reads C13. Special diets. Please tick to show if you are currently on any of the following special diets. Jenny Craig. 1 = Less than 6 months; 2 = More than 6 months;

Categorical

Drank alcohol in the past 1 year

Phase 2 data. Questionnaire reads C1. During the past 1 year; how often did you drink alcoholic drinks of any kind? Please only tick one box. 1 = Never or rarely; 2 = About once a month; 3 = 1-2 times per week; 4 = 3-4 times per week; 5 = Almost every day; 6 = Every day;

Categorical

Alcohol consumption changed

Phase 2 data. Questionnaire reads C2. Has your current alcohol consumption changed significantly compared with that of some years ago? Please only tick one box. 1 = My consumption has increased a lot; 2 = My consumption has slightly increased; 3 = I currently consume a similar amount as before; 4 = My consumption has slightly decreased; 5 = My consumption has decreased a lot; 6 = In the past and at present I have been consuming little or no alcohol;

Categorical

Units alcohol consumed wkday beer

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? With 1 unit equivalent to 1/2 pint of Beer; Lager; or cider. Number of units.

Real

Units alcohol consumed wkday wine

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? With 1 unit equivalent to 1/2 glass of Wine. Number of units.

Real

Units alcohol consumedwkday spirits

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? With 1 unit equivalent to 1 single measure of Spirits. Number of units.

Real

Units beer consumed wknd day

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? With 1 unit equivalent to 1/2 pint of Beer; Lager; or cider. Number of units.

Real

Units wine consumed wknd day

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? With 1 unit equivalent to 1/2 glass of Wine. Number of units.

Real

Units spirits consumed wknd day

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? With 1 unit equivalent to 1 single measure of Spirits. Number of units.

Real

Units fortifiedwine consumed wkday

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Fortified wine (such as sherry Cinzano Campari) With 1 unit equivalent to 1 glass of sherry. Number of units.

Real

Breakfast frequency

Phase 2 data. Questionnaire reads C4. How often do you usually eat breakfast? 1 = Never or rarely; 2 = 1-2 times per week; 3 = 3-5 times per week; 4 = More than 5 times per week

Categorical

Units fortwine consumed wkndday

Phase 2 data. Questionnaire reads C3. In a typical week; how many units of alcohol do you consume during weekdays (Monday through Thursday) and weekends (Friday through Sunday)? Fortified wine (such as sherry Cinzano Campari) With 1 unit equivalent to 1 glass of sherry. Number of units.

Real

Home delivery or take-away meals

Phase 2 data. Questionnaire reads C5. When eating your main meal at home; how often do you usually eat the following: Home delivery or take-away meals; 1 = Never or rarely; 2 = 1-2 times per week; 3 = 3-5 times per week; 4 = More than 5 times per week

Categorical

Ready-made meals or prepared foods

Phase 2 data. Questionnaire reads C5. When eating your main meal at home; how often do you usually eat the following: Ready-made meals/prepared foods; 1 = Never or rarely; 2 = 1-2 times per week; 3 = 3-5 times per week; 4 = More than 5 times per week

Categorical

Home cooked meals

Phase 2 data. Questionnaire reads C5. When eating your main meal at home; how often do you usually eat the following: Home cooked meals; 1 = Never or rarely; 2 = 1-2 times per week; 3 = 3-5 times per week; 4 = More than 5 times per week

Categorical

Meal ate outside of home

Phase 2 data. Questionnaire reads C6. On average how often do you eat a meal outside of the home (restaurants; pubs; fast-food outlets; etc)? 1 = Less than once a week; 2 = Once a week; 3 = 2-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = More than once a day;

Categorical

Ate meal watching tv or video

Phase 2 data. Questionnaire reads C7. How often do you eat your meal while watching television or video? 1 = Less than once a week; 2 = Once a week; 3 = 2-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = More than once a day;

Categorical

Ate meal using PC or similar device

Phase 2 data. Questionnaire reads C8. How often do you eat your meal while using PC; tablet; smartphone or similar electronic device? 1 = Less than once a week; 2 = Once a week; 3 = 2-4 times a week; 4 = 5-6 times a week; 5 = Once a day; 6 = More than once a day;

Categorical

Eat snack foods watching TV

Phase 2 data. Questionnaire reads C9. Apart from meals how often do you eat snack foods while watching television? 1 = Never or rarely; 2 = Occasionally; 3 = Usually; 4 = Always;

Categorical

GQ_ChestPain_action

New in R8. A5. What do you do if you experience pain or chest discomfort while walking? (from GQV1_A5eActionWhenChestDiscomfort GQV3_A5eActionWhenChestDiscomfort GQV4_A5eActionWhenChestDiscomfort) (raw info of gq_chestpain_action).

Categorical

A5. Action taken after chest discomfort from walking

A5. Action taken after chest discomfort from walking: 1=stop or slow down; 2=carry on; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Action taken after chest discomfort from walking

A3. What do you do if you experience pain or chest discomfort while walking? derived from GQ_V3.0_24/04: 1=stop or slow down;2=carry on;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_ChestPain_dr

New in R8. A5. Has your doctor ever told you that you have heart trouble? (from GQV1_A5aDrReportHeartTrouble GQV3_A5aDrReportHeartTrouble GQV4_A5aDrReportHeartTrouble) (raw info of gq_chestpain_dr).

Categorical

Derived Dr reported heart trouble

New for R8. A5. Has your doctor ever told you that you have heart trouble? derived from GQV1_A5aDrReportHeartTrouble GQV3_A5aDrReportHeartTrouble GQV4_A5aDrReportHeartTrouble after cleaning/harmonisation (see GQ_ChestPain_dr). 2 = Yes; 3 = No; -7 = not applicable/answered but undetermined; -1 = left blank;

Categorical

GQ_ChestPain_ever

New in R8. A5. Have you ever had any pain or discomfort in your chest? If no proceed to question 7. If yes please answer the next question. (from GQV1_A5bChestPain GQV3_A5bChestPain GQV4_A5bChestPain) (raw info of gq_chestpain_ever).

Categorical

A5. Chest pain ever

A5. Chest pain ever: 2=Yes; 3=No; -1=left blank

Categorical

A3. Chest pain ever

A3. Have you ever had any pain or discomfort in your chest? If no proceed to question 7. If yes please answer the next question. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_ChestPain_normal

New in R8. A5. Do you experience pain or chest discomfort when you walk at an ordinary pace on the level? (from GQV1_A5dChestPainNormalPace GQV3_A5dChestPainNormalPace GQV4_A5dChestPainNormalPace) (raw info of gq_chestpain_normal).

Categorical

A5. Chest discomfort from walking

A5. Chest discomfort from walking: 2=Yes; 3=No; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Chest discomfort from walking

A3. Do you experience pain or chest discomfort when you walk at an ordinary pace on the level? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_ChestPain_stop

New in R8. A5. If you stand still what happens to pain or chest discomfort? (from GQV1_A5fChestDiscomfortAfterStopping GQV3_A5fChestDiscomfortAfterStopping GQV4_A5fChestDiscomfortAfterStopping) (raw info of gq_chestpain_stop).

Categorical

A5. Chest discomfort after stopping

A5. Chest discomfort after stopping: 1=it gose away; 2=it remains the same or gets worse; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Chest discomfort after stopping

A3. If you stand still what happens to pain or chest discomfort? derived from GQ_V3.0_24/04: 1=it goes away;2=it remains the same or gets worse;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_ChestPain_uphill

New in R8. A5. Do you experience pain or chest discomfort when you walk uphill or hurry? (from GQV1_A5cChestPainUphill GQV3_A5cChestPainUphill GQV4_A5cChestPainUphill) (raw info of gq_chestpain_uphill).

Categorical

A5. Chest discomfort from walking uphill

A5. Chest discomfort from walking uphill: 2=Yes; 3=No; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Chest discomfort from walking uphill

A3. Do you experience pain or chest discomfort when you walk uphill or hurry? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_comments

New in R8. GQ. Additional comments made on any page with page number and text. TEXT. (from GQV1_FSGQComments GQV3_FSGQComments GQV4_FSGQComments)

Text

Shift work

Phase 2 data.

Real

Weekday go to bed time

Phase 2 data. Questionnaire reads C15. Sleeping patterns. Think about what time you went to sleep and you got up on a typical day in the last 4 weeks. If you had variable sleeping patterns (eg you did shift work) please record the typical time you went to bed and got up on weekdays and on weekend days. Please use 24 hr clock format. At what time did you go to bed on a weekday? -1 = left blank;

Time

Weekday wake time

Phase 2 data. Questionnaire reads C15. Sleeping patterns. Think about what time you went to sleep and you got up on a typical day in the last 4 weeks. If you had variable sleeping patterns (eg you did shift work) please record the typical time you went to bed and got up on weekdays and on weekend days. Please use 24 hr clock format. At what time did you wake up on a weekday? -1 = left blank;

Time

Weekend day go to bed time

Phase 2 data. Questionnaire reads C15. Sleeping patterns. Think about what time you went to sleep and you got up on a typical day in the last 4 weeks. If you had variable sleeping patterns (eg you did shift work) please record the typical time you went to bed and got up on weekdays and on weekend days. Please use 24 hr clock format. At what time did you go to bed on a weekend day? -1 = left blank;

Time

Weekend day wake time

Phase 2 data. Questionnaire reads C15. Sleeping patterns. Think about what time you went to sleep and you got up on a typical day in the last 4 weeks. If you had variable sleeping patterns (eg you did shift work) please record the typical time you went to bed and got up on weekdays and on weekend days. Please use 24 hr clock format. At what time did you wake up on a weekend day? -1 = left blank;

Time

Journey to Work1 from

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Mode of trsprt for journey to Wrk1

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Journey to Work1 to

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Journey to Work2 from

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Mode of trsprt for journey to Wrk2

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Journey to Work2 to

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Journey to Work3 from

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Mode of trsprt for journey to Wrk3

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Journey to Work3 to

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Journey to Work4 from

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Mode of trsprt for journey to Wrk4

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Journey to Work4 to

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Time at work from

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Time at work to

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

None

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Return from Wrk1 mode of transport

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Time return from wrk1

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

None

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Return from Wrk2 mode of transport

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Time return from wrk2

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

None

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Return from Wrk3 mode of transport

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Time return from wrk3

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

None

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Return from Wrk4 mode of transport

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = Walk; 2 = Cycle; 3 = Bus/train; 4 = Car/motorcycle

Categorical

Time return from wrk4

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. Time

Time

Do not travel direct to work

Phase 2 data. Questionnaire reads D16. Transportation/commuting patterns for work. Think about how you got to work on a typical day in the last 4 weeks. Which main mode(s) of transport did you use and what time did you start (different parts of) your journey to work? Similarly; think of your journey home which may or may not be the same sequence; just in reverse. Please use 24hr clock format; e.g. 08:30 and 16:30. If your usual journey home involves going vigorous intensity activity another location; include that in the table. 1 = I dont usually travel direct from work to home.

Categorical

C8. Meal while using an electric device

C8. How often do you eat your meal while watching television or video? derived from GQ_V3.0_24/04: 1=<1/wk;2=1/wk;3=2-4 times/wk;4=5-6 times/wk;5=once/d;6=>1/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

C10. Snack while using an electric device

C10. How often do you eat your meal while watching television or video? derived from GQ_V3.0_24/04: 1=<1/wk;2=1/wk;3=2-4 times/wk;4=5-6 times/wk;5=once/d;6=>1/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

D8. food tolerance to some foods

D8. food tolerance to some foods: 2=Yes; -7=not applicable/answered but undetermined

Categorical

C13. food tolerance or avoidance against some foods

C13. Special diet concerning intolerance to some foods (eg dairy fibre fish) derived from GQ_V3.0_24/04: 2=Yes;-7=not applicable/answered but undetermined

Categorical

C13. Intermittent Fasting; 5:2 etc.

C13. Intermittent Fasting; 5:2 etc. derived from GQ_V3.0_24/04: 2=Yes;-7=not applicable/answered but undetermined

Categorical

D8. gluten-free diet

D8. gluten-free diet: 2=Yes; -7=not applicable/answered but undetermined

Categorical

C13. gluten-free diet

C13. Special diet avoiding gluten (gluten-free diet) derived from GQ_V3.0_24/04: 2=Yes;-7=not applicable/answered but undetermined

Categorical

GQ_Diet_halal

New in R8. D8. Currently on a Halal diet. (from GQV1_D8hHalal GQV3_D8hHalal GQV4_D8hHalal) (raw info of gq_diet_halal).

Categorical

D8. Special diet - Halal diet

D8. Special diet - Halal diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Halal diet

C13. Currently on a Halal diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Diet_kosh

New in R8. D8. Currently on a Kosher diet. (from GQV1_D8gKosher GQV3_D8gKosher GQV4_D8gKosher) (raw info of gq_diet_kosh).

Categorical

D8. Special diet - Kosher diet

D8. Special diet - Kosher diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Kosher diet

C13. Currently on a Kosher diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

D8. lacto-free diet

D8. lacto-free diet: 2=Yes; -7=not applicable/answered but undetermined

Categorical

C13. lacto-free diet

C13. Special diet avoiding dairy products (lacto-free diet) derived from GQ_V3.0_24/04: 2=Yes;-7=not applicable/answered but undetermined

Categorical

GQ_Diet_lowc

New in R8. D8. Currently on a low carbohydrate diet eg Atkins Diet. (from GQV1_D8dLCD GQV3_D8dLCD GQV4_D8dLCD) (raw info of gq_diet_lowc).

Categorical

D8. Special diet - Low carbohydrate diet

D8. Special diet - Low carbohydrate diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Low carbohydrate diet

C13. Currently on a low carbohydrate diet eg Atkins Diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Diet_lowf

New in R8. D8. Currently on a low fat diet. (from GQV1_D8cLFD GQV3_D8cLFD GQV4_D8cLFD) (raw info of gq_diet_lowf).

Categorical

D8. Special diet - Low fat diet

D8. Special diet - Low fat diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Low fat diet

C13. Currently on a low fat diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

D8. Other special diets

D8. Other special diets: 2=Yes; -7=not applicable/answered but undetermined

Categorical

C13. Other special diets

C13. Special diet not classified to a specific type derived from GQ_V3.0_24/04: 2=Yes;-7=not applicable/answered but undetermined

Categorical

D8. Diet w/o meat

D8. Diet w/o meat: 1=vegan/vegetarian; 2=Pescetarian/ovo-vegetarian/low meat; -7=not applicable/answered but undetermined

Categorical

C13. Diet w/o meat

C13. Special diet not eating meat as vegans/vegetarians or as semi vegetarians eating fish (eg Pescetarian diet) or chicken or eggs derived from GQ_V3.0_24/04: 1=vegan/vegetarian;2=Pescetarian/ovo-vegetarian/low meat;-7=not applicable/answered but undetermined

Categorical

GQ_Diet_oth

New in R8. D8. Currently on an other diet. Please describe. TEXT

Text

GQ_Diet_slim

New in R8. D8. Currently on a 'Slimmers World' diet. (from GQV1_d8bSW GQV3_D8bSW GQV4_D8bSW) (raw info of gq_diet_slim).

Categorical

D8. Special diet - Slimmers World' diet

D8. Special diet - Slimmers World' diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Slimmers World' diet

C13. Currently on a 'Slimmers World' diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Diet_veg

New in R8. D8. Currently on a vegetarian diet. (from GQV1_D8eVegetarian GQV3_D8eVegetarian GQV4_D8eVegetarian) (raw info of gq_diet_veg).

Categorical

GQ_Diet_vegan

New in R8. D8. Currently on a vegan diet. (from GQV1_D8fVegan GQV3_D8fVegan GQV4_D8fVegan) (raw info of gq_diet_vegan).

Categorical

D8. Special diet - Vegan diet

D8. Special diet - Vegan diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Vegan diet

C13. Currently on a vegan diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

D8. Special diet - Vegetarian diet

D8. Special diet - Vegetarian diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Vegetarian diet

C13. Currently on a vegetarian diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

D8. Diet for wt manage/loss

D8. Diet for wt manage/loss: 2=Yes; -7=not applicable/answered but undetermined

Categorical

C13. Diet for wt manage/loss

C13. Special diet for weight loss derived from GQ_V3.0_24/04: 2=Yes;-7=not applicable/answered but undetermined

Categorical

GQ_Diet_ww

New in R8. D8. Currently on a 'Weight Watchers' diet. (from GQV1_D8aWW GQV3_D8aWW GQV4_D8aWW) (raw info of gq_diet_ww).

Categorical

D8. Special diet - Weight Watchers' diet

D8. Special diet - Weight Watchers' diet: 1=Yes for <6 m; 2=Yes for 6 m or longer; -7=not applicable/answered but undetermined; -1=left blank

Categorical

C13. Special diet - Weight Watchers' diet

C13. Currently on a 'Weight Watchers' diet. derived from GQ_V3.0_24/04: 1=Yes for <6 m;2=Yes for 6 m or longer;-7=not applicable/answered but undetermined;-1=left blank

Categorical

Overall health rating

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E1. Overall; how would you rate your health during the past 4 weeks? 1 = Excellent; 2 = Very good; 3 = Good; 4 = Fair; 5 = Poor; 6 = Very poor

Categorical

PA limited by health problems

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E2. During the past 4 weeks; how much did physical health problems limit your usual physical activities (walking; climbing stairs)? 1 = Not at all; 2 = Very little; 3 = Somewhat; 4 = Quite a lot; 5 = Could not do physical activities;

Categorical

Daily activities limited by health

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E3. During the past 4 weeks; how much difficulty did you have doing your daily work; both inside and outside the home; because of your physical health? 1 = Not at all; 2 = Very little; 3 = Somewhat; 4 = Quite a lot; 5 = Could not do daily work;

Categorical

Body pain

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E4. How much bodily pain have you had during the past 4 weeks? 1 = None; 2 = Very mild; 3 = Mild; 4 = Moderate; 5 = Severe; 6 = Very severe;

Categorical

Energy

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E5. During the past 4 weeks; how much energy did you have? 1 = Very much; 2 = Quite a bit; 3 = Some; 4 = A little; 5 = None;

Categorical

Social activities limited by health

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E6. During the past 4 weeks; how much did your physical health or emotional problems limit your usual social activities with family or friends? 1 = Not at all; 2 = Very little; 3 = Somewhat; 4 = Quite a lot; 5 = Could not do social activities;

Categorical

Emotional problems

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E7. During the past 4 weeks; how much have you been bothered by emotional problems (such as feeling anxious; depressed or irritable)? 1 = Not at all; 2 = Slightly; 3 = Moderately; 4 = Quite a lot; 5 = Extremely;

Categorical

Other activities limited by emotional problems

Phase 2 data. Questionnaire reads Self-Perceived Health Status. Mark the box that best describes your answer. E8. During the past 4 weeks; how much did personal or emotional problems keep you from doing your usual work; studies; or other daily activities? 1 = Not at all; 2 = Very little; 3 = Somewhat; 4 = Quite a lot; 5 = Could not do daily activities;

Categorical

Body outline yourself age 10

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Yourself at Age 10. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

Body outline yourself age 20

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Yourself at Age 20. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

Body outline yourself age 40

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Yourself at Age 40. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

Body outline yourself age current

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Yourself Currently. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

Body outline Fthr middle age

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Father in middle age. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

Weight at age 20 in Kg

Phase 2 data. Questionnaire reads E9. Approximately how much did you weigh when you were about 20 years old? In Kg

Real

Weight at age 20 in lbs

Phase 2 data. Questionnaire reads E9. Approximately how much did you weigh when you were about 20 years old? In lbs

Real

Weight at age 20 in Stone

Phase 2 data. Questionnaire reads E9. Approximately how much did you weigh when you were about 20 years old? In Stone

Real

Body outline Mthr middle age

Phase 2 data. Questionnaire reads E9. Which of the diagrams shown below best depicts your body outline at a given age and that of your parents when they were middle aged? Mother in middle age. Image 1 slimmest = 1 to Image 9 fattest = 9

Real

GQ_Eatout

New in R8. D3. On average how often do you eat a meal outside of the home (restaurants pubs fast-food outlets etc)? (from GQV1_D3EatOut GQV3_D3EatOut GQV4_D3EatOut) (raw info of gq_eatout).

Categorical

D3. How often eat out

D3. How often eat out: 1=<1/wk; 2=1/wk; 3=2-4 times/wk; 4=5-6 times/wk; 5=once/d; 6=>1/d; -1=left blank

Categorical

C6. How often eat out

C6. How often eat out: 1=<1/wk;2=1/wk;3=2-4 times/wk;4=5-6 times/wk;5=once/d;6=>1/d;-1=left blank

Categorical

GQ_Eat_Drink0204

New in R8. D7. Had a drink only snack between 2am - 4am E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D611dDrink GQV3_D611dDrink GQV4_D711dDrink) (raw info of gq_eat_drink0204).

Categorical

D7. Eating pattern - Drink only snack 2-4am

D7. Eating pattern - Drink only snack 2-4am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 2-4am

C11. Had a drink only snack between 2am - 4am E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink0406

New for R8. D7. Had a drink only snack between 4am - 6am E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D612dDrink GQV3_D612dDrink GQV4_D712dDrink) (raw info of gq_eat_drink0406)

Categorical

D7. Eating pattern - Drink only snack 4-6am

D7. Eating pattern - Drink only snack 4-6am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 4-6am

C11. Had a drink only snack between 4am - 6am E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink0608

New in R8. D7. Had a drink only snack between 6am - 8am E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D601dDrink GQV3_D601dDrink GQV4_D701dDrink) (raw info of gq_eat_drink0608).

Categorical

D7. Eating pattern - Drink only snack 6-8am

D7. Eating pattern - Drink only snack 6-8am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 6-8am

C11. Had a drink only snack between 6am - 8am E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink0810

New in R8. D7. Had a drink only snack between 8am - 10am E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D602dDrink GQV3_D602dDrink GQV4_D702dDrink) (raw info of gq_eat_drink0810).

Categorical

D7. Eating pattern - Drink only snack 8-10am

D7. Eating pattern - Drink only snack 8-10am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 8-10am

C11. Had a drink only snack between 8am - 10am E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink1012

New in R8. D7. Had a drink only snack between 10am - 12pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D603dDrink GQV3_D603dDrink GQV4_D703dDrink) (raw info of gq_eat_drink1012).

Categorical

D7. Eating pattern - Drink only snack 10am-12pm

D7. Eating pattern - Drink only snack 10am-12pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 10am-12pm

C11. Had a drink only snack between 10am - 12pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink1214

New in R8. D7. Had a drink only snack between 12pm - 2pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D604dDrink GQV3_D604dDrink GQV4_D704dDrink) (raw info of gq_eat_drink1214).

Categorical

D7. Eating pattern - Drink only snack 12-2pm

D7. Eating pattern - Drink only snack 12-2pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 12-2pm

C11. Had a drink only snack between 12pm - 2pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink1416

New in R8. D7. Had a drink only snack between 2pm - 4pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D605dDrink GQV3_D605dDrink GQV4_D705dDrink) (raw info of gq_eat_drink1416).

Categorical

D7. Eating pattern - Drink only snack 2-4pm

D7. Eating pattern - Drink only snack 2-4pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 2-4pm

C11. Had a drink only snack between 2pm - 4pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink1618

New in R8. D7. Had a drink only snack between 4pm - 6pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D606dDrink GQV3_D606dDrink GQV4_D706dDrink) (raw info of gq_eat_drink1618).

Categorical

D7. Eating pattern - Drink only snack 4-6pm

D7. Eating pattern - Drink only snack 4-6pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 4-6pm

C11. Had a drink only snack between 4pm - 6pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink1820

New in R8. D7. Had a drink only snack between 6pm - 8pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D607dDrink GQV3_D607dDrink GQV4_D707dDrink) (raw info of gq_eat_drink1820).

Categorical

D7. Eating pattern - Drink only snack 6-8pm

D7. Eating pattern - Drink only snack 6-8pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 6-8pm

C11. Had a drink only snack between 6pm - 8pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink2022

New in R8. D7. Had a drink only snack between 8pm - 10pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D608dDrink GQV3_D608dDrink GQV4_D708dDrink) (raw info of gq_eat_drink2022).

Categorical

D7. Eating pattern - Drink only snack 8-10pm

D7. Eating pattern - Drink only snack 8-10pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 8-10pm

C11. Had a drink only snack between 8pm - 10pm E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink2224

New in R8. D7. Had a drink only snack between 10pm - 12am E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D609dDrink GQV3_D609dDrink GQV4_D709dDrink) (raw info of gq_eat_drink2224).

Categorical

D7. Eating pattern - Drink only snack 10pm-12am

D7. Eating pattern - Drink only snack 10pm-12am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 10pm-12am

C11. Had a drink only snack between 10pm - 12am E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Drink2402

New in R8. D7. Had a drink only snack between 12am - 2am E.g. drinks with some milk or sugar in; not low calorie drinks or water. (from GQV1_D610dDrink GQV3_D610dDrink GQV4_D710dDrink) (raw info of gq_eat_drink2402).

Categorical

D7. Eating pattern - Drink only snack 0-2am

D7. Eating pattern - Drink only snack 0-2am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Drink only snack 0-2am

C11. Had a drink only snack between 12am - 2am E.g. drinks with some milk or sugar in; not low calorie drinks or water. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_fish

New in R8. D7. During the course of last year how many times a week did you eat Medium serving of Fish and fish products. (not asked in GQv4) (from GQV1_D7dFish GQV3_D7dFish ) (raw info of gq_eat_fish).

Categorical

D7. Frequency (servings/week) of eating Fish (v1 and v3)

D7. Frequency (servings/week) of eating Fish (v1 and v3): -8=not asked (GQ version difference); -1=left blank

Real

GQ_Eat_fruit

New in R8. D7. During the course of last year how many times a week did you eat Medium serving or 1 fruit of Fruit and fruit products (not including fruit juice). (not asked in GQv4) (from GQV1_D7cFruit GQV3_D7cFruit ) (raw info of gq_eat_fruit).

Categorical

D7. Frequency (servings/week) of eating fruit (v1 and v3)

D7. Frequency (servings/week) of eating fruit (v1 and v3): -8=not asked (GQ version difference); -1=left blank

Real

GQ_Eat_Light0204

New in R8. D7. Had a light meal between 2am - 4am E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D611bLight GQV3_D611bLight GQV4_D711bLight) (raw info of gq_eat_light0204).

Categorical

D7. Eating pattern - Light meal 2-4am

D7. Eating pattern - Light meal 2-4am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 2-4am

C11. Had a light meal between 2am - 4am E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light0406

New in R8. D7. Had a light meal between 4am - 6am E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D612bLight GQV3_D612bLight GQV4_D712bLight) (raw info of gq_eat_light0406).

Categorical

D7. Eating pattern - Light meal 4-6am

D7. Eating pattern - Light meal 4-6am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 4-6am

C11. Had a light meal between 4am - 6am E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light0608

New in R8. D7. Had a light meal between 6am - 8am E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D601bLight GQV3_D601bLight GQV4_D701bLight) (raw info of gq_eat_light0608).

Categorical

D7. Eating pattern - Light meal 6-8am

D7. Eating pattern - Light meal 6-8am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 6-8am

C11. Had a light meal between 6am - 8am E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light0810

New in R8. D7. Had a light meal between 8am - 10am E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D602bLight GQV3_D602bLight GQV4_D702bLight) (raw info of gq_eat_light0810).

Categorical

D7. Eating pattern - Light meal 8-10am

D7. Eating pattern - Light meal 8-10am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 8-10am

C11. Had a light meal between 8am - 10am E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light1012

New in R8. D7. Had a light meal between 10am - 12pm E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D603bLight GQV3_D603bLight GQV4_D703bLight) (raw info of gq_eat_light1012).

Categorical

D7. Eating pattern - Light meal 10am-12pm

D7. Eating pattern - Light meal 10am-12pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 10am-12pm

C11. Had a light meal between 10am - 12pm E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light1214

New in R8. D7. Had a light meal between 12pm -2pm E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D604bLight GQV3_D604bLight GQV4_D704bLight) (raw info of gq_eat_light1214).

Categorical

D7. Eating pattern - Light meal 12-2pm

D7. Eating pattern - Light meal 12-2pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 12-2pm

C11. Had a light meal between 12pm -2pm E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light1416

New in R8. D7. Had a light meal between 2pm - 4pm E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D605bLight GQV3_D605bLight GQV4_D705bLight) (raw info of gq_eat_light1416).

Categorical

D7. Eating pattern - Light meal 2-4pm

D7. Eating pattern - Light meal 2-4pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 2-4pm

C11. Had a light meal between 2pm - 4pm E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light1618

New in R8. D7. Had a light meal between 4pm - 6pm E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D606bLight GQV3_D606bLight GQV4_D706bLight) (raw info of gq_eat_light1618).

Categorical

D7. Eating pattern - Light meal 4-6pm

D7. Eating pattern - Light meal 4-6pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 4-6pm

C11. Had a light meal between 4pm - 6pm E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light1820

New in R8. D7. Had a light meal between 6pm - 8pm E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D607bLight GQV3_D607bLight GQV4_D707bLight) (raw info of gq_eat_light1820).

Categorical

D7. Eating pattern - Light meal 6-8pm

D7. Eating pattern - Light meal 6-8pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 6-8pm

C11. Had a light meal between 6pm - 8pm E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light2022

New in R8. D7. Had a light meal between 8pm - 10pm E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D608bLight GQV3_D608bLight GQV4_D708bLight) (raw info of gq_eat_light2022).

Categorical

D7. Eating pattern - Light meal 8-10pm

D7. Eating pattern - Light meal 8-10pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 8-10pm

C11. Had a light meal between 8pm - 10pm E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light2224

New in R8. D7. Had a light meal between 10pm - 12am E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D609bLight GQV3_D609bLight GQV4_D709bLight) (raw info of gq_eat_light2224).

Categorical

D7. Eating pattern - Light meal 10pm-12am

D7. Eating pattern - Light meal 10pm-12am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 10pm-12am

C11. Had a light meal between 10pm - 12am E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Light2402

New in R8. D7. Had a light meal between 12am - 2am E.g. porridge cereal toast sandwiches soup salad omelette. (from GQV1_D610bLight GQV3_D610bLight GQV4_D710bLight) (raw info of gq_eat_light2402).

Categorical

D7. Eating pattern - Light meal 0-2am

D7. Eating pattern - Light meal 0-2am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Light meal 0-2am

C11. Had a light meal between 12am - 2am E.g. porridge cereal toast sandwiches soup salad omelette. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main0204

New in R8. D7. Had a main meal between 2am - 4am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D611aMain GQV3_D611aMain GQV4_D711aMain) (raw info of gq_eat_main0204).

Categorical

D7. Eating pattern - Main meal 2-4am

D7. Eating pattern - Main meal 2-4am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 2-4am

C11. Had a main meal between 2am - 4am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main0406

New in R8. D7. Had a main meal between 4am - 6am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D612aMain GQV3_D612aMain GQV4_D712aMain) (raw info of gq_eat_main0406).

Categorical

D7. Eating pattern - Main meal 4-6am

D7. Eating pattern - Main meal 4-6am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 4-6am

C11. Had a main meal between 4am - 6am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main0608

New in R8. D7. Had a main meal between 6am - 8am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D601aMain GQV3_D601aMain GQV4_D701aMain) (raw info of gq_eat_main0608).

Categorical

D7. Eating pattern - Main meal 6-8am

D7. Eating pattern - Main meal 6-8am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 6-8am

C11. Had a main meal between 6am - 8am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main0810

New in R8. D7. Had a main meal between 8am - 10am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D602aMain GQV3_D602aMain GQV4_D702aMain) (raw info of gq_eat_main0810).

Categorical

D7. Eating pattern - Main meal 8-10am

D7. Eating pattern - Main meal 8-10am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 8-10am

C11. Had a main meal between 8am - 10am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main1012

New in R8. D7. Had a main meal between 10am - 12pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D603aMain GQV3_D603aMain GQV4_D703aMain) (raw info of gq_eat_main1012).

Categorical

D7. Eating pattern - Main meal 10am-12pm

D7. Eating pattern - Main meal 10am-12pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 10am-12pm

C11. Had a main meal between 10am - 12pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main1214

New in R8. D7. Had a main meal between 12pm - 2pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D604aMain GQV3_D604aMain GQV4_D704aMain) (raw info of gq_eat_main1214).

Categorical

D7. Eating pattern - Main meal 12-2pm

D7. Eating pattern - Main meal 12-2pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 12-2pm

C11. Had a main meal between 12pm - 2pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main1416

New in R8. D7. Had a main meal between 2pm - 4pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D605aMain GQV3_D605aMain GQV4_D705aMain) (raw info of gq_eat_main1416).

Categorical

D7. Eating pattern - Main meal 2-4pm

D7. Eating pattern - Main meal 2-4pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 2-4pm

C11. Had a main meal between 2pm - 4pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main1618

New in R8. D7. Had a main meal between 4pm - 6pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D606aMain GQV3_D606aMain GQV4_D706aMain) (raw info of gq_eat_main1618).

Categorical

D7. Eating pattern - Main meal 4-6pm

D7. Eating pattern - Main meal 4-6pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 4-6pm

C11. Had a main meal between 4pm - 6pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main1820

New in R8. D7. Had a main meal between 6pm - 8pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D607aMain GQV3_D607aMain GQV4_D707aMain) (raw info of gq_eat_main1820).

Categorical

D7. Eating pattern - Main meal 6-8pm

D7. Eating pattern - Main meal 6-8pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 6-8pm

C11. Had a main meal between 6pm - 8pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main2022

New in R8. D7. Had a main meal between 8pm - 10pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D608aMain GQV3_D608aMain GQV4_D708aMain) (raw info of gq_eat_main2022).

Categorical

D7. Eating pattern - Main meal 8-10pm

D7. Eating pattern - Main meal 8-10pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 8-10pm

C11. Had a main meal between 8pm - 10pm E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main2224

New in R8. D7. Had a main meal between 10pm - 12am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D609aMain GQV3_D609aMain GQV4_D709aMain) (raw info of gq_eat_main2224).

Categorical

D7. Eating pattern - Main meal 10pm-12am

D7. Eating pattern - Main meal 10pm-12am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 10pm-12am

C11. Had a main meal between 10pm - 12am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Main2402

New in R8. D7. Had a main meal between 12am - 2am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. (from GQV1_D610aMain GQV3_D610aMain GQV4_D710aMain) (raw info of gq_eat_main2402).

Categorical

D7. Eating pattern - Main meal 0-2am

D7. Eating pattern - Main meal 0-2am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Main meal 0-2am

C11. Had a main meal between 12am - 2am E.g. cooked dish meat with potatoes pizza lasagne fish and chips burgers fried breakfast. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_meat

New in R8. D7. During the course of last year how many times a week did you eat Medium serving of Meat meat products and meat dishes (including bacon ham or chicken).(not asked in GQv4) (from GQV1_D7eMeat GQV3_D7eMeat ) (raw info of gq_eat_meat).

Categorical

D7. Frequency (servings/week) of eating Meat (v1 and v3)

D7. Frequency (servings/week) of eating Meat (v1 and v3): -8=not asked (GQ version difference); -1=left blank

Real

GQ_Eat_salads

New in R8. D7. During the course of last year how many times a week did you eat Medium serving of Salads. (not asked in GQv4) (from GQV1_D7bSalad GQV3_D7bSalad ) (raw info of gq_eat_salads).

Categorical

D7. Frequency (servings/week) of eating salads (v1 and v3)

D7. Frequency (servings/week) of eating salads (v1 and v3): -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Real

GQ_Eat_Snack0204

New in R8. D7. Had a snack between 2am - 4am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D611cSnack GQV3_D611cSnack GQV4_D711cSnack) (raw info of gq_eat_snack0204).

Categorical

D7. Eating pattern - Snack 2-4am

D7. Eating pattern - Snack 2-4am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 2-4am

C11. Had a snack between 2am - 4am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack0406

New in R8. D7. Had a snack between 4am - 6am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D612cSnack GQV3_D612cSnack GQV4_D712cSnack) (raw info of gq_eat_snack0406).

Categorical

D7. Eating pattern - Snack 4-6am

D7. Eating pattern - Snack 4-6am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 4-6am

C11. Had a snack between 4am - 6am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack0608

New in R8. D7. Had a snack between 6am - 8am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D601cSnack GQV3_D601cSnack GQV4_D701cSnack) (raw info of gq_eat_snack0608).

Categorical

D7. Eating pattern - Snack 6-8am

D7. Eating pattern - Snack 6-8am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 6-8am

C11. Had a snack between 6am - 8am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack0810

New in R8. D7. Had a snack between 8am - 10am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D602cSnack GQV3_D602cSnack GQV4_D702cSnack) (raw info of gq_eat_snack0810).

Categorical

D7. Eating pattern - Snack 8-10am

D7. Eating pattern - Snack 8-10am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 8-10am

C11. Had a snack between 8am - 10am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack1012

New in R8. D7. Had a snack between 10am - 12pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D603cSnack GQV3_D603cSnack GQV4_D703cSnack) (raw info of gq_eat_snack1012).

Categorical

D7. Eating pattern - Snack 10am-12pm

D7. Eating pattern - Snack 10am-12pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 10am-12pm

C11. Had a snack between 10am - 12pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack1214

New in R8. D7. Had a snack between 12pm - 2pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D604cSnack GQV3_D604cSnack GQV4_D704cSnack) (raw info of gq_eat_snack1214).

Categorical

D7. Eating pattern - Snack 12-2pm

D7. Eating pattern - Snack 12-2pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 12-2pm

C11. Had a snack between 12pm - 2pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack1416

New in R8. D7. Had a snack between 2pm - 4pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D605cSnack GQV3_D605cSnack GQV4_D705cSnack) (raw info of gq_eat_snack1416).

Categorical

D7. Eating pattern - Snack 2-4pm

D7. Eating pattern - Snack 2-4pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 2-4pm

C11. Had a snack between 2pm - 4pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack1618

New in R8. D7. Had a snack between 4pm - 6pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D606cSnack GQV3_D606cSnack GQV4_D706cSnack) (raw info of gq_eat_snack1618).

Categorical

D7. Eating pattern - Snack 4-6pm

D7. Eating pattern - Snack 4-6pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 4-6pm

C11. Had a snack between 4pm - 6pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack1820

New in R8. D7. Had a snack between 6pm - 8pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D607cSnack GQV3_D607cSnack GQV4_D707cSnack) (raw info of gq_eat_snack1820).

Categorical

D7. Eating pattern - Snack 6-8pm

D7. Eating pattern - Snack 6-8pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 6-8pm

C11. Had a snack between 6pm - 8pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack2022

New in R8. D7. Had a snack between 8pm - 10pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D608cSnack GQV3_D608cSnack GQV4_D708cSnack) (raw info of gq_eat_snack2022).

Categorical

D7. Eating pattern - Snack 8-10pm

D7. Eating pattern - Snack 8-10pm: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 8-10pm

C11. Had a snack between 8pm - 10pm E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack2224

New in R8. D7. Had a snack between 10pm - 12am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D609cSnack GQV3_D609cSnack GQV4_D709cSnack) (raw info of gq_eat_snack2224).

Categorical

D7. Eating pattern - Snack 10pm-12am

D7. Eating pattern - Snack 10pm-12am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 10pm-12am

C11. Had a snack between 10pm - 12am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_Snack2402

New in R8. D7. Had a snack between 12am - 2am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. (from GQV1_D610cSnack GQV3_D610cSnack GQV4_D710cSnack) (raw info of gq_eat_snack2402).

Categorical

D7. Eating pattern - Snack 0-2am

D7. Eating pattern - Snack 0-2am: 2=ticked; -1=left blank

Categorical

C11. Eating pattern - Snack 0-2am

C11. Had a snack between 12am - 2am E.g. biscuit cake fruit sweets chocolate crisps nuts ice cream. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Eat_veg

New in R8. D7. During the course of last year how many times a week did you eat Medium serving of Vegetables (not including potatoes). (not asked in GQv4) (from GQV1_D7aVeg GQV3_D7aVeg ) (raw info of gq_eat_veg).

Categorical

D7. Frequency (servings/week) of eating Vegetables (v1 and v3)

D7. Frequency (servings/week) of eating Vegetables (v1 and v3): -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Real

GQ_Edu_age

New in R8. C7. At what age did you finish full time education (in years)? (Years of age) (from GQV1_DMC42aAgeEndFTE GQV3_C7AgeEndFTE GQV4_C7AgeEndFTE) (raw info of gq_edu_age) -10=text info;

Real

C7. Age finished full time education

C7. Age finished full time education: -7=not applicable/answered but undetermined; -5=Current or not finished; -1=left blank

Time

B7. Age finished full time education

B7. At what age did you finish full time education (in years)? (Years of age) - derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-5=Current or not finished;-1=left blank

Real

GQ_Edu_Alev

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). GCE A Level AS level Highers (from GQV1_DMc4eALevels GQV3_C6eALevels GQV4_C6eALevels) (raw info of gq_edu_alev).

Categorical

C6. A level qualification

C6. A level qualification: 2=ticked; -1=left blank

Categorical

B6. A level qualification

B6. Do you have any of the following qualifications? (tick all applicable). GCE A Level AS level Highers derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_apprentice

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Completed Apprenticeship. (from GQV1_DMC4hApprenticeship GQV3_C6hApprenticeship GQV4_C6hApprenticeship) (raw info of gq_edu_apprentice).

Categorical

C6. Completed apprenticeship

C6. Completed apprenticeship: 2=ticked; -1=left blank

Categorical

B6. Completed apprenticeship

B6. Do you have any of the following qualifications? (tick all applicable). Completed Apprenticeship. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_CSE

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). CSE. (from GQV1_DMC4bCSE GQV3_C6bCSE GQV4_C6bCSE) (raw info of gq_edu_cse).

Categorical

C6. CSE qualification

C6. CSE qualification: 2=ticked; -1=left blank

Categorical

B6. CSE qualification

B6. Do you have any of the following qualifications? (tick all applicable). CSE. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_degree

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). University Degree. (from GQV1_DMC4kDegree GQV3_C6kDegree GQV4_C6kDegree) (raw info of gq_edu_degree).

Categorical

C6. University degree qualification

C6. University degree qualification: 2=ticked; -1=left blank

Categorical

B6. University degree qualification

B6. Do you have any of the following qualifications? (tick all applicable). University Degree. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_GCSE

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). GCE O level or GCSE. (from GQV1_DMC4cGCSE GQV3_C6cGCSE GQV4_C6cGCSE) (raw info of gq_edu_gcse).

Categorical

C6. O level or GCSE qualification

C6. O level or GCSE qualification: 2=ticked; -1=left blank

Categorical

B6. O level or GCSE qualification

B6. Do you have any of the following qualifications? (tick all applicable). GCE O level or GCSE. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_HNC

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Teaching Diploma HNC NVQ. (from GQV1_DMC4jHMC GQV3_C6jHNC GQV4_C6jHNC) (raw info of gq_edu_hnc).

Categorical

C6. HNC or NVQ qualification

C6. HNC or NVQ qualification: 2=ticked; -1=left blank

Categorical

B6. HNC or NVQ qualification

B6. Do you have any of the following qualifications? (tick all applicable). Teaching Diploma HNC NVQ. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_HND_NVQ

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). HND or GNVQ. (from GQV1_DMC4gHND_GNVQ GQV3_C6gHND_NVQ GQV4_C6gHND_NVQ) (raw info of gq_edu_hnd_nvq).

Categorical

C6. HND or GNVQ qualification

C6. HND or GNVQ qualification: 2=ticked; -1=left blank

Categorical

B6. HND or GNVQ qualification

B6. Do you have any of the following qualifications? (tick all applicable). HND or GNVQ. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_matricul

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Matriculation. (from GQV1_DMC4dMatriculation GQV3_C6dMatriculation GQV4_C6dMatriculation) (raw info of gq_edu_matricul).

Categorical

C6. Matriculation qualification

C6. Matriculation qualification: 2=ticked; -1=left blank

Categorical

B6. Matriculation qualification

B6. Do you have any of the following qualifications? (tick all applicable). Matriculation. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_none

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). None. (from GQV1_DMC4nNone GQV3_C6nNone GQV4_C6nNone) (raw info of gq_edu_none).

Categorical

C6. No Qualifications

C6. No Qualifications: 2=ticked; -1=left blank

Categorical

GQ_Edu_others

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Other please describe. TEXT

Text

C6. Other qualifications

C6. Other qualifications: 2=GCE A level AS level or highers; 3=Secretarial coll exams; 4=CSE; 5=Technical coll exams city and guilds; 6=Teaching diploma HNC NVQ; 7=GCE O level or GCSE; 8=HND GNVQ; 9=University Degree; 12=Trade certificates; -7=not applicable/answered but undetermined; -5=unclear qualification (eg qual outside the UK); -3=>1 qualification written in text description; -1=left blank

Categorical

B6. Other qualifications

B6. Do you have any of the following qualifications? (tick all applicable). Other please describe. TEXT derived from GQ_V3.0_24/04: 2=GCE A level AS level or highers;3=Secretarial coll exams;4=CSE;5=Technical coll exams city and guilds;6=Teaching diploma HNC NVQ;7=GCE O level or GCSE;8=HND GNVQ;9=University Degree;12=Trade certificates;-7=not applicable/answered but undetermined;-5=unclear qualification (eg qual outside the UK);-3=>1 qualification written in text description;-1=left blank

Categorical

GQ_Edu_qual

New in R8. C2. What training or qualifications are (were) needed for your job ? (only asked in GQv1 25/11/2004 and 26/01/2005) TEXT

Text

GQ_Edu_secret

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Secretarial College Exams. (from GQV1_DMC4iSecretarial GQV3_C6iSecretarial GQV4_C6iSecretarial) (raw info of gq_edu_secret).

Categorical

C6. Secretarial College qualification

C6. Secretarial College qualification: 2=ticked; -1=left blank

Categorical

B6. Secretarial College qualification

B6. Do you have any of the following qualifications? (tick all applicable). Secretarial College Exams. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_SLC

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). School Leaving certificate. (from GQV1_DMC4aSLC GQV3_C6aSLC GQV4_C6aSLC) (raw info of gq_edu_slc).

Categorical

C6. School Leaving Certificate

C6. School Leaving Certificate: 2=ticked; -1=left blank

Categorical

B6. School Leaving Certificate

B6. Do you have any of the following qualifications? (tick all applicable). School Leaving certificate. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_TechCG

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Technical College exams City & Guilds. (from GQV1_DMC4fC_G GQV3_C6fC_G GQV4_C6fC_G) (raw info of gq_edu_techcg).

Categorical

C6. Technical or C&G qualification

C6. Technical or C&G qualification: 2=ticked; -1=left blank

Categorical

B6. Technical or C&G qualification

B6. Do you have any of the following qualifications? (tick all applicable). Technical College exams City & Guilds. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Edu_trade

New in R8. C6. Do you have any of the following qualifications? (tick all applicable). Trade Certificates.(from GQV1_DMC4lTradeCertificate GQV3_C6lTradeCertificate GQV4_C6lTradeCertificate) (raw info of gq_edu_trade).

Categorical

C6. Trade certificate qualification

C6. Trade certificate qualification: 2=ticked; -1=left blank

Categorical

B6. Trade certificate qualification

B6. Do you have any of the following qualifications? (tick all applicable). Trade Certificates. derived from GQ_V3.0_24/04: 2=ticked;-1=left blank

Categorical

GQ_Emp_n

New in R8. C3. Number of employees. How many people work (worked) for your employer? For self-employed: how many people you employ(ed)? (see GQ_emp_n_supervise for GQv1). (from GQV3_C3NumberPeopleEmployed GQV4_C3NumberPeopleEmployed) (raw info of gq_emp_n).

Categorical

C3. Number of people employed

C3. Number of people employed: 1=1 to 24 people; 2=>25; -7=not applicable/answered but undetermined; -1=left blank

Categorical

B3. Number of people employed

B3. Number of employees. How many people work (worked) for your employer? For self-employed: how many people you employ(ed)? derived from GQ_V3.0_24/04: 1=1 to 24 people;2=>25;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Emp_n_supervise

New in R8. C2. Number of employees. How many people work (worked) at the place where you work (worked)? For self-employed how many people you employ(ed)? (asked in GQv3 and GQv4 differently). Derived from GQV1_DMC2fNumerEmployees with cleaning/harmonisation (see GQ_Emp_n_supervise);

Categorical

C2. Number of people employed (if employers-v1 only)

C2. Number of people employed (if employers- v1 only): 1=1 to 24 people; 2=>25; -8=not asked (GQ version difference); -1=left blank

Categorical

GQ_Emp_occup

New in R8. C5. Occupation type: Current/last job. (not asked in GQv1) 8 categ. (from GQV3_C5Occupation GQV4_C5Occupation) (raw info of gq_emp_occup).

Categorical

C5. Occupation type

C5. Occupation type: 1=Mod prof job; 2=Clerical; 3=Senior manage; 4=Tech; 5=Semi-routine; 6=Routine; 7=Mid manage; 8=Traditional prof; -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Categorical

B5. Occupation type

B5. Occupation type: Current/last job. 8 categ. 1 Mod prof job 2 Clerical 3 Senior manage 4 tech 5 Semi-routine 6 Routine 7 Mid manage 8 Traditional prof derived from GQ_V3.0_24/04: 1=Mod prof job;2=Clerical;3=Senior manage;4=Tech;5=Semi-routine;6=Routine;7=Mid manage;8=Traditional prof;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Emp_partner

New in R8. C6. Is (was) he working as an employee or self-employed. (only asked in GQv1 25/11/2004 and 26/01/2005). (from GQV1_DMC6bPartnersEmployeeStatus ) (raw info of gq_emp_partner).

Categorical

C6. Partners employment status (v1 only)

C6. Partners employment status (v1 only): 1=as an employee; 2=as self-employed; -8=not asked (GQ version difference); -1=left blank

Categorical

GQ_Emp_supervise

New in R8. C4. Present or your last job: Supervisory status: Do (did) you supervise any other employees. (from GQV1_DMC2eSupervisoryStatus GQV3_C4SupervisoryStatus GQV4_C4SupervisoryStatus) (raw info of gq_emp_supervise).

Categorical

C4. Supervisory status without numbers

C4. Supervisory status without numbers: 2=Yes; 3=No; -1=left blank

Categorical

B4. Supervisory status without numbers

B4. Present or your last job: Supervisory status: Do (did) you supervise any other employees. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Emp_type

New in R8. C2. Do (did) you work as an employee or are (were) you self-employed? (GQv1 answer means slightly different things) (from GQV1_DMC2dEmployeeType GQV3_C2EmployeeType GQV4_C2EmployeeType) (raw info of gq_emp_type).

Categorical

C2. Employment type with employee data

C2. Employment type with employee data: 1=Employee; 2=Self employed w employees; 3=Self employed w/o employees; -7=not applicable/answered but undetermined; -1=left blank

Categorical

B2. Employment type with employee data

B2. Do (did) you work as an employee or are (were) you self-employed? derived from GQ_V3.0_24/04: 1=Employee;2=Self employed w employees;3=Self employed w/o employees;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_eth

New in R8. F1. Ethnicity. (not asked in GQv1) (2001 Census class.) (from GQV3_F1Ethnicity GQV4_F1Ethnicity) (raw info of gq_eth).

Categorical

F1. Ethnicity - 5 categories

F1. Ethnicity - 5 categories: 1=White; 2=South Asia; 3=Blacks; 4=East Asia; 5=Others; -8=not asked (GQ version difference); -1=left blank

Categorical

F1. Ethnicity - 17 categories

F1. Ethnicity - 17 categories: 1=British; 2=Irish; 3=other white; 4=Wh&Blk Carib; 5=Wh&Blk African; 6=Wh&Asian; 7=mixed; 8=India; 9=Pakistani; 10=Bangladeshi; 11=Any Asian; 12=Carib; 13=Afican; 14=any black; 15=Chinese; 16=any others; 17=not stated; -8=not asked (GQ version difference); -1=left blank

Categorical

A9b. Age of facial hair

A9b. If known at what age did you grow facial hair? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

A9b. Age of facial hair unknown

A9b. If known; at what age did you grow facial hair? Don't know. derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined 1=don’t know

Categorical

A9a. When facial hair.

A9a. When did you start to grow facial hair? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_FeelFaint

New in R8. A5. Do you often feel faint or have spells of severe dizziness? (from GQV1_A5gFeelFaint GQV3_A5gFeelFaint GQV4_A5gFeelFaint) (raw info of gq_feelfaint).

Categorical

A5. Feel faint or dizzy

A5. Feel faint or dizzy: 2=Yes; 3=No; -1=left blank

Categorical

A3. Feel faint or dizzy

A3. Do you often feel faint or have spells of severe dizziness? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

A5. Dr reported heart trouble

A5. Dr reported heart trouble: -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Dr reported heart trouble

A3. Has your doctor ever told you that you have heart trouble? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Homecooked

New in R8. D2. When eating your main meal at home how often do you usually eat Home cooked meals. (from GQV1_D2cEatHomeCookedMeals GQV3_D2cEatHomeCookedMeals GQV4_D2cEatHomeCookedMeals) (raw info of gq_homecooked).

Categorical

D2. How often eat home cooked meals

D2. How often eat home cooked meals: 1=never or rarely; 2=1-2 times/wk; 3=3-5 times/wk; 4=>5 times/wk; -1=left blank

Categorical

C5. How often eat home cooked meals

C5. When eating your main meal at home how often do you usually eat Home cooked meals. derived from GQ_V3.0_24/04: 1=never or rarely;2=1-2 times/wk;3=3-5 times/wk;4=>5 times/wk;-1=left blank

Categorical

GQ_Htn_dr

New in R8. A5. Has a doctor ever told you that your blood pressure was too high? (from GQV1_A5hDrReportBPHigh GQV3_A5hDrReportBPHigh GQV4_A5hDrReportBPHigh) (raw info of gq_htn_dr).

Categorical

A5. Dr reported high blood pressure

A5. Dr reported high blood pressure: 2=Yes; 3=No; -1=left blank

Categorical

A3. Dr reported high blood pressure

A3. Has a doctor ever told you that your blood pressure was too high? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Htn_trt

New in R8. A5. If you have been told that your blood pressure was too high are you now on treatment? (from GQV1_A5iTreatmentHighBP GQV3_A5iTreatmentHighBP GQV4_A5iTreatmentHighBP) (raw info of gq_htn_trt).

Categorical

A5. Treatment for high blood pressure

A5. Treatment for high blood pressure: 2=Yes; 3=No; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Treatment for high blood pressure

A3. If you have been told that your blood pressure was too high are you now on treatment? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Income

New in R8. C8. What is your total combined household income? In pounds sterling (from GQV1_DMC3HouseholdIncome GQV3_C8HouseholdIncome GQV4_C8HouseholdIncome) (raw info of gq_income).

Categorical

C8. Household income

C8. Household income: 1=<20000; 2=20000-40000; 3=>=40000; -7=not applicable/answered but undetermined; -1=left blank

Categorical

B8. Household income

B8. What is your total combined household income? derived from GQ_V3.0_24/04: 1=<20000;2=20000-40000;3=>=40000;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Job_full

New in R8. C1. What is your current work status? In work full time i.e. more than 30 hours per week. (from GQV1_DMC1aFullTime GQV3_C1aFullTime GQV4_C1aFullTime) (raw info of gq_job_full).

Categorical

C1. Job status - full time >30 h/wk

C1. Job status - full time >30 h/wk: 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - full time >30 h/wk

B1. What is your current work status? In work full time i.e. more than 30 hours per week. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Job_house

New in R8. C1. What is your current work status? Keeping house. (from GQV1_DMC1cKeepingHouse GQV3_C1cKeepingHouse GQV4_C1cKeepingHouse) (raw info of gq_job_house).

Categorical

C1. Job status - house-keeping

C1. Job status - house-keeping : 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - house-keeping

B1. What is your current work status? Keeping house. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Job_newjob

New in R8. C1. What is your current work status? Waiting to start a new job already obtained. (from GQV1_DMC1eObtainedNewJob GQV3_C1eObtainedNewJob GQV4_C1eObtainedNewJob) (raw info of gq_job_newjob).

Categorical

C1. Job status - obtained new job

C1. Job status - obtained new job: 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - obtained new job

B1. What is your current work status? Waiting to start a new job already obtained. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Job_oth

New in R8. C1. What is your current work status? If other please specify. TEXT

Text

C1. Job status others assigned integers 1 to 8 for classification

C1. Job status others assigned integers 1 to 8 for classification: 1=full time >30 h/wk; 2=part time <30 h/wk; 3=house-keeping; 4=retired; 6=unemployed; 7=temporarily sick; 8=permanently sick; -7=not applicable/answered but undetermined; -5=volunteer / unclassified; -3=student (unemployed) or studying while working

Categorical

B1. Job status others assigned integers 1 to 8 for classification

B1. What is your current work status? If other please specify. TEXT derived from GQ_V3.0_24/04: 1=full time >30 h/wk;2=part time <30 h/wk;3=house-keeping;4=retired;6=unemployed;7=temporarily sick;8=permanently sick;-7=not applicable/answered but undetermined;-5=volunteer / unclassified;-3=student (unemployed) or studying while working

Categorical

GQ_Job_part

New in R8. C1. What is your current work status? Part time work i.e. less than 30 hours per week. (from GQV1_DMC1bPartTime GQV3_C1bPartTime GQV4_C1bPartTime) (raw info of gq_job_part).

Categorical

GQ_Job_partner

New in R8. C6. Only for women who currently live with their partner. Please could you give us some details about your husband/partner's present or last job. (asked only in GQv1) TEXT -8=not assessed (version difference) (from GQV1_DMC6aPartnersJobDetails )

Text

GQ_Job_partnermanage

New in R8. C6. Does (did) he supervise or have management responsibility for the work of other people? (only in GQv1 25/11/2004 and 26/01/2005). (from GQV1_DMC6cPartnersManagementStatus ) (raw info of gq_job_partnermanage).

Categorical

C6. Partners management status (v1 only)

C6. Partners management status (v1 only): 1=No; 2=Yes 1 to 24 people; 3=Yes 25 or more people; -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Categorical

C1. Job status - part time <30 h/wk

C1. Job status - part time <30 h/wk: 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - part time <30 h/wk

B1. What is your current work status? Part time work i.e. less than 30 hours per week. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Job_retired

New in R8. C1. What is your current work status? Wholly retired from work (from GQV1_DMC1dRetired GQV3_C1dRetired GQV4_C1dRetired) (raw info of gq_job_retired).

Categorical

C1. Job status - retired

C1. Job status - retired : 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - retired

B1. What is your current work status? Wholly retired from work. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Job_sick

New in R8. C1. What is your current work status? Permanently sick or disabled. (from GQV1_DMC1hPermSick GQV3_C1hPermSick GQV4_C1hPermSick) (raw info of gq_job_sick).

Categorical

C1. Job status - permanently sick

C1. Job status - permanently sick: 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - permanently sick

B1. What is your current work status? Permanently sick or disabled. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Job_tempsick

New in R8. C1. What is your current work status? Out of work as temporarily sick. (from GQV1_DMC1gTempSick GQV3_C1gTempSick GQV4_C1gTempSick) (raw info of gq_job_tempsick).

Categorical

C1. Job status - temporarily sick

C1. Job status - temporarily sick: 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - temporarily sick

B1. What is your current work status? Out of work as temporarily sick. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Job_title

New in R8. C2. Please could you give us some details about your present or last job. What is (was) the title of your job ? (only asked in GQv1 25/11/2004 and 26/01/2005) TEXT

Text

GQ_Job_type

New in R8. C2. What kind of work do (did) you do in your job ? (only asked in GQv1 25/11/2004 and 26/01/2005) TEXT

Text

GQ_Job_unempl

New in R8. C1. What is your current work status? Unemployed and looking for work. (from GQV1_DMC1fUnemployed GQV3_C1fUnemployed GQV4_C1fUnemployed) (raw info of gq_job_unempl).

Categorical

C1. Job status - unemployed

C1. Job status - unemployed : 2=Yes; 3=No; -1=left blank

Categorical

B1. Job status - unemployed

B1. What is your current work status? Unemployed and looking for work. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Marit

New in R8. C12. What is your marital status? (Not asked in GQv1 and some GQv3 Mar2006 and May2006 versions) (from GQV3_C12MaritalStatus GQV4_C12MaritalStatus) (raw info of gq_marit).

Categorical

C12. Marital status (not in v1 and some in v3)

C12. Marital status (not in v1 and some in v3): 1=Single; 2=Married or living as married; 3=widowed; 4=Separated; 5=Divorced; -8=not asked (GQ version difference); -1=left blank

Categorical

B13. Marital status (not in v1 and some in v3)

B12. What is your marital status? (Not asked in GQv1 and some GQv3 Mar2006 and May2006 versions) derived from GQ_V3.0_24/04: 1=Single;2=Married or living as married;3=widowed;4=Separated;5=Divorced;-1=left blank;7=not applicable/answered but undetermined

Categorical

GQ_Meds

New in R8. A1. Are you taking any tablets or medicines at the moment? (from GQV1_A1OnMedication GQV3_A1OnMedication GQV4_A1OnMedication) (raw info of gq_meds).

Categorical

A1. On medication

A1. On medication: 2=Yes; 3=No; -1=left blank

Categorical

A1. On medication

A1. Are you taking any tablets or medicines at the moment? derived from GQ_V3.0_24/04: 2=Yes; 3=No;-1=left blank

Categorical

GQ_Med_a

New in R8. A2a. Current Medication Name of drug a.

Text

A2. ACE inhibitor

A2. ACE inhibitor: 2=yes self-reported; -1=left blank

Categorical

A2. ACE inhibitor

A2. Current self-reported meds - ACE inhibitor (eg perindopril enalapril lisinipril ramipril) derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Any self-reported medications

A2. Any self-reported medications: 2=yes self-reported; -1=left blank

Categorical

A2. Any self-reported medications

A2. Current self-reported meds - Any self-reported meds including unclassified meds: 1) weight loss drugs (orlistat/xenital) 2) drugs for smoking cessation / alcoholism / nasal discomfort / non-specific migraine 3) device for contraception 4) tamoxifen zoledex anastrozole exemestane or other anti-cancer drugs 5) related to specific organs (eg thyroid prostate bladder lung eye bone skin joint) unless noted on pain killers or autoimmune diseases. derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Angiotensin receptor blocker

A2. Angiotensin receptor blocker: 2=yes self-reported; -1=left blank

Categorical

A2. Angiotensin receptor blocker

A2. Current self-reported meds - Angio II receptor blocker (eg losartan olmesartan telmisartan valsartan) derived from GQ_V3.0_24/04: 2=yes self-reported;1=left blank

Categorical

A2. Aspirin

A2. Aspirin: 2=yes self-reported; -3=yes for pain/non-cardiac purpose; -1=left blank

Categorical

A2. Aspirin

A2. Current self-reported meds - Aspirin derived from GQ_V3.0_24/04: 2=yes self-reported;-3=yes for pain/non-cardiac purpose;-1=left blank

Categorical

A2. Drugs for autoimmune diseases

A2. Drugs for autoimmune diseases: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs for autoimmune diseases

A2. Current self-reported meds - Drugs for an autoimmune disease (eg carbimazole azathioprine dovobet fludrocortisone hydroxychloroquine methotrexate sulfasalazine) including: 1) gastro-intestinal conditions with a reason for Colitis or Coeliac disease 2) rheumatoid arthritis / psoriasis / systemic lupus erythematosus 3) multiple sclerosis 4) Addisons or Graves or Hashimotos diseases -- not including non-specific arthritis osteoarthritis asthma gout irritable-bowel syndrome and other immunological diseases without autoimmunity derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

GQ_Med_b

New in R8. A2b. Current Medication Name of drug b.

Text

A2. Beta blocker

A2. Beta blocker: 2=yes self-reported; -5=yes for psychiatric symptoms rather than migraine; -3=yes for migraine; -1=left blank

Categorical

A2. Beta blocker

A2. Current self-reported meds - Beta blocker (eg atenolol bisoprolol carvediol levobunolol emtoprolol sotalol propranolol) not including beta-blokers used as an eye drop derived from GQ_V3.0_24/04: 2=yes self-reported;5=yes for psychiatric symptoms rather than migraine;-3=yes for migraine;-1=left blank

Categorical

GQ_Med_bnf_a

New in R8. A2a. Current Medication BNF Code for drug a added by research team.

Text

GQ_Med_bnf_b

New in R8. A2b. Current Medication BNF Code for drug b added by research team. (from GQV1_A2bCurrentMedicationBNFCode GQV3_A2bCurrentMedicationBNFCode GQV4_A2bCurrentMedicationBNFCode).

Text

GQ_Med_bnf_c

New in R8. A2c. Current Medication BNF Code for drug c added by research team.

Text

GQ_Med_bnf_d

New in R8. A2d. Current Medication BNF Code for drug d added by research team.

Text

GQ_Med_bnf_e

New in R8. A2e. Current Medication BNF Code for drug e added by research team.

Text

GQ_Med_bnf_f

New in R8. A2f. Current Medication BNF Code for drug f added by research team.

Text

GQ_Med_bnf_g

New in R8. A2g. Current Medication BNF Code for drug g added by research team.

Text

GQ_Med_bnf_h

New in R8. A2h. Current Medication BNF Code for drug h added by research team.

Text

A2. Drugs for irritable bowel syndrome or constipation or others

A2. Drugs for irritable bowel syndrome or constipation or others: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs for irritable bowel syndrome or constipation or others

A2. Current self-reported meds - Drugs related to bowel conditions (alverine azathioprine buscopan lactulose lansoprazole mebeverine senna) including laxatives or IBS or others: marked if use of drugs for gastro-intestinal conditions indicated IBS Colitis Coeliac disease or Crohns disease derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

GQ_Med_c

New in R8. A2c. Current Medication Name of drug c. (from GQV1_A2cCurrentMedicationName GQV3_A2cCurrentMedicationName GQV4_A2cCurrentMedicationName).

Text

A2. Any cardiovascular drugs except blood-clotting drug such as tranexamte

A2. Any cardiovascular drugs except blood-clotting drug such as tranexamte: 2=yes self-reported; -5=yes indicated for non-cardiac use (eg beta-blockers for migraine); -1=left blank

Categorical

A2. Any cardiovascular drugs except blood-clotting drug such as tranexamte

A2. Current self-reported meds - Any cardiovascular drugs except blood-clotting drug (eg tranexamic acid) for menstrual blood loss. Broad categories are lipid-lowering drugs / ace inhibitors / ARB / beta blockers / diuretics / nitrates / Ca channele blockers / anticoagulants derived from GQ_V3.0_24/04: 2=yes self-reported;-5=yes indicated for non-cardiac use (eg beta-blockers for migraine);-1=left blank

Categorical

A2. Drugs acting on the central nervous system

A2. Drugs acting on the central nervous system: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs acting on the central nervous system

A2. Current self-reported meds - Any drugs acting on a central nervous system including 1) pain killers 2) psychiatric disorders 3) acid reflax derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

GQ_Med_d

New in R8. A2d. Current Medication Name of drug d.

Text

A2. Anti-depressant for depression mood anxiety or stress

A2. Anti-depressant for depression mood anxiety or stress: 2=yes self-reported; -1=left blank

Categorical

A2. Anti-depressant for depression mood anxiety or stress

A2. Current self-reported meds - Anti-depressant coded for depression anxiety stress panic attack (eg citalopram dosulepin duloxetine escitalopram fluoxetine mirtazapine paroxetine prozac seroxat quetiapine sertraline venlafaxine zopiclone) derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Diuretics

A2. Diuretics: 2=yes self-reported; -1=left blank

Categorical

A2. Diuretics

A2. Current self-reported meds - Diuretics (eg frusemide hydrochlorothiazide indapamide spironolactone zestoretic) including diuretic drugs used for water retention - not including ones used as eye drop derived from GQ_V3.0_24/04: 2=yes self-reported -1=left blank

Categorical

A2. Anti-diabetic medications (metformin) for polycystic ovary syndrome

A2. Anti-diabetic medications (metformin) for polycystic ovary syndrome: 2=yes self-reported; -1=left blank

Categorical

A2. Anti-diabetic medications (metformin) for polycystic ovary syndrome

A2. Current self-reported meds - Anti-diabetic meds (metformin) - all for polycystic ovary syndrome - participants should be free from diabetes at baseline. derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

GQ_Med_dose_a

New in R8. A2a. Current Medication Dose of drug a.

Text

GQ_Med_dose_b

New in R8. A2b. Current Medication Dose of drug b.

Text

GQ_Med_dose_c

New in R8. A2c. Current Medication Dose of drug c.

Text

GQ_Med_dose_d

New in R8. A2d. Current Medication Dose of drug d.

Text

GQ_Med_dose_e

New in R8. A2e. Current Medication Dose of drug e.

Text

GQ_Med_dose_f

New in R8. A2f. Current Medication Dose of drug f.

Text

GQ_Med_dose_g

New in R8. A2g. Current Medication Dose of drug g.

Text

GQ_Med_dose_h

New in R8. A2h. Current Medication Dose of drug h.

Text

GQ_Med_e

New in R8. A2e. Current Medication Name of drug e.

Text

GQ_Med_f

New in R8. A2f. Current Medication Name of drug f.

Text

GQ_Med_g

New in R8. A2g. Current Medication Name of drug g.

Text

A2. Drugs for gastric conditions

A2. Drugs for gastric conditions: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs for gastric conditions

A2. Current self-reported meds - Drugs for gastric conditions (eg gaviscon lansoprazole omeprazole ranitidine) including acid reflux a heartburn symptom or others caused by a gastrointestinal side-effect of other drugs derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

GQ_Med_h

New in R8. A2h. Current Medication Name of drug h.

Text

A2. Herbal supplements including non-herbal ones (eg ginko)

A2. Herbal supplements including non-herbal ones (eg ginko): 2=yes self-reported; -1=left blank

Categorical

A2. Herbal supplements including non-herbal ones (eg ginko)

A2. Current self-reported meds - Herbal supplements including plant oils for menopausal symptoms or other specific conditions (eg black cohosh primrose oil St Johns wort) - also including non-herbal plant-origin supplements (ginko garlic and others). derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Exogenous hormone including testosterone - not for endometriosis

A2. Exogenous hormone including testosterone - not for endometriosis: 2=yes self-reported; 3=no self-reported; -1=left blank

Categorical

A2. Exogenous hormone including testosterone - not for endometriosis

A2. Current self-reported meds - Exogenous hormone use (GQV1_A3HRT accounted for) (eg estradiol elleste climesse climagest sandrena premarine premique progynova tibolone vagefem provera testosterone) 1) including testosteron use among men 2) not including non-hormonal agents for menopausal conditions (drugs for osteoporosis / psychiatric drugs / St Johns Wort / primrose oil / black cohosh) 3) not including exogenous hormone use for endometriosis or for excess menstual blood loss 4) including HRT requiring transdermal dosage derived from GQ_V3.0_24/04: 2=yes self-reported;3=no self-reported;-1=left blank

Categorical

GQ_Med_hrt_v1

New in R8. A3. For women only. Are you on Hormone replacement therapy? Only asked in GQv1 (25/11/2004 and 26/01/2005). (from GQV1_A3HRT ) (raw info of gq_med_hrt_v1).

Categorical

A2. Drugs against infection

A2. Drugs against infection: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs against infection

A2. Current self-reported meds - Drugs (eg flucoxacillin lymecycline aciclovir metronidazole amoxicillin ) against 1) fungal infection including terbinafine 2) topical abnormality with use of lymecycline / minocycline / ocytetracycline 3) urinary tract infection 4) HIV derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Drugs for inflammation including NSAIDS antihistamine and others

A2. Drugs for inflammation including NSAIDS antihistamine and others: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs for inflammation including NSAIDS antihistamine and others

A2. Current self-reported meds - Drugs for inflammatory conditions (not including eczema) 1) irritable bowel syndrome crohn coeliac disease and colitus 2) asthma 3) inflammatory arthritis including gout non-autoimmune diseases and autoimmune diseases 4) topical medicine if specifically lupus or psoriasis was noted 5) hay fever / allergy / epipen for anaphylaxis 7) use of NSAIDS 8) antihistamine drugs (eg promethazine hydroxyzine acrivastine desloratadine fexofenadine levocetirizine loratadine mizolastine) derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Any lipid lowering drug (including omega-3 PUFA as BNF defines)

A2. Any lipid lowering drug (including omega-3 PUFA as BNF defines): 2=yes self-reported; -1=left blank

Categorical

A2. Any lipid lowering drug (including omega-3 PUFA as BNF defines)

A2. Current self-reported meds - Any lipid lowering drug (including omega-3 PUFA as BNF lists). Bile acid sequestrants are not included if use for a intestinal disorder was specified derived from GQ_V3.0_24/04: 2=yes self-reported;1=left blank

Categorical

A2. Nitrates including meds for transdermal dosage

A2. Nitrates including meds for transdermal dosage: 2=yes self-reported; -1=left blank

Categorical

A2. Nitrates including meds for transdermal dosage

A2. Current self-reported meds - Nitrates (eg trinitrate GTNspray nicorandil) including meds for transdermal dosage - considered as a cardiac drug unless notified derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. NSAIDs for any purpose not including aspirin (gq_med_asp)/topical NSAIDs

A2. NSAIDs for any purpose not including aspirin (gq_med_asp)/topical NSAIDs: 2=yes self-reported; -1=left blank

Categorical

A2. NSAIDs for any purpose not including aspirin (gq_med_asp)/topical NSAIDs

A2. Current self-reported meds - NSAIDs for any purpose (eg celecoxib diclofenac etodolac ibuprofen meloxicam naprosyn omeprazole) 1) not including aspirin (see gq_med_asp) 2) not including topical ones (eg eumovate cream) 3) coded in use of a gastrointestinal med against NSAID use derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Dieatry supplements (oils vitamins minerals) for any reasons

A2. Dieatry supplements (oils vitamins minerals) for any reasons: 2=yes self-reported; -1=left blank

Categorical

A2. Dieatry supplements (oils vitamins minerals) for any reasons

A2. Current self-reported meds - Dieatry supplements (oils vitamins minerals) (eg iron calcium zinc vitamin D) derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Oral contraceptive not including non-oral ones

A2. Oral contraceptive not including non-oral ones: 2=yes self-reported; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A2. Oral contraceptive not including non-oral ones

A2. Current self-reported meds - Oral contraceptives (eg cerazetta cilest depo gedarel loestrin marvelon micronor ovranette yasmin) 1) not including non-oral contraception eg (implanon mirena coil) 2) including cerazette for any reasons 3) birth control interpreted as oral contraceptive use 4) not including contraceptive drugs used for endometriosis or abnormal menstruation derived from GQ_V3.0_24/04: 2=yes self-reported;-7=not applicable/answered but undetermined;-1=left blank

Categorical

A2. NSAIDs or others used for pain as gq_med_pain

A2. NSAIDs or others used for pain as gq_med_pain: 2=yes self-reported; -1=left blank

Categorical

A2. NSAIDs or others used for pain as gq_med_pain

A2. Current self-reported meds - NSAIDs or others used for pain as gq_med_pain - including aspirin and beta-blocker used against migrane or for migraine profilaxis derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Any pain killers not classified as NSAIDs/aspirin/b-blockers

A2. Any pain killers not classified as NSAIDs/aspirin/b-blockers: 2=yes self-reported; -1=left blank

Categorical

A2. Any pain killers not classified as NSAIDs/aspirin/b-blockers

A2. Current self-reported meds - Any pain killers not classified as NSAIDs or aspirin (eg paracetamol almotriptan eletriptan frovatriptan naratriptan rizatriptan sumatriptan zolmitriptan pizotifen) or beta-blockers (propranol used for migraine) derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Drugs to aid sleeping - not necessarily sleeping disorder

A2. Drugs to aid sleeping - not necessarily sleeping disorder: 2=yes self-reported; -1=left blank

Categorical

A2. Drugs to aid sleeping - not necessarily sleeping disorder

A2. Current self-reported meds - Drugs to aid sleeping (etmazapam mirtazapine zopiclone) - mixed with a drug acting on central nervous system to suppress pain or other discomfort derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

A2. Statin

A2. Statin: 2=yes self-reported; -1=left blank

Categorical

A2. Statin

A2. Current self-reported meds - Statin (eg atorvastatin pravastatin rosuvastatin and simvastatin) derived from GQ_V3.0_24/04: 2=yes self-reported;-1=left blank

Categorical

GQ_Med_why_a

New in R8. A2a. Current Medication Reason for taking the drug a.

Text

GQ_Med_why_b

New in R8. A2b. Current Medication Reason for taking the drug b.

Text

GQ_Med_why_c

New in R8. A2c. Current Medication Reason for taking the drug c.

Text

GQ_Med_why_d

New in R8. A2d. Current Medication Reason for taking the drug d.

Text

GQ_Med_why_e

New in R8. A2e. Current Medication Reason for taking the drug e.

Text

GQ_Med_why_f

New in R8. A2f. Current Medication Reason for taking the drug f.

Text

GQ_Med_why_g

New in R8. A2g. Current Medication Reason for taking the drug g.

Text

GQ_Med_why_h

New in R8. A2h. Current Medication Reason for taking the drug h.

Text

GQ_Meno_age

New in R8. A7. If NO how old were you when you stopped having your periods (i.e. your age at menopause in years old)? YEARS of age (from GQV3_A7bAgePeriodsStopped GQV4_A7bAgePeriodsStopped) (raw info of gq_meno_age). number = age in years at menopause;

Categorical

A7. Age menstruation stopped

A7. Age menstruation stopped: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -5=hysterectomy or other answers (see text of GQ_Meno_age); -1=left blank

Time

A7. Age menstruation stopped

A7b. How old were you when your periods stopped completely and permanently? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

A7. Age menstruation stopped. Don't know.

A7b. How old were you when your periods stopped completely and permanently? Don't know. derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined 1=don’t know

Categorical

A7a. Menopause

A7a. Have you reached the menopause? (i.e. your periods have now stopped completely and you believe permanently and your last period was at least six months ago) derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined;2=yes;3=no 4=don’t know

Categorical

A7d. Mother’s age of natural menopause

A7d. What was your mother’s age of natural menopause? (years) derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

A7d. Mother’s age of natural menopause. Don't know.

A7d. What was your mother’s age of natural menopause? Don't know. derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined 1=don’t know

Categorical

A7c. Reason for periods stopping

A7c. What was the reason for your periods stopping? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined 1=natural menopause 2=natural menopause with HRT treatment 3=surgery 4=don’t know 5=others

Categorical

A7c. Reason for periods stopping. others.

A7c. What was the reason for your periods stopping? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined 1=checked for others.

Categorical

GQ_Menstr_age

New in R8. A6. How old were you when you had your first menstrual period (in years)? YEARS of age (from GQV3_A6AgeFirstMenstralPeriod GQV4_A6AgeFirstMenstralPeriod) (raw info of gq_menstr_age).

Real

A6. Age first menstruation

A6. Age first menstruation: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Time

A5. Age first menstruation

A5a. How old were you when you had your first menstrual period? (years) derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

A6b. Days between menstruations

A6b. About how many days are there usually from the first day of one menstrual period to the first day of the next? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

A6c. Irregular cycles.

A6c. Do you have irregular cycles? (i.e. you cannot predict within 5 days in either direction when your next period will start): -1=left blank;-7=not applicable/answered but undetermined;2=yes;3=no

Categorical

A6a. The first day of the last menstrual period.

A6a. On what date was the first day of your last menstrual period? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

GQ_Menstr_still

New in R8. A7. Are you still having menstrual periods? (from GQV3_A7aStillHaveMenstrualPeriods GQV4_A7aStillHaveMenstrualPeriods) (raw info of gq_menstr_still)

Categorical

A7. Still menstruating

A7. Still menstruating: 2=Yes; 3=No; -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Categorical

A5b. Still menstruation

A5b. Are you still having menstrual periods? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined;2=yes;3=no

Categorical

GQ_Nhouse

New in R8. C9. How many people are there in your household? (including children) Count. (from GQV3_C9NumberInHouse GQV4_C9NumberInHouse) (raw info of gq_nhouse).

Real

C9. Number of people in household

C9. Number of people in household: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Integer

B9. Number of people in household

B9. How many people are there in your household? (including children) Count derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Integer

C5. Occup Clerical and intermediate

C5. Occup Clerical and intermediate: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Clerical and intermediate

B5. Occupation type - Clerical and intermediate derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Middle or junir managers

C5. Occup Middle or junir managers: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Middle or junir managers

B5. Occupation type - Middle or junir managers derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Modern professional

C5. Occup Modern professional: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Modern professional

B5. Occupation type - Modern professional derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Routine manual and service occupations

C5. Occup Routine manual and service occupations: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Routine manual and service occupations

B5. Occupation type - Routine manual and service occupations derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Semi-routine manual and service occupations

C5. Occup Semi-routine manual and service occupations: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Semi-routine manual and service occupations

B5. Occupation type - Semi-routine manual and service occupations derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Senior manager or administrators

C5. Occup Senior manager or administrators: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Senior manager or administrators

B5. Occupation type - Senior manager or administrators derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Technical and craft

C5. Occup Technical and craft: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Technical and craft

B5. Occupation type - Technical and craft derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

C5. Occup Traditional professional occupations

C5. Occup Traditional professional occupations: 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

B5. Occup Traditional professional occupations

B5. Occupation type - Traditional professional occupations derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Owncars

New in R8. C10. Do you own a car or van ? (from GQV1_DMC5aCars GQV3_C10Cars GQV4_C10Cars) (raw info of gq_owncars).

Categorical

C10. Own a car or van

C10. Own a car or van: 2=Yes; 3=No; -7=not applicable/answered but undetermined; -1=left blank

Categorical

B10. Own a car or van

B10. Do you own a car or van ? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Ownhouse

New in R8. C11. Do you own or are you buying your own home? (from GQV1_DMC5bOwnHouse GQV3_C11aOwnHouse GQV4_C11aOwnHouse) (raw info of gq_ownhouse).

Categorical

C11. Own house

C11. Own house: 2=Yes; 3=No; -1=left blank

Categorical

B12. Own house

B12. Do you own or are you buying your own home? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_PA_reason

New in R8. A5. Is there any reason you know of that means you should not follow an activity programme even if you wanted to? (from GQV1_A5lReasonNotToDoPA GQV3_A5lReasonNotToDoPA GQV4_A5lReasonNotToDoPA) (raw info of gq_pa_reason).

Categorical

A5. Any reason not to do PA

A5. Any reason not to do PA: 2=Yes; 3=No; -1=left blank

Categorical

A3. Any reason not to do PA

A3. Is there any reason you know of that means you should not follow an activity programme even if you wanted to? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_Preg

New in R8. A5. Are you pregnant? (from GQV1_A5kPregnant GQV3_A5kPregnant GQV4_A5kPregnant) (raw info of gq_preg).

Categorical

A5. Pregnancy status

A5. Pregnancy status: 2=Yes; 3=No; -7=not applicable/answered but undetermined; -1=left blank

Categorical

A3. Pregnancy status

A3. Are you pregnant? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Readymeals

New in R8. D2. When eating your main meal at home how often do you usually eat Ready-made meals/prepared foods. (from GQV1_D2bEatReadyMeals GQV3_D2bEatReadyMeals GQV4_D2bEatReadyMeals) (raw info of gq_readymeals).

Categorical

D2. How often eat ready meals

D2. How often eat ready meals: 1=never or rarely; 2=1-2 times/wk; 3=3-5 times/wk; 4=>5 times/wk; -1=left blank

Categorical

C5. How often eat ready meals

C5. When eating your main meal at home how often do you usually eat Ready-made meals/prepared foods. derived from GQ_V3.0_24/04: 1=never or rarely;2=1-2 times/wk;3=3-5 times/wk;4=>5 times/wk;-1=left blank

Categorical

GQ_Renthouse

New in R8. C11. Do you rent your home?(from GQV1_DMC5cRenHouse GQV3_C11bRentHouse GQV4_C11bRentHouse) (raw info of gq_renthouse).

Categorical

C11. Rent house

C11. Rent house: 2=Yes; 3=No; -1=left blank

Categorical

B12. Rent house

B12. Do you rent your home? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_SelfR_emot

New in R8. E7. Self perceived health. During the past 4 weeks how much have you been bothered by emotional problems (such as feeling anxious depressed or irritable)? (not asked in GQv1) (from GQV3_E7SREmotional GQV4_E7SREmotional) (raw info of gq_selfr_emot).

Categorical

GQ_SelfR_emotwork

New in R8. E8. Self perceived health. During the past 4 weeks how much did personal or emotional problems keep you from doing your usual work studies or other daily activities? (not asked in GQv1) (from GQV3_E8SREmotionalDailyWork GQV4_E8SREmotionalDailyWork) (raw info of gq_selfr_emotwork).

Categorical

E8. Self perceived health - Emotional problems limiting daily work/activities

E8. Self perceived health - Emotional problems limiting daily work/activities: 1=not at all; 2=very little; 3=somewhat; 4=quite a lot; 5=could not do daily activities; -8=not asked (GQ version difference); -1=left blank

Categorical

E8. Self perceived health - Emotional problems limiting daily work/activities

E8. Self perceived health. During the past 4 weeks how much did personal or emotional problems keep you from doing your usual work studies or other daily activities? derived from GQ_V3.0_24/04: 1=not at all;2=very little;3=somewhat;4=quite a lot;5=could not do daily activities;-1=left blank;-7=not applicable/answered but undetermined

Categorical

E7. Self perceived health - Emotional problems

E7. Self perceived health - Emotional problems: 1=not at all; 2=slightly; 3=moderately; 4=quite a lot; 5=extremely; -8=not asked (GQ version difference); -1=left blank

Categorical

E7. Self perceived health - Emotional problems

E7. Self perceived health. During the past 4 weeks how much have you been bothered by emotional problems (such as feeling anxious depressed or irritable)? derived from GQ_V3.0_24/04: 1=not at all;2=slightly;3=moderately;4=quite a lot;5=extremely;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_SelfR_energy

New in R8. E5. Self perceived health. During the past 4 weeks how much energy did you have? (not asked in GQv1) (from GQV3_E5SREnergy GQV4_E5SREnergy) (raw info of gq_selfr_energy).

Categorical

E5. Self perceived health - Energy level

E5. Self perceived health - Energy level: 1=very much; 2=quite a bit; 3=some; 4=a little; 5=none; -8=not asked (GQ version difference); -1=left blank

Categorical

E5. Self perceived health - Energy level

E5. Self perceived health. During the past 4 weeks how much energy did you have? derived from GQ_V3.0_24/04: 1=very much;2=quite a bit;3=some;4=a little;5=none;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_SelfR_health

New in R8. E1. Self perceived health. Overall how would you rate your health during the past 4 weeks? (not asked in GQv1) (from GQV3_E1SRHealth GQV4_E1SRHealth) (raw info of gq_selfr_health).

Categorical

E1. Self perceived health - Self recorded health

E1. Self perceived health - Self recorded health: 1=excellent; 2=very good; 3=good; 4=fair; 5=poor; 6=very poor; -8=not asked (GQ version difference); -1=left blank

Categorical

E1. Self perceived health - Self recorded health

E1. Self perceived health. Overall how would you rate your health during the past 4 weeks? derived from GQ_V3.0_24/04: 1=excellent;2=very good;3=good;4=fair;5=poor;6=very poor;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_SelfR_pa

New in R8. E2. Self perceived health. During the past 4 weeks how much did physical health problems limit your usual physical activities (walking climbing stairs)? (not asked in GQv1) (from GQV3_E2SRPhysicalProblems GQV4_E2SRPhysicalProblems) (raw info of gq_selfr_pa).

Categorical

GQ_SelfR_pain

New in R8. E4. Self perceived health. How much bodily pain have you had during the past 4 weeks? (not asked in GQv1) (from GQV3_E4SRBodilyPain GQV4_E4SRBodilyPain) (raw info of gq_selfr_pain).

Categorical

E4. Self perceived health - Bodily pain

E4. Self perceived health - Bodily pain: 1=none; 2=very mild; 3=mild; 4=moderate; 5=severe; 6=very severe; -8=not asked (GQ version difference); -1=left blank

Categorical

E4. Self perceived health - Bodily pain

E4. Self perceived health. How much bodily pain have you had during the past 4 weeks? ) derived from GQ_V3.0_24/04: 1=none;2=very mild;3=mild;4=moderate;5=severe;6=very severe;-1=left blank;-7=not applicable/answered but undetermined

Categorical

E2. Self perceived health - Physical Activity limited by health problems

E2. Self perceived health - Physical Activity limited by health problems: 1=not at all; 2=very little; 3=somewhat; 4=quite a lot; 5=could not do physical activities; -8=not asked (GQ version difference); -1=left blank

Categorical

E2. Self perceived health - Physical Activity limited by health problems

E2. Self perceived health. During the past 4 weeks how much did physical health problems limit your usual physycal activities (walking climbing stairs)? derived from GQ_V3.0_24/04: 1=not at all;2=very little;3=somewhat;4=quite a lot;5=could not do physical activities;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_SelfR_social

New in R8. E6. Self perceived health. During the past 4 weeks how much did your physical health or emotional problems limit your social activities with family or friends? (not asked in GQv1) (from GQV3_E6SREmotionalSocial GQV4_E6SREmotionalSocial) (raw info of gq_selfr_social).

Categorical

E6. Self perceived health - Health/emotional problems affecting social activity

E6. Self perceived health - Health/emotional problems affecting social activity: 1=not at all; 2=very little; 3=somewhat; 4=quite a lot; 5=could not do social activities; -8=not asked (GQ version difference); -1=left blank

Categorical

E6. Self perceived health - Health/emotional problems affecting social activity

E6. Self perceived health. During the past 4 weeks how much did your physical health or emotional problems limit your social activities with family or friends? derived from GQ_V3.0_24/04: 1=not at all;2=very little;3=somewhat;4=quite a lot;5=could not do social activities;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_SelfR_work

New in R8. E3. Self perceived health. During the past 4 weeks how much difficulty did you have doing your daily work both inside and outside the home because of your physical health? (not asked in GQv1) (from GQV3_E3SRPhysicalDailyWork GQV4_E3SRPhysicalDailyWork) (raw info of gq_selfr_work).

Categorical

E3. Self perceived health - Difficulty doing daily work due to health problems

E3. Self perceived health - Difficulty doing daily work due to health problems: 1=not at all; 2=very little; 3=somewhat; 4=quite a lot; 5=could not do daily work; -8=not asked (GQ version difference); -1=left blank

Categorical

E3. Self perceived health - Difficulty doing daily work due to health problems

E3. Self perceived health. During the past 4 weeks how much difficulty did you have doing your daily work both inside and outside the home because of your physical health? derived from GQ_V3.0_24/04: 1=not at all;2=very little;3=somewhat;4=quite a lot;5=could not do daily work;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_Sm_agestart

New in R8. B1. At what age did you start smoking? Please enter age in years. (not asked in GQv1) YEARS of age or (from GQV3_B1cAgeStartSmoking GQV4_B1cAgeStartSmoking) (raw info of gq_sm_agestart). number = age in years;

B1. Age started smoking

B1. Age started smoking: -8=not asked (GQ version difference); -7=not applicable/answered but undetermined; -1=left blank

Time

A4. Age started smoking

A4. At what age did you start smoking? Please enter age in years derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

GQ_Sm_cur

New in R8. B1. Do you smoke now? (from GQV3_B1bCurrentlySmoke GQV4_B1bCurrentlySmoke) (raw info of gq_sm_cur).

Categorical

B1. Smoke currently (daily or occasionally)

B1. Smoke currently (daily or occasionally): 2=Yes; 3=No; -8=not asked (GQ version difference); -1=left blank

Categorical

A4. Smoke currently (daily or occasionally)

A4. Do you smoke now? derived from GQ_V3.0_24/04: 2=Yes;3=No;-7=not applicable/answered but undetermined;-1=left blank

Categorical

GQ_Sm_daily

New in R8. B1. Do you smoke daily? (only asked in GQv 1 25/11/2004 and 26/01/2005). (from GQV1_B1aSmokeDaily ) (raw info of gq_sm_daily).

Categorical

B1. Smoking habits

B1. Smoking habits: 1=Never smokers; 2=Former smokers; 3=Current smokers; 4=Ever smokers (unknown for current habit); -7=not applicable/answered but undetermined

Categorical

A4. Smoking habits

A4. Smoking habits based on multiple variables the Fenland Phase 2 general questionnaire GQ_V3.0_24/04: 1=Never smokers;2=Former smokers;3=Current smokers;4=Ever smokers (unknown for current habit);-7=not applicable/answered but undetermined

Categorical

B1. Smoking duration (years)

B1. Smoking duration (years): -8=not asked (GQ version difference); -7=not applicable/answered but undetermined

Time

A4. Smoking duration (years)

A4. Duration of smoking (years) projected from a time of starting smoking and a time of quitting smoking or current smoking habit (if smoking cessation during a certain calendar-time period was noted the period was accounted for as a non-smoking period.) derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-5=former smokers who reported a time of smoking cessation which appeared to be earlier than a starting date.

Real

GQ_Sm_ever

New in R8. B1. Have you ever smoked? If no please go to B2 on the next page. (from GQV1_B1cEverSmoked GQV3_B1aEverSmoked GQV4_B1aEverSmoked) (raw info of gq_sm_ever).

Categorical

B1. Ever smoked

B1. Ever smoked: 2=Yes; 3=No; -1=left blank

Categorical

A4. Ever smoked

A4. Have you ever smoked? If no please go to B2 on the next page. derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

B1. Smoke exposure(grams/day)

B1. Smoke exposure(grams/day): -7=not applicable/answered but undetermined

Real

A4. Smoke exposure(grams/day)

A4. Smoking exposure in volume (grams/day) based on N or gram of smoking with the formula (CIGARETTESx1.25 + CHEROOTSx2x1.25 + CIGARSx3x1.25 + TOBACCO/7) derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined

Real

GQ_Sm_Ncheroots

New in R8. B1. How many cheroots do you or did you smoke a day on average? Rounded to integers. (from GQV1_B1fNumberCherootsPerDay GQV3_B1fNumberCherootsPerDay GQV4_B1fNumberCherootsPerDay) (raw info of gq_sm_ncheroots).

Categorical

B1. N cheroots smoked per day

B1. N cheroots smoked per day: -7=not applicable/answered but undetermined; -1=left blank

Integer

A4. N cheroots smoked per day

A4. How many cheroots do you or did you smoke a day on average? Rounded to integers. derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Integer

GQ_Sm_Ncig

New in R8. B1. How many cigarettes do you or did you smoke a day on average? (rounded to an integer) (from GQV1_B1eNumberCigarettesPerDay GQV3_B1eNumberCigarettesPerDay GQV4_B1eNumberCigarettesPerDay) (raw info of gq_sm_ncig).

Categorical

GQ_Sm_Ncigars

New in R8. B1. How many cigars do you or did you smoke a day on average? Rounded to integers (from GQV1_B1gNumberCigarsPerDay GQV3_B1gNumberCigarsPerDay GQV4_B1gNumberCigarsPerDay) (raw info of gq_sm_ncigars).

Categorical

B1. N cigars per day

B1. N cigars per day: -7=not applicable/answered but undetermined; -1=left blank

Integer

A4. N cigars per day

A4. How many cigars do you or did you smoke a day on average? Rounded to integers derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Integer

B1. N cigarettes per day

B1. N cigarettes per day: -7=not applicable/answered but undetermined; -1=left blank

Integer

A4. N cigarettes per day

A4. How many cigarettes do you or did you smoke a day on average? (rounded to an integer) derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Integer

GQ_Sm_occasion

New in R8. B1. Do you smoke occasionally? (Only asked in GQv1 25/11/2004 and 26/01/2005). (from GQV1_B1bSmokeOccasionally ) (raw info of gq_sm_occasion).

Categorical

B1. Smoking pack-years (N x years)

B1. Smoking pack-years (N x years): -8=not asked (GQ version difference); -7=not applicable/answered but undetermined

Real

A4. Smoking pack-years (N x years)

A4. Smoking cumulative exposure (pack x years) with gq_sm_dur (years) x gq_sm_g / (1.25x20) (assuming 1.25 g per 1 cigarette and 20 cigarretes per 1 pack) derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined

Real

GQ_Sm_tobacco_grm

New in R8. B1. How much do you or did you smoke a day on average? Grams/week. Rounded to integers (from GQV1_B1hTobaccoPerWeek GQV3_B1hTobaccoPerWeek GQV4_B1hTobaccoPerWeek) (raw info of gq_sm_tobacco_grm).

Categorical

B1. Grams of tobacco per week

B1. Grams of tobacco per week: -7=not applicable/answered but undetermined; -1=left blank

Real

A4. Grams of tobacco per week

A4. How much do you or did you smoke a day on average? Grams/week. Rounded to integers derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

GQ_Sm_yearstop

New in R8. B1. If you have stopped smoking in which year did you quit? Calendar YEARS

Real

B1. Year stopped smoking

B1. Year stopped smoking: -7=not applicable/answered but undetermined; -1=left blank

Time

A4. Year stopped smoking

A4. If you have stopped smoking in which year did you quit? Calendar YEARS derived from GQ_V3.0_24/04: -7=not applicable/answered but undetermined;-1=left blank

Real

GQ_Takeaway

New in R8. D2. When eating your main meal at home how often do you usually eat Home delivery or take-away meals. (from GQV1_D2aEatTakeaways GQV3_D2aEatTakeaways GQV4_D2aEatTakeaways) (raw info of gq_takeaway).

Categorical

D2. How often eat take-away

D2. How often eat take-away: 1=never or rarely; 2=1-2 times/wk; 3=3-5 times/wk; 4=>5 times/wk; -1=left blank

Categorical

C5. How often eat take-away

C5. When eating your main meal at home how often do you usually eat Home delivery or take-away meals. derived from GQ_V3.0_24/04: 1=never or rarely;2=1-2 times/wk;3=3-5 times/wk;4=>5 times/wk;-1=left blank

Categorical

B11. TV or computer in a bedroom

B11. Do you have a TV or computer in your bedroom? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

GQ_TV_alc

New in R8. D6. How often drink alcohol while watching TV (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6fAlcohol) (raw info of gq_tv_alc).

Categorical

D6. How often drink alcohol while watching TV

D6. How often drink alcohol while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. How often drink alcohol while watching TV

C12. How often drink alcohol while watching TV (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_eat

New in R8. D4. How often do you eat your meal while watching television or video? (from GQV1_D4EatAndWatchTV GQV3_D4EatAndWatchTV GQV4_D4EatAndWatchTV) (raw info of gq_tv_eat).

Categorical

D4. Meal while watching TV

D4. Meal while watching TV: 1=<1/wk; 2=1/wk; 3=2-4 times/wk; 4=5-6 times/wk; 5=once/d; 6=>1/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C7. Meal while watching TV

C7. How often do you eat your meal while watching television or video? derived from GQ_V3.0_24/04: 1=<1/wk;2=1/wk;3=2-4 times/wk;4=5-6 times/wk;5=once/d;6=>1/d;-1=left blank

Categorical

GQ_TV_frjuice

New in R8. D6. How often did you have Fruit juice while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6gFruitJuice) (raw info of gq_tv_frjuice).

Categorical

D6. Fruit juice while watching TV

D6. Fruit juice while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Fruit juice while watching TV

C12. How often did you have Fruit juice while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_icecream

New in R8. D6. How often did you have Ice cream chocolate mousse while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6cIceCream) (raw info of gq_tv_icecream).

Categorical

D6. Ice cream while watching TV

D6. Ice cream while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Ice cream while watching TV

C12. How often did you have Ice cream chocolate mousse while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_milk

New in R8. D6. How often did you have Milk milkshake hot chocolate while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6iMilk) (raw info of gq_tv_milk).

Categorical

D6. Milk while watching TV

D6. Milk while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Milk while watching TV

C12. How often did you have Milk milkshake hot chocolate while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;8=4/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_others

New in R8. D6. Which other (please list) snacks did you have while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6kOther) (raw info of gq_tv_others).

Categorical

D6. Other snacks while watching TV

D6. Other snacks while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Other snacks while watching TV

C12. Which other (please list) snacks did you have while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;8=4/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_others_txt

New in R8. D6. Which other (please list) snacks did you have while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) TEXT. -8=not assessed (version difference) (from GQV4_D6lOtherText)

Text

GQ_TV_savory

New in R8. D6. How often did you have savoury snacks (crisps salted nuts..) while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6aSavoury) (raw info of gq_tv_savory).

Categorical

D6. Savoury snacks while watching TV

D6. Savoury snacks while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Savoury snacks while watching TV

C12. How often did you have savoury snacks (crisps salted nuts...) while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_snack

New in R8. D5. Apart from meals how often do you snack foods while watching television? (from GQV1_D5SnackAndWatchTV GQV3_D5SnackAndWatchTV GQV4_D5SnackAndWatchTV) (raw info of gq_tv_snack).

Categorical

D5. Snack foods while watching TV

D5. Snack foods while watching TV: 1=never; 2=occasionally; 3=usually; 4=alwyas; -8=not asked (GQ version difference); -1=left blank

Categorical

C9. Snack while watching TV

C9. How often do you eat your meal while watching television or video? derived from GQ_V3.0_24/04: 1=<1/wk;2=1/wk;3=2-4 times/wk;4=5-6 times/wk;5=once/d;6=>1/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_soda

New in R8. D6. How often did you have Soda (coke) while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6eSoda) (raw info of gq_tv_soda).

Categorical

D6. Soda or coke while watching TV

D6. Soda or coke while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Soda or coke while watching TV

C12. How often did you have Soda (coke Ë) while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;8=4/d;9=5/d;10=>5/d;-1=left blank

Categorical

GQ_TV_squash

New in R8. D6. How often did you have squash while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6hSquash) (raw info of gq_tv_squash).

Categorical

D6. Squash while watching TV

D6. Squash while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Squash while watching TV

C12. How often did you have squash while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;8=4/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_swts

New in R8. D6. How often did you have Sweets chocolate(s) (bars) cakes biscuits while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6bSweets) (raw info of gq_tv_swts).

Categorical

D6. Sweets while watching TV

D6. Sweets while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Sweets while watching TV

C12. How often did you have Sweets chocolate(s) (bars) cakes biscuits while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_teacoffee

New in R8. D6. How often did you have tea or coffeewhile watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6jTea_coffee) (raw info of gq_tv_teacoffee).

Categorical

D6. Tea or coffee while watching TV

D6. Tea or coffee while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Tea or coffee while watching TV

C12. How often did you have tea or coffeewhile watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;8=4/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_TV_yoghurt

New in R8. D6. How often did you have Yoghurt rice pudding while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? (Only asked in GQv4) (from GQV4_D6dYoghurt) (raw info of gq_tv_yoghurt).

Categorical

D6. Yoghurt while watching TV

D6. Yoghurt while watching TV: 1=none; 2=1-2/wk; 3=3-4/wk; 4=5-6/wk; 5=once/d; 6=2/d; 7=3/d; 8=4/d; 9=5/d; 10=>5/d; -8=not asked (GQ version difference); -1=left blank

Categorical

C12. Yoghurt while watching TV

C12. How often did you have Yoghurt rice pudding while watching TV in addition to breakfast lunch or dinner (last 4 weeks)? derived from GQ_V3.0_24/04: 1=none;2=1-2/wk;3=3-4/wk;4=5-6/wk;5=once/d;6=2/d;7=3/d;8=4/d;9=5/d;10=>5/d;-1=left blank;-7=not applicable/answered but undetermined

Categorical

GQ_v

New in R8. GQ. Version of the Fenland General Questionnaire (GQ). From GQV3_QVersion and GQV4_QVersion; (raw info of gq_v).

Categorical

A8b. Age of voice break

A8b. If known; at what age did your voice break? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined

Real

Phase 2 data.

Categorical

A8a. When voice break

A8a. When did your voice break? derived from GQ_V3.0_24/04: -1=left blank;-7=not applicable/answered but undetermined 1=younger than average 2=about average age 3=older than average 4=don’t know

Categorical

GQ. Version info

GQ. Version info: 1=GQ v1; 3=GQ v3; 4=GQ v4

Categorical

A3. Walk unaided for 10 minutes

A3. Can you walk unaided for 10 minutes at a moderate pace? derived from GQ_V3.0_24/04: 2=Yes;3=No;-1=left blank

Categorical

OLINK assay GRAP2

Phase 1 OLINK assay data for target GRAP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GRN

Phase 1 OLINK assay data for target GRN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GSAP

Phase 1 OLINK assay data for target GSAP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GSTP1

Phase 1 OLINK assay data for target GSTP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GT

Phase 1 OLINK assay data for target GT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GUSB

Phase 1 OLINK assay data for target GUSB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GZMA

Phase 1 OLINK assay data for target GZMA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GZMB

Phase 1 OLINK assay data for target GZMB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay GZMH

Phase 1 OLINK assay data for target GZMH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum Adiponectin CLEANED

Serum Adiponectin CLEANED in ug/ml. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 0.3.

Categorical

Serum Adiponectin CLEANED Comment

Serum Adiponectin measurement CLEANED comment (on threshold)

Text

Serum Adiponectin Threshold

Serum Adiponectin CLEANED threshold.

Categorical

G_AgeAtTest_Attended

New in R8. Calculated age of participant at first visit; rounded down to whole year. This variable replaces G_AgeAtTest

Calculated age of pt first visit

Phase 2 data. Calculated age of participant at first visit; rounded down to whole year.

Real

Alcohol Amount Consumption

Alcohol consumption amount. Derived from GenQ Qs by DM team JAVA script. 1 unit = 8g ethanol. Calculation: (Beer + Wine + Spirits+ Fort Wine)/7

Real

Alcohol Amount Consumption weekend

Phase 2 data. Alcohol consumption amount averaged per weekend day across fri-sat-sun. Please note: in phase 1 1 unit was defined as 1/2 pint of beer or 1 glass of wine or 1 single measure of spirits or 1 glass of sherry. For phase 2 the units were defined as 1/2 pint of beer or 1/2 glass of wine or 1 single measure of spirits or 1 glass of sherry. Derived from GenQ Qs by DM team JAVA script. Calculation: (Beer + Wine + Spirits+ Fort Wine)/3

Real

Alcohol amount consumption weekday

Phase 2 data. Alcohol consumption amount averaged per weekday across mon-tue-wed-thu. Derived from GenQ Qs by DM team JAVA script. Please note: in phase 1; 1 unit was defined as 1/2 pint of beer or 1 glass of wine or 1 single measure of spirits or 1 glass of sherry. For phase 2 the units were defined as 1/2 pint of beer or 1/2 glass of wine or 1 single measure of spirits or 1 glass of sherry. Calculation: (Beer + Wine + Spirits+ Fort Wine)/4

Real

Alcohol Consumption Frequency

Alcohol consumption frequency. Derived from GenQ Qs by DM team JAVA script. WARNING: CODE DEFINITION (NOT CODES) WRONG IN EARLIER RELEASES.

Categorical

Alcohol consumption frequency

Phase 2 data. Alcohol consumption frequency. Derived from GenQ Qs by DM team JAVA script. 1 = Occasional; 2 = 1-2/week; 3 = 3-4/week; 4 = Daily; 9 = not known; 0 = never;

Categorical

Alcohol History / Status

Current Alcohol Consumption History / Status. Derived from GenQ Qs by DM team JAVA script. If units of beer/wine/spirits and/or fortified wine = >0 then this is automatically adjusted to 4 = current; 0 = never, 1 = not current, 2 = ex, 3 = ever, 4 = current, 9 = not known

Categorical

Alcohol Consumption weekend

Phase 2 data. Current Alcohol Consumption on fri-sat-sun History / Status. Derived from GenQ Qs by DM team JAVA script. If units of beer/wine/spirits and/or fortified wine = >0 then this is automatically adjusted to 4 = current; 0 = never; 1 = not current; 2 = ex; 3 = ever; 4 = current; 9 = not known;

Categorical

Alcohol History

Phase 2 data. Current Alcohol Consumption on mon-tue-wed-thu History / Status. Derived from GenQ Qs by DM team JAVA script. If units of beer/wine/spirits and/or fortified wine = >0 then this is automatically adjusted to 4 = current; 0 = never; 1 = not current; 2 = ex; 3 = ever; 4 = current; 9 = not known;

Categorical

Serum Apo_A1 CLEANED

Serum Apo A1 measurement in g/L CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 0.2

Categorical

Apo_A1 CLEANED Comment

Serum Apo A1 measurement CLEANED comment (on threshold).

Text

Apo_A1 CLEANED Threshold

Serum Apo A1 measurement CLEANED Threshold.

Categorical

Serum Apo_B CLEANED

Serum Apo B measurement in g/L CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Categorical

Serum Apo_B CLEANED Comment

Serum Apo B measurement CLEANED comment (on threshold).

Text

Serum Apo_B CLEANED Threshold

Serum Apo B CLEANED Threshold.

Categorical

Status Drinks beer

Current Beer Drinking Status. Derived from GenQ Qs by DM team JAVA script.

Categorical

Beer Drinking Status weekend

Phase 2 data. Current Beer Drinking Status on fri-sat-sun. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink beer; 9 = not known; 0 = no does not drink beer;

Categorical

Beer drinking status weekday

Phase 2 data. Current Beer Drinking Status on mon-tue-wed-thu. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink beer; 9 = not known; 0 = no does not drink beer;

Categorical

OLINK assay G-CSF

Phase 1 OLINK assay data for target G-CSF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

C_Peptide CLEANED

C_Peptide measurement in pmol/L CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Categorical

C_Peptide CLEANED Comment

C_Peptide measurement CLEANED comment (on threshold).

Text

C_Peptide CLEANED Threshold

C_Peptide measurement CLEANED Threshold.

Categorical

General questionnaire Data management comment

Data management comment for general questionnaire data.

Text

Status Drinks fortified wines

Current Fortified Wine Drinking Status e.g.sherry. Derived from GenQ Qs by DM team JAVA script.

Categorical

Fort Wine Drinking Status wknd

Phase 2 data. Current Fortified Wine Drinking Status on fri-sat-sun e.g.sherry. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink Fortified Wine; 9 = not known; 0 = no does not drink Fortified Wine;

Categorical

Fortified Wine drink status weekday

Phase 2 data. Current Fortified Wine Drinking Status on mon-tue-wed-thu e.g.sherry. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink Fortified Wine; 9 = not known; 0 = no does not drink Fortified Wine;

Categorical

hs_CRP CLEANED

hs_CRP measurement CLEANED. Serum levels of C-reactive protein measured with high-sensitivity system. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 0.1

Categorical

hs_CRP CLEANED Comment

hs_CRP measurement CLEANED comment (on threshold).

Text

hs_CRP CLEANED Threshold

hs_CRP measurement CLEANED Theshold.

Categorical

Insulin CLEANED

Heparin Insulin measurement CLEANED in pmol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Categorical

Insulin CLEANED Comment

Heparin Insulin measurement CLEANED comment (on threshold).

Text

Insulin CLEANED Comment

Heparin Insulin measurement CLEANED comment (on threshold).

Text

Insulin CLEANED

Heparin Insulin measurement CLEANED in pmol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Real

Insulin CLEANED Threshold

Heparin Insulin measurement CLEANED Threshold.

Categorical

Insulin CLEANED Threshold

Heparin Insulin measurement CLEANED Threshold.

Categorical

Serum Iron CLEANED

Serum Iron measurement in umol/L CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Categorical

Serum Iron CLEANED Comment

Serum Iron measurement CLEANED comment (on threshold).

Text

Serum Iron Threshold

Serum Iron measurement CLEANED threshold

Categorical

Serum Leptin CLEANED

Serum Leptin measurement in ng/ml CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 0.1

Categorical

Serum Leptin CLEANED Comment

Serum Leptin measurement CLEANED comment (on threshold).

Text

Cln variable: Leptin comment

Phase 2 data. Serum Leptin measurement CLEANED comment (on threshold).

Text

Cln variable: Leptin measurement

Phase 2 data. Phase 2 Serum Leptin measurement in ng/ml CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 0.1 -88.8 = measured but results below threshold value;

Real

Serum Leptin Threshold

Serum Leptin measurement CLEANED threshold.

Categorical

Cln variable: Leptin threshold

Phase 2 data. Phase 2 Serum Leptin measurement CLEANED threshold. 1 = Average value; 2 = value less than threshold; 3 = Single value; -1 = Blank (not measured); -2 = sample problem; -3 = Interference; -4 = Unsuitable; -5 = Insufficient; -9 = Everything else; 0 = No sample;

Categorical

NEFA CLEANED

Heparin NEFA measurement CLEANED in umol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 50.

Categorical

NEFA CLEANED Comment

Heparin NEFA measurement CLEANED comment (on threshold).

Text

NEFA CLEANED Comment

Heparin NEFA measurement CLEANED comment (on threshold).

Text

NEFA CLEANED

Heparin NEFA measurement CLEANED in umol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 50.

Real

NEFA CLEANED Threshold

Heparin NEFA measurement CLEANED Threshold.

Categorical

NEFA CLEANED Threshold

Heparin NEFA measurement CLEANED Threshold.

Categorical

NT_proBNP RAW-changed CLEANED by DM

Serum NT_proBNP measurement in pg/ml RAW-changed CLEANED by DM. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 10

Categorical

NT_proBNP RAW-changed CLEANED Comment

Serum NT_proBNP measurement RAW-changed CLEANED comment (on threshold).

Text

NT_proBNP RAW-changed CLEANED Threshold

Serum NT_proBNP measurement RAW-changed CLEANED Threshold.

Categorical

Proinsulin CLEANED

Heparin Intact Pro-insulin measurement CLEANED in pmol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 1.25

Categorical

Proinsulin CLEANED Comment

Heparin Intact Pro-insulin measurement CLEANED comment (on threshold).

Text

Proinsulin CLEANED Threshold

Heparin Intact Pro-insulin measurement CLEANED Threshold.

Categorical

Smoking Amount in cigarettes

Current Smoking Amount in cigarette equivalents. Derived from GenQ Qs by DM team JAVA script. Rules: 1 cigarette = 1.25 g. 1 cheroot = 2 cigarettes 1 cigar = 3 cigarettes. Calculation: CIGARETTES + CHEROOTS*2 + CIGARS*3

Integer

Smoking Amount in grams

Retired in R8. Current Smoking Amount in grams equivalents either cigarettes pipes or cigars. Derived from GenQ Qs by DM team JAVA script. Rules: 1 cigarette = 1.25 g. 1 cheroot = 2 cigarettes 1 cigar = 3 cigarettes. Calculation: CIGARETTES*1.25 + CHEROOTS*2*1.25 + CIGARS*3*1.25 + TOBACCO/7. This variable has now been replaced with gq_sm_DER and has not been updated post R7.

Real

Smoking Amount in grams

Phase 2 data. Current Smoking Amount in grams equivalents either cigarettes pipes or cigars. Derived from GenQ Qs by DM team JAVA script. Rules: 1 cigarette = 1.25 g. 1 cheroot = 2 cigarettes 1 cigar = 3 cigarettes. Calculation: CIGARETTES*1.25 + CHEROOTS*2*1.25 + CIGARS*3*1.25 + TOBACCO/7

Real

Smoking Amount in cigarettes

Phase 2 data. Current Smoking Amount in cigarette equivalents. Derived from GenQ Qs by DM team JAVA script. Rules: 1 cigarette = 1.25 g. 1 cheroot = 2 cigarettes 1 cigar = 3 cigarettes. Calculation: CIGARETTES + CHEROOTS*2 + CIGARS*3

Integer

Smoking Duration

Retired in R8. Derived from GenQ Qs by DM team JAVA script. Current number of Years of Smoking. Blank if not calculated. Has been replaced by gq_sm_dur_DER.

Integer

Smoking Duration

Phase 2 data. Derived from GenQ Qs by DM team JAVA script. Current number of Years of Smoking. Blank if not calculated. Has been replaced by gq_sm_dur_DER.

Integer

Smoking History

Phase 2 data. Current Smoking Consumption History / Status. Data derived by DM team from GenQ Qs on smoking If number of cigarettes/ cheroots/ cigars and/ or tobacco >0 then this category gets adjusted automatically. 1 = not current (never or ex); 2 =Ex (former); 3 =Ever (former or current); 4 = Current; 9 = Not known; 0 = never;

Categorical

Smoking Type

Predominant smoking type(s). Derived from GenQ Qs by DM team JAVA script.

Categorical

Smoking type

Phase 2 data. Predominant smoking type(s). Derived from GenQ Qs by DM team JAVA script. 1 = cigarettes (chosen even if any of the other options has been ticked); 2 = cheroots-cigars (chosen if cigarettes = 0 and either cheroots or cigars >0); 9 = not known; -1 = non smoker (chosen if all of them are left blank or 0 AND smoking category = Never);

Categorical

Smoking Years Stopped

Derived from GenQ Qs by DM team JAVA script. Current number of Years Stopped Smoking. Blank if not calculated.

Integer

Smoking Years Stopped

Phase 2 data. Derived from GenQ Qs by DM team JAVA script. Current number of Years Stopped Smoking. Blank if not calculated.

Integer

Status Drinks spirits

Current Spirits Drinking Status. Derived from GenQ Qs by DM team JAVA script.

Categorical

Smoking History / Status

Current Smoking Consumption History / Status. Data derived by DM team from GenQ Qs on smoking as follows: for GQVersion1 code 1 applies to (ever smoke (ES) - other and smokes daily(D) - no and occasionally(O) - no); code 2 to (ES - yes and D - no and O - no); code 3 to (ES - yes and D -other and O - other); code 4 to either (ES - yes and (D - yes or O - yes) or (ES - no and (D - yes or O - yes); code 9 to (ES - no and (D - yes or O - yes). For GQversion 2 3 and 4 code 1 applies to (ES - other and current (C) - no); code 2 to (ES - yes and C- no); code 3 to (ES - yes and C - other); code 4 to either (ES - yes and C - yes) or (ES - other and C - yes); code 9 to either (ES - no and C - other) or (ES - other and C - other). If number of cigarettes/ cheroots/ cigars and/ or tobacco >0 then this category gets adjusted automatically. The data in this variable is slightly different from data in gq_sm_DER since different definitions for the answers have been applied.

Categorical

Spirits Drinking Status weekend

Phase 2 data. Current Spirits Drinking Status on fri-sat-sun. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink spirits; 9 = not known; 0 = no does not drink spirits;

Categorical

Spirits drinking status weekday

Phase 2 data. Current Spirits Drinking Status on mon-tue-wed-thu. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink spirits; 9 = not known; 0 = no does not drink spirits;

Categorical

SplitPI3233 CLEANED

Heparin 32-33 Split proinsulin measurement CLEANED in pmol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 1.25.

Categorical

SplitPI3233 CLEANED Comment

Heparin 32-33 Split proinsulin measurement CLEANED comment (on threshold).

Text

SplitPI3233 CLEANED Threshold

Heparin 32-33 Split proinsulin measurement CLEANED Threshold.

Categorical

Serum TIBC CLEANED

Serum TIBC (Total Iron Binding Capacity) measured in umol/L CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Categorical

G_TIBC_Com

TIBC measurement CLEANED comment (on threshold).

Text

G_TIBC_Threshold

TIBC measurement CLEANED Threshold.

Categorical

Serum Transferrin CLEANED

Serum transferrin measured in g/L CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: no verified threshold available.

Categorical

Serum Transferrin CLEANED Comment

Serum transferrin measurement CLEANED comment (on threshold).

Text

Serum Transferrin Threshold

Serum transferrin measurement CLEANED Threshold.

Categorical

Urine Albumin CLEANED

Urine Albumin measurement CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 2.5.

Categorical

Urine Albumin CLEANED Comment

Urine Albumin measurement CLEANED comment (on threshold).

Text

Cln variable: Urine Albumin cmnt

Phase 2 data. Urine Albumin measurement CLEANED comment (on threshold).

Text

Cln variable: UrAlbumin measurement

Phase 2 data. Urine Albumin measurement CLEANED. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 2.5. -88.8 = measured but results below threshold value;

Real

Urine Albumin CLEANED Threshold

Urine Albumin measurement CLEANED Threshold.

Categorical

Cln variable: Ur Albumin threshold

Phase 2 data. Urine Albumin measurement CLEANED Threshold. 1 = Average value; 2 = value less than threshold; 3 = Single value; -1 = Blank (not measured); -2 = sample problem; -3 = Interference; -4 = Unsuitable; -5 = Insufficient; -9 = Everything else; 0 = No sample;

Categorical

Urine Creatinine CLEANED

Urine Creatinine measurement CLEANED in mmol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: none.

Categorical

Urine Creatinine CLEANED Comment

Urine Creatinine measurement CLEANED comment (on threshold).

Text

Cln variable: UrCreatinine cmnt

Phase 2 data. Urine Creatinine measurement CLEANED comment (on threshold).

Text

Cln variable: Urine Creatinine

Phase 2 data. Urine Creatinine measurement CLEANED in mmol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: none. -88.8 = measured but results below threshold value;

Real

Urine Creatinine CLEANED Threshold

Urine Creatinine measurement CLEANED Threshold.

Categorical

Cln variable:UrCreatinine threshold

Phase 2 data. Urine Creatinine measurement CLEANED Threshold. 1 = Average value; 2 = value less than threshold; 3 = Single value; -1 = Blank (not measured); -2 = sample problem; -3 = Interference; -4 = Unsuitable; -5 = Insufficient; -9 = Everything else; 0 = No sample;

Categorical

G_VitaminCResult

Vitamin C Result CLEANED in umol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 10.

Categorical

G_VitaminCResult_Com

Vitamin C Result CLEANED comment (on threshold).

Text

G_VitaminCResult_Com

Vitamin C Result CLEANED comment (on threshold).

Text

G_VitaminCResult

Vitamin C Result CLEANED in umol/l. Left blank if not measured (reason provided in Threshold variable). (note on threshold value provided in Comment variable). Lower threshold: 10.

Real

G_VitaminCResult_Threshold

Vitamin C Result CLEANED Threshold.

Categorical

G_VitaminCResult_Threshold

Vitamin C Result CLEANED Threshold.

Categorical

Status Drinks wine

Current Wine Drinking Status. Derived from GenQ Qs by DM team JAVA script.

Categorical

Wine Drinking Status weekend

Phase 2 data. Current Wine Drinking Status on fri-sat-sun. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink wine; 9 = not known; 0 = no does not drink wine;

Categorical

Wine drinking status weekday

Phase 2 data. Current Wine Drinking Status on mon-tue-wed-thu. Derived from GenQ Qs by DM team JAVA script. 1 = yes does drink wine; 9 = not known; 0 = no does not drink wine;

Categorical

Haematocrit

Hematocrit (HCT) measures the proportion of red blood cells in your blood; indicating how much space they occupy. It's a key part of assessing overall blood health and diagnosing various conditions; including anemia and polycythemia. Normal hematocrit levels vary by sex and age; but generally range from .36-.48 for women and .41-.50% for men.

Real

Haemoglobin

The amount of Haemoglobin (Hb) in g/L in the blood sample. Haemoglobin is the protein found within red blood cells that carries oxygen from the lungs to the rest of the body. The normal range is: Adult Male 130 - 180 g/L and for Adult Female 115 - 165 g/L.

Real

OLINK assay HAGH

Phase 1 OLINK assay data for target HAGH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hand Grip Exclusion Check

Phase 2 data. Hand grip safety check done before hand grip test?. 0 = no; 1 = yes;

Categorical

None

Phase 2 data. Hand grip data

Text

OLINK assay HAOX1

Phase 1 OLINK assay data for target HAOX1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Indication if any data is available from the Core exome (InfiniumCoreExome-24v1 chip) chip. This includes any for whom the data actually failed data QC.

Categorical

Has Exome Data

Has participant got Exome data. Use this to check which magicid actually has GWAS data (having an exomeid does not guarantee having Illumina exome chip data).

Categorical

Has GWAS Data

Has participant got GWAS data. Use this to check which magicid actually has GWAS data (having a magicid does not guarantee having Affymetrix 500K GWAS data).

Categorical

Has Metabochip data

Has participant got Metabo chip data. Use this to check which metabo actually has metabo data (having a metabo does not guarantee having Illumina cardio metabochip data).

Categorical

OLINK assay HAVCR2

Phase 1 OLINK assay data for target HAVCR2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hba1C O_MM

Hba1C measurement taken at 0 minutes in mmol (IFCC output). Participants will either have Hba1C0_MM or Hba1C0_PC depending on when they are tested earlier on in the study the lab measured Hba1C0 in percentage. Later on in the study it was measured in mmol) You should therefore request Hba1C_PC too (more volunteers have Hba1C measured in % then in mmol n=7860+ and n=4460+ resp). To get a full set of data you will need to convert the data in the Hba1C0_PC to mmol.

Real

Hba1C0 MM

Phase 2 data. Hba1C measurement taken at 0 minutes in mmol (IFCC output). Participants will either have Hba1C0_MM or Hba1C0_PC depending on when they are tested earlier on in the study the lab measured Hba1C0 in percentage

Real

Hba1C O_%

Hba1C measurement taken at 0 minutes as a percentage (DCCT output) . Participants will either have Hba1C0_MM or Hba1C0_PC depending on when they are tested (earlier on in the study the lab measured Hba1C0 in percentage. Later on in the study it was measured in mmol) so you should request Hba1C_MM too (more volunteers have Hba1C measured in % then in mmol n=7860+ and n=4460+ resp). To get a full set of data you will need to convert the data in the Hba1C0_MM to percentage.

Real

Hba1C0 in percentage

Phase 2 data. Hba1C measurement taken at 0 minutes as a percentage (DCCT output) . Participants will either have Hba1C0_MM or Hba1C0_PC depending on when they are tested (earlier on in the study the lab measured Hba1C0 in percentage

Real

OLINK assay HB-EGF

Phase 1 OLINK assay data for target HB-EGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HCLS1

Phase 1 OLINK assay data for target HCLS1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HDGF

Phase 1 OLINK assay data for target HDGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

HDL 0 minutes

Serum HDL cholesterol measurement taken at 0 minutes in mmol/l

Real

HDL 0 minutes

Phase 2 data. Serum HDL cholestrol measurement taken at 0 minutes in mmol/l

Real

Hours of Digging shovelling or chopping wood

Please indicate the average length of time (in hours) you spent doing the activity per episode. Digging shovelling or chopping wood.

Integer

Hours of Digging shovelling or chopping wood CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Digging shovelling or chopping wood. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Heavy gardening hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Digging shovelling or chopping wood. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Heavy gardening hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Digging shovelling or chopping wood. -1 = left blank. DO NOT USE THIS VARIABLE. Use HeavyGardeningHr_CLEAN_P2 instead.

Real

Minutes of Digging shovelling or chopping wood

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Digging shovelling or chopping wood.

Integer

Minutes of Digging shovelling or chopping wood CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Digging shovelling or chopping wood. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Heavy gardening min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Digging shovelling or chopping wood. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Heavy gardening min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Digging shovelling or chopping wood. -1 = left blank. DO NOT USE THIS VARIABLE. Use HeavyGardeningMin_CLEAN_P2 instead.

Real

Frequency of Digging shovelling or chopping wood CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Heavy Gardening - Digging shovelling or chopping wood. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

heavyGardening_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Digging shovelling or chopping wood

Real

Cln variable: Heavy Gardening

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Heavy Gardening - Digging shovelling or chopping wood. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

HeavyGardening_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Heavy Gardening - Digging shovelling or chopping wood. Data normalised to DE template 1 data.

Categorical

Heavy gardening

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Digging shovelling or chopping wood. DO NOT USE THIS VARIABLE. Use HeavyGardening_CLEAN_P2 instead.

Real

Heavy Gardening

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Heavy Gardening - Digging shovelling or chopping wood. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Digging shovelling or chopping wood DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Heavy Gardening - Digging shovelling or chopping wood. Data entered using data entry template with 1-2-3-4-5-6-7 codes . This data cannot be compared with data in HeavyGardening_T2. Instead use HeavyGardening_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Digging shovelling or chopping wood DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Heavy Gardening - Digging shovelling or chopping wood. Data entered using data entry template with 1-3-4-5-6-7-8 codes . This data cannot be compared with data in HeavyGardening_T1. Instead use HeavyGardening_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Hemocue 1

First Hemocue glucose measurement taken at 0 minutes.

Real

Hemocue 120

Hemocue glucose measurement taken at 120 minutes.

Real

Hemocue 120

Phase 2 data. Hemocue glucose measurement taken at 120 minutes. mmol/l

Real

Hemocue 1

Phase 2 data. First Hemocue glucose measurement taken at 0 minutes.

Real

Hemocue 2

Second Hemocue glucose measurement taken at 0 minutes.

Real

Hemocue 2

Phase 2 data. Second Hemocue glucose measurement taken at 0 minutes.

Real

Hemocue 3

Third Hemocue glucose measurement taken at 0 minutes.

Real

Hemocue 3

Phase 2 data. Third Hemocue glucose measurement taken at 0 minutes. mmol/l

Real

Hemocue Used

Indication whether or not a hemocue test was used 0 = no; -1 = yes;

Categorical

Hemocue Used

Phase 2 data. Indication whether or not a hemocue test was used 0 = no; -1 = yes;

Categorical

OLINK assay HEXIM1

Phase 1 OLINK assay data for target HEXIM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hexose_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Hexose_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=1 LoD=20. 2nd and final QC step on this var created new and final var BIOR_140.

Real

OLINK assay HGF

Phase 1 OLINK assay data for target HGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HGF

Phase 1 OLINK assay data for target HGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

His_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable His_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_009.

Real

Histamine_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Histamine_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var .

Real

Land use mix

Herfindahl-Hirschman Index: A measure of how mixed the land uses in a neighbourhood are. There were 5 possible land uses contained in a neighbourhood; including residential; commercial; institutional/governmental; recreational and mixed landuses. (Range: 0 to 10000; 10000=least mixed; 0=most mixed) HHI = Sk(pk*100)^2 p is the proportion of land area devoted to the specific land use (k) in each buffer. As for the LUM entropy score; the proportions (pk) were calculated as the land area devoted to a specific land use divided by the total area of walkable land uses in each buffer. Note: LUM=10;000 (i.e. no mix) if none or only one of the relevant land uses fell into the buffer. Data Source: OS MasterMap Topography Layer Data (December 2016) AddressBase Premium Data (OS Managed GB Set)

Real

Land use mix P2

Phase 2 data: Herfindahl-Hirschman Index: A measure of how mixed the land uses in a neighbourhood are. There were 5 possible land uses contained in a neighbourhood; including residential; commercial; institutional/governmental; recreational and mixed landuses. (Range: 0 to 10000; 10000=least mixed; 0=most mixed) HHI = Sk(pk*100)^2 p is the proportion of land area devoted to the specific land use (k) in each buffer. As for the LUM entropy score; the proportions (pk) were calculated as the land area devoted to a specific land use divided by the total area of walkable land uses in each buffer. Note: LUM=10;000 (i.e. no mix) if none or only one of the relevant land uses fell into the buffer. Data Source: OS MasterMap Topography Layer Data (December 2016) AddressBase Premium Data (OS Managed GB Set)

Real

OLINK assay hK11

Phase 1 OLINK assay data for target hK11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay hK14

Phase 1 OLINK assay data for target hK14 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay hK8

Phase 1 OLINK assay data for target hK8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HMOX2

Phase 1 OLINK assay data for target HMOX2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HNMT

Phase 1 OLINK assay data for target HNMT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

For Lipidomics positive ionisation mode analysis.

Text

None

For Lipidomics positive ionisation mode analysis.

Text

Home

Participant postcode phase 1 is valid and lives within the study area of Cambridgeshire (1=yes; 2=no)

Categorical

Home postcode

What is the postcode for your home address? Data as entered by the participant.

Text

Home postcode CLEANED

Home postcode as entered by participant CLEANED

Text

Home postcode DERIVED

Home postcode as derived by PA team from home address data provided by participant using google.

Text

Home postcode

Phase 2 data. Questionnaire reads D12. What is the postcode for your home address? Data as entered by the participant. -1 = left blank

Text

HOMEtime

HOMEtime. Derived Intermediate not for general release. Data can be provided if necessary.

Real

HomeWorker

Created by PA team to facilitate data cleaning. Data can be provided if needed. Indication of wether the participant works from home or not.

Categorical

HOME_ACTMETS

Home domain activity energy expenditure [net METhrs/d]

Real

Home domain AEE

Phase 2 data. Derived with method 2. Home domain activity energy expenditure net METhrs/d

Real

Home_district

Random unique value for home postcode district in phase 1. Duplicate values indicate that home postcode is in the same postcode district (i.e. that participants are clustered within districts). -1 is missing home postcode

Integer

Uniuqe value for home postcode district

Phase 2 data. Random unique value for home postcode district in Phase 2 data. Duplicate values indicate that home postcode is in the same postcode district (i.e. that participants are clustered within districts). -1 is missing home postcode

Integer

HOME_METS

Home domain energy expenditure [METhrs/d]

Real

Home domain energy expenditure

Phase 2 data. Derived with method 2. Home domain energy expenditure METhrs/d

Real

Participant postcode

Phase 2 data. Participant postcode phase 2 is valid and lives within the study area of Cambridgeshire (1=yes; 2=no; -9=missing as participant declined to participate)

Categorical

HOME_PAEE

Home domain activity energy expenditure [kJ/kg/d]

Real

Home domain PAEE

Phase 2 data. Derived with method 2. Home domain activity energy expenditure kJ/kg/d

Real

Home_sector

Random unique value for home postcode sector in phase 1. Duplicate values indicate that home postcode is in the same postcode sector (i.e. that participants are clustered within sectors). -1 is missing home postcode

Integer

Unique value for home postcode sector

Phase 2 data. Random unique value for home postcode sector in Phase 2 data. Duplicate values indicate that home postcode is in the same postcode sector (i.e. that participants are clustered within sectors). -1 is missing home postcode

Integer

Home_Supermarket

Count of supermarkets within a 1 mile Eucladian distance of participants home Fenland phase 1 (-9 = missing)

Integer

Cnt of supermarkets 1 mile Pts home

Phase 2 data. Count of supermarkets within a 1 mile Eucladian distance of participants' home Fenland phase 2 (-9 = missing)

Integer

Home_Takeaway

Count of takeaways within a 1 mile Eucladian distance of participants home Fenland phase 1 (-9 = missing)

Integer

Cnt of takeaways 1 mile Pts home

Phase 2 data. Count of takeaways within a 1 mile Eucladian distance of participants' home Fenland phase 2 (-9 = missing)

Integer

Hours of Horse riding

Please indicate the average length of time (in hours) you spent doing the activity per episode. Horse riding.

Integer

Hours of Horse riding CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Horse riding. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Horse riding hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Horse riding. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Horse riding hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Horse riding. -1 = left blank. DO NOT USE THIS VARIABLE. Use HorseBasedHr_CLEAN_P2 instead.

Real

Minutes of Horse riding

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Horse riding.

Integer

Minutes of Horse riding CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Horse riding. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Horse riding min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Horse riding. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Horse riding min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Horse riding. -1 = left blank. DO NOT USE THIS VARIABLE. Use HorseBasedMin_CLEAN_P2 instead.

Real

Frequency of Horse riding CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

horseBased_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Horse riding

Real

Cln variable: Horse riding

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

HorseBased_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. Data normalised to DE template 1 data.

Categorical

Horse riding

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. DO NOT USE THIS VARIABLE. Use HorseBased_CLEAN_P2 instead.

Real

Horse riding

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Horse riding DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in HorseBased_T2. Instead use HorseBased_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Horse riding DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Horse riding. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in HorseBased_T1. Instead use HorseBased_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay hOSCAR

Phase 1 OLINK assay data for target hOSCAR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Pt relocated home postcode

Phase 2 data. Participant relocated as home postcode differed between phases 1 and 2 (-9 = missing; 1 = not relocated 2 = relocated)

Categorical

OLINK assay HO-1

Phase 1 OLINK assay data for target HO-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HPGDS

Phase 1 OLINK assay data for target HPGDS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Has the heart rate (actiheart) monitor been entered?

HR Actiheart Entered

Phase 2 data. Heart Rate and Achtiheart data entered? 0 = no; 1 = yes;

Categorical

OLINK assay HS3ST3B1

Phase 1 OLINK assay data for target HS3ST3B1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HS6ST1

Phase 1 OLINK assay data for target HS6ST1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HSD11B1

Phase 1 OLINK assay data for target HSD11B1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HSP90B1

Phase 1 OLINK assay data for target HSP90B1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay HSP 27

Phase 1 OLINK assay data for target HSP 27 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

hs_CRP

Serum biomarker hs_CRP measurement (Serum levels of C-reactive protein measured with high-sensitivity system). Raw data; lower detection limit is 10 mg/l. Cleaned data provided in variable G_hs_CRP with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

OLINK assay HTRA2

Phase 1 OLINK assay data for target HTRA2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of fishing CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Fishing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Hours of fishing

Please indicate the average length of time (in hours) you spent doing the activity per episode. Fishing.

Integer

Cln variable: Hunting hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Hunting shooting fishing. Error codes cleand by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Hunting Shooting Fishing hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Fishing. -1 = left blank. DO NOT USE THIS VARIABLE. Use HuntingShootingFishingHr_CLEAN_P2 instead.

Real

Minutes of fishing

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Fishing.

Integer

Cln variable: Hunting min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Hunting shooting fishing. Error codes cleand by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Hunting Shooting Fishing min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Fishing. -1 = left blank. DO NOT USE THIS VARIABLE. Use HuntingShootingFishingMin_CLEAN_P2 instead.

Real

Cln variable: Hunting

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Hunting shooting fishing. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

HuntingShootingFishing_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Fishing. Data normalised to DE template 1 data.

Categorical

Hunting Shooting Fishing

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Fishing. DO NOT USE THIS VARIABLE. Use HuntingShootingFishing_CLEAN_P2 instead.

Real

Fishing

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Fishing. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of fishing DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Fishing. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in HuntingShootingFishing_T2. Instead use HuntingShootingFishing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of fishing DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Fishing. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in HuntingShootingFishing_T1. Instead use HuntingShootingFishing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Minutes of fishing CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Fishing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Frequency of fishing CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Fishing. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

huntingShootingFish_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for fishing

Real

None

Hybridization control scale factor

Real

Hybridization control scale factor

Phase 2 data. Hybridization control scale factor

Real

OLINK assay ICA1

Phase 1 OLINK assay data for target ICA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ICAM1

Phase 1 OLINK assay data for target ICAM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ICAM3

Phase 1 OLINK assay data for target ICAM3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ICAM-2

Phase 1 OLINK assay data for target ICAM-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Ice-Skating

Please indicate the average length of time (in hours) you spent doing the activity per episode. Ice-Skating.

Integer

Hours of Ice-Skating CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Ice-Skating. Error codes cleand by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Ice-Skating hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Ice-Skating. Error codes cleand by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Ice or roller skating hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Ice-Skating. -1 = left blank.DO NOT USE THIS VARIABLE. Use iceSkatingHr_CLEAN_P2 instead.

Real

Minutes of Ice-Skating

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Ice-Skating.

Integer

Minutes of Ice-Skating CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Ice-Skating. Error codes cleand by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Ice-Skating min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Ice-Skating. Error codes cleand by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Ice or roller skating min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Ice-Skating. -1 = left blank.DO NOT USE THIS VARIABLE. Use iceSkatingMin_CLEAN_P2 instead.

Real

Frequency of Ice-Skating CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice-Skating. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

iceSkating_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Ice-Skating

Real

Cln variable: Ice-Skating

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice-Skating. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

iceSkating_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice-Skating. Data normalised to DE template 1 data.

Categorical

Ice or roller skating

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice or roller skating. DO NOT USE THIS VARIABLE. Use iceSkating_CLEAN_P2 instead.

Real

Ice-Skating

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice-Skating. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Ice-Skating DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice-Skating. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in iceSkating_T2. Instead use iceSkating_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Ice-Skating DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Ice-Skating. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in iceSkating_T1. Instead use iceSkating_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay ICOSLG

Phase 1 OLINK assay data for target ICOSLG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

iDEXA Height measurement in centimetres

New in R7. Height measurement in centimetres. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Direct comparison with study support data.

Real

iDEXA Height measurement

Phase 2 data. Height measurement in centimetres. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Direct comparison with study support data.

Real

iDEXA Weight measurement in kilograms

New in R7. Weight measurement in kilograms. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Direct comparison with study support data.

Real

iDEXA Weight measurement

Phase 2 data. Weight measurement in kilograms. Raw data from DEXA Lunar Prodigy reprocessed with iDEXA software. Calculation and or check: Direct comparison with study support data.

Real

iDEXA App lean mass

New in R7. Data derived by data management team by adding up data for AD15i_iDEXA_arms_lean_mass and AD39i_iDEXA_legs_lean_mass and rounding to 2 decimals.

Integer

iDEXA App lean mass

Phase 2 data. Data derived by data management team by adding up data for AD15i_iDEXA_arms_lean_mass and AD39i_iDEXA_legs_lean_mass and rounding to 2 decimals.

Integer

iDEXA Periph fat mass

New in R7. Data derived by data management team by adding up data for AD14i_iDEXA_arms_fat_mass and AD38i_iDEXA_legs_fat_mass and rounding to 2 decimals.

Integer

iDEXA Periph fat mass

Phase 2 data. Data derived by data management team by adding up data for AD14i_iDEXA_arms_fat_mass and AD38i_iDEXA_legs_fat_mass and rounding to 2 decimals.

Integer

OLINK assay IDUA

Phase 1 OLINK assay data for target IDUA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IFI30

Phase 1 OLINK assay data for target IFI30 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IFNL1

Phase 1 OLINK assay data for target IFNL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IFNLR1

Phase 1 OLINK assay data for target IFNLR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IFN-gamma

Phase 1 OLINK assay data for target IFN-gamma in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IFN-gamma-R1

Phase 1 OLINK assay data for target IFN-gamma-R1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGF1R

Phase 1 OLINK assay data for target IGF1R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGF2R

Phase 1 OLINK assay data for target IGF2R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGFBP3

Phase 1 OLINK assay data for target IGFBP3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGFBP6

Phase 1 OLINK assay data for target IGFBP6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGFBPL1

Phase 1 OLINK assay data for target IGFBPL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGFBP-1

Phase 1 OLINK assay data for target IGFBP-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGFBP-2

Phase 1 OLINK assay data for target IGFBP-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGFBP-7

Phase 1 OLINK assay data for target IGFBP-7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IgG Fc receptor II-b

Phase 1 OLINK assay data for target IgG Fc receptor II-b in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGLC2

Phase 1 OLINK assay data for target IGLC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IGSF3

Phase 1 OLINK assay data for target IGSF3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IKZF2

Phase 1 OLINK assay data for target IKZF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL10

Phase 1 OLINK assay data for target IL10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL10

Phase 1 OLINK assay data for target IL10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL12RB1

Phase 1 OLINK assay data for target IL12RB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL12

Phase 1 OLINK assay data for target IL12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL13RA1

Phase 1 OLINK assay data for target IL13RA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL13

Phase 1 OLINK assay data for target IL13 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL15

Phase 1 OLINK assay data for target IL15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL16

Phase 1 OLINK assay data for target IL16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL17RB

Phase 1 OLINK assay data for target IL17RB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL18

Phase 1 OLINK assay data for target IL18 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL18

Phase 1 OLINK assay data for target IL18 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL1RL2

Phase 1 OLINK assay data for target IL1RL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL2

Phase 1 OLINK assay data for target IL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL2-RA

Phase 1 OLINK assay data for target IL2-RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL32

Phase 1 OLINK assay data for target IL32 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL33

Phase 1 OLINK assay data for target IL33 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL3RA

Phase 1 OLINK assay data for target IL3RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL4

Phase 1 OLINK assay data for target IL4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL5

Phase 1 OLINK assay data for target IL5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL5

Phase 1 OLINK assay data for target IL5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL6

Phase 1 OLINK assay data for target IL6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL6

Phase 1 OLINK assay data for target IL6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL6

Phase 1 OLINK assay data for target IL6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL6

Phase 1 OLINK assay data for target IL6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL7R

Phase 1 OLINK assay data for target IL7R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL7

Phase 1 OLINK assay data for target IL7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL8

Phase 1 OLINK assay data for target IL8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Ile_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Ile_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_010.

Real

OLINK assay ILKAP

Phase 1 OLINK assay data for target ILKAP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-10RA

Phase 1 OLINK assay data for target IL-10RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-10RB

Phase 1 OLINK assay data for target IL-10RB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-12B

Phase 1 OLINK assay data for target IL-12B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-15RA

Phase 1 OLINK assay data for target IL-15RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-17A

Phase 1 OLINK assay data for target IL-17A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-17C

Phase 1 OLINK assay data for target IL-17C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-17D

Phase 1 OLINK assay data for target IL-17D in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-17RA

Phase 1 OLINK assay data for target IL-17RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-18BP

Phase 1 OLINK assay data for target IL-18BP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-18R1

Phase 1 OLINK assay data for target IL-18R1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-1ra

Phase 1 OLINK assay data for target IL-1ra in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-1RT1

Phase 1 OLINK assay data for target IL-1RT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-1RT2

Phase 1 OLINK assay data for target IL-1RT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-1 alpha

Phase 1 OLINK assay data for target IL-1 alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-20RA

Phase 1 OLINK assay data for target IL-20RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-20

Phase 1 OLINK assay data for target IL-20 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-22 RA1

Phase 1 OLINK assay data for target IL-22 RA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-24

Phase 1 OLINK assay data for target IL-24 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-27

Phase 1 OLINK assay data for target IL-27 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-2RB

Phase 1 OLINK assay data for target IL-2RB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-4RA

Phase 1 OLINK assay data for target IL-4RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-5R-alpha

Phase 1 OLINK assay data for target IL-5R-alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IL-6RA

Phase 1 OLINK assay data for target IL-6RA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

IMD 2009 subdomain barriers to housing rank

2009 IMD subdomain barriers to housing and services rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain barriers to housing score

2009 IMD subdomain barriers to housing and services score where lower scores are more deprived

Integer

IMD 2009 subdomain children rank

2009 IMD subdomain children and young people rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain children score

2009 IMD subdomain children and young people score where lower scores are more deprived

Integer

IMD 2009 subdomain crime rank

2009 IMD subdomain crime and disorder rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain crime score

2009 IMD subdomain crime and disorder score where lower scores are more deprived

Integer

None

IMD decile is England wide deprivation deciles attributed to their postcode. Decile 1 is most deprived.

Real

IMD_decile

Phase 2 data. IMD decile is England wide deprivation deciles attributed to their postcode. Decile 1 is most deprived.

Categorical

IMD 2009 subdomain education rank

2009 IMD subdomain education skills and training rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain education score

2009 IMD subdomain education skills and training score where lower scores are more deprived

Integer

IMD 2009 subdomain employment score

2009 IMD subdomain employment score where lower scores are more deprived

Integer

IMD 2009 subdomain employment rank

2009 IMD subdomain employment rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain living env rank

2009 IMD subdomain living environment rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain living env score

2009 IMD subdomain living environment score where lower scores are more deprived

Integer

2009 IMD score directly from LSOA list

2009 IMD score retrieved from the list reporting which postcode can be found in which Lower Super Output Area (LSOA). Only use for Fenland phase 1 participants.

Integer

IMD 2009 subdomain geographical barriers rank

2009 IMD subdomain geographical barriers rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain geograpical barriers score

2009 IMD subdomain geographical barriers score where lower scores are more deprived

Integer

IMD 2009 subdomain health deprivation rank

2009 IMD subdomain health deprivation and disability rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain health deprivation score

2009 IMD subdomain health deprivation and disability score where lower scores are more deprived

Integer

IMD_home_easting

Phase 2 data. Easting co-ordinates

Text

IMD_home_northing

Phase 2 data. Northing co-ordinates

Text

IMD_home_postcode

Phase 2 data. Home postcode

Text

IMD 2009 subdomain IDACI rank

2009 IMD subdomain Income Deprivation Affecting Children Index (IDACI) rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain IDACI score

2009 IMD subdomain Income Deprivation Affecting Children Index (IDACI) score where lower scores are more deprived

Integer

IMD 2009 subdomain IDAOPI rank

2009 IMD subdomain Income Deprivation Affecting Older People Index (IDAOPI) rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain IDAOPI score

2009 IMD subdomain Income Deprivation Affecting Older People Index (IDAOPI) score where lower scores are more deprived

Integer

IMD 2009 subdomain income rank

2009 IMD subdomain income rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain income score

2009 IMD subdomain income score where lower scores are more deprived

Integer

IMD 2009 subdomain indoors rank

2009 IMD subdomain indoors rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain indoors score

2009 IMD subdomain indoors score where lower scores are more deprived

Integer

IMD 2009 subdomain outdoors rank

2009 IMD subdomain outdoors rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain outdoors score

2009 IMD subdomain outdoors score where lower scores are more deprived

Integer

None

IMD rank is the England-wide ranking of the LSOA in which each postcode is located where a lower rank is more deprived (i.e. 1 is most deprived). This variable would allow anyone accessing the data to create their own relative measure of deprivation (e.g. quintiles) within the Fenland cohort.

Real

2009 IMD score

2009 IMD rank based on IMD score linking phase 1 participants home postcode unit to LSOA area. Lower ranks are more deprived. IMD information was retrieved from https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019. Only use for Fenland phase 1 participants.

Integer

IMD_rank

Phase 2 data. IMD rank is the England-wide ranking of the LSOA in which each postcode is located; where a lower rank is more deprived (i.e. 1 is most deprived). This variable would allow anyone accessing the data to create their own relative measure of deprivation (e.g. quintiles) within the Fenland cohort.

Real

IMD 2009 subdomain skills rank

2009 IMD subdomain skills rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain skills score

2009 IMD subdomain skills score where lower scores are more deprived

Integer

IMD 2009 subdomain wider barriers rank

2009 IMD subdomain wider barriers rank where lower ranks are more deprived. 1 is most deprived.

Integer

IMD 2009 subdomain wider barriers score

2009 IMD subdomain wider barriers score where lower scores are more deprived

Integer

IMD work Easting

Phase 2 data. Easting for phase 2 work postcode based on Work_postcode_cleaned_P2

Real

IMD work Northing

Phase 2 data. Northing for phase 2 work postcode based on Work_postcode_cleaned_P2

Real

None

year of enrolment

Real

IMD_year

Phase 2 data. Year of enrolment

Real

OLINK assay IMPA1

Phase 1 OLINK assay data for target IMPA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Date of data import.

Date

Incretin protein measured

Incretin protein measured. GIP_Total - Glucose-dependent insulinotropic polypeptide (total). GLP-1_Total - Glucagon-like peptide-1 (total). Glucagon - Glucagon peptide.

Text

Intra plate variation

The Coefficient of Variation of calculated concentration between intra plate duplicates - this is calculated by the LabOMatic software (where applicable).

Real

Mean incretin value

The mean of calculated concentration in (pg/mL) for GIP (total); and (pM) for GLP-1 (t) and Glucagon - this is calculated by the MSD software. EX5% - the result was excluded for this aliquot because it fell below the 5th percentile in all three analytes and is a suspected pipetting error. EX- the result was excluded on this plate for this analyte because the controls (Standards, Pool, QC) where outside of the acceptance limits. PD - the Conc_Calc_CV for the intra plate duplicate was higher than 20%. pM = (pg/ml)/(Molecular Weight in kilodalton)

Real

ULOD per plate

Upper limit of detection (ULOD) per plate expressed in (pg/mL) for GIP (total); and (pM) for GLP-1 (t) and Glucagon; calculated by the MSD software and adjusted by the lab team with the sample dilution factor (2). pM = (pg/ml)/(Molecular Weight in kilod

Real

LLOD per plate

Lower limit of detection (LLOD) per plate expressed in (pg/mL) for GIP (total); and (pM) for GLP-1 (t) and Glucagon; calculated by the MSD software and adjusted by the lab team with the sample dilution factor (2). pM = (pg/ml)/(Molecular Weight in kilod

Real

Sample FreezeThaw Cycles

Number of times the sample was thawed

Integer

Within detection limits

The calculated concentration is within detection limits (between Lower Limit of Detection and Upper Limit of Detection). NOTE: Samples outside of "In Detection Range" have not been excluded and may be used if needed to but technically do not pass lab QC.

Real

Increntin Plate Number

Incretin data number of the plate assigned by the lab team

Integer

Sample Timepoint

T000 minute plasma heparin aliquot - this sample was collected before OGTT test. T120 minute plasma heparin aliquot - this sample was collected after OGTT test

Text

Incretin well position

Well position within a 96-well plate

Integer

Information Sheet version date as written

Information Sheet version date (as written)

Date

Information Sheet version number

Information Sheet version number

Text

Info sheet version and date

InfoVersion. Version number and date of information sheet handed over to participant alongside consent form. This has been replaced by InfoVersion_Corrected in R8 as this data is now stored in a new variable which has version number data which has been improved. Do not use this variable anymore but use InfoVersion_Corrected instead.

InfoVersion_Corrected

New in R8. This is the same data as InfoVersion but the data in the variable has been consolidated across the study to ensure data uniformity. Use this var instead of InfoVersion

OLINK assay ING1

Phase 1 OLINK assay data for target ING1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay INHBC

Phase 1 OLINK assay data for target INHBC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay INPPL1

Phase 1 OLINK assay data for target INPPL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Insulin

Heparin biomarker Insulin measurement in pmol/l. Raw data; Cleaned data provide in variable G_Insulin with x_Threshold and x_Com variables provided for clarification. Lower threshold: none. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

Insulin Raw

Phase 2 data. Heparin biomarker Insulin measurement in pmol/l. Raw data; Cleaned data provide in variable G_Insulin with x_Threshold and x_Com variables provided for clarification. Lower threshold: none. Test date is the date of visit for Fenland Phase 2 data.

Real

None

Heparin biomarker Insulin measurement at T120 in pmol/l. Raw Fenland phase 1 data; Cleaned data not yet available.

Real

None

Heparin biomarker Insulin measurement at T120 in pmol/l. Raw Fenland phase 1 data; Lab commetns on test results and sample quality.

Text

None

Heparin biomarker Insulin measurement at T120 in pmol/l. Raw Fenland phase 1 data; Date of test

Date

Int24 food survey Alcohol(g)

Phase 2 data. Intake 24 Food Intake survey - Alcohol (g)

Real

Int24 food survey food brand

Phase 2 data. Intake 24 Food Intake survey brand. Asda; Tesco; Other; N/A

Text

Int24 food survey Calcium(mg)

Phase 2 data. Intake 24 Food Intake survey - Calcium (mg)

Real

Int24 food survey Carbohydrate(g)

Phase 2 data. Intake 24 Food Intake survey - Carbohydrate (g)

Real

Int24 food survey Cholesterol(mg)

Phase 2 data. Intake 24 Food Intake survey - Cholesterol (mg)

Real

Int24 food survey Energy(kcal)

Phase 2 data. Intake 24 Food Intake survey - Energy (kcal)

Real

Int24 food survey Energy(kj)

Phase 2 data. Intake 24 Food Intake survey - Energy (kj)

Real

Int24 food survey Fat(g)

Phase 2 data. Intake 24 Food Intake survey - Fat (g)

Real

Int24 food survey Folate(µg)

Phase 2 data. Intake 24 Food Intake survey - Folate (µg)

Real

Int24 food survey food desc En

Phase 2 data. Intake 24 Food Intake survey food description in English

Text

Int24 food surv food desc local

Phase 2 data. Intake 24 Food Intake survey food description in the local language

Text

Int24 food survey food group code

Phase 2 data. Intake 24 Food Intake survey food group code. 2 = ; 4 = ; etc

Text

Int24 food surv food group desc En

Phase 2 data. Intake 24 Food Intake survey food group description in English

Text

Int24 food surv foodgrp desc local

Phase 2 data. Intake 24 Food Intake survey food group description in the local language

Text

Int24 food survey food ID

Phase 2 data. Intake 24 Food Intake survey food ID. 1 = ; 2 = ; 3 = ; 4 = ; 5 = ; 6 = ; 7 = ; 8 = ; 9 = ; 10 = ;

Real

Int24 food survey food code

Phase 2 data. Intake 24 Food Intake survey food code. Lookup table

Text

Int24 food survey Iron(mg)

Phase 2 data. Intake 24 Food Intake survey - Iron (mg)

Real

Int24 food survey food leftovers

Phase 2 data. Intake 24 Food Intake survey leftovers after meal?

Text

Int24 food surv food leftoversimage

Phase 2 data. Intake 24 Food Intake survey meal leftovers image name

Text

Int24 food survey Meal ID

Phase 2 data. Intake 24 Food Intake survey meal ID. 1 = ; 2 = ; 3 = ; 4 = ; 5 = ; 6 = ;

Real

Int24 food survey Meal name

Phase 2 data. Intake 24 Food Intake survey meal name.Choices are Afternoon snack or drink; biscuit; Biscuit; Breakfast; drink; Early snack or drink; Evening meal; evening snack or drink; Late snack or drink;

Text

Int24 food survey food desc missing

Phase 2 data. Intake 24 Food Intake survey - description of foods reported as missing. This is an optional free text field completed by participant if they report a missing food

Text

Int24 food survey amt eaten missing

Phase 2 data. Intake 24 Food Intake survey - amount eaten of foods reported as missing. This is an optional free text field completed by participant if they report a missing food. Note: we are aware that the description does not match the Field Name for this variable but the Description is correct

Text

Int24 food survey missing methods

Phase 2 data. Intake 24 Food Intake survey - cooking method of foods reported as missing. This is an optional free text field completed by participant if they report a missing food. Note: we are aware that the description does not match the Field Name for this variable but the Description is correct

Text

Int24 food survey Non-milk

Phase 2 data. Intake 24 Food Intake survey - Non-milk extrinsic sugars (g)

Real

Int24 food surv nutrient table code

Phase 2 data. Intake 24 Food Intake survey nutrient table code from nutrient lookup table recorded in INT24_nutrient_table_code

Text

Int24 food surv nutrient table name

Phase 2 data. Intake 24 Food Intake survey nutrient table name used to lookup Nutrients. NDNS only option available

Text

Int24 food survey food portion size

Phase 2 data. Intake 24 Food Intake survey meal portion size in g/ml

Real

Int24 food survey Protein(g)

Phase 2 data. Intake 24 Food Intake survey - Protein (g)

Real

Int24 food survey food ready meal

Phase 2 data. Intake 24 Food Intake survey ready meal? Yes or no

Text

Int24 food survey reasonable amount

Phase 2 data. Intake 24 Food Intake survey. Reasonable amount? Yes or no

Text

Int24 food survey Saturated fatty

Phase 2 data. Intake 24 Food Intake survey - Saturated fatty acids (g)

Real

Int24 food survey search term

Phase 2 data. Intake 24 Food Intake survey search term. Search term as entered by participant

Text

Int24 food survey Selenium(µg)

Phase 2 data. Intake 24 Food Intake survey - Selenium (µg)

Real

Int24 food surv food serving image

Phase 2 data. Intake 24 Food Intake survey food serving image

Text

Int24 food survey food serving size

Phase 2 data. Intake 24 Food Intake survey food servig size in g/ml

Real

Int24 food survey Sodium(mg)

Phase 2 data. Intake 24 Food Intake survey - Sodium (mg)

Real

Int24 food survey start time

Phase 2 data. Intake 24 Food Intake survey start time

Time

Int24 food surv submission time

Phase 2 data. Intake 24 Food Intake survey submssion time

Time

Survey ID for the Intake24 recall

Phase 2 data. A unique identifier for the Intake24 recall

Text

Int24 food surv completion time

Phase 2 data. Intake 24 Food Intake survey time taken to complete survey

Text

Int24 food survey Total sugars(g)

Phase 2 data. Intake 24 Food Intake survey - Total sugars (g)

Real

Int24 food survey Vitamin A(µg)

Phase 2 data. Intake 24 Food Intake survey - Vitamin A (µg)

Real

Int24 food survey Vitamin C(mg)

Phase 2 data. Intake 24 Food Intake survey - Vitamin C (mg)

Real

Int24 food survey Vitamin D(µg)

Phase 2 data. Intake 24 Food Intake survey - Vitamin D (µg)

Real

Int24 food survey Vitamin E(mg)

Phase 2 data. Intake 24 Food Intake survey - Vitamin E (mg)

Real

Int24 food survey Zinc(mg)

Phase 2 data. Intake 24 Food Intake survey - Zinc (mg)

Real

OLINK assay IQGAP2

Phase 1 OLINK assay data for target IQGAP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IRAK1

Phase 1 OLINK assay data for target IRAK1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IRAK4

Phase 1 OLINK assay data for target IRAK4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay IRF9

Phase 1 OLINK assay data for target IRF9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum Iron measured Raw

Serum biomarker Iron measurement in umol/L. Raw data; cleaned data provided in variable G_Iron with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

OLINK assay ISLR2

Phase 1 OLINK assay data for target ISLR2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGA11

Phase 1 OLINK assay data for target ITGA11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGA5

Phase 1 OLINK assay data for target ITGA5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGA6

Phase 1 OLINK assay data for target ITGA6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGAM

Phase 1 OLINK assay data for target ITGAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGAV

Phase 1 OLINK assay data for target ITGAV in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB1BP1

Phase 1 OLINK assay data for target ITGB1BP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB1BP2

Phase 1 OLINK assay data for target ITGB1BP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB1

Phase 1 OLINK assay data for target ITGB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB2

Phase 1 OLINK assay data for target ITGB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB5

Phase 1 OLINK assay data for target ITGB5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB6

Phase 1 OLINK assay data for target ITGB6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITGB7

Phase 1 OLINK assay data for target ITGB7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ITM2A

Phase 1 OLINK assay data for target ITM2A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay JAM-A

Phase 1 OLINK assay data for target JAM-A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay JAM-B

Phase 1 OLINK assay data for target JAM-B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

JOBadj

JOBadj. Derived Intermediate not for general release. Data can be provided if necessary.

Hours of Jogging

Please indicate the average length of time (in hours) you spent doing the activity per episode. Jogging.

Integer

Hours of Jogging CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Jogging. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Jogging hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Jogging. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Jogging hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Jogging. -1 = left blank. DO NOT USE THIS VARIABLE. Use jogHr_CLEAN_P2 instead.

Real

Minutes of Jogging

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Jogging.

Integer

Minutes of Jogging CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Jogging. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Jogging min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Jogging. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Jogging min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Jogging. -1 = left blank. DO NOT USE THIS VARIABLE. Use jogMin_CLEAN_P2 instead.

Real

Frequency of Jogging CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

jog_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Jogging

Real

Cln variable: Jogging

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

jog_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. Data normalised to DE template 1 data.

Categorical

Jogging

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. DO NOT USE THIS VARIABLE. Use jog_CLEAN_P2 instead.

Real

Jogging

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Jogging DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in jog_T2. Instead use jog_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Jogging DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Jogging. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in jog_T1. Instead use jog_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Junction density

The number of three-or-more way intersections falling inside of the 800-metre street network buffers divided by the area of the buffer (km2): Data Source 2016 OS MasterMap Integrated Transport Network Layer

Real

Junction density P2

Phase 2 data: The number of three-or-more way intersections falling inside of the 800-metre street network buffers divided by the area of the buffer (km2): Data Source 2016 OS MasterMap Integrated Transport Network Layer

Real

OLINK assay JUN

Phase 1 OLINK assay data for target JUN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay JUN

Phase 1 OLINK assay data for target JUN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KAZALD1

Phase 1 OLINK assay data for target KAZALD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KIF1BP

Phase 1 OLINK assay data for target KIF1BP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KIM1

Phase 1 OLINK assay data for target KIM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KIM1

Phase 1 OLINK assay data for target KIM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KIR2DL3

Phase 1 OLINK assay data for target KIR2DL3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KIRREL2

Phase 1 OLINK assay data for target KIRREL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KIT

Phase 1 OLINK assay data for target KIT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KLB

Phase 1 OLINK assay data for target KLB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KLK10

Phase 1 OLINK assay data for target KLK10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KLK12

Phase 1 OLINK assay data for target KLK12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KLK13

Phase 1 OLINK assay data for target KLK13 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KLK6

Phase 1 OLINK assay data for target KLK6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KLRD1

Phase 1 OLINK assay data for target KLRD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KPNA1

Phase 1 OLINK assay data for target KPNA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KRT19

Phase 1 OLINK assay data for target KRT19 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay KYAT1

Phase 1 OLINK assay data for target KYAT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Kynurenine_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Kynurenine_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_027.

Real

OLINK assay KYNU

Phase 1 OLINK assay data for target KYNU in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAG3

Phase 1 OLINK assay data for target LAG3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAIR1

Phase 1 OLINK assay data for target LAIR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAIR-2

Phase 1 OLINK assay data for target LAIR-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAMA4

Phase 1 OLINK assay data for target LAMA4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAMP3

Phase 1 OLINK assay data for target LAMP3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAP TGF-beta-1

Phase 1 OLINK assay data for target LAP TGF-beta-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Large Unstained Cells

Large unstained cells (LUCs) are a specific type of white blood cell identified during a full blood count (FBC) test. They are large; peroxidase-negative cells that don't fit neatly into the typical white blood cell categories (neutrophils; lymphocytes; monocytes; etc.). Essentially; they represent a heterogeneous population of cells; including activated lymphocytes; atypical lymphocytes; and potentially other immature or abnormal cells. Increased LUC counts can be associated with various conditions; including viral and fungal infections; leukemia; inflammation; chronic renal failure; malaria; and postoperative responses. The normal range for LUC count is typically 0-0.4 x 10^9/L.

Real

OLINK assay LAT2

Phase 1 OLINK assay data for target LAT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAT

Phase 1 OLINK assay data for target LAT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LAYN

Phase 1 OLINK assay data for target LAYN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LCN2

Phase 1 OLINK assay data for target LCN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

LDL 0 minutes

Serum LDL cholesterol (calculated) at 0 minutes in mmol/l

Real

LDL 0 minutes

Phase 2 data. Serum LDL cholestrol (calculated) at 0 minutes in mmol/l

Real

OLINK assay LDL receptor

Phase 1 OLINK assay data for target LDL receptor in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

LEISadj

LEISadj. Derived Intermediate not for general release. Data can be provided if necessary.

Real

LEIStime

LEIStime. Derived Intermediate not for general release. Data can be provided if necessary.

Real

LEIS_ACTMETS

Leisure domain activity energy expenditure [net METhrs/d]

Real

Leisure domain AEE

Phase 2 data. Derived with method 2. Leisure domain activity energy expenditure net METhrs/d

Real

LEIS_METS

Leisure domain energy expenditure [METhrs/d]

Real

Leisure domain energy expenditure

Phase 2 data. Derived with method 2. Leisure domain energy expenditure METhrs/d

Real

LEIS_PAEE

Leisure domain activity energy expenditure [kJ/kg/d]

Real

Leisure domain PAEE

Phase 2 data. Derived with method 2. Leisure domain activity energy expenditure kJ/kg/d

Real

OLINK assay LEPR

Phase 1 OLINK assay data for target LEPR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum Leptin RAW

Serum biomarkjer Leptin measurement RAW in ng/ml. Raw data; cleaned data provided in variable G_Leptin with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

None

Lab comments relating to samples used for Leptin/Adiponectin analysis for phase 1

Text

Serum Leptin RAW

Phase 2 data. Leptin measurement for phase 2 sample. Only has data for 10 samples which were part of the PPARA set. Serum biomarker Leptin measurement RAW in ng/ml. Raw data; cleaned data provided in variable G_Leptin with x_Threshold and x_Com variables provided for clarification.

Real

None

Repeat leptin analysis (in ng/ml) of stored sample for those phase 1 volunteers whose leptin measurements were 3 SD below the mean of their body fat percent catagory. -1 = repeat sample not requested; -7 = required sample is missing

Categorical

None

Comments made by the lab on the quality of the sample being analysed.

Text

OLINK assay LEP

Phase 1 OLINK assay data for target LEP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Leu_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Leu_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_011.

Real

OLINK assay LGALS7

Phase 1 OLINK assay data for target LGALS7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LGMN

Phase 1 OLINK assay data for target LGMN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LHB

Phase 1 OLINK assay data for target LHB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LIF

Phase 1 OLINK assay data for target LIF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LIF-R

Phase 1 OLINK assay data for target LIF-R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

LIGHTtime

Time spent at light intensity activity [hrs/d]

Real

LIGHT_INTENSITY

Light intensity energy expenditure [METhrs/d]

Real

OLINK assay LILRA5

Phase 1 OLINK assay data for target LILRA5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LILRB1

Phase 1 OLINK assay data for target LILRB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LILRB2

Phase 1 OLINK assay data for target LILRB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LILRB4

Phase 1 OLINK assay data for target LILRB4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LILRB5

Phase 1 OLINK assay data for target LILRB5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

lipid_lowering

Phase 2 data. Binary variable indicating whether a drug from the lipid lowering agent class was prescribed. 0: No 1: Yes

Categorical

None

For Lipidomics positive ionisation mode analysis.

Text

None

Liver scan done? Data from study database. Please note this variable is not complete as it was not available at the start of the study and data should not be used for analysis.

Categorical

Liver Scan Done

Phase 2 data. Liver scan done? Data from study database. Please note this variable is not complete as it was not available at the start of the study and data should not be used for analysis. 1 = yes; 0 = no;

Categorical

Liver Score Taken

Phase 2 data. Liver Score Taken? From Study Database. Do not release. Use liver score variables from Anthro team 0 = no; 1 = yes;

Categorical

Lost epochs

Total number of lost epochs during free living (first wear of Actiheart only) [For quality of trace information]

Integer

OLINK assay LOX-1

Phase 1 OLINK assay data for target LOX-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay LPL

Phase 1 OLINK assay data for target LPL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LRIG1

Phase 1 OLINK assay data for target LRIG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LRMP

Phase 1 OLINK assay data for target LRMP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LRP11

Phase 1 OLINK assay data for target LRP11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LRP1

Phase 1 OLINK assay data for target LRP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LRRN1

Phase 1 OLINK assay data for target LRRN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LTA4H

Phase 1 OLINK assay data for target LTA4H in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LTBP2

Phase 1 OLINK assay data for target LTBP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LTBR

Phase 1 OLINK assay data for target LTBR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Land use mix

The Shannon Entropy Index: A measure of how mixed land uses most relevant for PA are in a neighbourhood (Range: 0 to 1; 1= most mixed; 0=least mixed) LUM=(-1) Sk(pklnpk)/ln N p is the proportion of land area devoted to the specific land use (k) in each buffer divided by ln N N is the number of land uses under consideration. In this case N=5 (i.e. residential; commercial; institutional/governmental; recreational and mixed areas) The proportions (pk) were calculated as the land area devoted to a specific land use divided by the total area of walkable land uses in each buffer. Note: LUM=0 (i.e.; no mix) if none or only one of the relevant land uses fell into the buffer. Data Source: OS MasterMap Topography Layer Data (December 2016) AddressBase Premium Data (OS Managed GB Set)

Real

Land use mix P2

Phase 2 data: The Shannon Entropy Index: A measure of how mixed land uses most relevant for PA are in a neighbourhood (Range: 0 to 1; 1= most mixed; 0=least mixed) LUM=(-1) Sk(pklnpk)/ln N p is the proportion of land area devoted to the specific land use (k) in each buffer divided by lnN N is the number of land uses under consideration. In this case N=5 (i.e. residential; commercial; institutional/governmental; recreational and mixed areas) The proportions (pk) were calculated as the land area devoted to a specific land use divided by the total area of walkable land uses in each buffer. Note: LUM=0 (i.e.; no mix) if none or only one of the relevant land uses fell into the buffer. Data Source: OS MasterMap Topography Layer Data (December 2016) AddressBase Premium Data (OS Managed GB Set)

Real

OLINK assay LXN

Phase 1 OLINK assay data for target LXN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LY75

Phase 1 OLINK assay data for target LY75 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LY9

Phase 1 OLINK assay data for target LY9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LYAR

Phase 1 OLINK assay data for target LYAR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Lymphocytes

lymphocytes are a type of white blood cell that play a crucial role in the immune system; helping the body fight infection and disease. Changes in lymphocyte levels; either higher or lower than normal; can indicate various health issues. Lymphocytosis (high lymphocyte count) may suggest infections; autoimmune diseases; or certain cancers. Lymphopenia (low lymphocyte count) can be associated with infections; autoimmune disorders; or bone marrow problems. The normal range for lymphocyte count in adults; as part of an FBC; is typically 1.0 to 4.0 x 10^9/L.

Real

OLINK assay LYN

Phase 1 OLINK assay data for target LYN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LYPD1

Phase 1 OLINK assay data for target LYPD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay LYPD3

Phase 1 OLINK assay data for target LYPD3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Lys_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Lys_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_012.

Real

lysoPCaC140_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC140_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=5. 2nd and final QC step on this var created new and final var BIOR_041.

Real

lysoPCaC160_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC160_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.12. 2nd and final QC step on this var created new and final var BIOR_048.

Real

lysoPCaC161_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC161_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=0.07. 2nd and final QC step on this var created new and final var BIOR_042.

Real

lysoPCaC170_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC170_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=0.05. 2nd and final QC step on this var created new and final var BIOR_043.

Real

lysoPCaC180_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC180_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=0.05. 2nd and final QC step on this var created new and final var BIOR_044.

Real

lysoPCaC181_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC181_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.1. 2nd and final QC step on this var created new and final var BIOR_049.

Real

lysoPCaC182_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC182_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=0.1. 2nd and final QC step on this var created new and final var BIOR_045.

Real

lysoPCaC203_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC203_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.2. 2nd and final QC step on this var created new and final var BIOR_050.

Real

lysoPCaC204_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC204_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_046.

Real

lysoPCaC240_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC240_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=1.3. 2nd and final QC step on this var created new and final var BIOR_051.

Real

lysoPCaC260_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC260_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.5. 2nd and final QC step on this var created new and final var BIOR_052.

Real

lysoPCaC261_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC261_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM; valid=0 LoD=4. 2nd and final QC step on this var created new and final var BIOR_047.

Real

lysoPCaC280_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC280_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.33. 2nd and final QC step on this var created new and final var BIOR_053.

Real

lysoPCaC281_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable lysoPCaC281_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.15. 2nd and final QC step on this var created new and final var BIOR_054.

Real

OLINK assay LYVE1

Phase 1 OLINK assay data for target LYVE1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

M237_2212T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (237.2212) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M239_2368T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (239.2368) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M254_2477T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (254.2477) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M261_2212T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (261.2212) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M263_2369T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (263.2369) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M265_2525T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (265.2525) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M279_2317T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (279.2317) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M280_2634T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (280.2634) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M285_2424T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (285.2424) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M287_2361T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (287.2361) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M289_2525T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (289.2525) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M294_2398T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (294.2398) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M311_2576T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (311.2576) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M313_2736T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (313.2736) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M327_2267T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (327.2267) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M335_2580T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (335.2580) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M337_2733T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (337.2733) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M337_3099T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (337.3099) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M339_2893T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (339.2893) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M341_3049T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (341.3049) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M361_2739T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (361.2739) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M367_3365T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (367.3365) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M369_4330T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (369.4330) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M381_3509T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (381.3509) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M383_3669T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (383.3669) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M480_3451T_1_LysoPC_P 16db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (480.3451) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M482_3601T_1_LysoPC_O 16db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (482.3601) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers

Real

M484_2825T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (484.2825) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M495_4409T_1_DG_H20 28db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (495.4409) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M580_5376T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (580.5376) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M583_5089T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (583.5089) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M605_5482T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (605.5482) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M611_5402T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (611.5402) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M617_5131T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (617.5131) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M496_3398T_1_LysoPC 16db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (496.3398) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M502_3288T_1_LysoPC_P 18db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (502.3288) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M504_3451T_1_LysoPC_P 18db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (504.3451) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M519_4411T_1_DG_H20 30db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (519.4411) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M520_3399T_1_LysoPC 18db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (520.3399) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M521_4565T_1_DG_H20 30db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (521.4565) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M619_5428T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (619.5428) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M630_6185T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (630.6185) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M632_6340T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (632.6340) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M650_5943T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (650.5943) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M522_3556T_1_LysoPC 18db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (522.3556) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M523_4722T_1_DG_H20 30db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (523.4722) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M524_3712T_1_LysoPC 18db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (524.3712) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M544_3392T_1_LysoPC 20db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (544.3392) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M545_4564T_1_DG_H20 32db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (545.4564) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M547_4724T_1_DG_H20 32db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (547.4724) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M650_6246T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (650.6246) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M651_6068T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (651.6068) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M653_5476T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (653.5476) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M655_6001T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (655.6001) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M549_4879T_1_DG_H20 32db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (549.4879) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M551_5033T_1_DG_H20 32db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (551.5033) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M561_4878T_1_DG_H20 33db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (561.4878) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M563_5034T_1_DG_H20 33db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (563.5034) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M571_4723T_1_DG_H20 34db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (571.4723) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M573_4879T_1_DG_H20 34db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (573.4879) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M666_4846T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (666.4846) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M679_4494T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (679.4494) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M716_5629T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (716.5629) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M720_5949T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (720.5949) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M575_5035T_1_DG_H20 34db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (575.5035) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M577_5190T_1_DG_H20 34db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (577.5190) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M587_5037T_1_DG_H20 35db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (587.5037) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M589_5191T_1_DG_H20 35db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (589.5191) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M591_5347T_1_DG_H20 35db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (591.5347) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M597_4878T_1_DG_H20 36db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (597.4878) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M724_5262T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (724.5262) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M726_5377T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (726.5377) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M726_5466T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (726.5466) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M741_5736T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (741.5736) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M599_5034T_1_DG_H20 36db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (599.5034) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M601_5190T_1_DG_H20 36db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (601.5190) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M603_5346T_1_DG_H20 36db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (603.5346) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M623_5035T_1_DG_H20 38db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (623.5035) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M625_5189T_1_DG_H20 38db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (625.5189) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M627_5347T_1_DG_H20 38db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (627.5347) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M745_4752T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (745.4752) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M749_5080T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (749.5080) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M752_5754T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (752.5754) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M753_5670T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (753.5670) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M629_5494T_1_DG_H20 38db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (629.5494) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M631_5655T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (631.5655) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M633_5811T_1_DG_H20 38db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (633.5811) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M640_6029T_1_CE 16db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (640.6029) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M642_6184T_1_CE 16db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (642.6184) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M643_5281T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (643.5281) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M754_5933T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (754.5933) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M757_6228T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (757.6228) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M758_0089T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (758.0089) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M758_5434T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (758.5434) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M649_5190T_1_DG_H20 40db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (649.5190) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M651_5347T_1_DG_H20 40db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (651.5347) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M656_5825T_1_TG 36db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (656.5825) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M664_6028T_1_CE 18db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (664.6028) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M666_6184T_1_CE 18db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (666.6184) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M668_6322T_1_CE 18db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (668.6322) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M758_7969T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (758.7969) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M762_6735T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (762.6735) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M764_5614T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (764.5614) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M768_7037T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (768.7037) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M673_5277T_1_SM 32db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (673.5277) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M675_5436T_1_SM 32db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (675.5436) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M688_6031T_1_CE 20db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (688.6031) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M689_5598T_1_SM 33db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (689.5598) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M690_6185T_1_CE 20db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (690.6185) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M692_6321T_1_CE 20db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (692.6321) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M769_5505T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (769.5505) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M772_5254T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (772.5254) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M772_6093T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (772.6093) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M774_6352T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (774.6352) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M701_5592T_1_SM 34db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (701.5592) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M703_5749T_1_SM 34db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (703.5749) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M704_5236T_1_DG 42db11

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (704.5236) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M706_5375T_1_PC 30db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (706.5375) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M714_6172T_1_CE 22db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (714.6172) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. CE = cholesteryl esters.

Real

M718_5377T_1_PE 34db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (718.5377) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M776_6891T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (776.6891) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M780_5885T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (780.5885) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M780_5989T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (780.5989) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M782_6018T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (782.6018) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M718_5750T_1_PC_P 32db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (718.5750) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M729_5905T_1_SM 36db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (729.5905) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M730_5376T_1_PC 32db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (730.5376) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M730_5743T_1_PC_O 33db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (730.5743) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M731_6064T_1_SM 36db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (731.6064) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M732_5542T_1_DG 44db11

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (732.5542) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. DG = diglycerides

Real

M782_6264T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (782.6264) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M800_6209T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (800.6209) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M808_6243T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (808.6243) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M823_6389T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (823.6389) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M734_5699T_1_PC 32db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (734.5699) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M742_5380T_1_PE 36db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (742.5380) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M744_5545T_1_PE 36db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (744.5545) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M744_5902T_1_PC_O 34db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (744.5902) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M745_6234T_1_SM 37db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (745.6234) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M746_5701T_1_PE 36db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (746.5701) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M825_6628T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (825.6628) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M827_6987T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (827.6987) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M828_5513T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (828.5513) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M829_6786T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (829.6786) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M746_6065T_1_PC_P 34db0

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (746.6065) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M754_5388T_1_PC 34db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (754.5388) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M756_5540T_1_PC 34db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (756.5540) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M758_5696T_1_PC 34db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (758.5696) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M758_6056T_1_PC_O 35db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (758.6056) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M759_6377T_1_SM 38db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (759.6377) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M830_5676T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (830.5676) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M836_6012T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (836.6012) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M838_6337T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (838.6337) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M840_5093T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (840.5093) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M760_5858T_1_PC 34db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (760.5858) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M766_5747T_1_PC_P 36db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (766.5747) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M768_5906T_1_PC_O 36db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (768.5906) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M770_5695T_1_PE 38db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (770.5695) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M770_6060T_1_PC_P 36db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (770.6060) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M771_6389T_1_SM 39db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (771.6389) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M841_7172T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (841.7172) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M846_6371T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (846.6371) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M849_6931T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (849.6931) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M852_8083T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (852.8083) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M772_5853T_1_PC 35db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (772.5853) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M772_6235T_1_PC_O 36db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (772.6235) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M773_6539T_1_SM 39db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (773.6539) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M774_6018T_1_PE 38db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (774.6018) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M778_5387T_1_PC 36db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (778.5387) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M780_5526T_1_PC 36db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (780.5526) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M855_7437T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (855.7437) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M857_7612T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (857.7612) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M860_6148T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (860.6148) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M864_5235T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (864.5235) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M782_5689T_1_PC 36db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (782.5689) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M784_5852T_1_PC 36db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (784.5852) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M785_6532T_1_SM 40db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (785.6532) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M786_6005T_1_PC 36db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (786.6005) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M787_6688T_1_SM 40db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (787.6688) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M788_6182T_1_PC 36db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (788.6182) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M872_6320T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (872.6320) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M874_6666T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (874.6666) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M876_7801T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (876.7801) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M880_8237T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (880.8237) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M790_5743T_1_PC_O 38db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (790.5743) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M792_5546T_1_PE 40db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (792.5546) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M792_5905T_1_PC_P 38db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (792.5905) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M792_7063T_1_TG 46db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (792.7063) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M794_5709T_1_PC 37db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (794.5709) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M794_6062T_1_PC_P 38db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (794.6062) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M904_5921T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (904.5921) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid.

Real

M904_7188T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (904.7188) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M909_5458T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (909.5458) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M930_8544T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (930.8544) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M794_7243T_1_TG 46db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (794.7243) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M796_5843T_1_PC 37db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (796.5843) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M796_6220T_1_PC_O 38db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (796.6220) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M798_6004T_1_PE 40db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (798.6004) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M801_6847T_1_SM 41db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (801.6847) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M804_5520T_1_PC 38db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (804.5520) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M932_8671T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (932.8671) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M944_7726T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (944.7726) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

M960_6852T_1_0

Explanation of var name M(1)_(2)T_(3)_(4) where 1.2 (960.6852) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified.

Real

OLINK assay MAD1L1

Phase 1 OLINK assay data for target MAD1L1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MAD homolog 5

Phase 1 OLINK assay data for target MAD homolog 5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

M806_5692T_1_PC 38db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (806.5692) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M808_5852T_1_PC 38db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (808.5852) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M808_7395T_1_TG 47db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (808.7395) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M810_6009T_1_PC 38db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (810.6009) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M811_6686T_1_SM 42db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (811.6686) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M812_6175T_1_PC 38db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (812.6175) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

OLINK assay MAEA

Phase 1 OLINK assay data for target MAEA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MAGED1

Phase 1 OLINK assay data for target MAGED1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MagicID

magicid also known as GWAS ID. Samples which are on the Affymetrix 500 K chip have been given a magicid. Having a magicid does not guaramantee they actually have magic (GWAS) data. Only those marked as HasGWASData -1 have data.

OLINK assay MANF

Phase 1 OLINK assay data for target MANF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

M813_6845T_1_SM 42db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (813.6845) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M815_7016T_1_SM 42db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (815.7016) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M816_5918T_1_PC_P 40db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (816.5918) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M818_6047T_1_PC_O 40db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (818.6047) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M820_6217T_1_PC_P 40db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (820.6217) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M820_7385T_1_TG 48db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (820.7385) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

OLINK assay MAP2K6

Phase 1 OLINK assay data for target MAP2K6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MAP4K5

Phase 1 OLINK assay data for target MAP4K5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MAPT

Phase 1 OLINK assay data for target MAPT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MARCO

Phase 1 OLINK assay data for target MARCO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MASP1

Phase 1 OLINK assay data for target MASP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MATN2

Phase 1 OLINK assay data for target MATN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

M822_7552T_1_TG 48db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (822.7552) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M824_6182T_1_PE 42db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (824.6182) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PE = phosphoethanolamines.

Real

M832_5843T_1_PC 40db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (832.5843) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M834_6008T_1_PC 40db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (834.6008) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M834_7546T_1_TG 49db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (834.7546) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M836_6183T_1_PC 40db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (836.6183) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

OLINK assay MATN3

Phase 1 OLINK assay data for target MATN3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Max obs Heart Rate

Maximum observed Heart rate during treadmill test. (Highest value observed during treadmill test).

Integer

Max obs HR during treadmill test

Phase 2 data. Maximum observed Heart rate during treadmill test. (Highest value observed during treadmill test).

Real

OLINK assay MAX

Phase 1 OLINK assay data for target MAX in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MBL2

Phase 1 OLINK assay data for target MBL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MB

Phase 1 OLINK assay data for target MB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MCFD2

Phase 1 OLINK assay data for target MCFD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MCP-1

Phase 1 OLINK assay data for target MCP-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MCP-1

Phase 1 OLINK assay data for target MCP-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MCP-2

Phase 1 OLINK assay data for target MCP-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

M836_7704T_1_TG 49db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (836.7704) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M837_6845T_1_SM 44db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (837.6845) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M846_7547T_1_TG 50db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (846.7547) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M848_7705T_1_TG 50db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (848.7705) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M850_7870T_1_TG 50db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (850.7870) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M852_6864T_1_PC_P 42db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (852.6864) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

OLINK assay MCP-3

Phase 1 OLINK assay data for target MCP-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MCP-4

Phase 1 OLINK assay data for target MCP-4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MDGA1

Phase 1 OLINK assay data for target MDGA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

M854_5692T_1_PC 42db10

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (854.5692) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M854_7021T_1_PC_O 42db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (854.7021) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M856_5833T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (856.5833) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M857_7460T_1_SM 45db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (857.7460) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. SM = sphingomyelins.

Real

M858_6023T_1_PC 42db8

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (858.6023) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M860_7703T_1_TG 51db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (860.7703) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M862_7869T_1_TG 51db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (862.7869) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M864_6485T_1_PC 42db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (864.6485) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC = phosphatidylcholines.

Real

M864_8027T_1_TG 51db1

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (864.8027) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M870_7550T_1_TG 52db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (870.7550) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M872_7705T_1_TG 52db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (872.7705) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M874_7862T_1_TG 52db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (874.7862) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M876_6848T_1_PC_P 44db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (876.6848) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_P = phosphatidylcholine alkenyl ethers.

Real

M876_8023T_1_TG 52db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (876.8023) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M878_6999T_1_PC_O 44db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (878.6999) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. PC_O = phosphatidylcholine alkyl ethers.

Real

M886_7854T_1_TG 53db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (886.7854) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M888_8026T_1_TG 53db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (888.8026) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M890_8189T_1_TG 53db2

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (890.8189) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M894_7541T_1_TG 54db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (894.7541) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M896_7705T_1_TG 54db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (896.7705) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M898_7863T_1_TG 54db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (898.7863) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M900_8022T_1_TG 54db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (900.8022) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M902_8182T_1_TG 54db3

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (902.8182) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M904_8368T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (904.8368) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

Meal Voucher Given

Meal Voucher Given

Mean Cell Volume

MCV provides information about the volume of red blood cells in femtoliters (fL). A normal MCV range is typically 80 to 100 femtoliters; which indicates that your red blood cells are of average size and functioning properly.

Real

Mean Corpuscular Haemoglobin Concentration

Mean Corpuscular Hemoglobin Concentration (MCHC) is a measure of the average concentration of hemoglobin within a red blood cell. It's a part of a full blood count test that helps assess the characteristics of red blood cells. Low MCHC Indicates that red blood cells have less hemoglobin than normal. This can be associated with iron deficiency anemia and thalassemias; while high MCHC can be a symptom of anemia and other conditions. among other conditions A normal MCHC range is typically 320 to 360 grams per liter (g/L).

Real

Mean Corpuscular Haemoglobin

Mean Corpuscular Hemoglobin (MCH) is a measurement in a complete blood count (CBC) that indicates the average amount of hemoglobin within a red blood cell; expressed in picograms (pg).  Low MCH levels may suggest iron deficiency or other anemias; while high levels could indicate macrocytic anemia or vitamin B12 or folate deficiencies. The normal range for MCH is typically between 27 and 33 pg per cell.

Real

Mean Platelet Volume

Mean platelet volume (MPV) measures the average size of platelets in your blood. Platelets are small blood cells that help with clotting. An MPV test is typically part of a full blood count (FBC) and is measured in femtoliters (fL). The normal range for MPV is generally between 7.5 and 11.5 fL.

Real

MeasurementComments

Any comments which are relevant to measurement data such as weight smoking alcohol intake waist andd hip measurements

Text

M910_7875T_1_TG 55db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (910.7875) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M912_8029T_1_TG 55db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (912.8029) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M914_8165T_1_TG 55db4

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (914.8165) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M918_7548T_1_TG 56db9

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (918.7548) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M920_7701T_1_TG 56db8

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (920.7701) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M922_7867T_1_TG 56db7

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (922.7867) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

None

Phase 2 data. Any comments which are relevant to measurement data such as weight smoking alcohol intake waist and hip measurements.

Text

MeasEnt

Measurements entered? Data from study database.

Measurement entered

Phase 2 data. Measurements entered? Data from study database.

Categorical

Beef roast steak mince stew or casserole ERROR CODES CLEANED

Average use last year of Beef: roast steak mince stew or casserole After cleaning this variable is renamed as BEEF which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Beefburgers ERROR CODES CLEANED

Average use last year of Beefburgers After cleaning this variable is renamed as BURGER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Pork roast chops stew or slices ERROR CODES CLEANED

Average use last year of Pork; roast chops stew or slices After cleaning this variable is renamed as PORK which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Lamb roast chops or stew ERROR CODES CLEANED

Average use last year of Lamb; roast chops or stew After cleaning this variable is renamed as LAMB which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

M924_8028T_1_TG 56db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (924.8028) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M926_8195T_1_TG 56db5

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (926.8195) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M928_8372T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (928.8372) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

M946_7876T_1_TG 58db9

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (946.7876) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M948_8031T_1_TG 58db8

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (948.8031) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M950_8191T_1_0

Improved name in R8. Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (950.8191) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds. LysoPC_PC = lyso-phosphatidylcholine alkenyl ethers.

Real

Chicken or other poultry eg turkey ERROR CODES CLEANED

Average use last year of Chicken or other poultry eg turkey After cleaning this variable is renamed as CHICKEN which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Bacon ERROR CODES CLEANED

Average use last year of Bacon After cleaning this variable is renamed as BACON which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Ham ERROR CODES CLEANED

Average use last year of Ham After cleaning this variable is renamed as HAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Corned Beef Spam luncheon meats ERROR CODES CLEANED

Average use last year of Corned Beef Spam luncheon meats After cleaning this variable is renamed as CORNED_BEEF which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sausages ERROR CODES CLEANED

Average use last year of Sausages After cleaning this variable is renamed as SAUSAGES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Savoury pies

Average use last year of Savoury pies eg meat pie; pork pie; pasties; steak & kidney ie; sausage rolls; Average use last year of Savoury pies eg. meat pie pork pie pasties steak and kidney pie sausage rolls. After cleaning this variable is renamed as SAVOURY_PIES which is then used by the FETA program for analys.

Categorical

M952_8344T_1_TG 58db6

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (952.8344) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

M972_8018T_1_TG 60db10

Explanation of var name M(1)_(2)T_(3)_(4_((5)db(6))) where 1.2 (972.8018) is the mass to charge ratio's of the ions measured (unit = m/z) (3) is the charge of the ions (1 in all cases which means that the numbers correspond to the Molecular weight of the ion including the source of the ionisation agent). Based on accurate mass to charge ratio libraries can be searched to identify the molecular formula and corresponding lipid. Where (4) is 0 these were not identified. For the identified lipids the identity was also confirmed by LCMSMS. Where identified (5) is the number of carbons in the fatty acids and (6) is the number of double bonds.TG = triglycerides.

Real

Savoury pies eg meat pie pork pie pasties steak & kidney pie sausage rolls ERROR CODES CLEANED

Average use last year of Savoury pies eg meat pie; pork pie; pasties; steak & kidney ie; sausage rolls; Average use last year of Savoury pies eg meat pie pork pie pasties steak and kidney pie sausage rolls After cleaning this variable is renamed as SAVOURY_PIES which is then used by the FETA program for analys All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Savoury pies

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Liver liver pate liver sausage

Average use last year of Liver liver pate liver sausage. After cleaning this variable is renamed as LIVER which is then used by the FETA program for analysis.

Categorical

Liver liver pate liver sausage ERROR CODES CLEANED

Average use last year of Liver liver pate liver sausage After cleaning this variable is renamed as LIVER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Liver pate liver sausage

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fried fish in batter as in fish and chips

Average use last year of Fried fish in batter as in fish and chips. After cleaning this variable is renamed as FRIED_FISH which is then used by the FETA program for analysis.

Categorical

Fried fish in batter as in fish and chips ERROR CODES CLEANED

Average use last year of Fried fish in batter as in fish and chips After cleaning this variable is renamed as FRIED_FISH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fried fish in batter

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fish Fingers fish cakes

Average use last year of Fish Fingers fish cakes. After cleaning this variable is renamed as FISH_FINGERS which is then used by the FETA program for analysis.

Categorical

Fish Fingers fish cakes ERROR CODES CLEANED

Average use last year of Fish Fingers fish cakes After cleaning this variable is renamed as FISH_FINGERS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fish Fingers fish cakes

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Other white fish fresh or frozen eg cod haddock plaice sole halibut

Average use last year of Other white fish fresh or frozen eg. cod haddock plaice sole halibut. After cleaning this variable is renamed as WHITE_FISH which is then used by the FETA program for analysis.

Categorical

Other white fish fresh or frozen eg cod haddock plaice sole halibut ERROR CODES CLEANED

Average use last year of Other white fish fresh or frozen eg cod haddock plaice sole halibut After cleaning this variable is renamed as WHITE_FISH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Other white fish fresh or frozen

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Oily fish fresh or canned eg mackerel kippers tuna salmon sardines herring

Average use last year of Oily fish fresh or canned eg. mackerel kippers tuna salmon sardines herring. After cleaning this variable is renamed as OILY_FISH which is then used by the FETA program for analysis.

Categorical

Oily fish fresh or canned eg mackerel kippers tuna salmon sardines herring ERROR CODES CLEANED

Average use last year of Oily fish fresh or canned eg mackerel kippers tuna salmon sardines herring After cleaning this variable is renamed as OILY_FISH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Oily fish fresh or canned 

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Shellfish eg crab prawns mussels

Average use last year of Shellfish eg. crab prawns mussels. After cleaning this variable is renamed as SHELLFISH which is then used by the FETA program for analysis.

Categorical

Shellfish eg crab prawns mussels ERROR CODES CLEANED

Average use last year of Shellfish eg crab prawns mussels After cleaning this variable is renamed as SHELLFISH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Shellfish eg crab prawns mussels

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fish Roe taramasalata

Average use last year of Fish Roe taramasalata. After cleaning this variable is renamed as ROE which is then used by the FETA program for analysis.

Categorical

Fish Roe taramasalata ERROR CODES CLEANED

Average use last year of Fish Roe taramasalata After cleaning this variable is renamed as ROE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fish Roe taramasalata

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Beef roast steak mince stew or casserole

Average use last year of Beef: roast steak mince stew or casserole. After cleaning this variable is renamed as BEEF which is then used by the FETA program for analysis.

Categorical

Beef roast steak mince stew or casserole

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Beefburgers

Average use last year of Beefburgers. After cleaning this variable is renamed as BURGER which is then used by the FETA program for analysis.

Categorical

Beefburgers

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Pork roast chops stew or slices

Average use last year of Pork; roast chops stew or slices. After cleaning this variable is renamed as PORK which is then used by the FETA program for analysis.

Categorical

Pork roast chops stew or slices

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Lamb roast chops or stew

Average use last year of Lamb; roast chops or stew. After cleaning this variable is renamed as LAMB which is then used by the FETA program for analysis.

Categorical

Lambs roast chops or stew

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Chicken or other poultry eg turkey

Average use last year of Chicken or other poultry eg turkey. After cleaning this variable is renamed as CHICKEN which is then used by the FETA program for analysis.

Categorical

Chicken or other poultry

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Bacon

Average use last year of Bacon. After cleaning this variable is renamed as BACON which is then used by the FETA program for analysis.

Categorical

Bacon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Ham

Average use last year of Ham. After cleaning this variable is renamed as HAM which is then used by the FETA program for analysis.

Categorical

Ham

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Corned Beef Spam luncheon meats

Average use last year of Corned Beef Spam luncheon meats. After cleaning this variable is renamed as CORNED_BEEF which is then used by the FETA program for analysis.

Categorical

Corned Beef Luncheon meats

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sausages

Average use last year of Sausages. After cleaning this variable is renamed as SAUSAGES which is then used by the FETA program for analysis.

Categorical

Sausages

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Media weekday after 6pm

Hours of TV DVD or video watched per day on a weekday after 6 pm. Average over the last 4 weeks.

Categorical

Media weekday after 6pm CLEANED

Hours of TV DVD or video watched per day on a weekday after 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Categorical

Cln variable: Media weekday post6pm

Phase 2 data. Hours of TV DVD or video watched per day on a weekday after 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Real

Hrs Media viewed weekday post 6pm

Phase 2 data. Questionnaire reads D2. TV; DVD or video viewing. Hours of TV DVD or video watched per day on a weekday after 6 pm. Average over the last 4 weeks. DO NOT USE THIS VARIABLE. Use Mediaweekdaypost6pm_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Media weekday before 6pm

Hours of TV DVD or video watched per day on a weekday before 6 pm. Average over the last 4 weeks.

Categorical

Media weekday before 6pm CLEANED

Hours of TV DVD or video watched per day on a weekday before 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Categorical

Cln variable: Media weekday pre6pm

Phase 2 data. Hours of TV DVD or video watched per day on a weekday before 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Real

Hrs Media viewed weekday pre 6pm

Phase 2 data. Questionnaire reads D2. TV; DVD or video viewing. Hours of TV DVD or video watched per day on a weekday before 6 pm. Average over the last 4 weeks. DO NOT USE THIS VARIABLE. Use Mediaweekdaypre6pm_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Media weekday after 6pm

Hours of TV DVD or video watched per day on a weekend after 6 pm. Average over the last 4 weeks.

Categorical

Media weekday after 6pm CLEANED

Hours of TV DVD or video watched per day on a weekend after 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Categorical

Cln variable: Media weekend post6pm

Phase 2 data. Hours of TV DVD or video watched per day on a weekend after 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Real

Hrs Media viewed weekend post 6pm

Phase 2 data. Questionnaire reads D2. TV; DVD or video viewing. Hours of TV DVD or video watched per day on a weekend after 6 pm. Average over the last 4 weeks. DO NOT USE THIS VARIABLE. Use Mediaweekendpost6pm_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

Media weekend before 6pm

Hours of TV DVD or video watched per day on a weekend before 6 pm. Average over the last 4 weeks.

Categorical

Media weekend before 6pm CLEANED

Hours of TV DVD or video watched per day on a weekend before 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Categorical

Cln variable: Media weekend pre6pm

Phase 2 data. Hours of TV DVD or video watched per day on a weekend before 6 pm. Average over the last 4 weeks. Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Real

Hrs Media viewed weekend pre 6pm

Phase 2 data. Questionnaire reads D2. TV; DVD or video viewing. Hours of TV DVD or video watched per day on a weekend before 6 pm. Average over the last 4 weeks. DO NOT USE THIS VARIABLE. Use Mediaweekendpre6pm_CLEAN_P2 instead. 1 = none; 2 = less than 1 hr a day; 3 = 1 to 2 hrs a day; 4 = 2 to 3 hrs a day; 5 = 3 to 4 hrs a day; 6 = more than 4 hrs a day;

Categorical

OLINK assay MEGF9

Phase 1 OLINK assay data for target MEGF9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MEP1B

Phase 1 OLINK assay data for target MEP1B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MEPE

Phase 1 OLINK assay data for target MEPE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MERTK

Phase 1 OLINK assay data for target MERTK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MESDC2

Phase 1 OLINK assay data for target MESDC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Metabo ID number

ID number assigned for sample on Illumina cardio metabo chip. Having a metabo (id) does not guarantee having metabo data. Samples with a metabo only have metabo data if they are marked as HasMetabodata - 1

Categorical

OLINK assay METAP1D

Phase 1 OLINK assay data for target METAP1D in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay METAP1

Phase 1 OLINK assay data for target METAP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MetAP 2

Phase 1 OLINK assay data for target MetAP 2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

metformin

Phase 2 data. Binary variable indicating whether a drug from the metforminr class was prescribed. 0: No 1: Yes

Categorical

OLINK assay METRNL

Phase 1 OLINK assay data for target METRNL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MetSO_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable MetSO_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_028.

Real

OLINK assay MET

Phase 1 OLINK assay data for target MET in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Met_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Met_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_013.

Real

OLINK assay MFAP5

Phase 1 OLINK assay data for target MFAP5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MFGE8

Phase 1 OLINK assay data for target MFGE8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MGMT

Phase 1 OLINK assay data for target MGMT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MIA

Phase 1 OLINK assay data for target MIA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MIC-A/B

Phase 1 OLINK assay data for target MIC-A/B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MIF

Phase 1 OLINK assay data for target MIF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

The list of milk types does not contain recent additions to the market such as rice/oat/coconut mil

Variable derived by study staff from raw data for A3aMilk and A3bOtherMilk. There is a non-specific milk code (a2002) available if a combination of milks is given or the text is uninformative. Currently the program only deals with one type of milk.

Categorical

1-none 2-Quarter of a pint 3-Half a pint 4-Three quarters of a pint 5-one pint 6-More than on pint -

Variable created by reviewing error coded data from raw FFQ data for A4MilkAmount.

Categorical

OLINK assay MILR1

Phase 1 OLINK assay data for target MILR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MISSING

MISSING. Derived Intermediate not for general release. Data can be provided if necessary.

MISSINGA

MISSINGA. Derived Intermediate not for general release. Data can be provided if necessary.

Categorical

MISSINGC

MISSINGC. Derived Intermediate not for general release. Data can be provided if necessary.

Categorical

MISSINGCOMMUT

MISSINGCOMMUT. Derived Intermediate not for general release. Data can be provided if necessary.

Categorical

MISSINGJOB

MISSINGJOB. Derived Intermediate not for general release. Data can be provided if necessary.

Categorical

OLINK assay MK

Phase 1 OLINK assay data for target MK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP12

Phase 1 OLINK assay data for target MMP12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP7

Phase 1 OLINK assay data for target MMP7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP-10

Phase 1 OLINK assay data for target MMP-10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP-1

Phase 1 OLINK assay data for target MMP-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP-2

Phase 1 OLINK assay data for target MMP-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP-3

Phase 1 OLINK assay data for target MMP-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MMP-9

Phase 1 OLINK assay data for target MMP-9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MODERATEtime

Time spent at moderate intensity activity [hrs/d]

Real

Time spent at moderate intensity activity work not inc

Phase 2 data. Derived with method 2. Time spent at moderate intensity activity; No work and no other acts hrs/d

Real

Time spent at moderate intensity activity work inc

Phase 2 data. Derived with method 2. Time spent at moderate intensity activity; Work inc but no other acts hrs/d

Real

MODERATE_INTENSITY

Moderate intensity energy expenditure [METhrs/d]

Real

OLINK assay MOG

Phase 1 OLINK assay data for target MOG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Monitor allocated

Has a monitor been allocated? Select one option.

Monocytes

Monocytes are a type of white blood cell that plays a crucial role in the immune system. They help destroy bacteria and other pathogens and signal other immune cells to fight infection. In a full blood count; the normal range for monocytes is typically 0.2 - 1.0 x 10^9/L

Real

Hours of Mowing the lawn

Please indicate the average length of time (in hours) you spent doing the activity per episode. Mowing the lawn.

Integer

Hours of Mowing the lawn CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Mowing the lawn. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Moving the lawn hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Mowing the lawn. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Mowing hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Mowing the lawn. -1 = left blank. DO NOT USE THIS VARIABLE. Use mowingHr_CLEAN_P2 instead.

Real

Minutes of Mowing the lawn

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Mowing the lawn.

Integer

Minutes of Mowing the lawn CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Mowing the lawn. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Moving the lawn min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Mowing the lawn. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Mowing min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Mowing the lawn. -1 = left blank. DO NOT USE THIS VARIABLE. Use mowingMin_CLEAN_P2 instead.

Real

Frequency of Mowing the lawn CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Mowing the lawn.Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

mowing_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Mowing the lawn

Real

Cln variable: Moving the lawn

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Mowing the lawn.Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

mowing_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Mowing the lawn. Data normalised to DE template 1 data.

Categorical

Mowing

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Mowing the lawn. DO NOT USE THIS VARIABLE. Use mowing_CLEAN_P2 instead.

Real

Mowing the lawn

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Mowing the lawn. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Mowing the lawn DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Mowing the lawn. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in mowing_T2. Instead use mowing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Mowing the lawn DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Mowing the lawn. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in mowing_T1. Instead use mowing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay MPO

Phase 1 OLINK assay data for target MPO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MRC2

Phase 1 OLINK assay data for target MRC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MSLN

Phase 1 OLINK assay data for target MSLN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MSMB

Phase 1 OLINK assay data for target MSMB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MSR1

Phase 1 OLINK assay data for target MSR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay MUC-16

Phase 1 OLINK assay data for target MUC-16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MET_QCd_MultiPairNr

New in R8. For those participants for whom more than one row of data is available data management created arbitrary pair-numbers and assigned them to rows of data belonging to the same participant to allow foraccurate data QC.

Integer

Hours of Musical Instrument Playing Or Singing CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Musical Instrument Playing Or Singing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding) . And then -10 errors cleaned by PA team.

Integer

Hours of Musical Instrument Playing Or Singing

Please indicate the average length of time (in hours) you spent doing the activity per episode. Musical Instrument Playing Or Singing.

Integer

Cln variable:Musical instrument hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Musical instrument playing or singing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Musical instrument playing hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Musical Instrument Playing Or Singing. -1 = left blank. DO NOT USE THIS VARIABLE. Use musicalInstrumentSingingHr_CLEAN_P2 instead.

Real

Minutes of Musical Instrument Playing Or Singing

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Musical Instrument Playing Or Singing.

Integer

Cln variable:Musical instrument min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Musical instrument playing or singing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Musical instrument playing min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Musical Instrument Playing Or Singing. -1 = left blank. DO NOT USE THIS VARIABLE. Use musicalInstrumentSingingMin_CLEAN_P2 instead.

Real

Cln variable: Musical instrument

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical instrument playing or singing. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

musicalInstrumentSinging_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical Instrument Playing Or Singing. Data normalised to DE template 1 data.

Categorical

Musical instrument playing

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical instrument playing or singing. DO NOT USE THIS VARIABLE. Use musicalInstrumentSinging_CLEAN_P2 instead.

Real

Musical Instrument Playing

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical Instrument Playing Or Singing. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Musical Instrument Playing Or Singing DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical Instrument Playing Or Singing. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in musicalInstrumentSinging_T2. Instead use musicalInstrumentSinging_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Musical Instrument Playing Or Singing DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical Instrument Playing Or Singing. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in musicalInstrumentSinging_T1. Instead use musicalInstrumentSinging_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Minutes of Musical Instrument Playing Or Singing CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Musical Instrument Playing Or Singing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding) . And then -10 errors cleaned by PA team.

Integer

Frequency of Musical Instrument Playing Or Singing CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Musical Instrument Playing Or Singing. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

musicalInstrumentSing_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Musical Instrument Playing Or Singing

Real

OLINK assay MVK

Phase 1 OLINK assay data for target MVK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Time spent moderate vigorous intensities wrk not inc

Phase 2 data. Derived with method 2. Time spent at mod+vig intensities; No work and no other acts hrs/d

Real

Time spent at moderate vigorous intensities work inc

Phase 2 data. Derived with method 2. Time spent at mod+vig intensities; Work inc but no other acts hrs/d

Real

OLINK assay MYOC

Phase 1 OLINK assay data for target MYOC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay N2DL-2

Phase 1 OLINK assay data for target N2DL-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NAA10

Phase 1 OLINK assay data for target NAA10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NAAA

Phase 1 OLINK assay data for target NAAA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NADK

Phase 1 OLINK assay data for target NADK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NBL1

Phase 1 OLINK assay data for target NBL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NBN

Phase 1 OLINK assay data for target NBN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NCAM1

Phase 1 OLINK assay data for target NCAM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NCAN

Phase 1 OLINK assay data for target NCAN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NCF2

Phase 1 OLINK assay data for target NCF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NCLN

Phase 1 OLINK assay data for target NCLN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NCR1

Phase 1 OLINK assay data for target NCR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NDRG1

Phase 1 OLINK assay data for target NDRG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NECTIN2

Phase 1 OLINK assay data for target NECTIN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

NEFA

Heparin biomarker NEFA measurement RAW in umol/l. Raw data; cleaned data provided in variable G_NEFA with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

None

Lab comments relating to samples used for NEFA analysis for phase 1

Text

NEFA Raw

Phase 2 data. Heparin biomarker NEFA measurement RAW in umol/l. Raw data; cleaned data provided in variable G_NEFA with x_Threshold and x_Com variables provided for clarification.

Real

OLINK assay NEFL

Phase 1 OLINK assay data for target NEFL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NEMO

Phase 1 OLINK assay data for target NEMO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NEP

Phase 1 OLINK assay data for target NEP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Home network dist 5 supermarket p1

Home average network distance to five closest supermarkets in phase 1

Integer

Home network dist 5 supermarket p2

Home average network distance to five closest supermarkets in phase 2

Integer

Home network dist 5 takeaway p1

Home average network distance to five closest takeaways in phase 1

Integer

Home network dist 5 takeaway p2

Home average network distance to five closest takeaways in phase 2

Integer

Home network dist closest supermarket p1

Home network distance to closest supermarkets in phase 1

Integer

Home network dist closest supermarket p2

Home network distance to closest supermarkets in phase 2

Integer

Home network distance closest takeaway p1

Home network distance to closest takeaways in phase 1

Integer

Home network distance closest takeaway p2

Home network distance to closest takeaways in phase 2

Integer

Work network dist 5 supermarket p1

Work average network distance to five closest supermarkets in phase 1

Integer

Work network dist 5 supermarket p2

Work average network distance to five closest supermarkets in phase 2

Integer

Work network dist 5 takeaway p1

Work average network distance to five closest takeaways in phase 1

Integer

Work network dist 5 takeaway p2

Work average network distance to five closest takeaways in phase 2

Integer

Work network dist closest supermarket p1

Work network distance to closest supermarkets in phase 1

Integer

Work network dist closest supermarket p2

Work network distance to closest supermarkets in phase 2

Integer

Work network distance closest takeaway p1

Work network distance to closest takeaways in phase 1

Integer

Work network distance closest takeaway p2

Work network distance to closest takeaways in phase 2

Integer

Hours of Netball Volleyball Or Basketball

Please indicate the average length of time (in hours) you spent doing the activity per episode. Netball Volleyball Or Basketball.

Integer

Hours of Netball Volleyball Or Basketball CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Netball Volleyball Or Basketball. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Netball hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Netball Volleyball Or Basketball. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Netball volleyball basketball hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Netball Volleyball Or Basketball. -1 = left blank. DO NOT USE THIS VARIABLE. Use netVolleyBasketBallHr_CLEAN_P2 instead.

Real

Minutes of Netball Volleyball Or Basketball

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Netball Volleyball Or Basketball.

Integer

Minutes of Netball Volleyball Or Basketball CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Netball Volleyball Or Basketball. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Netball min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Netball Volleyball Or Basketball. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Netball volleyball basketball min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Netball Volleyball Or Basketball. -1 = left blank. DO NOT USE THIS VARIABLE. Use netVolleyBasketBallMin_CLEAN_P2 instead.

Real

Frequency of Netball Volleyball Or Basketball CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball Volleyball Or Basketball. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

netVolleyBasketBall_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Netball Volleyball Or Basketball

Real

Cln variable: Netball

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball Volleyball Or Basketball. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

netVolleyBasketBall_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball Volleyball Or Basketball. Data normalised to DE template 1 data.

Categorical

Netball volleyball basketball

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball volleyball or basketball. DO NOT USE THIS VARIABLE. Use netVolleyBasketBall_CLEAN_P2 instead.

Real

Netball Volleyball or Basketball

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball Volleyball Or Basketball. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Netball Volleyball Or Basketball DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball Volleyball Or Basketball. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in netVolleyBasketBall_T2. Instead use netVolleyBasketBall_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Netball Volleyball Or Basketball DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Netball Volleyball Or Basketball. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in netVolleyBasketBall_T1. Instead use netVolleyBasketBall_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

No. of correctly identified targets (neutral image 1 image before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a neutral distractor picture shown 1 images before the target (i.e.; there were 0 neutral images between the distractor and the target); in the Rapid Serial Visualisation Task. All images were neutral.

Integer

No. of correctly identified targets (neutral image 2 images before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a neutral distractor picture shown 2 images before the target (i.e.; there was 1 neutral image between the distractor and the target); in the Rapid Serial Visualisation Task. All images were neutral.

Integer

No. of correctly identified targets (neutral image 3 image before target)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets in the trials where the target (a letter p or q) was on a neutral image; with a neutral distractor picture shown 3 images before the target (i.e.; there were 2 neutral images between the distractor and the target); in the Rapid Serial Visualisation Task. All images were neutral.

Integer

Neutrophils

Neutrophils are a type of white blood cell that plays a crucial role in the immune system; particularly in fighting bacterial and fungal infections. A normal neutrophil count; measured in a full blood count (FBC); typically ranges from 2.0 to 7.0 x 10^9/L. Deviations from this range; especially below 1.5 x 10^9/L (neutropenia); can indicate an increased risk of infection.

Real

No. of errors in go trials (neutral)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of errors across all Go Trials for neutral stimuli in the Food Go/No-Go with Affective Shifting task.

Integer

No. of inhibition errors (neutral)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of inhibition errors across all neutral stimuli. Inhibition errors = responses that should have been inhibited as a distractor was presented. Number of times the participant is instructed not to respond to blue-outlined or green-outlined images; but responds when these are neutral images.

Integer

OLINK assay NF2

Phase 1 OLINK assay data for target NF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NFATC1

Phase 1 OLINK assay data for target NFATC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NFATC3

Phase 1 OLINK assay data for target NFATC3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NFKBIE

Phase 1 OLINK assay data for target NFKBIE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NID1

Phase 1 OLINK assay data for target NID1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NID2

Phase 1 OLINK assay data for target NID2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NINJ1

Phase 1 OLINK assay data for target NINJ1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NMNAT1

Phase 1 OLINK assay data for target NMNAT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NOMO1

Phase 1 OLINK assay data for target NOMO1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Median signal normalization scale factor (0.005percent mix)

Real

Median signal normalization scale factor (0.005% mix)

Phase 2 data. Median signal normalization scale factor (0.005% mix)

Real

None

Median signal normalization scale factor (0.5percent mix)

Real

Median signal normalization scale factor (0.5% mix)

Phase 2 data. Median signal normalization scale factor (0.5% mix)

Real

None

Median signal normalization scale factor (20percent mix)

Real

Median signal normalization scale factor (20% mix)

Phase 2 data. Median signal normalization scale factor (20% mix)

Real

OLINK assay NOS3

Phase 1 OLINK assay data for target NOS3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NOTCH1

Phase 1 OLINK assay data for target NOTCH1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Notch 3

Phase 1 OLINK assay data for target Notch 3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NOV

Phase 1 OLINK assay data for target NOV in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NPDC1

Phase 1 OLINK assay data for target NPDC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NPM1

Phase 1 OLINK assay data for target NPM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NPPC

Phase 1 OLINK assay data for target NPPC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NPTXR

Phase 1 OLINK assay data for target NPTXR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NQO2

Phase 1 OLINK assay data for target NQO2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NRP1

Phase 1 OLINK assay data for target NRP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NRP2

Phase 1 OLINK assay data for target NRP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NRTN

Phase 1 OLINK assay data for target NRTN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Nr-CAM

Phase 1 OLINK assay data for target Nr-CAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NTF4

Phase 1 OLINK assay data for target NTF4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NTRK2

Phase 1 OLINK assay data for target NTRK2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NTRK3

Phase 1 OLINK assay data for target NTRK3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NT-3

Phase 1 OLINK assay data for target NT-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum NT_proBNP

Serum biomarker NT_proBNP measurement in pg/ml RAW-Changed. All measurements below 10 have been changed to <10 or <10.0 to ensure they are not used in any calculation. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

OLINK assay NT-proBNP

Phase 1 OLINK assay data for target NT-proBNP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NT-proBNP

Phase 1 OLINK assay data for target NT-proBNP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum NT_proBNP_RAW data

RAW Serum biomarker NT_proBNP measurement in pg/ml. NT pro-BNP lower detection limit is 10 pg/ml. This is RAW data where measurements below 10 are still displayed even though data is not reliable since result is below the manufacturers limit of detection. . Raw data; cleaned data provided in variable G_C_Peptide with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

NT_proBNP_RAW Comments

Lab Comments only relating to iron_measured Transferrin TIBC NT_proBNP ApoA1 ApoB and NT_proBNP_RAW assays regarding sample sufficiency and results below detection limits.

Text

OLINK assay NUB1

Phase 1 OLINK assay data for target NUB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NUCB2

Phase 1 OLINK assay data for target NUCB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay NUDT5

Phase 1 OLINK assay data for target NUDT5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

No. correctly recalled words delay

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of words the participant correctly recalls from the list of words presented during the Delayed Recall Task; after a period of delay following presentation of the words (=delayed recall). Allows for different spellings (e.g. color and colour) as well as obvious typos (e.g. curtaibn considered a typo for curtain and therefore counted; but e.g. hose not counted as a typo for house).

Integer

No. correctly recalled words

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of words the participant correctly recalls from the list of words presented during the Delayed Recall Task; immediately after presentation of the words (=immediate recall). Allows for different spellings (e.g. color and colour) as well as obvious typos (e.g. curtaibn considered a typo for curtain and therefore counted; but e.g. hose not counted as a typo for house).

Integer

OLINK assay NXPH1

Phase 1 OLINK assay data for target NXPH1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay N-CDase

Phase 1 OLINK assay data for target N-CDase in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay OMD

Phase 1 OLINK assay data for target OMD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay OMG

Phase 1 OLINK assay data for target OMG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OMICS_ID

OMICS_ID. A sample has an OMICS_ID if it is on the Affymetrix UK Biobank chip. Any sample not on the Affymetrix 500K chip (GWAS) at the time off assembly was placed on this chip.

Text

None

Phase 2 data.

Categorical

OnBetablockers

Data as entered on Study database. Is volunteer on beta blockers? tick = yes; left blank = no;

Real

Beta blockers

Phase 2 data. Data as entered on Study database. Is volunteer on beta blockers? Use version in PA dataset instead 0 = no; 1 = yes;

Categorical

OLINK assay OPG

Phase 1 OLINK assay data for target OPG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay OPG

Phase 1 OLINK assay data for target OPG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay OPN

Phase 1 OLINK assay data for target OPN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay OPTC

Phase 1 OLINK assay data for target OPTC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Orn_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Orn_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_014.

Real

OLINK assay OSMR

Phase 1 OLINK assay data for target OSMR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay OSM

Phase 1 OLINK assay data for target OSM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cln variable: Other household hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other household activities - eg hoovering. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other household activities hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other household activities (eg hoovering). -1 = left blank. DO NOT USE THIS VARIABLE. Use OtherHouseholdHr_CLEAN_P2 instead.

Real

Cln variable: Other household min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other household activities - eg hoovering. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Other household activities min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Other household activities (eg hoovering). -1 = left blank. DO NOT USE THIS VARIABLE. Use OtherHouseholdMin_CLEAN_P2 instead.

Real

Cln variable: Other household

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other household activities - eg hoovering. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

Other household activities

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Other household activities (eg hoovering). DO NOT USE THIS VARIABLE. Use OtherHousehold_CLEAN_P2 instead.

Real

Other household activities

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Other household activities (eg hoovering). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

OLINK assay P4HB

Phase 1 OLINK assay data for target P4HB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PADI2

Phase 1 OLINK assay data for target PADI2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

PAEE

Physical activity energy expenditure [kJ/kg/d]

Real

PAEE

Phase 2 data. Derived with method 2. Physical activity energy expenditure kJ/kg/d

Real

OLINK assay PAEP

Phase 1 OLINK assay data for target PAEP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Overall neighbourhood physical activity environment index

The sum of z-scores of junction density; the LUM entropy score; and population density variables. A higher score = higher walkability based on these three metrics

Real

Overall neighbourhood physical activity environment (PAE) index P2

Phase 2 data: The sum of z-scores of junction density; the LUM entropy score; and population density variables. A higher score = higher walkability based on these three metrics

Real

OLINK assay PAG1

Phase 1 OLINK assay data for target PAG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Employment during the last 4 weeks

Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. Have you been in employment during the last 4 weeks?

Categorical

Employment during the last 4 weeks CLEANED

Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. Have you been in employment during the last 4 weeks?

Categorical

Paid employment in the last 4 weeks

Phase 2 data. Phase 2 var derived by DMT from flipping Paidemployment_v2_P2. Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. Have you been in employment during the last 4 weeks? 1 = no; 2 = yes; -1 = left blank; -5 = more than one selected;

Categorical

Employment in the last 4 weeks

Phase 2 data. Questionnaire reads D5. Have you been in employment in the last 4 weeks? DO NOT USE THIS VARIABLE. Use Paidemployment_P2 instead. 1 = no; 2 = yes;

Categorical

OLINK assay PAI

Phase 1 OLINK assay data for target PAI in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PAK4

Phase 1 OLINK assay data for target PAK4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

PAL

Average daily Physical Activity Level during AH free living (PAL). [ Average PAL score (TEE/REE) as calculated using Adult: Group Act/Group HR (Old) in commercial software for purpose of volunteer feedback ONLY. This should NOT be used for data analysis.

Avg daily PA Level AH free living

Phase 2 data. Average daily Physical Activity Level during AH free living (PAL). Average PAL score (TEE/REE) as calculated using Adult: Group Act/Group HR (Old) in commercial software for purpose of volunteer feedback ONLY. This should NOT be used for data analysis.

Real

OLINK assay PAMR1

Phase 1 OLINK assay data for target PAMR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PAM

Phase 1 OLINK assay data for target PAM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PAPPA

Phase 1 OLINK assay data for target PAPPA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PARK7

Phase 1 OLINK assay data for target PARK7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PARP-1

Phase 1 OLINK assay data for target PARP-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

PartPostcodeEstimate

Created by PA team to facilitate data cleaning. Data can be provided if needed. Indication whether or not a partial postcode was used to calculate home-work distance. Yes if postcode was partial and left blank if not or not applicable. Where a part-postcode was used this postcode was entered into google and the mid-point of the region was used to claculate distance.

Text

OLINK assay PAR-1

Phase 1 OLINK assay data for target PAR-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

PCaaC240_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC240_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.1. 2nd and final QC step on this var created new and final var BIOR_055.

Real

PCaaC260_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC260_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=1.4. 2nd and final QC step on this var created new and final var BIOR_056.

Real

PCaaC281_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC281_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_057.

Real

PCaaC300_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC300_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.2. 2nd and final QC step on this var created new and final var BIOR_058.

Real

PCaaC320_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC320_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_059.

Real

PCaaC321_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC321_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.06. 2nd and final QC step on this var created new and final var BIOR_060.

Real

PCaaC322_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC322_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_061.

Real

PCaaC323_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC323_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.008. 2nd and final QC step on this var created new and final var BIOR_062.

Real

PCaaC341_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC341_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.06. 2nd and final QC step on this var created new and final var BIOR_063.

Real

PCaaC342_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC342_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.1. 2nd and final QC step on this var created new and final var BIOR_064.

Real

PCaaC343_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC343_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_065.

Real

PCaaC344_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC344_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_066.

Real

PCaaC360_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC360_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.2. 2nd and final QC step on this var created new and final var BIOR_067.

Real

PCaaC361_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC361_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_068.

Real

PCaaC362_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC362_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.15. 2nd and final QC step on this var created new and final var BIOR_069.

Real

PCaaC363_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC363_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_070.

Real

PCaaC364_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC364_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_071.

Real

PCaaC365_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC365_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_072.

Real

PCaaC366_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC366_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_073.

Real

PCaaC380_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC380_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.2. 2nd and final QC step on this var created new and final var BIOR_074.

Real

PCaaC381_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC381_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.08. 2nd and final QC step on this var created new and final var BIOR_075.

Real

PCaaC383_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC383_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_076.

Real

PCaaC384_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC384_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_077.

Real

PCaaC385_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC385_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_078.

Real

PCaaC386_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC386_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_079.

Real

PCaaC401_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC401_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.4. 2nd and final QC step on this var created new and final var BIOR_080.

Real

PCaaC402_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC402_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_081.

Real

PCaaC403_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC403_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_082.

Real

PCaaC404_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC404_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_083.

Real

PCaaC405_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC405_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.04. 2nd and final QC step on this var created new and final var BIOR_084.

Real

PCaaC406_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC406_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=1.2. 2nd and final QC step on this var created new and final var BIOR_085.

Real

PCaaC420_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC420_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.05. 2nd and final QC step on this var created new and final var BIOR_086.

Real

PCaaC421_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC421_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.008. 2nd and final QC step on this var created new and final var BIOR_087.

Real

PCaaC422_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC422_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_088.

Real

PCaaC424_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC424_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_089.

Real

PCaaC425_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC425_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.05. 2nd and final QC step on this var created new and final var BIOR_090.

Real

PCaaC426_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaaC426_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.3. 2nd and final QC step on this var created new and final var BIOR_091.

Real

PCaeC300_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC300_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.15. 2nd and final QC step on this var created new and final var BIOR_092.

Real

PCaeC301_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC301_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_093.

Real

PCaeC302_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC302_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.57. 2nd and final QC step on this var created new and final var BIOR_094.

Real

PCaeC321_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC321_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.009. 2nd and final QC step on this var created new and final var BIOR_095.

Real

PCaeC322_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC322_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_096.

Real

PCaeC340_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC340_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.017. 2nd and final QC step on this var created new and final var BIOR_097.

Real

PCaeC341_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC341_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.012. 2nd and final QC step on this var created new and final var BIOR_098.

Real

PCaeC342_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC342_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_099.

Real

PCaeC343_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC343_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_100.

Real

PCaeC360_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC360_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.12. 2nd and final QC step on this var created new and final var BIOR_101.

Real

PCaeC361_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC361_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_102.

Real

PCaeC362_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC362_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_103.

Real

PCaeC363_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC363_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.007. 2nd and final QC step on this var created new and final var BIOR_104.

Real

PCaeC364_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC364_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.013. 2nd and final QC step on this var created new and final var BIOR_105.

Real

PCaeC365_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC365_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.012. 2nd and final QC step on this var created new and final var BIOR_106.

Real

PCaeC380_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC380_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.066. 2nd and final QC step on this var created new and final var BIOR_107.

Real

PCaeC381_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC381_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_108.

Real

PCaeC382_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC382_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.018. 2nd and final QC step on this var created new and final var BIOR_109.

Real

PCaeC383_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC383_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_110.

Real

PCaeC384_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC384_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_111.

Real

PCaeC385_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC385_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_112.

Real

PCaeC386_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC386_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_113.

Real

PCaeC401_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC401_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.06. 2nd and final QC step on this var created new and final var BIOR_114.

Real

PCaeC402_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC402_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_115.

Real

PCaeC403_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC403_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_116.

Real

PCaeC404_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC404_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.1. 2nd and final QC step on this var created new and final var BIOR_117.

Real

PCaeC405_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC405_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_118.

Real

PCaeC406_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC406_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.025. 2nd and final QC step on this var created new and final var BIOR_119.

Real

PCaeC420_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC420_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.4. 2nd and final QC step on this var created new and final var BIOR_120.

Real

PCaeC421_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC421_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_121.

Real

PCaeC422_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC422_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_122.

Real

PCaeC423_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC423_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_123.

Real

PCaeC424_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC424_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.3. 2nd and final QC step on this var created new and final var BIOR_124.

Real

PCaeC425_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC425_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=1.3. 2nd and final QC step on this var created new and final var BIOR_125.

Real

PCaeC443_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC443_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.006. 2nd and final QC step on this var created new and final var BIOR_126.

Real

PCaeC446_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PCaeC446_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.02. 2nd and final QC step on this var created new and final var BIOR_128.

Real

MET_QCd_PCaeC446

New in R8. QCd metabolomics data for the metabolite phosphatidylcholine acyl-alkyl C446 which is part of the group glycerophospholipids. Lab raw variable name: PC ae C44:6. Data obtained from plasma sample using Liquid Chromatography Mass Spectrometry. Relative quantification. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.09

Real

HomePC_Final

New in R7. Cleaned home postcode variable. Data either as entered on private network OR as cleaned postcode data (postcode format corrected) OR as derived from data provided OR as home postcode entered on form (in that order of priority).

Text

Home_Coord_Lat

New in R7. Home postcode as converted into latitude coordinate (with added noise) using Free Map Tools.

Real

Home_Coord_Long

New in R7. Home postcode as converted into longitude coordinate (with added noise) using Free Map Tools.

Real

HWCentre_Coord_Lat

New in R7. Centre point between home and work postcode was calculated. Noise was added to de-identify the data. The coordinates of this centre point were then split into two variables - Lat and Long

Real

HWCentre_Coord_Long

New in R7. Centre point between home and work postcode was calculated. Noise was added to de-identify the data. The coordinates of this centre point were then split into two variables - Lat and Long

Real

Hwcentre_Error

New in R7. Home-work PC centre error code generated during processing of postcode data.

Categorical

HWCentre_Radius_KM

New in R7.The distance in km between home and centre point of home-work PCs if both PCs are available but not the same. This data is different between data releases as random noise is added at time of calculation.

Real

WorkPC_CL

New in R7. Work postcode as cleaned by physical activity team.

Text

WorkPC_CLerrorReason

New in R7. Of those with error code 99 204 PCs are estimated. They are marked as 1 in the PCder_WorkPC_Estimated variable.

Categorical

WorkPC_Clerror

New in R7. Error code assigned during cleaning of work postcode toi indicate why postcode is not complete.

Categorical

WorkPC_Est

New in R7. For all subjects with error code 99 in PCder_WorkPC_CleanErrorReason this variable indicates whether the work postcode has been estimated by the Physical activity team during data cleaning. If so the length of the road was used and the postcode was taken from the middle of the two end points.

Categorical

WorkPC_Final

New in R7. Cleaned work postcode variable. Data either as entered in study database OR as cleaned postcode data (postcode format corrected) OR as derived from data provided OR as work postcode entered on form (in that order of priority).

Text

Work_Coord_Lat

New in R7. Work postcode as converted into latitude coordinate (with added noise) using Free Map Tools.

Real

Work_Coord_Long

New in R7. Work postcode as converted into longitude coordinate (with added noise) using Free Map Tools.

Real

OLINK assay PCDH17

Phase 1 OLINK assay data for target PCDH17 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay PCOLCE

Phase 1 OLINK assay data for target PCOLCE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay PCSK9

Phase 1 OLINK assay data for target PCSK9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay PDCD1

Phase 1 OLINK assay data for target PDCD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. the CV of calculated concentration between intraplate duplicates - this is calculated by the MSD software (where applicable)

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. the mean of calculated concentration in pg/mL - this is calculated by the MSD software

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. the individual calculated concentration for each intra plate duplicate in pg/mL - this is calculated by the MSD software

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. Date of MSD PDGFcc experiment

Date

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. number of times the sample was thawed

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. Plate specific Lower limit of detection for PDGF-CC measurements.

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. barcode label by MSD - each plate is unique

Text

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. number of the plate assigned by the lab team

Real

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. well position within a 96-well plate

Text

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. The comment of wether the calculated concentration of the sample is within or outside the detection range of the assay; as assigned by the MSD software

Text

None

New for R9. Phase 1 plasma fluoride sample data for PDGF-CC. Plate specific Upper limit of detection for PDGF-CC measurements.

Real

OLINK assay PDGFC

Phase 1 OLINK assay data for target PDGFC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PDGFRB

Phase 1 OLINK assay data for target PDGFRB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PDGF-R-alpha

Phase 1 OLINK assay data for target PDGF-R-alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PDGF subunit A

Phase 1 OLINK assay data for target PDGF subunit A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PDGF subunit B

Phase 1 OLINK assay data for target PDGF subunit B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PDP1

Phase 1 OLINK assay data for target PDP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PD-L1

Phase 1 OLINK assay data for target PD-L1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PD-L2

Phase 1 OLINK assay data for target PD-L2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PEAR1

Phase 1 OLINK assay data for target PEAR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

PEA_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable PEA_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_015.

Real

OLINK assay PEBP1

Phase 1 OLINK assay data for target PEBP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PECAM-1

Phase 1 OLINK assay data for target PECAM-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Percentage of green space park area

Percentage of area in neighbourhood buffer covered by green spaces/parks percent: Data Source OS MasterMap Topography Layer Data (December 2016) AddressBase Premium Data (OS Managed GB Set)

Real

Percentage of green space/park area P2

Phase 2 data: Percentage of area in neighbourhood buffer covered by green spaces/parks %: Data Source OS MasterMap Topography Layer Data (December 2016) AddressBase Premium Data (OS Managed GB Set)

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay PFDN2

Phase 1 OLINK assay data for target PFDN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PFKM

Phase 1 OLINK assay data for target PFKM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PGF

Phase 1 OLINK assay data for target PGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PGF

Phase 1 OLINK assay data for target PGF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PGLYRP1

Phase 1 OLINK assay data for target PGLYRP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

PGS UKB

Polygenic risk score (PGS; also called genetic risk score) for BMI in Fenland-Omics samples: PGS for BMI based on variants identified in the trans-ethnic meta-analysis of the China Kadoorie GWAS and the UK Biobank GWAS (see BMI_PGS_beta_TE.csv)

Real

PGS TE

Polygenic risk score (PGS; also called genetic risk score) for BMI in Fenland-Omics samples: PGS for BMI based on variants identified in the UK Biobank GWAS (see BMI_PGS_beta_UKB.csv)

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

Phase_2

Participant included in Fenland phase 2 (1=yes; 2=no)

Categorical

None

Phase 2 data. Fenland Phase 1 or Phase 2 sample from

Text

Phe_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Phe_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_016.

Real

OLINK assay PHOSPHO1

Phase 1 OLINK assay data for target PHOSPHO1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PI3

Phase 1 OLINK assay data for target PI3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PIgR

Phase 1 OLINK assay data for target PIgR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PIK3AP1

Phase 1 OLINK assay data for target PIK3AP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PILRA

Phase 1 OLINK assay data for target PILRA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PILRB

Phase 1 OLINK assay data for target PILRB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

OLINK assay PLA2G10

Phase 1 OLINK assay data for target PLA2G10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLA2G4A

Phase 1 OLINK assay data for target PLA2G4A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLA2G7

Phase 1 OLINK assay data for target PLA2G7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MET_QCd_PlateBarcode_New

New in R8. To allow data sharing back with the external lab and simultaneously preventing unauthorised data matching a new random plate barcode was created. A plate barcode is required during data QC since plate-specific pooled sample data is required.

Text

None

Metabolomics indicator if samples in plate generated Absolute data and relative data. At times only 1 set of data was obtained and not both. 0 = no data at all; 1 = abs data only; 2 = rel data only; 3 = both abs and rel data;

Categorical

None

Sample Plate identifier

Integer

Sample Plate identifier

Phase 2 data. Sample Plate identifier

Integer

Platelet clumping

Platelet clumping; observed in a full blood count (FBC); can lead to inaccurate platelet counts. It occurs when platelets stick together; potentially causing a falsely low automated platelet count. This clumping can be due to factors like platelet activation during blood sample collection or the presence of EDTA-dependent antibodies. While often not a cause for clinical concern; clumping can sometimes indicate the need for further investigation; particularly if the initial automated platelet count is low.

Text

Platelet count

A full blood count (FBC) test includes a platelet count; which measures the number of platelets in your blood. Platelets are small blood cells that help with clotting; preventing excessive bleeding. The normal range for platelet count is typically 150-450 x 10^9/L. A count below this range is called thrombocytopenia; while a count above it is called thrombocytosis.

Real

MET_QCd_PlateNr_New

New in R8. To allow data sharing back with the external lab and simultaneously preventing unauthorised data matching a new random plate number was created. A plate number is required during data QC since plate-specific pooled sample data is required.

Integer

None

Date sample plate was run

Real

Date sample plate was run

Phase 2 data. Date sample plate was run

Text

OLINK assay PLC

Phase 1 OLINK assay data for target PLC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Any comments provided regarding PLIN1 Data analysis

Text

None

actual mutation as defined by Genetics specialist. Left blank if no mutation known or present.

Text

None

-1 = not tested; 0 = does not have a mutation; 1 = has a mutation;

Categorical

OLINK assay PLIN1

Phase 1 OLINK assay data for target PLIN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

plate number of sample during PLIN1 analysis - for use in QC

Real

None

plate position of sample during PLIN1 analysis - for use in QC

Text

None

rs id of gene in which PLIN1 mutation has been found. Left blank if no mutation known or present.

Text

OLINK assay PLTP

Phase 1 OLINK assay data for target PLTP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLXDC1

Phase 1 OLINK assay data for target PLXDC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLXNA4

Phase 1 OLINK assay data for target PLXNA4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLXNB1

Phase 1 OLINK assay data for target PLXNB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLXNB2

Phase 1 OLINK assay data for target PLXNB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PLXNB3

Phase 1 OLINK assay data for target PLXNB3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PMVK

Phase 1 OLINK assay data for target PMVK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PODXL2

Phase 1 OLINK assay data for target PODXL2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PODXL

Phase 1 OLINK assay data for target PODXL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PON2

Phase 1 OLINK assay data for target PON2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PON3

Phase 1 OLINK assay data for target PON3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Boiled; mashed; instant or jacket

Average use last year of a medium serving of Boiled mashed instant or jacket. After cleaning this variable is renamed as BOILED_POTATOES which is then used by the FETA program for analysis.

Categorical

Boiled; mashed; instant or jacket ERROR CODES CLEANED

Average use last year of a medium serving of Boiled mashed instant or jacket After cleaning this variable is renamed as BOILED_POTATOES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Chips ERROR CODES CLEANED

Average use last year of a medium serving of Chips After cleaning this variable is renamed as CHIPS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Roast potatoes ERROR CODES CLEANED

Average use last year of a medium serving of Roast potatoes After cleaning this variable is renamed as ROAST_POTATOES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Potato Salad ERROR CODES CLEANED

Average use last year of a medium serving of Potato Salad After cleaning this variable is renamed as POTATO_SALAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

White Rice ERROR CODES CLEANED

Average use last year of a medium serving of White Rice After cleaning this variable is renamed as WHITE_RICE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Brown Rice ERROR CODES CLEANED

Average use last year of a medium serving of Brown Rice After cleaning this variable is renamed as BROWN_RICE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

White or green pasta eg spaghetti macaroni noodles ERROR CODES CLEANED

Average use last year of a medium serving of White or green pasta eg spaghetti macaroni noodles After cleaning this variable is renamed as WHITE_PASTA which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Wholemeal Pasta ERROR CODES CLEANED

Average use last year of a medium serving of Wholemeal Pasta After cleaning this variable is renamed as WHOLEMEAL_PASTA which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Lasagne moussaka ERROR CODES CLEANED

Average use last year of a medium serving of Lasagne moussaka After cleaning this variable is renamed as LASAGNE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Pizza

Average use last year of a medium serving of Pizza. After cleaning this variable is renamed as PIZZA which is then used by the FETA program for analysis.

Categorical

Pizza ERROR CODES CLEANED

Average use last year of a medium serving of Pizza After cleaning this variable is renamed as PIZZA which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Pizza

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Potatoes Boiled; mashed; instant or jacket

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Chips

Average use last year of a medium serving of Chips. After cleaning this variable is renamed as CHIPS which is then used by the FETA program for analysis.

Categorical

Chips

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Roast potatoes

Average use last year of a medium serving of Roast potatoes. After cleaning this variable is renamed as ROAST_POTATOES which is then used by the FETA program for analysis.

Categorical

Roast potatoes

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Potato Salad

Average use last year of a medium serving of Potato Salad. After cleaning this variable is renamed as POTATO_SALAD which is then used by the FETA program for analysis.

Categorical

Potato Salad

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

White Rice

Average use last year of a medium serving of White Rice. After cleaning this variable is renamed as WHITE_RICE which is then used by the FETA program for analysis.

Categorical

White Rice

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Brown Rice

Average use last year of a medium serving of Brown Rice. After cleaning this variable is renamed as BROWN_RICE which is then used by the FETA program for analysis.

Categorical

Brown Rice

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

White or green pasta eg spaghetti macaroni noodles

Average use last year of a medium serving of White or green pasta eg. spaghetti macaroni noodles. After cleaning this variable is renamed as WHITE_PASTA which is then used by the FETA program for analysis.

Categorical

White or green pasta

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Wholemeal Pasta

Average use last year of a medium serving of Wholemeal Pasta. After cleaning this variable is renamed as WHOLEMEAL_PASTA which is then used by the FETA program for analysis.

Categorical

Wholemeal Pasta

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Lasagne moussaka

Average use last year of a medium serving of Lasagne moussaka. After cleaning this variable is renamed as LASAGNE which is then used by the FETA program for analysis.

Categorical

Lasagne moussaka

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay PPIB

Phase 1 OLINK assay data for target PPIB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Population density

The number of usual residents in a postcode area divided by the area (km2) of that specific postcode area. Data Source: Office for National Statistics 2011 Census

Real

Population density P2

Phase 2 data: The number of usual residents in a postcode area divided by the area (km2) of that specific postcode area. Data Source: Office for National Statistics 2011 Census

Real

OLINK assay PPM1B

Phase 1 OLINK assay data for target PPM1B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PPP1R2

Phase 1 OLINK assay data for target PPP1R2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PPP1R9B

Phase 1 OLINK assay data for target PPP1R9B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PPP3R1

Phase 1 OLINK assay data for target PPP3R1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PPY

Phase 1 OLINK assay data for target PPY in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Rational sensible approach

Phase 2 data. Questionnaire reads 10. I tend to value and follow a rational sensible approach to things. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Often act without thinking

Phase 2 data. Questionnaire reads 11. When I am upset I often act without thinking. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Welcome new experiences

Phase 2 data. Questionnaire reads 12. I welcome new and exciting experiences and sensations even if they are a little frightening and unconventional. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Feeling rejected

Phase 2 data. Questionnaire reads 13. When I feel rejected I will often say things that I later regret. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Learn to fly an airplane

Phase 2 data. Questionnaire reads 14. I would like to learn to fly an airplane. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Sensation of skiing very fast

Phase 2 data. Questionnaire reads 15. I would enjoy the sensation of skiing very fast down a high mountain slope. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Think carefully before acting

Phase 2 data. Questionnaire reads 16. I usually think carefully before doing anything. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

None

Phase 2 data. Questionnaire reads 17. Which would you rather have? 1 = £45 in three days; 2 - £70 in three months; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Like to see things through

Phase 2 data. Questionnaire reads 1. I generally like to see things through to the end. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Thinking careful and purposeful

Phase 2 data. Questionnaire reads 2. My thinking is usually careful and purposeful. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Unfinished tasks really bother me

Phase 2 data. Questionnaire reads 3. Unfinished tasks really bother me. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Think things over

Phase 2 data. Questionnaire reads 4. I like to stop and think things over before I do them. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Regret when feeling bad

Phase 2 data. Questionnaire reads 5.When I feel bad; I will often do things I later regret in order to make myself feel better now. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Hate to stop

Phase 2 data. Questionnaire reads 6. Once I get going on something I hate to stop. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Feel bad cant stop

Phase 2 data. Questionnaire reads 7. Sometimes when I feel bad; I can’t seem to stop what I am doing even though it is making me feel worse. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Enjoy taking risks

Phase 2 data. Questionnaire reads 8. I quite enjoy taking risks. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Finish what I start

Phase 2 data. Questionnaire reads 9. I finish what I start. 1 = Agree strongly; 2 = Somewhat agree; 3 = Somewhat disagree; 4 = Disagree strongly; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

Date finished ePersonality qnr

Phase 2 data. Date the participant finished filling in the Electronic Online Personality questionnaire.

Date

Date started ePersonality qnr

Phase 2 data. Date the participant started to fill in the Electronic Online Personality questionnaire.

Date

ePersonality qnr pt ID no

Phase 2 data. Electronic Personality questionnaire-specicifc participant ID number.

Text

ePersonality qnr ID no

Phase 2 data. Electronic Personality questionnaire ID number for version control.

Text

ePersonality qnr ID name

Phase 2 data. Electronic Personality questionnaire ID name for version control.

Text

Study phase ePersonality qnr

Phase 2 data. Study phase the Electronic Personality questionnaire was used for.

Text

Time finished ePersonality qnr

Phase 2 data. Time the participant finished filling in the Electronic OnlinePersonality questionnaire.

Time

Time started ePersonality qnr

Phase 2 data. Time the participant started to fill in the Electronic Online Personality questionnaire.

Time

ePersonality qnr version date

Phase 2 data. Electronic Personality questionnaire version date for version control.

Text

ePersonality qnr version no

Phase 2 data. Electronic Personality questionnaire version number for version control.

Text

ePersonality qnr webform version no

Phase 2 data. Electronic Personality questionnaire web form version number for version control.

Text

OLINK assay PRCP

Phase 1 OLINK assay data for target PRCP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRDX1

Phase 1 OLINK assay data for target PRDX1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRDX3

Phase 1 OLINK assay data for target PRDX3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRDX5

Phase 1 OLINK assay data for target PRDX5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRDX6

Phase 1 OLINK assay data for target PRDX6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PREB

Phase 1 OLINK assay data for target PREB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Predicted max HR

Prediction of volunteers maximal heart rate based on on age. Tanaka equation: 208-0.7*age in years

Real

Predict max HR based on on age

Phase 2 data. Prediction of volunteers maximal heart rate based on on age. Tanaka equation: 208-0.7*age in years

Real

Pregnancy Exclusion Check

Phase 2 data. Pregnancy exclusion check done prior to DEXA scan? 0 = no; 1 = yes;

Categorical

OLINK assay PRELP

Phase 1 OLINK assay data for target PRELP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRKAB1

Phase 1 OLINK assay data for target PRKAB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRKCQ

Phase 1 OLINK assay data for target PRKCQ in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRKRA

Phase 1 OLINK assay data for target PRKRA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PROC

Phase 1 OLINK assay data for target PROC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Proinsulin

Heparin biomarker Proinsulin measurement RAW in pmol/l. Also referred to as Intact Proinsulin. Raw data; cleaned data provided in variable G_Proinsulin with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

OLINK assay PROK1

Phase 1 OLINK assay data for target PROK1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

(100/120)*total_food_correct

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Proportion of correctly identified targets across all trials with food pictures in the Rapid Serial Visualisation Task. proportion_food_correct=(100/120)*total_food_correct.

Real

(100/120)*total_neu_correct

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Proportion of correctly identified targets across all trials with only neutral pictures in the Rapid Serial Visualisation Task. proportion_neu_correct=(100/120)*total_neu_correct.

Real

Pro_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Pro_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_017.

Real

OLINK assay PRSS27

Phase 1 OLINK assay data for target PRSS27 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRSS2

Phase 1 OLINK assay data for target PRSS2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRSS8

Phase 1 OLINK assay data for target PRSS8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRTFDC1

Phase 1 OLINK assay data for target PRTFDC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRTG

Phase 1 OLINK assay data for target PRTG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PRTN3

Phase 1 OLINK assay data for target PRTN3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PSG1

Phase 1 OLINK assay data for target PSG1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PSGL-1

Phase 1 OLINK assay data for target PSGL-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PSIP1

Phase 1 OLINK assay data for target PSIP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PSMA1

Phase 1 OLINK assay data for target PSMA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PSME1

Phase 1 OLINK assay data for target PSME1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PSP-D

Phase 1 OLINK assay data for target PSP-D in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTH1R

Phase 1 OLINK assay data for target PTH1R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTK7

Phase 1 OLINK assay data for target PTK7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTN

Phase 1 OLINK assay data for target PTN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTPN1

Phase 1 OLINK assay data for target PTPN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTPN6

Phase 1 OLINK assay data for target PTPN6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTPRF

Phase 1 OLINK assay data for target PTPRF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTPRJ

Phase 1 OLINK assay data for target PTPRJ in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTPRS

Phase 1 OLINK assay data for target PTPRS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTS

Phase 1 OLINK assay data for target PTS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PTX3

Phase 1 OLINK assay data for target PTX3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

PUBLICadj

PUBLICadj. Derived Intermediate not for general release. Data can be provided if necessary.

Real

PUBLICMILES

PUBLICMILES. Derived Intermediate not for general release. Data can be provided if necessary.

Real

OLINK assay PVALB

Phase 1 OLINK assay data for target PVALB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PVRL4

Phase 1 OLINK assay data for target PVRL4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PVR

Phase 1 OLINK assay data for target PVR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay PXN

Phase 1 OLINK assay data for target PXN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

ACC

PA_FREE_LIVING category. Average acceleration trunk longitudinal axis (m/s2). adjusted for diurnal stability weighted by Pwear.

Real

accPwearWgt_PAEE_Branch7

PA_PAEE and PA_PA_FREE_LIVING category Variable. Activity Energy Expenidture based on combined ACC&HR using group cal Not adj diurnal bias ACC Pwear weighted (kJ/kg/day).

Real

None

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using group cal (kJ/kg/day); Pwear based on acceleration only signal. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_0

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 0.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 0 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 0 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_1

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 0.075 m/s2 (Using Pwear_Acc)

Real

ACC_INT_PwAcc_10

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 2.25 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 2.25 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 2.25 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_11

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 2.50 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 2.5 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 2.5 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_12

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 2.75 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 2.75 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 2.75 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_13

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 3.00 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 3 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 3 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_14

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 3.25 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 3.25 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 3.25 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_15

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 3.50 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 3.5 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 3.5 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_16

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 3.75 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 3.75 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 3.75 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_17

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 4 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 4 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_18

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.25 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 4.25 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 4.25 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_19

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.50 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 4.5 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 4.5 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = .075 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = .075 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_2

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 0.25 m/s2 (Using Pwear_Acc)

Real

ACC_INT_PwAcc_20

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.75 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 4.75 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 4.75 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_21

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 5.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 5 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 5 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_22

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 6.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 6 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 6 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_23

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 7.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 7 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 7 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_24

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 8.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 8 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 8 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_25

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 9.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 9 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 9 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = .25 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = .25 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_3

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 0.50 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = .5 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = .5 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_4

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 0.75 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = .75 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = .75 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_5

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 1.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 1 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 1 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_6

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 1.25 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 1.25 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 1.25 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_7

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 1.50 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 1.5 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 1.5 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_8

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 1.75 m/s2 (Using Pwear_Acc)

Real

Fraction time spent< = 1.75 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 1.75 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_PwAcc_9

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 2.00 m/s2 (Using Pwear_Acc)

Real

Fraction of time spent< = 2 m/s2 using PwAcc

Phase 2 data. Fraction of time spent < = 2 m/s2 (PW_acc). Based on acceleration only signal using Pwear from acceleration only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Flagged due to correction of ACC

Phase 2 data. Binary flag to indicate if an adjustment in ACC was needed 1 = YES. Refer to min_ACC_obs for details(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

Avg acc PwHRAcc

Phase 2 data. Average acceleration; trunk longitudinal axis (m/s2) based on Pwear from combined heart rate and acceleration signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_PwACC

PA_FREE_LIVING category. New in R7. Average acceleration trunk longitudinal axis (m/s2) - Pwear_acc weighted

Real

Avg acc PwAcc

Phase 2 data. Average acceleration; trunk longitudinal axis (m/s2). Based on Pwear from acceleration signal only(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Age (years)

Phase 2 data. Age (years). Age at Date of Fenland visit - used in PA calculations

Integer

AH_Comments

MUST HAVE PA DATA and PA_FREE_LIVING category. Comments relating to files with potential technical issues

Text

Cmnts on files with issues

Phase 2 data. Further details relating to any notable corruptions made for Free-living or calibration traces. May also indicate whether action has been taken. Further details of further action to be taken may be found in AH_Recommendation(Measured/Derived from or related to Acitheart Monitor/Data )

Text

AH_FLAG

MUST HAVE PA DATA and PA_FREE_LIVING category. Flagged problem with trace. See AH_Comments & AH_Recommendations:

Categorical

AH_FLAG_ACC

MUST HAVE PA DATA and PA_FREE_LIVING category. Flagged problem relating to free-living accelerometry trace:

Categorical

Flagged problem relating to FL accl

Phase 2 data. Indicates whether a problem has been flagged with the trace relating to the free-living accelerometry signal during manual review process. Details as to what problem is can be found in AH_Comments; any action taken (or that needs to be taken) can be found in AH_Recommendations. Should it relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing. 1 = YES(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

AH_FLAG_Caltest

MUST HAVE PA DATA and PA_FREE_LIVING category. Flagged problem relating to Calibration Test:

Categorical

Flag problem relating to calibration Test

Phase 2 data. Indicates whether a problem has been flagged with the trace relating to the calibration test used. Details as to what problem is can be found in AH_Comments; any action taken (or that needs to be taken) can be found in AH_Recommendations. Should it relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing. 1 = YES(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

AH_FLAG_CLINICAL

MUST HAVE PA DATA and PA_FREE_LIVING category. Flagged problem during free-living accelerometry trace relating to clinical HR irregularities

Categorical

Flagged possible clinical irregular

Phase 2 data. Indicates whether a problem has been flagged with the trace relating to a possible clinical irregularity. This will have been noted during the manual review process and is not a diagnosis (and has not been confirmed by a clinician from this trace). Details as to what problem is can be found in AH_Comments; any action taken (or that needs to be taken) can be found in AH_Recommendations. Should it relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing. 1 = YES(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

AH_FLAG_HR

MUST HAVE PA DATA and PA_FREE_LIVING category. Flagged problem relating to free-living heart rate trace:

Categorical

Flagged problem relating to FL HR

Phase 2 data. Indicates whether a problem has been flagged with the trace relating to the free-living heart rate signal during manual review process. Details as to what problem is can be found in AH_Comments; any action taken (or that needs to be taken) can be found in AH_Recommendations. Should it relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing. 1 = YES(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

Flagged problem with trace

Phase 2 data. Indicates whether a problem has been flagged with the trace during manual review process. Details as to what problem is can be found in AH_Comments; any action taken (or that needs to be taken) can be found in AH_Recommendations. Should it relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing. 1 = YES(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

AH_FLAG_SHR

MUST HAVE PA DATA and PA_FREE_LIVING category. Flagged problem relating to Sleeping Heart Rate:

Categorical

Flagged problem relating to SHR est

Phase 2 data. Indicates whether a problem has been flagged with the trace relating to the sleeping heart rate that has been used. Details as to what problem is can be found in AH_Comments; any action taken (or that needs to be taken) can be found in AH_Recommendations. Should it relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing. 1 = YES(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

AH_Recommendations

MUST HAVE PA DATA and PA_FREE_LIVING category. Suggestions on dealing with files with potential technical issues.

Text

Suggestions on files with issues

Phase 2 data. Suggestions on further action that may be needed relating to a corruption in a trace. Where its relate to alternative models being needed then this model will have been applied already if using PAEE_consolidated and the other main variables affected will have been set to missing(Measured/Derived from or related to Acitheart Monitor/Data )

Text

alpha_rec_hrtime

PA_Clinic category. Treadmill test: Intercept regression of median HR against rectime (0-1.5min)

Real

Intercept regression mdn HR recovery time(0-1.5min) treadmill

Phase 2 data. Intercept; regression of median heart rate against recovery time (0-1.5min)- Treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

alpha_rest_hrtime

PA_Clinic category. Treadmill test: Offset residual regression of rest phase

Real

Offset residual regression of rest phase

Phase 2 data. Offset; residual regression of rest phase(Measured/Derived from or related to Acitheart Monitor/Data )

Real

alpha_tr_hrtime

PA_Clinic category. Treadmill test: Offset residual regression of test and recovery phases

Real

alpha_tr_hrtime_med

PA_Clinic category. Treadmill test: Intercept regression of median HR against testtime (omit first Time_excluded_beginTest min) - Amount omitted determined in review process (default=2.5mins)

Real

Intercept term regression mdn HR test time(omit frst 2.5min) treadmill

Phase 2 data. Intercept; regression of median heart rate against testtime (omit first 2.5min) - Treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Offset residual regression treadmill test recovery phases

Phase 2 data. Offset; residual regression of treadmill test and recovery phases(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept regression mdn HR test time omit frst 1min

Phase 2 data. Intercept; regression of median heart rate against testtime (omit first 1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Offset residual regression of test-recovery phases

Phase 2 data. Offset; residual regression of test and recovery phases(Measured/Derived from or related to Acitheart Monitor/Data )

Real

alternative_HRclean_cal

PA_Clinic category. Treadmill test: Using alternative Hr cleaning (0=median

Real

None

Phase 2 data. Indication of which method has been used to derive individual calibration and fitness values for treadmill variables. Median = 0; Regressed = 1. Median is default method; regressed is selected as alternative to deal with noisy HR or responses that are very different from reference (Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

beta05_tr_hrtime_med

PA_Clinic category. Treadmill test: Square root term regression of median HR against testtime (omit first Time_excluded_beginTest min) - Amount omitted determined in review process (default=2.5mins)

Real

Square root term regression mdn HR test time(omit frst 2.5min) treadmill

Phase 2 data. Square root term; regression of median heart rate against testtime (omit first 2.5min) - Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Square root regression mdn HR test time omit frst 1min

Phase 2 data. Square root term; regression of median heart rate against testtime (omit first 1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

beta2_rec_hrtime

PA_Clinic category. Treadmill test: Square term regression of median HR against rectime (0-1.5min)

Real

Square term regression mdn HR recovery time(0-1.5min) treadmill

Phase 2 data. Square term; regression of median heart rate against recovery time (0-1.5min) - treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

beta2_tr_hrtime_med

PA_Clinic category. Treadmill test: Square term regression of median HR against testtime (omit first Time_excluded_beginTest min)- Amount omitted determined in review process (default=2.5mins)

Real

Square term regression mdn HR test time(omit frst 2.5min) treadmill

Phase 2 data. Square term; regression of median heart rate against testtime (omit first 2.5min) -Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Square term regression mdn HR test time omit frst 1min

Phase 2 data. Square term; regression of median heart rate against testtime (omit first 1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

beta3_tr_hrtime_med

PA_Clinic category. Treadmill test: Quadratic term regression of median HR against testtime (omit first 2.5min)

Real

Quadratic term regression mdn HR test time(omit frst 2.5min) treadmill

Phase 2 data. Quadratic term; regression of median heart rate against testtime (omit first 2.5min) - Treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Quadractic term regression mdn HR test time omit frst 1min

Phase 2 data. Quadratic term; regression of median heart rate against testtime (omit first 1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Betablocker

Phase 2 data. Betablocked: 1 = yes; 0 = no. Participant has indicated they are taking betablocker medication. This does not include eye drops that may contain small amounts of betablockers. Used for Physical activity calculations

Categorical

beta_rec_hrtime

PA_Clinic category. Treadmill test: Linear term regression of median HR against rectime (0-1.5min)

Real

Linear term regression mdn HR recovery time(0-1.5min) treadmill

Phase 2 data. Linear term; regression of median heart rate against recovery time (0-1.5min) - treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

beta_rest_hrtime

PA_Clinic category. Treadmill test: Tilt residual regression of rest phase

Real

Tilt residual regression of rest phase

Phase 2 data. Tilt; residual regression of rest phase(Measured/Derived from or related to Acitheart Monitor/Data )

Real

beta_tr_hrtime

PA_Clinic category. Treadmill test: Tilt residual regression of test and recovery phases

Real

beta_tr_hrtime_med

PA_Clinic category. Treadmill test: Linear term regression of median HR against testtime (omit first Time_excluded_beginTest min)- Amount omitted determined in review process (default=2.5mins)

Real

Linear term regression mdn HR test time(omit frst 2.5min) treadmill

Phase 2 data. Linear term; regression of median heart rate against testtime (omit first 2.5min) - Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tilt residual regression treadmill test recovery phases

Phase 2 data. Tilt; residual regression of treadmill test and recovery phases(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Linear term regression mdn HR test time omit frst 1min

Phase 2 data. Linear term; regression of median heart rate against testtime (omit first 1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tilt residual regression of test-recovery phases

Phase 2 data. Tilt; residual regression of test and recovery phases(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 10min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 15min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 1min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 20min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 2min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 30min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 3min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 4min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 5min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 6min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 7min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 8min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3.5METs bouts >= 9min

Phase 2 data. Fraction of time spent > = 3.5METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 3.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 10min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 15min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 1min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 20min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 2min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 30min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 3min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 4min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 5min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 6min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 7min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 8min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 4METs bouts >= 9min

Phase 2 data. Fraction of time spent > = 4METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 4METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 10min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 15min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 1min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 20min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 2min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 30min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 3min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 4min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 5min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 6min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 7min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 8min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 5METs bouts >= 9min

Phase 2 data. Fraction of time spent > = 5METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 10min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 15min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 1min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 20min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 2min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 30min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 3min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 4min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 5min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 6min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 7min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 8min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 6METs bouts >= 9min

Phase 2 data. Fraction of time spent > = 6METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 6METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 10min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 15min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 1min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 20min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 2min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 30min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 3min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 4min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 5min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 6min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 7min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 8min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time bouts >= 9min; >= 2METs

Phase 2 data. Fraction of time spent > = 2METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 10min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 15min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 1min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 20min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 2min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 30min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 3min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 4min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 5min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 6min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 7min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 8min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction of time in bouts >= 9min

Phase 2 data. Fraction of time spent > = 2.5METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 2.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 10min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 10min. The fraction of time in bouts lasting longer than 10 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 15min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 1min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 1min. The fraction of time in bouts lasting longer than 1 minute above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 20min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 2min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 2min. The fraction of time in bouts lasting longer than 2 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 30min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 3min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 3min. The fraction of time in bouts lasting longer than 3 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 4min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 4min. The fraction of time in bouts lasting longer than 4 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 5min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 5min. The fraction of time in bouts lasting longer than 5 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 6min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 6min. The fraction of time in bouts lasting longer than 6 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 7min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 7min. The fraction of time in bouts lasting longer than 7 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 8min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 8min. The fraction of time in bouts lasting longer than 8 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent >= 3METs bouts >= 9min

Phase 2 data. Fraction of time spent > = 3METs in bouts > = 9min. The fraction of time in bouts lasting longer than 9 minutes; above or equal to 3METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr time spent <= 1METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 1METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 1METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr Tmespent <= 1.05METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr Tmespent <= 1.05METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 1.05METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr Tmespent <= 1.05METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 1.05METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr Tmespent <= 1.05METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr Tmespent <= 1.05METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr Tmespent <= 1.05METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 1.05METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 1.05METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 1.05METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 1.05METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 1.05METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 1.05METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.125METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 1.125METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 1.125METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.25METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 1.25METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 1.25METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.5METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 1.5METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 1.5METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Tmespent <= 1.75METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 1.75METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 1.75METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 120min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 120min. The fraction of time in bouts lasting longer than 120 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 150min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 150min. The fraction of time in bouts lasting longer than 150 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 15min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 15min. The fraction of time in bouts lasting longer than 15 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 180min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 180min. The fraction of time in bouts lasting longer than 180 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 20min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 20min. The fraction of time in bouts lasting longer than 20 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 210min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 210min. The fraction of time in bouts lasting longer than 210 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 240min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 240min. The fraction of time in bouts lasting longer than 240 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 300min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 300min. The fraction of time in bouts lasting longer than 300 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 30min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 30min. The fraction of time in bouts lasting longer than 30 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 45min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 45min. The fraction of time in bouts lasting longer than 45 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 60min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 60min. The fraction of time in bouts lasting longer than 60 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fr timespent <= 2METs bouts >= 90min

Phase 2 data. Fraction of time spent < = 2METs in bouts > = 90min. The fraction of time in bouts lasting longer than 90 minutes; below or equal to 2METs.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

BranchBox_1

PA_FREE_LIVING category. Fraction of observations translated by branch box 1 (P1_apriori'%HR weighting) (fraction).

Real

Obs translated by branch box 1

Phase 2 data. Fraction of observations translated by branch box 1 (%HR weighting)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

BranchBox_2

PA_FREE_LIVING category. Fraction of observations translated by branch box 2 (P1_apriori'%HR weighting) (fraction).

Real

Obs translated by branch box 2

Phase 2 data. Fraction of observations translated by branch box 2 (%HR weighting)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

BranchBox_3

PA_FREE_LIVING category. Fraction of observations translated by branch box 3 (P1_apriori'%HR weighting) (fraction).

Real

Obs translated by branch box 3

Phase 2 data. Fraction of observations translated by branch box 3 (%HR weighting)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

BranchBox_4

PA_FREE_LIVING category. Fraction of observations translated by branch box 4 (P1_apriori'%HR weighting) (fraction).

Real

Obs translated by branch box 4

Phase 2 data. Fraction of observations translated by branch box 4 (%HR weighting)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

BranchBox_5

PA_FREE_LIVING category. Fraction of observations translated by branch box 5 (P1_apriori'%HR weighting) (fraction).

Real

Obs translated by branch box 5

Phase 2 data. Fraction of observations translated by branch box 5 (%HR weighting)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

BranchBox_6

PA_FREE_LIVING category. Fraction of observations translated by branch box 6 (P1_apriori'%HR weighting) (fraction).

Real

Obs translated by branch box 6

Phase 2 data. Fraction of observations translated by branch box 6 (%HR weighting)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Branch_HRutilisation

PA_FREE_LIVING category.

Real

Mdn HR branched model

Phase 2 data. Mean reliance of heart rate estimate in branched model(Measured/Derived from or related to Acitheart Monitor/Data )

Real

calibration_protocol

PA_Clinic category. Treadmill test: Protocol name used for processing

Text

Protocol for treadmill test processing

Phase 2 data. Protocol used for treadmill test processing (Measured/Derived from or related to Acitheart Monitor/Data )

Text

days_betIC

PA_FREE_LIVING category. Number of days between Individual Calibration and start of Free-Living file used.

Real

No of days btwn Individual calibration

Phase 2 data. Number of days between individual calibration test and start of free-living file(Measured/Derived from or related to Acitheart Monitor/Data )

Real

diurnal_stability_B7

PA_FREE_LIVING category. Explained variation from regression of PAEE using morning and midnight axes

Real

Prevent diurnal bias

Phase 2 data. Explained variation from regression of physical activity energy expenditure using morning and midnight axes. Allows for adjustments to be made to prevent diurnal bias where possible(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Recording frequency of FL data

Phase 2 data. Recording frequency in which the data has been processed in seconds. This may not reflect the raw frequency the monitor recorded in.(Measured/Derived from or related to Acitheart Monitor/Data )

Time

FastWalktest_maxtimelimit

PA_Clinic category. Treadmill test: Upper test time limit for deriving fast walk calibration (min)

Real

Upper test time limit derived fast wlk calibration

Phase 2 data. Upper test time limit for deriving fast walk calibration (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

FastWalktest_mintimelimit

PA_Clinic category. Treadmill test: Lower test time limit for deriving fast walk calibration (min)

Real

Lower test time limit derived fast wlk calibration

Phase 2 data. Lower test time limit for deriving fast walk calibration (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

Suggestion for consolidated Fitness

Phase 2 data. Fitness (VO2 ml/kg/min) using the highest available calibration test. Priority order: Treadmill then Walk. Treadmill used if treadmill duration > = 10mins and useable HR quality. Energy cost for treadmill based on predicted energy expenditure from Brage et al 2007 (JAP). Submaximal response extrapolated to max HR (Tanaka 2001). Walk used if walk duration > = 1 and useable HR quality. Energy cost for Walk based on Ludlow 2016.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fitness source

Phase 2 data. Indicates which test was used for each participant for Fitness_Consolidated. 1 = Treadmill 2 = Self paced Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

flexHRaS

PA_FREE_LIVING category. Flex HR above Sleep used for group-calibrated estimates (bpm).

Real

Flex HR above Sleep grp-calibrationrated

Phase 2 data. Flex HR above Sleep; used for group-calibrated estimates (bpm). Reference Brage et a JAP2007(Measured/Derived from or related to Acitheart Monitor/Data )

Real

flexhr_offset

PA_FREE_LIVING category. Flex HR offset (bpm)

Real

Flex HR offset (bpm)

Phase 2 data. Added to calculation to reflect for rest and not sleep HR(Measured/Derived from or related to Acitheart Monitor/Data )

Real

GROUP_EQUATION

PA_FREE_LIVING category. Name of Group Calibration Equation the dataset was processed using

Text

Name grp equation used PAE

Phase 2 data. Name of group equation used for physical activity energy estimates. Group equations are used where no individual calibration is available. Usually derived from individual calibration tests that exist within the population already or a similar demographic population.(Measured/Derived from or related to Acitheart Monitor/Data )

Text

Height (metres)

Phase 2 data. Height (metres) used in all Physical activity estimates

Real

HEMISPHERE

PA_FREE_LIVING category.

Categorical

Hemisphere of the data collected

Phase 2 data. Hemisphere in which the data was collected(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

HIGH_BRANCH

PA_FREE_LIVING category. Highest branch used for fine mapping of intensity distribution int

Integer

Highest branch model

Phase 2 data. Highest available branch model to be used in the data set 1 = Treadmill with VO2; 2 = Treadmill without VO2; 4 = Step Test; 6 = Walk test derived from treadmill protocol; 7 = Group equation; 8 = Walk test. Please note these are coded and do not necessarily reflect validity order.(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

HRaS

PA_FREE_LIVING category. Average heart rate above sleeping heart rate in bpm. Adjusted for diurnal stability weighted by Pwear.

Real

Avg HRaS free living recording

Phase 2 data. Average heart rate above sleep during free-living recording(Measured/Derived from or related to Acitheart Monitor/Data )

Real

HR variability from FL during rest

Phase 2 data. Heart rate variability from Free-living data during rest (ms). Calculated from LT variability data collected from Actiheart monitor (uses difference between 2nd fastest and 2nd slowest beat per epoch)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

HR from FL during rest

Phase 2 data. Heart rate from Free-living data during rest used to calculate HRV_rest (bpm). ACC observations = 0 and HR observations at or below SHR(+10) (Measured/Derived from or related to Acitheart Monitor/Data )

Real

ibi_experiment

PA_Clinic category. Treadmill test: Experiment key index of IBI file used

Real

ibi_experiment2

PA_Clinic category. Experiment key index of 2nd IBI file used (if applicable) int

Real

ibi_filestarttime

PA_Clinic category. Treadmill test: Starttime of ibi file start. dd-mmm-yyyy hh:mm:ss

DateTime

ibi_filestarttime2

PA_Clinic category. Treadmill test: Date & time of IBI file2 start (if applicable) dd-mmm-yyyy hh:mm:ss

DateTime

Date time of ibi file2 start

Phase 2 data. Date and time of ibi file2 start (if applicable)(Measured/Derived from or related to Acitheart Monitor/Data )

DateTime

Start time of treadmill test file

Phase 2 data. Real start time of treadmill test file (Actiheart monitor started recording)(Measured/Derived from or related to Acitheart Monitor/Data )

DateTime

IND_CAL_OF_BRANCH_FLEX

PA_FREE_LIVING category. Using individually calibrated branch flex parameter?

Text

Individually calibration branch flex

Phase 2 data. Using individually calibrated branch flex parameter? YES/NO(Measured/Derived from or related to Acitheart Monitor/Data )

Text

ind_noise_buffer_rec

PA_Clinic category. Treadmill test: Scaling HR acceptance zone for recovery phase.

Real

Scaling HR accept zone recovery phase

Phase 2 data. Scaling HR acceptance zone for treadmill test recovery phase. Widening or narrowing of heart rate acceptance zone to aid cleaning and ensure only clean heart rate is included as much as possible(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ind_noise_buffer_rest

PA_Clinic category. Treadmill test: Scaling HR acceptance zone for rest phase.

Real

Scaling HR acceptance zone rest phase

Phase 2 data. Scaling HR acceptance zone for rest phase. Widening or narrowing of heart rate acceptance zone to aid cleaning and ensure only clean heart rate is included as much as possible(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ind_noise_buffer_test

PA_Clinic category. Treadmill test: Scaling HR acceptance zone for test phase.

Real

Scaling HR accept zone test phase

Phase 2 data. Scaling HR acceptance zone for treadmill test phase. Widening or narrowing of heart rate acceptance zone to aid cleaning and ensure only clean heart rate is included as much as possible(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ind_noise_shift_rec

PA_Clinic category. Treadmill test: Shift of HR reference for recovery phase (center of acceptance zone)

Real

Shift of HR reference recvry phase

Phase 2 data. Shift of HR reference for recovery phase of treadmill test (center of acceptance zone). Cleaning variable; indicates if the reference phase of heart which is deemed cleaned and useable has been shifted to ensure clean data only is included as much as possible. +10 indicates it have shifted up 10bpm (Measured/Derived from or related to Acitheart Monitor/Data )

Integer

ind_noise_shift_rest

PA_Clinic category. Treadmill test: Shift of HR reference for rest phase (center of acceptance zone)

Real

Shift of HR reference for rest phase

Phase 2 data. Shift of HR reference for rest phase (center of acceptance zone). Cleaning variable; indicates if the reference phase of heart which is deemed cleaned and useable has been shifted to ensure clean data only is included as much as possible. +10 indicates it have shifted up 10bpm (Measured/Derived from or related to Acitheart Monitor/Data )

Integer

ind_noise_shift_test

PA_Clinic category. Treadmill test: Shift of HR reference for test phase (center of acceptance zone)

Real

Shift of HR reference test phase

Phase 2 data. Shift of HR reference for test phase of treadmill test (center of acceptance zone). Cleaning variable; indicates if the reference phase of heart which is deemed cleaned and useable has been shifted to ensure clean data only is included as much as possible. +10 indicates it have shifted up 10bpm (Measured/Derived from or related to Acitheart Monitor/Data )

Integer

INT_05_2MET_Branch2

PA_Intensity and PA_FREE_LIVING category. % time spent between 1.5-3 METs calculated using Oxford 2005 equations; combined acceleration and heart rate using treadmill no VO2 cal. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear. (multiply by 1440 = min/day).

Real

% tme spent btwn 1.5-3MET t/mill

Phase 2 data. Fraction of time spent between 1.5-3METs (rmr); acceleration and heart rate using t/mill no VO2 calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a multi-point slope based estimate from the treadmill test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_2MET_Branch6

PA_Intensity and PA_FREE_LIVING category.% time spent between 1.5-3 METs calculated using Oxford 2005 equations; combined acceleration and heart rate using walk cal (fraction). Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spent btwn 1.5-3MET 3min wlk calibration

Phase 2 data. Fraction of time spent between 1.5-3METs (rmr);d acceleration and heart rate using 3-min walk calibration (from treadmill test). This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a 1pt calibration from 3min walk phase of treadmill protocol. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_2MET_Branch7

PA_Intensity and PA_FREE_LIVING category.% time spent between 1.5-3 METs calculated using Oxford 2005 equations; combined acceleration and heart rate using group calibration. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spent btwn 1.5-3MET grp calibration

Phase 2 data. Fraction of time spent between 1.5-3METs (rmr); acceleration and heart rate using group calibration. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. Equation used is indicated in GROUP_EQUATION. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spent btwn 1.5-3MET 200m wlk calibration

Phase 2 data. Fraction of time spent between 1.5-3METs (rmr); acceleration and heart rate using self paced 200m walk calibration. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a 1pt estimate from the self paced walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_2stdMET_Branch2

PA_Intensity and PA_FREE_LIVING category.% time spent between 1.5-3MET (std); ACC and HR using t/mill no VO2 cal calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear (multiply by 1440 = min/day).

Real

% tme spnt btwn 1.5-3MET std t/mill

Phase 2 data. Fraction of time between 1.5-3METs (std); acceleration and heart rate using t/mill no VO2 calibration . This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a multi-point slope based estimate from the treadmill test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_2stdMET_Branch6

PA_Intensity and PA_FREE_LIVING category.% time spent between 1.5-3MET (std); ACC and HR using walk cal (fraction) calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear (multiply by 1440 = min/day).

Real

% tme spnt btwn 1.5-3MET std 3minwlk calibration

Phase 2 data. Fraction of time between 1.5-3METs (std); acceleration and heart rate using 3-min walk calibration. This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a 1pt calibration from 3min walk phase of treadmill protocol. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_2stdMET_Branch7

PA_Intensity and PA_FREE_LIVING category.% time spent between 1.5-3MET (std); ACC and HR using group cal calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spnt btwn 1.5-3MET std 200mwlk calibration

Phase 2 data. Fraction of time between 1.5-3METs (std); acceleration and heart rate using self paced 200m walk calibration. This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a 1pt estimate from the self paced walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_MET_Branch2

PA_Intensity and PA_FREE_LIVING category. % time spent < = 1.5MET; calculated using Oxford 2005 equations; combined acceleration and heart rate using t/mill no VO2 cal. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear. (multiply by 1440 = min/day).

Real

% tme spent <= 1.5MET using t/mill

Phase 2 data. Fraction of time spent < = 1.5 MET (rmr); acceleration and heart rate using t/mill; no VO2 calibration. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a multi-point slope based estimate from the treadmill test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_MET_Branch6

PA_Intensity and PA_FREE_LIVING category. % time spent <=1.5 MET calculated using Oxford 2005 equations; (rmr);combined acceleration and heart rate using walk cal (fraction). Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear. (multiply by 1440 = min/day).

Real

% tme spent <= 1.5MET using 3min wlk calibration

Phase 2 data. Fraction of time spent < = 1.5 MET (rmr); acceleration and heart rate using 3-min walk calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a 1pt calibration from 3min walk phase of treadmill protocol. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt btwn 1.5-3MET std grp calibration

Phase 2 data. Fraction of time between 1.5-3METs (std); acceleration and heart rate using group calibration. This variable uses the resting metabolic rate calculation as defined in STANDARD_MET; same for every individual. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Equation used is indicated in GROUP_EQUATION. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_MET_Branch7

PA_Intensity and PA_FREE_LIVING category. % time spent < = 1.5 MET calculated using Oxford 2005 equations; combined acceleration and heart rate using group calibration. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear. (multiply by 1440 = min/day).

Real

% tme spent <= 1.5MET using grp calibration

Phase 2 data. Fraction of time spent < = 1.5 MET (rmr); acceleration and heart rate using group calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Equation used is indicated in GROUP_EQUATION. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spent <= 1.5MET using 200m wlk calibration

Phase 2 data. Fraction of time spent < = 1.5 MET (rmr); acceleration and heart rate using self paced 200m walk calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a 1pt estimate from the self paced walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_stdMET_Branch2

PA_Intensity and PA_FREE_LIVING category. % time spent <=1.5 MET (std); ACC and HR using t/mill no VO2 cal calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear. (multiply by 1440 = min/day).

Real

% tme spent <= 1.5METstd t/mill

Phase 2 data. Fraction of time spent < = 1.5 MET (std) acceleration and heart rate using t/mill; no VO2 calibration. This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a multi-point slope based estimate from the treadmill test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_stdMET_Branch6

PA_Intensity and PA_FREE_LIVING category. % time spent <=1.5 MET (std); ACC and HR using walk cal (fraction) calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spent <= 1.5METstd 3min wlk calibration

Phase 2 data. Fraction of time spent < = 1.5 MET (std); acceleration and heart rate using 3-min walk calibration; This variable uses the resting metabolic rate calculation as defined in STANDARD_MET; same for every individual. This is individually calibrated using a 1pt calibration from 3min walk phase of treadmill protocol. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_05_stdMET_Branch7

PA_Intensity and PA_FREE_LIVING category. % time spent <=1.5 MET (std); ACC and HR using group cal calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear. (multiply by 1440 = min/day).

Real

% tme spent <= 1.5METstd 200m wlk calibration

Phase 2 data. Fraction of time spent < = 1.5 MET (std); acceleration and heart rate using self paced 200m walk calibration; This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a 1pt estimate from the self paced walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_2MET_Branch2

PA_Intensity and PA_FREE_LIVING category.% time spent above 3 METs calculated using Oxford 2005 equations; combined acceleration and heart rate using t/mill no VO2 cal. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spent >= 3MET using t/mill

Phase 2 data. Fraction of time spent above 3MET (rmr); acceleration and heart rate using t/mill; no VO2 calibration. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a multi-point slope based estimate from the treadmill test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spent <= 1.5METstd grp calbiration

Phase 2 data. Fraction of time spent < = 1.5 MET (std); acceleration and heart rate using group calibration; This variable uses the resting metabolic rate calculation as defined in STANDARD_MET; same for every individual. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Equation used is indicated in GROUP_EQUATION. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_2MET_Branch6

PA_Intensity and PA_FREE_LIVING category.% time spent above 3 METs calculated using Oxford 2005 equations; combined acceleration and heart rate using walk cal (fraction). Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spent >= 3MET using 3min wlk calibration

Phase 2 data. Fraction of time spent above 3MET(rmr); acceleration and heart rate using 3-min walk calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a 1pt calibration from 3min walk phase of treadmill protocol. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_2MET_Branch7

PA_Intensity and PA_FREE_LIVING category.% time spent above 3 METs calculated using Oxford 2005 equations; combined acceleration and heart rate using group calibration. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spent >= 3MET using grp calibration

Phase 2 data. Fraction of time spent above 3MET (rmr); acceleration and heart rate using group calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Equation used is indicated in GROUP_EQUATION. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spent >= 3MET using 200m wlk calibration

Phase 2 data. Fraction of time spent above 3MET (rmr); acceleration and heart rate using self paced 200m walk calibration; This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation. This is individually calibrated using a 1pt estimate from the self paced walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_2stdMET_Branch2

PA_Intensity and PA_FREE_LIVING category.% time spent above 3MET (std); ACC and HR using t/mill no VO2 cal calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spnt >= 3MET std using t/mill

Phase 2 data. Fraction of time above 3METs (std); acceleration and heart rate using t/mill no VO2 calibration. This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a multi-point slope based estimate from the treadmill test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_2stdMET_Branch6

PA_Intensity and PA_FREE_LIVING category.% time spent above 3MET (std); ACC and HR using walk cal (fraction) calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability and Pwear.

Real

% tme spnt >= 3MET std using 3min wlk calibration

Phase 2 data. Fraction of time above 3METs (std); acceleration and heart rate using 3-min walk calibration. This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a 1pt calibration from 3min walk phase of treadmill protocol. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_2stdMET_Branch7

PA_Intensity and PA_FREE_LIVING category.% time spent above 3MET (std); ACC and HR using group cal calculated using STANDARD_MET. Proportion of time spent at this intensity level; adjusted for diurnal stability & Pwear.

Real

% tme spnt >= 3MET std 200m wlk calibration

Phase 2 data. Fraction of time above 3METs (std); acceleration and heart rate using self paced 200m walk calibration. This variable uses the resting metabolic rate as defined in STANDARD_MET; same for every individual. This is individually calibrated using a 1pt estimate from the self paced walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt >= 3MET std using grp calibration

Phase 2 data. Fraction of time above 3METs (std); acceleration and heart rate using group calibration. This variable uses the resting metabolic rate calculation as defined in STANDARD_MET; same for every individual. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Equation used is indicated in GROUP_EQUATION. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

MIDNIGHT_adj_coefficient

PA_FREE_LIVING category. Diurnal PAEE gradient 12pm-12am axis

Real

Diurnal PAEE gradient midnight

Phase 2 data. Diurnal PAEE gradient; 12pm-12am axis(Measured/Derived from or related to Acitheart Monitor/Data )

Real

minTimeRisePoint

PA_Clinic category. Treadmill test: Test time (earliest) at which lowest exercise HR occurs (based on first time derivative)

Real

Test time early lowest exercise HR occurs

Phase 2 data. Earliest time during treadmill test at which lowest exercise heart rate occurs (based on first derivative)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Lowest observed ACC reading

Phase 2 data. Lowest observed ACC reading in file (before adjustment). Some historical monitors presented issues regarding accelerometres meaning no movement periods were not recorded as zero. This is less common with the more recent monitors; however data is still checked for this error. File indicates lowest acc in file (should be 0)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

MORNING_adj_coefficient

PA_FREE_LIVING category. Diurnal PAEE gradient 6pm-6am axis

Real

Diurnal PAEE gradient 6pm-6am axis

Phase 2 data. Diurnal PAEE gradient; 6pm-6am axis(Measured/Derived from or related to Acitheart Monitor/Data )

Real

MVPA_10minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >10min (Std MET denominator)

Real

MVPA_10minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >10min (Std MET denominator)

Real

MVPA_1minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >1min (Std MET denominator)

Real

MVPA_1minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >1min (Std MET denominator)

Real

MVPA_2minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >2min (Std MET denominator)

Real

MVPA_2minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >2min (Std MET denominator)

Real

MVPA_3minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >3min (Std MET denominator)

Real

MVPA_3minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >3min (Std MET denominator)

Real

MVPA_4minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >4min (Std MET denominator)

Real

MVPA_4minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >4min (Std MET denominator)

Real

MVPA_5minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >5min (Std MET denominator)

Real

MVPA_5minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >5min (Std MET denominator)

Real

MVPA_6minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >6min (Std MET denominator)

Real

MVPA_6minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >6min (Std MET denominator)

Real

MVPA_7minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >7min (Std MET denominator)

Real

MVPA_7minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >7min (Std MET denominator)

Real

MVPA_8minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >8min (Std MET denominator)

Real

MVPA_8minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >8min (Std MET denominator)

Real

MVPA_9minBOUT_1

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>3METs) in bouts >9min (Std MET denominator)

Real

MVPA_9minBOUT_2

PA_FREE_LIVING category. New in R7. Fraction of time spent in MVPA (>4METs) in bouts >9min (Std MET denominator)

Real

naiveWeight_PAEE_ACC

PA_PAEE and PA_FREE_LIVING category variable. Energy expenditure from acceleration (kJ/kg/day). Assumes all obs valid (monitor worn)

Real

None

Phase 2 data. Energy expenditure from acceleration (kJ/kg/day). Ignores Pwear and assumes all observations are valid. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to acceleration estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

naiveWeight_PAEE_Branch7

PA_PAEE and PA_FREE_LIVING category variable. AEE based on combined ACC & HR using group cal (kJ/kg/day) Pwear set to 1.

Real

None

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using group cal (kJ/kg/day); All Pwear set to 1. All observations considered valid. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

New lowest observed ACC reading

Phase 2 data. If variable min_ACC_obs is not 0 then adjustments are made and new min acc displayed here. If no adjustment was needed this variable value will be . to indicate blank(Measured/Derived from or related to Acitheart Monitor/Data )

Real

P_obs_peakHRaS

PA_Clinic category. Treadmill test: New in R7. Peak running median HRaS during treadmill test (BPM)

Real

P_obs_peakHRaS_lastmin

PA_Clinic category. Treadmill test: New in R7. Peak running median HRaS during last minute of treadmill test (BPM)

Real

Peak run mdn HRaS last min treadmill test

Phase 2 data. Peak running median Heart Rate above sleep (HRaS) during last min of treadmill test bpm(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Peak run mdn HRaS treadmill test

Phase 2 data. Peak running median Heart Rate above Sleep (HRaS) during treadmill test bpm(Measured/Derived from or related to Acitheart Monitor/Data )

Real

obs_restHRaS

PA_Clinic category. Treadmill test: Observed resting HRaS during rest test (mean)

Real

Mean Obs resting HRaS rest test

Phase 2 data. mean observed resting heart rate above sleep during rest test from valid rest test observations(Measured/Derived from or related to Acitheart Monitor/Data )

Real

obs_restHRaS_p25

PA_Clinic category. Treadmill test: Observed resting HRaS during rest test (25th percentile)

Real

25th Percentile obs HRaS rest test

Phase 2 data. 25th percentile observed resting heart rate above sleep during rest test from valid rest test observations(Measured/Derived from or related to Acitheart Monitor/Data )

Real

paeescaled_acc

PA_PAEE and PA_FREE_LIVING category variable. Scaled AEE based on acceleration (kJ/kg/day).

Real

Scaled AEE based on acceleration

Phase 2 data. Scaled Physical Activity Energy Expenditure results based on acceleration only signal. If using an ACC only signal model then the estimate will have been scaled based on the relationship between PAEE_Branch (highest available) and PAEE_ACC and a mean taken from all individuals who have valid estimates for both and Pwear>48hr with >8hrs Pwear in each day quadrant (Morning; noon; afternoon; night). This is the scale factor for each participant that was included in producing mean scale factor for acceleration.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

paeescaled_hr

PA_PAEE and PA_FREE_LIVING category variable. Scaled AEE based on flexHR model (highest IC available) (kJ/kg/day).

Real

Scaled HR based on flexHR model

Phase 2 data. Scaled Physical Activity Energy Expenditure results based on heart rate only signal. If using an HR only signal model then the estimate will have been scaled based on the relationship between PAEE_Branch (highest available) and PAEE_HR (highest available) and a mean taken from all individuals who have valid estimates for both and Pwear>48hr with >8hrs Pwear in each day quadrant (Morning; noon; afternoon; night). This is the scale factor for each individual that was included in producing mean scale factor for heart rate only models(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_ACC_only

PA_PAEE and PA_FREE_LIVING category variable. Energy expenditure from acceleration (adjusted for diurnal stability weighted by pwear) (kJ/kg/day).

Real

Mean PAEE by Acceleration model

Phase 2 data. Mean Physical Activity energy expenditure based on acceleration only. Pwear taken from combined heart rate and acceleration signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_ACC_only_PwAccWeighted

PA_PAEE and PA_FREE_LIVING category variable. Energy expenditure from acceleration (adjusted for diurnal stability weighted by Pwear_acc) (kJ/kg/day).

Real

Mean PAEE by Acc PwACC weighted

Phase 2 data. Mean Physical Activity energy expenditure based on acceleration only. Pwear taken acceleration signal only (Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_Branch2

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on combined acceleration and heart rate using t/mill no VO2 (kJ/kg/day).

Real

AEE combined acc HR using t/mill

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using treadmill no VO2 (kJ/kg/day). This is used when the calibration test data are of sufficient quality to derive calibration factors and will be multiple point – if test duration is sufficient to derive slope-based estimate; e.g. >9.5 mins test duration. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_Branch6

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on combined ACC and HR using walk cal (no VO2) (kJ/kg/day)

Real

AEE combined acc HR using 3min wlk calibration

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using 3-min walk calibration from treadmill test (no VO2) (kJ/kg/day). Uses 1pt calibration to derive estimate where duration may not be sufficient for multiple point calibration. Those with sufficient treadmill length and quality for slope based will also have a 1pt calibration. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_Branch7

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on combined acceleration and heart rate using group calibration (Brage JAP 2007) - adjusted for diurnal stability & Pwear (kJ/kg/day).

Real

AEE combined acc HR using grp calibration

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using group cal (kJ/kg/day). Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

AEE combined acc HR using 200m wlk calibration

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using self paced 200m walk cal (kJ/kg/day). 1pt calibration used for those who undertook walk test. Present for all those who have a valid individual calibration file (as above) and valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_consolidated

MUST HAVE PA DATA PA_PAEE and PA_FREE_LIVING category variable. Suggestion for consolidated AEE(Highest IC Branch or scaled alt.model) (kJ/kg/day).

Real

Suggestion for consolidated AEE

Phase 2 data. Consolidated Physical Activity Energy Expenditure estimate where the highest available individually calibrated method has been used. Priority order multi point Treadmill (Branch2); 1pt Treadmill (Branch6); 1pt Walk test (Branch8); Group (Branch7). Where recommendations suggest alternative to branch equation is needed (due to possible corruption with the trace) then this model will have been scaled (as per paascaled_acc or paeescaled_hr) and used for this variable(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_flexHR13

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on flex heart rate model using 3-min walk cal no VO2 (kJ/kg/day).

Real

AEE flexHR using 3-min walk

Phase 2 data. Activity energy expenditure based on flexHR model using 3-min walk calibration from treadmill tests; no VO2 (kJ/kg/day). Based on Pwear from combined heart rate and acc signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_flexHR13_PwHrWeighted

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on flex heart rate model using 3-min walk cal no VO2 Pwear_hr_weighted (kJ/kg/day).

Real

AEE flexHR using slow walk calibration

Phase 2 data. Activity energy expenditure based on flexHR model using slow walk cal; no VO2; based on Pwear from heart rate only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_flexHR14

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on flex heart rate model using group calibration (adjusted for diurnal stability & Pwear) (kJ/kg/day).

Real

AEE flexHR model using group calibration

Phase 2 data. Activity energy expenditure based on flexHR model using group calibration (kJ/kg/day). Based on Pwear from combined heart rate and acc signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_flexHR14_PwHrWeighted

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on flex heart rate model using group calibration Pwear_hr weighted (adjusted for diurnal stability & Pwear_hr) (kJ/kg/day).

Real

AEE flexHR using group calibration

Phase 2 data. Activity energy expenditure based on flexHR model using group cal (kJ/kg/day); based on Pwear from heart rate only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

AEE flexHR self paced 200m walk

Phase 2 data. Activity energy expenditure based on flexHR model using self paced 200m walk calibration (kJ/kg/day). Based on Pwear from combined heart rate and acc signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

AEE flexHR self paced 200m walk calibration

Phase 2 data. Activity energy expenditure based on flexHR model using self paced 200m walk cal (kJ/kg/day); based on Pwear from heart rate only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_flexHR9

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on flex heart rate model using t/mill cal no VO2 (kJ/kg/day).

Real

AEE based on flexHR model

Phase 2 data. Activity energy expenditure based on flexHR model using t/mill calibration; no VO2 (kJ/kg/day). Based on Pwear from combined heart rate and acc signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE_flexHR9_PwHrWeighted

PA_PAEE and PA_FREE_LIVING category variable. Activity Energy expenditure based on flex heart rate model using t/mill cal no VO2 Pwear_hr_weighted (kJ/kg/day).

Real

AEE flexHR using t/mill calibration

Phase 2 data. Activity energy expenditure based on flexHR model using t/mill calibration; no VO2; based on Pwear from heart rate only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

predRMR

Predicted Resting Metabolic Rate (Oxford 2005 equation) (J/min/kg)

Real

predRMR_Oxford2005

PA_Intensity category. Predicted Resting Metabolic Rate (Oxford 2005 equation) (J/min/kg)

Real

Predicted Resting Metabolic Rate

Phase 2 data. Predicted Resting Metabolic Rate using Oxford 2005 equation (J/min/kg)

Real

Pwear

MUST HAVE PA DATA and PA_FREE_LIVING category variable. Time integral of wear probability based acc and hr in hours.

Real

Pwear_acc

MUST HAVE PA DATA and PA_FREE_LIVING category variable. Time integral of wear probability based on acceleration in hours.

Real

Pwear acceleration only 3PM-9PM

Phase 2 data. Number of hrs considered worn recorded during free-living; 3PM-9PM. Valid hour is where the monitor is considered as being worn based on the acceleration only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear acceleration only 3AM-9AM

Phase 2 data. Number of hrs considered worn recorded during free-living; 3AM-9AM. Valid hour is where the monitor is considered as being worn based on the acceleration only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear acceleration only 9PM-3AM

Phase 2 data. Number of hrs considered worn recorded during free-living; 9PM-3AM. Valid hour is where the monitor is considered as being worn based on the acceleration only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear acceleration only 9AM-3PM

Phase 2 data. Number of hrs considered worn recorded during free-living; 9AM-3PM. Valid hour is where the monitor is considered as being worn based on the acceleration only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear based on acceleration signal

Phase 2 data. Amount of time monitor is considered worn (and therefore data in included in estimates) based on the acceleration signal (Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear acceleration only weekend

Phase 2 data. Number of hours worn which fall on a weekend day (Saturday and Sunday). Based on acceleration only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear acceleration only weekday

Phase 2 data. Number of hours considered worn which fall on a weekday (Monday - Friday). Based on acceleration only signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_afternoon

MUST HAVE PA DATA and PA_FREE_LIVING category. Number of hours recorded during free-living 3PM-9PM in hours.

Real

Pwear 3PM-9PM

Phase 2 data. Number of hrs considered worn recorded during free-living; 3PM-9PM. Valid hour is where the monitor is considered as being worn based on the combined hear rate and acceleration signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_consolidated

MUST HAVE PA DATA and PA_FREE_LIVING category. Consolidated Pwear (for applied model in PAEE_consolidated) in hours.

Real

Consolidated Pwear

Phase 2 data. Amount of time (hrs) monitor is considered worn (and therefore data in included in estimates) for based on which model has been used for PAEE_Consolidated. Those where no notable corruptions have been flagged will use Pwear (wear time based on combined HR and ACC models). Suggest inclusion criteria based on this variable (as well as quadrant Pwear variables).(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_CONSTANT_regress

PA_FREE_LIVING category. New in R7. Intercept from double-sine regression model of Pwear

Real

Intercept regression Pwear

Phase 2 data. Intercept from double-sine regression model of Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_hr

MUST HAVE PA DATA and PA_FREE_LIVING category. Time integral of wear probability based on heart rate in hours.

Real

Pwear based on heart rate

Phase 2 data. Amount of time monitor is considered worn (and therefore data in included in estimates) based on the combined heart rate signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_MEAN

PA_FREE_LIVING category. New in R7. Average Pwear across the record. morning=night if 1.0

Real

Mean density of information

Phase 2 data. Mean density of information (mean Pwear)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_MIDNIGHT_DiurnalDensity

PA_FREE_LIVING category. Density bias of information along the noon-midnight axis (regression of pwear using morning and midnight axes). 12AM(+1) 12PM(-1)

Real

Noon-midnight Diurnal density

Phase 2 data. Density of information along the noon-midnight axis(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_MIDNIGHT_regress

PA_FREE_LIVING category. New in R7. Midnight coefficient from double-sine regression model of Pwear

Real

Midnight coefficient regression Pwear

Phase 2 data. Midnight coefficient from double-sine regression model of Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_morning

MUST HAVE PA DATA and PA_FREE_LIVING category. Number of hours recorded during free-living 3AM-9AM in hours.

Real

Pwear_MORNING_DiurnalDensity

PA_FREE_LIVING category. Density bias of information along the afternoon-morning axis (regression of pwear using morning and midnight axes). 6AM(+1) 6PM(-1)

Real

Afternoon-morning Diurnal density

Phase 2 data. Density of information along the afternoon-morning axis(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear 3AM-9AM

Phase 2 data. Number of hrs considered worn recorded during free-living; 3AM-9AM. Valid hour is where the monitor is considered as being worn based on the combined hear rate and acceleration signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_MORNING_regress

PA_FREE_LIVING category. New in R7. Branch model acceleration threshold for 2-min movement lag for diverting obs into 0% HR / 100% ACC weighting

Real

Morning coefficient regression Pwear

Phase 2 data. Morning coefficient from double-sine regression model of Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_night

MUST HAVE PA DATA and PA_FREE_LIVING category. Number of hours recorded during free-living 9PM-3AM in hours.

Real

Pwear 9PM-3AM

Phase 2 data. Number of hrs considered worn recorded during free-living; 9PM-3AM. Valid hour is where the monitor is considered as being worn based on the combined hear rate and acceleration signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_noon

MUST HAVE PA DATA and PA_FREE_LIVING category. Number of hours recorded during free-living 9AM-3PM in hours.

Real

Pwear 9AM-3PM

Phase 2 data. Number of hrs considered worn recorded during free-living; 9AM-3PM. Valid hour is where the monitor is considered as being worn based on the combined hear rate and acceleration signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear based on HR-acceleration

Phase 2 data. Amount of time monitor is considered worn for (and therefore data in included in estimates) based on the combined heart rate and acceleration signal(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_SPRING

PA_FREE_LIVING category. Seasonal Parameter: avg info density on AUTUMN-SPRING axis - Hemisphere adjusted

Real

Pwear Spring

Phase 2 data. Seasonal parameter: avg info density on AUTUMN-SPRING axis. Hemisphere-adjusted(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_weekend

PA_FREE_LIVING category. Number of hours recorded during free-living on weekenday in hours.

Real

Pwear weekend

Phase 2 data. Number of hours worn which fall on a weekend day (Saturday and Sunday). Based on combined heart rate and acceleration signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_WINTER

PA_FREE_LIVING category. Seasonal Parameter: avg info density on SUMMER-WINTER axis - Hemisphere adjusted

Real

Pwear Winter

Phase 2 data. Seasonal parameter: avg info density on SUMMER-WINTER axis. Hemisphere-adjusted ) (-1 to +1)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Pwear_wkday

PA_FREE_LIVING category. Number of hours recorded during free-living on weekday in hours.

Real

Pwear weekday

Phase 2 data. Number of hours considered worn which fall on a weekday (Monday - Friday). Based on combined heart rate and acceleration signals(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RecordLength

Length of Actiheart recording

Real

Total length of file recording

Phase 2 data. Total length of file recording (regardless of whether monitor is worn). This indicates time from monitor set up until download (or monitor reaches memory/battery capacity)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

recoveryduration

PA_Clinic category. Treadmill test: Duration of recovery phase (min)

Real

Duration of treadmill test recovery phase

Phase 2 data. Duration of treadmill test recovery phase (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

restduration

PA_Clinic category. Treadmill test: Duration of rest test (min)

Real

Duration of rest test (min)

Phase 2 data. Duration of rest test (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

reststart

PA_Clinic category. Treadmill test: Start time of rest test dd-mmm-yyyy hh:mm:ss

DateTime

Start time of rest test

Phase 2 data. Real start time of supine rest test. (Measured/Derived from or related to Acitheart Monitor/Data )

DateTime

rest_ACC_min_1

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 1 of rest test

Real

Mdn trunk acceleration min 10 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 10 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration min 1 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 1 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_ACC_min_2

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 2 of rest test

Real

Mdn trunk acceleration min 2 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 2 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_ACC_min_3

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 3 of rest test

Real

Mdn trunk acceleration min 3 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 3 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_ACC_min_4

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 4 of rest test

Real

Mdn trunk acceleration min 4 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 4 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_ACC_min_5

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 5 of rest test

Real

Mdn trunk acceleration min 5 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 5 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_ACC_min_6

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 6 of rest test

Real

Mdn trunk acceleration min 6 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 6 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration min 7 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 7 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration min 8 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 8 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration min 9 of rest test

Phase 2 data. Median trunk acceleration m/s2; min 9 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_HRaS_min_1

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 1 of rest test

Real

Median HRabovesleep min 10 rest test

Phase 2 data. Median heart rate above sleep bpm; min 10 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR abovesleep min 1 rest test

Phase 2 data. Median heart rate above sleep bpm; min 1 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_HRaS_min_2

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 2 of rest test

Real

Median HR abovesleep min 2 rest test

Phase 2 data. Median heart rate above sleep bpm; min 2 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_HRaS_min_3

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 3 of rest test

Real

Median HR abovesleep min 3 rest test

Phase 2 data. Median heart rate above sleep bpm; min 3 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_HRaS_min_4

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 4 of rest test

Real

Median HR abovesleep min 4 rest test

Phase 2 data. Median heart rate above sleep bpm; min 4 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_HRaS_min_5

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 5 of rest test

Real

Median HR abovesleep min 5 rest test

Phase 2 data. Median heart rate above sleep bpm; min 5 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

rest_HRaS_min_6

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 6 of rest test

Real

Median HR abovesleep min 6 rest test

Phase 2 data. Median heart rate above sleep bpm; min 6 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR abovesleep min 7 rest test

Phase 2 data. Median heart rate above sleep bpm; min 7 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR abovesleep min 8 rest test

Phase 2 data. Median heart rate above sleep bpm; min 8 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR abovesleep min 9 rest test

Phase 2 data. Median heart rate above sleep bpm; min 9 of supine rest test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RHRaS

PA_FREE_LIVING category. Rest HR above Sleep used as HR anchor point for all calibration levels (bpm).

Real

Rest HRaS anchor point

Phase 2 data. Rest heart rate above Sleep; used as heart rate anchor point for all calibration levels. Uses SHR variable in calculation(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RMSE_1passResid_rest

PA_Clinic category. Treadmill test: Error term residual regression of rest phase (1st pass)

Real

Error term residual regression of rest phase(1st pass)

Phase 2 data. Error term; residual regression of rest phase (1st pass)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RMSE_1passResid_testrec

PA_Clinic category. Treadmill test: Error term residual regression of test and recovery phases (1st pass)

Real

Error term residual regression treadmill test recovery phases(1st pass)

Phase 2 data. Error term; residual regression of treadmill test and recovery phases (1st pass)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RMSE_2passMed_rec

PA_Clinic category. Treadmill test: Error term regression of median HR against rectime (0-1.5 min)

Real

Error term regression mdn HR recovery time(0-1.5min) treadmill

Phase 2 data. Error term; regression of median heart rate against recovery time (0-1.5 min) - Treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RMSE_2passMed_test

PA_Clinic category. Treadmill test: Error term regression of median HR against testtime (omit first Time_excluded_beginTest min) - Amount omitted determined in review process (default=2.5mins)

Real

Error term regression mdn HR test time(omit frst 2.5min) treadmill

Phase 2 data. Error term; regression of median heart rate against testtime (omit first 2.5min) - Treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

RMSE_2passResid_testrec

PA_Clinic category. Treadmill test: Error term residual regression of test and recovery phases (2nd pass)

Real

Error term residual regression treadmill test recovery phases (2nd pass)

Phase 2 data. Error term; residual regression of treadmill test and recovery phases (2nd pass)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

SED_Breaks_acc

PA_FREE_LIVING category. Average Daily # Breaks in Sedentary time (Threshold: 0.075 m/s2)

Real

SED_Breaks_MET

PA_FREE_LIVING category. Average Daily # Breaks in Sedentary time (Threshold: 1.5 MET(std))

Real

Sex

Phase 2 data. Sex (0 = female; 1 = male) used in all physical activity estimates

Categorical

Error INT_stdMET_highIC_BRANCH_cat0

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat0(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat10

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat10(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat11

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat11(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat12

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat12(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat13

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat13(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat14

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat14(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat15

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat15(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat16

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat16(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat17

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat17(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat18

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat18(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat19

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat19(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat1

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat1(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat20

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat20(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat21

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat21(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat22

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat22(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat23

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat23(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat24

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat24(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ErrorINT_stdMET_highIC_BRANCH_cat25

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat25(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INTstdMEThighIC_BRANCH_cat26

Phase 2 data. Standard Error relating to variable se_INTstdMEThighIC_BRANCH_cat26(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INTstdMEThighIC_BRANCH_cat27

Phase 2 data. Standard Error relating to variable se_INTstdMEThighIC_BRANCH_cat27(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat2

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat2(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat3

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat3(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat4

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat4(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat5

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat5(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat6

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat6(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat7

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat7(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat8

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat8(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error INT_stdMET_highIC_BRANCH_cat9

Phase 2 data. Standard Error relating to variable INT_stdMET_highIC_BRANCH_cat9(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Std error relating to PAEE Branch2

Phase 2 data. Standard error relating to variable physical activity energy expenditure Branch2(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Std error relating to PAEE Branch6

Phase 2 data. Standard error relating to variable physical activity energy expenditure Branch6(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Std error relating to PAEE Branch7

Phase 2 data. Standard error relating to variable physical activity energy expenditure Branch7(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Std error relating to PAEE Branch8

Phase 2 data. Standard error relating to variable physical activity energy expenditure Branch8(Measured/Derived from or related to Acitheart Monitor/Data )

Real

SHR

PA_FREE_LIVING category. Sleep HR (beats/min)

Real

Sleep HR beats/min

Phase 2 data. Sleep heart rate beats/min value used for free-living analysis. Usually derived from associated Free-living recording. If no Free-living recording present then Fenland 1 SHR may be used. If this is also not present then it may be estimated from Rest test. Whether sleeping heart rate has been estimated is indicated in the AH_COMMENTS and AH_FLAG_SHR variables(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

simplewgt_PAEE_Branch7

PA_FREE_LIVING category. PA_PAEE category variable. Activity Energy expenditure based on combined acceleration & heart rate using group calibration (Brage JAP 2007) - non-adjusted for diurnal stability weighted by Pwear (kJ/kg/day).

Real

AEE simple weight grp calbiration

Phase 2 data. Activity energy expenditure based on combined acceleration and heart rate using group cal (kJ/kg/day). Not adjusted for diurnal bias. Where possible; a specific group equation is derived for that study using data from the IC tests. Where this is not possible; the most appropriate equation from another study will have been applied in the calculation of the group estimated physical activity energy expenditure results. Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear(Measured/Derived from or related to Acitheart Monitor/Data )

Real

STANDARD_MET

PA_Intensity and PA_FREE_LIVING category. Denominator used for absolute intensity evaluation (J/min/kg)

Real

Denominator std intensity MET cat

Phase 2 data. Value used as the denominator in the standard intensity MET categories - standard for everyone(Measured/Derived from or related to Acitheart Monitor/Data )

Real

startdate

PA_FREE_LIVING category. Date of first day of free-living recording (days past 1/1/1960).

Real

Start date of free-living recording

Phase 2 data. Date of first day of free-living recording (days past 1/1/1960)(Measured/Derived from or related to Acitheart Monitor/Data )

Date

startdayofweek

PA_FREE_LIVING category. Start day of week of free-living recording

Categorical

Start day wk of free-living record

Phase 2 data. Start day of week of free-living recording (1 = Monday; 2 = Tuesday; 3 = Wednesday; 4 = Thursday; 5 = Friday; 6 = Saturday; 7 = Sunday)(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

startdayofyear

PA_FREE_LIVING category. Start day of year of free-living recording (days past Dec 31st).

Real

Start day yr of free-living record

Phase 2 data. Start day of year of free-living recording (days past Dec 31st)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

startminofday

PA_FREE_LIVING category. Start time of free-living recording (minutes past 00:00)

Real

Start time of free-living recording

Phase 2 data. Start time of free-living recording (minutes past 00:00)(Measured/Derived from or related to Acitheart Monitor/Data )

Time

status

PA_Clinic category. Treadmill test: GREEN=.ibi data used ORANGE=uses polar salvaged data

Text

Type of data treadmill test calibration

Phase 2 data. Variable defines which type of data from the monitor has been able to be used for treadmill test calibration. GREEN indicates high quality HR data available and so full ibi data from Actiheart could be used for calibration. ORANGE indicates lower quality heart data available from Actiheart and so alternative heart rate from Polar monitor has been manually inputted into file(Measured/Derived from or related to Acitheart Monitor/Data )

Text

testduration

PA_Clinic category. Treadmill test: Duration of treadmill test completed (min)

Real

Duration treadmill test completed

Phase 2 data. Duration of treadmill Test completed (min); varies per participant(Measured/Derived from or related to Acitheart Monitor/Data )

Real

teststart

PA_Clinic category. Treadmill test: Start time of exercise test dd-mmm-yyyy hh:mm:ss

DateTime

Start time of actual treadmill test

Phase 2 data. Real start time of actual treadmill test; calibration protocol noted in calibration_protocol(Measured/Derived from or related to Acitheart Monitor/Data )

DateTime

TimeRisePoint

PA_Clinic category. Treadmill test: Test time (latest) at which lowest exercise HR occurs (based on first time derivative)

Real

Test time latest lowest exercise HR occurs

Phase 2 data. Latest time during treadmill test at which lowest exercise heart rate occurs (based on first derivative)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time spentbelow FlexHR -5bpm

Phase 2 data. Fraction of time spent below FlexHR -5bpm (derived from treadmill)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time spentbelow FlexHR +5bpm

Phase 2 data. Fraction of time spent below FlexHR +5bpm (derived from treadmill)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Ttime spentbelow FlexHR

Phase 2 data. Fraction of time spent below FlexHR (derived from treadmill)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

time_change

PA_FREE_LIVING category. Clock time change detected in time-series (

Categorical

Clock time change detected

Phase 2 data. Indicates whether the free-living wear cross over a clock change period ; -1 = clocks went backward during wear; 1 = clocks went forwards during wear. Data has been adjusted to remove duplicate data or avoid missing data(Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

Time_excluded_beginTest

PA_Clinic category. Treadmill test: Time after beginning of test beyond which observations are included

Real

Time after beginning of treadmill test beyond which obs are included

Phase 2 data. Time after beginning of treadmill test beyond which observations are included(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TIME_RESOLUTION

PA_FREE_LIVING category. New in R7. Time resolution (mins) of intermediate processing

Real

Time resolution intermediate processing

Phase 2 data. Level of intermediate processing before summary level variables produced. E.g Hourly data (60mins) which can then be further summarised to daily/summary level where required. This is stipulated pre-processing(Measured/Derived from or related to Acitheart Monitor/Data )

Time

Time_trend_HighIC_Branch

PA_FREE_LIVING category. New in R7. Within-record time trend [MET/hr]. Adjusted for diurnal rhythm and weekend

Real

Within-record time trend MET/hr

Phase 2 data. Within-record time trend MET/hr. Adj for diurnal rhythm and weekend(Measured/Derived from or related to Acitheart Monitor/Data )

Real

transHRaS

PA_FREE_LIVING category. Transition HR above Sleep used as HR branching point (branch 1 or 2) for all calibration levels (bpm).

Real

Transition HRaS

Phase 2 data. Transition heart rate above Sleep; used as heart rate branching point (b1/b2); all calibration levels. Reference Brage et al JAP2007(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_1ptALPHA_estPAI

PA_Clinic category. Treadmill test: Intercept 1pt calibration

Real

Intercept 1pt calibration

Phase 2 data. Intercept used for 1pt calibration derived from treadmill test (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_1ptBETA_estPAI

PA_Clinic category. Treadmill test: Beta-coefficient 1pt calibration (J/kg/beat)

Real

Beta-coefficient 1pt calibration

Phase 2 data. Beta coefficient used for 1pt calibration derived from treadmill test (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_1pt_HRaS

PA_Clinic category. Treadmill test: Mean HRaS between 4-5 min (used for 1pt calibration) (bpm).

Real

Mean HRaS btwn 4-5 min (1pt calibration)

Phase 2 data. Mean heart rate above sleep between 4 and 5 min (used for 1pt calibration) from treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_1

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 1 of treadmill test

Real

TR_ACC_min_10

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 10 of treadmill test

Real

Median trunk acceleration min 10

Phase 2 data. Median trunk acceleration m/s2; minute 10 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_11

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 11 of treadmill test

Real

Median trunk acceleration min 11

Phase 2 data. Median trunk acceleration m/s2; minute 11 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_12

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 12 of treadmill test

Real

Median trunk acceleration min 12

Phase 2 data. Median trunk acceleration m/s2; minute 12 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_13

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 13 of treadmill test

Real

Median trunk acceleration min 13

Phase 2 data. Median trunk acceleration m/s2; minute 13 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_14

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 14 of treadmill test

Real

Median trunk acceleration min 14

Phase 2 data. Median trunk acceleration m/s2; minute 14 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_15

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 15 of treadmill test

Real

Median trunk acceleration min 15

Phase 2 data. Median trunk acceleration m/s2; minute 15 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_16

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 16 of treadmill test

Real

Median trunk acceleration min 16

Phase 2 data. Median trunk acceleration m/s2; minute 16 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_17

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 17 of treadmill test

Real

Median trunk acceleration min 17

Phase 2 data. Median trunk acceleration m/s2; minute 17 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_18

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 18 of treadmill test

Real

Median trunk acceleration min 18

Phase 2 data. Median trunk acceleration m/s2; minute 18 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_19

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 19 of treadmill test

Real

Median trunk acceleration min 19

Phase 2 data. Median trunk acceleration m/s2; minute 19 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median trunk acceleration min 1

Phase 2 data. Median trunk acceleration m/s2; minute 1 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_2

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 2 of treadmill test

Real

TR_ACC_min_20

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 20 of treadmill test

Real

Median trunk acceleration min 20

Phase 2 data. Median trunk acceleration m/s2; minute 20 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_21

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 21 of treadmill test

Real

Median trunk acceleration min 21

Phase 2 data. Median trunk acceleration m/s2; minute 21 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median trunk acceleration min 2

Phase 2 data. Median trunk acceleration m/s2; minute 2 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_3

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 3 of treadmill test

Real

Median trunk acceleration min 3

Phase 2 data. Median trunk acceleration m/s2; minute 3 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_4

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 4 of treadmill test

Real

Median trunk acceleration min 4

Phase 2 data. Median trunk acceleration m/s2; minute 4 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_5

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 5 of treadmill test

Real

Median trunk acceleration min 5

Phase 2 data. Median trunk acceleration m/s2; minute 5 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_6

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 6 of treadmill test

Real

Median trunk acceleration min 6

Phase 2 data. Median trunk acceleration m/s2; minute 6 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_7

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 7 of treadmill test

Real

Median trunk acceleration min 7

Phase 2 data. Median trunk acceleration m/s2; minute 7 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_8

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 8 of treadmill test

Real

Median trunk acceleration min 8

Phase 2 data. Median trunk acceleration m/s2; minute 8 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_ACC_min_9

PA_Clinic category. Treadmill test: New in R7. Median trunk accleration (m/s2) min 9 of treadmill test

Real

Median trunk acceleration min 9

Phase 2 data. Median trunk acceleration m/s2; minute 9 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_AHSW_shr

PA_Clinic category. Treadmill test: Sleep HR (beats/min) [value used for treadmill test analysis]

Real

Sleep HR treadmill test analysis

Phase 2 data. Sleeping heart rate used for treadmill test analysis. Usually derived from associated Free-living recording. If no Free-living recording present then Fenland 1 SHR may be used. If this is also not present then it may be estimated from Rest test. Whether sleeping heart rate has been estimated is indicated in the AH_COMMENTS and AH_FLAG_SHR variables(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

TR_ALPHA_ESTPAI

PA_Clinic category. Treadmill test: Applied intercept of HRaS-PAEE relationship treadmill calibration

Real

TR_alpha_estPAI_10m

PA_Clinic category. Treadmill test: Mean HRaS between 8-10min (used for fast walk calibration) (bpm).

Real

Mean HRaS fast wlk calibration 8 -10min

Phase 2 data. Mean heart rate above sleep (HRaS) between 8 and 10min (used for fast walk calibration)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_alpha_estPAI_med

PA_Clinic category. Treadmill test: Intercept of HRaS-PAEE relationship using median HR during treadmill

Real

Intercept HRaS-PAEE mdn HR treadmill test

Phase 2 data. Intercept of heart rate above sleep-physical activity energy expenditure relationship using median heart rate during treadmill (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_alpha_estPAI_med_trunc10

PA_Clinic category. Treadmill test: New in R7. Intercept of HRaS-PAEE relationship using median HR during treadmill during 1st 10mins of treadmill test in J/min/kg

Real

Intercept HRaS-PAEE mdn HR frst 10min treadmill test

Phase 2 data. Intercept; heart rate above sleep-physical activity energy expenditure relationship (med heart rate); first 10min treadmill test (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_alpha_estPAI_med_trunc15

PA_Clinic category. Treadmill test: New in R7. Intercept of HRaS-PAEE relationship using median HR during first 15mins of treadmill treadmill in J/min/kg

Real

Intercept HRaS-PAEE mdn HR frst 15min treadmill test

Phase 2 data. Intercept; heart rate above sleep-physical activity energy expenditure relationship (med heart rate); first 15min treadmill test (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_alpha_estPAI_med_uncensored

PA_Clinic category. Treadmill test: Intercept of HRaS-PAEE relationship using median HR during t/mill (uncensored) (J/min/kg)

Real

Intercept HRaS-PAEE mdn HR treadmill test uncensored

Phase 2 data. Intercept of heart rate above sleep-physical activity energy expenditure relationship using median heart rate during t/mill (uncensored) (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Applied intercept of HRaS-PAEE

Phase 2 data. Applied intercept of heart rate above sleep-physical activity energy expenditure (est) relationship; tread.calibration (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_alpha_estPAI_reg

PA_Clinic category. Treadmill test: Intercept of HRaS-PAEE relationship using regressed HR during treadmill

Real

Intercept HRaS-PAEE regressioned HR treadmill test

Phase 2 data. Intercept of heart rate above sleep-physical activity energy expenditure relationship using regressed HR during treadmill (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_alpha_estPAI_slope

PA_Clinic category. Treadmill test: Intercept of HRaS-PAEE (est) relationship treadmill calibration.

Real

Intercept HRaS-PAEE treadmill calibration

Phase 2 data. Intercept of heart rate above sleep-physical activity energy expenditure (est) relationship; tread.calibration (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_BETA_ESTPAI

PA_Clinic category. Treadmill test: Applied beta coefficient of HRaS-PAEE relationship treadmill calibration. (J/kg/beat)

Real

TR_beta_estPAI_10m

PA_Clinic category. Treadmill test: HRaS/estPAI ratio fast walk calibration (8-10min) (J/kg/beat)

Real

HRaS estPAI ratio fast wlk calibration 8-10min

Phase 2 data. heart rate above sleep/estPAI ratio; fast walk calibration (8 to 10min) (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_beta_estPAI_med

PA_Clinic category. Treadmill test: Beta coeff. HRaS-PAEE relationship using median HR during treadmill (J/kg/beat)

Real

Slope HRaS-PAEE mdn HR treadmill test

Phase 2 data. Slope of heart rate above sleep-physical activity energy expenditure relationship using median heart rate during treadmill (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_beta_estPAI_med_trunc10

PA_Clinic category. Treadmill test: New in R7. Slope of HRaS-PAEE relationship using median HR during treadmill during fist 10mins of treadmill test. (J/kg/beat)

Real

Slope HRaS-PAEE mdn HR frst 10min treadmill test

Phase 2 data. Slope; heart rate above sleep-physical activity energy expenditure relationship (med heart rate); first 10min treadmill test (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_beta_estPAI_med_trunc15

PA_Clinic category. Treadmill test: New in R7. Slope of HRaS-PAEE relationship using median HR during first 15mins of treadmill test. (J/kg/beat)

Real

Slope HRaS-PAEE mdn HR frst 15min treadmill test

Phase 2 data. Slope; heart rate above sleep-physical activity energy expenditure relationship (med heart rate); first 15min treadmill test (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_beta_estPAI_med_uncensored

PA_Clinic category. Treadmill test: Beta coeff. HRaS-PAEE relationship using median HR during t/mill (uncensored)(J/kg/beat)

Real

Slope HRaS-PAEE mdn HR treadmill test uncensored

Phase 2 data. Slope of heart rate above sleep-physical activity energy expenditure relationship using median HR during treadmill test (uncensored)(J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Applied beta coefficient HRaS-PAEE

Phase 2 data. Applied beta coefficient of heart rate above sleep-physical activity energy expenditure (est) relationship; tread.cal. (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_beta_estPAI_reg

PA_Clinic category. Treadmill test: Beta coeff. HRaS-PAEE relationship using regressed HR during treadmill (J/kg/beat)

Real

Slope HRaS-PAEE regression HR treadmill test

Phase 2 data. Slope of heart rate above sleep-physical activity energy expenditure relationship using regressed HR during treadmill (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_beta_estPAI_slope

PA_Clinic category. Treadmill test: Beta coefficient of HRaS-PAEE (est) relationship tread.cal. (J/kg/beat)

Real

Beta coefficient HRaS-PAEE treadmill calibration

Phase 2 data. Beta coefficient of heart rate above sleep-physical activity energy expenditure (est) relationship; tread.cal. (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_estPAEE_1pt_40bpm

PA_Clinic category. Treadmill test: Point treadmill test 1-pt calibration curve: PAEE @ 40bpm (beats per minute) above SHR (sleeping heart rate)

Real

PAEE at 40bpm above SHR 1-pt

Phase 2 data. Point; treadmill test 1-pt calibration curve: physical activity energy expenditure @ 40bpm above sleeping heart rate (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_estPAEE_40bpm

PA_Clinic category. Treadmill test: Point appl treadmill test calibration curve: PAEE @ 40bpm (beats per minute) above SHR (sleeping heart rate)

Real

PAEE at 40bpm above SHR

Phase 2 data. Point; appl treadmill test calibration curve: physical activity energy expenditure @ 40bpm above sleeping heart rate (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_estPAEE_HighPt_40bpm

PA_Clinic category. Treadmill test: Point (PAI @ 40bpm) (beats per minute) on calibration curve resulting from fast walk calibration (J/min/kg)

Real

PAI at 40bpm from fast walk calibration

Phase 2 data. Point (physical activity intensity @ 40bpm) on calibration curve resulting from fast walk calibration (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_FITNESS_est

PA_Clinic category. Treadmill test VO2max estimate using estimated PAEE (ml O2/min/kg)

Real

Treadmill test VO2max estimate

Phase 2 data. Treadmill test VO2max estimate (ml O2/min/kg) using estimated physical activity energy expenditure. Estimate present if treadmill duration > = 10mins and useable HR quality. Energy cost based on predicted energy expenditure from Brage et al 2007 (JAP). Submaximal response extrapolated to max HR (Tanaka 2001)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_FITNESS_HighPt_est

PA_Clinic category. Treadmill test: New in R7. Treadmill test VO2max estimate (ml O2/min/kg) using estimated PAEE (High Point Model)

Real

Treadmill test VO2max HighPt model

Phase 2 data. Treadmill test VO2max estimate (ml O2/min/kg) using estimated physical activity energy expenditure (HighPt model)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_FITNESS_trunc15_est

PA_Clinic category. Treadmill test: New in R7. Treadmill test VO2max estimate (ml O2/min/kg) using estimated PAEE (truncated to 15mins)

Real

Treadmill VO2max estimate >15mins

Phase 2 data. Treadmill VO2max estimate (ml O2/min/kg) using estimated physical activity energy expenditure (disregard data >15mins)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_flexHRaS

PA_Clinic category. Treadmill test: Applied flex HR from treadmill test (beats/min)

Real

Applied flex HR treadmill test

Phase 2 data. Applied flex heart rate from treadmill test (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HighPtALPHA_estPAI

PA_Clinic category. Treadmill test: Intercept fast walk calibration (J/min/kg)

Real

Intercept fast walk calibration

Phase 2 data. Intercept used for fast walk calibration derived from treadmill test (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HighPtBETA_estPAI

PA_Clinic category. Treadmill test: Beta-coefficient fast walk calibration (J/kg/beat)

Real

Beta-coefficient fast walk calibration

Phase 2 data. Beta-coefficient used for fast walk calibration derived from treadmill test (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaSwalk_estPAI

PA_Clinic category. Treadmill test: Avg HRaS from rolling median HRaS between min 4-5 min during TM (bpm).

Real

Avg HRaS rolling mdn btwn min 4-5

Phase 2 data. Average heart rate above sleep from rolling median heart rate above sleep between min 4 and 5 during treadmill(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaSwalk_estPAI_reg

PA_Clinic category. Treadmill test: Avg HRaS from regressed HRaS between min 4-5min during TM (bpm).

Real

Avg HRaS regressioned btwn min 4-5

Phase 2 data. Average heart rate above sleep from regressed heart rate above sleep between min 4 and 5 during treadmill (Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_1

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 1 of treadmill test

Real

TR_HRaS_min_10

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 10 of treadmill test

Real

Median HR above sleep bpm min 10

Phase 2 data. Median heart rate above sleep bpm; minute 10 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_11

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 11 of treadmill test

Real

Median HR above sleep bpm min 11

Phase 2 data. Median heart rate above sleep bpm; minute 11 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_12

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 12 of treadmill test

Real

Median HR above sleep bpm min 12

Phase 2 data. Median heart rate above sleep bpm; minute 12 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_13

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 13 of treadmill test

Real

Median HR above sleep bpm min 13

Phase 2 data. Median heart rate above sleep bpm; minute 13 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_14

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 14 of treadmill test

Real

Median HR above sleep bpm min 14

Phase 2 data. Median heart rate above sleep bpm; minute 14 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_15

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 15 of treadmill test

Real

Median HR above sleep bpm min 15

Phase 2 data. Median heart rate above sleep bpm; minute 15 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_16

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 16 of treadmill test

Real

Median HR above sleep bpm min 16

Phase 2 data. Median heart rate above sleep bpm; minute 16 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_17

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 17 of treadmill test

Real

Median HR above sleep bpm min 17

Phase 2 data. Median heart rate above sleep bpm; minute 17 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_18

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 18 of treadmill test

Real

Median HR above sleep bpm min 18

Phase 2 data. Median heart rate above sleep bpm; minute 18 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_19

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 19 of treadmill test

Real

Median HR above sleep bpm min 19

Phase 2 data. Median heart rate above sleep bpm; minute 19 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep bpm min 1

Phase 2 data. Median heart rate above sleep bpm; minute 1 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_2

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 2 of treadmill test

Real

TR_HRaS_min_20

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 20 of treadmill test

Real

Median HR above sleep bpm min 20

Phase 2 data. Median heart rate above sleep bpm; minute 20 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_21

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 21 of treadmill test

Real

Median HR above sleep bpm min 21

Phase 2 data. Median heart rate above sleep bpm; minute 21 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep bpm min 2

Phase 2 data. Median heart rate above sleep bpm; minute 2 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_3

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 3 of treadmill test

Real

Median HR above sleep bpm min 3

Phase 2 data. Median heart rate above sleep bpm; minute 3 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_4

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 4 of treadmill test

Real

Median HR above sleep bpm min 4

Phase 2 data. Median heart rate above sleep bpm; minute 4 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_5

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 5 of treadmill test

Real

Median HR above sleep bpm min 5

Phase 2 data. Median heart rate above sleep bpm; minute 5 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_6

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 6 of treadmill test

Real

Median HR above sleep bpm min 6

Phase 2 data. Median heart rate above sleep bpm; minute 6 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_7

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 7 of treadmill test

Real

Median HR above sleep bpm min 7

Phase 2 data. Median heart rate above sleep bpm; minute 7 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_8

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 8 of treadmill test

Real

Median HR above sleep bpm min 8

Phase 2 data. Median heart rate above sleep bpm; minute 8 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_HRaS_min_9

PA_Clinic category. Treadmill test: New in R7. Median heart rate above sleep (bpm) min 9 of treadmill test

Real

Median HR above sleep bpm min 9

Phase 2 data. Median heart rate above sleep bpm; minute 9 of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_MAXestPAEE

PA_Clinic category. Treadmill test: Point appl treadmill test calibration curve: PAEE @ age-pred. max HR

Real

TR_MAXestPAEE_1pt

PA_Clinic category. Treadmill test: Point treadmill test 1-pt calibration curve: PAEE @ age-pred. max HR

Real

PAEE at age-pred max HR 1-pt

Phase 2 data. Point; treadmill test 1-pt calibration curve: physical activity energy expenditure @ age-pred. max heart rate (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_MAXestPAEE_HighPt

PA_Clinic category. Treadmill test: Point (PAI @ age-pred. maxHR) on calibration curve resulting from fast walk calibration (J/min/kg)

Real

PAI age-pred maxHR fast walk calibration

Phase 2 data. Point (physical activity intensity @ age-pred. max heart rate) on calibration curve resulting from fast walk calibration (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE at age-pred max HR

Phase 2 data. Point; appl treadmill test calibration curve: physical activity energy expenditure @ age-pred. max heart rate (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_MAXestPAEE_trunc15

PA_Clinic category. Treadmill test: New in R7. Point appl treadmill tet calibration curve truncated to 15mins: PAEE at age-pred max HR

Real

PAEE at age-pred max HR (trunc15)

Phase 2 data. Point; appl treadmill calibration curve (truncated to 15mins): physical activity energy expenditure @ age-pred. max heart rate (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_maxHRaS

PA_Clinic category. Treadmill test: Estimated max HR above sleep (208 - 0.7*age - shr - 20*betablocker) (bpm).

Real

Estimated max HR above sleep

Phase 2 data. Estimated max HR above sleep (208 - 0.7*age - shr - 20*betablocker)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_peak_1pt_estPAI

PA_Clinic category. Treadmill test: Median est. PAI during last 2min of test

Real

Median est. PAI last 2min of test

Phase 2 data. Median estimated physical activity intensity during last 2min of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_peak_1pt_HRaS

PA_Clinic category. Treadmill test: Median HRaS during last 2min of test (bpm).

Real

Median HRaS last 2min of test

Phase 2 data. Median heart rate above sleep during last 2min of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_recHR_1min

PA_Clinic category. Treadmill test: 1-min recovery HRaS from treadmill test (based on 90-sec regression) (bpm).

Real

TR_recHR_1min_globalRegress

PA_Clinic category. Treadmill test: 1-min recovery HRaS from treadmill test [based on global regression] (bpm).

Real

1-min rec HRaS treadmill test global regression

Phase 2 data. 1-min recovery heart rate above sleep from treadmill test based on global regression (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

1-min rec HRaS treadmill test 90-sec regression

Phase 2 data. 1-min recovery heart rate above sleep from treadmill test based on 90-sec regression (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_risePt_HRaS

PA_Clinic category. Treadmill test: Mean HRaS at TimeRisePoint (+/-0.25min) (bpm).

Real

Mean HRaS TimeRisePoint (+/-.25min)

Phase 2 data. Mean heart rate above sleep (HRaS) at TimeRisePoint (+/-.25min) from treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

TR_testdate

PA_Clinic category. Treadmill test: Date of treadmill Test dd-mmm-yyy

Date

Date of treadmill test

Phase 2 data. Date of treadmill test(Measured/Derived from or related to Acitheart Monitor/Data )

Date

valHR_obs_rec

PA_Clinic category. Treadmill test: Number of valid observations during recovery phase

Real

No valid obs treadmill test recovery phase

Phase 2 data. Number of valid observations from treadmill test recovery phase. Data must be annotated as within the annotated treadmill test recovery period from participant's visit; be between 0-90sec within that phase and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

valHR_obs_rest

PA_Clinic category. Treadmill test: Number of valid observations during rest phase

Real

No of valid observations rest test data

Phase 2 data. Number of valid observations from rest test data. Data must be annotated as within the annotated rest test period from participant's visit and occur between 3-10mins and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

valHR_obs_test

PA_Clinic category. Treadmill test: Number of valid observations during test phase

Real

valHR_obs_test10

PA_Clinic category. Treadmill test: Number of valid observations for fast walk calibration (8 to 10min)

Real

No valid obs treadmill test data 8-10min

Phase 2 data. Number of valid observations from treadmill test data 8-10mins. Data must be annotated as within the annotated treadmill test period from 8-10mins from participant's visit and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

valHR_obs_test_last2

PA_Clinic category. Treadmill test: Number of valid observations during last 2 minutes of test

Real

No valid obs treadmill test last 2 min test

Phase 2 data. Number of valid observations from treadmill test during last 2 minutes. Data must be annotated as within the annotated treadmill test period in last 2 minutes from participant's visit and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

No of valid obs during treadmill test data

Phase 2 data. Number of valid observations from treadmill test data. Data must be annotated as within the annotated treadmill test period from participant's visit; occur after time indicated in Time_excluded_beginTest and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

ValidHR_Time_p10

PA_Clinic category. Treadmill test: Time distribution of valid HR points (10th percentile)

Real

Time distribution of valid HR pts 10%ile treadmill test

Phase 2 data. Time distribution of valid HR points (10th percentile) -Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ValidHR_Time_p25

PA_Clinic category. Treadmill test: Time distribution of valid HR points (25th percentile)

Real

Time distribution of valid HR pts 25%ile treadmill test

Phase 2 data. Time distribution of valid HR points (25th percentile) -Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ValidHR_Time_p50

PA_Clinic category. Treadmill test: Time distribution of valid HR points (50th percentile)

Real

Time distribution of valid HR pts 50%ile treadmill test

Phase 2 data. Time distribution of valid HR points (50th percentile) -Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ValidHR_Time_p75

PA_Clinic category. Treadmill test: Time distribution of valid HR points (75th percentile)

Real

Time distribution of valid HR pts 75%ile treadmill test

Phase 2 data. Time distribution of valid HR points (75th percentile) -Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ValidHR_Time_p90

PA_Clinic category. Treadmill test: Time distribution of valid HR points (90th percentile)

Real

Time distribution of valid HR pts 90%ile treadmill test

Phase 2 data. Time distribution of valid HR points (90th percentile) -Treadmill Test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

walktest_maxtimelimit

PA_Clinic category. Treadmill test: Upper test time limit for deriving slow walk calibration (min)

Real

Upper test time slow walk calibrationrartion

Phase 2 data. Upper test time limit for deriving slow walk calibration (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

walktest_mintimelimit

PA_Clinic category. Treadmill test: Lower test time limit for deriving slow walk calibration (min)

Real

Lower test time slow walk calibration

Phase 2 data. Lower test time limit for deriving slow walk calibration (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept 1pt calibration walk test

Phase 2 data. Intercept used for 1pt calibration derived from walk test (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Beta-coefficient 1pt calibration walk test

Phase 2 data. Beta coefficient used for 1pt calibration derived from Walk test (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mean HRaS between 1 and 3 min

Phase 2 data. Mean heart rate above sleep (HRaS) between 1 and 3 min (used for 1pt calibration) for walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 120 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 120 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 150 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 150 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 180 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 180 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 210 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 210 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 240 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 240 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 270 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 270 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 300 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 300 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 30 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 30 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 330 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 330 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 360 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 360 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 390 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 390 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 420 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 420 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 60 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 60 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mdn trunk acceleration sec 90 of walk test

Phase 2 data. Median trunk acceleration m/s2; sec 90 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Sleep HR value used Walk test analysis

Phase 2 data. Sleeping heart rate used for walk test analysis. Usually derived from associated Free-living recording. If no Free-living recording present then Fenland 1 SHR may be used. If this is also not present then it may be estimated from Rest test. Whether sleeping heart rate has been estimated is indicated in the AH_COMMENTS and AH_FLAG_SHR variables.(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

Intercept of HRaS-PAEE mdn HR wlk

Phase 2 data. Intercept of HRaS-PAEE relationship using median HR during walk (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept of HRaS-PAEE wlk uncensored

Phase 2 data. Intercept of HRaS-PAEE relationship using median HR during t/walk (uncensored) (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Applied intercept of HRaS-PAEE wlk calibration

Phase 2 data. Applied intercept of HRaS-PAEE (est) relationship; walk calibration (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept of HRaS-PAEE regressioned HR wlk

Phase 2 data. Intercept of HRaS-PAEE relationship using regressed HR during walk (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept of HRaS-PAEE wlk calibration

Phase 2 data. Intercept of HRaS-PAEE (est) relationship; walk calibration (J/min/kg)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept regression mdn HR rectime 0-1min

Phase 2 data. Intercept; regression of median heart rate against rectime (0-1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Intercept regression mdn HR rectime 0-1.5min

Phase 2 data. Intercept; regression of median heart rate against rectime (0-1.5min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Methd to derive individual calibration fitness value walk test

Phase 2 data. Indication of which method has been used to derive individual calibration and fitness values for walk test. Median = 0; Regressed = 1. Median is default method; regressed is selected as alternative to deal with noisy HR or responses that are very different from reference (Measured/Derived from or related to Acitheart Monitor/Data )

Categorical

Square term regression mdn HR rectime 0-1min

Phase 2 data. Square term; regression of median heart rate against rectime (0-1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Square term regression mdn HR rectime 0-1.5min

Phase 2 data. Square term; regression of median heart rate against rectime (0-1.5min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Slope of HRaS-PAEE mdn HR wlk

Phase 2 data. Slope of HRaS-PAEE relationship using median HR during walk (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Slope of HRaS-PAEE wlk uncensored

Phase 2 data. Slope of HRaS-PAEE relationship using median HR during walk (uncensored)(J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Applied beta coefficient of HRaS-PAEE wlk calibration

Phase 2 data. Applied beta coefficient of HRaS-PAEE (est) relationship; walk calibration (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Slope of HRaS-PAEE regressioned HR wlk

Phase 2 data. Slope of HRaS-PAEE relationship using regressed HR during walk (J/kg/beat)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Beta coefficient of HRaS-PAEE wlk calibration

Phase 2 data. Beta coefficient of HRaS-PAEE (est) relationship; walk calibration (J/kg/beat) (Measured/Derived from or related to Acitheart Monitor/Data )

Real

Linear term regression mdn HR rectime 0-1min

Phase 2 data. Linear term; regression of median heart rate against rectime (0-1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Linear term regression mdn HR rectime 0-1.5min

Phase 2 data. Linear term; regression of median heart rate against rectime (0-1.5min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Protocol for walk test processing

Phase 2 data. Protocol used for walk test processing (Measured/Derived from or related to Acitheart Monitor/Data )

Text

Distance covered during walk test

Phase 2 data. Distance covered during walk test (metres)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE at 40bpm above sleep HR walk test 1pt calibration

Phase 2 data. Point; walk test 1-pt calibration curve: PAEE @ 40bpm above SHR (J/min/kg). Physical Activity energy expenditure at 40bpm above sleeping heart rate applied from the walk test using 1pt calibration.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE at 40bpm above sleeping HR walk test

Phase 2 data. Point; applied walk test calibration curve: PAEE @ 40bpm above SHR (J/min/kg). Physical Activity energy expenditure at 40bpm above sleeping heart rate applied from the walk test calibration curve.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fitness estimate derived from walk test

Phase 2 data. VO2max estimate (ml O2/min/kg). Fitness estimate derived from the Walk test. Estimate present if walk duration > = 1 and useable HR quality. Energy cost based on Ludlow 2016(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Flex HR derived from walk test

Phase 2 data. Flex heart rate that has been derived from the walk test (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Avg HRaS rolling mdn btwn min 1-3

Phase 2 data. Average heart rate above sleep (HRaS) from rolling median heart rate above sleep between min 1 and 3 during walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

AvgHRaS regressioned HRaS btwn min 1-3

Phase 2 data. Average heart rate above sleep (HRaS) from regressed heart rate above sleep between min 1 and 3 during walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 120 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 120 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 150 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 150 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 180 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 180 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 210 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 210 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 240 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 240 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 270 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 270 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 300 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 300 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 30 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 30 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 330 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 330 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 360 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 360 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 390 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 390 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 420 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 420 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 60 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 60 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HR above sleep sec 90 of walk test

Phase 2 data. Median heart rate above sleep bpm; sec 90 of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Start time of walk file

Phase 2 data. Real start time of walk test file (Actiheart monitor started recording)(Measured/Derived from or related to Acitheart Monitor/Data )

DateTime

Scaling HR acceptance zone for walk test recovery phase

Phase 2 data. Scaling HR acceptance zone for walk test recovery phase. Widening or narrowing of heart rate acceptance zone to aid cleaning and ensure only clean heart rate is included as much as possible(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Scaling HR acceptance zone walk test

Phase 2 data. Scaling HR acceptance zone for walk test phase. Widening or narrowing of heart rate acceptance zone to aid cleaning and ensure only clean heart rate is included as much as possible(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Shift of HR reference for recovery phase walk test

Phase 2 data. Shift of HR reference for rec phase of walk test (center of acceptance zone). Cleaning variable; indicates if the reference phase of heart which is deemed cleaned and useable has been shifted to ensure clean data only is included as much as possible. +10 indicates it have shifted up 10bpm (Measured/Derived from or related to Acitheart Monitor/Data )

Integer

Shift of HR reference for test phase walk test

Phase 2 data. Shift of HR reference for test phase of walk test (center of acceptance zone). Cleaning variable; indicates if the reference phase of heart which is deemed cleaned and useable has been shifted to ensure clean data only is included as much as possible. +10 indicates it have shifted up 10bpm (Measured/Derived from or related to Acitheart Monitor/Data )

Integer

PAEE age predicted max HR walk test 1pt calibration

Phase 2 data. Point; walk test 1-pt calibration curve: PAEE @ age-pred. max HR (J/min/kg). Physical Activity energy expenditure age-predicted maximum heart rate above sleeping heart rate applied from the walk test using 1pt calibration.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

PAEE at age predicted max HRaS walk test calibration

Phase 2 data. Point; applied walk test calibration curve: PAEE @ age-pred. max HR (J/min/kg). Physical Activity energy expenditure at age predicted maximum heart rate above sleeping heart rate applied from the walk test calibration curve.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Estimated max HR above sleep

Phase 2 data. Estimated maximum HR above sleep (HRaS) (208 - 0.7*age - shr - 20*betablocker) based on Tanaka equation (2001)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mean HRaS last minute of Walk test

Phase 2 data. Mean Heart Rate above Sleep during last minute of Walk test bpm(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Earliest time walk test lowest exercise HR occurs

Phase 2 data. Earliest time during walk test at which lowest exercise heart rate occurs (based on first derivative)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Peak running median HRaS last min walk test

Phase 2 data. Peak running median Heart Rate above Sleep (HRaS)during last min of Walk test bpm(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Peak running median HRaS Walk test

Phase 2 data. Peak running median Heart Rate above Sleep (HRaS) during Walk test bpm(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median est. PAI last 2min of walk test

Phase 2 data. Median estimated physical activity intensity during last 2 minutes of walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Median HRaS last 2min of walk test

Phase 2 data. Median heart rate above sleep (HRaS) during last 2min of walk test;(Measured/Derived from or related to Acitheart Monitor/Data )

Real

1-min recovery HRaS walk test global regression

Phase 2 data. 1-min recovery heart rate above sleep from walk test based on global regression (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

1-min recovery HRaS walk test 90-sec regression

Phase 2 data. 1-min recovery heart rate above sleep from walk test based on 90-sec regression (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

45sec rec HRaS Walk Test global regression

Phase 2 data. 45sec recovery heart rate above sleep from walk test based on global regression (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

45sec rec HRaS Walk Test 60sec regression

Phase 2 data. 45sec recovery heart rate above sleep from walk test based on 60sec regression (beats/min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Duration of walk test recovery phase

Phase 2 data. Duration of walk test recovery phase (min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Mean HRaS TimeRisePoint +/-.25min

Phase 2 data. Mean heart rate above sleep (HRaS) at TimeRisePoint (+/-.25min) from walk test (Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error term residual regression of test-recovery phases(1stpass)

Phase 2 data. Error term; residual regression of test and recovery phases (1st pass)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error term regression mdn HR rectime 0-1min

Phase 2 data. Error term; regression of median heart rate against rectime (0-1 min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error term regression mdn HR rectime 0-1.5min

Phase 2 data. Error term; regression of median heart rate against rectime (0-1.5 min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error term regression mdn HR test time omit frst 1min

Phase 2 data. Error term; regression of median heart rate against testtime (omit first 1min)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Error term residual regression of test-recovery phases(2ndpass)

Phase 2 data. Error term; residual regression of test and recovery phases (2nd pass)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Walking speed during walk test

Phase 2 data. Walking speed during walk test (km/hr). This has been calculated using distance (km) divided by duration of test (hrs)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Data type monitor used walk test

Phase 2 data. Variable defines which type of data from the monitor has been able to be used for walk test calibration. GREEN indicates high quality HR data available and so full ibi data from Actiheart could be used for calibration. ORANGE indicates lower quality heart data available from Actiheart and so alternative heart rate from Polar monitor has been manually inputted into file(Measured/Derived from or related to Acitheart Monitor/Data )

Text

Date of Walk test

Phase 2 data. Date of Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Date

Start time of walk test

Phase 2 data. Real start time of actual walk test; calibration protocol noted in WALK_calibration_protocol(Measured/Derived from or related to Acitheart Monitor/Data )

DateTime

Duration of Walk Test completed

Phase 2 data. Duration of Walk Test completed (min); varies per participant(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Latest time walk test lowest exercise HR occurs

Phase 2 data. Latest time during walk test at which lowest exercise heart rate occurs (based on first derivative)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time after beginning of walk test

Phase 2 data. Time after beginning of walk test beyond which observations are included(Measured/Derived from or related to Acitheart Monitor/Data )

Real

No of valid obs during walk test recovery

Phase 2 data. Number of valid observations during walk test recovery phase. Data must be annotated as within the annotated walk test recovery period from participants' visit; be between 0-90sec within that phase and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

No of valid observations walk test data

Phase 2 data. Number of valid observations from walk test data. Data must be annotated as within the annotated walk test period from participant's visit; occur after time indicated in WALK_Time_excluded_beginTest and not have been masked out as noisy during cleaning stage(Measured/Derived from or related to Acitheart Monitor/Data )

Integer

Time distribution of valid HR 10th percentile

Phase 2 data. Time distribution of valid HR points (10th percentile) - Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time distribution of valid HR 25th percentile

Phase 2 data. Time distribution of valid HR points (25th percentile) - Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time distribution of valid HR 50th percentile

Phase 2 data. Time distribution of valid HR points (50th percentile) - Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time disttribution of valid HR 75th percentile

Phase 2 data. Time distribution of valid HR points (75th percentile) - Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Time distribution of valid HR 90th percentile

Phase 2 data. Time distribution of valid HR points (90th percentile) - Walk test(Measured/Derived from or related to Acitheart Monitor/Data )

Real

weighted_obs

PA_FREE_LIVING category. Time integral of wear probability in recording in minutes.

Real

Obs Pwear indicated being worn

Phase 2 data. Number of observations where probability of wear is indicated as being worn (unit is dependant on intermediate time resolution)(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Weight (kg)

Phase 2 data. Weight (kg) used in all physical activity estimates

Real

X_2minLag

PA_FREE_LIVING category. Branch model acceleration threshold for 2-min movement lag for diverting obs into 0% HR / 100% ACC weighting (m/s2)

Real

Acceleration 2 Min lag

Phase 2 data. Threshold for acceleration for 2mins at which point observations are diverted into branch box 5(Measured/Derived from or related to Acitheart Monitor/Data )

Real

None

Reason for failing sample: 1=Assaynotes: EXCLUDE SAMPLE FROM ADAT; 2=scaling factor < 0.25 or > 4; 3=ANML fraction used < 30percent

Integer

Reason for failing sample

Phase 2 data. Reason for failing sample: 1 = Assaynotes: EXCLUDE SAMPLE FROM ADAT; 2 = scaling factor < 0.25 or > 4; 3 = ANML fraction used < 30%

Integer

None

Reason for flaging sample: 1=scaling factor <0.4 or > 2.5

Integer

Reason for flaging sample

Phase 2 data. Reason for flaging sample: 1=scaling factor <0.4 or > 2.5

Integer

OLINK assay QDPR

Phase 1 OLINK assay data for target QDPR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay QPCT

Phase 1 OLINK assay data for target QPCT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Questionnaires completed

Has volunteer completed the questionnaires? Used by study admin only.

Questionnaires completed

Phase 2 data. Questionnaires Complete? 0 = no; 1 = yes;

Categorical

QVersion_CLEAN

Data in variable RPAQ_Qversion as cleaned by data management team where free text was changed to codes.

Text

Questionnaire version

Phase 2 data. Data in variable RPAQ_Qversion as cleaned by data management team where free text was changed to codes. 8 = Version 8 29/09/2004; 9 = FEN_RPAQ_9.1_05/05/2007

Text

ACC_INT_0

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 0.00 m/s2

Real

Fraction of time spent< = 0 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 0 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_1

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 0.075 m/s2

Real

ACC_INT_10

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 2.25 m/s2. Data not compatible with same R6 variable with prefix P.

Real

Fraction time spent< = 2.25 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 2.25 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_11

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 2.50 m/s2. Data not compatible with same R6 variable with prefix P.

Real

Fraction time spent< = 2.5 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 2.5 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_12

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 2.75 m/s2. Data not compatible with same R6 variable with prefix P.

Real

Fraction time spent< = 2.75 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 2.75 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_13

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.00 m/s2. Data not compatible with same R6 variable with prefix P.

Real

Fraction of time spent< = 3 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 3 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_14

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.25 m/s2. Data not compatible with same R6 variable with prefix P.

Real

Fraction time spent< = 3.25 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 3.25 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_15

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.50 m/s2. Data not compatible with same R6 variable with prefix P.

Real

Fraction time spent< = 3.5 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 3.5 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_16

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 3.75 m/s2

Real

Fraction time spent< = 3.75 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 3.75 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_17

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.00 m/s2

Real

Fraction of time spent< = 4 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 4 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_18

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.25 m/s2

Real

Fraction time spent< = 4.25 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 4.25 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_19

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.50 m/s2

Real

Fraction time spent< = 4.5 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 4.5 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = .075 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = .075 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_2

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 0.25 m/s2

Real

ACC_INT_20

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 4.75 m/s2

Real

Fraction time spent< = 4.75 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 4.75 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_21

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 5.00 m/s2

Real

Fraction of time spent< = 5 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 5 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_22

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 6.00 m/s2

Real

Fraction of time spent< = 6 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 6 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_23

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 7.00 m/s2

Real

Fraction of time spent< = 7 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 7 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_24

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 8.00 m/s2

Real

Fraction of time spent< = 8 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 8 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_25

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 9.00 m/s2

Real

Fraction of time spent< = 9 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 9 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = .25 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = .25 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_3

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 0.50 m/s2

Real

Fraction of time spent< = .5 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = .5 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_4

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 0.75 m/s2

Real

Fractionof time spent< = .75 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = .75 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_5

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 1.00 m/s2

Real

Fraction of time spent< = 1 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 1 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_6

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 1.25 m/s2

Real

Fraction time spent< = 1.25 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 1.25 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_7

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 1.50 m/s2

Real

Fraction time spent< = 1.5 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 1.5 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_8

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 1.75 m/s2

Real

Fraction time spent< = 1.75 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 1.75 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

ACC_INT_9

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 2.00 m/s2

Real

Fraction of time spent< = 2 m/s2 acceleration only

Phase 2 data. Fraction of time spent < = 2 m/s2. Based on acceleration only signal using Pwear from combined estimate(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat0

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 1.00 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 1MET highlC

Phase 2 data. Fraction of time spent < = 1 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat1

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 1.25 METs (highest avail. IC lvl Branch model RMR denominator)

Real

INT_MET_highIC_BRANCH_cat10

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.50 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 3.5MET highlC

Phase 2 data. Fraction of time spent < = 3.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat11

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.75 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 3.75MET highlC

Phase 2 data. Fraction of time spent < = 3.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat12

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.00 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 4MET highlC

Phase 2 data. Fraction of time spent < = 4 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat13

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.25 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 4.25MET highlC

Phase 2 data. Fraction of time spent < = 4.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat14

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.50 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 4.5MET highlC

Phase 2 data. Fraction of time spent < = 4.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat15

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.75 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 4.75MET highlC

Phase 2 data. Fraction of time spent < = 4.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat16

PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 5.00 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 5MET highlC

Phase 2 data. Fraction of time spent < = 5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat17

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 5.25 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 5.25MET highlC

Phase 2 data. Fraction of time spent < = 5.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat18

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 5.50 METs (highest avail. IC lvl Branch model RMR denominator). Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 5.5MET highlC

Phase 2 data. Fraction of time spent < = 5.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat19

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 5.75 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 5.75MET highlC

Phase 2 data. Fraction of time spent < = 5.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.25MET highlC

Phase 2 data. Fraction of time spent < = 1.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat2

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 1.50 METs (highest avail. IC lvl Branch model RMR denominator)

Real

INT_MET_highIC_BRANCH_cat20

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 6.00 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 6MET highlC

Phase 2 data. Fraction of time spent < = 6 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat21

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 7.00 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 7MET highlC

Phase 2 data. Fraction of time spent < = 7 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat22

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 8.00 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 8MET highlC

Phase 2 data. Fraction of time spent < = 8 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat23

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 9.00 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 9MET highlC

Phase 2 data. Fraction of time spent < = 9 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat24

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 10.00 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 10MET highlC

Phase 2 data. Fraction of time spent < = 10 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat25

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 11.00 METs (highest avail. IC lvl Branch model RMR denominator).

Real

% tme spnt <= 11MET highlC

Phase 2 data. Fraction of time spent < = 11 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.05MET highlC

Phase 2 data. Fraction of time spent < = 1.05 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.125MET highlC

Phase 2 data. Fraction of time spent < = 1.125 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.5MET highlC

Phase 2 data. Fraction of time spent < = 1.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat3

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 1.75 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 1.75MET highlC

Phase 2 data. Fraction of time spent < = 1.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat4

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.00 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 2MET highlC

Phase 2 data. Fraction of time spent < = 2 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat5

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.25 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 2.25MET highlC

Phase 2 data. Fraction of time spent < = 2.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat6

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.50 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 2.5MET highlC

Phase 2 data. Fraction of time spent < = 2.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat7

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.75 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 2.75MET highlC

Phase 2 data. Fraction of time spent < = 2.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat8

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 3.00 METs (highest avail. IC lvl Branch model RMR denominator)

Real

% tme spnt <= 3MET highlC

Phase 2 data. Fraction of time spent < = 3 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_MET_highIC_BRANCH_cat9

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 3.25 METs (highest avail. IC lvl Branch model RMR denominator) Data not compatible with same R6 variable with prefix P.

Real

% tme spnt <= 3.25MET highlC

Phase 2 data. Fraction of time spent < = 3.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate calculation individualised for each person from the Oxford2005 equation.(Measured/Derived from or related to Acitheart Monitor/Data )

Real

INT_stdMET_highIC_BRANCH_cat0

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 1.00 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat1

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 1.25 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat10

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.50 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat11

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 3.75 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat12

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.00 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat13

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.25 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat14

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.50 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat15

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 4.75 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat16

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category. Fraction of time spent <= 5.00 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat17

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 5.25 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat18

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 5.50 METs (highest avail. IC lvl Branch model std MET denominator). Data not compatible with same R6 variable with prefix P.

Real

INT_stdMET_highIC_BRANCH_cat19

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 5.75METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat2

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 1.50 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat20

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 6.00 METs (highest avail. IC lvl Branch model std MET denominator).

Real

INT_stdMET_highIC_BRANCH_cat21

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 7.00 METs (highest avail. IC lvl Branch model std MET denominator).

Real

INT_stdMET_highIC_BRANCH_cat22

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 8.00 METs (highest avail. IC lvl Branch model std MET denominator).

Real

INT_stdMET_highIC_BRANCH_cat23

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 9.00 METs (highest avail. IC lvl Branch model std MET denominator).

Real

INT_stdMET_highIC_BRANCH_cat24

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 10.0 METs (highest avail. IC lvl Branch model std MET denominator).

Real

INT_stdMET_highIC_BRANCH_cat25

PA_Intensity and PA_FREE_LIVING category. New in R7. Fraction of time spent <= 11.0 METs (highest avail. IC lvl Branch model std MET denominator).

Real

INT_stdMET_highIC_BRANCH_cat3

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 1.75 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat4

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.00 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat5

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.25 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat6

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.50 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat7

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 2.75 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat8

PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 3.00 METs (highest avail. IC lvl Branch model std MET denominator)

Real

INT_stdMET_highIC_BRANCH_cat9

Definition changed for R7. PA_Intensity and PA_FREE_LIVING category.Fraction of time spent <= 3.25 METs (highest avail. IC lvl Branch model std MET denominator)

Real

% tme spnt <= 1MET std highlC

Phase 2 data. Fraction of time spent < = 1 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 3.5MET std highlC

Phase 2 data. Fraction of time spent < = 3.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 3.75MET std highlC

Phase 2 data. Fraction of time spent < = 3.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 4MET std highlC

Phase 2 data. Fraction of time spent < = 4 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 4.25MET std highlC

Phase 2 data. Fraction of time spent < = 4.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 4.5MET std highlC

Phase 2 data. Fraction of time spent < = 4.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 4.75MET std highlC

Phase 2 data. Fraction of time spent < = 4.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 5MET std highlC

Phase 2 data. Fraction of time spent < = 5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 5.25MET std highlC

Phase 2 data. Fraction of time spent < = 5.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 5.5MET std highlC

Phase 2 data. Fraction of time spent < = 5.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 5.75 METs using highlC

Phase 2 data. Fraction of time spent < = 5.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.25MET std highlC

Phase 2 data. Fraction of time spent < = 1.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 6 METs using highlC

Phase 2 data. Fraction of time spent < = 6 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 7 METs using highlC

Phase 2 data. Fraction of time spent < = 7 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 8 METs using highlC

Phase 2 data. Fraction of time spent < = 8 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 9 METs using highlC

Phase 2 data. Fraction of time spent < = 9 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 10 METs using highlC

Phase 2 data. Fraction of time spent < = 10 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 11 METs using highlC

Phase 2 data. Fraction of time spent < = 11 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 1.05 METs using highlC

Phase 2 data. Fraction of time spent < = 1.05 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

Fraction time spent< = 1.125 METs using highlC

Phase 2 data. Fraction of time spent < = 1.125 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.5MET std highlC

Phase 2 data. Fraction of time spent < = 1.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 1.75MET std highlC

Phase 2 data. Fraction of time spent < = 1.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 2MET std highlC

Phase 2 data. Fraction of time spent < = 2 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 2.25MET std highlC

Phase 2 data. Fraction of time spent < = 2.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 2.5MET std highlC

Phase 2 data. Fraction of time spent < = 2.5 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 2.75MET std highlC

Phase 2 data. Fraction of time spent < = 2.75 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 3MET std highlC

Phase 2 data. Fraction of time spent < = 3 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

% tme spnt <= 3.25MET std highlC

Phase 2 data. Fraction of time spent < = 3.25 METs using the highest available calibration level. Priority order of calibration levels is multi-point treadmill (B2); 1pt treadmill (B6); 1pt self paced walk (B8) and group equation (B7). Present for all those who have a valid free-living file i.e file present; no corruptions deemed to affect combined acc and heart rate estimate and >20hrs Pwear. This variable uses the resting metabolic rate as defined in STANDARD_MET and is the same for every individual(Measured/Derived from or related to Acitheart Monitor/Data )

Real

OLINK assay RAGE

Phase 1 OLINK assay data for target RAGE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RARRES1

Phase 1 OLINK assay data for target RARRES1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RARRES2

Phase 1 OLINK assay data for target RARRES2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RASA1

Phase 1 OLINK assay data for target RASA1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Rash Reported

Tick box only manually entered when reported a rash received from electrodes used with ActiHeart monitor

Categorical

Rash reported from wearing monitor

Phase 2 data. Rash reported by participant from wearing monitor? For use by study coordination and PA teams. Not for analysis. 0 = no; 1 = yes;

Categorical

OLINK assay RASSF2

Phase 1 OLINK assay data for target RASSF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RBKS

Phase 1 OLINK assay data for target RBKS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RCOR1

Phase 1 OLINK assay data for target RCOR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Recovered Epochs

Total number of recovered epochs during free living (first wear of Actiheart only). For quality of trace information.

Red Blood Cell Count

A Red Blood Cell (RBC) count is a blood test that measures the number of red blood cells in a specific volume of blood; typically expressed as x10^12/L (10 to the power of 12 per liter. Red blood cells contain hemoglobin; which is responsible for carrying oxygen from the lungs to the rest of the body. Normal Ranges are Men: 4.0 - 5.9 x 10^12/L and Women: 3.8 - 5.2 x 10^12/L.

Real

REE

Resting Energy Expenditure during AH free living (REE) - Average daily estimated resting energy expenditure calculated via Schofield equation in kcal/day.

Integer

JaegerDevice_ID

New in R8. Jaeger device used for REE measurement

Text

Masked Breaths in last 120s

New in R8. Breaths in last 120s of REE measurement masked during QC process. Includes mistriggers; and breaths which are physiologically implausible; non-representative or unstable.

Integer

AtmosphericPressure

New in R8. Mean atmospheric pressure during REE measurement as assessed by Jaeger device. Millibars.

Integer

AmbientTemperature

New in R8. Mean ambient temperature during REE measurement as assessed by Jaeger device. Degrees Celcius.

Integer

OK Breaths in last 120s

New in R8. Breaths in last 120s of REE measurement remaining after QC process. Includes valid; stable breaths representative of underlying metabolism. These breaths are used to calculate mean VO2; VCO2; REE and RER

Integer

REE during AH free living

Phase 2 data. Resting Energy Expenditure during AH free living (REE) - Average daily estimated resting energy expenditure calculated vigorous intensity activity Schofield equation in kcal/day. For participant feedback only. Not for analysis

Real

Proportion OK Breaths in last 120s

New in R8. Proportion of total breaths in last 120s of REE measurement remaining after QC process. = ree_ok_breaths_last120s / (ree_ok_breaths_last120s + ree_masked_breaths_last120s)

Real

Resting Energy Expenditure

New in R8. Resting energy expenditure derived using mean VO2 and VCO2 over last 120s. Calculated using Abbreviated Weir Formula; REE = 1.44(3.9VO2 + 1.1VCO2). Kcal/day

Real

Respiratory Exchange Ratio

New in R8. Respiratory Exchange Ratio derived using mean VO2 and VCO2 over last 120s. RER = VCO2 / VO2. Ratio

Real

TestSite

New in R8. Field Location where REE measurement undertaken

Text

DateofTest

New in R8. Date of REE measurement as exported from Jaeger device

Date

TestDuration

New in R8. Duration of full REE measurement based on Jaeger export. Seconds.

Integer

Mean VCO2 over last 120s

New in R8. Mean VCO2 (CO2 production) over last 120s of REE measurement based on breaths passing QC process. Derived by breath by Jaeger device and averaged over OK breaths in last 120s. mL/kg/min

Real

Mean VO2 over last 120s

New in R8. Mean VO2 (O2 consumption) over last 120s of REE measurement based on breaths passing QC process. Derived by breath by Jaeger device and averaged over OK breaths in last 120s. mL/kg/min

Real

OLINK assay REG1A

Phase 1 OLINK assay data for target REG1A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay REG3A

Phase 1 OLINK assay data for target REG3A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay REG4

Phase 1 OLINK assay data for target REG4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RELT

Phase 1 OLINK assay data for target RELT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay REN

Phase 1 OLINK assay data for target REN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Repeat Appointment Declined

Has the repeat appointment been declined?

Repeat Appointment Declined

Phase 2 data. Flag to show if Repeat OGTT appointment was declined by the participant . 0 = no; 1 = yes;

Categorical

None

Name of file with repeat data.

Repeat Glucose 0 minutes

Repeat Glucose measurement taken at 0 minutes in mmol/l

Real

Repeat Glucose 0 minutes

Phase 2 data. Repeat Glucose measurement taken at 0 minutes in mmol/l

Real

Repeat Glucose 120 minutes

Repeat Glucose measurement taken at 120 minutes in mmol/l

Real

Repeat Glucose 120 minutes

Phase 2 data. Repeat Glucose measurement taken at 120 minutes in mmol/l

Real

Repeat GP Letter Sent

Repeat General Practionars Letter Sent

Repeat GP Letter Sent

Phase 2 data. Date Repeat General Practionars Letter Sent

Date

None

Date of repeat import.

None

Has the repeat data been imported

Repeat Glucose Imported

Phase 2 data. Repeat Glucose data imported. 0 = no; 1 = yes;

Categorical

Repeat appointment Needed

Phase 2 data. Flag to show if Repeat OGTT appointment was suggested for the participant . 0 = no; 1 = yes;

Categorical

None

Has report page been entered?

Report Page Entered

Phase 2 data. Report Page Entered? From Study database

Categorical

ResearcherNote

Any additional comments made om data used for postcode and work-home distance cleaning and on methods used.

Text

Resting Heart Rate

Resting Heart Rate (Recording observed during minute 4 of rest test) in beats/min

Integer

Resting heart rate feedback only

Phase 2 data. Resting heart rate For participant feedback only. Not for analysis

Integer

Rest Start

Real start time for the rest test. Hrs:Mins:Secs

Time

Rest Start Time

Phase 2 data. Real start time for the rest test. Hrs:Mins:Secs

Time

Results admin comments

Comment provided on the (quality of) results produced reason results are missing factors influencing results etc.

Text

Result Status

Phase 2 data. Status of Results entry in study database. 0 = Initial data incomplete;1 = 1st GP letter pending;2 = Repeat data incomplete;3 = 2nd GP letter pending;4 = Report data incomplete;5 = Report pending;6 = Only Admin/US left;7 = Finished;

Categorical

Retrospective Consent Form version

Retrospective Consent Form version number. A retrospective consent form was only sent out to any participant who'd signed Consent form version 1.2 since that only contained statements 1-7 not 8 and 9.

Text

Retrospective Consent Form version date

Retrospective Consent Form version date. A retrospective consent form was only sent out to any participant who'd signed Consent form version 1.2 since that only contained statements 1-7 not 8 and 9.

Date

OLINK assay RETN

Phase 1 OLINK assay data for target RETN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

RetroConsentCompl

Retrospective consent letter complete (all items filled in). A Retrospective consent letter was needed for those participants who'd completed one of the earlier consent forms which did not cover consent for 8) to keep in touch and for follow up and 9) allowing access to medical records. Data entered by study coordination on manuakl review of retrospective consent form.

Categorical

RetroConsentLetterDate

Retrospective consent letter date. A Retrospective consent letter was needed for those participants who'd completed one of the earlier consent forms which did not cover consent for 8) to keep in touch and for follow up and 9) allowing access to medical records. Data entered into Study access db by study coordination

Categorical

RetroConsentReplyDate

Retrospective consent reply date. A Retrospective consent letter was needed for those participants who'd completed one of the earlier consent forms which did not cover consent for 8) to keep in touch and for follow up and 9) allowing access to medical records. Data entered into Study access db by study coordination

OLINK assay RET

Phase 1 OLINK assay data for target RET in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

RetroConsentSignMissing

Retrospective consent signatures missing. A Retrospective consent letter was needed for those participants who'd completed one of the earlier consent forms which did not cover consent for 8) to keep in touch and for follow up and 9) allowing access to medical records. No entry if none missing. Data entered into Study access db by study coordination on manual review of retrospective consent form.

Text

OLINK assay RGMA

Phase 1 OLINK assay data for target RGMA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RGMB

Phase 1 OLINK assay data for target RGMB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RGS8

Phase 1 OLINK assay data for target RGS8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RNASE3

Phase 1 OLINK assay data for target RNASE3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RNF31

Phase 1 OLINK assay data for target RNF31 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ROBO1

Phase 1 OLINK assay data for target ROBO1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ROBO2

Phase 1 OLINK assay data for target ROBO2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ROR1

Phase 1 OLINK assay data for target ROR1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Normalization acceptance criteria for all row scale factors

Real

Normalization acceptance criteria for all row scale factors

Phase 2 data. Normalization acceptance criteria for all row scale factors

Text

Hours of Rowing

Please indicate the average length of time (in hours) you spent doing the activity per episode. Rowing.

Integer

Hours of Rowing CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Rowing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Rowing hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Rowing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Rowing hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Rowing. -1 = left blank. DO NOT USE THIS VARIABLE. Use rowingHr_CLEAN_P2 instead.

Real

Minutes of Rowing

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Rowing.

Integer

Minutes of Rowing CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Rowing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Rowing min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Rowing. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Rowing min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Rowing. -1 = left blank. DO NOT USE THIS VARIABLE. Use rowingMin_CLEAN_P2 instead.

Real

Frequency of Rowing CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

rowing_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Rowing

Real

Cln variable: Rowing

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

rowing_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. Data normalised to DE template 1 data.

Categorical

Rowing

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. DO NOT USE THIS VARIABLE. Use rowing_CLEAN_P2 instead.

Real

Rowing

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Rowing DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in rowing_T2. Instead use rowing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Rowing DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Rowing. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in rowing_T1. Instead use rowing_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

RPAQ raw data Comments

Comments made on the RPAQ form.

Text

None

Day RPAQ received

Categorical

None

Month RPAQ received

Categorical

None

Year RPAQ received

Categorical

RPAQ_DE_TemplateType

New in R7. RPAQ Data entry template used. If version 1 was used the data entry company was asked to code the recreation variables (RPAQ section C) using codes 2-3-4-5-6 or 7 for options 2 to 7 in the list of 7 options. For version 2 they were asked to code them with codes 3-4-5-6-7 or 8 instead. This variable needs to be used alongside the raw RPAQ data to determine exact meaning of codes entered for these variables.

Categorical

DE_TemplateType_Used

New in R7. Indication of which RPAQ Data entry type (1 or 2) was used in the cleaning of the data. Since all raw RPAW data was normalised prior to data cleaning (either by the DM team or the PA team) this sh9ould be 1 for all data.

Categorical

None

RPAQ derived data Data Management Comment

Text

RPAQ_Qversion

Version number of the RPAQ form completed by the participant.

Categorical

OLINK assay RPS6KB1

Phase 1 OLINK assay data for target RPS6KB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RRM2B

Phase 1 OLINK assay data for target RRM2B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RSPO1

Phase 1 OLINK assay data for target RSPO1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RSPO3

Phase 1 OLINK assay data for target RSPO3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay RTN4R

Phase 1 OLINK assay data for target RTN4R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Reaction time go trials (food)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Median reaction time across all Go Trials for food stimuli in the Food Go/No-Go with Affective Shifting task.

Real

Reaction time go trials (neutral)

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Median reaction time across all Go Trials for neutral stimuli in the Food Go/No-Go with Affective Shifting task.

Real

OLINK assay S100A11

Phase 1 OLINK assay data for target S100A11 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay S100A4

Phase 1 OLINK assay data for target S100A4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay S100P

Phase 1 OLINK assay data for target S100P in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SAA4

Phase 1 OLINK assay data for target SAA4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Sailing Wind-Surfing Or Boating CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Sailing Wind-Surfing Or Boating. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding) . And then -10 errors cleaned by PA team.

Integer

Hours of Sailing Wind-Surfing Or Boating

Please indicate the average length of time (in hours) you spent doing the activity per episode. Sailing Wind-Surfing Or Boating.

Integer

Cln variable: Sailing hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode.Sailing windsurfing or boating. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Sailing wind-surfing or boating hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Sailing Wind-Surfing Or Boating. -1 = left blank. DO NOT USE THIS VARIABLE. Use sailingWindsurfBoatingHr_CLEAN_P2 instead.

Real

Minutes of Sailing Wind-Surfing Or Boating

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Sailing Wind-Surfing Or Boating.

Integer

Cln variable: Sailing min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Sailing windsurfing or boating. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Sailing wind-surfing or boating min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Sailing Wind-Surfing Or Boating. -1 = left blank. DO NOT USE THIS VARIABLE. Use sailingWindsurfBoatingMin_CLEAN_P2 instead.

Real

Cln variable: Sailing

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing windsurfing or boating. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

sailingWindsurfBoating_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing Wind-Surfing Or Boating. Data normalised to DE template 1 data.

Categorical

Sailing wind-surfing or boating

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing wind-surfing or boating. DO NOT USE THIS VARIABLE. Use sailingWindsurfBoating_CLEAN_P2 instead.

Real

Sailing Wind-Surfing or Boating

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing Wind-Surfing Or Boating. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Sailing Wind-Surfing Or Boating DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing Wind-Surfing Or Boating. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in sailingWindsurfBoating_T2. Instead use sailingWindsurfBoating_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Sailing Wind-Surfing Or Boating DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing Wind-Surfing Or Boating. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in sailingWindsurfBoating_T1. Instead use sailingWindsurfBoating_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Minutes of Sailing Wind-Surfing Or Boating CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Sailing Wind-Surfing Or Boating. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding) . And then -10 errors cleaned by PA team.

Integer

Frequency of Sailing Wind-Surfing Or Boating CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Sailing Wind-Surfing Or Boating. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

sailingWindsurfBoat_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Sailing Wind-Surfing Or Boating

Real

None

Supplemental sample information

Real

Supplemental sample information

Phase 2 data. Supplemental sample information

Text

Sample Dispatch Time

Phase 2 data. Time of sample dispatch

Text

None

Assay team sample observation

Real

Assay team sample observation

Phase 2 data. Assay team sample observation

Text

None

Sample or QC; Calibrator; Buffer

Real

Sample or QC; Calibrator; Buffer

Phase 2 data. Sample or QC; Calibrator; Buffer

Real

None

Has Fenland study sample checklist been completed? Data entered into Study access db by study coordination on manual review of sample checklist.

Sarcosine_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Sarcosine_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_031.

Real

OLINK assay SCAMP3

Phase 1 OLINK assay data for target SCAMP3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

ID of Scanner used to analyze slide

Real

ID of Scanner used to analyze slide

Phase 2 data. ID of Scanner used to analyze slide

Text

OLINK assay SCARA5

Phase 1 OLINK assay data for target SCARA5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCARB2

Phase 1 OLINK assay data for target SCARB2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCARF1

Phase 1 OLINK assay data for target SCARF1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCARF2

Phase 1 OLINK assay data for target SCARF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCF

Phase 1 OLINK assay data for target SCF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCF

Phase 1 OLINK assay data for target SCF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCF

Phase 1 OLINK assay data for target SCF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCGB1A1

Phase 1 OLINK assay data for target SCGB1A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCGB3A1

Phase 1 OLINK assay data for target SCGB3A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SCGB3A2

Phase 1 OLINK assay data for target SCGB3A2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

SCOREAERO

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREBAKPAK

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREBOWL

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREBOX

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECAR

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECOMMUTE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECOMP

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECOMRUN

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECRICK

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECYCLE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECYCPLE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORECYCRAC

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREDANCE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREDIG

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREDIY

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREEXER

SCOREEXER. Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREFISH

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREFLOOR

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREFOOT

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREGOLF

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREHOME

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREHORSE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREJOB

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREJOG

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORELAPSWI

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORELAWN

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORELEIS

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORELESSWI

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREMUSIC

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORENET

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREPUBLIC

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREROW

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORESAIL

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORESKATE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORESNOOK

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORESQUASH

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORESTAIRS

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORESTEP

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORETABTEN

SCORETABTEN. Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORETENBAD

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORETV

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREWALK

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREWALKPLEASURE

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREWATER

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREWEED

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCOREWGHT

Derived Intermediate not for general release. Data can be provided if necessary.

Real

SCORE_UNACCOUNTED

Derived Intermediate not for general release. Data can be provided if necessary.

Real

OLINK assay SDC4

Phase 1 OLINK assay data for target SDC4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

SDMA_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SDMA_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_024.

Real

SEDtime

Time spent sedentary excluding sleep (hrs/d)

Real

SED_INTENSITY

Sedentary behavior energy expenditure (METhrs/d)

Real

OLINK assay SELE

Phase 1 OLINK assay data for target SELE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SELL

Phase 1 OLINK assay data for target SELL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SELP

Phase 1 OLINK assay data for target SELP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SEMA3F

Phase 1 OLINK assay data for target SEMA3F in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SEMA4C

Phase 1 OLINK assay data for target SEMA4C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SEMA7A

Phase 1 OLINK assay data for target SEMA7A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Aptamer SeqId:10000-28;Target:CRBB2;UniProt:P43320

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10000-28;Target: CRBB2;UniProt: P43320;TargetFullName: Beta-crystallin B2;Organisim: human;Apparent_Kd_M: 1.238894E-10

Real

Aptamer SeqId: 10000-28 | Target: CRBB2 | UniProt: P43320

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10000-28 | Target: CRBB2 | UniProt: P43320 | TargetFullName: Beta-crystallin B2 | Organisim: human | Apparent_Kd_M: 1.238894E-10

Real

Aptamer SeqId:10001-7;Target:c-Raf;UniProt:P04049

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10001-7;Target: c-Raf;UniProt: P04049;TargetFullName: RAF proto-oncogene serine/threonine-protein kinase;Organisim: human;Apparent_Kd_M: 1.176058E-11

Real

Aptamer SeqId: 10001-7 | Target: c-Raf | UniProt: P04049

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10001-7 | Target: c-Raf | UniProt: P04049 | TargetFullName: RAF proto-oncogene serine/threonine-protein kinase | Organisim: human | Apparent_Kd_M: 1.176058E-11

Real

Aptamer SeqId:10003-15;Target:ZNF41;UniProt:P51814

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10003-15;Target: ZNF41;UniProt: P51814;TargetFullName: Zinc finger protein 41;Organisim: human;Apparent_Kd_M: 4.333333E-11

Real

Aptamer SeqId: 10003-15 | Target: ZNF41 | UniProt: P51814

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10003-15 | Target: ZNF41 | UniProt: P51814 | TargetFullName: Zinc finger protein 41 | Organisim: human | Apparent_Kd_M: 4.333333E-11

Real

Aptamer SeqId:10006-25;Target:ELK1;UniProt:P19419

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10006-25;Target: ELK1;UniProt: P19419;TargetFullName: ETS domain-containing protein Elk-1;Organisim: human;Apparent_Kd_M: 3.372673E-12

Real

Aptamer SeqId: 10006-25 | Target: ELK1 | UniProt: P19419

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10006-25 | Target: ELK1 | UniProt: P19419 | TargetFullName: ETS domain-containing protein Elk-1 | Organisim: human | Apparent_Kd_M: 3.372673E-12

Real

Aptamer SeqId:10008-43;Target:GUC1A;UniProt:P43080

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10008-43;Target: GUC1A;UniProt: P43080;TargetFullName: Guanylyl cyclase-activating protein 1;Organisim: human;Apparent_Kd_M: 5.2627E-11

Real

Aptamer SeqId: 10008-43 | Target: GUC1A | UniProt: P43080

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10008-43 | Target: GUC1A | UniProt: P43080 | TargetFullName: Guanylyl cyclase-activating protein 1 | Organisim: human | Apparent_Kd_M: 5.2627E-11

Real

Aptamer SeqId:10011-65;Target:OCRL;UniProt:Q01968

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10011-65;Target: OCRL;UniProt: Q01968;TargetFullName: Inositol polyphosphate 5-phosphatase OCRL-1;Organisim: human;Apparent_Kd_M: 7.245927E-11

Real

Aptamer SeqId: 10011-65 | Target: OCRL | UniProt: Q01968

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10011-65 | Target: OCRL | UniProt: Q01968 | TargetFullName: Inositol polyphosphate 5-phosphatase OCRL-1 | Organisim: human | Apparent_Kd_M: 7.245927E-11

Real

Aptamer SeqId:10012-5;Target:SPDEF;UniProt:O95238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10012-5;Target: SPDEF;UniProt: O95238;TargetFullName: SAM pointed domain-containing Ets transcription factor;Organisim: human;Apparent_Kd_M: 1.347432E-10

Real

Aptamer SeqId: 10012-5 | Target: SPDEF | UniProt: O95238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10012-5 | Target: SPDEF | UniProt: O95238 | TargetFullName: SAM pointed domain-containing Ets transcription factor | Organisim: human | Apparent_Kd_M: 1.347432E-10

Real

Aptamer SeqId:10013-34;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10013-34;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.95E-10

Real

Aptamer SeqId: 10013-34 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10013-34 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.95E-10

Real

Aptamer SeqId:10014-31;Target:SLUG;UniProt:O43623

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10014-31;Target: SLUG;UniProt: O43623;TargetFullName: Zinc finger protein SNAI2;Organisim: human;Apparent_Kd_M: 1.84026E-11

Real

Aptamer SeqId: 10014-31 | Target: SLUG | UniProt: O43623

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10014-31 | Target: SLUG | UniProt: O43623 | TargetFullName: Zinc finger protein SNAI2 | Organisim: human | Apparent_Kd_M: 1.84026E-11

Real

Aptamer SeqId:10015-119;Target:KCAB2;UniProt:Q13303

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10015-119;Target: KCAB2;UniProt: Q13303;TargetFullName: Voltage-gated potassium channel subunit beta-2;Organisim: human;Apparent_Kd_M: 7.988599E-11

Real

Aptamer SeqId: 10015-119 | Target: KCAB2 | UniProt: Q13303

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10015-119 | Target: KCAB2 | UniProt: Q13303 | TargetFullName: Voltage-gated potassium channel subunit beta-2 | Organisim: human | Apparent_Kd_M: 7.988599E-11

Real

Aptamer SeqId:10021-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10021-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.880228E-11

Real

Aptamer SeqId: 10021-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10021-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.880228E-11

Real

Aptamer SeqId:10022-207;Target:POLH;UniProt:Q9Y253

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10022-207;Target: POLH;UniProt: Q9Y253;TargetFullName: DNA polymerase eta;Organisim: human;Apparent_Kd_M: 2.339392E-11

Real

Aptamer SeqId: 10022-207 | Target: POLH | UniProt: Q9Y253

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10022-207 | Target: POLH | UniProt: Q9Y253 | TargetFullName: DNA polymerase eta | Organisim: human | Apparent_Kd_M: 2.339392E-11

Real

Aptamer SeqId:10023-32;Target:VDR;UniProt:P11473

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10023-32;Target: VDR;UniProt: P11473;TargetFullName: Vitamin D3 receptor;Organisim: human;Apparent_Kd_M: 3.01131E-11

Real

Aptamer SeqId: 10023-32 | Target: VDR | UniProt: P11473

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10023-32 | Target: VDR | UniProt: P11473 | TargetFullName: Vitamin D3 receptor | Organisim: human | Apparent_Kd_M: 3.01131E-11

Real

Aptamer SeqId:10024-44;Target:HOGA1;UniProt:Q86XE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10024-44;Target: HOGA1;UniProt: Q86XE5;TargetFullName: 4-hydroxy-2-oxoglutarate aldolase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.335377E-11

Real

Aptamer SeqId: 10024-44 | Target: HOGA1 | UniProt: Q86XE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10024-44 | Target: HOGA1 | UniProt: Q86XE5 | TargetFullName: 4-hydroxy-2-oxoglutarate aldolase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.335377E-11

Real

Aptamer SeqId:10030-8;Target:MutY homolog;UniProt:Q9UIF7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10030-8;Target: MutY homolog;UniProt: Q9UIF7;TargetFullName: Adenine DNA glycosylase;Organisim: human;Apparent_Kd_M: 5.121143E-12

Real

Aptamer SeqId: 10030-8 | Target: MutY homolog | UniProt: Q9UIF7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10030-8 | Target: MutY homolog | UniProt: Q9UIF7 | TargetFullName: Adenine DNA glycosylase | Organisim: human | Apparent_Kd_M: 5.121143E-12

Real

Aptamer SeqId:10034-16;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10034-16;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.360763E-11

Real

Aptamer SeqId: 10034-16 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10034-16 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.360763E-11

Real

Aptamer SeqId:10035-6;Target:DUS4;UniProt:Q13115

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10035-6;Target: DUS4;UniProt: Q13115;TargetFullName: Dual specificity protein phosphatase 4;Organisim: human;Apparent_Kd_M: 2.030154E-11

Real

Aptamer SeqId: 10035-6 | Target: DUS4 | UniProt: Q13115

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10035-6 | Target: DUS4 | UniProt: Q13115 | TargetFullName: Dual specificity protein phosphatase 4 | Organisim: human | Apparent_Kd_M: 2.030154E-11

Real

Aptamer SeqId:10036-201;Target:ZHX3;UniProt:Q9H4I2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10036-201;Target: ZHX3;UniProt: Q9H4I2;TargetFullName: Zinc fingers and homeoboxes protein 3;Organisim: human;Apparent_Kd_M: 4.105641E-10

Real

Aptamer SeqId: 10036-201 | Target: ZHX3 | UniProt: Q9H4I2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10036-201 | Target: ZHX3 | UniProt: Q9H4I2 | TargetFullName: Zinc fingers and homeoboxes protein 3 | Organisim: human | Apparent_Kd_M: 4.105641E-10

Real

Aptamer SeqId:10037-98;Target:SIG12;UniProt:Q96PQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10037-98;Target: SIG12;UniProt: Q96PQ1;TargetFullName: Sialic acid-binding Ig-like lectin 12;Organisim: human;Apparent_Kd_M: 4.449146E-12

Real

Aptamer SeqId: 10037-98 | Target: SIG12 | UniProt: Q96PQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10037-98 | Target: SIG12 | UniProt: Q96PQ1 | TargetFullName: Sialic acid-binding Ig-like lectin 12 | Organisim: human | Apparent_Kd_M: 4.449146E-12

Real

Aptamer SeqId:10040-63;Target:P73L;UniProt:Q9H3D4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10040-63;Target: P73L;UniProt: Q9H3D4;TargetFullName: Tumor protein 63;Organisim: human;Apparent_Kd_M: 4.363197E-11

Real

Aptamer SeqId: 10040-63 | Target: P73L | UniProt: Q9H3D4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10040-63 | Target: P73L | UniProt: Q9H3D4 | TargetFullName: Tumor protein 63 | Organisim: human | Apparent_Kd_M: 4.363197E-11

Real

Aptamer SeqId:10041-3;Target:HNF4A;UniProt:P41235

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10041-3;Target: HNF4A;UniProt: P41235;TargetFullName: Hepatocyte nuclear factor 4-alpha;Organisim: human;Apparent_Kd_M: 6.65E-11

Real

Aptamer SeqId: 10041-3 | Target: HNF4A | UniProt: P41235

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10041-3 | Target: HNF4A | UniProt: P41235 | TargetFullName: Hepatocyte nuclear factor 4-alpha | Organisim: human | Apparent_Kd_M: 6.65E-11

Real

Aptamer SeqId:10042-8;Target:SGK3;UniProt:Q96BR1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10042-8;Target: SGK3;UniProt: Q96BR1;TargetFullName: Serine/threonine-protein kinase Sgk3;Organisim: human;Apparent_Kd_M: 3.191409E-12

Real

Aptamer SeqId: 10042-8 | Target: SGK3 | UniProt: Q96BR1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10042-8 | Target: SGK3 | UniProt: Q96BR1 | TargetFullName: Serine/threonine-protein kinase Sgk3 | Organisim: human | Apparent_Kd_M: 3.191409E-12

Real

Aptamer SeqId:10043-31;Target:BRD4;UniProt:O60885

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10043-31;Target: BRD4;UniProt: O60885;TargetFullName: Bromodomain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.866373E-10

Real

Aptamer SeqId: 10043-31 | Target: BRD4 | UniProt: O60885

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10043-31 | Target: BRD4 | UniProt: O60885 | TargetFullName: Bromodomain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.866373E-10

Real

Aptamer SeqId:10044-12;Target:WN10A;UniProt:Q9GZT5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10044-12;Target: WN10A;UniProt: Q9GZT5;TargetFullName: Protein Wnt-10a;Organisim: human;Apparent_Kd_M: 3.182479E-11

Real

Aptamer SeqId: 10044-12 | Target: WN10A | UniProt: Q9GZT5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10044-12 | Target: WN10A | UniProt: Q9GZT5 | TargetFullName: Protein Wnt-10a | Organisim: human | Apparent_Kd_M: 3.182479E-11

Real

Aptamer SeqId:10045-47;Target:CUL3;UniProt:Q13618

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10045-47;Target: CUL3;UniProt: Q13618;TargetFullName: Cullin-3;Organisim: human;Apparent_Kd_M: 1.776801E-11

Real

Aptamer SeqId: 10045-47 | Target: CUL3 | UniProt: Q13618

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10045-47 | Target: CUL3 | UniProt: Q13618 | TargetFullName: Cullin-3 | Organisim: human | Apparent_Kd_M: 1.776801E-11

Real

Aptamer SeqId:10046-55;Target:cIAP-1;UniProt:Q13490

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10046-55;Target: cIAP-1;UniProt: Q13490;TargetFullName: Baculoviral IAP repeat-containing protein 2;Organisim: human;Apparent_Kd_M: 9.546274E-11

Real

Aptamer SeqId: 10046-55 | Target: cIAP-1 | UniProt: Q13490

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10046-55 | Target: cIAP-1 | UniProt: Q13490 | TargetFullName: Baculoviral IAP repeat-containing protein 2 | Organisim: human | Apparent_Kd_M: 9.546274E-11

Real

Aptamer SeqId:10047-12;Target:NCF-2;UniProt:P19878

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10047-12;Target: NCF-2;UniProt: P19878;TargetFullName: Neutrophil cytosol factor 2;Organisim: human;Apparent_Kd_M: 4.088833E-12

Real

Aptamer SeqId: 10047-12 | Target: NCF-2 | UniProt: P19878

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10047-12 | Target: NCF-2 | UniProt: P19878 | TargetFullName: Neutrophil cytosol factor 2 | Organisim: human | Apparent_Kd_M: 4.088833E-12

Real

Aptamer SeqId:10048-7;Target:PEBB;UniProt:Q13951

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10048-7;Target: PEBB;UniProt: Q13951;TargetFullName: Core-binding factor subunit beta;Organisim: human;Apparent_Kd_M: 2.017085E-11

Real

Aptamer SeqId: 10048-7 | Target: PEBB | UniProt: Q13951

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10048-7 | Target: PEBB | UniProt: Q13951 | TargetFullName: Core-binding factor subunit beta | Organisim: human | Apparent_Kd_M: 2.017085E-11

Real

Aptamer SeqId:10049-112;Target:TERF1;UniProt:P54274

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10049-112;Target: TERF1;UniProt: P54274;TargetFullName: Telomeric repeat-binding factor 1;Organisim: human;Apparent_Kd_M: 3.819645E-11

Real

Aptamer SeqId: 10049-112 | Target: TERF1 | UniProt: P54274

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10049-112 | Target: TERF1 | UniProt: P54274 | TargetFullName: Telomeric repeat-binding factor 1 | Organisim: human | Apparent_Kd_M: 3.819645E-11

Real

Aptamer SeqId:10053-5;Target:ILK1;UniProt:Q13418

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10053-5;Target: ILK1;UniProt: Q13418;TargetFullName: Integrin-linked protein kinase;Organisim: human;Apparent_Kd_M: 1.035866E-11

Real

Aptamer SeqId: 10053-5 | Target: ILK1 | UniProt: Q13418

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10053-5 | Target: ILK1 | UniProt: Q13418 | TargetFullName: Integrin-linked protein kinase | Organisim: human | Apparent_Kd_M: 1.035866E-11

Real

Aptamer SeqId:10054-3;Target:GAN;UniProt:Q9H2C0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10054-3;Target: GAN;UniProt: Q9H2C0;TargetFullName: Gigaxonin;Organisim: human;Apparent_Kd_M: 2.214327E-10

Real

Aptamer SeqId: 10054-3 | Target: GAN | UniProt: Q9H2C0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10054-3 | Target: GAN | UniProt: Q9H2C0 | TargetFullName: Gigaxonin | Organisim: human | Apparent_Kd_M: 2.214327E-10

Real

Aptamer SeqId:10056-5;Target:FOXM1;UniProt:Q08050

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10056-5;Target: FOXM1;UniProt: Q08050;TargetFullName: Forkhead box protein M1;Organisim: human;Apparent_Kd_M: 5.910351E-12

Real

Aptamer SeqId: 10056-5 | Target: FOXM1 | UniProt: Q08050

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10056-5 | Target: FOXM1 | UniProt: Q08050 | TargetFullName: Forkhead box protein M1 | Organisim: human | Apparent_Kd_M: 5.910351E-12

Real

Aptamer SeqId:10058-1;Target:RD23A;UniProt:P54725

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10058-1;Target: RD23A;UniProt: P54725;TargetFullName: UV excision repair protein RAD23 homolog A;Organisim: human;Apparent_Kd_M: 3.117482E-12

Real

Aptamer SeqId: 10058-1 | Target: RD23A | UniProt: P54725

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10058-1 | Target: RD23A | UniProt: P54725 | TargetFullName: UV excision repair protein RAD23 homolog A | Organisim: human | Apparent_Kd_M: 3.117482E-12

Real

Aptamer SeqId:10063-10;Target:FANCL;UniProt:Q9NW38

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10063-10;Target: FANCL;UniProt: Q9NW38;TargetFullName: E3 ubiquitin-protein ligase FANCL;Organisim: human;Apparent_Kd_M: 2.332352E-10

Real

Aptamer SeqId: 10063-10 | Target: FANCL | UniProt: Q9NW38

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10063-10 | Target: FANCL | UniProt: Q9NW38 | TargetFullName: E3 ubiquitin-protein ligase FANCL | Organisim: human | Apparent_Kd_M: 2.332352E-10

Real

Aptamer SeqId:10064-12;Target:RBBP9;UniProt:O75884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10064-12;Target: RBBP9;UniProt: O75884;TargetFullName: Putative hydrolase RBBP9;Organisim: human;Apparent_Kd_M: 1.619919E-10

Real

Aptamer SeqId: 10064-12 | Target: RBBP9 | UniProt: O75884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10064-12 | Target: RBBP9 | UniProt: O75884 | TargetFullName: Putative hydrolase RBBP9 | Organisim: human | Apparent_Kd_M: 1.619919E-10

Real

Aptamer SeqId:10070-22;Target:PLCG2;UniProt:P16885

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10070-22;Target: PLCG2;UniProt: P16885;TargetFullName: 1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase gamma-2;Organisim: human;Apparent_Kd_M: 5.696257E-12

Real

Aptamer SeqId: 10070-22 | Target: PLCG2 | UniProt: P16885

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10070-22 | Target: PLCG2 | UniProt: P16885 | TargetFullName: 1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase gamma-2 | Organisim: human | Apparent_Kd_M: 5.696257E-12

Real

Aptamer SeqId:10073-22;Target:TYDP1;UniProt:Q9NUW8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10073-22;Target: TYDP1;UniProt: Q9NUW8;TargetFullName: Tyrosyl-DNA phosphodiesterase 1;Organisim: human;Apparent_Kd_M: 7.088563E-13

Real

Aptamer SeqId: 10073-22 | Target: TYDP1 | UniProt: Q9NUW8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10073-22 | Target: TYDP1 | UniProt: Q9NUW8 | TargetFullName: Tyrosyl-DNA phosphodiesterase 1 | Organisim: human | Apparent_Kd_M: 7.088563E-13

Real

Aptamer SeqId:10074-128;Target:BRD2;UniProt:P25440

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10074-128;Target: BRD2;UniProt: P25440;TargetFullName: Bromodomain-containing protein 2;Organisim: human;Apparent_Kd_M: 4.346809E-12

Real

Aptamer SeqId: 10074-128 | Target: BRD2 | UniProt: P25440

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10074-128 | Target: BRD2 | UniProt: P25440 | TargetFullName: Bromodomain-containing protein 2 | Organisim: human | Apparent_Kd_M: 4.346809E-12

Real

Aptamer SeqId:10075-75;Target:ACBD6;UniProt:Q9BR61

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10075-75;Target: ACBD6;UniProt: Q9BR61;TargetFullName: Acyl-CoA-binding domain-containing protein 6;Organisim: human;Apparent_Kd_M: 2.572721E-12

Real

Aptamer SeqId: 10075-75 | Target: ACBD6 | UniProt: Q9BR61

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10075-75 | Target: ACBD6 | UniProt: Q9BR61 | TargetFullName: Acyl-CoA-binding domain-containing protein 6 | Organisim: human | Apparent_Kd_M: 2.572721E-12

Real

Aptamer SeqId:10076-1;Target:AP4M1;UniProt:O00189

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10076-1;Target: AP4M1;UniProt: O00189;TargetFullName: AP-4 complex subunit mu-1;Organisim: human;Apparent_Kd_M: 9.288883E-12

Real

Aptamer SeqId: 10076-1 | Target: AP4M1 | UniProt: O00189

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10076-1 | Target: AP4M1 | UniProt: O00189 | TargetFullName: AP-4 complex subunit mu-1 | Organisim: human | Apparent_Kd_M: 9.288883E-12

Real

Aptamer SeqId:10078-5;Target:BAG3;UniProt:O95817

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10078-5;Target: BAG3;UniProt: O95817;TargetFullName: BAG family molecular chaperone regulator 3;Organisim: human;Apparent_Kd_M: 2.483126E-11

Real

Aptamer SeqId: 10078-5 | Target: BAG3 | UniProt: O95817

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10078-5 | Target: BAG3 | UniProt: O95817 | TargetFullName: BAG family molecular chaperone regulator 3 | Organisim: human | Apparent_Kd_M: 2.483126E-11

Real

Aptamer SeqId:10080-9;Target:EI2BA;UniProt:Q14232

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10080-9;Target: EI2BA;UniProt: Q14232;TargetFullName: Translation initiation factor eIF-2B subunit alpha;Organisim: human;Apparent_Kd_M: 2.872901E-12

Real

Aptamer SeqId: 10080-9 | Target: EI2BA | UniProt: Q14232

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10080-9 | Target: EI2BA | UniProt: Q14232 | TargetFullName: Translation initiation factor eIF-2B subunit alpha | Organisim: human | Apparent_Kd_M: 2.872901E-12

Real

Aptamer SeqId:10081-17;Target:SATB2;UniProt:Q9UPW6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10081-17;Target: SATB2;UniProt: Q9UPW6;TargetFullName: DNA-binding protein SATB2;Organisim: human;Apparent_Kd_M: 5.985787E-12

Real

Aptamer SeqId: 10081-17 | Target: SATB2 | UniProt: Q9UPW6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10081-17 | Target: SATB2 | UniProt: Q9UPW6 | TargetFullName: DNA-binding protein SATB2 | Organisim: human | Apparent_Kd_M: 5.985787E-12

Real

Aptamer SeqId:10082-251;Target:NFL;UniProt:P07196

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10082-251;Target: NFL;UniProt: P07196;TargetFullName: Neurofilament light polypeptide;Organisim: human;Apparent_Kd_M: 1.951223E-12

Real

Aptamer SeqId: 10082-251 | Target: NFL | UniProt: P07196

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10082-251 | Target: NFL | UniProt: P07196 | TargetFullName: Neurofilament light polypeptide | Organisim: human | Apparent_Kd_M: 1.951223E-12

Real

Aptamer SeqId:10085-25;Target:STAR;UniProt:P49675

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10085-25;Target: STAR;UniProt: P49675;TargetFullName: Steroidogenic acute regulatory protein; mitochondrial;Organisim: human;Apparent_Kd_M: 3.465383E-11

Real

Aptamer SeqId: 10085-25 | Target: STAR | UniProt: P49675

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10085-25 | Target: STAR | UniProt: P49675 | TargetFullName: Steroidogenic acute regulatory protein; mitochondrial | Organisim: human | Apparent_Kd_M: 3.465383E-11

Real

Aptamer SeqId:10086-39;Target:CBS;UniProt:P35520

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10086-39;Target: CBS;UniProt: P35520;TargetFullName: Cystathionine beta-synthase;Organisim: human;Apparent_Kd_M: 3.895135E-11

Real

Aptamer SeqId: 10086-39 | Target: CBS | UniProt: P35520

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10086-39 | Target: CBS | UniProt: P35520 | TargetFullName: Cystathionine beta-synthase | Organisim: human | Apparent_Kd_M: 3.895135E-11

Real

Aptamer SeqId:10087-10;Target:Alpha crystallin A chain;UniProt:P02489

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10087-10;Target: Alpha crystallin A chain;UniProt: P02489;TargetFullName: Alpha-crystallin A chain;Organisim: human;Apparent_Kd_M: 6.003705E-11

Real

Aptamer SeqId: 10087-10 | Target: Alpha crystallin A chain

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10087-10 | Target: Alpha crystallin A chain | UniProt: P02489 | TargetFullName: Alpha-crystallin A chain | Organisim: human | Apparent_Kd_M: 6.003705E-11

Real

Aptamer SeqId:10088-37;Target:APT;UniProt:P07741

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10088-37;Target: APT;UniProt: P07741;TargetFullName: Adenine phosphoribosyltransferase;Organisim: human;Apparent_Kd_M: 1.475618E-11

Real

Aptamer SeqId: 10088-37 | Target: APT | UniProt: P07741

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10088-37 | Target: APT | UniProt: P07741 | TargetFullName: Adenine phosphoribosyltransferase | Organisim: human | Apparent_Kd_M: 1.475618E-11

Real

Aptamer SeqId:10089-7;Target:ASML;UniProt:O95671

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10089-7;Target: ASML;UniProt: O95671;TargetFullName: N-acetylserotonin O-methyltransferase-like protein;Organisim: human;Apparent_Kd_M: 4.406495E-12

Real

Aptamer SeqId: 10089-7 | Target: ASML | UniProt: O95671

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10089-7 | Target: ASML | UniProt: O95671 | TargetFullName: N-acetylserotonin O-methyltransferase-like protein | Organisim: human | Apparent_Kd_M: 4.406495E-12

Real

Aptamer SeqId:10336-3;Target:CHIP;UniProt:Q9UNE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10336-3;Target: CHIP;UniProt: Q9UNE7;TargetFullName: E3 ubiquitin-protein ligase CHIP;Organisim: human;Apparent_Kd_M: 3.43E-11

Real

Aptamer SeqId: 10336-3 | Target: CHIP | UniProt: Q9UNE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10336-3 | Target: CHIP | UniProt: Q9UNE7 | TargetFullName: E3 ubiquitin-protein ligase CHIP | Organisim: human | Apparent_Kd_M: 3.43E-11

Real

Aptamer SeqId:10339-48;Target:NSE;UniProt:P09104

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10339-48;Target: NSE;UniProt: P09104;TargetFullName: Gamma-enolase;Organisim: human;Apparent_Kd_M: 1.69E-10

Real

Aptamer SeqId: 10339-48 | Target: NSE | UniProt: P09104

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10339-48 | Target: NSE | UniProt: P09104 | TargetFullName: Gamma-enolase | Organisim: human | Apparent_Kd_M: 1.69E-10

Real

Aptamer SeqId:10342-55;Target:PIAS4;UniProt:Q8N2W9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10342-55;Target: PIAS4;UniProt: Q8N2W9;TargetFullName: E3 SUMO-protein ligase PIAS4;Organisim: human;Apparent_Kd_M: 9.37E-11

Real

Aptamer SeqId: 10342-55 | Target: PIAS4 | UniProt: Q8N2W9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10342-55 | Target: PIAS4 | UniProt: Q8N2W9 | TargetFullName: E3 SUMO-protein ligase PIAS4 | Organisim: human | Apparent_Kd_M: 9.37E-11

Real

Aptamer SeqId:10344-334;Target:IL-10 Ra;UniProt:Q13651

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10344-334;Target: IL-10 Ra;UniProt: Q13651;TargetFullName: Interleukin-10 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.75E-10

Real

Aptamer SeqId: 10344-334 | Target: IL-10 Ra | UniProt: Q13651

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10344-334 | Target: IL-10 Ra | UniProt: Q13651 | TargetFullName: Interleukin-10 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.75E-10

Real

Aptamer SeqId:10346-5;Target:STAT3;UniProt:P40763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10346-5;Target: STAT3;UniProt: P40763;TargetFullName: Signal transducer and activator of transcription 3;Organisim: human;Apparent_Kd_M: 9.46E-12

Real

Aptamer SeqId: 10346-5 | Target: STAT3 | UniProt: P40763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10346-5 | Target: STAT3 | UniProt: P40763 | TargetFullName: Signal transducer and activator of transcription 3 | Organisim: human | Apparent_Kd_M: 9.46E-12

Real

Aptamer SeqId:10356-21;Target:c-Jun;UniProt:P05412

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10356-21;Target: c-Jun;UniProt: P05412;TargetFullName: Transcription factor AP-1;Organisim: human;Apparent_Kd_M: 3.3E-10

Real

Aptamer SeqId: 10356-21 | Target: c-Jun | UniProt: P05412

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10356-21 | Target: c-Jun | UniProt: P05412 | TargetFullName: Transcription factor AP-1 | Organisim: human | Apparent_Kd_M: 3.3E-10

Real

Aptamer SeqId:10361-25;Target:OAS1;UniProt:P00973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10361-25;Target: OAS1;UniProt: P00973;TargetFullName: 2-5-oligoadenylate synthase 1;Organisim: human;Apparent_Kd_M: 3.5E-12

Real

Aptamer SeqId: 10361-25 | Target: OAS1 | UniProt: P00973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10361-25 | Target: OAS1 | UniProt: P00973 | TargetFullName: 2'-5'-oligoadenylate synthase 1 | Organisim: human | Apparent_Kd_M: 3.5E-12

Real

Aptamer SeqId:10362-35;Target:c-Myc;UniProt:P01106

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10362-35;Target: c-Myc;UniProt: P01106;TargetFullName: Myc proto-oncogene protein;Organisim: human;Apparent_Kd_M: 2.8E-11

Real

Aptamer SeqId: 10362-35 | Target: c-Myc | UniProt: P01106

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10362-35 | Target: c-Myc | UniProt: P01106 | TargetFullName: Myc proto-oncogene protein | Organisim: human | Apparent_Kd_M: 2.8E-11

Real

Aptamer SeqId:10363-13;Target:SMAD3;UniProt:P84022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10363-13;Target: SMAD3;UniProt: P84022;TargetFullName: Mothers against decapentaplegic homolog 3;Organisim: human;Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId: 10363-13 | Target: SMAD3 | UniProt: P84022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10363-13 | Target: SMAD3 | UniProt: P84022 | TargetFullName: Mothers against decapentaplegic homolog 3 | Organisim: human | Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId:10364-6;Target:SMAD2;UniProt:Q15796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10364-6;Target: SMAD2;UniProt: Q15796;TargetFullName: Mothers against decapentaplegic homolog 2;Organisim: human;Apparent_Kd_M: 2.73E-11

Real

Aptamer SeqId: 10364-6 | Target: SMAD2 | UniProt: Q15796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10364-6 | Target: SMAD2 | UniProt: Q15796 | TargetFullName: Mothers against decapentaplegic homolog 2 | Organisim: human | Apparent_Kd_M: 2.73E-11

Real

Aptamer SeqId:10365-132;Target:IL-23;UniProt:P29460;Q9NPF7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10365-132;Target: IL-23;UniProt: P29460|Q9NPF7;TargetFullName: Interleukin-23;Organisim: human;Apparent_Kd_M: 1.76E-12

Real

Aptamer SeqId: 10365-132 | Target: IL-23 | UniProt: P29460|Q9NPF7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10365-132 | Target: IL-23 | UniProt: P29460|Q9NPF7 | TargetFullName: Interleukin-23 | Organisim: human | Apparent_Kd_M: 1.76E-12

Real

Aptamer SeqId:10366-11;Target:PDGFRA;UniProt:P16234

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10366-11;Target: PDGFRA;UniProt: P16234;TargetFullName: Platelet-derived growth factor receptor alpha;Organisim: human;Apparent_Kd_M: 4.66E-11

Real

Aptamer SeqId: 10366-11 | Target: PDGFRA | UniProt: P16234

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10366-11 | Target: PDGFRA | UniProt: P16234 | TargetFullName: Platelet-derived growth factor receptor alpha | Organisim: human | Apparent_Kd_M: 4.66E-11

Real

Aptamer SeqId:10367-62;Target:IL-12;UniProt:P29459;P29460

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10367-62;Target: IL-12;UniProt: P29459|P29460;TargetFullName: Interleukin-12;Organisim: human;Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId: 10367-62 | Target: IL-12 | UniProt: P29459|P29460

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10367-62 | Target: IL-12 | UniProt: P29459|P29460 | TargetFullName: Interleukin-12 | Organisim: human | Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId:10370-21;Target:STAT1;UniProt:P42224

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10370-21;Target: STAT1;UniProt: P42224;TargetFullName: Signal transducer and activator of transcription 1-alpha/beta;Organisim: human;Apparent_Kd_M: 4.71E-12

Real

Aptamer SeqId: 10370-21 | Target: STAT1 | UniProt: P42224

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10370-21 | Target: STAT1 | UniProt: P42224 | TargetFullName: Signal transducer and activator of transcription 1-alpha/beta | Organisim: human | Apparent_Kd_M: 4.71E-12

Real

Aptamer SeqId:10372-18;Target:STAT6;UniProt:P42226

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10372-18;Target: STAT6;UniProt: P42226;TargetFullName: Signal transducer and activator of transcription 6;Organisim: human;Apparent_Kd_M: 2.06E-10

Real

Aptamer SeqId: 10372-18 | Target: STAT6 | UniProt: P42226

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10372-18 | Target: STAT6 | UniProt: P42226 | TargetFullName: Signal transducer and activator of transcription 6 | Organisim: human | Apparent_Kd_M: 2.06E-10

Real

Aptamer SeqId:10390-21;Target:ZNRF3;UniProt:Q9ULT6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10390-21;Target: ZNRF3;UniProt: Q9ULT6;TargetFullName: E3 ubiquitin-protein ligase ZNRF3;Organisim: human;Apparent_Kd_M: 2.453366E-12

Real

Aptamer SeqId: 10390-21 | Target: ZNRF3 | UniProt: Q9ULT6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10390-21 | Target: ZNRF3 | UniProt: Q9ULT6 | TargetFullName: E3 ubiquitin-protein ligase ZNRF3 | Organisim: human | Apparent_Kd_M: 2.453366E-12

Real

Aptamer SeqId:10391-1;Target:ANGL3;UniProt:Q9Y5C1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10391-1;Target: ANGL3;UniProt: Q9Y5C1;TargetFullName: Angiopoietin-related protein 3;Organisim: human;Apparent_Kd_M: 7.620613E-13

Real

Aptamer SeqId: 10391-1 | Target: ANGL3 | UniProt: Q9Y5C1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10391-1 | Target: ANGL3 | UniProt: Q9Y5C1 | TargetFullName: Angiopoietin-related protein 3 | Organisim: human | Apparent_Kd_M: 7.620613E-13

Real

Aptamer SeqId:10396-6;Target:Mcl-1;UniProt:Q07820

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10396-6;Target: Mcl-1;UniProt: Q07820;TargetFullName: Induced myeloid leukemia cell differentiation protein Mcl-1;Organisim: human;Apparent_Kd_M: 1.376639E-11

Real

Aptamer SeqId: 10396-6 | Target: Mcl-1 | UniProt: Q07820

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10396-6 | Target: Mcl-1 | UniProt: Q07820 | TargetFullName: Induced myeloid leukemia cell differentiation protein Mcl-1 | Organisim: human | Apparent_Kd_M: 1.376639E-11

Real

Aptamer SeqId:10416-79;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10416-79;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.130314E-11

Real

Aptamer SeqId: 10416-79 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10416-79 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.130314E-11

Real

Aptamer SeqId:10418-36;Target:STX12;UniProt:Q86Y82

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10418-36;Target: STX12;UniProt: Q86Y82;TargetFullName: Syntaxin-12;Organisim: human;Apparent_Kd_M: 2.916097E-11

Real

Aptamer SeqId: 10418-36 | Target: STX12 | UniProt: Q86Y82

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10418-36 | Target: STX12 | UniProt: Q86Y82 | TargetFullName: Syntaxin-12 | Organisim: human | Apparent_Kd_M: 2.916097E-11

Real

Aptamer SeqId:10419-1;Target:SCAR5;UniProt:Q6ZMJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10419-1;Target: SCAR5;UniProt: Q6ZMJ2;TargetFullName: Scavenger receptor class A member 5;Organisim: human;Apparent_Kd_M: 2.215019E-11

Real

Aptamer SeqId: 10419-1 | Target: SCAR5 | UniProt: Q6ZMJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10419-1 | Target: SCAR5 | UniProt: Q6ZMJ2 | TargetFullName: Scavenger receptor class A member 5 | Organisim: human | Apparent_Kd_M: 2.215019E-11

Real

Aptamer SeqId:10424-31;Target:NPDC1;UniProt:Q9NQX5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10424-31;Target: NPDC1;UniProt: Q9NQX5;TargetFullName: Neural proliferation differentiation and control protein 1;Organisim: human;Apparent_Kd_M: 4.638109E-11

Real

Aptamer SeqId: 10424-31 | Target: NPDC1 | UniProt: Q9NQX5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10424-31 | Target: NPDC1 | UniProt: Q9NQX5 | TargetFullName: Neural proliferation differentiation and control protein 1 | Organisim: human | Apparent_Kd_M: 4.638109E-11

Real

Aptamer SeqId:10425-3;Target:B4GT5;UniProt:O43286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10425-3;Target: B4GT5;UniProt: O43286;TargetFullName: Beta-1;4-galactosyltransferase 5;Organisim: human;Apparent_Kd_M: 8.817908E-11

Real

Aptamer SeqId: 10425-3 | Target: B4GT5 | UniProt: O43286

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10425-3 | Target: B4GT5 | UniProt: O43286 | TargetFullName: Beta-1;4-galactosyltransferase 5 | Organisim: human | Apparent_Kd_M: 8.817908E-11

Real

Aptamer SeqId:10426-21;Target:GOSR2;UniProt:O14653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10426-21;Target: GOSR2;UniProt: O14653;TargetFullName: Golgi SNAP receptor complex member 2;Organisim: human;Apparent_Kd_M: 1.182692E-11

Real

Aptamer SeqId: 10426-21 | Target: GOSR2 | UniProt: O14653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10426-21 | Target: GOSR2 | UniProt: O14653 | TargetFullName: Golgi SNAP receptor complex member 2 | Organisim: human | Apparent_Kd_M: 1.182692E-11

Real

Aptamer SeqId:10427-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10427-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId: 10427-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10427-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId:10428-1;Target:KI2S2;UniProt:P43631

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10428-1;Target: KI2S2;UniProt: P43631;TargetFullName: Killer cell immunoglobulin-like receptor 2DS2;Organisim: human;Apparent_Kd_M: 1.621698E-11

Real

Aptamer SeqId: 10428-1 | Target: KI2S2 | UniProt: P43631

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10428-1 | Target: KI2S2 | UniProt: P43631 | TargetFullName: Killer cell immunoglobulin-like receptor 2DS2 | Organisim: human | Apparent_Kd_M: 1.621698E-11

Real

Aptamer SeqId:10430-31;Target:4F2;UniProt:P08195

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10430-31;Target: 4F2;UniProt: P08195;TargetFullName: 4F2 cell-surface antigen heavy chain;Organisim: human;Apparent_Kd_M: 6.037419E-12

Real

Aptamer SeqId: 10430-31 | Target: 4F2 | UniProt: P08195

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10430-31 | Target: 4F2 | UniProt: P08195 | TargetFullName: 4F2 cell-surface antigen heavy chain | Organisim: human | Apparent_Kd_M: 6.037419E-12

Real

Aptamer SeqId:10432-3;Target:K1644;UniProt:Q3SXP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10432-3;Target: K1644;UniProt: Q3SXP7;TargetFullName: Uncharacterized protein KIAA1644;Organisim: human;Apparent_Kd_M: 5.78541E-11

Real

Aptamer SeqId: 10432-3 | Target: K1644 | UniProt: Q3SXP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10432-3 | Target: K1644 | UniProt: Q3SXP7 | TargetFullName: Uncharacterized protein KIAA1644 | Organisim: human | Apparent_Kd_M: 5.78541E-11

Real

Aptamer SeqId:10435-2;Target:ASPG;UniProt:P20933

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10435-2;Target: ASPG;UniProt: P20933;TargetFullName: N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase;Organisim: human;Apparent_Kd_M: 9.55E-10

Real

Aptamer SeqId: 10435-2 | Target: ASPG | UniProt: P20933

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10435-2 | Target: ASPG | UniProt: P20933 | TargetFullName: N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | Organisim: human | Apparent_Kd_M: 9.55E-10

Real

Aptamer SeqId:10438-19;Target:CSF2R;UniProt:P15509

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10438-19;Target: CSF2R;UniProt: P15509;TargetFullName: Granulocyte-macrophage colony-stimulating factor receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.562259E-11

Real

Aptamer SeqId: 10438-19 | Target: CSF2R | UniProt: P15509

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10438-19 | Target: CSF2R | UniProt: P15509 | TargetFullName: Granulocyte-macrophage colony-stimulating factor receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.562259E-11

Real

Aptamer SeqId:10440-26;Target:ACAM;UniProt:Q9H6B4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10440-26;Target: ACAM;UniProt: Q9H6B4;TargetFullName: CXADR-like membrane protein;Organisim: human;Apparent_Kd_M: 2.304908E-11

Real

Aptamer SeqId: 10440-26 | Target: ACAM | UniProt: Q9H6B4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10440-26 | Target: ACAM | UniProt: Q9H6B4 | TargetFullName: CXADR-like membrane protein | Organisim: human | Apparent_Kd_M: 2.304908E-11

Real

Aptamer SeqId:10442-1;Target:TM190;UniProt:Q8WZ59

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10442-1;Target: TM190;UniProt: Q8WZ59;TargetFullName: Transmembrane protein 190;Organisim: human;Apparent_Kd_M: 4.599096E-11

Real

Aptamer SeqId: 10442-1 | Target: TM190 | UniProt: Q8WZ59

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10442-1 | Target: TM190 | UniProt: Q8WZ59 | TargetFullName: Transmembrane protein 190 | Organisim: human | Apparent_Kd_M: 4.599096E-11

Real

Aptamer SeqId:10445-20;Target:ApoM;UniProt:O95445

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10445-20;Target: ApoM;UniProt: O95445;TargetFullName: Apolipoprotein M;Organisim: human;Apparent_Kd_M: 3.107137E-10

Real

Aptamer SeqId: 10445-20 | Target: ApoM | UniProt: O95445

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10445-20 | Target: ApoM | UniProt: O95445 | TargetFullName: Apolipoprotein M | Organisim: human | Apparent_Kd_M: 3.107137E-10

Real

Aptamer SeqId:10447-18;Target:PABP3;UniProt:Q9H361

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10447-18;Target: PABP3;UniProt: Q9H361;TargetFullName: Polyadenylate-binding protein 3;Organisim: human;Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId: 10447-18 | Target: PABP3 | UniProt: Q9H361

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10447-18 | Target: PABP3 | UniProt: Q9H361 | TargetFullName: Polyadenylate-binding protein 3 | Organisim: human | Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId:10449-31;Target:TMM46;UniProt:Q6UWI4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10449-31;Target: TMM46;UniProt: Q6UWI4;TargetFullName: Protein shisa-2 homolog;Organisim: human;Apparent_Kd_M: 1.898698E-10

Real

Aptamer SeqId: 10449-31 | Target: TMM46 | UniProt: Q6UWI4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10449-31 | Target: TMM46 | UniProt: Q6UWI4 | TargetFullName: Protein shisa-2 homolog | Organisim: human | Apparent_Kd_M: 1.898698E-10

Real

Aptamer SeqId:10451-11;Target:NUCB1;UniProt:Q02818

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10451-11;Target: NUCB1;UniProt: Q02818;TargetFullName: Nucleobindin-1;Organisim: human;Apparent_Kd_M: 8.039013E-12

Real

Aptamer SeqId: 10451-11 | Target: NUCB1 | UniProt: Q02818

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10451-11 | Target: NUCB1 | UniProt: Q02818 | TargetFullName: Nucleobindin-1 | Organisim: human | Apparent_Kd_M: 8.039013E-12

Real

Aptamer SeqId:10452-24;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10452-24;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.027581E-11

Real

Aptamer SeqId: 10452-24 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10452-24 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.027581E-11

Real

Aptamer SeqId:10453-7;Target:CEA20;UniProt:Q6UY09

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10453-7;Target: CEA20;UniProt: Q6UY09;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 20;Organisim: human;Apparent_Kd_M: 1.566371E-10

Real

Aptamer SeqId: 10453-7 | Target: CEA20 | UniProt: Q6UY09

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10453-7 | Target: CEA20 | UniProt: Q6UY09 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 20 | Organisim: human | Apparent_Kd_M: 1.566371E-10

Real

Aptamer SeqId:10454-99;Target:DJC16;UniProt:Q9Y2G8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10454-99;Target: DJC16;UniProt: Q9Y2G8;TargetFullName: DnaJ homolog subfamily C member 16;Organisim: human;Apparent_Kd_M: 4.035398E-12

Real

Aptamer SeqId: 10454-99 | Target: DJC16 | UniProt: Q9Y2G8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10454-99 | Target: DJC16 | UniProt: Q9Y2G8 | TargetFullName: DnaJ homolog subfamily C member 16 | Organisim: human | Apparent_Kd_M: 4.035398E-12

Real

Aptamer SeqId:10455-196;Target:IL-31;UniProt:Q6EBC2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10455-196;Target: IL-31;UniProt: Q6EBC2;TargetFullName: Interleukin-31;Organisim: human;Apparent_Kd_M: 3.972659E-11

Real

Aptamer SeqId: 10455-196 | Target: IL-31 | UniProt: Q6EBC2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10455-196 | Target: IL-31 | UniProt: Q6EBC2 | TargetFullName: Interleukin-31 | Organisim: human | Apparent_Kd_M: 3.972659E-11

Real

Aptamer SeqId:10461-57;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10461-57;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.219871E-11

Real

Aptamer SeqId: 10461-57 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10461-57 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.219871E-11

Real

Aptamer SeqId:10462-14;Target:INSL5;UniProt:Q9Y5Q6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10462-14;Target: INSL5;UniProt: Q9Y5Q6;TargetFullName: Insulin-like peptide INSL5;Organisim: human;Apparent_Kd_M: 6.563576E-12

Real

Aptamer SeqId: 10462-14 | Target: INSL5 | UniProt: Q9Y5Q6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10462-14 | Target: INSL5 | UniProt: Q9Y5Q6 | TargetFullName: Insulin-like peptide INSL5 | Organisim: human | Apparent_Kd_M: 6.563576E-12

Real

Aptamer SeqId:10464-6;Target:ANTR1;UniProt:Q9H6X2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10464-6;Target: ANTR1;UniProt: Q9H6X2;TargetFullName: Anthrax toxin receptor 1;Organisim: human;Apparent_Kd_M: 3.621896E-10

Real

Aptamer SeqId: 10464-6 | Target: ANTR1 | UniProt: Q9H6X2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10464-6 | Target: ANTR1 | UniProt: Q9H6X2 | TargetFullName: Anthrax toxin receptor 1 | Organisim: human | Apparent_Kd_M: 3.621896E-10

Real

Aptamer SeqId:10467-58;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10467-58;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.78488E-11

Real

Aptamer SeqId: 10467-58 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10467-58 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.78488E-11

Real

Aptamer SeqId:10471-25;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10471-25;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.816717E-12

Real

Aptamer SeqId: 10471-25 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10471-25 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.816717E-12

Real

Aptamer SeqId:10476-23;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10476-23;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.029042E-10

Real

Aptamer SeqId: 10476-23 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10476-23 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.029042E-10

Real

Aptamer SeqId:10477-162;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10477-162;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.766345E-11

Real

Aptamer SeqId: 10477-162 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10477-162 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.766345E-11

Real

Aptamer SeqId:10485-56;Target:MAGE-4;UniProt:P43358

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10485-56;Target: MAGE-4;UniProt: P43358;TargetFullName: Melanoma-associated antigen 4;Organisim: human;Apparent_Kd_M: 5.189515E-11

Real

Aptamer SeqId: 10485-56 | Target: MAGE-4 | UniProt: P43358

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10485-56 | Target: MAGE-4 | UniProt: P43358 | TargetFullName: Melanoma-associated antigen 4 | Organisim: human | Apparent_Kd_M: 5.189515E-11

Real

Aptamer SeqId:10489-19;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10489-19;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.240188E-12

Real

Aptamer SeqId: 10489-19 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10489-19 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.240188E-12

Real

Aptamer SeqId:10490-3;Target:RPN1;UniProt:P04843

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10490-3;Target: RPN1;UniProt: P04843;TargetFullName: Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1;Organisim: human;Apparent_Kd_M: 1.720938E-12

Real

Aptamer SeqId: 10490-3 | Target: RPN1 | UniProt: P04843

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10490-3 | Target: RPN1 | UniProt: P04843 | TargetFullName: Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | Organisim: human | Apparent_Kd_M: 1.720938E-12

Real

Aptamer SeqId:10491-21;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10491-21;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.582074E-11

Real

Aptamer SeqId: 10491-21 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10491-21 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.582074E-11

Real

Aptamer SeqId:10494-48;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10494-48;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.081063E-10

Real

Aptamer SeqId: 10494-48 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10494-48 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.081063E-10

Real

Aptamer SeqId:10495-10;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10495-10;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.709518E-11

Real

Aptamer SeqId: 10495-10 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10495-10 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.709518E-11

Real

Aptamer SeqId:10496-11;Target:CaCC;UniProt:A8K7I4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10496-11;Target: CaCC;UniProt: A8K7I4;TargetFullName: Calcium-activated chloride channel regulator 1;Organisim: human;Apparent_Kd_M: 3.054818E-10

Real

Aptamer SeqId: 10496-11 | Target: CaCC | UniProt: A8K7I4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10496-11 | Target: CaCC | UniProt: A8K7I4 | TargetFullName: Calcium-activated chloride channel regulator 1 | Organisim: human | Apparent_Kd_M: 3.054818E-10

Real

Aptamer SeqId:10497-242;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10497-242;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.731456E-10

Real

Aptamer SeqId: 10497-242 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10497-242 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.731456E-10

Real

Aptamer SeqId:10499-1;Target:T106A;UniProt:Q96A25

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10499-1;Target: T106A;UniProt: Q96A25;TargetFullName: Transmembrane protein 106A;Organisim: human;Apparent_Kd_M: 1.215218E-10

Real

Aptamer SeqId: 10499-1 | Target: T106A | UniProt: Q96A25

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10499-1 | Target: T106A | UniProt: Q96A25 | TargetFullName: Transmembrane protein 106A | Organisim: human | Apparent_Kd_M: 1.215218E-10

Real

Aptamer SeqId:10501-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10501-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.588051E-11

Real

Aptamer SeqId: 10501-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10501-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.588051E-11

Real

Aptamer SeqId:10502-15;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10502-15;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.484789E-12

Real

Aptamer SeqId: 10502-15 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10502-15 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.484789E-12

Real

Aptamer SeqId:10503-55;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10503-55;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.163683E-10

Real

Aptamer SeqId: 10503-55 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10503-55 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.163683E-10

Real

Aptamer SeqId:10504-6;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10504-6;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.845493E-12

Real

Aptamer SeqId: 10504-6 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10504-6 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.845493E-12

Real

Aptamer SeqId:10506-53;Target:PGRC2;UniProt:O15173

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10506-53;Target: PGRC2;UniProt: O15173;TargetFullName: Membrane-associated progesterone receptor component 2;Organisim: human;Apparent_Kd_M: 3.063879E-12

Real

Aptamer SeqId: 10506-53 | Target: PGRC2 | UniProt: O15173

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10506-53 | Target: PGRC2 | UniProt: O15173 | TargetFullName: Membrane-associated progesterone receptor component 2 | Organisim: human | Apparent_Kd_M: 3.063879E-12

Real

Aptamer SeqId:10507-166;Target:sperm protein 10;UniProt:P26436

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10507-166;Target: sperm protein 10;UniProt: P26436;TargetFullName: Acrosomal protein SP-10;Organisim: human;Apparent_Kd_M: 1.142748E-10

Real

Aptamer SeqId: 10507-166 | Target: sperm protein 10 | UniProt: P26436

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10507-166 | Target: sperm protein 10 | UniProt: P26436 | TargetFullName: Acrosomal protein SP-10 | Organisim: human | Apparent_Kd_M: 1.142748E-10

Real

Aptamer SeqId:10510-62;Target:SCIMP;UniProt:Q6UWF3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10510-62;Target: SCIMP;UniProt: Q6UWF3;TargetFullName: SLP adapter and CSK-interacting membrane protein;Organisim: human;Apparent_Kd_M: 3.66484E-10

Real

Aptamer SeqId: 10510-62 | Target: SCIMP | UniProt: Q6UWF3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10510-62 | Target: SCIMP | UniProt: Q6UWF3 | TargetFullName: SLP adapter and CSK-interacting membrane protein | Organisim: human | Apparent_Kd_M: 3.66484E-10

Real

Aptamer SeqId:10511-10;Target:Collagen alpha-3(VI);UniProt:P12111

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10511-10;Target: Collagen alpha-3(VI);UniProt: P12111;TargetFullName: Collagen alpha-3(VI) chain;Organisim: human;Apparent_Kd_M: 2.16179E-11

Real

Aptamer SeqId: 10511-10 | Target: Collagen alpha-3(VI) | UniProt: P12111

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10511-10 | Target: Collagen alpha-3(VI) | UniProt: P12111 | TargetFullName: Collagen alpha-3(VI) chain | Organisim: human | Apparent_Kd_M: 2.16179E-11

Real

Aptamer SeqId:10512-13;Target:IL3RB;UniProt:P32927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10512-13;Target: IL3RB;UniProt: P32927;TargetFullName: Cytokine receptor common subunit beta;Organisim: human;Apparent_Kd_M: 1.541846E-11

Real

Aptamer SeqId: 10512-13 | Target: IL3RB | UniProt: P32927

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10512-13 | Target: IL3RB | UniProt: P32927 | TargetFullName: Cytokine receptor common subunit beta | Organisim: human | Apparent_Kd_M: 1.541846E-11

Real

Aptamer SeqId:10513-13;Target:CSEN;UniProt:Q9Y2W7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10513-13;Target: CSEN;UniProt: Q9Y2W7;TargetFullName: Calsenilin;Organisim: human;Apparent_Kd_M: 3.615028E-11

Real

Aptamer SeqId: 10513-13 | Target: CSEN | UniProt: Q9Y2W7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10513-13 | Target: CSEN | UniProt: Q9Y2W7 | TargetFullName: Calsenilin | Organisim: human | Apparent_Kd_M: 3.615028E-11

Real

Aptamer SeqId:10514-5;Target:PGD2 synthase;UniProt:P41222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10514-5;Target: PGD2 synthase;UniProt: P41222;TargetFullName: Prostaglandin-H2 D-isomerase;Organisim: human;Apparent_Kd_M: 1.87172E-11

Real

Aptamer SeqId: 10514-5 | Target: PGD2 synthase | UniProt: P41222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10514-5 | Target: PGD2 synthase | UniProt: P41222 | TargetFullName: Prostaglandin-H2 D-isomerase | Organisim: human | Apparent_Kd_M: 1.87172E-11

Real

Aptamer SeqId:10516-53;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10516-53;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.947234E-11

Real

Aptamer SeqId: 10516-53 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10516-53 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.947234E-11

Real

Aptamer SeqId:10518-14;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10518-14;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.299399E-11

Real

Aptamer SeqId: 10518-14 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10518-14 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.299399E-11

Real

Aptamer SeqId:10521-10;Target:MXRA8;UniProt:Q9BRK3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10521-10;Target: MXRA8;UniProt: Q9BRK3;TargetFullName: Matrix-remodeling-associated protein 8;Organisim: human;Apparent_Kd_M: 3.395888E-12

Real

Aptamer SeqId: 10521-10 | Target: MXRA8 | UniProt: Q9BRK3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10521-10 | Target: MXRA8 | UniProt: Q9BRK3 | TargetFullName: Matrix-remodeling-associated protein 8 | Organisim: human | Apparent_Kd_M: 3.395888E-12

Real

Aptamer SeqId:10522-167;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10522-167;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.289894E-11

Real

Aptamer SeqId: 10522-167 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10522-167 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.289894E-11

Real

Aptamer SeqId:10527-22;Target:DHX9;UniProt:Q08211

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10527-22;Target: DHX9;UniProt: Q08211;TargetFullName: ATP-dependent RNA helicase A;Organisim: human;Apparent_Kd_M: 1.992942E-11

Real

Aptamer SeqId: 10527-22 | Target: DHX9 | UniProt: Q08211

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10527-22 | Target: DHX9 | UniProt: Q08211 | TargetFullName: ATP-dependent RNA helicase A | Organisim: human | Apparent_Kd_M: 1.992942E-11

Real

Aptamer SeqId:10529-19;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10529-19;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.01845E-11

Real

Aptamer SeqId: 10529-19 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10529-19 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.01845E-11

Real

Aptamer SeqId:10530-8;Target:PSB6;UniProt:P28072

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10530-8;Target: PSB6;UniProt: P28072;TargetFullName: Proteasome subunit beta type-6;Organisim: human;Apparent_Kd_M: 6.015654E-10

Real

Aptamer SeqId: 10530-8 | Target: PSB6 | UniProt: P28072

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10530-8 | Target: PSB6 | UniProt: P28072 | TargetFullName: Proteasome subunit beta type-6 | Organisim: human | Apparent_Kd_M: 6.015654E-10

Real

Aptamer SeqId:10531-18;Target:RASN;UniProt:P01111

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10531-18;Target: RASN;UniProt: P01111;TargetFullName: GTPase NRas;Organisim: human;Apparent_Kd_M: 4.119602E-11

Real

Aptamer SeqId: 10531-18 | Target: RASN | UniProt: P01111

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10531-18 | Target: RASN | UniProt: P01111 | TargetFullName: GTPase NRas | Organisim: human | Apparent_Kd_M: 4.119602E-11

Real

Aptamer SeqId:10533-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10533-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.839458E-11

Real

Aptamer SeqId: 10533-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10533-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.839458E-11

Real

Aptamer SeqId:10534-40;Target:PARP;UniProt:P09874

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10534-40;Target: PARP;UniProt: P09874;TargetFullName: Poly [ADP-ribose] polymerase 1;Organisim: human;Apparent_Kd_M: 5.630502E-11

Real

Aptamer SeqId: 10534-40 | Target: PARP | UniProt: P09874

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10534-40 | Target: PARP | UniProt: P09874 | TargetFullName: Poly ADP-ribose polymerase 1 | Organisim: human | Apparent_Kd_M: 5.630502E-11

Real

Aptamer SeqId:10535-25;Target:CX6A2;UniProt:Q02221

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10535-25;Target: CX6A2;UniProt: Q02221;TargetFullName: Cytochrome c oxidase subunit 6A2; mitochondrial;Organisim: human;Apparent_Kd_M: 2.605286E-11

Real

Aptamer SeqId: 10535-25 | Target: CX6A2 | UniProt: Q02221

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10535-25 | Target: CX6A2 | UniProt: Q02221 | TargetFullName: Cytochrome c oxidase subunit 6A2; mitochondrial | Organisim: human | Apparent_Kd_M: 2.605286E-11

Real

Aptamer SeqId:10539-30;Target:C99L2;UniProt:Q8TCZ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10539-30;Target: C99L2;UniProt: Q8TCZ2;TargetFullName: CD99 antigen-like protein 2;Organisim: human;Apparent_Kd_M: 7.189129E-10

Real

Aptamer SeqId: 10539-30 | Target: C99L2 | UniProt: Q8TCZ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10539-30 | Target: C99L2 | UniProt: Q8TCZ2 | TargetFullName: CD99 antigen-like protein 2 | Organisim: human | Apparent_Kd_M: 7.189129E-10

Real

Aptamer SeqId:10546-2;Target:TSEAR;UniProt:Q8WU66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10546-2;Target: TSEAR;UniProt: Q8WU66;TargetFullName: Thrombospondin-type laminin G domain and EAR repeat-containing protein;Organisim: human;Apparent_Kd_M: 2.713605E-10

Real

Aptamer SeqId: 10546-2 | Target: TSEAR | UniProt: Q8WU66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10546-2 | Target: TSEAR | UniProt: Q8WU66 | TargetFullName: Thrombospondin-type laminin G domain and EAR repeat-containing protein | Organisim: human | Apparent_Kd_M: 2.713605E-10

Real

Aptamer SeqId:10547-42;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10547-42;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.772629E-12

Real

Aptamer SeqId: 10547-42 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10547-42 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.772629E-12

Real

Aptamer SeqId:10548-35;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10548-35;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.848974E-11

Real

Aptamer SeqId: 10548-35 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10548-35 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.848974E-11

Real

Aptamer SeqId:10550-37;Target:BMP RIB;UniProt:O00238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10550-37;Target: BMP RIB;UniProt: O00238;TargetFullName: Bone morphogenetic protein receptor type-1B;Organisim: human;Apparent_Kd_M: 3.616782E-10

Real

Aptamer SeqId: 10550-37 | Target: BMP RIB | UniProt: O00238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10550-37 | Target: BMP RIB | UniProt: O00238 | TargetFullName: Bone morphogenetic protein receptor type-1B | Organisim: human | Apparent_Kd_M: 3.616782E-10

Real

Aptamer SeqId:10551-7;Target:LAT;UniProt:O43561

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10551-7;Target: LAT;UniProt: O43561;TargetFullName: Linker for activation of T-cells family member 1;Organisim: human;Apparent_Kd_M: 1.758048E-10

Real

Aptamer SeqId: 10551-7 | Target: LAT | UniProt: O43561

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10551-7 | Target: LAT | UniProt: O43561 | TargetFullName: Linker for activation of T-cells family member 1 | Organisim: human | Apparent_Kd_M: 1.758048E-10

Real

Aptamer SeqId:10552-88;Target:NKG2F;UniProt:O43908

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10552-88;Target: NKG2F;UniProt: O43908;TargetFullName: NKG2-F type II integral membrane protein;Organisim: human;Apparent_Kd_M: 6.016723E-12

Real

Aptamer SeqId: 10552-88 | Target: NKG2F | UniProt: O43908

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10552-88 | Target: NKG2F | UniProt: O43908 | TargetFullName: NKG2-F type II integral membrane protein | Organisim: human | Apparent_Kd_M: 6.016723E-12

Real

Aptamer SeqId:10553-8;Target:TOIP2;UniProt:Q8NFQ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10553-8;Target: TOIP2;UniProt: Q8NFQ8;TargetFullName: Torsin-1A-interacting protein 2;Organisim: human;Apparent_Kd_M: 1.530337E-11

Real

Aptamer SeqId: 10553-8 | Target: TOIP2 | UniProt: Q8NFQ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10553-8 | Target: TOIP2 | UniProt: Q8NFQ8 | TargetFullName: Torsin-1A-interacting protein 2 | Organisim: human | Apparent_Kd_M: 1.530337E-11

Real

Aptamer SeqId:10554-23;Target:BGAL;UniProt:P16278

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10554-23;Target: BGAL;UniProt: P16278;TargetFullName: Beta-galactosidase;Organisim: human;Apparent_Kd_M: 7.730195E-11

Real

Aptamer SeqId: 10554-23 | Target: BGAL | UniProt: P16278

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10554-23 | Target: BGAL | UniProt: P16278 | TargetFullName: Beta-galactosidase | Organisim: human | Apparent_Kd_M: 7.730195E-11

Real

Aptamer SeqId:10557-6;Target:TEX29;UniProt:Q8N6K0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10557-6;Target: TEX29;UniProt: Q8N6K0;TargetFullName: Testis-expressed sequence 29 protein;Organisim: human;Apparent_Kd_M: 7.220938E-12

Real

Aptamer SeqId: 10557-6 | Target: TEX29 | UniProt: Q8N6K0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10557-6 | Target: TEX29 | UniProt: Q8N6K0 | TargetFullName: Testis-expressed sequence 29 protein | Organisim: human | Apparent_Kd_M: 7.220938E-12

Real

Aptamer SeqId:10558-26;Target:PCDH9;UniProt:Q9HC56

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10558-26;Target: PCDH9;UniProt: Q9HC56;TargetFullName: Protocadherin-9;Organisim: human;Apparent_Kd_M: 1.333987E-10

Real

Aptamer SeqId: 10558-26 | Target: PCDH9 | UniProt: Q9HC56

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10558-26 | Target: PCDH9 | UniProt: Q9HC56 | TargetFullName: Protocadherin-9 | Organisim: human | Apparent_Kd_M: 1.333987E-10

Real

Aptamer SeqId:10560-1;Target:ITM2C;UniProt:Q9NQX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10560-1;Target: ITM2C;UniProt: Q9NQX7;TargetFullName: Integral membrane protein 2C;Organisim: human;Apparent_Kd_M: 6.835532E-12

Real

Aptamer SeqId: 10560-1 | Target: ITM2C | UniProt: Q9NQX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10560-1 | Target: ITM2C | UniProt: Q9NQX7 | TargetFullName: Integral membrane protein 2C | Organisim: human | Apparent_Kd_M: 6.835532E-12

Real

Aptamer SeqId:10561-5;Target:PGRP-I-alpha;UniProt:Q96LB9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10561-5;Target: PGRP-I-alpha;UniProt: Q96LB9;TargetFullName: Peptidoglycan recognition protein 3;Organisim: human;Apparent_Kd_M: 2.494541E-11

Real

Aptamer SeqId: 10561-5 | Target: PGRP-I-alpha | UniProt: Q96LB9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10561-5 | Target: PGRP-I-alpha | UniProt: Q96LB9 | TargetFullName: Peptidoglycan recognition protein 3 | Organisim: human | Apparent_Kd_M: 2.494541E-11

Real

Aptamer SeqId:10562-42;Target:NETO2;UniProt:Q8NC67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10562-42;Target: NETO2;UniProt: Q8NC67;TargetFullName: Neuropilin and tolloid-like protein 2;Organisim: human;Apparent_Kd_M: 5.001589E-11

Real

Aptamer SeqId: 10562-42 | Target: NETO2 | UniProt: Q8NC67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10562-42 | Target: NETO2 | UniProt: Q8NC67 | TargetFullName: Neuropilin and tolloid-like protein 2 | Organisim: human | Apparent_Kd_M: 5.001589E-11

Real

Aptamer SeqId:10563-13;Target:LYSM3;UniProt:Q7Z3D4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10563-13;Target: LYSM3;UniProt: Q7Z3D4;TargetFullName: LysM and putative peptidoglycan-binding domain-containing protein 3;Organisim: human;Apparent_Kd_M: 5.509922E-11

Real

Aptamer SeqId: 10563-13 | Target: LYSM3 | UniProt: Q7Z3D4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10563-13 | Target: LYSM3 | UniProt: Q7Z3D4 | TargetFullName: LysM and putative peptidoglycan-binding domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 5.509922E-11

Real

Aptamer SeqId:10565-19;Target:SLIK3;UniProt:O94933

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10565-19;Target: SLIK3;UniProt: O94933;TargetFullName: SLIT and NTRK-like protein 3;Organisim: human;Apparent_Kd_M: 8.958962E-12

Real

Aptamer SeqId: 10565-19 | Target: SLIK3 | UniProt: O94933

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10565-19 | Target: SLIK3 | UniProt: O94933 | TargetFullName: SLIT and NTRK-like protein 3 | Organisim: human | Apparent_Kd_M: 8.958962E-12

Real

Aptamer SeqId:10569-28;Target:MFAP2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10569-28;Target: MFAP2;UniProt:;TargetFullName: Microfibrillar-associated protein 2;Organisim: human;Apparent_Kd_M: 1.336087E-10

Real

Aptamer SeqId: 10569-28 | Target: MFAP2 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10569-28 | Target: MFAP2 | UniProt: | TargetFullName: Microfibrillar-associated protein 2 | Organisim: human | Apparent_Kd_M: 1.336087E-10

Real

Aptamer SeqId:10571-14;Target:MGAT1;UniProt:P26572

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10571-14;Target: MGAT1;UniProt: P26572;TargetFullName: Alpha-1;3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase;Organisim: human;Apparent_Kd_M: 1.026508E-11

Real

Aptamer SeqId: 10571-14 | Target: MGAT1 | UniProt: P26572

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10571-14 | Target: MGAT1 | UniProt: P26572 | TargetFullName: Alpha-1;3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Organisim: human | Apparent_Kd_M: 1.026508E-11

Real

Aptamer SeqId:10572-65;Target:CST8;UniProt:O60676

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10572-65;Target: CST8;UniProt: O60676;TargetFullName: Cystatin-8;Organisim: human;Apparent_Kd_M: 6.868947E-11

Real

Aptamer SeqId: 10572-65 | Target: CST8 | UniProt: O60676

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10572-65 | Target: CST8 | UniProt: O60676 | TargetFullName: Cystatin-8 | Organisim: human | Apparent_Kd_M: 6.868947E-11

Real

Aptamer SeqId:10574-10;Target:b2-Microglobulin

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10574-10;Target: b2-Microglobulin;UniProt:;TargetFullName: Beta-2-microglobulin;Organisim: human;Apparent_Kd_M: 3.855881E-12

Real

Aptamer SeqId: 10574-10 | Target: b2-Microglobulin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10574-10 | Target: b2-Microglobulin | UniProt: | TargetFullName: Beta-2-microglobulin | Organisim: human | Apparent_Kd_M: 3.855881E-12

Real

Aptamer SeqId:10575-31;Target:PUF60;UniProt:Q9UHX1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10575-31;Target: PUF60;UniProt: Q9UHX1;TargetFullName: Poly(U)-binding-splicing factor PUF60;Organisim: human;Apparent_Kd_M: 3.791703E-12

Real

Aptamer SeqId: 10575-31 | Target: PUF60 | UniProt: Q9UHX1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10575-31 | Target: PUF60 | UniProt: Q9UHX1 | TargetFullName: Poly(U)-binding-splicing factor PUF60 | Organisim: human | Apparent_Kd_M: 3.791703E-12

Real

Aptamer SeqId:10580-14;Target:SFTA2;UniProt:Q6UW10

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10580-14;Target: SFTA2;UniProt: Q6UW10;TargetFullName: Surfactant-associated protein 2;Organisim: human;Apparent_Kd_M: 2.491013E-11

Real

Aptamer SeqId: 10580-14 | Target: SFTA2 | UniProt: Q6UW10

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10580-14 | Target: SFTA2 | UniProt: Q6UW10 | TargetFullName: Surfactant-associated protein 2 | Organisim: human | Apparent_Kd_M: 2.491013E-11

Real

Aptamer SeqId:10582-36;Target:SG196;UniProt:Q9H5K3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10582-36;Target: SG196;UniProt: Q9H5K3;TargetFullName: Protein O-mannose kinase;Organisim: human;Apparent_Kd_M: 1.342557E-10

Real

Aptamer SeqId: 10582-36 | Target: SG196 | UniProt: Q9H5K3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10582-36 | Target: SG196 | UniProt: Q9H5K3 | TargetFullName: Protein O-mannose kinase | Organisim: human | Apparent_Kd_M: 1.342557E-10

Real

Aptamer SeqId:10583-1;Target:TM108;UniProt:Q6UXF1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10583-1;Target: TM108;UniProt: Q6UXF1;TargetFullName: Transmembrane protein 108;Organisim: human;Apparent_Kd_M: 1.605435E-10

Real

Aptamer SeqId: 10583-1 | Target: TM108 | UniProt: Q6UXF1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10583-1 | Target: TM108 | UniProt: Q6UXF1 | TargetFullName: Transmembrane protein 108 | Organisim: human | Apparent_Kd_M: 1.605435E-10

Real

Aptamer SeqId:10584-7;Target:NDUS4;UniProt:O43181

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10584-7;Target: NDUS4;UniProt: O43181;TargetFullName: NADH dehydrogenase [ubiquinone] iron-sulfur protein 4; mitochondrial;Organisim: human;Apparent_Kd_M: 2.432584E-11

Real

Aptamer SeqId: 10584-7 | Target: NDUS4 | UniProt: O43181

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10584-7 | Target: NDUS4 | UniProt: O43181 | TargetFullName: NADH dehydrogenase ubiquinone iron-sulfur protein 4; mitochondrial | Organisim: human | Apparent_Kd_M: 2.432584E-11

Real

Aptamer SeqId:10588-39;Target:SIAT9;UniProt:Q9UNP4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10588-39;Target: SIAT9;UniProt: Q9UNP4;TargetFullName: Lactosylceramide alpha-2;3-sialyltransferase;Organisim: human;Apparent_Kd_M: 4.334023E-11

Real

Aptamer SeqId: 10588-39 | Target: SIAT9 | UniProt: Q9UNP4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10588-39 | Target: SIAT9 | UniProt: Q9UNP4 | TargetFullName: Lactosylceramide alpha-2;3-sialyltransferase | Organisim: human | Apparent_Kd_M: 4.334023E-11

Real

Aptamer SeqId:10589-7;Target:RET1L;UniProt:Q5VY80

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10589-7;Target: RET1L;UniProt: Q5VY80;TargetFullName: Retinoic acid early transcript 1L protein;Organisim: human;Apparent_Kd_M: 2.192516E-10

Real

Aptamer SeqId: 10589-7 | Target: RET1L | UniProt: Q5VY80

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10589-7 | Target: RET1L | UniProt: Q5VY80 | TargetFullName: Retinoic acid early transcript 1L protein | Organisim: human | Apparent_Kd_M: 2.192516E-10

Real

Aptamer SeqId:10593-14;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10593-14;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.7512E-10

Real

Aptamer SeqId: 10593-14 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10593-14 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.7512E-10

Real

Aptamer SeqId:10600-24;Target:CLGN;UniProt:O14967

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10600-24;Target: CLGN;UniProt: O14967;TargetFullName: Calmegin;Organisim: human;Apparent_Kd_M: 6.299843E-11

Real

Aptamer SeqId: 10600-24 | Target: CLGN | UniProt: O14967

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10600-24 | Target: CLGN | UniProt: O14967 | TargetFullName: Calmegin | Organisim: human | Apparent_Kd_M: 6.299843E-11

Real

Aptamer SeqId:10603-1;Target:HIS3;UniProt:P15516

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10603-1;Target: HIS3;UniProt: P15516;TargetFullName: Histatin-3;Organisim: human;Apparent_Kd_M: 1.066727E-11

Real

Aptamer SeqId: 10603-1 | Target: HIS3 | UniProt: P15516

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10603-1 | Target: HIS3 | UniProt: P15516 | TargetFullName: Histatin-3 | Organisim: human | Apparent_Kd_M: 1.066727E-11

Real

Aptamer SeqId:10605-22;Target:APMAP;UniProt:Q9HDC9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10605-22;Target: APMAP;UniProt: Q9HDC9;TargetFullName: Adipocyte plasma membrane-associated protein;Organisim: human;Apparent_Kd_M: 5.630031E-11

Real

Aptamer SeqId: 10605-22 | Target: APMAP | UniProt: Q9HDC9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10605-22 | Target: APMAP | UniProt: Q9HDC9 | TargetFullName: Adipocyte plasma membrane-associated protein | Organisim: human | Apparent_Kd_M: 5.630031E-11

Real

Aptamer SeqId:10606-34;Target:TOIP1;UniProt:Q5JTV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10606-34;Target: TOIP1;UniProt: Q5JTV8;TargetFullName: Torsin-1A-interacting protein 1;Organisim: human;Apparent_Kd_M: 1.550677E-12

Real

Aptamer SeqId: 10606-34 | Target: TOIP1 | UniProt: Q5JTV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10606-34 | Target: TOIP1 | UniProt: Q5JTV8 | TargetFullName: Torsin-1A-interacting protein 1 | Organisim: human | Apparent_Kd_M: 1.550677E-12

Real

Aptamer SeqId:10607-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10607-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.36797E-12

Real

Aptamer SeqId: 10607-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10607-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.36797E-12

Real

Aptamer SeqId:10608-9;Target:HIS1;UniProt:P15515

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10608-9;Target: HIS1;UniProt: P15515;TargetFullName: Histatin-1;Organisim: human;Apparent_Kd_M: 4.501146E-10

Real

Aptamer SeqId: 10608-9 | Target: HIS1 | UniProt: P15515

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10608-9 | Target: HIS1 | UniProt: P15515 | TargetFullName: Histatin-1 | Organisim: human | Apparent_Kd_M: 4.501146E-10

Real

Aptamer SeqId:10610-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10610-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.354963E-11

Real

Aptamer SeqId: 10610-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10610-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.354963E-11

Real

Aptamer SeqId:10612-18;Target:PLOD3;UniProt:O60568

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10612-18;Target: PLOD3;UniProt: O60568;TargetFullName: Procollagen-lysine;2-oxoglutarate 5-dioxygenase 3;Organisim: human;Apparent_Kd_M: 9.427786E-13

Real

Aptamer SeqId: 10612-18 | Target: PLOD3 | UniProt: O60568

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10612-18 | Target: PLOD3 | UniProt: O60568 | TargetFullName: Procollagen-lysine;2-oxoglutarate 5-dioxygenase 3 | Organisim: human | Apparent_Kd_M: 9.427786E-13

Real

Aptamer SeqId:10613-33;Target:CASC4;UniProt:Q6P4E1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10613-33;Target: CASC4;UniProt: Q6P4E1;TargetFullName: Protein CASC4;Organisim: human;Apparent_Kd_M: 2.74337E-11

Real

Aptamer SeqId: 10613-33 | Target: CASC4 | UniProt: Q6P4E1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10613-33 | Target: CASC4 | UniProt: Q6P4E1 | TargetFullName: Protein CASC4 | Organisim: human | Apparent_Kd_M: 2.74337E-11

Real

Aptamer SeqId:10615-18;Target:MYP0;UniProt:P25189

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10615-18;Target: MYP0;UniProt: P25189;TargetFullName: Myelin protein P0;Organisim: human;Apparent_Kd_M: 6.128802E-12

Real

Aptamer SeqId: 10615-18 | Target: MYP0 | UniProt: P25189

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10615-18 | Target: MYP0 | UniProt: P25189 | TargetFullName: Myelin protein P0 | Organisim: human | Apparent_Kd_M: 6.128802E-12

Real

Aptamer SeqId:10616-67;Target:PDXL2;UniProt:Q9NZ53

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10616-67;Target: PDXL2;UniProt: Q9NZ53;TargetFullName: Podocalyxin-like protein 2;Organisim: human;Apparent_Kd_M: 4.298275E-12

Real

Aptamer SeqId: 10616-67 | Target: PDXL2 | UniProt: Q9NZ53

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10616-67 | Target: PDXL2 | UniProt: Q9NZ53 | TargetFullName: Podocalyxin-like protein 2 | Organisim: human | Apparent_Kd_M: 4.298275E-12

Real

Aptamer SeqId:10618-190;Target:megalin;UniProt:P98164

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10618-190;Target: megalin;UniProt: P98164;TargetFullName: Low-density lipoprotein receptor-related protein 2;Organisim: human;Apparent_Kd_M: 7.808546E-12

Real

Aptamer SeqId: 10618-190 | Target: megalin | UniProt: P98164

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10618-190 | Target: megalin | UniProt: P98164 | TargetFullName: Low-density lipoprotein receptor-related protein 2 | Organisim: human | Apparent_Kd_M: 7.808546E-12

Real

Aptamer SeqId:10620-21;Target:PSP-94;UniProt:P08118

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10620-21;Target: PSP-94;UniProt: P08118;TargetFullName: Beta-microseminoprotein;Organisim: human;Apparent_Kd_M: 8.14832E-13

Real

Aptamer SeqId: 10620-21 | Target: PSP-94 | UniProt: P08118

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10620-21 | Target: PSP-94 | UniProt: P08118 | TargetFullName: Beta-microseminoprotein | Organisim: human | Apparent_Kd_M: 8.14832E-13

Real

Aptamer SeqId:10621-26;Target:PRR16;UniProt:Q569H4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10621-26;Target: PRR16;UniProt: Q569H4;TargetFullName: Protein Largen;Organisim: human;Apparent_Kd_M: 3.872804E-11

Real

Aptamer SeqId: 10621-26 | Target: PRR16 | UniProt: Q569H4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10621-26 | Target: PRR16 | UniProt: Q569H4 | TargetFullName: Protein Largen | Organisim: human | Apparent_Kd_M: 3.872804E-11

Real

Aptamer SeqId:10622-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10622-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.496621E-12

Real

Aptamer SeqId: 10622-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10622-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.496621E-12

Real

Aptamer SeqId:10623-19;Target:MUC1;UniProt:P15941

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10623-19;Target: MUC1;UniProt: P15941;TargetFullName: Mucin-1;Organisim: human;Apparent_Kd_M: 2.389687E-12

Real

Aptamer SeqId: 10623-19 | Target: MUC1 | UniProt: P15941

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10623-19 | Target: MUC1 | UniProt: P15941 | TargetFullName: Mucin-1 | Organisim: human | Apparent_Kd_M: 2.389687E-12

Real

Aptamer SeqId:10624-45;Target:ISK13;UniProt:Q1W4C9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10624-45;Target: ISK13;UniProt: Q1W4C9;TargetFullName: Serine protease inhibitor Kazal-type 13;Organisim: human;Apparent_Kd_M: 3.100195E-12

Real

Aptamer SeqId: 10624-45 | Target: ISK13 | UniProt: Q1W4C9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10624-45 | Target: ISK13 | UniProt: Q1W4C9 | TargetFullName: Serine protease inhibitor Kazal-type 13 | Organisim: human | Apparent_Kd_M: 3.100195E-12

Real

Aptamer SeqId:10627-87;Target:APLP2;UniProt:Q06481

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10627-87;Target: APLP2;UniProt: Q06481;TargetFullName: Amyloid-like protein 2;Organisim: human;Apparent_Kd_M: 3.523689E-13

Real

Aptamer SeqId: 10627-87 | Target: APLP2 | UniProt: Q06481

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10627-87 | Target: APLP2 | UniProt: Q06481 | TargetFullName: Amyloid-like protein 2 | Organisim: human | Apparent_Kd_M: 3.523689E-13

Real

Aptamer SeqId:10630-5;Target:HTAI2;UniProt:Q9BUP3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10630-5;Target: HTAI2;UniProt: Q9BUP3;TargetFullName: Oxidoreductase HTATIP2;Organisim: human;Apparent_Kd_M: 2.92304E-11

Real

Aptamer SeqId: 10630-5 | Target: HTAI2 | UniProt: Q9BUP3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10630-5 | Target: HTAI2 | UniProt: Q9BUP3 | TargetFullName: Oxidoreductase HTATIP2 | Organisim: human | Apparent_Kd_M: 2.92304E-11

Real

Aptamer SeqId:10637-50;Target:K1324;UniProt:Q6UXG2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10637-50;Target: K1324;UniProt: Q6UXG2;TargetFullName: UPF0577 protein KIAA1324;Organisim: human;Apparent_Kd_M: 6.845908E-12

Real

Aptamer SeqId: 10637-50 | Target: K1324 | UniProt: Q6UXG2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10637-50 | Target: K1324 | UniProt: Q6UXG2 | TargetFullName: UPF0577 protein KIAA1324 | Organisim: human | Apparent_Kd_M: 6.845908E-12

Real

Aptamer SeqId:10638-1;Target:TINF2;UniProt:Q9BSI4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10638-1;Target: TINF2;UniProt: Q9BSI4;TargetFullName: TERF1-interacting nuclear factor 2;Organisim: human;Apparent_Kd_M: 5.426284E-12

Real

Aptamer SeqId: 10638-1 | Target: TINF2 | UniProt: Q9BSI4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10638-1 | Target: TINF2 | UniProt: Q9BSI4 | TargetFullName: TERF1-interacting nuclear factor 2 | Organisim: human | Apparent_Kd_M: 5.426284E-12

Real

Aptamer SeqId:10639-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10639-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.35E-10

Real

Aptamer SeqId: 10639-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10639-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.35E-10

Real

Aptamer SeqId:10640-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10640-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.993581E-13

Real

Aptamer SeqId: 10640-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10640-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.993581E-13

Real

Aptamer SeqId:10643-16;Target:NOE3;UniProt:Q96PB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10643-16;Target: NOE3;UniProt: Q96PB7;TargetFullName: Noelin-3;Organisim: human;Apparent_Kd_M: 3.850645E-12

Real

Aptamer SeqId: 10643-16 | Target: NOE3 | UniProt: Q96PB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10643-16 | Target: NOE3 | UniProt: Q96PB7 | TargetFullName: Noelin-3 | Organisim: human | Apparent_Kd_M: 3.850645E-12

Real

Aptamer SeqId:10645-72;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10645-72;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.130259E-11

Real

Aptamer SeqId: 10645-72 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10645-72 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.130259E-11

Real

Aptamer SeqId:10647-18;Target:ASCC1;UniProt:Q8N9N2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10647-18;Target: ASCC1;UniProt: Q8N9N2;TargetFullName: Activating signal cointegrator 1 complex subunit 1;Organisim: human;Apparent_Kd_M: 3.035603E-11

Real

Aptamer SeqId: 10647-18 | Target: ASCC1 | UniProt: Q8N9N2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10647-18 | Target: ASCC1 | UniProt: Q8N9N2 | TargetFullName: Activating signal cointegrator 1 complex subunit 1 | Organisim: human | Apparent_Kd_M: 3.035603E-11

Real

Aptamer SeqId:10655-43;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10655-43;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.100349E-12

Real

Aptamer SeqId: 10655-43 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10655-43 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.100349E-12

Real

Aptamer SeqId:10658-28;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10658-28;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.617205E-11

Real

Aptamer SeqId: 10658-28 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10658-28 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.617205E-11

Real

Aptamer SeqId:10659-49;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10659-49;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.12665E-11

Real

Aptamer SeqId: 10659-49 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10659-49 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.12665E-11

Real

Aptamer SeqId:10660-33;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10660-33;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.360944E-11

Real

Aptamer SeqId: 10660-33 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10660-33 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.360944E-11

Real

Aptamer SeqId:10661-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10661-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.496104E-11

Real

Aptamer SeqId: 10661-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10661-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.496104E-11

Real

Aptamer SeqId:10663-42;Target:INSI1;UniProt:O15503

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10663-42;Target: INSI1;UniProt: O15503;TargetFullName: Insulin-induced gene 1 protein;Organisim: human;Apparent_Kd_M: 2.074754E-11

Real

Aptamer SeqId: 10663-42 | Target: INSI1 | UniProt: O15503

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10663-42 | Target: INSI1 | UniProt: O15503 | TargetFullName: Insulin-induced gene 1 protein | Organisim: human | Apparent_Kd_M: 2.074754E-11

Real

Aptamer SeqId:10665-30;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10665-30;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.126561E-11

Real

Aptamer SeqId: 10665-30 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10665-30 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.126561E-11

Real

Aptamer SeqId:10666-7;Target:GNPTG;UniProt:Q9UJJ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10666-7;Target: GNPTG;UniProt: Q9UJJ9;TargetFullName: N-acetylglucosamine-1-phosphotransferase subunit gamma;Organisim: human;Apparent_Kd_M: 2.799442E-12

Real

Aptamer SeqId: 10666-7 | Target: GNPTG | UniProt: Q9UJJ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10666-7 | Target: GNPTG | UniProt: Q9UJJ9 | TargetFullName: N-acetylglucosamine-1-phosphotransferase subunit gamma | Organisim: human | Apparent_Kd_M: 2.799442E-12

Real

Aptamer SeqId:10667-78;Target:CA185;UniProt:Q5T7R7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10667-78;Target: CA185;UniProt: Q5T7R7;TargetFullName: Uncharacterized protein C1orf185;Organisim: human;Apparent_Kd_M: 1.099445E-11

Real

Aptamer SeqId: 10667-78 | Target: CA185 | UniProt: Q5T7R7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10667-78 | Target: CA185 | UniProt: Q5T7R7 | TargetFullName: Uncharacterized protein C1orf185 | Organisim: human | Apparent_Kd_M: 1.099445E-11

Real

Aptamer SeqId:10668-5;Target:STX4;UniProt:Q12846

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10668-5;Target: STX4;UniProt: Q12846;TargetFullName: Syntaxin-4;Organisim: human;Apparent_Kd_M: 1.656652E-11

Real

Aptamer SeqId: 10668-5 | Target: STX4 | UniProt: Q12846

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10668-5 | Target: STX4 | UniProt: Q12846 | TargetFullName: Syntaxin-4 | Organisim: human | Apparent_Kd_M: 1.656652E-11

Real

Aptamer SeqId:10671-67;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10671-67;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.90391E-12

Real

Aptamer SeqId: 10671-67 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10671-67 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.90391E-12

Real

Aptamer SeqId:10672-75;Target:SP-B;UniProt:P07988

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10672-75;Target: SP-B;UniProt: P07988;TargetFullName: Pulmonary surfactant-associated protein B;Organisim: human;Apparent_Kd_M: 6.508364E-11

Real

Aptamer SeqId: 10672-75 | Target: SP-B | UniProt: P07988

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10672-75 | Target: SP-B | UniProt: P07988 | TargetFullName: Pulmonary surfactant-associated protein B | Organisim: human | Apparent_Kd_M: 6.508364E-11

Real

Aptamer SeqId:10675-223;Target:TMX2;UniProt:Q9Y320

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10675-223;Target: TMX2;UniProt: Q9Y320;TargetFullName: Thioredoxin-related transmembrane protein 2;Organisim: human;Apparent_Kd_M: 1.04137E-10

Real

Aptamer SeqId: 10675-223 | Target: TMX2 | UniProt: Q9Y320

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10675-223 | Target: TMX2 | UniProt: Q9Y320 | TargetFullName: Thioredoxin-related transmembrane protein 2 | Organisim: human | Apparent_Kd_M: 1.04137E-10

Real

Aptamer SeqId:10677-9;Target:NDUB4;UniProt:O95168

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10677-9;Target: NDUB4;UniProt: O95168;TargetFullName: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4;Organisim: human;Apparent_Kd_M: 3.254193E-11

Real

Aptamer SeqId: 10677-9 | Target: NDUB4 | UniProt: O95168

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10677-9 | Target: NDUB4 | UniProt: O95168 | TargetFullName: NADH dehydrogenase ubiquinone 1 beta subcomplex subunit 4 | Organisim: human | Apparent_Kd_M: 3.254193E-11

Real

Aptamer SeqId:10692-48;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10692-48;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.240477E-12

Real

Aptamer SeqId: 10692-48 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10692-48 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.240477E-12

Real

Aptamer SeqId:10693-43;Target:KLRG2;UniProt:A4D1S0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10693-43;Target: KLRG2;UniProt: A4D1S0;TargetFullName: Killer cell lectin-like receptor subfamily G member 2;Organisim: human;Apparent_Kd_M: 4.771176E-11

Real

Aptamer SeqId: 10693-43 | Target: KLRG2 | UniProt: A4D1S0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10693-43 | Target: KLRG2 | UniProt: A4D1S0 | TargetFullName: Killer cell lectin-like receptor subfamily G member 2 | Organisim: human | Apparent_Kd_M: 4.771176E-11

Real

Aptamer SeqId:10695-12;Target:WF10B;UniProt:Q8IUB3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10695-12;Target: WF10B;UniProt: Q8IUB3;TargetFullName: Protein WFDC10B;Organisim: human;Apparent_Kd_M: 1.600743E-11

Real

Aptamer SeqId: 10695-12 | Target: WF10B | UniProt: Q8IUB3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10695-12 | Target: WF10B | UniProt: Q8IUB3 | TargetFullName: Protein WFDC10B | Organisim: human | Apparent_Kd_M: 1.600743E-11

Real

Aptamer SeqId:10699-52;Target:LRP1;UniProt:Q07954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10699-52;Target: LRP1;UniProt: Q07954;TargetFullName: Prolow-density lipoprotein receptor-related protein 1;Organisim: human;Apparent_Kd_M: 4.13069E-11

Real

Aptamer SeqId: 10699-52 | Target: LRP1 | UniProt: Q07954

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10699-52 | Target: LRP1 | UniProt: Q07954 | TargetFullName: Prolow-density lipoprotein receptor-related protein 1 | Organisim: human | Apparent_Kd_M: 4.13069E-11

Real

Aptamer SeqId:10700-10;Target:IGS11;UniProt:Q5DX21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10700-10;Target: IGS11;UniProt: Q5DX21;TargetFullName: Immunoglobulin superfamily member 11;Organisim: human;Apparent_Kd_M: 1.996639E-11

Real

Aptamer SeqId: 10700-10 | Target: IGS11 | UniProt: Q5DX21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10700-10 | Target: IGS11 | UniProt: Q5DX21 | TargetFullName: Immunoglobulin superfamily member 11 | Organisim: human | Apparent_Kd_M: 1.996639E-11

Real

Aptamer SeqId:10701-30;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10701-30;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.759508E-11

Real

Aptamer SeqId: 10701-30 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10701-30 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.759508E-11

Real

Aptamer SeqId:10702-1;Target:COSA1;UniProt:Q2UY09

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10702-1;Target: COSA1;UniProt: Q2UY09;TargetFullName: Collagen alpha-1(XXVIII) chain;Organisim: human;Apparent_Kd_M: 2.274225E-11

Real

Aptamer SeqId: 10702-1 | Target: COSA1 | UniProt: Q2UY09

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10702-1 | Target: COSA1 | UniProt: Q2UY09 | TargetFullName: Collagen alpha-1(XXVIII) chain | Organisim: human | Apparent_Kd_M: 2.274225E-11

Real

Aptamer SeqId:10703-203;Target:SDS3;UniProt:Q9H7L9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10703-203;Target: SDS3;UniProt: Q9H7L9;TargetFullName: Sin3 histone deacetylase corepressor complex component SDS3;Organisim: human;Apparent_Kd_M: 1.139953E-11

Real

Aptamer SeqId: 10703-203 | Target: SDS3 | UniProt: Q9H7L9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10703-203 | Target: SDS3 | UniProt: Q9H7L9 | TargetFullName: Sin3 histone deacetylase corepressor complex component SDS3 | Organisim: human | Apparent_Kd_M: 1.139953E-11

Real

Aptamer SeqId:10704-91;Target:LRMP;UniProt:Q12912

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10704-91;Target: LRMP;UniProt: Q12912;TargetFullName: Lymphoid-restricted membrane protein;Organisim: human;Apparent_Kd_M: 1.551691E-11

Real

Aptamer SeqId: 10704-91 | Target: LRMP | UniProt: Q12912

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10704-91 | Target: LRMP | UniProt: Q12912 | TargetFullName: Lymphoid-restricted membrane protein | Organisim: human | Apparent_Kd_M: 1.551691E-11

Real

Aptamer SeqId:10705-14;Target:SIA7C;UniProt:Q8NDV1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10705-14;Target: SIA7C;UniProt: Q8NDV1;TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 3;Organisim: human;Apparent_Kd_M: 2.608496E-11

Real

Aptamer SeqId: 10705-14 | Target: SIA7C | UniProt: Q8NDV1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10705-14 | Target: SIA7C | UniProt: Q8NDV1 | TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 3 | Organisim: human | Apparent_Kd_M: 2.608496E-11

Real

Aptamer SeqId:10708-3;Target:GON2;UniProt:O43555

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10708-3;Target: GON2;UniProt: O43555;TargetFullName: Progonadoliberin-2;Organisim: human;Apparent_Kd_M: 4.00928E-11

Real

Aptamer SeqId: 10708-3 | Target: GON2 | UniProt: O43555

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10708-3 | Target: GON2 | UniProt: O43555 | TargetFullName: Progonadoliberin-2 | Organisim: human | Apparent_Kd_M: 4.00928E-11

Real

Aptamer SeqId:10710-23;Target:ZPBP2;UniProt:Q6X784

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10710-23;Target: ZPBP2;UniProt: Q6X784;TargetFullName: Zona pellucida-binding protein 2;Organisim: human;Apparent_Kd_M: 4.664906E-12

Real

Aptamer SeqId: 10710-23 | Target: ZPBP2 | UniProt: Q6X784

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10710-23 | Target: ZPBP2 | UniProt: Q6X784 | TargetFullName: Zona pellucida-binding protein 2 | Organisim: human | Apparent_Kd_M: 4.664906E-12

Real

Aptamer SeqId:10713-151;Target:CLM7;UniProt:A8K4G0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10713-151;Target: CLM7;UniProt: A8K4G0;TargetFullName: CMRF35-like molecule 7;Organisim: human;Apparent_Kd_M: 7.037155E-12

Real

Aptamer SeqId: 10713-151 | Target: CLM7 | UniProt: A8K4G0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10713-151 | Target: CLM7 | UniProt: A8K4G0 | TargetFullName: CMRF35-like molecule 7 | Organisim: human | Apparent_Kd_M: 7.037155E-12

Real

Aptamer SeqId:10714-7;Target:ACE;UniProt:P12821

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10714-7;Target: ACE;UniProt: P12821;TargetFullName: Angiotensin-converting enzyme;Organisim: human;Apparent_Kd_M: 4.050056E-10

Real

Aptamer SeqId: 10714-7 | Target: ACE | UniProt: P12821

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10714-7 | Target: ACE | UniProt: P12821 | TargetFullName: Angiotensin-converting enzyme | Organisim: human | Apparent_Kd_M: 4.050056E-10

Real

Aptamer SeqId:10715-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10715-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.791798E-11

Real

Aptamer SeqId: 10715-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10715-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.791798E-11

Real

Aptamer SeqId:10716-35;Target:PSMD5;UniProt:Q16401

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10716-35;Target: PSMD5;UniProt: Q16401;TargetFullName: 26S proteasome non-ATPase regulatory subunit 5;Organisim: human;Apparent_Kd_M: 2.372455E-11

Real

Aptamer SeqId: 10716-35 | Target: PSMD5 | UniProt: Q16401

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10716-35 | Target: PSMD5 | UniProt: Q16401 | TargetFullName: 26S proteasome non-ATPase regulatory subunit 5 | Organisim: human | Apparent_Kd_M: 2.372455E-11

Real

Aptamer SeqId:10721-76;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10721-76;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 5.83598E-11

Real

Aptamer SeqId: 10721-76 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10721-76 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 5.83598E-11

Real

Aptamer SeqId:10722-13;Target:KSYK;UniProt:P43405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10722-13;Target: KSYK;UniProt: P43405;TargetFullName: Tyrosine-protein kinase SYK;Organisim: human;Apparent_Kd_M: 7.513084E-12

Real

Aptamer SeqId: 10722-13 | Target: KSYK | UniProt: P43405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10722-13 | Target: KSYK | UniProt: P43405 | TargetFullName: Tyrosine-protein kinase SYK | Organisim: human | Apparent_Kd_M: 7.513084E-12

Real

Aptamer SeqId:10723-41;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10723-41;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.708834E-10

Real

Aptamer SeqId: 10723-41 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10723-41 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.708834E-10

Real

Aptamer SeqId:10731-10;Target:HS3S5;UniProt:Q8IZT8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10731-10;Target: HS3S5;UniProt: Q8IZT8;TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 5;Organisim: human;Apparent_Kd_M: 5.034756E-11

Real

Aptamer SeqId: 10731-10 | Target: HS3S5 | UniProt: Q8IZT8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10731-10 | Target: HS3S5 | UniProt: Q8IZT8 | TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 5 | Organisim: human | Apparent_Kd_M: 5.034756E-11

Real

Aptamer SeqId:10734-339;Target:G3ST2;UniProt:Q9H3Q3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10734-339;Target: G3ST2;UniProt: Q9H3Q3;TargetFullName: Galactose-3-O-sulfotransferase 2;Organisim: human;Apparent_Kd_M: 1.417874E-10

Real

Aptamer SeqId: 10734-339 | Target: G3ST2 | UniProt: Q9H3Q3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10734-339 | Target: G3ST2 | UniProt: Q9H3Q3 | TargetFullName: Galactose-3-O-sulfotransferase 2 | Organisim: human | Apparent_Kd_M: 1.417874E-10

Real

Aptamer SeqId:10737-96;Target:Serpin B1;UniProt:P30740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10737-96;Target: Serpin B1;UniProt: P30740;TargetFullName: Leukocyte elastase inhibitor;Organisim: human;Apparent_Kd_M: 1.002494E-11

Real

Aptamer SeqId: 10737-96 | Target: Serpin B1 | UniProt: P30740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10737-96 | Target: Serpin B1 | UniProt: P30740 | TargetFullName: Leukocyte elastase inhibitor | Organisim: human | Apparent_Kd_M: 1.002494E-11

Real

Aptamer SeqId:10748-216;Target:PCDB2;UniProt:Q9Y5E7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10748-216;Target: PCDB2;UniProt: Q9Y5E7;TargetFullName: Protocadherin beta-2;Organisim: human;Apparent_Kd_M: 2.041404E-11

Real

Aptamer SeqId: 10748-216 | Target: PCDB2 | UniProt: Q9Y5E7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10748-216 | Target: PCDB2 | UniProt: Q9Y5E7 | TargetFullName: Protocadherin beta-2 | Organisim: human | Apparent_Kd_M: 2.041404E-11

Real

Aptamer SeqId:10749-18;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10749-18;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 8.183436E-11

Real

Aptamer SeqId: 10749-18 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10749-18 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 8.183436E-11

Real

Aptamer SeqId:10752-8;Target:CDYL2;UniProt:Q8N8U2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10752-8;Target: CDYL2;UniProt: Q8N8U2;TargetFullName: Chromodomain Y-like protein 2;Organisim: human;Apparent_Kd_M: 1.776828E-11

Real

Aptamer SeqId: 10752-8 | Target: CDYL2 | UniProt: Q8N8U2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10752-8 | Target: CDYL2 | UniProt: Q8N8U2 | TargetFullName: Chromodomain Y-like protein 2 | Organisim: human | Apparent_Kd_M: 1.776828E-11

Real

Aptamer SeqId:10753-31;Target:ADAM7;UniProt:Q9H2U9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10753-31;Target: ADAM7;UniProt: Q9H2U9;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 7;Organisim: human;Apparent_Kd_M: 1.90314E-12

Real

Aptamer SeqId: 10753-31 | Target: ADAM7 | UniProt: Q9H2U9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10753-31 | Target: ADAM7 | UniProt: Q9H2U9 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 7 | Organisim: human | Apparent_Kd_M: 1.90314E-12

Real

Aptamer SeqId:10754-113;Target:Prokineticin-2;UniProt:Q9HC23

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10754-113;Target: Prokineticin-2;UniProt: Q9HC23;TargetFullName: Prokineticin-2;Organisim: human;Apparent_Kd_M: 9.853775E-11

Real

Aptamer SeqId: 10754-113 | Target: Prokineticin-2 | UniProt: Q9HC23

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10754-113 | Target: Prokineticin-2 | UniProt: Q9HC23 | TargetFullName: Prokineticin-2 | Organisim: human | Apparent_Kd_M: 9.853775E-11

Real

Aptamer SeqId:10756-34;Target:UCN3;UniProt:Q969E3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10756-34;Target: UCN3;UniProt: Q969E3;TargetFullName: Urocortin-3;Organisim: human;Apparent_Kd_M: 1.531645E-10

Real

Aptamer SeqId: 10756-34 | Target: UCN3 | UniProt: Q969E3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10756-34 | Target: UCN3 | UniProt: Q969E3 | TargetFullName: Urocortin-3 | Organisim: human | Apparent_Kd_M: 1.531645E-10

Real

Aptamer SeqId:10758-2;Target:KERA;UniProt:O60938

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10758-2;Target: KERA;UniProt: O60938;TargetFullName: Keratocan;Organisim: human;Apparent_Kd_M: 5.926528E-11

Real

Aptamer SeqId: 10758-2 | Target: KERA | UniProt: O60938

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10758-2 | Target: KERA | UniProt: O60938 | TargetFullName: Keratocan | Organisim: human | Apparent_Kd_M: 5.926528E-11

Real

Aptamer SeqId:10760-107;Target:GRIA4;UniProt:P48058

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10760-107;Target: GRIA4;UniProt: P48058;TargetFullName: Glutamate receptor 4;Organisim: human;Apparent_Kd_M: 8.570896E-11

Real

Aptamer SeqId: 10760-107 | Target: GRIA4 | UniProt: P48058

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10760-107 | Target: GRIA4 | UniProt: P48058 | TargetFullName: Glutamate receptor 4 | Organisim: human | Apparent_Kd_M: 8.570896E-11

Real

Aptamer SeqId:10761-5;Target:TMED2;UniProt:Q15363

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10761-5;Target: TMED2;UniProt: Q15363;TargetFullName: Transmembrane emp24 domain-containing protein 2;Organisim: human;Apparent_Kd_M: 5.48175E-10

Real

Aptamer SeqId: 10761-5 | Target: TMED2 | UniProt: Q15363

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10761-5 | Target: TMED2 | UniProt: Q15363 | TargetFullName: Transmembrane emp24 domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 5.48175E-10

Real

Aptamer SeqId:10762-2;Target:KLRG2;UniProt:A4D1S0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10762-2;Target: KLRG2;UniProt: A4D1S0;TargetFullName: Killer cell lectin-like receptor subfamily G member 2;Organisim: human;Apparent_Kd_M: 1.364762E-10

Real

Aptamer SeqId: 10762-2 | Target: KLRG2 | UniProt: A4D1S0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10762-2 | Target: KLRG2 | UniProt: A4D1S0 | TargetFullName: Killer cell lectin-like receptor subfamily G member 2 | Organisim: human | Apparent_Kd_M: 1.364762E-10

Real

Aptamer SeqId:10767-52;Target:GPR64;UniProt:Q8IZP9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10767-52;Target: GPR64;UniProt: Q8IZP9;TargetFullName: G-protein coupled receptor 64;Organisim: human;Apparent_Kd_M: 8.684941E-11

Real

Aptamer SeqId: 10767-52 | Target: GPR64 | UniProt: Q8IZP9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10767-52 | Target: GPR64 | UniProt: Q8IZP9 | TargetFullName: G-protein coupled receptor 64 | Organisim: human | Apparent_Kd_M: 8.684941E-11

Real

Aptamer SeqId:10772-21;Target:CGAT2;UniProt:Q8N6G5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10772-21;Target: CGAT2;UniProt: Q8N6G5;TargetFullName: Chondroitin sulfate N-acetylgalactosaminyltransferase 2;Organisim: human;Apparent_Kd_M: 2.168157E-11

Real

Aptamer SeqId: 10772-21 | Target: CGAT2 | UniProt: Q8N6G5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10772-21 | Target: CGAT2 | UniProt: Q8N6G5 | TargetFullName: Chondroitin sulfate N-acetylgalactosaminyltransferase 2 | Organisim: human | Apparent_Kd_M: 2.168157E-11

Real

Aptamer SeqId:10781-19;Target:CLC4G;UniProt:Q6UXB4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10781-19;Target: CLC4G;UniProt: Q6UXB4;TargetFullName: C-type lectin domain family 4 member G;Organisim: human;Apparent_Kd_M: 3.750748E-11

Real

Aptamer SeqId: 10781-19 | Target: CLC4G | UniProt: Q6UXB4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10781-19 | Target: CLC4G | UniProt: Q6UXB4 | TargetFullName: C-type lectin domain family 4 member G | Organisim: human | Apparent_Kd_M: 3.750748E-11

Real

Aptamer SeqId:10785-8;Target:LRC52;UniProt:Q8N7C0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10785-8;Target: LRC52;UniProt: Q8N7C0;TargetFullName: Leucine-rich repeat-containing protein 52;Organisim: human;Apparent_Kd_M: 2.409164E-10

Real

Aptamer SeqId: 10785-8 | Target: LRC52 | UniProt: Q8N7C0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10785-8 | Target: LRC52 | UniProt: Q8N7C0 | TargetFullName: Leucine-rich repeat-containing protein 52 | Organisim: human | Apparent_Kd_M: 2.409164E-10

Real

Aptamer SeqId:10791-21;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10791-21;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.602132E-11

Real

Aptamer SeqId: 10791-21 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10791-21 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.602132E-11

Real

Aptamer SeqId:10798-4;Target:CLM2;UniProt:Q496F6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10798-4;Target: CLM2;UniProt: Q496F6;TargetFullName: CMRF35-like molecule 2;Organisim: human;Apparent_Kd_M: 4.902529E-12

Real

Aptamer SeqId: 10798-4 | Target: CLM2 | UniProt: Q496F6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10798-4 | Target: CLM2 | UniProt: Q496F6 | TargetFullName: CMRF35-like molecule 2 | Organisim: human | Apparent_Kd_M: 4.902529E-12

Real

Aptamer SeqId:10800-15;Target:Collagen-binding protein;UniProt:P50454

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10800-15;Target: Collagen-binding protein;UniProt: P50454;TargetFullName: Serpin H1;Organisim: human;Apparent_Kd_M: 4.438532E-11

Real

Aptamer SeqId: 10800-15 | Target: Collagen-binding protein

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10800-15 | Target: Collagen-binding protein | UniProt: P50454 | TargetFullName: Serpin H1 | Organisim: human | Apparent_Kd_M: 4.438532E-11

Real

Aptamer SeqId:10803-22;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10803-22;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 5.6742E-11

Real

Aptamer SeqId: 10803-22 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10803-22 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 5.6742E-11

Real

Aptamer SeqId:10809-14;Target:KLRB1;UniProt:Q12918

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10809-14;Target: KLRB1;UniProt: Q12918;TargetFullName: Killer cell lectin-like receptor subfamily B member 1;Organisim: human;Apparent_Kd_M: 5.428431E-11

Real

Aptamer SeqId: 10809-14 | Target: KLRB1 | UniProt: Q12918

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10809-14 | Target: KLRB1 | UniProt: Q12918 | TargetFullName: Killer cell lectin-like receptor subfamily B member 1 | Organisim: human | Apparent_Kd_M: 5.428431E-11

Real

Aptamer SeqId:10814-7;Target:CD1A;UniProt:P06126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10814-7;Target: CD1A;UniProt: P06126;TargetFullName: T-cell surface glycoprotein CD1a;Organisim: human;Apparent_Kd_M: 1.661939E-10

Real

Aptamer SeqId: 10814-7 | Target: CD1A | UniProt: P06126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10814-7 | Target: CD1A | UniProt: P06126 | TargetFullName: T-cell surface glycoprotein CD1a | Organisim: human | Apparent_Kd_M: 1.661939E-10

Real

Aptamer SeqId:10815-2;Target:HABP4;UniProt:Q5JVS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10815-2;Target: HABP4;UniProt: Q5JVS0;TargetFullName: Intracellular hyaluronan-binding protein 4;Organisim: human;Apparent_Kd_M: 3.471928E-11

Real

Aptamer SeqId: 10815-2 | Target: HABP4 | UniProt: Q5JVS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10815-2 | Target: HABP4 | UniProt: Q5JVS0 | TargetFullName: Intracellular hyaluronan-binding protein 4 | Organisim: human | Apparent_Kd_M: 3.471928E-11

Real

Aptamer SeqId:10816-150;Target:PILRA isoform FDF03-M14;UniProt:Q9UKJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10816-150;Target: PILRA isoform FDF03-M14;UniProt: Q9UKJ1;TargetFullName: Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-M14;Organisim: human;Apparent_Kd_M: 1.835519E-11

Real

Aptamer SeqId: 10816-150 | Target: PILRA isoform FDF03-M14

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10816-150 | Target: PILRA isoform FDF03-M14 | UniProt: Q9UKJ1 | TargetFullName: Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-M14 | Organisim: human | Apparent_Kd_M: 1.835519E-11

Real

Aptamer SeqId:10817-26;Target:TO20L;UniProt:Q6UXN7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10817-26;Target: TO20L;UniProt: Q6UXN7;TargetFullName: TOMM20-like protein 1;Organisim: human;Apparent_Kd_M: 3.735161E-11

Real

Aptamer SeqId: 10817-26 | Target: TO20L | UniProt: Q6UXN7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10817-26 | Target: TO20L | UniProt: Q6UXN7 | TargetFullName: TOMM20-like protein 1 | Organisim: human | Apparent_Kd_M: 3.735161E-11

Real

Aptamer SeqId:10818-36;Target:ASM;UniProt:P17405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10818-36;Target: ASM;UniProt: P17405;TargetFullName: Sphingomyelin phosphodiesterase;Organisim: human;Apparent_Kd_M: 1.091323E-10

Real

Aptamer SeqId: 10818-36 | Target: ASM | UniProt: P17405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10818-36 | Target: ASM | UniProt: P17405 | TargetFullName: Sphingomyelin phosphodiesterase | Organisim: human | Apparent_Kd_M: 1.091323E-10

Real

Aptamer SeqId:10823-19;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10823-19;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.488799E-11

Real

Aptamer SeqId: 10823-19 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10823-19 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.488799E-11

Real

Aptamer SeqId:10825-12;Target:VSI10;UniProt:Q8N0Z9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10825-12;Target: VSI10;UniProt: Q8N0Z9;TargetFullName: V-set and immunoglobulin domain-containing protein 10;Organisim: human;Apparent_Kd_M: 7.159368E-11

Real

Aptamer SeqId: 10825-12 | Target: VSI10 | UniProt: Q8N0Z9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10825-12 | Target: VSI10 | UniProt: Q8N0Z9 | TargetFullName: V-set and immunoglobulin domain-containing protein 10 | Organisim: human | Apparent_Kd_M: 7.159368E-11

Real

Aptamer SeqId:10827-67;Target:LIGO3;UniProt:P0C6S8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10827-67;Target: LIGO3;UniProt: P0C6S8;TargetFullName: Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3;Organisim: human;Apparent_Kd_M: 2.106725E-11

Real

Aptamer SeqId: 10827-67 | Target: LIGO3 | UniProt: P0C6S8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10827-67 | Target: LIGO3 | UniProt: P0C6S8 | TargetFullName: Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 | Organisim: human | Apparent_Kd_M: 2.106725E-11

Real

Aptamer SeqId:10830-5;Target:K0494;UniProt:O75071

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10830-5;Target: K0494;UniProt: O75071;TargetFullName: EF-hand calcium-binding domain-containing protein 14;Organisim: human;Apparent_Kd_M: 1.229157E-11

Real

Aptamer SeqId: 10830-5 | Target: K0494 | UniProt: O75071

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10830-5 | Target: K0494 | UniProt: O75071 | TargetFullName: EF-hand calcium-binding domain-containing protein 14 | Organisim: human | Apparent_Kd_M: 1.229157E-11

Real

Aptamer SeqId:10832-24;Target:B4GT6;UniProt:Q9UBX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10832-24;Target: B4GT6;UniProt: Q9UBX8;TargetFullName: Beta-1;4-galactosyltransferase 6;Organisim: human;Apparent_Kd_M: 5.91E-11

Real

Aptamer SeqId: 10832-24 | Target: B4GT6 | UniProt: Q9UBX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10832-24 | Target: B4GT6 | UniProt: Q9UBX8 | TargetFullName: Beta-1;4-galactosyltransferase 6 | Organisim: human | Apparent_Kd_M: 5.91E-11

Real

Aptamer SeqId:10833-64;Target:HHIP;UniProt:Q96QV1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10833-64;Target: HHIP;UniProt: Q96QV1;TargetFullName: Hedgehog-interacting protein;Organisim: human;Apparent_Kd_M: 5.787966E-11

Real

Aptamer SeqId: 10833-64 | Target: HHIP | UniProt: Q96QV1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10833-64 | Target: HHIP | UniProt: Q96QV1 | TargetFullName: Hedgehog-interacting protein | Organisim: human | Apparent_Kd_M: 5.787966E-11

Real

Aptamer SeqId:10835-25;Target:A4GCT;UniProt:Q9UNA3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10835-25;Target: A4GCT;UniProt: Q9UNA3;TargetFullName: Alpha-1;4-N-acetylglucosaminyltransferase;Organisim: human;Apparent_Kd_M: 5.85932E-11

Real

Aptamer SeqId: 10835-25 | Target: A4GCT | UniProt: Q9UNA3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10835-25 | Target: A4GCT | UniProt: Q9UNA3 | TargetFullName: Alpha-1;4-N-acetylglucosaminyltransferase | Organisim: human | Apparent_Kd_M: 5.85932E-11

Real

Aptamer SeqId:10842-7;Target:GCNT4;UniProt:Q9P109

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10842-7;Target: GCNT4;UniProt: Q9P109;TargetFullName: Beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;6-N-acetylglucosaminyltransferase 4;Organisim: human;Apparent_Kd_M: 3.379379E-11

Real

Aptamer SeqId: 10842-7 | Target: GCNT4 | UniProt: Q9P109

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10842-7 | Target: GCNT4 | UniProt: Q9P109 | TargetFullName: Beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;6-N-acetylglucosaminyltransferase 4 | Organisim: human | Apparent_Kd_M: 3.379379E-11

Real

Aptamer SeqId:10847-1;Target:SIG15;UniProt:Q6ZMC9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10847-1;Target: SIG15;UniProt: Q6ZMC9;TargetFullName: Sialic acid-binding Ig-like lectin 15;Organisim: human;Apparent_Kd_M: 4.203997E-12

Real

Aptamer SeqId: 10847-1 | Target: SIG15 | UniProt: Q6ZMC9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10847-1 | Target: SIG15 | UniProt: Q6ZMC9 | TargetFullName: Sialic acid-binding Ig-like lectin 15 | Organisim: human | Apparent_Kd_M: 4.203997E-12

Real

Aptamer SeqId:10848-137;Target:BTNL3;UniProt:Q6UXE8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10848-137;Target: BTNL3;UniProt: Q6UXE8;TargetFullName: Butyrophilin-like protein 3;Organisim: human;Apparent_Kd_M: 1.53409E-10

Real

Aptamer SeqId: 10848-137 | Target: BTNL3 | UniProt: Q6UXE8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10848-137 | Target: BTNL3 | UniProt: Q6UXE8 | TargetFullName: Butyrophilin-like protein 3 | Organisim: human | Apparent_Kd_M: 1.53409E-10

Real

Aptamer SeqId:10851-77;Target:IL27B;UniProt:Q14213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10851-77;Target: IL27B;UniProt: Q14213;TargetFullName: Interleukin-27 subunit beta;Organisim: human;Apparent_Kd_M: 2.841632E-11

Real

Aptamer SeqId: 10851-77 | Target: IL27B | UniProt: Q14213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10851-77 | Target: IL27B | UniProt: Q14213 | TargetFullName: Interleukin-27 subunit beta | Organisim: human | Apparent_Kd_M: 2.841632E-11

Real

Aptamer SeqId:10852-114;Target:HNRDL;UniProt:O14979

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10852-114;Target: HNRDL;UniProt: O14979;TargetFullName: Heterogeneous nuclear ribonucleoprotein D-like;Organisim: human;Apparent_Kd_M: 1.746954E-12

Real

Aptamer SeqId: 10852-114 | Target: HNRDL | UniProt: O14979

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10852-114 | Target: HNRDL | UniProt: O14979 | TargetFullName: Heterogeneous nuclear ribonucleoprotein D-like | Organisim: human | Apparent_Kd_M: 1.746954E-12

Real

Aptamer SeqId:10866-60;Target:P4R3A;UniProt:Q6IN85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10866-60;Target: P4R3A;UniProt: Q6IN85;TargetFullName: Serine/threonine-protein phosphatase 4 regulatory subunit 3A;Organisim: human;Apparent_Kd_M: 1.525652E-10

Real

Aptamer SeqId: 10866-60 | Target: P4R3A | UniProt: Q6IN85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10866-60 | Target: P4R3A | UniProt: Q6IN85 | TargetFullName: Serine/threonine-protein phosphatase 4 regulatory subunit 3A | Organisim: human | Apparent_Kd_M: 1.525652E-10

Real

Aptamer SeqId:10876-300;Target:BRAT1;UniProt:Q6PJG6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10876-300;Target: BRAT1;UniProt: Q6PJG6;TargetFullName: BRCA1-associated ATM activator 1;Organisim: human;Apparent_Kd_M: 3.12E-10

Real

Aptamer SeqId: 10876-300 | Target: BRAT1 | UniProt: Q6PJG6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10876-300 | Target: BRAT1 | UniProt: Q6PJG6 | TargetFullName: BRCA1-associated ATM activator 1 | Organisim: human | Apparent_Kd_M: 3.12E-10

Real

Aptamer SeqId:10880-38;Target:F163B;UniProt:P0C2L3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10880-38;Target: F163B;UniProt: P0C2L3;TargetFullName: Protein FAM163B;Organisim: human;Apparent_Kd_M: 4.507201E-11

Real

Aptamer SeqId: 10880-38 | Target: F163B | UniProt: P0C2L3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10880-38 | Target: F163B | UniProt: P0C2L3 | TargetFullName: Protein FAM163B | Organisim: human | Apparent_Kd_M: 4.507201E-11

Real

Aptamer SeqId:10882-12;Target:Desmocollin-1;UniProt:Q08554

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10882-12;Target: Desmocollin-1;UniProt: Q08554;TargetFullName: Desmocollin-1;Organisim: human;Apparent_Kd_M: 2.019101E-11

Real

Aptamer SeqId: 10882-12 | Target: Desmocollin-1 | UniProt: Q08554

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10882-12 | Target: Desmocollin-1 | UniProt: Q08554 | TargetFullName: Desmocollin-1 | Organisim: human | Apparent_Kd_M: 2.019101E-11

Real

Aptamer SeqId:10885-36;Target:CF089;UniProt:Q6UWU4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10885-36;Target: CF089;UniProt: Q6UWU4;TargetFullName: Bombesin receptor-activated protein C6orf89;Organisim: human;Apparent_Kd_M: 1.443445E-11

Real

Aptamer SeqId: 10885-36 | Target: CF089 | UniProt: Q6UWU4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10885-36 | Target: CF089 | UniProt: Q6UWU4 | TargetFullName: Bombesin receptor-activated protein C6orf89 | Organisim: human | Apparent_Kd_M: 1.443445E-11

Real

Aptamer SeqId:10888-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10888-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.498489E-10

Real

Aptamer SeqId: 10888-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10888-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.498489E-10

Real

Aptamer SeqId:10889-2;Target:MRAP2;UniProt:Q96G30

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10889-2;Target: MRAP2;UniProt: Q96G30;TargetFullName: Melanocortin-2 receptor accessory protein 2;Organisim: human;Apparent_Kd_M: 1.270566E-10

Real

Aptamer SeqId: 10889-2 | Target: MRAP2 | UniProt: Q96G30

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10889-2 | Target: MRAP2 | UniProt: Q96G30 | TargetFullName: Melanocortin-2 receptor accessory protein 2 | Organisim: human | Apparent_Kd_M: 1.270566E-10

Real

Aptamer SeqId:10890-135;Target:LCTL;UniProt:Q6UWM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10890-135;Target: LCTL;UniProt: Q6UWM7;TargetFullName: Lactase-like protein;Organisim: human;Apparent_Kd_M: 6.446244E-11

Real

Aptamer SeqId: 10890-135 | Target: LCTL | UniProt: Q6UWM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10890-135 | Target: LCTL | UniProt: Q6UWM7 | TargetFullName: Lactase-like protein | Organisim: human | Apparent_Kd_M: 6.446244E-11

Real

Aptamer SeqId:10892-8;Target:OSMR;UniProt:Q99650

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10892-8;Target: OSMR;UniProt: Q99650;TargetFullName: Oncostatin-M-specific receptor subunit beta;Organisim: human;Apparent_Kd_M: 8.083383E-11

Real

Aptamer SeqId: 10892-8 | Target: OSMR | UniProt: Q99650

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10892-8 | Target: OSMR | UniProt: Q99650 | TargetFullName: Oncostatin-M-specific receptor subunit beta | Organisim: human | Apparent_Kd_M: 8.083383E-11

Real

Aptamer SeqId:10895-28;Target:TM11B;UniProt:Q86T26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10895-28;Target: TM11B;UniProt: Q86T26;TargetFullName: Transmembrane protease serine 11B;Organisim: human;Apparent_Kd_M: 8.550133E-12

Real

Aptamer SeqId: 10895-28 | Target: TM11B | UniProt: Q86T26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10895-28 | Target: TM11B | UniProt: Q86T26 | TargetFullName: Transmembrane protease serine 11B | Organisim: human | Apparent_Kd_M: 8.550133E-12

Real

Aptamer SeqId:10900-272;Target:STMN2;UniProt:Q93045

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10900-272;Target: STMN2;UniProt: Q93045;TargetFullName: Stathmin-2;Organisim: human;Apparent_Kd_M: 1.737892E-10

Real

Aptamer SeqId: 10900-272 | Target: STMN2 | UniProt: Q93045

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10900-272 | Target: STMN2 | UniProt: Q93045 | TargetFullName: Stathmin-2 | Organisim: human | Apparent_Kd_M: 1.737892E-10

Real

Aptamer SeqId:10902-53;Target:APRV1;UniProt:Q53RT3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10902-53;Target: APRV1;UniProt: Q53RT3;TargetFullName: Retroviral-like aspartic protease 1;Organisim: human;Apparent_Kd_M: 3.082898E-11

Real

Aptamer SeqId: 10902-53 | Target: APRV1 | UniProt: Q53RT3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10902-53 | Target: APRV1 | UniProt: Q53RT3 | TargetFullName: Retroviral-like aspartic protease 1 | Organisim: human | Apparent_Kd_M: 3.082898E-11

Real

Aptamer SeqId:10903-50;Target:STX8;UniProt:Q9UNK0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10903-50;Target: STX8;UniProt: Q9UNK0;TargetFullName: Syntaxin-8;Organisim: human;Apparent_Kd_M: 3.130163E-12

Real

Aptamer SeqId: 10903-50 | Target: STX8 | UniProt: Q9UNK0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10903-50 | Target: STX8 | UniProt: Q9UNK0 | TargetFullName: Syntaxin-8 | Organisim: human | Apparent_Kd_M: 3.130163E-12

Real

Aptamer SeqId:10907-116;Target:NTRI;UniProt:Q9P121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10907-116;Target: NTRI;UniProt: Q9P121;TargetFullName: Neurotrimin;Organisim: human;Apparent_Kd_M: 4.044327E-11

Real

Aptamer SeqId: 10907-116 | Target: NTRI | UniProt: Q9P121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10907-116 | Target: NTRI | UniProt: Q9P121 | TargetFullName: Neurotrimin | Organisim: human | Apparent_Kd_M: 4.044327E-11

Real

Aptamer SeqId:10908-2;Target:GLT13;UniProt:Q8IUC8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10908-2;Target: GLT13;UniProt: Q8IUC8;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 13;Organisim: human;Apparent_Kd_M: 4.063708E-11

Real

Aptamer SeqId: 10908-2 | Target: GLT13 | UniProt: Q8IUC8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10908-2 | Target: GLT13 | UniProt: Q8IUC8 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 13 | Organisim: human | Apparent_Kd_M: 4.063708E-11

Real

Aptamer SeqId:10910-6;Target:CEAM4;UniProt:O75871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10910-6;Target: CEAM4;UniProt: O75871;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 4;Organisim: human;Apparent_Kd_M: 1.234926E-10

Real

Aptamer SeqId: 10910-6 | Target: CEAM4 | UniProt: O75871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10910-6 | Target: CEAM4 | UniProt: O75871 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 4 | Organisim: human | Apparent_Kd_M: 1.234926E-10

Real

Aptamer SeqId:10914-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10914-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.81236E-11

Real

Aptamer SeqId: 10914-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10914-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.81236E-11

Real

Aptamer SeqId:10916-44;Target:PLA2R;UniProt:Q13018

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10916-44;Target: PLA2R;UniProt: Q13018;TargetFullName: Secretory phospholipase A2 receptor;Organisim: human;Apparent_Kd_M: 2.012947E-11

Real

Aptamer SeqId: 10916-44 | Target: PLA2R | UniProt: Q13018

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10916-44 | Target: PLA2R | UniProt: Q13018 | TargetFullName: Secretory phospholipase A2 receptor | Organisim: human | Apparent_Kd_M: 2.012947E-11

Real

Aptamer SeqId:10917-40;Target:GBGT2;UniProt:O14610

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10917-40;Target: GBGT2;UniProt: O14610;TargetFullName: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2;Organisim: human;Apparent_Kd_M: 1.047676E-10

Real

Aptamer SeqId: 10917-40 | Target: GBGT2 | UniProt: O14610

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10917-40 | Target: GBGT2 | UniProt: O14610 | TargetFullName: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 | Organisim: human | Apparent_Kd_M: 1.047676E-10

Real

Aptamer SeqId:10924-258;Target:NEUFC;UniProt:Q8WUJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10924-258;Target: NEUFC;UniProt: Q8WUJ1;TargetFullName: Neuferricin;Organisim: human;Apparent_Kd_M: 4.094834E-11

Real

Aptamer SeqId: 10924-258 | Target: NEUFC | UniProt: Q8WUJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10924-258 | Target: NEUFC | UniProt: Q8WUJ1 | TargetFullName: Neuferricin | Organisim: human | Apparent_Kd_M: 4.094834E-11

Real

Aptamer SeqId:10927-65;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10927-65;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.446156E-11

Real

Aptamer SeqId: 10927-65 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10927-65 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.446156E-11

Real

Aptamer SeqId:10933-107;Target:CABP8;UniProt:Q9BXU9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10933-107;Target: CABP8;UniProt: Q9BXU9;TargetFullName: Calcium-binding protein 8;Organisim: human;Apparent_Kd_M: 2.860373E-10

Real

Aptamer SeqId: 10933-107 | Target: CABP8 | UniProt: Q9BXU9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10933-107 | Target: CABP8 | UniProt: Q9BXU9 | TargetFullName: Calcium-binding protein 8 | Organisim: human | Apparent_Kd_M: 2.860373E-10

Real

Aptamer SeqId:10938-13;Target:sLFA-3;UniProt:P19256

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10938-13;Target: sLFA-3;UniProt: P19256;TargetFullName: Lymphocyte function-associated antigen 3;Organisim: human;Apparent_Kd_M: 1.002097E-11

Real

Aptamer SeqId: 10938-13 | Target: sLFA-3 | UniProt: P19256

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10938-13 | Target: sLFA-3 | UniProt: P19256 | TargetFullName: Lymphocyte function-associated antigen 3 | Organisim: human | Apparent_Kd_M: 1.002097E-11

Real

Aptamer SeqId:10939-16;Target:PKHA4;UniProt:Q9H4M7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10939-16;Target: PKHA4;UniProt: Q9H4M7;TargetFullName: Pleckstrin homology domain-containing family A member 4;Organisim: human;Apparent_Kd_M: 1.515076E-11

Real

Aptamer SeqId: 10939-16 | Target: PKHA4 | UniProt: Q9H4M7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10939-16 | Target: PKHA4 | UniProt: Q9H4M7 | TargetFullName: Pleckstrin homology domain-containing family A member 4 | Organisim: human | Apparent_Kd_M: 1.515076E-11

Real

Aptamer SeqId:10940-25;Target:SRCA;UniProt:Q86TD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10940-25;Target: SRCA;UniProt: Q86TD4;TargetFullName: Sarcalumenin;Organisim: human;Apparent_Kd_M: 3.869524E-10

Real

Aptamer SeqId: 10940-25 | Target: SRCA | UniProt: Q86TD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10940-25 | Target: SRCA | UniProt: Q86TD4 | TargetFullName: Sarcalumenin | Organisim: human | Apparent_Kd_M: 3.869524E-10

Real

Aptamer SeqId:10943-36;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10943-36;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.043494E-10

Real

Aptamer SeqId: 10943-36 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10943-36 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.043494E-10

Real

Aptamer SeqId:10945-11;Target:Syntaxin-6;UniProt:O43752

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10945-11;Target: Syntaxin-6;UniProt: O43752;TargetFullName: Syntaxin-6;Organisim: human;Apparent_Kd_M: 1.788194E-11

Real

Aptamer SeqId: 10945-11 | Target: Syntaxin-6 | UniProt: O43752

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10945-11 | Target: Syntaxin-6 | UniProt: O43752 | TargetFullName: Syntaxin-6 | Organisim: human | Apparent_Kd_M: 1.788194E-11

Real

Aptamer SeqId:10948-14;Target:PLD3;UniProt:Q8IV08

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10948-14;Target: PLD3;UniProt: Q8IV08;TargetFullName: Phospholipase D3;Organisim: human;Apparent_Kd_M: 1.078237E-11

Real

Aptamer SeqId: 10948-14 | Target: PLD3 | UniProt: Q8IV08

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10948-14 | Target: PLD3 | UniProt: Q8IV08 | TargetFullName: Phospholipase D3 | Organisim: human | Apparent_Kd_M: 1.078237E-11

Real

Aptamer SeqId:10949-59;Target:RLA2;UniProt:P05387

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10949-59;Target: RLA2;UniProt: P05387;TargetFullName: 60S acidic ribosomal protein P2;Organisim: human;Apparent_Kd_M: 7.832073E-12

Real

Aptamer SeqId: 10949-59 | Target: RLA2 | UniProt: P05387

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10949-59 | Target: RLA2 | UniProt: P05387 | TargetFullName: 60S acidic ribosomal protein P2 | Organisim: human | Apparent_Kd_M: 7.832073E-12

Real

Aptamer SeqId:10953-14;Target:CLC2A;UniProt:Q6UVW9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10953-14;Target: CLC2A;UniProt: Q6UVW9;TargetFullName: C-type lectin domain family 2 member A;Organisim: human;Apparent_Kd_M: 2.36885E-11

Real

Aptamer SeqId: 10953-14 | Target: CLC2A | UniProt: Q6UVW9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10953-14 | Target: CLC2A | UniProt: Q6UVW9 | TargetFullName: C-type lectin domain family 2 member A | Organisim: human | Apparent_Kd_M: 2.36885E-11

Real

Aptamer SeqId:10955-4;Target:CLC10;UniProt:Q8IUN9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10955-4;Target: CLC10;UniProt: Q8IUN9;TargetFullName: C-type lectin domain family 10 member A;Organisim: human;Apparent_Kd_M: 5.624377E-10

Real

Aptamer SeqId: 10955-4 | Target: CLC10 | UniProt: Q8IUN9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10955-4 | Target: CLC10 | UniProt: Q8IUN9 | TargetFullName: C-type lectin domain family 10 member A | Organisim: human | Apparent_Kd_M: 5.624377E-10

Real

Aptamer SeqId:10956-82;Target:GCSH;UniProt:P23434

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10956-82;Target: GCSH;UniProt: P23434;TargetFullName: Glycine cleavage system H protein; mitochondrial;Organisim: human;Apparent_Kd_M: 1.389349E-10

Real

Aptamer SeqId: 10956-82 | Target: GCSH | UniProt: P23434

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10956-82 | Target: GCSH | UniProt: P23434 | TargetFullName: Glycine cleavage system H protein; mitochondrial | Organisim: human | Apparent_Kd_M: 1.389349E-10

Real

Aptamer SeqId:10959-125;Target:BET1L;UniProt:Q9NYM9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10959-125;Target: BET1L;UniProt: Q9NYM9;TargetFullName: BET1-like protein;Organisim: human;Apparent_Kd_M: 7.497972E-11

Real

Aptamer SeqId: 10959-125 | Target: BET1L | UniProt: Q9NYM9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10959-125 | Target: BET1L | UniProt: Q9NYM9 | TargetFullName: BET1-like protein | Organisim: human | Apparent_Kd_M: 7.497972E-11

Real

Aptamer SeqId:10961-15;Target:TIG3;UniProt:Q9UL19

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10961-15;Target: TIG3;UniProt: Q9UL19;TargetFullName: Retinoic acid receptor responder protein 3;Organisim: human;Apparent_Kd_M: 3.263711E-12

Real

Aptamer SeqId: 10961-15 | Target: TIG3 | UniProt: Q9UL19

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10961-15 | Target: TIG3 | UniProt: Q9UL19 | TargetFullName: Retinoic acid receptor responder protein 3 | Organisim: human | Apparent_Kd_M: 3.263711E-12

Real

Aptamer SeqId:10962-46;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10962-46;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.720592E-12

Real

Aptamer SeqId: 10962-46 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10962-46 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.720592E-12

Real

Aptamer SeqId:10974-20;Target:ISK7;UniProt:P58062

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10974-20;Target: ISK7;UniProt: P58062;TargetFullName: Serine protease inhibitor Kazal-type 7;Organisim: human;Apparent_Kd_M: 1.625032E-10

Real

Aptamer SeqId: 10974-20 | Target: ISK7 | UniProt: P58062

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10974-20 | Target: ISK7 | UniProt: P58062 | TargetFullName: Serine protease inhibitor Kazal-type 7 | Organisim: human | Apparent_Kd_M: 1.625032E-10

Real

Aptamer SeqId:10975-59;Target:MUCL1;UniProt:Q96DR8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10975-59;Target: MUCL1;UniProt: Q96DR8;TargetFullName: Mucin-like protein 1;Organisim: human;Apparent_Kd_M: 2.372352E-10

Real

Aptamer SeqId: 10975-59 | Target: MUCL1 | UniProt: Q96DR8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10975-59 | Target: MUCL1 | UniProt: Q96DR8 | TargetFullName: Mucin-like protein 1 | Organisim: human | Apparent_Kd_M: 2.372352E-10

Real

Aptamer SeqId:10977-55;Target:UCMA;UniProt:Q8WVF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10977-55;Target: UCMA;UniProt: Q8WVF2;TargetFullName: Unique cartilage matrix-associated protein;Organisim: human;Apparent_Kd_M: 1.033724E-12

Real

Aptamer SeqId: 10977-55 | Target: UCMA | UniProt: Q8WVF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10977-55 | Target: UCMA | UniProt: Q8WVF2 | TargetFullName: Unique cartilage matrix-associated protein | Organisim: human | Apparent_Kd_M: 1.033724E-12

Real

Aptamer SeqId:10978-39;Target:SOM2;UniProt:P01242

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10978-39;Target: SOM2;UniProt: P01242;TargetFullName: Growth hormone variant;Organisim: human;Apparent_Kd_M: 8.315765E-12

Real

Aptamer SeqId: 10978-39 | Target: SOM2 | UniProt: P01242

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10978-39 | Target: SOM2 | UniProt: P01242 | TargetFullName: Growth hormone variant | Organisim: human | Apparent_Kd_M: 8.315765E-12

Real

Aptamer SeqId:10981-56;Target:NRG3;UniProt:P56975

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10981-56;Target: NRG3;UniProt: P56975;TargetFullName: Pro-neuregulin-3; membrane-bound isoform;Organisim: human;Apparent_Kd_M: 1.951561E-11

Real

Aptamer SeqId: 10981-56 | Target: NRG3 | UniProt: P56975

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10981-56 | Target: NRG3 | UniProt: P56975 | TargetFullName: Pro-neuregulin-3; membrane-bound isoform | Organisim: human | Apparent_Kd_M: 1.951561E-11

Real

Aptamer SeqId:10990-21;Target:LRRK2;UniProt:Q5S007

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 10990-21;Target: LRRK2;UniProt: Q5S007;TargetFullName: Leucine-rich repeat serine/threonine-protein kinase 2;Organisim: human;Apparent_Kd_M: 1.304061E-10

Real

Aptamer SeqId: 10990-21 | Target: LRRK2 | UniProt: Q5S007

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 10990-21 | Target: LRRK2 | UniProt: Q5S007 | TargetFullName: Leucine-rich repeat serine/threonine-protein kinase 2 | Organisim: human | Apparent_Kd_M: 1.304061E-10

Real

Aptamer SeqId:11067-13;Target:Osteocalcin;UniProt:P02818

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11067-13;Target: Osteocalcin;UniProt: P02818;TargetFullName: Osteocalcin;Organisim: human;Apparent_Kd_M: 3.89E-11

Real

Aptamer SeqId: 11067-13 | Target: Osteocalcin | UniProt: P02818

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11067-13 | Target: Osteocalcin | UniProt: P02818 | TargetFullName: Osteocalcin | Organisim: human | Apparent_Kd_M: 3.89E-11

Real

Aptamer SeqId:11071-1;Target:IL-5;UniProt:P05113

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11071-1;Target: IL-5;UniProt: P05113;TargetFullName: Interleukin-5;Organisim: human;Apparent_Kd_M: 2.15E-10

Real

Aptamer SeqId: 11071-1 | Target: IL-5 | UniProt: P05113

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11071-1 | Target: IL-5 | UniProt: P05113 | TargetFullName: Interleukin-5 | Organisim: human | Apparent_Kd_M: 2.15E-10

Real

Aptamer SeqId:11089-7;Target:IgA;UniProt:P01876|P01877

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11089-7;Target: IgA;UniProt: P01876|P01877;TargetFullName: Immunoglobulin A;Organisim: human;Apparent_Kd_M: 1.85E-10

Real

Aptamer SeqId: 11089-7 | Target: IgA | UniProt: P01876|P01877

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11089-7 | Target: IgA | UniProt: P01876|P01877 | TargetFullName: Immunoglobulin A | Organisim: human | Apparent_Kd_M: 1.85E-10

Real

Aptamer SeqId:11094-104;Target:LPPL;UniProt:Q05315

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11094-104;Target: LPPL;UniProt: Q05315;TargetFullName: Galectin-10;Organisim: human;Apparent_Kd_M: 1.64E-10

Real

Aptamer SeqId: 11094-104 | Target: LPPL | UniProt: Q05315

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11094-104 | Target: LPPL | UniProt: Q05315 | TargetFullName: Galectin-10 | Organisim: human | Apparent_Kd_M: 1.64E-10

Real

Aptamer SeqId:11096-57;Target:HEMK2;UniProt:Q9Y5N5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11096-57;Target: HEMK2;UniProt: Q9Y5N5;TargetFullName: HemK methyltransferase family member 2;Organisim: human;Apparent_Kd_M: 1.97E-10

Real

Aptamer SeqId: 11096-57 | Target: HEMK2 | UniProt: Q9Y5N5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11096-57 | Target: HEMK2 | UniProt: Q9Y5N5 | TargetFullName: HemK methyltransferase family member 2 | Organisim: human | Apparent_Kd_M: 1.97E-10

Real

Aptamer SeqId:11098-1;Target:PDXK;UniProt:O00764

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11098-1;Target: PDXK;UniProt: O00764;TargetFullName: Pyridoxal kinase;Organisim: human;Apparent_Kd_M: 3.68E-11

Real

Aptamer SeqId: 11098-1 | Target: PDXK | UniProt: O00764

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11098-1 | Target: PDXK | UniProt: O00764 | TargetFullName: Pyridoxal kinase | Organisim: human | Apparent_Kd_M: 3.68E-11

Real

Aptamer SeqId:11101-18;Target:TLR4;UniProt:O00206

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11101-18;Target: TLR4;UniProt: O00206;TargetFullName: Toll-like receptor 4;Organisim: human;Apparent_Kd_M: 3.03E-11

Real

Aptamer SeqId: 11101-18 | Target: TLR4 | UniProt: O00206

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11101-18 | Target: TLR4 | UniProt: O00206 | TargetFullName: Toll-like receptor 4 | Organisim: human | Apparent_Kd_M: 3.03E-11

Real

Aptamer SeqId:11102-22;Target:REG4;UniProt:Q9BYZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11102-22;Target: REG4;UniProt: Q9BYZ8;TargetFullName: Regenerating islet-derived protein 4;Organisim: human;Apparent_Kd_M: 2.92E-12

Real

Aptamer SeqId: 11102-22 | Target: REG4 | UniProt: Q9BYZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11102-22 | Target: REG4 | UniProt: Q9BYZ8 | TargetFullName: Regenerating islet-derived protein 4 | Organisim: human | Apparent_Kd_M: 2.92E-12

Real

Aptamer SeqId:11103-24;Target:HSP 27;UniProt:P04792

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11103-24;Target: HSP 27;UniProt: P04792;TargetFullName: Heat shock protein beta-1;Organisim: human;Apparent_Kd_M: 1.85E-10

Real

Aptamer SeqId: 11103-24 | Target: HSP 27 | UniProt: P04792

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11103-24 | Target: HSP 27 | UniProt: P04792 | TargetFullName: Heat shock protein beta-1 | Organisim: human | Apparent_Kd_M: 1.85E-10

Real

Aptamer SeqId:11104-13;Target:YKL-40;UniProt:P36222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11104-13;Target: YKL-40;UniProt: P36222;TargetFullName: Chitinase-3-like protein 1;Organisim: human;Apparent_Kd_M: 1.33E-12

Real

Aptamer SeqId: 11104-13 | Target: YKL-40 | UniProt: P36222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11104-13 | Target: YKL-40 | UniProt: P36222 | TargetFullName: Chitinase-3-like protein 1 | Organisim: human | Apparent_Kd_M: 1.33E-12

Real

Aptamer SeqId:11105-171;Target:Alpha enolase;UniProt:P06733

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11105-171;Target: Alpha enolase;UniProt: P06733;TargetFullName: Alpha-enolase;Organisim: human;Apparent_Kd_M: 5.04E-12

Real

Aptamer SeqId: 11105-171 | Target: Alpha enolase | UniProt: P06733

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11105-171 | Target: Alpha enolase | UniProt: P06733 | TargetFullName: Alpha-enolase | Organisim: human | Apparent_Kd_M: 5.04E-12

Real

Aptamer SeqId:11107-25;Target:TEN3;UniProt:Q9P273

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11107-25;Target: TEN3;UniProt: Q9P273;TargetFullName: Teneurin-3;Organisim: human;Apparent_Kd_M: 1.541733E-11

Real

Aptamer SeqId: 11107-25 | Target: TEN3 | UniProt: Q9P273

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11107-25 | Target: TEN3 | UniProt: Q9P273 | TargetFullName: Teneurin-3 | Organisim: human | Apparent_Kd_M: 1.541733E-11

Real

Aptamer SeqId:11109-56;Target:SVEP1;UniProt:Q4LDE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11109-56;Target: SVEP1;UniProt: Q4LDE5;TargetFullName: Sushi; von Willebrand factor type A; EGF and pentraxin domain-containing protein 1;Organisim: human;Apparent_Kd_M: 7.95891E-12

Real

Aptamer SeqId: 11109-56 | Target: SVEP1 | UniProt: Q4LDE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11109-56 | Target: SVEP1 | UniProt: Q4LDE5 | TargetFullName: Sushi; von Willebrand factor type A; EGF and pentraxin domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 7.95891E-12

Real

Aptamer SeqId:11110-4;Target:TM119;UniProt:Q4V9L6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11110-4;Target: TM119;UniProt: Q4V9L6;TargetFullName: Transmembrane protein 119;Organisim: human;Apparent_Kd_M: 8.430286E-12

Real

Aptamer SeqId: 11110-4 | Target: TM119 | UniProt: Q4V9L6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11110-4 | Target: TM119 | UniProt: Q4V9L6 | TargetFullName: Transmembrane protein 119 | Organisim: human | Apparent_Kd_M: 8.430286E-12

Real

Aptamer SeqId:11112-18;Target:KISHA;UniProt:Q8TBQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11112-18;Target: KISHA;UniProt: Q8TBQ9;TargetFullName: Protein kish-A;Organisim: human;Apparent_Kd_M: 7.725425E-12

Real

Aptamer SeqId: 11112-18 | Target: KISHA | UniProt: Q8TBQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11112-18 | Target: KISHA | UniProt: Q8TBQ9 | TargetFullName: Protein kish-A | Organisim: human | Apparent_Kd_M: 7.725425E-12

Real

Aptamer SeqId:11116-16;Target:CK087;UniProt:Q6NUJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11116-16;Target: CK087;UniProt: Q6NUJ2;TargetFullName: Uncharacterized protein C11orf87;Organisim: human;Apparent_Kd_M: 1.614555E-10

Real

Aptamer SeqId: 11116-16 | Target: CK087 | UniProt: Q6NUJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11116-16 | Target: CK087 | UniProt: Q6NUJ2 | TargetFullName: Uncharacterized protein C11orf87 | Organisim: human | Apparent_Kd_M: 1.614555E-10

Real

Aptamer SeqId:11117-2;Target:SPT20;UniProt:Q8TB22

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11117-2;Target: SPT20;UniProt: Q8TB22;TargetFullName: Spermatogenesis-associated protein 20;Organisim: human;Apparent_Kd_M: 5.416315E-12

Real

Aptamer SeqId: 11117-2 | Target: SPT20 | UniProt: Q8TB22

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11117-2 | Target: SPT20 | UniProt: Q8TB22 | TargetFullName: Spermatogenesis-associated protein 20 | Organisim: human | Apparent_Kd_M: 5.416315E-12

Real

Aptamer SeqId:11118-107;Target:RAB17;UniProt:Q9H0T7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11118-107;Target: RAB17;UniProt: Q9H0T7;TargetFullName: Ras-related protein Rab-17;Organisim: human;Apparent_Kd_M: 2.684152E-10

Real

Aptamer SeqId: 11118-107 | Target: RAB17 | UniProt: Q9H0T7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11118-107 | Target: RAB17 | UniProt: Q9H0T7 | TargetFullName: Ras-related protein Rab-17 | Organisim: human | Apparent_Kd_M: 2.684152E-10

Real

Aptamer SeqId:11120-49;Target:NAT14;UniProt:Q8WUY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11120-49;Target: NAT14;UniProt: Q8WUY8;TargetFullName: N-acetyltransferase 14;Organisim: human;Apparent_Kd_M: 8.399935E-12

Real

Aptamer SeqId: 11120-49 | Target: NAT14 | UniProt: Q8WUY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11120-49 | Target: NAT14 | UniProt: Q8WUY8 | TargetFullName: N-acetyltransferase 14 | Organisim: human | Apparent_Kd_M: 8.399935E-12

Real

Aptamer SeqId:11122-97;Target:SPG21;UniProt:Q9NZD8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11122-97;Target: SPG21;UniProt: Q9NZD8;TargetFullName: Maspardin;Organisim: human;Apparent_Kd_M: 1.387156E-11

Real

Aptamer SeqId: 11122-97 | Target: SPG21 | UniProt: Q9NZD8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11122-97 | Target: SPG21 | UniProt: Q9NZD8 | TargetFullName: Maspardin | Organisim: human | Apparent_Kd_M: 1.387156E-11

Real

Aptamer SeqId:11126-102;Target:TRIO;UniProt:O75962

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11126-102;Target: TRIO;UniProt: O75962;TargetFullName: Triple functional domain protein;Organisim: human;Apparent_Kd_M: 6.739278E-12

Real

Aptamer SeqId: 11126-102 | Target: TRIO | UniProt: O75962

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11126-102 | Target: TRIO | UniProt: O75962 | TargetFullName: Triple functional domain protein | Organisim: human | Apparent_Kd_M: 6.739278E-12

Real

Aptamer SeqId:11128-29;Target:T132C;UniProt:Q8N3T6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11128-29;Target: T132C;UniProt: Q8N3T6;TargetFullName: Transmembrane protein 132C;Organisim: human;Apparent_Kd_M: 3.766379E-11

Real

Aptamer SeqId: 11128-29 | Target: T132C | UniProt: Q8N3T6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11128-29 | Target: T132C | UniProt: Q8N3T6 | TargetFullName: Transmembrane protein 132C | Organisim: human | Apparent_Kd_M: 3.766379E-11

Real

Aptamer SeqId:11129-66;Target:BMP15;UniProt:O95972

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11129-66;Target: BMP15;UniProt: O95972;TargetFullName: Bone morphogenetic protein 15;Organisim: human;Apparent_Kd_M: 1.250595E-10

Real

Aptamer SeqId: 11129-66 | Target: BMP15 | UniProt: O95972

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11129-66 | Target: BMP15 | UniProt: O95972 | TargetFullName: Bone morphogenetic protein 15 | Organisim: human | Apparent_Kd_M: 1.250595E-10

Real

Aptamer SeqId:11130-158;Target:CACB4;UniProt:O00305

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11130-158;Target: CACB4;UniProt: O00305;TargetFullName: Voltage-dependent L-type calcium channel subunit beta-4;Organisim: human;Apparent_Kd_M: 3.257101E-12

Real

Aptamer SeqId: 11130-158 | Target: CACB4 | UniProt: O00305

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11130-158 | Target: CACB4 | UniProt: O00305 | TargetFullName: Voltage-dependent L-type calcium channel subunit beta-4 | Organisim: human | Apparent_Kd_M: 3.257101E-12

Real

Aptamer SeqId:11134-30;Target:RF1ML;UniProt:Q9UGC7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11134-30;Target: RF1ML;UniProt: Q9UGC7;TargetFullName: Peptide chain release factor 1-like; mitochondrial;Organisim: human;Apparent_Kd_M: 4.411247E-11

Real

Aptamer SeqId: 11134-30 | Target: RF1ML | UniProt: Q9UGC7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11134-30 | Target: RF1ML | UniProt: Q9UGC7 | TargetFullName: Peptide chain release factor 1-like; mitochondrial | Organisim: human | Apparent_Kd_M: 4.411247E-11

Real

Aptamer SeqId:11135-5;Target:RM55;UniProt:Q7Z7F7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11135-5;Target: RM55;UniProt: Q7Z7F7;TargetFullName: 39S ribosomal protein L55; mitochondrial;Organisim: human;Apparent_Kd_M: 1.101351E-11

Real

Aptamer SeqId: 11135-5 | Target: RM55 | UniProt: Q7Z7F7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11135-5 | Target: RM55 | UniProt: Q7Z7F7 | TargetFullName: 39S ribosomal protein L55; mitochondrial | Organisim: human | Apparent_Kd_M: 1.101351E-11

Real

Aptamer SeqId:11137-43;Target:IL3RB;UniProt:P32927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11137-43;Target: IL3RB;UniProt: P32927;TargetFullName: Cytokine receptor common subunit beta;Organisim: human;Apparent_Kd_M: 3.172483E-11

Real

Aptamer SeqId: 11137-43 | Target: IL3RB | UniProt: P32927

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11137-43 | Target: IL3RB | UniProt: P32927 | TargetFullName: Cytokine receptor common subunit beta | Organisim: human | Apparent_Kd_M: 3.172483E-11

Real

Aptamer SeqId:11138-16;Target:RUNX3;UniProt:Q13761

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11138-16;Target: RUNX3;UniProt: Q13761;TargetFullName: Runt-related transcription factor 3;Organisim: human;Apparent_Kd_M: 1.764095E-11

Real

Aptamer SeqId: 11138-16 | Target: RUNX3 | UniProt: Q13761

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11138-16 | Target: RUNX3 | UniProt: Q13761 | TargetFullName: Runt-related transcription factor 3 | Organisim: human | Apparent_Kd_M: 1.764095E-11

Real

Aptamer SeqId:11139-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11139-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.227058E-11

Real

Aptamer SeqId: 11139-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11139-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.227058E-11

Real

Aptamer SeqId:11140-56;Target:CO1A1;UniProt:P02452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11140-56;Target: CO1A1;UniProt: P02452;TargetFullName: Collagen alpha-1(I) chain;Organisim: human;Apparent_Kd_M: 7.311312E-12

Real

Aptamer SeqId: 11140-56 | Target: CO1A1 | UniProt: P02452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11140-56 | Target: CO1A1 | UniProt: P02452 | TargetFullName: Collagen alpha-1(I) chain | Organisim: human | Apparent_Kd_M: 7.311312E-12

Real

Aptamer SeqId:11142-11;Target:ANGL1;UniProt:O95841

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11142-11;Target: ANGL1;UniProt: O95841;TargetFullName: Angiopoietin-related protein 1;Organisim: human;Apparent_Kd_M: 7.061599E-12

Real

Aptamer SeqId: 11142-11 | Target: ANGL1 | UniProt: O95841

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11142-11 | Target: ANGL1 | UniProt: O95841 | TargetFullName: Angiopoietin-related protein 1 | Organisim: human | Apparent_Kd_M: 7.061599E-12

Real

Aptamer SeqId:11143-32;Target:NOE3;UniProt:Q96PB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11143-32;Target: NOE3;UniProt: Q96PB7;TargetFullName: Noelin-3;Organisim: human;Apparent_Kd_M: 5.431442E-11

Real

Aptamer SeqId: 11143-32 | Target: NOE3 | UniProt: Q96PB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11143-32 | Target: NOE3 | UniProt: Q96PB7 | TargetFullName: Noelin-3 | Organisim: human | Apparent_Kd_M: 5.431442E-11

Real

Aptamer SeqId:11144-10;Target:DB116;UniProt:Q30KQ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11144-10;Target: DB116;UniProt: Q30KQ4;TargetFullName: Beta-defensin 116;Organisim: human;Apparent_Kd_M: 1.560015E-11

Real

Aptamer SeqId: 11144-10 | Target: DB116 | UniProt: Q30KQ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11144-10 | Target: DB116 | UniProt: Q30KQ4 | TargetFullName: Beta-defensin 116 | Organisim: human | Apparent_Kd_M: 1.560015E-11

Real

Aptamer SeqId:11145-72;Target:K154L;UniProt:Q6ZVL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11145-72;Target: K154L;UniProt: Q6ZVL6;TargetFullName: UPF0606 protein KIAA1549L;Organisim: human;Apparent_Kd_M: 4.963045E-12

Real

Aptamer SeqId: 11145-72 | Target: K154L | UniProt: Q6ZVL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11145-72 | Target: K154L | UniProt: Q6ZVL6 | TargetFullName: UPF0606 protein KIAA1549L | Organisim: human | Apparent_Kd_M: 4.963045E-12

Real

Aptamer SeqId:11146-4;Target:TBX22;UniProt:Q9Y458

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11146-4;Target: TBX22;UniProt: Q9Y458;TargetFullName: T-box transcription factor TBX22;Organisim: human;Apparent_Kd_M: 1.316523E-12

Real

Aptamer SeqId: 11146-4 | Target: TBX22 | UniProt: Q9Y458

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11146-4 | Target: TBX22 | UniProt: Q9Y458 | TargetFullName: T-box transcription factor TBX22 | Organisim: human | Apparent_Kd_M: 1.316523E-12

Real

Aptamer SeqId:11147-17;Target:TRML1;UniProt:Q86YW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11147-17;Target: TRML1;UniProt: Q86YW5;TargetFullName: Trem-like transcript 1 protein;Organisim: human;Apparent_Kd_M: 8.455481E-12

Real

Aptamer SeqId: 11147-17 | Target: TRML1 | UniProt: Q86YW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11147-17 | Target: TRML1 | UniProt: Q86YW5 | TargetFullName: Trem-like transcript 1 protein | Organisim: human | Apparent_Kd_M: 8.455481E-12

Real

Aptamer SeqId:11149-3;Target:TLR1;UniProt:Q15399

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11149-3;Target: TLR1;UniProt: Q15399;TargetFullName: Toll-like receptor 1;Organisim: human;Apparent_Kd_M: 3.711778E-11

Real

Aptamer SeqId: 11149-3 | Target: TLR1 | UniProt: Q15399

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11149-3 | Target: TLR1 | UniProt: Q15399 | TargetFullName: Toll-like receptor 1 | Organisim: human | Apparent_Kd_M: 3.711778E-11

Real

Aptamer SeqId:11152-46;Target:kallikrein 13;UniProt:Q9UKR3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11152-46;Target: kallikrein 13;UniProt: Q9UKR3;TargetFullName: Kallikrein-13;Organisim: human;Apparent_Kd_M: 2.586503E-12

Real

Aptamer SeqId: 11152-46 | Target: kallikrein 13 | UniProt: Q9UKR3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11152-46 | Target: kallikrein 13 | UniProt: Q9UKR3 | TargetFullName: Kallikrein-13 | Organisim: human | Apparent_Kd_M: 2.586503E-12

Real

Aptamer SeqId:11154-3;Target:NF2L1;UniProt:Q14494

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11154-3;Target: NF2L1;UniProt: Q14494;TargetFullName: Nuclear factor erythroid 2-related factor 1;Organisim: human;Apparent_Kd_M: 6.727296E-12

Real

Aptamer SeqId: 11154-3 | Target: NF2L1 | UniProt: Q14494

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11154-3 | Target: NF2L1 | UniProt: Q14494 | TargetFullName: Nuclear factor erythroid 2-related factor 1 | Organisim: human | Apparent_Kd_M: 6.727296E-12

Real

Aptamer SeqId:11155-16;Target:CO6A5;UniProt:A8TX70

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11155-16;Target: CO6A5;UniProt: A8TX70;TargetFullName: Collagen alpha-5(VI) chain;Organisim: human;Apparent_Kd_M: 4.595556E-11

Real

Aptamer SeqId: 11155-16 | Target: CO6A5 | UniProt: A8TX70

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11155-16 | Target: CO6A5 | UniProt: A8TX70 | TargetFullName: Collagen alpha-5(VI) chain | Organisim: human | Apparent_Kd_M: 4.595556E-11

Real

Aptamer SeqId:11157-35;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11157-35;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 1.152693E-11

Real

Aptamer SeqId: 11157-35 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11157-35 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 1.152693E-11

Real

Aptamer SeqId:11158-40;Target:BICR1;UniProt:Q6ZP65

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11158-40;Target: BICR1;UniProt: Q6ZP65;TargetFullName: Bicaudal D-related protein 1;Organisim: human;Apparent_Kd_M: 1.126791E-10

Real

Aptamer SeqId: 11158-40 | Target: BICR1 | UniProt: Q6ZP65

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11158-40 | Target: BICR1 | UniProt: Q6ZP65 | TargetFullName: Bicaudal D-related protein 1 | Organisim: human | Apparent_Kd_M: 1.126791E-10

Real

Aptamer SeqId:11160-56;Target:RN122;UniProt:Q9H9V4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11160-56;Target: RN122;UniProt: Q9H9V4;TargetFullName: RING finger protein 122;Organisim: human;Apparent_Kd_M: 1.401754E-11

Real

Aptamer SeqId: 11160-56 | Target: RN122 | UniProt: Q9H9V4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11160-56 | Target: RN122 | UniProt: Q9H9V4 | TargetFullName: RING finger protein 122 | Organisim: human | Apparent_Kd_M: 1.401754E-11

Real

Aptamer SeqId:11161-5;Target:SPG20;UniProt:Q8N0X7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11161-5;Target: SPG20;UniProt: Q8N0X7;TargetFullName: Spartin;Organisim: human;Apparent_Kd_M: 6.513137E-12

Real

Aptamer SeqId: 11161-5 | Target: SPG20 | UniProt: Q8N0X7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11161-5 | Target: SPG20 | UniProt: Q8N0X7 | TargetFullName: Spartin | Organisim: human | Apparent_Kd_M: 6.513137E-12

Real

Aptamer SeqId:11162-37;Target:EQTN;UniProt:Q9NQ60

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11162-37;Target: EQTN;UniProt: Q9NQ60;TargetFullName: Equatorin;Organisim: human;Apparent_Kd_M: 2.792528E-10

Real

Aptamer SeqId: 11162-37 | Target: EQTN | UniProt: Q9NQ60

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11162-37 | Target: EQTN | UniProt: Q9NQ60 | TargetFullName: Equatorin | Organisim: human | Apparent_Kd_M: 2.792528E-10

Real

Aptamer SeqId:11163-7;Target:F162B;UniProt:Q5T6X4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11163-7;Target: F162B;UniProt: Q5T6X4;TargetFullName: Protein FAM162B;Organisim: human;Apparent_Kd_M: 5.380156E-11

Real

Aptamer SeqId: 11163-7 | Target: F162B | UniProt: Q5T6X4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11163-7 | Target: F162B | UniProt: Q5T6X4 | TargetFullName: Protein FAM162B | Organisim: human | Apparent_Kd_M: 5.380156E-11

Real

Aptamer SeqId:11164-7;Target:TEN2;UniProt:Q9NT68

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11164-7;Target: TEN2;UniProt: Q9NT68;TargetFullName: Teneurin-2;Organisim: human;Apparent_Kd_M: 1.665816E-11

Real

Aptamer SeqId: 11164-7 | Target: TEN2 | UniProt: Q9NT68

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11164-7 | Target: TEN2 | UniProt: Q9NT68 | TargetFullName: Teneurin-2 | Organisim: human | Apparent_Kd_M: 1.665816E-11

Real

Aptamer SeqId:11167-6;Target:MTMR1;UniProt:Q13613

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11167-6;Target: MTMR1;UniProt: Q13613;TargetFullName: Myotubularin-related protein 1;Organisim: human;Apparent_Kd_M: 6.963717E-12

Real

Aptamer SeqId: 11167-6 | Target: MTMR1 | UniProt: Q13613

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11167-6 | Target: MTMR1 | UniProt: Q13613 | TargetFullName: Myotubularin-related protein 1 | Organisim: human | Apparent_Kd_M: 6.963717E-12

Real

Aptamer SeqId:11168-3;Target:MEG10;UniProt:Q96KG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11168-3;Target: MEG10;UniProt: Q96KG7;TargetFullName: Multiple epidermal growth factor-like domains protein 10;Organisim: human;Apparent_Kd_M: 1.173269E-11

Real

Aptamer SeqId: 11168-3 | Target: MEG10 | UniProt: Q96KG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11168-3 | Target: MEG10 | UniProt: Q96KG7 | TargetFullName: Multiple epidermal growth factor-like domains protein 10 | Organisim: human | Apparent_Kd_M: 1.173269E-11

Real

Aptamer SeqId:11171-25;Target:filamin A;UniProt:P21333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11171-25;Target: filamin A;UniProt: P21333;TargetFullName: Filamin-A;Organisim: human;Apparent_Kd_M: 2.089282E-12

Real

Aptamer SeqId: 11171-25 | Target: filamin A | UniProt: P21333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11171-25 | Target: filamin A | UniProt: P21333 | TargetFullName: Filamin-A | Organisim: human | Apparent_Kd_M: 2.089282E-12

Real

Aptamer SeqId:11173-29;Target:MILR1;UniProt:Q7Z6M3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11173-29;Target: MILR1;UniProt: Q7Z6M3;TargetFullName: Allergin-1;Organisim: human;Apparent_Kd_M: 1.649194E-11

Real

Aptamer SeqId: 11173-29 | Target: MILR1 | UniProt: Q7Z6M3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11173-29 | Target: MILR1 | UniProt: Q7Z6M3 | TargetFullName: Allergin-1 | Organisim: human | Apparent_Kd_M: 1.649194E-11

Real

Aptamer SeqId:11174-8;Target:THS7A;UniProt:Q9UPZ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11174-8;Target: THS7A;UniProt: Q9UPZ6;TargetFullName: Thrombospondin type-1 domain-containing protein 7A;Organisim: human;Apparent_Kd_M: 1.532943E-11

Real

Aptamer SeqId: 11174-8 | Target: THS7A | UniProt: Q9UPZ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11174-8 | Target: THS7A | UniProt: Q9UPZ6 | TargetFullName: Thrombospondin type-1 domain-containing protein 7A | Organisim: human | Apparent_Kd_M: 1.532943E-11

Real

Aptamer SeqId:11175-45;Target:PCAT2;UniProt:Q7L5N7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11175-45;Target: PCAT2;UniProt: Q7L5N7;TargetFullName: Lysophosphatidylcholine acyltransferase 2;Organisim: human;Apparent_Kd_M: 1.237341E-10

Real

Aptamer SeqId: 11175-45 | Target: PCAT2 | UniProt: Q7L5N7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11175-45 | Target: PCAT2 | UniProt: Q7L5N7 | TargetFullName: Lysophosphatidylcholine acyltransferase 2 | Organisim: human | Apparent_Kd_M: 1.237341E-10

Real

Aptamer SeqId:11177-16;Target:K2C5;UniProt:P13647

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11177-16;Target: K2C5;UniProt: P13647;TargetFullName: Keratin; type II cytoskeletal 5;Organisim: human;Apparent_Kd_M: 4.45E-12

Real

Aptamer SeqId: 11177-16 | Target: K2C5 | UniProt: P13647

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11177-16 | Target: K2C5 | UniProt: P13647 | TargetFullName: Keratin; type II cytoskeletal 5 | Organisim: human | Apparent_Kd_M: 4.45E-12

Real

Aptamer SeqId:11178-21;Target:SVEP1;UniProt:Q4LDE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11178-21;Target: SVEP1;UniProt: Q4LDE5;TargetFullName: Sushi; von Willebrand factor type A; EGF and pentraxin domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.748007E-11

Real

Aptamer SeqId: 11178-21 | Target: SVEP1 | UniProt: Q4LDE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11178-21 | Target: SVEP1 | UniProt: Q4LDE5 | TargetFullName: Sushi; von Willebrand factor type A; EGF and pentraxin domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.748007E-11

Real

Aptamer SeqId:11179-7;Target:TSSK1;UniProt:Q9BXA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11179-7;Target: TSSK1;UniProt: Q9BXA7;TargetFullName: Testis-specific serine/threonine-protein kinase 1;Organisim: human;Apparent_Kd_M: 6.274946E-11

Real

Aptamer SeqId: 11179-7 | Target: TSSK1 | UniProt: Q9BXA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11179-7 | Target: TSSK1 | UniProt: Q9BXA7 | TargetFullName: Testis-specific serine/threonine-protein kinase 1 | Organisim: human | Apparent_Kd_M: 6.274946E-11

Real

Aptamer SeqId:11180-17;Target:SMRC1;UniProt:Q92922

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11180-17;Target: SMRC1;UniProt: Q92922;TargetFullName: SWI/SNF complex subunit SMARCC1;Organisim: human;Apparent_Kd_M: 1.992654E-11

Real

Aptamer SeqId: 11180-17 | Target: SMRC1 | UniProt: Q92922

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11180-17 | Target: SMRC1 | UniProt: Q92922 | TargetFullName: SWI/SNF complex subunit SMARCC1 | Organisim: human | Apparent_Kd_M: 1.992654E-11

Real

Aptamer SeqId:11185-145;Target:GCH1;UniProt:P30793

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11185-145;Target: GCH1;UniProt: P30793;TargetFullName: GTP cyclohydrolase 1;Organisim: human;Apparent_Kd_M: 1.104633E-11

Real

Aptamer SeqId: 11185-145 | Target: GCH1 | UniProt: P30793

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11185-145 | Target: GCH1 | UniProt: P30793 | TargetFullName: GTP cyclohydrolase 1 | Organisim: human | Apparent_Kd_M: 1.104633E-11

Real

Aptamer SeqId:11186-12;Target:TMM52;UniProt:Q8NDY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11186-12;Target: TMM52;UniProt: Q8NDY8;TargetFullName: Transmembrane protein 52;Organisim: human;Apparent_Kd_M: 8.893346E-11

Real

Aptamer SeqId: 11186-12 | Target: TMM52 | UniProt: Q8NDY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11186-12 | Target: TMM52 | UniProt: Q8NDY8 | TargetFullName: Transmembrane protein 52 | Organisim: human | Apparent_Kd_M: 8.893346E-11

Real

Aptamer SeqId:11187-11;Target:CL12A;UniProt:Q5QGZ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11187-11;Target: CL12A;UniProt: Q5QGZ9;TargetFullName: C-type lectin domain family 12 member A;Organisim: human;Apparent_Kd_M: 2.253832E-12

Real

Aptamer SeqId: 11187-11 | Target: CL12A | UniProt: Q5QGZ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11187-11 | Target: CL12A | UniProt: Q5QGZ9 | TargetFullName: C-type lectin domain family 12 member A | Organisim: human | Apparent_Kd_M: 2.253832E-12

Real

Aptamer SeqId:11190-129;Target:YMEL1;UniProt:Q96TA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11190-129;Target: YMEL1;UniProt: Q96TA2;TargetFullName: ATP-dependent zinc metalloprotease YME1L1;Organisim: human;Apparent_Kd_M: 7.291078E-11

Real

Aptamer SeqId: 11190-129 | Target: YMEL1 | UniProt: Q96TA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11190-129 | Target: YMEL1 | UniProt: Q96TA2 | TargetFullName: ATP-dependent zinc metalloprotease YME1L1 | Organisim: human | Apparent_Kd_M: 7.291078E-11

Real

Aptamer SeqId:11192-168;Target:TINAL;UniProt:Q9GZM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11192-168;Target: TINAL;UniProt: Q9GZM7;TargetFullName: Tubulointerstitial nephritis antigen-like;Organisim: human;Apparent_Kd_M: 7.359185E-13

Real

Aptamer SeqId: 11192-168 | Target: TINAL | UniProt: Q9GZM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11192-168 | Target: TINAL | UniProt: Q9GZM7 | TargetFullName: Tubulointerstitial nephritis antigen-like | Organisim: human | Apparent_Kd_M: 7.359185E-13

Real

Aptamer SeqId:11193-27;Target:HNF1A;UniProt:P20823

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11193-27;Target: HNF1A;UniProt: P20823;TargetFullName: Hepatocyte nuclear factor 1-alpha;Organisim: human;Apparent_Kd_M: 2.274209E-12

Real

Aptamer SeqId: 11193-27 | Target: HNF1A | UniProt: P20823

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11193-27 | Target: HNF1A | UniProt: P20823 | TargetFullName: Hepatocyte nuclear factor 1-alpha | Organisim: human | Apparent_Kd_M: 2.274209E-12

Real

Aptamer SeqId:11194-6;Target:SIT1;UniProt:Q9Y3P8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11194-6;Target: SIT1;UniProt: Q9Y3P8;TargetFullName: Signaling threshold-regulating transmembrane adapter 1;Organisim: human;Apparent_Kd_M: 4.017099E-11

Real

Aptamer SeqId: 11194-6 | Target: SIT1 | UniProt: Q9Y3P8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11194-6 | Target: SIT1 | UniProt: Q9Y3P8 | TargetFullName: Signaling threshold-regulating transmembrane adapter 1 | Organisim: human | Apparent_Kd_M: 4.017099E-11

Real

Aptamer SeqId:11196-31;Target:Collagen alpha-3(VI);UniProt:P12111

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11196-31;Target: Collagen alpha-3(VI);UniProt: P12111;TargetFullName: Collagen alpha-3(VI) chain;Organisim: human;Apparent_Kd_M: 2.681462E-11

Real

Aptamer SeqId: 11196-31 | Target: Collagen alpha-3(VI) | UniProt: P12111

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11196-31 | Target: Collagen alpha-3(VI) | UniProt: P12111 | TargetFullName: Collagen alpha-3(VI) chain | Organisim: human | Apparent_Kd_M: 2.681462E-11

Real

Aptamer SeqId:11198-37;Target:CR3L1;UniProt:Q96BA8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11198-37;Target: CR3L1;UniProt: Q96BA8;TargetFullName: Cyclic AMP-responsive element-binding protein 3-like protein 1;Organisim: human;Apparent_Kd_M: 4.267596E-11

Real

Aptamer SeqId: 11198-37 | Target: CR3L1 | UniProt: Q96BA8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11198-37 | Target: CR3L1 | UniProt: Q96BA8 | TargetFullName: Cyclic AMP-responsive element-binding protein 3-like protein 1 | Organisim: human | Apparent_Kd_M: 4.267596E-11

Real

Aptamer SeqId:11201-19;Target:TRUA;UniProt:Q9Y606

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11201-19;Target: TRUA;UniProt: Q9Y606;TargetFullName: tRNA pseudouridine synthase A; mitochondrial;Organisim: human;Apparent_Kd_M: 1.636963E-11

Real

Aptamer SeqId: 11201-19 | Target: TRUA | UniProt: Q9Y606

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11201-19 | Target: TRUA | UniProt: Q9Y606 | TargetFullName: tRNA pseudouridine synthase A; mitochondrial | Organisim: human | Apparent_Kd_M: 1.636963E-11

Real

Aptamer SeqId:11202-70;Target:TBX5;UniProt:Q99593

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11202-70;Target: TBX5;UniProt: Q99593;TargetFullName: T-box transcription factor TBX5;Organisim: human;Apparent_Kd_M: 5.466399E-12

Real

Aptamer SeqId: 11202-70 | Target: TBX5 | UniProt: Q99593

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11202-70 | Target: TBX5 | UniProt: Q99593 | TargetFullName: T-box transcription factor TBX5 | Organisim: human | Apparent_Kd_M: 5.466399E-12

Real

Aptamer SeqId:11204-80;Target:CXAR;UniProt:P78310

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11204-80;Target: CXAR;UniProt: P78310;TargetFullName: Coxsackievirus and adenovirus receptor;Organisim: human;Apparent_Kd_M: 6.542611E-11

Real

Aptamer SeqId: 11204-80 | Target: CXAR | UniProt: P78310

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11204-80 | Target: CXAR | UniProt: P78310 | TargetFullName: Coxsackievirus and adenovirus receptor | Organisim: human | Apparent_Kd_M: 6.542611E-11

Real

Aptamer SeqId:11205-10;Target:Integrin beta-7;UniProt:P26010

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11205-10;Target: Integrin beta-7;UniProt: P26010;TargetFullName: Integrin beta-7;Organisim: human;Apparent_Kd_M: 9.254597E-12

Real

Aptamer SeqId: 11205-10 | Target: Integrin beta-7 | UniProt: P26010

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11205-10 | Target: Integrin beta-7 | UniProt: P26010 | TargetFullName: Integrin beta-7 | Organisim: human | Apparent_Kd_M: 9.254597E-12

Real

Aptamer SeqId:11207-3;Target:Macrophage scavenger receptor;UniProt:P21757

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11207-3;Target: Macrophage scavenger receptor;UniProt: P21757;TargetFullName: Macrophage scavenger receptor types I and II;Organisim: human;Apparent_Kd_M: 1.502653E-11

Real

Aptamer SeqId: 11207-3 | Target: Macrophage scavenger receptor

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11207-3 | Target: Macrophage scavenger receptor | UniProt: P21757 | TargetFullName: Macrophage scavenger receptor types I and II | Organisim: human | Apparent_Kd_M: 1.502653E-11

Real

Aptamer SeqId:11208-15;Target:NAGPA;UniProt:Q9UK23

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11208-15;Target: NAGPA;UniProt: Q9UK23;TargetFullName: N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase;Organisim: human;Apparent_Kd_M: 1.629906E-11

Real

Aptamer SeqId: 11208-15 | Target: NAGPA | UniProt: Q9UK23

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11208-15 | Target: NAGPA | UniProt: Q9UK23 | TargetFullName: N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase | Organisim: human | Apparent_Kd_M: 1.629906E-11

Real

Aptamer SeqId:11211-7;Target:TBCE;UniProt:Q15813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11211-7;Target: TBCE;UniProt: Q15813;TargetFullName: Tubulin-specific chaperone E;Organisim: human;Apparent_Kd_M: 3.524042E-12

Real

Aptamer SeqId: 11211-7 | Target: TBCE | UniProt: Q15813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11211-7 | Target: TBCE | UniProt: Q15813 | TargetFullName: Tubulin-specific chaperone E | Organisim: human | Apparent_Kd_M: 3.524042E-12

Real

Aptamer SeqId:11212-7;Target:TXND5;UniProt:Q8NBS9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11212-7;Target: TXND5;UniProt: Q8NBS9;TargetFullName: Thioredoxin domain-containing protein 5;Organisim: human;Apparent_Kd_M: 1.948882E-12

Real

Aptamer SeqId: 11212-7 | Target: TXND5 | UniProt: Q8NBS9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11212-7 | Target: TXND5 | UniProt: Q8NBS9 | TargetFullName: Thioredoxin domain-containing protein 5 | Organisim: human | Apparent_Kd_M: 1.948882E-12

Real

Aptamer SeqId:11214-40;Target:DNJB9;UniProt:Q9UBS3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11214-40;Target: DNJB9;UniProt: Q9UBS3;TargetFullName: DnaJ homolog subfamily B member 9;Organisim: human;Apparent_Kd_M: 7.616224E-12

Real

Aptamer SeqId: 11214-40 | Target: DNJB9 | UniProt: Q9UBS3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11214-40 | Target: DNJB9 | UniProt: Q9UBS3 | TargetFullName: DnaJ homolog subfamily B member 9 | Organisim: human | Apparent_Kd_M: 7.616224E-12

Real

Aptamer SeqId:11215-6;Target:CAD15;UniProt:P55291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11215-6;Target: CAD15;UniProt: P55291;TargetFullName: Cadherin-15;Organisim: human;Apparent_Kd_M: 1.69365E-11

Real

Aptamer SeqId: 11215-6 | Target: CAD15 | UniProt: P55291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11215-6 | Target: CAD15 | UniProt: P55291 | TargetFullName: Cadherin-15 | Organisim: human | Apparent_Kd_M: 1.69365E-11

Real

Aptamer SeqId:11217-16;Target:CTBP1;UniProt:Q13363

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11217-16;Target: CTBP1;UniProt: Q13363;TargetFullName: C-terminal-binding protein 1;Organisim: human;Apparent_Kd_M: 2.84218E-10

Real

Aptamer SeqId: 11217-16 | Target: CTBP1 | UniProt: Q13363

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11217-16 | Target: CTBP1 | UniProt: Q13363 | TargetFullName: C-terminal-binding protein 1 | Organisim: human | Apparent_Kd_M: 2.84218E-10

Real

Aptamer SeqId:11218-84;Target:TPMT;UniProt:P51580

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11218-84;Target: TPMT;UniProt: P51580;TargetFullName: Thiopurine S-methyltransferase;Organisim: human;Apparent_Kd_M: 9.119764E-12

Real

Aptamer SeqId: 11218-84 | Target: TPMT | UniProt: P51580

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11218-84 | Target: TPMT | UniProt: P51580 | TargetFullName: Thiopurine S-methyltransferase | Organisim: human | Apparent_Kd_M: 9.119764E-12

Real

Aptamer SeqId:11219-95;Target:FGFP3;UniProt:Q8TAT2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11219-95;Target: FGFP3;UniProt: Q8TAT2;TargetFullName: Fibroblast growth factor-binding protein 3;Organisim: human;Apparent_Kd_M: 1.314533E-10

Real

Aptamer SeqId: 11219-95 | Target: FGFP3 | UniProt: Q8TAT2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11219-95 | Target: FGFP3 | UniProt: Q8TAT2 | TargetFullName: Fibroblast growth factor-binding protein 3 | Organisim: human | Apparent_Kd_M: 1.314533E-10

Real

Aptamer SeqId:11220-53;Target:CJ105;UniProt:Q8TEF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11220-53;Target: CJ105;UniProt: Q8TEF2;TargetFullName: Uncharacterized protein C10orf105;Organisim: human;Apparent_Kd_M: 2.377041E-10

Real

Aptamer SeqId: 11220-53 | Target: CJ105 | UniProt: Q8TEF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11220-53 | Target: CJ105 | UniProt: Q8TEF2 | TargetFullName: Uncharacterized protein C10orf105 | Organisim: human | Apparent_Kd_M: 2.377041E-10

Real

Aptamer SeqId:11222-62;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11222-62;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.163176E-10

Real

Aptamer SeqId: 11222-62 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11222-62 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.163176E-10

Real

Aptamer SeqId:11223-1;Target:TM154;UniProt:Q6P9G4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11223-1;Target: TM154;UniProt: Q6P9G4;TargetFullName: Transmembrane protein 154;Organisim: human;Apparent_Kd_M: 4.605634E-12

Real

Aptamer SeqId: 11223-1 | Target: TM154 | UniProt: Q6P9G4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11223-1 | Target: TM154 | UniProt: Q6P9G4 | TargetFullName: Transmembrane protein 154 | Organisim: human | Apparent_Kd_M: 4.605634E-12

Real

Aptamer SeqId:11226-16;Target:UBE3A;UniProt:Q05086

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11226-16;Target: UBE3A;UniProt: Q05086;TargetFullName: Ubiquitin-protein ligase E3A;Organisim: human;Apparent_Kd_M: 4.130147E-12

Real

Aptamer SeqId: 11226-16 | Target: UBE3A | UniProt: Q05086

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11226-16 | Target: UBE3A | UniProt: Q05086 | TargetFullName: Ubiquitin-protein ligase E3A | Organisim: human | Apparent_Kd_M: 4.130147E-12

Real

Aptamer SeqId:11227-31;Target:TBL2;UniProt:Q9Y4P3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11227-31;Target: TBL2;UniProt: Q9Y4P3;TargetFullName: Transducin beta-like protein 2;Organisim: human;Apparent_Kd_M: 5.562146E-11

Real

Aptamer SeqId: 11227-31 | Target: TBL2 | UniProt: Q9Y4P3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11227-31 | Target: TBL2 | UniProt: Q9Y4P3 | TargetFullName: Transducin beta-like protein 2 | Organisim: human | Apparent_Kd_M: 5.562146E-11

Real

Aptamer SeqId:11228-37;Target:RIC3;UniProt:Q7Z5B4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11228-37;Target: RIC3;UniProt: Q7Z5B4;TargetFullName: Protein RIC-3;Organisim: human;Apparent_Kd_M: 3.240254E-10

Real

Aptamer SeqId: 11228-37 | Target: RIC3 | UniProt: Q7Z5B4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11228-37 | Target: RIC3 | UniProt: Q7Z5B4 | TargetFullName: Protein RIC-3 | Organisim: human | Apparent_Kd_M: 3.240254E-10

Real

Aptamer SeqId:11229-16;Target:ERN1;UniProt:O75460

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11229-16;Target: ERN1;UniProt: O75460;TargetFullName: Serine/threonine-protein kinase/endoribonuclease IRE1;Organisim: human;Apparent_Kd_M: 2.714274E-11

Real

Aptamer SeqId: 11229-16 | Target: ERN1 | UniProt: O75460

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11229-16 | Target: ERN1 | UniProt: O75460 | TargetFullName: Serine/threonine-protein kinase/endoribonuclease IRE1 | Organisim: human | Apparent_Kd_M: 2.714274E-11

Real

Aptamer SeqId:11230-12;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11230-12;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.176771E-12

Real

Aptamer SeqId: 11230-12 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11230-12 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.176771E-12

Real

Aptamer SeqId:11231-12;Target:ADXL;UniProt:Q6P4F2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11231-12;Target: ADXL;UniProt: Q6P4F2;TargetFullName: Adrenodoxin-like protein; mitochondrial;Organisim: human;Apparent_Kd_M: 3.427036E-11

Real

Aptamer SeqId: 11231-12 | Target: ADXL | UniProt: Q6P4F2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11231-12 | Target: ADXL | UniProt: Q6P4F2 | TargetFullName: Adrenodoxin-like protein; mitochondrial | Organisim: human | Apparent_Kd_M: 3.427036E-11

Real

Aptamer SeqId:11237-49;Target:PCOC1;UniProt:Q15113

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11237-49;Target: PCOC1;UniProt: Q15113;TargetFullName: Procollagen C-endopeptidase enhancer 1;Organisim: human;Apparent_Kd_M: 3.632229E-12

Real

Aptamer SeqId: 11237-49 | Target: PCOC1 | UniProt: Q15113

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11237-49 | Target: PCOC1 | UniProt: Q15113 | TargetFullName: Procollagen C-endopeptidase enhancer 1 | Organisim: human | Apparent_Kd_M: 3.632229E-12

Real

Aptamer SeqId:11239-49;Target:TMPS6;UniProt:Q8IU80

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11239-49;Target: TMPS6;UniProt: Q8IU80;TargetFullName: Transmembrane protease serine 6;Organisim: human;Apparent_Kd_M: 1.746197E-10

Real

Aptamer SeqId: 11239-49 | Target: TMPS6 | UniProt: Q8IU80

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11239-49 | Target: TMPS6 | UniProt: Q8IU80 | TargetFullName: Transmembrane protease serine 6 | Organisim: human | Apparent_Kd_M: 1.746197E-10

Real

Aptamer SeqId:11241-8;Target:ARLY;UniProt:P04424

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11241-8;Target: ARLY;UniProt: P04424;TargetFullName: Argininosuccinate lyase;Organisim: human;Apparent_Kd_M: 1.200677E-11

Real

Aptamer SeqId: 11241-8 | Target: ARLY | UniProt: P04424

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11241-8 | Target: ARLY | UniProt: P04424 | TargetFullName: Argininosuccinate lyase | Organisim: human | Apparent_Kd_M: 1.200677E-11

Real

Aptamer SeqId:11242-33;Target:TGM1;UniProt:P22735

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11242-33;Target: TGM1;UniProt: P22735;TargetFullName: Protein-glutamine gamma-glutamyltransferase K;Organisim: human;Apparent_Kd_M: 1.352349E-10

Real

Aptamer SeqId: 11242-33 | Target: TGM1 | UniProt: P22735

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11242-33 | Target: TGM1 | UniProt: P22735 | TargetFullName: Protein-glutamine gamma-glutamyltransferase K | Organisim: human | Apparent_Kd_M: 1.352349E-10

Real

Aptamer SeqId:11243-90;Target:GPR110;UniProt:Q5T601

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11243-90;Target: GPR110;UniProt: Q5T601;TargetFullName: Adhesion G-protein coupled receptor F1;Organisim: human;Apparent_Kd_M: 4.533773E-11

Real

Aptamer SeqId: 11243-90 | Target: GPR110 | UniProt: Q5T601

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11243-90 | Target: GPR110 | UniProt: Q5T601 | TargetFullName: Adhesion G-protein coupled receptor F1 | Organisim: human | Apparent_Kd_M: 4.533773E-11

Real

Aptamer SeqId:11247-20;Target:NAGS;UniProt:Q8N159

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11247-20;Target: NAGS;UniProt: Q8N159;TargetFullName: N-acetylglutamate synthase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.978105E-12

Real

Aptamer SeqId: 11247-20 | Target: NAGS | UniProt: Q8N159

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11247-20 | Target: NAGS | UniProt: Q8N159 | TargetFullName: N-acetylglutamate synthase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.978105E-12

Real

Aptamer SeqId:11248-43;Target:HEM4;UniProt:P10746

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11248-43;Target: HEM4;UniProt: P10746;TargetFullName: Uroporphyrinogen-III synthase;Organisim: human;Apparent_Kd_M: 3.881034E-12

Real

Aptamer SeqId: 11248-43 | Target: HEM4 | UniProt: P10746

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11248-43 | Target: HEM4 | UniProt: P10746 | TargetFullName: Uroporphyrinogen-III synthase | Organisim: human | Apparent_Kd_M: 3.881034E-12

Real

Aptamer SeqId:11252-30;Target:LRCH4;UniProt:O75427

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11252-30;Target: LRCH4;UniProt: O75427;TargetFullName: Leucine-rich repeat and calponin homology domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.060243E-11

Real

Aptamer SeqId: 11252-30 | Target: LRCH4 | UniProt: O75427

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11252-30 | Target: LRCH4 | UniProt: O75427 | TargetFullName: Leucine-rich repeat and calponin homology domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.060243E-11

Real

Aptamer SeqId:11254-13;Target:PPN;UniProt:O95428

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11254-13;Target: PPN;UniProt: O95428;TargetFullName: Papilin;Organisim: human;Apparent_Kd_M: 4.304814E-11

Real

Aptamer SeqId: 11254-13 | Target: PPN | UniProt: O95428

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11254-13 | Target: PPN | UniProt: O95428 | TargetFullName: Papilin | Organisim: human | Apparent_Kd_M: 4.304814E-11

Real

Aptamer SeqId:11257-1;Target:DHPR;UniProt:P09417

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11257-1;Target: DHPR;UniProt: P09417;TargetFullName: Dihydropteridine reductase;Organisim: human;Apparent_Kd_M: 1.951395E-12

Real

Aptamer SeqId: 11257-1 | Target: DHPR | UniProt: P09417

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11257-1 | Target: DHPR | UniProt: P09417 | TargetFullName: Dihydropteridine reductase | Organisim: human | Apparent_Kd_M: 1.951395E-12

Real

Aptamer SeqId:11258-41;Target:MAdCAM-1;UniProt:Q13477

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11258-41;Target: MAdCAM-1;UniProt: Q13477;TargetFullName: Mucosal addressin cell adhesion molecule 1;Organisim: human;Apparent_Kd_M: 1.358852E-10

Real

Aptamer SeqId: 11258-41 | Target: MAdCAM-1 | UniProt: Q13477

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11258-41 | Target: MAdCAM-1 | UniProt: Q13477 | TargetFullName: Mucosal addressin cell adhesion molecule 1 | Organisim: human | Apparent_Kd_M: 1.358852E-10

Real

Aptamer SeqId:11260-47;Target:SPA4L;UniProt:Q8TC36

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11260-47;Target: SPA4L;UniProt: Q8TC36;TargetFullName: SUN domain-containing protein 5;Organisim: human;Apparent_Kd_M: 1.084406E-10

Real

Aptamer SeqId: 11260-47 | Target: SPA4L | UniProt: Q8TC36

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11260-47 | Target: SPA4L | UniProt: Q8TC36 | TargetFullName: SUN domain-containing protein 5 | Organisim: human | Apparent_Kd_M: 1.084406E-10

Real

Aptamer SeqId:11262-39;Target:TRABD;UniProt:Q9H4I3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11262-39;Target: TRABD;UniProt: Q9H4I3;TargetFullName: TraB domain-containing protein;Organisim: human;Apparent_Kd_M: 1.168341E-10

Real

Aptamer SeqId: 11262-39 | Target: TRABD | UniProt: Q9H4I3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11262-39 | Target: TRABD | UniProt: Q9H4I3 | TargetFullName: TraB domain-containing protein | Organisim: human | Apparent_Kd_M: 1.168341E-10

Real

Aptamer SeqId:11263-57;Target:CASQ1;UniProt:P31415

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11263-57;Target: CASQ1;UniProt: P31415;TargetFullName: Calsequestrin-1;Organisim: human;Apparent_Kd_M: 4.338953E-10

Real

Aptamer SeqId: 11263-57 | Target: CASQ1 | UniProt: P31415

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11263-57 | Target: CASQ1 | UniProt: P31415 | TargetFullName: Calsequestrin-1 | Organisim: human | Apparent_Kd_M: 4.338953E-10

Real

Aptamer SeqId:11264-33;Target:XDH;UniProt:P47989

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11264-33;Target: XDH;UniProt: P47989;TargetFullName: Xanthine dehydrogenase/oxidase;Organisim: human;Apparent_Kd_M: 1.003404E-11

Real

Aptamer SeqId: 11264-33 | Target: XDH | UniProt: P47989

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11264-33 | Target: XDH | UniProt: P47989 | TargetFullName: Xanthine dehydrogenase/oxidase | Organisim: human | Apparent_Kd_M: 1.003404E-11

Real

Aptamer SeqId:11265-8;Target:Retinal dehydrogenase 1;UniProt:P00352

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11265-8;Target: Retinal dehydrogenase 1;UniProt: P00352;TargetFullName: Retinal dehydrogenase 1;Organisim: human;Apparent_Kd_M: 2.371671E-11

Real

Aptamer SeqId: 11265-8 | Target: Retinal dehydrogenase 1 | UniProt: P00352

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11265-8 | Target: Retinal dehydrogenase 1 | UniProt: P00352 | TargetFullName: Retinal dehydrogenase 1 | Organisim: human | Apparent_Kd_M: 2.371671E-11

Real

Aptamer SeqId:11266-8;Target:SELPL;UniProt:Q14242

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11266-8;Target: SELPL;UniProt: Q14242;TargetFullName: P-selectin glycoprotein ligand 1;Organisim: human;Apparent_Kd_M: 4.61E-11

Real

Aptamer SeqId: 11266-8 | Target: SELPL | UniProt: Q14242

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11266-8 | Target: SELPL | UniProt: Q14242 | TargetFullName: P-selectin glycoprotein ligand 1 | Organisim: human | Apparent_Kd_M: 4.61E-11

Real

Aptamer SeqId:11270-17;Target:CHC10;UniProt:Q8WYQ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11270-17;Target: CHC10;UniProt: Q8WYQ3;TargetFullName: Coiled-coil-helix-coiled-coil-helix domain-containing protein 10; mitochondrial;Organisim: human;Apparent_Kd_M: 4.425639E-12

Real

Aptamer SeqId: 11270-17 | Target: CHC10 | UniProt: Q8WYQ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11270-17 | Target: CHC10 | UniProt: Q8WYQ3 | TargetFullName: Coiled-coil-helix-coiled-coil-helix domain-containing protein 10; mitochondrial | Organisim: human | Apparent_Kd_M: 4.425639E-12

Real

Aptamer SeqId:11273-176;Target:GSTT2;UniProt:P0CG30

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11273-176;Target: GSTT2;UniProt: P0CG30;TargetFullName: Glutathione S-transferase theta-2B;Organisim: human;Apparent_Kd_M: 3.218031E-10

Real

Aptamer SeqId: 11273-176 | Target: GSTT2 | UniProt: P0CG30

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11273-176 | Target: GSTT2 | UniProt: P0CG30 | TargetFullName: Glutathione S-transferase theta-2B | Organisim: human | Apparent_Kd_M: 3.218031E-10

Real

Aptamer SeqId:11275-94;Target:LRP1B;UniProt:Q9NZR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11275-94;Target: LRP1B;UniProt: Q9NZR2;TargetFullName: Low-density lipoprotein receptor-related protein 1B;Organisim: human;Apparent_Kd_M: 2.069559E-11

Real

Aptamer SeqId: 11275-94 | Target: LRP1B | UniProt: Q9NZR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11275-94 | Target: LRP1B | UniProt: Q9NZR2 | TargetFullName: Low-density lipoprotein receptor-related protein 1B | Organisim: human | Apparent_Kd_M: 2.069559E-11

Real

Aptamer SeqId:11277-23;Target:ATF6A;UniProt:P18850

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11277-23;Target: ATF6A;UniProt: P18850;TargetFullName: Cyclic AMP-dependent transcription factor ATF-6 alpha;Organisim: human;Apparent_Kd_M: 1.463131E-12

Real

Aptamer SeqId: 11277-23 | Target: ATF6A | UniProt: P18850

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11277-23 | Target: ATF6A | UniProt: P18850 | TargetFullName: Cyclic AMP-dependent transcription factor ATF-6 alpha | Organisim: human | Apparent_Kd_M: 1.463131E-12

Real

Aptamer SeqId:11278-4;Target:COL11A2;UniProt:P13942

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11278-4;Target: COL11A2;UniProt: P13942;TargetFullName: Collagen alpha-2(XI) chain;Organisim: human;Apparent_Kd_M: 7.40327E-12

Real

Aptamer SeqId: 11278-4 | Target: COL11A2 | UniProt: P13942

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11278-4 | Target: COL11A2 | UniProt: P13942 | TargetFullName: Collagen alpha-2(XI) chain | Organisim: human | Apparent_Kd_M: 7.40327E-12

Real

Aptamer SeqId:11279-42;Target:GABR1;UniProt:Q9UBS5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11279-42;Target: GABR1;UniProt: Q9UBS5;TargetFullName: Gamma-aminobutyric acid type B receptor subunit 1;Organisim: human;Apparent_Kd_M: 8.626112E-12

Real

Aptamer SeqId: 11279-42 | Target: GABR1 | UniProt: Q9UBS5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11279-42 | Target: GABR1 | UniProt: Q9UBS5 | TargetFullName: Gamma-aminobutyric acid type B receptor subunit 1 | Organisim: human | Apparent_Kd_M: 8.626112E-12

Real

Aptamer SeqId:11280-6;Target:DCE1;UniProt:Q99259

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11280-6;Target: DCE1;UniProt: Q99259;TargetFullName: Glutamate decarboxylase 1;Organisim: human;Apparent_Kd_M: 9.593671E-11

Real

Aptamer SeqId: 11280-6 | Target: DCE1 | UniProt: Q99259

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11280-6 | Target: DCE1 | UniProt: Q99259 | TargetFullName: Glutamate decarboxylase 1 | Organisim: human | Apparent_Kd_M: 9.593671E-11

Real

Aptamer SeqId:11281-6;Target:GRB7;UniProt:Q14451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11281-6;Target: GRB7;UniProt: Q14451;TargetFullName: Growth factor receptor-bound protein 7;Organisim: human;Apparent_Kd_M: 7.343696E-12

Real

Aptamer SeqId: 11281-6 | Target: GRB7 | UniProt: Q14451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11281-6 | Target: GRB7 | UniProt: Q14451 | TargetFullName: Growth factor receptor-bound protein 7 | Organisim: human | Apparent_Kd_M: 7.343696E-12

Real

Aptamer SeqId:11283-13;Target:DCAF5;UniProt:Q96JK2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11283-13;Target: DCAF5;UniProt: Q96JK2;TargetFullName: DDB1- and CUL4-associated factor 5;Organisim: human;Apparent_Kd_M: 1.144763E-12

Real

Aptamer SeqId: 11283-13 | Target: DCAF5 | UniProt: Q96JK2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11283-13 | Target: DCAF5 | UniProt: Q96JK2 | TargetFullName: DDB1- and CUL4-associated factor 5 | Organisim: human | Apparent_Kd_M: 1.144763E-12

Real

Aptamer SeqId:11284-24;Target:LAIR1;UniProt:Q6GTX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11284-24;Target: LAIR1;UniProt: Q6GTX8;TargetFullName: Leukocyte-associated immunoglobulin-like receptor 1;Organisim: human;Apparent_Kd_M: 1.555293E-12

Real

Aptamer SeqId: 11284-24 | Target: LAIR1 | UniProt: Q6GTX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11284-24 | Target: LAIR1 | UniProt: Q6GTX8 | TargetFullName: Leukocyte-associated immunoglobulin-like receptor 1 | Organisim: human | Apparent_Kd_M: 1.555293E-12

Real

Aptamer SeqId:11286-78;Target:SELS;UniProt:Q9BQE4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11286-78;Target: SELS;UniProt: Q9BQE4;TargetFullName: Selenoprotein S;Organisim: human;Apparent_Kd_M: 6.059991E-12

Real

Aptamer SeqId: 11286-78 | Target: SELS | UniProt: Q9BQE4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11286-78 | Target: SELS | UniProt: Q9BQE4 | TargetFullName: Selenoprotein S | Organisim: human | Apparent_Kd_M: 6.059991E-12

Real

Aptamer SeqId:11287-14;Target:Cytochrome b5;UniProt:P00167

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11287-14;Target: Cytochrome b5;UniProt: P00167;TargetFullName: Cytochrome b5;Organisim: human;Apparent_Kd_M: 2.333026E-11

Real

Aptamer SeqId: 11287-14 | Target: Cytochrome b5 | UniProt: P00167

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11287-14 | Target: Cytochrome b5 | UniProt: P00167 | TargetFullName: Cytochrome b5 | Organisim: human | Apparent_Kd_M: 2.333026E-11

Real

Aptamer SeqId:11288-26;Target:5NTC;UniProt:P49902

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11288-26;Target: 5NTC;UniProt: P49902;TargetFullName: Cytosolic purine 5-nucleotidase;Organisim: human;Apparent_Kd_M: 9.045895E-11

Real

Aptamer SeqId: 11288-26 | Target: 5NTC | UniProt: P49902

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11288-26 | Target: 5NTC | UniProt: P49902 | TargetFullName: Cytosolic purine 5'-nucleotidase | Organisim: human | Apparent_Kd_M: 9.045895E-11

Real

Aptamer SeqId:11289-31;Target:KC1D;UniProt:P48730

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11289-31;Target: KC1D;UniProt: P48730;TargetFullName: Casein kinase I isoform delta;Organisim: human;Apparent_Kd_M: 2.26584E-11

Real

Aptamer SeqId: 11289-31 | Target: KC1D | UniProt: P48730

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11289-31 | Target: KC1D | UniProt: P48730 | TargetFullName: Casein kinase I isoform delta | Organisim: human | Apparent_Kd_M: 2.26584E-11

Real

Aptamer SeqId:11291-73;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11291-73;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.066854E-11

Real

Aptamer SeqId: 11291-73 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11291-73 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.066854E-11

Real

Aptamer SeqId:11292-13;Target:SCAR3;UniProt:Q6AZY7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11292-13;Target: SCAR3;UniProt: Q6AZY7;TargetFullName: Scavenger receptor class A member 3;Organisim: human;Apparent_Kd_M: 4.570475E-11

Real

Aptamer SeqId: 11292-13 | Target: SCAR3 | UniProt: Q6AZY7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11292-13 | Target: SCAR3 | UniProt: Q6AZY7 | TargetFullName: Scavenger receptor class A member 3 | Organisim: human | Apparent_Kd_M: 4.570475E-11

Real

Aptamer SeqId:11293-14;Target:LRRN1;UniProt:Q6UXK5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11293-14;Target: LRRN1;UniProt: Q6UXK5;TargetFullName: Leucine-rich repeat neuronal protein 1;Organisim: human;Apparent_Kd_M: 1.24384E-11

Real

Aptamer SeqId: 11293-14 | Target: LRRN1 | UniProt: Q6UXK5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11293-14 | Target: LRRN1 | UniProt: Q6UXK5 | TargetFullName: Leucine-rich repeat neuronal protein 1 | Organisim: human | Apparent_Kd_M: 1.24384E-11

Real

Aptamer SeqId:11297-54;Target:NOTC2;UniProt:Q04721

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11297-54;Target: NOTC2;UniProt: Q04721;TargetFullName: Neurogenic locus notch homolog protein 2;Organisim: human;Apparent_Kd_M: 1.738868E-11

Real

Aptamer SeqId: 11297-54 | Target: NOTC2 | UniProt: Q04721

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11297-54 | Target: NOTC2 | UniProt: Q04721 | TargetFullName: Neurogenic locus notch homolog protein 2 | Organisim: human | Apparent_Kd_M: 1.738868E-11

Real

Aptamer SeqId:11300-32;Target:SORT;UniProt:Q99523

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11300-32;Target: SORT;UniProt: Q99523;TargetFullName: Sortilin;Organisim: human;Apparent_Kd_M: 3.848463E-11

Real

Aptamer SeqId: 11300-32 | Target: SORT | UniProt: Q99523

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11300-32 | Target: SORT | UniProt: Q99523 | TargetFullName: Sortilin | Organisim: human | Apparent_Kd_M: 3.848463E-11

Real

Aptamer SeqId:11302-237;Target:TENR;UniProt:Q92752

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11302-237;Target: TENR;UniProt: Q92752;TargetFullName: Tenascin-R;Organisim: human;Apparent_Kd_M: 8.088612E-11

Real

Aptamer SeqId: 11302-237 | Target: TENR | UniProt: Q92752

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11302-237 | Target: TENR | UniProt: Q92752 | TargetFullName: Tenascin-R | Organisim: human | Apparent_Kd_M: 8.088612E-11

Real

Aptamer SeqId:11303-7;Target:SAMH1;UniProt:Q9Y3Z3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11303-7;Target: SAMH1;UniProt: Q9Y3Z3;TargetFullName: Deoxynucleoside triphosphate triphosphohydrolase SAMHD1;Organisim: human;Apparent_Kd_M: 9.93323E-12

Real

Aptamer SeqId: 11303-7 | Target: SAMH1 | UniProt: Q9Y3Z3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11303-7 | Target: SAMH1 | UniProt: Q9Y3Z3 | TargetFullName: Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | Organisim: human | Apparent_Kd_M: 9.93323E-12

Real

Aptamer SeqId:11307-33;Target:WWP1;UniProt:Q9H0M0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11307-33;Target: WWP1;UniProt: Q9H0M0;TargetFullName: NEDD4-like E3 ubiquitin-protein ligase WWP1;Organisim: human;Apparent_Kd_M: 5.145084E-12

Real

Aptamer SeqId: 11307-33 | Target: WWP1 | UniProt: Q9H0M0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11307-33 | Target: WWP1 | UniProt: Q9H0M0 | TargetFullName: NEDD4-like E3 ubiquitin-protein ligase WWP1 | Organisim: human | Apparent_Kd_M: 5.145084E-12

Real

Aptamer SeqId:11308-8;Target:CR3L4;UniProt:Q8TEY5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11308-8;Target: CR3L4;UniProt: Q8TEY5;TargetFullName: Cyclic AMP-responsive element-binding protein 3-like protein 4;Organisim: human;Apparent_Kd_M: 2.659548E-11

Real

Aptamer SeqId: 11308-8 | Target: CR3L4 | UniProt: Q8TEY5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11308-8 | Target: CR3L4 | UniProt: Q8TEY5 | TargetFullName: Cyclic AMP-responsive element-binding protein 3-like protein 4 | Organisim: human | Apparent_Kd_M: 2.659548E-11

Real

Aptamer SeqId:11311-79;Target:RAG-1;UniProt:P15918

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11311-79;Target: RAG-1;UniProt: P15918;TargetFullName: V(D)J recombination-activating protein 1;Organisim: human;Apparent_Kd_M: 8.855031E-10

Real

Aptamer SeqId: 11311-79 | Target: RAG-1 | UniProt: P15918

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11311-79 | Target: RAG-1 | UniProt: P15918 | TargetFullName: V(D)J recombination-activating protein 1 | Organisim: human | Apparent_Kd_M: 8.855031E-10

Real

Aptamer SeqId:11312-40;Target:PMS2;UniProt:P54278

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11312-40;Target: PMS2;UniProt: P54278;TargetFullName: Mismatch repair endonuclease PMS2;Organisim: human;Apparent_Kd_M: 1.498974E-11

Real

Aptamer SeqId: 11312-40 | Target: PMS2 | UniProt: P54278

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11312-40 | Target: PMS2 | UniProt: P54278 | TargetFullName: Mismatch repair endonuclease PMS2 | Organisim: human | Apparent_Kd_M: 1.498974E-11

Real

Aptamer SeqId:11313-100;Target:PHS;UniProt:P61457

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11313-100;Target: PHS;UniProt: P61457;TargetFullName: Pterin-4-alpha-carbinolamine dehydratase;Organisim: human;Apparent_Kd_M: 3.721893E-11

Real

Aptamer SeqId: 11313-100 | Target: PHS | UniProt: P61457

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11313-100 | Target: PHS | UniProt: P61457 | TargetFullName: Pterin-4-alpha-carbinolamine dehydratase | Organisim: human | Apparent_Kd_M: 3.721893E-11

Real

Aptamer SeqId:11315-148;Target:PPM1D;UniProt:O15297

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11315-148;Target: PPM1D;UniProt: O15297;TargetFullName: Protein phosphatase 1D;Organisim: human;Apparent_Kd_M: 4.301776E-12

Real

Aptamer SeqId: 11315-148 | Target: PPM1D | UniProt: O15297

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11315-148 | Target: PPM1D | UniProt: O15297 | TargetFullName: Protein phosphatase 1D | Organisim: human | Apparent_Kd_M: 4.301776E-12

Real

Aptamer SeqId:11319-106;Target:MRE11;UniProt:P49959

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11319-106;Target: MRE11;UniProt: P49959;TargetFullName: Double-strand break repair protein MRE11;Organisim: human;Apparent_Kd_M: 1.072669E-11

Real

Aptamer SeqId: 11319-106 | Target: MRE11 | UniProt: P49959

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11319-106 | Target: MRE11 | UniProt: P49959 | TargetFullName: Double-strand break repair protein MRE11 | Organisim: human | Apparent_Kd_M: 1.072669E-11

Real

Aptamer SeqId:11320-29;Target:CHFR;UniProt:Q96EP1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11320-29;Target: CHFR;UniProt: Q96EP1;TargetFullName: E3 ubiquitin-protein ligase CHFR;Organisim: human;Apparent_Kd_M: 3.831788E-11

Real

Aptamer SeqId: 11320-29 | Target: CHFR | UniProt: Q96EP1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11320-29 | Target: CHFR | UniProt: Q96EP1 | TargetFullName: E3 ubiquitin-protein ligase CHFR | Organisim: human | Apparent_Kd_M: 3.831788E-11

Real

Aptamer SeqId:11324-3;Target:PXDNL;UniProt:A1KZ92

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11324-3;Target: PXDNL;UniProt: A1KZ92;TargetFullName: Peroxidasin-like protein;Organisim: human;Apparent_Kd_M: 1.021713E-11

Real

Aptamer SeqId: 11324-3 | Target: PXDNL | UniProt: A1KZ92

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11324-3 | Target: PXDNL | UniProt: A1KZ92 | TargetFullName: Peroxidasin-like protein | Organisim: human | Apparent_Kd_M: 1.021713E-11

Real

Aptamer SeqId:11325-8;Target:BTG2;UniProt:P78543

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11325-8;Target: BTG2;UniProt: P78543;TargetFullName: Protein BTG2;Organisim: human;Apparent_Kd_M: 1.006572E-10

Real

Aptamer SeqId: 11325-8 | Target: BTG2 | UniProt: P78543

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11325-8 | Target: BTG2 | UniProt: P78543 | TargetFullName: Protein BTG2 | Organisim: human | Apparent_Kd_M: 1.006572E-10

Real

Aptamer SeqId:11327-56;Target:CLK2;UniProt:P49760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11327-56;Target: CLK2;UniProt: P49760;TargetFullName: Dual specificity protein kinase CLK2;Organisim: human;Apparent_Kd_M: 3.87731E-11

Real

Aptamer SeqId: 11327-56 | Target: CLK2 | UniProt: P49760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11327-56 | Target: CLK2 | UniProt: P49760 | TargetFullName: Dual specificity protein kinase CLK2 | Organisim: human | Apparent_Kd_M: 3.87731E-11

Real

Aptamer SeqId:11328-9;Target:USB1;UniProt:Q9BQ65

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11328-9;Target: USB1;UniProt: Q9BQ65;TargetFullName: U6 snRNA phosphodiesterase;Organisim: human;Apparent_Kd_M: 2.370659E-11

Real

Aptamer SeqId: 11328-9 | Target: USB1 | UniProt: Q9BQ65

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11328-9 | Target: USB1 | UniProt: Q9BQ65 | TargetFullName: U6 snRNA phosphodiesterase | Organisim: human | Apparent_Kd_M: 2.370659E-11

Real

Aptamer SeqId:11330-15;Target:CSK2B;UniProt:P67870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11330-15;Target: CSK2B;UniProt: P67870;TargetFullName: Casein kinase II subunit beta;Organisim: human;Apparent_Kd_M: 1.199878E-10

Real

Aptamer SeqId: 11330-15 | Target: CSK2B | UniProt: P67870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11330-15 | Target: CSK2B | UniProt: P67870 | TargetFullName: Casein kinase II subunit beta | Organisim: human | Apparent_Kd_M: 1.199878E-10

Real

Aptamer SeqId:11333-82;Target:RHG25;UniProt:P42331

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11333-82;Target: RHG25;UniProt: P42331;TargetFullName: Rho GTPase-activating protein 25;Organisim: human;Apparent_Kd_M: 1.493645E-12

Real

Aptamer SeqId: 11333-82 | Target: RHG25 | UniProt: P42331

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11333-82 | Target: RHG25 | UniProt: P42331 | TargetFullName: Rho GTPase-activating protein 25 | Organisim: human | Apparent_Kd_M: 1.493645E-12

Real

Aptamer SeqId:11334-7;Target:LIRB3;UniProt:O75022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11334-7;Target: LIRB3;UniProt: O75022;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 3;Organisim: human;Apparent_Kd_M: 6.260214E-12

Real

Aptamer SeqId: 11334-7 | Target: LIRB3 | UniProt: O75022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11334-7 | Target: LIRB3 | UniProt: O75022 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 3 | Organisim: human | Apparent_Kd_M: 6.260214E-12

Real

Aptamer SeqId:11336-9;Target:FANCF;UniProt:Q9NPI8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11336-9;Target: FANCF;UniProt: Q9NPI8;TargetFullName: Fanconi anemia group F protein;Organisim: human;Apparent_Kd_M: 8.479839E-13

Real

Aptamer SeqId: 11336-9 | Target: FANCF | UniProt: Q9NPI8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11336-9 | Target: FANCF | UniProt: Q9NPI8 | TargetFullName: Fanconi anemia group F protein | Organisim: human | Apparent_Kd_M: 8.479839E-13

Real

Aptamer SeqId:11338-49;Target:BLK;UniProt:P51451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11338-49;Target: BLK;UniProt: P51451;TargetFullName: Tyrosine-protein kinase BLK;Organisim: human;Apparent_Kd_M: 7.463648E-12

Real

Aptamer SeqId: 11338-49 | Target: BLK | UniProt: P51451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11338-49 | Target: BLK | UniProt: P51451 | TargetFullName: Tyrosine-protein kinase BLK | Organisim: human | Apparent_Kd_M: 7.463648E-12

Real

Aptamer SeqId:11342-59;Target:PXDC2;UniProt:Q6UX71

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11342-59;Target: PXDC2;UniProt: Q6UX71;TargetFullName: Plexin domain-containing protein 2;Organisim: human;Apparent_Kd_M: 4.491959E-12

Real

Aptamer SeqId: 11342-59 | Target: PXDC2 | UniProt: Q6UX71

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11342-59 | Target: PXDC2 | UniProt: Q6UX71 | TargetFullName: Plexin domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 4.491959E-12

Real

Aptamer SeqId:11347-9;Target:Transaldolase;UniProt:P37837

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11347-9;Target: Transaldolase;UniProt: P37837;TargetFullName: Transaldolase;Organisim: human;Apparent_Kd_M: 3.35318E-12

Real

Aptamer SeqId: 11347-9 | Target: Transaldolase | UniProt: P37837

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11347-9 | Target: Transaldolase | UniProt: P37837 | TargetFullName: Transaldolase | Organisim: human | Apparent_Kd_M: 3.35318E-12

Real

Aptamer SeqId:11348-132;Target:P4HA2;UniProt:O15460

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11348-132;Target: P4HA2;UniProt: O15460;TargetFullName: Prolyl 4-hydroxylase subunit alpha-2;Organisim: human;Apparent_Kd_M: 3.9946E-11

Real

Aptamer SeqId: 11348-132 | Target: P4HA2 | UniProt: O15460

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11348-132 | Target: P4HA2 | UniProt: O15460 | TargetFullName: Prolyl 4-hydroxylase subunit alpha-2 | Organisim: human | Apparent_Kd_M: 3.9946E-11

Real

Aptamer SeqId:11350-30;Target:CHIP;UniProt:Q9UNE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11350-30;Target: CHIP;UniProt: Q9UNE7;TargetFullName: E3 ubiquitin-protein ligase CHIP;Organisim: human;Apparent_Kd_M: 6.541949E-12

Real

Aptamer SeqId: 11350-30 | Target: CHIP | UniProt: Q9UNE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11350-30 | Target: CHIP | UniProt: Q9UNE7 | TargetFullName: E3 ubiquitin-protein ligase CHIP | Organisim: human | Apparent_Kd_M: 6.541949E-12

Real

Aptamer SeqId:11351-233;Target:NHEJ1;UniProt:Q9H9Q4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11351-233;Target: NHEJ1;UniProt: Q9H9Q4;TargetFullName: Non-homologous end-joining factor 1;Organisim: human;Apparent_Kd_M: 1.50951E-10

Real

Aptamer SeqId: 11351-233 | Target: NHEJ1 | UniProt: Q9H9Q4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11351-233 | Target: NHEJ1 | UniProt: Q9H9Q4 | TargetFullName: Non-homologous end-joining factor 1 | Organisim: human | Apparent_Kd_M: 1.50951E-10

Real

Aptamer SeqId:11352-42;Target:TITIN;UniProt:Q8WZ42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11352-42;Target: TITIN;UniProt: Q8WZ42;TargetFullName: Titin;Organisim: human;Apparent_Kd_M: 2.45321E-11

Real

Aptamer SeqId: 11352-42 | Target: TITIN | UniProt: Q8WZ42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11352-42 | Target: TITIN | UniProt: Q8WZ42 | TargetFullName: Titin | Organisim: human | Apparent_Kd_M: 2.45321E-11

Real

Aptamer SeqId:11354-21;Target:Phospholipase C-beta-1;UniProt:Q9NQ66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11354-21;Target: Phospholipase C-beta-1;UniProt: Q9NQ66;TargetFullName: 1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase beta-1;Organisim: human;Apparent_Kd_M: 1.985473E-11

Real

Aptamer SeqId: 11354-21 | Target: Phospholipase C-beta-1 | UniProt: Q9NQ66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11354-21 | Target: Phospholipase C-beta-1 | UniProt: Q9NQ66 | TargetFullName: 1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase beta-1 | Organisim: human | Apparent_Kd_M: 1.985473E-11

Real

Aptamer SeqId:11355-10;Target:IF5A2;UniProt:Q9GZV4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11355-10;Target: IF5A2;UniProt: Q9GZV4;TargetFullName: Eukaryotic translation initiation factor 5A-2;Organisim: human;Apparent_Kd_M: 4.034939E-11

Real

Aptamer SeqId: 11355-10 | Target: IF5A2 | UniProt: Q9GZV4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11355-10 | Target: IF5A2 | UniProt: Q9GZV4 | TargetFullName: Eukaryotic translation initiation factor 5A-2 | Organisim: human | Apparent_Kd_M: 4.034939E-11

Real

Aptamer SeqId:11356-19;Target:DGC14;UniProt:Q96DF8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11356-19;Target: DGC14;UniProt: Q96DF8;TargetFullName: Protein DGCR14;Organisim: human;Apparent_Kd_M: 3.232215E-12

Real

Aptamer SeqId: 11356-19 | Target: DGC14 | UniProt: Q96DF8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11356-19 | Target: DGC14 | UniProt: Q96DF8 | TargetFullName: Protein DGCR14 | Organisim: human | Apparent_Kd_M: 3.232215E-12

Real

Aptamer SeqId:11358-15;Target:GRB10;UniProt:Q13322

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11358-15;Target: GRB10;UniProt: Q13322;TargetFullName: Growth factor receptor-bound protein 10;Organisim: human;Apparent_Kd_M: 2.51165E-12

Real

Aptamer SeqId: 11358-15 | Target: GRB10 | UniProt: Q13322

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11358-15 | Target: GRB10 | UniProt: Q13322 | TargetFullName: Growth factor receptor-bound protein 10 | Organisim: human | Apparent_Kd_M: 2.51165E-12

Real

Aptamer SeqId:11360-39;Target:RRM1;UniProt:P23921

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11360-39;Target: RRM1;UniProt: P23921;TargetFullName: Ribonucleoside-diphosphate reductase large subunit;Organisim: human;Apparent_Kd_M: 4.871925E-12

Real

Aptamer SeqId: 11360-39 | Target: RRM1 | UniProt: P23921

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11360-39 | Target: RRM1 | UniProt: P23921 | TargetFullName: Ribonucleoside-diphosphate reductase large subunit | Organisim: human | Apparent_Kd_M: 4.871925E-12

Real

Aptamer SeqId:11361-73;Target:TP;UniProt:P19971

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11361-73;Target: TP;UniProt: P19971;TargetFullName: Thymidine phosphorylase;Organisim: human;Apparent_Kd_M: 1.545557E-11

Real

Aptamer SeqId: 11361-73 | Target: TP | UniProt: P19971

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11361-73 | Target: TP | UniProt: P19971 | TargetFullName: Thymidine phosphorylase | Organisim: human | Apparent_Kd_M: 1.545557E-11

Real

Aptamer SeqId:11363-58;Target:AQP4;UniProt:P55087

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11363-58;Target: AQP4;UniProt: P55087;TargetFullName: Aquaporin-4;Organisim: human;Apparent_Kd_M: 1.468242E-10

Real

Aptamer SeqId: 11363-58 | Target: AQP4 | UniProt: P55087

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11363-58 | Target: AQP4 | UniProt: P55087 | TargetFullName: Aquaporin-4 | Organisim: human | Apparent_Kd_M: 1.468242E-10

Real

Aptamer SeqId:11364-18;Target:MFN1;UniProt:Q8IWA4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11364-18;Target: MFN1;UniProt: Q8IWA4;TargetFullName: Mitofusin-1;Organisim: human;Apparent_Kd_M: 2.140551E-11

Real

Aptamer SeqId: 11364-18 | Target: MFN1 | UniProt: Q8IWA4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11364-18 | Target: MFN1 | UniProt: Q8IWA4 | TargetFullName: Mitofusin-1 | Organisim: human | Apparent_Kd_M: 2.140551E-11

Real

Aptamer SeqId:11365-17;Target:TEN4;UniProt:Q6N022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11365-17;Target: TEN4;UniProt: Q6N022;TargetFullName: Teneurin-4;Organisim: human;Apparent_Kd_M: 1.354983E-11

Real

Aptamer SeqId: 11365-17 | Target: TEN4 | UniProt: Q6N022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11365-17 | Target: TEN4 | UniProt: Q6N022 | TargetFullName: Teneurin-4 | Organisim: human | Apparent_Kd_M: 1.354983E-11

Real

Aptamer SeqId:11368-32;Target:KAD2;UniProt:P54819

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11368-32;Target: KAD2;UniProt: P54819;TargetFullName: Adenylate kinase 2; mitochondrial;Organisim: human;Apparent_Kd_M: 7.465696E-12

Real

Aptamer SeqId: 11368-32 | Target: KAD2 | UniProt: P54819

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11368-32 | Target: KAD2 | UniProt: P54819 | TargetFullName: Adenylate kinase 2; mitochondrial | Organisim: human | Apparent_Kd_M: 7.465696E-12

Real

Aptamer SeqId:11369-23;Target:ADHX;UniProt:P11766

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11369-23;Target: ADHX;UniProt: P11766;TargetFullName: Alcohol dehydrogenase class-3;Organisim: human;Apparent_Kd_M: 6.484281E-12

Real

Aptamer SeqId: 11369-23 | Target: ADHX | UniProt: P11766

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11369-23 | Target: ADHX | UniProt: P11766 | TargetFullName: Alcohol dehydrogenase class-3 | Organisim: human | Apparent_Kd_M: 6.484281E-12

Real

Aptamer SeqId:11370-20;Target:INP5E;UniProt:Q9NRR6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11370-20;Target: INP5E;UniProt: Q9NRR6;TargetFullName: 72 kDa inositol polyphosphate 5-phosphatase;Organisim: human;Apparent_Kd_M: 3.346285E-11

Real

Aptamer SeqId: 11370-20 | Target: INP5E | UniProt: Q9NRR6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11370-20 | Target: INP5E | UniProt: Q9NRR6 | TargetFullName: 72 kDa inositol polyphosphate 5-phosphatase | Organisim: human | Apparent_Kd_M: 3.346285E-11

Real

Aptamer SeqId:11371-1;Target:GP101;UniProt:Q96P66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11371-1;Target: GP101;UniProt: Q96P66;TargetFullName: Probable G-protein coupled receptor 101;Organisim: human;Apparent_Kd_M: 8.325254E-12

Real

Aptamer SeqId: 11371-1 | Target: GP101 | UniProt: Q96P66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11371-1 | Target: GP101 | UniProt: Q96P66 | TargetFullName: Probable G-protein coupled receptor 101 | Organisim: human | Apparent_Kd_M: 8.325254E-12

Real

Aptamer SeqId:11372-2;Target:ZNF18;UniProt:P17022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11372-2;Target: ZNF18;UniProt: P17022;TargetFullName: Zinc finger protein 18;Organisim: human;Apparent_Kd_M: 1.006891E-11

Real

Aptamer SeqId: 11372-2 | Target: ZNF18 | UniProt: P17022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11372-2 | Target: ZNF18 | UniProt: P17022 | TargetFullName: Zinc finger protein 18 | Organisim: human | Apparent_Kd_M: 1.006891E-11

Real

Aptamer SeqId:11375-49;Target:FOXL2;UniProt:P58012

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11375-49;Target: FOXL2;UniProt: P58012;TargetFullName: Forkhead box protein L2;Organisim: human;Apparent_Kd_M: 3.69467E-12

Real

Aptamer SeqId: 11375-49 | Target: FOXL2 | UniProt: P58012

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11375-49 | Target: FOXL2 | UniProt: P58012 | TargetFullName: Forkhead box protein L2 | Organisim: human | Apparent_Kd_M: 3.69467E-12

Real

Aptamer SeqId:11377-19;Target:ADH7;UniProt:P40394

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11377-19;Target: ADH7;UniProt: P40394;TargetFullName: Alcohol dehydrogenase class 4 mu/sigma chain;Organisim: human;Apparent_Kd_M: 8.262866E-12

Real

Aptamer SeqId: 11377-19 | Target: ADH7 | UniProt: P40394

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11377-19 | Target: ADH7 | UniProt: P40394 | TargetFullName: Alcohol dehydrogenase class 4 mu/sigma chain | Organisim: human | Apparent_Kd_M: 8.262866E-12

Real

Aptamer SeqId:11378-37;Target:KSYK;UniProt:P43405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11378-37;Target: KSYK;UniProt: P43405;TargetFullName: Tyrosine-protein kinase SYK;Organisim: human;Apparent_Kd_M: 2.606212E-11

Real

Aptamer SeqId: 11378-37 | Target: KSYK | UniProt: P43405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11378-37 | Target: KSYK | UniProt: P43405 | TargetFullName: Tyrosine-protein kinase SYK | Organisim: human | Apparent_Kd_M: 2.606212E-11

Real

Aptamer SeqId:11380-84;Target:RBM24;UniProt:Q9BX46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11380-84;Target: RBM24;UniProt: Q9BX46;TargetFullName: RNA-binding protein 24;Organisim: human;Apparent_Kd_M: 3.916686E-12

Real

Aptamer SeqId: 11380-84 | Target: RBM24 | UniProt: Q9BX46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11380-84 | Target: RBM24 | UniProt: Q9BX46 | TargetFullName: RNA-binding protein 24 | Organisim: human | Apparent_Kd_M: 3.916686E-12

Real

Aptamer SeqId:11381-56;Target:PRPS1;UniProt:P60891

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11381-56;Target: PRPS1;UniProt: P60891;TargetFullName: Ribose-phosphate pyrophosphokinase 1;Organisim: human;Apparent_Kd_M: 1.637295E-10

Real

Aptamer SeqId: 11381-56 | Target: PRPS1 | UniProt: P60891

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11381-56 | Target: PRPS1 | UniProt: P60891 | TargetFullName: Ribose-phosphate pyrophosphokinase 1 | Organisim: human | Apparent_Kd_M: 1.637295E-10

Real

Aptamer SeqId:11382-5;Target:BIEA;UniProt:P53004

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11382-5;Target: BIEA;UniProt: P53004;TargetFullName: Biliverdin reductase A;Organisim: human;Apparent_Kd_M: 4.655074E-12

Real

Aptamer SeqId: 11382-5 | Target: BIEA | UniProt: P53004

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11382-5 | Target: BIEA | UniProt: P53004 | TargetFullName: Biliverdin reductase A | Organisim: human | Apparent_Kd_M: 4.655074E-12

Real

Aptamer SeqId:11383-41;Target:Keratin 7;UniProt:P08729

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11383-41;Target: Keratin 7;UniProt: P08729;TargetFullName: Keratin; type II cytoskeletal 7;Organisim: human;Apparent_Kd_M: 3.774261E-11

Real

Aptamer SeqId: 11383-41 | Target: Keratin 7 | UniProt: P08729

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11383-41 | Target: Keratin 7 | UniProt: P08729 | TargetFullName: Keratin; type II cytoskeletal 7 | Organisim: human | Apparent_Kd_M: 3.774261E-11

Real

Aptamer SeqId:11387-3;Target:ATF6B;UniProt:Q99941

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11387-3;Target: ATF6B;UniProt: Q99941;TargetFullName: Cyclic AMP-dependent transcription factor ATF-6 beta;Organisim: human;Apparent_Kd_M: 5.340755E-11

Real

Aptamer SeqId: 11387-3 | Target: ATF6B | UniProt: Q99941

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11387-3 | Target: ATF6B | UniProt: Q99941 | TargetFullName: Cyclic AMP-dependent transcription factor ATF-6 beta | Organisim: human | Apparent_Kd_M: 5.340755E-11

Real

Aptamer SeqId:11388-75;Target:HE4;UniProt:Q14508

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11388-75;Target: HE4;UniProt: Q14508;TargetFullName: WAP four-disulfide core domain protein 2;Organisim: human;Apparent_Kd_M: 4.231434E-11

Real

Aptamer SeqId: 11388-75 | Target: HE4 | UniProt: Q14508

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11388-75 | Target: HE4 | UniProt: Q14508 | TargetFullName: WAP four-disulfide core domain protein 2 | Organisim: human | Apparent_Kd_M: 4.231434E-11

Real

Aptamer SeqId:11390-24;Target:Carbonic Anhydrase VIII;UniProt:P35219

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11390-24;Target: Carbonic Anhydrase VIII;UniProt: P35219;TargetFullName: Carbonic anhydrase-related protein;Organisim: human;Apparent_Kd_M: 1.519319E-10

Real

Aptamer SeqId: 11390-24 | Target: Carbonic Anhydrase VIII | UniProt: P35219

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11390-24 | Target: Carbonic Anhydrase VIII | UniProt: P35219 | TargetFullName: Carbonic anhydrase-related protein | Organisim: human | Apparent_Kd_M: 1.519319E-10

Real

Aptamer SeqId:11391-69;Target:MVK;UniProt:Q03426

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11391-69;Target: MVK;UniProt: Q03426;TargetFullName: Mevalonate kinase;Organisim: human;Apparent_Kd_M: 1.006672E-10

Real

Aptamer SeqId: 11391-69 | Target: MVK | UniProt: Q03426

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11391-69 | Target: MVK | UniProt: Q03426 | TargetFullName: Mevalonate kinase | Organisim: human | Apparent_Kd_M: 1.006672E-10

Real

Aptamer SeqId:11395-5;Target:FAK2;UniProt:Q14289

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11395-5;Target: FAK2;UniProt: Q14289;TargetFullName: Protein-tyrosine kinase 2-beta;Organisim: human;Apparent_Kd_M: 2.221677E-11

Real

Aptamer SeqId: 11395-5 | Target: FAK2 | UniProt: Q14289

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11395-5 | Target: FAK2 | UniProt: Q14289 | TargetFullName: Protein-tyrosine kinase 2-beta | Organisim: human | Apparent_Kd_M: 2.221677E-11

Real

Aptamer SeqId:11396-39;Target:DNAI1;UniProt:Q9UI46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11396-39;Target: DNAI1;UniProt: Q9UI46;TargetFullName: Dynein intermediate chain 1; axonemal;Organisim: human;Apparent_Kd_M: 1.213198E-10

Real

Aptamer SeqId: 11396-39 | Target: DNAI1 | UniProt: Q9UI46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11396-39 | Target: DNAI1 | UniProt: Q9UI46 | TargetFullName: Dynein intermediate chain 1; axonemal | Organisim: human | Apparent_Kd_M: 1.213198E-10

Real

Aptamer SeqId:11401-181;Target:RN146;UniProt:Q9NTX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11401-181;Target: RN146;UniProt: Q9NTX7;TargetFullName: E3 ubiquitin-protein ligase RNF146;Organisim: human;Apparent_Kd_M: 1.34719E-11

Real

Aptamer SeqId: 11401-181 | Target: RN146 | UniProt: Q9NTX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11401-181 | Target: RN146 | UniProt: Q9NTX7 | TargetFullName: E3 ubiquitin-protein ligase RNF146 | Organisim: human | Apparent_Kd_M: 1.34719E-11

Real

Aptamer SeqId:11402-17;Target:KMT2C;UniProt:Q8NEZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11402-17;Target: KMT2C;UniProt: Q8NEZ4;TargetFullName: Histone-lysine N-methyltransferase 2C;Organisim: human;Apparent_Kd_M: 7.477804E-13

Real

Aptamer SeqId: 11402-17 | Target: KMT2C | UniProt: Q8NEZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11402-17 | Target: KMT2C | UniProt: Q8NEZ4 | TargetFullName: Histone-lysine N-methyltransferase 2C | Organisim: human | Apparent_Kd_M: 7.477804E-13

Real

Aptamer SeqId:11405-150;Target:CARD9;UniProt:Q9H257

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11405-150;Target: CARD9;UniProt: Q9H257;TargetFullName: Caspase recruitment domain-containing protein 9;Organisim: human;Apparent_Kd_M: 5.481957E-11

Real

Aptamer SeqId: 11405-150 | Target: CARD9 | UniProt: Q9H257

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11405-150 | Target: CARD9 | UniProt: Q9H257 | TargetFullName: Caspase recruitment domain-containing protein 9 | Organisim: human | Apparent_Kd_M: 5.481957E-11

Real

Aptamer SeqId:11406-82;Target:ACAD8;UniProt:Q9UKU7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11406-82;Target: ACAD8;UniProt: Q9UKU7;TargetFullName: Isobutyryl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 8.817498E-11

Real

Aptamer SeqId: 11406-82 | Target: ACAD8 | UniProt: Q9UKU7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11406-82 | Target: ACAD8 | UniProt: Q9UKU7 | TargetFullName: Isobutyryl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 8.817498E-11

Real

Aptamer SeqId:11407-57;Target:PLS3;UniProt:Q9NRY6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11407-57;Target: PLS3;UniProt: Q9NRY6;TargetFullName: Phospholipid scramblase 3;Organisim: human;Apparent_Kd_M: 1.907302E-10

Real

Aptamer SeqId: 11407-57 | Target: PLS3 | UniProt: Q9NRY6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11407-57 | Target: PLS3 | UniProt: Q9NRY6 | TargetFullName: Phospholipid scramblase 3 | Organisim: human | Apparent_Kd_M: 1.907302E-10

Real

Aptamer SeqId:11416-23;Target:FBXL4;UniProt:Q9UKA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11416-23;Target: FBXL4;UniProt: Q9UKA2;TargetFullName: F-box/LRR-repeat protein 4;Organisim: human;Apparent_Kd_M: 3.399846E-11

Real

Aptamer SeqId: 11416-23 | Target: FBXL4 | UniProt: Q9UKA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11416-23 | Target: FBXL4 | UniProt: Q9UKA2 | TargetFullName: F-box/LRR-repeat protein 4 | Organisim: human | Apparent_Kd_M: 3.399846E-11

Real

Aptamer SeqId:11421-10;Target:EHD4;UniProt:Q9H223

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11421-10;Target: EHD4;UniProt: Q9H223;TargetFullName: EH domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.95482E-12

Real

Aptamer SeqId: 11421-10 | Target: EHD4 | UniProt: Q9H223

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11421-10 | Target: EHD4 | UniProt: Q9H223 | TargetFullName: EH domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.95482E-12

Real

Aptamer SeqId:11422-2;Target:DLX3;UniProt:O60479

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11422-2;Target: DLX3;UniProt: O60479;TargetFullName: Homeobox protein DLX-3;Organisim: human;Apparent_Kd_M: 2.261342E-11

Real

Aptamer SeqId: 11422-2 | Target: DLX3 | UniProt: O60479

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11422-2 | Target: DLX3 | UniProt: O60479 | TargetFullName: Homeobox protein DLX-3 | Organisim: human | Apparent_Kd_M: 2.261342E-11

Real

Aptamer SeqId:11424-4;Target:FAAA;UniProt:P16930

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11424-4;Target: FAAA;UniProt: P16930;TargetFullName: Fumarylacetoacetase;Organisim: human;Apparent_Kd_M: 1.516339E-11

Real

Aptamer SeqId: 11424-4 | Target: FAAA | UniProt: P16930

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11424-4 | Target: FAAA | UniProt: P16930 | TargetFullName: Fumarylacetoacetase | Organisim: human | Apparent_Kd_M: 1.516339E-11

Real

Aptamer SeqId:11425-31;Target:RUFY1;UniProt:Q96T51

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11425-31;Target: RUFY1;UniProt: Q96T51;TargetFullName: RUN and FYVE domain-containing protein 1;Organisim: human;Apparent_Kd_M: 8.882174E-11

Real

Aptamer SeqId: 11425-31 | Target: RUFY1 | UniProt: Q96T51

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11425-31 | Target: RUFY1 | UniProt: Q96T51 | TargetFullName: RUN and FYVE domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 8.882174E-11

Real

Aptamer SeqId:11428-31;Target:PDLI1;UniProt:O00151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11428-31;Target: PDLI1;UniProt: O00151;TargetFullName: PDZ and LIM domain protein 1;Organisim: human;Apparent_Kd_M: 1.50722E-11

Real

Aptamer SeqId: 11428-31 | Target: PDLI1 | UniProt: O00151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11428-31 | Target: PDLI1 | UniProt: O00151 | TargetFullName: PDZ and LIM domain protein 1 | Organisim: human | Apparent_Kd_M: 1.50722E-11

Real

Aptamer SeqId:11429-80;Target:hnRNP C1/C2;UniProt:P07910

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11429-80;Target: hnRNP C1/C2;UniProt: P07910;TargetFullName: Heterogeneous nuclear ribonucleoproteins C1/C2;Organisim: human;Apparent_Kd_M: 2.998584E-10

Real

Aptamer SeqId: 11429-80 | Target: hnRNP C1/C2 | UniProt: P07910

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11429-80 | Target: hnRNP C1/C2 | UniProt: P07910 | TargetFullName: Heterogeneous nuclear ribonucleoproteins C1/C2 | Organisim: human | Apparent_Kd_M: 2.998584E-10

Real

Aptamer SeqId:11430-49;Target:DTX1;UniProt:Q86Y01

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11430-49;Target: DTX1;UniProt: Q86Y01;TargetFullName: E3 ubiquitin-protein ligase DTX1;Organisim: human;Apparent_Kd_M: 1.656404E-10

Real

Aptamer SeqId: 11430-49 | Target: DTX1 | UniProt: Q86Y01

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11430-49 | Target: DTX1 | UniProt: Q86Y01 | TargetFullName: E3 ubiquitin-protein ligase DTX1 | Organisim: human | Apparent_Kd_M: 1.656404E-10

Real

Aptamer SeqId:11431-235;Target:RECQ1;UniProt:P46063

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11431-235;Target: RECQ1;UniProt: P46063;TargetFullName: ATP-dependent DNA helicase Q1;Organisim: human;Apparent_Kd_M: 6.150412E-12

Real

Aptamer SeqId: 11431-235 | Target: RECQ1 | UniProt: P46063

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11431-235 | Target: RECQ1 | UniProt: P46063 | TargetFullName: ATP-dependent DNA helicase Q1 | Organisim: human | Apparent_Kd_M: 6.150412E-12

Real

Aptamer SeqId:11432-11;Target:PQBP1;UniProt:O60828

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11432-11;Target: PQBP1;UniProt: O60828;TargetFullName: Polyglutamine-binding protein 1;Organisim: human;Apparent_Kd_M: 4.914578E-11

Real

Aptamer SeqId: 11432-11 | Target: PQBP1 | UniProt: O60828

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11432-11 | Target: PQBP1 | UniProt: O60828 | TargetFullName: Polyglutamine-binding protein 1 | Organisim: human | Apparent_Kd_M: 4.914578E-11

Real

Aptamer SeqId:11433-11;Target:TECT2;UniProt:Q96GX1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11433-11;Target: TECT2;UniProt: Q96GX1;TargetFullName: Tectonic-2;Organisim: human;Apparent_Kd_M: 2.801294E-10

Real

Aptamer SeqId: 11433-11 | Target: TECT2 | UniProt: Q96GX1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11433-11 | Target: TECT2 | UniProt: Q96GX1 | TargetFullName: Tectonic-2 | Organisim: human | Apparent_Kd_M: 2.801294E-10

Real

Aptamer SeqId:11436-6;Target:AINX;UniProt:Q16352

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11436-6;Target: AINX;UniProt: Q16352;TargetFullName: Alpha-internexin;Organisim: human;Apparent_Kd_M: 1.202525E-10

Real

Aptamer SeqId: 11436-6 | Target: AINX | UniProt: Q16352

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11436-6 | Target: AINX | UniProt: Q16352 | TargetFullName: Alpha-internexin | Organisim: human | Apparent_Kd_M: 1.202525E-10

Real

Aptamer SeqId:11438-6;Target:DNJB2;UniProt:P25686

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11438-6;Target: DNJB2;UniProt: P25686;TargetFullName: DnaJ homolog subfamily B member 2;Organisim: human;Apparent_Kd_M: 4.403681E-12

Real

Aptamer SeqId: 11438-6 | Target: DNJB2 | UniProt: P25686

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11438-6 | Target: DNJB2 | UniProt: P25686 | TargetFullName: DnaJ homolog subfamily B member 2 | Organisim: human | Apparent_Kd_M: 4.403681E-12

Real

Aptamer SeqId:11439-88;Target:RHPN2;UniProt:Q8IUC4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11439-88;Target: RHPN2;UniProt: Q8IUC4;TargetFullName: Rhophilin-2;Organisim: human;Apparent_Kd_M: 2.00107E-11

Real

Aptamer SeqId: 11439-88 | Target: RHPN2 | UniProt: Q8IUC4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11439-88 | Target: RHPN2 | UniProt: Q8IUC4 | TargetFullName: Rhophilin-2 | Organisim: human | Apparent_Kd_M: 2.00107E-11

Real

Aptamer SeqId:11440-58;Target:SOCS-3;UniProt:O14543

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11440-58;Target: SOCS-3;UniProt: O14543;TargetFullName: Suppressor of cytokine signaling 3;Organisim: human;Apparent_Kd_M: 1.818662E-11

Real

Aptamer SeqId: 11440-58 | Target: SOCS-3 | UniProt: O14543

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11440-58 | Target: SOCS-3 | UniProt: O14543 | TargetFullName: Suppressor of cytokine signaling 3 | Organisim: human | Apparent_Kd_M: 1.818662E-11

Real

Aptamer SeqId:11441-11;Target:PYGL;UniProt:P06737

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11441-11;Target: PYGL;UniProt: P06737;TargetFullName: Glycogen phosphorylase; liver form;Organisim: human;Apparent_Kd_M: 6.144466E-12

Real

Aptamer SeqId: 11441-11 | Target: PYGL | UniProt: P06737

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11441-11 | Target: PYGL | UniProt: P06737 | TargetFullName: Glycogen phosphorylase; liver form | Organisim: human | Apparent_Kd_M: 6.144466E-12

Real

Aptamer SeqId:11442-1;Target:DNER;UniProt:Q8NFT8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11442-1;Target: DNER;UniProt: Q8NFT8;TargetFullName: Delta and Notch-like epidermal growth factor-related receptor;Organisim: human;Apparent_Kd_M: 7.910162E-11

Real

Aptamer SeqId: 11442-1 | Target: DNER | UniProt: Q8NFT8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11442-1 | Target: DNER | UniProt: Q8NFT8 | TargetFullName: Delta and Notch-like epidermal growth factor-related receptor | Organisim: human | Apparent_Kd_M: 7.910162E-11

Real

Aptamer SeqId:11444-49;Target:RPC6;UniProt:Q9H1D9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11444-49;Target: RPC6;UniProt: Q9H1D9;TargetFullName: DNA-directed RNA polymerase III subunit RPC6;Organisim: human;Apparent_Kd_M: 1.091556E-11

Real

Aptamer SeqId: 11444-49 | Target: RPC6 | UniProt: Q9H1D9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11444-49 | Target: RPC6 | UniProt: Q9H1D9 | TargetFullName: DNA-directed RNA polymerase III subunit RPC6 | Organisim: human | Apparent_Kd_M: 1.091556E-11

Real

Aptamer SeqId:11448-34;Target:GALK1;UniProt:P51570

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11448-34;Target: GALK1;UniProt: P51570;TargetFullName: Galactokinase;Organisim: human;Apparent_Kd_M: 7.342014E-11

Real

Aptamer SeqId: 11448-34 | Target: GALK1 | UniProt: P51570

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11448-34 | Target: GALK1 | UniProt: P51570 | TargetFullName: Galactokinase | Organisim: human | Apparent_Kd_M: 7.342014E-11

Real

Aptamer SeqId:11449-22;Target:CAZA1;UniProt:P52907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11449-22;Target: CAZA1;UniProt: P52907;TargetFullName: F-actin-capping protein subunit alpha-1;Organisim: human;Apparent_Kd_M: 1.701582E-11

Real

Aptamer SeqId: 11449-22 | Target: CAZA1 | UniProt: P52907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11449-22 | Target: CAZA1 | UniProt: P52907 | TargetFullName: F-actin-capping protein subunit alpha-1 | Organisim: human | Apparent_Kd_M: 1.701582E-11

Real

Aptamer SeqId:11454-87;Target:EIF3G;UniProt:O75821

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11454-87;Target: EIF3G;UniProt: O75821;TargetFullName: Eukaryotic translation initiation factor 3 subunit G;Organisim: human;Apparent_Kd_M: 1.35251E-12

Real

Aptamer SeqId: 11454-87 | Target: EIF3G | UniProt: O75821

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11454-87 | Target: EIF3G | UniProt: O75821 | TargetFullName: Eukaryotic translation initiation factor 3 subunit G | Organisim: human | Apparent_Kd_M: 1.35251E-12

Real

Aptamer SeqId:11456-2;Target:MAGBA;UniProt:Q96LZ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11456-2;Target: MAGBA;UniProt: Q96LZ2;TargetFullName: Melanoma-associated antigen B10;Organisim: human;Apparent_Kd_M: 4.188535E-10

Real

Aptamer SeqId: 11456-2 | Target: MAGBA | UniProt: Q96LZ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11456-2 | Target: MAGBA | UniProt: Q96LZ2 | TargetFullName: Melanoma-associated antigen B10 | Organisim: human | Apparent_Kd_M: 4.188535E-10

Real

Aptamer SeqId:11457-53;Target:GALE;UniProt:Q14376

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11457-53;Target: GALE;UniProt: Q14376;TargetFullName: UDP-glucose 4-epimerase;Organisim: human;Apparent_Kd_M: 5.462034E-10

Real

Aptamer SeqId: 11457-53 | Target: GALE | UniProt: Q14376

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11457-53 | Target: GALE | UniProt: Q14376 | TargetFullName: UDP-glucose 4-epimerase | Organisim: human | Apparent_Kd_M: 5.462034E-10

Real

Aptamer SeqId:11458-30;Target:PCBP1;UniProt:Q15365

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11458-30;Target: PCBP1;UniProt: Q15365;TargetFullName: Poly(rC)-binding protein 1;Organisim: human;Apparent_Kd_M: 5.14996E-12

Real

Aptamer SeqId: 11458-30 | Target: PCBP1 | UniProt: Q15365

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11458-30 | Target: PCBP1 | UniProt: Q15365 | TargetFullName: Poly(rC)-binding protein 1 | Organisim: human | Apparent_Kd_M: 5.14996E-12

Real

Aptamer SeqId:11459-81;Target:ELL;UniProt:P55199

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11459-81;Target: ELL;UniProt: P55199;TargetFullName: RNA polymerase II elongation factor ELL;Organisim: human;Apparent_Kd_M: 9.497402E-11

Real

Aptamer SeqId: 11459-81 | Target: ELL | UniProt: P55199

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11459-81 | Target: ELL | UniProt: P55199 | TargetFullName: RNA polymerase II elongation factor ELL | Organisim: human | Apparent_Kd_M: 9.497402E-11

Real

Aptamer SeqId:11462-8;Target:RBM9;UniProt:O43251

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11462-8;Target: RBM9;UniProt: O43251;TargetFullName: RNA binding protein fox-1 homolog 2;Organisim: human;Apparent_Kd_M: 2.982274E-12

Real

Aptamer SeqId: 11462-8 | Target: RBM9 | UniProt: O43251

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11462-8 | Target: RBM9 | UniProt: O43251 | TargetFullName: RNA binding protein fox-1 homolog 2 | Organisim: human | Apparent_Kd_M: 2.982274E-12

Real

Aptamer SeqId:11464-9;Target:RELB;UniProt:Q01201

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11464-9;Target: RELB;UniProt: Q01201;TargetFullName: Transcription factor RelB;Organisim: human;Apparent_Kd_M: 2.132116E-10

Real

Aptamer SeqId: 11464-9 | Target: RELB | UniProt: Q01201

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11464-9 | Target: RELB | UniProt: Q01201 | TargetFullName: Transcription factor RelB | Organisim: human | Apparent_Kd_M: 2.132116E-10

Real

Aptamer SeqId:11465-4;Target:GP135;UniProt:Q8IZ08

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11465-4;Target: GP135;UniProt: Q8IZ08;TargetFullName: Probable G-protein coupled receptor 135;Organisim: human;Apparent_Kd_M: 2.548581E-11

Real

Aptamer SeqId: 11465-4 | Target: GP135 | UniProt: Q8IZ08

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11465-4 | Target: GP135 | UniProt: Q8IZ08 | TargetFullName: Probable G-protein coupled receptor 135 | Organisim: human | Apparent_Kd_M: 2.548581E-11

Real

Aptamer SeqId:11468-15;Target:RBM19;UniProt:Q9Y4C8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11468-15;Target: RBM19;UniProt: Q9Y4C8;TargetFullName: Probable RNA-binding protein 19;Organisim: human;Apparent_Kd_M: 4.328854E-12

Real

Aptamer SeqId: 11468-15 | Target: RBM19 | UniProt: Q9Y4C8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11468-15 | Target: RBM19 | UniProt: Q9Y4C8 | TargetFullName: Probable RNA-binding protein 19 | Organisim: human | Apparent_Kd_M: 4.328854E-12

Real

Aptamer SeqId:11476-43;Target:VPS4A;UniProt:Q9UN37

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11476-43;Target: VPS4A;UniProt: Q9UN37;TargetFullName: Vacuolar protein sorting-associated protein 4A;Organisim: human;Apparent_Kd_M: 3.520462E-12

Real

Aptamer SeqId: 11476-43 | Target: VPS4A | UniProt: Q9UN37

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11476-43 | Target: VPS4A | UniProt: Q9UN37 | TargetFullName: Vacuolar protein sorting-associated protein 4A | Organisim: human | Apparent_Kd_M: 3.520462E-12

Real

Aptamer SeqId:11480-1;Target:Aldehyde dehydrogenase; class 3;UniProt:P30838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11480-1;Target: Aldehyde dehydrogenase; class 3;UniProt: P30838;TargetFullName: Aldehyde dehydrogenase; dimeric NADP-preferring;Organisim: human;Apparent_Kd_M: 9.846936E-12

Real

Aptamer SeqId: 11480-1 | Target: Aldehyde dehydrogenase; class 3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11480-1 | Target: Aldehyde dehydrogenase; class 3 | UniProt: P30838 | TargetFullName: Aldehyde dehydrogenase; dimeric NADP-preferring | Organisim: human | Apparent_Kd_M: 9.846936E-12

Real

Aptamer SeqId:11481-25;Target:TIMD3;UniProt:Q8TDQ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11481-25;Target: TIMD3;UniProt: Q8TDQ0;TargetFullName: Hepatitis A virus cellular receptor 2;Organisim: human;Apparent_Kd_M: 1.016071E-11

Real

Aptamer SeqId: 11481-25 | Target: TIMD3 | UniProt: Q8TDQ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11481-25 | Target: TIMD3 | UniProt: Q8TDQ0 | TargetFullName: Hepatitis A virus cellular receptor 2 | Organisim: human | Apparent_Kd_M: 1.016071E-11

Real

Aptamer SeqId:11486-26;Target:ZN174;UniProt:Q15697

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11486-26;Target: ZN174;UniProt: Q15697;TargetFullName: Zinc finger protein 174;Organisim: human;Apparent_Kd_M: 4.627589E-12

Real

Aptamer SeqId: 11486-26 | Target: ZN174 | UniProt: Q15697

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11486-26 | Target: ZN174 | UniProt: Q15697 | TargetFullName: Zinc finger protein 174 | Organisim: human | Apparent_Kd_M: 4.627589E-12

Real

Aptamer SeqId:11490-42;Target:UBL4A;UniProt:P11441

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11490-42;Target: UBL4A;UniProt: P11441;TargetFullName: Ubiquitin-like protein 4A;Organisim: human;Apparent_Kd_M: 1.17721E-12

Real

Aptamer SeqId: 11490-42 | Target: UBL4A | UniProt: P11441

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11490-42 | Target: UBL4A | UniProt: P11441 | TargetFullName: Ubiquitin-like protein 4A | Organisim: human | Apparent_Kd_M: 1.17721E-12

Real

Aptamer SeqId:11493-169;Target:DYL2;UniProt:Q96FJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11493-169;Target: DYL2;UniProt: Q96FJ2;TargetFullName: Dynein light chain 2; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.491885E-12

Real

Aptamer SeqId: 11493-169 | Target: DYL2 | UniProt: Q96FJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11493-169 | Target: DYL2 | UniProt: Q96FJ2 | TargetFullName: Dynein light chain 2; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.491885E-12

Real

Aptamer SeqId:11494-4;Target:ELL2;UniProt:O00472

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11494-4;Target: ELL2;UniProt: O00472;TargetFullName: RNA polymerase II elongation factor ELL2;Organisim: human;Apparent_Kd_M: 6.618677E-12

Real

Aptamer SeqId: 11494-4 | Target: ELL2 | UniProt: O00472

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11494-4 | Target: ELL2 | UniProt: O00472 | TargetFullName: RNA polymerase II elongation factor ELL2 | Organisim: human | Apparent_Kd_M: 6.618677E-12

Real

Aptamer SeqId:11510-31;Target:Apo L1;UniProt:O14791

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11510-31;Target: Apo L1;UniProt: O14791;TargetFullName: Apolipoprotein L1;Organisim: human;Apparent_Kd_M: 1.21E-9

Real

Aptamer SeqId: 11510-31 | Target: Apo L1 | UniProt: O14791

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11510-31 | Target: Apo L1 | UniProt: O14791 | TargetFullName: Apolipoprotein L1 | Organisim: human | Apparent_Kd_M: 1.21E-9

Real

Aptamer SeqId:11513-92;Target:CD38;UniProt:P28907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11513-92;Target: CD38;UniProt: P28907;TargetFullName: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1;Organisim: human;Apparent_Kd_M: 9.91E-13

Real

Aptamer SeqId: 11513-92 | Target: CD38 | UniProt: P28907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11513-92 | Target: CD38 | UniProt: P28907 | TargetFullName: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | Organisim: human | Apparent_Kd_M: 9.91E-13

Real

Aptamer SeqId:11514-196;Target:CD59;UniProt:P13987

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11514-196;Target: CD59;UniProt: P13987;TargetFullName: CD59 glycoprotein;Organisim: human;Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId: 11514-196 | Target: CD59 | UniProt: P13987

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11514-196 | Target: CD59 | UniProt: P13987 | TargetFullName: CD59 glycoprotein | Organisim: human | Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId:11516-7;Target:FABPL;UniProt:P07148

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11516-7;Target: FABPL;UniProt: P07148;TargetFullName: Fatty acid-binding protein; liver;Organisim: human;Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId: 11516-7 | Target: FABPL | UniProt: P07148

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11516-7 | Target: FABPL | UniProt: P07148 | TargetFullName: Fatty acid-binding protein; liver | Organisim: human | Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId:11530-37;Target:HEM3;UniProt:P08397

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11530-37;Target: HEM3;UniProt: P08397;TargetFullName: Porphobilinogen deaminase;Organisim: human;Apparent_Kd_M: 2.720652E-12

Real

Aptamer SeqId: 11530-37 | Target: HEM3 | UniProt: P08397

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11530-37 | Target: HEM3 | UniProt: P08397 | TargetFullName: Porphobilinogen deaminase | Organisim: human | Apparent_Kd_M: 2.720652E-12

Real

Aptamer SeqId:11531-24;Target:GI24;UniProt:Q9H7M9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11531-24;Target: GI24;UniProt: Q9H7M9;TargetFullName: V-type immunoglobulin domain-containing suppressor of T-cell activation;Organisim: human;Apparent_Kd_M: 1.856786E-11

Real

Aptamer SeqId: 11531-24 | Target: GI24 | UniProt: Q9H7M9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11531-24 | Target: GI24 | UniProt: Q9H7M9 | TargetFullName: V-type immunoglobulin domain-containing suppressor of T-cell activation | Organisim: human | Apparent_Kd_M: 1.856786E-11

Real

Aptamer SeqId:11534-6;Target:LRIT3;UniProt:Q3SXY7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11534-6;Target: LRIT3;UniProt: Q3SXY7;TargetFullName: Leucine-rich repeat; immunoglobulin-like domain and transmembrane domain-containing protein 3;Organisim: human;Apparent_Kd_M: 1.886034E-10

Real

Aptamer SeqId: 11534-6 | Target: LRIT3 | UniProt: Q3SXY7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11534-6 | Target: LRIT3 | UniProt: Q3SXY7 | TargetFullName: Leucine-rich repeat; immunoglobulin-like domain and transmembrane domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 1.886034E-10

Real

Aptamer SeqId:11536-9;Target:MYSM1;UniProt:Q5VVJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11536-9;Target: MYSM1;UniProt: Q5VVJ2;TargetFullName: Histone H2A deubiquitinase MYSM1;Organisim: human;Apparent_Kd_M: 2.673174E-11

Real

Aptamer SeqId: 11536-9 | Target: MYSM1 | UniProt: Q5VVJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11536-9 | Target: MYSM1 | UniProt: Q5VVJ2 | TargetFullName: Histone H2A deubiquitinase MYSM1 | Organisim: human | Apparent_Kd_M: 2.673174E-11

Real

Aptamer SeqId:11537-12;Target:TFR2;UniProt:Q9UP52

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11537-12;Target: TFR2;UniProt: Q9UP52;TargetFullName: Transferrin receptor protein 2;Organisim: human;Apparent_Kd_M: 4.017576E-10

Real

Aptamer SeqId: 11537-12 | Target: TFR2 | UniProt: Q9UP52

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11537-12 | Target: TFR2 | UniProt: Q9UP52 | TargetFullName: Transferrin receptor protein 2 | Organisim: human | Apparent_Kd_M: 4.017576E-10

Real

Aptamer SeqId:11538-216;Target:DCMC;UniProt:O95822

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11538-216;Target: DCMC;UniProt: O95822;TargetFullName: Malonyl-CoA decarboxylase; mitochondrial;Organisim: human;Apparent_Kd_M: 9.866022E-11

Real

Aptamer SeqId: 11538-216 | Target: DCMC | UniProt: O95822

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11538-216 | Target: DCMC | UniProt: O95822 | TargetFullName: Malonyl-CoA decarboxylase; mitochondrial | Organisim: human | Apparent_Kd_M: 9.866022E-11

Real

Aptamer SeqId:11539-4;Target:ATPK;UniProt:P56134

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11539-4;Target: ATPK;UniProt: P56134;TargetFullName: ATP synthase subunit f; mitochondrial;Organisim: human;Apparent_Kd_M: 3.210803E-10

Real

Aptamer SeqId: 11539-4 | Target: ATPK | UniProt: P56134

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11539-4 | Target: ATPK | UniProt: P56134 | TargetFullName: ATP synthase subunit f; mitochondrial | Organisim: human | Apparent_Kd_M: 3.210803E-10

Real

Aptamer SeqId:11540-37;Target:FOXO3A;UniProt:O43524

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11540-37;Target: FOXO3A;UniProt: O43524;TargetFullName: Forkhead box protein O3;Organisim: human;Apparent_Kd_M: 1.192288E-11

Real

Aptamer SeqId: 11540-37 | Target: FOXO3A | UniProt: O43524

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11540-37 | Target: FOXO3A | UniProt: O43524 | TargetFullName: Forkhead box protein O3 | Organisim: human | Apparent_Kd_M: 1.192288E-11

Real

Aptamer SeqId:11542-11;Target:TM230;UniProt:Q96A57

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11542-11;Target: TM230;UniProt: Q96A57;TargetFullName: Transmembrane protein 230;Organisim: human;Apparent_Kd_M: 6.819256E-11

Real

Aptamer SeqId: 11542-11 | Target: TM230 | UniProt: Q96A57

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11542-11 | Target: TM230 | UniProt: Q96A57 | TargetFullName: Transmembrane protein 230 | Organisim: human | Apparent_Kd_M: 6.819256E-11

Real

Aptamer SeqId:11543-84;Target:LIMA1;UniProt:Q9UHB6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11543-84;Target: LIMA1;UniProt: Q9UHB6;TargetFullName: LIM domain and actin-binding protein 1;Organisim: human;Apparent_Kd_M: 4.248212E-10

Real

Aptamer SeqId: 11543-84 | Target: LIMA1 | UniProt: Q9UHB6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11543-84 | Target: LIMA1 | UniProt: Q9UHB6 | TargetFullName: LIM domain and actin-binding protein 1 | Organisim: human | Apparent_Kd_M: 4.248212E-10

Real

Aptamer SeqId:11544-39;Target:PHF3;UniProt:Q92576

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11544-39;Target: PHF3;UniProt: Q92576;TargetFullName: PHD finger protein 3;Organisim: human;Apparent_Kd_M: 1.735531E-11

Real

Aptamer SeqId: 11544-39 | Target: PHF3 | UniProt: Q92576

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11544-39 | Target: PHF3 | UniProt: Q92576 | TargetFullName: PHD finger protein 3 | Organisim: human | Apparent_Kd_M: 1.735531E-11

Real

Aptamer SeqId:11546-7;Target:CYGB;UniProt:Q8WWM9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11546-7;Target: CYGB;UniProt: Q8WWM9;TargetFullName: Cytoglobin;Organisim: human;Apparent_Kd_M: 2.873131E-11

Real

Aptamer SeqId: 11546-7 | Target: CYGB | UniProt: Q8WWM9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11546-7 | Target: CYGB | UniProt: Q8WWM9 | TargetFullName: Cytoglobin | Organisim: human | Apparent_Kd_M: 2.873131E-11

Real

Aptamer SeqId:11547-84;Target:MUSK;UniProt:O15146

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11547-84;Target: MUSK;UniProt: O15146;TargetFullName: Muscle; skeletal receptor tyrosine-protein kinase;Organisim: human;Apparent_Kd_M: 9.378678E-12

Real

Aptamer SeqId: 11547-84 | Target: MUSK | UniProt: O15146

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11547-84 | Target: MUSK | UniProt: O15146 | TargetFullName: Muscle; skeletal receptor tyrosine-protein kinase | Organisim: human | Apparent_Kd_M: 9.378678E-12

Real

Aptamer SeqId:11548-84;Target:MPIP1;UniProt:P30304

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11548-84;Target: MPIP1;UniProt: P30304;TargetFullName: M-phase inducer phosphatase 1;Organisim: human;Apparent_Kd_M: 2.600792E-11

Real

Aptamer SeqId: 11548-84 | Target: MPIP1 | UniProt: P30304

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11548-84 | Target: MPIP1 | UniProt: P30304 | TargetFullName: M-phase inducer phosphatase 1 | Organisim: human | Apparent_Kd_M: 2.600792E-11

Real

Aptamer SeqId:11549-6;Target:ISL1;UniProt:P61371

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11549-6;Target: ISL1;UniProt: P61371;TargetFullName: Insulin gene enhancer protein ISL-1;Organisim: human;Apparent_Kd_M: 3.233525E-11

Real

Aptamer SeqId: 11549-6 | Target: ISL1 | UniProt: P61371

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11549-6 | Target: ISL1 | UniProt: P61371 | TargetFullName: Insulin gene enhancer protein ISL-1 | Organisim: human | Apparent_Kd_M: 3.233525E-11

Real

Aptamer SeqId:11551-16;Target:HM20B;UniProt:Q9P0W2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11551-16;Target: HM20B;UniProt: Q9P0W2;TargetFullName: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related;Organisim: human;Apparent_Kd_M: 1.31035E-11

Real

Aptamer SeqId: 11551-16 | Target: HM20B | UniProt: Q9P0W2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11551-16 | Target: HM20B | UniProt: Q9P0W2 | TargetFullName: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related | Organisim: human | Apparent_Kd_M: 1.31035E-11

Real

Aptamer SeqId:11556-19;Target:ARFG1;UniProt:Q8N6T3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11556-19;Target: ARFG1;UniProt: Q8N6T3;TargetFullName: ADP-ribosylation factor GTPase-activating protein 1;Organisim: human;Apparent_Kd_M: 6.205927E-11

Real

Aptamer SeqId: 11556-19 | Target: ARFG1 | UniProt: Q8N6T3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11556-19 | Target: ARFG1 | UniProt: Q8N6T3 | TargetFullName: ADP-ribosylation factor GTPase-activating protein 1 | Organisim: human | Apparent_Kd_M: 6.205927E-11

Real

Aptamer SeqId:11557-3;Target:SMUF1;UniProt:Q9HCE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11557-3;Target: SMUF1;UniProt: Q9HCE7;TargetFullName: E3 ubiquitin-protein ligase SMURF1;Organisim: human;Apparent_Kd_M: 1.228872E-10

Real

Aptamer SeqId: 11557-3 | Target: SMUF1 | UniProt: Q9HCE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11557-3 | Target: SMUF1 | UniProt: Q9HCE7 | TargetFullName: E3 ubiquitin-protein ligase SMURF1 | Organisim: human | Apparent_Kd_M: 1.228872E-10

Real

Aptamer SeqId:11560-76;Target:NFAC4;UniProt:Q14934

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11560-76;Target: NFAC4;UniProt: Q14934;TargetFullName: Nuclear factor of activated T-cells; cytoplasmic 4;Organisim: human;Apparent_Kd_M: 9.199133E-12

Real

Aptamer SeqId: 11560-76 | Target: NFAC4 | UniProt: Q14934

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11560-76 | Target: NFAC4 | UniProt: Q14934 | TargetFullName: Nuclear factor of activated T-cells; cytoplasmic 4 | Organisim: human | Apparent_Kd_M: 9.199133E-12

Real

Aptamer SeqId:11561-32;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11561-32;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.99856E-10

Real

Aptamer SeqId: 11561-32 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11561-32 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.99856E-10

Real

Aptamer SeqId:11562-9;Target:DPOE2;UniProt:P56282

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11562-9;Target: DPOE2;UniProt: P56282;TargetFullName: DNA polymerase epsilon subunit 2;Organisim: human;Apparent_Kd_M: 2.499615E-12

Real

Aptamer SeqId: 11562-9 | Target: DPOE2 | UniProt: P56282

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11562-9 | Target: DPOE2 | UniProt: P56282 | TargetFullName: DNA polymerase epsilon subunit 2 | Organisim: human | Apparent_Kd_M: 2.499615E-12

Real

Aptamer SeqId:11563-51;Target:SYTL4;UniProt:Q96C24

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11563-51;Target: SYTL4;UniProt: Q96C24;TargetFullName: Synaptotagmin-like protein 4;Organisim: human;Apparent_Kd_M: 2.941549E-11

Real

Aptamer SeqId: 11563-51 | Target: SYTL4 | UniProt: Q96C24

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11563-51 | Target: SYTL4 | UniProt: Q96C24 | TargetFullName: Synaptotagmin-like protein 4 | Organisim: human | Apparent_Kd_M: 2.941549E-11

Real

Aptamer SeqId:11565-58;Target:ZNF23;UniProt:P17027

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11565-58;Target: ZNF23;UniProt: P17027;TargetFullName: Zinc finger protein 23;Organisim: human;Apparent_Kd_M: 2.752785E-11

Real

Aptamer SeqId: 11565-58 | Target: ZNF23 | UniProt: P17027

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11565-58 | Target: ZNF23 | UniProt: P17027 | TargetFullName: Zinc finger protein 23 | Organisim: human | Apparent_Kd_M: 2.752785E-11

Real

Aptamer SeqId:11566-48;Target:Keratin 72;UniProt:Q14CN4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11566-48;Target: Keratin 72;UniProt: Q14CN4;TargetFullName: Keratin; type II cytoskeletal 72;Organisim: human;Apparent_Kd_M: 9.118237E-12

Real

Aptamer SeqId: 11566-48 | Target: Keratin 72 | UniProt: Q14CN4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11566-48 | Target: Keratin 72 | UniProt: Q14CN4 | TargetFullName: Keratin; type II cytoskeletal 72 | Organisim: human | Apparent_Kd_M: 9.118237E-12

Real

Aptamer SeqId:11567-23;Target:ZNF10;UniProt:P21506

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11567-23;Target: ZNF10;UniProt: P21506;TargetFullName: Zinc finger protein 10;Organisim: human;Apparent_Kd_M: 3.624214E-11

Real

Aptamer SeqId: 11567-23 | Target: ZNF10 | UniProt: P21506

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11567-23 | Target: ZNF10 | UniProt: P21506 | TargetFullName: Zinc finger protein 10 | Organisim: human | Apparent_Kd_M: 3.624214E-11

Real

Aptamer SeqId:11568-2;Target:FKB1B;UniProt:P68106

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11568-2;Target: FKB1B;UniProt: P68106;TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP1B;Organisim: human;Apparent_Kd_M: 1.283366E-11

Real

Aptamer SeqId: 11568-2 | Target: FKB1B | UniProt: P68106

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11568-2 | Target: FKB1B | UniProt: P68106 | TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP1B | Organisim: human | Apparent_Kd_M: 1.283366E-11

Real

Aptamer SeqId:11570-94;Target:BAP29;UniProt:Q9UHQ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11570-94;Target: BAP29;UniProt: Q9UHQ4;TargetFullName: B-cell receptor-associated protein 29;Organisim: human;Apparent_Kd_M: 2.172304E-11

Real

Aptamer SeqId: 11570-94 | Target: BAP29 | UniProt: Q9UHQ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11570-94 | Target: BAP29 | UniProt: Q9UHQ4 | TargetFullName: B-cell receptor-associated protein 29 | Organisim: human | Apparent_Kd_M: 2.172304E-11

Real

Aptamer SeqId:11571-75;Target:NKG2E;UniProt:Q07444

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11571-75;Target: NKG2E;UniProt: Q07444;TargetFullName: NKG2-E type II integral membrane protein;Organisim: human;Apparent_Kd_M: 1.297699E-10

Real

Aptamer SeqId: 11571-75 | Target: NKG2E | UniProt: Q07444

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11571-75 | Target: NKG2E | UniProt: Q07444 | TargetFullName: NKG2-E type II integral membrane protein | Organisim: human | Apparent_Kd_M: 1.297699E-10

Real

Aptamer SeqId:11572-4;Target:DYN2;UniProt:P50570

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11572-4;Target: DYN2;UniProt: P50570;TargetFullName: Dynamin-2;Organisim: human;Apparent_Kd_M: 1.081032E-11

Real

Aptamer SeqId: 11572-4 | Target: DYN2 | UniProt: P50570

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11572-4 | Target: DYN2 | UniProt: P50570 | TargetFullName: Dynamin-2 | Organisim: human | Apparent_Kd_M: 1.081032E-11

Real

Aptamer SeqId:11573-3;Target:SRSF6;UniProt:Q13247

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11573-3;Target: SRSF6;UniProt: Q13247;TargetFullName: Serine/arginine-rich splicing factor 6;Organisim: human;Apparent_Kd_M: 4.136621E-11

Real

Aptamer SeqId: 11573-3 | Target: SRSF6 | UniProt: Q13247

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11573-3 | Target: SRSF6 | UniProt: Q13247 | TargetFullName: Serine/arginine-rich splicing factor 6 | Organisim: human | Apparent_Kd_M: 4.136621E-11

Real

Aptamer SeqId:11582-63;Target:DNJA2;UniProt:O60884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11582-63;Target: DNJA2;UniProt: O60884;TargetFullName: DnaJ homolog subfamily A member 2;Organisim: human;Apparent_Kd_M: 4.478575E-11

Real

Aptamer SeqId: 11582-63 | Target: DNJA2 | UniProt: O60884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11582-63 | Target: DNJA2 | UniProt: O60884 | TargetFullName: DnaJ homolog subfamily A member 2 | Organisim: human | Apparent_Kd_M: 4.478575E-11

Real

Aptamer SeqId:11587-5;Target:MGAP;UniProt:Q8IWI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11587-5;Target: MGAP;UniProt: Q8IWI9;TargetFullName: MAX gene-associated protein;Organisim: human;Apparent_Kd_M: 6.000809E-11

Real

Aptamer SeqId: 11587-5 | Target: MGAP | UniProt: Q8IWI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11587-5 | Target: MGAP | UniProt: Q8IWI9 | TargetFullName: MAX gene-associated protein | Organisim: human | Apparent_Kd_M: 6.000809E-11

Real

Aptamer SeqId:11590-5;Target:RBM23;UniProt:Q86U06

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11590-5;Target: RBM23;UniProt: Q86U06;TargetFullName: Probable RNA-binding protein 23;Organisim: human;Apparent_Kd_M: 2.876709E-12

Real

Aptamer SeqId: 11590-5 | Target: RBM23 | UniProt: Q86U06

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11590-5 | Target: RBM23 | UniProt: Q86U06 | TargetFullName: Probable RNA-binding protein 23 | Organisim: human | Apparent_Kd_M: 2.876709E-12

Real

Aptamer SeqId:11591-43;Target:PRC1;UniProt:O43663

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11591-43;Target: PRC1;UniProt: O43663;TargetFullName: Protein regulator of cytokinesis 1;Organisim: human;Apparent_Kd_M: 1.323006E-11

Real

Aptamer SeqId: 11591-43 | Target: PRC1 | UniProt: O43663

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11591-43 | Target: PRC1 | UniProt: O43663 | TargetFullName: Protein regulator of cytokinesis 1 | Organisim: human | Apparent_Kd_M: 1.323006E-11

Real

Aptamer SeqId:11592-1;Target:ELAV1;UniProt:Q15717

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11592-1;Target: ELAV1;UniProt: Q15717;TargetFullName: ELAV-like protein 1;Organisim: human;Apparent_Kd_M: 1.174819E-11

Real

Aptamer SeqId: 11592-1 | Target: ELAV1 | UniProt: Q15717

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11592-1 | Target: ELAV1 | UniProt: Q15717 | TargetFullName: ELAV-like protein 1 | Organisim: human | Apparent_Kd_M: 1.174819E-11

Real

Aptamer SeqId:11593-21;Target:MIG;UniProt:Q07325

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11593-21;Target: MIG;UniProt: Q07325;TargetFullName: C-X-C motif chemokine 9;Organisim: human;Apparent_Kd_M: 3.580832E-11

Real

Aptamer SeqId: 11593-21 | Target: MIG | UniProt: Q07325

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11593-21 | Target: MIG | UniProt: Q07325 | TargetFullName: C-X-C motif chemokine 9 | Organisim: human | Apparent_Kd_M: 3.580832E-11

Real

Aptamer SeqId:11596-47;Target:ZN75D;UniProt:P51815

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11596-47;Target: ZN75D;UniProt: P51815;TargetFullName: Zinc finger protein 75D;Organisim: human;Apparent_Kd_M: 1.408011E-11

Real

Aptamer SeqId: 11596-47 | Target: ZN75D | UniProt: P51815

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11596-47 | Target: ZN75D | UniProt: P51815 | TargetFullName: Zinc finger protein 75D | Organisim: human | Apparent_Kd_M: 1.408011E-11

Real

Aptamer SeqId:11601-26;Target:DHX8;UniProt:Q14562

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11601-26;Target: DHX8;UniProt: Q14562;TargetFullName: ATP-dependent RNA helicase DHX8;Organisim: human;Apparent_Kd_M: 4.476594E-12

Real

Aptamer SeqId: 11601-26 | Target: DHX8 | UniProt: Q14562

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11601-26 | Target: DHX8 | UniProt: Q14562 | TargetFullName: ATP-dependent RNA helicase DHX8 | Organisim: human | Apparent_Kd_M: 4.476594E-12

Real

Aptamer SeqId:11606-22;Target:DNJB6;UniProt:O75190

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11606-22;Target: DNJB6;UniProt: O75190;TargetFullName: DnaJ homolog subfamily B member 6;Organisim: human;Apparent_Kd_M: 2.269239E-11

Real

Aptamer SeqId: 11606-22 | Target: DNJB6 | UniProt: O75190

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11606-22 | Target: DNJB6 | UniProt: O75190 | TargetFullName: DnaJ homolog subfamily B member 6 | Organisim: human | Apparent_Kd_M: 2.269239E-11

Real

Aptamer SeqId:11607-15;Target:BRD1;UniProt:O95696

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11607-15;Target: BRD1;UniProt: O95696;TargetFullName: Bromodomain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.318534E-12

Real

Aptamer SeqId: 11607-15 | Target: BRD1 | UniProt: O95696

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11607-15 | Target: BRD1 | UniProt: O95696 | TargetFullName: Bromodomain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.318534E-12

Real

Aptamer SeqId:11608-5;Target:MLP3B;UniProt:Q9GZQ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11608-5;Target: MLP3B;UniProt: Q9GZQ8;TargetFullName: Microtubule-associated proteins 1A/1B light chain 3B;Organisim: human;Apparent_Kd_M: 2.099031E-12

Real

Aptamer SeqId: 11608-5 | Target: MLP3B | UniProt: Q9GZQ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11608-5 | Target: MLP3B | UniProt: Q9GZQ8 | TargetFullName: Microtubule-associated proteins 1A/1B light chain 3B | Organisim: human | Apparent_Kd_M: 2.099031E-12

Real

Aptamer SeqId:11614-29;Target:ERH;UniProt:P84090

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11614-29;Target: ERH;UniProt: P84090;TargetFullName: Enhancer of rudimentary homolog;Organisim: human;Apparent_Kd_M: 2.795803E-12

Real

Aptamer SeqId: 11614-29 | Target: ERH | UniProt: P84090

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11614-29 | Target: ERH | UniProt: P84090 | TargetFullName: Enhancer of rudimentary homolog | Organisim: human | Apparent_Kd_M: 2.795803E-12

Real

Aptamer SeqId:11615-16;Target:DAPP1;UniProt:Q9UN19

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11615-16;Target: DAPP1;UniProt: Q9UN19;TargetFullName: Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide;Organisim: human;Apparent_Kd_M: 2.188846E-12

Real

Aptamer SeqId: 11615-16 | Target: DAPP1 | UniProt: Q9UN19

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11615-16 | Target: DAPP1 | UniProt: Q9UN19 | TargetFullName: Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide | Organisim: human | Apparent_Kd_M: 2.188846E-12

Real

Aptamer SeqId:11616-9;Target:HSF1;UniProt:Q00613

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11616-9;Target: HSF1;UniProt: Q00613;TargetFullName: Heat shock factor protein 1;Organisim: human;Apparent_Kd_M: 6.895782E-13

Real

Aptamer SeqId: 11616-9 | Target: HSF1 | UniProt: Q00613

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11616-9 | Target: HSF1 | UniProt: Q00613 | TargetFullName: Heat shock factor protein 1 | Organisim: human | Apparent_Kd_M: 6.895782E-13

Real

Aptamer SeqId:11617-1;Target:LFA-1 alpha-L chain;UniProt:P20701

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11617-1;Target: LFA-1 alpha-L chain;UniProt: P20701;TargetFullName: Integrin alpha-L;Organisim: human;Apparent_Kd_M: 8.034004E-12

Real

Aptamer SeqId: 11617-1 | Target: LFA-1 alpha-L chain | UniProt: P20701

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11617-1 | Target: LFA-1 alpha-L chain | UniProt: P20701 | TargetFullName: Integrin alpha-L | Organisim: human | Apparent_Kd_M: 8.034004E-12

Real

Aptamer SeqId:11618-83;Target:MYB;UniProt:P10242

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11618-83;Target: MYB;UniProt: P10242;TargetFullName: Transcriptional activator Myb;Organisim: human;Apparent_Kd_M: 4.142378E-11

Real

Aptamer SeqId: 11618-83 | Target: MYB | UniProt: P10242

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11618-83 | Target: MYB | UniProt: P10242 | TargetFullName: Transcriptional activator Myb | Organisim: human | Apparent_Kd_M: 4.142378E-11

Real

Aptamer SeqId:11626-7;Target:UB2V1;UniProt:Q13404

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11626-7;Target: UB2V1;UniProt: Q13404;TargetFullName: Ubiquitin-conjugating enzyme E2 variant 1;Organisim: human;Apparent_Kd_M: 1.087697E-11

Real

Aptamer SeqId: 11626-7 | Target: UB2V1 | UniProt: Q13404

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11626-7 | Target: UB2V1 | UniProt: Q13404 | TargetFullName: Ubiquitin-conjugating enzyme E2 variant 1 | Organisim: human | Apparent_Kd_M: 1.087697E-11

Real

Aptamer SeqId:11633-89;Target:AHSA1;UniProt:O95433

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11633-89;Target: AHSA1;UniProt: O95433;TargetFullName: Activator of 90 kDa heat shock protein ATPase homolog 1;Organisim: human;Apparent_Kd_M: 1.452417E-11

Real

Aptamer SeqId: 11633-89 | Target: AHSA1 | UniProt: O95433

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11633-89 | Target: AHSA1 | UniProt: O95433 | TargetFullName: Activator of 90 kDa heat shock protein ATPase homolog 1 | Organisim: human | Apparent_Kd_M: 1.452417E-11

Real

Aptamer SeqId:11634-32;Target:RGS10;UniProt:O43665

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11634-32;Target: RGS10;UniProt: O43665;TargetFullName: Regulator of G-protein signaling 10;Organisim: human;Apparent_Kd_M: 9.688991E-12

Real

Aptamer SeqId: 11634-32 | Target: RGS10 | UniProt: O43665

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11634-32 | Target: RGS10 | UniProt: O43665 | TargetFullName: Regulator of G-protein signaling 10 | Organisim: human | Apparent_Kd_M: 9.688991E-12

Real

Aptamer SeqId:11636-33;Target:Transgelin-2;UniProt:P37802

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11636-33;Target: Transgelin-2;UniProt: P37802;TargetFullName: Transgelin-2;Organisim: human;Apparent_Kd_M: 1.799983E-11

Real

Aptamer SeqId: 11636-33 | Target: Transgelin-2 | UniProt: P37802

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11636-33 | Target: Transgelin-2 | UniProt: P37802 | TargetFullName: Transgelin-2 | Organisim: human | Apparent_Kd_M: 1.799983E-11

Real

Aptamer SeqId:11638-42;Target:B3GT2;UniProt:O43825

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11638-42;Target: B3GT2;UniProt: O43825;TargetFullName: Beta-1;3-galactosyltransferase 2;Organisim: human;Apparent_Kd_M: 2.377031E-11

Real

Aptamer SeqId: 11638-42 | Target: B3GT2 | UniProt: O43825

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11638-42 | Target: B3GT2 | UniProt: O43825 | TargetFullName: Beta-1;3-galactosyltransferase 2 | Organisim: human | Apparent_Kd_M: 2.377031E-11

Real

Aptamer SeqId:11643-73;Target:DTX3L;UniProt:Q8TDB6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11643-73;Target: DTX3L;UniProt: Q8TDB6;TargetFullName: E3 ubiquitin-protein ligase DTX3L;Organisim: human;Apparent_Kd_M: 1.083751E-11

Real

Aptamer SeqId: 11643-73 | Target: DTX3L | UniProt: Q8TDB6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11643-73 | Target: DTX3L | UniProt: Q8TDB6 | TargetFullName: E3 ubiquitin-protein ligase DTX3L | Organisim: human | Apparent_Kd_M: 1.083751E-11

Real

Aptamer SeqId:11645-9;Target:P4HA1;UniProt:P13674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11645-9;Target: P4HA1;UniProt: P13674;TargetFullName: Prolyl 4-hydroxylase subunit alpha-1;Organisim: human;Apparent_Kd_M: 4.507759E-11

Real

Aptamer SeqId: 11645-9 | Target: P4HA1 | UniProt: P13674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11645-9 | Target: P4HA1 | UniProt: P13674 | TargetFullName: Prolyl 4-hydroxylase subunit alpha-1 | Organisim: human | Apparent_Kd_M: 4.507759E-11

Real

Aptamer SeqId:11646-4;Target:Carbohydrate sulfotransferase 9;UniProt:Q7L1S5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11646-4;Target: Carbohydrate sulfotransferase 9;UniProt: Q7L1S5;TargetFullName: Carbohydrate sulfotransferase 9;Organisim: human;Apparent_Kd_M: 1.954101E-11

Real

Aptamer SeqId: 11646-4 | Target: Carbohydrate sulfotransferase 9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11646-4 | Target: Carbohydrate sulfotransferase 9 | UniProt: Q7L1S5 | TargetFullName: Carbohydrate sulfotransferase 9 | Organisim: human | Apparent_Kd_M: 1.954101E-11

Real

Aptamer SeqId:11647-6;Target:Frizzled-10;UniProt:Q9ULW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11647-6;Target: Frizzled-10;UniProt: Q9ULW2;TargetFullName: Frizzled-10;Organisim: human;Apparent_Kd_M: 3.29741E-11

Real

Aptamer SeqId: 11647-6 | Target: Frizzled-10 | UniProt: Q9ULW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11647-6 | Target: Frizzled-10 | UniProt: Q9ULW2 | TargetFullName: Frizzled-10 | Organisim: human | Apparent_Kd_M: 3.29741E-11

Real

Aptamer SeqId:11649-3;Target:SMAP1;UniProt:Q8IYB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11649-3;Target: SMAP1;UniProt: Q8IYB5;TargetFullName: Stromal membrane-associated protein 1;Organisim: human;Apparent_Kd_M: 2.631188E-11

Real

Aptamer SeqId: 11649-3 | Target: SMAP1 | UniProt: Q8IYB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11649-3 | Target: SMAP1 | UniProt: Q8IYB5 | TargetFullName: Stromal membrane-associated protein 1 | Organisim: human | Apparent_Kd_M: 2.631188E-11

Real

Aptamer SeqId:11653-69;Target:SC6A9;UniProt:P48067

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11653-69;Target: SC6A9;UniProt: P48067;TargetFullName: Sodium- and chloride-dependent glycine transporter 1;Organisim: human;Apparent_Kd_M: 1.571875E-11

Real

Aptamer SeqId: 11653-69 | Target: SC6A9 | UniProt: P48067

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11653-69 | Target: SC6A9 | UniProt: P48067 | TargetFullName: Sodium- and chloride-dependent glycine transporter 1 | Organisim: human | Apparent_Kd_M: 1.571875E-11

Real

Aptamer SeqId:11654-77;Target:NRSN1;UniProt:Q8IZ57

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11654-77;Target: NRSN1;UniProt: Q8IZ57;TargetFullName: Neurensin-1;Organisim: human;Apparent_Kd_M: 2.027308E-11

Real

Aptamer SeqId: 11654-77 | Target: NRSN1 | UniProt: Q8IZ57

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11654-77 | Target: NRSN1 | UniProt: Q8IZ57 | TargetFullName: Neurensin-1 | Organisim: human | Apparent_Kd_M: 2.027308E-11

Real

Aptamer SeqId:11656-110;Target:EVL;UniProt:Q9UI08

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11656-110;Target: EVL;UniProt: Q9UI08;TargetFullName: Ena/VASP-like protein;Organisim: human;Apparent_Kd_M: 2.647818E-11

Real

Aptamer SeqId: 11656-110 | Target: EVL | UniProt: Q9UI08

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11656-110 | Target: EVL | UniProt: Q9UI08 | TargetFullName: Ena/VASP-like protein | Organisim: human | Apparent_Kd_M: 2.647818E-11

Real

Aptamer SeqId:11657-86;Target:SOCS7;UniProt:O14512

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11657-86;Target: SOCS7;UniProt: O14512;TargetFullName: Suppressor of cytokine signaling 7;Organisim: human;Apparent_Kd_M: 1.686113E-11

Real

Aptamer SeqId: 11657-86 | Target: SOCS7 | UniProt: O14512

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11657-86 | Target: SOCS7 | UniProt: O14512 | TargetFullName: Suppressor of cytokine signaling 7 | Organisim: human | Apparent_Kd_M: 1.686113E-11

Real

Aptamer SeqId:11659-31;Target:EPN4;UniProt:Q14677

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11659-31;Target: EPN4;UniProt: Q14677;TargetFullName: Clathrin interactor 1;Organisim: human;Apparent_Kd_M: 7.429775E-12

Real

Aptamer SeqId: 11659-31 | Target: EPN4 | UniProt: Q14677

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11659-31 | Target: EPN4 | UniProt: Q14677 | TargetFullName: Clathrin interactor 1 | Organisim: human | Apparent_Kd_M: 7.429775E-12

Real

Aptamer SeqId:11661-11;Target:NALP1;UniProt:Q9C000

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11661-11;Target: NALP1;UniProt: Q9C000;TargetFullName: NACHT; LRR and PYD domains-containing protein 1;Organisim: human;Apparent_Kd_M: 1.207723E-11

Real

Aptamer SeqId: 11661-11 | Target: NALP1 | UniProt: Q9C000

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11661-11 | Target: NALP1 | UniProt: Q9C000 | TargetFullName: NACHT; LRR and PYD domains-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.207723E-11

Real

Aptamer SeqId:11664-32;Target:ARFG2;UniProt:Q8N6H7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11664-32;Target: ARFG2;UniProt: Q8N6H7;TargetFullName: ADP-ribosylation factor GTPase-activating protein 2;Organisim: human;Apparent_Kd_M: 1.096836E-11

Real

Aptamer SeqId: 11664-32 | Target: ARFG2 | UniProt: Q8N6H7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11664-32 | Target: ARFG2 | UniProt: Q8N6H7 | TargetFullName: ADP-ribosylation factor GTPase-activating protein 2 | Organisim: human | Apparent_Kd_M: 1.096836E-11

Real

Aptamer SeqId:11666-72;Target:RGS8;UniProt:P57771

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11666-72;Target: RGS8;UniProt: P57771;TargetFullName: Regulator of G-protein signaling 8;Organisim: human;Apparent_Kd_M: 9.674182E-12

Real

Aptamer SeqId: 11666-72 | Target: RGS8 | UniProt: P57771

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11666-72 | Target: RGS8 | UniProt: P57771 | TargetFullName: Regulator of G-protein signaling 8 | Organisim: human | Apparent_Kd_M: 9.674182E-12

Real

Aptamer SeqId:11667-29;Target:TENC1;UniProt:Q63HR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11667-29;Target: TENC1;UniProt: Q63HR2;TargetFullName: Tensin-2;Organisim: human;Apparent_Kd_M: 8.085797E-12

Real

Aptamer SeqId: 11667-29 | Target: TENC1 | UniProt: Q63HR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11667-29 | Target: TENC1 | UniProt: Q63HR2 | TargetFullName: Tensin-2 | Organisim: human | Apparent_Kd_M: 8.085797E-12

Real

Aptamer SeqId:11669-39;Target:SO5A1;UniProt:Q9H2Y9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11669-39;Target: SO5A1;UniProt: Q9H2Y9;TargetFullName: Solute carrier organic anion transporter family member 5A1;Organisim: human;Apparent_Kd_M: 1.902073E-11

Real

Aptamer SeqId: 11669-39 | Target: SO5A1 | UniProt: Q9H2Y9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11669-39 | Target: SO5A1 | UniProt: Q9H2Y9 | TargetFullName: Solute carrier organic anion transporter family member 5A1 | Organisim: human | Apparent_Kd_M: 1.902073E-11

Real

Aptamer SeqId:11671-19;Target:BRPF1;UniProt:P55201

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11671-19;Target: BRPF1;UniProt: P55201;TargetFullName: Peregrin;Organisim: human;Apparent_Kd_M: 6.541351E-12

Real

Aptamer SeqId: 11671-19 | Target: BRPF1 | UniProt: P55201

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11671-19 | Target: BRPF1 | UniProt: P55201 | TargetFullName: Peregrin | Organisim: human | Apparent_Kd_M: 6.541351E-12

Real

Aptamer SeqId:11672-17;Target:KI16B;UniProt:Q96L93

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11672-17;Target: KI16B;UniProt: Q96L93;TargetFullName: Kinesin-like protein KIF16B;Organisim: human;Apparent_Kd_M: 1.44505E-11

Real

Aptamer SeqId: 11672-17 | Target: KI16B | UniProt: Q96L93

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11672-17 | Target: KI16B | UniProt: Q96L93 | TargetFullName: Kinesin-like protein KIF16B | Organisim: human | Apparent_Kd_M: 1.44505E-11

Real

Aptamer SeqId:11677-17;Target:ZDH14;UniProt:Q8IZN3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11677-17;Target: ZDH14;UniProt: Q8IZN3;TargetFullName: Probable palmitoyltransferase ZDHHC14;Organisim: human;Apparent_Kd_M: 1.786119E-11

Real

Aptamer SeqId: 11677-17 | Target: ZDH14 | UniProt: Q8IZN3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11677-17 | Target: ZDH14 | UniProt: Q8IZN3 | TargetFullName: Probable palmitoyltransferase ZDHHC14 | Organisim: human | Apparent_Kd_M: 1.786119E-11

Real

Aptamer SeqId:11678-105;Target:CXD2;UniProt:Q9UKL4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11678-105;Target: CXD2;UniProt: Q9UKL4;TargetFullName: Gap junction delta-2 protein;Organisim: human;Apparent_Kd_M: 2.878914E-11

Real

Aptamer SeqId: 11678-105 | Target: CXD2 | UniProt: Q9UKL4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11678-105 | Target: CXD2 | UniProt: Q9UKL4 | TargetFullName: Gap junction delta-2 protein | Organisim: human | Apparent_Kd_M: 2.878914E-11

Real

Aptamer SeqId:11681-8;Target:NUPL;UniProt:P52594

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11681-8;Target: NUPL;UniProt: P52594;TargetFullName: Arf-GAP domain and FG repeat-containing protein 1;Organisim: human;Apparent_Kd_M: 1.193746E-11

Real

Aptamer SeqId: 11681-8 | Target: NUPL | UniProt: P52594

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11681-8 | Target: NUPL | UniProt: P52594 | TargetFullName: Arf-GAP domain and FG repeat-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.193746E-11

Real

Aptamer SeqId:11682-7;Target:TXNIP;UniProt:Q9H3M7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11682-7;Target: TXNIP;UniProt: Q9H3M7;TargetFullName: Thioredoxin-interacting protein;Organisim: human;Apparent_Kd_M: 4.724425E-11

Real

Aptamer SeqId: 11682-7 | Target: TXNIP | UniProt: Q9H3M7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11682-7 | Target: TXNIP | UniProt: Q9H3M7 | TargetFullName: Thioredoxin-interacting protein | Organisim: human | Apparent_Kd_M: 4.724425E-11

Real

Aptamer SeqId:11683-19;Target:GGA3;UniProt:Q9NZ52

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11683-19;Target: GGA3;UniProt: Q9NZ52;TargetFullName: ADP-ribosylation factor-binding protein GGA3;Organisim: human;Apparent_Kd_M: 9.685567E-12

Real

Aptamer SeqId: 11683-19 | Target: GGA3 | UniProt: Q9NZ52

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11683-19 | Target: GGA3 | UniProt: Q9NZ52 | TargetFullName: ADP-ribosylation factor-binding protein GGA3 | Organisim: human | Apparent_Kd_M: 9.685567E-12

Real

Aptamer SeqId:11690-47;Target:APC7;UniProt:Q9UJX3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11690-47;Target: APC7;UniProt: Q9UJX3;TargetFullName: Anaphase-promoting complex subunit 7;Organisim: human;Apparent_Kd_M: 1.297959E-10

Real

Aptamer SeqId: 11690-47 | Target: APC7 | UniProt: Q9UJX3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11690-47 | Target: APC7 | UniProt: Q9UJX3 | TargetFullName: Anaphase-promoting complex subunit 7 | Organisim: human | Apparent_Kd_M: 1.297959E-10

Real

Aptamer SeqId:11692-21;Target:SHC4;UniProt:Q6S5L8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11692-21;Target: SHC4;UniProt: Q6S5L8;TargetFullName: SHC-transforming protein 4;Organisim: human;Apparent_Kd_M: 2.690458E-10

Real

Aptamer SeqId: 11692-21 | Target: SHC4 | UniProt: Q6S5L8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11692-21 | Target: SHC4 | UniProt: Q6S5L8 | TargetFullName: SHC-transforming protein 4 | Organisim: human | Apparent_Kd_M: 2.690458E-10

Real

Aptamer SeqId:11696-7;Target:RABP2;UniProt:P29373

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11696-7;Target: RABP2;UniProt: P29373;TargetFullName: Cellular retinoic acid-binding protein 2;Organisim: human;Apparent_Kd_M: 3.355675E-12

Real

Aptamer SeqId: 11696-7 | Target: RABP2 | UniProt: P29373

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11696-7 | Target: RABP2 | UniProt: P29373 | TargetFullName: Cellular retinoic acid-binding protein 2 | Organisim: human | Apparent_Kd_M: 3.355675E-12

Real

Aptamer SeqId:11699-16;Target:TP4A2;UniProt:Q12974

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11699-16;Target: TP4A2;UniProt: Q12974;TargetFullName: Protein tyrosine phosphatase type IVA 2;Organisim: human;Apparent_Kd_M: 4.432672E-11

Real

Aptamer SeqId: 11699-16 | Target: TP4A2 | UniProt: Q12974

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11699-16 | Target: TP4A2 | UniProt: Q12974 | TargetFullName: Protein tyrosine phosphatase type IVA 2 | Organisim: human | Apparent_Kd_M: 4.432672E-11

Real

Aptamer SeqId:11708-2;Target:LCN1;UniProt:P31025

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11708-2;Target: LCN1;UniProt: P31025;TargetFullName: Lipocalin-1;Organisim: human;Apparent_Kd_M: 2.046388E-10

Real

Aptamer SeqId: 11708-2 | Target: LCN1 | UniProt: P31025

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11708-2 | Target: LCN1 | UniProt: P31025 | TargetFullName: Lipocalin-1 | Organisim: human | Apparent_Kd_M: 2.046388E-10

Real

Aptamer SeqId:11709-29;Target:CPT1B;UniProt:Q92523

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11709-29;Target: CPT1B;UniProt: Q92523;TargetFullName: Carnitine O-palmitoyltransferase 1; muscle isoform;Organisim: human;Apparent_Kd_M: 2.005406E-10

Real

Aptamer SeqId: 11709-29 | Target: CPT1B | UniProt: Q92523

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11709-29 | Target: CPT1B | UniProt: Q92523 | TargetFullName: Carnitine O-palmitoyltransferase 1; muscle isoform | Organisim: human | Apparent_Kd_M: 2.005406E-10

Real

Aptamer SeqId:11715-1;Target:PO2F1;UniProt:P14859

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11715-1;Target: PO2F1;UniProt: P14859;TargetFullName: POU domain; class 2; transcription factor 1;Organisim: human;Apparent_Kd_M: 3.00754E-11

Real

Aptamer SeqId: 11715-1 | Target: PO2F1 | UniProt: P14859

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11715-1 | Target: PO2F1 | UniProt: P14859 | TargetFullName: POU domain; class 2; transcription factor 1 | Organisim: human | Apparent_Kd_M: 3.00754E-11

Real

Aptamer SeqId:11716-28;Target:LRIT2;UniProt:A6NDA9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11716-28;Target: LRIT2;UniProt: A6NDA9;TargetFullName: Leucine-rich repeat; immunoglobulin-like domain and transmembrane domain-containing protein 2;Organisim: human;Apparent_Kd_M: 5.475047E-11

Real

Aptamer SeqId: 11716-28 | Target: LRIT2 | UniProt: A6NDA9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11716-28 | Target: LRIT2 | UniProt: A6NDA9 | TargetFullName: Leucine-rich repeat; immunoglobulin-like domain and transmembrane domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 5.475047E-11

Real

Aptamer SeqId:11816-84;Target:JAK2;UniProt:O60674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11816-84;Target: JAK2;UniProt: O60674;TargetFullName: Tyrosine-protein kinase JAK2;Organisim: human;Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId: 11816-84 | Target: JAK2 | UniProt: O60674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11816-84 | Target: JAK2 | UniProt: O60674 | TargetFullName: Tyrosine-protein kinase JAK2 | Organisim: human | Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId:11825-27;Target:PRGC1;UniProt:Q9UBK2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11825-27;Target: PRGC1;UniProt: Q9UBK2;TargetFullName: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha;Organisim: human;Apparent_Kd_M: 1.880125E-10

Real

Aptamer SeqId: 11825-27 | Target: PRGC1 | UniProt: Q9UBK2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11825-27 | Target: PRGC1 | UniProt: Q9UBK2 | TargetFullName: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha | Organisim: human | Apparent_Kd_M: 1.880125E-10

Real

Aptamer SeqId:11827-7;Target:RORG;UniProt:P51449

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11827-7;Target: RORG;UniProt: P51449;TargetFullName: Nuclear receptor ROR-gamma;Organisim: human;Apparent_Kd_M: 6.136328E-13

Real

Aptamer SeqId: 11827-7 | Target: RORG | UniProt: P51449

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11827-7 | Target: RORG | UniProt: P51449 | TargetFullName: Nuclear receptor ROR-gamma | Organisim: human | Apparent_Kd_M: 6.136328E-13

Real

Aptamer SeqId:11837-7;Target:GITR;UniProt:Q9Y5U5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11837-7;Target: GITR;UniProt: Q9Y5U5;TargetFullName: Tumor necrosis factor receptor superfamily member 18;Organisim: human;Apparent_Kd_M: 2.22E-11

Real

Aptamer SeqId: 11837-7 | Target: GITR | UniProt: Q9Y5U5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11837-7 | Target: GITR | UniProt: Q9Y5U5 | TargetFullName: Tumor necrosis factor receptor superfamily member 18 | Organisim: human | Apparent_Kd_M: 2.22E-11

Real

Aptamer SeqId:11838-130;Target:FA38A;UniProt:Q92508

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11838-130;Target: FA38A;UniProt: Q92508;TargetFullName: Piezo-type mechanosensitive ion channel component 1;Organisim: human;Apparent_Kd_M: 5.429152E-12

Real

Aptamer SeqId: 11838-130 | Target: FA38A | UniProt: Q92508

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11838-130 | Target: FA38A | UniProt: Q92508 | TargetFullName: Piezo-type mechanosensitive ion channel component 1 | Organisim: human | Apparent_Kd_M: 5.429152E-12

Real

Aptamer SeqId:11860-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11860-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.211488E-11

Real

Aptamer SeqId: 11860-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11860-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.211488E-11

Real

Aptamer SeqId:11872-9;Target:PCDGD;UniProt:Q9Y5G3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11872-9;Target: PCDGD;UniProt: Q9Y5G3;TargetFullName: Protocadherin gamma-B1;Organisim: human;Apparent_Kd_M: 8.767742E-11

Real

Aptamer SeqId: 11872-9 | Target: PCDGD | UniProt: Q9Y5G3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11872-9 | Target: PCDGD | UniProt: Q9Y5G3 | TargetFullName: Protocadherin gamma-B1 | Organisim: human | Apparent_Kd_M: 8.767742E-11

Real

Aptamer SeqId:11895-21;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11895-21;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.810143E-11

Real

Aptamer SeqId: 11895-21 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11895-21 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.810143E-11

Real

Aptamer SeqId:11910-27;Target:DLX4;UniProt:Q92988

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11910-27;Target: DLX4;UniProt: Q92988;TargetFullName: Homeobox protein DLX-4;Organisim: human;Apparent_Kd_M: 7.651296E-11

Real

Aptamer SeqId: 11910-27 | Target: DLX4 | UniProt: Q92988

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11910-27 | Target: DLX4 | UniProt: Q92988 | TargetFullName: Homeobox protein DLX-4 | Organisim: human | Apparent_Kd_M: 7.651296E-11

Real

Aptamer SeqId:11911-13;Target:LRC4B;UniProt:Q9NT99

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11911-13;Target: LRC4B;UniProt: Q9NT99;TargetFullName: Leucine-rich repeat-containing protein 4B;Organisim: human;Apparent_Kd_M: 1.15025E-10

Real

Aptamer SeqId: 11911-13 | Target: LRC4B | UniProt: Q9NT99

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11911-13 | Target: LRC4B | UniProt: Q9NT99 | TargetFullName: Leucine-rich repeat-containing protein 4B | Organisim: human | Apparent_Kd_M: 1.15025E-10

Real

Aptamer SeqId:11912-45;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11912-45;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.128134E-10

Real

Aptamer SeqId: 11912-45 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11912-45 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.128134E-10

Real

Aptamer SeqId:11917-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11917-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.38571E-11

Real

Aptamer SeqId: 11917-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11917-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.38571E-11

Real

Aptamer SeqId:11918-54;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11918-54;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.742954E-11

Real

Aptamer SeqId: 11918-54 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11918-54 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.742954E-11

Real

Aptamer SeqId:11919-84;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11919-84;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.105959E-11

Real

Aptamer SeqId: 11919-84 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11919-84 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.105959E-11

Real

Aptamer SeqId:11926-23;Target:P34;UniProt:Q6PD74

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11926-23;Target: P34;UniProt: Q6PD74;TargetFullName: Alpha- and gamma-adaptin-binding protein p34;Organisim: human;Apparent_Kd_M: 3.16237E-11

Real

Aptamer SeqId: 11926-23 | Target: P34 | UniProt: Q6PD74

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11926-23 | Target: P34 | UniProt: Q6PD74 | TargetFullName: Alpha- and gamma-adaptin-binding protein p34 | Organisim: human | Apparent_Kd_M: 3.16237E-11

Real

Aptamer SeqId:11927-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11927-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.627136E-11

Real

Aptamer SeqId: 11927-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11927-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.627136E-11

Real

Aptamer SeqId:11934-9;Target:INT3;UniProt:Q68E01

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11934-9;Target: INT3;UniProt: Q68E01;TargetFullName: Integrator complex subunit 3;Organisim: human;Apparent_Kd_M: 1.363192E-11

Real

Aptamer SeqId: 11934-9 | Target: INT3 | UniProt: Q68E01

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11934-9 | Target: INT3 | UniProt: Q68E01 | TargetFullName: Integrator complex subunit 3 | Organisim: human | Apparent_Kd_M: 1.363192E-11

Real

Aptamer SeqId:11939-11;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11939-11;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.896691E-11

Real

Aptamer SeqId: 11939-11 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11939-11 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.896691E-11

Real

Aptamer SeqId:11952-1;Target:IGDC3;UniProt:Q8IVU1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11952-1;Target: IGDC3;UniProt: Q8IVU1;TargetFullName: Immunoglobulin superfamily DCC subclass member 3;Organisim: human;Apparent_Kd_M: 1.388076E-10

Real

Aptamer SeqId: 11952-1 | Target: IGDC3 | UniProt: Q8IVU1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11952-1 | Target: IGDC3 | UniProt: Q8IVU1 | TargetFullName: Immunoglobulin superfamily DCC subclass member 3 | Organisim: human | Apparent_Kd_M: 1.388076E-10

Real

Aptamer SeqId:11955-1;Target:RHG01;UniProt:Q07960

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11955-1;Target: RHG01;UniProt: Q07960;TargetFullName: Rho GTPase-activating protein 1;Organisim: human;Apparent_Kd_M: 6.291374E-11

Real

Aptamer SeqId: 11955-1 | Target: RHG01 | UniProt: Q07960

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11955-1 | Target: RHG01 | UniProt: Q07960 | TargetFullName: Rho GTPase-activating protein 1 | Organisim: human | Apparent_Kd_M: 6.291374E-11

Real

Aptamer SeqId:11967-23;Target:RABP1;UniProt:P29762

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11967-23;Target: RABP1;UniProt: P29762;TargetFullName: Cellular retinoic acid-binding protein 1;Organisim: human;Apparent_Kd_M: 2.433921E-11

Real

Aptamer SeqId: 11967-23 | Target: RABP1 | UniProt: P29762

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11967-23 | Target: RABP1 | UniProt: P29762 | TargetFullName: Cellular retinoic acid-binding protein 1 | Organisim: human | Apparent_Kd_M: 2.433921E-11

Real

Aptamer SeqId:11969-5;Target:S100A2;UniProt:P29034

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11969-5;Target: S100A2;UniProt: P29034;TargetFullName: Protein S100-A2;Organisim: human;Apparent_Kd_M: 1.091208E-10

Real

Aptamer SeqId: 11969-5 | Target: S100A2 | UniProt: P29034

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11969-5 | Target: S100A2 | UniProt: P29034 | TargetFullName: Protein S100-A2 | Organisim: human | Apparent_Kd_M: 1.091208E-10

Real

Aptamer SeqId:11986-30;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11986-30;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.580557E-11

Real

Aptamer SeqId: 11986-30 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11986-30 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.580557E-11

Real

Aptamer SeqId:11988-24;Target:PTPRH;UniProt:Q9HD43

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11988-24;Target: PTPRH;UniProt: Q9HD43;TargetFullName: Receptor-type tyrosine-protein phosphatase H;Organisim: human;Apparent_Kd_M: 3.489357E-11

Real

Aptamer SeqId: 11988-24 | Target: PTPRH | UniProt: Q9HD43

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11988-24 | Target: PTPRH | UniProt: Q9HD43 | TargetFullName: Receptor-type tyrosine-protein phosphatase H | Organisim: human | Apparent_Kd_M: 3.489357E-11

Real

Aptamer SeqId:11989-35;Target:EMC1;UniProt:Q8N766

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11989-35;Target: EMC1;UniProt: Q8N766;TargetFullName: ER membrane protein complex subunit 1;Organisim: human;Apparent_Kd_M: 1.679051E-10

Real

Aptamer SeqId: 11989-35 | Target: EMC1 | UniProt: Q8N766

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11989-35 | Target: EMC1 | UniProt: Q8N766 | TargetFullName: ER membrane protein complex subunit 1 | Organisim: human | Apparent_Kd_M: 1.679051E-10

Real

Aptamer SeqId:11993-227;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 11993-227;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.503586E-11

Real

Aptamer SeqId: 11993-227 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 11993-227 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.503586E-11

Real

Aptamer SeqId:12001-7;Target:ZO1;UniProt:Q07157

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12001-7;Target: ZO1;UniProt: Q07157;TargetFullName: Tight junction protein ZO-1;Organisim: human;Apparent_Kd_M: 3.444973E-10

Real

Aptamer SeqId: 12001-7 | Target: ZO1 | UniProt: Q07157

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12001-7 | Target: ZO1 | UniProt: Q07157 | TargetFullName: Tight junction protein ZO-1 | Organisim: human | Apparent_Kd_M: 3.444973E-10

Real

Aptamer SeqId:12008-3;Target:CD7;UniProt:P09564

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12008-3;Target: CD7;UniProt: P09564;TargetFullName: T-cell antigen CD7;Organisim: human;Apparent_Kd_M: 4.018155E-11

Real

Aptamer SeqId: 12008-3 | Target: CD7 | UniProt: P09564

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12008-3 | Target: CD7 | UniProt: P09564 | TargetFullName: T-cell antigen CD7 | Organisim: human | Apparent_Kd_M: 4.018155E-11

Real

Aptamer SeqId:12012-33;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12012-33;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.829407E-11

Real

Aptamer SeqId: 12012-33 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12012-33 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.829407E-11

Real

Aptamer SeqId:12014-19;Target:PTPS;UniProt:Q03393

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12014-19;Target: PTPS;UniProt: Q03393;TargetFullName: 6-pyruvoyl tetrahydrobiopterin synthase;Organisim: human;Apparent_Kd_M: 4.570922E-11

Real

Aptamer SeqId: 12014-19 | Target: PTPS | UniProt: Q03393

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12014-19 | Target: PTPS | UniProt: Q03393 | TargetFullName: 6-pyruvoyl tetrahydrobiopterin synthase | Organisim: human | Apparent_Kd_M: 4.570922E-11

Real

Aptamer SeqId:12016-60;Target:CBL;UniProt:P22681

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12016-60;Target: CBL;UniProt: P22681;TargetFullName: E3 ubiquitin-protein ligase CBL;Organisim: human;Apparent_Kd_M: 1.495529E-12

Real

Aptamer SeqId: 12016-60 | Target: CBL | UniProt: P22681

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12016-60 | Target: CBL | UniProt: P22681 | TargetFullName: E3 ubiquitin-protein ligase CBL | Organisim: human | Apparent_Kd_M: 1.495529E-12

Real

Aptamer SeqId:12018-84;Target:TPK1;UniProt:Q9H3S4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12018-84;Target: TPK1;UniProt: Q9H3S4;TargetFullName: Thiamin pyrophosphokinase 1;Organisim: human;Apparent_Kd_M: 1.50718E-10

Real

Aptamer SeqId: 12018-84 | Target: TPK1 | UniProt: Q9H3S4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12018-84 | Target: TPK1 | UniProt: Q9H3S4 | TargetFullName: Thiamin pyrophosphokinase 1 | Organisim: human | Apparent_Kd_M: 1.50718E-10

Real

Aptamer SeqId:12020-39;Target:PMGE;UniProt:P07738

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12020-39;Target: PMGE;UniProt: P07738;TargetFullName: Bisphosphoglycerate mutase;Organisim: human;Apparent_Kd_M: 1.479729E-11

Real

Aptamer SeqId: 12020-39 | Target: PMGE | UniProt: P07738

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12020-39 | Target: PMGE | UniProt: P07738 | TargetFullName: Bisphosphoglycerate mutase | Organisim: human | Apparent_Kd_M: 1.479729E-11

Real

Aptamer SeqId:12022-12;Target:SMAD4;UniProt:Q13485

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12022-12;Target: SMAD4;UniProt: Q13485;TargetFullName: Mothers against decapentaplegic homolog 4;Organisim: human;Apparent_Kd_M: 6.754043E-11

Real

Aptamer SeqId: 12022-12 | Target: SMAD4 | UniProt: Q13485

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12022-12 | Target: SMAD4 | UniProt: Q13485 | TargetFullName: Mothers against decapentaplegic homolog 4 | Organisim: human | Apparent_Kd_M: 6.754043E-11

Real

Aptamer SeqId:12030-82;Target:Desmin;UniProt:P17661

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12030-82;Target: Desmin;UniProt: P17661;TargetFullName: Desmin;Organisim: human;Apparent_Kd_M: 7.501904E-12

Real

Aptamer SeqId: 12030-82 | Target: Desmin | UniProt: P17661

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12030-82 | Target: Desmin | UniProt: P17661 | TargetFullName: Desmin | Organisim: human | Apparent_Kd_M: 7.501904E-12

Real

Aptamer SeqId:12033-3;Target:BUB1;UniProt:O43683

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12033-3;Target: BUB1;UniProt: O43683;TargetFullName: Mitotic checkpoint serine/threonine-protein kinase BUB1;Organisim: human;Apparent_Kd_M: 4.273254E-11

Real

Aptamer SeqId: 12033-3 | Target: BUB1 | UniProt: O43683

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12033-3 | Target: BUB1 | UniProt: O43683 | TargetFullName: Mitotic checkpoint serine/threonine-protein kinase BUB1 | Organisim: human | Apparent_Kd_M: 4.273254E-11

Real

Aptamer SeqId:12034-28;Target:CAP 1;UniProt:Q01518

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12034-28;Target: CAP 1;UniProt: Q01518;TargetFullName: Adenylyl cyclase-associated protein 1;Organisim: human;Apparent_Kd_M: 1.994169E-10

Real

Aptamer SeqId: 12034-28 | Target: CAP 1 | UniProt: Q01518

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12034-28 | Target: CAP 1 | UniProt: Q01518 | TargetFullName: Adenylyl cyclase-associated protein 1 | Organisim: human | Apparent_Kd_M: 1.994169E-10

Real

Aptamer SeqId:12041-33;Target:HS71L;UniProt:P34931

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12041-33;Target: HS71L;UniProt: P34931;TargetFullName: Heat shock 70 kDa protein 1-like;Organisim: human;Apparent_Kd_M: 5.126939E-10

Real

Aptamer SeqId: 12041-33 | Target: HS71L | UniProt: P34931

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12041-33 | Target: HS71L | UniProt: P34931 | TargetFullName: Heat shock 70 kDa protein 1-like | Organisim: human | Apparent_Kd_M: 5.126939E-10

Real

Aptamer SeqId:12046-51;Target:TADBP;UniProt:Q13148

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12046-51;Target: TADBP;UniProt: Q13148;TargetFullName: TAR DNA-binding protein 43;Organisim: human;Apparent_Kd_M: 1.39184E-10

Real

Aptamer SeqId: 12046-51 | Target: TADBP | UniProt: Q13148

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12046-51 | Target: TADBP | UniProt: Q13148 | TargetFullName: TAR DNA-binding protein 43 | Organisim: human | Apparent_Kd_M: 1.39184E-10

Real

Aptamer SeqId:12329-21;Target:KS6A1;UniProt:Q15418

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12329-21;Target: KS6A1;UniProt: Q15418;TargetFullName: Ribosomal protein S6 kinase alpha-1;Organisim: human;Apparent_Kd_M: 2.248191E-10

Real

Aptamer SeqId: 12329-21 | Target: KS6A1 | UniProt: Q15418

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12329-21 | Target: KS6A1 | UniProt: Q15418 | TargetFullName: Ribosomal protein S6 kinase alpha-1 | Organisim: human | Apparent_Kd_M: 2.248191E-10

Real

Aptamer SeqId:12332-7;Target:EF2K;UniProt:O00418

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12332-7;Target: EF2K;UniProt: O00418;TargetFullName: Eukaryotic elongation factor 2 kinase;Organisim: human;Apparent_Kd_M: 2.704565E-11

Real

Aptamer SeqId: 12332-7 | Target: EF2K | UniProt: O00418

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12332-7 | Target: EF2K | UniProt: O00418 | TargetFullName: Eukaryotic elongation factor 2 kinase | Organisim: human | Apparent_Kd_M: 2.704565E-11

Real

Aptamer SeqId:12333-87;Target:RPIA;UniProt:P49247

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12333-87;Target: RPIA;UniProt: P49247;TargetFullName: Ribose-5-phosphate isomerase;Organisim: human;Apparent_Kd_M: 9.081164E-11

Real

Aptamer SeqId: 12333-87 | Target: RPIA | UniProt: P49247

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12333-87 | Target: RPIA | UniProt: P49247 | TargetFullName: Ribose-5-phosphate isomerase | Organisim: human | Apparent_Kd_M: 9.081164E-11

Real

Aptamer SeqId:12334-25;Target:cSHMT;UniProt:P34896

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12334-25;Target: cSHMT;UniProt: P34896;TargetFullName: Serine hydroxymethyltransferase; cytosolic;Organisim: human;Apparent_Kd_M: 8.212984E-12

Real

Aptamer SeqId: 12334-25 | Target: cSHMT | UniProt: P34896

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12334-25 | Target: cSHMT | UniProt: P34896 | TargetFullName: Serine hydroxymethyltransferase; cytosolic | Organisim: human | Apparent_Kd_M: 8.212984E-12

Real

Aptamer SeqId:12338-27;Target:EGFLA;UniProt:Q63HQ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12338-27;Target: EGFLA;UniProt: Q63HQ2;TargetFullName: Pikachurin;Organisim: human;Apparent_Kd_M: 7.166281E-12

Real

Aptamer SeqId: 12338-27 | Target: EGFLA | UniProt: Q63HQ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12338-27 | Target: EGFLA | UniProt: Q63HQ2 | TargetFullName: Pikachurin | Organisim: human | Apparent_Kd_M: 7.166281E-12

Real

Aptamer SeqId:12340-17;Target:SYAC;UniProt:P49588

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12340-17;Target: SYAC;UniProt: P49588;TargetFullName: Alanine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.497827E-12

Real

Aptamer SeqId: 12340-17 | Target: SYAC | UniProt: P49588

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12340-17 | Target: SYAC | UniProt: P49588 | TargetFullName: Alanine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.497827E-12

Real

Aptamer SeqId:12341-8;Target:DUS6;UniProt:Q16828

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12341-8;Target: DUS6;UniProt: Q16828;TargetFullName: Dual specificity protein phosphatase 6;Organisim: human;Apparent_Kd_M: 1.792609E-10

Real

Aptamer SeqId: 12341-8 | Target: DUS6 | UniProt: Q16828

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12341-8 | Target: DUS6 | UniProt: Q16828 | TargetFullName: Dual specificity protein phosphatase 6 | Organisim: human | Apparent_Kd_M: 1.792609E-10

Real

Aptamer SeqId:12343-14;Target:CENB2;UniProt:Q15057

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12343-14;Target: CENB2;UniProt: Q15057;TargetFullName: Arf-GAP with coiled-coil; ANK repeat and PH domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.33647E-10

Real

Aptamer SeqId: 12343-14 | Target: CENB2 | UniProt: Q15057

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12343-14 | Target: CENB2 | UniProt: Q15057 | TargetFullName: Arf-GAP with coiled-coil; ANK repeat and PH domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.33647E-10

Real

Aptamer SeqId:12345-4;Target:APC10;UniProt:Q9UM13

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12345-4;Target: APC10;UniProt: Q9UM13;TargetFullName: Anaphase-promoting complex subunit 10;Organisim: human;Apparent_Kd_M: 7.275293E-11

Real

Aptamer SeqId: 12345-4 | Target: APC10 | UniProt: Q9UM13

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12345-4 | Target: APC10 | UniProt: Q9UM13 | TargetFullName: Anaphase-promoting complex subunit 10 | Organisim: human | Apparent_Kd_M: 7.275293E-11

Real

Aptamer SeqId:12347-29;Target:CCM2;UniProt:Q9BSQ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12347-29;Target: CCM2;UniProt: Q9BSQ5;TargetFullName: Cerebral cavernous malformations 2 protein;Organisim: human;Apparent_Kd_M: 2.936135E-11

Real

Aptamer SeqId: 12347-29 | Target: CCM2 | UniProt: Q9BSQ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12347-29 | Target: CCM2 | UniProt: Q9BSQ5 | TargetFullName: Cerebral cavernous malformations 2 protein | Organisim: human | Apparent_Kd_M: 2.936135E-11

Real

Aptamer SeqId:12348-46;Target:SYSM;UniProt:Q9NP81

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12348-46;Target: SYSM;UniProt: Q9NP81;TargetFullName: Serine--tRNA ligase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.817599E-11

Real

Aptamer SeqId: 12348-46 | Target: SYSM | UniProt: Q9NP81

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12348-46 | Target: SYSM | UniProt: Q9NP81 | TargetFullName: Serine--tRNA ligase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.817599E-11

Real

Aptamer SeqId:12350-86;Target:ETS2;UniProt:P15036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12350-86;Target: ETS2;UniProt: P15036;TargetFullName: Protein C-ets-2;Organisim: human;Apparent_Kd_M: 2.76E-12

Real

Aptamer SeqId: 12350-86 | Target: ETS2 | UniProt: P15036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12350-86 | Target: ETS2 | UniProt: P15036 | TargetFullName: Protein C-ets-2 | Organisim: human | Apparent_Kd_M: 2.76E-12

Real

Aptamer SeqId:12352-70;Target:ARRD3;UniProt:Q96B67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12352-70;Target: ARRD3;UniProt: Q96B67;TargetFullName: Arrestin domain-containing protein 3;Organisim: human;Apparent_Kd_M: 4.620349E-12

Real

Aptamer SeqId: 12352-70 | Target: ARRD3 | UniProt: Q96B67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12352-70 | Target: ARRD3 | UniProt: Q96B67 | TargetFullName: Arrestin domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 4.620349E-12

Real

Aptamer SeqId:12355-223;Target:RRFM;UniProt:Q96E11

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12355-223;Target: RRFM;UniProt: Q96E11;TargetFullName: Ribosome-recycling factor; mitochondrial;Organisim: human;Apparent_Kd_M: 7.620073E-11

Real

Aptamer SeqId: 12355-223 | Target: RRFM | UniProt: Q96E11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12355-223 | Target: RRFM | UniProt: Q96E11 | TargetFullName: Ribosome-recycling factor; mitochondrial | Organisim: human | Apparent_Kd_M: 7.620073E-11

Real

Aptamer SeqId:12356-65;Target:Sorcin;UniProt:P30626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12356-65;Target: Sorcin;UniProt: P30626;TargetFullName: Sorcin;Organisim: human;Apparent_Kd_M: 1.525527E-10

Real

Aptamer SeqId: 12356-65 | Target: Sorcin | UniProt: P30626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12356-65 | Target: Sorcin | UniProt: P30626 | TargetFullName: Sorcin | Organisim: human | Apparent_Kd_M: 1.525527E-10

Real

Aptamer SeqId:12357-41;Target:SNP29;UniProt:O95721

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12357-41;Target: SNP29;UniProt: O95721;TargetFullName: Synaptosomal-associated protein 29;Organisim: human;Apparent_Kd_M: 1.229383E-10

Real

Aptamer SeqId: 12357-41 | Target: SNP29 | UniProt: O95721

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12357-41 | Target: SNP29 | UniProt: O95721 | TargetFullName: Synaptosomal-associated protein 29 | Organisim: human | Apparent_Kd_M: 1.229383E-10

Real

Aptamer SeqId:12358-6;Target:IGBP1;UniProt:P78318

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12358-6;Target: IGBP1;UniProt: P78318;TargetFullName: Immunoglobulin-binding protein 1;Organisim: human;Apparent_Kd_M: 3.743409E-12

Real

Aptamer SeqId: 12358-6 | Target: IGBP1 | UniProt: P78318

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12358-6 | Target: IGBP1 | UniProt: P78318 | TargetFullName: Immunoglobulin-binding protein 1 | Organisim: human | Apparent_Kd_M: 3.743409E-12

Real

Aptamer SeqId:12361-102;Target:RRAS2;UniProt:P62070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12361-102;Target: RRAS2;UniProt: P62070;TargetFullName: Ras-related protein R-Ras2;Organisim: human;Apparent_Kd_M: 4.69992E-11

Real

Aptamer SeqId: 12361-102 | Target: RRAS2 | UniProt: P62070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12361-102 | Target: RRAS2 | UniProt: P62070 | TargetFullName: Ras-related protein R-Ras2 | Organisim: human | Apparent_Kd_M: 4.69992E-11

Real

Aptamer SeqId:12363-70;Target:TRIB2;UniProt:Q92519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12363-70;Target: TRIB2;UniProt: Q92519;TargetFullName: Tribbles homolog 2;Organisim: human;Apparent_Kd_M: 2.012574E-11

Real

Aptamer SeqId: 12363-70 | Target: TRIB2 | UniProt: Q92519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12363-70 | Target: TRIB2 | UniProt: Q92519 | TargetFullName: Tribbles homolog 2 | Organisim: human | Apparent_Kd_M: 2.012574E-11

Real

Aptamer SeqId:12365-108;Target:RUVB1;UniProt:Q9Y265

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12365-108;Target: RUVB1;UniProt: Q9Y265;TargetFullName: RuvB-like 1;Organisim: human;Apparent_Kd_M: 5.321349E-11

Real

Aptamer SeqId: 12365-108 | Target: RUVB1 | UniProt: Q9Y265

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12365-108 | Target: RUVB1 | UniProt: Q9Y265 | TargetFullName: RuvB-like 1 | Organisim: human | Apparent_Kd_M: 5.321349E-11

Real

Aptamer SeqId:12366-16;Target:CRGD;UniProt:P07320

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12366-16;Target: CRGD;UniProt: P07320;TargetFullName: Gamma-crystallin D;Organisim: human;Apparent_Kd_M: 3.501916E-11

Real

Aptamer SeqId: 12366-16 | Target: CRGD | UniProt: P07320

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12366-16 | Target: CRGD | UniProt: P07320 | TargetFullName: Gamma-crystallin D | Organisim: human | Apparent_Kd_M: 3.501916E-11

Real

Aptamer SeqId:12367-52;Target:MACOI;UniProt:Q8N5G2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12367-52;Target: MACOI;UniProt: Q8N5G2;TargetFullName: Macoilin;Organisim: human;Apparent_Kd_M: 5.047972E-11

Real

Aptamer SeqId: 12367-52 | Target: MACOI | UniProt: Q8N5G2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12367-52 | Target: MACOI | UniProt: Q8N5G2 | TargetFullName: Macoilin | Organisim: human | Apparent_Kd_M: 5.047972E-11

Real

Aptamer SeqId:12368-18;Target:PCAF;UniProt:Q92831

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12368-18;Target: PCAF;UniProt: Q92831;TargetFullName: Histone acetyltransferase KAT2B;Organisim: human;Apparent_Kd_M: 1.588979E-11

Real

Aptamer SeqId: 12368-18 | Target: PCAF | UniProt: Q92831

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12368-18 | Target: PCAF | UniProt: Q92831 | TargetFullName: Histone acetyltransferase KAT2B | Organisim: human | Apparent_Kd_M: 1.588979E-11

Real

Aptamer SeqId:12370-30;Target:Apo F;UniProt:Q13790

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12370-30;Target: Apo F;UniProt: Q13790;TargetFullName: Apolipoprotein F;Organisim: human;Apparent_Kd_M: 2.042036E-11

Real

Aptamer SeqId: 12370-30 | Target: Apo F | UniProt: Q13790

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12370-30 | Target: Apo F | UniProt: Q13790 | TargetFullName: Apolipoprotein F | Organisim: human | Apparent_Kd_M: 2.042036E-11

Real

Aptamer SeqId:12373-73;Target:TRA2B;UniProt:P62995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12373-73;Target: TRA2B;UniProt: P62995;TargetFullName: Transformer-2 protein homolog beta;Organisim: human;Apparent_Kd_M: 1.703666E-12

Real

Aptamer SeqId: 12373-73 | Target: TRA2B | UniProt: P62995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12373-73 | Target: TRA2B | UniProt: P62995 | TargetFullName: Transformer-2 protein homolog beta | Organisim: human | Apparent_Kd_M: 1.703666E-12

Real

Aptamer SeqId:12374-8;Target:PA1B3;UniProt:Q15102

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12374-8;Target: PA1B3;UniProt: Q15102;TargetFullName: Platelet-activating factor acetylhydrolase IB subunit gamma;Organisim: human;Apparent_Kd_M: 7.239859E-12

Real

Aptamer SeqId: 12374-8 | Target: PA1B3 | UniProt: Q15102

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12374-8 | Target: PA1B3 | UniProt: Q15102 | TargetFullName: Platelet-activating factor acetylhydrolase IB subunit gamma | Organisim: human | Apparent_Kd_M: 7.239859E-12

Real

Aptamer SeqId:12376-85;Target:p19-INK4d;UniProt:P55273

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12376-85;Target: p19-INK4d;UniProt: P55273;TargetFullName: Cyclin-dependent kinase 4 inhibitor D;Organisim: human;Apparent_Kd_M: 9.783931E-12

Real

Aptamer SeqId: 12376-85 | Target: p19-INK4d | UniProt: P55273

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12376-85 | Target: p19-INK4d | UniProt: P55273 | TargetFullName: Cyclin-dependent kinase 4 inhibitor D | Organisim: human | Apparent_Kd_M: 9.783931E-12

Real

Aptamer SeqId:12378-71;Target:TPSN;UniProt:O15533

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12378-71;Target: TPSN;UniProt: O15533;TargetFullName: Tapasin;Organisim: human;Apparent_Kd_M: 4.18689E-11

Real

Aptamer SeqId: 12378-71 | Target: TPSN | UniProt: O15533

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12378-71 | Target: TPSN | UniProt: O15533 | TargetFullName: Tapasin | Organisim: human | Apparent_Kd_M: 4.18689E-11

Real

Aptamer SeqId:12381-26;Target:CBR1;UniProt:P16152

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12381-26;Target: CBR1;UniProt: P16152;TargetFullName: Carbonyl reductase [NADPH] 1;Organisim: human;Apparent_Kd_M: 1.055064E-11

Real

Aptamer SeqId: 12381-26 | Target: CBR1 | UniProt: P16152

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12381-26 | Target: CBR1 | UniProt: P16152 | TargetFullName: Carbonyl reductase NADPH 1 | Organisim: human | Apparent_Kd_M: 1.055064E-11

Real

Aptamer SeqId:12382-2;Target:DDX58;UniProt:O95786

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12382-2;Target: DDX58;UniProt: O95786;TargetFullName: Probable ATP-dependent RNA helicase DDX58;Organisim: human;Apparent_Kd_M: 5.723584E-12

Real

Aptamer SeqId: 12382-2 | Target: DDX58 | UniProt: O95786

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12382-2 | Target: DDX58 | UniProt: O95786 | TargetFullName: Probable ATP-dependent RNA helicase DDX58 | Organisim: human | Apparent_Kd_M: 5.723584E-12

Real

Aptamer SeqId:12384-92;Target:CSN7B;UniProt:Q9H9Q2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12384-92;Target: CSN7B;UniProt: Q9H9Q2;TargetFullName: COP9 signalosome complex subunit 7b;Organisim: human;Apparent_Kd_M: 5.613975E-11

Real

Aptamer SeqId: 12384-92 | Target: CSN7B | UniProt: Q9H9Q2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12384-92 | Target: CSN7B | UniProt: Q9H9Q2 | TargetFullName: COP9 signalosome complex subunit 7b | Organisim: human | Apparent_Kd_M: 5.613975E-11

Real

Aptamer SeqId:12385-4;Target:CAN3;UniProt:P20807

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12385-4;Target: CAN3;UniProt: P20807;TargetFullName: Calpain-3;Organisim: human;Apparent_Kd_M: 6.451892E-11

Real

Aptamer SeqId: 12385-4 | Target: CAN3 | UniProt: P20807

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12385-4 | Target: CAN3 | UniProt: P20807 | TargetFullName: Calpain-3 | Organisim: human | Apparent_Kd_M: 6.451892E-11

Real

Aptamer SeqId:12386-11;Target:AMPB;UniProt:Q9H4A4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12386-11;Target: AMPB;UniProt: Q9H4A4;TargetFullName: Aminopeptidase B;Organisim: human;Apparent_Kd_M: 4.953123E-11

Real

Aptamer SeqId: 12386-11 | Target: AMPB | UniProt: Q9H4A4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12386-11 | Target: AMPB | UniProt: Q9H4A4 | TargetFullName: Aminopeptidase B | Organisim: human | Apparent_Kd_M: 4.953123E-11

Real

Aptamer SeqId:12387-7;Target:PDLI4;UniProt:P50479

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12387-7;Target: PDLI4;UniProt: P50479;TargetFullName: PDZ and LIM domain protein 4;Organisim: human;Apparent_Kd_M: 2.82277E-12

Real

Aptamer SeqId: 12387-7 | Target: PDLI4 | UniProt: P50479

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12387-7 | Target: PDLI4 | UniProt: P50479 | TargetFullName: PDZ and LIM domain protein 4 | Organisim: human | Apparent_Kd_M: 2.82277E-12

Real

Aptamer SeqId:12389-4;Target:ORC6;UniProt:Q9Y5N6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12389-4;Target: ORC6;UniProt: Q9Y5N6;TargetFullName: Origin recognition complex subunit 6;Organisim: human;Apparent_Kd_M: 3.142377E-12

Real

Aptamer SeqId: 12389-4 | Target: ORC6 | UniProt: Q9Y5N6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12389-4 | Target: ORC6 | UniProt: Q9Y5N6 | TargetFullName: Origin recognition complex subunit 6 | Organisim: human | Apparent_Kd_M: 3.142377E-12

Real

Aptamer SeqId:12391-27;Target:PDZD7;UniProt:Q9H5P4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12391-27;Target: PDZD7;UniProt: Q9H5P4;TargetFullName: PDZ domain-containing protein 7;Organisim: human;Apparent_Kd_M: 6.550686E-12

Real

Aptamer SeqId: 12391-27 | Target: PDZD7 | UniProt: Q9H5P4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12391-27 | Target: PDZD7 | UniProt: Q9H5P4 | TargetFullName: PDZ domain-containing protein 7 | Organisim: human | Apparent_Kd_M: 6.550686E-12

Real

Aptamer SeqId:12392-30;Target:ARL1;UniProt:P40616

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12392-30;Target: ARL1;UniProt: P40616;TargetFullName: ADP-ribosylation factor-like protein 1;Organisim: human;Apparent_Kd_M: 9.031801E-11

Real

Aptamer SeqId: 12392-30 | Target: ARL1 | UniProt: P40616

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12392-30 | Target: ARL1 | UniProt: P40616 | TargetFullName: ADP-ribosylation factor-like protein 1 | Organisim: human | Apparent_Kd_M: 9.031801E-11

Real

Aptamer SeqId:12394-53;Target:CP054;UniProt:Q6UWD8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12394-53;Target: CP054;UniProt: Q6UWD8;TargetFullName: Transmembrane protein C16orf54;Organisim: human;Apparent_Kd_M: 5.331602E-11

Real

Aptamer SeqId: 12394-53 | Target: CP054 | UniProt: Q6UWD8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12394-53 | Target: CP054 | UniProt: Q6UWD8 | TargetFullName: Transmembrane protein C16orf54 | Organisim: human | Apparent_Kd_M: 5.331602E-11

Real

Aptamer SeqId:12395-86;Target:SYDM;UniProt:Q6PI48

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12395-86;Target: SYDM;UniProt: Q6PI48;TargetFullName: Aspartate--tRNA ligase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.14468E-12

Real

Aptamer SeqId: 12395-86 | Target: SYDM | UniProt: Q6PI48

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12395-86 | Target: SYDM | UniProt: Q6PI48 | TargetFullName: Aspartate--tRNA ligase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.14468E-12

Real

Aptamer SeqId:12396-19;Target:HIBCH;UniProt:Q6NVY1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12396-19;Target: HIBCH;UniProt: Q6NVY1;TargetFullName: 3-hydroxyisobutyryl-CoA hydrolase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.184377E-12

Real

Aptamer SeqId: 12396-19 | Target: HIBCH | UniProt: Q6NVY1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12396-19 | Target: HIBCH | UniProt: Q6NVY1 | TargetFullName: 3-hydroxyisobutyryl-CoA hydrolase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.184377E-12

Real

Aptamer SeqId:12398-15;Target:PAX4;UniProt:O43316

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12398-15;Target: PAX4;UniProt: O43316;TargetFullName: Paired box protein Pax-4;Organisim: human;Apparent_Kd_M: 7.158009E-12

Real

Aptamer SeqId: 12398-15 | Target: PAX4 | UniProt: O43316

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12398-15 | Target: PAX4 | UniProt: O43316 | TargetFullName: Paired box protein Pax-4 | Organisim: human | Apparent_Kd_M: 7.158009E-12

Real

Aptamer SeqId:12399-194;Target:CCD50;UniProt:Q8IVM0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12399-194;Target: CCD50;UniProt: Q8IVM0;TargetFullName: Coiled-coil domain-containing protein 50;Organisim: human;Apparent_Kd_M: 3.570673E-11

Real

Aptamer SeqId: 12399-194 | Target: CCD50 | UniProt: Q8IVM0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12399-194 | Target: CCD50 | UniProt: Q8IVM0 | TargetFullName: Coiled-coil domain-containing protein 50 | Organisim: human | Apparent_Kd_M: 3.570673E-11

Real

Aptamer SeqId:12400-25;Target:UBE2T;UniProt:Q9NPD8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12400-25;Target: UBE2T;UniProt: Q9NPD8;TargetFullName: Ubiquitin-conjugating enzyme E2 T;Organisim: human;Apparent_Kd_M: 1.005069E-11

Real

Aptamer SeqId: 12400-25 | Target: UBE2T | UniProt: Q9NPD8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12400-25 | Target: UBE2T | UniProt: Q9NPD8 | TargetFullName: Ubiquitin-conjugating enzyme E2 T | Organisim: human | Apparent_Kd_M: 1.005069E-11

Real

Aptamer SeqId:12401-3;Target:STALP;UniProt:Q96FJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12401-3;Target: STALP;UniProt: Q96FJ0;TargetFullName: AMSH-like protease;Organisim: human;Apparent_Kd_M: 1.202619E-12

Real

Aptamer SeqId: 12401-3 | Target: STALP | UniProt: Q96FJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12401-3 | Target: STALP | UniProt: Q96FJ0 | TargetFullName: AMSH-like protease | Organisim: human | Apparent_Kd_M: 1.202619E-12

Real

Aptamer SeqId:12403-30;Target:RB39B;UniProt:Q96DA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12403-30;Target: RB39B;UniProt: Q96DA2;TargetFullName: Ras-related protein Rab-39B;Organisim: human;Apparent_Kd_M: 1.69271E-11

Real

Aptamer SeqId: 12403-30 | Target: RB39B | UniProt: Q96DA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12403-30 | Target: RB39B | UniProt: Q96DA2 | TargetFullName: Ras-related protein Rab-39B | Organisim: human | Apparent_Kd_M: 1.69271E-11

Real

Aptamer SeqId:12406-119;Target:ARHI;UniProt:O95661

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12406-119;Target: ARHI;UniProt: O95661;TargetFullName: GTP-binding protein Di-Ras3;Organisim: human;Apparent_Kd_M: 2.292574E-11

Real

Aptamer SeqId: 12406-119 | Target: ARHI | UniProt: O95661

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12406-119 | Target: ARHI | UniProt: O95661 | TargetFullName: GTP-binding protein Di-Ras3 | Organisim: human | Apparent_Kd_M: 2.292574E-11

Real

Aptamer SeqId:12408-333;Target:RB22A;UniProt:Q9UL26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12408-333;Target: RB22A;UniProt: Q9UL26;TargetFullName: Ras-related protein Rab-22A;Organisim: human;Apparent_Kd_M: 1.155068E-10

Real

Aptamer SeqId: 12408-333 | Target: RB22A | UniProt: Q9UL26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12408-333 | Target: RB22A | UniProt: Q9UL26 | TargetFullName: Ras-related protein Rab-22A | Organisim: human | Apparent_Kd_M: 1.155068E-10

Real

Aptamer SeqId:12409-90;Target:RAB7B;UniProt:Q96AH8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12409-90;Target: RAB7B;UniProt: Q96AH8;TargetFullName: Ras-related protein Rab-7b;Organisim: human;Apparent_Kd_M: 5.217415E-12

Real

Aptamer SeqId: 12409-90 | Target: RAB7B | UniProt: Q96AH8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12409-90 | Target: RAB7B | UniProt: Q96AH8 | TargetFullName: Ras-related protein Rab-7b | Organisim: human | Apparent_Kd_M: 5.217415E-12

Real

Aptamer SeqId:12411-60;Target:MAX;UniProt:P61244

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12411-60;Target: MAX;UniProt: P61244;TargetFullName: Protein max;Organisim: human;Apparent_Kd_M: 4.30455E-12

Real

Aptamer SeqId: 12411-60 | Target: MAX | UniProt: P61244

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12411-60 | Target: MAX | UniProt: P61244 | TargetFullName: Protein max | Organisim: human | Apparent_Kd_M: 4.30455E-12

Real

Aptamer SeqId:12415-122;Target:EDF1;UniProt:O60869

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12415-122;Target: EDF1;UniProt: O60869;TargetFullName: Endothelial differentiation-related factor 1;Organisim: human;Apparent_Kd_M: 1.7442E-11

Real

Aptamer SeqId: 12415-122 | Target: EDF1 | UniProt: O60869

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12415-122 | Target: EDF1 | UniProt: O60869 | TargetFullName: Endothelial differentiation-related factor 1 | Organisim: human | Apparent_Kd_M: 1.7442E-11

Real

Aptamer SeqId:12417-46;Target:TPRKB;UniProt:Q9Y3C4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12417-46;Target: TPRKB;UniProt: Q9Y3C4;TargetFullName: EKC/KEOPS complex subunit TPRKB;Organisim: human;Apparent_Kd_M: 5.677964E-11

Real

Aptamer SeqId: 12417-46 | Target: TPRKB | UniProt: Q9Y3C4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12417-46 | Target: TPRKB | UniProt: Q9Y3C4 | TargetFullName: EKC/KEOPS complex subunit TPRKB | Organisim: human | Apparent_Kd_M: 5.677964E-11

Real

Aptamer SeqId:12420-10;Target:GPD1L;UniProt:Q8N335

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12420-10;Target: GPD1L;UniProt: Q8N335;TargetFullName: Glycerol-3-phosphate dehydrogenase 1-like protein;Organisim: human;Apparent_Kd_M: 4.033287E-11

Real

Aptamer SeqId: 12420-10 | Target: GPD1L | UniProt: Q8N335

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12420-10 | Target: GPD1L | UniProt: Q8N335 | TargetFullName: Glycerol-3-phosphate dehydrogenase 1-like protein | Organisim: human | Apparent_Kd_M: 4.033287E-11

Real

Aptamer SeqId:12422-143;Target:LX15B;UniProt:O15296

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12422-143;Target: LX15B;UniProt: O15296;TargetFullName: Arachidonate 15-lipoxygenase B;Organisim: human;Apparent_Kd_M: 3.190444E-11

Real

Aptamer SeqId: 12422-143 | Target: LX15B | UniProt: O15296

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12422-143 | Target: LX15B | UniProt: O15296 | TargetFullName: Arachidonate 15-lipoxygenase B | Organisim: human | Apparent_Kd_M: 3.190444E-11

Real

Aptamer SeqId:12423-38;Target:A1CF;UniProt:Q9NQ94

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12423-38;Target: A1CF;UniProt: Q9NQ94;TargetFullName: APOBEC1 complementation factor;Organisim: human;Apparent_Kd_M: 2.13E-10

Real

Aptamer SeqId: 12423-38 | Target: A1CF | UniProt: Q9NQ94

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12423-38 | Target: A1CF | UniProt: Q9NQ94 | TargetFullName: APOBEC1 complementation factor | Organisim: human | Apparent_Kd_M: 2.13E-10

Real

Aptamer SeqId:12424-107;Target:THYN1;UniProt:Q9P016

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12424-107;Target: THYN1;UniProt: Q9P016;TargetFullName: Thymocyte nuclear protein 1;Organisim: human;Apparent_Kd_M: 2.898899E-12

Real

Aptamer SeqId: 12424-107 | Target: THYN1 | UniProt: Q9P016

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12424-107 | Target: THYN1 | UniProt: Q9P016 | TargetFullName: Thymocyte nuclear protein 1 | Organisim: human | Apparent_Kd_M: 2.898899E-12

Real

Aptamer SeqId:12425-104;Target:ARF6;UniProt:P62330

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12425-104;Target: ARF6;UniProt: P62330;TargetFullName: ADP-ribosylation factor 6;Organisim: human;Apparent_Kd_M: 7.460557E-11

Real

Aptamer SeqId: 12425-104 | Target: ARF6 | UniProt: P62330

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12425-104 | Target: ARF6 | UniProt: P62330 | TargetFullName: ADP-ribosylation factor 6 | Organisim: human | Apparent_Kd_M: 7.460557E-11

Real

Aptamer SeqId:12426-19;Target:MOL1B;UniProt:Q9H8S9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12426-19;Target: MOL1B;UniProt: Q9H8S9;TargetFullName: MOB kinase activator 1A;Organisim: human;Apparent_Kd_M: 6.276468E-11

Real

Aptamer SeqId: 12426-19 | Target: MOL1B | UniProt: Q9H8S9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12426-19 | Target: MOL1B | UniProt: Q9H8S9 | TargetFullName: MOB kinase activator 1A | Organisim: human | Apparent_Kd_M: 6.276468E-11

Real

Aptamer SeqId:12427-8;Target:MPIP2;UniProt:P30305

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12427-8;Target: MPIP2;UniProt: P30305;TargetFullName: M-phase inducer phosphatase 2;Organisim: human;Apparent_Kd_M: 1.258088E-10

Real

Aptamer SeqId: 12427-8 | Target: MPIP2 | UniProt: P30305

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12427-8 | Target: MPIP2 | UniProt: P30305 | TargetFullName: M-phase inducer phosphatase 2 | Organisim: human | Apparent_Kd_M: 1.258088E-10

Real

Aptamer SeqId:12428-2;Target:LYPL1;UniProt:Q5VWZ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12428-2;Target: LYPL1;UniProt: Q5VWZ2;TargetFullName: Lysophospholipase-like protein 1;Organisim: human;Apparent_Kd_M: 2.485231E-10

Real

Aptamer SeqId: 12428-2 | Target: LYPL1 | UniProt: Q5VWZ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12428-2 | Target: LYPL1 | UniProt: Q5VWZ2 | TargetFullName: Lysophospholipase-like protein 1 | Organisim: human | Apparent_Kd_M: 2.485231E-10

Real

Aptamer SeqId:12430-78;Target:PAIP1;UniProt:Q9H074

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12430-78;Target: PAIP1;UniProt: Q9H074;TargetFullName: Polyadenylate-binding protein-interacting protein 1;Organisim: human;Apparent_Kd_M: 1.900245E-10

Real

Aptamer SeqId: 12430-78 | Target: PAIP1 | UniProt: Q9H074

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12430-78 | Target: PAIP1 | UniProt: Q9H074 | TargetFullName: Polyadenylate-binding protein-interacting protein 1 | Organisim: human | Apparent_Kd_M: 1.900245E-10

Real

Aptamer SeqId:12431-13;Target:PELO;UniProt:Q9BRX2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12431-13;Target: PELO;UniProt: Q9BRX2;TargetFullName: Protein pelota homolog;Organisim: human;Apparent_Kd_M: 9.636296E-12

Real

Aptamer SeqId: 12431-13 | Target: PELO | UniProt: Q9BRX2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12431-13 | Target: PELO | UniProt: Q9BRX2 | TargetFullName: Protein pelota homolog | Organisim: human | Apparent_Kd_M: 9.636296E-12

Real

Aptamer SeqId:12432-23;Target:CYBP;UniProt:Q9HB71

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12432-23;Target: CYBP;UniProt: Q9HB71;TargetFullName: Calcyclin-binding protein;Organisim: human;Apparent_Kd_M: 3.600995E-12

Real

Aptamer SeqId: 12432-23 | Target: CYBP | UniProt: Q9HB71

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12432-23 | Target: CYBP | UniProt: Q9HB71 | TargetFullName: Calcyclin-binding protein | Organisim: human | Apparent_Kd_M: 3.600995E-12

Real

Aptamer SeqId:12433-8;Target:ARL11;UniProt:Q969Q4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12433-8;Target: ARL11;UniProt: Q969Q4;TargetFullName: ADP-ribosylation factor-like protein 11;Organisim: human;Apparent_Kd_M: 5.559117E-11

Real

Aptamer SeqId: 12433-8 | Target: ARL11 | UniProt: Q969Q4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12433-8 | Target: ARL11 | UniProt: Q969Q4 | TargetFullName: ADP-ribosylation factor-like protein 11 | Organisim: human | Apparent_Kd_M: 5.559117E-11

Real

Aptamer SeqId:12434-25;Target:K0174;UniProt:P53990

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12434-25;Target: K0174;UniProt: P53990;TargetFullName: IST1 homolog;Organisim: human;Apparent_Kd_M: 8.48345E-12

Real

Aptamer SeqId: 12434-25 | Target: K0174 | UniProt: P53990

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12434-25 | Target: K0174 | UniProt: P53990 | TargetFullName: IST1 homolog | Organisim: human | Apparent_Kd_M: 8.48345E-12

Real

Aptamer SeqId:12436-84;Target:GST omega-1;UniProt:P78417

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12436-84;Target: GST omega-1;UniProt: P78417;TargetFullName: Glutathione S-transferase omega-1;Organisim: human;Apparent_Kd_M: 5.070662E-12

Real

Aptamer SeqId: 12436-84 | Target: GST omega-1 | UniProt: P78417

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12436-84 | Target: GST omega-1 | UniProt: P78417 | TargetFullName: Glutathione S-transferase omega-1 | Organisim: human | Apparent_Kd_M: 5.070662E-12

Real

Aptamer SeqId:12437-18;Target:ULK3;UniProt:Q6PHR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12437-18;Target: ULK3;UniProt: Q6PHR2;TargetFullName: Serine/threonine-protein kinase ULK3;Organisim: human;Apparent_Kd_M: 1.856171E-11

Real

Aptamer SeqId: 12437-18 | Target: ULK3 | UniProt: Q6PHR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12437-18 | Target: ULK3 | UniProt: Q6PHR2 | TargetFullName: Serine/threonine-protein kinase ULK3 | Organisim: human | Apparent_Kd_M: 1.856171E-11

Real

Aptamer SeqId:12438-127;Target:3MG;UniProt:P29372

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12438-127;Target: 3MG;UniProt: P29372;TargetFullName: DNA-3-methyladenine glycosylase;Organisim: human;Apparent_Kd_M: 7.565242E-12

Real

Aptamer SeqId: 12438-127 | Target: 3MG | UniProt: P29372

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12438-127 | Target: 3MG | UniProt: P29372 | TargetFullName: DNA-3-methyladenine glycosylase | Organisim: human | Apparent_Kd_M: 7.565242E-12

Real

Aptamer SeqId:12439-67;Target:ISGF3;UniProt:Q00978

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12439-67;Target: ISGF3;UniProt: Q00978;TargetFullName: Interferon regulatory factor 9;Organisim: human;Apparent_Kd_M: 2.333164E-11

Real

Aptamer SeqId: 12439-67 | Target: ISGF3 | UniProt: Q00978

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12439-67 | Target: ISGF3 | UniProt: Q00978 | TargetFullName: Interferon regulatory factor 9 | Organisim: human | Apparent_Kd_M: 2.333164E-11

Real

Aptamer SeqId:12442-4;Target:RHOD;UniProt:O00212

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12442-4;Target: RHOD;UniProt: O00212;TargetFullName: Rho-related GTP-binding protein RhoD;Organisim: human;Apparent_Kd_M: 1.938291E-11

Real

Aptamer SeqId: 12442-4 | Target: RHOD | UniProt: O00212

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12442-4 | Target: RHOD | UniProt: O00212 | TargetFullName: Rho-related GTP-binding protein RhoD | Organisim: human | Apparent_Kd_M: 1.938291E-11

Real

Aptamer SeqId:12444-39;Target:NR5A2;UniProt:O00482

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12444-39;Target: NR5A2;UniProt: O00482;TargetFullName: Nuclear receptor subfamily 5 group A member 2;Organisim: human;Apparent_Kd_M: 1.383146E-10

Real

Aptamer SeqId: 12444-39 | Target: NR5A2 | UniProt: O00482

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12444-39 | Target: NR5A2 | UniProt: O00482 | TargetFullName: Nuclear receptor subfamily 5 group A member 2 | Organisim: human | Apparent_Kd_M: 1.383146E-10

Real

Aptamer SeqId:12445-50;Target:ANR27;UniProt:Q96NW4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12445-50;Target: ANR27;UniProt: Q96NW4;TargetFullName: Ankyrin repeat domain-containing protein 27;Organisim: human;Apparent_Kd_M: 6.790518E-12

Real

Aptamer SeqId: 12445-50 | Target: ANR27 | UniProt: Q96NW4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12445-50 | Target: ANR27 | UniProt: Q96NW4 | TargetFullName: Ankyrin repeat domain-containing protein 27 | Organisim: human | Apparent_Kd_M: 6.790518E-12

Real

Aptamer SeqId:12449-16;Target:PPIH;UniProt:O43447

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12449-16;Target: PPIH;UniProt: O43447;TargetFullName: Peptidyl-prolyl cis-trans isomerase H;Organisim: human;Apparent_Kd_M: 3.102887E-11

Real

Aptamer SeqId: 12449-16 | Target: PPIH | UniProt: O43447

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12449-16 | Target: PPIH | UniProt: O43447 | TargetFullName: Peptidyl-prolyl cis-trans isomerase H | Organisim: human | Apparent_Kd_M: 3.102887E-11

Real

Aptamer SeqId:12450-42;Target:PMVK;UniProt:Q15126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12450-42;Target: PMVK;UniProt: Q15126;TargetFullName: Phosphomevalonate kinase;Organisim: human;Apparent_Kd_M: 2.758734E-11

Real

Aptamer SeqId: 12450-42 | Target: PMVK | UniProt: Q15126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12450-42 | Target: PMVK | UniProt: Q15126 | TargetFullName: Phosphomevalonate kinase | Organisim: human | Apparent_Kd_M: 2.758734E-11

Real

Aptamer SeqId:12451-62;Target:BACH1;UniProt:O14867

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12451-62;Target: BACH1;UniProt: O14867;TargetFullName: Transcription regulator protein BACH1;Organisim: human;Apparent_Kd_M: 1.196644E-10

Real

Aptamer SeqId: 12451-62 | Target: BACH1 | UniProt: O14867

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12451-62 | Target: BACH1 | UniProt: O14867 | TargetFullName: Transcription regulator protein BACH1 | Organisim: human | Apparent_Kd_M: 1.196644E-10

Real

Aptamer SeqId:12452-32;Target:SV422;UniProt:Q86Y97

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12452-32;Target: SV422;UniProt: Q86Y97;TargetFullName: Histone-lysine N-methyltransferase SUV420H2;Organisim: human;Apparent_Kd_M: 1.510694E-11

Real

Aptamer SeqId: 12452-32 | Target: SV422 | UniProt: Q86Y97

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12452-32 | Target: SV422 | UniProt: Q86Y97 | TargetFullName: Histone-lysine N-methyltransferase SUV420H2 | Organisim: human | Apparent_Kd_M: 1.510694E-11

Real

Aptamer SeqId:12453-161;Target:NXF1;UniProt:Q9UBU9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12453-161;Target: NXF1;UniProt: Q9UBU9;TargetFullName: Nuclear RNA export factor 1;Organisim: human;Apparent_Kd_M: 2.260108E-11

Real

Aptamer SeqId: 12453-161 | Target: NXF1 | UniProt: Q9UBU9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12453-161 | Target: NXF1 | UniProt: Q9UBU9 | TargetFullName: Nuclear RNA export factor 1 | Organisim: human | Apparent_Kd_M: 2.260108E-11

Real

Aptamer SeqId:12454-105;Target:NTM1A;UniProt:Q9BV86

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12454-105;Target: NTM1A;UniProt: Q9BV86;TargetFullName: N-terminal Xaa-Pro-Lys N-methyltransferase 1;Organisim: human;Apparent_Kd_M: 1.394544E-11

Real

Aptamer SeqId: 12454-105 | Target: NTM1A | UniProt: Q9BV86

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12454-105 | Target: NTM1A | UniProt: Q9BV86 | TargetFullName: N-terminal Xaa-Pro-Lys N-methyltransferase 1 | Organisim: human | Apparent_Kd_M: 1.394544E-11

Real

Aptamer SeqId:12455-48;Target:MYNN;UniProt:Q9NPC7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12455-48;Target: MYNN;UniProt: Q9NPC7;TargetFullName: Myoneurin;Organisim: human;Apparent_Kd_M: 8.305494E-11

Real

Aptamer SeqId: 12455-48 | Target: MYNN | UniProt: Q9NPC7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12455-48 | Target: MYNN | UniProt: Q9NPC7 | TargetFullName: Myoneurin | Organisim: human | Apparent_Kd_M: 8.305494E-11

Real

Aptamer SeqId:12456-5;Target:F263;UniProt:Q16875

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12456-5;Target: F263;UniProt: Q16875;TargetFullName: 6-phosphofructo-2-kinase/fructose-2;6-bisphosphatase 3;Organisim: human;Apparent_Kd_M: 4.275194E-11

Real

Aptamer SeqId: 12456-5 | Target: F263 | UniProt: Q16875

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12456-5 | Target: F263 | UniProt: Q16875 | TargetFullName: 6-phosphofructo-2-kinase/fructose-2;6-bisphosphatase 3 | Organisim: human | Apparent_Kd_M: 4.275194E-11

Real

Aptamer SeqId:12457-10;Target:MTND;UniProt:Q9BV57

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12457-10;Target: MTND;UniProt: Q9BV57;TargetFullName: 1;2-dihydroxy-3-keto-5-methylthiopentene dioxygenase;Organisim: human;Apparent_Kd_M: 9.917517E-11

Real

Aptamer SeqId: 12457-10 | Target: MTND | UniProt: Q9BV57

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12457-10 | Target: MTND | UniProt: Q9BV57 | TargetFullName: 1;2-dihydroxy-3-keto-5-methylthiopentene dioxygenase | Organisim: human | Apparent_Kd_M: 9.917517E-11

Real

Aptamer SeqId:12458-79;Target:CHP1;UniProt:Q99653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12458-79;Target: CHP1;UniProt: Q99653;TargetFullName: Calcineurin B homologous protein 1;Organisim: human;Apparent_Kd_M: 1.617079E-11

Real

Aptamer SeqId: 12458-79 | Target: CHP1 | UniProt: Q99653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12458-79 | Target: CHP1 | UniProt: Q99653 | TargetFullName: Calcineurin B homologous protein 1 | Organisim: human | Apparent_Kd_M: 1.617079E-11

Real

Aptamer SeqId:12459-13;Target:PKHA1;UniProt:Q9HB21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12459-13;Target: PKHA1;UniProt: Q9HB21;TargetFullName: Pleckstrin homology domain-containing family A member 1;Organisim: human;Apparent_Kd_M: 4.520747E-12

Real

Aptamer SeqId: 12459-13 | Target: PKHA1 | UniProt: Q9HB21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12459-13 | Target: PKHA1 | UniProt: Q9HB21 | TargetFullName: Pleckstrin homology domain-containing family A member 1 | Organisim: human | Apparent_Kd_M: 4.520747E-12

Real

Aptamer SeqId:12460-18;Target:PSA7;UniProt:O14818

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12460-18;Target: PSA7;UniProt: O14818;TargetFullName: Proteasome subunit alpha type-7;Organisim: human;Apparent_Kd_M: 7.258758E-12

Real

Aptamer SeqId: 12460-18 | Target: PSA7 | UniProt: O14818

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12460-18 | Target: PSA7 | UniProt: O14818 | TargetFullName: Proteasome subunit alpha type-7 | Organisim: human | Apparent_Kd_M: 7.258758E-12

Real

Aptamer SeqId:12461-8;Target:SIRT5;UniProt:Q9NXA8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12461-8;Target: SIRT5;UniProt: Q9NXA8;TargetFullName: NAD-dependent protein deacylase sirtuin-5; mitochondrial;Organisim: human;Apparent_Kd_M: 1.196735E-10

Real

Aptamer SeqId: 12461-8 | Target: SIRT5 | UniProt: Q9NXA8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12461-8 | Target: SIRT5 | UniProt: Q9NXA8 | TargetFullName: NAD-dependent protein deacylase sirtuin-5; mitochondrial | Organisim: human | Apparent_Kd_M: 1.196735E-10

Real

Aptamer SeqId:12462-20;Target:SETMR;UniProt:Q53H47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12462-20;Target: SETMR;UniProt: Q53H47;TargetFullName: Histone-lysine N-methyltransferase SETMAR;Organisim: human;Apparent_Kd_M: 1.647694E-12

Real

Aptamer SeqId: 12462-20 | Target: SETMR | UniProt: Q53H47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12462-20 | Target: SETMR | UniProt: Q53H47 | TargetFullName: Histone-lysine N-methyltransferase SETMAR | Organisim: human | Apparent_Kd_M: 1.647694E-12

Real

Aptamer SeqId:12463-7;Target:KLH13;UniProt:Q9P2N7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12463-7;Target: KLH13;UniProt: Q9P2N7;TargetFullName: Kelch-like protein 13;Organisim: human;Apparent_Kd_M: 2.025991E-11

Real

Aptamer SeqId: 12463-7 | Target: KLH13 | UniProt: Q9P2N7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12463-7 | Target: KLH13 | UniProt: Q9P2N7 | TargetFullName: Kelch-like protein 13 | Organisim: human | Apparent_Kd_M: 2.025991E-11

Real

Aptamer SeqId:12466-7;Target:ROA1;UniProt:P09651

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12466-7;Target: ROA1;UniProt: P09651;TargetFullName: Heterogeneous nuclear ribonucleoprotein A1;Organisim: human;Apparent_Kd_M: 2.743758E-12

Real

Aptamer SeqId: 12466-7 | Target: ROA1 | UniProt: P09651

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12466-7 | Target: ROA1 | UniProt: P09651 | TargetFullName: Heterogeneous nuclear ribonucleoprotein A1 | Organisim: human | Apparent_Kd_M: 2.743758E-12

Real

Aptamer SeqId:12469-19;Target:MARE1;UniProt:Q15691

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12469-19;Target: MARE1;UniProt: Q15691;TargetFullName: Microtubule-associated protein RP/EB family member 1;Organisim: human;Apparent_Kd_M: 8.979129E-13

Real

Aptamer SeqId: 12469-19 | Target: MARE1 | UniProt: Q15691

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12469-19 | Target: MARE1 | UniProt: Q15691 | TargetFullName: Microtubule-associated protein RP/EB family member 1 | Organisim: human | Apparent_Kd_M: 8.979129E-13

Real

Aptamer SeqId:12471-47;Target:STAU1;UniProt:O95793

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12471-47;Target: STAU1;UniProt: O95793;TargetFullName: Double-stranded RNA-binding protein Staufen homolog 1;Organisim: human;Apparent_Kd_M: 2.987069E-12

Real

Aptamer SeqId: 12471-47 | Target: STAU1 | UniProt: O95793

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12471-47 | Target: STAU1 | UniProt: O95793 | TargetFullName: Double-stranded RNA-binding protein Staufen homolog 1 | Organisim: human | Apparent_Kd_M: 2.987069E-12

Real

Aptamer SeqId:12473-48;Target:KCTD5;UniProt:Q9NXV2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12473-48;Target: KCTD5;UniProt: Q9NXV2;TargetFullName: BTB/POZ domain-containing protein KCTD5;Organisim: human;Apparent_Kd_M: 1.102293E-10

Real

Aptamer SeqId: 12473-48 | Target: KCTD5 | UniProt: Q9NXV2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12473-48 | Target: KCTD5 | UniProt: Q9NXV2 | TargetFullName: BTB/POZ domain-containing protein KCTD5 | Organisim: human | Apparent_Kd_M: 1.102293E-10

Real

Aptamer SeqId:12475-48;Target:CLIC5;UniProt:Q9NZA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12475-48;Target: CLIC5;UniProt: Q9NZA1;TargetFullName: Chloride intracellular channel protein 5;Organisim: human;Apparent_Kd_M: 4.279657E-13

Real

Aptamer SeqId: 12475-48 | Target: CLIC5 | UniProt: Q9NZA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12475-48 | Target: CLIC5 | UniProt: Q9NZA1 | TargetFullName: Chloride intracellular channel protein 5 | Organisim: human | Apparent_Kd_M: 4.279657E-13

Real

Aptamer SeqId:12476-50;Target:TIGAR;UniProt:Q9NQ88

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12476-50;Target: TIGAR;UniProt: Q9NQ88;TargetFullName: Fructose-2;6-bisphosphatase TIGAR;Organisim: human;Apparent_Kd_M: 1.031891E-11

Real

Aptamer SeqId: 12476-50 | Target: TIGAR | UniProt: Q9NQ88

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12476-50 | Target: TIGAR | UniProt: Q9NQ88 | TargetFullName: Fructose-2;6-bisphosphatase TIGAR | Organisim: human | Apparent_Kd_M: 1.031891E-11

Real

Aptamer SeqId:12477-42;Target:TSN;UniProt:Q15631

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12477-42;Target: TSN;UniProt: Q15631;TargetFullName: Translin;Organisim: human;Apparent_Kd_M: 2.780946E-11

Real

Aptamer SeqId: 12477-42 | Target: TSN | UniProt: Q15631

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12477-42 | Target: TSN | UniProt: Q15631 | TargetFullName: Translin | Organisim: human | Apparent_Kd_M: 2.780946E-11

Real

Aptamer SeqId:12478-15;Target:RL30;UniProt:P62888

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12478-15;Target: RL30;UniProt: P62888;TargetFullName: 60S ribosomal protein L30;Organisim: human;Apparent_Kd_M: 2.16501E-11

Real

Aptamer SeqId: 12478-15 | Target: RL30 | UniProt: P62888

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12478-15 | Target: RL30 | UniProt: P62888 | TargetFullName: 60S ribosomal protein L30 | Organisim: human | Apparent_Kd_M: 2.16501E-11

Real

Aptamer SeqId:12479-50;Target:KAP1;UniProt:P31321

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12479-50;Target: KAP1;UniProt: P31321;TargetFullName: cAMP-dependent protein kinase type I-beta regulatory subunit;Organisim: human;Apparent_Kd_M: 2.24592E-11

Real

Aptamer SeqId: 12479-50 | Target: KAP1 | UniProt: P31321

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12479-50 | Target: KAP1 | UniProt: P31321 | TargetFullName: cAMP-dependent protein kinase type I-beta regulatory subunit | Organisim: human | Apparent_Kd_M: 2.24592E-11

Real

Aptamer SeqId:12480-9;Target:OTUD5;UniProt:Q96G74

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12480-9;Target: OTUD5;UniProt: Q96G74;TargetFullName: OTU domain-containing protein 5;Organisim: human;Apparent_Kd_M: 1.289452E-10

Real

Aptamer SeqId: 12480-9 | Target: OTUD5 | UniProt: Q96G74

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12480-9 | Target: OTUD5 | UniProt: Q96G74 | TargetFullName: OTU domain-containing protein 5 | Organisim: human | Apparent_Kd_M: 1.289452E-10

Real

Aptamer SeqId:12482-5;Target:BPTF;UniProt:Q12830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12482-5;Target: BPTF;UniProt: Q12830;TargetFullName: Nucleosome-remodeling factor subunit BPTF;Organisim: human;Apparent_Kd_M: 5.780334E-11

Real

Aptamer SeqId: 12482-5 | Target: BPTF | UniProt: Q12830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12482-5 | Target: BPTF | UniProt: Q12830 | TargetFullName: Nucleosome-remodeling factor subunit BPTF | Organisim: human | Apparent_Kd_M: 5.780334E-11

Real

Aptamer SeqId:12483-62;Target:RORB;UniProt:Q92753

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12483-62;Target: RORB;UniProt: Q92753;TargetFullName: Nuclear receptor ROR-beta;Organisim: human;Apparent_Kd_M: 4.435893E-11

Real

Aptamer SeqId: 12483-62 | Target: RORB | UniProt: Q92753

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12483-62 | Target: RORB | UniProt: Q92753 | TargetFullName: Nuclear receptor ROR-beta | Organisim: human | Apparent_Kd_M: 4.435893E-11

Real

Aptamer SeqId:12484-67;Target:PIPNB;UniProt:P48739

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12484-67;Target: PIPNB;UniProt: P48739;TargetFullName: Phosphatidylinositol transfer protein beta isoform;Organisim: human;Apparent_Kd_M: 2.261349E-11

Real

Aptamer SeqId: 12484-67 | Target: PIPNB | UniProt: P48739

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12484-67 | Target: PIPNB | UniProt: P48739 | TargetFullName: Phosphatidylinositol transfer protein beta isoform | Organisim: human | Apparent_Kd_M: 2.261349E-11

Real

Aptamer SeqId:12486-8;Target:GLRX2;UniProt:Q9NS18

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12486-8;Target: GLRX2;UniProt: Q9NS18;TargetFullName: Glutaredoxin-2; mitochondrial;Organisim: human;Apparent_Kd_M: 5.525319E-12

Real

Aptamer SeqId: 12486-8 | Target: GLRX2 | UniProt: Q9NS18

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12486-8 | Target: GLRX2 | UniProt: Q9NS18 | TargetFullName: Glutaredoxin-2; mitochondrial | Organisim: human | Apparent_Kd_M: 5.525319E-12

Real

Aptamer SeqId:12488-9;Target:MCTS1;UniProt:Q9ULC4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12488-9;Target: MCTS1;UniProt: Q9ULC4;TargetFullName: Malignant T-cell-amplified sequence 1;Organisim: human;Apparent_Kd_M: 6.614786E-11

Real

Aptamer SeqId: 12488-9 | Target: MCTS1 | UniProt: Q9ULC4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12488-9 | Target: MCTS1 | UniProt: Q9ULC4 | TargetFullName: Malignant T-cell-amplified sequence 1 | Organisim: human | Apparent_Kd_M: 6.614786E-11

Real

Aptamer SeqId:12490-92;Target:LTOR3;UniProt:Q9UHA4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12490-92;Target: LTOR3;UniProt: Q9UHA4;TargetFullName: Ragulator complex protein LAMTOR3;Organisim: human;Apparent_Kd_M: 2.274545E-10

Real

Aptamer SeqId: 12490-92 | Target: LTOR3 | UniProt: Q9UHA4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12490-92 | Target: LTOR3 | UniProt: Q9UHA4 | TargetFullName: Ragulator complex protein LAMTOR3 | Organisim: human | Apparent_Kd_M: 2.274545E-10

Real

Aptamer SeqId:12493-42;Target:OTUB2;UniProt:Q96DC9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12493-42;Target: OTUB2;UniProt: Q96DC9;TargetFullName: Ubiquitin thioesterase OTUB2;Organisim: human;Apparent_Kd_M: 1.1591E-11

Real

Aptamer SeqId: 12493-42 | Target: OTUB2 | UniProt: Q96DC9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12493-42 | Target: OTUB2 | UniProt: Q96DC9 | TargetFullName: Ubiquitin thioesterase OTUB2 | Organisim: human | Apparent_Kd_M: 1.1591E-11

Real

Aptamer SeqId:12494-99;Target:GBRL2;UniProt:P60520

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12494-99;Target: GBRL2;UniProt: P60520;TargetFullName: Gamma-aminobutyric acid receptor-associated protein-like 2;Organisim: human;Apparent_Kd_M: 1.340299E-12

Real

Aptamer SeqId: 12494-99 | Target: GBRL2 | UniProt: P60520

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12494-99 | Target: GBRL2 | UniProt: P60520 | TargetFullName: Gamma-aminobutyric acid receptor-associated protein-like 2 | Organisim: human | Apparent_Kd_M: 1.340299E-12

Real

Aptamer SeqId:12497-29;Target:SDOS;UniProt:Q9BRJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12497-29;Target: SDOS;UniProt: Q9BRJ7;TargetFullName: Tudor-interacting repair regulator protein;Organisim: human;Apparent_Kd_M: 4.067927E-12

Real

Aptamer SeqId: 12497-29 | Target: SDOS | UniProt: Q9BRJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12497-29 | Target: SDOS | UniProt: Q9BRJ7 | TargetFullName: Tudor-interacting repair regulator protein | Organisim: human | Apparent_Kd_M: 4.067927E-12

Real

Aptamer SeqId:12498-12;Target:TX1B3;UniProt:O14907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12498-12;Target: TX1B3;UniProt: O14907;TargetFullName: Tax1-binding protein 3;Organisim: human;Apparent_Kd_M: 2.687606E-11

Real

Aptamer SeqId: 12498-12 | Target: TX1B3 | UniProt: O14907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12498-12 | Target: TX1B3 | UniProt: O14907 | TargetFullName: Tax1-binding protein 3 | Organisim: human | Apparent_Kd_M: 2.687606E-11

Real

Aptamer SeqId:12499-108;Target:SH3G2;UniProt:Q99962

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12499-108;Target: SH3G2;UniProt: Q99962;TargetFullName: Endophilin-A1;Organisim: human;Apparent_Kd_M: 1.141512E-11

Real

Aptamer SeqId: 12499-108 | Target: SH3G2 | UniProt: Q99962

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12499-108 | Target: SH3G2 | UniProt: Q99962 | TargetFullName: Endophilin-A1 | Organisim: human | Apparent_Kd_M: 1.141512E-11

Real

Aptamer SeqId:12500-88;Target:SAE2;UniProt:Q9UBT2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12500-88;Target: SAE2;UniProt: Q9UBT2;TargetFullName: SUMO-activating enzyme subunit 2;Organisim: human;Apparent_Kd_M: 2.007443E-11

Real

Aptamer SeqId: 12500-88 | Target: SAE2 | UniProt: Q9UBT2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12500-88 | Target: SAE2 | UniProt: Q9UBT2 | TargetFullName: SUMO-activating enzyme subunit 2 | Organisim: human | Apparent_Kd_M: 2.007443E-11

Real

Aptamer SeqId:12501-10;Target:TBCA;UniProt:O75347

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12501-10;Target: TBCA;UniProt: O75347;TargetFullName: Tubulin-specific chaperone A;Organisim: human;Apparent_Kd_M: 1.568968E-11

Real

Aptamer SeqId: 12501-10 | Target: TBCA | UniProt: O75347

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12501-10 | Target: TBCA | UniProt: O75347 | TargetFullName: Tubulin-specific chaperone A | Organisim: human | Apparent_Kd_M: 1.568968E-11

Real

Aptamer SeqId:12503-5;Target:SPR1;UniProt:Q15743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12503-5;Target: SPR1;UniProt: Q15743;TargetFullName: Ovarian cancer G-protein coupled receptor 1;Organisim: human;Apparent_Kd_M: 5.822689E-11

Real

Aptamer SeqId: 12503-5 | Target: SPR1 | UniProt: Q15743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12503-5 | Target: SPR1 | UniProt: Q15743 | TargetFullName: Ovarian cancer G-protein coupled receptor 1 | Organisim: human | Apparent_Kd_M: 5.822689E-11

Real

Aptamer SeqId:12504-26;Target:LMOD1;UniProt:P29536

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12504-26;Target: LMOD1;UniProt: P29536;TargetFullName: Leiomodin-1;Organisim: human;Apparent_Kd_M: 4.278385E-12

Real

Aptamer SeqId: 12504-26 | Target: LMOD1 | UniProt: P29536

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12504-26 | Target: LMOD1 | UniProt: P29536 | TargetFullName: Leiomodin-1 | Organisim: human | Apparent_Kd_M: 4.278385E-12

Real

Aptamer SeqId:12507-16;Target:IP3KC;UniProt:Q96DU7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12507-16;Target: IP3KC;UniProt: Q96DU7;TargetFullName: Inositol-trisphosphate 3-kinase C;Organisim: human;Apparent_Kd_M: 1.041991E-10

Real

Aptamer SeqId: 12507-16 | Target: IP3KC | UniProt: Q96DU7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12507-16 | Target: IP3KC | UniProt: Q96DU7 | TargetFullName: Inositol-trisphosphate 3-kinase C | Organisim: human | Apparent_Kd_M: 1.041991E-10

Real

Aptamer SeqId:12508-9;Target:CHMP3;UniProt:Q9Y3E7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12508-9;Target: CHMP3;UniProt: Q9Y3E7;TargetFullName: Charged multivesicular body protein 3;Organisim: human;Apparent_Kd_M: 3.895319E-12

Real

Aptamer SeqId: 12508-9 | Target: CHMP3 | UniProt: Q9Y3E7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12508-9 | Target: CHMP3 | UniProt: Q9Y3E7 | TargetFullName: Charged multivesicular body protein 3 | Organisim: human | Apparent_Kd_M: 3.895319E-12

Real

Aptamer SeqId:12509-115;Target:COMD1;UniProt:Q8N668

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12509-115;Target: COMD1;UniProt: Q8N668;TargetFullName: COMM domain-containing protein 1;Organisim: human;Apparent_Kd_M: 2.723342E-11

Real

Aptamer SeqId: 12509-115 | Target: COMD1 | UniProt: Q8N668

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12509-115 | Target: COMD1 | UniProt: Q8N668 | TargetFullName: COMM domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.723342E-11

Real

Aptamer SeqId:12510-3;Target:STAP1;UniProt:Q9ULZ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12510-3;Target: STAP1;UniProt: Q9ULZ2;TargetFullName: Signal-transducing adaptor protein 1;Organisim: human;Apparent_Kd_M: 4.245091E-11

Real

Aptamer SeqId: 12510-3 | Target: STAP1 | UniProt: Q9ULZ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12510-3 | Target: STAP1 | UniProt: Q9ULZ2 | TargetFullName: Signal-transducing adaptor protein 1 | Organisim: human | Apparent_Kd_M: 4.245091E-11

Real

Aptamer SeqId:12511-83;Target:S41A2;UniProt:Q96JW4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12511-83;Target: S41A2;UniProt: Q96JW4;TargetFullName: Solute carrier family 41 member 2;Organisim: human;Apparent_Kd_M: 1.497555E-11

Real

Aptamer SeqId: 12511-83 | Target: S41A2 | UniProt: Q96JW4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12511-83 | Target: S41A2 | UniProt: Q96JW4 | TargetFullName: Solute carrier family 41 member 2 | Organisim: human | Apparent_Kd_M: 1.497555E-11

Real

Aptamer SeqId:12513-8;Target:GLTP;UniProt:Q9NZD2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12513-8;Target: GLTP;UniProt: Q9NZD2;TargetFullName: Glycolipid transfer protein;Organisim: human;Apparent_Kd_M: 4.574007E-12

Real

Aptamer SeqId: 12513-8 | Target: GLTP | UniProt: Q9NZD2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12513-8 | Target: GLTP | UniProt: Q9NZD2 | TargetFullName: Glycolipid transfer protein | Organisim: human | Apparent_Kd_M: 4.574007E-12

Real

Aptamer SeqId:12514-16;Target:METTL1;UniProt:Q9UBP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12514-16;Target: METTL1;UniProt: Q9UBP6;TargetFullName: tRNA (guanine-N(7)-)-methyltransferase;Organisim: human;Apparent_Kd_M: 3.690007E-12

Real

Aptamer SeqId: 12514-16 | Target: METTL1 | UniProt: Q9UBP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12514-16 | Target: METTL1 | UniProt: Q9UBP6 | TargetFullName: tRNA (guanine-N(7)-)-methyltransferase | Organisim: human | Apparent_Kd_M: 3.690007E-12

Real

Aptamer SeqId:12515-45;Target:UCK2;UniProt:Q9BZX2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12515-45;Target: UCK2;UniProt: Q9BZX2;TargetFullName: Uridine-cytidine kinase 2;Organisim: human;Apparent_Kd_M: 2.034347E-11

Real

Aptamer SeqId: 12515-45 | Target: UCK2 | UniProt: Q9BZX2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12515-45 | Target: UCK2 | UniProt: Q9BZX2 | TargetFullName: Uridine-cytidine kinase 2 | Organisim: human | Apparent_Kd_M: 2.034347E-11

Real

Aptamer SeqId:12516-13;Target:TEAD4;UniProt:Q15561

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12516-13;Target: TEAD4;UniProt: Q15561;TargetFullName: Transcriptional enhancer factor TEF-3;Organisim: human;Apparent_Kd_M: 3.556776E-12

Real

Aptamer SeqId: 12516-13 | Target: TEAD4 | UniProt: Q15561

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12516-13 | Target: TEAD4 | UniProt: Q15561 | TargetFullName: Transcriptional enhancer factor TEF-3 | Organisim: human | Apparent_Kd_M: 3.556776E-12

Real

Aptamer SeqId:12517-52;Target:TFAR19;UniProt:O14737

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12517-52;Target: TFAR19;UniProt: O14737;TargetFullName: Programmed cell death protein 5;Organisim: human;Apparent_Kd_M: 2.141943E-11

Real

Aptamer SeqId: 12517-52 | Target: TFAR19 | UniProt: O14737

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12517-52 | Target: TFAR19 | UniProt: O14737 | TargetFullName: Programmed cell death protein 5 | Organisim: human | Apparent_Kd_M: 2.141943E-11

Real

Aptamer SeqId:12518-289;Target:PB1;UniProt:Q86U86

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12518-289;Target: PB1;UniProt: Q86U86;TargetFullName: Protein polybromo-1;Organisim: human;Apparent_Kd_M: 2.496419E-12

Real

Aptamer SeqId: 12518-289 | Target: PB1 | UniProt: Q86U86

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12518-289 | Target: PB1 | UniProt: Q86U86 | TargetFullName: Protein polybromo-1 | Organisim: human | Apparent_Kd_M: 2.496419E-12

Real

Aptamer SeqId:12521-3;Target:CDN2C;UniProt:P42773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12521-3;Target: CDN2C;UniProt: P42773;TargetFullName: Cyclin-dependent kinase 4 inhibitor C;Organisim: human;Apparent_Kd_M: 3.082374E-10

Real

Aptamer SeqId: 12521-3 | Target: CDN2C | UniProt: P42773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12521-3 | Target: CDN2C | UniProt: P42773 | TargetFullName: Cyclin-dependent kinase 4 inhibitor C | Organisim: human | Apparent_Kd_M: 3.082374E-10

Real

Aptamer SeqId:12522-6;Target:RD23B;UniProt:P54727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12522-6;Target: RD23B;UniProt: P54727;TargetFullName: UV excision repair protein RAD23 homolog B;Organisim: human;Apparent_Kd_M: 7.914259E-12

Real

Aptamer SeqId: 12522-6 | Target: RD23B | UniProt: P54727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12522-6 | Target: RD23B | UniProt: P54727 | TargetFullName: UV excision repair protein RAD23 homolog B | Organisim: human | Apparent_Kd_M: 7.914259E-12

Real

Aptamer SeqId:12524-18;Target:SAT2;UniProt:Q96F10

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12524-18;Target: SAT2;UniProt: Q96F10;TargetFullName: Diamine acetyltransferase 2;Organisim: human;Apparent_Kd_M: 1.161003E-12

Real

Aptamer SeqId: 12524-18 | Target: SAT2 | UniProt: Q96F10

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12524-18 | Target: SAT2 | UniProt: Q96F10 | TargetFullName: Diamine acetyltransferase 2 | Organisim: human | Apparent_Kd_M: 1.161003E-12

Real

Aptamer SeqId:12527-50;Target:THA;UniProt:P10827

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12527-50;Target: THA;UniProt: P10827;TargetFullName: Thyroid hormone receptor alpha;Organisim: human;Apparent_Kd_M: 2.065385E-10

Real

Aptamer SeqId: 12527-50 | Target: THA | UniProt: P10827

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12527-50 | Target: THA | UniProt: P10827 | TargetFullName: Thyroid hormone receptor alpha | Organisim: human | Apparent_Kd_M: 2.065385E-10

Real

Aptamer SeqId:12528-40;Target:WRIP1;UniProt:Q96S55

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12528-40;Target: WRIP1;UniProt: Q96S55;TargetFullName: ATPase WRNIP1;Organisim: human;Apparent_Kd_M: 1.411507E-12

Real

Aptamer SeqId: 12528-40 | Target: WRIP1 | UniProt: Q96S55

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12528-40 | Target: WRIP1 | UniProt: Q96S55 | TargetFullName: ATPase WRNIP1 | Organisim: human | Apparent_Kd_M: 1.411507E-12

Real

Aptamer SeqId:12529-32;Target:FKBP6;UniProt:O75344

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12529-32;Target: FKBP6;UniProt: O75344;TargetFullName: Inactive peptidyl-prolyl cis-trans isomerase FKBP6;Organisim: human;Apparent_Kd_M: 3.440024E-11

Real

Aptamer SeqId: 12529-32 | Target: FKBP6 | UniProt: O75344

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12529-32 | Target: FKBP6 | UniProt: O75344 | TargetFullName: Inactive peptidyl-prolyl cis-trans isomerase FKBP6 | Organisim: human | Apparent_Kd_M: 3.440024E-11

Real

Aptamer SeqId:12530-14;Target:CKS-1;UniProt:P61024

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12530-14;Target: CKS-1;UniProt: P61024;TargetFullName: Cyclin-dependent kinases regulatory subunit 1;Organisim: human;Apparent_Kd_M: 3.036649E-12

Real

Aptamer SeqId: 12530-14 | Target: CKS-1 | UniProt: P61024

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12530-14 | Target: CKS-1 | UniProt: P61024 | TargetFullName: Cyclin-dependent kinases regulatory subunit 1 | Organisim: human | Apparent_Kd_M: 3.036649E-12

Real

Aptamer SeqId:12531-5;Target:ERVV1;UniProt:B6SEH8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12531-5;Target: ERVV1;UniProt: B6SEH8;TargetFullName: Endogenous retrovirus group V member 1 Env polyprotein;Organisim: human;Apparent_Kd_M: 2.998967E-11

Real

Aptamer SeqId: 12531-5 | Target: ERVV1 | UniProt: B6SEH8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12531-5 | Target: ERVV1 | UniProt: B6SEH8 | TargetFullName: Endogenous retrovirus group V member 1 Env polyprotein | Organisim: human | Apparent_Kd_M: 2.998967E-11

Real

Aptamer SeqId:12532-28;Target:UB2R1;UniProt:P49427

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12532-28;Target: UB2R1;UniProt: P49427;TargetFullName: Ubiquitin-conjugating enzyme E2 R1;Organisim: human;Apparent_Kd_M: 2.274402E-11

Real

Aptamer SeqId: 12532-28 | Target: UB2R1 | UniProt: P49427

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12532-28 | Target: UB2R1 | UniProt: P49427 | TargetFullName: Ubiquitin-conjugating enzyme E2 R1 | Organisim: human | Apparent_Kd_M: 2.274402E-11

Real

Aptamer SeqId:12533-135;Target:CYH2;UniProt:Q99418

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12533-135;Target: CYH2;UniProt: Q99418;TargetFullName: Cytohesin-2;Organisim: human;Apparent_Kd_M: 5.342089E-12

Real

Aptamer SeqId: 12533-135 | Target: CYH2 | UniProt: Q99418

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12533-135 | Target: CYH2 | UniProt: Q99418 | TargetFullName: Cytohesin-2 | Organisim: human | Apparent_Kd_M: 5.342089E-12

Real

Aptamer SeqId:12534-10;Target:CACO2;UniProt:Q13137

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12534-10;Target: CACO2;UniProt: Q13137;TargetFullName: Calcium-binding and coiled-coil domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.128326E-12

Real

Aptamer SeqId: 12534-10 | Target: CACO2 | UniProt: Q13137

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12534-10 | Target: CACO2 | UniProt: Q13137 | TargetFullName: Calcium-binding and coiled-coil domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.128326E-12

Real

Aptamer SeqId:12535-2;Target:XRCC1;UniProt:P18887

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12535-2;Target: XRCC1;UniProt: P18887;TargetFullName: DNA repair protein XRCC1;Organisim: human;Apparent_Kd_M: 3.137685E-11

Real

Aptamer SeqId: 12535-2 | Target: XRCC1 | UniProt: P18887

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12535-2 | Target: XRCC1 | UniProt: P18887 | TargetFullName: DNA repair protein XRCC1 | Organisim: human | Apparent_Kd_M: 3.137685E-11

Real

Aptamer SeqId:12536-46;Target:MTMR6;UniProt:Q9Y217

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12536-46;Target: MTMR6;UniProt: Q9Y217;TargetFullName: Myotubularin-related protein 6;Organisim: human;Apparent_Kd_M: 4.394765E-12

Real

Aptamer SeqId: 12536-46 | Target: MTMR6 | UniProt: Q9Y217

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12536-46 | Target: MTMR6 | UniProt: Q9Y217 | TargetFullName: Myotubularin-related protein 6 | Organisim: human | Apparent_Kd_M: 4.394765E-12

Real

Aptamer SeqId:12537-88;Target:PURA;UniProt:Q00577

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12537-88;Target: PURA;UniProt: Q00577;TargetFullName: Transcriptional activator protein Pur-alpha;Organisim: human;Apparent_Kd_M: 1.382628E-11

Real

Aptamer SeqId: 12537-88 | Target: PURA | UniProt: Q00577

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12537-88 | Target: PURA | UniProt: Q00577 | TargetFullName: Transcriptional activator protein Pur-alpha | Organisim: human | Apparent_Kd_M: 1.382628E-11

Real

Aptamer SeqId:12538-19;Target:RGS7;UniProt:P49802

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12538-19;Target: RGS7;UniProt: P49802;TargetFullName: Regulator of G-protein signaling 7;Organisim: human;Apparent_Kd_M: 2.662997E-12

Real

Aptamer SeqId: 12538-19 | Target: RGS7 | UniProt: P49802

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12538-19 | Target: RGS7 | UniProt: P49802 | TargetFullName: Regulator of G-protein signaling 7 | Organisim: human | Apparent_Kd_M: 2.662997E-12

Real

Aptamer SeqId:12540-25;Target:RHOG;UniProt:P84095

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12540-25;Target: RHOG;UniProt: P84095;TargetFullName: Rho-related GTP-binding protein RhoG;Organisim: human;Apparent_Kd_M: 3.791045E-11

Real

Aptamer SeqId: 12540-25 | Target: RHOG | UniProt: P84095

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12540-25 | Target: RHOG | UniProt: P84095 | TargetFullName: Rho-related GTP-binding protein RhoG | Organisim: human | Apparent_Kd_M: 3.791045E-11

Real

Aptamer SeqId:12543-76;Target:ZN560;UniProt:Q96MR9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12543-76;Target: ZN560;UniProt: Q96MR9;TargetFullName: Zinc finger protein 560;Organisim: human;Apparent_Kd_M: 3.021541E-12

Real

Aptamer SeqId: 12543-76 | Target: ZN560 | UniProt: Q96MR9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12543-76 | Target: ZN560 | UniProt: Q96MR9 | TargetFullName: Zinc finger protein 560 | Organisim: human | Apparent_Kd_M: 3.021541E-12

Real

Aptamer SeqId:12546-1;Target:SMTN;UniProt:P53814

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12546-1;Target: SMTN;UniProt: P53814;TargetFullName: Smoothelin;Organisim: human;Apparent_Kd_M: 4.487986E-12

Real

Aptamer SeqId: 12546-1 | Target: SMTN | UniProt: P53814

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12546-1 | Target: SMTN | UniProt: P53814 | TargetFullName: Smoothelin | Organisim: human | Apparent_Kd_M: 4.487986E-12

Real

Aptamer SeqId:12548-75;Target:RRAGC;UniProt:Q9HB90

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12548-75;Target: RRAGC;UniProt: Q9HB90;TargetFullName: Ras-related GTP-binding protein C;Organisim: human;Apparent_Kd_M: 5.094915E-13

Real

Aptamer SeqId: 12548-75 | Target: RRAGC | UniProt: Q9HB90

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12548-75 | Target: RRAGC | UniProt: Q9HB90 | TargetFullName: Ras-related GTP-binding protein C | Organisim: human | Apparent_Kd_M: 5.094915E-13

Real

Aptamer SeqId:12549-33;Target:PTGD2;UniProt:O60760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12549-33;Target: PTGD2;UniProt: O60760;TargetFullName: Hematopoietic prostaglandin D synthase;Organisim: human;Apparent_Kd_M: 1.54E-12

Real

Aptamer SeqId: 12549-33 | Target: PTGD2 | UniProt: O60760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12549-33 | Target: PTGD2 | UniProt: O60760 | TargetFullName: Hematopoietic prostaglandin D synthase | Organisim: human | Apparent_Kd_M: 1.54E-12

Real

Aptamer SeqId:12551-3;Target:ITCH;UniProt:Q96J02

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12551-3;Target: ITCH;UniProt: Q96J02;TargetFullName: E3 ubiquitin-protein ligase Itchy homolog;Organisim: human;Apparent_Kd_M: 1.675886E-10

Real

Aptamer SeqId: 12551-3 | Target: ITCH | UniProt: Q96J02

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12551-3 | Target: ITCH | UniProt: Q96J02 | TargetFullName: E3 ubiquitin-protein ligase Itchy homolog | Organisim: human | Apparent_Kd_M: 1.675886E-10

Real

Aptamer SeqId:12553-5;Target:VRK1;UniProt:Q99986

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12553-5;Target: VRK1;UniProt: Q99986;TargetFullName: Serine/threonine-protein kinase VRK1;Organisim: human;Apparent_Kd_M: 4.77347E-11

Real

Aptamer SeqId: 12553-5 | Target: VRK1 | UniProt: Q99986

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12553-5 | Target: VRK1 | UniProt: Q99986 | TargetFullName: Serine/threonine-protein kinase VRK1 | Organisim: human | Apparent_Kd_M: 4.77347E-11

Real

Aptamer SeqId:12554-10;Target:RA51D;UniProt:O75771

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12554-10;Target: RA51D;UniProt: O75771;TargetFullName: DNA repair protein RAD51 homolog 4;Organisim: human;Apparent_Kd_M: 8.93053E-13

Real

Aptamer SeqId: 12554-10 | Target: RA51D | UniProt: O75771

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12554-10 | Target: RA51D | UniProt: O75771 | TargetFullName: DNA repair protein RAD51 homolog 4 | Organisim: human | Apparent_Kd_M: 8.93053E-13

Real

Aptamer SeqId:12556-7;Target:UBE2C;UniProt:O00762

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12556-7;Target: UBE2C;UniProt: O00762;TargetFullName: Ubiquitin-conjugating enzyme E2 C;Organisim: human;Apparent_Kd_M: 1.160877E-10

Real

Aptamer SeqId: 12556-7 | Target: UBE2C | UniProt: O00762

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12556-7 | Target: UBE2C | UniProt: O00762 | TargetFullName: Ubiquitin-conjugating enzyme E2 C | Organisim: human | Apparent_Kd_M: 1.160877E-10

Real

Aptamer SeqId:12557-18;Target:NOVA1;UniProt:P51513

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12557-18;Target: NOVA1;UniProt: P51513;TargetFullName: RNA-binding protein Nova-1;Organisim: human;Apparent_Kd_M: 4.7819E-13

Real

Aptamer SeqId: 12557-18 | Target: NOVA1 | UniProt: P51513

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12557-18 | Target: NOVA1 | UniProt: P51513 | TargetFullName: RNA-binding protein Nova-1 | Organisim: human | Apparent_Kd_M: 4.7819E-13

Real

Aptamer SeqId:12558-3;Target:UBS3B;UniProt:Q8TF42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12558-3;Target: UBS3B;UniProt: Q8TF42;TargetFullName: Ubiquitin-associated and SH3 domain-containing protein B;Organisim: human;Apparent_Kd_M: 1.25975E-12

Real

Aptamer SeqId: 12558-3 | Target: UBS3B | UniProt: Q8TF42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12558-3 | Target: UBS3B | UniProt: Q8TF42 | TargetFullName: Ubiquitin-associated and SH3 domain-containing protein B | Organisim: human | Apparent_Kd_M: 1.25975E-12

Real

Aptamer SeqId:12560-9;Target:NT5C;UniProt:Q8TCD5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12560-9;Target: NT5C;UniProt: Q8TCD5;TargetFullName: 5(3)-deoxyribonucleotidase; cytosolic type;Organisim: human;Apparent_Kd_M: 7.559983E-12

Real

Aptamer SeqId: 12560-9 | Target: NT5C | UniProt: Q8TCD5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12560-9 | Target: NT5C | UniProt: Q8TCD5 | TargetFullName: 5'(3')-deoxyribonucleotidase; cytosolic type | Organisim: human | Apparent_Kd_M: 7.559983E-12

Real

Aptamer SeqId:12562-1;Target:PKN1;UniProt:Q16512

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12562-1;Target: PKN1;UniProt: Q16512;TargetFullName: Serine/threonine-protein kinase N1;Organisim: human;Apparent_Kd_M: 5.227653E-12

Real

Aptamer SeqId: 12562-1 | Target: PKN1 | UniProt: Q16512

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12562-1 | Target: PKN1 | UniProt: Q16512 | TargetFullName: Serine/threonine-protein kinase N1 | Organisim: human | Apparent_Kd_M: 5.227653E-12

Real

Aptamer SeqId:12563-2;Target:TFIP8;UniProt:O95379

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12563-2;Target: TFIP8;UniProt: O95379;TargetFullName: Tumor necrosis factor alpha-induced protein 8;Organisim: human;Apparent_Kd_M: 8.035078E-12

Real

Aptamer SeqId: 12563-2 | Target: TFIP8 | UniProt: O95379

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12563-2 | Target: TFIP8 | UniProt: O95379 | TargetFullName: Tumor necrosis factor alpha-induced protein 8 | Organisim: human | Apparent_Kd_M: 8.035078E-12

Real

Aptamer SeqId:12564-9;Target:NIP7;UniProt:Q9Y221

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12564-9;Target: NIP7;UniProt: Q9Y221;TargetFullName: 60S ribosome subunit biogenesis protein NIP7 homolog;Organisim: human;Apparent_Kd_M: 4.802456E-12

Real

Aptamer SeqId: 12564-9 | Target: NIP7 | UniProt: Q9Y221

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12564-9 | Target: NIP7 | UniProt: Q9Y221 | TargetFullName: 60S ribosome subunit biogenesis protein NIP7 homolog | Organisim: human | Apparent_Kd_M: 4.802456E-12

Real

Aptamer SeqId:12568-14;Target:KEAP1;UniProt:Q14145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12568-14;Target: KEAP1;UniProt: Q14145;TargetFullName: Kelch-like ECH-associated protein 1;Organisim: human;Apparent_Kd_M: 6.786016E-12

Real

Aptamer SeqId: 12568-14 | Target: KEAP1 | UniProt: Q14145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12568-14 | Target: KEAP1 | UniProt: Q14145 | TargetFullName: Kelch-like ECH-associated protein 1 | Organisim: human | Apparent_Kd_M: 6.786016E-12

Real

Aptamer SeqId:12569-25;Target:TCP-1-epsilon;UniProt:P48643

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12569-25;Target: TCP-1-epsilon;UniProt: P48643;TargetFullName: T-complex protein 1 subunit epsilon;Organisim: human;Apparent_Kd_M: 8.858026E-12

Real

Aptamer SeqId: 12569-25 | Target: TCP-1-epsilon | UniProt: P48643

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12569-25 | Target: TCP-1-epsilon | UniProt: P48643 | TargetFullName: T-complex protein 1 subunit epsilon | Organisim: human | Apparent_Kd_M: 8.858026E-12

Real

Aptamer SeqId:12571-14;Target:ARL3;UniProt:P36405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12571-14;Target: ARL3;UniProt: P36405;TargetFullName: ADP-ribosylation factor-like protein 3;Organisim: human;Apparent_Kd_M: 2.691809E-11

Real

Aptamer SeqId: 12571-14 | Target: ARL3 | UniProt: P36405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12571-14 | Target: ARL3 | UniProt: P36405 | TargetFullName: ADP-ribosylation factor-like protein 3 | Organisim: human | Apparent_Kd_M: 2.691809E-11

Real

Aptamer SeqId:12572-236;Target:EFS;UniProt:O43281

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12572-236;Target: EFS;UniProt: O43281;TargetFullName: Embryonal Fyn-associated substrate;Organisim: human;Apparent_Kd_M: 1.349348E-11

Real

Aptamer SeqId: 12572-236 | Target: EFS | UniProt: O43281

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12572-236 | Target: EFS | UniProt: O43281 | TargetFullName: Embryonal Fyn-associated substrate | Organisim: human | Apparent_Kd_M: 1.349348E-11

Real

Aptamer SeqId:12573-80;Target:TRIM3;UniProt:O75382

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12573-80;Target: TRIM3;UniProt: O75382;TargetFullName: Tripartite motif-containing protein 3;Organisim: human;Apparent_Kd_M: 9.259938E-13

Real

Aptamer SeqId: 12573-80 | Target: TRIM3 | UniProt: O75382

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12573-80 | Target: TRIM3 | UniProt: O75382 | TargetFullName: Tripartite motif-containing protein 3 | Organisim: human | Apparent_Kd_M: 9.259938E-13

Real

Aptamer SeqId:12574-36;Target:Endothelin 2;UniProt:P20800

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12574-36;Target: Endothelin 2;UniProt: P20800;TargetFullName: Endothelin-2;Organisim: human;Apparent_Kd_M: 1.580506E-11

Real

Aptamer SeqId: 12574-36 | Target: Endothelin 2 | UniProt: P20800

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12574-36 | Target: Endothelin 2 | UniProt: P20800 | TargetFullName: Endothelin-2 | Organisim: human | Apparent_Kd_M: 1.580506E-11

Real

Aptamer SeqId:12575-30;Target:C1TC;UniProt:P11586

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12575-30;Target: C1TC;UniProt: P11586;TargetFullName: C-1-tetrahydrofolate synthase; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.92E-12

Real

Aptamer SeqId: 12575-30 | Target: C1TC | UniProt: P11586

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12575-30 | Target: C1TC | UniProt: P11586 | TargetFullName: C-1-tetrahydrofolate synthase; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.92E-12

Real

Aptamer SeqId:12576-21;Target:MAGE-3;UniProt:P43357

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12576-21;Target: MAGE-3;UniProt: P43357;TargetFullName: Melanoma-associated antigen 3;Organisim: human;Apparent_Kd_M: 1.107127E-11

Real

Aptamer SeqId: 12576-21 | Target: MAGE-3 | UniProt: P43357

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12576-21 | Target: MAGE-3 | UniProt: P43357 | TargetFullName: Melanoma-associated antigen 3 | Organisim: human | Apparent_Kd_M: 1.107127E-11

Real

Aptamer SeqId:12577-100;Target:FLAP endonuclease-1;UniProt:P39748

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12577-100;Target: FLAP endonuclease-1;UniProt: P39748;TargetFullName: Flap endonuclease 1;Organisim: human;Apparent_Kd_M: 3.330899E-11

Real

Aptamer SeqId: 12577-100 | Target: FLAP endonuclease-1 | UniProt: P39748

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12577-100 | Target: FLAP endonuclease-1 | UniProt: P39748 | TargetFullName: Flap endonuclease 1 | Organisim: human | Apparent_Kd_M: 3.330899E-11

Real

Aptamer SeqId:12578-13;Target:ARF3;UniProt:P61204

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12578-13;Target: ARF3;UniProt: P61204;TargetFullName: ADP-ribosylation factor 3;Organisim: human;Apparent_Kd_M: 1.190505E-12

Real

Aptamer SeqId: 12578-13 | Target: ARF3 | UniProt: P61204

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12578-13 | Target: ARF3 | UniProt: P61204 | TargetFullName: ADP-ribosylation factor 3 | Organisim: human | Apparent_Kd_M: 1.190505E-12

Real

Aptamer SeqId:12580-7;Target:PSB5;UniProt:P28074

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12580-7;Target: PSB5;UniProt: P28074;TargetFullName: Proteasome subunit beta type-5;Organisim: human;Apparent_Kd_M: 1.406713E-10

Real

Aptamer SeqId: 12580-7 | Target: PSB5 | UniProt: P28074

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12580-7 | Target: PSB5 | UniProt: P28074 | TargetFullName: Proteasome subunit beta type-5 | Organisim: human | Apparent_Kd_M: 1.406713E-10

Real

Aptamer SeqId:12581-39;Target:IMPA2;UniProt:O14732

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12581-39;Target: IMPA2;UniProt: O14732;TargetFullName: Inositol monophosphatase 2;Organisim: human;Apparent_Kd_M: 2.425769E-12

Real

Aptamer SeqId: 12581-39 | Target: IMPA2 | UniProt: O14732

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12581-39 | Target: IMPA2 | UniProt: O14732 | TargetFullName: Inositol monophosphatase 2 | Organisim: human | Apparent_Kd_M: 2.425769E-12

Real

Aptamer SeqId:12583-77;Target:ARAF;UniProt:P10398

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12583-77;Target: ARAF;UniProt: P10398;TargetFullName: Serine/threonine-protein kinase A-Raf;Organisim: human;Apparent_Kd_M: 5.041812E-12

Real

Aptamer SeqId: 12583-77 | Target: ARAF | UniProt: P10398

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12583-77 | Target: ARAF | UniProt: P10398 | TargetFullName: Serine/threonine-protein kinase A-Raf | Organisim: human | Apparent_Kd_M: 5.041812E-12

Real

Aptamer SeqId:12585-39;Target:ERCC1;UniProt:P07992

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12585-39;Target: ERCC1;UniProt: P07992;TargetFullName: DNA excision repair protein ERCC-1;Organisim: human;Apparent_Kd_M: 2.900142E-11

Real

Aptamer SeqId: 12585-39 | Target: ERCC1 | UniProt: P07992

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12585-39 | Target: ERCC1 | UniProt: P07992 | TargetFullName: DNA excision repair protein ERCC-1 | Organisim: human | Apparent_Kd_M: 2.900142E-11

Real

Aptamer SeqId:12587-65;Target:ARL2;UniProt:P36404

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12587-65;Target: ARL2;UniProt: P36404;TargetFullName: ADP-ribosylation factor-like protein 2;Organisim: human;Apparent_Kd_M: 1.303963E-10

Real

Aptamer SeqId: 12587-65 | Target: ARL2 | UniProt: P36404

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12587-65 | Target: ARL2 | UniProt: P36404 | TargetFullName: ADP-ribosylation factor-like protein 2 | Organisim: human | Apparent_Kd_M: 1.303963E-10

Real

Aptamer SeqId:12590-67;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12590-67;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.435277E-11

Real

Aptamer SeqId: 12590-67 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12590-67 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.435277E-11

Real

Aptamer SeqId:12591-27;Target:Oligophrenin-1;UniProt:O60890

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12591-27;Target: Oligophrenin-1;UniProt: O60890;TargetFullName: Oligophrenin-1;Organisim: human;Apparent_Kd_M: 6.091172E-13

Real

Aptamer SeqId: 12591-27 | Target: Oligophrenin-1 | UniProt: O60890

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12591-27 | Target: Oligophrenin-1 | UniProt: O60890 | TargetFullName: Oligophrenin-1 | Organisim: human | Apparent_Kd_M: 6.091172E-13

Real

Aptamer SeqId:12593-33;Target:PDRG1;UniProt:Q9NUG6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12593-33;Target: PDRG1;UniProt: Q9NUG6;TargetFullName: p53 and DNA damage-regulated protein 1;Organisim: human;Apparent_Kd_M: 1.329381E-11

Real

Aptamer SeqId: 12593-33 | Target: PDRG1 | UniProt: Q9NUG6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12593-33 | Target: PDRG1 | UniProt: Q9NUG6 | TargetFullName: p53 and DNA damage-regulated protein 1 | Organisim: human | Apparent_Kd_M: 1.329381E-11

Real

Aptamer SeqId:12594-5;Target:GRAN;UniProt:P28676

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12594-5;Target: GRAN;UniProt: P28676;TargetFullName: Grancalcin;Organisim: human;Apparent_Kd_M: 6.678882E-12

Real

Aptamer SeqId: 12594-5 | Target: GRAN | UniProt: P28676

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12594-5 | Target: GRAN | UniProt: P28676 | TargetFullName: Grancalcin | Organisim: human | Apparent_Kd_M: 6.678882E-12

Real

Aptamer SeqId:12595-11;Target:TMOD1;UniProt:P28289

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12595-11;Target: TMOD1;UniProt: P28289;TargetFullName: Tropomodulin-1;Organisim: human;Apparent_Kd_M: 2.025523E-12

Real

Aptamer SeqId: 12595-11 | Target: TMOD1 | UniProt: P28289

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12595-11 | Target: TMOD1 | UniProt: P28289 | TargetFullName: Tropomodulin-1 | Organisim: human | Apparent_Kd_M: 2.025523E-12

Real

Aptamer SeqId:12597-68;Target:Autophagy protein 5;UniProt:Q9H1Y0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12597-68;Target: Autophagy protein 5;UniProt: Q9H1Y0;TargetFullName: Autophagy protein 5;Organisim: human;Apparent_Kd_M: 1.048805E-11

Real

Aptamer SeqId: 12597-68 | Target: Autophagy protein 5 | UniProt: Q9H1Y0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12597-68 | Target: Autophagy protein 5 | UniProt: Q9H1Y0 | TargetFullName: Autophagy protein 5 | Organisim: human | Apparent_Kd_M: 1.048805E-11

Real

Aptamer SeqId:12599-10;Target:URP2;UniProt:Q86UX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12599-10;Target: URP2;UniProt: Q86UX7;TargetFullName: Fermitin family homolog 3;Organisim: human;Apparent_Kd_M: 4.161688E-11

Real

Aptamer SeqId: 12599-10 | Target: URP2 | UniProt: Q86UX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12599-10 | Target: URP2 | UniProt: Q86UX7 | TargetFullName: Fermitin family homolog 3 | Organisim: human | Apparent_Kd_M: 4.161688E-11

Real

Aptamer SeqId:12603-87;Target:PABP4;UniProt:Q13310

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12603-87;Target: PABP4;UniProt: Q13310;TargetFullName: Polyadenylate-binding protein 4;Organisim: human;Apparent_Kd_M: 3.064232E-12

Real

Aptamer SeqId: 12603-87 | Target: PABP4 | UniProt: Q13310

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12603-87 | Target: PABP4 | UniProt: Q13310 | TargetFullName: Polyadenylate-binding protein 4 | Organisim: human | Apparent_Kd_M: 3.064232E-12

Real

Aptamer SeqId:12604-16;Target:SCMH1;UniProt:Q96GD3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12604-16;Target: SCMH1;UniProt: Q96GD3;TargetFullName: Polycomb protein SCMH1;Organisim: human;Apparent_Kd_M: 5.041708E-13

Real

Aptamer SeqId: 12604-16 | Target: SCMH1 | UniProt: Q96GD3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12604-16 | Target: SCMH1 | UniProt: Q96GD3 | TargetFullName: Polycomb protein SCMH1 | Organisim: human | Apparent_Kd_M: 5.041708E-13

Real

Aptamer SeqId:12605-1;Target:Exosome component 3;UniProt:Q9NQT5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12605-1;Target: Exosome component 3;UniProt: Q9NQT5;TargetFullName: Exosome complex component RRP40;Organisim: human;Apparent_Kd_M: 9.14872E-12

Real

Aptamer SeqId: 12605-1 | Target: Exosome component 3 | UniProt: Q9NQT5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12605-1 | Target: Exosome component 3 | UniProt: Q9NQT5 | TargetFullName: Exosome complex component RRP40 | Organisim: human | Apparent_Kd_M: 9.14872E-12

Real

Aptamer SeqId:12612-37;Target:PSB1;UniProt:P20618

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12612-37;Target: PSB1;UniProt: P20618;TargetFullName: Proteasome subunit beta type-1;Organisim: human;Apparent_Kd_M: 5.872088E-12

Real

Aptamer SeqId: 12612-37 | Target: PSB1 | UniProt: P20618

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12612-37 | Target: PSB1 | UniProt: P20618 | TargetFullName: Proteasome subunit beta type-1 | Organisim: human | Apparent_Kd_M: 5.872088E-12

Real

Aptamer SeqId:12616-45;Target:NRBP;UniProt:Q9UHY1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12616-45;Target: NRBP;UniProt: Q9UHY1;TargetFullName: Nuclear receptor-binding protein;Organisim: human;Apparent_Kd_M: 1.150009E-11

Real

Aptamer SeqId: 12616-45 | Target: NRBP | UniProt: Q9UHY1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12616-45 | Target: NRBP | UniProt: Q9UHY1 | TargetFullName: Nuclear receptor-binding protein | Organisim: human | Apparent_Kd_M: 1.150009E-11

Real

Aptamer SeqId:12617-2;Target:STK24;UniProt:Q9Y6E0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12617-2;Target: STK24;UniProt: Q9Y6E0;TargetFullName: Serine/threonine-protein kinase 24;Organisim: human;Apparent_Kd_M: 1.45173E-12

Real

Aptamer SeqId: 12617-2 | Target: STK24 | UniProt: Q9Y6E0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12617-2 | Target: STK24 | UniProt: Q9Y6E0 | TargetFullName: Serine/threonine-protein kinase 24 | Organisim: human | Apparent_Kd_M: 1.45173E-12

Real

Aptamer SeqId:12618-50;Target:Aldo-keto reductase 1C1;UniProt:Q04828

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12618-50;Target: Aldo-keto reductase 1C1;UniProt: Q04828;TargetFullName: Aldo-keto reductase family 1 member C1;Organisim: human;Apparent_Kd_M: 2.472798E-11

Real

Aptamer SeqId: 12618-50 | Target: Aldo-keto reductase 1C1 | UniProt: Q04828

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12618-50 | Target: Aldo-keto reductase 1C1 | UniProt: Q04828 | TargetFullName: Aldo-keto reductase family 1 member C1 | Organisim: human | Apparent_Kd_M: 2.472798E-11

Real

Aptamer SeqId:12619-14;Target:Protein phophatase 2Ca;UniProt:P35813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12619-14;Target: Protein phophatase 2Ca;UniProt: P35813;TargetFullName: Protein phosphatase 1A;Organisim: human;Apparent_Kd_M: 8.190032E-11

Real

Aptamer SeqId: 12619-14 | Target: Protein phophatase 2Ca | UniProt: P35813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12619-14 | Target: Protein phophatase 2Ca | UniProt: P35813 | TargetFullName: Protein phosphatase 1A | Organisim: human | Apparent_Kd_M: 8.190032E-11

Real

Aptamer SeqId:12620-3;Target:Septin-11;UniProt:Q9NVA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12620-3;Target: Septin-11;UniProt: Q9NVA2;TargetFullName: Septin-11;Organisim: human;Apparent_Kd_M: 1.668901E-11

Real

Aptamer SeqId: 12620-3 | Target: Septin-11 | UniProt: Q9NVA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12620-3 | Target: Septin-11 | UniProt: Q9NVA2 | TargetFullName: Septin-11 | Organisim: human | Apparent_Kd_M: 1.668901E-11

Real

Aptamer SeqId:12621-55;Target:PP2AAA;UniProt:P30153

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12621-55;Target: PP2AAA;UniProt: P30153;TargetFullName: Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform;Organisim: human;Apparent_Kd_M: 1.347587E-11

Real

Aptamer SeqId: 12621-55 | Target: PP2AAA | UniProt: P30153

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12621-55 | Target: PP2AAA | UniProt: P30153 | TargetFullName: Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform | Organisim: human | Apparent_Kd_M: 1.347587E-11

Real

Aptamer SeqId:12622-96;Target:ASH1L;UniProt:Q9NR48

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12622-96;Target: ASH1L;UniProt: Q9NR48;TargetFullName: Histone-lysine N-methyltransferase ASH1L;Organisim: human;Apparent_Kd_M: 2.011191E-12

Real

Aptamer SeqId: 12622-96 | Target: ASH1L | UniProt: Q9NR48

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12622-96 | Target: ASH1L | UniProt: Q9NR48 | TargetFullName: Histone-lysine N-methyltransferase ASH1L | Organisim: human | Apparent_Kd_M: 2.011191E-12

Real

Aptamer SeqId:12623-84;Target:JARD2;UniProt:Q92833

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12623-84;Target: JARD2;UniProt: Q92833;TargetFullName: Protein Jumonji;Organisim: human;Apparent_Kd_M: 4.996536E-11

Real

Aptamer SeqId: 12623-84 | Target: JARD2 | UniProt: Q92833

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12623-84 | Target: JARD2 | UniProt: Q92833 | TargetFullName: Protein Jumonji | Organisim: human | Apparent_Kd_M: 4.996536E-11

Real

Aptamer SeqId:12625-138;Target:KLHL7;UniProt:Q8IXQ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12625-138;Target: KLHL7;UniProt: Q8IXQ5;TargetFullName: Kelch-like protein 7;Organisim: human;Apparent_Kd_M: 1.626664E-11

Real

Aptamer SeqId: 12625-138 | Target: KLHL7 | UniProt: Q8IXQ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12625-138 | Target: KLHL7 | UniProt: Q8IXQ5 | TargetFullName: Kelch-like protein 7 | Organisim: human | Apparent_Kd_M: 1.626664E-11

Real

Aptamer SeqId:12626-6;Target:SENP7;UniProt:Q9BQF6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12626-6;Target: SENP7;UniProt: Q9BQF6;TargetFullName: Sentrin-specific protease 7;Organisim: human;Apparent_Kd_M: 4.247094E-12

Real

Aptamer SeqId: 12626-6 | Target: SENP7 | UniProt: Q9BQF6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12626-6 | Target: SENP7 | UniProt: Q9BQF6 | TargetFullName: Sentrin-specific protease 7 | Organisim: human | Apparent_Kd_M: 4.247094E-12

Real

Aptamer SeqId:12627-97;Target:ATG7;UniProt:O95352

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12627-97;Target: ATG7;UniProt: O95352;TargetFullName: Ubiquitin-like modifier-activating enzyme ATG7;Organisim: human;Apparent_Kd_M: 1.235696E-10

Real

Aptamer SeqId: 12627-97 | Target: ATG7 | UniProt: O95352

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12627-97 | Target: ATG7 | UniProt: O95352 | TargetFullName: Ubiquitin-like modifier-activating enzyme ATG7 | Organisim: human | Apparent_Kd_M: 1.235696E-10

Real

Aptamer SeqId:12628-31;Target:LANC2;UniProt:Q9NS86

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12628-31;Target: LANC2;UniProt: Q9NS86;TargetFullName: LanC-like protein 2;Organisim: human;Apparent_Kd_M: 2.297732E-12

Real

Aptamer SeqId: 12628-31 | Target: LANC2 | UniProt: Q9NS86

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12628-31 | Target: LANC2 | UniProt: Q9NS86 | TargetFullName: LanC-like protein 2 | Organisim: human | Apparent_Kd_M: 2.297732E-12

Real

Aptamer SeqId:12630-8;Target:ARFP2;UniProt:P53365

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12630-8;Target: ARFP2;UniProt: P53365;TargetFullName: Arfaptin-2;Organisim: human;Apparent_Kd_M: 1.888015E-12

Real

Aptamer SeqId: 12630-8 | Target: ARFP2 | UniProt: P53365

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12630-8 | Target: ARFP2 | UniProt: P53365 | TargetFullName: Arfaptin-2 | Organisim: human | Apparent_Kd_M: 1.888015E-12

Real

Aptamer SeqId:12632-14;Target:ARY1;UniProt:P18440

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12632-14;Target: ARY1;UniProt: P18440;TargetFullName: Arylamine N-acetyltransferase 1;Organisim: human;Apparent_Kd_M: 8.013042E-11

Real

Aptamer SeqId: 12632-14 | Target: ARY1 | UniProt: P18440

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12632-14 | Target: ARY1 | UniProt: P18440 | TargetFullName: Arylamine N-acetyltransferase 1 | Organisim: human | Apparent_Kd_M: 8.013042E-11

Real

Aptamer SeqId:12633-3;Target:PTN9;UniProt:P43378

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12633-3;Target: PTN9;UniProt: P43378;TargetFullName: Tyrosine-protein phosphatase non-receptor type 9;Organisim: human;Apparent_Kd_M: 7.368138E-12

Real

Aptamer SeqId: 12633-3 | Target: PTN9 | UniProt: P43378

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12633-3 | Target: PTN9 | UniProt: P43378 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 9 | Organisim: human | Apparent_Kd_M: 7.368138E-12

Real

Aptamer SeqId:12634-79;Target:BCAR3;UniProt:O75815

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12634-79;Target: BCAR3;UniProt: O75815;TargetFullName: Breast cancer anti-estrogen resistance protein 3;Organisim: human;Apparent_Kd_M: 1.685386E-12

Real

Aptamer SeqId: 12634-79 | Target: BCAR3 | UniProt: O75815

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12634-79 | Target: BCAR3 | UniProt: O75815 | TargetFullName: Breast cancer anti-estrogen resistance protein 3 | Organisim: human | Apparent_Kd_M: 1.685386E-12

Real

Aptamer SeqId:12635-9;Target:TRDMT;UniProt:O14717

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12635-9;Target: TRDMT;UniProt: O14717;TargetFullName: tRNA (cytosine(38)-C(5))-methyltransferase;Organisim: human;Apparent_Kd_M: 1.972537E-12

Real

Aptamer SeqId: 12635-9 | Target: TRDMT | UniProt: O14717

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12635-9 | Target: TRDMT | UniProt: O14717 | TargetFullName: tRNA (cytosine(38)-C(5))-methyltransferase | Organisim: human | Apparent_Kd_M: 1.972537E-12

Real

Aptamer SeqId:12636-113;Target:SMYD2;UniProt:Q9NRG4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12636-113;Target: SMYD2;UniProt: Q9NRG4;TargetFullName: N-lysine methyltransferase SMYD2;Organisim: human;Apparent_Kd_M: 1.212417E-10

Real

Aptamer SeqId: 12636-113 | Target: SMYD2 | UniProt: Q9NRG4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12636-113 | Target: SMYD2 | UniProt: Q9NRG4 | TargetFullName: N-lysine methyltransferase SMYD2 | Organisim: human | Apparent_Kd_M: 1.212417E-10

Real

Aptamer SeqId:12637-7;Target:CACP;UniProt:P43155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12637-7;Target: CACP;UniProt: P43155;TargetFullName: Carnitine O-acetyltransferase;Organisim: human;Apparent_Kd_M: 1.769701E-12

Real

Aptamer SeqId: 12637-7 | Target: CACP | UniProt: P43155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12637-7 | Target: CACP | UniProt: P43155 | TargetFullName: Carnitine O-acetyltransferase | Organisim: human | Apparent_Kd_M: 1.769701E-12

Real

Aptamer SeqId:12641-3;Target:I5P2;UniProt:P32019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12641-3;Target: I5P2;UniProt: P32019;TargetFullName: Type II inositol 1;4;5-trisphosphate 5-phosphatase;Organisim: human;Apparent_Kd_M: 7.103134E-13

Real

Aptamer SeqId: 12641-3 | Target: I5P2 | UniProt: P32019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12641-3 | Target: I5P2 | UniProt: P32019 | TargetFullName: Type II inositol 1;4;5-trisphosphate 5-phosphatase | Organisim: human | Apparent_Kd_M: 7.103134E-13

Real

Aptamer SeqId:12643-4;Target:ARRB1;UniProt:P49407

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12643-4;Target: ARRB1;UniProt: P49407;TargetFullName: Beta-arrestin-1;Organisim: human;Apparent_Kd_M: 4.903937E-12

Real

Aptamer SeqId: 12643-4 | Target: ARRB1 | UniProt: P49407

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12643-4 | Target: ARRB1 | UniProt: P49407 | TargetFullName: Beta-arrestin-1 | Organisim: human | Apparent_Kd_M: 4.903937E-12

Real

Aptamer SeqId:12644-63;Target:PURA2;UniProt:P30520

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12644-63;Target: PURA2;UniProt: P30520;TargetFullName: Adenylosuccinate synthetase isozyme 2;Organisim: human;Apparent_Kd_M: 4.688279E-11

Real

Aptamer SeqId: 12644-63 | Target: PURA2 | UniProt: P30520

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12644-63 | Target: PURA2 | UniProt: P30520 | TargetFullName: Adenylosuccinate synthetase isozyme 2 | Organisim: human | Apparent_Kd_M: 4.688279E-11

Real

Aptamer SeqId:12646-2;Target:RPE;UniProt:Q96AT9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12646-2;Target: RPE;UniProt: Q96AT9;TargetFullName: Ribulose-phosphate 3-epimerase;Organisim: human;Apparent_Kd_M: 1.659856E-11

Real

Aptamer SeqId: 12646-2 | Target: RPE | UniProt: Q96AT9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12646-2 | Target: RPE | UniProt: Q96AT9 | TargetFullName: Ribulose-phosphate 3-epimerase | Organisim: human | Apparent_Kd_M: 1.659856E-11

Real

Aptamer SeqId:12647-52;Target:SETD2;UniProt:Q9BYW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12647-52;Target: SETD2;UniProt: Q9BYW2;TargetFullName: Histone-lysine N-methyltransferase SETD2;Organisim: human;Apparent_Kd_M: 5.400826E-12

Real

Aptamer SeqId: 12647-52 | Target: SETD2 | UniProt: Q9BYW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12647-52 | Target: SETD2 | UniProt: Q9BYW2 | TargetFullName: Histone-lysine N-methyltransferase SETD2 | Organisim: human | Apparent_Kd_M: 5.400826E-12

Real

Aptamer SeqId:12650-43;Target:GNAI3;UniProt:P08754

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12650-43;Target: GNAI3;UniProt: P08754;TargetFullName: Guanine nucleotide-binding protein G(k) subunit alpha;Organisim: human;Apparent_Kd_M: 3.989319E-11

Real

Aptamer SeqId: 12650-43 | Target: GNAI3 | UniProt: P08754

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12650-43 | Target: GNAI3 | UniProt: P08754 | TargetFullName: Guanine nucleotide-binding protein G(k) subunit alpha | Organisim: human | Apparent_Kd_M: 3.989319E-11

Real

Aptamer SeqId:12651-21;Target:PDK2;UniProt:Q15119

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12651-21;Target: PDK2;UniProt: Q15119;TargetFullName: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2; mitochondrial;Organisim: human;Apparent_Kd_M: 8.44694E-11

Real

Aptamer SeqId: 12651-21 | Target: PDK2 | UniProt: Q15119

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12651-21 | Target: PDK2 | UniProt: Q15119 | TargetFullName: Pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 2; mitochondrial | Organisim: human | Apparent_Kd_M: 8.44694E-11

Real

Aptamer SeqId:12652-37;Target:SAHH2;UniProt:O43865

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12652-37;Target: SAHH2;UniProt: O43865;TargetFullName: Adenosylhomocysteinase 2;Organisim: human;Apparent_Kd_M: 7.031602E-13

Real

Aptamer SeqId: 12652-37 | Target: SAHH2 | UniProt: O43865

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12652-37 | Target: SAHH2 | UniProt: O43865 | TargetFullName: Adenosylhomocysteinase 2 | Organisim: human | Apparent_Kd_M: 7.031602E-13

Real

Aptamer SeqId:12653-13;Target:CSNK1G2;UniProt:P78368

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12653-13;Target: CSNK1G2;UniProt: P78368;TargetFullName: Casein kinase I isoform gamma-2;Organisim: human;Apparent_Kd_M: 5.382137E-12

Real

Aptamer SeqId: 12653-13 | Target: CSNK1G2 | UniProt: P78368

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12653-13 | Target: CSNK1G2 | UniProt: P78368 | TargetFullName: Casein kinase I isoform gamma-2 | Organisim: human | Apparent_Kd_M: 5.382137E-12

Real

Aptamer SeqId:12655-30;Target:SNAB;UniProt:Q9H115

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12655-30;Target: SNAB;UniProt: Q9H115;TargetFullName: Beta-soluble NSF attachment protein;Organisim: human;Apparent_Kd_M: 6.605605E-11

Real

Aptamer SeqId: 12655-30 | Target: SNAB | UniProt: Q9H115

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12655-30 | Target: SNAB | UniProt: Q9H115 | TargetFullName: Beta-soluble NSF attachment protein | Organisim: human | Apparent_Kd_M: 6.605605E-11

Real

Aptamer SeqId:12656-1;Target:KLC1;UniProt:Q07866

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12656-1;Target: KLC1;UniProt: Q07866;TargetFullName: Kinesin light chain 1;Organisim: human;Apparent_Kd_M: 5.226167E-13

Real

Aptamer SeqId: 12656-1 | Target: KLC1 | UniProt: Q07866

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12656-1 | Target: KLC1 | UniProt: Q07866 | TargetFullName: Kinesin light chain 1 | Organisim: human | Apparent_Kd_M: 5.226167E-13

Real

Aptamer SeqId:12657-2;Target:FCL;UniProt:Q13630

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12657-2;Target: FCL;UniProt: Q13630;TargetFullName: GDP-L-fucose synthase;Organisim: human;Apparent_Kd_M: 2.092768E-11

Real

Aptamer SeqId: 12657-2 | Target: FCL | UniProt: Q13630

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12657-2 | Target: FCL | UniProt: Q13630 | TargetFullName: GDP-L-fucose synthase | Organisim: human | Apparent_Kd_M: 2.092768E-11

Real

Aptamer SeqId:12658-72;Target:PANK3;UniProt:Q9H999

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12658-72;Target: PANK3;UniProt: Q9H999;TargetFullName: Pantothenate kinase 3;Organisim: human;Apparent_Kd_M: 7.970779E-12

Real

Aptamer SeqId: 12658-72 | Target: PANK3 | UniProt: Q9H999

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12658-72 | Target: PANK3 | UniProt: Q9H999 | TargetFullName: Pantothenate kinase 3 | Organisim: human | Apparent_Kd_M: 7.970779E-12

Real

Aptamer SeqId:12659-13;Target:GTPB9;UniProt:Q9NTK5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12659-13;Target: GTPB9;UniProt: Q9NTK5;TargetFullName: Obg-like ATPase 1;Organisim: human;Apparent_Kd_M: 2.580965E-12

Real

Aptamer SeqId: 12659-13 | Target: GTPB9 | UniProt: Q9NTK5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12659-13 | Target: GTPB9 | UniProt: Q9NTK5 | TargetFullName: Obg-like ATPase 1 | Organisim: human | Apparent_Kd_M: 2.580965E-12

Real

Aptamer SeqId:12661-44;Target:GBRL1;UniProt:Q9H0R8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12661-44;Target: GBRL1;UniProt: Q9H0R8;TargetFullName: Gamma-aminobutyric acid receptor-associated protein-like 1;Organisim: human;Apparent_Kd_M: 8.205888E-13

Real

Aptamer SeqId: 12661-44 | Target: GBRL1 | UniProt: Q9H0R8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12661-44 | Target: GBRL1 | UniProt: Q9H0R8 | TargetFullName: Gamma-aminobutyric acid receptor-associated protein-like 1 | Organisim: human | Apparent_Kd_M: 8.205888E-13

Real

Aptamer SeqId:12662-82;Target:ECH1;UniProt:Q13011

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12662-82;Target: ECH1;UniProt: Q13011;TargetFullName: Delta(3;5)-Delta(2;4)-dienoyl-CoA isomerase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.156588E-13

Real

Aptamer SeqId: 12662-82 | Target: ECH1 | UniProt: Q13011

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12662-82 | Target: ECH1 | UniProt: Q13011 | TargetFullName: Delta(3;5)-Delta(2;4)-dienoyl-CoA isomerase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.156588E-13

Real

Aptamer SeqId:12663-1;Target:THTR;UniProt:Q16762

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12663-1;Target: THTR;UniProt: Q16762;TargetFullName: Thiosulfate sulfurtransferase;Organisim: human;Apparent_Kd_M: 9.347957E-12

Real

Aptamer SeqId: 12663-1 | Target: THTR | UniProt: Q16762

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12663-1 | Target: THTR | UniProt: Q16762 | TargetFullName: Thiosulfate sulfurtransferase | Organisim: human | Apparent_Kd_M: 9.347957E-12

Real

Aptamer SeqId:12664-19;Target:PTN13;UniProt:Q12923

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12664-19;Target: PTN13;UniProt: Q12923;TargetFullName: Tyrosine-protein phosphatase non-receptor type 13;Organisim: human;Apparent_Kd_M: 3.723006E-12

Real

Aptamer SeqId: 12664-19 | Target: PTN13 | UniProt: Q12923

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12664-19 | Target: PTN13 | UniProt: Q12923 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 13 | Organisim: human | Apparent_Kd_M: 3.723006E-12

Real

Aptamer SeqId:12665-16;Target:ILF2;UniProt:Q12905

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12665-16;Target: ILF2;UniProt: Q12905;TargetFullName: Interleukin enhancer-binding factor 2;Organisim: human;Apparent_Kd_M: 3.074766E-11

Real

Aptamer SeqId: 12665-16 | Target: ILF2 | UniProt: Q12905

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12665-16 | Target: ILF2 | UniProt: Q12905 | TargetFullName: Interleukin enhancer-binding factor 2 | Organisim: human | Apparent_Kd_M: 3.074766E-11

Real

Aptamer SeqId:12667-2;Target:GUAD;UniProt:Q9Y2T3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12667-2;Target: GUAD;UniProt: Q9Y2T3;TargetFullName: Guanine deaminase;Organisim: human;Apparent_Kd_M: 2.423289E-11

Real

Aptamer SeqId: 12667-2 | Target: GUAD | UniProt: Q9Y2T3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12667-2 | Target: GUAD | UniProt: Q9Y2T3 | TargetFullName: Guanine deaminase | Organisim: human | Apparent_Kd_M: 2.423289E-11

Real

Aptamer SeqId:12668-7;Target:VPS4B;UniProt:O75351

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12668-7;Target: VPS4B;UniProt: O75351;TargetFullName: Vacuolar protein sorting-associated protein 4B;Organisim: human;Apparent_Kd_M: 1.174434E-10

Real

Aptamer SeqId: 12668-7 | Target: VPS4B | UniProt: O75351

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12668-7 | Target: VPS4B | UniProt: O75351 | TargetFullName: Vacuolar protein sorting-associated protein 4B | Organisim: human | Apparent_Kd_M: 1.174434E-10

Real

Aptamer SeqId:12669-30;Target:HECW1;UniProt:Q76N89

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12669-30;Target: HECW1;UniProt: Q76N89;TargetFullName: E3 ubiquitin-protein ligase HECW1;Organisim: human;Apparent_Kd_M: 6.161533E-12

Real

Aptamer SeqId: 12669-30 | Target: HECW1 | UniProt: Q76N89

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12669-30 | Target: HECW1 | UniProt: Q76N89 | TargetFullName: E3 ubiquitin-protein ligase HECW1 | Organisim: human | Apparent_Kd_M: 6.161533E-12

Real

Aptamer SeqId:12670-15;Target:RAD1;UniProt:O60671

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12670-15;Target: RAD1;UniProt: O60671;TargetFullName: Cell cycle checkpoint protein RAD1;Organisim: human;Apparent_Kd_M: 1.138265E-11

Real

Aptamer SeqId: 12670-15 | Target: RAD1 | UniProt: O60671

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12670-15 | Target: RAD1 | UniProt: O60671 | TargetFullName: Cell cycle checkpoint protein RAD1 | Organisim: human | Apparent_Kd_M: 1.138265E-11

Real

Aptamer SeqId:12671-35;Target:ST1B1;UniProt:O43704

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12671-35;Target: ST1B1;UniProt: O43704;TargetFullName: Sulfotransferase family cytosolic 1B member 1;Organisim: human;Apparent_Kd_M: 1.270875E-12

Real

Aptamer SeqId: 12671-35 | Target: ST1B1 | UniProt: O43704

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12671-35 | Target: ST1B1 | UniProt: O43704 | TargetFullName: Sulfotransferase family cytosolic 1B member 1 | Organisim: human | Apparent_Kd_M: 1.270875E-12

Real

Aptamer SeqId:12675-14;Target:SYDC;UniProt:P14868

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12675-14;Target: SYDC;UniProt: P14868;TargetFullName: Aspartate--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 3.574687E-13

Real

Aptamer SeqId: 12675-14 | Target: SYDC | UniProt: P14868

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12675-14 | Target: SYDC | UniProt: P14868 | TargetFullName: Aspartate--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 3.574687E-13

Real

Aptamer SeqId:12676-1;Target:PACN1;UniProt:Q9BY11

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12676-1;Target: PACN1;UniProt: Q9BY11;TargetFullName: Protein kinase C and casein kinase substrate in neurons protein 1;Organisim: human;Apparent_Kd_M: 2.467782E-12

Real

Aptamer SeqId: 12676-1 | Target: PACN1 | UniProt: Q9BY11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12676-1 | Target: PACN1 | UniProt: Q9BY11 | TargetFullName: Protein kinase C and casein kinase substrate in neurons protein 1 | Organisim: human | Apparent_Kd_M: 2.467782E-12

Real

Aptamer SeqId:12677-164;Target:FLII;UniProt:Q13045

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12677-164;Target: FLII;UniProt: Q13045;TargetFullName: Protein flightless-1 homolog;Organisim: human;Apparent_Kd_M: 4.504943E-12

Real

Aptamer SeqId: 12677-164 | Target: FLII | UniProt: Q13045

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12677-164 | Target: FLII | UniProt: Q13045 | TargetFullName: Protein flightless-1 homolog | Organisim: human | Apparent_Kd_M: 4.504943E-12

Real

Aptamer SeqId:12678-66;Target:SNRPA;UniProt:P09012

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12678-66;Target: SNRPA;UniProt: P09012;TargetFullName: U1 small nuclear ribonucleoprotein A;Organisim: human;Apparent_Kd_M: 3.444969E-12

Real

Aptamer SeqId: 12678-66 | Target: SNRPA | UniProt: P09012

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12678-66 | Target: SNRPA | UniProt: P09012 | TargetFullName: U1 small nuclear ribonucleoprotein A | Organisim: human | Apparent_Kd_M: 3.444969E-12

Real

Aptamer SeqId:12681-63;Target:UBP21;UniProt:Q9UK80

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12681-63;Target: UBP21;UniProt: Q9UK80;TargetFullName: Ubiquitin carboxyl-terminal hydrolase 21;Organisim: human;Apparent_Kd_M: 5.224247E-11

Real

Aptamer SeqId: 12681-63 | Target: UBP21 | UniProt: Q9UK80

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12681-63 | Target: UBP21 | UniProt: Q9UK80 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase 21 | Organisim: human | Apparent_Kd_M: 5.224247E-11

Real

Aptamer SeqId:12682-5;Target:KAT3;UniProt:Q6YP21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12682-5;Target: KAT3;UniProt: Q6YP21;TargetFullName: Kynurenine--oxoglutarate transaminase 3;Organisim: human;Apparent_Kd_M: 4.580661E-12

Real

Aptamer SeqId: 12682-5 | Target: KAT3 | UniProt: Q6YP21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12682-5 | Target: KAT3 | UniProt: Q6YP21 | TargetFullName: Kynurenine--oxoglutarate transaminase 3 | Organisim: human | Apparent_Kd_M: 4.580661E-12

Real

Aptamer SeqId:12683-156;Target:DPYL5;UniProt:Q9BPU6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12683-156;Target: DPYL5;UniProt: Q9BPU6;TargetFullName: Dihydropyrimidinase-related protein 5;Organisim: human;Apparent_Kd_M: 4.478376E-12

Real

Aptamer SeqId: 12683-156 | Target: DPYL5 | UniProt: Q9BPU6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12683-156 | Target: DPYL5 | UniProt: Q9BPU6 | TargetFullName: Dihydropyrimidinase-related protein 5 | Organisim: human | Apparent_Kd_M: 4.478376E-12

Real

Aptamer SeqId:12684-5;Target:ADSV;UniProt:Q9Y6U3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12684-5;Target: ADSV;UniProt: Q9Y6U3;TargetFullName: Adseverin;Organisim: human;Apparent_Kd_M: 5.970319E-12

Real

Aptamer SeqId: 12684-5 | Target: ADSV | UniProt: Q9Y6U3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12684-5 | Target: ADSV | UniProt: Q9Y6U3 | TargetFullName: Adseverin | Organisim: human | Apparent_Kd_M: 5.970319E-12

Real

Aptamer SeqId:12685-57;Target:HOME2;UniProt:Q9NSB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12685-57;Target: HOME2;UniProt: Q9NSB8;TargetFullName: Homer protein homolog 2;Organisim: human;Apparent_Kd_M: 1.508906E-12

Real

Aptamer SeqId: 12685-57 | Target: HOME2 | UniProt: Q9NSB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12685-57 | Target: HOME2 | UniProt: Q9NSB8 | TargetFullName: Homer protein homolog 2 | Organisim: human | Apparent_Kd_M: 1.508906E-12

Real

Aptamer SeqId:12686-15;Target:THTM;UniProt:P25325

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12686-15;Target: THTM;UniProt: P25325;TargetFullName: 3-mercaptopyruvate sulfurtransferase;Organisim: human;Apparent_Kd_M: 4.854884E-11

Real

Aptamer SeqId: 12686-15 | Target: THTM | UniProt: P25325

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12686-15 | Target: THTM | UniProt: P25325 | TargetFullName: 3-mercaptopyruvate sulfurtransferase | Organisim: human | Apparent_Kd_M: 4.854884E-11

Real

Aptamer SeqId:12687-2;Target:DECR;UniProt:Q16698

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12687-2;Target: DECR;UniProt: Q16698;TargetFullName: 2;4-dienoyl-CoA reductase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.744848E-12

Real

Aptamer SeqId: 12687-2 | Target: DECR | UniProt: Q16698

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12687-2 | Target: DECR | UniProt: Q16698 | TargetFullName: 2;4-dienoyl-CoA reductase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.744848E-12

Real

Aptamer SeqId:12688-115;Target:KS6A6;UniProt:Q9UK32

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12688-115;Target: KS6A6;UniProt: Q9UK32;TargetFullName: Ribosomal protein S6 kinase alpha-6;Organisim: human;Apparent_Kd_M: 9.154435E-12

Real

Aptamer SeqId: 12688-115 | Target: KS6A6 | UniProt: Q9UK32

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12688-115 | Target: KS6A6 | UniProt: Q9UK32 | TargetFullName: Ribosomal protein S6 kinase alpha-6 | Organisim: human | Apparent_Kd_M: 9.154435E-12

Real

Aptamer SeqId:12689-56;Target:ARC1B;UniProt:O15143

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12689-56;Target: ARC1B;UniProt: O15143;TargetFullName: Actin-related protein 2/3 complex subunit 1B;Organisim: human;Apparent_Kd_M: 1.048608E-11

Real

Aptamer SeqId: 12689-56 | Target: ARC1B | UniProt: O15143

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12689-56 | Target: ARC1B | UniProt: O15143 | TargetFullName: Actin-related protein 2/3 complex subunit 1B | Organisim: human | Apparent_Kd_M: 1.048608E-11

Real

Aptamer SeqId:12690-33;Target:SEP10;UniProt:Q9P0V9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12690-33;Target: SEP10;UniProt: Q9P0V9;TargetFullName: Septin-10;Organisim: human;Apparent_Kd_M: 1.304484E-10

Real

Aptamer SeqId: 12690-33 | Target: SEP10 | UniProt: Q9P0V9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12690-33 | Target: SEP10 | UniProt: Q9P0V9 | TargetFullName: Septin-10 | Organisim: human | Apparent_Kd_M: 1.304484E-10

Real

Aptamer SeqId:12691-44;Target:GLYM;UniProt:P34897

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12691-44;Target: GLYM;UniProt: P34897;TargetFullName: Serine hydroxymethyltransferase; mitochondrial;Organisim: human;Apparent_Kd_M: 4.208966E-12

Real

Aptamer SeqId: 12691-44 | Target: GLYM | UniProt: P34897

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12691-44 | Target: GLYM | UniProt: P34897 | TargetFullName: Serine hydroxymethyltransferase; mitochondrial | Organisim: human | Apparent_Kd_M: 4.208966E-12

Real

Aptamer SeqId:12692-56;Target:DOT1L;UniProt:Q8TEK3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12692-56;Target: DOT1L;UniProt: Q8TEK3;TargetFullName: Histone-lysine N-methyltransferase; H3 lysine-79 specific;Organisim: human;Apparent_Kd_M: 1.694187E-11

Real

Aptamer SeqId: 12692-56 | Target: DOT1L | UniProt: Q8TEK3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12692-56 | Target: DOT1L | UniProt: Q8TEK3 | TargetFullName: Histone-lysine N-methyltransferase; H3 lysine-79 specific | Organisim: human | Apparent_Kd_M: 1.694187E-11

Real

Aptamer SeqId:12693-2;Target:SH3L1;UniProt:O75368

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12693-2;Target: SH3L1;UniProt: O75368;TargetFullName: SH3 domain-binding glutamic acid-rich-like protein;Organisim: human;Apparent_Kd_M: 3.387694E-11

Real

Aptamer SeqId: 12693-2 | Target: SH3L1 | UniProt: O75368

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12693-2 | Target: SH3L1 | UniProt: O75368 | TargetFullName: SH3 domain-binding glutamic acid-rich-like protein | Organisim: human | Apparent_Kd_M: 3.387694E-11

Real

Aptamer SeqId:12694-28;Target:DIM1;UniProt:Q9UNQ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12694-28;Target: DIM1;UniProt: Q9UNQ2;TargetFullName: Probable dimethyladenosine transferase;Organisim: human;Apparent_Kd_M: 5.29781E-12

Real

Aptamer SeqId: 12694-28 | Target: DIM1 | UniProt: Q9UNQ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12694-28 | Target: DIM1 | UniProt: Q9UNQ2 | TargetFullName: Probable dimethyladenosine transferase | Organisim: human | Apparent_Kd_M: 5.29781E-12

Real

Aptamer SeqId:12695-62;Target:KLH12;UniProt:Q53G59

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12695-62;Target: KLH12;UniProt: Q53G59;TargetFullName: Kelch-like protein 12;Organisim: human;Apparent_Kd_M: 4.02378E-12

Real

Aptamer SeqId: 12695-62 | Target: KLH12 | UniProt: Q53G59

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12695-62 | Target: KLH12 | UniProt: Q53G59 | TargetFullName: Kelch-like protein 12 | Organisim: human | Apparent_Kd_M: 4.02378E-12

Real

Aptamer SeqId:12696-166;Target:ANM3;UniProt:O60678

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12696-166;Target: ANM3;UniProt: O60678;TargetFullName: Protein arginine N-methyltransferase 3;Organisim: human;Apparent_Kd_M: 2.849719E-12

Real

Aptamer SeqId: 12696-166 | Target: ANM3 | UniProt: O60678

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12696-166 | Target: ANM3 | UniProt: O60678 | TargetFullName: Protein arginine N-methyltransferase 3 | Organisim: human | Apparent_Kd_M: 2.849719E-12

Real

Aptamer SeqId:12697-30;Target:PI42A;UniProt:P48426

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12697-30;Target: PI42A;UniProt: P48426;TargetFullName: Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha;Organisim: human;Apparent_Kd_M: 1.116151E-11

Real

Aptamer SeqId: 12697-30 | Target: PI42A | UniProt: P48426

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12697-30 | Target: PI42A | UniProt: P48426 | TargetFullName: Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Organisim: human | Apparent_Kd_M: 1.116151E-11

Real

Aptamer SeqId:12698-72;Target:IMA4;UniProt:O00629

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12698-72;Target: IMA4;UniProt: O00629;TargetFullName: Importin subunit alpha-3;Organisim: human;Apparent_Kd_M: 1.259179E-11

Real

Aptamer SeqId: 12698-72 | Target: IMA4 | UniProt: O00629

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12698-72 | Target: IMA4 | UniProt: O00629 | TargetFullName: Importin subunit alpha-3 | Organisim: human | Apparent_Kd_M: 1.259179E-11

Real

Aptamer SeqId:12699-28;Target:TCP-1-theta;UniProt:P50990

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12699-28;Target: TCP-1-theta;UniProt: P50990;TargetFullName: T-complex protein 1 subunit theta;Organisim: human;Apparent_Kd_M: 3.41935E-12

Real

Aptamer SeqId: 12699-28 | Target: TCP-1-theta | UniProt: P50990

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12699-28 | Target: TCP-1-theta | UniProt: P50990 | TargetFullName: T-complex protein 1 subunit theta | Organisim: human | Apparent_Kd_M: 3.41935E-12

Real

Aptamer SeqId:12700-9;Target:ACLY;UniProt:P53396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12700-9;Target: ACLY;UniProt: P53396;TargetFullName: ATP-citrate synthase;Organisim: human;Apparent_Kd_M: 1.33174E-11

Real

Aptamer SeqId: 12700-9 | Target: ACLY | UniProt: P53396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12700-9 | Target: ACLY | UniProt: P53396 | TargetFullName: ATP-citrate synthase | Organisim: human | Apparent_Kd_M: 1.33174E-11

Real

Aptamer SeqId:12701-1;Target:EIF1B;UniProt:O60739

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12701-1;Target: EIF1B;UniProt: O60739;TargetFullName: Eukaryotic translation initiation factor 1b;Organisim: human;Apparent_Kd_M: 8.649285E-13

Real

Aptamer SeqId: 12701-1 | Target: EIF1B | UniProt: O60739

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12701-1 | Target: EIF1B | UniProt: O60739 | TargetFullName: Eukaryotic translation initiation factor 1b | Organisim: human | Apparent_Kd_M: 8.649285E-13

Real

Aptamer SeqId:12702-13;Target:PELI2;UniProt:Q9HAT8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12702-13;Target: PELI2;UniProt: Q9HAT8;TargetFullName: E3 ubiquitin-protein ligase pellino homolog 2;Organisim: human;Apparent_Kd_M: 6.465873E-13

Real

Aptamer SeqId: 12702-13 | Target: PELI2 | UniProt: Q9HAT8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12702-13 | Target: PELI2 | UniProt: Q9HAT8 | TargetFullName: E3 ubiquitin-protein ligase pellino homolog 2 | Organisim: human | Apparent_Kd_M: 6.465873E-13

Real

Aptamer SeqId:12703-6;Target:NEK7;UniProt:Q8TDX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12703-6;Target: NEK7;UniProt: Q8TDX7;TargetFullName: Serine/threonine-protein kinase Nek7;Organisim: human;Apparent_Kd_M: 1.584063E-12

Real

Aptamer SeqId: 12703-6 | Target: NEK7 | UniProt: Q8TDX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12703-6 | Target: NEK7 | UniProt: Q8TDX7 | TargetFullName: Serine/threonine-protein kinase Nek7 | Organisim: human | Apparent_Kd_M: 1.584063E-12

Real

Aptamer SeqId:12704-26;Target:SH2D3;UniProt:Q8N5H7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12704-26;Target: SH2D3;UniProt: Q8N5H7;TargetFullName: SH2 domain-containing protein 3C;Organisim: human;Apparent_Kd_M: 1.777053E-11

Real

Aptamer SeqId: 12704-26 | Target: SH2D3 | UniProt: Q8N5H7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12704-26 | Target: SH2D3 | UniProt: Q8N5H7 | TargetFullName: SH2 domain-containing protein 3C | Organisim: human | Apparent_Kd_M: 1.777053E-11

Real

Aptamer SeqId:12705-9;Target:HERC1;UniProt:Q15751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12705-9;Target: HERC1;UniProt: Q15751;TargetFullName: Probable E3 ubiquitin-protein ligase HERC1;Organisim: human;Apparent_Kd_M: 8.865585E-13

Real

Aptamer SeqId: 12705-9 | Target: HERC1 | UniProt: Q15751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12705-9 | Target: HERC1 | UniProt: Q15751 | TargetFullName: Probable E3 ubiquitin-protein ligase HERC1 | Organisim: human | Apparent_Kd_M: 8.865585E-13

Real

Aptamer SeqId:12706-2;Target:MRCKA;UniProt:Q5VT25

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12706-2;Target: MRCKA;UniProt: Q5VT25;TargetFullName: Serine/threonine-protein kinase MRCK alpha;Organisim: human;Apparent_Kd_M: 4.120254E-11

Real

Aptamer SeqId: 12706-2 | Target: MRCKA | UniProt: Q5VT25

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12706-2 | Target: MRCKA | UniProt: Q5VT25 | TargetFullName: Serine/threonine-protein kinase MRCK alpha | Organisim: human | Apparent_Kd_M: 4.120254E-11

Real

Aptamer SeqId:12707-26;Target:DPYL3;UniProt:Q14195

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12707-26;Target: DPYL3;UniProt: Q14195;TargetFullName: Dihydropyrimidinase-related protein 3;Organisim: human;Apparent_Kd_M: 2.103954E-11

Real

Aptamer SeqId: 12707-26 | Target: DPYL3 | UniProt: Q14195

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12707-26 | Target: DPYL3 | UniProt: Q14195 | TargetFullName: Dihydropyrimidinase-related protein 3 | Organisim: human | Apparent_Kd_M: 2.103954E-11

Real

Aptamer SeqId:12708-91;Target:LMBL2;UniProt:Q969R5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12708-91;Target: LMBL2;UniProt: Q969R5;TargetFullName: Lethal(3)malignant brain tumor-like protein 2;Organisim: human;Apparent_Kd_M: 2.446667E-11

Real

Aptamer SeqId: 12708-91 | Target: LMBL2 | UniProt: Q969R5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12708-91 | Target: LMBL2 | UniProt: Q969R5 | TargetFullName: Lethal(3)malignant brain tumor-like protein 2 | Organisim: human | Apparent_Kd_M: 2.446667E-11

Real

Aptamer SeqId:12709-63;Target:H1X;UniProt:Q92522

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12709-63;Target: H1X;UniProt: Q92522;TargetFullName: Histone H1x;Organisim: human;Apparent_Kd_M: 5.807372E-12

Real

Aptamer SeqId: 12709-63 | Target: H1X | UniProt: Q92522

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12709-63 | Target: H1X | UniProt: Q92522 | TargetFullName: Histone H1x | Organisim: human | Apparent_Kd_M: 5.807372E-12

Real

Aptamer SeqId:12711-19;Target:CXA8;UniProt:P48165

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12711-19;Target: CXA8;UniProt: P48165;TargetFullName: Gap junction alpha-8 protein;Organisim: human;Apparent_Kd_M: 9.412742E-12

Real

Aptamer SeqId: 12711-19 | Target: CXA8 | UniProt: P48165

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12711-19 | Target: CXA8 | UniProt: P48165 | TargetFullName: Gap junction alpha-8 protein | Organisim: human | Apparent_Kd_M: 9.412742E-12

Real

Aptamer SeqId:12712-9;Target:HM20A;UniProt:Q9NP66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12712-9;Target: HM20A;UniProt: Q9NP66;TargetFullName: High mobility group protein 20A;Organisim: human;Apparent_Kd_M: 6.957338E-12

Real

Aptamer SeqId: 12712-9 | Target: HM20A | UniProt: Q9NP66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12712-9 | Target: HM20A | UniProt: Q9NP66 | TargetFullName: High mobility group protein 20A | Organisim: human | Apparent_Kd_M: 6.957338E-12

Real

Aptamer SeqId:12713-365;Target:RGS19;UniProt:P49795

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12713-365;Target: RGS19;UniProt: P49795;TargetFullName: Regulator of G-protein signaling 19;Organisim: human;Apparent_Kd_M: 2.636758E-10

Real

Aptamer SeqId: 12713-365 | Target: RGS19 | UniProt: P49795

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12713-365 | Target: RGS19 | UniProt: P49795 | TargetFullName: Regulator of G-protein signaling 19 | Organisim: human | Apparent_Kd_M: 2.636758E-10

Real

Aptamer SeqId:12714-38;Target:AP1G2;UniProt:O75843

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12714-38;Target: AP1G2;UniProt: O75843;TargetFullName: AP-1 complex subunit gamma-like 2;Organisim: human;Apparent_Kd_M: 8.971671E-13

Real

Aptamer SeqId: 12714-38 | Target: AP1G2 | UniProt: O75843

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12714-38 | Target: AP1G2 | UniProt: O75843 | TargetFullName: AP-1 complex subunit gamma-like 2 | Organisim: human | Apparent_Kd_M: 8.971671E-13

Real

Aptamer SeqId:12715-30;Target:DCP1B;UniProt:Q8IZD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12715-30;Target: DCP1B;UniProt: Q8IZD4;TargetFullName: mRNA-decapping enzyme 1B;Organisim: human;Apparent_Kd_M: 1.598127E-11

Real

Aptamer SeqId: 12715-30 | Target: DCP1B | UniProt: Q8IZD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12715-30 | Target: DCP1B | UniProt: Q8IZD4 | TargetFullName: mRNA-decapping enzyme 1B | Organisim: human | Apparent_Kd_M: 1.598127E-11

Real

Aptamer SeqId:12716-3;Target:ZN175;UniProt:Q9Y473

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12716-3;Target: ZN175;UniProt: Q9Y473;TargetFullName: Zinc finger protein 175;Organisim: human;Apparent_Kd_M: 7.710597E-11

Real

Aptamer SeqId: 12716-3 | Target: ZN175 | UniProt: Q9Y473

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12716-3 | Target: ZN175 | UniProt: Q9Y473 | TargetFullName: Zinc finger protein 175 | Organisim: human | Apparent_Kd_M: 7.710597E-11

Real

Aptamer SeqId:12717-65;Target:TOX3;UniProt:O15405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12717-65;Target: TOX3;UniProt: O15405;TargetFullName: TOX high mobility group box family member 3;Organisim: human;Apparent_Kd_M: 1.652798E-12

Real

Aptamer SeqId: 12717-65 | Target: TOX3 | UniProt: O15405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12717-65 | Target: TOX3 | UniProt: O15405 | TargetFullName: TOX high mobility group box family member 3 | Organisim: human | Apparent_Kd_M: 1.652798E-12

Real

Aptamer SeqId:12718-43;Target:PIN4;UniProt:Q9Y237

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12718-43;Target: PIN4;UniProt: Q9Y237;TargetFullName: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4;Organisim: human;Apparent_Kd_M: 2.353233E-12

Real

Aptamer SeqId: 12718-43 | Target: PIN4 | UniProt: Q9Y237

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12718-43 | Target: PIN4 | UniProt: Q9Y237 | TargetFullName: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | Organisim: human | Apparent_Kd_M: 2.353233E-12

Real

Aptamer SeqId:12720-71;Target:UBQL4;UniProt:Q9NRR5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12720-71;Target: UBQL4;UniProt: Q9NRR5;TargetFullName: Ubiquilin-4;Organisim: human;Apparent_Kd_M: 2.299794E-12

Real

Aptamer SeqId: 12720-71 | Target: UBQL4 | UniProt: Q9NRR5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12720-71 | Target: UBQL4 | UniProt: Q9NRR5 | TargetFullName: Ubiquilin-4 | Organisim: human | Apparent_Kd_M: 2.299794E-12

Real

Aptamer SeqId:12721-4;Target:TAXB1;UniProt:Q86VP1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12721-4;Target: TAXB1;UniProt: Q86VP1;TargetFullName: Tax1-binding protein 1;Organisim: human;Apparent_Kd_M: 1.120895E-11

Real

Aptamer SeqId: 12721-4 | Target: TAXB1 | UniProt: Q86VP1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12721-4 | Target: TAXB1 | UniProt: Q86VP1 | TargetFullName: Tax1-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.120895E-11

Real

Aptamer SeqId:12724-81;Target:CIRBP;UniProt:Q14011

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12724-81;Target: CIRBP;UniProt: Q14011;TargetFullName: Cold-inducible RNA-binding protein;Organisim: human;Apparent_Kd_M: 1.292622E-12

Real

Aptamer SeqId: 12724-81 | Target: CIRBP | UniProt: Q14011

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12724-81 | Target: CIRBP | UniProt: Q14011 | TargetFullName: Cold-inducible RNA-binding protein | Organisim: human | Apparent_Kd_M: 1.292622E-12

Real

Aptamer SeqId:12726-3;Target:RFXAP;UniProt:O00287

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12726-3;Target: RFXAP;UniProt: O00287;TargetFullName: Regulatory factor X-associated protein;Organisim: human;Apparent_Kd_M: 2.975559E-12

Real

Aptamer SeqId: 12726-3 | Target: RFXAP | UniProt: O00287

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12726-3 | Target: RFXAP | UniProt: O00287 | TargetFullName: Regulatory factor X-associated protein | Organisim: human | Apparent_Kd_M: 2.975559E-12

Real

Aptamer SeqId:12727-7;Target:FPRP;UniProt:Q9P2B2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12727-7;Target: FPRP;UniProt: Q9P2B2;TargetFullName: Prostaglandin F2 receptor negative regulator;Organisim: human;Apparent_Kd_M: 2.02257E-12

Real

Aptamer SeqId: 12727-7 | Target: FPRP | UniProt: Q9P2B2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12727-7 | Target: FPRP | UniProt: Q9P2B2 | TargetFullName: Prostaglandin F2 receptor negative regulator | Organisim: human | Apparent_Kd_M: 2.02257E-12

Real

Aptamer SeqId:12729-12;Target:PSMG3;UniProt:Q9BT73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12729-12;Target: PSMG3;UniProt: Q9BT73;TargetFullName: Proteasome assembly chaperone 3;Organisim: human;Apparent_Kd_M: 8.188086E-11

Real

Aptamer SeqId: 12729-12 | Target: PSMG3 | UniProt: Q9BT73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12729-12 | Target: PSMG3 | UniProt: Q9BT73 | TargetFullName: Proteasome assembly chaperone 3 | Organisim: human | Apparent_Kd_M: 8.188086E-11

Real

Aptamer SeqId:12730-3;Target:KNTC2;UniProt:O14777

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12730-3;Target: KNTC2;UniProt: O14777;TargetFullName: Kinetochore protein NDC80 homolog;Organisim: human;Apparent_Kd_M: 1.539582E-11

Real

Aptamer SeqId: 12730-3 | Target: KNTC2 | UniProt: O14777

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12730-3 | Target: KNTC2 | UniProt: O14777 | TargetFullName: Kinetochore protein NDC80 homolog | Organisim: human | Apparent_Kd_M: 1.539582E-11

Real

Aptamer SeqId:12731-12;Target:PKHA7;UniProt:Q6IQ23

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12731-12;Target: PKHA7;UniProt: Q6IQ23;TargetFullName: Pleckstrin homology domain-containing family A member 7;Organisim: human;Apparent_Kd_M: 4.040386E-12

Real

Aptamer SeqId: 12731-12 | Target: PKHA7 | UniProt: Q6IQ23

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12731-12 | Target: PKHA7 | UniProt: Q6IQ23 | TargetFullName: Pleckstrin homology domain-containing family A member 7 | Organisim: human | Apparent_Kd_M: 4.040386E-12

Real

Aptamer SeqId:12732-13;Target:MPP7;UniProt:Q5T2T1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12732-13;Target: MPP7;UniProt: Q5T2T1;TargetFullName: MAGUK p55 subfamily member 7;Organisim: human;Apparent_Kd_M: 3.28527E-12

Real

Aptamer SeqId: 12732-13 | Target: MPP7 | UniProt: Q5T2T1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12732-13 | Target: MPP7 | UniProt: Q5T2T1 | TargetFullName: MAGUK p55 subfamily member 7 | Organisim: human | Apparent_Kd_M: 3.28527E-12

Real

Aptamer SeqId:12734-112;Target:KIF22;UniProt:Q14807

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12734-112;Target: KIF22;UniProt: Q14807;TargetFullName: Kinesin-like protein KIF22;Organisim: human;Apparent_Kd_M: 5.99282E-12

Real

Aptamer SeqId: 12734-112 | Target: KIF22 | UniProt: Q14807

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12734-112 | Target: KIF22 | UniProt: Q14807 | TargetFullName: Kinesin-like protein KIF22 | Organisim: human | Apparent_Kd_M: 5.99282E-12

Real

Aptamer SeqId:12735-39;Target:CSDE1;UniProt:O75534

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12735-39;Target: CSDE1;UniProt: O75534;TargetFullName: Cold shock domain-containing protein E1;Organisim: human;Apparent_Kd_M: 1.717886E-11

Real

Aptamer SeqId: 12735-39 | Target: CSDE1 | UniProt: O75534

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12735-39 | Target: CSDE1 | UniProt: O75534 | TargetFullName: Cold shock domain-containing protein E1 | Organisim: human | Apparent_Kd_M: 1.717886E-11

Real

Aptamer SeqId:12737-12;Target:PLSI;UniProt:Q14651

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12737-12;Target: PLSI;UniProt: Q14651;TargetFullName: Plastin-1;Organisim: human;Apparent_Kd_M: 3.281388E-12

Real

Aptamer SeqId: 12737-12 | Target: PLSI | UniProt: Q14651

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12737-12 | Target: PLSI | UniProt: Q14651 | TargetFullName: Plastin-1 | Organisim: human | Apparent_Kd_M: 3.281388E-12

Real

Aptamer SeqId:12738-43;Target:NISCH;UniProt:Q9Y2I1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12738-43;Target: NISCH;UniProt: Q9Y2I1;TargetFullName: Nischarin;Organisim: human;Apparent_Kd_M: 1.012285E-11

Real

Aptamer SeqId: 12738-43 | Target: NISCH | UniProt: Q9Y2I1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12738-43 | Target: NISCH | UniProt: Q9Y2I1 | TargetFullName: Nischarin | Organisim: human | Apparent_Kd_M: 1.012285E-11

Real

Aptamer SeqId:12740-55;Target:FEV;UniProt:Q99581

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12740-55;Target: FEV;UniProt: Q99581;TargetFullName: Protein FEV;Organisim: human;Apparent_Kd_M: 3.443268E-12

Real

Aptamer SeqId: 12740-55 | Target: FEV | UniProt: Q99581

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12740-55 | Target: FEV | UniProt: Q99581 | TargetFullName: Protein FEV | Organisim: human | Apparent_Kd_M: 3.443268E-12

Real

Aptamer SeqId:12742-160;Target:TMM8B;UniProt:A6NDV4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12742-160;Target: TMM8B;UniProt: A6NDV4;TargetFullName: Transmembrane protein 8B;Organisim: human;Apparent_Kd_M: 1.131862E-10

Real

Aptamer SeqId: 12742-160 | Target: TMM8B | UniProt: A6NDV4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12742-160 | Target: TMM8B | UniProt: A6NDV4 | TargetFullName: Transmembrane protein 8B | Organisim: human | Apparent_Kd_M: 1.131862E-10

Real

Aptamer SeqId:12743-18;Target:BAG5;UniProt:Q9UL15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12743-18;Target: BAG5;UniProt: Q9UL15;TargetFullName: BAG family molecular chaperone regulator 5;Organisim: human;Apparent_Kd_M: 4.961209E-12

Real

Aptamer SeqId: 12743-18 | Target: BAG5 | UniProt: Q9UL15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12743-18 | Target: BAG5 | UniProt: Q9UL15 | TargetFullName: BAG family molecular chaperone regulator 5 | Organisim: human | Apparent_Kd_M: 4.961209E-12

Real

Aptamer SeqId:12746-4;Target:CYH4;UniProt:Q9UIA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12746-4;Target: CYH4;UniProt: Q9UIA0;TargetFullName: Cytohesin-4;Organisim: human;Apparent_Kd_M: 2.995725E-12

Real

Aptamer SeqId: 12746-4 | Target: CYH4 | UniProt: Q9UIA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12746-4 | Target: CYH4 | UniProt: Q9UIA0 | TargetFullName: Cytohesin-4 | Organisim: human | Apparent_Kd_M: 2.995725E-12

Real

Aptamer SeqId:12747-89;Target:RBM3;UniProt:P98179

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12747-89;Target: RBM3;UniProt: P98179;TargetFullName: RNA-binding protein 3;Organisim: human;Apparent_Kd_M: 1.353222E-12

Real

Aptamer SeqId: 12747-89 | Target: RBM3 | UniProt: P98179

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12747-89 | Target: RBM3 | UniProt: P98179 | TargetFullName: RNA-binding protein 3 | Organisim: human | Apparent_Kd_M: 1.353222E-12

Real

Aptamer SeqId:12748-6;Target:BRDT;UniProt:Q58F21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12748-6;Target: BRDT;UniProt: Q58F21;TargetFullName: Bromodomain testis-specific protein;Organisim: human;Apparent_Kd_M: 1.091537E-11

Real

Aptamer SeqId: 12748-6 | Target: BRDT | UniProt: Q58F21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12748-6 | Target: BRDT | UniProt: Q58F21 | TargetFullName: Bromodomain testis-specific protein | Organisim: human | Apparent_Kd_M: 1.091537E-11

Real

Aptamer SeqId:12750-9;Target:LFA-1 beta-2;UniProt:P05107

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12750-9;Target: LFA-1 beta-2;UniProt: P05107;TargetFullName: Integrin beta-2;Organisim: human;Apparent_Kd_M: 1.320004E-11

Real

Aptamer SeqId: 12750-9 | Target: LFA-1 beta-2 | UniProt: P05107

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12750-9 | Target: LFA-1 beta-2 | UniProt: P05107 | TargetFullName: Integrin beta-2 | Organisim: human | Apparent_Kd_M: 1.320004E-11

Real

Aptamer SeqId:12751-26;Target:ZHX1;UniProt:Q9UKY1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12751-26;Target: ZHX1;UniProt: Q9UKY1;TargetFullName: Zinc fingers and homeoboxes protein 1;Organisim: human;Apparent_Kd_M: 2.792077E-12

Real

Aptamer SeqId: 12751-26 | Target: ZHX1 | UniProt: Q9UKY1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12751-26 | Target: ZHX1 | UniProt: Q9UKY1 | TargetFullName: Zinc fingers and homeoboxes protein 1 | Organisim: human | Apparent_Kd_M: 2.792077E-12

Real

Aptamer SeqId:12753-6;Target:APBB2;UniProt:Q92870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12753-6;Target: APBB2;UniProt: Q92870;TargetFullName: Amyloid beta A4 precursor protein-binding family B member 2;Organisim: human;Apparent_Kd_M: 1.613299E-11

Real

Aptamer SeqId: 12753-6 | Target: APBB2 | UniProt: Q92870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12753-6 | Target: APBB2 | UniProt: Q92870 | TargetFullName: Amyloid beta A4 precursor protein-binding family B member 2 | Organisim: human | Apparent_Kd_M: 1.613299E-11

Real

Aptamer SeqId:12754-14;Target:CSDC2;UniProt:Q9Y534

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12754-14;Target: CSDC2;UniProt: Q9Y534;TargetFullName: Cold shock domain-containing protein C2;Organisim: human;Apparent_Kd_M: 5.859546E-12

Real

Aptamer SeqId: 12754-14 | Target: CSDC2 | UniProt: Q9Y534

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12754-14 | Target: CSDC2 | UniProt: Q9Y534 | TargetFullName: Cold shock domain-containing protein C2 | Organisim: human | Apparent_Kd_M: 5.859546E-12

Real

Aptamer SeqId:12756-3;Target:BACH2;UniProt:Q9BYV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12756-3;Target: BACH2;UniProt: Q9BYV9;TargetFullName: Transcription regulator protein BACH2;Organisim: human;Apparent_Kd_M: 2.242859E-11

Real

Aptamer SeqId: 12756-3 | Target: BACH2 | UniProt: Q9BYV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12756-3 | Target: BACH2 | UniProt: Q9BYV9 | TargetFullName: Transcription regulator protein BACH2 | Organisim: human | Apparent_Kd_M: 2.242859E-11

Real

Aptamer SeqId:12758-47;Target:GRID2;UniProt:O43424

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12758-47;Target: GRID2;UniProt: O43424;TargetFullName: Glutamate receptor ionotropic; delta-2;Organisim: human;Apparent_Kd_M: 9.892617E-12

Real

Aptamer SeqId: 12758-47 | Target: GRID2 | UniProt: O43424

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12758-47 | Target: GRID2 | UniProt: O43424 | TargetFullName: Glutamate receptor ionotropic; delta-2 | Organisim: human | Apparent_Kd_M: 9.892617E-12

Real

Aptamer SeqId:12759-47;Target:DRBP76;UniProt:Q12906

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12759-47;Target: DRBP76;UniProt: Q12906;TargetFullName: Interleukin enhancer-binding factor 3;Organisim: human;Apparent_Kd_M: 1.462054E-11

Real

Aptamer SeqId: 12759-47 | Target: DRBP76 | UniProt: Q12906

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12759-47 | Target: DRBP76 | UniProt: Q12906 | TargetFullName: Interleukin enhancer-binding factor 3 | Organisim: human | Apparent_Kd_M: 1.462054E-11

Real

Aptamer SeqId:12760-34;Target:ZN774;UniProt:Q6NX45

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12760-34;Target: ZN774;UniProt: Q6NX45;TargetFullName: Zinc finger protein 774;Organisim: human;Apparent_Kd_M: 7.587316E-12

Real

Aptamer SeqId: 12760-34 | Target: ZN774 | UniProt: Q6NX45

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12760-34 | Target: ZN774 | UniProt: Q6NX45 | TargetFullName: Zinc finger protein 774 | Organisim: human | Apparent_Kd_M: 7.587316E-12

Real

Aptamer SeqId:12761-12;Target:APBB2;UniProt:Q92870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12761-12;Target: APBB2;UniProt: Q92870;TargetFullName: Amyloid beta A4 precursor protein-binding family B member 2;Organisim: human;Apparent_Kd_M: 7.499269E-12

Real

Aptamer SeqId: 12761-12 | Target: APBB2 | UniProt: Q92870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12761-12 | Target: APBB2 | UniProt: Q92870 | TargetFullName: Amyloid beta A4 precursor protein-binding family B member 2 | Organisim: human | Apparent_Kd_M: 7.499269E-12

Real

Aptamer SeqId:12763-69;Target:ZN334;UniProt:Q9HCZ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12763-69;Target: ZN334;UniProt: Q9HCZ1;TargetFullName: Zinc finger protein 334;Organisim: human;Apparent_Kd_M: 1.35417E-11

Real

Aptamer SeqId: 12763-69 | Target: ZN334 | UniProt: Q9HCZ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12763-69 | Target: ZN334 | UniProt: Q9HCZ1 | TargetFullName: Zinc finger protein 334 | Organisim: human | Apparent_Kd_M: 1.35417E-11

Real

Aptamer SeqId:12764-3;Target:ELMO1;UniProt:Q92556

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12764-3;Target: ELMO1;UniProt: Q92556;TargetFullName: Engulfment and cell motility protein 1;Organisim: human;Apparent_Kd_M: 2.659548E-11

Real

Aptamer SeqId: 12764-3 | Target: ELMO1 | UniProt: Q92556

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12764-3 | Target: ELMO1 | UniProt: Q92556 | TargetFullName: Engulfment and cell motility protein 1 | Organisim: human | Apparent_Kd_M: 2.659548E-11

Real

Aptamer SeqId:12766-33;Target:GP142;UniProt:Q7Z601

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12766-33;Target: GP142;UniProt: Q7Z601;TargetFullName: Probable G-protein coupled receptor 142;Organisim: human;Apparent_Kd_M: 4.367729E-11

Real

Aptamer SeqId: 12766-33 | Target: GP142 | UniProt: Q7Z601

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12766-33 | Target: GP142 | UniProt: Q7Z601 | TargetFullName: Probable G-protein coupled receptor 142 | Organisim: human | Apparent_Kd_M: 4.367729E-11

Real

Aptamer SeqId:12768-3;Target:PPR3B;UniProt:Q86XI6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12768-3;Target: PPR3B;UniProt: Q86XI6;TargetFullName: Protein phosphatase 1 regulatory subunit 3B;Organisim: human;Apparent_Kd_M: 7.703609E-11

Real

Aptamer SeqId: 12768-3 | Target: PPR3B | UniProt: Q86XI6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12768-3 | Target: PPR3B | UniProt: Q86XI6 | TargetFullName: Protein phosphatase 1 regulatory subunit 3B | Organisim: human | Apparent_Kd_M: 7.703609E-11

Real

Aptamer SeqId:12771-19;Target:ZN180;UniProt:Q9UJW8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12771-19;Target: ZN180;UniProt: Q9UJW8;TargetFullName: Zinc finger protein 180;Organisim: human;Apparent_Kd_M: 3.138149E-12

Real

Aptamer SeqId: 12771-19 | Target: ZN180 | UniProt: Q9UJW8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12771-19 | Target: ZN180 | UniProt: Q9UJW8 | TargetFullName: Zinc finger protein 180 | Organisim: human | Apparent_Kd_M: 3.138149E-12

Real

Aptamer SeqId:12772-8;Target:NUP98;UniProt:P52948

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12772-8;Target: NUP98;UniProt: P52948;TargetFullName: Nuclear pore complex protein Nup98-Nup96;Organisim: human;Apparent_Kd_M: 8.193839E-12

Real

Aptamer SeqId: 12772-8 | Target: NUP98 | UniProt: P52948

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12772-8 | Target: NUP98 | UniProt: P52948 | TargetFullName: Nuclear pore complex protein Nup98-Nup96 | Organisim: human | Apparent_Kd_M: 8.193839E-12

Real

Aptamer SeqId:12774-12;Target:HCN1;UniProt:O60741

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12774-12;Target: HCN1;UniProt: O60741;TargetFullName: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1;Organisim: human;Apparent_Kd_M: 1.996694E-11

Real

Aptamer SeqId: 12774-12 | Target: HCN1 | UniProt: O60741

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12774-12 | Target: HCN1 | UniProt: O60741 | TargetFullName: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | Organisim: human | Apparent_Kd_M: 1.996694E-11

Real

Aptamer SeqId:12775-6;Target:HMGB3;UniProt:O15347

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12775-6;Target: HMGB3;UniProt: O15347;TargetFullName: High mobility group protein B3;Organisim: human;Apparent_Kd_M: 5.536468E-12

Real

Aptamer SeqId: 12775-6 | Target: HMGB3 | UniProt: O15347

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12775-6 | Target: HMGB3 | UniProt: O15347 | TargetFullName: High mobility group protein B3 | Organisim: human | Apparent_Kd_M: 5.536468E-12

Real

Aptamer SeqId:12777-11;Target:SF01;UniProt:Q15637

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12777-11;Target: SF01;UniProt: Q15637;TargetFullName: Splicing factor 1;Organisim: human;Apparent_Kd_M: 2.754613E-12

Real

Aptamer SeqId: 12777-11 | Target: SF01 | UniProt: Q15637

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12777-11 | Target: SF01 | UniProt: Q15637 | TargetFullName: Splicing factor 1 | Organisim: human | Apparent_Kd_M: 2.754613E-12

Real

Aptamer SeqId:12779-30;Target:PRDM4;UniProt:Q9UKN5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12779-30;Target: PRDM4;UniProt: Q9UKN5;TargetFullName: PR domain zinc finger protein 4;Organisim: human;Apparent_Kd_M: 3.143801E-11

Real

Aptamer SeqId: 12779-30 | Target: PRDM4 | UniProt: Q9UKN5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12779-30 | Target: PRDM4 | UniProt: Q9UKN5 | TargetFullName: PR domain zinc finger protein 4 | Organisim: human | Apparent_Kd_M: 3.143801E-11

Real

Aptamer SeqId:12781-2;Target:TRBP2;UniProt:Q15633

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12781-2;Target: TRBP2;UniProt: Q15633;TargetFullName: RISC-loading complex subunit TARBP2;Organisim: human;Apparent_Kd_M: 1.170139E-12

Real

Aptamer SeqId: 12781-2 | Target: TRBP2 | UniProt: Q15633

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12781-2 | Target: TRBP2 | UniProt: Q15633 | TargetFullName: RISC-loading complex subunit TARBP2 | Organisim: human | Apparent_Kd_M: 1.170139E-12

Real

Aptamer SeqId:12783-29;Target:HNRPM;UniProt:P52272

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12783-29;Target: HNRPM;UniProt: P52272;TargetFullName: Heterogeneous nuclear ribonucleoprotein M;Organisim: human;Apparent_Kd_M: 4.612941E-11

Real

Aptamer SeqId: 12783-29 | Target: HNRPM | UniProt: P52272

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12783-29 | Target: HNRPM | UniProt: P52272 | TargetFullName: Heterogeneous nuclear ribonucleoprotein M | Organisim: human | Apparent_Kd_M: 4.612941E-11

Real

Aptamer SeqId:12784-10;Target:APBB3;UniProt:O95704

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12784-10;Target: APBB3;UniProt: O95704;TargetFullName: Amyloid beta A4 precursor protein-binding family B member 3;Organisim: human;Apparent_Kd_M: 5.061588E-12

Real

Aptamer SeqId: 12784-10 | Target: APBB3 | UniProt: O95704

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12784-10 | Target: APBB3 | UniProt: O95704 | TargetFullName: Amyloid beta A4 precursor protein-binding family B member 3 | Organisim: human | Apparent_Kd_M: 5.061588E-12

Real

Aptamer SeqId:12785-49;Target:KAISO;UniProt:Q86T24

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12785-49;Target: KAISO;UniProt: Q86T24;TargetFullName: Transcriptional regulator Kaiso;Organisim: human;Apparent_Kd_M: 1.79E-10

Real

Aptamer SeqId: 12785-49 | Target: KAISO | UniProt: Q86T24

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12785-49 | Target: KAISO | UniProt: Q86T24 | TargetFullName: Transcriptional regulator Kaiso | Organisim: human | Apparent_Kd_M: 1.79E-10

Real

Aptamer SeqId:12786-61;Target:GDE5;UniProt:Q9NPB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12786-61;Target: GDE5;UniProt: Q9NPB8;TargetFullName: Glycerophosphocholine phosphodiesterase GPCPD1;Organisim: human;Apparent_Kd_M: 4.624408E-12

Real

Aptamer SeqId: 12786-61 | Target: GDE5 | UniProt: Q9NPB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12786-61 | Target: GDE5 | UniProt: Q9NPB8 | TargetFullName: Glycerophosphocholine phosphodiesterase GPCPD1 | Organisim: human | Apparent_Kd_M: 4.624408E-12

Real

Aptamer SeqId:12787-47;Target:ZN134;UniProt:P52741

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12787-47;Target: ZN134;UniProt: P52741;TargetFullName: Zinc finger protein 134;Organisim: human;Apparent_Kd_M: 3.097576E-13

Real

Aptamer SeqId: 12787-47 | Target: ZN134 | UniProt: P52741

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12787-47 | Target: ZN134 | UniProt: P52741 | TargetFullName: Zinc finger protein 134 | Organisim: human | Apparent_Kd_M: 3.097576E-13

Real

Aptamer SeqId:12788-6;Target:SGF29;UniProt:Q96ES7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12788-6;Target: SGF29;UniProt: Q96ES7;TargetFullName: SAGA-associated factor 29 homolog;Organisim: human;Apparent_Kd_M: 1.301049E-12

Real

Aptamer SeqId: 12788-6 | Target: SGF29 | UniProt: Q96ES7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12788-6 | Target: SGF29 | UniProt: Q96ES7 | TargetFullName: SAGA-associated factor 29 homolog | Organisim: human | Apparent_Kd_M: 1.301049E-12

Real

Aptamer SeqId:12790-10;Target:CCD51;UniProt:Q96ER9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12790-10;Target: CCD51;UniProt: Q96ER9;TargetFullName: Coiled-coil domain-containing protein 51;Organisim: human;Apparent_Kd_M: 7.479178E-12

Real

Aptamer SeqId: 12790-10 | Target: CCD51 | UniProt: Q96ER9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12790-10 | Target: CCD51 | UniProt: Q96ER9 | TargetFullName: Coiled-coil domain-containing protein 51 | Organisim: human | Apparent_Kd_M: 7.479178E-12

Real

Aptamer SeqId:12793-4;Target:PIWL1;UniProt:Q96J94

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12793-4;Target: PIWL1;UniProt: Q96J94;TargetFullName: Piwi-like protein 1;Organisim: human;Apparent_Kd_M: 1.135208E-11

Real

Aptamer SeqId: 12793-4 | Target: PIWL1 | UniProt: Q96J94

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12793-4 | Target: PIWL1 | UniProt: Q96J94 | TargetFullName: Piwi-like protein 1 | Organisim: human | Apparent_Kd_M: 1.135208E-11

Real

Aptamer SeqId:12794-6;Target:NALP4;UniProt:Q96MN2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12794-6;Target: NALP4;UniProt: Q96MN2;TargetFullName: NACHT; LRR and PYD domains-containing protein 4;Organisim: human;Apparent_Kd_M: 4.845849E-12

Real

Aptamer SeqId: 12794-6 | Target: NALP4 | UniProt: Q96MN2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12794-6 | Target: NALP4 | UniProt: Q96MN2 | TargetFullName: NACHT; LRR and PYD domains-containing protein 4 | Organisim: human | Apparent_Kd_M: 4.845849E-12

Real

Aptamer SeqId:12795-2;Target:ZN566;UniProt:Q969W8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12795-2;Target: ZN566;UniProt: Q969W8;TargetFullName: Zinc finger protein 566;Organisim: human;Apparent_Kd_M: 2.21143E-11

Real

Aptamer SeqId: 12795-2 | Target: ZN566 | UniProt: Q969W8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12795-2 | Target: ZN566 | UniProt: Q969W8 | TargetFullName: Zinc finger protein 566 | Organisim: human | Apparent_Kd_M: 2.21143E-11

Real

Aptamer SeqId:12796-44;Target:NUDT3;UniProt:O95989

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12796-44;Target: NUDT3;UniProt: O95989;TargetFullName: Diphosphoinositol polyphosphate phosphohydrolase 1;Organisim: human;Apparent_Kd_M: 2.593817E-11

Real

Aptamer SeqId: 12796-44 | Target: NUDT3 | UniProt: O95989

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12796-44 | Target: NUDT3 | UniProt: O95989 | TargetFullName: Diphosphoinositol polyphosphate phosphohydrolase 1 | Organisim: human | Apparent_Kd_M: 2.593817E-11

Real

Aptamer SeqId:12798-46;Target:S4A8;UniProt:Q2Y0W8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12798-46;Target: S4A8;UniProt: Q2Y0W8;TargetFullName: Electroneutral sodium bicarbonate exchanger 1;Organisim: human;Apparent_Kd_M: 1.274041E-11

Real

Aptamer SeqId: 12798-46 | Target: S4A8 | UniProt: Q2Y0W8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12798-46 | Target: S4A8 | UniProt: Q2Y0W8 | TargetFullName: Electroneutral sodium bicarbonate exchanger 1 | Organisim: human | Apparent_Kd_M: 1.274041E-11

Real

Aptamer SeqId:12799-65;Target:DJC27;UniProt:Q9NZQ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12799-65;Target: DJC27;UniProt: Q9NZQ0;TargetFullName: DnaJ homolog subfamily C member 27;Organisim: human;Apparent_Kd_M: 5.695413E-12

Real

Aptamer SeqId: 12799-65 | Target: DJC27 | UniProt: Q9NZQ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12799-65 | Target: DJC27 | UniProt: Q9NZQ0 | TargetFullName: DnaJ homolog subfamily C member 27 | Organisim: human | Apparent_Kd_M: 5.695413E-12

Real

Aptamer SeqId:12800-5;Target:TPPP2;UniProt:P59282

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12800-5;Target: TPPP2;UniProt: P59282;TargetFullName: Tubulin polymerization-promoting protein family member 2;Organisim: human;Apparent_Kd_M: 1.446775E-11

Real

Aptamer SeqId: 12800-5 | Target: TPPP2 | UniProt: P59282

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12800-5 | Target: TPPP2 | UniProt: P59282 | TargetFullName: Tubulin polymerization-promoting protein family member 2 | Organisim: human | Apparent_Kd_M: 1.446775E-11

Real

Aptamer SeqId:12801-33;Target:IRF2;UniProt:P14316

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12801-33;Target: IRF2;UniProt: P14316;TargetFullName: Interferon regulatory factor 2;Organisim: human;Apparent_Kd_M: 3.582017E-12

Real

Aptamer SeqId: 12801-33 | Target: IRF2 | UniProt: P14316

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12801-33 | Target: IRF2 | UniProt: P14316 | TargetFullName: Interferon regulatory factor 2 | Organisim: human | Apparent_Kd_M: 3.582017E-12

Real

Aptamer SeqId:12803-9;Target:ZN329;UniProt:Q86UD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12803-9;Target: ZN329;UniProt: Q86UD4;TargetFullName: Zinc finger protein 329;Organisim: human;Apparent_Kd_M: 1.842478E-11

Real

Aptamer SeqId: 12803-9 | Target: ZN329 | UniProt: Q86UD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12803-9 | Target: ZN329 | UniProt: Q86UD4 | TargetFullName: Zinc finger protein 329 | Organisim: human | Apparent_Kd_M: 1.842478E-11

Real

Aptamer SeqId:12804-5;Target:GMEB2;UniProt:Q9UKD1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12804-5;Target: GMEB2;UniProt: Q9UKD1;TargetFullName: Glucocorticoid modulatory element-binding protein 2;Organisim: human;Apparent_Kd_M: 3.452202E-13

Real

Aptamer SeqId: 12804-5 | Target: GMEB2 | UniProt: Q9UKD1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12804-5 | Target: GMEB2 | UniProt: Q9UKD1 | TargetFullName: Glucocorticoid modulatory element-binding protein 2 | Organisim: human | Apparent_Kd_M: 3.452202E-13

Real

Aptamer SeqId:12807-89;Target:RHG30;UniProt:Q7Z6I6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12807-89;Target: RHG30;UniProt: Q7Z6I6;TargetFullName: Rho GTPase-activating protein 30;Organisim: human;Apparent_Kd_M: 3.43313E-11

Real

Aptamer SeqId: 12807-89 | Target: RHG30 | UniProt: Q7Z6I6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12807-89 | Target: RHG30 | UniProt: Q7Z6I6 | TargetFullName: Rho GTPase-activating protein 30 | Organisim: human | Apparent_Kd_M: 3.43313E-11

Real

Aptamer SeqId:12808-103;Target:CHSP1;UniProt:Q9Y2V2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12808-103;Target: CHSP1;UniProt: Q9Y2V2;TargetFullName: Calcium-regulated heat-stable protein 1;Organisim: human;Apparent_Kd_M: 3.759425E-11

Real

Aptamer SeqId: 12808-103 | Target: CHSP1 | UniProt: Q9Y2V2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12808-103 | Target: CHSP1 | UniProt: Q9Y2V2 | TargetFullName: Calcium-regulated heat-stable protein 1 | Organisim: human | Apparent_Kd_M: 3.759425E-11

Real

Aptamer SeqId:12811-55;Target:ZN415;UniProt:Q09FC8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12811-55;Target: ZN415;UniProt: Q09FC8;TargetFullName: Zinc finger protein 415;Organisim: human;Apparent_Kd_M: 4.174193E-11

Real

Aptamer SeqId: 12811-55 | Target: ZN415 | UniProt: Q09FC8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12811-55 | Target: ZN415 | UniProt: Q09FC8 | TargetFullName: Zinc finger protein 415 | Organisim: human | Apparent_Kd_M: 4.174193E-11

Real

Aptamer SeqId:12812-25;Target:ACYP2;UniProt:P14621

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12812-25;Target: ACYP2;UniProt: P14621;TargetFullName: Acylphosphatase-2;Organisim: human;Apparent_Kd_M: 1.246265E-12

Real

Aptamer SeqId: 12812-25 | Target: ACYP2 | UniProt: P14621

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12812-25 | Target: ACYP2 | UniProt: P14621 | TargetFullName: Acylphosphatase-2 | Organisim: human | Apparent_Kd_M: 1.246265E-12

Real

Aptamer SeqId:12813-18;Target:EHBP1;UniProt:Q8NDI1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12813-18;Target: EHBP1;UniProt: Q8NDI1;TargetFullName: EH domain-binding protein 1;Organisim: human;Apparent_Kd_M: 1.144893E-11

Real

Aptamer SeqId: 12813-18 | Target: EHBP1 | UniProt: Q8NDI1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12813-18 | Target: EHBP1 | UniProt: Q8NDI1 | TargetFullName: EH domain-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.144893E-11

Real

Aptamer SeqId:12814-17;Target:RBM40;UniProt:Q96LT9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12814-17;Target: RBM40;UniProt: Q96LT9;TargetFullName: RNA-binding protein 40;Organisim: human;Apparent_Kd_M: 1.022523E-12

Real

Aptamer SeqId: 12814-17 | Target: RBM40 | UniProt: Q96LT9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12814-17 | Target: RBM40 | UniProt: Q96LT9 | TargetFullName: RNA-binding protein 40 | Organisim: human | Apparent_Kd_M: 1.022523E-12

Real

Aptamer SeqId:12815-9;Target:SYIC;UniProt:P41252

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12815-9;Target: SYIC;UniProt: P41252;TargetFullName: Isoleucine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.315853E-10

Real

Aptamer SeqId: 12815-9 | Target: SYIC | UniProt: P41252

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12815-9 | Target: SYIC | UniProt: P41252 | TargetFullName: Isoleucine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.315853E-10

Real

Aptamer SeqId:12817-1;Target:GEM;UniProt:P55040

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12817-1;Target: GEM;UniProt: P55040;TargetFullName: GTP-binding protein GEM;Organisim: human;Apparent_Kd_M: 6.697787E-11

Real

Aptamer SeqId: 12817-1 | Target: GEM | UniProt: P55040

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12817-1 | Target: GEM | UniProt: P55040 | TargetFullName: GTP-binding protein GEM | Organisim: human | Apparent_Kd_M: 6.697787E-11

Real

Aptamer SeqId:12818-159;Target:UT2;UniProt:Q15849

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12818-159;Target: UT2;UniProt: Q15849;TargetFullName: Urea transporter 2;Organisim: human;Apparent_Kd_M: 2.474021E-12

Real

Aptamer SeqId: 12818-159 | Target: UT2 | UniProt: Q15849

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12818-159 | Target: UT2 | UniProt: Q15849 | TargetFullName: Urea transporter 2 | Organisim: human | Apparent_Kd_M: 2.474021E-12

Real

Aptamer SeqId:12820-1;Target:GRAP;UniProt:Q13588

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12820-1;Target: GRAP;UniProt: Q13588;TargetFullName: GRB2-related adapter protein;Organisim: human;Apparent_Kd_M: 2.194109E-12

Real

Aptamer SeqId: 12820-1 | Target: GRAP | UniProt: Q13588

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12820-1 | Target: GRAP | UniProt: Q13588 | TargetFullName: GRB2-related adapter protein | Organisim: human | Apparent_Kd_M: 2.194109E-12

Real

Aptamer SeqId:12821-6;Target:NAL10;UniProt:Q86W26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12821-6;Target: NAL10;UniProt: Q86W26;TargetFullName: NACHT; LRR and PYD domains-containing protein 10;Organisim: human;Apparent_Kd_M: 1.071854E-12

Real

Aptamer SeqId: 12821-6 | Target: NAL10 | UniProt: Q86W26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12821-6 | Target: NAL10 | UniProt: Q86W26 | TargetFullName: NACHT; LRR and PYD domains-containing protein 10 | Organisim: human | Apparent_Kd_M: 1.071854E-12

Real

Aptamer SeqId:12822-34;Target:APBB1;UniProt:O00213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12822-34;Target: APBB1;UniProt: O00213;TargetFullName: Amyloid beta A4 precursor protein-binding family B member 1;Organisim: human;Apparent_Kd_M: 2.41E-11

Real

Aptamer SeqId: 12822-34 | Target: APBB1 | UniProt: O00213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12822-34 | Target: APBB1 | UniProt: O00213 | TargetFullName: Amyloid beta A4 precursor protein-binding family B member 1 | Organisim: human | Apparent_Kd_M: 2.41E-11

Real

Aptamer SeqId:12825-18;Target:DP13A;UniProt:Q9UKG1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12825-18;Target: DP13A;UniProt: Q9UKG1;TargetFullName: DCC-interacting protein 13-alpha;Organisim: human;Apparent_Kd_M: 9.857817E-11

Real

Aptamer SeqId: 12825-18 | Target: DP13A | UniProt: Q9UKG1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12825-18 | Target: DP13A | UniProt: Q9UKG1 | TargetFullName: DCC-interacting protein 13-alpha | Organisim: human | Apparent_Kd_M: 9.857817E-11

Real

Aptamer SeqId:12826-5;Target:SC5A5;UniProt:Q92911

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12826-5;Target: SC5A5;UniProt: Q92911;TargetFullName: Sodium/iodide cotransporter;Organisim: human;Apparent_Kd_M: 4.57399E-11

Real

Aptamer SeqId: 12826-5 | Target: SC5A5 | UniProt: Q92911

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12826-5 | Target: SC5A5 | UniProt: Q92911 | TargetFullName: Sodium/iodide cotransporter | Organisim: human | Apparent_Kd_M: 4.57399E-11

Real

Aptamer SeqId:12827-37;Target:RGS3;UniProt:P49796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12827-37;Target: RGS3;UniProt: P49796;TargetFullName: Regulator of G-protein signaling 3;Organisim: human;Apparent_Kd_M: 5.744717E-12

Real

Aptamer SeqId: 12827-37 | Target: RGS3 | UniProt: P49796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12827-37 | Target: RGS3 | UniProt: P49796 | TargetFullName: Regulator of G-protein signaling 3 | Organisim: human | Apparent_Kd_M: 5.744717E-12

Real

Aptamer SeqId:12830-4;Target:SAP18;UniProt:O00422

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12830-4;Target: SAP18;UniProt: O00422;TargetFullName: Histone deacetylase complex subunit SAP18;Organisim: human;Apparent_Kd_M: 5.6517E-12

Real

Aptamer SeqId: 12830-4 | Target: SAP18 | UniProt: O00422

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12830-4 | Target: SAP18 | UniProt: O00422 | TargetFullName: Histone deacetylase complex subunit SAP18 | Organisim: human | Apparent_Kd_M: 5.6517E-12

Real

Aptamer SeqId:12831-21;Target:TESC;UniProt:Q96BS2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12831-21;Target: TESC;UniProt: Q96BS2;TargetFullName: Calcineurin B homologous protein 3;Organisim: human;Apparent_Kd_M: 2.035371E-12

Real

Aptamer SeqId: 12831-21 | Target: TESC | UniProt: Q96BS2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12831-21 | Target: TESC | UniProt: Q96BS2 | TargetFullName: Calcineurin B homologous protein 3 | Organisim: human | Apparent_Kd_M: 2.035371E-12

Real

Aptamer SeqId:12832-10;Target:ASH2L;UniProt:Q9UBL3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12832-10;Target: ASH2L;UniProt: Q9UBL3;TargetFullName: Set1/Ash2 histone methyltransferase complex subunit ASH2;Organisim: human;Apparent_Kd_M: 4.998902E-11

Real

Aptamer SeqId: 12832-10 | Target: ASH2L | UniProt: Q9UBL3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12832-10 | Target: ASH2L | UniProt: Q9UBL3 | TargetFullName: Set1/Ash2 histone methyltransferase complex subunit ASH2 | Organisim: human | Apparent_Kd_M: 4.998902E-11

Real

Aptamer SeqId:12834-3;Target:KCNF1;UniProt:Q9H3M0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12834-3;Target: KCNF1;UniProt: Q9H3M0;TargetFullName: Potassium voltage-gated channel subfamily F member 1;Organisim: human;Apparent_Kd_M: 4.687532E-12

Real

Aptamer SeqId: 12834-3 | Target: KCNF1 | UniProt: Q9H3M0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12834-3 | Target: KCNF1 | UniProt: Q9H3M0 | TargetFullName: Potassium voltage-gated channel subfamily F member 1 | Organisim: human | Apparent_Kd_M: 4.687532E-12

Real

Aptamer SeqId:12835-101;Target:PYDC1;UniProt:Q8WXC3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12835-101;Target: PYDC1;UniProt: Q8WXC3;TargetFullName: Pyrin domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.231938E-11

Real

Aptamer SeqId: 12835-101 | Target: PYDC1 | UniProt: Q8WXC3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12835-101 | Target: PYDC1 | UniProt: Q8WXC3 | TargetFullName: Pyrin domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.231938E-11

Real

Aptamer SeqId:12838-28;Target:DUS15;UniProt:Q9H1R2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12838-28;Target: DUS15;UniProt: Q9H1R2;TargetFullName: Dual specificity protein phosphatase 15;Organisim: human;Apparent_Kd_M: 1.529003E-12

Real

Aptamer SeqId: 12838-28 | Target: DUS15 | UniProt: Q9H1R2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12838-28 | Target: DUS15 | UniProt: Q9H1R2 | TargetFullName: Dual specificity protein phosphatase 15 | Organisim: human | Apparent_Kd_M: 1.529003E-12

Real

Aptamer SeqId:12842-43;Target:STX10;UniProt:O60499

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12842-43;Target: STX10;UniProt: O60499;TargetFullName: Syntaxin-10;Organisim: human;Apparent_Kd_M: 7.474717E-11

Real

Aptamer SeqId: 12842-43 | Target: STX10 | UniProt: O60499

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12842-43 | Target: STX10 | UniProt: O60499 | TargetFullName: Syntaxin-10 | Organisim: human | Apparent_Kd_M: 7.474717E-11

Real

Aptamer SeqId:12843-6;Target:ZN410;UniProt:Q86VK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12843-6;Target: ZN410;UniProt: Q86VK4;TargetFullName: Zinc finger protein 410;Organisim: human;Apparent_Kd_M: 1.806972E-12

Real

Aptamer SeqId: 12843-6 | Target: ZN410 | UniProt: Q86VK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12843-6 | Target: ZN410 | UniProt: Q86VK4 | TargetFullName: Zinc finger protein 410 | Organisim: human | Apparent_Kd_M: 1.806972E-12

Real

Aptamer SeqId:12844-10;Target:BAG4;UniProt:O95429

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12844-10;Target: BAG4;UniProt: O95429;TargetFullName: BAG family molecular chaperone regulator 4;Organisim: human;Apparent_Kd_M: 4.339676E-11

Real

Aptamer SeqId: 12844-10 | Target: BAG4 | UniProt: O95429

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12844-10 | Target: BAG4 | UniProt: O95429 | TargetFullName: BAG family molecular chaperone regulator 4 | Organisim: human | Apparent_Kd_M: 4.339676E-11

Real

Aptamer SeqId:12845-18;Target:SNX17;UniProt:Q15036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12845-18;Target: SNX17;UniProt: Q15036;TargetFullName: Sorting nexin-17;Organisim: human;Apparent_Kd_M: 1.736673E-11

Real

Aptamer SeqId: 12845-18 | Target: SNX17 | UniProt: Q15036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12845-18 | Target: SNX17 | UniProt: Q15036 | TargetFullName: Sorting nexin-17 | Organisim: human | Apparent_Kd_M: 1.736673E-11

Real

Aptamer SeqId:12846-3;Target:FBXL5;UniProt:Q9UKA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12846-3;Target: FBXL5;UniProt: Q9UKA1;TargetFullName: F-box/LRR-repeat protein 5;Organisim: human;Apparent_Kd_M: 4.929149E-12

Real

Aptamer SeqId: 12846-3 | Target: FBXL5 | UniProt: Q9UKA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12846-3 | Target: FBXL5 | UniProt: Q9UKA1 | TargetFullName: F-box/LRR-repeat protein 5 | Organisim: human | Apparent_Kd_M: 4.929149E-12

Real

Aptamer SeqId:12847-27;Target:MCE1;UniProt:O60942

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12847-27;Target: MCE1;UniProt: O60942;TargetFullName: mRNA-capping enzyme;Organisim: human;Apparent_Kd_M: 9.391767E-11

Real

Aptamer SeqId: 12847-27 | Target: MCE1 | UniProt: O60942

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12847-27 | Target: MCE1 | UniProt: O60942 | TargetFullName: mRNA-capping enzyme | Organisim: human | Apparent_Kd_M: 9.391767E-11

Real

Aptamer SeqId:12848-9;Target:ARHG2;UniProt:Q92974

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12848-9;Target: ARHG2;UniProt: Q92974;TargetFullName: Rho guanine nucleotide exchange factor 2;Organisim: human;Apparent_Kd_M: 1.090336E-11

Real

Aptamer SeqId: 12848-9 | Target: ARHG2 | UniProt: Q92974

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12848-9 | Target: ARHG2 | UniProt: Q92974 | TargetFullName: Rho guanine nucleotide exchange factor 2 | Organisim: human | Apparent_Kd_M: 1.090336E-11

Real

Aptamer SeqId:12849-25;Target:GSKIP;UniProt:Q9P0R6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12849-25;Target: GSKIP;UniProt: Q9P0R6;TargetFullName: GSK3-beta interaction protein;Organisim: human;Apparent_Kd_M: 2.758829E-11

Real

Aptamer SeqId: 12849-25 | Target: GSKIP | UniProt: Q9P0R6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12849-25 | Target: GSKIP | UniProt: Q9P0R6 | TargetFullName: GSK3-beta interaction protein | Organisim: human | Apparent_Kd_M: 2.758829E-11

Real

Aptamer SeqId:12851-5;Target:DPOLM;UniProt:Q9NP87

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12851-5;Target: DPOLM;UniProt: Q9NP87;TargetFullName: DNA-directed DNA/RNA polymerase mu;Organisim: human;Apparent_Kd_M: 8.0856E-13

Real

Aptamer SeqId: 12851-5 | Target: DPOLM | UniProt: Q9NP87

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12851-5 | Target: DPOLM | UniProt: Q9NP87 | TargetFullName: DNA-directed DNA/RNA polymerase mu | Organisim: human | Apparent_Kd_M: 8.0856E-13

Real

Aptamer SeqId:12853-112;Target:TMOD2;UniProt:Q9NZR1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12853-112;Target: TMOD2;UniProt: Q9NZR1;TargetFullName: Tropomodulin-2;Organisim: human;Apparent_Kd_M: 4.433277E-11

Real

Aptamer SeqId: 12853-112 | Target: TMOD2 | UniProt: Q9NZR1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12853-112 | Target: TMOD2 | UniProt: Q9NZR1 | TargetFullName: Tropomodulin-2 | Organisim: human | Apparent_Kd_M: 4.433277E-11

Real

Aptamer SeqId:12854-3;Target:TEAD3;UniProt:Q99594

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12854-3;Target: TEAD3;UniProt: Q99594;TargetFullName: Transcriptional enhancer factor TEF-5;Organisim: human;Apparent_Kd_M: 4.346938E-12

Real

Aptamer SeqId: 12854-3 | Target: TEAD3 | UniProt: Q99594

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12854-3 | Target: TEAD3 | UniProt: Q99594 | TargetFullName: Transcriptional enhancer factor TEF-5 | Organisim: human | Apparent_Kd_M: 4.346938E-12

Real

Aptamer SeqId:12855-16;Target:CT032;UniProt:Q9NQ75

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12855-16;Target: CT032;UniProt: Q9NQ75;TargetFullName: Cas scaffolding protein family member 4;Organisim: human;Apparent_Kd_M: 8.217991E-12

Real

Aptamer SeqId: 12855-16 | Target: CT032 | UniProt: Q9NQ75

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12855-16 | Target: CT032 | UniProt: Q9NQ75 | TargetFullName: Cas scaffolding protein family member 4 | Organisim: human | Apparent_Kd_M: 8.217991E-12

Real

Aptamer SeqId:12856-14;Target:TM237;UniProt:Q96Q45

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12856-14;Target: TM237;UniProt: Q96Q45;TargetFullName: Transmembrane protein 237;Organisim: human;Apparent_Kd_M: 4.358254E-11

Real

Aptamer SeqId: 12856-14 | Target: TM237 | UniProt: Q96Q45

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12856-14 | Target: TM237 | UniProt: Q96Q45 | TargetFullName: Transmembrane protein 237 | Organisim: human | Apparent_Kd_M: 4.358254E-11

Real

Aptamer SeqId:12859-33;Target:PECI;UniProt:O75521

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12859-33;Target: PECI;UniProt: O75521;TargetFullName: Enoyl-CoA delta isomerase 2; mitochondrial;Organisim: human;Apparent_Kd_M: 1.945358E-12

Real

Aptamer SeqId: 12859-33 | Target: PECI | UniProt: O75521

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12859-33 | Target: PECI | UniProt: O75521 | TargetFullName: Enoyl-CoA delta isomerase 2; mitochondrial | Organisim: human | Apparent_Kd_M: 1.945358E-12

Real

Aptamer SeqId:12860-7;Target:cAMP-regulated phosphoprotein 21;UniProt:Q9UBL0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12860-7;Target: cAMP-regulated phosphoprotein 21;UniProt: Q9UBL0;TargetFullName: cAMP-regulated phosphoprotein 21;Organisim: human;Apparent_Kd_M: 7.39799E-13

Real

Aptamer SeqId: 12860-7 | Target: cAMP-regulated phosphoprotein 21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12860-7 | Target: cAMP-regulated phosphoprotein 21 | UniProt: Q9UBL0 | TargetFullName: cAMP-regulated phosphoprotein 21 | Organisim: human | Apparent_Kd_M: 7.39799E-13

Real

Aptamer SeqId:12861-13;Target:TMOD3;UniProt:Q9NYL9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12861-13;Target: TMOD3;UniProt: Q9NYL9;TargetFullName: Tropomodulin-3;Organisim: human;Apparent_Kd_M: 1.641047E-12

Real

Aptamer SeqId: 12861-13 | Target: TMOD3 | UniProt: Q9NYL9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12861-13 | Target: TMOD3 | UniProt: Q9NYL9 | TargetFullName: Tropomodulin-3 | Organisim: human | Apparent_Kd_M: 1.641047E-12

Real

Aptamer SeqId:12862-14;Target:CASL;UniProt:Q14511

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12862-14;Target: CASL;UniProt: Q14511;TargetFullName: Enhancer of filamentation 1;Organisim: human;Apparent_Kd_M: 2.794254E-10

Real

Aptamer SeqId: 12862-14 | Target: CASL | UniProt: Q14511

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12862-14 | Target: CASL | UniProt: Q14511 | TargetFullName: Enhancer of filamentation 1 | Organisim: human | Apparent_Kd_M: 2.794254E-10

Real

Aptamer SeqId:12864-9;Target:NIPA4;UniProt:Q0D2K0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12864-9;Target: NIPA4;UniProt: Q0D2K0;TargetFullName: Magnesium transporter NIPA4;Organisim: human;Apparent_Kd_M: 2.873819E-10

Real

Aptamer SeqId: 12864-9 | Target: NIPA4 | UniProt: Q0D2K0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12864-9 | Target: NIPA4 | UniProt: Q0D2K0 | TargetFullName: Magnesium transporter NIPA4 | Organisim: human | Apparent_Kd_M: 2.873819E-10

Real

Aptamer SeqId:12867-40;Target:DYLT3;UniProt:P51808

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12867-40;Target: DYLT3;UniProt: P51808;TargetFullName: Dynein light chain Tctex-type 3;Organisim: human;Apparent_Kd_M: 1.12043E-11

Real

Aptamer SeqId: 12867-40 | Target: DYLT3 | UniProt: P51808

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12867-40 | Target: DYLT3 | UniProt: P51808 | TargetFullName: Dynein light chain Tctex-type 3 | Organisim: human | Apparent_Kd_M: 1.12043E-11

Real

Aptamer SeqId:12869-68;Target:DDX6;UniProt:P26196

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12869-68;Target: DDX6;UniProt: P26196;TargetFullName: Probable ATP-dependent RNA helicase DDX6;Organisim: human;Apparent_Kd_M: 3.501141E-12

Real

Aptamer SeqId: 12869-68 | Target: DDX6 | UniProt: P26196

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12869-68 | Target: DDX6 | UniProt: P26196 | TargetFullName: Probable ATP-dependent RNA helicase DDX6 | Organisim: human | Apparent_Kd_M: 3.501141E-12

Real

Aptamer SeqId:12871-10;Target:TWF1;UniProt:Q12792

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12871-10;Target: TWF1;UniProt: Q12792;TargetFullName: Twinfilin-1;Organisim: human;Apparent_Kd_M: 7.016657E-12

Real

Aptamer SeqId: 12871-10 | Target: TWF1 | UniProt: Q12792

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12871-10 | Target: TWF1 | UniProt: Q12792 | TargetFullName: Twinfilin-1 | Organisim: human | Apparent_Kd_M: 7.016657E-12

Real

Aptamer SeqId:12872-35;Target:CNGA2;UniProt:Q16280

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12872-35;Target: CNGA2;UniProt: Q16280;TargetFullName: Cyclic nucleotide-gated olfactory channel;Organisim: human;Apparent_Kd_M: 4.545657E-12

Real

Aptamer SeqId: 12872-35 | Target: CNGA2 | UniProt: Q16280

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12872-35 | Target: CNGA2 | UniProt: Q16280 | TargetFullName: Cyclic nucleotide-gated olfactory channel | Organisim: human | Apparent_Kd_M: 4.545657E-12

Real

Aptamer SeqId:12873-11;Target:LEUK;UniProt:P16150

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12873-11;Target: LEUK;UniProt: P16150;TargetFullName: Leukosialin;Organisim: human;Apparent_Kd_M: 4.668252E-11

Real

Aptamer SeqId: 12873-11 | Target: LEUK | UniProt: P16150

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12873-11 | Target: LEUK | UniProt: P16150 | TargetFullName: Leukosialin | Organisim: human | Apparent_Kd_M: 4.668252E-11

Real

Aptamer SeqId:12875-28;Target:UBTD2;UniProt:Q8WUN7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12875-28;Target: UBTD2;UniProt: Q8WUN7;TargetFullName: Ubiquitin domain-containing protein 2;Organisim: human;Apparent_Kd_M: 4.090894E-12

Real

Aptamer SeqId: 12875-28 | Target: UBTD2 | UniProt: Q8WUN7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12875-28 | Target: UBTD2 | UniProt: Q8WUN7 | TargetFullName: Ubiquitin domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 4.090894E-12

Real

Aptamer SeqId:12876-39;Target:SPEF1;UniProt:Q9Y4P9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12876-39;Target: SPEF1;UniProt: Q9Y4P9;TargetFullName: Sperm flagellar protein 1;Organisim: human;Apparent_Kd_M: 2.132333E-11

Real

Aptamer SeqId: 12876-39 | Target: SPEF1 | UniProt: Q9Y4P9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12876-39 | Target: SPEF1 | UniProt: Q9Y4P9 | TargetFullName: Sperm flagellar protein 1 | Organisim: human | Apparent_Kd_M: 2.132333E-11

Real

Aptamer SeqId:12878-60;Target:OSB11;UniProt:Q9BXB4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12878-60;Target: OSB11;UniProt: Q9BXB4;TargetFullName: Oxysterol-binding protein-related protein 11;Organisim: human;Apparent_Kd_M: 2.118741E-12

Real

Aptamer SeqId: 12878-60 | Target: OSB11 | UniProt: Q9BXB4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12878-60 | Target: OSB11 | UniProt: Q9BXB4 | TargetFullName: Oxysterol-binding protein-related protein 11 | Organisim: human | Apparent_Kd_M: 2.118741E-12

Real

Aptamer SeqId:12879-5;Target:p107;UniProt:P28749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12879-5;Target: p107;UniProt: P28749;TargetFullName: Retinoblastoma-like protein 1;Organisim: human;Apparent_Kd_M: 1.066657E-11

Real

Aptamer SeqId: 12879-5 | Target: p107 | UniProt: P28749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12879-5 | Target: p107 | UniProt: P28749 | TargetFullName: Retinoblastoma-like protein 1 | Organisim: human | Apparent_Kd_M: 1.066657E-11

Real

Aptamer SeqId:12880-1;Target:SV2A;UniProt:Q7L0J3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12880-1;Target: SV2A;UniProt: Q7L0J3;TargetFullName: Synaptic vesicle glycoprotein 2A;Organisim: human;Apparent_Kd_M: 1.162094E-11

Real

Aptamer SeqId: 12880-1 | Target: SV2A | UniProt: Q7L0J3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12880-1 | Target: SV2A | UniProt: Q7L0J3 | TargetFullName: Synaptic vesicle glycoprotein 2A | Organisim: human | Apparent_Kd_M: 1.162094E-11

Real

Aptamer SeqId:12881-17;Target:RDH16;UniProt:O75452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12881-17;Target: RDH16;UniProt: O75452;TargetFullName: Retinol dehydrogenase 16;Organisim: human;Apparent_Kd_M: 7.56E-12

Real

Aptamer SeqId: 12881-17 | Target: RDH16 | UniProt: O75452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12881-17 | Target: RDH16 | UniProt: O75452 | TargetFullName: Retinol dehydrogenase 16 | Organisim: human | Apparent_Kd_M: 7.56E-12

Real

Aptamer SeqId:12882-7;Target:PAR11;UniProt:Q9NR21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12882-7;Target: PAR11;UniProt: Q9NR21;TargetFullName: Poly [ADP-ribose] polymerase 11;Organisim: human;Apparent_Kd_M: 3.196593E-12

Real

Aptamer SeqId: 12882-7 | Target: PAR11 | UniProt: Q9NR21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12882-7 | Target: PAR11 | UniProt: Q9NR21 | TargetFullName: Poly ADP-ribose polymerase 11 | Organisim: human | Apparent_Kd_M: 3.196593E-12

Real

Aptamer SeqId:12885-42;Target:NR1D2;UniProt:Q14995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12885-42;Target: NR1D2;UniProt: Q14995;TargetFullName: Nuclear receptor subfamily 1 group D member 2;Organisim: human;Apparent_Kd_M: 3.085646E-12

Real

Aptamer SeqId: 12885-42 | Target: NR1D2 | UniProt: Q14995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12885-42 | Target: NR1D2 | UniProt: Q14995 | TargetFullName: Nuclear receptor subfamily 1 group D member 2 | Organisim: human | Apparent_Kd_M: 3.085646E-12

Real

Aptamer SeqId:12888-18;Target:SAP30;UniProt:O75446

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12888-18;Target: SAP30;UniProt: O75446;TargetFullName: Histone deacetylase complex subunit SAP30;Organisim: human;Apparent_Kd_M: 2.393728E-11

Real

Aptamer SeqId: 12888-18 | Target: SAP30 | UniProt: O75446

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12888-18 | Target: SAP30 | UniProt: O75446 | TargetFullName: Histone deacetylase complex subunit SAP30 | Organisim: human | Apparent_Kd_M: 2.393728E-11

Real

Aptamer SeqId:12891-1;Target:MILK2;UniProt:Q8IY33

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12891-1;Target: MILK2;UniProt: Q8IY33;TargetFullName: MICAL-like protein 2;Organisim: human;Apparent_Kd_M: 6.944057E-12

Real

Aptamer SeqId: 12891-1 | Target: MILK2 | UniProt: Q8IY33

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12891-1 | Target: MILK2 | UniProt: Q8IY33 | TargetFullName: MICAL-like protein 2 | Organisim: human | Apparent_Kd_M: 6.944057E-12

Real

Aptamer SeqId:12892-10;Target:SYTL1;UniProt:Q8IYJ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12892-10;Target: SYTL1;UniProt: Q8IYJ3;TargetFullName: Synaptotagmin-like protein 1;Organisim: human;Apparent_Kd_M: 8.376356E-12

Real

Aptamer SeqId: 12892-10 | Target: SYTL1 | UniProt: Q8IYJ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12892-10 | Target: SYTL1 | UniProt: Q8IYJ3 | TargetFullName: Synaptotagmin-like protein 1 | Organisim: human | Apparent_Kd_M: 8.376356E-12

Real

Aptamer SeqId:12893-159;Target:IP16;UniProt:Q16666

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12893-159;Target: IP16;UniProt: Q16666;TargetFullName: Gamma-interferon-inducible protein 16;Organisim: human;Apparent_Kd_M: 1.728224E-12

Real

Aptamer SeqId: 12893-159 | Target: IP16 | UniProt: Q16666

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12893-159 | Target: IP16 | UniProt: Q16666 | TargetFullName: Gamma-interferon-inducible protein 16 | Organisim: human | Apparent_Kd_M: 1.728224E-12

Real

Aptamer SeqId:12894-3;Target:PAXI1;UniProt:Q6ZW49

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12894-3;Target: PAXI1;UniProt: Q6ZW49;TargetFullName: PAX-interacting protein 1;Organisim: human;Apparent_Kd_M: 1.108344E-11

Real

Aptamer SeqId: 12894-3 | Target: PAXI1 | UniProt: Q6ZW49

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12894-3 | Target: PAXI1 | UniProt: Q6ZW49 | TargetFullName: PAX-interacting protein 1 | Organisim: human | Apparent_Kd_M: 1.108344E-11

Real

Aptamer SeqId:12895-28;Target:DGKB;UniProt:Q9Y6T7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12895-28;Target: DGKB;UniProt: Q9Y6T7;TargetFullName: Diacylglycerol kinase beta;Organisim: human;Apparent_Kd_M: 6.512693E-12

Real

Aptamer SeqId: 12895-28 | Target: DGKB | UniProt: Q9Y6T7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12895-28 | Target: DGKB | UniProt: Q9Y6T7 | TargetFullName: Diacylglycerol kinase beta | Organisim: human | Apparent_Kd_M: 6.512693E-12

Real

Aptamer SeqId:12898-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12898-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.925559E-13

Real

Aptamer SeqId: 12898-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12898-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.925559E-13

Real

Aptamer SeqId:12900-29;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12900-29;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.82E-10

Real

Aptamer SeqId: 12900-29 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12900-29 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.82E-10

Real

Aptamer SeqId:12904-180;Target:cubilin;UniProt:O60494

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12904-180;Target: cubilin;UniProt: O60494;TargetFullName: cubilin;Organisim: human;Apparent_Kd_M: 6.891791E-11

Real

Aptamer SeqId: 12904-180 | Target: cubilin | UniProt: O60494

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12904-180 | Target: cubilin | UniProt: O60494 | TargetFullName: cubilin | Organisim: human | Apparent_Kd_M: 6.891791E-11

Real

Aptamer SeqId:12906-137;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12906-137;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.81E-12

Real

Aptamer SeqId: 12906-137 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12906-137 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.81E-12

Real

Aptamer SeqId:12912-25;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12912-25;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.580893E-12

Real

Aptamer SeqId: 12912-25 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12912-25 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.580893E-12

Real

Aptamer SeqId:12915-26;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12915-26;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.53E-12

Real

Aptamer SeqId: 12915-26 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12915-26 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.53E-12

Real

Aptamer SeqId:12921-51;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12921-51;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.79954E-11

Real

Aptamer SeqId: 12921-51 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12921-51 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.79954E-11

Real

Aptamer SeqId:12923-51;Target:Keratin 17;UniProt:Q04695

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12923-51;Target: Keratin 17;UniProt: Q04695;TargetFullName: Keratin; type I cytoskeletal 17;Organisim: human;Apparent_Kd_M: 2.152548E-11

Real

Aptamer SeqId: 12923-51 | Target: Keratin 17 | UniProt: Q04695

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12923-51 | Target: Keratin 17 | UniProt: Q04695 | TargetFullName: Keratin; type I cytoskeletal 17 | Organisim: human | Apparent_Kd_M: 2.152548E-11

Real

Aptamer SeqId:12925-105;Target:AXIN2;UniProt:Q9Y2T1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12925-105;Target: AXIN2;UniProt: Q9Y2T1;TargetFullName: Axin-2;Organisim: human;Apparent_Kd_M: 2.21E-10

Real

Aptamer SeqId: 12925-105 | Target: AXIN2 | UniProt: Q9Y2T1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12925-105 | Target: AXIN2 | UniProt: Q9Y2T1 | TargetFullName: Axin-2 | Organisim: human | Apparent_Kd_M: 2.21E-10

Real

Aptamer SeqId:12931-16;Target:MCR;UniProt:P08235

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12931-16;Target: MCR;UniProt: P08235;TargetFullName: Mineralocorticoid receptor;Organisim: human;Apparent_Kd_M: 8.134084E-11

Real

Aptamer SeqId: 12931-16 | Target: MCR | UniProt: P08235

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12931-16 | Target: MCR | UniProt: P08235 | TargetFullName: Mineralocorticoid receptor | Organisim: human | Apparent_Kd_M: 8.134084E-11

Real

Aptamer SeqId:12933-17;Target:ENOX1;UniProt:Q8TC92

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12933-17;Target: ENOX1;UniProt: Q8TC92;TargetFullName: Ecto-NOX disulfide-thiol exchanger 1;Organisim: human;Apparent_Kd_M: 1.121029E-11

Real

Aptamer SeqId: 12933-17 | Target: ENOX1 | UniProt: Q8TC92

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12933-17 | Target: ENOX1 | UniProt: Q8TC92 | TargetFullName: Ecto-NOX disulfide-thiol exchanger 1 | Organisim: human | Apparent_Kd_M: 1.121029E-11

Real

Aptamer SeqId:12934-1;Target:HERC5;UniProt:Q9UII4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12934-1;Target: HERC5;UniProt: Q9UII4;TargetFullName: E3 ISG15--protein ligase HERC5;Organisim: human;Apparent_Kd_M: 2.021865E-11

Real

Aptamer SeqId: 12934-1 | Target: HERC5 | UniProt: Q9UII4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12934-1 | Target: HERC5 | UniProt: Q9UII4 | TargetFullName: E3 ISG15--protein ligase HERC5 | Organisim: human | Apparent_Kd_M: 2.021865E-11

Real

Aptamer SeqId:12936-38;Target:RLBP1;UniProt:P12271

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12936-38;Target: RLBP1;UniProt: P12271;TargetFullName: Retinaldehyde-binding protein 1;Organisim: human;Apparent_Kd_M: 3.437483E-11

Real

Aptamer SeqId: 12936-38 | Target: RLBP1 | UniProt: P12271

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12936-38 | Target: RLBP1 | UniProt: P12271 | TargetFullName: Retinaldehyde-binding protein 1 | Organisim: human | Apparent_Kd_M: 3.437483E-11

Real

Aptamer SeqId:12939-1;Target:RPAC1;UniProt:O15160

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12939-1;Target: RPAC1;UniProt: O15160;TargetFullName: DNA-directed RNA polymerases I and III subunit RPAC1;Organisim: human;Apparent_Kd_M: 1.027497E-10

Real

Aptamer SeqId: 12939-1 | Target: RPAC1 | UniProt: O15160

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12939-1 | Target: RPAC1 | UniProt: O15160 | TargetFullName: DNA-directed RNA polymerases I and III subunit RPAC1 | Organisim: human | Apparent_Kd_M: 1.027497E-10

Real

Aptamer SeqId:12940-35;Target:AL3B1;UniProt:P43353

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12940-35;Target: AL3B1;UniProt: P43353;TargetFullName: Aldehyde dehydrogenase family 3 member B1;Organisim: human;Apparent_Kd_M: 1.497219E-11

Real

Aptamer SeqId: 12940-35 | Target: AL3B1 | UniProt: P43353

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12940-35 | Target: AL3B1 | UniProt: P43353 | TargetFullName: Aldehyde dehydrogenase family 3 member B1 | Organisim: human | Apparent_Kd_M: 1.497219E-11

Real

Aptamer SeqId:12941-24;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12941-24;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.023319E-10

Real

Aptamer SeqId: 12941-24 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12941-24 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.023319E-10

Real

Aptamer SeqId:12945-33;Target:RAB18;UniProt:Q9NP72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12945-33;Target: RAB18;UniProt: Q9NP72;TargetFullName: Ras-related protein Rab-18;Organisim: human;Apparent_Kd_M: 6.300422E-11

Real

Aptamer SeqId: 12945-33 | Target: RAB18 | UniProt: Q9NP72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12945-33 | Target: RAB18 | UniProt: Q9NP72 | TargetFullName: Ras-related protein Rab-18 | Organisim: human | Apparent_Kd_M: 6.300422E-11

Real

Aptamer SeqId:12954-71;Target:PPARa;UniProt:Q07869

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12954-71;Target: PPARa;UniProt: Q07869;TargetFullName: Peroxisome proliferator-activated receptor alpha;Organisim: human;Apparent_Kd_M: 4.337883E-12

Real

Aptamer SeqId: 12954-71 | Target: PPARa | UniProt: Q07869

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12954-71 | Target: PPARa | UniProt: Q07869 | TargetFullName: Peroxisome proliferator-activated receptor alpha | Organisim: human | Apparent_Kd_M: 4.337883E-12

Real

Aptamer SeqId:12956-40;Target:KBP;UniProt:Q96EK5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12956-40;Target: KBP;UniProt: Q96EK5;TargetFullName: KIF1-binding protein;Organisim: human;Apparent_Kd_M: 6.514977E-13

Real

Aptamer SeqId: 12956-40 | Target: KBP | UniProt: Q96EK5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12956-40 | Target: KBP | UniProt: Q96EK5 | TargetFullName: KIF1-binding protein | Organisim: human | Apparent_Kd_M: 6.514977E-13

Real

Aptamer SeqId:12957-62;Target:UCR6;UniProt:P14927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12957-62;Target: UCR6;UniProt: P14927;TargetFullName: Cytochrome b-c1 complex subunit 7;Organisim: human;Apparent_Kd_M: 3.298745E-11

Real

Aptamer SeqId: 12957-62 | Target: UCR6 | UniProt: P14927

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12957-62 | Target: UCR6 | UniProt: P14927 | TargetFullName: Cytochrome b-c1 complex subunit 7 | Organisim: human | Apparent_Kd_M: 3.298745E-11

Real

Aptamer SeqId:12958-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12958-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.696918E-12

Real

Aptamer SeqId: 12958-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12958-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.696918E-12

Real

Aptamer SeqId:12960-9;Target:HXK4;UniProt:P35557

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12960-9;Target: HXK4;UniProt: P35557;TargetFullName: Glucokinase;Organisim: human;Apparent_Kd_M: 1.385112E-10

Real

Aptamer SeqId: 12960-9 | Target: HXK4 | UniProt: P35557

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12960-9 | Target: HXK4 | UniProt: P35557 | TargetFullName: Glucokinase | Organisim: human | Apparent_Kd_M: 1.385112E-10

Real

Aptamer SeqId:12963-1;Target:GP107;UniProt:Q5VW38

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12963-1;Target: GP107;UniProt: Q5VW38;TargetFullName: Protein GPR107;Organisim: human;Apparent_Kd_M: 1.478297E-11

Real

Aptamer SeqId: 12963-1 | Target: GP107 | UniProt: Q5VW38

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12963-1 | Target: GP107 | UniProt: Q5VW38 | TargetFullName: Protein GPR107 | Organisim: human | Apparent_Kd_M: 1.478297E-11

Real

Aptamer SeqId:12968-2;Target:CSRP2;UniProt:Q16527

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12968-2;Target: CSRP2;UniProt: Q16527;TargetFullName: Cysteine and glycine-rich protein 2;Organisim: human;Apparent_Kd_M: 1.158485E-10

Real

Aptamer SeqId: 12968-2 | Target: CSRP2 | UniProt: Q16527

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12968-2 | Target: CSRP2 | UniProt: Q16527 | TargetFullName: Cysteine and glycine-rich protein 2 | Organisim: human | Apparent_Kd_M: 1.158485E-10

Real

Aptamer SeqId:12970-35;Target:STAU2;UniProt:Q9NUL3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12970-35;Target: STAU2;UniProt: Q9NUL3;TargetFullName: Double-stranded RNA-binding protein Staufen homolog 2;Organisim: human;Apparent_Kd_M: 3.020769E-12

Real

Aptamer SeqId: 12970-35 | Target: STAU2 | UniProt: Q9NUL3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12970-35 | Target: STAU2 | UniProt: Q9NUL3 | TargetFullName: Double-stranded RNA-binding protein Staufen homolog 2 | Organisim: human | Apparent_Kd_M: 3.020769E-12

Real

Aptamer SeqId:12975-11;Target:Keratin 20;UniProt:P35900

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12975-11;Target: Keratin 20;UniProt: P35900;TargetFullName: Keratin; type I cytoskeletal 20;Organisim: human;Apparent_Kd_M: 4.782091E-12

Real

Aptamer SeqId: 12975-11 | Target: Keratin 20 | UniProt: P35900

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12975-11 | Target: Keratin 20 | UniProt: P35900 | TargetFullName: Keratin; type I cytoskeletal 20 | Organisim: human | Apparent_Kd_M: 4.782091E-12

Real

Aptamer SeqId:12976-49;Target:Vinexin b;UniProt:O60504

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12976-49;Target: Vinexin b;UniProt: O60504;TargetFullName: Vinexin b;Organisim: human;Apparent_Kd_M: 7.074201E-12

Real

Aptamer SeqId: 12976-49 | Target: Vinexin b | UniProt: O60504

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12976-49 | Target: Vinexin b | UniProt: O60504 | TargetFullName: Vinexin b | Organisim: human | Apparent_Kd_M: 7.074201E-12

Real

Aptamer SeqId:12980-31;Target:RBM22;UniProt:Q9NW64

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12980-31;Target: RBM22;UniProt: Q9NW64;TargetFullName: Pre-mRNA-splicing factor RBM22;Organisim: human;Apparent_Kd_M: 1.467686E-10

Real

Aptamer SeqId: 12980-31 | Target: RBM22 | UniProt: Q9NW64

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12980-31 | Target: RBM22 | UniProt: Q9NW64 | TargetFullName: Pre-mRNA-splicing factor RBM22 | Organisim: human | Apparent_Kd_M: 1.467686E-10

Real

Aptamer SeqId:12986-12;Target:LIN7C;UniProt:Q9NUP9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12986-12;Target: LIN7C;UniProt: Q9NUP9;TargetFullName: Protein lin-7 homolog C;Organisim: human;Apparent_Kd_M: 7.806954E-11

Real

Aptamer SeqId: 12986-12 | Target: LIN7C | UniProt: Q9NUP9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12986-12 | Target: LIN7C | UniProt: Q9NUP9 | TargetFullName: Protein lin-7 homolog C | Organisim: human | Apparent_Kd_M: 7.806954E-11

Real

Aptamer SeqId:12987-12;Target:SRSF7;UniProt:Q16629

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12987-12;Target: SRSF7;UniProt: Q16629;TargetFullName: Serine/arginine-rich splicing factor 7;Organisim: human;Apparent_Kd_M: 4.297553E-11

Real

Aptamer SeqId: 12987-12 | Target: SRSF7 | UniProt: Q16629

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12987-12 | Target: SRSF7 | UniProt: Q16629 | TargetFullName: Serine/arginine-rich splicing factor 7 | Organisim: human | Apparent_Kd_M: 4.297553E-11

Real

Aptamer SeqId:12988-49;Target:EWS;UniProt:Q01844

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12988-49;Target: EWS;UniProt: Q01844;TargetFullName: RNA-binding protein EWS;Organisim: human;Apparent_Kd_M: 8.141322E-12

Real

Aptamer SeqId: 12988-49 | Target: EWS | UniProt: Q01844

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12988-49 | Target: EWS | UniProt: Q01844 | TargetFullName: RNA-binding protein EWS | Organisim: human | Apparent_Kd_M: 8.141322E-12

Real

Aptamer SeqId:12990-39;Target:MAP3K3;UniProt:Q99759

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12990-39;Target: MAP3K3;UniProt: Q99759;TargetFullName: Mitogen-activated protein kinase kinase kinase 3;Organisim: human;Apparent_Kd_M: 7.362652E-13

Real

Aptamer SeqId: 12990-39 | Target: MAP3K3 | UniProt: Q99759

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12990-39 | Target: MAP3K3 | UniProt: Q99759 | TargetFullName: Mitogen-activated protein kinase kinase kinase 3 | Organisim: human | Apparent_Kd_M: 7.362652E-13

Real

Aptamer SeqId:12991-49;Target:CUL9;UniProt:Q8IWT3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12991-49;Target: CUL9;UniProt: Q8IWT3;TargetFullName: Cullin-9;Organisim: human;Apparent_Kd_M: 1.87E-10

Real

Aptamer SeqId: 12991-49 | Target: CUL9 | UniProt: Q8IWT3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12991-49 | Target: CUL9 | UniProt: Q8IWT3 | TargetFullName: Cullin-9 | Organisim: human | Apparent_Kd_M: 1.87E-10

Real

Aptamer SeqId:12993-21;Target:NPL4;UniProt:Q8TAT6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 12993-21;Target: NPL4;UniProt: Q8TAT6;TargetFullName: Nuclear protein localization protein 4 homolog;Organisim: human;Apparent_Kd_M: 5.945236E-12

Real

Aptamer SeqId: 12993-21 | Target: NPL4 | UniProt: Q8TAT6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 12993-21 | Target: NPL4 | UniProt: Q8TAT6 | TargetFullName: Nuclear protein localization protein 4 homolog | Organisim: human | Apparent_Kd_M: 5.945236E-12

Real

Aptamer SeqId:13007-66;Target:LCN10;UniProt:Q6JVE6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13007-66;Target: LCN10;UniProt: Q6JVE6;TargetFullName: Epididymal-specific lipocalin-10;Organisim: human;Apparent_Kd_M: 6.095911E-11

Real

Aptamer SeqId: 13007-66 | Target: LCN10 | UniProt: Q6JVE6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13007-66 | Target: LCN10 | UniProt: Q6JVE6 | TargetFullName: Epididymal-specific lipocalin-10 | Organisim: human | Apparent_Kd_M: 6.095911E-11

Real

Aptamer SeqId:13011-20;Target:RS10;UniProt:P46783

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13011-20;Target: RS10;UniProt: P46783;TargetFullName: 40S ribosomal protein S10;Organisim: human;Apparent_Kd_M: 1.547548E-10

Real

Aptamer SeqId: 13011-20 | Target: RS10 | UniProt: P46783

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13011-20 | Target: RS10 | UniProt: P46783 | TargetFullName: 40S ribosomal protein S10 | Organisim: human | Apparent_Kd_M: 1.547548E-10

Real

Aptamer SeqId:13013-41;Target:PRKN2;UniProt:O60260

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13013-41;Target: PRKN2;UniProt: O60260;TargetFullName: E3 ubiquitin-protein ligase parkin;Organisim: human;Apparent_Kd_M: 2.917207E-11

Real

Aptamer SeqId: 13013-41 | Target: PRKN2 | UniProt: O60260

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13013-41 | Target: PRKN2 | UniProt: O60260 | TargetFullName: E3 ubiquitin-protein ligase parkin | Organisim: human | Apparent_Kd_M: 2.917207E-11

Real

Aptamer SeqId:13021-12;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13021-12;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.863371E-12

Real

Aptamer SeqId: 13021-12 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13021-12 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.863371E-12

Real

Aptamer SeqId:13022-20;Target:P5I11;UniProt:O14683

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13022-20;Target: P5I11;UniProt: O14683;TargetFullName: Tumor protein p53-inducible protein 11;Organisim: human;Apparent_Kd_M: 8.638396E-11

Real

Aptamer SeqId: 13022-20 | Target: P5I11 | UniProt: O14683

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13022-20 | Target: P5I11 | UniProt: O14683 | TargetFullName: Tumor protein p53-inducible protein 11 | Organisim: human | Apparent_Kd_M: 8.638396E-11

Real

Aptamer SeqId:13023-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13023-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.971225E-12

Real

Aptamer SeqId: 13023-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13023-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.971225E-12

Real

Aptamer SeqId:13025-4;Target:FRS2;UniProt:Q8WU20

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13025-4;Target: FRS2;UniProt: Q8WU20;TargetFullName: Fibroblast growth factor receptor substrate 2;Organisim: human;Apparent_Kd_M: 1.607955E-10

Real

Aptamer SeqId: 13025-4 | Target: FRS2 | UniProt: Q8WU20

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13025-4 | Target: FRS2 | UniProt: Q8WU20 | TargetFullName: Fibroblast growth factor receptor substrate 2 | Organisim: human | Apparent_Kd_M: 1.607955E-10

Real

Aptamer SeqId:13027-20;Target:CBX7;UniProt:O95931

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13027-20;Target: CBX7;UniProt: O95931;TargetFullName: Chromobox protein homolog 7;Organisim: human;Apparent_Kd_M: 6.096448E-12

Real

Aptamer SeqId: 13027-20 | Target: CBX7 | UniProt: O95931

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13027-20 | Target: CBX7 | UniProt: O95931 | TargetFullName: Chromobox protein homolog 7 | Organisim: human | Apparent_Kd_M: 6.096448E-12

Real

Aptamer SeqId:13028-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13028-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.725131E-12

Real

Aptamer SeqId: 13028-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13028-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.725131E-12

Real

Aptamer SeqId:13032-1;Target:BECN1;UniProt:Q14457

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13032-1;Target: BECN1;UniProt: Q14457;TargetFullName: Beclin-1;Organisim: human;Apparent_Kd_M: 6.99E-12

Real

Aptamer SeqId: 13032-1 | Target: BECN1 | UniProt: Q14457

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13032-1 | Target: BECN1 | UniProt: Q14457 | TargetFullName: Beclin-1 | Organisim: human | Apparent_Kd_M: 6.99E-12

Real

Aptamer SeqId:13039-1;Target:PP1R8;UniProt:Q12972

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13039-1;Target: PP1R8;UniProt: Q12972;TargetFullName: Nuclear inhibitor of protein phosphatase 1;Organisim: human;Apparent_Kd_M: 2.652804E-11

Real

Aptamer SeqId: 13039-1 | Target: PP1R8 | UniProt: Q12972

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13039-1 | Target: PP1R8 | UniProt: Q12972 | TargetFullName: Nuclear inhibitor of protein phosphatase 1 | Organisim: human | Apparent_Kd_M: 2.652804E-11

Real

Aptamer SeqId:13041-47;Target:TRAF4;UniProt:Q9BUZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13041-47;Target: TRAF4;UniProt: Q9BUZ4;TargetFullName: TNF receptor-associated factor 4;Organisim: human;Apparent_Kd_M: 3.189905E-12

Real

Aptamer SeqId: 13041-47 | Target: TRAF4 | UniProt: Q9BUZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13041-47 | Target: TRAF4 | UniProt: Q9BUZ4 | TargetFullName: TNF receptor-associated factor 4 | Organisim: human | Apparent_Kd_M: 3.189905E-12

Real

Aptamer SeqId:13042-7;Target:KCA10;UniProt:Q16322

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13042-7;Target: KCA10;UniProt: Q16322;TargetFullName: Potassium voltage-gated channel subfamily A member 10;Organisim: human;Apparent_Kd_M: 3.377202E-10

Real

Aptamer SeqId: 13042-7 | Target: KCA10 | UniProt: Q16322

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13042-7 | Target: KCA10 | UniProt: Q16322 | TargetFullName: Potassium voltage-gated channel subfamily A member 10 | Organisim: human | Apparent_Kd_M: 3.377202E-10

Real

Aptamer SeqId:13043-157;Target:ATAD2;UniProt:Q6PL18

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13043-157;Target: ATAD2;UniProt: Q6PL18;TargetFullName: ATPase family AAA domain-containing protein 2;Organisim: human;Apparent_Kd_M: 2.275165E-11

Real

Aptamer SeqId: 13043-157 | Target: ATAD2 | UniProt: Q6PL18

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13043-157 | Target: ATAD2 | UniProt: Q6PL18 | TargetFullName: ATPase family AAA domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 2.275165E-11

Real

Aptamer SeqId:13044-5;Target:TS101;UniProt:Q99816

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13044-5;Target: TS101;UniProt: Q99816;TargetFullName: Tumor susceptibility gene 101 protein;Organisim: human;Apparent_Kd_M: 3.338092E-12

Real

Aptamer SeqId: 13044-5 | Target: TS101 | UniProt: Q99816

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13044-5 | Target: TS101 | UniProt: Q99816 | TargetFullName: Tumor susceptibility gene 101 protein | Organisim: human | Apparent_Kd_M: 3.338092E-12

Real

Aptamer SeqId:13053-6;Target:S6A14;UniProt:Q9UN76

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13053-6;Target: S6A14;UniProt: Q9UN76;TargetFullName: Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+);Organisim: human;Apparent_Kd_M: 6.215447E-11

Real

Aptamer SeqId: 13053-6 | Target: S6A14 | UniProt: Q9UN76

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13053-6 | Target: S6A14 | UniProt: Q9UN76 | TargetFullName: Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) | Organisim: human | Apparent_Kd_M: 6.215447E-11

Real

Aptamer SeqId:13055-53;Target:PSD1;UniProt:A5PKW4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13055-53;Target: PSD1;UniProt: A5PKW4;TargetFullName: PH and SEC7 domain-containing protein 1;Organisim: human;Apparent_Kd_M: 2.816871E-11

Real

Aptamer SeqId: 13055-53 | Target: PSD1 | UniProt: A5PKW4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13055-53 | Target: PSD1 | UniProt: A5PKW4 | TargetFullName: PH and SEC7 domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.816871E-11

Real

Aptamer SeqId:13056-18;Target:S6A16;UniProt:Q9GZN6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13056-18;Target: S6A16;UniProt: Q9GZN6;TargetFullName: Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5;Organisim: human;Apparent_Kd_M: 3.64955E-12

Real

Aptamer SeqId: 13056-18 | Target: S6A16 | UniProt: Q9GZN6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13056-18 | Target: S6A16 | UniProt: Q9GZN6 | TargetFullName: Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 | Organisim: human | Apparent_Kd_M: 3.64955E-12

Real

Aptamer SeqId:13059-33;Target:RIFK;UniProt:Q969G6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13059-33;Target: RIFK;UniProt: Q969G6;TargetFullName: Riboflavin kinase;Organisim: human;Apparent_Kd_M: 2.697739E-12

Real

Aptamer SeqId: 13059-33 | Target: RIFK | UniProt: Q969G6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13059-33 | Target: RIFK | UniProt: Q969G6 | TargetFullName: Riboflavin kinase | Organisim: human | Apparent_Kd_M: 2.697739E-12

Real

Aptamer SeqId:13062-4;Target:GMFG;UniProt:O60234

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13062-4;Target: GMFG;UniProt: O60234;TargetFullName: Glia maturation factor gamma;Organisim: human;Apparent_Kd_M: 1.028543E-11

Real

Aptamer SeqId: 13062-4 | Target: GMFG | UniProt: O60234

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13062-4 | Target: GMFG | UniProt: O60234 | TargetFullName: Glia maturation factor gamma | Organisim: human | Apparent_Kd_M: 1.028543E-11

Real

Aptamer SeqId:13066-42;Target:EDC4;UniProt:Q6P2E9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13066-42;Target: EDC4;UniProt: Q6P2E9;TargetFullName: Enhancer of mRNA-decapping protein 4;Organisim: human;Apparent_Kd_M: 3.015356E-12

Real

Aptamer SeqId: 13066-42 | Target: EDC4 | UniProt: Q6P2E9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13066-42 | Target: EDC4 | UniProt: Q6P2E9 | TargetFullName: Enhancer of mRNA-decapping protein 4 | Organisim: human | Apparent_Kd_M: 3.015356E-12

Real

Aptamer SeqId:13067-5;Target:KGP1B;UniProt:Q13976

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13067-5;Target: KGP1B;UniProt: Q13976;TargetFullName: cGMP-dependent protein kinase 1; beta isozyme;Organisim: human;Apparent_Kd_M: 7.174044E-11

Real

Aptamer SeqId: 13067-5 | Target: KGP1B | UniProt: Q13976

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13067-5 | Target: KGP1B | UniProt: Q13976 | TargetFullName: cGMP-dependent protein kinase 1; beta isozyme | Organisim: human | Apparent_Kd_M: 7.174044E-11

Real

Aptamer SeqId:13068-139;Target:CCS;UniProt:O14618

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13068-139;Target: CCS;UniProt: O14618;TargetFullName: Copper chaperone for superoxide dismutase;Organisim: human;Apparent_Kd_M: 3.299687E-10

Real

Aptamer SeqId: 13068-139 | Target: CCS | UniProt: O14618

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13068-139 | Target: CCS | UniProt: O14618 | TargetFullName: Copper chaperone for superoxide dismutase | Organisim: human | Apparent_Kd_M: 3.299687E-10

Real

Aptamer SeqId:13073-14;Target:AN32A;UniProt:P39687

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13073-14;Target: AN32A;UniProt: P39687;TargetFullName: Acidic leucine-rich nuclear phosphoprotein 32 family member A;Organisim: human;Apparent_Kd_M: 9.26905E-11

Real

Aptamer SeqId: 13073-14 | Target: AN32A | UniProt: P39687

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13073-14 | Target: AN32A | UniProt: P39687 | TargetFullName: Acidic leucine-rich nuclear phosphoprotein 32 family member A | Organisim: human | Apparent_Kd_M: 9.26905E-11

Real

Aptamer SeqId:13076-4;Target:FXR1;UniProt:P51114

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13076-4;Target: FXR1;UniProt: P51114;TargetFullName: Fragile X mental retardation syndrome-related protein 1;Organisim: human;Apparent_Kd_M: 1.32639E-11

Real

Aptamer SeqId: 13076-4 | Target: FXR1 | UniProt: P51114

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13076-4 | Target: FXR1 | UniProt: P51114 | TargetFullName: Fragile X mental retardation syndrome-related protein 1 | Organisim: human | Apparent_Kd_M: 1.32639E-11

Real

Aptamer SeqId:13078-3;Target:CETN2;UniProt:P41208

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13078-3;Target: CETN2;UniProt: P41208;TargetFullName: Centrin-2;Organisim: human;Apparent_Kd_M: 2.69146E-12

Real

Aptamer SeqId: 13078-3 | Target: CETN2 | UniProt: P41208

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13078-3 | Target: CETN2 | UniProt: P41208 | TargetFullName: Centrin-2 | Organisim: human | Apparent_Kd_M: 2.69146E-12

Real

Aptamer SeqId:13082-9;Target:UN45A;UniProt:Q9H3U1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13082-9;Target: UN45A;UniProt: Q9H3U1;TargetFullName: Protein unc-45 homolog A;Organisim: human;Apparent_Kd_M: 3.42632E-12

Real

Aptamer SeqId: 13082-9 | Target: UN45A | UniProt: Q9H3U1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13082-9 | Target: UN45A | UniProt: Q9H3U1 | TargetFullName: Protein unc-45 homolog A | Organisim: human | Apparent_Kd_M: 3.42632E-12

Real

Aptamer SeqId:13083-18;Target:SYVC;UniProt:P26640

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13083-18;Target: SYVC;UniProt: P26640;TargetFullName: Valine--tRNA ligase;Organisim: human;Apparent_Kd_M: 1.392158E-10

Real

Aptamer SeqId: 13083-18 | Target: SYVC | UniProt: P26640

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13083-18 | Target: SYVC | UniProt: P26640 | TargetFullName: Valine--tRNA ligase | Organisim: human | Apparent_Kd_M: 1.392158E-10

Real

Aptamer SeqId:13085-18;Target:GLP1R;UniProt:P43220

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13085-18;Target: GLP1R;UniProt: P43220;TargetFullName: Glucagon-like peptide 1 receptor;Organisim: human;Apparent_Kd_M: 1.951398E-10

Real

Aptamer SeqId: 13085-18 | Target: GLP1R | UniProt: P43220

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13085-18 | Target: GLP1R | UniProt: P43220 | TargetFullName: Glucagon-like peptide 1 receptor | Organisim: human | Apparent_Kd_M: 1.951398E-10

Real

Aptamer SeqId:13088-397;Target:BTC;UniProt:P35070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13088-397;Target: BTC;UniProt: P35070;TargetFullName: Betacellulin;Organisim: human;Apparent_Kd_M: 3.03E-11

Real

Aptamer SeqId: 13088-397 | Target: BTC | UniProt: P35070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13088-397 | Target: BTC | UniProt: P35070 | TargetFullName: Betacellulin | Organisim: human | Apparent_Kd_M: 3.03E-11

Real

Aptamer SeqId:13089-6;Target:HIF-1a;UniProt:Q16665

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13089-6;Target: HIF-1a;UniProt: Q16665;TargetFullName: Hypoxia-inducible factor 1-alpha;Organisim: human;Apparent_Kd_M: 2.04E-10

Real

Aptamer SeqId: 13089-6 | Target: HIF-1a | UniProt: Q16665

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13089-6 | Target: HIF-1a | UniProt: Q16665 | TargetFullName: Hypoxia-inducible factor 1-alpha | Organisim: human | Apparent_Kd_M: 2.04E-10

Real

Aptamer SeqId:13090-17;Target:S100A6;UniProt:P06703

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13090-17;Target: S100A6;UniProt: P06703;TargetFullName: Protein S100-A6;Organisim: human;Apparent_Kd_M: 2.1E-11

Real

Aptamer SeqId: 13090-17 | Target: S100A6 | UniProt: P06703

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13090-17 | Target: S100A6 | UniProt: P06703 | TargetFullName: Protein S100-A6 | Organisim: human | Apparent_Kd_M: 2.1E-11

Real

Aptamer SeqId:13093-6;Target:SECTM1;UniProt:Q8WVN6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13093-6;Target: SECTM1;UniProt: Q8WVN6;TargetFullName: Secreted and transmembrane protein 1;Organisim: human;Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId: 13093-6 | Target: SECTM1 | UniProt: Q8WVN6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13093-6 | Target: SECTM1 | UniProt: Q8WVN6 | TargetFullName: Secreted and transmembrane protein 1 | Organisim: human | Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId:13094-75;Target:RSPO3;UniProt:Q9BXY4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13094-75;Target: RSPO3;UniProt: Q9BXY4;TargetFullName: R-spondin-3;Organisim: human;Apparent_Kd_M: 2.7E-12

Real

Aptamer SeqId: 13094-75 | Target: RSPO3 | UniProt: Q9BXY4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13094-75 | Target: RSPO3 | UniProt: Q9BXY4 | TargetFullName: R-spondin-3 | Organisim: human | Apparent_Kd_M: 2.7E-12

Real

Aptamer SeqId:13095-51;Target:PSP;UniProt:P05451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13095-51;Target: PSP;UniProt: P05451;TargetFullName: Lithostathine-1-alpha;Organisim: human;Apparent_Kd_M: 9.1E-13

Real

Aptamer SeqId: 13095-51 | Target: PSP | UniProt: P05451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13095-51 | Target: PSP | UniProt: P05451 | TargetFullName: Lithostathine-1-alpha | Organisim: human | Apparent_Kd_M: 9.1E-13

Real

Aptamer SeqId:13097-11;Target:Apoptosis regulator Bcl-W;UniProt:Q92843

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13097-11;Target: Apoptosis regulator Bcl-W;UniProt: Q92843;TargetFullName: Bcl-2-like protein 2;Organisim: human;Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId: 13097-11 | Target: Apoptosis regulator Bcl-W

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13097-11 | Target: Apoptosis regulator Bcl-W | UniProt: Q92843 | TargetFullName: Bcl-2-like protein 2 | Organisim: human | Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId:13098-93;Target:VEGF-D;UniProt:O43915

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13098-93;Target: VEGF-D;UniProt: O43915;TargetFullName: Vascular endothelial growth factor D;Organisim: human;Apparent_Kd_M: 6.1E-13

Real

Aptamer SeqId: 13098-93 | Target: VEGF-D | UniProt: O43915

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13098-93 | Target: VEGF-D | UniProt: O43915 | TargetFullName: Vascular endothelial growth factor D | Organisim: human | Apparent_Kd_M: 6.1E-13

Real

Aptamer SeqId:13101-60;Target:SOST;UniProt:Q9BQB4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13101-60;Target: SOST;UniProt: Q9BQB4;TargetFullName: Sclerostin;Organisim: human;Apparent_Kd_M: 2.79E-12

Real

Aptamer SeqId: 13101-60 | Target: SOST | UniProt: Q9BQB4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13101-60 | Target: SOST | UniProt: Q9BQB4 | TargetFullName: Sclerostin | Organisim: human | Apparent_Kd_M: 2.79E-12

Real

Aptamer SeqId:13102-1;Target:FAM3D;UniProt:Q96BQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13102-1;Target: FAM3D;UniProt: Q96BQ1;TargetFullName: Protein FAM3D;Organisim: human;Apparent_Kd_M: 1.82E-12

Real

Aptamer SeqId: 13102-1 | Target: FAM3D | UniProt: Q96BQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13102-1 | Target: FAM3D | UniProt: Q96BQ1 | TargetFullName: Protein FAM3D | Organisim: human | Apparent_Kd_M: 1.82E-12

Real

Aptamer SeqId:13103-125;Target:CSH;UniProt:P0DML2|P0DML3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13103-125;Target: CSH;UniProt: P0DML2|P0DML3;TargetFullName: Chorionic somatomammotropin hormone;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 13103-125 | Target: CSH | UniProt: P0DML2|P0DML3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13103-125 | Target: CSH | UniProt: P0DML2|P0DML3 | TargetFullName: Chorionic somatomammotropin hormone | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:13104-32;Target:EFNB1;UniProt:P98172

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13104-32;Target: EFNB1;UniProt: P98172;TargetFullName: Ephrin-B1;Organisim: human;Apparent_Kd_M: 9.72E-12

Real

Aptamer SeqId: 13104-32 | Target: EFNB1 | UniProt: P98172

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13104-32 | Target: EFNB1 | UniProt: P98172 | TargetFullName: Ephrin-B1 | Organisim: human | Apparent_Kd_M: 9.72E-12

Real

Aptamer SeqId:13105-7;Target:SNP25;UniProt:P60880

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13105-7;Target: SNP25;UniProt: P60880;TargetFullName: Synaptosomal-associated protein 25;Organisim: human;Apparent_Kd_M: 5.57E-11

Real

Aptamer SeqId: 13105-7 | Target: SNP25 | UniProt: P60880

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13105-7 | Target: SNP25 | UniProt: P60880 | TargetFullName: Synaptosomal-associated protein 25 | Organisim: human | Apparent_Kd_M: 5.57E-11

Real

Aptamer SeqId:13107-9;Target:LYPD3;UniProt:O95274

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13107-9;Target: LYPD3;UniProt: O95274;TargetFullName: Ly6/PLAUR domain-containing protein 3;Organisim: human;Apparent_Kd_M: 5.39E-11

Real

Aptamer SeqId: 13107-9 | Target: LYPD3 | UniProt: O95274

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13107-9 | Target: LYPD3 | UniProt: O95274 | TargetFullName: Ly6/PLAUR domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 5.39E-11

Real

Aptamer SeqId:13109-82;Target:NEGR1;UniProt:Q7Z3B1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13109-82;Target: NEGR1;UniProt: Q7Z3B1;TargetFullName: Neuronal growth regulator 1;Organisim: human;Apparent_Kd_M: 6.39E-12

Real

Aptamer SeqId: 13109-82 | Target: NEGR1 | UniProt: Q7Z3B1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13109-82 | Target: NEGR1 | UniProt: Q7Z3B1 | TargetFullName: Neuronal growth regulator 1 | Organisim: human | Apparent_Kd_M: 6.39E-12

Real

Aptamer SeqId:13111-79;Target:BCL6;UniProt:P41182

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13111-79;Target: BCL6;UniProt: P41182;TargetFullName: B-cell lymphoma 6 protein;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 13111-79 | Target: BCL6 | UniProt: P41182

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13111-79 | Target: BCL6 | UniProt: P41182 | TargetFullName: B-cell lymphoma 6 protein | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:13112-179;Target:FSTL1;UniProt:Q12841

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13112-179;Target: FSTL1;UniProt: Q12841;TargetFullName: Follistatin-related protein 1;Organisim: human;Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId: 13112-179 | Target: FSTL1 | UniProt: Q12841

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13112-179 | Target: FSTL1 | UniProt: Q12841 | TargetFullName: Follistatin-related protein 1 | Organisim: human | Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId:13113-7;Target:Osteopontin;UniProt:P10451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13113-7;Target: Osteopontin;UniProt: P10451;TargetFullName: Osteopontin;Organisim: human;Apparent_Kd_M: 1.27E-10

Real

Aptamer SeqId: 13113-7 | Target: Osteopontin | UniProt: P10451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13113-7 | Target: Osteopontin | UniProt: P10451 | TargetFullName: Osteopontin | Organisim: human | Apparent_Kd_M: 1.27E-10

Real

Aptamer SeqId:13114-50;Target:Lumican;UniProt:P51884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13114-50;Target: Lumican;UniProt: P51884;TargetFullName: Lumican;Organisim: human;Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId: 13114-50 | Target: Lumican | UniProt: P51884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13114-50 | Target: Lumican | UniProt: P51884 | TargetFullName: Lumican | Organisim: human | Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId:13116-25;Target:CD177;UniProt:Q8N6Q3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13116-25;Target: CD177;UniProt: Q8N6Q3;TargetFullName: CD177 antigen;Organisim: human;Apparent_Kd_M: 4.21E-12

Real

Aptamer SeqId: 13116-25 | Target: CD177 | UniProt: Q8N6Q3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13116-25 | Target: CD177 | UniProt: Q8N6Q3 | TargetFullName: CD177 antigen | Organisim: human | Apparent_Kd_M: 4.21E-12

Real

Aptamer SeqId:13118-5;Target:SMOC1;UniProt:Q9H4F8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13118-5;Target: SMOC1;UniProt: Q9H4F8;TargetFullName: SPARC-related modular calcium-binding protein 1;Organisim: human;Apparent_Kd_M: 5.63E-12

Real

Aptamer SeqId: 13118-5 | Target: SMOC1 | UniProt: Q9H4F8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13118-5 | Target: SMOC1 | UniProt: Q9H4F8 | TargetFullName: SPARC-related modular calcium-binding protein 1 | Organisim: human | Apparent_Kd_M: 5.63E-12

Real

Aptamer SeqId:13119-26;Target:protein Z inhibitor;UniProt:Q9UK55

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13119-26;Target: protein Z inhibitor;UniProt: Q9UK55;TargetFullName: Protein Z-dependent protease inhibitor;Organisim: human;Apparent_Kd_M: 1.47E-11

Real

Aptamer SeqId: 13119-26 | Target: protein Z inhibitor | UniProt: Q9UK55

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13119-26 | Target: protein Z inhibitor | UniProt: Q9UK55 | TargetFullName: Protein Z-dependent protease inhibitor | Organisim: human | Apparent_Kd_M: 1.47E-11

Real

Aptamer SeqId:13122-19;Target:FLRT2;UniProt:O43155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13122-19;Target: FLRT2;UniProt: O43155;TargetFullName: Leucine-rich repeat transmembrane protein FLRT2;Organisim: human;Apparent_Kd_M: 4.17E-12

Real

Aptamer SeqId: 13122-19 | Target: FLRT2 | UniProt: O43155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13122-19 | Target: FLRT2 | UniProt: O43155 | TargetFullName: Leucine-rich repeat transmembrane protein FLRT2 | Organisim: human | Apparent_Kd_M: 4.17E-12

Real

Aptamer SeqId:13123-3;Target:FLRT3;UniProt:Q9NZU0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13123-3;Target: FLRT3;UniProt: Q9NZU0;TargetFullName: Leucine-rich repeat transmembrane protein FLRT3;Organisim: human;Apparent_Kd_M: 9.11E-12

Real

Aptamer SeqId: 13123-3 | Target: FLRT3 | UniProt: Q9NZU0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13123-3 | Target: FLRT3 | UniProt: Q9NZU0 | TargetFullName: Leucine-rich repeat transmembrane protein FLRT3 | Organisim: human | Apparent_Kd_M: 9.11E-12

Real

Aptamer SeqId:13124-20;Target:ISLR2;UniProt:Q6UXK2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13124-20;Target: ISLR2;UniProt: Q6UXK2;TargetFullName: Immunoglobulin superfamily containing leucine-rich repeat protein 2;Organisim: human;Apparent_Kd_M: 7.07E-12

Real

Aptamer SeqId: 13124-20 | Target: ISLR2 | UniProt: Q6UXK2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13124-20 | Target: ISLR2 | UniProt: Q6UXK2 | TargetFullName: Immunoglobulin superfamily containing leucine-rich repeat protein 2 | Organisim: human | Apparent_Kd_M: 7.07E-12

Real

Aptamer SeqId:13125-45;Target:Vitronectin;UniProt:P04004

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13125-45;Target: Vitronectin;UniProt: P04004;TargetFullName: Vitronectin;Organisim: human;Apparent_Kd_M: 3.59E-11

Real

Aptamer SeqId: 13125-45 | Target: Vitronectin | UniProt: P04004

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13125-45 | Target: Vitronectin | UniProt: P04004 | TargetFullName: Vitronectin | Organisim: human | Apparent_Kd_M: 3.59E-11

Real

Aptamer SeqId:13126-52;Target:DSC2;UniProt:Q02487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13126-52;Target: DSC2;UniProt: Q02487;TargetFullName: Desmocollin-2;Organisim: human;Apparent_Kd_M: 1.37E-10

Real

Aptamer SeqId: 13126-52 | Target: DSC2 | UniProt: Q02487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13126-52 | Target: DSC2 | UniProt: Q02487 | TargetFullName: Desmocollin-2 | Organisim: human | Apparent_Kd_M: 1.37E-10

Real

Aptamer SeqId:13129-40;Target:LDLR;UniProt:P01130

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13129-40;Target: LDLR;UniProt: P01130;TargetFullName: Low-density lipoprotein receptor;Organisim: human;Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId: 13129-40 | Target: LDLR | UniProt: P01130

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13129-40 | Target: LDLR | UniProt: P01130 | TargetFullName: Low-density lipoprotein receptor | Organisim: human | Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId:13130-150;Target:HXK2;UniProt:P52789

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13130-150;Target: HXK2;UniProt: P52789;TargetFullName: Hexokinase-2;Organisim: human;Apparent_Kd_M: 1.04E-12

Real

Aptamer SeqId: 13130-150 | Target: HXK2 | UniProt: P52789

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13130-150 | Target: HXK2 | UniProt: P52789 | TargetFullName: Hexokinase-2 | Organisim: human | Apparent_Kd_M: 1.04E-12

Real

Aptamer SeqId:13131-5;Target:HXK1;UniProt:P19367

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13131-5;Target: HXK1;UniProt: P19367;TargetFullName: Hexokinase-1;Organisim: human;Apparent_Kd_M: 9.98E-12

Real

Aptamer SeqId: 13131-5 | Target: HXK1 | UniProt: P19367

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13131-5 | Target: HXK1 | UniProt: P19367 | TargetFullName: Hexokinase-1 | Organisim: human | Apparent_Kd_M: 9.98E-12

Real

Aptamer SeqId:13132-14;Target:SEM5A;UniProt:Q13591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13132-14;Target: SEM5A;UniProt: Q13591;TargetFullName: Semaphorin-5A;Organisim: human;Apparent_Kd_M: 3.13E-12

Real

Aptamer SeqId: 13132-14 | Target: SEM5A | UniProt: Q13591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13132-14 | Target: SEM5A | UniProt: Q13591 | TargetFullName: Semaphorin-5A | Organisim: human | Apparent_Kd_M: 3.13E-12

Real

Aptamer SeqId:13133-73;Target:LTBP4;UniProt:Q8N2S1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13133-73;Target: LTBP4;UniProt: Q8N2S1;TargetFullName: Latent-transforming growth factor beta-binding protein 4;Organisim: human;Apparent_Kd_M: 1.97E-11

Real

Aptamer SeqId: 13133-73 | Target: LTBP4 | UniProt: Q8N2S1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13133-73 | Target: LTBP4 | UniProt: Q8N2S1 | TargetFullName: Latent-transforming growth factor beta-binding protein 4 | Organisim: human | Apparent_Kd_M: 1.97E-11

Real

Aptamer SeqId:13228-75;Target:MDM2;UniProt:Q00987

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13228-75;Target: MDM2;UniProt: Q00987;TargetFullName: E3 ubiquitin-protein ligase Mdm2;Organisim: human;Apparent_Kd_M: 9.97E-12

Real

Aptamer SeqId: 13228-75 | Target: MDM2 | UniProt: Q00987

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13228-75 | Target: MDM2 | UniProt: Q00987 | TargetFullName: E3 ubiquitin-protein ligase Mdm2 | Organisim: human | Apparent_Kd_M: 9.97E-12

Real

Aptamer SeqId:13229-20;Target:MDM4;UniProt:O15151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13229-20;Target: MDM4;UniProt: O15151;TargetFullName: Protein Mdm4;Organisim: human;Apparent_Kd_M: 7.035702E-12

Real

Aptamer SeqId: 13229-20 | Target: MDM4 | UniProt: O15151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13229-20 | Target: MDM4 | UniProt: O15151 | TargetFullName: Protein Mdm4 | Organisim: human | Apparent_Kd_M: 7.035702E-12

Real

Aptamer SeqId:13230-174;Target:IgG2; Kappa;UniProt:P01859

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13230-174;Target: IgG2; Kappa;UniProt: P01859;TargetFullName: Ig gamma-2; Kappa;Organisim: human;Apparent_Kd_M: 1.29E-12

Real

Aptamer SeqId: 13230-174 | Target: IgG2; Kappa | UniProt: P01859

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13230-174 | Target: IgG2; Kappa | UniProt: P01859 | TargetFullName: Ig gamma-2; Kappa | Organisim: human | Apparent_Kd_M: 1.29E-12

Real

Aptamer SeqId:13231-90;Target:IgG4; Kappa;UniProt:P01861

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13231-90;Target: IgG4; Kappa;UniProt: P01861;TargetFullName: Ig gamma-4; Kappa;Organisim: human;Apparent_Kd_M: 5.534478E-13

Real

Aptamer SeqId: 13231-90 | Target: IgG4; Kappa | UniProt: P01861

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13231-90 | Target: IgG4; Kappa | UniProt: P01861 | TargetFullName: Ig gamma-4; Kappa | Organisim: human | Apparent_Kd_M: 5.534478E-13

Real

Aptamer SeqId:13236-25;Target:WNT3A;UniProt:P56704

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13236-25;Target: WNT3A;UniProt: P56704;TargetFullName: Protein Wnt-3a;Organisim: human;Apparent_Kd_M: 2.612E-10

Real

Aptamer SeqId: 13236-25 | Target: WNT3A | UniProt: P56704

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13236-25 | Target: WNT3A | UniProt: P56704 | TargetFullName: Protein Wnt-3a | Organisim: human | Apparent_Kd_M: 2.612E-10

Real

Aptamer SeqId:13240-170;Target:SHAN1;UniProt:Q9Y566

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13240-170;Target: SHAN1;UniProt: Q9Y566;TargetFullName: SH3 and multiple ankyrin repeat domains protein 1;Organisim: human;Apparent_Kd_M: 4.78E-12

Real

Aptamer SeqId: 13240-170 | Target: SHAN1 | UniProt: Q9Y566

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13240-170 | Target: SHAN1 | UniProt: Q9Y566 | TargetFullName: SH3 and multiple ankyrin repeat domains protein 1 | Organisim: human | Apparent_Kd_M: 4.78E-12

Real

Aptamer SeqId:13242-134;Target:SHAN3;UniProt:Q9BYB0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13242-134;Target: SHAN3;UniProt: Q9BYB0;TargetFullName: SH3 and multiple ankyrin repeat domains protein 3;Organisim: human;Apparent_Kd_M: 1.83E-12

Real

Aptamer SeqId: 13242-134 | Target: SHAN3 | UniProt: Q9BYB0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13242-134 | Target: SHAN3 | UniProt: Q9BYB0 | TargetFullName: SH3 and multiple ankyrin repeat domains protein 3 | Organisim: human | Apparent_Kd_M: 1.83E-12

Real

Aptamer SeqId:13268-45;Target:WNT5A;UniProt:P41221

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13268-45;Target: WNT5A;UniProt: P41221;TargetFullName: Protein Wnt-5a;Organisim: human;Apparent_Kd_M: 5.533821E-11

Real

Aptamer SeqId: 13268-45 | Target: WNT5A | UniProt: P41221

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13268-45 | Target: WNT5A | UniProt: P41221 | TargetFullName: Protein Wnt-5a | Organisim: human | Apparent_Kd_M: 5.533821E-11

Real

Aptamer SeqId:13374-4;Target:DB113;UniProt:Q30KQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13374-4;Target: DB113;UniProt: Q30KQ7;TargetFullName: Beta-defensin 113;Organisim: human;Apparent_Kd_M: 2.143492E-11

Real

Aptamer SeqId: 13374-4 | Target: DB113 | UniProt: Q30KQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13374-4 | Target: DB113 | UniProt: Q30KQ7 | TargetFullName: Beta-defensin 113 | Organisim: human | Apparent_Kd_M: 2.143492E-11

Real

Aptamer SeqId:13375-48;Target:SNG3;UniProt:O43761

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13375-48;Target: SNG3;UniProt: O43761;TargetFullName: Synaptogyrin-3;Organisim: human;Apparent_Kd_M: 3.779355E-12

Real

Aptamer SeqId: 13375-48 | Target: SNG3 | UniProt: O43761

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13375-48 | Target: SNG3 | UniProt: O43761 | TargetFullName: Synaptogyrin-3 | Organisim: human | Apparent_Kd_M: 3.779355E-12

Real

Aptamer SeqId:13377-3;Target:C56D1;UniProt:Q8N8Q1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13377-3;Target: C56D1;UniProt: Q8N8Q1;TargetFullName: Cytochrome b561 domain-containing protein 1;Organisim: human;Apparent_Kd_M: 9.406854E-11

Real

Aptamer SeqId: 13377-3 | Target: C56D1 | UniProt: Q8N8Q1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13377-3 | Target: C56D1 | UniProt: Q8N8Q1 | TargetFullName: Cytochrome b561 domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 9.406854E-11

Real

Aptamer SeqId:13378-80;Target:YD286;UniProt:A6NC05

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13378-80;Target: YD286;UniProt: A6NC05;TargetFullName: Glutaredoxin-like protein C5orf63;Organisim: human;Apparent_Kd_M: 7.83191E-11

Real

Aptamer SeqId: 13378-80 | Target: YD286 | UniProt: A6NC05

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13378-80 | Target: YD286 | UniProt: A6NC05 | TargetFullName: Glutaredoxin-like protein C5orf63 | Organisim: human | Apparent_Kd_M: 7.83191E-11

Real

Aptamer SeqId:13381-49;Target:B4GT1;UniProt:P15291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13381-49;Target: B4GT1;UniProt: P15291;TargetFullName: Beta-1;4-galactosyltransferase 1;Organisim: human;Apparent_Kd_M: 6.127807E-12

Real

Aptamer SeqId: 13381-49 | Target: B4GT1 | UniProt: P15291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13381-49 | Target: B4GT1 | UniProt: P15291 | TargetFullName: Beta-1;4-galactosyltransferase 1 | Organisim: human | Apparent_Kd_M: 6.127807E-12

Real

Aptamer SeqId:13384-110;Target:FUMH;UniProt:P07954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13384-110;Target: FUMH;UniProt: P07954;TargetFullName: Fumarate hydratase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.9314E-11

Real

Aptamer SeqId: 13384-110 | Target: FUMH | UniProt: P07954

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13384-110 | Target: FUMH | UniProt: P07954 | TargetFullName: Fumarate hydratase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.9314E-11

Real

Aptamer SeqId:13386-248;Target:RNF34;UniProt:Q969K3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13386-248;Target: RNF34;UniProt: Q969K3;TargetFullName: E3 ubiquitin-protein ligase RNF34;Organisim: human;Apparent_Kd_M: 3.368153E-11

Real

Aptamer SeqId: 13386-248 | Target: RNF34 | UniProt: Q969K3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13386-248 | Target: RNF34 | UniProt: Q969K3 | TargetFullName: E3 ubiquitin-protein ligase RNF34 | Organisim: human | Apparent_Kd_M: 3.368153E-11

Real

Aptamer SeqId:13387-55;Target:EHF;UniProt:Q9NZC4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13387-55;Target: EHF;UniProt: Q9NZC4;TargetFullName: ETS homologous factor;Organisim: human;Apparent_Kd_M: 8.281546E-12

Real

Aptamer SeqId: 13387-55 | Target: EHF | UniProt: Q9NZC4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13387-55 | Target: EHF | UniProt: Q9NZC4 | TargetFullName: ETS homologous factor | Organisim: human | Apparent_Kd_M: 8.281546E-12

Real

Aptamer SeqId:13388-57;Target:NEC1;UniProt:P29120

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13388-57;Target: NEC1;UniProt: P29120;TargetFullName: Neuroendocrine convertase 1;Organisim: human;Apparent_Kd_M: 7.818448E-11

Real

Aptamer SeqId: 13388-57 | Target: NEC1 | UniProt: P29120

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13388-57 | Target: NEC1 | UniProt: P29120 | TargetFullName: Neuroendocrine convertase 1 | Organisim: human | Apparent_Kd_M: 7.818448E-11

Real

Aptamer SeqId:13389-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13389-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.757617E-11

Real

Aptamer SeqId: 13389-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13389-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.757617E-11

Real

Aptamer SeqId:13392-13;Target:AT1B1;UniProt:P05026

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13392-13;Target: AT1B1;UniProt: P05026;TargetFullName: Sodium/potassium-transporting ATPase subunit beta-1;Organisim: human;Apparent_Kd_M: 4.001105E-11

Real

Aptamer SeqId: 13392-13 | Target: AT1B1 | UniProt: P05026

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13392-13 | Target: AT1B1 | UniProt: P05026 | TargetFullName: Sodium/potassium-transporting ATPase subunit beta-1 | Organisim: human | Apparent_Kd_M: 4.001105E-11

Real

Aptamer SeqId:13393-46;Target:DERL1;UniProt:Q9BUN8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13393-46;Target: DERL1;UniProt: Q9BUN8;TargetFullName: Derlin-1;Organisim: human;Apparent_Kd_M: 1.080858E-11

Real

Aptamer SeqId: 13393-46 | Target: DERL1 | UniProt: Q9BUN8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13393-46 | Target: DERL1 | UniProt: Q9BUN8 | TargetFullName: Derlin-1 | Organisim: human | Apparent_Kd_M: 1.080858E-11

Real

Aptamer SeqId:13397-88;Target:HBD-2;UniProt:O15263

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13397-88;Target: HBD-2;UniProt: O15263;TargetFullName: Beta-defensin 4A;Organisim: human;Apparent_Kd_M: 8.903659E-12

Real

Aptamer SeqId: 13397-88 | Target: HBD-2 | UniProt: O15263

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13397-88 | Target: HBD-2 | UniProt: O15263 | TargetFullName: Beta-defensin 4A | Organisim: human | Apparent_Kd_M: 8.903659E-12

Real

Aptamer SeqId:13399-33;Target:RELL1;UniProt:Q8IUW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13399-33;Target: RELL1;UniProt: Q8IUW5;TargetFullName: RELT-like protein 1;Organisim: human;Apparent_Kd_M: 3.463651E-11

Real

Aptamer SeqId: 13399-33 | Target: RELL1 | UniProt: Q8IUW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13399-33 | Target: RELL1 | UniProt: Q8IUW5 | TargetFullName: RELT-like protein 1 | Organisim: human | Apparent_Kd_M: 3.463651E-11

Real

Aptamer SeqId:13403-5;Target:ETV5;UniProt:P41161

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13403-5;Target: ETV5;UniProt: P41161;TargetFullName: ETS translocation variant 5;Organisim: human;Apparent_Kd_M: 1.057658E-11

Real

Aptamer SeqId: 13403-5 | Target: ETV5 | UniProt: P41161

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13403-5 | Target: ETV5 | UniProt: P41161 | TargetFullName: ETS translocation variant 5 | Organisim: human | Apparent_Kd_M: 1.057658E-11

Real

Aptamer SeqId:13405-61;Target:ISK2;UniProt:P20155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13405-61;Target: ISK2;UniProt: P20155;TargetFullName: Serine protease inhibitor Kazal-type 2;Organisim: human;Apparent_Kd_M: 4.772475E-12

Real

Aptamer SeqId: 13405-61 | Target: ISK2 | UniProt: P20155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13405-61 | Target: ISK2 | UniProt: P20155 | TargetFullName: Serine protease inhibitor Kazal-type 2 | Organisim: human | Apparent_Kd_M: 4.772475E-12

Real

Aptamer SeqId:13409-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13409-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.573979E-12

Real

Aptamer SeqId: 13409-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13409-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.573979E-12

Real

Aptamer SeqId:13411-21;Target:RNF41;UniProt:Q9H4P4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13411-21;Target: RNF41;UniProt: Q9H4P4;TargetFullName: E3 ubiquitin-protein ligase NRDP1;Organisim: human;Apparent_Kd_M: 8.538704E-12

Real

Aptamer SeqId: 13411-21 | Target: RNF41 | UniProt: Q9H4P4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13411-21 | Target: RNF41 | UniProt: Q9H4P4 | TargetFullName: E3 ubiquitin-protein ligase NRDP1 | Organisim: human | Apparent_Kd_M: 8.538704E-12

Real

Aptamer SeqId:13412-5;Target:WFDC6;UniProt:Q9BQY6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13412-5;Target: WFDC6;UniProt: Q9BQY6;TargetFullName: WAP four-disulfide core domain protein 6;Organisim: human;Apparent_Kd_M: 3.145936E-10

Real

Aptamer SeqId: 13412-5 | Target: WFDC6 | UniProt: Q9BQY6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13412-5 | Target: WFDC6 | UniProt: Q9BQY6 | TargetFullName: WAP four-disulfide core domain protein 6 | Organisim: human | Apparent_Kd_M: 3.145936E-10

Real

Aptamer SeqId:13416-8;Target:T132D;UniProt:Q14C87

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13416-8;Target: T132D;UniProt: Q14C87;TargetFullName: Transmembrane protein 132D;Organisim: human;Apparent_Kd_M: 5.077196E-12

Real

Aptamer SeqId: 13416-8 | Target: T132D | UniProt: Q14C87

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13416-8 | Target: T132D | UniProt: Q14C87 | TargetFullName: Transmembrane protein 132D | Organisim: human | Apparent_Kd_M: 5.077196E-12

Real

Aptamer SeqId:13421-17;Target:KISHB;UniProt:Q9NRX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13421-17;Target: KISHB;UniProt: Q9NRX6;TargetFullName: Protein kish-B;Organisim: human;Apparent_Kd_M: 4.06571E-12

Real

Aptamer SeqId: 13421-17 | Target: KISHB | UniProt: Q9NRX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13421-17 | Target: KISHB | UniProt: Q9NRX6 | TargetFullName: Protein kish-B | Organisim: human | Apparent_Kd_M: 4.06571E-12

Real

Aptamer SeqId:13422-66;Target:ENOX2;UniProt:Q16206

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13422-66;Target: ENOX2;UniProt: Q16206;TargetFullName: Ecto-NOX disulfide-thiol exchanger 2;Organisim: human;Apparent_Kd_M: 3.04E-12

Real

Aptamer SeqId: 13422-66 | Target: ENOX2 | UniProt: Q16206

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13422-66 | Target: ENOX2 | UniProt: Q16206 | TargetFullName: Ecto-NOX disulfide-thiol exchanger 2 | Organisim: human | Apparent_Kd_M: 3.04E-12

Real

Aptamer SeqId:13423-94;Target:CJ058;UniProt:Q9BRX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13423-94;Target: CJ058;UniProt: Q9BRX8;TargetFullName: Redox-regulatory protein FAM213A;Organisim: human;Apparent_Kd_M: 1.518612E-10

Real

Aptamer SeqId: 13423-94 | Target: CJ058 | UniProt: Q9BRX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13423-94 | Target: CJ058 | UniProt: Q9BRX8 | TargetFullName: Redox-regulatory protein FAM213A | Organisim: human | Apparent_Kd_M: 1.518612E-10

Real

Aptamer SeqId:13424-51;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13424-51;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.56E-12

Real

Aptamer SeqId: 13424-51 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13424-51 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.56E-12

Real

Aptamer SeqId:13427-66;Target:MA1C1;UniProt:Q9NR34

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13427-66;Target: MA1C1;UniProt: Q9NR34;TargetFullName: Mannosyl-oligosaccharide 1;2-alpha-mannosidase IC;Organisim: human;Apparent_Kd_M: 1.677572E-11

Real

Aptamer SeqId: 13427-66 | Target: MA1C1 | UniProt: Q9NR34

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13427-66 | Target: MA1C1 | UniProt: Q9NR34 | TargetFullName: Mannosyl-oligosaccharide 1;2-alpha-mannosidase IC | Organisim: human | Apparent_Kd_M: 1.677572E-11

Real

Aptamer SeqId:13429-3;Target:WF10A;UniProt:Q9H1F0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13429-3;Target: WF10A;UniProt: Q9H1F0;TargetFullName: WAP four-disulfide core domain protein 10A;Organisim: human;Apparent_Kd_M: 2.266226E-11

Real

Aptamer SeqId: 13429-3 | Target: WF10A | UniProt: Q9H1F0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13429-3 | Target: WF10A | UniProt: Q9H1F0 | TargetFullName: WAP four-disulfide core domain protein 10A | Organisim: human | Apparent_Kd_M: 2.266226E-11

Real

Aptamer SeqId:13430-50;Target:UT1;UniProt:Q13336

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13430-50;Target: UT1;UniProt: Q13336;TargetFullName: Urea transporter 1;Organisim: human;Apparent_Kd_M: 1.417642E-10

Real

Aptamer SeqId: 13430-50 | Target: UT1 | UniProt: Q13336

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13430-50 | Target: UT1 | UniProt: Q13336 | TargetFullName: Urea transporter 1 | Organisim: human | Apparent_Kd_M: 1.417642E-10

Real

Aptamer SeqId:13431-74;Target:F159A;UniProt:Q6UWV7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13431-74;Target: F159A;UniProt: Q6UWV7;TargetFullName: Membrane protein FAM159A;Organisim: human;Apparent_Kd_M: 5.851887E-11

Real

Aptamer SeqId: 13431-74 | Target: F159A | UniProt: Q6UWV7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13431-74 | Target: F159A | UniProt: Q6UWV7 | TargetFullName: Membrane protein FAM159A | Organisim: human | Apparent_Kd_M: 5.851887E-11

Real

Aptamer SeqId:13434-172;Target:PARVA;UniProt:Q9NVD7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13434-172;Target: PARVA;UniProt: Q9NVD7;TargetFullName: Alpha-parvin;Organisim: human;Apparent_Kd_M: 2.935925E-12

Real

Aptamer SeqId: 13434-172 | Target: PARVA | UniProt: Q9NVD7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13434-172 | Target: PARVA | UniProt: Q9NVD7 | TargetFullName: Alpha-parvin | Organisim: human | Apparent_Kd_M: 2.935925E-12

Real

Aptamer SeqId:13435-31;Target:IL-20 Rb;UniProt:Q6UXL0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13435-31;Target: IL-20 Rb;UniProt: Q6UXL0;TargetFullName: Interleukin-20 receptor subunit beta;Organisim: human;Apparent_Kd_M: 1.579869E-10

Real

Aptamer SeqId: 13435-31 | Target: IL-20 Rb | UniProt: Q6UXL0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13435-31 | Target: IL-20 Rb | UniProt: Q6UXL0 | TargetFullName: Interleukin-20 receptor subunit beta | Organisim: human | Apparent_Kd_M: 1.579869E-10

Real

Aptamer SeqId:13436-54;Target:MAZ;UniProt:P56270

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13436-54;Target: MAZ;UniProt: P56270;TargetFullName: Myc-associated zinc finger protein;Organisim: human;Apparent_Kd_M: 7.022378E-12

Real

Aptamer SeqId: 13436-54 | Target: MAZ | UniProt: P56270

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13436-54 | Target: MAZ | UniProt: P56270 | TargetFullName: Myc-associated zinc finger protein | Organisim: human | Apparent_Kd_M: 7.022378E-12

Real

Aptamer SeqId:13438-115;Target:CHRD;UniProt:Q9H2X0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13438-115;Target: CHRD;UniProt: Q9H2X0;TargetFullName: Chordin;Organisim: human;Apparent_Kd_M: 3.92091E-11

Real

Aptamer SeqId: 13438-115 | Target: CHRD | UniProt: Q9H2X0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13438-115 | Target: CHRD | UniProt: Q9H2X0 | TargetFullName: Chordin | Organisim: human | Apparent_Kd_M: 3.92091E-11

Real

Aptamer SeqId:13439-6;Target:IQCF3;UniProt:P0C7M6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13439-6;Target: IQCF3;UniProt: P0C7M6;TargetFullName: IQ domain-containing protein F3;Organisim: human;Apparent_Kd_M: 6.404992E-11

Real

Aptamer SeqId: 13439-6 | Target: IQCF3 | UniProt: P0C7M6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13439-6 | Target: IQCF3 | UniProt: P0C7M6 | TargetFullName: IQ domain-containing protein F3 | Organisim: human | Apparent_Kd_M: 6.404992E-11

Real

Aptamer SeqId:13441-30;Target:DIXC1;UniProt:Q155Q3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13441-30;Target: DIXC1;UniProt: Q155Q3;TargetFullName: Dixin;Organisim: human;Apparent_Kd_M: 9.07509E-12

Real

Aptamer SeqId: 13441-30 | Target: DIXC1 | UniProt: Q155Q3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13441-30 | Target: DIXC1 | UniProt: Q155Q3 | TargetFullName: Dixin | Organisim: human | Apparent_Kd_M: 9.07509E-12

Real

Aptamer SeqId:13447-42;Target:SPRN;UniProt:Q5BIV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13447-42;Target: SPRN;UniProt: Q5BIV9;TargetFullName: Shadow of prion protein;Organisim: human;Apparent_Kd_M: 1.762366E-10

Real

Aptamer SeqId: 13447-42 | Target: SPRN | UniProt: Q5BIV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13447-42 | Target: SPRN | UniProt: Q5BIV9 | TargetFullName: Shadow of prion protein | Organisim: human | Apparent_Kd_M: 1.762366E-10

Real

Aptamer SeqId:13449-25;Target:SF3B4;UniProt:Q15427

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13449-25;Target: SF3B4;UniProt: Q15427;TargetFullName: Splicing factor 3B subunit 4;Organisim: human;Apparent_Kd_M: 3.404686E-11

Real

Aptamer SeqId: 13449-25 | Target: SF3B4 | UniProt: Q15427

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13449-25 | Target: SF3B4 | UniProt: Q15427 | TargetFullName: Splicing factor 3B subunit 4 | Organisim: human | Apparent_Kd_M: 3.404686E-11

Real

Aptamer SeqId:13450-49;Target:UBP8;UniProt:P40818

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13450-49;Target: UBP8;UniProt: P40818;TargetFullName: Ubiquitin carboxyl-terminal hydrolase 8;Organisim: human;Apparent_Kd_M: 3.309157E-12

Real

Aptamer SeqId: 13450-49 | Target: UBP8 | UniProt: P40818

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13450-49 | Target: UBP8 | UniProt: P40818 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase 8 | Organisim: human | Apparent_Kd_M: 3.309157E-12

Real

Aptamer SeqId:13451-2;Target:FNDC4;UniProt:Q9H6D8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13451-2;Target: FNDC4;UniProt: Q9H6D8;TargetFullName: Fibronectin type III domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.015049E-11

Real

Aptamer SeqId: 13451-2 | Target: FNDC4 | UniProt: Q9H6D8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13451-2 | Target: FNDC4 | UniProt: Q9H6D8 | TargetFullName: Fibronectin type III domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.015049E-11

Real

Aptamer SeqId:13452-113;Target:SIM13;UniProt:P0DJ93

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13452-113;Target: SIM13;UniProt: P0DJ93;TargetFullName: Small integral membrane protein 13;Organisim: human;Apparent_Kd_M: 9.551225E-11

Real

Aptamer SeqId: 13452-113 | Target: SIM13 | UniProt: P0DJ93

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13452-113 | Target: SIM13 | UniProt: P0DJ93 | TargetFullName: Small integral membrane protein 13 | Organisim: human | Apparent_Kd_M: 9.551225E-11

Real

Aptamer SeqId:13453-2;Target:RM33;UniProt:O75394

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13453-2;Target: RM33;UniProt: O75394;TargetFullName: 39S ribosomal protein L33; mitochondrial;Organisim: human;Apparent_Kd_M: 1.032518E-10

Real

Aptamer SeqId: 13453-2 | Target: RM33 | UniProt: O75394

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13453-2 | Target: RM33 | UniProt: O75394 | TargetFullName: 39S ribosomal protein L33; mitochondrial | Organisim: human | Apparent_Kd_M: 1.032518E-10

Real

Aptamer SeqId:13455-10;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13455-10;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.19E-12

Real

Aptamer SeqId: 13455-10 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13455-10 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.19E-12

Real

Aptamer SeqId:13457-33;Target:ELF5;UniProt:Q9UKW6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13457-33;Target: ELF5;UniProt: Q9UKW6;TargetFullName: ETS-related transcription factor Elf-5;Organisim: human;Apparent_Kd_M: 1.92799E-12

Real

Aptamer SeqId: 13457-33 | Target: ELF5 | UniProt: Q9UKW6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13457-33 | Target: ELF5 | UniProt: Q9UKW6 | TargetFullName: ETS-related transcription factor Elf-5 | Organisim: human | Apparent_Kd_M: 1.92799E-12

Real

Aptamer SeqId:13459-30;Target:CI167;UniProt:Q9NXH8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13459-30;Target: CI167;UniProt: Q9NXH8;TargetFullName: Torsin-4A;Organisim: human;Apparent_Kd_M: 2.497011E-10

Real

Aptamer SeqId: 13459-30 | Target: CI167 | UniProt: Q9NXH8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13459-30 | Target: CI167 | UniProt: Q9NXH8 | TargetFullName: Torsin-4A | Organisim: human | Apparent_Kd_M: 2.497011E-10

Real

Aptamer SeqId:13460-4;Target:CHAD;UniProt:O15335

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13460-4;Target: CHAD;UniProt: O15335;TargetFullName: Chondroadherin;Organisim: human;Apparent_Kd_M: 1.867212E-12

Real

Aptamer SeqId: 13460-4 | Target: CHAD | UniProt: O15335

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13460-4 | Target: CHAD | UniProt: O15335 | TargetFullName: Chondroadherin | Organisim: human | Apparent_Kd_M: 1.867212E-12

Real

Aptamer SeqId:13463-1;Target:PXDN;UniProt:Q92626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13463-1;Target: PXDN;UniProt: Q92626;TargetFullName: Peroxidasin homolog;Organisim: human;Apparent_Kd_M: 1.336751E-11

Real

Aptamer SeqId: 13463-1 | Target: PXDN | UniProt: Q92626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13463-1 | Target: PXDN | UniProt: Q92626 | TargetFullName: Peroxidasin homolog | Organisim: human | Apparent_Kd_M: 1.336751E-11

Real

Aptamer SeqId:13464-8;Target:NRAC;UniProt:Q8N912

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13464-8;Target: NRAC;UniProt: Q8N912;TargetFullName: Nutritionally-regulated adipose and cardiac enriched protein homolog;Organisim: human;Apparent_Kd_M: 3.227078E-11

Real

Aptamer SeqId: 13464-8 | Target: NRAC | UniProt: Q8N912

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13464-8 | Target: NRAC | UniProt: Q8N912 | TargetFullName: Nutritionally-regulated adipose and cardiac enriched protein homolog | Organisim: human | Apparent_Kd_M: 3.227078E-11

Real

Aptamer SeqId:13465-5;Target:CCP1;UniProt:P53805

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13465-5;Target: CCP1;UniProt: P53805;TargetFullName: Calcipressin-1;Organisim: human;Apparent_Kd_M: 3.397345E-12

Real

Aptamer SeqId: 13465-5 | Target: CCP1 | UniProt: P53805

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13465-5 | Target: CCP1 | UniProt: P53805 | TargetFullName: Calcipressin-1 | Organisim: human | Apparent_Kd_M: 3.397345E-12

Real

Aptamer SeqId:13468-5;Target:NEUL4;UniProt:Q96JN8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13468-5;Target: NEUL4;UniProt: Q96JN8;TargetFullName: Neuralized-like protein 4;Organisim: human;Apparent_Kd_M: 6.077765E-11

Real

Aptamer SeqId: 13468-5 | Target: NEUL4 | UniProt: Q96JN8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13468-5 | Target: NEUL4 | UniProt: Q96JN8 | TargetFullName: Neuralized-like protein 4 | Organisim: human | Apparent_Kd_M: 6.077765E-11

Real

Aptamer SeqId:13470-43;Target:PTH1R;UniProt:Q03431

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13470-43;Target: PTH1R;UniProt: Q03431;TargetFullName: Parathyroid hormone/parathyroid hormone-related peptide receptor;Organisim: human;Apparent_Kd_M: 1.854714E-11

Real

Aptamer SeqId: 13470-43 | Target: PTH1R | UniProt: Q03431

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13470-43 | Target: PTH1R | UniProt: Q03431 | TargetFullName: Parathyroid hormone/parathyroid hormone-related peptide receptor | Organisim: human | Apparent_Kd_M: 1.854714E-11

Real

Aptamer SeqId:13472-35;Target:HDHD2;UniProt:Q9H0R4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13472-35;Target: HDHD2;UniProt: Q9H0R4;TargetFullName: Haloacid dehalogenase-like hydrolase domain-containing protein 2;Organisim: human;Apparent_Kd_M: 3.632704E-12

Real

Aptamer SeqId: 13472-35 | Target: HDHD2 | UniProt: Q9H0R4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13472-35 | Target: HDHD2 | UniProt: Q9H0R4 | TargetFullName: Haloacid dehalogenase-like hydrolase domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 3.632704E-12

Real

Aptamer SeqId:13473-55;Target:IP3KA;UniProt:P23677

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13473-55;Target: IP3KA;UniProt: P23677;TargetFullName: Inositol-trisphosphate 3-kinase A;Organisim: human;Apparent_Kd_M: 4.875127E-12

Real

Aptamer SeqId: 13473-55 | Target: IP3KA | UniProt: P23677

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13473-55 | Target: IP3KA | UniProt: P23677 | TargetFullName: Inositol-trisphosphate 3-kinase A | Organisim: human | Apparent_Kd_M: 4.875127E-12

Real

Aptamer SeqId:13474-40;Target:GSTK1;UniProt:Q9Y2Q3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13474-40;Target: GSTK1;UniProt: Q9Y2Q3;TargetFullName: Glutathione S-transferase kappa 1;Organisim: human;Apparent_Kd_M: 3.500664E-12

Real

Aptamer SeqId: 13474-40 | Target: GSTK1 | UniProt: Q9Y2Q3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13474-40 | Target: GSTK1 | UniProt: Q9Y2Q3 | TargetFullName: Glutathione S-transferase kappa 1 | Organisim: human | Apparent_Kd_M: 3.500664E-12

Real

Aptamer SeqId:13475-10;Target:UB2D4;UniProt:Q9Y2X8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13475-10;Target: UB2D4;UniProt: Q9Y2X8;TargetFullName: Ubiquitin-conjugating enzyme E2 D4;Organisim: human;Apparent_Kd_M: 1.295704E-11

Real

Aptamer SeqId: 13475-10 | Target: UB2D4 | UniProt: Q9Y2X8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13475-10 | Target: UB2D4 | UniProt: Q9Y2X8 | TargetFullName: Ubiquitin-conjugating enzyme E2 D4 | Organisim: human | Apparent_Kd_M: 1.295704E-11

Real

Aptamer SeqId:13476-16;Target:KIN17;UniProt:O60870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13476-16;Target: KIN17;UniProt: O60870;TargetFullName: DNA/RNA-binding protein KIN17;Organisim: human;Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId: 13476-16 | Target: KIN17 | UniProt: O60870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13476-16 | Target: KIN17 | UniProt: O60870 | TargetFullName: DNA/RNA-binding protein KIN17 | Organisim: human | Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId:13477-65;Target:LT4R1;UniProt:Q15722

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13477-65;Target: LT4R1;UniProt: Q15722;TargetFullName: Leukotriene B4 receptor 1;Organisim: human;Apparent_Kd_M: 7.361131E-12

Real

Aptamer SeqId: 13477-65 | Target: LT4R1 | UniProt: Q15722

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13477-65 | Target: LT4R1 | UniProt: Q15722 | TargetFullName: Leukotriene B4 receptor 1 | Organisim: human | Apparent_Kd_M: 7.361131E-12

Real

Aptamer SeqId:13479-8;Target:F1712;UniProt:A8MVW0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13479-8;Target: F1712;UniProt: A8MVW0;TargetFullName: Protein FAM171A2;Organisim: human;Apparent_Kd_M: 4.942294E-11

Real

Aptamer SeqId: 13479-8 | Target: F1712 | UniProt: A8MVW0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13479-8 | Target: F1712 | UniProt: A8MVW0 | TargetFullName: Protein FAM171A2 | Organisim: human | Apparent_Kd_M: 4.942294E-11

Real

Aptamer SeqId:13481-24;Target:TCEA2;UniProt:Q15560

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13481-24;Target: TCEA2;UniProt: Q15560;TargetFullName: Transcription elongation factor A protein 2;Organisim: human;Apparent_Kd_M: 5.06611E-12

Real

Aptamer SeqId: 13481-24 | Target: TCEA2 | UniProt: Q15560

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13481-24 | Target: TCEA2 | UniProt: Q15560 | TargetFullName: Transcription elongation factor A protein 2 | Organisim: human | Apparent_Kd_M: 5.06611E-12

Real

Aptamer SeqId:13482-14;Target:CNOT1;UniProt:A5YKK6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13482-14;Target: CNOT1;UniProt: A5YKK6;TargetFullName: CCR4-NOT transcription complex subunit 1;Organisim: human;Apparent_Kd_M: 1.448598E-12

Real

Aptamer SeqId: 13482-14 | Target: CNOT1 | UniProt: A5YKK6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13482-14 | Target: CNOT1 | UniProt: A5YKK6 | TargetFullName: CCR4-NOT transcription complex subunit 1 | Organisim: human | Apparent_Kd_M: 1.448598E-12

Real

Aptamer SeqId:13484-69;Target:CO1A1;UniProt:P02452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13484-69;Target: CO1A1;UniProt: P02452;TargetFullName: Collagen alpha-1(I) chain;Organisim: human;Apparent_Kd_M: 1.01E-10

Real

Aptamer SeqId: 13484-69 | Target: CO1A1 | UniProt: P02452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13484-69 | Target: CO1A1 | UniProt: P02452 | TargetFullName: Collagen alpha-1(I) chain | Organisim: human | Apparent_Kd_M: 1.01E-10

Real

Aptamer SeqId:13485-20;Target:TM87B;UniProt:Q96K49

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13485-20;Target: TM87B;UniProt: Q96K49;TargetFullName: Transmembrane protein 87B;Organisim: human;Apparent_Kd_M: 1.432262E-10

Real

Aptamer SeqId: 13485-20 | Target: TM87B | UniProt: Q96K49

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13485-20 | Target: TM87B | UniProt: Q96K49 | TargetFullName: Transmembrane protein 87B | Organisim: human | Apparent_Kd_M: 1.432262E-10

Real

Aptamer SeqId:13486-9;Target:PKD2;UniProt:Q13563

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13486-9;Target: PKD2;UniProt: Q13563;TargetFullName: Polycystin-2;Organisim: human;Apparent_Kd_M: 3.95E-11

Real

Aptamer SeqId: 13486-9 | Target: PKD2 | UniProt: Q13563

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13486-9 | Target: PKD2 | UniProt: Q13563 | TargetFullName: Polycystin-2 | Organisim: human | Apparent_Kd_M: 3.95E-11

Real

Aptamer SeqId:13487-24;Target:UN93B;UniProt:Q9H1C4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13487-24;Target: UN93B;UniProt: Q9H1C4;TargetFullName: Protein unc-93 homolog B1;Organisim: human;Apparent_Kd_M: 1.432385E-11

Real

Aptamer SeqId: 13487-24 | Target: UN93B | UniProt: Q9H1C4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13487-24 | Target: UN93B | UniProt: Q9H1C4 | TargetFullName: Protein unc-93 homolog B1 | Organisim: human | Apparent_Kd_M: 1.432385E-11

Real

Aptamer SeqId:13488-3;Target:ARFP1;UniProt:P53367

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13488-3;Target: ARFP1;UniProt: P53367;TargetFullName: Arfaptin-1;Organisim: human;Apparent_Kd_M: 8.60004E-12

Real

Aptamer SeqId: 13488-3 | Target: ARFP1 | UniProt: P53367

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13488-3 | Target: ARFP1 | UniProt: P53367 | TargetFullName: Arfaptin-1 | Organisim: human | Apparent_Kd_M: 8.60004E-12

Real

Aptamer SeqId:13490-1;Target:MPP6;UniProt:Q9NZW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13490-1;Target: MPP6;UniProt: Q9NZW5;TargetFullName: MAGUK p55 subfamily member 6;Organisim: human;Apparent_Kd_M: 2.147962E-11

Real

Aptamer SeqId: 13490-1 | Target: MPP6 | UniProt: Q9NZW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13490-1 | Target: MPP6 | UniProt: Q9NZW5 | TargetFullName: MAGUK p55 subfamily member 6 | Organisim: human | Apparent_Kd_M: 2.147962E-11

Real

Aptamer SeqId:13491-40;Target:PDE6D;UniProt:O43924

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13491-40;Target: PDE6D;UniProt: O43924;TargetFullName: Retinal rod rhodopsin-sensitive cGMP 3;5-cyclic phosphodiesterase subunit delta;Organisim: human;Apparent_Kd_M: 1.52959E-11

Real

Aptamer SeqId: 13491-40 | Target: PDE6D | UniProt: O43924

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13491-40 | Target: PDE6D | UniProt: O43924 | TargetFullName: Retinal rod rhodopsin-sensitive cGMP 3';5'-cyclic phosphodiesterase subunit delta | Organisim: human | Apparent_Kd_M: 1.52959E-11

Real

Aptamer SeqId:13492-44;Target:HSPA9B;UniProt:P38646

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13492-44;Target: HSPA9B;UniProt: P38646;TargetFullName: Stress-70 protein; mitochondrial;Organisim: human;Apparent_Kd_M: 1.044255E-10

Real

Aptamer SeqId: 13492-44 | Target: HSPA9B | UniProt: P38646

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13492-44 | Target: HSPA9B | UniProt: P38646 | TargetFullName: Stress-70 protein; mitochondrial | Organisim: human | Apparent_Kd_M: 1.044255E-10

Real

Aptamer SeqId:13493-5;Target:GRID1;UniProt:Q9ULK0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13493-5;Target: GRID1;UniProt: Q9ULK0;TargetFullName: Glutamate receptor ionotropic; delta-1;Organisim: human;Apparent_Kd_M: 1.177711E-11

Real

Aptamer SeqId: 13493-5 | Target: GRID1 | UniProt: Q9ULK0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13493-5 | Target: GRID1 | UniProt: Q9ULK0 | TargetFullName: Glutamate receptor ionotropic; delta-1 | Organisim: human | Apparent_Kd_M: 1.177711E-11

Real

Aptamer SeqId:13494-6;Target:CERS5;UniProt:Q8N5B7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13494-6;Target: CERS5;UniProt: Q8N5B7;TargetFullName: Ceramide synthase 5;Organisim: human;Apparent_Kd_M: 4.385256E-11

Real

Aptamer SeqId: 13494-6 | Target: CERS5 | UniProt: Q8N5B7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13494-6 | Target: CERS5 | UniProt: Q8N5B7 | TargetFullName: Ceramide synthase 5 | Organisim: human | Apparent_Kd_M: 4.385256E-11

Real

Aptamer SeqId:13495-48;Target:HCAR2;UniProt:Q8TDS4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13495-48;Target: HCAR2;UniProt: Q8TDS4;TargetFullName: Hydroxycarboxylic acid receptor 2;Organisim: human;Apparent_Kd_M: 5.7775E-12

Real

Aptamer SeqId: 13495-48 | Target: HCAR2 | UniProt: Q8TDS4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13495-48 | Target: HCAR2 | UniProt: Q8TDS4 | TargetFullName: Hydroxycarboxylic acid receptor 2 | Organisim: human | Apparent_Kd_M: 5.7775E-12

Real

Aptamer SeqId:13496-19;Target:HMCS1;UniProt:Q01581

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13496-19;Target: HMCS1;UniProt: Q01581;TargetFullName: Hydroxymethylglutaryl-CoA synthase; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.67E-11

Real

Aptamer SeqId: 13496-19 | Target: HMCS1 | UniProt: Q01581

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13496-19 | Target: HMCS1 | UniProt: Q01581 | TargetFullName: Hydroxymethylglutaryl-CoA synthase; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.67E-11

Real

Aptamer SeqId:13497-34;Target:EIF3J;UniProt:O75822

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13497-34;Target: EIF3J;UniProt: O75822;TargetFullName: Eukaryotic translation initiation factor 3 subunit J;Organisim: human;Apparent_Kd_M: 9.914086E-11

Real

Aptamer SeqId: 13497-34 | Target: EIF3J | UniProt: O75822

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13497-34 | Target: EIF3J | UniProt: O75822 | TargetFullName: Eukaryotic translation initiation factor 3 subunit J | Organisim: human | Apparent_Kd_M: 9.914086E-11

Real

Aptamer SeqId:13498-1;Target:MIOX;UniProt:Q9UGB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13498-1;Target: MIOX;UniProt: Q9UGB7;TargetFullName: Inositol oxygenase;Organisim: human;Apparent_Kd_M: 1.771076E-11

Real

Aptamer SeqId: 13498-1 | Target: MIOX | UniProt: Q9UGB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13498-1 | Target: MIOX | UniProt: Q9UGB7 | TargetFullName: Inositol oxygenase | Organisim: human | Apparent_Kd_M: 1.771076E-11

Real

Aptamer SeqId:13499-30;Target:Coagulation Factor VIII;UniProt:P00451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13499-30;Target: Coagulation Factor VIII;UniProt: P00451;TargetFullName: Coagulation Factor VIII;Organisim: human;Apparent_Kd_M: 7.6E-12

Real

Aptamer SeqId: 13499-30 | Target: Coagulation Factor VIII | UniProt: P00451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13499-30 | Target: Coagulation Factor VIII | UniProt: P00451 | TargetFullName: Coagulation Factor VIII | Organisim: human | Apparent_Kd_M: 7.6E-12

Real

Aptamer SeqId:13500-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13500-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.94E-12

Real

Aptamer SeqId: 13500-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13500-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.94E-12

Real

Aptamer SeqId:13501-10;Target:S35G2;UniProt:Q8TBE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13501-10;Target: S35G2;UniProt: Q8TBE7;TargetFullName: Solute carrier family 35 member G2;Organisim: human;Apparent_Kd_M: 3.722256E-11

Real

Aptamer SeqId: 13501-10 | Target: S35G2 | UniProt: Q8TBE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13501-10 | Target: S35G2 | UniProt: Q8TBE7 | TargetFullName: Solute carrier family 35 member G2 | Organisim: human | Apparent_Kd_M: 3.722256E-11

Real

Aptamer SeqId:13502-2;Target:S2611;UniProt:Q86WA9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13502-2;Target: S2611;UniProt: Q86WA9;TargetFullName: Sodium-independent sulfate anion transporter;Organisim: human;Apparent_Kd_M: 6.59338E-11

Real

Aptamer SeqId: 13502-2 | Target: S2611 | UniProt: Q86WA9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13502-2 | Target: S2611 | UniProt: Q86WA9 | TargetFullName: Sodium-independent sulfate anion transporter | Organisim: human | Apparent_Kd_M: 6.59338E-11

Real

Aptamer SeqId:13503-19;Target:PRAF3;UniProt:O75915

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13503-19;Target: PRAF3;UniProt: O75915;TargetFullName: PRA1 family protein 3;Organisim: human;Apparent_Kd_M: 6.470203E-12

Real

Aptamer SeqId: 13503-19 | Target: PRAF3 | UniProt: O75915

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13503-19 | Target: PRAF3 | UniProt: O75915 | TargetFullName: PRA1 family protein 3 | Organisim: human | Apparent_Kd_M: 6.470203E-12

Real

Aptamer SeqId:13506-10;Target:DUS2L;UniProt:Q9NX74

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13506-10;Target: DUS2L;UniProt: Q9NX74;TargetFullName: tRNA-dihydrouridine(20) synthase [NAD(P)+]-like;Organisim: human;Apparent_Kd_M: 4.745746E-12

Real

Aptamer SeqId: 13506-10 | Target: DUS2L | UniProt: Q9NX74

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13506-10 | Target: DUS2L | UniProt: Q9NX74 | TargetFullName: tRNA-dihydrouridine(20) synthase NAD(P)+-like | Organisim: human | Apparent_Kd_M: 4.745746E-12

Real

Aptamer SeqId:13507-51;Target:TRADD;UniProt:Q15628

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13507-51;Target: TRADD;UniProt: Q15628;TargetFullName: Tumor necrosis factor receptor type 1-associated DEATH domain protein;Organisim: human;Apparent_Kd_M: 2.573341E-11

Real

Aptamer SeqId: 13507-51 | Target: TRADD | UniProt: Q15628

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13507-51 | Target: TRADD | UniProt: Q15628 | TargetFullName: Tumor necrosis factor receptor type 1-associated DEATH domain protein | Organisim: human | Apparent_Kd_M: 2.573341E-11

Real

Aptamer SeqId:13509-5;Target:SCAM5;UniProt:Q8TAC9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13509-5;Target: SCAM5;UniProt: Q8TAC9;TargetFullName: Secretory carrier-associated membrane protein 5;Organisim: human;Apparent_Kd_M: 1.094814E-10

Real

Aptamer SeqId: 13509-5 | Target: SCAM5 | UniProt: Q8TAC9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13509-5 | Target: SCAM5 | UniProt: Q8TAC9 | TargetFullName: Secretory carrier-associated membrane protein 5 | Organisim: human | Apparent_Kd_M: 1.094814E-10

Real

Aptamer SeqId:13510-7;Target:AT2A3;UniProt:Q93084

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13510-7;Target: AT2A3;UniProt: Q93084;TargetFullName: Sarcoplasmic/endoplasmic reticulum calcium ATPase 3;Organisim: human;Apparent_Kd_M: 3.817897E-11

Real

Aptamer SeqId: 13510-7 | Target: AT2A3 | UniProt: Q93084

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13510-7 | Target: AT2A3 | UniProt: Q93084 | TargetFullName: Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Organisim: human | Apparent_Kd_M: 3.817897E-11

Real

Aptamer SeqId:13511-29;Target:SATB1;UniProt:Q01826

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13511-29;Target: SATB1;UniProt: Q01826;TargetFullName: DNA-binding protein SATB1;Organisim: human;Apparent_Kd_M: 2.569961E-11

Real

Aptamer SeqId: 13511-29 | Target: SATB1 | UniProt: Q01826

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13511-29 | Target: SATB1 | UniProt: Q01826 | TargetFullName: DNA-binding protein SATB1 | Organisim: human | Apparent_Kd_M: 2.569961E-11

Real

Aptamer SeqId:13512-28;Target:HNRPR;UniProt:O43390

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13512-28;Target: HNRPR;UniProt: O43390;TargetFullName: Heterogeneous nuclear ribonucleoprotein R;Organisim: human;Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId: 13512-28 | Target: HNRPR | UniProt: O43390

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13512-28 | Target: HNRPR | UniProt: O43390 | TargetFullName: Heterogeneous nuclear ribonucleoprotein R | Organisim: human | Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId:13513-174;Target:PIAS3;UniProt:Q9Y6X2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13513-174;Target: PIAS3;UniProt: Q9Y6X2;TargetFullName: E3 SUMO-protein ligase PIAS3;Organisim: human;Apparent_Kd_M: 6.077345E-11

Real

Aptamer SeqId: 13513-174 | Target: PIAS3 | UniProt: Q9Y6X2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13513-174 | Target: PIAS3 | UniProt: Q9Y6X2 | TargetFullName: E3 SUMO-protein ligase PIAS3 | Organisim: human | Apparent_Kd_M: 6.077345E-11

Real

Aptamer SeqId:13514-121;Target:Rab-1C;UniProt:Q15286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13514-121;Target: Rab-1C;UniProt: Q15286;TargetFullName: Ras-related protein Rab-35;Organisim: human;Apparent_Kd_M: 4.394461E-11

Real

Aptamer SeqId: 13514-121 | Target: Rab-1C | UniProt: Q15286

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13514-121 | Target: Rab-1C | UniProt: Q15286 | TargetFullName: Ras-related protein Rab-35 | Organisim: human | Apparent_Kd_M: 4.394461E-11

Real

Aptamer SeqId:13515-8;Target:RPR1A;UniProt:Q96P16

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13515-8;Target: RPR1A;UniProt: Q96P16;TargetFullName: Regulation of nuclear pre-mRNA domain-containing protein 1A;Organisim: human;Apparent_Kd_M: 4.212992E-12

Real

Aptamer SeqId: 13515-8 | Target: RPR1A | UniProt: Q96P16

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13515-8 | Target: RPR1A | UniProt: Q96P16 | TargetFullName: Regulation of nuclear pre-mRNA domain-containing protein 1A | Organisim: human | Apparent_Kd_M: 4.212992E-12

Real

Aptamer SeqId:13516-46;Target:TMM85;UniProt:Q5J8M3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13516-46;Target: TMM85;UniProt: Q5J8M3;TargetFullName: ER membrane protein complex subunit 4;Organisim: human;Apparent_Kd_M: 5.980225E-12

Real

Aptamer SeqId: 13516-46 | Target: TMM85 | UniProt: Q5J8M3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13516-46 | Target: TMM85 | UniProt: Q5J8M3 | TargetFullName: ER membrane protein complex subunit 4 | Organisim: human | Apparent_Kd_M: 5.980225E-12

Real

Aptamer SeqId:13517-3;Target:PTHD3;UniProt:Q3KNS1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13517-3;Target: PTHD3;UniProt: Q3KNS1;TargetFullName: Patched domain-containing protein 3;Organisim: human;Apparent_Kd_M: 8.155024E-11

Real

Aptamer SeqId: 13517-3 | Target: PTHD3 | UniProt: Q3KNS1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13517-3 | Target: PTHD3 | UniProt: Q3KNS1 | TargetFullName: Patched domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 8.155024E-11

Real

Aptamer SeqId:13518-5;Target:ASAP2;UniProt:O43150

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13518-5;Target: ASAP2;UniProt: O43150;TargetFullName: Arf-GAP with SH3 domain; ANK repeat and PH domain-containing protein 2;Organisim: human;Apparent_Kd_M: 4.97712E-11

Real

Aptamer SeqId: 13518-5 | Target: ASAP2 | UniProt: O43150

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13518-5 | Target: ASAP2 | UniProt: O43150 | TargetFullName: Arf-GAP with SH3 domain; ANK repeat and PH domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 4.97712E-11

Real

Aptamer SeqId:13519-112;Target:ARHGP;UniProt:Q86VW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13519-112;Target: ARHGP;UniProt: Q86VW2;TargetFullName: Rho guanine nucleotide exchange factor 25;Organisim: human;Apparent_Kd_M: 5.788743E-12

Real

Aptamer SeqId: 13519-112 | Target: ARHGP | UniProt: Q86VW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13519-112 | Target: ARHGP | UniProt: Q86VW2 | TargetFullName: Rho guanine nucleotide exchange factor 25 | Organisim: human | Apparent_Kd_M: 5.788743E-12

Real

Aptamer SeqId:13522-20;Target:VISL1;UniProt:P62760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13522-20;Target: VISL1;UniProt: P62760;TargetFullName: Visinin-like protein 1;Organisim: human;Apparent_Kd_M: 8.060738E-11

Real

Aptamer SeqId: 13522-20 | Target: VISL1 | UniProt: P62760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13522-20 | Target: VISL1 | UniProt: P62760 | TargetFullName: Visinin-like protein 1 | Organisim: human | Apparent_Kd_M: 8.060738E-11

Real

Aptamer SeqId:13524-25;Target:H6ST2;UniProt:Q96MM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13524-25;Target: H6ST2;UniProt: Q96MM7;TargetFullName: Heparan-sulfate 6-O-sulfotransferase 2;Organisim: human;Apparent_Kd_M: 2.316573E-10

Real

Aptamer SeqId: 13524-25 | Target: H6ST2 | UniProt: Q96MM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13524-25 | Target: H6ST2 | UniProt: Q96MM7 | TargetFullName: Heparan-sulfate 6-O-sulfotransferase 2 | Organisim: human | Apparent_Kd_M: 2.316573E-10

Real

Aptamer SeqId:13525-17;Target:KCNG4;UniProt:Q8TDN1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13525-17;Target: KCNG4;UniProt: Q8TDN1;TargetFullName: Potassium voltage-gated channel subfamily G member 4;Organisim: human;Apparent_Kd_M: 1.20827E-10

Real

Aptamer SeqId: 13525-17 | Target: KCNG4 | UniProt: Q8TDN1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13525-17 | Target: KCNG4 | UniProt: Q8TDN1 | TargetFullName: Potassium voltage-gated channel subfamily G member 4 | Organisim: human | Apparent_Kd_M: 1.20827E-10

Real

Aptamer SeqId:13526-5;Target:LA;UniProt:P05455

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13526-5;Target: LA;UniProt: P05455;TargetFullName: Lupus La protein;Organisim: human;Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId: 13526-5 | Target: LA | UniProt: P05455

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13526-5 | Target: LA | UniProt: P05455 | TargetFullName: Lupus La protein | Organisim: human | Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId:13529-39;Target:NP1L2;UniProt:Q9ULW6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13529-39;Target: NP1L2;UniProt: Q9ULW6;TargetFullName: Nucleosome assembly protein 1-like 2;Organisim: human;Apparent_Kd_M: 5.257424E-12

Real

Aptamer SeqId: 13529-39 | Target: NP1L2 | UniProt: Q9ULW6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13529-39 | Target: NP1L2 | UniProt: Q9ULW6 | TargetFullName: Nucleosome assembly protein 1-like 2 | Organisim: human | Apparent_Kd_M: 5.257424E-12

Real

Aptamer SeqId:13530-5;Target:UR2R;UniProt:Q9UKP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13530-5;Target: UR2R;UniProt: Q9UKP6;TargetFullName: Urotensin-2 receptor;Organisim: human;Apparent_Kd_M: 1.450744E-11

Real

Aptamer SeqId: 13530-5 | Target: UR2R | UniProt: Q9UKP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13530-5 | Target: UR2R | UniProt: Q9UKP6 | TargetFullName: Urotensin-2 receptor | Organisim: human | Apparent_Kd_M: 1.450744E-11

Real

Aptamer SeqId:13532-25;Target:NEPR1;UniProt:Q8N9A8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13532-25;Target: NEPR1;UniProt: Q8N9A8;TargetFullName: Nuclear envelope phosphatase-regulatory subunit 1;Organisim: human;Apparent_Kd_M: 1.19857E-10

Real

Aptamer SeqId: 13532-25 | Target: NEPR1 | UniProt: Q8N9A8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13532-25 | Target: NEPR1 | UniProt: Q8N9A8 | TargetFullName: Nuclear envelope phosphatase-regulatory subunit 1 | Organisim: human | Apparent_Kd_M: 1.19857E-10

Real

Aptamer SeqId:13534-20;Target:MYOM2;UniProt:P54296

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13534-20;Target: MYOM2;UniProt: P54296;TargetFullName: Myomesin-2;Organisim: human;Apparent_Kd_M: 2.545047E-11

Real

Aptamer SeqId: 13534-20 | Target: MYOM2 | UniProt: P54296

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13534-20 | Target: MYOM2 | UniProt: P54296 | TargetFullName: Myomesin-2 | Organisim: human | Apparent_Kd_M: 2.545047E-11

Real

Aptamer SeqId:13535-2;Target:C43BP;UniProt:Q9Y5P4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13535-2;Target: C43BP;UniProt: Q9Y5P4;TargetFullName: Collagen type IV alpha-3-binding protein;Organisim: human;Apparent_Kd_M: 4.89E-11

Real

Aptamer SeqId: 13535-2 | Target: C43BP | UniProt: Q9Y5P4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13535-2 | Target: C43BP | UniProt: Q9Y5P4 | TargetFullName: Collagen type IV alpha-3-binding protein | Organisim: human | Apparent_Kd_M: 4.89E-11

Real

Aptamer SeqId:13536-56;Target:POLI;UniProt:Q9UNA4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13536-56;Target: POLI;UniProt: Q9UNA4;TargetFullName: DNA polymerase iota;Organisim: human;Apparent_Kd_M: 4.521885E-12

Real

Aptamer SeqId: 13536-56 | Target: POLI | UniProt: Q9UNA4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13536-56 | Target: POLI | UniProt: Q9UNA4 | TargetFullName: DNA polymerase iota | Organisim: human | Apparent_Kd_M: 4.521885E-12

Real

Aptamer SeqId:13539-131;Target:KCNN1;UniProt:Q92952

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13539-131;Target: KCNN1;UniProt: Q92952;TargetFullName: Small conductance calcium-activated potassium channel protein 1;Organisim: human;Apparent_Kd_M: 6.494594E-12

Real

Aptamer SeqId: 13539-131 | Target: KCNN1 | UniProt: Q92952

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13539-131 | Target: KCNN1 | UniProt: Q92952 | TargetFullName: Small conductance calcium-activated potassium channel protein 1 | Organisim: human | Apparent_Kd_M: 6.494594E-12

Real

Aptamer SeqId:13540-1;Target:GPR26;UniProt:Q8NDV2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13540-1;Target: GPR26;UniProt: Q8NDV2;TargetFullName: G-protein coupled receptor 26;Organisim: human;Apparent_Kd_M: 4.486151E-11

Real

Aptamer SeqId: 13540-1 | Target: GPR26 | UniProt: Q8NDV2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13540-1 | Target: GPR26 | UniProt: Q8NDV2 | TargetFullName: G-protein coupled receptor 26 | Organisim: human | Apparent_Kd_M: 4.486151E-11

Real

Aptamer SeqId:13541-1;Target:MYCT1;UniProt:Q8N699

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13541-1;Target: MYCT1;UniProt: Q8N699;TargetFullName: Myc target protein 1;Organisim: human;Apparent_Kd_M: 3.820159E-11

Real

Aptamer SeqId: 13541-1 | Target: MYCT1 | UniProt: Q8N699

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13541-1 | Target: MYCT1 | UniProt: Q8N699 | TargetFullName: Myc target protein 1 | Organisim: human | Apparent_Kd_M: 3.820159E-11

Real

Aptamer SeqId:13544-9;Target:HMHA1;UniProt:Q92619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13544-9;Target: HMHA1;UniProt: Q92619;TargetFullName: Rho GTPase-activating protein 45;Organisim: human;Apparent_Kd_M: 9.35991E-12

Real

Aptamer SeqId: 13544-9 | Target: HMHA1 | UniProt: Q92619

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13544-9 | Target: HMHA1 | UniProt: Q92619 | TargetFullName: Rho GTPase-activating protein 45 | Organisim: human | Apparent_Kd_M: 9.35991E-12

Real

Aptamer SeqId:13545-97;Target:EIF1A;UniProt:Q8N9N8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13545-97;Target: EIF1A;UniProt: Q8N9N8;TargetFullName: Probable RNA-binding protein EIF1AD;Organisim: human;Apparent_Kd_M: 4.912507E-12

Real

Aptamer SeqId: 13545-97 | Target: EIF1A | UniProt: Q8N9N8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13545-97 | Target: EIF1A | UniProt: Q8N9N8 | TargetFullName: Probable RNA-binding protein EIF1AD | Organisim: human | Apparent_Kd_M: 4.912507E-12

Real

Aptamer SeqId:13547-5;Target:5HT7R;UniProt:P34969

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13547-5;Target: 5HT7R;UniProt: P34969;TargetFullName: 5-hydroxytryptamine receptor 7;Organisim: human;Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId: 13547-5 | Target: 5HT7R | UniProt: P34969

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13547-5 | Target: 5HT7R | UniProt: P34969 | TargetFullName: 5-hydroxytryptamine receptor 7 | Organisim: human | Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId:13548-53;Target:PPC1A;UniProt:Q5VZY2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13548-53;Target: PPC1A;UniProt: Q5VZY2;TargetFullName: Phosphatidate phosphatase PPAPDC1A;Organisim: human;Apparent_Kd_M: 7.001981E-12

Real

Aptamer SeqId: 13548-53 | Target: PPC1A | UniProt: Q5VZY2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13548-53 | Target: PPC1A | UniProt: Q5VZY2 | TargetFullName: Phosphatidate phosphatase PPAPDC1A | Organisim: human | Apparent_Kd_M: 7.001981E-12

Real

Aptamer SeqId:13549-15;Target:ADA29;UniProt:Q9UKF5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13549-15;Target: ADA29;UniProt: Q9UKF5;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 29;Organisim: human;Apparent_Kd_M: 9.884741E-12

Real

Aptamer SeqId: 13549-15 | Target: ADA29 | UniProt: Q9UKF5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13549-15 | Target: ADA29 | UniProt: Q9UKF5 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 29 | Organisim: human | Apparent_Kd_M: 9.884741E-12

Real

Aptamer SeqId:13552-7;Target:SWP70;UniProt:Q9UH65

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13552-7;Target: SWP70;UniProt: Q9UH65;TargetFullName: Switch-associated protein 70;Organisim: human;Apparent_Kd_M: 2.288357E-11

Real

Aptamer SeqId: 13552-7 | Target: SWP70 | UniProt: Q9UH65

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13552-7 | Target: SWP70 | UniProt: Q9UH65 | TargetFullName: Switch-associated protein 70 | Organisim: human | Apparent_Kd_M: 2.288357E-11

Real

Aptamer SeqId:13553-4;Target:DCNL3;UniProt:Q8IWE4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13553-4;Target: DCNL3;UniProt: Q8IWE4;TargetFullName: DCN1-like protein 3;Organisim: human;Apparent_Kd_M: 2.962673E-11

Real

Aptamer SeqId: 13553-4 | Target: DCNL3 | UniProt: Q8IWE4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13553-4 | Target: DCNL3 | UniProt: Q8IWE4 | TargetFullName: DCN1-like protein 3 | Organisim: human | Apparent_Kd_M: 2.962673E-11

Real

Aptamer SeqId:13554-78;Target:REPI1;UniProt:Q9BWE0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13554-78;Target: REPI1;UniProt: Q9BWE0;TargetFullName: Replication initiator 1;Organisim: human;Apparent_Kd_M: 2.067433E-11

Real

Aptamer SeqId: 13554-78 | Target: REPI1 | UniProt: Q9BWE0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13554-78 | Target: REPI1 | UniProt: Q9BWE0 | TargetFullName: Replication initiator 1 | Organisim: human | Apparent_Kd_M: 2.067433E-11

Real

Aptamer SeqId:13556-28;Target:5HT2A;UniProt:P28223

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13556-28;Target: 5HT2A;UniProt: P28223;TargetFullName: 5-hydroxytryptamine receptor 2A;Organisim: human;Apparent_Kd_M: 2.95E-11

Real

Aptamer SeqId: 13556-28 | Target: 5HT2A | UniProt: P28223

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13556-28 | Target: 5HT2A | UniProt: P28223 | TargetFullName: 5-hydroxytryptamine receptor 2A | Organisim: human | Apparent_Kd_M: 2.95E-11

Real

Aptamer SeqId:13557-3;Target:Nectin 3;UniProt:Q9NQS3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13557-3;Target: Nectin 3;UniProt: Q9NQS3;TargetFullName: Nectin-3;Organisim: human;Apparent_Kd_M: 1.74917E-11

Real

Aptamer SeqId: 13557-3 | Target: Nectin 3 | UniProt: Q9NQS3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13557-3 | Target: Nectin 3 | UniProt: Q9NQS3 | TargetFullName: Nectin-3 | Organisim: human | Apparent_Kd_M: 1.74917E-11

Real

Aptamer SeqId:13561-5;Target:5HT6R;UniProt:P50406

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13561-5;Target: 5HT6R;UniProt: P50406;TargetFullName: 5-hydroxytryptamine receptor 6;Organisim: human;Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId: 13561-5 | Target: 5HT6R | UniProt: P50406

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13561-5 | Target: 5HT6R | UniProt: P50406 | TargetFullName: 5-hydroxytryptamine receptor 6 | Organisim: human | Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId:13563-259;Target:ACBD7;UniProt:Q8N6N7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13563-259;Target: ACBD7;UniProt: Q8N6N7;TargetFullName: Acyl-CoA-binding domain-containing protein 7;Organisim: human;Apparent_Kd_M: 7.324428E-12

Real

Aptamer SeqId: 13563-259 | Target: ACBD7 | UniProt: Q8N6N7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13563-259 | Target: ACBD7 | UniProt: Q8N6N7 | TargetFullName: Acyl-CoA-binding domain-containing protein 7 | Organisim: human | Apparent_Kd_M: 7.324428E-12

Real

Aptamer SeqId:13565-2;Target:p130;UniProt:Q08999

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13565-2;Target: p130;UniProt: Q08999;TargetFullName: Retinoblastoma-like protein 2;Organisim: human;Apparent_Kd_M: 3.59E-10

Real

Aptamer SeqId: 13565-2 | Target: p130 | UniProt: Q08999

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13565-2 | Target: p130 | UniProt: Q08999 | TargetFullName: Retinoblastoma-like protein 2 | Organisim: human | Apparent_Kd_M: 3.59E-10

Real

Aptamer SeqId:13566-2;Target:SSU72;UniProt:Q9NP77

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13566-2;Target: SSU72;UniProt: Q9NP77;TargetFullName: RNA polymerase II subunit A C-terminal domain phosphatase SSU72;Organisim: human;Apparent_Kd_M: 6.897323E-12

Real

Aptamer SeqId: 13566-2 | Target: SSU72 | UniProt: Q9NP77

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13566-2 | Target: SSU72 | UniProt: Q9NP77 | TargetFullName: RNA polymerase II subunit A C-terminal domain phosphatase SSU72 | Organisim: human | Apparent_Kd_M: 6.897323E-12

Real

Aptamer SeqId:13567-1;Target:DPYL2;UniProt:Q16555

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13567-1;Target: DPYL2;UniProt: Q16555;TargetFullName: Dihydropyrimidinase-related protein 2;Organisim: human;Apparent_Kd_M: 8.383723E-12

Real

Aptamer SeqId: 13567-1 | Target: DPYL2 | UniProt: Q16555

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13567-1 | Target: DPYL2 | UniProt: Q16555 | TargetFullName: Dihydropyrimidinase-related protein 2 | Organisim: human | Apparent_Kd_M: 8.383723E-12

Real

Aptamer SeqId:13568-30;Target:PSMD4;UniProt:P55036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13568-30;Target: PSMD4;UniProt: P55036;TargetFullName: 26S proteasome non-ATPase regulatory subunit 4;Organisim: human;Apparent_Kd_M: 1.53802E-11

Real

Aptamer SeqId: 13568-30 | Target: PSMD4 | UniProt: P55036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13568-30 | Target: PSMD4 | UniProt: P55036 | TargetFullName: 26S proteasome non-ATPase regulatory subunit 4 | Organisim: human | Apparent_Kd_M: 1.53802E-11

Real

Aptamer SeqId:13570-43;Target:VIGLN;UniProt:Q00341

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13570-43;Target: VIGLN;UniProt: Q00341;TargetFullName: Vigilin;Organisim: human;Apparent_Kd_M: 4.768051E-11

Real

Aptamer SeqId: 13570-43 | Target: VIGLN | UniProt: Q00341

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13570-43 | Target: VIGLN | UniProt: Q00341 | TargetFullName: Vigilin | Organisim: human | Apparent_Kd_M: 4.768051E-11

Real

Aptamer SeqId:13572-43;Target:PSD11;UniProt:O00231

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13572-43;Target: PSD11;UniProt: O00231;TargetFullName: 26S proteasome non-ATPase regulatory subunit 11;Organisim: human;Apparent_Kd_M: 1.812309E-12

Real

Aptamer SeqId: 13572-43 | Target: PSD11 | UniProt: O00231

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13572-43 | Target: PSD11 | UniProt: O00231 | TargetFullName: 26S proteasome non-ATPase regulatory subunit 11 | Organisim: human | Apparent_Kd_M: 1.812309E-12

Real

Aptamer SeqId:13573-5;Target:p21-ARC;UniProt:O15145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13573-5;Target: p21-ARC;UniProt: O15145;TargetFullName: Actin-related protein 2/3 complex subunit 3;Organisim: human;Apparent_Kd_M: 1.227505E-11

Real

Aptamer SeqId: 13573-5 | Target: p21-ARC | UniProt: O15145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13573-5 | Target: p21-ARC | UniProt: O15145 | TargetFullName: Actin-related protein 2/3 complex subunit 3 | Organisim: human | Apparent_Kd_M: 1.227505E-11

Real

Aptamer SeqId:13574-50;Target:RND1;UniProt:Q92730

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13574-50;Target: RND1;UniProt: Q92730;TargetFullName: Rho-related GTP-binding protein Rho6;Organisim: human;Apparent_Kd_M: 1.761626E-10

Real

Aptamer SeqId: 13574-50 | Target: RND1 | UniProt: Q92730

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13574-50 | Target: RND1 | UniProt: Q92730 | TargetFullName: Rho-related GTP-binding protein Rho6 | Organisim: human | Apparent_Kd_M: 1.761626E-10

Real

Aptamer SeqId:13575-40;Target:DVL2;UniProt:O14641

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13575-40;Target: DVL2;UniProt: O14641;TargetFullName: Segment polarity protein dishevelled homolog DVL-2;Organisim: human;Apparent_Kd_M: 4.516577E-11

Real

Aptamer SeqId: 13575-40 | Target: DVL2 | UniProt: O14641

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13575-40 | Target: DVL2 | UniProt: O14641 | TargetFullName: Segment polarity protein dishevelled homolog DVL-2 | Organisim: human | Apparent_Kd_M: 4.516577E-11

Real

Aptamer SeqId:13577-25;Target:U2AF2;UniProt:P26368

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13577-25;Target: U2AF2;UniProt: P26368;TargetFullName: Splicing factor U2AF 65 kDa subunit;Organisim: human;Apparent_Kd_M: 6.109471E-11

Real

Aptamer SeqId: 13577-25 | Target: U2AF2 | UniProt: P26368

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13577-25 | Target: U2AF2 | UniProt: P26368 | TargetFullName: Splicing factor U2AF 65 kDa subunit | Organisim: human | Apparent_Kd_M: 6.109471E-11

Real

Aptamer SeqId:13578-98;Target:ABLM3;UniProt:O94929

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13578-98;Target: ABLM3;UniProt: O94929;TargetFullName: Actin-binding LIM protein 3;Organisim: human;Apparent_Kd_M: 1.42E-10

Real

Aptamer SeqId: 13578-98 | Target: ABLM3 | UniProt: O94929

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13578-98 | Target: ABLM3 | UniProt: O94929 | TargetFullName: Actin-binding LIM protein 3 | Organisim: human | Apparent_Kd_M: 1.42E-10

Real

Aptamer SeqId:13580-2;Target:Sperm-associated antigen 2;UniProt:Q16222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13580-2;Target: Sperm-associated antigen 2;UniProt: Q16222;TargetFullName: UDP-N-acetylhexosamine pyrophosphorylase;Organisim: human;Apparent_Kd_M: 6.926118E-11

Real

Aptamer SeqId: 13580-2 | Target: Sperm-associated antigen 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13580-2 | Target: Sperm-associated antigen 2 | UniProt: Q16222 | TargetFullName: UDP-N-acetylhexosamine pyrophosphorylase | Organisim: human | Apparent_Kd_M: 6.926118E-11

Real

Aptamer SeqId:13583-19;Target:Apaf-1;UniProt:O14727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13583-19;Target: Apaf-1;UniProt: O14727;TargetFullName: Apoptotic protease-activating factor 1;Organisim: human;Apparent_Kd_M: 8.321362E-11

Real

Aptamer SeqId: 13583-19 | Target: Apaf-1 | UniProt: O14727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13583-19 | Target: Apaf-1 | UniProt: O14727 | TargetFullName: Apoptotic protease-activating factor 1 | Organisim: human | Apparent_Kd_M: 8.321362E-11

Real

Aptamer SeqId:13587-10;Target:RGAP1;UniProt:Q9H0H5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13587-10;Target: RGAP1;UniProt: Q9H0H5;TargetFullName: Rac GTPase-activating protein 1;Organisim: human;Apparent_Kd_M: 4.201845E-12

Real

Aptamer SeqId: 13587-10 | Target: RGAP1 | UniProt: Q9H0H5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13587-10 | Target: RGAP1 | UniProt: Q9H0H5 | TargetFullName: Rac GTPase-activating protein 1 | Organisim: human | Apparent_Kd_M: 4.201845E-12

Real

Aptamer SeqId:13588-11;Target:ANXA9;UniProt:O76027

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13588-11;Target: ANXA9;UniProt: O76027;TargetFullName: Annexin A9;Organisim: human;Apparent_Kd_M: 1.959181E-10

Real

Aptamer SeqId: 13588-11 | Target: ANXA9 | UniProt: O76027

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13588-11 | Target: ANXA9 | UniProt: O76027 | TargetFullName: Annexin A9 | Organisim: human | Apparent_Kd_M: 1.959181E-10

Real

Aptamer SeqId:13589-10;Target:APBB3;UniProt:O95704

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13589-10;Target: APBB3;UniProt: O95704;TargetFullName: Amyloid beta A4 precursor protein-binding family B member 3;Organisim: human;Apparent_Kd_M: 4.77E-11

Real

Aptamer SeqId: 13589-10 | Target: APBB3 | UniProt: O95704

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13589-10 | Target: APBB3 | UniProt: O95704 | TargetFullName: Amyloid beta A4 precursor protein-binding family B member 3 | Organisim: human | Apparent_Kd_M: 4.77E-11

Real

Aptamer SeqId:13590-1;Target:ORN;UniProt:Q9Y3B8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13590-1;Target: ORN;UniProt: Q9Y3B8;TargetFullName: Oligoribonuclease; mitochondrial;Organisim: human;Apparent_Kd_M: 2.638814E-12

Real

Aptamer SeqId: 13590-1 | Target: ORN | UniProt: Q9Y3B8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13590-1 | Target: ORN | UniProt: Q9Y3B8 | TargetFullName: Oligoribonuclease; mitochondrial | Organisim: human | Apparent_Kd_M: 2.638814E-12

Real

Aptamer SeqId:13591-31;Target:PRI1;UniProt:P49642

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13591-31;Target: PRI1;UniProt: P49642;TargetFullName: DNA primase small subunit;Organisim: human;Apparent_Kd_M: 1.773282E-11

Real

Aptamer SeqId: 13591-31 | Target: PRI1 | UniProt: P49642

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13591-31 | Target: PRI1 | UniProt: P49642 | TargetFullName: DNA primase small subunit | Organisim: human | Apparent_Kd_M: 1.773282E-11

Real

Aptamer SeqId:13594-158;Target:GGA1;UniProt:Q9UJY5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13594-158;Target: GGA1;UniProt: Q9UJY5;TargetFullName: ADP-ribosylation factor-binding protein GGA1;Organisim: human;Apparent_Kd_M: 1.207675E-12

Real

Aptamer SeqId: 13594-158 | Target: GGA1 | UniProt: Q9UJY5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13594-158 | Target: GGA1 | UniProt: Q9UJY5 | TargetFullName: ADP-ribosylation factor-binding protein GGA1 | Organisim: human | Apparent_Kd_M: 1.207675E-12

Real

Aptamer SeqId:13595-20;Target:THTPA;UniProt:Q9BU02

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13595-20;Target: THTPA;UniProt: Q9BU02;TargetFullName: Thiamine-triphosphatase;Organisim: human;Apparent_Kd_M: 7.616058E-11

Real

Aptamer SeqId: 13595-20 | Target: THTPA | UniProt: Q9BU02

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13595-20 | Target: THTPA | UniProt: Q9BU02 | TargetFullName: Thiamine-triphosphatase | Organisim: human | Apparent_Kd_M: 7.616058E-11

Real

Aptamer SeqId:13596-3;Target:RB27B;UniProt:O00194

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13596-3;Target: RB27B;UniProt: O00194;TargetFullName: Ras-related protein Rab-27B;Organisim: human;Apparent_Kd_M: 1.384802E-11

Real

Aptamer SeqId: 13596-3 | Target: RB27B | UniProt: O00194

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13596-3 | Target: RB27B | UniProt: O00194 | TargetFullName: Ras-related protein Rab-27B | Organisim: human | Apparent_Kd_M: 1.384802E-11

Real

Aptamer SeqId:13597-20;Target:RAB31;UniProt:Q13636

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13597-20;Target: RAB31;UniProt: Q13636;TargetFullName: Ras-related protein Rab-31;Organisim: human;Apparent_Kd_M: 2.552558E-11

Real

Aptamer SeqId: 13597-20 | Target: RAB31 | UniProt: Q13636

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13597-20 | Target: RAB31 | UniProt: Q13636 | TargetFullName: Ras-related protein Rab-31 | Organisim: human | Apparent_Kd_M: 2.552558E-11

Real

Aptamer SeqId:13599-15;Target:RABEK;UniProt:Q7Z6M1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13599-15;Target: RABEK;UniProt: Q7Z6M1;TargetFullName: Rab9 effector protein with kelch motifs;Organisim: human;Apparent_Kd_M: 3.863279E-11

Real

Aptamer SeqId: 13599-15 | Target: RABEK | UniProt: Q7Z6M1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13599-15 | Target: RABEK | UniProt: Q7Z6M1 | TargetFullName: Rab9 effector protein with kelch motifs | Organisim: human | Apparent_Kd_M: 3.863279E-11

Real

Aptamer SeqId:13602-6;Target:NH2L1;UniProt:P55769

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13602-6;Target: NH2L1;UniProt: P55769;TargetFullName: NHP2-like protein 1;Organisim: human;Apparent_Kd_M: 4.339369E-11

Real

Aptamer SeqId: 13602-6 | Target: NH2L1 | UniProt: P55769

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13602-6 | Target: NH2L1 | UniProt: P55769 | TargetFullName: NHP2-like protein 1 | Organisim: human | Apparent_Kd_M: 4.339369E-11

Real

Aptamer SeqId:13603-7;Target:RFESD;UniProt:Q8TAC1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13603-7;Target: RFESD;UniProt: Q8TAC1;TargetFullName: Rieske domain-containing protein;Organisim: human;Apparent_Kd_M: 6.140028E-11

Real

Aptamer SeqId: 13603-7 | Target: RFESD | UniProt: Q8TAC1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13603-7 | Target: RFESD | UniProt: Q8TAC1 | TargetFullName: Rieske domain-containing protein | Organisim: human | Apparent_Kd_M: 6.140028E-11

Real

Aptamer SeqId:13604-27;Target:NEUL1;UniProt:O76050

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13604-27;Target: NEUL1;UniProt: O76050;TargetFullName: E3 ubiquitin-protein ligase NEURL1;Organisim: human;Apparent_Kd_M: 3.597537E-12

Real

Aptamer SeqId: 13604-27 | Target: NEUL1 | UniProt: O76050

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13604-27 | Target: NEUL1 | UniProt: O76050 | TargetFullName: E3 ubiquitin-protein ligase NEURL1 | Organisim: human | Apparent_Kd_M: 3.597537E-12

Real

Aptamer SeqId:13605-16;Target:ANX10;UniProt:Q9UJ72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13605-16;Target: ANX10;UniProt: Q9UJ72;TargetFullName: Annexin A10;Organisim: human;Apparent_Kd_M: 4.030342E-11

Real

Aptamer SeqId: 13605-16 | Target: ANX10 | UniProt: Q9UJ72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13605-16 | Target: ANX10 | UniProt: Q9UJ72 | TargetFullName: Annexin A10 | Organisim: human | Apparent_Kd_M: 4.030342E-11

Real

Aptamer SeqId:13609-11;Target:GTF2I;UniProt:P78347

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13609-11;Target: GTF2I;UniProt: P78347;TargetFullName: General transcription factor II-I;Organisim: human;Apparent_Kd_M: 2.454687E-11

Real

Aptamer SeqId: 13609-11 | Target: GTF2I | UniProt: P78347

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13609-11 | Target: GTF2I | UniProt: P78347 | TargetFullName: General transcription factor II-I | Organisim: human | Apparent_Kd_M: 2.454687E-11

Real

Aptamer SeqId:13610-9;Target:MAGE-10;UniProt:P43363

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13610-9;Target: MAGE-10;UniProt: P43363;TargetFullName: Melanoma-associated antigen 10;Organisim: human;Apparent_Kd_M: 8.163914E-11

Real

Aptamer SeqId: 13610-9 | Target: MAGE-10 | UniProt: P43363

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13610-9 | Target: MAGE-10 | UniProt: P43363 | TargetFullName: Melanoma-associated antigen 10 | Organisim: human | Apparent_Kd_M: 8.163914E-11

Real

Aptamer SeqId:13612-7;Target:CYTIP;UniProt:O60759

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13612-7;Target: CYTIP;UniProt: O60759;TargetFullName: Cytohesin-interacting protein;Organisim: human;Apparent_Kd_M: 6.930758E-12

Real

Aptamer SeqId: 13612-7 | Target: CYTIP | UniProt: O60759

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13612-7 | Target: CYTIP | UniProt: O60759 | TargetFullName: Cytohesin-interacting protein | Organisim: human | Apparent_Kd_M: 6.930758E-12

Real

Aptamer SeqId:13613-23;Target:Adenylate kinase isoenzyme 5;UniProt:Q9Y6K8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13613-23;Target: Adenylate kinase isoenzyme 5;UniProt: Q9Y6K8;TargetFullName: Adenylate kinase isoenzyme 5;Organisim: human;Apparent_Kd_M: 1.299997E-10

Real

Aptamer SeqId: 13613-23 | Target: Adenylate kinase isoenzyme 5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13613-23 | Target: Adenylate kinase isoenzyme 5 | UniProt: Q9Y6K8 | TargetFullName: Adenylate kinase isoenzyme 5 | Organisim: human | Apparent_Kd_M: 1.299997E-10

Real

Aptamer SeqId:13614-6;Target:CREB-binding protein;UniProt:Q92793

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13614-6;Target: CREB-binding protein;UniProt: Q92793;TargetFullName: CREB-binding protein;Organisim: human;Apparent_Kd_M: 4.557514E-11

Real

Aptamer SeqId: 13614-6 | Target: CREB-binding protein | UniProt: Q92793

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13614-6 | Target: CREB-binding protein | UniProt: Q92793 | TargetFullName: CREB-binding protein | Organisim: human | Apparent_Kd_M: 4.557514E-11

Real

Aptamer SeqId:13615-60;Target:NCK2;UniProt:O43639

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13615-60;Target: NCK2;UniProt: O43639;TargetFullName: Cytoplasmic protein NCK2;Organisim: human;Apparent_Kd_M: 1.83438E-11

Real

Aptamer SeqId: 13615-60 | Target: NCK2 | UniProt: O43639

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13615-60 | Target: NCK2 | UniProt: O43639 | TargetFullName: Cytoplasmic protein NCK2 | Organisim: human | Apparent_Kd_M: 1.83438E-11

Real

Aptamer SeqId:13618-15;Target:MD1L1;UniProt:Q9Y6D9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13618-15;Target: MD1L1;UniProt: Q9Y6D9;TargetFullName: Mitotic spindle assembly checkpoint protein MAD1;Organisim: human;Apparent_Kd_M: 7.550895E-12

Real

Aptamer SeqId: 13618-15 | Target: MD1L1 | UniProt: Q9Y6D9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13618-15 | Target: MD1L1 | UniProt: Q9Y6D9 | TargetFullName: Mitotic spindle assembly checkpoint protein MAD1 | Organisim: human | Apparent_Kd_M: 7.550895E-12

Real

Aptamer SeqId:13620-10;Target:ASNA;UniProt:O43681

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13620-10;Target: ASNA;UniProt: O43681;TargetFullName: ATPase ASNA1;Organisim: human;Apparent_Kd_M: 1.341221E-10

Real

Aptamer SeqId: 13620-10 | Target: ASNA | UniProt: O43681

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13620-10 | Target: ASNA | UniProt: O43681 | TargetFullName: ATPase ASNA1 | Organisim: human | Apparent_Kd_M: 1.341221E-10

Real

Aptamer SeqId:13621-31;Target:AP2A2;UniProt:O94973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13621-31;Target: AP2A2;UniProt: O94973;TargetFullName: AP-2 complex subunit alpha-2;Organisim: human;Apparent_Kd_M: 1.65E-12

Real

Aptamer SeqId: 13621-31 | Target: AP2A2 | UniProt: O94973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13621-31 | Target: AP2A2 | UniProt: O94973 | TargetFullName: AP-2 complex subunit alpha-2 | Organisim: human | Apparent_Kd_M: 1.65E-12

Real

Aptamer SeqId:13622-16;Target:2A5A;UniProt:Q15172

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13622-16;Target: 2A5A;UniProt: Q15172;TargetFullName: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform;Organisim: human;Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId: 13622-16 | Target: 2A5A | UniProt: Q15172

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13622-16 | Target: 2A5A | UniProt: Q15172 | TargetFullName: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | Organisim: human | Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId:13623-4;Target:MLL2;UniProt:O14686

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13623-4;Target: MLL2;UniProt: O14686;TargetFullName: Histone-lysine N-methyltransferase 2D;Organisim: human;Apparent_Kd_M: 6.62846E-12

Real

Aptamer SeqId: 13623-4 | Target: MLL2 | UniProt: O14686

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13623-4 | Target: MLL2 | UniProt: O14686 | TargetFullName: Histone-lysine N-methyltransferase 2D | Organisim: human | Apparent_Kd_M: 6.62846E-12

Real

Aptamer SeqId:13624-17;Target:NADK;UniProt:O95544

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13624-17;Target: NADK;UniProt: O95544;TargetFullName: NAD kinase;Organisim: human;Apparent_Kd_M: 3.58828E-12

Real

Aptamer SeqId: 13624-17 | Target: NADK | UniProt: O95544

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13624-17 | Target: NADK | UniProt: O95544 | TargetFullName: NAD kinase | Organisim: human | Apparent_Kd_M: 3.58828E-12

Real

Aptamer SeqId:13625-19;Target:LA;UniProt:P05455

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13625-19;Target: LA;UniProt: P05455;TargetFullName: Lupus La protein;Organisim: human;Apparent_Kd_M: 6.49E-11

Real

Aptamer SeqId: 13625-19 | Target: LA | UniProt: P05455

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13625-19 | Target: LA | UniProt: P05455 | TargetFullName: Lupus La protein | Organisim: human | Apparent_Kd_M: 6.49E-11

Real

Aptamer SeqId:13628-58;Target:GRB14;UniProt:Q14449

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13628-58;Target: GRB14;UniProt: Q14449;TargetFullName: Growth factor receptor-bound protein 14;Organisim: human;Apparent_Kd_M: 1.569638E-10

Real

Aptamer SeqId: 13628-58 | Target: GRB14 | UniProt: Q14449

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13628-58 | Target: GRB14 | UniProt: Q14449 | TargetFullName: Growth factor receptor-bound protein 14 | Organisim: human | Apparent_Kd_M: 1.569638E-10

Real

Aptamer SeqId:13629-25;Target:ATG4B;UniProt:Q9Y4P1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13629-25;Target: ATG4B;UniProt: Q9Y4P1;TargetFullName: Cysteine protease ATG4B;Organisim: human;Apparent_Kd_M: 5.401874E-11

Real

Aptamer SeqId: 13629-25 | Target: ATG4B | UniProt: Q9Y4P1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13629-25 | Target: ATG4B | UniProt: Q9Y4P1 | TargetFullName: Cysteine protease ATG4B | Organisim: human | Apparent_Kd_M: 5.401874E-11

Real

Aptamer SeqId:13631-1;Target:RB binding protein 5;UniProt:Q15291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13631-1;Target: RB binding protein 5;UniProt: Q15291;TargetFullName: Retinoblastoma-binding protein 5;Organisim: human;Apparent_Kd_M: 3.474175E-12

Real

Aptamer SeqId: 13631-1 | Target: RB binding protein 5 | UniProt: Q15291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13631-1 | Target: RB binding protein 5 | UniProt: Q15291 | TargetFullName: Retinoblastoma-binding protein 5 | Organisim: human | Apparent_Kd_M: 3.474175E-12

Real

Aptamer SeqId:13632-10;Target:Zyxin;UniProt:Q15942

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13632-10;Target: Zyxin;UniProt: Q15942;TargetFullName: Zyxin;Organisim: human;Apparent_Kd_M: 1.105713E-11

Real

Aptamer SeqId: 13632-10 | Target: Zyxin | UniProt: Q15942

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13632-10 | Target: Zyxin | UniProt: Q15942 | TargetFullName: Zyxin | Organisim: human | Apparent_Kd_M: 1.105713E-11

Real

Aptamer SeqId:13634-209;Target:PIR;UniProt:O00625

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13634-209;Target: PIR;UniProt: O00625;TargetFullName: Pirin;Organisim: human;Apparent_Kd_M: 4.51501E-12

Real

Aptamer SeqId: 13634-209 | Target: PIR | UniProt: O00625

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13634-209 | Target: PIR | UniProt: O00625 | TargetFullName: Pirin | Organisim: human | Apparent_Kd_M: 4.51501E-12

Real

Aptamer SeqId:13636-20;Target:NP1L1;UniProt:P55209

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13636-20;Target: NP1L1;UniProt: P55209;TargetFullName: Nucleosome assembly protein 1-like 1;Organisim: human;Apparent_Kd_M: 7.83871E-12

Real

Aptamer SeqId: 13636-20 | Target: NP1L1 | UniProt: P55209

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13636-20 | Target: NP1L1 | UniProt: P55209 | TargetFullName: Nucleosome assembly protein 1-like 1 | Organisim: human | Apparent_Kd_M: 7.83871E-12

Real

Aptamer SeqId:13639-101;Target:USO1;UniProt:O60763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13639-101;Target: USO1;UniProt: O60763;TargetFullName: General vesicular transport factor p115;Organisim: human;Apparent_Kd_M: 1.066422E-10

Real

Aptamer SeqId: 13639-101 | Target: USO1 | UniProt: O60763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13639-101 | Target: USO1 | UniProt: O60763 | TargetFullName: General vesicular transport factor p115 | Organisim: human | Apparent_Kd_M: 1.066422E-10

Real

Aptamer SeqId:13642-90;Target:CIG49;UniProt:O14879

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13642-90;Target: CIG49;UniProt: O14879;TargetFullName: Interferon-induced protein with tetratricopeptide repeats 3;Organisim: human;Apparent_Kd_M: 8.188334E-12

Real

Aptamer SeqId: 13642-90 | Target: CIG49 | UniProt: O14879

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13642-90 | Target: CIG49 | UniProt: O14879 | TargetFullName: Interferon-induced protein with tetratricopeptide repeats 3 | Organisim: human | Apparent_Kd_M: 8.188334E-12

Real

Aptamer SeqId:13644-30;Target:HGS;UniProt:O14964

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13644-30;Target: HGS;UniProt: O14964;TargetFullName: Hepatocyte growth factor-regulated tyrosine kinase substrate;Organisim: human;Apparent_Kd_M: 2.250544E-12

Real

Aptamer SeqId: 13644-30 | Target: HGS | UniProt: O14964

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13644-30 | Target: HGS | UniProt: O14964 | TargetFullName: Hepatocyte growth factor-regulated tyrosine kinase substrate | Organisim: human | Apparent_Kd_M: 2.250544E-12

Real

Aptamer SeqId:13645-14;Target:PRP16;UniProt:Q92620

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13645-14;Target: PRP16;UniProt: Q92620;TargetFullName: Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16;Organisim: human;Apparent_Kd_M: 5.551291E-11

Real

Aptamer SeqId: 13645-14 | Target: PRP16 | UniProt: Q92620

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13645-14 | Target: PRP16 | UniProt: Q92620 | TargetFullName: Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 | Organisim: human | Apparent_Kd_M: 5.551291E-11

Real

Aptamer SeqId:13650-11;Target:KCIP1;UniProt:Q9NZI2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13650-11;Target: KCIP1;UniProt: Q9NZI2;TargetFullName: Kv channel-interacting protein 1;Organisim: human;Apparent_Kd_M: 1.473081E-10

Real

Aptamer SeqId: 13650-11 | Target: KCIP1 | UniProt: Q9NZI2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13650-11 | Target: KCIP1 | UniProt: Q9NZI2 | TargetFullName: Kv channel-interacting protein 1 | Organisim: human | Apparent_Kd_M: 1.473081E-10

Real

Aptamer SeqId:13651-54;Target:ZFP91;UniProt:Q96JP5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13651-54;Target: ZFP91;UniProt: Q96JP5;TargetFullName: E3 ubiquitin-protein ligase ZFP91;Organisim: human;Apparent_Kd_M: 9.885553E-12

Real

Aptamer SeqId: 13651-54 | Target: ZFP91 | UniProt: Q96JP5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13651-54 | Target: ZFP91 | UniProt: Q96JP5 | TargetFullName: E3 ubiquitin-protein ligase ZFP91 | Organisim: human | Apparent_Kd_M: 9.885553E-12

Real

Aptamer SeqId:13652-2;Target:TM1L1;UniProt:O75674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13652-2;Target: TM1L1;UniProt: O75674;TargetFullName: TOM1-like protein 1;Organisim: human;Apparent_Kd_M: 7.911346E-12

Real

Aptamer SeqId: 13652-2 | Target: TM1L1 | UniProt: O75674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13652-2 | Target: TM1L1 | UniProt: O75674 | TargetFullName: TOM1-like protein 1 | Organisim: human | Apparent_Kd_M: 7.911346E-12

Real

Aptamer SeqId:13653-335;Target:MACD1;UniProt:Q9BQ69

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13653-335;Target: MACD1;UniProt: Q9BQ69;TargetFullName: O-acetyl-ADP-ribose deacetylase MACROD1;Organisim: human;Apparent_Kd_M: 5.74414E-11

Real

Aptamer SeqId: 13653-335 | Target: MACD1 | UniProt: Q9BQ69

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13653-335 | Target: MACD1 | UniProt: Q9BQ69 | TargetFullName: O-acetyl-ADP-ribose deacetylase MACROD1 | Organisim: human | Apparent_Kd_M: 5.74414E-11

Real

Aptamer SeqId:13654-1;Target:ROCK2;UniProt:O75116

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13654-1;Target: ROCK2;UniProt: O75116;TargetFullName: Rho-associated protein kinase 2;Organisim: human;Apparent_Kd_M: 1.838118E-10

Real

Aptamer SeqId: 13654-1 | Target: ROCK2 | UniProt: O75116

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13654-1 | Target: ROCK2 | UniProt: O75116 | TargetFullName: Rho-associated protein kinase 2 | Organisim: human | Apparent_Kd_M: 1.838118E-10

Real

Aptamer SeqId:13655-34;Target:Nucleolin;UniProt:P19338

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13655-34;Target: Nucleolin;UniProt: P19338;TargetFullName: Nucleolin;Organisim: human;Apparent_Kd_M: 9.192547E-12

Real

Aptamer SeqId: 13655-34 | Target: Nucleolin | UniProt: P19338

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13655-34 | Target: Nucleolin | UniProt: P19338 | TargetFullName: Nucleolin | Organisim: human | Apparent_Kd_M: 9.192547E-12

Real

Aptamer SeqId:13657-2;Target:PNKP;UniProt:Q96T60

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13657-2;Target: PNKP;UniProt: Q96T60;TargetFullName: Bifunctional polynucleotide phosphatase/kinase;Organisim: human;Apparent_Kd_M: 9.132099E-12

Real

Aptamer SeqId: 13657-2 | Target: PNKP | UniProt: Q96T60

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13657-2 | Target: PNKP | UniProt: Q96T60 | TargetFullName: Bifunctional polynucleotide phosphatase/kinase | Organisim: human | Apparent_Kd_M: 9.132099E-12

Real

Aptamer SeqId:13658-31;Target:PDGF-CC;UniProt:Q9NRA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13658-31;Target: PDGF-CC;UniProt: Q9NRA1;TargetFullName: Platelet-derived growth factor C;Organisim: human;Apparent_Kd_M: 1.01E-10

Real

Aptamer SeqId: 13658-31 | Target: PDGF-CC | UniProt: Q9NRA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13658-31 | Target: PDGF-CC | UniProt: Q9NRA1 | TargetFullName: Platelet-derived growth factor C | Organisim: human | Apparent_Kd_M: 1.01E-10

Real

Aptamer SeqId:13659-36;Target:AT131;UniProt:Q9HD20

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13659-36;Target: AT131;UniProt: Q9HD20;TargetFullName: Manganese-transporting ATPase 13A1;Organisim: human;Apparent_Kd_M: 9.708494E-11

Real

Aptamer SeqId: 13659-36 | Target: AT131 | UniProt: Q9HD20

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13659-36 | Target: AT131 | UniProt: Q9HD20 | TargetFullName: Manganese-transporting ATPase 13A1 | Organisim: human | Apparent_Kd_M: 9.708494E-11

Real

Aptamer SeqId:13665-35;Target:PP2A; subunit B;UniProt:Q06190

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13665-35;Target: PP2A; subunit B;UniProt: Q06190;TargetFullName: Serine/threonine-protein phosphatase 2A regulatory subunit B subunit alpha;Organisim: human;Apparent_Kd_M: 4.794455E-11

Real

Aptamer SeqId: 13665-35 | Target: PP2A; subunit B | UniProt: Q06190

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13665-35 | Target: PP2A; subunit B | UniProt: Q06190 | TargetFullName: Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha | Organisim: human | Apparent_Kd_M: 4.794455E-11

Real

Aptamer SeqId:13666-222;Target:Carbonic Anhydrase X;UniProt:Q9NS85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13666-222;Target: Carbonic Anhydrase X;UniProt: Q9NS85;TargetFullName: Carbonic anhydrase-related protein 10;Organisim: human;Apparent_Kd_M: 2.17E-11

Real

Aptamer SeqId: 13666-222 | Target: Carbonic Anhydrase X | UniProt: Q9NS85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13666-222 | Target: Carbonic Anhydrase X | UniProt: Q9NS85 | TargetFullName: Carbonic anhydrase-related protein 10 | Organisim: human | Apparent_Kd_M: 2.17E-11

Real

Aptamer SeqId:13669-6;Target:FGFR-3;UniProt:P22607

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13669-6;Target: FGFR-3;UniProt: P22607;TargetFullName: Fibroblast growth factor receptor 3;Organisim: human;Apparent_Kd_M: 3.4E-12

Real

Aptamer SeqId: 13669-6 | Target: FGFR-3 | UniProt: P22607

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13669-6 | Target: FGFR-3 | UniProt: P22607 | TargetFullName: Fibroblast growth factor receptor 3 | Organisim: human | Apparent_Kd_M: 3.4E-12

Real

Aptamer SeqId:13671-40;Target:Elastase;UniProt:P08246

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13671-40;Target: Elastase;UniProt: P08246;TargetFullName: Neutrophil elastase;Organisim: human;Apparent_Kd_M: 2.09E-12

Real

Aptamer SeqId: 13671-40 | Target: Elastase | UniProt: P08246

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13671-40 | Target: Elastase | UniProt: P08246 | TargetFullName: Neutrophil elastase | Organisim: human | Apparent_Kd_M: 2.09E-12

Real

Aptamer SeqId:13672-3;Target:HSP76;UniProt:P17066

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13672-3;Target: HSP76;UniProt: P17066;TargetFullName: Heat shock 70 kDa protein 6;Organisim: human;Apparent_Kd_M: 1.50901E-10

Real

Aptamer SeqId: 13672-3 | Target: HSP76 | UniProt: P17066

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13672-3 | Target: HSP76 | UniProt: P17066 | TargetFullName: Heat shock 70 kDa protein 6 | Organisim: human | Apparent_Kd_M: 1.50901E-10

Real

Aptamer SeqId:13673-21;Target:TCPH;UniProt:Q99832

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13673-21;Target: TCPH;UniProt: Q99832;TargetFullName: T-complex protein 1 subunit eta;Organisim: human;Apparent_Kd_M: 6.586271E-12

Real

Aptamer SeqId: 13673-21 | Target: TCPH | UniProt: Q99832

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13673-21 | Target: TCPH | UniProt: Q99832 | TargetFullName: T-complex protein 1 subunit eta | Organisim: human | Apparent_Kd_M: 6.586271E-12

Real

Aptamer SeqId:13676-46;Target:Inhibin bB chain;UniProt:P09529

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13676-46;Target: Inhibin bB chain;UniProt: P09529;TargetFullName: Inhibin beta B chain;Organisim: human;Apparent_Kd_M: 9.232558E-12

Real

Aptamer SeqId: 13676-46 | Target: Inhibin bB chain | UniProt: P09529

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13676-46 | Target: Inhibin bB chain | UniProt: P09529 | TargetFullName: Inhibin beta B chain | Organisim: human | Apparent_Kd_M: 9.232558E-12

Real

Aptamer SeqId:13680-3;Target:NAB2;UniProt:Q15742

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13680-3;Target: NAB2;UniProt: Q15742;TargetFullName: NGFI-A-binding protein 2;Organisim: human;Apparent_Kd_M: 2.075006E-12

Real

Aptamer SeqId: 13680-3 | Target: NAB2 | UniProt: Q15742

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13680-3 | Target: NAB2 | UniProt: Q15742 | TargetFullName: NGFI-A-binding protein 2 | Organisim: human | Apparent_Kd_M: 2.075006E-12

Real

Aptamer SeqId:13681-173;Target:CSK22;UniProt:P19784

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13681-173;Target: CSK22;UniProt: P19784;TargetFullName: Casein kinase II subunit alpha;Organisim: human;Apparent_Kd_M: 9.082997E-12

Real

Aptamer SeqId: 13681-173 | Target: CSK22 | UniProt: P19784

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13681-173 | Target: CSK22 | UniProt: P19784 | TargetFullName: Casein kinase II subunit alpha' | Organisim: human | Apparent_Kd_M: 9.082997E-12

Real

Aptamer SeqId:13682-47;Target:M-CSF R;UniProt:P07333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13682-47;Target: M-CSF R;UniProt: P07333;TargetFullName: Macrophage colony-stimulating factor 1 receptor;Organisim: human;Apparent_Kd_M: 1.0E-12

Real

Aptamer SeqId: 13682-47 | Target: M-CSF R | UniProt: P07333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13682-47 | Target: M-CSF R | UniProt: P07333 | TargetFullName: Macrophage colony-stimulating factor 1 receptor | Organisim: human | Apparent_Kd_M: 1.0E-12

Real

Aptamer SeqId:13683-18;Target:CLCKB;UniProt:P51801

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13683-18;Target: CLCKB;UniProt: P51801;TargetFullName: Chloride channel protein ClC-Kb;Organisim: human;Apparent_Kd_M: 5.030059E-11

Real

Aptamer SeqId: 13683-18 | Target: CLCKB | UniProt: P51801

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13683-18 | Target: CLCKB | UniProt: P51801 | TargetFullName: Chloride channel protein ClC-Kb | Organisim: human | Apparent_Kd_M: 5.030059E-11

Real

Aptamer SeqId:13686-2;Target:IL-5 Ra;UniProt:Q01344

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13686-2;Target: IL-5 Ra;UniProt: Q01344;TargetFullName: Interleukin-5 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 3.07E-11

Real

Aptamer SeqId: 13686-2 | Target: IL-5 Ra | UniProt: Q01344

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13686-2 | Target: IL-5 Ra | UniProt: Q01344 | TargetFullName: Interleukin-5 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 3.07E-11

Real

Aptamer SeqId:13688-2;Target:CAPSL;UniProt:Q8WWF8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13688-2;Target: CAPSL;UniProt: Q8WWF8;TargetFullName: Calcyphosin-like protein;Organisim: human;Apparent_Kd_M: 8.364098E-12

Real

Aptamer SeqId: 13688-2 | Target: CAPSL | UniProt: Q8WWF8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13688-2 | Target: CAPSL | UniProt: Q8WWF8 | TargetFullName: Calcyphosin-like protein | Organisim: human | Apparent_Kd_M: 8.364098E-12

Real

Aptamer SeqId:13689-2;Target:Ornithine decarboxylase;UniProt:P11926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13689-2;Target: Ornithine decarboxylase;UniProt: P11926;TargetFullName: Ornithine decarboxylase;Organisim: human;Apparent_Kd_M: 4.630516E-11

Real

Aptamer SeqId: 13689-2 | Target: Ornithine decarboxylase | UniProt: P11926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13689-2 | Target: Ornithine decarboxylase | UniProt: P11926 | TargetFullName: Ornithine decarboxylase | Organisim: human | Apparent_Kd_M: 4.630516E-11

Real

Aptamer SeqId:13691-10;Target:SC5A8;UniProt:Q8N695

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13691-10;Target: SC5A8;UniProt: Q8N695;TargetFullName: Sodium-coupled monocarboxylate transporter 1;Organisim: human;Apparent_Kd_M: 3.220796E-12

Real

Aptamer SeqId: 13691-10 | Target: SC5A8 | UniProt: Q8N695

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13691-10 | Target: SC5A8 | UniProt: Q8N695 | TargetFullName: Sodium-coupled monocarboxylate transporter 1 | Organisim: human | Apparent_Kd_M: 3.220796E-12

Real

Aptamer SeqId:13692-154;Target:WISP-1;UniProt:O95388

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13692-154;Target: WISP-1;UniProt: O95388;TargetFullName: WNT1-inducible-signaling pathway protein 1;Organisim: human;Apparent_Kd_M: 3.92E-12

Real

Aptamer SeqId: 13692-154 | Target: WISP-1 | UniProt: O95388

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13692-154 | Target: WISP-1 | UniProt: O95388 | TargetFullName: WNT1-inducible-signaling pathway protein 1 | Organisim: human | Apparent_Kd_M: 3.92E-12

Real

Aptamer SeqId:13694-24;Target:TSLP R;UniProt:Q9HC73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13694-24;Target: TSLP R;UniProt: Q9HC73;TargetFullName: Cytokine receptor-like factor 2;Organisim: human;Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId: 13694-24 | Target: TSLP R | UniProt: Q9HC73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13694-24 | Target: TSLP R | UniProt: Q9HC73 | TargetFullName: Cytokine receptor-like factor 2 | Organisim: human | Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId:13697-51;Target:GPDA;UniProt:P21695

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13697-51;Target: GPDA;UniProt: P21695;TargetFullName: Glycerol-3-phosphate dehydrogenase [NAD(+)]; cytoplasmic;Organisim: human;Apparent_Kd_M: 2.28E-12

Real

Aptamer SeqId: 13697-51 | Target: GPDA | UniProt: P21695

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13697-51 | Target: GPDA | UniProt: P21695 | TargetFullName: Glycerol-3-phosphate dehydrogenase NAD(+); cytoplasmic | Organisim: human | Apparent_Kd_M: 2.28E-12

Real

Aptamer SeqId:13698-28;Target:K319L;UniProt:Q8IZA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13698-28;Target: K319L;UniProt: Q8IZA0;TargetFullName: Dyslexia-associated protein KIAA0319-like protein;Organisim: human;Apparent_Kd_M: 1.641937E-10

Real

Aptamer SeqId: 13698-28 | Target: K319L | UniProt: Q8IZA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13698-28 | Target: K319L | UniProt: Q8IZA0 | TargetFullName: Dyslexia-associated protein KIAA0319-like protein | Organisim: human | Apparent_Kd_M: 1.641937E-10

Real

Aptamer SeqId:13700-10;Target:annexin II;UniProt:P07355

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13700-10;Target: annexin II;UniProt: P07355;TargetFullName: Annexin A2;Organisim: human;Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId: 13700-10 | Target: annexin II | UniProt: P07355

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13700-10 | Target: annexin II | UniProt: P07355 | TargetFullName: Annexin A2 | Organisim: human | Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId:13704-5;Target:HMCS2;UniProt:P54868

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13704-5;Target: HMCS2;UniProt: P54868;TargetFullName: Hydroxymethylglutaryl-CoA synthase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.563167E-11

Real

Aptamer SeqId: 13704-5 | Target: HMCS2 | UniProt: P54868

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13704-5 | Target: HMCS2 | UniProt: P54868 | TargetFullName: Hydroxymethylglutaryl-CoA synthase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.563167E-11

Real

Aptamer SeqId:13711-10;Target:CLH1;UniProt:Q00610

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13711-10;Target: CLH1;UniProt: Q00610;TargetFullName: Clathrin heavy chain 1;Organisim: human;Apparent_Kd_M: 1.75018E-11

Real

Aptamer SeqId: 13711-10 | Target: CLH1 | UniProt: Q00610

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13711-10 | Target: CLH1 | UniProt: Q00610 | TargetFullName: Clathrin heavy chain 1 | Organisim: human | Apparent_Kd_M: 1.75018E-11

Real

Aptamer SeqId:13713-164;Target:SC22A;UniProt:Q96IW7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13713-164;Target: SC22A;UniProt: Q96IW7;TargetFullName: Vesicle-trafficking protein SEC22a;Organisim: human;Apparent_Kd_M: 8.995284E-11

Real

Aptamer SeqId: 13713-164 | Target: SC22A | UniProt: Q96IW7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13713-164 | Target: SC22A | UniProt: Q96IW7 | TargetFullName: Vesicle-trafficking protein SEC22a | Organisim: human | Apparent_Kd_M: 8.995284E-11

Real

Aptamer SeqId:13717-15;Target:FCN2;UniProt:Q15485

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13717-15;Target: FCN2;UniProt: Q15485;TargetFullName: Ficolin-2;Organisim: human;Apparent_Kd_M: 8.1E-12

Real

Aptamer SeqId: 13717-15 | Target: FCN2 | UniProt: Q15485

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13717-15 | Target: FCN2 | UniProt: Q15485 | TargetFullName: Ficolin-2 | Organisim: human | Apparent_Kd_M: 8.1E-12

Real

Aptamer SeqId:13719-19;Target:PAK4;UniProt:O96013

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13719-19;Target: PAK4;UniProt: O96013;TargetFullName: Serine/threonine-protein kinase PAK 4;Organisim: human;Apparent_Kd_M: 3.143172E-12

Real

Aptamer SeqId: 13719-19 | Target: PAK4 | UniProt: O96013

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13719-19 | Target: PAK4 | UniProt: O96013 | TargetFullName: Serine/threonine-protein kinase PAK 4 | Organisim: human | Apparent_Kd_M: 3.143172E-12

Real

Aptamer SeqId:13720-95;Target:Proteinase-3;UniProt:P24158

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13720-95;Target: Proteinase-3;UniProt: P24158;TargetFullName: Myeloblastin;Organisim: human;Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId: 13720-95 | Target: Proteinase-3 | UniProt: P24158

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13720-95 | Target: Proteinase-3 | UniProt: P24158 | TargetFullName: Myeloblastin | Organisim: human | Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId:13724-27;Target:FGF-19;UniProt:O95750

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13724-27;Target: FGF-19;UniProt: O95750;TargetFullName: Fibroblast growth factor 19;Organisim: human;Apparent_Kd_M: 1.7E-12

Real

Aptamer SeqId: 13724-27 | Target: FGF-19 | UniProt: O95750

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13724-27 | Target: FGF-19 | UniProt: O95750 | TargetFullName: Fibroblast growth factor 19 | Organisim: human | Apparent_Kd_M: 1.7E-12

Real

Aptamer SeqId:13726-4;Target:B7;UniProt:P33681

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13726-4;Target: B7;UniProt: P33681;TargetFullName: T-lymphocyte activation antigen CD80;Organisim: human;Apparent_Kd_M: 1.75E-11

Real

Aptamer SeqId: 13726-4 | Target: B7 | UniProt: P33681

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13726-4 | Target: B7 | UniProt: P33681 | TargetFullName: T-lymphocyte activation antigen CD80 | Organisim: human | Apparent_Kd_M: 1.75E-11

Real

Aptamer SeqId:13727-44;Target:SPOP;UniProt:O43791

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13727-44;Target: SPOP;UniProt: O43791;TargetFullName: Speckle-type POZ protein;Organisim: human;Apparent_Kd_M: 1.478395E-12

Real

Aptamer SeqId: 13727-44 | Target: SPOP | UniProt: O43791

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13727-44 | Target: SPOP | UniProt: O43791 | TargetFullName: Speckle-type POZ protein | Organisim: human | Apparent_Kd_M: 1.478395E-12

Real

Aptamer SeqId:13728-19;Target:ERP29;UniProt:P30040

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13728-19;Target: ERP29;UniProt: P30040;TargetFullName: Endoplasmic reticulum resident protein 29;Organisim: human;Apparent_Kd_M: 6.99E-12

Real

Aptamer SeqId: 13728-19 | Target: ERP29 | UniProt: P30040

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13728-19 | Target: ERP29 | UniProt: P30040 | TargetFullName: Endoplasmic reticulum resident protein 29 | Organisim: human | Apparent_Kd_M: 6.99E-12

Real

Aptamer SeqId:13729-26;Target:SFXN5;UniProt:Q8TD22

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13729-26;Target: SFXN5;UniProt: Q8TD22;TargetFullName: Sideroflexin-5;Organisim: human;Apparent_Kd_M: 7.117484E-11

Real

Aptamer SeqId: 13729-26 | Target: SFXN5 | UniProt: Q8TD22

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13729-26 | Target: SFXN5 | UniProt: Q8TD22 | TargetFullName: Sideroflexin-5 | Organisim: human | Apparent_Kd_M: 7.117484E-11

Real

Aptamer SeqId:13733-5;Target:IL-12 p40;UniProt:P29460

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13733-5;Target: IL-12 p40;UniProt: P29460;TargetFullName: Interleukin-12 subunit beta;Organisim: human;Apparent_Kd_M: 7.639236E-12

Real

Aptamer SeqId: 13733-5 | Target: IL-12 p40 | UniProt: P29460

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13733-5 | Target: IL-12 p40 | UniProt: P29460 | TargetFullName: Interleukin-12 subunit beta | Organisim: human | Apparent_Kd_M: 7.639236E-12

Real

Aptamer SeqId:13735-1;Target:RPGP1;UniProt:P47736

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13735-1;Target: RPGP1;UniProt: P47736;TargetFullName: Rap1 GTPase-activating protein 1;Organisim: human;Apparent_Kd_M: 1.405821E-10

Real

Aptamer SeqId: 13735-1 | Target: RPGP1 | UniProt: P47736

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13735-1 | Target: RPGP1 | UniProt: P47736 | TargetFullName: Rap1 GTPase-activating protein 1 | Organisim: human | Apparent_Kd_M: 1.405821E-10

Real

Aptamer SeqId:13738-8;Target:Inhibin bA chain;UniProt:P08476

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13738-8;Target: Inhibin bA chain;UniProt: P08476;TargetFullName: Inhibin beta A chain;Organisim: human;Apparent_Kd_M: 1.418923E-11

Real

Aptamer SeqId: 13738-8 | Target: Inhibin bA chain | UniProt: P08476

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13738-8 | Target: Inhibin bA chain | UniProt: P08476 | TargetFullName: Inhibin beta A chain | Organisim: human | Apparent_Kd_M: 1.418923E-11

Real

Aptamer SeqId:13740-51;Target:sFRP-3;UniProt:Q92765

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13740-51;Target: sFRP-3;UniProt: Q92765;TargetFullName: Secreted frizzled-related protein 3;Organisim: human;Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId: 13740-51 | Target: sFRP-3 | UniProt: Q92765

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13740-51 | Target: sFRP-3 | UniProt: Q92765 | TargetFullName: Secreted frizzled-related protein 3 | Organisim: human | Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId:13743-56;Target:CUL4B;UniProt:Q13620

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13743-56;Target: CUL4B;UniProt: Q13620;TargetFullName: Cullin-4B;Organisim: human;Apparent_Kd_M: 4.188179E-11

Real

Aptamer SeqId: 13743-56 | Target: CUL4B | UniProt: Q13620

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13743-56 | Target: CUL4B | UniProt: Q13620 | TargetFullName: Cullin-4B | Organisim: human | Apparent_Kd_M: 4.188179E-11

Real

Aptamer SeqId:13744-37;Target:IL-3 Ra;UniProt:P26951

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13744-37;Target: IL-3 Ra;UniProt: P26951;TargetFullName: Interleukin-3 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 3.36E-12

Real

Aptamer SeqId: 13744-37 | Target: IL-3 Ra | UniProt: P26951

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13744-37 | Target: IL-3 Ra | UniProt: P26951 | TargetFullName: Interleukin-3 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 3.36E-12

Real

Aptamer SeqId:13745-10;Target:PKD2;UniProt:Q13563

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13745-10;Target: PKD2;UniProt: Q13563;TargetFullName: Polycystin-2;Organisim: human;Apparent_Kd_M: 6.61E-11

Real

Aptamer SeqId: 13745-10 | Target: PKD2 | UniProt: Q13563

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13745-10 | Target: PKD2 | UniProt: Q13563 | TargetFullName: Polycystin-2 | Organisim: human | Apparent_Kd_M: 6.61E-11

Real

Aptamer SeqId:13748-4;Target:MCP-2;UniProt:P80075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13748-4;Target: MCP-2;UniProt: P80075;TargetFullName: C-C motif chemokine 8;Organisim: human;Apparent_Kd_M: 8.59E-12

Real

Aptamer SeqId: 13748-4 | Target: MCP-2 | UniProt: P80075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13748-4 | Target: MCP-2 | UniProt: P80075 | TargetFullName: C-C motif chemokine 8 | Organisim: human | Apparent_Kd_M: 8.59E-12

Real

Aptamer SeqId:13926-1;Target:RMI1;UniProt:Q9H9A7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13926-1;Target: RMI1;UniProt: Q9H9A7;TargetFullName: RecQ-mediated genome instability protein 1;Organisim: human;Apparent_Kd_M: 4.160065E-11

Real

Aptamer SeqId: 13926-1 | Target: RMI1 | UniProt: Q9H9A7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13926-1 | Target: RMI1 | UniProt: Q9H9A7 | TargetFullName: RecQ-mediated genome instability protein 1 | Organisim: human | Apparent_Kd_M: 4.160065E-11

Real

Aptamer SeqId:13929-27;Target:OCTC;UniProt:Q9UKG9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13929-27;Target: OCTC;UniProt: Q9UKG9;TargetFullName: Peroxisomal carnitine O-octanoyltransferase;Organisim: human;Apparent_Kd_M: 3.301688E-12

Real

Aptamer SeqId: 13929-27 | Target: OCTC | UniProt: Q9UKG9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13929-27 | Target: OCTC | UniProt: Q9UKG9 | TargetFullName: Peroxisomal carnitine O-octanoyltransferase | Organisim: human | Apparent_Kd_M: 3.301688E-12

Real

Aptamer SeqId:13930-3;Target:ABC3G;UniProt:Q9HC16

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13930-3;Target: ABC3G;UniProt: Q9HC16;TargetFullName: DNA dC->dU-editing enzyme APOBEC-3G;Organisim: human;Apparent_Kd_M: 2.043927E-12

Real

Aptamer SeqId: 13930-3 | Target: ABC3G | UniProt: Q9HC16

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13930-3 | Target: ABC3G | UniProt: Q9HC16 | TargetFullName: DNA dC->dU-editing enzyme APOBEC-3G | Organisim: human | Apparent_Kd_M: 2.043927E-12

Real

Aptamer SeqId:13931-22;Target:PSMD9;UniProt:O00233

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13931-22;Target: PSMD9;UniProt: O00233;TargetFullName: 26S proteasome non-ATPase regulatory subunit 9;Organisim: human;Apparent_Kd_M: 1.023567E-11

Real

Aptamer SeqId: 13931-22 | Target: PSMD9 | UniProt: O00233

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13931-22 | Target: PSMD9 | UniProt: O00233 | TargetFullName: 26S proteasome non-ATPase regulatory subunit 9 | Organisim: human | Apparent_Kd_M: 1.023567E-11

Real

Aptamer SeqId:13932-45;Target:COOL-1;UniProt:Q14155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13932-45;Target: COOL-1;UniProt: Q14155;TargetFullName: Rho guanine nucleotide exchange factor 7;Organisim: human;Apparent_Kd_M: 5.205579E-11

Real

Aptamer SeqId: 13932-45 | Target: COOL-1 | UniProt: Q14155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13932-45 | Target: COOL-1 | UniProt: Q14155 | TargetFullName: Rho guanine nucleotide exchange factor 7 | Organisim: human | Apparent_Kd_M: 5.205579E-11

Real

Aptamer SeqId:13933-276;Target:NAB1;UniProt:Q13506

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13933-276;Target: NAB1;UniProt: Q13506;TargetFullName: NGFI-A-binding protein 1;Organisim: human;Apparent_Kd_M: 6.762284E-12

Real

Aptamer SeqId: 13933-276 | Target: NAB1 | UniProt: Q13506

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13933-276 | Target: NAB1 | UniProt: Q13506 | TargetFullName: NGFI-A-binding protein 1 | Organisim: human | Apparent_Kd_M: 6.762284E-12

Real

Aptamer SeqId:13934-3;Target:MCF2L;UniProt:O15068

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13934-3;Target: MCF2L;UniProt: O15068;TargetFullName: Guanine nucleotide exchange factor DBS;Organisim: human;Apparent_Kd_M: 1.45904E-11

Real

Aptamer SeqId: 13934-3 | Target: MCF2L | UniProt: O15068

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13934-3 | Target: MCF2L | UniProt: O15068 | TargetFullName: Guanine nucleotide exchange factor DBS | Organisim: human | Apparent_Kd_M: 1.45904E-11

Real

Aptamer SeqId:13936-24;Target:PGK2;UniProt:P07205

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13936-24;Target: PGK2;UniProt: P07205;TargetFullName: Phosphoglycerate kinase 2;Organisim: human;Apparent_Kd_M: 5.77863E-11

Real

Aptamer SeqId: 13936-24 | Target: PGK2 | UniProt: P07205

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13936-24 | Target: PGK2 | UniProt: P07205 | TargetFullName: Phosphoglycerate kinase 2 | Organisim: human | Apparent_Kd_M: 5.77863E-11

Real

Aptamer SeqId:13937-75;Target:CAND1;UniProt:Q86VP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13937-75;Target: CAND1;UniProt: Q86VP6;TargetFullName: Cullin-associated NEDD8-dissociated protein 1;Organisim: human;Apparent_Kd_M: 1.812179E-11

Real

Aptamer SeqId: 13937-75 | Target: CAND1 | UniProt: Q86VP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13937-75 | Target: CAND1 | UniProt: Q86VP6 | TargetFullName: Cullin-associated NEDD8-dissociated protein 1 | Organisim: human | Apparent_Kd_M: 1.812179E-11

Real

Aptamer SeqId:13939-14;Target:UGPA1;UniProt:Q16851

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13939-14;Target: UGPA1;UniProt: Q16851;TargetFullName: UTP--glucose-1-phosphate uridylyltransferase;Organisim: human;Apparent_Kd_M: 1.412788E-10

Real

Aptamer SeqId: 13939-14 | Target: UGPA1 | UniProt: Q16851

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13939-14 | Target: UGPA1 | UniProt: Q16851 | TargetFullName: UTP--glucose-1-phosphate uridylyltransferase | Organisim: human | Apparent_Kd_M: 1.412788E-10

Real

Aptamer SeqId:13940-19;Target:IP16;UniProt:Q16666

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13940-19;Target: IP16;UniProt: Q16666;TargetFullName: Gamma-interferon-inducible protein 16;Organisim: human;Apparent_Kd_M: 1.57E-12

Real

Aptamer SeqId: 13940-19 | Target: IP16 | UniProt: Q16666

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13940-19 | Target: IP16 | UniProt: Q16666 | TargetFullName: Gamma-interferon-inducible protein 16 | Organisim: human | Apparent_Kd_M: 1.57E-12

Real

Aptamer SeqId:13941-82;Target:SYFM;UniProt:O95363

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13941-82;Target: SYFM;UniProt: O95363;TargetFullName: Phenylalanine--tRNA ligase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.553948E-11

Real

Aptamer SeqId: 13941-82 | Target: SYFM | UniProt: O95363

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13941-82 | Target: SYFM | UniProt: O95363 | TargetFullName: Phenylalanine--tRNA ligase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.553948E-11

Real

Aptamer SeqId:13942-140;Target:SPSB1;UniProt:Q96BD6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13942-140;Target: SPSB1;UniProt: Q96BD6;TargetFullName: SPRY domain-containing SOCS box protein 1;Organisim: human;Apparent_Kd_M: 4.506301E-11

Real

Aptamer SeqId: 13942-140 | Target: SPSB1 | UniProt: Q96BD6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13942-140 | Target: SPSB1 | UniProt: Q96BD6 | TargetFullName: SPRY domain-containing SOCS box protein 1 | Organisim: human | Apparent_Kd_M: 4.506301E-11

Real

Aptamer SeqId:13943-38;Target:DPY30;UniProt:Q9C005

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13943-38;Target: DPY30;UniProt: Q9C005;TargetFullName: Protein dpy-30 homolog;Organisim: human;Apparent_Kd_M: 1.940519E-12

Real

Aptamer SeqId: 13943-38 | Target: DPY30 | UniProt: Q9C005

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13943-38 | Target: DPY30 | UniProt: Q9C005 | TargetFullName: Protein dpy-30 homolog | Organisim: human | Apparent_Kd_M: 1.940519E-12

Real

Aptamer SeqId:13944-3;Target:SULT 1A3;UniProt:P0DMM9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13944-3;Target: SULT 1A3;UniProt: P0DMM9;TargetFullName: Sulfotransferase 1A3;Organisim: human;Apparent_Kd_M: 4.448135E-12

Real

Aptamer SeqId: 13944-3 | Target: SULT 1A3 | UniProt: P0DMM9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13944-3 | Target: SULT 1A3 | UniProt: P0DMM9 | TargetFullName: Sulfotransferase 1A3 | Organisim: human | Apparent_Kd_M: 4.448135E-12

Real

Aptamer SeqId:13946-8;Target:DDX23;UniProt:Q9BUQ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13946-8;Target: DDX23;UniProt: Q9BUQ8;TargetFullName: Probable ATP-dependent RNA helicase DDX23;Organisim: human;Apparent_Kd_M: 1.420733E-10

Real

Aptamer SeqId: 13946-8 | Target: DDX23 | UniProt: Q9BUQ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13946-8 | Target: DDX23 | UniProt: Q9BUQ8 | TargetFullName: Probable ATP-dependent RNA helicase DDX23 | Organisim: human | Apparent_Kd_M: 1.420733E-10

Real

Aptamer SeqId:13947-371;Target:NUD12;UniProt:Q9BQG2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13947-371;Target: NUD12;UniProt: Q9BQG2;TargetFullName: Peroxisomal NADH pyrophosphatase NUDT12;Organisim: human;Apparent_Kd_M: 8.782994E-12

Real

Aptamer SeqId: 13947-371 | Target: NUD12 | UniProt: Q9BQG2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13947-371 | Target: NUD12 | UniProt: Q9BQG2 | TargetFullName: Peroxisomal NADH pyrophosphatase NUDT12 | Organisim: human | Apparent_Kd_M: 8.782994E-12

Real

Aptamer SeqId:13948-50;Target:GABR2;UniProt:O75899

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13948-50;Target: GABR2;UniProt: O75899;TargetFullName: Gamma-aminobutyric acid type B receptor subunit 2;Organisim: human;Apparent_Kd_M: 5.75E-11

Real

Aptamer SeqId: 13948-50 | Target: GABR2 | UniProt: O75899

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13948-50 | Target: GABR2 | UniProt: O75899 | TargetFullName: Gamma-aminobutyric acid type B receptor subunit 2 | Organisim: human | Apparent_Kd_M: 5.75E-11

Real

Aptamer SeqId:13950-9;Target:C43BP;UniProt:Q9Y5P4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13950-9;Target: C43BP;UniProt: Q9Y5P4;TargetFullName: Collagen type IV alpha-3-binding protein;Organisim: human;Apparent_Kd_M: 8.89E-13

Real

Aptamer SeqId: 13950-9 | Target: C43BP | UniProt: Q9Y5P4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13950-9 | Target: C43BP | UniProt: Q9Y5P4 | TargetFullName: Collagen type IV alpha-3-binding protein | Organisim: human | Apparent_Kd_M: 8.89E-13

Real

Aptamer SeqId:13954-9;Target:GNA1;UniProt:Q96EK6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13954-9;Target: GNA1;UniProt: Q96EK6;TargetFullName: Glucosamine 6-phosphate N-acetyltransferase;Organisim: human;Apparent_Kd_M: 4.46E-12

Real

Aptamer SeqId: 13954-9 | Target: GNA1 | UniProt: Q96EK6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13954-9 | Target: GNA1 | UniProt: Q96EK6 | TargetFullName: Glucosamine 6-phosphate N-acetyltransferase | Organisim: human | Apparent_Kd_M: 4.46E-12

Real

Aptamer SeqId:13955-33;Target:DAPK1;UniProt:P53355

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13955-33;Target: DAPK1;UniProt: P53355;TargetFullName: Death-associated protein kinase 1;Organisim: human;Apparent_Kd_M: 3.538969E-12

Real

Aptamer SeqId: 13955-33 | Target: DAPK1 | UniProt: P53355

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13955-33 | Target: DAPK1 | UniProt: P53355 | TargetFullName: Death-associated protein kinase 1 | Organisim: human | Apparent_Kd_M: 3.538969E-12

Real

Aptamer SeqId:13958-5;Target:RBM46;UniProt:Q8TBY0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13958-5;Target: RBM46;UniProt: Q8TBY0;TargetFullName: Probable RNA-binding protein 46;Organisim: human;Apparent_Kd_M: 1.630094E-12

Real

Aptamer SeqId: 13958-5 | Target: RBM46 | UniProt: Q8TBY0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13958-5 | Target: RBM46 | UniProt: Q8TBY0 | TargetFullName: Probable RNA-binding protein 46 | Organisim: human | Apparent_Kd_M: 1.630094E-12

Real

Aptamer SeqId:13959-7;Target:LAP;UniProt:P28838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13959-7;Target: LAP;UniProt: P28838;TargetFullName: Cytosol aminopeptidase;Organisim: human;Apparent_Kd_M: 4.58E-12

Real

Aptamer SeqId: 13959-7 | Target: LAP | UniProt: P28838

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13959-7 | Target: LAP | UniProt: P28838 | TargetFullName: Cytosol aminopeptidase | Organisim: human | Apparent_Kd_M: 4.58E-12

Real

Aptamer SeqId:13960-15;Target:AGAP3;UniProt:Q96P47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13960-15;Target: AGAP3;UniProt: Q96P47;TargetFullName: Arf-GAP with GTPase; ANK repeat and PH domain-containing protein 3;Organisim: human;Apparent_Kd_M: 2.044526E-11

Real

Aptamer SeqId: 13960-15 | Target: AGAP3 | UniProt: Q96P47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13960-15 | Target: AGAP3 | UniProt: Q96P47 | TargetFullName: Arf-GAP with GTPase; ANK repeat and PH domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 2.044526E-11

Real

Aptamer SeqId:13961-18;Target:KIF3A;UniProt:Q9Y496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13961-18;Target: KIF3A;UniProt: Q9Y496;TargetFullName: Kinesin-like protein KIF3A;Organisim: human;Apparent_Kd_M: 1.539953E-11

Real

Aptamer SeqId: 13961-18 | Target: KIF3A | UniProt: Q9Y496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13961-18 | Target: KIF3A | UniProt: Q9Y496 | TargetFullName: Kinesin-like protein KIF3A | Organisim: human | Apparent_Kd_M: 1.539953E-11

Real

Aptamer SeqId:13963-7;Target:tollip;UniProt:Q9H0E2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13963-7;Target: tollip;UniProt: Q9H0E2;TargetFullName: Toll-interacting protein;Organisim: human;Apparent_Kd_M: 1.159678E-11

Real

Aptamer SeqId: 13963-7 | Target: tollip | UniProt: Q9H0E2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13963-7 | Target: tollip | UniProt: Q9H0E2 | TargetFullName: Toll-interacting protein | Organisim: human | Apparent_Kd_M: 1.159678E-11

Real

Aptamer SeqId:13966-30;Target:MYOM3;UniProt:Q5VTT5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13966-30;Target: MYOM3;UniProt: Q5VTT5;TargetFullName: Myomesin-3;Organisim: human;Apparent_Kd_M: 1.120706E-10

Real

Aptamer SeqId: 13966-30 | Target: MYOM3 | UniProt: Q5VTT5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13966-30 | Target: MYOM3 | UniProt: Q5VTT5 | TargetFullName: Myomesin-3 | Organisim: human | Apparent_Kd_M: 1.120706E-10

Real

Aptamer SeqId:13967-14;Target:Thioredoxin reductase 1;UniProt:Q16881

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13967-14;Target: Thioredoxin reductase 1;UniProt: Q16881;TargetFullName: Thioredoxin reductase 1; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.861339E-12

Real

Aptamer SeqId: 13967-14 | Target: Thioredoxin reductase 1 | UniProt: Q16881

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13967-14 | Target: Thioredoxin reductase 1 | UniProt: Q16881 | TargetFullName: Thioredoxin reductase 1; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.861339E-12

Real

Aptamer SeqId:13969-24;Target:IMA7;UniProt:O60684

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13969-24;Target: IMA7;UniProt: O60684;TargetFullName: Importin subunit alpha-7;Organisim: human;Apparent_Kd_M: 1.804402E-11

Real

Aptamer SeqId: 13969-24 | Target: IMA7 | UniProt: O60684

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13969-24 | Target: IMA7 | UniProt: O60684 | TargetFullName: Importin subunit alpha-7 | Organisim: human | Apparent_Kd_M: 1.804402E-11

Real

Aptamer SeqId:13972-4;Target:DHB14;UniProt:Q9BPX1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13972-4;Target: DHB14;UniProt: Q9BPX1;TargetFullName: 17-beta-hydroxysteroid dehydrogenase 14;Organisim: human;Apparent_Kd_M: 8.536608E-12

Real

Aptamer SeqId: 13972-4 | Target: DHB14 | UniProt: Q9BPX1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13972-4 | Target: DHB14 | UniProt: Q9BPX1 | TargetFullName: 17-beta-hydroxysteroid dehydrogenase 14 | Organisim: human | Apparent_Kd_M: 8.536608E-12

Real

Aptamer SeqId:13973-62;Target:TTL;UniProt:Q8NG68

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13973-62;Target: TTL;UniProt: Q8NG68;TargetFullName: Tubulin--tyrosine ligase;Organisim: human;Apparent_Kd_M: 9.483174E-13

Real

Aptamer SeqId: 13973-62 | Target: TTL | UniProt: Q8NG68

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13973-62 | Target: TTL | UniProt: Q8NG68 | TargetFullName: Tubulin--tyrosine ligase | Organisim: human | Apparent_Kd_M: 9.483174E-13

Real

Aptamer SeqId:13975-56;Target:LIPA1;UniProt:Q13136

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13975-56;Target: LIPA1;UniProt: Q13136;TargetFullName: Liprin-alpha-1;Organisim: human;Apparent_Kd_M: 1.070743E-11

Real

Aptamer SeqId: 13975-56 | Target: LIPA1 | UniProt: Q13136

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13975-56 | Target: LIPA1 | UniProt: Q13136 | TargetFullName: Liprin-alpha-1 | Organisim: human | Apparent_Kd_M: 1.070743E-11

Real

Aptamer SeqId:13976-9;Target:ARHG1;UniProt:Q92888

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13976-9;Target: ARHG1;UniProt: Q92888;TargetFullName: Rho guanine nucleotide exchange factor 1;Organisim: human;Apparent_Kd_M: 4.205003E-11

Real

Aptamer SeqId: 13976-9 | Target: ARHG1 | UniProt: Q92888

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13976-9 | Target: ARHG1 | UniProt: Q92888 | TargetFullName: Rho guanine nucleotide exchange factor 1 | Organisim: human | Apparent_Kd_M: 4.205003E-11

Real

Aptamer SeqId:13977-28;Target:BARD1;UniProt:Q99728

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13977-28;Target: BARD1;UniProt: Q99728;TargetFullName: BRCA1-associated RING domain protein 1;Organisim: human;Apparent_Kd_M: 8.907234E-12

Real

Aptamer SeqId: 13977-28 | Target: BARD1 | UniProt: Q99728

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13977-28 | Target: BARD1 | UniProt: Q99728 | TargetFullName: BRCA1-associated RING domain protein 1 | Organisim: human | Apparent_Kd_M: 8.907234E-12

Real

Aptamer SeqId:13978-122;Target:Tbx3;UniProt:O15119

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13978-122;Target: Tbx3;UniProt: O15119;TargetFullName: T-box transcription factor TBX3;Organisim: human;Apparent_Kd_M: 1.852691E-12

Real

Aptamer SeqId: 13978-122 | Target: Tbx3 | UniProt: O15119

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13978-122 | Target: Tbx3 | UniProt: O15119 | TargetFullName: T-box transcription factor TBX3 | Organisim: human | Apparent_Kd_M: 1.852691E-12

Real

Aptamer SeqId:13979-3;Target:S26A7;UniProt:Q8TE54

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13979-3;Target: S26A7;UniProt: Q8TE54;TargetFullName: Anion exchange transporter;Organisim: human;Apparent_Kd_M: 9.697767E-11

Real

Aptamer SeqId: 13979-3 | Target: S26A7 | UniProt: Q8TE54

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13979-3 | Target: S26A7 | UniProt: Q8TE54 | TargetFullName: Anion exchange transporter | Organisim: human | Apparent_Kd_M: 9.697767E-11

Real

Aptamer SeqId:13982-33;Target:RGS18;UniProt:Q9NS28

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13982-33;Target: RGS18;UniProt: Q9NS28;TargetFullName: Regulator of G-protein signaling 18;Organisim: human;Apparent_Kd_M: 3.216424E-10

Real

Aptamer SeqId: 13982-33 | Target: RGS18 | UniProt: Q9NS28

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13982-33 | Target: RGS18 | UniProt: Q9NS28 | TargetFullName: Regulator of G-protein signaling 18 | Organisim: human | Apparent_Kd_M: 3.216424E-10

Real

Aptamer SeqId:13983-27;Target:QOR;UniProt:Q08257

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13983-27;Target: QOR;UniProt: Q08257;TargetFullName: Quinone oxidoreductase;Organisim: human;Apparent_Kd_M: 1.384014E-11

Real

Aptamer SeqId: 13983-27 | Target: QOR | UniProt: Q08257

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13983-27 | Target: QOR | UniProt: Q08257 | TargetFullName: Quinone oxidoreductase | Organisim: human | Apparent_Kd_M: 1.384014E-11

Real

Aptamer SeqId:13984-23;Target:DDX25;UniProt:Q9UHL0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13984-23;Target: DDX25;UniProt: Q9UHL0;TargetFullName: ATP-dependent RNA helicase DDX25;Organisim: human;Apparent_Kd_M: 3.345465E-11

Real

Aptamer SeqId: 13984-23 | Target: DDX25 | UniProt: Q9UHL0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13984-23 | Target: DDX25 | UniProt: Q9UHL0 | TargetFullName: ATP-dependent RNA helicase DDX25 | Organisim: human | Apparent_Kd_M: 3.345465E-11

Real

Aptamer SeqId:13985-12;Target:SMUF2;UniProt:Q9HAU4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13985-12;Target: SMUF2;UniProt: Q9HAU4;TargetFullName: E3 ubiquitin-protein ligase SMURF2;Organisim: human;Apparent_Kd_M: 1.70144E-12

Real

Aptamer SeqId: 13985-12 | Target: SMUF2 | UniProt: Q9HAU4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13985-12 | Target: SMUF2 | UniProt: Q9HAU4 | TargetFullName: E3 ubiquitin-protein ligase SMURF2 | Organisim: human | Apparent_Kd_M: 1.70144E-12

Real

Aptamer SeqId:13986-6;Target:LANC1;UniProt:O43813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13986-6;Target: LANC1;UniProt: O43813;TargetFullName: LanC-like protein 1;Organisim: human;Apparent_Kd_M: 6.118636E-12

Real

Aptamer SeqId: 13986-6 | Target: LANC1 | UniProt: O43813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13986-6 | Target: LANC1 | UniProt: O43813 | TargetFullName: LanC-like protein 1 | Organisim: human | Apparent_Kd_M: 6.118636E-12

Real

Aptamer SeqId:13988-67;Target:NMRL1;UniProt:Q9HBL8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13988-67;Target: NMRL1;UniProt: Q9HBL8;TargetFullName: NmrA-like family domain-containing protein 1;Organisim: human;Apparent_Kd_M: 8.309388E-13

Real

Aptamer SeqId: 13988-67 | Target: NMRL1 | UniProt: Q9HBL8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13988-67 | Target: NMRL1 | UniProt: Q9HBL8 | TargetFullName: NmrA-like family domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 8.309388E-13

Real

Aptamer SeqId:13990-1;Target:pyruvate carboxylase;UniProt:P11498

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13990-1;Target: pyruvate carboxylase;UniProt: P11498;TargetFullName: Pyruvate carboxylase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.732678E-11

Real

Aptamer SeqId: 13990-1 | Target: pyruvate carboxylase | UniProt: P11498

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13990-1 | Target: pyruvate carboxylase | UniProt: P11498 | TargetFullName: Pyruvate carboxylase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.732678E-11

Real

Aptamer SeqId:13991-47;Target:IF4G3;UniProt:O43432

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13991-47;Target: IF4G3;UniProt: O43432;TargetFullName: Eukaryotic translation initiation factor 4 gamma 3;Organisim: human;Apparent_Kd_M: 1.187855E-10

Real

Aptamer SeqId: 13991-47 | Target: IF4G3 | UniProt: O43432

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13991-47 | Target: IF4G3 | UniProt: O43432 | TargetFullName: Eukaryotic translation initiation factor 4 gamma 3 | Organisim: human | Apparent_Kd_M: 1.187855E-10

Real

Aptamer SeqId:13992-12;Target:NSF;UniProt:P46459

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13992-12;Target: NSF;UniProt: P46459;TargetFullName: Vesicle-fusing ATPase;Organisim: human;Apparent_Kd_M: 2.394635E-12

Real

Aptamer SeqId: 13992-12 | Target: NSF | UniProt: P46459

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13992-12 | Target: NSF | UniProt: P46459 | TargetFullName: Vesicle-fusing ATPase | Organisim: human | Apparent_Kd_M: 2.394635E-12

Real

Aptamer SeqId:13993-20;Target:E41L1;UniProt:Q9H4G0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13993-20;Target: E41L1;UniProt: Q9H4G0;TargetFullName: Band 4.1-like protein 1;Organisim: human;Apparent_Kd_M: 6.016881E-12

Real

Aptamer SeqId: 13993-20 | Target: E41L1 | UniProt: Q9H4G0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13993-20 | Target: E41L1 | UniProt: Q9H4G0 | TargetFullName: Band 4.1-like protein 1 | Organisim: human | Apparent_Kd_M: 6.016881E-12

Real

Aptamer SeqId:13994-1;Target:FBRL;UniProt:P22087

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13994-1;Target: FBRL;UniProt: P22087;TargetFullName: rRNA 2-O-methyltransferase fibrillarin;Organisim: human;Apparent_Kd_M: 1.085895E-10

Real

Aptamer SeqId: 13994-1 | Target: FBRL | UniProt: P22087

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13994-1 | Target: FBRL | UniProt: P22087 | TargetFullName: rRNA 2'-O-methyltransferase fibrillarin | Organisim: human | Apparent_Kd_M: 1.085895E-10

Real

Aptamer SeqId:13996-16;Target:COAC;UniProt:Q96CD2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13996-16;Target: COAC;UniProt: Q96CD2;TargetFullName: Phosphopantothenoylcysteine decarboxylase;Organisim: human;Apparent_Kd_M: 1.376886E-10

Real

Aptamer SeqId: 13996-16 | Target: COAC | UniProt: Q96CD2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13996-16 | Target: COAC | UniProt: Q96CD2 | TargetFullName: Phosphopantothenoylcysteine decarboxylase | Organisim: human | Apparent_Kd_M: 1.376886E-10

Real

Aptamer SeqId:13998-26;Target:PURA1;UniProt:Q8N142

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 13998-26;Target: PURA1;UniProt: Q8N142;TargetFullName: Adenylosuccinate synthetase isozyme 1;Organisim: human;Apparent_Kd_M: 4.474693E-12

Real

Aptamer SeqId: 13998-26 | Target: PURA1 | UniProt: Q8N142

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 13998-26 | Target: PURA1 | UniProt: Q8N142 | TargetFullName: Adenylosuccinate synthetase isozyme 1 | Organisim: human | Apparent_Kd_M: 4.474693E-12

Real

Aptamer SeqId:14002-18;Target:DOCK9;UniProt:Q9BZ29

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14002-18;Target: DOCK9;UniProt: Q9BZ29;TargetFullName: Dedicator of cytokinesis protein 9;Organisim: human;Apparent_Kd_M: 3.980992E-12

Real

Aptamer SeqId: 14002-18 | Target: DOCK9 | UniProt: Q9BZ29

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14002-18 | Target: DOCK9 | UniProt: Q9BZ29 | TargetFullName: Dedicator of cytokinesis protein 9 | Organisim: human | Apparent_Kd_M: 3.980992E-12

Real

Aptamer SeqId:14005-2;Target:CHD7;UniProt:Q9P2D1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14005-2;Target: CHD7;UniProt: Q9P2D1;TargetFullName: Chromodomain-helicase-DNA-binding protein 7;Organisim: human;Apparent_Kd_M: 4.978925E-12

Real

Aptamer SeqId: 14005-2 | Target: CHD7 | UniProt: Q9P2D1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14005-2 | Target: CHD7 | UniProt: Q9P2D1 | TargetFullName: Chromodomain-helicase-DNA-binding protein 7 | Organisim: human | Apparent_Kd_M: 4.978925E-12

Real

Aptamer SeqId:14006-36;Target:GNMT;UniProt:Q14749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14006-36;Target: GNMT;UniProt: Q14749;TargetFullName: Glycine N-methyltransferase;Organisim: human;Apparent_Kd_M: 7.633297E-11

Real

Aptamer SeqId: 14006-36 | Target: GNMT | UniProt: Q14749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14006-36 | Target: GNMT | UniProt: Q14749 | TargetFullName: Glycine N-methyltransferase | Organisim: human | Apparent_Kd_M: 7.633297E-11

Real

Aptamer SeqId:14007-22;Target:PAPS1;UniProt:O43252

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14007-22;Target: PAPS1;UniProt: O43252;TargetFullName: Bifunctional 3-phosphoadenosine 5-phosphosulfate synthase 1;Organisim: human;Apparent_Kd_M: 2.420758E-12

Real

Aptamer SeqId: 14007-22 | Target: PAPS1 | UniProt: O43252

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14007-22 | Target: PAPS1 | UniProt: O43252 | TargetFullName: Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 | Organisim: human | Apparent_Kd_M: 2.420758E-12

Real

Aptamer SeqId:14008-22;Target:DCP1A;UniProt:Q9NPI6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14008-22;Target: DCP1A;UniProt: Q9NPI6;TargetFullName: mRNA-decapping enzyme 1A;Organisim: human;Apparent_Kd_M: 2.776297E-11

Real

Aptamer SeqId: 14008-22 | Target: DCP1A | UniProt: Q9NPI6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14008-22 | Target: DCP1A | UniProt: Q9NPI6 | TargetFullName: mRNA-decapping enzyme 1A | Organisim: human | Apparent_Kd_M: 2.776297E-11

Real

Aptamer SeqId:14009-65;Target:TNFAIP3;UniProt:P21580

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14009-65;Target: TNFAIP3;UniProt: P21580;TargetFullName: Tumor necrosis factor alpha-induced protein 3;Organisim: human;Apparent_Kd_M: 3.130362E-11

Real

Aptamer SeqId: 14009-65 | Target: TNFAIP3 | UniProt: P21580

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14009-65 | Target: TNFAIP3 | UniProt: P21580 | TargetFullName: Tumor necrosis factor alpha-induced protein 3 | Organisim: human | Apparent_Kd_M: 3.130362E-11

Real

Aptamer SeqId:14011-17;Target:S100A11;UniProt:P31949

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14011-17;Target: S100A11;UniProt: P31949;TargetFullName: Protein S100-A11;Organisim: human;Apparent_Kd_M: 1.282973E-10

Real

Aptamer SeqId: 14011-17 | Target: S100A11 | UniProt: P31949

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14011-17 | Target: S100A11 | UniProt: P31949 | TargetFullName: Protein S100-A11 | Organisim: human | Apparent_Kd_M: 1.282973E-10

Real

Aptamer SeqId:14012-17;Target:LGP2;UniProt:Q96C10

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14012-17;Target: LGP2;UniProt: Q96C10;TargetFullName: Probable ATP-dependent RNA helicase DHX58;Organisim: human;Apparent_Kd_M: 2.859628E-12

Real

Aptamer SeqId: 14012-17 | Target: LGP2 | UniProt: Q96C10

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14012-17 | Target: LGP2 | UniProt: Q96C10 | TargetFullName: Probable ATP-dependent RNA helicase DHX58 | Organisim: human | Apparent_Kd_M: 2.859628E-12

Real

Aptamer SeqId:14013-11;Target:TANK;UniProt:Q92844

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14013-11;Target: TANK;UniProt: Q92844;TargetFullName: TRAF family member-associated NF-kappa-B activator;Organisim: human;Apparent_Kd_M: 8.905018E-11

Real

Aptamer SeqId: 14013-11 | Target: TANK | UniProt: Q92844

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14013-11 | Target: TANK | UniProt: Q92844 | TargetFullName: TRAF family member-associated NF-kappa-B activator | Organisim: human | Apparent_Kd_M: 8.905018E-11

Real

Aptamer SeqId:14019-73;Target:EVPL;UniProt:Q92817

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14019-73;Target: EVPL;UniProt: Q92817;TargetFullName: Envoplakin;Organisim: human;Apparent_Kd_M: 2.261611E-12

Real

Aptamer SeqId: 14019-73 | Target: EVPL | UniProt: Q92817

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14019-73 | Target: EVPL | UniProt: Q92817 | TargetFullName: Envoplakin | Organisim: human | Apparent_Kd_M: 2.261611E-12

Real

Aptamer SeqId:14021-81;Target:MED4;UniProt:Q9NPJ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14021-81;Target: MED4;UniProt: Q9NPJ6;TargetFullName: Mediator of RNA polymerase II transcription subunit 4;Organisim: human;Apparent_Kd_M: 5.955213E-11

Real

Aptamer SeqId: 14021-81 | Target: MED4 | UniProt: Q9NPJ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14021-81 | Target: MED4 | UniProt: Q9NPJ6 | TargetFullName: Mediator of RNA polymerase II transcription subunit 4 | Organisim: human | Apparent_Kd_M: 5.955213E-11

Real

Aptamer SeqId:14024-196;Target:EDA;UniProt:Q92838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14024-196;Target: EDA;UniProt: Q92838;TargetFullName: Ectodysplasin-A; secreted form;Organisim: human;Apparent_Kd_M: 1.37E-11

Real

Aptamer SeqId: 14024-196 | Target: EDA | UniProt: Q92838

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14024-196 | Target: EDA | UniProt: Q92838 | TargetFullName: Ectodysplasin-A; secreted form | Organisim: human | Apparent_Kd_M: 1.37E-11

Real

Aptamer SeqId:14025-18;Target:4-1BB;UniProt:Q07011

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14025-18;Target: 4-1BB;UniProt: Q07011;TargetFullName: Tumor necrosis factor receptor superfamily member 9;Organisim: human;Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId: 14025-18 | Target: 4-1BB | UniProt: Q07011

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14025-18 | Target: 4-1BB | UniProt: Q07011 | TargetFullName: Tumor necrosis factor receptor superfamily member 9 | Organisim: human | Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId:14026-24;Target:IL-17F;UniProt:Q96PD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14026-24;Target: IL-17F;UniProt: Q96PD4;TargetFullName: Interleukin-17F;Organisim: human;Apparent_Kd_M: 4.69E-12

Real

Aptamer SeqId: 14026-24 | Target: IL-17F | UniProt: Q96PD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14026-24 | Target: IL-17F | UniProt: Q96PD4 | TargetFullName: Interleukin-17F | Organisim: human | Apparent_Kd_M: 4.69E-12

Real

Aptamer SeqId:14028-22;Target:P3C2A;UniProt:O00443

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14028-22;Target: P3C2A;UniProt: O00443;TargetFullName: Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha;Organisim: human;Apparent_Kd_M: 7.340167E-12

Real

Aptamer SeqId: 14028-22 | Target: P3C2A | UniProt: O00443

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14028-22 | Target: P3C2A | UniProt: O00443 | TargetFullName: Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | Organisim: human | Apparent_Kd_M: 7.340167E-12

Real

Aptamer SeqId:14029-42;Target:CSN2;UniProt:P61201

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14029-42;Target: CSN2;UniProt: P61201;TargetFullName: COP9 signalosome complex subunit 2;Organisim: human;Apparent_Kd_M: 3.839305E-11

Real

Aptamer SeqId: 14029-42 | Target: CSN2 | UniProt: P61201

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14029-42 | Target: CSN2 | UniProt: P61201 | TargetFullName: COP9 signalosome complex subunit 2 | Organisim: human | Apparent_Kd_M: 3.839305E-11

Real

Aptamer SeqId:14034-22;Target:GA733-1 protein;UniProt:P09758

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14034-22;Target: GA733-1 protein;UniProt: P09758;TargetFullName: Tumor-associated calcium signal transducer 2;Organisim: human;Apparent_Kd_M: 8.33E-11

Real

Aptamer SeqId: 14034-22 | Target: GA733-1 protein | UniProt: P09758

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14034-22 | Target: GA733-1 protein | UniProt: P09758 | TargetFullName: Tumor-associated calcium signal transducer 2 | Organisim: human | Apparent_Kd_M: 8.33E-11

Real

Aptamer SeqId:14035-13;Target:TIAM1;UniProt:Q13009

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14035-13;Target: TIAM1;UniProt: Q13009;TargetFullName: T-lymphoma invasion and metastasis-inducing protein 1;Organisim: human;Apparent_Kd_M: 1.206542E-11

Real

Aptamer SeqId: 14035-13 | Target: TIAM1 | UniProt: Q13009

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14035-13 | Target: TIAM1 | UniProt: Q13009 | TargetFullName: T-lymphoma invasion and metastasis-inducing protein 1 | Organisim: human | Apparent_Kd_M: 1.206542E-11

Real

Aptamer SeqId:14036-116;Target:MPDZ;UniProt:O75970

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14036-116;Target: MPDZ;UniProt: O75970;TargetFullName: Multiple PDZ domain protein;Organisim: human;Apparent_Kd_M: 1.191479E-11

Real

Aptamer SeqId: 14036-116 | Target: MPDZ | UniProt: O75970

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14036-116 | Target: MPDZ | UniProt: O75970 | TargetFullName: Multiple PDZ domain protein | Organisim: human | Apparent_Kd_M: 1.191479E-11

Real

Aptamer SeqId:14037-18;Target:RANB3;UniProt:Q9H6Z4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14037-18;Target: RANB3;UniProt: Q9H6Z4;TargetFullName: Ran-binding protein 3;Organisim: human;Apparent_Kd_M: 3.326788E-12

Real

Aptamer SeqId: 14037-18 | Target: RANB3 | UniProt: Q9H6Z4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14037-18 | Target: RANB3 | UniProt: Q9H6Z4 | TargetFullName: Ran-binding protein 3 | Organisim: human | Apparent_Kd_M: 3.326788E-12

Real

Aptamer SeqId:14039-33;Target:kallikrein 5;UniProt:Q9Y337

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14039-33;Target: kallikrein 5;UniProt: Q9Y337;TargetFullName: Kallikrein-5;Organisim: human;Apparent_Kd_M: 1.87E-12

Real

Aptamer SeqId: 14039-33 | Target: kallikrein 5 | UniProt: Q9Y337

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14039-33 | Target: kallikrein 5 | UniProt: Q9Y337 | TargetFullName: Kallikrein-5 | Organisim: human | Apparent_Kd_M: 1.87E-12

Real

Aptamer SeqId:14043-12;Target:EEA1;UniProt:Q15075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14043-12;Target: EEA1;UniProt: Q15075;TargetFullName: Early endosome antigen 1;Organisim: human;Apparent_Kd_M: 3.643589E-11

Real

Aptamer SeqId: 14043-12 | Target: EEA1 | UniProt: Q15075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14043-12 | Target: EEA1 | UniProt: Q15075 | TargetFullName: Early endosome antigen 1 | Organisim: human | Apparent_Kd_M: 3.643589E-11

Real

Aptamer SeqId:14045-12;Target:NCOA2;UniProt:Q15596

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14045-12;Target: NCOA2;UniProt: Q15596;TargetFullName: Nuclear receptor coactivator 2;Organisim: human;Apparent_Kd_M: 3.632351E-12

Real

Aptamer SeqId: 14045-12 | Target: NCOA2 | UniProt: Q15596

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14045-12 | Target: NCOA2 | UniProt: Q15596 | TargetFullName: Nuclear receptor coactivator 2 | Organisim: human | Apparent_Kd_M: 3.632351E-12

Real

Aptamer SeqId:14047-78;Target:BDNF;UniProt:P23560

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14047-78;Target: BDNF;UniProt: P23560;TargetFullName: Brain-derived neurotrophic factor;Organisim: human;Apparent_Kd_M: 6.48E-12

Real

Aptamer SeqId: 14047-78 | Target: BDNF | UniProt: P23560

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14047-78 | Target: BDNF | UniProt: P23560 | TargetFullName: Brain-derived neurotrophic factor | Organisim: human | Apparent_Kd_M: 6.48E-12

Real

Aptamer SeqId:14048-7;Target:IL-1 R AcP;UniProt:Q9NPH3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14048-7;Target: IL-1 R AcP;UniProt: Q9NPH3;TargetFullName: Interleukin-1 Receptor accessory protein;Organisim: human;Apparent_Kd_M: 5.14E-12

Real

Aptamer SeqId: 14048-7 | Target: IL-1 R AcP | UniProt: Q9NPH3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14048-7 | Target: IL-1 R AcP | UniProt: Q9NPH3 | TargetFullName: Interleukin-1 Receptor accessory protein | Organisim: human | Apparent_Kd_M: 5.14E-12

Real

Aptamer SeqId:14051-54;Target:FOXC2;UniProt:Q99958

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14051-54;Target: FOXC2;UniProt: Q99958;TargetFullName: Forkhead box protein C2;Organisim: human;Apparent_Kd_M: 1.577293E-12

Real

Aptamer SeqId: 14051-54 | Target: FOXC2 | UniProt: Q99958

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14051-54 | Target: FOXC2 | UniProt: Q99958 | TargetFullName: Forkhead box protein C2 | Organisim: human | Apparent_Kd_M: 1.577293E-12

Real

Aptamer SeqId:14052-26;Target:UN13A;UniProt:Q9UPW8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14052-26;Target: UN13A;UniProt: Q9UPW8;TargetFullName: Protein unc-13 homolog A;Organisim: human;Apparent_Kd_M: 1.506135E-10

Real

Aptamer SeqId: 14052-26 | Target: UN13A | UniProt: Q9UPW8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14052-26 | Target: UN13A | UniProt: Q9UPW8 | TargetFullName: Protein unc-13 homolog A | Organisim: human | Apparent_Kd_M: 1.506135E-10

Real

Aptamer SeqId:14054-17;Target:IL-15 Ra;UniProt:Q13261

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14054-17;Target: IL-15 Ra;UniProt: Q13261;TargetFullName: Interleukin-15 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 2.04E-12

Real

Aptamer SeqId: 14054-17 | Target: IL-15 Ra | UniProt: Q13261

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14054-17 | Target: IL-15 Ra | UniProt: Q13261 | TargetFullName: Interleukin-15 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 2.04E-12

Real

Aptamer SeqId:14056-4;Target:Glycoprotein hormones a-chain;UniProt:P01215

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14056-4;Target: Glycoprotein hormones a-chain;UniProt: P01215;TargetFullName: Glycoprotein hormones alpha chain;Organisim: human;Apparent_Kd_M: 8.83536E-12

Real

Aptamer SeqId: 14056-4 | Target: Glycoprotein hormones a-chain

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14056-4 | Target: Glycoprotein hormones a-chain | UniProt: P01215 | TargetFullName: Glycoprotein hormones alpha chain | Organisim: human | Apparent_Kd_M: 8.83536E-12

Real

Aptamer SeqId:14060-67;Target:NCF4;UniProt:Q15080

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14060-67;Target: NCF4;UniProt: Q15080;TargetFullName: Neutrophil cytosol factor 4;Organisim: human;Apparent_Kd_M: 1.739092E-11

Real

Aptamer SeqId: 14060-67 | Target: NCF4 | UniProt: Q15080

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14060-67 | Target: NCF4 | UniProt: Q15080 | TargetFullName: Neutrophil cytosol factor 4 | Organisim: human | Apparent_Kd_M: 1.739092E-11

Real

Aptamer SeqId:14061-48;Target:sRANKL;UniProt:O14788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14061-48;Target: sRANKL;UniProt: O14788;TargetFullName: Tumor necrosis factor ligand superfamily member 11;Organisim: human;Apparent_Kd_M: 8.83E-11

Real

Aptamer SeqId: 14061-48 | Target: sRANKL | UniProt: O14788

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14061-48 | Target: sRANKL | UniProt: O14788 | TargetFullName: Tumor necrosis factor ligand superfamily member 11 | Organisim: human | Apparent_Kd_M: 8.83E-11

Real

Aptamer SeqId:14063-17;Target:OSM;UniProt:P13725

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14063-17;Target: OSM;UniProt: P13725;TargetFullName: Oncostatin-M;Organisim: human;Apparent_Kd_M: 8.74E-12

Real

Aptamer SeqId: 14063-17 | Target: OSM | UniProt: P13725

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14063-17 | Target: OSM | UniProt: P13725 | TargetFullName: Oncostatin-M | Organisim: human | Apparent_Kd_M: 8.74E-12

Real

Aptamer SeqId:14065-11;Target:CD5;UniProt:P06127

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14065-11;Target: CD5;UniProt: P06127;TargetFullName: T-cell surface glycoprotein CD5;Organisim: human;Apparent_Kd_M: 4.13E-11

Real

Aptamer SeqId: 14065-11 | Target: CD5 | UniProt: P06127

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14065-11 | Target: CD5 | UniProt: P06127 | TargetFullName: T-cell surface glycoprotein CD5 | Organisim: human | Apparent_Kd_M: 4.13E-11

Real

Aptamer SeqId:14066-49;Target:MAGI2;UniProt:Q86UL8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14066-49;Target: MAGI2;UniProt: Q86UL8;TargetFullName: Membrane-associated guanylate kinase; WW and PDZ domain-containing protein 2;Organisim: human;Apparent_Kd_M: 8.034514E-13

Real

Aptamer SeqId: 14066-49 | Target: MAGI2 | UniProt: Q86UL8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14066-49 | Target: MAGI2 | UniProt: Q86UL8 | TargetFullName: Membrane-associated guanylate kinase; WW and PDZ domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 8.034514E-13

Real

Aptamer SeqId:14067-6;Target:PKP2;UniProt:Q99959

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14067-6;Target: PKP2;UniProt: Q99959;TargetFullName: Plakophilin-2;Organisim: human;Apparent_Kd_M: 2.5792E-12

Real

Aptamer SeqId: 14067-6 | Target: PKP2 | UniProt: Q99959

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14067-6 | Target: PKP2 | UniProt: Q99959 | TargetFullName: Plakophilin-2 | Organisim: human | Apparent_Kd_M: 2.5792E-12

Real

Aptamer SeqId:14069-61;Target:Carbonic Anhydrase IV;UniProt:P22748

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14069-61;Target: Carbonic Anhydrase IV;UniProt: P22748;TargetFullName: Carbonic anhydrase 4;Organisim: human;Apparent_Kd_M: 2.49E-11

Real

Aptamer SeqId: 14069-61 | Target: Carbonic Anhydrase IV | UniProt: P22748

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14069-61 | Target: Carbonic Anhydrase IV | UniProt: P22748 | TargetFullName: Carbonic anhydrase 4 | Organisim: human | Apparent_Kd_M: 2.49E-11

Real

Aptamer SeqId:14070-56;Target:ITSN1;UniProt:Q15811

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14070-56;Target: ITSN1;UniProt: Q15811;TargetFullName: Intersectin-1;Organisim: human;Apparent_Kd_M: 3.671377E-11

Real

Aptamer SeqId: 14070-56 | Target: ITSN1 | UniProt: Q15811

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14070-56 | Target: ITSN1 | UniProt: Q15811 | TargetFullName: Intersectin-1 | Organisim: human | Apparent_Kd_M: 3.671377E-11

Real

Aptamer SeqId:14074-2;Target:SHC2;UniProt:P98077

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14074-2;Target: SHC2;UniProt: P98077;TargetFullName: SHC-transforming protein 2;Organisim: human;Apparent_Kd_M: 4.668199E-12

Real

Aptamer SeqId: 14074-2 | Target: SHC2 | UniProt: P98077

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14074-2 | Target: SHC2 | UniProt: P98077 | TargetFullName: SHC-transforming protein 2 | Organisim: human | Apparent_Kd_M: 4.668199E-12

Real

Aptamer SeqId:14076-74;Target:Cystatin-S;UniProt:P01036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14076-74;Target: Cystatin-S;UniProt: P01036;TargetFullName: Cystatin-S;Organisim: human;Apparent_Kd_M: 6.99E-11

Real

Aptamer SeqId: 14076-74 | Target: Cystatin-S | UniProt: P01036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14076-74 | Target: Cystatin-S | UniProt: P01036 | TargetFullName: Cystatin-S | Organisim: human | Apparent_Kd_M: 6.99E-11

Real

Aptamer SeqId:14079-14;Target:IL-18 Ra;UniProt:Q13478

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14079-14;Target: IL-18 Ra;UniProt: Q13478;TargetFullName: Interleukin-18 receptor 1;Organisim: human;Apparent_Kd_M: 1.79E-12

Real

Aptamer SeqId: 14079-14 | Target: IL-18 Ra | UniProt: Q13478

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14079-14 | Target: IL-18 Ra | UniProt: Q13478 | TargetFullName: Interleukin-18 receptor 1 | Organisim: human | Apparent_Kd_M: 1.79E-12

Real

Aptamer SeqId:14082-56;Target:TLN2;UniProt:Q9Y4G6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14082-56;Target: TLN2;UniProt: Q9Y4G6;TargetFullName: Talin-2;Organisim: human;Apparent_Kd_M: 2.448905E-11

Real

Aptamer SeqId: 14082-56 | Target: TLN2 | UniProt: Q9Y4G6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14082-56 | Target: TLN2 | UniProt: Q9Y4G6 | TargetFullName: Talin-2 | Organisim: human | Apparent_Kd_M: 2.448905E-11

Real

Aptamer SeqId:14083-25;Target:SPS1;UniProt:P49903

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14083-25;Target: SPS1;UniProt: P49903;TargetFullName: Selenide; water dikinase 1;Organisim: human;Apparent_Kd_M: 1.999658E-12

Real

Aptamer SeqId: 14083-25 | Target: SPS1 | UniProt: P49903

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14083-25 | Target: SPS1 | UniProt: P49903 | TargetFullName: Selenide; water dikinase 1 | Organisim: human | Apparent_Kd_M: 1.999658E-12

Real

Aptamer SeqId:14084-191;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14084-191;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.66E-11

Real

Aptamer SeqId: 14084-191 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14084-191 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.66E-11

Real

Aptamer SeqId:14088-38;Target:IGFBP-6;UniProt:P24592

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14088-38;Target: IGFBP-6;UniProt: P24592;TargetFullName: Insulin-like growth factor-binding protein 6;Organisim: human;Apparent_Kd_M: 2.59E-12

Real

Aptamer SeqId: 14088-38 | Target: IGFBP-6 | UniProt: P24592

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14088-38 | Target: IGFBP-6 | UniProt: P24592 | TargetFullName: Insulin-like growth factor-binding protein 6 | Organisim: human | Apparent_Kd_M: 2.59E-12

Real

Aptamer SeqId:14090-23;Target:DEFI6;UniProt:Q9H4E7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14090-23;Target: DEFI6;UniProt: Q9H4E7;TargetFullName: Differentially expressed in FDCP 6 homolog;Organisim: human;Apparent_Kd_M: 8.0085E-12

Real

Aptamer SeqId: 14090-23 | Target: DEFI6 | UniProt: Q9H4E7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14090-23 | Target: DEFI6 | UniProt: Q9H4E7 | TargetFullName: Differentially expressed in FDCP 6 homolog | Organisim: human | Apparent_Kd_M: 8.0085E-12

Real

Aptamer SeqId:14091-42;Target:Carbonyl reductase 3;UniProt:O75828

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14091-42;Target: Carbonyl reductase 3;UniProt: O75828;TargetFullName: Carbonyl reductase [NADPH] 3;Organisim: human;Apparent_Kd_M: 2.646915E-12

Real

Aptamer SeqId: 14091-42 | Target: Carbonyl reductase 3 | UniProt: O75828

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14091-42 | Target: Carbonyl reductase 3 | UniProt: O75828 | TargetFullName: Carbonyl reductase NADPH 3 | Organisim: human | Apparent_Kd_M: 2.646915E-12

Real

Aptamer SeqId:14093-10;Target:Flt3 ligand;UniProt:P49771

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14093-10;Target: Flt3 ligand;UniProt: P49771;TargetFullName: Fms-related tyrosine kinase 3 ligand;Organisim: human;Apparent_Kd_M: 4.74E-11

Real

Aptamer SeqId: 14093-10 | Target: Flt3 ligand | UniProt: P49771

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14093-10 | Target: Flt3 ligand | UniProt: P49771 | TargetFullName: Fms-related tyrosine kinase 3 ligand | Organisim: human | Apparent_Kd_M: 4.74E-11

Real

Aptamer SeqId:14094-29;Target:HB-EGF;UniProt:Q99075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14094-29;Target: HB-EGF;UniProt: Q99075;TargetFullName: Heparin-binding EGF-like growth factor;Organisim: human;Apparent_Kd_M: 4.35E-12

Real

Aptamer SeqId: 14094-29 | Target: HB-EGF | UniProt: Q99075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14094-29 | Target: HB-EGF | UniProt: Q99075 | TargetFullName: Heparin-binding EGF-like growth factor | Organisim: human | Apparent_Kd_M: 4.35E-12

Real

Aptamer SeqId:14095-1;Target:NKG2D;UniProt:P26718

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14095-1;Target: NKG2D;UniProt: P26718;TargetFullName: NKG2-D type II integral membrane protein;Organisim: human;Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId: 14095-1 | Target: NKG2D | UniProt: P26718

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14095-1 | Target: NKG2D | UniProt: P26718 | TargetFullName: NKG2-D type II integral membrane protein | Organisim: human | Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId:14098-28;Target:SYCC;UniProt:P49589

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14098-28;Target: SYCC;UniProt: P49589;TargetFullName: Cysteine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.996443E-11

Real

Aptamer SeqId: 14098-28 | Target: SYCC | UniProt: P49589

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14098-28 | Target: SYCC | UniProt: P49589 | TargetFullName: Cysteine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.996443E-11

Real

Aptamer SeqId:14099-20;Target:PSA4;UniProt:P25789

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14099-20;Target: PSA4;UniProt: P25789;TargetFullName: Proteasome subunit alpha type-4;Organisim: human;Apparent_Kd_M: 4.100326E-11

Real

Aptamer SeqId: 14099-20 | Target: PSA4 | UniProt: P25789

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14099-20 | Target: PSA4 | UniProt: P25789 | TargetFullName: Proteasome subunit alpha type-4 | Organisim: human | Apparent_Kd_M: 4.100326E-11

Real

Aptamer SeqId:14100-63;Target:C1QC;UniProt:P02747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14100-63;Target: C1QC;UniProt: P02747;TargetFullName: Complement C1q subcomponent subunit C;Organisim: human;Apparent_Kd_M: 1.215308E-10

Real

Aptamer SeqId: 14100-63 | Target: C1QC | UniProt: P02747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14100-63 | Target: C1QC | UniProt: P02747 | TargetFullName: Complement C1q subcomponent subunit C | Organisim: human | Apparent_Kd_M: 1.215308E-10

Real

Aptamer SeqId:14101-2;Target:CNTFR alpha;UniProt:P26992

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14101-2;Target: CNTFR alpha;UniProt: P26992;TargetFullName: Ciliary neurotrophic factor receptor subunit alpha;Organisim: human;Apparent_Kd_M: 4.29E-11

Real

Aptamer SeqId: 14101-2 | Target: CNTFR alpha | UniProt: P26992

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14101-2 | Target: CNTFR alpha | UniProt: P26992 | TargetFullName: Ciliary neurotrophic factor receptor subunit alpha | Organisim: human | Apparent_Kd_M: 4.29E-11

Real

Aptamer SeqId:14106-46;Target:GDP/GTP exchange protein;UniProt:P52306

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14106-46;Target: GDP/GTP exchange protein;UniProt: P52306;TargetFullName: Rap1 GTPase-GDP dissociation stimulator 1;Organisim: human;Apparent_Kd_M: 4.133072E-11

Real

Aptamer SeqId: 14106-46 | Target: GDP/GTP exchange protein

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14106-46 | Target: GDP/GTP exchange protein | UniProt: P52306 | TargetFullName: Rap1 GTPase-GDP dissociation stimulator 1 | Organisim: human | Apparent_Kd_M: 4.133072E-11

Real

Aptamer SeqId:14107-1;Target:MTHFS;UniProt:P49914

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14107-1;Target: MTHFS;UniProt: P49914;TargetFullName: 5-formyltetrahydrofolate cyclo-ligase;Organisim: human;Apparent_Kd_M: 1.052282E-12

Real

Aptamer SeqId: 14107-1 | Target: MTHFS | UniProt: P49914

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14107-1 | Target: MTHFS | UniProt: P49914 | TargetFullName: 5-formyltetrahydrofolate cyclo-ligase | Organisim: human | Apparent_Kd_M: 1.052282E-12

Real

Aptamer SeqId:14111-15;Target:TSP2;UniProt:P35442

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14111-15;Target: TSP2;UniProt: P35442;TargetFullName: Thrombospondin-2;Organisim: human;Apparent_Kd_M: 5.22E-12

Real

Aptamer SeqId: 14111-15 | Target: TSP2 | UniProt: P35442

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14111-15 | Target: TSP2 | UniProt: P35442 | TargetFullName: Thrombospondin-2 | Organisim: human | Apparent_Kd_M: 5.22E-12

Real

Aptamer SeqId:14112-40;Target:RELT;UniProt:Q969Z4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14112-40;Target: RELT;UniProt: Q969Z4;TargetFullName: Tumor necrosis factor receptor superfamily member 19L;Organisim: human;Apparent_Kd_M: 4.1E-12

Real

Aptamer SeqId: 14112-40 | Target: RELT | UniProt: Q969Z4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14112-40 | Target: RELT | UniProt: Q969Z4 | TargetFullName: Tumor necrosis factor receptor superfamily member 19L | Organisim: human | Apparent_Kd_M: 4.1E-12

Real

Aptamer SeqId:14114-18;Target:PIANP;UniProt:Q8IYJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14114-18;Target: PIANP;UniProt: Q8IYJ0;TargetFullName: PILR alpha-associated neural protein;Organisim: human;Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId: 14114-18 | Target: PIANP | UniProt: Q8IYJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14114-18 | Target: PIANP | UniProt: Q8IYJ0 | TargetFullName: PILR alpha-associated neural protein | Organisim: human | Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId:14115-34;Target:Adrenomedullin;UniProt:P35318

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14115-34;Target: Adrenomedullin;UniProt: P35318;TargetFullName: Adrenomedullin;Organisim: human;Apparent_Kd_M: 2.48E-11

Real

Aptamer SeqId: 14115-34 | Target: Adrenomedullin | UniProt: P35318

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14115-34 | Target: Adrenomedullin | UniProt: P35318 | TargetFullName: Adrenomedullin | Organisim: human | Apparent_Kd_M: 2.48E-11

Real

Aptamer SeqId:14116-129;Target:S100A4;UniProt:P26447

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14116-129;Target: S100A4;UniProt: P26447;TargetFullName: Protein S100-A4;Organisim: human;Apparent_Kd_M: 5.8E-11

Real

Aptamer SeqId: 14116-129 | Target: S100A4 | UniProt: P26447

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14116-129 | Target: S100A4 | UniProt: P26447 | TargetFullName: Protein S100-A4 | Organisim: human | Apparent_Kd_M: 5.8E-11

Real

Aptamer SeqId:14120-2;Target:RNF43;UniProt:Q68DV7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14120-2;Target: RNF43;UniProt: Q68DV7;TargetFullName: E3 ubiquitin-protein ligase RNF43;Organisim: human;Apparent_Kd_M: 8.36E-12

Real

Aptamer SeqId: 14120-2 | Target: RNF43 | UniProt: Q68DV7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14120-2 | Target: RNF43 | UniProt: Q68DV7 | TargetFullName: E3 ubiquitin-protein ligase RNF43 | Organisim: human | Apparent_Kd_M: 8.36E-12

Real

Aptamer SeqId:14121-24;Target:TRAIL R4;UniProt:Q9UBN6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14121-24;Target: TRAIL R4;UniProt: Q9UBN6;TargetFullName: Tumor necrosis factor receptor superfamily member 10D;Organisim: human;Apparent_Kd_M: 6.0E-12

Real

Aptamer SeqId: 14121-24 | Target: TRAIL R4 | UniProt: Q9UBN6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14121-24 | Target: TRAIL R4 | UniProt: Q9UBN6 | TargetFullName: Tumor necrosis factor receptor superfamily member 10D | Organisim: human | Apparent_Kd_M: 6.0E-12

Real

Aptamer SeqId:14122-132;Target:ZNRF3;UniProt:Q9ULT6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14122-132;Target: ZNRF3;UniProt: Q9ULT6;TargetFullName: E3 ubiquitin-protein ligase ZNRF3;Organisim: human;Apparent_Kd_M: 3.38E-12

Real

Aptamer SeqId: 14122-132 | Target: ZNRF3 | UniProt: Q9ULT6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14122-132 | Target: ZNRF3 | UniProt: Q9ULT6 | TargetFullName: E3 ubiquitin-protein ligase ZNRF3 | Organisim: human | Apparent_Kd_M: 3.38E-12

Real

Aptamer SeqId:14123-34;Target:GI24;UniProt:Q9H7M9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14123-34;Target: GI24;UniProt: Q9H7M9;TargetFullName: V-type immunoglobulin domain-containing suppressor of T-cell activation;Organisim: human;Apparent_Kd_M: 6.88E-12

Real

Aptamer SeqId: 14123-34 | Target: GI24 | UniProt: Q9H7M9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14123-34 | Target: GI24 | UniProt: Q9H7M9 | TargetFullName: V-type immunoglobulin domain-containing suppressor of T-cell activation | Organisim: human | Apparent_Kd_M: 6.88E-12

Real

Aptamer SeqId:14124-6;Target:Ephrin-A2;UniProt:O43921

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14124-6;Target: Ephrin-A2;UniProt: O43921;TargetFullName: Ephrin-A2;Organisim: human;Apparent_Kd_M: 2.18E-12

Real

Aptamer SeqId: 14124-6 | Target: Ephrin-A2 | UniProt: O43921

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14124-6 | Target: Ephrin-A2 | UniProt: O43921 | TargetFullName: Ephrin-A2 | Organisim: human | Apparent_Kd_M: 2.18E-12

Real

Aptamer SeqId:14127-240;Target:IFN-b;UniProt:P01574

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14127-240;Target: IFN-b;UniProt: P01574;TargetFullName: Interferon beta;Organisim: human;Apparent_Kd_M: 9.36E-12

Real

Aptamer SeqId: 14127-240 | Target: IFN-b | UniProt: P01574

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14127-240 | Target: IFN-b | UniProt: P01574 | TargetFullName: Interferon beta | Organisim: human | Apparent_Kd_M: 9.36E-12

Real

Aptamer SeqId:14128-121;Target:IFN10;UniProt:P01566

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14128-121;Target: IFN10;UniProt: P01566;TargetFullName: Interferon alpha-10;Organisim: human;Apparent_Kd_M: 8.2E-12

Real

Aptamer SeqId: 14128-121 | Target: IFN10 | UniProt: P01566

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14128-121 | Target: IFN10 | UniProt: P01566 | TargetFullName: Interferon alpha-10 | Organisim: human | Apparent_Kd_M: 8.2E-12

Real

Aptamer SeqId:14129-1;Target:IFNA7;UniProt:P01567

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14129-1;Target: IFNA7;UniProt: P01567;TargetFullName: Interferon alpha-7;Organisim: human;Apparent_Kd_M: 3.01E-12

Real

Aptamer SeqId: 14129-1 | Target: IFNA7 | UniProt: P01567

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14129-1 | Target: IFNA7 | UniProt: P01567 | TargetFullName: Interferon alpha-7 | Organisim: human | Apparent_Kd_M: 3.01E-12

Real

Aptamer SeqId:14131-37;Target:EFNB2;UniProt:P52799

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14131-37;Target: EFNB2;UniProt: P52799;TargetFullName: Ephrin-B2;Organisim: human;Apparent_Kd_M: 3.23E-11

Real

Aptamer SeqId: 14131-37 | Target: EFNB2 | UniProt: P52799

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14131-37 | Target: EFNB2 | UniProt: P52799 | TargetFullName: Ephrin-B2 | Organisim: human | Apparent_Kd_M: 3.23E-11

Real

Aptamer SeqId:14132-21;Target:HHLA2;UniProt:Q9UM44

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14132-21;Target: HHLA2;UniProt: Q9UM44;TargetFullName: HERV-H LTR-associating protein 2;Organisim: human;Apparent_Kd_M: 4.01E-11

Real

Aptamer SeqId: 14132-21 | Target: HHLA2 | UniProt: Q9UM44

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14132-21 | Target: HHLA2 | UniProt: Q9UM44 | TargetFullName: HERV-H LTR-associating protein 2 | Organisim: human | Apparent_Kd_M: 4.01E-11

Real

Aptamer SeqId:14133-93;Target:IL-1 sRII;UniProt:P27930

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14133-93;Target: IL-1 sRII;UniProt: P27930;TargetFullName: Interleukin-1 receptor type 2;Organisim: human;Apparent_Kd_M: 2.47E-12

Real

Aptamer SeqId: 14133-93 | Target: IL-1 sRII | UniProt: P27930

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14133-93 | Target: IL-1 sRII | UniProt: P27930 | TargetFullName: Interleukin-1 receptor type 2 | Organisim: human | Apparent_Kd_M: 2.47E-12

Real

Aptamer SeqId:14134-49;Target:AMGO2;UniProt:Q86SJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14134-49;Target: AMGO2;UniProt: Q86SJ2;TargetFullName: Amphoterin-induced protein 2;Organisim: human;Apparent_Kd_M: 2.93E-12

Real

Aptamer SeqId: 14134-49 | Target: AMGO2 | UniProt: Q86SJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14134-49 | Target: AMGO2 | UniProt: Q86SJ2 | TargetFullName: Amphoterin-induced protein 2 | Organisim: human | Apparent_Kd_M: 2.93E-12

Real

Aptamer SeqId:14135-3;Target:RXFP1;UniProt:Q9HBX9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14135-3;Target: RXFP1;UniProt: Q9HBX9;TargetFullName: Relaxin receptor 1;Organisim: human;Apparent_Kd_M: 5.01E-12

Real

Aptamer SeqId: 14135-3 | Target: RXFP1 | UniProt: Q9HBX9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14135-3 | Target: RXFP1 | UniProt: Q9HBX9 | TargetFullName: Relaxin receptor 1 | Organisim: human | Apparent_Kd_M: 5.01E-12

Real

Aptamer SeqId:14136-234;Target:C1QR1;UniProt:Q9NPY3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14136-234;Target: C1QR1;UniProt: Q9NPY3;TargetFullName: Complement component C1q receptor;Organisim: human;Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId: 14136-234 | Target: C1QR1 | UniProt: Q9NPY3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14136-234 | Target: C1QR1 | UniProt: Q9NPY3 | TargetFullName: Complement component C1q receptor | Organisim: human | Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId:14139-16;Target:NRG4;UniProt:Q8WWG1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14139-16;Target: NRG4;UniProt: Q8WWG1;TargetFullName: Neuregulin-4;Organisim: human;Apparent_Kd_M: 8.45E-12

Real

Aptamer SeqId: 14139-16 | Target: NRG4 | UniProt: Q8WWG1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14139-16 | Target: NRG4 | UniProt: Q8WWG1 | TargetFullName: Neuregulin-4 | Organisim: human | Apparent_Kd_M: 8.45E-12

Real

Aptamer SeqId:14143-8;Target:H2B2E;UniProt:Q16778

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14143-8;Target: H2B2E;UniProt: Q16778;TargetFullName: Histone H2B type 2-E;Organisim: human;Apparent_Kd_M: 5.28E-11

Real

Aptamer SeqId: 14143-8 | Target: H2B2E | UniProt: Q16778

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14143-8 | Target: H2B2E | UniProt: Q16778 | TargetFullName: Histone H2B type 2-E | Organisim: human | Apparent_Kd_M: 5.28E-11

Real

Aptamer SeqId:14144-3;Target:H2A3;UniProt:Q7L7L0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14144-3;Target: H2A3;UniProt: Q7L7L0;TargetFullName: Histone H2A type 3;Organisim: human;Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId: 14144-3 | Target: H2A3 | UniProt: Q7L7L0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14144-3 | Target: H2A3 | UniProt: Q7L7L0 | TargetFullName: Histone H2A type 3 | Organisim: human | Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId:14146-92;Target:H31;UniProt:P68431

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14146-92;Target: H31;UniProt: P68431;TargetFullName: Histone H3.1;Organisim: human;Apparent_Kd_M: 8.4E-11

Real

Aptamer SeqId: 14146-92 | Target: H31 | UniProt: P68431

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14146-92 | Target: H31 | UniProt: P68431 | TargetFullName: Histone H3.1 | Organisim: human | Apparent_Kd_M: 8.4E-11

Real

Aptamer SeqId:14149-9;Target:IL-1F8;UniProt:Q9NZH7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14149-9;Target: IL-1F8;UniProt: Q9NZH7;TargetFullName: Interleukin-36 beta;Organisim: human;Apparent_Kd_M: 4.67E-12

Real

Aptamer SeqId: 14149-9 | Target: IL-1F8 | UniProt: Q9NZH7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14149-9 | Target: IL-1F8 | UniProt: Q9NZH7 | TargetFullName: Interleukin-36 beta | Organisim: human | Apparent_Kd_M: 4.67E-12

Real

Aptamer SeqId:14150-7;Target:IL-1F6;UniProt:Q9UHA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14150-7;Target: IL-1F6;UniProt: Q9UHA7;TargetFullName: Interleukin-36 alpha;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 14150-7 | Target: IL-1F6 | UniProt: Q9UHA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14150-7 | Target: IL-1F6 | UniProt: Q9UHA7 | TargetFullName: Interleukin-36 alpha | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:14151-4;Target:UCRP;UniProt:P05161

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14151-4;Target: UCRP;UniProt: P05161;TargetFullName: Ubiquitin-like protein ISG15;Organisim: human;Apparent_Kd_M: 8.76E-12

Real

Aptamer SeqId: 14151-4 | Target: UCRP | UniProt: P05161

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14151-4 | Target: UCRP | UniProt: P05161 | TargetFullName: Ubiquitin-like protein ISG15 | Organisim: human | Apparent_Kd_M: 8.76E-12

Real

Aptamer SeqId:14153-8;Target:Ephrin-A3;UniProt:P52797

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14153-8;Target: Ephrin-A3;UniProt: P52797;TargetFullName: Ephrin-A3;Organisim: human;Apparent_Kd_M: 2.54E-12

Real

Aptamer SeqId: 14153-8 | Target: Ephrin-A3 | UniProt: P52797

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14153-8 | Target: Ephrin-A3 | UniProt: P52797 | TargetFullName: Ephrin-A3 | Organisim: human | Apparent_Kd_M: 2.54E-12

Real

Aptamer SeqId:14156-33;Target:14-3-3 protein beta/alpha;UniProt:P31946

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14156-33;Target: 14-3-3 protein beta/alpha;UniProt: P31946;TargetFullName: 14-3-3 protein beta/alpha;Organisim: human;Apparent_Kd_M: 2.07E-12

Real

Aptamer SeqId: 14156-33 | Target: 14-3-3 protein beta/alpha

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14156-33 | Target: 14-3-3 protein beta/alpha | UniProt: P31946 | TargetFullName: 14-3-3 protein beta/alpha | Organisim: human | Apparent_Kd_M: 2.07E-12

Real

Aptamer SeqId:14157-21;Target:14-3-3E;UniProt:P62258

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14157-21;Target: 14-3-3E;UniProt: P62258;TargetFullName: 14-3-3 protein epsilon;Organisim: human;Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId: 14157-21 | Target: 14-3-3E | UniProt: P62258

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14157-21 | Target: 14-3-3E | UniProt: P62258 | TargetFullName: 14-3-3 protein epsilon | Organisim: human | Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId:14158-17;Target:Annexin V;UniProt:P08758

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14158-17;Target: Annexin V;UniProt: P08758;TargetFullName: Annexin A5;Organisim: human;Apparent_Kd_M: 4.69E-11

Real

Aptamer SeqId: 14158-17 | Target: Annexin V | UniProt: P08758

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14158-17 | Target: Annexin V | UniProt: P08758 | TargetFullName: Annexin A5 | Organisim: human | Apparent_Kd_M: 4.69E-11

Real

Aptamer SeqId:14175-78;Target:SCP2D;UniProt:Q9UJQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14175-78;Target: SCP2D;UniProt: Q9UJQ7;TargetFullName: SCP2 sterol-binding domain-containing protein 1;Organisim: human;Apparent_Kd_M: 5.803231E-13

Real

Aptamer SeqId: 14175-78 | Target: SCP2D | UniProt: Q9UJQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14175-78 | Target: SCP2D | UniProt: Q9UJQ7 | TargetFullName: SCP2 sterol-binding domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 5.803231E-13

Real

Aptamer SeqId:14178-18;Target:CDKN3;UniProt:Q16667

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14178-18;Target: CDKN3;UniProt: Q16667;TargetFullName: Cyclin-dependent kinase inhibitor 3;Organisim: human;Apparent_Kd_M: 5.87994E-11

Real

Aptamer SeqId: 14178-18 | Target: CDKN3 | UniProt: Q16667

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14178-18 | Target: CDKN3 | UniProt: Q16667 | TargetFullName: Cyclin-dependent kinase inhibitor 3 | Organisim: human | Apparent_Kd_M: 5.87994E-11

Real

Aptamer SeqId:14186-13;Target:RFFL;UniProt:Q8WZ73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14186-13;Target: RFFL;UniProt: Q8WZ73;TargetFullName: E3 ubiquitin-protein ligase rififylin;Organisim: human;Apparent_Kd_M: 2.463989E-11

Real

Aptamer SeqId: 14186-13 | Target: RFFL | UniProt: Q8WZ73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14186-13 | Target: RFFL | UniProt: Q8WZ73 | TargetFullName: E3 ubiquitin-protein ligase rififylin | Organisim: human | Apparent_Kd_M: 2.463989E-11

Real

Aptamer SeqId:14192-31;Target:PDCL2;UniProt:Q8N4E4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14192-31;Target: PDCL2;UniProt: Q8N4E4;TargetFullName: Phosducin-like protein 2;Organisim: human;Apparent_Kd_M: 1.833322E-10

Real

Aptamer SeqId: 14192-31 | Target: PDCL2 | UniProt: Q8N4E4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14192-31 | Target: PDCL2 | UniProt: Q8N4E4 | TargetFullName: Phosducin-like protein 2 | Organisim: human | Apparent_Kd_M: 1.833322E-10

Real

Aptamer SeqId:14197-2;Target:PRDM1;UniProt:O75626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14197-2;Target: PRDM1;UniProt: O75626;TargetFullName: PR domain zinc finger protein 1;Organisim: human;Apparent_Kd_M: 1.82268E-11

Real

Aptamer SeqId: 14197-2 | Target: PRDM1 | UniProt: O75626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14197-2 | Target: PRDM1 | UniProt: O75626 | TargetFullName: PR domain zinc finger protein 1 | Organisim: human | Apparent_Kd_M: 1.82268E-11

Real

Aptamer SeqId:14203-3;Target:ANXA7;UniProt:P20073

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14203-3;Target: ANXA7;UniProt: P20073;TargetFullName: Annexin A7;Organisim: human;Apparent_Kd_M: 2.881946E-11

Real

Aptamer SeqId: 14203-3 | Target: ANXA7 | UniProt: P20073

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14203-3 | Target: ANXA7 | UniProt: P20073 | TargetFullName: Annexin A7 | Organisim: human | Apparent_Kd_M: 2.881946E-11

Real

Aptamer SeqId:14204-55;Target:FOXJ2;UniProt:Q9P0K8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14204-55;Target: FOXJ2;UniProt: Q9P0K8;TargetFullName: Forkhead box protein J2;Organisim: human;Apparent_Kd_M: 4.467056E-11

Real

Aptamer SeqId: 14204-55 | Target: FOXJ2 | UniProt: Q9P0K8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14204-55 | Target: FOXJ2 | UniProt: Q9P0K8 | TargetFullName: Forkhead box protein J2 | Organisim: human | Apparent_Kd_M: 4.467056E-11

Real

Aptamer SeqId:14205-6;Target:HEXI2;UniProt:Q96MH2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14205-6;Target: HEXI2;UniProt: Q96MH2;TargetFullName: Protein HEXIM2;Organisim: human;Apparent_Kd_M: 1.275497E-11

Real

Aptamer SeqId: 14205-6 | Target: HEXI2 | UniProt: Q96MH2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14205-6 | Target: HEXI2 | UniProt: Q96MH2 | TargetFullName: Protein HEXIM2 | Organisim: human | Apparent_Kd_M: 1.275497E-11

Real

Aptamer SeqId:14206-28;Target:APBB1;UniProt:O00213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14206-28;Target: APBB1;UniProt: O00213;TargetFullName: Amyloid beta A4 precursor protein-binding family B member 1;Organisim: human;Apparent_Kd_M: 3.15E-11

Real

Aptamer SeqId: 14206-28 | Target: APBB1 | UniProt: O00213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14206-28 | Target: APBB1 | UniProt: O00213 | TargetFullName: Amyloid beta A4 precursor protein-binding family B member 1 | Organisim: human | Apparent_Kd_M: 3.15E-11

Real

Aptamer SeqId:14208-3;Target:RET7;UniProt:Q96R05

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14208-3;Target: RET7;UniProt: Q96R05;TargetFullName: Retinoid-binding protein 7;Organisim: human;Apparent_Kd_M: 6.488497E-13

Real

Aptamer SeqId: 14208-3 | Target: RET7 | UniProt: Q96R05

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14208-3 | Target: RET7 | UniProt: Q96R05 | TargetFullName: Retinoid-binding protein 7 | Organisim: human | Apparent_Kd_M: 6.488497E-13

Real

Aptamer SeqId:14216-35;Target:DDX46;UniProt:Q7L014

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14216-35;Target: DDX46;UniProt: Q7L014;TargetFullName: Probable ATP-dependent RNA helicase DDX46;Organisim: human;Apparent_Kd_M: 2.384758E-10

Real

Aptamer SeqId: 14216-35 | Target: DDX46 | UniProt: Q7L014

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14216-35 | Target: DDX46 | UniProt: Q7L014 | TargetFullName: Probable ATP-dependent RNA helicase DDX46 | Organisim: human | Apparent_Kd_M: 2.384758E-10

Real

Aptamer SeqId:14226-120;Target:BHMT2;UniProt:Q9H2M3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14226-120;Target: BHMT2;UniProt: Q9H2M3;TargetFullName: S-methylmethionine--homocysteine S-methyltransferase BHMT2;Organisim: human;Apparent_Kd_M: 4.063761E-11

Real

Aptamer SeqId: 14226-120 | Target: BHMT2 | UniProt: Q9H2M3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14226-120 | Target: BHMT2 | UniProt: Q9H2M3 | TargetFullName: S-methylmethionine--homocysteine S-methyltransferase BHMT2 | Organisim: human | Apparent_Kd_M: 4.063761E-11

Real

Aptamer SeqId:14227-21;Target:MYL6B;UniProt:P14649

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14227-21;Target: MYL6B;UniProt: P14649;TargetFullName: Myosin light chain 6B;Organisim: human;Apparent_Kd_M: 3.03451E-11

Real

Aptamer SeqId: 14227-21 | Target: MYL6B | UniProt: P14649

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14227-21 | Target: MYL6B | UniProt: P14649 | TargetFullName: Myosin light chain 6B | Organisim: human | Apparent_Kd_M: 3.03451E-11

Real

Aptamer SeqId:14228-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14228-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.42166E-12

Real

Aptamer SeqId: 14228-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14228-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.42166E-12

Real

Aptamer SeqId:14229-5;Target:MOCS3;UniProt:O95396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14229-5;Target: MOCS3;UniProt: O95396;TargetFullName: Adenylyltransferase and sulfurtransferase MOCS3;Organisim: human;Apparent_Kd_M: 7.402201E-11

Real

Aptamer SeqId: 14229-5 | Target: MOCS3 | UniProt: O95396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14229-5 | Target: MOCS3 | UniProt: O95396 | TargetFullName: Adenylyltransferase and sulfurtransferase MOCS3 | Organisim: human | Apparent_Kd_M: 7.402201E-11

Real

Aptamer SeqId:14237-1;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14237-1;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 4.81303E-12

Real

Aptamer SeqId: 14237-1 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14237-1 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 4.81303E-12

Real

Aptamer SeqId:14245-195;Target:SNX7;UniProt:Q9UNH6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14245-195;Target: SNX7;UniProt: Q9UNH6;TargetFullName: Sorting nexin-7;Organisim: human;Apparent_Kd_M: 1.331199E-12

Real

Aptamer SeqId: 14245-195 | Target: SNX7 | UniProt: Q9UNH6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14245-195 | Target: SNX7 | UniProt: Q9UNH6 | TargetFullName: Sorting nexin-7 | Organisim: human | Apparent_Kd_M: 1.331199E-12

Real

Aptamer SeqId:14246-50;Target:DOK2;UniProt:O60496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14246-50;Target: DOK2;UniProt: O60496;TargetFullName: Docking protein 2;Organisim: human;Apparent_Kd_M: 6.23E-11

Real

Aptamer SeqId: 14246-50 | Target: DOK2 | UniProt: O60496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14246-50 | Target: DOK2 | UniProt: O60496 | TargetFullName: Docking protein 2 | Organisim: human | Apparent_Kd_M: 6.23E-11

Real

Aptamer SeqId:14249-68;Target:TRIM1;UniProt:Q9UJV3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14249-68;Target: TRIM1;UniProt: Q9UJV3;TargetFullName: Probable E3 ubiquitin-protein ligase MID2;Organisim: human;Apparent_Kd_M: 5.735354E-13

Real

Aptamer SeqId: 14249-68 | Target: TRIM1 | UniProt: Q9UJV3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14249-68 | Target: TRIM1 | UniProt: Q9UJV3 | TargetFullName: Probable E3 ubiquitin-protein ligase MID2 | Organisim: human | Apparent_Kd_M: 5.735354E-13

Real

Aptamer SeqId:14250-115;Target:BLMH;UniProt:Q13867

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14250-115;Target: BLMH;UniProt: Q13867;TargetFullName: Bleomycin hydrolase;Organisim: human;Apparent_Kd_M: 6.690209E-11

Real

Aptamer SeqId: 14250-115 | Target: BLMH | UniProt: Q13867

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14250-115 | Target: BLMH | UniProt: Q13867 | TargetFullName: Bleomycin hydrolase | Organisim: human | Apparent_Kd_M: 6.690209E-11

Real

Aptamer SeqId:14254-27;Target:PTN4;UniProt:P29074

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14254-27;Target: PTN4;UniProt: P29074;TargetFullName: Tyrosine-protein phosphatase non-receptor type 4;Organisim: human;Apparent_Kd_M: 4.455554E-11

Real

Aptamer SeqId: 14254-27 | Target: PTN4 | UniProt: P29074

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14254-27 | Target: PTN4 | UniProt: P29074 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 4 | Organisim: human | Apparent_Kd_M: 4.455554E-11

Real

Aptamer SeqId:14256-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14256-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.717701E-13

Real

Aptamer SeqId: 14256-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14256-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.717701E-13

Real

Aptamer SeqId:14260-112;Target:ARHG8;UniProt:Q7Z628

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14260-112;Target: ARHG8;UniProt: Q7Z628;TargetFullName: Neuroepithelial cell-transforming gene 1 protein;Organisim: human;Apparent_Kd_M: 3.206369E-11

Real

Aptamer SeqId: 14260-112 | Target: ARHG8 | UniProt: Q7Z628

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14260-112 | Target: ARHG8 | UniProt: Q7Z628 | TargetFullName: Neuroepithelial cell-transforming gene 1 protein | Organisim: human | Apparent_Kd_M: 3.206369E-11

Real

Aptamer SeqId:14268-4;Target:SRXN1;UniProt:Q9BYN0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14268-4;Target: SRXN1;UniProt: Q9BYN0;TargetFullName: Sulfiredoxin-1;Organisim: human;Apparent_Kd_M: 5.414658E-11

Real

Aptamer SeqId: 14268-4 | Target: SRXN1 | UniProt: Q9BYN0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14268-4 | Target: SRXN1 | UniProt: Q9BYN0 | TargetFullName: Sulfiredoxin-1 | Organisim: human | Apparent_Kd_M: 5.414658E-11

Real

Aptamer SeqId:14271-23;Target:RAB6B;UniProt:Q9NRW1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14271-23;Target: RAB6B;UniProt: Q9NRW1;TargetFullName: Ras-related protein Rab-6B;Organisim: human;Apparent_Kd_M: 2.957795E-12

Real

Aptamer SeqId: 14271-23 | Target: RAB6B | UniProt: Q9NRW1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14271-23 | Target: RAB6B | UniProt: Q9NRW1 | TargetFullName: Ras-related protein Rab-6B | Organisim: human | Apparent_Kd_M: 2.957795E-12

Real

Aptamer SeqId:14273-19;Target:PPCE;UniProt:P48147

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14273-19;Target: PPCE;UniProt: P48147;TargetFullName: Prolyl endopeptidase;Organisim: human;Apparent_Kd_M: 1.480898E-10

Real

Aptamer SeqId: 14273-19 | Target: PPCE | UniProt: P48147

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14273-19 | Target: PPCE | UniProt: P48147 | TargetFullName: Prolyl endopeptidase | Organisim: human | Apparent_Kd_M: 1.480898E-10

Real

Aptamer SeqId:14283-12;Target:RAB14;UniProt:P61106

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14283-12;Target: RAB14;UniProt: P61106;TargetFullName: Ras-related protein Rab-14;Organisim: human;Apparent_Kd_M: 5.876912E-11

Real

Aptamer SeqId: 14283-12 | Target: RAB14 | UniProt: P61106

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14283-12 | Target: RAB14 | UniProt: P61106 | TargetFullName: Ras-related protein Rab-14 | Organisim: human | Apparent_Kd_M: 5.876912E-11

Real

Aptamer SeqId:14284-23;Target:E2AK4;UniProt:Q9P2K8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14284-23;Target: E2AK4;UniProt: Q9P2K8;TargetFullName: eIF-2-alpha kinase GCN2;Organisim: human;Apparent_Kd_M: 2.459712E-11

Real

Aptamer SeqId: 14284-23 | Target: E2AK4 | UniProt: Q9P2K8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14284-23 | Target: E2AK4 | UniProt: Q9P2K8 | TargetFullName: eIF-2-alpha kinase GCN2 | Organisim: human | Apparent_Kd_M: 2.459712E-11

Real

Aptamer SeqId:14286-2;Target:NF-ATc1;UniProt:O95644

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14286-2;Target: NF-ATc1;UniProt: O95644;TargetFullName: Nuclear factor of activated T-cells; cytoplasmic 1;Organisim: human;Apparent_Kd_M: 2.060479E-12

Real

Aptamer SeqId: 14286-2 | Target: NF-ATc1 | UniProt: O95644

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14286-2 | Target: NF-ATc1 | UniProt: O95644 | TargetFullName: Nuclear factor of activated T-cells; cytoplasmic 1 | Organisim: human | Apparent_Kd_M: 2.060479E-12

Real

Aptamer SeqId:14287-6;Target:RAB5C;UniProt:P51148

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14287-6;Target: RAB5C;UniProt: P51148;TargetFullName: Ras-related protein Rab-5C;Organisim: human;Apparent_Kd_M: 9.55246E-12

Real

Aptamer SeqId: 14287-6 | Target: RAB5C | UniProt: P51148

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14287-6 | Target: RAB5C | UniProt: P51148 | TargetFullName: Ras-related protein Rab-5C | Organisim: human | Apparent_Kd_M: 9.55246E-12

Real

Aptamer SeqId:14291-53;Target:AGAP2;UniProt:Q99490

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14291-53;Target: AGAP2;UniProt: Q99490;TargetFullName: Arf-GAP with GTPase; ANK repeat and PH domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.134714E-12

Real

Aptamer SeqId: 14291-53 | Target: AGAP2 | UniProt: Q99490

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14291-53 | Target: AGAP2 | UniProt: Q99490 | TargetFullName: Arf-GAP with GTPase; ANK repeat and PH domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.134714E-12

Real

Aptamer SeqId:14294-61;Target:MBD1;UniProt:Q9UIS9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14294-61;Target: MBD1;UniProt: Q9UIS9;TargetFullName: Methyl-CpG-binding domain protein 1;Organisim: human;Apparent_Kd_M: 2.028491E-12

Real

Aptamer SeqId: 14294-61 | Target: MBD1 | UniProt: Q9UIS9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14294-61 | Target: MBD1 | UniProt: Q9UIS9 | TargetFullName: Methyl-CpG-binding domain protein 1 | Organisim: human | Apparent_Kd_M: 2.028491E-12

Real

Aptamer SeqId:14308-192;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14308-192;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.556009E-10

Real

Aptamer SeqId: 14308-192 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14308-192 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.556009E-10

Real

Aptamer SeqId:14309-8;Target:HNRH1;UniProt:P31943

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14309-8;Target: HNRH1;UniProt: P31943;TargetFullName: Heterogeneous nuclear ribonucleoprotein H;Organisim: human;Apparent_Kd_M: 8.158204E-11

Real

Aptamer SeqId: 14309-8 | Target: HNRH1 | UniProt: P31943

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14309-8 | Target: HNRH1 | UniProt: P31943 | TargetFullName: Heterogeneous nuclear ribonucleoprotein H | Organisim: human | Apparent_Kd_M: 8.158204E-11

Real

Aptamer SeqId:14314-6;Target:PPIL2;UniProt:Q13356

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14314-6;Target: PPIL2;UniProt: Q13356;TargetFullName: Peptidyl-prolyl cis-trans isomerase-like 2;Organisim: human;Apparent_Kd_M: 2.86319E-12

Real

Aptamer SeqId: 14314-6 | Target: PPIL2 | UniProt: Q13356

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14314-6 | Target: PPIL2 | UniProt: Q13356 | TargetFullName: Peptidyl-prolyl cis-trans isomerase-like 2 | Organisim: human | Apparent_Kd_M: 2.86319E-12

Real

Aptamer SeqId:14318-1;Target:VPS29;UniProt:Q9UBQ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14318-1;Target: VPS29;UniProt: Q9UBQ0;TargetFullName: Vacuolar protein sorting-associated protein 29;Organisim: human;Apparent_Kd_M: 6.475177E-11

Real

Aptamer SeqId: 14318-1 | Target: VPS29 | UniProt: Q9UBQ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14318-1 | Target: VPS29 | UniProt: Q9UBQ0 | TargetFullName: Vacuolar protein sorting-associated protein 29 | Organisim: human | Apparent_Kd_M: 6.475177E-11

Real

Aptamer SeqId:14324-52;Target:CSPG6;UniProt:Q9UQE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14324-52;Target: CSPG6;UniProt: Q9UQE7;TargetFullName: Structural maintenance of chromosomes protein 3;Organisim: human;Apparent_Kd_M: 1.717694E-10

Real

Aptamer SeqId: 14324-52 | Target: CSPG6 | UniProt: Q9UQE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14324-52 | Target: CSPG6 | UniProt: Q9UQE7 | TargetFullName: Structural maintenance of chromosomes protein 3 | Organisim: human | Apparent_Kd_M: 1.717694E-10

Real

Aptamer SeqId:14326-4;Target:UB2E1;UniProt:P51965

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14326-4;Target: UB2E1;UniProt: P51965;TargetFullName: Ubiquitin-conjugating enzyme E2 E1;Organisim: human;Apparent_Kd_M: 1.558013E-11

Real

Aptamer SeqId: 14326-4 | Target: UB2E1 | UniProt: P51965

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14326-4 | Target: UB2E1 | UniProt: P51965 | TargetFullName: Ubiquitin-conjugating enzyme E2 E1 | Organisim: human | Apparent_Kd_M: 1.558013E-11

Real

Aptamer SeqId:14329-4;Target:DIDO1;UniProt:Q9BTC0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14329-4;Target: DIDO1;UniProt: Q9BTC0;TargetFullName: Death-inducer obliterator 1;Organisim: human;Apparent_Kd_M: 1.899148E-11

Real

Aptamer SeqId: 14329-4 | Target: DIDO1 | UniProt: Q9BTC0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14329-4 | Target: DIDO1 | UniProt: Q9BTC0 | TargetFullName: Death-inducer obliterator 1 | Organisim: human | Apparent_Kd_M: 1.899148E-11

Real

Aptamer SeqId:14331-262;Target:DYLT1;UniProt:P63172

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14331-262;Target: DYLT1;UniProt: P63172;TargetFullName: Dynein light chain Tctex-type 1;Organisim: human;Apparent_Kd_M: 1.671838E-10

Real

Aptamer SeqId: 14331-262 | Target: DYLT1 | UniProt: P63172

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14331-262 | Target: DYLT1 | UniProt: P63172 | TargetFullName: Dynein light chain Tctex-type 1 | Organisim: human | Apparent_Kd_M: 1.671838E-10

Real

Aptamer SeqId:14332-3;Target:RALA;UniProt:P11233

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14332-3;Target: RALA;UniProt: P11233;TargetFullName: Ras-related protein Ral-A;Organisim: human;Apparent_Kd_M: 1.516378E-11

Real

Aptamer SeqId: 14332-3 | Target: RALA | UniProt: P11233

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14332-3 | Target: RALA | UniProt: P11233 | TargetFullName: Ras-related protein Ral-A | Organisim: human | Apparent_Kd_M: 1.516378E-11

Real

Aptamer SeqId:14334-3;Target:RECO;UniProt:P35243

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14334-3;Target: RECO;UniProt: P35243;TargetFullName: Recoverin;Organisim: human;Apparent_Kd_M: 1.768303E-10

Real

Aptamer SeqId: 14334-3 | Target: RECO | UniProt: P35243

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14334-3 | Target: RECO | UniProt: P35243 | TargetFullName: Recoverin | Organisim: human | Apparent_Kd_M: 1.768303E-10

Real

Aptamer SeqId:14337-1;Target:TPPC3;UniProt:O43617

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14337-1;Target: TPPC3;UniProt: O43617;TargetFullName: Trafficking protein particle complex subunit 3;Organisim: human;Apparent_Kd_M: 1.34992E-10

Real

Aptamer SeqId: 14337-1 | Target: TPPC3 | UniProt: O43617

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14337-1 | Target: TPPC3 | UniProt: O43617 | TargetFullName: Trafficking protein particle complex subunit 3 | Organisim: human | Apparent_Kd_M: 1.34992E-10

Real

Aptamer SeqId:14341-8;Target:FA69C;UniProt:Q0P6D2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14341-8;Target: FA69C;UniProt: Q0P6D2;TargetFullName: Protein FAM69C;Organisim: human;Apparent_Kd_M: 1.950336E-10

Real

Aptamer SeqId: 14341-8 | Target: FA69C | UniProt: Q0P6D2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14341-8 | Target: FA69C | UniProt: Q0P6D2 | TargetFullName: Protein FAM69C | Organisim: human | Apparent_Kd_M: 1.950336E-10

Real

Aptamer SeqId:14583-49;Target:Myostatin;UniProt:O14793

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14583-49;Target: Myostatin;UniProt: O14793;TargetFullName: Growth/differentiation factor 8;Organisim: human;Apparent_Kd_M: 7.328018E-12

Real

Aptamer SeqId: 14583-49 | Target: Myostatin | UniProt: O14793

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14583-49 | Target: Myostatin | UniProt: O14793 | TargetFullName: Growth/differentiation factor 8 | Organisim: human | Apparent_Kd_M: 7.328018E-12

Real

Aptamer SeqId:14587-16;Target:GDF-11;UniProt:O95390

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14587-16;Target: GDF-11;UniProt: O95390;TargetFullName: Growth/differentiation factor 11;Organisim: human;Apparent_Kd_M: 2.58E-11

Real

Aptamer SeqId: 14587-16 | Target: GDF-11 | UniProt: O95390

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14587-16 | Target: GDF-11 | UniProt: O95390 | TargetFullName: Growth/differentiation factor 11 | Organisim: human | Apparent_Kd_M: 2.58E-11

Real

Aptamer SeqId:14593-152;Target:F210A;UniProt:Q96ND0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14593-152;Target: F210A;UniProt: Q96ND0;TargetFullName: Protein FAM210A;Organisim: human;Apparent_Kd_M: 2.381593E-11

Real

Aptamer SeqId: 14593-152 | Target: F210A | UniProt: Q96ND0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14593-152 | Target: F210A | UniProt: Q96ND0 | TargetFullName: Protein FAM210A | Organisim: human | Apparent_Kd_M: 2.381593E-11

Real

Aptamer SeqId:14597-5;Target:SEM6C;UniProt:Q9H3T2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14597-5;Target: SEM6C;UniProt: Q9H3T2;TargetFullName: Semaphorin-6C;Organisim: human;Apparent_Kd_M: 1.508063E-11

Real

Aptamer SeqId: 14597-5 | Target: SEM6C | UniProt: Q9H3T2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14597-5 | Target: SEM6C | UniProt: Q9H3T2 | TargetFullName: Semaphorin-6C | Organisim: human | Apparent_Kd_M: 1.508063E-11

Real

Aptamer SeqId:14599-18;Target:STAB1;UniProt:Q9NY15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14599-18;Target: STAB1;UniProt: Q9NY15;TargetFullName: Stabilin-1;Organisim: human;Apparent_Kd_M: 3.486443E-11

Real

Aptamer SeqId: 14599-18 | Target: STAB1 | UniProt: Q9NY15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14599-18 | Target: STAB1 | UniProt: Q9NY15 | TargetFullName: Stabilin-1 | Organisim: human | Apparent_Kd_M: 3.486443E-11

Real

Aptamer SeqId:14603-51;Target:KIAA0040;UniProt:J3QR46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14603-51;Target: KIAA0040;UniProt: J3QR46;TargetFullName: Uncharacterized protein KIAA0040;Organisim: human;Apparent_Kd_M: 2.145769E-10

Real

Aptamer SeqId: 14603-51 | Target: KIAA0040 | UniProt: J3QR46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14603-51 | Target: KIAA0040 | UniProt: J3QR46 | TargetFullName: Uncharacterized protein KIAA0040 | Organisim: human | Apparent_Kd_M: 2.145769E-10

Real

Aptamer SeqId:14605-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14605-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.312386E-12

Real

Aptamer SeqId: 14605-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14605-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.312386E-12

Real

Aptamer SeqId:14614-41;Target:CA130;UniProt:Q5T1S8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14614-41;Target: CA130;UniProt: Q5T1S8;TargetFullName: Noncompact myelin-associated protein;Organisim: human;Apparent_Kd_M: 3.872555E-11

Real

Aptamer SeqId: 14614-41 | Target: CA130 | UniProt: Q5T1S8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14614-41 | Target: CA130 | UniProt: Q5T1S8 | TargetFullName: Noncompact myelin-associated protein | Organisim: human | Apparent_Kd_M: 3.872555E-11

Real

Aptamer SeqId:14615-46;Target:KRA24;UniProt:Q9BYR9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14615-46;Target: KRA24;UniProt: Q9BYR9;TargetFullName: Keratin-associated protein 2-4;Organisim: human;Apparent_Kd_M: 5.00067E-11

Real

Aptamer SeqId: 14615-46 | Target: KRA24 | UniProt: Q9BYR9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14615-46 | Target: KRA24 | UniProt: Q9BYR9 | TargetFullName: Keratin-associated protein 2-4 | Organisim: human | Apparent_Kd_M: 5.00067E-11

Real

Aptamer SeqId:14616-16;Target:ZN382;UniProt:Q96SR6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14616-16;Target: ZN382;UniProt: Q96SR6;TargetFullName: Zinc finger protein 382;Organisim: human;Apparent_Kd_M: 4.435869E-12

Real

Aptamer SeqId: 14616-16 | Target: ZN382 | UniProt: Q96SR6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14616-16 | Target: ZN382 | UniProt: Q96SR6 | TargetFullName: Zinc finger protein 382 | Organisim: human | Apparent_Kd_M: 4.435869E-12

Real

Aptamer SeqId:14617-7;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14617-7;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.273737E-12

Real

Aptamer SeqId: 14617-7 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14617-7 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.273737E-12

Real

Aptamer SeqId:14618-26;Target:ECOP;UniProt:Q96AW1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14618-26;Target: ECOP;UniProt: Q96AW1;TargetFullName: Vesicular; overexpressed in cancer; prosurvival protein 1;Organisim: human;Apparent_Kd_M: 4.35E-10

Real

Aptamer SeqId: 14618-26 | Target: ECOP | UniProt: Q96AW1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14618-26 | Target: ECOP | UniProt: Q96AW1 | TargetFullName: Vesicular; overexpressed in cancer; prosurvival protein 1 | Organisim: human | Apparent_Kd_M: 4.35E-10

Real

Aptamer SeqId:14619-8;Target:ZN526;UniProt:Q8TF50

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14619-8;Target: ZN526;UniProt: Q8TF50;TargetFullName: Zinc finger protein 526;Organisim: human;Apparent_Kd_M: 1.982913E-11

Real

Aptamer SeqId: 14619-8 | Target: ZN526 | UniProt: Q8TF50

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14619-8 | Target: ZN526 | UniProt: Q8TF50 | TargetFullName: Zinc finger protein 526 | Organisim: human | Apparent_Kd_M: 1.982913E-11

Real

Aptamer SeqId:14623-26;Target:SUMO3;UniProt:P55854

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14623-26;Target: SUMO3;UniProt: P55854;TargetFullName: Small ubiquitin-related modifier 3;Organisim: human;Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId: 14623-26 | Target: SUMO3 | UniProt: P55854

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14623-26 | Target: SUMO3 | UniProt: P55854 | TargetFullName: Small ubiquitin-related modifier 3 | Organisim: human | Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId:14624-51;Target:CTCF;UniProt:P49711

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14624-51;Target: CTCF;UniProt: P49711;TargetFullName: Transcriptional repressor CTCF;Organisim: human;Apparent_Kd_M: 5.031899E-12

Real

Aptamer SeqId: 14624-51 | Target: CTCF | UniProt: P49711

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14624-51 | Target: CTCF | UniProt: P49711 | TargetFullName: Transcriptional repressor CTCF | Organisim: human | Apparent_Kd_M: 5.031899E-12

Real

Aptamer SeqId:14628-72;Target:FBX3;UniProt:Q9UK99

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14628-72;Target: FBX3;UniProt: Q9UK99;TargetFullName: F-box only protein 3;Organisim: human;Apparent_Kd_M: 1.68E-10

Real

Aptamer SeqId: 14628-72 | Target: FBX3 | UniProt: Q9UK99

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14628-72 | Target: FBX3 | UniProt: Q9UK99 | TargetFullName: F-box only protein 3 | Organisim: human | Apparent_Kd_M: 1.68E-10

Real

Aptamer SeqId:14631-22;Target:DUS16;UniProt:Q9BY84

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14631-22;Target: DUS16;UniProt: Q9BY84;TargetFullName: Dual specificity protein phosphatase 16;Organisim: human;Apparent_Kd_M: 5.465475E-11

Real

Aptamer SeqId: 14631-22 | Target: DUS16 | UniProt: Q9BY84

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14631-22 | Target: DUS16 | UniProt: Q9BY84 | TargetFullName: Dual specificity protein phosphatase 16 | Organisim: human | Apparent_Kd_M: 5.465475E-11

Real

Aptamer SeqId:14633-26;Target:T185A;UniProt:Q8NFB2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14633-26;Target: T185A;UniProt: Q8NFB2;TargetFullName: Transmembrane protein 185A;Organisim: human;Apparent_Kd_M: 1.764517E-11

Real

Aptamer SeqId: 14633-26 | Target: T185A | UniProt: Q8NFB2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14633-26 | Target: T185A | UniProt: Q8NFB2 | TargetFullName: Transmembrane protein 185A | Organisim: human | Apparent_Kd_M: 1.764517E-11

Real

Aptamer SeqId:14634-13;Target:LSHR;UniProt:P22888

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14634-13;Target: LSHR;UniProt: P22888;TargetFullName: Lutropin-choriogonadotropic hormone receptor;Organisim: human;Apparent_Kd_M: 1.295774E-10

Real

Aptamer SeqId: 14634-13 | Target: LSHR | UniProt: P22888

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14634-13 | Target: LSHR | UniProt: P22888 | TargetFullName: Lutropin-choriogonadotropic hormone receptor | Organisim: human | Apparent_Kd_M: 1.295774E-10

Real

Aptamer SeqId:14635-28;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14635-28;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.78E-11

Real

Aptamer SeqId: 14635-28 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14635-28 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.78E-11

Real

Aptamer SeqId:14636-25;Target:Ribonuclease UK114;UniProt:P52758

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14636-25;Target: Ribonuclease UK114;UniProt: P52758;TargetFullName: Ribonuclease UK114;Organisim: human;Apparent_Kd_M: 6.94646E-12

Real

Aptamer SeqId: 14636-25 | Target: Ribonuclease UK114 | UniProt: P52758

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14636-25 | Target: Ribonuclease UK114 | UniProt: P52758 | TargetFullName: Ribonuclease UK114 | Organisim: human | Apparent_Kd_M: 6.94646E-12

Real

Aptamer SeqId:14645-253;Target:GSTA4;UniProt:O15217

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14645-253;Target: GSTA4;UniProt: O15217;TargetFullName: Glutathione S-transferase A4;Organisim: human;Apparent_Kd_M: 3.846705E-11

Real

Aptamer SeqId: 14645-253 | Target: GSTA4 | UniProt: O15217

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14645-253 | Target: GSTA4 | UniProt: O15217 | TargetFullName: Glutathione S-transferase A4 | Organisim: human | Apparent_Kd_M: 3.846705E-11

Real

Aptamer SeqId:14655-1;Target:DJC17;UniProt:Q9NVM6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14655-1;Target: DJC17;UniProt: Q9NVM6;TargetFullName: DnaJ homolog subfamily C member 17;Organisim: human;Apparent_Kd_M: 1.517149E-12

Real

Aptamer SeqId: 14655-1 | Target: DJC17 | UniProt: Q9NVM6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14655-1 | Target: DJC17 | UniProt: Q9NVM6 | TargetFullName: DnaJ homolog subfamily C member 17 | Organisim: human | Apparent_Kd_M: 1.517149E-12

Real

Aptamer SeqId:14662-6;Target:MZF1;UniProt:P28698

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14662-6;Target: MZF1;UniProt: P28698;TargetFullName: Myeloid zinc finger 1;Organisim: human;Apparent_Kd_M: 4.495456E-12

Real

Aptamer SeqId: 14662-6 | Target: MZF1 | UniProt: P28698

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14662-6 | Target: MZF1 | UniProt: P28698 | TargetFullName: Myeloid zinc finger 1 | Organisim: human | Apparent_Kd_M: 4.495456E-12

Real

Aptamer SeqId:14663-44;Target:RNF8;UniProt:O76064

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14663-44;Target: RNF8;UniProt: O76064;TargetFullName: E3 ubiquitin-protein ligase RNF8;Organisim: human;Apparent_Kd_M: 9.149981E-11

Real

Aptamer SeqId: 14663-44 | Target: RNF8 | UniProt: O76064

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14663-44 | Target: RNF8 | UniProt: O76064 | TargetFullName: E3 ubiquitin-protein ligase RNF8 | Organisim: human | Apparent_Kd_M: 9.149981E-11

Real

Aptamer SeqId:14670-1;Target:SKIL;UniProt:P12757

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14670-1;Target: SKIL;UniProt: P12757;TargetFullName: Ski-like protein;Organisim: human;Apparent_Kd_M: 3.511063E-11

Real

Aptamer SeqId: 14670-1 | Target: SKIL | UniProt: P12757

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14670-1 | Target: SKIL | UniProt: P12757 | TargetFullName: Ski-like protein | Organisim: human | Apparent_Kd_M: 3.511063E-11

Real

Aptamer SeqId:14674-63;Target:PACN3;UniProt:Q9UKS6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14674-63;Target: PACN3;UniProt: Q9UKS6;TargetFullName: Protein kinase C and casein kinase substrate in neurons protein 3;Organisim: human;Apparent_Kd_M: 3.123757E-11

Real

Aptamer SeqId: 14674-63 | Target: PACN3 | UniProt: Q9UKS6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14674-63 | Target: PACN3 | UniProt: Q9UKS6 | TargetFullName: Protein kinase C and casein kinase substrate in neurons protein 3 | Organisim: human | Apparent_Kd_M: 3.123757E-11

Real

Aptamer SeqId:14675-20;Target:IF4B;UniProt:P23588

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14675-20;Target: IF4B;UniProt: P23588;TargetFullName: Eukaryotic translation initiation factor 4B;Organisim: human;Apparent_Kd_M: 1.335893E-12

Real

Aptamer SeqId: 14675-20 | Target: IF4B | UniProt: P23588

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14675-20 | Target: IF4B | UniProt: P23588 | TargetFullName: Eukaryotic translation initiation factor 4B | Organisim: human | Apparent_Kd_M: 1.335893E-12

Real

Aptamer SeqId:14684-17;Target:CAN2;UniProt:P17655

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14684-17;Target: CAN2;UniProt: P17655;TargetFullName: Calpain-2 catalytic subunit;Organisim: human;Apparent_Kd_M: 1.029195E-11

Real

Aptamer SeqId: 14684-17 | Target: CAN2 | UniProt: P17655

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14684-17 | Target: CAN2 | UniProt: P17655 | TargetFullName: Calpain-2 catalytic subunit | Organisim: human | Apparent_Kd_M: 1.029195E-11

Real

Aptamer SeqId:14685-17;Target:PKB beta;UniProt:P31751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14685-17;Target: PKB beta;UniProt: P31751;TargetFullName: RAC-beta serine/threonine-protein kinase;Organisim: human;Apparent_Kd_M: 8.07E-12

Real

Aptamer SeqId: 14685-17 | Target: PKB beta | UniProt: P31751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14685-17 | Target: PKB beta | UniProt: P31751 | TargetFullName: RAC-beta serine/threonine-protein kinase | Organisim: human | Apparent_Kd_M: 8.07E-12

Real

Aptamer SeqId:14687-6;Target:M6PBP;UniProt:O60664

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14687-6;Target: M6PBP;UniProt: O60664;TargetFullName: Perilipin-3;Organisim: human;Apparent_Kd_M: 3.174483E-10

Real

Aptamer SeqId: 14687-6 | Target: M6PBP | UniProt: O60664

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14687-6 | Target: M6PBP | UniProt: O60664 | TargetFullName: Perilipin-3 | Organisim: human | Apparent_Kd_M: 3.174483E-10

Real

Aptamer SeqId:14688-6;Target:PTN7;UniProt:P35236

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14688-6;Target: PTN7;UniProt: P35236;TargetFullName: Tyrosine-protein phosphatase non-receptor type 7;Organisim: human;Apparent_Kd_M: 1.005664E-11

Real

Aptamer SeqId: 14688-6 | Target: PTN7 | UniProt: P35236

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14688-6 | Target: PTN7 | UniProt: P35236 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 7 | Organisim: human | Apparent_Kd_M: 1.005664E-11

Real

Aptamer SeqId:14689-3;Target:SEC13;UniProt:P55735

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14689-3;Target: SEC13;UniProt: P55735;TargetFullName: Protein SEC13 homolog;Organisim: human;Apparent_Kd_M: 1.966571E-11

Real

Aptamer SeqId: 14689-3 | Target: SEC13 | UniProt: P55735

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14689-3 | Target: SEC13 | UniProt: P55735 | TargetFullName: Protein SEC13 homolog | Organisim: human | Apparent_Kd_M: 1.966571E-11

Real

Aptamer SeqId:14692-3;Target:ZN276;UniProt:Q8N554

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14692-3;Target: ZN276;UniProt: Q8N554;TargetFullName: Zinc finger protein 276;Organisim: human;Apparent_Kd_M: 1.601425E-11

Real

Aptamer SeqId: 14692-3 | Target: ZN276 | UniProt: Q8N554

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14692-3 | Target: ZN276 | UniProt: Q8N554 | TargetFullName: Zinc finger protein 276 | Organisim: human | Apparent_Kd_M: 1.601425E-11

Real

Aptamer SeqId:14705-1;Target:VEGF-D;UniProt:O43915

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14705-1;Target: VEGF-D;UniProt: O43915;TargetFullName: Vascular endothelial growth factor D;Organisim: human;Apparent_Kd_M: 4.87E-11

Real

Aptamer SeqId: 14705-1 | Target: VEGF-D | UniProt: O43915

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14705-1 | Target: VEGF-D | UniProt: O43915 | TargetFullName: Vascular endothelial growth factor D | Organisim: human | Apparent_Kd_M: 4.87E-11

Real

Aptamer SeqId:14708-59;Target:CO8G;UniProt:P07360

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14708-59;Target: CO8G;UniProt: P07360;TargetFullName: Complement component C8 gamma chain;Organisim: human;Apparent_Kd_M: 2.234602E-11

Real

Aptamer SeqId: 14708-59 | Target: CO8G | UniProt: P07360

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14708-59 | Target: CO8G | UniProt: P07360 | TargetFullName: Complement component C8 gamma chain | Organisim: human | Apparent_Kd_M: 2.234602E-11

Real

Aptamer SeqId:14711-27;Target:Cystatin M;UniProt:Q15828

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14711-27;Target: Cystatin M;UniProt: Q15828;TargetFullName: Cystatin-M;Organisim: human;Apparent_Kd_M: 6.64E-12

Real

Aptamer SeqId: 14711-27 | Target: Cystatin M | UniProt: Q15828

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14711-27 | Target: Cystatin M | UniProt: Q15828 | TargetFullName: Cystatin-M | Organisim: human | Apparent_Kd_M: 6.64E-12

Real

Aptamer SeqId:14713-46;Target:Azurocidin;UniProt:P20160

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14713-46;Target: Azurocidin;UniProt: P20160;TargetFullName: Azurocidin;Organisim: human;Apparent_Kd_M: 7.14E-12

Real

Aptamer SeqId: 14713-46 | Target: Azurocidin | UniProt: P20160

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14713-46 | Target: Azurocidin | UniProt: P20160 | TargetFullName: Azurocidin | Organisim: human | Apparent_Kd_M: 7.14E-12

Real

Aptamer SeqId:14747-9;Target:CRLF1;UniProt:O75462

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14747-9;Target: CRLF1;UniProt: O75462;TargetFullName: Cytokine receptor-like factor 1;Organisim: human;Apparent_Kd_M: 4.149359E-11

Real

Aptamer SeqId: 14747-9 | Target: CRLF1 | UniProt: O75462

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14747-9 | Target: CRLF1 | UniProt: O75462 | TargetFullName: Cytokine receptor-like factor 1 | Organisim: human | Apparent_Kd_M: 4.149359E-11

Real

Aptamer SeqId:14748-31;Target:RHG05;UniProt:Q13017

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 14748-31;Target: RHG05;UniProt: Q13017;TargetFullName: Rho GTPase-activating protein 5;Organisim: human;Apparent_Kd_M: 2.457874E-12

Real

Aptamer SeqId: 14748-31 | Target: RHG05 | UniProt: Q13017

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 14748-31 | Target: RHG05 | UniProt: Q13017 | TargetFullName: Rho GTPase-activating protein 5 | Organisim: human | Apparent_Kd_M: 2.457874E-12

Real

Aptamer SeqId:15295-81;Target:IGF-II;UniProt:P01344

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15295-81;Target: IGF-II;UniProt: P01344;TargetFullName: Insulin-like growth factor II;Organisim: human;Apparent_Kd_M: 2.71E-11

Real

Aptamer SeqId: 15295-81 | Target: IGF-II | UniProt: P01344

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15295-81 | Target: IGF-II | UniProt: P01344 | TargetFullName: Insulin-like growth factor II | Organisim: human | Apparent_Kd_M: 2.71E-11

Real

Aptamer SeqId:15297-3;Target:S100A3;UniProt:P33764

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15297-3;Target: S100A3;UniProt: P33764;TargetFullName: Protein S100-A3;Organisim: human;Apparent_Kd_M: 2.59E-12

Real

Aptamer SeqId: 15297-3 | Target: S100A3 | UniProt: P33764

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15297-3 | Target: S100A3 | UniProt: P33764 | TargetFullName: Protein S100-A3 | Organisim: human | Apparent_Kd_M: 2.59E-12

Real

Aptamer SeqId:15298-199;Target:NETO1;UniProt:Q8TDF5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15298-199;Target: NETO1;UniProt: Q8TDF5;TargetFullName: Neuropilin and tolloid-like protein 1;Organisim: human;Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId: 15298-199 | Target: NETO1 | UniProt: Q8TDF5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15298-199 | Target: NETO1 | UniProt: Q8TDF5 | TargetFullName: Neuropilin and tolloid-like protein 1 | Organisim: human | Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId:15299-102;Target:MESD2;UniProt:Q14696

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15299-102;Target: MESD2;UniProt: Q14696;TargetFullName: LDLR chaperone MESD;Organisim: human;Apparent_Kd_M: 4.52E-12

Real

Aptamer SeqId: 15299-102 | Target: MESD2 | UniProt: Q14696

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15299-102 | Target: MESD2 | UniProt: Q14696 | TargetFullName: LDLR chaperone MESD | Organisim: human | Apparent_Kd_M: 4.52E-12

Real

Aptamer SeqId:15300-66;Target:CC134;UniProt:Q9H6E4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15300-66;Target: CC134;UniProt: Q9H6E4;TargetFullName: Coiled-coil domain-containing protein 134;Organisim: human;Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId: 15300-66 | Target: CC134 | UniProt: Q9H6E4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15300-66 | Target: CC134 | UniProt: Q9H6E4 | TargetFullName: Coiled-coil domain-containing protein 134 | Organisim: human | Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId:15301-24;Target:sperm protein 10;UniProt:P26436

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15301-24;Target: sperm protein 10;UniProt: P26436;TargetFullName: Acrosomal protein SP-10;Organisim: human;Apparent_Kd_M: 4.54E-10

Real

Aptamer SeqId: 15301-24 | Target: sperm protein 10 | UniProt: P26436

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15301-24 | Target: sperm protein 10 | UniProt: P26436 | TargetFullName: Acrosomal protein SP-10 | Organisim: human | Apparent_Kd_M: 4.54E-10

Real

Aptamer SeqId:15303-63;Target:S100A5;UniProt:P33763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15303-63;Target: S100A5;UniProt: P33763;TargetFullName: Protein S100-A5;Organisim: human;Apparent_Kd_M: 5.3E-11

Real

Aptamer SeqId: 15303-63 | Target: S100A5 | UniProt: P33763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15303-63 | Target: S100A5 | UniProt: P33763 | TargetFullName: Protein S100-A5 | Organisim: human | Apparent_Kd_M: 5.3E-11

Real

Aptamer SeqId:15304-1;Target:PAP1;UniProt:Q06141

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15304-1;Target: PAP1;UniProt: Q06141;TargetFullName: Regenerating islet-derived protein 3-alpha;Organisim: human;Apparent_Kd_M: 1.23E-12

Real

Aptamer SeqId: 15304-1 | Target: PAP1 | UniProt: Q06141

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15304-1 | Target: PAP1 | UniProt: Q06141 | TargetFullName: Regenerating islet-derived protein 3-alpha | Organisim: human | Apparent_Kd_M: 1.23E-12

Real

Aptamer SeqId:15305-7;Target:Secretagogin;UniProt:O76038

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15305-7;Target: Secretagogin;UniProt: O76038;TargetFullName: Secretagogin;Organisim: human;Apparent_Kd_M: 2.49E-12

Real

Aptamer SeqId: 15305-7 | Target: Secretagogin | UniProt: O76038

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15305-7 | Target: Secretagogin | UniProt: O76038 | TargetFullName: Secretagogin | Organisim: human | Apparent_Kd_M: 2.49E-12

Real

Aptamer SeqId:15306-20;Target:IgJ;UniProt:P01591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15306-20;Target: IgJ;UniProt: P01591;TargetFullName: Immunoglobulin J chain;Organisim: human;Apparent_Kd_M: 4.35E-11

Real

Aptamer SeqId: 15306-20 | Target: IgJ | UniProt: P01591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15306-20 | Target: IgJ | UniProt: P01591 | TargetFullName: Immunoglobulin J chain | Organisim: human | Apparent_Kd_M: 4.35E-11

Real

Aptamer SeqId:15308-108;Target:VWC2;UniProt:Q2TAL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15308-108;Target: VWC2;UniProt: Q2TAL6;TargetFullName: Brorin;Organisim: human;Apparent_Kd_M: 3.18E-12

Real

Aptamer SeqId: 15308-108 | Target: VWC2 | UniProt: Q2TAL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15308-108 | Target: VWC2 | UniProt: Q2TAL6 | TargetFullName: Brorin | Organisim: human | Apparent_Kd_M: 3.18E-12

Real

Aptamer SeqId:15310-61;Target:PRC1;UniProt:O43663

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15310-61;Target: PRC1;UniProt: O43663;TargetFullName: Protein regulator of cytokinesis 1;Organisim: human;Apparent_Kd_M: 5.5E-11

Real

Aptamer SeqId: 15310-61 | Target: PRC1 | UniProt: O43663

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15310-61 | Target: PRC1 | UniProt: O43663 | TargetFullName: Protein regulator of cytokinesis 1 | Organisim: human | Apparent_Kd_M: 5.5E-11

Real

Aptamer SeqId:15312-14;Target:AGO1;UniProt:Q9UL18

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15312-14;Target: AGO1;UniProt: Q9UL18;TargetFullName: Protein argonaute-1;Organisim: human;Apparent_Kd_M: 2.56E-12

Real

Aptamer SeqId: 15312-14 | Target: AGO1 | UniProt: Q9UL18

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15312-14 | Target: AGO1 | UniProt: Q9UL18 | TargetFullName: Protein argonaute-1 | Organisim: human | Apparent_Kd_M: 2.56E-12

Real

Aptamer SeqId:15313-28;Target:MD2L1;UniProt:Q13257

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15313-28;Target: MD2L1;UniProt: Q13257;TargetFullName: Mitotic spindle assembly checkpoint protein MAD2A;Organisim: human;Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId: 15313-28 | Target: MD2L1 | UniProt: Q13257

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15313-28 | Target: MD2L1 | UniProt: Q13257 | TargetFullName: Mitotic spindle assembly checkpoint protein MAD2A | Organisim: human | Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId:15314-49;Target:CLIC4;UniProt:Q9Y696

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15314-49;Target: CLIC4;UniProt: Q9Y696;TargetFullName: Chloride intracellular channel protein 4;Organisim: human;Apparent_Kd_M: 9.13E-13

Real

Aptamer SeqId: 15314-49 | Target: CLIC4 | UniProt: Q9Y696

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15314-49 | Target: CLIC4 | UniProt: Q9Y696 | TargetFullName: Chloride intracellular channel protein 4 | Organisim: human | Apparent_Kd_M: 9.13E-13

Real

Aptamer SeqId:15315-64;Target:CUTC;UniProt:Q9NTM9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15315-64;Target: CUTC;UniProt: Q9NTM9;TargetFullName: Copper homeostasis protein cutC homolog;Organisim: human;Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId: 15315-64 | Target: CUTC | UniProt: Q9NTM9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15315-64 | Target: CUTC | UniProt: Q9NTM9 | TargetFullName: Copper homeostasis protein cutC homolog | Organisim: human | Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId:15316-262;Target:TXN4B;UniProt:Q9NX01

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15316-262;Target: TXN4B;UniProt: Q9NX01;TargetFullName: Thioredoxin-like protein 4B;Organisim: human;Apparent_Kd_M: 1.37E-12

Real

Aptamer SeqId: 15316-262 | Target: TXN4B | UniProt: Q9NX01

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15316-262 | Target: TXN4B | UniProt: Q9NX01 | TargetFullName: Thioredoxin-like protein 4B | Organisim: human | Apparent_Kd_M: 1.37E-12

Real

Aptamer SeqId:15318-75;Target:Calpactin I light chain;UniProt:P60903

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15318-75;Target: Calpactin I light chain;UniProt: P60903;TargetFullName: Protein S100-A10;Organisim: human;Apparent_Kd_M: 3.76E-11

Real

Aptamer SeqId: 15318-75 | Target: Calpactin I light chain | UniProt: P60903

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15318-75 | Target: Calpactin I light chain | UniProt: P60903 | TargetFullName: Protein S100-A10 | Organisim: human | Apparent_Kd_M: 3.76E-11

Real

Aptamer SeqId:15319-226;Target:CCNA1;UniProt:P78396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15319-226;Target: CCNA1;UniProt: P78396;TargetFullName: Cyclin-A1;Organisim: human;Apparent_Kd_M: 4.566387E-12

Real

Aptamer SeqId: 15319-226 | Target: CCNA1 | UniProt: P78396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15319-226 | Target: CCNA1 | UniProt: P78396 | TargetFullName: Cyclin-A1 | Organisim: human | Apparent_Kd_M: 4.566387E-12

Real

Aptamer SeqId:15321-8;Target:CPLX2;UniProt:Q6PUV4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15321-8;Target: CPLX2;UniProt: Q6PUV4;TargetFullName: Complexin-2;Organisim: human;Apparent_Kd_M: 5.37E-13

Real

Aptamer SeqId: 15321-8 | Target: CPLX2 | UniProt: Q6PUV4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15321-8 | Target: CPLX2 | UniProt: Q6PUV4 | TargetFullName: Complexin-2 | Organisim: human | Apparent_Kd_M: 5.37E-13

Real

Aptamer SeqId:15322-35;Target:CRADD;UniProt:P78560

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15322-35;Target: CRADD;UniProt: P78560;TargetFullName: Death domain-containing protein CRADD;Organisim: human;Apparent_Kd_M: 1.991715E-11

Real

Aptamer SeqId: 15322-35 | Target: CRADD | UniProt: P78560

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15322-35 | Target: CRADD | UniProt: P78560 | TargetFullName: Death domain-containing protein CRADD | Organisim: human | Apparent_Kd_M: 1.991715E-11

Real

Aptamer SeqId:15323-112;Target:AGO3;UniProt:Q9H9G7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15323-112;Target: AGO3;UniProt: Q9H9G7;TargetFullName: Protein argonaute-3;Organisim: human;Apparent_Kd_M: 2.187586E-10

Real

Aptamer SeqId: 15323-112 | Target: AGO3 | UniProt: Q9H9G7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15323-112 | Target: AGO3 | UniProt: Q9H9G7 | TargetFullName: Protein argonaute-3 | Organisim: human | Apparent_Kd_M: 2.187586E-10

Real

Aptamer SeqId:15324-58;Target:Ferritin light chain;UniProt:P02792

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15324-58;Target: Ferritin light chain;UniProt: P02792;TargetFullName: Ferritin light chain;Organisim: human;Apparent_Kd_M: 3.04E-11

Real

Aptamer SeqId: 15324-58 | Target: Ferritin light chain | UniProt: P02792

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15324-58 | Target: Ferritin light chain | UniProt: P02792 | TargetFullName: Ferritin light chain | Organisim: human | Apparent_Kd_M: 3.04E-11

Real

Aptamer SeqId:15325-14;Target:NEUM;UniProt:P17677

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15325-14;Target: NEUM;UniProt: P17677;TargetFullName: Neuromodulin;Organisim: human;Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId: 15325-14 | Target: NEUM | UniProt: P17677

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15325-14 | Target: NEUM | UniProt: P17677 | TargetFullName: Neuromodulin | Organisim: human | Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId:15326-64;Target:GBP1;UniProt:P32455

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15326-64;Target: GBP1;UniProt: P32455;TargetFullName: Guanylate-binding protein 1;Organisim: human;Apparent_Kd_M: 1.39E-12

Real

Aptamer SeqId: 15326-64 | Target: GBP1 | UniProt: P32455

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15326-64 | Target: GBP1 | UniProt: P32455 | TargetFullName: Guanylate-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.39E-12

Real

Aptamer SeqId:15329-167;Target:MAPIP;UniProt:Q9Y2Q5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15329-167;Target: MAPIP;UniProt: Q9Y2Q5;TargetFullName: Ragulator complex protein LAMTOR2;Organisim: human;Apparent_Kd_M: 1.594153E-11

Real

Aptamer SeqId: 15329-167 | Target: MAPIP | UniProt: Q9Y2Q5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15329-167 | Target: MAPIP | UniProt: Q9Y2Q5 | TargetFullName: Ragulator complex protein LAMTOR2 | Organisim: human | Apparent_Kd_M: 1.594153E-11

Real

Aptamer SeqId:15331-47;Target:RBBP4;UniProt:Q09028

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15331-47;Target: RBBP4;UniProt: Q09028;TargetFullName: Histone-binding protein RBBP4;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 15331-47 | Target: RBBP4 | UniProt: Q09028

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15331-47 | Target: RBBP4 | UniProt: Q09028 | TargetFullName: Histone-binding protein RBBP4 | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:15333-11;Target:SDF2;UniProt:Q99470

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15333-11;Target: SDF2;UniProt: Q99470;TargetFullName: Stromal cell-derived factor 2;Organisim: human;Apparent_Kd_M: 2.72E-11

Real

Aptamer SeqId: 15333-11 | Target: SDF2 | UniProt: Q99470

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15333-11 | Target: SDF2 | UniProt: Q99470 | TargetFullName: Stromal cell-derived factor 2 | Organisim: human | Apparent_Kd_M: 2.72E-11

Real

Aptamer SeqId:15336-7;Target:SELM;UniProt:Q8WWX9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15336-7;Target: SELM;UniProt: Q8WWX9;TargetFullName: Selenoprotein M;Organisim: human;Apparent_Kd_M: 1.863418E-12

Real

Aptamer SeqId: 15336-7 | Target: SELM | UniProt: Q8WWX9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15336-7 | Target: SELM | UniProt: Q8WWX9 | TargetFullName: Selenoprotein M | Organisim: human | Apparent_Kd_M: 1.863418E-12

Real

Aptamer SeqId:15339-32;Target:COF2;UniProt:Q9Y281

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15339-32;Target: COF2;UniProt: Q9Y281;TargetFullName: Cofilin-2;Organisim: human;Apparent_Kd_M: 7.864838E-11

Real

Aptamer SeqId: 15339-32 | Target: COF2 | UniProt: Q9Y281

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15339-32 | Target: COF2 | UniProt: Q9Y281 | TargetFullName: Cofilin-2 | Organisim: human | Apparent_Kd_M: 7.864838E-11

Real

Aptamer SeqId:15343-337;Target:Kininogen; HMW; Two Chain;UniProt:P01042

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15343-337;Target: Kininogen; HMW; Two Chain;UniProt: P01042;TargetFullName: Kininogen; HMW; Two Chain;Organisim: human;Apparent_Kd_M: 5.22E-11

Real

Aptamer SeqId: 15343-337 | Target: Kininogen HMW Two Chain

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15343-337 | Target: Kininogen; HMW; Two Chain | UniProt: P01042 | TargetFullName: Kininogen; HMW; Two Chain | Organisim: human | Apparent_Kd_M: 5.22E-11

Real

Aptamer SeqId:15346-31;Target:IFN-g;UniProt:P01579

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15346-31;Target: IFN-g;UniProt: P01579;TargetFullName: Interferon gamma;Organisim: human;Apparent_Kd_M: 6.758157E-11

Real

Aptamer SeqId: 15346-31 | Target: IFN-g | UniProt: P01579

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15346-31 | Target: IFN-g | UniProt: P01579 | TargetFullName: Interferon gamma | Organisim: human | Apparent_Kd_M: 6.758157E-11

Real

Aptamer SeqId:15347-12;Target:Hemopexin;UniProt:P02790

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15347-12;Target: Hemopexin;UniProt: P02790;TargetFullName: Hemopexin;Organisim: human;Apparent_Kd_M: 1.75E-12

Real

Aptamer SeqId: 15347-12 | Target: Hemopexin | UniProt: P02790

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15347-12 | Target: Hemopexin | UniProt: P02790 | TargetFullName: Hemopexin | Organisim: human | Apparent_Kd_M: 1.75E-12

Real

Aptamer SeqId:15358-28;Target:7B2;UniProt:P05408

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15358-28;Target: 7B2;UniProt: P05408;TargetFullName: Neuroendocrine protein 7B2;Organisim: human;Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId: 15358-28 | Target: 7B2 | UniProt: P05408

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15358-28 | Target: 7B2 | UniProt: P05408 | TargetFullName: Neuroendocrine protein 7B2 | Organisim: human | Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId:15361-37;Target:ANKR1;UniProt:Q15327

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15361-37;Target: ANKR1;UniProt: Q15327;TargetFullName: Ankyrin repeat domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 15361-37 | Target: ANKR1 | UniProt: Q15327

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15361-37 | Target: ANKR1 | UniProt: Q15327 | TargetFullName: Ankyrin repeat domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:15363-32;Target:Apo A-V;UniProt:Q6Q788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15363-32;Target: Apo A-V;UniProt: Q6Q788;TargetFullName: Apolipoprotein A-V;Organisim: human;Apparent_Kd_M: 4.01E-11

Real

Aptamer SeqId: 15363-32 | Target: Apo A-V | UniProt: Q6Q788

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15363-32 | Target: Apo A-V | UniProt: Q6Q788 | TargetFullName: Apolipoprotein A-V | Organisim: human | Apparent_Kd_M: 4.01E-11

Real

Aptamer SeqId:15364-101;Target:Apo C-I;UniProt:P02654

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15364-101;Target: Apo C-I;UniProt: P02654;TargetFullName: Apolipoprotein C-I;Organisim: human;Apparent_Kd_M: 3.43E-12

Real

Aptamer SeqId: 15364-101 | Target: Apo C-I | UniProt: P02654

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15364-101 | Target: Apo C-I | UniProt: P02654 | TargetFullName: Apolipoprotein C-I | Organisim: human | Apparent_Kd_M: 3.43E-12

Real

Aptamer SeqId:15365-41;Target:BAI3;UniProt:O60242

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15365-41;Target: BAI3;UniProt: O60242;TargetFullName: Adhesion G protein-coupled receptor B3;Organisim: human;Apparent_Kd_M: 6.0E-12

Real

Aptamer SeqId: 15365-41 | Target: BAI3 | UniProt: O60242

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15365-41 | Target: BAI3 | UniProt: O60242 | TargetFullName: Adhesion G protein-coupled receptor B3 | Organisim: human | Apparent_Kd_M: 6.0E-12

Real

Aptamer SeqId:15367-38;Target:LPLC1;UniProt:Q8TDL5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15367-38;Target: LPLC1;UniProt: Q8TDL5;TargetFullName: BPI fold-containing family B member 1;Organisim: human;Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId: 15367-38 | Target: LPLC1 | UniProt: Q8TDL5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15367-38 | Target: LPLC1 | UniProt: Q8TDL5 | TargetFullName: BPI fold-containing family B member 1 | Organisim: human | Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId:15368-3;Target:BMPER;UniProt:Q8N8U9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15368-3;Target: BMPER;UniProt: Q8N8U9;TargetFullName: BMP-binding endothelial regulator protein;Organisim: human;Apparent_Kd_M: 5.13E-12

Real

Aptamer SeqId: 15368-3 | Target: BMPER | UniProt: Q8N8U9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15368-3 | Target: BMPER | UniProt: Q8N8U9 | TargetFullName: BMP-binding endothelial regulator protein | Organisim: human | Apparent_Kd_M: 5.13E-12

Real

Aptamer SeqId:15370-5;Target:BOLA1;UniProt:Q9Y3E2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15370-5;Target: BOLA1;UniProt: Q9Y3E2;TargetFullName: BolA-like protein 1;Organisim: human;Apparent_Kd_M: 1.66E-12

Real

Aptamer SeqId: 15370-5 | Target: BOLA1 | UniProt: Q9Y3E2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15370-5 | Target: BOLA1 | UniProt: Q9Y3E2 | TargetFullName: BolA-like protein 1 | Organisim: human | Apparent_Kd_M: 1.66E-12

Real

Aptamer SeqId:15372-43;Target:BRD2;UniProt:P25440

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15372-43;Target: BRD2;UniProt: P25440;TargetFullName: Bromodomain-containing protein 2;Organisim: human;Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId: 15372-43 | Target: BRD2 | UniProt: P25440

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15372-43 | Target: BRD2 | UniProt: P25440 | TargetFullName: Bromodomain-containing protein 2 | Organisim: human | Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId:15374-15;Target:CA11 protein;UniProt:Q9NS71

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15374-15;Target: CA11 protein;UniProt: Q9NS71;TargetFullName: Gastrokine-1;Organisim: human;Apparent_Kd_M: 1.68E-10

Real

Aptamer SeqId: 15374-15 | Target: CA11 protein | UniProt: Q9NS71

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15374-15 | Target: CA11 protein | UniProt: Q9NS71 | TargetFullName: Gastrokine-1 | Organisim: human | Apparent_Kd_M: 1.68E-10

Real

Aptamer SeqId:15375-49;Target:Carboxypeptidase B1;UniProt:P15086

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15375-49;Target: Carboxypeptidase B1;UniProt: P15086;TargetFullName: Carboxypeptidase B;Organisim: human;Apparent_Kd_M: 3.41E-12

Real

Aptamer SeqId: 15375-49 | Target: Carboxypeptidase B1 | UniProt: P15086

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15375-49 | Target: Carboxypeptidase B1 | UniProt: P15086 | TargetFullName: Carboxypeptidase B | Organisim: human | Apparent_Kd_M: 3.41E-12

Real

Aptamer SeqId:15376-134;Target:CATE;UniProt:P14091

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15376-134;Target: CATE;UniProt: P14091;TargetFullName: Cathepsin E;Organisim: human;Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId: 15376-134 | Target: CATE | UniProt: P14091

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15376-134 | Target: CATE | UniProt: P14091 | TargetFullName: Cathepsin E | Organisim: human | Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId:15381-45;Target:Discoidin domain receptor 2;UniProt:Q16832

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15381-45;Target: Discoidin domain receptor 2;UniProt: Q16832;TargetFullName: Discoidin domain-containing receptor 2;Organisim: human;Apparent_Kd_M: 4.44E-11

Real

Aptamer SeqId: 15381-45 | Target: Discoidin domain receptor 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15381-45 | Target: Discoidin domain receptor 2 | UniProt: Q16832 | TargetFullName: Discoidin domain-containing receptor 2 | Organisim: human | Apparent_Kd_M: 4.44E-11

Real

Aptamer SeqId:15383-200;Target:Endothelin 3;UniProt:P14138

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15383-200;Target: Endothelin 3;UniProt: P14138;TargetFullName: Endothelin-3;Organisim: human;Apparent_Kd_M: 6.85E-11

Real

Aptamer SeqId: 15383-200 | Target: Endothelin 3 | UniProt: P14138

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15383-200 | Target: Endothelin 3 | UniProt: P14138 | TargetFullName: Endothelin-3 | Organisim: human | Apparent_Kd_M: 6.85E-11

Real

Aptamer SeqId:15384-15;Target:KLOTHO;UniProt:Q9UEF7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15384-15;Target: KLOTHO;UniProt: Q9UEF7;TargetFullName: Klotho;Organisim: human;Apparent_Kd_M: 1.33E-12

Real

Aptamer SeqId: 15384-15 | Target: KLOTHO | UniProt: Q9UEF7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15384-15 | Target: KLOTHO | UniProt: Q9UEF7 | TargetFullName: Klotho | Organisim: human | Apparent_Kd_M: 1.33E-12

Real

Aptamer SeqId:15385-116;Target:FABP2;UniProt:P12104

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15385-116;Target: FABP2;UniProt: P12104;TargetFullName: Fatty acid-binding protein; intestinal;Organisim: human;Apparent_Kd_M: 1.4E-12

Real

Aptamer SeqId: 15385-116 | Target: FABP2 | UniProt: P12104

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15385-116 | Target: FABP2 | UniProt: P12104 | TargetFullName: Fatty acid-binding protein; intestinal | Organisim: human | Apparent_Kd_M: 1.4E-12

Real

Aptamer SeqId:15386-7;Target:FABPA;UniProt:P15090

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15386-7;Target: FABPA;UniProt: P15090;TargetFullName: Fatty acid-binding protein; adipocyte;Organisim: human;Apparent_Kd_M: 2.73E-12

Real

Aptamer SeqId: 15386-7 | Target: FABPA | UniProt: P15090

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15386-7 | Target: FABPA | UniProt: P15090 | TargetFullName: Fatty acid-binding protein; adipocyte | Organisim: human | Apparent_Kd_M: 2.73E-12

Real

Aptamer SeqId:15387-44;Target:Neuropilin-2;UniProt:O60462

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15387-44;Target: Neuropilin-2;UniProt: O60462;TargetFullName: Neuropilin-2;Organisim: human;Apparent_Kd_M: 7.14E-13

Real

Aptamer SeqId: 15387-44 | Target: Neuropilin-2 | UniProt: O60462

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15387-44 | Target: Neuropilin-2 | UniProt: O60462 | TargetFullName: Neuropilin-2 | Organisim: human | Apparent_Kd_M: 7.14E-13

Real

Aptamer SeqId:15388-24;Target:FcRIIIa;UniProt:P08637

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15388-24;Target: FcRIIIa;UniProt: P08637;TargetFullName: Low affinity immunoglobulin gamma Fc region receptor III-A;Organisim: human;Apparent_Kd_M: 3.29E-11

Real

Aptamer SeqId: 15388-24 | Target: FcRIIIa | UniProt: P08637

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15388-24 | Target: FcRIIIa | UniProt: P08637 | TargetFullName: Low affinity immunoglobulin gamma Fc region receptor III-A | Organisim: human | Apparent_Kd_M: 3.29E-11

Real

Aptamer SeqId:15389-1;Target:FRDA;UniProt:Q16595

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15389-1;Target: FRDA;UniProt: Q16595;TargetFullName: Frataxin; mitochondrial;Organisim: human;Apparent_Kd_M: 9.52E-12

Real

Aptamer SeqId: 15389-1 | Target: FRDA | UniProt: Q16595

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15389-1 | Target: FRDA | UniProt: Q16595 | TargetFullName: Frataxin; mitochondrial | Organisim: human | Apparent_Kd_M: 9.52E-12

Real

Aptamer SeqId:15390-3;Target:Galanin;UniProt:P22466

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15390-3;Target: Galanin;UniProt: P22466;TargetFullName: Galanin;Organisim: human;Apparent_Kd_M: 2.51E-11

Real

Aptamer SeqId: 15390-3 | Target: Galanin | UniProt: P22466

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15390-3 | Target: Galanin | UniProt: P22466 | TargetFullName: Galanin | Organisim: human | Apparent_Kd_M: 2.51E-11

Real

Aptamer SeqId:15391-114;Target:GAS-6;UniProt:Q14393

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15391-114;Target: GAS-6;UniProt: Q14393;TargetFullName: Growth arrest-specific protein 6;Organisim: human;Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId: 15391-114 | Target: GAS-6 | UniProt: Q14393

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15391-114 | Target: GAS-6 | UniProt: Q14393 | TargetFullName: Growth arrest-specific protein 6 | Organisim: human | Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId:15394-79;Target:UNC5B;UniProt:Q8IZJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15394-79;Target: UNC5B;UniProt: Q8IZJ1;TargetFullName: Netrin receptor UNC5B;Organisim: human;Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId: 15394-79 | Target: UNC5B | UniProt: Q8IZJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15394-79 | Target: UNC5B | UniProt: Q8IZJ1 | TargetFullName: Netrin receptor UNC5B | Organisim: human | Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId:15395-15;Target:GST M1-1;UniProt:P09488

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15395-15;Target: GST M1-1;UniProt: P09488;TargetFullName: Glutathione S-transferase Mu 1;Organisim: human;Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId: 15395-15 | Target: GST M1-1 | UniProt: P09488

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15395-15 | Target: GST M1-1 | UniProt: P09488 | TargetFullName: Glutathione S-transferase Mu 1 | Organisim: human | Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId:15398-2;Target:HERV1;UniProt:P55789

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15398-2;Target: HERV1;UniProt: P55789;TargetFullName: FAD-linked sulfhydryl oxidase ALR;Organisim: human;Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId: 15398-2 | Target: HERV1 | UniProt: P55789

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15398-2 | Target: HERV1 | UniProt: P55789 | TargetFullName: FAD-linked sulfhydryl oxidase ALR | Organisim: human | Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId:15402-2;Target:ID-1;UniProt:P41134

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15402-2;Target: ID-1;UniProt: P41134;TargetFullName: DNA-binding protein inhibitor ID-1;Organisim: human;Apparent_Kd_M: 2.18E-11

Real

Aptamer SeqId: 15402-2 | Target: ID-1 | UniProt: P41134

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15402-2 | Target: ID-1 | UniProt: P41134 | TargetFullName: DNA-binding protein inhibitor ID-1 | Organisim: human | Apparent_Kd_M: 2.18E-11

Real

Aptamer SeqId:15403-53;Target:ID2;UniProt:Q02363

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15403-53;Target: ID2;UniProt: Q02363;TargetFullName: DNA-binding protein inhibitor ID-2;Organisim: human;Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId: 15403-53 | Target: ID2 | UniProt: Q02363

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15403-53 | Target: ID2 | UniProt: Q02363 | TargetFullName: DNA-binding protein inhibitor ID-2 | Organisim: human | Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId:15404-3;Target:IFN21;UniProt:P01568

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15404-3;Target: IFN21;UniProt: P01568;TargetFullName: Interferon alpha-21;Organisim: human;Apparent_Kd_M: 2.64E-12

Real

Aptamer SeqId: 15404-3 | Target: IFN21 | UniProt: P01568

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15404-3 | Target: IFN21 | UniProt: P01568 | TargetFullName: Interferon alpha-21 | Organisim: human | Apparent_Kd_M: 2.64E-12

Real

Aptamer SeqId:15405-23;Target:IFNA4;UniProt:P05014

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15405-23;Target: IFNA4;UniProt: P05014;TargetFullName: Interferon alpha-4;Organisim: human;Apparent_Kd_M: 2.79E-12

Real

Aptamer SeqId: 15405-23 | Target: IFNA4 | UniProt: P05014

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15405-23 | Target: IFNA4 | UniProt: P05014 | TargetFullName: Interferon alpha-4 | Organisim: human | Apparent_Kd_M: 2.79E-12

Real

Aptamer SeqId:15412-40;Target:KIAP;UniProt:Q96CA5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15412-40;Target: KIAP;UniProt: Q96CA5;TargetFullName: Baculoviral IAP repeat-containing protein 7;Organisim: human;Apparent_Kd_M: 2.53E-11

Real

Aptamer SeqId: 15412-40 | Target: KIAP | UniProt: Q96CA5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15412-40 | Target: KIAP | UniProt: Q96CA5 | TargetFullName: Baculoviral IAP repeat-containing protein 7 | Organisim: human | Apparent_Kd_M: 2.53E-11

Real

Aptamer SeqId:15413-3;Target:LCAT;UniProt:P04180

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15413-3;Target: LCAT;UniProt: P04180;TargetFullName: Phosphatidylcholine-sterol acyltransferase;Organisim: human;Apparent_Kd_M: 5.88E-12

Real

Aptamer SeqId: 15413-3 | Target: LCAT | UniProt: P04180

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15413-3 | Target: LCAT | UniProt: P04180 | TargetFullName: Phosphatidylcholine-sterol acyltransferase | Organisim: human | Apparent_Kd_M: 5.88E-12

Real

Aptamer SeqId:15414-316;Target:LDHA;UniProt:P00338

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15414-316;Target: LDHA;UniProt: P00338;TargetFullName: L-lactate dehydrogenase A chain;Organisim: human;Apparent_Kd_M: 8.36E-12

Real

Aptamer SeqId: 15414-316 | Target: LDHA | UniProt: P00338

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15414-316 | Target: LDHA | UniProt: P00338 | TargetFullName: L-lactate dehydrogenase A chain | Organisim: human | Apparent_Kd_M: 8.36E-12

Real

Aptamer SeqId:15416-54;Target:LYG2;UniProt:Q86SG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15416-54;Target: LYG2;UniProt: Q86SG7;TargetFullName: Lysozyme g-like protein 2;Organisim: human;Apparent_Kd_M: 1.83E-11

Real

Aptamer SeqId: 15416-54 | Target: LYG2 | UniProt: Q86SG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15416-54 | Target: LYG2 | UniProt: Q86SG7 | TargetFullName: Lysozyme g-like protein 2 | Organisim: human | Apparent_Kd_M: 1.83E-11

Real

Aptamer SeqId:15417-3;Target:Maspin;UniProt:P36952

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15417-3;Target: Maspin;UniProt: P36952;TargetFullName: Serpin B5;Organisim: human;Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId: 15417-3 | Target: Maspin | UniProt: P36952

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15417-3 | Target: Maspin | UniProt: P36952 | TargetFullName: Serpin B5 | Organisim: human | Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId:15418-25;Target:MK10;UniProt:P53779

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15418-25;Target: MK10;UniProt: P53779;TargetFullName: Mitogen-activated protein kinase 10;Organisim: human;Apparent_Kd_M: 2.03E-12

Real

Aptamer SeqId: 15418-25 | Target: MK10 | UniProt: P53779

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15418-25 | Target: MK10 | UniProt: P53779 | TargetFullName: Mitogen-activated protein kinase 10 | Organisim: human | Apparent_Kd_M: 2.03E-12

Real

Aptamer SeqId:15419-15;Target:MMP20;UniProt:O60882

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15419-15;Target: MMP20;UniProt: O60882;TargetFullName: Matrix metalloproteinase-20;Organisim: human;Apparent_Kd_M: 1.36E-11

Real

Aptamer SeqId: 15419-15 | Target: MMP20 | UniProt: O60882

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15419-15 | Target: MMP20 | UniProt: O60882 | TargetFullName: Matrix metalloproteinase-20 | Organisim: human | Apparent_Kd_M: 1.36E-11

Real

Aptamer SeqId:15422-12;Target:MYP2;UniProt:P02689

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15422-12;Target: MYP2;UniProt: P02689;TargetFullName: Myelin P2 protein;Organisim: human;Apparent_Kd_M: 5.52E-12

Real

Aptamer SeqId: 15422-12 | Target: MYP2 | UniProt: P02689

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15422-12 | Target: MYP2 | UniProt: P02689 | TargetFullName: Myelin P2 protein | Organisim: human | Apparent_Kd_M: 5.52E-12

Real

Aptamer SeqId:15426-5;Target:NEUR1;UniProt:Q99519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15426-5;Target: NEUR1;UniProt: Q99519;TargetFullName: Sialidase-1;Organisim: human;Apparent_Kd_M: 9.93E-12

Real

Aptamer SeqId: 15426-5 | Target: NEUR1 | UniProt: Q99519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15426-5 | Target: NEUR1 | UniProt: Q99519 | TargetFullName: Sialidase-1 | Organisim: human | Apparent_Kd_M: 9.93E-12

Real

Aptamer SeqId:15427-35;Target:LOXL3;UniProt:P58215

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15427-35;Target: LOXL3;UniProt: P58215;TargetFullName: Lysyl oxidase homolog 3;Organisim: human;Apparent_Kd_M: 1.94E-12

Real

Aptamer SeqId: 15427-35 | Target: LOXL3 | UniProt: P58215

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15427-35 | Target: LOXL3 | UniProt: P58215 | TargetFullName: Lysyl oxidase homolog 3 | Organisim: human | Apparent_Kd_M: 1.94E-12

Real

Aptamer SeqId:15430-165;Target:OPT;UniProt:Q9UBM4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15430-165;Target: OPT;UniProt: Q9UBM4;TargetFullName: Opticin;Organisim: human;Apparent_Kd_M: 2.68E-11

Real

Aptamer SeqId: 15430-165 | Target: OPT | UniProt: Q9UBM4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15430-165 | Target: OPT | UniProt: Q9UBM4 | TargetFullName: Opticin | Organisim: human | Apparent_Kd_M: 2.68E-11

Real

Aptamer SeqId:15431-31;Target:OTCase;UniProt:P00480

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15431-31;Target: OTCase;UniProt: P00480;TargetFullName: Ornithine carbamoyltransferase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.73E-12

Real

Aptamer SeqId: 15431-31 | Target: OTCase | UniProt: P00480

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15431-31 | Target: OTCase | UniProt: P00480 | TargetFullName: Ornithine carbamoyltransferase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.73E-12

Real

Aptamer SeqId:15432-1;Target:Otoraplin;UniProt:Q9NRC9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15432-1;Target: Otoraplin;UniProt: Q9NRC9;TargetFullName: Otoraplin;Organisim: human;Apparent_Kd_M: 6.68E-11

Real

Aptamer SeqId: 15432-1 | Target: Otoraplin | UniProt: Q9NRC9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15432-1 | Target: Otoraplin | UniProt: Q9NRC9 | TargetFullName: Otoraplin | Organisim: human | Apparent_Kd_M: 6.68E-11

Real

Aptamer SeqId:15433-4;Target:p60-Src;UniProt:P12931

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15433-4;Target: p60-Src;UniProt: P12931;TargetFullName: Proto-oncogene tyrosine-protein kinase Src;Organisim: human;Apparent_Kd_M: 1.95E-12

Real

Aptamer SeqId: 15433-4 | Target: p60-Src | UniProt: P12931

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15433-4 | Target: p60-Src | UniProt: P12931 | TargetFullName: Proto-oncogene tyrosine-protein kinase Src | Organisim: human | Apparent_Kd_M: 1.95E-12

Real

Aptamer SeqId:15434-5;Target:PNOC;UniProt:Q13519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15434-5;Target: PNOC;UniProt: Q13519;TargetFullName: Prepronociceptin;Organisim: human;Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId: 15434-5 | Target: PNOC | UniProt: Q13519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15434-5 | Target: PNOC | UniProt: Q13519 | TargetFullName: Prepronociceptin | Organisim: human | Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId:15435-4;Target:PNP;UniProt:P00491

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15435-4;Target: PNP;UniProt: P00491;TargetFullName: Purine nucleoside phosphorylase;Organisim: human;Apparent_Kd_M: 9.23E-12

Real

Aptamer SeqId: 15435-4 | Target: PNP | UniProt: P00491

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15435-4 | Target: PNP | UniProt: P00491 | TargetFullName: Purine nucleoside phosphorylase | Organisim: human | Apparent_Kd_M: 9.23E-12

Real

Aptamer SeqId:15436-40;Target:RAMP1;UniProt:O60894

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15436-40;Target: RAMP1;UniProt: O60894;TargetFullName: Receptor activity-modifying protein 1;Organisim: human;Apparent_Kd_M: 1.64E-11

Real

Aptamer SeqId: 15436-40 | Target: RAMP1 | UniProt: O60894

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15436-40 | Target: RAMP1 | UniProt: O60894 | TargetFullName: Receptor activity-modifying protein 1 | Organisim: human | Apparent_Kd_M: 1.64E-11

Real

Aptamer SeqId:15437-11;Target:RAMP3;UniProt:O60896

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15437-11;Target: RAMP3;UniProt: O60896;TargetFullName: Receptor activity-modifying protein 3;Organisim: human;Apparent_Kd_M: 1.51E-10

Real

Aptamer SeqId: 15437-11 | Target: RAMP3 | UniProt: O60896

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15437-11 | Target: RAMP3 | UniProt: O60896 | TargetFullName: Receptor activity-modifying protein 3 | Organisim: human | Apparent_Kd_M: 1.51E-10

Real

Aptamer SeqId:15439-21;Target:RND3;UniProt:P61587

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15439-21;Target: RND3;UniProt: P61587;TargetFullName: Rho-related GTP-binding protein RhoE;Organisim: human;Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId: 15439-21 | Target: RND3 | UniProt: P61587

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15439-21 | Target: RND3 | UniProt: P61587 | TargetFullName: Rho-related GTP-binding protein RhoE | Organisim: human | Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId:15440-57;Target:NEC2;UniProt:P16519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15440-57;Target: NEC2;UniProt: P16519;TargetFullName: Neuroendocrine convertase 2;Organisim: human;Apparent_Kd_M: 5.24E-11

Real

Aptamer SeqId: 15440-57 | Target: NEC2 | UniProt: P16519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15440-57 | Target: NEC2 | UniProt: P16519 | TargetFullName: Neuroendocrine convertase 2 | Organisim: human | Apparent_Kd_M: 5.24E-11

Real

Aptamer SeqId:15441-6;Target:SAP3;UniProt:P17900

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15441-6;Target: SAP3;UniProt: P17900;TargetFullName: Ganglioside GM2 activator;Organisim: human;Apparent_Kd_M: 5.97E-11

Real

Aptamer SeqId: 15441-6 | Target: SAP3 | UniProt: P17900

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15441-6 | Target: SAP3 | UniProt: P17900 | TargetFullName: Ganglioside GM2 activator | Organisim: human | Apparent_Kd_M: 5.97E-11

Real

Aptamer SeqId:15444-45;Target:SCCA2;UniProt:P48594

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15444-45;Target: SCCA2;UniProt: P48594;TargetFullName: Serpin B4;Organisim: human;Apparent_Kd_M: 4.56E-11

Real

Aptamer SeqId: 15444-45 | Target: SCCA2 | UniProt: P48594

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15444-45 | Target: SCCA2 | UniProt: P48594 | TargetFullName: Serpin B4 | Organisim: human | Apparent_Kd_M: 4.56E-11

Real

Aptamer SeqId:15446-25;Target:SMDF;UniProt:Q02297

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15446-25;Target: SMDF;UniProt: Q02297;TargetFullName: Neuregulin-1; sensory and motor neuron-derived factor isoform;Organisim: human;Apparent_Kd_M: 3.06E-10

Real

Aptamer SeqId: 15446-25 | Target: SMDF | UniProt: Q02297

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15446-25 | Target: SMDF | UniProt: Q02297 | TargetFullName: Neuregulin-1; sensory and motor neuron-derived factor isoform | Organisim: human | Apparent_Kd_M: 3.06E-10

Real

Aptamer SeqId:15447-45;Target:Sorbitol dehydrogenase;UniProt:Q00796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15447-45;Target: Sorbitol dehydrogenase;UniProt: Q00796;TargetFullName: Sorbitol dehydrogenase;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 15447-45 | Target: Sorbitol dehydrogenase | UniProt: Q00796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15447-45 | Target: Sorbitol dehydrogenase | UniProt: Q00796 | TargetFullName: Sorbitol dehydrogenase | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:15448-47;Target:SQSTM;UniProt:Q13501

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15448-47;Target: SQSTM;UniProt: Q13501;TargetFullName: Sequestosome-1;Organisim: human;Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId: 15448-47 | Target: SQSTM | UniProt: Q13501

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15448-47 | Target: SQSTM | UniProt: Q13501 | TargetFullName: Sequestosome-1 | Organisim: human | Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId:15449-33;Target:TIM-4;UniProt:Q96H15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15449-33;Target: TIM-4;UniProt: Q96H15;TargetFullName: T-cell immunoglobulin and mucin domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.27E-12

Real

Aptamer SeqId: 15449-33 | Target: TIM-4 | UniProt: Q96H15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15449-33 | Target: TIM-4 | UniProt: Q96H15 | TargetFullName: T-cell immunoglobulin and mucin domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.27E-12

Real

Aptamer SeqId:15452-5;Target:5-Nucleotidase;UniProt:P21589

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15452-5;Target: 5-Nucleotidase;UniProt: P21589;TargetFullName: 5-Nucleotidase;Organisim: human;Apparent_Kd_M: 2.08E-12

Real

Aptamer SeqId: 15452-5 | Target: 5'-Nucleotidase | UniProt: P21589

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15452-5 | Target: 5'-Nucleotidase | UniProt: P21589 | TargetFullName: 5'-Nucleotidase | Organisim: human | Apparent_Kd_M: 2.08E-12

Real

Aptamer SeqId:15453-3;Target:a1-Microglobulin;UniProt:P02760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15453-3;Target: a1-Microglobulin;UniProt: P02760;TargetFullName: Alpha-1-microglobulin;Organisim: human;Apparent_Kd_M: 5.27E-12

Real

Aptamer SeqId: 15453-3 | Target: a1-Microglobulin | UniProt: P02760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15453-3 | Target: a1-Microglobulin | UniProt: P02760 | TargetFullName: Alpha-1-microglobulin | Organisim: human | Apparent_Kd_M: 5.27E-12

Real

Aptamer SeqId:15455-40;Target:ADA15;UniProt:Q13444

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15455-40;Target: ADA15;UniProt: Q13444;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 15;Organisim: human;Apparent_Kd_M: 4.32E-12

Real

Aptamer SeqId: 15455-40 | Target: ADA15 | UniProt: Q13444

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15455-40 | Target: ADA15 | UniProt: Q13444 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 15 | Organisim: human | Apparent_Kd_M: 4.32E-12

Real

Aptamer SeqId:15457-14;Target:Aminopeptidase N;UniProt:P15144

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15457-14;Target: Aminopeptidase N;UniProt: P15144;TargetFullName: Aminopeptidase N;Organisim: human;Apparent_Kd_M: 2.32E-11

Real

Aptamer SeqId: 15457-14 | Target: Aminopeptidase N | UniProt: P15144

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15457-14 | Target: Aminopeptidase N | UniProt: P15144 | TargetFullName: Aminopeptidase N | Organisim: human | Apparent_Kd_M: 2.32E-11

Real

Aptamer SeqId:15460-9;Target:CD26;UniProt:P27487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15460-9;Target: CD26;UniProt: P27487;TargetFullName: Dipeptidyl peptidase 4;Organisim: human;Apparent_Kd_M: 6.38E-11

Real

Aptamer SeqId: 15460-9 | Target: CD26 | UniProt: P27487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15460-9 | Target: CD26 | UniProt: P27487 | TargetFullName: Dipeptidyl peptidase 4 | Organisim: human | Apparent_Kd_M: 6.38E-11

Real

Aptamer SeqId:15462-28;Target:CD8A;UniProt:P01732

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15462-28;Target: CD8A;UniProt: P01732;TargetFullName: T-cell surface glycoprotein CD8 alpha chain;Organisim: human;Apparent_Kd_M: 6.32E-12

Real

Aptamer SeqId: 15462-28 | Target: CD8A | UniProt: P01732

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15462-28 | Target: CD8A | UniProt: P01732 | TargetFullName: T-cell surface glycoprotein CD8 alpha chain | Organisim: human | Apparent_Kd_M: 6.32E-12

Real

Aptamer SeqId:15465-79;Target:CNPY4;UniProt:Q8N129

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15465-79;Target: CNPY4;UniProt: Q8N129;TargetFullName: Protein canopy homolog 4;Organisim: human;Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId: 15465-79 | Target: CNPY4 | UniProt: Q8N129

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15465-79 | Target: CNPY4 | UniProt: Q8N129 | TargetFullName: Protein canopy homolog 4 | Organisim: human | Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId:15466-30;Target:CO9A1;UniProt:P20849

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15466-30;Target: CO9A1;UniProt: P20849;TargetFullName: Collagen alpha-1(IX) chain;Organisim: human;Apparent_Kd_M: 1.32E-12

Real

Aptamer SeqId: 15466-30 | Target: CO9A1 | UniProt: P20849

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15466-30 | Target: CO9A1 | UniProt: P20849 | TargetFullName: Collagen alpha-1(IX) chain | Organisim: human | Apparent_Kd_M: 1.32E-12

Real

Aptamer SeqId:15467-10;Target:CTHR1;UniProt:Q96CG8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15467-10;Target: CTHR1;UniProt: Q96CG8;TargetFullName: Collagen triple helix repeat-containing protein 1;Organisim: human;Apparent_Kd_M: 2.27E-11

Real

Aptamer SeqId: 15467-10 | Target: CTHR1 | UniProt: Q96CG8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15467-10 | Target: CTHR1 | UniProt: Q96CG8 | TargetFullName: Collagen triple helix repeat-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.27E-11

Real

Aptamer SeqId:15468-14;Target:FHR1;UniProt:Q03591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15468-14;Target: FHR1;UniProt: Q03591;TargetFullName: Complement factor H-related protein 1;Organisim: human;Apparent_Kd_M: 6.1E-12

Real

Aptamer SeqId: 15468-14 | Target: FHR1 | UniProt: Q03591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15468-14 | Target: FHR1 | UniProt: Q03591 | TargetFullName: Complement factor H-related protein 1 | Organisim: human | Apparent_Kd_M: 6.1E-12

Real

Aptamer SeqId:15470-11;Target:Hexosaminidase B;UniProt:P07686

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15470-11;Target: Hexosaminidase B;UniProt: P07686;TargetFullName: Beta-hexosaminidase subunit beta;Organisim: human;Apparent_Kd_M: 1.72E-12

Real

Aptamer SeqId: 15470-11 | Target: Hexosaminidase B | UniProt: P07686

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15470-11 | Target: Hexosaminidase B | UniProt: P07686 | TargetFullName: Beta-hexosaminidase subunit beta | Organisim: human | Apparent_Kd_M: 1.72E-12

Real

Aptamer SeqId:15471-29;Target:LIPR2;UniProt:P54317

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15471-29;Target: LIPR2;UniProt: P54317;TargetFullName: Pancreatic lipase-related protein 2;Organisim: human;Apparent_Kd_M: 2.9E-12

Real

Aptamer SeqId: 15471-29 | Target: LIPR2 | UniProt: P54317

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15471-29 | Target: LIPR2 | UniProt: P54317 | TargetFullName: Pancreatic lipase-related protein 2 | Organisim: human | Apparent_Kd_M: 2.9E-12

Real

Aptamer SeqId:15472-16;Target:LRP11;UniProt:Q86VZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15472-16;Target: LRP11;UniProt: Q86VZ4;TargetFullName: Low-density lipoprotein receptor-related protein 11;Organisim: human;Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId: 15472-16 | Target: LRP11 | UniProt: Q86VZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15472-16 | Target: LRP11 | UniProt: Q86VZ4 | TargetFullName: Low-density lipoprotein receptor-related protein 11 | Organisim: human | Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId:15474-7;Target:PIN1;UniProt:Q13526

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15474-7;Target: PIN1;UniProt: Q13526;TargetFullName: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1;Organisim: human;Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId: 15474-7 | Target: PIN1 | UniProt: Q13526

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15474-7 | Target: PIN1 | UniProt: Q13526 | TargetFullName: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Organisim: human | Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId:15475-4;Target:PLTP;UniProt:P55058

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15475-4;Target: PLTP;UniProt: P55058;TargetFullName: Phospholipid transfer protein;Organisim: human;Apparent_Kd_M: 5.93E-12

Real

Aptamer SeqId: 15475-4 | Target: PLTP | UniProt: P55058

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15475-4 | Target: PLTP | UniProt: P55058 | TargetFullName: Phospholipid transfer protein | Organisim: human | Apparent_Kd_M: 5.93E-12

Real

Aptamer SeqId:15476-6;Target:REG3G;UniProt:Q6UW15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15476-6;Target: REG3G;UniProt: Q6UW15;TargetFullName: Regenerating islet-derived protein 3-gamma;Organisim: human;Apparent_Kd_M: 4.83E-13

Real

Aptamer SeqId: 15476-6 | Target: REG3G | UniProt: Q6UW15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15476-6 | Target: REG3G | UniProt: Q6UW15 | TargetFullName: Regenerating islet-derived protein 3-gamma | Organisim: human | Apparent_Kd_M: 4.83E-13

Real

Aptamer SeqId:15480-2;Target:VNN2;UniProt:O95498

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15480-2;Target: VNN2;UniProt: O95498;TargetFullName: Vascular non-inflammatory molecule 2;Organisim: human;Apparent_Kd_M: 1.95E-12

Real

Aptamer SeqId: 15480-2 | Target: VNN2 | UniProt: O95498

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15480-2 | Target: VNN2 | UniProt: O95498 | TargetFullName: Vascular non-inflammatory molecule 2 | Organisim: human | Apparent_Kd_M: 1.95E-12

Real

Aptamer SeqId:15481-45;Target:LL-37;UniProt:P49913

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15481-45;Target: LL-37;UniProt: P49913;TargetFullName: Antibacterial protein LL-37;Organisim: human;Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId: 15481-45 | Target: LL-37 | UniProt: P49913

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15481-45 | Target: LL-37 | UniProt: P49913 | TargetFullName: Antibacterial protein LL-37 | Organisim: human | Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId:15482-12;Target:A2ML1;UniProt:A8K2U0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15482-12;Target: A2ML1;UniProt: A8K2U0;TargetFullName: Alpha-2-macroglobulin-like protein 1;Organisim: human;Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId: 15482-12 | Target: A2ML1 | UniProt: A8K2U0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15482-12 | Target: A2ML1 | UniProt: A8K2U0 | TargetFullName: Alpha-2-macroglobulin-like protein 1 | Organisim: human | Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId:15483-377;Target:Agrin;UniProt:O00468

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15483-377;Target: Agrin;UniProt: O00468;TargetFullName: Agrin;Organisim: human;Apparent_Kd_M: 1.67E-12

Real

Aptamer SeqId: 15483-377 | Target: Agrin | UniProt: O00468

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15483-377 | Target: Agrin | UniProt: O00468 | TargetFullName: Agrin | Organisim: human | Apparent_Kd_M: 1.67E-12

Real

Aptamer SeqId:15486-126;Target:ABP1;UniProt:P19801

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15486-126;Target: ABP1;UniProt: P19801;TargetFullName: Amiloride-sensitive amine oxidase [copper-containing];Organisim: human;Apparent_Kd_M: 2.45E-12

Real

Aptamer SeqId: 15486-126 | Target: ABP1 | UniProt: P19801

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15486-126 | Target: ABP1 | UniProt: P19801 | TargetFullName: Amiloride-sensitive amine oxidase copper-containing | Organisim: human | Apparent_Kd_M: 2.45E-12

Real

Aptamer SeqId:15487-164;Target:carboxylesterase; liver;UniProt:P23141

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15487-164;Target: carboxylesterase; liver;UniProt: P23141;TargetFullName: Liver carboxylesterase 1;Organisim: human;Apparent_Kd_M: 5.9E-11

Real

Aptamer SeqId: 15487-164 | Target: carboxylesterase liver

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15487-164 | Target: carboxylesterase; liver | UniProt: P23141 | TargetFullName: Liver carboxylesterase 1 | Organisim: human | Apparent_Kd_M: 5.9E-11

Real

Aptamer SeqId:15491-20;Target:CD248;UniProt:Q9HCU0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15491-20;Target: CD248;UniProt: Q9HCU0;TargetFullName: Endosialin;Organisim: human;Apparent_Kd_M: 3.17E-12

Real

Aptamer SeqId: 15491-20 | Target: CD248 | UniProt: Q9HCU0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15491-20 | Target: CD248 | UniProt: Q9HCU0 | TargetFullName: Endosialin | Organisim: human | Apparent_Kd_M: 3.17E-12

Real

Aptamer SeqId:15492-1;Target:CRIM1;UniProt:Q9NZV1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15492-1;Target: CRIM1;UniProt: Q9NZV1;TargetFullName: Cysteine-rich motor neuron 1 protein;Organisim: human;Apparent_Kd_M: 2.03E-11

Real

Aptamer SeqId: 15492-1 | Target: CRIM1 | UniProt: Q9NZV1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15492-1 | Target: CRIM1 | UniProt: Q9NZV1 | TargetFullName: Cysteine-rich motor neuron 1 protein | Organisim: human | Apparent_Kd_M: 2.03E-11

Real

Aptamer SeqId:15494-11;Target:FGFP1;UniProt:Q14512

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15494-11;Target: FGFP1;UniProt: Q14512;TargetFullName: Fibroblast growth factor-binding protein 1;Organisim: human;Apparent_Kd_M: 1.77E-12

Real

Aptamer SeqId: 15494-11 | Target: FGFP1 | UniProt: Q14512

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15494-11 | Target: FGFP1 | UniProt: Q14512 | TargetFullName: Fibroblast growth factor-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.77E-12

Real

Aptamer SeqId:15495-9;Target:FOLR3;UniProt:P41439

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15495-9;Target: FOLR3;UniProt: P41439;TargetFullName: Folate receptor gamma;Organisim: human;Apparent_Kd_M: 6.78E-11

Real

Aptamer SeqId: 15495-9 | Target: FOLR3 | UniProt: P41439

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15495-9 | Target: FOLR3 | UniProt: P41439 | TargetFullName: Folate receptor gamma | Organisim: human | Apparent_Kd_M: 6.78E-11

Real

Aptamer SeqId:15497-9;Target:HS3S1;UniProt:O14792

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15497-9;Target: HS3S1;UniProt: O14792;TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 1;Organisim: human;Apparent_Kd_M: 1.59E-12

Real

Aptamer SeqId: 15497-9 | Target: HS3S1 | UniProt: O14792

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15497-9 | Target: HS3S1 | UniProt: O14792 | TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 1 | Organisim: human | Apparent_Kd_M: 1.59E-12

Real

Aptamer SeqId:15499-11;Target:Attractin;UniProt:O75882

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15499-11;Target: Attractin;UniProt: O75882;TargetFullName: Attractin;Organisim: human;Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId: 15499-11 | Target: Attractin | UniProt: O75882

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15499-11 | Target: Attractin | UniProt: O75882 | TargetFullName: Attractin | Organisim: human | Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId:15503-15;Target:Lefty-A;UniProt:O00292

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15503-15;Target: Lefty-A;UniProt: O00292;TargetFullName: Left-right determination factor 2;Organisim: human;Apparent_Kd_M: 5.94E-12

Real

Aptamer SeqId: 15503-15 | Target: Lefty-A | UniProt: O00292

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15503-15 | Target: Lefty-A | UniProt: O00292 | TargetFullName: Left-right determination factor 2 | Organisim: human | Apparent_Kd_M: 5.94E-12

Real

Aptamer SeqId:15503-20;Target:Lefty-A;UniProt:O00292

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15503-20;Target: Lefty-A;UniProt: O00292;TargetFullName: Left-right determination factor 2;Organisim: human;Apparent_Kd_M: 6.95E-12

Real

Aptamer SeqId: 15503-20 | Target: Lefty-A | UniProt: O00292

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15503-20 | Target: Lefty-A | UniProt: O00292 | TargetFullName: Left-right determination factor 2 | Organisim: human | Apparent_Kd_M: 6.95E-12

Real

Aptamer SeqId:15504-39;Target:Livin B;UniProt:Q96CA5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15504-39;Target: Livin B;UniProt: Q96CA5;TargetFullName: Baculoviral IAP repeat-containing protein 7 Isoform beta;Organisim: human;Apparent_Kd_M: 2.87E-11

Real

Aptamer SeqId: 15504-39 | Target: Livin B | UniProt: Q96CA5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15504-39 | Target: Livin B | UniProt: Q96CA5 | TargetFullName: Baculoviral IAP repeat-containing protein 7 Isoform beta | Organisim: human | Apparent_Kd_M: 2.87E-11

Real

Aptamer SeqId:15506-34;Target:LRP12;UniProt:Q9Y561

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15506-34;Target: LRP12;UniProt: Q9Y561;TargetFullName: Low-density lipoprotein receptor-related protein 12;Organisim: human;Apparent_Kd_M: 1.54E-11

Real

Aptamer SeqId: 15506-34 | Target: LRP12 | UniProt: Q9Y561

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15506-34 | Target: LRP12 | UniProt: Q9Y561 | TargetFullName: Low-density lipoprotein receptor-related protein 12 | Organisim: human | Apparent_Kd_M: 1.54E-11

Real

Aptamer SeqId:15509-2;Target:NAG;UniProt:P54802

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15509-2;Target: NAG;UniProt: P54802;TargetFullName: Alpha-N-acetylglucosaminidase;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 15509-2 | Target: NAG | UniProt: P54802

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15509-2 | Target: NAG | UniProt: P54802 | TargetFullName: Alpha-N-acetylglucosaminidase | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:15511-37;Target:NPTXR;UniProt:O95502

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15511-37;Target: NPTXR;UniProt: O95502;TargetFullName: Neuronal pentraxin receptor;Organisim: human;Apparent_Kd_M: 3.09E-11

Real

Aptamer SeqId: 15511-37 | Target: NPTXR | UniProt: O95502

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15511-37 | Target: NPTXR | UniProt: O95502 | TargetFullName: Neuronal pentraxin receptor | Organisim: human | Apparent_Kd_M: 3.09E-11

Real

Aptamer SeqId:15513-108;Target:Prostasin;UniProt:Q16651

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15513-108;Target: Prostasin;UniProt: Q16651;TargetFullName: Prostasin;Organisim: human;Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId: 15513-108 | Target: Prostasin | UniProt: Q16651

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15513-108 | Target: Prostasin | UniProt: Q16651 | TargetFullName: Prostasin | Organisim: human | Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId:15514-26;Target:Pseudocholinesterase;UniProt:P06276

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15514-26;Target: Pseudocholinesterase;UniProt: P06276;TargetFullName: Cholinesterase;Organisim: human;Apparent_Kd_M: 1.85E-12

Real

Aptamer SeqId: 15514-26 | Target: Pseudocholinesterase | UniProt: P06276

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15514-26 | Target: Pseudocholinesterase | UniProt: P06276 | TargetFullName: Cholinesterase | Organisim: human | Apparent_Kd_M: 1.85E-12

Real

Aptamer SeqId:15515-2;Target:SAA;UniProt:P0DJI8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15515-2;Target: SAA;UniProt: P0DJI8;TargetFullName: Serum amyloid A-1 protein;Organisim: human;Apparent_Kd_M: 4.25E-12

Real

Aptamer SeqId: 15515-2 | Target: SAA | UniProt: P0DJI8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15515-2 | Target: SAA | UniProt: P0DJI8 | TargetFullName: Serum amyloid A-1 protein | Organisim: human | Apparent_Kd_M: 4.25E-12

Real

Aptamer SeqId:15516-12;Target:SAA-4;UniProt:P35542

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15516-12;Target: SAA-4;UniProt: P35542;TargetFullName: Serum amyloid A-4 protein;Organisim: human;Apparent_Kd_M: 8.03E-12

Real

Aptamer SeqId: 15516-12 | Target: SAA-4 | UniProt: P35542

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15516-12 | Target: SAA-4 | UniProt: P35542 | TargetFullName: Serum amyloid A-4 protein | Organisim: human | Apparent_Kd_M: 8.03E-12

Real

Aptamer SeqId:15521-4;Target:Alcadein alpha-1;UniProt:O94985

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15521-4;Target: Alcadein alpha-1;UniProt: O94985;TargetFullName: Calsyntenin-1;Organisim: human;Apparent_Kd_M: 9.6E-11

Real

Aptamer SeqId: 15521-4 | Target: Alcadein alpha-1 | UniProt: O94985

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15521-4 | Target: Alcadein alpha-1 | UniProt: O94985 | TargetFullName: Calsyntenin-1 | Organisim: human | Apparent_Kd_M: 9.6E-11

Real

Aptamer SeqId:15522-2;Target:GAPR1;UniProt:Q9H4G4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15522-2;Target: GAPR1;UniProt: Q9H4G4;TargetFullName: Golgi-associated plant pathogenesis-related protein 1;Organisim: human;Apparent_Kd_M: 1.9E-12

Real

Aptamer SeqId: 15522-2 | Target: GAPR1 | UniProt: Q9H4G4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15522-2 | Target: GAPR1 | UniProt: Q9H4G4 | TargetFullName: Golgi-associated plant pathogenesis-related protein 1 | Organisim: human | Apparent_Kd_M: 1.9E-12

Real

Aptamer SeqId:15523-9;Target:HEM2;UniProt:P13716

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15523-9;Target: HEM2;UniProt: P13716;TargetFullName: Delta-aminolevulinic acid dehydratase;Organisim: human;Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId: 15523-9 | Target: HEM2 | UniProt: P13716

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15523-9 | Target: HEM2 | UniProt: P13716 | TargetFullName: Delta-aminolevulinic acid dehydratase | Organisim: human | Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId:15524-30;Target:PGAM2;UniProt:P15259

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15524-30;Target: PGAM2;UniProt: P15259;TargetFullName: Phosphoglycerate mutase 2;Organisim: human;Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId: 15524-30 | Target: PGAM2 | UniProt: P15259

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15524-30 | Target: PGAM2 | UniProt: P15259 | TargetFullName: Phosphoglycerate mutase 2 | Organisim: human | Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId:15525-294;Target:ADH1G;UniProt:P00326

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15525-294;Target: ADH1G;UniProt: P00326;TargetFullName: Alcohol dehydrogenase 1C;Organisim: human;Apparent_Kd_M: 3.4E-11

Real

Aptamer SeqId: 15525-294 | Target: ADH1G | UniProt: P00326

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15525-294 | Target: ADH1G | UniProt: P00326 | TargetFullName: Alcohol dehydrogenase 1C | Organisim: human | Apparent_Kd_M: 3.4E-11

Real

Aptamer SeqId:15526-33;Target:GSHB;UniProt:P48637

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15526-33;Target: GSHB;UniProt: P48637;TargetFullName: Glutathione synthetase;Organisim: human;Apparent_Kd_M: 1.78E-11

Real

Aptamer SeqId: 15526-33 | Target: GSHB | UniProt: P48637

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15526-33 | Target: GSHB | UniProt: P48637 | TargetFullName: Glutathione synthetase | Organisim: human | Apparent_Kd_M: 1.78E-11

Real

Aptamer SeqId:15527-90;Target:DLDH;UniProt:P09622

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15527-90;Target: DLDH;UniProt: P09622;TargetFullName: Dihydrolipoyl dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId: 15527-90 | Target: DLDH | UniProt: P09622

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15527-90 | Target: DLDH | UniProt: P09622 | TargetFullName: Dihydrolipoyl dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId:15529-33;Target:Cysteine-rich protein 1;UniProt:P21291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15529-33;Target: Cysteine-rich protein 1;UniProt: P21291;TargetFullName: Cysteine and glycine-rich protein 1;Organisim: human;Apparent_Kd_M: 7.93E-12

Real

Aptamer SeqId: 15529-33 | Target: Cysteine-rich protein 1 | UniProt: P21291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15529-33 | Target: Cysteine-rich protein 1 | UniProt: P21291 | TargetFullName: Cysteine and glycine-rich protein 1 | Organisim: human | Apparent_Kd_M: 7.93E-12

Real

Aptamer SeqId:15530-33;Target:EphB4;UniProt:P54760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15530-33;Target: EphB4;UniProt: P54760;TargetFullName: Ephrin type-B receptor 4;Organisim: human;Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId: 15530-33 | Target: EphB4 | UniProt: P54760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15530-33 | Target: EphB4 | UniProt: P54760 | TargetFullName: Ephrin type-B receptor 4 | Organisim: human | Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId:15533-97;Target:Macrophage scavenger receptor;UniProt:P21757

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15533-97;Target: Macrophage scavenger receptor;UniProt: P21757;TargetFullName: Macrophage scavenger receptor types I and II;Organisim: human;Apparent_Kd_M: 4.52E-12

Real

Aptamer SeqId: 15533-97 | Target: Macrophage scavenger receptor

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15533-97 | Target: Macrophage scavenger receptor | UniProt: P21757 | TargetFullName: Macrophage scavenger receptor types I and II | Organisim: human | Apparent_Kd_M: 4.52E-12

Real

Aptamer SeqId:15534-26;Target:Malate dehydrogenase 2;UniProt:P40926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15534-26;Target: Malate dehydrogenase 2;UniProt: P40926;TargetFullName: Malate dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.37E-12

Real

Aptamer SeqId: 15534-26 | Target: Malate dehydrogenase 2 | UniProt: P40926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15534-26 | Target: Malate dehydrogenase 2 | UniProt: P40926 | TargetFullName: Malate dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.37E-12

Real

Aptamer SeqId:15535-3;Target:Marapsin;UniProt:Q9BQR3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15535-3;Target: Marapsin;UniProt: Q9BQR3;TargetFullName: Serine protease 27;Organisim: human;Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId: 15535-3 | Target: Marapsin | UniProt: Q9BQR3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15535-3 | Target: Marapsin | UniProt: Q9BQR3 | TargetFullName: Serine protease 27 | Organisim: human | Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId:15539-15;Target:SLIK1;UniProt:Q96PX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15539-15;Target: SLIK1;UniProt: Q96PX8;TargetFullName: SLIT and NTRK-like protein 1;Organisim: human;Apparent_Kd_M: 1.63E-11

Real

Aptamer SeqId: 15539-15 | Target: SLIK1 | UniProt: Q96PX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15539-15 | Target: SLIK1 | UniProt: Q96PX8 | TargetFullName: SLIT and NTRK-like protein 1 | Organisim: human | Apparent_Kd_M: 1.63E-11

Real

Aptamer SeqId:15540-6;Target:Vimentin;UniProt:P08670

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15540-6;Target: Vimentin;UniProt: P08670;TargetFullName: Vimentin;Organisim: human;Apparent_Kd_M: 7.69E-11

Real

Aptamer SeqId: 15540-6 | Target: Vimentin | UniProt: P08670

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15540-6 | Target: Vimentin | UniProt: P08670 | TargetFullName: Vimentin | Organisim: human | Apparent_Kd_M: 7.69E-11

Real

Aptamer SeqId:15542-19;Target:KCRU;UniProt:P12532

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15542-19;Target: KCRU;UniProt: P12532;TargetFullName: Creatine kinase U-type; mitochondrial;Organisim: human;Apparent_Kd_M: 6.25E-12

Real

Aptamer SeqId: 15542-19 | Target: KCRU | UniProt: P12532

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15542-19 | Target: KCRU | UniProt: P12532 | TargetFullName: Creatine kinase U-type; mitochondrial | Organisim: human | Apparent_Kd_M: 6.25E-12

Real

Aptamer SeqId:15544-25;Target:kallikrein 14;UniProt:Q9P0G3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15544-25;Target: kallikrein 14;UniProt: Q9P0G3;TargetFullName: Kallikrein-14;Organisim: human;Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId: 15544-25 | Target: kallikrein 14 | UniProt: Q9P0G3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15544-25 | Target: kallikrein 14 | UniProt: Q9P0G3 | TargetFullName: Kallikrein-14 | Organisim: human | Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId:15545-13;Target:Calcineurin B a;UniProt:P63098

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15545-13;Target: Calcineurin B a;UniProt: P63098;TargetFullName: Calcineurin subunit B type 1;Organisim: human;Apparent_Kd_M: 1.27E-11

Real

Aptamer SeqId: 15545-13 | Target: Calcineurin B a | UniProt: P63098

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15545-13 | Target: Calcineurin B a | UniProt: P63098 | TargetFullName: Calcineurin subunit B type 1 | Organisim: human | Apparent_Kd_M: 1.27E-11

Real

Aptamer SeqId:15548-35;Target:SERA;UniProt:O43175

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15548-35;Target: SERA;UniProt: O43175;TargetFullName: D-3-phosphoglycerate dehydrogenase;Organisim: human;Apparent_Kd_M: 3.69E-11

Real

Aptamer SeqId: 15548-35 | Target: SERA | UniProt: O43175

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15548-35 | Target: SERA | UniProt: O43175 | TargetFullName: D-3-phosphoglycerate dehydrogenase | Organisim: human | Apparent_Kd_M: 3.69E-11

Real

Aptamer SeqId:15553-22;Target:ACES;UniProt:P22303

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15553-22;Target: ACES;UniProt: P22303;TargetFullName: Acetylcholinesterase;Organisim: human;Apparent_Kd_M: 2.18E-11

Real

Aptamer SeqId: 15553-22 | Target: ACES | UniProt: P22303

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15553-22 | Target: ACES | UniProt: P22303 | TargetFullName: Acetylcholinesterase | Organisim: human | Apparent_Kd_M: 2.18E-11

Real

Aptamer SeqId:15556-49;Target:Alpha-amylase 2B;UniProt:P19961

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15556-49;Target: Alpha-amylase 2B;UniProt: P19961;TargetFullName: Alpha-amylase 2B;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 15556-49 | Target: Alpha-amylase 2B | UniProt: P19961

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15556-49 | Target: Alpha-amylase 2B | UniProt: P19961 | TargetFullName: Alpha-amylase 2B | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:15558-63;Target:AMPE;UniProt:Q07075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15558-63;Target: AMPE;UniProt: Q07075;TargetFullName: Glutamyl aminopeptidase;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 15558-63 | Target: AMPE | UniProt: Q07075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15558-63 | Target: AMPE | UniProt: Q07075 | TargetFullName: Glutamyl aminopeptidase | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:15559-5;Target:ANTR2;UniProt:P58335

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15559-5;Target: ANTR2;UniProt: P58335;TargetFullName: Anthrax toxin receptor 2;Organisim: human;Apparent_Kd_M: 1.0E-10

Real

Aptamer SeqId: 15559-5 | Target: ANTR2 | UniProt: P58335

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15559-5 | Target: ANTR2 | UniProt: P58335 | TargetFullName: Anthrax toxin receptor 2 | Organisim: human | Apparent_Kd_M: 1.0E-10

Real

Aptamer SeqId:15560-52;Target:Apo-TC II;UniProt:P20062

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15560-52;Target: Apo-TC II;UniProt: P20062;TargetFullName: Transcobalamin-2;Organisim: human;Apparent_Kd_M: 4.06E-12

Real

Aptamer SeqId: 15560-52 | Target: Apo-TC II | UniProt: P20062

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15560-52 | Target: Apo-TC II | UniProt: P20062 | TargetFullName: Transcobalamin-2 | Organisim: human | Apparent_Kd_M: 4.06E-12

Real

Aptamer SeqId:15562-24;Target:BGLR;UniProt:P08236

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15562-24;Target: BGLR;UniProt: P08236;TargetFullName: Beta-glucuronidase;Organisim: human;Apparent_Kd_M: 2.72E-12

Real

Aptamer SeqId: 15562-24 | Target: BGLR | UniProt: P08236

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15562-24 | Target: BGLR | UniProt: P08236 | TargetFullName: Beta-glucuronidase | Organisim: human | Apparent_Kd_M: 2.72E-12

Real

Aptamer SeqId:15565-102;Target:CA125;UniProt:Q8WXI7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15565-102;Target: CA125;UniProt: Q8WXI7;TargetFullName: Mucin-16;Organisim: human;Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId: 15565-102 | Target: CA125 | UniProt: Q8WXI7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15565-102 | Target: CA125 | UniProt: Q8WXI7 | TargetFullName: Mucin-16 | Organisim: human | Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId:15566-10;Target:Calponin-1;UniProt:P51911

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15566-10;Target: Calponin-1;UniProt: P51911;TargetFullName: Calponin-1;Organisim: human;Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId: 15566-10 | Target: Calponin-1 | UniProt: P51911

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15566-10 | Target: Calponin-1 | UniProt: P51911 | TargetFullName: Calponin-1 | Organisim: human | Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId:15567-2;Target:CD3-zeta;UniProt:P20963

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15567-2;Target: CD3-zeta;UniProt: P20963;TargetFullName: T-cell surface glycoprotein CD3 zeta chain;Organisim: human;Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId: 15567-2 | Target: CD3-zeta | UniProt: P20963

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15567-2 | Target: CD3-zeta | UniProt: P20963 | TargetFullName: T-cell surface glycoprotein CD3 zeta chain | Organisim: human | Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId:15569-15;Target:Collagen II;UniProt:P02458

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15569-15;Target: Collagen II;UniProt: P02458;TargetFullName: Collagen Type II;Organisim: human;Apparent_Kd_M: 1.35E-12

Real

Aptamer SeqId: 15569-15 | Target: Collagen II | UniProt: P02458

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15569-15 | Target: Collagen II | UniProt: P02458 | TargetFullName: Collagen Type II | Organisim: human | Apparent_Kd_M: 1.35E-12

Real

Aptamer SeqId:15570-99;Target:Complement receptor type 2;UniProt:P20023

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15570-99;Target: Complement receptor type 2;UniProt: P20023;TargetFullName: Complement receptor type 2;Organisim: human;Apparent_Kd_M: 1.89E-12

Real

Aptamer SeqId: 15570-99 | Target: Complement receptor type 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15570-99 | Target: Complement receptor type 2 | UniProt: P20023 | TargetFullName: Complement receptor type 2 | Organisim: human | Apparent_Kd_M: 1.89E-12

Real

Aptamer SeqId:15573-110;Target:CSPG3;UniProt:O14594

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15573-110;Target: CSPG3;UniProt: O14594;TargetFullName: Neurocan core protein;Organisim: human;Apparent_Kd_M: 3.93E-12

Real

Aptamer SeqId: 15573-110 | Target: CSPG3 | UniProt: O14594

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15573-110 | Target: CSPG3 | UniProt: O14594 | TargetFullName: Neurocan core protein | Organisim: human | Apparent_Kd_M: 3.93E-12

Real

Aptamer SeqId:15574-37;Target:Cyclin A;UniProt:P20248

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15574-37;Target: Cyclin A;UniProt: P20248;TargetFullName: Cyclin-A2;Organisim: human;Apparent_Kd_M: 8.1E-12

Real

Aptamer SeqId: 15574-37 | Target: Cyclin A | UniProt: P20248

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15574-37 | Target: Cyclin A | UniProt: P20248 | TargetFullName: Cyclin-A2 | Organisim: human | Apparent_Kd_M: 8.1E-12

Real

Aptamer SeqId:15576-158;Target:ECP;UniProt:P12724

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15576-158;Target: ECP;UniProt: P12724;TargetFullName: Eosinophil cationic protein;Organisim: human;Apparent_Kd_M: 4.07E-14

Real

Aptamer SeqId: 15576-158 | Target: ECP | UniProt: P12724

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15576-158 | Target: ECP | UniProt: P12724 | TargetFullName: Eosinophil cationic protein | Organisim: human | Apparent_Kd_M: 4.07E-14

Real

Aptamer SeqId:15579-26;Target:ENPP6;UniProt:Q6UWR7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15579-26;Target: ENPP6;UniProt: Q6UWR7;TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 6;Organisim: human;Apparent_Kd_M: 1.26E-12

Real

Aptamer SeqId: 15579-26 | Target: ENPP6 | UniProt: Q6UWR7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15579-26 | Target: ENPP6 | UniProt: Q6UWR7 | TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 | Organisim: human | Apparent_Kd_M: 1.26E-12

Real

Aptamer SeqId:15580-2;Target:EPHA7;UniProt:Q15375

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15580-2;Target: EPHA7;UniProt: Q15375;TargetFullName: Ephrin type-A receptor 7;Organisim: human;Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId: 15580-2 | Target: EPHA7 | UniProt: Q15375

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15580-2 | Target: EPHA7 | UniProt: Q15375 | TargetFullName: Ephrin type-A receptor 7 | Organisim: human | Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId:15581-16;Target:FANK1;UniProt:Q8TC84

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15581-16;Target: FANK1;UniProt: Q8TC84;TargetFullName: Fibronectin type 3 and ankyrin repeat domains protein 1;Organisim: human;Apparent_Kd_M: 3.04E-11

Real

Aptamer SeqId: 15581-16 | Target: FANK1 | UniProt: Q8TC84

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15581-16 | Target: FANK1 | UniProt: Q8TC84 | TargetFullName: Fibronectin type 3 and ankyrin repeat domains protein 1 | Organisim: human | Apparent_Kd_M: 3.04E-11

Real

Aptamer SeqId:15582-25;Target:FCN1;UniProt:O00602

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15582-25;Target: FCN1;UniProt: O00602;TargetFullName: Ficolin-1;Organisim: human;Apparent_Kd_M: 3.64E-11

Real

Aptamer SeqId: 15582-25 | Target: FCN1 | UniProt: O00602

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15582-25 | Target: FCN1 | UniProt: O00602 | TargetFullName: Ficolin-1 | Organisim: human | Apparent_Kd_M: 3.64E-11

Real

Aptamer SeqId:15583-18;Target:FCRLB;UniProt:Q6BAA4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15583-18;Target: FCRLB;UniProt: Q6BAA4;TargetFullName: Fc receptor-like B;Organisim: human;Apparent_Kd_M: 1.4E-11

Real

Aptamer SeqId: 15583-18 | Target: FCRLB | UniProt: Q6BAA4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15583-18 | Target: FCRLB | UniProt: Q6BAA4 | TargetFullName: Fc receptor-like B | Organisim: human | Apparent_Kd_M: 1.4E-11

Real

Aptamer SeqId:15584-9;Target:FHR2;UniProt:P36980

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15584-9;Target: FHR2;UniProt: P36980;TargetFullName: Complement factor H-related protein 2;Organisim: human;Apparent_Kd_M: 5.29E-12

Real

Aptamer SeqId: 15584-9 | Target: FHR2 | UniProt: P36980

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15584-9 | Target: FHR2 | UniProt: P36980 | TargetFullName: Complement factor H-related protein 2 | Organisim: human | Apparent_Kd_M: 5.29E-12

Real

Aptamer SeqId:15585-304;Target:fibulin 5;UniProt:Q9UBX5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15585-304;Target: fibulin 5;UniProt: Q9UBX5;TargetFullName: Fibulin-5;Organisim: human;Apparent_Kd_M: 3.09E-11

Real

Aptamer SeqId: 15585-304 | Target: fibulin 5 | UniProt: Q9UBX5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15585-304 | Target: fibulin 5 | UniProt: Q9UBX5 | TargetFullName: Fibulin-5 | Organisim: human | Apparent_Kd_M: 3.09E-11

Real

Aptamer SeqId:15587-20;Target:FOLR2;UniProt:P14207

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15587-20;Target: FOLR2;UniProt: P14207;TargetFullName: Folate receptor beta;Organisim: human;Apparent_Kd_M: 9.71E-12

Real

Aptamer SeqId: 15587-20 | Target: FOLR2 | UniProt: P14207

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15587-20 | Target: FOLR2 | UniProt: P14207 | TargetFullName: Folate receptor beta | Organisim: human | Apparent_Kd_M: 9.71E-12

Real

Aptamer SeqId:15588-17;Target:galactosidase; alpha;UniProt:P06280

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15588-17;Target: galactosidase; alpha;UniProt: P06280;TargetFullName: Alpha-galactosidase A;Organisim: human;Apparent_Kd_M: 1.49E-10

Real

Aptamer SeqId: 15588-17 | Target: galactosidase; alpha | UniProt: P06280

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15588-17 | Target: galactosidase; alpha | UniProt: P06280 | TargetFullName: Alpha-galactosidase A | Organisim: human | Apparent_Kd_M: 1.49E-10

Real

Aptamer SeqId:15589-1;Target:Gc-Globulin; Mixed Type;UniProt:P02774

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15589-1;Target: Gc-Globulin; Mixed Type;UniProt: P02774;TargetFullName: Vitamin D-binding protein;Organisim: human;Apparent_Kd_M: 3.91E-11

Real

Aptamer SeqId: 15589-1 | Target: Gc-Globulin; Mixed Type | UniProt: P02774

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15589-1 | Target: Gc-Globulin; Mixed Type | UniProt: P02774 | TargetFullName: Vitamin D-binding protein | Organisim: human | Apparent_Kd_M: 3.91E-11

Real

Aptamer SeqId:15591-28;Target:Glutathione peroxidase;UniProt:P07203

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15591-28;Target: Glutathione peroxidase;UniProt: P07203;TargetFullName: Glutathione peroxidase 1;Organisim: human;Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId: 15591-28 | Target: Glutathione peroxidase | UniProt: P07203

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15591-28 | Target: Glutathione peroxidase | UniProt: P07203 | TargetFullName: Glutathione peroxidase 1 | Organisim: human | Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId:15594-47;Target:HTRA1;UniProt:Q92743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15594-47;Target: HTRA1;UniProt: Q92743;TargetFullName: Serine protease HTRA1;Organisim: human;Apparent_Kd_M: 1.7E-12

Real

Aptamer SeqId: 15594-47 | Target: HTRA1 | UniProt: Q92743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15594-47 | Target: HTRA1 | UniProt: Q92743 | TargetFullName: Serine protease HTRA1 | Organisim: human | Apparent_Kd_M: 1.7E-12

Real

Aptamer SeqId:15596-7;Target:HEXI1;UniProt:O94992

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15596-7;Target: HEXI1;UniProt: O94992;TargetFullName: Protein HEXIM1;Organisim: human;Apparent_Kd_M: 4.71E-12

Real

Aptamer SeqId: 15596-7 | Target: HEXI1 | UniProt: O94992

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15596-7 | Target: HEXI1 | UniProt: O94992 | TargetFullName: Protein HEXIM1 | Organisim: human | Apparent_Kd_M: 4.71E-12

Real

Aptamer SeqId:15602-43;Target:IL-6 sRa;UniProt:P08887

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15602-43;Target: IL-6 sRa;UniProt: P08887;TargetFullName: Interleukin-6 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId: 15602-43 | Target: IL-6 sRa | UniProt: P08887

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15602-43 | Target: IL-6 sRa | UniProt: P08887 | TargetFullName: Interleukin-6 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId:15603-20;Target:Integrin alpha-2;UniProt:P17301

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15603-20;Target: Integrin alpha-2;UniProt: P17301;TargetFullName: Integrin alpha-2;Organisim: human;Apparent_Kd_M: 6.38E-12

Real

Aptamer SeqId: 15603-20 | Target: Integrin alpha-2 | UniProt: P17301

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15603-20 | Target: Integrin alpha-2 | UniProt: P17301 | TargetFullName: Integrin alpha-2 | Organisim: human | Apparent_Kd_M: 6.38E-12

Real

Aptamer SeqId:15604-18;Target:JNK2;UniProt:P45984

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15604-18;Target: JNK2;UniProt: P45984;TargetFullName: Mitogen-activated protein kinase 9;Organisim: human;Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId: 15604-18 | Target: JNK2 | UniProt: P45984

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15604-18 | Target: JNK2 | UniProt: P45984 | TargetFullName: Mitogen-activated protein kinase 9 | Organisim: human | Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId:15606-19;Target:Keratin 19;UniProt:P08727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15606-19;Target: Keratin 19;UniProt: P08727;TargetFullName: Keratin; type I cytoskeletal 19;Organisim: human;Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId: 15606-19 | Target: Keratin 19 | UniProt: P08727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15606-19 | Target: Keratin 19 | UniProt: P08727 | TargetFullName: Keratin; type I cytoskeletal 19 | Organisim: human | Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId:15607-56;Target:KPYR;UniProt:P30613

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15607-56;Target: KPYR;UniProt: P30613;TargetFullName: Pyruvate kinase PKLR;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 15607-56 | Target: KPYR | UniProt: P30613

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15607-56 | Target: KPYR | UniProt: P30613 | TargetFullName: Pyruvate kinase PKLR | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:15608-5;Target:KS6B1;UniProt:P23443

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15608-5;Target: KS6B1;UniProt: P23443;TargetFullName: Ribosomal protein S6 kinase beta-1;Organisim: human;Apparent_Kd_M: 3.67E-12

Real

Aptamer SeqId: 15608-5 | Target: KS6B1 | UniProt: P23443

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15608-5 | Target: KS6B1 | UniProt: P23443 | TargetFullName: Ribosomal protein S6 kinase beta-1 | Organisim: human | Apparent_Kd_M: 3.67E-12

Real

Aptamer SeqId:15610-72;Target:LAP;UniProt:P28838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15610-72;Target: LAP;UniProt: P28838;TargetFullName: Cytosol aminopeptidase;Organisim: human;Apparent_Kd_M: 4.89E-12

Real

Aptamer SeqId: 15610-72 | Target: LAP | UniProt: P28838

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15610-72 | Target: LAP | UniProt: P28838 | TargetFullName: Cytosol aminopeptidase | Organisim: human | Apparent_Kd_M: 4.89E-12

Real

Aptamer SeqId:15612-5;Target:LIN7B;UniProt:Q9HAP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15612-5;Target: LIN7B;UniProt: Q9HAP6;TargetFullName: Protein lin-7 homolog B;Organisim: human;Apparent_Kd_M: 6.99E-12

Real

Aptamer SeqId: 15612-5 | Target: LIN7B | UniProt: Q9HAP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15612-5 | Target: LIN7B | UniProt: Q9HAP6 | TargetFullName: Protein lin-7 homolog B | Organisim: human | Apparent_Kd_M: 6.99E-12

Real

Aptamer SeqId:15613-16;Target:LIPP;UniProt:P16233

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15613-16;Target: LIPP;UniProt: P16233;TargetFullName: Pancreatic triacylglycerol lipase;Organisim: human;Apparent_Kd_M: 6.27E-12

Real

Aptamer SeqId: 15613-16 | Target: LIPP | UniProt: P16233

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15613-16 | Target: LIPP | UniProt: P16233 | TargetFullName: Pancreatic triacylglycerol lipase | Organisim: human | Apparent_Kd_M: 6.27E-12

Real

Aptamer SeqId:15614-168;Target:LIRA2;UniProt:Q8N149

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15614-168;Target: LIRA2;UniProt: Q8N149;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 2;Organisim: human;Apparent_Kd_M: 2.54E-11

Real

Aptamer SeqId: 15614-168 | Target: LIRA2 | UniProt: Q8N149

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15614-168 | Target: LIRA2 | UniProt: Q8N149 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 2 | Organisim: human | Apparent_Kd_M: 2.54E-11

Real

Aptamer SeqId:15615-8;Target:LIRB3;UniProt:O75022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15615-8;Target: LIRB3;UniProt: O75022;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 3;Organisim: human;Apparent_Kd_M: 2.36E-12

Real

Aptamer SeqId: 15615-8 | Target: LIRB3 | UniProt: O75022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15615-8 | Target: LIRB3 | UniProt: O75022 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 3 | Organisim: human | Apparent_Kd_M: 2.36E-12

Real

Aptamer SeqId:15617-8;Target:lymphotactin beta;UniProt:Q9UBD3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15617-8;Target: lymphotactin beta;UniProt: Q9UBD3;TargetFullName: Cytokine SCM-1 beta;Organisim: human;Apparent_Kd_M: 5.7E-12

Real

Aptamer SeqId: 15617-8 | Target: lymphotactin beta | UniProt: Q9UBD3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15617-8 | Target: lymphotactin beta | UniProt: Q9UBD3 | TargetFullName: Cytokine SCM-1 beta | Organisim: human | Apparent_Kd_M: 5.7E-12

Real

Aptamer SeqId:15619-49;Target:MOG;UniProt:Q16653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15619-49;Target: MOG;UniProt: Q16653;TargetFullName: Myelin-oligodendrocyte glycoprotein;Organisim: human;Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId: 15619-49 | Target: MOG | UniProt: Q16653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15619-49 | Target: MOG | UniProt: Q16653 | TargetFullName: Myelin-oligodendrocyte glycoprotein | Organisim: human | Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId:15620-4;Target:NLGN1;UniProt:Q8N2Q7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15620-4;Target: NLGN1;UniProt: Q8N2Q7;TargetFullName: Neuroligin-1;Organisim: human;Apparent_Kd_M: 4.2E-11

Real

Aptamer SeqId: 15620-4 | Target: NLGN1 | UniProt: Q8N2Q7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15620-4 | Target: NLGN1 | UniProt: Q8N2Q7 | TargetFullName: Neuroligin-1 | Organisim: human | Apparent_Kd_M: 4.2E-11

Real

Aptamer SeqId:15622-13;Target:OBCAM;UniProt:Q14982

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15622-13;Target: OBCAM;UniProt: Q14982;TargetFullName: Opioid-binding protein/cell adhesion molecule;Organisim: human;Apparent_Kd_M: 5.72E-11

Real

Aptamer SeqId: 15622-13 | Target: OBCAM | UniProt: Q14982

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15622-13 | Target: OBCAM | UniProt: Q14982 | TargetFullName: Opioid-binding protein/cell adhesion molecule | Organisim: human | Apparent_Kd_M: 5.72E-11

Real

Aptamer SeqId:15623-1;Target:PD-1;UniProt:Q15116

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15623-1;Target: PD-1;UniProt: Q15116;TargetFullName: Programmed cell death protein 1;Organisim: human;Apparent_Kd_M: 2.19E-10

Real

Aptamer SeqId: 15623-1 | Target: PD-1 | UniProt: Q15116

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15623-1 | Target: PD-1 | UniProt: Q15116 | TargetFullName: Programmed cell death protein 1 | Organisim: human | Apparent_Kd_M: 2.19E-10

Real

Aptamer SeqId:15626-223;Target:Perlecan;UniProt:P98160

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15626-223;Target: Perlecan;UniProt: P98160;TargetFullName: Basement membrane-specific heparan sulfate proteoglycan core protein;Organisim: human;Apparent_Kd_M: 6.01E-12

Real

Aptamer SeqId: 15626-223 | Target: Perlecan | UniProt: P98160

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15626-223 | Target: Perlecan | UniProt: P98160 | TargetFullName: Basement membrane-specific heparan sulfate proteoglycan core protein | Organisim: human | Apparent_Kd_M: 6.01E-12

Real

Aptamer SeqId:15627-83;Target:PKB;UniProt:P31749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15627-83;Target: PKB;UniProt: P31749;TargetFullName: RAC-alpha serine/threonine-protein kinase;Organisim: human;Apparent_Kd_M: 2.7E-12

Real

Aptamer SeqId: 15627-83 | Target: PKB | UniProt: P31749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15627-83 | Target: PKB | UniProt: P31749 | TargetFullName: RAC-alpha serine/threonine-protein kinase | Organisim: human | Apparent_Kd_M: 2.7E-12

Real

Aptamer SeqId:15631-18;Target:PSG1;UniProt:P11464

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15631-18;Target: PSG1;UniProt: P11464;TargetFullName: Pregnancy-specific beta-1-glycoprotein 1;Organisim: human;Apparent_Kd_M: 1.86E-12

Real

Aptamer SeqId: 15631-18 | Target: PSG1 | UniProt: P11464

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15631-18 | Target: PSG1 | UniProt: P11464 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 1 | Organisim: human | Apparent_Kd_M: 1.86E-12

Real

Aptamer SeqId:15633-6;Target:RBP;UniProt:P02753

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15633-6;Target: RBP;UniProt: P02753;TargetFullName: Retinol-binding protein 4;Organisim: human;Apparent_Kd_M: 3.15E-11

Real

Aptamer SeqId: 15633-6 | Target: RBP | UniProt: P02753

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15633-6 | Target: RBP | UniProt: P02753 | TargetFullName: Retinol-binding protein 4 | Organisim: human | Apparent_Kd_M: 3.15E-11

Real

Aptamer SeqId:15634-139;Target:SLIT1;UniProt:O75093

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15634-139;Target: SLIT1;UniProt: O75093;TargetFullName: Slit homolog 1 protein;Organisim: human;Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId: 15634-139 | Target: SLIT1 | UniProt: O75093

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15634-139 | Target: SLIT1 | UniProt: O75093 | TargetFullName: Slit homolog 1 protein | Organisim: human | Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId:15635-4;Target:SMOC2;UniProt:Q9H3U7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15635-4;Target: SMOC2;UniProt: Q9H3U7;TargetFullName: SPARC-related modular calcium-binding protein 2;Organisim: human;Apparent_Kd_M: 3.02E-12

Real

Aptamer SeqId: 15635-4 | Target: SMOC2 | UniProt: Q9H3U7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15635-4 | Target: SMOC2 | UniProt: Q9H3U7 | TargetFullName: SPARC-related modular calcium-binding protein 2 | Organisim: human | Apparent_Kd_M: 3.02E-12

Real

Aptamer SeqId:15636-49;Target:SORC1;UniProt:Q8WY21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15636-49;Target: SORC1;UniProt: Q8WY21;TargetFullName: VPS10 domain-containing receptor SorCS1;Organisim: human;Apparent_Kd_M: 9.51E-11

Real

Aptamer SeqId: 15636-49 | Target: SORC1 | UniProt: Q8WY21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15636-49 | Target: SORC1 | UniProt: Q8WY21 | TargetFullName: VPS10 domain-containing receptor SorCS1 | Organisim: human | Apparent_Kd_M: 9.51E-11

Real

Aptamer SeqId:15637-38;Target:SORC3;UniProt:Q9UPU3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15637-38;Target: SORC3;UniProt: Q9UPU3;TargetFullName: VPS10 domain-containing receptor SorCS3;Organisim: human;Apparent_Kd_M: 4.32E-11

Real

Aptamer SeqId: 15637-38 | Target: SORC3 | UniProt: Q9UPU3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15637-38 | Target: SORC3 | UniProt: Q9UPU3 | TargetFullName: VPS10 domain-containing receptor SorCS3 | Organisim: human | Apparent_Kd_M: 4.32E-11

Real

Aptamer SeqId:15640-54;Target:TAGL;UniProt:Q01995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15640-54;Target: TAGL;UniProt: Q01995;TargetFullName: Transgelin;Organisim: human;Apparent_Kd_M: 1.34E-12

Real

Aptamer SeqId: 15640-54 | Target: TAGL | UniProt: Q01995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15640-54 | Target: TAGL | UniProt: Q01995 | TargetFullName: Transgelin | Organisim: human | Apparent_Kd_M: 1.34E-12

Real

Aptamer SeqId:15641-20;Target:TEFF1;UniProt:Q8IYR6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15641-20;Target: TEFF1;UniProt: Q8IYR6;TargetFullName: Tomoregulin-1;Organisim: human;Apparent_Kd_M: 4.8E-12

Real

Aptamer SeqId: 15641-20 | Target: TEFF1 | UniProt: Q8IYR6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15641-20 | Target: TEFF1 | UniProt: Q8IYR6 | TargetFullName: Tomoregulin-1 | Organisim: human | Apparent_Kd_M: 4.8E-12

Real

Aptamer SeqId:15644-1;Target:Biotinidase;UniProt:P43251

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15644-1;Target: Biotinidase;UniProt: P43251;TargetFullName: Biotinidase;Organisim: human;Apparent_Kd_M: 4.15E-12

Real

Aptamer SeqId: 15644-1 | Target: Biotinidase | UniProt: P43251

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15644-1 | Target: Biotinidase | UniProt: P43251 | TargetFullName: Biotinidase | Organisim: human | Apparent_Kd_M: 4.15E-12

Real

Aptamer SeqId:15653-9;Target:COAA1;UniProt:Q03692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15653-9;Target: COAA1;UniProt: Q03692;TargetFullName: Collagen alpha-1(X) chain;Organisim: human;Apparent_Kd_M: 5.172025E-11

Real

Aptamer SeqId: 15653-9 | Target: COAA1 | UniProt: Q03692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15653-9 | Target: COAA1 | UniProt: Q03692 | TargetFullName: Collagen alpha-1(X) chain | Organisim: human | Apparent_Kd_M: 5.172025E-11

Real

Aptamer SeqId:15666-21;Target:BMP-2;UniProt:P12643

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15666-21;Target: BMP-2;UniProt: P12643;TargetFullName: Bone morphogenetic protein 2;Organisim: human;Apparent_Kd_M: 8.54E-12

Real

Aptamer SeqId: 15666-21 | Target: BMP-2 | UniProt: P12643

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15666-21 | Target: BMP-2 | UniProt: P12643 | TargetFullName: Bone morphogenetic protein 2 | Organisim: human | Apparent_Kd_M: 8.54E-12

Real

Aptamer SeqId:15667-39;Target:BMP-4;UniProt:P12644

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15667-39;Target: BMP-4;UniProt: P12644;TargetFullName: Bone morphogenetic protein 4;Organisim: human;Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId: 15667-39 | Target: BMP-4 | UniProt: P12644

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15667-39 | Target: BMP-4 | UniProt: P12644 | TargetFullName: Bone morphogenetic protein 4 | Organisim: human | Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId:15668-19;Target:BMP-8;UniProt:P34820

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15668-19;Target: BMP-8;UniProt: P34820;TargetFullName: Bone morphogenetic protein 8B;Organisim: human;Apparent_Kd_M: 6.53E-11

Real

Aptamer SeqId: 15668-19 | Target: BMP-8 | UniProt: P34820

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15668-19 | Target: BMP-8 | UniProt: P34820 | TargetFullName: Bone morphogenetic protein 8B | Organisim: human | Apparent_Kd_M: 6.53E-11

Real

Aptamer SeqId:15669-7;Target:BRAF1;UniProt:P15056

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15669-7;Target: BRAF1;UniProt: P15056;TargetFullName: Serine/threonine-protein kinase B-raf;Organisim: human;Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId: 15669-7 | Target: BRAF1 | UniProt: P15056

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15669-7 | Target: BRAF1 | UniProt: P15056 | TargetFullName: Serine/threonine-protein kinase B-raf | Organisim: human | Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId:15670-15;Target:C1QL2;UniProt:Q7Z5L3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15670-15;Target: C1QL2;UniProt: Q7Z5L3;TargetFullName: Complement C1q-like protein 2;Organisim: human;Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId: 15670-15 | Target: C1QL2 | UniProt: Q7Z5L3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15670-15 | Target: C1QL2 | UniProt: Q7Z5L3 | TargetFullName: Complement C1q-like protein 2 | Organisim: human | Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId:15674-3;Target:CD79A;UniProt:P11912

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15674-3;Target: CD79A;UniProt: P11912;TargetFullName: B-cell antigen receptor complex-associated protein alpha chain;Organisim: human;Apparent_Kd_M: 1.78E-11

Real

Aptamer SeqId: 15674-3 | Target: CD79A | UniProt: P11912

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15674-3 | Target: CD79A | UniProt: P11912 | TargetFullName: B-cell antigen receptor complex-associated protein alpha chain | Organisim: human | Apparent_Kd_M: 1.78E-11

Real

Aptamer SeqId:15675-3;Target:CEBPB;UniProt:P17676

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15675-3;Target: CEBPB;UniProt: P17676;TargetFullName: CCAAT/enhancer-binding protein beta;Organisim: human;Apparent_Kd_M: 1.47E-11

Real

Aptamer SeqId: 15675-3 | Target: CEBPB | UniProt: P17676

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15675-3 | Target: CEBPB | UniProt: P17676 | TargetFullName: CCAAT/enhancer-binding protein beta | Organisim: human | Apparent_Kd_M: 1.47E-11

Real

Aptamer SeqId:15678-71;Target:DKK2;UniProt:Q9UBU2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15678-71;Target: DKK2;UniProt: Q9UBU2;TargetFullName: Dickkopf-related protein 2;Organisim: human;Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId: 15678-71 | Target: DKK2 | UniProt: Q9UBU2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15678-71 | Target: DKK2 | UniProt: Q9UBU2 | TargetFullName: Dickkopf-related protein 2 | Organisim: human | Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId:15686-49;Target:INHBC;UniProt:P55103

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15686-49;Target: INHBC;UniProt: P55103;TargetFullName: Inhibin beta C chain;Organisim: human;Apparent_Kd_M: 3.08E-11

Real

Aptamer SeqId: 15686-49 | Target: INHBC | UniProt: P55103

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15686-49 | Target: INHBC | UniProt: P55103 | TargetFullName: Inhibin beta C chain | Organisim: human | Apparent_Kd_M: 3.08E-11

Real

Aptamer SeqId:15688-30;Target:Mannose-binding lectin;UniProt:P49257

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15688-30;Target: Mannose-binding lectin;UniProt: P49257;TargetFullName: Protein ERGIC-53;Organisim: human;Apparent_Kd_M: 1.67E-11

Real

Aptamer SeqId: 15688-30 | Target: Mannose-binding lectin | UniProt: P49257

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15688-30 | Target: Mannose-binding lectin | UniProt: P49257 | TargetFullName: Protein ERGIC-53 | Organisim: human | Apparent_Kd_M: 1.67E-11

Real

Aptamer SeqId:15692-300;Target:NODAL;UniProt:Q96S42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15692-300;Target: NODAL;UniProt: Q96S42;TargetFullName: Nodal homolog;Organisim: human;Apparent_Kd_M: 9.08E-12

Real

Aptamer SeqId: 15692-300 | Target: NODAL | UniProt: Q96S42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15692-300 | Target: NODAL | UniProt: Q96S42 | TargetFullName: Nodal homolog | Organisim: human | Apparent_Kd_M: 9.08E-12

Real

Aptamer SeqId:15693-9;Target:PgR;UniProt:P06401

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15693-9;Target: PgR;UniProt: P06401;TargetFullName: Progesterone receptor;Organisim: human;Apparent_Kd_M: 5.58E-13

Real

Aptamer SeqId: 15693-9 | Target: PgR | UniProt: P06401

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15693-9 | Target: PgR | UniProt: P06401 | TargetFullName: Progesterone receptor | Organisim: human | Apparent_Kd_M: 5.58E-13

Real

Aptamer SeqId:15698-6;Target:TXLNA;UniProt:P40222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 15698-6;Target: TXLNA;UniProt: P40222;TargetFullName: Alpha-taxilin;Organisim: human;Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId: 15698-6 | Target: TXLNA | UniProt: P40222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 15698-6 | Target: TXLNA | UniProt: P40222 | TargetFullName: Alpha-taxilin | Organisim: human | Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId:16015-19;Target:ALT;UniProt:P24298

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16015-19;Target: ALT;UniProt: P24298;TargetFullName: Alanine aminotransferase 1;Organisim: human;Apparent_Kd_M: 9.43E-11

Real

Aptamer SeqId: 16015-19 | Target: ALT | UniProt: P24298

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16015-19 | Target: ALT | UniProt: P24298 | TargetFullName: Alanine aminotransferase 1 | Organisim: human | Apparent_Kd_M: 9.43E-11

Real

Aptamer SeqId:16021-30;Target:Cadherin-8;UniProt:P55286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16021-30;Target: Cadherin-8;UniProt: P55286;TargetFullName: Cadherin-8;Organisim: human;Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId: 16021-30 | Target: Cadherin-8 | UniProt: P55286

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16021-30 | Target: Cadherin-8 | UniProt: P55286 | TargetFullName: Cadherin-8 | Organisim: human | Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId:16035-8;Target:VEGF sR3;UniProt:P35916

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16035-8;Target: VEGF sR3;UniProt: P35916;TargetFullName: Vascular endothelial growth factor receptor 3;Organisim: human;Apparent_Kd_M: 1.385256E-12

Real

Aptamer SeqId: 16035-8 | Target: VEGF sR3 | UniProt: P35916

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16035-8 | Target: VEGF sR3 | UniProt: P35916 | TargetFullName: Vascular endothelial growth factor receptor 3 | Organisim: human | Apparent_Kd_M: 1.385256E-12

Real

Aptamer SeqId:16043-30;Target:SHC1;UniProt:P29353

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16043-30;Target: SHC1;UniProt: P29353;TargetFullName: SHC-transforming protein 1;Organisim: human;Apparent_Kd_M: 1.782693E-12

Real

Aptamer SeqId: 16043-30 | Target: SHC1 | UniProt: P29353

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16043-30 | Target: SHC1 | UniProt: P29353 | TargetFullName: SHC-transforming protein 1 | Organisim: human | Apparent_Kd_M: 1.782693E-12

Real

Aptamer SeqId:16049-43;Target:OLR1;UniProt:P78380

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16049-43;Target: OLR1;UniProt: P78380;TargetFullName: Oxidized low-density lipoprotein receptor 1;Organisim: human;Apparent_Kd_M: 6.65E-12

Real

Aptamer SeqId: 16049-43 | Target: OLR1 | UniProt: P78380

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16049-43 | Target: OLR1 | UniProt: P78380 | TargetFullName: Oxidized low-density lipoprotein receptor 1 | Organisim: human | Apparent_Kd_M: 6.65E-12

Real

Aptamer SeqId:16055-3;Target:complement factor H-related 5;UniProt:Q9BXR6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16055-3;Target: complement factor H-related 5;UniProt: Q9BXR6;TargetFullName: Complement factor H-related protein 5;Organisim: human;Apparent_Kd_M: 5.82E-12

Real

Aptamer SeqId: 16055-3 | Target: complement factor H-related 5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16055-3 | Target: complement factor H-related 5 | UniProt: Q9BXR6 | TargetFullName: Complement factor H-related protein 5 | Organisim: human | Apparent_Kd_M: 5.82E-12

Real

Aptamer SeqId:16057-6;Target:IGF-II receptor;UniProt:P11717

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16057-6;Target: IGF-II receptor;UniProt: P11717;TargetFullName: Cation-independent mannose-6-phosphate receptor;Organisim: human;Apparent_Kd_M: 3.824875E-11

Real

Aptamer SeqId: 16057-6 | Target: IGF-II receptor | UniProt: P11717

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16057-6 | Target: IGF-II receptor | UniProt: P11717 | TargetFullName: Cation-independent mannose-6-phosphate receptor | Organisim: human | Apparent_Kd_M: 3.824875E-11

Real

Aptamer SeqId:16060-99;Target:NID2;UniProt:Q14112

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16060-99;Target: NID2;UniProt: Q14112;TargetFullName: Nidogen-2;Organisim: human;Apparent_Kd_M: 2.226339E-11

Real

Aptamer SeqId: 16060-99 | Target: NID2 | UniProt: Q14112

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16060-99 | Target: NID2 | UniProt: Q14112 | TargetFullName: Nidogen-2 | Organisim: human | Apparent_Kd_M: 2.226339E-11

Real

Aptamer SeqId:16070-7;Target:WIF-1;UniProt:Q9Y5W5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16070-7;Target: WIF-1;UniProt: Q9Y5W5;TargetFullName: Wnt inhibitory factor 1;Organisim: human;Apparent_Kd_M: 2.939165E-12

Real

Aptamer SeqId: 16070-7 | Target: WIF-1 | UniProt: Q9Y5W5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16070-7 | Target: WIF-1 | UniProt: Q9Y5W5 | TargetFullName: Wnt inhibitory factor 1 | Organisim: human | Apparent_Kd_M: 2.939165E-12

Real

Aptamer SeqId:16074-12;Target:GRB2-related adapter protein 2;UniProt:O75791

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16074-12;Target: GRB2-related adapter protein 2;UniProt: O75791;TargetFullName: GRB2-related adapter protein 2;Organisim: human;Apparent_Kd_M: 1.274287E-11

Real

Aptamer SeqId: 16074-12 | Target: GRB2-related adapter protein 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16074-12 | Target: GRB2-related adapter protein 2 | UniProt: O75791 | TargetFullName: GRB2-related adapter protein 2 | Organisim: human | Apparent_Kd_M: 1.274287E-11

Real

Aptamer SeqId:16079-2;Target:TEC;UniProt:P42680

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16079-2;Target: TEC;UniProt: P42680;TargetFullName: Tyrosine-protein kinase Tec;Organisim: human;Apparent_Kd_M: 1.9E-12

Real

Aptamer SeqId: 16079-2 | Target: TEC | UniProt: P42680

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16079-2 | Target: TEC | UniProt: P42680 | TargetFullName: Tyrosine-protein kinase Tec | Organisim: human | Apparent_Kd_M: 1.9E-12

Real

Aptamer SeqId:16081-38;Target:Aldose reductase-like;UniProt:O60218

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16081-38;Target: Aldose reductase-like;UniProt: O60218;TargetFullName: Aldo-keto reductase family 1 member B10;Organisim: human;Apparent_Kd_M: 1.74E-11

Real

Aptamer SeqId: 16081-38 | Target: Aldose reductase-like | UniProt: O60218

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16081-38 | Target: Aldose reductase-like | UniProt: O60218 | TargetFullName: Aldo-keto reductase family 1 member B10 | Organisim: human | Apparent_Kd_M: 1.74E-11

Real

Aptamer SeqId:16288-17;Target:EPHA4;UniProt:P54764

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16288-17;Target: EPHA4;UniProt: P54764;TargetFullName: Ephrin type-A receptor 4;Organisim: human;Apparent_Kd_M: 3.35E-12

Real

Aptamer SeqId: 16288-17 | Target: EPHA4 | UniProt: P54764

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16288-17 | Target: EPHA4 | UniProt: P54764 | TargetFullName: Ephrin type-A receptor 4 | Organisim: human | Apparent_Kd_M: 3.35E-12

Real

Aptamer SeqId:16292-288;Target:GIP;UniProt:P09681

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16292-288;Target: GIP;UniProt: P09681;TargetFullName: Gastric inhibitory polypeptide;Organisim: human;Apparent_Kd_M: 1.89E-12

Real

Aptamer SeqId: 16292-288 | Target: GIP | UniProt: P09681

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16292-288 | Target: GIP | UniProt: P09681 | TargetFullName: Gastric inhibitory polypeptide | Organisim: human | Apparent_Kd_M: 1.89E-12

Real

Aptamer SeqId:16293-1;Target:Growth hormone-releasing factor;UniProt:P01286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16293-1;Target: Growth hormone-releasing factor;UniProt: P01286;TargetFullName: Somatoliberin;Organisim: human;Apparent_Kd_M: 3.839629E-12

Real

Aptamer SeqId: 16293-1 | Target: Growth hormone-releasing factor

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16293-1 | Target: Growth hormone-releasing factor | UniProt: P01286 | TargetFullName: Somatoliberin | Organisim: human | Apparent_Kd_M: 3.839629E-12

Real

Aptamer SeqId:16296-43;Target:LGR5;UniProt:O75473

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16296-43;Target: LGR5;UniProt: O75473;TargetFullName: Leucine-rich repeat-containing G-protein coupled receptor 5;Organisim: human;Apparent_Kd_M: 3.29E-12

Real

Aptamer SeqId: 16296-43 | Target: LGR5 | UniProt: O75473

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16296-43 | Target: LGR5 | UniProt: O75473 | TargetFullName: Leucine-rich repeat-containing G-protein coupled receptor 5 | Organisim: human | Apparent_Kd_M: 3.29E-12

Real

Aptamer SeqId:16297-14;Target:ROBO4;UniProt:Q8WZ75

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16297-14;Target: ROBO4;UniProt: Q8WZ75;TargetFullName: Roundabout homolog 4;Organisim: human;Apparent_Kd_M: 2.22E-12

Real

Aptamer SeqId: 16297-14 | Target: ROBO4 | UniProt: Q8WZ75

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16297-14 | Target: ROBO4 | UniProt: Q8WZ75 | TargetFullName: Roundabout homolog 4 | Organisim: human | Apparent_Kd_M: 2.22E-12

Real

Aptamer SeqId:16298-84;Target:sPLA(2)-IID;UniProt:Q9UNK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16298-84;Target: sPLA(2)-IID;UniProt: Q9UNK4;TargetFullName: Group IID secretory phospholipase A2;Organisim: human;Apparent_Kd_M: 5.94E-11

Real

Aptamer SeqId: 16298-84 | Target: sPLA(2)-IID | UniProt: Q9UNK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16298-84 | Target: sPLA(2)-IID | UniProt: Q9UNK4 | TargetFullName: Group IID secretory phospholipase A2 | Organisim: human | Apparent_Kd_M: 5.94E-11

Real

Aptamer SeqId:16299-13;Target:TIGIT;UniProt:Q495A1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16299-13;Target: TIGIT;UniProt: Q495A1;TargetFullName: T-cell immunoreceptor with Ig and ITIM domains;Organisim: human;Apparent_Kd_M: 9.49E-11

Real

Aptamer SeqId: 16299-13 | Target: TIGIT | UniProt: Q495A1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16299-13 | Target: TIGIT | UniProt: Q495A1 | TargetFullName: T-cell immunoreceptor with Ig and ITIM domains | Organisim: human | Apparent_Kd_M: 9.49E-11

Real

Aptamer SeqId:16300-4;Target:TREM2;UniProt:Q9NZC2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16300-4;Target: TREM2;UniProt: Q9NZC2;TargetFullName: Triggering receptor expressed on myeloid cells 2;Organisim: human;Apparent_Kd_M: 4.05E-12

Real

Aptamer SeqId: 16300-4 | Target: TREM2 | UniProt: Q9NZC2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16300-4 | Target: TREM2 | UniProt: Q9NZC2 | TargetFullName: Triggering receptor expressed on myeloid cells 2 | Organisim: human | Apparent_Kd_M: 4.05E-12

Real

Aptamer SeqId:16302-11;Target:SPLC2;UniProt:Q96DR5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16302-11;Target: SPLC2;UniProt: Q96DR5;TargetFullName: BPI fold-containing family A member 2;Organisim: human;Apparent_Kd_M: 5.59E-12

Real

Aptamer SeqId: 16302-11 | Target: SPLC2 | UniProt: Q96DR5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16302-11 | Target: SPLC2 | UniProt: Q96DR5 | TargetFullName: BPI fold-containing family A member 2 | Organisim: human | Apparent_Kd_M: 5.59E-12

Real

Aptamer SeqId:16304-6;Target:LGR4;UniProt:Q9BXB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16304-6;Target: LGR4;UniProt: Q9BXB1;TargetFullName: Leucine-rich repeat-containing G-protein coupled receptor 4;Organisim: human;Apparent_Kd_M: 2.84E-11

Real

Aptamer SeqId: 16304-6 | Target: LGR4 | UniProt: Q9BXB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16304-6 | Target: LGR4 | UniProt: Q9BXB1 | TargetFullName: Leucine-rich repeat-containing G-protein coupled receptor 4 | Organisim: human | Apparent_Kd_M: 2.84E-11

Real

Aptamer SeqId:16305-10;Target:Cadherin-11;UniProt:P55287

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16305-10;Target: Cadherin-11;UniProt: P55287;TargetFullName: Cadherin-11;Organisim: human;Apparent_Kd_M: 4.585595E-11

Real

Aptamer SeqId: 16305-10 | Target: Cadherin-11 | UniProt: P55287

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16305-10 | Target: Cadherin-11 | UniProt: P55287 | TargetFullName: Cadherin-11 | Organisim: human | Apparent_Kd_M: 4.585595E-11

Real

Aptamer SeqId:16307-22;Target:UNC5H4;UniProt:Q6UXZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16307-22;Target: UNC5H4;UniProt: Q6UXZ4;TargetFullName: Netrin receptor UNC5D;Organisim: human;Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId: 16307-22 | Target: UNC5H4 | UniProt: Q6UXZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16307-22 | Target: UNC5H4 | UniProt: Q6UXZ4 | TargetFullName: Netrin receptor UNC5D | Organisim: human | Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId:16308-14;Target:BTLA;UniProt:Q7Z6A9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16308-14;Target: BTLA;UniProt: Q7Z6A9;TargetFullName: B- and T-lymphocyte attenuator;Organisim: human;Apparent_Kd_M: 1.082681E-11

Real

Aptamer SeqId: 16308-14 | Target: BTLA | UniProt: Q7Z6A9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16308-14 | Target: BTLA | UniProt: Q7Z6A9 | TargetFullName: B- and T-lymphocyte attenuator | Organisim: human | Apparent_Kd_M: 1.082681E-11

Real

Aptamer SeqId:16309-30;Target:Soggy-1;UniProt:Q9UK85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16309-30;Target: Soggy-1;UniProt: Q9UK85;TargetFullName: Dickkopf-like protein 1;Organisim: human;Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId: 16309-30 | Target: Soggy-1 | UniProt: Q9UK85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16309-30 | Target: Soggy-1 | UniProt: Q9UK85 | TargetFullName: Dickkopf-like protein 1 | Organisim: human | Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId:16312-45;Target:Cadherin-6;UniProt:P55285

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16312-45;Target: Cadherin-6;UniProt: P55285;TargetFullName: Cadherin-6;Organisim: human;Apparent_Kd_M: 1.548678E-10

Real

Aptamer SeqId: 16312-45 | Target: Cadherin-6 | UniProt: P55285

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16312-45 | Target: Cadherin-6 | UniProt: P55285 | TargetFullName: Cadherin-6 | Organisim: human | Apparent_Kd_M: 1.548678E-10

Real

Aptamer SeqId:16315-105;Target:VEGF sR1;UniProt:P17948

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16315-105;Target: VEGF sR1;UniProt: P17948;TargetFullName: Vascular endothelial growth factor receptor 1;Organisim: human;Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId: 16315-105 | Target: VEGF sR1 | UniProt: P17948

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16315-105 | Target: VEGF sR1 | UniProt: P17948 | TargetFullName: Vascular endothelial growth factor receptor 1 | Organisim: human | Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId:16317-20;Target:Desmoglein-3;UniProt:P32926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16317-20;Target: Desmoglein-3;UniProt: P32926;TargetFullName: Desmoglein-3;Organisim: human;Apparent_Kd_M: 2.723323E-11

Real

Aptamer SeqId: 16317-20 | Target: Desmoglein-3 | UniProt: P32926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16317-20 | Target: Desmoglein-3 | UniProt: P32926 | TargetFullName: Desmoglein-3 | Organisim: human | Apparent_Kd_M: 2.723323E-11

Real

Aptamer SeqId:16318-12;Target:ALK-1;UniProt:P37023

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16318-12;Target: ALK-1;UniProt: P37023;TargetFullName: Serine/threonine-protein kinase receptor R3;Organisim: human;Apparent_Kd_M: 3.372926E-12

Real

Aptamer SeqId: 16318-12 | Target: ALK-1 | UniProt: P37023

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16318-12 | Target: ALK-1 | UniProt: P37023 | TargetFullName: Serine/threonine-protein kinase receptor R3 | Organisim: human | Apparent_Kd_M: 3.372926E-12

Real

Aptamer SeqId:16320-139;Target:CD320;UniProt:Q9NPF0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16320-139;Target: CD320;UniProt: Q9NPF0;TargetFullName: CD320 antigen;Organisim: human;Apparent_Kd_M: 1.149189E-10

Real

Aptamer SeqId: 16320-139 | Target: CD320 | UniProt: Q9NPF0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16320-139 | Target: CD320 | UniProt: Q9NPF0 | TargetFullName: CD320 antigen | Organisim: human | Apparent_Kd_M: 1.149189E-10

Real

Aptamer SeqId:16322-10;Target:PACAP;UniProt:Q8WU39

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16322-10;Target: PACAP;UniProt: Q8WU39;TargetFullName: Marginal zone B- and B1-cell-specific protein;Organisim: human;Apparent_Kd_M: 2.77E-12

Real

Aptamer SeqId: 16322-10 | Target: PACAP | UniProt: Q8WU39

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16322-10 | Target: PACAP | UniProt: Q8WU39 | TargetFullName: Marginal zone B- and B1-cell-specific protein | Organisim: human | Apparent_Kd_M: 2.77E-12

Real

Aptamer SeqId:16323-8;Target:NRX3A;UniProt:Q9Y4C0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16323-8;Target: NRX3A;UniProt: Q9Y4C0;TargetFullName: Neurexin-3;Organisim: human;Apparent_Kd_M: 1.91E-12

Real

Aptamer SeqId: 16323-8 | Target: NRX3A | UniProt: Q9Y4C0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16323-8 | Target: NRX3A | UniProt: Q9Y4C0 | TargetFullName: Neurexin-3 | Organisim: human | Apparent_Kd_M: 1.91E-12

Real

Aptamer SeqId:16324-38;Target:TLR1;UniProt:Q15399

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16324-38;Target: TLR1;UniProt: Q15399;TargetFullName: Toll-like receptor 1;Organisim: human;Apparent_Kd_M: 6.4E-12

Real

Aptamer SeqId: 16324-38 | Target: TLR1 | UniProt: Q15399

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16324-38 | Target: TLR1 | UniProt: Q15399 | TargetFullName: Toll-like receptor 1 | Organisim: human | Apparent_Kd_M: 6.4E-12

Real

Aptamer SeqId:16535-61;Target:GFP_AEQVI;UniProt:P42212

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16535-61;Target: GFP_AEQVI;UniProt: P42212;TargetFullName: Green fluorescent protein_AEQVI;Organisim: aequorea victoria (jellyfish);Apparent_Kd_M: 2.11E-12

Real

Aptamer SeqId: 16535-61 | Target: GFP_AEQVI | UniProt: P42212

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16535-61 | Target: GFP_AEQVI | UniProt: P42212 | TargetFullName: Green fluorescent protein_AEQVI | Organisim: aequorea victoria (jellyfish) | Apparent_Kd_M: 2.11E-12

Real

Aptamer SeqId:16536-3;Target:HMGA1;UniProt:P17096

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16536-3;Target: HMGA1;UniProt: P17096;TargetFullName: High mobility group protein HMG-I/HMG-Y;Organisim: human;Apparent_Kd_M: 2.78E-12

Real

Aptamer SeqId: 16536-3 | Target: HMGA1 | UniProt: P17096

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16536-3 | Target: HMGA1 | UniProt: P17096 | TargetFullName: High mobility group protein HMG-I/HMG-Y | Organisim: human | Apparent_Kd_M: 2.78E-12

Real

Aptamer SeqId:16551-14;Target:STA5B;UniProt:P51692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16551-14;Target: STA5B;UniProt: P51692;TargetFullName: Signal transducer and activator of transcription 5B;Organisim: human;Apparent_Kd_M: 1.64E-10

Real

Aptamer SeqId: 16551-14 | Target: STA5B | UniProt: P51692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16551-14 | Target: STA5B | UniProt: P51692 | TargetFullName: Signal transducer and activator of transcription 5B | Organisim: human | Apparent_Kd_M: 1.64E-10

Real

Aptamer SeqId:16558-2;Target:MYOC;UniProt:Q99972

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16558-2;Target: MYOC;UniProt: Q99972;TargetFullName: Myocilin;Organisim: human;Apparent_Kd_M: 2.1E-11

Real

Aptamer SeqId: 16558-2 | Target: MYOC | UniProt: Q99972

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16558-2 | Target: MYOC | UniProt: Q99972 | TargetFullName: Myocilin | Organisim: human | Apparent_Kd_M: 2.1E-11

Real

Aptamer SeqId:16561-9;Target:Alpha-1B-glycoprotein;UniProt:P04217

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16561-9;Target: Alpha-1B-glycoprotein;UniProt: P04217;TargetFullName: Alpha-1B-glycoprotein;Organisim: human;Apparent_Kd_M: 7.37E-11

Real

Aptamer SeqId: 16561-9 | Target: Alpha-1B-glycoprotein | UniProt: P04217

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16561-9 | Target: Alpha-1B-glycoprotein | UniProt: P04217 | TargetFullName: Alpha-1B-glycoprotein | Organisim: human | Apparent_Kd_M: 7.37E-11

Real

Aptamer SeqId:16583-8;Target:AP4A;UniProt:P50583

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16583-8;Target: AP4A;UniProt: P50583;TargetFullName: Bis(5-nucleosyl)-tetraphosphatase [asymmetrical];Organisim: human;Apparent_Kd_M: 2.17E-12

Real

Aptamer SeqId: 16583-8 | Target: AP4A | UniProt: P50583

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16583-8 | Target: AP4A | UniProt: P50583 | TargetFullName: Bis(5'-nucleosyl)-tetraphosphatase asymmetrical | Organisim: human | Apparent_Kd_M: 2.17E-12

Real

Aptamer SeqId:16585-16;Target:B3GN4;UniProt:Q9C0J1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16585-16;Target: B3GN4;UniProt: Q9C0J1;TargetFullName: N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase 4;Organisim: human;Apparent_Kd_M: 1.189325E-12

Real

Aptamer SeqId: 16585-16 | Target: B3GN4 | UniProt: Q9C0J1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16585-16 | Target: B3GN4 | UniProt: Q9C0J1 | TargetFullName: N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase 4 | Organisim: human | Apparent_Kd_M: 1.189325E-12

Real

Aptamer SeqId:16587-1;Target:Beta-casein;UniProt:P05814

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16587-1;Target: Beta-casein;UniProt: P05814;TargetFullName: Beta-casein;Organisim: human;Apparent_Kd_M: 6.11E-11

Real

Aptamer SeqId: 16587-1 | Target: Beta-casein | UniProt: P05814

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16587-1 | Target: Beta-casein | UniProt: P05814 | TargetFullName: Beta-casein | Organisim: human | Apparent_Kd_M: 6.11E-11

Real

Aptamer SeqId:16588-10;Target:BiP;UniProt:P11021

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16588-10;Target: BiP;UniProt: P11021;TargetFullName: 78 kDa glucose-regulated protein;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 16588-10 | Target: BiP | UniProt: P11021

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16588-10 | Target: BiP | UniProt: P11021 | TargetFullName: 78 kDa glucose-regulated protein | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:16591-71;Target:CHIA;UniProt:Q9BZP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16591-71;Target: CHIA;UniProt: Q9BZP6;TargetFullName: Acidic mammalian chitinase;Organisim: human;Apparent_Kd_M: 1.22E-10

Real

Aptamer SeqId: 16591-71 | Target: CHIA | UniProt: Q9BZP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16591-71 | Target: CHIA | UniProt: Q9BZP6 | TargetFullName: Acidic mammalian chitinase | Organisim: human | Apparent_Kd_M: 1.22E-10

Real

Aptamer SeqId:16593-3;Target:FADD;UniProt:Q13158

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16593-3;Target: FADD;UniProt: Q13158;TargetFullName: FAS-associated death domain protein;Organisim: human;Apparent_Kd_M: 2.338958E-11

Real

Aptamer SeqId: 16593-3 | Target: FADD | UniProt: Q13158

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16593-3 | Target: FADD | UniProt: Q13158 | TargetFullName: FAS-associated death domain protein | Organisim: human | Apparent_Kd_M: 2.338958E-11

Real

Aptamer SeqId:16594-44;Target:FAIM1;UniProt:Q9NVQ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16594-44;Target: FAIM1;UniProt: Q9NVQ4;TargetFullName: Fas apoptotic inhibitory molecule 1;Organisim: human;Apparent_Kd_M: 2.17E-11

Real

Aptamer SeqId: 16594-44 | Target: FAIM1 | UniProt: Q9NVQ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16594-44 | Target: FAIM1 | UniProt: Q9NVQ4 | TargetFullName: Fas apoptotic inhibitory molecule 1 | Organisim: human | Apparent_Kd_M: 2.17E-11

Real

Aptamer SeqId:16596-25;Target:GLRX3;UniProt:O76003

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16596-25;Target: GLRX3;UniProt: O76003;TargetFullName: Glutaredoxin-3;Organisim: human;Apparent_Kd_M: 2.248472E-12

Real

Aptamer SeqId: 16596-25 | Target: GLRX3 | UniProt: O76003

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16596-25 | Target: GLRX3 | UniProt: O76003 | TargetFullName: Glutaredoxin-3 | Organisim: human | Apparent_Kd_M: 2.248472E-12

Real

Aptamer SeqId:16597-11;Target:GLRX5;UniProt:Q86SX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16597-11;Target: GLRX5;UniProt: Q86SX6;TargetFullName: Glutaredoxin-related protein 5; mitochondrial;Organisim: human;Apparent_Kd_M: 1.175847E-10

Real

Aptamer SeqId: 16597-11 | Target: GLRX5 | UniProt: Q86SX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16597-11 | Target: GLRX5 | UniProt: Q86SX6 | TargetFullName: Glutaredoxin-related protein 5; mitochondrial | Organisim: human | Apparent_Kd_M: 1.175847E-10

Real

Aptamer SeqId:16599-38;Target:GPN1;UniProt:Q9HCN4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16599-38;Target: GPN1;UniProt: Q9HCN4;TargetFullName: GPN-loop GTPase 1;Organisim: human;Apparent_Kd_M: 2.381421E-12

Real

Aptamer SeqId: 16599-38 | Target: GPN1 | UniProt: Q9HCN4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16599-38 | Target: GPN1 | UniProt: Q9HCN4 | TargetFullName: GPN-loop GTPase 1 | Organisim: human | Apparent_Kd_M: 2.381421E-12

Real

Aptamer SeqId:16605-2;Target:C1T9A;UniProt:P0C862

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16605-2;Target: C1T9A;UniProt: P0C862;TargetFullName: Complement C1q and tumor necrosis factor-related protein 9A;Organisim: human;Apparent_Kd_M: 4.93E-12

Real

Aptamer SeqId: 16605-2 | Target: C1T9A | UniProt: P0C862

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16605-2 | Target: C1T9A | UniProt: P0C862 | TargetFullName: Complement C1q and tumor necrosis factor-related protein 9A | Organisim: human | Apparent_Kd_M: 4.93E-12

Real

Aptamer SeqId:16606-85;Target:Aldose reductase;UniProt:P15121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16606-85;Target: Aldose reductase;UniProt: P15121;TargetFullName: Aldose reductase;Organisim: human;Apparent_Kd_M: 8.06E-12

Real

Aptamer SeqId: 16606-85 | Target: Aldose reductase | UniProt: P15121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16606-85 | Target: Aldose reductase | UniProt: P15121 | TargetFullName: Aldose reductase | Organisim: human | Apparent_Kd_M: 8.06E-12

Real

Aptamer SeqId:16607-78;Target:Gelsolin;UniProt:P06396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16607-78;Target: Gelsolin;UniProt: P06396;TargetFullName: Gelsolin;Organisim: human;Apparent_Kd_M: 7.360044E-13

Real

Aptamer SeqId: 16607-78 | Target: Gelsolin | UniProt: P06396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16607-78 | Target: Gelsolin | UniProt: P06396 | TargetFullName: Gelsolin | Organisim: human | Apparent_Kd_M: 7.360044E-13

Real

Aptamer SeqId:16609-106;Target:KIRR2;UniProt:Q6UWL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16609-106;Target: KIRR2;UniProt: Q6UWL6;TargetFullName: Kin of IRRE-like protein 2;Organisim: human;Apparent_Kd_M: 2.406157E-11

Real

Aptamer SeqId: 16609-106 | Target: KIRR2 | UniProt: Q6UWL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16609-106 | Target: KIRR2 | UniProt: Q6UWL6 | TargetFullName: Kin of IRRE-like protein 2 | Organisim: human | Apparent_Kd_M: 2.406157E-11

Real

Aptamer SeqId:16610-13;Target:LRP10;UniProt:Q7Z4F1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16610-13;Target: LRP10;UniProt: Q7Z4F1;TargetFullName: Low-density lipoprotein receptor-related protein 10;Organisim: human;Apparent_Kd_M: 1.163579E-12

Real

Aptamer SeqId: 16610-13 | Target: LRP10 | UniProt: Q7Z4F1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16610-13 | Target: LRP10 | UniProt: Q7Z4F1 | TargetFullName: Low-density lipoprotein receptor-related protein 10 | Organisim: human | Apparent_Kd_M: 1.163579E-12

Real

Aptamer SeqId:16612-28;Target:SDC3;UniProt:O75056

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16612-28;Target: SDC3;UniProt: O75056;TargetFullName: Syndecan-3;Organisim: human;Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId: 16612-28 | Target: SDC3 | UniProt: O75056

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16612-28 | Target: SDC3 | UniProt: O75056 | TargetFullName: Syndecan-3 | Organisim: human | Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId:16613-3;Target:CAD17;UniProt:Q12864

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16613-3;Target: CAD17;UniProt: Q12864;TargetFullName: Cadherin-17;Organisim: human;Apparent_Kd_M: 9.72E-13

Real

Aptamer SeqId: 16613-3 | Target: CAD17 | UniProt: Q12864

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16613-3 | Target: CAD17 | UniProt: Q12864 | TargetFullName: Cadherin-17 | Organisim: human | Apparent_Kd_M: 9.72E-13

Real

Aptamer SeqId:16614-27;Target:RSPO1;UniProt:Q2MKA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16614-27;Target: RSPO1;UniProt: Q2MKA7;TargetFullName: R-spondin-1;Organisim: human;Apparent_Kd_M: 7.931083E-13

Real

Aptamer SeqId: 16614-27 | Target: RSPO1 | UniProt: Q2MKA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16614-27 | Target: RSPO1 | UniProt: Q2MKA7 | TargetFullName: R-spondin-1 | Organisim: human | Apparent_Kd_M: 7.931083E-13

Real

Aptamer SeqId:16616-137;Target:ENOB;UniProt:P13929

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16616-137;Target: ENOB;UniProt: P13929;TargetFullName: Beta-enolase;Organisim: human;Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId: 16616-137 | Target: ENOB | UniProt: P13929

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16616-137 | Target: ENOB | UniProt: P13929 | TargetFullName: Beta-enolase | Organisim: human | Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId:16617-14;Target:Caspase-14;UniProt:P31944

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16617-14;Target: Caspase-14;UniProt: P31944;TargetFullName: Caspase-14;Organisim: human;Apparent_Kd_M: 2.67E-12

Real

Aptamer SeqId: 16617-14 | Target: Caspase-14 | UniProt: P31944

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16617-14 | Target: Caspase-14 | UniProt: P31944 | TargetFullName: Caspase-14 | Organisim: human | Apparent_Kd_M: 2.67E-12

Real

Aptamer SeqId:16618-7;Target:CD69;UniProt:Q07108

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16618-7;Target: CD69;UniProt: Q07108;TargetFullName: Early activation antigen CD69;Organisim: human;Apparent_Kd_M: 3.09E-12

Real

Aptamer SeqId: 16618-7 | Target: CD69 | UniProt: Q07108

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16618-7 | Target: CD69 | UniProt: Q07108 | TargetFullName: Early activation antigen CD69 | Organisim: human | Apparent_Kd_M: 3.09E-12

Real

Aptamer SeqId:16620-26;Target:LY75;UniProt:O60449

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16620-26;Target: LY75;UniProt: O60449;TargetFullName: Lymphocyte antigen 75;Organisim: human;Apparent_Kd_M: 5.70148E-13

Real

Aptamer SeqId: 16620-26 | Target: LY75 | UniProt: O60449

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16620-26 | Target: LY75 | UniProt: O60449 | TargetFullName: Lymphocyte antigen 75 | Organisim: human | Apparent_Kd_M: 5.70148E-13

Real

Aptamer SeqId:16621-77;Target:AIBP;UniProt:Q8NCW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16621-77;Target: AIBP;UniProt: Q8NCW5;TargetFullName: NAD(P)H-hydrate epimerase;Organisim: human;Apparent_Kd_M: 7.24E-13

Real

Aptamer SeqId: 16621-77 | Target: AIBP | UniProt: Q8NCW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16621-77 | Target: AIBP | UniProt: Q8NCW5 | TargetFullName: NAD(P)H-hydrate epimerase | Organisim: human | Apparent_Kd_M: 7.24E-13

Real

Aptamer SeqId:16746-12;Target:Activin B;UniProt:P09529

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16746-12;Target: Activin B;UniProt: P09529;TargetFullName: Inhibin beta B chain;Organisim: human;Apparent_Kd_M: 1.449156E-11

Real

Aptamer SeqId: 16746-12 | Target: Activin B | UniProt: P09529

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16746-12 | Target: Activin B | UniProt: P09529 | TargetFullName: Inhibin beta B chain | Organisim: human | Apparent_Kd_M: 1.449156E-11

Real

Aptamer SeqId:16748-1;Target:BMP-3;UniProt:P12645

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16748-1;Target: BMP-3;UniProt: P12645;TargetFullName: Bone morphogenetic protein 3;Organisim: human;Apparent_Kd_M: 3.414668E-12

Real

Aptamer SeqId: 16748-1 | Target: BMP-3 | UniProt: P12645

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16748-1 | Target: BMP-3 | UniProt: P12645 | TargetFullName: Bone morphogenetic protein 3 | Organisim: human | Apparent_Kd_M: 3.414668E-12

Real

Aptamer SeqId:16749-79;Target:BMP-3b;UniProt:P55107

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16749-79;Target: BMP-3b;UniProt: P55107;TargetFullName: Growth/differentiation factor 10;Organisim: human;Apparent_Kd_M: 7.444813E-12

Real

Aptamer SeqId: 16749-79 | Target: BMP-3b | UniProt: P55107

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16749-79 | Target: BMP-3b | UniProt: P55107 | TargetFullName: Growth/differentiation factor 10 | Organisim: human | Apparent_Kd_M: 7.444813E-12

Real

Aptamer SeqId:16751-15;Target:BNP;UniProt:P16860

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16751-15;Target: BNP;UniProt: P16860;TargetFullName: Natriuretic peptides B;Organisim: human;Apparent_Kd_M: 4.058353E-11

Real

Aptamer SeqId: 16751-15 | Target: BNP | UniProt: P16860

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16751-15 | Target: BNP | UniProt: P16860 | TargetFullName: Natriuretic peptides B | Organisim: human | Apparent_Kd_M: 4.058353E-11

Real

Aptamer SeqId:16753-46;Target:CO6A2;UniProt:P12110

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16753-46;Target: CO6A2;UniProt: P12110;TargetFullName: Collagen alpha-2(VI) chain;Organisim: human;Apparent_Kd_M: 3.287554E-11

Real

Aptamer SeqId: 16753-46 | Target: CO6A2 | UniProt: P12110

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16753-46 | Target: CO6A2 | UniProt: P12110 | TargetFullName: Collagen alpha-2(VI) chain | Organisim: human | Apparent_Kd_M: 3.287554E-11

Real

Aptamer SeqId:16754-40;Target:CSKP;UniProt:O14936

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16754-40;Target: CSKP;UniProt: O14936;TargetFullName: Peripheral plasma membrane protein CASK;Organisim: human;Apparent_Kd_M: 2.521072E-11

Real

Aptamer SeqId: 16754-40 | Target: CSKP | UniProt: O14936

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16754-40 | Target: CSKP | UniProt: O14936 | TargetFullName: Peripheral plasma membrane protein CASK | Organisim: human | Apparent_Kd_M: 2.521072E-11

Real

Aptamer SeqId:16755-195;Target:GDF-3;UniProt:Q9NR23

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16755-195;Target: GDF-3;UniProt: Q9NR23;TargetFullName: Growth/differentiation factor 3;Organisim: human;Apparent_Kd_M: 1.557838E-11

Real

Aptamer SeqId: 16755-195 | Target: GDF-3 | UniProt: Q9NR23

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16755-195 | Target: GDF-3 | UniProt: Q9NR23 | TargetFullName: Growth/differentiation factor 3 | Organisim: human | Apparent_Kd_M: 1.557838E-11

Real

Aptamer SeqId:16756-30;Target:GDF7;UniProt:Q7Z4P5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16756-30;Target: GDF7;UniProt: Q7Z4P5;TargetFullName: Growth/differentiation factor 7;Organisim: human;Apparent_Kd_M: 4.444178E-12

Real

Aptamer SeqId: 16756-30 | Target: GDF7 | UniProt: Q7Z4P5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16756-30 | Target: GDF7 | UniProt: Q7Z4P5 | TargetFullName: Growth/differentiation factor 7 | Organisim: human | Apparent_Kd_M: 4.444178E-12

Real

Aptamer SeqId:16758-96;Target:HDGF;UniProt:P51858

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16758-96;Target: HDGF;UniProt: P51858;TargetFullName: Hepatoma-derived growth factor;Organisim: human;Apparent_Kd_M: 5.179158E-12

Real

Aptamer SeqId: 16758-96 | Target: HDGF | UniProt: P51858

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16758-96 | Target: HDGF | UniProt: P51858 | TargetFullName: Hepatoma-derived growth factor | Organisim: human | Apparent_Kd_M: 5.179158E-12

Real

Aptamer SeqId:16760-2;Target:IL-26;UniProt:Q9NPH9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16760-2;Target: IL-26;UniProt: Q9NPH9;TargetFullName: Interleukin-26;Organisim: human;Apparent_Kd_M: 3.918191E-11

Real

Aptamer SeqId: 16760-2 | Target: IL-26 | UniProt: Q9NPH9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16760-2 | Target: IL-26 | UniProt: Q9NPH9 | TargetFullName: Interleukin-26 | Organisim: human | Apparent_Kd_M: 3.918191E-11

Real

Aptamer SeqId:16763-11;Target:LECT2;UniProt:O14960

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16763-11;Target: LECT2;UniProt: O14960;TargetFullName: Leukocyte cell-derived chemotaxin-2;Organisim: human;Apparent_Kd_M: 5.907459E-12

Real

Aptamer SeqId: 16763-11 | Target: LECT2 | UniProt: O14960

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16763-11 | Target: LECT2 | UniProt: O14960 | TargetFullName: Leukocyte cell-derived chemotaxin-2 | Organisim: human | Apparent_Kd_M: 5.907459E-12

Real

Aptamer SeqId:16765-52;Target:PBP;UniProt:P02775

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16765-52;Target: PBP;UniProt: P02775;TargetFullName: Platelet basic protein;Organisim: human;Apparent_Kd_M: 3.767972E-12

Real

Aptamer SeqId: 16765-52 | Target: PBP | UniProt: P02775

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16765-52 | Target: PBP | UniProt: P02775 | TargetFullName: Platelet basic protein | Organisim: human | Apparent_Kd_M: 3.767972E-12

Real

Aptamer SeqId:16768-3;Target:PLAK;UniProt:P14923

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16768-3;Target: PLAK;UniProt: P14923;TargetFullName: Junction plakoglobin;Organisim: human;Apparent_Kd_M: 2.531416E-11

Real

Aptamer SeqId: 16768-3 | Target: PLAK | UniProt: P14923

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16768-3 | Target: PLAK | UniProt: P14923 | TargetFullName: Junction plakoglobin | Organisim: human | Apparent_Kd_M: 2.531416E-11

Real

Aptamer SeqId:16769-20;Target:RAC3;UniProt:P60763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16769-20;Target: RAC3;UniProt: P60763;TargetFullName: Ras-related C3 botulinum toxin substrate 3;Organisim: human;Apparent_Kd_M: 5.216645E-11

Real

Aptamer SeqId: 16769-20 | Target: RAC3 | UniProt: P60763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16769-20 | Target: RAC3 | UniProt: P60763 | TargetFullName: Ras-related C3 botulinum toxin substrate 3 | Organisim: human | Apparent_Kd_M: 5.216645E-11

Real

Aptamer SeqId:16770-3;Target:REG1B;UniProt:P48304

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16770-3;Target: REG1B;UniProt: P48304;TargetFullName: Lithostathine-1-beta;Organisim: human;Apparent_Kd_M: 2.223966E-12

Real

Aptamer SeqId: 16770-3 | Target: REG1B | UniProt: P48304

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16770-3 | Target: REG1B | UniProt: P48304 | TargetFullName: Lithostathine-1-beta | Organisim: human | Apparent_Kd_M: 2.223966E-12

Real

Aptamer SeqId:16773-29;Target:SCUB3;UniProt:Q8IX30

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16773-29;Target: SCUB3;UniProt: Q8IX30;TargetFullName: Signal peptide; CUB and EGF-like domain-containing protein 3;Organisim: human;Apparent_Kd_M: 1.339805E-12

Real

Aptamer SeqId: 16773-29 | Target: SCUB3 | UniProt: Q8IX30

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16773-29 | Target: SCUB3 | UniProt: Q8IX30 | TargetFullName: Signal peptide; CUB and EGF-like domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 1.339805E-12

Real

Aptamer SeqId:16780-6;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16780-6;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 3.149031E-11

Real

Aptamer SeqId: 16780-6 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16780-6 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 3.149031E-11

Real

Aptamer SeqId:16781-2;Target:ENASE;UniProt:Q8NFI3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16781-2;Target: ENASE;UniProt: Q8NFI3;TargetFullName: Cytosolic endo-beta-N-acetylglucosaminidase;Organisim: human;Apparent_Kd_M: 2.741606E-12

Real

Aptamer SeqId: 16781-2 | Target: ENASE | UniProt: Q8NFI3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16781-2 | Target: ENASE | UniProt: Q8NFI3 | TargetFullName: Cytosolic endo-beta-N-acetylglucosaminidase | Organisim: human | Apparent_Kd_M: 2.741606E-12

Real

Aptamer SeqId:16785-45;Target:HD-5;UniProt:Q01523

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16785-45;Target: HD-5;UniProt: Q01523;TargetFullName: Defensin-5;Organisim: human;Apparent_Kd_M: 1.049737E-11

Real

Aptamer SeqId: 16785-45 | Target: HD-5 | UniProt: Q01523

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16785-45 | Target: HD-5 | UniProt: Q01523 | TargetFullName: Defensin-5 | Organisim: human | Apparent_Kd_M: 1.049737E-11

Real

Aptamer SeqId:16792-4;Target:Siglec-5;UniProt:O15389

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16792-4;Target: Siglec-5;UniProt: O15389;TargetFullName: Sialic acid-binding Ig-like lectin 5;Organisim: human;Apparent_Kd_M: 8.173935E-12

Real

Aptamer SeqId: 16792-4 | Target: Siglec-5 | UniProt: O15389

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16792-4 | Target: Siglec-5 | UniProt: O15389 | TargetFullName: Sialic acid-binding Ig-like lectin 5 | Organisim: human | Apparent_Kd_M: 8.173935E-12

Real

Aptamer SeqId:16802-31;Target:OCAD1;UniProt:Q9NX40

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16802-31;Target: OCAD1;UniProt: Q9NX40;TargetFullName: OCIA domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.308981E-10

Real

Aptamer SeqId: 16802-31 | Target: OCAD1 | UniProt: Q9NX40

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16802-31 | Target: OCAD1 | UniProt: Q9NX40 | TargetFullName: OCIA domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.308981E-10

Real

Aptamer SeqId:16803-4;Target:CALB2;UniProt:P22676

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16803-4;Target: CALB2;UniProt: P22676;TargetFullName: Calretinin;Organisim: human;Apparent_Kd_M: 6.263958E-12

Real

Aptamer SeqId: 16803-4 | Target: CALB2 | UniProt: P22676

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16803-4 | Target: CALB2 | UniProt: P22676 | TargetFullName: Calretinin | Organisim: human | Apparent_Kd_M: 6.263958E-12

Real

Aptamer SeqId:16805-5;Target:PDE5A;UniProt:O76074

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16805-5;Target: PDE5A;UniProt: O76074;TargetFullName: cGMP-specific 3;5-cyclic phosphodiesterase;Organisim: human;Apparent_Kd_M: 4.827439E-11

Real

Aptamer SeqId: 16805-5 | Target: PDE5A | UniProt: O76074

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16805-5 | Target: PDE5A | UniProt: O76074 | TargetFullName: cGMP-specific 3';5'-cyclic phosphodiesterase | Organisim: human | Apparent_Kd_M: 4.827439E-11

Real

Aptamer SeqId:16807-35;Target:TNNT3;UniProt:P45378

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16807-35;Target: TNNT3;UniProt: P45378;TargetFullName: Troponin T; fast skeletal muscle;Organisim: human;Apparent_Kd_M: 1.709123E-11

Real

Aptamer SeqId: 16807-35 | Target: TNNT3 | UniProt: P45378

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16807-35 | Target: TNNT3 | UniProt: P45378 | TargetFullName: Troponin T; fast skeletal muscle | Organisim: human | Apparent_Kd_M: 1.709123E-11

Real

Aptamer SeqId:16809-1;Target:NDKM;UniProt:O00746

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16809-1;Target: NDKM;UniProt: O00746;TargetFullName: Nucleoside diphosphate kinase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.43384E-11

Real

Aptamer SeqId: 16809-1 | Target: NDKM | UniProt: O00746

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16809-1 | Target: NDKM | UniProt: O00746 | TargetFullName: Nucleoside diphosphate kinase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.43384E-11

Real

Aptamer SeqId:16810-3;Target:RhoGDI;UniProt:P31150

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16810-3;Target: RhoGDI;UniProt: P31150;TargetFullName: Rab GDP dissociation inhibitor alpha;Organisim: human;Apparent_Kd_M: 2.738634E-11

Real

Aptamer SeqId: 16810-3 | Target: RhoGDI | UniProt: P31150

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16810-3 | Target: RhoGDI | UniProt: P31150 | TargetFullName: Rab GDP dissociation inhibitor alpha | Organisim: human | Apparent_Kd_M: 2.738634E-11

Real

Aptamer SeqId:16814-13;Target:SLIM 1;UniProt:Q13642

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16814-13;Target: SLIM 1;UniProt: Q13642;TargetFullName: Four and a half LIM domains protein 1;Organisim: human;Apparent_Kd_M: 3.661102E-11

Real

Aptamer SeqId: 16814-13 | Target: SLIM 1 | UniProt: Q13642

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16814-13 | Target: SLIM 1 | UniProt: Q13642 | TargetFullName: Four and a half LIM domains protein 1 | Organisim: human | Apparent_Kd_M: 3.661102E-11

Real

Aptamer SeqId:16818-200;Target:CDCP1;UniProt:Q9H5V8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16818-200;Target: CDCP1;UniProt: Q9H5V8;TargetFullName: CUB domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.693897E-12

Real

Aptamer SeqId: 16818-200 | Target: CDCP1 | UniProt: Q9H5V8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16818-200 | Target: CDCP1 | UniProt: Q9H5V8 | TargetFullName: CUB domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.693897E-12

Real

Aptamer SeqId:16823-75;Target:APOL3;UniProt:O95236

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16823-75;Target: APOL3;UniProt: O95236;TargetFullName: Apolipoprotein L3;Organisim: human;Apparent_Kd_M: 8.485199E-11

Real

Aptamer SeqId: 16823-75 | Target: APOL3 | UniProt: O95236

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16823-75 | Target: APOL3 | UniProt: O95236 | TargetFullName: Apolipoprotein L3 | Organisim: human | Apparent_Kd_M: 8.485199E-11

Real

Aptamer SeqId:16825-20;Target:ATX3;UniProt:P54252

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16825-20;Target: ATX3;UniProt: P54252;TargetFullName: Ataxin-3;Organisim: human;Apparent_Kd_M: 5.649137E-12

Real

Aptamer SeqId: 16825-20 | Target: ATX3 | UniProt: P54252

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16825-20 | Target: ATX3 | UniProt: P54252 | TargetFullName: Ataxin-3 | Organisim: human | Apparent_Kd_M: 5.649137E-12

Real

Aptamer SeqId:16828-8;Target:Collagen a1(VI);UniProt:P12109

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16828-8;Target: Collagen a1(VI);UniProt: P12109;TargetFullName: Collagen alpha-1(VI) chain;Organisim: human;Apparent_Kd_M: 4.138864E-12

Real

Aptamer SeqId: 16828-8 | Target: Collagen a1(VI) | UniProt: P12109

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16828-8 | Target: Collagen a1(VI) | UniProt: P12109 | TargetFullName: Collagen alpha-1(VI) chain | Organisim: human | Apparent_Kd_M: 4.138864E-12

Real

Aptamer SeqId:16831-7;Target:DOK1;UniProt:Q99704

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16831-7;Target: DOK1;UniProt: Q99704;TargetFullName: Docking protein 1;Organisim: human;Apparent_Kd_M: 1.164319E-11

Real

Aptamer SeqId: 16831-7 | Target: DOK1 | UniProt: Q99704

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16831-7 | Target: DOK1 | UniProt: Q99704 | TargetFullName: Docking protein 1 | Organisim: human | Apparent_Kd_M: 1.164319E-11

Real

Aptamer SeqId:16836-1;Target:FHR3;UniProt:Q02985

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16836-1;Target: FHR3;UniProt: Q02985;TargetFullName: Complement factor H-related protein 3;Organisim: human;Apparent_Kd_M: 8.229739E-11

Real

Aptamer SeqId: 16836-1 | Target: FHR3 | UniProt: Q02985

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16836-1 | Target: FHR3 | UniProt: Q02985 | TargetFullName: Complement factor H-related protein 3 | Organisim: human | Apparent_Kd_M: 8.229739E-11

Real

Aptamer SeqId:16837-20;Target:FLIP;UniProt:O15519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16837-20;Target: FLIP;UniProt: O15519;TargetFullName: CASP8 and FADD-like apoptosis regulator;Organisim: human;Apparent_Kd_M: 3.201695E-12

Real

Aptamer SeqId: 16837-20 | Target: FLIP | UniProt: O15519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16837-20 | Target: FLIP | UniProt: O15519 | TargetFullName: CASP8 and FADD-like apoptosis regulator | Organisim: human | Apparent_Kd_M: 3.201695E-12

Real

Aptamer SeqId:16845-15;Target:MPZL1;UniProt:O95297

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16845-15;Target: MPZL1;UniProt: O95297;TargetFullName: Myelin protein zero-like protein 1;Organisim: human;Apparent_Kd_M: 1.857E-11

Real

Aptamer SeqId: 16845-15 | Target: MPZL1 | UniProt: O95297

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16845-15 | Target: MPZL1 | UniProt: O95297 | TargetFullName: Myelin protein zero-like protein 1 | Organisim: human | Apparent_Kd_M: 1.857E-11

Real

Aptamer SeqId:16847-39;Target:RAB3B;UniProt:P20337

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16847-39;Target: RAB3B;UniProt: P20337;TargetFullName: Ras-related protein Rab-3B;Organisim: human;Apparent_Kd_M: 5.195905E-11

Real

Aptamer SeqId: 16847-39 | Target: RAB3B | UniProt: P20337

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16847-39 | Target: RAB3B | UniProt: P20337 | TargetFullName: Ras-related protein Rab-3B | Organisim: human | Apparent_Kd_M: 5.195905E-11

Real

Aptamer SeqId:16850-5;Target:RGS5;UniProt:O15539

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16850-5;Target: RGS5;UniProt: O15539;TargetFullName: Regulator of G-protein signaling 5;Organisim: human;Apparent_Kd_M: 6.090741E-11

Real

Aptamer SeqId: 16850-5 | Target: RGS5 | UniProt: O15539

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16850-5 | Target: RGS5 | UniProt: O15539 | TargetFullName: Regulator of G-protein signaling 5 | Organisim: human | Apparent_Kd_M: 6.090741E-11

Real

Aptamer SeqId:16851-50;Target:SCO2;UniProt:O43819

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16851-50;Target: SCO2;UniProt: O43819;TargetFullName: Protein SCO2 homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 9.971753E-12

Real

Aptamer SeqId: 16851-50 | Target: SCO2 | UniProt: O43819

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16851-50 | Target: SCO2 | UniProt: O43819 | TargetFullName: Protein SCO2 homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 9.971753E-12

Real

Aptamer SeqId:16852-10;Target:NHRF3;UniProt:Q5T2W1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16852-10;Target: NHRF3;UniProt: Q5T2W1;TargetFullName: Na(+)/H(+) exchange regulatory cofactor NHE-RF3;Organisim: human;Apparent_Kd_M: 2.459986E-11

Real

Aptamer SeqId: 16852-10 | Target: NHRF3 | UniProt: Q5T2W1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16852-10 | Target: NHRF3 | UniProt: Q5T2W1 | TargetFullName: Na(+)/H(+) exchange regulatory cofactor NHE-RF3 | Organisim: human | Apparent_Kd_M: 2.459986E-11

Real

Aptamer SeqId:16853-5;Target:NRK1;UniProt:Q9NWW6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16853-5;Target: NRK1;UniProt: Q9NWW6;TargetFullName: Nicotinamide riboside kinase 1;Organisim: human;Apparent_Kd_M: 3.312692E-11

Real

Aptamer SeqId: 16853-5 | Target: NRK1 | UniProt: Q9NWW6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16853-5 | Target: NRK1 | UniProt: Q9NWW6 | TargetFullName: Nicotinamide riboside kinase 1 | Organisim: human | Apparent_Kd_M: 3.312692E-11

Real

Aptamer SeqId:16854-17;Target:LSM4;UniProt:Q9Y4Z0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16854-17;Target: LSM4;UniProt: Q9Y4Z0;TargetFullName: U6 snRNA-associated Sm-like protein LSm4;Organisim: human;Apparent_Kd_M: 3.085535E-11

Real

Aptamer SeqId: 16854-17 | Target: LSM4 | UniProt: Q9Y4Z0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16854-17 | Target: LSM4 | UniProt: Q9Y4Z0 | TargetFullName: U6 snRNA-associated Sm-like protein LSm4 | Organisim: human | Apparent_Kd_M: 3.085535E-11

Real

Aptamer SeqId:16856-79;Target:MARE2;UniProt:Q15555

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16856-79;Target: MARE2;UniProt: Q15555;TargetFullName: Microtubule-associated protein RP/EB family member 2;Organisim: human;Apparent_Kd_M: 1.536791E-10

Real

Aptamer SeqId: 16856-79 | Target: MARE2 | UniProt: Q15555

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16856-79 | Target: MARE2 | UniProt: Q15555 | TargetFullName: Microtubule-associated protein RP/EB family member 2 | Organisim: human | Apparent_Kd_M: 1.536791E-10

Real

Aptamer SeqId:16857-2;Target:RAB2A;UniProt:P61019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16857-2;Target: RAB2A;UniProt: P61019;TargetFullName: Ras-related protein Rab-2A;Organisim: human;Apparent_Kd_M: 2.041296E-11

Real

Aptamer SeqId: 16857-2 | Target: RAB2A | UniProt: P61019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16857-2 | Target: RAB2A | UniProt: P61019 | TargetFullName: Ras-related protein Rab-2A | Organisim: human | Apparent_Kd_M: 2.041296E-11

Real

Aptamer SeqId:16858-384;Target:RCN3;UniProt:Q96D15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16858-384;Target: RCN3;UniProt: Q96D15;TargetFullName: Reticulocalbin-3;Organisim: human;Apparent_Kd_M: 8.433873E-11

Real

Aptamer SeqId: 16858-384 | Target: RCN3 | UniProt: Q96D15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16858-384 | Target: RCN3 | UniProt: Q96D15 | TargetFullName: Reticulocalbin-3 | Organisim: human | Apparent_Kd_M: 8.433873E-11

Real

Aptamer SeqId:16859-100;Target:SHLB1;UniProt:Q9Y371

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16859-100;Target: SHLB1;UniProt: Q9Y371;TargetFullName: Endophilin-B1;Organisim: human;Apparent_Kd_M: 1.195108E-10

Real

Aptamer SeqId: 16859-100 | Target: SHLB1 | UniProt: Q9Y371

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16859-100 | Target: SHLB1 | UniProt: Q9Y371 | TargetFullName: Endophilin-B1 | Organisim: human | Apparent_Kd_M: 1.195108E-10

Real

Aptamer SeqId:16863-47;Target:NANP;UniProt:Q8TBE9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16863-47;Target: NANP;UniProt: Q8TBE9;TargetFullName: N-acylneuraminate-9-phosphatase;Organisim: human;Apparent_Kd_M: 5.906363E-11

Real

Aptamer SeqId: 16863-47 | Target: NANP | UniProt: Q8TBE9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16863-47 | Target: NANP | UniProt: Q8TBE9 | TargetFullName: N-acylneuraminate-9-phosphatase | Organisim: human | Apparent_Kd_M: 5.906363E-11

Real

Aptamer SeqId:16865-62;Target:RBP56;UniProt:Q92804

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16865-62;Target: RBP56;UniProt: Q92804;TargetFullName: TATA-binding protein-associated factor 2N;Organisim: human;Apparent_Kd_M: 1.063287E-11

Real

Aptamer SeqId: 16865-62 | Target: RBP56 | UniProt: Q92804

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16865-62 | Target: RBP56 | UniProt: Q92804 | TargetFullName: TATA-binding protein-associated factor 2N | Organisim: human | Apparent_Kd_M: 1.063287E-11

Real

Aptamer SeqId:16867-76;Target:PCTK1;UniProt:Q00536

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16867-76;Target: PCTK1;UniProt: Q00536;TargetFullName: Cyclin-dependent kinase 16;Organisim: human;Apparent_Kd_M: 1.421841E-11

Real

Aptamer SeqId: 16867-76 | Target: PCTK1 | UniProt: Q00536

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16867-76 | Target: PCTK1 | UniProt: Q00536 | TargetFullName: Cyclin-dependent kinase 16 | Organisim: human | Apparent_Kd_M: 1.421841E-11

Real

Aptamer SeqId:16872-248;Target:MAAI;UniProt:O43708

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16872-248;Target: MAAI;UniProt: O43708;TargetFullName: Maleylacetoacetate isomerase;Organisim: human;Apparent_Kd_M: 2.291695E-10

Real

Aptamer SeqId: 16872-248 | Target: MAAI | UniProt: O43708

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16872-248 | Target: MAAI | UniProt: O43708 | TargetFullName: Maleylacetoacetate isomerase | Organisim: human | Apparent_Kd_M: 2.291695E-10

Real

Aptamer SeqId:16875-13;Target:MGN2;UniProt:Q96A72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16875-13;Target: MGN2;UniProt: Q96A72;TargetFullName: Protein mago nashi homolog 2;Organisim: human;Apparent_Kd_M: 2.663681E-11

Real

Aptamer SeqId: 16875-13 | Target: MGN2 | UniProt: Q96A72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16875-13 | Target: MGN2 | UniProt: Q96A72 | TargetFullName: Protein mago nashi homolog 2 | Organisim: human | Apparent_Kd_M: 2.663681E-11

Real

Aptamer SeqId:16877-19;Target:MSRB2;UniProt:Q9Y3D2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16877-19;Target: MSRB2;UniProt: Q9Y3D2;TargetFullName: Methionine-R-sulfoxide reductase B2; mitochondrial;Organisim: human;Apparent_Kd_M: 1.133965E-11

Real

Aptamer SeqId: 16877-19 | Target: MSRB2 | UniProt: Q9Y3D2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16877-19 | Target: MSRB2 | UniProt: Q9Y3D2 | TargetFullName: Methionine-R-sulfoxide reductase B2; mitochondrial | Organisim: human | Apparent_Kd_M: 1.133965E-11

Real

Aptamer SeqId:16882-27;Target:PHP14;UniProt:Q9NRX4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16882-27;Target: PHP14;UniProt: Q9NRX4;TargetFullName: 14 kDa phosphohistidine phosphatase;Organisim: human;Apparent_Kd_M: 1.466435E-10

Real

Aptamer SeqId: 16882-27 | Target: PHP14 | UniProt: Q9NRX4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16882-27 | Target: PHP14 | UniProt: Q9NRX4 | TargetFullName: 14 kDa phosphohistidine phosphatase | Organisim: human | Apparent_Kd_M: 1.466435E-10

Real

Aptamer SeqId:16883-57;Target:RAB4A;UniProt:P20338

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16883-57;Target: RAB4A;UniProt: P20338;TargetFullName: Ras-related protein Rab-4A;Organisim: human;Apparent_Kd_M: 9.705301E-12

Real

Aptamer SeqId: 16883-57 | Target: RAB4A | UniProt: P20338

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16883-57 | Target: RAB4A | UniProt: P20338 | TargetFullName: Ras-related protein Rab-4A | Organisim: human | Apparent_Kd_M: 9.705301E-12

Real

Aptamer SeqId:16885-49;Target:MARE3;UniProt:Q9UPY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16885-49;Target: MARE3;UniProt: Q9UPY8;TargetFullName: Microtubule-associated protein RP/EB family member 3;Organisim: human;Apparent_Kd_M: 2.975868E-12

Real

Aptamer SeqId: 16885-49 | Target: MARE3 | UniProt: Q9UPY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16885-49 | Target: MARE3 | UniProt: Q9UPY8 | TargetFullName: Microtubule-associated protein RP/EB family member 3 | Organisim: human | Apparent_Kd_M: 2.975868E-12

Real

Aptamer SeqId:16887-29;Target:PTH2;UniProt:Q9Y3E5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16887-29;Target: PTH2;UniProt: Q9Y3E5;TargetFullName: Peptidyl-tRNA hydrolase 2; mitochondrial;Organisim: human;Apparent_Kd_M: 3.464724E-12

Real

Aptamer SeqId: 16887-29 | Target: PTH2 | UniProt: Q9Y3E5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16887-29 | Target: PTH2 | UniProt: Q9Y3E5 | TargetFullName: Peptidyl-tRNA hydrolase 2; mitochondrial | Organisim: human | Apparent_Kd_M: 3.464724E-12

Real

Aptamer SeqId:16890-37;Target:ATL1;UniProt:Q8N6G6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16890-37;Target: ATL1;UniProt: Q8N6G6;TargetFullName: ADAMTS-like protein 1;Organisim: human;Apparent_Kd_M: 1.708191E-12

Real

Aptamer SeqId: 16890-37 | Target: ATL1 | UniProt: Q8N6G6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16890-37 | Target: ATL1 | UniProt: Q8N6G6 | TargetFullName: ADAMTS-like protein 1 | Organisim: human | Apparent_Kd_M: 1.708191E-12

Real

Aptamer SeqId:16892-23;Target:ENPP2;UniProt:Q13822

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16892-23;Target: ENPP2;UniProt: Q13822;TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;Organisim: human;Apparent_Kd_M: 4.055568E-12

Real

Aptamer SeqId: 16892-23 | Target: ENPP2 | UniProt: Q13822

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16892-23 | Target: ENPP2 | UniProt: Q13822 | TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Organisim: human | Apparent_Kd_M: 4.055568E-12

Real

Aptamer SeqId:16899-59;Target:OSBL9;UniProt:Q96SU4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16899-59;Target: OSBL9;UniProt: Q96SU4;TargetFullName: Oxysterol-binding protein-related protein 9;Organisim: human;Apparent_Kd_M: 9.762173E-11

Real

Aptamer SeqId: 16899-59 | Target: OSBL9 | UniProt: Q96SU4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16899-59 | Target: OSBL9 | UniProt: Q96SU4 | TargetFullName: Oxysterol-binding protein-related protein 9 | Organisim: human | Apparent_Kd_M: 9.762173E-11

Real

Aptamer SeqId:16900-29;Target:MDGA1;UniProt:Q8NFP4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16900-29;Target: MDGA1;UniProt: Q8NFP4;TargetFullName: MAM domain-containing glycosylphosphatidylinositol anchor protein 1;Organisim: human;Apparent_Kd_M: 4.919168E-12

Real

Aptamer SeqId: 16900-29 | Target: MDGA1 | UniProt: Q8NFP4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16900-29 | Target: MDGA1 | UniProt: Q8NFP4 | TargetFullName: MAM domain-containing glycosylphosphatidylinositol anchor protein 1 | Organisim: human | Apparent_Kd_M: 4.919168E-12

Real

Aptamer SeqId:16902-17;Target:LAMP1;UniProt:P11279

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16902-17;Target: LAMP1;UniProt: P11279;TargetFullName: Lysosome-associated membrane glycoprotein 1;Organisim: human;Apparent_Kd_M: 2.326273E-11

Real

Aptamer SeqId: 16902-17 | Target: LAMP1 | UniProt: P11279

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16902-17 | Target: LAMP1 | UniProt: P11279 | TargetFullName: Lysosome-associated membrane glycoprotein 1 | Organisim: human | Apparent_Kd_M: 2.326273E-11

Real

Aptamer SeqId:16907-3;Target:Nectin-like protein 3;UniProt:Q8N3J6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16907-3;Target: Nectin-like protein 3;UniProt: Q8N3J6;TargetFullName: Cell adhesion molecule 2;Organisim: human;Apparent_Kd_M: 5.62963E-11

Real

Aptamer SeqId: 16907-3 | Target: Nectin-like protein 3 | UniProt: Q8N3J6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16907-3 | Target: Nectin-like protein 3 | UniProt: Q8N3J6 | TargetFullName: Cell adhesion molecule 2 | Organisim: human | Apparent_Kd_M: 5.62963E-11

Real

Aptamer SeqId:16908-5;Target:OMGP;UniProt:P23515

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16908-5;Target: OMGP;UniProt: P23515;TargetFullName: Oligodendrocyte-myelin glycoprotein;Organisim: human;Apparent_Kd_M: 3.037119E-12

Real

Aptamer SeqId: 16908-5 | Target: OMGP | UniProt: P23515

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16908-5 | Target: OMGP | UniProt: P23515 | TargetFullName: Oligodendrocyte-myelin glycoprotein | Organisim: human | Apparent_Kd_M: 3.037119E-12

Real

Aptamer SeqId:16913-8;Target:RNT2;UniProt:O00584

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16913-8;Target: RNT2;UniProt: O00584;TargetFullName: Ribonuclease T2;Organisim: human;Apparent_Kd_M: 2.100166E-11

Real

Aptamer SeqId: 16913-8 | Target: RNT2 | UniProt: O00584

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16913-8 | Target: RNT2 | UniProt: O00584 | TargetFullName: Ribonuclease T2 | Organisim: human | Apparent_Kd_M: 2.100166E-11

Real

Aptamer SeqId:16914-104;Target:sCD14;UniProt:P08571

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16914-104;Target: sCD14;UniProt: P08571;TargetFullName: Monocyte differentiation antigen CD14; soluble;Organisim: human;Apparent_Kd_M: 6.779422E-12

Real

Aptamer SeqId: 16914-104 | Target: sCD14 | UniProt: P08571

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16914-104 | Target: sCD14 | UniProt: P08571 | TargetFullName: Monocyte differentiation antigen CD14; soluble | Organisim: human | Apparent_Kd_M: 6.779422E-12

Real

Aptamer SeqId:16915-153;Target:SEM4A;UniProt:Q9H3S1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16915-153;Target: SEM4A;UniProt: Q9H3S1;TargetFullName: Semaphorin-4A;Organisim: human;Apparent_Kd_M: 9.575184E-13

Real

Aptamer SeqId: 16915-153 | Target: SEM4A | UniProt: Q9H3S1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16915-153 | Target: SEM4A | UniProt: Q9H3S1 | TargetFullName: Semaphorin-4A | Organisim: human | Apparent_Kd_M: 9.575184E-13

Real

Aptamer SeqId:16916-19;Target:SLIK6;UniProt:Q9H5Y7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16916-19;Target: SLIK6;UniProt: Q9H5Y7;TargetFullName: SLIT and NTRK-like protein 6;Organisim: human;Apparent_Kd_M: 3.580543E-12

Real

Aptamer SeqId: 16916-19 | Target: SLIK6 | UniProt: Q9H5Y7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16916-19 | Target: SLIK6 | UniProt: Q9H5Y7 | TargetFullName: SLIT and NTRK-like protein 6 | Organisim: human | Apparent_Kd_M: 3.580543E-12

Real

Aptamer SeqId:16918-198;Target:TLR3;UniProt:O15455

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16918-198;Target: TLR3;UniProt: O15455;TargetFullName: Toll-like receptor 3;Organisim: human;Apparent_Kd_M: 5.851103E-12

Real

Aptamer SeqId: 16918-198 | Target: TLR3 | UniProt: O15455

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16918-198 | Target: TLR3 | UniProt: O15455 | TargetFullName: Toll-like receptor 3 | Organisim: human | Apparent_Kd_M: 5.851103E-12

Real

Aptamer SeqId:16919-1;Target:ACBP;UniProt:P07108

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16919-1;Target: ACBP;UniProt: P07108;TargetFullName: Acyl-CoA-binding protein;Organisim: human;Apparent_Kd_M: 3.516301E-13

Real

Aptamer SeqId: 16919-1 | Target: ACBP | UniProt: P07108

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16919-1 | Target: ACBP | UniProt: P07108 | TargetFullName: Acyl-CoA-binding protein | Organisim: human | Apparent_Kd_M: 3.516301E-13

Real

Aptamer SeqId:16922-53;Target:PLXB3;UniProt:Q9ULL4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16922-53;Target: PLXB3;UniProt: Q9ULL4;TargetFullName: Plexin-B3;Organisim: human;Apparent_Kd_M: 1.009782E-11

Real

Aptamer SeqId: 16922-53 | Target: PLXB3 | UniProt: Q9ULL4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16922-53 | Target: PLXB3 | UniProt: Q9ULL4 | TargetFullName: Plexin-B3 | Organisim: human | Apparent_Kd_M: 1.009782E-11

Real

Aptamer SeqId:16923-20;Target:Profilin II;UniProt:P35080

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16923-20;Target: Profilin II;UniProt: P35080;TargetFullName: Profilin-2;Organisim: human;Apparent_Kd_M: 8.507672E-11

Real

Aptamer SeqId: 16923-20 | Target: Profilin II | UniProt: P35080

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16923-20 | Target: Profilin II | UniProt: P35080 | TargetFullName: Profilin-2 | Organisim: human | Apparent_Kd_M: 8.507672E-11

Real

Aptamer SeqId:16926-44;Target:Alkaline phosphatase; liver;UniProt:P05186

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16926-44;Target: Alkaline phosphatase; liver;UniProt: P05186;TargetFullName: Alkaline phosphatase; tissue-nonspecific isozyme;Organisim: human;Apparent_Kd_M: 2.563496E-11

Real

Aptamer SeqId: 16926-44 | Target: Alkaline phosphatase liver

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16926-44 | Target: Alkaline phosphatase; liver | UniProt: P05186 | TargetFullName: Alkaline phosphatase; tissue-nonspecific isozyme | Organisim: human | Apparent_Kd_M: 2.563496E-11

Real

Aptamer SeqId:16927-9;Target:Coagulation factor XIII;UniProt:P00488|P05160

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16927-9;Target: Coagulation factor XIII;UniProt: P00488|P05160;TargetFullName: Coagulation factor XIII;Organisim: human;Apparent_Kd_M: 2.05227E-12

Real

Aptamer SeqId: 16927-9 | Target: Coagulation factor XIII

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16927-9 | Target: Coagulation factor XIII | UniProt: P00488|P05160 | TargetFullName: Coagulation factor XIII | Organisim: human | Apparent_Kd_M: 2.05227E-12

Real

Aptamer SeqId:16932-5;Target:SULT 1E;UniProt:P49888

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 16932-5;Target: SULT 1E;UniProt: P49888;TargetFullName: Estrogen sulfotransferase;Organisim: human;Apparent_Kd_M: 1.74E-11

Real

Aptamer SeqId: 16932-5 | Target: SULT 1E | UniProt: P49888

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 16932-5 | Target: SULT 1E | UniProt: P49888 | TargetFullName: Estrogen sulfotransferase | Organisim: human | Apparent_Kd_M: 1.74E-11

Real

Aptamer SeqId:17137-160;Target:Beta-globin;UniProt:P68871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17137-160;Target: Beta-globin;UniProt: P68871;TargetFullName: Hemoglobin subunit beta;Organisim: human;Apparent_Kd_M: 5.61E-12

Real

Aptamer SeqId: 17137-160 | Target: Beta-globin | UniProt: P68871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17137-160 | Target: Beta-globin | UniProt: P68871 | TargetFullName: Hemoglobin subunit beta | Organisim: human | Apparent_Kd_M: 5.61E-12

Real

Aptamer SeqId:17138-8;Target:GST A1-1;UniProt:P08263

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17138-8;Target: GST A1-1;UniProt: P08263;TargetFullName: Glutathione S-transferase A1;Organisim: human;Apparent_Kd_M: 7.18E-12

Real

Aptamer SeqId: 17138-8 | Target: GST A1-1 | UniProt: P08263

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17138-8 | Target: GST A1-1 | UniProt: P08263 | TargetFullName: Glutathione S-transferase A1 | Organisim: human | Apparent_Kd_M: 7.18E-12

Real

Aptamer SeqId:17140-57;Target:PDGFD;UniProt:Q9GZP0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17140-57;Target: PDGFD;UniProt: Q9GZP0;TargetFullName: Platelet-derived growth factor D;Organisim: human;Apparent_Kd_M: 2.18E-12

Real

Aptamer SeqId: 17140-57 | Target: PDGFD | UniProt: Q9GZP0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17140-57 | Target: PDGFD | UniProt: Q9GZP0 | TargetFullName: Platelet-derived growth factor D | Organisim: human | Apparent_Kd_M: 2.18E-12

Real

Aptamer SeqId:17145-1;Target:S100A8/S100A9;UniProt:P05109|P06702

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17145-1;Target: S100A8/S100A9;UniProt: P05109|P06702;TargetFullName: Protein S100-A8/A9 heterodimer;Organisim: human;Apparent_Kd_M: 7.72E-11

Real

Aptamer SeqId: 17145-1 | Target: S100A8/S100A9 | UniProt: P05109|P06702

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17145-1 | Target: S100A8/S100A9 | UniProt: P05109|P06702 | TargetFullName: Protein S100-A8/A9 heterodimer | Organisim: human | Apparent_Kd_M: 7.72E-11

Real

Aptamer SeqId:17148-7;Target:BLVRB;UniProt:P30043

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17148-7;Target: BLVRB;UniProt: P30043;TargetFullName: Flavin reductase (NADPH);Organisim: human;Apparent_Kd_M: 3.39E-12

Real

Aptamer SeqId: 17148-7 | Target: BLVRB | UniProt: P30043

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17148-7 | Target: BLVRB | UniProt: P30043 | TargetFullName: Flavin reductase (NADPH) | Organisim: human | Apparent_Kd_M: 3.39E-12

Real

Aptamer SeqId:17150-8;Target:HSP 10;UniProt:P61604

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17150-8;Target: HSP 10;UniProt: P61604;TargetFullName: 10 kDa heat shock protein; mitochondrial;Organisim: human;Apparent_Kd_M: 2.92E-11

Real

Aptamer SeqId: 17150-8 | Target: HSP 10 | UniProt: P61604

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17150-8 | Target: HSP 10 | UniProt: P61604 | TargetFullName: 10 kDa heat shock protein; mitochondrial | Organisim: human | Apparent_Kd_M: 2.92E-11

Real

Aptamer SeqId:17151-84;Target:IRF-3;UniProt:Q14653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17151-84;Target: IRF-3;UniProt: Q14653;TargetFullName: Interferon regulatory factor 3;Organisim: human;Apparent_Kd_M: 5.34E-12

Real

Aptamer SeqId: 17151-84 | Target: IRF-3 | UniProt: Q14653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17151-84 | Target: IRF-3 | UniProt: Q14653 | TargetFullName: Interferon regulatory factor 3 | Organisim: human | Apparent_Kd_M: 5.34E-12

Real

Aptamer SeqId:17152-10;Target:KI2S4;UniProt:P43632

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17152-10;Target: KI2S4;UniProt: P43632;TargetFullName: Killer cell immunoglobulin-like receptor 2DS4;Organisim: human;Apparent_Kd_M: 3.66E-12

Real

Aptamer SeqId: 17152-10 | Target: KI2S4 | UniProt: P43632

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17152-10 | Target: KI2S4 | UniProt: P43632 | TargetFullName: Killer cell immunoglobulin-like receptor 2DS4 | Organisim: human | Apparent_Kd_M: 3.66E-12

Real

Aptamer SeqId:17153-46;Target:KI2L3;UniProt:P43628

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17153-46;Target: KI2L3;UniProt: P43628;TargetFullName: Killer cell immunoglobulin-like receptor 2DL3;Organisim: human;Apparent_Kd_M: 1.71E-13

Real

Aptamer SeqId: 17153-46 | Target: KI2L3 | UniProt: P43628

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17153-46 | Target: KI2L3 | UniProt: P43628 | TargetFullName: Killer cell immunoglobulin-like receptor 2DL3 | Organisim: human | Apparent_Kd_M: 1.71E-13

Real

Aptamer SeqId:17154-2;Target:TEBP;UniProt:Q15185

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17154-2;Target: TEBP;UniProt: Q15185;TargetFullName: Prostaglandin E synthase 3;Organisim: human;Apparent_Kd_M: 4.05E-11

Real

Aptamer SeqId: 17154-2 | Target: TEBP | UniProt: Q15185

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17154-2 | Target: TEBP | UniProt: Q15185 | TargetFullName: Prostaglandin E synthase 3 | Organisim: human | Apparent_Kd_M: 4.05E-11

Real

Aptamer SeqId:17155-1;Target:VPS28 protein homolog;UniProt:Q9UK41

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17155-1;Target: VPS28 protein homolog;UniProt: Q9UK41;TargetFullName: Vacuolar protein sorting-associated protein 28 homolog;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 17155-1 | Target: VPS28 protein homolog | UniProt: Q9UK41

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17155-1 | Target: VPS28 protein homolog | UniProt: Q9UK41 | TargetFullName: Vacuolar protein sorting-associated protein 28 homolog | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:17156-72;Target:DCAK1;UniProt:O15075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17156-72;Target: DCAK1;UniProt: O15075;TargetFullName: Serine/threonine-protein kinase DCLK1;Organisim: human;Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId: 17156-72 | Target: DCAK1 | UniProt: O15075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17156-72 | Target: DCAK1 | UniProt: O15075 | TargetFullName: Serine/threonine-protein kinase DCLK1 | Organisim: human | Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId:17158-17;Target:UB2G1;UniProt:P62253

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17158-17;Target: UB2G1;UniProt: P62253;TargetFullName: Ubiquitin-conjugating enzyme E2 G1;Organisim: human;Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId: 17158-17 | Target: UB2G1 | UniProt: P62253

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17158-17 | Target: UB2G1 | UniProt: P62253 | TargetFullName: Ubiquitin-conjugating enzyme E2 G1 | Organisim: human | Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId:17161-1;Target:OST48;UniProt:P39656

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17161-1;Target: OST48;UniProt: P39656;TargetFullName: Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 17161-1 | Target: OST48 | UniProt: P39656

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17161-1 | Target: OST48 | UniProt: P39656 | TargetFullName: Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:17163-117;Target:Annexin III;UniProt:P12429

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17163-117;Target: Annexin III;UniProt: P12429;TargetFullName: Annexin A3;Organisim: human;Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId: 17163-117 | Target: Annexin III | UniProt: P12429

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17163-117 | Target: Annexin III | UniProt: P12429 | TargetFullName: Annexin A3 | Organisim: human | Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId:17164-15;Target:annexin IV;UniProt:P09525

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17164-15;Target: annexin IV;UniProt: P09525;TargetFullName: Annexin A4;Organisim: human;Apparent_Kd_M: 6.69E-12

Real

Aptamer SeqId: 17164-15 | Target: annexin IV | UniProt: P09525

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17164-15 | Target: annexin IV | UniProt: P09525 | TargetFullName: Annexin A4 | Organisim: human | Apparent_Kd_M: 6.69E-12

Real

Aptamer SeqId:17165-1;Target:BTG;UniProt:P02775

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17165-1;Target: BTG;UniProt: P02775;TargetFullName: Beta-thromboglobulin;Organisim: human;Apparent_Kd_M: 1.47E-12

Real

Aptamer SeqId: 17165-1 | Target: BTG | UniProt: P02775

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17165-1 | Target: BTG | UniProt: P02775 | TargetFullName: Beta-thromboglobulin | Organisim: human | Apparent_Kd_M: 1.47E-12

Real

Aptamer SeqId:17166-4;Target:FGF-8F;UniProt:P55075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17166-4;Target: FGF-8F;UniProt: P55075;TargetFullName: Fibroblast growth factor 8 isoform F;Organisim: human;Apparent_Kd_M: 5.54E-12

Real

Aptamer SeqId: 17166-4 | Target: FGF-8F | UniProt: P55075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17166-4 | Target: FGF-8F | UniProt: P55075 | TargetFullName: Fibroblast growth factor 8 isoform F | Organisim: human | Apparent_Kd_M: 5.54E-12

Real

Aptamer SeqId:17170-15;Target:CALCB;UniProt:P10092

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17170-15;Target: CALCB;UniProt: P10092;TargetFullName: Calcitonin gene-related peptide 2;Organisim: human;Apparent_Kd_M: 2.18E-12

Real

Aptamer SeqId: 17170-15 | Target: CALCB | UniProt: P10092

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17170-15 | Target: CALCB | UniProt: P10092 | TargetFullName: Calcitonin gene-related peptide 2 | Organisim: human | Apparent_Kd_M: 2.18E-12

Real

Aptamer SeqId:17172-19;Target:STAT;UniProt:P02808

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17172-19;Target: STAT;UniProt: P02808;TargetFullName: Statherin;Organisim: human;Apparent_Kd_M: 7.12E-12

Real

Aptamer SeqId: 17172-19 | Target: STAT | UniProt: P02808

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17172-19 | Target: STAT | UniProt: P02808 | TargetFullName: Statherin | Organisim: human | Apparent_Kd_M: 7.12E-12

Real

Aptamer SeqId:17175-5;Target:MP2K6;UniProt:P52564

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17175-5;Target: MP2K6;UniProt: P52564;TargetFullName: Dual specificity mitogen-activated protein kinase kinase 6;Organisim: human;Apparent_Kd_M: 3.56E-11

Real

Aptamer SeqId: 17175-5 | Target: MP2K6 | UniProt: P52564

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17175-5 | Target: MP2K6 | UniProt: P52564 | TargetFullName: Dual specificity mitogen-activated protein kinase kinase 6 | Organisim: human | Apparent_Kd_M: 3.56E-11

Real

Aptamer SeqId:17176-13;Target:PSIP1;UniProt:O75475

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17176-13;Target: PSIP1;UniProt: O75475;TargetFullName: PC4 and SFRS1-interacting protein;Organisim: human;Apparent_Kd_M: 7.295377E-12

Real

Aptamer SeqId: 17176-13 | Target: PSIP1 | UniProt: O75475

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17176-13 | Target: PSIP1 | UniProt: O75475 | TargetFullName: PC4 and SFRS1-interacting protein | Organisim: human | Apparent_Kd_M: 7.295377E-12

Real

Aptamer SeqId:17195-43;Target:BAG-1;UniProt:Q99933

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17195-43;Target: BAG-1;UniProt: Q99933;TargetFullName: BAG family molecular chaperone regulator 1;Organisim: human;Apparent_Kd_M: 1.498154E-11

Real

Aptamer SeqId: 17195-43 | Target: BAG-1 | UniProt: Q99933

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17195-43 | Target: BAG-1 | UniProt: Q99933 | TargetFullName: BAG family molecular chaperone regulator 1 | Organisim: human | Apparent_Kd_M: 1.498154E-11

Real

Aptamer SeqId:17196-5;Target:ClpP endopeptidase;UniProt:Q16740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17196-5;Target: ClpP endopeptidase;UniProt: Q16740;TargetFullName: ATP-dependent Clp protease proteolytic subunit; mitochondrial;Organisim: human;Apparent_Kd_M: 1.711723E-11

Real

Aptamer SeqId: 17196-5 | Target: ClpP endopeptidase | UniProt: Q16740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17196-5 | Target: ClpP endopeptidase | UniProt: Q16740 | TargetFullName: ATP-dependent Clp protease proteolytic subunit; mitochondrial | Organisim: human | Apparent_Kd_M: 1.711723E-11

Real

Aptamer SeqId:17199-43;Target:HIF1N;UniProt:Q9NWT6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17199-43;Target: HIF1N;UniProt: Q9NWT6;TargetFullName: Hypoxia-inducible factor 1-alpha inhibitor;Organisim: human;Apparent_Kd_M: 7.51E-11

Real

Aptamer SeqId: 17199-43 | Target: HIF1N | UniProt: Q9NWT6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17199-43 | Target: HIF1N | UniProt: Q9NWT6 | TargetFullName: Hypoxia-inducible factor 1-alpha inhibitor | Organisim: human | Apparent_Kd_M: 7.51E-11

Real

Aptamer SeqId:17200-50;Target:KI2L1;UniProt:P43626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17200-50;Target: KI2L1;UniProt: P43626;TargetFullName: Killer cell immunoglobulin-like receptor 2DL1;Organisim: human;Apparent_Kd_M: 8.06E-11

Real

Aptamer SeqId: 17200-50 | Target: KI2L1 | UniProt: P43626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17200-50 | Target: KI2L1 | UniProt: P43626 | TargetFullName: Killer cell immunoglobulin-like receptor 2DL1 | Organisim: human | Apparent_Kd_M: 8.06E-11

Real

Aptamer SeqId:17202-37;Target:PDCD4;UniProt:Q53EL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17202-37;Target: PDCD4;UniProt: Q53EL6;TargetFullName: Programmed cell death protein 4;Organisim: human;Apparent_Kd_M: 3.12E-11

Real

Aptamer SeqId: 17202-37 | Target: PDCD4 | UniProt: Q53EL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17202-37 | Target: PDCD4 | UniProt: Q53EL6 | TargetFullName: Programmed cell death protein 4 | Organisim: human | Apparent_Kd_M: 3.12E-11

Real

Aptamer SeqId:17204-17;Target:PNMT;UniProt:P11086

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17204-17;Target: PNMT;UniProt: P11086;TargetFullName: Phenylethanolamine N-methyltransferase;Organisim: human;Apparent_Kd_M: 4.85E-11

Real

Aptamer SeqId: 17204-17 | Target: PNMT | UniProt: P11086

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17204-17 | Target: PNMT | UniProt: P11086 | TargetFullName: Phenylethanolamine N-methyltransferase | Organisim: human | Apparent_Kd_M: 4.85E-11

Real

Aptamer SeqId:17205-21;Target:RAB5A;UniProt:P20339

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17205-21;Target: RAB5A;UniProt: P20339;TargetFullName: Ras-related protein Rab-5A;Organisim: human;Apparent_Kd_M: 2.45E-12

Real

Aptamer SeqId: 17205-21 | Target: RAB5A | UniProt: P20339

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17205-21 | Target: RAB5A | UniProt: P20339 | TargetFullName: Ras-related protein Rab-5A | Organisim: human | Apparent_Kd_M: 2.45E-12

Real

Aptamer SeqId:17209-27;Target:ST2B1;UniProt:O00204

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17209-27;Target: ST2B1;UniProt: O00204;TargetFullName: Sulfotransferase family cytosolic 2B member 1;Organisim: human;Apparent_Kd_M: 4.79E-12

Real

Aptamer SeqId: 17209-27 | Target: ST2B1 | UniProt: O00204

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17209-27 | Target: ST2B1 | UniProt: O00204 | TargetFullName: Sulfotransferase family cytosolic 2B member 1 | Organisim: human | Apparent_Kd_M: 4.79E-12

Real

Aptamer SeqId:17210-2;Target:TCL1A;UniProt:P56279

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17210-2;Target: TCL1A;UniProt: P56279;TargetFullName: T-cell leukemia/lymphoma protein 1A;Organisim: human;Apparent_Kd_M: 2.41E-11

Real

Aptamer SeqId: 17210-2 | Target: TCL1A | UniProt: P56279

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17210-2 | Target: TCL1A | UniProt: P56279 | TargetFullName: T-cell leukemia/lymphoma protein 1A | Organisim: human | Apparent_Kd_M: 2.41E-11

Real

Aptamer SeqId:17224-12;Target:MIME;UniProt:P20774

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17224-12;Target: MIME;UniProt: P20774;TargetFullName: Mimecan;Organisim: human;Apparent_Kd_M: 1.9E-10

Real

Aptamer SeqId: 17224-12 | Target: MIME | UniProt: P20774

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17224-12 | Target: MIME | UniProt: P20774 | TargetFullName: Mimecan | Organisim: human | Apparent_Kd_M: 1.9E-10

Real

Aptamer SeqId:17231-1;Target:L-plastin;UniProt:P13796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17231-1;Target: L-plastin;UniProt: P13796;TargetFullName: Plastin-2;Organisim: human;Apparent_Kd_M: 3.19E-12

Real

Aptamer SeqId: 17231-1 | Target: L-plastin | UniProt: P13796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17231-1 | Target: L-plastin | UniProt: P13796 | TargetFullName: Plastin-2 | Organisim: human | Apparent_Kd_M: 3.19E-12

Real

Aptamer SeqId:17319-1;Target:SELH;UniProt:Q8IZQ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17319-1;Target: SELH;UniProt: Q8IZQ5;TargetFullName: Selenoprotein H;Organisim: human;Apparent_Kd_M: 4.18E-11

Real

Aptamer SeqId: 17319-1 | Target: SELH | UniProt: Q8IZQ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17319-1 | Target: SELH | UniProt: Q8IZQ5 | TargetFullName: Selenoprotein H | Organisim: human | Apparent_Kd_M: 4.18E-11

Real

Aptamer SeqId:17320-19;Target:ADPPT;UniProt:Q9NRN7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17320-19;Target: ADPPT;UniProt: Q9NRN7;TargetFullName: L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase;Organisim: human;Apparent_Kd_M: 1.52E-12

Real

Aptamer SeqId: 17320-19 | Target: ADPPT | UniProt: Q9NRN7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17320-19 | Target: ADPPT | UniProt: Q9NRN7 | TargetFullName: L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | Organisim: human | Apparent_Kd_M: 1.52E-12

Real

Aptamer SeqId:17325-10;Target:KGUA;UniProt:Q16774

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17325-10;Target: KGUA;UniProt: Q16774;TargetFullName: Guanylate kinase;Organisim: human;Apparent_Kd_M: 2.2E-12

Real

Aptamer SeqId: 17325-10 | Target: KGUA | UniProt: Q16774

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17325-10 | Target: KGUA | UniProt: Q16774 | TargetFullName: Guanylate kinase | Organisim: human | Apparent_Kd_M: 2.2E-12

Real

Aptamer SeqId:17326-44;Target:DUS23;UniProt:Q9BVJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17326-44;Target: DUS23;UniProt: Q9BVJ7;TargetFullName: Dual specificity protein phosphatase 23;Organisim: human;Apparent_Kd_M: 7.64E-11

Real

Aptamer SeqId: 17326-44 | Target: DUS23 | UniProt: Q9BVJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17326-44 | Target: DUS23 | UniProt: Q9BVJ7 | TargetFullName: Dual specificity protein phosphatase 23 | Organisim: human | Apparent_Kd_M: 7.64E-11

Real

Aptamer SeqId:17327-3;Target:CNPY3;UniProt:Q9BT09

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17327-3;Target: CNPY3;UniProt: Q9BT09;TargetFullName: Protein canopy homolog 3;Organisim: human;Apparent_Kd_M: 2.43E-10

Real

Aptamer SeqId: 17327-3 | Target: CNPY3 | UniProt: Q9BT09

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17327-3 | Target: CNPY3 | UniProt: Q9BT09 | TargetFullName: Protein canopy homolog 3 | Organisim: human | Apparent_Kd_M: 2.43E-10

Real

Aptamer SeqId:17329-2;Target:BDH2;UniProt:Q9BUT1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17329-2;Target: BDH2;UniProt: Q9BUT1;TargetFullName: 3-hydroxybutyrate dehydrogenase type 2;Organisim: human;Apparent_Kd_M: 8.37E-12

Real

Aptamer SeqId: 17329-2 | Target: BDH2 | UniProt: Q9BUT1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17329-2 | Target: BDH2 | UniProt: Q9BUT1 | TargetFullName: 3-hydroxybutyrate dehydrogenase type 2 | Organisim: human | Apparent_Kd_M: 8.37E-12

Real

Aptamer SeqId:17331-138;Target:KREM1;UniProt:Q96MU8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17331-138;Target: KREM1;UniProt: Q96MU8;TargetFullName: Kremen protein 1;Organisim: human;Apparent_Kd_M: 9.18E-11

Real

Aptamer SeqId: 17331-138 | Target: KREM1 | UniProt: Q96MU8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17331-138 | Target: KREM1 | UniProt: Q96MU8 | TargetFullName: Kremen protein 1 | Organisim: human | Apparent_Kd_M: 9.18E-11

Real

Aptamer SeqId:17332-3;Target:ARHL2;UniProt:Q9NX46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17332-3;Target: ARHL2;UniProt: Q9NX46;TargetFullName: Poly(ADP-ribose) glycohydrolase ARH3;Organisim: human;Apparent_Kd_M: 8.07E-13

Real

Aptamer SeqId: 17332-3 | Target: ARHL2 | UniProt: Q9NX46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17332-3 | Target: ARHL2 | UniProt: Q9NX46 | TargetFullName: Poly(ADP-ribose) glycohydrolase ARH3 | Organisim: human | Apparent_Kd_M: 8.07E-13

Real

Aptamer SeqId:17333-20;Target:ACADM;UniProt:P11310

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17333-20;Target: ACADM;UniProt: P11310;TargetFullName: Medium-chain specific acyl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId: 17333-20 | Target: ACADM | UniProt: P11310

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17333-20 | Target: ACADM | UniProt: P11310 | TargetFullName: Medium-chain specific acyl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId:17335-18;Target:VAMP2;UniProt:P63027

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17335-18;Target: VAMP2;UniProt: P63027;TargetFullName: Vesicle-associated membrane protein 2;Organisim: human;Apparent_Kd_M: 7.84E-12

Real

Aptamer SeqId: 17335-18 | Target: VAMP2 | UniProt: P63027

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17335-18 | Target: VAMP2 | UniProt: P63027 | TargetFullName: Vesicle-associated membrane protein 2 | Organisim: human | Apparent_Kd_M: 7.84E-12

Real

Aptamer SeqId:17336-54;Target:CR3L2;UniProt:Q70SY1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17336-54;Target: CR3L2;UniProt: Q70SY1;TargetFullName: Cyclic AMP-responsive element-binding protein 3-like protein 2;Organisim: human;Apparent_Kd_M: 8.86E-11

Real

Aptamer SeqId: 17336-54 | Target: CR3L2 | UniProt: Q70SY1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17336-54 | Target: CR3L2 | UniProt: Q70SY1 | TargetFullName: Cyclic AMP-responsive element-binding protein 3-like protein 2 | Organisim: human | Apparent_Kd_M: 8.86E-11

Real

Aptamer SeqId:17337-1;Target:TYY1;UniProt:P25490

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17337-1;Target: TYY1;UniProt: P25490;TargetFullName: Transcriptional repressor protein YY1;Organisim: human;Apparent_Kd_M: 3.0E-10

Real

Aptamer SeqId: 17337-1 | Target: TYY1 | UniProt: P25490

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17337-1 | Target: TYY1 | UniProt: P25490 | TargetFullName: Transcriptional repressor protein YY1 | Organisim: human | Apparent_Kd_M: 3.0E-10

Real

Aptamer SeqId:17341-89;Target:THIC;UniProt:Q9BWD1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17341-89;Target: THIC;UniProt: Q9BWD1;TargetFullName: Acetyl-CoA acetyltransferase; cytosolic;Organisim: human;Apparent_Kd_M: 1.61E-11

Real

Aptamer SeqId: 17341-89 | Target: THIC | UniProt: Q9BWD1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17341-89 | Target: THIC | UniProt: Q9BWD1 | TargetFullName: Acetyl-CoA acetyltransferase; cytosolic | Organisim: human | Apparent_Kd_M: 1.61E-11

Real

Aptamer SeqId:17342-13;Target:AGR3;UniProt:Q8TD06

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17342-13;Target: AGR3;UniProt: Q8TD06;TargetFullName: Anterior gradient protein 3;Organisim: human;Apparent_Kd_M: 4.9E-11

Real

Aptamer SeqId: 17342-13 | Target: AGR3 | UniProt: Q8TD06

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17342-13 | Target: AGR3 | UniProt: Q8TD06 | TargetFullName: Anterior gradient protein 3 | Organisim: human | Apparent_Kd_M: 4.9E-11

Real

Aptamer SeqId:17343-6;Target:SNPH;UniProt:O15079

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17343-6;Target: SNPH;UniProt: O15079;TargetFullName: Syntaphilin;Organisim: human;Apparent_Kd_M: 2.81E-11

Real

Aptamer SeqId: 17343-6 | Target: SNPH | UniProt: O15079

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17343-6 | Target: SNPH | UniProt: O15079 | TargetFullName: Syntaphilin | Organisim: human | Apparent_Kd_M: 2.81E-11

Real

Aptamer SeqId:17344-23;Target:STML1;UniProt:Q9UBI4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17344-23;Target: STML1;UniProt: Q9UBI4;TargetFullName: Stomatin-like protein 1;Organisim: human;Apparent_Kd_M: 5.79E-11

Real

Aptamer SeqId: 17344-23 | Target: STML1 | UniProt: Q9UBI4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17344-23 | Target: STML1 | UniProt: Q9UBI4 | TargetFullName: Stomatin-like protein 1 | Organisim: human | Apparent_Kd_M: 5.79E-11

Real

Aptamer SeqId:17345-12;Target:ZADH2;UniProt:Q8N4Q0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17345-12;Target: ZADH2;UniProt: Q8N4Q0;TargetFullName: Prostaglandin reductase 3;Organisim: human;Apparent_Kd_M: 2.67E-12

Real

Aptamer SeqId: 17345-12 | Target: ZADH2 | UniProt: Q8N4Q0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17345-12 | Target: ZADH2 | UniProt: Q8N4Q0 | TargetFullName: Prostaglandin reductase 3 | Organisim: human | Apparent_Kd_M: 2.67E-12

Real

Aptamer SeqId:17346-61;Target:FDSCP;UniProt:Q8NFU4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17346-61;Target: FDSCP;UniProt: Q8NFU4;TargetFullName: Follicular dendritic cell secreted peptide;Organisim: human;Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId: 17346-61 | Target: FDSCP | UniProt: Q8NFU4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17346-61 | Target: FDSCP | UniProt: Q8NFU4 | TargetFullName: Follicular dendritic cell secreted peptide | Organisim: human | Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId:17347-80;Target:CA080;UniProt:Q96BJ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17347-80;Target: CA080;UniProt: Q96BJ3;TargetFullName: Axin interactor; dorsalization-associated protein;Organisim: human;Apparent_Kd_M: 2.15E-12

Real

Aptamer SeqId: 17347-80 | Target: CA080 | UniProt: Q96BJ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17347-80 | Target: CA080 | UniProt: Q96BJ3 | TargetFullName: Axin interactor; dorsalization-associated protein | Organisim: human | Apparent_Kd_M: 2.15E-12

Real

Aptamer SeqId:17348-5;Target:SYJ2B;UniProt:P57105

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17348-5;Target: SYJ2B;UniProt: P57105;TargetFullName: Synaptojanin-2-binding protein;Organisim: human;Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId: 17348-5 | Target: SYJ2B | UniProt: P57105

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17348-5 | Target: SYJ2B | UniProt: P57105 | TargetFullName: Synaptojanin-2-binding protein | Organisim: human | Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId:17350-13;Target:CHM2B;UniProt:Q9UQN3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17350-13;Target: CHM2B;UniProt: Q9UQN3;TargetFullName: Charged multivesicular body protein 2b;Organisim: human;Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId: 17350-13 | Target: CHM2B | UniProt: Q9UQN3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17350-13 | Target: CHM2B | UniProt: Q9UQN3 | TargetFullName: Charged multivesicular body protein 2b | Organisim: human | Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId:17355-56;Target:SYT4;UniProt:Q9H2B2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17355-56;Target: SYT4;UniProt: Q9H2B2;TargetFullName: Synaptotagmin-4;Organisim: human;Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId: 17355-56 | Target: SYT4 | UniProt: Q9H2B2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17355-56 | Target: SYT4 | UniProt: Q9H2B2 | TargetFullName: Synaptotagmin-4 | Organisim: human | Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId:17356-34;Target:IL1FA;UniProt:Q8WWZ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17356-34;Target: IL1FA;UniProt: Q8WWZ1;TargetFullName: Interleukin-1 family member 10;Organisim: human;Apparent_Kd_M: 1.27E-10

Real

Aptamer SeqId: 17356-34 | Target: IL1FA | UniProt: Q8WWZ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17356-34 | Target: IL1FA | UniProt: Q8WWZ1 | TargetFullName: Interleukin-1 family member 10 | Organisim: human | Apparent_Kd_M: 1.27E-10

Real

Aptamer SeqId:17357-33;Target:SPCS;UniProt:Q9HD40

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17357-33;Target: SPCS;UniProt: Q9HD40;TargetFullName: O-phosphoseryl-tRNA(Sec) selenium transferase;Organisim: human;Apparent_Kd_M: 2.83E-11

Real

Aptamer SeqId: 17357-33 | Target: SPCS | UniProt: Q9HD40

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17357-33 | Target: SPCS | UniProt: Q9HD40 | TargetFullName: O-phosphoseryl-tRNA(Sec) selenium transferase | Organisim: human | Apparent_Kd_M: 2.83E-11

Real

Aptamer SeqId:17362-5;Target:VHL;UniProt:P40337

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17362-5;Target: VHL;UniProt: P40337;TargetFullName: Von Hippel-Lindau disease tumor suppressor;Organisim: human;Apparent_Kd_M: 1.03E-10

Real

Aptamer SeqId: 17362-5 | Target: VHL | UniProt: P40337

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17362-5 | Target: VHL | UniProt: P40337 | TargetFullName: Von Hippel-Lindau disease tumor suppressor | Organisim: human | Apparent_Kd_M: 1.03E-10

Real

Aptamer SeqId:17364-8;Target:RU2B;UniProt:P08579

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17364-8;Target: RU2B;UniProt: P08579;TargetFullName: U2 small nuclear ribonucleoprotein B;Organisim: human;Apparent_Kd_M: 5.41E-12

Real

Aptamer SeqId: 17364-8 | Target: RU2B | UniProt: P08579

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17364-8 | Target: RU2B | UniProt: P08579 | TargetFullName: U2 small nuclear ribonucleoprotein B'' | Organisim: human | Apparent_Kd_M: 5.41E-12

Real

Aptamer SeqId:17365-7;Target:KAT1;UniProt:Q16773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17365-7;Target: KAT1;UniProt: Q16773;TargetFullName: Kynurenine--oxoglutarate transaminase 1;Organisim: human;Apparent_Kd_M: 3.35E-11

Real

Aptamer SeqId: 17365-7 | Target: KAT1 | UniProt: Q16773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17365-7 | Target: KAT1 | UniProt: Q16773 | TargetFullName: Kynurenine--oxoglutarate transaminase 1 | Organisim: human | Apparent_Kd_M: 3.35E-11

Real

Aptamer SeqId:17366-6;Target:DCNL1;UniProt:Q96GG9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17366-6;Target: DCNL1;UniProt: Q96GG9;TargetFullName: DCN1-like protein 1;Organisim: human;Apparent_Kd_M: 4.43E-11

Real

Aptamer SeqId: 17366-6 | Target: DCNL1 | UniProt: Q96GG9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17366-6 | Target: DCNL1 | UniProt: Q96GG9 | TargetFullName: DCN1-like protein 1 | Organisim: human | Apparent_Kd_M: 4.43E-11

Real

Aptamer SeqId:17367-5;Target:Stathmin;UniProt:P16949

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17367-5;Target: Stathmin;UniProt: P16949;TargetFullName: Stathmin;Organisim: human;Apparent_Kd_M: 4.91E-11

Real

Aptamer SeqId: 17367-5 | Target: Stathmin | UniProt: P16949

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17367-5 | Target: Stathmin | UniProt: P16949 | TargetFullName: Stathmin | Organisim: human | Apparent_Kd_M: 4.91E-11

Real

Aptamer SeqId:17370-186;Target:ABHDA;UniProt:Q9NUJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17370-186;Target: ABHDA;UniProt: Q9NUJ1;TargetFullName: Mycophenolic acid acyl-glucuronide esterase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId: 17370-186 | Target: ABHDA | UniProt: Q9NUJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17370-186 | Target: ABHDA | UniProt: Q9NUJ1 | TargetFullName: Mycophenolic acid acyl-glucuronide esterase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId:17372-5;Target:4EBP1;UniProt:Q13541

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17372-5;Target: 4EBP1;UniProt: Q13541;TargetFullName: Eukaryotic translation initiation factor 4E-binding protein 1;Organisim: human;Apparent_Kd_M: 4.91E-11

Real

Aptamer SeqId: 17372-5 | Target: 4EBP1 | UniProt: Q13541

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17372-5 | Target: 4EBP1 | UniProt: Q13541 | TargetFullName: Eukaryotic translation initiation factor 4E-binding protein 1 | Organisim: human | Apparent_Kd_M: 4.91E-11

Real

Aptamer SeqId:17377-1;Target:Aldose reductase-like C3;UniProt:P42330

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17377-1;Target: Aldose reductase-like C3;UniProt: P42330;TargetFullName: Aldo-keto reductase family 1 member C3;Organisim: human;Apparent_Kd_M: 3.52E-12

Real

Aptamer SeqId: 17377-1 | Target: Aldose reductase-like C3 | UniProt: P42330

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17377-1 | Target: Aldose reductase-like C3 | UniProt: P42330 | TargetFullName: Aldo-keto reductase family 1 member C3 | Organisim: human | Apparent_Kd_M: 3.52E-12

Real

Aptamer SeqId:17380-2;Target:UBE2K;UniProt:P61086

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17380-2;Target: UBE2K;UniProt: P61086;TargetFullName: Ubiquitin-conjugating enzyme E2 K;Organisim: human;Apparent_Kd_M: 4.63E-12

Real

Aptamer SeqId: 17380-2 | Target: UBE2K | UniProt: P61086

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17380-2 | Target: UBE2K | UniProt: P61086 | TargetFullName: Ubiquitin-conjugating enzyme E2 K | Organisim: human | Apparent_Kd_M: 4.63E-12

Real

Aptamer SeqId:17383-4;Target:STAR5;UniProt:Q9NSY2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17383-4;Target: STAR5;UniProt: Q9NSY2;TargetFullName: StAR-related lipid transfer protein 5;Organisim: human;Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId: 17383-4 | Target: STAR5 | UniProt: Q9NSY2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17383-4 | Target: STAR5 | UniProt: Q9NSY2 | TargetFullName: StAR-related lipid transfer protein 5 | Organisim: human | Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId:17384-110;Target:K6PF;UniProt:P08237

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17384-110;Target: K6PF;UniProt: P08237;TargetFullName: ATP-dependent 6-phosphofructokinase; muscle type;Organisim: human;Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId: 17384-110 | Target: K6PF | UniProt: P08237

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17384-110 | Target: K6PF | UniProt: P08237 | TargetFullName: ATP-dependent 6-phosphofructokinase; muscle type | Organisim: human | Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId:17387-27;Target:IKB-beta;UniProt:Q15653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17387-27;Target: IKB-beta;UniProt: Q15653;TargetFullName: NF-kappa-B inhibitor beta;Organisim: human;Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId: 17387-27 | Target: IKB-beta | UniProt: Q15653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17387-27 | Target: IKB-beta | UniProt: Q15653 | TargetFullName: NF-kappa-B inhibitor beta | Organisim: human | Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId:17391-10;Target:SPF45;UniProt:Q96I25

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17391-10;Target: SPF45;UniProt: Q96I25;TargetFullName: Splicing factor 45;Organisim: human;Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId: 17391-10 | Target: SPF45 | UniProt: Q96I25

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17391-10 | Target: SPF45 | UniProt: Q96I25 | TargetFullName: Splicing factor 45 | Organisim: human | Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId:17393-13;Target:SCAD;UniProt:P16219

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17393-13;Target: SCAD;UniProt: P16219;TargetFullName: Short-chain specific acyl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 9.15E-12

Real

Aptamer SeqId: 17393-13 | Target: SCAD | UniProt: P16219

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17393-13 | Target: SCAD | UniProt: P16219 | TargetFullName: Short-chain specific acyl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 9.15E-12

Real

Aptamer SeqId:17396-23;Target:ADH1A;UniProt:P07327

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17396-23;Target: ADH1A;UniProt: P07327;TargetFullName: Alcohol dehydrogenase 1A;Organisim: human;Apparent_Kd_M: 6.02E-11

Real

Aptamer SeqId: 17396-23 | Target: ADH1A | UniProt: P07327

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17396-23 | Target: ADH1A | UniProt: P07327 | TargetFullName: Alcohol dehydrogenase 1A | Organisim: human | Apparent_Kd_M: 6.02E-11

Real

Aptamer SeqId:17397-8;Target:DHB11;UniProt:Q8NBQ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17397-8;Target: DHB11;UniProt: Q8NBQ5;TargetFullName: Estradiol 17-beta-dehydrogenase 11;Organisim: human;Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId: 17397-8 | Target: DHB11 | UniProt: Q8NBQ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17397-8 | Target: DHB11 | UniProt: Q8NBQ5 | TargetFullName: Estradiol 17-beta-dehydrogenase 11 | Organisim: human | Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId:17398-55;Target:HO-1;UniProt:P09601

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17398-55;Target: HO-1;UniProt: P09601;TargetFullName: Heme oxygenase 1;Organisim: human;Apparent_Kd_M: 2.01E-12

Real

Aptamer SeqId: 17398-55 | Target: HO-1 | UniProt: P09601

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17398-55 | Target: HO-1 | UniProt: P09601 | TargetFullName: Heme oxygenase 1 | Organisim: human | Apparent_Kd_M: 2.01E-12

Real

Aptamer SeqId:17400-71;Target:ACOT8;UniProt:O14734

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17400-71;Target: ACOT8;UniProt: O14734;TargetFullName: Acyl-coenzyme A thioesterase 8;Organisim: human;Apparent_Kd_M: 8.81E-11

Real

Aptamer SeqId: 17400-71 | Target: ACOT8 | UniProt: O14734

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17400-71 | Target: ACOT8 | UniProt: O14734 | TargetFullName: Acyl-coenzyme A thioesterase 8 | Organisim: human | Apparent_Kd_M: 8.81E-11

Real

Aptamer SeqId:17403-14;Target:acyl-Coenzyme A dehydrogenase;UniProt:P45954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17403-14;Target: acyl-Coenzyme A dehydrogenase;UniProt: P45954;TargetFullName: Short/branched chain specific acyl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 4.28E-11

Real

Aptamer SeqId: 17403-14 | Target: acyl-Coenzyme A dehydrogenase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17403-14 | Target: acyl-Coenzyme A dehydrogenase | UniProt: P45954 | TargetFullName: Short/branched chain specific acyl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 4.28E-11

Real

Aptamer SeqId:17404-5;Target:ARL5B;UniProt:Q96KC2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17404-5;Target: ARL5B;UniProt: Q96KC2;TargetFullName: ADP-ribosylation factor-like protein 5B;Organisim: human;Apparent_Kd_M: 2.27E-11

Real

Aptamer SeqId: 17404-5 | Target: ARL5B | UniProt: Q96KC2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17404-5 | Target: ARL5B | UniProt: Q96KC2 | TargetFullName: ADP-ribosylation factor-like protein 5B | Organisim: human | Apparent_Kd_M: 2.27E-11

Real

Aptamer SeqId:17405-2;Target:UCHL5;UniProt:Q9Y5K5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17405-2;Target: UCHL5;UniProt: Q9Y5K5;TargetFullName: Ubiquitin carboxyl-terminal hydrolase isozyme L5;Organisim: human;Apparent_Kd_M: 2.06E-11

Real

Aptamer SeqId: 17405-2 | Target: UCHL5 | UniProt: Q9Y5K5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17405-2 | Target: UCHL5 | UniProt: Q9Y5K5 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Organisim: human | Apparent_Kd_M: 2.06E-11

Real

Aptamer SeqId:17408-2;Target:PMM1;UniProt:Q92871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17408-2;Target: PMM1;UniProt: Q92871;TargetFullName: Phosphomannomutase 1;Organisim: human;Apparent_Kd_M: 6.25E-11

Real

Aptamer SeqId: 17408-2 | Target: PMM1 | UniProt: Q92871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17408-2 | Target: PMM1 | UniProt: Q92871 | TargetFullName: Phosphomannomutase 1 | Organisim: human | Apparent_Kd_M: 6.25E-11

Real

Aptamer SeqId:17410-5;Target:CETN3;UniProt:O15182

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17410-5;Target: CETN3;UniProt: O15182;TargetFullName: Centrin-3;Organisim: human;Apparent_Kd_M: 8.76E-12

Real

Aptamer SeqId: 17410-5 | Target: CETN3 | UniProt: O15182

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17410-5 | Target: CETN3 | UniProt: O15182 | TargetFullName: Centrin-3 | Organisim: human | Apparent_Kd_M: 8.76E-12

Real

Aptamer SeqId:17411-55;Target:UFD1;UniProt:Q92890

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17411-55;Target: UFD1;UniProt: Q92890;TargetFullName: Ubiquitin recognition factor in ER-associated degradation protein 1;Organisim: human;Apparent_Kd_M: 1.95E-11

Real

Aptamer SeqId: 17411-55 | Target: UFD1 | UniProt: Q92890

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17411-55 | Target: UFD1 | UniProt: Q92890 | TargetFullName: Ubiquitin recognition factor in ER-associated degradation protein 1 | Organisim: human | Apparent_Kd_M: 1.95E-11

Real

Aptamer SeqId:17419-17;Target:TES;UniProt:Q9UGI8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17419-17;Target: TES;UniProt: Q9UGI8;TargetFullName: Testin;Organisim: human;Apparent_Kd_M: 8.55E-11

Real

Aptamer SeqId: 17419-17 | Target: TES | UniProt: Q9UGI8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17419-17 | Target: TES | UniProt: Q9UGI8 | TargetFullName: Testin | Organisim: human | Apparent_Kd_M: 8.55E-11

Real

Aptamer SeqId:17427-26;Target:NLGN3;UniProt:Q9NZ94

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17427-26;Target: NLGN3;UniProt: Q9NZ94;TargetFullName: Neuroligin-3;Organisim: human;Apparent_Kd_M: 4.35E-12

Real

Aptamer SeqId: 17427-26 | Target: NLGN3 | UniProt: Q9NZ94

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17427-26 | Target: NLGN3 | UniProt: Q9NZ94 | TargetFullName: Neuroligin-3 | Organisim: human | Apparent_Kd_M: 4.35E-12

Real

Aptamer SeqId:17432-25;Target:KAD4;UniProt:P27144

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17432-25;Target: KAD4;UniProt: P27144;TargetFullName: Adenylate kinase 4; mitochondrial;Organisim: human;Apparent_Kd_M: 8.77E-11

Real

Aptamer SeqId: 17432-25 | Target: KAD4 | UniProt: P27144

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17432-25 | Target: KAD4 | UniProt: P27144 | TargetFullName: Adenylate kinase 4; mitochondrial | Organisim: human | Apparent_Kd_M: 8.77E-11

Real

Aptamer SeqId:17435-43;Target:ETFA;UniProt:P13804

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17435-43;Target: ETFA;UniProt: P13804;TargetFullName: Electron transfer flavoprotein subunit alpha; mitochondrial;Organisim: human;Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId: 17435-43 | Target: ETFA | UniProt: P13804

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17435-43 | Target: ETFA | UniProt: P13804 | TargetFullName: Electron transfer flavoprotein subunit alpha; mitochondrial | Organisim: human | Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId:17436-193;Target:CSNK1G2;UniProt:P78368

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17436-193;Target: CSNK1G2;UniProt: P78368;TargetFullName: Casein kinase I isoform gamma-2;Organisim: human;Apparent_Kd_M: 4.28E-11

Real

Aptamer SeqId: 17436-193 | Target: CSNK1G2 | UniProt: P78368

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17436-193 | Target: CSNK1G2 | UniProt: P78368 | TargetFullName: Casein kinase I isoform gamma-2 | Organisim: human | Apparent_Kd_M: 4.28E-11

Real

Aptamer SeqId:17441-4;Target:Alkaline phosphatase; intestine;UniProt:P09923

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17441-4;Target: Alkaline phosphatase; intestine;UniProt: P09923;TargetFullName: Intestinal-type alkaline phosphatase;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 17441-4 | Target: Alkaline phosphatase intestine

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17441-4 | Target: Alkaline phosphatase; intestine | UniProt: P09923 | TargetFullName: Intestinal-type alkaline phosphatase | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:17447-52;Target:SFRP4;UniProt:Q6FHJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17447-52;Target: SFRP4;UniProt: Q6FHJ7;TargetFullName: Secreted frizzled-related protein 4;Organisim: human;Apparent_Kd_M: 3.78E-12

Real

Aptamer SeqId: 17447-52 | Target: SFRP4 | UniProt: Q6FHJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17447-52 | Target: SFRP4 | UniProt: Q6FHJ7 | TargetFullName: Secreted frizzled-related protein 4 | Organisim: human | Apparent_Kd_M: 3.78E-12

Real

Aptamer SeqId:17449-23;Target:CD9;UniProt:P21926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17449-23;Target: CD9;UniProt: P21926;TargetFullName: CD9 antigen;Organisim: human;Apparent_Kd_M: 2.446283E-10

Real

Aptamer SeqId: 17449-23 | Target: CD9 | UniProt: P21926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17449-23 | Target: CD9 | UniProt: P21926 | TargetFullName: CD9 antigen | Organisim: human | Apparent_Kd_M: 2.446283E-10

Real

Aptamer SeqId:17450-51;Target:Histidyl-tRNA synthetase;UniProt:P12081

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17450-51;Target: Histidyl-tRNA synthetase;UniProt: P12081;TargetFullName: Histidine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.37E-12

Real

Aptamer SeqId: 17450-51 | Target: Histidyl-tRNA synthetase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17450-51 | Target: Histidyl-tRNA synthetase | UniProt: P12081 | TargetFullName: Histidine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.37E-12

Real

Aptamer SeqId:17451-13;Target:BIM;UniProt:O43521

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17451-13;Target: BIM;UniProt: O43521;TargetFullName: Bcl-2-like protein 11;Organisim: human;Apparent_Kd_M: 2.069766E-10

Real

Aptamer SeqId: 17451-13 | Target: BIM | UniProt: O43521

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17451-13 | Target: BIM | UniProt: O43521 | TargetFullName: Bcl-2-like protein 11 | Organisim: human | Apparent_Kd_M: 2.069766E-10

Real

Aptamer SeqId:17453-34;Target:Ceruloplasmin;UniProt:P00450

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17453-34;Target: Ceruloplasmin;UniProt: P00450;TargetFullName: Ceruloplasmin;Organisim: human;Apparent_Kd_M: 1.65E-10

Real

Aptamer SeqId: 17453-34 | Target: Ceruloplasmin | UniProt: P00450

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17453-34 | Target: Ceruloplasmin | UniProt: P00450 | TargetFullName: Ceruloplasmin | Organisim: human | Apparent_Kd_M: 1.65E-10

Real

Aptamer SeqId:17454-15;Target:EGFL6;UniProt:Q8IUX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17454-15;Target: EGFL6;UniProt: Q8IUX8;TargetFullName: Epidermal growth factor-like protein 6;Organisim: human;Apparent_Kd_M: 2.22E-11

Real

Aptamer SeqId: 17454-15 | Target: EGFL6 | UniProt: Q8IUX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17454-15 | Target: EGFL6 | UniProt: Q8IUX8 | TargetFullName: Epidermal growth factor-like protein 6 | Organisim: human | Apparent_Kd_M: 2.22E-11

Real

Aptamer SeqId:17455-42;Target:FOLR1;UniProt:P15328

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17455-42;Target: FOLR1;UniProt: P15328;TargetFullName: Folate receptor alpha;Organisim: human;Apparent_Kd_M: 7.05E-12

Real

Aptamer SeqId: 17455-42 | Target: FOLR1 | UniProt: P15328

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17455-42 | Target: FOLR1 | UniProt: P15328 | TargetFullName: Folate receptor alpha | Organisim: human | Apparent_Kd_M: 7.05E-12

Real

Aptamer SeqId:17456-53;Target:GOLM1;UniProt:Q8NBJ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17456-53;Target: GOLM1;UniProt: Q8NBJ4;TargetFullName: Golgi membrane protein 1;Organisim: human;Apparent_Kd_M: 4.74E-12

Real

Aptamer SeqId: 17456-53 | Target: GOLM1 | UniProt: Q8NBJ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17456-53 | Target: GOLM1 | UniProt: Q8NBJ4 | TargetFullName: Golgi membrane protein 1 | Organisim: human | Apparent_Kd_M: 4.74E-12

Real

Aptamer SeqId:17460-51;Target:Mx1;UniProt:P20591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17460-51;Target: Mx1;UniProt: P20591;TargetFullName: Interferon-induced GTP-binding protein Mx1;Organisim: human;Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId: 17460-51 | Target: Mx1 | UniProt: P20591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17460-51 | Target: Mx1 | UniProt: P20591 | TargetFullName: Interferon-induced GTP-binding protein Mx1 | Organisim: human | Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId:17462-19;Target:IRF1;UniProt:P10914

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17462-19;Target: IRF1;UniProt: P10914;TargetFullName: Interferon regulatory factor 1;Organisim: human;Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId: 17462-19 | Target: IRF1 | UniProt: P10914

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17462-19 | Target: IRF1 | UniProt: P10914 | TargetFullName: Interferon regulatory factor 1 | Organisim: human | Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId:17466-72;Target:ACSF2;UniProt:Q96CM8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17466-72;Target: ACSF2;UniProt: Q96CM8;TargetFullName: Acyl-CoA synthetase family member 2; mitochondrial;Organisim: human;Apparent_Kd_M: 4.64E-12

Real

Aptamer SeqId: 17466-72 | Target: ACSF2 | UniProt: Q96CM8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17466-72 | Target: ACSF2 | UniProt: Q96CM8 | TargetFullName: Acyl-CoA synthetase family member 2; mitochondrial | Organisim: human | Apparent_Kd_M: 4.64E-12

Real

Aptamer SeqId:17467-1;Target:DHRS9;UniProt:Q9BPW9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17467-1;Target: DHRS9;UniProt: Q9BPW9;TargetFullName: Dehydrogenase/reductase SDR family member 9;Organisim: human;Apparent_Kd_M: 4.3E-11

Real

Aptamer SeqId: 17467-1 | Target: DHRS9 | UniProt: Q9BPW9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17467-1 | Target: DHRS9 | UniProt: Q9BPW9 | TargetFullName: Dehydrogenase/reductase SDR family member 9 | Organisim: human | Apparent_Kd_M: 4.3E-11

Real

Aptamer SeqId:17468-1;Target:SUFU;UniProt:Q9UMX1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17468-1;Target: SUFU;UniProt: Q9UMX1;TargetFullName: Suppressor of fused homolog;Organisim: human;Apparent_Kd_M: 2.87E-11

Real

Aptamer SeqId: 17468-1 | Target: SUFU | UniProt: Q9UMX1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17468-1 | Target: SUFU | UniProt: Q9UMX1 | TargetFullName: Suppressor of fused homolog | Organisim: human | Apparent_Kd_M: 2.87E-11

Real

Aptamer SeqId:17474-106;Target:YETS4;UniProt:O95619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17474-106;Target: YETS4;UniProt: O95619;TargetFullName: YEATS domain-containing protein 4;Organisim: human;Apparent_Kd_M: 3.39E-11

Real

Aptamer SeqId: 17474-106 | Target: YETS4 | UniProt: O95619

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17474-106 | Target: YETS4 | UniProt: O95619 | TargetFullName: YEATS domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 3.39E-11

Real

Aptamer SeqId:17475-18;Target:TOPK;UniProt:Q96KB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17475-18;Target: TOPK;UniProt: Q96KB5;TargetFullName: Lymphokine-activated killer T-cell-originated protein kinase;Organisim: human;Apparent_Kd_M: 3.19E-11

Real

Aptamer SeqId: 17475-18 | Target: TOPK | UniProt: Q96KB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17475-18 | Target: TOPK | UniProt: Q96KB5 | TargetFullName: Lymphokine-activated killer T-cell-originated protein kinase | Organisim: human | Apparent_Kd_M: 3.19E-11

Real

Aptamer SeqId:17490-4;Target:SH3BGRL3-like protein;UniProt:Q9H299

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17490-4;Target: SH3BGRL3-like protein;UniProt: Q9H299;TargetFullName: SH3 domain-binding glutamic acid-rich-like protein 3;Organisim: human;Apparent_Kd_M: 1.144902E-10

Real

Aptamer SeqId: 17490-4 | Target: SH3BGRL3-like protein | UniProt: Q9H299

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17490-4 | Target: SH3BGRL3-like protein | UniProt: Q9H299 | TargetFullName: SH3 domain-binding glutamic acid-rich-like protein 3 | Organisim: human | Apparent_Kd_M: 1.144902E-10

Real

Aptamer SeqId:17495-141;Target:SIR3;UniProt:Q9NTG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17495-141;Target: SIR3;UniProt: Q9NTG7;TargetFullName: NAD-dependent protein deacetylase sirtuin-3; mitochondrial;Organisim: human;Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId: 17495-141 | Target: SIR3 | UniProt: Q9NTG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17495-141 | Target: SIR3 | UniProt: Q9NTG7 | TargetFullName: NAD-dependent protein deacetylase sirtuin-3; mitochondrial | Organisim: human | Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId:17505-125;Target:NALDL;UniProt:Q9UQQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17505-125;Target: NALDL;UniProt: Q9UQQ1;TargetFullName: N-acetylated-alpha-linked acidic dipeptidase-like protein;Organisim: human;Apparent_Kd_M: 5.08E-11

Real

Aptamer SeqId: 17505-125 | Target: NALDL | UniProt: Q9UQQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17505-125 | Target: NALDL | UniProt: Q9UQQ1 | TargetFullName: N-acetylated-alpha-linked acidic dipeptidase-like protein | Organisim: human | Apparent_Kd_M: 5.08E-11

Real

Aptamer SeqId:17509-6;Target:HPPD;UniProt:P32754

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17509-6;Target: HPPD;UniProt: P32754;TargetFullName: 4-hydroxyphenylpyruvate dioxygenase;Organisim: human;Apparent_Kd_M: 6.958946E-11

Real

Aptamer SeqId: 17509-6 | Target: HPPD | UniProt: P32754

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17509-6 | Target: HPPD | UniProt: P32754 | TargetFullName: 4-hydroxyphenylpyruvate dioxygenase | Organisim: human | Apparent_Kd_M: 6.958946E-11

Real

Aptamer SeqId:17510-7;Target:SRP14;UniProt:P37108

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17510-7;Target: SRP14;UniProt: P37108;TargetFullName: Signal recognition particle 14 kDa protein;Organisim: human;Apparent_Kd_M: 3.09E-12

Real

Aptamer SeqId: 17510-7 | Target: SRP14 | UniProt: P37108

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17510-7 | Target: SRP14 | UniProt: P37108 | TargetFullName: Signal recognition particle 14 kDa protein | Organisim: human | Apparent_Kd_M: 3.09E-12

Real

Aptamer SeqId:17511-10;Target:RPP30;UniProt:P78346

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17511-10;Target: RPP30;UniProt: P78346;TargetFullName: Ribonuclease P protein subunit p30;Organisim: human;Apparent_Kd_M: 9.34E-12

Real

Aptamer SeqId: 17511-10 | Target: RPP30 | UniProt: P78346

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17511-10 | Target: RPP30 | UniProt: P78346 | TargetFullName: Ribonuclease P protein subunit p30 | Organisim: human | Apparent_Kd_M: 9.34E-12

Real

Aptamer SeqId:17512-2;Target:NMI;UniProt:Q13287

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17512-2;Target: NMI;UniProt: Q13287;TargetFullName: N-myc-interactor;Organisim: human;Apparent_Kd_M: 2.447968E-11

Real

Aptamer SeqId: 17512-2 | Target: NMI | UniProt: Q13287

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17512-2 | Target: NMI | UniProt: Q13287 | TargetFullName: N-myc-interactor | Organisim: human | Apparent_Kd_M: 2.447968E-11

Real

Aptamer SeqId:17513-11;Target:ANX11;UniProt:P50995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17513-11;Target: ANX11;UniProt: P50995;TargetFullName: Annexin A11;Organisim: human;Apparent_Kd_M: 3.932212E-11

Real

Aptamer SeqId: 17513-11 | Target: ANX11 | UniProt: P50995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17513-11 | Target: ANX11 | UniProt: P50995 | TargetFullName: Annexin A11 | Organisim: human | Apparent_Kd_M: 3.932212E-11

Real

Aptamer SeqId:17514-48;Target:RAB21;UniProt:Q9UL25

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17514-48;Target: RAB21;UniProt: Q9UL25;TargetFullName: Ras-related protein Rab-21;Organisim: human;Apparent_Kd_M: 2.406208E-12

Real

Aptamer SeqId: 17514-48 | Target: RAB21 | UniProt: Q9UL25

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17514-48 | Target: RAB21 | UniProt: Q9UL25 | TargetFullName: Ras-related protein Rab-21 | Organisim: human | Apparent_Kd_M: 2.406208E-12

Real

Aptamer SeqId:17515-6;Target:STCH;UniProt:P48723

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17515-6;Target: STCH;UniProt: P48723;TargetFullName: Heat shock 70 kDa protein 13;Organisim: human;Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId: 17515-6 | Target: STCH | UniProt: P48723

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17515-6 | Target: STCH | UniProt: P48723 | TargetFullName: Heat shock 70 kDa protein 13 | Organisim: human | Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId:17516-7;Target:Rab3A;UniProt:P20336

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17516-7;Target: Rab3A;UniProt: P20336;TargetFullName: Ras-related protein Rab-3A;Organisim: human;Apparent_Kd_M: 1.78E-12

Real

Aptamer SeqId: 17516-7 | Target: Rab3A | UniProt: P20336

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17516-7 | Target: Rab3A | UniProt: P20336 | TargetFullName: Ras-related protein Rab-3A | Organisim: human | Apparent_Kd_M: 1.78E-12

Real

Aptamer SeqId:17671-58;Target:ING4;UniProt:Q9UNL4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17671-58;Target: ING4;UniProt: Q9UNL4;TargetFullName: Inhibitor of growth protein 4;Organisim: human;Apparent_Kd_M: 4.01E-11

Real

Aptamer SeqId: 17671-58 | Target: ING4 | UniProt: Q9UNL4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17671-58 | Target: ING4 | UniProt: Q9UNL4 | TargetFullName: Inhibitor of growth protein 4 | Organisim: human | Apparent_Kd_M: 4.01E-11

Real

Aptamer SeqId:17672-184;Target:Gastric intrinsic factor;UniProt:P27352

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17672-184;Target: Gastric intrinsic factor;UniProt: P27352;TargetFullName: Gastric intrinsic factor;Organisim: human;Apparent_Kd_M: 2.81E-12

Real

Aptamer SeqId: 17672-184 | Target: Gastric intrinsic factor

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17672-184 | Target: Gastric intrinsic factor | UniProt: P27352 | TargetFullName: Gastric intrinsic factor | Organisim: human | Apparent_Kd_M: 2.81E-12

Real

Aptamer SeqId:17673-34;Target:Carbonic Anhydrase VB;UniProt:Q9Y2D0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17673-34;Target: Carbonic Anhydrase VB;UniProt: Q9Y2D0;TargetFullName: Carbonic anhydrase 5B; mitochondrial;Organisim: human;Apparent_Kd_M: 1.85E-11

Real

Aptamer SeqId: 17673-34 | Target: Carbonic Anhydrase VB | UniProt: Q9Y2D0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17673-34 | Target: Carbonic Anhydrase VB | UniProt: Q9Y2D0 | TargetFullName: Carbonic anhydrase 5B; mitochondrial | Organisim: human | Apparent_Kd_M: 1.85E-11

Real

Aptamer SeqId:17675-17;Target:ACO13;UniProt:Q9NPJ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17675-17;Target: ACO13;UniProt: Q9NPJ3;TargetFullName: Acyl-coenzyme A thioesterase 13;Organisim: human;Apparent_Kd_M: 7.95E-12

Real

Aptamer SeqId: 17675-17 | Target: ACO13 | UniProt: Q9NPJ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17675-17 | Target: ACO13 | UniProt: Q9NPJ3 | TargetFullName: Acyl-coenzyme A thioesterase 13 | Organisim: human | Apparent_Kd_M: 7.95E-12

Real

Aptamer SeqId:17676-13;Target:CIP4;UniProt:Q15642

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17676-13;Target: CIP4;UniProt: Q15642;TargetFullName: Cdc42-interacting protein 4;Organisim: human;Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId: 17676-13 | Target: CIP4 | UniProt: Q15642

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17676-13 | Target: CIP4 | UniProt: Q15642 | TargetFullName: Cdc42-interacting protein 4 | Organisim: human | Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId:17677-47;Target:BY55;UniProt:O95971

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17677-47;Target: BY55;UniProt: O95971;TargetFullName: CD160 antigen;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 17677-47 | Target: BY55 | UniProt: O95971

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17677-47 | Target: BY55 | UniProt: O95971 | TargetFullName: CD160 antigen | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:17680-12;Target:EPHB1;UniProt:P54762

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17680-12;Target: EPHB1;UniProt: P54762;TargetFullName: Ephrin type-B receptor 1;Organisim: human;Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId: 17680-12 | Target: EPHB1 | UniProt: P54762

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17680-12 | Target: EPHB1 | UniProt: P54762 | TargetFullName: Ephrin type-B receptor 1 | Organisim: human | Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId:17682-1;Target:CD46;UniProt:P15529

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17682-1;Target: CD46;UniProt: P15529;TargetFullName: Membrane cofactor protein;Organisim: human;Apparent_Kd_M: 3.64E-12

Real

Aptamer SeqId: 17682-1 | Target: CD46 | UniProt: P15529

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17682-1 | Target: CD46 | UniProt: P15529 | TargetFullName: Membrane cofactor protein | Organisim: human | Apparent_Kd_M: 3.64E-12

Real

Aptamer SeqId:17683-2;Target:COMD9;UniProt:Q9P000

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17683-2;Target: COMD9;UniProt: Q9P000;TargetFullName: COMM domain-containing protein 9;Organisim: human;Apparent_Kd_M: 2.84E-11

Real

Aptamer SeqId: 17683-2 | Target: COMD9 | UniProt: Q9P000

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17683-2 | Target: COMD9 | UniProt: Q9P000 | TargetFullName: COMM domain-containing protein 9 | Organisim: human | Apparent_Kd_M: 2.84E-11

Real

Aptamer SeqId:17685-9;Target:Apo A-IV;UniProt:P06727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17685-9;Target: Apo A-IV;UniProt: P06727;TargetFullName: Apolipoprotein A-IV;Organisim: human;Apparent_Kd_M: 1.57E-11

Real

Aptamer SeqId: 17685-9 | Target: Apo A-IV | UniProt: P06727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17685-9 | Target: Apo A-IV | UniProt: P06727 | TargetFullName: Apolipoprotein A-IV | Organisim: human | Apparent_Kd_M: 1.57E-11

Real

Aptamer SeqId:17686-27;Target:TBCB;UniProt:Q99426

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17686-27;Target: TBCB;UniProt: Q99426;TargetFullName: Tubulin-folding cofactor B;Organisim: human;Apparent_Kd_M: 7.31E-12

Real

Aptamer SeqId: 17686-27 | Target: TBCB | UniProt: Q99426

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17686-27 | Target: TBCB | UniProt: Q99426 | TargetFullName: Tubulin-folding cofactor B | Organisim: human | Apparent_Kd_M: 7.31E-12

Real

Aptamer SeqId:17691-1;Target:TPP1;UniProt:O14773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17691-1;Target: TPP1;UniProt: O14773;TargetFullName: Tripeptidyl-peptidase 1;Organisim: human;Apparent_Kd_M: 7.59E-12

Real

Aptamer SeqId: 17691-1 | Target: TPP1 | UniProt: O14773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17691-1 | Target: TPP1 | UniProt: O14773 | TargetFullName: Tripeptidyl-peptidase 1 | Organisim: human | Apparent_Kd_M: 7.59E-12

Real

Aptamer SeqId:17692-2;Target:BT3A3;UniProt:O00478

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17692-2;Target: BT3A3;UniProt: O00478;TargetFullName: Butyrophilin subfamily 3 member A3;Organisim: human;Apparent_Kd_M: 7.84E-12

Real

Aptamer SeqId: 17692-2 | Target: BT3A3 | UniProt: O00478

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17692-2 | Target: BT3A3 | UniProt: O00478 | TargetFullName: Butyrophilin subfamily 3 member A3 | Organisim: human | Apparent_Kd_M: 7.84E-12

Real

Aptamer SeqId:17693-2;Target:Septin-6;UniProt:Q14141

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17693-2;Target: Septin-6;UniProt: Q14141;TargetFullName: Septin-6;Organisim: human;Apparent_Kd_M: 5.39E-11

Real

Aptamer SeqId: 17693-2 | Target: Septin-6 | UniProt: Q14141

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17693-2 | Target: Septin-6 | UniProt: Q14141 | TargetFullName: Septin-6 | Organisim: human | Apparent_Kd_M: 5.39E-11

Real

Aptamer SeqId:17694-32;Target:PSME2;UniProt:Q9UL46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17694-32;Target: PSME2;UniProt: Q9UL46;TargetFullName: Proteasome activator complex subunit 2;Organisim: human;Apparent_Kd_M: 8.28E-12

Real

Aptamer SeqId: 17694-32 | Target: PSME2 | UniProt: Q9UL46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17694-32 | Target: PSME2 | UniProt: Q9UL46 | TargetFullName: Proteasome activator complex subunit 2 | Organisim: human | Apparent_Kd_M: 8.28E-12

Real

Aptamer SeqId:17696-1;Target:TIRP;UniProt:Q86XR7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17696-1;Target: TIRP;UniProt: Q86XR7;TargetFullName: TIR domain-containing adapter molecule 2;Organisim: human;Apparent_Kd_M: 1.96E-11

Real

Aptamer SeqId: 17696-1 | Target: TIRP | UniProt: Q86XR7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17696-1 | Target: TIRP | UniProt: Q86XR7 | TargetFullName: TIR domain-containing adapter molecule 2 | Organisim: human | Apparent_Kd_M: 1.96E-11

Real

Aptamer SeqId:17697-2;Target:OVCA2;UniProt:Q8WZ82

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17697-2;Target: OVCA2;UniProt: Q8WZ82;TargetFullName: Esterase OVCA2;Organisim: human;Apparent_Kd_M: 2.0E-12

Real

Aptamer SeqId: 17697-2 | Target: OVCA2 | UniProt: Q8WZ82

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17697-2 | Target: OVCA2 | UniProt: Q8WZ82 | TargetFullName: Esterase OVCA2 | Organisim: human | Apparent_Kd_M: 2.0E-12

Real

Aptamer SeqId:17698-15;Target:WBP2;UniProt:Q969T9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17698-15;Target: WBP2;UniProt: Q969T9;TargetFullName: WW domain-binding protein 2;Organisim: human;Apparent_Kd_M: 3.77E-12

Real

Aptamer SeqId: 17698-15 | Target: WBP2 | UniProt: Q969T9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17698-15 | Target: WBP2 | UniProt: Q969T9 | TargetFullName: WW domain-binding protein 2 | Organisim: human | Apparent_Kd_M: 3.77E-12

Real

Aptamer SeqId:17699-43;Target:TIMELESS;UniProt:Q9UNS1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17699-43;Target: TIMELESS;UniProt: Q9UNS1;TargetFullName: Protein timeless homolog;Organisim: human;Apparent_Kd_M: 2.52E-12

Real

Aptamer SeqId: 17699-43 | Target: TIMELESS | UniProt: Q9UNS1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17699-43 | Target: TIMELESS | UniProt: Q9UNS1 | TargetFullName: Protein timeless homolog | Organisim: human | Apparent_Kd_M: 2.52E-12

Real

Aptamer SeqId:17702-53;Target:UGT 1A1;UniProt:P22309

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17702-53;Target: UGT 1A1;UniProt: P22309;TargetFullName: UDP-glucuronosyltransferase 1-1;Organisim: human;Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId: 17702-53 | Target: UGT 1A1 | UniProt: P22309

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17702-53 | Target: UGT 1A1 | UniProt: P22309 | TargetFullName: UDP-glucuronosyltransferase 1-1 | Organisim: human | Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId:17703-40;Target:GEMI;UniProt:O75496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17703-40;Target: GEMI;UniProt: O75496;TargetFullName: Geminin;Organisim: human;Apparent_Kd_M: 6.63E-12

Real

Aptamer SeqId: 17703-40 | Target: GEMI | UniProt: O75496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17703-40 | Target: GEMI | UniProt: O75496 | TargetFullName: Geminin | Organisim: human | Apparent_Kd_M: 6.63E-12

Real

Aptamer SeqId:17704-74;Target:HS105;UniProt:Q92598

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17704-74;Target: HS105;UniProt: Q92598;TargetFullName: Heat shock protein 105 kDa;Organisim: human;Apparent_Kd_M: 9.43E-12

Real

Aptamer SeqId: 17704-74 | Target: HS105 | UniProt: Q92598

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17704-74 | Target: HS105 | UniProt: Q92598 | TargetFullName: Heat shock protein 105 kDa | Organisim: human | Apparent_Kd_M: 9.43E-12

Real

Aptamer SeqId:17706-4;Target:PPR1A;UniProt:Q13522

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17706-4;Target: PPR1A;UniProt: Q13522;TargetFullName: Protein phosphatase 1 regulatory subunit 1A;Organisim: human;Apparent_Kd_M: 4.96E-12

Real

Aptamer SeqId: 17706-4 | Target: PPR1A | UniProt: Q13522

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17706-4 | Target: PPR1A | UniProt: Q13522 | TargetFullName: Protein phosphatase 1 regulatory subunit 1A | Organisim: human | Apparent_Kd_M: 4.96E-12

Real

Aptamer SeqId:17710-40;Target:TPD53;UniProt:Q16890

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17710-40;Target: TPD53;UniProt: Q16890;TargetFullName: Tumor protein D53;Organisim: human;Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId: 17710-40 | Target: TPD53 | UniProt: Q16890

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17710-40 | Target: TPD53 | UniProt: Q16890 | TargetFullName: Tumor protein D53 | Organisim: human | Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId:17711-13;Target:VAMP1;UniProt:P23763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17711-13;Target: VAMP1;UniProt: P23763;TargetFullName: Vesicle-associated membrane protein 1;Organisim: human;Apparent_Kd_M: 2.1E-11

Real

Aptamer SeqId: 17711-13 | Target: VAMP1 | UniProt: P23763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17711-13 | Target: VAMP1 | UniProt: P23763 | TargetFullName: Vesicle-associated membrane protein 1 | Organisim: human | Apparent_Kd_M: 2.1E-11

Real

Aptamer SeqId:17712-7;Target:IDI1;UniProt:Q13907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17712-7;Target: IDI1;UniProt: Q13907;TargetFullName: Isopentenyl-diphosphate Delta-isomerase 1;Organisim: human;Apparent_Kd_M: 1.9E-11

Real

Aptamer SeqId: 17712-7 | Target: IDI1 | UniProt: Q13907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17712-7 | Target: IDI1 | UniProt: Q13907 | TargetFullName: Isopentenyl-diphosphate Delta-isomerase 1 | Organisim: human | Apparent_Kd_M: 1.9E-11

Real

Aptamer SeqId:17721-82;Target:GAS7;UniProt:O60861

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17721-82;Target: GAS7;UniProt: O60861;TargetFullName: Growth arrest-specific protein 7;Organisim: human;Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId: 17721-82 | Target: GAS7 | UniProt: O60861

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17721-82 | Target: GAS7 | UniProt: O60861 | TargetFullName: Growth arrest-specific protein 7 | Organisim: human | Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId:17722-5;Target:FKBP52 protein;UniProt:Q02790

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17722-5;Target: FKBP52 protein;UniProt: Q02790;TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP4;Organisim: human;Apparent_Kd_M: 4.75E-12

Real

Aptamer SeqId: 17722-5 | Target: FKBP52 protein | UniProt: Q02790

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17722-5 | Target: FKBP52 protein | UniProt: Q02790 | TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP4 | Organisim: human | Apparent_Kd_M: 4.75E-12

Real

Aptamer SeqId:17724-3;Target:WWOX;UniProt:Q9NZC7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17724-3;Target: WWOX;UniProt: Q9NZC7;TargetFullName: WW domain-containing oxidoreductase;Organisim: human;Apparent_Kd_M: 8.93E-11

Real

Aptamer SeqId: 17724-3 | Target: WWOX | UniProt: Q9NZC7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17724-3 | Target: WWOX | UniProt: Q9NZC7 | TargetFullName: WW domain-containing oxidoreductase | Organisim: human | Apparent_Kd_M: 8.93E-11

Real

Aptamer SeqId:17725-37;Target:USH1C;UniProt:Q9Y6N9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17725-37;Target: USH1C;UniProt: Q9Y6N9;TargetFullName: Harmonin;Organisim: human;Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId: 17725-37 | Target: USH1C | UniProt: Q9Y6N9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17725-37 | Target: USH1C | UniProt: Q9Y6N9 | TargetFullName: Harmonin | Organisim: human | Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId:17726-3;Target:SAR1A;UniProt:Q9NR31

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17726-3;Target: SAR1A;UniProt: Q9NR31;TargetFullName: GTP-binding protein SAR1a;Organisim: human;Apparent_Kd_M: 2.92E-11

Real

Aptamer SeqId: 17726-3 | Target: SAR1A | UniProt: Q9NR31

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17726-3 | Target: SAR1A | UniProt: Q9NR31 | TargetFullName: GTP-binding protein SAR1a | Organisim: human | Apparent_Kd_M: 2.92E-11

Real

Aptamer SeqId:17727-1;Target:Securin;UniProt:O95997

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17727-1;Target: Securin;UniProt: O95997;TargetFullName: Securin;Organisim: human;Apparent_Kd_M: 1.06E-11

Real

Aptamer SeqId: 17727-1 | Target: Securin | UniProt: O95997

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17727-1 | Target: Securin | UniProt: O95997 | TargetFullName: Securin | Organisim: human | Apparent_Kd_M: 1.06E-11

Real

Aptamer SeqId:17728-61;Target:CHM2A;UniProt:O43633

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17728-61;Target: CHM2A;UniProt: O43633;TargetFullName: Charged multivesicular body protein 2a;Organisim: human;Apparent_Kd_M: 2.45E-12

Real

Aptamer SeqId: 17728-61 | Target: CHM2A | UniProt: O43633

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17728-61 | Target: CHM2A | UniProt: O43633 | TargetFullName: Charged multivesicular body protein 2a | Organisim: human | Apparent_Kd_M: 2.45E-12

Real

Aptamer SeqId:17729-20;Target:UBE2S;UniProt:Q16763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17729-20;Target: UBE2S;UniProt: Q16763;TargetFullName: Ubiquitin-conjugating enzyme E2 S;Organisim: human;Apparent_Kd_M: 9.61E-12

Real

Aptamer SeqId: 17729-20 | Target: UBE2S | UniProt: Q16763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17729-20 | Target: UBE2S | UniProt: Q16763 | TargetFullName: Ubiquitin-conjugating enzyme E2 S | Organisim: human | Apparent_Kd_M: 9.61E-12

Real

Aptamer SeqId:17734-13;Target:a-endosulfine;UniProt:O43768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17734-13;Target: a-endosulfine;UniProt: O43768;TargetFullName: Alpha-endosulfine;Organisim: human;Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId: 17734-13 | Target: a-endosulfine | UniProt: O43768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17734-13 | Target: a-endosulfine | UniProt: O43768 | TargetFullName: Alpha-endosulfine | Organisim: human | Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId:17735-130;Target:GBRAP;UniProt:O95166

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17735-130;Target: GBRAP;UniProt: O95166;TargetFullName: Gamma-aminobutyric acid receptor-associated protein;Organisim: human;Apparent_Kd_M: 2.24E-12

Real

Aptamer SeqId: 17735-130 | Target: GBRAP | UniProt: O95166

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17735-130 | Target: GBRAP | UniProt: O95166 | TargetFullName: Gamma-aminobutyric acid receptor-associated protein | Organisim: human | Apparent_Kd_M: 2.24E-12

Real

Aptamer SeqId:17736-105;Target:APTX;UniProt:Q7Z2E3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17736-105;Target: APTX;UniProt: Q7Z2E3;TargetFullName: Aprataxin;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 17736-105 | Target: APTX | UniProt: Q7Z2E3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17736-105 | Target: APTX | UniProt: Q7Z2E3 | TargetFullName: Aprataxin | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:17737-7;Target:IVD;UniProt:P26440

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17737-7;Target: IVD;UniProt: P26440;TargetFullName: Isovaleryl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 5.15E-12

Real

Aptamer SeqId: 17737-7 | Target: IVD | UniProt: P26440

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17737-7 | Target: IVD | UniProt: P26440 | TargetFullName: Isovaleryl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 5.15E-12

Real

Aptamer SeqId:17738-7;Target:CRNN;UniProt:Q9UBG3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17738-7;Target: CRNN;UniProt: Q9UBG3;TargetFullName: Cornulin;Organisim: human;Apparent_Kd_M: 4.33E-12

Real

Aptamer SeqId: 17738-7 | Target: CRNN | UniProt: Q9UBG3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17738-7 | Target: CRNN | UniProt: Q9UBG3 | TargetFullName: Cornulin | Organisim: human | Apparent_Kd_M: 4.33E-12

Real

Aptamer SeqId:17739-1;Target:HCDH;UniProt:Q16836

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17739-1;Target: HCDH;UniProt: Q16836;TargetFullName: Hydroxyacyl-coenzyme A dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 5.2E-12

Real

Aptamer SeqId: 17739-1 | Target: HCDH | UniProt: Q16836

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17739-1 | Target: HCDH | UniProt: Q16836 | TargetFullName: Hydroxyacyl-coenzyme A dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 5.2E-12

Real

Aptamer SeqId:17742-2;Target:RRAS;UniProt:P10301

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17742-2;Target: RRAS;UniProt: P10301;TargetFullName: Ras-related protein R-Ras;Organisim: human;Apparent_Kd_M: 8.48E-12

Real

Aptamer SeqId: 17742-2 | Target: RRAS | UniProt: P10301

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17742-2 | Target: RRAS | UniProt: P10301 | TargetFullName: Ras-related protein R-Ras | Organisim: human | Apparent_Kd_M: 8.48E-12

Real

Aptamer SeqId:17743-14;Target:UBE2A;UniProt:P49459

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17743-14;Target: UBE2A;UniProt: P49459;TargetFullName: Ubiquitin-conjugating enzyme E2 A;Organisim: human;Apparent_Kd_M: 4.06E-12

Real

Aptamer SeqId: 17743-14 | Target: UBE2A | UniProt: P49459

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17743-14 | Target: UBE2A | UniProt: P49459 | TargetFullName: Ubiquitin-conjugating enzyme E2 A | Organisim: human | Apparent_Kd_M: 4.06E-12

Real

Aptamer SeqId:17744-31;Target:RB11A;UniProt:P62491

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17744-31;Target: RB11A;UniProt: P62491;TargetFullName: Ras-related protein Rab-11A;Organisim: human;Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId: 17744-31 | Target: RB11A | UniProt: P62491

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17744-31 | Target: RB11A | UniProt: P62491 | TargetFullName: Ras-related protein Rab-11A | Organisim: human | Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId:17746-77;Target:FIS1;UniProt:Q9Y3D6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17746-77;Target: FIS1;UniProt: Q9Y3D6;TargetFullName: Mitochondrial fission 1 protein;Organisim: human;Apparent_Kd_M: 2.48E-11

Real

Aptamer SeqId: 17746-77 | Target: FIS1 | UniProt: Q9Y3D6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17746-77 | Target: FIS1 | UniProt: Q9Y3D6 | TargetFullName: Mitochondrial fission 1 protein | Organisim: human | Apparent_Kd_M: 2.48E-11

Real

Aptamer SeqId:17747-45;Target:TRAF1;UniProt:Q13077

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17747-45;Target: TRAF1;UniProt: Q13077;TargetFullName: TNF receptor-associated factor 1;Organisim: human;Apparent_Kd_M: 3.26E-11

Real

Aptamer SeqId: 17747-45 | Target: TRAF1 | UniProt: Q13077

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17747-45 | Target: TRAF1 | UniProt: Q13077 | TargetFullName: TNF receptor-associated factor 1 | Organisim: human | Apparent_Kd_M: 3.26E-11

Real

Aptamer SeqId:17748-21;Target:QORX;UniProt:Q53FA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17748-21;Target: QORX;UniProt: Q53FA7;TargetFullName: Quinone oxidoreductase PIG3;Organisim: human;Apparent_Kd_M: 2.53E-12

Real

Aptamer SeqId: 17748-21 | Target: QORX | UniProt: Q53FA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17748-21 | Target: QORX | UniProt: Q53FA7 | TargetFullName: Quinone oxidoreductase PIG3 | Organisim: human | Apparent_Kd_M: 2.53E-12

Real

Aptamer SeqId:17750-8;Target:RIR2;UniProt:P31350

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17750-8;Target: RIR2;UniProt: P31350;TargetFullName: Ribonucleoside-diphosphate reductase subunit M2;Organisim: human;Apparent_Kd_M: 3.7E-11

Real

Aptamer SeqId: 17750-8 | Target: RIR2 | UniProt: P31350

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17750-8 | Target: RIR2 | UniProt: P31350 | TargetFullName: Ribonucleoside-diphosphate reductase subunit M2 | Organisim: human | Apparent_Kd_M: 3.7E-11

Real

Aptamer SeqId:17751-68;Target:CRBB1;UniProt:P53674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17751-68;Target: CRBB1;UniProt: P53674;TargetFullName: Beta-crystallin B1;Organisim: human;Apparent_Kd_M: 6.44E-12

Real

Aptamer SeqId: 17751-68 | Target: CRBB1 | UniProt: P53674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17751-68 | Target: CRBB1 | UniProt: P53674 | TargetFullName: Beta-crystallin B1 | Organisim: human | Apparent_Kd_M: 6.44E-12

Real

Aptamer SeqId:17752-24;Target:Arginase;UniProt:P78540

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17752-24;Target: Arginase;UniProt: P78540;TargetFullName: Arginase-2; mitochondrial;Organisim: human;Apparent_Kd_M: 2.08E-11

Real

Aptamer SeqId: 17752-24 | Target: Arginase | UniProt: P78540

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17752-24 | Target: Arginase | UniProt: P78540 | TargetFullName: Arginase-2; mitochondrial | Organisim: human | Apparent_Kd_M: 2.08E-11

Real

Aptamer SeqId:17755-5;Target:UGDH;UniProt:O60701

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17755-5;Target: UGDH;UniProt: O60701;TargetFullName: UDP-glucose 6-dehydrogenase;Organisim: human;Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId: 17755-5 | Target: UGDH | UniProt: O60701

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17755-5 | Target: UGDH | UniProt: O60701 | TargetFullName: UDP-glucose 6-dehydrogenase | Organisim: human | Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId:17756-69;Target:DCTD;UniProt:P32321

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17756-69;Target: DCTD;UniProt: P32321;TargetFullName: Deoxycytidylate deaminase;Organisim: human;Apparent_Kd_M: 3.48E-11

Real

Aptamer SeqId: 17756-69 | Target: DCTD | UniProt: P32321

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17756-69 | Target: DCTD | UniProt: P32321 | TargetFullName: Deoxycytidylate deaminase | Organisim: human | Apparent_Kd_M: 3.48E-11

Real

Aptamer SeqId:17757-86;Target:CAB39;UniProt:Q9Y376

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17757-86;Target: CAB39;UniProt: Q9Y376;TargetFullName: Calcium-binding protein 39;Organisim: human;Apparent_Kd_M: 1.9E-12

Real

Aptamer SeqId: 17757-86 | Target: CAB39 | UniProt: Q9Y376

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17757-86 | Target: CAB39 | UniProt: Q9Y376 | TargetFullName: Calcium-binding protein 39 | Organisim: human | Apparent_Kd_M: 1.9E-12

Real

Aptamer SeqId:17758-79;Target:DCXR;UniProt:Q7Z4W1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17758-79;Target: DCXR;UniProt: Q7Z4W1;TargetFullName: L-xylulose reductase;Organisim: human;Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId: 17758-79 | Target: DCXR | UniProt: Q7Z4W1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17758-79 | Target: DCXR | UniProt: Q7Z4W1 | TargetFullName: L-xylulose reductase | Organisim: human | Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId:17760-128;Target:WDR5;UniProt:P61964

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17760-128;Target: WDR5;UniProt: P61964;TargetFullName: WD repeat-containing protein 5;Organisim: human;Apparent_Kd_M: 8.69E-12

Real

Aptamer SeqId: 17760-128 | Target: WDR5 | UniProt: P61964

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17760-128 | Target: WDR5 | UniProt: P61964 | TargetFullName: WD repeat-containing protein 5 | Organisim: human | Apparent_Kd_M: 8.69E-12

Real

Aptamer SeqId:17761-2;Target:NUDT5;UniProt:Q9UKK9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17761-2;Target: NUDT5;UniProt: Q9UKK9;TargetFullName: ADP-sugar pyrophosphatase;Organisim: human;Apparent_Kd_M: 4.19E-11

Real

Aptamer SeqId: 17761-2 | Target: NUDT5 | UniProt: Q9UKK9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17761-2 | Target: NUDT5 | UniProt: Q9UKK9 | TargetFullName: ADP-sugar pyrophosphatase | Organisim: human | Apparent_Kd_M: 4.19E-11

Real

Aptamer SeqId:17764-108;Target:RHOC;UniProt:P08134

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17764-108;Target: RHOC;UniProt: P08134;TargetFullName: Rho-related GTP-binding protein RhoC;Organisim: human;Apparent_Kd_M: 2.19E-11

Real

Aptamer SeqId: 17764-108 | Target: RHOC | UniProt: P08134

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17764-108 | Target: RHOC | UniProt: P08134 | TargetFullName: Rho-related GTP-binding protein RhoC | Organisim: human | Apparent_Kd_M: 2.19E-11

Real

Aptamer SeqId:17765-3;Target:SPN1;UniProt:O95149

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17765-3;Target: SPN1;UniProt: O95149;TargetFullName: Snurportin-1;Organisim: human;Apparent_Kd_M: 7.2E-13

Real

Aptamer SeqId: 17765-3 | Target: SPN1 | UniProt: O95149

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17765-3 | Target: SPN1 | UniProt: O95149 | TargetFullName: Snurportin-1 | Organisim: human | Apparent_Kd_M: 7.2E-13

Real

Aptamer SeqId:17766-5;Target:NCF-1;UniProt:P14598

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17766-5;Target: NCF-1;UniProt: P14598;TargetFullName: Neutrophil cytosol factor 1;Organisim: human;Apparent_Kd_M: 3.26E-12

Real

Aptamer SeqId: 17766-5 | Target: NCF-1 | UniProt: P14598

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17766-5 | Target: NCF-1 | UniProt: P14598 | TargetFullName: Neutrophil cytosol factor 1 | Organisim: human | Apparent_Kd_M: 3.26E-12

Real

Aptamer SeqId:17768-50;Target:HAOX1;UniProt:Q9UJM8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17768-50;Target: HAOX1;UniProt: Q9UJM8;TargetFullName: Hydroxyacid oxidase 1;Organisim: human;Apparent_Kd_M: 1.9E-11

Real

Aptamer SeqId: 17768-50 | Target: HAOX1 | UniProt: Q9UJM8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17768-50 | Target: HAOX1 | UniProt: Q9UJM8 | TargetFullName: Hydroxyacid oxidase 1 | Organisim: human | Apparent_Kd_M: 1.9E-11

Real

Aptamer SeqId:17769-28;Target:PCNP;UniProt:Q8WW12

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17769-28;Target: PCNP;UniProt: Q8WW12;TargetFullName: PEST proteolytic signal-containing nuclear protein;Organisim: human;Apparent_Kd_M: 5.88E-12

Real

Aptamer SeqId: 17769-28 | Target: PCNP | UniProt: Q8WW12

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17769-28 | Target: PCNP | UniProt: Q8WW12 | TargetFullName: PEST proteolytic signal-containing nuclear protein | Organisim: human | Apparent_Kd_M: 5.88E-12

Real

Aptamer SeqId:17770-42;Target:EMC8;UniProt:O43402

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17770-42;Target: EMC8;UniProt: O43402;TargetFullName: ER membrane protein complex subunit 8;Organisim: human;Apparent_Kd_M: 1.02E-10

Real

Aptamer SeqId: 17770-42 | Target: EMC8 | UniProt: O43402

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17770-42 | Target: EMC8 | UniProt: O43402 | TargetFullName: ER membrane protein complex subunit 8 | Organisim: human | Apparent_Kd_M: 1.02E-10

Real

Aptamer SeqId:17771-35;Target:RPC9;UniProt:O75575

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17771-35;Target: RPC9;UniProt: O75575;TargetFullName: DNA-directed RNA polymerase III subunit RPC9;Organisim: human;Apparent_Kd_M: 2.99E-11

Real

Aptamer SeqId: 17771-35 | Target: RPC9 | UniProt: O75575

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17771-35 | Target: RPC9 | UniProt: O75575 | TargetFullName: DNA-directed RNA polymerase III subunit RPC9 | Organisim: human | Apparent_Kd_M: 2.99E-11

Real

Aptamer SeqId:17772-7;Target:UBD;UniProt:O15205

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17772-7;Target: UBD;UniProt: O15205;TargetFullName: Ubiquitin D;Organisim: human;Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId: 17772-7 | Target: UBD | UniProt: O15205

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17772-7 | Target: UBD | UniProt: O15205 | TargetFullName: Ubiquitin D | Organisim: human | Apparent_Kd_M: 1.7E-11

Real

Aptamer SeqId:17773-26;Target:SNAG;UniProt:Q99747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17773-26;Target: SNAG;UniProt: Q99747;TargetFullName: Gamma-soluble NSF attachment protein;Organisim: human;Apparent_Kd_M: 1.31E-10

Real

Aptamer SeqId: 17773-26 | Target: SNAG | UniProt: Q99747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17773-26 | Target: SNAG | UniProt: Q99747 | TargetFullName: Gamma-soluble NSF attachment protein | Organisim: human | Apparent_Kd_M: 1.31E-10

Real

Aptamer SeqId:17774-38;Target:SMD3;UniProt:P62318

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17774-38;Target: SMD3;UniProt: P62318;TargetFullName: Small nuclear ribonucleoprotein Sm D3;Organisim: human;Apparent_Kd_M: 2.085831E-9

Real

Aptamer SeqId: 17774-38 | Target: SMD3 | UniProt: P62318

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17774-38 | Target: SMD3 | UniProt: P62318 | TargetFullName: Small nuclear ribonucleoprotein Sm D3 | Organisim: human | Apparent_Kd_M: 2.085831E-9

Real

Aptamer SeqId:17775-8;Target:TAGL3;UniProt:Q9UI15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17775-8;Target: TAGL3;UniProt: Q9UI15;TargetFullName: Transgelin-3;Organisim: human;Apparent_Kd_M: 6.14E-12

Real

Aptamer SeqId: 17775-8 | Target: TAGL3 | UniProt: Q9UI15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17775-8 | Target: TAGL3 | UniProt: Q9UI15 | TargetFullName: Transgelin-3 | Organisim: human | Apparent_Kd_M: 6.14E-12

Real

Aptamer SeqId:17776-15;Target:PECR;UniProt:Q9BY49

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17776-15;Target: PECR;UniProt: Q9BY49;TargetFullName: Peroxisomal trans-2-enoyl-CoA reductase;Organisim: human;Apparent_Kd_M: 3.08E-11

Real

Aptamer SeqId: 17776-15 | Target: PECR | UniProt: Q9BY49

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17776-15 | Target: PECR | UniProt: Q9BY49 | TargetFullName: Peroxisomal trans-2-enoyl-CoA reductase | Organisim: human | Apparent_Kd_M: 3.08E-11

Real

Aptamer SeqId:17777-31;Target:SDSL;UniProt:Q96GA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17777-31;Target: SDSL;UniProt: Q96GA7;TargetFullName: Serine dehydratase-like;Organisim: human;Apparent_Kd_M: 3.55E-11

Real

Aptamer SeqId: 17777-31 | Target: SDSL | UniProt: Q96GA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17777-31 | Target: SDSL | UniProt: Q96GA7 | TargetFullName: Serine dehydratase-like | Organisim: human | Apparent_Kd_M: 3.55E-11

Real

Aptamer SeqId:17778-19;Target:RAB32;UniProt:Q13637

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17778-19;Target: RAB32;UniProt: Q13637;TargetFullName: Ras-related protein Rab-32;Organisim: human;Apparent_Kd_M: 3.36E-11

Real

Aptamer SeqId: 17778-19 | Target: RAB32 | UniProt: Q13637

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17778-19 | Target: RAB32 | UniProt: Q13637 | TargetFullName: Ras-related protein Rab-32 | Organisim: human | Apparent_Kd_M: 3.36E-11

Real

Aptamer SeqId:17781-191;Target:MLP3A;UniProt:Q9H492

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17781-191;Target: MLP3A;UniProt: Q9H492;TargetFullName: Microtubule-associated proteins 1A/1B light chain 3A;Organisim: human;Apparent_Kd_M: 4.55E-12

Real

Aptamer SeqId: 17781-191 | Target: MLP3A | UniProt: Q9H492

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17781-191 | Target: MLP3A | UniProt: Q9H492 | TargetFullName: Microtubule-associated proteins 1A/1B light chain 3A | Organisim: human | Apparent_Kd_M: 4.55E-12

Real

Aptamer SeqId:17782-23;Target:THIK;UniProt:P09110

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17782-23;Target: THIK;UniProt: P09110;TargetFullName: 3-ketoacyl-CoA thiolase; peroxisomal;Organisim: human;Apparent_Kd_M: 4.71E-11

Real

Aptamer SeqId: 17782-23 | Target: THIK | UniProt: P09110

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17782-23 | Target: THIK | UniProt: P09110 | TargetFullName: 3-ketoacyl-CoA thiolase; peroxisomal | Organisim: human | Apparent_Kd_M: 4.71E-11

Real

Aptamer SeqId:17783-9;Target:MMAB;UniProt:Q96EY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17783-9;Target: MMAB;UniProt: Q96EY8;TargetFullName: Cob(I)yrinic acid a;c-diamide adenosyltransferase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.2E-11

Real

Aptamer SeqId: 17783-9 | Target: MMAB | UniProt: Q96EY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17783-9 | Target: MMAB | UniProt: Q96EY8 | TargetFullName: Cob(I)yrinic acid a;c-diamide adenosyltransferase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.2E-11

Real

Aptamer SeqId:17784-23;Target:GMFB;UniProt:P60983

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17784-23;Target: GMFB;UniProt: P60983;TargetFullName: Glia maturation factor beta;Organisim: human;Apparent_Kd_M: 5.45E-11

Real

Aptamer SeqId: 17784-23 | Target: GMFB | UniProt: P60983

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17784-23 | Target: GMFB | UniProt: P60983 | TargetFullName: Glia maturation factor beta | Organisim: human | Apparent_Kd_M: 5.45E-11

Real

Aptamer SeqId:17785-11;Target:RCL;UniProt:O43598

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17785-11;Target: RCL;UniProt: O43598;TargetFullName: 2-deoxynucleoside 5-phosphate N-hydrolase 1;Organisim: human;Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId: 17785-11 | Target: RCL | UniProt: O43598

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17785-11 | Target: RCL | UniProt: O43598 | TargetFullName: 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | Organisim: human | Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId:17786-5;Target:GGPPS;UniProt:O95749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17786-5;Target: GGPPS;UniProt: O95749;TargetFullName: Geranylgeranyl pyrophosphate synthase;Organisim: human;Apparent_Kd_M: 9.29E-11

Real

Aptamer SeqId: 17786-5 | Target: GGPPS | UniProt: O95749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17786-5 | Target: GGPPS | UniProt: O95749 | TargetFullName: Geranylgeranyl pyrophosphate synthase | Organisim: human | Apparent_Kd_M: 9.29E-11

Real

Aptamer SeqId:17787-1;Target:Enoyl-CoA hydratase;UniProt:P30084

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17787-1;Target: Enoyl-CoA hydratase;UniProt: P30084;TargetFullName: Enoyl-CoA hydratase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.77E-12

Real

Aptamer SeqId: 17787-1 | Target: Enoyl-CoA hydratase | UniProt: P30084

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17787-1 | Target: Enoyl-CoA hydratase | UniProt: P30084 | TargetFullName: Enoyl-CoA hydratase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.77E-12

Real

Aptamer SeqId:17789-1;Target:NADC;UniProt:Q15274

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17789-1;Target: NADC;UniProt: Q15274;TargetFullName: Nicotinate-nucleotide pyrophosphorylase [carboxylating];Organisim: human;Apparent_Kd_M: 9.37E-11

Real

Aptamer SeqId: 17789-1 | Target: NADC | UniProt: Q15274

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17789-1 | Target: NADC | UniProt: Q15274 | TargetFullName: Nicotinate-nucleotide pyrophosphorylase carboxylating | Organisim: human | Apparent_Kd_M: 9.37E-11

Real

Aptamer SeqId:17791-25;Target:HPCL1;UniProt:P37235

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17791-25;Target: HPCL1;UniProt: P37235;TargetFullName: Hippocalcin-like protein 1;Organisim: human;Apparent_Kd_M: 7.89E-12

Real

Aptamer SeqId: 17791-25 | Target: HPCL1 | UniProt: P37235

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17791-25 | Target: HPCL1 | UniProt: P37235 | TargetFullName: Hippocalcin-like protein 1 | Organisim: human | Apparent_Kd_M: 7.89E-12

Real

Aptamer SeqId:17792-158;Target:SSDH;UniProt:P51649

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17792-158;Target: SSDH;UniProt: P51649;TargetFullName: Succinate-semialdehyde dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 4.93E-11

Real

Aptamer SeqId: 17792-158 | Target: SSDH | UniProt: P51649

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17792-158 | Target: SSDH | UniProt: P51649 | TargetFullName: Succinate-semialdehyde dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 4.93E-11

Real

Aptamer SeqId:17793-4;Target:DIRA1;UniProt:O95057

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17793-4;Target: DIRA1;UniProt: O95057;TargetFullName: GTP-binding protein Di-Ras1;Organisim: human;Apparent_Kd_M: 1.93E-11

Real

Aptamer SeqId: 17793-4 | Target: DIRA1 | UniProt: O95057

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17793-4 | Target: DIRA1 | UniProt: O95057 | TargetFullName: GTP-binding protein Di-Ras1 | Organisim: human | Apparent_Kd_M: 1.93E-11

Real

Aptamer SeqId:17794-6;Target:Phosphomannomutase 2;UniProt:O15305

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17794-6;Target: Phosphomannomutase 2;UniProt: O15305;TargetFullName: Phosphomannomutase 2;Organisim: human;Apparent_Kd_M: 1.98E-11

Real

Aptamer SeqId: 17794-6 | Target: Phosphomannomutase 2 | UniProt: O15305

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17794-6 | Target: Phosphomannomutase 2 | UniProt: O15305 | TargetFullName: Phosphomannomutase 2 | Organisim: human | Apparent_Kd_M: 1.98E-11

Real

Aptamer SeqId:17795-176;Target:LSM1;UniProt:O15116

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17795-176;Target: LSM1;UniProt: O15116;TargetFullName: U6 snRNA-associated Sm-like protein LSm1;Organisim: human;Apparent_Kd_M: 2.91E-11

Real

Aptamer SeqId: 17795-176 | Target: LSM1 | UniProt: O15116

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17795-176 | Target: LSM1 | UniProt: O15116 | TargetFullName: U6 snRNA-associated Sm-like protein LSm1 | Organisim: human | Apparent_Kd_M: 2.91E-11

Real

Aptamer SeqId:17796-15;Target:IMPA1;UniProt:P29218

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17796-15;Target: IMPA1;UniProt: P29218;TargetFullName: Inositol monophosphatase 1;Organisim: human;Apparent_Kd_M: 7.9E-11

Real

Aptamer SeqId: 17796-15 | Target: IMPA1 | UniProt: P29218

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17796-15 | Target: IMPA1 | UniProt: P29218 | TargetFullName: Inositol monophosphatase 1 | Organisim: human | Apparent_Kd_M: 7.9E-11

Real

Aptamer SeqId:17797-1;Target:CUL1;UniProt:Q13616

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17797-1;Target: CUL1;UniProt: Q13616;TargetFullName: Cullin-1;Organisim: human;Apparent_Kd_M: 4.77E-11

Real

Aptamer SeqId: 17797-1 | Target: CUL1 | UniProt: Q13616

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17797-1 | Target: CUL1 | UniProt: Q13616 | TargetFullName: Cullin-1 | Organisim: human | Apparent_Kd_M: 4.77E-11

Real

Aptamer SeqId:17799-9;Target:6PGL;UniProt:O95336

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17799-9;Target: 6PGL;UniProt: O95336;TargetFullName: 6-phosphogluconolactonase;Organisim: human;Apparent_Kd_M: 2.08E-12

Real

Aptamer SeqId: 17799-9 | Target: 6PGL | UniProt: O95336

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17799-9 | Target: 6PGL | UniProt: O95336 | TargetFullName: 6-phosphogluconolactonase | Organisim: human | Apparent_Kd_M: 2.08E-12

Real

Aptamer SeqId:17800-33;Target:SCAND1;UniProt:P57086

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17800-33;Target: SCAND1;UniProt: P57086;TargetFullName: SCAN domain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.31E-12

Real

Aptamer SeqId: 17800-33 | Target: SCAND1 | UniProt: P57086

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17800-33 | Target: SCAND1 | UniProt: P57086 | TargetFullName: SCAN domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.31E-12

Real

Aptamer SeqId:17802-4;Target:SIAS;UniProt:Q9NR45

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17802-4;Target: SIAS;UniProt: Q9NR45;TargetFullName: Sialic acid synthase;Organisim: human;Apparent_Kd_M: 1.89E-11

Real

Aptamer SeqId: 17802-4 | Target: SIAS | UniProt: Q9NR45

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17802-4 | Target: SIAS | UniProt: Q9NR45 | TargetFullName: Sialic acid synthase | Organisim: human | Apparent_Kd_M: 1.89E-11

Real

Aptamer SeqId:17804-102;Target:PNPO;UniProt:Q9NVS9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17804-102;Target: PNPO;UniProt: Q9NVS9;TargetFullName: Pyridoxine-5-phosphate oxidase;Organisim: human;Apparent_Kd_M: 2.32E-11

Real

Aptamer SeqId: 17804-102 | Target: PNPO | UniProt: Q9NVS9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17804-102 | Target: PNPO | UniProt: Q9NVS9 | TargetFullName: Pyridoxine-5'-phosphate oxidase | Organisim: human | Apparent_Kd_M: 2.32E-11

Real

Aptamer SeqId:17805-35;Target:SPF30;UniProt:O75940

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17805-35;Target: SPF30;UniProt: O75940;TargetFullName: Survival of motor neuron-related-splicing factor 30;Organisim: human;Apparent_Kd_M: 4.58E-12

Real

Aptamer SeqId: 17805-35 | Target: SPF30 | UniProt: O75940

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17805-35 | Target: SPF30 | UniProt: O75940 | TargetFullName: Survival of motor neuron-related-splicing factor 30 | Organisim: human | Apparent_Kd_M: 4.58E-12

Real

Aptamer SeqId:17806-6;Target:Syntenin 1;UniProt:O00560

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17806-6;Target: Syntenin 1;UniProt: O00560;TargetFullName: Syntenin-1;Organisim: human;Apparent_Kd_M: 1.82E-12

Real

Aptamer SeqId: 17806-6 | Target: Syntenin 1 | UniProt: O00560

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17806-6 | Target: Syntenin 1 | UniProt: O00560 | TargetFullName: Syntenin-1 | Organisim: human | Apparent_Kd_M: 1.82E-12

Real

Aptamer SeqId:17808-37;Target:NIT2;UniProt:Q9NQR4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17808-37;Target: NIT2;UniProt: Q9NQR4;TargetFullName: Omega-amidase NIT2;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 17808-37 | Target: NIT2 | UniProt: Q9NQR4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17808-37 | Target: NIT2 | UniProt: Q9NQR4 | TargetFullName: Omega-amidase NIT2 | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:17811-78;Target:ST1C2;UniProt:O00338

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17811-78;Target: ST1C2;UniProt: O00338;TargetFullName: Sulfotransferase 1C2;Organisim: human;Apparent_Kd_M: 1.86E-11

Real

Aptamer SeqId: 17811-78 | Target: ST1C2 | UniProt: O00338

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17811-78 | Target: ST1C2 | UniProt: O00338 | TargetFullName: Sulfotransferase 1C2 | Organisim: human | Apparent_Kd_M: 1.86E-11

Real

Aptamer SeqId:17812-2;Target:TP4A1;UniProt:Q93096

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17812-2;Target: TP4A1;UniProt: Q93096;TargetFullName: Protein tyrosine phosphatase type IVA 1;Organisim: human;Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId: 17812-2 | Target: TP4A1 | UniProt: Q93096

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17812-2 | Target: TP4A1 | UniProt: Q93096 | TargetFullName: Protein tyrosine phosphatase type IVA 1 | Organisim: human | Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId:17813-21;Target:BPHL;UniProt:Q86WA6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17813-21;Target: BPHL;UniProt: Q86WA6;TargetFullName: Valacyclovir hydrolase;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 17813-21 | Target: BPHL | UniProt: Q86WA6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17813-21 | Target: BPHL | UniProt: Q86WA6 | TargetFullName: Valacyclovir hydrolase | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:17814-8;Target:BPNT1;UniProt:O95861

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17814-8;Target: BPNT1;UniProt: O95861;TargetFullName: 3(2);5-bisphosphate nucleotidase 1;Organisim: human;Apparent_Kd_M: 3.04E-11

Real

Aptamer SeqId: 17814-8 | Target: BPNT1 | UniProt: O95861

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17814-8 | Target: BPNT1 | UniProt: O95861 | TargetFullName: 3'(2');5'-bisphosphate nucleotidase 1 | Organisim: human | Apparent_Kd_M: 3.04E-11

Real

Aptamer SeqId:17816-58;Target:NCALD;UniProt:P61601

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17816-58;Target: NCALD;UniProt: P61601;TargetFullName: Neurocalcin-delta;Organisim: human;Apparent_Kd_M: 3.72E-11

Real

Aptamer SeqId: 17816-58 | Target: NCALD | UniProt: P61601

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17816-58 | Target: NCALD | UniProt: P61601 | TargetFullName: Neurocalcin-delta | Organisim: human | Apparent_Kd_M: 3.72E-11

Real

Aptamer SeqId:17817-22;Target:DDIT4;UniProt:Q9NX09

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17817-22;Target: DDIT4;UniProt: Q9NX09;TargetFullName: DNA damage-inducible transcript 4 protein;Organisim: human;Apparent_Kd_M: 9.56E-11

Real

Aptamer SeqId: 17817-22 | Target: DDIT4 | UniProt: Q9NX09

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17817-22 | Target: DDIT4 | UniProt: Q9NX09 | TargetFullName: DNA damage-inducible transcript 4 protein | Organisim: human | Apparent_Kd_M: 9.56E-11

Real

Aptamer SeqId:17818-22;Target:SUGT1;UniProt:Q9Y2Z0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17818-22;Target: SUGT1;UniProt: Q9Y2Z0;TargetFullName: Protein SGT1 homolog;Organisim: human;Apparent_Kd_M: 8.84E-11

Real

Aptamer SeqId: 17818-22 | Target: SUGT1 | UniProt: Q9Y2Z0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17818-22 | Target: SUGT1 | UniProt: Q9Y2Z0 | TargetFullName: Protein SGT1 homolog | Organisim: human | Apparent_Kd_M: 8.84E-11

Real

Aptamer SeqId:17819-30;Target:FAHD1;UniProt:Q6P587

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17819-30;Target: FAHD1;UniProt: Q6P587;TargetFullName: Acylpyruvase FAHD1; mitochondrial;Organisim: human;Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId: 17819-30 | Target: FAHD1 | UniProt: Q6P587

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17819-30 | Target: FAHD1 | UniProt: Q6P587 | TargetFullName: Acylpyruvase FAHD1; mitochondrial | Organisim: human | Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId:17820-170;Target:MLF1;UniProt:P58340

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17820-170;Target: MLF1;UniProt: P58340;TargetFullName: Myeloid leukemia factor 1;Organisim: human;Apparent_Kd_M: 5.455873E-11

Real

Aptamer SeqId: 17820-170 | Target: MLF1 | UniProt: P58340

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17820-170 | Target: MLF1 | UniProt: P58340 | TargetFullName: Myeloid leukemia factor 1 | Organisim: human | Apparent_Kd_M: 5.455873E-11

Real

Aptamer SeqId:17821-20;Target:NMT2;UniProt:O60551

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17821-20;Target: NMT2;UniProt: O60551;TargetFullName: Glycylpeptide N-tetradecanoyltransferase 2;Organisim: human;Apparent_Kd_M: 4.73E-12

Real

Aptamer SeqId: 17821-20 | Target: NMT2 | UniProt: O60551

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17821-20 | Target: NMT2 | UniProt: O60551 | TargetFullName: Glycylpeptide N-tetradecanoyltransferase 2 | Organisim: human | Apparent_Kd_M: 4.73E-12

Real

Aptamer SeqId:17822-57;Target:RERG;UniProt:Q96A58

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17822-57;Target: RERG;UniProt: Q96A58;TargetFullName: Ras-related and estrogen-regulated growth inhibitor;Organisim: human;Apparent_Kd_M: 3.063918E-11

Real

Aptamer SeqId: 17822-57 | Target: RERG | UniProt: Q96A58

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17822-57 | Target: RERG | UniProt: Q96A58 | TargetFullName: Ras-related and estrogen-regulated growth inhibitor | Organisim: human | Apparent_Kd_M: 3.063918E-11

Real

Aptamer SeqId:17823-40;Target:SMD2;UniProt:P62316

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17823-40;Target: SMD2;UniProt: P62316;TargetFullName: Small nuclear ribonucleoprotein Sm D2;Organisim: human;Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId: 17823-40 | Target: SMD2 | UniProt: P62316

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17823-40 | Target: SMD2 | UniProt: P62316 | TargetFullName: Small nuclear ribonucleoprotein Sm D2 | Organisim: human | Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId:17826-341;Target:EF1D;UniProt:P29692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17826-341;Target: EF1D;UniProt: P29692;TargetFullName: Elongation factor 1-delta;Organisim: human;Apparent_Kd_M: 4.66E-11

Real

Aptamer SeqId: 17826-341 | Target: EF1D | UniProt: P29692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17826-341 | Target: EF1D | UniProt: P29692 | TargetFullName: Elongation factor 1-delta | Organisim: human | Apparent_Kd_M: 4.66E-11

Real

Aptamer SeqId:17827-53;Target:DLRB2;UniProt:Q8TF09

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17827-53;Target: DLRB2;UniProt: Q8TF09;TargetFullName: Dynein light chain roadblock-type 2;Organisim: human;Apparent_Kd_M: 4.17E-11

Real

Aptamer SeqId: 17827-53 | Target: DLRB2 | UniProt: Q8TF09

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17827-53 | Target: DLRB2 | UniProt: Q8TF09 | TargetFullName: Dynein light chain roadblock-type 2 | Organisim: human | Apparent_Kd_M: 4.17E-11

Real

Aptamer SeqId:17828-3;Target:S100A14;UniProt:Q9HCY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17828-3;Target: S100A14;UniProt: Q9HCY8;TargetFullName: Protein S100-A14;Organisim: human;Apparent_Kd_M: 5.88E-11

Real

Aptamer SeqId: 17828-3 | Target: S100A14 | UniProt: Q9HCY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17828-3 | Target: S100A14 | UniProt: Q9HCY8 | TargetFullName: Protein S100-A14 | Organisim: human | Apparent_Kd_M: 5.88E-11

Real

Aptamer SeqId:17829-2;Target:TREX2;UniProt:Q9BQ50

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17829-2;Target: TREX2;UniProt: Q9BQ50;TargetFullName: Three prime repair exonuclease 2;Organisim: human;Apparent_Kd_M: 4.39E-11

Real

Aptamer SeqId: 17829-2 | Target: TREX2 | UniProt: Q9BQ50

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17829-2 | Target: TREX2 | UniProt: Q9BQ50 | TargetFullName: Three prime repair exonuclease 2 | Organisim: human | Apparent_Kd_M: 4.39E-11

Real

Aptamer SeqId:17832-12;Target:IDI2;UniProt:Q9BXS1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17832-12;Target: IDI2;UniProt: Q9BXS1;TargetFullName: Isopentenyl-diphosphate delta-isomerase 2;Organisim: human;Apparent_Kd_M: 1.58E-10

Real

Aptamer SeqId: 17832-12 | Target: IDI2 | UniProt: Q9BXS1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17832-12 | Target: IDI2 | UniProt: Q9BXS1 | TargetFullName: Isopentenyl-diphosphate delta-isomerase 2 | Organisim: human | Apparent_Kd_M: 1.58E-10

Real

Aptamer SeqId:17835-28;Target:ANX13;UniProt:P27216

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17835-28;Target: ANX13;UniProt: P27216;TargetFullName: Annexin A13;Organisim: human;Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId: 17835-28 | Target: ANX13 | UniProt: P27216

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17835-28 | Target: ANX13 | UniProt: P27216 | TargetFullName: Annexin A13 | Organisim: human | Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId:17836-17;Target:S100A16;UniProt:Q96FQ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17836-17;Target: S100A16;UniProt: Q96FQ6;TargetFullName: Protein S100-A16;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 17836-17 | Target: S100A16 | UniProt: Q96FQ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17836-17 | Target: S100A16 | UniProt: Q96FQ6 | TargetFullName: Protein S100-A16 | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:17837-5;Target:CLIC2;UniProt:O15247

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17837-5;Target: CLIC2;UniProt: O15247;TargetFullName: Chloride intracellular channel protein 2;Organisim: human;Apparent_Kd_M: 1.5E-12

Real

Aptamer SeqId: 17837-5 | Target: CLIC2 | UniProt: O15247

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17837-5 | Target: CLIC2 | UniProt: O15247 | TargetFullName: Chloride intracellular channel protein 2 | Organisim: human | Apparent_Kd_M: 1.5E-12

Real

Aptamer SeqId:17843-30;Target:PPCS;UniProt:Q9HAB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17843-30;Target: PPCS;UniProt: Q9HAB8;TargetFullName: Phosphopantothenate--cysteine ligase;Organisim: human;Apparent_Kd_M: 3.07E-12

Real

Aptamer SeqId: 17843-30 | Target: PPCS | UniProt: Q9HAB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17843-30 | Target: PPCS | UniProt: Q9HAB8 | TargetFullName: Phosphopantothenate--cysteine ligase | Organisim: human | Apparent_Kd_M: 3.07E-12

Real

Aptamer SeqId:17849-6;Target:DRG1;UniProt:Q9Y295

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17849-6;Target: DRG1;UniProt: Q9Y295;TargetFullName: Developmentally-regulated GTP-binding protein 1;Organisim: human;Apparent_Kd_M: 8.98E-12

Real

Aptamer SeqId: 17849-6 | Target: DRG1 | UniProt: Q9Y295

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17849-6 | Target: DRG1 | UniProt: Q9Y295 | TargetFullName: Developmentally-regulated GTP-binding protein 1 | Organisim: human | Apparent_Kd_M: 8.98E-12

Real

Aptamer SeqId:17850-42;Target:KLF4;UniProt:O43474

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17850-42;Target: KLF4;UniProt: O43474;TargetFullName: Krueppel-like factor 4;Organisim: human;Apparent_Kd_M: 2.66E-11

Real

Aptamer SeqId: 17850-42 | Target: KLF4 | UniProt: O43474

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17850-42 | Target: KLF4 | UniProt: O43474 | TargetFullName: Krueppel-like factor 4 | Organisim: human | Apparent_Kd_M: 2.66E-11

Real

Aptamer SeqId:17852-5;Target:PPME1;UniProt:Q9Y570

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17852-5;Target: PPME1;UniProt: Q9Y570;TargetFullName: Protein phosphatase methylesterase 1;Organisim: human;Apparent_Kd_M: 5.24E-12

Real

Aptamer SeqId: 17852-5 | Target: PPME1 | UniProt: Q9Y570

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17852-5 | Target: PPME1 | UniProt: Q9Y570 | TargetFullName: Protein phosphatase methylesterase 1 | Organisim: human | Apparent_Kd_M: 5.24E-12

Real

Aptamer SeqId:17854-33;Target:NAA10;UniProt:P41227

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17854-33;Target: NAA10;UniProt: P41227;TargetFullName: N-alpha-acetyltransferase 10;Organisim: human;Apparent_Kd_M: 7.04E-12

Real

Aptamer SeqId: 17854-33 | Target: NAA10 | UniProt: P41227

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17854-33 | Target: NAA10 | UniProt: P41227 | TargetFullName: N-alpha-acetyltransferase 10 | Organisim: human | Apparent_Kd_M: 7.04E-12

Real

Aptamer SeqId:17855-28;Target:RGS4;UniProt:P49798

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17855-28;Target: RGS4;UniProt: P49798;TargetFullName: Regulator of G-protein signaling 4;Organisim: human;Apparent_Kd_M: 4.56E-12

Real

Aptamer SeqId: 17855-28 | Target: RGS4 | UniProt: P49798

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17855-28 | Target: RGS4 | UniProt: P49798 | TargetFullName: Regulator of G-protein signaling 4 | Organisim: human | Apparent_Kd_M: 4.56E-12

Real

Aptamer SeqId:17856-23;Target:NT5M;UniProt:Q9NPB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17856-23;Target: NT5M;UniProt: Q9NPB1;TargetFullName: 5(3)-deoxyribonucleotidase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId: 17856-23 | Target: NT5M | UniProt: Q9NPB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17856-23 | Target: NT5M | UniProt: Q9NPB1 | TargetFullName: 5'(3')-deoxyribonucleotidase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId:17857-6;Target:ACADL;UniProt:P28330

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 17857-6;Target: ACADL;UniProt: P28330;TargetFullName: Long-chain specific acyl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.1E-11

Real

Aptamer SeqId: 17857-6 | Target: ACADL | UniProt: P28330

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 17857-6 | Target: ACADL | UniProt: P28330 | TargetFullName: Long-chain specific acyl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.1E-11

Real

Aptamer SeqId:18156-7;Target:ATG3;UniProt:Q9NT62

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18156-7;Target: ATG3;UniProt: Q9NT62;TargetFullName: Ubiquitin-like-conjugating enzyme ATG3;Organisim: human;Apparent_Kd_M: 1.07E-10

Real

Aptamer SeqId: 18156-7 | Target: ATG3 | UniProt: Q9NT62

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18156-7 | Target: ATG3 | UniProt: Q9NT62 | TargetFullName: Ubiquitin-like-conjugating enzyme ATG3 | Organisim: human | Apparent_Kd_M: 1.07E-10

Real

Aptamer SeqId:18158-45;Target:Caspase-8;UniProt:Q14790

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18158-45;Target: Caspase-8;UniProt: Q14790;TargetFullName: Caspase-8;Organisim: human;Apparent_Kd_M: 3.2E-11

Real

Aptamer SeqId: 18158-45 | Target: Caspase-8 | UniProt: Q14790

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18158-45 | Target: Caspase-8 | UniProt: Q14790 | TargetFullName: Caspase-8 | Organisim: human | Apparent_Kd_M: 3.2E-11

Real

Aptamer SeqId:18160-2;Target:PIMT;UniProt:P22061

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18160-2;Target: PIMT;UniProt: P22061;TargetFullName: Protein-L-isoaspartate(D-aspartate) O-methyltransferase;Organisim: human;Apparent_Kd_M: 7.45E-11

Real

Aptamer SeqId: 18160-2 | Target: PIMT | UniProt: P22061

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18160-2 | Target: PIMT | UniProt: P22061 | TargetFullName: Protein-L-isoaspartate(D-aspartate) O-methyltransferase | Organisim: human | Apparent_Kd_M: 7.45E-11

Real

Aptamer SeqId:18162-167;Target:IRAK4;UniProt:Q9NWZ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18162-167;Target: IRAK4;UniProt: Q9NWZ3;TargetFullName: Interleukin-1 receptor-associated kinase 4;Organisim: human;Apparent_Kd_M: 1.3E-10

Real

Aptamer SeqId: 18162-167 | Target: IRAK4 | UniProt: Q9NWZ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18162-167 | Target: IRAK4 | UniProt: Q9NWZ3 | TargetFullName: Interleukin-1 receptor-associated kinase 4 | Organisim: human | Apparent_Kd_M: 1.3E-10

Real

Aptamer SeqId:18165-181;Target:UB2V2;UniProt:Q15819

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18165-181;Target: UB2V2;UniProt: Q15819;TargetFullName: Ubiquitin-conjugating enzyme E2 variant 2;Organisim: human;Apparent_Kd_M: 2.53E-11

Real

Aptamer SeqId: 18165-181 | Target: UB2V2 | UniProt: Q15819

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18165-181 | Target: UB2V2 | UniProt: Q15819 | TargetFullName: Ubiquitin-conjugating enzyme E2 variant 2 | Organisim: human | Apparent_Kd_M: 2.53E-11

Real

Aptamer SeqId:18166-4;Target:RHOB;UniProt:P62745

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18166-4;Target: RHOB;UniProt: P62745;TargetFullName: Rho-related GTP-binding protein RhoB;Organisim: human;Apparent_Kd_M: 4.64E-11

Real

Aptamer SeqId: 18166-4 | Target: RHOB | UniProt: P62745

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18166-4 | Target: RHOB | UniProt: P62745 | TargetFullName: Rho-related GTP-binding protein RhoB | Organisim: human | Apparent_Kd_M: 4.64E-11

Real

Aptamer SeqId:18170-46;Target:P5CR1;UniProt:P32322

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18170-46;Target: P5CR1;UniProt: P32322;TargetFullName: Pyrroline-5-carboxylate reductase 1; mitochondrial;Organisim: human;Apparent_Kd_M: 5.79E-11

Real

Aptamer SeqId: 18170-46 | Target: P5CR1 | UniProt: P32322

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18170-46 | Target: P5CR1 | UniProt: P32322 | TargetFullName: Pyrroline-5-carboxylate reductase 1; mitochondrial | Organisim: human | Apparent_Kd_M: 5.79E-11

Real

Aptamer SeqId:18172-71;Target:ASF1A;UniProt:Q9Y294

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18172-71;Target: ASF1A;UniProt: Q9Y294;TargetFullName: Histone chaperone ASF1A;Organisim: human;Apparent_Kd_M: 6.8E-12

Real

Aptamer SeqId: 18172-71 | Target: ASF1A | UniProt: Q9Y294

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18172-71 | Target: ASF1A | UniProt: Q9Y294 | TargetFullName: Histone chaperone ASF1A | Organisim: human | Apparent_Kd_M: 6.8E-12

Real

Aptamer SeqId:18173-11;Target:ARK73;UniProt:O95154

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18173-11;Target: ARK73;UniProt: O95154;TargetFullName: Aflatoxin B1 aldehyde reductase member 3;Organisim: human;Apparent_Kd_M: 2.73E-12

Real

Aptamer SeqId: 18173-11 | Target: ARK73 | UniProt: O95154

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18173-11 | Target: ARK73 | UniProt: O95154 | TargetFullName: Aflatoxin B1 aldehyde reductase member 3 | Organisim: human | Apparent_Kd_M: 2.73E-12

Real

Aptamer SeqId:18174-79;Target:PDC6I;UniProt:Q8WUM4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18174-79;Target: PDC6I;UniProt: Q8WUM4;TargetFullName: Programmed cell death 6-interacting protein;Organisim: human;Apparent_Kd_M: 7.36E-12

Real

Aptamer SeqId: 18174-79 | Target: PDC6I | UniProt: Q8WUM4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18174-79 | Target: PDC6I | UniProt: Q8WUM4 | TargetFullName: Programmed cell death 6-interacting protein | Organisim: human | Apparent_Kd_M: 7.36E-12

Real

Aptamer SeqId:18175-65;Target:VAT1;UniProt:Q99536

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18175-65;Target: VAT1;UniProt: Q99536;TargetFullName: Synaptic vesicle membrane protein VAT-1 homolog;Organisim: human;Apparent_Kd_M: 8.4E-12

Real

Aptamer SeqId: 18175-65 | Target: VAT1 | UniProt: Q99536

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18175-65 | Target: VAT1 | UniProt: Q99536 | TargetFullName: Synaptic vesicle membrane protein VAT-1 homolog | Organisim: human | Apparent_Kd_M: 8.4E-12

Real

Aptamer SeqId:18177-49;Target:ULA1;UniProt:Q13564

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18177-49;Target: ULA1;UniProt: Q13564;TargetFullName: NEDD8-activating enzyme E1 regulatory subunit;Organisim: human;Apparent_Kd_M: 3.2E-11

Real

Aptamer SeqId: 18177-49 | Target: ULA1 | UniProt: Q13564

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18177-49 | Target: ULA1 | UniProt: Q13564 | TargetFullName: NEDD8-activating enzyme E1 regulatory subunit | Organisim: human | Apparent_Kd_M: 3.2E-11

Real

Aptamer SeqId:18178-13;Target:SYSC;UniProt:P49591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18178-13;Target: SYSC;UniProt: P49591;TargetFullName: Serine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 6.11E-11

Real

Aptamer SeqId: 18178-13 | Target: SYSC | UniProt: P49591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18178-13 | Target: SYSC | UniProt: P49591 | TargetFullName: Serine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 6.11E-11

Real

Aptamer SeqId:18179-56;Target:SPSY;UniProt:P52788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18179-56;Target: SPSY;UniProt: P52788;TargetFullName: Spermine synthase;Organisim: human;Apparent_Kd_M: 2.92E-10

Real

Aptamer SeqId: 18179-56 | Target: SPSY | UniProt: P52788

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18179-56 | Target: SPSY | UniProt: P52788 | TargetFullName: Spermine synthase | Organisim: human | Apparent_Kd_M: 2.92E-10

Real

Aptamer SeqId:18180-58;Target:RT4I1;UniProt:Q8WWV3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18180-58;Target: RT4I1;UniProt: Q8WWV3;TargetFullName: Reticulon-4-interacting protein 1; mitochondrial;Organisim: human;Apparent_Kd_M: 5.45E-12

Real

Aptamer SeqId: 18180-58 | Target: RT4I1 | UniProt: Q8WWV3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18180-58 | Target: RT4I1 | UniProt: Q8WWV3 | TargetFullName: Reticulon-4-interacting protein 1; mitochondrial | Organisim: human | Apparent_Kd_M: 5.45E-12

Real

Aptamer SeqId:18181-2;Target:TSSC4;UniProt:Q9Y5U2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18181-2;Target: TSSC4;UniProt: Q9Y5U2;TargetFullName: Protein TSSC4;Organisim: human;Apparent_Kd_M: 8.3E-12

Real

Aptamer SeqId: 18181-2 | Target: TSSC4 | UniProt: Q9Y5U2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18181-2 | Target: TSSC4 | UniProt: Q9Y5U2 | TargetFullName: Protein TSSC4 | Organisim: human | Apparent_Kd_M: 8.3E-12

Real

Aptamer SeqId:18182-24;Target:PCKGC;UniProt:P35558

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18182-24;Target: PCKGC;UniProt: P35558;TargetFullName: Phosphoenolpyruvate carboxykinase; cytosolic [GTP];Organisim: human;Apparent_Kd_M: 1.59E-10

Real

Aptamer SeqId: 18182-24 | Target: PCKGC | UniProt: P35558

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18182-24 | Target: PCKGC | UniProt: P35558 | TargetFullName: Phosphoenolpyruvate carboxykinase; cytosolic GTP | Organisim: human | Apparent_Kd_M: 1.59E-10

Real

Aptamer SeqId:18183-3;Target:ARH;UniProt:Q5SW96

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18183-3;Target: ARH;UniProt: Q5SW96;TargetFullName: Low density lipoprotein receptor adapter protein 1;Organisim: human;Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId: 18183-3 | Target: ARH | UniProt: Q5SW96

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18183-3 | Target: ARH | UniProt: Q5SW96 | TargetFullName: Low density lipoprotein receptor adapter protein 1 | Organisim: human | Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId:18184-28;Target:GUAA;UniProt:P49915

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18184-28;Target: GUAA;UniProt: P49915;TargetFullName: GMP synthase [glutamine-hydrolyzing];Organisim: human;Apparent_Kd_M: 1.35E-11

Real

Aptamer SeqId: 18184-28 | Target: GUAA | UniProt: P49915

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18184-28 | Target: GUAA | UniProt: P49915 | TargetFullName: GMP synthase glutamine-hydrolyzing | Organisim: human | Apparent_Kd_M: 1.35E-11

Real

Aptamer SeqId:18185-118;Target:ALDOB;UniProt:P05062

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18185-118;Target: ALDOB;UniProt: P05062;TargetFullName: Fructose-bisphosphate aldolase B;Organisim: human;Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId: 18185-118 | Target: ALDOB | UniProt: P05062

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18185-118 | Target: ALDOB | UniProt: P05062 | TargetFullName: Fructose-bisphosphate aldolase B | Organisim: human | Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId:18186-15;Target:SYTC;UniProt:P26639

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18186-15;Target: SYTC;UniProt: P26639;TargetFullName: Threonine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 2.42E-11

Real

Aptamer SeqId: 18186-15 | Target: SYTC | UniProt: P26639

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18186-15 | Target: SYTC | UniProt: P26639 | TargetFullName: Threonine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 2.42E-11

Real

Aptamer SeqId:18187-16;Target:ACY2;UniProt:P45381

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18187-16;Target: ACY2;UniProt: P45381;TargetFullName: Aspartoacylase;Organisim: human;Apparent_Kd_M: 2.18E-10

Real

Aptamer SeqId: 18187-16 | Target: ACY2 | UniProt: P45381

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18187-16 | Target: ACY2 | UniProt: P45381 | TargetFullName: Aspartoacylase | Organisim: human | Apparent_Kd_M: 2.18E-10

Real

Aptamer SeqId:18188-12;Target:GATM;UniProt:P50440

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18188-12;Target: GATM;UniProt: P50440;TargetFullName: Glycine amidinotransferase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId: 18188-12 | Target: GATM | UniProt: P50440

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18188-12 | Target: GATM | UniProt: P50440 | TargetFullName: Glycine amidinotransferase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId:18189-12;Target:VPS25;UniProt:Q9BRG1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18189-12;Target: VPS25;UniProt: Q9BRG1;TargetFullName: Vacuolar protein-sorting-associated protein 25;Organisim: human;Apparent_Kd_M: 7.12E-12

Real

Aptamer SeqId: 18189-12 | Target: VPS25 | UniProt: Q9BRG1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18189-12 | Target: VPS25 | UniProt: Q9BRG1 | TargetFullName: Vacuolar protein-sorting-associated protein 25 | Organisim: human | Apparent_Kd_M: 7.12E-12

Real

Aptamer SeqId:18190-15;Target:ICBR;UniProt:P57730

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18190-15;Target: ICBR;UniProt: P57730;TargetFullName: Caspase recruitment domain-containing protein 18;Organisim: human;Apparent_Kd_M: 7.53E-11

Real

Aptamer SeqId: 18190-15 | Target: ICBR | UniProt: P57730

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18190-15 | Target: ICBR | UniProt: P57730 | TargetFullName: Caspase recruitment domain-containing protein 18 | Organisim: human | Apparent_Kd_M: 7.53E-11

Real

Aptamer SeqId:18191-23;Target:RANG;UniProt:P43487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18191-23;Target: RANG;UniProt: P43487;TargetFullName: Ran-specific GTPase-activating protein;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 18191-23 | Target: RANG | UniProt: P43487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18191-23 | Target: RANG | UniProt: P43487 | TargetFullName: Ran-specific GTPase-activating protein | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:18192-69;Target:MAGE-5;UniProt:P43359

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18192-69;Target: MAGE-5;UniProt: P43359;TargetFullName: Melanoma-associated antigen 5;Organisim: human;Apparent_Kd_M: 5.12E-11

Real

Aptamer SeqId: 18192-69 | Target: MAGE-5 | UniProt: P43359

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18192-69 | Target: MAGE-5 | UniProt: P43359 | TargetFullName: Melanoma-associated antigen 5 | Organisim: human | Apparent_Kd_M: 5.12E-11

Real

Aptamer SeqId:18193-165;Target:MO4L1;UniProt:Q9UBU8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18193-165;Target: MO4L1;UniProt: Q9UBU8;TargetFullName: Mortality factor 4-like protein 1;Organisim: human;Apparent_Kd_M: 6.37E-12

Real

Aptamer SeqId: 18193-165 | Target: MO4L1 | UniProt: Q9UBU8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18193-165 | Target: MO4L1 | UniProt: Q9UBU8 | TargetFullName: Mortality factor 4-like protein 1 | Organisim: human | Apparent_Kd_M: 6.37E-12

Real

Aptamer SeqId:18194-18;Target:FABP9;UniProt:Q0Z7S8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18194-18;Target: FABP9;UniProt: Q0Z7S8;TargetFullName: Fatty acid-binding protein 9;Organisim: human;Apparent_Kd_M: 3.8E-12

Real

Aptamer SeqId: 18194-18 | Target: FABP9 | UniProt: Q0Z7S8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18194-18 | Target: FABP9 | UniProt: Q0Z7S8 | TargetFullName: Fatty acid-binding protein 9 | Organisim: human | Apparent_Kd_M: 3.8E-12

Real

Aptamer SeqId:18195-3;Target:ORAV1;UniProt:Q8WV07

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18195-3;Target: ORAV1;UniProt: Q8WV07;TargetFullName: Oral cancer-overexpressed protein 1;Organisim: human;Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId: 18195-3 | Target: ORAV1 | UniProt: Q8WV07

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18195-3 | Target: ORAV1 | UniProt: Q8WV07 | TargetFullName: Oral cancer-overexpressed protein 1 | Organisim: human | Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId:18197-97;Target:KCRS;UniProt:P17540

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18197-97;Target: KCRS;UniProt: P17540;TargetFullName: Creatine kinase S-type; mitochondrial;Organisim: human;Apparent_Kd_M: 9.21E-11

Real

Aptamer SeqId: 18197-97 | Target: KCRS | UniProt: P17540

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18197-97 | Target: KCRS | UniProt: P17540 | TargetFullName: Creatine kinase S-type; mitochondrial | Organisim: human | Apparent_Kd_M: 9.21E-11

Real

Aptamer SeqId:18198-51;Target:HBAT;UniProt:P09105

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18198-51;Target: HBAT;UniProt: P09105;TargetFullName: Hemoglobin subunit theta-1;Organisim: human;Apparent_Kd_M: 5.66E-11

Real

Aptamer SeqId: 18198-51 | Target: HBAT | UniProt: P09105

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18198-51 | Target: HBAT | UniProt: P09105 | TargetFullName: Hemoglobin subunit theta-1 | Organisim: human | Apparent_Kd_M: 5.66E-11

Real

Aptamer SeqId:18202-22;Target:CD37;UniProt:P11049

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18202-22;Target: CD37;UniProt: P11049;TargetFullName: Leukocyte antigen CD37;Organisim: human;Apparent_Kd_M: 7.78E-11

Real

Aptamer SeqId: 18202-22 | Target: CD37 | UniProt: P11049

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18202-22 | Target: CD37 | UniProt: P11049 | TargetFullName: Leukocyte antigen CD37 | Organisim: human | Apparent_Kd_M: 7.78E-11

Real

Aptamer SeqId:18204-1;Target:TCEA1;UniProt:P23193

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18204-1;Target: TCEA1;UniProt: P23193;TargetFullName: Transcription elongation factor A protein 1;Organisim: human;Apparent_Kd_M: 3.14E-12

Real

Aptamer SeqId: 18204-1 | Target: TCEA1 | UniProt: P23193

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18204-1 | Target: TCEA1 | UniProt: P23193 | TargetFullName: Transcription elongation factor A protein 1 | Organisim: human | Apparent_Kd_M: 3.14E-12

Real

Aptamer SeqId:18205-123;Target:MAGE-6;UniProt:P43360

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18205-123;Target: MAGE-6;UniProt: P43360;TargetFullName: Melanoma-associated antigen 6;Organisim: human;Apparent_Kd_M: 7.07E-11

Real

Aptamer SeqId: 18205-123 | Target: MAGE-6 | UniProt: P43360

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18205-123 | Target: MAGE-6 | UniProt: P43360 | TargetFullName: Melanoma-associated antigen 6 | Organisim: human | Apparent_Kd_M: 7.07E-11

Real

Aptamer SeqId:18206-18;Target:ADH6;UniProt:P28332

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18206-18;Target: ADH6;UniProt: P28332;TargetFullName: Alcohol dehydrogenase 6;Organisim: human;Apparent_Kd_M: 4.14E-12

Real

Aptamer SeqId: 18206-18 | Target: ADH6 | UniProt: P28332

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18206-18 | Target: ADH6 | UniProt: P28332 | TargetFullName: Alcohol dehydrogenase 6 | Organisim: human | Apparent_Kd_M: 4.14E-12

Real

Aptamer SeqId:18208-3;Target:CCNB2;UniProt:O95067

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18208-3;Target: CCNB2;UniProt: O95067;TargetFullName: G2/mitotic-specific cyclin-B2;Organisim: human;Apparent_Kd_M: 1.91E-10

Real

Aptamer SeqId: 18208-3 | Target: CCNB2 | UniProt: O95067

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18208-3 | Target: CCNB2 | UniProt: O95067 | TargetFullName: G2/mitotic-specific cyclin-B2 | Organisim: human | Apparent_Kd_M: 1.91E-10

Real

Aptamer SeqId:18210-12;Target:SPIN1;UniProt:Q9Y657

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18210-12;Target: SPIN1;UniProt: Q9Y657;TargetFullName: Spindlin-1;Organisim: human;Apparent_Kd_M: 3.56E-11

Real

Aptamer SeqId: 18210-12 | Target: SPIN1 | UniProt: Q9Y657

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18210-12 | Target: SPIN1 | UniProt: Q9Y657 | TargetFullName: Spindlin-1 | Organisim: human | Apparent_Kd_M: 3.56E-11

Real

Aptamer SeqId:18213-30;Target:UBE2F;UniProt:Q969M7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18213-30;Target: UBE2F;UniProt: Q969M7;TargetFullName: NEDD8-conjugating enzyme UBE2F;Organisim: human;Apparent_Kd_M: 8.03E-11

Real

Aptamer SeqId: 18213-30 | Target: UBE2F | UniProt: Q969M7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18213-30 | Target: UBE2F | UniProt: Q969M7 | TargetFullName: NEDD8-conjugating enzyme UBE2F | Organisim: human | Apparent_Kd_M: 8.03E-11

Real

Aptamer SeqId:18214-2;Target:GSH0;UniProt:P48507

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18214-2;Target: GSH0;UniProt: P48507;TargetFullName: Glutamate--cysteine ligase regulatory subunit;Organisim: human;Apparent_Kd_M: 9.78E-11

Real

Aptamer SeqId: 18214-2 | Target: GSH0 | UniProt: P48507

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18214-2 | Target: GSH0 | UniProt: P48507 | TargetFullName: Glutamate--cysteine ligase regulatory subunit | Organisim: human | Apparent_Kd_M: 9.78E-11

Real

Aptamer SeqId:18215-5;Target:THG1;UniProt:Q9NWX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18215-5;Target: THG1;UniProt: Q9NWX6;TargetFullName: Probable tRNA(His) guanylyltransferase;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 18215-5 | Target: THG1 | UniProt: Q9NWX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18215-5 | Target: THG1 | UniProt: Q9NWX6 | TargetFullName: Probable tRNA(His) guanylyltransferase | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:18216-22;Target:IL-11 RA;UniProt:Q14626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18216-22;Target: IL-11 RA;UniProt: Q14626;TargetFullName: Interleukin-11 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 4.99E-12

Real

Aptamer SeqId: 18216-22 | Target: IL-11 RA | UniProt: Q14626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18216-22 | Target: IL-11 RA | UniProt: Q14626 | TargetFullName: Interleukin-11 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 4.99E-12

Real

Aptamer SeqId:18218-48;Target:CB032;UniProt:Q96F85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18218-48;Target: CB032;UniProt: Q96F85;TargetFullName: CB1 cannabinoid receptor-interacting protein 1;Organisim: human;Apparent_Kd_M: 7.11E-12

Real

Aptamer SeqId: 18218-48 | Target: CB032 | UniProt: Q96F85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18218-48 | Target: CB032 | UniProt: Q96F85 | TargetFullName: CB1 cannabinoid receptor-interacting protein 1 | Organisim: human | Apparent_Kd_M: 7.11E-12

Real

Aptamer SeqId:18220-141;Target:SRA1;UniProt:Q9HD15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18220-141;Target: SRA1;UniProt: Q9HD15;TargetFullName: Steroid receptor RNA activator 1;Organisim: human;Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId: 18220-141 | Target: SRA1 | UniProt: Q9HD15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18220-141 | Target: SRA1 | UniProt: Q9HD15 | TargetFullName: Steroid receptor RNA activator 1 | Organisim: human | Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId:18222-34;Target:SHLB2;UniProt:Q9NR46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18222-34;Target: SHLB2;UniProt: Q9NR46;TargetFullName: Endophilin-B2;Organisim: human;Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId: 18222-34 | Target: SHLB2 | UniProt: Q9NR46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18222-34 | Target: SHLB2 | UniProt: Q9NR46 | TargetFullName: Endophilin-B2 | Organisim: human | Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId:18225-13;Target:HEBP1;UniProt:Q9NRV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18225-13;Target: HEBP1;UniProt: Q9NRV9;TargetFullName: Heme-binding protein 1;Organisim: human;Apparent_Kd_M: 5.93E-12

Real

Aptamer SeqId: 18225-13 | Target: HEBP1 | UniProt: Q9NRV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18225-13 | Target: HEBP1 | UniProt: Q9NRV9 | TargetFullName: Heme-binding protein 1 | Organisim: human | Apparent_Kd_M: 5.93E-12

Real

Aptamer SeqId:18226-148;Target:COX5A;UniProt:P20674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18226-148;Target: COX5A;UniProt: P20674;TargetFullName: Cytochrome c oxidase subunit 5A; mitochondrial;Organisim: human;Apparent_Kd_M: 5.36E-12

Real

Aptamer SeqId: 18226-148 | Target: COX5A | UniProt: P20674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18226-148 | Target: COX5A | UniProt: P20674 | TargetFullName: Cytochrome c oxidase subunit 5A; mitochondrial | Organisim: human | Apparent_Kd_M: 5.36E-12

Real

Aptamer SeqId:18227-3;Target:CDKA2;UniProt:O75956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18227-3;Target: CDKA2;UniProt: O75956;TargetFullName: Cyclin-dependent kinase 2-associated protein 2;Organisim: human;Apparent_Kd_M: 5.7E-12

Real

Aptamer SeqId: 18227-3 | Target: CDKA2 | UniProt: O75956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18227-3 | Target: CDKA2 | UniProt: O75956 | TargetFullName: Cyclin-dependent kinase 2-associated protein 2 | Organisim: human | Apparent_Kd_M: 5.7E-12

Real

Aptamer SeqId:18228-30;Target:NOP16;UniProt:Q9Y3C1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18228-30;Target: NOP16;UniProt: Q9Y3C1;TargetFullName: Nucleolar protein 16;Organisim: human;Apparent_Kd_M: 6.24E-11

Real

Aptamer SeqId: 18228-30 | Target: NOP16 | UniProt: Q9Y3C1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18228-30 | Target: NOP16 | UniProt: Q9Y3C1 | TargetFullName: Nucleolar protein 16 | Organisim: human | Apparent_Kd_M: 6.24E-11

Real

Aptamer SeqId:18231-147;Target:PRND;UniProt:Q9UKY0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18231-147;Target: PRND;UniProt: Q9UKY0;TargetFullName: Prion-like protein doppel;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 18231-147 | Target: PRND | UniProt: Q9UKY0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18231-147 | Target: PRND | UniProt: Q9UKY0 | TargetFullName: Prion-like protein doppel | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:18232-42;Target:PI42B;UniProt:P78356

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18232-42;Target: PI42B;UniProt: P78356;TargetFullName: Phosphatidylinositol 5-phosphate 4-kinase type-2 beta;Organisim: human;Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId: 18232-42 | Target: PI42B | UniProt: P78356

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18232-42 | Target: PI42B | UniProt: P78356 | TargetFullName: Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Organisim: human | Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId:18235-16;Target:PGP;UniProt:A6NDG6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18235-16;Target: PGP;UniProt: A6NDG6;TargetFullName: Glycerol-3-phosphate phosphatase;Organisim: human;Apparent_Kd_M: 6.01E-11

Real

Aptamer SeqId: 18235-16 | Target: PGP | UniProt: A6NDG6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18235-16 | Target: PGP | UniProt: A6NDG6 | TargetFullName: Glycerol-3-phosphate phosphatase | Organisim: human | Apparent_Kd_M: 6.01E-11

Real

Aptamer SeqId:18236-3;Target:LEGL;UniProt:Q3ZCW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18236-3;Target: LEGL;UniProt: Q3ZCW2;TargetFullName: Galectin-related protein;Organisim: human;Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId: 18236-3 | Target: LEGL | UniProt: Q3ZCW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18236-3 | Target: LEGL | UniProt: Q3ZCW2 | TargetFullName: Galectin-related protein | Organisim: human | Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId:18237-29;Target:NRIP3;UniProt:Q9NQ35

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18237-29;Target: NRIP3;UniProt: Q9NQ35;TargetFullName: Nuclear receptor-interacting protein 3;Organisim: human;Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId: 18237-29 | Target: NRIP3 | UniProt: Q9NQ35

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18237-29 | Target: NRIP3 | UniProt: Q9NQ35 | TargetFullName: Nuclear receptor-interacting protein 3 | Organisim: human | Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId:18240-6;Target:OMP;UniProt:P47874

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18240-6;Target: OMP;UniProt: P47874;TargetFullName: Olfactory marker protein;Organisim: human;Apparent_Kd_M: 6.52E-12

Real

Aptamer SeqId: 18240-6 | Target: OMP | UniProt: P47874

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18240-6 | Target: OMP | UniProt: P47874 | TargetFullName: Olfactory marker protein | Organisim: human | Apparent_Kd_M: 6.52E-12

Real

Aptamer SeqId:18241-18;Target:HEM6;UniProt:P36551

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18241-18;Target: HEM6;UniProt: P36551;TargetFullName: Oxygen-dependent coproporphyrinogen-III oxidase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.58E-11

Real

Aptamer SeqId: 18241-18 | Target: HEM6 | UniProt: P36551

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18241-18 | Target: HEM6 | UniProt: P36551 | TargetFullName: Oxygen-dependent coproporphyrinogen-III oxidase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.58E-11

Real

Aptamer SeqId:18242-8;Target:Sperm protein 17;UniProt:Q15506

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18242-8;Target: Sperm protein 17;UniProt: Q15506;TargetFullName: Sperm surface protein Sp17;Organisim: human;Apparent_Kd_M: 1.2E-10

Real

Aptamer SeqId: 18242-8 | Target: Sperm protein 17 | UniProt: Q15506

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18242-8 | Target: Sperm protein 17 | UniProt: Q15506 | TargetFullName: Sperm surface protein Sp17 | Organisim: human | Apparent_Kd_M: 1.2E-10

Real

Aptamer SeqId:18243-9;Target:Cytidylate kinase;UniProt:P30085

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18243-9;Target: Cytidylate kinase;UniProt: P30085;TargetFullName: UMP-CMP kinase;Organisim: human;Apparent_Kd_M: 2.28E-11

Real

Aptamer SeqId: 18243-9 | Target: Cytidylate kinase | UniProt: P30085

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18243-9 | Target: Cytidylate kinase | UniProt: P30085 | TargetFullName: UMP-CMP kinase | Organisim: human | Apparent_Kd_M: 2.28E-11

Real

Aptamer SeqId:18244-1;Target:ANXA7;UniProt:P20073

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18244-1;Target: ANXA7;UniProt: P20073;TargetFullName: Annexin A7;Organisim: human;Apparent_Kd_M: 3.4E-11

Real

Aptamer SeqId: 18244-1 | Target: ANXA7 | UniProt: P20073

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18244-1 | Target: ANXA7 | UniProt: P20073 | TargetFullName: Annexin A7 | Organisim: human | Apparent_Kd_M: 3.4E-11

Real

Aptamer SeqId:18255-6;Target:NB5R1;UniProt:Q9UHQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18255-6;Target: NB5R1;UniProt: Q9UHQ9;TargetFullName: NADH-cytochrome b5 reductase 1;Organisim: human;Apparent_Kd_M: 2.69E-12

Real

Aptamer SeqId: 18255-6 | Target: NB5R1 | UniProt: Q9UHQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18255-6 | Target: NB5R1 | UniProt: Q9UHQ9 | TargetFullName: NADH-cytochrome b5 reductase 1 | Organisim: human | Apparent_Kd_M: 2.69E-12

Real

Aptamer SeqId:18257-64;Target:SRP19;UniProt:P09132

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18257-64;Target: SRP19;UniProt: P09132;TargetFullName: Signal recognition particle 19 kDa protein;Organisim: human;Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId: 18257-64 | Target: SRP19 | UniProt: P09132

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18257-64 | Target: SRP19 | UniProt: P09132 | TargetFullName: Signal recognition particle 19 kDa protein | Organisim: human | Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId:18259-15;Target:MEOX2;UniProt:P50222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18259-15;Target: MEOX2;UniProt: P50222;TargetFullName: Homeobox protein MOX-2;Organisim: human;Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId: 18259-15 | Target: MEOX2 | UniProt: P50222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18259-15 | Target: MEOX2 | UniProt: P50222 | TargetFullName: Homeobox protein MOX-2 | Organisim: human | Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId:18261-34;Target:NATD1;UniProt:Q8N6N6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18261-34;Target: NATD1;UniProt: Q8N6N6;TargetFullName: Protein NATD1;Organisim: human;Apparent_Kd_M: 2.39E-10

Real

Aptamer SeqId: 18261-34 | Target: NATD1 | UniProt: Q8N6N6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18261-34 | Target: NATD1 | UniProt: Q8N6N6 | TargetFullName: Protein NATD1 | Organisim: human | Apparent_Kd_M: 2.39E-10

Real

Aptamer SeqId:18264-12;Target:CCD25;UniProt:Q86WR0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18264-12;Target: CCD25;UniProt: Q86WR0;TargetFullName: Coiled-coil domain-containing protein 25;Organisim: human;Apparent_Kd_M: 2.3E-11

Real

Aptamer SeqId: 18264-12 | Target: CCD25 | UniProt: Q86WR0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18264-12 | Target: CCD25 | UniProt: Q86WR0 | TargetFullName: Coiled-coil domain-containing protein 25 | Organisim: human | Apparent_Kd_M: 2.3E-11

Real

Aptamer SeqId:18265-18;Target:ZNF34;UniProt:Q8IZ26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18265-18;Target: ZNF34;UniProt: Q8IZ26;TargetFullName: Zinc finger protein 34;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 18265-18 | Target: ZNF34 | UniProt: Q8IZ26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18265-18 | Target: ZNF34 | UniProt: Q8IZ26 | TargetFullName: Zinc finger protein 34 | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:18267-74;Target:CAR17;UniProt:Q5XLA6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18267-74;Target: CAR17;UniProt: Q5XLA6;TargetFullName: Caspase recruitment domain-containing protein 17;Organisim: human;Apparent_Kd_M: 1.13E-10

Real

Aptamer SeqId: 18267-74 | Target: CAR17 | UniProt: Q5XLA6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18267-74 | Target: CAR17 | UniProt: Q5XLA6 | TargetFullName: Caspase recruitment domain-containing protein 17 | Organisim: human | Apparent_Kd_M: 1.13E-10

Real

Aptamer SeqId:18268-5;Target:GAG2A;UniProt:Q6NT46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18268-5;Target: GAG2A;UniProt: Q6NT46;TargetFullName: G antigen 2A;Organisim: human;Apparent_Kd_M: 3.73E-12

Real

Aptamer SeqId: 18268-5 | Target: GAG2A | UniProt: Q6NT46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18268-5 | Target: GAG2A | UniProt: Q6NT46 | TargetFullName: G antigen 2A | Organisim: human | Apparent_Kd_M: 3.73E-12

Real

Aptamer SeqId:18270-10;Target:TAF10;UniProt:Q12962

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18270-10;Target: TAF10;UniProt: Q12962;TargetFullName: Transcription initiation factor TFIID subunit 10;Organisim: human;Apparent_Kd_M: 8.14E-11

Real

Aptamer SeqId: 18270-10 | Target: TAF10 | UniProt: Q12962

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18270-10 | Target: TAF10 | UniProt: Q12962 | TargetFullName: Transcription initiation factor TFIID subunit 10 | Organisim: human | Apparent_Kd_M: 8.14E-11

Real

Aptamer SeqId:18271-43;Target:OXSM;UniProt:Q9NWU1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18271-43;Target: OXSM;UniProt: Q9NWU1;TargetFullName: 3-oxoacyl-[acyl-carrier-protein] synthase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.13E-11

Real

Aptamer SeqId: 18271-43 | Target: OXSM | UniProt: Q9NWU1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18271-43 | Target: OXSM | UniProt: Q9NWU1 | TargetFullName: 3-oxoacyl-acyl-carrier-protein synthase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.13E-11

Real

Aptamer SeqId:18273-14;Target:GGE2D;UniProt:Q9UEU5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18273-14;Target: GGE2D;UniProt: Q9UEU5;TargetFullName: G antigen 2D;Organisim: human;Apparent_Kd_M: 2.52E-12

Real

Aptamer SeqId: 18273-14 | Target: GGE2D | UniProt: Q9UEU5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18273-14 | Target: GGE2D | UniProt: Q9UEU5 | TargetFullName: G antigen 2D | Organisim: human | Apparent_Kd_M: 2.52E-12

Real

Aptamer SeqId:18274-2;Target:SERF2;UniProt:P84101

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18274-2;Target: SERF2;UniProt: P84101;TargetFullName: Small EDRK-rich factor 2;Organisim: human;Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId: 18274-2 | Target: SERF2 | UniProt: P84101

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18274-2 | Target: SERF2 | UniProt: P84101 | TargetFullName: Small EDRK-rich factor 2 | Organisim: human | Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId:18275-5;Target:CRIP1;UniProt:P50238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18275-5;Target: CRIP1;UniProt: P50238;TargetFullName: Cysteine-rich protein 1;Organisim: human;Apparent_Kd_M: 4.26E-11

Real

Aptamer SeqId: 18275-5 | Target: CRIP1 | UniProt: P50238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18275-5 | Target: CRIP1 | UniProt: P50238 | TargetFullName: Cysteine-rich protein 1 | Organisim: human | Apparent_Kd_M: 4.26E-11

Real

Aptamer SeqId:18276-34;Target:TCL1B;UniProt:O95988

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18276-34;Target: TCL1B;UniProt: O95988;TargetFullName: T-cell leukemia/lymphoma protein 1B;Organisim: human;Apparent_Kd_M: 7.35E-12

Real

Aptamer SeqId: 18276-34 | Target: TCL1B | UniProt: O95988

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18276-34 | Target: TCL1B | UniProt: O95988 | TargetFullName: T-cell leukemia/lymphoma protein 1B | Organisim: human | Apparent_Kd_M: 7.35E-12

Real

Aptamer SeqId:18277-28;Target:TRIA1;UniProt:O43715

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18277-28;Target: TRIA1;UniProt: O43715;TargetFullName: TP53-regulated inhibitor of apoptosis 1;Organisim: human;Apparent_Kd_M: 2.4E-11

Real

Aptamer SeqId: 18277-28 | Target: TRIA1 | UniProt: O43715

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18277-28 | Target: TRIA1 | UniProt: O43715 | TargetFullName: TP53-regulated inhibitor of apoptosis 1 | Organisim: human | Apparent_Kd_M: 2.4E-11

Real

Aptamer SeqId:18280-29;Target:DTD2;UniProt:Q96FN9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18280-29;Target: DTD2;UniProt: Q96FN9;TargetFullName: Putative D-tyrosyl-tRNA(Tyr) deacylase 2;Organisim: human;Apparent_Kd_M: 3.1E-12

Real

Aptamer SeqId: 18280-29 | Target: DTD2 | UniProt: Q96FN9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18280-29 | Target: DTD2 | UniProt: Q96FN9 | TargetFullName: Putative D-tyrosyl-tRNA(Tyr) deacylase 2 | Organisim: human | Apparent_Kd_M: 3.1E-12

Real

Aptamer SeqId:18282-1;Target:GBG11;UniProt:P61952

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18282-1;Target: GBG11;UniProt: P61952;TargetFullName: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11;Organisim: human;Apparent_Kd_M: 3.19E-11

Real

Aptamer SeqId: 18282-1 | Target: GBG11 | UniProt: P61952

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18282-1 | Target: GBG11 | UniProt: P61952 | TargetFullName: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 | Organisim: human | Apparent_Kd_M: 3.19E-11

Real

Aptamer SeqId:18284-77;Target:WWC1;UniProt:Q8IX03

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18284-77;Target: WWC1;UniProt: Q8IX03;TargetFullName: Protein KIBRA;Organisim: human;Apparent_Kd_M: 1.09E-12

Real

Aptamer SeqId: 18284-77 | Target: WWC1 | UniProt: Q8IX03

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18284-77 | Target: WWC1 | UniProt: Q8IX03 | TargetFullName: Protein KIBRA | Organisim: human | Apparent_Kd_M: 1.09E-12

Real

Aptamer SeqId:18285-6;Target:SVIP;UniProt:Q8NHG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18285-6;Target: SVIP;UniProt: Q8NHG7;TargetFullName: Small VCP/p97-interacting protein;Organisim: human;Apparent_Kd_M: 8.92E-11

Real

Aptamer SeqId: 18285-6 | Target: SVIP | UniProt: Q8NHG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18285-6 | Target: SVIP | UniProt: Q8NHG7 | TargetFullName: Small VCP/p97-interacting protein | Organisim: human | Apparent_Kd_M: 8.92E-11

Real

Aptamer SeqId:18286-3;Target:ZWINT;UniProt:O95229

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18286-3;Target: ZWINT;UniProt: O95229;TargetFullName: ZW10 interactor;Organisim: human;Apparent_Kd_M: 6.42E-12

Real

Aptamer SeqId: 18286-3 | Target: ZWINT | UniProt: O95229

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18286-3 | Target: ZWINT | UniProt: O95229 | TargetFullName: ZW10 interactor | Organisim: human | Apparent_Kd_M: 6.42E-12

Real

Aptamer SeqId:18289-16;Target:MIP-5;UniProt:Q16663

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18289-16;Target: MIP-5;UniProt: Q16663;TargetFullName: C-C motif chemokine 15;Organisim: human;Apparent_Kd_M: 5.06E-12

Real

Aptamer SeqId: 18289-16 | Target: MIP-5 | UniProt: Q16663

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18289-16 | Target: MIP-5 | UniProt: Q16663 | TargetFullName: C-C motif chemokine 15 | Organisim: human | Apparent_Kd_M: 5.06E-12

Real

Aptamer SeqId:18290-6;Target:Annexin A8;UniProt:P13928

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18290-6;Target: Annexin A8;UniProt: P13928;TargetFullName: Annexin A8;Organisim: human;Apparent_Kd_M: 1.94E-10

Real

Aptamer SeqId: 18290-6 | Target: Annexin A8 | UniProt: P13928

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18290-6 | Target: Annexin A8 | UniProt: P13928 | TargetFullName: Annexin A8 | Organisim: human | Apparent_Kd_M: 1.94E-10

Real

Aptamer SeqId:18291-8;Target:p21;UniProt:P38936

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18291-8;Target: p21;UniProt: P38936;TargetFullName: Cyclin-dependent kinase inhibitor 1;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 18291-8 | Target: p21 | UniProt: P38936

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18291-8 | Target: p21 | UniProt: P38936 | TargetFullName: Cyclin-dependent kinase inhibitor 1 | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:18294-26;Target:SOX2;UniProt:P48431

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18294-26;Target: SOX2;UniProt: P48431;TargetFullName: Transcription factor SOX-2;Organisim: human;Apparent_Kd_M: 9.63E-12

Real

Aptamer SeqId: 18294-26 | Target: SOX2 | UniProt: P48431

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18294-26 | Target: SOX2 | UniProt: P48431 | TargetFullName: Transcription factor SOX-2 | Organisim: human | Apparent_Kd_M: 9.63E-12

Real

Aptamer SeqId:18295-102;Target:GRHPR;UniProt:Q9UBQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18295-102;Target: GRHPR;UniProt: Q9UBQ7;TargetFullName: Glyoxylate reductase/hydroxypyruvate reductase;Organisim: human;Apparent_Kd_M: 2.94E-12

Real

Aptamer SeqId: 18295-102 | Target: GRHPR | UniProt: Q9UBQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18295-102 | Target: GRHPR | UniProt: Q9UBQ7 | TargetFullName: Glyoxylate reductase/hydroxypyruvate reductase | Organisim: human | Apparent_Kd_M: 2.94E-12

Real

Aptamer SeqId:18297-8;Target:RASM;UniProt:O14807

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18297-8;Target: RASM;UniProt: O14807;TargetFullName: Ras-related protein M-Ras;Organisim: human;Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId: 18297-8 | Target: RASM | UniProt: O14807

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18297-8 | Target: RASM | UniProt: O14807 | TargetFullName: Ras-related protein M-Ras | Organisim: human | Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId:18299-13;Target:CPNS1;UniProt:P04632

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18299-13;Target: CPNS1;UniProt: P04632;TargetFullName: Calpain small subunit 1;Organisim: human;Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId: 18299-13 | Target: CPNS1 | UniProt: P04632

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18299-13 | Target: CPNS1 | UniProt: P04632 | TargetFullName: Calpain small subunit 1 | Organisim: human | Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId:18300-39;Target:PURB;UniProt:Q96QR8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18300-39;Target: PURB;UniProt: Q96QR8;TargetFullName: Transcriptional activator protein Pur-beta;Organisim: human;Apparent_Kd_M: 1.27E-11

Real

Aptamer SeqId: 18300-39 | Target: PURB | UniProt: Q96QR8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18300-39 | Target: PURB | UniProt: Q96QR8 | TargetFullName: Transcriptional activator protein Pur-beta | Organisim: human | Apparent_Kd_M: 1.27E-11

Real

Aptamer SeqId:18301-10;Target:NAIF1;UniProt:Q69YI7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18301-10;Target: NAIF1;UniProt: Q69YI7;TargetFullName: Nuclear apoptosis-inducing factor 1;Organisim: human;Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId: 18301-10 | Target: NAIF1 | UniProt: Q69YI7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18301-10 | Target: NAIF1 | UniProt: Q69YI7 | TargetFullName: Nuclear apoptosis-inducing factor 1 | Organisim: human | Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId:18302-204;Target:ZWILC;UniProt:Q9H900

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18302-204;Target: ZWILC;UniProt: Q9H900;TargetFullName: Protein zwilch homolog;Organisim: human;Apparent_Kd_M: 6.63E-12

Real

Aptamer SeqId: 18302-204 | Target: ZWILC | UniProt: Q9H900

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18302-204 | Target: ZWILC | UniProt: Q9H900 | TargetFullName: Protein zwilch homolog | Organisim: human | Apparent_Kd_M: 6.63E-12

Real

Aptamer SeqId:18303-39;Target:NEUG;UniProt:Q92686

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18303-39;Target: NEUG;UniProt: Q92686;TargetFullName: Neurogranin;Organisim: human;Apparent_Kd_M: 2.0E-12

Real

Aptamer SeqId: 18303-39 | Target: NEUG | UniProt: Q92686

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18303-39 | Target: NEUG | UniProt: Q92686 | TargetFullName: Neurogranin | Organisim: human | Apparent_Kd_M: 2.0E-12

Real

Aptamer SeqId:18304-19;Target:BCCIP;UniProt:Q9P287

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18304-19;Target: BCCIP;UniProt: Q9P287;TargetFullName: BRCA2 and CDKN1A-interacting protein;Organisim: human;Apparent_Kd_M: 6.56E-11

Real

Aptamer SeqId: 18304-19 | Target: BCCIP | UniProt: Q9P287

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18304-19 | Target: BCCIP | UniProt: Q9P287 | TargetFullName: BRCA2 and CDKN1A-interacting protein | Organisim: human | Apparent_Kd_M: 6.56E-11

Real

Aptamer SeqId:18306-1;Target:PALM;UniProt:O75781

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18306-1;Target: PALM;UniProt: O75781;TargetFullName: Paralemmin-1;Organisim: human;Apparent_Kd_M: 3.02E-10

Real

Aptamer SeqId: 18306-1 | Target: PALM | UniProt: O75781

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18306-1 | Target: PALM | UniProt: O75781 | TargetFullName: Paralemmin-1 | Organisim: human | Apparent_Kd_M: 3.02E-10

Real

Aptamer SeqId:18307-71;Target:PPase 2;UniProt:Q9H2U2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18307-71;Target: PPase 2;UniProt: Q9H2U2;TargetFullName: Inorganic pyrophosphatase 2; mitochondrial;Organisim: human;Apparent_Kd_M: 3.98E-11

Real

Aptamer SeqId: 18307-71 | Target: PPase 2 | UniProt: Q9H2U2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18307-71 | Target: PPase 2 | UniProt: Q9H2U2 | TargetFullName: Inorganic pyrophosphatase 2; mitochondrial | Organisim: human | Apparent_Kd_M: 3.98E-11

Real

Aptamer SeqId:18308-30;Target:STXB6;UniProt:Q8NFX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18308-30;Target: STXB6;UniProt: Q8NFX7;TargetFullName: Syntaxin-binding protein 6;Organisim: human;Apparent_Kd_M: 8.57E-12

Real

Aptamer SeqId: 18308-30 | Target: STXB6 | UniProt: Q8NFX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18308-30 | Target: STXB6 | UniProt: Q8NFX7 | TargetFullName: Syntaxin-binding protein 6 | Organisim: human | Apparent_Kd_M: 8.57E-12

Real

Aptamer SeqId:18309-18;Target:CISY;UniProt:O75390

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18309-18;Target: CISY;UniProt: O75390;TargetFullName: Citrate synthase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.8E-12

Real

Aptamer SeqId: 18309-18 | Target: CISY | UniProt: O75390

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18309-18 | Target: CISY | UniProt: O75390 | TargetFullName: Citrate synthase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.8E-12

Real

Aptamer SeqId:18310-26;Target:SELW;UniProt:P63302

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18310-26;Target: SELW;UniProt: P63302;TargetFullName: Selenoprotein W;Organisim: human;Apparent_Kd_M: 5.67E-12

Real

Aptamer SeqId: 18310-26 | Target: SELW | UniProt: P63302

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18310-26 | Target: SELW | UniProt: P63302 | TargetFullName: Selenoprotein W | Organisim: human | Apparent_Kd_M: 5.67E-12

Real

Aptamer SeqId:18311-44;Target:DCTN6;UniProt:O00399

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18311-44;Target: DCTN6;UniProt: O00399;TargetFullName: Dynactin subunit 6;Organisim: human;Apparent_Kd_M: 6.43E-11

Real

Aptamer SeqId: 18311-44 | Target: DCTN6 | UniProt: O00399

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18311-44 | Target: DCTN6 | UniProt: O00399 | TargetFullName: Dynactin subunit 6 | Organisim: human | Apparent_Kd_M: 6.43E-11

Real

Aptamer SeqId:18312-68;Target:NDRG3;UniProt:Q9UGV2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18312-68;Target: NDRG3;UniProt: Q9UGV2;TargetFullName: Protein NDRG3;Organisim: human;Apparent_Kd_M: 7.3E-11

Real

Aptamer SeqId: 18312-68 | Target: NDRG3 | UniProt: Q9UGV2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18312-68 | Target: NDRG3 | UniProt: Q9UGV2 | TargetFullName: Protein NDRG3 | Organisim: human | Apparent_Kd_M: 7.3E-11

Real

Aptamer SeqId:18313-4;Target:Asparaginase-like protein 1;UniProt:Q7L266

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18313-4;Target: Asparaginase-like protein 1;UniProt: Q7L266;TargetFullName: Isoaspartyl peptidase/L-asparaginase;Organisim: human;Apparent_Kd_M: 3.65E-12

Real

Aptamer SeqId: 18313-4 | Target: Asparaginase-like protein 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18313-4 | Target: Asparaginase-like protein 1 | UniProt: Q7L266 | TargetFullName: Isoaspartyl peptidase/L-asparaginase | Organisim: human | Apparent_Kd_M: 3.65E-12

Real

Aptamer SeqId:18315-38;Target:RTP4;UniProt:Q96DX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18315-38;Target: RTP4;UniProt: Q96DX8;TargetFullName: Receptor-transporting protein 4;Organisim: human;Apparent_Kd_M: 7.56E-12

Real

Aptamer SeqId: 18315-38 | Target: RTP4 | UniProt: Q96DX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18315-38 | Target: RTP4 | UniProt: Q96DX8 | TargetFullName: Receptor-transporting protein 4 | Organisim: human | Apparent_Kd_M: 7.56E-12

Real

Aptamer SeqId:18316-75;Target:SEPT3;UniProt:Q9UH03

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18316-75;Target: SEPT3;UniProt: Q9UH03;TargetFullName: Neuronal-specific septin-3;Organisim: human;Apparent_Kd_M: 1.68E-10

Real

Aptamer SeqId: 18316-75 | Target: SEPT3 | UniProt: Q9UH03

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18316-75 | Target: SEPT3 | UniProt: Q9UH03 | TargetFullName: Neuronal-specific septin-3 | Organisim: human | Apparent_Kd_M: 1.68E-10

Real

Aptamer SeqId:18317-111;Target:ZFAN5;UniProt:O76080

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18317-111;Target: ZFAN5;UniProt: O76080;TargetFullName: AN1-type zinc finger protein 5;Organisim: human;Apparent_Kd_M: 4.56E-12

Real

Aptamer SeqId: 18317-111 | Target: ZFAN5 | UniProt: O76080

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18317-111 | Target: ZFAN5 | UniProt: O76080 | TargetFullName: AN1-type zinc finger protein 5 | Organisim: human | Apparent_Kd_M: 4.56E-12

Real

Aptamer SeqId:18318-98;Target:SH3G3;UniProt:Q99963

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18318-98;Target: SH3G3;UniProt: Q99963;TargetFullName: Endophilin-A3;Organisim: human;Apparent_Kd_M: 4.88E-12

Real

Aptamer SeqId: 18318-98 | Target: SH3G3 | UniProt: Q99963

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18318-98 | Target: SH3G3 | UniProt: Q99963 | TargetFullName: Endophilin-A3 | Organisim: human | Apparent_Kd_M: 4.88E-12

Real

Aptamer SeqId:18319-7;Target:ODPX;UniProt:O00330

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18319-7;Target: ODPX;UniProt: O00330;TargetFullName: Pyruvate dehydrogenase protein X component; mitochondrial;Organisim: human;Apparent_Kd_M: 1.04E-12

Real

Aptamer SeqId: 18319-7 | Target: ODPX | UniProt: O00330

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18319-7 | Target: ODPX | UniProt: O00330 | TargetFullName: Pyruvate dehydrogenase protein X component; mitochondrial | Organisim: human | Apparent_Kd_M: 1.04E-12

Real

Aptamer SeqId:18321-38;Target:MTDC;UniProt:P13995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18321-38;Target: MTDC;UniProt: P13995;TargetFullName: Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId: 18321-38 | Target: MTDC | UniProt: P13995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18321-38 | Target: MTDC | UniProt: P13995 | TargetFullName: Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId:18322-15;Target:JMJD6;UniProt:Q6NYC1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18322-15;Target: JMJD6;UniProt: Q6NYC1;TargetFullName: Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6;Organisim: human;Apparent_Kd_M: 2.48E-11

Real

Aptamer SeqId: 18322-15 | Target: JMJD6 | UniProt: Q6NYC1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18322-15 | Target: JMJD6 | UniProt: Q6NYC1 | TargetFullName: Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 | Organisim: human | Apparent_Kd_M: 2.48E-11

Real

Aptamer SeqId:18323-39;Target:DRP-1;UniProt:Q14194

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18323-39;Target: DRP-1;UniProt: Q14194;TargetFullName: Dihydropyrimidinase-related protein 1;Organisim: human;Apparent_Kd_M: 8.52E-11

Real

Aptamer SeqId: 18323-39 | Target: DRP-1 | UniProt: Q14194

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18323-39 | Target: DRP-1 | UniProt: Q14194 | TargetFullName: Dihydropyrimidinase-related protein 1 | Organisim: human | Apparent_Kd_M: 8.52E-11

Real

Aptamer SeqId:18324-61;Target:SUOX;UniProt:P51687

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18324-61;Target: SUOX;UniProt: P51687;TargetFullName: Sulfite oxidase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.72E-11

Real

Aptamer SeqId: 18324-61 | Target: SUOX | UniProt: P51687

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18324-61 | Target: SUOX | UniProt: P51687 | TargetFullName: Sulfite oxidase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.72E-11

Real

Aptamer SeqId:18326-50;Target:MAGA8;UniProt:P43361

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18326-50;Target: MAGA8;UniProt: P43361;TargetFullName: Melanoma-associated antigen 8;Organisim: human;Apparent_Kd_M: 8.56E-11

Real

Aptamer SeqId: 18326-50 | Target: MAGA8 | UniProt: P43361

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18326-50 | Target: MAGA8 | UniProt: P43361 | TargetFullName: Melanoma-associated antigen 8 | Organisim: human | Apparent_Kd_M: 8.56E-11

Real

Aptamer SeqId:18327-6;Target:SNX5;UniProt:Q9Y5X3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18327-6;Target: SNX5;UniProt: Q9Y5X3;TargetFullName: Sorting nexin-5;Organisim: human;Apparent_Kd_M: 3.88E-11

Real

Aptamer SeqId: 18327-6 | Target: SNX5 | UniProt: Q9Y5X3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18327-6 | Target: SNX5 | UniProt: Q9Y5X3 | TargetFullName: Sorting nexin-5 | Organisim: human | Apparent_Kd_M: 3.88E-11

Real

Aptamer SeqId:18328-36;Target:P5CR2;UniProt:Q96C36

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18328-36;Target: P5CR2;UniProt: Q96C36;TargetFullName: Pyrroline-5-carboxylate reductase 2;Organisim: human;Apparent_Kd_M: 2.29E-10

Real

Aptamer SeqId: 18328-36 | Target: P5CR2 | UniProt: Q96C36

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18328-36 | Target: P5CR2 | UniProt: Q96C36 | TargetFullName: Pyrroline-5-carboxylate reductase 2 | Organisim: human | Apparent_Kd_M: 2.29E-10

Real

Aptamer SeqId:18329-4;Target:PRPS2;UniProt:P11908

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18329-4;Target: PRPS2;UniProt: P11908;TargetFullName: Ribose-phosphate pyrophosphokinase 2;Organisim: human;Apparent_Kd_M: 3.64E-11

Real

Aptamer SeqId: 18329-4 | Target: PRPS2 | UniProt: P11908

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18329-4 | Target: PRPS2 | UniProt: P11908 | TargetFullName: Ribose-phosphate pyrophosphokinase 2 | Organisim: human | Apparent_Kd_M: 3.64E-11

Real

Aptamer SeqId:18330-7;Target:PGM2;UniProt:Q96G03

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18330-7;Target: PGM2;UniProt: Q96G03;TargetFullName: Phosphoglucomutase-2;Organisim: human;Apparent_Kd_M: 1.87E-11

Real

Aptamer SeqId: 18330-7 | Target: PGM2 | UniProt: Q96G03

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18330-7 | Target: PGM2 | UniProt: Q96G03 | TargetFullName: Phosphoglucomutase-2 | Organisim: human | Apparent_Kd_M: 1.87E-11

Real

Aptamer SeqId:18332-17;Target:CPLX1;UniProt:O14810

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18332-17;Target: CPLX1;UniProt: O14810;TargetFullName: Complexin-1;Organisim: human;Apparent_Kd_M: 7.78E-12

Real

Aptamer SeqId: 18332-17 | Target: CPLX1 | UniProt: O14810

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18332-17 | Target: CPLX1 | UniProt: O14810 | TargetFullName: Complexin-1 | Organisim: human | Apparent_Kd_M: 7.78E-12

Real

Aptamer SeqId:18337-4;Target:GMDS;UniProt:O60547

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18337-4;Target: GMDS;UniProt: O60547;TargetFullName: GDP-mannose 4;6 dehydratase;Organisim: human;Apparent_Kd_M: 5.31E-11

Real

Aptamer SeqId: 18337-4 | Target: GMDS | UniProt: O60547

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18337-4 | Target: GMDS | UniProt: O60547 | TargetFullName: GDP-mannose 4;6 dehydratase | Organisim: human | Apparent_Kd_M: 5.31E-11

Real

Aptamer SeqId:18338-26;Target:IDH;UniProt:O75874

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18338-26;Target: IDH;UniProt: O75874;TargetFullName: Isocitrate dehydrogenase [NADP] cytoplasmic;Organisim: human;Apparent_Kd_M: 7.36E-11

Real

Aptamer SeqId: 18338-26 | Target: IDH | UniProt: O75874

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18338-26 | Target: IDH | UniProt: O75874 | TargetFullName: Isocitrate dehydrogenase NADP cytoplasmic | Organisim: human | Apparent_Kd_M: 7.36E-11

Real

Aptamer SeqId:18339-207;Target:PSB3;UniProt:P49720

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18339-207;Target: PSB3;UniProt: P49720;TargetFullName: Proteasome subunit beta type-3;Organisim: human;Apparent_Kd_M: 2.24E-10

Real

Aptamer SeqId: 18339-207 | Target: PSB3 | UniProt: P49720

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18339-207 | Target: PSB3 | UniProt: P49720 | TargetFullName: Proteasome subunit beta type-3 | Organisim: human | Apparent_Kd_M: 2.24E-10

Real

Aptamer SeqId:18340-2;Target:Proteasome beta chain;UniProt:P28070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18340-2;Target: Proteasome beta chain;UniProt: P28070;TargetFullName: Proteasome subunit beta type-4;Organisim: human;Apparent_Kd_M: 1.47E-12

Real

Aptamer SeqId: 18340-2 | Target: Proteasome beta chain | UniProt: P28070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18340-2 | Target: Proteasome beta chain | UniProt: P28070 | TargetFullName: Proteasome subunit beta type-4 | Organisim: human | Apparent_Kd_M: 1.47E-12

Real

Aptamer SeqId:18342-2;Target:SERC;UniProt:Q9Y617

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18342-2;Target: SERC;UniProt: Q9Y617;TargetFullName: Phosphoserine aminotransferase;Organisim: human;Apparent_Kd_M: 1.66E-11

Real

Aptamer SeqId: 18342-2 | Target: SERC | UniProt: Q9Y617

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18342-2 | Target: SERC | UniProt: Q9Y617 | TargetFullName: Phosphoserine aminotransferase | Organisim: human | Apparent_Kd_M: 1.66E-11

Real

Aptamer SeqId:18343-10;Target:DECR2;UniProt:Q9NUI1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18343-10;Target: DECR2;UniProt: Q9NUI1;TargetFullName: Peroxisomal 2;4-dienoyl-CoA reductase;Organisim: human;Apparent_Kd_M: 5.58E-11

Real

Aptamer SeqId: 18343-10 | Target: DECR2 | UniProt: Q9NUI1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18343-10 | Target: DECR2 | UniProt: Q9NUI1 | TargetFullName: Peroxisomal 2;4-dienoyl-CoA reductase | Organisim: human | Apparent_Kd_M: 5.58E-11

Real

Aptamer SeqId:18347-15;Target:Laminin-2;UniProt:P24043|P07942|P11047

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18347-15;Target: Laminin-2;UniProt: P24043|P07942|P11047;TargetFullName: Laminin-2;Organisim: human;Apparent_Kd_M: 4.68E-11

Real

Aptamer SeqId: 18347-15 | Target: Laminin-2 | UniProt: P24043|P07942|P11047

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18347-15 | Target: Laminin-2 | UniProt: P24043|P07942|P11047 | TargetFullName: Laminin-2 | Organisim: human | Apparent_Kd_M: 4.68E-11

Real

Aptamer SeqId:18348-89;Target:HNRPD;UniProt:Q14103

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18348-89;Target: HNRPD;UniProt: Q14103;TargetFullName: Heterogeneous nuclear ribonucleoprotein D0;Organisim: human;Apparent_Kd_M: 2.25E-12

Real

Aptamer SeqId: 18348-89 | Target: HNRPD | UniProt: Q14103

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18348-89 | Target: HNRPD | UniProt: Q14103 | TargetFullName: Heterogeneous nuclear ribonucleoprotein D0 | Organisim: human | Apparent_Kd_M: 2.25E-12

Real

Aptamer SeqId:18373-13;Target:Radixin;UniProt:P35241

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18373-13;Target: Radixin;UniProt: P35241;TargetFullName: Radixin;Organisim: human;Apparent_Kd_M: 7.82E-13

Real

Aptamer SeqId: 18373-13 | Target: Radixin | UniProt: P35241

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18373-13 | Target: Radixin | UniProt: P35241 | TargetFullName: Radixin | Organisim: human | Apparent_Kd_M: 7.82E-13

Real

Aptamer SeqId:18375-28;Target:IL-1F5;UniProt:Q9UBH0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18375-28;Target: IL-1F5;UniProt: Q9UBH0;TargetFullName: Interleukin-36 receptor antagonist protein;Organisim: human;Apparent_Kd_M: 5.65E-12

Real

Aptamer SeqId: 18375-28 | Target: IL-1F5 | UniProt: Q9UBH0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18375-28 | Target: IL-1F5 | UniProt: Q9UBH0 | TargetFullName: Interleukin-36 receptor antagonist protein | Organisim: human | Apparent_Kd_M: 5.65E-12

Real

Aptamer SeqId:18376-19;Target:Myosin light chain 1;UniProt:P08590

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18376-19;Target: Myosin light chain 1;UniProt: P08590;TargetFullName: Myosin light chain 3;Organisim: human;Apparent_Kd_M: 2.78E-11

Real

Aptamer SeqId: 18376-19 | Target: Myosin light chain 1 | UniProt: P08590

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18376-19 | Target: Myosin light chain 1 | UniProt: P08590 | TargetFullName: Myosin light chain 3 | Organisim: human | Apparent_Kd_M: 2.78E-11

Real

Aptamer SeqId:18380-78;Target:Albumin;UniProt:P02768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18380-78;Target: Albumin;UniProt: P02768;TargetFullName: Serum albumin;Organisim: human;Apparent_Kd_M: 2.19E-10

Real

Aptamer SeqId: 18380-78 | Target: Albumin | UniProt: P02768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18380-78 | Target: Albumin | UniProt: P02768 | TargetFullName: Serum albumin | Organisim: human | Apparent_Kd_M: 2.19E-10

Real

Aptamer SeqId:18381-16;Target:ALDH-E2;UniProt:P05091

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18381-16;Target: ALDH-E2;UniProt: P05091;TargetFullName: Aldehyde dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 6.97E-12

Real

Aptamer SeqId: 18381-16 | Target: ALDH-E2 | UniProt: P05091

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18381-16 | Target: ALDH-E2 | UniProt: P05091 | TargetFullName: Aldehyde dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 6.97E-12

Real

Aptamer SeqId:18382-109;Target:Catechol O-methyltransferase;UniProt:P21964

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18382-109;Target: Catechol O-methyltransferase;UniProt: P21964;TargetFullName: Catechol O-methyltransferase;Organisim: human;Apparent_Kd_M: 2.7E-11

Real

Aptamer SeqId: 18382-109 | Target: Catechol O-methyltransferase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18382-109 | Target: Catechol O-methyltransferase | UniProt: P21964 | TargetFullName: Catechol O-methyltransferase | Organisim: human | Apparent_Kd_M: 2.7E-11

Real

Aptamer SeqId:18383-9;Target:FKBP3;UniProt:Q00688

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18383-9;Target: FKBP3;UniProt: Q00688;TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP3;Organisim: human;Apparent_Kd_M: 9.05E-13

Real

Aptamer SeqId: 18383-9 | Target: FKBP3 | UniProt: Q00688

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18383-9 | Target: FKBP3 | UniProt: Q00688 | TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP3 | Organisim: human | Apparent_Kd_M: 9.05E-13

Real

Aptamer SeqId:18385-4;Target:PSD10;UniProt:O75832

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18385-4;Target: PSD10;UniProt: O75832;TargetFullName: 26S proteasome non-ATPase regulatory subunit 10;Organisim: human;Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId: 18385-4 | Target: PSD10 | UniProt: O75832

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18385-4 | Target: PSD10 | UniProt: O75832 | TargetFullName: 26S proteasome non-ATPase regulatory subunit 10 | Organisim: human | Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId:18386-36;Target:GLRX1;UniProt:P35754

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18386-36;Target: GLRX1;UniProt: P35754;TargetFullName: Glutaredoxin-1;Organisim: human;Apparent_Kd_M: 2.7E-11

Real

Aptamer SeqId: 18386-36 | Target: GLRX1 | UniProt: P35754

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18386-36 | Target: GLRX1 | UniProt: P35754 | TargetFullName: Glutaredoxin-1 | Organisim: human | Apparent_Kd_M: 2.7E-11

Real

Aptamer SeqId:18387-7;Target:suppression of tumorigenicity 13;UniProt:P50502

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18387-7;Target: suppression of tumorigenicity 13;UniProt: P50502;TargetFullName: Hsc70-interacting protein;Organisim: human;Apparent_Kd_M: 5.66E-12

Real

Aptamer SeqId: 18387-7 | Target: suppression of tumorigenicity 13

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18387-7 | Target: suppression of tumorigenicity 13 | UniProt: P50502 | TargetFullName: Hsc70-interacting protein | Organisim: human | Apparent_Kd_M: 5.66E-12

Real

Aptamer SeqId:18389-11;Target:IFNA1;UniProt:P01562

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18389-11;Target: IFNA1;UniProt: P01562;TargetFullName: Interferon alpha-1/13;Organisim: human;Apparent_Kd_M: 6.33E-12

Real

Aptamer SeqId: 18389-11 | Target: IFNA1 | UniProt: P01562

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18389-11 | Target: IFNA1 | UniProt: P01562 | TargetFullName: Interferon alpha-1/13 | Organisim: human | Apparent_Kd_M: 6.33E-12

Real

Aptamer SeqId:18392-19;Target:MAT2B;UniProt:Q9NZL9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18392-19;Target: MAT2B;UniProt: Q9NZL9;TargetFullName: Methionine adenosyltransferase 2 subunit beta;Organisim: human;Apparent_Kd_M: 2.6E-12

Real

Aptamer SeqId: 18392-19 | Target: MAT2B | UniProt: Q9NZL9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18392-19 | Target: MAT2B | UniProt: Q9NZL9 | TargetFullName: Methionine adenosyltransferase 2 subunit beta | Organisim: human | Apparent_Kd_M: 2.6E-12

Real

Aptamer SeqId:18395-5;Target:ADPRH;UniProt:P54922

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18395-5;Target: ADPRH;UniProt: P54922;TargetFullName: [Protein ADP-ribosylarginine] hydrolase;Organisim: human;Apparent_Kd_M: 2.6E-10

Real

Aptamer SeqId: 18395-5 | Target: ADPRH | UniProt: P54922

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18395-5 | Target: ADPRH | UniProt: P54922 | TargetFullName: Protein ADP-ribosylarginine hydrolase | Organisim: human | Apparent_Kd_M: 2.6E-10

Real

Aptamer SeqId:18396-10;Target:AES;UniProt:Q08117

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18396-10;Target: AES;UniProt: Q08117;TargetFullName: Amino-terminal enhancer of split;Organisim: human;Apparent_Kd_M: 9.8E-12

Real

Aptamer SeqId: 18396-10 | Target: AES | UniProt: Q08117

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18396-10 | Target: AES | UniProt: Q08117 | TargetFullName: Amino-terminal enhancer of split | Organisim: human | Apparent_Kd_M: 9.8E-12

Real

Aptamer SeqId:18397-5;Target:AK1C4;UniProt:P17516

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18397-5;Target: AK1C4;UniProt: P17516;TargetFullName: Aldo-keto reductase family 1 member C4;Organisim: human;Apparent_Kd_M: 5.28E-12

Real

Aptamer SeqId: 18397-5 | Target: AK1C4 | UniProt: P17516

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18397-5 | Target: AK1C4 | UniProt: P17516 | TargetFullName: Aldo-keto reductase family 1 member C4 | Organisim: human | Apparent_Kd_M: 5.28E-12

Real

Aptamer SeqId:18398-1;Target:AK1D1;UniProt:P51857

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18398-1;Target: AK1D1;UniProt: P51857;TargetFullName: 3-oxo-5-beta-steroid 4-dehydrogenase;Organisim: human;Apparent_Kd_M: 1.94E-12

Real

Aptamer SeqId: 18398-1 | Target: AK1D1 | UniProt: P51857

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18398-1 | Target: AK1D1 | UniProt: P51857 | TargetFullName: 3-oxo-5-beta-steroid 4-dehydrogenase | Organisim: human | Apparent_Kd_M: 1.94E-12

Real

Aptamer SeqId:18399-1;Target:AKA7A;UniProt:O43687

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18399-1;Target: AKA7A;UniProt: O43687;TargetFullName: A-kinase anchor protein 7 isoforms alpha and beta;Organisim: human;Apparent_Kd_M: 1.81E-10

Real

Aptamer SeqId: 18399-1 | Target: AKA7A | UniProt: O43687

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18399-1 | Target: AKA7A | UniProt: O43687 | TargetFullName: A-kinase anchor protein 7 isoforms alpha and beta | Organisim: human | Apparent_Kd_M: 1.81E-10

Real

Aptamer SeqId:18400-52;Target:ALKB2;UniProt:Q6NS38

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18400-52;Target: ALKB2;UniProt: Q6NS38;TargetFullName: DNA oxidative demethylase ALKBH2;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 18400-52 | Target: ALKB2 | UniProt: Q6NS38

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18400-52 | Target: ALKB2 | UniProt: Q6NS38 | TargetFullName: DNA oxidative demethylase ALKBH2 | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:18401-18;Target:ALKB3;UniProt:Q96Q83

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18401-18;Target: ALKB3;UniProt: Q96Q83;TargetFullName: Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3;Organisim: human;Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId: 18401-18 | Target: ALKB3 | UniProt: Q96Q83

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18401-18 | Target: ALKB3 | UniProt: Q96Q83 | TargetFullName: Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 | Organisim: human | Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId:18402-1;Target:AMERL;UniProt:Q6DCA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18402-1;Target: AMERL;UniProt: Q6DCA0;TargetFullName: AMMECR1-like protein;Organisim: human;Apparent_Kd_M: 8.56E-12

Real

Aptamer SeqId: 18402-1 | Target: AMERL | UniProt: Q6DCA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18402-1 | Target: AMERL | UniProt: Q6DCA0 | TargetFullName: AMMECR1-like protein | Organisim: human | Apparent_Kd_M: 8.56E-12

Real

Aptamer SeqId:18403-25;Target:AMPD2;UniProt:Q01433

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18403-25;Target: AMPD2;UniProt: Q01433;TargetFullName: AMP deaminase 2;Organisim: human;Apparent_Kd_M: 1.15E-10

Real

Aptamer SeqId: 18403-25 | Target: AMPD2 | UniProt: Q01433

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18403-25 | Target: AMPD2 | UniProt: Q01433 | TargetFullName: AMP deaminase 2 | Organisim: human | Apparent_Kd_M: 1.15E-10

Real

Aptamer SeqId:18404-22;Target:ANR54;UniProt:Q6NXT1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18404-22;Target: ANR54;UniProt: Q6NXT1;TargetFullName: Ankyrin repeat domain-containing protein 54;Organisim: human;Apparent_Kd_M: 2.59E-10

Real

Aptamer SeqId: 18404-22 | Target: ANR54 | UniProt: Q6NXT1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18404-22 | Target: ANR54 | UniProt: Q6NXT1 | TargetFullName: Ankyrin repeat domain-containing protein 54 | Organisim: human | Apparent_Kd_M: 2.59E-10

Real

Aptamer SeqId:18405-117;Target:AP1S2;UniProt:P56377

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18405-117;Target: AP1S2;UniProt: P56377;TargetFullName: AP-1 complex subunit sigma-2;Organisim: human;Apparent_Kd_M: 4.02E-11

Real

Aptamer SeqId: 18405-117 | Target: AP1S2 | UniProt: P56377

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18405-117 | Target: AP1S2 | UniProt: P56377 | TargetFullName: AP-1 complex subunit sigma-2 | Organisim: human | Apparent_Kd_M: 4.02E-11

Real

Aptamer SeqId:18407-36;Target:AR2BP;UniProt:Q9Y2Y0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18407-36;Target: AR2BP;UniProt: Q9Y2Y0;TargetFullName: ADP-ribosylation factor-like protein 2-binding protein;Organisim: human;Apparent_Kd_M: 2.53E-10

Real

Aptamer SeqId: 18407-36 | Target: AR2BP | UniProt: Q9Y2Y0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18407-36 | Target: AR2BP | UniProt: Q9Y2Y0 | TargetFullName: ADP-ribosylation factor-like protein 2-binding protein | Organisim: human | Apparent_Kd_M: 2.53E-10

Real

Aptamer SeqId:18408-26;Target:ARF4;UniProt:P18085

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18408-26;Target: ARF4;UniProt: P18085;TargetFullName: ADP-ribosylation factor 4;Organisim: human;Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId: 18408-26 | Target: ARF4 | UniProt: P18085

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18408-26 | Target: ARF4 | UniProt: P18085 | TargetFullName: ADP-ribosylation factor 4 | Organisim: human | Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId:18409-61;Target:ARF5;UniProt:P84085

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18409-61;Target: ARF5;UniProt: P84085;TargetFullName: ADP-ribosylation factor 5;Organisim: human;Apparent_Kd_M: 4.83E-11

Real

Aptamer SeqId: 18409-61 | Target: ARF5 | UniProt: P84085

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18409-61 | Target: ARF5 | UniProt: P84085 | TargetFullName: ADP-ribosylation factor 5 | Organisim: human | Apparent_Kd_M: 4.83E-11

Real

Aptamer SeqId:18410-26;Target:ARL14;UniProt:Q8N4G2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18410-26;Target: ARL14;UniProt: Q8N4G2;TargetFullName: ADP-ribosylation factor-like protein 14;Organisim: human;Apparent_Kd_M: 3.76E-11

Real

Aptamer SeqId: 18410-26 | Target: ARL14 | UniProt: Q8N4G2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18410-26 | Target: ARL14 | UniProt: Q8N4G2 | TargetFullName: ADP-ribosylation factor-like protein 14 | Organisim: human | Apparent_Kd_M: 3.76E-11

Real

Aptamer SeqId:18411-83;Target:ARL15;UniProt:Q9NXU5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18411-83;Target: ARL15;UniProt: Q9NXU5;TargetFullName: ADP-ribosylation factor-like protein 15;Organisim: human;Apparent_Kd_M: 8.17E-11

Real

Aptamer SeqId: 18411-83 | Target: ARL15 | UniProt: Q9NXU5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18411-83 | Target: ARL15 | UniProt: Q9NXU5 | TargetFullName: ADP-ribosylation factor-like protein 15 | Organisim: human | Apparent_Kd_M: 8.17E-11

Real

Aptamer SeqId:18413-24;Target:ARL4D;UniProt:P49703

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18413-24;Target: ARL4D;UniProt: P49703;TargetFullName: ADP-ribosylation factor-like protein 4D;Organisim: human;Apparent_Kd_M: 1.91E-10

Real

Aptamer SeqId: 18413-24 | Target: ARL4D | UniProt: P49703

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18413-24 | Target: ARL4D | UniProt: P49703 | TargetFullName: ADP-ribosylation factor-like protein 4D | Organisim: human | Apparent_Kd_M: 1.91E-10

Real

Aptamer SeqId:18414-26;Target:ARL5A;UniProt:Q9Y689

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18414-26;Target: ARL5A;UniProt: Q9Y689;TargetFullName: ADP-ribosylation factor-like protein 5A;Organisim: human;Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId: 18414-26 | Target: ARL5A | UniProt: Q9Y689

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18414-26 | Target: ARL5A | UniProt: Q9Y689 | TargetFullName: ADP-ribosylation factor-like protein 5A | Organisim: human | Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId:18415-16;Target:ARL6;UniProt:Q9H0F7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18415-16;Target: ARL6;UniProt: Q9H0F7;TargetFullName: ADP-ribosylation factor-like protein 6;Organisim: human;Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId: 18415-16 | Target: ARL6 | UniProt: Q9H0F7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18415-16 | Target: ARL6 | UniProt: Q9H0F7 | TargetFullName: ADP-ribosylation factor-like protein 6 | Organisim: human | Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId:18416-3;Target:ARL9;UniProt:Q6T311

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18416-3;Target: ARL9;UniProt: Q6T311;TargetFullName: ADP-ribosylation factor-like protein 9;Organisim: human;Apparent_Kd_M: 9.72E-11

Real

Aptamer SeqId: 18416-3 | Target: ARL9 | UniProt: Q6T311

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18416-3 | Target: ARL9 | UniProt: Q6T311 | TargetFullName: ADP-ribosylation factor-like protein 9 | Organisim: human | Apparent_Kd_M: 9.72E-11

Real

Aptamer SeqId:18417-3;Target:AS3MT;UniProt:Q9HBK9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18417-3;Target: AS3MT;UniProt: Q9HBK9;TargetFullName: Arsenite methyltransferase;Organisim: human;Apparent_Kd_M: 1.29E-10

Real

Aptamer SeqId: 18417-3 | Target: AS3MT | UniProt: Q9HBK9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18417-3 | Target: AS3MT | UniProt: Q9HBK9 | TargetFullName: Arsenite methyltransferase | Organisim: human | Apparent_Kd_M: 1.29E-10

Real

Aptamer SeqId:18419-20;Target:p16-ARC;UniProt:O15511

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18419-20;Target: p16-ARC;UniProt: O15511;TargetFullName: Actin-related protein 2/3 complex subunit 5;Organisim: human;Apparent_Kd_M: 3.041764E-11

Real

Aptamer SeqId: 18419-20 | Target: p16-ARC | UniProt: O15511

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18419-20 | Target: p16-ARC | UniProt: O15511 | TargetFullName: Actin-related protein 2/3 complex subunit 5 | Organisim: human | Apparent_Kd_M: 3.041764E-11

Real

Aptamer SeqId:18422-41;Target:ERG19;UniProt:P53602

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18422-41;Target: ERG19;UniProt: P53602;TargetFullName: Diphosphomevalonate decarboxylase;Organisim: human;Apparent_Kd_M: 1.140803E-10

Real

Aptamer SeqId: 18422-41 | Target: ERG19 | UniProt: P53602

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18422-41 | Target: ERG19 | UniProt: P53602 | TargetFullName: Diphosphomevalonate decarboxylase | Organisim: human | Apparent_Kd_M: 1.140803E-10

Real

Aptamer SeqId:18429-10;Target:Cadherin E;UniProt:P12830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18429-10;Target: Cadherin E;UniProt: P12830;TargetFullName: Cadherin-1;Organisim: human;Apparent_Kd_M: 6.38005E-10

Real

Aptamer SeqId: 18429-10 | Target: Cadherin E | UniProt: P12830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18429-10 | Target: Cadherin E | UniProt: P12830 | TargetFullName: Cadherin-1 | Organisim: human | Apparent_Kd_M: 6.38005E-10

Real

Aptamer SeqId:18432-32;Target:RALB;UniProt:P11234

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18432-32;Target: RALB;UniProt: P11234;TargetFullName: Ras-related protein Ral-B;Organisim: human;Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId: 18432-32 | Target: RALB | UniProt: P11234

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18432-32 | Target: RALB | UniProt: P11234 | TargetFullName: Ras-related protein Ral-B | Organisim: human | Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId:18434-141;Target:TBPL1;UniProt:P62380

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18434-141;Target: TBPL1;UniProt: P62380;TargetFullName: TATA box-binding protein-like protein 1;Organisim: human;Apparent_Kd_M: 1.395633E-11

Real

Aptamer SeqId: 18434-141 | Target: TBPL1 | UniProt: P62380

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18434-141 | Target: TBPL1 | UniProt: P62380 | TargetFullName: TATA box-binding protein-like protein 1 | Organisim: human | Apparent_Kd_M: 1.395633E-11

Real

Aptamer SeqId:18435-40;Target:UBX2B;UniProt:Q14CS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18435-40;Target: UBX2B;UniProt: Q14CS0;TargetFullName: UBX domain-containing protein 2B;Organisim: human;Apparent_Kd_M: 6.390593E-12

Real

Aptamer SeqId: 18435-40 | Target: UBX2B | UniProt: Q14CS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18435-40 | Target: UBX2B | UniProt: Q14CS0 | TargetFullName: UBX domain-containing protein 2B | Organisim: human | Apparent_Kd_M: 6.390593E-12

Real

Aptamer SeqId:18449-33;Target:PPIG;UniProt:Q13427

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18449-33;Target: PPIG;UniProt: Q13427;TargetFullName: Peptidyl-prolyl cis-trans isomerase G;Organisim: human;Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId: 18449-33 | Target: PPIG | UniProt: Q13427

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18449-33 | Target: PPIG | UniProt: Q13427 | TargetFullName: Peptidyl-prolyl cis-trans isomerase G | Organisim: human | Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId:18458-4;Target:PGES2;UniProt:Q9H7Z7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18458-4;Target: PGES2;UniProt: Q9H7Z7;TargetFullName: Prostaglandin E synthase 2;Organisim: human;Apparent_Kd_M: 7.481023E-12

Real

Aptamer SeqId: 18458-4 | Target: PGES2 | UniProt: Q9H7Z7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18458-4 | Target: PGES2 | UniProt: Q9H7Z7 | TargetFullName: Prostaglandin E synthase 2 | Organisim: human | Apparent_Kd_M: 7.481023E-12

Real

Aptamer SeqId:18483-36;Target:MSS4;UniProt:P47224

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18483-36;Target: MSS4;UniProt: P47224;TargetFullName: Guanine nucleotide exchange factor MSS4;Organisim: human;Apparent_Kd_M: 4.695049E-11

Real

Aptamer SeqId: 18483-36 | Target: MSS4 | UniProt: P47224

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18483-36 | Target: MSS4 | UniProt: P47224 | TargetFullName: Guanine nucleotide exchange factor MSS4 | Organisim: human | Apparent_Kd_M: 4.695049E-11

Real

Aptamer SeqId:18813-15;Target:DD19A;UniProt:Q9NUU7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18813-15;Target: DD19A;UniProt: Q9NUU7;TargetFullName: ATP-dependent RNA helicase DDX19A;Organisim: human;Apparent_Kd_M: 2.82E-11

Real

Aptamer SeqId: 18813-15 | Target: DD19A | UniProt: Q9NUU7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18813-15 | Target: DD19A | UniProt: Q9NUU7 | TargetFullName: ATP-dependent RNA helicase DDX19A | Organisim: human | Apparent_Kd_M: 2.82E-11

Real

Aptamer SeqId:18814-21;Target:Activin AC;UniProt:P08476|P55103

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18814-21;Target: Activin AC;UniProt: P08476|P55103;TargetFullName: Inhibin beta A chain:Inhibin beta C chain heterodimer;Organisim: human;Apparent_Kd_M: 6.35E-11

Real

Aptamer SeqId: 18814-21 | Target: Activin AC | UniProt: P08476|P55103

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18814-21 | Target: Activin AC | UniProt: P08476|P55103 | TargetFullName: Inhibin beta A chain:Inhibin beta C chain heterodimer | Organisim: human | Apparent_Kd_M: 6.35E-11

Real

Aptamer SeqId:18817-50;Target:CBX1;UniProt:P83916

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18817-50;Target: CBX1;UniProt: P83916;TargetFullName: Chromobox protein homolog 1;Organisim: human;Apparent_Kd_M: 7.49E-11

Real

Aptamer SeqId: 18817-50 | Target: CBX1 | UniProt: P83916

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18817-50 | Target: CBX1 | UniProt: P83916 | TargetFullName: Chromobox protein homolog 1 | Organisim: human | Apparent_Kd_M: 7.49E-11

Real

Aptamer SeqId:18819-21;Target:PPIC;UniProt:P45877

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18819-21;Target: PPIC;UniProt: P45877;TargetFullName: Peptidyl-prolyl cis-trans isomerase C;Organisim: human;Apparent_Kd_M: 5.32E-12

Real

Aptamer SeqId: 18819-21 | Target: PPIC | UniProt: P45877

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18819-21 | Target: PPIC | UniProt: P45877 | TargetFullName: Peptidyl-prolyl cis-trans isomerase C | Organisim: human | Apparent_Kd_M: 5.32E-12

Real

Aptamer SeqId:18821-9;Target:C4a;UniProt:P0C0L4|P0C0L5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18821-9;Target: C4a;UniProt: P0C0L4|P0C0L5;TargetFullName: C4a anaphylatoxin;Organisim: human;Apparent_Kd_M: 7.64E-11

Real

Aptamer SeqId: 18821-9 | Target: C4a | UniProt: P0C0L4|P0C0L5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18821-9 | Target: C4a | UniProt: P0C0L4|P0C0L5 | TargetFullName: C4a anaphylatoxin | Organisim: human | Apparent_Kd_M: 7.64E-11

Real

Aptamer SeqId:18823-52;Target:H2B3B;UniProt:Q8N257

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18823-52;Target: H2B3B;UniProt: Q8N257;TargetFullName: Histone H2B type 3-B;Organisim: human;Apparent_Kd_M: 1.33E-10

Real

Aptamer SeqId: 18823-52 | Target: H2B3B | UniProt: Q8N257

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18823-52 | Target: H2B3B | UniProt: Q8N257 | TargetFullName: Histone H2B type 3-B | Organisim: human | Apparent_Kd_M: 1.33E-10

Real

Aptamer SeqId:18824-7;Target:IF4A2;UniProt:Q14240

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18824-7;Target: IF4A2;UniProt: Q14240;TargetFullName: Eukaryotic initiation factor 4A-II;Organisim: human;Apparent_Kd_M: 3.78E-11

Real

Aptamer SeqId: 18824-7 | Target: IF4A2 | UniProt: Q14240

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18824-7 | Target: IF4A2 | UniProt: Q14240 | TargetFullName: Eukaryotic initiation factor 4A-II | Organisim: human | Apparent_Kd_M: 3.78E-11

Real

Aptamer SeqId:18829-4;Target:IF4A1;UniProt:P60842

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18829-4;Target: IF4A1;UniProt: P60842;TargetFullName: Eukaryotic initiation factor 4A-I;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 18829-4 | Target: IF4A1 | UniProt: P60842

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18829-4 | Target: IF4A1 | UniProt: P60842 | TargetFullName: Eukaryotic initiation factor 4A-I | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:18830-1;Target:Omentin;UniProt:Q8WWA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18830-1;Target: Omentin;UniProt: Q8WWA0;TargetFullName: Intelectin-1;Organisim: human;Apparent_Kd_M: 8.1E-11

Real

Aptamer SeqId: 18830-1 | Target: Omentin | UniProt: Q8WWA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18830-1 | Target: Omentin | UniProt: Q8WWA0 | TargetFullName: Intelectin-1 | Organisim: human | Apparent_Kd_M: 8.1E-11

Real

Aptamer SeqId:18831-6;Target:LRIG1;UniProt:Q96JA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18831-6;Target: LRIG1;UniProt: Q96JA1;TargetFullName: Leucine-rich repeats and immunoglobulin-like domains protein 1;Organisim: human;Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId: 18831-6 | Target: LRIG1 | UniProt: Q96JA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18831-6 | Target: LRIG1 | UniProt: Q96JA1 | TargetFullName: Leucine-rich repeats and immunoglobulin-like domains protein 1 | Organisim: human | Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId:18832-65;Target:SAA2;UniProt:P0DJI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18832-65;Target: SAA2;UniProt: P0DJI9;TargetFullName: Serum amyloid A-2 protein;Organisim: human;Apparent_Kd_M: 1.21E-10

Real

Aptamer SeqId: 18832-65 | Target: SAA2 | UniProt: P0DJI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18832-65 | Target: SAA2 | UniProt: P0DJI9 | TargetFullName: Serum amyloid A-2 protein | Organisim: human | Apparent_Kd_M: 1.21E-10

Real

Aptamer SeqId:18833-76;Target:PEA15;UniProt:Q15121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18833-76;Target: PEA15;UniProt: Q15121;TargetFullName: Astrocytic phosphoprotein PEA-15;Organisim: human;Apparent_Kd_M: 3.24E-10

Real

Aptamer SeqId: 18833-76 | Target: PEA15 | UniProt: Q15121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18833-76 | Target: PEA15 | UniProt: Q15121 | TargetFullName: Astrocytic phosphoprotein PEA-15 | Organisim: human | Apparent_Kd_M: 3.24E-10

Real

Aptamer SeqId:18837-9;Target:SGTB;UniProt:Q96EQ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18837-9;Target: SGTB;UniProt: Q96EQ0;TargetFullName: Small glutamine-rich tetratricopeptide repeat-containing protein beta;Organisim: human;Apparent_Kd_M: 3.32E-10

Real

Aptamer SeqId: 18837-9 | Target: SGTB | UniProt: Q96EQ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18837-9 | Target: SGTB | UniProt: Q96EQ0 | TargetFullName: Small glutamine-rich tetratricopeptide repeat-containing protein beta | Organisim: human | Apparent_Kd_M: 3.32E-10

Real

Aptamer SeqId:18839-24;Target:Thyroglobulin;UniProt:P01266

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18839-24;Target: Thyroglobulin;UniProt: P01266;TargetFullName: Thyroglobulin;Organisim: human;Apparent_Kd_M: 3.73E-11

Real

Aptamer SeqId: 18839-24 | Target: Thyroglobulin | UniProt: P01266

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18839-24 | Target: Thyroglobulin | UniProt: P01266 | TargetFullName: Thyroglobulin | Organisim: human | Apparent_Kd_M: 3.73E-11

Real

Aptamer SeqId:18840-205;Target:SH21B;UniProt:O14796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18840-205;Target: SH21B;UniProt: O14796;TargetFullName: SH2 domain-containing protein 1B;Organisim: human;Apparent_Kd_M: 1.09E-10

Real

Aptamer SeqId: 18840-205 | Target: SH21B | UniProt: O14796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18840-205 | Target: SH21B | UniProt: O14796 | TargetFullName: SH2 domain-containing protein 1B | Organisim: human | Apparent_Kd_M: 1.09E-10

Real

Aptamer SeqId:18841-1;Target:SPB13;UniProt:Q9UIV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18841-1;Target: SPB13;UniProt: Q9UIV8;TargetFullName: Serpin B13;Organisim: human;Apparent_Kd_M: 8.16E-11

Real

Aptamer SeqId: 18841-1 | Target: SPB13 | UniProt: Q9UIV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18841-1 | Target: SPB13 | UniProt: Q9UIV8 | TargetFullName: Serpin B13 | Organisim: human | Apparent_Kd_M: 8.16E-11

Real

Aptamer SeqId:18842-24;Target:UB2D2;UniProt:P62837

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18842-24;Target: UB2D2;UniProt: P62837;TargetFullName: Ubiquitin-conjugating enzyme E2 D2;Organisim: human;Apparent_Kd_M: 3.02E-10

Real

Aptamer SeqId: 18842-24 | Target: UB2D2 | UniProt: P62837

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18842-24 | Target: UB2D2 | UniProt: P62837 | TargetFullName: Ubiquitin-conjugating enzyme E2 D2 | Organisim: human | Apparent_Kd_M: 3.02E-10

Real

Aptamer SeqId:18859-7;Target:4EBP3;UniProt:O60516

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18859-7;Target: 4EBP3;UniProt: O60516;TargetFullName: Eukaryotic translation initiation factor 4E-binding protein 3;Organisim: human;Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId: 18859-7 | Target: 4EBP3 | UniProt: O60516

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18859-7 | Target: 4EBP3 | UniProt: O60516 | TargetFullName: Eukaryotic translation initiation factor 4E-binding protein 3 | Organisim: human | Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId:18860-2;Target:CaMKK alpha;UniProt:Q8N5S9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18860-2;Target: CaMKK alpha;UniProt: Q8N5S9;TargetFullName: Calcium/calmodulin-dependent protein kinase kinase 1;Organisim: human;Apparent_Kd_M: 5.58E-11

Real

Aptamer SeqId: 18860-2 | Target: CaMKK alpha | UniProt: Q8N5S9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18860-2 | Target: CaMKK alpha | UniProt: Q8N5S9 | TargetFullName: Calcium/calmodulin-dependent protein kinase kinase 1 | Organisim: human | Apparent_Kd_M: 5.58E-11

Real

Aptamer SeqId:18863-176;Target:CHST2;UniProt:Q9Y4C5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18863-176;Target: CHST2;UniProt: Q9Y4C5;TargetFullName: Carbohydrate sulfotransferase 2;Organisim: human;Apparent_Kd_M: 2.36E-12

Real

Aptamer SeqId: 18863-176 | Target: CHST2 | UniProt: Q9Y4C5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18863-176 | Target: CHST2 | UniProt: Q9Y4C5 | TargetFullName: Carbohydrate sulfotransferase 2 | Organisim: human | Apparent_Kd_M: 2.36E-12

Real

Aptamer SeqId:18864-7;Target:TRY3;UniProt:P35030

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18864-7;Target: TRY3;UniProt: P35030;TargetFullName: Trypsin-3;Organisim: human;Apparent_Kd_M: 2.87E-12

Real

Aptamer SeqId: 18864-7 | Target: TRY3 | UniProt: P35030

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18864-7 | Target: TRY3 | UniProt: P35030 | TargetFullName: Trypsin-3 | Organisim: human | Apparent_Kd_M: 2.87E-12

Real

Aptamer SeqId:18866-8;Target:CANB2;UniProt:Q96LZ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18866-8;Target: CANB2;UniProt: Q96LZ3;TargetFullName: Calcineurin subunit B type 2;Organisim: human;Apparent_Kd_M: 7.6E-11

Real

Aptamer SeqId: 18866-8 | Target: CANB2 | UniProt: Q96LZ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18866-8 | Target: CANB2 | UniProt: Q96LZ3 | TargetFullName: Calcineurin subunit B type 2 | Organisim: human | Apparent_Kd_M: 7.6E-11

Real

Aptamer SeqId:18868-7;Target:CBX3;UniProt:Q13185

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18868-7;Target: CBX3;UniProt: Q13185;TargetFullName: Chromobox protein homolog 3;Organisim: human;Apparent_Kd_M: 7.81E-11

Real

Aptamer SeqId: 18868-7 | Target: CBX3 | UniProt: Q13185

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18868-7 | Target: CBX3 | UniProt: Q13185 | TargetFullName: Chromobox protein homolog 3 | Organisim: human | Apparent_Kd_M: 7.81E-11

Real

Aptamer SeqId:18870-1;Target:CD3E;UniProt:P07766

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18870-1;Target: CD3E;UniProt: P07766;TargetFullName: T-cell surface glycoprotein CD3 epsilon chain;Organisim: human;Apparent_Kd_M: 4.56E-10

Real

Aptamer SeqId: 18870-1 | Target: CD3E | UniProt: P07766

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18870-1 | Target: CD3E | UniProt: P07766 | TargetFullName: T-cell surface glycoprotein CD3 epsilon chain | Organisim: human | Apparent_Kd_M: 4.56E-10

Real

Aptamer SeqId:18871-24;Target:AIF1L;UniProt:Q9BQI0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18871-24;Target: AIF1L;UniProt: Q9BQI0;TargetFullName: Allograft inflammatory factor 1-like;Organisim: human;Apparent_Kd_M: 6.14E-12

Real

Aptamer SeqId: 18871-24 | Target: AIF1L | UniProt: Q9BQI0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18871-24 | Target: AIF1L | UniProt: Q9BQI0 | TargetFullName: Allograft inflammatory factor 1-like | Organisim: human | Apparent_Kd_M: 6.14E-12

Real

Aptamer SeqId:18873-8;Target:CEAM8;UniProt:P31997

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18873-8;Target: CEAM8;UniProt: P31997;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 8;Organisim: human;Apparent_Kd_M: 6.74E-12

Real

Aptamer SeqId: 18873-8 | Target: CEAM8 | UniProt: P31997

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18873-8 | Target: CEAM8 | UniProt: P31997 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 8 | Organisim: human | Apparent_Kd_M: 6.74E-12

Real

Aptamer SeqId:18874-66;Target:CEBPA;UniProt:P49715

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18874-66;Target: CEBPA;UniProt: P49715;TargetFullName: CCAAT/enhancer-binding protein alpha;Organisim: human;Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId: 18874-66 | Target: CEBPA | UniProt: P49715

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18874-66 | Target: CEBPA | UniProt: P49715 | TargetFullName: CCAAT/enhancer-binding protein alpha | Organisim: human | Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId:18875-125;Target:Chondrocalcin;UniProt:P02458

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18875-125;Target: Chondrocalcin;UniProt: P02458;TargetFullName: Chondrocalcin;Organisim: human;Apparent_Kd_M: 5.38E-12

Real

Aptamer SeqId: 18875-125 | Target: Chondrocalcin | UniProt: P02458

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18875-125 | Target: Chondrocalcin | UniProt: P02458 | TargetFullName: Chondrocalcin | Organisim: human | Apparent_Kd_M: 5.38E-12

Real

Aptamer SeqId:18876-77;Target:CHST4;UniProt:Q8NCG5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18876-77;Target: CHST4;UniProt: Q8NCG5;TargetFullName: Carbohydrate sulfotransferase 4;Organisim: human;Apparent_Kd_M: 7.2E-13

Real

Aptamer SeqId: 18876-77 | Target: CHST4 | UniProt: Q8NCG5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18876-77 | Target: CHST4 | UniProt: Q8NCG5 | TargetFullName: Carbohydrate sulfotransferase 4 | Organisim: human | Apparent_Kd_M: 7.2E-13

Real

Aptamer SeqId:18877-15;Target:CNN2;UniProt:Q99439

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18877-15;Target: CNN2;UniProt: Q99439;TargetFullName: Calponin-2;Organisim: human;Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId: 18877-15 | Target: CNN2 | UniProt: Q99439

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18877-15 | Target: CNN2 | UniProt: Q99439 | TargetFullName: Calponin-2 | Organisim: human | Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId:18878-15;Target:GREM1;UniProt:O60565

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18878-15;Target: GREM1;UniProt: O60565;TargetFullName: Gremlin-1;Organisim: human;Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId: 18878-15 | Target: GREM1 | UniProt: O60565

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18878-15 | Target: GREM1 | UniProt: O60565 | TargetFullName: Gremlin-1 | Organisim: human | Apparent_Kd_M: 1.13E-11

Real

Aptamer SeqId:18880-81;Target:Collagen Type III;UniProt:P02461

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18880-81;Target: Collagen Type III;UniProt: P02461;TargetFullName: Collagen Type III;Organisim: human;Apparent_Kd_M: 9.33E-12

Real

Aptamer SeqId: 18880-81 | Target: Collagen Type III | UniProt: P02461

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18880-81 | Target: Collagen Type III | UniProt: P02461 | TargetFullName: Collagen Type III | Organisim: human | Apparent_Kd_M: 9.33E-12

Real

Aptamer SeqId:18881-7;Target:CD97;UniProt:P48960

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18881-7;Target: CD97;UniProt: P48960;TargetFullName: CD97 antigen;Organisim: human;Apparent_Kd_M: 2.54E-10

Real

Aptamer SeqId: 18881-7 | Target: CD97 | UniProt: P48960

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18881-7 | Target: CD97 | UniProt: P48960 | TargetFullName: CD97 antigen | Organisim: human | Apparent_Kd_M: 2.54E-10

Real

Aptamer SeqId:18882-7;Target:CSTN2;UniProt:Q9H4D0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18882-7;Target: CSTN2;UniProt: Q9H4D0;TargetFullName: Calsyntenin-2;Organisim: human;Apparent_Kd_M: 3.81E-12

Real

Aptamer SeqId: 18882-7 | Target: CSTN2 | UniProt: Q9H4D0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18882-7 | Target: CSTN2 | UniProt: Q9H4D0 | TargetFullName: Calsyntenin-2 | Organisim: human | Apparent_Kd_M: 3.81E-12

Real

Aptamer SeqId:18883-4;Target:DEST;UniProt:P60981

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18883-4;Target: DEST;UniProt: P60981;TargetFullName: Destrin;Organisim: human;Apparent_Kd_M: 7.07E-11

Real

Aptamer SeqId: 18883-4 | Target: DEST | UniProt: P60981

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18883-4 | Target: DEST | UniProt: P60981 | TargetFullName: Destrin | Organisim: human | Apparent_Kd_M: 7.07E-11

Real

Aptamer SeqId:18884-22;Target:DNJB4;UniProt:Q9UDY4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18884-22;Target: DNJB4;UniProt: Q9UDY4;TargetFullName: DnaJ homolog subfamily B member 4;Organisim: human;Apparent_Kd_M: 2.24E-11

Real

Aptamer SeqId: 18884-22 | Target: DNJB4 | UniProt: Q9UDY4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18884-22 | Target: DNJB4 | UniProt: Q9UDY4 | TargetFullName: DnaJ homolog subfamily B member 4 | Organisim: human | Apparent_Kd_M: 2.24E-11

Real

Aptamer SeqId:18886-28;Target:DSCL1;UniProt:Q8TD84

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18886-28;Target: DSCL1;UniProt: Q8TD84;TargetFullName: Down syndrome cell adhesion molecule-like protein 1;Organisim: human;Apparent_Kd_M: 3.57E-12

Real

Aptamer SeqId: 18886-28 | Target: DSCL1 | UniProt: Q8TD84

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18886-28 | Target: DSCL1 | UniProt: Q8TD84 | TargetFullName: Down syndrome cell adhesion molecule-like protein 1 | Organisim: human | Apparent_Kd_M: 3.57E-12

Real

Aptamer SeqId:18887-7;Target:ENTP2;UniProt:Q9Y5L3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18887-7;Target: ENTP2;UniProt: Q9Y5L3;TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 2;Organisim: human;Apparent_Kd_M: 8.62E-12

Real

Aptamer SeqId: 18887-7 | Target: ENTP2 | UniProt: Q9Y5L3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18887-7 | Target: ENTP2 | UniProt: Q9Y5L3 | TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 2 | Organisim: human | Apparent_Kd_M: 8.62E-12

Real

Aptamer SeqId:18888-37;Target:FBP12;UniProt:A6NFH5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18888-37;Target: FBP12;UniProt: A6NFH5;TargetFullName: Fatty acid-binding protein 12;Organisim: human;Apparent_Kd_M: 2.96E-11

Real

Aptamer SeqId: 18888-37 | Target: FBP12 | UniProt: A6NFH5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18888-37 | Target: FBP12 | UniProt: A6NFH5 | TargetFullName: Fatty acid-binding protein 12 | Organisim: human | Apparent_Kd_M: 2.96E-11

Real

Aptamer SeqId:18890-227;Target:Fibrinogen B;UniProt:P02675

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18890-227;Target: Fibrinogen B;UniProt: P02675;TargetFullName: Fibrinogen beta chain;Organisim: human;Apparent_Kd_M: 9.13E-11

Real

Aptamer SeqId: 18890-227 | Target: Fibrinogen B | UniProt: P02675

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18890-227 | Target: Fibrinogen B | UniProt: P02675 | TargetFullName: Fibrinogen beta chain | Organisim: human | Apparent_Kd_M: 9.13E-11

Real

Aptamer SeqId:18891-98;Target:GBP2;UniProt:P32456

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18891-98;Target: GBP2;UniProt: P32456;TargetFullName: Guanylate-binding protein 2;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 18891-98 | Target: GBP2 | UniProt: P32456

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18891-98 | Target: GBP2 | UniProt: P32456 | TargetFullName: Guanylate-binding protein 2 | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:18892-48;Target:GPC4;UniProt:O75487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18892-48;Target: GPC4;UniProt: O75487;TargetFullName: Glypican-4;Organisim: human;Apparent_Kd_M: 1.27E-10

Real

Aptamer SeqId: 18892-48 | Target: GPC4 | UniProt: O75487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18892-48 | Target: GPC4 | UniProt: O75487 | TargetFullName: Glypican-4 | Organisim: human | Apparent_Kd_M: 1.27E-10

Real

Aptamer SeqId:18893-26;Target:GPR56;UniProt:Q9Y653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18893-26;Target: GPR56;UniProt: Q9Y653;TargetFullName: Adhesion G-protein coupled receptor G1;Organisim: human;Apparent_Kd_M: 3.45E-11

Real

Aptamer SeqId: 18893-26 | Target: GPR56 | UniProt: Q9Y653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18893-26 | Target: GPR56 | UniProt: Q9Y653 | TargetFullName: Adhesion G-protein coupled receptor G1 | Organisim: human | Apparent_Kd_M: 3.45E-11

Real

Aptamer SeqId:18894-1;Target:GPX2;UniProt:P18283

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18894-1;Target: GPX2;UniProt: P18283;TargetFullName: Glutathione peroxidase 2;Organisim: human;Apparent_Kd_M: 1.23E-10

Real

Aptamer SeqId: 18894-1 | Target: GPX2 | UniProt: P18283

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18894-1 | Target: GPX2 | UniProt: P18283 | TargetFullName: Glutathione peroxidase 2 | Organisim: human | Apparent_Kd_M: 1.23E-10

Real

Aptamer SeqId:18895-54;Target:GSTM4;UniProt:Q03013

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18895-54;Target: GSTM4;UniProt: Q03013;TargetFullName: Glutathione S-transferase Mu 4;Organisim: human;Apparent_Kd_M: 7.76E-11

Real

Aptamer SeqId: 18895-54 | Target: GSTM4 | UniProt: Q03013

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18895-54 | Target: GSTM4 | UniProt: Q03013 | TargetFullName: Glutathione S-transferase Mu 4 | Organisim: human | Apparent_Kd_M: 7.76E-11

Real

Aptamer SeqId:18896-23;Target:H6ST3;UniProt:Q8IZP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18896-23;Target: H6ST3;UniProt: Q8IZP7;TargetFullName: Heparan-sulfate 6-O-sulfotransferase 3;Organisim: human;Apparent_Kd_M: 3.19E-12

Real

Aptamer SeqId: 18896-23 | Target: H6ST3 | UniProt: Q8IZP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18896-23 | Target: H6ST3 | UniProt: Q8IZP7 | TargetFullName: Heparan-sulfate 6-O-sulfotransferase 3 | Organisim: human | Apparent_Kd_M: 3.19E-12

Real

Aptamer SeqId:18897-31;Target:HDAC2;UniProt:Q92769

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18897-31;Target: HDAC2;UniProt: Q92769;TargetFullName: Histone deacetylase 2;Organisim: human;Apparent_Kd_M: 2.21E-11

Real

Aptamer SeqId: 18897-31 | Target: HDAC2 | UniProt: Q92769

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18897-31 | Target: HDAC2 | UniProt: Q92769 | TargetFullName: Histone deacetylase 2 | Organisim: human | Apparent_Kd_M: 2.21E-11

Real

Aptamer SeqId:18898-36;Target:HDGL1;UniProt:Q5TGJ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18898-36;Target: HDGL1;UniProt: Q5TGJ6;TargetFullName: Hepatoma-derived growth factor-like protein 1;Organisim: human;Apparent_Kd_M: 6.62E-11

Real

Aptamer SeqId: 18898-36 | Target: HDGL1 | UniProt: Q5TGJ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18898-36 | Target: HDGL1 | UniProt: Q5TGJ6 | TargetFullName: Hepatoma-derived growth factor-like protein 1 | Organisim: human | Apparent_Kd_M: 6.62E-11

Real

Aptamer SeqId:18899-82;Target:HDGR3;UniProt:Q9Y3E1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18899-82;Target: HDGR3;UniProt: Q9Y3E1;TargetFullName: Hepatoma-derived growth factor-related protein 3;Organisim: human;Apparent_Kd_M: 6.17E-12

Real

Aptamer SeqId: 18899-82 | Target: HDGR3 | UniProt: Q9Y3E1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18899-82 | Target: HDGR3 | UniProt: Q9Y3E1 | TargetFullName: Hepatoma-derived growth factor-related protein 3 | Organisim: human | Apparent_Kd_M: 6.17E-12

Real

Aptamer SeqId:18900-37;Target:H-ras (WT);UniProt:P01112

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18900-37;Target: H-ras (WT);UniProt: P01112;TargetFullName: GTPase HRas;Organisim: human;Apparent_Kd_M: 3.49E-11

Real

Aptamer SeqId: 18900-37 | Target: H-ras (WT) | UniProt: P01112

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18900-37 | Target: H-ras (WT) | UniProt: P01112 | TargetFullName: GTPase HRas | Organisim: human | Apparent_Kd_M: 3.49E-11

Real

Aptamer SeqId:18901-26;Target:HS71B;UniProt:P0DMV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18901-26;Target: HS71B;UniProt: P0DMV9;TargetFullName: Heat shock 70 kDa protein 1B;Organisim: human;Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId: 18901-26 | Target: HS71B | UniProt: P0DMV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18901-26 | Target: HS71B | UniProt: P0DMV9 | TargetFullName: Heat shock 70 kDa protein 1B | Organisim: human | Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId:18904-23;Target:KCC4;UniProt:Q16566

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18904-23;Target: KCC4;UniProt: Q16566;TargetFullName: Calcium/calmodulin-dependent protein kinase type IV;Organisim: human;Apparent_Kd_M: 5.41E-11

Real

Aptamer SeqId: 18904-23 | Target: KCC4 | UniProt: Q16566

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18904-23 | Target: KCC4 | UniProt: Q16566 | TargetFullName: Calcium/calmodulin-dependent protein kinase type IV | Organisim: human | Apparent_Kd_M: 5.41E-11

Real

Aptamer SeqId:18905-5;Target:Keratin-16;UniProt:P08779

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18905-5;Target: Keratin-16;UniProt: P08779;TargetFullName: Keratin; type I cytoskeletal 16;Organisim: human;Apparent_Kd_M: 1.91E-10

Real

Aptamer SeqId: 18905-5 | Target: Keratin-16 | UniProt: P08779

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18905-5 | Target: Keratin-16 | UniProt: P08779 | TargetFullName: Keratin; type I cytoskeletal 16 | Organisim: human | Apparent_Kd_M: 1.91E-10

Real

Aptamer SeqId:18907-97;Target:KI3L1;UniProt:P43629

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18907-97;Target: KI3L1;UniProt: P43629;TargetFullName: Killer cell immunoglobulin-like receptor 3DL1;Organisim: human;Apparent_Kd_M: 1.66E-10

Real

Aptamer SeqId: 18907-97 | Target: KI3L1 | UniProt: P43629

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18907-97 | Target: KI3L1 | UniProt: P43629 | TargetFullName: Killer cell immunoglobulin-like receptor 3DL1 | Organisim: human | Apparent_Kd_M: 1.66E-10

Real

Aptamer SeqId:18909-11;Target:EXOS8;UniProt:Q96B26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18909-11;Target: EXOS8;UniProt: Q96B26;TargetFullName: Exosome complex component RRP43;Organisim: human;Apparent_Kd_M: 2.91E-11

Real

Aptamer SeqId: 18909-11 | Target: EXOS8 | UniProt: Q96B26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18909-11 | Target: EXOS8 | UniProt: Q96B26 | TargetFullName: Exosome complex component RRP43 | Organisim: human | Apparent_Kd_M: 2.91E-11

Real

Aptamer SeqId:18910-45;Target:LIN7A;UniProt:O14910

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18910-45;Target: LIN7A;UniProt: O14910;TargetFullName: Protein lin-7 homolog A;Organisim: human;Apparent_Kd_M: 6.21E-11

Real

Aptamer SeqId: 18910-45 | Target: LIN7A | UniProt: O14910

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18910-45 | Target: LIN7A | UniProt: O14910 | TargetFullName: Protein lin-7 homolog A | Organisim: human | Apparent_Kd_M: 6.21E-11

Real

Aptamer SeqId:18913-3;Target:Cyclin H;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18913-3;Target: Cyclin H;UniProt:;TargetFullName: Cyclin-H;Organisim: human;Apparent_Kd_M: 3.72E-12

Real

Aptamer SeqId: 18913-3 | Target: Cyclin H | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18913-3 | Target: Cyclin H | UniProt: | TargetFullName: Cyclin-H | Organisim: human | Apparent_Kd_M: 3.72E-12

Real

Aptamer SeqId:18914-188;Target:PAFA2;UniProt:Q99487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18914-188;Target: PAFA2;UniProt: Q99487;TargetFullName: Platelet-activating factor acetylhydrolase 2; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.92E-11

Real

Aptamer SeqId: 18914-188 | Target: PAFA2 | UniProt: Q99487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18914-188 | Target: PAFA2 | UniProt: Q99487 | TargetFullName: Platelet-activating factor acetylhydrolase 2; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.92E-11

Real

Aptamer SeqId:18916-25;Target:Inosine triphosphatase;UniProt:Q9BY32

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18916-25;Target: Inosine triphosphatase;UniProt: Q9BY32;TargetFullName: Inosine triphosphate pyrophosphatase;Organisim: human;Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId: 18916-25 | Target: Inosine triphosphatase | UniProt: Q9BY32

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18916-25 | Target: Inosine triphosphatase | UniProt: Q9BY32 | TargetFullName: Inosine triphosphate pyrophosphatase | Organisim: human | Apparent_Kd_M: 1.18E-11

Real

Aptamer SeqId:18917-53;Target:Pancreatic alpha-amylase;UniProt:P04746

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18917-53;Target: Pancreatic alpha-amylase;UniProt: P04746;TargetFullName: Pancreatic alpha-amylase;Organisim: human;Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId: 18917-53 | Target: Pancreatic alpha-amylase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18917-53 | Target: Pancreatic alpha-amylase | UniProt: P04746 | TargetFullName: Pancreatic alpha-amylase | Organisim: human | Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId:18918-86;Target:PDE4A;UniProt:P27815

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18918-86;Target: PDE4A;UniProt: P27815;TargetFullName: cAMP-specific 3;5-cyclic phosphodiesterase 4A;Organisim: human;Apparent_Kd_M: 7.82E-11

Real

Aptamer SeqId: 18918-86 | Target: PDE4A | UniProt: P27815

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18918-86 | Target: PDE4A | UniProt: P27815 | TargetFullName: cAMP-specific 3';5'-cyclic phosphodiesterase 4A | Organisim: human | Apparent_Kd_M: 7.82E-11

Real

Aptamer SeqId:18921-30;Target:PHEX;UniProt:P78562

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18921-30;Target: PHEX;UniProt: P78562;TargetFullName: Phosphate-regulating neutral endopeptidase;Organisim: human;Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId: 18921-30 | Target: PHEX | UniProt: P78562

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18921-30 | Target: PHEX | UniProt: P78562 | TargetFullName: Phosphate-regulating neutral endopeptidase | Organisim: human | Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId:18922-27;Target:CD68;UniProt:P34810

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18922-27;Target: CD68;UniProt: P34810;TargetFullName: Macrosialin;Organisim: human;Apparent_Kd_M: 1.75E-10

Real

Aptamer SeqId: 18922-27 | Target: CD68 | UniProt: P34810

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18922-27 | Target: CD68 | UniProt: P34810 | TargetFullName: Macrosialin | Organisim: human | Apparent_Kd_M: 1.75E-10

Real

Aptamer SeqId:18925-24;Target:Proteasome subunit alpha type 5;UniProt:P28066

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18925-24;Target: Proteasome subunit alpha type 5;UniProt: P28066;TargetFullName: Proteasome subunit alpha type-5;Organisim: human;Apparent_Kd_M: 1.19E-10

Real

Aptamer SeqId: 18925-24 | Target: Proteasome subunit alpha type 5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18925-24 | Target: Proteasome subunit alpha type 5 | UniProt: P28066 | TargetFullName: Proteasome subunit alpha type-5 | Organisim: human | Apparent_Kd_M: 1.19E-10

Real

Aptamer SeqId:18926-7;Target:PSA3;UniProt:P25788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18926-7;Target: PSA3;UniProt: P25788;TargetFullName: Proteasome subunit alpha type-3;Organisim: human;Apparent_Kd_M: 7.57E-11

Real

Aptamer SeqId: 18926-7 | Target: PSA3 | UniProt: P25788

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18926-7 | Target: PSA3 | UniProt: P25788 | TargetFullName: Proteasome subunit alpha type-3 | Organisim: human | Apparent_Kd_M: 7.57E-11

Real

Aptamer SeqId:18927-14;Target:RET1G;UniProt:Q6H3X3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18927-14;Target: RET1G;UniProt: Q6H3X3;TargetFullName: Retinoic acid early transcript 1G protein;Organisim: human;Apparent_Kd_M: 1.3E-10

Real

Aptamer SeqId: 18927-14 | Target: RET1G | UniProt: Q6H3X3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18927-14 | Target: RET1G | UniProt: Q6H3X3 | TargetFullName: Retinoic acid early transcript 1G protein | Organisim: human | Apparent_Kd_M: 1.3E-10

Real

Aptamer SeqId:18928-10;Target:S100Z;UniProt:Q8WXG8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18928-10;Target: S100Z;UniProt: Q8WXG8;TargetFullName: Protein S100-Z;Organisim: human;Apparent_Kd_M: 6.25E-12

Real

Aptamer SeqId: 18928-10 | Target: S100Z | UniProt: Q8WXG8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18928-10 | Target: S100Z | UniProt: Q8WXG8 | TargetFullName: Protein S100-Z | Organisim: human | Apparent_Kd_M: 6.25E-12

Real

Aptamer SeqId:18930-28;Target:SLIT2;UniProt:O94813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18930-28;Target: SLIT2;UniProt: O94813;TargetFullName: Slit homolog 2 protein;Organisim: human;Apparent_Kd_M: 2.485481E-12

Real

Aptamer SeqId: 18930-28 | Target: SLIT2 | UniProt: O94813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18930-28 | Target: SLIT2 | UniProt: O94813 | TargetFullName: Slit homolog 2 protein | Organisim: human | Apparent_Kd_M: 2.485481E-12

Real

Aptamer SeqId:18931-40;Target:SLIT3;UniProt:O75094

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18931-40;Target: SLIT3;UniProt: O75094;TargetFullName: Slit homolog 3 protein;Organisim: human;Apparent_Kd_M: 5.44E-11

Real

Aptamer SeqId: 18931-40 | Target: SLIT3 | UniProt: O75094

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18931-40 | Target: SLIT3 | UniProt: O75094 | TargetFullName: Slit homolog 3 protein | Organisim: human | Apparent_Kd_M: 5.44E-11

Real

Aptamer SeqId:18932-84;Target:NMNA1;UniProt:Q9HAN9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18932-84;Target: NMNA1;UniProt: Q9HAN9;TargetFullName: Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1;Organisim: human;Apparent_Kd_M: 1.46E-10

Real

Aptamer SeqId: 18932-84 | Target: NMNA1 | UniProt: Q9HAN9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18932-84 | Target: NMNA1 | UniProt: Q9HAN9 | TargetFullName: Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 | Organisim: human | Apparent_Kd_M: 1.46E-10

Real

Aptamer SeqId:18933-4;Target:TGM4;UniProt:P49221

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18933-4;Target: TGM4;UniProt: P49221;TargetFullName: Protein-glutamine gamma-glutamyltransferase 4;Organisim: human;Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId: 18933-4 | Target: TGM4 | UniProt: P49221

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18933-4 | Target: TGM4 | UniProt: P49221 | TargetFullName: Protein-glutamine gamma-glutamyltransferase 4 | Organisim: human | Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId:18934-50;Target:Tissue transglutaminase;UniProt:P21980

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18934-50;Target: Tissue transglutaminase;UniProt: P21980;TargetFullName: Protein-glutamine gamma-glutamyltransferase 2;Organisim: human;Apparent_Kd_M: 1.95E-11

Real

Aptamer SeqId: 18934-50 | Target: Tissue transglutaminase | UniProt: P21980

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18934-50 | Target: Tissue transglutaminase | UniProt: P21980 | TargetFullName: Protein-glutamine gamma-glutamyltransferase 2 | Organisim: human | Apparent_Kd_M: 1.95E-11

Real

Aptamer SeqId:18935-14;Target:TLR5;UniProt:O60602

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18935-14;Target: TLR5;UniProt: O60602;TargetFullName: Toll-like receptor 5;Organisim: human;Apparent_Kd_M: 5.23E-11

Real

Aptamer SeqId: 18935-14 | Target: TLR5 | UniProt: O60602

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18935-14 | Target: TLR5 | UniProt: O60602 | TargetFullName: Toll-like receptor 5 | Organisim: human | Apparent_Kd_M: 5.23E-11

Real

Aptamer SeqId:18938-3;Target:VLDLR;UniProt:P98155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18938-3;Target: VLDLR;UniProt: P98155;TargetFullName: Very low-density lipoprotein receptor;Organisim: human;Apparent_Kd_M: 1.64E-10

Real

Aptamer SeqId: 18938-3 | Target: VLDLR | UniProt: P98155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18938-3 | Target: VLDLR | UniProt: P98155 | TargetFullName: Very low-density lipoprotein receptor | Organisim: human | Apparent_Kd_M: 1.64E-10

Real

Aptamer SeqId:18942-11;Target:PSB9;UniProt:P28065

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18942-11;Target: PSB9;UniProt: P28065;TargetFullName: Proteasome subunit beta type-9;Organisim: human;Apparent_Kd_M: 5.57E-11

Real

Aptamer SeqId: 18942-11 | Target: PSB9 | UniProt: P28065

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18942-11 | Target: PSB9 | UniProt: P28065 | TargetFullName: Proteasome subunit beta type-9 | Organisim: human | Apparent_Kd_M: 5.57E-11

Real

Aptamer SeqId:18943-4;Target:PTGR2;UniProt:Q8N8N7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18943-4;Target: PTGR2;UniProt: Q8N8N7;TargetFullName: Prostaglandin reductase 2;Organisim: human;Apparent_Kd_M: 3.27E-11

Real

Aptamer SeqId: 18943-4 | Target: PTGR2 | UniProt: Q8N8N7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18943-4 | Target: PTGR2 | UniProt: Q8N8N7 | TargetFullName: Prostaglandin reductase 2 | Organisim: human | Apparent_Kd_M: 3.27E-11

Real

Aptamer SeqId:18945-11;Target:RGS1;UniProt:Q08116

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18945-11;Target: RGS1;UniProt: Q08116;TargetFullName: Regulator of G-protein signaling 1;Organisim: human;Apparent_Kd_M: 1.14E-10

Real

Aptamer SeqId: 18945-11 | Target: RGS1 | UniProt: Q08116

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18945-11 | Target: RGS1 | UniProt: Q08116 | TargetFullName: Regulator of G-protein signaling 1 | Organisim: human | Apparent_Kd_M: 1.14E-10

Real

Aptamer SeqId:18947-3;Target:LRC3B;UniProt:Q96PB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18947-3;Target: LRC3B;UniProt: Q96PB8;TargetFullName: Leucine-rich repeat-containing protein 3B;Organisim: human;Apparent_Kd_M: 9.89E-11

Real

Aptamer SeqId: 18947-3 | Target: LRC3B | UniProt: Q96PB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18947-3 | Target: LRC3B | UniProt: Q96PB8 | TargetFullName: Leucine-rich repeat-containing protein 3B | Organisim: human | Apparent_Kd_M: 9.89E-11

Real

Aptamer SeqId:18950-13;Target:RAC2;UniProt:P15153

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 18950-13;Target: RAC2;UniProt: P15153;TargetFullName: Ras-related C3 botulinum toxin substrate 2;Organisim: human;Apparent_Kd_M: 2.58E-10

Real

Aptamer SeqId: 18950-13 | Target: RAC2 | UniProt: P15153

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 18950-13 | Target: RAC2 | UniProt: P15153 | TargetFullName: Ras-related C3 botulinum toxin substrate 2 | Organisim: human | Apparent_Kd_M: 2.58E-10

Real

Aptamer SeqId:19108-50;Target:MECP2;UniProt:P51608

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19108-50;Target: MECP2;UniProt: P51608;TargetFullName: Methyl-CpG-binding protein 2;Organisim: human;Apparent_Kd_M: 4.6E-11

Real

Aptamer SeqId: 19108-50 | Target: MECP2 | UniProt: P51608

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19108-50 | Target: MECP2 | UniProt: P51608 | TargetFullName: Methyl-CpG-binding protein 2 | Organisim: human | Apparent_Kd_M: 4.6E-11

Real

Aptamer SeqId:19109-32;Target:TCAL8;UniProt:Q8IYN2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19109-32;Target: TCAL8;UniProt: Q8IYN2;TargetFullName: Transcription elongation factor A protein-like 8;Organisim: human;Apparent_Kd_M: 7.925254E-11

Real

Aptamer SeqId: 19109-32 | Target: TCAL8 | UniProt: Q8IYN2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19109-32 | Target: TCAL8 | UniProt: Q8IYN2 | TargetFullName: Transcription elongation factor A protein-like 8 | Organisim: human | Apparent_Kd_M: 7.925254E-11

Real

Aptamer SeqId:19110-6;Target:MEMO1;UniProt:Q9Y316

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19110-6;Target: MEMO1;UniProt: Q9Y316;TargetFullName: Protein MEMO1;Organisim: human;Apparent_Kd_M: 4.72E-11

Real

Aptamer SeqId: 19110-6 | Target: MEMO1 | UniProt: Q9Y316

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19110-6 | Target: MEMO1 | UniProt: Q9Y316 | TargetFullName: Protein MEMO1 | Organisim: human | Apparent_Kd_M: 4.72E-11

Real

Aptamer SeqId:19111-10;Target:UBC12;UniProt:P61081

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19111-10;Target: UBC12;UniProt: P61081;TargetFullName: NEDD8-conjugating enzyme Ubc12;Organisim: human;Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId: 19111-10 | Target: UBC12 | UniProt: P61081

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19111-10 | Target: UBC12 | UniProt: P61081 | TargetFullName: NEDD8-conjugating enzyme Ubc12 | Organisim: human | Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId:19112-2;Target:TCAL3;UniProt:Q969E4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19112-2;Target: TCAL3;UniProt: Q969E4;TargetFullName: Transcription elongation factor A protein-like 3;Organisim: human;Apparent_Kd_M: 2.34E-11

Real

Aptamer SeqId: 19112-2 | Target: TCAL3 | UniProt: Q969E4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19112-2 | Target: TCAL3 | UniProt: Q969E4 | TargetFullName: Transcription elongation factor A protein-like 3 | Organisim: human | Apparent_Kd_M: 2.34E-11

Real

Aptamer SeqId:19113-66;Target:SH3L2;UniProt:Q9UJC5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19113-66;Target: SH3L2;UniProt: Q9UJC5;TargetFullName: SH3 domain-binding glutamic acid-rich-like protein 2;Organisim: human;Apparent_Kd_M: 5.78E-12

Real

Aptamer SeqId: 19113-66 | Target: SH3L2 | UniProt: Q9UJC5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19113-66 | Target: SH3L2 | UniProt: Q9UJC5 | TargetFullName: SH3 domain-binding glutamic acid-rich-like protein 2 | Organisim: human | Apparent_Kd_M: 5.78E-12

Real

Aptamer SeqId:19114-8;Target:KITM;UniProt:O00142

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19114-8;Target: KITM;UniProt: O00142;TargetFullName: Thymidine kinase 2; mitochondrial;Organisim: human;Apparent_Kd_M: 4.0E-11

Real

Aptamer SeqId: 19114-8 | Target: KITM | UniProt: O00142

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19114-8 | Target: KITM | UniProt: O00142 | TargetFullName: Thymidine kinase 2; mitochondrial | Organisim: human | Apparent_Kd_M: 4.0E-11

Real

Aptamer SeqId:19115-13;Target:CMBL;UniProt:Q96DG6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19115-13;Target: CMBL;UniProt: Q96DG6;TargetFullName: Carboxymethylenebutenolidase homolog;Organisim: human;Apparent_Kd_M: 2.166089E-10

Real

Aptamer SeqId: 19115-13 | Target: CMBL | UniProt: Q96DG6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19115-13 | Target: CMBL | UniProt: Q96DG6 | TargetFullName: Carboxymethylenebutenolidase homolog | Organisim: human | Apparent_Kd_M: 2.166089E-10

Real

Aptamer SeqId:19116-1;Target:MUTED;UniProt:Q8TDH9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19116-1;Target: MUTED;UniProt: Q8TDH9;TargetFullName: Biogenesis of lysosome-related organelles complex 1 subunit 5;Organisim: human;Apparent_Kd_M: 2.27E-10

Real

Aptamer SeqId: 19116-1 | Target: MUTED | UniProt: Q8TDH9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19116-1 | Target: MUTED | UniProt: Q8TDH9 | TargetFullName: Biogenesis of lysosome-related organelles complex 1 subunit 5 | Organisim: human | Apparent_Kd_M: 2.27E-10

Real

Aptamer SeqId:19117-3;Target:PP14A;UniProt:Q96A00

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19117-3;Target: PP14A;UniProt: Q96A00;TargetFullName: Protein phosphatase 1 regulatory subunit 14A;Organisim: human;Apparent_Kd_M: 9.64E-12

Real

Aptamer SeqId: 19117-3 | Target: PP14A | UniProt: Q96A00

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19117-3 | Target: PP14A | UniProt: Q96A00 | TargetFullName: Protein phosphatase 1 regulatory subunit 14A | Organisim: human | Apparent_Kd_M: 9.64E-12

Real

Aptamer SeqId:19118-47;Target:OSTF1;UniProt:Q92882

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19118-47;Target: OSTF1;UniProt: Q92882;TargetFullName: Osteoclast-stimulating factor 1;Organisim: human;Apparent_Kd_M: 4.51E-11

Real

Aptamer SeqId: 19118-47 | Target: OSTF1 | UniProt: Q92882

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19118-47 | Target: OSTF1 | UniProt: Q92882 | TargetFullName: Osteoclast-stimulating factor 1 | Organisim: human | Apparent_Kd_M: 4.51E-11

Real

Aptamer SeqId:19119-10;Target:DDIT3;UniProt:P35638

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19119-10;Target: DDIT3;UniProt: P35638;TargetFullName: DNA damage-inducible transcript 3 protein;Organisim: human;Apparent_Kd_M: 4.849107E-11

Real

Aptamer SeqId: 19119-10 | Target: DDIT3 | UniProt: P35638

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19119-10 | Target: DDIT3 | UniProt: P35638 | TargetFullName: DNA damage-inducible transcript 3 protein | Organisim: human | Apparent_Kd_M: 4.849107E-11

Real

Aptamer SeqId:19120-33;Target:OXDA;UniProt:P14920

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19120-33;Target: OXDA;UniProt: P14920;TargetFullName: D-amino-acid oxidase;Organisim: human;Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId: 19120-33 | Target: OXDA | UniProt: P14920

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19120-33 | Target: OXDA | UniProt: P14920 | TargetFullName: D-amino-acid oxidase | Organisim: human | Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId:19121-3;Target:UBQL2;UniProt:Q9UHD9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19121-3;Target: UBQL2;UniProt: Q9UHD9;TargetFullName: Ubiquilin-2;Organisim: human;Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId: 19121-3 | Target: UBQL2 | UniProt: Q9UHD9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19121-3 | Target: UBQL2 | UniProt: Q9UHD9 | TargetFullName: Ubiquilin-2 | Organisim: human | Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId:19122-47;Target:ML12B;UniProt:O14950

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19122-47;Target: ML12B;UniProt: O14950;TargetFullName: Myosin regulatory light chain 12B;Organisim: human;Apparent_Kd_M: 5.62E-11

Real

Aptamer SeqId: 19122-47 | Target: ML12B | UniProt: O14950

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19122-47 | Target: ML12B | UniProt: O14950 | TargetFullName: Myosin regulatory light chain 12B | Organisim: human | Apparent_Kd_M: 5.62E-11

Real

Aptamer SeqId:19123-6;Target:IKBD;UniProt:Q8NI38

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19123-6;Target: IKBD;UniProt: Q8NI38;TargetFullName: NF-kappa-B inhibitor delta;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 19123-6 | Target: IKBD | UniProt: Q8NI38

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19123-6 | Target: IKBD | UniProt: Q8NI38 | TargetFullName: NF-kappa-B inhibitor delta | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:19124-9;Target:UBCP1;UniProt:Q8WVY7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19124-9;Target: UBCP1;UniProt: Q8WVY7;TargetFullName: Ubiquitin-like domain-containing CTD phosphatase 1;Organisim: human;Apparent_Kd_M: 4.53E-12

Real

Aptamer SeqId: 19124-9 | Target: UBCP1 | UniProt: Q8WVY7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19124-9 | Target: UBCP1 | UniProt: Q8WVY7 | TargetFullName: Ubiquitin-like domain-containing CTD phosphatase 1 | Organisim: human | Apparent_Kd_M: 4.53E-12

Real

Aptamer SeqId:19125-26;Target:KAP2;UniProt:P13861

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19125-26;Target: KAP2;UniProt: P13861;TargetFullName: cAMP-dependent protein kinase type II-alpha regulatory subunit;Organisim: human;Apparent_Kd_M: 3.69E-11

Real

Aptamer SeqId: 19125-26 | Target: KAP2 | UniProt: P13861

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19125-26 | Target: KAP2 | UniProt: P13861 | TargetFullName: cAMP-dependent protein kinase type II-alpha regulatory subunit | Organisim: human | Apparent_Kd_M: 3.69E-11

Real

Aptamer SeqId:19126-4;Target:C20orf77;UniProt:Q9NQG5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19126-4;Target: C20orf77;UniProt: Q9NQG5;TargetFullName: Regulation of nuclear pre-mRNA domain-containing protein 1B;Organisim: human;Apparent_Kd_M: 1.212425E-11

Real

Aptamer SeqId: 19126-4 | Target: C20orf77 | UniProt: Q9NQG5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19126-4 | Target: C20orf77 | UniProt: Q9NQG5 | TargetFullName: Regulation of nuclear pre-mRNA domain-containing protein 1B | Organisim: human | Apparent_Kd_M: 1.212425E-11

Real

Aptamer SeqId:19127-1;Target:HSPB6;UniProt:O14558

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19127-1;Target: HSPB6;UniProt: O14558;TargetFullName: Heat shock protein beta-6;Organisim: human;Apparent_Kd_M: 3.92E-11

Real

Aptamer SeqId: 19127-1 | Target: HSPB6 | UniProt: O14558

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19127-1 | Target: HSPB6 | UniProt: O14558 | TargetFullName: Heat shock protein beta-6 | Organisim: human | Apparent_Kd_M: 3.92E-11

Real

Aptamer SeqId:19129-15;Target:MTHFSD;UniProt:Q2M296

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19129-15;Target: MTHFSD;UniProt: Q2M296;TargetFullName: Methenyltetrahydrofolate synthase domain-containing protein;Organisim: human;Apparent_Kd_M: 6.41E-12

Real

Aptamer SeqId: 19129-15 | Target: MTHFSD | UniProt: Q2M296

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19129-15 | Target: MTHFSD | UniProt: Q2M296 | TargetFullName: Methenyltetrahydrofolate synthase domain-containing protein | Organisim: human | Apparent_Kd_M: 6.41E-12

Real

Aptamer SeqId:19130-81;Target:SPB8;UniProt:P50452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19130-81;Target: SPB8;UniProt: P50452;TargetFullName: Serpin B8;Organisim: human;Apparent_Kd_M: 8.31E-12

Real

Aptamer SeqId: 19130-81 | Target: SPB8 | UniProt: P50452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19130-81 | Target: SPB8 | UniProt: P50452 | TargetFullName: Serpin B8 | Organisim: human | Apparent_Kd_M: 8.31E-12

Real

Aptamer SeqId:19131-184;Target:TIAR;UniProt:Q01085

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19131-184;Target: TIAR;UniProt: Q01085;TargetFullName: Nucleolysin TIAR;Organisim: human;Apparent_Kd_M: 1.11E-12

Real

Aptamer SeqId: 19131-184 | Target: TIAR | UniProt: Q01085

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19131-184 | Target: TIAR | UniProt: Q01085 | TargetFullName: Nucleolysin TIAR | Organisim: human | Apparent_Kd_M: 1.11E-12

Real

Aptamer SeqId:19132-1;Target:RM02;UniProt:Q5T653

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19132-1;Target: RM02;UniProt: Q5T653;TargetFullName: 39S ribosomal protein L2; mitochondrial;Organisim: human;Apparent_Kd_M: 4.38E-11

Real

Aptamer SeqId: 19132-1 | Target: RM02 | UniProt: Q5T653

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19132-1 | Target: RM02 | UniProt: Q5T653 | TargetFullName: 39S ribosomal protein L2; mitochondrial | Organisim: human | Apparent_Kd_M: 4.38E-11

Real

Aptamer SeqId:19134-66;Target:RPAB4;UniProt:P53803

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19134-66;Target: RPAB4;UniProt: P53803;TargetFullName: DNA-directed RNA polymerases I; II; and III subunit RPABC4;Organisim: human;Apparent_Kd_M: 1.98E-11

Real

Aptamer SeqId: 19134-66 | Target: RPAB4 | UniProt: P53803

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19134-66 | Target: RPAB4 | UniProt: P53803 | TargetFullName: DNA-directed RNA polymerases I; II; and III subunit RPABC4 | Organisim: human | Apparent_Kd_M: 1.98E-11

Real

Aptamer SeqId:19135-5;Target:Cytosolic 5-nucleotidase protein;UniProt:Q969T7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19135-5;Target: Cytosolic 5-nucleotidase III-like protein;UniProt: Q969T7;TargetFullName: 7-methylguanosine phosphate-specific 5-nucleotidase;Organisim: human;Apparent_Kd_M: 3.694275E-11

Real

Aptamer SeqId: 19135-5 | Target: Cytosolic 5-nucleotidase III-like protein

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19135-5 | Target: Cytosolic 5'-nucleotidase III-like protein | UniProt: Q969T7 | TargetFullName: 7-methylguanosine phosphate-specific 5'-nucleotidase | Organisim: human | Apparent_Kd_M: 3.694275E-11

Real

Aptamer SeqId:19136-22;Target:MMSA;UniProt:Q02252

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19136-22;Target: MMSA;UniProt: Q02252;TargetFullName: Methylmalonate-semialdehyde dehydrogenase [acylating]; mitochondrial;Organisim: human;Apparent_Kd_M: 8.606591E-12

Real

Aptamer SeqId: 19136-22 | Target: MMSA | UniProt: Q02252

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19136-22 | Target: MMSA | UniProt: Q02252 | TargetFullName: Methylmalonate-semialdehyde dehydrogenase acylating; mitochondrial | Organisim: human | Apparent_Kd_M: 8.606591E-12

Real

Aptamer SeqId:19139-3;Target:HSF2B;UniProt:O75031

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19139-3;Target: HSF2B;UniProt: O75031;TargetFullName: Heat shock factor 2-binding protein;Organisim: human;Apparent_Kd_M: 3.199085E-11

Real

Aptamer SeqId: 19139-3 | Target: HSF2B | UniProt: O75031

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19139-3 | Target: HSF2B | UniProt: O75031 | TargetFullName: Heat shock factor 2-binding protein | Organisim: human | Apparent_Kd_M: 3.199085E-11

Real

Aptamer SeqId:19141-22;Target:DAP1;UniProt:P51397

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19141-22;Target: DAP1;UniProt: P51397;TargetFullName: Death-associated protein 1;Organisim: human;Apparent_Kd_M: 2.788486E-11

Real

Aptamer SeqId: 19141-22 | Target: DAP1 | UniProt: P51397

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19141-22 | Target: DAP1 | UniProt: P51397 | TargetFullName: Death-associated protein 1 | Organisim: human | Apparent_Kd_M: 2.788486E-11

Real

Aptamer SeqId:19142-39;Target:DNM3L;UniProt:Q9UJW3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19142-39;Target: DNM3L;UniProt: Q9UJW3;TargetFullName: DNA (cytosine-5)-methyltransferase 3-like;Organisim: human;Apparent_Kd_M: 5.01659E-12

Real

Aptamer SeqId: 19142-39 | Target: DNM3L | UniProt: Q9UJW3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19142-39 | Target: DNM3L | UniProt: Q9UJW3 | TargetFullName: DNA (cytosine-5)-methyltransferase 3-like | Organisim: human | Apparent_Kd_M: 5.01659E-12

Real

Aptamer SeqId:19143-38;Target:NB5R2;UniProt:Q6BCY4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19143-38;Target: NB5R2;UniProt: Q6BCY4;TargetFullName: NADH-cytochrome b5 reductase 2;Organisim: human;Apparent_Kd_M: 1.813018E-12

Real

Aptamer SeqId: 19143-38 | Target: NB5R2 | UniProt: Q6BCY4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19143-38 | Target: NB5R2 | UniProt: Q6BCY4 | TargetFullName: NADH-cytochrome b5 reductase 2 | Organisim: human | Apparent_Kd_M: 1.813018E-12

Real

Aptamer SeqId:19144-9;Target:ITF2;UniProt:P15884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19144-9;Target: ITF2;UniProt: P15884;TargetFullName: Transcription factor 4;Organisim: human;Apparent_Kd_M: 7.501491E-12

Real

Aptamer SeqId: 19144-9 | Target: ITF2 | UniProt: P15884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19144-9 | Target: ITF2 | UniProt: P15884 | TargetFullName: Transcription factor 4 | Organisim: human | Apparent_Kd_M: 7.501491E-12

Real

Aptamer SeqId:19145-4;Target:MREG;UniProt:Q8N565

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19145-4;Target: MREG;UniProt: Q8N565;TargetFullName: Melanoregulin;Organisim: human;Apparent_Kd_M: 7.897401E-12

Real

Aptamer SeqId: 19145-4 | Target: MREG | UniProt: Q8N565

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19145-4 | Target: MREG | UniProt: Q8N565 | TargetFullName: Melanoregulin | Organisim: human | Apparent_Kd_M: 7.897401E-12

Real

Aptamer SeqId:19147-6;Target:PP13;UniProt:Q9UHV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19147-6;Target: PP13;UniProt: Q9UHV8;TargetFullName: Galactoside-binding soluble lectin 13;Organisim: human;Apparent_Kd_M: 9.172513E-11

Real

Aptamer SeqId: 19147-6 | Target: PP13 | UniProt: Q9UHV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19147-6 | Target: PP13 | UniProt: Q9UHV8 | TargetFullName: Galactoside-binding soluble lectin 13 | Organisim: human | Apparent_Kd_M: 9.172513E-11

Real

Aptamer SeqId:19148-58;Target:TIM8A;UniProt:O60220

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19148-58;Target: TIM8A;UniProt: O60220;TargetFullName: Mitochondrial import inner membrane translocase subunit Tim8 A;Organisim: human;Apparent_Kd_M: 9.132771E-12

Real

Aptamer SeqId: 19148-58 | Target: TIM8A | UniProt: O60220

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19148-58 | Target: TIM8A | UniProt: O60220 | TargetFullName: Mitochondrial import inner membrane translocase subunit Tim8 A | Organisim: human | Apparent_Kd_M: 9.132771E-12

Real

Aptamer SeqId:19150-20;Target:KPRB;UniProt:O60256

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19150-20;Target: KPRB;UniProt: O60256;TargetFullName: Phosphoribosyl pyrophosphate synthase-associated protein 2;Organisim: human;Apparent_Kd_M: 9.321001E-12

Real

Aptamer SeqId: 19150-20 | Target: KPRB | UniProt: O60256

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19150-20 | Target: KPRB | UniProt: O60256 | TargetFullName: Phosphoribosyl pyrophosphate synthase-associated protein 2 | Organisim: human | Apparent_Kd_M: 9.321001E-12

Real

Aptamer SeqId:19152-4;Target:IPP2;UniProt:P41236

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19152-4;Target: IPP2;UniProt: P41236;TargetFullName: Protein phosphatase inhibitor 2;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 19152-4 | Target: IPP2 | UniProt: P41236

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19152-4 | Target: IPP2 | UniProt: P41236 | TargetFullName: Protein phosphatase inhibitor 2 | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:19153-53;Target:MPPD2;UniProt:Q15777

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19153-53;Target: MPPD2;UniProt: Q15777;TargetFullName: Metallophosphoesterase MPPED2;Organisim: human;Apparent_Kd_M: 4.077022E-11

Real

Aptamer SeqId: 19153-53 | Target: MPPD2 | UniProt: Q15777

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19153-53 | Target: MPPD2 | UniProt: Q15777 | TargetFullName: Metallophosphoesterase MPPED2 | Organisim: human | Apparent_Kd_M: 4.077022E-11

Real

Aptamer SeqId:19154-41;Target:Protease nexin I;UniProt:P07093

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19154-41;Target: Protease nexin I;UniProt: P07093;TargetFullName: Glia-derived nexin;Organisim: human;Apparent_Kd_M: 1.059498E-12

Real

Aptamer SeqId: 19154-41 | Target: Protease nexin I | UniProt: P07093

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19154-41 | Target: Protease nexin I | UniProt: P07093 | TargetFullName: Glia-derived nexin | Organisim: human | Apparent_Kd_M: 1.059498E-12

Real

Aptamer SeqId:19158-1;Target:PAF;UniProt:Q15004

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19158-1;Target: PAF;UniProt: Q15004;TargetFullName: PCNA-associated factor;Organisim: human;Apparent_Kd_M: 2.144228E-11

Real

Aptamer SeqId: 19158-1 | Target: PAF | UniProt: Q15004

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19158-1 | Target: PAF | UniProt: Q15004 | TargetFullName: PCNA-associated factor | Organisim: human | Apparent_Kd_M: 2.144228E-11

Real

Aptamer SeqId:19159-9;Target:DNA polymerase subunit delta 4;UniProt:Q9HCU8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19159-9;Target: DNA polymerase subunit delta 4;UniProt: Q9HCU8;TargetFullName: DNA polymerase delta subunit 4;Organisim: human;Apparent_Kd_M: 8.302115E-11

Real

Aptamer SeqId: 19159-9 | Target: DNA polymerase subunit delta 4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19159-9 | Target: DNA polymerase subunit delta 4 | UniProt: Q9HCU8 | TargetFullName: DNA polymerase delta subunit 4 | Organisim: human | Apparent_Kd_M: 8.302115E-11

Real

Aptamer SeqId:19161-1;Target:UBP15;UniProt:Q9Y4E8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19161-1;Target: UBP15;UniProt: Q9Y4E8;TargetFullName: Ubiquitin carboxyl-terminal hydrolase 15;Organisim: human;Apparent_Kd_M: 5.533908E-12

Real

Aptamer SeqId: 19161-1 | Target: UBP15 | UniProt: Q9Y4E8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19161-1 | Target: UBP15 | UniProt: Q9Y4E8 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase 15 | Organisim: human | Apparent_Kd_M: 5.533908E-12

Real

Aptamer SeqId:19163-26;Target:LRC59;UniProt:Q96AG4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19163-26;Target: LRC59;UniProt: Q96AG4;TargetFullName: Leucine-rich repeat-containing protein 59;Organisim: human;Apparent_Kd_M: 8.970088E-12

Real

Aptamer SeqId: 19163-26 | Target: LRC59 | UniProt: Q96AG4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19163-26 | Target: LRC59 | UniProt: Q96AG4 | TargetFullName: Leucine-rich repeat-containing protein 59 | Organisim: human | Apparent_Kd_M: 8.970088E-12

Real

Aptamer SeqId:19166-15;Target:RS19;UniProt:P39019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19166-15;Target: RS19;UniProt: P39019;TargetFullName: 40S ribosomal protein S19;Organisim: human;Apparent_Kd_M: 1.264089E-11

Real

Aptamer SeqId: 19166-15 | Target: RS19 | UniProt: P39019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19166-15 | Target: RS19 | UniProt: P39019 | TargetFullName: 40S ribosomal protein S19 | Organisim: human | Apparent_Kd_M: 1.264089E-11

Real

Aptamer SeqId:19168-71;Target:PPIP1;UniProt:O43586

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19168-71;Target: PPIP1;UniProt: O43586;TargetFullName: Proline-serine-threonine phosphatase-interacting protein 1;Organisim: human;Apparent_Kd_M: 7.223435E-12

Real

Aptamer SeqId: 19168-71 | Target: PPIP1 | UniProt: O43586

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19168-71 | Target: PPIP1 | UniProt: O43586 | TargetFullName: Proline-serine-threonine phosphatase-interacting protein 1 | Organisim: human | Apparent_Kd_M: 7.223435E-12

Real

Aptamer SeqId:19169-88;Target:FIBP;UniProt:O43427

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19169-88;Target: FIBP;UniProt: O43427;TargetFullName: Acidic fibroblast growth factor intracellular-binding protein;Organisim: human;Apparent_Kd_M: 6.521447E-12

Real

Aptamer SeqId: 19169-88 | Target: FIBP | UniProt: O43427

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19169-88 | Target: FIBP | UniProt: O43427 | TargetFullName: Acidic fibroblast growth factor intracellular-binding protein | Organisim: human | Apparent_Kd_M: 6.521447E-12

Real

Aptamer SeqId:19170-25;Target:DPOE3;UniProt:Q9NRF9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19170-25;Target: DPOE3;UniProt: Q9NRF9;TargetFullName: DNA polymerase epsilon subunit 3;Organisim: human;Apparent_Kd_M: 1.125884E-11

Real

Aptamer SeqId: 19170-25 | Target: DPOE3 | UniProt: Q9NRF9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19170-25 | Target: DPOE3 | UniProt: Q9NRF9 | TargetFullName: DNA polymerase epsilon subunit 3 | Organisim: human | Apparent_Kd_M: 1.125884E-11

Real

Aptamer SeqId:19173-5;Target:ZFAN1;UniProt:Q8TCF1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19173-5;Target: ZFAN1;UniProt: Q8TCF1;TargetFullName: AN1-type zinc finger protein 1;Organisim: human;Apparent_Kd_M: 5.14551E-12

Real

Aptamer SeqId: 19173-5 | Target: ZFAN1 | UniProt: Q8TCF1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19173-5 | Target: ZFAN1 | UniProt: Q8TCF1 | TargetFullName: AN1-type zinc finger protein 1 | Organisim: human | Apparent_Kd_M: 5.14551E-12

Real

Aptamer SeqId:19174-141;Target:GOGA7;UniProt:Q7Z5G4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19174-141;Target: GOGA7;UniProt: Q7Z5G4;TargetFullName: Golgin subfamily A member 7;Organisim: human;Apparent_Kd_M: 5.875708E-11

Real

Aptamer SeqId: 19174-141 | Target: GOGA7 | UniProt: Q7Z5G4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19174-141 | Target: GOGA7 | UniProt: Q7Z5G4 | TargetFullName: Golgin subfamily A member 7 | Organisim: human | Apparent_Kd_M: 5.875708E-11

Real

Aptamer SeqId:19175-18;Target:MARCKSL1;UniProt:P49006

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19175-18;Target: MARCKSL1;UniProt: P49006;TargetFullName: MARCKS-related protein;Organisim: human;Apparent_Kd_M: 3.423579E-12

Real

Aptamer SeqId: 19175-18 | Target: MARCKSL1 | UniProt: P49006

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19175-18 | Target: MARCKSL1 | UniProt: P49006 | TargetFullName: MARCKS-related protein | Organisim: human | Apparent_Kd_M: 3.423579E-12

Real

Aptamer SeqId:19176-27;Target:FA49B;UniProt:Q9NUQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19176-27;Target: FA49B;UniProt: Q9NUQ9;TargetFullName: Protein FAM49B;Organisim: human;Apparent_Kd_M: 2.732296E-12

Real

Aptamer SeqId: 19176-27 | Target: FA49B | UniProt: Q9NUQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19176-27 | Target: FA49B | UniProt: Q9NUQ9 | TargetFullName: Protein FAM49B | Organisim: human | Apparent_Kd_M: 2.732296E-12

Real

Aptamer SeqId:19177-7;Target:MOL1A;UniProt:Q7L9L4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19177-7;Target: MOL1A;UniProt: Q7L9L4;TargetFullName: MOB kinase activator 1B;Organisim: human;Apparent_Kd_M: 3.197803E-12

Real

Aptamer SeqId: 19177-7 | Target: MOL1A | UniProt: Q7L9L4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19177-7 | Target: MOL1A | UniProt: Q7L9L4 | TargetFullName: MOB kinase activator 1B | Organisim: human | Apparent_Kd_M: 3.197803E-12

Real

Aptamer SeqId:19180-38;Target:GULP1;UniProt:Q9UBP9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19180-38;Target: GULP1;UniProt: Q9UBP9;TargetFullName: PTB domain-containing engulfment adapter protein 1;Organisim: human;Apparent_Kd_M: 2.76582E-11

Real

Aptamer SeqId: 19180-38 | Target: GULP1 | UniProt: Q9UBP9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19180-38 | Target: GULP1 | UniProt: Q9UBP9 | TargetFullName: PTB domain-containing engulfment adapter protein 1 | Organisim: human | Apparent_Kd_M: 2.76582E-11

Real

Aptamer SeqId:19183-164;Target:RL12;UniProt:P30050

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19183-164;Target: RL12;UniProt: P30050;TargetFullName: 60S ribosomal protein L12;Organisim: human;Apparent_Kd_M: 4.95137E-12

Real

Aptamer SeqId: 19183-164 | Target: RL12 | UniProt: P30050

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19183-164 | Target: RL12 | UniProt: P30050 | TargetFullName: 60S ribosomal protein L12 | Organisim: human | Apparent_Kd_M: 4.95137E-12

Real

Aptamer SeqId:19187-21;Target:STABP;UniProt:O95630

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19187-21;Target: STABP;UniProt: O95630;TargetFullName: STAM-binding protein;Organisim: human;Apparent_Kd_M: 2.13062E-11

Real

Aptamer SeqId: 19187-21 | Target: STABP | UniProt: O95630

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19187-21 | Target: STABP | UniProt: O95630 | TargetFullName: STAM-binding protein | Organisim: human | Apparent_Kd_M: 2.13062E-11

Real

Aptamer SeqId:19188-21;Target:NAP2L;UniProt:Q99733

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19188-21;Target: NAP2L;UniProt: Q99733;TargetFullName: nucleosome assembly protein 1-like 4;Organisim: human;Apparent_Kd_M: 3.709419E-12

Real

Aptamer SeqId: 19188-21 | Target: NAP2L | UniProt: Q99733

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19188-21 | Target: NAP2L | UniProt: Q99733 | TargetFullName: nucleosome assembly protein 1-like 4 | Organisim: human | Apparent_Kd_M: 3.709419E-12

Real

Aptamer SeqId:19189-2;Target:UBP14;UniProt:P54578

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19189-2;Target: UBP14;UniProt: P54578;TargetFullName: Ubiquitin carboxyl-terminal hydrolase 14;Organisim: human;Apparent_Kd_M: 6.268981E-12

Real

Aptamer SeqId: 19189-2 | Target: UBP14 | UniProt: P54578

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19189-2 | Target: UBP14 | UniProt: P54578 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase 14 | Organisim: human | Apparent_Kd_M: 6.268981E-12

Real

Aptamer SeqId:19190-4;Target:UB2L6;UniProt:O14933

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19190-4;Target: UB2L6;UniProt: O14933;TargetFullName: Ubiquitin/ISG15-conjugating enzyme E2 L6;Organisim: human;Apparent_Kd_M: 1.848601E-11

Real

Aptamer SeqId: 19190-4 | Target: UB2L6 | UniProt: O14933

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19190-4 | Target: UB2L6 | UniProt: O14933 | TargetFullName: Ubiquitin/ISG15-conjugating enzyme E2 L6 | Organisim: human | Apparent_Kd_M: 1.848601E-11

Real

Aptamer SeqId:19193-18;Target:PFD3;UniProt:P61758

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19193-18;Target: PFD3;UniProt: P61758;TargetFullName: Prefoldin subunit 3;Organisim: human;Apparent_Kd_M: 3.718621E-11

Real

Aptamer SeqId: 19193-18 | Target: PFD3 | UniProt: P61758

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19193-18 | Target: PFD3 | UniProt: P61758 | TargetFullName: Prefoldin subunit 3 | Organisim: human | Apparent_Kd_M: 3.718621E-11

Real

Aptamer SeqId:19194-9;Target:Histidyl-tRNA synthetase-related;UniProt:Q8TEA8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19194-9;Target: Histidyl-tRNA synthetase-related;UniProt: Q8TEA8;TargetFullName: D-tyrosyl-tRNA(Tyr) deacylase 1;Organisim: human;Apparent_Kd_M: 1.838461E-11

Real

Aptamer SeqId: 19194-9 | Target: Histidyl-tRNA synthetase-related

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19194-9 | Target: Histidyl-tRNA synthetase-related | UniProt: Q8TEA8 | TargetFullName: D-tyrosyl-tRNA(Tyr) deacylase 1 | Organisim: human | Apparent_Kd_M: 1.838461E-11

Real

Aptamer SeqId:19195-85;Target:RS5;UniProt:P46782

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19195-85;Target: RS5;UniProt: P46782;TargetFullName: 40S ribosomal protein S5;Organisim: human;Apparent_Kd_M: 3.623484E-11

Real

Aptamer SeqId: 19195-85 | Target: RS5 | UniProt: P46782

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19195-85 | Target: RS5 | UniProt: P46782 | TargetFullName: 40S ribosomal protein S5 | Organisim: human | Apparent_Kd_M: 3.623484E-11

Real

Aptamer SeqId:19196-73;Target:HOP;UniProt:Q9BPY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19196-73;Target: HOP;UniProt: Q9BPY8;TargetFullName: Homeodomain-only protein;Organisim: human;Apparent_Kd_M: 5.449909E-11

Real

Aptamer SeqId: 19196-73 | Target: HOP | UniProt: Q9BPY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19196-73 | Target: HOP | UniProt: Q9BPY8 | TargetFullName: Homeodomain-only protein | Organisim: human | Apparent_Kd_M: 5.449909E-11

Real

Aptamer SeqId:19197-95;Target:THIL;UniProt:P24752

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19197-95;Target: THIL;UniProt: P24752;TargetFullName: Acetyl-CoA acetyltransferase; mitochondrial;Organisim: human;Apparent_Kd_M: 6.441777E-12

Real

Aptamer SeqId: 19197-95 | Target: THIL | UniProt: P24752

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19197-95 | Target: THIL | UniProt: P24752 | TargetFullName: Acetyl-CoA acetyltransferase; mitochondrial | Organisim: human | Apparent_Kd_M: 6.441777E-12

Real

Aptamer SeqId:19199-3;Target:RPB11;UniProt:P52435

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19199-3;Target: RPB11;UniProt: P52435;TargetFullName: DNA-directed RNA polymerase II subunit RPB11-a;Organisim: human;Apparent_Kd_M: 4.360683E-12

Real

Aptamer SeqId: 19199-3 | Target: RPB11 | UniProt: P52435

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19199-3 | Target: RPB11 | UniProt: P52435 | TargetFullName: DNA-directed RNA polymerase II subunit RPB11-a | Organisim: human | Apparent_Kd_M: 4.360683E-12

Real

Aptamer SeqId:19200-16;Target:NDUA5;UniProt:Q16718

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19200-16;Target: NDUA5;UniProt: Q16718;TargetFullName: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5;Organisim: human;Apparent_Kd_M: 4.371611E-11

Real

Aptamer SeqId: 19200-16 | Target: NDUA5 | UniProt: Q16718

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19200-16 | Target: NDUA5 | UniProt: Q16718 | TargetFullName: NADH dehydrogenase ubiquinone 1 alpha subcomplex subunit 5 | Organisim: human | Apparent_Kd_M: 4.371611E-11

Real

Aptamer SeqId:19202-10;Target:BTK;UniProt:Q06187

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19202-10;Target: BTK;UniProt: Q06187;TargetFullName: Tyrosine-protein kinase BTK;Organisim: human;Apparent_Kd_M: 4.988695E-12

Real

Aptamer SeqId: 19202-10 | Target: BTK | UniProt: Q06187

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19202-10 | Target: BTK | UniProt: Q06187 | TargetFullName: Tyrosine-protein kinase BTK | Organisim: human | Apparent_Kd_M: 4.988695E-12

Real

Aptamer SeqId:19206-20;Target:8ODP;UniProt:P36639

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19206-20;Target: 8ODP;UniProt: P36639;TargetFullName: 7;8-dihydro-8-oxoguanine triphosphatase;Organisim: human;Apparent_Kd_M: 1.782335E-11

Real

Aptamer SeqId: 19206-20 | Target: 8ODP | UniProt: P36639

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19206-20 | Target: 8ODP | UniProt: P36639 | TargetFullName: 7;8-dihydro-8-oxoguanine triphosphatase | Organisim: human | Apparent_Kd_M: 1.782335E-11

Real

Aptamer SeqId:19207-119;Target:ADK;UniProt:P55263

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19207-119;Target: ADK;UniProt: P55263;TargetFullName: Adenosine kinase;Organisim: human;Apparent_Kd_M: 1.043601E-10

Real

Aptamer SeqId: 19207-119 | Target: ADK | UniProt: P55263

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19207-119 | Target: ADK | UniProt: P55263 | TargetFullName: Adenosine kinase | Organisim: human | Apparent_Kd_M: 1.043601E-10

Real

Aptamer SeqId:19208-8;Target:Activin RIIA;UniProt:P27037

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19208-8;Target: Activin RIIA;UniProt: P27037;TargetFullName: Activin receptor type-2A;Organisim: human;Apparent_Kd_M: 1.099064E-10

Real

Aptamer SeqId: 19208-8 | Target: Activin RIIA | UniProt: P27037

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19208-8 | Target: Activin RIIA | UniProt: P27037 | TargetFullName: Activin receptor type-2A | Organisim: human | Apparent_Kd_M: 1.099064E-10

Real

Aptamer SeqId:19209-6;Target:IKB-alpha;UniProt:P25963

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19209-6;Target: IKB-alpha;UniProt: P25963;TargetFullName: NF-kappa-B inhibitor alpha;Organisim: human;Apparent_Kd_M: 2.855595E-11

Real

Aptamer SeqId: 19209-6 | Target: IKB-alpha | UniProt: P25963

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19209-6 | Target: IKB-alpha | UniProt: P25963 | TargetFullName: NF-kappa-B inhibitor alpha | Organisim: human | Apparent_Kd_M: 2.855595E-11

Real

Aptamer SeqId:19212-4;Target:DMBT1;UniProt:Q9UGM3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19212-4;Target: DMBT1;UniProt: Q9UGM3;TargetFullName: Deleted in malignant brain tumors 1 protein;Organisim: human;Apparent_Kd_M: 9.85769E-11

Real

Aptamer SeqId: 19212-4 | Target: DMBT1 | UniProt: Q9UGM3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19212-4 | Target: DMBT1 | UniProt: Q9UGM3 | TargetFullName: Deleted in malignant brain tumors 1 protein | Organisim: human | Apparent_Kd_M: 9.85769E-11

Real

Aptamer SeqId:19213-1;Target:ISK4;UniProt:O60575

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19213-1;Target: ISK4;UniProt: O60575;TargetFullName: Serine protease inhibitor Kazal-type 4;Organisim: human;Apparent_Kd_M: 3.967488E-11

Real

Aptamer SeqId: 19213-1 | Target: ISK4 | UniProt: O60575

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19213-1 | Target: ISK4 | UniProt: O60575 | TargetFullName: Serine protease inhibitor Kazal-type 4 | Organisim: human | Apparent_Kd_M: 3.967488E-11

Real

Aptamer SeqId:19215-7;Target:NDRG1;UniProt:Q92597

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19215-7;Target: NDRG1;UniProt: Q92597;TargetFullName: Protein NDRG1;Organisim: human;Apparent_Kd_M: 2.97E-11

Real

Aptamer SeqId: 19215-7 | Target: NDRG1 | UniProt: Q92597

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19215-7 | Target: NDRG1 | UniProt: Q92597 | TargetFullName: Protein NDRG1 | Organisim: human | Apparent_Kd_M: 2.97E-11

Real

Aptamer SeqId:19219-71;Target:NTF-2;UniProt:P61970

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19219-71;Target: NTF-2;UniProt: P61970;TargetFullName: Nuclear transport factor 2;Organisim: human;Apparent_Kd_M: 2.91E-11

Real

Aptamer SeqId: 19219-71 | Target: NTF-2 | UniProt: P61970

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19219-71 | Target: NTF-2 | UniProt: P61970 | TargetFullName: Nuclear transport factor 2 | Organisim: human | Apparent_Kd_M: 2.91E-11

Real

Aptamer SeqId:19222-124;Target:RAB5B;UniProt:P61020

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19222-124;Target: RAB5B;UniProt: P61020;TargetFullName: Ras-related protein Rab-5B;Organisim: human;Apparent_Kd_M: 1.967878E-12

Real

Aptamer SeqId: 19222-124 | Target: RAB5B | UniProt: P61020

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19222-124 | Target: RAB5B | UniProt: P61020 | TargetFullName: Ras-related protein Rab-5B | Organisim: human | Apparent_Kd_M: 1.967878E-12

Real

Aptamer SeqId:19223-6;Target:RAB1A;UniProt:P62820

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19223-6;Target: RAB1A;UniProt: P62820;TargetFullName: Ras-related protein Rab-1A;Organisim: human;Apparent_Kd_M: 2.384549E-12

Real

Aptamer SeqId: 19223-6 | Target: RAB1A | UniProt: P62820

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19223-6 | Target: RAB1A | UniProt: P62820 | TargetFullName: Ras-related protein Rab-1A | Organisim: human | Apparent_Kd_M: 2.384549E-12

Real

Aptamer SeqId:19224-5;Target:IF1AY;UniProt:O14602

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19224-5;Target: IF1AY;UniProt: O14602;TargetFullName: Eukaryotic translation initiation factor 1A; Y-chromosomal;Organisim: human;Apparent_Kd_M: 1.326179E-12

Real

Aptamer SeqId: 19224-5 | Target: IF1AY | UniProt: O14602

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19224-5 | Target: IF1AY | UniProt: O14602 | TargetFullName: Eukaryotic translation initiation factor 1A; Y-chromosomal | Organisim: human | Apparent_Kd_M: 1.326179E-12

Real

Aptamer SeqId:19225-11;Target:BLNK;UniProt:Q8WV28

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19225-11;Target: BLNK;UniProt: Q8WV28;TargetFullName: B-cell linker protein;Organisim: human;Apparent_Kd_M: 2.064143E-11

Real

Aptamer SeqId: 19225-11 | Target: BLNK | UniProt: Q8WV28

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19225-11 | Target: BLNK | UniProt: Q8WV28 | TargetFullName: B-cell linker protein | Organisim: human | Apparent_Kd_M: 2.064143E-11

Real

Aptamer SeqId:19227-18;Target:BATF;UniProt:Q16520

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19227-18;Target: BATF;UniProt: Q16520;TargetFullName: Basic leucine zipper transcriptional factor ATF-like;Organisim: human;Apparent_Kd_M: 1.04535E-10

Real

Aptamer SeqId: 19227-18 | Target: BATF | UniProt: Q16520

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19227-18 | Target: BATF | UniProt: Q16520 | TargetFullName: Basic leucine zipper transcriptional factor ATF-like | Organisim: human | Apparent_Kd_M: 1.04535E-10

Real

Aptamer SeqId:19228-11;Target:BAG-2;UniProt:O95816

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19228-11;Target: BAG-2;UniProt: O95816;TargetFullName: BAG family molecular chaperone regulator 2;Organisim: human;Apparent_Kd_M: 3.836856E-11

Real

Aptamer SeqId: 19228-11 | Target: BAG-2 | UniProt: O95816

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19228-11 | Target: BAG-2 | UniProt: O95816 | TargetFullName: BAG family molecular chaperone regulator 2 | Organisim: human | Apparent_Kd_M: 3.836856E-11

Real

Aptamer SeqId:19229-92;Target:HOME1;UniProt:Q86YM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19229-92;Target: HOME1;UniProt: Q86YM7;TargetFullName: Homer protein homolog 1;Organisim: human;Apparent_Kd_M: 1.466573E-11

Real

Aptamer SeqId: 19229-92 | Target: HOME1 | UniProt: Q86YM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19229-92 | Target: HOME1 | UniProt: Q86YM7 | TargetFullName: Homer protein homolog 1 | Organisim: human | Apparent_Kd_M: 1.466573E-11

Real

Aptamer SeqId:19230-12;Target:GSTT1;UniProt:P30711

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19230-12;Target: GSTT1;UniProt: P30711;TargetFullName: Glutathione S-transferase theta-1;Organisim: human;Apparent_Kd_M: 2.852595E-11

Real

Aptamer SeqId: 19230-12 | Target: GSTT1 | UniProt: P30711

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19230-12 | Target: GSTT1 | UniProt: P30711 | TargetFullName: Glutathione S-transferase theta-1 | Organisim: human | Apparent_Kd_M: 2.852595E-11

Real

Aptamer SeqId:19231-22;Target:PRL-3;UniProt:O75365

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19231-22;Target: PRL-3;UniProt: O75365;TargetFullName: Protein tyrosine phosphatase type IVA 3;Organisim: human;Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId: 19231-22 | Target: PRL-3 | UniProt: O75365

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19231-22 | Target: PRL-3 | UniProt: O75365 | TargetFullName: Protein tyrosine phosphatase type IVA 3 | Organisim: human | Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId:19233-75;Target:ATOX1;UniProt:O00244

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19233-75;Target: ATOX1;UniProt: O00244;TargetFullName: Copper transport protein ATOX1;Organisim: human;Apparent_Kd_M: 1.848747E-11

Real

Aptamer SeqId: 19233-75 | Target: ATOX1 | UniProt: O00244

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19233-75 | Target: ATOX1 | UniProt: O00244 | TargetFullName: Copper transport protein ATOX1 | Organisim: human | Apparent_Kd_M: 1.848747E-11

Real

Aptamer SeqId:19236-24;Target:TCP4;UniProt:P53999

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19236-24;Target: TCP4;UniProt: P53999;TargetFullName: Activated RNA polymerase II transcriptional coactivator p15;Organisim: human;Apparent_Kd_M: 9.020125E-12

Real

Aptamer SeqId: 19236-24 | Target: TCP4 | UniProt: P53999

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19236-24 | Target: TCP4 | UniProt: P53999 | TargetFullName: Activated RNA polymerase II transcriptional coactivator p15 | Organisim: human | Apparent_Kd_M: 9.020125E-12

Real

Aptamer SeqId:19237-17;Target:D-dopachrome decarboxylase;UniProt:P30046

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19237-17;Target: D-dopachrome decarboxylase;UniProt: P30046;TargetFullName: D-dopachrome decarboxylase;Organisim: human;Apparent_Kd_M: 6.641272E-11

Real

Aptamer SeqId: 19237-17 | Target: D-dopachrome decarboxylase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19237-17 | Target: D-dopachrome decarboxylase | UniProt: P30046 | TargetFullName: D-dopachrome decarboxylase | Organisim: human | Apparent_Kd_M: 6.641272E-11

Real

Aptamer SeqId:19238-12;Target:GLNA;UniProt:P15104

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19238-12;Target: GLNA;UniProt: P15104;TargetFullName: Glutamine synthetase;Organisim: human;Apparent_Kd_M: 1.925306E-11

Real

Aptamer SeqId: 19238-12 | Target: GLNA | UniProt: P15104

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19238-12 | Target: GLNA | UniProt: P15104 | TargetFullName: Glutamine synthetase | Organisim: human | Apparent_Kd_M: 1.925306E-11

Real

Aptamer SeqId:19239-5;Target:ARF1;UniProt:P84077

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19239-5;Target: ARF1;UniProt: P84077;TargetFullName: ADP-ribosylation factor 1;Organisim: human;Apparent_Kd_M: 5.46195E-12

Real

Aptamer SeqId: 19239-5 | Target: ARF1 | UniProt: P84077

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19239-5 | Target: ARF1 | UniProt: P84077 | TargetFullName: ADP-ribosylation factor 1 | Organisim: human | Apparent_Kd_M: 5.46195E-12

Real

Aptamer SeqId:19240-265;Target:HAP28;UniProt:Q13442

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19240-265;Target: HAP28;UniProt: Q13442;TargetFullName: 28 kDa heat- and acid-stable phosphoprotein;Organisim: human;Apparent_Kd_M: 1.857245E-11

Real

Aptamer SeqId: 19240-265 | Target: HAP28 | UniProt: Q13442

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19240-265 | Target: HAP28 | UniProt: Q13442 | TargetFullName: 28 kDa heat- and acid-stable phosphoprotein | Organisim: human | Apparent_Kd_M: 1.857245E-11

Real

Aptamer SeqId:19241-31;Target:RBP-III;UniProt:P82980

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19241-31;Target: RBP-III;UniProt: P82980;TargetFullName: Retinol-binding protein 5;Organisim: human;Apparent_Kd_M: 1.441323E-12

Real

Aptamer SeqId: 19241-31 | Target: RBP-III | UniProt: P82980

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19241-31 | Target: RBP-III | UniProt: P82980 | TargetFullName: Retinol-binding protein 5 | Organisim: human | Apparent_Kd_M: 1.441323E-12

Real

Aptamer SeqId:19242-21;Target:PFD1;UniProt:O60925

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19242-21;Target: PFD1;UniProt: O60925;TargetFullName: Prefoldin subunit 1;Organisim: human;Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId: 19242-21 | Target: PFD1 | UniProt: O60925

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19242-21 | Target: PFD1 | UniProt: O60925 | TargetFullName: Prefoldin subunit 1 | Organisim: human | Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId:19243-2;Target:PFD2;UniProt:Q9UHV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19243-2;Target: PFD2;UniProt: Q9UHV9;TargetFullName: Prefoldin subunit 2;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 19243-2 | Target: PFD2 | UniProt: Q9UHV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19243-2 | Target: PFD2 | UniProt: Q9UHV9 | TargetFullName: Prefoldin subunit 2 | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:19247-1;Target:UB2D1;UniProt:P51668

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19247-1;Target: UB2D1;UniProt: P51668;TargetFullName: Ubiquitin-conjugating enzyme E2 D1;Organisim: human;Apparent_Kd_M: 2.777399E-12

Real

Aptamer SeqId: 19247-1 | Target: UB2D1 | UniProt: P51668

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19247-1 | Target: UB2D1 | UniProt: P51668 | TargetFullName: Ubiquitin-conjugating enzyme E2 D1 | Organisim: human | Apparent_Kd_M: 2.777399E-12

Real

Aptamer SeqId:19249-18;Target:SYK;UniProt:Q15046

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19249-18;Target: SYK;UniProt: Q15046;TargetFullName: Lysine--tRNA ligase;Organisim: human;Apparent_Kd_M: 1.064767E-12

Real

Aptamer SeqId: 19249-18 | Target: SYK | UniProt: Q15046

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19249-18 | Target: SYK | UniProt: Q15046 | TargetFullName: Lysine--tRNA ligase | Organisim: human | Apparent_Kd_M: 1.064767E-12

Real

Aptamer SeqId:19250-50;Target:MYCBP;UniProt:Q99417

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19250-50;Target: MYCBP;UniProt: Q99417;TargetFullName: C-Myc-binding protein;Organisim: human;Apparent_Kd_M: 3.695883E-12

Real

Aptamer SeqId: 19250-50 | Target: MYCBP | UniProt: Q99417

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19250-50 | Target: MYCBP | UniProt: Q99417 | TargetFullName: C-Myc-binding protein | Organisim: human | Apparent_Kd_M: 3.695883E-12

Real

Aptamer SeqId:19251-56;Target:Platelet proteoglycan;UniProt:P10124

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19251-56;Target: Platelet proteoglycan;UniProt: P10124;TargetFullName: Serglycin;Organisim: human;Apparent_Kd_M: 8.987261E-12

Real

Aptamer SeqId: 19251-56 | Target: Platelet proteoglycan | UniProt: P10124

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19251-56 | Target: Platelet proteoglycan | UniProt: P10124 | TargetFullName: Serglycin | Organisim: human | Apparent_Kd_M: 8.987261E-12

Real

Aptamer SeqId:19252-67;Target:PSB2;UniProt:P49721

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19252-67;Target: PSB2;UniProt: P49721;TargetFullName: Proteasome subunit beta type-2;Organisim: human;Apparent_Kd_M: 1.614494E-11

Real

Aptamer SeqId: 19252-67 | Target: PSB2 | UniProt: P49721

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19252-67 | Target: PSB2 | UniProt: P49721 | TargetFullName: Proteasome subunit beta type-2 | Organisim: human | Apparent_Kd_M: 1.614494E-11

Real

Aptamer SeqId:19253-82;Target:RAB2B;UniProt:Q8WUD1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19253-82;Target: RAB2B;UniProt: Q8WUD1;TargetFullName: Ras-related protein Rab-2B;Organisim: human;Apparent_Kd_M: 3.659759E-11

Real

Aptamer SeqId: 19253-82 | Target: RAB2B | UniProt: Q8WUD1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19253-82 | Target: RAB2B | UniProt: Q8WUD1 | TargetFullName: Ras-related protein Rab-2B | Organisim: human | Apparent_Kd_M: 3.659759E-11

Real

Aptamer SeqId:19254-125;Target:GMPR1;UniProt:P36959

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19254-125;Target: GMPR1;UniProt: P36959;TargetFullName: GMP reductase 1;Organisim: human;Apparent_Kd_M: 1.146786E-11

Real

Aptamer SeqId: 19254-125 | Target: GMPR1 | UniProt: P36959

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19254-125 | Target: GMPR1 | UniProt: P36959 | TargetFullName: GMP reductase 1 | Organisim: human | Apparent_Kd_M: 1.146786E-11

Real

Aptamer SeqId:19255-124;Target:NXT2;UniProt:Q9NPJ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19255-124;Target: NXT2;UniProt: Q9NPJ8;TargetFullName: NTF2-related export protein 2;Organisim: human;Apparent_Kd_M: 7.042508E-12

Real

Aptamer SeqId: 19255-124 | Target: NXT2 | UniProt: Q9NPJ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19255-124 | Target: NXT2 | UniProt: Q9NPJ8 | TargetFullName: NTF2-related export protein 2 | Organisim: human | Apparent_Kd_M: 7.042508E-12

Real

Aptamer SeqId:19257-11;Target:CLCA;UniProt:P09496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19257-11;Target: CLCA;UniProt: P09496;TargetFullName: Clathrin light chain A;Organisim: human;Apparent_Kd_M: 3.367E-11

Real

Aptamer SeqId: 19257-11 | Target: CLCA | UniProt: P09496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19257-11 | Target: CLCA | UniProt: P09496 | TargetFullName: Clathrin light chain A | Organisim: human | Apparent_Kd_M: 3.367E-11

Real

Aptamer SeqId:19258-24;Target:GCDH;UniProt:Q92947

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19258-24;Target: GCDH;UniProt: Q92947;TargetFullName: Glutaryl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 7.914749E-12

Real

Aptamer SeqId: 19258-24 | Target: GCDH | UniProt: Q92947

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19258-24 | Target: GCDH | UniProt: Q92947 | TargetFullName: Glutaryl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 7.914749E-12

Real

Aptamer SeqId:19259-176;Target:IF2A;UniProt:P05198

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19259-176;Target: IF2A;UniProt: P05198;TargetFullName: Eukaryotic translation initiation factor 2 subunit 1;Organisim: human;Apparent_Kd_M: 2.256247E-11

Real

Aptamer SeqId: 19259-176 | Target: IF2A | UniProt: P05198

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19259-176 | Target: IF2A | UniProt: P05198 | TargetFullName: Eukaryotic translation initiation factor 2 subunit 1 | Organisim: human | Apparent_Kd_M: 2.256247E-11

Real

Aptamer SeqId:19260-4;Target:GIPC1;UniProt:O14908

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19260-4;Target: GIPC1;UniProt: O14908;TargetFullName: PDZ domain-containing protein GIPC1;Organisim: human;Apparent_Kd_M: 1.773143E-11

Real

Aptamer SeqId: 19260-4 | Target: GIPC1 | UniProt: O14908

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19260-4 | Target: GIPC1 | UniProt: O14908 | TargetFullName: PDZ domain-containing protein GIPC1 | Organisim: human | Apparent_Kd_M: 1.773143E-11

Real

Aptamer SeqId:19261-12;Target:SDCB2;UniProt:Q9H190

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19261-12;Target: SDCB2;UniProt: Q9H190;TargetFullName: Syntenin-2;Organisim: human;Apparent_Kd_M: 1.254117E-12

Real

Aptamer SeqId: 19261-12 | Target: SDCB2 | UniProt: Q9H190

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19261-12 | Target: SDCB2 | UniProt: Q9H190 | TargetFullName: Syntenin-2 | Organisim: human | Apparent_Kd_M: 1.254117E-12

Real

Aptamer SeqId:19262-219;Target:ACADV;UniProt:P49748

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19262-219;Target: ACADV;UniProt: P49748;TargetFullName: Very long-chain specific acyl-CoA dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.11796E-11

Real

Aptamer SeqId: 19262-219 | Target: ACADV | UniProt: P49748

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19262-219 | Target: ACADV | UniProt: P49748 | TargetFullName: Very long-chain specific acyl-CoA dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.11796E-11

Real

Aptamer SeqId:19263-147;Target:IF4E;UniProt:P06730

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19263-147;Target: IF4E;UniProt: P06730;TargetFullName: Eukaryotic translation initiation factor 4E;Organisim: human;Apparent_Kd_M: 2.78964E-12

Real

Aptamer SeqId: 19263-147 | Target: IF4E | UniProt: P06730

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19263-147 | Target: IF4E | UniProt: P06730 | TargetFullName: Eukaryotic translation initiation factor 4E | Organisim: human | Apparent_Kd_M: 2.78964E-12

Real

Aptamer SeqId:19264-6;Target:RFA2;UniProt:P15927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19264-6;Target: RFA2;UniProt: P15927;TargetFullName: Replication protein A 32 kDa subunit;Organisim: human;Apparent_Kd_M: 1.17358E-10

Real

Aptamer SeqId: 19264-6 | Target: RFA2 | UniProt: P15927

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19264-6 | Target: RFA2 | UniProt: P15927 | TargetFullName: Replication protein A 32 kDa subunit | Organisim: human | Apparent_Kd_M: 1.17358E-10

Real

Aptamer SeqId:19265-9;Target:TCPA;UniProt:P17987

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19265-9;Target: TCPA;UniProt: P17987;TargetFullName: T-complex protein 1 subunit alpha;Organisim: human;Apparent_Kd_M: 4.938671E-11

Real

Aptamer SeqId: 19265-9 | Target: TCPA | UniProt: P17987

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19265-9 | Target: TCPA | UniProt: P17987 | TargetFullName: T-complex protein 1 subunit alpha | Organisim: human | Apparent_Kd_M: 4.938671E-11

Real

Aptamer SeqId:19266-35;Target:G3BP1;UniProt:Q13283

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19266-35;Target: G3BP1;UniProt: Q13283;TargetFullName: Ras GTPase-activating protein-binding protein 1;Organisim: human;Apparent_Kd_M: 7.868901E-12

Real

Aptamer SeqId: 19266-35 | Target: G3BP1 | UniProt: Q13283

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19266-35 | Target: G3BP1 | UniProt: Q13283 | TargetFullName: Ras GTPase-activating protein-binding protein 1 | Organisim: human | Apparent_Kd_M: 7.868901E-12

Real

Aptamer SeqId:19267-14;Target:GLO2;UniProt:Q16775

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19267-14;Target: GLO2;UniProt: Q16775;TargetFullName: Hydroxyacylglutathione hydrolase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.455165E-12

Real

Aptamer SeqId: 19267-14 | Target: GLO2 | UniProt: Q16775

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19267-14 | Target: GLO2 | UniProt: Q16775 | TargetFullName: Hydroxyacylglutathione hydrolase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.455165E-12

Real

Aptamer SeqId:19270-26;Target:SYYC;UniProt:P54577

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19270-26;Target: SYYC;UniProt: P54577;TargetFullName: Tyrosine--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 3.646377E-12

Real

Aptamer SeqId: 19270-26 | Target: SYYC | UniProt: P54577

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19270-26 | Target: SYYC | UniProt: P54577 | TargetFullName: Tyrosine--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 3.646377E-12

Real

Aptamer SeqId:19271-64;Target:GNAI1;UniProt:P63096

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19271-64;Target: GNAI1;UniProt: P63096;TargetFullName: Guanine nucleotide-binding protein G(i) subunit alpha-1;Organisim: human;Apparent_Kd_M: 2.774652E-11

Real

Aptamer SeqId: 19271-64 | Target: GNAI1 | UniProt: P63096

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19271-64 | Target: GNAI1 | UniProt: P63096 | TargetFullName: Guanine nucleotide-binding protein G(i) subunit alpha-1 | Organisim: human | Apparent_Kd_M: 2.774652E-11

Real

Aptamer SeqId:19272-9;Target:PEF1;UniProt:Q9UBV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19272-9;Target: PEF1;UniProt: Q9UBV8;TargetFullName: Peflin;Organisim: human;Apparent_Kd_M: 1.834456E-11

Real

Aptamer SeqId: 19272-9 | Target: PEF1 | UniProt: Q9UBV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19272-9 | Target: PEF1 | UniProt: Q9UBV8 | TargetFullName: Peflin | Organisim: human | Apparent_Kd_M: 1.834456E-11

Real

Aptamer SeqId:19273-3;Target:Glutathione reductase;UniProt:P00390

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19273-3;Target: Glutathione reductase;UniProt: P00390;TargetFullName: Glutathione reductase; mitochondrial;Organisim: human;Apparent_Kd_M: 9.914427E-12

Real

Aptamer SeqId: 19273-3 | Target: Glutathione reductase | UniProt: P00390

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19273-3 | Target: Glutathione reductase | UniProt: P00390 | TargetFullName: Glutathione reductase; mitochondrial | Organisim: human | Apparent_Kd_M: 9.914427E-12

Real

Aptamer SeqId:19274-80;Target:Alpha-1-syntrophin;UniProt:Q13424

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19274-80;Target: Alpha-1-syntrophin;UniProt: Q13424;TargetFullName: Alpha-1-syntrophin;Organisim: human;Apparent_Kd_M: 9.412048E-12

Real

Aptamer SeqId: 19274-80 | Target: Alpha-1-syntrophin | UniProt: Q13424

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19274-80 | Target: Alpha-1-syntrophin | UniProt: Q13424 | TargetFullName: Alpha-1-syntrophin | Organisim: human | Apparent_Kd_M: 9.412048E-12

Real

Aptamer SeqId:19275-68;Target:IDH3G;UniProt:P51553

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19275-68;Target: IDH3G;UniProt: P51553;TargetFullName: Isocitrate dehydrogenase [NAD] subunit gamma; mitochondrial;Organisim: human;Apparent_Kd_M: 5.944485E-12

Real

Aptamer SeqId: 19275-68 | Target: IDH3G | UniProt: P51553

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19275-68 | Target: IDH3G | UniProt: P51553 | TargetFullName: Isocitrate dehydrogenase NAD subunit gamma; mitochondrial | Organisim: human | Apparent_Kd_M: 5.944485E-12

Real

Aptamer SeqId:19276-124;Target:RUXG;UniProt:P62308

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19276-124;Target: RUXG;UniProt: P62308;TargetFullName: Small nuclear ribonucleoprotein G;Organisim: human;Apparent_Kd_M: 5.917617E-12

Real

Aptamer SeqId: 19276-124 | Target: RUXG | UniProt: P62308

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19276-124 | Target: RUXG | UniProt: P62308 | TargetFullName: Small nuclear ribonucleoprotein G | Organisim: human | Apparent_Kd_M: 5.917617E-12

Real

Aptamer SeqId:19277-4;Target:KAT;UniProt:Q8NFU3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19277-4;Target: KAT;UniProt: Q8NFU3;TargetFullName: Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1;Organisim: human;Apparent_Kd_M: 7.066518E-11

Real

Aptamer SeqId: 19277-4 | Target: KAT | UniProt: Q8NFU3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19277-4 | Target: KAT | UniProt: Q8NFU3 | TargetFullName: Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 7.066518E-11

Real

Aptamer SeqId:19278-19;Target:RAB1B;UniProt:Q9H0U4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19278-19;Target: RAB1B;UniProt: Q9H0U4;TargetFullName: Ras-related protein Rab-1B;Organisim: human;Apparent_Kd_M: 2.845123E-12

Real

Aptamer SeqId: 19278-19 | Target: RAB1B | UniProt: Q9H0U4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19278-19 | Target: RAB1B | UniProt: Q9H0U4 | TargetFullName: Ras-related protein Rab-1B | Organisim: human | Apparent_Kd_M: 2.845123E-12

Real

Aptamer SeqId:19279-42;Target:CRBP;UniProt:P09455

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19279-42;Target: CRBP;UniProt: P09455;TargetFullName: Retinol-binding protein 1;Organisim: human;Apparent_Kd_M: 3.462096E-12

Real

Aptamer SeqId: 19279-42 | Target: CRBP | UniProt: P09455

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19279-42 | Target: CRBP | UniProt: P09455 | TargetFullName: Retinol-binding protein 1 | Organisim: human | Apparent_Kd_M: 3.462096E-12

Real

Aptamer SeqId:19280-29;Target:UB2D3;UniProt:P61077

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19280-29;Target: UB2D3;UniProt: P61077;TargetFullName: Ubiquitin-conjugating enzyme E2 D3;Organisim: human;Apparent_Kd_M: 1.505366E-11

Real

Aptamer SeqId: 19280-29 | Target: UB2D3 | UniProt: P61077

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19280-29 | Target: UB2D3 | UniProt: P61077 | TargetFullName: Ubiquitin-conjugating enzyme E2 D3 | Organisim: human | Apparent_Kd_M: 1.505366E-11

Real

Aptamer SeqId:19281-86;Target:MAFG;UniProt:O15525

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19281-86;Target: MAFG;UniProt: O15525;TargetFullName: Transcription factor MafG;Organisim: human;Apparent_Kd_M: 1.10119E-11

Real

Aptamer SeqId: 19281-86 | Target: MAFG | UniProt: O15525

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19281-86 | Target: MAFG | UniProt: O15525 | TargetFullName: Transcription factor MafG | Organisim: human | Apparent_Kd_M: 1.10119E-11

Real

Aptamer SeqId:19282-3;Target:RAB13;UniProt:P51153

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19282-3;Target: RAB13;UniProt: P51153;TargetFullName: Ras-related protein Rab-13;Organisim: human;Apparent_Kd_M: 3.547241E-11

Real

Aptamer SeqId: 19282-3 | Target: RAB13 | UniProt: P51153

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19282-3 | Target: RAB13 | UniProt: P51153 | TargetFullName: Ras-related protein Rab-13 | Organisim: human | Apparent_Kd_M: 3.547241E-11

Real

Aptamer SeqId:19286-30;Target:MLR5;UniProt:Q02045

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19286-30;Target: MLR5;UniProt: Q02045;TargetFullName: Myosin light chain 5;Organisim: human;Apparent_Kd_M: 9.616932E-12

Real

Aptamer SeqId: 19286-30 | Target: MLR5 | UniProt: Q02045

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19286-30 | Target: MLR5 | UniProt: Q02045 | TargetFullName: Myosin light chain 5 | Organisim: human | Apparent_Kd_M: 9.616932E-12

Real

Aptamer SeqId:19287-59;Target:DENR;UniProt:O43583

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19287-59;Target: DENR;UniProt: O43583;TargetFullName: Density-regulated protein;Organisim: human;Apparent_Kd_M: 2.918118E-11

Real

Aptamer SeqId: 19287-59 | Target: DENR | UniProt: O43583

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19287-59 | Target: DENR | UniProt: O43583 | TargetFullName: Density-regulated protein | Organisim: human | Apparent_Kd_M: 2.918118E-11

Real

Aptamer SeqId:19289-29;Target:DCUP;UniProt:P06132

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19289-29;Target: DCUP;UniProt: P06132;TargetFullName: Uroporphyrinogen decarboxylase;Organisim: human;Apparent_Kd_M: 1.142143E-11

Real

Aptamer SeqId: 19289-29 | Target: DCUP | UniProt: P06132

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19289-29 | Target: DCUP | UniProt: P06132 | TargetFullName: Uroporphyrinogen decarboxylase | Organisim: human | Apparent_Kd_M: 1.142143E-11

Real

Aptamer SeqId:19290-5;Target:HPRT;UniProt:P00492

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19290-5;Target: HPRT;UniProt: P00492;TargetFullName: Hypoxanthine-guanine phosphoribosyltransferase;Organisim: human;Apparent_Kd_M: 5.30638E-12

Real

Aptamer SeqId: 19290-5 | Target: HPRT | UniProt: P00492

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19290-5 | Target: HPRT | UniProt: P00492 | TargetFullName: Hypoxanthine-guanine phosphoribosyltransferase | Organisim: human | Apparent_Kd_M: 5.30638E-12

Real

Aptamer SeqId:19291-2;Target:CASQ2;UniProt:O14958

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19291-2;Target: CASQ2;UniProt: O14958;TargetFullName: Calsequestrin-2;Organisim: human;Apparent_Kd_M: 3.154055E-11

Real

Aptamer SeqId: 19291-2 | Target: CASQ2 | UniProt: O14958

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19291-2 | Target: CASQ2 | UniProt: O14958 | TargetFullName: Calsequestrin-2 | Organisim: human | Apparent_Kd_M: 3.154055E-11

Real

Aptamer SeqId:19293-6;Target:VP26A;UniProt:O75436

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19293-6;Target: VP26A;UniProt: O75436;TargetFullName: Vacuolar protein sorting-associated protein 26A;Organisim: human;Apparent_Kd_M: 4.128258E-12

Real

Aptamer SeqId: 19293-6 | Target: VP26A | UniProt: O75436

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19293-6 | Target: VP26A | UniProt: O75436 | TargetFullName: Vacuolar protein sorting-associated protein 26A | Organisim: human | Apparent_Kd_M: 4.128258E-12

Real

Aptamer SeqId:19294-26;Target:CRIPT;UniProt:Q9P021

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19294-26;Target: CRIPT;UniProt: Q9P021;TargetFullName: Cysteine-rich PDZ-binding protein;Organisim: human;Apparent_Kd_M: 6.475773E-12

Real

Aptamer SeqId: 19294-26 | Target: CRIPT | UniProt: Q9P021

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19294-26 | Target: CRIPT | UniProt: Q9P021 | TargetFullName: Cysteine-rich PDZ-binding protein | Organisim: human | Apparent_Kd_M: 6.475773E-12

Real

Aptamer SeqId:19295-32;Target:PP1G;UniProt:P36873

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19295-32;Target: PP1G;UniProt: P36873;TargetFullName: Serine/threonine-protein phosphatase PP1-gamma catalytic subunit;Organisim: human;Apparent_Kd_M: 7.498895E-12

Real

Aptamer SeqId: 19295-32 | Target: PP1G | UniProt: P36873

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19295-32 | Target: PP1G | UniProt: P36873 | TargetFullName: Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Organisim: human | Apparent_Kd_M: 7.498895E-12

Real

Aptamer SeqId:19296-51;Target:MLRA;UniProt:Q01449

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19296-51;Target: MLRA;UniProt: Q01449;TargetFullName: Myosin regulatory light chain 2; atrial isoform;Organisim: human;Apparent_Kd_M: 2.507055E-11

Real

Aptamer SeqId: 19296-51 | Target: MLRA | UniProt: Q01449

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19296-51 | Target: MLRA | UniProt: Q01449 | TargetFullName: Myosin regulatory light chain 2; atrial isoform | Organisim: human | Apparent_Kd_M: 2.507055E-11

Real

Aptamer SeqId:19297-4;Target:G6PD;UniProt:P11413

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19297-4;Target: G6PD;UniProt: P11413;TargetFullName: Glucose-6-phosphate 1-dehydrogenase;Organisim: human;Apparent_Kd_M: 3.06316E-12

Real

Aptamer SeqId: 19297-4 | Target: G6PD | UniProt: P11413

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19297-4 | Target: G6PD | UniProt: P11413 | TargetFullName: Glucose-6-phosphate 1-dehydrogenase | Organisim: human | Apparent_Kd_M: 3.06316E-12

Real

Aptamer SeqId:19302-7;Target:GIMA6;UniProt:Q6P9H5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19302-7;Target: GIMA6;UniProt: Q6P9H5;TargetFullName: GTPase IMAP family member 6;Organisim: human;Apparent_Kd_M: 7.18E-11

Real

Aptamer SeqId: 19302-7 | Target: GIMA6 | UniProt: Q6P9H5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19302-7 | Target: GIMA6 | UniProt: Q6P9H5 | TargetFullName: GTPase IMAP family member 6 | Organisim: human | Apparent_Kd_M: 7.18E-11

Real

Aptamer SeqId:19303-64;Target:PT117;UniProt:Q6UWS5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19303-64;Target: PT117;UniProt: Q6UWS5;TargetFullName: Protein PET117 homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 9.945875E-12

Real

Aptamer SeqId: 19303-64 | Target: PT117 | UniProt: Q6UWS5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19303-64 | Target: PT117 | UniProt: Q6UWS5 | TargetFullName: Protein PET117 homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 9.945875E-12

Real

Aptamer SeqId:19310-81;Target:COPE;UniProt:O14579

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19310-81;Target: COPE;UniProt: O14579;TargetFullName: Coatomer subunit epsilon;Organisim: human;Apparent_Kd_M: 3.92E-11

Real

Aptamer SeqId: 19310-81 | Target: COPE | UniProt: O14579

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19310-81 | Target: COPE | UniProt: O14579 | TargetFullName: Coatomer subunit epsilon | Organisim: human | Apparent_Kd_M: 3.92E-11

Real

Aptamer SeqId:19311-15;Target:CRBS;UniProt:P22914

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19311-15;Target: CRBS;UniProt: P22914;TargetFullName: Beta-crystallin S;Organisim: human;Apparent_Kd_M: 5.54E-12

Real

Aptamer SeqId: 19311-15 | Target: CRBS | UniProt: P22914

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19311-15 | Target: CRBS | UniProt: P22914 | TargetFullName: Beta-crystallin S | Organisim: human | Apparent_Kd_M: 5.54E-12

Real

Aptamer SeqId:19316-2;Target:HSC20;UniProt:Q8IWL3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19316-2;Target: HSC20;UniProt: Q8IWL3;TargetFullName: Iron-sulfur cluster co-chaperone protein HscB; mitochondrial;Organisim: human;Apparent_Kd_M: 1.0E-10

Real

Aptamer SeqId: 19316-2 | Target: HSC20 | UniProt: Q8IWL3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19316-2 | Target: HSC20 | UniProt: Q8IWL3 | TargetFullName: Iron-sulfur cluster co-chaperone protein HscB; mitochondrial | Organisim: human | Apparent_Kd_M: 1.0E-10

Real

Aptamer SeqId:19317-114;Target:Prostatic acid phosphatase;UniProt:P15309

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19317-114;Target: Prostatic acid phosphatase;UniProt: P15309;TargetFullName: Prostatic acid phosphatase;Organisim: human;Apparent_Kd_M: 2.621277E-11

Real

Aptamer SeqId: 19317-114 | Target: Prostatic acid phosphatase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19317-114 | Target: Prostatic acid phosphatase | UniProt: P15309 | TargetFullName: Prostatic acid phosphatase | Organisim: human | Apparent_Kd_M: 2.621277E-11

Real

Aptamer SeqId:19323-1;Target:RCAS1;UniProt:O00559

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19323-1;Target: RCAS1;UniProt: O00559;TargetFullName: Receptor-binding cancer antigen expressed on SiSo cells;Organisim: human;Apparent_Kd_M: 2.808498E-11

Real

Aptamer SeqId: 19323-1 | Target: RCAS1 | UniProt: O00559

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19323-1 | Target: RCAS1 | UniProt: O00559 | TargetFullName: Receptor-binding cancer antigen expressed on SiSo cells | Organisim: human | Apparent_Kd_M: 2.808498E-11

Real

Aptamer SeqId:19325-21;Target:ABHEB;UniProt:Q96IU4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19325-21;Target: ABHEB;UniProt: Q96IU4;TargetFullName: Protein ABHD14B;Organisim: human;Apparent_Kd_M: 7.93E-11

Real

Aptamer SeqId: 19325-21 | Target: ABHEB | UniProt: Q96IU4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19325-21 | Target: ABHEB | UniProt: Q96IU4 | TargetFullName: Protein ABHD14B | Organisim: human | Apparent_Kd_M: 7.93E-11

Real

Aptamer SeqId:19327-31;Target:Hat1;UniProt:O14929

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19327-31;Target: Hat1;UniProt: O14929;TargetFullName: Histone acetyltransferase type B catalytic subunit;Organisim: human;Apparent_Kd_M: 9.75E-11

Real

Aptamer SeqId: 19327-31 | Target: Hat1 | UniProt: O14929

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19327-31 | Target: Hat1 | UniProt: O14929 | TargetFullName: Histone acetyltransferase type B catalytic subunit | Organisim: human | Apparent_Kd_M: 9.75E-11

Real

Aptamer SeqId:19328-51;Target:Chk2;UniProt:O96017

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19328-51;Target: Chk2;UniProt: O96017;TargetFullName: Serine/threonine-protein kinase Chk2;Organisim: human;Apparent_Kd_M: 2.42E-11

Real

Aptamer SeqId: 19328-51 | Target: Chk2 | UniProt: O96017

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19328-51 | Target: Chk2 | UniProt: O96017 | TargetFullName: Serine/threonine-protein kinase Chk2 | Organisim: human | Apparent_Kd_M: 2.42E-11

Real

Aptamer SeqId:19329-31;Target:HIPK3;UniProt:Q9H422

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19329-31;Target: HIPK3;UniProt: Q9H422;TargetFullName: Homeodomain-interacting protein kinase 3;Organisim: human;Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId: 19329-31 | Target: HIPK3 | UniProt: Q9H422

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19329-31 | Target: HIPK3 | UniProt: Q9H422 | TargetFullName: Homeodomain-interacting protein kinase 3 | Organisim: human | Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId:19331-18;Target:BAIP2;UniProt:Q9UQB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19331-18;Target: BAIP2;UniProt: Q9UQB8;TargetFullName: Brain-specific angiogenesis inhibitor 1-associated protein 2;Organisim: human;Apparent_Kd_M: 3.05585E-11

Real

Aptamer SeqId: 19331-18 | Target: BAIP2 | UniProt: Q9UQB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19331-18 | Target: BAIP2 | UniProt: Q9UQB8 | TargetFullName: Brain-specific angiogenesis inhibitor 1-associated protein 2 | Organisim: human | Apparent_Kd_M: 3.05585E-11

Real

Aptamer SeqId:19332-1;Target:MOBL3;UniProt:Q9Y3A3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19332-1;Target: MOBL3;UniProt: Q9Y3A3;TargetFullName: MOB-like protein phocein;Organisim: human;Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId: 19332-1 | Target: MOBL3 | UniProt: Q9Y3A3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19332-1 | Target: MOBL3 | UniProt: Q9Y3A3 | TargetFullName: MOB-like protein phocein | Organisim: human | Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId:19333-4;Target:hnRNP K;UniProt:P61978

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19333-4;Target: hnRNP K;UniProt: P61978;TargetFullName: Heterogeneous nuclear ribonucleoprotein K;Organisim: human;Apparent_Kd_M: 6.813381E-11

Real

Aptamer SeqId: 19333-4 | Target: hnRNP K | UniProt: P61978

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19333-4 | Target: hnRNP K | UniProt: P61978 | TargetFullName: Heterogeneous nuclear ribonucleoprotein K | Organisim: human | Apparent_Kd_M: 6.813381E-11

Real

Aptamer SeqId:19334-62;Target:TXD12;UniProt:O95881

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19334-62;Target: TXD12;UniProt: O95881;TargetFullName: Thioredoxin domain-containing protein 12;Organisim: human;Apparent_Kd_M: 5.943266E-12

Real

Aptamer SeqId: 19334-62 | Target: TXD12 | UniProt: O95881

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19334-62 | Target: TXD12 | UniProt: O95881 | TargetFullName: Thioredoxin domain-containing protein 12 | Organisim: human | Apparent_Kd_M: 5.943266E-12

Real

Aptamer SeqId:19335-2;Target:HN1;UniProt:Q9UK76

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19335-2;Target: HN1;UniProt: Q9UK76;TargetFullName: Hematological and neurological expressed 1 protein;Organisim: human;Apparent_Kd_M: 3.038031E-11

Real

Aptamer SeqId: 19335-2 | Target: HN1 | UniProt: Q9UK76

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19335-2 | Target: HN1 | UniProt: Q9UK76 | TargetFullName: Hematological and neurological expressed 1 protein | Organisim: human | Apparent_Kd_M: 3.038031E-11

Real

Aptamer SeqId:19338-3;Target:LZIC;UniProt:Q8WZA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19338-3;Target: LZIC;UniProt: Q8WZA0;TargetFullName: Protein LZIC;Organisim: human;Apparent_Kd_M: 6.06E-11

Real

Aptamer SeqId: 19338-3 | Target: LZIC | UniProt: Q8WZA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19338-3 | Target: LZIC | UniProt: Q8WZA0 | TargetFullName: Protein LZIC | Organisim: human | Apparent_Kd_M: 6.06E-11

Real

Aptamer SeqId:19341-36;Target:ACBD6;UniProt:Q9BR61

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19341-36;Target: ACBD6;UniProt: Q9BR61;TargetFullName: Acyl-CoA-binding domain-containing protein 6;Organisim: human;Apparent_Kd_M: 7.23E-12

Real

Aptamer SeqId: 19341-36 | Target: ACBD6 | UniProt: Q9BR61

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19341-36 | Target: ACBD6 | UniProt: Q9BR61 | TargetFullName: Acyl-CoA-binding domain-containing protein 6 | Organisim: human | Apparent_Kd_M: 7.23E-12

Real

Aptamer SeqId:19347-37;Target:Carbonic Anhydrase XII;UniProt:O43570

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19347-37;Target: Carbonic Anhydrase XII;UniProt: O43570;TargetFullName: Carbonic anhydrase 12;Organisim: human;Apparent_Kd_M: 3.114533E-11

Real

Aptamer SeqId: 19347-37 | Target: Carbonic Anhydrase XII | UniProt: O43570

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19347-37 | Target: Carbonic Anhydrase XII | UniProt: O43570 | TargetFullName: Carbonic anhydrase 12 | Organisim: human | Apparent_Kd_M: 3.114533E-11

Real

Aptamer SeqId:19353-25;Target:OSTM1;UniProt:Q86WC4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19353-25;Target: OSTM1;UniProt: Q86WC4;TargetFullName: Osteopetrosis-associated transmembrane protein 1;Organisim: human;Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId: 19353-25 | Target: OSTM1 | UniProt: Q86WC4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19353-25 | Target: OSTM1 | UniProt: Q86WC4 | TargetFullName: Osteopetrosis-associated transmembrane protein 1 | Organisim: human | Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId:19356-20;Target:TM1L2;UniProt:Q6ZVM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19356-20;Target: TM1L2;UniProt: Q6ZVM7;TargetFullName: TOM1-like protein 2;Organisim: human;Apparent_Kd_M: 4.352605E-11

Real

Aptamer SeqId: 19356-20 | Target: TM1L2 | UniProt: Q6ZVM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19356-20 | Target: TM1L2 | UniProt: Q6ZVM7 | TargetFullName: TOM1-like protein 2 | Organisim: human | Apparent_Kd_M: 4.352605E-11

Real

Aptamer SeqId:19357-11;Target:VAMP7;UniProt:P51809

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19357-11;Target: VAMP7;UniProt: P51809;TargetFullName: Vesicle-associated membrane protein 7;Organisim: human;Apparent_Kd_M: 5.890206E-12

Real

Aptamer SeqId: 19357-11 | Target: VAMP7 | UniProt: P51809

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19357-11 | Target: VAMP7 | UniProt: P51809 | TargetFullName: Vesicle-associated membrane protein 7 | Organisim: human | Apparent_Kd_M: 5.890206E-12

Real

Aptamer SeqId:19360-22;Target:LRRT1;UniProt:Q86UE6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19360-22;Target: LRRT1;UniProt: Q86UE6;TargetFullName: Leucine-rich repeat transmembrane neuronal protein 1;Organisim: human;Apparent_Kd_M: 5.917151E-12

Real

Aptamer SeqId: 19360-22 | Target: LRRT1 | UniProt: Q86UE6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19360-22 | Target: LRRT1 | UniProt: Q86UE6 | TargetFullName: Leucine-rich repeat transmembrane neuronal protein 1 | Organisim: human | Apparent_Kd_M: 5.917151E-12

Real

Aptamer SeqId:19361-78;Target:MATN3;UniProt:O15232

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19361-78;Target: MATN3;UniProt: O15232;TargetFullName: Matrilin-3;Organisim: human;Apparent_Kd_M: 1.89E-10

Real

Aptamer SeqId: 19361-78 | Target: MATN3 | UniProt: O15232

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19361-78 | Target: MATN3 | UniProt: O15232 | TargetFullName: Matrilin-3 | Organisim: human | Apparent_Kd_M: 1.89E-10

Real

Aptamer SeqId:19364-163;Target:PCNA;UniProt:P12004

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19364-163;Target: PCNA;UniProt: P12004;TargetFullName: Proliferating cell nuclear antigen;Organisim: human;Apparent_Kd_M: 1.03536E-11

Real

Aptamer SeqId: 19364-163 | Target: PCNA | UniProt: P12004

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19364-163 | Target: PCNA | UniProt: P12004 | TargetFullName: Proliferating cell nuclear antigen | Organisim: human | Apparent_Kd_M: 1.03536E-11

Real

Aptamer SeqId:19365-11;Target:BCAT2;UniProt:O15382

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19365-11;Target: BCAT2;UniProt: O15382;TargetFullName: Branched-chain-amino-acid aminotransferase; mitochondrial;Organisim: human;Apparent_Kd_M: 4.242997E-12

Real

Aptamer SeqId: 19365-11 | Target: BCAT2 | UniProt: O15382

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19365-11 | Target: BCAT2 | UniProt: O15382 | TargetFullName: Branched-chain-amino-acid aminotransferase; mitochondrial | Organisim: human | Apparent_Kd_M: 4.242997E-12

Real

Aptamer SeqId:19366-8;Target:PEX26;UniProt:Q7Z412

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19366-8;Target: PEX26;UniProt: Q7Z412;TargetFullName: Peroxisome assembly protein 26;Organisim: human;Apparent_Kd_M: 1.723281E-10

Real

Aptamer SeqId: 19366-8 | Target: PEX26 | UniProt: Q7Z412

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19366-8 | Target: PEX26 | UniProt: Q7Z412 | TargetFullName: Peroxisome assembly protein 26 | Organisim: human | Apparent_Kd_M: 1.723281E-10

Real

Aptamer SeqId:19367-34;Target:D3D2;UniProt:P42126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19367-34;Target: D3D2;UniProt: P42126;TargetFullName: Enoyl-CoA delta isomerase 1; mitochondrial;Organisim: human;Apparent_Kd_M: 2.279256E-11

Real

Aptamer SeqId: 19367-34 | Target: D3D2 | UniProt: P42126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19367-34 | Target: D3D2 | UniProt: P42126 | TargetFullName: Enoyl-CoA delta isomerase 1; mitochondrial | Organisim: human | Apparent_Kd_M: 2.279256E-11

Real

Aptamer SeqId:19369-17;Target:GCNL2;UniProt:Q92830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19369-17;Target: GCNL2;UniProt: Q92830;TargetFullName: Histone acetyltransferase KAT2A;Organisim: human;Apparent_Kd_M: 1.367739E-11

Real

Aptamer SeqId: 19369-17 | Target: GCNL2 | UniProt: Q92830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19369-17 | Target: GCNL2 | UniProt: Q92830 | TargetFullName: Histone acetyltransferase KAT2A | Organisim: human | Apparent_Kd_M: 1.367739E-11

Real

Aptamer SeqId:19370-30;Target:HS3S4;UniProt:Q9Y661

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19370-30;Target: HS3S4;UniProt: Q9Y661;TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 4;Organisim: human;Apparent_Kd_M: 7.197426E-12

Real

Aptamer SeqId: 19370-30 | Target: HS3S4 | UniProt: Q9Y661

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19370-30 | Target: HS3S4 | UniProt: Q9Y661 | TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 4 | Organisim: human | Apparent_Kd_M: 7.197426E-12

Real

Aptamer SeqId:19372-7;Target:MDGA2;UniProt:Q7Z553

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19372-7;Target: MDGA2;UniProt: Q7Z553;TargetFullName: MAM domain-containing glycosylphosphatidylinositol anchor protein 2;Organisim: human;Apparent_Kd_M: 1.623933E-12

Real

Aptamer SeqId: 19372-7 | Target: MDGA2 | UniProt: Q7Z553

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19372-7 | Target: MDGA2 | UniProt: Q7Z553 | TargetFullName: MAM domain-containing glycosylphosphatidylinositol anchor protein 2 | Organisim: human | Apparent_Kd_M: 1.623933E-12

Real

Aptamer SeqId:19373-3;Target:MLRM;UniProt:P19105

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19373-3;Target: MLRM;UniProt: P19105;TargetFullName: Myosin regulatory light chain 12A;Organisim: human;Apparent_Kd_M: 1.450259E-11

Real

Aptamer SeqId: 19373-3 | Target: MLRM | UniProt: P19105

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19373-3 | Target: MLRM | UniProt: P19105 | TargetFullName: Myosin regulatory light chain 12A | Organisim: human | Apparent_Kd_M: 1.450259E-11

Real

Aptamer SeqId:19374-72;Target:MTCP1;UniProt:P56278

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19374-72;Target: MTCP1;UniProt: P56278;TargetFullName: Protein p13 MTCP-1;Organisim: human;Apparent_Kd_M: 5.484149E-12

Real

Aptamer SeqId: 19374-72 | Target: MTCP1 | UniProt: P56278

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19374-72 | Target: MTCP1 | UniProt: P56278 | TargetFullName: Protein p13 MTCP-1 | Organisim: human | Apparent_Kd_M: 5.484149E-12

Real

Aptamer SeqId:19376-74;Target:NNMT;UniProt:P40261

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19376-74;Target: NNMT;UniProt: P40261;TargetFullName: Nicotinamide N-methyltransferase;Organisim: human;Apparent_Kd_M: 1.057059E-11

Real

Aptamer SeqId: 19376-74 | Target: NNMT | UniProt: P40261

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19376-74 | Target: NNMT | UniProt: P40261 | TargetFullName: Nicotinamide N-methyltransferase | Organisim: human | Apparent_Kd_M: 1.057059E-11

Real

Aptamer SeqId:19377-14;Target:NOE2;UniProt:O95897

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19377-14;Target: NOE2;UniProt: O95897;TargetFullName: Noelin-2;Organisim: human;Apparent_Kd_M: 2.76894E-11

Real

Aptamer SeqId: 19377-14 | Target: NOE2 | UniProt: O95897

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19377-14 | Target: NOE2 | UniProt: O95897 | TargetFullName: Noelin-2 | Organisim: human | Apparent_Kd_M: 2.76894E-11

Real

Aptamer SeqId:19379-154;Target:RAB3D;UniProt:O95716

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19379-154;Target: RAB3D;UniProt: O95716;TargetFullName: Ras-related protein Rab-3D;Organisim: human;Apparent_Kd_M: 3.141673E-12

Real

Aptamer SeqId: 19379-154 | Target: RAB3D | UniProt: O95716

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19379-154 | Target: RAB3D | UniProt: O95716 | TargetFullName: Ras-related protein Rab-3D | Organisim: human | Apparent_Kd_M: 3.141673E-12

Real

Aptamer SeqId:19381-7;Target:RGS21;UniProt:Q2M5E4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19381-7;Target: RGS21;UniProt: Q2M5E4;TargetFullName: Regulator of G-protein signaling 21;Organisim: human;Apparent_Kd_M: 7.607231E-12

Real

Aptamer SeqId: 19381-7 | Target: RGS21 | UniProt: Q2M5E4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19381-7 | Target: RGS21 | UniProt: Q2M5E4 | TargetFullName: Regulator of G-protein signaling 21 | Organisim: human | Apparent_Kd_M: 7.607231E-12

Real

Aptamer SeqId:19383-131;Target:CINP;UniProt:Q9BW66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19383-131;Target: CINP;UniProt: Q9BW66;TargetFullName: Cyclin-dependent kinase 2-interacting protein;Organisim: human;Apparent_Kd_M: 5.964902E-12

Real

Aptamer SeqId: 19383-131 | Target: CINP | UniProt: Q9BW66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19383-131 | Target: CINP | UniProt: Q9BW66 | TargetFullName: Cyclin-dependent kinase 2-interacting protein | Organisim: human | Apparent_Kd_M: 5.964902E-12

Real

Aptamer SeqId:19388-2;Target:Cadherin-12;UniProt:P55289

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19388-2;Target: Cadherin-12;UniProt: P55289;TargetFullName: Cadherin-12;Organisim: human;Apparent_Kd_M: 1.498474E-10

Real

Aptamer SeqId: 19388-2 | Target: Cadherin-12 | UniProt: P55289

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19388-2 | Target: Cadherin-12 | UniProt: P55289 | TargetFullName: Cadherin-12 | Organisim: human | Apparent_Kd_M: 1.498474E-10

Real

Aptamer SeqId:19392-6;Target:DDAH1;UniProt:O94760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19392-6;Target: DDAH1;UniProt: O94760;TargetFullName: N(G);N(G)-dimethylarginine dimethylaminohydrolase 1;Organisim: human;Apparent_Kd_M: 1.414571E-11

Real

Aptamer SeqId: 19392-6 | Target: DDAH1 | UniProt: O94760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19392-6 | Target: DDAH1 | UniProt: O94760 | TargetFullName: N(G);N(G)-dimethylarginine dimethylaminohydrolase 1 | Organisim: human | Apparent_Kd_M: 1.414571E-11

Real

Aptamer SeqId:19437-61;Target:L-VEGF165;UniProt:P15692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19437-61;Target: L-VEGF165;UniProt: P15692;TargetFullName: Isoform L-VEGF165;Organisim: human;Apparent_Kd_M: 1.09387E-11

Real

Aptamer SeqId: 19437-61 | Target: L-VEGF165 | UniProt: P15692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19437-61 | Target: L-VEGF165 | UniProt: P15692 | TargetFullName: Isoform L-VEGF165 | Organisim: human | Apparent_Kd_M: 1.09387E-11

Real

Aptamer SeqId:19438-68;Target:SYF2;UniProt:O95926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19438-68;Target: SYF2;UniProt: O95926;TargetFullName: Pre-mRNA-splicing factor SYF2;Organisim: human;Apparent_Kd_M: 3.036319E-11

Real

Aptamer SeqId: 19438-68 | Target: SYF2 | UniProt: O95926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19438-68 | Target: SYF2 | UniProt: O95926 | TargetFullName: Pre-mRNA-splicing factor SYF2 | Organisim: human | Apparent_Kd_M: 3.036319E-11

Real

Aptamer SeqId:19446-1;Target:GMPR2;UniProt:Q9P2T1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19446-1;Target: GMPR2;UniProt: Q9P2T1;TargetFullName: GMP reductase 2;Organisim: human;Apparent_Kd_M: 1.30711E-11

Real

Aptamer SeqId: 19446-1 | Target: GMPR2 | UniProt: Q9P2T1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19446-1 | Target: GMPR2 | UniProt: Q9P2T1 | TargetFullName: GMP reductase 2 | Organisim: human | Apparent_Kd_M: 1.30711E-11

Real

Aptamer SeqId:19448-104;Target:UPP1;UniProt:Q16831

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19448-104;Target: UPP1;UniProt: Q16831;TargetFullName: Uridine phosphorylase 1;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 19448-104 | Target: UPP1 | UniProt: Q16831

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19448-104 | Target: UPP1 | UniProt: Q16831 | TargetFullName: Uridine phosphorylase 1 | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:19467-3;Target:RBSK;UniProt:Q9H477

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19467-3;Target: RBSK;UniProt: Q9H477;TargetFullName: Ribokinase;Organisim: human;Apparent_Kd_M: 4.367158E-11

Real

Aptamer SeqId: 19467-3 | Target: RBSK | UniProt: Q9H477

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19467-3 | Target: RBSK | UniProt: Q9H477 | TargetFullName: Ribokinase | Organisim: human | Apparent_Kd_M: 4.367158E-11

Real

Aptamer SeqId:19482-11;Target:HDHD3;UniProt:Q9BSH5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19482-11;Target: HDHD3;UniProt: Q9BSH5;TargetFullName: Haloacid dehalogenase-like hydrolase domain-containing protein 3;Organisim: human;Apparent_Kd_M: 2.2078E-11

Real

Aptamer SeqId: 19482-11 | Target: HDHD3 | UniProt: Q9BSH5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19482-11 | Target: HDHD3 | UniProt: Q9BSH5 | TargetFullName: Haloacid dehalogenase-like hydrolase domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 2.2078E-11

Real

Aptamer SeqId:19483-16;Target:KDSR;UniProt:Q06136

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19483-16;Target: KDSR;UniProt: Q06136;TargetFullName: 3-ketodihydrosphingosine reductase;Organisim: human;Apparent_Kd_M: 6.93238E-12

Real

Aptamer SeqId: 19483-16 | Target: KDSR | UniProt: Q06136

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19483-16 | Target: KDSR | UniProt: Q06136 | TargetFullName: 3-ketodihydrosphingosine reductase | Organisim: human | Apparent_Kd_M: 6.93238E-12

Real

Aptamer SeqId:19488-1;Target:PDCD6;UniProt:O75340

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19488-1;Target: PDCD6;UniProt: O75340;TargetFullName: Programmed cell death protein 6;Organisim: human;Apparent_Kd_M: 8.974219E-12

Real

Aptamer SeqId: 19488-1 | Target: PDCD6 | UniProt: O75340

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19488-1 | Target: PDCD6 | UniProt: O75340 | TargetFullName: Programmed cell death protein 6 | Organisim: human | Apparent_Kd_M: 8.974219E-12

Real

Aptamer SeqId:19491-11;Target:DHB8;UniProt:Q92506

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19491-11;Target: DHB8;UniProt: Q92506;TargetFullName: Estradiol 17-beta-dehydrogenase 8;Organisim: human;Apparent_Kd_M: 1.265898E-11

Real

Aptamer SeqId: 19491-11 | Target: DHB8 | UniProt: Q92506

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19491-11 | Target: DHB8 | UniProt: Q92506 | TargetFullName: Estradiol 17-beta-dehydrogenase 8 | Organisim: human | Apparent_Kd_M: 1.265898E-11

Real

Aptamer SeqId:19492-5;Target:KAAG1;UniProt:Q9UBP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19492-5;Target: KAAG1;UniProt: Q9UBP8;TargetFullName: Kidney-associated antigen 1;Organisim: human;Apparent_Kd_M: 3.938085E-12

Real

Aptamer SeqId: 19492-5 | Target: KAAG1 | UniProt: Q9UBP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19492-5 | Target: KAAG1 | UniProt: Q9UBP8 | TargetFullName: Kidney-associated antigen 1 | Organisim: human | Apparent_Kd_M: 3.938085E-12

Real

Aptamer SeqId:19496-1;Target:NPL;UniProt:Q9BXD5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19496-1;Target: NPL;UniProt: Q9BXD5;TargetFullName: N-acetylneuraminate lyase;Organisim: human;Apparent_Kd_M: 1.436244E-11

Real

Aptamer SeqId: 19496-1 | Target: NPL | UniProt: Q9BXD5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19496-1 | Target: NPL | UniProt: Q9BXD5 | TargetFullName: N-acetylneuraminate lyase | Organisim: human | Apparent_Kd_M: 1.436244E-11

Real

Aptamer SeqId:19503-2;Target:SNX3;UniProt:O60493

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19503-2;Target: SNX3;UniProt: O60493;TargetFullName: Sorting nexin-3;Organisim: human;Apparent_Kd_M: 2.67E-12

Real

Aptamer SeqId: 19503-2 | Target: SNX3 | UniProt: O60493

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19503-2 | Target: SNX3 | UniProt: O60493 | TargetFullName: Sorting nexin-3 | Organisim: human | Apparent_Kd_M: 2.67E-12

Real

Aptamer SeqId:19504-22;Target:KTHY;UniProt:P23919

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19504-22;Target: KTHY;UniProt: P23919;TargetFullName: Thymidylate kinase;Organisim: human;Apparent_Kd_M: 4.4495E-12

Real

Aptamer SeqId: 19504-22 | Target: KTHY | UniProt: P23919

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19504-22 | Target: KTHY | UniProt: P23919 | TargetFullName: Thymidylate kinase | Organisim: human | Apparent_Kd_M: 4.4495E-12

Real

Aptamer SeqId:19506-6;Target:GLYAT;UniProt:Q6IB77

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19506-6;Target: GLYAT;UniProt: Q6IB77;TargetFullName: Glycine N-acyltransferase;Organisim: human;Apparent_Kd_M: 1.227664E-12

Real

Aptamer SeqId: 19506-6 | Target: GLYAT | UniProt: Q6IB77

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19506-6 | Target: GLYAT | UniProt: Q6IB77 | TargetFullName: Glycine N-acyltransferase | Organisim: human | Apparent_Kd_M: 1.227664E-12

Real

Aptamer SeqId:19511-8;Target:DCNL2;UniProt:Q6PH85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19511-8;Target: DCNL2;UniProt: Q6PH85;TargetFullName: DCN1-like protein 2;Organisim: human;Apparent_Kd_M: 1.785239E-11

Real

Aptamer SeqId: 19511-8 | Target: DCNL2 | UniProt: Q6PH85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19511-8 | Target: DCNL2 | UniProt: Q6PH85 | TargetFullName: DCN1-like protein 2 | Organisim: human | Apparent_Kd_M: 1.785239E-11

Real

Aptamer SeqId:19516-10;Target:HMGA2;UniProt:P52926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19516-10;Target: HMGA2;UniProt: P52926;TargetFullName: High mobility group protein HMGI-C;Organisim: human;Apparent_Kd_M: 8.863154E-12

Real

Aptamer SeqId: 19516-10 | Target: HMGA2 | UniProt: P52926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19516-10 | Target: HMGA2 | UniProt: P52926 | TargetFullName: High mobility group protein HMGI-C | Organisim: human | Apparent_Kd_M: 8.863154E-12

Real

Aptamer SeqId:19518-12;Target:HXK3;UniProt:P52790

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19518-12;Target: HXK3;UniProt: P52790;TargetFullName: Hexokinase-3;Organisim: human;Apparent_Kd_M: 4.192696E-11

Real

Aptamer SeqId: 19518-12 | Target: HXK3 | UniProt: P52790

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19518-12 | Target: HXK3 | UniProt: P52790 | TargetFullName: Hexokinase-3 | Organisim: human | Apparent_Kd_M: 4.192696E-11

Real

Aptamer SeqId:19523-215;Target:PARK7;UniProt:Q99497

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19523-215;Target: PARK7;UniProt: Q99497;TargetFullName: Protein DJ-1;Organisim: human;Apparent_Kd_M: 7.553336E-12

Real

Aptamer SeqId: 19523-215 | Target: PARK7 | UniProt: Q99497

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19523-215 | Target: PARK7 | UniProt: Q99497 | TargetFullName: Protein DJ-1 | Organisim: human | Apparent_Kd_M: 7.553336E-12

Real

Aptamer SeqId:19545-145;Target:Oxidized PARK7;UniProt:Q99497

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19545-145;Target: Oxidized PARK7;UniProt: Q99497;TargetFullName: Oxidized Protein deglycase DJ-1;Organisim: human;Apparent_Kd_M: 3.844816E-10

Real

Aptamer SeqId: 19545-145 | Target: Oxidized PARK7 | UniProt: Q99497

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19545-145 | Target: Oxidized PARK7 | UniProt: Q99497 | TargetFullName: Oxidized Protein deglycase DJ-1 | Organisim: human | Apparent_Kd_M: 3.844816E-10

Real

Aptamer SeqId:19553-14;Target:STX1a;UniProt:Q16623

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19553-14;Target: STX1a;UniProt: Q16623;TargetFullName: Syntaxin-1A;Organisim: human;Apparent_Kd_M: 4.812981E-12

Real

Aptamer SeqId: 19553-14 | Target: STX1a | UniProt: Q16623

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19553-14 | Target: STX1a | UniProt: Q16623 | TargetFullName: Syntaxin-1A | Organisim: human | Apparent_Kd_M: 4.812981E-12

Real

Aptamer SeqId:19555-1;Target:SUMO2;UniProt:P61956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19555-1;Target: SUMO2;UniProt: P61956;TargetFullName: Small ubiquitin-related modifier 2;Organisim: human;Apparent_Kd_M: 6.978434E-13

Real

Aptamer SeqId: 19555-1 | Target: SUMO2 | UniProt: P61956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19555-1 | Target: SUMO2 | UniProt: P61956 | TargetFullName: Small ubiquitin-related modifier 2 | Organisim: human | Apparent_Kd_M: 6.978434E-13

Real

Aptamer SeqId:19556-12;Target:Complement receptor type 1;UniProt:P17927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19556-12;Target: Complement receptor type 1;UniProt: P17927;TargetFullName: Complement receptor type 1;Organisim: human;Apparent_Kd_M: 1.05E-12

Real

Aptamer SeqId: 19556-12 | Target: Complement receptor type 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19556-12 | Target: Complement receptor type 1 | UniProt: P17927 | TargetFullName: Complement receptor type 1 | Organisim: human | Apparent_Kd_M: 1.05E-12

Real

Aptamer SeqId:19557-3;Target:KLOTB;UniProt:Q86Z14

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19557-3;Target: KLOTB;UniProt: Q86Z14;TargetFullName: Beta-klotho;Organisim: human;Apparent_Kd_M: 9.647868E-13

Real

Aptamer SeqId: 19557-3 | Target: KLOTB | UniProt: Q86Z14

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19557-3 | Target: KLOTB | UniProt: Q86Z14 | TargetFullName: Beta-klotho | Organisim: human | Apparent_Kd_M: 9.647868E-13

Real

Aptamer SeqId:19558-10;Target:LRP4;UniProt:O75096

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19558-10;Target: LRP4;UniProt: O75096;TargetFullName: Low-density lipoprotein receptor-related protein 4;Organisim: human;Apparent_Kd_M: 4.075105E-12

Real

Aptamer SeqId: 19558-10 | Target: LRP4 | UniProt: O75096

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19558-10 | Target: LRP4 | UniProt: O75096 | TargetFullName: Low-density lipoprotein receptor-related protein 4 | Organisim: human | Apparent_Kd_M: 4.075105E-12

Real

Aptamer SeqId:19560-23;Target:PLXA4;UniProt:Q9HCM2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19560-23;Target: PLXA4;UniProt: Q9HCM2;TargetFullName: Plexin-A4;Organisim: human;Apparent_Kd_M: 1.595146E-12

Real

Aptamer SeqId: 19560-23 | Target: PLXA4 | UniProt: Q9HCM2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19560-23 | Target: PLXA4 | UniProt: Q9HCM2 | TargetFullName: Plexin-A4 | Organisim: human | Apparent_Kd_M: 1.595146E-12

Real

Aptamer SeqId:19561-216;Target:PLXD1;UniProt:Q9Y4D7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19561-216;Target: PLXD1;UniProt: Q9Y4D7;TargetFullName: Plexin-D1;Organisim: human;Apparent_Kd_M: 1.789233E-12

Real

Aptamer SeqId: 19561-216 | Target: PLXD1 | UniProt: Q9Y4D7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19561-216 | Target: PLXD1 | UniProt: Q9Y4D7 | TargetFullName: Plexin-D1 | Organisim: human | Apparent_Kd_M: 1.789233E-12

Real

Aptamer SeqId:19562-8;Target:UBP28;UniProt:Q96RU2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19562-8;Target: UBP28;UniProt: Q96RU2;TargetFullName: Ubiquitin carboxyl-terminal hydrolase 28;Organisim: human;Apparent_Kd_M: 1.794333E-10

Real

Aptamer SeqId: 19562-8 | Target: UBP28 | UniProt: Q96RU2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19562-8 | Target: UBP28 | UniProt: Q96RU2 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase 28 | Organisim: human | Apparent_Kd_M: 1.794333E-10

Real

Aptamer SeqId:19563-3;Target:SEZ6L;UniProt:Q9BYH1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19563-3;Target: SEZ6L;UniProt: Q9BYH1;TargetFullName: Seizure 6-like protein;Organisim: human;Apparent_Kd_M: 1.832901E-12

Real

Aptamer SeqId: 19563-3 | Target: SEZ6L | UniProt: Q9BYH1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19563-3 | Target: SEZ6L | UniProt: Q9BYH1 | TargetFullName: Seizure 6-like protein | Organisim: human | Apparent_Kd_M: 1.832901E-12

Real

Aptamer SeqId:19564-61;Target:IRF4;UniProt:Q15306

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19564-61;Target: IRF4;UniProt: Q15306;TargetFullName: Interferon regulatory factor 4;Organisim: human;Apparent_Kd_M: 8.31E-12

Real

Aptamer SeqId: 19564-61 | Target: IRF4 | UniProt: Q15306

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19564-61 | Target: IRF4 | UniProt: Q15306 | TargetFullName: Interferon regulatory factor 4 | Organisim: human | Apparent_Kd_M: 8.31E-12

Real

Aptamer SeqId:19567-1;Target:EGFRvIII;UniProt:P00533

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19567-1;Target: EGFRvIII;UniProt: P00533;TargetFullName: Epidermal growth factor receptor variant III;Organisim: human;Apparent_Kd_M: 3.73E-11

Real

Aptamer SeqId: 19567-1 | Target: EGFRvIII | UniProt: P00533

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19567-1 | Target: EGFRvIII | UniProt: P00533 | TargetFullName: Epidermal growth factor receptor variant III | Organisim: human | Apparent_Kd_M: 3.73E-11

Real

Aptamer SeqId:19568-17;Target:IL-15;UniProt:P40933

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19568-17;Target: IL-15;UniProt: P40933;TargetFullName: Interleukin-15;Organisim: human;Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId: 19568-17 | Target: IL-15 | UniProt: P40933

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19568-17 | Target: IL-15 | UniProt: P40933 | TargetFullName: Interleukin-15 | Organisim: human | Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId:19570-12;Target:FGF-8;UniProt:P55075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19570-12;Target: FGF-8;UniProt: P55075;TargetFullName: Fibroblast growth factor 8;Organisim: human;Apparent_Kd_M: 4.43E-12

Real

Aptamer SeqId: 19570-12 | Target: FGF-8 | UniProt: P55075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19570-12 | Target: FGF-8 | UniProt: P55075 | TargetFullName: Fibroblast growth factor 8 | Organisim: human | Apparent_Kd_M: 4.43E-12

Real

Aptamer SeqId:19572-10;Target:CEBPG;UniProt:P53567

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19572-10;Target: CEBPG;UniProt: P53567;TargetFullName: CCAAT/enhancer-binding protein gamma;Organisim: human;Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId: 19572-10 | Target: CEBPG | UniProt: P53567

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19572-10 | Target: CEBPG | UniProt: P53567 | TargetFullName: CCAAT/enhancer-binding protein gamma | Organisim: human | Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId:19574-5;Target:gpIIbIIIa;UniProt:P08514|P05106

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19574-5;Target: gpIIbIIIa;UniProt: P08514|P05106;TargetFullName: Integrin alpha-IIb: beta-3 complex;Organisim: human;Apparent_Kd_M: 3.74655E-11

Real

Aptamer SeqId: 19574-5 | Target: gpIIbIIIa | UniProt: P08514|P05106

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19574-5 | Target: gpIIbIIIa | UniProt: P08514|P05106 | TargetFullName: Integrin alpha-IIb: beta-3 complex | Organisim: human | Apparent_Kd_M: 3.74655E-11

Real

Aptamer SeqId:19575-4;Target:EPO-R;UniProt:P19235

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19575-4;Target: EPO-R;UniProt: P19235;TargetFullName: Erythropoietin receptor;Organisim: human;Apparent_Kd_M: 2.28E-11

Real

Aptamer SeqId: 19575-4 | Target: EPO-R | UniProt: P19235

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19575-4 | Target: EPO-R | UniProt: P19235 | TargetFullName: Erythropoietin receptor | Organisim: human | Apparent_Kd_M: 2.28E-11

Real

Aptamer SeqId:19578-19;Target:DOK2;UniProt:O60496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19578-19;Target: DOK2;UniProt: O60496;TargetFullName: Docking protein 2;Organisim: human;Apparent_Kd_M: 5.48E-12

Real

Aptamer SeqId: 19578-19 | Target: DOK2 | UniProt: O60496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19578-19 | Target: DOK2 | UniProt: O60496 | TargetFullName: Docking protein 2 | Organisim: human | Apparent_Kd_M: 5.48E-12

Real

Aptamer SeqId:19579-5;Target:HNP-1;UniProt:P59665

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19579-5;Target: HNP-1;UniProt: P59665;TargetFullName: Neutrophil defensin 1;Organisim: human;Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId: 19579-5 | Target: HNP-1 | UniProt: P59665

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19579-5 | Target: HNP-1 | UniProt: P59665 | TargetFullName: Neutrophil defensin 1 | Organisim: human | Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId:19581-15;Target:IGFBP-5;UniProt:P24593

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19581-15;Target: IGFBP-5;UniProt: P24593;TargetFullName: Insulin-like growth factor-binding protein 5;Organisim: human;Apparent_Kd_M: 3.09E-12

Real

Aptamer SeqId: 19581-15 | Target: IGFBP-5 | UniProt: P24593

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19581-15 | Target: IGFBP-5 | UniProt: P24593 | TargetFullName: Insulin-like growth factor-binding protein 5 | Organisim: human | Apparent_Kd_M: 3.09E-12

Real

Aptamer SeqId:19584-33;Target:FGF9;UniProt:P31371

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19584-33;Target: FGF9;UniProt: P31371;TargetFullName: Fibroblast growth factor 9;Organisim: human;Apparent_Kd_M: 2.59E-12

Real

Aptamer SeqId: 19584-33 | Target: FGF9 | UniProt: P31371

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19584-33 | Target: FGF9 | UniProt: P31371 | TargetFullName: Fibroblast growth factor 9 | Organisim: human | Apparent_Kd_M: 2.59E-12

Real

Aptamer SeqId:19586-89;Target:RAB3C;UniProt:Q96E17

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19586-89;Target: RAB3C;UniProt: Q96E17;TargetFullName: Ras-related protein Rab-3C;Organisim: human;Apparent_Kd_M: 3.008535E-11

Real

Aptamer SeqId: 19586-89 | Target: RAB3C | UniProt: Q96E17

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19586-89 | Target: RAB3C | UniProt: Q96E17 | TargetFullName: Ras-related protein Rab-3C | Organisim: human | Apparent_Kd_M: 3.008535E-11

Real

Aptamer SeqId:19587-12;Target:IMA5;UniProt:P52294

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19587-12;Target: IMA5;UniProt: P52294;TargetFullName: Importin subunit alpha-5;Organisim: human;Apparent_Kd_M: 2.63E-11

Real

Aptamer SeqId: 19587-12 | Target: IMA5 | UniProt: P52294

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19587-12 | Target: IMA5 | UniProt: P52294 | TargetFullName: Importin subunit alpha-5 | Organisim: human | Apparent_Kd_M: 2.63E-11

Real

Aptamer SeqId:19590-46;Target:SP-D;UniProt:P35247

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19590-46;Target: SP-D;UniProt: P35247;TargetFullName: Pulmonary surfactant-associated protein D;Organisim: human;Apparent_Kd_M: 3.179932E-11

Real

Aptamer SeqId: 19590-46 | Target: SP-D | UniProt: P35247

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19590-46 | Target: SP-D | UniProt: P35247 | TargetFullName: Pulmonary surfactant-associated protein D | Organisim: human | Apparent_Kd_M: 3.179932E-11

Real

Aptamer SeqId:19596-18;Target:BRF-1;UniProt:Q92994

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19596-18;Target: BRF-1;UniProt: Q92994;TargetFullName: Transcription factor IIIB 90 kDa subunit;Organisim: human;Apparent_Kd_M: 9.36E-11

Real

Aptamer SeqId: 19596-18 | Target: BRF-1 | UniProt: Q92994

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19596-18 | Target: BRF-1 | UniProt: Q92994 | TargetFullName: Transcription factor IIIB 90 kDa subunit | Organisim: human | Apparent_Kd_M: 9.36E-11

Real

Aptamer SeqId:19601-15;Target:ASB9;UniProt:Q96DX5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19601-15;Target: ASB9;UniProt: Q96DX5;TargetFullName: Ankyrin repeat and SOCS box protein 9;Organisim: human;Apparent_Kd_M: 3.842785E-11

Real

Aptamer SeqId: 19601-15 | Target: ASB9 | UniProt: Q96DX5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19601-15 | Target: ASB9 | UniProt: Q96DX5 | TargetFullName: Ankyrin repeat and SOCS box protein 9 | Organisim: human | Apparent_Kd_M: 3.842785E-11

Real

Aptamer SeqId:19602-36;Target:jun-D;UniProt:P17535

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19602-36;Target: jun-D;UniProt: P17535;TargetFullName: Transcription factor jun-D;Organisim: human;Apparent_Kd_M: 5.414665E-12

Real

Aptamer SeqId: 19602-36 | Target: jun-D | UniProt: P17535

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19602-36 | Target: jun-D | UniProt: P17535 | TargetFullName: Transcription factor jun-D | Organisim: human | Apparent_Kd_M: 5.414665E-12

Real

Aptamer SeqId:19606-28;Target:ihh;UniProt:Q14623

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19606-28;Target: ihh;UniProt: Q14623;TargetFullName: Indian hedgehog protein;Organisim: human;Apparent_Kd_M: 2.165878E-11

Real

Aptamer SeqId: 19606-28 | Target: ihh | UniProt: Q14623

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19606-28 | Target: ihh | UniProt: Q14623 | TargetFullName: Indian hedgehog protein | Organisim: human | Apparent_Kd_M: 2.165878E-11

Real

Aptamer SeqId:19612-3;Target:CD81;UniProt:P60033

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19612-3;Target: CD81;UniProt: P60033;TargetFullName: CD81 antigen;Organisim: human;Apparent_Kd_M: 1.952468E-10

Real

Aptamer SeqId: 19612-3 | Target: CD81 | UniProt: P60033

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19612-3 | Target: CD81 | UniProt: P60033 | TargetFullName: CD81 antigen | Organisim: human | Apparent_Kd_M: 1.952468E-10

Real

Aptamer SeqId:19614-8;Target:Holo-TC I;UniProt:P20061

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19614-8;Target: Holo-TC I;UniProt: P20061;TargetFullName: Transcobalamin-1;Organisim: human;Apparent_Kd_M: 3.296429E-12

Real

Aptamer SeqId: 19614-8 | Target: Holo-TC I | UniProt: P20061

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19614-8 | Target: Holo-TC I | UniProt: P20061 | TargetFullName: Transcobalamin-1 | Organisim: human | Apparent_Kd_M: 3.296429E-12

Real

Aptamer SeqId:19615-213;Target:5NT3;UniProt:Q9H0P0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19615-213;Target: 5NT3;UniProt: Q9H0P0;TargetFullName: Cytosolic 5-nucleotidase 3A;Organisim: human;Apparent_Kd_M: 7.602666E-12

Real

Aptamer SeqId: 19615-213 | Target: 5NT3 | UniProt: Q9H0P0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19615-213 | Target: 5NT3 | UniProt: Q9H0P0 | TargetFullName: Cytosolic 5'-nucleotidase 3A | Organisim: human | Apparent_Kd_M: 7.602666E-12

Real

Aptamer SeqId:19616-100;Target:EFHD1;UniProt:Q9BUP0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19616-100;Target: EFHD1;UniProt: Q9BUP0;TargetFullName: EF-hand domain-containing protein D1;Organisim: human;Apparent_Kd_M: 2.021984E-12

Real

Aptamer SeqId: 19616-100 | Target: EFHD1 | UniProt: Q9BUP0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19616-100 | Target: EFHD1 | UniProt: Q9BUP0 | TargetFullName: EF-hand domain-containing protein D1 | Organisim: human | Apparent_Kd_M: 2.021984E-12

Real

Aptamer SeqId:19617-5;Target:LTB4DH;UniProt:Q14914

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19617-5;Target: LTB4DH;UniProt: Q14914;TargetFullName: Prostaglandin reductase 1;Organisim: human;Apparent_Kd_M: 1.787524E-12

Real

Aptamer SeqId: 19617-5 | Target: LTB4DH | UniProt: Q14914

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19617-5 | Target: LTB4DH | UniProt: Q14914 | TargetFullName: Prostaglandin reductase 1 | Organisim: human | Apparent_Kd_M: 1.787524E-12

Real

Aptamer SeqId:19620-16;Target:DLG2;UniProt:Q15700

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19620-16;Target: DLG2;UniProt: Q15700;TargetFullName: Disks large homolog 2;Organisim: human;Apparent_Kd_M: 2.269593E-12

Real

Aptamer SeqId: 19620-16 | Target: DLG2 | UniProt: Q15700

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19620-16 | Target: DLG2 | UniProt: Q15700 | TargetFullName: Disks large homolog 2 | Organisim: human | Apparent_Kd_M: 2.269593E-12

Real

Aptamer SeqId:19622-7;Target:Activin A;UniProt:P08476

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19622-7;Target: Activin A;UniProt: P08476;TargetFullName: Inhibin beta A chain;Organisim: human;Apparent_Kd_M: 2.9564E-12

Real

Aptamer SeqId: 19622-7 | Target: Activin A | UniProt: P08476

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19622-7 | Target: Activin A | UniProt: P08476 | TargetFullName: Inhibin beta A chain | Organisim: human | Apparent_Kd_M: 2.9564E-12

Real

Aptamer SeqId:19623-26;Target:40S ribosomal protein SA;UniProt:P08865

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19623-26;Target: 40S ribosomal protein SA;UniProt: P08865;TargetFullName: 40S ribosomal protein SA;Organisim: human;Apparent_Kd_M: 3.783614E-12

Real

Aptamer SeqId: 19623-26 | Target: 40S ribosomal protein SA

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19623-26 | Target: 40S ribosomal protein SA | UniProt: P08865 | TargetFullName: 40S ribosomal protein SA | Organisim: human | Apparent_Kd_M: 3.783614E-12

Real

Aptamer SeqId:19631-13;Target:Kininostatin;UniProt:P01042

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19631-13;Target: Kininostatin;UniProt: P01042;TargetFullName: Kininostatin;Organisim: human;Apparent_Kd_M: 5.458265E-11

Real

Aptamer SeqId: 19631-13 | Target: Kininostatin | UniProt: P01042

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19631-13 | Target: Kininostatin | UniProt: P01042 | TargetFullName: Kininostatin | Organisim: human | Apparent_Kd_M: 5.458265E-11

Real

Aptamer SeqId:19635-69;Target:FGL2;UniProt:Q14314

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19635-69;Target: FGL2;UniProt: Q14314;TargetFullName: Fibroleukin;Organisim: human;Apparent_Kd_M: 3.035508E-11

Real

Aptamer SeqId: 19635-69 | Target: FGL2 | UniProt: Q14314

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19635-69 | Target: FGL2 | UniProt: Q14314 | TargetFullName: Fibroleukin | Organisim: human | Apparent_Kd_M: 3.035508E-11

Real

Aptamer SeqId:19636-23;Target:HLA-G;UniProt:P17693

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19636-23;Target: HLA-G;UniProt: P17693;TargetFullName: HLA class I histocompatibility antigen; alpha chain G;Organisim: human;Apparent_Kd_M: 1.294933E-10

Real

Aptamer SeqId: 19636-23 | Target: HLA-G | UniProt: P17693

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19636-23 | Target: HLA-G | UniProt: P17693 | TargetFullName: HLA class I histocompatibility antigen; alpha chain G | Organisim: human | Apparent_Kd_M: 1.294933E-10

Real

Aptamer SeqId:19637-9;Target:CRH;UniProt:P06850

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19637-9;Target: CRH;UniProt: P06850;TargetFullName: Corticoliberin;Organisim: human;Apparent_Kd_M: 2.053152E-11

Real

Aptamer SeqId: 19637-9 | Target: CRH | UniProt: P06850

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19637-9 | Target: CRH | UniProt: P06850 | TargetFullName: Corticoliberin | Organisim: human | Apparent_Kd_M: 2.053152E-11

Real

Aptamer SeqId:19638-9;Target:Dynorphin A (1-17);UniProt:P01213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19638-9;Target: Dynorphin A (1-17);UniProt: P01213;TargetFullName: Dynorphin A (1-17);Organisim: human;Apparent_Kd_M: 3.258531E-12

Real

Aptamer SeqId: 19638-9 | Target: Dynorphin A (1-17) | UniProt: P01213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19638-9 | Target: Dynorphin A (1-17) | UniProt: P01213 | TargetFullName: Dynorphin A (1-17) | Organisim: human | Apparent_Kd_M: 3.258531E-12

Real

Aptamer SeqId:19639-53;Target:IAPP;UniProt:P10997

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19639-53;Target: IAPP;UniProt: P10997;TargetFullName: Islet amyloid polypeptide;Organisim: human;Apparent_Kd_M: 5.277639E-12

Real

Aptamer SeqId: 19639-53 | Target: IAPP | UniProt: P10997

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19639-53 | Target: IAPP | UniProt: P10997 | TargetFullName: Islet amyloid polypeptide | Organisim: human | Apparent_Kd_M: 5.277639E-12

Real

Aptamer SeqId:19640-2;Target:Parathyroid Hormone1-34;UniProt:P01270

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 19640-2;Target: Parathyroid Hormone1-34;UniProt: P01270;TargetFullName: Parathyroid Hormone1-34;Organisim: human;Apparent_Kd_M: 1.053322E-11

Real

Aptamer SeqId: 19640-2 | Target: Parathyroid Hormone1-34 | UniProt: P01270

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 19640-2 | Target: Parathyroid Hormone1-34 | UniProt: P01270 | TargetFullName: Parathyroid Hormone1-34 | Organisim: human | Apparent_Kd_M: 1.053322E-11

Real

Aptamer SeqId:2052-1;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2052-1;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2052-1 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2052-1 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2053-2;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2053-2;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2053-2 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2053-2 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2054-3;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2054-3;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2054-3 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2054-3 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2055-4;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2055-4;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2055-4 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2055-4 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2056-5;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2056-5;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2056-5 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2056-5 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2057-6;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2057-6;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2057-6 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2057-6 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2058-7;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2058-7;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2058-7 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2058-7 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2060-9;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2060-9;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2060-9 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2060-9 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2061-10;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2061-10;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2061-10 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2061-10 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2171-12;Target:HCE001796;UniProt:HCE001796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2171-12;Target: HCE001796;UniProt: HCE001796;TargetFullName: HCE001796;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2171-12 | Target: HCE001796 | UniProt: HCE001796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2171-12 | Target: HCE001796 | UniProt: HCE001796 | TargetFullName: HCE001796 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2178-55;Target:HCE003167;UniProt:HCE003167

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2178-55;Target: HCE003167;UniProt: HCE003167;TargetFullName: HCE003167;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2178-55 | Target: HCE003167 | UniProt: HCE003167

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2178-55 | Target: HCE003167 | UniProt: HCE003167 | TargetFullName: HCE003167 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2182-54;Target:C4b;UniProt:P0C0L4|P0C0L5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2182-54;Target: C4b;UniProt: P0C0L4|P0C0L5;TargetFullName: Complement C4b;Organisim: human;Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId: 2182-54 | Target: C4b | UniProt: P0C0L4|P0C0L5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2182-54 | Target: C4b | UniProt: P0C0L4|P0C0L5 | TargetFullName: Complement C4b | Organisim: human | Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId:2190-55;Target:Coagulation Factor XI;UniProt:P03951

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2190-55;Target: Coagulation Factor XI;UniProt: P03951;TargetFullName: Coagulation Factor XI;Organisim: human;Apparent_Kd_M: 9.2E-12

Real

Aptamer SeqId: 2190-55 | Target: Coagulation Factor XI | UniProt: P03951

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2190-55 | Target: Coagulation Factor XI | UniProt: P03951 | TargetFullName: Coagulation Factor XI | Organisim: human | Apparent_Kd_M: 9.2E-12

Real

Aptamer SeqId:2192-63;Target:CTACK;UniProt:Q9Y4X3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2192-63;Target: CTACK;UniProt: Q9Y4X3;TargetFullName: C-C motif chemokine 27;Organisim: human;Apparent_Kd_M: 3.13E-12

Real

Aptamer SeqId: 2192-63 | Target: CTACK | UniProt: Q9Y4X3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2192-63 | Target: CTACK | UniProt: Q9Y4X3 | TargetFullName: C-C motif chemokine 27 | Organisim: human | Apparent_Kd_M: 3.13E-12

Real

Aptamer SeqId:2194-91;Target:HCE000414;UniProt:HCE000414

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2194-91;Target: HCE000414;UniProt: HCE000414;TargetFullName: HCE000414;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2194-91 | Target: HCE000414 | UniProt: HCE000414

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2194-91 | Target: HCE000414 | UniProt: HCE000414 | TargetFullName: HCE000414 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2201-17;Target:Endostatin;UniProt:P39060

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2201-17;Target: Endostatin;UniProt: P39060;TargetFullName: Endostatin;Organisim: human;Apparent_Kd_M: 3.148545E-12

Real

Aptamer SeqId: 2201-17 | Target: Endostatin | UniProt: P39060

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2201-17 | Target: Endostatin | UniProt: P39060 | TargetFullName: Endostatin | Organisim: human | Apparent_Kd_M: 3.148545E-12

Real

Aptamer SeqId:2211-9;Target:TIMP-1;UniProt:P01033

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2211-9;Target: TIMP-1;UniProt: P01033;TargetFullName: Metalloproteinase inhibitor 1;Organisim: human;Apparent_Kd_M: 7.22E-12

Real

Aptamer SeqId: 2211-9 | Target: TIMP-1 | UniProt: P01033

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2211-9 | Target: TIMP-1 | UniProt: P01033 | TargetFullName: Metalloproteinase inhibitor 1 | Organisim: human | Apparent_Kd_M: 7.22E-12

Real

Aptamer SeqId:2212-69;Target:tPA;UniProt:P00750

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2212-69;Target: tPA;UniProt: P00750;TargetFullName: Tissue-type plasminogen activator;Organisim: human;Apparent_Kd_M: 3.82E-11

Real

Aptamer SeqId: 2212-69 | Target: tPA | UniProt: P00750

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2212-69 | Target: tPA | UniProt: P00750 | TargetFullName: Tissue-type plasminogen activator | Organisim: human | Apparent_Kd_M: 3.82E-11

Real

Aptamer SeqId:2229-54;Target:HCE003183;UniProt:HCE003183

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2229-54;Target: HCE003183;UniProt: HCE003183;TargetFullName: HCE003183;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2229-54 | Target: HCE003183 | UniProt: HCE003183

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2229-54 | Target: HCE003183 | UniProt: HCE003183 | TargetFullName: HCE003183 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2247-20;Target:EG-VEGF;UniProt:P58294

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2247-20;Target: EG-VEGF;UniProt: P58294;TargetFullName: Prokineticin-1;Organisim: human;Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId: 2247-20 | Target: EG-VEGF | UniProt: P58294

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2247-20 | Target: EG-VEGF | UniProt: P58294 | TargetFullName: Prokineticin-1 | Organisim: human | Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId:2249-25;Target:HCE004333;UniProt:HCE004333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2249-25;Target: HCE004333;UniProt: HCE004333;TargetFullName: HCE004333;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2249-25 | Target: HCE004333 | UniProt: HCE004333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2249-25 | Target: HCE004333 | UniProt: HCE004333 | TargetFullName: HCE004333 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2273-34;Target:HCE004359;UniProt:HCE004359

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2273-34;Target: HCE004359;UniProt: HCE004359;TargetFullName: HCE004359;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2273-34 | Target: HCE004359 | UniProt: HCE004359

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2273-34 | Target: HCE004359 | UniProt: HCE004359 | TargetFullName: HCE004359 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2278-61;Target:TIMP-2;UniProt:P16035

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2278-61;Target: TIMP-2;UniProt: P16035;TargetFullName: Metalloproteinase inhibitor 2;Organisim: human;Apparent_Kd_M: 3.08E-12

Real

Aptamer SeqId: 2278-61 | Target: TIMP-2 | UniProt: P16035

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2278-61 | Target: TIMP-2 | UniProt: P16035 | TargetFullName: Metalloproteinase inhibitor 2 | Organisim: human | Apparent_Kd_M: 3.08E-12

Real

Aptamer SeqId:2288-7;Target:HCE004331;UniProt:HCE004331

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2288-7;Target: HCE004331;UniProt: HCE004331;TargetFullName: HCE004331;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2288-7 | Target: HCE004331 | UniProt: HCE004331

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2288-7 | Target: HCE004331 | UniProt: HCE004331 | TargetFullName: HCE004331 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2305-52;Target:HCE003300;UniProt:HCE003300

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2305-52;Target: HCE003300;UniProt: HCE003300;TargetFullName: HCE003300;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2305-52 | Target: HCE003300 | UniProt: HCE003300

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2305-52 | Target: HCE003300 | UniProt: HCE003300 | TargetFullName: HCE003300 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2312-13;Target:HCE000483;UniProt:HCE000483

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2312-13;Target: HCE000483;UniProt: HCE000483;TargetFullName: HCE000483;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2312-13 | Target: HCE000483 | UniProt: HCE000483

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2312-13 | Target: HCE000483 | UniProt: HCE000483 | TargetFullName: HCE000483 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2333-72;Target:TGF-b1;UniProt:P01137

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2333-72;Target: TGF-b1;UniProt: P01137;TargetFullName: Transforming growth factor beta-1;Organisim: human;Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId: 2333-72 | Target: TGF-b1 | UniProt: P01137

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2333-72 | Target: TGF-b1 | UniProt: P01137 | TargetFullName: Transforming growth factor beta-1 | Organisim: human | Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId:2359-65;Target:HCE004152;UniProt:HCE004152

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2359-65;Target: HCE004152;UniProt: HCE004152;TargetFullName: HCE004152;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2359-65 | Target: HCE004152 | UniProt: HCE004152

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2359-65 | Target: HCE004152 | UniProt: HCE004152 | TargetFullName: HCE004152 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2381-52;Target:C5;UniProt:P01031

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2381-52;Target: C5;UniProt: P01031;TargetFullName: Complement C5;Organisim: human;Apparent_Kd_M: 7.61E-11

Real

Aptamer SeqId: 2381-52 | Target: C5 | UniProt: P01031

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2381-52 | Target: C5 | UniProt: P01031 | TargetFullName: Complement C5 | Organisim: human | Apparent_Kd_M: 7.61E-11

Real

Aptamer SeqId:2418-55;Target:Apo E;UniProt:P02649

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2418-55;Target: Apo E;UniProt: P02649;TargetFullName: Apolipoprotein E;Organisim: human;Apparent_Kd_M: 2.31E-10

Real

Aptamer SeqId: 2418-55 | Target: Apo E | UniProt: P02649

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2418-55 | Target: Apo E | UniProt: P02649 | TargetFullName: Apolipoprotein E | Organisim: human | Apparent_Kd_M: 2.31E-10

Real

Aptamer SeqId:2421-7;Target:BDNF;UniProt:P23560

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2421-7;Target: BDNF;UniProt: P23560;TargetFullName: Brain-derived neurotrophic factor;Organisim: human;Apparent_Kd_M: 7.05E-12

Real

Aptamer SeqId: 2421-7 | Target: BDNF | UniProt: P23560

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2421-7 | Target: BDNF | UniProt: P23560 | TargetFullName: Brain-derived neurotrophic factor | Organisim: human | Apparent_Kd_M: 7.05E-12

Real

Aptamer SeqId:2429-27;Target:C8;UniProt:P07357|P07358|P07360

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2429-27;Target: C8;UniProt: P07357|P07358|P07360;TargetFullName: Complement component C8;Organisim: human;Apparent_Kd_M: 4.82E-11

Real

Aptamer SeqId: 2429-27 | Target: C8 | UniProt: P07357|P07358|P07360

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2429-27 | Target: C8 | UniProt: P07357|P07358|P07360 | TargetFullName: Complement component C8 | Organisim: human | Apparent_Kd_M: 4.82E-11

Real

Aptamer SeqId:2430-52;Target:HCE000342;UniProt:HCE000342

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2430-52;Target: HCE000342;UniProt: HCE000342;TargetFullName: HCE000342;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2430-52 | Target: HCE000342 | UniProt: HCE000342

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2430-52 | Target: HCE000342 | UniProt: HCE000342 | TargetFullName: HCE000342 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2431-17;Target:Cathepsin G;UniProt:P08311

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2431-17;Target: Cathepsin G;UniProt: P08311;TargetFullName: Cathepsin G;Organisim: human;Apparent_Kd_M: 9.96E-11

Real

Aptamer SeqId: 2431-17 | Target: Cathepsin G | UniProt: P08311

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2431-17 | Target: Cathepsin G | UniProt: P08311 | TargetFullName: Cathepsin G | Organisim: human | Apparent_Kd_M: 9.96E-11

Real

Aptamer SeqId:2436-49;Target:CXCL16; soluble;UniProt:Q9H2A7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2436-49;Target: CXCL16; soluble;UniProt: Q9H2A7;TargetFullName: C-X-C motif chemokine 16;Organisim: human;Apparent_Kd_M: 4.85E-12

Real

Aptamer SeqId: 2436-49 | Target: CXCL16; soluble | UniProt: Q9H2A7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2436-49 | Target: CXCL16; soluble | UniProt: Q9H2A7 | TargetFullName: C-X-C motif chemokine 16 | Organisim: human | Apparent_Kd_M: 4.85E-12

Real

Aptamer SeqId:2441-2;Target:FGF-10;UniProt:O15520

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2441-2;Target: FGF-10;UniProt: O15520;TargetFullName: Fibroblast growth factor 10;Organisim: human;Apparent_Kd_M: 6.58E-12

Real

Aptamer SeqId: 2441-2 | Target: FGF-10 | UniProt: O15520

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2441-2 | Target: FGF-10 | UniProt: O15520 | TargetFullName: Fibroblast growth factor 10 | Organisim: human | Apparent_Kd_M: 6.58E-12

Real

Aptamer SeqId:2443-10;Target:FGF-8B;UniProt:P55075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2443-10;Target: FGF-8B;UniProt: P55075;TargetFullName: Fibroblast growth factor 8 isoform B;Organisim: human;Apparent_Kd_M: 8.61E-11

Real

Aptamer SeqId: 2443-10 | Target: FGF-8B | UniProt: P55075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2443-10 | Target: FGF-8B | UniProt: P55075 | TargetFullName: Fibroblast growth factor 8 isoform B | Organisim: human | Apparent_Kd_M: 8.61E-11

Real

Aptamer SeqId:2447-7;Target:GIIE;UniProt:Q9NZK7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2447-7;Target: GIIE;UniProt: Q9NZK7;TargetFullName: Group IIE secretory phospholipase A2;Organisim: human;Apparent_Kd_M: 3.61E-12

Real

Aptamer SeqId: 2447-7 | Target: GIIE | UniProt: Q9NZK7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2447-7 | Target: GIIE | UniProt: Q9NZK7 | TargetFullName: Group IIE secretory phospholipase A2 | Organisim: human | Apparent_Kd_M: 3.61E-12

Real

Aptamer SeqId:2449-1;Target:GV;UniProt:P39877

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2449-1;Target: GV;UniProt: P39877;TargetFullName: Calcium-dependent phospholipase A2;Organisim: human;Apparent_Kd_M: 9.06E-13

Real

Aptamer SeqId: 2449-1 | Target: GV | UniProt: P39877

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2449-1 | Target: GV | UniProt: P39877 | TargetFullName: Calcium-dependent phospholipase A2 | Organisim: human | Apparent_Kd_M: 9.06E-13

Real

Aptamer SeqId:2468-62;Target:MIP-3a;UniProt:P78556

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2468-62;Target: MIP-3a;UniProt: P78556;TargetFullName: C-C motif chemokine 20;Organisim: human;Apparent_Kd_M: 3.97E-12

Real

Aptamer SeqId: 2468-62 | Target: MIP-3a | UniProt: P78556

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2468-62 | Target: MIP-3a | UniProt: P78556 | TargetFullName: C-C motif chemokine 20 | Organisim: human | Apparent_Kd_M: 3.97E-12

Real

Aptamer SeqId:2474-54;Target:SAP;UniProt:P02743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2474-54;Target: SAP;UniProt: P02743;TargetFullName: Serum amyloid P-component;Organisim: human;Apparent_Kd_M: 7.87E-12

Real

Aptamer SeqId: 2474-54 | Target: SAP | UniProt: P02743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2474-54 | Target: SAP | UniProt: P02743 | TargetFullName: Serum amyloid P-component | Organisim: human | Apparent_Kd_M: 7.87E-12

Real

Aptamer SeqId:2475-1;Target:SCF sR;UniProt:P10721

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2475-1;Target: SCF sR;UniProt: P10721;TargetFullName: Mast/stem cell growth factor receptor Kit;Organisim: human;Apparent_Kd_M: 1.68E-12

Real

Aptamer SeqId: 2475-1 | Target: SCF sR | UniProt: P10721

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2475-1 | Target: SCF sR | UniProt: P10721 | TargetFullName: Mast/stem cell growth factor receptor Kit | Organisim: human | Apparent_Kd_M: 1.68E-12

Real

Aptamer SeqId:2480-58;Target:TIMP-3;UniProt:P35625

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2480-58;Target: TIMP-3;UniProt: P35625;TargetFullName: Metalloproteinase inhibitor 3;Organisim: human;Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId: 2480-58 | Target: TIMP-3 | UniProt: P35625

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2480-58 | Target: TIMP-3 | UniProt: P35625 | TargetFullName: Metalloproteinase inhibitor 3 | Organisim: human | Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId:2500-2;Target:Angiopoietin-4;UniProt:Q9Y264

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2500-2;Target: Angiopoietin-4;UniProt: Q9Y264;TargetFullName: Angiopoietin-4;Organisim: human;Apparent_Kd_M: 5.41E-12

Real

Aptamer SeqId: 2500-2 | Target: Angiopoietin-4 | UniProt: Q9Y264

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2500-2 | Target: Angiopoietin-4 | UniProt: Q9Y264 | TargetFullName: Angiopoietin-4 | Organisim: human | Apparent_Kd_M: 5.41E-12

Real

Aptamer SeqId:2505-49;Target:GFRa-3;UniProt:O60609

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2505-49;Target: GFRa-3;UniProt: O60609;TargetFullName: GDNF family receptor alpha-3;Organisim: human;Apparent_Kd_M: 4.24E-11

Real

Aptamer SeqId: 2505-49 | Target: GFRa-3 | UniProt: O60609

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2505-49 | Target: GFRa-3 | UniProt: O60609 | TargetFullName: GDNF family receptor alpha-3 | Organisim: human | Apparent_Kd_M: 4.24E-11

Real

Aptamer SeqId:2513-7;Target:HCE000104;UniProt:HCE000104

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2513-7;Target: HCE000104;UniProt: HCE000104;TargetFullName: HCE000104;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2513-7 | Target: HCE000104 | UniProt: HCE000104

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2513-7 | Target: HCE000104 | UniProt: HCE000104 | TargetFullName: HCE000104 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2514-65;Target:Ephrin-B3;UniProt:Q15768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2514-65;Target: Ephrin-B3;UniProt: Q15768;TargetFullName: Ephrin-B3;Organisim: human;Apparent_Kd_M: 9.04E-11

Real

Aptamer SeqId: 2514-65 | Target: Ephrin-B3 | UniProt: Q15768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2514-65 | Target: Ephrin-B3 | UniProt: Q15768 | TargetFullName: Ephrin-B3 | Organisim: human | Apparent_Kd_M: 9.04E-11

Real

Aptamer SeqId:2515-14;Target:GFRa-2;UniProt:O00451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2515-14;Target: GFRa-2;UniProt: O00451;TargetFullName: GDNF family receptor alpha-2;Organisim: human;Apparent_Kd_M: 4.34E-12

Real

Aptamer SeqId: 2515-14 | Target: GFRa-2 | UniProt: O00451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2515-14 | Target: GFRa-2 | UniProt: O00451 | TargetFullName: GDNF family receptor alpha-2 | Organisim: human | Apparent_Kd_M: 4.34E-12

Real

Aptamer SeqId:2516-57;Target:6Ckine;UniProt:O00585

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2516-57;Target: 6Ckine;UniProt: O00585;TargetFullName: C-C motif chemokine 21;Organisim: human;Apparent_Kd_M: 7.44E-12

Real

Aptamer SeqId: 2516-57 | Target: 6Ckine | UniProt: O00585

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2516-57 | Target: 6Ckine | UniProt: O00585 | TargetFullName: C-C motif chemokine 21 | Organisim: human | Apparent_Kd_M: 7.44E-12

Real

Aptamer SeqId:2524-56;Target:HMG-1;UniProt:P09429

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2524-56;Target: HMG-1;UniProt: P09429;TargetFullName: High mobility group protein B1;Organisim: human;Apparent_Kd_M: 3.71E-11

Real

Aptamer SeqId: 2524-56 | Target: HMG-1 | UniProt: P09429

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2524-56 | Target: HMG-1 | UniProt: P09429 | TargetFullName: High mobility group protein B1 | Organisim: human | Apparent_Kd_M: 3.71E-11

Real

Aptamer SeqId:2558-51;Target:b-Endorphin;UniProt:P01189

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2558-51;Target: b-Endorphin;UniProt: P01189;TargetFullName: Beta-endorphin;Organisim: human;Apparent_Kd_M: 6.24E-11

Real

Aptamer SeqId: 2558-51 | Target: b-Endorphin | UniProt: P01189

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2558-51 | Target: b-Endorphin | UniProt: P01189 | TargetFullName: Beta-endorphin | Organisim: human | Apparent_Kd_M: 6.24E-11

Real

Aptamer SeqId:2567-5;Target:Factor I;UniProt:P05156

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2567-5;Target: Factor I;UniProt: P05156;TargetFullName: Complement factor I;Organisim: human;Apparent_Kd_M: 8.09E-13

Real

Aptamer SeqId: 2567-5 | Target: Factor I | UniProt: P05156

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2567-5 | Target: Factor I | UniProt: P05156 | TargetFullName: Complement factor I | Organisim: human | Apparent_Kd_M: 8.09E-13

Real

Aptamer SeqId:2571-12;Target:IGFBP-3;UniProt:P17936

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2571-12;Target: IGFBP-3;UniProt: P17936;TargetFullName: Insulin-like growth factor-binding protein 3;Organisim: human;Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId: 2571-12 | Target: IGFBP-3 | UniProt: P17936

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2571-12 | Target: IGFBP-3 | UniProt: P17936 | TargetFullName: Insulin-like growth factor-binding protein 3 | Organisim: human | Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId:2578-67;Target:MCP-1;UniProt:P13500

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2578-67;Target: MCP-1;UniProt: P13500;TargetFullName: C-C motif chemokine 2;Organisim: human;Apparent_Kd_M: 6.88E-12

Real

Aptamer SeqId: 2578-67 | Target: MCP-1 | UniProt: P13500

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2578-67 | Target: MCP-1 | UniProt: P13500 | TargetFullName: C-C motif chemokine 2 | Organisim: human | Apparent_Kd_M: 6.88E-12

Real

Aptamer SeqId:2579-17;Target:MMP-9;UniProt:P14780

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2579-17;Target: MMP-9;UniProt: P14780;TargetFullName: Matrix metalloproteinase-9;Organisim: human;Apparent_Kd_M: 2.89E-11

Real

Aptamer SeqId: 2579-17 | Target: MMP-9 | UniProt: P14780

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2579-17 | Target: MMP-9 | UniProt: P14780 | TargetFullName: Matrix metalloproteinase-9 | Organisim: human | Apparent_Kd_M: 2.89E-11

Real

Aptamer SeqId:2580-83;Target:Myeloperoxidase;UniProt:P05164

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2580-83;Target: Myeloperoxidase;UniProt: P05164;TargetFullName: Myeloperoxidase;Organisim: human;Apparent_Kd_M: 1.7E-12

Real

Aptamer SeqId: 2580-83 | Target: Myeloperoxidase | UniProt: P05164

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2580-83 | Target: Myeloperoxidase | UniProt: P05164 | TargetFullName: Myeloperoxidase | Organisim: human | Apparent_Kd_M: 1.7E-12

Real

Aptamer SeqId:2585-2;Target:PRL;UniProt:P01236

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2585-2;Target: PRL;UniProt: P01236;TargetFullName: Prolactin;Organisim: human;Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId: 2585-2 | Target: PRL | UniProt: P01236

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2585-2 | Target: PRL | UniProt: P01236 | TargetFullName: Prolactin | Organisim: human | Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId:2590-69;Target:ROR1;UniProt:Q01973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2590-69;Target: ROR1;UniProt: Q01973;TargetFullName: Inactive tyrosine-protein kinase transmembrane receptor ROR1;Organisim: human;Apparent_Kd_M: 4.97E-12

Real

Aptamer SeqId: 2590-69 | Target: ROR1 | UniProt: Q01973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2590-69 | Target: ROR1 | UniProt: Q01973 | TargetFullName: Inactive tyrosine-protein kinase transmembrane receptor ROR1 | Organisim: human | Apparent_Kd_M: 4.97E-12

Real

Aptamer SeqId:2597-8;Target:VEGF;UniProt:P15692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2597-8;Target: VEGF;UniProt: P15692;TargetFullName: Vascular endothelial growth factor A;Organisim: human;Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId: 2597-8 | Target: VEGF | UniProt: P15692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2597-8 | Target: VEGF | UniProt: P15692 | TargetFullName: Vascular endothelial growth factor A | Organisim: human | Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId:2599-51;Target:4-1BB ligand;UniProt:P41273

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2599-51;Target: 4-1BB ligand;UniProt: P41273;TargetFullName: Tumor necrosis factor ligand superfamily member 9;Organisim: human;Apparent_Kd_M: 2.71E-11

Real

Aptamer SeqId: 2599-51 | Target: 4-1BB ligand | UniProt: P41273

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2599-51 | Target: 4-1BB ligand | UniProt: P41273 | TargetFullName: Tumor necrosis factor ligand superfamily member 9 | Organisim: human | Apparent_Kd_M: 2.71E-11

Real

Aptamer SeqId:2602-2;Target:Angiopoietin-2;UniProt:O15123

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2602-2;Target: Angiopoietin-2;UniProt: O15123;TargetFullName: Angiopoietin-2;Organisim: human;Apparent_Kd_M: 1.89E-11

Real

Aptamer SeqId: 2602-2 | Target: Angiopoietin-2 | UniProt: O15123

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2602-2 | Target: Angiopoietin-2 | UniProt: O15123 | TargetFullName: Angiopoietin-2 | Organisim: human | Apparent_Kd_M: 1.89E-11

Real

Aptamer SeqId:2605-49;Target:CD30;UniProt:P28908

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2605-49;Target: CD30;UniProt: P28908;TargetFullName: Tumor necrosis factor receptor superfamily member 8;Organisim: human;Apparent_Kd_M: 1.76E-10

Real

Aptamer SeqId: 2605-49 | Target: CD30 | UniProt: P28908

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2605-49 | Target: CD30 | UniProt: P28908 | TargetFullName: Tumor necrosis factor receptor superfamily member 8 | Organisim: human | Apparent_Kd_M: 1.76E-10

Real

Aptamer SeqId:2607-54;Target:CLF-1/CLC Complex;UniProt:O75462|Q9UBD9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2607-54;Target: CLF-1/CLC Complex;UniProt: O75462|Q9UBD9;TargetFullName: Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex;Organisim: human;Apparent_Kd_M: 8.02E-11

Real

Aptamer SeqId: 2607-54 | Target: CLF-1/CLC Complex | UniProt: O75462|Q9UBD9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2607-54 | Target: CLF-1/CLC Complex | UniProt: O75462|Q9UBD9 | TargetFullName: Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex | Organisim: human | Apparent_Kd_M: 8.02E-11

Real

Aptamer SeqId:2609-59;Target:Cystatin C;UniProt:P01034

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2609-59;Target: Cystatin C;UniProt: P01034;TargetFullName: Cystatin-C;Organisim: human;Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId: 2609-59 | Target: Cystatin C | UniProt: P01034

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2609-59 | Target: Cystatin C | UniProt: P01034 | TargetFullName: Cystatin-C | Organisim: human | Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId:2611-72;Target:Dtk;UniProt:Q06418

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2611-72;Target: Dtk;UniProt: Q06418;TargetFullName: Tyrosine-protein kinase receptor TYRO3;Organisim: human;Apparent_Kd_M: 2.28E-10

Real

Aptamer SeqId: 2611-72 | Target: Dtk | UniProt: Q06418

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2611-72 | Target: Dtk | UniProt: Q06418 | TargetFullName: Tyrosine-protein kinase receptor TYRO3 | Organisim: human | Apparent_Kd_M: 2.28E-10

Real

Aptamer SeqId:2612-5;Target:eIF-5;UniProt:P55010

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2612-5;Target: eIF-5;UniProt: P55010;TargetFullName: Eukaryotic translation initiation factor 5;Organisim: human;Apparent_Kd_M: 3.23E-11

Real

Aptamer SeqId: 2612-5 | Target: eIF-5 | UniProt: P55010

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2612-5 | Target: eIF-5 | UniProt: P55010 | TargetFullName: Eukaryotic translation initiation factor 5 | Organisim: human | Apparent_Kd_M: 3.23E-11

Real

Aptamer SeqId:2614-28;Target:Ephrin-A4;UniProt:P52798

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2614-28;Target: Ephrin-A4;UniProt: P52798;TargetFullName: Ephrin-A4;Organisim: human;Apparent_Kd_M: 3.68E-11

Real

Aptamer SeqId: 2614-28 | Target: Ephrin-A4 | UniProt: P52798

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2614-28 | Target: Ephrin-A4 | UniProt: P52798 | TargetFullName: Ephrin-A4 | Organisim: human | Apparent_Kd_M: 3.68E-11

Real

Aptamer SeqId:2615-60;Target:Ephrin-A5;UniProt:P52803

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2615-60;Target: Ephrin-A5;UniProt: P52803;TargetFullName: Ephrin-A5;Organisim: human;Apparent_Kd_M: 7.82E-12

Real

Aptamer SeqId: 2615-60 | Target: Ephrin-A5 | UniProt: P52803

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2615-60 | Target: Ephrin-A5 | UniProt: P52803 | TargetFullName: Ephrin-A5 | Organisim: human | Apparent_Kd_M: 7.82E-12

Real

Aptamer SeqId:2616-23;Target:ERBB2;UniProt:P04626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2616-23;Target: ERBB2;UniProt: P04626;TargetFullName: Receptor tyrosine-protein kinase erbB-2;Organisim: human;Apparent_Kd_M: 2.93E-10

Real

Aptamer SeqId: 2616-23 | Target: ERBB2 | UniProt: P04626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2616-23 | Target: ERBB2 | UniProt: P04626 | TargetFullName: Receptor tyrosine-protein kinase erbB-2 | Organisim: human | Apparent_Kd_M: 2.93E-10

Real

Aptamer SeqId:2617-56;Target:ERBB3;UniProt:P21860

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2617-56;Target: ERBB3;UniProt: P21860;TargetFullName: Receptor tyrosine-protein kinase erbB-3;Organisim: human;Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId: 2617-56 | Target: ERBB3 | UniProt: P21860

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2617-56 | Target: ERBB3 | UniProt: P21860 | TargetFullName: Receptor tyrosine-protein kinase erbB-3 | Organisim: human | Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId:2618-10;Target:ERBB4;UniProt:Q15303

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2618-10;Target: ERBB4;UniProt: Q15303;TargetFullName: Receptor tyrosine-protein kinase erbB-4;Organisim: human;Apparent_Kd_M: 3.05E-10

Real

Aptamer SeqId: 2618-10 | Target: ERBB4 | UniProt: Q15303

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2618-10 | Target: ERBB4 | UniProt: Q15303 | TargetFullName: Receptor tyrosine-protein kinase erbB-4 | Organisim: human | Apparent_Kd_M: 3.05E-10

Real

Aptamer SeqId:2619-72;Target:GA733-1 protein;UniProt:P09758

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2619-72;Target: GA733-1 protein;UniProt: P09758;TargetFullName: Tumor-associated calcium signal transducer 2;Organisim: human;Apparent_Kd_M: 3.94E-11

Real

Aptamer SeqId: 2619-72 | Target: GA733-1 protein | UniProt: P09758

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2619-72 | Target: GA733-1 protein | UniProt: P09758 | TargetFullName: Tumor-associated calcium signal transducer 2 | Organisim: human | Apparent_Kd_M: 3.94E-11

Real

Aptamer SeqId:2620-4;Target:gp130; soluble;UniProt:P40189

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2620-4;Target: gp130; soluble;UniProt: P40189;TargetFullName: Interleukin-6 receptor subunit beta;Organisim: human;Apparent_Kd_M: 6.379439E-12

Real

Aptamer SeqId: 2620-4 | Target: gp130; soluble | UniProt: P40189

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2620-4 | Target: gp130; soluble | UniProt: P40189 | TargetFullName: Interleukin-6 receptor subunit beta | Organisim: human | Apparent_Kd_M: 6.379439E-12

Real

Aptamer SeqId:2622-18;Target:HO-2;UniProt:P30519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2622-18;Target: HO-2;UniProt: P30519;TargetFullName: Heme oxygenase 2;Organisim: human;Apparent_Kd_M: 7.84E-11

Real

Aptamer SeqId: 2622-18 | Target: HO-2 | UniProt: P30519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2622-18 | Target: HO-2 | UniProt: P30519 | TargetFullName: Heme oxygenase 2 | Organisim: human | Apparent_Kd_M: 7.84E-11

Real

Aptamer SeqId:2625-53;Target:HSP 90a/b;UniProt:P07900|P08238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2625-53;Target: HSP 90a/b;UniProt: P07900|P08238;TargetFullName: Heat shock protein HSP 90-alpha/beta;Organisim: human;Apparent_Kd_M: 4.993405E-12

Real

Aptamer SeqId: 2625-53 | Target: HSP 90a/b | UniProt: P07900|P08238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2625-53 | Target: HSP 90a/b | UniProt: P07900|P08238 | TargetFullName: Heat shock protein HSP 90-alpha/beta | Organisim: human | Apparent_Kd_M: 4.993405E-12

Real

Aptamer SeqId:2631-50;Target:IL-10 Rb;UniProt:Q08334

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2631-50;Target: IL-10 Rb;UniProt: Q08334;TargetFullName: Interleukin-10 receptor subunit beta;Organisim: human;Apparent_Kd_M: 4.5E-11

Real

Aptamer SeqId: 2631-50 | Target: IL-10 Rb | UniProt: Q08334

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2631-50 | Target: IL-10 Rb | UniProt: Q08334 | TargetFullName: Interleukin-10 receptor subunit beta | Organisim: human | Apparent_Kd_M: 4.5E-11

Real

Aptamer SeqId:2632-5;Target:IL-12 Rb1;UniProt:P42701

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2632-5;Target: IL-12 Rb1;UniProt: P42701;TargetFullName: Interleukin-12 receptor subunit beta-1;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 2632-5 | Target: IL-12 Rb1 | UniProt: P42701

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2632-5 | Target: IL-12 Rb1 | UniProt: P42701 | TargetFullName: Interleukin-12 receptor subunit beta-1 | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:2633-52;Target:IL-13 Ra1;UniProt:P78552

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2633-52;Target: IL-13 Ra1;UniProt: P78552;TargetFullName: Interleukin-13 receptor subunit alpha-1;Organisim: human;Apparent_Kd_M: 1.01E-10

Real

Aptamer SeqId: 2633-52 | Target: IL-13 Ra1 | UniProt: P78552

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2633-52 | Target: IL-13 Ra1 | UniProt: P78552 | TargetFullName: Interleukin-13 receptor subunit alpha-1 | Organisim: human | Apparent_Kd_M: 1.01E-10

Real

Aptamer SeqId:2634-2;Target:IL-2 sRg;UniProt:P31785

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2634-2;Target: IL-2 sRg;UniProt: P31785;TargetFullName: Cytokine receptor common subunit gamma;Organisim: human;Apparent_Kd_M: 3.08E-11

Real

Aptamer SeqId: 2634-2 | Target: IL-2 sRg | UniProt: P31785

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2634-2 | Target: IL-2 sRg | UniProt: P31785 | TargetFullName: Cytokine receptor common subunit gamma | Organisim: human | Apparent_Kd_M: 3.08E-11

Real

Aptamer SeqId:2635-61;Target:Layilin;UniProt:Q6UX15

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2635-61;Target: Layilin;UniProt: Q6UX15;TargetFullName: Layilin;Organisim: human;Apparent_Kd_M: 1.42E-11

Real

Aptamer SeqId: 2635-61 | Target: Layilin | UniProt: Q6UX15

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2635-61 | Target: Layilin | UniProt: Q6UX15 | TargetFullName: Layilin | Organisim: human | Apparent_Kd_M: 1.42E-11

Real

Aptamer SeqId:2636-10;Target:Lymphotoxin b R;UniProt:P36941

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2636-10;Target: Lymphotoxin b R;UniProt: P36941;TargetFullName: Tumor necrosis factor receptor superfamily member 3;Organisim: human;Apparent_Kd_M: 2.97E-11

Real

Aptamer SeqId: 2636-10 | Target: Lymphotoxin b R | UniProt: P36941

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2636-10 | Target: Lymphotoxin b R | UniProt: P36941 | TargetFullName: Tumor necrosis factor receptor superfamily member 3 | Organisim: human | Apparent_Kd_M: 2.97E-11

Real

Aptamer SeqId:2637-77;Target:Macrophage mannose receptor;UniProt:P22897

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2637-77;Target: Macrophage mannose receptor;UniProt: P22897;TargetFullName: Macrophage mannose receptor 1;Organisim: human;Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId: 2637-77 | Target: Macrophage mannose receptor

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2637-77 | Target: Macrophage mannose receptor | UniProt: P22897 | TargetFullName: Macrophage mannose receptor 1 | Organisim: human | Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId:2640-3;Target:MSP R;UniProt:Q04912

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2640-3;Target: MSP R;UniProt: Q04912;TargetFullName: Macrophage-stimulating protein receptor;Organisim: human;Apparent_Kd_M: 1.61E-11

Real

Aptamer SeqId: 2640-3 | Target: MSP R | UniProt: Q04912

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2640-3 | Target: MSP R | UniProt: Q04912 | TargetFullName: Macrophage-stimulating protein receptor | Organisim: human | Apparent_Kd_M: 1.61E-11

Real

Aptamer SeqId:2642-4;Target:PAFAH beta subunit;UniProt:P68402

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2642-4;Target: PAFAH beta subunit;UniProt: P68402;TargetFullName: Platelet-activating factor acetylhydrolase IB subunit beta;Organisim: human;Apparent_Kd_M: 4.99E-11

Real

Aptamer SeqId: 2642-4 | Target: PAFAH beta subunit | UniProt: P68402

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2642-4 | Target: PAFAH beta subunit | UniProt: P68402 | TargetFullName: Platelet-activating factor acetylhydrolase IB subunit beta | Organisim: human | Apparent_Kd_M: 4.99E-11

Real

Aptamer SeqId:2643-57;Target:P-Cadherin;UniProt:P22223

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2643-57;Target: P-Cadherin;UniProt: P22223;TargetFullName: Cadherin-3;Organisim: human;Apparent_Kd_M: 2.49E-11

Real

Aptamer SeqId: 2643-57 | Target: P-Cadherin | UniProt: P22223

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2643-57 | Target: P-Cadherin | UniProt: P22223 | TargetFullName: Cadherin-3 | Organisim: human | Apparent_Kd_M: 2.49E-11

Real

Aptamer SeqId:2644-11;Target:PKC-A;UniProt:P17252

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2644-11;Target: PKC-A;UniProt: P17252;TargetFullName: Protein kinase C alpha type;Organisim: human;Apparent_Kd_M: 3.14E-11

Real

Aptamer SeqId: 2644-11 | Target: PKC-A | UniProt: P17252

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2644-11 | Target: PKC-A | UniProt: P17252 | TargetFullName: Protein kinase C alpha type | Organisim: human | Apparent_Kd_M: 3.14E-11

Real

Aptamer SeqId:2645-54;Target:PKC-Z;UniProt:Q05513

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2645-54;Target: PKC-Z;UniProt: Q05513;TargetFullName: Protein kinase C zeta type;Organisim: human;Apparent_Kd_M: 3.81E-11

Real

Aptamer SeqId: 2645-54 | Target: PKC-Z | UniProt: Q05513

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2645-54 | Target: PKC-Z | UniProt: Q05513 | TargetFullName: Protein kinase C zeta type | Organisim: human | Apparent_Kd_M: 3.81E-11

Real

Aptamer SeqId:2647-66;Target:Rab GDP dissociation inhibitor beta;UniProt:P50395

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2647-66;Target: Rab GDP dissociation inhibitor beta;UniProt: P50395;TargetFullName: Rab GDP dissociation inhibitor beta;Organisim: human;Apparent_Kd_M: 1.61E-11

Real

Aptamer SeqId: 2647-66 | Target: Rab GDP dissociation inhibitor beta

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2647-66 | Target: Rab GDP dissociation inhibitor beta | UniProt: P50395 | TargetFullName: Rab GDP dissociation inhibitor beta | Organisim: human | Apparent_Kd_M: 1.61E-11

Real

Aptamer SeqId:2649-77;Target:sICAM-3;UniProt:P32942

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2649-77;Target: sICAM-3;UniProt: P32942;TargetFullName: Intercellular adhesion molecule 3;Organisim: human;Apparent_Kd_M: 1.32E-10

Real

Aptamer SeqId: 2649-77 | Target: sICAM-3 | UniProt: P32942

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2649-77 | Target: sICAM-3 | UniProt: P32942 | TargetFullName: Intercellular adhesion molecule 3 | Organisim: human | Apparent_Kd_M: 1.32E-10

Real

Aptamer SeqId:2652-15;Target:suPAR;UniProt:Q03405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2652-15;Target: suPAR;UniProt: Q03405;TargetFullName: Urokinase plasminogen activator surface receptor;Organisim: human;Apparent_Kd_M: 6.83E-12

Real

Aptamer SeqId: 2652-15 | Target: suPAR | UniProt: Q03405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2652-15 | Target: suPAR | UniProt: Q03405 | TargetFullName: Urokinase plasminogen activator surface receptor | Organisim: human | Apparent_Kd_M: 6.83E-12

Real

Aptamer SeqId:2654-19;Target:TNF sR-I;UniProt:P19438

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2654-19;Target: TNF sR-I;UniProt: P19438;TargetFullName: Tumor necrosis factor receptor superfamily member 1A;Organisim: human;Apparent_Kd_M: 2.45E-11

Real

Aptamer SeqId: 2654-19 | Target: TNF sR-I | UniProt: P19438

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2654-19 | Target: TNF sR-I | UniProt: P19438 | TargetFullName: Tumor necrosis factor receptor superfamily member 1A | Organisim: human | Apparent_Kd_M: 2.45E-11

Real

Aptamer SeqId:2658-27;Target:TrkC;UniProt:Q16288

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2658-27;Target: TrkC;UniProt: Q16288;TargetFullName: NT-3 growth factor receptor;Organisim: human;Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId: 2658-27 | Target: TrkC | UniProt: Q16288

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2658-27 | Target: TrkC | UniProt: Q16288 | TargetFullName: NT-3 growth factor receptor | Organisim: human | Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId:2665-26;Target:BCMA;UniProt:Q02223

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2665-26;Target: BCMA;UniProt: Q02223;TargetFullName: Tumor necrosis factor receptor superfamily member 17;Organisim: human;Apparent_Kd_M: 5.43E-11

Real

Aptamer SeqId: 2665-26 | Target: BCMA | UniProt: Q02223

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2665-26 | Target: BCMA | UniProt: Q02223 | TargetFullName: Tumor necrosis factor receptor superfamily member 17 | Organisim: human | Apparent_Kd_M: 5.43E-11

Real

Aptamer SeqId:2666-53;Target:Bone proteoglycan II;UniProt:P07585

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2666-53;Target: Bone proteoglycan II;UniProt: P07585;TargetFullName: Decorin;Organisim: human;Apparent_Kd_M: 5.67E-11

Real

Aptamer SeqId: 2666-53 | Target: Bone proteoglycan II | UniProt: P07585

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2666-53 | Target: Bone proteoglycan II | UniProt: P07585 | TargetFullName: Decorin | Organisim: human | Apparent_Kd_M: 5.67E-11

Real

Aptamer SeqId:2668-70;Target:Calpain I;UniProt:P07384|P04632

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2668-70;Target: Calpain I;UniProt: P07384|P04632;TargetFullName: Calpain I;Organisim: human;Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId: 2668-70 | Target: Calpain I | UniProt: P07384|P04632

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2668-70 | Target: Calpain I | UniProt: P07384|P04632 | TargetFullName: Calpain I | Organisim: human | Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId:2677-1;Target:ERBB1;UniProt:P00533

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2677-1;Target: ERBB1;UniProt: P00533;TargetFullName: Epidermal growth factor receptor;Organisim: human;Apparent_Kd_M: 6.97E-12

Real

Aptamer SeqId: 2677-1 | Target: ERBB1 | UniProt: P00533

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2677-1 | Target: ERBB1 | UniProt: P00533 | TargetFullName: Epidermal growth factor receptor | Organisim: human | Apparent_Kd_M: 6.97E-12

Real

Aptamer SeqId:2681-23;Target:HGF;UniProt:P14210

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2681-23;Target: HGF;UniProt: P14210;TargetFullName: Hepatocyte growth factor;Organisim: human;Apparent_Kd_M: 1.33E-12

Real

Aptamer SeqId: 2681-23 | Target: HGF | UniProt: P14210

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2681-23 | Target: HGF | UniProt: P14210 | TargetFullName: Hepatocyte growth factor | Organisim: human | Apparent_Kd_M: 1.33E-12

Real

Aptamer SeqId:2682-68;Target:HSP 60;UniProt:P10809

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2682-68;Target: HSP 60;UniProt: P10809;TargetFullName: 60 kDa heat shock protein; mitochondrial;Organisim: human;Apparent_Kd_M: 7.0E-12

Real

Aptamer SeqId: 2682-68 | Target: HSP 60 | UniProt: P10809

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2682-68 | Target: HSP 60 | UniProt: P10809 | TargetFullName: 60 kDa heat shock protein; mitochondrial | Organisim: human | Apparent_Kd_M: 7.0E-12

Real

Aptamer SeqId:2683-1;Target:iC3b;UniProt:P01024

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2683-1;Target: iC3b;UniProt: P01024;TargetFullName: Complement C3b; inactivated;Organisim: human;Apparent_Kd_M: 5.28E-13

Real

Aptamer SeqId: 2683-1 | Target: iC3b | UniProt: P01024

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2683-1 | Target: iC3b | UniProt: P01024 | TargetFullName: Complement C3b; inactivated | Organisim: human | Apparent_Kd_M: 5.28E-13

Real

Aptamer SeqId:2687-2;Target:MIA;UniProt:Q16674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2687-2;Target: MIA;UniProt: Q16674;TargetFullName: Melanoma-derived growth regulatory protein;Organisim: human;Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId: 2687-2 | Target: MIA | UniProt: Q16674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2687-2 | Target: MIA | UniProt: Q16674 | TargetFullName: Melanoma-derived growth regulatory protein | Organisim: human | Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId:2692-74;Target:NPS-PLA2;UniProt:P14555

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2692-74;Target: NPS-PLA2;UniProt: P14555;TargetFullName: Phospholipase A2; membrane associated;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 2692-74 | Target: NPS-PLA2 | UniProt: P14555

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2692-74 | Target: NPS-PLA2 | UniProt: P14555 | TargetFullName: Phospholipase A2; membrane associated | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:2693-20;Target:OSM;UniProt:P13725

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2693-20;Target: OSM;UniProt: P13725;TargetFullName: Oncostatin-M;Organisim: human;Apparent_Kd_M: 7.95E-12

Real

Aptamer SeqId: 2693-20 | Target: OSM | UniProt: P13725

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2693-20 | Target: OSM | UniProt: P13725 | TargetFullName: Oncostatin-M | Organisim: human | Apparent_Kd_M: 7.95E-12

Real

Aptamer SeqId:2695-25;Target:PECAM-1;UniProt:P16284

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2695-25;Target: PECAM-1;UniProt: P16284;TargetFullName: Platelet endothelial cell adhesion molecule;Organisim: human;Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId: 2695-25 | Target: PECAM-1 | UniProt: P16284

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2695-25 | Target: PECAM-1 | UniProt: P16284 | TargetFullName: Platelet endothelial cell adhesion molecule | Organisim: human | Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId:2696-87;Target:Persephin;UniProt:O60542

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2696-87;Target: Persephin;UniProt: O60542;TargetFullName: Persephin;Organisim: human;Apparent_Kd_M: 3.39E-11

Real

Aptamer SeqId: 2696-87 | Target: Persephin | UniProt: O60542

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2696-87 | Target: Persephin | UniProt: O60542 | TargetFullName: Persephin | Organisim: human | Apparent_Kd_M: 3.39E-11

Real

Aptamer SeqId:2697-7;Target:PF-4;UniProt:P02776

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2697-7;Target: PF-4;UniProt: P02776;TargetFullName: Platelet factor 4;Organisim: human;Apparent_Kd_M: 3.75E-12

Real

Aptamer SeqId: 2697-7 | Target: PF-4 | UniProt: P02776

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2697-7 | Target: PF-4 | UniProt: P02776 | TargetFullName: Platelet factor 4 | Organisim: human | Apparent_Kd_M: 3.75E-12

Real

Aptamer SeqId:2700-56;Target:Protein S;UniProt:P07225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2700-56;Target: Protein S;UniProt: P07225;TargetFullName: Vitamin K-dependent protein S;Organisim: human;Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId: 2700-56 | Target: Protein S | UniProt: P07225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2700-56 | Target: Protein S | UniProt: P07225 | TargetFullName: Vitamin K-dependent protein S | Organisim: human | Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId:2704-74;Target:TACI;UniProt:O14836

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2704-74;Target: TACI;UniProt: O14836;TargetFullName: Tumor necrosis factor receptor superfamily member 13B;Organisim: human;Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId: 2704-74 | Target: TACI | UniProt: O14836

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2704-74 | Target: TACI | UniProt: O14836 | TargetFullName: Tumor necrosis factor receptor superfamily member 13B | Organisim: human | Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId:2705-5;Target:TECK;UniProt:O15444

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2705-5;Target: TECK;UniProt: O15444;TargetFullName: C-C motif chemokine 25;Organisim: human;Apparent_Kd_M: 2.82E-12

Real

Aptamer SeqId: 2705-5 | Target: TECK | UniProt: O15444

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2705-5 | Target: TECK | UniProt: O15444 | TargetFullName: C-C motif chemokine 25 | Organisim: human | Apparent_Kd_M: 2.82E-12

Real

Aptamer SeqId:2706-69;Target:Thyroxine-Binding Globulin;UniProt:P05543

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2706-69;Target: Thyroxine-Binding Globulin;UniProt: P05543;TargetFullName: Thyroxine-binding globulin;Organisim: human;Apparent_Kd_M: 1.43E-12

Real

Aptamer SeqId: 2706-69 | Target: Thyroxine-Binding Globulin

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2706-69 | Target: Thyroxine-Binding Globulin | UniProt: P05543 | TargetFullName: Thyroxine-binding globulin | Organisim: human | Apparent_Kd_M: 1.43E-12

Real

Aptamer SeqId:2708-54;Target:TNFSF18;UniProt:Q9UNG2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2708-54;Target: TNFSF18;UniProt: Q9UNG2;TargetFullName: Tumor necrosis factor ligand superfamily member 18;Organisim: human;Apparent_Kd_M: 2.5054E-11

Real

Aptamer SeqId: 2708-54 | Target: TNFSF18 | UniProt: Q9UNG2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2708-54 | Target: TNFSF18 | UniProt: Q9UNG2 | TargetFullName: Tumor necrosis factor ligand superfamily member 18 | Organisim: human | Apparent_Kd_M: 2.5054E-11

Real

Aptamer SeqId:2714-78;Target:EMAP-2;UniProt:Q12904

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2714-78;Target: EMAP-2;UniProt: Q12904;TargetFullName: Endothelial monocyte-activating polypeptide 2;Organisim: human;Apparent_Kd_M: 8.775512E-12

Real

Aptamer SeqId: 2714-78 | Target: EMAP-2 | UniProt: Q12904

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2714-78 | Target: EMAP-2 | UniProt: Q12904 | TargetFullName: Endothelial monocyte-activating polypeptide 2 | Organisim: human | Apparent_Kd_M: 8.775512E-12

Real

Aptamer SeqId:2719-3;Target:G-CSF-R;UniProt:Q99062

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2719-3;Target: G-CSF-R;UniProt: Q99062;TargetFullName: Granulocyte colony-stimulating factor receptor;Organisim: human;Apparent_Kd_M: 9.09E-11

Real

Aptamer SeqId: 2719-3 | Target: G-CSF-R | UniProt: Q99062

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2719-3 | Target: G-CSF-R | UniProt: Q99062 | TargetFullName: Granulocyte colony-stimulating factor receptor | Organisim: human | Apparent_Kd_M: 9.09E-11

Real

Aptamer SeqId:2723-9;Target:IL-1F7;UniProt:Q9NZH6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2723-9;Target: IL-1F7;UniProt: Q9NZH6;TargetFullName: Interleukin-37;Organisim: human;Apparent_Kd_M: 4.12E-12

Real

Aptamer SeqId: 2723-9 | Target: IL-1F7 | UniProt: Q9NZH6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2723-9 | Target: IL-1F7 | UniProt: Q9NZH6 | TargetFullName: Interleukin-37 | Organisim: human | Apparent_Kd_M: 4.12E-12

Real

Aptamer SeqId:2728-62;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2728-62;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 9.376657E-11

Real

Aptamer SeqId: 2728-62 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2728-62 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 9.376657E-11

Real

Aptamer SeqId:2730-58;Target:MICA;UniProt:Q29983

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2730-58;Target: MICA;UniProt: Q29983;TargetFullName: MHC class I polypeptide-related sequence A;Organisim: human;Apparent_Kd_M: 6.82E-12

Real

Aptamer SeqId: 2730-58 | Target: MICA | UniProt: Q29983

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2730-58 | Target: MICA | UniProt: Q29983 | TargetFullName: MHC class I polypeptide-related sequence A | Organisim: human | Apparent_Kd_M: 6.82E-12

Real

Aptamer SeqId:2731-29;Target:NADPH-P450 Oxidoreductase;UniProt:P16435

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2731-29;Target: NADPH-P450 Oxidoreductase;UniProt: P16435;TargetFullName: NADPH--cytochrome P450 reductase;Organisim: human;Apparent_Kd_M: 1.404035E-11

Real

Aptamer SeqId: 2731-29 | Target: NADPH-P450 Oxidoreductase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2731-29 | Target: NADPH-P450 Oxidoreductase | UniProt: P16435 | TargetFullName: NADPH--cytochrome P450 reductase | Organisim: human | Apparent_Kd_M: 1.404035E-11

Real

Aptamer SeqId:2732-58;Target:NANOG;UniProt:Q9H9S0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2732-58;Target: NANOG;UniProt: Q9H9S0;TargetFullName: Homeobox protein NANOG;Organisim: human;Apparent_Kd_M: 1.37E-11

Real

Aptamer SeqId: 2732-58 | Target: NANOG | UniProt: Q9H9S0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2732-58 | Target: NANOG | UniProt: Q9H9S0 | TargetFullName: Homeobox protein NANOG | Organisim: human | Apparent_Kd_M: 1.37E-11

Real

Aptamer SeqId:2734-49;Target:NKp44;UniProt:O95944

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2734-49;Target: NKp44;UniProt: O95944;TargetFullName: Natural cytotoxicity triggering receptor 2;Organisim: human;Apparent_Kd_M: 1.131831E-10

Real

Aptamer SeqId: 2734-49 | Target: NKp44 | UniProt: O95944

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2734-49 | Target: NKp44 | UniProt: O95944 | TargetFullName: Natural cytotoxicity triggering receptor 2 | Organisim: human | Apparent_Kd_M: 1.131831E-10

Real

Aptamer SeqId:2737-22;Target:NovH;UniProt:P48745

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2737-22;Target: NovH;UniProt: P48745;TargetFullName: Protein NOV homolog;Organisim: human;Apparent_Kd_M: 1.572713E-11

Real

Aptamer SeqId: 2737-22 | Target: NovH | UniProt: P48745

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2737-22 | Target: NovH | UniProt: P48745 | TargetFullName: Protein NOV homolog | Organisim: human | Apparent_Kd_M: 1.572713E-11

Real

Aptamer SeqId:2741-22;Target:Siglec-6;UniProt:O43699

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2741-22;Target: Siglec-6;UniProt: O43699;TargetFullName: Sialic acid-binding Ig-like lectin 6;Organisim: human;Apparent_Kd_M: 1.482731E-11

Real

Aptamer SeqId: 2741-22 | Target: Siglec-6 | UniProt: O43699

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2741-22 | Target: Siglec-6 | UniProt: O43699 | TargetFullName: Sialic acid-binding Ig-like lectin 6 | Organisim: human | Apparent_Kd_M: 1.482731E-11

Real

Aptamer SeqId:2742-68;Target:Siglec-7;UniProt:Q9Y286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2742-68;Target: Siglec-7;UniProt: Q9Y286;TargetFullName: Sialic acid-binding Ig-like lectin 7;Organisim: human;Apparent_Kd_M: 7.25E-13

Real

Aptamer SeqId: 2742-68 | Target: Siglec-7 | UniProt: Q9Y286

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2742-68 | Target: Siglec-7 | UniProt: Q9Y286 | TargetFullName: Sialic acid-binding Ig-like lectin 7 | Organisim: human | Apparent_Kd_M: 7.25E-13

Real

Aptamer SeqId:2743-5;Target:Sonic Hedgehog;UniProt:Q15465

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2743-5;Target: Sonic Hedgehog;UniProt: Q15465;TargetFullName: Sonic hedgehog protein;Organisim: human;Apparent_Kd_M: 1.2E-12

Real

Aptamer SeqId: 2743-5 | Target: Sonic Hedgehog | UniProt: Q15465

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2743-5 | Target: Sonic Hedgehog | UniProt: Q15465 | TargetFullName: Sonic hedgehog protein | Organisim: human | Apparent_Kd_M: 1.2E-12

Real

Aptamer SeqId:2744-57;Target:IgG;UniProt:P01857

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2744-57;Target: IgG;UniProt: P01857;TargetFullName: Immunoglobulin G;Organisim: human;Apparent_Kd_M: 2.19E-11

Real

Aptamer SeqId: 2744-57 | Target: IgG | UniProt: P01857

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2744-57 | Target: IgG | UniProt: P01857 | TargetFullName: Immunoglobulin G | Organisim: human | Apparent_Kd_M: 2.19E-11

Real

Aptamer SeqId:2747-3;Target:ULBP-3;UniProt:Q9BZM4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2747-3;Target: ULBP-3;UniProt: Q9BZM4;TargetFullName: NKG2D ligand 3;Organisim: human;Apparent_Kd_M: 4.02E-11

Real

Aptamer SeqId: 2747-3 | Target: ULBP-3 | UniProt: Q9BZM4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2747-3 | Target: ULBP-3 | UniProt: Q9BZM4 | TargetFullName: NKG2D ligand 3 | Organisim: human | Apparent_Kd_M: 4.02E-11

Real

Aptamer SeqId:2750-3;Target:Apo A-I;UniProt:P02647

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2750-3;Target: Apo A-I;UniProt: P02647;TargetFullName: Apolipoprotein A-I;Organisim: human;Apparent_Kd_M: 1.67E-10

Real

Aptamer SeqId: 2750-3 | Target: Apo A-I | UniProt: P02647

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2750-3 | Target: Apo A-I | UniProt: P02647 | TargetFullName: Apolipoprotein A-I | Organisim: human | Apparent_Kd_M: 1.67E-10

Real

Aptamer SeqId:2752-62;Target:BMP-14;UniProt:P43026

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2752-62;Target: BMP-14;UniProt: P43026;TargetFullName: Growth/differentiation factor 5;Organisim: human;Apparent_Kd_M: 2.05E-11

Real

Aptamer SeqId: 2752-62 | Target: BMP-14 | UniProt: P43026

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2752-62 | Target: BMP-14 | UniProt: P43026 | TargetFullName: Growth/differentiation factor 5 | Organisim: human | Apparent_Kd_M: 2.05E-11

Real

Aptamer SeqId:2753-2;Target:C1q;UniProt:P02745|P02746|P02747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2753-2;Target: C1q;UniProt: P02745|P02746|P02747;TargetFullName: Complement C1q subcomponent;Organisim: human;Apparent_Kd_M: 2.61E-12

Real

Aptamer SeqId: 2753-2 | Target: C1q | UniProt: P02745|P02746|P02747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2753-2 | Target: C1q | UniProt: P02745|P02746|P02747 | TargetFullName: Complement C1q subcomponent | Organisim: human | Apparent_Kd_M: 2.61E-12

Real

Aptamer SeqId:2754-50;Target:C3;UniProt:P01024

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2754-50;Target: C3;UniProt: P01024;TargetFullName: Complement C3;Organisim: human;Apparent_Kd_M: 8.52E-13

Real

Aptamer SeqId: 2754-50 | Target: C3 | UniProt: P01024

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2754-50 | Target: C3 | UniProt: P01024 | TargetFullName: Complement C3 | Organisim: human | Apparent_Kd_M: 8.52E-13

Real

Aptamer SeqId:2755-8;Target:Deprecated;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2755-8;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 6.22E-12

Real

Aptamer SeqId: 2755-8 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2755-8 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 6.22E-12

Real

Aptamer SeqId:2760-2;Target:DRR1;UniProt:O95990

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2760-2;Target: DRR1;UniProt: O95990;TargetFullName: Protein FAM107A;Organisim: human;Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId: 2760-2 | Target: DRR1 | UniProt: O95990

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2760-2 | Target: DRR1 | UniProt: O95990 | TargetFullName: Protein FAM107A | Organisim: human | Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId:2761-49;Target:FGF-18;UniProt:O76093

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2761-49;Target: FGF-18;UniProt: O76093;TargetFullName: Fibroblast growth factor 18;Organisim: human;Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId: 2761-49 | Target: FGF-18 | UniProt: O76093

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2761-49 | Target: FGF-18 | UniProt: O76093 | TargetFullName: Fibroblast growth factor 18 | Organisim: human | Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId:2763-66;Target:FGF-20;UniProt:Q9NP95

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2763-66;Target: FGF-20;UniProt: Q9NP95;TargetFullName: Fibroblast growth factor 20;Organisim: human;Apparent_Kd_M: 7.48E-12

Real

Aptamer SeqId: 2763-66 | Target: FGF-20 | UniProt: Q9NP95

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2763-66 | Target: FGF-20 | UniProt: Q9NP95 | TargetFullName: Fibroblast growth factor 20 | Organisim: human | Apparent_Kd_M: 7.48E-12

Real

Aptamer SeqId:2765-4;Target:GDF-11/8;UniProt:O95390|O14793

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2765-4;Target: GDF-11/8;UniProt: O95390|O14793;TargetFullName: Growth/differentiation factor 11/8;Organisim: human;Apparent_Kd_M: 4.65E-12

Real

Aptamer SeqId: 2765-4 | Target: GDF-11/8 | UniProt: O95390|O14793

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2765-4 | Target: GDF-11/8 | UniProt: O95390|O14793 | TargetFullName: Growth/differentiation factor 11/8 | Organisim: human | Apparent_Kd_M: 4.65E-12

Real

Aptamer SeqId:2769-3;Target:HIV-2 Rev;UniProt:P18093

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2769-3;Target: HIV-2 Rev;UniProt: P18093;TargetFullName: Protein Rev_HV2BE;Organisim: isolate ben;Apparent_Kd_M: 6.59E-11

Real

Aptamer SeqId: 2769-3 | Target: HIV-2 Rev | UniProt: P18093

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2769-3 | Target: HIV-2 Rev | UniProt: P18093 | TargetFullName: Protein Rev_HV2BE | Organisim: isolate ben | Apparent_Kd_M: 6.59E-11

Real

Aptamer SeqId:2770-51;Target:I-309;UniProt:P22362

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2770-51;Target: I-309;UniProt: P22362;TargetFullName: C-C motif chemokine 1;Organisim: human;Apparent_Kd_M: 5.61E-12

Real

Aptamer SeqId: 2770-51 | Target: I-309 | UniProt: P22362

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2770-51 | Target: I-309 | UniProt: P22362 | TargetFullName: C-C motif chemokine 1 | Organisim: human | Apparent_Kd_M: 5.61E-12

Real

Aptamer SeqId:2771-35;Target:IGFBP-1;UniProt:P08833

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2771-35;Target: IGFBP-1;UniProt: P08833;TargetFullName: Insulin-like growth factor-binding protein 1;Organisim: human;Apparent_Kd_M: 1.03E-11

Real

Aptamer SeqId: 2771-35 | Target: IGFBP-1 | UniProt: P08833

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2771-35 | Target: IGFBP-1 | UniProt: P08833 | TargetFullName: Insulin-like growth factor-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.03E-11

Real

Aptamer SeqId:2773-50;Target:IL-10;UniProt:P22301

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2773-50;Target: IL-10;UniProt: P22301;TargetFullName: Interleukin-10;Organisim: human;Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId: 2773-50 | Target: IL-10 | UniProt: P22301

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2773-50 | Target: IL-10 | UniProt: P22301 | TargetFullName: Interleukin-10 | Organisim: human | Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId:2774-10;Target:IL-16;UniProt:Q14005

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2774-10;Target: IL-16;UniProt: Q14005;TargetFullName: Interleukin-16;Organisim: human;Apparent_Kd_M: 4.583266E-13

Real

Aptamer SeqId: 2774-10 | Target: IL-16 | UniProt: Q14005

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2774-10 | Target: IL-16 | UniProt: Q14005 | TargetFullName: Interleukin-16 | Organisim: human | Apparent_Kd_M: 4.583266E-13

Real

Aptamer SeqId:2778-10;Target:IL-22;UniProt:Q9GZX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2778-10;Target: IL-22;UniProt: Q9GZX6;TargetFullName: Interleukin-22;Organisim: human;Apparent_Kd_M: 1.86E-12

Real

Aptamer SeqId: 2778-10 | Target: IL-22 | UniProt: Q9GZX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2778-10 | Target: IL-22 | UniProt: Q9GZX6 | TargetFullName: Interleukin-22 | Organisim: human | Apparent_Kd_M: 1.86E-12

Real

Aptamer SeqId:2780-35;Target:Lactoferrin;UniProt:P02788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2780-35;Target: Lactoferrin;UniProt: P02788;TargetFullName: Lactotransferrin;Organisim: human;Apparent_Kd_M: 1.5E-12

Real

Aptamer SeqId: 2780-35 | Target: Lactoferrin | UniProt: P02788

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2780-35 | Target: Lactoferrin | UniProt: P02788 | TargetFullName: Lactotransferrin | Organisim: human | Apparent_Kd_M: 1.5E-12

Real

Aptamer SeqId:2781-63;Target:LAG-1;UniProt:Q8NHW4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2781-63;Target: LAG-1;UniProt: Q8NHW4;TargetFullName: C-C motif chemokine 4-like;Organisim: human;Apparent_Kd_M: 9.07E-12

Real

Aptamer SeqId: 2781-63 | Target: LAG-1 | UniProt: Q8NHW4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2781-63 | Target: LAG-1 | UniProt: Q8NHW4 | TargetFullName: C-C motif chemokine 4-like | Organisim: human | Apparent_Kd_M: 9.07E-12

Real

Aptamer SeqId:2783-18;Target:LD78-beta;UniProt:P16619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2783-18;Target: LD78-beta;UniProt: P16619;TargetFullName: C-C motif chemokine 3-like 1;Organisim: human;Apparent_Kd_M: 3.96E-11

Real

Aptamer SeqId: 2783-18 | Target: LD78-beta | UniProt: P16619

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2783-18 | Target: LD78-beta | UniProt: P16619 | TargetFullName: C-C motif chemokine 3-like 1 | Organisim: human | Apparent_Kd_M: 3.96E-11

Real

Aptamer SeqId:2788-55;Target:MMP-3;UniProt:P08254

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2788-55;Target: MMP-3;UniProt: P08254;TargetFullName: Stromelysin-1;Organisim: human;Apparent_Kd_M: 4.53E-11

Real

Aptamer SeqId: 2788-55 | Target: MMP-3 | UniProt: P08254

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2788-55 | Target: MMP-3 | UniProt: P08254 | TargetFullName: Stromelysin-1 | Organisim: human | Apparent_Kd_M: 4.53E-11

Real

Aptamer SeqId:2789-26;Target:MMP-7;UniProt:P09237

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2789-26;Target: MMP-7;UniProt: P09237;TargetFullName: Matrilysin;Organisim: human;Apparent_Kd_M: 7.89E-12

Real

Aptamer SeqId: 2789-26 | Target: MMP-7 | UniProt: P09237

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2789-26 | Target: MMP-7 | UniProt: P09237 | TargetFullName: Matrilysin | Organisim: human | Apparent_Kd_M: 7.89E-12

Real

Aptamer SeqId:2790-54;Target:NAP-2;UniProt:P02775

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2790-54;Target: NAP-2;UniProt: P02775;TargetFullName: Neutrophil-activating peptide 2;Organisim: human;Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId: 2790-54 | Target: NAP-2 | UniProt: P02775

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2790-54 | Target: NAP-2 | UniProt: P02775 | TargetFullName: Neutrophil-activating peptide 2 | Organisim: human | Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId:2794-60;Target:SOD;UniProt:P00441

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2794-60;Target: SOD;UniProt: P00441;TargetFullName: Superoxide dismutase [Cu-Zn];Organisim: human;Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId: 2794-60 | Target: SOD | UniProt: P00441

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2794-60 | Target: SOD | UniProt: P00441 | TargetFullName: Superoxide dismutase Cu-Zn | Organisim: human | Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId:2796-62;Target:Fibrinogen;UniProt:P02671|P02675|P02679

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2796-62;Target: Fibrinogen;UniProt: P02671|P02675|P02679;TargetFullName: Fibrinogen;Organisim: human;Apparent_Kd_M: 5.84E-12

Real

Aptamer SeqId: 2796-62 | Target: Fibrinogen | UniProt: P02671|P02675|P02679

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2796-62 | Target: Fibrinogen | UniProt: P02671|P02675|P02679 | TargetFullName: Fibrinogen | Organisim: human | Apparent_Kd_M: 5.84E-12

Real

Aptamer SeqId:2797-56;Target:Apo B;UniProt:P04114

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2797-56;Target: Apo B;UniProt: P04114;TargetFullName: Apolipoprotein B;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 2797-56 | Target: Apo B | UniProt: P04114

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2797-56 | Target: Apo B | UniProt: P04114 | TargetFullName: Apolipoprotein B | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:2805-6;Target:ACE2;UniProt:Q9BYF1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2805-6;Target: ACE2;UniProt: Q9BYF1;TargetFullName: Angiotensin-converting enzyme 2;Organisim: human;Apparent_Kd_M: 9.98E-11

Real

Aptamer SeqId: 2805-6 | Target: ACE2 | UniProt: Q9BYF1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2805-6 | Target: ACE2 | UniProt: Q9BYF1 | TargetFullName: Angiotensin-converting enzyme 2 | Organisim: human | Apparent_Kd_M: 9.98E-11

Real

Aptamer SeqId:2806-49;Target:Activin RIB;UniProt:P36896

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2806-49;Target: Activin RIB;UniProt: P36896;TargetFullName: Activin receptor type-1B;Organisim: human;Apparent_Kd_M: 1.65E-10

Real

Aptamer SeqId: 2806-49 | Target: Activin RIB | UniProt: P36896

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2806-49 | Target: Activin RIB | UniProt: P36896 | TargetFullName: Activin receptor type-1B | Organisim: human | Apparent_Kd_M: 1.65E-10

Real

Aptamer SeqId:2809-25;Target:ADAMTS-4;UniProt:O75173

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2809-25;Target: ADAMTS-4;UniProt: O75173;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 4;Organisim: human;Apparent_Kd_M: 1.44E-12

Real

Aptamer SeqId: 2809-25 | Target: ADAMTS-4 | UniProt: O75173

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2809-25 | Target: ADAMTS-4 | UniProt: O75173 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 4 | Organisim: human | Apparent_Kd_M: 1.44E-12

Real

Aptamer SeqId:2811-27;Target:Angiopoietin-1;UniProt:Q15389

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2811-27;Target: Angiopoietin-1;UniProt: Q15389;TargetFullName: Angiopoietin-1;Organisim: human;Apparent_Kd_M: 2.338007E-11

Real

Aptamer SeqId: 2811-27 | Target: Angiopoietin-1 | UniProt: Q15389

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2811-27 | Target: Angiopoietin-1 | UniProt: Q15389 | TargetFullName: Angiopoietin-1 | Organisim: human | Apparent_Kd_M: 2.338007E-11

Real

Aptamer SeqId:2813-11;Target:ART;UniProt:O00253

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2813-11;Target: ART;UniProt: O00253;TargetFullName: Agouti-related protein;Organisim: human;Apparent_Kd_M: 5.700085E-12

Real

Aptamer SeqId: 2813-11 | Target: ART | UniProt: O00253

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2813-11 | Target: ART | UniProt: O00253 | TargetFullName: Agouti-related protein | Organisim: human | Apparent_Kd_M: 5.700085E-12

Real

Aptamer SeqId:2816-50;Target:BCAM;UniProt:P50895

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2816-50;Target: BCAM;UniProt: P50895;TargetFullName: Basal Cell Adhesion Molecule;Organisim: human;Apparent_Kd_M: 2.08E-11

Real

Aptamer SeqId: 2816-50 | Target: BCAM | UniProt: P50895

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2816-50 | Target: BCAM | UniProt: P50895 | TargetFullName: Basal Cell Adhesion Molecule | Organisim: human | Apparent_Kd_M: 2.08E-11

Real

Aptamer SeqId:2819-23;Target:Cadherin-5;UniProt:P33151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2819-23;Target: Cadherin-5;UniProt: P33151;TargetFullName: Cadherin-5;Organisim: human;Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId: 2819-23 | Target: Cadherin-5 | UniProt: P33151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2819-23 | Target: Cadherin-5 | UniProt: P33151 | TargetFullName: Cadherin-5 | Organisim: human | Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId:2823-7;Target:COMMD7;UniProt:Q86VX2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2823-7;Target: COMMD7;UniProt: Q86VX2;TargetFullName: COMM domain-containing protein 7;Organisim: human;Apparent_Kd_M: 2.259954E-11

Real

Aptamer SeqId: 2823-7 | Target: COMMD7 | UniProt: Q86VX2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2823-7 | Target: COMMD7 | UniProt: Q86VX2 | TargetFullName: COMM domain-containing protein 7 | Organisim: human | Apparent_Kd_M: 2.259954E-11

Real

Aptamer SeqId:2826-53;Target:EDA;UniProt:Q92838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2826-53;Target: EDA;UniProt: Q92838;TargetFullName: Ectodysplasin-A; secreted form;Organisim: human;Apparent_Kd_M: 1.295973E-11

Real

Aptamer SeqId: 2826-53 | Target: EDA | UniProt: Q92838

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2826-53 | Target: EDA | UniProt: Q92838 | TargetFullName: Ectodysplasin-A; secreted form | Organisim: human | Apparent_Kd_M: 1.295973E-11

Real

Aptamer SeqId:2827-23;Target:Fractalkine/CX3CL-1;UniProt:P78423

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2827-23;Target: Fractalkine/CX3CL-1;UniProt: P78423;TargetFullName: Fractalkine;Organisim: human;Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId: 2827-23 | Target: Fractalkine/CX3CL-1 | UniProt: P78423

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2827-23 | Target: Fractalkine/CX3CL-1 | UniProt: P78423 | TargetFullName: Fractalkine | Organisim: human | Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId:2828-82;Target:HAI-1;UniProt:O43278

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2828-82;Target: HAI-1;UniProt: O43278;TargetFullName: Kunitz-type protease inhibitor 1;Organisim: human;Apparent_Kd_M: 9.73E-12

Real

Aptamer SeqId: 2828-82 | Target: HAI-1 | UniProt: O43278

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2828-82 | Target: HAI-1 | UniProt: O43278 | TargetFullName: Kunitz-type protease inhibitor 1 | Organisim: human | Apparent_Kd_M: 9.73E-12

Real

Aptamer SeqId:2829-19;Target:IL-27;UniProt:Q8NEV9|Q14213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2829-19;Target: IL-27;UniProt: Q8NEV9|Q14213;TargetFullName: Interleukin-27;Organisim: human;Apparent_Kd_M: 8.23E-12

Real

Aptamer SeqId: 2829-19 | Target: IL-27 | UniProt: Q8NEV9|Q14213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2829-19 | Target: IL-27 | UniProt: Q8NEV9|Q14213 | TargetFullName: Interleukin-27 | Organisim: human | Apparent_Kd_M: 8.23E-12

Real

Aptamer SeqId:2831-29;Target:Kallikrein 11;UniProt:Q9UBX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2831-29;Target: Kallikrein 11;UniProt: Q9UBX7;TargetFullName: Kallikrein-11;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 2831-29 | Target: Kallikrein 11 | UniProt: Q9UBX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2831-29 | Target: Kallikrein 11 | UniProt: Q9UBX7 | TargetFullName: Kallikrein-11 | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:2833-20;Target:Kallikrein 4;UniProt:Q9Y5K2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2833-20;Target: Kallikrein 4;UniProt: Q9Y5K2;TargetFullName: Kallikrein-4;Organisim: human;Apparent_Kd_M: 1.99E-11

Real

Aptamer SeqId: 2833-20 | Target: Kallikrein 4 | UniProt: Q9Y5K2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2833-20 | Target: Kallikrein 4 | UniProt: Q9Y5K2 | TargetFullName: Kallikrein-4 | Organisim: human | Apparent_Kd_M: 1.99E-11

Real

Aptamer SeqId:2834-54;Target:kallikrein 8;UniProt:O60259

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2834-54;Target: kallikrein 8;UniProt: O60259;TargetFullName: Kallikrein-8;Organisim: human;Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId: 2834-54 | Target: kallikrein 8 | UniProt: O60259

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2834-54 | Target: kallikrein 8 | UniProt: O60259 | TargetFullName: Kallikrein-8 | Organisim: human | Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId:2835-1;Target:Ku70;UniProt:P12956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2835-1;Target: Ku70;UniProt: P12956;TargetFullName: X-ray repair cross-complementing protein 6;Organisim: human;Apparent_Kd_M: 1.318429E-11

Real

Aptamer SeqId: 2835-1 | Target: Ku70 | UniProt: P12956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2835-1 | Target: Ku70 | UniProt: P12956 | TargetFullName: X-ray repair cross-complementing protein 6 | Organisim: human | Apparent_Kd_M: 1.318429E-11

Real

Aptamer SeqId:2836-68;Target:Lipocalin 2;UniProt:P80188

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2836-68;Target: Lipocalin 2;UniProt: P80188;TargetFullName: Neutrophil gelatinase-associated lipocalin;Organisim: human;Apparent_Kd_M: 4.094249E-12

Real

Aptamer SeqId: 2836-68 | Target: Lipocalin 2 | UniProt: P80188

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2836-68 | Target: Lipocalin 2 | UniProt: P80188 | TargetFullName: Neutrophil gelatinase-associated lipocalin | Organisim: human | Apparent_Kd_M: 4.094249E-12

Real

Aptamer SeqId:2837-3;Target:Met;UniProt:P08581

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2837-3;Target: Met;UniProt: P08581;TargetFullName: Hepatocyte growth factor receptor;Organisim: human;Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId: 2837-3 | Target: Met | UniProt: P08581

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2837-3 | Target: Met | UniProt: P08581 | TargetFullName: Hepatocyte growth factor receptor | Organisim: human | Apparent_Kd_M: 2.43E-12

Real

Aptamer SeqId:2838-53;Target:MMP-17;UniProt:Q9ULZ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2838-53;Target: MMP-17;UniProt: Q9ULZ9;TargetFullName: Matrix metalloproteinase-17;Organisim: human;Apparent_Kd_M: 1.88E-10

Real

Aptamer SeqId: 2838-53 | Target: MMP-17 | UniProt: Q9ULZ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2838-53 | Target: MMP-17 | UniProt: Q9ULZ9 | TargetFullName: Matrix metalloproteinase-17 | Organisim: human | Apparent_Kd_M: 1.88E-10

Real

Aptamer SeqId:2839-2;Target:OX40 Ligand;UniProt:P23510

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2839-2;Target: OX40 Ligand;UniProt: P23510;TargetFullName: Tumor necrosis factor ligand superfamily member 4;Organisim: human;Apparent_Kd_M: 1.03E-10

Real

Aptamer SeqId: 2839-2 | Target: OX40 Ligand | UniProt: P23510

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2839-2 | Target: OX40 Ligand | UniProt: P23510 | TargetFullName: Tumor necrosis factor ligand superfamily member 4 | Organisim: human | Apparent_Kd_M: 1.03E-10

Real

Aptamer SeqId:2843-13;Target:SPINT2;UniProt:O43291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2843-13;Target: SPINT2;UniProt: O43291;TargetFullName: Kunitz-type protease inhibitor 2;Organisim: human;Apparent_Kd_M: 3.61E-12

Real

Aptamer SeqId: 2843-13 | Target: SPINT2 | UniProt: O43291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2843-13 | Target: SPINT2 | UniProt: O43291 | TargetFullName: Kunitz-type protease inhibitor 2 | Organisim: human | Apparent_Kd_M: 3.61E-12

Real

Aptamer SeqId:2844-53;Target:sTie-1;UniProt:P35590

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2844-53;Target: sTie-1;UniProt: P35590;TargetFullName: Tyrosine-protein kinase receptor Tie-1; soluble;Organisim: human;Apparent_Kd_M: 4.38E-11

Real

Aptamer SeqId: 2844-53 | Target: sTie-1 | UniProt: P35590

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2844-53 | Target: sTie-1 | UniProt: P35590 | TargetFullName: Tyrosine-protein kinase receptor Tie-1; soluble | Organisim: human | Apparent_Kd_M: 4.38E-11

Real

Aptamer SeqId:2846-24;Target:Ubiquitin+1;UniProt:P62979

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2846-24;Target: Ubiquitin+1;UniProt: P62979;TargetFullName: Ubiquitin+1; truncated mutation for UbB;Organisim: human;Apparent_Kd_M: 9.31E-13

Real

Aptamer SeqId: 2846-24 | Target: Ubiquitin+1 | UniProt: P62979

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2846-24 | Target: Ubiquitin+1 | UniProt: P62979 | TargetFullName: Ubiquitin+1; truncated mutation for UbB | Organisim: human | Apparent_Kd_M: 9.31E-13

Real

Aptamer SeqId:2849-49;Target:AIF1;UniProt:P55008

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2849-49;Target: AIF1;UniProt: P55008;TargetFullName: Allograft inflammatory factor 1;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 2849-49 | Target: AIF1 | UniProt: P55008

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2849-49 | Target: AIF1 | UniProt: P55008 | TargetFullName: Allograft inflammatory factor 1 | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:2851-63;Target:C5a;UniProt:P01031

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2851-63;Target: C5a;UniProt: P01031;TargetFullName: C5a anaphylatoxin;Organisim: human;Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId: 2851-63 | Target: C5a | UniProt: P01031

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2851-63 | Target: C5a | UniProt: P01031 | TargetFullName: C5a anaphylatoxin | Organisim: human | Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId:2853-68;Target:CHK1;UniProt:O14757

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2853-68;Target: CHK1;UniProt: O14757;TargetFullName: Serine/threonine-protein kinase Chk1;Organisim: human;Apparent_Kd_M: 7.169917E-12

Real

Aptamer SeqId: 2853-68 | Target: CHK1 | UniProt: O14757

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2853-68 | Target: CHK1 | UniProt: O14757 | TargetFullName: Serine/threonine-protein kinase Chk1 | Organisim: human | Apparent_Kd_M: 7.169917E-12

Real

Aptamer SeqId:2855-49;Target:ERK-1;UniProt:P27361

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2855-49;Target: ERK-1;UniProt: P27361;TargetFullName: Mitogen-activated protein kinase 3;Organisim: human;Apparent_Kd_M: 4.0E-12

Real

Aptamer SeqId: 2855-49 | Target: ERK-1 | UniProt: P27361

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2855-49 | Target: ERK-1 | UniProt: P27361 | TargetFullName: Mitogen-activated protein kinase 3 | Organisim: human | Apparent_Kd_M: 4.0E-12

Real

Aptamer SeqId:2859-69;Target:HDAC8;UniProt:Q9BY41

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2859-69;Target: HDAC8;UniProt: Q9BY41;TargetFullName: Histone deacetylase 8;Organisim: human;Apparent_Kd_M: 1.007847E-11

Real

Aptamer SeqId: 2859-69 | Target: HDAC8 | UniProt: Q9BY41

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2859-69 | Target: HDAC8 | UniProt: Q9BY41 | TargetFullName: Histone deacetylase 8 | Organisim: human | Apparent_Kd_M: 1.007847E-11

Real

Aptamer SeqId:2860-19;Target:Karyopherin-a2;UniProt:P52292

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2860-19;Target: Karyopherin-a2;UniProt: P52292;TargetFullName: Importin subunit alpha-1;Organisim: human;Apparent_Kd_M: 4.42E-11

Real

Aptamer SeqId: 2860-19 | Target: Karyopherin-a2 | UniProt: P52292

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2860-19 | Target: Karyopherin-a2 | UniProt: P52292 | TargetFullName: Importin subunit alpha-1 | Organisim: human | Apparent_Kd_M: 4.42E-11

Real

Aptamer SeqId:2864-2;Target:MEK1;UniProt:Q02750

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2864-2;Target: MEK1;UniProt: Q02750;TargetFullName: Dual specificity mitogen-activated protein kinase kinase 1;Organisim: human;Apparent_Kd_M: 1.792765E-11

Real

Aptamer SeqId: 2864-2 | Target: MEK1 | UniProt: Q02750

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2864-2 | Target: MEK1 | UniProt: Q02750 | TargetFullName: Dual specificity mitogen-activated protein kinase kinase 1 | Organisim: human | Apparent_Kd_M: 1.792765E-11

Real

Aptamer SeqId:2870-29;Target:RAC1;UniProt:P63000

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2870-29;Target: RAC1;UniProt: P63000;TargetFullName: Ras-related C3 botulinum toxin substrate 1;Organisim: human;Apparent_Kd_M: 7.66E-12

Real

Aptamer SeqId: 2870-29 | Target: RAC1 | UniProt: P63000

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2870-29 | Target: RAC1 | UniProt: P63000 | TargetFullName: Ras-related C3 botulinum toxin substrate 1 | Organisim: human | Apparent_Kd_M: 7.66E-12

Real

Aptamer SeqId:2871-73;Target:RAD51;UniProt:Q06609

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2871-73;Target: RAD51;UniProt: Q06609;TargetFullName: DNA repair protein RAD51 homolog 1;Organisim: human;Apparent_Kd_M: 3.83E-11

Real

Aptamer SeqId: 2871-73 | Target: RAD51 | UniProt: Q06609

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2871-73 | Target: RAD51 | UniProt: Q06609 | TargetFullName: DNA repair protein RAD51 homolog 1 | Organisim: human | Apparent_Kd_M: 3.83E-11

Real

Aptamer SeqId:2875-15;Target:TBP;UniProt:P20226

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2875-15;Target: TBP;UniProt: P20226;TargetFullName: TATA-box-binding protein;Organisim: human;Apparent_Kd_M: 2.26E-10

Real

Aptamer SeqId: 2875-15 | Target: TBP | UniProt: P20226

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2875-15 | Target: TBP | UniProt: P20226 | TargetFullName: TATA-box-binding protein | Organisim: human | Apparent_Kd_M: 2.26E-10

Real

Aptamer SeqId:2876-74;Target:Topoisomerase I;UniProt:P11387

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2876-74;Target: Topoisomerase I;UniProt: P11387;TargetFullName: DNA topoisomerase 1;Organisim: human;Apparent_Kd_M: 6.27E-11

Real

Aptamer SeqId: 2876-74 | Target: Topoisomerase I | UniProt: P11387

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2876-74 | Target: Topoisomerase I | UniProt: P11387 | TargetFullName: DNA topoisomerase 1 | Organisim: human | Apparent_Kd_M: 6.27E-11

Real

Aptamer SeqId:2877-3;Target:UBC9;UniProt:P63279

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2877-3;Target: UBC9;UniProt: P63279;TargetFullName: SUMO-conjugating enzyme UBC9;Organisim: human;Apparent_Kd_M: 1.03E-11

Real

Aptamer SeqId: 2877-3 | Target: UBC9 | UniProt: P63279

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2877-3 | Target: UBC9 | UniProt: P63279 | TargetFullName: SUMO-conjugating enzyme UBC9 | Organisim: human | Apparent_Kd_M: 1.03E-11

Real

Aptamer SeqId:2878-66;Target:YES;UniProt:P07947

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2878-66;Target: YES;UniProt: P07947;TargetFullName: Tyrosine-protein kinase Yes;Organisim: human;Apparent_Kd_M: 3.55E-11

Real

Aptamer SeqId: 2878-66 | Target: YES | UniProt: P07947

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2878-66 | Target: YES | UniProt: P07947 | TargetFullName: Tyrosine-protein kinase Yes | Organisim: human | Apparent_Kd_M: 3.55E-11

Real

Aptamer SeqId:2879-9;Target:a1-Antichymotrypsin;UniProt:P01011

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2879-9;Target: a1-Antichymotrypsin;UniProt: P01011;TargetFullName: Alpha-1-antichymotrypsin;Organisim: human;Apparent_Kd_M: 2.3E-12

Real

Aptamer SeqId: 2879-9 | Target: a1-Antichymotrypsin | UniProt: P01011

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2879-9 | Target: a1-Antichymotrypsin | UniProt: P01011 | TargetFullName: Alpha-1-antichymotrypsin | Organisim: human | Apparent_Kd_M: 2.3E-12

Real

Aptamer SeqId:2888-49;Target:C7;UniProt:P10643

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2888-49;Target: C7;UniProt: P10643;TargetFullName: Complement component C7;Organisim: human;Apparent_Kd_M: 3.27E-11

Real

Aptamer SeqId: 2888-49 | Target: C7 | UniProt: P10643

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2888-49 | Target: C7 | UniProt: P10643 | TargetFullName: Complement component C7 | Organisim: human | Apparent_Kd_M: 3.27E-11

Real

Aptamer SeqId:2889-37;Target:Cardiotrophin-1;UniProt:Q16619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2889-37;Target: Cardiotrophin-1;UniProt: Q16619;TargetFullName: Cardiotrophin-1;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 2889-37 | Target: Cardiotrophin-1 | UniProt: Q16619

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2889-37 | Target: Cardiotrophin-1 | UniProt: Q16619 | TargetFullName: Cardiotrophin-1 | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:2890-59;Target:CCL28;UniProt:Q9NRJ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2890-59;Target: CCL28;UniProt: Q9NRJ3;TargetFullName: C-C motif chemokine 28;Organisim: human;Apparent_Kd_M: 8.18E-12

Real

Aptamer SeqId: 2890-59 | Target: CCL28 | UniProt: Q9NRJ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2890-59 | Target: CCL28 | UniProt: Q9NRJ3 | TargetFullName: C-C motif chemokine 28 | Organisim: human | Apparent_Kd_M: 8.18E-12

Real

Aptamer SeqId:2891-1;Target:Deprecated;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2891-1;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 2.16E-10

Real

Aptamer SeqId: 2891-1 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2891-1 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 2.16E-10

Real

Aptamer SeqId:2900-53;Target:HCC-1;UniProt:Q16627

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2900-53;Target: HCC-1;UniProt: Q16627;TargetFullName: C-C motif chemokine 14;Organisim: human;Apparent_Kd_M: 6.07E-11

Real

Aptamer SeqId: 2900-53 | Target: HCC-1 | UniProt: Q16627

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2900-53 | Target: HCC-1 | UniProt: Q16627 | TargetFullName: C-C motif chemokine 14 | Organisim: human | Apparent_Kd_M: 6.07E-11

Real

Aptamer SeqId:2906-55;Target:IL-4;UniProt:P05112

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2906-55;Target: IL-4;UniProt: P05112;TargetFullName: Interleukin-4;Organisim: human;Apparent_Kd_M: 1.15E-12

Real

Aptamer SeqId: 2906-55 | Target: IL-4 | UniProt: P05112

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2906-55 | Target: IL-4 | UniProt: P05112 | TargetFullName: Interleukin-4 | Organisim: human | Apparent_Kd_M: 1.15E-12

Real

Aptamer SeqId:2911-27;Target:Midkine;UniProt:P21741

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2911-27;Target: Midkine;UniProt: P21741;TargetFullName: Midkine;Organisim: human;Apparent_Kd_M: 5.58E-12

Real

Aptamer SeqId: 2911-27 | Target: Midkine | UniProt: P21741

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2911-27 | Target: Midkine | UniProt: P21741 | TargetFullName: Midkine | Organisim: human | Apparent_Kd_M: 5.58E-12

Real

Aptamer SeqId:2913-1;Target:MPIF-1;UniProt:P55773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2913-1;Target: MPIF-1;UniProt: P55773;TargetFullName: C-C motif chemokine 23;Organisim: human;Apparent_Kd_M: 4.65E-11

Real

Aptamer SeqId: 2913-1 | Target: MPIF-1 | UniProt: P55773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2913-1 | Target: MPIF-1 | UniProt: P55773 | TargetFullName: C-C motif chemokine 23 | Organisim: human | Apparent_Kd_M: 4.65E-11

Real

Aptamer SeqId:2925-9;Target:PAI-1;UniProt:P05121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2925-9;Target: PAI-1;UniProt: P05121;TargetFullName: Plasminogen activator inhibitor 1;Organisim: human;Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId: 2925-9 | Target: PAI-1 | UniProt: P05121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2925-9 | Target: PAI-1 | UniProt: P05121 | TargetFullName: Plasminogen activator inhibitor 1 | Organisim: human | Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId:2937-10;Target:Deprecated;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2937-10;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 7.4E-12

Real

Aptamer SeqId: 2937-10 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2937-10 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 7.4E-12

Real

Aptamer SeqId:2938-55;Target:Deprecated;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2938-55;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 2.44E-12

Real

Aptamer SeqId: 2938-55 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2938-55 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 2.44E-12

Real

Aptamer SeqId:2939-10;Target:Artemin;UniProt:Q5T4W7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2939-10;Target: Artemin;UniProt: Q5T4W7;TargetFullName: Artemin;Organisim: human;Apparent_Kd_M: 2.75E-11

Real

Aptamer SeqId: 2939-10 | Target: Artemin | UniProt: Q5T4W7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2939-10 | Target: Artemin | UniProt: Q5T4W7 | TargetFullName: Artemin | Organisim: human | Apparent_Kd_M: 2.75E-11

Real

Aptamer SeqId:2942-50;Target:Cytochrome c;UniProt:P99999

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2942-50;Target: Cytochrome c;UniProt: P99999;TargetFullName: Cytochrome c;Organisim: human;Apparent_Kd_M: 2.3E-11

Real

Aptamer SeqId: 2942-50 | Target: Cytochrome c | UniProt: P99999

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2942-50 | Target: Cytochrome c | UniProt: P99999 | TargetFullName: Cytochrome c | Organisim: human | Apparent_Kd_M: 2.3E-11

Real

Aptamer SeqId:2943-5;Target:Cytochrome P450 3A4;UniProt:P08684

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2943-5;Target: Cytochrome P450 3A4;UniProt: P08684;TargetFullName: Cytochrome P450 3A4;Organisim: human;Apparent_Kd_M: 5.45E-12

Real

Aptamer SeqId: 2943-5 | Target: Cytochrome P450 3A4 | UniProt: P08684

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2943-5 | Target: Cytochrome P450 3A4 | UniProt: P08684 | TargetFullName: Cytochrome P450 3A4 | Organisim: human | Apparent_Kd_M: 5.45E-12

Real

Aptamer SeqId:2944-66;Target:DAN;UniProt:P41271

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2944-66;Target: DAN;UniProt: P41271;TargetFullName: Neuroblastoma suppressor of tumorigenicity 1;Organisim: human;Apparent_Kd_M: 2.44E-11

Real

Aptamer SeqId: 2944-66 | Target: DAN | UniProt: P41271

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2944-66 | Target: DAN | UniProt: P41271 | TargetFullName: Neuroblastoma suppressor of tumorigenicity 1 | Organisim: human | Apparent_Kd_M: 2.44E-11

Real

Aptamer SeqId:2946-52;Target:Factor D;UniProt:P00746

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2946-52;Target: Factor D;UniProt: P00746;TargetFullName: Complement factor D;Organisim: human;Apparent_Kd_M: 1.141147E-10

Real

Aptamer SeqId: 2946-52 | Target: Factor D | UniProt: P00746

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2946-52 | Target: Factor D | UniProt: P00746 | TargetFullName: Complement factor D | Organisim: human | Apparent_Kd_M: 1.141147E-10

Real

Aptamer SeqId:2948-58;Target:Growth hormone receptor;UniProt:P10912

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2948-58;Target: Growth hormone receptor;UniProt: P10912;TargetFullName: Growth hormone receptor;Organisim: human;Apparent_Kd_M: 2.67E-11

Real

Aptamer SeqId: 2948-58 | Target: Growth hormone receptor | UniProt: P10912

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2948-58 | Target: Growth hormone receptor | UniProt: P10912 | TargetFullName: Growth hormone receptor | Organisim: human | Apparent_Kd_M: 2.67E-11

Real

Aptamer SeqId:2949-6;Target:GX;UniProt:O15496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2949-6;Target: GX;UniProt: O15496;TargetFullName: Group 10 secretory phospholipase A2;Organisim: human;Apparent_Kd_M: 8.19E-12

Real

Aptamer SeqId: 2949-6 | Target: GX | UniProt: O15496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2949-6 | Target: GX | UniProt: O15496 | TargetFullName: Group 10 secretory phospholipase A2 | Organisim: human | Apparent_Kd_M: 8.19E-12

Real

Aptamer SeqId:2950-57;Target:IGFBP-4;UniProt:P22692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2950-57;Target: IGFBP-4;UniProt: P22692;TargetFullName: Insulin-like growth factor-binding protein 4;Organisim: human;Apparent_Kd_M: 3.66E-12

Real

Aptamer SeqId: 2950-57 | Target: IGFBP-4 | UniProt: P22692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2950-57 | Target: IGFBP-4 | UniProt: P22692 | TargetFullName: Insulin-like growth factor-binding protein 4 | Organisim: human | Apparent_Kd_M: 3.66E-12

Real

Aptamer SeqId:2952-75;Target:IGF-I;UniProt:P05019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2952-75;Target: IGF-I;UniProt: P05019;TargetFullName: Insulin-like growth factor I;Organisim: human;Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId: 2952-75 | Target: IGF-I | UniProt: P05019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2952-75 | Target: IGF-I | UniProt: P05019 | TargetFullName: Insulin-like growth factor I | Organisim: human | Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId:2953-31;Target:Luteinizing hormone;UniProt:P01215|P01229

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2953-31;Target: Luteinizing hormone;UniProt: P01215|P01229;TargetFullName: Luteinizing hormone;Organisim: human;Apparent_Kd_M: 5.35E-11

Real

Aptamer SeqId: 2953-31 | Target: Luteinizing hormone

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2953-31 | Target: Luteinizing hormone | UniProt: P01215|P01229 | TargetFullName: Luteinizing hormone | Organisim: human | Apparent_Kd_M: 5.35E-11

Real

Aptamer SeqId:2960-66;Target:Properdin;UniProt:P27918

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2960-66;Target: Properdin;UniProt: P27918;TargetFullName: Properdin;Organisim: human;Apparent_Kd_M: 6.49E-11

Real

Aptamer SeqId: 2960-66 | Target: Properdin | UniProt: P27918

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2960-66 | Target: Properdin | UniProt: P27918 | TargetFullName: Properdin | Organisim: human | Apparent_Kd_M: 6.49E-11

Real

Aptamer SeqId:2961-1;Target:Protein C;UniProt:P04070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2961-1;Target: Protein C;UniProt: P04070;TargetFullName: Vitamin K-dependent protein C;Organisim: human;Apparent_Kd_M: 3.31E-11

Real

Aptamer SeqId: 2961-1 | Target: Protein C | UniProt: P04070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2961-1 | Target: Protein C | UniProt: P04070 | TargetFullName: Vitamin K-dependent protein C | Organisim: human | Apparent_Kd_M: 3.31E-11

Real

Aptamer SeqId:2962-50;Target:PTHrP;UniProt:P12272

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2962-50;Target: PTHrP;UniProt: P12272;TargetFullName: Parathyroid hormone-related protein;Organisim: human;Apparent_Kd_M: 2.44E-11

Real

Aptamer SeqId: 2962-50 | Target: PTHrP | UniProt: P12272

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2962-50 | Target: PTHrP | UniProt: P12272 | TargetFullName: Parathyroid hormone-related protein | Organisim: human | Apparent_Kd_M: 2.44E-11

Real

Aptamer SeqId:2966-65;Target:SCGF-beta;UniProt:Q9Y240

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2966-65;Target: SCGF-beta;UniProt: Q9Y240;TargetFullName: Stem cell growth factor-beta;Organisim: human;Apparent_Kd_M: 9.77E-11

Real

Aptamer SeqId: 2966-65 | Target: SCGF-beta | UniProt: Q9Y240

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2966-65 | Target: SCGF-beta | UniProt: Q9Y240 | TargetFullName: Stem cell growth factor-beta | Organisim: human | Apparent_Kd_M: 9.77E-11

Real

Aptamer SeqId:2967-8;Target:VCAM-1;UniProt:P19320

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2967-8;Target: VCAM-1;UniProt: P19320;TargetFullName: Vascular cell adhesion protein 1;Organisim: human;Apparent_Kd_M: 1.73E-10

Real

Aptamer SeqId: 2967-8 | Target: VCAM-1 | UniProt: P19320

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2967-8 | Target: VCAM-1 | UniProt: P19320 | TargetFullName: Vascular cell adhesion protein 1 | Organisim: human | Apparent_Kd_M: 1.73E-10

Real

Aptamer SeqId:2968-61;Target:TNFSF15;UniProt:O95150

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2968-61;Target: TNFSF15;UniProt: O95150;TargetFullName: Tumor necrosis factor ligand superfamily member 15;Organisim: human;Apparent_Kd_M: 2.81E-12

Real

Aptamer SeqId: 2968-61 | Target: TNFSF15 | UniProt: O95150

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2968-61 | Target: TNFSF15 | UniProt: O95150 | TargetFullName: Tumor necrosis factor ligand superfamily member 15 | Organisim: human | Apparent_Kd_M: 2.81E-12

Real

Aptamer SeqId:2970-60;Target:AREG;UniProt:P15514

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2970-60;Target: AREG;UniProt: P15514;TargetFullName: Amphiregulin;Organisim: human;Apparent_Kd_M: 2.03E-11

Real

Aptamer SeqId: 2970-60 | Target: AREG | UniProt: P15514

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2970-60 | Target: AREG | UniProt: P15514 | TargetFullName: Amphiregulin | Organisim: human | Apparent_Kd_M: 2.03E-11

Real

Aptamer SeqId:2972-57;Target:BMP-7;UniProt:P18075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2972-57;Target: BMP-7;UniProt: P18075;TargetFullName: Bone morphogenetic protein 7;Organisim: human;Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId: 2972-57 | Target: BMP-7 | UniProt: P18075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2972-57 | Target: BMP-7 | UniProt: P18075 | TargetFullName: Bone morphogenetic protein 7 | Organisim: human | Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId:2973-15;Target:CD36 ANTIGEN;UniProt:P16671

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2973-15;Target: CD36 ANTIGEN;UniProt: P16671;TargetFullName: Platelet glycoprotein 4;Organisim: human;Apparent_Kd_M: 6.47E-11

Real

Aptamer SeqId: 2973-15 | Target: CD36 ANTIGEN | UniProt: P16671

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2973-15 | Target: CD36 ANTIGEN | UniProt: P16671 | TargetFullName: Platelet glycoprotein 4 | Organisim: human | Apparent_Kd_M: 6.47E-11

Real

Aptamer SeqId:2974-61;Target:contactin-1;UniProt:Q12860

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2974-61;Target: contactin-1;UniProt: Q12860;TargetFullName: Contactin-1;Organisim: human;Apparent_Kd_M: 3.79E-12

Real

Aptamer SeqId: 2974-61 | Target: contactin-1 | UniProt: Q12860

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2974-61 | Target: contactin-1 | UniProt: Q12860 | TargetFullName: Contactin-1 | Organisim: human | Apparent_Kd_M: 3.79E-12

Real

Aptamer SeqId:2975-19;Target:CTGF;UniProt:P29279

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2975-19;Target: CTGF;UniProt: P29279;TargetFullName: Connective tissue growth factor;Organisim: human;Apparent_Kd_M: 2.31E-11

Real

Aptamer SeqId: 2975-19 | Target: CTGF | UniProt: P29279

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2975-19 | Target: CTGF | UniProt: P29279 | TargetFullName: Connective tissue growth factor | Organisim: human | Apparent_Kd_M: 2.31E-11

Real

Aptamer SeqId:2976-58;Target:Desmoglein-1;UniProt:Q02413

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2976-58;Target: Desmoglein-1;UniProt: Q02413;TargetFullName: Desmoglein-1;Organisim: human;Apparent_Kd_M: 4.76E-11

Real

Aptamer SeqId: 2976-58 | Target: Desmoglein-1 | UniProt: Q02413

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2976-58 | Target: Desmoglein-1 | UniProt: Q02413 | TargetFullName: Desmoglein-1 | Organisim: human | Apparent_Kd_M: 4.76E-11

Real

Aptamer SeqId:2977-7;Target:EDAR;UniProt:Q9UNE0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2977-7;Target: EDAR;UniProt: Q9UNE0;TargetFullName: Tumor necrosis factor receptor superfamily member EDAR;Organisim: human;Apparent_Kd_M: 2.72E-12

Real

Aptamer SeqId: 2977-7 | Target: EDAR | UniProt: Q9UNE0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2977-7 | Target: EDAR | UniProt: Q9UNE0 | TargetFullName: Tumor necrosis factor receptor superfamily member EDAR | Organisim: human | Apparent_Kd_M: 2.72E-12

Real

Aptamer SeqId:2979-8;Target:ENA-78;UniProt:P42830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2979-8;Target: ENA-78;UniProt: P42830;TargetFullName: C-X-C motif chemokine 5;Organisim: human;Apparent_Kd_M: 1.26E-10

Real

Aptamer SeqId: 2979-8 | Target: ENA-78 | UniProt: P42830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2979-8 | Target: ENA-78 | UniProt: P42830 | TargetFullName: C-X-C motif chemokine 5 | Organisim: human | Apparent_Kd_M: 1.26E-10

Real

Aptamer SeqId:2982-82;Target:Galectin-4;UniProt:P56470

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2982-82;Target: Galectin-4;UniProt: P56470;TargetFullName: Galectin-4;Organisim: human;Apparent_Kd_M: 2.27E-12

Real

Aptamer SeqId: 2982-82 | Target: Galectin-4 | UniProt: P56470

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2982-82 | Target: Galectin-4 | UniProt: P56470 | TargetFullName: Galectin-4 | Organisim: human | Apparent_Kd_M: 2.27E-12

Real

Aptamer SeqId:2985-35;Target:Gro-a;UniProt:P09341

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2985-35;Target: Gro-a;UniProt: P09341;TargetFullName: Growth-regulated alpha protein;Organisim: human;Apparent_Kd_M: 7.99284E-12

Real

Aptamer SeqId: 2985-35 | Target: Gro-a | UniProt: P09341

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2985-35 | Target: Gro-a | UniProt: P09341 | TargetFullName: Growth-regulated alpha protein | Organisim: human | Apparent_Kd_M: 7.99284E-12

Real

Aptamer SeqId:2987-37;Target:Histone H1.2;UniProt:P16403

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2987-37;Target: Histone H1.2;UniProt: P16403;TargetFullName: Histone H1.2;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 2987-37 | Target: Histone H1.2 | UniProt: P16403

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2987-37 | Target: Histone H1.2 | UniProt: P16403 | TargetFullName: Histone H1.2 | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:2991-9;Target:IL-1 sRI;UniProt:P14778

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2991-9;Target: IL-1 sRI;UniProt: P14778;TargetFullName: Interleukin-1 receptor type 1;Organisim: human;Apparent_Kd_M: 3.58E-12

Real

Aptamer SeqId: 2991-9 | Target: IL-1 sRI | UniProt: P14778

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2991-9 | Target: IL-1 sRI | UniProt: P14778 | TargetFullName: Interleukin-1 receptor type 1 | Organisim: human | Apparent_Kd_M: 3.58E-12

Real

Aptamer SeqId:2992-59;Target:IL-17 sR;UniProt:Q96F46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2992-59;Target: IL-17 sR;UniProt: Q96F46;TargetFullName: Interleukin-17 receptor A;Organisim: human;Apparent_Kd_M: 2.02E-11

Real

Aptamer SeqId: 2992-59 | Target: IL-17 sR | UniProt: Q96F46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2992-59 | Target: IL-17 sR | UniProt: Q96F46 | TargetFullName: Interleukin-17 receptor A | Organisim: human | Apparent_Kd_M: 2.02E-11

Real

Aptamer SeqId:2993-1;Target:IL-18 Rb;UniProt:O95256

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2993-1;Target: IL-18 Rb;UniProt: O95256;TargetFullName: Interleukin-18 receptor accessory protein;Organisim: human;Apparent_Kd_M: 3.47E-12

Real

Aptamer SeqId: 2993-1 | Target: IL-18 Rb | UniProt: O95256

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2993-1 | Target: IL-18 Rb | UniProt: O95256 | TargetFullName: Interleukin-18 receptor accessory protein | Organisim: human | Apparent_Kd_M: 3.47E-12

Real

Aptamer SeqId:2994-71;Target:IL-1Rrp2;UniProt:Q9HB29

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2994-71;Target: IL-1Rrp2;UniProt: Q9HB29;TargetFullName: Interleukin-1 receptor-like 2;Organisim: human;Apparent_Kd_M: 1.889796E-11

Real

Aptamer SeqId: 2994-71 | Target: IL-1Rrp2 | UniProt: Q9HB29

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2994-71 | Target: IL-1Rrp2 | UniProt: Q9HB29 | TargetFullName: Interleukin-1 receptor-like 2 | Organisim: human | Apparent_Kd_M: 1.889796E-11

Real

Aptamer SeqId:2997-8;Target:JAM-B;UniProt:P57087

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2997-8;Target: JAM-B;UniProt: P57087;TargetFullName: Junctional adhesion molecule B;Organisim: human;Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId: 2997-8 | Target: JAM-B | UniProt: P57087

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2997-8 | Target: JAM-B | UniProt: P57087 | TargetFullName: Junctional adhesion molecule B | Organisim: human | Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId:2998-53;Target:JAM-C;UniProt:Q9BX67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2998-53;Target: JAM-C;UniProt: Q9BX67;TargetFullName: Junctional adhesion molecule C;Organisim: human;Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId: 2998-53 | Target: JAM-C | UniProt: Q9BX67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2998-53 | Target: JAM-C | UniProt: Q9BX67 | TargetFullName: Junctional adhesion molecule C | Organisim: human | Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId:2999-6;Target:LSAMP;UniProt:Q13449

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 2999-6;Target: LSAMP;UniProt: Q13449;TargetFullName: Limbic system-associated membrane protein;Organisim: human;Apparent_Kd_M: 4.57E-11

Real

Aptamer SeqId: 2999-6 | Target: LSAMP | UniProt: Q13449

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 2999-6 | Target: LSAMP | UniProt: Q13449 | TargetFullName: Limbic system-associated membrane protein | Organisim: human | Apparent_Kd_M: 4.57E-11

Real

Aptamer SeqId:3000-66;Target:MBL;UniProt:P11226

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3000-66;Target: MBL;UniProt: P11226;TargetFullName: Mannose-binding protein C;Organisim: human;Apparent_Kd_M: 2.31E-11

Real

Aptamer SeqId: 3000-66 | Target: MBL | UniProt: P11226

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3000-66 | Target: MBL | UniProt: P11226 | TargetFullName: Mannose-binding protein C | Organisim: human | Apparent_Kd_M: 2.31E-11

Real

Aptamer SeqId:3003-29;Target:NKp30;UniProt:O14931

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3003-29;Target: NKp30;UniProt: O14931;TargetFullName: Natural cytotoxicity triggering receptor 3;Organisim: human;Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId: 3003-29 | Target: NKp30 | UniProt: O14931

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3003-29 | Target: NKp30 | UniProt: O14931 | TargetFullName: Natural cytotoxicity triggering receptor 3 | Organisim: human | Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId:3004-67;Target:PD-L2;UniProt:Q9BQ51

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3004-67;Target: PD-L2;UniProt: Q9BQ51;TargetFullName: Programmed cell death 1 ligand 2;Organisim: human;Apparent_Kd_M: 3.13E-10

Real

Aptamer SeqId: 3004-67 | Target: PD-L2 | UniProt: Q9BQ51

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3004-67 | Target: PD-L2 | UniProt: Q9BQ51 | TargetFullName: Programmed cell death 1 ligand 2 | Organisim: human | Apparent_Kd_M: 3.13E-10

Real

Aptamer SeqId:3005-5;Target:PTP-1B;UniProt:P18031

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3005-5;Target: PTP-1B;UniProt: P18031;TargetFullName: Tyrosine-protein phosphatase non-receptor type 1;Organisim: human;Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId: 3005-5 | Target: PTP-1B | UniProt: P18031

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3005-5 | Target: PTP-1B | UniProt: P18031 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 1 | Organisim: human | Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId:3007-7;Target:Siglec-9;UniProt:Q9Y336

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3007-7;Target: Siglec-9;UniProt: Q9Y336;TargetFullName: Sialic acid-binding Ig-like lectin 9;Organisim: human;Apparent_Kd_M: 8.78E-12

Real

Aptamer SeqId: 3007-7 | Target: Siglec-9 | UniProt: Q9Y336

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3007-7 | Target: Siglec-9 | UniProt: Q9Y336 | TargetFullName: Sialic acid-binding Ig-like lectin 9 | Organisim: human | Apparent_Kd_M: 8.78E-12

Real

Aptamer SeqId:3009-3;Target:TGF-b R III;UniProt:Q03167

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3009-3;Target: TGF-b R III;UniProt: Q03167;TargetFullName: Transforming growth factor beta receptor type 3;Organisim: human;Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId: 3009-3 | Target: TGF-b R III | UniProt: Q03167

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3009-3 | Target: TGF-b R III | UniProt: Q03167 | TargetFullName: Transforming growth factor beta receptor type 3 | Organisim: human | Apparent_Kd_M: 4.44E-12

Real

Aptamer SeqId:3010-53;Target:TSLP;UniProt:Q969D9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3010-53;Target: TSLP;UniProt: Q969D9;TargetFullName: Thymic stromal lymphopoietin;Organisim: human;Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId: 3010-53 | Target: TSLP | UniProt: Q969D9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3010-53 | Target: TSLP | UniProt: Q969D9 | TargetFullName: Thymic stromal lymphopoietin | Organisim: human | Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId:3022-4;Target:CTLA-4;UniProt:P16410

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3022-4;Target: CTLA-4;UniProt: P16410;TargetFullName: Cytotoxic T-lymphocyte protein 4;Organisim: human;Apparent_Kd_M: 3.63E-11

Real

Aptamer SeqId: 3022-4 | Target: CTLA-4 | UniProt: P16410

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3022-4 | Target: CTLA-4 | UniProt: P16410 | TargetFullName: Cytotoxic T-lymphocyte protein 4 | Organisim: human | Apparent_Kd_M: 3.63E-11

Real

Aptamer SeqId:3024-18;Target:a2-Antiplasmin;UniProt:P08697

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3024-18;Target: a2-Antiplasmin;UniProt: P08697;TargetFullName: Alpha-2-antiplasmin;Organisim: human;Apparent_Kd_M: 4.95E-11

Real

Aptamer SeqId: 3024-18 | Target: a2-Antiplasmin | UniProt: P08697

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3024-18 | Target: a2-Antiplasmin | UniProt: P08697 | TargetFullName: Alpha-2-antiplasmin | Organisim: human | Apparent_Kd_M: 4.95E-11

Real

Aptamer SeqId:3025-50;Target:bFGF;UniProt:P09038

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3025-50;Target: bFGF;UniProt: P09038;TargetFullName: Fibroblast growth factor 2;Organisim: human;Apparent_Kd_M: 3.33E-12

Real

Aptamer SeqId: 3025-50 | Target: bFGF | UniProt: P09038

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3025-50 | Target: bFGF | UniProt: P09038 | TargetFullName: Fibroblast growth factor 2 | Organisim: human | Apparent_Kd_M: 3.33E-12

Real

Aptamer SeqId:3026-5;Target:Calpastatin;UniProt:P20810

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3026-5;Target: Calpastatin;UniProt: P20810;TargetFullName: Calpastatin;Organisim: human;Apparent_Kd_M: 1.8E-10

Real

Aptamer SeqId: 3026-5 | Target: Calpastatin | UniProt: P20810

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3026-5 | Target: Calpastatin | UniProt: P20810 | TargetFullName: Calpastatin | Organisim: human | Apparent_Kd_M: 1.8E-10

Real

Aptamer SeqId:3028-36;Target:Ck-b-8-1;UniProt:P55773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3028-36;Target: Ck-b-8-1;UniProt: P55773;TargetFullName: Ck-beta-8-1;Organisim: human;Apparent_Kd_M: 9.73E-13

Real

Aptamer SeqId: 3028-36 | Target: Ck-b-8-1 | UniProt: P55773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3028-36 | Target: Ck-b-8-1 | UniProt: P55773 | TargetFullName: Ck-beta-8-1 | Organisim: human | Apparent_Kd_M: 9.73E-13

Real

Aptamer SeqId:3029-52;Target:DC-SIGN;UniProt:Q9NNX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3029-52;Target: DC-SIGN;UniProt: Q9NNX6;TargetFullName: CD209 antigen;Organisim: human;Apparent_Kd_M: 4.0E-11

Real

Aptamer SeqId: 3029-52 | Target: DC-SIGN | UniProt: Q9NNX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3029-52 | Target: DC-SIGN | UniProt: Q9NNX6 | TargetFullName: CD209 antigen | Organisim: human | Apparent_Kd_M: 4.0E-11

Real

Aptamer SeqId:3030-3;Target:DC-SIGNR;UniProt:Q9H2X3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3030-3;Target: DC-SIGNR;UniProt: Q9H2X3;TargetFullName: C-type lectin domain family 4 member M;Organisim: human;Apparent_Kd_M: 2.88E-11

Real

Aptamer SeqId: 3030-3 | Target: DC-SIGNR | UniProt: Q9H2X3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3030-3 | Target: DC-SIGNR | UniProt: Q9H2X3 | TargetFullName: C-type lectin domain family 4 member M | Organisim: human | Apparent_Kd_M: 2.88E-11

Real

Aptamer SeqId:3032-11;Target:FSH;UniProt:P01215|P01225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3032-11;Target: FSH;UniProt: P01215|P01225;TargetFullName: Follicle stimulating hormone;Organisim: human;Apparent_Kd_M: 4.98E-12

Real

Aptamer SeqId: 3032-11 | Target: FSH | UniProt: P01215|P01225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3032-11 | Target: FSH | UniProt: P01215|P01225 | TargetFullName: Follicle stimulating hormone | Organisim: human | Apparent_Kd_M: 4.98E-12

Real

Aptamer SeqId:3033-57;Target:Galectin-2;UniProt:P05162

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3033-57;Target: Galectin-2;UniProt: P05162;TargetFullName: Galectin-2;Organisim: human;Apparent_Kd_M: 2.89E-11

Real

Aptamer SeqId: 3033-57 | Target: Galectin-2 | UniProt: P05162

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3033-57 | Target: Galectin-2 | UniProt: P05162 | TargetFullName: Galectin-2 | Organisim: human | Apparent_Kd_M: 2.89E-11

Real

Aptamer SeqId:3034-1;Target:GFAP;UniProt:P14136

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3034-1;Target: GFAP;UniProt: P14136;TargetFullName: Glial fibrillary acidic protein;Organisim: human;Apparent_Kd_M: 5.01E-11

Real

Aptamer SeqId: 3034-1 | Target: GFAP | UniProt: P14136

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3034-1 | Target: GFAP | UniProt: P14136 | TargetFullName: Glial fibrillary acidic protein | Organisim: human | Apparent_Kd_M: 5.01E-11

Real

Aptamer SeqId:3035-80;Target:IL-19;UniProt:Q9UHD0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3035-80;Target: IL-19;UniProt: Q9UHD0;TargetFullName: Interleukin-19;Organisim: human;Apparent_Kd_M: 2.89E-12

Real

Aptamer SeqId: 3035-80 | Target: IL-19 | UniProt: Q9UHD0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3035-80 | Target: IL-19 | UniProt: Q9UHD0 | TargetFullName: Interleukin-19 | Organisim: human | Apparent_Kd_M: 2.89E-12

Real

Aptamer SeqId:3037-62;Target:IL-1b;UniProt:P01584

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3037-62;Target: IL-1b;UniProt: P01584;TargetFullName: Interleukin-1 beta;Organisim: human;Apparent_Kd_M: 8.08E-11

Real

Aptamer SeqId: 3037-62 | Target: IL-1b | UniProt: P01584

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3037-62 | Target: IL-1b | UniProt: P01584 | TargetFullName: Interleukin-1 beta | Organisim: human | Apparent_Kd_M: 8.08E-11

Real

Aptamer SeqId:3038-9;Target:I-TAC;UniProt:O14625

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3038-9;Target: I-TAC;UniProt: O14625;TargetFullName: C-X-C motif chemokine 11;Organisim: human;Apparent_Kd_M: 2.84E-12

Real

Aptamer SeqId: 3038-9 | Target: I-TAC | UniProt: O14625

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3038-9 | Target: I-TAC | UniProt: O14625 | TargetFullName: C-X-C motif chemokine 11 | Organisim: human | Apparent_Kd_M: 2.84E-12

Real

Aptamer SeqId:3040-59;Target:MIP-1a;UniProt:P10147

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3040-59;Target: MIP-1a;UniProt: P10147;TargetFullName: C-C motif chemokine 3;Organisim: human;Apparent_Kd_M: 4.2E-11

Real

Aptamer SeqId: 3040-59 | Target: MIP-1a | UniProt: P10147

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3040-59 | Target: MIP-1a | UniProt: P10147 | TargetFullName: C-C motif chemokine 3 | Organisim: human | Apparent_Kd_M: 4.2E-11

Real

Aptamer SeqId:3041-55;Target:MRC2;UniProt:Q9UBG0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3041-55;Target: MRC2;UniProt: Q9UBG0;TargetFullName: C-type mannose receptor 2;Organisim: human;Apparent_Kd_M: 2.11E-12

Real

Aptamer SeqId: 3041-55 | Target: MRC2 | UniProt: Q9UBG0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3041-55 | Target: MRC2 | UniProt: Q9UBG0 | TargetFullName: C-type mannose receptor 2 | Organisim: human | Apparent_Kd_M: 2.11E-12

Real

Aptamer SeqId:3042-7;Target:Myoglobin;UniProt:P02144

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3042-7;Target: Myoglobin;UniProt: P02144;TargetFullName: Myoglobin;Organisim: human;Apparent_Kd_M: 8.92E-12

Real

Aptamer SeqId: 3042-7 | Target: Myoglobin | UniProt: P02144

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3042-7 | Target: Myoglobin | UniProt: P02144 | TargetFullName: Myoglobin | Organisim: human | Apparent_Kd_M: 8.92E-12

Real

Aptamer SeqId:3043-49;Target:ON;UniProt:P09486

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3043-49;Target: ON;UniProt: P09486;TargetFullName: SPARC;Organisim: human;Apparent_Kd_M: 5.73E-12

Real

Aptamer SeqId: 3043-49 | Target: ON | UniProt: P09486

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3043-49 | Target: ON | UniProt: P09486 | TargetFullName: SPARC | Organisim: human | Apparent_Kd_M: 5.73E-12

Real

Aptamer SeqId:3044-3;Target:PARC;UniProt:P55774

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3044-3;Target: PARC;UniProt: P55774;TargetFullName: C-C motif chemokine 18;Organisim: human;Apparent_Kd_M: 6.68E-12

Real

Aptamer SeqId: 3044-3 | Target: PARC | UniProt: P55774

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3044-3 | Target: PARC | UniProt: P55774 | TargetFullName: C-C motif chemokine 18 | Organisim: human | Apparent_Kd_M: 6.68E-12

Real

Aptamer SeqId:3045-72;Target:PTN;UniProt:P21246

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3045-72;Target: PTN;UniProt: P21246;TargetFullName: Pleiotrophin;Organisim: human;Apparent_Kd_M: 2.9E-12

Real

Aptamer SeqId: 3045-72 | Target: PTN | UniProt: P21246

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3045-72 | Target: PTN | UniProt: P21246 | TargetFullName: Pleiotrophin | Organisim: human | Apparent_Kd_M: 2.9E-12

Real

Aptamer SeqId:3046-31;Target:resistin;UniProt:Q9HD89

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3046-31;Target: resistin;UniProt: Q9HD89;TargetFullName: Resistin;Organisim: human;Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId: 3046-31 | Target: resistin | UniProt: Q9HD89

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3046-31 | Target: resistin | UniProt: Q9HD89 | TargetFullName: Resistin | Organisim: human | Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId:3049-61;Target:Trypsin;UniProt:P07477

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3049-61;Target: Trypsin;UniProt: P07477;TargetFullName: Trypsin-1;Organisim: human;Apparent_Kd_M: 1.33E-13

Real

Aptamer SeqId: 3049-61 | Target: Trypsin | UniProt: P07477

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3049-61 | Target: Trypsin | UniProt: P07477 | TargetFullName: Trypsin-1 | Organisim: human | Apparent_Kd_M: 1.33E-13

Real

Aptamer SeqId:3050-7;Target:vWF;UniProt:P04275

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3050-7;Target: vWF;UniProt: P04275;TargetFullName: von Willebrand factor;Organisim: human;Apparent_Kd_M: 6.43E-11

Real

Aptamer SeqId: 3050-7 | Target: vWF | UniProt: P04275

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3050-7 | Target: vWF | UniProt: P04275 | TargetFullName: von Willebrand factor | Organisim: human | Apparent_Kd_M: 6.43E-11

Real

Aptamer SeqId:3052-8;Target:Fas ligand; soluble;UniProt:P48023

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3052-8;Target: Fas ligand; soluble;UniProt: P48023;TargetFullName: Tumor necrosis factor ligand superfamily member 6; soluble form;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 3052-8 | Target: Fas ligand; soluble | UniProt: P48023

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3052-8 | Target: Fas ligand; soluble | UniProt: P48023 | TargetFullName: Tumor necrosis factor ligand superfamily member 6; soluble form | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:3054-3;Target:Haptoglobin; Mixed Type;UniProt:P00738

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3054-3;Target: Haptoglobin; Mixed Type;UniProt: P00738;TargetFullName: Haptoglobin;Organisim: human;Apparent_Kd_M: 1.34E-11

Real

Aptamer SeqId: 3054-3 | Target: Haptoglobin; Mixed Type | UniProt: P00738

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3054-3 | Target: Haptoglobin; Mixed Type | UniProt: P00738 | TargetFullName: Haptoglobin | Organisim: human | Apparent_Kd_M: 1.34E-11

Real

Aptamer SeqId:3055-54;Target:IL-4 sR;UniProt:P24394

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3055-54;Target: IL-4 sR;UniProt: P24394;TargetFullName: Interleukin-4 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.72E-10

Real

Aptamer SeqId: 3055-54 | Target: IL-4 sR | UniProt: P24394

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3055-54 | Target: IL-4 sR | UniProt: P24394 | TargetFullName: Interleukin-4 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.72E-10

Real

Aptamer SeqId:3057-55;Target:WISP-1;UniProt:O95388

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3057-55;Target: WISP-1;UniProt: O95388;TargetFullName: WNT1-inducible-signaling pathway protein 1;Organisim: human;Apparent_Kd_M: 9.6E-11

Real

Aptamer SeqId: 3057-55 | Target: WISP-1 | UniProt: O95388

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3057-55 | Target: WISP-1 | UniProt: O95388 | TargetFullName: WNT1-inducible-signaling pathway protein 1 | Organisim: human | Apparent_Kd_M: 9.6E-11

Real

Aptamer SeqId:3059-50;Target:BAFF;UniProt:Q9Y275

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3059-50;Target: BAFF;UniProt: Q9Y275;TargetFullName: Tumor necrosis factor ligand superfamily member 13B;Organisim: human;Apparent_Kd_M: 1.14E-11

Real

Aptamer SeqId: 3059-50 | Target: BAFF | UniProt: Q9Y275

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3059-50 | Target: BAFF | UniProt: Q9Y275 | TargetFullName: Tumor necrosis factor ligand superfamily member 13B | Organisim: human | Apparent_Kd_M: 1.14E-11

Real

Aptamer SeqId:3060-43;Target:C9;UniProt:P02748

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3060-43;Target: C9;UniProt: P02748;TargetFullName: Complement component C9;Organisim: human;Apparent_Kd_M: 1.57E-12

Real

Aptamer SeqId: 3060-43 | Target: C9 | UniProt: P02748

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3060-43 | Target: C9 | UniProt: P02748 | TargetFullName: Complement component C9 | Organisim: human | Apparent_Kd_M: 1.57E-12

Real

Aptamer SeqId:3065-65;Target:FGF-5;UniProt:P12034

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3065-65;Target: FGF-5;UniProt: P12034;TargetFullName: Fibroblast growth factor 5;Organisim: human;Apparent_Kd_M: 4.27E-11

Real

Aptamer SeqId: 3065-65 | Target: FGF-5 | UniProt: P12034

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3065-65 | Target: FGF-5 | UniProt: P12034 | TargetFullName: Fibroblast growth factor 5 | Organisim: human | Apparent_Kd_M: 4.27E-11

Real

Aptamer SeqId:3066-12;Target:Galectin-3;UniProt:P17931

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3066-12;Target: Galectin-3;UniProt: P17931;TargetFullName: Galectin-3;Organisim: human;Apparent_Kd_M: 4.9E-12

Real

Aptamer SeqId: 3066-12 | Target: Galectin-3 | UniProt: P17931

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3066-12 | Target: Galectin-3 | UniProt: P17931 | TargetFullName: Galectin-3 | Organisim: human | Apparent_Kd_M: 4.9E-12

Real

Aptamer SeqId:3067-67;Target:GDF-9;UniProt:O60383

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3067-67;Target: GDF-9;UniProt: O60383;TargetFullName: Growth/differentiation factor 9;Organisim: human;Apparent_Kd_M: 3.6E-10

Real

Aptamer SeqId: 3067-67 | Target: GDF-9 | UniProt: O60383

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3067-67 | Target: GDF-9 | UniProt: O60383 | TargetFullName: Growth/differentiation factor 9 | Organisim: human | Apparent_Kd_M: 3.6E-10

Real

Aptamer SeqId:3069-52;Target:IgM;UniProt:P01871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3069-52;Target: IgM;UniProt: P01871;TargetFullName: Immunoglobulin M;Organisim: human;Apparent_Kd_M: 1.34E-10

Real

Aptamer SeqId: 3069-52 | Target: IgM | UniProt: P01871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3069-52 | Target: IgM | UniProt: P01871 | TargetFullName: Immunoglobulin M | Organisim: human | Apparent_Kd_M: 1.34E-10

Real

Aptamer SeqId:3070-1;Target:IL-2;UniProt:P60568

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3070-1;Target: IL-2;UniProt: P60568;TargetFullName: Interleukin-2;Organisim: human;Apparent_Kd_M: 2.98E-12

Real

Aptamer SeqId: 3070-1 | Target: IL-2 | UniProt: P60568

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3070-1 | Target: IL-2 | UniProt: P60568 | TargetFullName: Interleukin-2 | Organisim: human | Apparent_Kd_M: 2.98E-12

Real

Aptamer SeqId:3072-4;Target:IL-13;UniProt:P35225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3072-4;Target: IL-13;UniProt: P35225;TargetFullName: Interleukin-13;Organisim: human;Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId: 3072-4 | Target: IL-13 | UniProt: P35225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3072-4 | Target: IL-13 | UniProt: P35225 | TargetFullName: Interleukin-13 | Organisim: human | Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId:3073-51;Target:IL-18 BPa;UniProt:O95998

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3073-51;Target: IL-18 BPa;UniProt: O95998;TargetFullName: Interleukin-18-binding protein;Organisim: human;Apparent_Kd_M: 1.51E-10

Real

Aptamer SeqId: 3073-51 | Target: IL-18 BPa | UniProt: O95998

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3073-51 | Target: IL-18 BPa | UniProt: O95998 | TargetFullName: Interleukin-18-binding protein | Organisim: human | Apparent_Kd_M: 1.51E-10

Real

Aptamer SeqId:3074-6;Target:LBP;UniProt:P18428

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3074-6;Target: LBP;UniProt: P18428;TargetFullName: Lipopolysaccharide-binding protein;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 3074-6 | Target: LBP | UniProt: P18428

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3074-6 | Target: LBP | UniProt: P18428 | TargetFullName: Lipopolysaccharide-binding protein | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:3077-66;Target:Coagulation Factor Xa;UniProt:P00742

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3077-66;Target: Coagulation Factor Xa;UniProt: P00742;TargetFullName: Coagulation factor Xa;Organisim: human;Apparent_Kd_M: 4.48E-13

Real

Aptamer SeqId: 3077-66 | Target: Coagulation Factor Xa | UniProt: P00742

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3077-66 | Target: Coagulation Factor Xa | UniProt: P00742 | TargetFullName: Coagulation factor Xa | Organisim: human | Apparent_Kd_M: 4.48E-13

Real

Aptamer SeqId:3078-1;Target:PlGF;UniProt:P49763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3078-1;Target: PlGF;UniProt: P49763;TargetFullName: Placenta growth factor;Organisim: human;Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId: 3078-1 | Target: PlGF | UniProt: P49763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3078-1 | Target: PlGF | UniProt: P49763 | TargetFullName: Placenta growth factor | Organisim: human | Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId:3079-62;Target:TIG2;UniProt:Q99969

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3079-62;Target: TIG2;UniProt: Q99969;TargetFullName: Retinoic acid receptor responder protein 2;Organisim: human;Apparent_Kd_M: 3.0E-12

Real

Aptamer SeqId: 3079-62 | Target: TIG2 | UniProt: Q99969

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3079-62 | Target: TIG2 | UniProt: Q99969 | TargetFullName: Retinoic acid receptor responder protein 2 | Organisim: human | Apparent_Kd_M: 3.0E-12

Real

Aptamer SeqId:3081-70;Target:ULBP-1;UniProt:Q9BZM6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3081-70;Target: ULBP-1;UniProt: Q9BZM6;TargetFullName: NKG2D ligand 1;Organisim: human;Apparent_Kd_M: 5.45E-11

Real

Aptamer SeqId: 3081-70 | Target: ULBP-1 | UniProt: Q9BZM6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3081-70 | Target: ULBP-1 | UniProt: Q9BZM6 | TargetFullName: NKG2D ligand 1 | Organisim: human | Apparent_Kd_M: 5.45E-11

Real

Aptamer SeqId:3082-9;Target:ULBP-2;UniProt:Q9BZM5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3082-9;Target: ULBP-2;UniProt: Q9BZM5;TargetFullName: NKG2D ligand 2;Organisim: human;Apparent_Kd_M: 3.73E-11

Real

Aptamer SeqId: 3082-9 | Target: ULBP-2 | UniProt: Q9BZM5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3082-9 | Target: ULBP-2 | UniProt: Q9BZM5 | TargetFullName: NKG2D ligand 2 | Organisim: human | Apparent_Kd_M: 3.73E-11

Real

Aptamer SeqId:3083-71;Target:XEDAR;UniProt:Q9HAV5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3083-71;Target: XEDAR;UniProt: Q9HAV5;TargetFullName: Tumor necrosis factor receptor superfamily member 27;Organisim: human;Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId: 3083-71 | Target: XEDAR | UniProt: Q9HAV5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3083-71 | Target: XEDAR | UniProt: Q9HAV5 | TargetFullName: Tumor necrosis factor receptor superfamily member 27 | Organisim: human | Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId:3091-70;Target:Aurora kinase A;UniProt:O14965

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3091-70;Target: Aurora kinase A;UniProt: O14965;TargetFullName: Aurora kinase A;Organisim: human;Apparent_Kd_M: 2.06E-11

Real

Aptamer SeqId: 3091-70 | Target: Aurora kinase A | UniProt: O14965

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3091-70 | Target: Aurora kinase A | UniProt: O14965 | TargetFullName: Aurora kinase A | Organisim: human | Apparent_Kd_M: 2.06E-11

Real

Aptamer SeqId:3115-64;Target:MK01;UniProt:P28482

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3115-64;Target: MK01;UniProt: P28482;TargetFullName: Mitogen-activated protein kinase 1;Organisim: human;Apparent_Kd_M: 1.23E-12

Real

Aptamer SeqId: 3115-64 | Target: MK01 | UniProt: P28482

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3115-64 | Target: MK01 | UniProt: P28482 | TargetFullName: Mitogen-activated protein kinase 1 | Organisim: human | Apparent_Kd_M: 1.23E-12

Real

Aptamer SeqId:3122-6;Target:SMAC;UniProt:Q9NR28

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3122-6;Target: SMAC;UniProt: Q9NR28;TargetFullName: Diablo homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId: 3122-6 | Target: SMAC | UniProt: Q9NR28

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3122-6 | Target: SMAC | UniProt: Q9NR28 | TargetFullName: Diablo homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId:3132-1;Target:VEGF-C;UniProt:P49767

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3132-1;Target: VEGF-C;UniProt: P49767;TargetFullName: Vascular endothelial growth factor C;Organisim: human;Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId: 3132-1 | Target: VEGF-C | UniProt: P49767

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3132-1 | Target: VEGF-C | UniProt: P49767 | TargetFullName: Vascular endothelial growth factor C | Organisim: human | Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId:3143-3;Target:sCD4;UniProt:P01730

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3143-3;Target: sCD4;UniProt: P01730;TargetFullName: T-cell surface glycoprotein CD4;Organisim: human;Apparent_Kd_M: 3.88E-11

Real

Aptamer SeqId: 3143-3 | Target: sCD4 | UniProt: P01730

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3143-3 | Target: sCD4 | UniProt: P01730 | TargetFullName: T-cell surface glycoprotein CD4 | Organisim: human | Apparent_Kd_M: 3.88E-11

Real

Aptamer SeqId:3148-49;Target:Gro-b/g;UniProt:P19876|P19875

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3148-49;Target: Gro-b/g;UniProt: P19876|P19875;TargetFullName: Gro-beta/gamma;Organisim: human;Apparent_Kd_M: 8.59E-13

Real

Aptamer SeqId: 3148-49 | Target: Gro-b/g | UniProt: P19876|P19875

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3148-49 | Target: Gro-b/g | UniProt: P19876|P19875 | TargetFullName: Gro-beta/gamma | Organisim: human | Apparent_Kd_M: 8.59E-13

Real

Aptamer SeqId:3151-6;Target:IL-2 sRa;UniProt:P01589

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3151-6;Target: IL-2 sRa;UniProt: P01589;TargetFullName: Interleukin-2 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.88E-11

Real

Aptamer SeqId: 3151-6 | Target: IL-2 sRa | UniProt: P01589

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3151-6 | Target: IL-2 sRa | UniProt: P01589 | TargetFullName: Interleukin-2 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.88E-11

Real

Aptamer SeqId:3152-57;Target:TNF sR-II;UniProt:P20333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3152-57;Target: TNF sR-II;UniProt: P20333;TargetFullName: Tumor necrosis factor receptor superfamily member 1B;Organisim: human;Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId: 3152-57 | Target: TNF sR-II | UniProt: P20333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3152-57 | Target: TNF sR-II | UniProt: P20333 | TargetFullName: Tumor necrosis factor receptor superfamily member 1B | Organisim: human | Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId:3166-92;Target:Siglec-3;UniProt:P20138

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3166-92;Target: Siglec-3;UniProt: P20138;TargetFullName: Myeloid cell surface antigen CD33;Organisim: human;Apparent_Kd_M: 4.5E-11

Real

Aptamer SeqId: 3166-92 | Target: Siglec-3 | UniProt: P20138

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3166-92 | Target: Siglec-3 | UniProt: P20138 | TargetFullName: Myeloid cell surface antigen CD33 | Organisim: human | Apparent_Kd_M: 4.5E-11

Real

Aptamer SeqId:3168-8;Target:ADAMTS-5;UniProt:Q9UNA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3168-8;Target: ADAMTS-5;UniProt: Q9UNA0;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 5;Organisim: human;Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId: 3168-8 | Target: ADAMTS-5 | UniProt: Q9UNA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3168-8 | Target: ADAMTS-5 | UniProt: Q9UNA0 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 5 | Organisim: human | Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId:3169-70;Target:IDUA;UniProt:P35475

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3169-70;Target: IDUA;UniProt: P35475;TargetFullName: Alpha-L-iduronidase;Organisim: human;Apparent_Kd_M: 4.8E-12

Real

Aptamer SeqId: 3169-70 | Target: IDUA | UniProt: P35475

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3169-70 | Target: IDUA | UniProt: P35475 | TargetFullName: Alpha-L-iduronidase | Organisim: human | Apparent_Kd_M: 4.8E-12

Real

Aptamer SeqId:3170-6;Target:AMPM2;UniProt:P50579

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3170-6;Target: AMPM2;UniProt: P50579;TargetFullName: Methionine aminopeptidase 2;Organisim: human;Apparent_Kd_M: 5.24E-11

Real

Aptamer SeqId: 3170-6 | Target: AMPM2 | UniProt: P50579

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3170-6 | Target: AMPM2 | UniProt: P50579 | TargetFullName: Methionine aminopeptidase 2 | Organisim: human | Apparent_Kd_M: 5.24E-11

Real

Aptamer SeqId:3171-57;Target:amyloid precursor protein;UniProt:P05067

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3171-57;Target: amyloid precursor protein;UniProt: P05067;TargetFullName: Amyloid beta A4 protein;Organisim: human;Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId: 3171-57 | Target: amyloid precursor protein

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3171-57 | Target: amyloid precursor protein | UniProt: P05067 | TargetFullName: Amyloid beta A4 protein | Organisim: human | Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId:3172-28;Target:ARSB;UniProt:P15848

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3172-28;Target: ARSB;UniProt: P15848;TargetFullName: Arylsulfatase B;Organisim: human;Apparent_Kd_M: 1.35E-11

Real

Aptamer SeqId: 3172-28 | Target: ARSB | UniProt: P15848

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3172-28 | Target: ARSB | UniProt: P15848 | TargetFullName: Arylsulfatase B | Organisim: human | Apparent_Kd_M: 1.35E-11

Real

Aptamer SeqId:3173-49;Target:ASAHL;UniProt:Q02083

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3173-49;Target: ASAHL;UniProt: Q02083;TargetFullName: N-acylethanolamine-hydrolyzing acid amidase;Organisim: human;Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId: 3173-49 | Target: ASAHL | UniProt: Q02083

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3173-49 | Target: ASAHL | UniProt: Q02083 | TargetFullName: N-acylethanolamine-hydrolyzing acid amidase | Organisim: human | Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId:3174-2;Target:ATS1;UniProt:Q9UHI8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3174-2;Target: ATS1;UniProt: Q9UHI8;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 1;Organisim: human;Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId: 3174-2 | Target: ATS1 | UniProt: Q9UHI8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3174-2 | Target: ATS1 | UniProt: Q9UHI8 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 1 | Organisim: human | Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId:3175-51;Target:ATS13;UniProt:Q76LX8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3175-51;Target: ATS13;UniProt: Q76LX8;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 13;Organisim: human;Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId: 3175-51 | Target: ATS13 | UniProt: Q76LX8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3175-51 | Target: ATS13 | UniProt: Q76LX8 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 13 | Organisim: human | Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId:3178-5;Target:CATC;UniProt:P53634

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3178-5;Target: CATC;UniProt: P53634;TargetFullName: Dipeptidyl peptidase 1;Organisim: human;Apparent_Kd_M: 6.56E-11

Real

Aptamer SeqId: 3178-5 | Target: CATC | UniProt: P53634

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3178-5 | Target: CATC | UniProt: P53634 | TargetFullName: Dipeptidyl peptidase 1 | Organisim: human | Apparent_Kd_M: 6.56E-11

Real

Aptamer SeqId:3179-51;Target:Cathepsin A;UniProt:P10619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3179-51;Target: Cathepsin A;UniProt: P10619;TargetFullName: Lysosomal protective protein;Organisim: human;Apparent_Kd_M: 3.22E-12

Real

Aptamer SeqId: 3179-51 | Target: Cathepsin A | UniProt: P10619

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3179-51 | Target: Cathepsin A | UniProt: P10619 | TargetFullName: Lysosomal protective protein | Organisim: human | Apparent_Kd_M: 3.22E-12

Real

Aptamer SeqId:3181-50;Target:Cathepsin S;UniProt:P25774

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3181-50;Target: Cathepsin S;UniProt: P25774;TargetFullName: Cathepsin S;Organisim: human;Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId: 3181-50 | Target: Cathepsin S | UniProt: P25774

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3181-50 | Target: Cathepsin S | UniProt: P25774 | TargetFullName: Cathepsin S | Organisim: human | Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId:3182-38;Target:CD39;UniProt:P49961

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3182-38;Target: CD39;UniProt: P49961;TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 1;Organisim: human;Apparent_Kd_M: 3.64E-12

Real

Aptamer SeqId: 3182-38 | Target: CD39 | UniProt: P49961

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3182-38 | Target: CD39 | UniProt: P49961 | TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 1 | Organisim: human | Apparent_Kd_M: 3.64E-12

Real

Aptamer SeqId:3184-25;Target:Coagulation Factor VII;UniProt:P08709

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3184-25;Target: Coagulation Factor VII;UniProt: P08709;TargetFullName: Coagulation factor VII;Organisim: human;Apparent_Kd_M: 5.38E-11

Real

Aptamer SeqId: 3184-25 | Target: Coagulation Factor VII | UniProt: P08709

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3184-25 | Target: Coagulation Factor VII | UniProt: P08709 | TargetFullName: Coagulation factor VII | Organisim: human | Apparent_Kd_M: 5.38E-11

Real

Aptamer SeqId:3186-2;Target:C2;UniProt:P06681

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3186-2;Target: C2;UniProt: P06681;TargetFullName: Complement C2;Organisim: human;Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId: 3186-2 | Target: C2 | UniProt: P06681

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3186-2 | Target: C2 | UniProt: P06681 | TargetFullName: Complement C2 | Organisim: human | Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId:3187-52;Target:CRIS3;UniProt:P54108

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3187-52;Target: CRIS3;UniProt: P54108;TargetFullName: Cysteine-rich secretory protein 3;Organisim: human;Apparent_Kd_M: 6.51E-12

Real

Aptamer SeqId: 3187-52 | Target: CRIS3 | UniProt: P54108

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3187-52 | Target: CRIS3 | UniProt: P54108 | TargetFullName: Cysteine-rich secretory protein 3 | Organisim: human | Apparent_Kd_M: 6.51E-12

Real

Aptamer SeqId:3189-61;Target:Enterokinase;UniProt:P98073

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3189-61;Target: Enterokinase;UniProt: P98073;TargetFullName: Enteropeptidase;Organisim: human;Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId: 3189-61 | Target: Enterokinase | UniProt: P98073

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3189-61 | Target: Enterokinase | UniProt: P98073 | TargetFullName: Enteropeptidase | Organisim: human | Apparent_Kd_M: 1.45E-11

Real

Aptamer SeqId:3191-50;Target:WFKN1;UniProt:Q96NZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3191-50;Target: WFKN1;UniProt: Q96NZ8;TargetFullName: WAP; kazal; immunoglobulin; kunitz and NTR domain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.41E-11

Real

Aptamer SeqId: 3191-50 | Target: WFKN1 | UniProt: Q96NZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3191-50 | Target: WFKN1 | UniProt: Q96NZ8 | TargetFullName: WAP; kazal; immunoglobulin; kunitz and NTR domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.41E-11

Real

Aptamer SeqId:3192-3;Target:Glutamate carboxypeptidase;UniProt:Q96KP4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3192-3;Target: Glutamate carboxypeptidase;UniProt: Q96KP4;TargetFullName: Cytosolic non-specific dipeptidase;Organisim: human;Apparent_Kd_M: 1.49E-10

Real

Aptamer SeqId: 3192-3 | Target: Glutamate carboxypeptidase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3192-3 | Target: Glutamate carboxypeptidase | UniProt: Q96KP4 | TargetFullName: Cytosolic non-specific dipeptidase | Organisim: human | Apparent_Kd_M: 1.49E-10

Real

Aptamer SeqId:3194-36;Target:GPVI;UniProt:Q9HCN6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3194-36;Target: GPVI;UniProt: Q9HCN6;TargetFullName: Platelet glycoprotein VI;Organisim: human;Apparent_Kd_M: 1.39E-12

Real

Aptamer SeqId: 3194-36 | Target: GPVI | UniProt: Q9HCN6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3194-36 | Target: GPVI | UniProt: Q9HCN6 | TargetFullName: Platelet glycoprotein VI | Organisim: human | Apparent_Kd_M: 1.39E-12

Real

Aptamer SeqId:3195-50;Target:Granulysin;UniProt:P22749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3195-50;Target: Granulysin;UniProt: P22749;TargetFullName: Granulysin;Organisim: human;Apparent_Kd_M: 2.23E-12

Real

Aptamer SeqId: 3195-50 | Target: Granulysin | UniProt: P22749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3195-50 | Target: Granulysin | UniProt: P22749 | TargetFullName: Granulysin | Organisim: human | Apparent_Kd_M: 2.23E-12

Real

Aptamer SeqId:3196-6;Target:HPLN1;UniProt:P10915

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3196-6;Target: HPLN1;UniProt: P10915;TargetFullName: Hyaluronan and proteoglycan link protein 1;Organisim: human;Apparent_Kd_M: 2.29E-12

Real

Aptamer SeqId: 3196-6 | Target: HPLN1 | UniProt: P10915

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3196-6 | Target: HPLN1 | UniProt: P10915 | TargetFullName: Hyaluronan and proteoglycan link protein 1 | Organisim: human | Apparent_Kd_M: 2.29E-12

Real

Aptamer SeqId:3197-70;Target:IDE;UniProt:P14735

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3197-70;Target: IDE;UniProt: P14735;TargetFullName: Insulin-degrading enzyme;Organisim: human;Apparent_Kd_M: 6.27E-12

Real

Aptamer SeqId: 3197-70 | Target: IDE | UniProt: P14735

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3197-70 | Target: IDE | UniProt: P14735 | TargetFullName: Insulin-degrading enzyme | Organisim: human | Apparent_Kd_M: 6.27E-12

Real

Aptamer SeqId:3198-4;Target:IDS;UniProt:P22304

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3198-4;Target: IDS;UniProt: P22304;TargetFullName: Iduronate 2-sulfatase;Organisim: human;Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId: 3198-4 | Target: IDS | UniProt: P22304

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3198-4 | Target: IDS | UniProt: P22304 | TargetFullName: Iduronate 2-sulfatase | Organisim: human | Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId:3199-54;Target:kallikrein 12;UniProt:Q9UKR0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3199-54;Target: kallikrein 12;UniProt: Q9UKR0;TargetFullName: Kallikrein-12;Organisim: human;Apparent_Kd_M: 1.03E-12

Real

Aptamer SeqId: 3199-54 | Target: kallikrein 12 | UniProt: Q9UKR0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3199-54 | Target: kallikrein 12 | UniProt: Q9UKR0 | TargetFullName: Kallikrein-12 | Organisim: human | Apparent_Kd_M: 1.03E-12

Real

Aptamer SeqId:3201-49;Target:kallikrein 5;UniProt:Q9Y337

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3201-49;Target: kallikrein 5;UniProt: Q9Y337;TargetFullName: Kallikrein-5;Organisim: human;Apparent_Kd_M: 5.1E-13

Real

Aptamer SeqId: 3201-49 | Target: kallikrein 5 | UniProt: Q9Y337

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3201-49 | Target: kallikrein 5 | UniProt: Q9Y337 | TargetFullName: Kallikrein-5 | Organisim: human | Apparent_Kd_M: 5.1E-13

Real

Aptamer SeqId:3202-28;Target:KREM2;UniProt:Q8NCW0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3202-28;Target: KREM2;UniProt: Q8NCW0;TargetFullName: Kremen protein 2;Organisim: human;Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId: 3202-28 | Target: KREM2 | UniProt: Q8NCW0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3202-28 | Target: KREM2 | UniProt: Q8NCW0 | TargetFullName: Kremen protein 2 | Organisim: human | Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId:3204-2;Target:LKHA4;UniProt:P09960

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3204-2;Target: LKHA4;UniProt: P09960;TargetFullName: Leukotriene A-4 hydrolase;Organisim: human;Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId: 3204-2 | Target: LKHA4 | UniProt: P09960

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3204-2 | Target: LKHA4 | UniProt: P09960 | TargetFullName: Leukotriene A-4 hydrolase | Organisim: human | Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId:3206-4;Target:LYVE1;UniProt:Q9Y5Y7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3206-4;Target: LYVE1;UniProt: Q9Y5Y7;TargetFullName: Lymphatic vessel endothelial hyaluronic acid receptor 1;Organisim: human;Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId: 3206-4 | Target: LYVE1 | UniProt: Q9Y5Y7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3206-4 | Target: LYVE1 | UniProt: Q9Y5Y7 | TargetFullName: Lymphatic vessel endothelial hyaluronic acid receptor 1 | Organisim: human | Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId:3209-69;Target:MEPE;UniProt:Q9NQ76

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3209-69;Target: MEPE;UniProt: Q9NQ76;TargetFullName: Matrix extracellular phosphoglycoprotein;Organisim: human;Apparent_Kd_M: 5.9E-11

Real

Aptamer SeqId: 3209-69 | Target: MEPE | UniProt: Q9NQ76

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3209-69 | Target: MEPE | UniProt: Q9NQ76 | TargetFullName: Matrix extracellular phosphoglycoprotein | Organisim: human | Apparent_Kd_M: 5.9E-11

Real

Aptamer SeqId:3210-1;Target:METAP1;UniProt:P53582

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3210-1;Target: METAP1;UniProt: P53582;TargetFullName: Methionine aminopeptidase 1;Organisim: human;Apparent_Kd_M: 8.3E-12

Real

Aptamer SeqId: 3210-1 | Target: METAP1 | UniProt: P53582

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3210-1 | Target: METAP1 | UniProt: P53582 | TargetFullName: Methionine aminopeptidase 1 | Organisim: human | Apparent_Kd_M: 8.3E-12

Real

Aptamer SeqId:3212-30;Target:ASAH2;UniProt:Q9NR71

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3212-30;Target: ASAH2;UniProt: Q9NR71;TargetFullName: Neutral ceramidase;Organisim: human;Apparent_Kd_M: 1.8E-11

Real

Aptamer SeqId: 3212-30 | Target: ASAH2 | UniProt: Q9NR71

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3212-30 | Target: ASAH2 | UniProt: Q9NR71 | TargetFullName: Neutral ceramidase | Organisim: human | Apparent_Kd_M: 1.8E-11

Real

Aptamer SeqId:3213-65;Target:Nidogen;UniProt:P14543

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3213-65;Target: Nidogen;UniProt: P14543;TargetFullName: Nidogen-1;Organisim: human;Apparent_Kd_M: 1.1E-10

Real

Aptamer SeqId: 3213-65 | Target: Nidogen | UniProt: P14543

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3213-65 | Target: Nidogen | UniProt: P14543 | TargetFullName: Nidogen-1 | Organisim: human | Apparent_Kd_M: 1.1E-10

Real

Aptamer SeqId:3216-2;Target:PIGR;UniProt:P01833

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3216-2;Target: PIGR;UniProt: P01833;TargetFullName: Polymeric immunoglobulin receptor;Organisim: human;Apparent_Kd_M: 2.79E-12

Real

Aptamer SeqId: 3216-2 | Target: PIGR | UniProt: P01833

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3216-2 | Target: PIGR | UniProt: P01833 | TargetFullName: Polymeric immunoglobulin receptor | Organisim: human | Apparent_Kd_M: 2.79E-12

Real

Aptamer SeqId:3220-40;Target:RET;UniProt:P07949

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3220-40;Target: RET;UniProt: P07949;TargetFullName: Proto-oncogene tyrosine-protein kinase receptor Ret;Organisim: human;Apparent_Kd_M: 6.66E-12

Real

Aptamer SeqId: 3220-40 | Target: RET | UniProt: P07949

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3220-40 | Target: RET | UniProt: P07949 | TargetFullName: Proto-oncogene tyrosine-protein kinase receptor Ret | Organisim: human | Apparent_Kd_M: 6.66E-12

Real

Aptamer SeqId:3221-54;Target:SARP-2;UniProt:Q8N474

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3221-54;Target: SARP-2;UniProt: Q8N474;TargetFullName: Secreted frizzled-related protein 1;Organisim: human;Apparent_Kd_M: 6.07E-11

Real

Aptamer SeqId: 3221-54 | Target: SARP-2 | UniProt: Q8N474

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3221-54 | Target: SARP-2 | UniProt: Q8N474 | TargetFullName: Secreted frizzled-related protein 1 | Organisim: human | Apparent_Kd_M: 6.07E-11

Real

Aptamer SeqId:3222-11;Target:Semaphorin 3A;UniProt:Q14563

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3222-11;Target: Semaphorin 3A;UniProt: Q14563;TargetFullName: Semaphorin-3A;Organisim: human;Apparent_Kd_M: 7.59E-11

Real

Aptamer SeqId: 3222-11 | Target: Semaphorin 3A | UniProt: Q14563

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3222-11 | Target: Semaphorin 3A | UniProt: Q14563 | TargetFullName: Semaphorin-3A | Organisim: human | Apparent_Kd_M: 7.59E-11

Real

Aptamer SeqId:3232-28;Target:TrATPase;UniProt:P13686

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3232-28;Target: TrATPase;UniProt: P13686;TargetFullName: Tartrate-resistant acid phosphatase type 5;Organisim: human;Apparent_Kd_M: 7.26E-12

Real

Aptamer SeqId: 3232-28 | Target: TrATPase | UniProt: P13686

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3232-28 | Target: TrATPase | UniProt: P13686 | TargetFullName: Tartrate-resistant acid phosphatase type 5 | Organisim: human | Apparent_Kd_M: 7.26E-12

Real

Aptamer SeqId:3234-23;Target:URB;UniProt:Q76M96

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3234-23;Target: URB;UniProt: Q76M96;TargetFullName: Coiled-coil domain-containing protein 80;Organisim: human;Apparent_Kd_M: 2.45E-11

Real

Aptamer SeqId: 3234-23 | Target: URB | UniProt: Q76M96

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3234-23 | Target: URB | UniProt: Q76M96 | TargetFullName: Coiled-coil domain-containing protein 80 | Organisim: human | Apparent_Kd_M: 2.45E-11

Real

Aptamer SeqId:3235-50;Target:WFKN2;UniProt:Q8TEU8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3235-50;Target: WFKN2;UniProt: Q8TEU8;TargetFullName: WAP; Kazal; immunoglobulin; Kunitz and NTR domain-containing protein 2;Organisim: human;Apparent_Kd_M: 6.54E-12

Real

Aptamer SeqId: 3235-50 | Target: WFKN2 | UniProt: Q8TEU8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3235-50 | Target: WFKN2 | UniProt: Q8TEU8 | TargetFullName: WAP; Kazal; immunoglobulin; Kunitz and NTR domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 6.54E-12

Real

Aptamer SeqId:3280-49;Target:Aggrecan;UniProt:P16112

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3280-49;Target: Aggrecan;UniProt: P16112;TargetFullName: Aggrecan core protein;Organisim: human;Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId: 3280-49 | Target: Aggrecan | UniProt: P16112

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3280-49 | Target: Aggrecan | UniProt: P16112 | TargetFullName: Aggrecan core protein | Organisim: human | Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId:3283-21;Target:BGH3;UniProt:Q15582

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3283-21;Target: BGH3;UniProt: Q15582;TargetFullName: Transforming growth factor-beta-induced protein ig-h3;Organisim: human;Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId: 3283-21 | Target: BGH3 | UniProt: Q15582

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3283-21 | Target: BGH3 | UniProt: Q15582 | TargetFullName: Transforming growth factor-beta-induced protein ig-h3 | Organisim: human | Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId:3284-75;Target:BGN;UniProt:P21810

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3284-75;Target: BGN;UniProt: P21810;TargetFullName: Biglycan;Organisim: human;Apparent_Kd_M: 2.97E-11

Real

Aptamer SeqId: 3284-75 | Target: BGN | UniProt: P21810

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3284-75 | Target: BGN | UniProt: P21810 | TargetFullName: Biglycan | Organisim: human | Apparent_Kd_M: 2.97E-11

Real

Aptamer SeqId:3285-23;Target:C1r;UniProt:P00736

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3285-23;Target: C1r;UniProt: P00736;TargetFullName: Complement C1r subcomponent;Organisim: human;Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId: 3285-23 | Target: C1r | UniProt: P00736

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3285-23 | Target: C1r | UniProt: P00736 | TargetFullName: Complement C1r subcomponent | Organisim: human | Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId:3290-50;Target:CD109;UniProt:Q6YHK3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3290-50;Target: CD109;UniProt: Q6YHK3;TargetFullName: CD109 antigen;Organisim: human;Apparent_Kd_M: 6.33E-11

Real

Aptamer SeqId: 3290-50 | Target: CD109 | UniProt: Q6YHK3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3290-50 | Target: CD109 | UniProt: Q6YHK3 | TargetFullName: CD109 antigen | Organisim: human | Apparent_Kd_M: 6.33E-11

Real

Aptamer SeqId:3291-30;Target:CD23;UniProt:P06734

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3291-30;Target: CD23;UniProt: P06734;TargetFullName: Low affinity immunoglobulin epsilon Fc receptor;Organisim: human;Apparent_Kd_M: 2.88E-12

Real

Aptamer SeqId: 3291-30 | Target: CD23 | UniProt: P06734

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3291-30 | Target: CD23 | UniProt: P06734 | TargetFullName: Low affinity immunoglobulin epsilon Fc receptor | Organisim: human | Apparent_Kd_M: 2.88E-12

Real

Aptamer SeqId:3292-75;Target:CD48;UniProt:P09326

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3292-75;Target: CD48;UniProt: P09326;TargetFullName: CD48 antigen;Organisim: human;Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId: 3292-75 | Target: CD48 | UniProt: P09326

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3292-75 | Target: CD48 | UniProt: P09326 | TargetFullName: CD48 antigen | Organisim: human | Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId:3293-2;Target:CD5L;UniProt:O43866

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3293-2;Target: CD5L;UniProt: O43866;TargetFullName: CD5 antigen-like;Organisim: human;Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId: 3293-2 | Target: CD5L | UniProt: O43866

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3293-2 | Target: CD5L | UniProt: O43866 | TargetFullName: CD5 antigen-like | Organisim: human | Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId:3294-55;Target:CFC1;UniProt:P0CG37

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3294-55;Target: CFC1;UniProt: P0CG37;TargetFullName: Cryptic protein;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 3294-55 | Target: CFC1 | UniProt: P0CG37

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3294-55 | Target: CFC1 | UniProt: P0CG37 | TargetFullName: Cryptic protein | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:3296-92;Target:CNTN2;UniProt:Q02246

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3296-92;Target: CNTN2;UniProt: Q02246;TargetFullName: Contactin-2;Organisim: human;Apparent_Kd_M: 4.39E-11

Real

Aptamer SeqId: 3296-92 | Target: CNTN2 | UniProt: Q02246

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3296-92 | Target: CNTN2 | UniProt: Q02246 | TargetFullName: Contactin-2 | Organisim: human | Apparent_Kd_M: 4.39E-11

Real

Aptamer SeqId:3298-52;Target:Contactin-4;UniProt:Q8IWV2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3298-52;Target: Contactin-4;UniProt: Q8IWV2;TargetFullName: Contactin-4;Organisim: human;Apparent_Kd_M: 5.74E-12

Real

Aptamer SeqId: 3298-52 | Target: Contactin-4 | UniProt: Q8IWV2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3298-52 | Target: Contactin-4 | UniProt: Q8IWV2 | TargetFullName: Contactin-4 | Organisim: human | Apparent_Kd_M: 5.74E-12

Real

Aptamer SeqId:3299-29;Target:Contactin-5;UniProt:O94779

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3299-29;Target: Contactin-5;UniProt: O94779;TargetFullName: Contactin-5;Organisim: human;Apparent_Kd_M: 7.54E-12

Real

Aptamer SeqId: 3299-29 | Target: Contactin-5 | UniProt: O94779

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3299-29 | Target: Contactin-5 | UniProt: O94779 | TargetFullName: Contactin-5 | Organisim: human | Apparent_Kd_M: 7.54E-12

Real

Aptamer SeqId:3302-58;Target:CYTF;UniProt:O76096

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3302-58;Target: CYTF;UniProt: O76096;TargetFullName: Cystatin-F;Organisim: human;Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId: 3302-58 | Target: CYTF | UniProt: O76096

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3302-58 | Target: CYTF | UniProt: O76096 | TargetFullName: Cystatin-F | Organisim: human | Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId:3305-6;Target:DLL4;UniProt:Q9NR61

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3305-6;Target: DLL4;UniProt: Q9NR61;TargetFullName: Delta-like protein 4;Organisim: human;Apparent_Kd_M: 1.69E-11

Real

Aptamer SeqId: 3305-6 | Target: DLL4 | UniProt: Q9NR61

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3305-6 | Target: DLL4 | UniProt: Q9NR61 | TargetFullName: Delta-like protein 4 | Organisim: human | Apparent_Kd_M: 1.69E-11

Real

Aptamer SeqId:3309-2;Target:FCG2A;UniProt:P12318

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3309-2;Target: FCG2A;UniProt: P12318;TargetFullName: Low affinity immunoglobulin gamma Fc region receptor II-a;Organisim: human;Apparent_Kd_M: 7.19E-12

Real

Aptamer SeqId: 3309-2 | Target: FCG2A | UniProt: P12318

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3309-2 | Target: FCG2A | UniProt: P12318 | TargetFullName: Low affinity immunoglobulin gamma Fc region receptor II-a | Organisim: human | Apparent_Kd_M: 7.19E-12

Real

Aptamer SeqId:3310-62;Target:FCG2B;UniProt:P31994

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3310-62;Target: FCG2B;UniProt: P31994;TargetFullName: Low affinity immunoglobulin gamma Fc region receptor II-b;Organisim: human;Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId: 3310-62 | Target: FCG2B | UniProt: P31994

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3310-62 | Target: FCG2B | UniProt: P31994 | TargetFullName: Low affinity immunoglobulin gamma Fc region receptor II-b | Organisim: human | Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId:3311-27;Target:FCG3B;UniProt:O75015

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3311-27;Target: FCG3B;UniProt: O75015;TargetFullName: Low affinity immunoglobulin gamma Fc region receptor III-B;Organisim: human;Apparent_Kd_M: 8.35E-12

Real

Aptamer SeqId: 3311-27 | Target: FCG3B | UniProt: O75015

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3311-27 | Target: FCG3B | UniProt: O75015 | TargetFullName: Low affinity immunoglobulin gamma Fc region receptor III-B | Organisim: human | Apparent_Kd_M: 8.35E-12

Real

Aptamer SeqId:3312-64;Target:FCGR1;UniProt:P12314

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3312-64;Target: FCGR1;UniProt: P12314;TargetFullName: High affinity immunoglobulin gamma Fc receptor I;Organisim: human;Apparent_Kd_M: 4.5E-12

Real

Aptamer SeqId: 3312-64 | Target: FCGR1 | UniProt: P12314

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3312-64 | Target: FCGR1 | UniProt: P12314 | TargetFullName: High affinity immunoglobulin gamma Fc receptor I | Organisim: human | Apparent_Kd_M: 4.5E-12

Real

Aptamer SeqId:3313-21;Target:FCN2;UniProt:Q15485

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3313-21;Target: FCN2;UniProt: Q15485;TargetFullName: Ficolin-2;Organisim: human;Apparent_Kd_M: 7.94E-10

Real

Aptamer SeqId: 3313-21 | Target: FCN2 | UniProt: Q15485

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3313-21 | Target: FCN2 | UniProt: Q15485 | TargetFullName: Ficolin-2 | Organisim: human | Apparent_Kd_M: 7.94E-10

Real

Aptamer SeqId:3314-74;Target:GFRa-1;UniProt:P56159

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3314-74;Target: GFRa-1;UniProt: P56159;TargetFullName: GDNF family receptor alpha-1;Organisim: human;Apparent_Kd_M: 1.52E-12

Real

Aptamer SeqId: 3314-74 | Target: GFRa-1 | UniProt: P56159

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3314-74 | Target: GFRa-1 | UniProt: P56159 | TargetFullName: GDNF family receptor alpha-1 | Organisim: human | Apparent_Kd_M: 1.52E-12

Real

Aptamer SeqId:3315-15;Target:GPC2;UniProt:Q8N158

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3315-15;Target: GPC2;UniProt: Q8N158;TargetFullName: Glypican-2;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 3315-15 | Target: GPC2 | UniProt: Q8N158

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3315-15 | Target: GPC2 | UniProt: Q8N158 | TargetFullName: Glypican-2 | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:3316-58;Target:Heparin cofactor II;UniProt:P05546

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3316-58;Target: Heparin cofactor II;UniProt: P05546;TargetFullName: Heparin cofactor 2;Organisim: human;Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId: 3316-58 | Target: Heparin cofactor II | UniProt: P05546

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3316-58 | Target: Heparin cofactor II | UniProt: P05546 | TargetFullName: Heparin cofactor 2 | Organisim: human | Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId:3317-33;Target:HTRA2;UniProt:O43464

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3317-33;Target: HTRA2;UniProt: O43464;TargetFullName: Serine protease HTRA2; mitochondrial;Organisim: human;Apparent_Kd_M: 8.69E-12

Real

Aptamer SeqId: 3317-33 | Target: HTRA2 | UniProt: O43464

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3317-33 | Target: HTRA2 | UniProt: O43464 | TargetFullName: Serine protease HTRA2; mitochondrial | Organisim: human | Apparent_Kd_M: 8.69E-12

Real

Aptamer SeqId:3320-49;Target:IGFBP-7;UniProt:Q16270

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3320-49;Target: IGFBP-7;UniProt: Q16270;TargetFullName: Insulin-like growth factor-binding protein 7;Organisim: human;Apparent_Kd_M: 2.4E-12

Real

Aptamer SeqId: 3320-49 | Target: IGFBP-7 | UniProt: Q16270

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3320-49 | Target: IGFBP-7 | UniProt: Q16270 | TargetFullName: Insulin-like growth factor-binding protein 7 | Organisim: human | Apparent_Kd_M: 2.4E-12

Real

Aptamer SeqId:3321-2;Target:IL24;UniProt:Q13007

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3321-2;Target: IL24;UniProt: Q13007;TargetFullName: Interleukin-24;Organisim: human;Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId: 3321-2 | Target: IL24 | UniProt: Q13007

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3321-2 | Target: IL24 | UniProt: Q13007 | TargetFullName: Interleukin-24 | Organisim: human | Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId:3322-52;Target:LRIG3;UniProt:Q6UXM1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3322-52;Target: LRIG3;UniProt: Q6UXM1;TargetFullName: Leucine-rich repeats and immunoglobulin-like domains protein 3;Organisim: human;Apparent_Kd_M: 7.52E-12

Real

Aptamer SeqId: 3322-52 | Target: LRIG3 | UniProt: Q6UXM1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3322-52 | Target: LRIG3 | UniProt: Q6UXM1 | TargetFullName: Leucine-rich repeats and immunoglobulin-like domains protein 3 | Organisim: human | Apparent_Kd_M: 7.52E-12

Real

Aptamer SeqId:3323-37;Target:LRP8;UniProt:Q14114

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3323-37;Target: LRP8;UniProt: Q14114;TargetFullName: Low-density lipoprotein receptor-related protein 8;Organisim: human;Apparent_Kd_M: 1.26E-10

Real

Aptamer SeqId: 3323-37 | Target: LRP8 | UniProt: Q14114

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3323-37 | Target: LRP8 | UniProt: Q14114 | TargetFullName: Low-density lipoprotein receptor-related protein 8 | Organisim: human | Apparent_Kd_M: 1.26E-10

Real

Aptamer SeqId:3324-51;Target:LY9;UniProt:Q9HBG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3324-51;Target: LY9;UniProt: Q9HBG7;TargetFullName: T-lymphocyte surface antigen Ly-9;Organisim: human;Apparent_Kd_M: 9.26E-12

Real

Aptamer SeqId: 3324-51 | Target: LY9 | UniProt: Q9HBG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3324-51 | Target: LY9 | UniProt: Q9HBG7 | TargetFullName: T-lymphocyte surface antigen Ly-9 | Organisim: human | Apparent_Kd_M: 9.26E-12

Real

Aptamer SeqId:3325-2;Target:MATN2;UniProt:O00339

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3325-2;Target: MATN2;UniProt: O00339;TargetFullName: Matrilin-2;Organisim: human;Apparent_Kd_M: 1.55E-12

Real

Aptamer SeqId: 3325-2 | Target: MATN2 | UniProt: O00339

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3325-2 | Target: MATN2 | UniProt: O00339 | TargetFullName: Matrilin-2 | Organisim: human | Apparent_Kd_M: 1.55E-12

Real

Aptamer SeqId:3326-58;Target:Nectin-like protein 2;UniProt:Q9BY67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3326-58;Target: Nectin-like protein 2;UniProt: Q9BY67;TargetFullName: Cell adhesion molecule 1;Organisim: human;Apparent_Kd_M: 2.5E-11

Real

Aptamer SeqId: 3326-58 | Target: Nectin-like protein 2 | UniProt: Q9BY67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3326-58 | Target: Nectin-like protein 2 | UniProt: Q9BY67 | TargetFullName: Cell adhesion molecule 1 | Organisim: human | Apparent_Kd_M: 2.5E-11

Real

Aptamer SeqId:3327-27;Target:NET4;UniProt:Q9HB63

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3327-27;Target: NET4;UniProt: Q9HB63;TargetFullName: Netrin-4;Organisim: human;Apparent_Kd_M: 1.43E-12

Real

Aptamer SeqId: 3327-27 | Target: NET4 | UniProt: Q9HB63

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3327-27 | Target: NET4 | UniProt: Q9HB63 | TargetFullName: Netrin-4 | Organisim: human | Apparent_Kd_M: 1.43E-12

Real

Aptamer SeqId:3329-14;Target:PGRP-S;UniProt:O75594

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3329-14;Target: PGRP-S;UniProt: O75594;TargetFullName: Peptidoglycan recognition protein 1;Organisim: human;Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId: 3329-14 | Target: PGRP-S | UniProt: O75594

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3329-14 | Target: PGRP-S | UniProt: O75594 | TargetFullName: Peptidoglycan recognition protein 1 | Organisim: human | Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId:3331-8;Target:RGMB;UniProt:Q6NW40

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3331-8;Target: RGMB;UniProt: Q6NW40;TargetFullName: RGM domain family member B;Organisim: human;Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId: 3331-8 | Target: RGMB | UniProt: Q6NW40

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3331-8 | Target: RGMB | UniProt: Q6NW40 | TargetFullName: RGM domain family member B | Organisim: human | Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId:3332-57;Target:RGM-C;UniProt:Q6ZVN8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3332-57;Target: RGM-C;UniProt: Q6ZVN8;TargetFullName: Hemojuvelin;Organisim: human;Apparent_Kd_M: 6.92E-12

Real

Aptamer SeqId: 3332-57 | Target: RGM-C | UniProt: Q6ZVN8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3332-57 | Target: RGM-C | UniProt: Q6ZVN8 | TargetFullName: Hemojuvelin | Organisim: human | Apparent_Kd_M: 6.92E-12

Real

Aptamer SeqId:3336-50;Target:TFPI;UniProt:P10646

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3336-50;Target: TFPI;UniProt: P10646;TargetFullName: Tissue factor pathway inhibitor;Organisim: human;Apparent_Kd_M: 2.28E-12

Real

Aptamer SeqId: 3336-50 | Target: TFPI | UniProt: P10646

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3336-50 | Target: TFPI | UniProt: P10646 | TargetFullName: Tissue factor pathway inhibitor | Organisim: human | Apparent_Kd_M: 2.28E-12

Real

Aptamer SeqId:3339-33;Target:TSP2;UniProt:P35442

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3339-33;Target: TSP2;UniProt: P35442;TargetFullName: Thrombospondin-2;Organisim: human;Apparent_Kd_M: 4.47E-11

Real

Aptamer SeqId: 3339-33 | Target: TSP2 | UniProt: P35442

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3339-33 | Target: TSP2 | UniProt: P35442 | TargetFullName: Thrombospondin-2 | Organisim: human | Apparent_Kd_M: 4.47E-11

Real

Aptamer SeqId:3340-53;Target:TSP4;UniProt:P35443

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3340-53;Target: TSP4;UniProt: P35443;TargetFullName: Thrombospondin-4;Organisim: human;Apparent_Kd_M: 1.51E-10

Real

Aptamer SeqId: 3340-53 | Target: TSP4 | UniProt: P35443

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3340-53 | Target: TSP4 | UniProt: P35443 | TargetFullName: Thrombospondin-4 | Organisim: human | Apparent_Kd_M: 1.51E-10

Real

Aptamer SeqId:3341-33;Target:ABL1;UniProt:P00519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3341-33;Target: ABL1;UniProt: P00519;TargetFullName: Tyrosine-protein kinase ABL1;Organisim: human;Apparent_Kd_M: 6.18E-11

Real

Aptamer SeqId: 3341-33 | Target: ABL1 | UniProt: P00519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3341-33 | Target: ABL1 | UniProt: P00519 | TargetFullName: Tyrosine-protein kinase ABL1 | Organisim: human | Apparent_Kd_M: 6.18E-11

Real

Aptamer SeqId:3342-76;Target:ABL2;UniProt:P42684

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3342-76;Target: ABL2;UniProt: P42684;TargetFullName: Abelson tyrosine-protein kinase 2;Organisim: human;Apparent_Kd_M: 2.75E-11

Real

Aptamer SeqId: 3342-76 | Target: ABL2 | UniProt: P42684

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3342-76 | Target: ABL2 | UniProt: P42684 | TargetFullName: Abelson tyrosine-protein kinase 2 | Organisim: human | Apparent_Kd_M: 2.75E-11

Real

Aptamer SeqId:3343-1;Target:Aminoacylase-1;UniProt:Q03154

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3343-1;Target: Aminoacylase-1;UniProt: Q03154;TargetFullName: Aminoacylase-1;Organisim: human;Apparent_Kd_M: 5.6E-12

Real

Aptamer SeqId: 3343-1 | Target: Aminoacylase-1 | UniProt: Q03154

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3343-1 | Target: Aminoacylase-1 | UniProt: Q03154 | TargetFullName: Aminoacylase-1 | Organisim: human | Apparent_Kd_M: 5.6E-12

Real

Aptamer SeqId:3344-60;Target:Antithrombin III;UniProt:P01008

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3344-60;Target: Antithrombin III;UniProt: P01008;TargetFullName: Antithrombin-III;Organisim: human;Apparent_Kd_M: 2.4E-11

Real

Aptamer SeqId: 3344-60 | Target: Antithrombin III | UniProt: P01008

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3344-60 | Target: Antithrombin III | UniProt: P01008 | TargetFullName: Antithrombin-III | Organisim: human | Apparent_Kd_M: 2.4E-11

Real

Aptamer SeqId:3346-72;Target:AURKB;UniProt:Q96GD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3346-72;Target: AURKB;UniProt: Q96GD4;TargetFullName: Aurora kinase B;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 3346-72 | Target: AURKB | UniProt: Q96GD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3346-72 | Target: AURKB | UniProt: Q96GD4 | TargetFullName: Aurora kinase B | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:3347-9;Target:BARK1;UniProt:P25098

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3347-9;Target: BARK1;UniProt: P25098;TargetFullName: beta-adrenergic receptor kinase 1;Organisim: human;Apparent_Kd_M: 1.29E-12

Real

Aptamer SeqId: 3347-9 | Target: BARK1 | UniProt: P25098

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3347-9 | Target: BARK1 | UniProt: P25098 | TargetFullName: beta-adrenergic receptor kinase 1 | Organisim: human | Apparent_Kd_M: 1.29E-12

Real

Aptamer SeqId:3348-49;Target:BMP-1;UniProt:P13497

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3348-49;Target: BMP-1;UniProt: P13497;TargetFullName: Bone morphogenetic protein 1;Organisim: human;Apparent_Kd_M: 5.68E-11

Real

Aptamer SeqId: 3348-49 | Target: BMP-1 | UniProt: P13497

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3348-49 | Target: BMP-1 | UniProt: P13497 | TargetFullName: Bone morphogenetic protein 1 | Organisim: human | Apparent_Kd_M: 5.68E-11

Real

Aptamer SeqId:3350-53;Target:CAMK2A;UniProt:Q9UQM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3350-53;Target: CAMK2A;UniProt: Q9UQM7;TargetFullName: Calcium/calmodulin-dependent protein kinase type II subunit alpha;Organisim: human;Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId: 3350-53 | Target: CAMK2A | UniProt: Q9UQM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3350-53 | Target: CAMK2A | UniProt: Q9UQM7 | TargetFullName: Calcium/calmodulin-dependent protein kinase type II subunit alpha | Organisim: human | Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId:3351-1;Target:CAMK2B;UniProt:Q13554

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3351-1;Target: CAMK2B;UniProt: Q13554;TargetFullName: Calcium/calmodulin-dependent protein kinase type II subunit beta;Organisim: human;Apparent_Kd_M: 4.21E-12

Real

Aptamer SeqId: 3351-1 | Target: CAMK2B | UniProt: Q13554

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3351-1 | Target: CAMK2B | UniProt: Q13554 | TargetFullName: Calcium/calmodulin-dependent protein kinase type II subunit beta | Organisim: human | Apparent_Kd_M: 4.21E-12

Real

Aptamer SeqId:3352-80;Target:Carbonic anhydrase 6;UniProt:P23280

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3352-80;Target: Carbonic anhydrase 6;UniProt: P23280;TargetFullName: Carbonic anhydrase 6;Organisim: human;Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId: 3352-80 | Target: Carbonic anhydrase 6 | UniProt: P23280

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3352-80 | Target: Carbonic anhydrase 6 | UniProt: P23280 | TargetFullName: Carbonic anhydrase 6 | Organisim: human | Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId:3356-50;Target:Carbonic anhydrase VII;UniProt:P43166

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3356-50;Target: Carbonic anhydrase VII;UniProt: P43166;TargetFullName: Carbonic anhydrase 7;Organisim: human;Apparent_Kd_M: 1.43E-10

Real

Aptamer SeqId: 3356-50 | Target: Carbonic anhydrase VII | UniProt: P43166

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3356-50 | Target: Carbonic anhydrase VII | UniProt: P43166 | TargetFullName: Carbonic anhydrase 7 | Organisim: human | Apparent_Kd_M: 1.43E-10

Real

Aptamer SeqId:3357-67;Target:CDK2/cyclin A;UniProt:P24941|P20248

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3357-67;Target: CDK2/cyclin A;UniProt: P24941|P20248;TargetFullName: Cyclin-dependent kinase 2:Cyclin-A2 complex;Organisim: human;Apparent_Kd_M: 3.36E-12

Real

Aptamer SeqId: 3357-67 | Target: CDK2/cyclin A | UniProt: P24941|P20248

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3357-67 | Target: CDK2/cyclin A | UniProt: P24941|P20248 | TargetFullName: Cyclin-dependent kinase 2:Cyclin-A2 complex | Organisim: human | Apparent_Kd_M: 3.36E-12

Real

Aptamer SeqId:3358-51;Target:CDK5/p35;UniProt:Q00535|Q15078

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3358-51;Target: CDK5/p35;UniProt: Q00535|Q15078;TargetFullName: Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex;Organisim: human;Apparent_Kd_M: 2.46E-11

Real

Aptamer SeqId: 3358-51 | Target: CDK5/p35 | UniProt: Q00535|Q15078

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3358-51 | Target: CDK5/p35 | UniProt: Q00535|Q15078 | TargetFullName: Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex | Organisim: human | Apparent_Kd_M: 2.46E-11

Real

Aptamer SeqId:3359-11;Target:CDK8/cyclin C;UniProt:P49336|P24863

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3359-11;Target: CDK8/cyclin C;UniProt: P49336|P24863;TargetFullName: Cyclin-dependent kinase 8:Cyclin-C complex;Organisim: human;Apparent_Kd_M: 5.76E-11

Real

Aptamer SeqId: 3359-11 | Target: CDK8/cyclin C | UniProt: P49336|P24863

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3359-11 | Target: CDK8/cyclin C | UniProt: P49336|P24863 | TargetFullName: Cyclin-dependent kinase 8:Cyclin-C complex | Organisim: human | Apparent_Kd_M: 5.76E-11

Real

Aptamer SeqId:3361-26;Target:CLC4K;UniProt:Q9UJ71

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3361-26;Target: CLC4K;UniProt: Q9UJ71;TargetFullName: C-type lectin domain family 4 member K;Organisim: human;Apparent_Kd_M: 1.87E-11

Real

Aptamer SeqId: 3361-26 | Target: CLC4K | UniProt: Q9UJ71

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3361-26 | Target: CLC4K | UniProt: Q9UJ71 | TargetFullName: C-type lectin domain family 4 member K | Organisim: human | Apparent_Kd_M: 1.87E-11

Real

Aptamer SeqId:3362-61;Target:CRDL1;UniProt:Q9BU40

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3362-61;Target: CRDL1;UniProt: Q9BU40;TargetFullName: Chordin-like protein 1;Organisim: human;Apparent_Kd_M: 7.97E-12

Real

Aptamer SeqId: 3362-61 | Target: CRDL1 | UniProt: Q9BU40

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3362-61 | Target: CRDL1 | UniProt: Q9BU40 | TargetFullName: Chordin-like protein 1 | Organisim: human | Apparent_Kd_M: 7.97E-12

Real

Aptamer SeqId:3363-31;Target:CSK;UniProt:P41240

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3363-31;Target: CSK;UniProt: P41240;TargetFullName: Tyrosine-protein kinase CSK;Organisim: human;Apparent_Kd_M: 1.88E-12

Real

Aptamer SeqId: 3363-31 | Target: CSK | UniProt: P41240

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3363-31 | Target: CSK | UniProt: P41240 | TargetFullName: Tyrosine-protein kinase CSK | Organisim: human | Apparent_Kd_M: 1.88E-12

Real

Aptamer SeqId:3364-76;Target:Cathepsin V;UniProt:O60911

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3364-76;Target: Cathepsin V;UniProt: O60911;TargetFullName: Cathepsin L2;Organisim: human;Apparent_Kd_M: 3.6E-12

Real

Aptamer SeqId: 3364-76 | Target: Cathepsin V | UniProt: O60911

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3364-76 | Target: Cathepsin V | UniProt: O60911 | TargetFullName: Cathepsin L2 | Organisim: human | Apparent_Kd_M: 3.6E-12

Real

Aptamer SeqId:3365-7;Target:Dkk-4;UniProt:Q9UBT3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3365-7;Target: Dkk-4;UniProt: Q9UBT3;TargetFullName: Dickkopf-related protein 4;Organisim: human;Apparent_Kd_M: 1.67E-11

Real

Aptamer SeqId: 3365-7 | Target: Dkk-4 | UniProt: Q9UBT3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3365-7 | Target: Dkk-4 | UniProt: Q9UBT3 | TargetFullName: Dickkopf-related protein 4 | Organisim: human | Apparent_Kd_M: 1.67E-11

Real

Aptamer SeqId:3366-51;Target:ECM1;UniProt:Q16610

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3366-51;Target: ECM1;UniProt: Q16610;TargetFullName: Extracellular matrix protein 1;Organisim: human;Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId: 3366-51 | Target: ECM1 | UniProt: Q16610

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3366-51 | Target: ECM1 | UniProt: Q16610 | TargetFullName: Extracellular matrix protein 1 | Organisim: human | Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId:3367-8;Target:FETUB;UniProt:Q9UGM5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3367-8;Target: FETUB;UniProt: Q9UGM5;TargetFullName: Fetuin-B;Organisim: human;Apparent_Kd_M: 2.9E-12

Real

Aptamer SeqId: 3367-8 | Target: FETUB | UniProt: Q9UGM5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3367-8 | Target: FETUB | UniProt: Q9UGM5 | TargetFullName: Fetuin-B | Organisim: human | Apparent_Kd_M: 2.9E-12

Real

Aptamer SeqId:3373-5;Target:Granzyme H;UniProt:P20718

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3373-5;Target: Granzyme H;UniProt: P20718;TargetFullName: Granzyme H;Organisim: human;Apparent_Kd_M: 5.64E-12

Real

Aptamer SeqId: 3373-5 | Target: Granzyme H | UniProt: P20718

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3373-5 | Target: Granzyme H | UniProt: P20718 | TargetFullName: Granzyme H | Organisim: human | Apparent_Kd_M: 5.64E-12

Real

Aptamer SeqId:3374-49;Target:HCK;UniProt:P08631

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3374-49;Target: HCK;UniProt: P08631;TargetFullName: Tyrosine-protein kinase HCK;Organisim: human;Apparent_Kd_M: 1.65E-10

Real

Aptamer SeqId: 3374-49 | Target: HCK | UniProt: P08631

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3374-49 | Target: HCK | UniProt: P08631 | TargetFullName: Tyrosine-protein kinase HCK | Organisim: human | Apparent_Kd_M: 1.65E-10

Real

Aptamer SeqId:3376-49;Target:IL-17 RD;UniProt:Q8NFM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3376-49;Target: IL-17 RD;UniProt: Q8NFM7;TargetFullName: Interleukin-17 receptor D;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 3376-49 | Target: IL-17 RD | UniProt: Q8NFM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3376-49 | Target: IL-17 RD | UniProt: Q8NFM7 | TargetFullName: Interleukin-17 receptor D | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:3378-49;Target:Kallikrein 7;UniProt:P49862

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3378-49;Target: Kallikrein 7;UniProt: P49862;TargetFullName: Kallikrein-7;Organisim: human;Apparent_Kd_M: 6.81E-12

Real

Aptamer SeqId: 3378-49 | Target: Kallikrein 7 | UniProt: P49862

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3378-49 | Target: Kallikrein 7 | UniProt: P49862 | TargetFullName: Kallikrein-7 | Organisim: human | Apparent_Kd_M: 6.81E-12

Real

Aptamer SeqId:3379-29;Target:KPCI;UniProt:P41743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3379-29;Target: KPCI;UniProt: P41743;TargetFullName: Protein kinase C iota type;Organisim: human;Apparent_Kd_M: 4.8E-11

Real

Aptamer SeqId: 3379-29 | Target: KPCI | UniProt: P41743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3379-29 | Target: KPCI | UniProt: P41743 | TargetFullName: Protein kinase C iota type | Organisim: human | Apparent_Kd_M: 4.8E-11

Real

Aptamer SeqId:3381-24;Target:LYNB;UniProt:P07948

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3381-24;Target: LYNB;UniProt: P07948;TargetFullName: Tyrosine-protein kinase Lyn; isoform B;Organisim: human;Apparent_Kd_M: 5.71E-12

Real

Aptamer SeqId: 3381-24 | Target: LYNB | UniProt: P07948

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3381-24 | Target: LYNB | UniProt: P07948 | TargetFullName: Tyrosine-protein kinase Lyn; isoform B | Organisim: human | Apparent_Kd_M: 5.71E-12

Real

Aptamer SeqId:3387-1;Target:PAK3;UniProt:O75914

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3387-1;Target: PAK3;UniProt: O75914;TargetFullName: Serine/threonine-protein kinase PAK 3;Organisim: human;Apparent_Kd_M: 3.37E-11

Real

Aptamer SeqId: 3387-1 | Target: PAK3 | UniProt: O75914

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3387-1 | Target: PAK3 | UniProt: O75914 | TargetFullName: Serine/threonine-protein kinase PAK 3 | Organisim: human | Apparent_Kd_M: 3.37E-11

Real

Aptamer SeqId:3388-58;Target:PAK7;UniProt:Q9P286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3388-58;Target: PAK7;UniProt: Q9P286;TargetFullName: Serine/threonine-protein kinase PAK 5;Organisim: human;Apparent_Kd_M: 1.59E-12

Real

Aptamer SeqId: 3388-58 | Target: PAK7 | UniProt: Q9P286

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3388-58 | Target: PAK7 | UniProt: Q9P286 | TargetFullName: Serine/threonine-protein kinase PAK 5 | Organisim: human | Apparent_Kd_M: 1.59E-12

Real

Aptamer SeqId:3389-7;Target:PCI;UniProt:P05154

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3389-7;Target: PCI;UniProt: P05154;TargetFullName: Plasma serine protease inhibitor;Organisim: human;Apparent_Kd_M: 6.04E-11

Real

Aptamer SeqId: 3389-7 | Target: PCI | UniProt: P05154

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3389-7 | Target: PCI | UniProt: P05154 | TargetFullName: Plasma serine protease inhibitor | Organisim: human | Apparent_Kd_M: 6.04E-11

Real

Aptamer SeqId:3390-72;Target:PIK3CA/PIK3R1;UniProt:P42336|P27986

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3390-72;Target: PIK3CA/PIK3R1;UniProt: P42336|P27986;TargetFullName: PIK3CA/PIK3R1;Organisim: human;Apparent_Kd_M: 2.95E-12

Real

Aptamer SeqId: 3390-72 | Target: PIK3CA/PIK3R1 | UniProt: P42336|P27986

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3390-72 | Target: PIK3CA/PIK3R1 | UniProt: P42336|P27986 | TargetFullName: PIK3CA/PIK3R1 | Organisim: human | Apparent_Kd_M: 2.95E-12

Real

Aptamer SeqId:3391-10;Target:PK3CG;UniProt:P48736

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3391-10;Target: PK3CG;UniProt: P48736;TargetFullName: Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit gamma isoform;Organisim: human;Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId: 3391-10 | Target: PK3CG | UniProt: P48736

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3391-10 | Target: PK3CG | UniProt: P48736 | TargetFullName: Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit gamma isoform | Organisim: human | Apparent_Kd_M: 1.19E-11

Real

Aptamer SeqId:3392-68;Target:PKB a/b/g;UniProt:P31749|P31751|Q9Y243

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3392-68;Target: PKB a/b/g;UniProt: P31749|P31751|Q9Y243;TargetFullName: RAC-alpha/beta/gamma serine/threonine-protein kinase;Organisim: human;Apparent_Kd_M: 8.61E-12

Real

Aptamer SeqId: 3392-68 | Target: PKB a/b/g | UniProt: P31749|P31751|Q9Y243

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3392-68 | Target: PKB a/b/g | UniProt: P31749|P31751|Q9Y243 | TargetFullName: RAC-alpha/beta/gamma serine/threonine-protein kinase | Organisim: human | Apparent_Kd_M: 8.61E-12

Real

Aptamer SeqId:3394-81;Target:PLK-1;UniProt:P53350

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3394-81;Target: PLK-1;UniProt: P53350;TargetFullName: Serine/threonine-protein kinase PLK1;Organisim: human;Apparent_Kd_M: 1.2E-10

Real

Aptamer SeqId: 3394-81 | Target: PLK-1 | UniProt: P53350

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3394-81 | Target: PLK-1 | UniProt: P53350 | TargetFullName: Serine/threonine-protein kinase PLK1 | Organisim: human | Apparent_Kd_M: 1.2E-10

Real

Aptamer SeqId:3396-54;Target:Renin;UniProt:P00797

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3396-54;Target: Renin;UniProt: P00797;TargetFullName: Renin;Organisim: human;Apparent_Kd_M: 1.09E-12

Real

Aptamer SeqId: 3396-54 | Target: Renin | UniProt: P00797

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3396-54 | Target: Renin | UniProt: P00797 | TargetFullName: Renin | Organisim: human | Apparent_Kd_M: 1.09E-12

Real

Aptamer SeqId:3397-7;Target:SHP-2;UniProt:Q06124

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3397-7;Target: SHP-2;UniProt: Q06124;TargetFullName: Tyrosine-protein phosphatase non-receptor type 11;Organisim: human;Apparent_Kd_M: 3.87E-12

Real

Aptamer SeqId: 3397-7 | Target: SHP-2 | UniProt: Q06124

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3397-7 | Target: SHP-2 | UniProt: Q06124 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 11 | Organisim: human | Apparent_Kd_M: 3.87E-12

Real

Aptamer SeqId:3399-31;Target:STAB2;UniProt:Q8WWQ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3399-31;Target: STAB2;UniProt: Q8WWQ8;TargetFullName: Stabilin-2;Organisim: human;Apparent_Kd_M: 5.1E-12

Real

Aptamer SeqId: 3399-31 | Target: STAB2 | UniProt: Q8WWQ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3399-31 | Target: STAB2 | UniProt: Q8WWQ8 | TargetFullName: Stabilin-2 | Organisim: human | Apparent_Kd_M: 5.1E-12

Real

Aptamer SeqId:3400-49;Target:TBK1;UniProt:Q9UHD2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3400-49;Target: TBK1;UniProt: Q9UHD2;TargetFullName: Serine/threonine-protein kinase TBK1;Organisim: human;Apparent_Kd_M: 2.61E-11

Real

Aptamer SeqId: 3400-49 | Target: TBK1 | UniProt: Q9UHD2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3400-49 | Target: TBK1 | UniProt: Q9UHD2 | TargetFullName: Serine/threonine-protein kinase TBK1 | Organisim: human | Apparent_Kd_M: 2.61E-11

Real

Aptamer SeqId:3401-8;Target:TCPTP;UniProt:P17706

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3401-8;Target: TCPTP;UniProt: P17706;TargetFullName: Tyrosine-protein phosphatase non-receptor type 2;Organisim: human;Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId: 3401-8 | Target: TCPTP | UniProt: P17706

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3401-8 | Target: TCPTP | UniProt: P17706 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 2 | Organisim: human | Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId:3403-1;Target:TPSB2;UniProt:P20231

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3403-1;Target: TPSB2;UniProt: P20231;TargetFullName: Tryptase beta-2;Organisim: human;Apparent_Kd_M: 1.1E-12

Real

Aptamer SeqId: 3403-1 | Target: TPSB2 | UniProt: P20231

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3403-1 | Target: TPSB2 | UniProt: P20231 | TargetFullName: Tryptase beta-2 | Organisim: human | Apparent_Kd_M: 1.1E-12

Real

Aptamer SeqId:3404-51;Target:TPSG1;UniProt:Q9NRR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3404-51;Target: TPSG1;UniProt: Q9NRR2;TargetFullName: Tryptase gamma;Organisim: human;Apparent_Kd_M: 7.16E-11

Real

Aptamer SeqId: 3404-51 | Target: TPSG1 | UniProt: Q9NRR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3404-51 | Target: TPSG1 | UniProt: Q9NRR2 | TargetFullName: Tryptase gamma | Organisim: human | Apparent_Kd_M: 7.16E-11

Real

Aptamer SeqId:3405-6;Target:UFC1;UniProt:Q9Y3C8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3405-6;Target: UFC1;UniProt: Q9Y3C8;TargetFullName: Ubiquitin-fold modifier-conjugating enzyme 1;Organisim: human;Apparent_Kd_M: 5.35E-12

Real

Aptamer SeqId: 3405-6 | Target: UFC1 | UniProt: Q9Y3C8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3405-6 | Target: UFC1 | UniProt: Q9Y3C8 | TargetFullName: Ubiquitin-fold modifier-conjugating enzyme 1 | Organisim: human | Apparent_Kd_M: 5.35E-12

Real

Aptamer SeqId:3412-7;Target:Bcl-2;UniProt:P10415

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3412-7;Target: Bcl-2;UniProt: P10415;TargetFullName: Apoptosis regulator Bcl-2;Organisim: human;Apparent_Kd_M: 5.26E-12

Real

Aptamer SeqId: 3412-7 | Target: Bcl-2 | UniProt: P10415

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3412-7 | Target: Bcl-2 | UniProt: P10415 | TargetFullName: Apoptosis regulator Bcl-2 | Organisim: human | Apparent_Kd_M: 5.26E-12

Real

Aptamer SeqId:3413-50;Target:BFL1;UniProt:Q16548

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3413-50;Target: BFL1;UniProt: Q16548;TargetFullName: Bcl-2-related protein A1;Organisim: human;Apparent_Kd_M: 6.12E-12

Real

Aptamer SeqId: 3413-50 | Target: BFL1 | UniProt: Q16548

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3413-50 | Target: BFL1 | UniProt: Q16548 | TargetFullName: Bcl-2-related protein A1 | Organisim: human | Apparent_Kd_M: 6.12E-12

Real

Aptamer SeqId:3414-40;Target:BMX;UniProt:P51813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3414-40;Target: BMX;UniProt: P51813;TargetFullName: Cytoplasmic tyrosine-protein kinase BMX;Organisim: human;Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId: 3414-40 | Target: BMX | UniProt: P51813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3414-40 | Target: BMX | UniProt: P51813 | TargetFullName: Cytoplasmic tyrosine-protein kinase BMX | Organisim: human | Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId:3415-61;Target:BSP;UniProt:P21815

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3415-61;Target: BSP;UniProt: P21815;TargetFullName: Bone sialoprotein 2;Organisim: human;Apparent_Kd_M: 3.98E-11

Real

Aptamer SeqId: 3415-61 | Target: BSP | UniProt: P21815

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3415-61 | Target: BSP | UniProt: P21815 | TargetFullName: Bone sialoprotein 2 | Organisim: human | Apparent_Kd_M: 3.98E-11

Real

Aptamer SeqId:3418-12;Target:CAMK1D;UniProt:Q8IU85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3418-12;Target: CAMK1D;UniProt: Q8IU85;TargetFullName: Calcium/calmodulin-dependent protein kinase type 1D;Organisim: human;Apparent_Kd_M: 2.78E-10

Real

Aptamer SeqId: 3418-12 | Target: CAMK1D | UniProt: Q8IU85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3418-12 | Target: CAMK1D | UniProt: Q8IU85 | TargetFullName: Calcium/calmodulin-dependent protein kinase type 1D | Organisim: human | Apparent_Kd_M: 2.78E-10

Real

Aptamer SeqId:3419-49;Target:CAMK2D;UniProt:Q13557

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3419-49;Target: CAMK2D;UniProt: Q13557;TargetFullName: Calcium/calmodulin-dependent protein kinase type II subunit delta;Organisim: human;Apparent_Kd_M: 1.81E-12

Real

Aptamer SeqId: 3419-49 | Target: CAMK2D | UniProt: Q13557

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3419-49 | Target: CAMK2D | UniProt: Q13557 | TargetFullName: Calcium/calmodulin-dependent protein kinase type II subunit delta | Organisim: human | Apparent_Kd_M: 1.81E-12

Real

Aptamer SeqId:3420-21;Target:Carbonic anhydrase XIII;UniProt:Q8N1Q1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3420-21;Target: Carbonic anhydrase XIII;UniProt: Q8N1Q1;TargetFullName: Carbonic anhydrase 13;Organisim: human;Apparent_Kd_M: 2.7E-11

Real

Aptamer SeqId: 3420-21 | Target: Carbonic anhydrase XIII | UniProt: Q8N1Q1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3420-21 | Target: Carbonic anhydrase XIII | UniProt: Q8N1Q1 | TargetFullName: Carbonic anhydrase 13 | Organisim: human | Apparent_Kd_M: 2.7E-11

Real

Aptamer SeqId:3421-54;Target:CD30 Ligand;UniProt:P32971

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3421-54;Target: CD30 Ligand;UniProt: P32971;TargetFullName: Tumor necrosis factor ligand superfamily member 8;Organisim: human;Apparent_Kd_M: 8.87E-12

Real

Aptamer SeqId: 3421-54 | Target: CD30 Ligand | UniProt: P32971

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3421-54 | Target: CD30 Ligand | UniProt: P32971 | TargetFullName: Tumor necrosis factor ligand superfamily member 8 | Organisim: human | Apparent_Kd_M: 8.87E-12

Real

Aptamer SeqId:3422-4;Target:CDK1/cyclin B;UniProt:P06493|P14635

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3422-4;Target: CDK1/cyclin B;UniProt: P06493|P14635;TargetFullName: Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex;Organisim: human;Apparent_Kd_M: 3.53E-11

Real

Aptamer SeqId: 3422-4 | Target: CDK1/cyclin B | UniProt: P06493|P14635

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3422-4 | Target: CDK1/cyclin B | UniProt: P06493|P14635 | TargetFullName: Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex | Organisim: human | Apparent_Kd_M: 3.53E-11

Real

Aptamer SeqId:3423-59;Target:Chymase;UniProt:P23946

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3423-59;Target: Chymase;UniProt: P23946;TargetFullName: Chymase;Organisim: human;Apparent_Kd_M: 3.96E-12

Real

Aptamer SeqId: 3423-59 | Target: Chymase | UniProt: P23946

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3423-59 | Target: Chymase | UniProt: P23946 | TargetFullName: Chymase | Organisim: human | Apparent_Kd_M: 3.96E-12

Real

Aptamer SeqId:3427-63;Target:CSK21;UniProt:P68400

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3427-63;Target: CSK21;UniProt: P68400;TargetFullName: Casein kinase II subunit alpha;Organisim: human;Apparent_Kd_M: 1.65E-12

Real

Aptamer SeqId: 3427-63 | Target: CSK21 | UniProt: P68400

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3427-63 | Target: CSK21 | UniProt: P68400 | TargetFullName: Casein kinase II subunit alpha | Organisim: human | Apparent_Kd_M: 1.65E-12

Real

Aptamer SeqId:3431-54;Target:EphA1;UniProt:P21709

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3431-54;Target: EphA1;UniProt: P21709;TargetFullName: Ephrin type-A receptor 1;Organisim: human;Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId: 3431-54 | Target: EphA1 | UniProt: P21709

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3431-54 | Target: EphA1 | UniProt: P21709 | TargetFullName: Ephrin type-A receptor 1 | Organisim: human | Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId:3432-21;Target:EPHA3;UniProt:P29320

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3432-21;Target: EPHA3;UniProt: P29320;TargetFullName: Ephrin type-A receptor 3;Organisim: human;Apparent_Kd_M: 3.24E-11

Real

Aptamer SeqId: 3432-21 | Target: EPHA3 | UniProt: P29320

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3432-21 | Target: EPHA3 | UniProt: P29320 | TargetFullName: Ephrin type-A receptor 3 | Organisim: human | Apparent_Kd_M: 3.24E-11

Real

Aptamer SeqId:3434-34;Target:FN1.3;UniProt:P02751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3434-34;Target: FN1.3;UniProt: P02751;TargetFullName: Fibronectin Fragment 3;Organisim: human;Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId: 3434-34 | Target: FN1.3 | UniProt: P02751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3434-34 | Target: FN1.3 | UniProt: P02751 | TargetFullName: Fibronectin Fragment 3 | Organisim: human | Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId:3435-53;Target:FN1.4;UniProt:P02751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3435-53;Target: FN1.4;UniProt: P02751;TargetFullName: Fibronectin Fragment 4;Organisim: human;Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId: 3435-53 | Target: FN1.4 | UniProt: P02751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3435-53 | Target: FN1.4 | UniProt: P02751 | TargetFullName: Fibronectin Fragment 4 | Organisim: human | Apparent_Kd_M: 2.74E-12

Real

Aptamer SeqId:3437-80;Target:Flt-3;UniProt:P36888

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3437-80;Target: Flt-3;UniProt: P36888;TargetFullName: Receptor-type tyrosine-protein kinase FLT3;Organisim: human;Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId: 3437-80 | Target: Flt-3 | UniProt: P36888

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3437-80 | Target: Flt-3 | UniProt: P36888 | TargetFullName: Receptor-type tyrosine-protein kinase FLT3 | Organisim: human | Apparent_Kd_M: 1.6E-11

Real

Aptamer SeqId:3438-10;Target:FSTL3;UniProt:O95633

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3438-10;Target: FSTL3;UniProt: O95633;TargetFullName: Follistatin-related protein 3;Organisim: human;Apparent_Kd_M: 3.11E-12

Real

Aptamer SeqId: 3438-10 | Target: FSTL3 | UniProt: O95633

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3438-10 | Target: FSTL3 | UniProt: O95633 | TargetFullName: Follistatin-related protein 3 | Organisim: human | Apparent_Kd_M: 3.11E-12

Real

Aptamer SeqId:3440-7;Target:granzyme A;UniProt:P12544

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3440-7;Target: granzyme A;UniProt: P12544;TargetFullName: Granzyme A;Organisim: human;Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId: 3440-7 | Target: granzyme A | UniProt: P12544

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3440-7 | Target: granzyme A | UniProt: P12544 | TargetFullName: Granzyme A | Organisim: human | Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId:3441-64;Target:GSK-3 alpha/beta;UniProt:P49840|P49841

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3441-64;Target: GSK-3 alpha/beta;UniProt: P49840|P49841;TargetFullName: Glycogen synthase kinase-3 alpha/beta;Organisim: human;Apparent_Kd_M: 4.74E-12

Real

Aptamer SeqId: 3441-64 | Target: GSK-3 alpha/beta | UniProt: P49840|P49841

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3441-64 | Target: GSK-3 alpha/beta | UniProt: P49840|P49841 | TargetFullName: Glycogen synthase kinase-3 alpha/beta | Organisim: human | Apparent_Kd_M: 4.74E-12

Real

Aptamer SeqId:3445-53;Target:IL-15 Ra;UniProt:Q13261

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3445-53;Target: IL-15 Ra;UniProt: Q13261;TargetFullName: Interleukin-15 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 8.75E-12

Real

Aptamer SeqId: 3445-53 | Target: IL-15 Ra | UniProt: Q13261

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3445-53 | Target: IL-15 Ra | UniProt: Q13261 | TargetFullName: Interleukin-15 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 8.75E-12

Real

Aptamer SeqId:3447-64;Target:IL-8;UniProt:P10145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3447-64;Target: IL-8;UniProt: P10145;TargetFullName: Interleukin-8;Organisim: human;Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId: 3447-64 | Target: IL-8 | UniProt: P10145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3447-64 | Target: IL-8 | UniProt: P10145 | TargetFullName: Interleukin-8 | Organisim: human | Apparent_Kd_M: 1.1E-11

Real

Aptamer SeqId:3448-13;Target:IR;UniProt:P06213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3448-13;Target: IR;UniProt: P06213;TargetFullName: Insulin receptor;Organisim: human;Apparent_Kd_M: 8.9E-12

Real

Aptamer SeqId: 3448-13 | Target: IR | UniProt: P06213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3448-13 | Target: IR | UniProt: P06213 | TargetFullName: Insulin receptor | Organisim: human | Apparent_Kd_M: 8.9E-12

Real

Aptamer SeqId:3449-58;Target:Kallistatin;UniProt:P29622

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3449-58;Target: Kallistatin;UniProt: P29622;TargetFullName: Kallistatin;Organisim: human;Apparent_Kd_M: 7.73E-12

Real

Aptamer SeqId: 3449-58 | Target: Kallistatin | UniProt: P29622

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3449-58 | Target: Kallistatin | UniProt: P29622 | TargetFullName: Kallistatin | Organisim: human | Apparent_Kd_M: 7.73E-12

Real

Aptamer SeqId:3450-4;Target:Kallikrein 6;UniProt:Q92876

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3450-4;Target: Kallikrein 6;UniProt: Q92876;TargetFullName: Kallikrein-6;Organisim: human;Apparent_Kd_M: 2.12E-11

Real

Aptamer SeqId: 3450-4 | Target: Kallikrein 6 | UniProt: Q92876

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3450-4 | Target: Kallikrein 6 | UniProt: Q92876 | TargetFullName: Kallikrein-6 | Organisim: human | Apparent_Kd_M: 2.12E-11

Real

Aptamer SeqId:3452-17;Target:LCK;UniProt:P06239

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3452-17;Target: LCK;UniProt: P06239;TargetFullName: Tyrosine-protein kinase Lck;Organisim: human;Apparent_Kd_M: 2.02E-11

Real

Aptamer SeqId: 3452-17 | Target: LCK | UniProt: P06239

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3452-17 | Target: LCK | UniProt: P06239 | TargetFullName: Tyrosine-protein kinase Lck | Organisim: human | Apparent_Kd_M: 2.02E-11

Real

Aptamer SeqId:3453-87;Target:LYN;UniProt:P07948

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3453-87;Target: LYN;UniProt: P07948;TargetFullName: Tyrosine-protein kinase Lyn;Organisim: human;Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId: 3453-87 | Target: LYN | UniProt: P07948

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3453-87 | Target: LYN | UniProt: P07948 | TargetFullName: Tyrosine-protein kinase Lyn | Organisim: human | Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId:3457-57;Target:Periostin;UniProt:Q15063

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3457-57;Target: Periostin;UniProt: Q15063;TargetFullName: Periostin;Organisim: human;Apparent_Kd_M: 4.38E-12

Real

Aptamer SeqId: 3457-57 | Target: Periostin | UniProt: Q15063

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3457-57 | Target: Periostin | UniProt: Q15063 | TargetFullName: Periostin | Organisim: human | Apparent_Kd_M: 4.38E-12

Real

Aptamer SeqId:3459-49;Target:PDGF Rb;UniProt:P09619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3459-49;Target: PDGF Rb;UniProt: P09619;TargetFullName: Platelet-derived growth factor receptor beta;Organisim: human;Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId: 3459-49 | Target: PDGF Rb | UniProt: P09619

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3459-49 | Target: PDGF Rb | UniProt: P09619 | TargetFullName: Platelet-derived growth factor receptor beta | Organisim: human | Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId:3461-58;Target:PGCB;UniProt:Q96GW7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3461-58;Target: PGCB;UniProt: Q96GW7;TargetFullName: Brevican core protein;Organisim: human;Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId: 3461-58 | Target: PGCB | UniProt: Q96GW7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3461-58 | Target: PGCB | UniProt: Q96GW7 | TargetFullName: Brevican core protein | Organisim: human | Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId:3466-8;Target:PRKACA;UniProt:P17612

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3466-8;Target: PRKACA;UniProt: P17612;TargetFullName: cAMP-dependent protein kinase catalytic subunit alpha;Organisim: human;Apparent_Kd_M: 4.89E-11

Real

Aptamer SeqId: 3466-8 | Target: PRKACA | UniProt: P17612

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3466-8 | Target: PRKACA | UniProt: P17612 | TargetFullName: cAMP-dependent protein kinase catalytic subunit alpha | Organisim: human | Apparent_Kd_M: 4.89E-11

Real

Aptamer SeqId:3469-74;Target:RPS6KA3;UniProt:P51812

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3469-74;Target: RPS6KA3;UniProt: P51812;TargetFullName: Ribosomal protein S6 kinase alpha-3;Organisim: human;Apparent_Kd_M: 2.22E-12

Real

Aptamer SeqId: 3469-74 | Target: RPS6KA3 | UniProt: P51812

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3469-74 | Target: RPS6KA3 | UniProt: P51812 | TargetFullName: Ribosomal protein S6 kinase alpha-3 | Organisim: human | Apparent_Kd_M: 2.22E-12

Real

Aptamer SeqId:3470-1;Target:sE-Selectin;UniProt:P16581

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3470-1;Target: sE-Selectin;UniProt: P16581;TargetFullName: E-selectin;Organisim: human;Apparent_Kd_M: 1.23E-12

Real

Aptamer SeqId: 3470-1 | Target: sE-Selectin | UniProt: P16581

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3470-1 | Target: sE-Selectin | UniProt: P16581 | TargetFullName: E-selectin | Organisim: human | Apparent_Kd_M: 1.23E-12

Real

Aptamer SeqId:3471-49;Target:STK16;UniProt:O75716

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3471-49;Target: STK16;UniProt: O75716;TargetFullName: Serine/threonine-protein kinase 16;Organisim: human;Apparent_Kd_M: 1.64E-11

Real

Aptamer SeqId: 3471-49 | Target: STK16 | UniProt: O75716

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3471-49 | Target: STK16 | UniProt: O75716 | TargetFullName: Serine/threonine-protein kinase 16 | Organisim: human | Apparent_Kd_M: 1.64E-11

Real

Aptamer SeqId:3472-40;Target:Survivin;UniProt:O15392

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3472-40;Target: Survivin;UniProt: O15392;TargetFullName: Baculoviral IAP repeat-containing protein 5;Organisim: human;Apparent_Kd_M: 7.73E-12

Real

Aptamer SeqId: 3472-40 | Target: Survivin | UniProt: O15392

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3472-40 | Target: Survivin | UniProt: O15392 | TargetFullName: Baculoviral IAP repeat-containing protein 5 | Organisim: human | Apparent_Kd_M: 7.73E-12

Real

Aptamer SeqId:3473-78;Target:Thrombopoietin Receptor;UniProt:P40238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3473-78;Target: Thrombopoietin Receptor;UniProt: P40238;TargetFullName: Thrombopoietin Receptor;Organisim: human;Apparent_Kd_M: 3.44E-11

Real

Aptamer SeqId: 3473-78 | Target: Thrombopoietin Receptor | UniProt: P40238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3473-78 | Target: Thrombopoietin Receptor | UniProt: P40238 | TargetFullName: Thrombopoietin Receptor | Organisim: human | Apparent_Kd_M: 3.44E-11

Real

Aptamer SeqId:3474-19;Target:Thrombospondin-1;UniProt:P07996

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3474-19;Target: Thrombospondin-1;UniProt: P07996;TargetFullName: Thrombospondin-1;Organisim: human;Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId: 3474-19 | Target: Thrombospondin-1 | UniProt: P07996

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3474-19 | Target: Thrombospondin-1 | UniProt: P07996 | TargetFullName: Thrombospondin-1 | Organisim: human | Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId:3477-63;Target:TrkA;UniProt:P04629

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3477-63;Target: TrkA;UniProt: P04629;TargetFullName: High affinity nerve growth factor receptor;Organisim: human;Apparent_Kd_M: 1.37E-10

Real

Aptamer SeqId: 3477-63 | Target: TrkA | UniProt: P04629

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3477-63 | Target: TrkA | UniProt: P04629 | TargetFullName: High affinity nerve growth factor receptor | Organisim: human | Apparent_Kd_M: 1.37E-10

Real

Aptamer SeqId:3480-7;Target:DUS3;UniProt:P51452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3480-7;Target: DUS3;UniProt: P51452;TargetFullName: Dual specificity protein phosphatase 3;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 3480-7 | Target: DUS3 | UniProt: P51452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3480-7 | Target: DUS3 | UniProt: P51452 | TargetFullName: Dual specificity protein phosphatase 3 | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:3481-87;Target:XPNPEP1;UniProt:Q9NQW7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3481-87;Target: XPNPEP1;UniProt: Q9NQW7;TargetFullName: Xaa-Pro aminopeptidase 1;Organisim: human;Apparent_Kd_M: 5.13E-11

Real

Aptamer SeqId: 3481-87 | Target: XPNPEP1 | UniProt: Q9NQW7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3481-87 | Target: XPNPEP1 | UniProt: Q9NQW7 | TargetFullName: Xaa-Pro aminopeptidase 1 | Organisim: human | Apparent_Kd_M: 5.13E-11

Real

Aptamer SeqId:3484-60;Target:Angiotensinogen;UniProt:P01019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3484-60;Target: Angiotensinogen;UniProt: P01019;TargetFullName: Angiotensinogen;Organisim: human;Apparent_Kd_M: 5.68E-11

Real

Aptamer SeqId: 3484-60 | Target: Angiotensinogen | UniProt: P01019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3484-60 | Target: Angiotensinogen | UniProt: P01019 | TargetFullName: Angiotensinogen | Organisim: human | Apparent_Kd_M: 5.68E-11

Real

Aptamer SeqId:3485-28;Target:b2-Microglobulin;UniProt:P61769

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3485-28;Target: b2-Microglobulin;UniProt: P61769;TargetFullName: Beta-2-microglobulin;Organisim: human;Apparent_Kd_M: 6.02E-12

Real

Aptamer SeqId: 3485-28 | Target: b2-Microglobulin | UniProt: P61769

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3485-28 | Target: b2-Microglobulin | UniProt: P61769 | TargetFullName: Beta-2-microglobulin | Organisim: human | Apparent_Kd_M: 6.02E-12

Real

Aptamer SeqId:3486-58;Target:b-ECGF;UniProt:P05230

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3486-58;Target: b-ECGF;UniProt: P05230;TargetFullName: Fibroblast growth factor 1;Organisim: human;Apparent_Kd_M: 1.25E-12

Real

Aptamer SeqId: 3486-58 | Target: b-ECGF | UniProt: P05230

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3486-58 | Target: b-ECGF | UniProt: P05230 | TargetFullName: Fibroblast growth factor 1 | Organisim: human | Apparent_Kd_M: 1.25E-12

Real

Aptamer SeqId:3487-32;Target:BLC;UniProt:O43927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3487-32;Target: BLC;UniProt: O43927;TargetFullName: C-X-C motif chemokine 13;Organisim: human;Apparent_Kd_M: 1.86E-12

Real

Aptamer SeqId: 3487-32 | Target: BLC | UniProt: O43927

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3487-32 | Target: BLC | UniProt: O43927 | TargetFullName: C-X-C motif chemokine 13 | Organisim: human | Apparent_Kd_M: 1.86E-12

Real

Aptamer SeqId:3488-64;Target:Catalase;UniProt:P04040

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3488-64;Target: Catalase;UniProt: P04040;TargetFullName: Catalase;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 3488-64 | Target: Catalase | UniProt: P04040

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3488-64 | Target: Catalase | UniProt: P04040 | TargetFullName: Catalase | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:3489-9;Target:CNTF;UniProt:P26441

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3489-9;Target: CNTF;UniProt: P26441;TargetFullName: Ciliary neurotrophic factor;Organisim: human;Apparent_Kd_M: 2.37E-12

Real

Aptamer SeqId: 3489-9 | Target: CNTF | UniProt: P26441

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3489-9 | Target: CNTF | UniProt: P26441 | TargetFullName: Ciliary neurotrophic factor | Organisim: human | Apparent_Kd_M: 2.37E-12

Real

Aptamer SeqId:3494-71;Target:FGF-17;UniProt:O60258

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3494-71;Target: FGF-17;UniProt: O60258;TargetFullName: Fibroblast growth factor 17;Organisim: human;Apparent_Kd_M: 1.66E-10

Real

Aptamer SeqId: 3494-71 | Target: FGF-17 | UniProt: O60258

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3494-71 | Target: FGF-17 | UniProt: O60258 | TargetFullName: Fibroblast growth factor 17 | Organisim: human | Apparent_Kd_M: 1.66E-10

Real

Aptamer SeqId:3495-15;Target:GCP-2;UniProt:P80162

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3495-15;Target: GCP-2;UniProt: P80162;TargetFullName: C-X-C motif chemokine 6;Organisim: human;Apparent_Kd_M: 5.64E-12

Real

Aptamer SeqId: 3495-15 | Target: GCP-2 | UniProt: P80162

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3495-15 | Target: GCP-2 | UniProt: P80162 | TargetFullName: C-X-C motif chemokine 6 | Organisim: human | Apparent_Kd_M: 5.64E-12

Real

Aptamer SeqId:3497-13;Target:IFN-aA;UniProt:P01563

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3497-13;Target: IFN-aA;UniProt: P01563;TargetFullName: Interferon alpha-2;Organisim: human;Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId: 3497-13 | Target: IFN-aA | UniProt: P01563

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3497-13 | Target: IFN-aA | UniProt: P01563 | TargetFullName: Interferon alpha-2 | Organisim: human | Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId:3499-77;Target:IL-17B;UniProt:Q9UHF5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3499-77;Target: IL-17B;UniProt: Q9UHF5;TargetFullName: Interleukin-17B;Organisim: human;Apparent_Kd_M: 1.06E-12

Real

Aptamer SeqId: 3499-77 | Target: IL-17B | UniProt: Q9UHF5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3499-77 | Target: IL-17B | UniProt: Q9UHF5 | TargetFullName: Interleukin-17B | Organisim: human | Apparent_Kd_M: 1.06E-12

Real

Aptamer SeqId:3503-4;Target:Integrin a1b1;UniProt:P56199|P05556

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3503-4;Target: Integrin a1b1;UniProt: P56199|P05556;TargetFullName: Integrin alpha-I: beta-1 complex;Organisim: human;Apparent_Kd_M: 7.63E-11

Real

Aptamer SeqId: 3503-4 | Target: Integrin a1b1 | UniProt: P56199|P05556

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3503-4 | Target: Integrin a1b1 | UniProt: P56199|P05556 | TargetFullName: Integrin alpha-I: beta-1 complex | Organisim: human | Apparent_Kd_M: 7.63E-11

Real

Aptamer SeqId:3504-58;Target:LEAP-1;UniProt:P81172

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3504-58;Target: LEAP-1;UniProt: P81172;TargetFullName: Hepcidin;Organisim: human;Apparent_Kd_M: 1.52E-10

Real

Aptamer SeqId: 3504-58 | Target: LEAP-1 | UniProt: P81172

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3504-58 | Target: LEAP-1 | UniProt: P81172 | TargetFullName: Hepcidin | Organisim: human | Apparent_Kd_M: 1.52E-10

Real

Aptamer SeqId:3505-6;Target:Lymphotoxin a1/b2;UniProt:P01374|Q06643

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3505-6;Target: Lymphotoxin a1/b2;UniProt: P01374|Q06643;TargetFullName: Lymphotoxin alpha1:beta2;Organisim: human;Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId: 3505-6 | Target: Lymphotoxin a1/b2 | UniProt: P01374|Q06643

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3505-6 | Target: Lymphotoxin a1/b2 | UniProt: P01374|Q06643 | TargetFullName: Lymphotoxin alpha1:beta2 | Organisim: human | Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId:3506-49;Target:Lymphotoxin a2/b1;UniProt:P01374|Q06643

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3506-49;Target: Lymphotoxin a2/b1;UniProt: P01374|Q06643;TargetFullName: Lymphotoxin alpha2:beta1;Organisim: human;Apparent_Kd_M: 1.69E-12

Real

Aptamer SeqId: 3506-49 | Target: Lymphotoxin a2/b1 | UniProt: P01374|Q06643

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3506-49 | Target: Lymphotoxin a2/b1 | UniProt: P01374|Q06643 | TargetFullName: Lymphotoxin alpha2:beta1 | Organisim: human | Apparent_Kd_M: 1.69E-12

Real

Aptamer SeqId:3507-1;Target:MDH_THETH;UniProt:P10584

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3507-1;Target: MDH_THETH;UniProt: P10584;TargetFullName: Malic dehydrogenase_THETH;Organisim: thermus thermophilus;Apparent_Kd_M: 8.35E-12

Real

Aptamer SeqId: 3507-1 | Target: MDH_THETH | UniProt: P10584

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3507-1 | Target: MDH_THETH | UniProt: P10584 | TargetFullName: Malic dehydrogenase_THETH | Organisim: thermus thermophilus | Apparent_Kd_M: 8.35E-12

Real

Aptamer SeqId:3508-78;Target:MDC;UniProt:O00626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3508-78;Target: MDC;UniProt: O00626;TargetFullName: C-C motif chemokine 22;Organisim: human;Apparent_Kd_M: 6.58E-12

Real

Aptamer SeqId: 3508-78 | Target: MDC | UniProt: O00626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3508-78 | Target: MDC | UniProt: O00626 | TargetFullName: C-C motif chemokine 22 | Organisim: human | Apparent_Kd_M: 6.58E-12

Real

Aptamer SeqId:3512-72;Target:KAD_GEOSE;UniProt:P27142

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3512-72;Target: KAD_GEOSE;UniProt: P27142;TargetFullName: Adenylate kinase_GEOSE;Organisim: geobacillus stearothermophilus (bacillus stearothermophilus);Apparent_Kd_M: 2.2E-12

Real

Aptamer SeqId: 3512-72 | Target: KAD_GEOSE | UniProt: P27142

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3512-72 | Target: KAD_GEOSE | UniProt: P27142 | TargetFullName: Adenylate kinase_GEOSE | Organisim: geobacillus stearothermophilus (bacillus stearothermophilus) | Apparent_Kd_M: 2.2E-12

Real

Aptamer SeqId:3516-60;Target:SDF-1;UniProt:P48061

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3516-60;Target: SDF-1;UniProt: P48061;TargetFullName: Stromal cell-derived factor 1;Organisim: human;Apparent_Kd_M: 1.32E-12

Real

Aptamer SeqId: 3516-60 | Target: SDF-1 | UniProt: P48061

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3516-60 | Target: SDF-1 | UniProt: P48061 | TargetFullName: Stromal cell-derived factor 1 | Organisim: human | Apparent_Kd_M: 1.32E-12

Real

Aptamer SeqId:3518-54;Target:TAFI;UniProt:Q96IY4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3518-54;Target: TAFI;UniProt: Q96IY4;TargetFullName: Carboxypeptidase B2;Organisim: human;Apparent_Kd_M: 3.93E-12

Real

Aptamer SeqId: 3518-54 | Target: TAFI | UniProt: Q96IY4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3518-54 | Target: TAFI | UniProt: Q96IY4 | TargetFullName: Carboxypeptidase B2 | Organisim: human | Apparent_Kd_M: 3.93E-12

Real

Aptamer SeqId:3519-3;Target:TARC;UniProt:Q92583

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3519-3;Target: TARC;UniProt: Q92583;TargetFullName: C-C motif chemokine 17;Organisim: human;Apparent_Kd_M: 1.06E-12

Real

Aptamer SeqId: 3519-3 | Target: TARC | UniProt: Q92583

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3519-3 | Target: TARC | UniProt: Q92583 | TargetFullName: C-C motif chemokine 17 | Organisim: human | Apparent_Kd_M: 1.06E-12

Real

Aptamer SeqId:3520-58;Target:TGF-b3;UniProt:P10600

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3520-58;Target: TGF-b3;UniProt: P10600;TargetFullName: Transforming growth factor beta-3;Organisim: human;Apparent_Kd_M: 2.93E-12

Real

Aptamer SeqId: 3520-58 | Target: TGF-b3 | UniProt: P10600

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3520-58 | Target: TGF-b3 | UniProt: P10600 | TargetFullName: Transforming growth factor beta-3 | Organisim: human | Apparent_Kd_M: 2.93E-12

Real

Aptamer SeqId:3521-16;Target:TSH;UniProt:P01215|P01222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3521-16;Target: TSH;UniProt: P01215|P01222;TargetFullName: Thyroid Stimulating Hormone;Organisim: human;Apparent_Kd_M: 9.75E-12

Real

Aptamer SeqId: 3521-16 | Target: TSH | UniProt: P01215|P01222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3521-16 | Target: TSH | UniProt: P01215|P01222 | TargetFullName: Thyroid Stimulating Hormone | Organisim: human | Apparent_Kd_M: 9.75E-12

Real

Aptamer SeqId:3522-57;Target:Vasoactive Intestinal Peptide;UniProt:P01282

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3522-57;Target: Vasoactive Intestinal Peptide;UniProt: P01282;TargetFullName: Vasoactive Intestinal Peptide;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 3522-57 | Target: Vasoactive Intestinal Peptide

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3522-57 | Target: Vasoactive Intestinal Peptide | UniProt: P01282 | TargetFullName: Vasoactive Intestinal Peptide | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:3525-1;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3525-1;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 3525-1 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3525-1 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:3525-2;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3525-2;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 3525-2 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3525-2 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:3525-3;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3525-3;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 3525-3 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3525-3 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:3525-4;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3525-4;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 3525-4 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3525-4 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:3534-14;Target:CD40 ligand; soluble;UniProt:P29965

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3534-14;Target: CD40 ligand; soluble;UniProt: P29965;TargetFullName: CD40 ligand;Organisim: human;Apparent_Kd_M: 6.38E-12

Real

Aptamer SeqId: 3534-14 | Target: CD40 ligand; soluble | UniProt: P29965

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3534-14 | Target: CD40 ligand; soluble | UniProt: P29965 | TargetFullName: CD40 ligand | Organisim: human | Apparent_Kd_M: 6.38E-12

Real

Aptamer SeqId:3535-84;Target:DKK1;UniProt:O94907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3535-84;Target: DKK1;UniProt: O94907;TargetFullName: Dickkopf-related protein 1;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 3535-84 | Target: DKK1 | UniProt: O94907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3535-84 | Target: DKK1 | UniProt: O94907 | TargetFullName: Dickkopf-related protein 1 | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:3538-26;Target:dopa decarboxylase;UniProt:P20711

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3538-26;Target: dopa decarboxylase;UniProt: P20711;TargetFullName: Aromatic-L-amino-acid decarboxylase;Organisim: human;Apparent_Kd_M: 4.37E-12

Real

Aptamer SeqId: 3538-26 | Target: dopa decarboxylase | UniProt: P20711

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3538-26 | Target: dopa decarboxylase | UniProt: P20711 | TargetFullName: Aromatic-L-amino-acid decarboxylase | Organisim: human | Apparent_Kd_M: 4.37E-12

Real

Aptamer SeqId:3554-24;Target:Adiponectin;UniProt:Q15848

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3554-24;Target: Adiponectin;UniProt: Q15848;TargetFullName: Adiponectin;Organisim: human;Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId: 3554-24 | Target: Adiponectin | UniProt: Q15848

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3554-24 | Target: Adiponectin | UniProt: Q15848 | TargetFullName: Adiponectin | Organisim: human | Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId:3580-25;Target:a1-Antitrypsin;UniProt:P01009

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3580-25;Target: a1-Antitrypsin;UniProt: P01009;TargetFullName: Alpha-1-antitrypsin;Organisim: human;Apparent_Kd_M: 3.05E-10

Real

Aptamer SeqId: 3580-25 | Target: a1-Antitrypsin | UniProt: P01009

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3580-25 | Target: a1-Antitrypsin | UniProt: P01009 | TargetFullName: Alpha-1-antitrypsin | Organisim: human | Apparent_Kd_M: 3.05E-10

Real

Aptamer SeqId:3581-53;Target:a2-HS-Glycoprotein;UniProt:P02765

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3581-53;Target: a2-HS-Glycoprotein;UniProt: P02765;TargetFullName: Alpha-2-HS-glycoprotein;Organisim: human;Apparent_Kd_M: 1.14E-10

Real

Aptamer SeqId: 3581-53 | Target: a2-HS-Glycoprotein | UniProt: P02765

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3581-53 | Target: a2-HS-Glycoprotein | UniProt: P02765 | TargetFullName: Alpha-2-HS-glycoprotein | Organisim: human | Apparent_Kd_M: 1.14E-10

Real

Aptamer SeqId:3583-54;Target:Arylsulfatase A;UniProt:P15289

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3583-54;Target: Arylsulfatase A;UniProt: P15289;TargetFullName: Arylsulfatase A;Organisim: human;Apparent_Kd_M: 8.56E-11

Real

Aptamer SeqId: 3583-54 | Target: Arylsulfatase A | UniProt: P15289

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3583-54 | Target: Arylsulfatase A | UniProt: P15289 | TargetFullName: Arylsulfatase A | Organisim: human | Apparent_Kd_M: 8.56E-11

Real

Aptamer SeqId:3585-54;Target:BASI;UniProt:P35613

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3585-54;Target: BASI;UniProt: P35613;TargetFullName: Basigin;Organisim: human;Apparent_Kd_M: 6.94E-11

Real

Aptamer SeqId: 3585-54 | Target: BASI | UniProt: P35613

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3585-54 | Target: BASI | UniProt: P35613 | TargetFullName: Basigin | Organisim: human | Apparent_Kd_M: 6.94E-11

Real

Aptamer SeqId:3587-53;Target:BMP10;UniProt:O95393

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3587-53;Target: BMP10;UniProt: O95393;TargetFullName: Bone morphogenetic protein 10;Organisim: human;Apparent_Kd_M: 9.08E-11

Real

Aptamer SeqId: 3587-53 | Target: BMP10 | UniProt: O95393

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3587-53 | Target: BMP10 | UniProt: O95393 | TargetFullName: Bone morphogenetic protein 10 | Organisim: human | Apparent_Kd_M: 9.08E-11

Real

Aptamer SeqId:3592-4;Target:CAMK1;UniProt:Q14012

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3592-4;Target: CAMK1;UniProt: Q14012;TargetFullName: Calcium/calmodulin-dependent protein kinase type 1;Organisim: human;Apparent_Kd_M: 8.0E-11

Real

Aptamer SeqId: 3592-4 | Target: CAMK1 | UniProt: Q14012

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3592-4 | Target: CAMK1 | UniProt: Q14012 | TargetFullName: Calcium/calmodulin-dependent protein kinase type 1 | Organisim: human | Apparent_Kd_M: 8.0E-11

Real

Aptamer SeqId:3593-72;Target:Caspase-3;UniProt:P42574

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3593-72;Target: Caspase-3;UniProt: P42574;TargetFullName: Caspase-3;Organisim: human;Apparent_Kd_M: 2.37E-12

Real

Aptamer SeqId: 3593-72 | Target: Caspase-3 | UniProt: P42574

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3593-72 | Target: Caspase-3 | UniProt: P42574 | TargetFullName: Caspase-3 | Organisim: human | Apparent_Kd_M: 2.37E-12

Real

Aptamer SeqId:3600-2;Target:Chitotriosidase-1;UniProt:Q13231

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3600-2;Target: Chitotriosidase-1;UniProt: Q13231;TargetFullName: Chitotriosidase-1;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 3600-2 | Target: Chitotriosidase-1 | UniProt: Q13231

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3600-2 | Target: Chitotriosidase-1 | UniProt: Q13231 | TargetFullName: Chitotriosidase-1 | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:3603-60;Target:CLC7A;UniProt:Q9BXN2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3603-60;Target: CLC7A;UniProt: Q9BXN2;TargetFullName: C-type lectin domain family 7 member A;Organisim: human;Apparent_Kd_M: 8.329448E-11

Real

Aptamer SeqId: 3603-60 | Target: CLC7A | UniProt: Q9BXN2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3603-60 | Target: CLC7A | UniProt: Q9BXN2 | TargetFullName: C-type lectin domain family 7 member A | Organisim: human | Apparent_Kd_M: 8.329448E-11

Real

Aptamer SeqId:3605-77;Target:MASP3;UniProt:P48740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3605-77;Target: MASP3;UniProt: P48740;TargetFullName: Mannan-binding lectin serine protease 1;Organisim: human;Apparent_Kd_M: 2.7E-10

Real

Aptamer SeqId: 3605-77 | Target: MASP3 | UniProt: P48740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3605-77 | Target: MASP3 | UniProt: P48740 | TargetFullName: Mannan-binding lectin serine protease 1 | Organisim: human | Apparent_Kd_M: 2.7E-10

Real

Aptamer SeqId:3607-71;Target:DKK3;UniProt:Q9UBP4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3607-71;Target: DKK3;UniProt: Q9UBP4;TargetFullName: Dickkopf-related protein 3;Organisim: human;Apparent_Kd_M: 3.38E-11

Real

Aptamer SeqId: 3607-71 | Target: DKK3 | UniProt: Q9UBP4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3607-71 | Target: DKK3 | UniProt: Q9UBP4 | TargetFullName: Dickkopf-related protein 3 | Organisim: human | Apparent_Kd_M: 3.38E-11

Real

Aptamer SeqId:3616-3;Target:GNS;UniProt:P15586

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3616-3;Target: GNS;UniProt: P15586;TargetFullName: N-acetylglucosamine-6-sulfatase;Organisim: human;Apparent_Kd_M: 3.08E-12

Real

Aptamer SeqId: 3616-3 | Target: GNS | UniProt: P15586

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3616-3 | Target: GNS | UniProt: P15586 | TargetFullName: N-acetylglucosamine-6-sulfatase | Organisim: human | Apparent_Kd_M: 3.08E-12

Real

Aptamer SeqId:3617-80;Target:HGFA;UniProt:Q04756

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3617-80;Target: HGFA;UniProt: Q04756;TargetFullName: Hepatocyte growth factor activator;Organisim: human;Apparent_Kd_M: 1.83E-12

Real

Aptamer SeqId: 3617-80 | Target: HGFA | UniProt: Q04756

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3617-80 | Target: HGFA | UniProt: Q04756 | TargetFullName: Hepatocyte growth factor activator | Organisim: human | Apparent_Kd_M: 1.83E-12

Real

Aptamer SeqId:3620-67;Target:IL22RA1;UniProt:Q8N6P7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3620-67;Target: IL22RA1;UniProt: Q8N6P7;TargetFullName: Interleukin-22 receptor subunit alpha-1;Organisim: human;Apparent_Kd_M: 1.509775E-11

Real

Aptamer SeqId: 3620-67 | Target: IL22RA1 | UniProt: Q8N6P7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3620-67 | Target: IL22RA1 | UniProt: Q8N6P7 | TargetFullName: Interleukin-22 receptor subunit alpha-1 | Organisim: human | Apparent_Kd_M: 1.509775E-11

Real

Aptamer SeqId:3622-33;Target:LGMN;UniProt:Q99538

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3622-33;Target: LGMN;UniProt: Q99538;TargetFullName: Legumain;Organisim: human;Apparent_Kd_M: 6.95E-12

Real

Aptamer SeqId: 3622-33 | Target: LGMN | UniProt: Q99538

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3622-33 | Target: LGMN | UniProt: Q99538 | TargetFullName: Legumain | Organisim: human | Apparent_Kd_M: 6.95E-12

Real

Aptamer SeqId:3623-84;Target:LY86;UniProt:O95711

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3623-84;Target: LY86;UniProt: O95711;TargetFullName: Lymphocyte antigen 86;Organisim: human;Apparent_Kd_M: 6.62E-11

Real

Aptamer SeqId: 3623-84 | Target: LY86 | UniProt: O95711

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3623-84 | Target: LY86 | UniProt: O95711 | TargetFullName: Lymphocyte antigen 86 | Organisim: human | Apparent_Kd_M: 6.62E-11

Real

Aptamer SeqId:3627-71;Target:MMEL2;UniProt:Q495T6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3627-71;Target: MMEL2;UniProt: Q495T6;TargetFullName: Membrane metallo-endopeptidase-like 1;Organisim: human;Apparent_Kd_M: 5.86E-12

Real

Aptamer SeqId: 3627-71 | Target: MMEL2 | UniProt: Q495T6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3627-71 | Target: MMEL2 | UniProt: Q495T6 | TargetFullName: Membrane metallo-endopeptidase-like 1 | Organisim: human | Apparent_Kd_M: 5.86E-12

Real

Aptamer SeqId:3628-3;Target:MP2K2;UniProt:P36507

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3628-3;Target: MP2K2;UniProt: P36507;TargetFullName: Dual specificity mitogen-activated protein kinase kinase 2;Organisim: human;Apparent_Kd_M: 2.58E-11

Real

Aptamer SeqId: 3628-3 | Target: MP2K2 | UniProt: P36507

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3628-3 | Target: MP2K2 | UniProt: P36507 | TargetFullName: Dual specificity mitogen-activated protein kinase kinase 2 | Organisim: human | Apparent_Kd_M: 2.58E-11

Real

Aptamer SeqId:3629-60;Target:MRCKB;UniProt:Q9Y5S2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3629-60;Target: MRCKB;UniProt: Q9Y5S2;TargetFullName: Serine/threonine-protein kinase MRCK beta;Organisim: human;Apparent_Kd_M: 1.25E-10

Real

Aptamer SeqId: 3629-60 | Target: MRCKB | UniProt: Q9Y5S2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3629-60 | Target: MRCKB | UniProt: Q9Y5S2 | TargetFullName: Serine/threonine-protein kinase MRCK beta | Organisim: human | Apparent_Kd_M: 1.25E-10

Real

Aptamer SeqId:3630-27;Target:Nectin-like protein 1;UniProt:Q8N126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3630-27;Target: Nectin-like protein 1;UniProt: Q8N126;TargetFullName: Cell adhesion molecule 3;Organisim: human;Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId: 3630-27 | Target: Nectin-like protein 1 | UniProt: Q8N126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3630-27 | Target: Nectin-like protein 1 | UniProt: Q8N126 | TargetFullName: Cell adhesion molecule 3 | Organisim: human | Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId:3640-14;Target:RAP;UniProt:P30533

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3640-14;Target: RAP;UniProt: P30533;TargetFullName: alpha-2-macroglobulin receptor-associated protein;Organisim: human;Apparent_Kd_M: 1.3E-12

Real

Aptamer SeqId: 3640-14 | Target: RAP | UniProt: P30533

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3640-14 | Target: RAP | UniProt: P30533 | TargetFullName: alpha-2-macroglobulin receptor-associated protein | Organisim: human | Apparent_Kd_M: 1.3E-12

Real

Aptamer SeqId:3647-49;Target:TLR4:MD-2 complex;UniProt:O00206|Q9Y6Y9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3647-49;Target: TLR4:MD-2 complex;UniProt: O00206|Q9Y6Y9;TargetFullName: Toll-like receptor 4:Lymphocyte antigen 96 complex;Organisim: human;Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId: 3647-49 | Target: TLR4:MD-2 complex | UniProt: O00206|Q9Y6Y9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3647-49 | Target: TLR4:MD-2 complex | UniProt: O00206|Q9Y6Y9 | TargetFullName: Toll-like receptor 4:Lymphocyte antigen 96 complex | Organisim: human | Apparent_Kd_M: 2.35E-11

Real

Aptamer SeqId:3650-8;Target:GFP_AEQVI;UniProt:P42212

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3650-8;Target: GFP_AEQVI;UniProt: P42212;TargetFullName: Green fluorescent protein_AEQVI;Organisim: aequorea victoria (jellyfish);Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId: 3650-8 | Target: GFP_AEQVI | UniProt: P42212

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3650-8 | Target: GFP_AEQVI | UniProt: P42212 | TargetFullName: Green fluorescent protein_AEQVI | Organisim: aequorea victoria (jellyfish) | Apparent_Kd_M: 4.84E-12

Real

Aptamer SeqId:3651-50;Target:VEGF sR2;UniProt:P35968

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3651-50;Target: VEGF sR2;UniProt: P35968;TargetFullName: Vascular endothelial growth factor receptor 2;Organisim: human;Apparent_Kd_M: 1.06E-11

Real

Aptamer SeqId: 3651-50 | Target: VEGF sR2 | UniProt: P35968

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3651-50 | Target: VEGF sR2 | UniProt: P35968 | TargetFullName: Vascular endothelial growth factor receptor 2 | Organisim: human | Apparent_Kd_M: 1.06E-11

Real

Aptamer SeqId:3685-53;Target:MFRP;UniProt:Q9BY79

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3685-53;Target: MFRP;UniProt: Q9BY79;TargetFullName: Membrane frizzled-related protein;Organisim: human;Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId: 3685-53 | Target: MFRP | UniProt: Q9BY79

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3685-53 | Target: MFRP | UniProt: Q9BY79 | TargetFullName: Membrane frizzled-related protein | Organisim: human | Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId:3708-62;Target:a2-Macroglobulin;UniProt:P01023

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3708-62;Target: a2-Macroglobulin;UniProt: P01023;TargetFullName: Alpha-2-macroglobulin;Organisim: human;Apparent_Kd_M: 4.7E-11

Real

Aptamer SeqId: 3708-62 | Target: a2-Macroglobulin | UniProt: P01023

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3708-62 | Target: a2-Macroglobulin | UniProt: P01023 | TargetFullName: Alpha-2-macroglobulin | Organisim: human | Apparent_Kd_M: 4.7E-11

Real

Aptamer SeqId:3710-49;Target:Angiostatin;UniProt:P00747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3710-49;Target: Angiostatin;UniProt: P00747;TargetFullName: Angiostatin;Organisim: human;Apparent_Kd_M: 3.13E-11

Real

Aptamer SeqId: 3710-49 | Target: Angiostatin | UniProt: P00747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3710-49 | Target: Angiostatin | UniProt: P00747 | TargetFullName: Angiostatin | Organisim: human | Apparent_Kd_M: 3.13E-11

Real

Aptamer SeqId:3714-49;Target:CK-MB;UniProt:P12277|P06732

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3714-49;Target: CK-MB;UniProt: P12277|P06732;TargetFullName: Creatine kinase M-type:Creatine kinase B-type heterodimer;Organisim: human;Apparent_Kd_M: 6.6E-11

Real

Aptamer SeqId: 3714-49 | Target: CK-MB | UniProt: P12277|P06732

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3714-49 | Target: CK-MB | UniProt: P12277|P06732 | TargetFullName: Creatine kinase M-type:Creatine kinase B-type heterodimer | Organisim: human | Apparent_Kd_M: 6.6E-11

Real

Aptamer SeqId:3717-23;Target:LUCI_PHOPY;UniProt:P08659

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3717-23;Target: LUCI_PHOPY;UniProt: P08659;TargetFullName: Luciferin 4-monooxygenase_PHOPY;Organisim: photinus pyralis (north american firefly);Apparent_Kd_M: 1.81E-10

Real

Aptamer SeqId: 3717-23 | Target: LUCI_PHOPY | UniProt: P08659

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3717-23 | Target: LUCI_PHOPY | UniProt: P08659 | TargetFullName: Luciferin 4-monooxygenase_PHOPY | Organisim: photinus pyralis (north american firefly) | Apparent_Kd_M: 1.81E-10

Real

Aptamer SeqId:3719-2;Target:p27Kip1;UniProt:P46527

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3719-2;Target: p27Kip1;UniProt: P46527;TargetFullName: Cyclin-dependent kinase inhibitor 1B;Organisim: human;Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId: 3719-2 | Target: p27Kip1 | UniProt: P46527

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3719-2 | Target: p27Kip1 | UniProt: P46527 | TargetFullName: Cyclin-dependent kinase inhibitor 1B | Organisim: human | Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId:3721-5;Target:NOH4_RHIML;UniProt:P06237

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3721-5;Target: NOH4_RHIML;UniProt: P06237;TargetFullName: Nodulation protein H_NOH4;Organisim: rhizobium meliloti (ensifer meliloti) (sinorhizobium meliloti);Apparent_Kd_M: 1.101054E-11

Real

Aptamer SeqId: 3721-5 | Target: NOH4_RHIML | UniProt: P06237

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3721-5 | Target: NOH4_RHIML | UniProt: P06237 | TargetFullName: Nodulation protein H_NOH4 | Organisim: rhizobium meliloti (ensifer meliloti) (sinorhizobium meliloti) | Apparent_Kd_M: 1.101054E-11

Real

Aptamer SeqId:3723-1;Target:BNP-32;UniProt:P16860

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3723-1;Target: BNP-32;UniProt: P16860;TargetFullName: Brain natriuretic peptide 32;Organisim: human;Apparent_Kd_M: 1.78E-10

Real

Aptamer SeqId: 3723-1 | Target: BNP-32 | UniProt: P16860

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3723-1 | Target: BNP-32 | UniProt: P16860 | TargetFullName: Brain natriuretic peptide 32 | Organisim: human | Apparent_Kd_M: 1.78E-10

Real

Aptamer SeqId:3724-64;Target:EXE4_HELSU;UniProt:P26349

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3724-64;Target: EXE4_HELSU;UniProt: P26349;TargetFullName: Exendin-4_HELSU;Organisim: heloderma suspectum (gila monster);Apparent_Kd_M: 9.059929E-10

Real

Aptamer SeqId: 3724-64 | Target: EXE4_HELSU | UniProt: P26349

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3724-64 | Target: EXE4_HELSU | UniProt: P26349 | TargetFullName: Exendin-4_HELSU | Organisim: heloderma suspectum (gila monster) | Apparent_Kd_M: 9.059929E-10

Real

Aptamer SeqId:3727-35;Target:PYY;UniProt:P10082

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3727-35;Target: PYY;UniProt: P10082;TargetFullName: Peptide YY;Organisim: human;Apparent_Kd_M: 1.95E-11

Real

Aptamer SeqId: 3727-35 | Target: PYY | UniProt: P10082

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3727-35 | Target: PYY | UniProt: P10082 | TargetFullName: Peptide YY | Organisim: human | Apparent_Kd_M: 1.95E-11

Real

Aptamer SeqId:3728-52;Target:Secretin;UniProt:P09683

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3728-52;Target: Secretin;UniProt: P09683;TargetFullName: Secretin;Organisim: human;Apparent_Kd_M: 4.32E-12

Real

Aptamer SeqId: 3728-52 | Target: Secretin | UniProt: P09683

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3728-52 | Target: Secretin | UniProt: P09683 | TargetFullName: Secretin | Organisim: human | Apparent_Kd_M: 4.32E-12

Real

Aptamer SeqId:3730-81;Target:TNR4;UniProt:P43489

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3730-81;Target: TNR4;UniProt: P43489;TargetFullName: Tumor necrosis factor receptor superfamily member 4;Organisim: human;Apparent_Kd_M: 5.56E-11

Real

Aptamer SeqId: 3730-81 | Target: TNR4 | UniProt: P43489

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3730-81 | Target: TNR4 | UniProt: P43489 | TargetFullName: Tumor necrosis factor receptor superfamily member 4 | Organisim: human | Apparent_Kd_M: 5.56E-11

Real

Aptamer SeqId:3738-54;Target:CSF-1;UniProt:P09603

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3738-54;Target: CSF-1;UniProt: P09603;TargetFullName: Macrophage colony-stimulating factor 1;Organisim: human;Apparent_Kd_M: 1.06E-11

Real

Aptamer SeqId: 3738-54 | Target: CSF-1 | UniProt: P09603

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3738-54 | Target: CSF-1 | UniProt: P09603 | TargetFullName: Macrophage colony-stimulating factor 1 | Organisim: human | Apparent_Kd_M: 1.06E-11

Real

Aptamer SeqId:3742-78;Target:NIGB_SAMNI;UniProt:P33183

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3742-78;Target: NIGB_SAMNI;UniProt: P33183;TargetFullName: Nigrin b_SAMNI;Organisim: sambucus nigra (european elder);Apparent_Kd_M: 5.66E-11

Real

Aptamer SeqId: 3742-78 | Target: NIGB_SAMNI | UniProt: P33183

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3742-78 | Target: NIGB_SAMNI | UniProt: P33183 | TargetFullName: Nigrin b_SAMNI | Organisim: sambucus nigra (european elder) | Apparent_Kd_M: 5.66E-11

Real

Aptamer SeqId:3758-68;Target:Activated Protein C;UniProt:P04070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3758-68;Target: Activated Protein C;UniProt: P04070;TargetFullName: Activated Protein C;Organisim: human;Apparent_Kd_M: 5.31E-12

Real

Aptamer SeqId: 3758-68 | Target: Activated Protein C | UniProt: P04070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3758-68 | Target: Activated Protein C | UniProt: P04070 | TargetFullName: Activated Protein C | Organisim: human | Apparent_Kd_M: 5.31E-12

Real

Aptamer SeqId:3761-4;Target:COX-2;UniProt:P35354

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3761-4;Target: COX-2;UniProt: P35354;TargetFullName: Prostaglandin G/H synthase 2;Organisim: human;Apparent_Kd_M: 7.14E-11

Real

Aptamer SeqId: 3761-4 | Target: COX-2 | UniProt: P35354

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3761-4 | Target: COX-2 | UniProt: P35354 | TargetFullName: Prostaglandin G/H synthase 2 | Organisim: human | Apparent_Kd_M: 7.14E-11

Real

Aptamer SeqId:3773-15;Target:sTie-2;UniProt:Q02763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3773-15;Target: sTie-2;UniProt: Q02763;TargetFullName: Angiopoietin-1 receptor; soluble;Organisim: human;Apparent_Kd_M: 9.79E-11

Real

Aptamer SeqId: 3773-15 | Target: sTie-2 | UniProt: Q02763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3773-15 | Target: sTie-2 | UniProt: Q02763 | TargetFullName: Angiopoietin-1 receptor; soluble | Organisim: human | Apparent_Kd_M: 9.79E-11

Real

Aptamer SeqId:3795-6;Target:ADAM 9;UniProt:Q13443

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3795-6;Target: ADAM 9;UniProt: Q13443;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 9;Organisim: human;Apparent_Kd_M: 4.47E-12

Real

Aptamer SeqId: 3795-6 | Target: ADAM 9 | UniProt: Q13443

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3795-6 | Target: ADAM 9 | UniProt: Q13443 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 9 | Organisim: human | Apparent_Kd_M: 4.47E-12

Real

Aptamer SeqId:3796-79;Target:ANGL4;UniProt:Q9BY76

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3796-79;Target: ANGL4;UniProt: Q9BY76;TargetFullName: Angiopoietin-related protein 4;Organisim: human;Apparent_Kd_M: 6.16E-11

Real

Aptamer SeqId: 3796-79 | Target: ANGL4 | UniProt: Q9BY76

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3796-79 | Target: ANGL4 | UniProt: Q9BY76 | TargetFullName: Angiopoietin-related protein 4 | Organisim: human | Apparent_Kd_M: 6.16E-11

Real

Aptamer SeqId:3797-1;Target:Cadherin-2;UniProt:P19022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3797-1;Target: Cadherin-2;UniProt: P19022;TargetFullName: Cadherin-2;Organisim: human;Apparent_Kd_M: 3.32E-10

Real

Aptamer SeqId: 3797-1 | Target: Cadherin-2 | UniProt: P19022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3797-1 | Target: Cadherin-2 | UniProt: P19022 | TargetFullName: Cadherin-2 | Organisim: human | Apparent_Kd_M: 3.32E-10

Real

Aptamer SeqId:3798-71;Target:Carbonic anhydrase 9;UniProt:Q16790

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3798-71;Target: Carbonic anhydrase 9;UniProt: Q16790;TargetFullName: Carbonic anhydrase 9;Organisim: human;Apparent_Kd_M: 7.35E-11

Real

Aptamer SeqId: 3798-71 | Target: Carbonic anhydrase 9 | UniProt: Q16790

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3798-71 | Target: Carbonic anhydrase 9 | UniProt: Q16790 | TargetFullName: Carbonic anhydrase 9 | Organisim: human | Apparent_Kd_M: 7.35E-11

Real

Aptamer SeqId:3799-11;Target:Carbonic anhydrase III;UniProt:P07451

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3799-11;Target: Carbonic anhydrase III;UniProt: P07451;TargetFullName: Carbonic anhydrase 3;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 3799-11 | Target: Carbonic anhydrase III | UniProt: P07451

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3799-11 | Target: Carbonic anhydrase III | UniProt: P07451 | TargetFullName: Carbonic anhydrase 3 | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:3800-71;Target:CK-BB;UniProt:P12277

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3800-71;Target: CK-BB;UniProt: P12277;TargetFullName: Creatine kinase B-type;Organisim: human;Apparent_Kd_M: 5.67E-11

Real

Aptamer SeqId: 3800-71 | Target: CK-BB | UniProt: P12277

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3800-71 | Target: CK-BB | UniProt: P12277 | TargetFullName: Creatine kinase B-type | Organisim: human | Apparent_Kd_M: 5.67E-11

Real

Aptamer SeqId:3803-10;Target:CYTD;UniProt:P28325

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3803-10;Target: CYTD;UniProt: P28325;TargetFullName: Cystatin-D;Organisim: human;Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId: 3803-10 | Target: CYTD | UniProt: P28325

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3803-10 | Target: CYTD | UniProt: P28325 | TargetFullName: Cystatin-D | Organisim: human | Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId:3805-16;Target:Endocan;UniProt:Q9NQ30

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3805-16;Target: Endocan;UniProt: Q9NQ30;TargetFullName: Endothelial cell-specific molecule 1;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 3805-16 | Target: Endocan | UniProt: Q9NQ30

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3805-16 | Target: Endocan | UniProt: Q9NQ30 | TargetFullName: Endothelial cell-specific molecule 1 | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:3806-55;Target:EphA5;UniProt:P54756

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3806-55;Target: EphA5;UniProt: P54756;TargetFullName: Ephrin type-A receptor 5;Organisim: human;Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId: 3806-55 | Target: EphA5 | UniProt: P54756

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3806-55 | Target: EphA5 | UniProt: P54756 | TargetFullName: Ephrin type-A receptor 5 | Organisim: human | Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId:3807-1;Target:FGF23;UniProt:Q9GZV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3807-1;Target: FGF23;UniProt: Q9GZV9;TargetFullName: Fibroblast growth factor 23;Organisim: human;Apparent_Kd_M: 5.47E-12

Real

Aptamer SeqId: 3807-1 | Target: FGF23 | UniProt: Q9GZV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3807-1 | Target: FGF23 | UniProt: Q9GZV9 | TargetFullName: Fibroblast growth factor 23 | Organisim: human | Apparent_Kd_M: 5.47E-12

Real

Aptamer SeqId:3808-76;Target:FGFR-2;UniProt:P21802

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3808-76;Target: FGFR-2;UniProt: P21802;TargetFullName: Fibroblast growth factor receptor 2;Organisim: human;Apparent_Kd_M: 2.66E-11

Real

Aptamer SeqId: 3808-76 | Target: FGFR-2 | UniProt: P21802

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3808-76 | Target: FGFR-2 | UniProt: P21802 | TargetFullName: Fibroblast growth factor receptor 2 | Organisim: human | Apparent_Kd_M: 2.66E-11

Real

Aptamer SeqId:3809-1;Target:FGFR-3;UniProt:P22607

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3809-1;Target: FGFR-3;UniProt: P22607;TargetFullName: Fibroblast growth factor receptor 3;Organisim: human;Apparent_Kd_M: 2.2E-10

Real

Aptamer SeqId: 3809-1 | Target: FGFR-3 | UniProt: P22607

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3809-1 | Target: FGFR-3 | UniProt: P22607 | TargetFullName: Fibroblast growth factor receptor 3 | Organisim: human | Apparent_Kd_M: 2.2E-10

Real

Aptamer SeqId:3810-50;Target:FGR;UniProt:P09769

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3810-50;Target: FGR;UniProt: P09769;TargetFullName: Tyrosine-protein kinase Fgr;Organisim: human;Apparent_Kd_M: 2.84E-11

Real

Aptamer SeqId: 3810-50 | Target: FGR | UniProt: P09769

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3810-50 | Target: FGR | UniProt: P09769 | TargetFullName: Tyrosine-protein kinase Fgr | Organisim: human | Apparent_Kd_M: 2.84E-11

Real

Aptamer SeqId:3813-3;Target:FYN;UniProt:P06241

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3813-3;Target: FYN;UniProt: P06241;TargetFullName: Tyrosine-protein kinase Fyn;Organisim: human;Apparent_Kd_M: 3.07E-12

Real

Aptamer SeqId: 3813-3 | Target: FYN | UniProt: P06241

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3813-3 | Target: FYN | UniProt: P06241 | TargetFullName: Tyrosine-protein kinase Fyn | Organisim: human | Apparent_Kd_M: 3.07E-12

Real

Aptamer SeqId:3815-14;Target:IL-12 RB2;UniProt:Q99665

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3815-14;Target: IL-12 RB2;UniProt: Q99665;TargetFullName: Interleukin-12 receptor subunit beta-2;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 3815-14 | Target: IL-12 RB2 | UniProt: Q99665

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3815-14 | Target: IL-12 RB2 | UniProt: Q99665 | TargetFullName: Interleukin-12 receptor subunit beta-2 | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:3817-18;Target:KPCT;UniProt:Q04759

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3817-18;Target: KPCT;UniProt: Q04759;TargetFullName: Protein kinase C theta type;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 3817-18 | Target: KPCT | UniProt: Q04759

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3817-18 | Target: KPCT | UniProt: Q04759 | TargetFullName: Protein kinase C theta type | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:3820-68;Target:MAPK2;UniProt:P49137

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3820-68;Target: MAPK2;UniProt: P49137;TargetFullName: MAP kinase-activated protein kinase 2;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 3820-68 | Target: MAPK2 | UniProt: P49137

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3820-68 | Target: MAPK2 | UniProt: P49137 | TargetFullName: MAP kinase-activated protein kinase 2 | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:3821-28;Target:MAPK5;UniProt:Q8IW41

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3821-28;Target: MAPK5;UniProt: Q8IW41;TargetFullName: MAP kinase-activated protein kinase 5;Organisim: human;Apparent_Kd_M: 7.95E-12

Real

Aptamer SeqId: 3821-28 | Target: MAPK5 | UniProt: Q8IW41

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3821-28 | Target: MAPK5 | UniProt: Q8IW41 | TargetFullName: MAP kinase-activated protein kinase 5 | Organisim: human | Apparent_Kd_M: 7.95E-12

Real

Aptamer SeqId:3822-54;Target:MAPKAPK3;UniProt:Q16644

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3822-54;Target: MAPKAPK3;UniProt: Q16644;TargetFullName: MAP kinase-activated protein kinase 3;Organisim: human;Apparent_Kd_M: 4.47E-12

Real

Aptamer SeqId: 3822-54 | Target: MAPKAPK3 | UniProt: Q16644

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3822-54 | Target: MAPKAPK3 | UniProt: Q16644 | TargetFullName: MAP kinase-activated protein kinase 3 | Organisim: human | Apparent_Kd_M: 4.47E-12

Real

Aptamer SeqId:3823-9;Target:MATK;UniProt:P42679

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3823-9;Target: MATK;UniProt: P42679;TargetFullName: Megakaryocyte-associated tyrosine-protein kinase;Organisim: human;Apparent_Kd_M: 6.47E-11

Real

Aptamer SeqId: 3823-9 | Target: MATK | UniProt: P42679

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3823-9 | Target: MATK | UniProt: P42679 | TargetFullName: Megakaryocyte-associated tyrosine-protein kinase | Organisim: human | Apparent_Kd_M: 6.47E-11

Real

Aptamer SeqId:3825-18;Target:MK08;UniProt:P45983

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3825-18;Target: MK08;UniProt: P45983;TargetFullName: Mitogen-activated protein kinase 8;Organisim: human;Apparent_Kd_M: 5.74E-12

Real

Aptamer SeqId: 3825-18 | Target: MK08 | UniProt: P45983

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3825-18 | Target: MK08 | UniProt: P45983 | TargetFullName: Mitogen-activated protein kinase 8 | Organisim: human | Apparent_Kd_M: 5.74E-12

Real

Aptamer SeqId:3827-22;Target:PAK6;UniProt:Q9NQU5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3827-22;Target: PAK6;UniProt: Q9NQU5;TargetFullName: Serine/threonine-protein kinase PAK 6;Organisim: human;Apparent_Kd_M: 2.9E-11

Real

Aptamer SeqId: 3827-22 | Target: PAK6 | UniProt: Q9NQU5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3827-22 | Target: PAK6 | UniProt: Q9NQU5 | TargetFullName: Serine/threonine-protein kinase PAK 6 | Organisim: human | Apparent_Kd_M: 2.9E-11

Real

Aptamer SeqId:3831-21;Target:pTEN;UniProt:P60484

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3831-21;Target: pTEN;UniProt: P60484;TargetFullName: Phosphatidylinositol 3;4;5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN;Organisim: human;Apparent_Kd_M: 8.29E-11

Real

Aptamer SeqId: 3831-21 | Target: pTEN | UniProt: P60484

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3831-21 | Target: pTEN | UniProt: P60484 | TargetFullName: Phosphatidylinositol 3;4;5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN | Organisim: human | Apparent_Kd_M: 8.29E-11

Real

Aptamer SeqId:3832-51;Target:PTK6;UniProt:Q13882

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3832-51;Target: PTK6;UniProt: Q13882;TargetFullName: Protein-tyrosine kinase 6;Organisim: human;Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId: 3832-51 | Target: PTK6 | UniProt: Q13882

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3832-51 | Target: PTK6 | UniProt: Q13882 | TargetFullName: Protein-tyrosine kinase 6 | Organisim: human | Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId:3835-11;Target:TLR2;UniProt:O60603

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3835-11;Target: TLR2;UniProt: O60603;TargetFullName: Toll-like receptor 2;Organisim: human;Apparent_Kd_M: 4.89E-11

Real

Aptamer SeqId: 3835-11 | Target: TLR2 | UniProt: O60603

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3835-11 | Target: TLR2 | UniProt: O60603 | TargetFullName: Toll-like receptor 2 | Organisim: human | Apparent_Kd_M: 4.89E-11

Real

Aptamer SeqId:3836-51;Target:UFM1;UniProt:P61960

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3836-51;Target: UFM1;UniProt: P61960;TargetFullName: Ubiquitin-fold modifier 1;Organisim: human;Apparent_Kd_M: 2.03E-11

Real

Aptamer SeqId: 3836-51 | Target: UFM1 | UniProt: P61960

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3836-51 | Target: UFM1 | UniProt: P61960 | TargetFullName: Ubiquitin-fold modifier 1 | Organisim: human | Apparent_Kd_M: 2.03E-11

Real

Aptamer SeqId:3837-6;Target:ZAP70;UniProt:P43403

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3837-6;Target: ZAP70;UniProt: P43403;TargetFullName: Tyrosine-protein kinase ZAP-70;Organisim: human;Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId: 3837-6 | Target: ZAP70 | UniProt: P43403

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3837-6 | Target: ZAP70 | UniProt: P43403 | TargetFullName: Tyrosine-protein kinase ZAP-70 | Organisim: human | Apparent_Kd_M: 2.56E-11

Real

Aptamer SeqId:3839-60;Target:AIP;UniProt:O00170

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3839-60;Target: AIP;UniProt: O00170;TargetFullName: AH receptor-interacting protein;Organisim: human;Apparent_Kd_M: 6.06E-11

Real

Aptamer SeqId: 3839-60 | Target: AIP | UniProt: O00170

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3839-60 | Target: AIP | UniProt: O00170 | TargetFullName: AH receptor-interacting protein | Organisim: human | Apparent_Kd_M: 6.06E-11

Real

Aptamer SeqId:3844-2;Target:Cyclophilin A;UniProt:P62937

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3844-2;Target: Cyclophilin A;UniProt: P62937;TargetFullName: Peptidyl-prolyl cis-trans isomerase A;Organisim: human;Apparent_Kd_M: 9.81E-13

Real

Aptamer SeqId: 3844-2 | Target: Cyclophilin A | UniProt: P62937

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3844-2 | Target: Cyclophilin A | UniProt: P62937 | TargetFullName: Peptidyl-prolyl cis-trans isomerase A | Organisim: human | Apparent_Kd_M: 9.81E-13

Real

Aptamer SeqId:3845-51;Target:DLRB1;UniProt:Q9NP97

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3845-51;Target: DLRB1;UniProt: Q9NP97;TargetFullName: Dynein light chain roadblock-type 1;Organisim: human;Apparent_Kd_M: 2.57E-11

Real

Aptamer SeqId: 3845-51 | Target: DLRB1 | UniProt: Q9NP97

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3845-51 | Target: DLRB1 | UniProt: Q9NP97 | TargetFullName: Dynein light chain roadblock-type 1 | Organisim: human | Apparent_Kd_M: 2.57E-11

Real

Aptamer SeqId:3847-56;Target:ETHE1;UniProt:O95571

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3847-56;Target: ETHE1;UniProt: O95571;TargetFullName: Persulfide dioxygenase ETHE1; mitochondrial;Organisim: human;Apparent_Kd_M: 3.21E-11

Real

Aptamer SeqId: 3847-56 | Target: ETHE1 | UniProt: O95571

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3847-56 | Target: ETHE1 | UniProt: O95571 | TargetFullName: Persulfide dioxygenase ETHE1; mitochondrial | Organisim: human | Apparent_Kd_M: 3.21E-11

Real

Aptamer SeqId:3848-14;Target:GAPDH; liver;UniProt:P04406

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3848-14;Target: GAPDH; liver;UniProt: P04406;TargetFullName: Glyceraldehyde-3-phosphate dehydrogenase;Organisim: human;Apparent_Kd_M: 8.75E-12

Real

Aptamer SeqId: 3848-14 | Target: GAPDH; liver | UniProt: P04406

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3848-14 | Target: GAPDH; liver | UniProt: P04406 | TargetFullName: Glyceraldehyde-3-phosphate dehydrogenase | Organisim: human | Apparent_Kd_M: 8.75E-12

Real

Aptamer SeqId:3849-56;Target:GFP_AEQVI;UniProt:P42212

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3849-56;Target: GFP_AEQVI;UniProt: P42212;TargetFullName: Green fluorescent protein_AEQVI;Organisim: aequorea victoria (jellyfish);Apparent_Kd_M: 1.13E-12

Real

Aptamer SeqId: 3849-56 | Target: GFP_AEQVI | UniProt: P42212

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3849-56 | Target: GFP_AEQVI | UniProt: P42212 | TargetFullName: Green fluorescent protein_AEQVI | Organisim: aequorea victoria (jellyfish) | Apparent_Kd_M: 1.13E-12

Real

Aptamer SeqId:3852-19;Target:HSP 40;UniProt:P25685

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3852-19;Target: HSP 40;UniProt: P25685;TargetFullName: DnaJ homolog subfamily B member 1;Organisim: human;Apparent_Kd_M: 3.38E-11

Real

Aptamer SeqId: 3852-19 | Target: HSP 40 | UniProt: P25685

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3852-19 | Target: HSP 40 | UniProt: P25685 | TargetFullName: DnaJ homolog subfamily B member 1 | Organisim: human | Apparent_Kd_M: 3.38E-11

Real

Aptamer SeqId:3853-56;Target:MDHC;UniProt:P40925

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3853-56;Target: MDHC;UniProt: P40925;TargetFullName: Malate dehydrogenase; cytoplasmic;Organisim: human;Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId: 3853-56 | Target: MDHC | UniProt: P40925

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3853-56 | Target: MDHC | UniProt: P40925 | TargetFullName: Malate dehydrogenase; cytoplasmic | Organisim: human | Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId:3854-24;Target:NACA;UniProt:Q13765

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3854-24;Target: NACA;UniProt: Q13765;TargetFullName: Nascent polypeptide-associated complex subunit alpha;Organisim: human;Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId: 3854-24 | Target: NACA | UniProt: Q13765

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3854-24 | Target: NACA | UniProt: Q13765 | TargetFullName: Nascent polypeptide-associated complex subunit alpha | Organisim: human | Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId:3855-56;Target:Peroxiredoxin-1;UniProt:Q06830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3855-56;Target: Peroxiredoxin-1;UniProt: Q06830;TargetFullName: Peroxiredoxin-1;Organisim: human;Apparent_Kd_M: 9.36E-11

Real

Aptamer SeqId: 3855-56 | Target: Peroxiredoxin-1 | UniProt: Q06830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3855-56 | Target: Peroxiredoxin-1 | UniProt: Q06830 | TargetFullName: Peroxiredoxin-1 | Organisim: human | Apparent_Kd_M: 9.36E-11

Real

Aptamer SeqId:3858-5;Target:PPAC;UniProt:P24666

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3858-5;Target: PPAC;UniProt: P24666;TargetFullName: Low molecular weight phosphotyrosine protein phosphatase;Organisim: human;Apparent_Kd_M: 3.46E-11

Real

Aptamer SeqId: 3858-5 | Target: PPAC | UniProt: P24666

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3858-5 | Target: PPAC | UniProt: P24666 | TargetFullName: Low molecular weight phosphotyrosine protein phosphatase | Organisim: human | Apparent_Kd_M: 3.46E-11

Real

Aptamer SeqId:3859-50;Target:PSA1;UniProt:P25786

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3859-50;Target: PSA1;UniProt: P25786;TargetFullName: Proteasome subunit alpha type-1;Organisim: human;Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId: 3859-50 | Target: PSA1 | UniProt: P25786

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3859-50 | Target: PSA1 | UniProt: P25786 | TargetFullName: Proteasome subunit alpha type-1 | Organisim: human | Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId:3860-7;Target:PSA6;UniProt:P60900

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3860-7;Target: PSA6;UniProt: P60900;TargetFullName: Proteasome subunit alpha type-6;Organisim: human;Apparent_Kd_M: 1.17E-10

Real

Aptamer SeqId: 3860-7 | Target: PSA6 | UniProt: P60900

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3860-7 | Target: PSA6 | UniProt: P60900 | TargetFullName: Proteasome subunit alpha type-6 | Organisim: human | Apparent_Kd_M: 1.17E-10

Real

Aptamer SeqId:3864-5;Target:RS7;UniProt:P62081

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3864-5;Target: RS7;UniProt: P62081;TargetFullName: 40S ribosomal protein S7;Organisim: human;Apparent_Kd_M: 9.14E-11

Real

Aptamer SeqId: 3864-5 | Target: RS7 | UniProt: P62081

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3864-5 | Target: RS7 | UniProt: P62081 | TargetFullName: 40S ribosomal protein S7 | Organisim: human | Apparent_Kd_M: 9.14E-11

Real

Aptamer SeqId:3866-7;Target:SBDS;UniProt:Q9Y3A5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3866-7;Target: SBDS;UniProt: Q9Y3A5;TargetFullName: Ribosome maturation protein SBDS;Organisim: human;Apparent_Kd_M: 5.57E-11

Real

Aptamer SeqId: 3866-7 | Target: SBDS | UniProt: Q9Y3A5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3866-7 | Target: SBDS | UniProt: Q9Y3A5 | TargetFullName: Ribosome maturation protein SBDS | Organisim: human | Apparent_Kd_M: 5.57E-11

Real

Aptamer SeqId:3867-49;Target:SE6L2;UniProt:Q6UXD5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3867-49;Target: SE6L2;UniProt: Q6UXD5;TargetFullName: Seizure 6-like protein 2;Organisim: human;Apparent_Kd_M: 1.1E-10

Real

Aptamer SeqId: 3867-49 | Target: SE6L2 | UniProt: Q6UXD5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3867-49 | Target: SE6L2 | UniProt: Q6UXD5 | TargetFullName: Seizure 6-like protein 2 | Organisim: human | Apparent_Kd_M: 1.1E-10

Real

Aptamer SeqId:3868-8;Target:SGTA;UniProt:O43765

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3868-8;Target: SGTA;UniProt: O43765;TargetFullName: Small glutamine-rich tetratricopeptide repeat-containing protein alpha;Organisim: human;Apparent_Kd_M: 1.93E-11

Real

Aptamer SeqId: 3868-8 | Target: SGTA | UniProt: O43765

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3868-8 | Target: SGTA | UniProt: O43765 | TargetFullName: Small glutamine-rich tetratricopeptide repeat-containing protein alpha | Organisim: human | Apparent_Kd_M: 1.93E-11

Real

Aptamer SeqId:3872-2;Target:TCTP;UniProt:P13693

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3872-2;Target: TCTP;UniProt: P13693;TargetFullName: Translationally-controlled tumor protein;Organisim: human;Apparent_Kd_M: 9.18E-12

Real

Aptamer SeqId: 3872-2 | Target: TCTP | UniProt: P13693

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3872-2 | Target: TCTP | UniProt: P13693 | TargetFullName: Translationally-controlled tumor protein | Organisim: human | Apparent_Kd_M: 9.18E-12

Real

Aptamer SeqId:3873-51;Target:TMA;UniProt:P07202

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3873-51;Target: TMA;UniProt: P07202;TargetFullName: Thyroid peroxidase;Organisim: human;Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId: 3873-51 | Target: TMA | UniProt: P07202

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3873-51 | Target: TMA | UniProt: P07202 | TargetFullName: Thyroid peroxidase | Organisim: human | Apparent_Kd_M: 1.17E-11

Real

Aptamer SeqId:3874-8;Target:UB2L3;UniProt:P68036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3874-8;Target: UB2L3;UniProt: P68036;TargetFullName: Ubiquitin-conjugating enzyme E2 L3;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 3874-8 | Target: UB2L3 | UniProt: P68036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3874-8 | Target: UB2L3 | UniProt: P68036 | TargetFullName: Ubiquitin-conjugating enzyme E2 L3 | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:3875-62;Target:ARI3A;UniProt:Q99856

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3875-62;Target: ARI3A;UniProt: Q99856;TargetFullName: AT-rich interactive domain-containing protein 3A;Organisim: human;Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId: 3875-62 | Target: ARI3A | UniProt: Q99856

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3875-62 | Target: ARI3A | UniProt: Q99856 | TargetFullName: AT-rich interactive domain-containing protein 3A | Organisim: human | Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId:3879-50;Target:CDC37;UniProt:Q16543

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3879-50;Target: CDC37;UniProt: Q16543;TargetFullName: Hsp90 co-chaperone Cdc37;Organisim: human;Apparent_Kd_M: 2.13E-10

Real

Aptamer SeqId: 3879-50 | Target: CDC37 | UniProt: Q16543

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3879-50 | Target: CDC37 | UniProt: Q16543 | TargetFullName: Hsp90 co-chaperone Cdc37 | Organisim: human | Apparent_Kd_M: 2.13E-10

Real

Aptamer SeqId:3881-49;Target:DLC8;UniProt:P63167

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3881-49;Target: DLC8;UniProt: P63167;TargetFullName: Dynein light chain 1; cytoplasmic;Organisim: human;Apparent_Kd_M: 1.34E-10

Real

Aptamer SeqId: 3881-49 | Target: DLC8 | UniProt: P63167

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3881-49 | Target: DLC8 | UniProt: P63167 | TargetFullName: Dynein light chain 1; cytoplasmic | Organisim: human | Apparent_Kd_M: 1.34E-10

Real

Aptamer SeqId:3887-90;Target:IMB1;UniProt:Q14974

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3887-90;Target: IMB1;UniProt: Q14974;TargetFullName: Importin subunit beta-1;Organisim: human;Apparent_Kd_M: 3.16E-11

Real

Aptamer SeqId: 3887-90 | Target: IMB1 | UniProt: Q14974

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3887-90 | Target: IMB1 | UniProt: Q14974 | TargetFullName: Importin subunit beta-1 | Organisim: human | Apparent_Kd_M: 3.16E-11

Real

Aptamer SeqId:3888-8;Target:ING1;UniProt:Q9UK53

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3888-8;Target: ING1;UniProt: Q9UK53;TargetFullName: Inhibitor of growth protein 1;Organisim: human;Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId: 3888-8 | Target: ING1 | UniProt: Q9UK53

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3888-8 | Target: ING1 | UniProt: Q9UK53 | TargetFullName: Inhibitor of growth protein 1 | Organisim: human | Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId:3889-64;Target:Lamin-B1;UniProt:P20700

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3889-64;Target: Lamin-B1;UniProt: P20700;TargetFullName: Lamin-B1;Organisim: human;Apparent_Kd_M: 8.66E-12

Real

Aptamer SeqId: 3889-64 | Target: Lamin-B1 | UniProt: P20700

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3889-64 | Target: Lamin-B1 | UniProt: P20700 | TargetFullName: Lamin-B1 | Organisim: human | Apparent_Kd_M: 8.66E-12

Real

Aptamer SeqId:3890-8;Target:LDH-H 1;UniProt:P07195

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3890-8;Target: LDH-H 1;UniProt: P07195;TargetFullName: L-lactate dehydrogenase B chain;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 3890-8 | Target: LDH-H 1 | UniProt: P07195

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3890-8 | Target: LDH-H 1 | UniProt: P07195 | TargetFullName: L-lactate dehydrogenase B chain | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:3891-56;Target:MBD4;UniProt:O95243

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3891-56;Target: MBD4;UniProt: O95243;TargetFullName: Methyl-CpG-binding domain protein 4;Organisim: human;Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId: 3891-56 | Target: MBD4 | UniProt: O95243

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3891-56 | Target: MBD4 | UniProt: O95243 | TargetFullName: Methyl-CpG-binding domain protein 4 | Organisim: human | Apparent_Kd_M: 1.16E-11

Real

Aptamer SeqId:3892-21;Target:MED-1;UniProt:Q15648

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3892-21;Target: MED-1;UniProt: Q15648;TargetFullName: Mediator of RNA polymerase II transcription subunit 1;Organisim: human;Apparent_Kd_M: 1.25E-10

Real

Aptamer SeqId: 3892-21 | Target: MED-1 | UniProt: Q15648

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3892-21 | Target: MED-1 | UniProt: Q15648 | TargetFullName: Mediator of RNA polymerase II transcription subunit 1 | Organisim: human | Apparent_Kd_M: 1.25E-10

Real

Aptamer SeqId:3893-64;Target:Mesothelin;UniProt:Q13421

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3893-64;Target: Mesothelin;UniProt: Q13421;TargetFullName: Mesothelin;Organisim: human;Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId: 3893-64 | Target: Mesothelin | UniProt: Q13421

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3893-64 | Target: Mesothelin | UniProt: Q13421 | TargetFullName: Mesothelin | Organisim: human | Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId:3894-15;Target:NAGK;UniProt:Q9UJ70

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3894-15;Target: NAGK;UniProt: Q9UJ70;TargetFullName: N-acetyl-D-glucosamine kinase;Organisim: human;Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId: 3894-15 | Target: NAGK | UniProt: Q9UJ70

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3894-15 | Target: NAGK | UniProt: Q9UJ70 | TargetFullName: N-acetyl-D-glucosamine kinase | Organisim: human | Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId:3896-5;Target:Phosphoglycerate mutase 1;UniProt:P18669

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3896-5;Target: Phosphoglycerate mutase 1;UniProt: P18669;TargetFullName: Phosphoglycerate mutase 1;Organisim: human;Apparent_Kd_M: 7.91E-12

Real

Aptamer SeqId: 3896-5 | Target: Phosphoglycerate mutase 1 | UniProt: P18669

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3896-5 | Target: Phosphoglycerate mutase 1 | UniProt: P18669 | TargetFullName: Phosphoglycerate mutase 1 | Organisim: human | Apparent_Kd_M: 7.91E-12

Real

Aptamer SeqId:3897-61;Target:PLPP;UniProt:Q96GD0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3897-61;Target: PLPP;UniProt: Q96GD0;TargetFullName: Pyridoxal phosphate phosphatase;Organisim: human;Apparent_Kd_M: 2.82E-11

Real

Aptamer SeqId: 3897-61 | Target: PLPP | UniProt: Q96GD0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3897-61 | Target: PLPP | UniProt: Q96GD0 | TargetFullName: Pyridoxal phosphate phosphatase | Organisim: human | Apparent_Kd_M: 2.82E-11

Real

Aptamer SeqId:3898-5;Target:PSD7;UniProt:P51665

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3898-5;Target: PSD7;UniProt: P51665;TargetFullName: 26S proteasome non-ATPase regulatory subunit 7;Organisim: human;Apparent_Kd_M: 1.06E-10

Real

Aptamer SeqId: 3898-5 | Target: PSD7 | UniProt: P51665

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3898-5 | Target: PSD7 | UniProt: P51665 | TargetFullName: 26S proteasome non-ATPase regulatory subunit 7 | Organisim: human | Apparent_Kd_M: 1.06E-10

Real

Aptamer SeqId:3902-21;Target:SKP1;UniProt:P63208

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3902-21;Target: SKP1;UniProt: P63208;TargetFullName: S-phase kinase-associated protein 1;Organisim: human;Apparent_Kd_M: 4.6E-10

Real

Aptamer SeqId: 3902-21 | Target: SKP1 | UniProt: P63208

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3902-21 | Target: SKP1 | UniProt: P63208 | TargetFullName: S-phase kinase-associated protein 1 | Organisim: human | Apparent_Kd_M: 4.6E-10

Real

Aptamer SeqId:3903-49;Target:Sorting nexin 4;UniProt:O95219

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3903-49;Target: Sorting nexin 4;UniProt: O95219;TargetFullName: Sorting nexin-4;Organisim: human;Apparent_Kd_M: 9.04E-12

Real

Aptamer SeqId: 3903-49 | Target: Sorting nexin 4 | UniProt: O95219

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3903-49 | Target: Sorting nexin 4 | UniProt: O95219 | TargetFullName: Sorting nexin-4 | Organisim: human | Apparent_Kd_M: 9.04E-12

Real

Aptamer SeqId:3905-62;Target:UBE2N;UniProt:P61088

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 3905-62;Target: UBE2N;UniProt: P61088;TargetFullName: Ubiquitin-conjugating enzyme E2 N;Organisim: human;Apparent_Kd_M: 8.13E-12

Real

Aptamer SeqId: 3905-62 | Target: UBE2N | UniProt: P61088

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 3905-62 | Target: UBE2N | UniProt: P61088 | TargetFullName: Ubiquitin-conjugating enzyme E2 N | Organisim: human | Apparent_Kd_M: 8.13E-12

Real

Aptamer SeqId:4122-12;Target:discoidin domain receptor 1;UniProt:Q08345

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4122-12;Target: discoidin domain receptor 1;UniProt: Q08345;TargetFullName: Epithelial discoidin domain-containing receptor 1;Organisim: human;Apparent_Kd_M: 3.45E-11

Real

Aptamer SeqId: 4122-12 | Target: discoidin domain receptor 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4122-12 | Target: discoidin domain receptor 1 | UniProt: Q08345 | TargetFullName: Epithelial discoidin domain-containing receptor 1 | Organisim: human | Apparent_Kd_M: 3.45E-11

Real

Aptamer SeqId:4123-60;Target:FGF-4;UniProt:P08620

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4123-60;Target: FGF-4;UniProt: P08620;TargetFullName: Fibroblast growth factor 4;Organisim: human;Apparent_Kd_M: 4.17E-12

Real

Aptamer SeqId: 4123-60 | Target: FGF-4 | UniProt: P08620

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4123-60 | Target: FGF-4 | UniProt: P08620 | TargetFullName: Fibroblast growth factor 4 | Organisim: human | Apparent_Kd_M: 4.17E-12

Real

Aptamer SeqId:4124-24;Target:HSP 70;UniProt:P0DMV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4124-24;Target: HSP 70;UniProt: P0DMV8;TargetFullName: Heat shock 70 kDa protein 1A;Organisim: human;Apparent_Kd_M: 2.67E-11

Real

Aptamer SeqId: 4124-24 | Target: HSP 70 | UniProt: P0DMV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4124-24 | Target: HSP 70 | UniProt: P0DMV8 | TargetFullName: Heat shock 70 kDa protein 1A | Organisim: human | Apparent_Kd_M: 2.67E-11

Real

Aptamer SeqId:4125-52;Target:sRAGE;UniProt:Q15109

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4125-52;Target: sRAGE;UniProt: Q15109;TargetFullName: Advanced glycosylation end product-specific receptor; soluble;Organisim: human;Apparent_Kd_M: 5.5E-12

Real

Aptamer SeqId: 4125-52 | Target: sRAGE | UniProt: Q15109

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4125-52 | Target: sRAGE | UniProt: Q15109 | TargetFullName: Advanced glycosylation end product-specific receptor; soluble | Organisim: human | Apparent_Kd_M: 5.5E-12

Real

Aptamer SeqId:4126-22;Target:BPI;UniProt:P17213

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4126-22;Target: BPI;UniProt: P17213;TargetFullName: Bactericidal permeability-increasing protein;Organisim: human;Apparent_Kd_M: 3.336306E-12

Real

Aptamer SeqId: 4126-22 | Target: BPI | UniProt: P17213

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4126-22 | Target: BPI | UniProt: P17213 | TargetFullName: Bactericidal permeability-increasing protein | Organisim: human | Apparent_Kd_M: 3.336306E-12

Real

Aptamer SeqId:4127-75;Target:C6;UniProt:P13671

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4127-75;Target: C6;UniProt: P13671;TargetFullName: Complement component C6;Organisim: human;Apparent_Kd_M: 4.98E-12

Real

Aptamer SeqId: 4127-75 | Target: C6 | UniProt: P13671

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4127-75 | Target: C6 | UniProt: P13671 | TargetFullName: Complement component C6 | Organisim: human | Apparent_Kd_M: 4.98E-12

Real

Aptamer SeqId:4128-27;Target:Eotaxin-2;UniProt:O00175

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4128-27;Target: Eotaxin-2;UniProt: O00175;TargetFullName: C-C motif chemokine 24;Organisim: human;Apparent_Kd_M: 6.17E-12

Real

Aptamer SeqId: 4128-27 | Target: Eotaxin-2 | UniProt: O00175

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4128-27 | Target: Eotaxin-2 | UniProt: O00175 | TargetFullName: C-C motif chemokine 24 | Organisim: human | Apparent_Kd_M: 6.17E-12

Real

Aptamer SeqId:4129-72;Target:Factor B;UniProt:P00751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4129-72;Target: Factor B;UniProt: P00751;TargetFullName: Complement factor B;Organisim: human;Apparent_Kd_M: 4.13E-12

Real

Aptamer SeqId: 4129-72 | Target: Factor B | UniProt: P00751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4129-72 | Target: Factor B | UniProt: P00751 | TargetFullName: Complement factor B | Organisim: human | Apparent_Kd_M: 4.13E-12

Real

Aptamer SeqId:4130-71;Target:FGF-6;UniProt:P10767

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4130-71;Target: FGF-6;UniProt: P10767;TargetFullName: Fibroblast growth factor 6;Organisim: human;Apparent_Kd_M: 1.63E-11

Real

Aptamer SeqId: 4130-71 | Target: FGF-6 | UniProt: P10767

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4130-71 | Target: FGF-6 | UniProt: P10767 | TargetFullName: Fibroblast growth factor 6 | Organisim: human | Apparent_Kd_M: 1.63E-11

Real

Aptamer SeqId:4131-72;Target:Fibronectin;UniProt:P02751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4131-72;Target: Fibronectin;UniProt: P02751;TargetFullName: Fibronectin;Organisim: human;Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId: 4131-72 | Target: Fibronectin | UniProt: P02751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4131-72 | Target: Fibronectin | UniProt: P02751 | TargetFullName: Fibronectin | Organisim: human | Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId:4132-27;Target:FST;UniProt:P19883

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4132-27;Target: FST;UniProt: P19883;TargetFullName: Follistatin;Organisim: human;Apparent_Kd_M: 1.23E-11

Real

Aptamer SeqId: 4132-27 | Target: FST | UniProt: P19883

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4132-27 | Target: FST | UniProt: P19883 | TargetFullName: Follistatin | Organisim: human | Apparent_Kd_M: 1.23E-11

Real

Aptamer SeqId:4133-54;Target:Granzyme B;UniProt:P10144

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4133-54;Target: Granzyme B;UniProt: P10144;TargetFullName: Granzyme B;Organisim: human;Apparent_Kd_M: 3.41E-12

Real

Aptamer SeqId: 4133-54 | Target: Granzyme B | UniProt: P10144

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4133-54 | Target: Granzyme B | UniProt: P10144 | TargetFullName: Granzyme B | Organisim: human | Apparent_Kd_M: 3.41E-12

Real

Aptamer SeqId:4135-84;Target:IgE;UniProt:P01854

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4135-84;Target: IgE;UniProt: P01854;TargetFullName: Immunoglobulin E;Organisim: human;Apparent_Kd_M: 8.36E-12

Real

Aptamer SeqId: 4135-84 | Target: IgE | UniProt: P01854

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4135-84 | Target: IgE | UniProt: P01854 | TargetFullName: Immunoglobulin E | Organisim: human | Apparent_Kd_M: 8.36E-12

Real

Aptamer SeqId:4136-40;Target:IL-17D;UniProt:Q8TAD2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4136-40;Target: IL-17D;UniProt: Q8TAD2;TargetFullName: Interleukin-17D;Organisim: human;Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId: 4136-40 | Target: IL-17D | UniProt: Q8TAD2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4136-40 | Target: IL-17D | UniProt: Q8TAD2 | TargetFullName: Interleukin-17D | Organisim: human | Apparent_Kd_M: 1.15E-11

Real

Aptamer SeqId:4137-57;Target:IL-17E;UniProt:Q9H293

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4137-57;Target: IL-17E;UniProt: Q9H293;TargetFullName: Interleukin-25;Organisim: human;Apparent_Kd_M: 2.82E-11

Real

Aptamer SeqId: 4137-57 | Target: IL-17E | UniProt: Q9H293

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4137-57 | Target: IL-17E | UniProt: Q9H293 | TargetFullName: Interleukin-25 | Organisim: human | Apparent_Kd_M: 2.82E-11

Real

Aptamer SeqId:4138-25;Target:IL-20;UniProt:Q9NYY1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4138-25;Target: IL-20;UniProt: Q9NYY1;TargetFullName: Interleukin-20;Organisim: human;Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId: 4138-25 | Target: IL-20 | UniProt: Q9NYY1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4138-25 | Target: IL-20 | UniProt: Q9NYY1 | TargetFullName: Interleukin-20 | Organisim: human | Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId:4140-3;Target:IL-7;UniProt:P13232

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4140-3;Target: IL-7;UniProt: P13232;TargetFullName: Interleukin-7;Organisim: human;Apparent_Kd_M: 5.85E-12

Real

Aptamer SeqId: 4140-3 | Target: IL-7 | UniProt: P13232

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4140-3 | Target: IL-7 | UniProt: P13232 | TargetFullName: Interleukin-7 | Organisim: human | Apparent_Kd_M: 5.85E-12

Real

Aptamer SeqId:4141-79;Target:IP-10;UniProt:P02778

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4141-79;Target: IP-10;UniProt: P02778;TargetFullName: C-X-C motif chemokine 10;Organisim: human;Apparent_Kd_M: 7.34E-12

Real

Aptamer SeqId: 4141-79 | Target: IP-10 | UniProt: P02778

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4141-79 | Target: IP-10 | UniProt: P02778 | TargetFullName: C-X-C motif chemokine 10 | Organisim: human | Apparent_Kd_M: 7.34E-12

Real

Aptamer SeqId:4143-74;Target:Lymphotactin;UniProt:P47992

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4143-74;Target: Lymphotactin;UniProt: P47992;TargetFullName: Lymphotactin;Organisim: human;Apparent_Kd_M: 7.68E-12

Real

Aptamer SeqId: 4143-74 | Target: Lymphotactin | UniProt: P47992

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4143-74 | Target: Lymphotactin | UniProt: P47992 | TargetFullName: Lymphotactin | Organisim: human | Apparent_Kd_M: 7.68E-12

Real

Aptamer SeqId:4144-13;Target:MCP-4;UniProt:Q99616

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4144-13;Target: MCP-4;UniProt: Q99616;TargetFullName: C-C motif chemokine 13;Organisim: human;Apparent_Kd_M: 8.47E-12

Real

Aptamer SeqId: 4144-13 | Target: MCP-4 | UniProt: Q99616

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4144-13 | Target: MCP-4 | UniProt: Q99616 | TargetFullName: C-C motif chemokine 13 | Organisim: human | Apparent_Kd_M: 8.47E-12

Real

Aptamer SeqId:4145-58;Target:Neurotrophin-3;UniProt:P20783

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4145-58;Target: Neurotrophin-3;UniProt: P20783;TargetFullName: Neurotrophin-3;Organisim: human;Apparent_Kd_M: 2.91E-12

Real

Aptamer SeqId: 4145-58 | Target: Neurotrophin-3 | UniProt: P20783

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4145-58 | Target: Neurotrophin-3 | UniProt: P20783 | TargetFullName: Neurotrophin-3 | Organisim: human | Apparent_Kd_M: 2.91E-12

Real

Aptamer SeqId:4146-58;Target:Neurotrophin-5;UniProt:P34130

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4146-58;Target: Neurotrophin-5;UniProt: P34130;TargetFullName: Neurotrophin-4;Organisim: human;Apparent_Kd_M: 1.38E-11

Real

Aptamer SeqId: 4146-58 | Target: Neurotrophin-5 | UniProt: P34130

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4146-58 | Target: Neurotrophin-5 | UniProt: P34130 | TargetFullName: Neurotrophin-4 | Organisim: human | Apparent_Kd_M: 1.38E-11

Real

Aptamer SeqId:4148-49;Target:PAPP-A;UniProt:Q13219

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4148-49;Target: PAPP-A;UniProt: Q13219;TargetFullName: Pappalysin-1;Organisim: human;Apparent_Kd_M: 8.63E-12

Real

Aptamer SeqId: 4148-49 | Target: PAPP-A | UniProt: Q13219

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4148-49 | Target: PAPP-A | UniProt: Q13219 | TargetFullName: Pappalysin-1 | Organisim: human | Apparent_Kd_M: 8.63E-12

Real

Aptamer SeqId:4149-8;Target:PDGF-BB;UniProt:P01127

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4149-8;Target: PDGF-BB;UniProt: P01127;TargetFullName: Platelet-derived growth factor subunit B;Organisim: human;Apparent_Kd_M: 1.92E-11

Real

Aptamer SeqId: 4149-8 | Target: PDGF-BB | UniProt: P01127

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4149-8 | Target: PDGF-BB | UniProt: P01127 | TargetFullName: Platelet-derived growth factor subunit B | Organisim: human | Apparent_Kd_M: 1.92E-11

Real

Aptamer SeqId:4150-75;Target:Plasmin;UniProt:P00747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4150-75;Target: Plasmin;UniProt: P00747;TargetFullName: Plasmin;Organisim: human;Apparent_Kd_M: 4.41E-11

Real

Aptamer SeqId: 4150-75 | Target: Plasmin | UniProt: P00747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4150-75 | Target: Plasmin | UniProt: P00747 | TargetFullName: Plasmin | Organisim: human | Apparent_Kd_M: 4.41E-11

Real

Aptamer SeqId:4151-6;Target:Plasminogen;UniProt:P00747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4151-6;Target: Plasminogen;UniProt: P00747;TargetFullName: Plasminogen;Organisim: human;Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId: 4151-6 | Target: Plasminogen | UniProt: P00747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4151-6 | Target: Plasminogen | UniProt: P00747 | TargetFullName: Plasminogen | Organisim: human | Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId:4152-58;Target:Prekallikrein;UniProt:P03952

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4152-58;Target: Prekallikrein;UniProt: P03952;TargetFullName: Plasma kallikrein;Organisim: human;Apparent_Kd_M: 1.62E-12

Real

Aptamer SeqId: 4152-58 | Target: Prekallikrein | UniProt: P03952

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4152-58 | Target: Prekallikrein | UniProt: P03952 | TargetFullName: Plasma kallikrein | Organisim: human | Apparent_Kd_M: 1.62E-12

Real

Aptamer SeqId:4153-11;Target:alpha-1-antichymotrypsin complex;UniProt:P01011

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4153-11;Target: alpha-1-antichymotrypsin complex;UniProt: P01011;TargetFullName: Alpha-1-antichymotrypsin complex;Organisim: human;Apparent_Kd_M: 3.11E-12

Real

Aptamer SeqId: 4153-11 | Target: alpha-1-antichymotrypsin complex

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4153-11 | Target: alpha-1-antichymotrypsin complex | UniProt: P01011 | TargetFullName: Alpha-1-antichymotrypsin complex | Organisim: human | Apparent_Kd_M: 3.11E-12

Real

Aptamer SeqId:4154-57;Target:P-Selectin;UniProt:P16109

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4154-57;Target: P-Selectin;UniProt: P16109;TargetFullName: P-selectin;Organisim: human;Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId: 4154-57 | Target: P-Selectin | UniProt: P16109

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4154-57 | Target: P-Selectin | UniProt: P16109 | TargetFullName: P-selectin | Organisim: human | Apparent_Kd_M: 1.48E-12

Real

Aptamer SeqId:4155-3;Target:Tenascin;UniProt:P24821

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4155-3;Target: Tenascin;UniProt: P24821;TargetFullName: Tenascin;Organisim: human;Apparent_Kd_M: 4.74E-11

Real

Aptamer SeqId: 4155-3 | Target: Tenascin | UniProt: P24821

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4155-3 | Target: Tenascin | UniProt: P24821 | TargetFullName: Tenascin | Organisim: human | Apparent_Kd_M: 4.74E-11

Real

Aptamer SeqId:4156-74;Target:TGF-b2;UniProt:P61812

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4156-74;Target: TGF-b2;UniProt: P61812;TargetFullName: Transforming growth factor beta-2;Organisim: human;Apparent_Kd_M: 2.47E-11

Real

Aptamer SeqId: 4156-74 | Target: TGF-b2 | UniProt: P61812

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4156-74 | Target: TGF-b2 | UniProt: P61812 | TargetFullName: Transforming growth factor beta-2 | Organisim: human | Apparent_Kd_M: 2.47E-11

Real

Aptamer SeqId:4157-2;Target:Thrombin;UniProt:P00734

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4157-2;Target: Thrombin;UniProt: P00734;TargetFullName: Thrombin;Organisim: human;Apparent_Kd_M: 1.36E-11

Real

Aptamer SeqId: 4157-2 | Target: Thrombin | UniProt: P00734

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4157-2 | Target: Thrombin | UniProt: P00734 | TargetFullName: Thrombin | Organisim: human | Apparent_Kd_M: 1.36E-11

Real

Aptamer SeqId:4158-54;Target:uPA;UniProt:P00749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4158-54;Target: uPA;UniProt: P00749;TargetFullName: Urokinase-type plasminogen activator;Organisim: human;Apparent_Kd_M: 4.59E-12

Real

Aptamer SeqId: 4158-54 | Target: uPA | UniProt: P00749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4158-54 | Target: uPA | UniProt: P00749 | TargetFullName: Urokinase-type plasminogen activator | Organisim: human | Apparent_Kd_M: 4.59E-12

Real

Aptamer SeqId:4159-130;Target:Factor H;UniProt:P08603

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4159-130;Target: Factor H;UniProt: P08603;TargetFullName: Complement factor H;Organisim: human;Apparent_Kd_M: 5.09E-12

Real

Aptamer SeqId: 4159-130 | Target: Factor H | UniProt: P08603

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4159-130 | Target: Factor H | UniProt: P08603 | TargetFullName: Complement factor H | Organisim: human | Apparent_Kd_M: 5.09E-12

Real

Aptamer SeqId:4160-49;Target:MMP-2;UniProt:P08253

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4160-49;Target: MMP-2;UniProt: P08253;TargetFullName: 72 kDa type IV collagenase;Organisim: human;Apparent_Kd_M: 1.42E-11

Real

Aptamer SeqId: 4160-49 | Target: MMP-2 | UniProt: P08253

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4160-49 | Target: MMP-2 | UniProt: P08253 | TargetFullName: 72 kDa type IV collagenase | Organisim: human | Apparent_Kd_M: 1.42E-11

Real

Aptamer SeqId:4162-54;Target:Transferrin;UniProt:P02787

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4162-54;Target: Transferrin;UniProt: P02787;TargetFullName: Serotransferrin;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 4162-54 | Target: Transferrin | UniProt: P02787

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4162-54 | Target: Transferrin | UniProt: P02787 | TargetFullName: Serotransferrin | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:4163-5;Target:Histone H2A.z;UniProt:P0C0S5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4163-5;Target: Histone H2A.z;UniProt: P0C0S5;TargetFullName: Histone H2A.z;Organisim: human;Apparent_Kd_M: 9.8E-10

Real

Aptamer SeqId: 4163-5 | Target: Histone H2A.z | UniProt: P0C0S5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4163-5 | Target: Histone H2A.z | UniProt: P0C0S5 | TargetFullName: Histone H2A.z | Organisim: human | Apparent_Kd_M: 9.8E-10

Real

Aptamer SeqId:4179-57;Target:14-3-3;UniProt:P31946;P62258;P61981;Q04917

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4179-57;Target: 14-3-3;UniProt: P31946|P62258|P61981|Q04917|P27348|P63104|P31947;TargetFullName: 14-3-3 protein family;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 4179-57 | Target: 14-3-3 protein family

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4179-57 | Target: 14-3-3 | UniProt: P31946|P62258|P61981|Q04917|P27348|P63104|P31947 | TargetFullName: 14-3-3 protein family | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:4184-43;Target:4EBP2;UniProt:Q13542

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4184-43;Target: 4EBP2;UniProt: Q13542;TargetFullName: Eukaryotic translation initiation factor 4E-binding protein 2;Organisim: human;Apparent_Kd_M: 7.22E-11

Real

Aptamer SeqId: 4184-43 | Target: 4EBP2 | UniProt: Q13542

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4184-43 | Target: 4EBP2 | UniProt: Q13542 | TargetFullName: Eukaryotic translation initiation factor 4E-binding protein 2 | Organisim: human | Apparent_Kd_M: 7.22E-11

Real

Aptamer SeqId:4187-49;Target:6-Phosphogluconate dehydrogenase;UniProt:P52209

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4187-49;Target: 6-Phosphogluconate dehydrogenase;UniProt: P52209;TargetFullName: 6-phosphogluconate dehydrogenase; decarboxylating;Organisim: human;Apparent_Kd_M: 9.6E-12

Real

Aptamer SeqId: 4187-49 | Target: 6-Phosphogluconate dehydrogenase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4187-49 | Target: 6-Phosphogluconate dehydrogenase | UniProt: P52209 | TargetFullName: 6-phosphogluconate dehydrogenase; decarboxylating | Organisim: human | Apparent_Kd_M: 9.6E-12

Real

Aptamer SeqId:4188-1;Target:Aflatoxin B1 aldehyde reductase;UniProt:O43488

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4188-1;Target: Aflatoxin B1 aldehyde reductase;UniProt: O43488;TargetFullName: Aflatoxin B1 aldehyde reductase member 2;Organisim: human;Apparent_Kd_M: 1.65E-12

Real

Aptamer SeqId: 4188-1 | Target: Aflatoxin B1 aldehyde reductase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4188-1 | Target: Aflatoxin B1 aldehyde reductase | UniProt: O43488 | TargetFullName: Aflatoxin B1 aldehyde reductase member 2 | Organisim: human | Apparent_Kd_M: 1.65E-12

Real

Aptamer SeqId:4192-10;Target:AK1A1;UniProt:P14550

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4192-10;Target: AK1A1;UniProt: P14550;TargetFullName: Alcohol dehydrogenase [NADP(+)];Organisim: human;Apparent_Kd_M: 1.27E-11

Real

Aptamer SeqId: 4192-10 | Target: AK1A1 | UniProt: P14550

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4192-10 | Target: AK1A1 | UniProt: P14550 | TargetFullName: Alcohol dehydrogenase NADP(+) | Organisim: human | Apparent_Kd_M: 1.27E-11

Real

Aptamer SeqId:4194-26;Target:AN32B;UniProt:Q92688

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4194-26;Target: AN32B;UniProt: Q92688;TargetFullName: Acidic leucine-rich nuclear phosphoprotein 32 family member B;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 4194-26 | Target: AN32B | UniProt: Q92688

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4194-26 | Target: AN32B | UniProt: Q92688 | TargetFullName: Acidic leucine-rich nuclear phosphoprotein 32 family member B | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:4203-50;Target:Cofilin-1;UniProt:P23528

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4203-50;Target: Cofilin-1;UniProt: P23528;TargetFullName: Cofilin-1;Organisim: human;Apparent_Kd_M: 4.98E-11

Real

Aptamer SeqId: 4203-50 | Target: Cofilin-1 | UniProt: P23528

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4203-50 | Target: Cofilin-1 | UniProt: P23528 | TargetFullName: Cofilin-1 | Organisim: human | Apparent_Kd_M: 4.98E-11

Real

Aptamer SeqId:4209-60;Target:DRG-1;UniProt:Q9NP79

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4209-60;Target: DRG-1;UniProt: Q9NP79;TargetFullName: Vacuolar protein sorting-associated protein VTA1 homolog;Organisim: human;Apparent_Kd_M: 2.15E-12

Real

Aptamer SeqId: 4209-60 | Target: DRG-1 | UniProt: Q9NP79

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4209-60 | Target: DRG-1 | UniProt: Q9NP79 | TargetFullName: Vacuolar protein sorting-associated protein VTA1 homolog | Organisim: human | Apparent_Kd_M: 2.15E-12

Real

Aptamer SeqId:4212-5;Target:EP15R;UniProt:Q9UBC2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4212-5;Target: EP15R;UniProt: Q9UBC2;TargetFullName: Epidermal growth factor receptor substrate 15-like 1;Organisim: human;Apparent_Kd_M: 7.55E-11

Real

Aptamer SeqId: 4212-5 | Target: EP15R | UniProt: Q9UBC2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4212-5 | Target: EP15R | UniProt: Q9UBC2 | TargetFullName: Epidermal growth factor receptor substrate 15-like 1 | Organisim: human | Apparent_Kd_M: 7.55E-11

Real

Aptamer SeqId:4217-49;Target:ERAB;UniProt:Q99714

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4217-49;Target: ERAB;UniProt: Q99714;TargetFullName: 3-hydroxyacyl-CoA dehydrogenase type-2;Organisim: human;Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId: 4217-49 | Target: ERAB | UniProt: Q99714

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4217-49 | Target: ERAB | UniProt: Q99714 | TargetFullName: 3-hydroxyacyl-CoA dehydrogenase type-2 | Organisim: human | Apparent_Kd_M: 2.79E-11

Real

Aptamer SeqId:4220-39;Target:FER;UniProt:P16591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4220-39;Target: FER;UniProt: P16591;TargetFullName: Tyrosine-protein kinase Fer;Organisim: human;Apparent_Kd_M: 1.57E-12

Real

Aptamer SeqId: 4220-39 | Target: FER | UniProt: P16591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4220-39 | Target: FER | UniProt: P16591 | TargetFullName: Tyrosine-protein kinase Fer | Organisim: human | Apparent_Kd_M: 1.57E-12

Real

Aptamer SeqId:4224-7;Target:HNRPQ;UniProt:O60506

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4224-7;Target: HNRPQ;UniProt: O60506;TargetFullName: Heterogeneous nuclear ribonucleoprotein Q;Organisim: human;Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId: 4224-7 | Target: HNRPQ | UniProt: O60506

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4224-7 | Target: HNRPQ | UniProt: O60506 | TargetFullName: Heterogeneous nuclear ribonucleoprotein Q | Organisim: human | Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId:4230-1;Target:IF4G2;UniProt:P78344

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4230-1;Target: IF4G2;UniProt: P78344;TargetFullName: Eukaryotic translation initiation factor 4 gamma 2;Organisim: human;Apparent_Kd_M: 1.31E-10

Real

Aptamer SeqId: 4230-1 | Target: IF4G2 | UniProt: P78344

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4230-1 | Target: IF4G2 | UniProt: P78344 | TargetFullName: Eukaryotic translation initiation factor 4 gamma 2 | Organisim: human | Apparent_Kd_M: 1.31E-10

Real

Aptamer SeqId:4232-19;Target:IGF-I sR;UniProt:P08069

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4232-19;Target: IGF-I sR;UniProt: P08069;TargetFullName: Insulin-like growth factor 1 receptor;Organisim: human;Apparent_Kd_M: 2.65E-11

Real

Aptamer SeqId: 4232-19 | Target: IGF-I sR | UniProt: P08069

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4232-19 | Target: IGF-I sR | UniProt: P08069 | TargetFullName: Insulin-like growth factor 1 receptor | Organisim: human | Apparent_Kd_M: 2.65E-11

Real

Aptamer SeqId:4234-8;Target:IL-1 R4;UniProt:Q01638

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4234-8;Target: IL-1 R4;UniProt: Q01638;TargetFullName: Interleukin-1 receptor-like 1;Organisim: human;Apparent_Kd_M: 3.21E-12

Real

Aptamer SeqId: 4234-8 | Target: IL-1 R4 | UniProt: Q01638

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4234-8 | Target: IL-1 R4 | UniProt: Q01638 | TargetFullName: Interleukin-1 receptor-like 1 | Organisim: human | Apparent_Kd_M: 3.21E-12

Real

Aptamer SeqId:4237-70;Target:LCMT1;UniProt:Q9UIC8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4237-70;Target: LCMT1;UniProt: Q9UIC8;TargetFullName: Leucine carboxyl methyltransferase 1;Organisim: human;Apparent_Kd_M: 5.98E-11

Real

Aptamer SeqId: 4237-70 | Target: LCMT1 | UniProt: Q9UIC8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4237-70 | Target: LCMT1 | UniProt: Q9UIC8 | TargetFullName: Leucine carboxyl methyltransferase 1 | Organisim: human | Apparent_Kd_M: 5.98E-11

Real

Aptamer SeqId:4240-31;Target:M2-PK;UniProt:P14618

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4240-31;Target: M2-PK;UniProt: P14618;TargetFullName: Pyruvate kinase PKM;Organisim: human;Apparent_Kd_M: 1.42E-11

Real

Aptamer SeqId: 4240-31 | Target: M2-PK | UniProt: P14618

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4240-31 | Target: M2-PK | UniProt: P14618 | TargetFullName: Pyruvate kinase PKM | Organisim: human | Apparent_Kd_M: 1.42E-11

Real

Aptamer SeqId:4246-40;Target:NCAM-L1;UniProt:P32004

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4246-40;Target: NCAM-L1;UniProt: P32004;TargetFullName: Neural cell adhesion molecule L1;Organisim: human;Apparent_Kd_M: 1.85E-11

Real

Aptamer SeqId: 4246-40 | Target: NCAM-L1 | UniProt: P32004

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4246-40 | Target: NCAM-L1 | UniProt: P32004 | TargetFullName: Neural cell adhesion molecule L1 | Organisim: human | Apparent_Kd_M: 1.85E-11

Real

Aptamer SeqId:4249-64;Target:NDP kinase B;UniProt:P22392

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4249-64;Target: NDP kinase B;UniProt: P22392;TargetFullName: Nucleoside diphosphate kinase B;Organisim: human;Apparent_Kd_M: 9.0E-12

Real

Aptamer SeqId: 4249-64 | Target: NDP kinase B | UniProt: P22392

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4249-64 | Target: NDP kinase B | UniProt: P22392 | TargetFullName: Nucleoside diphosphate kinase B | Organisim: human | Apparent_Kd_M: 9.0E-12

Real

Aptamer SeqId:4250-23;Target:NSF1C;UniProt:Q9UNZ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4250-23;Target: NSF1C;UniProt: Q9UNZ2;TargetFullName: NSFL1 cofactor p47;Organisim: human;Apparent_Kd_M: 2.6E-11

Real

Aptamer SeqId: 4250-23 | Target: NSF1C | UniProt: Q9UNZ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4250-23 | Target: NSF1C | UniProt: Q9UNZ2 | TargetFullName: NSFL1 cofactor p47 | Organisim: human | Apparent_Kd_M: 2.6E-11

Real

Aptamer SeqId:4254-6;Target:NUDC3;UniProt:Q8IVD9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4254-6;Target: NUDC3;UniProt: Q8IVD9;TargetFullName: NudC domain-containing protein 3;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 4254-6 | Target: NUDC3 | UniProt: Q8IVD9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4254-6 | Target: NUDC3 | UniProt: Q8IVD9 | TargetFullName: NudC domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:4258-15;Target:PA2G4;UniProt:Q9UQ80

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4258-15;Target: PA2G4;UniProt: Q9UQ80;TargetFullName: Proliferation-associated protein 2G4;Organisim: human;Apparent_Kd_M: 4.16E-12

Real

Aptamer SeqId: 4258-15 | Target: PA2G4 | UniProt: Q9UQ80

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4258-15 | Target: PA2G4 | UniProt: Q9UQ80 | TargetFullName: Proliferation-associated protein 2G4 | Organisim: human | Apparent_Kd_M: 4.16E-12

Real

Aptamer SeqId:4261-55;Target:paraoxonase 1;UniProt:P27169

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4261-55;Target: paraoxonase 1;UniProt: P27169;TargetFullName: Serum paraoxonase/arylesterase 1;Organisim: human;Apparent_Kd_M: 2.18E-11

Real

Aptamer SeqId: 4261-55 | Target: paraoxonase 1 | UniProt: P27169

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4261-55 | Target: paraoxonase 1 | UniProt: P27169 | TargetFullName: Serum paraoxonase/arylesterase 1 | Organisim: human | Apparent_Kd_M: 2.18E-11

Real

Aptamer SeqId:4267-81;Target:PESC;UniProt:O00541

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4267-81;Target: PESC;UniProt: O00541;TargetFullName: Pescadillo homolog;Organisim: human;Apparent_Kd_M: 9.64E-11

Real

Aptamer SeqId: 4267-81 | Target: PESC | UniProt: O00541

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4267-81 | Target: PESC | UniProt: O00541 | TargetFullName: Pescadillo homolog | Organisim: human | Apparent_Kd_M: 9.64E-11

Real

Aptamer SeqId:4271-75;Target:PFD5;UniProt:Q99471

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4271-75;Target: PFD5;UniProt: Q99471;TargetFullName: Prefoldin subunit 5;Organisim: human;Apparent_Kd_M: 3.51E-12

Real

Aptamer SeqId: 4271-75 | Target: PFD5 | UniProt: Q99471

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4271-75 | Target: PFD5 | UniProt: Q99471 | TargetFullName: Prefoldin subunit 5 | Organisim: human | Apparent_Kd_M: 3.51E-12

Real

Aptamer SeqId:4272-46;Target:PHI;UniProt:P06744

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4272-46;Target: PHI;UniProt: P06744;TargetFullName: Glucose-6-phosphate isomerase;Organisim: human;Apparent_Kd_M: 1.44E-10

Real

Aptamer SeqId: 4272-46 | Target: PHI | UniProt: P06744

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4272-46 | Target: PHI | UniProt: P06744 | TargetFullName: Glucose-6-phosphate isomerase | Organisim: human | Apparent_Kd_M: 1.44E-10

Real

Aptamer SeqId:4276-10;Target:prostatic binding protein;UniProt:P30086

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4276-10;Target: prostatic binding protein;UniProt: P30086;TargetFullName: Phosphatidylethanolamine-binding protein 1;Organisim: human;Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId: 4276-10 | Target: prostatic binding protein

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4276-10 | Target: prostatic binding protein | UniProt: P30086 | TargetFullName: Phosphatidylethanolamine-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId:4278-14;Target:Protein disulfide-isomerase;UniProt:P07237

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4278-14;Target: Protein disulfide-isomerase;UniProt: P07237;TargetFullName: Protein disulfide-isomerase;Organisim: human;Apparent_Kd_M: 1.33E-9

Real

Aptamer SeqId: 4278-14 | Target: Protein disulfide-isomerase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4278-14 | Target: Protein disulfide-isomerase | UniProt: P07237 | TargetFullName: Protein disulfide-isomerase | Organisim: human | Apparent_Kd_M: 1.33E-9

Real

Aptamer SeqId:4280-47;Target:PSA2;UniProt:P25787

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4280-47;Target: PSA2;UniProt: P25787;TargetFullName: Proteasome subunit alpha type-2;Organisim: human;Apparent_Kd_M: 6.05E-12

Real

Aptamer SeqId: 4280-47 | Target: PSA2 | UniProt: P25787

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4280-47 | Target: PSA2 | UniProt: P25787 | TargetFullName: Proteasome subunit alpha type-2 | Organisim: human | Apparent_Kd_M: 6.05E-12

Real

Aptamer SeqId:4282-3;Target:RAN;UniProt:P62826

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4282-3;Target: RAN;UniProt: P62826;TargetFullName: GTP-binding nuclear protein Ran;Organisim: human;Apparent_Kd_M: 7.03E-12

Real

Aptamer SeqId: 4282-3 | Target: RAN | UniProt: P62826

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4282-3 | Target: RAN | UniProt: P62826 | TargetFullName: GTP-binding nuclear protein Ran | Organisim: human | Apparent_Kd_M: 7.03E-12

Real

Aptamer SeqId:4284-18;Target:RBM39;UniProt:Q14498

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4284-18;Target: RBM39;UniProt: Q14498;TargetFullName: RNA-binding protein 39;Organisim: human;Apparent_Kd_M: 8.74E-12

Real

Aptamer SeqId: 4284-18 | Target: RBM39 | UniProt: Q14498

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4284-18 | Target: RBM39 | UniProt: Q14498 | TargetFullName: RNA-binding protein 39 | Organisim: human | Apparent_Kd_M: 8.74E-12

Real

Aptamer SeqId:4292-5;Target:SNAA;UniProt:P54920

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4292-5;Target: SNAA;UniProt: P54920;TargetFullName: Alpha-soluble NSF attachment protein;Organisim: human;Apparent_Kd_M: 1.4E-12

Real

Aptamer SeqId: 4292-5 | Target: SNAA | UniProt: P54920

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4292-5 | Target: SNAA | UniProt: P54920 | TargetFullName: Alpha-soluble NSF attachment protein | Organisim: human | Apparent_Kd_M: 1.4E-12

Real

Aptamer SeqId:4294-16;Target:Sphingosine kinase 1;UniProt:Q9NYA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4294-16;Target: Sphingosine kinase 1;UniProt: Q9NYA1;TargetFullName: Sphingosine kinase 1;Organisim: human;Apparent_Kd_M: 2.5E-12

Real

Aptamer SeqId: 4294-16 | Target: Sphingosine kinase 1 | UniProt: Q9NYA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4294-16 | Target: Sphingosine kinase 1 | UniProt: Q9NYA1 | TargetFullName: Sphingosine kinase 1 | Organisim: human | Apparent_Kd_M: 2.5E-12

Real

Aptamer SeqId:4297-62;Target:Spondin-1;UniProt:Q9HCB6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4297-62;Target: Spondin-1;UniProt: Q9HCB6;TargetFullName: Spondin-1;Organisim: human;Apparent_Kd_M: 4.13E-12

Real

Aptamer SeqId: 4297-62 | Target: Spondin-1 | UniProt: Q9HCB6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4297-62 | Target: Spondin-1 | UniProt: Q9HCB6 | TargetFullName: Spondin-1 | Organisim: human | Apparent_Kd_M: 4.13E-12

Real

Aptamer SeqId:4301-58;Target:Thymidine kinase;UniProt:P04183

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4301-58;Target: Thymidine kinase;UniProt: P04183;TargetFullName: Thymidine kinase; cytosolic;Organisim: human;Apparent_Kd_M: 8.39E-11

Real

Aptamer SeqId: 4301-58 | Target: Thymidine kinase | UniProt: P04183

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4301-58 | Target: Thymidine kinase | UniProt: P04183 | TargetFullName: Thymidine kinase; cytosolic | Organisim: human | Apparent_Kd_M: 8.39E-11

Real

Aptamer SeqId:4304-18;Target:transcription factor MLR1;UniProt:Q8N3X6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4304-18;Target: transcription factor MLR1; isoform CRA_b;UniProt: Q8N3X6;TargetFullName: Ligand-dependent nuclear receptor corepressor-like protein;Organisim: human;Apparent_Kd_M: 8.98E-12

Real

Aptamer SeqId: 4304-18 | Target: transcription factor MLR1 isoform CRA_b

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4304-18 | Target: transcription factor MLR1; isoform CRA_b | UniProt: Q8N3X6 | TargetFullName: Ligand-dependent nuclear receptor corepressor-like protein | Organisim: human | Apparent_Kd_M: 8.98E-12

Real

Aptamer SeqId:4306-4;Target:Transketolase;UniProt:P29401

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4306-4;Target: Transketolase;UniProt: P29401;TargetFullName: Transketolase;Organisim: human;Apparent_Kd_M: 2.88E-12

Real

Aptamer SeqId: 4306-4 | Target: Transketolase | UniProt: P29401

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4306-4 | Target: Transketolase | UniProt: P29401 | TargetFullName: Transketolase | Organisim: human | Apparent_Kd_M: 2.88E-12

Real

Aptamer SeqId:4309-59;Target:Triosephosphate isomerase;UniProt:P60174

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4309-59;Target: Triosephosphate isomerase;UniProt: P60174;TargetFullName: Triosephosphate isomerase;Organisim: human;Apparent_Kd_M: 1.14E-11

Real

Aptamer SeqId: 4309-59 | Target: Triosephosphate isomerase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4309-59 | Target: Triosephosphate isomerase | UniProt: P60174 | TargetFullName: Triosephosphate isomerase | Organisim: human | Apparent_Kd_M: 1.14E-11

Real

Aptamer SeqId:4314-12;Target:XTP3A;UniProt:Q9H773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4314-12;Target: XTP3A;UniProt: Q9H773;TargetFullName: dCTP pyrophosphatase 1;Organisim: human;Apparent_Kd_M: 5.35E-12

Real

Aptamer SeqId: 4314-12 | Target: XTP3A | UniProt: Q9H773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4314-12 | Target: XTP3A | UniProt: Q9H773 | TargetFullName: dCTP pyrophosphatase 1 | Organisim: human | Apparent_Kd_M: 5.35E-12

Real

Aptamer SeqId:4318-12;Target:PTP-1C;UniProt:P29350

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4318-12;Target: PTP-1C;UniProt: P29350;TargetFullName: Tyrosine-protein phosphatase non-receptor type 6;Organisim: human;Apparent_Kd_M: 3.79E-12

Real

Aptamer SeqId: 4318-12 | Target: PTP-1C | UniProt: P29350

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4318-12 | Target: PTP-1C | UniProt: P29350 | TargetFullName: Tyrosine-protein phosphatase non-receptor type 6 | Organisim: human | Apparent_Kd_M: 3.79E-12

Real

Aptamer SeqId:4322-28;Target:AMNLS;UniProt:Q9BXJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4322-28;Target: AMNLS;UniProt: Q9BXJ7;TargetFullName: Protein amnionless;Organisim: human;Apparent_Kd_M: 1.38E-10

Real

Aptamer SeqId: 4322-28 | Target: AMNLS | UniProt: Q9BXJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4322-28 | Target: AMNLS | UniProt: Q9BXJ7 | TargetFullName: Protein amnionless | Organisim: human | Apparent_Kd_M: 1.38E-10

Real

Aptamer SeqId:4324-33;Target:CYTT;UniProt:P09228

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4324-33;Target: CYTT;UniProt: P09228;TargetFullName: Cystatin-SA;Organisim: human;Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId: 4324-33 | Target: CYTT | UniProt: P09228

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4324-33 | Target: CYTT | UniProt: P09228 | TargetFullName: Cystatin-SA | Organisim: human | Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId:4328-2;Target:BOC;UniProt:Q9BWV1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4328-2;Target: BOC;UniProt: Q9BWV1;TargetFullName: Brother of CDO;Organisim: human;Apparent_Kd_M: 1.79E-12

Real

Aptamer SeqId: 4328-2 | Target: BOC | UniProt: Q9BWV1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4328-2 | Target: BOC | UniProt: Q9BWV1 | TargetFullName: Brother of CDO | Organisim: human | Apparent_Kd_M: 1.79E-12

Real

Aptamer SeqId:4332-6;Target:CLC1B;UniProt:Q9P126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4332-6;Target: CLC1B;UniProt: Q9P126;TargetFullName: C-type lectin domain family 1 member B;Organisim: human;Apparent_Kd_M: 1.11E-12

Real

Aptamer SeqId: 4332-6 | Target: CLC1B | UniProt: Q9P126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4332-6 | Target: CLC1B | UniProt: Q9P126 | TargetFullName: C-type lectin domain family 1 member B | Organisim: human | Apparent_Kd_M: 1.11E-12

Real

Aptamer SeqId:4337-49;Target:CRP;UniProt:P02741

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4337-49;Target: CRP;UniProt: P02741;TargetFullName: C-reactive protein;Organisim: human;Apparent_Kd_M: 1.89E-11

Real

Aptamer SeqId: 4337-49 | Target: CRP | UniProt: P02741

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4337-49 | Target: CRP | UniProt: P02741 | TargetFullName: C-reactive protein | Organisim: human | Apparent_Kd_M: 1.89E-11

Real

Aptamer SeqId:4342-10;Target:sICAM-1;UniProt:P05362

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4342-10;Target: sICAM-1;UniProt: P05362;TargetFullName: Intercellular adhesion molecule 1;Organisim: human;Apparent_Kd_M: 6.38E-11

Real

Aptamer SeqId: 4342-10 | Target: sICAM-1 | UniProt: P05362

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4342-10 | Target: sICAM-1 | UniProt: P05362 | TargetFullName: Intercellular adhesion molecule 1 | Organisim: human | Apparent_Kd_M: 6.38E-11

Real

Aptamer SeqId:4355-13;Target:DAPK2;UniProt:Q9UIK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4355-13;Target: DAPK2;UniProt: Q9UIK4;TargetFullName: Death-associated protein kinase 2;Organisim: human;Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId: 4355-13 | Target: DAPK2 | UniProt: Q9UIK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4355-13 | Target: DAPK2 | UniProt: Q9UIK4 | TargetFullName: Death-associated protein kinase 2 | Organisim: human | Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId:4359-87;Target:DYRK3;UniProt:O43781

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4359-87;Target: DYRK3;UniProt: O43781;TargetFullName: Dual specificity tyrosine-phosphorylation-regulated kinase 3;Organisim: human;Apparent_Kd_M: 5.53E-12

Real

Aptamer SeqId: 4359-87 | Target: DYRK3 | UniProt: O43781

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4359-87 | Target: DYRK3 | UniProt: O43781 | TargetFullName: Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Organisim: human | Apparent_Kd_M: 5.53E-12

Real

Aptamer SeqId:4374-45;Target:MIC-1;UniProt:Q99988

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4374-45;Target: MIC-1;UniProt: Q99988;TargetFullName: Growth/differentiation factor 15;Organisim: human;Apparent_Kd_M: 3.345686E-12

Real

Aptamer SeqId: 4374-45 | Target: MIC-1 | UniProt: Q99988

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4374-45 | Target: MIC-1 | UniProt: Q99988 | TargetFullName: Growth/differentiation factor 15 | Organisim: human | Apparent_Kd_M: 3.345686E-12

Real

Aptamer SeqId:4389-2;Target:DHH;UniProt:O43323

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4389-2;Target: DHH;UniProt: O43323;TargetFullName: Desert hedgehog protein N-product;Organisim: human;Apparent_Kd_M: 2.51E-11

Real

Aptamer SeqId: 4389-2 | Target: DHH | UniProt: O43323

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4389-2 | Target: DHH | UniProt: O43323 | TargetFullName: Desert hedgehog protein N-product | Organisim: human | Apparent_Kd_M: 2.51E-11

Real

Aptamer SeqId:4392-54;Target:FGF-12;UniProt:P61328

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4392-54;Target: FGF-12;UniProt: P61328;TargetFullName: Fibroblast growth factor 12;Organisim: human;Apparent_Kd_M: 4.15E-11

Real

Aptamer SeqId: 4392-54 | Target: FGF-12 | UniProt: P61328

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4392-54 | Target: FGF-12 | UniProt: P61328 | TargetFullName: Fibroblast growth factor 12 | Organisim: human | Apparent_Kd_M: 4.15E-11

Real

Aptamer SeqId:4393-3;Target:FGF-16;UniProt:O43320

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4393-3;Target: FGF-16;UniProt: O43320;TargetFullName: Fibroblast growth factor 16;Organisim: human;Apparent_Kd_M: 3.49E-11

Real

Aptamer SeqId: 4393-3 | Target: FGF-16 | UniProt: O43320

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4393-3 | Target: FGF-16 | UniProt: O43320 | TargetFullName: Fibroblast growth factor 16 | Organisim: human | Apparent_Kd_M: 3.49E-11

Real

Aptamer SeqId:4394-71;Target:FGF-8A;UniProt:P55075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4394-71;Target: FGF-8A;UniProt: P55075;TargetFullName: Fibroblast growth factor 8 isoform A;Organisim: human;Apparent_Kd_M: 1.08E-10

Real

Aptamer SeqId: 4394-71 | Target: FGF-8A | UniProt: P55075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4394-71 | Target: FGF-8A | UniProt: P55075 | TargetFullName: Fibroblast growth factor 8 isoform A | Organisim: human | Apparent_Kd_M: 1.08E-10

Real

Aptamer SeqId:4396-54;Target:IFN-lambda 1;UniProt:Q8IU54

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4396-54;Target: IFN-lambda 1;UniProt: Q8IU54;TargetFullName: Interferon lambda-1;Organisim: human;Apparent_Kd_M: 1.08E-12

Real

Aptamer SeqId: 4396-54 | Target: IFN-lambda 1 | UniProt: Q8IU54

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4396-54 | Target: IFN-lambda 1 | UniProt: Q8IU54 | TargetFullName: Interferon lambda-1 | Organisim: human | Apparent_Kd_M: 1.08E-12

Real

Aptamer SeqId:4397-26;Target:IFN-lambda 2;UniProt:Q8IZJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4397-26;Target: IFN-lambda 2;UniProt: Q8IZJ0;TargetFullName: Interferon lambda-2;Organisim: human;Apparent_Kd_M: 5.22E-12

Real

Aptamer SeqId: 4397-26 | Target: IFN-lambda 2 | UniProt: Q8IZJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4397-26 | Target: IFN-lambda 2 | UniProt: Q8IZJ0 | TargetFullName: Interferon lambda-2 | Organisim: human | Apparent_Kd_M: 5.22E-12

Real

Aptamer SeqId:4407-10;Target:MSP;UniProt:P26927

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4407-10;Target: MSP;UniProt: P26927;TargetFullName: Hepatocyte growth factor-like protein;Organisim: human;Apparent_Kd_M: 3.72E-12

Real

Aptamer SeqId: 4407-10 | Target: MSP | UniProt: P26927

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4407-10 | Target: MSP | UniProt: P26927 | TargetFullName: Hepatocyte growth factor-like protein | Organisim: human | Apparent_Kd_M: 3.72E-12

Real

Aptamer SeqId:4413-3;Target:SLPI;UniProt:P03973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4413-3;Target: SLPI;UniProt: P03973;TargetFullName: Antileukoproteinase;Organisim: human;Apparent_Kd_M: 6.52E-12

Real

Aptamer SeqId: 4413-3 | Target: SLPI | UniProt: P03973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4413-3 | Target: SLPI | UniProt: P03973 | TargetFullName: Antileukoproteinase | Organisim: human | Apparent_Kd_M: 6.52E-12

Real

Aptamer SeqId:4420-7;Target:ADAM12;UniProt:O43184

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4420-7;Target: ADAM12;UniProt: O43184;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 12;Organisim: human;Apparent_Kd_M: 4.49E-11

Real

Aptamer SeqId: 4420-7 | Target: ADAM12 | UniProt: O43184

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4420-7 | Target: ADAM12 | UniProt: O43184 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 12 | Organisim: human | Apparent_Kd_M: 4.49E-11

Real

Aptamer SeqId:4423-77;Target:BCL2-like 1 protein;UniProt:Q07817

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4423-77;Target: BCL2-like 1 protein;UniProt: Q07817;TargetFullName: Bcl-2-like protein 1;Organisim: human;Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId: 4423-77 | Target: BCL2-like 1 protein | UniProt: Q07817

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4423-77 | Target: BCL2-like 1 protein | UniProt: Q07817 | TargetFullName: Bcl-2-like protein 1 | Organisim: human | Apparent_Kd_M: 1.49E-11

Real

Aptamer SeqId:4429-51;Target:CHST6;UniProt:Q9GZX3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4429-51;Target: CHST6;UniProt: Q9GZX3;TargetFullName: Carbohydrate sulfotransferase 6;Organisim: human;Apparent_Kd_M: 1.07E-10

Real

Aptamer SeqId: 4429-51 | Target: CHST6 | UniProt: Q9GZX3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4429-51 | Target: CHST6 | UniProt: Q9GZX3 | TargetFullName: Carbohydrate sulfotransferase 6 | Organisim: human | Apparent_Kd_M: 1.07E-10

Real

Aptamer SeqId:4430-44;Target:Collectin Kidney 1;UniProt:Q9BWP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4430-44;Target: Collectin Kidney 1;UniProt: Q9BWP8;TargetFullName: Collectin-11;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 4430-44 | Target: Collectin Kidney 1 | UniProt: Q9BWP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4430-44 | Target: Collectin Kidney 1 | UniProt: Q9BWP8 | TargetFullName: Collectin-11 | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:4435-66;Target:ENPP7;UniProt:Q6UWV6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4435-66;Target: ENPP7;UniProt: Q6UWV6;TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 7;Organisim: human;Apparent_Kd_M: 4.89E-12

Real

Aptamer SeqId: 4435-66 | Target: ENPP7 | UniProt: Q6UWV6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4435-66 | Target: ENPP7 | UniProt: Q6UWV6 | TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 | Organisim: human | Apparent_Kd_M: 4.89E-12

Real

Aptamer SeqId:4436-1;Target:ENTP3;UniProt:O75355

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4436-1;Target: ENTP3;UniProt: O75355;TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 3;Organisim: human;Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId: 4436-1 | Target: ENTP3 | UniProt: O75355

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4436-1 | Target: ENTP3 | UniProt: O75355 | TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 3 | Organisim: human | Apparent_Kd_M: 1.77E-11

Real

Aptamer SeqId:4437-56;Target:ENTP5;UniProt:O75356

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4437-56;Target: ENTP5;UniProt: O75356;TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 5;Organisim: human;Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId: 4437-56 | Target: ENTP5 | UniProt: O75356

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4437-56 | Target: ENTP5 | UniProt: O75356 | TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 5 | Organisim: human | Apparent_Kd_M: 3.12E-12

Real

Aptamer SeqId:4440-15;Target:FCRL3;UniProt:Q96P31

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4440-15;Target: FCRL3;UniProt: Q96P31;TargetFullName: Fc receptor-like protein 3;Organisim: human;Apparent_Kd_M: 8.27E-12

Real

Aptamer SeqId: 4440-15 | Target: FCRL3 | UniProt: Q96P31

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4440-15 | Target: FCRL3 | UniProt: Q96P31 | TargetFullName: Fc receptor-like protein 3 | Organisim: human | Apparent_Kd_M: 8.27E-12

Real

Aptamer SeqId:4453-83;Target:LRRT3;UniProt:Q86VH5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4453-83;Target: LRRT3;UniProt: Q86VH5;TargetFullName: Leucine-rich repeat transmembrane neuronal protein 3;Organisim: human;Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId: 4453-83 | Target: LRRT3 | UniProt: Q86VH5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4453-83 | Target: LRRT3 | UniProt: Q86VH5 | TargetFullName: Leucine-rich repeat transmembrane neuronal protein 3 | Organisim: human | Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId:4455-89;Target:MFGM;UniProt:Q08431

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4455-89;Target: MFGM;UniProt: Q08431;TargetFullName: Lactadherin;Organisim: human;Apparent_Kd_M: 1.92E-11

Real

Aptamer SeqId: 4455-89 | Target: MFGM | UniProt: Q08431

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4455-89 | Target: MFGM | UniProt: Q08431 | TargetFullName: Lactadherin | Organisim: human | Apparent_Kd_M: 1.92E-11

Real

Aptamer SeqId:4459-68;Target:PCSK7;UniProt:Q16549

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4459-68;Target: PCSK7;UniProt: Q16549;TargetFullName: Proprotein convertase subtilisin/kexin type 7;Organisim: human;Apparent_Kd_M: 6.38E-12

Real

Aptamer SeqId: 4459-68 | Target: PCSK7 | UniProt: Q16549

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4459-68 | Target: PCSK7 | UniProt: Q16549 | TargetFullName: Proprotein convertase subtilisin/kexin type 7 | Organisim: human | Apparent_Kd_M: 6.38E-12

Real

Aptamer SeqId:4460-8;Target:PDPK1;UniProt:O15530

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4460-8;Target: PDPK1;UniProt: O15530;TargetFullName: 3-phosphoinositide-dependent protein kinase 1;Organisim: human;Apparent_Kd_M: 1.16E-12

Real

Aptamer SeqId: 4460-8 | Target: PDPK1 | UniProt: O15530

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4460-8 | Target: PDPK1 | UniProt: O15530 | TargetFullName: 3-phosphoinositide-dependent protein kinase 1 | Organisim: human | Apparent_Kd_M: 1.16E-12

Real

Aptamer SeqId:4464-10;Target:Sialoadhesin;UniProt:Q9BZZ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4464-10;Target: Sialoadhesin;UniProt: Q9BZZ2;TargetFullName: Sialoadhesin;Organisim: human;Apparent_Kd_M: 3.842279E-11

Real

Aptamer SeqId: 4464-10 | Target: Sialoadhesin | UniProt: Q9BZZ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4464-10 | Target: Sialoadhesin | UniProt: Q9BZZ2 | TargetFullName: Sialoadhesin | Organisim: human | Apparent_Kd_M: 3.842279E-11

Real

Aptamer SeqId:4467-49;Target:SPARCL1;UniProt:Q14515

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4467-49;Target: SPARCL1;UniProt: Q14515;TargetFullName: SPARC-like protein 1;Organisim: human;Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId: 4467-49 | Target: SPARCL1 | UniProt: Q14515

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4467-49 | Target: SPARCL1 | UniProt: Q14515 | TargetFullName: SPARC-like protein 1 | Organisim: human | Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId:4468-21;Target:SPHK2;UniProt:Q9NRA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4468-21;Target: SPHK2;UniProt: Q9NRA0;TargetFullName: Sphingosine kinase 2;Organisim: human;Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId: 4468-21 | Target: SPHK2 | UniProt: Q9NRA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4468-21 | Target: SPHK2 | UniProt: Q9NRA0 | TargetFullName: Sphingosine kinase 2 | Organisim: human | Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId:4469-78;Target:ST4S6;UniProt:Q7LFX5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4469-78;Target: ST4S6;UniProt: Q7LFX5;TargetFullName: Carbohydrate sulfotransferase 15;Organisim: human;Apparent_Kd_M: 6.28E-12

Real

Aptamer SeqId: 4469-78 | Target: ST4S6 | UniProt: Q7LFX5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4469-78 | Target: ST4S6 | UniProt: Q7LFX5 | TargetFullName: Carbohydrate sulfotransferase 15 | Organisim: human | Apparent_Kd_M: 6.28E-12

Real

Aptamer SeqId:4471-50;Target:TGM3;UniProt:Q08188

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4471-50;Target: TGM3;UniProt: Q08188;TargetFullName: Protein-glutamine gamma-glutamyltransferase E;Organisim: human;Apparent_Kd_M: 2.94E-12

Real

Aptamer SeqId: 4471-50 | Target: TGM3 | UniProt: Q08188

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4471-50 | Target: TGM3 | UniProt: Q08188 | TargetFullName: Protein-glutamine gamma-glutamyltransferase E | Organisim: human | Apparent_Kd_M: 2.94E-12

Real

Aptamer SeqId:4472-5;Target:Tropomyosin 2;UniProt:P07951

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4472-5;Target: Tropomyosin 2;UniProt: P07951;TargetFullName: Tropomyosin beta chain;Organisim: human;Apparent_Kd_M: 8.49E-11

Real

Aptamer SeqId: 4472-5 | Target: Tropomyosin 2 | UniProt: P07951

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4472-5 | Target: Tropomyosin 2 | UniProt: P07951 | TargetFullName: Tropomyosin beta chain | Organisim: human | Apparent_Kd_M: 8.49E-11

Real

Aptamer SeqId:4474-19;Target:Ubiquitin;UniProt:P62979

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4474-19;Target: Ubiquitin;UniProt: P62979;TargetFullName: Ubiquitin;Organisim: human;Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId: 4474-19 | Target: Ubiquitin | UniProt: P62979

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4474-19 | Target: Ubiquitin | UniProt: P62979 | TargetFullName: Ubiquitin | Organisim: human | Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId:4476-22;Target:ZAP70;UniProt:P43403

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4476-22;Target: ZAP70;UniProt: P43403;TargetFullName: Tyrosine-protein kinase ZAP-70;Organisim: human;Apparent_Kd_M: 1.72E-11

Real

Aptamer SeqId: 4476-22 | Target: ZAP70 | UniProt: P43403

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4476-22 | Target: ZAP70 | UniProt: P43403 | TargetFullName: Tyrosine-protein kinase ZAP-70 | Organisim: human | Apparent_Kd_M: 1.72E-11

Real

Aptamer SeqId:4479-14;Target:C1-Esterase Inhibitor;UniProt:P05155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4479-14;Target: C1-Esterase Inhibitor;UniProt: P05155;TargetFullName: Plasma protease C1 inhibitor;Organisim: human;Apparent_Kd_M: 5.28E-11

Real

Aptamer SeqId: 4479-14 | Target: C1-Esterase Inhibitor | UniProt: P05155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4479-14 | Target: C1-Esterase Inhibitor | UniProt: P05155 | TargetFullName: Plasma protease C1 inhibitor | Organisim: human | Apparent_Kd_M: 5.28E-11

Real

Aptamer SeqId:4480-59;Target:C3b;UniProt:P01024

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4480-59;Target: C3b;UniProt: P01024;TargetFullName: Complement C3b;Organisim: human;Apparent_Kd_M: 4.08E-11

Real

Aptamer SeqId: 4480-59 | Target: C3b | UniProt: P01024

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4480-59 | Target: C3b | UniProt: P01024 | TargetFullName: Complement C3b | Organisim: human | Apparent_Kd_M: 4.08E-11

Real

Aptamer SeqId:4481-34;Target:C4;UniProt:P0C0L4|P0C0L5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4481-34;Target: C4;UniProt: P0C0L4|P0C0L5;TargetFullName: Complement C4;Organisim: human;Apparent_Kd_M: 5.37E-12

Real

Aptamer SeqId: 4481-34 | Target: C4 | UniProt: P0C0L4|P0C0L5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4481-34 | Target: C4 | UniProt: P0C0L4|P0C0L5 | TargetFullName: Complement C4 | Organisim: human | Apparent_Kd_M: 5.37E-12

Real

Aptamer SeqId:4482-66;Target:C5b; 6 Complex;UniProt:P01031|P13671

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4482-66;Target: C5b; 6 Complex;UniProt: P01031|P13671;TargetFullName: Complement C5b-C6 complex;Organisim: human;Apparent_Kd_M: 6.57E-13

Real

Aptamer SeqId: 4482-66 | Target: C5b; 6 Complex | UniProt: P01031|P13671

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4482-66 | Target: C5b; 6 Complex | UniProt: P01031|P13671 | TargetFullName: Complement C5b-C6 complex | Organisim: human | Apparent_Kd_M: 6.57E-13

Real

Aptamer SeqId:4487-1;Target:FGF7;UniProt:P21781

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4487-1;Target: FGF7;UniProt: P21781;TargetFullName: Fibroblast growth factor 7;Organisim: human;Apparent_Kd_M: 5.23E-12

Real

Aptamer SeqId: 4487-1 | Target: FGF7 | UniProt: P21781

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4487-1 | Target: FGF7 | UniProt: P21781 | TargetFullName: Fibroblast growth factor 7 | Organisim: human | Apparent_Kd_M: 5.23E-12

Real

Aptamer SeqId:4493-92;Target:IL-11;UniProt:P20809

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4493-92;Target: IL-11;UniProt: P20809;TargetFullName: Interleukin-11;Organisim: human;Apparent_Kd_M: 1.67E-12

Real

Aptamer SeqId: 4493-92 | Target: IL-11 | UniProt: P20809

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4493-92 | Target: IL-11 | UniProt: P20809 | TargetFullName: Interleukin-11 | Organisim: human | Apparent_Kd_M: 1.67E-12

Real

Aptamer SeqId:4496-60;Target:MMP-12;UniProt:P39900

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4496-60;Target: MMP-12;UniProt: P39900;TargetFullName: Macrophage metalloelastase;Organisim: human;Apparent_Kd_M: 1.49E-12

Real

Aptamer SeqId: 4496-60 | Target: MMP-12 | UniProt: P39900

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4496-60 | Target: MMP-12 | UniProt: P39900 | TargetFullName: Macrophage metalloelastase | Organisim: human | Apparent_Kd_M: 1.49E-12

Real

Aptamer SeqId:4498-62;Target:NCAM-120;UniProt:P13591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4498-62;Target: NCAM-120;UniProt: P13591;TargetFullName: Neural cell adhesion molecule 1; 120 kDa isoform;Organisim: human;Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId: 4498-62 | Target: NCAM-120 | UniProt: P13591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4498-62 | Target: NCAM-120 | UniProt: P13591 | TargetFullName: Neural cell adhesion molecule 1; 120 kDa isoform | Organisim: human | Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId:4499-21;Target:PDGF-AA;UniProt:P04085

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4499-21;Target: PDGF-AA;UniProt: P04085;TargetFullName: Platelet-derived growth factor subunit A;Organisim: human;Apparent_Kd_M: 2.72E-11

Real

Aptamer SeqId: 4499-21 | Target: PDGF-AA | UniProt: P04085

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4499-21 | Target: PDGF-AA | UniProt: P04085 | TargetFullName: Platelet-derived growth factor subunit A | Organisim: human | Apparent_Kd_M: 2.72E-11

Real

Aptamer SeqId:4500-50;Target:SCGF-alpha;UniProt:Q9Y240

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4500-50;Target: SCGF-alpha;UniProt: Q9Y240;TargetFullName: Stem cell growth factor-alpha;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 4500-50 | Target: SCGF-alpha | UniProt: Q9Y240

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4500-50 | Target: SCGF-alpha | UniProt: Q9Y240 | TargetFullName: Stem cell growth factor-alpha | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:4533-76;Target:ATS15;UniProt:Q8TE58

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4533-76;Target: ATS15;UniProt: Q8TE58;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 15;Organisim: human;Apparent_Kd_M: 5.372008E-11

Real

Aptamer SeqId: 4533-76 | Target: ATS15 | UniProt: Q8TE58

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4533-76 | Target: ATS15 | UniProt: Q8TE58 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 15 | Organisim: human | Apparent_Kd_M: 5.372008E-11

Real

Aptamer SeqId:4534-10;Target:BSSP4;UniProt:Q9GZN4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4534-10;Target: BSSP4;UniProt: Q9GZN4;TargetFullName: Brain-specific serine protease 4;Organisim: human;Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId: 4534-10 | Target: BSSP4 | UniProt: Q9GZN4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4534-10 | Target: BSSP4 | UniProt: Q9GZN4 | TargetFullName: Brain-specific serine protease 4 | Organisim: human | Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId:4535-50;Target:BST1;UniProt:Q10588

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4535-50;Target: BST1;UniProt: Q10588;TargetFullName: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2;Organisim: human;Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId: 4535-50 | Target: BST1 | UniProt: Q10588

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4535-50 | Target: BST1 | UniProt: Q10588 | TargetFullName: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 | Organisim: human | Apparent_Kd_M: 1.26E-11

Real

Aptamer SeqId:4540-11;Target:CBX5;UniProt:P45973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4540-11;Target: CBX5;UniProt: P45973;TargetFullName: Chromobox protein homolog 5;Organisim: human;Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId: 4540-11 | Target: CBX5 | UniProt: P45973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4540-11 | Target: CBX5 | UniProt: P45973 | TargetFullName: Chromobox protein homolog 5 | Organisim: human | Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId:4541-49;Target:CDON;UniProt:Q4KMG0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4541-49;Target: CDON;UniProt: Q4KMG0;TargetFullName: Cell adhesion molecule-related/down-regulated by oncogenes;Organisim: human;Apparent_Kd_M: 2.39E-12

Real

Aptamer SeqId: 4541-49 | Target: CDON | UniProt: Q4KMG0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4541-49 | Target: CDON | UniProt: Q4KMG0 | TargetFullName: Cell adhesion molecule-related/down-regulated by oncogenes | Organisim: human | Apparent_Kd_M: 2.39E-12

Real

Aptamer SeqId:4542-24;Target:Clusterin;UniProt:P10909

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4542-24;Target: Clusterin;UniProt: P10909;TargetFullName: Clusterin;Organisim: human;Apparent_Kd_M: 5.95E-11

Real

Aptamer SeqId: 4542-24 | Target: Clusterin | UniProt: P10909

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4542-24 | Target: Clusterin | UniProt: P10909 | TargetFullName: Clusterin | Organisim: human | Apparent_Kd_M: 5.95E-11

Real

Aptamer SeqId:4543-65;Target:CONA1;UniProt:Q86Y22

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4543-65;Target: CONA1;UniProt: Q86Y22;TargetFullName: Collagen alpha-1(XXIII) chain;Organisim: human;Apparent_Kd_M: 1.43E-10

Real

Aptamer SeqId: 4543-65 | Target: CONA1 | UniProt: Q86Y22

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4543-65 | Target: CONA1 | UniProt: Q86Y22 | TargetFullName: Collagen alpha-1(XXIII) chain | Organisim: human | Apparent_Kd_M: 1.43E-10

Real

Aptamer SeqId:4544-4;Target:CTAP-III;UniProt:P02775

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4544-4;Target: CTAP-III;UniProt: P02775;TargetFullName: Connective tissue-activating peptide III;Organisim: human;Apparent_Kd_M: 3.68E-12

Real

Aptamer SeqId: 4544-4 | Target: CTAP-III | UniProt: P02775

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4544-4 | Target: CTAP-III | UniProt: P02775 | TargetFullName: Connective tissue-activating peptide III | Organisim: human | Apparent_Kd_M: 3.68E-12

Real

Aptamer SeqId:4545-53;Target:DnaJ homolog;UniProt:Q96DA6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4545-53;Target: DnaJ homolog;UniProt: Q96DA6;TargetFullName: Mitochondrial import inner membrane translocase subunit TIM14;Organisim: human;Apparent_Kd_M: 4.22E-12

Real

Aptamer SeqId: 4545-53 | Target: DnaJ homolog | UniProt: Q96DA6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4545-53 | Target: DnaJ homolog | UniProt: Q96DA6 | TargetFullName: Mitochondrial import inner membrane translocase subunit TIM14 | Organisim: human | Apparent_Kd_M: 4.22E-12

Real

Aptamer SeqId:4546-27;Target:EMR2;UniProt:Q9UHX3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4546-27;Target: EMR2;UniProt: Q9UHX3;TargetFullName: Adhesion G protein-coupled receptor E2;Organisim: human;Apparent_Kd_M: 6.88E-11

Real

Aptamer SeqId: 4546-27 | Target: EMR2 | UniProt: Q9UHX3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4546-27 | Target: EMR2 | UniProt: Q9UHX3 | TargetFullName: Adhesion G protein-coupled receptor E2 | Organisim: human | Apparent_Kd_M: 6.88E-11

Real

Aptamer SeqId:4547-59;Target:FLRT1;UniProt:Q9NZU1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4547-59;Target: FLRT1;UniProt: Q9NZU1;TargetFullName: Leucine-rich repeat transmembrane protein FLRT1;Organisim: human;Apparent_Kd_M: 2.24E-11

Real

Aptamer SeqId: 4547-59 | Target: FLRT1 | UniProt: Q9NZU1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4547-59 | Target: FLRT1 | UniProt: Q9NZU1 | TargetFullName: Leucine-rich repeat transmembrane protein FLRT1 | Organisim: human | Apparent_Kd_M: 2.24E-11

Real

Aptamer SeqId:4548-4;Target:Fucosyltransferase 3;UniProt:P21217

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4548-4;Target: Fucosyltransferase 3;UniProt: P21217;TargetFullName: Galactoside 3(4)-L-fucosyltransferase;Organisim: human;Apparent_Kd_M: 8.41E-12

Real

Aptamer SeqId: 4548-4 | Target: Fucosyltransferase 3 | UniProt: P21217

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4548-4 | Target: Fucosyltransferase 3 | UniProt: P21217 | TargetFullName: Galactoside 3(4)-L-fucosyltransferase | Organisim: human | Apparent_Kd_M: 8.41E-12

Real

Aptamer SeqId:4549-78;Target:FUT5;UniProt:Q11128

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4549-78;Target: FUT5;UniProt: Q11128;TargetFullName: Alpha-(1;3)-fucosyltransferase 5;Organisim: human;Apparent_Kd_M: 2.23E-12

Real

Aptamer SeqId: 4549-78 | Target: FUT5 | UniProt: Q11128

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4549-78 | Target: FUT5 | UniProt: Q11128 | TargetFullName: Alpha-(1;3)-fucosyltransferase 5 | Organisim: human | Apparent_Kd_M: 2.23E-12

Real

Aptamer SeqId:4551-72;Target:GP114;UniProt:Q8IZF4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4551-72;Target: GP114;UniProt: Q8IZF4;TargetFullName: Adhesion G-protein coupled receptor G5;Organisim: human;Apparent_Kd_M: 6.64E-11

Real

Aptamer SeqId: 4551-72 | Target: GP114 | UniProt: Q8IZF4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4551-72 | Target: GP114 | UniProt: Q8IZF4 | TargetFullName: Adhesion G-protein coupled receptor G5 | Organisim: human | Apparent_Kd_M: 6.64E-11

Real

Aptamer SeqId:4553-65;Target:HDGR2;UniProt:Q7Z4V5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4553-65;Target: HDGR2;UniProt: Q7Z4V5;TargetFullName: Hepatoma-derived growth factor-related protein 2;Organisim: human;Apparent_Kd_M: 6.33E-12

Real

Aptamer SeqId: 4553-65 | Target: HDGR2 | UniProt: Q7Z4V5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4553-65 | Target: HDGR2 | UniProt: Q7Z4V5 | TargetFullName: Hepatoma-derived growth factor-related protein 2 | Organisim: human | Apparent_Kd_M: 6.33E-12

Real

Aptamer SeqId:4556-10;Target:IL-34;UniProt:Q6ZMJ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4556-10;Target: IL-34;UniProt: Q6ZMJ4;TargetFullName: Interleukin-34;Organisim: human;Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId: 4556-10 | Target: IL-34 | UniProt: Q6ZMJ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4556-10 | Target: IL-34 | UniProt: Q6ZMJ4 | TargetFullName: Interleukin-34 | Organisim: human | Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId:4557-61;Target:KIRR3;UniProt:Q8IZU9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4557-61;Target: KIRR3;UniProt: Q8IZU9;TargetFullName: Kin of IRRE-like protein 3;Organisim: human;Apparent_Kd_M: 7.41E-12

Real

Aptamer SeqId: 4557-61 | Target: KIRR3 | UniProt: Q8IZU9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4557-61 | Target: KIRR3 | UniProt: Q8IZU9 | TargetFullName: Kin of IRRE-like protein 3 | Organisim: human | Apparent_Kd_M: 7.41E-12

Real

Aptamer SeqId:4559-64;Target:KYNU;UniProt:Q16719

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4559-64;Target: KYNU;UniProt: Q16719;TargetFullName: Kynureninase;Organisim: human;Apparent_Kd_M: 4.29E-11

Real

Aptamer SeqId: 4559-64 | Target: KYNU | UniProt: Q16719

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4559-64 | Target: KYNU | UniProt: Q16719 | TargetFullName: Kynureninase | Organisim: human | Apparent_Kd_M: 4.29E-11

Real

Aptamer SeqId:4560-34;Target:LCK;UniProt:P06239

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4560-34;Target: LCK;UniProt: P06239;TargetFullName: Tyrosine-protein kinase Lck;Organisim: human;Apparent_Kd_M: 7.67E-12

Real

Aptamer SeqId: 4560-34 | Target: LCK | UniProt: P06239

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4560-34 | Target: LCK | UniProt: P06239 | TargetFullName: Tyrosine-protein kinase Lck | Organisim: human | Apparent_Kd_M: 7.67E-12

Real

Aptamer SeqId:4562-1;Target:NXPH1;UniProt:P58417

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4562-1;Target: NXPH1;UniProt: P58417;TargetFullName: Neurexophilin-1;Organisim: human;Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId: 4562-1 | Target: NXPH1 | UniProt: P58417

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4562-1 | Target: NXPH1 | UniProt: P58417 | TargetFullName: Neurexophilin-1 | Organisim: human | Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId:4563-61;Target:PLCG1;UniProt:P19174

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4563-61;Target: PLCG1;UniProt: P19174;TargetFullName: 1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase gamma-1;Organisim: human;Apparent_Kd_M: 2.55E-12

Real

Aptamer SeqId: 4563-61 | Target: PLCG1 | UniProt: P19174

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4563-61 | Target: PLCG1 | UniProt: P19174 | TargetFullName: 1-phosphatidylinositol 4;5-bisphosphate phosphodiesterase gamma-1 | Organisim: human | Apparent_Kd_M: 2.55E-12

Real

Aptamer SeqId:4564-2;Target:PLXC1;UniProt:O60486

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4564-2;Target: PLXC1;UniProt: O60486;TargetFullName: Plexin-C1;Organisim: human;Apparent_Kd_M: 1.69E-12

Real

Aptamer SeqId: 4564-2 | Target: PLXC1 | UniProt: O60486

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4564-2 | Target: PLXC1 | UniProt: O60486 | TargetFullName: Plexin-C1 | Organisim: human | Apparent_Kd_M: 1.69E-12

Real

Aptamer SeqId:4566-24;Target:RSPO2;UniProt:Q6UXX9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4566-24;Target: RSPO2;UniProt: Q6UXX9;TargetFullName: R-spondin-2;Organisim: human;Apparent_Kd_M: 9.2E-12

Real

Aptamer SeqId: 4566-24 | Target: RSPO2 | UniProt: Q6UXX9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4566-24 | Target: RSPO2 | UniProt: Q6UXX9 | TargetFullName: R-spondin-2 | Organisim: human | Apparent_Kd_M: 9.2E-12

Real

Aptamer SeqId:4567-82;Target:SH21A;UniProt:O60880

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4567-82;Target: SH21A;UniProt: O60880;TargetFullName: SH2 domain-containing protein 1A;Organisim: human;Apparent_Kd_M: 3.14E-12

Real

Aptamer SeqId: 4567-82 | Target: SH21A | UniProt: O60880

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4567-82 | Target: SH21A | UniProt: O60880 | TargetFullName: SH2 domain-containing protein 1A | Organisim: human | Apparent_Kd_M: 3.14E-12

Real

Aptamer SeqId:4568-17;Target:SLIK5;UniProt:O94991

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4568-17;Target: SLIK5;UniProt: O94991;TargetFullName: SLIT and NTRK-like protein 5;Organisim: human;Apparent_Kd_M: 5.22E-12

Real

Aptamer SeqId: 4568-17 | Target: SLIK5 | UniProt: O94991

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4568-17 | Target: SLIK5 | UniProt: O94991 | TargetFullName: SLIT and NTRK-like protein 5 | Organisim: human | Apparent_Kd_M: 5.22E-12

Real

Aptamer SeqId:4569-52;Target:SORC2;UniProt:Q96PQ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4569-52;Target: SORC2;UniProt: Q96PQ0;TargetFullName: VPS10 domain-containing receptor SorCS2;Organisim: human;Apparent_Kd_M: 5.04E-11

Real

Aptamer SeqId: 4569-52 | Target: SORC2 | UniProt: Q96PQ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4569-52 | Target: SORC2 | UniProt: Q96PQ0 | TargetFullName: VPS10 domain-containing receptor SorCS2 | Organisim: human | Apparent_Kd_M: 5.04E-11

Real

Aptamer SeqId:4584-5;Target:MEL_VESMG;UniProt:P68408

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4584-5;Target: MEL_VESMG;UniProt: P68408;TargetFullName: Melittin_VESMG;Organisim: hornet;Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId: 4584-5 | Target: MEL_VESMG | UniProt: P68408

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4584-5 | Target: MEL_VESMG | UniProt: P68408 | TargetFullName: Melittin_VESMG | Organisim: hornet | Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId:4588-1;Target:PH;UniProt:P01298

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4588-1;Target: PH;UniProt: P01298;TargetFullName: Pancreatic hormone;Organisim: human;Apparent_Kd_M: 2.26E-11

Real

Aptamer SeqId: 4588-1 | Target: PH | UniProt: P01298

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4588-1 | Target: PH | UniProt: P01298 | TargetFullName: Pancreatic hormone | Organisim: human | Apparent_Kd_M: 2.26E-11

Real

Aptamer SeqId:4666-193;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-193;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-193 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-193 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-194;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-194;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-194 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-194 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-195;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-195;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-195 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-195 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-199;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-199;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-199 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-199 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-200;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-200;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-200 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-200 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-202;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-202;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-202 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-202 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-205;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-205;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-205 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-205 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-206;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-206;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-206 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-206 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-212;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-212;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-212 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-212 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-213;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-213;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-213 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-213 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-214;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-214;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-214 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-214 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-218;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-218;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-218 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-218 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-219;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-219;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-219 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-219 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-220;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-220;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-220 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-220 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-222;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-222;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-222 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-222 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-223;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-223;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-223 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-223 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-224;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-224;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-224 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-224 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-225;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-225;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-225 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-225 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-230;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-230;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-230 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-230 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-232;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-232;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-232 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-232 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4666-236;Target:No Protein;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4666-236;Target: No Protein;UniProt:;TargetFullName: No protein;Organisim: human;Apparent_Kd_M:

Real

Aptamer SeqId: 4666-236 | Target: No Protein | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4666-236 | Target: No Protein | UniProt: | TargetFullName: No protein | Organisim: human | Apparent_Kd_M:

Real

Aptamer SeqId:4673-13;Target:IL-6;UniProt:P05231

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4673-13;Target: IL-6;UniProt: P05231;TargetFullName: Interleukin-6;Organisim: human;Apparent_Kd_M: 4.55E-12

Real

Aptamer SeqId: 4673-13 | Target: IL-6 | UniProt: P05231

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4673-13 | Target: IL-6 | UniProt: P05231 | TargetFullName: Interleukin-6 | Organisim: human | Apparent_Kd_M: 4.55E-12

Real

Aptamer SeqId:4693-72;Target:3HIDH;UniProt:P31937

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4693-72;Target: 3HIDH;UniProt: P31937;TargetFullName: 3-hydroxyisobutyrate dehydrogenase; mitochondrial;Organisim: human;Apparent_Kd_M: 3.76E-11

Real

Aptamer SeqId: 4693-72 | Target: 3HIDH | UniProt: P31937

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4693-72 | Target: 3HIDH | UniProt: P31937 | TargetFullName: 3-hydroxyisobutyrate dehydrogenase; mitochondrial | Organisim: human | Apparent_Kd_M: 3.76E-11

Real

Aptamer SeqId:4697-59;Target:GM-CSF;UniProt:P04141

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4697-59;Target: GM-CSF;UniProt: P04141;TargetFullName: Granulocyte-macrophage colony-stimulating factor;Organisim: human;Apparent_Kd_M: 1.36E-11

Real

Aptamer SeqId: 4697-59 | Target: GM-CSF | UniProt: P04141

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4697-59 | Target: GM-CSF | UniProt: P04141 | TargetFullName: Granulocyte-macrophage colony-stimulating factor | Organisim: human | Apparent_Kd_M: 1.36E-11

Real

Aptamer SeqId:4703-87;Target:TNF-b;UniProt:P01374

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4703-87;Target: TNF-b;UniProt: P01374;TargetFullName: Lymphotoxin-alpha;Organisim: human;Apparent_Kd_M: 2.92E-10

Real

Aptamer SeqId: 4703-87 | Target: TNF-b | UniProt: P01374

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4703-87 | Target: TNF-b | UniProt: P01374 | TargetFullName: Lymphotoxin-alpha | Organisim: human | Apparent_Kd_M: 2.92E-10

Real

Aptamer SeqId:4706-17;Target:41;UniProt:P11171

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4706-17;Target: 41;UniProt: P11171;TargetFullName: Protein 4.1;Organisim: human;Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId: 4706-17 | Target: 41 | UniProt: P11171

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4706-17 | Target: 41 | UniProt: P11171 | TargetFullName: Protein 4.1 | Organisim: human | Apparent_Kd_M: 1.01E-11

Real

Aptamer SeqId:4707-50;Target:14-3-3;UniProt:P31946;P62258;P61981;Q04917;P27348

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4707-50;Target: 14-3-3;UniProt: P31946|P62258|P61981|Q04917|P27348|P63104|P31947;TargetFullName: 14-3-3 protein family;Organisim: human;Apparent_Kd_M: 4.38E-12

Real

Aptamer SeqId: 4707-50 | Target: 14-3-3 protein family

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4707-50 | Target: 14-3-3 | UniProt: P31946|P62258|P61981|Q04917|P27348|P63104|P31947 | TargetFullName: 14-3-3 protein family | Organisim: human | Apparent_Kd_M: 4.38E-12

Real

Aptamer SeqId:4708-3;Target:17-beta-HSD 1;UniProt:P14061

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4708-3;Target: 17-beta-HSD 1;UniProt: P14061;TargetFullName: Estradiol 17-beta-dehydrogenase 1;Organisim: human;Apparent_Kd_M: 7.89E-13

Real

Aptamer SeqId: 4708-3 | Target: 17-beta-HSD 1 | UniProt: P14061

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4708-3 | Target: 17-beta-HSD 1 | UniProt: P14061 | TargetFullName: Estradiol 17-beta-dehydrogenase 1 | Organisim: human | Apparent_Kd_M: 7.89E-13

Real

Aptamer SeqId:4712-28;Target:Apo D;UniProt:P05090

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4712-28;Target: Apo D;UniProt: P05090;TargetFullName: Apolipoprotein D;Organisim: human;Apparent_Kd_M: 4.64E-11

Real

Aptamer SeqId: 4712-28 | Target: Apo D | UniProt: P05090

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4712-28 | Target: Apo D | UniProt: P05090 | TargetFullName: Apolipoprotein D | Organisim: human | Apparent_Kd_M: 4.64E-11

Real

Aptamer SeqId:4717-55;Target:IL-3;UniProt:P08700

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4717-55;Target: IL-3;UniProt: P08700;TargetFullName: Interleukin-3;Organisim: human;Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId: 4717-55 | Target: IL-3 | UniProt: P08700

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4717-55 | Target: IL-3 | UniProt: P08700 | TargetFullName: Interleukin-3 | Organisim: human | Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId:4718-5;Target:PPIB;UniProt:P23284

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4718-5;Target: PPIB;UniProt: P23284;TargetFullName: Peptidyl-prolyl cis-trans isomerase B;Organisim: human;Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId: 4718-5 | Target: PPIB | UniProt: P23284

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4718-5 | Target: PPIB | UniProt: P23284 | TargetFullName: Peptidyl-prolyl cis-trans isomerase B | Organisim: human | Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId:4719-58;Target:Protein disulfide isomerase A3;UniProt:P30101

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4719-58;Target: Protein disulfide isomerase A3;UniProt: P30101;TargetFullName: Protein disulfide-isomerase A3;Organisim: human;Apparent_Kd_M: 8.53E-12

Real

Aptamer SeqId: 4719-58 | Target: Protein disulfide isomerase A3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4719-58 | Target: Protein disulfide isomerase A3 | UniProt: P30101 | TargetFullName: Protein disulfide-isomerase A3 | Organisim: human | Apparent_Kd_M: 8.53E-12

Real

Aptamer SeqId:4721-54;Target:TFF3;UniProt:Q07654

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4721-54;Target: TFF3;UniProt: Q07654;TargetFullName: Trefoil factor 3;Organisim: human;Apparent_Kd_M: 1.49E-12

Real

Aptamer SeqId: 4721-54 | Target: TFF3 | UniProt: Q07654

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4721-54 | Target: TFF3 | UniProt: Q07654 | TargetFullName: Trefoil factor 3 | Organisim: human | Apparent_Kd_M: 1.49E-12

Real

Aptamer SeqId:4763-31;Target:Afamin;UniProt:P43652

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4763-31;Target: Afamin;UniProt: P43652;TargetFullName: Afamin;Organisim: human;Apparent_Kd_M: 6.16E-12

Real

Aptamer SeqId: 4763-31 | Target: Afamin | UniProt: P43652

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4763-31 | Target: Afamin | UniProt: P43652 | TargetFullName: Afamin | Organisim: human | Apparent_Kd_M: 6.16E-12

Real

Aptamer SeqId:4769-10;Target:Olfactomedin-4;UniProt:Q6UX06

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4769-10;Target: Olfactomedin-4;UniProt: Q6UX06;TargetFullName: Olfactomedin-4;Organisim: human;Apparent_Kd_M: 2.93E-12

Real

Aptamer SeqId: 4769-10 | Target: Olfactomedin-4 | UniProt: Q6UX06

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4769-10 | Target: Olfactomedin-4 | UniProt: Q6UX06 | TargetFullName: Olfactomedin-4 | Organisim: human | Apparent_Kd_M: 2.93E-12

Real

Aptamer SeqId:4771-10;Target:ASM3A;UniProt:Q92484

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4771-10;Target: ASM3A;UniProt: Q92484;TargetFullName: Acid sphingomyelinase-like phosphodiesterase 3a;Organisim: human;Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId: 4771-10 | Target: ASM3A | UniProt: Q92484

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4771-10 | Target: ASM3A | UniProt: Q92484 | TargetFullName: Acid sphingomyelinase-like phosphodiesterase 3a | Organisim: human | Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId:4775-34;Target:Gelsolin;UniProt:P06396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4775-34;Target: Gelsolin;UniProt: P06396;TargetFullName: Gelsolin;Organisim: human;Apparent_Kd_M: 1.96E-10

Real

Aptamer SeqId: 4775-34 | Target: Gelsolin | UniProt: P06396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4775-34 | Target: Gelsolin | UniProt: P06396 | TargetFullName: Gelsolin | Organisim: human | Apparent_Kd_M: 1.96E-10

Real

Aptamer SeqId:4785-30;Target:CBG;UniProt:P08185

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4785-30;Target: CBG;UniProt: P08185;TargetFullName: Corticosteroid-binding globulin;Organisim: human;Apparent_Kd_M: 5.52E-11

Real

Aptamer SeqId: 4785-30 | Target: CBG | UniProt: P08185

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4785-30 | Target: CBG | UniProt: P08185 | TargetFullName: Corticosteroid-binding globulin | Organisim: human | Apparent_Kd_M: 5.52E-11

Real

Aptamer SeqId:4792-51;Target:C34 gp41 HIV Fragment;UniProt:Q70626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4792-51;Target: C34 gp41 HIV Fragment;UniProt: Q70626;TargetFullName: gp41 C34 peptide; HIV;Organisim: isolate lw123;Apparent_Kd_M: 2.5E-11

Real

Aptamer SeqId: 4792-51 | Target: C34 gp41 HIV Fragment | UniProt: Q70626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4792-51 | Target: C34 gp41 HIV Fragment | UniProt: Q70626 | TargetFullName: gp41 C34 peptide; HIV | Organisim: isolate lw123 | Apparent_Kd_M: 2.5E-11

Real

Aptamer SeqId:4801-13;Target:PERL;UniProt:P22079

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4801-13;Target: PERL;UniProt: P22079;TargetFullName: Lactoperoxidase;Organisim: human;Apparent_Kd_M: 5.94E-12

Real

Aptamer SeqId: 4801-13 | Target: PERL | UniProt: P22079

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4801-13 | Target: PERL | UniProt: P22079 | TargetFullName: Lactoperoxidase | Organisim: human | Apparent_Kd_M: 5.94E-12

Real

Aptamer SeqId:4807-13;Target:CO8A1;UniProt:P27658

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4807-13;Target: CO8A1;UniProt: P27658;TargetFullName: Collagen alpha-1(VIII) chain;Organisim: human;Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId: 4807-13 | Target: CO8A1 | UniProt: P27658

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4807-13 | Target: CO8A1 | UniProt: P27658 | TargetFullName: Collagen alpha-1(VIII) chain | Organisim: human | Apparent_Kd_M: 1.09E-11

Real

Aptamer SeqId:4811-33;Target:ITI heavy chain H4;UniProt:Q14624

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4811-33;Target: ITI heavy chain H4;UniProt: Q14624;TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H4;Organisim: human;Apparent_Kd_M: 2.25E-11

Real

Aptamer SeqId: 4811-33 | Target: ITI heavy chain H4 | UniProt: Q14624

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4811-33 | Target: ITI heavy chain H4 | UniProt: Q14624 | TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H4 | Organisim: human | Apparent_Kd_M: 2.25E-11

Real

Aptamer SeqId:4829-43;Target:STRATIFIN;UniProt:P31947

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4829-43;Target: STRATIFIN;UniProt: P31947;TargetFullName: 14-3-3 protein sigma;Organisim: human;Apparent_Kd_M: 2.26E-12

Real

Aptamer SeqId: 4829-43 | Target: STRATIFIN | UniProt: P31947

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4829-43 | Target: STRATIFIN | UniProt: P31947 | TargetFullName: 14-3-3 protein sigma | Organisim: human | Apparent_Kd_M: 2.26E-12

Real

Aptamer SeqId:4831-4;Target:sL-Selectin;UniProt:P14151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4831-4;Target: sL-Selectin;UniProt: P14151;TargetFullName: L-Selectin;Organisim: human;Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId: 4831-4 | Target: sL-Selectin | UniProt: P14151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4831-4 | Target: sL-Selectin | UniProt: P14151 | TargetFullName: L-Selectin | Organisim: human | Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId:4832-75;Target:TRAIL R1;UniProt:O00220

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4832-75;Target: TRAIL R1;UniProt: O00220;TargetFullName: Tumor necrosis factor receptor superfamily member 10A;Organisim: human;Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId: 4832-75 | Target: TRAIL R1 | UniProt: O00220

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4832-75 | Target: TRAIL R1 | UniProt: O00220 | TargetFullName: Tumor necrosis factor receptor superfamily member 10A | Organisim: human | Apparent_Kd_M: 1.81E-11

Real

Aptamer SeqId:4834-61;Target:Epithelial cell kinase;UniProt:P29317

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4834-61;Target: Epithelial cell kinase;UniProt: P29317;TargetFullName: Ephrin type-A receptor 2;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 4834-61 | Target: Epithelial cell kinase | UniProt: P29317

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4834-61 | Target: Epithelial cell kinase | UniProt: P29317 | TargetFullName: Ephrin type-A receptor 2 | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:4840-73;Target:G-CSF;UniProt:P09919

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4840-73;Target: G-CSF;UniProt: P09919;TargetFullName: Granulocyte colony-stimulating factor;Organisim: human;Apparent_Kd_M: 3.14E-12

Real

Aptamer SeqId: 4840-73 | Target: G-CSF | UniProt: P09919

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4840-73 | Target: G-CSF | UniProt: P09919 | TargetFullName: Granulocyte colony-stimulating factor | Organisim: human | Apparent_Kd_M: 3.14E-12

Real

Aptamer SeqId:4842-62;Target:Glypican 3;UniProt:P51654

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4842-62;Target: Glypican 3;UniProt: P51654;TargetFullName: Glypican-3;Organisim: human;Apparent_Kd_M: 1.46E-12

Real

Aptamer SeqId: 4842-62 | Target: Glypican 3 | UniProt: P51654

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4842-62 | Target: Glypican 3 | UniProt: P51654 | TargetFullName: Glypican-3 | Organisim: human | Apparent_Kd_M: 1.46E-12

Real

Aptamer SeqId:4851-25;Target:IL-1a;UniProt:P01583

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4851-25;Target: IL-1a;UniProt: P01583;TargetFullName: Interleukin-1 alpha;Organisim: human;Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId: 4851-25 | Target: IL-1a | UniProt: P01583

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4851-25 | Target: IL-1a | UniProt: P01583 | TargetFullName: Interleukin-1 alpha | Organisim: human | Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId:4862-63;Target:BMP RII;UniProt:Q13873

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4862-63;Target: BMP RII;UniProt: Q13873;TargetFullName: Bone morphogenetic protein receptor type-2;Organisim: human;Apparent_Kd_M: 2.324111E-11

Real

Aptamer SeqId: 4862-63 | Target: BMP RII | UniProt: Q13873

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4862-63 | Target: BMP RII | UniProt: Q13873 | TargetFullName: Bone morphogenetic protein receptor type-2 | Organisim: human | Apparent_Kd_M: 2.324111E-11

Real

Aptamer SeqId:4866-59;Target:TrkB;UniProt:Q16620

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4866-59;Target: TrkB;UniProt: Q16620;TargetFullName: BDNF/NT-3 growth factors receptor;Organisim: human;Apparent_Kd_M: 2.31E-11

Real

Aptamer SeqId: 4866-59 | Target: TrkB | UniProt: Q16620

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4866-59 | Target: TrkB | UniProt: Q16620 | TargetFullName: BDNF/NT-3 growth factors receptor | Organisim: human | Apparent_Kd_M: 2.31E-11

Real

Aptamer SeqId:4867-15;Target:VEGF121;UniProt:P15692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4867-15;Target: VEGF121;UniProt: P15692;TargetFullName: Vascular endothelial growth factor A; isoform 121;Organisim: human;Apparent_Kd_M: 7.46E-12

Real

Aptamer SeqId: 4867-15 | Target: VEGF121 | UniProt: P15692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4867-15 | Target: VEGF121 | UniProt: P15692 | TargetFullName: Vascular endothelial growth factor A; isoform 121 | Organisim: human | Apparent_Kd_M: 7.46E-12

Real

Aptamer SeqId:4874-3;Target:Angiogenin;UniProt:P03950

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4874-3;Target: Angiogenin;UniProt: P03950;TargetFullName: Angiogenin;Organisim: human;Apparent_Kd_M: 2.14E-12

Real

Aptamer SeqId: 4874-3 | Target: Angiogenin | UniProt: P03950

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4874-3 | Target: Angiogenin | UniProt: P03950 | TargetFullName: Angiogenin | Organisim: human | Apparent_Kd_M: 2.14E-12

Real

Aptamer SeqId:4876-32;Target:Coagulation Factor IX;UniProt:P00740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4876-32;Target: Coagulation Factor IX;UniProt: P00740;TargetFullName: Coagulation factor IX;Organisim: human;Apparent_Kd_M: 5.53E-13

Real

Aptamer SeqId: 4876-32 | Target: Coagulation Factor IX | UniProt: P00740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4876-32 | Target: Coagulation Factor IX | UniProt: P00740 | TargetFullName: Coagulation factor IX | Organisim: human | Apparent_Kd_M: 5.53E-13

Real

Aptamer SeqId:4878-3;Target:Coagulation Factor X;UniProt:P00742

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4878-3;Target: Coagulation Factor X;UniProt: P00742;TargetFullName: Coagulation Factor X;Organisim: human;Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId: 4878-3 | Target: Coagulation Factor X | UniProt: P00742

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4878-3 | Target: Coagulation Factor X | UniProt: P00742 | TargetFullName: Coagulation Factor X | Organisim: human | Apparent_Kd_M: 4.36E-12

Real

Aptamer SeqId:4880-21;Target:GDF2;UniProt:Q9UK05

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4880-21;Target: GDF2;UniProt: Q9UK05;TargetFullName: Growth/differentiation factor 2;Organisim: human;Apparent_Kd_M: 5.95E-12

Real

Aptamer SeqId: 4880-21 | Target: GDF2 | UniProt: Q9UK05

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4880-21 | Target: GDF2 | UniProt: Q9UK05 | TargetFullName: Growth/differentiation factor 2 | Organisim: human | Apparent_Kd_M: 5.95E-12

Real

Aptamer SeqId:4883-56;Target:Insulin;UniProt:P01308

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4883-56;Target: Insulin;UniProt: P01308;TargetFullName: Insulin;Organisim: human;Apparent_Kd_M: 1.73E-10

Real

Aptamer SeqId: 4883-56 | Target: Insulin | UniProt: P01308

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4883-56 | Target: Insulin | UniProt: P01308 | TargetFullName: Insulin | Organisim: human | Apparent_Kd_M: 1.73E-10

Real

Aptamer SeqId:4886-3;Target:MCP-3;UniProt:P80098

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4886-3;Target: MCP-3;UniProt: P80098;TargetFullName: C-C motif chemokine 7;Organisim: human;Apparent_Kd_M: 7.62E-13

Real

Aptamer SeqId: 4886-3 | Target: MCP-3 | UniProt: P80098

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4886-3 | Target: MCP-3 | UniProt: P80098 | TargetFullName: C-C motif chemokine 7 | Organisim: human | Apparent_Kd_M: 7.62E-13

Real

Aptamer SeqId:4889-82;Target:WNT7A;UniProt:O00755

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4889-82;Target: WNT7A;UniProt: O00755;TargetFullName: Protein Wnt-7a;Organisim: human;Apparent_Kd_M: 8.88E-11

Real

Aptamer SeqId: 4889-82 | Target: WNT7A | UniProt: O00755

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4889-82 | Target: WNT7A | UniProt: O00755 | TargetFullName: Protein Wnt-7a | Organisim: human | Apparent_Kd_M: 8.88E-11

Real

Aptamer SeqId:4890-10;Target:ACTH;UniProt:P01189

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4890-10;Target: ACTH;UniProt: P01189;TargetFullName: Corticotropin;Organisim: human;Apparent_Kd_M: 5.35E-12

Real

Aptamer SeqId: 4890-10 | Target: ACTH | UniProt: P01189

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4890-10 | Target: ACTH | UniProt: P01189 | TargetFullName: Corticotropin | Organisim: human | Apparent_Kd_M: 5.35E-12

Real

Aptamer SeqId:4891-50;Target:Glucagon;UniProt:P01275

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4891-50;Target: Glucagon;UniProt: P01275;TargetFullName: Glucagon;Organisim: human;Apparent_Kd_M: 3.56E-11

Real

Aptamer SeqId: 4891-50 | Target: Glucagon | UniProt: P01275

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4891-50 | Target: Glucagon | UniProt: P01275 | TargetFullName: Glucagon | Organisim: human | Apparent_Kd_M: 3.56E-11

Real

Aptamer SeqId:4900-8;Target:C3a;UniProt:P01024

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4900-8;Target: C3a;UniProt: P01024;TargetFullName: C3a anaphylatoxin;Organisim: human;Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId: 4900-8 | Target: C3a | UniProt: P01024

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4900-8 | Target: C3a | UniProt: P01024 | TargetFullName: C3a anaphylatoxin | Organisim: human | Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId:4903-72;Target:Calcineurin;UniProt:Q08209|P63098

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4903-72;Target: Calcineurin;UniProt: Q08209|P63098;TargetFullName: Calcineurin;Organisim: human;Apparent_Kd_M: 7.32E-12

Real

Aptamer SeqId: 4903-72 | Target: Calcineurin | UniProt: Q08209|P63098

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4903-72 | Target: Calcineurin | UniProt: Q08209|P63098 | TargetFullName: Calcineurin | Organisim: human | Apparent_Kd_M: 7.32E-12

Real

Aptamer SeqId:4904-7;Target:Caspase-2;UniProt:P42575

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4904-7;Target: Caspase-2;UniProt: P42575;TargetFullName: Caspase-2;Organisim: human;Apparent_Kd_M: 2.78E-10

Real

Aptamer SeqId: 4904-7 | Target: Caspase-2 | UniProt: P42575

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4904-7 | Target: Caspase-2 | UniProt: P42575 | TargetFullName: Caspase-2 | Organisim: human | Apparent_Kd_M: 2.78E-10

Real

Aptamer SeqId:4905-63;Target:Coactosin-like protein;UniProt:Q14019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4905-63;Target: Coactosin-like protein;UniProt: Q14019;TargetFullName: Coactosin-like protein;Organisim: human;Apparent_Kd_M: 8.1E-11

Real

Aptamer SeqId: 4905-63 | Target: Coactosin-like protein | UniProt: Q14019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4905-63 | Target: Coactosin-like protein | UniProt: Q14019 | TargetFullName: Coactosin-like protein | Organisim: human | Apparent_Kd_M: 8.1E-11

Real

Aptamer SeqId:4906-35;Target:Coagulation Factor V;UniProt:P12259

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4906-35;Target: Coagulation Factor V;UniProt: P12259;TargetFullName: Coagulation Factor V;Organisim: human;Apparent_Kd_M: 8.46E-12

Real

Aptamer SeqId: 4906-35 | Target: Coagulation Factor V | UniProt: P12259

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4906-35 | Target: Coagulation Factor V | UniProt: P12259 | TargetFullName: Coagulation Factor V | Organisim: human | Apparent_Kd_M: 8.46E-12

Real

Aptamer SeqId:4907-56;Target:D-dimer;UniProt:P02671|P02675|P02679

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4907-56;Target: D-dimer;UniProt: P02671|P02675|P02679;TargetFullName: D-dimer;Organisim: human;Apparent_Kd_M: 1.07E-10

Real

Aptamer SeqId: 4907-56 | Target: D-dimer | UniProt: P02671|P02675|P02679

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4907-56 | Target: D-dimer | UniProt: P02671|P02675|P02679 | TargetFullName: D-dimer | Organisim: human | Apparent_Kd_M: 1.07E-10

Real

Aptamer SeqId:4908-6;Target:Endoglin;UniProt:P17813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4908-6;Target: Endoglin;UniProt: P17813;TargetFullName: Endoglin;Organisim: human;Apparent_Kd_M: 1.6E-10

Real

Aptamer SeqId: 4908-6 | Target: Endoglin | UniProt: P17813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4908-6 | Target: Endoglin | UniProt: P17813 | TargetFullName: Endoglin | Organisim: human | Apparent_Kd_M: 1.6E-10

Real

Aptamer SeqId:4909-68;Target:Galectin-8;UniProt:O00214

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4909-68;Target: Galectin-8;UniProt: O00214;TargetFullName: Galectin-8;Organisim: human;Apparent_Kd_M: 2.66E-11

Real

Aptamer SeqId: 4909-68 | Target: Galectin-8 | UniProt: O00214

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4909-68 | Target: Galectin-8 | UniProt: O00214 | TargetFullName: Galectin-8 | Organisim: human | Apparent_Kd_M: 2.66E-11

Real

Aptamer SeqId:4910-21;Target:GIB;UniProt:P04054

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4910-21;Target: GIB;UniProt: P04054;TargetFullName: Phospholipase A2;Organisim: human;Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId: 4910-21 | Target: GIB | UniProt: P04054

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4910-21 | Target: GIB | UniProt: P04054 | TargetFullName: Phospholipase A2 | Organisim: human | Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId:4911-49;Target:Glutathione S-transferase Pi;UniProt:P09211

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4911-49;Target: Glutathione S-transferase Pi;UniProt: P09211;TargetFullName: Glutathione S-transferase P;Organisim: human;Apparent_Kd_M: 9.43E-12

Real

Aptamer SeqId: 4911-49 | Target: Glutathione S-transferase Pi

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4911-49 | Target: Glutathione S-transferase Pi | UniProt: P09211 | TargetFullName: Glutathione S-transferase P | Organisim: human | Apparent_Kd_M: 9.43E-12

Real

Aptamer SeqId:4912-17;Target:GOT1;UniProt:P17174

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4912-17;Target: GOT1;UniProt: P17174;TargetFullName: Aspartate aminotransferase; cytoplasmic;Organisim: human;Apparent_Kd_M: 8.22E-11

Real

Aptamer SeqId: 4912-17 | Target: GOT1 | UniProt: P17174

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4912-17 | Target: GOT1 | UniProt: P17174 | TargetFullName: Aspartate aminotransferase; cytoplasmic | Organisim: human | Apparent_Kd_M: 8.22E-11

Real

Aptamer SeqId:4913-78;Target:HCC-4;UniProt:O15467

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4913-78;Target: HCC-4;UniProt: O15467;TargetFullName: C-C motif chemokine 16;Organisim: human;Apparent_Kd_M: 2.91E-12

Real

Aptamer SeqId: 4913-78 | Target: HCC-4 | UniProt: O15467

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4913-78 | Target: HCC-4 | UniProt: O15467 | TargetFullName: C-C motif chemokine 16 | Organisim: human | Apparent_Kd_M: 2.91E-12

Real

Aptamer SeqId:4914-10;Target:HCG;UniProt:P01215|P01233

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4914-10;Target: HCG;UniProt: P01215|P01233;TargetFullName: Human Chorionic Gonadotropin;Organisim: human;Apparent_Kd_M: 5.57E-12

Real

Aptamer SeqId: 4914-10 | Target: HCG | UniProt: P01215|P01233

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4914-10 | Target: HCG | UniProt: P01215|P01233 | TargetFullName: Human Chorionic Gonadotropin | Organisim: human | Apparent_Kd_M: 5.57E-12

Real

Aptamer SeqId:4915-64;Target:Hemoglobin;UniProt:P69905|P68871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4915-64;Target: Hemoglobin;UniProt: P69905|P68871;TargetFullName: Hemoglobin;Organisim: human;Apparent_Kd_M: 3.72E-11

Real

Aptamer SeqId: 4915-64 | Target: Hemoglobin | UniProt: P69905|P68871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4915-64 | Target: Hemoglobin | UniProt: P69905|P68871 | TargetFullName: Hemoglobin | Organisim: human | Apparent_Kd_M: 3.72E-11

Real

Aptamer SeqId:4916-2;Target:IgD;UniProt:P01880

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4916-2;Target: IgD;UniProt: P01880;TargetFullName: Immunoglobulin D;Organisim: human;Apparent_Kd_M: 2.79E-10

Real

Aptamer SeqId: 4916-2 | Target: IgD | UniProt: P01880

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4916-2 | Target: IgD | UniProt: P01880 | TargetFullName: Immunoglobulin D | Organisim: human | Apparent_Kd_M: 2.79E-10

Real

Aptamer SeqId:4917-62;Target:Integrin aVb5;UniProt:P06756|P18084

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4917-62;Target: Integrin aVb5;UniProt: P06756|P18084;TargetFullName: Integrin alpha-V: beta-5 complex;Organisim: human;Apparent_Kd_M: 4.73E-12

Real

Aptamer SeqId: 4917-62 | Target: Integrin aVb5 | UniProt: P06756|P18084

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4917-62 | Target: Integrin aVb5 | UniProt: P06756|P18084 | TargetFullName: Integrin alpha-V: beta-5 complex | Organisim: human | Apparent_Kd_M: 4.73E-12

Real

Aptamer SeqId:4920-10;Target:Lysozyme;UniProt:P61626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4920-10;Target: Lysozyme;UniProt: P61626;TargetFullName: Lysozyme C;Organisim: human;Apparent_Kd_M: 9.91E-12

Real

Aptamer SeqId: 4920-10 | Target: Lysozyme | UniProt: P61626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4920-10 | Target: Lysozyme | UniProt: P61626 | TargetFullName: Lysozyme C | Organisim: human | Apparent_Kd_M: 9.91E-12

Real

Aptamer SeqId:4922-13;Target:MIP-3b;UniProt:Q99731

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4922-13;Target: MIP-3b;UniProt: Q99731;TargetFullName: C-C motif chemokine 19;Organisim: human;Apparent_Kd_M: 1.22E-12

Real

Aptamer SeqId: 4922-13 | Target: MIP-3b | UniProt: Q99731

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4922-13 | Target: MIP-3b | UniProt: Q99731 | TargetFullName: C-C motif chemokine 19 | Organisim: human | Apparent_Kd_M: 1.22E-12

Real

Aptamer SeqId:4923-79;Target:MIS;UniProt:P03971

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4923-79;Target: MIS;UniProt: P03971;TargetFullName: Muellerian-inhibiting factor;Organisim: human;Apparent_Kd_M: 6.77E-12

Real

Aptamer SeqId: 4923-79 | Target: MIS | UniProt: P03971

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4923-79 | Target: MIS | UniProt: P03971 | TargetFullName: Muellerian-inhibiting factor | Organisim: human | Apparent_Kd_M: 6.77E-12

Real

Aptamer SeqId:4924-32;Target:MMP-1;UniProt:P03956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4924-32;Target: MMP-1;UniProt: P03956;TargetFullName: Interstitial collagenase;Organisim: human;Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId: 4924-32 | Target: MMP-1 | UniProt: P03956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4924-32 | Target: MMP-1 | UniProt: P03956 | TargetFullName: Interstitial collagenase | Organisim: human | Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId:4925-54;Target:MMP-13;UniProt:P45452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4925-54;Target: MMP-13;UniProt: P45452;TargetFullName: Collagenase 3;Organisim: human;Apparent_Kd_M: 1.93E-11

Real

Aptamer SeqId: 4925-54 | Target: MMP-13 | UniProt: P45452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4925-54 | Target: MMP-13 | UniProt: P45452 | TargetFullName: Collagenase 3 | Organisim: human | Apparent_Kd_M: 1.93E-11

Real

Aptamer SeqId:4929-55;Target:SHBG;UniProt:P04278

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4929-55;Target: SHBG;UniProt: P04278;TargetFullName: Sex hormone-binding globulin;Organisim: human;Apparent_Kd_M: 4.04E-12

Real

Aptamer SeqId: 4929-55 | Target: SHBG | UniProt: P04278

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4929-55 | Target: SHBG | UniProt: P04278 | TargetFullName: Sex hormone-binding globulin | Organisim: human | Apparent_Kd_M: 4.04E-12

Real

Aptamer SeqId:4930-21;Target:Stanniocalcin-1;UniProt:P52823

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4930-21;Target: Stanniocalcin-1;UniProt: P52823;TargetFullName: Stanniocalcin-1;Organisim: human;Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId: 4930-21 | Target: Stanniocalcin-1 | UniProt: P52823

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4930-21 | Target: Stanniocalcin-1 | UniProt: P52823 | TargetFullName: Stanniocalcin-1 | Organisim: human | Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId:4931-59;Target:TF;UniProt:P13726

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4931-59;Target: TF;UniProt: P13726;TargetFullName: Tissue Factor;Organisim: human;Apparent_Kd_M: 9.62E-11

Real

Aptamer SeqId: 4931-59 | Target: TF | UniProt: P13726

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4931-59 | Target: TF | UniProt: P13726 | TargetFullName: Tissue Factor | Organisim: human | Apparent_Kd_M: 9.62E-11

Real

Aptamer SeqId:4956-2;Target:EPI;UniProt:O14944

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4956-2;Target: EPI;UniProt: O14944;TargetFullName: Epiregulin;Organisim: human;Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId: 4956-2 | Target: EPI | UniProt: O14944

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4956-2 | Target: EPI | UniProt: O14944 | TargetFullName: Epiregulin | Organisim: human | Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId:4959-2;Target:AGR2;UniProt:O95994

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4959-2;Target: AGR2;UniProt: O95994;TargetFullName: Anterior gradient protein 2 homolog;Organisim: human;Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId: 4959-2 | Target: AGR2 | UniProt: O95994

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4959-2 | Target: AGR2 | UniProt: O95994 | TargetFullName: Anterior gradient protein 2 homolog | Organisim: human | Apparent_Kd_M: 1.51E-11

Real

Aptamer SeqId:4960-72;Target:annexin I;UniProt:P04083

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4960-72;Target: annexin I;UniProt: P04083;TargetFullName: Annexin A1;Organisim: human;Apparent_Kd_M: 7.05E-12

Real

Aptamer SeqId: 4960-72 | Target: annexin I | UniProt: P04083

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4960-72 | Target: annexin I | UniProt: P04083 | TargetFullName: Annexin A1 | Organisim: human | Apparent_Kd_M: 7.05E-12

Real

Aptamer SeqId:4961-17;Target:annexin II;UniProt:P07355

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4961-17;Target: annexin II;UniProt: P07355;TargetFullName: Annexin A2;Organisim: human;Apparent_Kd_M: 1.54E-11

Real

Aptamer SeqId: 4961-17 | Target: annexin II | UniProt: P07355

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4961-17 | Target: annexin II | UniProt: P07355 | TargetFullName: Annexin A2 | Organisim: human | Apparent_Kd_M: 1.54E-11

Real

Aptamer SeqId:4962-52;Target:ARMEL;UniProt:Q49AH0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4962-52;Target: ARMEL;UniProt: Q49AH0;TargetFullName: Cerebral dopamine neurotrophic factor;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 4962-52 | Target: ARMEL | UniProt: Q49AH0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4962-52 | Target: ARMEL | UniProt: Q49AH0 | TargetFullName: Cerebral dopamine neurotrophic factor | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:4963-19;Target:ARP19;UniProt:P56211

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4963-19;Target: ARP19;UniProt: P56211;TargetFullName: cAMP-regulated phosphoprotein 19;Organisim: human;Apparent_Kd_M: 2.68E-11

Real

Aptamer SeqId: 4963-19 | Target: ARP19 | UniProt: P56211

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4963-19 | Target: ARP19 | UniProt: P56211 | TargetFullName: cAMP-regulated phosphoprotein 19 | Organisim: human | Apparent_Kd_M: 2.68E-11

Real

Aptamer SeqId:4964-67;Target:ARTS1;UniProt:Q9NZ08

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4964-67;Target: ARTS1;UniProt: Q9NZ08;TargetFullName: Endoplasmic reticulum aminopeptidase 1;Organisim: human;Apparent_Kd_M: 1.85E-12

Real

Aptamer SeqId: 4964-67 | Target: ARTS1 | UniProt: Q9NZ08

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4964-67 | Target: ARTS1 | UniProt: Q9NZ08 | TargetFullName: Endoplasmic reticulum aminopeptidase 1 | Organisim: human | Apparent_Kd_M: 1.85E-12

Real

Aptamer SeqId:4965-27;Target:ATP synthase beta chain;UniProt:P06576

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4965-27;Target: ATP synthase beta chain;UniProt: P06576;TargetFullName: ATP synthase subunit beta; mitochondrial;Organisim: human;Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId: 4965-27 | Target: ATP synthase beta chain | UniProt: P06576

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4965-27 | Target: ATP synthase beta chain | UniProt: P06576 | TargetFullName: ATP synthase subunit beta; mitochondrial | Organisim: human | Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId:4967-1;Target:C1QBP;UniProt:Q07021

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4967-1;Target: C1QBP;UniProt: Q07021;TargetFullName: Complement component 1 Q subcomponent-binding protein; mitochondrial;Organisim: human;Apparent_Kd_M: 9.65E-11

Real

Aptamer SeqId: 4967-1 | Target: C1QBP | UniProt: Q07021

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4967-1 | Target: C1QBP | UniProt: Q07021 | TargetFullName: Complement component 1 Q subcomponent-binding protein; mitochondrial | Organisim: human | Apparent_Kd_M: 9.65E-11

Real

Aptamer SeqId:4968-50;Target:CAPG;UniProt:P40121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4968-50;Target: CAPG;UniProt: P40121;TargetFullName: Macrophage-capping protein;Organisim: human;Apparent_Kd_M: 2.263217E-11

Real

Aptamer SeqId: 4968-50 | Target: CAPG | UniProt: P40121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4968-50 | Target: CAPG | UniProt: P40121 | TargetFullName: Macrophage-capping protein | Organisim: human | Apparent_Kd_M: 2.263217E-11

Real

Aptamer SeqId:4969-2;Target:Carbonic anhydrase I;UniProt:P00915

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4969-2;Target: Carbonic anhydrase I;UniProt: P00915;TargetFullName: Carbonic anhydrase 1;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 4969-2 | Target: Carbonic anhydrase I | UniProt: P00915

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4969-2 | Target: Carbonic anhydrase I | UniProt: P00915 | TargetFullName: Carbonic anhydrase 1 | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:4970-55;Target:carbonic anhydrase II;UniProt:P00918

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4970-55;Target: carbonic anhydrase II;UniProt: P00918;TargetFullName: Carbonic anhydrase 2;Organisim: human;Apparent_Kd_M: 4.94E-11

Real

Aptamer SeqId: 4970-55 | Target: carbonic anhydrase II | UniProt: P00918

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4970-55 | Target: carbonic anhydrase II | UniProt: P00918 | TargetFullName: Carbonic anhydrase 2 | Organisim: human | Apparent_Kd_M: 4.94E-11

Real

Aptamer SeqId:4971-1;Target:CATZ;UniProt:Q9UBR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4971-1;Target: CATZ;UniProt: Q9UBR2;TargetFullName: Cathepsin Z;Organisim: human;Apparent_Kd_M: 3.267001E-11

Real

Aptamer SeqId: 4971-1 | Target: CATZ | UniProt: Q9UBR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4971-1 | Target: CATZ | UniProt: Q9UBR2 | TargetFullName: Cathepsin Z | Organisim: human | Apparent_Kd_M: 3.267001E-11

Real

Aptamer SeqId:4973-18;Target:cIAP-2;UniProt:Q13489

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4973-18;Target: cIAP-2;UniProt: Q13489;TargetFullName: Baculoviral IAP repeat-containing protein 3;Organisim: human;Apparent_Kd_M: 8.658367E-11

Real

Aptamer SeqId: 4973-18 | Target: cIAP-2 | UniProt: Q13489

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4973-18 | Target: cIAP-2 | UniProt: Q13489 | TargetFullName: Baculoviral IAP repeat-containing protein 3 | Organisim: human | Apparent_Kd_M: 8.658367E-11

Real

Aptamer SeqId:4976-57;Target:CRK;UniProt:P46108

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4976-57;Target: CRK;UniProt: P46108;TargetFullName: Adapter molecule crk;Organisim: human;Apparent_Kd_M: 7.79E-12

Real

Aptamer SeqId: 4976-57 | Target: CRK | UniProt: P46108

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4976-57 | Target: CRK | UniProt: P46108 | TargetFullName: Adapter molecule crk | Organisim: human | Apparent_Kd_M: 7.79E-12

Real

Aptamer SeqId:4978-54;Target:DBNL;UniProt:Q9UJU6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4978-54;Target: DBNL;UniProt: Q9UJU6;TargetFullName: Drebrin-like protein;Organisim: human;Apparent_Kd_M: 3.94E-11

Real

Aptamer SeqId: 4978-54 | Target: DBNL | UniProt: Q9UJU6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4978-54 | Target: DBNL | UniProt: Q9UJU6 | TargetFullName: Drebrin-like protein | Organisim: human | Apparent_Kd_M: 3.94E-11

Real

Aptamer SeqId:4979-34;Target:DERM;UniProt:Q07507

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4979-34;Target: DERM;UniProt: Q07507;TargetFullName: Dermatopontin;Organisim: human;Apparent_Kd_M: 2.72E-11

Real

Aptamer SeqId: 4979-34 | Target: DERM | UniProt: Q07507

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4979-34 | Target: DERM | UniProt: Q07507 | TargetFullName: Dermatopontin | Organisim: human | Apparent_Kd_M: 2.72E-11

Real

Aptamer SeqId:4981-6;Target:DSC3;UniProt:Q14574

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4981-6;Target: DSC3;UniProt: Q14574;TargetFullName: Desmocollin-3;Organisim: human;Apparent_Kd_M: 3.310403E-11

Real

Aptamer SeqId: 4981-6 | Target: DSC3 | UniProt: Q14574

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4981-6 | Target: DSC3 | UniProt: Q14574 | TargetFullName: Desmocollin-3 | Organisim: human | Apparent_Kd_M: 3.310403E-11

Real

Aptamer SeqId:4982-54;Target:Elafin;UniProt:P19957

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4982-54;Target: Elafin;UniProt: P19957;TargetFullName: Elafin;Organisim: human;Apparent_Kd_M: 4.8E-12

Real

Aptamer SeqId: 4982-54 | Target: Elafin | UniProt: P19957

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4982-54 | Target: Elafin | UniProt: P19957 | TargetFullName: Elafin | Organisim: human | Apparent_Kd_M: 4.8E-12

Real

Aptamer SeqId:4984-83;Target:Esterase D;UniProt:P10768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4984-83;Target: Esterase D;UniProt: P10768;TargetFullName: S-formylglutathione hydrolase;Organisim: human;Apparent_Kd_M: 1.19E-10

Real

Aptamer SeqId: 4984-83 | Target: Esterase D | UniProt: P10768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4984-83 | Target: Esterase D | UniProt: P10768 | TargetFullName: S-formylglutathione hydrolase | Organisim: human | Apparent_Kd_M: 1.19E-10

Real

Aptamer SeqId:4985-11;Target:FABPE;UniProt:Q01469

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4985-11;Target: FABPE;UniProt: Q01469;TargetFullName: Fatty acid-binding protein; epidermal;Organisim: human;Apparent_Kd_M: 4.09E-11

Real

Aptamer SeqId: 4985-11 | Target: FABPE | UniProt: Q01469

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4985-11 | Target: FABPE | UniProt: Q01469 | TargetFullName: Fatty acid-binding protein; epidermal | Organisim: human | Apparent_Kd_M: 4.09E-11

Real

Aptamer SeqId:4986-59;Target:FAK1;UniProt:Q05397

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4986-59;Target: FAK1;UniProt: Q05397;TargetFullName: Focal adhesion kinase 1;Organisim: human;Apparent_Kd_M: 4.34E-11

Real

Aptamer SeqId: 4986-59 | Target: FAK1 | UniProt: Q05397

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4986-59 | Target: FAK1 | UniProt: Q05397 | TargetFullName: Focal adhesion kinase 1 | Organisim: human | Apparent_Kd_M: 4.34E-11

Real

Aptamer SeqId:4987-17;Target:FCAR;UniProt:P24071

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4987-17;Target: FCAR;UniProt: P24071;TargetFullName: Immunoglobulin alpha Fc receptor;Organisim: human;Apparent_Kd_M: 4.79E-10

Real

Aptamer SeqId: 4987-17 | Target: FCAR | UniProt: P24071

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4987-17 | Target: FCAR | UniProt: P24071 | TargetFullName: Immunoglobulin alpha Fc receptor | Organisim: human | Apparent_Kd_M: 4.79E-10

Real

Aptamer SeqId:4988-49;Target:FGFR4;UniProt:P22455

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4988-49;Target: FGFR4;UniProt: P22455;TargetFullName: Fibroblast growth factor receptor 4;Organisim: human;Apparent_Kd_M: 1.88E-10

Real

Aptamer SeqId: 4988-49 | Target: FGFR4 | UniProt: P22455

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4988-49 | Target: FGFR4 | UniProt: P22455 | TargetFullName: Fibroblast growth factor receptor 4 | Organisim: human | Apparent_Kd_M: 1.88E-10

Real

Aptamer SeqId:4989-7;Target:Fibrinogen g-chain dimer;UniProt:P02679

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4989-7;Target: Fibrinogen g-chain dimer;UniProt: P02679;TargetFullName: Fibrinogen gamma chain;Organisim: human;Apparent_Kd_M: 3.1E-12

Real

Aptamer SeqId: 4989-7 | Target: Fibrinogen g-chain dimer | UniProt: P02679

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4989-7 | Target: Fibrinogen g-chain dimer | UniProt: P02679 | TargetFullName: Fibrinogen gamma chain | Organisim: human | Apparent_Kd_M: 3.1E-12

Real

Aptamer SeqId:4990-87;Target:GP1BA;UniProt:P07359

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4990-87;Target: GP1BA;UniProt: P07359;TargetFullName: Platelet glycoprotein Ib alpha chain;Organisim: human;Apparent_Kd_M: 7.68E-11

Real

Aptamer SeqId: 4990-87 | Target: GP1BA | UniProt: P07359

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4990-87 | Target: GP1BA | UniProt: P07359 | TargetFullName: Platelet glycoprotein Ib alpha chain | Organisim: human | Apparent_Kd_M: 7.68E-11

Real

Aptamer SeqId:4991-12;Target:GPC5;UniProt:P78333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4991-12;Target: GPC5;UniProt: P78333;TargetFullName: Glypican-5;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 4991-12 | Target: GPC5 | UniProt: P78333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4991-12 | Target: GPC5 | UniProt: P78333 | TargetFullName: Glypican-5 | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:4992-49;Target:GRN;UniProt:P28799

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4992-49;Target: GRN;UniProt: P28799;TargetFullName: Granulins;Organisim: human;Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId: 4992-49 | Target: GRN | UniProt: P28799

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4992-49 | Target: GRN | UniProt: P28799 | TargetFullName: Granulins | Organisim: human | Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId:4993-16;Target:GSTA3;UniProt:Q16772

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4993-16;Target: GSTA3;UniProt: Q16772;TargetFullName: Glutathione S-transferase A3;Organisim: human;Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId: 4993-16 | Target: GSTA3 | UniProt: Q16772

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4993-16 | Target: GSTA3 | UniProt: Q16772 | TargetFullName: Glutathione S-transferase A3 | Organisim: human | Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId:4995-16;Target:HPG-;UniProt:P15428

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4995-16;Target: HPG-;UniProt: P15428;TargetFullName: 15-hydroxyprostaglandin dehydrogenase [NAD(+)];Organisim: human;Apparent_Kd_M: 2.99E-10

Real

Aptamer SeqId: 4995-16 | Target: HPG- | UniProt: P15428

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4995-16 | Target: HPG- | UniProt: P15428 | TargetFullName: 15-hydroxyprostaglandin dehydrogenase NAD(+) | Organisim: human | Apparent_Kd_M: 2.99E-10

Real

Aptamer SeqId:4996-66;Target:HRG;UniProt:P04196

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4996-66;Target: HRG;UniProt: P04196;TargetFullName: Histidine-rich glycoprotein;Organisim: human;Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId: 4996-66 | Target: HRG | UniProt: P04196

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4996-66 | Target: HRG | UniProt: P04196 | TargetFullName: Histidine-rich glycoprotein | Organisim: human | Apparent_Kd_M: 1.25E-11

Real

Aptamer SeqId:4997-19;Target:IF4A3;UniProt:P38919

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 4997-19;Target: IF4A3;UniProt: P38919;TargetFullName: Eukaryotic initiation factor 4A-III;Organisim: human;Apparent_Kd_M: 1.74E-10

Real

Aptamer SeqId: 4997-19 | Target: IF4A3 | UniProt: P38919

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 4997-19 | Target: IF4A3 | UniProt: P38919 | TargetFullName: Eukaryotic initiation factor 4A-III | Organisim: human | Apparent_Kd_M: 1.74E-10

Real

Aptamer SeqId:5000-52;Target:LG3BP;UniProt:Q08380

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5000-52;Target: LG3BP;UniProt: Q08380;TargetFullName: Galectin-3-binding protein;Organisim: human;Apparent_Kd_M: 3.05E-10

Real

Aptamer SeqId: 5000-52 | Target: LG3BP | UniProt: Q08380

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5000-52 | Target: LG3BP | UniProt: Q08380 | TargetFullName: Galectin-3-binding protein | Organisim: human | Apparent_Kd_M: 3.05E-10

Real

Aptamer SeqId:5001-6;Target:Mammaglobin 2;UniProt:O75556

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5001-6;Target: Mammaglobin 2;UniProt: O75556;TargetFullName: Mammaglobin-B;Organisim: human;Apparent_Kd_M: 8.07E-11

Real

Aptamer SeqId: 5001-6 | Target: Mammaglobin 2 | UniProt: O75556

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5001-6 | Target: Mammaglobin 2 | UniProt: O75556 | TargetFullName: Mammaglobin-B | Organisim: human | Apparent_Kd_M: 8.07E-11

Real

Aptamer SeqId:5002-76;Target:MMP-14;UniProt:P50281

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5002-76;Target: MMP-14;UniProt: P50281;TargetFullName: Matrix metalloproteinase-14;Organisim: human;Apparent_Kd_M: 3.71E-11

Real

Aptamer SeqId: 5002-76 | Target: MMP-14 | UniProt: P50281

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5002-76 | Target: MMP-14 | UniProt: P50281 | TargetFullName: Matrix metalloproteinase-14 | Organisim: human | Apparent_Kd_M: 3.71E-11

Real

Aptamer SeqId:5004-69;Target:MK11;UniProt:Q15759

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5004-69;Target: MK11;UniProt: Q15759;TargetFullName: Mitogen-activated protein kinase 11;Organisim: human;Apparent_Kd_M: 8.26E-12

Real

Aptamer SeqId: 5004-69 | Target: MK11 | UniProt: Q15759

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5004-69 | Target: MK11 | UniProt: Q15759 | TargetFullName: Mitogen-activated protein kinase 11 | Organisim: human | Apparent_Kd_M: 8.26E-12

Real

Aptamer SeqId:5005-4;Target:MK12;UniProt:P53778

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5005-4;Target: MK12;UniProt: P53778;TargetFullName: Mitogen-activated protein kinase 12;Organisim: human;Apparent_Kd_M: 4.5E-11

Real

Aptamer SeqId: 5005-4 | Target: MK12 | UniProt: P53778

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5005-4 | Target: MK12 | UniProt: P53778 | TargetFullName: Mitogen-activated protein kinase 12 | Organisim: human | Apparent_Kd_M: 4.5E-11

Real

Aptamer SeqId:5006-71;Target:MK13;UniProt:O15264

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5006-71;Target: MK13;UniProt: O15264;TargetFullName: Mitogen-activated protein kinase 13;Organisim: human;Apparent_Kd_M: 4.15E-12

Real

Aptamer SeqId: 5006-71 | Target: MK13 | UniProt: O15264

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5006-71 | Target: MK13 | UniProt: O15264 | TargetFullName: Mitogen-activated protein kinase 13 | Organisim: human | Apparent_Kd_M: 4.15E-12

Real

Aptamer SeqId:5007-1;Target:MAPK14;UniProt:Q16539

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5007-1;Target: MAPK14;UniProt: Q16539;TargetFullName: Mitogen-activated protein kinase 14;Organisim: human;Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId: 5007-1 | Target: MAPK14 | UniProt: Q16539

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5007-1 | Target: MAPK14 | UniProt: Q16539 | TargetFullName: Mitogen-activated protein kinase 14 | Organisim: human | Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId:5008-51;Target:Mn SOD;UniProt:P04179

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5008-51;Target: Mn SOD;UniProt: P04179;TargetFullName: Superoxide dismutase [Mn]; mitochondrial;Organisim: human;Apparent_Kd_M: 8.25E-11

Real

Aptamer SeqId: 5008-51 | Target: Mn SOD | UniProt: P04179

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5008-51 | Target: Mn SOD | UniProt: P04179 | TargetFullName: Superoxide dismutase Mn; mitochondrial | Organisim: human | Apparent_Kd_M: 8.25E-11

Real

Aptamer SeqId:5009-11;Target:Moesin;UniProt:P26038

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5009-11;Target: Moesin;UniProt: P26038;TargetFullName: Moesin;Organisim: human;Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId: 5009-11 | Target: Moesin | UniProt: P26038

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5009-11 | Target: Moesin | UniProt: P26038 | TargetFullName: Moesin | Organisim: human | Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId:5011-11;Target:PBEF;UniProt:P43490

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5011-11;Target: PBEF;UniProt: P43490;TargetFullName: Nicotinamide phosphoribosyltransferase;Organisim: human;Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId: 5011-11 | Target: PBEF | UniProt: P43490

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5011-11 | Target: PBEF | UniProt: P43490 | TargetFullName: Nicotinamide phosphoribosyltransferase | Organisim: human | Apparent_Kd_M: 3.59E-12

Real

Aptamer SeqId:5012-67;Target:Myokinase; human;UniProt:P00568

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5012-67;Target: Myokinase; human;UniProt: P00568;TargetFullName: Adenylate kinase isoenzyme 1;Organisim: human;Apparent_Kd_M: 4.42E-12

Real

Aptamer SeqId: 5012-67 | Target: Myokinase; human | UniProt: P00568

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5012-67 | Target: Myokinase; human | UniProt: P00568 | TargetFullName: Adenylate kinase isoenzyme 1 | Organisim: human | Apparent_Kd_M: 4.42E-12

Real

Aptamer SeqId:5013-2;Target:NCC27;UniProt:O00299

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5013-2;Target: NCC27;UniProt: O00299;TargetFullName: Chloride intracellular channel protein 1;Organisim: human;Apparent_Kd_M: 2.95E-11

Real

Aptamer SeqId: 5013-2 | Target: NCC27 | UniProt: O00299

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5013-2 | Target: NCC27 | UniProt: O00299 | TargetFullName: Chloride intracellular channel protein 1 | Organisim: human | Apparent_Kd_M: 2.95E-11

Real

Aptamer SeqId:5014-49;Target:NCK1;UniProt:P16333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5014-49;Target: NCK1;UniProt: P16333;TargetFullName: Cytoplasmic protein NCK1;Organisim: human;Apparent_Kd_M: 4.83E-12

Real

Aptamer SeqId: 5014-49 | Target: NCK1 | UniProt: P16333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5014-49 | Target: NCK1 | UniProt: P16333 | TargetFullName: Cytoplasmic protein NCK1 | Organisim: human | Apparent_Kd_M: 4.83E-12

Real

Aptamer SeqId:5015-15;Target:PAFAH;UniProt:Q13093

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5015-15;Target: PAFAH;UniProt: Q13093;TargetFullName: Platelet-activating factor acetylhydrolase;Organisim: human;Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId: 5015-15 | Target: PAFAH | UniProt: Q13093

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5015-15 | Target: PAFAH | UniProt: Q13093 | TargetFullName: Platelet-activating factor acetylhydrolase | Organisim: human | Apparent_Kd_M: 3.0E-11

Real

Aptamer SeqId:5017-19;Target:Peroxiredoxin-5;UniProt:P30044

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5017-19;Target: Peroxiredoxin-5;UniProt: P30044;TargetFullName: Peroxiredoxin-5; mitochondrial;Organisim: human;Apparent_Kd_M: 1.05E-10

Real

Aptamer SeqId: 5017-19 | Target: Peroxiredoxin-5 | UniProt: P30044

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5017-19 | Target: Peroxiredoxin-5 | UniProt: P30044 | TargetFullName: Peroxiredoxin-5; mitochondrial | Organisim: human | Apparent_Kd_M: 1.05E-10

Real

Aptamer SeqId:5018-68;Target:Peroxiredoxin-6;UniProt:P30041

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5018-68;Target: Peroxiredoxin-6;UniProt: P30041;TargetFullName: Peroxiredoxin-6;Organisim: human;Apparent_Kd_M: 1.66E-11

Real

Aptamer SeqId: 5018-68 | Target: Peroxiredoxin-6 | UniProt: P30041

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5018-68 | Target: Peroxiredoxin-6 | UniProt: P30041 | TargetFullName: Peroxiredoxin-6 | Organisim: human | Apparent_Kd_M: 1.66E-11

Real

Aptamer SeqId:5019-16;Target:PGP9.5;UniProt:P09936

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5019-16;Target: PGP9.5;UniProt: P09936;TargetFullName: Ubiquitin carboxyl-terminal hydrolase isozyme L1;Organisim: human;Apparent_Kd_M: 2.42E-11

Real

Aptamer SeqId: 5019-16 | Target: PGP9.5 | UniProt: P09936

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5019-16 | Target: PGP9.5 | UniProt: P09936 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Organisim: human | Apparent_Kd_M: 2.42E-11

Real

Aptamer SeqId:5020-50;Target:phosphoglycerate kinase 1;UniProt:P00558

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5020-50;Target: phosphoglycerate kinase 1;UniProt: P00558;TargetFullName: Phosphoglycerate kinase 1;Organisim: human;Apparent_Kd_M: 5.24E-11

Real

Aptamer SeqId: 5020-50 | Target: phosphoglycerate kinase 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5020-50 | Target: phosphoglycerate kinase 1 | UniProt: P00558 | TargetFullName: Phosphoglycerate kinase 1 | Organisim: human | Apparent_Kd_M: 5.24E-11

Real

Aptamer SeqId:5021-13;Target:PPase;UniProt:Q15181

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5021-13;Target: PPase;UniProt: Q15181;TargetFullName: Inorganic pyrophosphatase;Organisim: human;Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId: 5021-13 | Target: PPase | UniProt: Q15181

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5021-13 | Target: PPase | UniProt: Q15181 | TargetFullName: Inorganic pyrophosphatase | Organisim: human | Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId:5023-23;Target:PUR8;UniProt:P30566

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5023-23;Target: PUR8;UniProt: P30566;TargetFullName: Adenylosuccinate lyase;Organisim: human;Apparent_Kd_M: 8.11E-11

Real

Aptamer SeqId: 5023-23 | Target: PUR8 | UniProt: P30566

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5023-23 | Target: PUR8 | UniProt: P30566 | TargetFullName: Adenylosuccinate lyase | Organisim: human | Apparent_Kd_M: 8.11E-11

Real

Aptamer SeqId:5024-67;Target:Rb;UniProt:P06400

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5024-67;Target: Rb;UniProt: P06400;TargetFullName: Retinoblastoma-associated protein;Organisim: human;Apparent_Kd_M: 5.47E-11

Real

Aptamer SeqId: 5024-67 | Target: Rb | UniProt: P06400

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5024-67 | Target: Rb | UniProt: P06400 | TargetFullName: Retinoblastoma-associated protein | Organisim: human | Apparent_Kd_M: 5.47E-11

Real

Aptamer SeqId:5026-66;Target:RS3;UniProt:P23396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5026-66;Target: RS3;UniProt: P23396;TargetFullName: 40S ribosomal protein S3;Organisim: human;Apparent_Kd_M: 3.65E-11

Real

Aptamer SeqId: 5026-66 | Target: RS3 | UniProt: P23396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5026-66 | Target: RS3 | UniProt: P23396 | TargetFullName: 40S ribosomal protein S3 | Organisim: human | Apparent_Kd_M: 3.65E-11

Real

Aptamer SeqId:5028-59;Target:sCD163;UniProt:Q86VB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5028-59;Target: sCD163;UniProt: Q86VB7;TargetFullName: Scavenger receptor cysteine-rich type 1 protein M130;Organisim: human;Apparent_Kd_M: 4.55E-11

Real

Aptamer SeqId: 5028-59 | Target: sCD163 | UniProt: Q86VB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5028-59 | Target: sCD163 | UniProt: Q86VB7 | TargetFullName: Scavenger receptor cysteine-rich type 1 protein M130 | Organisim: human | Apparent_Kd_M: 4.55E-11

Real

Aptamer SeqId:5029-3;Target:SEPR;UniProt:Q12884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5029-3;Target: SEPR;UniProt: Q12884;TargetFullName: Prolyl endopeptidase FAP;Organisim: human;Apparent_Kd_M: 6.12E-11

Real

Aptamer SeqId: 5029-3 | Target: SEPR | UniProt: Q12884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5029-3 | Target: SEPR | UniProt: Q12884 | TargetFullName: Prolyl endopeptidase FAP | Organisim: human | Apparent_Kd_M: 6.12E-11

Real

Aptamer SeqId:5030-52;Target:SIRT2;UniProt:Q8IXJ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5030-52;Target: SIRT2;UniProt: Q8IXJ6;TargetFullName: NAD-dependent protein deacetylase sirtuin-2;Organisim: human;Apparent_Kd_M: 4.55E-11

Real

Aptamer SeqId: 5030-52 | Target: SIRT2 | UniProt: Q8IXJ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5030-52 | Target: SIRT2 | UniProt: Q8IXJ6 | TargetFullName: NAD-dependent protein deacetylase sirtuin-2 | Organisim: human | Apparent_Kd_M: 4.55E-11

Real

Aptamer SeqId:5031-10;Target:SPTA2;UniProt:Q13813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5031-10;Target: SPTA2;UniProt: Q13813;TargetFullName: Spectrin alpha chain; non-erythrocytic 1;Organisim: human;Apparent_Kd_M: 2.72E-10

Real

Aptamer SeqId: 5031-10 | Target: SPTA2 | UniProt: Q13813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5031-10 | Target: SPTA2 | UniProt: Q13813 | TargetFullName: Spectrin alpha chain; non-erythrocytic 1 | Organisim: human | Apparent_Kd_M: 2.72E-10

Real

Aptamer SeqId:5032-64;Target:SSRP1;UniProt:Q08945

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5032-64;Target: SSRP1;UniProt: Q08945;TargetFullName: FACT complex subunit SSRP1;Organisim: human;Apparent_Kd_M: 8.95E-11

Real

Aptamer SeqId: 5032-64 | Target: SSRP1 | UniProt: Q08945

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5032-64 | Target: SSRP1 | UniProt: Q08945 | TargetFullName: FACT complex subunit SSRP1 | Organisim: human | Apparent_Kd_M: 8.95E-11

Real

Aptamer SeqId:5033-27;Target:Tropomyosin 1 alpha chain;UniProt:P09493

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5033-27;Target: Tropomyosin 1 alpha chain;UniProt: P09493;TargetFullName: Tropomyosin alpha-1 chain;Organisim: human;Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId: 5033-27 | Target: Tropomyosin 1 alpha chain

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5033-27 | Target: Tropomyosin 1 alpha chain | UniProt: P09493 | TargetFullName: Tropomyosin alpha-1 chain | Organisim: human | Apparent_Kd_M: 1.53E-11

Real

Aptamer SeqId:5034-79;Target:Trypsin 2;UniProt:P07478

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5034-79;Target: Trypsin 2;UniProt: P07478;TargetFullName: Trypsin-2;Organisim: human;Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId: 5034-79 | Target: Trypsin 2 | UniProt: P07478

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5034-79 | Target: Trypsin 2 | UniProt: P07478 | TargetFullName: Trypsin-2 | Organisim: human | Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId:5035-7;Target:TS;UniProt:P04818

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5035-7;Target: TS;UniProt: P04818;TargetFullName: Thymidylate synthase;Organisim: human;Apparent_Kd_M: 5.12E-11

Real

Aptamer SeqId: 5035-7 | Target: TS | UniProt: P04818

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5035-7 | Target: TS | UniProt: P04818 | TargetFullName: Thymidylate synthase | Organisim: human | Apparent_Kd_M: 5.12E-11

Real

Aptamer SeqId:5036-50;Target:TSG-6;UniProt:P98066

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5036-50;Target: TSG-6;UniProt: P98066;TargetFullName: Tumor necrosis factor-inducible gene 6 protein;Organisim: human;Apparent_Kd_M: 1.62E-12

Real

Aptamer SeqId: 5036-50 | Target: TSG-6 | UniProt: P98066

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5036-50 | Target: TSG-6 | UniProt: P98066 | TargetFullName: Tumor necrosis factor-inducible gene 6 protein | Organisim: human | Apparent_Kd_M: 1.62E-12

Real

Aptamer SeqId:5060-62;Target:B7-H1;UniProt:Q9NZQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5060-62;Target: B7-H1;UniProt: Q9NZQ7;TargetFullName: Programmed cell death 1 ligand 1;Organisim: human;Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId: 5060-62 | Target: B7-H1 | UniProt: Q9NZQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5060-62 | Target: B7-H1 | UniProt: Q9NZQ7 | TargetFullName: Programmed cell death 1 ligand 1 | Organisim: human | Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId:5061-27;Target:B7-H2;UniProt:O75144

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5061-27;Target: B7-H2;UniProt: O75144;TargetFullName: ICOS ligand;Organisim: human;Apparent_Kd_M: 1.25E-10

Real

Aptamer SeqId: 5061-27 | Target: B7-H2 | UniProt: O75144

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5061-27 | Target: B7-H2 | UniProt: O75144 | TargetFullName: ICOS ligand | Organisim: human | Apparent_Kd_M: 1.25E-10

Real

Aptamer SeqId:5062-60;Target:CD226;UniProt:Q15762

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5062-60;Target: CD226;UniProt: Q15762;TargetFullName: CD226 antigen;Organisim: human;Apparent_Kd_M: 2.01E-10

Real

Aptamer SeqId: 5062-60 | Target: CD226 | UniProt: Q15762

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5062-60 | Target: CD226 | UniProt: Q15762 | TargetFullName: CD226 antigen | Organisim: human | Apparent_Kd_M: 2.01E-10

Real

Aptamer SeqId:5063-12;Target:CD244;UniProt:Q9BZW8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5063-12;Target: CD244;UniProt: Q9BZW8;TargetFullName: Natural killer cell receptor 2B4;Organisim: human;Apparent_Kd_M: 2.93E-11

Real

Aptamer SeqId: 5063-12 | Target: CD244 | UniProt: Q9BZW8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5063-12 | Target: CD244 | UniProt: Q9BZW8 | TargetFullName: Natural killer cell receptor 2B4 | Organisim: human | Apparent_Kd_M: 2.93E-11

Real

Aptamer SeqId:5065-8;Target:CD83;UniProt:Q01151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5065-8;Target: CD83;UniProt: Q01151;TargetFullName: CD83 antigen;Organisim: human;Apparent_Kd_M: 5.15E-11

Real

Aptamer SeqId: 5065-8 | Target: CD83 | UniProt: Q01151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5065-8 | Target: CD83 | UniProt: Q01151 | TargetFullName: CD83 antigen | Organisim: human | Apparent_Kd_M: 5.15E-11

Real

Aptamer SeqId:5066-134;Target:CLM6;UniProt:Q08708

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5066-134;Target: CLM6;UniProt: Q08708;TargetFullName: CMRF35-like molecule 6;Organisim: human;Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId: 5066-134 | Target: CLM6 | UniProt: Q08708

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5066-134 | Target: CLM6 | UniProt: Q08708 | TargetFullName: CMRF35-like molecule 6 | Organisim: human | Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId:5069-9;Target:DAF;UniProt:P08174

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5069-9;Target: DAF;UniProt: P08174;TargetFullName: Complement decay-accelerating factor;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 5069-9 | Target: DAF | UniProt: P08174

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5069-9 | Target: DAF | UniProt: P08174 | TargetFullName: Complement decay-accelerating factor | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:5070-76;Target:DcR3;UniProt:O95407

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5070-76;Target: DcR3;UniProt: O95407;TargetFullName: Tumor necrosis factor receptor superfamily member 6B;Organisim: human;Apparent_Kd_M: 4.9E-11

Real

Aptamer SeqId: 5070-76 | Target: DcR3 | UniProt: O95407

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5070-76 | Target: DcR3 | UniProt: O95407 | TargetFullName: Tumor necrosis factor receptor superfamily member 6B | Organisim: human | Apparent_Kd_M: 4.9E-11

Real

Aptamer SeqId:5076-53;Target:EPHAA;UniProt:Q5JZY3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5076-53;Target: EPHAA;UniProt: Q5JZY3;TargetFullName: Ephrin type-A receptor 10;Organisim: human;Apparent_Kd_M: 2.46E-12

Real

Aptamer SeqId: 5076-53 | Target: EPHAA | UniProt: Q5JZY3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5076-53 | Target: EPHAA | UniProt: Q5JZY3 | TargetFullName: Ephrin type-A receptor 10 | Organisim: human | Apparent_Kd_M: 2.46E-12

Real

Aptamer SeqId:5078-82;Target:EphB6;UniProt:O15197

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5078-82;Target: EphB6;UniProt: O15197;TargetFullName: Ephrin type-B receptor 6;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 5078-82 | Target: EphB6 | UniProt: O15197

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5078-82 | Target: EphB6 | UniProt: O15197 | TargetFullName: Ephrin type-B receptor 6 | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:5082-51;Target:IL-1 sR9;UniProt:Q9NP60

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5082-51;Target: IL-1 sR9;UniProt: Q9NP60;TargetFullName: X-linked interleukin-1 receptor accessory protein-like 2;Organisim: human;Apparent_Kd_M: 1.73E-11

Real

Aptamer SeqId: 5082-51 | Target: IL-1 sR9 | UniProt: Q9NP60

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5082-51 | Target: IL-1 sR9 | UniProt: Q9NP60 | TargetFullName: X-linked interleukin-1 receptor accessory protein-like 2 | Organisim: human | Apparent_Kd_M: 1.73E-11

Real

Aptamer SeqId:5085-18;Target:IL-20 Ra;UniProt:Q9UHF4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5085-18;Target: IL-20 Ra;UniProt: Q9UHF4;TargetFullName: Interleukin-20 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId: 5085-18 | Target: IL-20 Ra | UniProt: Q9UHF4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5085-18 | Target: IL-20 Ra | UniProt: Q9UHF4 | TargetFullName: Interleukin-20 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.28E-12

Real

Aptamer SeqId:5087-5;Target:IL-22BP;UniProt:Q969J5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5087-5;Target: IL-22BP;UniProt: Q969J5;TargetFullName: Interleukin-22 receptor subunit alpha-2;Organisim: human;Apparent_Kd_M: 5.54E-12

Real

Aptamer SeqId: 5087-5 | Target: IL-22BP | UniProt: Q969J5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5087-5 | Target: IL-22BP | UniProt: Q969J5 | TargetFullName: Interleukin-22 receptor subunit alpha-2 | Organisim: human | Apparent_Kd_M: 5.54E-12

Real

Aptamer SeqId:5088-175;Target:IL-23 R;UniProt:Q5VWK5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5088-175;Target: IL-23 R;UniProt: Q5VWK5;TargetFullName: Interleukin-23 receptor;Organisim: human;Apparent_Kd_M: 2.7E-12

Real

Aptamer SeqId: 5088-175 | Target: IL-23 R | UniProt: Q5VWK5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5088-175 | Target: IL-23 R | UniProt: Q5VWK5 | TargetFullName: Interleukin-23 receptor | Organisim: human | Apparent_Kd_M: 2.7E-12

Real

Aptamer SeqId:5089-11;Target:IL-7 Ra;UniProt:P16871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5089-11;Target: IL-7 Ra;UniProt: P16871;TargetFullName: Interleukin-7 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 2.06E-11

Real

Aptamer SeqId: 5089-11 | Target: IL-7 Ra | UniProt: P16871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5089-11 | Target: IL-7 Ra | UniProt: P16871 | TargetFullName: Interleukin-7 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 2.06E-11

Real

Aptamer SeqId:5090-49;Target:ILT-2;UniProt:Q8NHL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5090-49;Target: ILT-2;UniProt: Q8NHL6;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 1;Organisim: human;Apparent_Kd_M: 4.72E-12

Real

Aptamer SeqId: 5090-49 | Target: ILT-2 | UniProt: Q8NHL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5090-49 | Target: ILT-2 | UniProt: Q8NHL6 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 1 | Organisim: human | Apparent_Kd_M: 4.72E-12

Real

Aptamer SeqId:5091-28;Target:ILT-4;UniProt:Q8N423

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5091-28;Target: ILT-4;UniProt: Q8N423;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 2;Organisim: human;Apparent_Kd_M: 1.6E-12

Real

Aptamer SeqId: 5091-28 | Target: ILT-4 | UniProt: Q8N423

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5091-28 | Target: ILT-4 | UniProt: Q8N423 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 2 | Organisim: human | Apparent_Kd_M: 1.6E-12

Real

Aptamer SeqId:5092-51;Target:JAG1;UniProt:P78504

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5092-51;Target: JAG1;UniProt: P78504;TargetFullName: Protein jagged-1;Organisim: human;Apparent_Kd_M: 3.99E-12

Real

Aptamer SeqId: 5092-51 | Target: JAG1 | UniProt: P78504

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5092-51 | Target: JAG1 | UniProt: P78504 | TargetFullName: Protein jagged-1 | Organisim: human | Apparent_Kd_M: 3.99E-12

Real

Aptamer SeqId:5093-47;Target:JAG2;UniProt:Q9Y219

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5093-47;Target: JAG2;UniProt: Q9Y219;TargetFullName: Protein jagged-2;Organisim: human;Apparent_Kd_M: 1.35E-11

Real

Aptamer SeqId: 5093-47 | Target: JAG2 | UniProt: Q9Y219

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5093-47 | Target: JAG2 | UniProt: Q9Y219 | TargetFullName: Protein jagged-2 | Organisim: human | Apparent_Kd_M: 1.35E-11

Real

Aptamer SeqId:5094-62;Target:JAML1;UniProt:Q86YT9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5094-62;Target: JAML1;UniProt: Q86YT9;TargetFullName: Junctional adhesion molecule-like;Organisim: human;Apparent_Kd_M: 4.76E-12

Real

Aptamer SeqId: 5094-62 | Target: JAML1 | UniProt: Q86YT9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5094-62 | Target: JAML1 | UniProt: Q86YT9 | TargetFullName: Junctional adhesion molecule-like | Organisim: human | Apparent_Kd_M: 4.76E-12

Real

Aptamer SeqId:5095-21;Target:KI2L4;UniProt:Q99706

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5095-21;Target: KI2L4;UniProt: Q99706;TargetFullName: Killer cell immunoglobulin-like receptor 2DL4;Organisim: human;Apparent_Kd_M: 1.08E-10

Real

Aptamer SeqId: 5095-21 | Target: KI2L4 | UniProt: Q99706

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5095-21 | Target: KI2L4 | UniProt: Q99706 | TargetFullName: Killer cell immunoglobulin-like receptor 2DL4 | Organisim: human | Apparent_Kd_M: 1.08E-10

Real

Aptamer SeqId:5096-51;Target:KI3L2;UniProt:P43630

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5096-51;Target: KI3L2;UniProt: P43630;TargetFullName: Killer cell immunoglobulin-like receptor 3DL2;Organisim: human;Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId: 5096-51 | Target: KI3L2 | UniProt: P43630

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5096-51 | Target: KI3L2 | UniProt: P43630 | TargetFullName: Killer cell immunoglobulin-like receptor 3DL2 | Organisim: human | Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId:5097-14;Target:KI3S1;UniProt:Q14943

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5097-14;Target: KI3S1;UniProt: Q14943;TargetFullName: Killer cell immunoglobulin-like receptor 3DS1;Organisim: human;Apparent_Kd_M: 1.19E-10

Real

Aptamer SeqId: 5097-14 | Target: KI3S1 | UniProt: Q14943

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5097-14 | Target: KI3S1 | UniProt: Q14943 | TargetFullName: Killer cell immunoglobulin-like receptor 3DS1 | Organisim: human | Apparent_Kd_M: 1.19E-10

Real

Aptamer SeqId:5098-79;Target:KLRF1;UniProt:Q9NZS2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5098-79;Target: KLRF1;UniProt: Q9NZS2;TargetFullName: Killer cell lectin-like receptor subfamily F member 1;Organisim: human;Apparent_Kd_M: 8.2E-12

Real

Aptamer SeqId: 5098-79 | Target: KLRF1 | UniProt: Q9NZS2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5098-79 | Target: KLRF1 | UniProt: Q9NZS2 | TargetFullName: Killer cell lectin-like receptor subfamily F member 1 | Organisim: human | Apparent_Kd_M: 8.2E-12

Real

Aptamer SeqId:5100-53;Target:LIMP II;UniProt:Q14108

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5100-53;Target: LIMP II;UniProt: Q14108;TargetFullName: Lysosome membrane protein 2;Organisim: human;Apparent_Kd_M: 8.7E-11

Real

Aptamer SeqId: 5100-53 | Target: LIMP II | UniProt: Q14108

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5100-53 | Target: LIMP II | UniProt: Q14108 | TargetFullName: Lysosome membrane protein 2 | Organisim: human | Apparent_Kd_M: 8.7E-11

Real

Aptamer SeqId:5102-55;Target:MICB;UniProt:Q29980

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5102-55;Target: MICB;UniProt: Q29980;TargetFullName: MHC class I polypeptide-related sequence B;Organisim: human;Apparent_Kd_M: 7.17E-12

Real

Aptamer SeqId: 5102-55 | Target: MICB | UniProt: Q29980

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5102-55 | Target: MICB | UniProt: Q29980 | TargetFullName: MHC class I polypeptide-related sequence B | Organisim: human | Apparent_Kd_M: 7.17E-12

Real

Aptamer SeqId:5103-30;Target:MO2R1;UniProt:Q8TD46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5103-30;Target: MO2R1;UniProt: Q8TD46;TargetFullName: Cell surface glycoprotein CD200 receptor 1;Organisim: human;Apparent_Kd_M: 1.73E-10

Real

Aptamer SeqId: 5103-30 | Target: MO2R1 | UniProt: Q8TD46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5103-30 | Target: MO2R1 | UniProt: Q8TD46 | TargetFullName: Cell surface glycoprotein CD200 receptor 1 | Organisim: human | Apparent_Kd_M: 1.73E-10

Real

Aptamer SeqId:5105-2;Target:Nogo Receptor;UniProt:Q9BZR6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5105-2;Target: Nogo Receptor;UniProt: Q9BZR6;TargetFullName: Reticulon-4 receptor;Organisim: human;Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId: 5105-2 | Target: Nogo Receptor | UniProt: Q9BZR6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5105-2 | Target: Nogo Receptor | UniProt: Q9BZR6 | TargetFullName: Reticulon-4 receptor | Organisim: human | Apparent_Kd_M: 1.39E-11

Real

Aptamer SeqId:5106-52;Target:NOTC2;UniProt:Q04721

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5106-52;Target: NOTC2;UniProt: Q04721;TargetFullName: Neurogenic locus notch homolog protein 2;Organisim: human;Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId: 5106-52 | Target: NOTC2 | UniProt: Q04721

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5106-52 | Target: NOTC2 | UniProt: Q04721 | TargetFullName: Neurogenic locus notch homolog protein 2 | Organisim: human | Apparent_Kd_M: 1.41E-11

Real

Aptamer SeqId:5107-7;Target:Notch 1;UniProt:P46531

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5107-7;Target: Notch 1;UniProt: P46531;TargetFullName: Neurogenic locus notch homolog protein 1;Organisim: human;Apparent_Kd_M: 2.38E-12

Real

Aptamer SeqId: 5107-7 | Target: Notch 1 | UniProt: P46531

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5107-7 | Target: Notch 1 | UniProt: P46531 | TargetFullName: Neurogenic locus notch homolog protein 1 | Organisim: human | Apparent_Kd_M: 2.38E-12

Real

Aptamer SeqId:5108-72;Target:Notch-3;UniProt:Q9UM47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5108-72;Target: Notch-3;UniProt: Q9UM47;TargetFullName: Neurogenic locus notch homolog protein 3;Organisim: human;Apparent_Kd_M: 7.57E-12

Real

Aptamer SeqId: 5108-72 | Target: Notch-3 | UniProt: Q9UM47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5108-72 | Target: Notch-3 | UniProt: Q9UM47 | TargetFullName: Neurogenic locus notch homolog protein 3 | Organisim: human | Apparent_Kd_M: 7.57E-12

Real

Aptamer SeqId:5109-24;Target:Nr-CAM;UniProt:Q92823

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5109-24;Target: Nr-CAM;UniProt: Q92823;TargetFullName: Neuronal cell adhesion molecule;Organisim: human;Apparent_Kd_M: 5.19E-12

Real

Aptamer SeqId: 5109-24 | Target: Nr-CAM | UniProt: Q92823

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5109-24 | Target: Nr-CAM | UniProt: Q92823 | TargetFullName: Neuronal cell adhesion molecule | Organisim: human | Apparent_Kd_M: 5.19E-12

Real

Aptamer SeqId:5110-84;Target:NRX1B;UniProt:P58400

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5110-84;Target: NRX1B;UniProt: P58400;TargetFullName: Neurexin-1-beta;Organisim: human;Apparent_Kd_M: 4.88E-11

Real

Aptamer SeqId: 5110-84 | Target: NRX1B | UniProt: P58400

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5110-84 | Target: NRX1B | UniProt: P58400 | TargetFullName: Neurexin-1-beta | Organisim: human | Apparent_Kd_M: 4.88E-11

Real

Aptamer SeqId:5111-15;Target:NRX3B;UniProt:Q9HDB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5111-15;Target: NRX3B;UniProt: Q9HDB5;TargetFullName: Neurexin-3-beta;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 5111-15 | Target: NRX3B | UniProt: Q9HDB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5111-15 | Target: NRX3B | UniProt: Q9HDB5 | TargetFullName: Neurexin-3-beta | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:5112-73;Target:OX2G;UniProt:P41217

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5112-73;Target: OX2G;UniProt: P41217;TargetFullName: OX-2 membrane glycoprotein;Organisim: human;Apparent_Kd_M: 2.95E-12

Real

Aptamer SeqId: 5112-73 | Target: OX2G | UniProt: P41217

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5112-73 | Target: OX2G | UniProt: P41217 | TargetFullName: OX-2 membrane glycoprotein | Organisim: human | Apparent_Kd_M: 2.95E-12

Real

Aptamer SeqId:5114-65;Target:Prolactin Receptor;UniProt:P16471

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5114-65;Target: Prolactin Receptor;UniProt: P16471;TargetFullName: Prolactin receptor;Organisim: human;Apparent_Kd_M: 8.19E-12

Real

Aptamer SeqId: 5114-65 | Target: Prolactin Receptor | UniProt: P16471

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5114-65 | Target: Prolactin Receptor | UniProt: P16471 | TargetFullName: Prolactin receptor | Organisim: human | Apparent_Kd_M: 8.19E-12

Real

Aptamer SeqId:5116-62;Target:ROBO2;UniProt:Q9HCK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5116-62;Target: ROBO2;UniProt: Q9HCK4;TargetFullName: Roundabout homolog 2;Organisim: human;Apparent_Kd_M: 1.12E-12

Real

Aptamer SeqId: 5116-62 | Target: ROBO2 | UniProt: Q9HCK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5116-62 | Target: ROBO2 | UniProt: Q9HCK4 | TargetFullName: Roundabout homolog 2 | Organisim: human | Apparent_Kd_M: 1.12E-12

Real

Aptamer SeqId:5117-14;Target:ROBO3;UniProt:Q96MS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5117-14;Target: ROBO3;UniProt: Q96MS0;TargetFullName: Roundabout homolog 3;Organisim: human;Apparent_Kd_M: 4.14E-12

Real

Aptamer SeqId: 5117-14 | Target: ROBO3 | UniProt: Q96MS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5117-14 | Target: ROBO3 | UniProt: Q96MS0 | TargetFullName: Roundabout homolog 3 | Organisim: human | Apparent_Kd_M: 4.14E-12

Real

Aptamer SeqId:5121-3;Target:SEM6B;UniProt:Q9H3T3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5121-3;Target: SEM6B;UniProt: Q9H3T3;TargetFullName: Semaphorin-6B;Organisim: human;Apparent_Kd_M: 8.39E-12

Real

Aptamer SeqId: 5121-3 | Target: SEM6B | UniProt: Q9H3T3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5121-3 | Target: SEM6B | UniProt: Q9H3T3 | TargetFullName: Semaphorin-6B | Organisim: human | Apparent_Kd_M: 8.39E-12

Real

Aptamer SeqId:5124-69;Target:sICAM-5;UniProt:Q9UMF0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5124-69;Target: sICAM-5;UniProt: Q9UMF0;TargetFullName: Intercellular adhesion molecule 5;Organisim: human;Apparent_Kd_M: 2.54E-12

Real

Aptamer SeqId: 5124-69 | Target: sICAM-5 | UniProt: Q9UMF0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5124-69 | Target: sICAM-5 | UniProt: Q9UMF0 | TargetFullName: Intercellular adhesion molecule 5 | Organisim: human | Apparent_Kd_M: 2.54E-12

Real

Aptamer SeqId:5128-53;Target:SLAF6;UniProt:Q96DU3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5128-53;Target: SLAF6;UniProt: Q96DU3;TargetFullName: SLAM family member 6;Organisim: human;Apparent_Kd_M: 2.3E-10

Real

Aptamer SeqId: 5128-53 | Target: SLAF6 | UniProt: Q96DU3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5128-53 | Target: SLAF6 | UniProt: Q96DU3 | TargetFullName: SLAM family member 6 | Organisim: human | Apparent_Kd_M: 2.3E-10

Real

Aptamer SeqId:5129-12;Target:SREC-I;UniProt:Q14162

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5129-12;Target: SREC-I;UniProt: Q14162;TargetFullName: Scavenger receptor class F member 1;Organisim: human;Apparent_Kd_M: 1.09E-12

Real

Aptamer SeqId: 5129-12 | Target: SREC-I | UniProt: Q14162

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5129-12 | Target: SREC-I | UniProt: Q14162 | TargetFullName: Scavenger receptor class F member 1 | Organisim: human | Apparent_Kd_M: 1.09E-12

Real

Aptamer SeqId:5131-15;Target:TAJ;UniProt:Q9NS68

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5131-15;Target: TAJ;UniProt: Q9NS68;TargetFullName: Tumor necrosis factor receptor superfamily member 19;Organisim: human;Apparent_Kd_M: 6.0E-11

Real

Aptamer SeqId: 5131-15 | Target: TAJ | UniProt: Q9NS68

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5131-15 | Target: TAJ | UniProt: Q9NS68 | TargetFullName: Tumor necrosis factor receptor superfamily member 19 | Organisim: human | Apparent_Kd_M: 6.0E-11

Real

Aptamer SeqId:5132-71;Target:TCCR;UniProt:Q6UWB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5132-71;Target: TCCR;UniProt: Q6UWB1;TargetFullName: Interleukin-27 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 5.46E-12

Real

Aptamer SeqId: 5132-71 | Target: TCCR | UniProt: Q6UWB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5132-71 | Target: TCCR | UniProt: Q6UWB1 | TargetFullName: Interleukin-27 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 5.46E-12

Real

Aptamer SeqId:5133-17;Target:TGF-b R II;UniProt:P37173

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5133-17;Target: TGF-b R II;UniProt: P37173;TargetFullName: TGF-beta receptor type-2;Organisim: human;Apparent_Kd_M: 6.91E-11

Real

Aptamer SeqId: 5133-17 | Target: TGF-b R II | UniProt: P37173

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5133-17 | Target: TGF-b R II | UniProt: P37173 | TargetFullName: TGF-beta receptor type-2 | Organisim: human | Apparent_Kd_M: 6.91E-11

Real

Aptamer SeqId:5134-52;Target:TIMD3;UniProt:Q8TDQ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5134-52;Target: TIMD3;UniProt: Q8TDQ0;TargetFullName: Hepatitis A virus cellular receptor 2;Organisim: human;Apparent_Kd_M: 6.83E-12

Real

Aptamer SeqId: 5134-52 | Target: TIMD3 | UniProt: Q8TDQ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5134-52 | Target: TIMD3 | UniProt: Q8TDQ0 | TargetFullName: Hepatitis A virus cellular receptor 2 | Organisim: human | Apparent_Kd_M: 6.83E-12

Real

Aptamer SeqId:5138-50;Target:TWEAKR;UniProt:Q9NP84

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5138-50;Target: TWEAKR;UniProt: Q9NP84;TargetFullName: Tumor necrosis factor receptor superfamily member 12A;Organisim: human;Apparent_Kd_M: 3.55E-12

Real

Aptamer SeqId: 5138-50 | Target: TWEAKR | UniProt: Q9NP84

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5138-50 | Target: TWEAKR | UniProt: Q9NP84 | TargetFullName: Tumor necrosis factor receptor superfamily member 12A | Organisim: human | Apparent_Kd_M: 3.55E-12

Real

Aptamer SeqId:5139-32;Target:UNC5H3;UniProt:O95185

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5139-32;Target: UNC5H3;UniProt: O95185;TargetFullName: Netrin receptor UNC5C;Organisim: human;Apparent_Kd_M: 1.55E-12

Real

Aptamer SeqId: 5139-32 | Target: UNC5H3 | UniProt: O95185

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5139-32 | Target: UNC5H3 | UniProt: O95185 | TargetFullName: Netrin receptor UNC5C | Organisim: human | Apparent_Kd_M: 1.55E-12

Real

Aptamer SeqId:5178-5;Target:PDE7A;UniProt:Q13946

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5178-5;Target: PDE7A;UniProt: Q13946;TargetFullName: High affinity cAMP-specific 3;5-cyclic phosphodiesterase 7A;Organisim: human;Apparent_Kd_M: 2.16E-12

Real

Aptamer SeqId: 5178-5 | Target: PDE7A | UniProt: Q13946

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5178-5 | Target: PDE7A | UniProt: Q13946 | TargetFullName: High affinity cAMP-specific 3';5'-cyclic phosphodiesterase 7A | Organisim: human | Apparent_Kd_M: 2.16E-12

Real

Aptamer SeqId:5183-53;Target:AMPK a1b1g1;UniProt:Q13131|Q9Y478|P54619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5183-53;Target: AMPK a1b1g1;UniProt: Q13131|Q9Y478|P54619;TargetFullName: AMP Kinase (alpha1beta1gamma1);Organisim: human;Apparent_Kd_M: 7.49E-12

Real

Aptamer SeqId: 5183-53 | Target: AMPK a1b1g1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5183-53 | Target: AMPK a1b1g1 | UniProt: Q13131|Q9Y478|P54619 | TargetFullName: AMP Kinase (alpha1beta1gamma1) | Organisim: human | Apparent_Kd_M: 7.49E-12

Real

Aptamer SeqId:5196-7;Target:NMT1;UniProt:P30419

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5196-7;Target: NMT1;UniProt: P30419;TargetFullName: Glycylpeptide N-tetradecanoyltransferase 1;Organisim: human;Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId: 5196-7 | Target: NMT1 | UniProt: P30419

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5196-7 | Target: NMT1 | UniProt: P30419 | TargetFullName: Glycylpeptide N-tetradecanoyltransferase 1 | Organisim: human | Apparent_Kd_M: 2.86E-11

Real

Aptamer SeqId:5201-50;Target:PDE9A;UniProt:O76083

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5201-50;Target: PDE9A;UniProt: O76083;TargetFullName: High affinity cGMP-specific 3;5-cyclic phosphodiesterase 9A;Organisim: human;Apparent_Kd_M: 2.82E-10

Real

Aptamer SeqId: 5201-50 | Target: PDE9A | UniProt: O76083

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5201-50 | Target: PDE9A | UniProt: O76083 | TargetFullName: High affinity cGMP-specific 3';5'-cyclic phosphodiesterase 9A | Organisim: human | Apparent_Kd_M: 2.82E-10

Real

Aptamer SeqId:5202-4;Target:PPID;UniProt:Q08752

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5202-4;Target: PPID;UniProt: Q08752;TargetFullName: Peptidyl-prolyl cis-trans isomerase D;Organisim: human;Apparent_Kd_M: 4.1E-12

Real

Aptamer SeqId: 5202-4 | Target: PPID | UniProt: Q08752

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5202-4 | Target: PPID | UniProt: Q08752 | TargetFullName: Peptidyl-prolyl cis-trans isomerase D | Organisim: human | Apparent_Kd_M: 4.1E-12

Real

Aptamer SeqId:5204-13;Target:PSME3;UniProt:P61289

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5204-13;Target: PSME3;UniProt: P61289;TargetFullName: Proteasome activator complex subunit 3;Organisim: human;Apparent_Kd_M: 2.52E-10

Real

Aptamer SeqId: 5204-13 | Target: PSME3 | UniProt: P61289

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5204-13 | Target: PSME3 | UniProt: P61289 | TargetFullName: Proteasome activator complex subunit 3 | Organisim: human | Apparent_Kd_M: 2.52E-10

Real

Aptamer SeqId:5223-59;Target:GCKR;UniProt:Q14397

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5223-59;Target: GCKR;UniProt: Q14397;TargetFullName: Glucokinase regulatory protein;Organisim: human;Apparent_Kd_M: 1.97E-12

Real

Aptamer SeqId: 5223-59 | Target: GCKR | UniProt: Q14397

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5223-59 | Target: GCKR | UniProt: Q14397 | TargetFullName: Glucokinase regulatory protein | Organisim: human | Apparent_Kd_M: 1.97E-12

Real

Aptamer SeqId:5224-20;Target:CSK21;UniProt:P68400

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5224-20;Target: CSK21;UniProt: P68400;TargetFullName: Casein kinase II subunit alpha;Organisim: human;Apparent_Kd_M: 9.34E-12

Real

Aptamer SeqId: 5224-20 | Target: CSK21 | UniProt: P68400

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5224-20 | Target: CSK21 | UniProt: P68400 | TargetFullName: Casein kinase II subunit alpha | Organisim: human | Apparent_Kd_M: 9.34E-12

Real

Aptamer SeqId:5225-50;Target:CK2-A1:B;UniProt:P68400|P67870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5225-50;Target: CK2-A1:B;UniProt: P68400|P67870;TargetFullName: Casein kinase II 2-alpha:2-beta heterotetramer;Organisim: human;Apparent_Kd_M: 6.48E-12

Real

Aptamer SeqId: 5225-50 | Target: CK2-A1:B | UniProt: P68400|P67870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5225-50 | Target: CK2-A1:B | UniProt: P68400|P67870 | TargetFullName: Casein kinase II 2-alpha:2-beta heterotetramer | Organisim: human | Apparent_Kd_M: 6.48E-12

Real

Aptamer SeqId:5226-36;Target:CK2-A2:B;UniProt:P19784|P67870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5226-36;Target: CK2-A2:B;UniProt: P19784|P67870;TargetFullName: Casein kinase II 2-alpha:2-beta heterotetramer;Organisim: human;Apparent_Kd_M: 8.92E-12

Real

Aptamer SeqId: 5226-36 | Target: CK2-A2:B | UniProt: P19784|P67870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5226-36 | Target: CK2-A2:B | UniProt: P19784|P67870 | TargetFullName: Casein kinase II 2-alpha':2-beta heterotetramer | Organisim: human | Apparent_Kd_M: 8.92E-12

Real

Aptamer SeqId:5227-60;Target:PDK1;UniProt:Q15118

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5227-60;Target: PDK1;UniProt: Q15118;TargetFullName: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1; mitochondrial;Organisim: human;Apparent_Kd_M: 2.08E-11

Real

Aptamer SeqId: 5227-60 | Target: PDK1 | UniProt: Q15118

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5227-60 | Target: PDK1 | UniProt: Q15118 | TargetFullName: Pyruvate dehydrogenase (acetyl-transferring) kinase isozyme 1; mitochondrial | Organisim: human | Apparent_Kd_M: 2.08E-11

Real

Aptamer SeqId:5228-25;Target:KIF23;UniProt:Q02241

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5228-25;Target: KIF23;UniProt: Q02241;TargetFullName: Kinesin-like protein KIF23;Organisim: human;Apparent_Kd_M: 2.37E-12

Real

Aptamer SeqId: 5228-25 | Target: KIF23 | UniProt: Q02241

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5228-25 | Target: KIF23 | UniProt: Q02241 | TargetFullName: Kinesin-like protein KIF23 | Organisim: human | Apparent_Kd_M: 2.37E-12

Real

Aptamer SeqId:5229-90;Target:IMDH1;UniProt:P20839

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5229-90;Target: IMDH1;UniProt: P20839;TargetFullName: Inosine-5-monophosphate dehydrogenase 1;Organisim: human;Apparent_Kd_M: 7.01E-12

Real

Aptamer SeqId: 5229-90 | Target: IMDH1 | UniProt: P20839

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5229-90 | Target: IMDH1 | UniProt: P20839 | TargetFullName: Inosine-5'-monophosphate dehydrogenase 1 | Organisim: human | Apparent_Kd_M: 7.01E-12

Real

Aptamer SeqId:5230-99;Target:HMGR;UniProt:P04035

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5230-99;Target: HMGR;UniProt: P04035;TargetFullName: 3-hydroxy-3-methylglutaryl-coenzyme A reductase;Organisim: human;Apparent_Kd_M: 4.09E-13

Real

Aptamer SeqId: 5230-99 | Target: HMGR | UniProt: P04035

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5230-99 | Target: HMGR | UniProt: P04035 | TargetFullName: 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Organisim: human | Apparent_Kd_M: 4.09E-13

Real

Aptamer SeqId:5231-79;Target:PCSK9;UniProt:Q8NBP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5231-79;Target: PCSK9;UniProt: Q8NBP7;TargetFullName: Proprotein convertase subtilisin/kexin type 9;Organisim: human;Apparent_Kd_M: 8.8E-13

Real

Aptamer SeqId: 5231-79 | Target: PCSK9 | UniProt: Q8NBP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5231-79 | Target: PCSK9 | UniProt: Q8NBP7 | TargetFullName: Proprotein convertase subtilisin/kexin type 9 | Organisim: human | Apparent_Kd_M: 8.8E-13

Real

Aptamer SeqId:5236-2;Target:NR1D1;UniProt:P20393

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5236-2;Target: NR1D1;UniProt: P20393;TargetFullName: Nuclear receptor subfamily 1 group D member 1;Organisim: human;Apparent_Kd_M: 5.64E-11

Real

Aptamer SeqId: 5236-2 | Target: NR1D1 | UniProt: P20393

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5236-2 | Target: NR1D1 | UniProt: P20393 | TargetFullName: Nuclear receptor subfamily 1 group D member 1 | Organisim: human | Apparent_Kd_M: 5.64E-11

Real

Aptamer SeqId:5238-26;Target:PPIE;UniProt:Q9UNP9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5238-26;Target: PPIE;UniProt: Q9UNP9;TargetFullName: Peptidyl-prolyl cis-trans isomerase E;Organisim: human;Apparent_Kd_M: 2.26E-11

Real

Aptamer SeqId: 5238-26 | Target: PPIE | UniProt: Q9UNP9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5238-26 | Target: PPIE | UniProt: Q9UNP9 | TargetFullName: Peptidyl-prolyl cis-trans isomerase E | Organisim: human | Apparent_Kd_M: 2.26E-11

Real

Aptamer SeqId:5242-37;Target:MP2K4;UniProt:P45985

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5242-37;Target: MP2K4;UniProt: P45985;TargetFullName: Dual specificity mitogen-activated protein kinase kinase 4;Organisim: human;Apparent_Kd_M: 9.9E-12

Real

Aptamer SeqId: 5242-37 | Target: MP2K4 | UniProt: P45985

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5242-37 | Target: MP2K4 | UniProt: P45985 | TargetFullName: Dual specificity mitogen-activated protein kinase kinase 4 | Organisim: human | Apparent_Kd_M: 9.9E-12

Real

Aptamer SeqId:5245-40;Target:AMPK a2b2g1;UniProt:P54646|O43741|P54619

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5245-40;Target: AMPK a2b2g1;UniProt: P54646|O43741|P54619;TargetFullName: AMP Kinase (alpha2beta2gamma1);Organisim: human;Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId: 5245-40 | Target: AMPK a2b2g1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5245-40 | Target: AMPK a2b2g1 | UniProt: P54646|O43741|P54619 | TargetFullName: AMP Kinase (alpha2beta2gamma1) | Organisim: human | Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId:5246-64;Target:cGMP-stimulated PDE;UniProt:O00408

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5246-64;Target: cGMP-stimulated PDE;UniProt: O00408;TargetFullName: cGMP-dependent 3;5-cyclic phosphodiesterase;Organisim: human;Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId: 5246-64 | Target: cGMP-stimulated PDE | UniProt: O00408

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5246-64 | Target: cGMP-stimulated PDE | UniProt: O00408 | TargetFullName: cGMP-dependent 3';5'-cyclic phosphodiesterase | Organisim: human | Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId:5248-68;Target:Cyclophilin F;UniProt:P30405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5248-68;Target: Cyclophilin F;UniProt: P30405;TargetFullName: Peptidyl-prolyl cis-trans isomerase F; mitochondrial;Organisim: human;Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId: 5248-68 | Target: Cyclophilin F | UniProt: P30405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5248-68 | Target: Cyclophilin F | UniProt: P30405 | TargetFullName: Peptidyl-prolyl cis-trans isomerase F; mitochondrial | Organisim: human | Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId:5249-31;Target:DRAK2;UniProt:O94768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5249-31;Target: DRAK2;UniProt: O94768;TargetFullName: Serine/threonine-protein kinase 17B;Organisim: human;Apparent_Kd_M: 8.91E-13

Real

Aptamer SeqId: 5249-31 | Target: DRAK2 | UniProt: O94768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5249-31 | Target: DRAK2 | UniProt: O94768 | TargetFullName: Serine/threonine-protein kinase 17B | Organisim: human | Apparent_Kd_M: 8.91E-13

Real

Aptamer SeqId:5250-53;Target:IMDH2;UniProt:P12268

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5250-53;Target: IMDH2;UniProt: P12268;TargetFullName: Inosine-5-monophosphate dehydrogenase 2;Organisim: human;Apparent_Kd_M: 2.96E-11

Real

Aptamer SeqId: 5250-53 | Target: IMDH2 | UniProt: P12268

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5250-53 | Target: IMDH2 | UniProt: P12268 | TargetFullName: Inosine-5'-monophosphate dehydrogenase 2 | Organisim: human | Apparent_Kd_M: 2.96E-11

Real

Aptamer SeqId:5252-33;Target:PDE11;UniProt:Q9HCR9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5252-33;Target: PDE11;UniProt: Q9HCR9;TargetFullName: Dual 3;5-cyclic-AMP and -GMP phosphodiesterase 11A;Organisim: human;Apparent_Kd_M: 4.82E-11

Real

Aptamer SeqId: 5252-33 | Target: PDE11 | UniProt: Q9HCR9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5252-33 | Target: PDE11 | UniProt: Q9HCR9 | TargetFullName: Dual 3';5'-cyclic-AMP and -GMP phosphodiesterase 11A | Organisim: human | Apparent_Kd_M: 4.82E-11

Real

Aptamer SeqId:5253-1;Target:PDE1A;UniProt:P54750

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5253-1;Target: PDE1A;UniProt: P54750;TargetFullName: Calcium/calmodulin-dependent 3;5-cyclic nucleotide phosphodiesterase 1A;Organisim: human;Apparent_Kd_M: 2.17E-11

Real

Aptamer SeqId: 5253-1 | Target: PDE1A | UniProt: P54750

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5253-1 | Target: PDE1A | UniProt: P54750 | TargetFullName: Calcium/calmodulin-dependent 3';5'-cyclic nucleotide phosphodiesterase 1A | Organisim: human | Apparent_Kd_M: 2.17E-11

Real

Aptamer SeqId:5254-69;Target:PDE3A;UniProt:Q14432

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5254-69;Target: PDE3A;UniProt: Q14432;TargetFullName: cGMP-inhibited 3;5-cyclic phosphodiesterase A;Organisim: human;Apparent_Kd_M: 3.18E-10

Real

Aptamer SeqId: 5254-69 | Target: PDE3A | UniProt: Q14432

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5254-69 | Target: PDE3A | UniProt: Q14432 | TargetFullName: cGMP-inhibited 3';5'-cyclic phosphodiesterase A | Organisim: human | Apparent_Kd_M: 3.18E-10

Real

Aptamer SeqId:5255-22;Target:PDE4D;UniProt:Q08499

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5255-22;Target: PDE4D;UniProt: Q08499;TargetFullName: cAMP-specific 3;5-cyclic phosphodiesterase 4D;Organisim: human;Apparent_Kd_M: 4.2E-10

Real

Aptamer SeqId: 5255-22 | Target: PDE4D | UniProt: Q08499

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5255-22 | Target: PDE4D | UniProt: Q08499 | TargetFullName: cAMP-specific 3';5'-cyclic phosphodiesterase 4D | Organisim: human | Apparent_Kd_M: 4.2E-10

Real

Aptamer SeqId:5256-86;Target:PDE5A;UniProt:O76074

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5256-86;Target: PDE5A;UniProt: O76074;TargetFullName: cGMP-specific 3;5-cyclic phosphodiesterase;Organisim: human;Apparent_Kd_M: 7.9E-12

Real

Aptamer SeqId: 5256-86 | Target: PDE5A | UniProt: O76074

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5256-86 | Target: PDE5A | UniProt: O76074 | TargetFullName: cGMP-specific 3';5'-cyclic phosphodiesterase | Organisim: human | Apparent_Kd_M: 7.9E-12

Real

Aptamer SeqId:5259-2;Target:TAK1-TAB1;UniProt:O43318|Q15750

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5259-2;Target: TAK1-TAB1;UniProt: O43318|Q15750;TargetFullName: Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion;Organisim: human;Apparent_Kd_M: 1.69E-10

Real

Aptamer SeqId: 5259-2 | Target: TAK1-TAB1 | UniProt: O43318|Q15750

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5259-2 | Target: TAK1-TAB1 | UniProt: O43318|Q15750 | TargetFullName: Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion | Organisim: human | Apparent_Kd_M: 1.69E-10

Real

Aptamer SeqId:5260-80;Target:TYK2;UniProt:P29597

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5260-80;Target: TYK2;UniProt: P29597;TargetFullName: Non-receptor tyrosine-protein kinase TYK2;Organisim: human;Apparent_Kd_M: 2.4E-11

Real

Aptamer SeqId: 5260-80 | Target: TYK2 | UniProt: P29597

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5260-80 | Target: TYK2 | UniProt: P29597 | TargetFullName: Non-receptor tyrosine-protein kinase TYK2 | Organisim: human | Apparent_Kd_M: 2.4E-11

Real

Aptamer SeqId:5261-13;Target:ABL2;UniProt:P42684

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5261-13;Target: ABL2;UniProt: P42684;TargetFullName: Abelson tyrosine-protein kinase 2;Organisim: human;Apparent_Kd_M: 1.89E-12

Real

Aptamer SeqId: 5261-13 | Target: ABL2 | UniProt: P42684

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5261-13 | Target: ABL2 | UniProt: P42684 | TargetFullName: Abelson tyrosine-protein kinase 2 | Organisim: human | Apparent_Kd_M: 1.89E-12

Real

Aptamer SeqId:5262-57;Target:BCAR3;UniProt:O75815

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5262-57;Target: BCAR3;UniProt: O75815;TargetFullName: Breast cancer anti-estrogen resistance protein 3;Organisim: human;Apparent_Kd_M: 7.42E-13

Real

Aptamer SeqId: 5262-57 | Target: BCAR3 | UniProt: O75815

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5262-57 | Target: BCAR3 | UniProt: O75815 | TargetFullName: Breast cancer anti-estrogen resistance protein 3 | Organisim: human | Apparent_Kd_M: 7.42E-13

Real

Aptamer SeqId:5264-65;Target:calreticulin;UniProt:P27797

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5264-65;Target: calreticulin;UniProt: P27797;TargetFullName: Calreticulin;Organisim: human;Apparent_Kd_M: 9.35E-11

Real

Aptamer SeqId: 5264-65 | Target: calreticulin | UniProt: P27797

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5264-65 | Target: calreticulin | UniProt: P27797 | TargetFullName: Calreticulin | Organisim: human | Apparent_Kd_M: 9.35E-11

Real

Aptamer SeqId:5265-12;Target:GRB2-related adapter protein 2;UniProt:O75791

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5265-12;Target: GRB2-related adapter protein 2;UniProt: O75791;TargetFullName: GRB2-related adapter protein 2;Organisim: human;Apparent_Kd_M: 8.05E-12

Real

Aptamer SeqId: 5265-12 | Target: GRB2-related adapter protein 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5265-12 | Target: GRB2-related adapter protein 2 | UniProt: O75791 | TargetFullName: GRB2-related adapter protein 2 | Organisim: human | Apparent_Kd_M: 8.05E-12

Real

Aptamer SeqId:5268-49;Target:MMP-16;UniProt:P51512

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5268-49;Target: MMP-16;UniProt: P51512;TargetFullName: Matrix metalloproteinase-16;Organisim: human;Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId: 5268-49 | Target: MMP-16 | UniProt: P51512

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5268-49 | Target: MMP-16 | UniProt: P51512 | TargetFullName: Matrix metalloproteinase-16 | Organisim: human | Apparent_Kd_M: 1.55E-11

Real

Aptamer SeqId:5272-55;Target:SHC1;UniProt:P29353

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5272-55;Target: SHC1;UniProt: P29353;TargetFullName: SHC-transforming protein 1;Organisim: human;Apparent_Kd_M: 1.06E-12

Real

Aptamer SeqId: 5272-55 | Target: SHC1 | UniProt: P29353

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5272-55 | Target: SHC1 | UniProt: P29353 | TargetFullName: SHC-transforming protein 1 | Organisim: human | Apparent_Kd_M: 1.06E-12

Real

Aptamer SeqId:5275-28;Target:VAV;UniProt:P15498

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5275-28;Target: VAV;UniProt: P15498;TargetFullName: Proto-oncogene vav;Organisim: human;Apparent_Kd_M: 1.43E-12

Real

Aptamer SeqId: 5275-28 | Target: VAV | UniProt: P15498

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5275-28 | Target: VAV | UniProt: P15498 | TargetFullName: Proto-oncogene vav | Organisim: human | Apparent_Kd_M: 1.43E-12

Real

Aptamer SeqId:5280-68;Target:GHC2;UniProt:Q9H1K4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5280-68;Target: GHC2;UniProt: Q9H1K4;TargetFullName: Mitochondrial glutamate carrier 2;Organisim: human;Apparent_Kd_M: 7.44E-11

Real

Aptamer SeqId: 5280-68 | Target: GHC2 | UniProt: Q9H1K4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5280-68 | Target: GHC2 | UniProt: Q9H1K4 | TargetFullName: Mitochondrial glutamate carrier 2 | Organisim: human | Apparent_Kd_M: 7.44E-11

Real

Aptamer SeqId:5301-7;Target:Eotaxin;UniProt:P51671

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5301-7;Target: Eotaxin;UniProt: P51671;TargetFullName: Eotaxin;Organisim: human;Apparent_Kd_M: 1.01E-12

Real

Aptamer SeqId: 5301-7 | Target: Eotaxin | UniProt: P51671

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5301-7 | Target: Eotaxin | UniProt: P51671 | TargetFullName: Eotaxin | Organisim: human | Apparent_Kd_M: 1.01E-12

Real

Aptamer SeqId:5307-12;Target:Coagulation Factor IXab;UniProt:P00740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5307-12;Target: Coagulation Factor IXab;UniProt: P00740;TargetFullName: Coagulation factor IXab;Organisim: human;Apparent_Kd_M: 4.43E-12

Real

Aptamer SeqId: 5307-12 | Target: Coagulation Factor IXab | UniProt: P00740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5307-12 | Target: Coagulation Factor IXab | UniProt: P00740 | TargetFullName: Coagulation factor IXab | Organisim: human | Apparent_Kd_M: 4.43E-12

Real

Aptamer SeqId:5312-49;Target:Deprecated;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5312-49;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 9.15E-12

Real

Aptamer SeqId: 5312-49 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5312-49 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 9.15E-12

Real

Aptamer SeqId:5315-22;Target:Troponin T;UniProt:P45379

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5315-22;Target: Troponin T;UniProt: P45379;TargetFullName: Troponin T; cardiac muscle;Organisim: human;Apparent_Kd_M: 2.99E-12

Real

Aptamer SeqId: 5315-22 | Target: Troponin T | UniProt: P45379

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5315-22 | Target: Troponin T | UniProt: P45379 | TargetFullName: Troponin T; cardiac muscle | Organisim: human | Apparent_Kd_M: 2.99E-12

Real

Aptamer SeqId:5316-54;Target:Prothrombin;UniProt:P00734

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5316-54;Target: Prothrombin;UniProt: P00734;TargetFullName: Prothrombin;Organisim: human;Apparent_Kd_M: 1.04E-12

Real

Aptamer SeqId: 5316-54 | Target: Prothrombin | UniProt: P00734

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5316-54 | Target: Prothrombin | UniProt: P00734 | TargetFullName: Prothrombin | Organisim: human | Apparent_Kd_M: 1.04E-12

Real

Aptamer SeqId:5335-73;Target:annexin VI;UniProt:P08133

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5335-73;Target: annexin VI;UniProt: P08133;TargetFullName: Annexin A6;Organisim: human;Apparent_Kd_M: 7.49E-11

Real

Aptamer SeqId: 5335-73 | Target: annexin VI | UniProt: P08133

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5335-73 | Target: annexin VI | UniProt: P08133 | TargetFullName: Annexin A6 | Organisim: human | Apparent_Kd_M: 7.49E-11

Real

Aptamer SeqId:5337-64;Target:B7-2;UniProt:P42081

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5337-64;Target: B7-2;UniProt: P42081;TargetFullName: T-lymphocyte activation antigen CD86;Organisim: human;Apparent_Kd_M: 4.75E-11

Real

Aptamer SeqId: 5337-64 | Target: B7-2 | UniProt: P42081

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5337-64 | Target: B7-2 | UniProt: P42081 | TargetFullName: T-lymphocyte activation antigen CD86 | Organisim: human | Apparent_Kd_M: 4.75E-11

Real

Aptamer SeqId:5339-49;Target:calgranulin B;UniProt:P06702

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5339-49;Target: calgranulin B;UniProt: P06702;TargetFullName: Protein S100-A9;Organisim: human;Apparent_Kd_M: 4.845704E-11

Real

Aptamer SeqId: 5339-49 | Target: calgranulin B | UniProt: P06702

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5339-49 | Target: calgranulin B | UniProt: P06702 | TargetFullName: Protein S100-A9 | Organisim: human | Apparent_Kd_M: 4.845704E-11

Real

Aptamer SeqId:5340-24;Target:Caspase-10;UniProt:Q92851

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5340-24;Target: Caspase-10;UniProt: Q92851;TargetFullName: Caspase-10;Organisim: human;Apparent_Kd_M: 7.36E-12

Real

Aptamer SeqId: 5340-24 | Target: Caspase-10 | UniProt: Q92851

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5340-24 | Target: Caspase-10 | UniProt: Q92851 | TargetFullName: Caspase-10 | Organisim: human | Apparent_Kd_M: 7.36E-12

Real

Aptamer SeqId:5343-74;Target:CBPE;UniProt:P16870

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5343-74;Target: CBPE;UniProt: P16870;TargetFullName: Carboxypeptidase E;Organisim: human;Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId: 5343-74 | Target: CBPE | UniProt: P16870

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5343-74 | Target: CBPE | UniProt: P16870 | TargetFullName: Carboxypeptidase E | Organisim: human | Apparent_Kd_M: 1.56E-11

Real

Aptamer SeqId:5345-51;Target:CKAP2;UniProt:Q8WWK9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5345-51;Target: CKAP2;UniProt: Q8WWK9;TargetFullName: Cytoskeleton-associated protein 2;Organisim: human;Apparent_Kd_M: 6.06E-11

Real

Aptamer SeqId: 5345-51 | Target: CKAP2 | UniProt: Q8WWK9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5345-51 | Target: CKAP2 | UniProt: Q8WWK9 | TargetFullName: Cytoskeleton-associated protein 2 | Organisim: human | Apparent_Kd_M: 6.06E-11

Real

Aptamer SeqId:5346-24;Target:CPNE1;UniProt:Q99829

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5346-24;Target: CPNE1;UniProt: Q99829;TargetFullName: Copine-1;Organisim: human;Apparent_Kd_M: 8.92E-12

Real

Aptamer SeqId: 5346-24 | Target: CPNE1 | UniProt: Q99829

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5346-24 | Target: CPNE1 | UniProt: Q99829 | TargetFullName: Copine-1 | Organisim: human | Apparent_Kd_M: 8.92E-12

Real

Aptamer SeqId:5347-59;Target:Cyclin B1;UniProt:P14635

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5347-59;Target: Cyclin B1;UniProt: P14635;TargetFullName: G2/mitotic-specific cyclin-B1;Organisim: human;Apparent_Kd_M: 4.52E-12

Real

Aptamer SeqId: 5347-59 | Target: Cyclin B1 | UniProt: P14635

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5347-59 | Target: Cyclin B1 | UniProt: P14635 | TargetFullName: G2/mitotic-specific cyclin-B1 | Organisim: human | Apparent_Kd_M: 4.52E-12

Real

Aptamer SeqId:5349-69;Target:DLL1;UniProt:O00548

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5349-69;Target: DLL1;UniProt: O00548;TargetFullName: Delta-like protein 1;Organisim: human;Apparent_Kd_M: 3.01E-12

Real

Aptamer SeqId: 5349-69 | Target: DLL1 | UniProt: O00548

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5349-69 | Target: DLL1 | UniProt: O00548 | TargetFullName: Delta-like protein 1 | Organisim: human | Apparent_Kd_M: 3.01E-12

Real

Aptamer SeqId:5350-14;Target:GPC6;UniProt:Q9Y625

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5350-14;Target: GPC6;UniProt: Q9Y625;TargetFullName: Glypican-6;Organisim: human;Apparent_Kd_M: 1.15E-10

Real

Aptamer SeqId: 5350-14 | Target: GPC6 | UniProt: Q9Y625

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5350-14 | Target: GPC6 | UniProt: Q9Y625 | TargetFullName: Glypican-6 | Organisim: human | Apparent_Kd_M: 1.15E-10

Real

Aptamer SeqId:5351-52;Target:hnRNP A2/B1;UniProt:P22626

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5351-52;Target: hnRNP A2/B1;UniProt: P22626;TargetFullName: Heterogeneous nuclear ribonucleoproteins A2/B1;Organisim: human;Apparent_Kd_M: 3.75E-12

Real

Aptamer SeqId: 5351-52 | Target: hnRNP A2/B1 | UniProt: P22626

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5351-52 | Target: hnRNP A2/B1 | UniProt: P22626 | TargetFullName: Heterogeneous nuclear ribonucleoproteins A2/B1 | Organisim: human | Apparent_Kd_M: 3.75E-12

Real

Aptamer SeqId:5352-11;Target:HVEM;UniProt:Q92956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5352-11;Target: HVEM;UniProt: Q92956;TargetFullName: Tumor necrosis factor receptor superfamily member 14;Organisim: human;Apparent_Kd_M: 8.99E-12

Real

Aptamer SeqId: 5352-11 | Target: HVEM | UniProt: Q92956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5352-11 | Target: HVEM | UniProt: Q92956 | TargetFullName: Tumor necrosis factor receptor superfamily member 14 | Organisim: human | Apparent_Kd_M: 8.99E-12

Real

Aptamer SeqId:5353-89;Target:IL-1Ra;UniProt:P18510

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5353-89;Target: IL-1Ra;UniProt: P18510;TargetFullName: Interleukin-1 receptor antagonist protein;Organisim: human;Apparent_Kd_M: 8.9E-12

Real

Aptamer SeqId: 5353-89 | Target: IL-1Ra | UniProt: P18510

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5353-89 | Target: IL-1Ra | UniProt: P18510 | TargetFullName: Interleukin-1 receptor antagonist protein | Organisim: human | Apparent_Kd_M: 8.9E-12

Real

Aptamer SeqId:5354-11;Target:Keratin 18;UniProt:P05783

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5354-11;Target: Keratin 18;UniProt: P05783;TargetFullName: Keratin; type I cytoskeletal 18;Organisim: human;Apparent_Kd_M: 5.63E-11

Real

Aptamer SeqId: 5354-11 | Target: Keratin 18 | UniProt: P05783

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5354-11 | Target: Keratin 18 | UniProt: P05783 | TargetFullName: Keratin; type I cytoskeletal 18 | Organisim: human | Apparent_Kd_M: 5.63E-11

Real

Aptamer SeqId:5355-69;Target:LIGHT;UniProt:O43557

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5355-69;Target: LIGHT;UniProt: O43557;TargetFullName: Tumor necrosis factor ligand superfamily member 14;Organisim: human;Apparent_Kd_M: 5.78E-12

Real

Aptamer SeqId: 5355-69 | Target: LIGHT | UniProt: O43557

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5355-69 | Target: LIGHT | UniProt: O43557 | TargetFullName: Tumor necrosis factor ligand superfamily member 14 | Organisim: human | Apparent_Kd_M: 5.78E-12

Real

Aptamer SeqId:5357-60;Target:NLGNX;UniProt:Q8N0W4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5357-60;Target: NLGNX;UniProt: Q8N0W4;TargetFullName: Neuroligin-4; X-linked;Organisim: human;Apparent_Kd_M: 1.24E-12

Real

Aptamer SeqId: 5357-60 | Target: NLGNX | UniProt: Q8N0W4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5357-60 | Target: NLGNX | UniProt: Q8N0W4 | TargetFullName: Neuroligin-4; X-linked | Organisim: human | Apparent_Kd_M: 1.24E-12

Real

Aptamer SeqId:5358-3;Target:OMD;UniProt:Q99983

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5358-3;Target: OMD;UniProt: Q99983;TargetFullName: Osteomodulin;Organisim: human;Apparent_Kd_M: 2.11E-12

Real

Aptamer SeqId: 5358-3 | Target: OMD | UniProt: Q99983

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5358-3 | Target: OMD | UniProt: Q99983 | TargetFullName: Osteomodulin | Organisim: human | Apparent_Kd_M: 2.11E-12

Real

Aptamer SeqId:5359-65;Target:PIM1;UniProt:P11309

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5359-65;Target: PIM1;UniProt: P11309;TargetFullName: Serine/threonine-protein kinase pim-1;Organisim: human;Apparent_Kd_M: 7.23E-11

Real

Aptamer SeqId: 5359-65 | Target: PIM1 | UniProt: P11309

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5359-65 | Target: PIM1 | UniProt: P11309 | TargetFullName: Serine/threonine-protein kinase pim-1 | Organisim: human | Apparent_Kd_M: 7.23E-11

Real

Aptamer SeqId:5360-9;Target:PKB beta;UniProt:P31751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5360-9;Target: PKB beta;UniProt: P31751;TargetFullName: RAC-beta serine/threonine-protein kinase;Organisim: human;Apparent_Kd_M: 2.78E-11

Real

Aptamer SeqId: 5360-9 | Target: PKB beta | UniProt: P31751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5360-9 | Target: PKB beta | UniProt: P31751 | TargetFullName: RAC-beta serine/threonine-protein kinase | Organisim: human | Apparent_Kd_M: 2.78E-11

Real

Aptamer SeqId:5363-51;Target:Semaphorin 3E;UniProt:O15041

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5363-51;Target: Semaphorin 3E;UniProt: O15041;TargetFullName: Semaphorin-3E;Organisim: human;Apparent_Kd_M: 1.47E-12

Real

Aptamer SeqId: 5363-51 | Target: Semaphorin 3E | UniProt: O15041

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5363-51 | Target: Semaphorin 3E | UniProt: O15041 | TargetFullName: Semaphorin-3E | Organisim: human | Apparent_Kd_M: 1.47E-12

Real

Aptamer SeqId:5364-7;Target:SET;UniProt:Q01105

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5364-7;Target: SET;UniProt: Q01105;TargetFullName: Protein SET;Organisim: human;Apparent_Kd_M: 1.031148E-11

Real

Aptamer SeqId: 5364-7 | Target: SET | UniProt: Q01105

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5364-7 | Target: SET | UniProt: Q01105 | TargetFullName: Protein SET | Organisim: human | Apparent_Kd_M: 1.031148E-11

Real

Aptamer SeqId:5383-14;Target:BAFF Receptor;UniProt:Q96RJ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5383-14;Target: BAFF Receptor;UniProt: Q96RJ3;TargetFullName: Tumor necrosis factor receptor superfamily member 13C;Organisim: human;Apparent_Kd_M: 1.05E-10

Real

Aptamer SeqId: 5383-14 | Target: BAFF Receptor | UniProt: Q96RJ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5383-14 | Target: BAFF Receptor | UniProt: Q96RJ3 | TargetFullName: Tumor necrosis factor receptor superfamily member 13C | Organisim: human | Apparent_Kd_M: 1.05E-10

Real

Aptamer SeqId:5392-73;Target:Fas; soluble;UniProt:P25445

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5392-73;Target: Fas; soluble;UniProt: P25445;TargetFullName: Tumor necrosis factor receptor superfamily member 6;Organisim: human;Apparent_Kd_M: 6.54E-12

Real

Aptamer SeqId: 5392-73 | Target: Fas; soluble | UniProt: P25445

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5392-73 | Target: Fas; soluble | UniProt: P25445 | TargetFullName: Tumor necrosis factor receptor superfamily member 6 | Organisim: human | Apparent_Kd_M: 6.54E-12

Real

Aptamer SeqId:5400-52;Target:sLeptin R;UniProt:P48357

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5400-52;Target: sLeptin R;UniProt: P48357;TargetFullName: Leptin receptor;Organisim: human;Apparent_Kd_M: 3.66E-12

Real

Aptamer SeqId: 5400-52 | Target: sLeptin R | UniProt: P48357

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5400-52 | Target: sLeptin R | UniProt: P48357 | TargetFullName: Leptin receptor | Organisim: human | Apparent_Kd_M: 3.66E-12

Real

Aptamer SeqId:5404-53;Target:DR6;UniProt:O75509

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5404-53;Target: DR6;UniProt: O75509;TargetFullName: Tumor necrosis factor receptor superfamily member 21;Organisim: human;Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId: 5404-53 | Target: DR6 | UniProt: O75509

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5404-53 | Target: DR6 | UniProt: O75509 | TargetFullName: Tumor necrosis factor receptor superfamily member 21 | Organisim: human | Apparent_Kd_M: 1.73E-12

Real

Aptamer SeqId:5410-53;Target:CAD15;UniProt:P55291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5410-53;Target: CAD15;UniProt: P55291;TargetFullName: Cadherin-15;Organisim: human;Apparent_Kd_M: 6.21E-11

Real

Aptamer SeqId: 5410-53 | Target: CAD15 | UniProt: P55291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5410-53 | Target: CAD15 | UniProt: P55291 | TargetFullName: Cadherin-15 | Organisim: human | Apparent_Kd_M: 6.21E-11

Real

Aptamer SeqId:5412-53;Target:CD27;UniProt:P26842

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5412-53;Target: CD27;UniProt: P26842;TargetFullName: CD27 antigen;Organisim: human;Apparent_Kd_M: 4.13E-12

Real

Aptamer SeqId: 5412-53 | Target: CD27 | UniProt: P26842

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5412-53 | Target: CD27 | UniProt: P26842 | TargetFullName: CD27 antigen | Organisim: human | Apparent_Kd_M: 4.13E-12

Real

Aptamer SeqId:5430-66;Target:SHPS1;UniProt:P78324

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5430-66;Target: SHPS1;UniProt: P78324;TargetFullName: Tyrosine-protein phosphatase non-receptor type substrate 1;Organisim: human;Apparent_Kd_M: 4.67E-11

Real

Aptamer SeqId: 5430-66 | Target: SHPS1 | UniProt: P78324

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5430-66 | Target: SHPS1 | UniProt: P78324 | TargetFullName: Tyrosine-protein phosphatase non-receptor type substrate 1 | Organisim: human | Apparent_Kd_M: 4.67E-11

Real

Aptamer SeqId:5437-63;Target:FABP;UniProt:P05413

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5437-63;Target: FABP;UniProt: P05413;TargetFullName: Fatty acid-binding protein; heart;Organisim: human;Apparent_Kd_M: 5.75E-13

Real

Aptamer SeqId: 5437-63 | Target: FABP | UniProt: P05413

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5437-63 | Target: FABP | UniProt: P05413 | TargetFullName: Fatty acid-binding protein; heart | Organisim: human | Apparent_Kd_M: 5.75E-13

Real

Aptamer SeqId:5440-26;Target:Troponin I; skeletal; fast twitch;UniProt:P48788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5440-26;Target: Troponin I; skeletal; fast twitch;UniProt: P48788;TargetFullName: Troponin I; fast skeletal muscle;Organisim: human;Apparent_Kd_M: 9.79E-12

Real

Aptamer SeqId: 5440-26 | Target: Troponin I skeletal fast twitch

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5440-26 | Target: Troponin I; skeletal; fast twitch | UniProt: P48788 | TargetFullName: Troponin I; fast skeletal muscle | Organisim: human | Apparent_Kd_M: 9.79E-12

Real

Aptamer SeqId:5441-67;Target:Troponin I;UniProt:P19429

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5441-67;Target: Troponin I;UniProt: P19429;TargetFullName: Troponin I; cardiac muscle;Organisim: human;Apparent_Kd_M: 8.64E-13

Real

Aptamer SeqId: 5441-67 | Target: Troponin I | UniProt: P19429

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5441-67 | Target: Troponin I | UniProt: P19429 | TargetFullName: Troponin I; cardiac muscle | Organisim: human | Apparent_Kd_M: 8.64E-13

Real

Aptamer SeqId:5443-62;Target:ANP;UniProt:P01160

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5443-62;Target: ANP;UniProt: P01160;TargetFullName: Atrial natriuretic factor;Organisim: human;Apparent_Kd_M: 4.27E-11

Real

Aptamer SeqId: 5443-62 | Target: ANP | UniProt: P01160

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5443-62 | Target: ANP | UniProt: P01160 | TargetFullName: Atrial natriuretic factor | Organisim: human | Apparent_Kd_M: 4.27E-11

Real

Aptamer SeqId:5451-1;Target:ALCAM;UniProt:Q13740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5451-1;Target: ALCAM;UniProt: Q13740;TargetFullName: CD166 antigen;Organisim: human;Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId: 5451-1 | Target: ALCAM | UniProt: Q13740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5451-1 | Target: ALCAM | UniProt: Q13740 | TargetFullName: CD166 antigen | Organisim: human | Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId:5452-71;Target:ASGR1;UniProt:P07306

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5452-71;Target: ASGR1;UniProt: P07306;TargetFullName: Asialoglycoprotein receptor 1;Organisim: human;Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId: 5452-71 | Target: ASGR1 | UniProt: P07306

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5452-71 | Target: ASGR1 | UniProt: P07306 | TargetFullName: Asialoglycoprotein receptor 1 | Organisim: human | Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId:5456-59;Target:CNDP1;UniProt:Q96KN2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5456-59;Target: CNDP1;UniProt: Q96KN2;TargetFullName: Beta-Ala-His dipeptidase;Organisim: human;Apparent_Kd_M: 2.2E-12

Real

Aptamer SeqId: 5456-59 | Target: CNDP1 | UniProt: Q96KN2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5456-59 | Target: CNDP1 | UniProt: Q96KN2 | TargetFullName: Beta-Ala-His dipeptidase | Organisim: human | Apparent_Kd_M: 2.2E-12

Real

Aptamer SeqId:5457-5;Target:COLEC12;UniProt:Q5KU26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5457-5;Target: COLEC12;UniProt: Q5KU26;TargetFullName: Collectin-12;Organisim: human;Apparent_Kd_M: 6.33E-12

Real

Aptamer SeqId: 5457-5 | Target: COLEC12 | UniProt: Q5KU26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5457-5 | Target: COLEC12 | UniProt: Q5KU26 | TargetFullName: Collectin-12 | Organisim: human | Apparent_Kd_M: 6.33E-12

Real

Aptamer SeqId:5459-33;Target:CYTN;UniProt:P01037

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5459-33;Target: CYTN;UniProt: P01037;TargetFullName: Cystatin-SN;Organisim: human;Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId: 5459-33 | Target: CYTN | UniProt: P01037

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5459-33 | Target: CYTN | UniProt: P01037 | TargetFullName: Cystatin-SN | Organisim: human | Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId:5460-60;Target:DEAD-box protein 19B;UniProt:Q9UMR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5460-60;Target: DEAD-box protein 19B;UniProt: Q9UMR2;TargetFullName: ATP-dependent RNA helicase DDX19B;Organisim: human;Apparent_Kd_M: 1.3E-10

Real

Aptamer SeqId: 5460-60 | Target: DEAD-box protein 19B | UniProt: Q9UMR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5460-60 | Target: DEAD-box protein 19B | UniProt: Q9UMR2 | TargetFullName: ATP-dependent RNA helicase DDX19B | Organisim: human | Apparent_Kd_M: 1.3E-10

Real

Aptamer SeqId:5462-62;Target:Ficolin-3;UniProt:O75636

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5462-62;Target: Ficolin-3;UniProt: O75636;TargetFullName: Ficolin-3;Organisim: human;Apparent_Kd_M: 5.63E-11

Real

Aptamer SeqId: 5462-62 | Target: Ficolin-3 | UniProt: O75636

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5462-62 | Target: Ficolin-3 | UniProt: O75636 | TargetFullName: Ficolin-3 | Organisim: human | Apparent_Kd_M: 5.63E-11

Real

Aptamer SeqId:5463-22;Target:GAS1;UniProt:P54826

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5463-22;Target: GAS1;UniProt: P54826;TargetFullName: Growth arrest-specific protein 1;Organisim: human;Apparent_Kd_M: 8.14E-12

Real

Aptamer SeqId: 5463-22 | Target: GAS1 | UniProt: P54826

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5463-22 | Target: GAS1 | UniProt: P54826 | TargetFullName: Growth arrest-specific protein 1 | Organisim: human | Apparent_Kd_M: 8.14E-12

Real

Aptamer SeqId:5464-52;Target:GRB2 adapter protein;UniProt:P62993

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5464-52;Target: GRB2 adapter protein;UniProt: P62993;TargetFullName: Growth factor receptor-bound protein 2;Organisim: human;Apparent_Kd_M: 9.65E-12

Real

Aptamer SeqId: 5464-52 | Target: GRB2 adapter protein | UniProt: P62993

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5464-52 | Target: GRB2 adapter protein | UniProt: P62993 | TargetFullName: Growth factor receptor-bound protein 2 | Organisim: human | Apparent_Kd_M: 9.65E-12

Real

Aptamer SeqId:5465-32;Target:H6ST1;UniProt:O60243

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5465-32;Target: H6ST1;UniProt: O60243;TargetFullName: Heparan-sulfate 6-O-sulfotransferase 1;Organisim: human;Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId: 5465-32 | Target: H6ST1 | UniProt: O60243

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5465-32 | Target: H6ST1 | UniProt: O60243 | TargetFullName: Heparan-sulfate 6-O-sulfotransferase 1 | Organisim: human | Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId:5467-15;Target:HSP 90b;UniProt:P08238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5467-15;Target: HSP 90b;UniProt: P08238;TargetFullName: Heat shock protein HSP 90-beta;Organisim: human;Apparent_Kd_M: 3.89E-11

Real

Aptamer SeqId: 5467-15 | Target: HSP 90b | UniProt: P08238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5467-15 | Target: HSP 90b | UniProt: P08238 | TargetFullName: Heat shock protein HSP 90-beta | Organisim: human | Apparent_Kd_M: 3.89E-11

Real

Aptamer SeqId:5468-67;Target:IL-17 RC;UniProt:Q8NAC3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5468-67;Target: IL-17 RC;UniProt: Q8NAC3;TargetFullName: Interleukin-17 receptor C;Organisim: human;Apparent_Kd_M: 2.13E-11

Real

Aptamer SeqId: 5468-67 | Target: IL-17 RC | UniProt: Q8NAC3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5468-67 | Target: IL-17 RC | UniProt: Q8NAC3 | TargetFullName: Interleukin-17 receptor C | Organisim: human | Apparent_Kd_M: 2.13E-11

Real

Aptamer SeqId:5475-10;Target:PKC-B-II;UniProt:P05771

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5475-10;Target: PKC-B-II;UniProt: P05771;TargetFullName: Protein kinase C beta type (splice variant beta-II);Organisim: human;Apparent_Kd_M: 6.26E-11

Real

Aptamer SeqId: 5475-10 | Target: PKC-B-II | UniProt: P05771

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5475-10 | Target: PKC-B-II | UniProt: P05771 | TargetFullName: Protein kinase C beta type (splice variant beta-II) | Organisim: human | Apparent_Kd_M: 6.26E-11

Real

Aptamer SeqId:5476-66;Target:PKC-G;UniProt:P05129

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5476-66;Target: PKC-G;UniProt: P05129;TargetFullName: Protein kinase C gamma type;Organisim: human;Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId: 5476-66 | Target: PKC-G | UniProt: P05129

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5476-66 | Target: PKC-G | UniProt: P05129 | TargetFullName: Protein kinase C gamma type | Organisim: human | Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId:5478-50;Target:PSMA;UniProt:Q04609

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5478-50;Target: PSMA;UniProt: Q04609;TargetFullName: Glutamate carboxypeptidase 2;Organisim: human;Apparent_Kd_M: 3.45E-11

Real

Aptamer SeqId: 5478-50 | Target: PSMA | UniProt: Q04609

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5478-50 | Target: PSMA | UniProt: Q04609 | TargetFullName: Glutamate carboxypeptidase 2 | Organisim: human | Apparent_Kd_M: 3.45E-11

Real

Aptamer SeqId:5480-49;Target:RANTES;UniProt:P13501

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5480-49;Target: RANTES;UniProt: P13501;TargetFullName: C-C motif chemokine 5;Organisim: human;Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId: 5480-49 | Target: RANTES | UniProt: P13501

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5480-49 | Target: RANTES | UniProt: P13501 | TargetFullName: C-C motif chemokine 5 | Organisim: human | Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId:5481-16;Target:RASA1;UniProt:P20936

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5481-16;Target: RASA1;UniProt: P20936;TargetFullName: Ras GTPase-activating protein 1;Organisim: human;Apparent_Kd_M: 7.21E-12

Real

Aptamer SeqId: 5481-16 | Target: RASA1 | UniProt: P20936

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5481-16 | Target: RASA1 | UniProt: P20936 | TargetFullName: Ras GTPase-activating protein 1 | Organisim: human | Apparent_Kd_M: 7.21E-12

Real

Aptamer SeqId:5483-1;Target:RGMA;UniProt:Q96B86

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5483-1;Target: RGMA;UniProt: Q96B86;TargetFullName: Repulsive guidance molecule A;Organisim: human;Apparent_Kd_M: 2.3E-11

Real

Aptamer SeqId: 5483-1 | Target: RGMA | UniProt: Q96B86

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5483-1 | Target: RGMA | UniProt: Q96B86 | TargetFullName: Repulsive guidance molecule A | Organisim: human | Apparent_Kd_M: 2.3E-11

Real

Aptamer SeqId:5484-63;Target:RS3A;UniProt:P61247

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5484-63;Target: RS3A;UniProt: P61247;TargetFullName: 40S ribosomal protein S3a;Organisim: human;Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId: 5484-63 | Target: RS3A | UniProt: P61247

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5484-63 | Target: RS3A | UniProt: P61247 | TargetFullName: 40S ribosomal protein S3a | Organisim: human | Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId:5486-73;Target:sICAM-2;UniProt:P13598

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5486-73;Target: sICAM-2;UniProt: P13598;TargetFullName: Intercellular adhesion molecule 2;Organisim: human;Apparent_Kd_M: 9.91E-11

Real

Aptamer SeqId: 5486-73 | Target: sICAM-2 | UniProt: P13598

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5486-73 | Target: sICAM-2 | UniProt: P13598 | TargetFullName: Intercellular adhesion molecule 2 | Organisim: human | Apparent_Kd_M: 9.91E-11

Real

Aptamer SeqId:5487-7;Target:SLAF7;UniProt:Q9NQ25

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5487-7;Target: SLAF7;UniProt: Q9NQ25;TargetFullName: SLAM family member 7;Organisim: human;Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId: 5487-7 | Target: SLAF7 | UniProt: Q9NQ25

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5487-7 | Target: SLAF7 | UniProt: Q9NQ25 | TargetFullName: SLAM family member 7 | Organisim: human | Apparent_Kd_M: 2.57E-12

Real

Aptamer SeqId:5488-74;Target:SRCN1;UniProt:P12931

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5488-74;Target: SRCN1;UniProt: P12931;TargetFullName: Proto-oncogene tyrosine-protein kinase Src;Organisim: human;Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId: 5488-74 | Target: SRCN1 | UniProt: P12931

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5488-74 | Target: SRCN1 | UniProt: P12931 | TargetFullName: Proto-oncogene tyrosine-protein kinase Src | Organisim: human | Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId:5489-18;Target:Stress-induced-phosphoprotein 1;UniProt:P31948

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5489-18;Target: Stress-induced-phosphoprotein 1;UniProt: P31948;TargetFullName: Stress-induced-phosphoprotein 1;Organisim: human;Apparent_Kd_M: 3.68E-12

Real

Aptamer SeqId: 5489-18 | Target: Stress-induced-phosphoprotein 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5489-18 | Target: Stress-induced-phosphoprotein 1 | UniProt: P31948 | TargetFullName: Stress-induced-phosphoprotein 1 | Organisim: human | Apparent_Kd_M: 3.68E-12

Real

Aptamer SeqId:5490-53;Target:Testican-1;UniProt:Q08629

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5490-53;Target: Testican-1;UniProt: Q08629;TargetFullName: Testican-1;Organisim: human;Apparent_Kd_M: 7.4E-11

Real

Aptamer SeqId: 5490-53 | Target: Testican-1 | UniProt: Q08629

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5490-53 | Target: Testican-1 | UniProt: Q08629 | TargetFullName: Testican-1 | Organisim: human | Apparent_Kd_M: 7.4E-11

Real

Aptamer SeqId:5491-12;Target:Testican-2;UniProt:Q92563

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5491-12;Target: Testican-2;UniProt: Q92563;TargetFullName: Testican-2;Organisim: human;Apparent_Kd_M: 1.26E-12

Real

Aptamer SeqId: 5491-12 | Target: Testican-2 | UniProt: Q92563

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5491-12 | Target: Testican-2 | UniProt: Q92563 | TargetFullName: Testican-2 | Organisim: human | Apparent_Kd_M: 1.26E-12

Real

Aptamer SeqId:5493-17;Target:WNK3;UniProt:Q9BYP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5493-17;Target: WNK3;UniProt: Q9BYP7;TargetFullName: Serine/threonine-protein kinase WNK3;Organisim: human;Apparent_Kd_M: 4.11E-12

Real

Aptamer SeqId: 5493-17 | Target: WNK3 | UniProt: Q9BYP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5493-17 | Target: WNK3 | UniProt: Q9BYP7 | TargetFullName: Serine/threonine-protein kinase WNK3 | Organisim: human | Apparent_Kd_M: 4.11E-12

Real

Aptamer SeqId:5494-52;Target:RUXF;UniProt:P62306

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5494-52;Target: RUXF;UniProt: P62306;TargetFullName: Small nuclear ribonucleoprotein F;Organisim: human;Apparent_Kd_M: 9.79E-12

Real

Aptamer SeqId: 5494-52 | Target: RUXF | UniProt: P62306

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5494-52 | Target: RUXF | UniProt: P62306 | TargetFullName: Small nuclear ribonucleoprotein F | Organisim: human | Apparent_Kd_M: 9.79E-12

Real

Aptamer SeqId:5508-62;Target:Cathepsin D;UniProt:P07339

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5508-62;Target: Cathepsin D;UniProt: P07339;TargetFullName: Cathepsin D;Organisim: human;Apparent_Kd_M: 1.75E-12

Real

Aptamer SeqId: 5508-62 | Target: Cathepsin D | UniProt: P07339

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5508-62 | Target: Cathepsin D | UniProt: P07339 | TargetFullName: Cathepsin D | Organisim: human | Apparent_Kd_M: 1.75E-12

Real

Aptamer SeqId:5509-7;Target:EGF;UniProt:P01133

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5509-7;Target: EGF;UniProt: P01133;TargetFullName: Epidermal growth factor;Organisim: human;Apparent_Kd_M: 1.38E-10

Real

Aptamer SeqId: 5509-7 | Target: EGF | UniProt: P01133

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5509-7 | Target: EGF | UniProt: P01133 | TargetFullName: Epidermal growth factor | Organisim: human | Apparent_Kd_M: 1.38E-10

Real

Aptamer SeqId:5526-53;Target:GITR;UniProt:Q9Y5U5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5526-53;Target: GITR;UniProt: Q9Y5U5;TargetFullName: Tumor necrosis factor receptor superfamily member 18;Organisim: human;Apparent_Kd_M: 1.76E-10

Real

Aptamer SeqId: 5526-53 | Target: GITR | UniProt: Q9Y5U5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5526-53 | Target: GITR | UniProt: Q9Y5U5 | TargetFullName: Tumor necrosis factor receptor superfamily member 18 | Organisim: human | Apparent_Kd_M: 1.76E-10

Real

Aptamer SeqId:5532-53;Target:bFGF-R;UniProt:P11362

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5532-53;Target: bFGF-R;UniProt: P11362;TargetFullName: Fibroblast growth factor receptor 1;Organisim: human;Apparent_Kd_M: 1.76E-12

Real

Aptamer SeqId: 5532-53 | Target: bFGF-R | UniProt: P11362

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5532-53 | Target: bFGF-R | UniProt: P11362 | TargetFullName: Fibroblast growth factor receptor 1 | Organisim: human | Apparent_Kd_M: 1.76E-12

Real

Aptamer SeqId:5534-49;Target:TRAIL R2;UniProt:O14763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5534-49;Target: TRAIL R2;UniProt: O14763;TargetFullName: Tumor necrosis factor receptor superfamily member 10B;Organisim: human;Apparent_Kd_M: 1.28E-10

Real

Aptamer SeqId: 5534-49 | Target: TRAIL R2 | UniProt: O14763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5534-49 | Target: TRAIL R2 | UniProt: O14763 | TargetFullName: Tumor necrosis factor receptor superfamily member 10B | Organisim: human | Apparent_Kd_M: 1.28E-10

Real

Aptamer SeqId:5542-22;Target:NRP1;UniProt:O14786

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5542-22;Target: NRP1;UniProt: O14786;TargetFullName: Neuropilin-1;Organisim: human;Apparent_Kd_M: 3.18E-12

Real

Aptamer SeqId: 5542-22 | Target: NRP1 | UniProt: O14786

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5542-22 | Target: NRP1 | UniProt: O14786 | TargetFullName: Neuropilin-1 | Organisim: human | Apparent_Kd_M: 3.18E-12

Real

Aptamer SeqId:5581-28;Target:FGL1;UniProt:Q08830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5581-28;Target: FGL1;UniProt: Q08830;TargetFullName: Fibrinogen-like protein 1;Organisim: human;Apparent_Kd_M: 6.63E-11

Real

Aptamer SeqId: 5581-28 | Target: FGL1 | UniProt: Q08830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5581-28 | Target: FGL1 | UniProt: Q08830 | TargetFullName: Fibrinogen-like protein 1 | Organisim: human | Apparent_Kd_M: 6.63E-11

Real

Aptamer SeqId:5583-62;Target:RYK;UniProt:P34925

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5583-62;Target: RYK;UniProt: P34925;TargetFullName: Tyrosine-protein kinase RYK;Organisim: human;Apparent_Kd_M: 6.507064E-11

Real

Aptamer SeqId: 5583-62 | Target: RYK | UniProt: P34925

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5583-62 | Target: RYK | UniProt: P34925 | TargetFullName: Tyrosine-protein kinase RYK | Organisim: human | Apparent_Kd_M: 6.507064E-11

Real

Aptamer SeqId:5584-21;Target:Holo-TC II;UniProt:P20062

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5584-21;Target: Holo-TC II;UniProt: P20062;TargetFullName: Holo-Transcobalamin-2;Organisim: human;Apparent_Kd_M: 4.797939E-12

Real

Aptamer SeqId: 5584-21 | Target: Holo-TC II | UniProt: P20062

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5584-21 | Target: Holo-TC II | UniProt: P20062 | TargetFullName: Holo-Transcobalamin-2 | Organisim: human | Apparent_Kd_M: 4.797939E-12

Real

Aptamer SeqId:5586-66;Target:MINP1;UniProt:Q9UNW1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5586-66;Target: MINP1;UniProt: Q9UNW1;TargetFullName: Multiple inositol polyphosphate phosphatase 1;Organisim: human;Apparent_Kd_M: 4.742687E-12

Real

Aptamer SeqId: 5586-66 | Target: MINP1 | UniProt: Q9UNW1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5586-66 | Target: MINP1 | UniProt: Q9UNW1 | TargetFullName: Multiple inositol polyphosphate phosphatase 1 | Organisim: human | Apparent_Kd_M: 4.742687E-12

Real

Aptamer SeqId:5590-11;Target:ZPLD1;UniProt:Q8TCW7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5590-11;Target: ZPLD1;UniProt: Q8TCW7;TargetFullName: Zona pellucida-like domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.53647E-11

Real

Aptamer SeqId: 5590-11 | Target: ZPLD1 | UniProt: Q8TCW7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5590-11 | Target: ZPLD1 | UniProt: Q8TCW7 | TargetFullName: Zona pellucida-like domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.53647E-11

Real

Aptamer SeqId:5593-11;Target:PDIA5;UniProt:Q14554

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5593-11;Target: PDIA5;UniProt: Q14554;TargetFullName: Protein disulfide-isomerase A5;Organisim: human;Apparent_Kd_M: 1.564568E-11

Real

Aptamer SeqId: 5593-11 | Target: PDIA5 | UniProt: Q14554

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5593-11 | Target: PDIA5 | UniProt: Q14554 | TargetFullName: Protein disulfide-isomerase A5 | Organisim: human | Apparent_Kd_M: 1.564568E-11

Real

Aptamer SeqId:5596-75;Target:CD5;UniProt:P06127

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5596-75;Target: CD5;UniProt: P06127;TargetFullName: T-cell surface glycoprotein CD5;Organisim: human;Apparent_Kd_M: 7.57E-11

Real

Aptamer SeqId: 5596-75 | Target: CD5 | UniProt: P06127

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5596-75 | Target: CD5 | UniProt: P06127 | TargetFullName: T-cell surface glycoprotein CD5 | Organisim: human | Apparent_Kd_M: 7.57E-11

Real

Aptamer SeqId:5598-3;Target:GREM2;UniProt:Q9H772

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5598-3;Target: GREM2;UniProt: Q9H772;TargetFullName: Gremlin-2;Organisim: human;Apparent_Kd_M: 3.710353E-11

Real

Aptamer SeqId: 5598-3 | Target: GREM2 | UniProt: Q9H772

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5598-3 | Target: GREM2 | UniProt: Q9H772 | TargetFullName: Gremlin-2 | Organisim: human | Apparent_Kd_M: 3.710353E-11

Real

Aptamer SeqId:5599-88;Target:PCYXL;UniProt:Q8NBM8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5599-88;Target: PCYXL;UniProt: Q8NBM8;TargetFullName: Prenylcysteine oxidase-like;Organisim: human;Apparent_Kd_M: 1.69197E-11

Real

Aptamer SeqId: 5599-88 | Target: PCYXL | UniProt: Q8NBM8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5599-88 | Target: PCYXL | UniProt: Q8NBM8 | TargetFullName: Prenylcysteine oxidase-like | Organisim: human | Apparent_Kd_M: 1.69197E-11

Real

Aptamer SeqId:5601-2;Target:PGRP-L;UniProt:Q96PD5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5601-2;Target: PGRP-L;UniProt: Q96PD5;TargetFullName: N-acetylmuramoyl-L-alanine amidase;Organisim: human;Apparent_Kd_M: 4.72E-11

Real

Aptamer SeqId: 5601-2 | Target: PGRP-L | UniProt: Q96PD5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5601-2 | Target: PGRP-L | UniProt: Q96PD5 | TargetFullName: N-acetylmuramoyl-L-alanine amidase | Organisim: human | Apparent_Kd_M: 4.72E-11

Real

Aptamer SeqId:5602-62;Target:RNS10;UniProt:Q5GAN6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5602-62;Target: RNS10;UniProt: Q5GAN6;TargetFullName: Inactive ribonuclease-like protein 10;Organisim: human;Apparent_Kd_M: 3.406101E-11

Real

Aptamer SeqId: 5602-62 | Target: RNS10 | UniProt: Q5GAN6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5602-62 | Target: RNS10 | UniProt: Q5GAN6 | TargetFullName: Inactive ribonuclease-like protein 10 | Organisim: human | Apparent_Kd_M: 3.406101E-11

Real

Aptamer SeqId:5604-30;Target:HPSE;UniProt:Q9Y251

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5604-30;Target: HPSE;UniProt: Q9Y251;TargetFullName: Heparanase;Organisim: human;Apparent_Kd_M: 5.984992E-11

Real

Aptamer SeqId: 5604-30 | Target: HPSE | UniProt: Q9Y251

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5604-30 | Target: HPSE | UniProt: Q9Y251 | TargetFullName: Heparanase | Organisim: human | Apparent_Kd_M: 5.984992E-11

Real

Aptamer SeqId:5605-77;Target:MFNG;UniProt:O00587

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5605-77;Target: MFNG;UniProt: O00587;TargetFullName: Beta-1;3-N-acetylglucosaminyltransferase manic fringe;Organisim: human;Apparent_Kd_M: 8.188151E-12

Real

Aptamer SeqId: 5605-77 | Target: MFNG | UniProt: O00587

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5605-77 | Target: MFNG | UniProt: O00587 | TargetFullName: Beta-1;3-N-acetylglucosaminyltransferase manic fringe | Organisim: human | Apparent_Kd_M: 8.188151E-12

Real

Aptamer SeqId:5606-24;Target:MFAP1;UniProt:P55081

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5606-24;Target: MFAP1;UniProt: P55081;TargetFullName: Microfibrillar-associated protein 1;Organisim: human;Apparent_Kd_M: 4.329375E-12

Real

Aptamer SeqId: 5606-24 | Target: MFAP1 | UniProt: P55081

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5606-24 | Target: MFAP1 | UniProt: P55081 | TargetFullName: Microfibrillar-associated protein 1 | Organisim: human | Apparent_Kd_M: 4.329375E-12

Real

Aptamer SeqId:5609-92;Target:F19A5;UniProt:Q7Z5A7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5609-92;Target: F19A5;UniProt: Q7Z5A7;TargetFullName: Protein FAM19A5;Organisim: human;Apparent_Kd_M: 4.54E-11

Real

Aptamer SeqId: 5609-92 | Target: F19A5 | UniProt: Q7Z5A7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5609-92 | Target: F19A5 | UniProt: Q7Z5A7 | TargetFullName: Protein FAM19A5 | Organisim: human | Apparent_Kd_M: 4.54E-11

Real

Aptamer SeqId:5610-32;Target:CJ038;UniProt:Q5VUB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5610-32;Target: CJ038;UniProt: Q5VUB5;TargetFullName: Protein FAM171A1;Organisim: human;Apparent_Kd_M: 1.550745E-10

Real

Aptamer SeqId: 5610-32 | Target: CJ038 | UniProt: Q5VUB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5610-32 | Target: CJ038 | UniProt: Q5VUB5 | TargetFullName: Protein FAM171A1 | Organisim: human | Apparent_Kd_M: 1.550745E-10

Real

Aptamer SeqId:5611-56;Target:D108B;UniProt:Q8NET1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5611-56;Target: D108B;UniProt: Q8NET1;TargetFullName: Beta-defensin 108B;Organisim: human;Apparent_Kd_M: 4.034996E-11

Real

Aptamer SeqId: 5611-56 | Target: D108B | UniProt: Q8NET1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5611-56 | Target: D108B | UniProt: Q8NET1 | TargetFullName: Beta-defensin 108B | Organisim: human | Apparent_Kd_M: 4.034996E-11

Real

Aptamer SeqId:5612-16;Target:HINT2;UniProt:Q9BX68

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5612-16;Target: HINT2;UniProt: Q9BX68;TargetFullName: Histidine triad nucleotide-binding protein 2; mitochondrial;Organisim: human;Apparent_Kd_M: 3.950975E-11

Real

Aptamer SeqId: 5612-16 | Target: HINT2 | UniProt: Q9BX68

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5612-16 | Target: HINT2 | UniProt: Q9BX68 | TargetFullName: Histidine triad nucleotide-binding protein 2; mitochondrial | Organisim: human | Apparent_Kd_M: 3.950975E-11

Real

Aptamer SeqId:5613-75;Target:NTAL;UniProt:Q9GZY6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5613-75;Target: NTAL;UniProt: Q9GZY6;TargetFullName: Linker for activation of T-cells family member 2;Organisim: human;Apparent_Kd_M: 5.660116E-11

Real

Aptamer SeqId: 5613-75 | Target: NTAL | UniProt: Q9GZY6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5613-75 | Target: NTAL | UniProt: Q9GZY6 | TargetFullName: Linker for activation of T-cells family member 2 | Organisim: human | Apparent_Kd_M: 5.660116E-11

Real

Aptamer SeqId:5614-44;Target:CRH;UniProt:P06850

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5614-44;Target: CRH;UniProt: P06850;TargetFullName: Corticoliberin;Organisim: human;Apparent_Kd_M: 5.19E-12

Real

Aptamer SeqId: 5614-44 | Target: CRH | UniProt: P06850

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5614-44 | Target: CRH | UniProt: P06850 | TargetFullName: Corticoliberin | Organisim: human | Apparent_Kd_M: 5.19E-12

Real

Aptamer SeqId:5615-62;Target:F172A;UniProt:Q8WUF8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5615-62;Target: F172A;UniProt: Q8WUF8;TargetFullName: Protein FAM172A;Organisim: human;Apparent_Kd_M: 1.181401E-10

Real

Aptamer SeqId: 5615-62 | Target: F172A | UniProt: Q8WUF8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5615-62 | Target: F172A | UniProt: Q8WUF8 | TargetFullName: Protein FAM172A | Organisim: human | Apparent_Kd_M: 1.181401E-10

Real

Aptamer SeqId:5617-41;Target:NPFF;UniProt:O15130

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5617-41;Target: NPFF;UniProt: O15130;TargetFullName: Pro-FMRFamide-related neuropeptide FF;Organisim: human;Apparent_Kd_M: 1.35448E-11

Real

Aptamer SeqId: 5617-41 | Target: NPFF | UniProt: O15130

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5617-41 | Target: NPFF | UniProt: O15130 | TargetFullName: Pro-FMRFamide-related neuropeptide FF | Organisim: human | Apparent_Kd_M: 1.35448E-11

Real

Aptamer SeqId:5618-50;Target:FAM3B;UniProt:P58499

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5618-50;Target: FAM3B;UniProt: P58499;TargetFullName: Protein FAM3B;Organisim: human;Apparent_Kd_M: 3.83E-11

Real

Aptamer SeqId: 5618-50 | Target: FAM3B | UniProt: P58499

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5618-50 | Target: FAM3B | UniProt: P58499 | TargetFullName: Protein FAM3B | Organisim: human | Apparent_Kd_M: 3.83E-11

Real

Aptamer SeqId:5620-13;Target:AMD;UniProt:P19021

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5620-13;Target: AMD;UniProt: P19021;TargetFullName: Peptidyl-glycine alpha-amidating monooxygenase;Organisim: human;Apparent_Kd_M: 1.071204E-11

Real

Aptamer SeqId: 5620-13 | Target: AMD | UniProt: P19021

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5620-13 | Target: AMD | UniProt: P19021 | TargetFullName: Peptidyl-glycine alpha-amidating monooxygenase | Organisim: human | Apparent_Kd_M: 1.071204E-11

Real

Aptamer SeqId:5621-64;Target:THSD1;UniProt:Q9NS62

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5621-64;Target: THSD1;UniProt: Q9NS62;TargetFullName: Thrombospondin type-1 domain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.789316E-11

Real

Aptamer SeqId: 5621-64 | Target: THSD1 | UniProt: Q9NS62

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5621-64 | Target: THSD1 | UniProt: Q9NS62 | TargetFullName: Thrombospondin type-1 domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.789316E-11

Real

Aptamer SeqId:5623-11;Target:CLM1;UniProt:Q8TDQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5623-11;Target: CLM1;UniProt: Q8TDQ1;TargetFullName: CMRF35-like molecule 1;Organisim: human;Apparent_Kd_M: 1.938788E-11

Real

Aptamer SeqId: 5623-11 | Target: CLM1 | UniProt: Q8TDQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5623-11 | Target: CLM1 | UniProt: Q8TDQ1 | TargetFullName: CMRF35-like molecule 1 | Organisim: human | Apparent_Kd_M: 1.938788E-11

Real

Aptamer SeqId:5626-20;Target:CTRC;UniProt:Q99895

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5626-20;Target: CTRC;UniProt: Q99895;TargetFullName: Chymotrypsin-C;Organisim: human;Apparent_Kd_M: 6.793299E-11

Real

Aptamer SeqId: 5626-20 | Target: CTRC | UniProt: Q99895

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5626-20 | Target: CTRC | UniProt: Q99895 | TargetFullName: Chymotrypsin-C | Organisim: human | Apparent_Kd_M: 6.793299E-11

Real

Aptamer SeqId:5627-53;Target:GON1;UniProt:P01148

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5627-53;Target: GON1;UniProt: P01148;TargetFullName: Progonadoliberin-1;Organisim: human;Apparent_Kd_M: 2.114084E-11

Real

Aptamer SeqId: 5627-53 | Target: GON1 | UniProt: P01148

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5627-53 | Target: GON1 | UniProt: P01148 | TargetFullName: Progonadoliberin-1 | Organisim: human | Apparent_Kd_M: 2.114084E-11

Real

Aptamer SeqId:5628-21;Target:SEM3G;UniProt:Q9NS98

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5628-21;Target: SEM3G;UniProt: Q9NS98;TargetFullName: Semaphorin-3G;Organisim: human;Apparent_Kd_M: 2.096476E-11

Real

Aptamer SeqId: 5628-21 | Target: SEM3G | UniProt: Q9NS98

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5628-21 | Target: SEM3G | UniProt: Q9NS98 | TargetFullName: Semaphorin-3G | Organisim: human | Apparent_Kd_M: 2.096476E-11

Real

Aptamer SeqId:5629-58;Target:NKG2A;UniProt:P26715

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5629-58;Target: NKG2A;UniProt: P26715;TargetFullName: NKG2-A/NKG2-B type II integral membrane protein;Organisim: human;Apparent_Kd_M: 5.382212E-11

Real

Aptamer SeqId: 5629-58 | Target: NKG2A | UniProt: P26715

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5629-58 | Target: NKG2A | UniProt: P26715 | TargetFullName: NKG2-A/NKG2-B type II integral membrane protein | Organisim: human | Apparent_Kd_M: 5.382212E-11

Real

Aptamer SeqId:5630-48;Target:CM35H;UniProt:Q9UGN4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5630-48;Target: CM35H;UniProt: Q9UGN4;TargetFullName: CMRF35-like molecule 8;Organisim: human;Apparent_Kd_M: 5.58E-12

Real

Aptamer SeqId: 5630-48 | Target: CM35H | UniProt: Q9UGN4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5630-48 | Target: CM35H | UniProt: Q9UGN4 | TargetFullName: CMRF35-like molecule 8 | Organisim: human | Apparent_Kd_M: 5.58E-12

Real

Aptamer SeqId:5631-83;Target:MOTI;UniProt:P12872

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5631-83;Target: MOTI;UniProt: P12872;TargetFullName: Promotilin;Organisim: human;Apparent_Kd_M: 1.021714E-10

Real

Aptamer SeqId: 5631-83 | Target: MOTI | UniProt: P12872

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5631-83 | Target: MOTI | UniProt: P12872 | TargetFullName: Promotilin | Organisim: human | Apparent_Kd_M: 1.021714E-10

Real

Aptamer SeqId:5632-6;Target:CRAC1;UniProt:Q9NQ79

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5632-6;Target: CRAC1;UniProt: Q9NQ79;TargetFullName: Cartilage acidic protein 1;Organisim: human;Apparent_Kd_M: 1.114244E-10

Real

Aptamer SeqId: 5632-6 | Target: CRAC1 | UniProt: Q9NQ79

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5632-6 | Target: CRAC1 | UniProt: Q9NQ79 | TargetFullName: Cartilage acidic protein 1 | Organisim: human | Apparent_Kd_M: 1.114244E-10

Real

Aptamer SeqId:5634-39;Target:OFUT1;UniProt:Q9H488

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5634-39;Target: OFUT1;UniProt: Q9H488;TargetFullName: GDP-fucose protein O-fucosyltransferase 1;Organisim: human;Apparent_Kd_M: 1.080884E-11

Real

Aptamer SeqId: 5634-39 | Target: OFUT1 | UniProt: Q9H488

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5634-39 | Target: OFUT1 | UniProt: Q9H488 | TargetFullName: GDP-fucose protein O-fucosyltransferase 1 | Organisim: human | Apparent_Kd_M: 1.080884E-11

Real

Aptamer SeqId:5636-10;Target:MFAP4;UniProt:P55083

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5636-10;Target: MFAP4;UniProt: P55083;TargetFullName: Microfibril-associated glycoprotein 4;Organisim: human;Apparent_Kd_M: 1.088905E-10

Real

Aptamer SeqId: 5636-10 | Target: MFAP4 | UniProt: P55083

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5636-10 | Target: MFAP4 | UniProt: P55083 | TargetFullName: Microfibril-associated glycoprotein 4 | Organisim: human | Apparent_Kd_M: 1.088905E-10

Real

Aptamer SeqId:5637-81;Target:NTNG1;UniProt:Q9Y2I2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5637-81;Target: NTNG1;UniProt: Q9Y2I2;TargetFullName: Netrin-G1;Organisim: human;Apparent_Kd_M: 2.173556E-11

Real

Aptamer SeqId: 5637-81 | Target: NTNG1 | UniProt: Q9Y2I2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5637-81 | Target: NTNG1 | UniProt: Q9Y2I2 | TargetFullName: Netrin-G1 | Organisim: human | Apparent_Kd_M: 2.173556E-11

Real

Aptamer SeqId:5638-23;Target:GT251;UniProt:Q8NBJ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5638-23;Target: GT251;UniProt: Q8NBJ5;TargetFullName: Procollagen galactosyltransferase 1;Organisim: human;Apparent_Kd_M: 9.092331E-11

Real

Aptamer SeqId: 5638-23 | Target: GT251 | UniProt: Q8NBJ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5638-23 | Target: GT251 | UniProt: Q8NBJ5 | TargetFullName: Procollagen galactosyltransferase 1 | Organisim: human | Apparent_Kd_M: 9.092331E-11

Real

Aptamer SeqId:5639-49;Target:NETO1;UniProt:Q8TDF5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5639-49;Target: NETO1;UniProt: Q8TDF5;TargetFullName: Neuropilin and tolloid-like protein 1;Organisim: human;Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId: 5639-49 | Target: NETO1 | UniProt: Q8TDF5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5639-49 | Target: NETO1 | UniProt: Q8TDF5 | TargetFullName: Neuropilin and tolloid-like protein 1 | Organisim: human | Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId:5643-2;Target:LCN8;UniProt:Q6JVE9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5643-2;Target: LCN8;UniProt: Q6JVE9;TargetFullName: Epididymal-specific lipocalin-8;Organisim: human;Apparent_Kd_M: 1.550936E-11

Real

Aptamer SeqId: 5643-2 | Target: LCN8 | UniProt: Q6JVE9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5643-2 | Target: LCN8 | UniProt: Q6JVE9 | TargetFullName: Epididymal-specific lipocalin-8 | Organisim: human | Apparent_Kd_M: 1.550936E-11

Real

Aptamer SeqId:5644-60;Target:RNAS4;UniProt:P34096

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5644-60;Target: RNAS4;UniProt: P34096;TargetFullName: Ribonuclease 4;Organisim: human;Apparent_Kd_M: 4.441821E-11

Real

Aptamer SeqId: 5644-60 | Target: RNAS4 | UniProt: P34096

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5644-60 | Target: RNAS4 | UniProt: P34096 | TargetFullName: Ribonuclease 4 | Organisim: human | Apparent_Kd_M: 4.441821E-11

Real

Aptamer SeqId:5646-20;Target:RNAS6;UniProt:Q93091

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5646-20;Target: RNAS6;UniProt: Q93091;TargetFullName: Ribonuclease K6;Organisim: human;Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId: 5646-20 | Target: RNAS6 | UniProt: Q93091

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5646-20 | Target: RNAS6 | UniProt: Q93091 | TargetFullName: Ribonuclease K6 | Organisim: human | Apparent_Kd_M: 3.18E-11

Real

Aptamer SeqId:5648-28;Target:CTRB2;UniProt:Q6GPI1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5648-28;Target: CTRB2;UniProt: Q6GPI1;TargetFullName: Chymotrypsinogen B2;Organisim: human;Apparent_Kd_M: 1.050203E-11

Real

Aptamer SeqId: 5648-28 | Target: CTRB2 | UniProt: Q6GPI1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5648-28 | Target: CTRB2 | UniProt: Q6GPI1 | TargetFullName: Chymotrypsinogen B2 | Organisim: human | Apparent_Kd_M: 1.050203E-11

Real

Aptamer SeqId:5649-83;Target:PSG4;UniProt:Q00888

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5649-83;Target: PSG4;UniProt: Q00888;TargetFullName: Pregnancy-specific beta-1-glycoprotein 4;Organisim: human;Apparent_Kd_M: 1.056322E-11

Real

Aptamer SeqId: 5649-83 | Target: PSG4 | UniProt: Q00888

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5649-83 | Target: PSG4 | UniProt: Q00888 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 4 | Organisim: human | Apparent_Kd_M: 1.056322E-11

Real

Aptamer SeqId:5650-9;Target:PDIA6;UniProt:Q15084

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5650-9;Target: PDIA6;UniProt: Q15084;TargetFullName: Protein disulfide-isomerase A6;Organisim: human;Apparent_Kd_M: 4.48748E-12

Real

Aptamer SeqId: 5650-9 | Target: PDIA6 | UniProt: Q15084

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5650-9 | Target: PDIA6 | UniProt: Q15084 | TargetFullName: Protein disulfide-isomerase A6 | Organisim: human | Apparent_Kd_M: 4.48748E-12

Real

Aptamer SeqId:5651-50;Target:PSG7;UniProt:Q13046

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5651-50;Target: PSG7;UniProt: Q13046;TargetFullName: Putative pregnancy-specific beta-1-glycoprotein 7;Organisim: human;Apparent_Kd_M: 5.86E-12

Real

Aptamer SeqId: 5651-50 | Target: PSG7 | UniProt: Q13046

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5651-50 | Target: PSG7 | UniProt: Q13046 | TargetFullName: Putative pregnancy-specific beta-1-glycoprotein 7 | Organisim: human | Apparent_Kd_M: 5.86E-12

Real

Aptamer SeqId:5653-23;Target:PRS37;UniProt:A4D1T9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5653-23;Target: PRS37;UniProt: A4D1T9;TargetFullName: Probable inactive serine protease 37;Organisim: human;Apparent_Kd_M: 1.602967E-11

Real

Aptamer SeqId: 5653-23 | Target: PRS37 | UniProt: A4D1T9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5653-23 | Target: PRS37 | UniProt: A4D1T9 | TargetFullName: Probable inactive serine protease 37 | Organisim: human | Apparent_Kd_M: 1.602967E-11

Real

Aptamer SeqId:5654-70;Target:TMX3;UniProt:Q96JJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5654-70;Target: TMX3;UniProt: Q96JJ7;TargetFullName: Protein disulfide-isomerase TMX3;Organisim: human;Apparent_Kd_M: 2.264108E-11

Real

Aptamer SeqId: 5654-70 | Target: TMX3 | UniProt: Q96JJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5654-70 | Target: TMX3 | UniProt: Q96JJ7 | TargetFullName: Protein disulfide-isomerase TMX3 | Organisim: human | Apparent_Kd_M: 2.264108E-11

Real

Aptamer SeqId:5656-53;Target:PP11;UniProt:P21128

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5656-53;Target: PP11;UniProt: P21128;TargetFullName: Poly(U)-specific endoribonuclease;Organisim: human;Apparent_Kd_M: 4.860815E-11

Real

Aptamer SeqId: 5656-53 | Target: PP11 | UniProt: P21128

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5656-53 | Target: PP11 | UniProt: P21128 | TargetFullName: Poly(U)-specific endoribonuclease | Organisim: human | Apparent_Kd_M: 4.860815E-11

Real

Aptamer SeqId:5657-28;Target:SIA4A;UniProt:Q11201

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5657-28;Target: SIA4A;UniProt: Q11201;TargetFullName: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2;3-sialyltransferase 1;Organisim: human;Apparent_Kd_M: 2.21399E-11

Real

Aptamer SeqId: 5657-28 | Target: SIA4A | UniProt: Q11201

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5657-28 | Target: SIA4A | UniProt: Q11201 | TargetFullName: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2;3-sialyltransferase 1 | Organisim: human | Apparent_Kd_M: 2.21399E-11

Real

Aptamer SeqId:5658-64;Target:coagulation factor XIII B;UniProt:P05160

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5658-64;Target: coagulation factor XIII B;UniProt: P05160;TargetFullName: Coagulation factor XIII B chain;Organisim: human;Apparent_Kd_M: 3.31465E-11

Real

Aptamer SeqId: 5658-64 | Target: coagulation factor XIII B

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5658-64 | Target: coagulation factor XIII B | UniProt: P05160 | TargetFullName: Coagulation factor XIII B chain | Organisim: human | Apparent_Kd_M: 3.31465E-11

Real

Aptamer SeqId:5659-11;Target:TRH;UniProt:P20396

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5659-11;Target: TRH;UniProt: P20396;TargetFullName: Pro-Thyrotropin-releasing hormone;Organisim: human;Apparent_Kd_M: 3.427851E-11

Real

Aptamer SeqId: 5659-11 | Target: TRH | UniProt: P20396

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5659-11 | Target: TRH | UniProt: P20396 | TargetFullName: Pro-Thyrotropin-releasing hormone | Organisim: human | Apparent_Kd_M: 3.427851E-11

Real

Aptamer SeqId:5660-51;Target:SOD3;UniProt:P08294

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5660-51;Target: SOD3;UniProt: P08294;TargetFullName: Extracellular superoxide dismutase [Cu-Zn];Organisim: human;Apparent_Kd_M: 4.93E-12

Real

Aptamer SeqId: 5660-51 | Target: SOD3 | UniProt: P08294

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5660-51 | Target: SOD3 | UniProt: P08294 | TargetFullName: Extracellular superoxide dismutase Cu-Zn | Organisim: human | Apparent_Kd_M: 4.93E-12

Real

Aptamer SeqId:5661-15;Target:IL-18;UniProt:Q14116

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5661-15;Target: IL-18;UniProt: Q14116;TargetFullName: Interleukin-18;Organisim: human;Apparent_Kd_M: 1.481881E-10

Real

Aptamer SeqId: 5661-15 | Target: IL-18 | UniProt: Q14116

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5661-15 | Target: IL-18 | UniProt: Q14116 | TargetFullName: Interleukin-18 | Organisim: human | Apparent_Kd_M: 1.481881E-10

Real

Aptamer SeqId:5663-18;Target:PF4V;UniProt:P10720

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5663-18;Target: PF4V;UniProt: P10720;TargetFullName: Platelet factor 4 variant;Organisim: human;Apparent_Kd_M: 2.889615E-11

Real

Aptamer SeqId: 5663-18 | Target: PF4V | UniProt: P10720

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5663-18 | Target: PF4V | UniProt: P10720 | TargetFullName: Platelet factor 4 variant | Organisim: human | Apparent_Kd_M: 2.889615E-11

Real

Aptamer SeqId:5664-57;Target:D106A;UniProt:Q8N104

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5664-57;Target: D106A;UniProt: Q8N104;TargetFullName: Beta-defensin 106;Organisim: human;Apparent_Kd_M: 2.472107E-11

Real

Aptamer SeqId: 5664-57 | Target: D106A | UniProt: Q8N104

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5664-57 | Target: D106A | UniProt: Q8N104 | TargetFullName: Beta-defensin 106 | Organisim: human | Apparent_Kd_M: 2.472107E-11

Real

Aptamer SeqId:5667-3;Target:SEM3B;UniProt:Q13214

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5667-3;Target: SEM3B;UniProt: Q13214;TargetFullName: Semaphorin-3B;Organisim: human;Apparent_Kd_M: 2.49395E-11

Real

Aptamer SeqId: 5667-3 | Target: SEM3B | UniProt: Q13214

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5667-3 | Target: SEM3B | UniProt: Q13214 | TargetFullName: Semaphorin-3B | Organisim: human | Apparent_Kd_M: 2.49395E-11

Real

Aptamer SeqId:5669-26;Target:SIRB2;UniProt:Q5JXA9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5669-26;Target: SIRB2;UniProt: Q5JXA9;TargetFullName: Signal-regulatory protein beta-2;Organisim: human;Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId: 5669-26 | Target: SIRB2 | UniProt: Q5JXA9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5669-26 | Target: SIRB2 | UniProt: Q5JXA9 | TargetFullName: Signal-regulatory protein beta-2 | Organisim: human | Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId:5671-1;Target:Chymotrypsin;UniProt:P17538

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5671-1;Target: Chymotrypsin;UniProt: P17538;TargetFullName: Chymotrypsinogen B;Organisim: human;Apparent_Kd_M: 1.283621E-10

Real

Aptamer SeqId: 5671-1 | Target: Chymotrypsin | UniProt: P17538

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5671-1 | Target: Chymotrypsin | UniProt: P17538 | TargetFullName: Chymotrypsinogen B | Organisim: human | Apparent_Kd_M: 1.283621E-10

Real

Aptamer SeqId:5675-6;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5675-6;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 1.808638E-10

Real

Aptamer SeqId: 5675-6 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5675-6 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 1.808638E-10

Real

Aptamer SeqId:5676-54;Target:ASIP;UniProt:P42127

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5676-54;Target: ASIP;UniProt: P42127;TargetFullName: Agouti-signaling protein;Organisim: human;Apparent_Kd_M: 8.547198E-11

Real

Aptamer SeqId: 5676-54 | Target: ASIP | UniProt: P42127

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5676-54 | Target: ASIP | UniProt: P42127 | TargetFullName: Agouti-signaling protein | Organisim: human | Apparent_Kd_M: 8.547198E-11

Real

Aptamer SeqId:5677-15;Target:CB066;UniProt:Q6UXQ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5677-15;Target: CB066;UniProt: Q6UXQ4;TargetFullName: Uncharacterized protein C2orf66;Organisim: human;Apparent_Kd_M: 1.281353E-11

Real

Aptamer SeqId: 5677-15 | Target: CB066 | UniProt: Q6UXQ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5677-15 | Target: CB066 | UniProt: Q6UXQ4 | TargetFullName: Uncharacterized protein C2orf66 | Organisim: human | Apparent_Kd_M: 1.281353E-11

Real

Aptamer SeqId:5679-16;Target:HBD-3;UniProt:P81534

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5679-16;Target: HBD-3;UniProt: P81534;TargetFullName: Beta-defensin 103;Organisim: human;Apparent_Kd_M: 7.6973E-11

Real

Aptamer SeqId: 5679-16 | Target: HBD-3 | UniProt: P81534

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5679-16 | Target: HBD-3 | UniProt: P81534 | TargetFullName: Beta-defensin 103 | Organisim: human | Apparent_Kd_M: 7.6973E-11

Real

Aptamer SeqId:5680-54;Target:OBP2B;UniProt:Q9NPH6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5680-54;Target: OBP2B;UniProt: Q9NPH6;TargetFullName: Odorant-binding protein 2b;Organisim: human;Apparent_Kd_M: 2.494725E-11

Real

Aptamer SeqId: 5680-54 | Target: OBP2B | UniProt: Q9NPH6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5680-54 | Target: OBP2B | UniProt: Q9NPH6 | TargetFullName: Odorant-binding protein 2b | Organisim: human | Apparent_Kd_M: 2.494725E-11

Real

Aptamer SeqId:5682-13;Target:VASN;UniProt:Q6EMK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5682-13;Target: VASN;UniProt: Q6EMK4;TargetFullName: Vasorin;Organisim: human;Apparent_Kd_M: 2.322254E-11

Real

Aptamer SeqId: 5682-13 | Target: VASN | UniProt: Q6EMK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5682-13 | Target: VASN | UniProt: Q6EMK4 | TargetFullName: Vasorin | Organisim: human | Apparent_Kd_M: 2.322254E-11

Real

Aptamer SeqId:5687-5;Target:GLU2B;UniProt:P14314

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5687-5;Target: GLU2B;UniProt: P14314;TargetFullName: Glucosidase 2 subunit beta;Organisim: human;Apparent_Kd_M: 1.39267E-11

Real

Aptamer SeqId: 5687-5 | Target: GLU2B | UniProt: P14314

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5687-5 | Target: GLU2B | UniProt: P14314 | TargetFullName: Glucosidase 2 subunit beta | Organisim: human | Apparent_Kd_M: 1.39267E-11

Real

Aptamer SeqId:5688-65;Target:CBLN4;UniProt:Q9NTU7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5688-65;Target: CBLN4;UniProt: Q9NTU7;TargetFullName: Cerebellin-4;Organisim: human;Apparent_Kd_M: 2.129453E-11

Real

Aptamer SeqId: 5688-65 | Target: CBLN4 | UniProt: Q9NTU7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5688-65 | Target: CBLN4 | UniProt: Q9NTU7 | TargetFullName: Cerebellin-4 | Organisim: human | Apparent_Kd_M: 2.129453E-11

Real

Aptamer SeqId:5689-1;Target:DB112;UniProt:Q30KQ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5689-1;Target: DB112;UniProt: Q30KQ8;TargetFullName: Beta-defensin 112;Organisim: human;Apparent_Kd_M: 3.24E-12

Real

Aptamer SeqId: 5689-1 | Target: DB112 | UniProt: Q30KQ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5689-1 | Target: DB112 | UniProt: Q30KQ8 | TargetFullName: Beta-defensin 112 | Organisim: human | Apparent_Kd_M: 3.24E-12

Real

Aptamer SeqId:5690-49;Target:TUFT1;UniProt:Q9NNX1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5690-49;Target: TUFT1;UniProt: Q9NNX1;TargetFullName: Tuftelin;Organisim: human;Apparent_Kd_M: 2.55369E-11

Real

Aptamer SeqId: 5690-49 | Target: TUFT1 | UniProt: Q9NNX1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5690-49 | Target: TUFT1 | UniProt: Q9NNX1 | TargetFullName: Tuftelin | Organisim: human | Apparent_Kd_M: 2.55369E-11

Real

Aptamer SeqId:5691-2;Target:CRLD2;UniProt:Q9H0B8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5691-2;Target: CRLD2;UniProt: Q9H0B8;TargetFullName: Cysteine-rich secretory protein LCCL domain-containing 2;Organisim: human;Apparent_Kd_M: 3.742972E-11

Real

Aptamer SeqId: 5691-2 | Target: CRLD2 | UniProt: Q9H0B8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5691-2 | Target: CRLD2 | UniProt: Q9H0B8 | TargetFullName: Cysteine-rich secretory protein LCCL domain-containing 2 | Organisim: human | Apparent_Kd_M: 3.742972E-11

Real

Aptamer SeqId:5698-60;Target:Tenascin-X;UniProt:P22105

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5698-60;Target: Tenascin-X;UniProt: P22105;TargetFullName: Tenascin-X;Organisim: human;Apparent_Kd_M: 3.766822E-11

Real

Aptamer SeqId: 5698-60 | Target: Tenascin-X | UniProt: P22105

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5698-60 | Target: Tenascin-X | UniProt: P22105 | TargetFullName: Tenascin-X | Organisim: human | Apparent_Kd_M: 3.766822E-11

Real

Aptamer SeqId:5701-81;Target:Tetranectin;UniProt:P05452

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5701-81;Target: Tetranectin;UniProt: P05452;TargetFullName: Tetranectin;Organisim: human;Apparent_Kd_M: 2.41E-11

Real

Aptamer SeqId: 5701-81 | Target: Tetranectin | UniProt: P05452

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5701-81 | Target: Tetranectin | UniProt: P05452 | TargetFullName: Tetranectin | Organisim: human | Apparent_Kd_M: 2.41E-11

Real

Aptamer SeqId:5703-26;Target:NOE1;UniProt:Q99784

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5703-26;Target: NOE1;UniProt: Q99784;TargetFullName: Noelin;Organisim: human;Apparent_Kd_M: 2.22E-11

Real

Aptamer SeqId: 5703-26 | Target: NOE1 | UniProt: Q99784

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5703-26 | Target: NOE1 | UniProt: Q99784 | TargetFullName: Noelin | Organisim: human | Apparent_Kd_M: 2.22E-11

Real

Aptamer SeqId:5704-74;Target:Granzyme M;UniProt:P51124

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5704-74;Target: Granzyme M;UniProt: P51124;TargetFullName: Granzyme M;Organisim: human;Apparent_Kd_M: 9.425172E-12

Real

Aptamer SeqId: 5704-74 | Target: Granzyme M | UniProt: P51124

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5704-74 | Target: Granzyme M | UniProt: P51124 | TargetFullName: Granzyme M | Organisim: human | Apparent_Kd_M: 9.425172E-12

Real

Aptamer SeqId:5707-55;Target:ELK3;UniProt:P41970

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5707-55;Target: ELK3;UniProt: P41970;TargetFullName: ETS domain-containing protein Elk-3;Organisim: human;Apparent_Kd_M: 6.757889E-11

Real

Aptamer SeqId: 5707-55 | Target: ELK3 | UniProt: P41970

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5707-55 | Target: ELK3 | UniProt: P41970 | TargetFullName: ETS domain-containing protein Elk-3 | Organisim: human | Apparent_Kd_M: 6.757889E-11

Real

Aptamer SeqId:5708-1;Target:LEAP2;UniProt:Q969E1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5708-1;Target: LEAP2;UniProt: Q969E1;TargetFullName: Liver-expressed antimicrobial peptide 2;Organisim: human;Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId: 5708-1 | Target: LEAP2 | UniProt: Q969E1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5708-1 | Target: LEAP2 | UniProt: Q969E1 | TargetFullName: Liver-expressed antimicrobial peptide 2 | Organisim: human | Apparent_Kd_M: 1.44E-11

Real

Aptamer SeqId:5713-9;Target:IFN-lambda 3;UniProt:Q8IZI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5713-9;Target: IFN-lambda 3;UniProt: Q8IZI9;TargetFullName: Interferon lambda-3;Organisim: human;Apparent_Kd_M: 3.469201E-12

Real

Aptamer SeqId: 5713-9 | Target: IFN-lambda 3 | UniProt: Q8IZI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5713-9 | Target: IFN-lambda 3 | UniProt: Q8IZI9 | TargetFullName: Interferon lambda-3 | Organisim: human | Apparent_Kd_M: 3.469201E-12

Real

Aptamer SeqId:5714-88;Target:IFNA6;UniProt:P05013

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5714-88;Target: IFNA6;UniProt: P05013;TargetFullName: Interferon alpha-6;Organisim: human;Apparent_Kd_M: 1.750382E-10

Real

Aptamer SeqId: 5714-88 | Target: IFNA6 | UniProt: P05013

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5714-88 | Target: IFNA6 | UniProt: P05013 | TargetFullName: Interferon alpha-6 | Organisim: human | Apparent_Kd_M: 1.750382E-10

Real

Aptamer SeqId:5715-4;Target:ABHEA;UniProt:Q9BUJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5715-4;Target: ABHEA;UniProt: Q9BUJ0;TargetFullName: Protein ABHD14A;Organisim: human;Apparent_Kd_M: 5.274607E-11

Real

Aptamer SeqId: 5715-4 | Target: ABHEA | UniProt: Q9BUJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5715-4 | Target: ABHEA | UniProt: Q9BUJ0 | TargetFullName: Protein ABHD14A | Organisim: human | Apparent_Kd_M: 5.274607E-11

Real

Aptamer SeqId:5716-49;Target:CSAG1;UniProt:Q6PB30

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5716-49;Target: CSAG1;UniProt: Q6PB30;TargetFullName: Putative chondrosarcoma-associated gene 1 protein;Organisim: human;Apparent_Kd_M: 2.716691E-11

Real

Aptamer SeqId: 5716-49 | Target: CSAG1 | UniProt: Q6PB30

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5716-49 | Target: CSAG1 | UniProt: Q6PB30 | TargetFullName: Putative chondrosarcoma-associated gene 1 protein | Organisim: human | Apparent_Kd_M: 2.716691E-11

Real

Aptamer SeqId:5717-2;Target:CILP;UniProt:O75339

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5717-2;Target: CILP;UniProt: O75339;TargetFullName: Cartilage intermediate layer protein 1;Organisim: human;Apparent_Kd_M: 3.790369E-11

Real

Aptamer SeqId: 5717-2 | Target: CILP | UniProt: O75339

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5717-2 | Target: CILP | UniProt: O75339 | TargetFullName: Cartilage intermediate layer protein 1 | Organisim: human | Apparent_Kd_M: 3.790369E-11

Real

Aptamer SeqId:5719-66;Target:CI061;UniProt:Q15884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5719-66;Target: CI061;UniProt: Q15884;TargetFullName: Protein FAM189A2;Organisim: human;Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId: 5719-66 | Target: CI061 | UniProt: Q15884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5719-66 | Target: CI061 | UniProt: Q15884 | TargetFullName: Protein FAM189A2 | Organisim: human | Apparent_Kd_M: 1.65E-11

Real

Aptamer SeqId:5722-78;Target:Prolylcarboxypeptidase;UniProt:P42785

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5722-78;Target: Prolylcarboxypeptidase;UniProt: P42785;TargetFullName: Lysosomal Pro-X carboxypeptidase;Organisim: human;Apparent_Kd_M: 1.15948E-11

Real

Aptamer SeqId: 5722-78 | Target: Prolylcarboxypeptidase | UniProt: P42785

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5722-78 | Target: Prolylcarboxypeptidase | UniProt: P42785 | TargetFullName: Lysosomal Pro-X carboxypeptidase | Organisim: human | Apparent_Kd_M: 1.15948E-11

Real

Aptamer SeqId:5723-4;Target:INSL3;UniProt:P51460

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5723-4;Target: INSL3;UniProt: P51460;TargetFullName: Insulin-like 3;Organisim: human;Apparent_Kd_M: 1.608226E-11

Real

Aptamer SeqId: 5723-4 | Target: INSL3 | UniProt: P51460

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5723-4 | Target: INSL3 | UniProt: P51460 | TargetFullName: Insulin-like 3 | Organisim: human | Apparent_Kd_M: 1.608226E-11

Real

Aptamer SeqId:5724-58;Target:SBSN;UniProt:Q6UWP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5724-58;Target: SBSN;UniProt: Q6UWP8;TargetFullName: Suprabasin;Organisim: human;Apparent_Kd_M: 6.326337E-11

Real

Aptamer SeqId: 5724-58 | Target: SBSN | UniProt: Q6UWP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5724-58 | Target: SBSN | UniProt: Q6UWP8 | TargetFullName: Suprabasin | Organisim: human | Apparent_Kd_M: 6.326337E-11

Real

Aptamer SeqId:5726-49;Target:SG11A;UniProt:Q6PDA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5726-49;Target: SG11A;UniProt: Q6PDA7;TargetFullName: Sperm-associated antigen 11A;Organisim: human;Apparent_Kd_M: 1.151562E-11

Real

Aptamer SeqId: 5726-49 | Target: SG11A | UniProt: Q6PDA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5726-49 | Target: SG11A | UniProt: Q6PDA7 | TargetFullName: Sperm-associated antigen 11A | Organisim: human | Apparent_Kd_M: 1.151562E-11

Real

Aptamer SeqId:5727-35;Target:B3GLT;UniProt:Q6Y288

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5727-35;Target: B3GLT;UniProt: Q6Y288;TargetFullName: Beta-1;3-glucosyltransferase;Organisim: human;Apparent_Kd_M: 6.733666E-12

Real

Aptamer SeqId: 5727-35 | Target: B3GLT | UniProt: Q6Y288

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5727-35 | Target: B3GLT | UniProt: Q6Y288 | TargetFullName: Beta-1;3-glucosyltransferase | Organisim: human | Apparent_Kd_M: 6.733666E-12

Real

Aptamer SeqId:5728-60;Target:FCRL1;UniProt:Q96LA6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5728-60;Target: FCRL1;UniProt: Q96LA6;TargetFullName: Fc receptor-like protein 1;Organisim: human;Apparent_Kd_M: 9.14E-12

Real

Aptamer SeqId: 5728-60 | Target: FCRL1 | UniProt: Q96LA6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5728-60 | Target: FCRL1 | UniProt: Q96LA6 | TargetFullName: Fc receptor-like protein 1 | Organisim: human | Apparent_Kd_M: 9.14E-12

Real

Aptamer SeqId:5730-60;Target:BRAK;UniProt:O95715

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5730-60;Target: BRAK;UniProt: O95715;TargetFullName: C-X-C motif chemokine 14;Organisim: human;Apparent_Kd_M: 3.527827E-11

Real

Aptamer SeqId: 5730-60 | Target: BRAK | UniProt: O95715

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5730-60 | Target: BRAK | UniProt: O95715 | TargetFullName: C-X-C motif chemokine 14 | Organisim: human | Apparent_Kd_M: 3.527827E-11

Real

Aptamer SeqId:5731-1;Target:ISK6;UniProt:Q6UWN8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5731-1;Target: ISK6;UniProt: Q6UWN8;TargetFullName: Serine protease inhibitor Kazal-type 6;Organisim: human;Apparent_Kd_M: 1.194348E-11

Real

Aptamer SeqId: 5731-1 | Target: ISK6 | UniProt: Q6UWN8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5731-1 | Target: ISK6 | UniProt: Q6UWN8 | TargetFullName: Serine protease inhibitor Kazal-type 6 | Organisim: human | Apparent_Kd_M: 1.194348E-11

Real

Aptamer SeqId:5734-13;Target:nectin-4;UniProt:Q96NY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5734-13;Target: nectin-4;UniProt: Q96NY8;TargetFullName: Nectin-4;Organisim: human;Apparent_Kd_M: 4.717683E-12

Real

Aptamer SeqId: 5734-13 | Target: nectin-4 | UniProt: Q96NY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5734-13 | Target: nectin-4 | UniProt: Q96NY8 | TargetFullName: Nectin-4 | Organisim: human | Apparent_Kd_M: 4.717683E-12

Real

Aptamer SeqId:5735-54;Target:C1GLC;UniProt:Q96EU7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5735-54;Target: C1GLC;UniProt: Q96EU7;TargetFullName: C1GALT1-specific chaperone 1;Organisim: human;Apparent_Kd_M: 9.579592E-12

Real

Aptamer SeqId: 5735-54 | Target: C1GLC | UniProt: Q96EU7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5735-54 | Target: C1GLC | UniProt: Q96EU7 | TargetFullName: C1GALT1-specific chaperone 1 | Organisim: human | Apparent_Kd_M: 9.579592E-12

Real

Aptamer SeqId:5736-1;Target:TRML2;UniProt:Q5T2D2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5736-1;Target: TRML2;UniProt: Q5T2D2;TargetFullName: Trem-like transcript 2 protein;Organisim: human;Apparent_Kd_M: 2.574806E-12

Real

Aptamer SeqId: 5736-1 | Target: TRML2 | UniProt: Q5T2D2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5736-1 | Target: TRML2 | UniProt: Q5T2D2 | TargetFullName: Trem-like transcript 2 protein | Organisim: human | Apparent_Kd_M: 2.574806E-12

Real

Aptamer SeqId:5737-61;Target:SEM4D;UniProt:Q92854

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5737-61;Target: SEM4D;UniProt: Q92854;TargetFullName: Semaphorin-4D;Organisim: human;Apparent_Kd_M: 8.411657E-12

Real

Aptamer SeqId: 5737-61 | Target: SEM4D | UniProt: Q92854

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5737-61 | Target: SEM4D | UniProt: Q92854 | TargetFullName: Semaphorin-4D | Organisim: human | Apparent_Kd_M: 8.411657E-12

Real

Aptamer SeqId:5738-25;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5738-25;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 8.729183E-11

Real

Aptamer SeqId: 5738-25 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5738-25 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 8.729183E-11

Real

Aptamer SeqId:5739-75;Target:KTDAP;UniProt:P60985

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5739-75;Target: KTDAP;UniProt: P60985;TargetFullName: Keratinocyte differentiation-associated protein;Organisim: human;Apparent_Kd_M: 4.0188E-11

Real

Aptamer SeqId: 5739-75 | Target: KTDAP | UniProt: P60985

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5739-75 | Target: KTDAP | UniProt: P60985 | TargetFullName: Keratinocyte differentiation-associated protein | Organisim: human | Apparent_Kd_M: 4.0188E-11

Real

Aptamer SeqId:5740-17;Target:ROBO1;UniProt:Q9Y6N7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5740-17;Target: ROBO1;UniProt: Q9Y6N7;TargetFullName: Roundabout homolog 1;Organisim: human;Apparent_Kd_M: 8.638373E-12

Real

Aptamer SeqId: 5740-17 | Target: ROBO1 | UniProt: Q9Y6N7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5740-17 | Target: ROBO1 | UniProt: Q9Y6N7 | TargetFullName: Roundabout homolog 1 | Organisim: human | Apparent_Kd_M: 8.638373E-12

Real

Aptamer SeqId:5742-14;Target:PPA6;UniProt:Q9NPH0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5742-14;Target: PPA6;UniProt: Q9NPH0;TargetFullName: Lysophosphatidic acid phosphatase type 6;Organisim: human;Apparent_Kd_M: 7.672495E-12

Real

Aptamer SeqId: 5742-14 | Target: PPA6 | UniProt: Q9NPH0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5742-14 | Target: PPA6 | UniProt: Q9NPH0 | TargetFullName: Lysophosphatidic acid phosphatase type 6 | Organisim: human | Apparent_Kd_M: 7.672495E-12

Real

Aptamer SeqId:5743-82;Target:CART;UniProt:Q16568

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5743-82;Target: CART;UniProt: Q16568;TargetFullName: Cocaine- and amphetamine-regulated transcript protein;Organisim: human;Apparent_Kd_M: 1.04362E-10

Real

Aptamer SeqId: 5743-82 | Target: CART | UniProt: Q16568

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5743-82 | Target: CART | UniProt: Q16568 | TargetFullName: Cocaine- and amphetamine-regulated transcript protein | Organisim: human | Apparent_Kd_M: 1.04362E-10

Real

Aptamer SeqId:5744-12;Target:CA056;UniProt:Q9BUN1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5744-12;Target: CA056;UniProt: Q9BUN1;TargetFullName: Protein MENT;Organisim: human;Apparent_Kd_M: 7.794186E-12

Real

Aptamer SeqId: 5744-12 | Target: CA056 | UniProt: Q9BUN1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5744-12 | Target: CA056 | UniProt: Q9BUN1 | TargetFullName: Protein MENT | Organisim: human | Apparent_Kd_M: 7.794186E-12

Real

Aptamer SeqId:5745-64;Target:PI15;UniProt:O43692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5745-64;Target: PI15;UniProt: O43692;TargetFullName: Peptidase inhibitor 15;Organisim: human;Apparent_Kd_M: 8.871513E-11

Real

Aptamer SeqId: 5745-64 | Target: PI15 | UniProt: O43692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5745-64 | Target: PI15 | UniProt: O43692 | TargetFullName: Peptidase inhibitor 15 | Organisim: human | Apparent_Kd_M: 8.871513E-11

Real

Aptamer SeqId:5748-20;Target:Acid ceramidase;UniProt:Q13510

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5748-20;Target: Acid ceramidase;UniProt: Q13510;TargetFullName: Acid ceramidase;Organisim: human;Apparent_Kd_M: 1.065025E-10

Real

Aptamer SeqId: 5748-20 | Target: Acid ceramidase | UniProt: Q13510

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5748-20 | Target: Acid ceramidase | UniProt: Q13510 | TargetFullName: Acid ceramidase | Organisim: human | Apparent_Kd_M: 1.065025E-10

Real

Aptamer SeqId:5749-53;Target:COL;UniProt:P04118

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5749-53;Target: COL;UniProt: P04118;TargetFullName: Colipase;Organisim: human;Apparent_Kd_M: 4.397143E-11

Real

Aptamer SeqId: 5749-53 | Target: COL | UniProt: P04118

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5749-53 | Target: COL | UniProt: P04118 | TargetFullName: Colipase | Organisim: human | Apparent_Kd_M: 4.397143E-11

Real

Aptamer SeqId:5751-14;Target:HCCR-1;UniProt:Q6P1Q0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5751-14;Target: HCCR-1;UniProt: Q6P1Q0;TargetFullName: LETM1 domain-containing protein 1;Organisim: human;Apparent_Kd_M: 2.190788E-11

Real

Aptamer SeqId: 5751-14 | Target: HCCR-1 | UniProt: Q6P1Q0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5751-14 | Target: HCCR-1 | UniProt: Q6P1Q0 | TargetFullName: LETM1 domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.190788E-11

Real

Aptamer SeqId:5752-63;Target:SUSD3;UniProt:Q96L08

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5752-63;Target: SUSD3;UniProt: Q96L08;TargetFullName: Sushi domain-containing protein 3;Organisim: human;Apparent_Kd_M: 1.072831E-11

Real

Aptamer SeqId: 5752-63 | Target: SUSD3 | UniProt: Q96L08

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5752-63 | Target: SUSD3 | UniProt: Q96L08 | TargetFullName: Sushi domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 1.072831E-11

Real

Aptamer SeqId:5753-21;Target:F19A1;UniProt:Q7Z5A9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5753-21;Target: F19A1;UniProt: Q7Z5A9;TargetFullName: Protein FAM19A1;Organisim: human;Apparent_Kd_M: 8.166987E-11

Real

Aptamer SeqId: 5753-21 | Target: F19A1 | UniProt: Q7Z5A9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5753-21 | Target: F19A1 | UniProt: Q7Z5A9 | TargetFullName: Protein FAM19A1 | Organisim: human | Apparent_Kd_M: 8.166987E-11

Real

Aptamer SeqId:5754-76;Target:INSL6;UniProt:Q9Y581

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5754-76;Target: INSL6;UniProt: Q9Y581;TargetFullName: Insulin-like peptide INSL6;Organisim: human;Apparent_Kd_M: 4.824118E-11

Real

Aptamer SeqId: 5754-76 | Target: INSL6 | UniProt: Q9Y581

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5754-76 | Target: INSL6 | UniProt: Q9Y581 | TargetFullName: Insulin-like peptide INSL6 | Organisim: human | Apparent_Kd_M: 4.824118E-11

Real

Aptamer SeqId:5755-29;Target:GIP;UniProt:P09681

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5755-29;Target: GIP;UniProt: P09681;TargetFullName: Gastric inhibitory polypeptide;Organisim: human;Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId: 5755-29 | Target: GIP | UniProt: P09681

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5755-29 | Target: GIP | UniProt: P09681 | TargetFullName: Gastric inhibitory polypeptide | Organisim: human | Apparent_Kd_M: 1.79E-11

Real

Aptamer SeqId:5756-66;Target:PAPP2;UniProt:Q9BXP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5756-66;Target: PAPP2;UniProt: Q9BXP8;TargetFullName: Pappalysin-2;Organisim: human;Apparent_Kd_M: 5.652476E-11

Real

Aptamer SeqId: 5756-66 | Target: PAPP2 | UniProt: Q9BXP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5756-66 | Target: PAPP2 | UniProt: Q9BXP8 | TargetFullName: Pappalysin-2 | Organisim: human | Apparent_Kd_M: 5.652476E-11

Real

Aptamer SeqId:5757-45;Target:GNAS3;UniProt:O95467

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5757-45;Target: GNAS3;UniProt: O95467;TargetFullName: Neuroendocrine secretory protein 55;Organisim: human;Apparent_Kd_M: 9.435249E-12

Real

Aptamer SeqId: 5757-45 | Target: GNAS3 | UniProt: O95467

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5757-45 | Target: GNAS3 | UniProt: O95467 | TargetFullName: Neuroendocrine secretory protein 55 | Organisim: human | Apparent_Kd_M: 9.435249E-12

Real

Aptamer SeqId:5758-49;Target:kallikrein 9;UniProt:Q9UKQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5758-49;Target: kallikrein 9;UniProt: Q9UKQ9;TargetFullName: Kallikrein-9;Organisim: human;Apparent_Kd_M: 2.04435E-11

Real

Aptamer SeqId: 5758-49 | Target: kallikrein 9 | UniProt: Q9UKQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5758-49 | Target: kallikrein 9 | UniProt: Q9UKQ9 | TargetFullName: Kallikrein-9 | Organisim: human | Apparent_Kd_M: 2.04435E-11

Real

Aptamer SeqId:5762-35;Target:Sperm-associated antigen 11;UniProt:Q08648

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5762-35;Target: Sperm-associated antigen 11;UniProt: Q08648;TargetFullName: Sperm-associated antigen 11B;Organisim: human;Apparent_Kd_M: 4.057682E-11

Real

Aptamer SeqId: 5762-35 | Target: Sperm-associated antigen 11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5762-35 | Target: Sperm-associated antigen 11 | UniProt: Q08648 | TargetFullName: Sperm-associated antigen 11B | Organisim: human | Apparent_Kd_M: 4.057682E-11

Real

Aptamer SeqId:5763-67;Target:HBD-4;UniProt:Q8WTQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5763-67;Target: HBD-4;UniProt: Q8WTQ1;TargetFullName: Beta-defensin 104;Organisim: human;Apparent_Kd_M: 6.307552E-11

Real

Aptamer SeqId: 5763-67 | Target: HBD-4 | UniProt: Q8WTQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5763-67 | Target: HBD-4 | UniProt: Q8WTQ1 | TargetFullName: Beta-defensin 104 | Organisim: human | Apparent_Kd_M: 6.307552E-11

Real

Aptamer SeqId:5764-4;Target:GALT2;UniProt:Q10471

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5764-4;Target: GALT2;UniProt: Q10471;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 2;Organisim: human;Apparent_Kd_M: 1.796379E-10

Real

Aptamer SeqId: 5764-4 | Target: GALT2 | UniProt: Q10471

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5764-4 | Target: GALT2 | UniProt: Q10471 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 2 | Organisim: human | Apparent_Kd_M: 1.796379E-10

Real

Aptamer SeqId:5765-53;Target:DB121;UniProt:Q5J5C9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5765-53;Target: DB121;UniProt: Q5J5C9;TargetFullName: Beta-defensin 121;Organisim: human;Apparent_Kd_M: 2.622461E-11

Real

Aptamer SeqId: 5765-53 | Target: DB121 | UniProt: Q5J5C9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5765-53 | Target: DB121 | UniProt: Q5J5C9 | TargetFullName: Beta-defensin 121 | Organisim: human | Apparent_Kd_M: 2.622461E-11

Real

Aptamer SeqId:5792-8;Target:AFP;UniProt:P02771

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5792-8;Target: AFP;UniProt: P02771;TargetFullName: alpha-Fetoprotein;Organisim: human;Apparent_Kd_M: 2.63E-10

Real

Aptamer SeqId: 5792-8 | Target: AFP | UniProt: P02771

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5792-8 | Target: AFP | UniProt: P02771 | TargetFullName: alpha-Fetoprotein | Organisim: human | Apparent_Kd_M: 2.63E-10

Real

Aptamer SeqId:5798-3;Target:BID;UniProt:P55957

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5798-3;Target: BID;UniProt: P55957;TargetFullName: BH3-interacting domain death agonist;Organisim: human;Apparent_Kd_M: 1.56E-10

Real

Aptamer SeqId: 5798-3 | Target: BID | UniProt: P55957

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5798-3 | Target: BID | UniProt: P55957 | TargetFullName: BH3-interacting domain death agonist | Organisim: human | Apparent_Kd_M: 1.56E-10

Real

Aptamer SeqId:5801-72;Target:b-NGF;UniProt:P01138

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5801-72;Target: b-NGF;UniProt: P01138;TargetFullName: beta-nerve growth factor;Organisim: human;Apparent_Kd_M: 9.57E-12

Real

Aptamer SeqId: 5801-72 | Target: b-NGF | UniProt: P01138

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5801-72 | Target: b-NGF | UniProt: P01138 | TargetFullName: beta-nerve growth factor | Organisim: human | Apparent_Kd_M: 9.57E-12

Real

Aptamer SeqId:5803-24;Target:C3d;UniProt:P01024

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5803-24;Target: C3d;UniProt: P01024;TargetFullName: Complement C3d fragment;Organisim: human;Apparent_Kd_M: 7.62E-12

Real

Aptamer SeqId: 5803-24 | Target: C3d | UniProt: P01024

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5803-24 | Target: C3d | UniProt: P01024 | TargetFullName: Complement C3d fragment | Organisim: human | Apparent_Kd_M: 7.62E-12

Real

Aptamer SeqId:5807-77;Target:CD70;UniProt:P32970

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5807-77;Target: CD70;UniProt: P32970;TargetFullName: CD70 antigen;Organisim: human;Apparent_Kd_M: 9.24E-11

Real

Aptamer SeqId: 5807-77 | Target: CD70 | UniProt: P32970

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5807-77 | Target: CD70 | UniProt: P32970 | TargetFullName: CD70 antigen | Organisim: human | Apparent_Kd_M: 9.24E-11

Real

Aptamer SeqId:5810-25;Target:Cripto;UniProt:P13385

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5810-25;Target: Cripto;UniProt: P13385;TargetFullName: Teratocarcinoma-derived growth factor 1;Organisim: human;Apparent_Kd_M: 3.13E-11

Real

Aptamer SeqId: 5810-25 | Target: Cripto | UniProt: P13385

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5810-25 | Target: Cripto | UniProt: P13385 | TargetFullName: Teratocarcinoma-derived growth factor 1 | Organisim: human | Apparent_Kd_M: 3.13E-11

Real

Aptamer SeqId:5813-58;Target:Epo;UniProt:P01588

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5813-58;Target: Epo;UniProt: P01588;TargetFullName: Erythropoietin;Organisim: human;Apparent_Kd_M: 3.74E-12

Real

Aptamer SeqId: 5813-58 | Target: Epo | UniProt: P01588

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5813-58 | Target: Epo | UniProt: P01588 | TargetFullName: Erythropoietin | Organisim: human | Apparent_Kd_M: 3.74E-12

Real

Aptamer SeqId:5822-22;Target:GDNF;UniProt:P39905

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5822-22;Target: GDNF;UniProt: P39905;TargetFullName: Glial cell line-derived neurotrophic factor;Organisim: human;Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId: 5822-22 | Target: GDNF | UniProt: P39905

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5822-22 | Target: GDNF | UniProt: P39905 | TargetFullName: Glial cell line-derived neurotrophic factor | Organisim: human | Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId:5825-49;Target:IFN-g R1;UniProt:P15260

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5825-49;Target: IFN-g R1;UniProt: P15260;TargetFullName: Interferon gamma receptor 1;Organisim: human;Apparent_Kd_M: 1.02E-10

Real

Aptamer SeqId: 5825-49 | Target: IFN-g R1 | UniProt: P15260

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5825-49 | Target: IFN-g R1 | UniProt: P15260 | TargetFullName: Interferon gamma receptor 1 | Organisim: human | Apparent_Kd_M: 1.02E-10

Real

Aptamer SeqId:5834-18;Target:IL-9;UniProt:P15248

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5834-18;Target: IL-9;UniProt: P15248;TargetFullName: Interleukin-9;Organisim: human;Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId: 5834-18 | Target: IL-9 | UniProt: P15248

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5834-18 | Target: IL-9 | UniProt: P15248 | TargetFullName: Interleukin-9 | Organisim: human | Apparent_Kd_M: 2.41E-12

Real

Aptamer SeqId:5837-49;Target:LIF sR;UniProt:P42702

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5837-49;Target: LIF sR;UniProt: P42702;TargetFullName: Leukemia inhibitory factor receptor;Organisim: human;Apparent_Kd_M: 1.51E-12

Real

Aptamer SeqId: 5837-49 | Target: LIF sR | UniProt: P42702

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5837-49 | Target: LIF sR | UniProt: P42702 | TargetFullName: Leukemia inhibitory factor receptor | Organisim: human | Apparent_Kd_M: 1.51E-12

Real

Aptamer SeqId:5843-60;Target:NG36;UniProt:Q96KQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5843-60;Target: NG36;UniProt: Q96KQ7;TargetFullName: Histone-lysine N-methyltransferase EHMT2;Organisim: human;Apparent_Kd_M: 2.78E-11

Real

Aptamer SeqId: 5843-60 | Target: NG36 | UniProt: Q96KQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5843-60 | Target: NG36 | UniProt: Q96KQ7 | TargetFullName: Histone-lysine N-methyltransferase EHMT2 | Organisim: human | Apparent_Kd_M: 2.78E-11

Real

Aptamer SeqId:5852-6;Target:S100A12;UniProt:P80511

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5852-6;Target: S100A12;UniProt: P80511;TargetFullName: Protein S100-A12;Organisim: human;Apparent_Kd_M: 9.53E-12

Real

Aptamer SeqId: 5852-6 | Target: S100A12 | UniProt: P80511

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5852-6 | Target: S100A12 | UniProt: P80511 | TargetFullName: Protein S100-A12 | Organisim: human | Apparent_Kd_M: 9.53E-12

Real

Aptamer SeqId:5854-60;Target:tau;UniProt:P10636

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5854-60;Target: tau;UniProt: P10636;TargetFullName: Microtubule-associated protein tau;Organisim: human;Apparent_Kd_M: 3.31E-11

Real

Aptamer SeqId: 5854-60 | Target: tau | UniProt: P10636

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5854-60 | Target: tau | UniProt: P10636 | TargetFullName: Microtubule-associated protein tau | Organisim: human | Apparent_Kd_M: 3.31E-11

Real

Aptamer SeqId:5858-6;Target:14-3-3 protein zeta/delta;UniProt:P63104

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5858-6;Target: 14-3-3 protein zeta/delta;UniProt: P63104;TargetFullName: 14-3-3 protein zeta/delta;Organisim: human;Apparent_Kd_M: 2.73E-12

Real

Aptamer SeqId: 5858-6 | Target: 14-3-3 protein zeta/delta | UniProt: P63104

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5858-6 | Target: 14-3-3 protein zeta/delta | UniProt: P63104 | TargetFullName: 14-3-3 protein zeta/delta | Organisim: human | Apparent_Kd_M: 2.73E-12

Real

Aptamer SeqId:5861-78;Target:3HAO;UniProt:P46952

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5861-78;Target: 3HAO;UniProt: P46952;TargetFullName: 3-hydroxyanthranilate 3;4-dioxygenase;Organisim: human;Apparent_Kd_M: 7.28E-11

Real

Aptamer SeqId: 5861-78 | Target: 3HAO | UniProt: P46952

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5861-78 | Target: 3HAO | UniProt: P46952 | TargetFullName: 3-hydroxyanthranilate 3;4-dioxygenase | Organisim: human | Apparent_Kd_M: 7.28E-11

Real

Aptamer SeqId:5864-10;Target:aldolase A;UniProt:P04075

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5864-10;Target: aldolase A;UniProt: P04075;TargetFullName: Fructose-bisphosphate aldolase A;Organisim: human;Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId: 5864-10 | Target: aldolase A | UniProt: P04075

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5864-10 | Target: aldolase A | UniProt: P04075 | TargetFullName: Fructose-bisphosphate aldolase A | Organisim: human | Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId:5867-60;Target:ARGI1;UniProt:P05089

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5867-60;Target: ARGI1;UniProt: P05089;TargetFullName: Arginase-1;Organisim: human;Apparent_Kd_M: 2.63E-10

Real

Aptamer SeqId: 5867-60 | Target: ARGI1 | UniProt: P05089

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5867-60 | Target: ARGI1 | UniProt: P05089 | TargetFullName: Arginase-1 | Organisim: human | Apparent_Kd_M: 2.63E-10

Real

Aptamer SeqId:5870-23;Target:BAD;UniProt:Q92934

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5870-23;Target: BAD;UniProt: Q92934;TargetFullName: Bcl2-associated agonist of cell death;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 5870-23 | Target: BAD | UniProt: Q92934

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5870-23 | Target: BAD | UniProt: Q92934 | TargetFullName: Bcl2-associated agonist of cell death | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:5879-51;Target:Dynactin subunit 2;UniProt:Q13561

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5879-51;Target: Dynactin subunit 2;UniProt: Q13561;TargetFullName: Dynactin subunit 2;Organisim: human;Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId: 5879-51 | Target: Dynactin subunit 2 | UniProt: Q13561

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5879-51 | Target: Dynactin subunit 2 | UniProt: Q13561 | TargetFullName: Dynactin subunit 2 | Organisim: human | Apparent_Kd_M: 1.59E-11

Real

Aptamer SeqId:5882-34;Target:EF-1-beta;UniProt:P24534

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5882-34;Target: EF-1-beta;UniProt: P24534;TargetFullName: Elongation factor 1-beta;Organisim: human;Apparent_Kd_M: 4.29E-11

Real

Aptamer SeqId: 5882-34 | Target: EF-1-beta | UniProt: P24534

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5882-34 | Target: EF-1-beta | UniProt: P24534 | TargetFullName: Elongation factor 1-beta | Organisim: human | Apparent_Kd_M: 4.29E-11

Real

Aptamer SeqId:5885-55;Target:eIF-4H;UniProt:Q15056

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5885-55;Target: eIF-4H;UniProt: Q15056;TargetFullName: Eukaryotic translation initiation factor 4H;Organisim: human;Apparent_Kd_M: 8.87E-12

Real

Aptamer SeqId: 5885-55 | Target: eIF-4H | UniProt: Q15056

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5885-55 | Target: eIF-4H | UniProt: Q15056 | TargetFullName: Eukaryotic translation initiation factor 4H | Organisim: human | Apparent_Kd_M: 8.87E-12

Real

Aptamer SeqId:5888-29;Target:eIF-5A-1;UniProt:P63241

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5888-29;Target: eIF-5A-1;UniProt: P63241;TargetFullName: Eukaryotic translation initiation factor 5A-1;Organisim: human;Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId: 5888-29 | Target: eIF-5A-1 | UniProt: P63241

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5888-29 | Target: eIF-5A-1 | UniProt: P63241 | TargetFullName: Eukaryotic translation initiation factor 5A-1 | Organisim: human | Apparent_Kd_M: 1.39E-10

Real

Aptamer SeqId:5897-58;Target:Gastrin-releasing peptide;UniProt:P07492

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5897-58;Target: Gastrin-releasing peptide;UniProt: P07492;TargetFullName: Gastrin-releasing peptide;Organisim: human;Apparent_Kd_M: 6.83E-11

Real

Aptamer SeqId: 5897-58 | Target: Gastrin-releasing peptide

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5897-58 | Target: Gastrin-releasing peptide | UniProt: P07492 | TargetFullName: Gastrin-releasing peptide | Organisim: human | Apparent_Kd_M: 6.83E-11

Real

Aptamer SeqId:5900-11;Target:HINT1;UniProt:P49773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5900-11;Target: HINT1;UniProt: P49773;TargetFullName: Histidine triad nucleotide-binding protein 1;Organisim: human;Apparent_Kd_M: 1.28E-10

Real

Aptamer SeqId: 5900-11 | Target: HINT1 | UniProt: P49773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5900-11 | Target: HINT1 | UniProt: P49773 | TargetFullName: Histidine triad nucleotide-binding protein 1 | Organisim: human | Apparent_Kd_M: 1.28E-10

Real

Aptamer SeqId:5903-91;Target:HSP70 protein 8;UniProt:P11142

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5903-91;Target: HSP70 protein 8;UniProt: P11142;TargetFullName: Heat shock cognate 71 kDa protein;Organisim: human;Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId: 5903-91 | Target: HSP70 protein 8 | UniProt: P11142

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5903-91 | Target: HSP70 protein 8 | UniProt: P11142 | TargetFullName: Heat shock cognate 71 kDa protein | Organisim: human | Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId:5909-51;Target:Nucleoside diphosphate kinase A;UniProt:P15531

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5909-51;Target: Nucleoside diphosphate kinase A;UniProt: P15531;TargetFullName: Nucleoside diphosphate kinase A;Organisim: human;Apparent_Kd_M: 2.95E-11

Real

Aptamer SeqId: 5909-51 | Target: Nucleoside diphosphate kinase A

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5909-51 | Target: Nucleoside diphosphate kinase A | UniProt: P15531 | TargetFullName: Nucleoside diphosphate kinase A | Organisim: human | Apparent_Kd_M: 2.95E-11

Real

Aptamer SeqId:5915-58;Target:PEX5;UniProt:P50542

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5915-58;Target: PEX5;UniProt: P50542;TargetFullName: Peroxisomal targeting signal 1 receptor;Organisim: human;Apparent_Kd_M: 4.04E-11

Real

Aptamer SeqId: 5915-58 | Target: PEX5 | UniProt: P50542

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5915-58 | Target: PEX5 | UniProt: P50542 | TargetFullName: Peroxisomal targeting signal 1 receptor | Organisim: human | Apparent_Kd_M: 4.04E-11

Real

Aptamer SeqId:5918-5;Target:PSME1;UniProt:Q06323

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5918-5;Target: PSME1;UniProt: Q06323;TargetFullName: Proteasome activator complex subunit 1;Organisim: human;Apparent_Kd_M: 5.1E-12

Real

Aptamer SeqId: 5918-5 | Target: PSME1 | UniProt: Q06323

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5918-5 | Target: PSME1 | UniProt: Q06323 | TargetFullName: Proteasome activator complex subunit 1 | Organisim: human | Apparent_Kd_M: 5.1E-12

Real

Aptamer SeqId:5927-4;Target:WISP-3;UniProt:O95389

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5927-4;Target: WISP-3;UniProt: O95389;TargetFullName: WNT1-inducible-signaling pathway protein 3;Organisim: human;Apparent_Kd_M: 2.92E-11

Real

Aptamer SeqId: 5927-4 | Target: WISP-3 | UniProt: O95389

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5927-4 | Target: WISP-3 | UniProt: O95389 | TargetFullName: WNT1-inducible-signaling pathway protein 3 | Organisim: human | Apparent_Kd_M: 2.92E-11

Real

Aptamer SeqId:5934-1;Target:Ferritin;UniProt:P02794|P02792

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5934-1;Target: Ferritin;UniProt: P02794|P02792;TargetFullName: Ferritin;Organisim: human;Apparent_Kd_M: 6.31E-12

Real

Aptamer SeqId: 5934-1 | Target: Ferritin | UniProt: P02794|P02792

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5934-1 | Target: Ferritin | UniProt: P02794|P02792 | TargetFullName: Ferritin | Organisim: human | Apparent_Kd_M: 6.31E-12

Real

Aptamer SeqId:5936-53;Target:TNF-a;UniProt:P01375

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5936-53;Target: TNF-a;UniProt: P01375;TargetFullName: Tumor necrosis factor;Organisim: human;Apparent_Kd_M: 3.65E-12

Real

Aptamer SeqId: 5936-53 | Target: TNF-a | UniProt: P01375

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5936-53 | Target: TNF-a | UniProt: P01375 | TargetFullName: Tumor necrosis factor | Organisim: human | Apparent_Kd_M: 3.65E-12

Real

Aptamer SeqId:5939-42;Target:TWEAK;UniProt:O43508

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5939-42;Target: TWEAK;UniProt: O43508;TargetFullName: Tumor necrosis factor ligand superfamily member 12;Organisim: human;Apparent_Kd_M: 2.26E-11

Real

Aptamer SeqId: 5939-42 | Target: TWEAK | UniProt: O43508

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5939-42 | Target: TWEAK | UniProt: O43508 | TargetFullName: Tumor necrosis factor ligand superfamily member 12 | Organisim: human | Apparent_Kd_M: 2.26E-11

Real

Aptamer SeqId:5947-90;Target:Tpo;UniProt:P40225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5947-90;Target: Tpo;UniProt: P40225;TargetFullName: Thrombopoietin;Organisim: human;Apparent_Kd_M: 6.52E-12

Real

Aptamer SeqId: 5947-90 | Target: Tpo | UniProt: P40225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5947-90 | Target: Tpo | UniProt: P40225 | TargetFullName: Thrombopoietin | Organisim: human | Apparent_Kd_M: 6.52E-12

Real

Aptamer SeqId:5954-62;Target:PTH;UniProt:P01270

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5954-62;Target: PTH;UniProt: P01270;TargetFullName: Parathyroid hormone;Organisim: human;Apparent_Kd_M: 1.64E-12

Real

Aptamer SeqId: 5954-62 | Target: PTH | UniProt: P01270

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5954-62 | Target: PTH | UniProt: P01270 | TargetFullName: Parathyroid hormone | Organisim: human | Apparent_Kd_M: 1.64E-12

Real

Aptamer SeqId:5957-30;Target:Somatostatin-28;UniProt:P61278

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5957-30;Target: Somatostatin-28;UniProt: P61278;TargetFullName: Somatostatin-28;Organisim: human;Apparent_Kd_M: 3.97E-11

Real

Aptamer SeqId: 5957-30 | Target: Somatostatin-28 | UniProt: P61278

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5957-30 | Target: Somatostatin-28 | UniProt: P61278 | TargetFullName: Somatostatin-28 | Organisim: human | Apparent_Kd_M: 3.97E-11

Real

Aptamer SeqId:5960-49;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5960-49;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.810613E-11

Real

Aptamer SeqId: 5960-49 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5960-49 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.810613E-11

Real

Aptamer SeqId:5963-9;Target:Dermokine;UniProt:Q6E0U4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5963-9;Target: Dermokine;UniProt: Q6E0U4;TargetFullName: Dermokine;Organisim: human;Apparent_Kd_M: 4.8571E-11

Real

Aptamer SeqId: 5963-9 | Target: Dermokine | UniProt: Q6E0U4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5963-9 | Target: Dermokine | UniProt: Q6E0U4 | TargetFullName: Dermokine | Organisim: human | Apparent_Kd_M: 4.8571E-11

Real

Aptamer SeqId:5980-55;Target:BOLA3;UniProt:Q53S33

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5980-55;Target: BOLA3;UniProt: Q53S33;TargetFullName: BolA-like protein 3;Organisim: human;Apparent_Kd_M: 1.08E-12

Real

Aptamer SeqId: 5980-55 | Target: BOLA3 | UniProt: Q53S33

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5980-55 | Target: BOLA3 | UniProt: Q53S33 | TargetFullName: BolA-like protein 3 | Organisim: human | Apparent_Kd_M: 1.08E-12

Real

Aptamer SeqId:5981-6;Target:ES1;UniProt:P30042

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5981-6;Target: ES1;UniProt: P30042;TargetFullName: ES1 protein homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 2.273871E-10

Real

Aptamer SeqId: 5981-6 | Target: ES1 | UniProt: P30042

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5981-6 | Target: ES1 | UniProt: P30042 | TargetFullName: ES1 protein homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 2.273871E-10

Real

Aptamer SeqId:5988-49;Target:LIGHT;UniProt:O43557

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 5988-49;Target: LIGHT;UniProt: O43557;TargetFullName: Tumor necrosis factor ligand superfamily member 14;Organisim: human;Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId: 5988-49 | Target: LIGHT | UniProt: O43557

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 5988-49 | Target: LIGHT | UniProt: O43557 | TargetFullName: Tumor necrosis factor ligand superfamily member 14 | Organisim: human | Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId:6020-52;Target:Urotensin-II;UniProt:O95399

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6020-52;Target: Urotensin-II;UniProt: O95399;TargetFullName: Urotensin-2;Organisim: human;Apparent_Kd_M: 1.519948E-10

Real

Aptamer SeqId: 6020-52 | Target: Urotensin-II | UniProt: O95399

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6020-52 | Target: Urotensin-II | UniProt: O95399 | TargetFullName: Urotensin-2 | Organisim: human | Apparent_Kd_M: 1.519948E-10

Real

Aptamer SeqId:6022-57;Target:NELL2;UniProt:Q99435

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6022-57;Target: NELL2;UniProt: Q99435;TargetFullName: Protein kinase C-binding protein NELL2;Organisim: human;Apparent_Kd_M: 2.126702E-10

Real

Aptamer SeqId: 6022-57 | Target: NELL2 | UniProt: Q99435

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6022-57 | Target: NELL2 | UniProt: Q99435 | TargetFullName: Protein kinase C-binding protein NELL2 | Organisim: human | Apparent_Kd_M: 2.126702E-10

Real

Aptamer SeqId:6027-31;Target:REL3;UniProt:Q8WXF3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6027-31;Target: REL3;UniProt: Q8WXF3;TargetFullName: Relaxin-3;Organisim: human;Apparent_Kd_M: 6.611203E-12

Real

Aptamer SeqId: 6027-31 | Target: REL3 | UniProt: Q8WXF3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6027-31 | Target: REL3 | UniProt: Q8WXF3 | TargetFullName: Relaxin-3 | Organisim: human | Apparent_Kd_M: 6.611203E-12

Real

Aptamer SeqId:6035-2;Target:SIAT1;UniProt:P15907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6035-2;Target: SIAT1;UniProt: P15907;TargetFullName: Beta-galactoside alpha-2;6-sialyltransferase 1;Organisim: human;Apparent_Kd_M: 2.735933E-11

Real

Aptamer SeqId: 6035-2 | Target: SIAT1 | UniProt: P15907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6035-2 | Target: SIAT1 | UniProt: P15907 | TargetFullName: Beta-galactoside alpha-2;6-sialyltransferase 1 | Organisim: human | Apparent_Kd_M: 2.735933E-11

Real

Aptamer SeqId:6036-78;Target:Deprecated;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6036-78;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId: 6036-78 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6036-78 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId:6037-6;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6037-6;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.395124E-12

Real

Aptamer SeqId: 6037-6 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6037-6 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.395124E-12

Real

Aptamer SeqId:6039-24;Target:CRHBP;UniProt:P24387

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6039-24;Target: CRHBP;UniProt: P24387;TargetFullName: Corticotropin-releasing factor-binding protein;Organisim: human;Apparent_Kd_M: 5.523453E-12

Real

Aptamer SeqId: 6039-24 | Target: CRHBP | UniProt: P24387

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6039-24 | Target: CRHBP | UniProt: P24387 | TargetFullName: Corticotropin-releasing factor-binding protein | Organisim: human | Apparent_Kd_M: 5.523453E-12

Real

Aptamer SeqId:6042-52;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6042-52;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 1.054136E-10

Real

Aptamer SeqId: 6042-52 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6042-52 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 1.054136E-10

Real

Aptamer SeqId:6048-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6048-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.069818E-12

Real

Aptamer SeqId: 6048-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6048-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.069818E-12

Real

Aptamer SeqId:6049-64;Target:PTPRS;UniProt:Q13332

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6049-64;Target: PTPRS;UniProt: Q13332;TargetFullName: Receptor-type tyrosine-protein phosphatase S;Organisim: human;Apparent_Kd_M: 1.381394E-12

Real

Aptamer SeqId: 6049-64 | Target: PTPRS | UniProt: Q13332

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6049-64 | Target: PTPRS | UniProt: Q13332 | TargetFullName: Receptor-type tyrosine-protein phosphatase S | Organisim: human | Apparent_Kd_M: 1.381394E-12

Real

Aptamer SeqId:6054-6;Target:NXPH3;UniProt:O95157

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6054-6;Target: NXPH3;UniProt: O95157;TargetFullName: Neurexophilin-3;Organisim: human;Apparent_Kd_M: 1.211888E-10

Real

Aptamer SeqId: 6054-6 | Target: NXPH3 | UniProt: O95157

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6054-6 | Target: NXPH3 | UniProt: O95157 | TargetFullName: Neurexophilin-3 | Organisim: human | Apparent_Kd_M: 1.211888E-10

Real

Aptamer SeqId:6060-2;Target:PIP;UniProt:P12273

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6060-2;Target: PIP;UniProt: P12273;TargetFullName: Prolactin-inducible protein;Organisim: human;Apparent_Kd_M: 6.746792E-11

Real

Aptamer SeqId: 6060-2 | Target: PIP | UniProt: P12273

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6060-2 | Target: PIP | UniProt: P12273 | TargetFullName: Prolactin-inducible protein | Organisim: human | Apparent_Kd_M: 6.746792E-11

Real

Aptamer SeqId:6064-4;Target:TXNDC4;UniProt:Q9BS26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6064-4;Target: TXNDC4;UniProt: Q9BS26;TargetFullName: Endoplasmic reticulum resident protein 44;Organisim: human;Apparent_Kd_M: 8.687695E-11

Real

Aptamer SeqId: 6064-4 | Target: TXNDC4 | UniProt: Q9BS26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6064-4 | Target: TXNDC4 | UniProt: Q9BS26 | TargetFullName: Endoplasmic reticulum resident protein 44 | Organisim: human | Apparent_Kd_M: 8.687695E-11

Real

Aptamer SeqId:6069-71;Target:SUMF2;UniProt:Q8NBJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6069-71;Target: SUMF2;UniProt: Q8NBJ7;TargetFullName: Sulfatase-modifying factor 2;Organisim: human;Apparent_Kd_M: 3.255026E-11

Real

Aptamer SeqId: 6069-71 | Target: SUMF2 | UniProt: Q8NBJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6069-71 | Target: SUMF2 | UniProt: Q8NBJ7 | TargetFullName: Sulfatase-modifying factor 2 | Organisim: human | Apparent_Kd_M: 3.255026E-11

Real

Aptamer SeqId:6070-11;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6070-11;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.07E-12

Real

Aptamer SeqId: 6070-11 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6070-11 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.07E-12

Real

Aptamer SeqId:6077-63;Target:CECR1;UniProt:Q9NZK5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6077-63;Target: CECR1;UniProt: Q9NZK5;TargetFullName: Adenosine deaminase CECR1;Organisim: human;Apparent_Kd_M: 1.300889E-12

Real

Aptamer SeqId: 6077-63 | Target: CECR1 | UniProt: Q9NZK5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6077-63 | Target: CECR1 | UniProt: Q9NZK5 | TargetFullName: Adenosine deaminase CECR1 | Organisim: human | Apparent_Kd_M: 1.300889E-12

Real

Aptamer SeqId:6079-59;Target:ACPL2;UniProt:Q8TE99

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6079-59;Target: ACPL2;UniProt: Q8TE99;TargetFullName: 2-phosphoxylose phosphatase 1;Organisim: human;Apparent_Kd_M: 1.620029E-12

Real

Aptamer SeqId: 6079-59 | Target: ACPL2 | UniProt: Q8TE99

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6079-59 | Target: ACPL2 | UniProt: Q8TE99 | TargetFullName: 2-phosphoxylose phosphatase 1 | Organisim: human | Apparent_Kd_M: 1.620029E-12

Real

Aptamer SeqId:6081-52;Target:PCOC2;UniProt:Q9UKZ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6081-52;Target: PCOC2;UniProt: Q9UKZ9;TargetFullName: Procollagen C-endopeptidase enhancer 2;Organisim: human;Apparent_Kd_M: 2.74629E-12

Real

Aptamer SeqId: 6081-52 | Target: PCOC2 | UniProt: Q9UKZ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6081-52 | Target: PCOC2 | UniProt: Q9UKZ9 | TargetFullName: Procollagen C-endopeptidase enhancer 2 | Organisim: human | Apparent_Kd_M: 2.74629E-12

Real

Aptamer SeqId:6086-15;Target:CRDL2;UniProt:Q6WN34

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6086-15;Target: CRDL2;UniProt: Q6WN34;TargetFullName: Chordin-like protein 2;Organisim: human;Apparent_Kd_M: 9.38812E-12

Real

Aptamer SeqId: 6086-15 | Target: CRDL2 | UniProt: Q6WN34

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6086-15 | Target: CRDL2 | UniProt: Q6WN34 | TargetFullName: Chordin-like protein 2 | Organisim: human | Apparent_Kd_M: 9.38812E-12

Real

Aptamer SeqId:6102-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6102-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.731757E-12

Real

Aptamer SeqId: 6102-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6102-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.731757E-12

Real

Aptamer SeqId:6103-70;Target:FCRL5;UniProt:Q96RD9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6103-70;Target: FCRL5;UniProt: Q96RD9;TargetFullName: Fc receptor-like protein 5;Organisim: human;Apparent_Kd_M: 3.414976E-10

Real

Aptamer SeqId: 6103-70 | Target: FCRL5 | UniProt: Q96RD9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6103-70 | Target: FCRL5 | UniProt: Q96RD9 | TargetFullName: Fc receptor-like protein 5 | Organisim: human | Apparent_Kd_M: 3.414976E-10

Real

Aptamer SeqId:6107-3;Target:ELA1;UniProt:Q9UNI1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6107-3;Target: ELA1;UniProt: Q9UNI1;TargetFullName: Chymotrypsin-like elastase family member 1;Organisim: human;Apparent_Kd_M: 9.658131E-11

Real

Aptamer SeqId: 6107-3 | Target: ELA1 | UniProt: Q9UNI1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6107-3 | Target: ELA1 | UniProt: Q9UNI1 | TargetFullName: Chymotrypsin-like elastase family member 1 | Organisim: human | Apparent_Kd_M: 9.658131E-11

Real

Aptamer SeqId:6115-40;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6115-40;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.074507E-11

Real

Aptamer SeqId: 6115-40 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6115-40 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.074507E-11

Real

Aptamer SeqId:6117-4;Target:NEC2;UniProt:P16519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6117-4;Target: NEC2;UniProt: P16519;TargetFullName: Neuroendocrine convertase 2;Organisim: human;Apparent_Kd_M: 3.4E-11

Real

Aptamer SeqId: 6117-4 | Target: NEC2 | UniProt: P16519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6117-4 | Target: NEC2 | UniProt: P16519 | TargetFullName: Neuroendocrine convertase 2 | Organisim: human | Apparent_Kd_M: 3.4E-11

Real

Aptamer SeqId:6119-14;Target:MAMC2;UniProt:Q7Z304

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6119-14;Target: MAMC2;UniProt: Q7Z304;TargetFullName: MAM domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.75E-10

Real

Aptamer SeqId: 6119-14 | Target: MAMC2 | UniProt: Q7Z304

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6119-14 | Target: MAMC2 | UniProt: Q7Z304 | TargetFullName: MAM domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.75E-10

Real

Aptamer SeqId:6121-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6121-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId: 6121-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6121-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId:6123-69;Target:p53;UniProt:P04637

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6123-69;Target: p53;UniProt: P04637;TargetFullName: Cellular tumor antigen p53;Organisim: human;Apparent_Kd_M: 4.249735E-12

Real

Aptamer SeqId: 6123-69 | Target: p53 | UniProt: P04637

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6123-69 | Target: p53 | UniProt: P04637 | TargetFullName: Cellular tumor antigen p53 | Organisim: human | Apparent_Kd_M: 4.249735E-12

Real

Aptamer SeqId:6151-18;Target:MP2K3;UniProt:P46734

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6151-18;Target: MP2K3;UniProt: P46734;TargetFullName: Dual specificity mitogen-activated protein kinase kinase 3;Organisim: human;Apparent_Kd_M: 2.75E-10

Real

Aptamer SeqId: 6151-18 | Target: MP2K3 | UniProt: P46734

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6151-18 | Target: MP2K3 | UniProt: P46734 | TargetFullName: Dual specificity mitogen-activated protein kinase kinase 3 | Organisim: human | Apparent_Kd_M: 2.75E-10

Real

Aptamer SeqId:6168-11;Target:p53 R175H;UniProt:P04637

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6168-11;Target: p53 R175H;UniProt: P04637;TargetFullName: Cellular tumor antigen p53 R175H mutant;Organisim: human;Apparent_Kd_M: 6.379042E-12

Real

Aptamer SeqId: 6168-11 | Target: p53 R175H | UniProt: P04637

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6168-11 | Target: p53 R175H | UniProt: P04637 | TargetFullName: Cellular tumor antigen p53 R175H mutant | Organisim: human | Apparent_Kd_M: 6.379042E-12

Real

Aptamer SeqId:6207-10;Target:prosaposin;UniProt:P07602

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6207-10;Target: prosaposin;UniProt: P07602;TargetFullName: Prosaposin;Organisim: human;Apparent_Kd_M: 6.945042E-11

Real

Aptamer SeqId: 6207-10 | Target: prosaposin | UniProt: P07602

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6207-10 | Target: prosaposin | UniProt: P07602 | TargetFullName: Prosaposin | Organisim: human | Apparent_Kd_M: 6.945042E-11

Real

Aptamer SeqId:6210-100;Target:IFNA5;UniProt:P01569

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6210-100;Target: IFNA5;UniProt: P01569;TargetFullName: Interferon alpha-5;Organisim: human;Apparent_Kd_M: 1.52E-10

Real

Aptamer SeqId: 6210-100 | Target: IFNA5 | UniProt: P01569

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6210-100 | Target: IFNA5 | UniProt: P01569 | TargetFullName: Interferon alpha-5 | Organisim: human | Apparent_Kd_M: 1.52E-10

Real

Aptamer SeqId:6213-10;Target:CGB2;UniProt:Q6NT52

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6213-10;Target: CGB2;UniProt: Q6NT52;TargetFullName: Choriogonadotropin subunit beta variant 2;Organisim: human;Apparent_Kd_M: 9.387504E-11

Real

Aptamer SeqId: 6213-10 | Target: CGB2 | UniProt: Q6NT52

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6213-10 | Target: CGB2 | UniProt: Q6NT52 | TargetFullName: Choriogonadotropin subunit beta variant 2 | Organisim: human | Apparent_Kd_M: 9.387504E-11

Real

Aptamer SeqId:6214-84;Target:IFNA8;UniProt:P32881

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6214-84;Target: IFNA8;UniProt: P32881;TargetFullName: Interferon alpha-8;Organisim: human;Apparent_Kd_M: 5.28E-10

Real

Aptamer SeqId: 6214-84 | Target: IFNA8 | UniProt: P32881

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6214-84 | Target: IFNA8 | UniProt: P32881 | TargetFullName: Interferon alpha-8 | Organisim: human | Apparent_Kd_M: 5.28E-10

Real

Aptamer SeqId:6219-14;Target:PDZ11;UniProt:Q5EBL8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6219-14;Target: PDZ11;UniProt: Q5EBL8;TargetFullName: PDZ domain-containing protein 11;Organisim: human;Apparent_Kd_M: 2.910885E-10

Real

Aptamer SeqId: 6219-14 | Target: PDZ11 | UniProt: Q5EBL8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6219-14 | Target: PDZ11 | UniProt: Q5EBL8 | TargetFullName: PDZ domain-containing protein 11 | Organisim: human | Apparent_Kd_M: 2.910885E-10

Real

Aptamer SeqId:6221-1;Target:ADPGK;UniProt:Q9BRR6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6221-1;Target: ADPGK;UniProt: Q9BRR6;TargetFullName: ADP-dependent glucokinase;Organisim: human;Apparent_Kd_M: 1.633294E-10

Real

Aptamer SeqId: 6221-1 | Target: ADPGK | UniProt: Q9BRR6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6221-1 | Target: ADPGK | UniProt: Q9BRR6 | TargetFullName: ADP-dependent glucokinase | Organisim: human | Apparent_Kd_M: 1.633294E-10

Real

Aptamer SeqId:6223-5;Target:GUC2B;UniProt:Q16661

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6223-5;Target: GUC2B;UniProt: Q16661;TargetFullName: Guanylate cyclase activator 2B;Organisim: human;Apparent_Kd_M: 2.299597E-11

Real

Aptamer SeqId: 6223-5 | Target: GUC2B | UniProt: Q16661

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6223-5 | Target: GUC2B | UniProt: Q16661 | TargetFullName: Guanylate cyclase activator 2B | Organisim: human | Apparent_Kd_M: 2.299597E-11

Real

Aptamer SeqId:6226-69;Target:EFHA1;UniProt:Q8IYU8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6226-69;Target: EFHA1;UniProt: Q8IYU8;TargetFullName: Calcium uptake protein 2; mitochondrial;Organisim: human;Apparent_Kd_M: 1.624838E-11

Real

Aptamer SeqId: 6226-69 | Target: EFHA1 | UniProt: Q8IYU8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6226-69 | Target: EFHA1 | UniProt: Q8IYU8 | TargetFullName: Calcium uptake protein 2; mitochondrial | Organisim: human | Apparent_Kd_M: 1.624838E-11

Real

Aptamer SeqId:6227-1;Target:kallikrein 10;UniProt:O43240

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6227-1;Target: kallikrein 10;UniProt: O43240;TargetFullName: Kallikrein-10;Organisim: human;Apparent_Kd_M: 1.944188E-12

Real

Aptamer SeqId: 6227-1 | Target: kallikrein 10 | UniProt: O43240

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6227-1 | Target: kallikrein 10 | UniProt: O43240 | TargetFullName: Kallikrein-10 | Organisim: human | Apparent_Kd_M: 1.944188E-12

Real

Aptamer SeqId:6228-58;Target:sperm acrosome associated 1;UniProt:Q9HBV2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6228-58;Target: sperm acrosome associated 1;UniProt: Q9HBV2;TargetFullName: Sperm acrosome membrane-associated protein 1;Organisim: human;Apparent_Kd_M: 1.01559E-10

Real

Aptamer SeqId: 6228-58 | Target: sperm acrosome associated 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6228-58 | Target: sperm acrosome associated 1 | UniProt: Q9HBV2 | TargetFullName: Sperm acrosome membrane-associated protein 1 | Organisim: human | Apparent_Kd_M: 1.01559E-10

Real

Aptamer SeqId:6230-56;Target:CER1;UniProt:O95813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6230-56;Target: CER1;UniProt: O95813;TargetFullName: Cerberus;Organisim: human;Apparent_Kd_M: 4.26E-12

Real

Aptamer SeqId: 6230-56 | Target: CER1 | UniProt: O95813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6230-56 | Target: CER1 | UniProt: O95813 | TargetFullName: Cerberus | Organisim: human | Apparent_Kd_M: 4.26E-12

Real

Aptamer SeqId:6231-46;Target:STC2;UniProt:O76061

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6231-46;Target: STC2;UniProt: O76061;TargetFullName: Stanniocalcin-2;Organisim: human;Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId: 6231-46 | Target: STC2 | UniProt: O76061

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6231-46 | Target: STC2 | UniProt: O76061 | TargetFullName: Stanniocalcin-2 | Organisim: human | Apparent_Kd_M: 1.24E-10

Real

Aptamer SeqId:6234-74;Target:VITRN;UniProt:Q6UXI7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6234-74;Target: VITRN;UniProt: Q6UXI7;TargetFullName: Vitrin;Organisim: human;Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId: 6234-74 | Target: VITRN | UniProt: Q6UXI7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6234-74 | Target: VITRN | UniProt: Q6UXI7 | TargetFullName: Vitrin | Organisim: human | Apparent_Kd_M: 1.43E-11

Real

Aptamer SeqId:6237-11;Target:FGRL1;UniProt:Q8N441

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6237-11;Target: FGRL1;UniProt: Q8N441;TargetFullName: Fibroblast growth factor receptor-like 1;Organisim: human;Apparent_Kd_M: 3.05E-11

Real

Aptamer SeqId: 6237-11 | Target: FGRL1 | UniProt: Q8N441

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6237-11 | Target: FGRL1 | UniProt: Q8N441 | TargetFullName: Fibroblast growth factor receptor-like 1 | Organisim: human | Apparent_Kd_M: 3.05E-11

Real

Aptamer SeqId:6238-55;Target:PSG8;UniProt:Q9UQ74

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6238-55;Target: PSG8;UniProt: Q9UQ74;TargetFullName: Pregnancy-specific beta-1-glycoprotein 8;Organisim: human;Apparent_Kd_M: 2.551326E-10

Real

Aptamer SeqId: 6238-55 | Target: PSG8 | UniProt: Q9UQ74

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6238-55 | Target: PSG8 | UniProt: Q9UQ74 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 8 | Organisim: human | Apparent_Kd_M: 2.551326E-10

Real

Aptamer SeqId:6240-70;Target:RSPO1;UniProt:Q2MKA7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6240-70;Target: RSPO1;UniProt: Q2MKA7;TargetFullName: R-spondin-1;Organisim: human;Apparent_Kd_M: 1.470514E-10

Real

Aptamer SeqId: 6240-70 | Target: RSPO1 | UniProt: Q2MKA7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6240-70 | Target: RSPO1 | UniProt: Q2MKA7 | TargetFullName: R-spondin-1 | Organisim: human | Apparent_Kd_M: 1.470514E-10

Real

Aptamer SeqId:6245-4;Target:Nectin-2;UniProt:Q92692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6245-4;Target: Nectin-2;UniProt: Q92692;TargetFullName: Nectin-2;Organisim: human;Apparent_Kd_M: 1.26E-10

Real

Aptamer SeqId: 6245-4 | Target: Nectin-2 | UniProt: Q92692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6245-4 | Target: Nectin-2 | UniProt: Q92692 | TargetFullName: Nectin-2 | Organisim: human | Apparent_Kd_M: 1.26E-10

Real

Aptamer SeqId:6247-9;Target:SIRB1;UniProt:O00241

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6247-9;Target: SIRB1;UniProt: O00241;TargetFullName: Signal-regulatory protein beta-1;Organisim: human;Apparent_Kd_M: 9.85E-11

Real

Aptamer SeqId: 6247-9 | Target: SIRB1 | UniProt: O00241

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6247-9 | Target: SIRB1 | UniProt: O00241 | TargetFullName: Signal-regulatory protein beta-1 | Organisim: human | Apparent_Kd_M: 9.85E-11

Real

Aptamer SeqId:6252-62;Target:Secretoglobin family 3A member 1;UniProt:Q96QR1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6252-62;Target: Secretoglobin family 3A member 1;UniProt: Q96QR1;TargetFullName: Secretoglobin family 3A member 1;Organisim: human;Apparent_Kd_M: 1.318691E-11

Real

Aptamer SeqId: 6252-62 | Target: Secretoglobin family 3A member 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6252-62 | Target: Secretoglobin family 3A member 1 | UniProt: Q96QR1 | TargetFullName: Secretoglobin family 3A member 1 | Organisim: human | Apparent_Kd_M: 1.318691E-11

Real

Aptamer SeqId:6255-74;Target:CPXM1;UniProt:Q96SM3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6255-74;Target: CPXM1;UniProt: Q96SM3;TargetFullName: Probable carboxypeptidase X1;Organisim: human;Apparent_Kd_M: 2.37579E-12

Real

Aptamer SeqId: 6255-74 | Target: CPXM1 | UniProt: Q96SM3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6255-74 | Target: CPXM1 | UniProt: Q96SM3 | TargetFullName: Probable carboxypeptidase X1 | Organisim: human | Apparent_Kd_M: 2.37579E-12

Real

Aptamer SeqId:6256-9;Target:LY66C;UniProt:O95867

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6256-9;Target: LY66C;UniProt: O95867;TargetFullName: Lymphocyte antigen 6 complex locus protein G6c;Organisim: human;Apparent_Kd_M: 6.735453E-12

Real

Aptamer SeqId: 6256-9 | Target: LY66C | UniProt: O95867

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6256-9 | Target: LY66C | UniProt: O95867 | TargetFullName: Lymphocyte antigen 6 complex locus protein G6c | Organisim: human | Apparent_Kd_M: 6.735453E-12

Real

Aptamer SeqId:6257-56;Target:CGRE1;UniProt:Q99674

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6257-56;Target: CGRE1;UniProt: Q99674;TargetFullName: Cell growth regulator with EF hand domain protein 1;Organisim: human;Apparent_Kd_M: 3.387136E-11

Real

Aptamer SeqId: 6257-56 | Target: CGRE1 | UniProt: Q99674

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6257-56 | Target: CGRE1 | UniProt: Q99674 | TargetFullName: Cell growth regulator with EF hand domain protein 1 | Organisim: human | Apparent_Kd_M: 3.387136E-11

Real

Aptamer SeqId:6259-60;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6259-60;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 2.812028E-12

Real

Aptamer SeqId: 6259-60 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6259-60 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 2.812028E-12

Real

Aptamer SeqId:6260-14;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6260-14;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 3.133958E-12

Real

Aptamer SeqId: 6260-14 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6260-14 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 3.133958E-12

Real

Aptamer SeqId:6262-14;Target:IL-17B R;UniProt:Q9NRM6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6262-14;Target: IL-17B R;UniProt: Q9NRM6;TargetFullName: Interleukin-17 receptor B;Organisim: human;Apparent_Kd_M: 4.23E-11

Real

Aptamer SeqId: 6262-14 | Target: IL-17B R | UniProt: Q9NRM6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6262-14 | Target: IL-17B R | UniProt: Q9NRM6 | TargetFullName: Interleukin-17 receptor B | Organisim: human | Apparent_Kd_M: 4.23E-11

Real

Aptamer SeqId:6264-9;Target:CYR61;UniProt:O00622

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6264-9;Target: CYR61;UniProt: O00622;TargetFullName: Protein CYR61;Organisim: human;Apparent_Kd_M: 4.71E-12

Real

Aptamer SeqId: 6264-9 | Target: CYR61 | UniProt: O00622

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6264-9 | Target: CYR61 | UniProt: O00622 | TargetFullName: Protein CYR61 | Organisim: human | Apparent_Kd_M: 4.71E-12

Real

Aptamer SeqId:6267-51;Target:STMN4;UniProt:Q9H169

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6267-51;Target: STMN4;UniProt: Q9H169;TargetFullName: Stathmin-4;Organisim: human;Apparent_Kd_M: 1.183131E-11

Real

Aptamer SeqId: 6267-51 | Target: STMN4 | UniProt: Q9H169

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6267-51 | Target: STMN4 | UniProt: Q9H169 | TargetFullName: Stathmin-4 | Organisim: human | Apparent_Kd_M: 1.183131E-11

Real

Aptamer SeqId:6273-58;Target:P3H1;UniProt:Q32P28

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6273-58;Target: P3H1;UniProt: Q32P28;TargetFullName: Prolyl 3-hydroxylase 1;Organisim: human;Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId: 6273-58 | Target: P3H1 | UniProt: Q32P28

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6273-58 | Target: P3H1 | UniProt: Q32P28 | TargetFullName: Prolyl 3-hydroxylase 1 | Organisim: human | Apparent_Kd_M: 2.0E-11

Real

Aptamer SeqId:6274-15;Target:WSCD2;UniProt:Q2TBF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6274-15;Target: WSCD2;UniProt: Q2TBF2;TargetFullName: WSC domain-containing protein 2;Organisim: human;Apparent_Kd_M: 2.152435E-11

Real

Aptamer SeqId: 6274-15 | Target: WSCD2 | UniProt: Q2TBF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6274-15 | Target: WSCD2 | UniProt: Q2TBF2 | TargetFullName: WSC domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 2.152435E-11

Real

Aptamer SeqId:6276-16;Target:Furin;UniProt:P09958

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6276-16;Target: Furin;UniProt: P09958;TargetFullName: Furin;Organisim: human;Apparent_Kd_M: 1.910763E-11

Real

Aptamer SeqId: 6276-16 | Target: Furin | UniProt: P09958

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6276-16 | Target: Furin | UniProt: P09958 | TargetFullName: Furin | Organisim: human | Apparent_Kd_M: 1.910763E-11

Real

Aptamer SeqId:6277-55;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6277-55;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.543171E-12

Real

Aptamer SeqId: 6277-55 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6277-55 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.543171E-12

Real

Aptamer SeqId:6280-11;Target:PCDH8;UniProt:O95206

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6280-11;Target: PCDH8;UniProt: O95206;TargetFullName: Protocadherin-8;Organisim: human;Apparent_Kd_M: 3.025023E-11

Real

Aptamer SeqId: 6280-11 | Target: PCDH8 | UniProt: O95206

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6280-11 | Target: PCDH8 | UniProt: O95206 | TargetFullName: Protocadherin-8 | Organisim: human | Apparent_Kd_M: 3.025023E-11

Real

Aptamer SeqId:6281-51;Target:SIA4B;UniProt:Q16842

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6281-51;Target: SIA4B;UniProt: Q16842;TargetFullName: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2;3-sialyltransferase 2;Organisim: human;Apparent_Kd_M: 7.437269E-12

Real

Aptamer SeqId: 6281-51 | Target: SIA4B | UniProt: Q16842

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6281-51 | Target: SIA4B | UniProt: Q16842 | TargetFullName: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2;3-sialyltransferase 2 | Organisim: human | Apparent_Kd_M: 7.437269E-12

Real

Aptamer SeqId:6283-60;Target:MCEM1;UniProt:Q8IX19

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6283-60;Target: MCEM1;UniProt: Q8IX19;TargetFullName: Mast cell-expressed membrane protein 1;Organisim: human;Apparent_Kd_M: 1.418962E-11

Real

Aptamer SeqId: 6283-60 | Target: MCEM1 | UniProt: Q8IX19

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6283-60 | Target: MCEM1 | UniProt: Q8IX19 | TargetFullName: Mast cell-expressed membrane protein 1 | Organisim: human | Apparent_Kd_M: 1.418962E-11

Real

Aptamer SeqId:6284-7;Target:F150B;UniProt:Q6UX46

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6284-7;Target: F150B;UniProt: Q6UX46;TargetFullName: ALK and LTK ligand 2;Organisim: human;Apparent_Kd_M: 1.174614E-11

Real

Aptamer SeqId: 6284-7 | Target: F150B | UniProt: Q6UX46

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6284-7 | Target: F150B | UniProt: Q6UX46 | TargetFullName: ALK and LTK ligand 2 | Organisim: human | Apparent_Kd_M: 1.174614E-11

Real

Aptamer SeqId:6285-71;Target:K0152;UniProt:Q14165

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6285-71;Target: K0152;UniProt: Q14165;TargetFullName: Malectin;Organisim: human;Apparent_Kd_M: 2.324202E-11

Real

Aptamer SeqId: 6285-71 | Target: K0152 | UniProt: Q14165

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6285-71 | Target: K0152 | UniProt: Q14165 | TargetFullName: Malectin | Organisim: human | Apparent_Kd_M: 2.324202E-11

Real

Aptamer SeqId:6289-78;Target:RHG36;UniProt:Q6ZRI8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6289-78;Target: RHG36;UniProt: Q6ZRI8;TargetFullName: Rho GTPase-activating protein 36;Organisim: human;Apparent_Kd_M: 1.892049E-11

Real

Aptamer SeqId: 6289-78 | Target: RHG36 | UniProt: Q6ZRI8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6289-78 | Target: RHG36 | UniProt: Q6ZRI8 | TargetFullName: Rho GTPase-activating protein 36 | Organisim: human | Apparent_Kd_M: 1.892049E-11

Real

Aptamer SeqId:6290-3;Target:UTS2B;UniProt:Q765I0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6290-3;Target: UTS2B;UniProt: Q765I0;TargetFullName: Urotensin-2B;Organisim: human;Apparent_Kd_M: 1.785404E-11

Real

Aptamer SeqId: 6290-3 | Target: UTS2B | UniProt: Q765I0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6290-3 | Target: UTS2B | UniProt: Q765I0 | TargetFullName: Urotensin-2B | Organisim: human | Apparent_Kd_M: 1.785404E-11

Real

Aptamer SeqId:6291-55;Target:Alcadein-beta;UniProt:Q9BQT9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6291-55;Target: Alcadein-beta;UniProt: Q9BQT9;TargetFullName: Calsyntenin-3;Organisim: human;Apparent_Kd_M: 3.375357E-11

Real

Aptamer SeqId: 6291-55 | Target: Alcadein-beta | UniProt: Q9BQT9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6291-55 | Target: Alcadein-beta | UniProt: Q9BQT9 | TargetFullName: Calsyntenin-3 | Organisim: human | Apparent_Kd_M: 3.375357E-11

Real

Aptamer SeqId:6294-11;Target:BAGE2;UniProt:Q86Y30

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6294-11;Target: BAGE2;UniProt: Q86Y30;TargetFullName: B melanoma antigen 2;Organisim: human;Apparent_Kd_M: 2.747723E-11

Real

Aptamer SeqId: 6294-11 | Target: BAGE2 | UniProt: Q86Y30

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6294-11 | Target: BAGE2 | UniProt: Q86Y30 | TargetFullName: B melanoma antigen 2 | Organisim: human | Apparent_Kd_M: 2.747723E-11

Real

Aptamer SeqId:6295-67;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6295-67;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.357712E-12

Real

Aptamer SeqId: 6295-67 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6295-67 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.357712E-12

Real

Aptamer SeqId:6296-36;Target:OIT3;UniProt:Q8WWZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6296-36;Target: OIT3;UniProt: Q8WWZ8;TargetFullName: Oncoprotein-induced transcript 3 protein;Organisim: human;Apparent_Kd_M: 7.66E-12

Real

Aptamer SeqId: 6296-36 | Target: OIT3 | UniProt: Q8WWZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6296-36 | Target: OIT3 | UniProt: Q8WWZ8 | TargetFullName: Oncoprotein-induced transcript 3 protein | Organisim: human | Apparent_Kd_M: 7.66E-12

Real

Aptamer SeqId:6300-14;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6300-14;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.18E-12

Real

Aptamer SeqId: 6300-14 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6300-14 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.18E-12

Real

Aptamer SeqId:6304-8;Target:C1QT1;UniProt:Q9BXJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6304-8;Target: C1QT1;UniProt: Q9BXJ1;TargetFullName: Complement C1q tumor necrosis factor-related protein 1;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 6304-8 | Target: C1QT1 | UniProt: Q9BXJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6304-8 | Target: C1QT1 | UniProt: Q9BXJ1 | TargetFullName: Complement C1q tumor necrosis factor-related protein 1 | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:6315-58;Target:PLBL1;UniProt:Q6P4A8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6315-58;Target: PLBL1;UniProt: Q6P4A8;TargetFullName: Phospholipase B-like 1;Organisim: human;Apparent_Kd_M: 9.071494E-11

Real

Aptamer SeqId: 6315-58 | Target: PLBL1 | UniProt: Q6P4A8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6315-58 | Target: PLBL1 | UniProt: Q6P4A8 | TargetFullName: Phospholipase B-like 1 | Organisim: human | Apparent_Kd_M: 9.071494E-11

Real

Aptamer SeqId:6321-65;Target:PCDGA;UniProt:Q9Y5H3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6321-65;Target: PCDGA;UniProt: Q9Y5H3;TargetFullName: Protocadherin gamma-A10;Organisim: human;Apparent_Kd_M: 1.988317E-11

Real

Aptamer SeqId: 6321-65 | Target: PCDGA | UniProt: Q9Y5H3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6321-65 | Target: PCDGA | UniProt: Q9Y5H3 | TargetFullName: Protocadherin gamma-A10 | Organisim: human | Apparent_Kd_M: 1.988317E-11

Real

Aptamer SeqId:6324-11;Target:DNSL2;UniProt:Q92874

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6324-11;Target: DNSL2;UniProt: Q92874;TargetFullName: Deoxyribonuclease-1-like 2;Organisim: human;Apparent_Kd_M: 1.754243E-11

Real

Aptamer SeqId: 6324-11 | Target: DNSL2 | UniProt: Q92874

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6324-11 | Target: DNSL2 | UniProt: Q92874 | TargetFullName: Deoxyribonuclease-1-like 2 | Organisim: human | Apparent_Kd_M: 1.754243E-11

Real

Aptamer SeqId:6326-20;Target:BMP-4;UniProt:P12644

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6326-20;Target: BMP-4;UniProt: P12644;TargetFullName: Bone morphogenetic protein 4;Organisim: human;Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId: 6326-20 | Target: BMP-4 | UniProt: P12644

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6326-20 | Target: BMP-4 | UniProt: P12644 | TargetFullName: Bone morphogenetic protein 4 | Organisim: human | Apparent_Kd_M: 2.15E-11

Real

Aptamer SeqId:6334-9;Target:GGT2;UniProt:P36268

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6334-9;Target: GGT2;UniProt: P36268;TargetFullName: Inactive gamma-glutamyltranspeptidase 2;Organisim: human;Apparent_Kd_M: 5.068099E-11

Real

Aptamer SeqId: 6334-9 | Target: GGT2 | UniProt: P36268

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6334-9 | Target: GGT2 | UniProt: P36268 | TargetFullName: Inactive gamma-glutamyltranspeptidase 2 | Organisim: human | Apparent_Kd_M: 5.068099E-11

Real

Aptamer SeqId:6340-10;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6340-10;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.352301E-12

Real

Aptamer SeqId: 6340-10 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6340-10 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.352301E-12

Real

Aptamer SeqId:6342-10;Target:Nephronectin;UniProt:Q6UXI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6342-10;Target: Nephronectin;UniProt: Q6UXI9;TargetFullName: Nephronectin;Organisim: human;Apparent_Kd_M: 3.648321E-12

Real

Aptamer SeqId: 6342-10 | Target: Nephronectin | UniProt: Q6UXI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6342-10 | Target: Nephronectin | UniProt: Q6UXI9 | TargetFullName: Nephronectin | Organisim: human | Apparent_Kd_M: 3.648321E-12

Real

Aptamer SeqId:6350-43;Target:Apo C-II;UniProt:P02655

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6350-43;Target: Apo C-II;UniProt: P02655;TargetFullName: Apolipoprotein C-II;Organisim: human;Apparent_Kd_M: 1.252696E-12

Real

Aptamer SeqId: 6350-43 | Target: Apo C-II | UniProt: P02655

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6350-43 | Target: Apo C-II | UniProt: P02655 | TargetFullName: Apolipoprotein C-II | Organisim: human | Apparent_Kd_M: 1.252696E-12

Real

Aptamer SeqId:6351-55;Target:CD79B;UniProt:P40259

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6351-55;Target: CD79B;UniProt: P40259;TargetFullName: B-cell antigen receptor complex-associated protein beta chain;Organisim: human;Apparent_Kd_M: 3.468736E-12

Real

Aptamer SeqId: 6351-55 | Target: CD79B | UniProt: P40259

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6351-55 | Target: CD79B | UniProt: P40259 | TargetFullName: B-cell antigen receptor complex-associated protein beta chain | Organisim: human | Apparent_Kd_M: 3.468736E-12

Real

Aptamer SeqId:6352-8;Target:INSRR;UniProt:P14616

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6352-8;Target: INSRR;UniProt: P14616;TargetFullName: Insulin receptor-related protein;Organisim: human;Apparent_Kd_M: 2.913889E-12

Real

Aptamer SeqId: 6352-8 | Target: INSRR | UniProt: P14616

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6352-8 | Target: INSRR | UniProt: P14616 | TargetFullName: Insulin receptor-related protein | Organisim: human | Apparent_Kd_M: 2.913889E-12

Real

Aptamer SeqId:6353-60;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6353-60;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.967951E-12

Real

Aptamer SeqId: 6353-60 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6353-60 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.967951E-12

Real

Aptamer SeqId:6354-13;Target:HPHL1;UniProt:Q6MZM0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6354-13;Target: HPHL1;UniProt: Q6MZM0;TargetFullName: Hephaestin-like protein 1;Organisim: human;Apparent_Kd_M: 1.685411E-10

Real

Aptamer SeqId: 6354-13 | Target: HPHL1 | UniProt: Q6MZM0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6354-13 | Target: HPHL1 | UniProt: Q6MZM0 | TargetFullName: Hephaestin-like protein 1 | Organisim: human | Apparent_Kd_M: 1.685411E-10

Real

Aptamer SeqId:6357-83;Target:ELA3B;UniProt:P08861

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6357-83;Target: ELA3B;UniProt: P08861;TargetFullName: Chymotrypsin-like elastase family member 3B;Organisim: human;Apparent_Kd_M: 2.458081E-11

Real

Aptamer SeqId: 6357-83 | Target: ELA3B | UniProt: P08861

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6357-83 | Target: ELA3B | UniProt: P08861 | TargetFullName: Chymotrypsin-like elastase family member 3B | Organisim: human | Apparent_Kd_M: 2.458081E-11

Real

Aptamer SeqId:6359-50;Target:AGO61;UniProt:Q8NAT1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6359-50;Target: AGO61;UniProt: Q8NAT1;TargetFullName: Protein O-linked-mannose beta-1;4-N-acetylglucosaminyltransferase 2;Organisim: human;Apparent_Kd_M: 2.741728E-12

Real

Aptamer SeqId: 6359-50 | Target: AGO61 | UniProt: Q8NAT1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6359-50 | Target: AGO61 | UniProt: Q8NAT1 | TargetFullName: Protein O-linked-mannose beta-1;4-N-acetylglucosaminyltransferase 2 | Organisim: human | Apparent_Kd_M: 2.741728E-12

Real

Aptamer SeqId:6360-7;Target:DB128;UniProt:Q7Z7B8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6360-7;Target: DB128;UniProt: Q7Z7B8;TargetFullName: Beta-defensin 128;Organisim: human;Apparent_Kd_M: 1.260759E-10

Real

Aptamer SeqId: 6360-7 | Target: DB128 | UniProt: Q7Z7B8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6360-7 | Target: DB128 | UniProt: Q7Z7B8 | TargetFullName: Beta-defensin 128 | Organisim: human | Apparent_Kd_M: 1.260759E-10

Real

Aptamer SeqId:6361-49;Target:PTPRR;UniProt:Q15256

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6361-49;Target: PTPRR;UniProt: Q15256;TargetFullName: Receptor-type tyrosine-protein phosphatase R;Organisim: human;Apparent_Kd_M: 1.937803E-11

Real

Aptamer SeqId: 6361-49 | Target: PTPRR | UniProt: Q15256

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6361-49 | Target: PTPRR | UniProt: Q15256 | TargetFullName: Receptor-type tyrosine-protein phosphatase R | Organisim: human | Apparent_Kd_M: 1.937803E-11

Real

Aptamer SeqId:6362-6;Target:AUGN;UniProt:Q9H1Z8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6362-6;Target: AUGN;UniProt: Q9H1Z8;TargetFullName: Augurin;Organisim: human;Apparent_Kd_M: 1.500438E-10

Real

Aptamer SeqId: 6362-6 | Target: AUGN | UniProt: Q9H1Z8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6362-6 | Target: AUGN | UniProt: Q9H1Z8 | TargetFullName: Augurin | Organisim: human | Apparent_Kd_M: 1.500438E-10

Real

Aptamer SeqId:6363-55;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6363-55;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.130653E-12

Real

Aptamer SeqId: 6363-55 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6363-55 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.130653E-12

Real

Aptamer SeqId:6364-7;Target:TPSNR;UniProt:Q9BX59

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6364-7;Target: TPSNR;UniProt: Q9BX59;TargetFullName: Tapasin-related protein;Organisim: human;Apparent_Kd_M: 3.590924E-12

Real

Aptamer SeqId: 6364-7 | Target: TPSNR | UniProt: Q9BX59

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6364-7 | Target: TPSNR | UniProt: Q9BX59 | TargetFullName: Tapasin-related protein | Organisim: human | Apparent_Kd_M: 3.590924E-12

Real

Aptamer SeqId:6365-62;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6365-62;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.643011E-11

Real

Aptamer SeqId: 6365-62 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6365-62 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.643011E-11

Real

Aptamer SeqId:6366-38;Target:TXD15;UniProt:Q96J42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6366-38;Target: TXD15;UniProt: Q96J42;TargetFullName: Thioredoxin domain-containing protein 15;Organisim: human;Apparent_Kd_M: 2.09E-11

Real

Aptamer SeqId: 6366-38 | Target: TXD15 | UniProt: Q96J42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6366-38 | Target: TXD15 | UniProt: Q96J42 | TargetFullName: Thioredoxin domain-containing protein 15 | Organisim: human | Apparent_Kd_M: 2.09E-11

Real

Aptamer SeqId:6367-66;Target:fibromodulin;UniProt:Q06828

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6367-66;Target: fibromodulin;UniProt: Q06828;TargetFullName: fibromodulin;Organisim: human;Apparent_Kd_M: 1.232158E-10

Real

Aptamer SeqId: 6367-66 | Target: fibromodulin | UniProt: Q06828

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6367-66 | Target: fibromodulin | UniProt: Q06828 | TargetFullName: fibromodulin | Organisim: human | Apparent_Kd_M: 1.232158E-10

Real

Aptamer SeqId:6368-9;Target:CST1L;UniProt:Q9H114

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6368-9;Target: CST1L;UniProt: Q9H114;TargetFullName: Cystatin-like 1;Organisim: human;Apparent_Kd_M: 3.581922E-12

Real

Aptamer SeqId: 6368-9 | Target: CST1L | UniProt: Q9H114

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6368-9 | Target: CST1L | UniProt: Q9H114 | TargetFullName: Cystatin-like 1 | Organisim: human | Apparent_Kd_M: 3.581922E-12

Real

Aptamer SeqId:6369-82;Target:DEAF1;UniProt:O75398

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6369-82;Target: DEAF1;UniProt: O75398;TargetFullName: Deformed epidermal autoregulatory factor 1 homolog;Organisim: human;Apparent_Kd_M: 1.94858E-11

Real

Aptamer SeqId: 6369-82 | Target: DEAF1 | UniProt: O75398

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6369-82 | Target: DEAF1 | UniProt: O75398 | TargetFullName: Deformed epidermal autoregulatory factor 1 homolog | Organisim: human | Apparent_Kd_M: 1.94858E-11

Real

Aptamer SeqId:6371-50;Target:ANGL7;UniProt:O43827

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6371-50;Target: ANGL7;UniProt: O43827;TargetFullName: Angiopoietin-related protein 7;Organisim: human;Apparent_Kd_M: 1.603027E-10

Real

Aptamer SeqId: 6371-50 | Target: ANGL7 | UniProt: O43827

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6371-50 | Target: ANGL7 | UniProt: O43827 | TargetFullName: Angiopoietin-related protein 7 | Organisim: human | Apparent_Kd_M: 1.603027E-10

Real

Aptamer SeqId:6372-7;Target:YBOX2;UniProt:Q9Y2T7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6372-7;Target: YBOX2;UniProt: Q9Y2T7;TargetFullName: Y-box-binding protein 2;Organisim: human;Apparent_Kd_M: 2.153723E-11

Real

Aptamer SeqId: 6372-7 | Target: YBOX2 | UniProt: Q9Y2T7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6372-7 | Target: YBOX2 | UniProt: Q9Y2T7 | TargetFullName: Y-box-binding protein 2 | Organisim: human | Apparent_Kd_M: 2.153723E-11

Real

Aptamer SeqId:6373-54;Target:DLK1;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6373-54;Target: DLK1;UniProt:;TargetFullName: Protein delta homolog 1;Organisim: human;Apparent_Kd_M: 1.642086E-12

Real

Aptamer SeqId: 6373-54 | Target: DLK1 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6373-54 | Target: DLK1 | UniProt: | TargetFullName: Protein delta homolog 1 | Organisim: human | Apparent_Kd_M: 1.642086E-12

Real

Aptamer SeqId:6375-75;Target:XXLT1;UniProt:Q8NBI6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6375-75;Target: XXLT1;UniProt: Q8NBI6;TargetFullName: Xyloside xylosyltransferase 1;Organisim: human;Apparent_Kd_M: 7.057346E-12

Real

Aptamer SeqId: 6375-75 | Target: XXLT1 | UniProt: Q8NBI6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6375-75 | Target: XXLT1 | UniProt: Q8NBI6 | TargetFullName: Xyloside xylosyltransferase 1 | Organisim: human | Apparent_Kd_M: 7.057346E-12

Real

Aptamer SeqId:6377-54;Target:LYZL2;UniProt:Q7Z4W2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6377-54;Target: LYZL2;UniProt: Q7Z4W2;TargetFullName: Lysozyme-like protein 2;Organisim: human;Apparent_Kd_M: 2.120471E-11

Real

Aptamer SeqId: 6377-54 | Target: LYZL2 | UniProt: Q7Z4W2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6377-54 | Target: LYZL2 | UniProt: Q7Z4W2 | TargetFullName: Lysozyme-like protein 2 | Organisim: human | Apparent_Kd_M: 2.120471E-11

Real

Aptamer SeqId:6378-2;Target:CEI;UniProt:Q86SI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6378-2;Target: CEI;UniProt: Q86SI9;TargetFullName: Protein CEI;Organisim: human;Apparent_Kd_M: 5.963488E-11

Real

Aptamer SeqId: 6378-2 | Target: CEI | UniProt: Q86SI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6378-2 | Target: CEI | UniProt: Q86SI9 | TargetFullName: Protein CEI | Organisim: human | Apparent_Kd_M: 5.963488E-11

Real

Aptamer SeqId:6379-62;Target:ATL2;UniProt:Q86TH1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6379-62;Target: ATL2;UniProt: Q86TH1;TargetFullName: ADAMTS-like protein 2;Organisim: human;Apparent_Kd_M: 2.761828E-12

Real

Aptamer SeqId: 6379-62 | Target: ATL2 | UniProt: Q86TH1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6379-62 | Target: ATL2 | UniProt: Q86TH1 | TargetFullName: ADAMTS-like protein 2 | Organisim: human | Apparent_Kd_M: 2.761828E-12

Real

Aptamer SeqId:6380-23;Target:ICT1;UniProt:Q14197

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6380-23;Target: ICT1;UniProt: Q14197;TargetFullName: Peptidyl-tRNA hydrolase ICT1; mitochondrial;Organisim: human;Apparent_Kd_M: 1.388004E-11

Real

Aptamer SeqId: 6380-23 | Target: ICT1 | UniProt: Q14197

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6380-23 | Target: ICT1 | UniProt: Q14197 | TargetFullName: Peptidyl-tRNA hydrolase ICT1; mitochondrial | Organisim: human | Apparent_Kd_M: 1.388004E-11

Real

Aptamer SeqId:6382-17;Target:MANBA;UniProt:O00462

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6382-17;Target: MANBA;UniProt: O00462;TargetFullName: Beta-mannosidase;Organisim: human;Apparent_Kd_M: 1.70677E-10

Real

Aptamer SeqId: 6382-17 | Target: MANBA | UniProt: O00462

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6382-17 | Target: MANBA | UniProt: O00462 | TargetFullName: Beta-mannosidase | Organisim: human | Apparent_Kd_M: 1.70677E-10

Real

Aptamer SeqId:6383-90;Target:TLL1;UniProt:O43897

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6383-90;Target: TLL1;UniProt: O43897;TargetFullName: Tolloid-like protein 1;Organisim: human;Apparent_Kd_M: 5.102399E-12

Real

Aptamer SeqId: 6383-90 | Target: TLL1 | UniProt: O43897

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6383-90 | Target: TLL1 | UniProt: O43897 | TargetFullName: Tolloid-like protein 1 | Organisim: human | Apparent_Kd_M: 5.102399E-12

Real

Aptamer SeqId:6384-19;Target:WFDC3;UniProt:Q8IUB2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6384-19;Target: WFDC3;UniProt: Q8IUB2;TargetFullName: WAP four-disulfide core domain protein 3;Organisim: human;Apparent_Kd_M: 1.116919E-11

Real

Aptamer SeqId: 6384-19 | Target: WFDC3 | UniProt: Q8IUB2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6384-19 | Target: WFDC3 | UniProt: Q8IUB2 | TargetFullName: WAP four-disulfide core domain protein 3 | Organisim: human | Apparent_Kd_M: 1.116919E-11

Real

Aptamer SeqId:6385-63;Target:VWA1;UniProt:Q6PCB0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6385-63;Target: VWA1;UniProt: Q6PCB0;TargetFullName: von Willebrand factor A domain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.216101E-11

Real

Aptamer SeqId: 6385-63 | Target: VWA1 | UniProt: Q6PCB0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6385-63 | Target: VWA1 | UniProt: Q6PCB0 | TargetFullName: von Willebrand factor A domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.216101E-11

Real

Aptamer SeqId:6386-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6386-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.551058E-11

Real

Aptamer SeqId: 6386-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6386-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.551058E-11

Real

Aptamer SeqId:6388-21;Target:CC126;UniProt:Q96EE4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6388-21;Target: CC126;UniProt: Q96EE4;TargetFullName: Coiled-coil domain-containing protein 126;Organisim: human;Apparent_Kd_M: 9.216758E-12

Real

Aptamer SeqId: 6388-21 | Target: CC126 | UniProt: Q96EE4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6388-21 | Target: CC126 | UniProt: Q96EE4 | TargetFullName: Coiled-coil domain-containing protein 126 | Organisim: human | Apparent_Kd_M: 9.216758E-12

Real

Aptamer SeqId:6389-57;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6389-57;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.950667E-11

Real

Aptamer SeqId: 6389-57 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6389-57 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.950667E-11

Real

Aptamer SeqId:6390-18;Target:NPS;UniProt:P0C0P6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6390-18;Target: NPS;UniProt: P0C0P6;TargetFullName: Neuropeptide S;Organisim: human;Apparent_Kd_M: 1.185476E-11

Real

Aptamer SeqId: 6390-18 | Target: NPS | UniProt: P0C0P6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6390-18 | Target: NPS | UniProt: P0C0P6 | TargetFullName: Neuropeptide S | Organisim: human | Apparent_Kd_M: 1.185476E-11

Real

Aptamer SeqId:6391-52;Target:LIRA3;UniProt:Q8N6C8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6391-52;Target: LIRA3;UniProt: Q8N6C8;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 3;Organisim: human;Apparent_Kd_M: 3.961649E-12

Real

Aptamer SeqId: 6391-52 | Target: LIRA3 | UniProt: Q8N6C8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6391-52 | Target: LIRA3 | UniProt: Q8N6C8 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 3 | Organisim: human | Apparent_Kd_M: 3.961649E-12

Real

Aptamer SeqId:6392-7;Target:WISP-2;UniProt:O76076

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6392-7;Target: WISP-2;UniProt: O76076;TargetFullName: WNT1-inducible-signaling pathway protein 2;Organisim: human;Apparent_Kd_M: 2.235969E-11

Real

Aptamer SeqId: 6392-7 | Target: WISP-2 | UniProt: O76076

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6392-7 | Target: WISP-2 | UniProt: O76076 | TargetFullName: WNT1-inducible-signaling pathway protein 2 | Organisim: human | Apparent_Kd_M: 2.235969E-11

Real

Aptamer SeqId:6393-63;Target:Endoplasmin;UniProt:P14625

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6393-63;Target: Endoplasmin;UniProt: P14625;TargetFullName: Endoplasmin;Organisim: human;Apparent_Kd_M: 1.965207E-11

Real

Aptamer SeqId: 6393-63 | Target: Endoplasmin | UniProt: P14625

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6393-63 | Target: Endoplasmin | UniProt: P14625 | TargetFullName: Endoplasmin | Organisim: human | Apparent_Kd_M: 1.965207E-11

Real

Aptamer SeqId:6395-58;Target:GPHA2;UniProt:Q96T91

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6395-58;Target: GPHA2;UniProt: Q96T91;TargetFullName: Glycoprotein hormone alpha-2;Organisim: human;Apparent_Kd_M: 7.591015E-12

Real

Aptamer SeqId: 6395-58 | Target: GPHA2 | UniProt: Q96T91

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6395-58 | Target: GPHA2 | UniProt: Q96T91 | TargetFullName: Glycoprotein hormone alpha-2 | Organisim: human | Apparent_Kd_M: 7.591015E-12

Real

Aptamer SeqId:6398-12;Target:LONM;UniProt:P36776

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6398-12;Target: LONM;UniProt: P36776;TargetFullName: Lon protease homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 8.17E-12

Real

Aptamer SeqId: 6398-12 | Target: LONM | UniProt: P36776

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6398-12 | Target: LONM | UniProt: P36776 | TargetFullName: Lon protease homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 8.17E-12

Real

Aptamer SeqId:6399-52;Target:D107A;UniProt:Q8IZN7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6399-52;Target: D107A;UniProt: Q8IZN7;TargetFullName: Beta-defensin 107;Organisim: human;Apparent_Kd_M: 2.0E-10

Real

Aptamer SeqId: 6399-52 | Target: D107A | UniProt: Q8IZN7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6399-52 | Target: D107A | UniProt: Q8IZN7 | TargetFullName: Beta-defensin 107 | Organisim: human | Apparent_Kd_M: 2.0E-10

Real

Aptamer SeqId:6400-33;Target:P5I13;UniProt:Q8NBR0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6400-33;Target: P5I13;UniProt: Q8NBR0;TargetFullName: Tumor protein p53-inducible protein 13;Organisim: human;Apparent_Kd_M: 6.6E-11

Real

Aptamer SeqId: 6400-33 | Target: P5I13 | UniProt: Q8NBR0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6400-33 | Target: P5I13 | UniProt: Q8NBR0 | TargetFullName: Tumor protein p53-inducible protein 13 | Organisim: human | Apparent_Kd_M: 6.6E-11

Real

Aptamer SeqId:6401-73;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6401-73;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.825166E-11

Real

Aptamer SeqId: 6401-73 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6401-73 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.825166E-11

Real

Aptamer SeqId:6402-8;Target:PILRA isoform FDF03-deltaTM;UniProt:Q9UKJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6402-8;Target: PILRA isoform FDF03-deltaTM;UniProt: Q9UKJ1;TargetFullName: Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM;Organisim: human;Apparent_Kd_M: 2.483891E-12

Real

Aptamer SeqId: 6402-8 | Target: PILRA isoform FDF03-deltaTM

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6402-8 | Target: PILRA isoform FDF03-deltaTM | UniProt: Q9UKJ1 | TargetFullName: Paired immunoglobulin-like type 2 receptor alpha isoform FDF03-deltaTM | Organisim: human | Apparent_Kd_M: 2.483891E-12

Real

Aptamer SeqId:6404-20;Target:C1QRF;UniProt:O75973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6404-20;Target: C1QRF;UniProt: O75973;TargetFullName: C1q-related factor;Organisim: human;Apparent_Kd_M: 1.794246E-11

Real

Aptamer SeqId: 6404-20 | Target: C1QRF | UniProt: O75973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6404-20 | Target: C1QRF | UniProt: O75973 | TargetFullName: C1q-related factor | Organisim: human | Apparent_Kd_M: 1.794246E-11

Real

Aptamer SeqId:6405-74;Target:PSG2;UniProt:P11465

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6405-74;Target: PSG2;UniProt: P11465;TargetFullName: Pregnancy-specific beta-1-glycoprotein 2;Organisim: human;Apparent_Kd_M: 1.167056E-12

Real

Aptamer SeqId: 6405-74 | Target: PSG2 | UniProt: P11465

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6405-74 | Target: PSG2 | UniProt: P11465 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 2 | Organisim: human | Apparent_Kd_M: 1.167056E-12

Real

Aptamer SeqId:6406-3;Target:NMES1;UniProt:Q9C002

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6406-3;Target: NMES1;UniProt: Q9C002;TargetFullName: Normal mucosa of esophagus-specific gene 1 protein;Organisim: human;Apparent_Kd_M: 3.140404E-12

Real

Aptamer SeqId: 6406-3 | Target: NMES1 | UniProt: Q9C002

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6406-3 | Target: NMES1 | UniProt: Q9C002 | TargetFullName: Normal mucosa of esophagus-specific gene 1 protein | Organisim: human | Apparent_Kd_M: 3.140404E-12

Real

Aptamer SeqId:6407-63;Target:LAD1;UniProt:O00515

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6407-63;Target: LAD1;UniProt: O00515;TargetFullName: Ladinin-1;Organisim: human;Apparent_Kd_M: 6.79E-11

Real

Aptamer SeqId: 6407-63 | Target: LAD1 | UniProt: O00515

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6407-63 | Target: LAD1 | UniProt: O00515 | TargetFullName: Ladinin-1 | Organisim: human | Apparent_Kd_M: 6.79E-11

Real

Aptamer SeqId:6408-2;Target:INHBC;UniProt:P55103

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6408-2;Target: INHBC;UniProt: P55103;TargetFullName: Inhibin beta C chain;Organisim: human;Apparent_Kd_M: 6.0E-11

Real

Aptamer SeqId: 6408-2 | Target: INHBC | UniProt: P55103

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6408-2 | Target: INHBC | UniProt: P55103 | TargetFullName: Inhibin beta C chain | Organisim: human | Apparent_Kd_M: 6.0E-11

Real

Aptamer SeqId:6409-57;Target:GP116;UniProt:Q8IZF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6409-57;Target: GP116;UniProt: Q8IZF2;TargetFullName: Adhesion G protein-coupled receptor F5;Organisim: human;Apparent_Kd_M: 8.004315E-11

Real

Aptamer SeqId: 6409-57 | Target: GP116 | UniProt: Q8IZF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6409-57 | Target: GP116 | UniProt: Q8IZF2 | TargetFullName: Adhesion G protein-coupled receptor F5 | Organisim: human | Apparent_Kd_M: 8.004315E-11

Real

Aptamer SeqId:6410-26;Target:INSL4;UniProt:Q14641

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6410-26;Target: INSL4;UniProt: Q14641;TargetFullName: Early placenta insulin-like peptide;Organisim: human;Apparent_Kd_M: 4.623997E-11

Real

Aptamer SeqId: 6410-26 | Target: INSL4 | UniProt: Q14641

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6410-26 | Target: INSL4 | UniProt: Q14641 | TargetFullName: Early placenta insulin-like peptide | Organisim: human | Apparent_Kd_M: 4.623997E-11

Real

Aptamer SeqId:6411-58;Target:DB135;UniProt:Q30KP9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6411-58;Target: DB135;UniProt: Q30KP9;TargetFullName: Beta-defensin 135;Organisim: human;Apparent_Kd_M: 3.090139E-11

Real

Aptamer SeqId: 6411-58 | Target: DB135 | UniProt: Q30KP9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6411-58 | Target: DB135 | UniProt: Q30KP9 | TargetFullName: Beta-defensin 135 | Organisim: human | Apparent_Kd_M: 3.090139E-11

Real

Aptamer SeqId:6412-26;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6412-26;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.972528E-12

Real

Aptamer SeqId: 6412-26 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6412-26 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.972528E-12

Real

Aptamer SeqId:6413-79;Target:LIPK;UniProt:Q5VXJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6413-79;Target: LIPK;UniProt: Q5VXJ0;TargetFullName: Lipase member K;Organisim: human;Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId: 6413-79 | Target: LIPK | UniProt: Q5VXJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6413-79 | Target: LIPK | UniProt: Q5VXJ0 | TargetFullName: Lipase member K | Organisim: human | Apparent_Kd_M: 1.32E-11

Real

Aptamer SeqId:6414-8;Target:OAF;UniProt:Q86UD1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6414-8;Target: OAF;UniProt: Q86UD1;TargetFullName: Out at first protein homolog;Organisim: human;Apparent_Kd_M: 9.704727E-12

Real

Aptamer SeqId: 6414-8 | Target: OAF | UniProt: Q86UD1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6414-8 | Target: OAF | UniProt: Q86UD1 | TargetFullName: Out at first protein homolog | Organisim: human | Apparent_Kd_M: 9.704727E-12

Real

Aptamer SeqId:6415-90;Target:CPN2;UniProt:P22792

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6415-90;Target: CPN2;UniProt: P22792;TargetFullName: Carboxypeptidase N subunit 2;Organisim: human;Apparent_Kd_M: 1.517215E-11

Real

Aptamer SeqId: 6415-90 | Target: CPN2 | UniProt: P22792

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6415-90 | Target: CPN2 | UniProt: P22792 | TargetFullName: Carboxypeptidase N subunit 2 | Organisim: human | Apparent_Kd_M: 1.517215E-11

Real

Aptamer SeqId:6416-8;Target:GKN2;UniProt:Q86XP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6416-8;Target: GKN2;UniProt: Q86XP6;TargetFullName: Gastrokine-2;Organisim: human;Apparent_Kd_M: 1.641471E-10

Real

Aptamer SeqId: 6416-8 | Target: GKN2 | UniProt: Q86XP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6416-8 | Target: GKN2 | UniProt: Q86XP6 | TargetFullName: Gastrokine-2 | Organisim: human | Apparent_Kd_M: 1.641471E-10

Real

Aptamer SeqId:6417-55;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6417-55;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.519256E-11

Real

Aptamer SeqId: 6417-55 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6417-55 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.519256E-11

Real

Aptamer SeqId:6419-75;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6419-75;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.286421E-12

Real

Aptamer SeqId: 6419-75 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6419-75 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.286421E-12

Real

Aptamer SeqId:6420-4;Target:SDHF2;UniProt:Q9NX18

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6420-4;Target: SDHF2;UniProt: Q9NX18;TargetFullName: Succinate dehydrogenase assembly factor 2; mitochondrial;Organisim: human;Apparent_Kd_M: 9.823543E-12

Real

Aptamer SeqId: 6420-4 | Target: SDHF2 | UniProt: Q9NX18

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6420-4 | Target: SDHF2 | UniProt: Q9NX18 | TargetFullName: Succinate dehydrogenase assembly factor 2; mitochondrial | Organisim: human | Apparent_Kd_M: 9.823543E-12

Real

Aptamer SeqId:6421-52;Target:IFN16;UniProt:P05015

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6421-52;Target: IFN16;UniProt: P05015;TargetFullName: Interferon alpha-16;Organisim: human;Apparent_Kd_M: 4.091017E-12

Real

Aptamer SeqId: 6421-52 | Target: IFN16 | UniProt: P05015

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6421-52 | Target: IFN16 | UniProt: P05015 | TargetFullName: Interferon alpha-16 | Organisim: human | Apparent_Kd_M: 4.091017E-12

Real

Aptamer SeqId:6424-2;Target:RNS13;UniProt:Q5GAN3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6424-2;Target: RNS13;UniProt: Q5GAN3;TargetFullName: Probable inactive ribonuclease-like protein 13;Organisim: human;Apparent_Kd_M: 1.479855E-11

Real

Aptamer SeqId: 6424-2 | Target: RNS13 | UniProt: Q5GAN3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6424-2 | Target: RNS13 | UniProt: Q5GAN3 | TargetFullName: Probable inactive ribonuclease-like protein 13 | Organisim: human | Apparent_Kd_M: 1.479855E-11

Real

Aptamer SeqId:6425-87;Target:MMP19;UniProt:Q99542

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6425-87;Target: MMP19;UniProt: Q99542;TargetFullName: Matrix metalloproteinase-19;Organisim: human;Apparent_Kd_M: 2.686982E-12

Real

Aptamer SeqId: 6425-87 | Target: MMP19 | UniProt: Q99542

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6425-87 | Target: MMP19 | UniProt: Q99542 | TargetFullName: Matrix metalloproteinase-19 | Organisim: human | Apparent_Kd_M: 2.686982E-12

Real

Aptamer SeqId:6430-36;Target:F19A2;UniProt:Q8N3H0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6430-36;Target: F19A2;UniProt: Q8N3H0;TargetFullName: Protein FAM19A2;Organisim: human;Apparent_Kd_M: 6.191995E-11

Real

Aptamer SeqId: 6430-36 | Target: F19A2 | UniProt: Q8N3H0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6430-36 | Target: F19A2 | UniProt: Q8N3H0 | TargetFullName: Protein FAM19A2 | Organisim: human | Apparent_Kd_M: 6.191995E-11

Real

Aptamer SeqId:6431-68;Target:PCYOX;UniProt:Q9UHG3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6431-68;Target: PCYOX;UniProt: Q9UHG3;TargetFullName: Prenylcysteine oxidase 1;Organisim: human;Apparent_Kd_M: 1.177655E-10

Real

Aptamer SeqId: 6431-68 | Target: PCYOX | UniProt: Q9UHG3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6431-68 | Target: PCYOX | UniProt: Q9UHG3 | TargetFullName: Prenylcysteine oxidase 1 | Organisim: human | Apparent_Kd_M: 1.177655E-10

Real

Aptamer SeqId:6433-57;Target:FA20A;UniProt:Q96MK3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6433-57;Target: FA20A;UniProt: Q96MK3;TargetFullName: Pseudokinase FAM20A;Organisim: human;Apparent_Kd_M: 6.066204E-11

Real

Aptamer SeqId: 6433-57 | Target: FA20A | UniProt: Q96MK3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6433-57 | Target: FA20A | UniProt: Q96MK3 | TargetFullName: Pseudokinase FAM20A | Organisim: human | Apparent_Kd_M: 6.066204E-11

Real

Aptamer SeqId:6434-18;Target:Amine oxidase;UniProt:O75106

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6434-18;Target: Amine oxidase;UniProt: O75106;TargetFullName: Retina-specific copper amine oxidase;Organisim: human;Apparent_Kd_M: 3.537468E-12

Real

Aptamer SeqId: 6434-18 | Target: Amine oxidase | UniProt: O75106

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6434-18 | Target: Amine oxidase | UniProt: O75106 | TargetFullName: Retina-specific copper amine oxidase | Organisim: human | Apparent_Kd_M: 3.537468E-12

Real

Aptamer SeqId:6439-59;Target:CN093;UniProt:Q9H972

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6439-59;Target: CN093;UniProt: Q9H972;TargetFullName: Uncharacterized protein C14orf93;Organisim: human;Apparent_Kd_M: 4.636499E-12

Real

Aptamer SeqId: 6439-59 | Target: CN093 | UniProt: Q9H972

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6439-59 | Target: CN093 | UniProt: Q9H972 | TargetFullName: Uncharacterized protein C14orf93 | Organisim: human | Apparent_Kd_M: 4.636499E-12

Real

Aptamer SeqId:6440-31;Target:MFAP5;UniProt:Q13361

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6440-31;Target: MFAP5;UniProt: Q13361;TargetFullName: Microfibrillar-associated protein 5;Organisim: human;Apparent_Kd_M: 1.27682E-11

Real

Aptamer SeqId: 6440-31 | Target: MFAP5 | UniProt: Q13361

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6440-31 | Target: MFAP5 | UniProt: Q13361 | TargetFullName: Microfibrillar-associated protein 5 | Organisim: human | Apparent_Kd_M: 1.27682E-11

Real

Aptamer SeqId:6441-62;Target:ATS6;UniProt:Q9UKP5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6441-62;Target: ATS6;UniProt: Q9UKP5;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 6;Organisim: human;Apparent_Kd_M: 2.561274E-12

Real

Aptamer SeqId: 6441-62 | Target: ATS6 | UniProt: Q9UKP5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6441-62 | Target: ATS6 | UniProt: Q9UKP5 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 6 | Organisim: human | Apparent_Kd_M: 2.561274E-12

Real

Aptamer SeqId:6442-6;Target:BAGE3;UniProt:Q86Y29

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6442-6;Target: BAGE3;UniProt: Q86Y29;TargetFullName: B melanoma antigen 3;Organisim: human;Apparent_Kd_M: 2.468582E-11

Real

Aptamer SeqId: 6442-6 | Target: BAGE3 | UniProt: Q86Y29

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6442-6 | Target: BAGE3 | UniProt: Q86Y29 | TargetFullName: B melanoma antigen 3 | Organisim: human | Apparent_Kd_M: 2.468582E-11

Real

Aptamer SeqId:6443-68;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6443-68;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.61E-11

Real

Aptamer SeqId: 6443-68 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6443-68 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.61E-11

Real

Aptamer SeqId:6444-15;Target:PSG3;UniProt:Q16557

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6444-15;Target: PSG3;UniProt: Q16557;TargetFullName: Pregnancy-specific beta-1-glycoprotein 3;Organisim: human;Apparent_Kd_M: 7.001791E-12

Real

Aptamer SeqId: 6444-15 | Target: PSG3 | UniProt: Q16557

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6444-15 | Target: PSG3 | UniProt: Q16557 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 3 | Organisim: human | Apparent_Kd_M: 7.001791E-12

Real

Aptamer SeqId:6447-73;Target:PTX3;UniProt:P26022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6447-73;Target: PTX3;UniProt: P26022;TargetFullName: Pentraxin-related protein PTX3;Organisim: human;Apparent_Kd_M: 5.591102E-11

Real

Aptamer SeqId: 6447-73 | Target: PTX3 | UniProt: P26022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6447-73 | Target: PTX3 | UniProt: P26022 | TargetFullName: Pentraxin-related protein PTX3 | Organisim: human | Apparent_Kd_M: 5.591102E-11

Real

Aptamer SeqId:6448-36;Target:Sema E;UniProt:Q99985

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6448-36;Target: Sema E;UniProt: Q99985;TargetFullName: Semaphorin-3C;Organisim: human;Apparent_Kd_M: 8.091061E-12

Real

Aptamer SeqId: 6448-36 | Target: Sema E | UniProt: Q99985

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6448-36 | Target: Sema E | UniProt: Q99985 | TargetFullName: Semaphorin-3C | Organisim: human | Apparent_Kd_M: 8.091061E-12

Real

Aptamer SeqId:6450-8;Target:FABP6;UniProt:P51161

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6450-8;Target: FABP6;UniProt: P51161;TargetFullName: Gastrotropin;Organisim: human;Apparent_Kd_M: 2.444607E-11

Real

Aptamer SeqId: 6450-8 | Target: FABP6 | UniProt: P51161

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6450-8 | Target: FABP6 | UniProt: P51161 | TargetFullName: Gastrotropin | Organisim: human | Apparent_Kd_M: 2.444607E-11

Real

Aptamer SeqId:6451-64;Target:ASPN;UniProt:Q9BXN1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6451-64;Target: ASPN;UniProt: Q9BXN1;TargetFullName: Asporin;Organisim: human;Apparent_Kd_M: 4.795251E-12

Real

Aptamer SeqId: 6451-64 | Target: ASPN | UniProt: Q9BXN1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6451-64 | Target: ASPN | UniProt: Q9BXN1 | TargetFullName: Asporin | Organisim: human | Apparent_Kd_M: 4.795251E-12

Real

Aptamer SeqId:6453-70;Target:LIRB4;UniProt:Q8NHJ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6453-70;Target: LIRB4;UniProt: Q8NHJ6;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 4;Organisim: human;Apparent_Kd_M: 1.695426E-12

Real

Aptamer SeqId: 6453-70 | Target: LIRB4 | UniProt: Q8NHJ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6453-70 | Target: LIRB4 | UniProt: Q8NHJ6 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 4 | Organisim: human | Apparent_Kd_M: 1.695426E-12

Real

Aptamer SeqId:6454-38;Target:Rho-GDIa;UniProt:P52565

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6454-38;Target: Rho-GDIa;UniProt: P52565;TargetFullName: Rho GDP-dissociation inhibitor 1;Organisim: human;Apparent_Kd_M: 9.22161E-11

Real

Aptamer SeqId: 6454-38 | Target: Rho-GDIa | UniProt: P52565

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6454-38 | Target: Rho-GDIa | UniProt: P52565 | TargetFullName: Rho GDP-dissociation inhibitor 1 | Organisim: human | Apparent_Kd_M: 9.22161E-11

Real

Aptamer SeqId:6455-52;Target:HPLN4;UniProt:Q86UW8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6455-52;Target: HPLN4;UniProt: Q86UW8;TargetFullName: Hyaluronan and proteoglycan link protein 4;Organisim: human;Apparent_Kd_M: 2.466674E-12

Real

Aptamer SeqId: 6455-52 | Target: HPLN4 | UniProt: Q86UW8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6455-52 | Target: HPLN4 | UniProt: Q86UW8 | TargetFullName: Hyaluronan and proteoglycan link protein 4 | Organisim: human | Apparent_Kd_M: 2.466674E-12

Real

Aptamer SeqId:6456-17;Target:PSG6;UniProt:Q00889

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6456-17;Target: PSG6;UniProt: Q00889;TargetFullName: Pregnancy-specific beta-1-glycoprotein 6;Organisim: human;Apparent_Kd_M: 3.118143E-11

Real

Aptamer SeqId: 6456-17 | Target: PSG6 | UniProt: Q00889

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6456-17 | Target: PSG6 | UniProt: Q00889 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 6 | Organisim: human | Apparent_Kd_M: 3.118143E-11

Real

Aptamer SeqId:6457-50;Target:PCDG1;UniProt:Q9Y5H4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6457-50;Target: PCDG1;UniProt: Q9Y5H4;TargetFullName: Protocadherin gamma-A1;Organisim: human;Apparent_Kd_M: 8.107633E-12

Real

Aptamer SeqId: 6457-50 | Target: PCDG1 | UniProt: Q9Y5H4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6457-50 | Target: PCDG1 | UniProt: Q9Y5H4 | TargetFullName: Protocadherin gamma-A1 | Organisim: human | Apparent_Kd_M: 8.107633E-12

Real

Aptamer SeqId:6458-6;Target:RPN1;UniProt:P04843

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6458-6;Target: RPN1;UniProt: P04843;TargetFullName: Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1;Organisim: human;Apparent_Kd_M: 1.051868E-11

Real

Aptamer SeqId: 6458-6 | Target: RPN1 | UniProt: P04843

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6458-6 | Target: RPN1 | UniProt: P04843 | TargetFullName: Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | Organisim: human | Apparent_Kd_M: 1.051868E-11

Real

Aptamer SeqId:6461-54;Target:Apo C-III;UniProt:P02656

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6461-54;Target: Apo C-III;UniProt: P02656;TargetFullName: Apolipoprotein C-III;Organisim: human;Apparent_Kd_M: 4.771643E-12

Real

Aptamer SeqId: 6461-54 | Target: Apo C-III | UniProt: P02656

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6461-54 | Target: Apo C-III | UniProt: P02656 | TargetFullName: Apolipoprotein C-III | Organisim: human | Apparent_Kd_M: 4.771643E-12

Real

Aptamer SeqId:6462-12;Target:TIMP-4;UniProt:Q99727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6462-12;Target: TIMP-4;UniProt: Q99727;TargetFullName: Metalloproteinase inhibitor 4;Organisim: human;Apparent_Kd_M: 2.1318E-12

Real

Aptamer SeqId: 6462-12 | Target: TIMP-4 | UniProt: Q99727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6462-12 | Target: TIMP-4 | UniProt: Q99727 | TargetFullName: Metalloproteinase inhibitor 4 | Organisim: human | Apparent_Kd_M: 2.1318E-12

Real

Aptamer SeqId:6463-59;Target:OX26;UniProt:P83859

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6463-59;Target: OX26;UniProt: P83859;TargetFullName: Orexigenic neuropeptide QRFP;Organisim: human;Apparent_Kd_M: 8.490205E-11

Real

Aptamer SeqId: 6463-59 | Target: OX26 | UniProt: P83859

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6463-59 | Target: OX26 | UniProt: P83859 | TargetFullName: Orexigenic neuropeptide QRFP | Organisim: human | Apparent_Kd_M: 8.490205E-11

Real

Aptamer SeqId:6464-40;Target:PVRIG;UniProt:Q6DKI7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6464-40;Target: PVRIG;UniProt: Q6DKI7;TargetFullName: Transmembrane protein PVRIG;Organisim: human;Apparent_Kd_M: 6.44675E-11

Real

Aptamer SeqId: 6464-40 | Target: PVRIG | UniProt: Q6DKI7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6464-40 | Target: PVRIG | UniProt: Q6DKI7 | TargetFullName: Transmembrane protein PVRIG | Organisim: human | Apparent_Kd_M: 6.44675E-11

Real

Aptamer SeqId:6466-7;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6466-7;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.195974E-11

Real

Aptamer SeqId: 6466-7 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6466-7 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.195974E-11

Real

Aptamer SeqId:6467-65;Target:KTEL1;UniProt:Q8NBL1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6467-65;Target: KTEL1;UniProt: Q8NBL1;TargetFullName: Protein O-glucosyltransferase 1;Organisim: human;Apparent_Kd_M: 1.532903E-11

Real

Aptamer SeqId: 6467-65 | Target: KTEL1 | UniProt: Q8NBL1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6467-65 | Target: KTEL1 | UniProt: Q8NBL1 | TargetFullName: Protein O-glucosyltransferase 1 | Organisim: human | Apparent_Kd_M: 1.532903E-11

Real

Aptamer SeqId:6468-37;Target:TKN4;UniProt:Q86UU9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6468-37;Target: TKN4;UniProt: Q86UU9;TargetFullName: Tachykinin-4;Organisim: human;Apparent_Kd_M: 7.593385E-11

Real

Aptamer SeqId: 6468-37 | Target: TKN4 | UniProt: Q86UU9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6468-37 | Target: TKN4 | UniProt: Q86UU9 | TargetFullName: Tachykinin-4 | Organisim: human | Apparent_Kd_M: 7.593385E-11

Real

Aptamer SeqId:6469-62;Target:LY66D;UniProt:O95868

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6469-62;Target: LY66D;UniProt: O95868;TargetFullName: Lymphocyte antigen 6 complex locus protein G6d;Organisim: human;Apparent_Kd_M: 1.298921E-10

Real

Aptamer SeqId: 6469-62 | Target: LY66D | UniProt: O95868

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6469-62 | Target: LY66D | UniProt: O95868 | TargetFullName: Lymphocyte antigen 6 complex locus protein G6d | Organisim: human | Apparent_Kd_M: 1.298921E-10

Real

Aptamer SeqId:6470-19;Target:fibulin 1;UniProt:P23142

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6470-19;Target: fibulin 1;UniProt: P23142;TargetFullName: Fibulin-1;Organisim: human;Apparent_Kd_M: 1.52E-10

Real

Aptamer SeqId: 6470-19 | Target: fibulin 1 | UniProt: P23142

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6470-19 | Target: fibulin 1 | UniProt: P23142 | TargetFullName: Fibulin-1 | Organisim: human | Apparent_Kd_M: 1.52E-10

Real

Aptamer SeqId:6471-53;Target:FHR4;UniProt:Q92496

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6471-53;Target: FHR4;UniProt: Q92496;TargetFullName: Complement factor H-related protein 4;Organisim: human;Apparent_Kd_M: 3.206741E-11

Real

Aptamer SeqId: 6471-53 | Target: FHR4 | UniProt: Q92496

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6471-53 | Target: FHR4 | UniProt: Q92496 | TargetFullName: Complement factor H-related protein 4 | Organisim: human | Apparent_Kd_M: 3.206741E-11

Real

Aptamer SeqId:6472-40;Target:GP100;UniProt:P40967

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6472-40;Target: GP100;UniProt: P40967;TargetFullName: Melanocyte protein PMEL;Organisim: human;Apparent_Kd_M: 1.771007E-10

Real

Aptamer SeqId: 6472-40 | Target: GP100 | UniProt: P40967

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6472-40 | Target: GP100 | UniProt: P40967 | TargetFullName: Melanocyte protein PMEL | Organisim: human | Apparent_Kd_M: 1.771007E-10

Real

Aptamer SeqId:6473-55;Target:PLUNC;UniProt:Q9NP55

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6473-55;Target: PLUNC;UniProt: Q9NP55;TargetFullName: BPI fold-containing family A member 1;Organisim: human;Apparent_Kd_M: 3.647417E-11

Real

Aptamer SeqId: 6473-55 | Target: PLUNC | UniProt: Q9NP55

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6473-55 | Target: PLUNC | UniProt: Q9NP55 | TargetFullName: BPI fold-containing family A member 1 | Organisim: human | Apparent_Kd_M: 3.647417E-11

Real

Aptamer SeqId:6478-2;Target:IGLO5;UniProt:A6NGN9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6478-2;Target: IGLO5;UniProt: A6NGN9;TargetFullName: IgLON family member 5;Organisim: human;Apparent_Kd_M: 2.43965E-11

Real

Aptamer SeqId: 6478-2 | Target: IGLO5 | UniProt: A6NGN9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6478-2 | Target: IGLO5 | UniProt: A6NGN9 | TargetFullName: IgLON family member 5 | Organisim: human | Apparent_Kd_M: 2.43965E-11

Real

Aptamer SeqId:6480-1;Target:CANT1;UniProt:Q8WVQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6480-1;Target: CANT1;UniProt: Q8WVQ1;TargetFullName: Soluble calcium-activated nucleotidase 1;Organisim: human;Apparent_Kd_M: 8.48842E-11

Real

Aptamer SeqId: 6480-1 | Target: CANT1 | UniProt: Q8WVQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6480-1 | Target: CANT1 | UniProt: Q8WVQ1 | TargetFullName: Soluble calcium-activated nucleotidase 1 | Organisim: human | Apparent_Kd_M: 8.48842E-11

Real

Aptamer SeqId:6485-59;Target:IGLL1;UniProt:P15814

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6485-59;Target: IGLL1;UniProt: P15814;TargetFullName: Immunoglobulin lambda-like polypeptide 1;Organisim: human;Apparent_Kd_M: 1.857948E-11

Real

Aptamer SeqId: 6485-59 | Target: IGLL1 | UniProt: P15814

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6485-59 | Target: IGLL1 | UniProt: P15814 | TargetFullName: Immunoglobulin lambda-like polypeptide 1 | Organisim: human | Apparent_Kd_M: 1.857948E-11

Real

Aptamer SeqId:6491-59;Target:kallikrein 15;UniProt:Q9H2R5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6491-59;Target: kallikrein 15;UniProt: Q9H2R5;TargetFullName: Kallikrein-15;Organisim: human;Apparent_Kd_M: 1.286854E-12

Real

Aptamer SeqId: 6491-59 | Target: kallikrein 15 | UniProt: Q9H2R5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6491-59 | Target: kallikrein 15 | UniProt: Q9H2R5 | TargetFullName: Kallikrein-15 | Organisim: human | Apparent_Kd_M: 1.286854E-12

Real

Aptamer SeqId:6493-9;Target:CBPZ;UniProt:Q66K79

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6493-9;Target: CBPZ;UniProt: Q66K79;TargetFullName: Carboxypeptidase Z;Organisim: human;Apparent_Kd_M: 5.376207E-11

Real

Aptamer SeqId: 6493-9 | Target: CBPZ | UniProt: Q66K79

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6493-9 | Target: CBPZ | UniProt: Q66K79 | TargetFullName: Carboxypeptidase Z | Organisim: human | Apparent_Kd_M: 5.376207E-11

Real

Aptamer SeqId:6494-60;Target:sperm acrosome associated 5;UniProt:Q96QH8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6494-60;Target: sperm acrosome associated 5;UniProt: Q96QH8;TargetFullName: Sperm acrosome-associated protein 5;Organisim: human;Apparent_Kd_M: 1.824037E-11

Real

Aptamer SeqId: 6494-60 | Target: sperm acrosome associated 5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6494-60 | Target: sperm acrosome associated 5 | UniProt: Q96QH8 | TargetFullName: Sperm acrosome-associated protein 5 | Organisim: human | Apparent_Kd_M: 1.824037E-11

Real

Aptamer SeqId:6495-14;Target:Endothelin 1;UniProt:P05305

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6495-14;Target: Endothelin 1;UniProt: P05305;TargetFullName: Endothelin-1;Organisim: human;Apparent_Kd_M: 1.015502E-11

Real

Aptamer SeqId: 6495-14 | Target: Endothelin 1 | UniProt: P05305

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6495-14 | Target: Endothelin 1 | UniProt: P05305 | TargetFullName: Endothelin-1 | Organisim: human | Apparent_Kd_M: 1.015502E-11

Real

Aptamer SeqId:6496-60;Target:DLK1;UniProt:P80370

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6496-60;Target: DLK1;UniProt: P80370;TargetFullName: Protein delta homolog 1;Organisim: human;Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId: 6496-60 | Target: DLK1 | UniProt: P80370

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6496-60 | Target: DLK1 | UniProt: P80370 | TargetFullName: Protein delta homolog 1 | Organisim: human | Apparent_Kd_M: 1.05E-11

Real

Aptamer SeqId:6497-10;Target:XLRS1;UniProt:O15537

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6497-10;Target: XLRS1;UniProt: O15537;TargetFullName: Retinoschisin;Organisim: human;Apparent_Kd_M: 1.266484E-11

Real

Aptamer SeqId: 6497-10 | Target: XLRS1 | UniProt: O15537

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6497-10 | Target: XLRS1 | UniProt: O15537 | TargetFullName: Retinoschisin | Organisim: human | Apparent_Kd_M: 1.266484E-11

Real

Aptamer SeqId:6504-65;Target:Lysyl oxidase-like protein 2;UniProt:Q9Y4K0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6504-65;Target: Lysyl oxidase-like protein 2;UniProt: Q9Y4K0;TargetFullName: Lysyl oxidase homolog 2;Organisim: human;Apparent_Kd_M: 2.495741E-12

Real

Aptamer SeqId: 6504-65 | Target: Lysyl oxidase-like protein 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6504-65 | Target: Lysyl oxidase-like protein 2 | UniProt: Q9Y4K0 | TargetFullName: Lysyl oxidase homolog 2 | Organisim: human | Apparent_Kd_M: 2.495741E-12

Real

Aptamer SeqId:6506-54;Target:TMEDA;UniProt:P49755

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6506-54;Target: TMEDA;UniProt: P49755;TargetFullName: Transmembrane emp24 domain-containing protein 10;Organisim: human;Apparent_Kd_M: 2.693806E-11

Real

Aptamer SeqId: 6506-54 | Target: TMEDA | UniProt: P49755

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6506-54 | Target: TMEDA | UniProt: P49755 | TargetFullName: Transmembrane emp24 domain-containing protein 10 | Organisim: human | Apparent_Kd_M: 2.693806E-11

Real

Aptamer SeqId:6507-16;Target:NCAM2;UniProt:O15394

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6507-16;Target: NCAM2;UniProt: O15394;TargetFullName: Neural cell adhesion molecule 2;Organisim: human;Apparent_Kd_M: 2.820561E-11

Real

Aptamer SeqId: 6507-16 | Target: NCAM2 | UniProt: O15394

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6507-16 | Target: NCAM2 | UniProt: O15394 | TargetFullName: Neural cell adhesion molecule 2 | Organisim: human | Apparent_Kd_M: 2.820561E-11

Real

Aptamer SeqId:6508-68;Target:SG1D2;UniProt:O95969

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6508-68;Target: SG1D2;UniProt: O95969;TargetFullName: Secretoglobin family 1D member 2;Organisim: human;Apparent_Kd_M: 1.237952E-11

Real

Aptamer SeqId: 6508-68 | Target: SG1D2 | UniProt: O95969

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6508-68 | Target: SG1D2 | UniProt: O95969 | TargetFullName: Secretoglobin family 1D member 2 | Organisim: human | Apparent_Kd_M: 1.237952E-11

Real

Aptamer SeqId:6510-56;Target:RN128;UniProt:Q8TEB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6510-56;Target: RN128;UniProt: Q8TEB7;TargetFullName: E3 ubiquitin-protein ligase RNF128;Organisim: human;Apparent_Kd_M: 1.03E-10

Real

Aptamer SeqId: 6510-56 | Target: RN128 | UniProt: Q8TEB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6510-56 | Target: RN128 | UniProt: Q8TEB7 | TargetFullName: E3 ubiquitin-protein ligase RNF128 | Organisim: human | Apparent_Kd_M: 1.03E-10

Real

Aptamer SeqId:6511-17;Target:F19A4;UniProt:Q96LR4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6511-17;Target: F19A4;UniProt: Q96LR4;TargetFullName: Protein FAM19A4;Organisim: human;Apparent_Kd_M: 1.978868E-11

Real

Aptamer SeqId: 6511-17 | Target: F19A4 | UniProt: Q96LR4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6511-17 | Target: F19A4 | UniProt: Q96LR4 | TargetFullName: Protein FAM19A4 | Organisim: human | Apparent_Kd_M: 1.978868E-11

Real

Aptamer SeqId:6517-14;Target:BMP-3b;UniProt:P55107

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6517-14;Target: BMP-3b;UniProt: P55107;TargetFullName: Growth/differentiation factor 10;Organisim: human;Apparent_Kd_M: 8.11E-12

Real

Aptamer SeqId: 6517-14 | Target: BMP-3b | UniProt: P55107

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6517-14 | Target: BMP-3b | UniProt: P55107 | TargetFullName: Growth/differentiation factor 10 | Organisim: human | Apparent_Kd_M: 8.11E-12

Real

Aptamer SeqId:6518-85;Target:ghrelin;UniProt:Q9UBU3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6518-85;Target: ghrelin;UniProt: Q9UBU3;TargetFullName: Appetite-regulating hormone;Organisim: human;Apparent_Kd_M: 8.42E-12

Real

Aptamer SeqId: 6518-85 | Target: ghrelin | UniProt: Q9UBU3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6518-85 | Target: ghrelin | UniProt: Q9UBU3 | TargetFullName: Appetite-regulating hormone | Organisim: human | Apparent_Kd_M: 8.42E-12

Real

Aptamer SeqId:6520-87;Target:MGP;UniProt:P08493

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6520-87;Target: MGP;UniProt: P08493;TargetFullName: Matrix Gla protein;Organisim: human;Apparent_Kd_M: 6.719876E-12

Real

Aptamer SeqId: 6520-87 | Target: MGP | UniProt: P08493

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6520-87 | Target: MGP | UniProt: P08493 | TargetFullName: Matrix Gla protein | Organisim: human | Apparent_Kd_M: 6.719876E-12

Real

Aptamer SeqId:6521-35;Target:NPTX2;UniProt:P47972

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6521-35;Target: NPTX2;UniProt: P47972;TargetFullName: Neuronal pentraxin-2;Organisim: human;Apparent_Kd_M: 4.062646E-12

Real

Aptamer SeqId: 6521-35 | Target: NPTX2 | UniProt: P47972

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6521-35 | Target: NPTX2 | UniProt: P47972 | TargetFullName: Neuronal pentraxin-2 | Organisim: human | Apparent_Kd_M: 4.062646E-12

Real

Aptamer SeqId:6522-57;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6522-57;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.825209E-11

Real

Aptamer SeqId: 6522-57 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6522-57 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.825209E-11

Real

Aptamer SeqId:6525-17;Target:DUSP13;UniProt:Q6B8I1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6525-17;Target: DUSP13;UniProt: Q6B8I1;TargetFullName: Dual specificity protein phosphatase 13 isoform A;Organisim: human;Apparent_Kd_M: 8.089877E-12

Real

Aptamer SeqId: 6525-17 | Target: DUSP13 | UniProt: Q6B8I1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6525-17 | Target: DUSP13 | UniProt: Q6B8I1 | TargetFullName: Dual specificity protein phosphatase 13 isoform A | Organisim: human | Apparent_Kd_M: 8.089877E-12

Real

Aptamer SeqId:6526-77;Target:OBP2A;UniProt:Q9NY56

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6526-77;Target: OBP2A;UniProt: Q9NY56;TargetFullName: Odorant-binding protein 2a;Organisim: human;Apparent_Kd_M: 2.692759E-12

Real

Aptamer SeqId: 6526-77 | Target: OBP2A | UniProt: Q9NY56

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6526-77 | Target: OBP2A | UniProt: Q9NY56 | TargetFullName: Odorant-binding protein 2a | Organisim: human | Apparent_Kd_M: 2.692759E-12

Real

Aptamer SeqId:6527-1;Target:TRIL;UniProt:Q7L0X0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6527-1;Target: TRIL;UniProt: Q7L0X0;TargetFullName: TLR4 interactor with leucine rich repeats;Organisim: human;Apparent_Kd_M: 4.04E-12

Real

Aptamer SeqId: 6527-1 | Target: TRIL | UniProt: Q7L0X0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6527-1 | Target: TRIL | UniProt: Q7L0X0 | TargetFullName: TLR4 interactor with leucine rich repeats | Organisim: human | Apparent_Kd_M: 4.04E-12

Real

Aptamer SeqId:6528-95;Target:EXTL2;UniProt:Q9UBQ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6528-95;Target: EXTL2;UniProt: Q9UBQ6;TargetFullName: Exostosin-like 2;Organisim: human;Apparent_Kd_M: 2.042332E-11

Real

Aptamer SeqId: 6528-95 | Target: EXTL2 | UniProt: Q9UBQ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6528-95 | Target: EXTL2 | UniProt: Q9UBQ6 | TargetFullName: Exostosin-like 2 | Organisim: human | Apparent_Kd_M: 2.042332E-11

Real

Aptamer SeqId:6530-63;Target:PROL1;UniProt:Q99935

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6530-63;Target: PROL1;UniProt: Q99935;TargetFullName: Opiorphin prepropeptide;Organisim: human;Apparent_Kd_M: 1.493071E-11

Real

Aptamer SeqId: 6530-63 | Target: PROL1 | UniProt: Q99935

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6530-63 | Target: PROL1 | UniProt: Q99935 | TargetFullName: Opiorphin prepropeptide | Organisim: human | Apparent_Kd_M: 1.493071E-11

Real

Aptamer SeqId:6531-29;Target:F162A;UniProt:Q96A26

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6531-29;Target: F162A;UniProt: Q96A26;TargetFullName: Protein FAM162A;Organisim: human;Apparent_Kd_M: 1.822529E-11

Real

Aptamer SeqId: 6531-29 | Target: F162A | UniProt: Q96A26

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6531-29 | Target: F162A | UniProt: Q96A26 | TargetFullName: Protein FAM162A | Organisim: human | Apparent_Kd_M: 1.822529E-11

Real

Aptamer SeqId:6533-20;Target:DNS2B;UniProt:Q8WZ79

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6533-20;Target: DNS2B;UniProt: Q8WZ79;TargetFullName: Deoxyribonuclease-2-beta;Organisim: human;Apparent_Kd_M: 9.64153E-12

Real

Aptamer SeqId: 6533-20 | Target: DNS2B | UniProt: Q8WZ79

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6533-20 | Target: DNS2B | UniProt: Q8WZ79 | TargetFullName: Deoxyribonuclease-2-beta | Organisim: human | Apparent_Kd_M: 9.64153E-12

Real

Aptamer SeqId:6536-54;Target:LAML2;UniProt:Q8NHP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6536-54;Target: LAML2;UniProt: Q8NHP8;TargetFullName: Putative phospholipase B-like 2;Organisim: human;Apparent_Kd_M: 7.482411E-11

Real

Aptamer SeqId: 6536-54 | Target: LAML2 | UniProt: Q8NHP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6536-54 | Target: LAML2 | UniProt: Q8NHP8 | TargetFullName: Putative phospholipase B-like 2 | Organisim: human | Apparent_Kd_M: 7.482411E-11

Real

Aptamer SeqId:6538-90;Target:K2013;UniProt:Q8IYS2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6538-90;Target: K2013;UniProt: Q8IYS2;TargetFullName: Uncharacterized protein KIAA2013;Organisim: human;Apparent_Kd_M: 1.047975E-12

Real

Aptamer SeqId: 6538-90 | Target: K2013 | UniProt: Q8IYS2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6538-90 | Target: K2013 | UniProt: Q8IYS2 | TargetFullName: Uncharacterized protein KIAA2013 | Organisim: human | Apparent_Kd_M: 1.047975E-12

Real

Aptamer SeqId:6543-182;Target:PRRP;UniProt:P81277

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6543-182;Target: PRRP;UniProt: P81277;TargetFullName: Prolactin-releasing peptide;Organisim: human;Apparent_Kd_M: 1.950023E-11

Real

Aptamer SeqId: 6543-182 | Target: PRRP | UniProt: P81277

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6543-182 | Target: PRRP | UniProt: P81277 | TargetFullName: Prolactin-releasing peptide | Organisim: human | Apparent_Kd_M: 1.950023E-11

Real

Aptamer SeqId:6544-33;Target:NELL1;UniProt:Q92832

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6544-33;Target: NELL1;UniProt: Q92832;TargetFullName: Protein kinase C-binding protein NELL1;Organisim: human;Apparent_Kd_M: 6.646086E-12

Real

Aptamer SeqId: 6544-33 | Target: NELL1 | UniProt: Q92832

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6544-33 | Target: NELL1 | UniProt: Q92832 | TargetFullName: Protein kinase C-binding protein NELL1 | Organisim: human | Apparent_Kd_M: 6.646086E-12

Real

Aptamer SeqId:6545-58;Target:PRIO;UniProt:P04156

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6545-58;Target: PRIO;UniProt: P04156;TargetFullName: Major prion protein;Organisim: human;Apparent_Kd_M: 1.259962E-10

Real

Aptamer SeqId: 6545-58 | Target: PRIO | UniProt: P04156

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6545-58 | Target: PRIO | UniProt: P04156 | TargetFullName: Major prion protein | Organisim: human | Apparent_Kd_M: 1.259962E-10

Real

Aptamer SeqId:6547-83;Target:TM11D;UniProt:O60235

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6547-83;Target: TM11D;UniProt: O60235;TargetFullName: Transmembrane protease serine 11D;Organisim: human;Apparent_Kd_M: 1.117375E-11

Real

Aptamer SeqId: 6547-83 | Target: TM11D | UniProt: O60235

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6547-83 | Target: TM11D | UniProt: O60235 | TargetFullName: Transmembrane protease serine 11D | Organisim: human | Apparent_Kd_M: 1.117375E-11

Real

Aptamer SeqId:6549-60;Target:VTM2L;UniProt:Q96N03

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6549-60;Target: VTM2L;UniProt: Q96N03;TargetFullName: V-set and transmembrane domain-containing protein 2-like protein;Organisim: human;Apparent_Kd_M: 2.078715E-12

Real

Aptamer SeqId: 6549-60 | Target: VTM2L | UniProt: Q96N03

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6549-60 | Target: VTM2L | UniProt: Q96N03 | TargetFullName: V-set and transmembrane domain-containing protein 2-like protein | Organisim: human | Apparent_Kd_M: 2.078715E-12

Real

Aptamer SeqId:6550-4;Target:ICAM4;UniProt:Q14773

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6550-4;Target: ICAM4;UniProt: Q14773;TargetFullName: Intercellular adhesion molecule 4;Organisim: human;Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId: 6550-4 | Target: ICAM4 | UniProt: Q14773

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6550-4 | Target: ICAM4 | UniProt: Q14773 | TargetFullName: Intercellular adhesion molecule 4 | Organisim: human | Apparent_Kd_M: 2.43E-11

Real

Aptamer SeqId:6551-94;Target:Vaspin;UniProt:Q8IW75

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6551-94;Target: Vaspin;UniProt: Q8IW75;TargetFullName: Serpin A12;Organisim: human;Apparent_Kd_M: 4.880764E-12

Real

Aptamer SeqId: 6551-94 | Target: Vaspin | UniProt: Q8IW75

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6551-94 | Target: Vaspin | UniProt: Q8IW75 | TargetFullName: Serpin A12 | Organisim: human | Apparent_Kd_M: 4.880764E-12

Real

Aptamer SeqId:6553-68;Target:CCD19;UniProt:Q9UL16

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6553-68;Target: CCD19;UniProt: Q9UL16;TargetFullName: Cilia- and flagella-associated protein 45;Organisim: human;Apparent_Kd_M: 1.002896E-11

Real

Aptamer SeqId: 6553-68 | Target: CCD19 | UniProt: Q9UL16

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6553-68 | Target: CCD19 | UniProt: Q9UL16 | TargetFullName: Cilia- and flagella-associated protein 45 | Organisim: human | Apparent_Kd_M: 1.002896E-11

Real

Aptamer SeqId:6555-58;Target:Stomatin-like protein 2;UniProt:Q9UJZ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6555-58;Target: Stomatin-like protein 2;UniProt: Q9UJZ1;TargetFullName: Stomatin-like protein 2; mitochondrial;Organisim: human;Apparent_Kd_M: 6.53599E-12

Real

Aptamer SeqId: 6555-58 | Target: Stomatin-like protein 2 | UniProt: Q9UJZ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6555-58 | Target: Stomatin-like protein 2 | UniProt: Q9UJZ1 | TargetFullName: Stomatin-like protein 2; mitochondrial | Organisim: human | Apparent_Kd_M: 6.53599E-12

Real

Aptamer SeqId:6556-5;Target:ENPP5;UniProt:Q9UJA9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6556-5;Target: ENPP5;UniProt: Q9UJA9;TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 5;Organisim: human;Apparent_Kd_M: 4.518232E-12

Real

Aptamer SeqId: 6556-5 | Target: ENPP5 | UniProt: Q9UJA9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6556-5 | Target: ENPP5 | UniProt: Q9UJA9 | TargetFullName: Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 | Organisim: human | Apparent_Kd_M: 4.518232E-12

Real

Aptamer SeqId:6557-50;Target:LRC15;UniProt:Q8TF66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6557-50;Target: LRC15;UniProt: Q8TF66;TargetFullName: Leucine-rich repeat-containing protein 15;Organisim: human;Apparent_Kd_M: 4.364592E-12

Real

Aptamer SeqId: 6557-50 | Target: LRC15 | UniProt: Q8TF66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6557-50 | Target: LRC15 | UniProt: Q8TF66 | TargetFullName: Leucine-rich repeat-containing protein 15 | Organisim: human | Apparent_Kd_M: 4.364592E-12

Real

Aptamer SeqId:6558-5;Target:COL10;UniProt:Q9Y6Z7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6558-5;Target: COL10;UniProt: Q9Y6Z7;TargetFullName: Collectin-10;Organisim: human;Apparent_Kd_M: 9.344111E-12

Real

Aptamer SeqId: 6558-5 | Target: COL10 | UniProt: Q9Y6Z7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6558-5 | Target: COL10 | UniProt: Q9Y6Z7 | TargetFullName: Collectin-10 | Organisim: human | Apparent_Kd_M: 9.344111E-12

Real

Aptamer SeqId:6561-77;Target:Ig K chain V-I region HK102-like;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6561-77;Target: Ig K chain V-I region HK102-like;UniProt:;TargetFullName: Ig Kappa chain V-I region HK102- like;Organisim: human;Apparent_Kd_M: 1.011005E-10

Real

Aptamer SeqId: 6561-77 | Target: Ig K chain V-I region HK102-like

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6561-77 | Target: Ig K chain V-I region HK102-like | UniProt: | TargetFullName: Ig Kappa chain V-I region HK102- like | Organisim: human | Apparent_Kd_M: 1.011005E-10

Real

Aptamer SeqId:6563-78;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6563-78;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 5.567233E-12

Real

Aptamer SeqId: 6563-78 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6563-78 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 5.567233E-12

Real

Aptamer SeqId:6570-1;Target:CODA1;UniProt:Q5TAT6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6570-1;Target: CODA1;UniProt: Q5TAT6;TargetFullName: Collagen alpha-1(XIII) chain;Organisim: human;Apparent_Kd_M: 1.422908E-11

Real

Aptamer SeqId: 6570-1 | Target: CODA1 | UniProt: Q5TAT6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6570-1 | Target: CODA1 | UniProt: Q5TAT6 | TargetFullName: Collagen alpha-1(XIII) chain | Organisim: human | Apparent_Kd_M: 1.422908E-11

Real

Aptamer SeqId:6571-75;Target:CQ078;UniProt:Q8N4C9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6571-75;Target: CQ078;UniProt: Q8N4C9;TargetFullName: Uncharacterized protein C17orf78;Organisim: human;Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId: 6571-75 | Target: CQ078 | UniProt: Q8N4C9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6571-75 | Target: CQ078 | UniProt: Q8N4C9 | TargetFullName: Uncharacterized protein C17orf78 | Organisim: human | Apparent_Kd_M: 8.52E-12

Real

Aptamer SeqId:6572-10;Target:LRRT4;UniProt:Q86VH4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6572-10;Target: LRRT4;UniProt: Q86VH4;TargetFullName: Leucine-rich repeat transmembrane neuronal protein 4;Organisim: human;Apparent_Kd_M: 4.58E-12

Real

Aptamer SeqId: 6572-10 | Target: LRRT4 | UniProt: Q86VH4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6572-10 | Target: LRRT4 | UniProt: Q86VH4 | TargetFullName: Leucine-rich repeat transmembrane neuronal protein 4 | Organisim: human | Apparent_Kd_M: 4.58E-12

Real

Aptamer SeqId:6574-11;Target:FAIM3;UniProt:O60667

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6574-11;Target: FAIM3;UniProt: O60667;TargetFullName: Fas apoptotic inhibitory molecule 3;Organisim: human;Apparent_Kd_M: 3.999935E-11

Real

Aptamer SeqId: 6574-11 | Target: FAIM3 | UniProt: O60667

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6574-11 | Target: FAIM3 | UniProt: O60667 | TargetFullName: Fas apoptotic inhibitory molecule 3 | Organisim: human | Apparent_Kd_M: 3.999935E-11

Real

Aptamer SeqId:6576-1;Target:ART4;UniProt:Q93070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6576-1;Target: ART4;UniProt: Q93070;TargetFullName: Ecto-ADP-ribosyltransferase 4;Organisim: human;Apparent_Kd_M: 5.11E-11

Real

Aptamer SeqId: 6576-1 | Target: ART4 | UniProt: Q93070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6576-1 | Target: ART4 | UniProt: Q93070 | TargetFullName: Ecto-ADP-ribosyltransferase 4 | Organisim: human | Apparent_Kd_M: 5.11E-11

Real

Aptamer SeqId:6577-64;Target:LAMA4;UniProt:Q16363

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6577-64;Target: LAMA4;UniProt: Q16363;TargetFullName: Laminin subunit alpha-4;Organisim: human;Apparent_Kd_M: 4.369937E-11

Real

Aptamer SeqId: 6577-64 | Target: LAMA4 | UniProt: Q16363

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6577-64 | Target: LAMA4 | UniProt: Q16363 | TargetFullName: Laminin subunit alpha-4 | Organisim: human | Apparent_Kd_M: 4.369937E-11

Real

Aptamer SeqId:6578-29;Target:TNMD;UniProt:Q9H2S6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6578-29;Target: TNMD;UniProt: Q9H2S6;TargetFullName: Tenomodulin;Organisim: human;Apparent_Kd_M: 1.154869E-11

Real

Aptamer SeqId: 6578-29 | Target: TNMD | UniProt: Q9H2S6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6578-29 | Target: TNMD | UniProt: Q9H2S6 | TargetFullName: Tenomodulin | Organisim: human | Apparent_Kd_M: 1.154869E-11

Real

Aptamer SeqId:6580-29;Target:Pregnancy zone protein;UniProt:P20742

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6580-29;Target: Pregnancy zone protein;UniProt: P20742;TargetFullName: Pregnancy zone protein;Organisim: human;Apparent_Kd_M: 5.383221E-11

Real

Aptamer SeqId: 6580-29 | Target: Pregnancy zone protein | UniProt: P20742

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6580-29 | Target: Pregnancy zone protein | UniProt: P20742 | TargetFullName: Pregnancy zone protein | Organisim: human | Apparent_Kd_M: 5.383221E-11

Real

Aptamer SeqId:6584-1;Target:SRCH;UniProt:P23327

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6584-1;Target: SRCH;UniProt: P23327;TargetFullName: Sarcoplasmic reticulum histidine-rich calcium-binding protein;Organisim: human;Apparent_Kd_M: 2.427834E-11

Real

Aptamer SeqId: 6584-1 | Target: SRCH | UniProt: P23327

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6584-1 | Target: SRCH | UniProt: P23327 | TargetFullName: Sarcoplasmic reticulum histidine-rich calcium-binding protein | Organisim: human | Apparent_Kd_M: 2.427834E-11

Real

Aptamer SeqId:6586-19;Target:ADA11;UniProt:O75078

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6586-19;Target: ADA11;UniProt: O75078;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 11;Organisim: human;Apparent_Kd_M: 4.814859E-12

Real

Aptamer SeqId: 6586-19 | Target: ADA11 | UniProt: O75078

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6586-19 | Target: ADA11 | UniProt: O75078 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 11 | Organisim: human | Apparent_Kd_M: 4.814859E-12

Real

Aptamer SeqId:6587-6;Target:LRFN5;UniProt:Q96NI6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6587-6;Target: LRFN5;UniProt: Q96NI6;TargetFullName: Leucine-rich repeat and fibronectin type-III domain-containing protein 5;Organisim: human;Apparent_Kd_M: 5.884121E-12

Real

Aptamer SeqId: 6587-6 | Target: LRFN5 | UniProt: Q96NI6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6587-6 | Target: LRFN5 | UniProt: Q96NI6 | TargetFullName: Leucine-rich repeat and fibronectin type-III domain-containing protein 5 | Organisim: human | Apparent_Kd_M: 5.884121E-12

Real

Aptamer SeqId:6593-5;Target:GALT3;UniProt:Q14435

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6593-5;Target: GALT3;UniProt: Q14435;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 3;Organisim: human;Apparent_Kd_M: 9.146254E-12

Real

Aptamer SeqId: 6593-5 | Target: GALT3 | UniProt: Q14435

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6593-5 | Target: GALT3 | UniProt: Q14435 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 3 | Organisim: human | Apparent_Kd_M: 9.146254E-12

Real

Aptamer SeqId:6594-64;Target:SMDC1;UniProt:Q9NPB0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6594-64;Target: SMDC1;UniProt: Q9NPB0;TargetFullName: SAYSvFN domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.791185E-11

Real

Aptamer SeqId: 6594-64 | Target: SMDC1 | UniProt: Q9NPB0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6594-64 | Target: SMDC1 | UniProt: Q9NPB0 | TargetFullName: SAYSvFN domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.791185E-11

Real

Aptamer SeqId:6597-24;Target:TM157;UniProt:Q8TBP5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6597-24;Target: TM157;UniProt: Q8TBP5;TargetFullName: Membrane protein FAM174A;Organisim: human;Apparent_Kd_M: 2.915167E-12

Real

Aptamer SeqId: 6597-24 | Target: TM157 | UniProt: Q8TBP5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6597-24 | Target: TM157 | UniProt: Q8TBP5 | TargetFullName: Membrane protein FAM174A | Organisim: human | Apparent_Kd_M: 2.915167E-12

Real

Aptamer SeqId:6599-5;Target:APCD1;UniProt:Q8J025

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6599-5;Target: APCD1;UniProt: Q8J025;TargetFullName: Protein APCDD1;Organisim: human;Apparent_Kd_M: 2.948456E-12

Real

Aptamer SeqId: 6599-5 | Target: APCD1 | UniProt: Q8J025

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6599-5 | Target: APCD1 | UniProt: Q8J025 | TargetFullName: Protein APCDD1 | Organisim: human | Apparent_Kd_M: 2.948456E-12

Real

Aptamer SeqId:6600-70;Target:RELL2;UniProt:Q8NC24

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6600-70;Target: RELL2;UniProt: Q8NC24;TargetFullName: RELT-like protein 2;Organisim: human;Apparent_Kd_M: 5.272156E-11

Real

Aptamer SeqId: 6600-70 | Target: RELL2 | UniProt: Q8NC24

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6600-70 | Target: RELL2 | UniProt: Q8NC24 | TargetFullName: RELT-like protein 2 | Organisim: human | Apparent_Kd_M: 5.272156E-11

Real

Aptamer SeqId:6603-18;Target:KALM;UniProt:P23352

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6603-18;Target: KALM;UniProt: P23352;TargetFullName: Anosmin-1;Organisim: human;Apparent_Kd_M: 5.413777E-11

Real

Aptamer SeqId: 6603-18 | Target: KALM | UniProt: P23352

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6603-18 | Target: KALM | UniProt: P23352 | TargetFullName: Anosmin-1 | Organisim: human | Apparent_Kd_M: 5.413777E-11

Real

Aptamer SeqId:6604-59;Target:CD031;UniProt:Q8TB73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6604-59;Target: CD031;UniProt: Q8TB73;TargetFullName: Protein NDNF;Organisim: human;Apparent_Kd_M: 2.366832E-11

Real

Aptamer SeqId: 6604-59 | Target: CD031 | UniProt: Q8TB73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6604-59 | Target: CD031 | UniProt: Q8TB73 | TargetFullName: Protein NDNF | Organisim: human | Apparent_Kd_M: 2.366832E-11

Real

Aptamer SeqId:6605-17;Target:IGFALS;UniProt:P35858

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6605-17;Target: IGFALS;UniProt: P35858;TargetFullName: Insulin-like growth factor-binding protein complex acid labile subunit;Organisim: human;Apparent_Kd_M: 2.611866E-12

Real

Aptamer SeqId: 6605-17 | Target: IGFALS | UniProt: P35858

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6605-17 | Target: IGFALS | UniProt: P35858 | TargetFullName: Insulin-like growth factor-binding protein complex acid labile subunit | Organisim: human | Apparent_Kd_M: 2.611866E-12

Real

Aptamer SeqId:6606-61;Target:KISS1;UniProt:Q15726

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6606-61;Target: KISS1;UniProt: Q15726;TargetFullName: Metastasis-suppressor KiSS-1;Organisim: human;Apparent_Kd_M: 6.556847E-11

Real

Aptamer SeqId: 6606-61 | Target: KISS1 | UniProt: Q15726

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6606-61 | Target: KISS1 | UniProt: Q15726 | TargetFullName: Metastasis-suppressor KiSS-1 | Organisim: human | Apparent_Kd_M: 6.556847E-11

Real

Aptamer SeqId:6609-22;Target:CN37;UniProt:P09543

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6609-22;Target: CN37;UniProt: P09543;TargetFullName: 2;3-cyclic-nucleotide 3-phosphodiesterase;Organisim: human;Apparent_Kd_M: 4.690567E-12

Real

Aptamer SeqId: 6609-22 | Target: CN37 | UniProt: P09543

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6609-22 | Target: CN37 | UniProt: P09543 | TargetFullName: 2';3'-cyclic-nucleotide 3'-phosphodiesterase | Organisim: human | Apparent_Kd_M: 4.690567E-12

Real

Aptamer SeqId:6611-8;Target:KDEL1;UniProt:Q6UW63

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6611-8;Target: KDEL1;UniProt: Q6UW63;TargetFullName: KDEL motif-containing protein 1;Organisim: human;Apparent_Kd_M: 5.244319E-12

Real

Aptamer SeqId: 6611-8 | Target: KDEL1 | UniProt: Q6UW63

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6611-8 | Target: KDEL1 | UniProt: Q6UW63 | TargetFullName: KDEL motif-containing protein 1 | Organisim: human | Apparent_Kd_M: 5.244319E-12

Real

Aptamer SeqId:6612-90;Target:CP079;UniProt:Q6PL45

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6612-90;Target: CP079;UniProt: Q6PL45;TargetFullName: BRICHOS domain-containing protein 5;Organisim: human;Apparent_Kd_M: 1.308895E-11

Real

Aptamer SeqId: 6612-90 | Target: CP079 | UniProt: Q6PL45

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6612-90 | Target: CP079 | UniProt: Q6PL45 | TargetFullName: BRICHOS domain-containing protein 5 | Organisim: human | Apparent_Kd_M: 1.308895E-11

Real

Aptamer SeqId:6617-12;Target:FCRL6;UniProt:Q6DN72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6617-12;Target: FCRL6;UniProt: Q6DN72;TargetFullName: Fc receptor-like protein 6;Organisim: human;Apparent_Kd_M: 8.3941E-12

Real

Aptamer SeqId: 6617-12 | Target: FCRL6 | UniProt: Q6DN72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6617-12 | Target: FCRL6 | UniProt: Q6DN72 | TargetFullName: Fc receptor-like protein 6 | Organisim: human | Apparent_Kd_M: 8.3941E-12

Real

Aptamer SeqId:6620-82;Target:LIGO1;UniProt:Q96FE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6620-82;Target: LIGO1;UniProt: Q96FE5;TargetFullName: Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1;Organisim: human;Apparent_Kd_M: 1.052755E-11

Real

Aptamer SeqId: 6620-82 | Target: LIGO1 | UniProt: Q96FE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6620-82 | Target: LIGO1 | UniProt: Q96FE5 | TargetFullName: Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 | Organisim: human | Apparent_Kd_M: 1.052755E-11

Real

Aptamer SeqId:6621-10;Target:REL2;UniProt:P04090

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6621-10;Target: REL2;UniProt: P04090;TargetFullName: Prorelaxin H2;Organisim: human;Apparent_Kd_M: 5.453934E-12

Real

Aptamer SeqId: 6621-10 | Target: REL2 | UniProt: P04090

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6621-10 | Target: REL2 | UniProt: P04090 | TargetFullName: Prorelaxin H2 | Organisim: human | Apparent_Kd_M: 5.453934E-12

Real

Aptamer SeqId:6622-90;Target:APEL;UniProt:Q9ULZ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6622-90;Target: APEL;UniProt: Q9ULZ1;TargetFullName: Apelin;Organisim: human;Apparent_Kd_M: 2.582089E-11

Real

Aptamer SeqId: 6622-90 | Target: APEL | UniProt: Q9ULZ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6622-90 | Target: APEL | UniProt: Q9ULZ1 | TargetFullName: Apelin | Organisim: human | Apparent_Kd_M: 2.582089E-11

Real

Aptamer SeqId:6624-94;Target:WNT11;UniProt:O96014

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6624-94;Target: WNT11;UniProt: O96014;TargetFullName: Protein Wnt-11;Organisim: human;Apparent_Kd_M: 2.228506E-11

Real

Aptamer SeqId: 6624-94 | Target: WNT11 | UniProt: O96014

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6624-94 | Target: WNT11 | UniProt: O96014 | TargetFullName: Protein Wnt-11 | Organisim: human | Apparent_Kd_M: 2.228506E-11

Real

Aptamer SeqId:6625-31;Target:ATAD1;UniProt:Q8NBU5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6625-31;Target: ATAD1;UniProt: Q8NBU5;TargetFullName: ATPase family AAA domain-containing protein 1;Organisim: human;Apparent_Kd_M: 8.519485E-12

Real

Aptamer SeqId: 6625-31 | Target: ATAD1 | UniProt: Q8NBU5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6625-31 | Target: ATAD1 | UniProt: Q8NBU5 | TargetFullName: ATPase family AAA domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 8.519485E-12

Real

Aptamer SeqId:6626-81;Target:CHSTC;UniProt:Q9NRB3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6626-81;Target: CHSTC;UniProt: Q9NRB3;TargetFullName: Carbohydrate sulfotransferase 12;Organisim: human;Apparent_Kd_M: 2.549013E-11

Real

Aptamer SeqId: 6626-81 | Target: CHSTC | UniProt: Q9NRB3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6626-81 | Target: CHSTC | UniProt: Q9NRB3 | TargetFullName: Carbohydrate sulfotransferase 12 | Organisim: human | Apparent_Kd_M: 2.549013E-11

Real

Aptamer SeqId:6627-25;Target:LIPR1;UniProt:P54315

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6627-25;Target: LIPR1;UniProt: P54315;TargetFullName: Inactive pancreatic lipase-related protein 1;Organisim: human;Apparent_Kd_M: 4.14632E-12

Real

Aptamer SeqId: 6627-25 | Target: LIPR1 | UniProt: P54315

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6627-25 | Target: LIPR1 | UniProt: P54315 | TargetFullName: Inactive pancreatic lipase-related protein 1 | Organisim: human | Apparent_Kd_M: 4.14632E-12

Real

Aptamer SeqId:6629-3;Target:HBD-1;UniProt:P60022

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6629-3;Target: HBD-1;UniProt: P60022;TargetFullName: Beta-defensin 1;Organisim: human;Apparent_Kd_M: 4.494471E-12

Real

Aptamer SeqId: 6629-3 | Target: HBD-1 | UniProt: P60022

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6629-3 | Target: HBD-1 | UniProt: P60022 | TargetFullName: Beta-defensin 1 | Organisim: human | Apparent_Kd_M: 4.494471E-12

Real

Aptamer SeqId:6631-17;Target:CO9A1;UniProt:P20849

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6631-17;Target: CO9A1;UniProt: P20849;TargetFullName: Collagen alpha-1(IX) chain;Organisim: human;Apparent_Kd_M: 7.41E-12

Real

Aptamer SeqId: 6631-17 | Target: CO9A1 | UniProt: P20849

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6631-17 | Target: CO9A1 | UniProt: P20849 | TargetFullName: Collagen alpha-1(IX) chain | Organisim: human | Apparent_Kd_M: 7.41E-12

Real

Aptamer SeqId:6633-43;Target:UPK3L;UniProt:B0FP48

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6633-43;Target: UPK3L;UniProt: B0FP48;TargetFullName: Uroplakin-3b-like protein;Organisim: human;Apparent_Kd_M: 2.688382E-11

Real

Aptamer SeqId: 6633-43 | Target: UPK3L | UniProt: B0FP48

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6633-43 | Target: UPK3L | UniProt: B0FP48 | TargetFullName: Uroplakin-3b-like protein | Organisim: human | Apparent_Kd_M: 2.688382E-11

Real

Aptamer SeqId:6641-60;Target:PolyUbiquitin K48;UniProt:P0CG47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6641-60;Target: PolyUbiquitin K48;UniProt: P0CG47;TargetFullName: PolyUbiquitin K48-linked;Organisim: human;Apparent_Kd_M: 7.9E-12

Real

Aptamer SeqId: 6641-60 | Target: PolyUbiquitin K48 | UniProt: P0CG47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6641-60 | Target: PolyUbiquitin K48 | UniProt: P0CG47 | TargetFullName: PolyUbiquitin K48-linked | Organisim: human | Apparent_Kd_M: 7.9E-12

Real

Aptamer SeqId:6647-55;Target:PolyUbiquitin K63;UniProt:P0CG48

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6647-55;Target: PolyUbiquitin K63;UniProt: P0CG48;TargetFullName: PolyUbiquitin K63-linked;Organisim: human;Apparent_Kd_M: 1.44E-12

Real

Aptamer SeqId: 6647-55 | Target: PolyUbiquitin K63 | UniProt: P0CG48

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6647-55 | Target: PolyUbiquitin K63 | UniProt: P0CG48 | TargetFullName: PolyUbiquitin K63-linked | Organisim: human | Apparent_Kd_M: 1.44E-12

Real

Aptamer SeqId:6649-51;Target:NET1;UniProt:O95631

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6649-51;Target: NET1;UniProt: O95631;TargetFullName: Netrin-1;Organisim: human;Apparent_Kd_M: 4.93E-11

Real

Aptamer SeqId: 6649-51 | Target: NET1 | UniProt: O95631

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6649-51 | Target: NET1 | UniProt: O95631 | TargetFullName: Netrin-1 | Organisim: human | Apparent_Kd_M: 4.93E-11

Real

Aptamer SeqId:6651-74;Target:PolyUbiquitin K48;UniProt:P0CG47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6651-74;Target: PolyUbiquitin K48;UniProt: P0CG47;TargetFullName: PolyUbiquitin K48-linked;Organisim: human;Apparent_Kd_M: 1.23E-11

Real

Aptamer SeqId: 6651-74 | Target: PolyUbiquitin K48 | UniProt: P0CG47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6651-74 | Target: PolyUbiquitin K48 | UniProt: P0CG47 | TargetFullName: PolyUbiquitin K48-linked | Organisim: human | Apparent_Kd_M: 1.23E-11

Real

Aptamer SeqId:6653-58;Target:CD47;UniProt:Q08722

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6653-58;Target: CD47;UniProt: Q08722;TargetFullName: Leukocyte surface antigen CD47;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 6653-58 | Target: CD47 | UniProt: Q08722

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6653-58 | Target: CD47 | UniProt: Q08722 | TargetFullName: Leukocyte surface antigen CD47 | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:6706-18;Target:PPBN;UniProt:P10696

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6706-18;Target: PPBN;UniProt: P10696;TargetFullName: Alkaline phosphatase; placental-like;Organisim: human;Apparent_Kd_M: 2.21E-11

Real

Aptamer SeqId: 6706-18 | Target: PPBN | UniProt: P10696

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6706-18 | Target: PPBN | UniProt: P10696 | TargetFullName: Alkaline phosphatase; placental-like | Organisim: human | Apparent_Kd_M: 2.21E-11

Real

Aptamer SeqId:6713-4;Target:LRP11;UniProt:Q86VZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6713-4;Target: LRP11;UniProt: Q86VZ4;TargetFullName: Low-density lipoprotein receptor-related protein 11;Organisim: human;Apparent_Kd_M: 4.292451E-11

Real

Aptamer SeqId: 6713-4 | Target: LRP11 | UniProt: Q86VZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6713-4 | Target: LRP11 | UniProt: Q86VZ4 | TargetFullName: Low-density lipoprotein receptor-related protein 11 | Organisim: human | Apparent_Kd_M: 4.292451E-11

Real

Aptamer SeqId:6715-63;Target:PPBN;UniProt:P10696

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6715-63;Target: PPBN;UniProt: P10696;TargetFullName: Alkaline phosphatase; placental-like;Organisim: human;Apparent_Kd_M: 4.026601E-11

Real

Aptamer SeqId: 6715-63 | Target: PPBN | UniProt: P10696

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6715-63 | Target: PPBN | UniProt: P10696 | TargetFullName: Alkaline phosphatase; placental-like | Organisim: human | Apparent_Kd_M: 4.026601E-11

Real

Aptamer SeqId:6895-1;Target:TR;UniProt:P02786

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6895-1;Target: TR;UniProt: P02786;TargetFullName: Transferrin receptor protein 1;Organisim: human;Apparent_Kd_M: 4.27E-11

Real

Aptamer SeqId: 6895-1 | Target: TR | UniProt: P02786

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6895-1 | Target: TR | UniProt: P02786 | TargetFullName: Transferrin receptor protein 1 | Organisim: human | Apparent_Kd_M: 4.27E-11

Real

Aptamer SeqId:6896-3;Target:CA162;UniProt:Q8NEQ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6896-3;Target: CA162;UniProt: Q8NEQ5;TargetFullName: Transmembrane protein C1orf162;Organisim: human;Apparent_Kd_M: 2.55758E-11

Real

Aptamer SeqId: 6896-3 | Target: CA162 | UniProt: Q8NEQ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6896-3 | Target: CA162 | UniProt: Q8NEQ5 | TargetFullName: Transmembrane protein C1orf162 | Organisim: human | Apparent_Kd_M: 2.55758E-11

Real

Aptamer SeqId:6897-38;Target:B3GA3;UniProt:O94766

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6897-38;Target: B3GA3;UniProt: O94766;TargetFullName: Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3;Organisim: human;Apparent_Kd_M: 3.963414E-10

Real

Aptamer SeqId: 6897-38 | Target: B3GA3 | UniProt: O94766

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6897-38 | Target: B3GA3 | UniProt: O94766 | TargetFullName: Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 | Organisim: human | Apparent_Kd_M: 3.963414E-10

Real

Aptamer SeqId:6899-37;Target:PHS2;UniProt:Q9H0N5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6899-37;Target: PHS2;UniProt: Q9H0N5;TargetFullName: Pterin-4-alpha-carbinolamine dehydratase 2;Organisim: human;Apparent_Kd_M: 1.120383E-11

Real

Aptamer SeqId: 6899-37 | Target: PHS2 | UniProt: Q9H0N5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6899-37 | Target: PHS2 | UniProt: Q9H0N5 | TargetFullName: Pterin-4-alpha-carbinolamine dehydratase 2 | Organisim: human | Apparent_Kd_M: 1.120383E-11

Real

Aptamer SeqId:6900-30;Target:UB2J1;UniProt:Q9Y385

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6900-30;Target: UB2J1;UniProt: Q9Y385;TargetFullName: Ubiquitin-conjugating enzyme E2 J1;Organisim: human;Apparent_Kd_M: 5.088807E-11

Real

Aptamer SeqId: 6900-30 | Target: UB2J1 | UniProt: Q9Y385

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6900-30 | Target: UB2J1 | UniProt: Q9Y385 | TargetFullName: Ubiquitin-conjugating enzyme E2 J1 | Organisim: human | Apparent_Kd_M: 5.088807E-11

Real

Aptamer SeqId:6904-14;Target:LRRT2;UniProt:O43300

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6904-14;Target: LRRT2;UniProt: O43300;TargetFullName: Leucine-rich repeat transmembrane neuronal protein 2;Organisim: human;Apparent_Kd_M: 6.27471E-13

Real

Aptamer SeqId: 6904-14 | Target: LRRT2 | UniProt: O43300

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6904-14 | Target: LRRT2 | UniProt: O43300 | TargetFullName: Leucine-rich repeat transmembrane neuronal protein 2 | Organisim: human | Apparent_Kd_M: 6.27471E-13

Real

Aptamer SeqId:6907-17;Target:TMC5A;UniProt:Q8N6Q1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6907-17;Target: TMC5A;UniProt: Q8N6Q1;TargetFullName: Transmembrane and coiled-coil domain-containing protein 5A;Organisim: human;Apparent_Kd_M: 8.331894E-11

Real

Aptamer SeqId: 6907-17 | Target: TMC5A | UniProt: Q8N6Q1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6907-17 | Target: TMC5A | UniProt: Q8N6Q1 | TargetFullName: Transmembrane and coiled-coil domain-containing protein 5A | Organisim: human | Apparent_Kd_M: 8.331894E-11

Real

Aptamer SeqId:6909-40;Target:MGAT2;UniProt:Q10469

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6909-40;Target: MGAT2;UniProt: Q10469;TargetFullName: Alpha-1;6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase;Organisim: human;Apparent_Kd_M: 2.312675E-11

Real

Aptamer SeqId: 6909-40 | Target: MGAT2 | UniProt: Q10469

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6909-40 | Target: MGAT2 | UniProt: Q10469 | TargetFullName: Alpha-1;6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Organisim: human | Apparent_Kd_M: 2.312675E-11

Real

Aptamer SeqId:6911-103;Target:CLC6A;UniProt:Q6EIG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6911-103;Target: CLC6A;UniProt: Q6EIG7;TargetFullName: C-type lectin domain family 6 member A;Organisim: human;Apparent_Kd_M: 1.152124E-11

Real

Aptamer SeqId: 6911-103 | Target: CLC6A | UniProt: Q6EIG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6911-103 | Target: CLC6A | UniProt: Q6EIG7 | TargetFullName: C-type lectin domain family 6 member A | Organisim: human | Apparent_Kd_M: 1.152124E-11

Real

Aptamer SeqId:6912-6;Target:EFHA2;UniProt:Q86XE3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6912-6;Target: EFHA2;UniProt: Q86XE3;TargetFullName: Calcium uptake protein 3; mitochondrial;Organisim: human;Apparent_Kd_M: 3.796102E-12

Real

Aptamer SeqId: 6912-6 | Target: EFHA2 | UniProt: Q86XE3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6912-6 | Target: EFHA2 | UniProt: Q86XE3 | TargetFullName: Calcium uptake protein 3; mitochondrial | Organisim: human | Apparent_Kd_M: 3.796102E-12

Real

Aptamer SeqId:6913-189;Target:HMG-2;UniProt:P26583

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6913-189;Target: HMG-2;UniProt: P26583;TargetFullName: High mobility group protein B2;Organisim: human;Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId: 6913-189 | Target: HMG-2 | UniProt: P26583

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6913-189 | Target: HMG-2 | UniProt: P26583 | TargetFullName: High mobility group protein B2 | Organisim: human | Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId:6915-2;Target:C16L2;UniProt:Q6UWJ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6915-2;Target: C16L2;UniProt: Q6UWJ8;TargetFullName: CD164 sialomucin-like 2 protein;Organisim: human;Apparent_Kd_M: 1.169193E-10

Real

Aptamer SeqId: 6915-2 | Target: C16L2 | UniProt: Q6UWJ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6915-2 | Target: C16L2 | UniProt: Q6UWJ8 | TargetFullName: CD164 sialomucin-like 2 protein | Organisim: human | Apparent_Kd_M: 1.169193E-10

Real

Aptamer SeqId:6917-49;Target:LRRC3;UniProt:Q9BY71

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6917-49;Target: LRRC3;UniProt: Q9BY71;TargetFullName: Leucine-rich repeat-containing protein 3;Organisim: human;Apparent_Kd_M: 2.531386E-12

Real

Aptamer SeqId: 6917-49 | Target: LRRC3 | UniProt: Q9BY71

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6917-49 | Target: LRRC3 | UniProt: Q9BY71 | TargetFullName: Leucine-rich repeat-containing protein 3 | Organisim: human | Apparent_Kd_M: 2.531386E-12

Real

Aptamer SeqId:6918-183;Target:CCKN;UniProt:P06307

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6918-183;Target: CCKN;UniProt: P06307;TargetFullName: Cholecystokinin;Organisim: human;Apparent_Kd_M: 3.014752E-11

Real

Aptamer SeqId: 6918-183 | Target: CCKN | UniProt: P06307

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6918-183 | Target: CCKN | UniProt: P06307 | TargetFullName: Cholecystokinin | Organisim: human | Apparent_Kd_M: 3.014752E-11

Real

Aptamer SeqId:6919-3;Target:HBAZ;UniProt:P02008

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6919-3;Target: HBAZ;UniProt: P02008;TargetFullName: Hemoglobin subunit zeta;Organisim: human;Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId: 6919-3 | Target: HBAZ | UniProt: P02008

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6919-3 | Target: HBAZ | UniProt: P02008 | TargetFullName: Hemoglobin subunit zeta | Organisim: human | Apparent_Kd_M: 1.12E-11

Real

Aptamer SeqId:6920-1;Target:GFRAL;UniProt:Q6UXV0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6920-1;Target: GFRAL;UniProt: Q6UXV0;TargetFullName: GDNF family receptor alpha-like;Organisim: human;Apparent_Kd_M: 2.846468E-12

Real

Aptamer SeqId: 6920-1 | Target: GFRAL | UniProt: Q6UXV0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6920-1 | Target: GFRAL | UniProt: Q6UXV0 | TargetFullName: GDNF family receptor alpha-like | Organisim: human | Apparent_Kd_M: 2.846468E-12

Real

Aptamer SeqId:6921-24;Target:B4GT3;UniProt:O60512

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6921-24;Target: B4GT3;UniProt: O60512;TargetFullName: Beta-1;4-galactosyltransferase 3;Organisim: human;Apparent_Kd_M: 5.875243E-11

Real

Aptamer SeqId: 6921-24 | Target: B4GT3 | UniProt: O60512

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6921-24 | Target: B4GT3 | UniProt: O60512 | TargetFullName: Beta-1;4-galactosyltransferase 3 | Organisim: human | Apparent_Kd_M: 5.875243E-11

Real

Aptamer SeqId:6923-1;Target:PLOD2;UniProt:O00469

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6923-1;Target: PLOD2;UniProt: O00469;TargetFullName: Procollagen-lysine;2-oxoglutarate 5-dioxygenase 2;Organisim: human;Apparent_Kd_M: 6.53E-12

Real

Aptamer SeqId: 6923-1 | Target: PLOD2 | UniProt: O00469

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6923-1 | Target: PLOD2 | UniProt: O00469 | TargetFullName: Procollagen-lysine;2-oxoglutarate 5-dioxygenase 2 | Organisim: human | Apparent_Kd_M: 6.53E-12

Real

Aptamer SeqId:6925-26;Target:SNX8;UniProt:Q9Y5X2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6925-26;Target: SNX8;UniProt: Q9Y5X2;TargetFullName: Sorting nexin-8;Organisim: human;Apparent_Kd_M: 6.169727E-12

Real

Aptamer SeqId: 6925-26 | Target: SNX8 | UniProt: Q9Y5X2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6925-26 | Target: SNX8 | UniProt: Q9Y5X2 | TargetFullName: Sorting nexin-8 | Organisim: human | Apparent_Kd_M: 6.169727E-12

Real

Aptamer SeqId:6927-7;Target:NDST1;UniProt:P52848

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6927-7;Target: NDST1;UniProt: P52848;TargetFullName: Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1;Organisim: human;Apparent_Kd_M: 8.073237E-13

Real

Aptamer SeqId: 6927-7 | Target: NDST1 | UniProt: P52848

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6927-7 | Target: NDST1 | UniProt: P52848 | TargetFullName: Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 | Organisim: human | Apparent_Kd_M: 8.073237E-13

Real

Aptamer SeqId:6929-10;Target:SIA8C;UniProt:O43173

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6929-10;Target: SIA8C;UniProt: O43173;TargetFullName: Sia-alpha-2;3-Gal-beta-1;4-GlcNAc-R:alpha 2;8-sialyltransferase;Organisim: human;Apparent_Kd_M: 4.993419E-12

Real

Aptamer SeqId: 6929-10 | Target: SIA8C | UniProt: O43173

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6929-10 | Target: SIA8C | UniProt: O43173 | TargetFullName: Sia-alpha-2;3-Gal-beta-1;4-GlcNAc-R:alpha 2;8-sialyltransferase | Organisim: human | Apparent_Kd_M: 4.993419E-12

Real

Aptamer SeqId:6930-95;Target:SIA8F;UniProt:P61647

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6930-95;Target: SIA8F;UniProt: P61647;TargetFullName: Alpha-2;8-sialyltransferase 8F;Organisim: human;Apparent_Kd_M: 1.043889E-10

Real

Aptamer SeqId: 6930-95 | Target: SIA8F | UniProt: P61647

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6930-95 | Target: SIA8F | UniProt: P61647 | TargetFullName: Alpha-2;8-sialyltransferase 8F | Organisim: human | Apparent_Kd_M: 1.043889E-10

Real

Aptamer SeqId:6932-42;Target:ITA5;UniProt:P08648

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6932-42;Target: ITA5;UniProt: P08648;TargetFullName: Integrin alpha-5;Organisim: human;Apparent_Kd_M: 2.230537E-10

Real

Aptamer SeqId: 6932-42 | Target: ITA5 | UniProt: P08648

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6932-42 | Target: ITA5 | UniProt: P08648 | TargetFullName: Integrin alpha-5 | Organisim: human | Apparent_Kd_M: 2.230537E-10

Real

Aptamer SeqId:6933-20;Target:RM34;UniProt:Q9BQ48

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6933-20;Target: RM34;UniProt: Q9BQ48;TargetFullName: 39S ribosomal protein L34; mitochondrial;Organisim: human;Apparent_Kd_M: 1.776216E-11

Real

Aptamer SeqId: 6933-20 | Target: RM34 | UniProt: Q9BQ48

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6933-20 | Target: RM34 | UniProt: Q9BQ48 | TargetFullName: 39S ribosomal protein L34; mitochondrial | Organisim: human | Apparent_Kd_M: 1.776216E-11

Real

Aptamer SeqId:6934-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6934-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.603209E-11

Real

Aptamer SeqId: 6934-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6934-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.603209E-11

Real

Aptamer SeqId:6936-7;Target:PMEPA;UniProt:Q969W9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6936-7;Target: PMEPA;UniProt: Q969W9;TargetFullName: Protein TMEPAI;Organisim: human;Apparent_Kd_M: 7.35848E-12

Real

Aptamer SeqId: 6936-7 | Target: PMEPA | UniProt: Q969W9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6936-7 | Target: PMEPA | UniProt: Q969W9 | TargetFullName: Protein TMEPAI | Organisim: human | Apparent_Kd_M: 7.35848E-12

Real

Aptamer SeqId:6937-251;Target:CA043;UniProt:Q9BWL3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6937-251;Target: CA043;UniProt: Q9BWL3;TargetFullName: Uncharacterized protein C1orf43;Organisim: human;Apparent_Kd_M: 1.464564E-11

Real

Aptamer SeqId: 6937-251 | Target: CA043 | UniProt: Q9BWL3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6937-251 | Target: CA043 | UniProt: Q9BWL3 | TargetFullName: Uncharacterized protein C1orf43 | Organisim: human | Apparent_Kd_M: 1.464564E-11

Real

Aptamer SeqId:6938-21;Target:PCDGC;UniProt:O60330

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6938-21;Target: PCDGC;UniProt: O60330;TargetFullName: Protocadherin gamma-A12;Organisim: human;Apparent_Kd_M: 1.151376E-10

Real

Aptamer SeqId: 6938-21 | Target: PCDGC | UniProt: O60330

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6938-21 | Target: PCDGC | UniProt: O60330 | TargetFullName: Protocadherin gamma-A12 | Organisim: human | Apparent_Kd_M: 1.151376E-10

Real

Aptamer SeqId:6940-18;Target:JPH1;UniProt:Q9HDC5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6940-18;Target: JPH1;UniProt: Q9HDC5;TargetFullName: Junctophilin-1;Organisim: human;Apparent_Kd_M: 1.269947E-11

Real

Aptamer SeqId: 6940-18 | Target: JPH1 | UniProt: Q9HDC5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6940-18 | Target: JPH1 | UniProt: Q9HDC5 | TargetFullName: Junctophilin-1 | Organisim: human | Apparent_Kd_M: 1.269947E-11

Real

Aptamer SeqId:6941-11;Target:SUMF1;UniProt:Q8NBK3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6941-11;Target: SUMF1;UniProt: Q8NBK3;TargetFullName: Sulfatase-modifying factor 1;Organisim: human;Apparent_Kd_M: 1.987705E-10

Real

Aptamer SeqId: 6941-11 | Target: SUMF1 | UniProt: Q8NBK3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6941-11 | Target: SUMF1 | UniProt: Q8NBK3 | TargetFullName: Sulfatase-modifying factor 1 | Organisim: human | Apparent_Kd_M: 1.987705E-10

Real

Aptamer SeqId:6947-4;Target:SIA10;UniProt:Q9Y274

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6947-4;Target: SIA10;UniProt: Q9Y274;TargetFullName: Type 2 lactosamine alpha-2;3-sialyltransferase;Organisim: human;Apparent_Kd_M: 2.531747E-12

Real

Aptamer SeqId: 6947-4 | Target: SIA10 | UniProt: Q9Y274

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6947-4 | Target: SIA10 | UniProt: Q9Y274 | TargetFullName: Type 2 lactosamine alpha-2;3-sialyltransferase | Organisim: human | Apparent_Kd_M: 2.531747E-12

Real

Aptamer SeqId:6948-82;Target:FIG4;UniProt:Q92562

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6948-82;Target: FIG4;UniProt: Q92562;TargetFullName: Polyphosphoinositide phosphatase;Organisim: human;Apparent_Kd_M: 8.858766E-11

Real

Aptamer SeqId: 6948-82 | Target: FIG4 | UniProt: Q92562

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6948-82 | Target: FIG4 | UniProt: Q92562 | TargetFullName: Polyphosphoinositide phosphatase | Organisim: human | Apparent_Kd_M: 8.858766E-11

Real

Aptamer SeqId:6951-26;Target:ASIC4;UniProt:Q96FT7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6951-26;Target: ASIC4;UniProt: Q96FT7;TargetFullName: Acid-sensing ion channel 4;Organisim: human;Apparent_Kd_M: 1.533205E-11

Real

Aptamer SeqId: 6951-26 | Target: ASIC4 | UniProt: Q96FT7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6951-26 | Target: ASIC4 | UniProt: Q96FT7 | TargetFullName: Acid-sensing ion channel 4 | Organisim: human | Apparent_Kd_M: 1.533205E-11

Real

Aptamer SeqId:6955-68;Target:SNX1;UniProt:Q13596

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6955-68;Target: SNX1;UniProt: Q13596;TargetFullName: Sorting nexin-1;Organisim: human;Apparent_Kd_M: 2.33E-11

Real

Aptamer SeqId: 6955-68 | Target: SNX1 | UniProt: Q13596

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6955-68 | Target: SNX1 | UniProt: Q13596 | TargetFullName: Sorting nexin-1 | Organisim: human | Apparent_Kd_M: 2.33E-11

Real

Aptamer SeqId:6961-14;Target:IGFL3;UniProt:Q6UXB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6961-14;Target: IGFL3;UniProt: Q6UXB1;TargetFullName: Insulin growth factor-like family member 3;Organisim: human;Apparent_Kd_M: 1.257984E-10

Real

Aptamer SeqId: 6961-14 | Target: IGFL3 | UniProt: Q6UXB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6961-14 | Target: IGFL3 | UniProt: Q6UXB1 | TargetFullName: Insulin growth factor-like family member 3 | Organisim: human | Apparent_Kd_M: 1.257984E-10

Real

Aptamer SeqId:6962-5;Target:DRB3;UniProt:P79483

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6962-5;Target: DRB3;UniProt: P79483;TargetFullName: HLA class II histocompatibility antigen; DR beta 3 chain;Organisim: human;Apparent_Kd_M: 2.823101E-11

Real

Aptamer SeqId: 6962-5 | Target: DRB3 | UniProt: P79483

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6962-5 | Target: DRB3 | UniProt: P79483 | TargetFullName: HLA class II histocompatibility antigen; DR beta 3 chain | Organisim: human | Apparent_Kd_M: 2.823101E-11

Real

Aptamer SeqId:6965-19;Target:CNTP2;UniProt:Q9UHC6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6965-19;Target: CNTP2;UniProt: Q9UHC6;TargetFullName: Contactin-associated protein-like 2;Organisim: human;Apparent_Kd_M: 1.709871E-12

Real

Aptamer SeqId: 6965-19 | Target: CNTP2 | UniProt: Q9UHC6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6965-19 | Target: CNTP2 | UniProt: Q9UHC6 | TargetFullName: Contactin-associated protein-like 2 | Organisim: human | Apparent_Kd_M: 1.709871E-12

Real

Aptamer SeqId:6966-144;Target:STX1B;UniProt:P61266

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6966-144;Target: STX1B;UniProt: P61266;TargetFullName: Syntaxin-1B;Organisim: human;Apparent_Kd_M: 1.865861E-10

Real

Aptamer SeqId: 6966-144 | Target: STX1B | UniProt: P61266

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6966-144 | Target: STX1B | UniProt: P61266 | TargetFullName: Syntaxin-1B | Organisim: human | Apparent_Kd_M: 1.865861E-10

Real

Aptamer SeqId:6967-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6967-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.723744E-12

Real

Aptamer SeqId: 6967-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6967-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.723744E-12

Real

Aptamer SeqId:6969-14;Target:WFDC5;UniProt:Q8TCV5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6969-14;Target: WFDC5;UniProt: Q8TCV5;TargetFullName: WAP four-disulfide core domain protein 5;Organisim: human;Apparent_Kd_M: 1.273881E-10

Real

Aptamer SeqId: 6969-14 | Target: WFDC5 | UniProt: Q8TCV5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6969-14 | Target: WFDC5 | UniProt: Q8TCV5 | TargetFullName: WAP four-disulfide core domain protein 5 | Organisim: human | Apparent_Kd_M: 1.273881E-10

Real

Aptamer SeqId:6974-6;Target:HG2A;UniProt:P04233

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6974-6;Target: HG2A;UniProt: P04233;TargetFullName: HLA class II histocompatibility antigen gamma chain;Organisim: human;Apparent_Kd_M: 1.94E-11

Real

Aptamer SeqId: 6974-6 | Target: HG2A | UniProt: P04233

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6974-6 | Target: HG2A | UniProt: P04233 | TargetFullName: HLA class II histocompatibility antigen gamma chain | Organisim: human | Apparent_Kd_M: 1.94E-11

Real

Aptamer SeqId:6975-52;Target:SNAPN;UniProt:O95295

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6975-52;Target: SNAPN;UniProt: O95295;TargetFullName: SNARE-associated protein Snapin;Organisim: human;Apparent_Kd_M: 1.50499E-11

Real

Aptamer SeqId: 6975-52 | Target: SNAPN | UniProt: O95295

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6975-52 | Target: SNAPN | UniProt: O95295 | TargetFullName: SNARE-associated protein Snapin | Organisim: human | Apparent_Kd_M: 1.50499E-11

Real

Aptamer SeqId:6984-6;Target:IGSF8;UniProt:Q969P0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6984-6;Target: IGSF8;UniProt: Q969P0;TargetFullName: Immunoglobulin superfamily member 8;Organisim: human;Apparent_Kd_M: 3.478251E-12

Real

Aptamer SeqId: 6984-6 | Target: IGSF8 | UniProt: Q969P0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6984-6 | Target: IGSF8 | UniProt: Q969P0 | TargetFullName: Immunoglobulin superfamily member 8 | Organisim: human | Apparent_Kd_M: 3.478251E-12

Real

Aptamer SeqId:6986-17;Target:HS3SB;UniProt:Q9Y662

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6986-17;Target: HS3SB;UniProt: Q9Y662;TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 3B1;Organisim: human;Apparent_Kd_M: 5.792256E-11

Real

Aptamer SeqId: 6986-17 | Target: HS3SB | UniProt: Q9Y662

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6986-17 | Target: HS3SB | UniProt: Q9Y662 | TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 | Organisim: human | Apparent_Kd_M: 5.792256E-11

Real

Aptamer SeqId:6990-44;Target:SDF2L;UniProt:Q9HCN8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6990-44;Target: SDF2L;UniProt: Q9HCN8;TargetFullName: Stromal cell-derived factor 2-like protein 1;Organisim: human;Apparent_Kd_M: 4.549655E-11

Real

Aptamer SeqId: 6990-44 | Target: SDF2L | UniProt: Q9HCN8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6990-44 | Target: SDF2L | UniProt: Q9HCN8 | TargetFullName: Stromal cell-derived factor 2-like protein 1 | Organisim: human | Apparent_Kd_M: 4.549655E-11

Real

Aptamer SeqId:6991-24;Target:FUT9;UniProt:Q9Y231

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6991-24;Target: FUT9;UniProt: Q9Y231;TargetFullName: Alpha-(1;3)-fucosyltransferase 9;Organisim: human;Apparent_Kd_M: 1.745618E-10

Real

Aptamer SeqId: 6991-24 | Target: FUT9 | UniProt: Q9Y231

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6991-24 | Target: FUT9 | UniProt: Q9Y231 | TargetFullName: Alpha-(1;3)-fucosyltransferase 9 | Organisim: human | Apparent_Kd_M: 1.745618E-10

Real

Aptamer SeqId:6992-67;Target:HBD;UniProt:P02042

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6992-67;Target: HBD;UniProt: P02042;TargetFullName: Hemoglobin subunit delta;Organisim: human;Apparent_Kd_M: 2.24E-10

Real

Aptamer SeqId: 6992-67 | Target: HBD | UniProt: P02042

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6992-67 | Target: HBD | UniProt: P02042 | TargetFullName: Hemoglobin subunit delta | Organisim: human | Apparent_Kd_M: 2.24E-10

Real

Aptamer SeqId:6994-19;Target:CC018;UniProt:Q9UK00

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6994-19;Target: CC018;UniProt: Q9UK00;TargetFullName: Uncharacterized protein C3orf18;Organisim: human;Apparent_Kd_M: 2.502114E-10

Real

Aptamer SeqId: 6994-19 | Target: CC018 | UniProt: Q9UK00

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6994-19 | Target: CC018 | UniProt: Q9UK00 | TargetFullName: Uncharacterized protein C3orf18 | Organisim: human | Apparent_Kd_M: 2.502114E-10

Real

Aptamer SeqId:6997-32;Target:RAB26;UniProt:Q9ULW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6997-32;Target: RAB26;UniProt: Q9ULW5;TargetFullName: Ras-related protein Rab-26;Organisim: human;Apparent_Kd_M: 1.952732E-10

Real

Aptamer SeqId: 6997-32 | Target: RAB26 | UniProt: Q9ULW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6997-32 | Target: RAB26 | UniProt: Q9ULW5 | TargetFullName: Ras-related protein Rab-26 | Organisim: human | Apparent_Kd_M: 1.952732E-10

Real

Aptamer SeqId:6998-106;Target:HAAH;UniProt:Q12797

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 6998-106;Target: HAAH;UniProt: Q12797;TargetFullName: Aspartyl/asparaginyl beta-hydroxylase;Organisim: human;Apparent_Kd_M: 8.45882E-12

Real

Aptamer SeqId: 6998-106 | Target: HAAH | UniProt: Q12797

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 6998-106 | Target: HAAH | UniProt: Q12797 | TargetFullName: Aspartyl/asparaginyl beta-hydroxylase | Organisim: human | Apparent_Kd_M: 8.45882E-12

Real

Aptamer SeqId:7003-4;Target:GLT10;UniProt:Q86SR1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7003-4;Target: GLT10;UniProt: Q86SR1;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 10;Organisim: human;Apparent_Kd_M: 6.371791E-11

Real

Aptamer SeqId: 7003-4 | Target: GLT10 | UniProt: Q86SR1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7003-4 | Target: GLT10 | UniProt: Q86SR1 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 10 | Organisim: human | Apparent_Kd_M: 6.371791E-11

Real

Aptamer SeqId:7006-4;Target:COPA1;UniProt:Q9BXS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7006-4;Target: COPA1;UniProt: Q9BXS0;TargetFullName: Collagen alpha-1(XXV) chain;Organisim: human;Apparent_Kd_M: 2.833975E-11

Real

Aptamer SeqId: 7006-4 | Target: COPA1 | UniProt: Q9BXS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7006-4 | Target: COPA1 | UniProt: Q9BXS0 | TargetFullName: Collagen alpha-1(XXV) chain | Organisim: human | Apparent_Kd_M: 2.833975E-11

Real

Aptamer SeqId:7007-24;Target:TRAPPC4;UniProt:Q9Y296

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7007-24;Target: TRAPPC4;UniProt: Q9Y296;TargetFullName: Trafficking protein particle complex subunit 4;Organisim: human;Apparent_Kd_M: 1.706947E-11

Real

Aptamer SeqId: 7007-24 | Target: TRAPPC4 | UniProt: Q9Y296

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7007-24 | Target: TRAPPC4 | UniProt: Q9Y296 | TargetFullName: Trafficking protein particle complex subunit 4 | Organisim: human | Apparent_Kd_M: 1.706947E-11

Real

Aptamer SeqId:7009-8;Target:CD72;UniProt:P21854

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7009-8;Target: CD72;UniProt: P21854;TargetFullName: B-cell differentiation antigen CD72;Organisim: human;Apparent_Kd_M: 2.12E-11

Real

Aptamer SeqId: 7009-8 | Target: CD72 | UniProt: P21854

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7009-8 | Target: CD72 | UniProt: P21854 | TargetFullName: B-cell differentiation antigen CD72 | Organisim: human | Apparent_Kd_M: 2.12E-11

Real

Aptamer SeqId:7011-8;Target:KCIP4;UniProt:Q6PIL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7011-8;Target: KCIP4;UniProt: Q6PIL6;TargetFullName: Kv channel-interacting protein 4;Organisim: human;Apparent_Kd_M: 4.886963E-11

Real

Aptamer SeqId: 7011-8 | Target: KCIP4 | UniProt: Q6PIL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7011-8 | Target: KCIP4 | UniProt: Q6PIL6 | TargetFullName: Kv channel-interacting protein 4 | Organisim: human | Apparent_Kd_M: 4.886963E-11

Real

Aptamer SeqId:7014-27;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7014-27;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.016404E-12

Real

Aptamer SeqId: 7014-27 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7014-27 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.016404E-12

Real

Aptamer SeqId:7015-8;Target:LIRB5;UniProt:O75023

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7015-8;Target: LIRB5;UniProt: O75023;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 5;Organisim: human;Apparent_Kd_M: 6.719643E-12

Real

Aptamer SeqId: 7015-8 | Target: LIRB5 | UniProt: O75023

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7015-8 | Target: LIRB5 | UniProt: O75023 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily B member 5 | Organisim: human | Apparent_Kd_M: 6.719643E-12

Real

Aptamer SeqId:7016-12;Target:GCNT1;UniProt:Q02742

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7016-12;Target: GCNT1;UniProt: Q02742;TargetFullName: Beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;6-N-acetylglucosaminyltransferase;Organisim: human;Apparent_Kd_M: 2.42E-10

Real

Aptamer SeqId: 7016-12 | Target: GCNT1 | UniProt: Q02742

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7016-12 | Target: GCNT1 | UniProt: Q02742 | TargetFullName: Beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;6-N-acetylglucosaminyltransferase | Organisim: human | Apparent_Kd_M: 2.42E-10

Real

Aptamer SeqId:7018-10;Target:TSR3;UniProt:Q9UJK0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7018-10;Target: TSR3;UniProt: Q9UJK0;TargetFullName: Ribosome biogenesis protein TSR3 homolog;Organisim: human;Apparent_Kd_M: 2.141036E-10

Real

Aptamer SeqId: 7018-10 | Target: TSR3 | UniProt: Q9UJK0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7018-10 | Target: TSR3 | UniProt: Q9UJK0 | TargetFullName: Ribosome biogenesis protein TSR3 homolog | Organisim: human | Apparent_Kd_M: 2.141036E-10

Real

Aptamer SeqId:7019-13;Target:Semaphorin-7A;UniProt:O75326

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7019-13;Target: Semaphorin-7A;UniProt: O75326;TargetFullName: Semaphorin-7A;Organisim: human;Apparent_Kd_M: 3.562159E-11

Real

Aptamer SeqId: 7019-13 | Target: Semaphorin-7A | UniProt: O75326

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7019-13 | Target: Semaphorin-7A | UniProt: O75326 | TargetFullName: Semaphorin-7A | Organisim: human | Apparent_Kd_M: 3.562159E-11

Real

Aptamer SeqId:7020-13;Target:CHST5;UniProt:Q9GZS9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7020-13;Target: CHST5;UniProt: Q9GZS9;TargetFullName: Carbohydrate sulfotransferase 5;Organisim: human;Apparent_Kd_M: 3.176733E-11

Real

Aptamer SeqId: 7020-13 | Target: CHST5 | UniProt: Q9GZS9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7020-13 | Target: CHST5 | UniProt: Q9GZS9 | TargetFullName: Carbohydrate sulfotransferase 5 | Organisim: human | Apparent_Kd_M: 3.176733E-11

Real

Aptamer SeqId:7034-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7034-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.747067E-11

Real

Aptamer SeqId: 7034-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7034-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.747067E-11

Real

Aptamer SeqId:7038-45;Target:SIA8D;UniProt:Q92187

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7038-45;Target: SIA8D;UniProt: Q92187;TargetFullName: CMP-N-acetylneuraminate-poly-alpha-2;8-sialyltransferase;Organisim: human;Apparent_Kd_M: 3.193587E-11

Real

Aptamer SeqId: 7038-45 | Target: SIA8D | UniProt: Q92187

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7038-45 | Target: SIA8D | UniProt: Q92187 | TargetFullName: CMP-N-acetylneuraminate-poly-alpha-2;8-sialyltransferase | Organisim: human | Apparent_Kd_M: 3.193587E-11

Real

Aptamer SeqId:7045-4;Target:BNIP3;UniProt:Q12983

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7045-4;Target: BNIP3;UniProt: Q12983;TargetFullName: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3;Organisim: human;Apparent_Kd_M: 5.761044E-11

Real

Aptamer SeqId: 7045-4 | Target: BNIP3 | UniProt: Q12983

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7045-4 | Target: BNIP3 | UniProt: Q12983 | TargetFullName: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 | Organisim: human | Apparent_Kd_M: 5.761044E-11

Real

Aptamer SeqId:7046-6;Target:CT173;UniProt:Q96LM9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7046-6;Target: CT173;UniProt: Q96LM9;TargetFullName: Uncharacterized protein C20orf173;Organisim: human;Apparent_Kd_M: 2.13E-10

Real

Aptamer SeqId: 7046-6 | Target: CT173 | UniProt: Q96LM9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7046-6 | Target: CT173 | UniProt: Q96LM9 | TargetFullName: Uncharacterized protein C20orf173 | Organisim: human | Apparent_Kd_M: 2.13E-10

Real

Aptamer SeqId:7048-4;Target:CEA19;UniProt:Q7Z692

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7048-4;Target: CEA19;UniProt: Q7Z692;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 19;Organisim: human;Apparent_Kd_M: 2.177148E-10

Real

Aptamer SeqId: 7048-4 | Target: CEA19 | UniProt: Q7Z692

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7048-4 | Target: CEA19 | UniProt: Q7Z692 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 19 | Organisim: human | Apparent_Kd_M: 2.177148E-10

Real

Aptamer SeqId:7049-2;Target:ADAM 23;UniProt:O75077

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7049-2;Target: ADAM 23;UniProt: O75077;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 23;Organisim: human;Apparent_Kd_M: 6.99852E-12

Real

Aptamer SeqId: 7049-2 | Target: ADAM 23 | UniProt: O75077

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7049-2 | Target: ADAM 23 | UniProt: O75077 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 23 | Organisim: human | Apparent_Kd_M: 6.99852E-12

Real

Aptamer SeqId:7050-5;Target:NEGR1;UniProt:Q7Z3B1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7050-5;Target: NEGR1;UniProt: Q7Z3B1;TargetFullName: Neuronal growth regulator 1;Organisim: human;Apparent_Kd_M: 6.44E-11

Real

Aptamer SeqId: 7050-5 | Target: NEGR1 | UniProt: Q7Z3B1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7050-5 | Target: NEGR1 | UniProt: Q7Z3B1 | TargetFullName: Neuronal growth regulator 1 | Organisim: human | Apparent_Kd_M: 6.44E-11

Real

Aptamer SeqId:7054-87;Target:CLC2D;UniProt:Q9UHP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7054-87;Target: CLC2D;UniProt: Q9UHP7;TargetFullName: C-type lectin domain family 2 member D;Organisim: human;Apparent_Kd_M: 2.186042E-10

Real

Aptamer SeqId: 7054-87 | Target: CLC2D | UniProt: Q9UHP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7054-87 | Target: CLC2D | UniProt: Q9UHP7 | TargetFullName: C-type lectin domain family 2 member D | Organisim: human | Apparent_Kd_M: 2.186042E-10

Real

Aptamer SeqId:7057-18;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7057-18;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.045897E-11

Real

Aptamer SeqId: 7057-18 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7057-18 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.045897E-11

Real

Aptamer SeqId:7059-14;Target:LIRA6;UniProt:Q6PI73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7059-14;Target: LIRA6;UniProt: Q6PI73;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 6;Organisim: human;Apparent_Kd_M: 2.70774E-11

Real

Aptamer SeqId: 7059-14 | Target: LIRA6 | UniProt: Q6PI73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7059-14 | Target: LIRA6 | UniProt: Q6PI73 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 6 | Organisim: human | Apparent_Kd_M: 2.70774E-11

Real

Aptamer SeqId:7060-2;Target:ERO1A;UniProt:Q96HE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7060-2;Target: ERO1A;UniProt: Q96HE7;TargetFullName: ERO1-like protein alpha;Organisim: human;Apparent_Kd_M: 2.298602E-11

Real

Aptamer SeqId: 7060-2 | Target: ERO1A | UniProt: Q96HE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7060-2 | Target: ERO1A | UniProt: Q96HE7 | TargetFullName: ERO1-like protein alpha | Organisim: human | Apparent_Kd_M: 2.298602E-11

Real

Aptamer SeqId:7064-2;Target:VAMP8;UniProt:Q9BV40

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7064-2;Target: VAMP8;UniProt: Q9BV40;TargetFullName: Vesicle-associated membrane protein 8;Organisim: human;Apparent_Kd_M: 4.167692E-12

Real

Aptamer SeqId: 7064-2 | Target: VAMP8 | UniProt: Q9BV40

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7064-2 | Target: VAMP8 | UniProt: Q9BV40 | TargetFullName: Vesicle-associated membrane protein 8 | Organisim: human | Apparent_Kd_M: 4.167692E-12

Real

Aptamer SeqId:7065-1;Target:G6B;UniProt:O95866

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7065-1;Target: G6B;UniProt: O95866;TargetFullName: Protein G6b;Organisim: human;Apparent_Kd_M: 4.26E-12

Real

Aptamer SeqId: 7065-1 | Target: G6B | UniProt: O95866

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7065-1 | Target: G6B | UniProt: O95866 | TargetFullName: Protein G6b | Organisim: human | Apparent_Kd_M: 4.26E-12

Real

Aptamer SeqId:7066-199;Target:F209B;UniProt:Q5JX69

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7066-199;Target: F209B;UniProt: Q5JX69;TargetFullName: Protein FAM209B;Organisim: human;Apparent_Kd_M: 2.427769E-10

Real

Aptamer SeqId: 7066-199 | Target: F209B | UniProt: Q5JX69

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7066-199 | Target: F209B | UniProt: Q5JX69 | TargetFullName: Protein FAM209B | Organisim: human | Apparent_Kd_M: 2.427769E-10

Real

Aptamer SeqId:7069-9;Target:TSNA1;UniProt:Q96NA8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7069-9;Target: TSNA1;UniProt: Q96NA8;TargetFullName: t-SNARE domain-containing protein 1;Organisim: human;Apparent_Kd_M: 8.357362E-11

Real

Aptamer SeqId: 7069-9 | Target: TSNA1 | UniProt: Q96NA8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7069-9 | Target: TSNA1 | UniProt: Q96NA8 | TargetFullName: t-SNARE domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 8.357362E-11

Real

Aptamer SeqId:7070-25;Target:KELL;UniProt:P23276

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7070-25;Target: KELL;UniProt: P23276;TargetFullName: Kell blood group glycoprotein;Organisim: human;Apparent_Kd_M: 5.825511E-12

Real

Aptamer SeqId: 7070-25 | Target: KELL | UniProt: P23276

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7070-25 | Target: KELL | UniProt: P23276 | TargetFullName: Kell blood group glycoprotein | Organisim: human | Apparent_Kd_M: 5.825511E-12

Real

Aptamer SeqId:7071-23;Target:MA1B1;UniProt:Q9UKM7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7071-23;Target: MA1B1;UniProt: Q9UKM7;TargetFullName: Endoplasmic reticulum mannosyl-oligosaccharide 1;2-alpha-mannosidase;Organisim: human;Apparent_Kd_M: 1.622742E-11

Real

Aptamer SeqId: 7071-23 | Target: MA1B1 | UniProt: Q9UKM7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7071-23 | Target: MA1B1 | UniProt: Q9UKM7 | TargetFullName: Endoplasmic reticulum mannosyl-oligosaccharide 1;2-alpha-mannosidase | Organisim: human | Apparent_Kd_M: 1.622742E-11

Real

Aptamer SeqId:7073-69;Target:CV015;UniProt:Q8WYQ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7073-69;Target: CV015;UniProt: Q8WYQ4;TargetFullName: Uncharacterized protein C22orf15;Organisim: human;Apparent_Kd_M: 1.165503E-12

Real

Aptamer SeqId: 7073-69 | Target: CV015 | UniProt: Q8WYQ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7073-69 | Target: CV015 | UniProt: Q8WYQ4 | TargetFullName: Uncharacterized protein C22orf15 | Organisim: human | Apparent_Kd_M: 1.165503E-12

Real

Aptamer SeqId:7076-17;Target:ECEL1;UniProt:O95672

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7076-17;Target: ECEL1;UniProt: O95672;TargetFullName: Endothelin-converting enzyme-like 1;Organisim: human;Apparent_Kd_M: 1.753178E-10

Real

Aptamer SeqId: 7076-17 | Target: ECEL1 | UniProt: O95672

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7076-17 | Target: ECEL1 | UniProt: O95672 | TargetFullName: Endothelin-converting enzyme-like 1 | Organisim: human | Apparent_Kd_M: 1.753178E-10

Real

Aptamer SeqId:7077-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7077-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.895499E-12

Real

Aptamer SeqId: 7077-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7077-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.895499E-12

Real

Aptamer SeqId:7081-2;Target:BT3A1;UniProt:O00481

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7081-2;Target: BT3A1;UniProt: O00481;TargetFullName: Butyrophilin subfamily 3 member A1;Organisim: human;Apparent_Kd_M: 1.562424E-10

Real

Aptamer SeqId: 7081-2 | Target: BT3A1 | UniProt: O00481

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7081-2 | Target: BT3A1 | UniProt: O00481 | TargetFullName: Butyrophilin subfamily 3 member A1 | Organisim: human | Apparent_Kd_M: 1.562424E-10

Real

Aptamer SeqId:7082-2;Target:B3GN6;UniProt:Q6ZMB0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7082-2;Target: B3GN6;UniProt: Q6ZMB0;TargetFullName: UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 6;Organisim: human;Apparent_Kd_M: 8.449109E-12

Real

Aptamer SeqId: 7082-2 | Target: B3GN6 | UniProt: Q6ZMB0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7082-2 | Target: B3GN6 | UniProt: Q6ZMB0 | TargetFullName: UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 6 | Organisim: human | Apparent_Kd_M: 8.449109E-12

Real

Aptamer SeqId:7083-74;Target:MATN4;UniProt:O95460

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7083-74;Target: MATN4;UniProt: O95460;TargetFullName: Matrilin-4;Organisim: human;Apparent_Kd_M: 1.945107E-11

Real

Aptamer SeqId: 7083-74 | Target: MATN4 | UniProt: O95460

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7083-74 | Target: MATN4 | UniProt: O95460 | TargetFullName: Matrilin-4 | Organisim: human | Apparent_Kd_M: 1.945107E-11

Real

Aptamer SeqId:7084-1;Target:DRAXI;UniProt:Q8NBI3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7084-1;Target: DRAXI;UniProt: Q8NBI3;TargetFullName: Draxin;Organisim: human;Apparent_Kd_M: 3.020077E-11

Real

Aptamer SeqId: 7084-1 | Target: DRAXI | UniProt: Q8NBI3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7084-1 | Target: DRAXI | UniProt: Q8NBI3 | TargetFullName: Draxin | Organisim: human | Apparent_Kd_M: 3.020077E-11

Real

Aptamer SeqId:7085-81;Target:CDSN;UniProt:Q15517

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7085-81;Target: CDSN;UniProt: Q15517;TargetFullName: Corneodesmosin;Organisim: human;Apparent_Kd_M: 1.561106E-11

Real

Aptamer SeqId: 7085-81 | Target: CDSN | UniProt: Q15517

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7085-81 | Target: CDSN | UniProt: Q15517 | TargetFullName: Corneodesmosin | Organisim: human | Apparent_Kd_M: 1.561106E-11

Real

Aptamer SeqId:7089-42;Target:SYT11;UniProt:Q9BT88

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7089-42;Target: SYT11;UniProt: Q9BT88;TargetFullName: Synaptotagmin-11;Organisim: human;Apparent_Kd_M: 5.158153E-12

Real

Aptamer SeqId: 7089-42 | Target: SYT11 | UniProt: Q9BT88

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7089-42 | Target: SYT11 | UniProt: Q9BT88 | TargetFullName: Synaptotagmin-11 | Organisim: human | Apparent_Kd_M: 5.158153E-12

Real

Aptamer SeqId:7090-17;Target:GALT1;UniProt:Q10472

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7090-17;Target: GALT1;UniProt: Q10472;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 1;Organisim: human;Apparent_Kd_M: 4.21479E-11

Real

Aptamer SeqId: 7090-17 | Target: GALT1 | UniProt: Q10472

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7090-17 | Target: GALT1 | UniProt: Q10472 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 1 | Organisim: human | Apparent_Kd_M: 4.21479E-11

Real

Aptamer SeqId:7092-7;Target:PDILT;UniProt:Q8N807

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7092-7;Target: PDILT;UniProt: Q8N807;TargetFullName: Protein disulfide-isomerase-like protein of the testis;Organisim: human;Apparent_Kd_M: 7.863994E-11

Real

Aptamer SeqId: 7092-7 | Target: PDILT | UniProt: Q8N807

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7092-7 | Target: PDILT | UniProt: Q8N807 | TargetFullName: Protein disulfide-isomerase-like protein of the testis | Organisim: human | Apparent_Kd_M: 7.863994E-11

Real

Aptamer SeqId:7096-30;Target:RMD1;UniProt:Q96DB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7096-30;Target: RMD1;UniProt: Q96DB5;TargetFullName: Regulator of microtubule dynamics protein 1;Organisim: human;Apparent_Kd_M: 9.146878E-12

Real

Aptamer SeqId: 7096-30 | Target: RMD1 | UniProt: Q96DB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7096-30 | Target: RMD1 | UniProt: Q96DB5 | TargetFullName: Regulator of microtubule dynamics protein 1 | Organisim: human | Apparent_Kd_M: 9.146878E-12

Real

Aptamer SeqId:7097-8;Target:CDY1;UniProt:Q9Y6F8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7097-8;Target: CDY1;UniProt: Q9Y6F8;TargetFullName: Testis-specific chromodomain protein Y 1;Organisim: human;Apparent_Kd_M: 8.755242E-12

Real

Aptamer SeqId: 7097-8 | Target: CDY1 | UniProt: Q9Y6F8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7097-8 | Target: CDY1 | UniProt: Q9Y6F8 | TargetFullName: Testis-specific chromodomain protein Y 1 | Organisim: human | Apparent_Kd_M: 8.755242E-12

Real

Aptamer SeqId:7099-33;Target:FSTL5;UniProt:Q8N475

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7099-33;Target: FSTL5;UniProt: Q8N475;TargetFullName: Follistatin-related protein 5;Organisim: human;Apparent_Kd_M: 1.070847E-11

Real

Aptamer SeqId: 7099-33 | Target: FSTL5 | UniProt: Q8N475

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7099-33 | Target: FSTL5 | UniProt: Q8N475 | TargetFullName: Follistatin-related protein 5 | Organisim: human | Apparent_Kd_M: 1.070847E-11

Real

Aptamer SeqId:7100-31;Target:CD2;UniProt:P06729

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7100-31;Target: CD2;UniProt: P06729;TargetFullName: T-cell surface antigen CD2;Organisim: human;Apparent_Kd_M: 2.863343E-10

Real

Aptamer SeqId: 7100-31 | Target: CD2 | UniProt: P06729

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7100-31 | Target: CD2 | UniProt: P06729 | TargetFullName: T-cell surface antigen CD2 | Organisim: human | Apparent_Kd_M: 2.863343E-10

Real

Aptamer SeqId:7104-71;Target:CABP7;UniProt:Q86V35

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7104-71;Target: CABP7;UniProt: Q86V35;TargetFullName: Calcium-binding protein 7;Organisim: human;Apparent_Kd_M: 1.35E-10

Real

Aptamer SeqId: 7104-71 | Target: CABP7 | UniProt: Q86V35

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7104-71 | Target: CABP7 | UniProt: Q86V35 | TargetFullName: Calcium-binding protein 7 | Organisim: human | Apparent_Kd_M: 1.35E-10

Real

Aptamer SeqId:7105-7;Target:CABL2;UniProt:Q9BTV7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7105-7;Target: CABL2;UniProt: Q9BTV7;TargetFullName: CDK5 and ABL1 enzyme substrate 2;Organisim: human;Apparent_Kd_M: 2.731885E-11

Real

Aptamer SeqId: 7105-7 | Target: CABL2 | UniProt: Q9BTV7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7105-7 | Target: CABL2 | UniProt: Q9BTV7 | TargetFullName: CDK5 and ABL1 enzyme substrate 2 | Organisim: human | Apparent_Kd_M: 2.731885E-11

Real

Aptamer SeqId:7106-37;Target:PLACL;UniProt:Q86WS3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7106-37;Target: PLACL;UniProt: Q86WS3;TargetFullName: Oocyte-secreted protein 2;Organisim: human;Apparent_Kd_M: 5.501814E-11

Real

Aptamer SeqId: 7106-37 | Target: PLACL | UniProt: Q86WS3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7106-37 | Target: PLACL | UniProt: Q86WS3 | TargetFullName: Oocyte-secreted protein 2 | Organisim: human | Apparent_Kd_M: 5.501814E-11

Real

Aptamer SeqId:7108-7;Target:CS077;UniProt:O75264

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7108-7;Target: CS077;UniProt: O75264;TargetFullName: Small integral membrane protein 24;Organisim: human;Apparent_Kd_M: 4.962675E-12

Real

Aptamer SeqId: 7108-7 | Target: CS077 | UniProt: O75264

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7108-7 | Target: CS077 | UniProt: O75264 | TargetFullName: Small integral membrane protein 24 | Organisim: human | Apparent_Kd_M: 4.962675E-12

Real

Aptamer SeqId:7110-2;Target:DJB11;UniProt:Q9UBS4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7110-2;Target: DJB11;UniProt: Q9UBS4;TargetFullName: DnaJ homolog subfamily B member 11;Organisim: human;Apparent_Kd_M: 4.567925E-11

Real

Aptamer SeqId: 7110-2 | Target: DJB11 | UniProt: Q9UBS4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7110-2 | Target: DJB11 | UniProt: Q9UBS4 | TargetFullName: DnaJ homolog subfamily B member 11 | Organisim: human | Apparent_Kd_M: 4.567925E-11

Real

Aptamer SeqId:7113-1;Target:GRPE1;UniProt:Q9HAV7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7113-1;Target: GRPE1;UniProt: Q9HAV7;TargetFullName: GrpE protein homolog 1; mitochondrial;Organisim: human;Apparent_Kd_M: 2.988692E-11

Real

Aptamer SeqId: 7113-1 | Target: GRPE1 | UniProt: Q9HAV7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7113-1 | Target: GRPE1 | UniProt: Q9HAV7 | TargetFullName: GrpE protein homolog 1; mitochondrial | Organisim: human | Apparent_Kd_M: 2.988692E-11

Real

Aptamer SeqId:7115-5;Target:Semenogelin;UniProt:P04279

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7115-5;Target: Semenogelin;UniProt: P04279;TargetFullName: Semenogelin-1;Organisim: human;Apparent_Kd_M: 3.1632E-11

Real

Aptamer SeqId: 7115-5 | Target: Semenogelin | UniProt: P04279

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7115-5 | Target: Semenogelin | UniProt: P04279 | TargetFullName: Semenogelin-1 | Organisim: human | Apparent_Kd_M: 3.1632E-11

Real

Aptamer SeqId:7116-31;Target:OSCAR;UniProt:Q8IYS5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7116-31;Target: OSCAR;UniProt: Q8IYS5;TargetFullName: Osteoclast-associated immunoglobulin-like receptor;Organisim: human;Apparent_Kd_M: 3.159295E-11

Real

Aptamer SeqId: 7116-31 | Target: OSCAR | UniProt: Q8IYS5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7116-31 | Target: OSCAR | UniProt: Q8IYS5 | TargetFullName: Osteoclast-associated immunoglobulin-like receptor | Organisim: human | Apparent_Kd_M: 3.159295E-11

Real

Aptamer SeqId:7117-21;Target:SPI2;UniProt:O75830

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7117-21;Target: SPI2;UniProt: O75830;TargetFullName: Serpin I2;Organisim: human;Apparent_Kd_M: 7.469633E-11

Real

Aptamer SeqId: 7117-21 | Target: SPI2 | UniProt: O75830

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7117-21 | Target: SPI2 | UniProt: O75830 | TargetFullName: Serpin I2 | Organisim: human | Apparent_Kd_M: 7.469633E-11

Real

Aptamer SeqId:7118-24;Target:IGDC3;UniProt:Q8IVU1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7118-24;Target: IGDC3;UniProt: Q8IVU1;TargetFullName: Immunoglobulin superfamily DCC subclass member 3;Organisim: human;Apparent_Kd_M: 2.005522E-11

Real

Aptamer SeqId: 7118-24 | Target: IGDC3 | UniProt: Q8IVU1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7118-24 | Target: IGDC3 | UniProt: Q8IVU1 | TargetFullName: Immunoglobulin superfamily DCC subclass member 3 | Organisim: human | Apparent_Kd_M: 2.005522E-11

Real

Aptamer SeqId:7121-2;Target:SYT7;UniProt:O43581

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7121-2;Target: SYT7;UniProt: O43581;TargetFullName: Synaptotagmin-7;Organisim: human;Apparent_Kd_M: 1.075285E-11

Real

Aptamer SeqId: 7121-2 | Target: SYT7 | UniProt: O43581

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7121-2 | Target: SYT7 | UniProt: O43581 | TargetFullName: Synaptotagmin-7 | Organisim: human | Apparent_Kd_M: 1.075285E-11

Real

Aptamer SeqId:7123-25;Target:RM52;UniProt:Q86TS9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7123-25;Target: RM52;UniProt: Q86TS9;TargetFullName: 39S ribosomal protein L52; mitochondrial;Organisim: human;Apparent_Kd_M: 4.316134E-11

Real

Aptamer SeqId: 7123-25 | Target: RM52 | UniProt: Q86TS9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7123-25 | Target: RM52 | UniProt: Q86TS9 | TargetFullName: 39S ribosomal protein L52; mitochondrial | Organisim: human | Apparent_Kd_M: 4.316134E-11

Real

Aptamer SeqId:7124-18;Target:IL-21;UniProt:Q9HBE4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7124-18;Target: IL-21;UniProt: Q9HBE4;TargetFullName: Interleukin-21;Organisim: human;Apparent_Kd_M: 4.35044E-12

Real

Aptamer SeqId: 7124-18 | Target: IL-21 | UniProt: Q9HBE4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7124-18 | Target: IL-21 | UniProt: Q9HBE4 | TargetFullName: Interleukin-21 | Organisim: human | Apparent_Kd_M: 4.35044E-12

Real

Aptamer SeqId:7125-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7125-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.39479E-12

Real

Aptamer SeqId: 7125-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7125-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.39479E-12

Real

Aptamer SeqId:7127-3;Target:Apo A-II;UniProt:P02652

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7127-3;Target: Apo A-II;UniProt: P02652;TargetFullName: Apolipoprotein A-II;Organisim: human;Apparent_Kd_M: 1.06102E-11

Real

Aptamer SeqId: 7127-3 | Target: Apo A-II | UniProt: P02652

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7127-3 | Target: Apo A-II | UniProt: P02652 | TargetFullName: Apolipoprotein A-II | Organisim: human | Apparent_Kd_M: 1.06102E-11

Real

Aptamer SeqId:7128-9;Target:VWA2;UniProt:Q5GFL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7128-9;Target: VWA2;UniProt: Q5GFL6;TargetFullName: von Willebrand factor A domain-containing protein 2;Organisim: human;Apparent_Kd_M: 3.111178E-11

Real

Aptamer SeqId: 7128-9 | Target: VWA2 | UniProt: Q5GFL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7128-9 | Target: VWA2 | UniProt: Q5GFL6 | TargetFullName: von Willebrand factor A domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 3.111178E-11

Real

Aptamer SeqId:7130-4;Target:LAIR2;UniProt:Q6ISS4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7130-4;Target: LAIR2;UniProt: Q6ISS4;TargetFullName: Leukocyte-associated immunoglobulin-like receptor 2;Organisim: human;Apparent_Kd_M: 1.557383E-11

Real

Aptamer SeqId: 7130-4 | Target: LAIR2 | UniProt: Q6ISS4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7130-4 | Target: LAIR2 | UniProt: Q6ISS4 | TargetFullName: Leukocyte-associated immunoglobulin-like receptor 2 | Organisim: human | Apparent_Kd_M: 1.557383E-11

Real

Aptamer SeqId:7131-207;Target:Tenascin;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7131-207;Target: Tenascin;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 5.173196E-11

Real

Aptamer SeqId: 7131-207 | Target: Tenascin | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7131-207 | Target: Tenascin | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 5.173196E-11

Real

Aptamer SeqId:7132-55;Target:C1QL4;UniProt:Q86Z23

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7132-55;Target: C1QL4;UniProt: Q86Z23;TargetFullName: Complement C1q-like protein 4;Organisim: human;Apparent_Kd_M: 1.745356E-11

Real

Aptamer SeqId: 7132-55 | Target: C1QL4 | UniProt: Q86Z23

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7132-55 | Target: C1QL4 | UniProt: Q86Z23 | TargetFullName: Complement C1q-like protein 4 | Organisim: human | Apparent_Kd_M: 1.745356E-11

Real

Aptamer SeqId:7136-7;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7136-7;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.44E-13

Real

Aptamer SeqId: 7136-7 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7136-7 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.44E-13

Real

Aptamer SeqId:7137-8;Target:MSRA;UniProt:Q9UJ68

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7137-8;Target: MSRA;UniProt: Q9UJ68;TargetFullName: Mitochondrial peptide methionine sulfoxide reductase;Organisim: human;Apparent_Kd_M: 1.836359E-10

Real

Aptamer SeqId: 7137-8 | Target: MSRA | UniProt: Q9UJ68

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7137-8 | Target: MSRA | UniProt: Q9UJ68 | TargetFullName: Mitochondrial peptide methionine sulfoxide reductase | Organisim: human | Apparent_Kd_M: 1.836359E-10

Real

Aptamer SeqId:7139-14;Target:SLIK4;UniProt:Q8IW52

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7139-14;Target: SLIK4;UniProt: Q8IW52;TargetFullName: SLIT and NTRK-like protein 4;Organisim: human;Apparent_Kd_M: 3.564829E-11

Real

Aptamer SeqId: 7139-14 | Target: SLIK4 | UniProt: Q8IW52

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7139-14 | Target: SLIK4 | UniProt: Q8IW52 | TargetFullName: SLIT and NTRK-like protein 4 | Organisim: human | Apparent_Kd_M: 3.564829E-11

Real

Aptamer SeqId:7140-1;Target:ELA2A;UniProt:P08217

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7140-1;Target: ELA2A;UniProt: P08217;TargetFullName: Chymotrypsin-like elastase family member 2A;Organisim: human;Apparent_Kd_M: 1.91096E-11

Real

Aptamer SeqId: 7140-1 | Target: ELA2A | UniProt: P08217

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7140-1 | Target: ELA2A | UniProt: P08217 | TargetFullName: Chymotrypsin-like elastase family member 2A | Organisim: human | Apparent_Kd_M: 1.91096E-11

Real

Aptamer SeqId:7141-21;Target:MGT4B;UniProt:Q9UQ53

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7141-21;Target: MGT4B;UniProt: Q9UQ53;TargetFullName: Alpha-1;3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B;Organisim: human;Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId: 7141-21 | Target: MGT4B | UniProt: Q9UQ53

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7141-21 | Target: MGT4B | UniProt: Q9UQ53 | TargetFullName: Alpha-1;3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B | Organisim: human | Apparent_Kd_M: 1.46E-11

Real

Aptamer SeqId:7142-5;Target:CBPN;UniProt:P15169

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7142-5;Target: CBPN;UniProt: P15169;TargetFullName: Carboxypeptidase N catalytic chain;Organisim: human;Apparent_Kd_M: 1.387727E-11

Real

Aptamer SeqId: 7142-5 | Target: CBPN | UniProt: P15169

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7142-5 | Target: CBPN | UniProt: P15169 | TargetFullName: Carboxypeptidase N catalytic chain | Organisim: human | Apparent_Kd_M: 1.387727E-11

Real

Aptamer SeqId:7143-9;Target:GNT2C;UniProt:Q8NFS9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7143-9;Target: GNT2C;UniProt: Q8NFS9;TargetFullName: N-acetyllactosaminide beta-1;6-N-acetylglucosaminyl-transferase; isoform C;Organisim: human;Apparent_Kd_M: 1.582344E-10

Real

Aptamer SeqId: 7143-9 | Target: GNT2C | UniProt: Q8NFS9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7143-9 | Target: GNT2C | UniProt: Q8NFS9 | TargetFullName: N-acetyllactosaminide beta-1;6-N-acetylglucosaminyl-transferase; isoform C | Organisim: human | Apparent_Kd_M: 1.582344E-10

Real

Aptamer SeqId:7144-234;Target:KAZD1;UniProt:Q96I82

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7144-234;Target: KAZD1;UniProt: Q96I82;TargetFullName: Kazal-type serine protease inhibitor domain-containing protein 1;Organisim: human;Apparent_Kd_M: 2.52183E-11

Real

Aptamer SeqId: 7144-234 | Target: KAZD1 | UniProt: Q96I82

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7144-234 | Target: KAZD1 | UniProt: Q96I82 | TargetFullName: Kazal-type serine protease inhibitor domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.52183E-11

Real

Aptamer SeqId:7145-1;Target:ITIH3;UniProt:Q06033

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7145-1;Target: ITIH3;UniProt: Q06033;TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H3;Organisim: human;Apparent_Kd_M: 7.335923E-11

Real

Aptamer SeqId: 7145-1 | Target: ITIH3 | UniProt: Q06033

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7145-1 | Target: ITIH3 | UniProt: Q06033 | TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H3 | Organisim: human | Apparent_Kd_M: 7.335923E-11

Real

Aptamer SeqId:7146-16;Target:PDIA4;UniProt:P13667

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7146-16;Target: PDIA4;UniProt: P13667;TargetFullName: Protein disulfide-isomerase A4;Organisim: human;Apparent_Kd_M: 4.67E-11

Real

Aptamer SeqId: 7146-16 | Target: PDIA4 | UniProt: P13667

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7146-16 | Target: PDIA4 | UniProt: P13667 | TargetFullName: Protein disulfide-isomerase A4 | Organisim: human | Apparent_Kd_M: 4.67E-11

Real

Aptamer SeqId:7147-35;Target:WFDC8;UniProt:Q8IUA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7147-35;Target: WFDC8;UniProt: Q8IUA0;TargetFullName: WAP four-disulfide core domain protein 8;Organisim: human;Apparent_Kd_M: 9.347653E-12

Real

Aptamer SeqId: 7147-35 | Target: WFDC8 | UniProt: Q8IUA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7147-35 | Target: WFDC8 | UniProt: Q8IUA0 | TargetFullName: WAP four-disulfide core domain protein 8 | Organisim: human | Apparent_Kd_M: 9.347653E-12

Real

Aptamer SeqId:7148-42;Target:F173A;UniProt:Q9BQD7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7148-42;Target: F173A;UniProt: Q9BQD7;TargetFullName: Protein FAM173A;Organisim: human;Apparent_Kd_M: 2.330027E-11

Real

Aptamer SeqId: 7148-42 | Target: F173A | UniProt: Q9BQD7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7148-42 | Target: F173A | UniProt: Q9BQD7 | TargetFullName: Protein FAM173A | Organisim: human | Apparent_Kd_M: 2.330027E-11

Real

Aptamer SeqId:7153-66;Target:NGRN;UniProt:Q9NPE2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7153-66;Target: NGRN;UniProt: Q9NPE2;TargetFullName: Neugrin;Organisim: human;Apparent_Kd_M: 8.050365E-12

Real

Aptamer SeqId: 7153-66 | Target: NGRN | UniProt: Q9NPE2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7153-66 | Target: NGRN | UniProt: Q9NPE2 | TargetFullName: Neugrin | Organisim: human | Apparent_Kd_M: 8.050365E-12

Real

Aptamer SeqId:7154-92;Target:CF058;UniProt:Q6P5S2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7154-92;Target: CF058;UniProt: Q6P5S2;TargetFullName: Protein LEG1 homolog;Organisim: human;Apparent_Kd_M: 1.856635E-11

Real

Aptamer SeqId: 7154-92 | Target: CF058 | UniProt: Q6P5S2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7154-92 | Target: CF058 | UniProt: Q6P5S2 | TargetFullName: Protein LEG1 homolog | Organisim: human | Apparent_Kd_M: 1.856635E-11

Real

Aptamer SeqId:7155-46;Target:C4b-binding protein beta chain;UniProt:P20851

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7155-46;Target: C4b-binding protein beta chain;UniProt: P20851;TargetFullName: C4b-binding protein beta chain;Organisim: human;Apparent_Kd_M: 2.240317E-11

Real

Aptamer SeqId: 7155-46 | Target: C4b-binding protein beta chain

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7155-46 | Target: C4b-binding protein beta chain | UniProt: P20851 | TargetFullName: C4b-binding protein beta chain | Organisim: human | Apparent_Kd_M: 2.240317E-11

Real

Aptamer SeqId:7156-2;Target:FUT10;UniProt:Q6P4F1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7156-2;Target: FUT10;UniProt: Q6P4F1;TargetFullName: Alpha-(1;3)-fucosyltransferase 10;Organisim: human;Apparent_Kd_M: 2.90943E-12

Real

Aptamer SeqId: 7156-2 | Target: FUT10 | UniProt: Q6P4F1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7156-2 | Target: FUT10 | UniProt: Q6P4F1 | TargetFullName: Alpha-(1;3)-fucosyltransferase 10 | Organisim: human | Apparent_Kd_M: 2.90943E-12

Real

Aptamer SeqId:7157-22;Target:PCDA4;UniProt:Q9UN74

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7157-22;Target: PCDA4;UniProt: Q9UN74;TargetFullName: Protocadherin alpha-4;Organisim: human;Apparent_Kd_M: 5.02E-11

Real

Aptamer SeqId: 7157-22 | Target: PCDA4 | UniProt: Q9UN74

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7157-22 | Target: PCDA4 | UniProt: Q9UN74 | TargetFullName: Protocadherin alpha-4 | Organisim: human | Apparent_Kd_M: 5.02E-11

Real

Aptamer SeqId:7161-25;Target:G6PE;UniProt:O95479

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7161-25;Target: G6PE;UniProt: O95479;TargetFullName: GDH/6PGL endoplasmic bifunctional protein;Organisim: human;Apparent_Kd_M: 1.264998E-11

Real

Aptamer SeqId: 7161-25 | Target: G6PE | UniProt: O95479

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7161-25 | Target: G6PE | UniProt: O95479 | TargetFullName: GDH/6PGL endoplasmic bifunctional protein | Organisim: human | Apparent_Kd_M: 1.264998E-11

Real

Aptamer SeqId:7163-26;Target:lacritin;UniProt:Q9GZZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7163-26;Target: lacritin;UniProt: Q9GZZ8;TargetFullName: Extracellular glycoprotein lacritin;Organisim: human;Apparent_Kd_M: 1.636109E-11

Real

Aptamer SeqId: 7163-26 | Target: lacritin | UniProt: Q9GZZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7163-26 | Target: lacritin | UniProt: Q9GZZ8 | TargetFullName: Extracellular glycoprotein lacritin | Organisim: human | Apparent_Kd_M: 1.636109E-11

Real

Aptamer SeqId:7167-102;Target:VAPA;UniProt:Q9P0L0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7167-102;Target: VAPA;UniProt: Q9P0L0;TargetFullName: Vesicle-associated membrane protein-associated protein A;Organisim: human;Apparent_Kd_M: 4.382126E-12

Real

Aptamer SeqId: 7167-102 | Target: VAPA | UniProt: Q9P0L0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7167-102 | Target: VAPA | UniProt: Q9P0L0 | TargetFullName: Vesicle-associated membrane protein-associated protein A | Organisim: human | Apparent_Kd_M: 4.382126E-12

Real

Aptamer SeqId:7173-141;Target:T132C;UniProt:Q8N3T6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7173-141;Target: T132C;UniProt: Q8N3T6;TargetFullName: Transmembrane protein 132C;Organisim: human;Apparent_Kd_M: 4.98E-11

Real

Aptamer SeqId: 7173-141 | Target: T132C | UniProt: Q8N3T6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7173-141 | Target: T132C | UniProt: Q8N3T6 | TargetFullName: Transmembrane protein 132C | Organisim: human | Apparent_Kd_M: 4.98E-11

Real

Aptamer SeqId:7175-4;Target:PCDG2;UniProt:Q9Y5H1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7175-4;Target: PCDG2;UniProt: Q9Y5H1;TargetFullName: Protocadherin gamma-A2;Organisim: human;Apparent_Kd_M: 8.195621E-11

Real

Aptamer SeqId: 7175-4 | Target: PCDG2 | UniProt: Q9Y5H1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7175-4 | Target: PCDG2 | UniProt: Q9Y5H1 | TargetFullName: Protocadherin gamma-A2 | Organisim: human | Apparent_Kd_M: 8.195621E-11

Real

Aptamer SeqId:7178-59;Target:DEPP;UniProt:Q9NTK1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7178-59;Target: DEPP;UniProt: Q9NTK1;TargetFullName: Protein DEPP;Organisim: human;Apparent_Kd_M: 3.500687E-11

Real

Aptamer SeqId: 7178-59 | Target: DEPP | UniProt: Q9NTK1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7178-59 | Target: DEPP | UniProt: Q9NTK1 | TargetFullName: Protein DEPP | Organisim: human | Apparent_Kd_M: 3.500687E-11

Real

Aptamer SeqId:7179-69;Target:NFASC;UniProt:O94856

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7179-69;Target: NFASC;UniProt: O94856;TargetFullName: Neurofascin;Organisim: human;Apparent_Kd_M: 2.799038E-12

Real

Aptamer SeqId: 7179-69 | Target: NFASC | UniProt: O94856

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7179-69 | Target: NFASC | UniProt: O94856 | TargetFullName: Neurofascin | Organisim: human | Apparent_Kd_M: 2.799038E-12

Real

Aptamer SeqId:7180-114;Target:IFN14;UniProt:P01570

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7180-114;Target: IFN14;UniProt: P01570;TargetFullName: Interferon alpha-14;Organisim: human;Apparent_Kd_M: 2.536957E-11

Real

Aptamer SeqId: 7180-114 | Target: IFN14 | UniProt: P01570

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7180-114 | Target: IFN14 | UniProt: P01570 | TargetFullName: Interferon alpha-14 | Organisim: human | Apparent_Kd_M: 2.536957E-11

Real

Aptamer SeqId:7181-17;Target:VAPB;UniProt:O95292

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7181-17;Target: VAPB;UniProt: O95292;TargetFullName: Vesicle-associated membrane protein-associated protein B/C;Organisim: human;Apparent_Kd_M: 9.282958E-12

Real

Aptamer SeqId: 7181-17 | Target: VAPB | UniProt: O95292

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7181-17 | Target: VAPB | UniProt: O95292 | TargetFullName: Vesicle-associated membrane protein-associated protein B/C | Organisim: human | Apparent_Kd_M: 9.282958E-12

Real

Aptamer SeqId:7183-102;Target:TD26;UniProt:Q6UXH0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7183-102;Target: TD26;UniProt: Q6UXH0;TargetFullName: Angiopoietin-like protein 8;Organisim: human;Apparent_Kd_M: 6.735987E-12

Real

Aptamer SeqId: 7183-102 | Target: TD26 | UniProt: Q6UXH0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7183-102 | Target: TD26 | UniProt: Q6UXH0 | TargetFullName: Angiopoietin-like protein 8 | Organisim: human | Apparent_Kd_M: 6.735987E-12

Real

Aptamer SeqId:7184-13;Target:CEAM7;UniProt:Q14002

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7184-13;Target: CEAM7;UniProt: Q14002;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 7;Organisim: human;Apparent_Kd_M: 5.335929E-11

Real

Aptamer SeqId: 7184-13 | Target: CEAM7 | UniProt: Q14002

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7184-13 | Target: CEAM7 | UniProt: Q14002 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 7 | Organisim: human | Apparent_Kd_M: 5.335929E-11

Real

Aptamer SeqId:7185-29;Target:GPV;UniProt:P40197

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7185-29;Target: GPV;UniProt: P40197;TargetFullName: Platelet glycoprotein V;Organisim: human;Apparent_Kd_M: 2.483899E-12

Real

Aptamer SeqId: 7185-29 | Target: GPV | UniProt: P40197

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7185-29 | Target: GPV | UniProt: P40197 | TargetFullName: Platelet glycoprotein V | Organisim: human | Apparent_Kd_M: 2.483899E-12

Real

Aptamer SeqId:7186-111;Target:STX3;UniProt:Q13277

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7186-111;Target: STX3;UniProt: Q13277;TargetFullName: Syntaxin-3;Organisim: human;Apparent_Kd_M: 2.228013E-11

Real

Aptamer SeqId: 7186-111 | Target: STX3 | UniProt: Q13277

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7186-111 | Target: STX3 | UniProt: Q13277 | TargetFullName: Syntaxin-3 | Organisim: human | Apparent_Kd_M: 2.228013E-11

Real

Aptamer SeqId:7187-3;Target:PPM1L;UniProt:Q5SGD2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7187-3;Target: PPM1L;UniProt: Q5SGD2;TargetFullName: Protein phosphatase 1L;Organisim: human;Apparent_Kd_M: 3.34554E-10

Real

Aptamer SeqId: 7187-3 | Target: PPM1L | UniProt: Q5SGD2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7187-3 | Target: PPM1L | UniProt: Q5SGD2 | TargetFullName: Protein phosphatase 1L | Organisim: human | Apparent_Kd_M: 3.34554E-10

Real

Aptamer SeqId:7189-55;Target:CHST3;UniProt:Q7LGC8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7189-55;Target: CHST3;UniProt: Q7LGC8;TargetFullName: Carbohydrate sulfotransferase 3;Organisim: human;Apparent_Kd_M: 1.448659E-10

Real

Aptamer SeqId: 7189-55 | Target: CHST3 | UniProt: Q7LGC8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7189-55 | Target: CHST3 | UniProt: Q7LGC8 | TargetFullName: Carbohydrate sulfotransferase 3 | Organisim: human | Apparent_Kd_M: 1.448659E-10

Real

Aptamer SeqId:7191-32;Target:SLMAP;UniProt:Q14BN4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7191-32;Target: SLMAP;UniProt: Q14BN4;TargetFullName: Sarcolemmal membrane-associated protein;Organisim: human;Apparent_Kd_M: 6.22E-11

Real

Aptamer SeqId: 7191-32 | Target: SLMAP | UniProt: Q14BN4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7191-32 | Target: SLMAP | UniProt: Q14BN4 | TargetFullName: Sarcolemmal membrane-associated protein | Organisim: human | Apparent_Kd_M: 6.22E-11

Real

Aptamer SeqId:7192-37;Target:CRF2-12;UniProt:Q8IU57

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7192-37;Target: CRF2-12;UniProt: Q8IU57;TargetFullName: Interferon lambda receptor 1;Organisim: human;Apparent_Kd_M: 1.933193E-11

Real

Aptamer SeqId: 7192-37 | Target: CRF2-12 | UniProt: Q8IU57

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7192-37 | Target: CRF2-12 | UniProt: Q8IU57 | TargetFullName: Interferon lambda receptor 1 | Organisim: human | Apparent_Kd_M: 1.933193E-11

Real

Aptamer SeqId:7193-98;Target:PCDC1;UniProt:Q9H158

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7193-98;Target: PCDC1;UniProt: Q9H158;TargetFullName: Protocadherin alpha-C1;Organisim: human;Apparent_Kd_M: 1.281087E-10

Real

Aptamer SeqId: 7193-98 | Target: PCDC1 | UniProt: Q9H158

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7193-98 | Target: PCDC1 | UniProt: Q9H158 | TargetFullName: Protocadherin alpha-C1 | Organisim: human | Apparent_Kd_M: 1.281087E-10

Real

Aptamer SeqId:7194-36;Target:NPTN;UniProt:Q9Y639

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7194-36;Target: NPTN;UniProt: Q9Y639;TargetFullName: Neuroplastin;Organisim: human;Apparent_Kd_M: 3.220418E-12

Real

Aptamer SeqId: 7194-36 | Target: NPTN | UniProt: Q9Y639

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7194-36 | Target: NPTN | UniProt: Q9Y639 | TargetFullName: Neuroplastin | Organisim: human | Apparent_Kd_M: 3.220418E-12

Real

Aptamer SeqId:7196-21;Target:IFN-w;UniProt:P05000

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7196-21;Target: IFN-w;UniProt: P05000;TargetFullName: Interferon omega-1;Organisim: human;Apparent_Kd_M: 2.574077E-12

Real

Aptamer SeqId: 7196-21 | Target: IFN-w | UniProt: P05000

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7196-21 | Target: IFN-w | UniProt: P05000 | TargetFullName: Interferon omega-1 | Organisim: human | Apparent_Kd_M: 2.574077E-12

Real

Aptamer SeqId:7197-2;Target:DJC15;UniProt:Q9Y5T4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7197-2;Target: DJC15;UniProt: Q9Y5T4;TargetFullName: DnaJ homolog subfamily C member 15;Organisim: human;Apparent_Kd_M: 4.613849E-11

Real

Aptamer SeqId: 7197-2 | Target: DJC15 | UniProt: Q9Y5T4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7197-2 | Target: DJC15 | UniProt: Q9Y5T4 | TargetFullName: DnaJ homolog subfamily C member 15 | Organisim: human | Apparent_Kd_M: 4.613849E-11

Real

Aptamer SeqId:7198-197;Target:FA20B;UniProt:O75063

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7198-197;Target: FA20B;UniProt: O75063;TargetFullName: Glycosaminoglycan xylosylkinase;Organisim: human;Apparent_Kd_M: 1.869451E-12

Real

Aptamer SeqId: 7198-197 | Target: FA20B | UniProt: O75063

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7198-197 | Target: FA20B | UniProt: O75063 | TargetFullName: Glycosaminoglycan xylosylkinase | Organisim: human | Apparent_Kd_M: 1.869451E-12

Real

Aptamer SeqId:7199-3;Target:SYN3;UniProt:O14994

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7199-3;Target: SYN3;UniProt: O14994;TargetFullName: Synapsin-3;Organisim: human;Apparent_Kd_M: 1.441807E-10

Real

Aptamer SeqId: 7199-3 | Target: SYN3 | UniProt: O14994

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7199-3 | Target: SYN3 | UniProt: O14994 | TargetFullName: Synapsin-3 | Organisim: human | Apparent_Kd_M: 1.441807E-10

Real

Aptamer SeqId:7200-4;Target:LRFN2;UniProt:Q9ULH4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7200-4;Target: LRFN2;UniProt: Q9ULH4;TargetFullName: Leucine-rich repeat and fibronectin type-III domain-containing protein 2;Organisim: human;Apparent_Kd_M: 4.721949E-12

Real

Aptamer SeqId: 7200-4 | Target: LRFN2 | UniProt: Q9ULH4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7200-4 | Target: LRFN2 | UniProt: Q9ULH4 | TargetFullName: Leucine-rich repeat and fibronectin type-III domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 4.721949E-12

Real

Aptamer SeqId:7201-5;Target:ISCU;UniProt:Q9H1K1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7201-5;Target: ISCU;UniProt: Q9H1K1;TargetFullName: Iron-sulfur cluster assembly enzyme ISCU; mitochondrial;Organisim: human;Apparent_Kd_M: 3.288003E-11

Real

Aptamer SeqId: 7201-5 | Target: ISCU | UniProt: Q9H1K1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7201-5 | Target: ISCU | UniProt: Q9H1K1 | TargetFullName: Iron-sulfur cluster assembly enzyme ISCU; mitochondrial | Organisim: human | Apparent_Kd_M: 3.288003E-11

Real

Aptamer SeqId:7202-107;Target:SEMA6C;UniProt:Q9H3T2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7202-107;Target: SEMA6C;UniProt: Q9H3T2;TargetFullName: Semaphorin-6C;Organisim: human;Apparent_Kd_M: 2.381011E-11

Real

Aptamer SeqId: 7202-107 | Target: SEMA6C | UniProt: Q9H3T2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7202-107 | Target: SEMA6C | UniProt: Q9H3T2 | TargetFullName: Semaphorin-6C | Organisim: human | Apparent_Kd_M: 2.381011E-11

Real

Aptamer SeqId:7203-125;Target:RFNG;UniProt:Q9Y644

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7203-125;Target: RFNG;UniProt: Q9Y644;TargetFullName: Beta-1;3-N-acetylglucosaminyltransferase radical fringe;Organisim: human;Apparent_Kd_M: 7.58E-12

Real

Aptamer SeqId: 7203-125 | Target: RFNG | UniProt: Q9Y644

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7203-125 | Target: RFNG | UniProt: Q9Y644 | TargetFullName: Beta-1;3-N-acetylglucosaminyltransferase radical fringe | Organisim: human | Apparent_Kd_M: 7.58E-12

Real

Aptamer SeqId:7204-1;Target:CEA21;UniProt:Q3KPI0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7204-1;Target: CEA21;UniProt: Q3KPI0;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 21;Organisim: human;Apparent_Kd_M: 5.923975E-11

Real

Aptamer SeqId: 7204-1 | Target: CEA21 | UniProt: Q3KPI0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7204-1 | Target: CEA21 | UniProt: Q3KPI0 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 21 | Organisim: human | Apparent_Kd_M: 5.923975E-11

Real

Aptamer SeqId:7206-20;Target:F16P1;UniProt:P09467

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7206-20;Target: F16P1;UniProt: P09467;TargetFullName: Fructose-1;6-bisphosphatase 1;Organisim: human;Apparent_Kd_M: 2.073657E-11

Real

Aptamer SeqId: 7206-20 | Target: F16P1 | UniProt: P09467

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7206-20 | Target: F16P1 | UniProt: P09467 | TargetFullName: Fructose-1;6-bisphosphatase 1 | Organisim: human | Apparent_Kd_M: 2.073657E-11

Real

Aptamer SeqId:7207-4;Target:RED;UniProt:Q13123

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7207-4;Target: RED;UniProt: Q13123;TargetFullName: Protein Red;Organisim: human;Apparent_Kd_M: 1.264217E-11

Real

Aptamer SeqId: 7207-4 | Target: RED | UniProt: Q13123

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7207-4 | Target: RED | UniProt: Q13123 | TargetFullName: Protein Red | Organisim: human | Apparent_Kd_M: 1.264217E-11

Real

Aptamer SeqId:7208-60;Target:MGT4C;UniProt:Q9UBM8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7208-60;Target: MGT4C;UniProt: Q9UBM8;TargetFullName: Alpha-1;3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C;Organisim: human;Apparent_Kd_M: 8.334868E-12

Real

Aptamer SeqId: 7208-60 | Target: MGT4C | UniProt: Q9UBM8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7208-60 | Target: MGT4C | UniProt: Q9UBM8 | TargetFullName: Alpha-1;3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C | Organisim: human | Apparent_Kd_M: 8.334868E-12

Real

Aptamer SeqId:7210-25;Target:Amyloid-like protein 1;UniProt:P51693

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7210-25;Target: Amyloid-like protein 1;UniProt: P51693;TargetFullName: Amyloid-like protein 1;Organisim: human;Apparent_Kd_M: 1.393736E-12

Real

Aptamer SeqId: 7210-25 | Target: Amyloid-like protein 1 | UniProt: P51693

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7210-25 | Target: Amyloid-like protein 1 | UniProt: P51693 | TargetFullName: Amyloid-like protein 1 | Organisim: human | Apparent_Kd_M: 1.393736E-12

Real

Aptamer SeqId:7211-2;Target:RNase 1;UniProt:P07998

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7211-2;Target: RNase 1;UniProt: P07998;TargetFullName: Ribonuclease pancreatic;Organisim: human;Apparent_Kd_M: 5.118885E-10

Real

Aptamer SeqId: 7211-2 | Target: RNase 1 | UniProt: P07998

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7211-2 | Target: RNase 1 | UniProt: P07998 | TargetFullName: Ribonuclease pancreatic | Organisim: human | Apparent_Kd_M: 5.118885E-10

Real

Aptamer SeqId:7215-18;Target:NADH-cytochrome b5 reductase;UniProt:P00387

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7215-18;Target: NADH-cytochrome b5 reductase;UniProt: P00387;TargetFullName: NADH-cytochrome b5 reductase 3;Organisim: human;Apparent_Kd_M: 7.979516E-11

Real

Aptamer SeqId: 7215-18 | Target: NADH-cytochrome b5 reductase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7215-18 | Target: NADH-cytochrome b5 reductase | UniProt: P00387 | TargetFullName: NADH-cytochrome b5 reductase 3 | Organisim: human | Apparent_Kd_M: 7.979516E-11

Real

Aptamer SeqId:7218-87;Target:AT1B2;UniProt:P14415

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7218-87;Target: AT1B2;UniProt: P14415;TargetFullName: Sodium/potassium-transporting ATPase subunit beta-2;Organisim: human;Apparent_Kd_M: 2.464043E-12

Real

Aptamer SeqId: 7218-87 | Target: AT1B2 | UniProt: P14415

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7218-87 | Target: AT1B2 | UniProt: P14415 | TargetFullName: Sodium/potassium-transporting ATPase subunit beta-2 | Organisim: human | Apparent_Kd_M: 2.464043E-12

Real

Aptamer SeqId:7219-152;Target:HSP 70;UniProt:

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7219-152;Target: HSP 70;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 2.334565E-11

Real

Aptamer SeqId: 7219-152 | Target: HSP 70 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7219-152 | Target: HSP 70 | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 2.334565E-11

Real

Aptamer SeqId:7221-56;Target:CKAP4;UniProt:Q07065

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7221-56;Target: CKAP4;UniProt: Q07065;TargetFullName: Cytoskeleton-associated protein 4;Organisim: human;Apparent_Kd_M: 2.541661E-10

Real

Aptamer SeqId: 7221-56 | Target: CKAP4 | UniProt: Q07065

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7221-56 | Target: CKAP4 | UniProt: Q07065 | TargetFullName: Cytoskeleton-associated protein 4 | Organisim: human | Apparent_Kd_M: 2.541661E-10

Real

Aptamer SeqId:7223-60;Target:S100A13;UniProt:Q99584

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7223-60;Target: S100A13;UniProt: Q99584;TargetFullName: Protein S100-A13;Organisim: human;Apparent_Kd_M: 1.719686E-10

Real

Aptamer SeqId: 7223-60 | Target: S100A13 | UniProt: Q99584

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7223-60 | Target: S100A13 | UniProt: Q99584 | TargetFullName: Protein S100-A13 | Organisim: human | Apparent_Kd_M: 1.719686E-10

Real

Aptamer SeqId:7224-11;Target:TRAT1;UniProt:Q6PIZ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7224-11;Target: TRAT1;UniProt: Q6PIZ9;TargetFullName: T-cell receptor-associated transmembrane adapter 1;Organisim: human;Apparent_Kd_M: 2.083566E-10

Real

Aptamer SeqId: 7224-11 | Target: TRAT1 | UniProt: Q6PIZ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7224-11 | Target: TRAT1 | UniProt: Q6PIZ9 | TargetFullName: T-cell receptor-associated transmembrane adapter 1 | Organisim: human | Apparent_Kd_M: 2.083566E-10

Real

Aptamer SeqId:7225-51;Target:MMGT1;UniProt:Q8N4V1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7225-51;Target: MMGT1;UniProt: Q8N4V1;TargetFullName: Membrane magnesium transporter 1;Organisim: human;Apparent_Kd_M: 8.208988E-11

Real

Aptamer SeqId: 7225-51 | Target: MMGT1 | UniProt: Q8N4V1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7225-51 | Target: MMGT1 | UniProt: Q8N4V1 | TargetFullName: Membrane magnesium transporter 1 | Organisim: human | Apparent_Kd_M: 8.208988E-11

Real

Aptamer SeqId:7227-75;Target:COCH;UniProt:O43405

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7227-75;Target: COCH;UniProt: O43405;TargetFullName: Cochlin;Organisim: human;Apparent_Kd_M: 1.009731E-12

Real

Aptamer SeqId: 7227-75 | Target: COCH | UniProt: O43405

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7227-75 | Target: COCH | UniProt: O43405 | TargetFullName: Cochlin | Organisim: human | Apparent_Kd_M: 1.009731E-12

Real

Aptamer SeqId:7228-2;Target:SIA7F;UniProt:Q969X2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7228-2;Target: SIA7F;UniProt: Q969X2;TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 6;Organisim: human;Apparent_Kd_M: 3.944138E-11

Real

Aptamer SeqId: 7228-2 | Target: SIA7F | UniProt: Q969X2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7228-2 | Target: SIA7F | UniProt: Q969X2 | TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 6 | Organisim: human | Apparent_Kd_M: 3.944138E-11

Real

Aptamer SeqId:7231-37;Target:TM11A;UniProt:Q6ZMR5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7231-37;Target: TM11A;UniProt: Q6ZMR5;TargetFullName: Transmembrane protease serine 11A;Organisim: human;Apparent_Kd_M: 3.235025E-12

Real

Aptamer SeqId: 7231-37 | Target: TM11A | UniProt: Q6ZMR5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7231-37 | Target: TM11A | UniProt: Q6ZMR5 | TargetFullName: Transmembrane protease serine 11A | Organisim: human | Apparent_Kd_M: 3.235025E-12

Real

Aptamer SeqId:7233-73;Target:P2RX6;UniProt:O15547

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7233-73;Target: P2RX6;UniProt: O15547;TargetFullName: P2X purinoceptor 6;Organisim: human;Apparent_Kd_M: 2.7794E-12

Real

Aptamer SeqId: 7233-73 | Target: P2RX6 | UniProt: O15547

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7233-73 | Target: P2RX6 | UniProt: O15547 | TargetFullName: P2X purinoceptor 6 | Organisim: human | Apparent_Kd_M: 2.7794E-12

Real

Aptamer SeqId:7234-12;Target:GT252;UniProt:Q8IYK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7234-12;Target: GT252;UniProt: Q8IYK4;TargetFullName: Procollagen galactosyltransferase 2;Organisim: human;Apparent_Kd_M: 4.708019E-12

Real

Aptamer SeqId: 7234-12 | Target: GT252 | UniProt: Q8IYK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7234-12 | Target: GT252 | UniProt: Q8IYK4 | TargetFullName: Procollagen galactosyltransferase 2 | Organisim: human | Apparent_Kd_M: 4.708019E-12

Real

Aptamer SeqId:7240-2;Target:MBTP1;UniProt:Q14703

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7240-2;Target: MBTP1;UniProt: Q14703;TargetFullName: Membrane-bound transcription factor site-1 protease;Organisim: human;Apparent_Kd_M: 1.849621E-11

Real

Aptamer SeqId: 7240-2 | Target: MBTP1 | UniProt: Q14703

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7240-2 | Target: MBTP1 | UniProt: Q14703 | TargetFullName: Membrane-bound transcription factor site-1 protease | Organisim: human | Apparent_Kd_M: 1.849621E-11

Real

Aptamer SeqId:7242-14;Target:CJ072;UniProt:Q8IW00

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7242-14;Target: CJ072;UniProt: Q8IW00;TargetFullName: V-set and transmembrane domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.454001E-10

Real

Aptamer SeqId: 7242-14 | Target: CJ072 | UniProt: Q8IW00

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7242-14 | Target: CJ072 | UniProt: Q8IW00 | TargetFullName: V-set and transmembrane domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.454001E-10

Real

Aptamer SeqId:7244-16;Target:TM149;UniProt:Q9H665

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7244-16;Target: TM149;UniProt: Q9H665;TargetFullName: IGF-like family receptor 1;Organisim: human;Apparent_Kd_M: 1.205365E-11

Real

Aptamer SeqId: 7244-16 | Target: TM149 | UniProt: Q9H665

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7244-16 | Target: TM149 | UniProt: Q9H665 | TargetFullName: IGF-like family receptor 1 | Organisim: human | Apparent_Kd_M: 1.205365E-11

Real

Aptamer SeqId:7245-2;Target:CELF2;UniProt:O95319

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7245-2;Target: CELF2;UniProt: O95319;TargetFullName: CUGBP Elav-like family member 2;Organisim: human;Apparent_Kd_M: 2.454089E-10

Real

Aptamer SeqId: 7245-2 | Target: CELF2 | UniProt: O95319

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7245-2 | Target: CELF2 | UniProt: O95319 | TargetFullName: CUGBP Elav-like family member 2 | Organisim: human | Apparent_Kd_M: 2.454089E-10

Real

Aptamer SeqId:7246-4;Target:FREM2;UniProt:Q5SZK8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7246-4;Target: FREM2;UniProt: Q5SZK8;TargetFullName: FRAS1-related extracellular matrix protein 2;Organisim: human;Apparent_Kd_M: 1.682385E-10

Real

Aptamer SeqId: 7246-4 | Target: FREM2 | UniProt: Q5SZK8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7246-4 | Target: FREM2 | UniProt: Q5SZK8 | TargetFullName: FRAS1-related extracellular matrix protein 2 | Organisim: human | Apparent_Kd_M: 1.682385E-10

Real

Aptamer SeqId:7247-1;Target:GORAB;UniProt:Q5T7V8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7247-1;Target: GORAB;UniProt: Q5T7V8;TargetFullName: RAB6-interacting golgin;Organisim: human;Apparent_Kd_M: 5.611159E-11

Real

Aptamer SeqId: 7247-1 | Target: GORAB | UniProt: Q5T7V8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7247-1 | Target: GORAB | UniProt: Q5T7V8 | TargetFullName: RAB6-interacting golgin | Organisim: human | Apparent_Kd_M: 5.611159E-11

Real

Aptamer SeqId:7249-307;Target:B2L10;UniProt:Q9HD36

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7249-307;Target: B2L10;UniProt: Q9HD36;TargetFullName: Bcl-2-like protein 10;Organisim: human;Apparent_Kd_M: 1.147467E-10

Real

Aptamer SeqId: 7249-307 | Target: B2L10 | UniProt: Q9HD36

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7249-307 | Target: B2L10 | UniProt: Q9HD36 | TargetFullName: Bcl-2-like protein 10 | Organisim: human | Apparent_Kd_M: 1.147467E-10

Real

Aptamer SeqId:7251-64;Target:C1QT3;UniProt:Q9BXJ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7251-64;Target: C1QT3;UniProt: Q9BXJ4;TargetFullName: Complement C1q tumor necrosis factor-related protein 3;Organisim: human;Apparent_Kd_M: 2.31E-10

Real

Aptamer SeqId: 7251-64 | Target: C1QT3 | UniProt: Q9BXJ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7251-64 | Target: C1QT3 | UniProt: Q9BXJ4 | TargetFullName: Complement C1q tumor necrosis factor-related protein 3 | Organisim: human | Apparent_Kd_M: 2.31E-10

Real

Aptamer SeqId:7253-6;Target:QKI;UniProt:Q96PU8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7253-6;Target: QKI;UniProt: Q96PU8;TargetFullName: Protein quaking;Organisim: human;Apparent_Kd_M: 7.214447E-11

Real

Aptamer SeqId: 7253-6 | Target: QKI | UniProt: Q96PU8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7253-6 | Target: QKI | UniProt: Q96PU8 | TargetFullName: Protein quaking | Organisim: human | Apparent_Kd_M: 7.214447E-11

Real

Aptamer SeqId:7257-18;Target:TIP39;UniProt:Q96A98

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7257-18;Target: TIP39;UniProt: Q96A98;TargetFullName: Tuberoinfundibular peptide of 39 residues;Organisim: human;Apparent_Kd_M: 3.384162E-12

Real

Aptamer SeqId: 7257-18 | Target: TIP39 | UniProt: Q96A98

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7257-18 | Target: TIP39 | UniProt: Q96A98 | TargetFullName: Tuberoinfundibular peptide of 39 residues | Organisim: human | Apparent_Kd_M: 3.384162E-12

Real

Aptamer SeqId:7258-5;Target:EMBP;UniProt:P13727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7258-5;Target: EMBP;UniProt: P13727;TargetFullName: Bone marrow proteoglycan;Organisim: human;Apparent_Kd_M: 1.521429E-11

Real

Aptamer SeqId: 7258-5 | Target: EMBP | UniProt: P13727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7258-5 | Target: EMBP | UniProt: P13727 | TargetFullName: Bone marrow proteoglycan | Organisim: human | Apparent_Kd_M: 1.521429E-11

Real

Aptamer SeqId:7262-191;Target:CHSTE;UniProt:Q8NCH0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7262-191;Target: CHSTE;UniProt: Q8NCH0;TargetFullName: Carbohydrate sulfotransferase 14;Organisim: human;Apparent_Kd_M: 3.023693E-12

Real

Aptamer SeqId: 7262-191 | Target: CHSTE | UniProt: Q8NCH0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7262-191 | Target: CHSTE | UniProt: Q8NCH0 | TargetFullName: Carbohydrate sulfotransferase 14 | Organisim: human | Apparent_Kd_M: 3.023693E-12

Real

Aptamer SeqId:7265-32;Target:OSTN;UniProt:P61366

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7265-32;Target: OSTN;UniProt: P61366;TargetFullName: Osteocrin;Organisim: human;Apparent_Kd_M: 2.950333E-11

Real

Aptamer SeqId: 7265-32 | Target: OSTN | UniProt: P61366

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7265-32 | Target: OSTN | UniProt: P61366 | TargetFullName: Osteocrin | Organisim: human | Apparent_Kd_M: 2.950333E-11

Real

Aptamer SeqId:7266-4;Target:SPA9;UniProt:Q86WD7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7266-4;Target: SPA9;UniProt: Q86WD7;TargetFullName: Serpin A9;Organisim: human;Apparent_Kd_M: 2.100763E-12

Real

Aptamer SeqId: 7266-4 | Target: SPA9 | UniProt: Q86WD7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7266-4 | Target: SPA9 | UniProt: Q86WD7 | TargetFullName: Serpin A9 | Organisim: human | Apparent_Kd_M: 2.100763E-12

Real

Aptamer SeqId:7267-2;Target:LCB2;UniProt:O15270

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7267-2;Target: LCB2;UniProt: O15270;TargetFullName: Serine palmitoyltransferase 2;Organisim: human;Apparent_Kd_M: 2.267334E-10

Real

Aptamer SeqId: 7267-2 | Target: LCB2 | UniProt: O15270

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7267-2 | Target: LCB2 | UniProt: O15270 | TargetFullName: Serine palmitoyltransferase 2 | Organisim: human | Apparent_Kd_M: 2.267334E-10

Real

Aptamer SeqId:7551-33;Target:LRC32;UniProt:Q14392

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7551-33;Target: LRC32;UniProt: Q14392;TargetFullName: Leucine-rich repeat-containing protein 32;Organisim: human;Apparent_Kd_M: 4.937785E-12

Real

Aptamer SeqId: 7551-33 | Target: LRC32 | UniProt: Q14392

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7551-33 | Target: LRC32 | UniProt: Q14392 | TargetFullName: Leucine-rich repeat-containing protein 32 | Organisim: human | Apparent_Kd_M: 4.937785E-12

Real

Aptamer SeqId:7624-19;Target:ANK2;UniProt:Q01484

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7624-19;Target: ANK2;UniProt: Q01484;TargetFullName: Ankyrin-2;Organisim: human;Apparent_Kd_M: 3.24E-11

Real

Aptamer SeqId: 7624-19 | Target: ANK2 | UniProt: Q01484

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7624-19 | Target: ANK2 | UniProt: Q01484 | TargetFullName: Ankyrin-2 | Organisim: human | Apparent_Kd_M: 3.24E-11

Real

Aptamer SeqId:7625-27;Target:14-3-3 protein theta;UniProt:P27348

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7625-27;Target: 14-3-3 protein theta;UniProt: P27348;TargetFullName: 14-3-3 protein theta;Organisim: human;Apparent_Kd_M: 1.13E-10

Real

Aptamer SeqId: 7625-27 | Target: 14-3-3 protein theta | UniProt: P27348

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7625-27 | Target: 14-3-3 protein theta | UniProt: P27348 | TargetFullName: 14-3-3 protein theta | Organisim: human | Apparent_Kd_M: 1.13E-10

Real

Aptamer SeqId:7628-40;Target:CREL1;UniProt:Q96HD1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7628-40;Target: CREL1;UniProt: Q96HD1;TargetFullName: Cysteine-rich with EGF-like domain protein 1;Organisim: human;Apparent_Kd_M: 5.77E-12

Real

Aptamer SeqId: 7628-40 | Target: CREL1 | UniProt: Q96HD1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7628-40 | Target: CREL1 | UniProt: Q96HD1 | TargetFullName: Cysteine-rich with EGF-like domain protein 1 | Organisim: human | Apparent_Kd_M: 5.77E-12

Real

Aptamer SeqId:7638-30;Target:Lectin; mannose-binding 2;UniProt:Q12907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7638-30;Target: Lectin; mannose-binding 2;UniProt: Q12907;TargetFullName: Vesicular integral-membrane protein VIP36;Organisim: human;Apparent_Kd_M: 6.94E-12

Real

Aptamer SeqId: 7638-30 | Target: Lectin mannose-binding 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7638-30 | Target: Lectin; mannose-binding 2 | UniProt: Q12907 | TargetFullName: Vesicular integral-membrane protein VIP36 | Organisim: human | Apparent_Kd_M: 6.94E-12

Real

Aptamer SeqId:7648-9;Target:MYPC1;UniProt:Q00872

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7648-9;Target: MYPC1;UniProt: Q00872;TargetFullName: Myosin-binding protein C; slow-type;Organisim: human;Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId: 7648-9 | Target: MYPC1 | UniProt: Q00872

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7648-9 | Target: MYPC1 | UniProt: Q00872 | TargetFullName: Myosin-binding protein C; slow-type | Organisim: human | Apparent_Kd_M: 2.31E-12

Real

Aptamer SeqId:7655-11;Target:N-terminal pro-BNP;UniProt:P16860

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7655-11;Target: N-terminal pro-BNP;UniProt: P16860;TargetFullName: N-terminal pro-BNP;Organisim: human;Apparent_Kd_M: 1.83E-12

Real

Aptamer SeqId: 7655-11 | Target: N-terminal pro-BNP | UniProt: P16860

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7655-11 | Target: N-terminal pro-BNP | UniProt: P16860 | TargetFullName: N-terminal pro-BNP | Organisim: human | Apparent_Kd_M: 1.83E-12

Real

Aptamer SeqId:7696-3;Target:NBR1;UniProt:Q14596

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7696-3;Target: NBR1;UniProt: Q14596;TargetFullName: Next to BRCA1 gene 1 protein;Organisim: human;Apparent_Kd_M: 1.149229E-9

Real

Aptamer SeqId: 7696-3 | Target: NBR1 | UniProt: Q14596

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7696-3 | Target: NBR1 | UniProt: Q14596 | TargetFullName: Next to BRCA1 gene 1 protein | Organisim: human | Apparent_Kd_M: 1.149229E-9

Real

Aptamer SeqId:7713-102;Target:FMR1;UniProt:Q06787

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7713-102;Target: FMR1;UniProt: Q06787;TargetFullName: Fragile X mental retardation protein 1;Organisim: human;Apparent_Kd_M: 1.163933E-10

Real

Aptamer SeqId: 7713-102 | Target: FMR1 | UniProt: Q06787

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7713-102 | Target: FMR1 | UniProt: Q06787 | TargetFullName: Fragile X mental retardation protein 1 | Organisim: human | Apparent_Kd_M: 1.163933E-10

Real

Aptamer SeqId:7717-95;Target:CFTR;UniProt:P13569

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7717-95;Target: CFTR;UniProt: P13569;TargetFullName: Cystic fibrosis transmembrane conductance regulator;Organisim: human;Apparent_Kd_M: 6.814283E-12

Real

Aptamer SeqId: 7717-95 | Target: CFTR | UniProt: P13569

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7717-95 | Target: CFTR | UniProt: P13569 | TargetFullName: Cystic fibrosis transmembrane conductance regulator | Organisim: human | Apparent_Kd_M: 6.814283E-12

Real

Aptamer SeqId:7732-45;Target:VAMP4;UniProt:O75379

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7732-45;Target: VAMP4;UniProt: O75379;TargetFullName: Vesicle-associated membrane protein 4;Organisim: human;Apparent_Kd_M: 1.393479E-11

Real

Aptamer SeqId: 7732-45 | Target: VAMP4 | UniProt: O75379

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7732-45 | Target: VAMP4 | UniProt: O75379 | TargetFullName: Vesicle-associated membrane protein 4 | Organisim: human | Apparent_Kd_M: 1.393479E-11

Real

Aptamer SeqId:7736-28;Target:OPALI;UniProt:Q96PE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7736-28;Target: OPALI;UniProt: Q96PE5;TargetFullName: Opalin;Organisim: human;Apparent_Kd_M: 1.029892E-10

Real

Aptamer SeqId: 7736-28 | Target: OPALI | UniProt: Q96PE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7736-28 | Target: OPALI | UniProt: Q96PE5 | TargetFullName: Opalin | Organisim: human | Apparent_Kd_M: 1.029892E-10

Real

Aptamer SeqId:7737-76;Target:ITB6;UniProt:P18564

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7737-76;Target: ITB6;UniProt: P18564;TargetFullName: Integrin beta-6;Organisim: human;Apparent_Kd_M: 1.033911E-10

Real

Aptamer SeqId: 7737-76 | Target: ITB6 | UniProt: P18564

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7737-76 | Target: ITB6 | UniProt: P18564 | TargetFullName: Integrin beta-6 | Organisim: human | Apparent_Kd_M: 1.033911E-10

Real

Aptamer SeqId:7738-299;Target:STX2;UniProt:P32856

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7738-299;Target: STX2;UniProt: P32856;TargetFullName: Syntaxin-2;Organisim: human;Apparent_Kd_M: 1.452103E-11

Real

Aptamer SeqId: 7738-299 | Target: STX2 | UniProt: P32856

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7738-299 | Target: STX2 | UniProt: P32856 | TargetFullName: Syntaxin-2 | Organisim: human | Apparent_Kd_M: 1.452103E-11

Real

Aptamer SeqId:7740-33;Target:FATE1;UniProt:Q969F0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7740-33;Target: FATE1;UniProt: Q969F0;TargetFullName: Fetal and adult testis-expressed transcript protein;Organisim: human;Apparent_Kd_M: 5.511694E-11

Real

Aptamer SeqId: 7740-33 | Target: FATE1 | UniProt: Q969F0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7740-33 | Target: FATE1 | UniProt: Q969F0 | TargetFullName: Fetal and adult testis-expressed transcript protein | Organisim: human | Apparent_Kd_M: 5.511694E-11

Real

Aptamer SeqId:7741-111;Target:RTF1;UniProt:Q92541

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7741-111;Target: RTF1;UniProt: Q92541;TargetFullName: RNA polymerase-associated protein RTF1 homolog;Organisim: human;Apparent_Kd_M: 5.295403E-11

Real

Aptamer SeqId: 7741-111 | Target: RTF1 | UniProt: Q92541

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7741-111 | Target: RTF1 | UniProt: Q92541 | TargetFullName: RNA polymerase-associated protein RTF1 homolog | Organisim: human | Apparent_Kd_M: 5.295403E-11

Real

Aptamer SeqId:7742-11;Target:RN148;UniProt:Q8N7C7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7742-11;Target: RN148;UniProt: Q8N7C7;TargetFullName: RING finger protein 148;Organisim: human;Apparent_Kd_M: 1.85E-10

Real

Aptamer SeqId: 7742-11 | Target: RN148 | UniProt: Q8N7C7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7742-11 | Target: RN148 | UniProt: Q8N7C7 | TargetFullName: RING finger protein 148 | Organisim: human | Apparent_Kd_M: 1.85E-10

Real

Aptamer SeqId:7743-5;Target:TIM50;UniProt:Q3ZCQ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7743-5;Target: TIM50;UniProt: Q3ZCQ8;TargetFullName: Mitochondrial import inner membrane translocase subunit TIM50;Organisim: human;Apparent_Kd_M: 1.920235E-11

Real

Aptamer SeqId: 7743-5 | Target: TIM50 | UniProt: Q3ZCQ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7743-5 | Target: TIM50 | UniProt: Q3ZCQ8 | TargetFullName: Mitochondrial import inner membrane translocase subunit TIM50 | Organisim: human | Apparent_Kd_M: 1.920235E-11

Real

Aptamer SeqId:7745-3;Target:ZCD1;UniProt:Q9NZ45

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7745-3;Target: ZCD1;UniProt: Q9NZ45;TargetFullName: CDGSH iron-sulfur domain-containing protein 1;Organisim: human;Apparent_Kd_M: 7.167482E-11

Real

Aptamer SeqId: 7745-3 | Target: ZCD1 | UniProt: Q9NZ45

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7745-3 | Target: ZCD1 | UniProt: Q9NZ45 | TargetFullName: CDGSH iron-sulfur domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 7.167482E-11

Real

Aptamer SeqId:7746-230;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7746-230;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.020184E-10

Real

Aptamer SeqId: 7746-230 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7746-230 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.020184E-10

Real

Aptamer SeqId:7747-47;Target:NDUBB;UniProt:Q9NX14

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7747-47;Target: NDUBB;UniProt: Q9NX14;TargetFullName: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11; mitochondrial;Organisim: human;Apparent_Kd_M: 3.829652E-11

Real

Aptamer SeqId: 7747-47 | Target: NDUBB | UniProt: Q9NX14

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7747-47 | Target: NDUBB | UniProt: Q9NX14 | TargetFullName: NADH dehydrogenase ubiquinone 1 beta subcomplex subunit 11; mitochondrial | Organisim: human | Apparent_Kd_M: 3.829652E-11

Real

Aptamer SeqId:7748-11;Target:NDUV2;UniProt:P19404

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7748-11;Target: NDUV2;UniProt: P19404;TargetFullName: NADH dehydrogenase [ubiquinone] flavoprotein 2; mitochondrial;Organisim: human;Apparent_Kd_M: 9.996318E-12

Real

Aptamer SeqId: 7748-11 | Target: NDUV2 | UniProt: P19404

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7748-11 | Target: NDUV2 | UniProt: P19404 | TargetFullName: NADH dehydrogenase ubiquinone flavoprotein 2; mitochondrial | Organisim: human | Apparent_Kd_M: 9.996318E-12

Real

Aptamer SeqId:7751-121;Target:SARP-1;UniProt:Q96HF1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7751-121;Target: SARP-1;UniProt: Q96HF1;TargetFullName: Secreted frizzled-related protein 2;Organisim: human;Apparent_Kd_M: 6.66863E-11

Real

Aptamer SeqId: 7751-121 | Target: SARP-1 | UniProt: Q96HF1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7751-121 | Target: SARP-1 | UniProt: Q96HF1 | TargetFullName: Secreted frizzled-related protein 2 | Organisim: human | Apparent_Kd_M: 6.66863E-11

Real

Aptamer SeqId:7752-31;Target:CLC4D;UniProt:Q8WXI8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7752-31;Target: CLC4D;UniProt: Q8WXI8;TargetFullName: C-type lectin domain family 4 member D;Organisim: human;Apparent_Kd_M: 1.709018E-11

Real

Aptamer SeqId: 7752-31 | Target: CLC4D | UniProt: Q8WXI8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7752-31 | Target: CLC4D | UniProt: Q8WXI8 | TargetFullName: C-type lectin domain family 4 member D | Organisim: human | Apparent_Kd_M: 1.709018E-11

Real

Aptamer SeqId:7753-21;Target:HTAI2;UniProt:Q9BUP3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7753-21;Target: HTAI2;UniProt: Q9BUP3;TargetFullName: Oxidoreductase HTATIP2;Organisim: human;Apparent_Kd_M: 6.34E-12

Real

Aptamer SeqId: 7753-21 | Target: HTAI2 | UniProt: Q9BUP3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7753-21 | Target: HTAI2 | UniProt: Q9BUP3 | TargetFullName: Oxidoreductase HTATIP2 | Organisim: human | Apparent_Kd_M: 6.34E-12

Real

Aptamer SeqId:7754-11;Target:JAG1;UniProt:P78504

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7754-11;Target: JAG1;UniProt: P78504;TargetFullName: Protein jagged-1;Organisim: human;Apparent_Kd_M: 5.27E-11

Real

Aptamer SeqId: 7754-11 | Target: JAG1 | UniProt: P78504

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7754-11 | Target: JAG1 | UniProt: P78504 | TargetFullName: Protein jagged-1 | Organisim: human | Apparent_Kd_M: 5.27E-11

Real

Aptamer SeqId:7755-37;Target:ITB5;UniProt:P18084

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7755-37;Target: ITB5;UniProt: P18084;TargetFullName: Integrin beta-5;Organisim: human;Apparent_Kd_M: 2.350152E-11

Real

Aptamer SeqId: 7755-37 | Target: ITB5 | UniProt: P18084

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7755-37 | Target: ITB5 | UniProt: P18084 | TargetFullName: Integrin beta-5 | Organisim: human | Apparent_Kd_M: 2.350152E-11

Real

Aptamer SeqId:7757-5;Target:DQA2;UniProt:P01906

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7757-5;Target: DQA2;UniProt: P01906;TargetFullName: HLA class II histocompatibility antigen; DQ alpha 2 chain;Organisim: human;Apparent_Kd_M: 1.198247E-11

Real

Aptamer SeqId: 7757-5 | Target: DQA2 | UniProt: P01906

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7757-5 | Target: DQA2 | UniProt: P01906 | TargetFullName: HLA class II histocompatibility antigen; DQ alpha 2 chain | Organisim: human | Apparent_Kd_M: 1.198247E-11

Real

Aptamer SeqId:7758-217;Target:RN215;UniProt:Q9Y6U7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7758-217;Target: RN215;UniProt: Q9Y6U7;TargetFullName: RING finger protein 215;Organisim: human;Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId: 7758-217 | Target: RN215 | UniProt: Q9Y6U7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7758-217 | Target: RN215 | UniProt: Q9Y6U7 | TargetFullName: RING finger protein 215 | Organisim: human | Apparent_Kd_M: 1.62E-10

Real

Aptamer SeqId:7761-125;Target:CHKB;UniProt:Q9Y259

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7761-125;Target: CHKB;UniProt: Q9Y259;TargetFullName: Choline/ethanolamine kinase;Organisim: human;Apparent_Kd_M: 1.91E-12

Real

Aptamer SeqId: 7761-125 | Target: CHKB | UniProt: Q9Y259

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7761-125 | Target: CHKB | UniProt: Q9Y259 | TargetFullName: Choline/ethanolamine kinase | Organisim: human | Apparent_Kd_M: 1.91E-12

Real

Aptamer SeqId:7762-30;Target:SNN;UniProt:O75324

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7762-30;Target: SNN;UniProt: O75324;TargetFullName: Stannin;Organisim: human;Apparent_Kd_M: 3.013219E-10

Real

Aptamer SeqId: 7762-30 | Target: SNN | UniProt: O75324

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7762-30 | Target: SNN | UniProt: O75324 | TargetFullName: Stannin | Organisim: human | Apparent_Kd_M: 3.013219E-10

Real

Aptamer SeqId:7763-25;Target:Cadherin-11;UniProt:P55287

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7763-25;Target: Cadherin-11;UniProt: P55287;TargetFullName: Cadherin-11;Organisim: human;Apparent_Kd_M: 4.03E-12

Real

Aptamer SeqId: 7763-25 | Target: Cadherin-11 | UniProt: P55287

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7763-25 | Target: Cadherin-11 | UniProt: P55287 | TargetFullName: Cadherin-11 | Organisim: human | Apparent_Kd_M: 4.03E-12

Real

Aptamer SeqId:7765-15;Target:ITM2A;UniProt:O43736

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7765-15;Target: ITM2A;UniProt: O43736;TargetFullName: Integral membrane protein 2A;Organisim: human;Apparent_Kd_M: 2.15E-10

Real

Aptamer SeqId: 7765-15 | Target: ITM2A | UniProt: O43736

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7765-15 | Target: ITM2A | UniProt: O43736 | TargetFullName: Integral membrane protein 2A | Organisim: human | Apparent_Kd_M: 2.15E-10

Real

Aptamer SeqId:7766-25;Target:ZP4;UniProt:Q12836

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7766-25;Target: ZP4;UniProt: Q12836;TargetFullName: Zona pellucida sperm-binding protein 4;Organisim: human;Apparent_Kd_M: 6.09E-11

Real

Aptamer SeqId: 7766-25 | Target: ZP4 | UniProt: Q12836

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7766-25 | Target: ZP4 | UniProt: Q12836 | TargetFullName: Zona pellucida sperm-binding protein 4 | Organisim: human | Apparent_Kd_M: 6.09E-11

Real

Aptamer SeqId:7767-1;Target:CF126;UniProt:Q6UWE3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7767-1;Target: CF126;UniProt: Q6UWE3;TargetFullName: Colipase-like protein 2;Organisim: human;Apparent_Kd_M: 3.85737E-11

Real

Aptamer SeqId: 7767-1 | Target: CF126 | UniProt: Q6UWE3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7767-1 | Target: CF126 | UniProt: Q6UWE3 | TargetFullName: Colipase-like protein 2 | Organisim: human | Apparent_Kd_M: 3.85737E-11

Real

Aptamer SeqId:7769-29;Target:3BP2;UniProt:P78314

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7769-29;Target: 3BP2;UniProt: P78314;TargetFullName: SH3 domain-binding protein 2;Organisim: human;Apparent_Kd_M: 3.79E-12

Real

Aptamer SeqId: 7769-29 | Target: 3BP2 | UniProt: P78314

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7769-29 | Target: 3BP2 | UniProt: P78314 | TargetFullName: SH3 domain-binding protein 2 | Organisim: human | Apparent_Kd_M: 3.79E-12

Real

Aptamer SeqId:7770-25;Target:NFU1;UniProt:Q9UMS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7770-25;Target: NFU1;UniProt: Q9UMS0;TargetFullName: NFU1 iron-sulfur cluster scaffold homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 4.667899E-11

Real

Aptamer SeqId: 7770-25 | Target: NFU1 | UniProt: Q9UMS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7770-25 | Target: NFU1 | UniProt: Q9UMS0 | TargetFullName: NFU1 iron-sulfur cluster scaffold homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 4.667899E-11

Real

Aptamer SeqId:7773-20;Target:KI2L2;UniProt:P43627

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7773-20;Target: KI2L2;UniProt: P43627;TargetFullName: Killer cell immunoglobulin-like receptor 2DL2;Organisim: human;Apparent_Kd_M: 7.724129E-11

Real

Aptamer SeqId: 7773-20 | Target: KI2L2 | UniProt: P43627

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7773-20 | Target: KI2L2 | UniProt: P43627 | TargetFullName: Killer cell immunoglobulin-like receptor 2DL2 | Organisim: human | Apparent_Kd_M: 7.724129E-11

Real

Aptamer SeqId:7776-20;Target:UNC5B;UniProt:Q8IZJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7776-20;Target: UNC5B;UniProt: Q8IZJ1;TargetFullName: Netrin receptor UNC5B;Organisim: human;Apparent_Kd_M: 9.7E-12

Real

Aptamer SeqId: 7776-20 | Target: UNC5B | UniProt: Q8IZJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7776-20 | Target: UNC5B | UniProt: Q8IZJ1 | TargetFullName: Netrin receptor UNC5B | Organisim: human | Apparent_Kd_M: 9.7E-12

Real

Aptamer SeqId:7778-104;Target:BINCA;UniProt:Q96LW7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7778-104;Target: BINCA;UniProt: Q96LW7;TargetFullName: Caspase recruitment domain-containing protein 19;Organisim: human;Apparent_Kd_M: 9.466718E-12

Real

Aptamer SeqId: 7778-104 | Target: BINCA | UniProt: Q96LW7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7778-104 | Target: BINCA | UniProt: Q96LW7 | TargetFullName: Caspase recruitment domain-containing protein 19 | Organisim: human | Apparent_Kd_M: 9.466718E-12

Real

Aptamer SeqId:7779-86;Target:CHSTB;UniProt:Q9NPF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7779-86;Target: CHSTB;UniProt: Q9NPF2;TargetFullName: Carbohydrate sulfotransferase 11;Organisim: human;Apparent_Kd_M: 1.622318E-11

Real

Aptamer SeqId: 7779-86 | Target: CHSTB | UniProt: Q9NPF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7779-86 | Target: CHSTB | UniProt: Q9NPF2 | TargetFullName: Carbohydrate sulfotransferase 11 | Organisim: human | Apparent_Kd_M: 1.622318E-11

Real

Aptamer SeqId:7782-34;Target:EP3B;UniProt:P56851

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7782-34;Target: EP3B;UniProt: P56851;TargetFullName: Epididymal secretory protein E3-beta;Organisim: human;Apparent_Kd_M: 1.358993E-11

Real

Aptamer SeqId: 7782-34 | Target: EP3B | UniProt: P56851

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7782-34 | Target: EP3B | UniProt: P56851 | TargetFullName: Epididymal secretory protein E3-beta | Organisim: human | Apparent_Kd_M: 1.358993E-11

Real

Aptamer SeqId:7784-1;Target:Kininogen; HMW;UniProt:P01042

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7784-1;Target: Kininogen; HMW;UniProt: P01042;TargetFullName: Kininogen-1;Organisim: human;Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId: 7784-1 | Target: Kininogen; HMW | UniProt: P01042

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7784-1 | Target: Kininogen; HMW | UniProt: P01042 | TargetFullName: Kininogen-1 | Organisim: human | Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId:7785-1;Target:Ephrin-B3;UniProt:Q15768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7785-1;Target: Ephrin-B3;UniProt: Q15768;TargetFullName: Ephrin-B3;Organisim: human;Apparent_Kd_M: 8.11E-11

Real

Aptamer SeqId: 7785-1 | Target: Ephrin-B3 | UniProt: Q15768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7785-1 | Target: Ephrin-B3 | UniProt: Q15768 | TargetFullName: Ephrin-B3 | Organisim: human | Apparent_Kd_M: 8.11E-11

Real

Aptamer SeqId:7786-83;Target:CLC2B;UniProt:Q92478

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7786-83;Target: CLC2B;UniProt: Q92478;TargetFullName: C-type lectin domain family 2 member B;Organisim: human;Apparent_Kd_M: 6.030364E-11

Real

Aptamer SeqId: 7786-83 | Target: CLC2B | UniProt: Q92478

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7786-83 | Target: CLC2B | UniProt: Q92478 | TargetFullName: C-type lectin domain family 2 member B | Organisim: human | Apparent_Kd_M: 6.030364E-11

Real

Aptamer SeqId:7787-25;Target:LIRA5;UniProt:A6NI73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7787-25;Target: LIRA5;UniProt: A6NI73;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 5;Organisim: human;Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId: 7787-25 | Target: LIRA5 | UniProt: A6NI73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7787-25 | Target: LIRA5 | UniProt: A6NI73 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 5 | Organisim: human | Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId:7788-1;Target:CF6;UniProt:P18859

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7788-1;Target: CF6;UniProt: P18859;TargetFullName: ATP synthase-coupling factor 6; mitochondrial;Organisim: human;Apparent_Kd_M: 4.936004E-12

Real

Aptamer SeqId: 7788-1 | Target: CF6 | UniProt: P18859

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7788-1 | Target: CF6 | UniProt: P18859 | TargetFullName: ATP synthase-coupling factor 6; mitochondrial | Organisim: human | Apparent_Kd_M: 4.936004E-12

Real

Aptamer SeqId:7789-182;Target:PRDX4;UniProt:Q13162

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7789-182;Target: PRDX4;UniProt: Q13162;TargetFullName: Peroxiredoxin-4;Organisim: human;Apparent_Kd_M: 2.6E-10

Real

Aptamer SeqId: 7789-182 | Target: PRDX4 | UniProt: Q13162

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7789-182 | Target: PRDX4 | UniProt: Q13162 | TargetFullName: Peroxiredoxin-4 | Organisim: human | Apparent_Kd_M: 2.6E-10

Real

Aptamer SeqId:7790-21;Target:LIF;UniProt:P15018

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7790-21;Target: LIF;UniProt: P15018;TargetFullName: Leukemia inhibitory factor;Organisim: human;Apparent_Kd_M: 6.330612E-11

Real

Aptamer SeqId: 7790-21 | Target: LIF | UniProt: P15018

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7790-21 | Target: LIF | UniProt: P15018 | TargetFullName: Leukemia inhibitory factor | Organisim: human | Apparent_Kd_M: 6.330612E-11

Real

Aptamer SeqId:7792-58;Target:CC90B;UniProt:Q9GZT6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7792-58;Target: CC90B;UniProt: Q9GZT6;TargetFullName: Coiled-coil domain-containing protein 90B; mitochondrial;Organisim: human;Apparent_Kd_M: 1.563322E-11

Real

Aptamer SeqId: 7792-58 | Target: CC90B | UniProt: Q9GZT6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7792-58 | Target: CC90B | UniProt: Q9GZT6 | TargetFullName: Coiled-coil domain-containing protein 90B; mitochondrial | Organisim: human | Apparent_Kd_M: 1.563322E-11

Real

Aptamer SeqId:7795-14;Target:NKG2E;UniProt:Q07444

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7795-14;Target: NKG2E;UniProt: Q07444;TargetFullName: NKG2-E type II integral membrane protein;Organisim: human;Apparent_Kd_M: 1.03E-11

Real

Aptamer SeqId: 7795-14 | Target: NKG2E | UniProt: Q07444

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7795-14 | Target: NKG2E | UniProt: Q07444 | TargetFullName: NKG2-E type II integral membrane protein | Organisim: human | Apparent_Kd_M: 1.03E-11

Real

Aptamer SeqId:7796-10;Target:CD79A;UniProt:P11912

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7796-10;Target: CD79A;UniProt: P11912;TargetFullName: B-cell antigen receptor complex-associated protein alpha chain;Organisim: human;Apparent_Kd_M: 2.85E-12

Real

Aptamer SeqId: 7796-10 | Target: CD79A | UniProt: P11912

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7796-10 | Target: CD79A | UniProt: P11912 | TargetFullName: B-cell antigen receptor complex-associated protein alpha chain | Organisim: human | Apparent_Kd_M: 2.85E-12

Real

Aptamer SeqId:7797-11;Target:CC167;UniProt:Q9P0B6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7797-11;Target: CC167;UniProt: Q9P0B6;TargetFullName: Coiled-coil domain-containing protein 167;Organisim: human;Apparent_Kd_M: 9.698634E-12

Real

Aptamer SeqId: 7797-11 | Target: CC167 | UniProt: Q9P0B6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7797-11 | Target: CC167 | UniProt: Q9P0B6 | TargetFullName: Coiled-coil domain-containing protein 167 | Organisim: human | Apparent_Kd_M: 9.698634E-12

Real

Aptamer SeqId:7800-85;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7800-85;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.75321E-10

Real

Aptamer SeqId: 7800-85 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7800-85 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.75321E-10

Real

Aptamer SeqId:7801-30;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7801-30;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.25E-13

Real

Aptamer SeqId: 7801-30 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7801-30 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.25E-13

Real

Aptamer SeqId:7802-53;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7802-53;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.328118E-11

Real

Aptamer SeqId: 7802-53 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7802-53 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.328118E-11

Real

Aptamer SeqId:7803-4;Target:CHST1;UniProt:O43916

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7803-4;Target: CHST1;UniProt: O43916;TargetFullName: Carbohydrate sulfotransferase 1;Organisim: human;Apparent_Kd_M: 7.685588E-12

Real

Aptamer SeqId: 7803-4 | Target: CHST1 | UniProt: O43916

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7803-4 | Target: CHST1 | UniProt: O43916 | TargetFullName: Carbohydrate sulfotransferase 1 | Organisim: human | Apparent_Kd_M: 7.685588E-12

Real

Aptamer SeqId:7805-52;Target:GOS-28;UniProt:O95249

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7805-52;Target: GOS-28;UniProt: O95249;TargetFullName: Golgi SNAP receptor complex member 1;Organisim: human;Apparent_Kd_M: 3.315634E-11

Real

Aptamer SeqId: 7805-52 | Target: GOS-28 | UniProt: O95249

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7805-52 | Target: GOS-28 | UniProt: O95249 | TargetFullName: Golgi SNAP receptor complex member 1 | Organisim: human | Apparent_Kd_M: 3.315634E-11

Real

Aptamer SeqId:7806-33;Target:B4GT7;UniProt:Q9UBV7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7806-33;Target: B4GT7;UniProt: Q9UBV7;TargetFullName: Beta-1;4-galactosyltransferase 7;Organisim: human;Apparent_Kd_M: 3.05794E-12

Real

Aptamer SeqId: 7806-33 | Target: B4GT7 | UniProt: Q9UBV7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7806-33 | Target: B4GT7 | UniProt: Q9UBV7 | TargetFullName: Beta-1;4-galactosyltransferase 7 | Organisim: human | Apparent_Kd_M: 3.05794E-12

Real

Aptamer SeqId:7808-5;Target:GLCE;UniProt:O94923

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7808-5;Target: GLCE;UniProt: O94923;TargetFullName: D-glucuronyl C5-epimerase;Organisim: human;Apparent_Kd_M: 1.738994E-11

Real

Aptamer SeqId: 7808-5 | Target: GLCE | UniProt: O94923

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7808-5 | Target: GLCE | UniProt: O94923 | TargetFullName: D-glucuronyl C5-epimerase | Organisim: human | Apparent_Kd_M: 1.738994E-11

Real

Aptamer SeqId:7809-22;Target:SPAT9;UniProt:Q9BWV2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7809-22;Target: SPAT9;UniProt: Q9BWV2;TargetFullName: Spermatogenesis-associated protein 9;Organisim: human;Apparent_Kd_M: 9.54325E-12

Real

Aptamer SeqId: 7809-22 | Target: SPAT9 | UniProt: Q9BWV2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7809-22 | Target: SPAT9 | UniProt: Q9BWV2 | TargetFullName: Spermatogenesis-associated protein 9 | Organisim: human | Apparent_Kd_M: 9.54325E-12

Real

Aptamer SeqId:7810-20;Target:C1QTNF5;UniProt:Q9BXJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7810-20;Target: C1QTNF5;UniProt: Q9BXJ0;TargetFullName: Complement C1q tumor necrosis factor-related protein 5;Organisim: human;Apparent_Kd_M: 1.175769E-11

Real

Aptamer SeqId: 7810-20 | Target: C1QTNF5 | UniProt: Q9BXJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7810-20 | Target: C1QTNF5 | UniProt: Q9BXJ0 | TargetFullName: Complement C1q tumor necrosis factor-related protein 5 | Organisim: human | Apparent_Kd_M: 1.175769E-11

Real

Aptamer SeqId:7813-6;Target:Alkaline phosphatase; placental;UniProt:P05187

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7813-6;Target: Alkaline phosphatase; placental;UniProt: P05187;TargetFullName: Alkaline phosphatase; placental type;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 7813-6 | Target: Alkaline phosphatase placental

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7813-6 | Target: Alkaline phosphatase; placental | UniProt: P05187 | TargetFullName: Alkaline phosphatase; placental type | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:7815-49;Target:IBPL1;UniProt:Q8WX77

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7815-49;Target: IBPL1;UniProt: Q8WX77;TargetFullName: Insulin-like growth factor-binding protein-like 1;Organisim: human;Apparent_Kd_M: 8.581667E-11

Real

Aptamer SeqId: 7815-49 | Target: IBPL1 | UniProt: Q8WX77

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7815-49 | Target: IBPL1 | UniProt: Q8WX77 | TargetFullName: Insulin-like growth factor-binding protein-like 1 | Organisim: human | Apparent_Kd_M: 8.581667E-11

Real

Aptamer SeqId:7816-23;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7816-23;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId: 7816-23 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7816-23 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.35E-12

Real

Aptamer SeqId:7817-36;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7817-36;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.183505E-12

Real

Aptamer SeqId: 7817-36 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7817-36 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.183505E-12

Real

Aptamer SeqId:7818-101;Target:GBP6;UniProt:Q6ZN66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7818-101;Target: GBP6;UniProt: Q6ZN66;TargetFullName: Guanylate-binding protein 6;Organisim: human;Apparent_Kd_M: 1.32E-10

Real

Aptamer SeqId: 7818-101 | Target: GBP6 | UniProt: Q6ZN66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7818-101 | Target: GBP6 | UniProt: Q6ZN66 | TargetFullName: Guanylate-binding protein 6 | Organisim: human | Apparent_Kd_M: 1.32E-10

Real

Aptamer SeqId:7821-6;Target:C1D;UniProt:Q13901

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7821-6;Target: C1D;UniProt: Q13901;TargetFullName: Nuclear nucleic acid-binding protein C1D;Organisim: human;Apparent_Kd_M: 5.648232E-11

Real

Aptamer SeqId: 7821-6 | Target: C1D | UniProt: Q13901

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7821-6 | Target: C1D | UniProt: Q13901 | TargetFullName: Nuclear nucleic acid-binding protein C1D | Organisim: human | Apparent_Kd_M: 5.648232E-11

Real

Aptamer SeqId:7822-11;Target:HRSL2;UniProt:Q9NWW9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7822-11;Target: HRSL2;UniProt: Q9NWW9;TargetFullName: HRAS-like suppressor 2;Organisim: human;Apparent_Kd_M: 8.534368E-12

Real

Aptamer SeqId: 7822-11 | Target: HRSL2 | UniProt: Q9NWW9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7822-11 | Target: HRSL2 | UniProt: Q9NWW9 | TargetFullName: HRAS-like suppressor 2 | Organisim: human | Apparent_Kd_M: 8.534368E-12

Real

Aptamer SeqId:7823-22;Target:SIA7B;UniProt:Q9UJ37

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7823-22;Target: SIA7B;UniProt: Q9UJ37;TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 2;Organisim: human;Apparent_Kd_M: 1.84311E-11

Real

Aptamer SeqId: 7823-22 | Target: SIA7B | UniProt: Q9UJ37

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7823-22 | Target: SIA7B | UniProt: Q9UJ37 | TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 2 | Organisim: human | Apparent_Kd_M: 1.84311E-11

Real

Aptamer SeqId:7824-88;Target:MSRB3;UniProt:Q8IXL7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7824-88;Target: MSRB3;UniProt: Q8IXL7;TargetFullName: Methionine-R-sulfoxide reductase B3;Organisim: human;Apparent_Kd_M: 3.594169E-11

Real

Aptamer SeqId: 7824-88 | Target: MSRB3 | UniProt: Q8IXL7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7824-88 | Target: MSRB3 | UniProt: Q8IXL7 | TargetFullName: Methionine-R-sulfoxide reductase B3 | Organisim: human | Apparent_Kd_M: 3.594169E-11

Real

Aptamer SeqId:7825-7;Target:ABD12;UniProt:Q8N2K0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7825-7;Target: ABD12;UniProt: Q8N2K0;TargetFullName: Monoacylglycerol lipase ABHD12;Organisim: human;Apparent_Kd_M: 5.45E-12

Real

Aptamer SeqId: 7825-7 | Target: ABD12 | UniProt: Q8N2K0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7825-7 | Target: ABD12 | UniProt: Q8N2K0 | TargetFullName: Monoacylglycerol lipase ABHD12 | Organisim: human | Apparent_Kd_M: 5.45E-12

Real

Aptamer SeqId:7826-1;Target:DCLK3;UniProt:Q9C098

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7826-1;Target: DCLK3;UniProt: Q9C098;TargetFullName: Serine/threonine-protein kinase DCLK3;Organisim: human;Apparent_Kd_M: 1.384729E-10

Real

Aptamer SeqId: 7826-1 | Target: DCLK3 | UniProt: Q9C098

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7826-1 | Target: DCLK3 | UniProt: Q9C098 | TargetFullName: Serine/threonine-protein kinase DCLK3 | Organisim: human | Apparent_Kd_M: 1.384729E-10

Real

Aptamer SeqId:7827-20;Target:ADA32;UniProt:Q8TC27

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7827-20;Target: ADA32;UniProt: Q8TC27;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 32;Organisim: human;Apparent_Kd_M: 2.006212E-11

Real

Aptamer SeqId: 7827-20 | Target: ADA32 | UniProt: Q8TC27

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7827-20 | Target: ADA32 | UniProt: Q8TC27 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 32 | Organisim: human | Apparent_Kd_M: 2.006212E-11

Real

Aptamer SeqId:7835-2;Target:BNI3L;UniProt:O60238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7835-2;Target: BNI3L;UniProt: O60238;TargetFullName: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like;Organisim: human;Apparent_Kd_M: 5.09E-11

Real

Aptamer SeqId: 7835-2 | Target: BNI3L | UniProt: O60238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7835-2 | Target: BNI3L | UniProt: O60238 | TargetFullName: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like | Organisim: human | Apparent_Kd_M: 5.09E-11

Real

Aptamer SeqId:7838-27;Target:SMR3A;UniProt:Q99954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7838-27;Target: SMR3A;UniProt: Q99954;TargetFullName: Submaxillary gland androgen-regulated protein 3A;Organisim: human;Apparent_Kd_M: 6.039508E-11

Real

Aptamer SeqId: 7838-27 | Target: SMR3A | UniProt: Q99954

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7838-27 | Target: SMR3A | UniProt: Q99954 | TargetFullName: Submaxillary gland androgen-regulated protein 3A | Organisim: human | Apparent_Kd_M: 6.039508E-11

Real

Aptamer SeqId:7839-99;Target:F19A3;UniProt:Q7Z5A8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7839-99;Target: F19A3;UniProt: Q7Z5A8;TargetFullName: Protein FAM19A3;Organisim: human;Apparent_Kd_M: 3.687957E-10

Real

Aptamer SeqId: 7839-99 | Target: F19A3 | UniProt: Q7Z5A8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7839-99 | Target: F19A3 | UniProt: Q7Z5A8 | TargetFullName: Protein FAM19A3 | Organisim: human | Apparent_Kd_M: 3.687957E-10

Real

Aptamer SeqId:7841-84;Target:ESAM;UniProt:Q96AP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7841-84;Target: ESAM;UniProt: Q96AP7;TargetFullName: Endothelial cell-selective adhesion molecule;Organisim: human;Apparent_Kd_M: 4.43E-12

Real

Aptamer SeqId: 7841-84 | Target: ESAM | UniProt: Q96AP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7841-84 | Target: ESAM | UniProt: Q96AP7 | TargetFullName: Endothelial cell-selective adhesion molecule | Organisim: human | Apparent_Kd_M: 4.43E-12

Real

Aptamer SeqId:7842-52;Target:SERF1;UniProt:O75920

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7842-52;Target: SERF1;UniProt: O75920;TargetFullName: Small EDRK-rich factor 1;Organisim: human;Apparent_Kd_M: 2.579044E-11

Real

Aptamer SeqId: 7842-52 | Target: SERF1 | UniProt: O75920

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7842-52 | Target: SERF1 | UniProt: O75920 | TargetFullName: Small EDRK-rich factor 1 | Organisim: human | Apparent_Kd_M: 2.579044E-11

Real

Aptamer SeqId:7843-152;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7843-152;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.937217E-12

Real

Aptamer SeqId: 7843-152 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7843-152 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.937217E-12

Real

Aptamer SeqId:7846-44;Target:PSG11;UniProt:Q9UQ72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7846-44;Target: PSG11;UniProt: Q9UQ72;TargetFullName: Pregnancy-specific beta-1-glycoprotein 11;Organisim: human;Apparent_Kd_M: 9.11E-11

Real

Aptamer SeqId: 7846-44 | Target: PSG11 | UniProt: Q9UQ72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7846-44 | Target: PSG11 | UniProt: Q9UQ72 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 11 | Organisim: human | Apparent_Kd_M: 9.11E-11

Real

Aptamer SeqId:7847-66;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7847-66;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 7847-66 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7847-66 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:7849-3;Target:Glutaminyl cyclase;UniProt:Q16769

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7849-3;Target: Glutaminyl cyclase;UniProt: Q16769;TargetFullName: Glutaminyl-peptide cyclotransferase;Organisim: human;Apparent_Kd_M: 8.455663E-11

Real

Aptamer SeqId: 7849-3 | Target: Glutaminyl cyclase | UniProt: Q16769

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7849-3 | Target: Glutaminyl cyclase | UniProt: Q16769 | TargetFullName: Glutaminyl-peptide cyclotransferase | Organisim: human | Apparent_Kd_M: 8.455663E-11

Real

Aptamer SeqId:7850-1;Target:COX42;UniProt:Q96KJ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7850-1;Target: COX42;UniProt: Q96KJ9;TargetFullName: Cytochrome c oxidase subunit 4 isoform 2; mitochondrial;Organisim: human;Apparent_Kd_M: 1.492417E-11

Real

Aptamer SeqId: 7850-1 | Target: COX42 | UniProt: Q96KJ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7850-1 | Target: COX42 | UniProt: Q96KJ9 | TargetFullName: Cytochrome c oxidase subunit 4 isoform 2; mitochondrial | Organisim: human | Apparent_Kd_M: 1.492417E-11

Real

Aptamer SeqId:7851-30;Target:ANR46;UniProt:Q86W74

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7851-30;Target: ANR46;UniProt: Q86W74;TargetFullName: Ankyrin repeat domain-containing protein 46;Organisim: human;Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId: 7851-30 | Target: ANR46 | UniProt: Q86W74

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7851-30 | Target: ANR46 | UniProt: Q86W74 | TargetFullName: Ankyrin repeat domain-containing protein 46 | Organisim: human | Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId:7852-9;Target:IF3M;UniProt:Q9H2K0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7852-9;Target: IF3M;UniProt: Q9H2K0;TargetFullName: Translation initiation factor IF-3; mitochondrial;Organisim: human;Apparent_Kd_M: 4.057324E-12

Real

Aptamer SeqId: 7852-9 | Target: IF3M | UniProt: Q9H2K0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7852-9 | Target: IF3M | UniProt: Q9H2K0 | TargetFullName: Translation initiation factor IF-3; mitochondrial | Organisim: human | Apparent_Kd_M: 4.057324E-12

Real

Aptamer SeqId:7853-19;Target:SCO1;UniProt:O75880

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7853-19;Target: SCO1;UniProt: O75880;TargetFullName: Protein SCO1 homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 1.132019E-10

Real

Aptamer SeqId: 7853-19 | Target: SCO1 | UniProt: O75880

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7853-19 | Target: SCO1 | UniProt: O75880 | TargetFullName: Protein SCO1 homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 1.132019E-10

Real

Aptamer SeqId:7854-38;Target:NR3L1;UniProt:Q68D85

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7854-38;Target: NR3L1;UniProt: Q68D85;TargetFullName: Natural cytotoxicity triggering receptor 3 ligand 1;Organisim: human;Apparent_Kd_M: 4.90931E-11

Real

Aptamer SeqId: 7854-38 | Target: NR3L1 | UniProt: Q68D85

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7854-38 | Target: NR3L1 | UniProt: Q68D85 | TargetFullName: Natural cytotoxicity triggering receptor 3 ligand 1 | Organisim: human | Apparent_Kd_M: 4.90931E-11

Real

Aptamer SeqId:7856-51;Target:F151A;UniProt:Q8WW52

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7856-51;Target: F151A;UniProt: Q8WW52;TargetFullName: Protein FAM151A;Organisim: human;Apparent_Kd_M: 1.219101E-11

Real

Aptamer SeqId: 7856-51 | Target: F151A | UniProt: Q8WW52

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7856-51 | Target: F151A | UniProt: Q8WW52 | TargetFullName: Protein FAM151A | Organisim: human | Apparent_Kd_M: 1.219101E-11

Real

Aptamer SeqId:7857-22;Target:NEUT;UniProt:P30990

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7857-22;Target: NEUT;UniProt: P30990;TargetFullName: Neurotensin/neuromedin N;Organisim: human;Apparent_Kd_M: 6.964586E-12

Real

Aptamer SeqId: 7857-22 | Target: NEUT | UniProt: P30990

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7857-22 | Target: NEUT | UniProt: P30990 | TargetFullName: Neurotensin/neuromedin N | Organisim: human | Apparent_Kd_M: 6.964586E-12

Real

Aptamer SeqId:7859-21;Target:PCDGK;UniProt:Q9UN70

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7859-21;Target: PCDGK;UniProt: Q9UN70;TargetFullName: Protocadherin gamma-C3;Organisim: human;Apparent_Kd_M: 5.789088E-12

Real

Aptamer SeqId: 7859-21 | Target: PCDGK | UniProt: Q9UN70

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7859-21 | Target: PCDGK | UniProt: Q9UN70 | TargetFullName: Protocadherin gamma-C3 | Organisim: human | Apparent_Kd_M: 5.789088E-12

Real

Aptamer SeqId:7860-9;Target:HERC4;UniProt:Q5GLZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7860-9;Target: HERC4;UniProt: Q5GLZ8;TargetFullName: Probable E3 ubiquitin-protein ligase HERC4;Organisim: human;Apparent_Kd_M: 2.910066E-10

Real

Aptamer SeqId: 7860-9 | Target: HERC4 | UniProt: Q5GLZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7860-9 | Target: HERC4 | UniProt: Q5GLZ8 | TargetFullName: Probable E3 ubiquitin-protein ligase HERC4 | Organisim: human | Apparent_Kd_M: 2.910066E-10

Real

Aptamer SeqId:7861-9;Target:ROR2;UniProt:Q01974

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7861-9;Target: ROR2;UniProt: Q01974;TargetFullName: Tyrosine-protein kinase transmembrane receptor ROR2;Organisim: human;Apparent_Kd_M: 1.79E-12

Real

Aptamer SeqId: 7861-9 | Target: ROR2 | UniProt: Q01974

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7861-9 | Target: ROR2 | UniProt: Q01974 | TargetFullName: Tyrosine-protein kinase transmembrane receptor ROR2 | Organisim: human | Apparent_Kd_M: 1.79E-12

Real

Aptamer SeqId:7863-50;Target:PGRC1;UniProt:O00264

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7863-50;Target: PGRC1;UniProt: O00264;TargetFullName: Membrane-associated progesterone receptor component 1;Organisim: human;Apparent_Kd_M: 4.251275E-11

Real

Aptamer SeqId: 7863-50 | Target: PGRC1 | UniProt: O00264

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7863-50 | Target: PGRC1 | UniProt: O00264 | TargetFullName: Membrane-associated progesterone receptor component 1 | Organisim: human | Apparent_Kd_M: 4.251275E-11

Real

Aptamer SeqId:7864-3;Target:SIGL8;UniProt:Q9NYZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7864-3;Target: SIGL8;UniProt: Q9NYZ4;TargetFullName: Sialic acid-binding Ig-like lectin 8;Organisim: human;Apparent_Kd_M: 3.573035E-10

Real

Aptamer SeqId: 7864-3 | Target: SIGL8 | UniProt: Q9NYZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7864-3 | Target: SIGL8 | UniProt: Q9NYZ4 | TargetFullName: Sialic acid-binding Ig-like lectin 8 | Organisim: human | Apparent_Kd_M: 3.573035E-10

Real

Aptamer SeqId:7865-126;Target:HRSL3;UniProt:P53816

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7865-126;Target: HRSL3;UniProt: P53816;TargetFullName: HRAS-like suppressor 3;Organisim: human;Apparent_Kd_M: 1.332664E-10

Real

Aptamer SeqId: 7865-126 | Target: HRSL3 | UniProt: P53816

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7865-126 | Target: HRSL3 | UniProt: P53816 | TargetFullName: HRAS-like suppressor 3 | Organisim: human | Apparent_Kd_M: 1.332664E-10

Real

Aptamer SeqId:7866-11;Target:DJC30;UniProt:Q96LL9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7866-11;Target: DJC30;UniProt: Q96LL9;TargetFullName: DnaJ homolog subfamily C member 30;Organisim: human;Apparent_Kd_M: 1.334317E-11

Real

Aptamer SeqId: 7866-11 | Target: DJC30 | UniProt: Q96LL9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7866-11 | Target: DJC30 | UniProt: Q96LL9 | TargetFullName: DnaJ homolog subfamily C member 30 | Organisim: human | Apparent_Kd_M: 1.334317E-11

Real

Aptamer SeqId:7867-154;Target:SIA7A;UniProt:Q9NSC7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7867-154;Target: SIA7A;UniProt: Q9NSC7;TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 1;Organisim: human;Apparent_Kd_M: 6.932508E-12

Real

Aptamer SeqId: 7867-154 | Target: SIA7A | UniProt: Q9NSC7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7867-154 | Target: SIA7A | UniProt: Q9NSC7 | TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 1 | Organisim: human | Apparent_Kd_M: 6.932508E-12

Real

Aptamer SeqId:7871-16;Target:T132A;UniProt:Q24JP5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7871-16;Target: T132A;UniProt: Q24JP5;TargetFullName: Transmembrane protein 132A;Organisim: human;Apparent_Kd_M: 3.949906E-12

Real

Aptamer SeqId: 7871-16 | Target: T132A | UniProt: Q24JP5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7871-16 | Target: T132A | UniProt: Q24JP5 | TargetFullName: Transmembrane protein 132A | Organisim: human | Apparent_Kd_M: 3.949906E-12

Real

Aptamer SeqId:7872-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7872-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.999362E-11

Real

Aptamer SeqId: 7872-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7872-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.999362E-11

Real

Aptamer SeqId:7873-32;Target:TSSK2;UniProt:Q96PF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7873-32;Target: TSSK2;UniProt: Q96PF2;TargetFullName: Testis-specific serine/threonine-protein kinase 2;Organisim: human;Apparent_Kd_M: 5.765698E-11

Real

Aptamer SeqId: 7873-32 | Target: TSSK2 | UniProt: Q96PF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7873-32 | Target: TSSK2 | UniProt: Q96PF2 | TargetFullName: Testis-specific serine/threonine-protein kinase 2 | Organisim: human | Apparent_Kd_M: 5.765698E-11

Real

Aptamer SeqId:7875-86;Target:PLEK;UniProt:P08567

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7875-86;Target: PLEK;UniProt: P08567;TargetFullName: Pleckstrin;Organisim: human;Apparent_Kd_M: 6.018212E-12

Real

Aptamer SeqId: 7875-86 | Target: PLEK | UniProt: P08567

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7875-86 | Target: PLEK | UniProt: P08567 | TargetFullName: Pleckstrin | Organisim: human | Apparent_Kd_M: 6.018212E-12

Real

Aptamer SeqId:7878-2;Target:SC61B;UniProt:P60468

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7878-2;Target: SC61B;UniProt: P60468;TargetFullName: Protein transport protein Sec61 subunit beta;Organisim: human;Apparent_Kd_M: 1.791472E-11

Real

Aptamer SeqId: 7878-2 | Target: SC61B | UniProt: P60468

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7878-2 | Target: SC61B | UniProt: P60468 | TargetFullName: Protein transport protein Sec61 subunit beta | Organisim: human | Apparent_Kd_M: 1.791472E-11

Real

Aptamer SeqId:7879-12;Target:Cytochrome P450 3A4;UniProt:P08684

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7879-12;Target: Cytochrome P450 3A4;UniProt: P08684;TargetFullName: Cytochrome P450 3A4;Organisim: human;Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId: 7879-12 | Target: Cytochrome P450 3A4 | UniProt: P08684

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7879-12 | Target: Cytochrome P450 3A4 | UniProt: P08684 | TargetFullName: Cytochrome P450 3A4 | Organisim: human | Apparent_Kd_M: 2.23E-11

Real

Aptamer SeqId:7880-9;Target:PSA1;UniProt:P25786

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7880-9;Target: PSA1;UniProt: P25786;TargetFullName: Proteasome subunit alpha type-1;Organisim: human;Apparent_Kd_M: 8.5E-11

Real

Aptamer SeqId: 7880-9 | Target: PSA1 | UniProt: P25786

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7880-9 | Target: PSA1 | UniProt: P25786 | TargetFullName: Proteasome subunit alpha type-1 | Organisim: human | Apparent_Kd_M: 8.5E-11

Real

Aptamer SeqId:7881-244;Target:PAR16;UniProt:Q8N5Y8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7881-244;Target: PAR16;UniProt: Q8N5Y8;TargetFullName: Mono [ADP-ribose] polymerase PARP16;Organisim: human;Apparent_Kd_M: 2.682631E-12

Real

Aptamer SeqId: 7881-244 | Target: PAR16 | UniProt: Q8N5Y8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7881-244 | Target: PAR16 | UniProt: Q8N5Y8 | TargetFullName: Mono ADP-ribose polymerase PARP16 | Organisim: human | Apparent_Kd_M: 2.682631E-12

Real

Aptamer SeqId:7886-26;Target:SPTC1;UniProt:O15269

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7886-26;Target: SPTC1;UniProt: O15269;TargetFullName: Serine palmitoyltransferase 1;Organisim: human;Apparent_Kd_M: 7.26904E-12

Real

Aptamer SeqId: 7886-26 | Target: SPTC1 | UniProt: O15269

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7886-26 | Target: SPTC1 | UniProt: O15269 | TargetFullName: Serine palmitoyltransferase 1 | Organisim: human | Apparent_Kd_M: 7.26904E-12

Real

Aptamer SeqId:7887-57;Target:COX5B;UniProt:P10606

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7887-57;Target: COX5B;UniProt: P10606;TargetFullName: Cytochrome c oxidase subunit 5B; mitochondrial;Organisim: human;Apparent_Kd_M: 2.85E-10

Real

Aptamer SeqId: 7887-57 | Target: COX5B | UniProt: P10606

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7887-57 | Target: COX5B | UniProt: P10606 | TargetFullName: Cytochrome c oxidase subunit 5B; mitochondrial | Organisim: human | Apparent_Kd_M: 2.85E-10

Real

Aptamer SeqId:7888-58;Target:CCD56;UniProt:Q9Y2R0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7888-58;Target: CCD56;UniProt: Q9Y2R0;TargetFullName: Cytochrome c oxidase assembly factor 3 homolog; mitochondrial;Organisim: human;Apparent_Kd_M: 1.778919E-10

Real

Aptamer SeqId: 7888-58 | Target: CCD56 | UniProt: Q9Y2R0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7888-58 | Target: CCD56 | UniProt: Q9Y2R0 | TargetFullName: Cytochrome c oxidase assembly factor 3 homolog; mitochondrial | Organisim: human | Apparent_Kd_M: 1.778919E-10

Real

Aptamer SeqId:7890-68;Target:DPP10;UniProt:Q8N608

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7890-68;Target: DPP10;UniProt: Q8N608;TargetFullName: Inactive dipeptidyl peptidase 10;Organisim: human;Apparent_Kd_M: 1.6E-10

Real

Aptamer SeqId: 7890-68 | Target: DPP10 | UniProt: Q8N608

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7890-68 | Target: DPP10 | UniProt: Q8N608 | TargetFullName: Inactive dipeptidyl peptidase 10 | Organisim: human | Apparent_Kd_M: 1.6E-10

Real

Aptamer SeqId:7891-45;Target:UGT 1A6;UniProt:P19224

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7891-45;Target: UGT 1A6;UniProt: P19224;TargetFullName: UDP-glucuronosyltransferase 1-6;Organisim: human;Apparent_Kd_M: 3.935566E-12

Real

Aptamer SeqId: 7891-45 | Target: UGT 1A6 | UniProt: P19224

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7891-45 | Target: UGT 1A6 | UniProt: P19224 | TargetFullName: UDP-glucuronosyltransferase 1-6 | Organisim: human | Apparent_Kd_M: 3.935566E-12

Real

Aptamer SeqId:7892-132;Target:K1467;UniProt:A2RU67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7892-132;Target: K1467;UniProt: A2RU67;TargetFullName: Protein FAM234B;Organisim: human;Apparent_Kd_M: 2.27E-12

Real

Aptamer SeqId: 7892-132 | Target: K1467 | UniProt: A2RU67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7892-132 | Target: K1467 | UniProt: A2RU67 | TargetFullName: Protein FAM234B | Organisim: human | Apparent_Kd_M: 2.27E-12

Real

Aptamer SeqId:7894-155;Target:FGF-3;UniProt:P11487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7894-155;Target: FGF-3;UniProt: P11487;TargetFullName: Fibroblast growth factor 3;Organisim: human;Apparent_Kd_M: 2.282123E-11

Real

Aptamer SeqId: 7894-155 | Target: FGF-3 | UniProt: P11487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7894-155 | Target: FGF-3 | UniProt: P11487 | TargetFullName: Fibroblast growth factor 3 | Organisim: human | Apparent_Kd_M: 2.282123E-11

Real

Aptamer SeqId:7895-108;Target:MRAP;UniProt:Q8TCY5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7895-108;Target: MRAP;UniProt: Q8TCY5;TargetFullName: Melanocortin-2 receptor accessory protein;Organisim: human;Apparent_Kd_M: 1.15808E-11

Real

Aptamer SeqId: 7895-108 | Target: MRAP | UniProt: Q8TCY5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7895-108 | Target: MRAP | UniProt: Q8TCY5 | TargetFullName: Melanocortin-2 receptor accessory protein | Organisim: human | Apparent_Kd_M: 1.15808E-11

Real

Aptamer SeqId:7897-75;Target:DLG3;UniProt:Q92796

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7897-75;Target: DLG3;UniProt: Q92796;TargetFullName: Disks large homolog 3;Organisim: human;Apparent_Kd_M: 1.056206E-11

Real

Aptamer SeqId: 7897-75 | Target: DLG3 | UniProt: Q92796

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7897-75 | Target: DLG3 | UniProt: Q92796 | TargetFullName: Disks large homolog 3 | Organisim: human | Apparent_Kd_M: 1.056206E-11

Real

Aptamer SeqId:7898-29;Target:MDM1;UniProt:Q8TC05

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7898-29;Target: MDM1;UniProt: Q8TC05;TargetFullName: Nuclear protein MDM1;Organisim: human;Apparent_Kd_M: 4.316497E-12

Real

Aptamer SeqId: 7898-29 | Target: MDM1 | UniProt: Q8TC05

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7898-29 | Target: MDM1 | UniProt: Q8TC05 | TargetFullName: Nuclear protein MDM1 | Organisim: human | Apparent_Kd_M: 4.316497E-12

Real

Aptamer SeqId:7903-18;Target:VAMP3;UniProt:Q15836

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7903-18;Target: VAMP3;UniProt: Q15836;TargetFullName: Vesicle-associated membrane protein 3;Organisim: human;Apparent_Kd_M: 9.896858E-12

Real

Aptamer SeqId: 7903-18 | Target: VAMP3 | UniProt: Q15836

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7903-18 | Target: VAMP3 | UniProt: Q15836 | TargetFullName: Vesicle-associated membrane protein 3 | Organisim: human | Apparent_Kd_M: 9.896858E-12

Real

Aptamer SeqId:7905-30;Target:HPT;UniProt:P00738

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7905-30;Target: HPT;UniProt: P00738;TargetFullName: Haptoglobin;Organisim: human;Apparent_Kd_M: 1.780947E-11

Real

Aptamer SeqId: 7905-30 | Target: HPT | UniProt: P00738

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7905-30 | Target: HPT | UniProt: P00738 | TargetFullName: Haptoglobin | Organisim: human | Apparent_Kd_M: 1.780947E-11

Real

Aptamer SeqId:7910-41;Target:LRFN1;UniProt:Q9P244

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7910-41;Target: LRFN1;UniProt: Q9P244;TargetFullName: Leucine-rich repeat and fibronectin type III domain-containing protein 1;Organisim: human;Apparent_Kd_M: 8.670075E-11

Real

Aptamer SeqId: 7910-41 | Target: LRFN1 | UniProt: Q9P244

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7910-41 | Target: LRFN1 | UniProt: Q9P244 | TargetFullName: Leucine-rich repeat and fibronectin type III domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 8.670075E-11

Real

Aptamer SeqId:7911-29;Target:SCN4B;UniProt:Q8IWT1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7911-29;Target: SCN4B;UniProt: Q8IWT1;TargetFullName: Sodium channel subunit beta-4;Organisim: human;Apparent_Kd_M: 1.335426E-11

Real

Aptamer SeqId: 7911-29 | Target: SCN4B | UniProt: Q8IWT1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7911-29 | Target: SCN4B | UniProt: Q8IWT1 | TargetFullName: Sodium channel subunit beta-4 | Organisim: human | Apparent_Kd_M: 1.335426E-11

Real

Aptamer SeqId:7916-10;Target:S100A7;UniProt:P31151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7916-10;Target: S100A7;UniProt: P31151;TargetFullName: Protein S100-A7;Organisim: human;Apparent_Kd_M: 3.05E-12

Real

Aptamer SeqId: 7916-10 | Target: S100A7 | UniProt: P31151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7916-10 | Target: S100A7 | UniProt: P31151 | TargetFullName: Protein S100-A7 | Organisim: human | Apparent_Kd_M: 3.05E-12

Real

Aptamer SeqId:7917-17;Target:CBPD;UniProt:O75976

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7917-17;Target: CBPD;UniProt: O75976;TargetFullName: Carboxypeptidase D;Organisim: human;Apparent_Kd_M: 9.322247E-11

Real

Aptamer SeqId: 7917-17 | Target: CBPD | UniProt: O75976

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7917-17 | Target: CBPD | UniProt: O75976 | TargetFullName: Carboxypeptidase D | Organisim: human | Apparent_Kd_M: 9.322247E-11

Real

Aptamer SeqId:7918-114;Target:Amylase; alpha 1A;UniProt:P04745

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7918-114;Target: Amylase; alpha 1A;UniProt: P04745;TargetFullName: Alpha-amylase 1;Organisim: human;Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId: 7918-114 | Target: Amylase; alpha 1A | UniProt: P04745

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7918-114 | Target: Amylase; alpha 1A | UniProt: P04745 | TargetFullName: Alpha-amylase 1 | Organisim: human | Apparent_Kd_M: 1.21E-11

Real

Aptamer SeqId:7920-30;Target:SIA8B;UniProt:Q92186

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7920-30;Target: SIA8B;UniProt: Q92186;TargetFullName: Alpha-2;8-sialyltransferase 8B;Organisim: human;Apparent_Kd_M: 5.253099E-11

Real

Aptamer SeqId: 7920-30 | Target: SIA8B | UniProt: Q92186

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7920-30 | Target: SIA8B | UniProt: Q92186 | TargetFullName: Alpha-2;8-sialyltransferase 8B | Organisim: human | Apparent_Kd_M: 5.253099E-11

Real

Aptamer SeqId:7921-65;Target:FJX1;UniProt:Q86VR8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7921-65;Target: FJX1;UniProt: Q86VR8;TargetFullName: Four-jointed box protein 1;Organisim: human;Apparent_Kd_M: 3.261788E-12

Real

Aptamer SeqId: 7921-65 | Target: FJX1 | UniProt: Q86VR8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7921-65 | Target: FJX1 | UniProt: Q86VR8 | TargetFullName: Four-jointed box protein 1 | Organisim: human | Apparent_Kd_M: 3.261788E-12

Real

Aptamer SeqId:7922-5;Target:Adrenomedullin;UniProt:P35318

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7922-5;Target: Adrenomedullin;UniProt: P35318;TargetFullName: Adrenomedullin;Organisim: human;Apparent_Kd_M: 2.36E-11

Real

Aptamer SeqId: 7922-5 | Target: Adrenomedullin | UniProt: P35318

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7922-5 | Target: Adrenomedullin | UniProt: P35318 | TargetFullName: Adrenomedullin | Organisim: human | Apparent_Kd_M: 2.36E-11

Real

Aptamer SeqId:7923-41;Target:SEM4C;UniProt:Q9C0C4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7923-41;Target: SEM4C;UniProt: Q9C0C4;TargetFullName: Semaphorin-4C;Organisim: human;Apparent_Kd_M: 3.76059E-11

Real

Aptamer SeqId: 7923-41 | Target: SEM4C | UniProt: Q9C0C4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7923-41 | Target: SEM4C | UniProt: Q9C0C4 | TargetFullName: Semaphorin-4C | Organisim: human | Apparent_Kd_M: 3.76059E-11

Real

Aptamer SeqId:7924-7;Target:CD3G;UniProt:P09693

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7924-7;Target: CD3G;UniProt: P09693;TargetFullName: T-cell surface glycoprotein CD3 gamma chain;Organisim: human;Apparent_Kd_M: 1.596429E-10

Real

Aptamer SeqId: 7924-7 | Target: CD3G | UniProt: P09693

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7924-7 | Target: CD3G | UniProt: P09693 | TargetFullName: T-cell surface glycoprotein CD3 gamma chain | Organisim: human | Apparent_Kd_M: 1.596429E-10

Real

Aptamer SeqId:7925-18;Target:CL070;UniProt:A6NFE2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7925-18;Target: CL070;UniProt: A6NFE2;TargetFullName: Single-pass membrane and coiled-coil domain-containing protein 2;Organisim: human;Apparent_Kd_M: 9.508422E-12

Real

Aptamer SeqId: 7925-18 | Target: CL070 | UniProt: A6NFE2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7925-18 | Target: CL070 | UniProt: A6NFE2 | TargetFullName: Single-pass membrane and coiled-coil domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 9.508422E-12

Real

Aptamer SeqId:7926-13;Target:SPIT3;UniProt:P49223

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7926-13;Target: SPIT3;UniProt: P49223;TargetFullName: Kunitz-type protease inhibitor 3;Organisim: human;Apparent_Kd_M: 4.94E-12

Real

Aptamer SeqId: 7926-13 | Target: SPIT3 | UniProt: P49223

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7926-13 | Target: SPIT3 | UniProt: P49223 | TargetFullName: Kunitz-type protease inhibitor 3 | Organisim: human | Apparent_Kd_M: 4.94E-12

Real

Aptamer SeqId:7927-16;Target:SIA7E;UniProt:Q9BVH7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7927-16;Target: SIA7E;UniProt: Q9BVH7;TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 5;Organisim: human;Apparent_Kd_M: 7.807617E-12

Real

Aptamer SeqId: 7927-16 | Target: SIA7E | UniProt: Q9BVH7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7927-16 | Target: SIA7E | UniProt: Q9BVH7 | TargetFullName: Alpha-N-acetylgalactosaminide alpha-2;6-sialyltransferase 5 | Organisim: human | Apparent_Kd_M: 7.807617E-12

Real

Aptamer SeqId:7928-183;Target:TPST1;UniProt:O60507

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7928-183;Target: TPST1;UniProt: O60507;TargetFullName: Protein-tyrosine sulfotransferase 1;Organisim: human;Apparent_Kd_M: 1.337043E-11

Real

Aptamer SeqId: 7928-183 | Target: TPST1 | UniProt: O60507

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7928-183 | Target: TPST1 | UniProt: O60507 | TargetFullName: Protein-tyrosine sulfotransferase 1 | Organisim: human | Apparent_Kd_M: 1.337043E-11

Real

Aptamer SeqId:7930-3;Target:EXOS1;UniProt:Q9Y3B2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7930-3;Target: EXOS1;UniProt: Q9Y3B2;TargetFullName: Exosome complex component CSL4;Organisim: human;Apparent_Kd_M: 2.0E-10

Real

Aptamer SeqId: 7930-3 | Target: EXOS1 | UniProt: Q9Y3B2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7930-3 | Target: EXOS1 | UniProt: Q9Y3B2 | TargetFullName: Exosome complex component CSL4 | Organisim: human | Apparent_Kd_M: 2.0E-10

Real

Aptamer SeqId:7932-23;Target:SYT8;UniProt:Q8NBV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7932-23;Target: SYT8;UniProt: Q8NBV8;TargetFullName: Synaptotagmin-8;Organisim: human;Apparent_Kd_M: 3.70615E-10

Real

Aptamer SeqId: 7932-23 | Target: SYT8 | UniProt: Q8NBV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7932-23 | Target: SYT8 | UniProt: Q8NBV8 | TargetFullName: Synaptotagmin-8 | Organisim: human | Apparent_Kd_M: 3.70615E-10

Real

Aptamer SeqId:7933-75;Target:ADA22;UniProt:Q9P0K1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7933-75;Target: ADA22;UniProt: Q9P0K1;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 22;Organisim: human;Apparent_Kd_M: 3.886273E-12

Real

Aptamer SeqId: 7933-75 | Target: ADA22 | UniProt: Q9P0K1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7933-75 | Target: ADA22 | UniProt: Q9P0K1 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 22 | Organisim: human | Apparent_Kd_M: 3.886273E-12

Real

Aptamer SeqId:7934-11;Target:NDRG4;UniProt:Q9ULP0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7934-11;Target: NDRG4;UniProt: Q9ULP0;TargetFullName: Protein NDRG4;Organisim: human;Apparent_Kd_M: 2.939887E-10

Real

Aptamer SeqId: 7934-11 | Target: NDRG4 | UniProt: Q9ULP0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7934-11 | Target: NDRG4 | UniProt: Q9ULP0 | TargetFullName: Protein NDRG4 | Organisim: human | Apparent_Kd_M: 2.939887E-10

Real

Aptamer SeqId:7935-26;Target:LARGE;UniProt:O95461

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7935-26;Target: LARGE;UniProt: O95461;TargetFullName: Glycosyltransferase-like protein LARGE1;Organisim: human;Apparent_Kd_M: 4.654612E-12

Real

Aptamer SeqId: 7935-26 | Target: LARGE | UniProt: O95461

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7935-26 | Target: LARGE | UniProt: O95461 | TargetFullName: Glycosyltransferase-like protein LARGE1 | Organisim: human | Apparent_Kd_M: 4.654612E-12

Real

Aptamer SeqId:7939-1;Target:CC055;UniProt:A1A4F0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7939-1;Target: CC055;UniProt: A1A4F0;TargetFullName: Putative uncharacterized protein PQLC2L;Organisim: human;Apparent_Kd_M: 1.82E-10

Real

Aptamer SeqId: 7939-1 | Target: CC055 | UniProt: A1A4F0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7939-1 | Target: CC055 | UniProt: A1A4F0 | TargetFullName: Putative uncharacterized protein PQLC2L | Organisim: human | Apparent_Kd_M: 1.82E-10

Real

Aptamer SeqId:7943-16;Target:CUZD1;UniProt:Q86UP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7943-16;Target: CUZD1;UniProt: Q86UP6;TargetFullName: CUB and zona pellucida-like domain-containing protein 1;Organisim: human;Apparent_Kd_M: 9.254376E-11

Real

Aptamer SeqId: 7943-16 | Target: CUZD1 | UniProt: Q86UP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7943-16 | Target: CUZD1 | UniProt: Q86UP6 | TargetFullName: CUB and zona pellucida-like domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 9.254376E-11

Real

Aptamer SeqId:7944-1;Target:KI3L3;UniProt:Q8N743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7944-1;Target: KI3L3;UniProt: Q8N743;TargetFullName: Killer cell immunoglobulin-like receptor 3DL3;Organisim: human;Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId: 7944-1 | Target: KI3L3 | UniProt: Q8N743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7944-1 | Target: KI3L3 | UniProt: Q8N743 | TargetFullName: Killer cell immunoglobulin-like receptor 3DL3 | Organisim: human | Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId:7945-10;Target:Semaphorin-6A;UniProt:Q9H2E6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7945-10;Target: Semaphorin-6A;UniProt: Q9H2E6;TargetFullName: Semaphorin-6A;Organisim: human;Apparent_Kd_M: 7.82E-12

Real

Aptamer SeqId: 7945-10 | Target: Semaphorin-6A | UniProt: Q9H2E6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7945-10 | Target: Semaphorin-6A | UniProt: Q9H2E6 | TargetFullName: Semaphorin-6A | Organisim: human | Apparent_Kd_M: 7.82E-12

Real

Aptamer SeqId:7947-19;Target:AP4AT;UniProt:Q96N21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7947-19;Target: AP4AT;UniProt: Q96N21;TargetFullName: AP-4 complex accessory subunit tepsin;Organisim: human;Apparent_Kd_M: 4.753621E-11

Real

Aptamer SeqId: 7947-19 | Target: AP4AT | UniProt: Q96N21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7947-19 | Target: AP4AT | UniProt: Q96N21 | TargetFullName: AP-4 complex accessory subunit tepsin | Organisim: human | Apparent_Kd_M: 4.753621E-11

Real

Aptamer SeqId:7948-129;Target:GLTD2;UniProt:A6NH11

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7948-129;Target: GLTD2;UniProt: A6NH11;TargetFullName: Glycolipid transfer protein domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.765909E-11

Real

Aptamer SeqId: 7948-129 | Target: GLTD2 | UniProt: A6NH11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7948-129 | Target: GLTD2 | UniProt: A6NH11 | TargetFullName: Glycolipid transfer protein domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.765909E-11

Real

Aptamer SeqId:7950-142;Target:BTNL9;UniProt:Q6UXG8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7950-142;Target: BTNL9;UniProt: Q6UXG8;TargetFullName: Butyrophilin-like protein 9;Organisim: human;Apparent_Kd_M: 1.53E-10

Real

Aptamer SeqId: 7950-142 | Target: BTNL9 | UniProt: Q6UXG8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7950-142 | Target: BTNL9 | UniProt: Q6UXG8 | TargetFullName: Butyrophilin-like protein 9 | Organisim: human | Apparent_Kd_M: 1.53E-10

Real

Aptamer SeqId:7952-2;Target:VTI1A;UniProt:Q96AJ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7952-2;Target: VTI1A;UniProt: Q96AJ9;TargetFullName: Vesicle transport through interaction with t-SNAREs homolog 1A;Organisim: human;Apparent_Kd_M: 1.80367E-11

Real

Aptamer SeqId: 7952-2 | Target: VTI1A | UniProt: Q96AJ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7952-2 | Target: VTI1A | UniProt: Q96AJ9 | TargetFullName: Vesicle transport through interaction with t-SNAREs homolog 1A | Organisim: human | Apparent_Kd_M: 1.80367E-11

Real

Aptamer SeqId:7953-20;Target:SLAF1;UniProt:Q13291

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7953-20;Target: SLAF1;UniProt: Q13291;TargetFullName: Signaling lymphocytic activation molecule;Organisim: human;Apparent_Kd_M: 1.617373E-10

Real

Aptamer SeqId: 7953-20 | Target: SLAF1 | UniProt: Q13291

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7953-20 | Target: SLAF1 | UniProt: Q13291 | TargetFullName: Signaling lymphocytic activation molecule | Organisim: human | Apparent_Kd_M: 1.617373E-10

Real

Aptamer SeqId:7955-195;Target:ITI heavy chain H1;UniProt:P19827

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7955-195;Target: ITI heavy chain H1;UniProt: P19827;TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H1;Organisim: human;Apparent_Kd_M: 2.759817E-11

Real

Aptamer SeqId: 7955-195 | Target: ITI heavy chain H1 | UniProt: P19827

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7955-195 | Target: ITI heavy chain H1 | UniProt: P19827 | TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H1 | Organisim: human | Apparent_Kd_M: 2.759817E-11

Real

Aptamer SeqId:7956-11;Target:MOS1;UniProt:Q5TGZ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7956-11;Target: MOS1;UniProt: Q5TGZ0;TargetFullName: MICOS complex subunit MIC10;Organisim: human;Apparent_Kd_M: 1.037936E-11

Real

Aptamer SeqId: 7956-11 | Target: MOS1 | UniProt: Q5TGZ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7956-11 | Target: MOS1 | UniProt: Q5TGZ0 | TargetFullName: MICOS complex subunit MIC10 | Organisim: human | Apparent_Kd_M: 1.037936E-11

Real

Aptamer SeqId:7957-2;Target:SCG3;UniProt:Q8WXD2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7957-2;Target: SCG3;UniProt: Q8WXD2;TargetFullName: Secretogranin-3;Organisim: human;Apparent_Kd_M: 1.21442E-11

Real

Aptamer SeqId: 7957-2 | Target: SCG3 | UniProt: Q8WXD2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7957-2 | Target: SCG3 | UniProt: Q8WXD2 | TargetFullName: Secretogranin-3 | Organisim: human | Apparent_Kd_M: 1.21442E-11

Real

Aptamer SeqId:7959-34;Target:CADH7;UniProt:Q9ULB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7959-34;Target: CADH7;UniProt: Q9ULB5;TargetFullName: Cadherin-7;Organisim: human;Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId: 7959-34 | Target: CADH7 | UniProt: Q9ULB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7959-34 | Target: CADH7 | UniProt: Q9ULB5 | TargetFullName: Cadherin-7 | Organisim: human | Apparent_Kd_M: 1.07E-11

Real

Aptamer SeqId:7960-53;Target:POTEG;UniProt:Q6S5H5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7960-53;Target: POTEG;UniProt: Q6S5H5;TargetFullName: POTE ankyrin domain family member G;Organisim: human;Apparent_Kd_M: 2.906228E-10

Real

Aptamer SeqId: 7960-53 | Target: POTEG | UniProt: Q6S5H5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7960-53 | Target: POTEG | UniProt: Q6S5H5 | TargetFullName: POTE ankyrin domain family member G | Organisim: human | Apparent_Kd_M: 2.906228E-10

Real

Aptamer SeqId:7962-11;Target:ISK8;UniProt:P0C7L1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7962-11;Target: ISK8;UniProt: P0C7L1;TargetFullName: Serine protease inhibitor Kazal-type 8;Organisim: human;Apparent_Kd_M: 4.190992E-11

Real

Aptamer SeqId: 7962-11 | Target: ISK8 | UniProt: P0C7L1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7962-11 | Target: ISK8 | UniProt: P0C7L1 | TargetFullName: Serine protease inhibitor Kazal-type 8 | Organisim: human | Apparent_Kd_M: 4.190992E-11

Real

Aptamer SeqId:7963-36;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7963-36;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.532591E-11

Real

Aptamer SeqId: 7963-36 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7963-36 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.532591E-11

Real

Aptamer SeqId:7967-38;Target:POTEM;UniProt:A6NI47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7967-38;Target: POTEM;UniProt: A6NI47;TargetFullName: Putative POTE ankyrin domain family member M;Organisim: human;Apparent_Kd_M: 7.602262E-11

Real

Aptamer SeqId: 7967-38 | Target: POTEM | UniProt: A6NI47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7967-38 | Target: POTEM | UniProt: A6NI47 | TargetFullName: Putative POTE ankyrin domain family member M | Organisim: human | Apparent_Kd_M: 7.602262E-11

Real

Aptamer SeqId:7968-15;Target:CRTAM;UniProt:O95727

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7968-15;Target: CRTAM;UniProt: O95727;TargetFullName: Cytotoxic and regulatory T-cell molecule;Organisim: human;Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId: 7968-15 | Target: CRTAM | UniProt: O95727

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7968-15 | Target: CRTAM | UniProt: O95727 | TargetFullName: Cytotoxic and regulatory T-cell molecule | Organisim: human | Apparent_Kd_M: 1.22E-11

Real

Aptamer SeqId:7969-163;Target:WFD11;UniProt:Q8NEX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7969-163;Target: WFD11;UniProt: Q8NEX6;TargetFullName: Protein WFDC11;Organisim: human;Apparent_Kd_M: 6.248364E-11

Real

Aptamer SeqId: 7969-163 | Target: WFD11 | UniProt: Q8NEX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7969-163 | Target: WFD11 | UniProt: Q8NEX6 | TargetFullName: Protein WFDC11 | Organisim: human | Apparent_Kd_M: 6.248364E-11

Real

Aptamer SeqId:7970-315;Target:NAR3;UniProt:Q13508

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7970-315;Target: NAR3;UniProt: Q13508;TargetFullName: Ecto-ADP-ribosyltransferase 3;Organisim: human;Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId: 7970-315 | Target: NAR3 | UniProt: Q13508

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7970-315 | Target: NAR3 | UniProt: Q13508 | TargetFullName: Ecto-ADP-ribosyltransferase 3 | Organisim: human | Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId:7975-97;Target:UNC5A;UniProt:Q6ZN44

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7975-97;Target: UNC5A;UniProt: Q6ZN44;TargetFullName: Netrin receptor UNC5A;Organisim: human;Apparent_Kd_M: 1.321916E-11

Real

Aptamer SeqId: 7975-97 | Target: UNC5A | UniProt: Q6ZN44

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7975-97 | Target: UNC5A | UniProt: Q6ZN44 | TargetFullName: Netrin receptor UNC5A | Organisim: human | Apparent_Kd_M: 1.321916E-11

Real

Aptamer SeqId:7976-19;Target:FRS1L;UniProt:Q9P0K9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7976-19;Target: FRS1L;UniProt: Q9P0K9;TargetFullName: DOMON domain-containing protein FRRS1L;Organisim: human;Apparent_Kd_M: 3.192368E-11

Real

Aptamer SeqId: 7976-19 | Target: FRS1L | UniProt: Q9P0K9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7976-19 | Target: FRS1L | UniProt: Q9P0K9 | TargetFullName: DOMON domain-containing protein FRRS1L | Organisim: human | Apparent_Kd_M: 3.192368E-11

Real

Aptamer SeqId:7980-72;Target:B3GN2;UniProt:Q9NY97

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7980-72;Target: B3GN2;UniProt: Q9NY97;TargetFullName: N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase 2;Organisim: human;Apparent_Kd_M: 2.141297E-11

Real

Aptamer SeqId: 7980-72 | Target: B3GN2 | UniProt: Q9NY97

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7980-72 | Target: B3GN2 | UniProt: Q9NY97 | TargetFullName: N-acetyllactosaminide beta-1;3-N-acetylglucosaminyltransferase 2 | Organisim: human | Apparent_Kd_M: 2.141297E-11

Real

Aptamer SeqId:7981-230;Target:B3GT6;UniProt:Q96L58

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7981-230;Target: B3GT6;UniProt: Q96L58;TargetFullName: Beta-1;3-galactosyltransferase 6;Organisim: human;Apparent_Kd_M: 3.108879E-11

Real

Aptamer SeqId: 7981-230 | Target: B3GT6 | UniProt: Q96L58

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7981-230 | Target: B3GT6 | UniProt: Q96L58 | TargetFullName: Beta-1;3-galactosyltransferase 6 | Organisim: human | Apparent_Kd_M: 3.108879E-11

Real

Aptamer SeqId:7982-10;Target:RM32;UniProt:Q9BYC8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7982-10;Target: RM32;UniProt: Q9BYC8;TargetFullName: 39S ribosomal protein L32; mitochondrial;Organisim: human;Apparent_Kd_M: 1.812824E-11

Real

Aptamer SeqId: 7982-10 | Target: RM32 | UniProt: Q9BYC8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7982-10 | Target: RM32 | UniProt: Q9BYC8 | TargetFullName: 39S ribosomal protein L32; mitochondrial | Organisim: human | Apparent_Kd_M: 1.812824E-11

Real

Aptamer SeqId:7983-1;Target:PCDGM;UniProt:Q9Y5F6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7983-1;Target: PCDGM;UniProt: Q9Y5F6;TargetFullName: Protocadherin gamma-C5;Organisim: human;Apparent_Kd_M: 1.678747E-11

Real

Aptamer SeqId: 7983-1 | Target: PCDGM | UniProt: Q9Y5F6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7983-1 | Target: PCDGM | UniProt: Q9Y5F6 | TargetFullName: Protocadherin gamma-C5 | Organisim: human | Apparent_Kd_M: 1.678747E-11

Real

Aptamer SeqId:7986-98;Target:NALD2;UniProt:Q9Y3Q0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7986-98;Target: NALD2;UniProt: Q9Y3Q0;TargetFullName: N-acetylated-alpha-linked acidic dipeptidase 2;Organisim: human;Apparent_Kd_M: 1.303427E-10

Real

Aptamer SeqId: 7986-98 | Target: NALD2 | UniProt: Q9Y3Q0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7986-98 | Target: NALD2 | UniProt: Q9Y3Q0 | TargetFullName: N-acetylated-alpha-linked acidic dipeptidase 2 | Organisim: human | Apparent_Kd_M: 1.303427E-10

Real

Aptamer SeqId:7989-5;Target:CA226;UniProt:A1L170

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7989-5;Target: CA226;UniProt: A1L170;TargetFullName: Uncharacterized protein C1orf226;Organisim: human;Apparent_Kd_M: 3.026286E-10

Real

Aptamer SeqId: 7989-5 | Target: CA226 | UniProt: A1L170

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7989-5 | Target: CA226 | UniProt: A1L170 | TargetFullName: Uncharacterized protein C1orf226 | Organisim: human | Apparent_Kd_M: 3.026286E-10

Real

Aptamer SeqId:7991-54;Target:IQCF1;UniProt:Q8N6M8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7991-54;Target: IQCF1;UniProt: Q8N6M8;TargetFullName: IQ domain-containing protein F1;Organisim: human;Apparent_Kd_M: 1.95E-10

Real

Aptamer SeqId: 7991-54 | Target: IQCF1 | UniProt: Q8N6M8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7991-54 | Target: IQCF1 | UniProt: Q8N6M8 | TargetFullName: IQ domain-containing protein F1 | Organisim: human | Apparent_Kd_M: 1.95E-10

Real

Aptamer SeqId:7992-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7992-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.031898E-10

Real

Aptamer SeqId: 7992-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7992-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.031898E-10

Real

Aptamer SeqId:7993-23;Target:ASTL;UniProt:Q6HA08

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7993-23;Target: ASTL;UniProt: Q6HA08;TargetFullName: Astacin-like metalloendopeptidase;Organisim: human;Apparent_Kd_M: 8.206606E-12

Real

Aptamer SeqId: 7993-23 | Target: ASTL | UniProt: Q6HA08

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7993-23 | Target: ASTL | UniProt: Q6HA08 | TargetFullName: Astacin-like metalloendopeptidase | Organisim: human | Apparent_Kd_M: 8.206606E-12

Real

Aptamer SeqId:7994-41;Target:ERO1B;UniProt:Q86YB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7994-41;Target: ERO1B;UniProt: Q86YB8;TargetFullName: ERO1-like protein beta;Organisim: human;Apparent_Kd_M: 9.887859E-11

Real

Aptamer SeqId: 7994-41 | Target: ERO1B | UniProt: Q86YB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7994-41 | Target: ERO1B | UniProt: Q86YB8 | TargetFullName: ERO1-like protein beta | Organisim: human | Apparent_Kd_M: 9.887859E-11

Real

Aptamer SeqId:7995-16;Target:VWC2L;UniProt:B2RUY7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7995-16;Target: VWC2L;UniProt: B2RUY7;TargetFullName: von Willebrand factor C domain-containing protein 2-like;Organisim: human;Apparent_Kd_M: 2.512963E-10

Real

Aptamer SeqId: 7995-16 | Target: VWC2L | UniProt: B2RUY7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7995-16 | Target: VWC2L | UniProt: B2RUY7 | TargetFullName: von Willebrand factor C domain-containing protein 2-like | Organisim: human | Apparent_Kd_M: 2.512963E-10

Real

Aptamer SeqId:7997-118;Target:DOC2B;UniProt:Q14184

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7997-118;Target: DOC2B;UniProt: Q14184;TargetFullName: Double C2-like domain-containing protein beta;Organisim: human;Apparent_Kd_M: 6.188603E-11

Real

Aptamer SeqId: 7997-118 | Target: DOC2B | UniProt: Q14184

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7997-118 | Target: DOC2B | UniProt: Q14184 | TargetFullName: Double C2-like domain-containing protein beta | Organisim: human | Apparent_Kd_M: 6.188603E-11

Real

Aptamer SeqId:7999-23;Target:CD39;UniProt:P49961

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 7999-23;Target: CD39;UniProt: P49961;TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 1;Organisim: human;Apparent_Kd_M: 6.25E-12

Real

Aptamer SeqId: 7999-23 | Target: CD39 | UniProt: P49961

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 7999-23 | Target: CD39 | UniProt: P49961 | TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 1 | Organisim: human | Apparent_Kd_M: 6.25E-12

Real

Aptamer SeqId:8000-17;Target:KI2LA;UniProt:Q8N109

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8000-17;Target: KI2LA;UniProt: Q8N109;TargetFullName: Killer cell immunoglobulin-like receptor 2DL5A;Organisim: human;Apparent_Kd_M: 6.23E-12

Real

Aptamer SeqId: 8000-17 | Target: KI2LA | UniProt: Q8N109

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8000-17 | Target: KI2LA | UniProt: Q8N109 | TargetFullName: Killer cell immunoglobulin-like receptor 2DL5A | Organisim: human | Apparent_Kd_M: 6.23E-12

Real

Aptamer SeqId:8002-27;Target:Spinesin;UniProt:Q9H3S3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8002-27;Target: Spinesin;UniProt: Q9H3S3;TargetFullName: Transmembrane protease serine 5;Organisim: human;Apparent_Kd_M: 7.263001E-11

Real

Aptamer SeqId: 8002-27 | Target: Spinesin | UniProt: Q9H3S3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8002-27 | Target: Spinesin | UniProt: Q9H3S3 | TargetFullName: Transmembrane protease serine 5 | Organisim: human | Apparent_Kd_M: 7.263001E-11

Real

Aptamer SeqId:8003-57;Target:LGI3;UniProt:Q8N145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8003-57;Target: LGI3;UniProt: Q8N145;TargetFullName: Leucine-rich repeat LGI family member 3;Organisim: human;Apparent_Kd_M: 1.391593E-11

Real

Aptamer SeqId: 8003-57 | Target: LGI3 | UniProt: Q8N145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8003-57 | Target: LGI3 | UniProt: Q8N145 | TargetFullName: Leucine-rich repeat LGI family member 3 | Organisim: human | Apparent_Kd_M: 1.391593E-11

Real

Aptamer SeqId:8004-15;Target:G3PT;UniProt:O14556

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8004-15;Target: G3PT;UniProt: O14556;TargetFullName: Glyceraldehyde-3-phosphate dehydrogenase; testis-specific;Organisim: human;Apparent_Kd_M: 1.15102E-10

Real

Aptamer SeqId: 8004-15 | Target: G3PT | UniProt: O14556

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8004-15 | Target: G3PT | UniProt: O14556 | TargetFullName: Glyceraldehyde-3-phosphate dehydrogenase; testis-specific | Organisim: human | Apparent_Kd_M: 1.15102E-10

Real

Aptamer SeqId:8005-1;Target:MXRA7;UniProt:P84157

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8005-1;Target: MXRA7;UniProt: P84157;TargetFullName: Matrix-remodeling-associated protein 7;Organisim: human;Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId: 8005-1 | Target: MXRA7 | UniProt: P84157

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8005-1 | Target: MXRA7 | UniProt: P84157 | TargetFullName: Matrix-remodeling-associated protein 7 | Organisim: human | Apparent_Kd_M: 1.12E-10

Real

Aptamer SeqId:8006-12;Target:DJB12;UniProt:Q9NXW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8006-12;Target: DJB12;UniProt: Q9NXW2;TargetFullName: DnaJ homolog subfamily B member 12;Organisim: human;Apparent_Kd_M: 3.262026E-12

Real

Aptamer SeqId: 8006-12 | Target: DJB12 | UniProt: Q9NXW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8006-12 | Target: DJB12 | UniProt: Q9NXW2 | TargetFullName: DnaJ homolog subfamily B member 12 | Organisim: human | Apparent_Kd_M: 3.262026E-12

Real

Aptamer SeqId:8007-19;Target:Cathepsin B;UniProt:P07858

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8007-19;Target: Cathepsin B;UniProt: P07858;TargetFullName: Cathepsin B;Organisim: human;Apparent_Kd_M: 5.47E-12

Real

Aptamer SeqId: 8007-19 | Target: Cathepsin B | UniProt: P07858

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8007-19 | Target: Cathepsin B | UniProt: P07858 | TargetFullName: Cathepsin B | Organisim: human | Apparent_Kd_M: 5.47E-12

Real

Aptamer SeqId:8008-28;Target:HRK;UniProt:O00198

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8008-28;Target: HRK;UniProt: O00198;TargetFullName: Activator of apoptosis harakiri;Organisim: human;Apparent_Kd_M: 2.69E-10

Real

Aptamer SeqId: 8008-28 | Target: HRK | UniProt: O00198

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8008-28 | Target: HRK | UniProt: O00198 | TargetFullName: Activator of apoptosis harakiri | Organisim: human | Apparent_Kd_M: 2.69E-10

Real

Aptamer SeqId:8009-121;Target:SURF1;UniProt:Q15526

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8009-121;Target: SURF1;UniProt: Q15526;TargetFullName: Surfeit locus protein 1;Organisim: human;Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId: 8009-121 | Target: SURF1 | UniProt: Q15526

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8009-121 | Target: SURF1 | UniProt: Q15526 | TargetFullName: Surfeit locus protein 1 | Organisim: human | Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId:8011-96;Target:PAPL;UniProt:Q6ZNF0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8011-96;Target: PAPL;UniProt: Q6ZNF0;TargetFullName: Iron/zinc purple acid phosphatase-like protein;Organisim: human;Apparent_Kd_M: 1.91963E-12

Real

Aptamer SeqId: 8011-96 | Target: PAPL | UniProt: Q6ZNF0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8011-96 | Target: PAPL | UniProt: Q6ZNF0 | TargetFullName: Iron/zinc purple acid phosphatase-like protein | Organisim: human | Apparent_Kd_M: 1.91963E-12

Real

Aptamer SeqId:8013-9;Target:LMA2L;UniProt:Q9H0V9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8013-9;Target: LMA2L;UniProt: Q9H0V9;TargetFullName: VIP36-like protein;Organisim: human;Apparent_Kd_M: 8.824464E-12

Real

Aptamer SeqId: 8013-9 | Target: LMA2L | UniProt: Q9H0V9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8013-9 | Target: LMA2L | UniProt: Q9H0V9 | TargetFullName: VIP36-like protein | Organisim: human | Apparent_Kd_M: 8.824464E-12

Real

Aptamer SeqId:8014-359;Target:MANEA;UniProt:Q5SRI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8014-359;Target: MANEA;UniProt: Q5SRI9;TargetFullName: Glycoprotein endo-alpha-1;2-mannosidase;Organisim: human;Apparent_Kd_M: 6.917222E-12

Real

Aptamer SeqId: 8014-359 | Target: MANEA | UniProt: Q5SRI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8014-359 | Target: MANEA | UniProt: Q5SRI9 | TargetFullName: Glycoprotein endo-alpha-1;2-mannosidase | Organisim: human | Apparent_Kd_M: 6.917222E-12

Real

Aptamer SeqId:8015-144;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8015-144;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.948895E-11

Real

Aptamer SeqId: 8015-144 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8015-144 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.948895E-11

Real

Aptamer SeqId:8016-19;Target:DNJC4;UniProt:Q9NNZ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8016-19;Target: DNJC4;UniProt: Q9NNZ3;TargetFullName: DnaJ homolog subfamily C member 4;Organisim: human;Apparent_Kd_M: 3.52E-11

Real

Aptamer SeqId: 8016-19 | Target: DNJC4 | UniProt: Q9NNZ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8016-19 | Target: DNJC4 | UniProt: Q9NNZ3 | TargetFullName: DnaJ homolog subfamily C member 4 | Organisim: human | Apparent_Kd_M: 3.52E-11

Real

Aptamer SeqId:8017-23;Target:FXRD1;UniProt:Q96CU9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8017-23;Target: FXRD1;UniProt: Q96CU9;TargetFullName: FAD-dependent oxidoreductase domain-containing protein 1;Organisim: human;Apparent_Kd_M: 5.022978E-11

Real

Aptamer SeqId: 8017-23 | Target: FXRD1 | UniProt: Q96CU9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8017-23 | Target: FXRD1 | UniProt: Q96CU9 | TargetFullName: FAD-dependent oxidoreductase domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 5.022978E-11

Real

Aptamer SeqId:8018-43;Target:VSIG2;UniProt:Q96IQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8018-43;Target: VSIG2;UniProt: Q96IQ7;TargetFullName: V-set and immunoglobulin domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 8018-43 | Target: VSIG2 | UniProt: Q96IQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8018-43 | Target: VSIG2 | UniProt: Q96IQ7 | TargetFullName: V-set and immunoglobulin domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:8019-73;Target:STMN3;UniProt:Q9NZ72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8019-73;Target: STMN3;UniProt: Q9NZ72;TargetFullName: Stathmin-3;Organisim: human;Apparent_Kd_M: 7.31E-11

Real

Aptamer SeqId: 8019-73 | Target: STMN3 | UniProt: Q9NZ72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8019-73 | Target: STMN3 | UniProt: Q9NZ72 | TargetFullName: Stathmin-3 | Organisim: human | Apparent_Kd_M: 7.31E-11

Real

Aptamer SeqId:8021-59;Target:RM14;UniProt:Q6P1L8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8021-59;Target: RM14;UniProt: Q6P1L8;TargetFullName: 39S ribosomal protein L14; mitochondrial;Organisim: human;Apparent_Kd_M: 2.871166E-10

Real

Aptamer SeqId: 8021-59 | Target: RM14 | UniProt: Q6P1L8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8021-59 | Target: RM14 | UniProt: Q6P1L8 | TargetFullName: 39S ribosomal protein L14; mitochondrial | Organisim: human | Apparent_Kd_M: 2.871166E-10

Real

Aptamer SeqId:8023-23;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8023-23;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.949324E-11

Real

Aptamer SeqId: 8023-23 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8023-23 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.949324E-11

Real

Aptamer SeqId:8024-64;Target:TPST2;UniProt:O60704

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8024-64;Target: TPST2;UniProt: O60704;TargetFullName: Protein-tyrosine sulfotransferase 2;Organisim: human;Apparent_Kd_M: 6.990052E-11

Real

Aptamer SeqId: 8024-64 | Target: TPST2 | UniProt: O60704

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8024-64 | Target: TPST2 | UniProt: O60704 | TargetFullName: Protein-tyrosine sulfotransferase 2 | Organisim: human | Apparent_Kd_M: 6.990052E-11

Real

Aptamer SeqId:8028-22;Target:SPINK5;UniProt:Q9NQ38

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8028-22;Target: SPINK5;UniProt: Q9NQ38;TargetFullName: Serine protease inhibitor Kazal-type 5;Organisim: human;Apparent_Kd_M: 3.323798E-11

Real

Aptamer SeqId: 8028-22 | Target: SPINK5 | UniProt: Q9NQ38

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8028-22 | Target: SPINK5 | UniProt: Q9NQ38 | TargetFullName: Serine protease inhibitor Kazal-type 5 | Organisim: human | Apparent_Kd_M: 3.323798E-11

Real

Aptamer SeqId:8029-35;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8029-35;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.14915E-11

Real

Aptamer SeqId: 8029-35 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8029-35 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.14915E-11

Real

Aptamer SeqId:8031-11;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8031-11;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.265995E-11

Real

Aptamer SeqId: 8031-11 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8031-11 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.265995E-11

Real

Aptamer SeqId:8032-23;Target:MCCD1;UniProt:P59942

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8032-23;Target: MCCD1;UniProt: P59942;TargetFullName: Mitochondrial coiled-coil domain protein 1;Organisim: human;Apparent_Kd_M: 2.117015E-10

Real

Aptamer SeqId: 8032-23 | Target: MCCD1 | UniProt: P59942

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8032-23 | Target: MCCD1 | UniProt: P59942 | TargetFullName: Mitochondrial coiled-coil domain protein 1 | Organisim: human | Apparent_Kd_M: 2.117015E-10

Real

Aptamer SeqId:8033-1;Target:DJC18;UniProt:Q9H819

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8033-1;Target: DJC18;UniProt: Q9H819;TargetFullName: DnaJ homolog subfamily C member 18;Organisim: human;Apparent_Kd_M: 6.477627E-12

Real

Aptamer SeqId: 8033-1 | Target: DJC18 | UniProt: Q9H819

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8033-1 | Target: DJC18 | UniProt: Q9H819 | TargetFullName: DnaJ homolog subfamily C member 18 | Organisim: human | Apparent_Kd_M: 6.477627E-12

Real

Aptamer SeqId:8034-6;Target:DRGX;UniProt:A6NNA5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8034-6;Target: DRGX;UniProt: A6NNA5;TargetFullName: Dorsal root ganglia homeobox protein;Organisim: human;Apparent_Kd_M: 6.083276E-12

Real

Aptamer SeqId: 8034-6 | Target: DRGX | UniProt: A6NNA5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8034-6 | Target: DRGX | UniProt: A6NNA5 | TargetFullName: Dorsal root ganglia homeobox protein | Organisim: human | Apparent_Kd_M: 6.083276E-12

Real

Aptamer SeqId:8035-6;Target:CA198;UniProt:Q9H425

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8035-6;Target: CA198;UniProt: Q9H425;TargetFullName: Uncharacterized protein C1orf198;Organisim: human;Apparent_Kd_M: 2.386915E-11

Real

Aptamer SeqId: 8035-6 | Target: CA198 | UniProt: Q9H425

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8035-6 | Target: CA198 | UniProt: Q9H425 | TargetFullName: Uncharacterized protein C1orf198 | Organisim: human | Apparent_Kd_M: 2.386915E-11

Real

Aptamer SeqId:8036-75;Target:FSHB;UniProt:P01225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8036-75;Target: FSHB;UniProt: P01225;TargetFullName: Follitropin subunit beta;Organisim: human;Apparent_Kd_M: 1.073358E-10

Real

Aptamer SeqId: 8036-75 | Target: FSHB | UniProt: P01225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8036-75 | Target: FSHB | UniProt: P01225 | TargetFullName: Follitropin subunit beta | Organisim: human | Apparent_Kd_M: 1.073358E-10

Real

Aptamer SeqId:8038-41;Target:NSDHL;UniProt:Q15738

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8038-41;Target: NSDHL;UniProt: Q15738;TargetFullName: Sterol-4-alpha-carboxylate 3-dehydrogenase; decarboxylating;Organisim: human;Apparent_Kd_M: 8.993994E-12

Real

Aptamer SeqId: 8038-41 | Target: NSDHL | UniProt: Q15738

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8038-41 | Target: NSDHL | UniProt: Q15738 | TargetFullName: Sterol-4-alpha-carboxylate 3-dehydrogenase; decarboxylating | Organisim: human | Apparent_Kd_M: 8.993994E-12

Real

Aptamer SeqId:8039-41;Target:F177A;UniProt:Q8N128

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8039-41;Target: F177A;UniProt: Q8N128;TargetFullName: Protein FAM177A1;Organisim: human;Apparent_Kd_M: 3.920842E-11

Real

Aptamer SeqId: 8039-41 | Target: F177A | UniProt: Q8N128

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8039-41 | Target: F177A | UniProt: Q8N128 | TargetFullName: Protein FAM177A1 | Organisim: human | Apparent_Kd_M: 3.920842E-11

Real

Aptamer SeqId:8040-9;Target:LEMD1;UniProt:Q68G75

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8040-9;Target: LEMD1;UniProt: Q68G75;TargetFullName: LEM domain-containing protein 1;Organisim: human;Apparent_Kd_M: 9.174705E-12

Real

Aptamer SeqId: 8040-9 | Target: LEMD1 | UniProt: Q68G75

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8040-9 | Target: LEMD1 | UniProt: Q68G75 | TargetFullName: LEM domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 9.174705E-12

Real

Aptamer SeqId:8041-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8041-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.437274E-11

Real

Aptamer SeqId: 8041-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8041-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.437274E-11

Real

Aptamer SeqId:8042-88;Target:ISK9;UniProt:Q5DT21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8042-88;Target: ISK9;UniProt: Q5DT21;TargetFullName: Serine protease inhibitor Kazal-type 9;Organisim: human;Apparent_Kd_M: 5.090768E-11

Real

Aptamer SeqId: 8042-88 | Target: ISK9 | UniProt: Q5DT21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8042-88 | Target: ISK9 | UniProt: Q5DT21 | TargetFullName: Serine protease inhibitor Kazal-type 9 | Organisim: human | Apparent_Kd_M: 5.090768E-11

Real

Aptamer SeqId:8043-153;Target:COMP;UniProt:P49747

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8043-153;Target: COMP;UniProt: P49747;TargetFullName: Cartilage oligomeric matrix protein;Organisim: human;Apparent_Kd_M: 2.720908E-10

Real

Aptamer SeqId: 8043-153 | Target: COMP | UniProt: P49747

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8043-153 | Target: COMP | UniProt: P49747 | TargetFullName: Cartilage oligomeric matrix protein | Organisim: human | Apparent_Kd_M: 2.720908E-10

Real

Aptamer SeqId:8044-90;Target:XG;UniProt:P55808

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8044-90;Target: XG;UniProt: P55808;TargetFullName: Glycoprotein Xg;Organisim: human;Apparent_Kd_M: 4.7E-11

Real

Aptamer SeqId: 8044-90 | Target: XG | UniProt: P55808

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8044-90 | Target: XG | UniProt: P55808 | TargetFullName: Glycoprotein Xg | Organisim: human | Apparent_Kd_M: 4.7E-11

Real

Aptamer SeqId:8045-3;Target:KI3L3;UniProt:Q8N743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8045-3;Target: KI3L3;UniProt: Q8N743;TargetFullName: Killer cell immunoglobulin-like receptor 3DL3;Organisim: human;Apparent_Kd_M: 1.66E-10

Real

Aptamer SeqId: 8045-3 | Target: KI3L3 | UniProt: Q8N743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8045-3 | Target: KI3L3 | UniProt: Q8N743 | TargetFullName: Killer cell immunoglobulin-like receptor 3DL3 | Organisim: human | Apparent_Kd_M: 1.66E-10

Real

Aptamer SeqId:8046-9;Target:Galectin-1;UniProt:P09382

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8046-9;Target: Galectin-1;UniProt: P09382;TargetFullName: Galectin-1;Organisim: human;Apparent_Kd_M: 2.818388E-10

Real

Aptamer SeqId: 8046-9 | Target: Galectin-1 | UniProt: P09382

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8046-9 | Target: Galectin-1 | UniProt: P09382 | TargetFullName: Galectin-1 | Organisim: human | Apparent_Kd_M: 2.818388E-10

Real

Aptamer SeqId:8048-9;Target:FTMT;UniProt:Q8N4E7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8048-9;Target: FTMT;UniProt: Q8N4E7;TargetFullName: Ferritin; mitochondrial;Organisim: human;Apparent_Kd_M: 6.26E-11

Real

Aptamer SeqId: 8048-9 | Target: FTMT | UniProt: Q8N4E7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8048-9 | Target: FTMT | UniProt: Q8N4E7 | TargetFullName: Ferritin; mitochondrial | Organisim: human | Apparent_Kd_M: 6.26E-11

Real

Aptamer SeqId:8051-10;Target:AGGF1;UniProt:Q8N302

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8051-10;Target: AGGF1;UniProt: Q8N302;TargetFullName: Angiogenic factor with G patch and FHA domains 1;Organisim: human;Apparent_Kd_M: 4.472491E-11

Real

Aptamer SeqId: 8051-10 | Target: AGGF1 | UniProt: Q8N302

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8051-10 | Target: AGGF1 | UniProt: Q8N302 | TargetFullName: Angiogenic factor with G patch and FHA domains 1 | Organisim: human | Apparent_Kd_M: 4.472491E-11

Real

Aptamer SeqId:8053-16;Target:DJB14;UniProt:Q8TBM8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8053-16;Target: DJB14;UniProt: Q8TBM8;TargetFullName: DnaJ homolog subfamily B member 14;Organisim: human;Apparent_Kd_M: 6.58E-12

Real

Aptamer SeqId: 8053-16 | Target: DJB14 | UniProt: Q8TBM8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8053-16 | Target: DJB14 | UniProt: Q8TBM8 | TargetFullName: DnaJ homolog subfamily B member 14 | Organisim: human | Apparent_Kd_M: 6.58E-12

Real

Aptamer SeqId:8055-33;Target:IDD;UniProt:P98153

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8055-33;Target: IDD;UniProt: P98153;TargetFullName: Integral membrane protein DGCR2/IDD;Organisim: human;Apparent_Kd_M: 1.594547E-11

Real

Aptamer SeqId: 8055-33 | Target: IDD | UniProt: P98153

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8055-33 | Target: IDD | UniProt: P98153 | TargetFullName: Integral membrane protein DGCR2/IDD | Organisim: human | Apparent_Kd_M: 1.594547E-11

Real

Aptamer SeqId:8057-78;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8057-78;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.931321E-12

Real

Aptamer SeqId: 8057-78 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8057-78 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.931321E-12

Real

Aptamer SeqId:8059-1;Target:Tpo;UniProt:P40225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8059-1;Target: Tpo;UniProt: P40225;TargetFullName: Thrombopoietin;Organisim: human;Apparent_Kd_M: 4.72E-12

Real

Aptamer SeqId: 8059-1 | Target: Tpo | UniProt: P40225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8059-1 | Target: Tpo | UniProt: P40225 | TargetFullName: Thrombopoietin | Organisim: human | Apparent_Kd_M: 4.72E-12

Real

Aptamer SeqId:8060-7;Target:NRG2;UniProt:O14511

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8060-7;Target: NRG2;UniProt: O14511;TargetFullName: Pro-neuregulin-2; membrane-bound isoform;Organisim: human;Apparent_Kd_M: 1.510965E-11

Real

Aptamer SeqId: 8060-7 | Target: NRG2 | UniProt: O14511

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8060-7 | Target: NRG2 | UniProt: O14511 | TargetFullName: Pro-neuregulin-2; membrane-bound isoform | Organisim: human | Apparent_Kd_M: 1.510965E-11

Real

Aptamer SeqId:8061-102;Target:F171B;UniProt:Q6P995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8061-102;Target: F171B;UniProt: Q6P995;TargetFullName: Protein FAM171B;Organisim: human;Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId: 8061-102 | Target: F171B | UniProt: Q6P995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8061-102 | Target: F171B | UniProt: Q6P995 | TargetFullName: Protein FAM171B | Organisim: human | Apparent_Kd_M: 2.07E-11

Real

Aptamer SeqId:8062-15;Target:F176B;UniProt:Q9NVM1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8062-15;Target: F176B;UniProt: Q9NVM1;TargetFullName: Protein eva-1 homolog B;Organisim: human;Apparent_Kd_M: 3.303676E-11

Real

Aptamer SeqId: 8062-15 | Target: F176B | UniProt: Q9NVM1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8062-15 | Target: F176B | UniProt: Q9NVM1 | TargetFullName: Protein eva-1 homolog B | Organisim: human | Apparent_Kd_M: 3.303676E-11

Real

Aptamer SeqId:8064-125;Target:Poliovirus receptor;UniProt:P15151

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8064-125;Target: Poliovirus receptor;UniProt: P15151;TargetFullName: Poliovirus receptor;Organisim: human;Apparent_Kd_M: 3.766836E-10

Real

Aptamer SeqId: 8064-125 | Target: Poliovirus receptor | UniProt: P15151

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8064-125 | Target: Poliovirus receptor | UniProt: P15151 | TargetFullName: Poliovirus receptor | Organisim: human | Apparent_Kd_M: 3.766836E-10

Real

Aptamer SeqId:8065-245;Target:PATE4;UniProt:P0C8F1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8065-245;Target: PATE4;UniProt: P0C8F1;TargetFullName: Prostate and testis expressed protein 4;Organisim: human;Apparent_Kd_M: 1.137321E-11

Real

Aptamer SeqId: 8065-245 | Target: PATE4 | UniProt: P0C8F1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8065-245 | Target: PATE4 | UniProt: P0C8F1 | TargetFullName: Prostate and testis expressed protein 4 | Organisim: human | Apparent_Kd_M: 1.137321E-11

Real

Aptamer SeqId:8066-38;Target:SYT9;UniProt:Q86SS6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8066-38;Target: SYT9;UniProt: Q86SS6;TargetFullName: Synaptotagmin-9;Organisim: human;Apparent_Kd_M: 1.006136E-11

Real

Aptamer SeqId: 8066-38 | Target: SYT9 | UniProt: Q86SS6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8066-38 | Target: SYT9 | UniProt: Q86SS6 | TargetFullName: Synaptotagmin-9 | Organisim: human | Apparent_Kd_M: 1.006136E-11

Real

Aptamer SeqId:8067-21;Target:KCNE3;UniProt:Q9Y6H6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8067-21;Target: KCNE3;UniProt: Q9Y6H6;TargetFullName: Potassium voltage-gated channel subfamily E member 3;Organisim: human;Apparent_Kd_M: 1.47E-10

Real

Aptamer SeqId: 8067-21 | Target: KCNE3 | UniProt: Q9Y6H6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8067-21 | Target: KCNE3 | UniProt: Q9Y6H6 | TargetFullName: Potassium voltage-gated channel subfamily E member 3 | Organisim: human | Apparent_Kd_M: 1.47E-10

Real

Aptamer SeqId:8068-43;Target:K1161;UniProt:Q6NSJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8068-43;Target: K1161;UniProt: Q6NSJ0;TargetFullName: Uncharacterized family 31 glucosidase KIAA1161;Organisim: human;Apparent_Kd_M: 9.69E-11

Real

Aptamer SeqId: 8068-43 | Target: K1161 | UniProt: Q6NSJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8068-43 | Target: K1161 | UniProt: Q6NSJ0 | TargetFullName: Uncharacterized family 31 glucosidase KIAA1161 | Organisim: human | Apparent_Kd_M: 9.69E-11

Real

Aptamer SeqId:8069-85;Target:CD3E;UniProt:P07766

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8069-85;Target: CD3E;UniProt: P07766;TargetFullName: T-cell surface glycoprotein CD3 epsilon chain;Organisim: human;Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId: 8069-85 | Target: CD3E | UniProt: P07766

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8069-85 | Target: CD3E | UniProt: P07766 | TargetFullName: T-cell surface glycoprotein CD3 epsilon chain | Organisim: human | Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId:8070-88;Target:DLG4;UniProt:P78352

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8070-88;Target: DLG4;UniProt: P78352;TargetFullName: Disks large homolog 4;Organisim: human;Apparent_Kd_M: 2.572475E-12

Real

Aptamer SeqId: 8070-88 | Target: DLG4 | UniProt: P78352

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8070-88 | Target: DLG4 | UniProt: P78352 | TargetFullName: Disks large homolog 4 | Organisim: human | Apparent_Kd_M: 2.572475E-12

Real

Aptamer SeqId:8071-114;Target:PCDB7;UniProt:Q9Y5E2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8071-114;Target: PCDB7;UniProt: Q9Y5E2;TargetFullName: Protocadherin beta-7;Organisim: human;Apparent_Kd_M: 1.695905E-10

Real

Aptamer SeqId: 8071-114 | Target: PCDB7 | UniProt: Q9Y5E2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8071-114 | Target: PCDB7 | UniProt: Q9Y5E2 | TargetFullName: Protocadherin beta-7 | Organisim: human | Apparent_Kd_M: 1.695905E-10

Real

Aptamer SeqId:8072-19;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8072-19;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.537184E-11

Real

Aptamer SeqId: 8072-19 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8072-19 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.537184E-11

Real

Aptamer SeqId:8074-32;Target:TMM70;UniProt:Q9BUB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8074-32;Target: TMM70;UniProt: Q9BUB7;TargetFullName: Transmembrane protein 70; mitochondrial;Organisim: human;Apparent_Kd_M: 6.607048E-11

Real

Aptamer SeqId: 8074-32 | Target: TMM70 | UniProt: Q9BUB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8074-32 | Target: TMM70 | UniProt: Q9BUB7 | TargetFullName: Transmembrane protein 70; mitochondrial | Organisim: human | Apparent_Kd_M: 6.607048E-11

Real

Aptamer SeqId:8076-4;Target:SACA3;UniProt:Q8IXA5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8076-4;Target: SACA3;UniProt: Q8IXA5;TargetFullName: Sperm acrosome membrane-associated protein 3;Organisim: human;Apparent_Kd_M: 4.597139E-12

Real

Aptamer SeqId: 8076-4 | Target: SACA3 | UniProt: Q8IXA5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8076-4 | Target: SACA3 | UniProt: Q8IXA5 | TargetFullName: Sperm acrosome membrane-associated protein 3 | Organisim: human | Apparent_Kd_M: 4.597139E-12

Real

Aptamer SeqId:8078-15;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8078-15;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.889328E-12

Real

Aptamer SeqId: 8078-15 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8078-15 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.889328E-12

Real

Aptamer SeqId:8079-39;Target:EID3;UniProt:Q8N140

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8079-39;Target: EID3;UniProt: Q8N140;TargetFullName: EP300-interacting inhibitor of differentiation 3;Organisim: human;Apparent_Kd_M: 5.220835E-11

Real

Aptamer SeqId: 8079-39 | Target: EID3 | UniProt: Q8N140

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8079-39 | Target: EID3 | UniProt: Q8N140 | TargetFullName: EP300-interacting inhibitor of differentiation 3 | Organisim: human | Apparent_Kd_M: 5.220835E-11

Real

Aptamer SeqId:8080-24;Target:PSMP;UniProt:Q1L6U9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8080-24;Target: PSMP;UniProt: Q1L6U9;TargetFullName: Prostate-associated microseminoprotein;Organisim: human;Apparent_Kd_M: 1.114506E-11

Real

Aptamer SeqId: 8080-24 | Target: PSMP | UniProt: Q1L6U9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8080-24 | Target: PSMP | UniProt: Q1L6U9 | TargetFullName: Prostate-associated microseminoprotein | Organisim: human | Apparent_Kd_M: 1.114506E-11

Real

Aptamer SeqId:8081-55;Target:PLD5;UniProt:Q8N7P1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8081-55;Target: PLD5;UniProt: Q8N7P1;TargetFullName: Inactive phospholipase D5;Organisim: human;Apparent_Kd_M: 8.555169E-11

Real

Aptamer SeqId: 8081-55 | Target: PLD5 | UniProt: Q8N7P1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8081-55 | Target: PLD5 | UniProt: Q8N7P1 | TargetFullName: Inactive phospholipase D5 | Organisim: human | Apparent_Kd_M: 8.555169E-11

Real

Aptamer SeqId:8085-10;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8085-10;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId: 8085-10 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8085-10 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId:8086-49;Target:ITM2B;UniProt:Q9Y287

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8086-49;Target: ITM2B;UniProt: Q9Y287;TargetFullName: Integral membrane protein 2B;Organisim: human;Apparent_Kd_M: 1.418411E-10

Real

Aptamer SeqId: 8086-49 | Target: ITM2B | UniProt: Q9Y287

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8086-49 | Target: ITM2B | UniProt: Q9Y287 | TargetFullName: Integral membrane protein 2B | Organisim: human | Apparent_Kd_M: 1.418411E-10

Real

Aptamer SeqId:8087-250;Target:RNF13;UniProt:O43567

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8087-250;Target: RNF13;UniProt: O43567;TargetFullName: E3 ubiquitin-protein ligase RNF13;Organisim: human;Apparent_Kd_M: 2.649727E-11

Real

Aptamer SeqId: 8087-250 | Target: RNF13 | UniProt: O43567

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8087-250 | Target: RNF13 | UniProt: O43567 | TargetFullName: E3 ubiquitin-protein ligase RNF13 | Organisim: human | Apparent_Kd_M: 2.649727E-11

Real

Aptamer SeqId:8088-56;Target:CA210;UniProt:Q8IVY1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8088-56;Target: CA210;UniProt: Q8IVY1;TargetFullName: Type III endosome membrane protein TEMP;Organisim: human;Apparent_Kd_M: 7.416853E-12

Real

Aptamer SeqId: 8088-56 | Target: CA210 | UniProt: Q8IVY1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8088-56 | Target: CA210 | UniProt: Q8IVY1 | TargetFullName: Type III endosome membrane protein TEMP | Organisim: human | Apparent_Kd_M: 7.416853E-12

Real

Aptamer SeqId:8089-173;Target:NR4A1;UniProt:P22736

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8089-173;Target: NR4A1;UniProt: P22736;TargetFullName: Nuclear receptor subfamily 4 group A member 1;Organisim: human;Apparent_Kd_M: 4.24552E-11

Real

Aptamer SeqId: 8089-173 | Target: NR4A1 | UniProt: P22736

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8089-173 | Target: NR4A1 | UniProt: P22736 | TargetFullName: Nuclear receptor subfamily 4 group A member 1 | Organisim: human | Apparent_Kd_M: 4.24552E-11

Real

Aptamer SeqId:8093-13;Target:K1161;UniProt:Q6NSJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8093-13;Target: K1161;UniProt: Q6NSJ0;TargetFullName: Uncharacterized family 31 glucosidase KIAA1161;Organisim: human;Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId: 8093-13 | Target: K1161 | UniProt: Q6NSJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8093-13 | Target: K1161 | UniProt: Q6NSJ0 | TargetFullName: Uncharacterized family 31 glucosidase KIAA1161 | Organisim: human | Apparent_Kd_M: 1.24E-11

Real

Aptamer SeqId:8094-20;Target:CISD2;UniProt:Q8N5K1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8094-20;Target: CISD2;UniProt: Q8N5K1;TargetFullName: CDGSH iron-sulfur domain-containing protein 2;Organisim: human;Apparent_Kd_M: 2.57849E-11

Real

Aptamer SeqId: 8094-20 | Target: CISD2 | UniProt: Q8N5K1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8094-20 | Target: CISD2 | UniProt: Q8N5K1 | TargetFullName: CDGSH iron-sulfur domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 2.57849E-11

Real

Aptamer SeqId:8097-77;Target:LIPN;UniProt:Q5VXI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8097-77;Target: LIPN;UniProt: Q5VXI9;TargetFullName: Lipase member N;Organisim: human;Apparent_Kd_M: 3.750358E-12

Real

Aptamer SeqId: 8097-77 | Target: LIPN | UniProt: Q5VXI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8097-77 | Target: LIPN | UniProt: Q5VXI9 | TargetFullName: Lipase member N | Organisim: human | Apparent_Kd_M: 3.750358E-12

Real

Aptamer SeqId:8098-37;Target:THAS;UniProt:P24557

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8098-37;Target: THAS;UniProt: P24557;TargetFullName: Thromboxane-A synthase;Organisim: human;Apparent_Kd_M: 1.954798E-10

Real

Aptamer SeqId: 8098-37 | Target: THAS | UniProt: P24557

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8098-37 | Target: THAS | UniProt: P24557 | TargetFullName: Thromboxane-A synthase | Organisim: human | Apparent_Kd_M: 1.954798E-10

Real

Aptamer SeqId:8099-42;Target:SPON2;UniProt:Q9BUD6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8099-42;Target: SPON2;UniProt: Q9BUD6;TargetFullName: Spondin-2;Organisim: human;Apparent_Kd_M: 4.628419E-12

Real

Aptamer SeqId: 8099-42 | Target: SPON2 | UniProt: Q9BUD6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8099-42 | Target: SPON2 | UniProt: Q9BUD6 | TargetFullName: Spondin-2 | Organisim: human | Apparent_Kd_M: 4.628419E-12

Real

Aptamer SeqId:8100-15;Target:ADM2;UniProt:Q7Z4H4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8100-15;Target: ADM2;UniProt: Q7Z4H4;TargetFullName: ADM2;Organisim: human;Apparent_Kd_M: 9.938457E-12

Real

Aptamer SeqId: 8100-15 | Target: ADM2 | UniProt: Q7Z4H4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8100-15 | Target: ADM2 | UniProt: Q7Z4H4 | TargetFullName: ADM2 | Organisim: human | Apparent_Kd_M: 9.938457E-12

Real

Aptamer SeqId:8102-239;Target:CA186;UniProt:Q6ZWK4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8102-239;Target: CA186;UniProt: Q6ZWK4;TargetFullName: Uncharacterized protein C1orf186;Organisim: human;Apparent_Kd_M: 1.322364E-10

Real

Aptamer SeqId: 8102-239 | Target: CA186 | UniProt: Q6ZWK4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8102-239 | Target: CA186 | UniProt: Q6ZWK4 | TargetFullName: Uncharacterized protein C1orf186 | Organisim: human | Apparent_Kd_M: 1.322364E-10

Real

Aptamer SeqId:8104-21;Target:IL-10 Ra;UniProt:Q13651

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8104-21;Target: IL-10 Ra;UniProt: Q13651;TargetFullName: Interleukin-10 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId: 8104-21 | Target: IL-10 Ra | UniProt: Q13651

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8104-21 | Target: IL-10 Ra | UniProt: Q13651 | TargetFullName: Interleukin-10 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 1.63E-10

Real

Aptamer SeqId:8106-15;Target:SSRA;UniProt:P43307

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8106-15;Target: SSRA;UniProt: P43307;TargetFullName: Translocon-associated protein subunit alpha;Organisim: human;Apparent_Kd_M: 2.992605E-11

Real

Aptamer SeqId: 8106-15 | Target: SSRA | UniProt: P43307

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8106-15 | Target: SSRA | UniProt: P43307 | TargetFullName: Translocon-associated protein subunit alpha | Organisim: human | Apparent_Kd_M: 2.992605E-11

Real

Aptamer SeqId:8107-12;Target:TM234;UniProt:Q8WY98

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8107-12;Target: TM234;UniProt: Q8WY98;TargetFullName: Transmembrane protein 234;Organisim: human;Apparent_Kd_M: 7.40099E-11

Real

Aptamer SeqId: 8107-12 | Target: TM234 | UniProt: Q8WY98

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8107-12 | Target: TM234 | UniProt: Q8WY98 | TargetFullName: Transmembrane protein 234 | Organisim: human | Apparent_Kd_M: 7.40099E-11

Real

Aptamer SeqId:8219-14;Target:ZG16;UniProt:O60844

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8219-14;Target: ZG16;UniProt: O60844;TargetFullName: Zymogen granule membrane protein 16;Organisim: human;Apparent_Kd_M: 7.69E-12

Real

Aptamer SeqId: 8219-14 | Target: ZG16 | UniProt: O60844

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8219-14 | Target: ZG16 | UniProt: O60844 | TargetFullName: Zymogen granule membrane protein 16 | Organisim: human | Apparent_Kd_M: 7.69E-12

Real

Aptamer SeqId:8220-15;Target:CJ035;UniProt:Q96D05

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8220-15;Target: CJ035;UniProt: Q96D05;TargetFullName: Uncharacterized protein C10orf35;Organisim: human;Apparent_Kd_M: 4.683084E-11

Real

Aptamer SeqId: 8220-15 | Target: CJ035 | UniProt: Q96D05

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8220-15 | Target: CJ035 | UniProt: Q96D05 | TargetFullName: Uncharacterized protein C10orf35 | Organisim: human | Apparent_Kd_M: 4.683084E-11

Real

Aptamer SeqId:8221-19;Target:MIF;UniProt:P14174

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8221-19;Target: MIF;UniProt: P14174;TargetFullName: Macrophage migration inhibitory factor;Organisim: human;Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId: 8221-19 | Target: MIF | UniProt: P14174

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8221-19 | Target: MIF | UniProt: P14174 | TargetFullName: Macrophage migration inhibitory factor | Organisim: human | Apparent_Kd_M: 3.06E-11

Real

Aptamer SeqId:8222-49;Target:CDHR3;UniProt:Q6ZTQ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8222-49;Target: CDHR3;UniProt: Q6ZTQ4;TargetFullName: Cadherin-related family member 3;Organisim: human;Apparent_Kd_M: 4.68E-12

Real

Aptamer SeqId: 8222-49 | Target: CDHR3 | UniProt: Q6ZTQ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8222-49 | Target: CDHR3 | UniProt: Q6ZTQ4 | TargetFullName: Cadherin-related family member 3 | Organisim: human | Apparent_Kd_M: 4.68E-12

Real

Aptamer SeqId:8225-86;Target:EPHB2;UniProt:P29323

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8225-86;Target: EPHB2;UniProt: P29323;TargetFullName: Ephrin type-B receptor 2;Organisim: human;Apparent_Kd_M: 1.22E-12

Real

Aptamer SeqId: 8225-86 | Target: EPHB2 | UniProt: P29323

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8225-86 | Target: EPHB2 | UniProt: P29323 | TargetFullName: Ephrin type-B receptor 2 | Organisim: human | Apparent_Kd_M: 1.22E-12

Real

Aptamer SeqId:8228-10;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8228-10;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.183098E-11

Real

Aptamer SeqId: 8228-10 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8228-10 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.183098E-11

Real

Aptamer SeqId:8229-1;Target:GXLT1;UniProt:Q4G148

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8229-1;Target: GXLT1;UniProt: Q4G148;TargetFullName: Glucoside xylosyltransferase 1;Organisim: human;Apparent_Kd_M: 1.981038E-11

Real

Aptamer SeqId: 8229-1 | Target: GXLT1 | UniProt: Q4G148

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8229-1 | Target: GXLT1 | UniProt: Q4G148 | TargetFullName: Glucoside xylosyltransferase 1 | Organisim: human | Apparent_Kd_M: 1.981038E-11

Real

Aptamer SeqId:8231-122;Target:VEGF sR1;UniProt:P17948

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8231-122;Target: VEGF sR1;UniProt: P17948;TargetFullName: Vascular endothelial growth factor receptor 1;Organisim: human;Apparent_Kd_M: 7.56E-11

Real

Aptamer SeqId: 8231-122 | Target: VEGF sR1 | UniProt: P17948

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8231-122 | Target: VEGF sR1 | UniProt: P17948 | TargetFullName: Vascular endothelial growth factor receptor 1 | Organisim: human | Apparent_Kd_M: 7.56E-11

Real

Aptamer SeqId:8233-2;Target:ITIH5;UniProt:Q86UX2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8233-2;Target: ITIH5;UniProt: Q86UX2;TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H5;Organisim: human;Apparent_Kd_M: 1.62059E-12

Real

Aptamer SeqId: 8233-2 | Target: ITIH5 | UniProt: Q86UX2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8233-2 | Target: ITIH5 | UniProt: Q86UX2 | TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H5 | Organisim: human | Apparent_Kd_M: 1.62059E-12

Real

Aptamer SeqId:8235-48;Target:SCG1;UniProt:P05060

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8235-48;Target: SCG1;UniProt: P05060;TargetFullName: Secretogranin-1;Organisim: human;Apparent_Kd_M: 2.672539E-11

Real

Aptamer SeqId: 8235-48 | Target: SCG1 | UniProt: P05060

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8235-48 | Target: SCG1 | UniProt: P05060 | TargetFullName: Secretogranin-1 | Organisim: human | Apparent_Kd_M: 2.672539E-11

Real

Aptamer SeqId:8236-8;Target:CR032;UniProt:Q8TCD1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8236-8;Target: CR032;UniProt: Q8TCD1;TargetFullName: UPF0729 protein C18orf32;Organisim: human;Apparent_Kd_M: 7.584924E-12

Real

Aptamer SeqId: 8236-8 | Target: CR032 | UniProt: Q8TCD1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8236-8 | Target: CR032 | UniProt: Q8TCD1 | TargetFullName: UPF0729 protein C18orf32 | Organisim: human | Apparent_Kd_M: 7.584924E-12

Real

Aptamer SeqId:8237-56;Target:SOSD1;UniProt:Q6X4U4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8237-56;Target: SOSD1;UniProt: Q6X4U4;TargetFullName: Sclerostin domain-containing protein 1;Organisim: human;Apparent_Kd_M: 7.989003E-11

Real

Aptamer SeqId: 8237-56 | Target: SOSD1 | UniProt: Q6X4U4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8237-56 | Target: SOSD1 | UniProt: Q6X4U4 | TargetFullName: Sclerostin domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 7.989003E-11

Real

Aptamer SeqId:8242-9;Target:CLC2L;UniProt:P0C7M8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8242-9;Target: CLC2L;UniProt: P0C7M8;TargetFullName: C-type lectin domain family 2 member L;Organisim: human;Apparent_Kd_M: 1.719982E-10

Real

Aptamer SeqId: 8242-9 | Target: CLC2L | UniProt: P0C7M8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8242-9 | Target: CLC2L | UniProt: P0C7M8 | TargetFullName: C-type lectin domain family 2 member L | Organisim: human | Apparent_Kd_M: 1.719982E-10

Real

Aptamer SeqId:8243-55;Target:TATI;UniProt:P00995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8243-55;Target: TATI;UniProt: P00995;TargetFullName: Serine protease inhibitor Kazal-type 1;Organisim: human;Apparent_Kd_M: 1.140135E-11

Real

Aptamer SeqId: 8243-55 | Target: TATI | UniProt: P00995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8243-55 | Target: TATI | UniProt: P00995 | TargetFullName: Serine protease inhibitor Kazal-type 1 | Organisim: human | Apparent_Kd_M: 1.140135E-11

Real

Aptamer SeqId:8244-16;Target:FUT8;UniProt:Q9BYC5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8244-16;Target: FUT8;UniProt: Q9BYC5;TargetFullName: Alpha-(1;6)-fucosyltransferase;Organisim: human;Apparent_Kd_M: 1.639499E-12

Real

Aptamer SeqId: 8244-16 | Target: FUT8 | UniProt: Q9BYC5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8244-16 | Target: FUT8 | UniProt: Q9BYC5 | TargetFullName: Alpha-(1;6)-fucosyltransferase | Organisim: human | Apparent_Kd_M: 1.639499E-12

Real

Aptamer SeqId:8245-27;Target:sICAM-5;UniProt:Q9UMF0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8245-27;Target: sICAM-5;UniProt: Q9UMF0;TargetFullName: Intercellular adhesion molecule 5;Organisim: human;Apparent_Kd_M: 7.39E-12

Real

Aptamer SeqId: 8245-27 | Target: sICAM-5 | UniProt: Q9UMF0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8245-27 | Target: sICAM-5 | UniProt: Q9UMF0 | TargetFullName: Intercellular adhesion molecule 5 | Organisim: human | Apparent_Kd_M: 7.39E-12

Real

Aptamer SeqId:8248-222;Target:SIG14;UniProt:Q08ET2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8248-222;Target: SIG14;UniProt: Q08ET2;TargetFullName: Sialic acid-binding Ig-like lectin 14;Organisim: human;Apparent_Kd_M: 1.08E-12

Real

Aptamer SeqId: 8248-222 | Target: SIG14 | UniProt: Q08ET2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8248-222 | Target: SIG14 | UniProt: Q08ET2 | TargetFullName: Sialic acid-binding Ig-like lectin 14 | Organisim: human | Apparent_Kd_M: 1.08E-12

Real

Aptamer SeqId:8249-124;Target:ALK;UniProt:Q9UM73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8249-124;Target: ALK;UniProt: Q9UM73;TargetFullName: ALK tyrosine kinase receptor;Organisim: human;Apparent_Kd_M: 4.848776E-11

Real

Aptamer SeqId: 8249-124 | Target: ALK | UniProt: Q9UM73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8249-124 | Target: ALK | UniProt: Q9UM73 | TargetFullName: ALK tyrosine kinase receptor | Organisim: human | Apparent_Kd_M: 4.848776E-11

Real

Aptamer SeqId:8250-2;Target:PTPRJ;UniProt:Q12913

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8250-2;Target: PTPRJ;UniProt: Q12913;TargetFullName: Receptor-type tyrosine-protein phosphatase eta;Organisim: human;Apparent_Kd_M: 1.15E-10

Real

Aptamer SeqId: 8250-2 | Target: PTPRJ | UniProt: Q12913

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8250-2 | Target: PTPRJ | UniProt: Q12913 | TargetFullName: Receptor-type tyrosine-protein phosphatase eta | Organisim: human | Apparent_Kd_M: 1.15E-10

Real

Aptamer SeqId:8252-2;Target:NOTUM;UniProt:Q6P988

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8252-2;Target: NOTUM;UniProt: Q6P988;TargetFullName: Palmitoleoyl-protein carboxylesterase NOTUM;Organisim: human;Apparent_Kd_M: 2.994046E-11

Real

Aptamer SeqId: 8252-2 | Target: NOTUM | UniProt: Q6P988

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8252-2 | Target: NOTUM | UniProt: Q6P988 | TargetFullName: Palmitoleoyl-protein carboxylesterase NOTUM | Organisim: human | Apparent_Kd_M: 2.994046E-11

Real

Aptamer SeqId:8253-2;Target:PMGT1;UniProt:Q8WZA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8253-2;Target: PMGT1;UniProt: Q8WZA1;TargetFullName: Protein O-linked-mannose beta-1;2-N-acetylglucosaminyltransferase 1;Organisim: human;Apparent_Kd_M: 3.032504E-11

Real

Aptamer SeqId: 8253-2 | Target: PMGT1 | UniProt: Q8WZA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8253-2 | Target: PMGT1 | UniProt: Q8WZA1 | TargetFullName: Protein O-linked-mannose beta-1;2-N-acetylglucosaminyltransferase 1 | Organisim: human | Apparent_Kd_M: 3.032504E-11

Real

Aptamer SeqId:8255-34;Target:MRVI1;UniProt:Q9Y6F6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8255-34;Target: MRVI1;UniProt: Q9Y6F6;TargetFullName: Protein MRVI1;Organisim: human;Apparent_Kd_M: 4.947062E-11

Real

Aptamer SeqId: 8255-34 | Target: MRVI1 | UniProt: Q9Y6F6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8255-34 | Target: MRVI1 | UniProt: Q9Y6F6 | TargetFullName: Protein MRVI1 | Organisim: human | Apparent_Kd_M: 4.947062E-11

Real

Aptamer SeqId:8258-22;Target:UXS1;UniProt:Q8NBZ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8258-22;Target: UXS1;UniProt: Q8NBZ7;TargetFullName: UDP-glucuronic acid decarboxylase 1;Organisim: human;Apparent_Kd_M: 6.20996E-11

Real

Aptamer SeqId: 8258-22 | Target: UXS1 | UniProt: Q8NBZ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8258-22 | Target: UXS1 | UniProt: Q8NBZ7 | TargetFullName: UDP-glucuronic acid decarboxylase 1 | Organisim: human | Apparent_Kd_M: 6.20996E-11

Real

Aptamer SeqId:8259-25;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8259-25;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.915895E-11

Real

Aptamer SeqId: 8259-25 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8259-25 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.915895E-11

Real

Aptamer SeqId:8260-13;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8260-13;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.583933E-11

Real

Aptamer SeqId: 8260-13 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8260-13 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.583933E-11

Real

Aptamer SeqId:8261-51;Target:STOM;UniProt:P27105

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8261-51;Target: STOM;UniProt: P27105;TargetFullName: Erythrocyte band 7 integral membrane protein;Organisim: human;Apparent_Kd_M: 6.57876E-11

Real

Aptamer SeqId: 8261-51 | Target: STOM | UniProt: P27105

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8261-51 | Target: STOM | UniProt: P27105 | TargetFullName: Erythrocyte band 7 integral membrane protein | Organisim: human | Apparent_Kd_M: 6.57876E-11

Real

Aptamer SeqId:8263-64;Target:CR056;UniProt:Q8TAI1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8263-64;Target: CR056;UniProt: Q8TAI1;TargetFullName: TYMS opposite strand protein;Organisim: human;Apparent_Kd_M: 8.217893E-11

Real

Aptamer SeqId: 8263-64 | Target: CR056 | UniProt: Q8TAI1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8263-64 | Target: CR056 | UniProt: Q8TAI1 | TargetFullName: TYMS opposite strand protein | Organisim: human | Apparent_Kd_M: 8.217893E-11

Real

Aptamer SeqId:8265-225;Target:LAP2B;UniProt:P42167

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8265-225;Target: LAP2B;UniProt: P42167;TargetFullName: Lamina-associated polypeptide 2; isoforms beta/gamma;Organisim: human;Apparent_Kd_M: 6.250331E-12

Real

Aptamer SeqId: 8265-225 | Target: LAP2B | UniProt: P42167

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8265-225 | Target: LAP2B | UniProt: P42167 | TargetFullName: Lamina-associated polypeptide 2; isoforms beta/gamma | Organisim: human | Apparent_Kd_M: 6.250331E-12

Real

Aptamer SeqId:8268-98;Target:HS3SA;UniProt:Q9Y663

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8268-98;Target: HS3SA;UniProt: Q9Y663;TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 3A1;Organisim: human;Apparent_Kd_M: 1.005689E-11

Real

Aptamer SeqId: 8268-98 | Target: HS3SA | UniProt: Q9Y663

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8268-98 | Target: HS3SA | UniProt: Q9Y663 | TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 | Organisim: human | Apparent_Kd_M: 1.005689E-11

Real

Aptamer SeqId:8269-327;Target:ARSK;UniProt:Q6UWY0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8269-327;Target: ARSK;UniProt: Q6UWY0;TargetFullName: Arylsulfatase K;Organisim: human;Apparent_Kd_M: 4.866251E-11

Real

Aptamer SeqId: 8269-327 | Target: ARSK | UniProt: Q6UWY0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8269-327 | Target: ARSK | UniProt: Q6UWY0 | TargetFullName: Arylsulfatase K | Organisim: human | Apparent_Kd_M: 4.866251E-11

Real

Aptamer SeqId:8271-24;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8271-24;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.883936E-12

Real

Aptamer SeqId: 8271-24 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8271-24 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.883936E-12

Real

Aptamer SeqId:8272-22;Target:DHB7;UniProt:P56937

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8272-22;Target: DHB7;UniProt: P56937;TargetFullName: 3-keto-steroid reductase;Organisim: human;Apparent_Kd_M: 2.5E-11

Real

Aptamer SeqId: 8272-22 | Target: DHB7 | UniProt: P56937

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8272-22 | Target: DHB7 | UniProt: P56937 | TargetFullName: 3-keto-steroid reductase | Organisim: human | Apparent_Kd_M: 2.5E-11

Real

Aptamer SeqId:8273-84;Target:IL31R;UniProt:Q8NI17

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8273-84;Target: IL31R;UniProt: Q8NI17;TargetFullName: Interleukin-31 receptor subunit alpha;Organisim: human;Apparent_Kd_M: 4.709172E-11

Real

Aptamer SeqId: 8273-84 | Target: IL31R | UniProt: Q8NI17

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8273-84 | Target: IL31R | UniProt: Q8NI17 | TargetFullName: Interleukin-31 receptor subunit alpha | Organisim: human | Apparent_Kd_M: 4.709172E-11

Real

Aptamer SeqId:8274-64;Target:Syntaxin-7;UniProt:O15400

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8274-64;Target: Syntaxin-7;UniProt: O15400;TargetFullName: Syntaxin-7;Organisim: human;Apparent_Kd_M: 8.278391E-12

Real

Aptamer SeqId: 8274-64 | Target: Syntaxin-7 | UniProt: O15400

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8274-64 | Target: Syntaxin-7 | UniProt: O15400 | TargetFullName: Syntaxin-7 | Organisim: human | Apparent_Kd_M: 8.278391E-12

Real

Aptamer SeqId:8275-31;Target:PEAR1;UniProt:Q5VY43

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8275-31;Target: PEAR1;UniProt: Q5VY43;TargetFullName: Platelet endothelial aggregation receptor 1;Organisim: human;Apparent_Kd_M: 6.97E-12

Real

Aptamer SeqId: 8275-31 | Target: PEAR1 | UniProt: Q5VY43

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8275-31 | Target: PEAR1 | UniProt: Q5VY43 | TargetFullName: Platelet endothelial aggregation receptor 1 | Organisim: human | Apparent_Kd_M: 6.97E-12

Real

Aptamer SeqId:8282-15;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8282-15;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.165559E-11

Real

Aptamer SeqId: 8282-15 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8282-15 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.165559E-11

Real

Aptamer SeqId:8285-64;Target:PACA;UniProt:P18509

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8285-64;Target: PACA;UniProt: P18509;TargetFullName: Pituitary adenylate cyclase-activating polypeptide;Organisim: human;Apparent_Kd_M: 2.767171E-11

Real

Aptamer SeqId: 8285-64 | Target: PACA | UniProt: P18509

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8285-64 | Target: PACA | UniProt: P18509 | TargetFullName: Pituitary adenylate cyclase-activating polypeptide | Organisim: human | Apparent_Kd_M: 2.767171E-11

Real

Aptamer SeqId:8286-44;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8286-44;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.199095E-11

Real

Aptamer SeqId: 8286-44 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8286-44 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.199095E-11

Real

Aptamer SeqId:8288-27;Target:b2-Glycoprotein I;UniProt:P02749

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8288-27;Target: b2-Glycoprotein I;UniProt: P02749;TargetFullName: Beta-2-glycoprotein 1;Organisim: human;Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId: 8288-27 | Target: b2-Glycoprotein I | UniProt: P02749

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8288-27 | Target: b2-Glycoprotein I | UniProt: P02749 | TargetFullName: Beta-2-glycoprotein 1 | Organisim: human | Apparent_Kd_M: 4.18E-12

Real

Aptamer SeqId:8289-8;Target:GPNMB;UniProt:Q14956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8289-8;Target: GPNMB;UniProt: Q14956;TargetFullName: Transmembrane glycoprotein NMB;Organisim: human;Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId: 8289-8 | Target: GPNMB | UniProt: Q14956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8289-8 | Target: GPNMB | UniProt: Q14956 | TargetFullName: Transmembrane glycoprotein NMB | Organisim: human | Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId:8290-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8290-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.863769E-11

Real

Aptamer SeqId: 8290-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8290-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.863769E-11

Real

Aptamer SeqId:8296-117;Target:KDEL2;UniProt:Q7Z4H8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8296-117;Target: KDEL2;UniProt: Q7Z4H8;TargetFullName: KDEL motif-containing protein 2;Organisim: human;Apparent_Kd_M: 8.667411E-12

Real

Aptamer SeqId: 8296-117 | Target: KDEL2 | UniProt: Q7Z4H8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8296-117 | Target: KDEL2 | UniProt: Q7Z4H8 | TargetFullName: KDEL motif-containing protein 2 | Organisim: human | Apparent_Kd_M: 8.667411E-12

Real

Aptamer SeqId:8297-8;Target:DJC10;UniProt:Q8IXB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8297-8;Target: DJC10;UniProt: Q8IXB1;TargetFullName: DnaJ homolog subfamily C member 10;Organisim: human;Apparent_Kd_M: 1.49155E-11

Real

Aptamer SeqId: 8297-8 | Target: DJC10 | UniProt: Q8IXB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8297-8 | Target: DJC10 | UniProt: Q8IXB1 | TargetFullName: DnaJ homolog subfamily C member 10 | Organisim: human | Apparent_Kd_M: 1.49155E-11

Real

Aptamer SeqId:8298-8;Target:CG045;UniProt:Q8WWF3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8298-8;Target: CG045;UniProt: Q8WWF3;TargetFullName: Serine-rich single-pass membrane protein 1;Organisim: human;Apparent_Kd_M: 1.588024E-11

Real

Aptamer SeqId: 8298-8 | Target: CG045 | UniProt: Q8WWF3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8298-8 | Target: CG045 | UniProt: Q8WWF3 | TargetFullName: Serine-rich single-pass membrane protein 1 | Organisim: human | Apparent_Kd_M: 1.588024E-11

Real

Aptamer SeqId:8299-66;Target:LIRA4;UniProt:P59901

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8299-66;Target: LIRA4;UniProt: P59901;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 4;Organisim: human;Apparent_Kd_M: 1.70822E-10

Real

Aptamer SeqId: 8299-66 | Target: LIRA4 | UniProt: P59901

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8299-66 | Target: LIRA4 | UniProt: P59901 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 4 | Organisim: human | Apparent_Kd_M: 1.70822E-10

Real

Aptamer SeqId:8300-82;Target:PEX14;UniProt:O75381

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8300-82;Target: PEX14;UniProt: O75381;TargetFullName: Peroxisomal membrane protein PEX14;Organisim: human;Apparent_Kd_M: 7.7E-13

Real

Aptamer SeqId: 8300-82 | Target: PEX14 | UniProt: O75381

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8300-82 | Target: PEX14 | UniProt: O75381 | TargetFullName: Peroxisomal membrane protein PEX14 | Organisim: human | Apparent_Kd_M: 7.7E-13

Real

Aptamer SeqId:8303-102;Target:MYG1;UniProt:Q9HB07

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8303-102;Target: MYG1;UniProt: Q9HB07;TargetFullName: UPF0160 protein MYG1; mitochondrial;Organisim: human;Apparent_Kd_M: 2.327342E-11

Real

Aptamer SeqId: 8303-102 | Target: MYG1 | UniProt: Q9HB07

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8303-102 | Target: MYG1 | UniProt: Q9HB07 | TargetFullName: UPF0160 protein MYG1; mitochondrial | Organisim: human | Apparent_Kd_M: 2.327342E-11

Real

Aptamer SeqId:8304-50;Target:OPG;UniProt:O00300

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8304-50;Target: OPG;UniProt: O00300;TargetFullName: Tumor necrosis factor receptor superfamily member 11B;Organisim: human;Apparent_Kd_M: 3.52E-12

Real

Aptamer SeqId: 8304-50 | Target: OPG | UniProt: O00300

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8304-50 | Target: OPG | UniProt: O00300 | TargetFullName: Tumor necrosis factor receptor superfamily member 11B | Organisim: human | Apparent_Kd_M: 3.52E-12

Real

Aptamer SeqId:8305-18;Target:SULF2;UniProt:Q8IWU5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8305-18;Target: SULF2;UniProt: Q8IWU5;TargetFullName: Extracellular sulfatase Sulf-2;Organisim: human;Apparent_Kd_M: 9.234543E-12

Real

Aptamer SeqId: 8305-18 | Target: SULF2 | UniProt: Q8IWU5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8305-18 | Target: SULF2 | UniProt: Q8IWU5 | TargetFullName: Extracellular sulfatase Sulf-2 | Organisim: human | Apparent_Kd_M: 9.234543E-12

Real

Aptamer SeqId:8306-54;Target:TMG1;UniProt:O14668

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8306-54;Target: TMG1;UniProt: O14668;TargetFullName: Transmembrane gamma-carboxyglutamic acid protein 1;Organisim: human;Apparent_Kd_M: 4.55E-12

Real

Aptamer SeqId: 8306-54 | Target: TMG1 | UniProt: O14668

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8306-54 | Target: TMG1 | UniProt: O14668 | TargetFullName: Transmembrane gamma-carboxyglutamic acid protein 1 | Organisim: human | Apparent_Kd_M: 4.55E-12

Real

Aptamer SeqId:8307-47;Target:CK068;UniProt:Q9H3H3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8307-47;Target: CK068;UniProt: Q9H3H3;TargetFullName: UPF0696 protein C11orf68;Organisim: human;Apparent_Kd_M: 1.376207E-11

Real

Aptamer SeqId: 8307-47 | Target: CK068 | UniProt: Q9H3H3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8307-47 | Target: CK068 | UniProt: Q9H3H3 | TargetFullName: UPF0696 protein C11orf68 | Organisim: human | Apparent_Kd_M: 1.376207E-11

Real

Aptamer SeqId:8309-12;Target:HYAL1;UniProt:Q12794

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8309-12;Target: HYAL1;UniProt: Q12794;TargetFullName: Hyaluronidase-1;Organisim: human;Apparent_Kd_M: 3.472387E-11

Real

Aptamer SeqId: 8309-12 | Target: HYAL1 | UniProt: Q12794

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8309-12 | Target: HYAL1 | UniProt: Q12794 | TargetFullName: Hyaluronidase-1 | Organisim: human | Apparent_Kd_M: 3.472387E-11

Real

Aptamer SeqId:8310-6;Target:U773;UniProt:Q96DA0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8310-6;Target: U773;UniProt: Q96DA0;TargetFullName: Zymogen granule protein 16 homolog B;Organisim: human;Apparent_Kd_M: 1.651995E-11

Real

Aptamer SeqId: 8310-6 | Target: U773 | UniProt: Q96DA0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8310-6 | Target: U773 | UniProt: Q96DA0 | TargetFullName: Zymogen granule protein 16 homolog B | Organisim: human | Apparent_Kd_M: 1.651995E-11

Real

Aptamer SeqId:8315-5;Target:DB119;UniProt:Q8N690

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8315-5;Target: DB119;UniProt: Q8N690;TargetFullName: Beta-defensin 119;Organisim: human;Apparent_Kd_M: 3.6E-11

Real

Aptamer SeqId: 8315-5 | Target: DB119 | UniProt: Q8N690

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8315-5 | Target: DB119 | UniProt: Q8N690 | TargetFullName: Beta-defensin 119 | Organisim: human | Apparent_Kd_M: 3.6E-11

Real

Aptamer SeqId:8316-36;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8316-36;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.96E-12

Real

Aptamer SeqId: 8316-36 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8316-36 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.96E-12

Real

Aptamer SeqId:8318-13;Target:SPRE1;UniProt:Q7Z699

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8318-13;Target: SPRE1;UniProt: Q7Z699;TargetFullName: Sprouty-related; EVH1 domain-containing protein 1;Organisim: human;Apparent_Kd_M: 2.243762E-12

Real

Aptamer SeqId: 8318-13 | Target: SPRE1 | UniProt: Q7Z699

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8318-13 | Target: SPRE1 | UniProt: Q7Z699 | TargetFullName: Sprouty-related; EVH1 domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.243762E-12

Real

Aptamer SeqId:8320-5;Target:SLTM;UniProt:Q9NWH9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8320-5;Target: SLTM;UniProt: Q9NWH9;TargetFullName: SAFB-like transcription modulator;Organisim: human;Apparent_Kd_M: 6.64205E-12

Real

Aptamer SeqId: 8320-5 | Target: SLTM | UniProt: Q9NWH9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8320-5 | Target: SLTM | UniProt: Q9NWH9 | TargetFullName: SAFB-like transcription modulator | Organisim: human | Apparent_Kd_M: 6.64205E-12

Real

Aptamer SeqId:8321-27;Target:ZN843;UniProt:Q8N446

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8321-27;Target: ZN843;UniProt: Q8N446;TargetFullName: Zinc finger protein 843;Organisim: human;Apparent_Kd_M: 1.52905E-11

Real

Aptamer SeqId: 8321-27 | Target: ZN843 | UniProt: Q8N446

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8321-27 | Target: ZN843 | UniProt: Q8N446 | TargetFullName: Zinc finger protein 843 | Organisim: human | Apparent_Kd_M: 1.52905E-11

Real

Aptamer SeqId:8323-163;Target:TFF3;UniProt:Q07654

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8323-163;Target: TFF3;UniProt: Q07654;TargetFullName: Trefoil factor 3;Organisim: human;Apparent_Kd_M: 3.05E-11

Real

Aptamer SeqId: 8323-163 | Target: TFF3 | UniProt: Q07654

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8323-163 | Target: TFF3 | UniProt: Q07654 | TargetFullName: Trefoil factor 3 | Organisim: human | Apparent_Kd_M: 3.05E-11

Real

Aptamer SeqId:8325-37;Target:ADH4;UniProt:P08319

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8325-37;Target: ADH4;UniProt: P08319;TargetFullName: Alcohol dehydrogenase 4;Organisim: human;Apparent_Kd_M: 5.307125E-11

Real

Aptamer SeqId: 8325-37 | Target: ADH4 | UniProt: P08319

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8325-37 | Target: ADH4 | UniProt: P08319 | TargetFullName: Alcohol dehydrogenase 4 | Organisim: human | Apparent_Kd_M: 5.307125E-11

Real

Aptamer SeqId:8326-63;Target:SIGIRR;UniProt:Q6IA17

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8326-63;Target: SIGIRR;UniProt: Q6IA17;TargetFullName: Single Ig IL-1-related receptor;Organisim: human;Apparent_Kd_M: 7.011596E-11

Real

Aptamer SeqId: 8326-63 | Target: SIGIRR | UniProt: Q6IA17

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8326-63 | Target: SIGIRR | UniProt: Q6IA17 | TargetFullName: Single Ig IL-1-related receptor | Organisim: human | Apparent_Kd_M: 7.011596E-11

Real

Aptamer SeqId:8327-26;Target:DPEP2;UniProt:Q9H4A9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8327-26;Target: DPEP2;UniProt: Q9H4A9;TargetFullName: Dipeptidase 2;Organisim: human;Apparent_Kd_M: 5.678713E-12

Real

Aptamer SeqId: 8327-26 | Target: DPEP2 | UniProt: Q9H4A9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8327-26 | Target: DPEP2 | UniProt: Q9H4A9 | TargetFullName: Dipeptidase 2 | Organisim: human | Apparent_Kd_M: 5.678713E-12

Real

Aptamer SeqId:8328-9;Target:EKI1;UniProt:Q9HBU6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8328-9;Target: EKI1;UniProt: Q9HBU6;TargetFullName: Ethanolamine kinase 1;Organisim: human;Apparent_Kd_M: 3.542787E-11

Real

Aptamer SeqId: 8328-9 | Target: EKI1 | UniProt: Q9HBU6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8328-9 | Target: EKI1 | UniProt: Q9HBU6 | TargetFullName: Ethanolamine kinase 1 | Organisim: human | Apparent_Kd_M: 3.542787E-11

Real

Aptamer SeqId:8334-65;Target:TCP11;UniProt:Q8WWU5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8334-65;Target: TCP11;UniProt: Q8WWU5;TargetFullName: T-complex protein 11 homolog;Organisim: human;Apparent_Kd_M: 2.131431E-10

Real

Aptamer SeqId: 8334-65 | Target: TCP11 | UniProt: Q8WWU5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8334-65 | Target: TCP11 | UniProt: Q8WWU5 | TargetFullName: T-complex protein 11 homolog | Organisim: human | Apparent_Kd_M: 2.131431E-10

Real

Aptamer SeqId:8336-267;Target:GRM1C;UniProt:Q8IYS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8336-267;Target: GRM1C;UniProt: Q8IYS0;TargetFullName: GRAM domain-containing protein 1C;Organisim: human;Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId: 8336-267 | Target: GRM1C | UniProt: Q8IYS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8336-267 | Target: GRM1C | UniProt: Q8IYS0 | TargetFullName: GRAM domain-containing protein 1C | Organisim: human | Apparent_Kd_M: 1.84E-11

Real

Aptamer SeqId:8337-65;Target:PTPRU;UniProt:Q92729

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8337-65;Target: PTPRU;UniProt: Q92729;TargetFullName: Receptor-type tyrosine-protein phosphatase U;Organisim: human;Apparent_Kd_M: 1.339168E-12

Real

Aptamer SeqId: 8337-65 | Target: PTPRU | UniProt: Q92729

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8337-65 | Target: PTPRU | UniProt: Q92729 | TargetFullName: Receptor-type tyrosine-protein phosphatase U | Organisim: human | Apparent_Kd_M: 1.339168E-12

Real

Aptamer SeqId:8340-9;Target:DB110;UniProt:Q30KQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8340-9;Target: DB110;UniProt: Q30KQ9;TargetFullName: Beta-defensin 110;Organisim: human;Apparent_Kd_M: 1.749178E-10

Real

Aptamer SeqId: 8340-9 | Target: DB110 | UniProt: Q30KQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8340-9 | Target: DB110 | UniProt: Q30KQ9 | TargetFullName: Beta-defensin 110 | Organisim: human | Apparent_Kd_M: 1.749178E-10

Real

Aptamer SeqId:8343-224;Target:PAPOG;UniProt:Q9BWT3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8343-224;Target: PAPOG;UniProt: Q9BWT3;TargetFullName: Poly(A) polymerase gamma;Organisim: human;Apparent_Kd_M: 1.060761E-10

Real

Aptamer SeqId: 8343-224 | Target: PAPOG | UniProt: Q9BWT3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8343-224 | Target: PAPOG | UniProt: Q9BWT3 | TargetFullName: Poly(A) polymerase gamma | Organisim: human | Apparent_Kd_M: 1.060761E-10

Real

Aptamer SeqId:8345-27;Target:GPX7;UniProt:Q96SL4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8345-27;Target: GPX7;UniProt: Q96SL4;TargetFullName: Glutathione peroxidase 7;Organisim: human;Apparent_Kd_M: 3.362084E-11

Real

Aptamer SeqId: 8345-27 | Target: GPX7 | UniProt: Q96SL4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8345-27 | Target: GPX7 | UniProt: Q96SL4 | TargetFullName: Glutathione peroxidase 7 | Organisim: human | Apparent_Kd_M: 3.362084E-11

Real

Aptamer SeqId:8346-9;Target:DPP2;UniProt:Q9UHL4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8346-9;Target: DPP2;UniProt: Q9UHL4;TargetFullName: Dipeptidyl peptidase 2;Organisim: human;Apparent_Kd_M: 4.92E-11

Real

Aptamer SeqId: 8346-9 | Target: DPP2 | UniProt: Q9UHL4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8346-9 | Target: DPP2 | UniProt: Q9UHL4 | TargetFullName: Dipeptidyl peptidase 2 | Organisim: human | Apparent_Kd_M: 4.92E-11

Real

Aptamer SeqId:8347-222;Target:DB129;UniProt:Q9H1M3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8347-222;Target: DB129;UniProt: Q9H1M3;TargetFullName: Beta-defensin 129;Organisim: human;Apparent_Kd_M: 8.160712E-12

Real

Aptamer SeqId: 8347-222 | Target: DB129 | UniProt: Q9H1M3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8347-222 | Target: DB129 | UniProt: Q9H1M3 | TargetFullName: Beta-defensin 129 | Organisim: human | Apparent_Kd_M: 8.160712E-12

Real

Aptamer SeqId:8351-17;Target:PRS57;UniProt:Q6UWY2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8351-17;Target: PRS57;UniProt: Q6UWY2;TargetFullName: Serine protease 57;Organisim: human;Apparent_Kd_M: 1.063001E-11

Real

Aptamer SeqId: 8351-17 | Target: PRS57 | UniProt: Q6UWY2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8351-17 | Target: PRS57 | UniProt: Q6UWY2 | TargetFullName: Serine protease 57 | Organisim: human | Apparent_Kd_M: 1.063001E-11

Real

Aptamer SeqId:8352-26;Target:SIG12;UniProt:Q96PQ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8352-26;Target: SIG12;UniProt: Q96PQ1;TargetFullName: Sialic acid-binding Ig-like lectin 12;Organisim: human;Apparent_Kd_M: 6.73E-11

Real

Aptamer SeqId: 8352-26 | Target: SIG12 | UniProt: Q96PQ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8352-26 | Target: SIG12 | UniProt: Q96PQ1 | TargetFullName: Sialic acid-binding Ig-like lectin 12 | Organisim: human | Apparent_Kd_M: 6.73E-11

Real

Aptamer SeqId:8353-15;Target:SCN2B;UniProt:O60939

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8353-15;Target: SCN2B;UniProt: O60939;TargetFullName: Sodium channel subunit beta-2;Organisim: human;Apparent_Kd_M: 8.333218E-12

Real

Aptamer SeqId: 8353-15 | Target: SCN2B | UniProt: O60939

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8353-15 | Target: SCN2B | UniProt: O60939 | TargetFullName: Sodium channel subunit beta-2 | Organisim: human | Apparent_Kd_M: 8.333218E-12

Real

Aptamer SeqId:8355-80;Target:ISM1;UniProt:B1AKI9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8355-80;Target: ISM1;UniProt: B1AKI9;TargetFullName: Isthmin-1;Organisim: human;Apparent_Kd_M: 5.323204E-11

Real

Aptamer SeqId: 8355-80 | Target: ISM1 | UniProt: B1AKI9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8355-80 | Target: ISM1 | UniProt: B1AKI9 | TargetFullName: Isthmin-1 | Organisim: human | Apparent_Kd_M: 5.323204E-11

Real

Aptamer SeqId:8356-88;Target:NEU1;UniProt:P01178

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8356-88;Target: NEU1;UniProt: P01178;TargetFullName: Oxytocin-neurophysin 1;Organisim: human;Apparent_Kd_M: 1.32E-10

Real

Aptamer SeqId: 8356-88 | Target: NEU1 | UniProt: P01178

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8356-88 | Target: NEU1 | UniProt: P01178 | TargetFullName: Oxytocin-neurophysin 1 | Organisim: human | Apparent_Kd_M: 1.32E-10

Real

Aptamer SeqId:8357-43;Target:ST4A1;UniProt:Q9BR01

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8357-43;Target: ST4A1;UniProt: Q9BR01;TargetFullName: Sulfotransferase 4A1;Organisim: human;Apparent_Kd_M: 1.181908E-11

Real

Aptamer SeqId: 8357-43 | Target: ST4A1 | UniProt: Q9BR01

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8357-43 | Target: ST4A1 | UniProt: Q9BR01 | TargetFullName: Sulfotransferase 4A1 | Organisim: human | Apparent_Kd_M: 1.181908E-11

Real

Aptamer SeqId:8358-30;Target:Peroxiredoxin-3;UniProt:P30048

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8358-30;Target: Peroxiredoxin-3;UniProt: P30048;TargetFullName: Thioredoxin-dependent peroxide reductase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.5E-10

Real

Aptamer SeqId: 8358-30 | Target: Peroxiredoxin-3 | UniProt: P30048

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8358-30 | Target: Peroxiredoxin-3 | UniProt: P30048 | TargetFullName: Thioredoxin-dependent peroxide reductase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.5E-10

Real

Aptamer SeqId:8360-169;Target:NKp46;UniProt:O76036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8360-169;Target: NKp46;UniProt: O76036;TargetFullName: Natural cytotoxicity triggering receptor 1;Organisim: human;Apparent_Kd_M: 3.385701E-11

Real

Aptamer SeqId: 8360-169 | Target: NKp46 | UniProt: O76036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8360-169 | Target: NKp46 | UniProt: O76036 | TargetFullName: Natural cytotoxicity triggering receptor 1 | Organisim: human | Apparent_Kd_M: 3.385701E-11

Real

Aptamer SeqId:8363-18;Target:K132L;UniProt:A8MWY0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8363-18;Target: K132L;UniProt: A8MWY0;TargetFullName: UPF0577 protein KIAA1324-like;Organisim: human;Apparent_Kd_M: 4.014134E-10

Real

Aptamer SeqId: 8363-18 | Target: K132L | UniProt: A8MWY0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8363-18 | Target: K132L | UniProt: A8MWY0 | TargetFullName: UPF0577 protein KIAA1324-like | Organisim: human | Apparent_Kd_M: 4.014134E-10

Real

Aptamer SeqId:8364-74;Target:UST;UniProt:Q9Y2C2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8364-74;Target: UST;UniProt: Q9Y2C2;TargetFullName: Uronyl 2-sulfotransferase;Organisim: human;Apparent_Kd_M: 3.033817E-11

Real

Aptamer SeqId: 8364-74 | Target: UST | UniProt: Q9Y2C2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8364-74 | Target: UST | UniProt: Q9Y2C2 | TargetFullName: Uronyl 2-sulfotransferase | Organisim: human | Apparent_Kd_M: 3.033817E-11

Real

Aptamer SeqId:8366-19;Target:CA115;UniProt:Q9H7X2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8366-19;Target: CA115;UniProt: Q9H7X2;TargetFullName: Uncharacterized protein C1orf115;Organisim: human;Apparent_Kd_M: 3.718016E-11

Real

Aptamer SeqId: 8366-19 | Target: CA115 | UniProt: Q9H7X2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8366-19 | Target: CA115 | UniProt: Q9H7X2 | TargetFullName: Uncharacterized protein C1orf115 | Organisim: human | Apparent_Kd_M: 3.718016E-11

Real

Aptamer SeqId:8367-142;Target:VSIG1;UniProt:Q86XK7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8367-142;Target: VSIG1;UniProt: Q86XK7;TargetFullName: V-set and immunoglobulin domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.066161E-11

Real

Aptamer SeqId: 8367-142 | Target: VSIG1 | UniProt: Q86XK7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8367-142 | Target: VSIG1 | UniProt: Q86XK7 | TargetFullName: V-set and immunoglobulin domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.066161E-11

Real

Aptamer SeqId:8368-102;Target:TNF sR-II;UniProt:P20333

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8368-102;Target: TNF sR-II;UniProt: P20333;TargetFullName: Tumor necrosis factor receptor superfamily member 1B;Organisim: human;Apparent_Kd_M: 2.452055E-12

Real

Aptamer SeqId: 8368-102 | Target: TNF sR-II | UniProt: P20333

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8368-102 | Target: TNF sR-II | UniProt: P20333 | TargetFullName: Tumor necrosis factor receptor superfamily member 1B | Organisim: human | Apparent_Kd_M: 2.452055E-12

Real

Aptamer SeqId:8369-102;Target:DAG1;UniProt:Q14118

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8369-102;Target: DAG1;UniProt: Q14118;TargetFullName: Dystroglycan;Organisim: human;Apparent_Kd_M: 3.913924E-11

Real

Aptamer SeqId: 8369-102 | Target: DAG1 | UniProt: Q14118

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8369-102 | Target: DAG1 | UniProt: Q14118 | TargetFullName: Dystroglycan | Organisim: human | Apparent_Kd_M: 3.913924E-11

Real

Aptamer SeqId:8372-29;Target:CDHR1;UniProt:Q96JP9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8372-29;Target: CDHR1;UniProt: Q96JP9;TargetFullName: Cadherin-related family member 1;Organisim: human;Apparent_Kd_M: 3.590441E-11

Real

Aptamer SeqId: 8372-29 | Target: CDHR1 | UniProt: Q96JP9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8372-29 | Target: CDHR1 | UniProt: Q96JP9 | TargetFullName: Cadherin-related family member 1 | Organisim: human | Apparent_Kd_M: 3.590441E-11

Real

Aptamer SeqId:8374-5;Target:NGF R;UniProt:P08138

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8374-5;Target: NGF R;UniProt: P08138;TargetFullName: Tumor necrosis factor receptor superfamily member 16;Organisim: human;Apparent_Kd_M: 1.409537E-11

Real

Aptamer SeqId: 8374-5 | Target: NGF R | UniProt: P08138

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8374-5 | Target: NGF R | UniProt: P08138 | TargetFullName: Tumor necrosis factor receptor superfamily member 16 | Organisim: human | Apparent_Kd_M: 1.409537E-11

Real

Aptamer SeqId:8376-25;Target:LSHB;UniProt:P01229

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8376-25;Target: LSHB;UniProt: P01229;TargetFullName: Lutropin subunit beta;Organisim: human;Apparent_Kd_M: 2.810139E-11

Real

Aptamer SeqId: 8376-25 | Target: LSHB | UniProt: P01229

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8376-25 | Target: LSHB | UniProt: P01229 | TargetFullName: Lutropin subunit beta | Organisim: human | Apparent_Kd_M: 2.810139E-11

Real

Aptamer SeqId:8377-87;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8377-87;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.2364E-10

Real

Aptamer SeqId: 8377-87 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8377-87 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.2364E-10

Real

Aptamer SeqId:8378-3;Target:LDOC1;UniProt:O95751

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8378-3;Target: LDOC1;UniProt: O95751;TargetFullName: Protein LDOC1;Organisim: human;Apparent_Kd_M: 8.42E-11

Real

Aptamer SeqId: 8378-3 | Target: LDOC1 | UniProt: O95751

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8378-3 | Target: LDOC1 | UniProt: O95751 | TargetFullName: Protein LDOC1 | Organisim: human | Apparent_Kd_M: 8.42E-11

Real

Aptamer SeqId:8380-244;Target:DLK1;UniProt:P80370

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8380-244;Target: DLK1;UniProt: P80370;TargetFullName: Protein delta homolog 1;Organisim: human;Apparent_Kd_M: 5.72E-11

Real

Aptamer SeqId: 8380-244 | Target: DLK1 | UniProt: P80370

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8380-244 | Target: DLK1 | UniProt: P80370 | TargetFullName: Protein delta homolog 1 | Organisim: human | Apparent_Kd_M: 5.72E-11

Real

Aptamer SeqId:8381-18;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8381-18;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.335547E-11

Real

Aptamer SeqId: 8381-18 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8381-18 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.335547E-11

Real

Aptamer SeqId:8382-47;Target:MAPK5;UniProt:Q8IW41

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8382-47;Target: MAPK5;UniProt: Q8IW41;TargetFullName: MAP kinase-activated protein kinase 5;Organisim: human;Apparent_Kd_M: 9.69567E-12

Real

Aptamer SeqId: 8382-47 | Target: MAPK5 | UniProt: Q8IW41

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8382-47 | Target: MAPK5 | UniProt: Q8IW41 | TargetFullName: MAP kinase-activated protein kinase 5 | Organisim: human | Apparent_Kd_M: 9.69567E-12

Real

Aptamer SeqId:8383-20;Target:CK094;UniProt:C9JXX5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8383-20;Target: CK094;UniProt: C9JXX5;TargetFullName: Uncharacterized protein C11orf94;Organisim: human;Apparent_Kd_M: 1.334377E-11

Real

Aptamer SeqId: 8383-20 | Target: CK094 | UniProt: C9JXX5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8383-20 | Target: CK094 | UniProt: C9JXX5 | TargetFullName: Uncharacterized protein C11orf94 | Organisim: human | Apparent_Kd_M: 1.334377E-11

Real

Aptamer SeqId:8386-11;Target:PATE;UniProt:Q8WXA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8386-11;Target: PATE;UniProt: Q8WXA2;TargetFullName: Prostate and testis expressed protein 1;Organisim: human;Apparent_Kd_M: 2.345996E-10

Real

Aptamer SeqId: 8386-11 | Target: PATE | UniProt: Q8WXA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8386-11 | Target: PATE | UniProt: Q8WXA2 | TargetFullName: Prostate and testis expressed protein 1 | Organisim: human | Apparent_Kd_M: 2.345996E-10

Real

Aptamer SeqId:8388-24;Target:Spastin;UniProt:Q9UBP0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8388-24;Target: Spastin;UniProt: Q9UBP0;TargetFullName: Spastin;Organisim: human;Apparent_Kd_M: 2.581677E-11

Real

Aptamer SeqId: 8388-24 | Target: Spastin | UniProt: Q9UBP0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8388-24 | Target: Spastin | UniProt: Q9UBP0 | TargetFullName: Spastin | Organisim: human | Apparent_Kd_M: 2.581677E-11

Real

Aptamer SeqId:8389-8;Target:CN16B;UniProt:Q0VAA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8389-8;Target: CN16B;UniProt: Q0VAA2;TargetFullName: Leucine-rich repeat-containing protein 74A;Organisim: human;Apparent_Kd_M: 3.05524E-11

Real

Aptamer SeqId: 8389-8 | Target: CN16B | UniProt: Q0VAA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8389-8 | Target: CN16B | UniProt: Q0VAA2 | TargetFullName: Leucine-rich repeat-containing protein 74A | Organisim: human | Apparent_Kd_M: 3.05524E-11

Real

Aptamer SeqId:8390-25;Target:CX7A1;UniProt:P24310

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8390-25;Target: CX7A1;UniProt: P24310;TargetFullName: Cytochrome c oxidase subunit 7A1; mitochondrial;Organisim: human;Apparent_Kd_M: 3.353739E-12

Real

Aptamer SeqId: 8390-25 | Target: CX7A1 | UniProt: P24310

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8390-25 | Target: CX7A1 | UniProt: P24310 | TargetFullName: Cytochrome c oxidase subunit 7A1; mitochondrial | Organisim: human | Apparent_Kd_M: 3.353739E-12

Real

Aptamer SeqId:8391-12;Target:DB115;UniProt:Q30KQ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8391-12;Target: DB115;UniProt: Q30KQ5;TargetFullName: Beta-defensin 115;Organisim: human;Apparent_Kd_M: 5.259342E-12

Real

Aptamer SeqId: 8391-12 | Target: DB115 | UniProt: Q30KQ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8391-12 | Target: DB115 | UniProt: Q30KQ5 | TargetFullName: Beta-defensin 115 | Organisim: human | Apparent_Kd_M: 5.259342E-12

Real

Aptamer SeqId:8394-56;Target:RNase 2;UniProt:P10153

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8394-56;Target: RNase 2;UniProt: P10153;TargetFullName: Non-secretory ribonuclease;Organisim: human;Apparent_Kd_M: 8.147688E-11

Real

Aptamer SeqId: 8394-56 | Target: RNase 2 | UniProt: P10153

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8394-56 | Target: RNase 2 | UniProt: P10153 | TargetFullName: Non-secretory ribonuclease | Organisim: human | Apparent_Kd_M: 8.147688E-11

Real

Aptamer SeqId:8396-42;Target:FAAH2;UniProt:Q6GMR7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8396-42;Target: FAAH2;UniProt: Q6GMR7;TargetFullName: Fatty-acid amide hydrolase 2;Organisim: human;Apparent_Kd_M: 6.903415E-12

Real

Aptamer SeqId: 8396-42 | Target: FAAH2 | UniProt: Q6GMR7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8396-42 | Target: FAAH2 | UniProt: Q6GMR7 | TargetFullName: Fatty-acid amide hydrolase 2 | Organisim: human | Apparent_Kd_M: 6.903415E-12

Real

Aptamer SeqId:8397-147;Target:QSOX2;UniProt:Q6ZRP7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8397-147;Target: QSOX2;UniProt: Q6ZRP7;TargetFullName: Sulfhydryl oxidase 2;Organisim: human;Apparent_Kd_M: 9.25572E-11

Real

Aptamer SeqId: 8397-147 | Target: QSOX2 | UniProt: Q6ZRP7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8397-147 | Target: QSOX2 | UniProt: Q6ZRP7 | TargetFullName: Sulfhydryl oxidase 2 | Organisim: human | Apparent_Kd_M: 9.25572E-11

Real

Aptamer SeqId:8398-277;Target:RAR-responsive protein TIG1;UniProt:P49788

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8398-277;Target: RAR-responsive protein TIG1;UniProt: P49788;TargetFullName: Retinoic acid receptor responder protein 1;Organisim: human;Apparent_Kd_M: 1.992652E-12

Real

Aptamer SeqId: 8398-277 | Target: RAR-responsive protein TIG1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8398-277 | Target: RAR-responsive protein TIG1 | UniProt: P49788 | TargetFullName: Retinoic acid receptor responder protein 1 | Organisim: human | Apparent_Kd_M: 1.992652E-12

Real

Aptamer SeqId:8399-6;Target:DRAK2;UniProt:O94768

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8399-6;Target: DRAK2;UniProt: O94768;TargetFullName: Serine/threonine-protein kinase 17B;Organisim: human;Apparent_Kd_M: 7.14E-12

Real

Aptamer SeqId: 8399-6 | Target: DRAK2 | UniProt: O94768

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8399-6 | Target: DRAK2 | UniProt: O94768 | TargetFullName: Serine/threonine-protein kinase 17B | Organisim: human | Apparent_Kd_M: 7.14E-12

Real

Aptamer SeqId:8400-74;Target:Gastrin-releasing peptide;UniProt:P07492

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8400-74;Target: Gastrin-releasing peptide;UniProt: P07492;TargetFullName: Gastrin-releasing peptide;Organisim: human;Apparent_Kd_M: 6.11E-12

Real

Aptamer SeqId: 8400-74 | Target: Gastrin-releasing peptide

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8400-74 | Target: Gastrin-releasing peptide | UniProt: P07492 | TargetFullName: Gastrin-releasing peptide | Organisim: human | Apparent_Kd_M: 6.11E-12

Real

Aptamer SeqId:8402-22;Target:CYTL1;UniProt:Q9NRR1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8402-22;Target: CYTL1;UniProt: Q9NRR1;TargetFullName: Cytokine-like protein 1;Organisim: human;Apparent_Kd_M: 1.365328E-11

Real

Aptamer SeqId: 8402-22 | Target: CYTL1 | UniProt: Q9NRR1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8402-22 | Target: CYTL1 | UniProt: Q9NRR1 | TargetFullName: Cytokine-like protein 1 | Organisim: human | Apparent_Kd_M: 1.365328E-11

Real

Aptamer SeqId:8403-18;Target:Fatty acid synthase;UniProt:P49327

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8403-18;Target: Fatty acid synthase;UniProt: P49327;TargetFullName: Fatty acid synthase;Organisim: human;Apparent_Kd_M: 8.416629E-12

Real

Aptamer SeqId: 8403-18 | Target: Fatty acid synthase | UniProt: P49327

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8403-18 | Target: Fatty acid synthase | UniProt: P49327 | TargetFullName: Fatty acid synthase | Organisim: human | Apparent_Kd_M: 8.416629E-12

Real

Aptamer SeqId:8404-102;Target:BolA-like protein 2;UniProt:Q9H3K6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8404-102;Target: BolA-like protein 2;UniProt: Q9H3K6;TargetFullName: BolA-like protein 2;Organisim: human;Apparent_Kd_M: 1.344734E-11

Real

Aptamer SeqId: 8404-102 | Target: BolA-like protein 2 | UniProt: Q9H3K6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8404-102 | Target: BolA-like protein 2 | UniProt: Q9H3K6 | TargetFullName: BolA-like protein 2 | Organisim: human | Apparent_Kd_M: 1.344734E-11

Real

Aptamer SeqId:8405-108;Target:ADAM 10;UniProt:O14672

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8405-108;Target: ADAM 10;UniProt: O14672;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 10;Organisim: human;Apparent_Kd_M: 1.152552E-10

Real

Aptamer SeqId: 8405-108 | Target: ADAM 10 | UniProt: O14672

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8405-108 | Target: ADAM 10 | UniProt: O14672 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 10 | Organisim: human | Apparent_Kd_M: 1.152552E-10

Real

Aptamer SeqId:8406-17;Target:IGF-I;UniProt:P05019

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8406-17;Target: IGF-I;UniProt: P05019;TargetFullName: Insulin-like growth factor I;Organisim: human;Apparent_Kd_M: 1.67E-10

Real

Aptamer SeqId: 8406-17 | Target: IGF-I | UniProt: P05019

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8406-17 | Target: IGF-I | UniProt: P05019 | TargetFullName: Insulin-like growth factor I | Organisim: human | Apparent_Kd_M: 1.67E-10

Real

Aptamer SeqId:8409-3;Target:RSPO2;UniProt:Q6UXX9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8409-3;Target: RSPO2;UniProt: Q6UXX9;TargetFullName: R-spondin-2;Organisim: human;Apparent_Kd_M: 4.269587E-12

Real

Aptamer SeqId: 8409-3 | Target: RSPO2 | UniProt: Q6UXX9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8409-3 | Target: RSPO2 | UniProt: Q6UXX9 | TargetFullName: R-spondin-2 | Organisim: human | Apparent_Kd_M: 4.269587E-12

Real

Aptamer SeqId:8424-269;Target:b-Catenin;UniProt:P35222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8424-269;Target: b-Catenin;UniProt: P35222;TargetFullName: Catenin beta-1;Organisim: human;Apparent_Kd_M: 1.434611E-11

Real

Aptamer SeqId: 8424-269 | Target: b-Catenin | UniProt: P35222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8424-269 | Target: b-Catenin | UniProt: P35222 | TargetFullName: Catenin beta-1 | Organisim: human | Apparent_Kd_M: 1.434611E-11

Real

Aptamer SeqId:8427-118;Target:RSPO3;UniProt:Q9BXY4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8427-118;Target: RSPO3;UniProt: Q9BXY4;TargetFullName: R-spondin-3;Organisim: human;Apparent_Kd_M: 1.499766E-12

Real

Aptamer SeqId: 8427-118 | Target: RSPO3 | UniProt: Q9BXY4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8427-118 | Target: RSPO3 | UniProt: Q9BXY4 | TargetFullName: R-spondin-3 | Organisim: human | Apparent_Kd_M: 1.499766E-12

Real

Aptamer SeqId:8428-102;Target:NTRI;UniProt:Q9P121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8428-102;Target: NTRI;UniProt: Q9P121;TargetFullName: Neurotrimin;Organisim: human;Apparent_Kd_M: 4.058838E-12

Real

Aptamer SeqId: 8428-102 | Target: NTRI | UniProt: Q9P121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8428-102 | Target: NTRI | UniProt: Q9P121 | TargetFullName: Neurotrimin | Organisim: human | Apparent_Kd_M: 4.058838E-12

Real

Aptamer SeqId:8429-16;Target:AXIN2;UniProt:Q9Y2T1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8429-16;Target: AXIN2;UniProt: Q9Y2T1;TargetFullName: Axin-2;Organisim: human;Apparent_Kd_M: 1.550853E-11

Real

Aptamer SeqId: 8429-16 | Target: AXIN2 | UniProt: Q9Y2T1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8429-16 | Target: AXIN2 | UniProt: Q9Y2T1 | TargetFullName: Axin-2 | Organisim: human | Apparent_Kd_M: 1.550853E-11

Real

Aptamer SeqId:8443-9;Target:Magainin-1_XENLA;UniProt:P11006

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8443-9;Target: Magainin-1_XENLA;UniProt: P11006;TargetFullName: Magainin-1; Xenopus laevis;Organisim: african clawed frog;Apparent_Kd_M: 1.016537E-11

Real

Aptamer SeqId: 8443-9 | Target: Magainin-1_XENLA | UniProt: P11006

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8443-9 | Target: Magainin-1_XENLA | UniProt: P11006 | TargetFullName: Magainin-1; Xenopus laevis | Organisim: african clawed frog | Apparent_Kd_M: 1.016537E-11

Real

Aptamer SeqId:8444-3;Target:Magainin-2_XENLA;UniProt:P11006

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8444-3;Target: Magainin-2_XENLA;UniProt: P11006;TargetFullName: Magainin-2_XENLA;Organisim: african clawed frog;Apparent_Kd_M: 2.39E-10

Real

Aptamer SeqId: 8444-3 | Target: Magainin-2_XENLA | UniProt: P11006

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8444-3 | Target: Magainin-2_XENLA | UniProt: P11006 | TargetFullName: Magainin-2_XENLA | Organisim: african clawed frog | Apparent_Kd_M: 2.39E-10

Real

Aptamer SeqId:8444-46;Target:Magainin-2_XENLA;UniProt:P11006

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8444-46;Target: Magainin-2_XENLA;UniProt: P11006;TargetFullName: Magainin-2_XENLA;Organisim: african clawed frog;Apparent_Kd_M: 3.17E-11

Real

Aptamer SeqId: 8444-46 | Target: Magainin-2_XENLA | UniProt: P11006

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8444-46 | Target: Magainin-2_XENLA | UniProt: P11006 | TargetFullName: Magainin-2_XENLA | Organisim: african clawed frog | Apparent_Kd_M: 3.17E-11

Real

Aptamer SeqId:8445-184;Target:MEL_VESMG;UniProt:P68408

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8445-184;Target: MEL_VESMG;UniProt: P68408;TargetFullName: Melittin_VESMG;Organisim: hornet;Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId: 8445-184 | Target: MEL_VESMG | UniProt: P68408

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8445-184 | Target: MEL_VESMG | UniProt: P68408 | TargetFullName: Melittin_VESMG | Organisim: hornet | Apparent_Kd_M: 1.3E-11

Real

Aptamer SeqId:8445-54;Target:MEL_VESMG;UniProt:P68408

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8445-54;Target: MEL_VESMG;UniProt: P68408;TargetFullName: Melittin_VESMG;Organisim: hornet;Apparent_Kd_M: 3.83E-11

Real

Aptamer SeqId: 8445-54 | Target: MEL_VESMG | UniProt: P68408

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8445-54 | Target: MEL_VESMG | UniProt: P68408 | TargetFullName: Melittin_VESMG | Organisim: hornet | Apparent_Kd_M: 3.83E-11

Real

Aptamer SeqId:8446-4;Target:PACAP-27;UniProt:P18509

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8446-4;Target: PACAP-27;UniProt: P18509;TargetFullName: Pituitary adenylate cyclase-activating polypeptide 27;Organisim: human;Apparent_Kd_M: 3.76E-12

Real

Aptamer SeqId: 8446-4 | Target: PACAP-27 | UniProt: P18509

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8446-4 | Target: PACAP-27 | UniProt: P18509 | TargetFullName: Pituitary adenylate cyclase-activating polypeptide 27 | Organisim: human | Apparent_Kd_M: 3.76E-12

Real

Aptamer SeqId:8447-11;Target:ghrelin;UniProt:Q9UBU3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8447-11;Target: ghrelin;UniProt: Q9UBU3;TargetFullName: Appetite-regulating hormone;Organisim: human;Apparent_Kd_M: 6.48E-11

Real

Aptamer SeqId: 8447-11 | Target: ghrelin | UniProt: Q9UBU3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8447-11 | Target: ghrelin | UniProt: Q9UBU3 | TargetFullName: Appetite-regulating hormone | Organisim: human | Apparent_Kd_M: 6.48E-11

Real

Aptamer SeqId:8449-103;Target:EXE4_HELSU;UniProt:P26349

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8449-103;Target: EXE4_HELSU;UniProt: P26349;TargetFullName: Exendin-4_HELSU;Organisim: heloderma suspectum (gila monster);Apparent_Kd_M: 3.96E-11

Real

Aptamer SeqId: 8449-103 | Target: EXE4_HELSU | UniProt: P26349

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8449-103 | Target: EXE4_HELSU | UniProt: P26349 | TargetFullName: Exendin-4_HELSU | Organisim: heloderma suspectum (gila monster) | Apparent_Kd_M: 3.96E-11

Real

Aptamer SeqId:8449-124;Target:EXE4_HELSU;UniProt:P26349

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8449-124;Target: EXE4_HELSU;UniProt: P26349;TargetFullName: Exendin-4_HELSU;Organisim: heloderma suspectum (gila monster);Apparent_Kd_M: 4.7E-11

Real

Aptamer SeqId: 8449-124 | Target: EXE4_HELSU | UniProt: P26349

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8449-124 | Target: EXE4_HELSU | UniProt: P26349 | TargetFullName: Exendin-4_HELSU | Organisim: heloderma suspectum (gila monster) | Apparent_Kd_M: 4.7E-11

Real

Aptamer SeqId:8450-36;Target:PACAP-38;UniProt:P18509

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8450-36;Target: PACAP-38;UniProt: P18509;TargetFullName: Pituitary adenylate cyclase-activating polypeptide 38;Organisim: human;Apparent_Kd_M: 3.53E-11

Real

Aptamer SeqId: 8450-36 | Target: PACAP-38 | UniProt: P18509

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8450-36 | Target: PACAP-38 | UniProt: P18509 | TargetFullName: Pituitary adenylate cyclase-activating polypeptide 38 | Organisim: human | Apparent_Kd_M: 3.53E-11

Real

Aptamer SeqId:8458-111;Target:a-Synuclein;UniProt:P37840

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8458-111;Target: a-Synuclein;UniProt: P37840;TargetFullName: Alpha-synuclein;Organisim: human;Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId: 8458-111 | Target: a-Synuclein | UniProt: P37840

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8458-111 | Target: a-Synuclein | UniProt: P37840 | TargetFullName: Alpha-synuclein | Organisim: human | Apparent_Kd_M: 1.76E-11

Real

Aptamer SeqId:8459-10;Target:BMP-6;UniProt:P22004

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8459-10;Target: BMP-6;UniProt: P22004;TargetFullName: Bone morphogenetic protein 6;Organisim: human;Apparent_Kd_M: 3.05E-12

Real

Aptamer SeqId: 8459-10 | Target: BMP-6 | UniProt: P22004

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8459-10 | Target: BMP-6 | UniProt: P22004 | TargetFullName: Bone morphogenetic protein 6 | Organisim: human | Apparent_Kd_M: 3.05E-12

Real

Aptamer SeqId:8462-18;Target:HGH;UniProt:P01241

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8462-18;Target: HGH;UniProt: P01241;TargetFullName: Somatotropin;Organisim: human;Apparent_Kd_M: 4.16E-12

Real

Aptamer SeqId: 8462-18 | Target: HGH | UniProt: P01241

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8462-18 | Target: HGH | UniProt: P01241 | TargetFullName: Somatotropin | Organisim: human | Apparent_Kd_M: 4.16E-12

Real

Aptamer SeqId:8464-31;Target:RSPO4;UniProt:Q2I0M5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8464-31;Target: RSPO4;UniProt: Q2I0M5;TargetFullName: R-spondin-4;Organisim: human;Apparent_Kd_M: 1.54E-12

Real

Aptamer SeqId: 8464-31 | Target: RSPO4 | UniProt: Q2I0M5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8464-31 | Target: RSPO4 | UniProt: Q2I0M5 | TargetFullName: R-spondin-4 | Organisim: human | Apparent_Kd_M: 1.54E-12

Real

Aptamer SeqId:8465-52;Target:Cathepsin H;UniProt:P09668

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8465-52;Target: Cathepsin H;UniProt: P09668;TargetFullName: Cathepsin H;Organisim: human;Apparent_Kd_M: 9.88E-11

Real

Aptamer SeqId: 8465-52 | Target: Cathepsin H | UniProt: P09668

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8465-52 | Target: Cathepsin H | UniProt: P09668 | TargetFullName: Cathepsin H | Organisim: human | Apparent_Kd_M: 9.88E-11

Real

Aptamer SeqId:8467-9;Target:Activin AB;UniProt:P08476|P09529

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8467-9;Target: Activin AB;UniProt: P08476|P09529;TargetFullName: Inhibin beta A chain:Inhibin beta B chain heterodimer;Organisim: human;Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId: 8467-9 | Target: Activin AB | UniProt: P08476|P09529

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8467-9 | Target: Activin AB | UniProt: P08476|P09529 | TargetFullName: Inhibin beta A chain:Inhibin beta B chain heterodimer | Organisim: human | Apparent_Kd_M: 2.59E-11

Real

Aptamer SeqId:8468-19;Target:PSA;UniProt:P07288

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8468-19;Target: PSA;UniProt: P07288;TargetFullName: Prostate-specific antigen;Organisim: human;Apparent_Kd_M: 5.21E-13

Real

Aptamer SeqId: 8468-19 | Target: PSA | UniProt: P07288

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8468-19 | Target: PSA | UniProt: P07288 | TargetFullName: Prostate-specific antigen | Organisim: human | Apparent_Kd_M: 5.21E-13

Real

Aptamer SeqId:8469-41;Target:IGFBP-2;UniProt:P18065

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8469-41;Target: IGFBP-2;UniProt: P18065;TargetFullName: Insulin-like growth factor-binding protein 2;Organisim: human;Apparent_Kd_M: 2.52E-12

Real

Aptamer SeqId: 8469-41 | Target: IGFBP-2 | UniProt: P18065

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8469-41 | Target: IGFBP-2 | UniProt: P18065 | TargetFullName: Insulin-like growth factor-binding protein 2 | Organisim: human | Apparent_Kd_M: 2.52E-12

Real

Aptamer SeqId:8470-213;Target:RNase H1;UniProt:O60930

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8470-213;Target: RNase H1;UniProt: O60930;TargetFullName: Ribonuclease H1;Organisim: human;Apparent_Kd_M: 4.92E-12

Real

Aptamer SeqId: 8470-213 | Target: RNase H1 | UniProt: O60930

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8470-213 | Target: RNase H1 | UniProt: O60930 | TargetFullName: Ribonuclease H1 | Organisim: human | Apparent_Kd_M: 4.92E-12

Real

Aptamer SeqId:8471-53;Target:Allophycocyanin_CYACA;UniProt:Q9TLS8|Q9TLS7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8471-53;Target: Allophycocyanin_CYACA;UniProt: Q9TLS8|Q9TLS7;TargetFullName: Allophycocyanin_CYACA;Organisim: cyanidium caldarium;Apparent_Kd_M: 4.256983E-13

Real

Aptamer SeqId: 8471-53 | Target: Allophycocyanin_CYACA

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8471-53 | Target: Allophycocyanin_CYACA | UniProt: Q9TLS8|Q9TLS7 | TargetFullName: Allophycocyanin_CYACA | Organisim: cyanidium caldarium | Apparent_Kd_M: 4.256983E-13

Real

Aptamer SeqId:8476-11;Target:CgA;UniProt:P10645

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8476-11;Target: CgA;UniProt: P10645;TargetFullName: Chromogranin-A;Organisim: human;Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId: 8476-11 | Target: CgA | UniProt: P10645

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8476-11 | Target: CgA | UniProt: P10645 | TargetFullName: Chromogranin-A | Organisim: human | Apparent_Kd_M: 1.29E-11

Real

Aptamer SeqId:8479-4;Target:MMP-10;UniProt:P09238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8479-4;Target: MMP-10;UniProt: P09238;TargetFullName: Stromelysin-2;Organisim: human;Apparent_Kd_M: 9.37E-12

Real

Aptamer SeqId: 8479-4 | Target: MMP-10 | UniProt: P09238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8479-4 | Target: MMP-10 | UniProt: P09238 | TargetFullName: Stromelysin-2 | Organisim: human | Apparent_Kd_M: 9.37E-12

Real

Aptamer SeqId:8480-29;Target:FBLN3;UniProt:Q12805

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8480-29;Target: FBLN3;UniProt: Q12805;TargetFullName: EGF-containing fibulin-like extracellular matrix protein 1;Organisim: human;Apparent_Kd_M: 4.05E-11

Real

Aptamer SeqId: 8480-29 | Target: FBLN3 | UniProt: Q12805

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8480-29 | Target: FBLN3 | UniProt: Q12805 | TargetFullName: EGF-containing fibulin-like extracellular matrix protein 1 | Organisim: human | Apparent_Kd_M: 4.05E-11

Real

Aptamer SeqId:8481-26;Target:MDH_THETH;UniProt:P10584

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8481-26;Target: MDH_THETH;UniProt: P10584;TargetFullName: Malic dehydrogenase_THETH;Organisim: thermus thermophilus;Apparent_Kd_M: 6.98E-12

Real

Aptamer SeqId: 8481-26 | Target: MDH_THETH | UniProt: P10584

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8481-26 | Target: MDH_THETH | UniProt: P10584 | TargetFullName: Malic dehydrogenase_THETH | Organisim: thermus thermophilus | Apparent_Kd_M: 6.98E-12

Real

Aptamer SeqId:8481-44;Target:MDH_THETH;UniProt:P10584

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8481-44;Target: MDH_THETH;UniProt: P10584;TargetFullName: Malic dehydrogenase_THETH;Organisim: thermus thermophilus;Apparent_Kd_M: 4.67E-12

Real

Aptamer SeqId: 8481-44 | Target: MDH_THETH | UniProt: P10584

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8481-44 | Target: MDH_THETH | UniProt: P10584 | TargetFullName: Malic dehydrogenase_THETH | Organisim: thermus thermophilus | Apparent_Kd_M: 4.67E-12

Real

Aptamer SeqId:8482-39;Target:NIGB_SAMNI;UniProt:P33183

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8482-39;Target: NIGB_SAMNI;UniProt: P33183;TargetFullName: Nigrin b_SAMNI;Organisim: sambucus nigra (european elder);Apparent_Kd_M: 8.52E-11

Real

Aptamer SeqId: 8482-39 | Target: NIGB_SAMNI | UniProt: P33183

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8482-39 | Target: NIGB_SAMNI | UniProt: P33183 | TargetFullName: Nigrin b_SAMNI | Organisim: sambucus nigra (european elder) | Apparent_Kd_M: 8.52E-11

Real

Aptamer SeqId:8483-5;Target:LUCI_PHOPY;UniProt:P08659

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8483-5;Target: LUCI_PHOPY;UniProt: P08659;TargetFullName: Luciferin 4-monooxygenase_PHOPY;Organisim: photinus pyralis (north american firefly);Apparent_Kd_M: 2.23E-12

Real

Aptamer SeqId: 8483-5 | Target: LUCI_PHOPY | UniProt: P08659

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8483-5 | Target: LUCI_PHOPY | UniProt: P08659 | TargetFullName: Luciferin 4-monooxygenase_PHOPY | Organisim: photinus pyralis (north american firefly) | Apparent_Kd_M: 2.23E-12

Real

Aptamer SeqId:8484-24;Target:Leptin;UniProt:P41159

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8484-24;Target: Leptin;UniProt: P41159;TargetFullName: Leptin;Organisim: human;Apparent_Kd_M: 9.57E-12

Real

Aptamer SeqId: 8484-24 | Target: Leptin | UniProt: P41159

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8484-24 | Target: Leptin | UniProt: P41159 | TargetFullName: Leptin | Organisim: human | Apparent_Kd_M: 9.57E-12

Real

Aptamer SeqId:8485-7;Target:KEAP1;UniProt:Q14145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8485-7;Target: KEAP1;UniProt: Q14145;TargetFullName: Kelch-like ECH-associated protein 1;Organisim: human;Apparent_Kd_M: 1.56E-10

Real

Aptamer SeqId: 8485-7 | Target: KEAP1 | UniProt: Q14145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8485-7 | Target: KEAP1 | UniProt: Q14145 | TargetFullName: Kelch-like ECH-associated protein 1 | Organisim: human | Apparent_Kd_M: 1.56E-10

Real

Aptamer SeqId:8518-55;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8518-55;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.381388E-11

Real

Aptamer SeqId: 8518-55 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8518-55 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.381388E-11

Real

Aptamer SeqId:8520-8;Target:ADA30;UniProt:Q9UKF2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8520-8;Target: ADA30;UniProt: Q9UKF2;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 30;Organisim: human;Apparent_Kd_M: 6.414023E-11

Real

Aptamer SeqId: 8520-8 | Target: ADA30 | UniProt: Q9UKF2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8520-8 | Target: ADA30 | UniProt: Q9UKF2 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 30 | Organisim: human | Apparent_Kd_M: 6.414023E-11

Real

Aptamer SeqId:8529-1;Target:TRAIL R2;UniProt:O14763

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8529-1;Target: TRAIL R2;UniProt: O14763;TargetFullName: Tumor necrosis factor receptor superfamily member 10B;Organisim: human;Apparent_Kd_M: 6.956581E-11

Real

Aptamer SeqId: 8529-1 | Target: TRAIL R2 | UniProt: O14763

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8529-1 | Target: TRAIL R2 | UniProt: O14763 | TargetFullName: Tumor necrosis factor receptor superfamily member 10B | Organisim: human | Apparent_Kd_M: 6.956581E-11

Real

Aptamer SeqId:8535-102;Target:Dermokine;UniProt:Q6E0U4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8535-102;Target: Dermokine;UniProt: Q6E0U4;TargetFullName: Dermokine;Organisim: human;Apparent_Kd_M: 1.23E-11

Real

Aptamer SeqId: 8535-102 | Target: Dermokine | UniProt: Q6E0U4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8535-102 | Target: Dermokine | UniProt: Q6E0U4 | TargetFullName: Dermokine | Organisim: human | Apparent_Kd_M: 1.23E-11

Real

Aptamer SeqId:8556-5;Target:F134B;UniProt:Q9H6L5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8556-5;Target: F134B;UniProt: Q9H6L5;TargetFullName: Protein FAM134B;Organisim: human;Apparent_Kd_M: 8.522849E-12

Real

Aptamer SeqId: 8556-5 | Target: F134B | UniProt: Q9H6L5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8556-5 | Target: F134B | UniProt: Q9H6L5 | TargetFullName: Protein FAM134B | Organisim: human | Apparent_Kd_M: 8.522849E-12

Real

Aptamer SeqId:8565-160;Target:PLVAP;UniProt:Q9BX97

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8565-160;Target: PLVAP;UniProt: Q9BX97;TargetFullName: Plasmalemma vesicle-associated protein;Organisim: human;Apparent_Kd_M: 8.708012E-11

Real

Aptamer SeqId: 8565-160 | Target: PLVAP | UniProt: Q9BX97

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8565-160 | Target: PLVAP | UniProt: Q9BX97 | TargetFullName: Plasmalemma vesicle-associated protein | Organisim: human | Apparent_Kd_M: 8.708012E-11

Real

Aptamer SeqId:8569-147;Target:ARL8B;UniProt:Q9NVJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8569-147;Target: ARL8B;UniProt: Q9NVJ2;TargetFullName: ADP-ribosylation factor-like protein 8B;Organisim: human;Apparent_Kd_M: 5.734724E-11

Real

Aptamer SeqId: 8569-147 | Target: ARL8B | UniProt: Q9NVJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8569-147 | Target: ARL8B | UniProt: Q9NVJ2 | TargetFullName: ADP-ribosylation factor-like protein 8B | Organisim: human | Apparent_Kd_M: 5.734724E-11

Real

Aptamer SeqId:8578-45;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8578-45;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.603605E-12

Real

Aptamer SeqId: 8578-45 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8578-45 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.603605E-12

Real

Aptamer SeqId:8587-21;Target:ISK52;UniProt:Q6IE38

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8587-21;Target: ISK52;UniProt: Q6IE38;TargetFullName: Serine protease inhibitor Kazal-type 14;Organisim: human;Apparent_Kd_M: 9.204797E-11

Real

Aptamer SeqId: 8587-21 | Target: ISK52 | UniProt: Q6IE38

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8587-21 | Target: ISK52 | UniProt: Q6IE38 | TargetFullName: Serine protease inhibitor Kazal-type 14 | Organisim: human | Apparent_Kd_M: 9.204797E-11

Real

Aptamer SeqId:8589-13;Target:CDCP1;UniProt:Q9H5V8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8589-13;Target: CDCP1;UniProt: Q9H5V8;TargetFullName: CUB domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.74E-11

Real

Aptamer SeqId: 8589-13 | Target: CDCP1 | UniProt: Q9H5V8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8589-13 | Target: CDCP1 | UniProt: Q9H5V8 | TargetFullName: CUB domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.74E-11

Real

Aptamer SeqId:8595-75;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8595-75;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.671581E-12

Real

Aptamer SeqId: 8595-75 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8595-75 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.671581E-12

Real

Aptamer SeqId:8597-1;Target:TMEM9;UniProt:Q9P0T7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8597-1;Target: TMEM9;UniProt: Q9P0T7;TargetFullName: Transmembrane protein 9;Organisim: human;Apparent_Kd_M: 6.768618E-11

Real

Aptamer SeqId: 8597-1 | Target: TMEM9 | UniProt: Q9P0T7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8597-1 | Target: TMEM9 | UniProt: Q9P0T7 | TargetFullName: Transmembrane protein 9 | Organisim: human | Apparent_Kd_M: 6.768618E-11

Real

Aptamer SeqId:8601-167;Target:sLRP1;UniProt:Q07954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8601-167;Target: sLRP1;UniProt: Q07954;TargetFullName: Low-density lipoprotein receptor-related protein 1; soluble;Organisim: human;Apparent_Kd_M: 4.244327E-11

Real

Aptamer SeqId: 8601-167 | Target: sLRP1 | UniProt: Q07954

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8601-167 | Target: sLRP1 | UniProt: Q07954 | TargetFullName: Low-density lipoprotein receptor-related protein 1; soluble | Organisim: human | Apparent_Kd_M: 4.244327E-11

Real

Aptamer SeqId:8606-39;Target:GPNMB;UniProt:Q14956

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8606-39;Target: GPNMB;UniProt: Q14956;TargetFullName: Transmembrane glycoprotein NMB;Organisim: human;Apparent_Kd_M: 2.12E-12

Real

Aptamer SeqId: 8606-39 | Target: GPNMB | UniProt: Q14956

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8606-39 | Target: GPNMB | UniProt: Q14956 | TargetFullName: Transmembrane glycoprotein NMB | Organisim: human | Apparent_Kd_M: 2.12E-12

Real

Aptamer SeqId:8613-97;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8613-97;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.46E-10

Real

Aptamer SeqId: 8613-97 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8613-97 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.46E-10

Real

Aptamer SeqId:8619-12;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8619-12;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.036687E-12

Real

Aptamer SeqId: 8619-12 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8619-12 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.036687E-12

Real

Aptamer SeqId:8631-13;Target:ERMAP;UniProt:Q96PL5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8631-13;Target: ERMAP;UniProt: Q96PL5;TargetFullName: Erythroid membrane-associated protein;Organisim: human;Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId: 8631-13 | Target: ERMAP | UniProt: Q96PL5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8631-13 | Target: ERMAP | UniProt: Q96PL5 | TargetFullName: Erythroid membrane-associated protein | Organisim: human | Apparent_Kd_M: 1.58E-11

Real

Aptamer SeqId:8633-18;Target:RN128;UniProt:Q8TEB7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8633-18;Target: RN128;UniProt: Q8TEB7;TargetFullName: E3 ubiquitin-protein ligase RNF128;Organisim: human;Apparent_Kd_M: 8.37E-11

Real

Aptamer SeqId: 8633-18 | Target: RN128 | UniProt: Q8TEB7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8633-18 | Target: RN128 | UniProt: Q8TEB7 | TargetFullName: E3 ubiquitin-protein ligase RNF128 | Organisim: human | Apparent_Kd_M: 8.37E-11

Real

Aptamer SeqId:8634-187;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8634-187;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.664723E-12

Real

Aptamer SeqId: 8634-187 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8634-187 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.664723E-12

Real

Aptamer SeqId:8635-283;Target:ZPBP1;UniProt:Q9BS86

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8635-283;Target: ZPBP1;UniProt: Q9BS86;TargetFullName: Zona pellucida-binding protein 1;Organisim: human;Apparent_Kd_M: 2.698971E-10

Real

Aptamer SeqId: 8635-283 | Target: ZPBP1 | UniProt: Q9BS86

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8635-283 | Target: ZPBP1 | UniProt: Q9BS86 | TargetFullName: Zona pellucida-binding protein 1 | Organisim: human | Apparent_Kd_M: 2.698971E-10

Real

Aptamer SeqId:8646-61;Target:LRRT4;UniProt:Q86VH4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8646-61;Target: LRRT4;UniProt: Q86VH4;TargetFullName: Leucine-rich repeat transmembrane neuronal protein 4;Organisim: human;Apparent_Kd_M: 2.49E-11

Real

Aptamer SeqId: 8646-61 | Target: LRRT4 | UniProt: Q86VH4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8646-61 | Target: LRRT4 | UniProt: Q86VH4 | TargetFullName: Leucine-rich repeat transmembrane neuronal protein 4 | Organisim: human | Apparent_Kd_M: 2.49E-11

Real

Aptamer SeqId:8653-132;Target:DNJC4;UniProt:Q9NNZ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8653-132;Target: DNJC4;UniProt: Q9NNZ3;TargetFullName: DnaJ homolog subfamily C member 4;Organisim: human;Apparent_Kd_M: 7.26E-11

Real

Aptamer SeqId: 8653-132 | Target: DNJC4 | UniProt: Q9NNZ3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8653-132 | Target: DNJC4 | UniProt: Q9NNZ3 | TargetFullName: DnaJ homolog subfamily C member 4 | Organisim: human | Apparent_Kd_M: 7.26E-11

Real

Aptamer SeqId:8654-13;Target:ADAM 10;UniProt:O14672

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8654-13;Target: ADAM 10;UniProt: O14672;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 10;Organisim: human;Apparent_Kd_M: 3.19393E-10

Real

Aptamer SeqId: 8654-13 | Target: ADAM 10 | UniProt: O14672

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8654-13 | Target: ADAM 10 | UniProt: O14672 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 10 | Organisim: human | Apparent_Kd_M: 3.19393E-10

Real

Aptamer SeqId:8659-68;Target:G6B;UniProt:O95866

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8659-68;Target: G6B;UniProt: O95866;TargetFullName: Protein G6b;Organisim: human;Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId: 8659-68 | Target: G6B | UniProt: O95866

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8659-68 | Target: G6B | UniProt: O95866 | TargetFullName: Protein G6b | Organisim: human | Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId:8660-5;Target:OLFL3;UniProt:Q9NRN5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8660-5;Target: OLFL3;UniProt: Q9NRN5;TargetFullName: Olfactomedin-like protein 3;Organisim: human;Apparent_Kd_M: 3.32E-11

Real

Aptamer SeqId: 8660-5 | Target: OLFL3 | UniProt: Q9NRN5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8660-5 | Target: OLFL3 | UniProt: Q9NRN5 | TargetFullName: Olfactomedin-like protein 3 | Organisim: human | Apparent_Kd_M: 3.32E-11

Real

Aptamer SeqId:8664-36;Target:PKDCC;UniProt:Q504Y2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8664-36;Target: PKDCC;UniProt: Q504Y2;TargetFullName: Extracellular tyrosine-protein kinase PKDCC;Organisim: human;Apparent_Kd_M: 2.814014E-11

Real

Aptamer SeqId: 8664-36 | Target: PKDCC | UniProt: Q504Y2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8664-36 | Target: PKDCC | UniProt: Q504Y2 | TargetFullName: Extracellular tyrosine-protein kinase PKDCC | Organisim: human | Apparent_Kd_M: 2.814014E-11

Real

Aptamer SeqId:8667-42;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8667-42;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.73E-11

Real

Aptamer SeqId: 8667-42 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8667-42 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.73E-11

Real

Aptamer SeqId:8671-378;Target:TPPC5;UniProt:Q8IUR0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8671-378;Target: TPPC5;UniProt: Q8IUR0;TargetFullName: Trafficking protein particle complex subunit 5;Organisim: human;Apparent_Kd_M: 4.984448E-11

Real

Aptamer SeqId: 8671-378 | Target: TPPC5 | UniProt: Q8IUR0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8671-378 | Target: TPPC5 | UniProt: Q8IUR0 | TargetFullName: Trafficking protein particle complex subunit 5 | Organisim: human | Apparent_Kd_M: 4.984448E-11

Real

Aptamer SeqId:8675-79;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8675-79;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.01E-11

Real

Aptamer SeqId: 8675-79 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8675-79 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.01E-11

Real

Aptamer SeqId:8681-93;Target:PGRC2;UniProt:O15173

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8681-93;Target: PGRC2;UniProt: O15173;TargetFullName: Membrane-associated progesterone receptor component 2;Organisim: human;Apparent_Kd_M: 5.43E-11

Real

Aptamer SeqId: 8681-93 | Target: PGRC2 | UniProt: O15173

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8681-93 | Target: PGRC2 | UniProt: O15173 | TargetFullName: Membrane-associated progesterone receptor component 2 | Organisim: human | Apparent_Kd_M: 5.43E-11

Real

Aptamer SeqId:8686-342;Target:HIKES;UniProt:Q53FT3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8686-342;Target: HIKES;UniProt: Q53FT3;TargetFullName: Protein Hikeshi;Organisim: human;Apparent_Kd_M: 1.181642E-11

Real

Aptamer SeqId: 8686-342 | Target: HIKES | UniProt: Q53FT3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8686-342 | Target: HIKES | UniProt: Q53FT3 | TargetFullName: Protein Hikeshi | Organisim: human | Apparent_Kd_M: 1.181642E-11

Real

Aptamer SeqId:8687-26;Target:T106B;UniProt:Q9NUM4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8687-26;Target: T106B;UniProt: Q9NUM4;TargetFullName: Transmembrane protein 106B;Organisim: human;Apparent_Kd_M: 3.108046E-11

Real

Aptamer SeqId: 8687-26 | Target: T106B | UniProt: Q9NUM4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8687-26 | Target: T106B | UniProt: Q9NUM4 | TargetFullName: Transmembrane protein 106B | Organisim: human | Apparent_Kd_M: 3.108046E-11

Real

Aptamer SeqId:8690-25;Target:CAV3;UniProt:P56539

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8690-25;Target: CAV3;UniProt: P56539;TargetFullName: Caveolin-3;Organisim: human;Apparent_Kd_M: 6.867748E-11

Real

Aptamer SeqId: 8690-25 | Target: CAV3 | UniProt: P56539

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8690-25 | Target: CAV3 | UniProt: P56539 | TargetFullName: Caveolin-3 | Organisim: human | Apparent_Kd_M: 6.867748E-11

Real

Aptamer SeqId:8696-15;Target:G3ST1;UniProt:Q99999

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8696-15;Target: G3ST1;UniProt: Q99999;TargetFullName: Galactosylceramide sulfotransferase;Organisim: human;Apparent_Kd_M: 4.299585E-11

Real

Aptamer SeqId: 8696-15 | Target: G3ST1 | UniProt: Q99999

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8696-15 | Target: G3ST1 | UniProt: Q99999 | TargetFullName: Galactosylceramide sulfotransferase | Organisim: human | Apparent_Kd_M: 4.299585E-11

Real

Aptamer SeqId:8697-38;Target:Glypican 1;UniProt:P35052

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8697-38;Target: Glypican 1;UniProt: P35052;TargetFullName: Glypican-1;Organisim: human;Apparent_Kd_M: 2.794155E-11

Real

Aptamer SeqId: 8697-38 | Target: Glypican 1 | UniProt: P35052

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8697-38 | Target: Glypican 1 | UniProt: P35052 | TargetFullName: Glypican-1 | Organisim: human | Apparent_Kd_M: 2.794155E-11

Real

Aptamer SeqId:8699-43;Target:CRIM1;UniProt:Q9NZV1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8699-43;Target: CRIM1;UniProt: Q9NZV1;TargetFullName: Cysteine-rich motor neuron 1 protein;Organisim: human;Apparent_Kd_M: 8.26E-11

Real

Aptamer SeqId: 8699-43 | Target: CRIM1 | UniProt: Q9NZV1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8699-43 | Target: CRIM1 | UniProt: Q9NZV1 | TargetFullName: Cysteine-rich motor neuron 1 protein | Organisim: human | Apparent_Kd_M: 8.26E-11

Real

Aptamer SeqId:8700-325;Target:GLT11;UniProt:Q8NCW6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8700-325;Target: GLT11;UniProt: Q8NCW6;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 11;Organisim: human;Apparent_Kd_M: 7.608824E-11

Real

Aptamer SeqId: 8700-325 | Target: GLT11 | UniProt: Q8NCW6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8700-325 | Target: GLT11 | UniProt: Q8NCW6 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 11 | Organisim: human | Apparent_Kd_M: 7.608824E-11

Real

Aptamer SeqId:8748-45;Target:HG2A;UniProt:P04233

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8748-45;Target: HG2A;UniProt: P04233;TargetFullName: HLA class II histocompatibility antigen gamma chain;Organisim: human;Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId: 8748-45 | Target: HG2A | UniProt: P04233

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8748-45 | Target: HG2A | UniProt: P04233 | TargetFullName: HLA class II histocompatibility antigen gamma chain | Organisim: human | Apparent_Kd_M: 1.31E-11

Real

Aptamer SeqId:8749-194;Target:CD1D;UniProt:P15813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8749-194;Target: CD1D;UniProt: P15813;TargetFullName: Antigen-presenting glycoprotein CD1d;Organisim: human;Apparent_Kd_M: 5.53E-12

Real

Aptamer SeqId: 8749-194 | Target: CD1D | UniProt: P15813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8749-194 | Target: CD1D | UniProt: P15813 | TargetFullName: Antigen-presenting glycoprotein CD1d | Organisim: human | Apparent_Kd_M: 5.53E-12

Real

Aptamer SeqId:8750-46;Target:Vinculin;UniProt:P18206

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8750-46;Target: Vinculin;UniProt: P18206;TargetFullName: Vinculin;Organisim: human;Apparent_Kd_M: 5.758763E-12

Real

Aptamer SeqId: 8750-46 | Target: Vinculin | UniProt: P18206

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8750-46 | Target: Vinculin | UniProt: P18206 | TargetFullName: Vinculin | Organisim: human | Apparent_Kd_M: 5.758763E-12

Real

Aptamer SeqId:8752-6;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8752-6;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.953772E-11

Real

Aptamer SeqId: 8752-6 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8752-6 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.953772E-11

Real

Aptamer SeqId:8754-5;Target:NMU;UniProt:P48645

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8754-5;Target: NMU;UniProt: P48645;TargetFullName: Neuromedin-U;Organisim: human;Apparent_Kd_M: 1.078694E-10

Real

Aptamer SeqId: 8754-5 | Target: NMU | UniProt: P48645

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8754-5 | Target: NMU | UniProt: P48645 | TargetFullName: Neuromedin-U | Organisim: human | Apparent_Kd_M: 1.078694E-10

Real

Aptamer SeqId:8755-202;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8755-202;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.867771E-11

Real

Aptamer SeqId: 8755-202 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8755-202 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.867771E-11

Real

Aptamer SeqId:8756-41;Target:KCE1L;UniProt:Q9UJ90

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8756-41;Target: KCE1L;UniProt: Q9UJ90;TargetFullName: Potassium voltage-gated channel subfamily E regulatory beta subunit 5;Organisim: human;Apparent_Kd_M: 3.31E-12

Real

Aptamer SeqId: 8756-41 | Target: KCE1L | UniProt: Q9UJ90

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8756-41 | Target: KCE1L | UniProt: Q9UJ90 | TargetFullName: Potassium voltage-gated channel subfamily E regulatory beta subunit 5 | Organisim: human | Apparent_Kd_M: 3.31E-12

Real

Aptamer SeqId:8758-2;Target:PCDA7;UniProt:Q9UN72

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8758-2;Target: PCDA7;UniProt: Q9UN72;TargetFullName: Protocadherin alpha-7;Organisim: human;Apparent_Kd_M: 2.130822E-11

Real

Aptamer SeqId: 8758-2 | Target: PCDA7 | UniProt: Q9UN72

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8758-2 | Target: PCDA7 | UniProt: Q9UN72 | TargetFullName: Protocadherin alpha-7 | Organisim: human | Apparent_Kd_M: 2.130822E-11

Real

Aptamer SeqId:8759-29;Target:a1;4-Galactosyltransferase;UniProt:Q9NPC4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8759-29;Target: a1;4-Galactosyltransferase;UniProt: Q9NPC4;TargetFullName: Lactosylceramide 4-alpha-galactosyltransferase;Organisim: human;Apparent_Kd_M: 6.95E-12

Real

Aptamer SeqId: 8759-29 | Target: a1 4-Galactosyltransferase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8759-29 | Target: a1;4-Galactosyltransferase | UniProt: Q9NPC4 | TargetFullName: Lactosylceramide 4-alpha-galactosyltransferase | Organisim: human | Apparent_Kd_M: 6.95E-12

Real

Aptamer SeqId:8760-10;Target:DCNL5;UniProt:Q9BTE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8760-10;Target: DCNL5;UniProt: Q9BTE7;TargetFullName: DCN1-like protein 5;Organisim: human;Apparent_Kd_M: 6.284481E-11

Real

Aptamer SeqId: 8760-10 | Target: DCNL5 | UniProt: Q9BTE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8760-10 | Target: DCNL5 | UniProt: Q9BTE7 | TargetFullName: DCN1-like protein 5 | Organisim: human | Apparent_Kd_M: 6.284481E-11

Real

Aptamer SeqId:8761-7;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8761-7;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId: 8761-7 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8761-7 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId:8766-29;Target:LIRA5;UniProt:A6NI73

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8766-29;Target: LIRA5;UniProt: A6NI73;TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 5;Organisim: human;Apparent_Kd_M: 4.05E-11

Real

Aptamer SeqId: 8766-29 | Target: LIRA5 | UniProt: A6NI73

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8766-29 | Target: LIRA5 | UniProt: A6NI73 | TargetFullName: Leukocyte immunoglobulin-like receptor subfamily A member 5 | Organisim: human | Apparent_Kd_M: 4.05E-11

Real

Aptamer SeqId:8767-44;Target:Endothelin-converting enzyme 1;UniProt:P42892

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8767-44;Target: Endothelin-converting enzyme 1;UniProt: P42892;TargetFullName: Endothelin-converting enzyme 1;Organisim: human;Apparent_Kd_M: 9.9E-13

Real

Aptamer SeqId: 8767-44 | Target: Endothelin-converting enzyme 1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8767-44 | Target: Endothelin-converting enzyme 1 | UniProt: P42892 | TargetFullName: Endothelin-converting enzyme 1 | Organisim: human | Apparent_Kd_M: 9.9E-13

Real

Aptamer SeqId:8768-4;Target:Bcl-10;UniProt:O95999

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8768-4;Target: Bcl-10;UniProt: O95999;TargetFullName: B-cell lymphoma/leukemia 10;Organisim: human;Apparent_Kd_M: 2.988377E-12

Real

Aptamer SeqId: 8768-4 | Target: Bcl-10 | UniProt: O95999

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8768-4 | Target: Bcl-10 | UniProt: O95999 | TargetFullName: B-cell lymphoma/leukemia 10 | Organisim: human | Apparent_Kd_M: 2.988377E-12

Real

Aptamer SeqId:8769-30;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8769-30;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.01E-12

Real

Aptamer SeqId: 8769-30 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8769-30 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.01E-12

Real

Aptamer SeqId:8770-136;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8770-136;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.45E-12

Real

Aptamer SeqId: 8770-136 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8770-136 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.45E-12

Real

Aptamer SeqId:8772-5;Target:EFNB2;UniProt:P52799

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8772-5;Target: EFNB2;UniProt: P52799;TargetFullName: Ephrin-B2;Organisim: human;Apparent_Kd_M: 6.34E-12

Real

Aptamer SeqId: 8772-5 | Target: EFNB2 | UniProt: P52799

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8772-5 | Target: EFNB2 | UniProt: P52799 | TargetFullName: Ephrin-B2 | Organisim: human | Apparent_Kd_M: 6.34E-12

Real

Aptamer SeqId:8773-172;Target:EMIL3;UniProt:Q9NT22

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8773-172;Target: EMIL3;UniProt: Q9NT22;TargetFullName: EMILIN-3;Organisim: human;Apparent_Kd_M: 6.14E-11

Real

Aptamer SeqId: 8773-172 | Target: EMIL3 | UniProt: Q9NT22

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8773-172 | Target: EMIL3 | UniProt: Q9NT22 | TargetFullName: EMILIN-3 | Organisim: human | Apparent_Kd_M: 6.14E-11

Real

Aptamer SeqId:8775-61;Target:FA24B;UniProt:Q8N5W8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8775-61;Target: FA24B;UniProt: Q8N5W8;TargetFullName: Protein FAM24B;Organisim: human;Apparent_Kd_M: 2.920255E-11

Real

Aptamer SeqId: 8775-61 | Target: FA24B | UniProt: Q8N5W8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8775-61 | Target: FA24B | UniProt: Q8N5W8 | TargetFullName: Protein FAM24B | Organisim: human | Apparent_Kd_M: 2.920255E-11

Real

Aptamer SeqId:8776-10;Target:ERLN1;UniProt:O75477

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8776-10;Target: ERLN1;UniProt: O75477;TargetFullName: Erlin-1;Organisim: human;Apparent_Kd_M: 3.058568E-12

Real

Aptamer SeqId: 8776-10 | Target: ERLN1 | UniProt: O75477

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8776-10 | Target: ERLN1 | UniProt: O75477 | TargetFullName: Erlin-1 | Organisim: human | Apparent_Kd_M: 3.058568E-12

Real

Aptamer SeqId:8777-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8777-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.770226E-12

Real

Aptamer SeqId: 8777-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8777-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.770226E-12

Real

Aptamer SeqId:8778-3;Target:Noggin;UniProt:Q13253

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8778-3;Target: Noggin;UniProt: Q13253;TargetFullName: Noggin;Organisim: human;Apparent_Kd_M: 6.56E-12

Real

Aptamer SeqId: 8778-3 | Target: Noggin | UniProt: Q13253

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8778-3 | Target: Noggin | UniProt: Q13253 | TargetFullName: Noggin | Organisim: human | Apparent_Kd_M: 6.56E-12

Real

Aptamer SeqId:8780-2;Target:PCD10;UniProt:Q9P2E7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8780-2;Target: PCD10;UniProt: Q9P2E7;TargetFullName: Protocadherin-10;Organisim: human;Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId: 8780-2 | Target: PCD10 | UniProt: Q9P2E7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8780-2 | Target: PCD10 | UniProt: Q9P2E7 | TargetFullName: Protocadherin-10 | Organisim: human | Apparent_Kd_M: 1.28E-11

Real

Aptamer SeqId:8783-216;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8783-216;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.467928E-11

Real

Aptamer SeqId: 8783-216 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8783-216 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.467928E-11

Real

Aptamer SeqId:8784-7;Target:F175A;UniProt:Q6UWZ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8784-7;Target: F175A;UniProt: Q6UWZ7;TargetFullName: BRCA1-A complex subunit Abraxas;Organisim: human;Apparent_Kd_M: 2.883754E-12

Real

Aptamer SeqId: 8784-7 | Target: F175A | UniProt: Q6UWZ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8784-7 | Target: F175A | UniProt: Q6UWZ7 | TargetFullName: BRCA1-A complex subunit Abraxas | Organisim: human | Apparent_Kd_M: 2.883754E-12

Real

Aptamer SeqId:8785-1;Target:ARMC5;UniProt:Q96C12

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8785-1;Target: ARMC5;UniProt: Q96C12;TargetFullName: Armadillo repeat-containing protein 5;Organisim: human;Apparent_Kd_M: 9.94E-12

Real

Aptamer SeqId: 8785-1 | Target: ARMC5 | UniProt: Q96C12

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8785-1 | Target: ARMC5 | UniProt: Q96C12 | TargetFullName: Armadillo repeat-containing protein 5 | Organisim: human | Apparent_Kd_M: 9.94E-12

Real

Aptamer SeqId:8786-6;Target:F171B;UniProt:Q6P995

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8786-6;Target: F171B;UniProt: Q6P995;TargetFullName: Protein FAM171B;Organisim: human;Apparent_Kd_M: 1.1E-12

Real

Aptamer SeqId: 8786-6 | Target: F171B | UniProt: Q6P995

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8786-6 | Target: F171B | UniProt: Q6P995 | TargetFullName: Protein FAM171B | Organisim: human | Apparent_Kd_M: 1.1E-12

Real

Aptamer SeqId:8787-21;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8787-21;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.168468E-11

Real

Aptamer SeqId: 8787-21 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8787-21 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.168468E-11

Real

Aptamer SeqId:8791-151;Target:Carbonic Anhydrase VA;UniProt:P35218

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8791-151;Target: Carbonic Anhydrase VA;UniProt: P35218;TargetFullName: Carbonic anhydrase 5A; mitochondrial;Organisim: human;Apparent_Kd_M: 2.280843E-12

Real

Aptamer SeqId: 8791-151 | Target: Carbonic Anhydrase VA | UniProt: P35218

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8791-151 | Target: Carbonic Anhydrase VA | UniProt: P35218 | TargetFullName: Carbonic anhydrase 5A; mitochondrial | Organisim: human | Apparent_Kd_M: 2.280843E-12

Real

Aptamer SeqId:8792-17;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8792-17;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.400153E-12

Real

Aptamer SeqId: 8792-17 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8792-17 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.400153E-12

Real

Aptamer SeqId:8793-13;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8793-13;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.501193E-12

Real

Aptamer SeqId: 8793-13 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8793-13 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.501193E-12

Real

Aptamer SeqId:8794-13;Target:DPEP1;UniProt:P16444

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8794-13;Target: DPEP1;UniProt: P16444;TargetFullName: Dipeptidase 1;Organisim: human;Apparent_Kd_M: 9.69E-11

Real

Aptamer SeqId: 8794-13 | Target: DPEP1 | UniProt: P16444

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8794-13 | Target: DPEP1 | UniProt: P16444 | TargetFullName: Dipeptidase 1 | Organisim: human | Apparent_Kd_M: 9.69E-11

Real

Aptamer SeqId:8795-48;Target:TR;UniProt:P02786

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8795-48;Target: TR;UniProt: P02786;TargetFullName: Transferrin receptor protein 1;Organisim: human;Apparent_Kd_M: 6.35E-11

Real

Aptamer SeqId: 8795-48 | Target: TR | UniProt: P02786

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8795-48 | Target: TR | UniProt: P02786 | TargetFullName: Transferrin receptor protein 1 | Organisim: human | Apparent_Kd_M: 6.35E-11

Real

Aptamer SeqId:8800-14;Target:TTC17;UniProt:Q96AE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8800-14;Target: TTC17;UniProt: Q96AE7;TargetFullName: Tetratricopeptide repeat protein 17;Organisim: human;Apparent_Kd_M: 6.86E-11

Real

Aptamer SeqId: 8800-14 | Target: TTC17 | UniProt: Q96AE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8800-14 | Target: TTC17 | UniProt: Q96AE7 | TargetFullName: Tetratricopeptide repeat protein 17 | Organisim: human | Apparent_Kd_M: 6.86E-11

Real

Aptamer SeqId:8802-24;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8802-24;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.94E-12

Real

Aptamer SeqId: 8802-24 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8802-24 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.94E-12

Real

Aptamer SeqId:8803-61;Target:nectin-1 gamma;UniProt:Q15223

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8803-61;Target: nectin-1 gamma;UniProt: Q15223;TargetFullName: Nectin-1; isoform gamma;Organisim: human;Apparent_Kd_M: 8.67E-11

Real

Aptamer SeqId: 8803-61 | Target: nectin-1 gamma | UniProt: Q15223

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8803-61 | Target: nectin-1 gamma | UniProt: Q15223 | TargetFullName: Nectin-1; isoform gamma | Organisim: human | Apparent_Kd_M: 8.67E-11

Real

Aptamer SeqId:8804-39;Target:COKA1;UniProt:Q9P218

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8804-39;Target: COKA1;UniProt: Q9P218;TargetFullName: Collagen alpha-1(XX) chain;Organisim: human;Apparent_Kd_M: 1.037699E-11

Real

Aptamer SeqId: 8804-39 | Target: COKA1 | UniProt: Q9P218

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8804-39 | Target: COKA1 | UniProt: Q9P218 | TargetFullName: Collagen alpha-1(XX) chain | Organisim: human | Apparent_Kd_M: 1.037699E-11

Real

Aptamer SeqId:8806-18;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8806-18;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.20428E-11

Real

Aptamer SeqId: 8806-18 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8806-18 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.20428E-11

Real

Aptamer SeqId:8807-13;Target:SNX1;UniProt:Q13596

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8807-13;Target: SNX1;UniProt: Q13596;TargetFullName: Sorting nexin-1;Organisim: human;Apparent_Kd_M: 4.22E-12

Real

Aptamer SeqId: 8807-13 | Target: SNX1 | UniProt: Q13596

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8807-13 | Target: SNX1 | UniProt: Q13596 | TargetFullName: Sorting nexin-1 | Organisim: human | Apparent_Kd_M: 4.22E-12

Real

Aptamer SeqId:8808-90;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8808-90;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.94E-11

Real

Aptamer SeqId: 8808-90 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8808-90 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.94E-11

Real

Aptamer SeqId:8810-26;Target:HEPACAM;UniProt:Q14CZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8810-26;Target: HEPACAM;UniProt: Q14CZ8;TargetFullName: Hepatocyte cell adhesion molecule;Organisim: human;Apparent_Kd_M: 1.789094E-11

Real

Aptamer SeqId: 8810-26 | Target: HEPACAM | UniProt: Q14CZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8810-26 | Target: HEPACAM | UniProt: Q14CZ8 | TargetFullName: Hepatocyte cell adhesion molecule | Organisim: human | Apparent_Kd_M: 1.789094E-11

Real

Aptamer SeqId:8811-24;Target:BAMBI;UniProt:Q13145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8811-24;Target: BAMBI;UniProt: Q13145;TargetFullName: BMP and activin membrane-bound inhibitor homolog;Organisim: human;Apparent_Kd_M: 6.14E-11

Real

Aptamer SeqId: 8811-24 | Target: BAMBI | UniProt: Q13145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8811-24 | Target: BAMBI | UniProt: Q13145 | TargetFullName: BMP and activin membrane-bound inhibitor homolog | Organisim: human | Apparent_Kd_M: 6.14E-11

Real

Aptamer SeqId:8813-160;Target:Thioredoxin;UniProt:P10599

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8813-160;Target: Thioredoxin;UniProt: P10599;TargetFullName: Thioredoxin;Organisim: human;Apparent_Kd_M: 5.91E-11

Real

Aptamer SeqId: 8813-160 | Target: Thioredoxin | UniProt: P10599

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8813-160 | Target: Thioredoxin | UniProt: P10599 | TargetFullName: Thioredoxin | Organisim: human | Apparent_Kd_M: 5.91E-11

Real

Aptamer SeqId:8814-33;Target:SAPL1;UniProt:Q6NUJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8814-33;Target: SAPL1;UniProt: Q6NUJ1;TargetFullName: Proactivator polypeptide-like 1;Organisim: human;Apparent_Kd_M: 1.589073E-12

Real

Aptamer SeqId: 8814-33 | Target: SAPL1 | UniProt: Q6NUJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8814-33 | Target: SAPL1 | UniProt: Q6NUJ1 | TargetFullName: Proactivator polypeptide-like 1 | Organisim: human | Apparent_Kd_M: 1.589073E-12

Real

Aptamer SeqId:8815-1;Target:OLFL1;UniProt:Q6UWY5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8815-1;Target: OLFL1;UniProt: Q6UWY5;TargetFullName: Olfactomedin-like protein 1;Organisim: human;Apparent_Kd_M: 1.058171E-10

Real

Aptamer SeqId: 8815-1 | Target: OLFL1 | UniProt: Q6UWY5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8815-1 | Target: OLFL1 | UniProt: Q6UWY5 | TargetFullName: Olfactomedin-like protein 1 | Organisim: human | Apparent_Kd_M: 1.058171E-10

Real

Aptamer SeqId:8817-29;Target:CENPV;UniProt:Q7Z7K6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8817-29;Target: CENPV;UniProt: Q7Z7K6;TargetFullName: Centromere protein V;Organisim: human;Apparent_Kd_M: 7.64716E-12

Real

Aptamer SeqId: 8817-29 | Target: CENPV | UniProt: Q7Z7K6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8817-29 | Target: CENPV | UniProt: Q7Z7K6 | TargetFullName: Centromere protein V | Organisim: human | Apparent_Kd_M: 7.64716E-12

Real

Aptamer SeqId:8818-13;Target:INGR2;UniProt:P38484

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8818-13;Target: INGR2;UniProt: P38484;TargetFullName: Interferon gamma receptor 2;Organisim: human;Apparent_Kd_M: 7.43E-11

Real

Aptamer SeqId: 8818-13 | Target: INGR2 | UniProt: P38484

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8818-13 | Target: INGR2 | UniProt: P38484 | TargetFullName: Interferon gamma receptor 2 | Organisim: human | Apparent_Kd_M: 7.43E-11

Real

Aptamer SeqId:8820-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8820-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.205364E-11

Real

Aptamer SeqId: 8820-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8820-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.205364E-11

Real

Aptamer SeqId:8822-163;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8822-163;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.632684E-12

Real

Aptamer SeqId: 8822-163 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8822-163 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.632684E-12

Real

Aptamer SeqId:8824-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8824-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.94E-12

Real

Aptamer SeqId: 8824-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8824-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.94E-12

Real

Aptamer SeqId:8825-4;Target:PILRA;UniProt:Q9UKJ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8825-4;Target: PILRA;UniProt: Q9UKJ1;TargetFullName: Paired immunoglobulin-like type 2 receptor alpha;Organisim: human;Apparent_Kd_M: 6.76E-12

Real

Aptamer SeqId: 8825-4 | Target: PILRA | UniProt: Q9UKJ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8825-4 | Target: PILRA | UniProt: Q9UKJ1 | TargetFullName: Paired immunoglobulin-like type 2 receptor alpha | Organisim: human | Apparent_Kd_M: 6.76E-12

Real

Aptamer SeqId:8828-21;Target:ESRP1;UniProt:Q6NXG1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8828-21;Target: ESRP1;UniProt: Q6NXG1;TargetFullName: Epithelial splicing regulatory protein 1;Organisim: human;Apparent_Kd_M: 7.556231E-12

Real

Aptamer SeqId: 8828-21 | Target: ESRP1 | UniProt: Q6NXG1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8828-21 | Target: ESRP1 | UniProt: Q6NXG1 | TargetFullName: Epithelial splicing regulatory protein 1 | Organisim: human | Apparent_Kd_M: 7.556231E-12

Real

Aptamer SeqId:8832-55;Target:BST-2;UniProt:Q10589

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8832-55;Target: BST-2;UniProt: Q10589;TargetFullName: Bone marrow stromal antigen 2;Organisim: human;Apparent_Kd_M: 1.131147E-11

Real

Aptamer SeqId: 8832-55 | Target: BST-2 | UniProt: Q10589

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8832-55 | Target: BST-2 | UniProt: Q10589 | TargetFullName: Bone marrow stromal antigen 2 | Organisim: human | Apparent_Kd_M: 1.131147E-11

Real

Aptamer SeqId:8833-20;Target:TRAIL;UniProt:P50591

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8833-20;Target: TRAIL;UniProt: P50591;TargetFullName: Tumor necrosis factor ligand superfamily member 10;Organisim: human;Apparent_Kd_M: 6.335906E-11

Real

Aptamer SeqId: 8833-20 | Target: TRAIL | UniProt: P50591

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8833-20 | Target: TRAIL | UniProt: P50591 | TargetFullName: Tumor necrosis factor ligand superfamily member 10 | Organisim: human | Apparent_Kd_M: 6.335906E-11

Real

Aptamer SeqId:8834-58;Target:Calnexin;UniProt:P27824

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8834-58;Target: Calnexin;UniProt: P27824;TargetFullName: Calnexin;Organisim: human;Apparent_Kd_M: 1.146332E-11

Real

Aptamer SeqId: 8834-58 | Target: Calnexin | UniProt: P27824

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8834-58 | Target: Calnexin | UniProt: P27824 | TargetFullName: Calnexin | Organisim: human | Apparent_Kd_M: 1.146332E-11

Real

Aptamer SeqId:8837-8;Target:MFA3L;UniProt:O75121

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8837-8;Target: MFA3L;UniProt: O75121;TargetFullName: Microfibrillar-associated protein 3-like;Organisim: human;Apparent_Kd_M: 6.890754E-12

Real

Aptamer SeqId: 8837-8 | Target: MFA3L | UniProt: O75121

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8837-8 | Target: MFA3L | UniProt: O75121 | TargetFullName: Microfibrillar-associated protein 3-like | Organisim: human | Apparent_Kd_M: 6.890754E-12

Real

Aptamer SeqId:8838-10;Target:CASC4;UniProt:Q6P4E1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8838-10;Target: CASC4;UniProt: Q6P4E1;TargetFullName: Protein CASC4;Organisim: human;Apparent_Kd_M: 2.967975E-11

Real

Aptamer SeqId: 8838-10 | Target: CASC4 | UniProt: Q6P4E1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8838-10 | Target: CASC4 | UniProt: Q6P4E1 | TargetFullName: Protein CASC4 | Organisim: human | Apparent_Kd_M: 2.967975E-11

Real

Aptamer SeqId:8839-4;Target:Metaxin-2;UniProt:O75431

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8839-4;Target: Metaxin-2;UniProt: O75431;TargetFullName: Metaxin-2;Organisim: human;Apparent_Kd_M: 5.605279E-11

Real

Aptamer SeqId: 8839-4 | Target: Metaxin-2 | UniProt: O75431

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8839-4 | Target: Metaxin-2 | UniProt: O75431 | TargetFullName: Metaxin-2 | Organisim: human | Apparent_Kd_M: 5.605279E-11

Real

Aptamer SeqId:8840-61;Target:C1s;UniProt:P09871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8840-61;Target: C1s;UniProt: P09871;TargetFullName: Complement C1s subcomponent;Organisim: human;Apparent_Kd_M: 1.689441E-11

Real

Aptamer SeqId: 8840-61 | Target: C1s | UniProt: P09871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8840-61 | Target: C1s | UniProt: P09871 | TargetFullName: Complement C1s subcomponent | Organisim: human | Apparent_Kd_M: 1.689441E-11

Real

Aptamer SeqId:8841-65;Target:CILP2;UniProt:Q8IUL8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8841-65;Target: CILP2;UniProt: Q8IUL8;TargetFullName: Cartilage intermediate layer protein 2;Organisim: human;Apparent_Kd_M: 4.067676E-12

Real

Aptamer SeqId: 8841-65 | Target: CILP2 | UniProt: Q8IUL8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8841-65 | Target: CILP2 | UniProt: Q8IUL8 | TargetFullName: Cartilage intermediate layer protein 2 | Organisim: human | Apparent_Kd_M: 4.067676E-12

Real

Aptamer SeqId:8842-16;Target:GRM1C;UniProt:Q8IYS0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8842-16;Target: GRM1C;UniProt: Q8IYS0;TargetFullName: GRAM domain-containing protein 1C;Organisim: human;Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId: 8842-16 | Target: GRM1C | UniProt: Q8IYS0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8842-16 | Target: GRM1C | UniProt: Q8IYS0 | TargetFullName: GRAM domain-containing protein 1C | Organisim: human | Apparent_Kd_M: 1.18E-10

Real

Aptamer SeqId:8843-34;Target:MRF;UniProt:Q9Y2G1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8843-34;Target: MRF;UniProt: Q9Y2G1;TargetFullName: Myelin regulatory factor;Organisim: human;Apparent_Kd_M: 3.323251E-11

Real

Aptamer SeqId: 8843-34 | Target: MRF | UniProt: Q9Y2G1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8843-34 | Target: MRF | UniProt: Q9Y2G1 | TargetFullName: Myelin regulatory factor | Organisim: human | Apparent_Kd_M: 3.323251E-11

Real

Aptamer SeqId:8845-2;Target:ATS3;UniProt:O15072

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8845-2;Target: ATS3;UniProt: O15072;TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 3;Organisim: human;Apparent_Kd_M: 2.974789E-11

Real

Aptamer SeqId: 8845-2 | Target: ATS3 | UniProt: O15072

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8845-2 | Target: ATS3 | UniProt: O15072 | TargetFullName: A disintegrin and metalloproteinase with thrombospondin motifs 3 | Organisim: human | Apparent_Kd_M: 2.974789E-11

Real

Aptamer SeqId:8850-5;Target:PA2GC;UniProt:Q5R387

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8850-5;Target: PA2GC;UniProt: Q5R387;TargetFullName: Putative inactive group IIC secretory phospholipase A2;Organisim: human;Apparent_Kd_M: 3.223819E-11

Real

Aptamer SeqId: 8850-5 | Target: PA2GC | UniProt: Q5R387

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8850-5 | Target: PA2GC | UniProt: Q5R387 | TargetFullName: Putative inactive group IIC secretory phospholipase A2 | Organisim: human | Apparent_Kd_M: 3.223819E-11

Real

Aptamer SeqId:8852-10;Target:SUN3;UniProt:Q8TAQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8852-10;Target: SUN3;UniProt: Q8TAQ9;TargetFullName: SUN domain-containing protein 3;Organisim: human;Apparent_Kd_M: 2.749897E-11

Real

Aptamer SeqId: 8852-10 | Target: SUN3 | UniProt: Q8TAQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8852-10 | Target: SUN3 | UniProt: Q8TAQ9 | TargetFullName: SUN domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 2.749897E-11

Real

Aptamer SeqId:8853-2;Target:CLC4A;UniProt:Q9UMR7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8853-2;Target: CLC4A;UniProt: Q9UMR7;TargetFullName: C-type lectin domain family 4 member A;Organisim: human;Apparent_Kd_M: 8.033008E-11

Real

Aptamer SeqId: 8853-2 | Target: CLC4A | UniProt: Q9UMR7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8853-2 | Target: CLC4A | UniProt: Q9UMR7 | TargetFullName: C-type lectin domain family 4 member A | Organisim: human | Apparent_Kd_M: 8.033008E-11

Real

Aptamer SeqId:8858-21;Target:BATF3;UniProt:Q9NR55

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8858-21;Target: BATF3;UniProt: Q9NR55;TargetFullName: Basic leucine zipper transcriptional factor ATF-like 3;Organisim: human;Apparent_Kd_M: 1.237616E-11

Real

Aptamer SeqId: 8858-21 | Target: BATF3 | UniProt: Q9NR55

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8858-21 | Target: BATF3 | UniProt: Q9NR55 | TargetFullName: Basic leucine zipper transcriptional factor ATF-like 3 | Organisim: human | Apparent_Kd_M: 1.237616E-11

Real

Aptamer SeqId:8859-51;Target:CAH11;UniProt:O75493

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8859-51;Target: CAH11;UniProt: O75493;TargetFullName: Carbonic anhydrase-related protein 11;Organisim: human;Apparent_Kd_M: 8.017669E-12

Real

Aptamer SeqId: 8859-51 | Target: CAH11 | UniProt: O75493

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8859-51 | Target: CAH11 | UniProt: O75493 | TargetFullName: Carbonic anhydrase-related protein 11 | Organisim: human | Apparent_Kd_M: 8.017669E-12

Real

Aptamer SeqId:8863-3;Target:P85A;UniProt:P27986

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8863-3;Target: P85A;UniProt: P27986;TargetFullName: Phosphatidylinositol 3-kinase regulatory subunit alpha;Organisim: human;Apparent_Kd_M: 5.061582E-12

Real

Aptamer SeqId: 8863-3 | Target: P85A | UniProt: P27986

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8863-3 | Target: P85A | UniProt: P27986 | TargetFullName: Phosphatidylinositol 3-kinase regulatory subunit alpha | Organisim: human | Apparent_Kd_M: 5.061582E-12

Real

Aptamer SeqId:8864-59;Target:CENPW;UniProt:Q5EE01

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8864-59;Target: CENPW;UniProt: Q5EE01;TargetFullName: Centromere protein W;Organisim: human;Apparent_Kd_M: 6.146169E-12

Real

Aptamer SeqId: 8864-59 | Target: CENPW | UniProt: Q5EE01

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8864-59 | Target: CENPW | UniProt: Q5EE01 | TargetFullName: Centromere protein W | Organisim: human | Apparent_Kd_M: 6.146169E-12

Real

Aptamer SeqId:8866-53;Target:QPCTL;UniProt:Q9NXS2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8866-53;Target: QPCTL;UniProt: Q9NXS2;TargetFullName: Glutaminyl-peptide cyclotransferase-like protein;Organisim: human;Apparent_Kd_M: 6.273073E-12

Real

Aptamer SeqId: 8866-53 | Target: QPCTL | UniProt: Q9NXS2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8866-53 | Target: QPCTL | UniProt: Q9NXS2 | TargetFullName: Glutaminyl-peptide cyclotransferase-like protein | Organisim: human | Apparent_Kd_M: 6.273073E-12

Real

Aptamer SeqId:8867-18;Target:Glycodelin;UniProt:P09466

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8867-18;Target: Glycodelin;UniProt: P09466;TargetFullName: Glycodelin;Organisim: human;Apparent_Kd_M: 3.21E-11

Real

Aptamer SeqId: 8867-18 | Target: Glycodelin | UniProt: P09466

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8867-18 | Target: Glycodelin | UniProt: P09466 | TargetFullName: Glycodelin | Organisim: human | Apparent_Kd_M: 3.21E-11

Real

Aptamer SeqId:8868-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8868-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.453598E-11

Real

Aptamer SeqId: 8868-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8868-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.453598E-11

Real

Aptamer SeqId:8869-5;Target:BT2A1;UniProt:Q7KYR7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8869-5;Target: BT2A1;UniProt: Q7KYR7;TargetFullName: Butyrophilin subfamily 2 member A1;Organisim: human;Apparent_Kd_M: 8.56533E-11

Real

Aptamer SeqId: 8869-5 | Target: BT2A1 | UniProt: Q7KYR7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8869-5 | Target: BT2A1 | UniProt: Q7KYR7 | TargetFullName: Butyrophilin subfamily 2 member A1 | Organisim: human | Apparent_Kd_M: 8.56533E-11

Real

Aptamer SeqId:8870-38;Target:NPM1;UniProt:P06748

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8870-38;Target: NPM1;UniProt: P06748;TargetFullName: Nucleophosmin;Organisim: human;Apparent_Kd_M: 2.490283E-10

Real

Aptamer SeqId: 8870-38 | Target: NPM1 | UniProt: P06748

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8870-38 | Target: NPM1 | UniProt: P06748 | TargetFullName: Nucleophosmin | Organisim: human | Apparent_Kd_M: 2.490283E-10

Real

Aptamer SeqId:8872-1;Target:SC61G;UniProt:P60059

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8872-1;Target: SC61G;UniProt: P60059;TargetFullName: Protein transport protein Sec61 subunit gamma;Organisim: human;Apparent_Kd_M: 1.080654E-11

Real

Aptamer SeqId: 8872-1 | Target: SC61G | UniProt: P60059

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8872-1 | Target: SC61G | UniProt: P60059 | TargetFullName: Protein transport protein Sec61 subunit gamma | Organisim: human | Apparent_Kd_M: 1.080654E-11

Real

Aptamer SeqId:8874-53;Target:CLN5;UniProt:O75503

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8874-53;Target: CLN5;UniProt: O75503;TargetFullName: Ceroid-lipofuscinosis neuronal protein 5;Organisim: human;Apparent_Kd_M: 2.44E-11

Real

Aptamer SeqId: 8874-53 | Target: CLN5 | UniProt: O75503

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8874-53 | Target: CLN5 | UniProt: O75503 | TargetFullName: Ceroid-lipofuscinosis neuronal protein 5 | Organisim: human | Apparent_Kd_M: 2.44E-11

Real

Aptamer SeqId:8876-51;Target:NRX2B;UniProt:P58401

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8876-51;Target: NRX2B;UniProt: P58401;TargetFullName: Neurexin-2-beta;Organisim: human;Apparent_Kd_M: 5.023218E-12

Real

Aptamer SeqId: 8876-51 | Target: NRX2B | UniProt: P58401

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8876-51 | Target: NRX2B | UniProt: P58401 | TargetFullName: Neurexin-2-beta | Organisim: human | Apparent_Kd_M: 5.023218E-12

Real

Aptamer SeqId:8877-22;Target:F176C;UniProt:P58658

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8877-22;Target: F176C;UniProt: P58658;TargetFullName: Protein eva-1 homolog C;Organisim: human;Apparent_Kd_M: 2.28E-11

Real

Aptamer SeqId: 8877-22 | Target: F176C | UniProt: P58658

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8877-22 | Target: F176C | UniProt: P58658 | TargetFullName: Protein eva-1 homolog C | Organisim: human | Apparent_Kd_M: 2.28E-11

Real

Aptamer SeqId:8878-48;Target:YTDC1;UniProt:Q96MU7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8878-48;Target: YTDC1;UniProt: Q96MU7;TargetFullName: YTH domain-containing protein 1;Organisim: human;Apparent_Kd_M: 2.212952E-12

Real

Aptamer SeqId: 8878-48 | Target: YTDC1 | UniProt: Q96MU7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8878-48 | Target: YTDC1 | UniProt: Q96MU7 | TargetFullName: YTH domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 2.212952E-12

Real

Aptamer SeqId:8882-1;Target:ADAM 17;UniProt:P78536

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8882-1;Target: ADAM 17;UniProt: P78536;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 17;Organisim: human;Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId: 8882-1 | Target: ADAM 17 | UniProt: P78536

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8882-1 | Target: ADAM 17 | UniProt: P78536 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 17 | Organisim: human | Apparent_Kd_M: 2.29E-11

Real

Aptamer SeqId:8885-6;Target:CA2D3;UniProt:Q8IZS8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8885-6;Target: CA2D3;UniProt: Q8IZS8;TargetFullName: Voltage-dependent calcium channel subunit alpha-2/delta-3;Organisim: human;Apparent_Kd_M: 2.914052E-11

Real

Aptamer SeqId: 8885-6 | Target: CA2D3 | UniProt: Q8IZS8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8885-6 | Target: CA2D3 | UniProt: Q8IZS8 | TargetFullName: Voltage-dependent calcium channel subunit alpha-2/delta-3 | Organisim: human | Apparent_Kd_M: 2.914052E-11

Real

Aptamer SeqId:8887-21;Target:NUDC;UniProt:Q9Y266

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8887-21;Target: NUDC;UniProt: Q9Y266;TargetFullName: Nuclear migration protein nudC;Organisim: human;Apparent_Kd_M: 5.44E-12

Real

Aptamer SeqId: 8887-21 | Target: NUDC | UniProt: Q9Y266

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8887-21 | Target: NUDC | UniProt: Q9Y266 | TargetFullName: Nuclear migration protein nudC | Organisim: human | Apparent_Kd_M: 5.44E-12

Real

Aptamer SeqId:8888-33;Target:CX068;UniProt:A6NGZ8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8888-33;Target: CX068;UniProt: A6NGZ8;TargetFullName: Small integral membrane protein 9;Organisim: human;Apparent_Kd_M: 2.172526E-11

Real

Aptamer SeqId: 8888-33 | Target: CX068 | UniProt: A6NGZ8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8888-33 | Target: CX068 | UniProt: A6NGZ8 | TargetFullName: Small integral membrane protein 9 | Organisim: human | Apparent_Kd_M: 2.172526E-11

Real

Aptamer SeqId:8889-5;Target:CCPG1;UniProt:Q9ULG6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8889-5;Target: CCPG1;UniProt: Q9ULG6;TargetFullName: Cell cycle progression protein 1;Organisim: human;Apparent_Kd_M: 3.937674E-12

Real

Aptamer SeqId: 8889-5 | Target: CCPG1 | UniProt: Q9ULG6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8889-5 | Target: CCPG1 | UniProt: Q9ULG6 | TargetFullName: Cell cycle progression protein 1 | Organisim: human | Apparent_Kd_M: 3.937674E-12

Real

Aptamer SeqId:8890-9;Target:T132B;UniProt:Q14DG7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8890-9;Target: T132B;UniProt: Q14DG7;TargetFullName: Transmembrane protein 132B;Organisim: human;Apparent_Kd_M: 1.711747E-12

Real

Aptamer SeqId: 8890-9 | Target: T132B | UniProt: Q14DG7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8890-9 | Target: T132B | UniProt: Q14DG7 | TargetFullName: Transmembrane protein 132B | Organisim: human | Apparent_Kd_M: 1.711747E-12

Real

Aptamer SeqId:8891-7;Target:CPVL;UniProt:Q9H3G5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8891-7;Target: CPVL;UniProt: Q9H3G5;TargetFullName: Probable serine carboxypeptidase CPVL;Organisim: human;Apparent_Kd_M: 1.64856E-11

Real

Aptamer SeqId: 8891-7 | Target: CPVL | UniProt: Q9H3G5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8891-7 | Target: CPVL | UniProt: Q9H3G5 | TargetFullName: Probable serine carboxypeptidase CPVL | Organisim: human | Apparent_Kd_M: 1.64856E-11

Real

Aptamer SeqId:8892-14;Target:PEAR1;UniProt:Q5VY43

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8892-14;Target: PEAR1;UniProt: Q5VY43;TargetFullName: Platelet endothelial aggregation receptor 1;Organisim: human;Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId: 8892-14 | Target: PEAR1 | UniProt: Q5VY43

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8892-14 | Target: PEAR1 | UniProt: Q5VY43 | TargetFullName: Platelet endothelial aggregation receptor 1 | Organisim: human | Apparent_Kd_M: 3.02E-11

Real

Aptamer SeqId:8893-29;Target:PARP;UniProt:P09874

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8893-29;Target: PARP;UniProt: P09874;TargetFullName: Poly [ADP-ribose] polymerase 1;Organisim: human;Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId: 8893-29 | Target: PARP | UniProt: P09874

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8893-29 | Target: PARP | UniProt: P09874 | TargetFullName: Poly ADP-ribose polymerase 1 | Organisim: human | Apparent_Kd_M: 1.52E-11

Real

Aptamer SeqId:8894-80;Target:hnRNP A/B;UniProt:Q99729

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8894-80;Target: hnRNP A/B;UniProt: Q99729;TargetFullName: Heterogeneous nuclear ribonucleoprotein A/B;Organisim: human;Apparent_Kd_M: 8.69E-13

Real

Aptamer SeqId: 8894-80 | Target: hnRNP A/B | UniProt: Q99729

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8894-80 | Target: hnRNP A/B | UniProt: Q99729 | TargetFullName: Heterogeneous nuclear ribonucleoprotein A/B | Organisim: human | Apparent_Kd_M: 8.69E-13

Real

Aptamer SeqId:8897-3;Target:L37A2;UniProt:A6NM11

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8897-3;Target: L37A2;UniProt: A6NM11;TargetFullName: Leucine-rich repeat-containing protein 37A2;Organisim: human;Apparent_Kd_M: 3.366414E-11

Real

Aptamer SeqId: 8897-3 | Target: L37A2 | UniProt: A6NM11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8897-3 | Target: L37A2 | UniProt: A6NM11 | TargetFullName: Leucine-rich repeat-containing protein 37A2 | Organisim: human | Apparent_Kd_M: 3.366414E-11

Real

Aptamer SeqId:8898-19;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8898-19;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.215711E-12

Real

Aptamer SeqId: 8898-19 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8898-19 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.215711E-12

Real

Aptamer SeqId:8899-75;Target:UD18;UniProt:Q9HAW9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8899-75;Target: UD18;UniProt: Q9HAW9;TargetFullName: UDP-glucuronosyltransferase 1-8;Organisim: human;Apparent_Kd_M: 2.352172E-11

Real

Aptamer SeqId: 8899-75 | Target: UD18 | UniProt: Q9HAW9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8899-75 | Target: UD18 | UniProt: Q9HAW9 | TargetFullName: UDP-glucuronosyltransferase 1-8 | Organisim: human | Apparent_Kd_M: 2.352172E-11

Real

Aptamer SeqId:8900-28;Target:NEO1;UniProt:Q92859

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8900-28;Target: NEO1;UniProt: Q92859;TargetFullName: Neogenin;Organisim: human;Apparent_Kd_M: 7.102043E-12

Real

Aptamer SeqId: 8900-28 | Target: NEO1 | UniProt: Q92859

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8900-28 | Target: NEO1 | UniProt: Q92859 | TargetFullName: Neogenin | Organisim: human | Apparent_Kd_M: 7.102043E-12

Real

Aptamer SeqId:8901-40;Target:Deprecated

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8901-40;Target: Deprecated;UniProt:;TargetFullName:;Organisim: human;Apparent_Kd_M: 7.967902E-12

Real

Aptamer SeqId: 8901-40 | Target: Deprecated | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8901-40 | Target: Deprecated | UniProt: | TargetFullName: | Organisim: human | Apparent_Kd_M: 7.967902E-12

Real

Aptamer SeqId:8903-1;Target:COX6C;UniProt:P09669

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8903-1;Target: COX6C;UniProt: P09669;TargetFullName: Cytochrome c oxidase subunit 6C;Organisim: human;Apparent_Kd_M: 6.744751E-12

Real

Aptamer SeqId: 8903-1 | Target: COX6C | UniProt: P09669

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8903-1 | Target: COX6C | UniProt: P09669 | TargetFullName: Cytochrome c oxidase subunit 6C | Organisim: human | Apparent_Kd_M: 6.744751E-12

Real

Aptamer SeqId:8905-20;Target:KCMB3;UniProt:Q9NPA1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8905-20;Target: KCMB3;UniProt: Q9NPA1;TargetFullName: Calcium-activated potassium channel subunit beta-3;Organisim: human;Apparent_Kd_M: 1.032584E-11

Real

Aptamer SeqId: 8905-20 | Target: KCMB3 | UniProt: Q9NPA1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8905-20 | Target: KCMB3 | UniProt: Q9NPA1 | TargetFullName: Calcium-activated potassium channel subunit beta-3 | Organisim: human | Apparent_Kd_M: 1.032584E-11

Real

Aptamer SeqId:8906-60;Target:LRTM2;UniProt:Q8N967

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8906-60;Target: LRTM2;UniProt: Q8N967;TargetFullName: Leucine-rich repeat and transmembrane domain-containing protein 2;Organisim: human;Apparent_Kd_M: 9.454653E-13

Real

Aptamer SeqId: 8906-60 | Target: LRTM2 | UniProt: Q8N967

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8906-60 | Target: LRTM2 | UniProt: Q8N967 | TargetFullName: Leucine-rich repeat and transmembrane domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 9.454653E-13

Real

Aptamer SeqId:8907-11;Target:UD2A1;UniProt:Q9Y4X1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8907-11;Target: UD2A1;UniProt: Q9Y4X1;TargetFullName: UDP-glucuronosyltransferase 2A1;Organisim: human;Apparent_Kd_M: 7.4672E-12

Real

Aptamer SeqId: 8907-11 | Target: UD2A1 | UniProt: Q9Y4X1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8907-11 | Target: UD2A1 | UniProt: Q9Y4X1 | TargetFullName: UDP-glucuronosyltransferase 2A1 | Organisim: human | Apparent_Kd_M: 7.4672E-12

Real

Aptamer SeqId:8908-14;Target:KCE1L;UniProt:Q9UJ90

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8908-14;Target: KCE1L;UniProt: Q9UJ90;TargetFullName: Potassium voltage-gated channel subfamily E regulatory beta subunit 5;Organisim: human;Apparent_Kd_M: 6.47E-12

Real

Aptamer SeqId: 8908-14 | Target: KCE1L | UniProt: Q9UJ90

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8908-14 | Target: KCE1L | UniProt: Q9UJ90 | TargetFullName: Potassium voltage-gated channel subfamily E regulatory beta subunit 5 | Organisim: human | Apparent_Kd_M: 6.47E-12

Real

Aptamer SeqId:8909-77;Target:GNPI1;UniProt:P46926

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8909-77;Target: GNPI1;UniProt: P46926;TargetFullName: Glucosamine-6-phosphate isomerase 1;Organisim: human;Apparent_Kd_M: 3.450125E-12

Real

Aptamer SeqId: 8909-77 | Target: GNPI1 | UniProt: P46926

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8909-77 | Target: GNPI1 | UniProt: P46926 | TargetFullName: Glucosamine-6-phosphate isomerase 1 | Organisim: human | Apparent_Kd_M: 3.450125E-12

Real

Aptamer SeqId:8913-22;Target:SIG11;UniProt:Q96RL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8913-22;Target: SIG11;UniProt: Q96RL6;TargetFullName: Sialic acid-binding Ig-like lectin 11;Organisim: human;Apparent_Kd_M: 1.301892E-10

Real

Aptamer SeqId: 8913-22 | Target: SIG11 | UniProt: Q96RL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8913-22 | Target: SIG11 | UniProt: Q96RL6 | TargetFullName: Sialic acid-binding Ig-like lectin 11 | Organisim: human | Apparent_Kd_M: 1.301892E-10

Real

Aptamer SeqId:8916-32;Target:STIM1;UniProt:Q13586

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8916-32;Target: STIM1;UniProt: Q13586;TargetFullName: Stromal interaction molecule 1;Organisim: human;Apparent_Kd_M: 5.12E-12

Real

Aptamer SeqId: 8916-32 | Target: STIM1 | UniProt: Q13586

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8916-32 | Target: STIM1 | UniProt: Q13586 | TargetFullName: Stromal interaction molecule 1 | Organisim: human | Apparent_Kd_M: 5.12E-12

Real

Aptamer SeqId:8918-64;Target:FAK2;UniProt:Q14289

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8918-64;Target: FAK2;UniProt: Q14289;TargetFullName: Protein-tyrosine kinase 2-beta;Organisim: human;Apparent_Kd_M: 2.5E-12

Real

Aptamer SeqId: 8918-64 | Target: FAK2 | UniProt: Q14289

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8918-64 | Target: FAK2 | UniProt: Q14289 | TargetFullName: Protein-tyrosine kinase 2-beta | Organisim: human | Apparent_Kd_M: 2.5E-12

Real

Aptamer SeqId:8921-139;Target:PABP2;UniProt:Q86U42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8921-139;Target: PABP2;UniProt: Q86U42;TargetFullName: Polyadenylate-binding protein 2;Organisim: human;Apparent_Kd_M: 8.796106E-11

Real

Aptamer SeqId: 8921-139 | Target: PABP2 | UniProt: Q86U42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8921-139 | Target: PABP2 | UniProt: Q86U42 | TargetFullName: Polyadenylate-binding protein 2 | Organisim: human | Apparent_Kd_M: 8.796106E-11

Real

Aptamer SeqId:8922-4;Target:TMCC3;UniProt:Q9ULS5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8922-4;Target: TMCC3;UniProt: Q9ULS5;TargetFullName: Transmembrane and coiled-coil domains protein 3;Organisim: human;Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId: 8922-4 | Target: TMCC3 | UniProt: Q9ULS5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8922-4 | Target: TMCC3 | UniProt: Q9ULS5 | TargetFullName: Transmembrane and coiled-coil domains protein 3 | Organisim: human | Apparent_Kd_M: 4.06E-11

Real

Aptamer SeqId:8923-94;Target:GLTL1;UniProt:Q8N428

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8923-94;Target: GLTL1;UniProt: Q8N428;TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 16;Organisim: human;Apparent_Kd_M: 3.457662E-12

Real

Aptamer SeqId: 8923-94 | Target: GLTL1 | UniProt: Q8N428

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8923-94 | Target: GLTL1 | UniProt: Q8N428 | TargetFullName: Polypeptide N-acetylgalactosaminyltransferase 16 | Organisim: human | Apparent_Kd_M: 3.457662E-12

Real

Aptamer SeqId:8924-55;Target:CALY;UniProt:Q9NYX4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8924-55;Target: CALY;UniProt: Q9NYX4;TargetFullName: Neuron-specific vesicular protein calcyon;Organisim: human;Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId: 8924-55 | Target: CALY | UniProt: Q9NYX4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8924-55 | Target: CALY | UniProt: Q9NYX4 | TargetFullName: Neuron-specific vesicular protein calcyon | Organisim: human | Apparent_Kd_M: 5.96E-11

Real

Aptamer SeqId:8925-25;Target:RIR2B;UniProt:Q7LG56

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8925-25;Target: RIR2B;UniProt: Q7LG56;TargetFullName: Ribonucleoside-diphosphate reductase subunit M2 B;Organisim: human;Apparent_Kd_M: 5.03E-12

Real

Aptamer SeqId: 8925-25 | Target: RIR2B | UniProt: Q7LG56

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8925-25 | Target: RIR2B | UniProt: Q7LG56 | TargetFullName: Ribonucleoside-diphosphate reductase subunit M2 B | Organisim: human | Apparent_Kd_M: 5.03E-12

Real

Aptamer SeqId:8927-6;Target:CG073;UniProt:E0CX11

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8927-6;Target: CG073;UniProt: E0CX11;TargetFullName: Uncharacterized protein C7orf73;Organisim: human;Apparent_Kd_M: 1.098438E-10

Real

Aptamer SeqId: 8927-6 | Target: CG073 | UniProt: E0CX11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8927-6 | Target: CG073 | UniProt: E0CX11 | TargetFullName: Uncharacterized protein C7orf73 | Organisim: human | Apparent_Kd_M: 1.098438E-10

Real

Aptamer SeqId:8929-7;Target:BDP1;UniProt:A6H8Y1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8929-7;Target: BDP1;UniProt: A6H8Y1;TargetFullName: Transcription factor TFIIIB component B homolog;Organisim: human;Apparent_Kd_M: 7.493924E-12

Real

Aptamer SeqId: 8929-7 | Target: BDP1 | UniProt: A6H8Y1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8929-7 | Target: BDP1 | UniProt: A6H8Y1 | TargetFullName: Transcription factor TFIIIB component B'' homolog | Organisim: human | Apparent_Kd_M: 7.493924E-12

Real

Aptamer SeqId:8931-124;Target:G0S2;UniProt:P27469

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8931-124;Target: G0S2;UniProt: P27469;TargetFullName: G0/G1 switch protein 2;Organisim: human;Apparent_Kd_M: 1.338412E-11

Real

Aptamer SeqId: 8931-124 | Target: G0S2 | UniProt: P27469

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8931-124 | Target: G0S2 | UniProt: P27469 | TargetFullName: G0/G1 switch protein 2 | Organisim: human | Apparent_Kd_M: 1.338412E-11

Real

Aptamer SeqId:8932-1;Target:ENTP6;UniProt:O75354

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8932-1;Target: ENTP6;UniProt: O75354;TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 6;Organisim: human;Apparent_Kd_M: 2.076181E-11

Real

Aptamer SeqId: 8932-1 | Target: ENTP6 | UniProt: O75354

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8932-1 | Target: ENTP6 | UniProt: O75354 | TargetFullName: Ectonucleoside triphosphate diphosphohydrolase 6 | Organisim: human | Apparent_Kd_M: 2.076181E-11

Real

Aptamer SeqId:8933-84;Target:MEF2C;UniProt:Q06413

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8933-84;Target: MEF2C;UniProt: Q06413;TargetFullName: Myocyte-specific enhancer factor 2C;Organisim: human;Apparent_Kd_M: 1.888053E-12

Real

Aptamer SeqId: 8933-84 | Target: MEF2C | UniProt: Q06413

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8933-84 | Target: MEF2C | UniProt: Q06413 | TargetFullName: Myocyte-specific enhancer factor 2C | Organisim: human | Apparent_Kd_M: 1.888053E-12

Real

Aptamer SeqId:8935-22;Target:MRP6;UniProt:O95255

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8935-22;Target: MRP6;UniProt: O95255;TargetFullName: Multidrug resistance-associated protein 6;Organisim: human;Apparent_Kd_M: 3.130753E-11

Real

Aptamer SeqId: 8935-22 | Target: MRP6 | UniProt: O95255

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8935-22 | Target: MRP6 | UniProt: O95255 | TargetFullName: Multidrug resistance-associated protein 6 | Organisim: human | Apparent_Kd_M: 3.130753E-11

Real

Aptamer SeqId:8941-4;Target:NLGN3;UniProt:Q9NZ94

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8941-4;Target: NLGN3;UniProt: Q9NZ94;TargetFullName: Neuroligin-3;Organisim: human;Apparent_Kd_M: 1.53E-12

Real

Aptamer SeqId: 8941-4 | Target: NLGN3 | UniProt: Q9NZ94

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8941-4 | Target: NLGN3 | UniProt: Q9NZ94 | TargetFullName: Neuroligin-3 | Organisim: human | Apparent_Kd_M: 1.53E-12

Real

Aptamer SeqId:8942-2;Target:RM21;UniProt:Q7Z2W9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8942-2;Target: RM21;UniProt: Q7Z2W9;TargetFullName: 39S ribosomal protein L21; mitochondrial;Organisim: human;Apparent_Kd_M: 2.938094E-11

Real

Aptamer SeqId: 8942-2 | Target: RM21 | UniProt: Q7Z2W9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8942-2 | Target: RM21 | UniProt: Q7Z2W9 | TargetFullName: 39S ribosomal protein L21; mitochondrial | Organisim: human | Apparent_Kd_M: 2.938094E-11

Real

Aptamer SeqId:8944-42;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8944-42;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.54E-11

Real

Aptamer SeqId: 8944-42 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8944-42 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.54E-11

Real

Aptamer SeqId:8945-7;Target:F175B;UniProt:Q15018

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8945-7;Target: F175B;UniProt: Q15018;TargetFullName: BRISC complex subunit Abro1;Organisim: human;Apparent_Kd_M: 6.67E-12

Real

Aptamer SeqId: 8945-7 | Target: F175B | UniProt: Q15018

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8945-7 | Target: F175B | UniProt: Q15018 | TargetFullName: BRISC complex subunit Abro1 | Organisim: human | Apparent_Kd_M: 6.67E-12

Real

Aptamer SeqId:8946-38;Target:NR1H4;UniProt:Q96RI1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8946-38;Target: NR1H4;UniProt: Q96RI1;TargetFullName: Bile acid receptor;Organisim: human;Apparent_Kd_M: 1.823857E-11

Real

Aptamer SeqId: 8946-38 | Target: NR1H4 | UniProt: Q96RI1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8946-38 | Target: NR1H4 | UniProt: Q96RI1 | TargetFullName: Bile acid receptor | Organisim: human | Apparent_Kd_M: 1.823857E-11

Real

Aptamer SeqId:8947-268;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8947-268;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.612346E-12

Real

Aptamer SeqId: 8947-268 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8947-268 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.612346E-12

Real

Aptamer SeqId:8948-13;Target:ADA19;UniProt:Q9H013

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8948-13;Target: ADA19;UniProt: Q9H013;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 19;Organisim: human;Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId: 8948-13 | Target: ADA19 | UniProt: Q9H013

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8948-13 | Target: ADA19 | UniProt: Q9H013 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 19 | Organisim: human | Apparent_Kd_M: 1.02E-11

Real

Aptamer SeqId:8949-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8949-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.38E-12

Real

Aptamer SeqId: 8949-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8949-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.38E-12

Real

Aptamer SeqId:8950-4;Target:CLCA2;UniProt:Q9UQC9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8950-4;Target: CLCA2;UniProt: Q9UQC9;TargetFullName: Calcium-activated chloride channel regulator 2;Organisim: human;Apparent_Kd_M: 3.008883E-11

Real

Aptamer SeqId: 8950-4 | Target: CLCA2 | UniProt: Q9UQC9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8950-4 | Target: CLCA2 | UniProt: Q9UQC9 | TargetFullName: Calcium-activated chloride channel regulator 2 | Organisim: human | Apparent_Kd_M: 3.008883E-11

Real

Aptamer SeqId:8951-162;Target:CSPG4;UniProt:Q6UVK1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8951-162;Target: CSPG4;UniProt: Q6UVK1;TargetFullName: Chondroitin sulfate proteoglycan 4;Organisim: human;Apparent_Kd_M: 2.600951E-12

Real

Aptamer SeqId: 8951-162 | Target: CSPG4 | UniProt: Q6UVK1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8951-162 | Target: CSPG4 | UniProt: Q6UVK1 | TargetFullName: Chondroitin sulfate proteoglycan 4 | Organisim: human | Apparent_Kd_M: 2.600951E-12

Real

Aptamer SeqId:8953-47;Target:HDGF;UniProt:P51858

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8953-47;Target: HDGF;UniProt: P51858;TargetFullName: Hepatoma-derived growth factor;Organisim: human;Apparent_Kd_M: 8.03E-12

Real

Aptamer SeqId: 8953-47 | Target: HDGF | UniProt: P51858

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8953-47 | Target: HDGF | UniProt: P51858 | TargetFullName: Hepatoma-derived growth factor | Organisim: human | Apparent_Kd_M: 8.03E-12

Real

Aptamer SeqId:8954-30;Target:M4K1;UniProt:Q92918

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8954-30;Target: M4K1;UniProt: Q92918;TargetFullName: Mitogen-activated protein kinase kinase kinase kinase 1;Organisim: human;Apparent_Kd_M: 2.082788E-11

Real

Aptamer SeqId: 8954-30 | Target: M4K1 | UniProt: Q92918

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8954-30 | Target: M4K1 | UniProt: Q92918 | TargetFullName: Mitogen-activated protein kinase kinase kinase kinase 1 | Organisim: human | Apparent_Kd_M: 2.082788E-11

Real

Aptamer SeqId:8955-60;Target:GL8D1;UniProt:Q68CQ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8955-60;Target: GL8D1;UniProt: Q68CQ7;TargetFullName: Glycosyltransferase 8 domain-containing protein 1;Organisim: human;Apparent_Kd_M: 6.375928E-11

Real

Aptamer SeqId: 8955-60 | Target: GL8D1 | UniProt: Q68CQ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8955-60 | Target: GL8D1 | UniProt: Q68CQ7 | TargetFullName: Glycosyltransferase 8 domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 6.375928E-11

Real

Aptamer SeqId:8956-96;Target:SREC-II;UniProt:Q96GP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8956-96;Target: SREC-II;UniProt: Q96GP6;TargetFullName: Scavenger receptor class F member 2;Organisim: human;Apparent_Kd_M: 8.79E-12

Real

Aptamer SeqId: 8956-96 | Target: SREC-II | UniProt: Q96GP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8956-96 | Target: SREC-II | UniProt: Q96GP6 | TargetFullName: Scavenger receptor class F member 2 | Organisim: human | Apparent_Kd_M: 8.79E-12

Real

Aptamer SeqId:8957-72;Target:XTP3B;UniProt:Q96DZ1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8957-72;Target: XTP3B;UniProt: Q96DZ1;TargetFullName: Endoplasmic reticulum lectin 1;Organisim: human;Apparent_Kd_M: 7.188528E-12

Real

Aptamer SeqId: 8957-72 | Target: XTP3B | UniProt: Q96DZ1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8957-72 | Target: XTP3B | UniProt: Q96DZ1 | TargetFullName: Endoplasmic reticulum lectin 1 | Organisim: human | Apparent_Kd_M: 7.188528E-12

Real

Aptamer SeqId:8958-51;Target:CHL1;UniProt:O00533

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8958-51;Target: CHL1;UniProt: O00533;TargetFullName: Neural cell adhesion molecule L1-like protein;Organisim: human;Apparent_Kd_M: 2.04E-12

Real

Aptamer SeqId: 8958-51 | Target: CHL1 | UniProt: O00533

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8958-51 | Target: CHL1 | UniProt: O00533 | TargetFullName: Neural cell adhesion molecule L1-like protein | Organisim: human | Apparent_Kd_M: 2.04E-12

Real

Aptamer SeqId:8959-61;Target:ADAM 17;UniProt:P78536

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8959-61;Target: ADAM 17;UniProt: P78536;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 17;Organisim: human;Apparent_Kd_M: 4.49E-11

Real

Aptamer SeqId: 8959-61 | Target: ADAM 17 | UniProt: P78536

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8959-61 | Target: ADAM 17 | UniProt: P78536 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 17 | Organisim: human | Apparent_Kd_M: 4.49E-11

Real

Aptamer SeqId:8960-3;Target:LRAP;UniProt:Q6P179

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8960-3;Target: LRAP;UniProt: Q6P179;TargetFullName: Endoplasmic reticulum aminopeptidase 2;Organisim: human;Apparent_Kd_M: 4.953124E-12

Real

Aptamer SeqId: 8960-3 | Target: LRAP | UniProt: Q6P179

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8960-3 | Target: LRAP | UniProt: Q6P179 | TargetFullName: Endoplasmic reticulum aminopeptidase 2 | Organisim: human | Apparent_Kd_M: 4.953124E-12

Real

Aptamer SeqId:8962-48;Target:KS6B1;UniProt:P23443

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8962-48;Target: KS6B1;UniProt: P23443;TargetFullName: Ribosomal protein S6 kinase beta-1;Organisim: human;Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId: 8962-48 | Target: KS6B1 | UniProt: P23443

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8962-48 | Target: KS6B1 | UniProt: P23443 | TargetFullName: Ribosomal protein S6 kinase beta-1 | Organisim: human | Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId:8963-8;Target:Vti1-rp1;UniProt:Q9UEU0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8963-8;Target: Vti1-rp1;UniProt: Q9UEU0;TargetFullName: Vesicle transport through interaction with t-SNAREs homolog 1B;Organisim: human;Apparent_Kd_M: 2.640325E-12

Real

Aptamer SeqId: 8963-8 | Target: Vti1-rp1 | UniProt: Q9UEU0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8963-8 | Target: Vti1-rp1 | UniProt: Q9UEU0 | TargetFullName: Vesicle transport through interaction with t-SNAREs homolog 1B | Organisim: human | Apparent_Kd_M: 2.640325E-12

Real

Aptamer SeqId:8964-14;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8964-14;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId: 8964-14 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8964-14 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.33E-11

Real

Aptamer SeqId:8967-6;Target:DUS26;UniProt:Q9BV47

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8967-6;Target: DUS26;UniProt: Q9BV47;TargetFullName: Dual specificity protein phosphatase 26;Organisim: human;Apparent_Kd_M: 2.441575E-11

Real

Aptamer SeqId: 8967-6 | Target: DUS26 | UniProt: Q9BV47

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8967-6 | Target: DUS26 | UniProt: Q9BV47 | TargetFullName: Dual specificity protein phosphatase 26 | Organisim: human | Apparent_Kd_M: 2.441575E-11

Real

Aptamer SeqId:8969-49;Target:CD14;UniProt:P08571

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8969-49;Target: CD14;UniProt: P08571;TargetFullName: Monocyte differentiation antigen CD14;Organisim: human;Apparent_Kd_M: 1.993792E-12

Real

Aptamer SeqId: 8969-49 | Target: CD14 | UniProt: P08571

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8969-49 | Target: CD14 | UniProt: P08571 | TargetFullName: Monocyte differentiation antigen CD14 | Organisim: human | Apparent_Kd_M: 1.993792E-12

Real

Aptamer SeqId:8970-9;Target:RIPK2;UniProt:O43353

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8970-9;Target: RIPK2;UniProt: O43353;TargetFullName: Receptor-interacting serine/threonine-protein kinase 2;Organisim: human;Apparent_Kd_M: 1.96E-10

Real

Aptamer SeqId: 8970-9 | Target: RIPK2 | UniProt: O43353

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8970-9 | Target: RIPK2 | UniProt: O43353 | TargetFullName: Receptor-interacting serine/threonine-protein kinase 2 | Organisim: human | Apparent_Kd_M: 1.96E-10

Real

Aptamer SeqId:8971-9;Target:NRX1A;UniProt:Q9ULB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8971-9;Target: NRX1A;UniProt: Q9ULB1;TargetFullName: Neurexin-1;Organisim: human;Apparent_Kd_M: 1.106772E-11

Real

Aptamer SeqId: 8971-9 | Target: NRX1A | UniProt: Q9ULB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8971-9 | Target: NRX1A | UniProt: Q9ULB1 | TargetFullName: Neurexin-1 | Organisim: human | Apparent_Kd_M: 1.106772E-11

Real

Aptamer SeqId:8973-23;Target:FCRL4;UniProt:Q96PJ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8973-23;Target: FCRL4;UniProt: Q96PJ5;TargetFullName: Fc receptor-like protein 4;Organisim: human;Apparent_Kd_M: 4.38E-12

Real

Aptamer SeqId: 8973-23 | Target: FCRL4 | UniProt: Q96PJ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8973-23 | Target: FCRL4 | UniProt: Q96PJ5 | TargetFullName: Fc receptor-like protein 4 | Organisim: human | Apparent_Kd_M: 4.38E-12

Real

Aptamer SeqId:8974-172;Target:COFA1;UniProt:P39059

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8974-172;Target: COFA1;UniProt: P39059;TargetFullName: Collagen alpha-1(XV) chain;Organisim: human;Apparent_Kd_M: 3.613182E-12

Real

Aptamer SeqId: 8974-172 | Target: COFA1 | UniProt: P39059

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8974-172 | Target: COFA1 | UniProt: P39059 | TargetFullName: Collagen alpha-1(XV) chain | Organisim: human | Apparent_Kd_M: 3.613182E-12

Real

Aptamer SeqId:8975-26;Target:RCD1;UniProt:Q92600

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8975-26;Target: RCD1;UniProt: Q92600;TargetFullName: Cell differentiation protein RCD1 homolog;Organisim: human;Apparent_Kd_M: 7.895752E-12

Real

Aptamer SeqId: 8975-26 | Target: RCD1 | UniProt: Q92600

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8975-26 | Target: RCD1 | UniProt: Q92600 | TargetFullName: Cell differentiation protein RCD1 homolog | Organisim: human | Apparent_Kd_M: 7.895752E-12

Real

Aptamer SeqId:8976-13;Target:B4GN1;UniProt:Q00973

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8976-13;Target: B4GN1;UniProt: Q00973;TargetFullName: Beta-1;4 N-acetylgalactosaminyltransferase 1;Organisim: human;Apparent_Kd_M: 1.184943E-10

Real

Aptamer SeqId: 8976-13 | Target: B4GN1 | UniProt: Q00973

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8976-13 | Target: B4GN1 | UniProt: Q00973 | TargetFullName: Beta-1;4 N-acetylgalactosaminyltransferase 1 | Organisim: human | Apparent_Kd_M: 1.184943E-10

Real

Aptamer SeqId:8978-30;Target:M4K3;UniProt:Q8IVH8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8978-30;Target: M4K3;UniProt: Q8IVH8;TargetFullName: Mitogen-activated protein kinase kinase kinase kinase 3;Organisim: human;Apparent_Kd_M: 1.374491E-11

Real

Aptamer SeqId: 8978-30 | Target: M4K3 | UniProt: Q8IVH8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8978-30 | Target: M4K3 | UniProt: Q8IVH8 | TargetFullName: Mitogen-activated protein kinase kinase kinase kinase 3 | Organisim: human | Apparent_Kd_M: 1.374491E-11

Real

Aptamer SeqId:8979-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8979-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.808517E-13

Real

Aptamer SeqId: 8979-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8979-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.808517E-13

Real

Aptamer SeqId:8980-19;Target:MO2R2;UniProt:Q6Q8B3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8980-19;Target: MO2R2;UniProt: Q6Q8B3;TargetFullName: Cell surface glycoprotein CD200 receptor 2;Organisim: human;Apparent_Kd_M: 6.094786E-11

Real

Aptamer SeqId: 8980-19 | Target: MO2R2 | UniProt: Q6Q8B3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8980-19 | Target: MO2R2 | UniProt: Q6Q8B3 | TargetFullName: Cell surface glycoprotein CD200 receptor 2 | Organisim: human | Apparent_Kd_M: 6.094786E-11

Real

Aptamer SeqId:8982-65;Target:TSP3;UniProt:P49746

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8982-65;Target: TSP3;UniProt: P49746;TargetFullName: Thrombospondin-3;Organisim: human;Apparent_Kd_M: 2.90397E-12

Real

Aptamer SeqId: 8982-65 | Target: TSP3 | UniProt: P49746

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8982-65 | Target: TSP3 | UniProt: P49746 | TargetFullName: Thrombospondin-3 | Organisim: human | Apparent_Kd_M: 2.90397E-12

Real

Aptamer SeqId:8983-7;Target:GOLM1;UniProt:Q8NBJ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8983-7;Target: GOLM1;UniProt: Q8NBJ4;TargetFullName: Golgi membrane protein 1;Organisim: human;Apparent_Kd_M: 4.34E-12

Real

Aptamer SeqId: 8983-7 | Target: GOLM1 | UniProt: Q8NBJ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8983-7 | Target: GOLM1 | UniProt: Q8NBJ4 | TargetFullName: Golgi membrane protein 1 | Organisim: human | Apparent_Kd_M: 4.34E-12

Real

Aptamer SeqId:8985-13;Target:SRAC1;UniProt:Q96JX3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8985-13;Target: SRAC1;UniProt: Q96JX3;TargetFullName: Protein SERAC1;Organisim: human;Apparent_Kd_M: 1.863821E-11

Real

Aptamer SeqId: 8985-13 | Target: SRAC1 | UniProt: Q96JX3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8985-13 | Target: SRAC1 | UniProt: Q96JX3 | TargetFullName: Protein SERAC1 | Organisim: human | Apparent_Kd_M: 1.863821E-11

Real

Aptamer SeqId:8989-40;Target:SCUB1;UniProt:Q8IWY4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8989-40;Target: SCUB1;UniProt: Q8IWY4;TargetFullName: Signal peptide; CUB and EGF-like domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.828633E-11

Real

Aptamer SeqId: 8989-40 | Target: SCUB1 | UniProt: Q8IWY4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8989-40 | Target: SCUB1 | UniProt: Q8IWY4 | TargetFullName: Signal peptide; CUB and EGF-like domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.828633E-11

Real

Aptamer SeqId:8990-42;Target:AT1B3;UniProt:P54709

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8990-42;Target: AT1B3;UniProt: P54709;TargetFullName: Sodium/potassium-transporting ATPase subunit beta-3;Organisim: human;Apparent_Kd_M: 2.167251E-12

Real

Aptamer SeqId: 8990-42 | Target: AT1B3 | UniProt: P54709

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8990-42 | Target: AT1B3 | UniProt: P54709 | TargetFullName: Sodium/potassium-transporting ATPase subunit beta-3 | Organisim: human | Apparent_Kd_M: 2.167251E-12

Real

Aptamer SeqId:8991-115;Target:FCRL4;UniProt:Q96PJ5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8991-115;Target: FCRL4;UniProt: Q96PJ5;TargetFullName: Fc receptor-like protein 4;Organisim: human;Apparent_Kd_M: 1.95E-10

Real

Aptamer SeqId: 8991-115 | Target: FCRL4 | UniProt: Q96PJ5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8991-115 | Target: FCRL4 | UniProt: Q96PJ5 | TargetFullName: Fc receptor-like protein 4 | Organisim: human | Apparent_Kd_M: 1.95E-10

Real

Aptamer SeqId:8992-1;Target:TMEM2;UniProt:Q9UHN6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8992-1;Target: TMEM2;UniProt: Q9UHN6;TargetFullName: Transmembrane protein 2;Organisim: human;Apparent_Kd_M: 1.414496E-11

Real

Aptamer SeqId: 8992-1 | Target: TMEM2 | UniProt: Q9UHN6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8992-1 | Target: TMEM2 | UniProt: Q9UHN6 | TargetFullName: Transmembrane protein 2 | Organisim: human | Apparent_Kd_M: 1.414496E-11

Real

Aptamer SeqId:8993-151;Target:RIPK2;UniProt:O43353

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8993-151;Target: RIPK2;UniProt: O43353;TargetFullName: Receptor-interacting serine/threonine-protein kinase 2;Organisim: human;Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId: 8993-151 | Target: RIPK2 | UniProt: O43353

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8993-151 | Target: RIPK2 | UniProt: O43353 | TargetFullName: Receptor-interacting serine/threonine-protein kinase 2 | Organisim: human | Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId:8994-65;Target:SLAMF8;UniProt:Q9P0V8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8994-65;Target: SLAMF8;UniProt: Q9P0V8;TargetFullName: SLAM family member 8;Organisim: human;Apparent_Kd_M: 4.057493E-11

Real

Aptamer SeqId: 8994-65 | Target: SLAMF8 | UniProt: Q9P0V8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8994-65 | Target: SLAMF8 | UniProt: Q9P0V8 | TargetFullName: SLAM family member 8 | Organisim: human | Apparent_Kd_M: 4.057493E-11

Real

Aptamer SeqId:8998-15;Target:HS3S4;UniProt:Q9Y661

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8998-15;Target: HS3S4;UniProt: Q9Y661;TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 4;Organisim: human;Apparent_Kd_M: 4.37E-12

Real

Aptamer SeqId: 8998-15 | Target: HS3S4 | UniProt: Q9Y661

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8998-15 | Target: HS3S4 | UniProt: Q9Y661 | TargetFullName: Heparan sulfate glucosamine 3-O-sulfotransferase 4 | Organisim: human | Apparent_Kd_M: 4.37E-12

Real

Aptamer SeqId:8999-19;Target:CEAM3;UniProt:P40198

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 8999-19;Target: CEAM3;UniProt: P40198;TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 3;Organisim: human;Apparent_Kd_M: 1.123368E-10

Real

Aptamer SeqId: 8999-19 | Target: CEAM3 | UniProt: P40198

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 8999-19 | Target: CEAM3 | UniProt: P40198 | TargetFullName: Carcinoembryonic antigen-related cell adhesion molecule 3 | Organisim: human | Apparent_Kd_M: 1.123368E-10

Real

Aptamer SeqId:9000-177;Target:SLC31;UniProt:Q07837

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9000-177;Target: SLC31;UniProt: Q07837;TargetFullName: Neutral and basic amino acid transport protein rBAT;Organisim: human;Apparent_Kd_M: 9.488766E-11

Real

Aptamer SeqId: 9000-177 | Target: SLC31 | UniProt: Q07837

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9000-177 | Target: SLC31 | UniProt: Q07837 | TargetFullName: Neutral and basic amino acid transport protein rBAT | Organisim: human | Apparent_Kd_M: 9.488766E-11

Real

Aptamer SeqId:9002-36;Target:SPA11;UniProt:Q86U17

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9002-36;Target: SPA11;UniProt: Q86U17;TargetFullName: Serpin A11;Organisim: human;Apparent_Kd_M: 1.533984E-11

Real

Aptamer SeqId: 9002-36 | Target: SPA11 | UniProt: Q86U17

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9002-36 | Target: SPA11 | UniProt: Q86U17 | TargetFullName: Serpin A11 | Organisim: human | Apparent_Kd_M: 1.533984E-11

Real

Aptamer SeqId:9003-99;Target:MARCO;UniProt:Q9UEW3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9003-99;Target: MARCO;UniProt: Q9UEW3;TargetFullName: Macrophage receptor MARCO;Organisim: human;Apparent_Kd_M: 1.462149E-10

Real

Aptamer SeqId: 9003-99 | Target: MARCO | UniProt: Q9UEW3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9003-99 | Target: MARCO | UniProt: Q9UEW3 | TargetFullName: Macrophage receptor MARCO | Organisim: human | Apparent_Kd_M: 1.462149E-10

Real

Aptamer SeqId:9004-24;Target:CR001;UniProt:O15165

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9004-24;Target: CR001;UniProt: O15165;TargetFullName: Low-density lipoprotein receptor class A domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.142413E-11

Real

Aptamer SeqId: 9004-24 | Target: CR001 | UniProt: O15165

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9004-24 | Target: CR001 | UniProt: O15165 | TargetFullName: Low-density lipoprotein receptor class A domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.142413E-11

Real

Aptamer SeqId:9005-16;Target:PLXA1;UniProt:Q9UIW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9005-16;Target: PLXA1;UniProt: Q9UIW2;TargetFullName: Plexin-A1;Organisim: human;Apparent_Kd_M: 3.98902E-12

Real

Aptamer SeqId: 9005-16 | Target: PLXA1 | UniProt: Q9UIW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9005-16 | Target: PLXA1 | UniProt: Q9UIW2 | TargetFullName: Plexin-A1 | Organisim: human | Apparent_Kd_M: 3.98902E-12

Real

Aptamer SeqId:9008-6;Target:TMG1;UniProt:O14668

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9008-6;Target: TMG1;UniProt: O14668;TargetFullName: Transmembrane gamma-carboxyglutamic acid protein 1;Organisim: human;Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId: 9008-6 | Target: TMG1 | UniProt: O14668

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9008-6 | Target: TMG1 | UniProt: O14668 | TargetFullName: Transmembrane gamma-carboxyglutamic acid protein 1 | Organisim: human | Apparent_Kd_M: 1.8E-12

Real

Aptamer SeqId:9010-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9010-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.089875E-11

Real

Aptamer SeqId: 9010-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9010-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.089875E-11

Real

Aptamer SeqId:9012-1;Target:PRP6;UniProt:O94906

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9012-1;Target: PRP6;UniProt: O94906;TargetFullName: Pre-mRNA-processing factor 6;Organisim: human;Apparent_Kd_M: 1.76E-12

Real

Aptamer SeqId: 9012-1 | Target: PRP6 | UniProt: O94906

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9012-1 | Target: PRP6 | UniProt: O94906 | TargetFullName: Pre-mRNA-processing factor 6 | Organisim: human | Apparent_Kd_M: 1.76E-12

Real

Aptamer SeqId:9014-18;Target:TMM25;UniProt:Q86YD3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9014-18;Target: TMM25;UniProt: Q86YD3;TargetFullName: Transmembrane protein 25;Organisim: human;Apparent_Kd_M: 8.276182E-11

Real

Aptamer SeqId: 9014-18 | Target: TMM25 | UniProt: Q86YD3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9014-18 | Target: TMM25 | UniProt: Q86YD3 | TargetFullName: Transmembrane protein 25 | Organisim: human | Apparent_Kd_M: 8.276182E-11

Real

Aptamer SeqId:9015-1;Target:PRG3;UniProt:Q9Y2Y8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9015-1;Target: PRG3;UniProt: Q9Y2Y8;TargetFullName: Proteoglycan 3;Organisim: human;Apparent_Kd_M: 2.729369E-11

Real

Aptamer SeqId: 9015-1 | Target: PRG3 | UniProt: Q9Y2Y8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9015-1 | Target: PRG3 | UniProt: Q9Y2Y8 | TargetFullName: Proteoglycan 3 | Organisim: human | Apparent_Kd_M: 2.729369E-11

Real

Aptamer SeqId:9016-12;Target:NR1H2;UniProt:P55055

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9016-12;Target: NR1H2;UniProt: P55055;TargetFullName: Oxysterols receptor LXR-beta;Organisim: human;Apparent_Kd_M: 2.683337E-11

Real

Aptamer SeqId: 9016-12 | Target: NR1H2 | UniProt: P55055

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9016-12 | Target: NR1H2 | UniProt: P55055 | TargetFullName: Oxysterols receptor LXR-beta | Organisim: human | Apparent_Kd_M: 2.683337E-11

Real

Aptamer SeqId:9017-58;Target:LPH;UniProt:P09848

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9017-58;Target: LPH;UniProt: P09848;TargetFullName: Lactase-phlorizin hydrolase;Organisim: human;Apparent_Kd_M: 2.523141E-11

Real

Aptamer SeqId: 9017-58 | Target: LPH | UniProt: P09848

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9017-58 | Target: LPH | UniProt: P09848 | TargetFullName: Lactase-phlorizin hydrolase | Organisim: human | Apparent_Kd_M: 2.523141E-11

Real

Aptamer SeqId:9018-38;Target:PCD10;UniProt:Q9P2E7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9018-38;Target: PCD10;UniProt: Q9P2E7;TargetFullName: Protocadherin-10;Organisim: human;Apparent_Kd_M: 9.64E-11

Real

Aptamer SeqId: 9018-38 | Target: PCD10 | UniProt: Q9P2E7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9018-38 | Target: PCD10 | UniProt: Q9P2E7 | TargetFullName: Protocadherin-10 | Organisim: human | Apparent_Kd_M: 9.64E-11

Real

Aptamer SeqId:9021-1;Target:TIM-1;UniProt:Q96D42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9021-1;Target: TIM-1;UniProt: Q96D42;TargetFullName: Hepatitis A virus cellular receptor 1;Organisim: human;Apparent_Kd_M: 5.07E-12

Real

Aptamer SeqId: 9021-1 | Target: TIM-1 | UniProt: Q96D42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9021-1 | Target: TIM-1 | UniProt: Q96D42 | TargetFullName: Hepatitis A virus cellular receptor 1 | Organisim: human | Apparent_Kd_M: 5.07E-12

Real

Aptamer SeqId:9022-49;Target:DB132;UniProt:Q7Z7B7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9022-49;Target: DB132;UniProt: Q7Z7B7;TargetFullName: Beta-defensin 132;Organisim: human;Apparent_Kd_M: 2.670471E-11

Real

Aptamer SeqId: 9022-49 | Target: DB132 | UniProt: Q7Z7B7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9022-49 | Target: DB132 | UniProt: Q7Z7B7 | TargetFullName: Beta-defensin 132 | Organisim: human | Apparent_Kd_M: 2.670471E-11

Real

Aptamer SeqId:9023-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9023-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.17E-13

Real

Aptamer SeqId: 9023-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9023-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.17E-13

Real

Aptamer SeqId:9025-5;Target:AHSP;UniProt:Q9NZD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9025-5;Target: AHSP;UniProt: Q9NZD4;TargetFullName: Alpha-hemoglobin-stabilizing protein;Organisim: human;Apparent_Kd_M: 5.715717E-11

Real

Aptamer SeqId: 9025-5 | Target: AHSP | UniProt: Q9NZD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9025-5 | Target: AHSP | UniProt: Q9NZD4 | TargetFullName: Alpha-hemoglobin-stabilizing protein | Organisim: human | Apparent_Kd_M: 5.715717E-11

Real

Aptamer SeqId:9026-40;Target:BTNL8;UniProt:Q6UX41

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9026-40;Target: BTNL8;UniProt: Q6UX41;TargetFullName: Butyrophilin-like protein 8;Organisim: human;Apparent_Kd_M: 8.555269E-11

Real

Aptamer SeqId: 9026-40 | Target: BTNL8 | UniProt: Q6UX41

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9026-40 | Target: BTNL8 | UniProt: Q6UX41 | TargetFullName: Butyrophilin-like protein 8 | Organisim: human | Apparent_Kd_M: 8.555269E-11

Real

Aptamer SeqId:9027-10;Target:NLGN2;UniProt:Q8NFZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9027-10;Target: NLGN2;UniProt: Q8NFZ4;TargetFullName: Neuroligin-2;Organisim: human;Apparent_Kd_M: 4.06E-12

Real

Aptamer SeqId: 9027-10 | Target: NLGN2 | UniProt: Q8NFZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9027-10 | Target: NLGN2 | UniProt: Q8NFZ4 | TargetFullName: Neuroligin-2 | Organisim: human | Apparent_Kd_M: 4.06E-12

Real

Aptamer SeqId:9028-5;Target:PAPD1;UniProt:Q9NVV4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9028-5;Target: PAPD1;UniProt: Q9NVV4;TargetFullName: Poly(A) RNA polymerase; mitochondrial;Organisim: human;Apparent_Kd_M: 8.823446E-12

Real

Aptamer SeqId: 9028-5 | Target: PAPD1 | UniProt: Q9NVV4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9028-5 | Target: PAPD1 | UniProt: Q9NVV4 | TargetFullName: Poly(A) RNA polymerase; mitochondrial | Organisim: human | Apparent_Kd_M: 8.823446E-12

Real

Aptamer SeqId:9030-56;Target:CQ089;UniProt:A1L188

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9030-56;Target: CQ089;UniProt: A1L188;TargetFullName: Uncharacterized protein C17orf89;Organisim: human;Apparent_Kd_M: 1.007547E-11

Real

Aptamer SeqId: 9030-56 | Target: CQ089 | UniProt: A1L188

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9030-56 | Target: CQ089 | UniProt: A1L188 | TargetFullName: Uncharacterized protein C17orf89 | Organisim: human | Apparent_Kd_M: 1.007547E-11

Real

Aptamer SeqId:9032-30;Target:ROS1;UniProt:P08922

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9032-30;Target: ROS1;UniProt: P08922;TargetFullName: Proto-oncogene tyrosine-protein kinase ROS;Organisim: human;Apparent_Kd_M: 1.45594E-12

Real

Aptamer SeqId: 9032-30 | Target: ROS1 | UniProt: P08922

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9032-30 | Target: ROS1 | UniProt: P08922 | TargetFullName: Proto-oncogene tyrosine-protein kinase ROS | Organisim: human | Apparent_Kd_M: 1.45594E-12

Real

Aptamer SeqId:9035-2;Target:MXI1;UniProt:P50539

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9035-2;Target: MXI1;UniProt: P50539;TargetFullName: MAX-interacting protein 1;Organisim: human;Apparent_Kd_M: 1.094203E-11

Real

Aptamer SeqId: 9035-2 | Target: MXI1 | UniProt: P50539

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9035-2 | Target: MXI1 | UniProt: P50539 | TargetFullName: MAX-interacting protein 1 | Organisim: human | Apparent_Kd_M: 1.094203E-11

Real

Aptamer SeqId:9037-1;Target:STX18;UniProt:Q9P2W9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9037-1;Target: STX18;UniProt: Q9P2W9;TargetFullName: Syntaxin-18;Organisim: human;Apparent_Kd_M: 7.431641E-11

Real

Aptamer SeqId: 9037-1 | Target: STX18 | UniProt: Q9P2W9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9037-1 | Target: STX18 | UniProt: Q9P2W9 | TargetFullName: Syntaxin-18 | Organisim: human | Apparent_Kd_M: 7.431641E-11

Real

Aptamer SeqId:9038-12;Target:JTB;UniProt:O76095

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9038-12;Target: JTB;UniProt: O76095;TargetFullName: Protein JTB;Organisim: human;Apparent_Kd_M: 5.751648E-12

Real

Aptamer SeqId: 9038-12 | Target: JTB | UniProt: O76095

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9038-12 | Target: JTB | UniProt: O76095 | TargetFullName: Protein JTB | Organisim: human | Apparent_Kd_M: 5.751648E-12

Real

Aptamer SeqId:9039-47;Target:TOIP1;UniProt:Q5JTV8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9039-47;Target: TOIP1;UniProt: Q5JTV8;TargetFullName: Torsin-1A-interacting protein 1;Organisim: human;Apparent_Kd_M: 2.75E-11

Real

Aptamer SeqId: 9039-47 | Target: TOIP1 | UniProt: Q5JTV8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9039-47 | Target: TOIP1 | UniProt: Q5JTV8 | TargetFullName: Torsin-1A-interacting protein 1 | Organisim: human | Apparent_Kd_M: 2.75E-11

Real

Aptamer SeqId:9040-144;Target:EPDR1;UniProt:Q9UM22

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9040-144;Target: EPDR1;UniProt: Q9UM22;TargetFullName: Mammalian ependymin-related protein 1;Organisim: human;Apparent_Kd_M: 1.852025E-10

Real

Aptamer SeqId: 9040-144 | Target: EPDR1 | UniProt: Q9UM22

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9040-144 | Target: EPDR1 | UniProt: Q9UM22 | TargetFullName: Mammalian ependymin-related protein 1 | Organisim: human | Apparent_Kd_M: 1.852025E-10

Real

Aptamer SeqId:9043-7;Target:TFP11;UniProt:Q9UBB9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9043-7;Target: TFP11;UniProt: Q9UBB9;TargetFullName: Tuftelin-interacting protein 11;Organisim: human;Apparent_Kd_M: 7.634652E-12

Real

Aptamer SeqId: 9043-7 | Target: TFP11 | UniProt: Q9UBB9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9043-7 | Target: TFP11 | UniProt: Q9UBB9 | TargetFullName: Tuftelin-interacting protein 11 | Organisim: human | Apparent_Kd_M: 7.634652E-12

Real

Aptamer SeqId:9044-1;Target:CNTP5;UniProt:Q8WYK1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9044-1;Target: CNTP5;UniProt: Q8WYK1;TargetFullName: Contactin-associated protein-like 5;Organisim: human;Apparent_Kd_M: 9.303757E-12

Real

Aptamer SeqId: 9044-1 | Target: CNTP5 | UniProt: Q8WYK1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9044-1 | Target: CNTP5 | UniProt: Q8WYK1 | TargetFullName: Contactin-associated protein-like 5 | Organisim: human | Apparent_Kd_M: 9.303757E-12

Real

Aptamer SeqId:9045-3;Target:S27A2;UniProt:O14975

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9045-3;Target: S27A2;UniProt: O14975;TargetFullName: Very long-chain acyl-CoA synthetase;Organisim: human;Apparent_Kd_M: 1.411928E-11

Real

Aptamer SeqId: 9045-3 | Target: S27A2 | UniProt: O14975

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9045-3 | Target: S27A2 | UniProt: O14975 | TargetFullName: Very long-chain acyl-CoA synthetase | Organisim: human | Apparent_Kd_M: 1.411928E-11

Real

Aptamer SeqId:9046-46;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9046-46;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 9.68E-13

Real

Aptamer SeqId: 9046-46 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9046-46 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 9.68E-13

Real

Aptamer SeqId:9049-2;Target:MOT4;UniProt:O15427

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9049-2;Target: MOT4;UniProt: O15427;TargetFullName: Monocarboxylate transporter 4;Organisim: human;Apparent_Kd_M: 1.786768E-11

Real

Aptamer SeqId: 9049-2 | Target: MOT4 | UniProt: O15427

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9049-2 | Target: MOT4 | UniProt: O15427 | TargetFullName: Monocarboxylate transporter 4 | Organisim: human | Apparent_Kd_M: 1.786768E-11

Real

Aptamer SeqId:9050-170;Target:CA063;UniProt:Q9BUV0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9050-170;Target: CA063;UniProt: Q9BUV0;TargetFullName: Arginine/serine-rich protein 1;Organisim: human;Apparent_Kd_M: 1.36672E-11

Real

Aptamer SeqId: 9050-170 | Target: CA063 | UniProt: Q9BUV0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9050-170 | Target: CA063 | UniProt: Q9BUV0 | TargetFullName: Arginine/serine-rich protein 1 | Organisim: human | Apparent_Kd_M: 1.36672E-11

Real

Aptamer SeqId:9051-13;Target:IL32;UniProt:P24001

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9051-13;Target: IL32;UniProt: P24001;TargetFullName: Interleukin-32;Organisim: human;Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId: 9051-13 | Target: IL32 | UniProt: P24001

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9051-13 | Target: IL32 | UniProt: P24001 | TargetFullName: Interleukin-32 | Organisim: human | Apparent_Kd_M: 1.62E-11

Real

Aptamer SeqId:9053-16;Target:CRIP2;UniProt:P52943

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9053-16;Target: CRIP2;UniProt: P52943;TargetFullName: Cysteine-rich protein 2;Organisim: human;Apparent_Kd_M: 8.812649E-11

Real

Aptamer SeqId: 9053-16 | Target: CRIP2 | UniProt: P52943

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9053-16 | Target: CRIP2 | UniProt: P52943 | TargetFullName: Cysteine-rich protein 2 | Organisim: human | Apparent_Kd_M: 8.812649E-11

Real

Aptamer SeqId:9054-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9054-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.245978E-12

Real

Aptamer SeqId: 9054-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9054-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.245978E-12

Real

Aptamer SeqId:9055-81;Target:MYZAP;UniProt:P0CAP1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9055-81;Target: MYZAP;UniProt: P0CAP1;TargetFullName: Myocardial zonula adherens protein;Organisim: human;Apparent_Kd_M: 6.12E-12

Real

Aptamer SeqId: 9055-81 | Target: MYZAP | UniProt: P0CAP1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9055-81 | Target: MYZAP | UniProt: P0CAP1 | TargetFullName: Myocardial zonula adherens protein | Organisim: human | Apparent_Kd_M: 6.12E-12

Real

Aptamer SeqId:9057-19;Target:ADRM1;UniProt:Q16186

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9057-19;Target: ADRM1;UniProt: Q16186;TargetFullName: Proteasomal ubiquitin receptor ADRM1;Organisim: human;Apparent_Kd_M: 5.415682E-11

Real

Aptamer SeqId: 9057-19 | Target: ADRM1 | UniProt: Q16186

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9057-19 | Target: ADRM1 | UniProt: Q16186 | TargetFullName: Proteasomal ubiquitin receptor ADRM1 | Organisim: human | Apparent_Kd_M: 5.415682E-11

Real

Aptamer SeqId:9058-1;Target:TIM21;UniProt:Q9BVV7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9058-1;Target: TIM21;UniProt: Q9BVV7;TargetFullName: Mitochondrial import inner membrane translocase subunit Tim21;Organisim: human;Apparent_Kd_M: 4.528955E-12

Real

Aptamer SeqId: 9058-1 | Target: TIM21 | UniProt: Q9BVV7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9058-1 | Target: TIM21 | UniProt: Q9BVV7 | TargetFullName: Mitochondrial import inner membrane translocase subunit Tim21 | Organisim: human | Apparent_Kd_M: 4.528955E-12

Real

Aptamer SeqId:9059-14;Target:RPGF5;UniProt:Q92565

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9059-14;Target: RPGF5;UniProt: Q92565;TargetFullName: Rap guanine nucleotide exchange factor 5;Organisim: human;Apparent_Kd_M: 8.734675E-11

Real

Aptamer SeqId: 9059-14 | Target: RPGF5 | UniProt: Q92565

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9059-14 | Target: RPGF5 | UniProt: Q92565 | TargetFullName: Rap guanine nucleotide exchange factor 5 | Organisim: human | Apparent_Kd_M: 8.734675E-11

Real

Aptamer SeqId:9060-27;Target:TUTLB;UniProt:Q9UPX0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9060-27;Target: TUTLB;UniProt: Q9UPX0;TargetFullName: Protein turtle homolog B;Organisim: human;Apparent_Kd_M: 1.75571E-11

Real

Aptamer SeqId: 9060-27 | Target: TUTLB | UniProt: Q9UPX0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9060-27 | Target: TUTLB | UniProt: Q9UPX0 | TargetFullName: Protein turtle homolog B | Organisim: human | Apparent_Kd_M: 1.75571E-11

Real

Aptamer SeqId:9061-3;Target:ARHGA;UniProt:O15013

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9061-3;Target: ARHGA;UniProt: O15013;TargetFullName: Rho guanine nucleotide exchange factor 10;Organisim: human;Apparent_Kd_M: 2.381391E-11

Real

Aptamer SeqId: 9061-3 | Target: ARHGA | UniProt: O15013

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9061-3 | Target: ARHGA | UniProt: O15013 | TargetFullName: Rho guanine nucleotide exchange factor 10 | Organisim: human | Apparent_Kd_M: 2.381391E-11

Real

Aptamer SeqId:9063-9;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9063-9;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.26E-11

Real

Aptamer SeqId: 9063-9 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9063-9 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.26E-11

Real

Aptamer SeqId:9064-12;Target:RN215;UniProt:Q9Y6U7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9064-12;Target: RN215;UniProt: Q9Y6U7;TargetFullName: RING finger protein 215;Organisim: human;Apparent_Kd_M: 1.94E-10

Real

Aptamer SeqId: 9064-12 | Target: RN215 | UniProt: Q9Y6U7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9064-12 | Target: RN215 | UniProt: Q9Y6U7 | TargetFullName: RING finger protein 215 | Organisim: human | Apparent_Kd_M: 1.94E-10

Real

Aptamer SeqId:9067-152;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9067-152;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.86E-12

Real

Aptamer SeqId: 9067-152 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9067-152 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.86E-12

Real

Aptamer SeqId:9068-17;Target:JKIP3;UniProt:Q5VZ66

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9068-17;Target: JKIP3;UniProt: Q5VZ66;TargetFullName: Janus kinase and microtubule-interacting protein 3;Organisim: human;Apparent_Kd_M: 2.866844E-11

Real

Aptamer SeqId: 9068-17 | Target: JKIP3 | UniProt: Q5VZ66

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9068-17 | Target: JKIP3 | UniProt: Q5VZ66 | TargetFullName: Janus kinase and microtubule-interacting protein 3 | Organisim: human | Apparent_Kd_M: 2.866844E-11

Real

Aptamer SeqId:9070-1;Target:CQ067;UniProt:Q0P5P2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9070-1;Target: CQ067;UniProt: Q0P5P2;TargetFullName: Uncharacterized protein C17orf67;Organisim: human;Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId: 9070-1 | Target: CQ067 | UniProt: Q0P5P2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9070-1 | Target: CQ067 | UniProt: Q0P5P2 | TargetFullName: Uncharacterized protein C17orf67 | Organisim: human | Apparent_Kd_M: 1.08E-11

Real

Aptamer SeqId:9073-35;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9073-35;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.545875E-11

Real

Aptamer SeqId: 9073-35 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9073-35 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.545875E-11

Real

Aptamer SeqId:9074-6;Target:CE004;UniProt:Q96IV6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9074-6;Target: CE004;UniProt: Q96IV6;TargetFullName: Fatty acid hydroxylase domain-containing protein 2;Organisim: human;Apparent_Kd_M: 3.015646E-10

Real

Aptamer SeqId: 9074-6 | Target: CE004 | UniProt: Q96IV6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9074-6 | Target: CE004 | UniProt: Q96IV6 | TargetFullName: Fatty acid hydroxylase domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 3.015646E-10

Real

Aptamer SeqId:9075-121;Target:K1024;UniProt:Q9UPX6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9075-121;Target: K1024;UniProt: Q9UPX6;TargetFullName: UPF0258 protein KIAA1024;Organisim: human;Apparent_Kd_M: 5.11069E-11

Real

Aptamer SeqId: 9075-121 | Target: K1024 | UniProt: Q9UPX6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9075-121 | Target: K1024 | UniProt: Q9UPX6 | TargetFullName: UPF0258 protein KIAA1024 | Organisim: human | Apparent_Kd_M: 5.11069E-11

Real

Aptamer SeqId:9076-25;Target:PENK;UniProt:P01210

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9076-25;Target: PENK;UniProt: P01210;TargetFullName: Proenkephalin-A;Organisim: human;Apparent_Kd_M: 3.741179E-12

Real

Aptamer SeqId: 9076-25 | Target: PENK | UniProt: P01210

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9076-25 | Target: PENK | UniProt: P01210 | TargetFullName: Proenkephalin-A | Organisim: human | Apparent_Kd_M: 3.741179E-12

Real

Aptamer SeqId:9077-10;Target:MA1A2;UniProt:O60476

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9077-10;Target: MA1A2;UniProt: O60476;TargetFullName: Mannosyl-oligosaccharide 1;2-alpha-mannosidase IB;Organisim: human;Apparent_Kd_M: 4.354173E-12

Real

Aptamer SeqId: 9077-10 | Target: MA1A2 | UniProt: O60476

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9077-10 | Target: MA1A2 | UniProt: O60476 | TargetFullName: Mannosyl-oligosaccharide 1;2-alpha-mannosidase IB | Organisim: human | Apparent_Kd_M: 4.354173E-12

Real

Aptamer SeqId:9078-207;Target:SNTB1;UniProt:Q13884

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9078-207;Target: SNTB1;UniProt: Q13884;TargetFullName: Beta-1-syntrophin;Organisim: human;Apparent_Kd_M: 2.460806E-10

Real

Aptamer SeqId: 9078-207 | Target: SNTB1 | UniProt: Q13884

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9078-207 | Target: SNTB1 | UniProt: Q13884 | TargetFullName: Beta-1-syntrophin | Organisim: human | Apparent_Kd_M: 2.460806E-10

Real

Aptamer SeqId:9080-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9080-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.86E-11

Real

Aptamer SeqId: 9080-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9080-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.86E-11

Real

Aptamer SeqId:9081-39;Target:ZNT3;UniProt:Q99726

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9081-39;Target: ZNT3;UniProt: Q99726;TargetFullName: Zinc transporter 3;Organisim: human;Apparent_Kd_M: 1.271315E-10

Real

Aptamer SeqId: 9081-39 | Target: ZNT3 | UniProt: Q99726

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9081-39 | Target: ZNT3 | UniProt: Q99726 | TargetFullName: Zinc transporter 3 | Organisim: human | Apparent_Kd_M: 1.271315E-10

Real

Aptamer SeqId:9082-25;Target:SE1L2;UniProt:Q5TEA6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9082-25;Target: SE1L2;UniProt: Q5TEA6;TargetFullName: Protein sel-1 homolog 2;Organisim: human;Apparent_Kd_M: 1.828958E-10

Real

Aptamer SeqId: 9082-25 | Target: SE1L2 | UniProt: Q5TEA6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9082-25 | Target: SE1L2 | UniProt: Q5TEA6 | TargetFullName: Protein sel-1 homolog 2 | Organisim: human | Apparent_Kd_M: 1.828958E-10

Real

Aptamer SeqId:9087-8;Target:NHLC3;UniProt:Q5JS37

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9087-8;Target: NHLC3;UniProt: Q5JS37;TargetFullName: NHL repeat-containing protein 3;Organisim: human;Apparent_Kd_M: 3.536141E-11

Real

Aptamer SeqId: 9087-8 | Target: NHLC3 | UniProt: Q5JS37

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9087-8 | Target: NHLC3 | UniProt: Q5JS37 | TargetFullName: NHL repeat-containing protein 3 | Organisim: human | Apparent_Kd_M: 3.536141E-11

Real

Aptamer SeqId:9088-20;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9088-20;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.030379E-11

Real

Aptamer SeqId: 9088-20 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9088-20 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.030379E-11

Real

Aptamer SeqId:9089-77;Target:JPH3;UniProt:Q8WXH2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9089-77;Target: JPH3;UniProt: Q8WXH2;TargetFullName: Junctophilin-3;Organisim: human;Apparent_Kd_M: 6.249853E-11

Real

Aptamer SeqId: 9089-77 | Target: JPH3 | UniProt: Q8WXH2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9089-77 | Target: JPH3 | UniProt: Q8WXH2 | TargetFullName: Junctophilin-3 | Organisim: human | Apparent_Kd_M: 6.249853E-11

Real

Aptamer SeqId:9090-9;Target:SYTL4;UniProt:Q96C24

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9090-9;Target: SYTL4;UniProt: Q96C24;TargetFullName: Synaptotagmin-like protein 4;Organisim: human;Apparent_Kd_M: 9.9E-12

Real

Aptamer SeqId: 9090-9 | Target: SYTL4 | UniProt: Q96C24

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9090-9 | Target: SYTL4 | UniProt: Q96C24 | TargetFullName: Synaptotagmin-like protein 4 | Organisim: human | Apparent_Kd_M: 9.9E-12

Real

Aptamer SeqId:9092-33;Target:ANGL1;UniProt:O95841

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9092-33;Target: ANGL1;UniProt: O95841;TargetFullName: Angiopoietin-related protein 1;Organisim: human;Apparent_Kd_M: 8.9E-11

Real

Aptamer SeqId: 9092-33 | Target: ANGL1 | UniProt: O95841

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9092-33 | Target: ANGL1 | UniProt: O95841 | TargetFullName: Angiopoietin-related protein 1 | Organisim: human | Apparent_Kd_M: 8.9E-11

Real

Aptamer SeqId:9094-5;Target:CLC4C;UniProt:Q8WTT0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9094-5;Target: CLC4C;UniProt: Q8WTT0;TargetFullName: C-type lectin domain family 4 member C;Organisim: human;Apparent_Kd_M: 9.951627E-12

Real

Aptamer SeqId: 9094-5 | Target: CLC4C | UniProt: Q8WTT0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9094-5 | Target: CLC4C | UniProt: Q8WTT0 | TargetFullName: C-type lectin domain family 4 member C | Organisim: human | Apparent_Kd_M: 9.951627E-12

Real

Aptamer SeqId:9095-5;Target:MTFR1;UniProt:Q15390

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9095-5;Target: MTFR1;UniProt: Q15390;TargetFullName: Mitochondrial fission regulator 1;Organisim: human;Apparent_Kd_M: 3.477547E-11

Real

Aptamer SeqId: 9095-5 | Target: MTFR1 | UniProt: Q15390

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9095-5 | Target: MTFR1 | UniProt: Q15390 | TargetFullName: Mitochondrial fission regulator 1 | Organisim: human | Apparent_Kd_M: 3.477547E-11

Real

Aptamer SeqId:9097-5;Target:K1324;UniProt:Q6UXG2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9097-5;Target: K1324;UniProt: Q6UXG2;TargetFullName: UPF0577 protein KIAA1324;Organisim: human;Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId: 9097-5 | Target: K1324 | UniProt: Q6UXG2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9097-5 | Target: K1324 | UniProt: Q6UXG2 | TargetFullName: UPF0577 protein KIAA1324 | Organisim: human | Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId:9099-19;Target:SYT5;UniProt:O00445

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9099-19;Target: SYT5;UniProt: O00445;TargetFullName: Synaptotagmin-5;Organisim: human;Apparent_Kd_M: 7.706502E-11

Real

Aptamer SeqId: 9099-19 | Target: SYT5 | UniProt: O00445

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9099-19 | Target: SYT5 | UniProt: O00445 | TargetFullName: Synaptotagmin-5 | Organisim: human | Apparent_Kd_M: 7.706502E-11

Real

Aptamer SeqId:9100-32;Target:CE046;UniProt:Q6UWT4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9100-32;Target: CE046;UniProt: Q6UWT4;TargetFullName: Uncharacterized protein C5orf46;Organisim: human;Apparent_Kd_M: 1.566704E-10

Real

Aptamer SeqId: 9100-32 | Target: CE046 | UniProt: Q6UWT4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9100-32 | Target: CE046 | UniProt: Q6UWT4 | TargetFullName: Uncharacterized protein C5orf46 | Organisim: human | Apparent_Kd_M: 1.566704E-10

Real

Aptamer SeqId:9102-28;Target:ZFY27;UniProt:Q5T4F4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9102-28;Target: ZFY27;UniProt: Q5T4F4;TargetFullName: Protrudin;Organisim: human;Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId: 9102-28 | Target: ZFY27 | UniProt: Q5T4F4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9102-28 | Target: ZFY27 | UniProt: Q5T4F4 | TargetFullName: Protrudin | Organisim: human | Apparent_Kd_M: 1.5E-11

Real

Aptamer SeqId:9106-87;Target:LYSM4;UniProt:Q5XG99

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9106-87;Target: LYSM4;UniProt: Q5XG99;TargetFullName: LysM and putative peptidoglycan-binding domain-containing protein 4;Organisim: human;Apparent_Kd_M: 2.29579E-11

Real

Aptamer SeqId: 9106-87 | Target: LYSM4 | UniProt: Q5XG99

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9106-87 | Target: LYSM4 | UniProt: Q5XG99 | TargetFullName: LysM and putative peptidoglycan-binding domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 2.29579E-11

Real

Aptamer SeqId:9107-59;Target:ARM10;UniProt:Q8N2F6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9107-59;Target: ARM10;UniProt: Q8N2F6;TargetFullName: Armadillo repeat-containing protein 10;Organisim: human;Apparent_Kd_M: 2.123994E-10

Real

Aptamer SeqId: 9107-59 | Target: ARM10 | UniProt: Q8N2F6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9107-59 | Target: ARM10 | UniProt: Q8N2F6 | TargetFullName: Armadillo repeat-containing protein 10 | Organisim: human | Apparent_Kd_M: 2.123994E-10

Real

Aptamer SeqId:9108-48;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9108-48;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.609323E-13

Real

Aptamer SeqId: 9108-48 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9108-48 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.609323E-13

Real

Aptamer SeqId:9110-2;Target:SYT17;UniProt:Q9BSW7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9110-2;Target: SYT17;UniProt: Q9BSW7;TargetFullName: Synaptotagmin-17;Organisim: human;Apparent_Kd_M: 8.364912E-11

Real

Aptamer SeqId: 9110-2 | Target: SYT17 | UniProt: Q9BSW7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9110-2 | Target: SYT17 | UniProt: Q9BSW7 | TargetFullName: Synaptotagmin-17 | Organisim: human | Apparent_Kd_M: 8.364912E-11

Real

Aptamer SeqId:9111-40;Target:JPH4;UniProt:Q96JJ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9111-40;Target: JPH4;UniProt: Q96JJ6;TargetFullName: Junctophilin-4;Organisim: human;Apparent_Kd_M: 1.793929E-10

Real

Aptamer SeqId: 9111-40 | Target: JPH4 | UniProt: Q96JJ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9111-40 | Target: JPH4 | UniProt: Q96JJ6 | TargetFullName: Junctophilin-4 | Organisim: human | Apparent_Kd_M: 1.793929E-10

Real

Aptamer SeqId:9114-84;Target:UROL1;UniProt:Q5DID0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9114-84;Target: UROL1;UniProt: Q5DID0;TargetFullName: Uromodulin-like 1;Organisim: human;Apparent_Kd_M: 8.131073E-12

Real

Aptamer SeqId: 9114-84 | Target: UROL1 | UniProt: Q5DID0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9114-84 | Target: UROL1 | UniProt: Q5DID0 | TargetFullName: Uromodulin-like 1 | Organisim: human | Apparent_Kd_M: 8.131073E-12

Real

Aptamer SeqId:9115-78;Target:ADEC1;UniProt:O15204

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9115-78;Target: ADEC1;UniProt: O15204;TargetFullName: ADAM DEC1;Organisim: human;Apparent_Kd_M: 2.967875E-10

Real

Aptamer SeqId: 9115-78 | Target: ADEC1 | UniProt: O15204

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9115-78 | Target: ADEC1 | UniProt: O15204 | TargetFullName: ADAM DEC1 | Organisim: human | Apparent_Kd_M: 2.967875E-10

Real

Aptamer SeqId:9116-28;Target:HECA2;UniProt:A8MVW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9116-28;Target: HECA2;UniProt: A8MVW5;TargetFullName: HEPACAM family member 2;Organisim: human;Apparent_Kd_M: 1.38E-11

Real

Aptamer SeqId: 9116-28 | Target: HECA2 | UniProt: A8MVW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9116-28 | Target: HECA2 | UniProt: A8MVW5 | TargetFullName: HEPACAM family member 2 | Organisim: human | Apparent_Kd_M: 1.38E-11

Real

Aptamer SeqId:9117-4;Target:IL-1F9;UniProt:Q9NZH8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9117-4;Target: IL-1F9;UniProt: Q9NZH8;TargetFullName: Interleukin-36 gamma;Organisim: human;Apparent_Kd_M: 3.52526E-11

Real

Aptamer SeqId: 9117-4 | Target: IL-1F9 | UniProt: Q9NZH8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9117-4 | Target: IL-1F9 | UniProt: Q9NZH8 | TargetFullName: Interleukin-36 gamma | Organisim: human | Apparent_Kd_M: 3.52526E-11

Real

Aptamer SeqId:9118-7;Target:PSD2;UniProt:Q9BQI7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9118-7;Target: PSD2;UniProt: Q9BQI7;TargetFullName: PH and SEC7 domain-containing protein 2;Organisim: human;Apparent_Kd_M: 4.372099E-11

Real

Aptamer SeqId: 9118-7 | Target: PSD2 | UniProt: Q9BQI7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9118-7 | Target: PSD2 | UniProt: Q9BQI7 | TargetFullName: PH and SEC7 domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 4.372099E-11

Real

Aptamer SeqId:9121-28;Target:FUT2;UniProt:Q10981

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9121-28;Target: FUT2;UniProt: Q10981;TargetFullName: Galactoside 2-alpha-L-fucosyltransferase 2;Organisim: human;Apparent_Kd_M: 1.413621E-10

Real

Aptamer SeqId: 9121-28 | Target: FUT2 | UniProt: Q10981

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9121-28 | Target: FUT2 | UniProt: Q10981 | TargetFullName: Galactoside 2-alpha-L-fucosyltransferase 2 | Organisim: human | Apparent_Kd_M: 1.413621E-10

Real

Aptamer SeqId:9122-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9122-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.603303E-11

Real

Aptamer SeqId: 9122-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9122-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.603303E-11

Real

Aptamer SeqId:9123-18;Target:DOS;UniProt:Q8N350

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9123-18;Target: DOS;UniProt: Q8N350;TargetFullName: Protein Dos;Organisim: human;Apparent_Kd_M: 1.08496E-10

Real

Aptamer SeqId: 9123-18 | Target: DOS | UniProt: Q8N350

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9123-18 | Target: DOS | UniProt: Q8N350 | TargetFullName: Protein Dos | Organisim: human | Apparent_Kd_M: 1.08496E-10

Real

Aptamer SeqId:9125-23;Target:MASP3;UniProt:P48740

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9125-23;Target: MASP3;UniProt: P48740;TargetFullName: Mannan-binding lectin serine protease 1;Organisim: human;Apparent_Kd_M: 5.58E-11

Real

Aptamer SeqId: 9125-23 | Target: MASP3 | UniProt: P48740

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9125-23 | Target: MASP3 | UniProt: P48740 | TargetFullName: Mannan-binding lectin serine protease 1 | Organisim: human | Apparent_Kd_M: 5.58E-11

Real

Aptamer SeqId:9126-171;Target:NT5D3;UniProt:Q86UY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9126-171;Target: NT5D3;UniProt: Q86UY8;TargetFullName: 5-nucleotidase domain-containing protein 3;Organisim: human;Apparent_Kd_M: 9.567969E-11

Real

Aptamer SeqId: 9126-171 | Target: NT5D3 | UniProt: Q86UY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9126-171 | Target: NT5D3 | UniProt: Q86UY8 | TargetFullName: 5'-nucleotidase domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 9.567969E-11

Real

Aptamer SeqId:9127-4;Target:S26A5;UniProt:P58743

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9127-4;Target: S26A5;UniProt: P58743;TargetFullName: Prestin;Organisim: human;Apparent_Kd_M: 2.430013E-11

Real

Aptamer SeqId: 9127-4 | Target: S26A5 | UniProt: P58743

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9127-4 | Target: S26A5 | UniProt: P58743 | TargetFullName: Prestin | Organisim: human | Apparent_Kd_M: 2.430013E-11

Real

Aptamer SeqId:9128-34;Target:FLRT3;UniProt:Q9NZU0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9128-34;Target: FLRT3;UniProt: Q9NZU0;TargetFullName: Leucine-rich repeat transmembrane protein FLRT3;Organisim: human;Apparent_Kd_M: 5.03E-11

Real

Aptamer SeqId: 9128-34 | Target: FLRT3 | UniProt: Q9NZU0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9128-34 | Target: FLRT3 | UniProt: Q9NZU0 | TargetFullName: Leucine-rich repeat transmembrane protein FLRT3 | Organisim: human | Apparent_Kd_M: 5.03E-11

Real

Aptamer SeqId:9168-31;Target:Eotaxin-3;UniProt:Q9Y258

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9168-31;Target: Eotaxin-3;UniProt: Q9Y258;TargetFullName: C-C motif chemokine 26;Organisim: human;Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId: 9168-31 | Target: Eotaxin-3 | UniProt: Q9Y258

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9168-31 | Target: Eotaxin-3 | UniProt: Q9Y258 | TargetFullName: C-C motif chemokine 26 | Organisim: human | Apparent_Kd_M: 2.34E-12

Real

Aptamer SeqId:9170-24;Target:IL-17;UniProt:Q16552

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9170-24;Target: IL-17;UniProt: Q16552;TargetFullName: Interleukin-17A;Organisim: human;Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId: 9170-24 | Target: IL-17 | UniProt: Q16552

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9170-24 | Target: IL-17 | UniProt: Q16552 | TargetFullName: Interleukin-17A | Organisim: human | Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId:9171-11;Target:CSRP3;UniProt:P50461

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9171-11;Target: CSRP3;UniProt: P50461;TargetFullName: Cysteine and glycine-rich protein 3;Organisim: human;Apparent_Kd_M: 1.9E-11

Real

Aptamer SeqId: 9171-11 | Target: CSRP3 | UniProt: P50461

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9171-11 | Target: CSRP3 | UniProt: P50461 | TargetFullName: Cysteine and glycine-rich protein 3 | Organisim: human | Apparent_Kd_M: 1.9E-11

Real

Aptamer SeqId:9172-69;Target:MMP-8;UniProt:P22894

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9172-69;Target: MMP-8;UniProt: P22894;TargetFullName: Neutrophil collagenase;Organisim: human;Apparent_Kd_M: 3.51E-12

Real

Aptamer SeqId: 9172-69 | Target: MMP-8 | UniProt: P22894

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9172-69 | Target: MMP-8 | UniProt: P22894 | TargetFullName: Neutrophil collagenase | Organisim: human | Apparent_Kd_M: 3.51E-12

Real

Aptamer SeqId:9173-21;Target:PGM1;UniProt:P36871

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9173-21;Target: PGM1;UniProt: P36871;TargetFullName: Phosphoglucomutase-1;Organisim: human;Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId: 9173-21 | Target: PGM1 | UniProt: P36871

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9173-21 | Target: PGM1 | UniProt: P36871 | TargetFullName: Phosphoglucomutase-1 | Organisim: human | Apparent_Kd_M: 1.68E-11

Real

Aptamer SeqId:9175-48;Target:DSCAM;UniProt:O60469

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9175-48;Target: DSCAM;UniProt: O60469;TargetFullName: Down syndrome cell adhesion molecule;Organisim: human;Apparent_Kd_M: 3.01E-12

Real

Aptamer SeqId: 9175-48 | Target: DSCAM | UniProt: O60469

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9175-48 | Target: DSCAM | UniProt: O60469 | TargetFullName: Down syndrome cell adhesion molecule | Organisim: human | Apparent_Kd_M: 3.01E-12

Real

Aptamer SeqId:9176-3;Target:MUC1;UniProt:P15941

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9176-3;Target: MUC1;UniProt: P15941;TargetFullName: Mucin-1;Organisim: human;Apparent_Kd_M: 6.28E-11

Real

Aptamer SeqId: 9176-3 | Target: MUC1 | UniProt: P15941

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9176-3 | Target: MUC1 | UniProt: P15941 | TargetFullName: Mucin-1 | Organisim: human | Apparent_Kd_M: 6.28E-11

Real

Aptamer SeqId:9177-6;Target:FAM3B;UniProt:P58499

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9177-6;Target: FAM3B;UniProt: P58499;TargetFullName: Protein FAM3B;Organisim: human;Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId: 9177-6 | Target: FAM3B | UniProt: P58499

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9177-6 | Target: FAM3B | UniProt: P58499 | TargetFullName: Protein FAM3B | Organisim: human | Apparent_Kd_M: 1.11E-11

Real

Aptamer SeqId:9178-30;Target:NEUREGULIN-1;UniProt:Q02297

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9178-30;Target: NEUREGULIN-1;UniProt: Q02297;TargetFullName: Neuregulin-1;Organisim: human;Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId: 9178-30 | Target: NEUREGULIN-1 | UniProt: Q02297

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9178-30 | Target: NEUREGULIN-1 | UniProt: Q02297 | TargetFullName: Neuregulin-1 | Organisim: human | Apparent_Kd_M: 1.74E-12

Real

Aptamer SeqId:9180-6;Target:INGR2;UniProt:P38484

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9180-6;Target: INGR2;UniProt: P38484;TargetFullName: Interferon gamma receptor 2;Organisim: human;Apparent_Kd_M: 9.7E-11

Real

Aptamer SeqId: 9180-6 | Target: INGR2 | UniProt: P38484

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9180-6 | Target: INGR2 | UniProt: P38484 | TargetFullName: Interferon gamma receptor 2 | Organisim: human | Apparent_Kd_M: 9.7E-11

Real

Aptamer SeqId:9182-3;Target:sLRP1;UniProt:Q07954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9182-3;Target: sLRP1;UniProt: Q07954;TargetFullName: Low-density lipoprotein receptor-related protein 1; soluble;Organisim: human;Apparent_Kd_M: 2.54E-11

Real

Aptamer SeqId: 9182-3 | Target: sLRP1 | UniProt: Q07954

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9182-3 | Target: sLRP1 | UniProt: Q07954 | TargetFullName: Low-density lipoprotein receptor-related protein 1; soluble | Organisim: human | Apparent_Kd_M: 2.54E-11

Real

Aptamer SeqId:9183-7;Target:IFN-a/b R1;UniProt:P17181

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9183-7;Target: IFN-a/b R1;UniProt: P17181;TargetFullName: Interferon alpha/beta receptor 1;Organisim: human;Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId: 9183-7 | Target: IFN-a/b R1 | UniProt: P17181

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9183-7 | Target: IFN-a/b R1 | UniProt: P17181 | TargetFullName: Interferon alpha/beta receptor 1 | Organisim: human | Apparent_Kd_M: 4.16E-11

Real

Aptamer SeqId:9185-15;Target:TFF1;UniProt:P04155

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9185-15;Target: TFF1;UniProt: P04155;TargetFullName: Trefoil factor 1;Organisim: human;Apparent_Kd_M: 1.96E-12

Real

Aptamer SeqId: 9185-15 | Target: TFF1 | UniProt: P04155

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9185-15 | Target: TFF1 | UniProt: P04155 | TargetFullName: Trefoil factor 1 | Organisim: human | Apparent_Kd_M: 1.96E-12

Real

Aptamer SeqId:9187-2;Target:HMGN1;UniProt:P05114

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9187-2;Target: HMGN1;UniProt: P05114;TargetFullName: Non-histone chromosomal protein HMG-14;Organisim: human;Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId: 9187-2 | Target: HMGN1 | UniProt: P05114

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9187-2 | Target: HMGN1 | UniProt: P05114 | TargetFullName: Non-histone chromosomal protein HMG-14 | Organisim: human | Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId:9188-119;Target:MIG;UniProt:Q07325

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9188-119;Target: MIG;UniProt: Q07325;TargetFullName: C-X-C motif chemokine 9;Organisim: human;Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId: 9188-119 | Target: MIG | UniProt: Q07325

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9188-119 | Target: MIG | UniProt: Q07325 | TargetFullName: C-X-C motif chemokine 9 | Organisim: human | Apparent_Kd_M: 1.0E-11

Real

Aptamer SeqId:9190-7;Target:CD63;UniProt:P08962

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9190-7;Target: CD63;UniProt: P08962;TargetFullName: CD63 antigen;Organisim: human;Apparent_Kd_M: 1.44E-12

Real

Aptamer SeqId: 9190-7 | Target: CD63 | UniProt: P08962

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9190-7 | Target: CD63 | UniProt: P08962 | TargetFullName: CD63 antigen | Organisim: human | Apparent_Kd_M: 1.44E-12

Real

Aptamer SeqId:9191-8;Target:Trefoil factor 2;UniProt:Q03403

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9191-8;Target: Trefoil factor 2;UniProt: Q03403;TargetFullName: Trefoil factor 2;Organisim: human;Apparent_Kd_M: 9.4E-12

Real

Aptamer SeqId: 9191-8 | Target: Trefoil factor 2 | UniProt: Q03403

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9191-8 | Target: Trefoil factor 2 | UniProt: Q03403 | TargetFullName: Trefoil factor 2 | Organisim: human | Apparent_Kd_M: 9.4E-12

Real

Aptamer SeqId:9196-8;Target:Galectin-7;UniProt:P47929

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9196-8;Target: Galectin-7;UniProt: P47929;TargetFullName: Galectin-7;Organisim: human;Apparent_Kd_M: 3.44E-11

Real

Aptamer SeqId: 9196-8 | Target: Galectin-7 | UniProt: P47929

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9196-8 | Target: Galectin-7 | UniProt: P47929 | TargetFullName: Galectin-7 | Organisim: human | Apparent_Kd_M: 3.44E-11

Real

Aptamer SeqId:9197-4;Target:LEG9;UniProt:O00182

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9197-4;Target: LEG9;UniProt: O00182;TargetFullName: Galectin-9;Organisim: human;Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId: 9197-4 | Target: LEG9 | UniProt: O00182

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9197-4 | Target: LEG9 | UniProt: O00182 | TargetFullName: Galectin-9 | Organisim: human | Apparent_Kd_M: 1.04E-11

Real

Aptamer SeqId:9199-6;Target:UB2G2;UniProt:P60604

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9199-6;Target: UB2G2;UniProt: P60604;TargetFullName: Ubiquitin-conjugating enzyme E2 G2;Organisim: human;Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId: 9199-6 | Target: UB2G2 | UniProt: P60604

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9199-6 | Target: UB2G2 | UniProt: P60604 | TargetFullName: Ubiquitin-conjugating enzyme E2 G2 | Organisim: human | Apparent_Kd_M: 1.82E-11

Real

Aptamer SeqId:9201-13;Target:Transgelin-2;UniProt:P37802

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9201-13;Target: Transgelin-2;UniProt: P37802;TargetFullName: Transgelin-2;Organisim: human;Apparent_Kd_M: 8.69E-11

Real

Aptamer SeqId: 9201-13 | Target: Transgelin-2 | UniProt: P37802

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9201-13 | Target: Transgelin-2 | UniProt: P37802 | TargetFullName: Transgelin-2 | Organisim: human | Apparent_Kd_M: 8.69E-11

Real

Aptamer SeqId:9202-309;Target:ATPO;UniProt:P48047

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9202-309;Target: ATPO;UniProt: P48047;TargetFullName: ATP synthase subunit O; mitochondrial;Organisim: human;Apparent_Kd_M: 3.51E-13

Real

Aptamer SeqId: 9202-309 | Target: ATPO | UniProt: P48047

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9202-309 | Target: ATPO | UniProt: P48047 | TargetFullName: ATP synthase subunit O; mitochondrial | Organisim: human | Apparent_Kd_M: 3.51E-13

Real

Aptamer SeqId:9204-33;Target:Corticotropin-lipotropin;UniProt:P01189

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9204-33;Target: Corticotropin-lipotropin;UniProt: P01189;TargetFullName: Pro-opiomelanocortin;Organisim: human;Apparent_Kd_M: 7.29E-12

Real

Aptamer SeqId: 9204-33 | Target: Corticotropin-lipotropin | UniProt: P01189

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9204-33 | Target: Corticotropin-lipotropin | UniProt: P01189 | TargetFullName: Pro-opiomelanocortin | Organisim: human | Apparent_Kd_M: 7.29E-12

Real

Aptamer SeqId:9207-60;Target:QORL1;UniProt:O95825

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9207-60;Target: QORL1;UniProt: O95825;TargetFullName: Quinone oxidoreductase-like protein 1;Organisim: human;Apparent_Kd_M: 2.77E-11

Real

Aptamer SeqId: 9207-60 | Target: QORL1 | UniProt: O95825

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9207-60 | Target: QORL1 | UniProt: O95825 | TargetFullName: Quinone oxidoreductase-like protein 1 | Organisim: human | Apparent_Kd_M: 2.77E-11

Real

Aptamer SeqId:9211-19;Target:PEDF;UniProt:P36955

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9211-19;Target: PEDF;UniProt: P36955;TargetFullName: Pigment epithelium-derived factor;Organisim: human;Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId: 9211-19 | Target: PEDF | UniProt: P36955

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9211-19 | Target: PEDF | UniProt: P36955 | TargetFullName: Pigment epithelium-derived factor | Organisim: human | Apparent_Kd_M: 1.71E-11

Real

Aptamer SeqId:9212-22;Target:CATF;UniProt:Q9UBX1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9212-22;Target: CATF;UniProt: Q9UBX1;TargetFullName: Cathepsin F;Organisim: human;Apparent_Kd_M: 1.4E-11

Real

Aptamer SeqId: 9212-22 | Target: CATF | UniProt: Q9UBX1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9212-22 | Target: CATF | UniProt: Q9UBX1 | TargetFullName: Cathepsin F | Organisim: human | Apparent_Kd_M: 1.4E-11

Real

Aptamer SeqId:9213-24;Target:FTCD;UniProt:O95954

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9213-24;Target: FTCD;UniProt: O95954;TargetFullName: Formimidoyltransferase-cyclodeaminase;Organisim: human;Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId: 9213-24 | Target: FTCD | UniProt: O95954

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9213-24 | Target: FTCD | UniProt: O95954 | TargetFullName: Formimidoyltransferase-cyclodeaminase | Organisim: human | Apparent_Kd_M: 2.71E-12

Real

Aptamer SeqId:9215-117;Target:UBP25;UniProt:Q9UHP3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9215-117;Target: UBP25;UniProt: Q9UHP3;TargetFullName: Ubiquitin carboxyl-terminal hydrolase 25;Organisim: human;Apparent_Kd_M: 6.69E-11

Real

Aptamer SeqId: 9215-117 | Target: UBP25 | UniProt: Q9UHP3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9215-117 | Target: UBP25 | UniProt: Q9UHP3 | TargetFullName: Ubiquitin carboxyl-terminal hydrolase 25 | Organisim: human | Apparent_Kd_M: 6.69E-11

Real

Aptamer SeqId:9216-100;Target:PLXB2;UniProt:O15031

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9216-100;Target: PLXB2;UniProt: O15031;TargetFullName: Plexin-B2;Organisim: human;Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId: 9216-100 | Target: PLXB2 | UniProt: O15031

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9216-100 | Target: PLXB2 | UniProt: O15031 | TargetFullName: Plexin-B2 | Organisim: human | Apparent_Kd_M: 3.62E-11

Real

Aptamer SeqId:9219-70;Target:NENF;UniProt:Q9UMX5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9219-70;Target: NENF;UniProt: Q9UMX5;TargetFullName: Neudesin;Organisim: human;Apparent_Kd_M: 3.465395E-11

Real

Aptamer SeqId: 9219-70 | Target: NENF | UniProt: Q9UMX5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9219-70 | Target: NENF | UniProt: Q9UMX5 | TargetFullName: Neudesin | Organisim: human | Apparent_Kd_M: 3.465395E-11

Real

Aptamer SeqId:9220-7;Target:EPHB3;UniProt:P54753

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9220-7;Target: EPHB3;UniProt: P54753;TargetFullName: Ephrin type-B receptor 3;Organisim: human;Apparent_Kd_M: 2.275568E-10

Real

Aptamer SeqId: 9220-7 | Target: EPHB3 | UniProt: P54753

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9220-7 | Target: EPHB3 | UniProt: P54753 | TargetFullName: Ephrin type-B receptor 3 | Organisim: human | Apparent_Kd_M: 2.275568E-10

Real

Aptamer SeqId:9221-6;Target:IPIL1;UniProt:Q6GPH6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9221-6;Target: IPIL1;UniProt: Q6GPH6;TargetFullName: Inositol 1;4;5-trisphosphate receptor-interacting protein-like 1;Organisim: human;Apparent_Kd_M: 1.750415E-11

Real

Aptamer SeqId: 9221-6 | Target: IPIL1 | UniProt: Q6GPH6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9221-6 | Target: IPIL1 | UniProt: Q6GPH6 | TargetFullName: Inositol 1;4;5-trisphosphate receptor-interacting protein-like 1 | Organisim: human | Apparent_Kd_M: 1.750415E-11

Real

Aptamer SeqId:9223-11;Target:ARMET;UniProt:P55145

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9223-11;Target: ARMET;UniProt: P55145;TargetFullName: Mesencephalic astrocyte-derived neurotrophic factor;Organisim: human;Apparent_Kd_M: 1.182797E-11

Real

Aptamer SeqId: 9223-11 | Target: ARMET | UniProt: P55145

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9223-11 | Target: ARMET | UniProt: P55145 | TargetFullName: Mesencephalic astrocyte-derived neurotrophic factor | Organisim: human | Apparent_Kd_M: 1.182797E-11

Real

Aptamer SeqId:9226-6;Target:TMUB2;UniProt:Q71RG4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9226-6;Target: TMUB2;UniProt: Q71RG4;TargetFullName: Transmembrane and ubiquitin-like domain-containing protein 2;Organisim: human;Apparent_Kd_M: 2.951953E-11

Real

Aptamer SeqId: 9226-6 | Target: TMUB2 | UniProt: Q71RG4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9226-6 | Target: TMUB2 | UniProt: Q71RG4 | TargetFullName: Transmembrane and ubiquitin-like domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 2.951953E-11

Real

Aptamer SeqId:9229-9;Target:CTRL;UniProt:P40313

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9229-9;Target: CTRL;UniProt: P40313;TargetFullName: Chymotrypsin-like protease CTRL-1;Organisim: human;Apparent_Kd_M: 5.143201E-11

Real

Aptamer SeqId: 9229-9 | Target: CTRL | UniProt: P40313

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9229-9 | Target: CTRL | UniProt: P40313 | TargetFullName: Chymotrypsin-like protease CTRL-1 | Organisim: human | Apparent_Kd_M: 5.143201E-11

Real

Aptamer SeqId:9231-23;Target:IMPA3;UniProt:Q9NX62

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9231-23;Target: IMPA3;UniProt: Q9NX62;TargetFullName: Inositol monophosphatase 3;Organisim: human;Apparent_Kd_M: 2.930909E-11

Real

Aptamer SeqId: 9231-23 | Target: IMPA3 | UniProt: Q9NX62

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9231-23 | Target: IMPA3 | UniProt: Q9NX62 | TargetFullName: Inositol monophosphatase 3 | Organisim: human | Apparent_Kd_M: 2.930909E-11

Real

Aptamer SeqId:9233-71;Target:TFPI -2;UniProt:P48307

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9233-71;Target: TFPI -2;UniProt: P48307;TargetFullName: Tissue factor pathway inhibitor 2;Organisim: human;Apparent_Kd_M: 7.476052E-11

Real

Aptamer SeqId: 9233-71 | Target: TFPI -2 | UniProt: P48307

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9233-71 | Target: TFPI -2 | UniProt: P48307 | TargetFullName: Tissue factor pathway inhibitor 2 | Organisim: human | Apparent_Kd_M: 7.476052E-11

Real

Aptamer SeqId:9234-8;Target:TWSG1;UniProt:Q9GZX9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9234-8;Target: TWSG1;UniProt: Q9GZX9;TargetFullName: Twisted gastrulation protein homolog 1;Organisim: human;Apparent_Kd_M: 2.93101E-11

Real

Aptamer SeqId: 9234-8 | Target: TWSG1 | UniProt: Q9GZX9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9234-8 | Target: TWSG1 | UniProt: Q9GZX9 | TargetFullName: Twisted gastrulation protein homolog 1 | Organisim: human | Apparent_Kd_M: 2.93101E-11

Real

Aptamer SeqId:9235-3;Target:PXDC1;UniProt:Q8IUK5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9235-3;Target: PXDC1;UniProt: Q8IUK5;TargetFullName: Plexin domain-containing protein 1;Organisim: human;Apparent_Kd_M: 5.68138E-11

Real

Aptamer SeqId: 9235-3 | Target: PXDC1 | UniProt: Q8IUK5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9235-3 | Target: PXDC1 | UniProt: Q8IUK5 | TargetFullName: Plexin domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 5.68138E-11

Real

Aptamer SeqId:9237-54;Target:Lysosomal acid phosphatase;UniProt:P11117

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9237-54;Target: Lysosomal acid phosphatase;UniProt: P11117;TargetFullName: Lysosomal acid phosphatase;Organisim: human;Apparent_Kd_M: 4.953519E-11

Real

Aptamer SeqId: 9237-54 | Target: Lysosomal acid phosphatase

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9237-54 | Target: Lysosomal acid phosphatase | UniProt: P11117 | TargetFullName: Lysosomal acid phosphatase | Organisim: human | Apparent_Kd_M: 4.953519E-11

Real

Aptamer SeqId:9241-40;Target:SIRPG;UniProt:Q9P1W8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9241-40;Target: SIRPG;UniProt: Q9P1W8;TargetFullName: Signal-regulatory protein gamma;Organisim: human;Apparent_Kd_M: 1.063151E-10

Real

Aptamer SeqId: 9241-40 | Target: SIRPG | UniProt: Q9P1W8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9241-40 | Target: SIRPG | UniProt: Q9P1W8 | TargetFullName: Signal-regulatory protein gamma | Organisim: human | Apparent_Kd_M: 1.063151E-10

Real

Aptamer SeqId:9243-10;Target:LYG1;UniProt:Q8N1E2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9243-10;Target: LYG1;UniProt: Q8N1E2;TargetFullName: Lysozyme g-like protein 1;Organisim: human;Apparent_Kd_M: 4.033643E-11

Real

Aptamer SeqId: 9243-10 | Target: LYG1 | UniProt: Q8N1E2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9243-10 | Target: LYG1 | UniProt: Q8N1E2 | TargetFullName: Lysozyme g-like protein 1 | Organisim: human | Apparent_Kd_M: 4.033643E-11

Real

Aptamer SeqId:9244-27;Target:PPT1;UniProt:P50897

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9244-27;Target: PPT1;UniProt: P50897;TargetFullName: Palmitoyl-protein thioesterase 1;Organisim: human;Apparent_Kd_M: 3.68873E-12

Real

Aptamer SeqId: 9244-27 | Target: PPT1 | UniProt: P50897

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9244-27 | Target: PPT1 | UniProt: P50897 | TargetFullName: Palmitoyl-protein thioesterase 1 | Organisim: human | Apparent_Kd_M: 3.68873E-12

Real

Aptamer SeqId:9246-1;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9246-1;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.518742E-11

Real

Aptamer SeqId: 9246-1 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9246-1 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.518742E-11

Real

Aptamer SeqId:9248-36;Target:CS010;UniProt:Q969H8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9248-36;Target: CS010;UniProt: Q969H8;TargetFullName: Myeloid-derived growth factor;Organisim: human;Apparent_Kd_M: 5.762784E-10

Real

Aptamer SeqId: 9248-36 | Target: CS010 | UniProt: Q969H8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9248-36 | Target: CS010 | UniProt: Q969H8 | TargetFullName: Myeloid-derived growth factor | Organisim: human | Apparent_Kd_M: 5.762784E-10

Real

Aptamer SeqId:9249-17;Target:TMEM9;UniProt:Q9P0T7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9249-17;Target: TMEM9;UniProt: Q9P0T7;TargetFullName: Transmembrane protein 9;Organisim: human;Apparent_Kd_M: 4.683144E-11

Real

Aptamer SeqId: 9249-17 | Target: TMEM9 | UniProt: Q9P0T7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9249-17 | Target: TMEM9 | UniProt: Q9P0T7 | TargetFullName: Transmembrane protein 9 | Organisim: human | Apparent_Kd_M: 4.683144E-11

Real

Aptamer SeqId:9251-28;Target:MA2B2;UniProt:Q9Y2E5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9251-28;Target: MA2B2;UniProt: Q9Y2E5;TargetFullName: Epididymis-specific alpha-mannosidase;Organisim: human;Apparent_Kd_M: 7.272952E-12

Real

Aptamer SeqId: 9251-28 | Target: MA2B2 | UniProt: Q9Y2E5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9251-28 | Target: MA2B2 | UniProt: Q9Y2E5 | TargetFullName: Epididymis-specific alpha-mannosidase | Organisim: human | Apparent_Kd_M: 7.272952E-12

Real

Aptamer SeqId:9253-52;Target:BGAT;UniProt:P16442

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9253-52;Target: BGAT;UniProt: P16442;TargetFullName: Histo-blood group ABO system transferase;Organisim: human;Apparent_Kd_M: 4.535182E-12

Real

Aptamer SeqId: 9253-52 | Target: BGAT | UniProt: P16442

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9253-52 | Target: BGAT | UniProt: P16442 | TargetFullName: Histo-blood group ABO system transferase | Organisim: human | Apparent_Kd_M: 4.535182E-12

Real

Aptamer SeqId:9254-18;Target:FCERA;UniProt:P12319

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9254-18;Target: FCERA;UniProt: P12319;TargetFullName: High affinity immunoglobulin epsilon receptor subunit alpha;Organisim: human;Apparent_Kd_M: 2.160748E-11

Real

Aptamer SeqId: 9254-18 | Target: FCERA | UniProt: P12319

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9254-18 | Target: FCERA | UniProt: P12319 | TargetFullName: High affinity immunoglobulin epsilon receptor subunit alpha | Organisim: human | Apparent_Kd_M: 2.160748E-11

Real

Aptamer SeqId:9255-5;Target:IL-17C;UniProt:Q9P0M4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9255-5;Target: IL-17C;UniProt: Q9P0M4;TargetFullName: Interleukin-17C;Organisim: human;Apparent_Kd_M: 3.03617E-12

Real

Aptamer SeqId: 9255-5 | Target: IL-17C | UniProt: Q9P0M4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9255-5 | Target: IL-17C | UniProt: Q9P0M4 | TargetFullName: Interleukin-17C | Organisim: human | Apparent_Kd_M: 3.03617E-12

Real

Aptamer SeqId:9256-78;Target:NPTX1;UniProt:Q15818

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9256-78;Target: NPTX1;UniProt: Q15818;TargetFullName: Neuronal pentraxin-1;Organisim: human;Apparent_Kd_M: 1.520808E-11

Real

Aptamer SeqId: 9256-78 | Target: NPTX1 | UniProt: Q15818

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9256-78 | Target: NPTX1 | UniProt: Q15818 | TargetFullName: Neuronal pentraxin-1 | Organisim: human | Apparent_Kd_M: 1.520808E-11

Real

Aptamer SeqId:9257-14;Target:TACO1;UniProt:Q9BSH4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9257-14;Target: TACO1;UniProt: Q9BSH4;TargetFullName: Translational activator of cytochrome c oxidase 1;Organisim: human;Apparent_Kd_M: 5.949225E-12

Real

Aptamer SeqId: 9257-14 | Target: TACO1 | UniProt: Q9BSH4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9257-14 | Target: TACO1 | UniProt: Q9BSH4 | TargetFullName: Translational activator of cytochrome c oxidase 1 | Organisim: human | Apparent_Kd_M: 5.949225E-12

Real

Aptamer SeqId:9258-14;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9258-14;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.243115E-10

Real

Aptamer SeqId: 9258-14 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9258-14 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.243115E-10

Real

Aptamer SeqId:9263-57;Target:SIAE;UniProt:Q9HAT2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9263-57;Target: SIAE;UniProt: Q9HAT2;TargetFullName: Sialate O-acetylesterase;Organisim: human;Apparent_Kd_M: 3.954396E-11

Real

Aptamer SeqId: 9263-57 | Target: SIAE | UniProt: Q9HAT2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9263-57 | Target: SIAE | UniProt: Q9HAT2 | TargetFullName: Sialate O-acetylesterase | Organisim: human | Apparent_Kd_M: 3.954396E-11

Real

Aptamer SeqId:9264-11;Target:CATO;UniProt:P43234

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9264-11;Target: CATO;UniProt: P43234;TargetFullName: Cathepsin O;Organisim: human;Apparent_Kd_M: 5.162219E-11

Real

Aptamer SeqId: 9264-11 | Target: CATO | UniProt: P43234

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9264-11 | Target: CATO | UniProt: P43234 | TargetFullName: Cathepsin O | Organisim: human | Apparent_Kd_M: 5.162219E-11

Real

Aptamer SeqId:9265-10;Target:GLIP1;UniProt:P48060

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9265-10;Target: GLIP1;UniProt: P48060;TargetFullName: Glioma pathogenesis-related protein 1;Organisim: human;Apparent_Kd_M: 1.759888E-11

Real

Aptamer SeqId: 9265-10 | Target: GLIP1 | UniProt: P48060

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9265-10 | Target: GLIP1 | UniProt: P48060 | TargetFullName: Glioma pathogenesis-related protein 1 | Organisim: human | Apparent_Kd_M: 1.759888E-11

Real

Aptamer SeqId:9266-1;Target:sTREM-1;UniProt:Q9NP99

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9266-1;Target: sTREM-1;UniProt: Q9NP99;TargetFullName: Triggering receptor expressed on myeloid cells 1;Organisim: human;Apparent_Kd_M: 1.480024E-11

Real

Aptamer SeqId: 9266-1 | Target: sTREM-1 | UniProt: Q9NP99

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9266-1 | Target: sTREM-1 | UniProt: Q9NP99 | TargetFullName: Triggering receptor expressed on myeloid cells 1 | Organisim: human | Apparent_Kd_M: 1.480024E-11

Real

Aptamer SeqId:9267-2;Target:CBPA4;UniProt:Q9UI42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9267-2;Target: CBPA4;UniProt: Q9UI42;TargetFullName: Carboxypeptidase A4;Organisim: human;Apparent_Kd_M: 3.032838E-12

Real

Aptamer SeqId: 9267-2 | Target: CBPA4 | UniProt: Q9UI42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9267-2 | Target: CBPA4 | UniProt: Q9UI42 | TargetFullName: Carboxypeptidase A4 | Organisim: human | Apparent_Kd_M: 3.032838E-12

Real

Aptamer SeqId:9271-101;Target:STIM1;UniProt:Q13586

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9271-101;Target: STIM1;UniProt: Q13586;TargetFullName: Stromal interaction molecule 1;Organisim: human;Apparent_Kd_M: 6.564064E-11

Real

Aptamer SeqId: 9271-101 | Target: STIM1 | UniProt: Q13586

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9271-101 | Target: STIM1 | UniProt: Q13586 | TargetFullName: Stromal interaction molecule 1 | Organisim: human | Apparent_Kd_M: 6.564064E-11

Real

Aptamer SeqId:9275-2;Target:Siglec-5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9275-2;Target: Siglec-5;UniProt:;TargetFullName: Sialic acid-binding Ig-like lectin 5;Organisim: human;Apparent_Kd_M: 5.39668E-12

Real

Aptamer SeqId: 9275-2 | Target: Siglec-5 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9275-2 | Target: Siglec-5 | UniProt: | TargetFullName: Sialic acid-binding Ig-like lectin 5 | Organisim: human | Apparent_Kd_M: 5.39668E-12

Real

Aptamer SeqId:9276-7;Target:CBPA2;UniProt:P48052

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9276-7;Target: CBPA2;UniProt: P48052;TargetFullName: Carboxypeptidase A2;Organisim: human;Apparent_Kd_M: 8.214512E-12

Real

Aptamer SeqId: 9276-7 | Target: CBPA2 | UniProt: P48052

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9276-7 | Target: CBPA2 | UniProt: P48052 | TargetFullName: Carboxypeptidase A2 | Organisim: human | Apparent_Kd_M: 8.214512E-12

Real

Aptamer SeqId:9278-9;Target:SDF-1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9278-9;Target: SDF-1;UniProt:;TargetFullName: Stromal cell-derived factor 1;Organisim: human;Apparent_Kd_M: 1.705199E-12

Real

Aptamer SeqId: 9278-9 | Target: SDF-1 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9278-9 | Target: SDF-1 | UniProt: | TargetFullName: Stromal cell-derived factor 1 | Organisim: human | Apparent_Kd_M: 1.705199E-12

Real

Aptamer SeqId:9281-50;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9281-50;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.07562E-10

Real

Aptamer SeqId: 9281-50 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9281-50 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.07562E-10

Real

Aptamer SeqId:9282-12;Target:CRIS2;UniProt:P16562

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9282-12;Target: CRIS2;UniProt: P16562;TargetFullName: Cysteine-rich secretory protein 2;Organisim: human;Apparent_Kd_M: 5.232475E-12

Real

Aptamer SeqId: 9282-12 | Target: CRIS2 | UniProt: P16562

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9282-12 | Target: CRIS2 | UniProt: P16562 | TargetFullName: Cysteine-rich secretory protein 2 | Organisim: human | Apparent_Kd_M: 5.232475E-12

Real

Aptamer SeqId:9283-8;Target:CD44;UniProt:P16070

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9283-8;Target: CD44;UniProt: P16070;TargetFullName: CD44 antigen;Organisim: human;Apparent_Kd_M: 6.190248E-11

Real

Aptamer SeqId: 9283-8 | Target: CD44 | UniProt: P16070

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9283-8 | Target: CD44 | UniProt: P16070 | TargetFullName: CD44 antigen | Organisim: human | Apparent_Kd_M: 6.190248E-11

Real

Aptamer SeqId:9287-6;Target:SPRE;UniProt:P35270

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9287-6;Target: SPRE;UniProt: P35270;TargetFullName: Sepiapterin reductase;Organisim: human;Apparent_Kd_M: 1.80508E-10

Real

Aptamer SeqId: 9287-6 | Target: SPRE | UniProt: P35270

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9287-6 | Target: SPRE | UniProt: P35270 | TargetFullName: Sepiapterin reductase | Organisim: human | Apparent_Kd_M: 1.80508E-10

Real

Aptamer SeqId:9288-7;Target:FKBP7;UniProt:Q9Y680

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9288-7;Target: FKBP7;UniProt: Q9Y680;TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP7;Organisim: human;Apparent_Kd_M: 9.40715E-12

Real

Aptamer SeqId: 9288-7 | Target: FKBP7 | UniProt: Q9Y680

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9288-7 | Target: FKBP7 | UniProt: Q9Y680 | TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP7 | Organisim: human | Apparent_Kd_M: 9.40715E-12

Real

Aptamer SeqId:9290-8;Target:RMD3;UniProt:Q96TC7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9290-8;Target: RMD3;UniProt: Q96TC7;TargetFullName: Regulator of microtubule dynamics protein 3;Organisim: human;Apparent_Kd_M: 3.103174E-11

Real

Aptamer SeqId: 9290-8 | Target: RMD3 | UniProt: Q96TC7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9290-8 | Target: RMD3 | UniProt: Q96TC7 | TargetFullName: Regulator of microtubule dynamics protein 3 | Organisim: human | Apparent_Kd_M: 3.103174E-11

Real

Aptamer SeqId:9294-45;Target:MFAP2;UniProt:P55001

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9294-45;Target: MFAP2;UniProt: P55001;TargetFullName: Microfibrillar-associated protein 2;Organisim: human;Apparent_Kd_M: 2.457214E-11

Real

Aptamer SeqId: 9294-45 | Target: MFAP2 | UniProt: P55001

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9294-45 | Target: MFAP2 | UniProt: P55001 | TargetFullName: Microfibrillar-associated protein 2 | Organisim: human | Apparent_Kd_M: 2.457214E-11

Real

Aptamer SeqId:9296-15;Target:PTPRD;UniProt:P23468

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9296-15;Target: PTPRD;UniProt: P23468;TargetFullName: Receptor-type tyrosine-protein phosphatase delta;Organisim: human;Apparent_Kd_M: 1.360495E-12

Real

Aptamer SeqId: 9296-15 | Target: PTPRD | UniProt: P23468

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9296-15 | Target: PTPRD | UniProt: P23468 | TargetFullName: Receptor-type tyrosine-protein phosphatase delta | Organisim: human | Apparent_Kd_M: 1.360495E-12

Real

Aptamer SeqId:9297-12;Target:B3GN8;UniProt:Q7Z7M8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9297-12;Target: B3GN8;UniProt: Q7Z7M8;TargetFullName: UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 8;Organisim: human;Apparent_Kd_M: 6.541243E-11

Real

Aptamer SeqId: 9297-12 | Target: B3GN8 | UniProt: Q7Z7M8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9297-12 | Target: B3GN8 | UniProt: Q7Z7M8 | TargetFullName: UDP-GlcNAc:betaGal beta-1;3-N-acetylglucosaminyltransferase 8 | Organisim: human | Apparent_Kd_M: 6.541243E-11

Real

Aptamer SeqId:9302-90;Target:G45IP;UniProt:Q8TAE8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9302-90;Target: G45IP;UniProt: Q8TAE8;TargetFullName: Growth arrest and DNA damage-inducible proteins-interacting protein 1;Organisim: human;Apparent_Kd_M: 5.12E-11

Real

Aptamer SeqId: 9302-90 | Target: G45IP | UniProt: Q8TAE8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9302-90 | Target: G45IP | UniProt: Q8TAE8 | TargetFullName: Growth arrest and DNA damage-inducible proteins-interacting protein 1 | Organisim: human | Apparent_Kd_M: 5.12E-11

Real

Aptamer SeqId:9306-7;Target:DB118;UniProt:Q96PH6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9306-7;Target: DB118;UniProt: Q96PH6;TargetFullName: Beta-defensin 118;Organisim: human;Apparent_Kd_M: 4.236814E-11

Real

Aptamer SeqId: 9306-7 | Target: DB118 | UniProt: Q96PH6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9306-7 | Target: DB118 | UniProt: Q96PH6 | TargetFullName: Beta-defensin 118 | Organisim: human | Apparent_Kd_M: 4.236814E-11

Real

Aptamer SeqId:9310-2;Target:CD8B;UniProt:P10966

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9310-2;Target: CD8B;UniProt: P10966;TargetFullName: T-cell surface glycoprotein CD8 beta chain;Organisim: human;Apparent_Kd_M: 6.776121E-11

Real

Aptamer SeqId: 9310-2 | Target: CD8B | UniProt: P10966

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9310-2 | Target: CD8B | UniProt: P10966 | TargetFullName: T-cell surface glycoprotein CD8 beta chain | Organisim: human | Apparent_Kd_M: 6.776121E-11

Real

Aptamer SeqId:9312-8;Target:AZGP1;UniProt:P25311

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9312-8;Target: AZGP1;UniProt: P25311;TargetFullName: Zinc-alpha-2-glycoprotein;Organisim: human;Apparent_Kd_M: 4.44937E-11

Real

Aptamer SeqId: 9312-8 | Target: AZGP1 | UniProt: P25311

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9312-8 | Target: AZGP1 | UniProt: P25311 | TargetFullName: Zinc-alpha-2-glycoprotein | Organisim: human | Apparent_Kd_M: 4.44937E-11

Real

Aptamer SeqId:9313-27;Target:CBLN1;UniProt:P23435

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9313-27;Target: CBLN1;UniProt: P23435;TargetFullName: Cerebellin-1;Organisim: human;Apparent_Kd_M: 1.369743E-11

Real

Aptamer SeqId: 9313-27 | Target: CBLN1 | UniProt: P23435

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9313-27 | Target: CBLN1 | UniProt: P23435 | TargetFullName: Cerebellin-1 | Organisim: human | Apparent_Kd_M: 1.369743E-11

Real

Aptamer SeqId:9314-9;Target:PSG5;UniProt:Q15238

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9314-9;Target: PSG5;UniProt: Q15238;TargetFullName: Pregnancy-specific beta-1-glycoprotein 5;Organisim: human;Apparent_Kd_M: 7.575096E-12

Real

Aptamer SeqId: 9314-9 | Target: PSG5 | UniProt: Q15238

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9314-9 | Target: PSG5 | UniProt: Q15238 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 5 | Organisim: human | Apparent_Kd_M: 7.575096E-12

Real

Aptamer SeqId:9315-16;Target:MUL1;UniProt:Q969V5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9315-16;Target: MUL1;UniProt: Q969V5;TargetFullName: Mitochondrial ubiquitin ligase activator of NFKB 1;Organisim: human;Apparent_Kd_M: 3.719568E-12

Real

Aptamer SeqId: 9315-16 | Target: MUL1 | UniProt: Q969V5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9315-16 | Target: MUL1 | UniProt: Q969V5 | TargetFullName: Mitochondrial ubiquitin ligase activator of NFKB 1 | Organisim: human | Apparent_Kd_M: 3.719568E-12

Real

Aptamer SeqId:9316-67;Target:WFDC1;UniProt:Q9HC57

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9316-67;Target: WFDC1;UniProt: Q9HC57;TargetFullName: WAP four-disulfide core domain protein 1;Organisim: human;Apparent_Kd_M: 5.075056E-11

Real

Aptamer SeqId: 9316-67 | Target: WFDC1 | UniProt: Q9HC57

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9316-67 | Target: WFDC1 | UniProt: Q9HC57 | TargetFullName: WAP four-disulfide core domain protein 1 | Organisim: human | Apparent_Kd_M: 5.075056E-11

Real

Aptamer SeqId:9317-4;Target:LRC25;UniProt:Q8N386

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9317-4;Target: LRC25;UniProt: Q8N386;TargetFullName: Leucine-rich repeat-containing protein 25;Organisim: human;Apparent_Kd_M: 4.381817E-11

Real

Aptamer SeqId: 9317-4 | Target: LRC25 | UniProt: Q8N386

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9317-4 | Target: LRC25 | UniProt: Q8N386 | TargetFullName: Leucine-rich repeat-containing protein 25 | Organisim: human | Apparent_Kd_M: 4.381817E-11

Real

Aptamer SeqId:9319-59;Target:TMED4;UniProt:Q7Z7H5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9319-59;Target: TMED4;UniProt: Q7Z7H5;TargetFullName: Transmembrane emp24 domain-containing protein 4;Organisim: human;Apparent_Kd_M: 1.73844E-12

Real

Aptamer SeqId: 9319-59 | Target: TMED4 | UniProt: Q7Z7H5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9319-59 | Target: TMED4 | UniProt: Q7Z7H5 | TargetFullName: Transmembrane emp24 domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 1.73844E-12

Real

Aptamer SeqId:9321-400;Target:NMB;UniProt:P08949

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9321-400;Target: NMB;UniProt: P08949;TargetFullName: Neuromedin-B;Organisim: human;Apparent_Kd_M: 1.878266E-11

Real

Aptamer SeqId: 9321-400 | Target: NMB | UniProt: P08949

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9321-400 | Target: NMB | UniProt: P08949 | TargetFullName: Neuromedin-B | Organisim: human | Apparent_Kd_M: 1.878266E-11

Real

Aptamer SeqId:9322-15;Target:RCN1;UniProt:Q15293

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9322-15;Target: RCN1;UniProt: Q15293;TargetFullName: Reticulocalbin-1;Organisim: human;Apparent_Kd_M: 4.349429E-12

Real

Aptamer SeqId: 9322-15 | Target: RCN1 | UniProt: Q15293

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9322-15 | Target: RCN1 | UniProt: Q15293 | TargetFullName: Reticulocalbin-1 | Organisim: human | Apparent_Kd_M: 4.349429E-12

Real

Aptamer SeqId:9326-33;Target:ITI heavy chain H2;UniProt:P19823

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9326-33;Target: ITI heavy chain H2;UniProt: P19823;TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H2;Organisim: human;Apparent_Kd_M: 1.543716E-11

Real

Aptamer SeqId: 9326-33 | Target: ITI heavy chain H2 | UniProt: P19823

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9326-33 | Target: ITI heavy chain H2 | UniProt: P19823 | TargetFullName: Inter-alpha-trypsin inhibitor heavy chain H2 | Organisim: human | Apparent_Kd_M: 1.543716E-11

Real

Aptamer SeqId:9327-3;Target:LYPD1;UniProt:Q8N2G4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9327-3;Target: LYPD1;UniProt: Q8N2G4;TargetFullName: Ly6/PLAUR domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.758913E-10

Real

Aptamer SeqId: 9327-3 | Target: LYPD1 | UniProt: Q8N2G4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9327-3 | Target: LYPD1 | UniProt: Q8N2G4 | TargetFullName: Ly6/PLAUR domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.758913E-10

Real

Aptamer SeqId:9329-28;Target:TRML1;UniProt:Q86YW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9329-28;Target: TRML1;UniProt: Q86YW5;TargetFullName: Trem-like transcript 1 protein;Organisim: human;Apparent_Kd_M: 1.132413E-11

Real

Aptamer SeqId: 9329-28 | Target: TRML1 | UniProt: Q86YW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9329-28 | Target: TRML1 | UniProt: Q86YW5 | TargetFullName: Trem-like transcript 1 protein | Organisim: human | Apparent_Kd_M: 1.132413E-11

Real

Aptamer SeqId:9332-6;Target:DB136;UniProt:Q30KP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9332-6;Target: DB136;UniProt: Q30KP8;TargetFullName: Beta-defensin 136;Organisim: human;Apparent_Kd_M: 5.477111E-11

Real

Aptamer SeqId: 9332-6 | Target: DB136 | UniProt: Q30KP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9332-6 | Target: DB136 | UniProt: Q30KP8 | TargetFullName: Beta-defensin 136 | Organisim: human | Apparent_Kd_M: 5.477111E-11

Real

Aptamer SeqId:9333-59;Target:ERP27;UniProt:Q96DN0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9333-59;Target: ERP27;UniProt: Q96DN0;TargetFullName: Endoplasmic reticulum resident protein 27;Organisim: human;Apparent_Kd_M: 3.198817E-11

Real

Aptamer SeqId: 9333-59 | Target: ERP27 | UniProt: Q96DN0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9333-59 | Target: ERP27 | UniProt: Q96DN0 | TargetFullName: Endoplasmic reticulum resident protein 27 | Organisim: human | Apparent_Kd_M: 3.198817E-11

Real

Aptamer SeqId:9335-28;Target:PSG9;UniProt:Q00887

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9335-28;Target: PSG9;UniProt: Q00887;TargetFullName: Pregnancy-specific beta-1-glycoprotein 9;Organisim: human;Apparent_Kd_M: 1.699024E-12

Real

Aptamer SeqId: 9335-28 | Target: PSG9 | UniProt: Q00887

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9335-28 | Target: PSG9 | UniProt: Q00887 | TargetFullName: Pregnancy-specific beta-1-glycoprotein 9 | Organisim: human | Apparent_Kd_M: 1.699024E-12

Real

Aptamer SeqId:9337-43;Target:TKN1;UniProt:P20366

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9337-43;Target: TKN1;UniProt: P20366;TargetFullName: Protachykinin-1;Organisim: human;Apparent_Kd_M: 3.678823E-11

Real

Aptamer SeqId: 9337-43 | Target: TKN1 | UniProt: P20366

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9337-43 | Target: TKN1 | UniProt: P20366 | TargetFullName: Protachykinin-1 | Organisim: human | Apparent_Kd_M: 3.678823E-11

Real

Aptamer SeqId:9338-2;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9338-2;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.233121E-12

Real

Aptamer SeqId: 9338-2 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9338-2 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.233121E-12

Real

Aptamer SeqId:9339-204;Target:FKBP2;UniProt:P26885

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9339-204;Target: FKBP2;UniProt: P26885;TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP2;Organisim: human;Apparent_Kd_M: 6.431814E-11

Real

Aptamer SeqId: 9339-204 | Target: FKBP2 | UniProt: P26885

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9339-204 | Target: FKBP2 | UniProt: P26885 | TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP2 | Organisim: human | Apparent_Kd_M: 6.431814E-11

Real

Aptamer SeqId:9340-17;Target:FKB14;UniProt:Q9NWM8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9340-17;Target: FKB14;UniProt: Q9NWM8;TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP14;Organisim: human;Apparent_Kd_M: 1.009916E-11

Real

Aptamer SeqId: 9340-17 | Target: FKB14 | UniProt: Q9NWM8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9340-17 | Target: FKB14 | UniProt: Q9NWM8 | TargetFullName: Peptidyl-prolyl cis-trans isomerase FKBP14 | Organisim: human | Apparent_Kd_M: 1.009916E-11

Real

Aptamer SeqId:9341-1;Target:PDGFD;UniProt:Q9GZP0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9341-1;Target: PDGFD;UniProt: Q9GZP0;TargetFullName: Platelet-derived growth factor D;Organisim: human;Apparent_Kd_M: 7.124924E-13

Real

Aptamer SeqId: 9341-1 | Target: PDGFD | UniProt: Q9GZP0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9341-1 | Target: PDGFD | UniProt: Q9GZP0 | TargetFullName: Platelet-derived growth factor D | Organisim: human | Apparent_Kd_M: 7.124924E-13

Real

Aptamer SeqId:9343-16;Target:IL-2 sRb;UniProt:P14784

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9343-16;Target: IL-2 sRb;UniProt: P14784;TargetFullName: Interleukin-2 receptor subunit beta;Organisim: human;Apparent_Kd_M: 2.238077E-12

Real

Aptamer SeqId: 9343-16 | Target: IL-2 sRb | UniProt: P14784

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9343-16 | Target: IL-2 sRb | UniProt: P14784 | TargetFullName: Interleukin-2 receptor subunit beta | Organisim: human | Apparent_Kd_M: 2.238077E-12

Real

Aptamer SeqId:9345-436;Target:WFD13;UniProt:Q8IUB5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9345-436;Target: WFD13;UniProt: Q8IUB5;TargetFullName: WAP four-disulfide core domain protein 13;Organisim: human;Apparent_Kd_M: 4.414798E-12

Real

Aptamer SeqId: 9345-436 | Target: WFD13 | UniProt: Q8IUB5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9345-436 | Target: WFD13 | UniProt: Q8IUB5 | TargetFullName: WAP four-disulfide core domain protein 13 | Organisim: human | Apparent_Kd_M: 4.414798E-12

Real

Aptamer SeqId:9347-13;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9347-13;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.005206E-12

Real

Aptamer SeqId: 9347-13 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9347-13 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.005206E-12

Real

Aptamer SeqId:9348-1;Target:C1RL1;UniProt:Q9NZP8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9348-1;Target: C1RL1;UniProt: Q9NZP8;TargetFullName: Complement C1r subcomponent-like protein;Organisim: human;Apparent_Kd_M: 3.822779E-11

Real

Aptamer SeqId: 9348-1 | Target: C1RL1 | UniProt: Q9NZP8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9348-1 | Target: C1RL1 | UniProt: Q9NZP8 | TargetFullName: Complement C1r subcomponent-like protein | Organisim: human | Apparent_Kd_M: 3.822779E-11

Real

Aptamer SeqId:9350-3;Target:FSTL4;UniProt:Q6MZW2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9350-3;Target: FSTL4;UniProt: Q6MZW2;TargetFullName: Follistatin-related protein 4;Organisim: human;Apparent_Kd_M: 6.525048E-11

Real

Aptamer SeqId: 9350-3 | Target: FSTL4 | UniProt: Q6MZW2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9350-3 | Target: FSTL4 | UniProt: Q6MZW2 | TargetFullName: Follistatin-related protein 4 | Organisim: human | Apparent_Kd_M: 6.525048E-11

Real

Aptamer SeqId:9353-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9353-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.325738E-11

Real

Aptamer SeqId: 9353-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9353-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.325738E-11

Real

Aptamer SeqId:9355-26;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9355-26;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 4.586252E-12

Real

Aptamer SeqId: 9355-26 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9355-26 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 4.586252E-12

Real

Aptamer SeqId:9357-4;Target:CREG1;UniProt:O75629

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9357-4;Target: CREG1;UniProt: O75629;TargetFullName: Protein CREG1;Organisim: human;Apparent_Kd_M: 2.245605E-11

Real

Aptamer SeqId: 9357-4 | Target: CREG1 | UniProt: O75629

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9357-4 | Target: CREG1 | UniProt: O75629 | TargetFullName: Protein CREG1 | Organisim: human | Apparent_Kd_M: 2.245605E-11

Real

Aptamer SeqId:9358-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9358-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.040479E-11

Real

Aptamer SeqId: 9358-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9358-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.040479E-11

Real

Aptamer SeqId:9359-9;Target:EGFL9;UniProt:Q6UY11

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9359-9;Target: EGFL9;UniProt: Q6UY11;TargetFullName: Protein delta homolog 2;Organisim: human;Apparent_Kd_M: 2.045348E-11

Real

Aptamer SeqId: 9359-9 | Target: EGFL9 | UniProt: Q6UY11

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9359-9 | Target: EGFL9 | UniProt: Q6UY11 | TargetFullName: Protein delta homolog 2 | Organisim: human | Apparent_Kd_M: 2.045348E-11

Real

Aptamer SeqId:9360-33;Target:EDIL3;UniProt:O43854

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9360-33;Target: EDIL3;UniProt: O43854;TargetFullName: EGF-like repeat and discoidin I-like domain-containing protein 3;Organisim: human;Apparent_Kd_M: 3.29142E-12

Real

Aptamer SeqId: 9360-33 | Target: EDIL3 | UniProt: O43854

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9360-33 | Target: EDIL3 | UniProt: O43854 | TargetFullName: EGF-like repeat and discoidin I-like domain-containing protein 3 | Organisim: human | Apparent_Kd_M: 3.29142E-12

Real

Aptamer SeqId:9361-7;Target:PCDC2;UniProt:Q9Y5I4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9361-7;Target: PCDC2;UniProt: Q9Y5I4;TargetFullName: Protocadherin alpha-C2;Organisim: human;Apparent_Kd_M: 2.150466E-10

Real

Aptamer SeqId: 9361-7 | Target: PCDC2 | UniProt: Q9Y5I4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9361-7 | Target: PCDC2 | UniProt: Q9Y5I4 | TargetFullName: Protocadherin alpha-C2 | Organisim: human | Apparent_Kd_M: 2.150466E-10

Real

Aptamer SeqId:9362-11;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9362-11;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.252226E-11

Real

Aptamer SeqId: 9362-11 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9362-11 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.252226E-11

Real

Aptamer SeqId:9363-11;Target:CX048;UniProt:Q8WUE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9363-11;Target: CX048;UniProt: Q8WUE5;TargetFullName: Cancer/testis antigen 55;Organisim: human;Apparent_Kd_M: 1.728021E-10

Real

Aptamer SeqId: 9363-11 | Target: CX048 | UniProt: Q8WUE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9363-11 | Target: CX048 | UniProt: Q8WUE5 | TargetFullName: Cancer/testis antigen 55 | Organisim: human | Apparent_Kd_M: 1.728021E-10

Real

Aptamer SeqId:9365-91;Target:EYS;UniProt:Q5T1H1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9365-91;Target: EYS;UniProt: Q5T1H1;TargetFullName: Protein eyes shut homolog;Organisim: human;Apparent_Kd_M: 2.813507E-10

Real

Aptamer SeqId: 9365-91 | Target: EYS | UniProt: Q5T1H1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9365-91 | Target: EYS | UniProt: Q5T1H1 | TargetFullName: Protein eyes shut homolog | Organisim: human | Apparent_Kd_M: 2.813507E-10

Real

Aptamer SeqId:9366-54;Target:IL-21 sR;UniProt:Q9HBE5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9366-54;Target: IL-21 sR;UniProt: Q9HBE5;TargetFullName: Interleukin-21 receptor;Organisim: human;Apparent_Kd_M: 9.166879E-11

Real

Aptamer SeqId: 9366-54 | Target: IL-21 sR | UniProt: Q9HBE5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9366-54 | Target: IL-21 sR | UniProt: Q9HBE5 | TargetFullName: Interleukin-21 receptor | Organisim: human | Apparent_Kd_M: 9.166879E-11

Real

Aptamer SeqId:9368-64;Target:LRTM1;UniProt:Q9HBL6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9368-64;Target: LRTM1;UniProt: Q9HBL6;TargetFullName: Leucine-rich repeat and transmembrane domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.997289E-11

Real

Aptamer SeqId: 9368-64 | Target: LRTM1 | UniProt: Q9HBL6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9368-64 | Target: LRTM1 | UniProt: Q9HBL6 | TargetFullName: Leucine-rich repeat and transmembrane domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.997289E-11

Real

Aptamer SeqId:9369-174;Target:NGL1;UniProt:Q9HCJ2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9369-174;Target: NGL1;UniProt: Q9HCJ2;TargetFullName: Leucine-rich repeat-containing protein 4C;Organisim: human;Apparent_Kd_M: 1.350296E-11

Real

Aptamer SeqId: 9369-174 | Target: NGL1 | UniProt: Q9HCJ2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9369-174 | Target: NGL1 | UniProt: Q9HCJ2 | TargetFullName: Leucine-rich repeat-containing protein 4C | Organisim: human | Apparent_Kd_M: 1.350296E-11

Real

Aptamer SeqId:9370-69;Target:GGH;UniProt:Q92820

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9370-69;Target: GGH;UniProt: Q92820;TargetFullName: Gamma-glutamyl hydrolase;Organisim: human;Apparent_Kd_M: 1.05E-10

Real

Aptamer SeqId: 9370-69 | Target: GGH | UniProt: Q92820

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9370-69 | Target: GGH | UniProt: Q92820 | TargetFullName: Gamma-glutamyl hydrolase | Organisim: human | Apparent_Kd_M: 1.05E-10

Real

Aptamer SeqId:9372-157;Target:MPZL2;UniProt:O60487

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9372-157;Target: MPZL2;UniProt: O60487;TargetFullName: Myelin protein zero-like protein 2;Organisim: human;Apparent_Kd_M: 3.786995E-10

Real

Aptamer SeqId: 9372-157 | Target: MPZL2 | UniProt: O60487

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9372-157 | Target: MPZL2 | UniProt: O60487 | TargetFullName: Myelin protein zero-like protein 2 | Organisim: human | Apparent_Kd_M: 3.786995E-10

Real

Aptamer SeqId:9373-405;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9373-405;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.846208E-12

Real

Aptamer SeqId: 9373-405 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9373-405 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.846208E-12

Real

Aptamer SeqId:9374-24;Target:NNAT;UniProt:Q16517

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9374-24;Target: NNAT;UniProt: Q16517;TargetFullName: Neuronatin;Organisim: human;Apparent_Kd_M: 4.881379E-11

Real

Aptamer SeqId: 9374-24 | Target: NNAT | UniProt: Q16517

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9374-24 | Target: NNAT | UniProt: Q16517 | TargetFullName: Neuronatin | Organisim: human | Apparent_Kd_M: 4.881379E-11

Real

Aptamer SeqId:9377-25;Target:SCF;UniProt:P21583

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9377-25;Target: SCF;UniProt: P21583;TargetFullName: Kit ligand;Organisim: human;Apparent_Kd_M: 1.219602E-10

Real

Aptamer SeqId: 9377-25 | Target: SCF | UniProt: P21583

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9377-25 | Target: SCF | UniProt: P21583 | TargetFullName: Kit ligand | Organisim: human | Apparent_Kd_M: 1.219602E-10

Real

Aptamer SeqId:9378-6;Target:FBCD1;UniProt:Q8N539

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9378-6;Target: FBCD1;UniProt: Q8N539;TargetFullName: Fibrinogen C domain-containing protein 1;Organisim: human;Apparent_Kd_M: 9.644376E-12

Real

Aptamer SeqId: 9378-6 | Target: FBCD1 | UniProt: Q8N539

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9378-6 | Target: FBCD1 | UniProt: Q8N539 | TargetFullName: Fibrinogen C domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 9.644376E-12

Real

Aptamer SeqId:9379-248;Target:CX069;UniProt:Q96HG1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9379-248;Target: CX069;UniProt: Q96HG1;TargetFullName: Small integral membrane protein 10;Organisim: human;Apparent_Kd_M: 3.230824E-11

Real

Aptamer SeqId: 9379-248 | Target: CX069 | UniProt: Q96HG1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9379-248 | Target: CX069 | UniProt: Q96HG1 | TargetFullName: Small integral membrane protein 10 | Organisim: human | Apparent_Kd_M: 3.230824E-11

Real

Aptamer SeqId:9380-2;Target:sPLA(2)-XIII;UniProt:Q9BX93

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9380-2;Target: sPLA(2)-XIII;UniProt: Q9BX93;TargetFullName: Group XIIB secretory phospholipase A2-like protein;Organisim: human;Apparent_Kd_M: 7.78E-12

Real

Aptamer SeqId: 9380-2 | Target: sPLA(2)-XIII | UniProt: Q9BX93

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9380-2 | Target: sPLA(2)-XIII | UniProt: Q9BX93 | TargetFullName: Group XIIB secretory phospholipase A2-like protein | Organisim: human | Apparent_Kd_M: 7.78E-12

Real

Aptamer SeqId:9383-24;Target:CH3L2;UniProt:Q15782

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9383-24;Target: CH3L2;UniProt: Q15782;TargetFullName: Chitinase-3-like protein 2;Organisim: human;Apparent_Kd_M: 6.646729E-11

Real

Aptamer SeqId: 9383-24 | Target: CH3L2 | UniProt: Q15782

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9383-24 | Target: CH3L2 | UniProt: Q15782 | TargetFullName: Chitinase-3-like protein 2 | Organisim: human | Apparent_Kd_M: 6.646729E-11

Real

Aptamer SeqId:9384-17;Target:Cathelicidin peptide;UniProt:P49913

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9384-17;Target: Cathelicidin peptide;UniProt: P49913;TargetFullName: Cathelicidin antimicrobial peptide;Organisim: human;Apparent_Kd_M: 1.28E-10

Real

Aptamer SeqId: 9384-17 | Target: Cathelicidin peptide | UniProt: P49913

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9384-17 | Target: Cathelicidin peptide | UniProt: P49913 | TargetFullName: Cathelicidin antimicrobial peptide | Organisim: human | Apparent_Kd_M: 1.28E-10

Real

Aptamer SeqId:9385-4;Target:GAA;UniProt:P10253

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9385-4;Target: GAA;UniProt: P10253;TargetFullName: Lysosomal alpha-glucosidase;Organisim: human;Apparent_Kd_M: 3.010004E-11

Real

Aptamer SeqId: 9385-4 | Target: GAA | UniProt: P10253

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9385-4 | Target: GAA | UniProt: P10253 | TargetFullName: Lysosomal alpha-glucosidase | Organisim: human | Apparent_Kd_M: 3.010004E-11

Real

Aptamer SeqId:9386-42;Target:TTC9B;UniProt:Q8N6N2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9386-42;Target: TTC9B;UniProt: Q8N6N2;TargetFullName: Tetratricopeptide repeat protein 9B;Organisim: human;Apparent_Kd_M: 6.669466E-12

Real

Aptamer SeqId: 9386-42 | Target: TTC9B | UniProt: Q8N6N2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9386-42 | Target: TTC9B | UniProt: Q8N6N2 | TargetFullName: Tetratricopeptide repeat protein 9B | Organisim: human | Apparent_Kd_M: 6.669466E-12

Real

Aptamer SeqId:9387-13;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9387-13;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.060672E-11

Real

Aptamer SeqId: 9387-13 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9387-13 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.060672E-11

Real

Aptamer SeqId:9388-18;Target:MCEE;UniProt:Q96PE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9388-18;Target: MCEE;UniProt: Q96PE7;TargetFullName: Methylmalonyl-CoA epimerase; mitochondrial;Organisim: human;Apparent_Kd_M: 2.632592E-12

Real

Aptamer SeqId: 9388-18 | Target: MCEE | UniProt: Q96PE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9388-18 | Target: MCEE | UniProt: Q96PE7 | TargetFullName: Methylmalonyl-CoA epimerase; mitochondrial | Organisim: human | Apparent_Kd_M: 2.632592E-12

Real

Aptamer SeqId:9389-12;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9389-12;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.042654E-11

Real

Aptamer SeqId: 9389-12 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9389-12 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.042654E-11

Real

Aptamer SeqId:9391-60;Target:PCSK1;UniProt:Q9UHG2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9391-60;Target: PCSK1;UniProt: Q9UHG2;TargetFullName: ProSAAS;Organisim: human;Apparent_Kd_M: 7.482995E-11

Real

Aptamer SeqId: 9391-60 | Target: PCSK1 | UniProt: Q9UHG2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9391-60 | Target: PCSK1 | UniProt: Q9UHG2 | TargetFullName: ProSAAS | Organisim: human | Apparent_Kd_M: 7.482995E-11

Real

Aptamer SeqId:9392-43;Target:MGT4A;UniProt:Q9UM21

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9392-43;Target: MGT4A;UniProt: Q9UM21;TargetFullName: Alpha-1;3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A;Organisim: human;Apparent_Kd_M: 1.781285E-10

Real

Aptamer SeqId: 9392-43 | Target: MGT4A | UniProt: Q9UM21

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9392-43 | Target: MGT4A | UniProt: Q9UM21 | TargetFullName: Alpha-1;3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Organisim: human | Apparent_Kd_M: 1.781285E-10

Real

Aptamer SeqId:9394-19;Target:Aminopeptidase;UniProt:Q9Y646

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9394-19;Target: Aminopeptidase;UniProt: Q9Y646;TargetFullName: Carboxypeptidase Q;Organisim: human;Apparent_Kd_M: 9.981058E-12

Real

Aptamer SeqId: 9394-19 | Target: Aminopeptidase | UniProt: Q9Y646

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9394-19 | Target: Aminopeptidase | UniProt: Q9Y646 | TargetFullName: Carboxypeptidase Q | Organisim: human | Apparent_Kd_M: 9.981058E-12

Real

Aptamer SeqId:9398-30;Target:GALP;UniProt:Q9UBC7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9398-30;Target: GALP;UniProt: Q9UBC7;TargetFullName: Galanin-like peptide;Organisim: human;Apparent_Kd_M: 5.574856E-11

Real

Aptamer SeqId: 9398-30 | Target: GALP | UniProt: Q9UBC7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9398-30 | Target: GALP | UniProt: Q9UBC7 | TargetFullName: Galanin-like peptide | Organisim: human | Apparent_Kd_M: 5.574856E-11

Real

Aptamer SeqId:9401-57;Target:CB089;UniProt:Q86V40

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9401-57;Target: CB089;UniProt: Q86V40;TargetFullName: Metalloprotease TIKI1;Organisim: human;Apparent_Kd_M: 1.246193E-10

Real

Aptamer SeqId: 9401-57 | Target: CB089 | UniProt: Q86V40

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9401-57 | Target: CB089 | UniProt: Q86V40 | TargetFullName: Metalloprotease TIKI1 | Organisim: human | Apparent_Kd_M: 1.246193E-10

Real

Aptamer SeqId:9402-18;Target:DCBD1;UniProt:Q8N8Z6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9402-18;Target: DCBD1;UniProt: Q8N8Z6;TargetFullName: Discoidin; CUB and LCCL domain-containing protein 1;Organisim: human;Apparent_Kd_M: 8.054044E-11

Real

Aptamer SeqId: 9402-18 | Target: DCBD1 | UniProt: Q8N8Z6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9402-18 | Target: DCBD1 | UniProt: Q8N8Z6 | TargetFullName: Discoidin; CUB and LCCL domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 8.054044E-11

Real

Aptamer SeqId:9409-11;Target:TRYB1;UniProt:Q15661

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9409-11;Target: TRYB1;UniProt: Q15661;TargetFullName: Tryptase beta-1;Organisim: human;Apparent_Kd_M: 2.158659E-12

Real

Aptamer SeqId: 9409-11 | Target: TRYB1 | UniProt: Q15661

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9409-11 | Target: TRYB1 | UniProt: Q15661 | TargetFullName: Tryptase beta-1 | Organisim: human | Apparent_Kd_M: 2.158659E-12

Real

Aptamer SeqId:9412-52;Target:Activin RIIB;UniProt:Q13705

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9412-52;Target: Activin RIIB;UniProt: Q13705;TargetFullName: Activin receptor type-2B;Organisim: human;Apparent_Kd_M: 3.431124E-12

Real

Aptamer SeqId: 9412-52 | Target: Activin RIIB | UniProt: Q13705

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9412-52 | Target: Activin RIIB | UniProt: Q13705 | TargetFullName: Activin receptor type-2B | Organisim: human | Apparent_Kd_M: 3.431124E-12

Real

Aptamer SeqId:9416-77;Target:CBPM;UniProt:P14384

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9416-77;Target: CBPM;UniProt: P14384;TargetFullName: Carboxypeptidase M;Organisim: human;Apparent_Kd_M: 3.595236E-12

Real

Aptamer SeqId: 9416-77 | Target: CBPM | UniProt: P14384

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9416-77 | Target: CBPM | UniProt: P14384 | TargetFullName: Carboxypeptidase M | Organisim: human | Apparent_Kd_M: 3.595236E-12

Real

Aptamer SeqId:9439-454;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9439-454;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.435378E-11

Real

Aptamer SeqId: 9439-454 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9439-454 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.435378E-11

Real

Aptamer SeqId:9443-137;Target:cathepsin K;UniProt:P43235

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9443-137;Target: cathepsin K;UniProt: P43235;TargetFullName: Cathepsin K;Organisim: human;Apparent_Kd_M: 1.394358E-11

Real

Aptamer SeqId: 9443-137 | Target: cathepsin K | UniProt: P43235

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9443-137 | Target: cathepsin K | UniProt: P43235 | TargetFullName: Cathepsin K | Organisim: human | Apparent_Kd_M: 1.394358E-11

Real

Aptamer SeqId:9444-70;Target:DGCR6;UniProt:Q14129

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9444-70;Target: DGCR6;UniProt: Q14129;TargetFullName: Protein DGCR6;Organisim: human;Apparent_Kd_M: 4.428885E-11

Real

Aptamer SeqId: 9444-70 | Target: DGCR6 | UniProt: Q14129

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9444-70 | Target: DGCR6 | UniProt: Q14129 | TargetFullName: Protein DGCR6 | Organisim: human | Apparent_Kd_M: 4.428885E-11

Real

Aptamer SeqId:9445-44;Target:CS018;UniProt:Q8NEA5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9445-44;Target: CS018;UniProt: Q8NEA5;TargetFullName: Uncharacterized protein C19orf18;Organisim: human;Apparent_Kd_M: 2.013016E-11

Real

Aptamer SeqId: 9445-44 | Target: CS018 | UniProt: Q8NEA5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9445-44 | Target: CS018 | UniProt: Q8NEA5 | TargetFullName: Uncharacterized protein C19orf18 | Organisim: human | Apparent_Kd_M: 2.013016E-11

Real

Aptamer SeqId:9449-150;Target:C4b-binding protein alpha chain;UniProt:P04003

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9449-150;Target: C4b-binding protein alpha chain;UniProt: P04003;TargetFullName: C4b-binding protein alpha chain;Organisim: human;Apparent_Kd_M: 8.775205E-10

Real

Aptamer SeqId: 9449-150 | Target: C4b-binding protein alpha chain

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9449-150 | Target: C4b-binding protein alpha chain | UniProt: P04003 | TargetFullName: C4b-binding protein alpha chain | Organisim: human | Apparent_Kd_M: 8.775205E-10

Real

Aptamer SeqId:9450-18;Target:CDKA1;UniProt:O14519

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9450-18;Target: CDKA1;UniProt: O14519;TargetFullName: Cyclin-dependent kinase 2-associated protein 1;Organisim: human;Apparent_Kd_M: 6.738343E-12

Real

Aptamer SeqId: 9450-18 | Target: CDKA1 | UniProt: O14519

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9450-18 | Target: CDKA1 | UniProt: O14519 | TargetFullName: Cyclin-dependent kinase 2-associated protein 1 | Organisim: human | Apparent_Kd_M: 6.738343E-12

Real

Aptamer SeqId:9451-20;Target:Uromodulin;UniProt:P07911

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9451-20;Target: Uromodulin;UniProt: P07911;TargetFullName: Uromodulin;Organisim: human;Apparent_Kd_M: 6.882476E-11

Real

Aptamer SeqId: 9451-20 | Target: Uromodulin | UniProt: P07911

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9451-20 | Target: Uromodulin | UniProt: P07911 | TargetFullName: Uromodulin | Organisim: human | Apparent_Kd_M: 6.882476E-11

Real

Aptamer SeqId:9453-12;Target:VEGF-B;UniProt:P49765

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9453-12;Target: VEGF-B;UniProt: P49765;TargetFullName: Vascular endothelial growth factor B;Organisim: human;Apparent_Kd_M: 1.033138E-11

Real

Aptamer SeqId: 9453-12 | Target: VEGF-B | UniProt: P49765

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9453-12 | Target: VEGF-B | UniProt: P49765 | TargetFullName: Vascular endothelial growth factor B | Organisim: human | Apparent_Kd_M: 1.033138E-11

Real

Aptamer SeqId:9457-3;Target:CAV2;UniProt:P51636

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9457-3;Target: CAV2;UniProt: P51636;TargetFullName: Caveolin-2;Organisim: human;Apparent_Kd_M: 4.065596E-11

Real

Aptamer SeqId: 9457-3 | Target: CAV2 | UniProt: P51636

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9457-3 | Target: CAV2 | UniProt: P51636 | TargetFullName: Caveolin-2 | Organisim: human | Apparent_Kd_M: 4.065596E-11

Real

Aptamer SeqId:9459-7;Target:Fas; soluble;UniProt:P25445

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9459-7;Target: Fas; soluble;UniProt: P25445;TargetFullName: Tumor necrosis factor receptor superfamily member 6;Organisim: human;Apparent_Kd_M: 1.026872E-11

Real

Aptamer SeqId: 9459-7 | Target: Fas; soluble | UniProt: P25445

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9459-7 | Target: Fas; soluble | UniProt: P25445 | TargetFullName: Tumor necrosis factor receptor superfamily member 6 | Organisim: human | Apparent_Kd_M: 1.026872E-11

Real

Aptamer SeqId:9463-26;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9463-26;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.686686E-12

Real

Aptamer SeqId: 9463-26 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9463-26 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.686686E-12

Real

Aptamer SeqId:9467-24;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9467-24;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.074336E-11

Real

Aptamer SeqId: 9467-24 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9467-24 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.074336E-11

Real

Aptamer SeqId:9468-8;Target:Lectin; mannose-binding 2;UniProt:Q12907

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9468-8;Target: Lectin; mannose-binding 2;UniProt: Q12907;TargetFullName: Vesicular integral-membrane protein VIP36;Organisim: human;Apparent_Kd_M: 2.179075E-12

Real

Aptamer SeqId: 9468-8 | Target: Lectin; mannose-binding 2 | UniProt: Q12907

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9468-8 | Target: Lectin; mannose-binding 2 | UniProt: Q12907 | TargetFullName: Vesicular integral-membrane protein VIP36 | Organisim: human | Apparent_Kd_M: 2.179075E-12

Real

Aptamer SeqId:9470-15;Target:MET24;UniProt:Q5JXM2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9470-15;Target: MET24;UniProt: Q5JXM2;TargetFullName: Methyltransferase-like protein 24;Organisim: human;Apparent_Kd_M: 2.292963E-11

Real

Aptamer SeqId: 9470-15 | Target: MET24 | UniProt: Q5JXM2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9470-15 | Target: MET24 | UniProt: Q5JXM2 | TargetFullName: Methyltransferase-like protein 24 | Organisim: human | Apparent_Kd_M: 2.292963E-11

Real

Aptamer SeqId:9474-22;Target:ASGR2;UniProt:P07307

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9474-22;Target: ASGR2;UniProt: P07307;TargetFullName: Asialoglycoprotein receptor 2;Organisim: human;Apparent_Kd_M: 7.531957E-11

Real

Aptamer SeqId: 9474-22 | Target: ASGR2 | UniProt: P07307

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9474-22 | Target: ASGR2 | UniProt: P07307 | TargetFullName: Asialoglycoprotein receptor 2 | Organisim: human | Apparent_Kd_M: 7.531957E-11

Real

Aptamer SeqId:9475-22;Target:GPX5;UniProt:O75715

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9475-22;Target: GPX5;UniProt: O75715;TargetFullName: Epididymal secretory glutathione peroxidase;Organisim: human;Apparent_Kd_M: 2.102851E-10

Real

Aptamer SeqId: 9475-22 | Target: GPX5 | UniProt: O75715

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9475-22 | Target: GPX5 | UniProt: O75715 | TargetFullName: Epididymal secretory glutathione peroxidase | Organisim: human | Apparent_Kd_M: 2.102851E-10

Real

Aptamer SeqId:9478-69;Target:KPRA;UniProt:Q14558

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9478-69;Target: KPRA;UniProt: Q14558;TargetFullName: Phosphoribosyl pyrophosphate synthase-associated protein 1;Organisim: human;Apparent_Kd_M: 4.190513E-11

Real

Aptamer SeqId: 9478-69 | Target: KPRA | UniProt: Q14558

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9478-69 | Target: KPRA | UniProt: Q14558 | TargetFullName: Phosphoribosyl pyrophosphate synthase-associated protein 1 | Organisim: human | Apparent_Kd_M: 4.190513E-11

Real

Aptamer SeqId:9482-110;Target:NUDT9;UniProt:Q9BW91

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9482-110;Target: NUDT9;UniProt: Q9BW91;TargetFullName: ADP-ribose pyrophosphatase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.278504E-12

Real

Aptamer SeqId: 9482-110 | Target: NUDT9 | UniProt: Q9BW91

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9482-110 | Target: NUDT9 | UniProt: Q9BW91 | TargetFullName: ADP-ribose pyrophosphatase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.278504E-12

Real

Aptamer SeqId:9484-75;Target:Desmoglein-2;UniProt:Q14126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9484-75;Target: Desmoglein-2;UniProt: Q14126;TargetFullName: Desmoglein-2;Organisim: human;Apparent_Kd_M: 5.692999E-11

Real

Aptamer SeqId: 9484-75 | Target: Desmoglein-2 | UniProt: Q14126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9484-75 | Target: Desmoglein-2 | UniProt: Q14126 | TargetFullName: Desmoglein-2 | Organisim: human | Apparent_Kd_M: 5.692999E-11

Real

Aptamer SeqId:9486-13;Target:DB125;UniProt:Q8N687

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9486-13;Target: DB125;UniProt: Q8N687;TargetFullName: Beta-defensin 125;Organisim: human;Apparent_Kd_M: 7.180709E-11

Real

Aptamer SeqId: 9486-13 | Target: DB125 | UniProt: Q8N687

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9486-13 | Target: DB125 | UniProt: Q8N687 | TargetFullName: Beta-defensin 125 | Organisim: human | Apparent_Kd_M: 7.180709E-11

Real

Aptamer SeqId:9487-60;Target:Growth hormone-releasing factor;UniProt:P01286

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9487-60;Target: Growth hormone-releasing factor;UniProt: P01286;TargetFullName: Somatoliberin;Organisim: human;Apparent_Kd_M: 3.979898E-11

Real

Aptamer SeqId: 9487-60 | Target: Growth hormone-releasing factor

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9487-60 | Target: Growth hormone-releasing factor | UniProt: P01286 | TargetFullName: Somatoliberin | Organisim: human | Apparent_Kd_M: 3.979898E-11

Real

Aptamer SeqId:9490-3;Target:CD032;UniProt:Q8N8J7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9490-3;Target: CD032;UniProt: Q8N8J7;TargetFullName: Uncharacterized protein C4orf32;Organisim: human;Apparent_Kd_M: 2.964129E-11

Real

Aptamer SeqId: 9490-3 | Target: CD032 | UniProt: Q8N8J7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9490-3 | Target: CD032 | UniProt: Q8N8J7 | TargetFullName: Uncharacterized protein C4orf32 | Organisim: human | Apparent_Kd_M: 2.964129E-11

Real

Aptamer SeqId:9491-13;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9491-13;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 6.000729E-11

Real

Aptamer SeqId: 9491-13 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9491-13 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 6.000729E-11

Real

Aptamer SeqId:9492-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9492-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.40634E-11

Real

Aptamer SeqId: 9492-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9492-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.40634E-11

Real

Aptamer SeqId:9493-56;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9493-56;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.067572E-10

Real

Aptamer SeqId: 9493-56 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9493-56 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.067572E-10

Real

Aptamer SeqId:9495-10;Target:VCC1;UniProt:Q6UXB2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9495-10;Target: VCC1;UniProt: Q6UXB2;TargetFullName: C-X-C motif chemokine 17;Organisim: human;Apparent_Kd_M: 4.154463E-10

Real

Aptamer SeqId: 9495-10 | Target: VCC1 | UniProt: Q6UXB2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9495-10 | Target: VCC1 | UniProt: Q6UXB2 | TargetFullName: C-X-C motif chemokine 17 | Organisim: human | Apparent_Kd_M: 4.154463E-10

Real

Aptamer SeqId:9497-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9497-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 5.160125E-12

Real

Aptamer SeqId: 9497-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9497-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 5.160125E-12

Real

Aptamer SeqId:9500-5;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9500-5;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.473797E-11

Real

Aptamer SeqId: 9500-5 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9500-5 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.473797E-11

Real

Aptamer SeqId:9503-1;Target:NMS;UniProt:Q5H8A3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9503-1;Target: NMS;UniProt: Q5H8A3;TargetFullName: Neuromedin-S;Organisim: human;Apparent_Kd_M: 2.930654E-11

Real

Aptamer SeqId: 9503-1 | Target: NMS | UniProt: Q5H8A3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9503-1 | Target: NMS | UniProt: Q5H8A3 | TargetFullName: Neuromedin-S | Organisim: human | Apparent_Kd_M: 2.930654E-11

Real

Aptamer SeqId:9504-19;Target:RB27A;UniProt:P51159

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9504-19;Target: RB27A;UniProt: P51159;TargetFullName: Ras-related protein Rab-27A;Organisim: human;Apparent_Kd_M: 1.873664E-10

Real

Aptamer SeqId: 9504-19 | Target: RB27A | UniProt: P51159

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9504-19 | Target: RB27A | UniProt: P51159 | TargetFullName: Ras-related protein Rab-27A | Organisim: human | Apparent_Kd_M: 1.873664E-10

Real

Aptamer SeqId:9506-10;Target:Apo L1;UniProt:O14791

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9506-10;Target: Apo L1;UniProt: O14791;TargetFullName: Apolipoprotein L1;Organisim: human;Apparent_Kd_M: 3.526054E-12

Real

Aptamer SeqId: 9506-10 | Target: Apo L1 | UniProt: O14791

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9506-10 | Target: Apo L1 | UniProt: O14791 | TargetFullName: Apolipoprotein L1 | Organisim: human | Apparent_Kd_M: 3.526054E-12

Real

Aptamer SeqId:9508-104;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9508-104;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.658566E-12

Real

Aptamer SeqId: 9508-104 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9508-104 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.658566E-12

Real

Aptamer SeqId:9509-4;Target:TM38B;UniProt:Q9NVV0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9509-4;Target: TM38B;UniProt: Q9NVV0;TargetFullName: Trimeric intracellular cation channel type B;Organisim: human;Apparent_Kd_M: 2.600566E-10

Real

Aptamer SeqId: 9509-4 | Target: TM38B | UniProt: Q9NVV0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9509-4 | Target: TM38B | UniProt: Q9NVV0 | TargetFullName: Trimeric intracellular cation channel type B | Organisim: human | Apparent_Kd_M: 2.600566E-10

Real

Aptamer SeqId:9511-61;Target:NXPH2;UniProt:O95156

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9511-61;Target: NXPH2;UniProt: O95156;TargetFullName: Neurexophilin-2;Organisim: human;Apparent_Kd_M: 2.435817E-11

Real

Aptamer SeqId: 9511-61 | Target: NXPH2 | UniProt: O95156

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9511-61 | Target: NXPH2 | UniProt: O95156 | TargetFullName: Neurexophilin-2 | Organisim: human | Apparent_Kd_M: 2.435817E-11

Real

Aptamer SeqId:9512-24;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9512-24;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.395444E-11

Real

Aptamer SeqId: 9512-24 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9512-24 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.395444E-11

Real

Aptamer SeqId:9513-9;Target:FGF22;UniProt:Q9HCT0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9513-9;Target: FGF22;UniProt: Q9HCT0;TargetFullName: Fibroblast growth factor 22;Organisim: human;Apparent_Kd_M: 1.433623E-10

Real

Aptamer SeqId: 9513-9 | Target: FGF22 | UniProt: Q9HCT0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9513-9 | Target: FGF22 | UniProt: Q9HCT0 | TargetFullName: Fibroblast growth factor 22 | Organisim: human | Apparent_Kd_M: 1.433623E-10

Real

Aptamer SeqId:9518-95;Target:PLA1A;UniProt:Q53H76

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9518-95;Target: PLA1A;UniProt: Q53H76;TargetFullName: Phospholipase A1 member A;Organisim: human;Apparent_Kd_M: 3.218665E-10

Real

Aptamer SeqId: 9518-95 | Target: PLA1A | UniProt: Q53H76

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9518-95 | Target: PLA1A | UniProt: Q53H76 | TargetFullName: Phospholipase A1 member A | Organisim: human | Apparent_Kd_M: 3.218665E-10

Real

Aptamer SeqId:9522-3;Target:AIF;UniProt:O95831

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9522-3;Target: AIF;UniProt: O95831;TargetFullName: Apoptosis-inducing factor 1; mitochondrial;Organisim: human;Apparent_Kd_M: 6.472734E-11

Real

Aptamer SeqId: 9522-3 | Target: AIF | UniProt: O95831

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9522-3 | Target: AIF | UniProt: O95831 | TargetFullName: Apoptosis-inducing factor 1; mitochondrial | Organisim: human | Apparent_Kd_M: 6.472734E-11

Real

Aptamer SeqId:9523-34;Target:ITM2C;UniProt:Q9NQX7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9523-34;Target: ITM2C;UniProt: Q9NQX7;TargetFullName: Integral membrane protein 2C;Organisim: human;Apparent_Kd_M: 1.068517E-10

Real

Aptamer SeqId: 9523-34 | Target: ITM2C | UniProt: Q9NQX7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9523-34 | Target: ITM2C | UniProt: Q9NQX7 | TargetFullName: Integral membrane protein 2C | Organisim: human | Apparent_Kd_M: 1.068517E-10

Real

Aptamer SeqId:9524-46;Target:S31D4;UniProt:Q6ZUB0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9524-46;Target: S31D4;UniProt: Q6ZUB0;TargetFullName: Putative spermatogenesis-associated protein 31D4;Organisim: human;Apparent_Kd_M: 1.405188E-10

Real

Aptamer SeqId: 9524-46 | Target: S31D4 | UniProt: Q6ZUB0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9524-46 | Target: S31D4 | UniProt: Q6ZUB0 | TargetFullName: Putative spermatogenesis-associated protein 31D4 | Organisim: human | Apparent_Kd_M: 1.405188E-10

Real

Aptamer SeqId:9525-1;Target:PTK7;UniProt:Q13308

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9525-1;Target: PTK7;UniProt: Q13308;TargetFullName: Inactive tyrosine-protein kinase 7;Organisim: human;Apparent_Kd_M: 1.136495E-10

Real

Aptamer SeqId: 9525-1 | Target: PTK7 | UniProt: Q13308

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9525-1 | Target: PTK7 | UniProt: Q13308 | TargetFullName: Inactive tyrosine-protein kinase 7 | Organisim: human | Apparent_Kd_M: 1.136495E-10

Real

Aptamer SeqId:9526-3;Target:COLL1;UniProt:A2RUU4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9526-3;Target: COLL1;UniProt: A2RUU4;TargetFullName: Colipase-like protein 1;Organisim: human;Apparent_Kd_M: 6.17041E-11

Real

Aptamer SeqId: 9526-3 | Target: COLL1 | UniProt: A2RUU4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9526-3 | Target: COLL1 | UniProt: A2RUU4 | TargetFullName: Colipase-like protein 1 | Organisim: human | Apparent_Kd_M: 6.17041E-11

Real

Aptamer SeqId:9530-6;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9530-6;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.615199E-12

Real

Aptamer SeqId: 9530-6 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9530-6 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.615199E-12

Real

Aptamer SeqId:9531-24;Target:LST1;UniProt:O00453

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9531-24;Target: LST1;UniProt: O00453;TargetFullName: Leukocyte-specific transcript 1 protein;Organisim: human;Apparent_Kd_M: 1.033033E-11

Real

Aptamer SeqId: 9531-24 | Target: LST1 | UniProt: O00453

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9531-24 | Target: LST1 | UniProt: O00453 | TargetFullName: Leukocyte-specific transcript 1 protein | Organisim: human | Apparent_Kd_M: 1.033033E-11

Real

Aptamer SeqId:9532-5;Target:WBP1L;UniProt:Q9NX94

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9532-5;Target: WBP1L;UniProt: Q9NX94;TargetFullName: WW domain binding protein 1-like;Organisim: human;Apparent_Kd_M: 5.892026E-12

Real

Aptamer SeqId: 9532-5 | Target: WBP1L | UniProt: Q9NX94

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9532-5 | Target: WBP1L | UniProt: Q9NX94 | TargetFullName: WW domain binding protein 1-like | Organisim: human | Apparent_Kd_M: 5.892026E-12

Real

Aptamer SeqId:9535-14;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9535-14;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 3.375149E-10

Real

Aptamer SeqId: 9535-14 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9535-14 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 3.375149E-10

Real

Aptamer SeqId:9536-16;Target:EP3A;UniProt:Q14507

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9536-16;Target: EP3A;UniProt: Q14507;TargetFullName: Epididymal secretory protein E3-alpha;Organisim: human;Apparent_Kd_M: 7.326717E-11

Real

Aptamer SeqId: 9536-16 | Target: EP3A | UniProt: Q14507

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9536-16 | Target: EP3A | UniProt: Q14507 | TargetFullName: Epididymal secretory protein E3-alpha | Organisim: human | Apparent_Kd_M: 7.326717E-11

Real

Aptamer SeqId:9539-25;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9539-25;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.366936E-11

Real

Aptamer SeqId: 9539-25 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9539-25 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.366936E-11

Real

Aptamer SeqId:9541-15;Target:B3GT1;UniProt:Q9Y5Z6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9541-15;Target: B3GT1;UniProt: Q9Y5Z6;TargetFullName: Beta-1;3-galactosyltransferase 1;Organisim: human;Apparent_Kd_M: 6.742607E-11

Real

Aptamer SeqId: 9541-15 | Target: B3GT1 | UniProt: Q9Y5Z6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9541-15 | Target: B3GT1 | UniProt: Q9Y5Z6 | TargetFullName: Beta-1;3-galactosyltransferase 1 | Organisim: human | Apparent_Kd_M: 6.742607E-11

Real

Aptamer SeqId:9543-131;Target:COG8;UniProt:Q96MW5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9543-131;Target: COG8;UniProt: Q96MW5;TargetFullName: Conserved oligomeric Golgi complex subunit 8;Organisim: human;Apparent_Kd_M: 7.740219E-12

Real

Aptamer SeqId: 9543-131 | Target: COG8 | UniProt: Q96MW5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9543-131 | Target: COG8 | UniProt: Q96MW5 | TargetFullName: Conserved oligomeric Golgi complex subunit 8 | Organisim: human | Apparent_Kd_M: 7.740219E-12

Real

Aptamer SeqId:9544-24;Target:CG069;UniProt:Q9H7B7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9544-24;Target: CG069;UniProt: Q9H7B7;TargetFullName: Uncharacterized protein C7orf69;Organisim: human;Apparent_Kd_M: 1.077323E-10

Real

Aptamer SeqId: 9544-24 | Target: CG069 | UniProt: Q9H7B7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9544-24 | Target: CG069 | UniProt: Q9H7B7 | TargetFullName: Uncharacterized protein C7orf69 | Organisim: human | Apparent_Kd_M: 1.077323E-10

Real

Aptamer SeqId:9545-156;Target:Granzyme K;UniProt:P49863

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9545-156;Target: Granzyme K;UniProt: P49863;TargetFullName: Granzyme K;Organisim: human;Apparent_Kd_M: 8.85015E-11

Real

Aptamer SeqId: 9545-156 | Target: Granzyme K | UniProt: P49863

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9545-156 | Target: Granzyme K | UniProt: P49863 | TargetFullName: Granzyme K | Organisim: human | Apparent_Kd_M: 8.85015E-11

Real

Aptamer SeqId:9547-29;Target:EMID1;UniProt:Q96A84

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9547-29;Target: EMID1;UniProt: Q96A84;TargetFullName: EMI domain-containing protein 1;Organisim: human;Apparent_Kd_M: 1.103009E-11

Real

Aptamer SeqId: 9547-29 | Target: EMID1 | UniProt: Q96A84

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9547-29 | Target: EMID1 | UniProt: Q96A84 | TargetFullName: EMI domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 1.103009E-11

Real

Aptamer SeqId:9550-153;Target:TTC17;UniProt:Q96AE7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9550-153;Target: TTC17;UniProt: Q96AE7;TargetFullName: Tetratricopeptide repeat protein 17;Organisim: human;Apparent_Kd_M: 1.16024E-10

Real

Aptamer SeqId: 9550-153 | Target: TTC17 | UniProt: Q96AE7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9550-153 | Target: TTC17 | UniProt: Q96AE7 | TargetFullName: Tetratricopeptide repeat protein 17 | Organisim: human | Apparent_Kd_M: 1.16024E-10

Real

Aptamer SeqId:9557-5;Target:MANS1;UniProt:Q9H8J5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9557-5;Target: MANS1;UniProt: Q9H8J5;TargetFullName: MANSC domain-containing protein 1;Organisim: human;Apparent_Kd_M: 4.111841E-12

Real

Aptamer SeqId: 9557-5 | Target: MANS1 | UniProt: Q9H8J5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9557-5 | Target: MANS1 | UniProt: Q9H8J5 | TargetFullName: MANSC domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 4.111841E-12

Real

Aptamer SeqId:9561-21;Target:CSPG2;UniProt:P13611

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9561-21;Target: CSPG2;UniProt: P13611;TargetFullName: Versican core protein;Organisim: human;Apparent_Kd_M: 9.765808E-12

Real

Aptamer SeqId: 9561-21 | Target: CSPG2 | UniProt: P13611

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9561-21 | Target: CSPG2 | UniProt: P13611 | TargetFullName: Versican core protein | Organisim: human | Apparent_Kd_M: 9.765808E-12

Real

Aptamer SeqId:9565-6;Target:PAWR;UniProt:Q96IZ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9565-6;Target: PAWR;UniProt: Q96IZ0;TargetFullName: PRKC apoptosis WT1 regulator protein;Organisim: human;Apparent_Kd_M: 6.358591E-11

Real

Aptamer SeqId: 9565-6 | Target: PAWR | UniProt: Q96IZ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9565-6 | Target: PAWR | UniProt: Q96IZ0 | TargetFullName: PRKC apoptosis WT1 regulator protein | Organisim: human | Apparent_Kd_M: 6.358591E-11

Real

Aptamer SeqId:9566-103;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9566-103;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.876763E-11

Real

Aptamer SeqId: 9566-103 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9566-103 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.876763E-11

Real

Aptamer SeqId:9568-289;Target:FCAMR;UniProt:Q8WWV6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9568-289;Target: FCAMR;UniProt: Q8WWV6;TargetFullName: High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor;Organisim: human;Apparent_Kd_M: 2.666147E-11

Real

Aptamer SeqId: 9568-289 | Target: FCAMR | UniProt: Q8WWV6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9568-289 | Target: FCAMR | UniProt: Q8WWV6 | TargetFullName: High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor | Organisim: human | Apparent_Kd_M: 2.666147E-11

Real

Aptamer SeqId:9573-108;Target:TXD11;UniProt:Q6PKC3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9573-108;Target: TXD11;UniProt: Q6PKC3;TargetFullName: Thioredoxin domain-containing protein 11;Organisim: human;Apparent_Kd_M: 8.783749E-12

Real

Aptamer SeqId: 9573-108 | Target: TXD11 | UniProt: Q6PKC3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9573-108 | Target: TXD11 | UniProt: Q6PKC3 | TargetFullName: Thioredoxin domain-containing protein 11 | Organisim: human | Apparent_Kd_M: 8.783749E-12

Real

Aptamer SeqId:9574-11;Target:BIN1;UniProt:O00499

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9574-11;Target: BIN1;UniProt: O00499;TargetFullName: Myc box-dependent-interacting protein 1;Organisim: human;Apparent_Kd_M: 5.17945E-12

Real

Aptamer SeqId: 9574-11 | Target: BIN1 | UniProt: O00499

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9574-11 | Target: BIN1 | UniProt: O00499 | TargetFullName: Myc box-dependent-interacting protein 1 | Organisim: human | Apparent_Kd_M: 5.17945E-12

Real

Aptamer SeqId:9576-58;Target:MNX1;UniProt:P50219

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9576-58;Target: MNX1;UniProt: P50219;TargetFullName: Motor neuron and pancreas homeobox protein 1;Organisim: human;Apparent_Kd_M: 1.96112E-11

Real

Aptamer SeqId: 9576-58 | Target: MNX1 | UniProt: P50219

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9576-58 | Target: MNX1 | UniProt: P50219 | TargetFullName: Motor neuron and pancreas homeobox protein 1 | Organisim: human | Apparent_Kd_M: 1.96112E-11

Real

Aptamer SeqId:9577-26;Target:SYT2;UniProt:Q8N9I0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9577-26;Target: SYT2;UniProt: Q8N9I0;TargetFullName: Synaptotagmin-2;Organisim: human;Apparent_Kd_M: 2.121199E-12

Real

Aptamer SeqId: 9577-26 | Target: SYT2 | UniProt: Q8N9I0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9577-26 | Target: SYT2 | UniProt: Q8N9I0 | TargetFullName: Synaptotagmin-2 | Organisim: human | Apparent_Kd_M: 2.121199E-12

Real

Aptamer SeqId:9578-263;Target:MANS4;UniProt:A6NHS7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9578-263;Target: MANS4;UniProt: A6NHS7;TargetFullName: MANSC domain-containing protein 4;Organisim: human;Apparent_Kd_M: 3.246052E-12

Real

Aptamer SeqId: 9578-263 | Target: MANS4 | UniProt: A6NHS7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9578-263 | Target: MANS4 | UniProt: A6NHS7 | TargetFullName: MANSC domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 3.246052E-12

Real

Aptamer SeqId:9579-59;Target:TMG4;UniProt:Q9BZD6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9579-59;Target: TMG4;UniProt: Q9BZD6;TargetFullName: Transmembrane gamma-carboxyglutamic acid protein 4;Organisim: human;Apparent_Kd_M: 3.29337E-11

Real

Aptamer SeqId: 9579-59 | Target: TMG4 | UniProt: Q9BZD6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9579-59 | Target: TMG4 | UniProt: Q9BZD6 | TargetFullName: Transmembrane gamma-carboxyglutamic acid protein 4 | Organisim: human | Apparent_Kd_M: 3.29337E-11

Real

Aptamer SeqId:9580-5;Target:Laminin gamma-2;UniProt:Q13753

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9580-5;Target: Laminin gamma-2;UniProt: Q13753;TargetFullName: Laminin subunit gamma-2;Organisim: human;Apparent_Kd_M: 5.166967E-11

Real

Aptamer SeqId: 9580-5 | Target: Laminin gamma-2 | UniProt: Q13753

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9580-5 | Target: Laminin gamma-2 | UniProt: Q13753 | TargetFullName: Laminin subunit gamma-2 | Organisim: human | Apparent_Kd_M: 5.166967E-11

Real

Aptamer SeqId:9581-4;Target:PRP6;UniProt:O94906

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9581-4;Target: PRP6;UniProt: O94906;TargetFullName: Pre-mRNA-processing factor 6;Organisim: human;Apparent_Kd_M: 8.929032E-12

Real

Aptamer SeqId: 9581-4 | Target: PRP6 | UniProt: O94906

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9581-4 | Target: PRP6 | UniProt: O94906 | TargetFullName: Pre-mRNA-processing factor 6 | Organisim: human | Apparent_Kd_M: 8.929032E-12

Real

Aptamer SeqId:9582-93;Target:SUSD1;UniProt:Q6UWL2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9582-93;Target: SUSD1;UniProt: Q6UWL2;TargetFullName: Sushi domain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.195472E-12

Real

Aptamer SeqId: 9582-93 | Target: SUSD1 | UniProt: Q6UWL2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9582-93 | Target: SUSD1 | UniProt: Q6UWL2 | TargetFullName: Sushi domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.195472E-12

Real

Aptamer SeqId:9583-17;Target:RNF24;UniProt:Q9Y225

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9583-17;Target: RNF24;UniProt: Q9Y225;TargetFullName: RING finger protein 24;Organisim: human;Apparent_Kd_M: 7.696511E-11

Real

Aptamer SeqId: 9583-17 | Target: RNF24 | UniProt: Q9Y225

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9583-17 | Target: RNF24 | UniProt: Q9Y225 | TargetFullName: RING finger protein 24 | Organisim: human | Apparent_Kd_M: 7.696511E-11

Real

Aptamer SeqId:9584-105;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9584-105;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.261278E-11

Real

Aptamer SeqId: 9584-105 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9584-105 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.261278E-11

Real

Aptamer SeqId:9585-80;Target:ACAM;UniProt:Q9H6B4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9585-80;Target: ACAM;UniProt: Q9H6B4;TargetFullName: CXADR-like membrane protein;Organisim: human;Apparent_Kd_M: 2.815404E-11

Real

Aptamer SeqId: 9585-80 | Target: ACAM | UniProt: Q9H6B4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9585-80 | Target: ACAM | UniProt: Q9H6B4 | TargetFullName: CXADR-like membrane protein | Organisim: human | Apparent_Kd_M: 2.815404E-11

Real

Aptamer SeqId:9590-10;Target:COX7R;UniProt:O14548

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9590-10;Target: COX7R;UniProt: O14548;TargetFullName: Cytochrome c oxidase subunit 7A-related protein; mitochondrial;Organisim: human;Apparent_Kd_M: 2.293517E-11

Real

Aptamer SeqId: 9590-10 | Target: COX7R | UniProt: O14548

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9590-10 | Target: COX7R | UniProt: O14548 | TargetFullName: Cytochrome c oxidase subunit 7A-related protein; mitochondrial | Organisim: human | Apparent_Kd_M: 2.293517E-11

Real

Aptamer SeqId:9594-30;Target:ZNT5;UniProt:Q8TAD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9594-30;Target: ZNT5;UniProt: Q8TAD4;TargetFullName: Zinc transporter 5;Organisim: human;Apparent_Kd_M: 1.654355E-10

Real

Aptamer SeqId: 9594-30 | Target: ZNT5 | UniProt: Q8TAD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9594-30 | Target: ZNT5 | UniProt: Q8TAD4 | TargetFullName: Zinc transporter 5 | Organisim: human | Apparent_Kd_M: 1.654355E-10

Real

Aptamer SeqId:9595-11;Target:B4GT2;UniProt:O60909

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9595-11;Target: B4GT2;UniProt: O60909;TargetFullName: Beta-1;4-galactosyltransferase 2;Organisim: human;Apparent_Kd_M: 9.425846E-12

Real

Aptamer SeqId: 9595-11 | Target: B4GT2 | UniProt: O60909

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9595-11 | Target: B4GT2 | UniProt: O60909 | TargetFullName: Beta-1;4-galactosyltransferase 2 | Organisim: human | Apparent_Kd_M: 9.425846E-12

Real

Aptamer SeqId:9598-23;Target:CSMD1;UniProt:Q96PZ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9598-23;Target: CSMD1;UniProt: Q96PZ7;TargetFullName: CUB and sushi domain-containing protein 1;Organisim: human;Apparent_Kd_M: 3.198582E-12

Real

Aptamer SeqId: 9598-23 | Target: CSMD1 | UniProt: Q96PZ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9598-23 | Target: CSMD1 | UniProt: Q96PZ7 | TargetFullName: CUB and sushi domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 3.198582E-12

Real

Aptamer SeqId:9599-6;Target:PIANP;UniProt:Q8IYJ0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9599-6;Target: PIANP;UniProt: Q8IYJ0;TargetFullName: PILR alpha-associated neural protein;Organisim: human;Apparent_Kd_M: 2.562663E-12

Real

Aptamer SeqId: 9599-6 | Target: PIANP | UniProt: Q8IYJ0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9599-6 | Target: PIANP | UniProt: Q8IYJ0 | TargetFullName: PILR alpha-associated neural protein | Organisim: human | Apparent_Kd_M: 2.562663E-12

Real

Aptamer SeqId:9600-55;Target:THS7A;UniProt:Q9UPZ6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9600-55;Target: THS7A;UniProt: Q9UPZ6;TargetFullName: Thrombospondin type-1 domain-containing protein 7A;Organisim: human;Apparent_Kd_M: 5.305308E-11

Real

Aptamer SeqId: 9600-55 | Target: THS7A | UniProt: Q9UPZ6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9600-55 | Target: THS7A | UniProt: Q9UPZ6 | TargetFullName: Thrombospondin type-1 domain-containing protein 7A | Organisim: human | Apparent_Kd_M: 5.305308E-11

Real

Aptamer SeqId:9606-4;Target:P210L;UniProt:Q5VU65

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9606-4;Target: P210L;UniProt: Q5VU65;TargetFullName: Nuclear pore membrane glycoprotein 210-like;Organisim: human;Apparent_Kd_M: 1.041356E-11

Real

Aptamer SeqId: 9606-4 | Target: P210L | UniProt: Q5VU65

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9606-4 | Target: P210L | UniProt: Q5VU65 | TargetFullName: Nuclear pore membrane glycoprotein 210-like | Organisim: human | Apparent_Kd_M: 1.041356E-11

Real

Aptamer SeqId:9607-39;Target:CD040;UniProt:Q6MZM9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9607-39;Target: CD040;UniProt: Q6MZM9;TargetFullName: Proline-rich protein 27;Organisim: human;Apparent_Kd_M: 4.033716E-11

Real

Aptamer SeqId: 9607-39 | Target: CD040 | UniProt: Q6MZM9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9607-39 | Target: CD040 | UniProt: Q6MZM9 | TargetFullName: Proline-rich protein 27 | Organisim: human | Apparent_Kd_M: 4.033716E-11

Real

Aptamer SeqId:9609-25;Target:ZN275;UniProt:Q9NSD4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9609-25;Target: ZN275;UniProt: Q9NSD4;TargetFullName: Zinc finger protein 275;Organisim: human;Apparent_Kd_M: 8.643724E-11

Real

Aptamer SeqId: 9609-25 | Target: ZN275 | UniProt: Q9NSD4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9609-25 | Target: ZN275 | UniProt: Q9NSD4 | TargetFullName: Zinc finger protein 275 | Organisim: human | Apparent_Kd_M: 8.643724E-11

Real

Aptamer SeqId:9613-16;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9613-16;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.315692E-11

Real

Aptamer SeqId: 9613-16 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9613-16 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.315692E-11

Real

Aptamer SeqId:9638-2;Target:TIGIT;UniProt:Q495A1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9638-2;Target: TIGIT;UniProt: Q495A1;TargetFullName: T-cell immunoreceptor with Ig and ITIM domains;Organisim: human;Apparent_Kd_M: 1.75E-11

Real

Aptamer SeqId: 9638-2 | Target: TIGIT | UniProt: Q495A1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9638-2 | Target: TIGIT | UniProt: Q495A1 | TargetFullName: T-cell immunoreceptor with Ig and ITIM domains | Organisim: human | Apparent_Kd_M: 1.75E-11

Real

Aptamer SeqId:9713-67;Target:PGFRL;UniProt:Q15198

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9713-67;Target: PGFRL;UniProt: Q15198;TargetFullName: Platelet-derived growth factor receptor-like protein;Organisim: human;Apparent_Kd_M: 2.547737E-11

Real

Aptamer SeqId: 9713-67 | Target: PGFRL | UniProt: Q15198

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9713-67 | Target: PGFRL | UniProt: Q15198 | TargetFullName: Platelet-derived growth factor receptor-like protein | Organisim: human | Apparent_Kd_M: 2.547737E-11

Real

Aptamer SeqId:9715-15;Target:IGSF3;UniProt:O75054

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9715-15;Target: IGSF3;UniProt: O75054;TargetFullName: Immunoglobulin superfamily member 3;Organisim: human;Apparent_Kd_M: 1.155386E-11

Real

Aptamer SeqId: 9715-15 | Target: IGSF3 | UniProt: O75054

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9715-15 | Target: IGSF3 | UniProt: O75054 | TargetFullName: Immunoglobulin superfamily member 3 | Organisim: human | Apparent_Kd_M: 1.155386E-11

Real

Aptamer SeqId:9719-145;Target:MMP-16;UniProt:P51512

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9719-145;Target: MMP-16;UniProt: P51512;TargetFullName: Matrix metalloproteinase-16;Organisim: human;Apparent_Kd_M: 2.141334E-12

Real

Aptamer SeqId: 9719-145 | Target: MMP-16 | UniProt: P51512

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9719-145 | Target: MMP-16 | UniProt: P51512 | TargetFullName: Matrix metalloproteinase-16 | Organisim: human | Apparent_Kd_M: 2.141334E-12

Real

Aptamer SeqId:9723-105;Target:EMILIN-3;UniProt:Q9H8L6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9723-105;Target: EMILIN-3;UniProt: Q9H8L6;TargetFullName: Multimerin-2;Organisim: human;Apparent_Kd_M: 8.330176E-11

Real

Aptamer SeqId: 9723-105 | Target: EMILIN-3 | UniProt: Q9H8L6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9723-105 | Target: EMILIN-3 | UniProt: Q9H8L6 | TargetFullName: Multimerin-2 | Organisim: human | Apparent_Kd_M: 8.330176E-11

Real

Aptamer SeqId:9728-4;Target:CIP1;UniProt:Q9NPC3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9728-4;Target: CIP1;UniProt: Q9NPC3;TargetFullName: E3 ubiquitin-protein ligase CCNB1IP1;Organisim: human;Apparent_Kd_M: 4.610692E-12

Real

Aptamer SeqId: 9728-4 | Target: CIP1 | UniProt: Q9NPC3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9728-4 | Target: CIP1 | UniProt: Q9NPC3 | TargetFullName: E3 ubiquitin-protein ligase CCNB1IP1 | Organisim: human | Apparent_Kd_M: 4.610692E-12

Real

Aptamer SeqId:9730-22;Target:GHDC;UniProt:Q8N2G8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9730-22;Target: GHDC;UniProt: Q8N2G8;TargetFullName: GH3 domain-containing protein;Organisim: human;Apparent_Kd_M: 3.473794E-10

Real

Aptamer SeqId: 9730-22 | Target: GHDC | UniProt: Q8N2G8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9730-22 | Target: GHDC | UniProt: Q8N2G8 | TargetFullName: GH3 domain-containing protein | Organisim: human | Apparent_Kd_M: 3.473794E-10

Real

Aptamer SeqId:9735-44;Target:TACT;UniProt:P40200

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9735-44;Target: TACT;UniProt: P40200;TargetFullName: T-cell surface protein tactile;Organisim: human;Apparent_Kd_M: 7.635263E-11

Real

Aptamer SeqId: 9735-44 | Target: TACT | UniProt: P40200

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9735-44 | Target: TACT | UniProt: P40200 | TargetFullName: T-cell surface protein tactile | Organisim: human | Apparent_Kd_M: 7.635263E-11

Real

Aptamer SeqId:9738-7;Target:FAF2;UniProt:Q96CS3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9738-7;Target: FAF2;UniProt: Q96CS3;TargetFullName: FAS-associated factor 2;Organisim: human;Apparent_Kd_M: 1.102649E-12

Real

Aptamer SeqId: 9738-7 | Target: FAF2 | UniProt: Q96CS3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9738-7 | Target: FAF2 | UniProt: Q96CS3 | TargetFullName: FAS-associated factor 2 | Organisim: human | Apparent_Kd_M: 1.102649E-12

Real

Aptamer SeqId:9739-4;Target:MSH2;UniProt:P43246

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9739-4;Target: MSH2;UniProt: P43246;TargetFullName: DNA mismatch repair protein Msh2;Organisim: human;Apparent_Kd_M: 1.733793E-11

Real

Aptamer SeqId: 9739-4 | Target: MSH2 | UniProt: P43246

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9739-4 | Target: MSH2 | UniProt: P43246 | TargetFullName: DNA mismatch repair protein Msh2 | Organisim: human | Apparent_Kd_M: 1.733793E-11

Real

Aptamer SeqId:9742-59;Target:BAT1;UniProt:Q13838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9742-59;Target: BAT1;UniProt: Q13838;TargetFullName: Spliceosome RNA helicase DDX39B;Organisim: human;Apparent_Kd_M: 3.99148E-12

Real

Aptamer SeqId: 9742-59 | Target: BAT1 | UniProt: Q13838

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9742-59 | Target: BAT1 | UniProt: Q13838 | TargetFullName: Spliceosome RNA helicase DDX39B | Organisim: human | Apparent_Kd_M: 3.99148E-12

Real

Aptamer SeqId:9744-139;Target:DNJA4;UniProt:Q8WW22

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9744-139;Target: DNJA4;UniProt: Q8WW22;TargetFullName: DnaJ homolog subfamily A member 4;Organisim: human;Apparent_Kd_M: 8.646424E-12

Real

Aptamer SeqId: 9744-139 | Target: DNJA4 | UniProt: Q8WW22

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9744-139 | Target: DNJA4 | UniProt: Q8WW22 | TargetFullName: DnaJ homolog subfamily A member 4 | Organisim: human | Apparent_Kd_M: 8.646424E-12

Real

Aptamer SeqId:9745-20;Target:IF4E2;UniProt:O60573

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9745-20;Target: IF4E2;UniProt: O60573;TargetFullName: Eukaryotic translation initiation factor 4E type 2;Organisim: human;Apparent_Kd_M: 1.836128E-11

Real

Aptamer SeqId: 9745-20 | Target: IF4E2 | UniProt: O60573

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9745-20 | Target: IF4E2 | UniProt: O60573 | TargetFullName: Eukaryotic translation initiation factor 4E type 2 | Organisim: human | Apparent_Kd_M: 1.836128E-11

Real

Aptamer SeqId:9747-48;Target:MARK3;UniProt:P27448

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9747-48;Target: MARK3;UniProt: P27448;TargetFullName: MAP/microtubule affinity-regulating kinase 3;Organisim: human;Apparent_Kd_M: 2.044785E-10

Real

Aptamer SeqId: 9747-48 | Target: MARK3 | UniProt: P27448

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9747-48 | Target: MARK3 | UniProt: P27448 | TargetFullName: MAP/microtubule affinity-regulating kinase 3 | Organisim: human | Apparent_Kd_M: 2.044785E-10

Real

Aptamer SeqId:9748-31;Target:GSTM3-3;UniProt:P21266

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9748-31;Target: GSTM3-3;UniProt: P21266;TargetFullName: Glutathione S-transferase Mu 3;Organisim: human;Apparent_Kd_M: 1.161925E-11

Real

Aptamer SeqId: 9748-31 | Target: GSTM3-3 | UniProt: P21266

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9748-31 | Target: GSTM3-3 | UniProt: P21266 | TargetFullName: Glutathione S-transferase Mu 3 | Organisim: human | Apparent_Kd_M: 1.161925E-11

Real

Aptamer SeqId:9751-72;Target:NSEP1;UniProt:P67809

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9751-72;Target: NSEP1;UniProt: P67809;TargetFullName: Nuclease-sensitive element-binding protein 1;Organisim: human;Apparent_Kd_M: 2.227368E-11

Real

Aptamer SeqId: 9751-72 | Target: NSEP1 | UniProt: P67809

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9751-72 | Target: NSEP1 | UniProt: P67809 | TargetFullName: Nuclease-sensitive element-binding protein 1 | Organisim: human | Apparent_Kd_M: 2.227368E-11

Real

Aptamer SeqId:9753-17;Target:Ezrin;UniProt:P15311

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9753-17;Target: Ezrin;UniProt: P15311;TargetFullName: Ezrin;Organisim: human;Apparent_Kd_M: 8.719149E-12

Real

Aptamer SeqId: 9753-17 | Target: Ezrin | UniProt: P15311

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9753-17 | Target: Ezrin | UniProt: P15311 | TargetFullName: Ezrin | Organisim: human | Apparent_Kd_M: 8.719149E-12

Real

Aptamer SeqId:9754-33;Target:Quinone reductase 2;UniProt:P16083

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9754-33;Target: Quinone reductase 2;UniProt: P16083;TargetFullName: Ribosyldihydronicotinamide dehydrogenase [quinone];Organisim: human;Apparent_Kd_M: 6.841689E-11

Real

Aptamer SeqId: 9754-33 | Target: Quinone reductase 2 | UniProt: P16083

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9754-33 | Target: Quinone reductase 2 | UniProt: P16083 | TargetFullName: Ribosyldihydronicotinamide dehydrogenase quinone | Organisim: human | Apparent_Kd_M: 6.841689E-11

Real

Aptamer SeqId:9757-29;Target:ENAH;UniProt:Q8N8S7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9757-29;Target: ENAH;UniProt: Q8N8S7;TargetFullName: Protein enabled homolog;Organisim: human;Apparent_Kd_M: 1.544523E-11

Real

Aptamer SeqId: 9757-29 | Target: ENAH | UniProt: Q8N8S7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9757-29 | Target: ENAH | UniProt: Q8N8S7 | TargetFullName: Protein enabled homolog | Organisim: human | Apparent_Kd_M: 1.544523E-11

Real

Aptamer SeqId:9758-17;Target:RS4X;UniProt:P62701

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9758-17;Target: RS4X;UniProt: P62701;TargetFullName: 40S ribosomal protein S4; X isoform;Organisim: human;Apparent_Kd_M: 1.179148E-10

Real

Aptamer SeqId: 9758-17 | Target: RS4X | UniProt: P62701

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9758-17 | Target: RS4X | UniProt: P62701 | TargetFullName: 40S ribosomal protein S4; X isoform | Organisim: human | Apparent_Kd_M: 1.179148E-10

Real

Aptamer SeqId:9759-13;Target:INDO;UniProt:P14902

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9759-13;Target: INDO;UniProt: P14902;TargetFullName: Indoleamine 2;3-dioxygenase 1;Organisim: human;Apparent_Kd_M: 1.269456E-11

Real

Aptamer SeqId: 9759-13 | Target: INDO | UniProt: P14902

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9759-13 | Target: INDO | UniProt: P14902 | TargetFullName: Indoleamine 2;3-dioxygenase 1 | Organisim: human | Apparent_Kd_M: 1.269456E-11

Real

Aptamer SeqId:9762-14;Target:VASP;UniProt:P50552

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9762-14;Target: VASP;UniProt: P50552;TargetFullName: Vasodilator-stimulated phosphoprotein;Organisim: human;Apparent_Kd_M: 6.433772E-12

Real

Aptamer SeqId: 9762-14 | Target: VASP | UniProt: P50552

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9762-14 | Target: VASP | UniProt: P50552 | TargetFullName: Vasodilator-stimulated phosphoprotein | Organisim: human | Apparent_Kd_M: 6.433772E-12

Real

Aptamer SeqId:9764-79;Target:HNRPF;UniProt:P52597

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9764-79;Target: HNRPF;UniProt: P52597;TargetFullName: Heterogeneous nuclear ribonucleoprotein F;Organisim: human;Apparent_Kd_M: 1.533539E-11

Real

Aptamer SeqId: 9764-79 | Target: HNRPF | UniProt: P52597

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9764-79 | Target: HNRPF | UniProt: P52597 | TargetFullName: Heterogeneous nuclear ribonucleoprotein F | Organisim: human | Apparent_Kd_M: 1.533539E-11

Real

Aptamer SeqId:9765-4;Target:NDE1;UniProt:Q9NXR1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9765-4;Target: NDE1;UniProt: Q9NXR1;TargetFullName: Nuclear distribution protein nudE homolog 1;Organisim: human;Apparent_Kd_M: 1.070902E-10

Real

Aptamer SeqId: 9765-4 | Target: NDE1 | UniProt: Q9NXR1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9765-4 | Target: NDE1 | UniProt: Q9NXR1 | TargetFullName: Nuclear distribution protein nudE homolog 1 | Organisim: human | Apparent_Kd_M: 1.070902E-10

Real

Aptamer SeqId:9767-22;Target:RIPP1;UniProt:Q0D2K3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9767-22;Target: RIPP1;UniProt: Q0D2K3;TargetFullName: Protein ripply1;Organisim: human;Apparent_Kd_M: 1.351735E-10

Real

Aptamer SeqId: 9767-22 | Target: RIPP1 | UniProt: Q0D2K3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9767-22 | Target: RIPP1 | UniProt: Q0D2K3 | TargetFullName: Protein ripply1 | Organisim: human | Apparent_Kd_M: 1.351735E-10

Real

Aptamer SeqId:9769-48;Target:DNER;UniProt:Q8NFT8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9769-48;Target: DNER;UniProt: Q8NFT8;TargetFullName: Delta and Notch-like epidermal growth factor-related receptor;Organisim: human;Apparent_Kd_M: 1.223573E-10

Real

Aptamer SeqId: 9769-48 | Target: DNER | UniProt: Q8NFT8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9769-48 | Target: DNER | UniProt: Q8NFT8 | TargetFullName: Delta and Notch-like epidermal growth factor-related receptor | Organisim: human | Apparent_Kd_M: 1.223573E-10

Real

Aptamer SeqId:9772-153;Target:NLGN2;UniProt:Q8NFZ4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9772-153;Target: NLGN2;UniProt: Q8NFZ4;TargetFullName: Neuroligin-2;Organisim: human;Apparent_Kd_M: 4.096905E-12

Real

Aptamer SeqId: 9772-153 | Target: NLGN2 | UniProt: Q8NFZ4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9772-153 | Target: NLGN2 | UniProt: Q8NFZ4 | TargetFullName: Neuroligin-2 | Organisim: human | Apparent_Kd_M: 4.096905E-12

Real

Aptamer SeqId:9773-15;Target:RN149;UniProt:Q8NC42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9773-15;Target: RN149;UniProt: Q8NC42;TargetFullName: E3 ubiquitin-protein ligase RNF149;Organisim: human;Apparent_Kd_M: 2.983498E-10

Real

Aptamer SeqId: 9773-15 | Target: RN149 | UniProt: Q8NC42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9773-15 | Target: RN149 | UniProt: Q8NC42 | TargetFullName: E3 ubiquitin-protein ligase RNF149 | Organisim: human | Apparent_Kd_M: 2.983498E-10

Real

Aptamer SeqId:9774-59;Target:RN150;UniProt:Q9ULK6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9774-59;Target: RN150;UniProt: Q9ULK6;TargetFullName: RING finger protein 150;Organisim: human;Apparent_Kd_M: 3.016095E-11

Real

Aptamer SeqId: 9774-59 | Target: RN150 | UniProt: Q9ULK6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9774-59 | Target: RN150 | UniProt: Q9ULK6 | TargetFullName: RING finger protein 150 | Organisim: human | Apparent_Kd_M: 3.016095E-11

Real

Aptamer SeqId:9778-45;Target:TM52B;UniProt:Q4KMG9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9778-45;Target: TM52B;UniProt: Q4KMG9;TargetFullName: Transmembrane protein 52B;Organisim: human;Apparent_Kd_M: 2.304784E-10

Real

Aptamer SeqId: 9778-45 | Target: TM52B | UniProt: Q4KMG9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9778-45 | Target: TM52B | UniProt: Q4KMG9 | TargetFullName: Transmembrane protein 52B | Organisim: human | Apparent_Kd_M: 2.304784E-10

Real

Aptamer SeqId:9779-63;Target:HERP2;UniProt:Q9BSE4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9779-63;Target: HERP2;UniProt: Q9BSE4;TargetFullName: Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein;Organisim: human;Apparent_Kd_M: 1.879274E-10

Real

Aptamer SeqId: 9779-63 | Target: HERP2 | UniProt: Q9BSE4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9779-63 | Target: HERP2 | UniProt: Q9BSE4 | TargetFullName: Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein | Organisim: human | Apparent_Kd_M: 1.879274E-10

Real

Aptamer SeqId:9783-75;Target:DJC11;UniProt:Q9NVH1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9783-75;Target: DJC11;UniProt: Q9NVH1;TargetFullName: DnaJ homolog subfamily C member 11;Organisim: human;Apparent_Kd_M: 1.383299E-11

Real

Aptamer SeqId: 9783-75 | Target: DJC11 | UniProt: Q9NVH1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9783-75 | Target: DJC11 | UniProt: Q9NVH1 | TargetFullName: DnaJ homolog subfamily C member 11 | Organisim: human | Apparent_Kd_M: 1.383299E-11

Real

Aptamer SeqId:9786-310;Target:IEX1;UniProt:P46695

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9786-310;Target: IEX1;UniProt: P46695;TargetFullName: Radiation-inducible immediate-early gene IEX-1;Organisim: human;Apparent_Kd_M: 8.958664E-11

Real

Aptamer SeqId: 9786-310 | Target: IEX1 | UniProt: P46695

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9786-310 | Target: IEX1 | UniProt: P46695 | TargetFullName: Radiation-inducible immediate-early gene IEX-1 | Organisim: human | Apparent_Kd_M: 8.958664E-11

Real

Aptamer SeqId:9789-52;Target:Nesprin-2;UniProt:Q8WXH0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9789-52;Target: Nesprin-2;UniProt: Q8WXH0;TargetFullName: Nesprin-2;Organisim: human;Apparent_Kd_M: 1.444874E-11

Real

Aptamer SeqId: 9789-52 | Target: Nesprin-2 | UniProt: Q8WXH0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9789-52 | Target: Nesprin-2 | UniProt: Q8WXH0 | TargetFullName: Nesprin-2 | Organisim: human | Apparent_Kd_M: 1.444874E-11

Real

Aptamer SeqId:9790-28;Target:BR serine/threonine kinase 2;UniProt:Q8IWQ3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9790-28;Target: BR serine/threonine kinase 2;UniProt: Q8IWQ3;TargetFullName: Serine/threonine-protein kinase BRSK2;Organisim: human;Apparent_Kd_M: 1.536622E-11

Real

Aptamer SeqId: 9790-28 | Target: BR serine/threonine kinase 2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9790-28 | Target: BR serine/threonine kinase 2 | UniProt: Q8IWQ3 | TargetFullName: Serine/threonine-protein kinase BRSK2 | Organisim: human | Apparent_Kd_M: 1.536622E-11

Real

Aptamer SeqId:9793-145;Target:IGDC4;UniProt:Q8TDY8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9793-145;Target: IGDC4;UniProt: Q8TDY8;TargetFullName: Immunoglobulin superfamily DCC subclass member 4;Organisim: human;Apparent_Kd_M: 9.339202E-12

Real

Aptamer SeqId: 9793-145 | Target: IGDC4 | UniProt: Q8TDY8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9793-145 | Target: IGDC4 | UniProt: Q8TDY8 | TargetFullName: Immunoglobulin superfamily DCC subclass member 4 | Organisim: human | Apparent_Kd_M: 9.339202E-12

Real

Aptamer SeqId:9794-17;Target:ADCK4;UniProt:Q96D53

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9794-17;Target: ADCK4;UniProt: Q96D53;TargetFullName: AarF domain-containing protein kinase 4;Organisim: human;Apparent_Kd_M: 8.143169E-11

Real

Aptamer SeqId: 9794-17 | Target: ADCK4 | UniProt: Q96D53

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9794-17 | Target: ADCK4 | UniProt: Q96D53 | TargetFullName: AarF domain-containing protein kinase 4 | Organisim: human | Apparent_Kd_M: 8.143169E-11

Real

Aptamer SeqId:9796-4;Target:CEL;UniProt:P19835

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9796-4;Target: CEL;UniProt: P19835;TargetFullName: Bile salt-activated lipase;Organisim: human;Apparent_Kd_M: 1.068903E-11

Real

Aptamer SeqId: 9796-4 | Target: CEL | UniProt: P19835

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9796-4 | Target: CEL | UniProt: P19835 | TargetFullName: Bile salt-activated lipase | Organisim: human | Apparent_Kd_M: 1.068903E-11

Real

Aptamer SeqId:9799-3;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9799-3;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 7.318714E-12

Real

Aptamer SeqId: 9799-3 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9799-3 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 7.318714E-12

Real

Aptamer SeqId:9800-20;Target:NDUB8;UniProt:O95169

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9800-20;Target: NDUB8;UniProt: O95169;TargetFullName: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8; mitochondrial;Organisim: human;Apparent_Kd_M: 2.691945E-11

Real

Aptamer SeqId: 9800-20 | Target: NDUB8 | UniProt: O95169

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9800-20 | Target: NDUB8 | UniProt: O95169 | TargetFullName: NADH dehydrogenase ubiquinone 1 beta subcomplex subunit 8; mitochondrial | Organisim: human | Apparent_Kd_M: 2.691945E-11

Real

Aptamer SeqId:9802-27;Target:PLPL2;UniProt:Q96AD5

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9802-27;Target: PLPL2;UniProt: Q96AD5;TargetFullName: Patatin-like phospholipase domain-containing protein 2;Organisim: human;Apparent_Kd_M: 1.301096E-10

Real

Aptamer SeqId: 9802-27 | Target: PLPL2 | UniProt: Q96AD5

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9802-27 | Target: PLPL2 | UniProt: Q96AD5 | TargetFullName: Patatin-like phospholipase domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 1.301096E-10

Real

Aptamer SeqId:9804-11;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9804-11;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.360879E-12

Real

Aptamer SeqId: 9804-11 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9804-11 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.360879E-12

Real

Aptamer SeqId:9805-51;Target:SEM4B;UniProt:Q9NPR2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9805-51;Target: SEM4B;UniProt: Q9NPR2;TargetFullName: Semaphorin-4B;Organisim: human;Apparent_Kd_M: 4.850947E-10

Real

Aptamer SeqId: 9805-51 | Target: SEM4B | UniProt: Q9NPR2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9805-51 | Target: SEM4B | UniProt: Q9NPR2 | TargetFullName: Semaphorin-4B | Organisim: human | Apparent_Kd_M: 4.850947E-10

Real

Aptamer SeqId:9808-41;Target:TNR6B;UniProt:Q9UPQ9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9808-41;Target: TNR6B;UniProt: Q9UPQ9;TargetFullName: Trinucleotide repeat-containing gene 6B protein;Organisim: human;Apparent_Kd_M: 3.985204E-11

Real

Aptamer SeqId: 9808-41 | Target: TNR6B | UniProt: Q9UPQ9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9808-41 | Target: TNR6B | UniProt: Q9UPQ9 | TargetFullName: Trinucleotide repeat-containing gene 6B protein | Organisim: human | Apparent_Kd_M: 3.985204E-11

Real

Aptamer SeqId:9815-5;Target:RHG01;UniProt:Q07960

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9815-5;Target: RHG01;UniProt: Q07960;TargetFullName: Rho GTPase-activating protein 1;Organisim: human;Apparent_Kd_M: 3.418986E-11

Real

Aptamer SeqId: 9815-5 | Target: RHG01 | UniProt: Q07960

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9815-5 | Target: RHG01 | UniProt: Q07960 | TargetFullName: Rho GTPase-activating protein 1 | Organisim: human | Apparent_Kd_M: 3.418986E-11

Real

Aptamer SeqId:9816-37;Target:ISOC1;UniProt:Q96CN7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9816-37;Target: ISOC1;UniProt: Q96CN7;TargetFullName: Isochorismatase domain-containing protein 1;Organisim: human;Apparent_Kd_M: 9.952201E-12

Real

Aptamer SeqId: 9816-37 | Target: ISOC1 | UniProt: Q96CN7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9816-37 | Target: ISOC1 | UniProt: Q96CN7 | TargetFullName: Isochorismatase domain-containing protein 1 | Organisim: human | Apparent_Kd_M: 9.952201E-12

Real

Aptamer SeqId:9819-110;Target:Mcl-1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9819-110;Target: Mcl-1;UniProt:;TargetFullName: Induced myeloid leukemia cell differentiation protein Mcl-1;Organisim: human;Apparent_Kd_M: 7.790727E-12

Real

Aptamer SeqId: 9819-110 | Target: Mcl-1 | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9819-110 | Target: Mcl-1 | UniProt: | TargetFullName: Induced myeloid leukemia cell differentiation protein Mcl-1 | Organisim: human | Apparent_Kd_M: 7.790727E-12

Real

Aptamer SeqId:9823-2;Target:DYR;UniProt:P00374

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9823-2;Target: DYR;UniProt: P00374;TargetFullName: Dihydrofolate reductase;Organisim: human;Apparent_Kd_M: 1.318774E-11

Real

Aptamer SeqId: 9823-2 | Target: DYR | UniProt: P00374

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9823-2 | Target: DYR | UniProt: P00374 | TargetFullName: Dihydrofolate reductase | Organisim: human | Apparent_Kd_M: 1.318774E-11

Real

Aptamer SeqId:9826-135;Target:Fragile histidine triad protein;UniProt:P49789

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9826-135;Target: Fragile histidine triad protein;UniProt: P49789;TargetFullName: Bis(5-adenosyl)-triphosphatase;Organisim: human;Apparent_Kd_M: 4.558285E-12

Real

Aptamer SeqId: 9826-135 | Target: Fragile histidine triad protein

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9826-135 | Target: Fragile histidine triad protein | UniProt: P49789 | TargetFullName: Bis(5'-adenosyl)-triphosphatase | Organisim: human | Apparent_Kd_M: 4.558285E-12

Real

Aptamer SeqId:9828-86;Target:LDHC;UniProt:P07864

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9828-86;Target: LDHC;UniProt: P07864;TargetFullName: L-lactate dehydrogenase C chain;Organisim: human;Apparent_Kd_M: 1.604893E-11

Real

Aptamer SeqId: 9828-86 | Target: LDHC | UniProt: P07864

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9828-86 | Target: LDHC | UniProt: P07864 | TargetFullName: L-lactate dehydrogenase C chain | Organisim: human | Apparent_Kd_M: 1.604893E-11

Real

Aptamer SeqId:9829-91;Target:SULT 2A1;UniProt:Q06520

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9829-91;Target: SULT 2A1;UniProt: Q06520;TargetFullName: Bile salt sulfotransferase;Organisim: human;Apparent_Kd_M: 4.48356E-12

Real

Aptamer SeqId: 9829-91 | Target: SULT 2A1 | UniProt: Q06520

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9829-91 | Target: SULT 2A1 | UniProt: Q06520 | TargetFullName: Bile salt sulfotransferase | Organisim: human | Apparent_Kd_M: 4.48356E-12

Real

Aptamer SeqId:9830-109;Target:VAV3;UniProt:Q9UKW4

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9830-109;Target: VAV3;UniProt: Q9UKW4;TargetFullName: Guanine nucleotide exchange factor VAV3;Organisim: human;Apparent_Kd_M: 2.637339E-12

Real

Aptamer SeqId: 9830-109 | Target: VAV3 | UniProt: Q9UKW4

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9830-109 | Target: VAV3 | UniProt: Q9UKW4 | TargetFullName: Guanine nucleotide exchange factor VAV3 | Organisim: human | Apparent_Kd_M: 2.637339E-12

Real

Aptamer SeqId:9831-12;Target:G3BP2;UniProt:Q9UN86

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9831-12;Target: G3BP2;UniProt: Q9UN86;TargetFullName: Ras GTPase-activating protein-binding protein 2;Organisim: human;Apparent_Kd_M: 9.202797E-12

Real

Aptamer SeqId: 9831-12 | Target: G3BP2 | UniProt: Q9UN86

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9831-12 | Target: G3BP2 | UniProt: Q9UN86 | TargetFullName: Ras GTPase-activating protein-binding protein 2 | Organisim: human | Apparent_Kd_M: 9.202797E-12

Real

Aptamer SeqId:9832-33;Target:HGD;UniProt:Q93099

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9832-33;Target: HGD;UniProt: Q93099;TargetFullName: Homogentisate 1;2-dioxygenase;Organisim: human;Apparent_Kd_M: 2.152875E-11

Real

Aptamer SeqId: 9832-33 | Target: HGD | UniProt: Q93099

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9832-33 | Target: HGD | UniProt: Q93099 | TargetFullName: Homogentisate 1;2-dioxygenase | Organisim: human | Apparent_Kd_M: 2.152875E-11

Real

Aptamer SeqId:9834-62;Target:ADH1B;UniProt:P00325

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9834-62;Target: ADH1B;UniProt: P00325;TargetFullName: Alcohol dehydrogenase 1B;Organisim: human;Apparent_Kd_M: 6.699684E-11

Real

Aptamer SeqId: 9834-62 | Target: ADH1B | UniProt: P00325

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9834-62 | Target: ADH1B | UniProt: P00325 | TargetFullName: Alcohol dehydrogenase 1B | Organisim: human | Apparent_Kd_M: 6.699684E-11

Real

Aptamer SeqId:9835-16;Target:AL1A3;UniProt:P47895

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9835-16;Target: AL1A3;UniProt: P47895;TargetFullName: Aldehyde dehydrogenase family 1 member A3;Organisim: human;Apparent_Kd_M: 1.979651E-10

Real

Aptamer SeqId: 9835-16 | Target: AL1A3 | UniProt: P47895

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9835-16 | Target: AL1A3 | UniProt: P47895 | TargetFullName: Aldehyde dehydrogenase family 1 member A3 | Organisim: human | Apparent_Kd_M: 1.979651E-10

Real

Aptamer SeqId:9836-20;Target:DCK;UniProt:P27707

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9836-20;Target: DCK;UniProt: P27707;TargetFullName: Deoxycytidine kinase;Organisim: human;Apparent_Kd_M: 2.429662E-12

Real

Aptamer SeqId: 9836-20 | Target: DCK | UniProt: P27707

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9836-20 | Target: DCK | UniProt: P27707 | TargetFullName: Deoxycytidine kinase | Organisim: human | Apparent_Kd_M: 2.429662E-12

Real

Aptamer SeqId:9837-60;Target:NAD(P)H dehydrogenase;UniProt:P15559

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9837-60;Target: NAD(P)H dehydrogenase;UniProt: P15559;TargetFullName: NAD(P)H dehydrogenase [quinone] 1;Organisim: human;Apparent_Kd_M: 5.591784E-13

Real

Aptamer SeqId: 9837-60 | Target: NAD(P)H dehydrogenase | UniProt: P15559

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9837-60 | Target: NAD(P)H dehydrogenase | UniProt: P15559 | TargetFullName: NAD(P)H dehydrogenase quinone 1 | Organisim: human | Apparent_Kd_M: 5.591784E-13

Real

Aptamer SeqId:9838-4;Target:SMAD1;UniProt:Q15797

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9838-4;Target: SMAD1;UniProt: Q15797;TargetFullName: Mothers against decapentaplegic homolog 1;Organisim: human;Apparent_Kd_M: 2.00055E-11

Real

Aptamer SeqId: 9838-4 | Target: SMAD1 | UniProt: Q15797

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9838-4 | Target: SMAD1 | UniProt: Q15797 | TargetFullName: Mothers against decapentaplegic homolog 1 | Organisim: human | Apparent_Kd_M: 2.00055E-11

Real

Aptamer SeqId:9839-148;Target:Tirap;UniProt:P58753

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9839-148;Target: Tirap;UniProt: P58753;TargetFullName: Toll/interleukin-1 receptor domain-containing adapter protein;Organisim: human;Apparent_Kd_M: 1.086674E-11

Real

Aptamer SeqId: 9839-148 | Target: Tirap | UniProt: P58753

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9839-148 | Target: Tirap | UniProt: P58753 | TargetFullName: Toll/interleukin-1 receptor domain-containing adapter protein | Organisim: human | Apparent_Kd_M: 1.086674E-11

Real

Aptamer SeqId:9840-2;Target:Cdc42Hs;UniProt:P60953

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9840-2;Target: Cdc42Hs;UniProt: P60953;TargetFullName: Cell division control protein 42 homolog;Organisim: human;Apparent_Kd_M: 1.735028E-11

Real

Aptamer SeqId: 9840-2 | Target: Cdc42Hs | UniProt: P60953

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9840-2 | Target: Cdc42Hs | UniProt: P60953 | TargetFullName: Cell division control protein 42 homolog | Organisim: human | Apparent_Kd_M: 1.735028E-11

Real

Aptamer SeqId:9841-197;Target:Multifunctional protein ADE2;UniProt:P22234

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9841-197;Target: Multifunctional protein ADE2;UniProt: P22234;TargetFullName: Multifunctional protein ADE2;Organisim: human;Apparent_Kd_M: 8.345578E-11

Real

Aptamer SeqId: 9841-197 | Target: Multifunctional protein ADE2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9841-197 | Target: Multifunctional protein ADE2 | UniProt: P22234 | TargetFullName: Multifunctional protein ADE2 | Organisim: human | Apparent_Kd_M: 8.345578E-11

Real

Aptamer SeqId:9842-2;Target:b-Catenin;UniProt:P35222

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9842-2;Target: b-Catenin;UniProt: P35222;TargetFullName: Catenin beta-1;Organisim: human;Apparent_Kd_M: 2.154416E-12

Real

Aptamer SeqId: 9842-2 | Target: b-Catenin | UniProt: P35222

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9842-2 | Target: b-Catenin | UniProt: P35222 | TargetFullName: Catenin beta-1 | Organisim: human | Apparent_Kd_M: 2.154416E-12

Real

Aptamer SeqId:9843-5;Target:ACTN1;UniProt:P12814

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9843-5;Target: ACTN1;UniProt: P12814;TargetFullName: Alpha-actinin-1;Organisim: human;Apparent_Kd_M: 1.902555E-11

Real

Aptamer SeqId: 9843-5 | Target: ACTN1 | UniProt: P12814

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9843-5 | Target: ACTN1 | UniProt: P12814 | TargetFullName: Alpha-actinin-1 | Organisim: human | Apparent_Kd_M: 1.902555E-11

Real

Aptamer SeqId:9844-138;Target:ACTN2;UniProt:P35609

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9844-138;Target: ACTN2;UniProt: P35609;TargetFullName: Alpha-actinin-2;Organisim: human;Apparent_Kd_M: 2.859785E-13

Real

Aptamer SeqId: 9844-138 | Target: ACTN2 | UniProt: P35609

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9844-138 | Target: ACTN2 | UniProt: P35609 | TargetFullName: Alpha-actinin-2 | Organisim: human | Apparent_Kd_M: 2.859785E-13

Real

Aptamer SeqId:9846-32;Target:Rho-GDI beta;UniProt:P52566

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9846-32;Target: Rho-GDI beta;UniProt: P52566;TargetFullName: Rho GDP-dissociation inhibitor 2;Organisim: human;Apparent_Kd_M: 1.062164E-11

Real

Aptamer SeqId: 9846-32 | Target: Rho-GDI beta | UniProt: P52566

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9846-32 | Target: Rho-GDI beta | UniProt: P52566 | TargetFullName: Rho GDP-dissociation inhibitor 2 | Organisim: human | Apparent_Kd_M: 1.062164E-11

Real

Aptamer SeqId:9847-21;Target:TGIF2;UniProt:Q9GZN2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9847-21;Target: TGIF2;UniProt: Q9GZN2;TargetFullName: Homeobox protein TGIF2;Organisim: human;Apparent_Kd_M: 3.01802E-12

Real

Aptamer SeqId: 9847-21 | Target: TGIF2 | UniProt: Q9GZN2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9847-21 | Target: TGIF2 | UniProt: Q9GZN2 | TargetFullName: Homeobox protein TGIF2 | Organisim: human | Apparent_Kd_M: 3.01802E-12

Real

Aptamer SeqId:9848-22;Target:Cyclin H;UniProt:P51946

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9848-22;Target: Cyclin H;UniProt: P51946;TargetFullName: Cyclin-H;Organisim: human;Apparent_Kd_M: 3.805136E-12

Real

Aptamer SeqId: 9848-22 | Target: Cyclin H | UniProt: P51946

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9848-22 | Target: Cyclin H | UniProt: P51946 | TargetFullName: Cyclin-H | Organisim: human | Apparent_Kd_M: 3.805136E-12

Real

Aptamer SeqId:9849-13;Target:APEX1;UniProt:P27695

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9849-13;Target: APEX1;UniProt: P27695;TargetFullName: DNA-(apurinic or apyrimidinic site) lyase;Organisim: human;Apparent_Kd_M: 1.67134E-12

Real

Aptamer SeqId: 9849-13 | Target: APEX1 | UniProt: P27695

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9849-13 | Target: APEX1 | UniProt: P27695 | TargetFullName: DNA-(apurinic or apyrimidinic site) lyase | Organisim: human | Apparent_Kd_M: 1.67134E-12

Real

Aptamer SeqId:9850-38;Target:IF1AX;UniProt:P47813

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9850-38;Target: IF1AX;UniProt: P47813;TargetFullName: Eukaryotic translation initiation factor 1A; X-chromosomal;Organisim: human;Apparent_Kd_M: 5.199095E-11

Real

Aptamer SeqId: 9850-38 | Target: IF1AX | UniProt: P47813

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9850-38 | Target: IF1AX | UniProt: P47813 | TargetFullName: Eukaryotic translation initiation factor 1A; X-chromosomal | Organisim: human | Apparent_Kd_M: 5.199095E-11

Real

Aptamer SeqId:9853-3;Target:IFIT2;UniProt:P09913

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9853-3;Target: IFIT2;UniProt: P09913;TargetFullName: Interferon-induced protein with tetratricopeptide repeats 2;Organisim: human;Apparent_Kd_M: 7.619957E-12

Real

Aptamer SeqId: 9853-3 | Target: IFIT2 | UniProt: P09913

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9853-3 | Target: IFIT2 | UniProt: P09913 | TargetFullName: Interferon-induced protein with tetratricopeptide repeats 2 | Organisim: human | Apparent_Kd_M: 7.619957E-12

Real

Aptamer SeqId:9855-10;Target:Rho A;UniProt:P61586

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9855-10;Target: Rho A;UniProt: P61586;TargetFullName: Transforming protein RhoA;Organisim: human;Apparent_Kd_M: 6.383195E-13

Real

Aptamer SeqId: 9855-10 | Target: Rho A | UniProt: P61586

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9855-10 | Target: Rho A | UniProt: P61586 | TargetFullName: Transforming protein RhoA | Organisim: human | Apparent_Kd_M: 6.383195E-13

Real

Aptamer SeqId:9856-22;Target:DHYS;UniProt:P49366

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9856-22;Target: DHYS;UniProt: P49366;TargetFullName: Deoxyhypusine synthase;Organisim: human;Apparent_Kd_M: 4.116456E-11

Real

Aptamer SeqId: 9856-22 | Target: DHYS | UniProt: P49366

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9856-22 | Target: DHYS | UniProt: P49366 | TargetFullName: Deoxyhypusine synthase | Organisim: human | Apparent_Kd_M: 4.116456E-11

Real

Aptamer SeqId:9859-180;Target:SSAT-1;UniProt:P21673

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9859-180;Target: SSAT-1;UniProt: P21673;TargetFullName: Diamine acetyltransferase 1;Organisim: human;Apparent_Kd_M: 2.215399E-11

Real

Aptamer SeqId: 9859-180 | Target: SSAT-1 | UniProt: P21673

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9859-180 | Target: SSAT-1 | UniProt: P21673 | TargetFullName: Diamine acetyltransferase 1 | Organisim: human | Apparent_Kd_M: 2.215399E-11

Real

Aptamer SeqId:9863-1;Target:Tropomyosin 4;UniProt:P67936

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9863-1;Target: Tropomyosin 4;UniProt: P67936;TargetFullName: Tropomyosin alpha-4 chain;Organisim: human;Apparent_Kd_M: 1.120614E-11

Real

Aptamer SeqId: 9863-1 | Target: Tropomyosin 4 | UniProt: P67936

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9863-1 | Target: Tropomyosin 4 | UniProt: P67936 | TargetFullName: Tropomyosin alpha-4 chain | Organisim: human | Apparent_Kd_M: 1.120614E-11

Real

Aptamer SeqId:9864-38;Target:TTC1;UniProt:Q99614

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9864-38;Target: TTC1;UniProt: Q99614;TargetFullName: Tetratricopeptide repeat protein 1;Organisim: human;Apparent_Kd_M: 6.96733E-12

Real

Aptamer SeqId: 9864-38 | Target: TTC1 | UniProt: Q99614

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9864-38 | Target: TTC1 | UniProt: Q99614 | TargetFullName: Tetratricopeptide repeat protein 1 | Organisim: human | Apparent_Kd_M: 6.96733E-12

Real

Aptamer SeqId:9865-40;Target:UBE2B;UniProt:P63146

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9865-40;Target: UBE2B;UniProt: P63146;TargetFullName: Ubiquitin-conjugating enzyme E2 B;Organisim: human;Apparent_Kd_M: 7.757858E-11

Real

Aptamer SeqId: 9865-40 | Target: UBE2B | UniProt: P63146

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9865-40 | Target: UBE2B | UniProt: P63146 | TargetFullName: Ubiquitin-conjugating enzyme E2 B | Organisim: human | Apparent_Kd_M: 7.757858E-11

Real

Aptamer SeqId:9867-23;Target:F16P2;UniProt:O00757

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9867-23;Target: F16P2;UniProt: O00757;TargetFullName: Fructose-1;6-bisphosphatase isozyme 2;Organisim: human;Apparent_Kd_M: 1.699066E-12

Real

Aptamer SeqId: 9867-23 | Target: F16P2 | UniProt: O00757

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9867-23 | Target: F16P2 | UniProt: O00757 | TargetFullName: Fructose-1;6-bisphosphatase isozyme 2 | Organisim: human | Apparent_Kd_M: 1.699066E-12

Real

Aptamer SeqId:9869-28;Target:NF-kappa-B p105;UniProt:P19838

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9869-28;Target: NF-kappa-B p105;UniProt: P19838;TargetFullName: Nuclear factor NF-kappa-B p105 subunit;Organisim: human;Apparent_Kd_M: 5.889158E-12

Real

Aptamer SeqId: 9869-28 | Target: NF-kappa-B p105 | UniProt: P19838

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9869-28 | Target: NF-kappa-B p105 | UniProt: P19838 | TargetFullName: Nuclear factor NF-kappa-B p105 subunit | Organisim: human | Apparent_Kd_M: 5.889158E-12

Real

Aptamer SeqId:9870-17;Target:SYWC;UniProt:P23381

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9870-17;Target: SYWC;UniProt: P23381;TargetFullName: Tryptophan--tRNA ligase; cytoplasmic;Organisim: human;Apparent_Kd_M: 3.08E-12

Real

Aptamer SeqId: 9870-17 | Target: SYWC | UniProt: P23381

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9870-17 | Target: SYWC | UniProt: P23381 | TargetFullName: Tryptophan--tRNA ligase; cytoplasmic | Organisim: human | Apparent_Kd_M: 3.08E-12

Real

Aptamer SeqId:9872-23;Target:CTNA2;UniProt:P26232

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9872-23;Target: CTNA2;UniProt: P26232;TargetFullName: Catenin alpha-2;Organisim: human;Apparent_Kd_M: 2.129183E-12

Real

Aptamer SeqId: 9872-23 | Target: CTNA2 | UniProt: P26232

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9872-23 | Target: CTNA2 | UniProt: P26232 | TargetFullName: Catenin alpha-2 | Organisim: human | Apparent_Kd_M: 2.129183E-12

Real

Aptamer SeqId:9873-17;Target:ERRalpha;UniProt:P11474

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9873-17;Target: ERRalpha;UniProt: P11474;TargetFullName: Steroid hormone receptor ERR1;Organisim: human;Apparent_Kd_M: 2.789678E-11

Real

Aptamer SeqId: 9873-17 | Target: ERRalpha | UniProt: P11474

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9873-17 | Target: ERRalpha | UniProt: P11474 | TargetFullName: Steroid hormone receptor ERR1 | Organisim: human | Apparent_Kd_M: 2.789678E-11

Real

Aptamer SeqId:9874-28;Target:p15-INK4b;UniProt:P42772

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9874-28;Target: p15-INK4b;UniProt: P42772;TargetFullName: Cyclin-dependent kinase 4 inhibitor B;Organisim: human;Apparent_Kd_M: 3.113053E-11

Real

Aptamer SeqId: 9874-28 | Target: p15-INK4b | UniProt: P42772

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9874-28 | Target: p15-INK4b | UniProt: P42772 | TargetFullName: Cyclin-dependent kinase 4 inhibitor B | Organisim: human | Apparent_Kd_M: 3.113053E-11

Real

Aptamer SeqId:9875-107;Target:THOC1;UniProt:Q96FV9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9875-107;Target: THOC1;UniProt: Q96FV9;TargetFullName: THO complex subunit 1;Organisim: human;Apparent_Kd_M: 5.465579E-11

Real

Aptamer SeqId: 9875-107 | Target: THOC1 | UniProt: Q96FV9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9875-107 | Target: THOC1 | UniProt: Q96FV9 | TargetFullName: THO complex subunit 1 | Organisim: human | Apparent_Kd_M: 5.465579E-11

Real

Aptamer SeqId:9876-20;Target:aldolase C;UniProt:P09972

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9876-20;Target: aldolase C;UniProt: P09972;TargetFullName: Fructose-bisphosphate aldolase C;Organisim: human;Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId: 9876-20 | Target: aldolase C | UniProt: P09972

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9876-20 | Target: aldolase C | UniProt: P09972 | TargetFullName: Fructose-bisphosphate aldolase C | Organisim: human | Apparent_Kd_M: 1.48E-11

Real

Aptamer SeqId:9877-28;Target:CRKL;UniProt:P46109

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9877-28;Target: CRKL;UniProt: P46109;TargetFullName: Crk-like protein;Organisim: human;Apparent_Kd_M: 2.863793E-12

Real

Aptamer SeqId: 9877-28 | Target: CRKL | UniProt: P46109

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9877-28 | Target: CRKL | UniProt: P46109 | TargetFullName: Crk-like protein | Organisim: human | Apparent_Kd_M: 2.863793E-12

Real

Aptamer SeqId:9880-33;Target:T23O;UniProt:P48775

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9880-33;Target: T23O;UniProt: P48775;TargetFullName: Tryptophan 2;3-dioxygenase;Organisim: human;Apparent_Kd_M: 5.110391E-11

Real

Aptamer SeqId: 9880-33 | Target: T23O | UniProt: P48775

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9880-33 | Target: T23O | UniProt: P48775 | TargetFullName: Tryptophan 2;3-dioxygenase | Organisim: human | Apparent_Kd_M: 5.110391E-11

Real

Aptamer SeqId:9883-29;Target:Glyoxalase I;UniProt:Q04760

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9883-29;Target: Glyoxalase I;UniProt: Q04760;TargetFullName: Lactoylglutathione lyase;Organisim: human;Apparent_Kd_M: 2.514988E-11

Real

Aptamer SeqId: 9883-29 | Target: Glyoxalase I | UniProt: Q04760

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9883-29 | Target: Glyoxalase I | UniProt: Q04760 | TargetFullName: Lactoylglutathione lyase | Organisim: human | Apparent_Kd_M: 2.514988E-11

Real

Aptamer SeqId:9884-8;Target:PPIL1;UniProt:Q9Y3C6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9884-8;Target: PPIL1;UniProt: Q9Y3C6;TargetFullName: Peptidyl-prolyl cis-trans isomerase-like 1;Organisim: human;Apparent_Kd_M: 8.103752E-11

Real

Aptamer SeqId: 9884-8 | Target: PPIL1 | UniProt: Q9Y3C6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9884-8 | Target: PPIL1 | UniProt: Q9Y3C6 | TargetFullName: Peptidyl-prolyl cis-trans isomerase-like 1 | Organisim: human | Apparent_Kd_M: 8.103752E-11

Real

Aptamer SeqId:9885-41;Target:RAP2A;UniProt:P10114

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9885-41;Target: RAP2A;UniProt: P10114;TargetFullName: Ras-related protein Rap-2a;Organisim: human;Apparent_Kd_M: 2.096902E-11

Real

Aptamer SeqId: 9885-41 | Target: RAP2A | UniProt: P10114

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9885-41 | Target: RAP2A | UniProt: P10114 | TargetFullName: Ras-related protein Rap-2a | Organisim: human | Apparent_Kd_M: 2.096902E-11

Real

Aptamer SeqId:9886-28;Target:XRCC4;UniProt:Q13426

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9886-28;Target: XRCC4;UniProt: Q13426;TargetFullName: DNA repair protein XRCC4;Organisim: human;Apparent_Kd_M: 1.469693E-11

Real

Aptamer SeqId: 9886-28 | Target: XRCC4 | UniProt: Q13426

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9886-28 | Target: XRCC4 | UniProt: Q13426 | TargetFullName: DNA repair protein XRCC4 | Organisim: human | Apparent_Kd_M: 1.469693E-11

Real

Aptamer SeqId:9887-40;Target:RBBP6;UniProt:Q7Z6E9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9887-40;Target: RBBP6;UniProt: Q7Z6E9;TargetFullName: E3 ubiquitin-protein ligase RBBP6;Organisim: human;Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId: 9887-40 | Target: RBBP6 | UniProt: Q7Z6E9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9887-40 | Target: RBBP6 | UniProt: Q7Z6E9 | TargetFullName: E3 ubiquitin-protein ligase RBBP6 | Organisim: human | Apparent_Kd_M: 2.37E-11

Real

Aptamer SeqId:9889-42;Target:AF1L1;UniProt:Q8TED9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9889-42;Target: AF1L1;UniProt: Q8TED9;TargetFullName: Actin filament-associated protein 1-like 1;Organisim: human;Apparent_Kd_M: 8.652232E-12

Real

Aptamer SeqId: 9889-42 | Target: AF1L1 | UniProt: Q8TED9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9889-42 | Target: AF1L1 | UniProt: Q8TED9 | TargetFullName: Actin filament-associated protein 1-like 1 | Organisim: human | Apparent_Kd_M: 8.652232E-12

Real

Aptamer SeqId:9893-27;Target:Ornithine decarboxylase antizyme;UniProt:P54368

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9893-27;Target: Ornithine decarboxylase antizyme;UniProt: P54368;TargetFullName: Ornithine decarboxylase antizyme 1;Organisim: human;Apparent_Kd_M: 4.392866E-12

Real

Aptamer SeqId: 9893-27 | Target: Ornithine decarboxylase antizyme

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9893-27 | Target: Ornithine decarboxylase antizyme | UniProt: P54368 | TargetFullName: Ornithine decarboxylase antizyme 1 | Organisim: human | Apparent_Kd_M: 4.392866E-12

Real

Aptamer SeqId:9894-13;Target:MYO6;UniProt:Q9UM54

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9894-13;Target: MYO6;UniProt: Q9UM54;TargetFullName: Unconventional myosin-VI;Organisim: human;Apparent_Kd_M: 4.086388E-12

Real

Aptamer SeqId: 9894-13 | Target: MYO6 | UniProt: Q9UM54

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9894-13 | Target: MYO6 | UniProt: Q9UM54 | TargetFullName: Unconventional myosin-VI | Organisim: human | Apparent_Kd_M: 4.086388E-12

Real

Aptamer SeqId:9895-77;Target:XPF;UniProt:Q92889

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9895-77;Target: XPF;UniProt: Q92889;TargetFullName: DNA repair endonuclease XPF;Organisim: human;Apparent_Kd_M: 1.835656E-11

Real

Aptamer SeqId: 9895-77 | Target: XPF | UniProt: Q92889

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9895-77 | Target: XPF | UniProt: Q92889 | TargetFullName: DNA repair endonuclease XPF | Organisim: human | Apparent_Kd_M: 1.835656E-11

Real

Aptamer SeqId:9896-21;Target:FOXGB;UniProt:P55316

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9896-21;Target: FOXGB;UniProt: P55316;TargetFullName: Forkhead box protein G1;Organisim: human;Apparent_Kd_M: 5.04E-13

Real

Aptamer SeqId: 9896-21 | Target: FOXGB | UniProt: P55316

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9896-21 | Target: FOXGB | UniProt: P55316 | TargetFullName: Forkhead box protein G1 | Organisim: human | Apparent_Kd_M: 5.04E-13

Real

Aptamer SeqId:9897-9;Target:MCM6;UniProt:Q14566

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9897-9;Target: MCM6;UniProt: Q14566;TargetFullName: DNA replication licensing factor MCM6;Organisim: human;Apparent_Kd_M: 8.165406E-11

Real

Aptamer SeqId: 9897-9 | Target: MCM6 | UniProt: Q14566

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9897-9 | Target: MCM6 | UniProt: Q14566 | TargetFullName: DNA replication licensing factor MCM6 | Organisim: human | Apparent_Kd_M: 8.165406E-11

Real

Aptamer SeqId:9898-161;Target:ARI1A;UniProt:O14497

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9898-161;Target: ARI1A;UniProt: O14497;TargetFullName: AT-rich interactive domain-containing protein 1A;Organisim: human;Apparent_Kd_M: 1.704294E-11

Real

Aptamer SeqId: 9898-161 | Target: ARI1A | UniProt: O14497

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9898-161 | Target: ARI1A | UniProt: O14497 | TargetFullName: AT-rich interactive domain-containing protein 1A | Organisim: human | Apparent_Kd_M: 1.704294E-11

Real

Aptamer SeqId:9899-28;Target:KIF1C;UniProt:O43896

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9899-28;Target: KIF1C;UniProt: O43896;TargetFullName: Kinesin-like protein KIF1C;Organisim: human;Apparent_Kd_M: 1.689836E-10

Real

Aptamer SeqId: 9899-28 | Target: KIF1C | UniProt: O43896

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9899-28 | Target: KIF1C | UniProt: O43896 | TargetFullName: Kinesin-like protein KIF1C | Organisim: human | Apparent_Kd_M: 1.689836E-10

Real

Aptamer SeqId:9900-36;Target:NFH;UniProt:P12036

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9900-36;Target: NFH;UniProt: P12036;TargetFullName: Neurofilament heavy polypeptide;Organisim: human;Apparent_Kd_M: 2.580986E-12

Real

Aptamer SeqId: 9900-36 | Target: NFH | UniProt: P12036

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9900-36 | Target: NFH | UniProt: P12036 | TargetFullName: Neurofilament heavy polypeptide | Organisim: human | Apparent_Kd_M: 2.580986E-12

Real

Aptamer SeqId:9901-28;Target:EGLN1;UniProt:Q9GZT9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9901-28;Target: EGLN1;UniProt: Q9GZT9;TargetFullName: Egl nine homolog 1;Organisim: human;Apparent_Kd_M: 1.378629E-12

Real

Aptamer SeqId: 9901-28 | Target: EGLN1 | UniProt: Q9GZT9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9901-28 | Target: EGLN1 | UniProt: Q9GZT9 | TargetFullName: Egl nine homolog 1 | Organisim: human | Apparent_Kd_M: 1.378629E-12

Real

Aptamer SeqId:9905-8;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9905-8;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 2.119802E-11

Real

Aptamer SeqId: 9905-8 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9905-8 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 2.119802E-11

Real

Aptamer SeqId:9906-21;Target:TICN3;UniProt:Q9BQ16

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9906-21;Target: TICN3;UniProt: Q9BQ16;TargetFullName: Testican-3;Organisim: human;Apparent_Kd_M: 8.536491E-12

Real

Aptamer SeqId: 9906-21 | Target: TICN3 | UniProt: Q9BQ16

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9906-21 | Target: TICN3 | UniProt: Q9BQ16 | TargetFullName: Testican-3 | Organisim: human | Apparent_Kd_M: 8.536491E-12

Real

Aptamer SeqId:9907-216;Target:Tankyrase-1;UniProt:O95271

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9907-216;Target: Tankyrase-1;UniProt: O95271;TargetFullName: Tankyrase-1;Organisim: human;Apparent_Kd_M: 3.016627E-11

Real

Aptamer SeqId: 9907-216 | Target: Tankyrase-1 | UniProt: O95271

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9907-216 | Target: Tankyrase-1 | UniProt: O95271 | TargetFullName: Tankyrase-1 | Organisim: human | Apparent_Kd_M: 3.016627E-11

Real

Aptamer SeqId:9909-4;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9909-4;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 1.829845E-12

Real

Aptamer SeqId: 9909-4 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9909-4 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 1.829845E-12

Real

Aptamer SeqId:9910-9;Target:MTAP;UniProt:Q13126

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9910-9;Target: MTAP;UniProt: Q13126;TargetFullName: S-methyl-5-thioadenosine phosphorylase;Organisim: human;Apparent_Kd_M: 2.611022E-11

Real

Aptamer SeqId: 9910-9 | Target: MTAP | UniProt: Q13126

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9910-9 | Target: MTAP | UniProt: Q13126 | TargetFullName: S-methyl-5'-thioadenosine phosphorylase | Organisim: human | Apparent_Kd_M: 2.611022E-11

Real

Aptamer SeqId:9913-4;Target:RRBP1;UniProt:Q9P2E9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9913-4;Target: RRBP1;UniProt: Q9P2E9;TargetFullName: Ribosome-binding protein 1;Organisim: human;Apparent_Kd_M: 5.866914E-12

Real

Aptamer SeqId: 9913-4 | Target: RRBP1 | UniProt: Q9P2E9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9913-4 | Target: RRBP1 | UniProt: Q9P2E9 | TargetFullName: Ribosome-binding protein 1 | Organisim: human | Apparent_Kd_M: 5.866914E-12

Real

Aptamer SeqId:9916-146;Target:LRC4B;UniProt:Q9NT99

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9916-146;Target: LRC4B;UniProt: Q9NT99;TargetFullName: Leucine-rich repeat-containing protein 4B;Organisim: human;Apparent_Kd_M: 6.017747E-11

Real

Aptamer SeqId: 9916-146 | Target: LRC4B | UniProt: Q9NT99

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9916-146 | Target: LRC4B | UniProt: Q9NT99 | TargetFullName: Leucine-rich repeat-containing protein 4B | Organisim: human | Apparent_Kd_M: 6.017747E-11

Real

Aptamer SeqId:9917-16;Target:Fc_MOUSE

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9917-16;Target: Fc_MOUSE;UniProt:;TargetFullName:;Organisim: mouse;Apparent_Kd_M: 8.997413E-12

Real

Aptamer SeqId: 9917-16 | Target: Fc_MOUSE | UniProt:

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9917-16 | Target: Fc_MOUSE | UniProt: | TargetFullName: | Organisim: mouse | Apparent_Kd_M: 8.997413E-12

Real

Aptamer SeqId:9918-23;Target:Calbindin D28;UniProt:P05937

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9918-23;Target: Calbindin D28;UniProt: P05937;TargetFullName: Calbindin;Organisim: human;Apparent_Kd_M: 2.86627E-10

Real

Aptamer SeqId: 9918-23 | Target: Calbindin D28 | UniProt: P05937

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9918-23 | Target: Calbindin D28 | UniProt: P05937 | TargetFullName: Calbindin | Organisim: human | Apparent_Kd_M: 2.86627E-10

Real

Aptamer SeqId:9923-6;Target:SOS1;UniProt:Q07889

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9923-6;Target: SOS1;UniProt: Q07889;TargetFullName: Son of sevenless homolog 1;Organisim: human;Apparent_Kd_M: 1.266014E-11

Real

Aptamer SeqId: 9923-6 | Target: SOS1 | UniProt: Q07889

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9923-6 | Target: SOS1 | UniProt: Q07889 | TargetFullName: Son of sevenless homolog 1 | Organisim: human | Apparent_Kd_M: 1.266014E-11

Real

Aptamer SeqId:9925-56;Target:SREC-II;UniProt:Q96GP6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9925-56;Target: SREC-II;UniProt: Q96GP6;TargetFullName: Scavenger receptor class F member 2;Organisim: human;Apparent_Kd_M: 2.359879E-11

Real

Aptamer SeqId: 9925-56 | Target: SREC-II | UniProt: Q96GP6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9925-56 | Target: SREC-II | UniProt: Q96GP6 | TargetFullName: Scavenger receptor class F member 2 | Organisim: human | Apparent_Kd_M: 2.359879E-11

Real

Aptamer SeqId:9926-4;Target:S100P;UniProt:P25815

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9926-4;Target: S100P;UniProt: P25815;TargetFullName: Protein S100-P;Organisim: human;Apparent_Kd_M: 4.099221E-10

Real

Aptamer SeqId: 9926-4 | Target: S100P | UniProt: P25815

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9926-4 | Target: S100P | UniProt: P25815 | TargetFullName: Protein S100-P | Organisim: human | Apparent_Kd_M: 4.099221E-10

Real

Aptamer SeqId:9927-96;Target:TENS4;UniProt:Q8IZW8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9927-96;Target: TENS4;UniProt: Q8IZW8;TargetFullName: Tensin-4;Organisim: human;Apparent_Kd_M: 5.56782E-11

Real

Aptamer SeqId: 9927-96 | Target: TENS4 | UniProt: Q8IZW8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9927-96 | Target: TENS4 | UniProt: Q8IZW8 | TargetFullName: Tensin-4 | Organisim: human | Apparent_Kd_M: 5.56782E-11

Real

Aptamer SeqId:9928-125;Target:LECT1;UniProt:O75829

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9928-125;Target: LECT1;UniProt: O75829;TargetFullName: Leukocyte cell-derived chemotaxin 1;Organisim: human;Apparent_Kd_M: 4.619483E-11

Real

Aptamer SeqId: 9928-125 | Target: LECT1 | UniProt: O75829

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9928-125 | Target: LECT1 | UniProt: O75829 | TargetFullName: Leukocyte cell-derived chemotaxin 1 | Organisim: human | Apparent_Kd_M: 4.619483E-11

Real

Aptamer SeqId:9929-16;Target:DHB7;UniProt:P56937

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9929-16;Target: DHB7;UniProt: P56937;TargetFullName: 3-keto-steroid reductase;Organisim: human;Apparent_Kd_M: 5.287485E-11

Real

Aptamer SeqId: 9929-16 | Target: DHB7 | UniProt: P56937

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9929-16 | Target: DHB7 | UniProt: P56937 | TargetFullName: 3-keto-steroid reductase | Organisim: human | Apparent_Kd_M: 5.287485E-11

Real

Aptamer SeqId:9930-48;Target:GABR2;UniProt:O75899

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9930-48;Target: GABR2;UniProt: O75899;TargetFullName: Gamma-aminobutyric acid type B receptor subunit 2;Organisim: human;Apparent_Kd_M: 2.826891E-11

Real

Aptamer SeqId: 9930-48 | Target: GABR2 | UniProt: O75899

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9930-48 | Target: GABR2 | UniProt: O75899 | TargetFullName: Gamma-aminobutyric acid type B receptor subunit 2 | Organisim: human | Apparent_Kd_M: 2.826891E-11

Real

Aptamer SeqId:9931-20;Target:Keratin-1;UniProt:P04264

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9931-20;Target: Keratin-1;UniProt: P04264;TargetFullName: Keratin; type II cytoskeletal 1;Organisim: human;Apparent_Kd_M: 7.503065E-12

Real

Aptamer SeqId: 9931-20 | Target: Keratin-1 | UniProt: P04264

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9931-20 | Target: Keratin-1 | UniProt: P04264 | TargetFullName: Keratin; type II cytoskeletal 1 | Organisim: human | Apparent_Kd_M: 7.503065E-12

Real

Aptamer SeqId:9932-49;Target:SEM4F;UniProt:O95754

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9932-49;Target: SEM4F;UniProt: O95754;TargetFullName: Semaphorin-4F;Organisim: human;Apparent_Kd_M: 2.970112E-12

Real

Aptamer SeqId: 9932-49 | Target: SEM4F | UniProt: O95754

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9932-49 | Target: SEM4F | UniProt: O95754 | TargetFullName: Semaphorin-4F | Organisim: human | Apparent_Kd_M: 2.970112E-12

Real

Aptamer SeqId:9933-49;Target:AT1B4;UniProt:Q9UN42

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9933-49;Target: AT1B4;UniProt: Q9UN42;TargetFullName: Protein ATP1B4;Organisim: human;Apparent_Kd_M: 7.73363E-11

Real

Aptamer SeqId: 9933-49 | Target: AT1B4 | UniProt: Q9UN42

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9933-49 | Target: AT1B4 | UniProt: Q9UN42 | TargetFullName: Protein ATP1B4 | Organisim: human | Apparent_Kd_M: 7.73363E-11

Real

Aptamer SeqId:9934-29;Target:PIPNA;UniProt:Q00169

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9934-29;Target: PIPNA;UniProt: Q00169;TargetFullName: Phosphatidylinositol transfer protein alpha isoform;Organisim: human;Apparent_Kd_M: 4.414651E-11

Real

Aptamer SeqId: 9934-29 | Target: PIPNA | UniProt: Q00169

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9934-29 | Target: PIPNA | UniProt: Q00169 | TargetFullName: Phosphatidylinositol transfer protein alpha isoform | Organisim: human | Apparent_Kd_M: 4.414651E-11

Real

Aptamer SeqId:9936-27;Target:LNX1;UniProt:Q8TBB1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9936-27;Target: LNX1;UniProt: Q8TBB1;TargetFullName: E3 ubiquitin-protein ligase LNX;Organisim: human;Apparent_Kd_M: 2.835494E-10

Real

Aptamer SeqId: 9936-27 | Target: LNX1 | UniProt: Q8TBB1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9936-27 | Target: LNX1 | UniProt: Q8TBB1 | TargetFullName: E3 ubiquitin-protein ligase LNX | Organisim: human | Apparent_Kd_M: 2.835494E-10

Real

Aptamer SeqId:9937-7;Target:CXA1;UniProt:P17302

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9937-7;Target: CXA1;UniProt: P17302;TargetFullName: Gap junction alpha-1 protein;Organisim: human;Apparent_Kd_M: 4.827497E-12

Real

Aptamer SeqId: 9937-7 | Target: CXA1 | UniProt: P17302

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9937-7 | Target: CXA1 | UniProt: P17302 | TargetFullName: Gap junction alpha-1 protein | Organisim: human | Apparent_Kd_M: 4.827497E-12

Real

Aptamer SeqId:9940-35;Target:DUS28;UniProt:Q4G0W2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9940-35;Target: DUS28;UniProt: Q4G0W2;TargetFullName: Dual specificity phosphatase 28;Organisim: human;Apparent_Kd_M: 1.661009E-11

Real

Aptamer SeqId: 9940-35 | Target: DUS28 | UniProt: Q4G0W2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9940-35 | Target: DUS28 | UniProt: Q4G0W2 | TargetFullName: Dual specificity phosphatase 28 | Organisim: human | Apparent_Kd_M: 1.661009E-11

Real

Aptamer SeqId:9941-70;Target:PCDB1;UniProt:Q9Y5F3

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9941-70;Target: PCDB1;UniProt: Q9Y5F3;TargetFullName: Protocadherin beta-1;Organisim: human;Apparent_Kd_M: 3.192822E-11

Real

Aptamer SeqId: 9941-70 | Target: PCDB1 | UniProt: Q9Y5F3

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9941-70 | Target: PCDB1 | UniProt: Q9Y5F3 | TargetFullName: Protocadherin beta-1 | Organisim: human | Apparent_Kd_M: 3.192822E-11

Real

Aptamer SeqId:9942-2;Target:NXT1;UniProt:Q9UKK6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9942-2;Target: NXT1;UniProt: Q9UKK6;TargetFullName: NTF2-related export protein 1;Organisim: human;Apparent_Kd_M: 1.399311E-12

Real

Aptamer SeqId: 9942-2 | Target: NXT1 | UniProt: Q9UKK6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9942-2 | Target: NXT1 | UniProt: Q9UKK6 | TargetFullName: NTF2-related export protein 1 | Organisim: human | Apparent_Kd_M: 1.399311E-12

Real

Aptamer SeqId:9947-22;Target:TOPB1;UniProt:Q92547

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9947-22;Target: TOPB1;UniProt: Q92547;TargetFullName: DNA topoisomerase 2-binding protein 1;Organisim: human;Apparent_Kd_M: 4.948617E-12

Real

Aptamer SeqId: 9947-22 | Target: TOPB1 | UniProt: Q92547

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9947-22 | Target: TOPB1 | UniProt: Q92547 | TargetFullName: DNA topoisomerase 2-binding protein 1 | Organisim: human | Apparent_Kd_M: 4.948617E-12

Real

Aptamer SeqId:9950-229;Target:LAG-3;UniProt:P18627

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9950-229;Target: LAG-3;UniProt: P18627;TargetFullName: Lymphocyte activation gene 3 protein;Organisim: human;Apparent_Kd_M: 4.561892E-12

Real

Aptamer SeqId: 9950-229 | Target: LAG-3 | UniProt: P18627

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9950-229 | Target: LAG-3 | UniProt: P18627 | TargetFullName: Lymphocyte activation gene 3 protein | Organisim: human | Apparent_Kd_M: 4.561892E-12

Real

Aptamer SeqId:9951-36;Target:FBXL4;UniProt:Q9UKA2

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9951-36;Target: FBXL4;UniProt: Q9UKA2;TargetFullName: F-box/LRR-repeat protein 4;Organisim: human;Apparent_Kd_M: 4.406228E-12

Real

Aptamer SeqId: 9951-36 | Target: FBXL4 | UniProt: Q9UKA2

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9951-36 | Target: FBXL4 | UniProt: Q9UKA2 | TargetFullName: F-box/LRR-repeat protein 4 | Organisim: human | Apparent_Kd_M: 4.406228E-12

Real

Aptamer SeqId:9952-57;Target:TFAM;UniProt:Q00059

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9952-57;Target: TFAM;UniProt: Q00059;TargetFullName: Transcription factor A; mitochondrial;Organisim: human;Apparent_Kd_M: 3.301148E-11

Real

Aptamer SeqId: 9952-57 | Target: TFAM | UniProt: Q00059

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9952-57 | Target: TFAM | UniProt: Q00059 | TargetFullName: Transcription factor A; mitochondrial | Organisim: human | Apparent_Kd_M: 3.301148E-11

Real

Aptamer SeqId:9954-2;Target:NPPL3;UniProt:Q92617

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9954-2;Target: NPPL3;UniProt: Q92617;TargetFullName: Nuclear pore complex-interacting protein family member B3;Organisim: human;Apparent_Kd_M: 2.11101E-10

Real

Aptamer SeqId: 9954-2 | Target: NPPL3 | UniProt: Q92617

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9954-2 | Target: NPPL3 | UniProt: Q92617 | TargetFullName: Nuclear pore complex-interacting protein family member B3 | Organisim: human | Apparent_Kd_M: 2.11101E-10

Real

Aptamer SeqId:9955-40;Target:RN148;UniProt:Q8N7C7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9955-40;Target: RN148;UniProt: Q8N7C7;TargetFullName: RING finger protein 148;Organisim: human;Apparent_Kd_M: 1.360985E-10

Real

Aptamer SeqId: 9955-40 | Target: RN148 | UniProt: Q8N7C7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9955-40 | Target: RN148 | UniProt: Q8N7C7 | TargetFullName: RING finger protein 148 | Organisim: human | Apparent_Kd_M: 1.360985E-10

Real

Aptamer SeqId:9956-7;Target:ADA15;UniProt:Q13444

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9956-7;Target: ADA15;UniProt: Q13444;TargetFullName: Disintegrin and metalloproteinase domain-containing protein 15;Organisim: human;Apparent_Kd_M: 1.323101E-11

Real

Aptamer SeqId: 9956-7 | Target: ADA15 | UniProt: Q13444

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9956-7 | Target: ADA15 | UniProt: Q13444 | TargetFullName: Disintegrin and metalloproteinase domain-containing protein 15 | Organisim: human | Apparent_Kd_M: 1.323101E-11

Real

Aptamer SeqId:9957-9;Target:RN114;UniProt:Q9Y508

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9957-9;Target: RN114;UniProt: Q9Y508;TargetFullName: E3 ubiquitin-protein ligase RNF114;Organisim: human;Apparent_Kd_M: 2.111665E-11

Real

Aptamer SeqId: 9957-9 | Target: RN114 | UniProt: Q9Y508

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9957-9 | Target: RN114 | UniProt: Q9Y508 | TargetFullName: E3 ubiquitin-protein ligase RNF114 | Organisim: human | Apparent_Kd_M: 2.111665E-11

Real

Aptamer SeqId:9959-60;Target:TM59L;UniProt:Q9UK28

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9959-60;Target: TM59L;UniProt: Q9UK28;TargetFullName: Transmembrane protein 59-like;Organisim: human;Apparent_Kd_M: 2.482952E-10

Real

Aptamer SeqId: 9959-60 | Target: TM59L | UniProt: Q9UK28

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9959-60 | Target: TM59L | UniProt: Q9UK28 | TargetFullName: Transmembrane protein 59-like | Organisim: human | Apparent_Kd_M: 2.482952E-10

Real

Aptamer SeqId:9960-2;Target:TBCD5;UniProt:Q92609

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9960-2;Target: TBCD5;UniProt: Q92609;TargetFullName: TBC1 domain family member 5;Organisim: human;Apparent_Kd_M: 9.275158E-12

Real

Aptamer SeqId: 9960-2 | Target: TBCD5 | UniProt: Q92609

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9960-2 | Target: TBCD5 | UniProt: Q92609 | TargetFullName: TBC1 domain family member 5 | Organisim: human | Apparent_Kd_M: 9.275158E-12

Real

Aptamer SeqId:9962-1;Target:MUCDL;UniProt:Q9HBB8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9962-1;Target: MUCDL;UniProt: Q9HBB8;TargetFullName: Cadherin-related family member 5;Organisim: human;Apparent_Kd_M: 4.511979E-11

Real

Aptamer SeqId: 9962-1 | Target: MUCDL | UniProt: Q9HBB8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9962-1 | Target: MUCDL | UniProt: Q9HBB8 | TargetFullName: Cadherin-related family member 5 | Organisim: human | Apparent_Kd_M: 4.511979E-11

Real

Aptamer SeqId:9963-19;Target:PCDBA;UniProt:Q9UN67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9963-19;Target: PCDBA;UniProt: Q9UN67;TargetFullName: Protocadherin beta-10;Organisim: human;Apparent_Kd_M: 5.419752E-11

Real

Aptamer SeqId: 9963-19 | Target: PCDBA | UniProt: Q9UN67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9963-19 | Target: PCDBA | UniProt: Q9UN67 | TargetFullName: Protocadherin beta-10 | Organisim: human | Apparent_Kd_M: 5.419752E-11

Real

Aptamer SeqId:9964-10;Target:MYZAP;UniProt:P0CAP1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9964-10;Target: MYZAP;UniProt: P0CAP1;TargetFullName: Myocardial zonula adherens protein;Organisim: human;Apparent_Kd_M: 4.957583E-12

Real

Aptamer SeqId: 9964-10 | Target: MYZAP | UniProt: P0CAP1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9964-10 | Target: MYZAP | UniProt: P0CAP1 | TargetFullName: Myocardial zonula adherens protein | Organisim: human | Apparent_Kd_M: 4.957583E-12

Real

Aptamer SeqId:9969-8;Target:S22AG;UniProt:Q86VW1

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9969-8;Target: S22AG;UniProt: Q86VW1;TargetFullName: Solute carrier family 22 member 16;Organisim: human;Apparent_Kd_M: 2.93512E-11

Real

Aptamer SeqId: 9969-8 | Target: S22AG | UniProt: Q86VW1

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9969-8 | Target: S22AG | UniProt: Q86VW1 | TargetFullName: Solute carrier family 22 member 16 | Organisim: human | Apparent_Kd_M: 2.93512E-11

Real

Aptamer SeqId:9970-7;Target:UBXN4;UniProt:Q92575

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9970-7;Target: UBXN4;UniProt: Q92575;TargetFullName: UBX domain-containing protein 4;Organisim: human;Apparent_Kd_M: 4.017147E-12

Real

Aptamer SeqId: 9970-7 | Target: UBXN4 | UniProt: Q92575

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9970-7 | Target: UBXN4 | UniProt: Q92575 | TargetFullName: UBX domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 4.017147E-12

Real

Aptamer SeqId:9971-5;Target:CSMD2;UniProt:Q7Z408

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9971-5;Target: CSMD2;UniProt: Q7Z408;TargetFullName: CUB and sushi domain-containing protein 2;Organisim: human;Apparent_Kd_M: 3.25592E-12

Real

Aptamer SeqId: 9971-5 | Target: CSMD2 | UniProt: Q7Z408

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9971-5 | Target: CSMD2 | UniProt: Q7Z408 | TargetFullName: CUB and sushi domain-containing protein 2 | Organisim: human | Apparent_Kd_M: 3.25592E-12

Real

Aptamer SeqId:9974-8;Target:DLL3;UniProt:Q9NYJ7

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9974-8;Target: DLL3;UniProt: Q9NYJ7;TargetFullName: Delta-like protein 3;Organisim: human;Apparent_Kd_M: 1.142051E-10

Real

Aptamer SeqId: 9974-8 | Target: DLL3 | UniProt: Q9NYJ7

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9974-8 | Target: DLL3 | UniProt: Q9NYJ7 | TargetFullName: Delta-like protein 3 | Organisim: human | Apparent_Kd_M: 1.142051E-10

Real

Aptamer SeqId:9979-13;Target:AMGO1;UniProt:Q86WK6

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9979-13;Target: AMGO1;UniProt: Q86WK6;TargetFullName: Amphoterin-induced protein 1;Organisim: human;Apparent_Kd_M: 8.891196E-12

Real

Aptamer SeqId: 9979-13 | Target: AMGO1 | UniProt: Q86WK6

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9979-13 | Target: AMGO1 | UniProt: Q86WK6 | TargetFullName: Amphoterin-induced protein 1 | Organisim: human | Apparent_Kd_M: 8.891196E-12

Real

Aptamer SeqId:9981-18;Target:K1467;UniProt:A2RU67

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9981-18;Target: K1467;UniProt: A2RU67;TargetFullName: Protein FAM234B;Organisim: human;Apparent_Kd_M: 9.978888E-12

Real

Aptamer SeqId: 9981-18 | Target: K1467 | UniProt: A2RU67

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9981-18 | Target: K1467 | UniProt: A2RU67 | TargetFullName: Protein FAM234B | Organisim: human | Apparent_Kd_M: 9.978888E-12

Real

Aptamer SeqId:9983-97;Target:PRS35;UniProt:Q8N3Z0

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9983-97;Target: PRS35;UniProt: Q8N3Z0;TargetFullName: Inactive serine protease 35;Organisim: human;Apparent_Kd_M: 3.116451E-10

Real

Aptamer SeqId: 9983-97 | Target: PRS35 | UniProt: Q8N3Z0

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9983-97 | Target: PRS35 | UniProt: Q8N3Z0 | TargetFullName: Inactive serine protease 35 | Organisim: human | Apparent_Kd_M: 3.116451E-10

Real

Aptamer SeqId:9984-12;Target:YIPF6;UniProt:Q96EC8

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9984-12;Target: YIPF6;UniProt: Q96EC8;TargetFullName: Protein YIPF6;Organisim: human;Apparent_Kd_M: 1.508299E-11

Real

Aptamer SeqId: 9984-12 | Target: YIPF6 | UniProt: Q96EC8

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9984-12 | Target: YIPF6 | UniProt: Q96EC8 | TargetFullName: Protein YIPF6 | Organisim: human | Apparent_Kd_M: 1.508299E-11

Real

Aptamer SeqId:9986-14;Target:Neuropeptide W;UniProt:Q8N729

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9986-14;Target: Neuropeptide W;UniProt: Q8N729;TargetFullName: Neuropeptide W;Organisim: human;Apparent_Kd_M: 9.007485E-11

Real

Aptamer SeqId: 9986-14 | Target: Neuropeptide W | UniProt: Q8N729

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9986-14 | Target: Neuropeptide W | UniProt: Q8N729 | TargetFullName: Neuropeptide W | Organisim: human | Apparent_Kd_M: 9.007485E-11

Real

Aptamer SeqId:9989-12;Target:LRC24;UniProt:Q50LG9

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9989-12;Target: LRC24;UniProt: Q50LG9;TargetFullName: Leucine-rich repeat-containing protein 24;Organisim: human;Apparent_Kd_M: 1.127049E-10

Real

Aptamer SeqId: 9989-12 | Target: LRC24 | UniProt: Q50LG9

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9989-12 | Target: LRC24 | UniProt: Q50LG9 | TargetFullName: Leucine-rich repeat-containing protein 24 | Organisim: human | Apparent_Kd_M: 1.127049E-10

Real

Aptamer SeqId:9993-11;Target:ZN264;UniProt:O43296

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9993-11;Target: ZN264;UniProt: O43296;TargetFullName: Zinc finger protein 264;Organisim: human;Apparent_Kd_M: 4.172888E-11

Real

Aptamer SeqId: 9993-11 | Target: ZN264 | UniProt: O43296

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9993-11 | Target: ZN264 | UniProt: O43296 | TargetFullName: Zinc finger protein 264 | Organisim: human | Apparent_Kd_M: 4.172888E-11

Real

Aptamer SeqId:9994-217;Target:ATP4B;UniProt:P51164

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9994-217;Target: ATP4B;UniProt: P51164;TargetFullName: Potassium-transporting ATPase subunit beta;Organisim: human;Apparent_Kd_M: 3.593211E-11

Real

Aptamer SeqId: 9994-217 | Target: ATP4B | UniProt: P51164

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9994-217 | Target: ATP4B | UniProt: P51164 | TargetFullName: Potassium-transporting ATPase subunit beta | Organisim: human | Apparent_Kd_M: 3.593211E-11

Real

Aptamer SeqId:9995-6;Target:DUT;UniProt:P33316

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9995-6;Target: DUT;UniProt: P33316;TargetFullName: Deoxyuridine 5-triphosphate nucleotidohydrolase; mitochondrial;Organisim: human;Apparent_Kd_M: 1.687954E-11

Real

Aptamer SeqId: 9995-6 | Target: DUT | UniProt: P33316

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9995-6 | Target: DUT | UniProt: P33316 | TargetFullName: Deoxyuridine 5'-triphosphate nucleotidohydrolase; mitochondrial | Organisim: human | Apparent_Kd_M: 1.687954E-11

Real

Aptamer SeqId:9997-12;Target:UBXN4;UniProt:Q92575

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9997-12;Target: UBXN4;UniProt: Q92575;TargetFullName: UBX domain-containing protein 4;Organisim: human;Apparent_Kd_M: 5.798382E-12

Real

Aptamer SeqId: 9997-12 | Target: UBXN4 | UniProt: Q92575

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9997-12 | Target: UBXN4 | UniProt: Q92575 | TargetFullName: UBX domain-containing protein 4 | Organisim: human | Apparent_Kd_M: 5.798382E-12

Real

Aptamer SeqId:9999-1;Target:IRF6;UniProt:O14896

Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants;SeqId: 9999-1;Target: IRF6;UniProt: O14896;TargetFullName: Interferon regulatory factor 6;Organisim: human;Apparent_Kd_M: 3.161946E-11

Real

Aptamer SeqId: 9999-1 | Target: IRF6 | UniProt: O14896

Phase 2 data. Somalogic Aptamer analysis used to determine protein concentrations in Fenland EDTA-plasma samples from baseline examinations of all Fenland participants | SeqId: 9999-1 | Target: IRF6 | UniProt: O14896 | TargetFullName: Interferon regulatory factor 6 | Organisim: human | Apparent_Kd_M: 3.161946E-11

Real

Serotonin_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Serotonin_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_032.

Real

OLINK assay SERPINA12

Phase 1 OLINK assay data for target SERPINA12 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SERPINA5

Phase 1 OLINK assay data for target SERPINA5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SERPINA7

Phase 1 OLINK assay data for target SERPINA7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SERPINA9

Phase 1 OLINK assay data for target SERPINA9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SERPINB6

Phase 1 OLINK assay data for target SERPINB6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SERPINB8

Phase 1 OLINK assay data for target SERPINB8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Ser_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Ser_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_018.

Real

Sex of Participant

Participants gender as recorded in study database.

Categorical

OLINK assay SEZ6L2

Phase 1 OLINK assay data for target SEZ6L2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SEZ6L

Phase 1 OLINK assay data for target SEZ6L in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SFRP1

Phase 1 OLINK assay data for target SFRP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay sFRP-3

Phase 1 OLINK assay data for target sFRP-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SH2B3

Phase 1 OLINK assay data for target SH2B3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SH2D1A

Phase 1 OLINK assay data for target SH2D1A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cln variable: Shift worker

Phase 2 data. Variable to indicate shift worker (1=ticked shift work in GenQ) - cleaned

Real

OLINK assay SHPS-1

Phase 1 OLINK assay data for target SHPS-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIGLEC10

Phase 1 OLINK assay data for target SIGLEC10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIGLEC1

Phase 1 OLINK assay data for target SIGLEC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIGLEC6

Phase 1 OLINK assay data for target SIGLEC6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIGLEC7

Phase 1 OLINK assay data for target SIGLEC7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay Siglec-9

Phase 1 OLINK assay data for target Siglec-9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Whether the consent form has any signatures with-held.

Categorical

OLINK assay SIRPB1

Phase 1 OLINK assay data for target SIRPB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIRT2

Phase 1 OLINK assay data for target SIRT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIRT5

Phase 1 OLINK assay data for target SIRT5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SIT1

Phase 1 OLINK assay data for target SIT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Av breaks occ1 breaks/hr

Phase 2 data. Average number of breaks interrupting sitting time while doing occupation 1. (breaks/hr)

Real

Av breaks occ2 breaks/hr

Phase 2 data. Average number of breaks interrupting sitting time while doing occupation 2. (breaks/hr)

Real

Av breaks occupation breaks/hr

Phase 2 data. The average number breaks interrupting sitting time while doing an occupation. Average of reported breaks during occupation 1 and occupation 2. (breaks/hr)

Real

Av breaks watching TV breaks/hr

Phase 2 data. Average number of breaks interrupting sitting time while watching TV. (breaks/hr)

Real

None

Phase 2 data. Wyman Dillon comment if Q completion date is not legible and why.

Text

None

Phase 2 data. Wyman Dillon comment if scanning of ID sticker fails stating that scanning failed and why if known for 7DSB form

Text

Avg of multiple sleep times

Phase 2 data. 1 = Average of multiple sleep times used as participant reported two or more sleep times.

Categorical

Completion date flag-codes in dictionary

Phase 2 data. Flag the completion date of questionnaire as it was: 1 = had to be cleaned/changed due to typos; minus 10 variable or data entry issues; 2 = completion date was missing therefore last day of Actiheart wear imputed; 3 = completion date was outside of data collection dates therefore last day of Actiheart wear imputed; 4 = no completion date or Actiheart/free-living file to use therefore date will still be missing.

Categorical

Flag for double qnr entry for pt

Phase 2 data. 1 = flag to indicate there were two different questionnaire entries for the participant. One entry was chosen based on the entry matching the actiheart wear dates. Note this was not always possible; therefore the most complete entry was used in these cases.

Categorical

Flag for empty questionnaire

Phase 2 data. Flag to indicate if the questionnaire was empty/participant did not complete. 1 = flagged by data management as fully empty questionnaire/participant did not complete any of the questions; 2 = participant did not complete any of the questions however there was a comment in the comments variable to indicate this. All variables (included those imputed e.g. Completion Date) set to missing for those flagged as empty.

Categorical

Sleep duration data

Phase 2 data. 1 = Weekday or weekend sleep durations flagged as duration <=3 hours or >=14 hours. Sleep duration data set to missing for these.

Categorical

Flag for total sedentary time p/day

Phase 2 data. Flag to indicate if total sedentary time per day is >1440 minutes. 1 = total sedetary time >1440 minutes; 2 = total sedetary time not including sleep >1440 minutes. Variable values are not capped in the dataset at 1440 but flagged here for information.

Categorical

7DSBR comment from participant

Phase 2 data. 7-day sedentary behaviour recall comment from participant. If any additional comments appear on ANY page of the questionnaire please enter them as page number and the comment.

Text

Wkday get up time decimal

Phase 2 data. Get up time on a weekday from reported get up hour; minutes and am/pm variable. (decimal)

Real

Wkend get up time decimal

Phase 2 data. Get up time on a weekend day from reported get up hour; minutes and am/pm variable. (decimal)

Real

Wkday go sleep time decimal

Phase 2 data. Go to sleep time on a weekday from reported go sleep hour; minutes and am/pm variable. (decimal)

Real

Wkend go to sleep time decimal

Phase 2 data. Go to sleep time on a weekend day from reported go sleep hour; minutes and am/pm variable. (decimal)

Real

Date (day) 7DSBQ filled in

Phase 2 data. Date 7DSBQ was filled in by participant; day. Format DD (eg 01 for January).

Date

Date (month) 7DSBQ filled in

Phase 2 data. Date 7DSBQ was filled in by participant; month. Format MM (eg 02 for February).

Date

Date (year) 7DSBQ filled in

Phase 2 data. Date 7DSBQ was filled in by participant; year. Format YYYY (4-digits).

Date

Date 7DSBQ filled in

Phase 2 data. Date 7DSBQ was filled in by participant; date. Format DD-Mon-YYYY (eg 01-Jan-2000 for 01 January 2000). Generated from QCompletionDate_Day; QCompletionDate_Month; QCompletionDate_Year variables. Cleaned. Variable is flagged if has been cleaned or imputed - see variable FLAG_CompletionDate for details.

Date

None

Phase 2 data. Tracker variable created by DMT. 1 = paper; 2 = electronic; 3 = private network study db; 9 = paper and electronic;

Real

7DSB form version number

Phase 2 data. 7DSB form version number. Version numbers available: 2 = v 2.0 120914; 3 = V3.0_160117. Cleaned.

Categorical

None

Phase 2 data. 7DSB form version number. Version numbers available: 2 = v 2.0 120914; 3 = V3.0_160117;

Real

Go to sleep time on weekday am/pm

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? This variable is am or pm on a weekday. Cleaned.

Time

Go to sleep time on weekday (am/pm)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? Am or pm on a weekday.-1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Go to sleep time on weekday hr

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? This variable is the hour value on a weekday. Hour and minutes entered as separate variables. Cleaned.

Time

Go to sleep time on weekday (hr)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? Hour and minutes entered as separate values - hour value on a weekday. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Go to sleep time on weekday min

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? This variable is the minutes value on a weekday. Hour and minutes entered as separate variables. Cleaned.

Time

Go to sleep time on weekday (min)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? Hour and minutes entered as separate values - minutes value on a weekday. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Get up time on weekday am/pm

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? This variable is am or pm on a weekday. Cleaned.

Time

Get up time on weekday hr

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read - Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? This variable is the hour value on a weekday. Hour and minutes entered as separate variables. Cleaned.

Time

Get up time on weekday min

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? This variable is the minutes value on a weekday. Hour and minutes entered as separate variables. Cleaned.

Time

Go sleep time weekend day am/pm

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekend day? This variable is am or pm on a weekend day. Cleaned.

Time

Get up time on weekday (am/pm)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? Am or pm on a weekday. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Get up time on weekday (hr)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? Hour and minutes entered as separate values - hour value on a weekday. Hour and minutes entered as separate values - hour value on a weekday. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Get up time on weekday (min)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? Hour and minutes entered as separate values - minutes value on a weekday. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Go sleep time weekend day (am/pm)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? Am or pm on a weekend day. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Go sleep time weekend day hr

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekend day? This variable is the hour value on a weekend day. Hour and minutes entered as separate variables. Cleaned.

Time

Go sleep time weekend day (hr)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? Hour and minutes entered as separate values - hour value on a weekend day.. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Go sleep time weekend day min

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekend day? This variable is the minutes value on a weekend day. Hour and minutes entered as separate variables. Cleaned.

Time

Get up time on weekend day am/pm

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekend day? This variable is am or pm on a weekend day. Cleaned.

Categorical

Get up time on weekend day hr

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekend day? This variable is the hour value on a weekend day. Hour and minutes entered as separate variables. Cleaned.

Time

Get up time on weekend day min

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekend day? This variable is the minutes value on a weekend day. Hour and minutes entered as separate variables. Cleaned.

Time

Go sleep time weekend day (min)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you go to sleep on a weekday? Hour and minutes entered as separate values - minutes value on a weekend day. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Get up time on weekend day (am/pm)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? Am or pm on a weekend day. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Get up time on weekend day (hr)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? Hour and minutes entered as separate values - hour value on a weekday. Hour and minutes entered as separate values - hour value on a weekend day. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Get up time on weekend day (min)

Phase 2 data. SLEEPING AND NAPPING. Think about what time you went to sleep and got up in the last 7 days. If you had variable sleeping patterns (eg you did shift work) please record the average time you went to bed and got up on weekdays and on weekend days. Do not include reading or watching TV before falling asleep or after waking. This is part of section 5. 1. In the last 7 days at what time did you get up on a weekday? Hour and minutes entered as separate values - minutes value on a weekend day. -1 = left blank; -4 = range entered; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Dur of nap on a weekday min

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -A nap is a brief period of sleep often during the day. A nap can be taken on a sofa as well as in a bed. 2. In the last 7 days on average how long did you nap per day on a weekday? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day napping on a weekday.

Real

Dur of nap on a weekday min

Phase 2 data. SLEEPING AND NAPPING. A nap is a brief period of sleep often during the day. A nap can be taken on a sofa as well as in a bed. 2. In the last 7 days on average how long did you nap per day on a weekday?. 1 = No daily napping; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min - 1 hour; 6 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Dur of nap on a weekend day min

Phase 2 data. SLEEPING AND NAPPING. Questionnaire read -A nap is a brief period of sleep often during the day. A nap can be taken on a sofa as well as in a bed. 2. In the last 7 days on average how long did you nap per day on a weekend day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day napping on a weekend day.

Real

Dur of nap on a weekend day min

Phase 2 data. SLEEPING AND NAPPING. A nap is a brief period of sleep often during the day. A nap can be taken on a sofa as well as in a bed. 2. In the last 7 days on average how long did you nap per day on a weekend day?. 1 = No daily napping; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min - 1 hour; 6 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Working studying or volunteering

Phase 2 data. TRANSPORTATION. Questionnaire read -4. Have you been working studying or volunteering (referred to as occupation) in the last 7 days? Occupation refers to three different types of activities: work; study and volunteering. Work refers to all tasks done to earn money. Study refers to educational activities. Volunteering refers to work that you do for no pay such as helping in a sports club. Please think about all three of these categories for the following questions? 2 = yes; 3 = no; -1 = left blank. Cleaned.

Categorical

Working/studying/volunteering

Phase 2 data. TRANSPORTATION. 4. Have you been working studying or volunteering (referred to as occupation) in the last 7 days? Occupation refers to three different types of activities: work; study and volunteering. Work refers to all tasks done to earn money. Study refers to educational activities. Volunteering refers to work that you do for no pay such as helping in a sports club. Please think about all three of these categories for the following questions. 2 = yes; 3 = no; -1 = left blank; -5 = more than one selected;

Categorical

Sitting wkday breakfast min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting during breakfast on a weekday.

Real

Sitting wkday breakfast min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKDAY - BREAKFAST 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Sitting wkday lunch min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting during lunch on a weekday.

Real

Sitting wkday lunch min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKDAY - LUNCH. 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Sitting wkday dinner min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting during dinner on a weekday.

Real

Sitting wkday dinner min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work …) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKDAY - DINNER 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Days sitting travel to/from occ1

Phase 2 data. TRAVELLING TO AND FROM OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 5. In the last 7 days how many days a week did you sit while travelling to and from your occupation 1? In number of days. Cleaned.

Real

Days sitting travel to/from occ1

Phase 2 data. TRAVELLING TO AND FROM OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 5. In the last 7 days how many days a week did you sit while travelling to and from your occupation 1? In number of days. -1 = left blank; -4 = range entered;

Real

Days sitting travel to/from occ2

Phase 2 data. TRAVELLING TO AND FROM OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 5. In the last 7 days how many days a week did you sit while travelling to and from your occupation 2? In number of days. Cleaned.

Real

Sitting wkend day lunch min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting during lunch on a weekend day.

Real

Sitting wkend day lunch min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKEND DAY - BREAKFAST 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Sitting wkend day dinner min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting during dinner on a weekend day.

Real

Sitting wkend day dinner min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKEND DAY - LUNCH. 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Sitting wkday snack min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while snacking on a weekday.

Real

Days sitting travel to/from occ2

Phase 2 data. TRAVELLING TO AND FROM OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 5. In the last 7 days how many days a week did you sit while travelling to and from your occupation 2? In number of days. -1 = left blank; -4 = range entered;

Real

Days sitting travel part of occ1

Phase 2 data. TRAVELLING AS PART OF OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 1 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 7. In the last 7 days how many days a week did you sit while travelling as part of your occupation? In number in days. Cleaned.

Real

Days sitting travel part of occ1

Phase 2 data. TRAVELLING AS PART OF OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 1 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 7. In the last 7 days how many days a week did you sit while travelling as part of your occupation? In number in days. -1 = left blank; -4 = range entered;

Real

Days sitting travel part of occ2

Phase 2 data. TRAVELLING AS PART OF OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 2 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 7. In the last 7 days how many days a week did you sit while travelling as part of your occupation? In number in days. Cleaned.

Real

Sitting wkday snack min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKEND DAY - DINNER 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Sitting wkend day breakfast min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting during breakfast on a weekend day.

Real

Sitting wkend day breakfast min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKDAY - SNACKS 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Sitting wkend day snack min

Phase 2 data. MEALS. Questionnaire read -Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while snacking on a weekend day.

Real

Sitting wkend day snack min

Phase 2 data. MEALS. Please think about the amount of time you spent sitting for breakfast; lunch and dinner; on average in the last 7 days. DO INCLUDE time spent sitting for breakfast lunch dinner or snacks (at home; work) also when you were reading chatting to other people or listening to the radio. For example if you spent 30 minutes sitting for breakfast while reading the newspaper or for lunch while working then include this in this section. 3. In the last 7 days on average; how long did you sit for each of these meals per day? WEEKEND DAY - SNACKS 1 = none; 2 = 1-10 min; 3 = 10-20 min; 4 = 20-30 min; 5 = 30-45 min; 6 = 45 min - 1 hour; 7 = more than one hour a day; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Days sitting travel part of occ2

Phase 2 data. TRAVELLING AS PART OF OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 2 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 7. In the last 7 days how many days a week did you sit while travelling as part of your occupation? In number in days. -1 = left blank; -4 = range entered;

Real

Occupation in last 7 days

Phase 2 data. WORK STUDY VOLUNTEERING. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 10. Did you have an occupation in the last 7 days? 2 = yes; 3 = no; -1 = left blank. Cleaned.

Categorical

Occupation in last 7 days (2=Y;3=N)

Phase 2 data. WORK STUDY VOLUNTEERING. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 10. Did you have an occupation in the last 7 days? If you did not have an occupation in the last 7 days please skip to section 5. 2 = yes; 3 = no; -1 = left blank; -5 = more than one selected;

Categorical

Type of occupation1

Phase 2 data. WORK STUDY VOLUNTEERING. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 11a. Type of occupation 1? 1 = work; 2 = study; 3 = volunteering. If more than one type of occupation was selected; kept information by coding with decimal e.g.?(-5)1 and ? recoded as 1.2. Cleaned.

Categorical

Wkday sitting watch TV min

Phase 2 data. SCREEN TIME. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? WATCHING TV; dvds/videos on a WEEKDAY. DO include meals while sitting and watching TV? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying while watching TV on a weekday.

Real

Wkday sitting while TV min

Phase 2 data. SCREEN TIME. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? WATCHING TV; dvds/videos on a WEEKDAY. DO include meals while sitting and watching TV. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkend sitting watch TV min

Phase 2 data. SCREEN TIME. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? WATCHING TV; dvds/videos on a WEEKEND DAY. DO include meals while sitting and watching TV? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying while watching TV on a weekend day.

Real

Wkend sitting while TV min

Phase 2 data. SCREEN TIME. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? WATCHING TV; dvds/videos on a WEEKEND DAY. DO include meals while sitting and watching TV. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sit using computer min

Phase 2 data. SCREEN TIME. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? USING COMPUTER apart from work (internet; e-mail; chat; networking (Facebook) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying while using a computer apart from work on a weekday.

Real

Type of occ1

Phase 2 data. WORK STUDY VOLUNTEERING. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 11a. Type of occupation 1. 1 = work; 2 = study; 3 = volunteering; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions;

Categorical

Name of occupation 1

Phase 2 data. WORK STUDY VOLUNTEERING. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 12a. Name of occupation 1 (e.g. receptionist)? -1 = left blank.

Text

Name of occupation 1

Phase 2 data. WORK STUDY VOLUNTEERING. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 12a. Name of occupation 1 (e.g. receptionist). -1 = left blank;

Text

Number of days doing occ1

Phase 2 data. WORK STUDY VOLUNTEERING OCC 1. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 13a. How many days did you do occupation 1 in the last 7 days? In number of days. Cleaned.

Real

Wkday sit using computer min

Phase 2 data. SCREEN TIME. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? USING COMPUTER apart from work (internet; e-mail; chat; networking (Facebook;…)) on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkend sit using computer min

Phase 2 data. SCREEN TIME. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? USING COMPUTER apart from work (internet; e-mail; chat; networking (Facebook) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying while using a computer apart from work on a weekend day.

Real

Wkend sit using computer min

Phase 2 data. SCREEN TIME. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? USING COMPUTER apart from work (internet; e-mail; chat; networking (Facebook;…)) on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sit computer games min

Phase 2 data. SCREEN TIME. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? PLAYING COMPUTER GAMES (playstation; Xbox etc) do NOT included non-sitting games; on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying while playing computer games on a weekday.

Real

Wkday sit computer games min

Phase 2 data. SCREEN TIME. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? PLAYING COMPUTER GAMES (playstation; Xbox etc) do NOT included non-sitting games; on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Number of days doing occ1

Phase 2 data. WORK STUDY VOLUNTEERING OCC 1. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 13a. How many days did you do occupation 1 in the last 7 days? In number of days. -1 = left blank; -4 = range entered;

Real

Freq interrupt sitting time occ1

Phase 2 data. WORK STUDY VOLUNTEERING OCC 1. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 15a. In the last 7 days on average how many times per day did you interrupt your sitting time while doing occupation 1 for example by standing up; walking somewhere or getting a coffee? Cleaned. Number/day.

Real

Freq interrupt sitting time occ1

Phase 2 data. WORK STUDY VOLUNTEERING OCC 1. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 15a. In the last 7 days on average how many times per day did you interrupt your sitting time while doing occupation 1 for example by standing up; walking somewhere or getting a coffee? -1 = left blank; -4 = range entered;

Real

Wkend sit computer games min

Phase 2 data. SCREEN TIME. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? PLAYING COMPUTER GAMES (playstation; Xbox etc) do NOT included non-sitting games; on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying while playing computer games on a weekend day.

Real

Wkend sit computer games min

Phase 2 data. SCREEN TIME. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. 17. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? PLAYING COMPUTER GAMES (playstation; Xbox etc) do NOT included non-sitting games; on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday time sit travel not from occ

Phase 2 data. GETTING ABOUT. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while getting about apart from your occupation for example when going to the supermarket; going to visit friends etc. Please include time spent sitting to and from your destination. DO NOT include cycling on a pedal bicycle. 9. In the last 7 days on average how long did you sit for getting about apart from your occupation per day on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while travelling for getting about apart from your occupation on a weekday.

Real

Wkd time sit travel apart from occ

Phase 2 data. GETTING ABOUT. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while getting about apart from your occupation for example when going to the supermarket; going to visit friends etc. Please include time spent sitting to and from your destination. DO NOT include cycling on a pedal bicycle. 9. In the last 7 days on average how long did you sit for getting about apart from your occupation per day on a WEEKDAY? 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min -1 hour; 6 = 1-1.5 hours; 7 = 1.5-2 hours; 8 = 2-2.5 hours; 9 = 2.5-3 hours; 10 = 3-4 hours; 11 = 4-5 hours; 12 = 5-6 hours ; 13 = 6-7 hours; 14 = More than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkend time sit travel not from occ

Phase 2 data. GETTING ABOUT. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while getting about apart from your occupation for example when going to the supermarket; going to visit friends etc. Please include time spent sitting to and from your destination. DO NOT include cycling on a pedal bicycle. 9. In the last 7 days on average how long did you sit for getting about apart from your occupation per day on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while travelling for getting about apart from your occupation on a weekend day.

Real

Second occupation

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 16. Did you have a second occupation in the last 7 days? 2 = yes; 3 = no; -1 = left blank. Cleaned.

Categorical

Second occupation

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 16. Did you have a second occupation in the last 7 days? 2 = yes; 3 = no; -1 = left blank; -5 = more than one selected;

Categorical

Type of occupation2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 11b. Type of occupation 2. 1 = work; 2 = study; 3 = volunteering. If more than one type of occupation was selected; kept information by coding with decimal e.g.?(-5)1 and ? recoded as 1.2. Cleaned.

Categorical

Type of occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 11b. Type of occupation 2. 1 = work; 2 = study; 3 = volunteering; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions;

Categorical

Wknd time sit travel apart from occ

Phase 2 data. GETTING ABOUT. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while getting about apart from your occupation for example when going to the supermarket; going to visit friends etc. Please include time spent sitting to and from your destination. DO NOT include cycling on a pedal bicycle. 9. In the last 7 days on average how long did you sit for getting about apart from your occupation per day on a WEEKEND DAY? 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min -1 hour; 6 = 1-1.5 hours; 7 = 1.5-2 hours; 8 = 2-2.5 hours; 9 = 2.5-3 hours; 10 = 3-4 hours; 11 = 4-5 hours; 12 = 5-6 hours ; 13 = 6-7 hours; 14 = More than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Time sit travel to/from occ1 min

Phase 2 data. TRAVELLING TO AND FROM OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 6. In the last 7 days on average how long did you sit while travelling to and from your occupation 1 on such a day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while travelling to and from occupation 1.

Real

Time sit travel to/from occ1 (min)

Phase 2 data. TRAVELLING TO AND FROM OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 6. In the last 7 days on average how long did you sit while travelling to and from your occupation 1 on such a day? 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min -1 hour; 6 = 1-1.5 hours; 7 = 1.5-2 hours; 8 = 2-2.5 hours; 9 = 2.5-3 hours; 10 = 3-4 hours; 11 = 4-5 hours; 12 = 5-6 hours ; 13 = 6-7 hours; 14 = More than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Time sit travel to/from occ2 min

Phase 2 data. TRAVELLING TO AND FROM OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 6. In the last 7 days on average how long did you sit while travelling to and from your occupation 2 on such a day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while travelling to and from occupation 2.

Real

Time sit travel to/from occ2 (min)

Phase 2 data. TRAVELLING TO AND FROM OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. The questions are about travelling to and from your occupation - travelling as part of your occupation and getting about apart from your occupation. DO NOT include cycling on a pedal bicycle. 6. In the last 7 days on average how long did you sit while travelling to and from your occupation 2 on such a day? 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min -1 hour; 6 = 1-1.5 hours; 7 = 1.5-2 hours; 8 = 2-2.5 hours; 9 = 2.5-3 hours; 10 = 3-4 hours; 11 = 4-5 hours; 12 = 5-6 hours ; 13 = 6-7 hours; 14 = More than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Name of occupation 2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 12B. Name of occupation 2 (e.g. receptionist)? -1 = left blank.

Text

Name of occupation 2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 12B. Name of occupation 2 (e.g. receptionist). -1 = left blank;

Text

Number of days doing occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 13B. How many days did you do occupation 2 in the last 7 days? In number of days. Cleaned.

Real

Number of days doing occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 13B. How many days did you do occupation 2 in the last 7 days? In number of days. -1 = left blank; -4 = range entered;

Real

Freq interrupt sitting time occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 15B. In the last 7 days on average how many times per day did you interrupt your sitting time while doing occupation 2 for example by standing up; walking somewhere or getting a coffee? Cleaned. Number/day.

Real

Time sit travel part of occ1 min

Phase 2 data. TRAVELLING AS PART OF OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 1 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 8. In the last 7 days on average how long did you sit while travelling as part of your occupation 1 on such a day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while travelling as part of occupation 1.

Real

Time sit travel part of occ1 (min)

Phase 2 data. TRAVELLING AS PART OF OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 1 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 8. In the last 7 days on average how long did you sit while travelling as part of your occupation 1 on such a day? 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min -1 hour; 6 = 1-1.5 hours; 7 = 1.5-2 hours; 8 = 2-2.5 hours; 9 = 2.5-3 hours; 10 = 3-4 hours; 11 = 4-5 hours; 12 = 5-6 hours ; 13 = 6-7 hours; 14 = More than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Time sit travel part of occ2 min

Phase 2 data. TRAVELLING AS PART OF OCC. Questionnaire read -This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 1 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 8. In the last 7 days on average how long did you sit while travelling as part of your occupation 2 on such a day? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while travelling as part of occupation 2.

Real

Time sit travel part of occ2 (min)

Phase 2 data. TRAVELLING AS PART OF OCC. This section refers to the time you spent sitting during transportation (travelling in a car - bus - train - on a motorbike etc.) in the last 7 days. Now think about the time you sit while travelling as part of your occupation 1 for example driving from one customer to another - driving a taxi etc. DO NOT include cycling on a pedal bicycle. 8. In the last 7 days on average how long did you sit while travelling as part of your occupation 2 on such a day? 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30-45 min; 5 = 45 min -1 hour; 6 = 1-1.5 hours; 7 = 1.5-2 hours; 8 = 2-2.5 hours; 9 = 2.5-3 hours; 10 = 3-4 hours; 11 = 4-5 hours; 12 = 5-6 hours ; 13 = 6-7 hours; 14 = More than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Time sitting while doing occ1

Phase 2 data. WORK STUDY VOLUNTEERING OCC 1. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 14a. In the last 7 days on average how much time per day did you spend sitting while doing occupation 1? Do NOT include time spent sitting for transportation (in a car - bus - train - on a motorbike etc.) either for travelling to and from this occupation or as part of this occupation or breakfast; lunch or dinner as these were part of section 2 and 3? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while doing occupation 1.

Real

Freq interrupt sitting time occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 15B. In the last 7 days on average how many times per day did you interrupt your sitting time while doing occupation 2 for example by standing up; walking somewhere or getting a coffee? -1 = left blank; -4 = range entered;

Real

Freq interrupt TV sitting time

Phase 2 data. SCREEN TIME. Questionnaire read -Now think about the total time you spent watching TV in the last 7 days. If you did not watch TV in the last 7 days please skip to the Other activities section below. If you did watch TV in the last 7 days please answer the questions below. 18. In the last 7 days on average how many times per day did you interrupt your sitting time while watching TV? for example by standing up; walking somewhere or getting a drink? In number of times? Number/day. Cleaned.

Real

Freq interrupt TV sitting time

Phase 2 data. SCREEN TIME. Now think about the total time you spent watching TV in the last 7 days. If you did not watch TV in the last 7 days please skip to the Other activities section below. If you did watch TV in the last 7 dayS please answer the questions below. 18. In the last 7 days on average how many times per day did you interrupt your sitting time while watching TV? for example by standing up; walking somewhere or getting a drink? In number of times. -1 = left blank; -4 = range entered;

Real

Av sed travel apart from occmin

Phase 2 data. Total sedentary time travelling apart from occupation. Calculated and weighted by weekday and weekend day sedentary travelling time. (mins/day)

Real

Av day sed caring min

Phase 2 data. Average time spent sitting while caring; weighted by weekday and weekend day. (mins/day)

Real

Time sitting while doing occ1

Phase 2 data. WORK STUDY VOLUNTEERING OCC 1. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 14a. In the last 7 days on average how much time per day did you spend sitting while doing occupation 1? Do NOT include time spent sitting for transportation (in a car - bus - train - on a motorbike etc.) either for travelling to and from this occupation or as part of this occupation. This was part of section 3 or breakfast - lunch or dinner. This was part of section 2. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = 7-8 hours; 12 = more than 8 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Time sitting while doing occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. Questionnaire read -This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 14B. In the last 7 days on average how much time per day did you spend sitting while doing occupation 2? Do NOT include time spent sitting for transportation (in a car - bus - train - on a motorbike etc.) either for travelling to and from this occupation or as part of this occupation or breakfast; lunch or dinner as these were part of section 2 and 3? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting while doing occupation 2.

Real

Time spentsitting while doing occ2

Phase 2 data. WORK STUDY VOLUNTEERING OCC 2. This section is about the time you spent sitting during your occupation which refers to work - study and volunteering. Please think about all three of these categories for the following questions. 14B. In the last 7 days on average how much time per day did you spend sitting while doing occupation 2? Do NOT include time spent sitting for transportation (in a car - bus - train - on a motorbike etc.) either for travelling to and from this occupation or as part of this occupation. This was part of section 3 or breakfast - lunch or dinner. This was part of section 2. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = 7-8 hours; 12 = more than 8 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting reading min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE READING (book; magazine; newspaper; ) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while reading on a weekday.

Real

Wkday sitting reading min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE READING (book; magazine; newspaper; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Av sed computer; non-occ min

Phase 2 data. Average day sedentary time while using a computer apart from work; weighted by weekday and weekend day. (mins/day)

Real

Av sed non-occ computer min

Phase 2 data. Average day sedentary time while using a computer for non-occupational use. Calculated from tot_dur_comp_day and tot_dur_game_day; weighted by weekday and weekend day. (mins/day)

Real

Wkday sed non-occ computer min

Phase 2 data. Weekday sedentary time while using a computer for non-occupational use. Calculated from dE17_3_dur_comp_wd_c and dE17_5_dur_game_wd_c. (mins/day)

Real

Wkend sed non-occ computer min

Phase 2 data. Weekend day sedentary time while using a computer for non-occupational use. Calculated from dE17_4_dur_comp_wndd_c dE17_6_dur_game_wndd_c. (mins/day)

Real

Av sed computer games min

Phase 2 data. Average day sedentary time while playing computer games; weighted by weekday and weekend day. (mins/day)

Real

Wkend sitting reading min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE READING (book; magazine; newspaper) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while reading on a weekend day.

Real

Wkend sitting reading min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE READING (book; magazine; newspaper; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting household min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE DOING HOUSEHOLD TASKS (cooking; ironing) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while doing household tasks on a weekday.

Real

Wkday sitting household min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE DOING HOUSEHOLD TASKS (cooking; ironing; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Av day sed hobbies min

Phase 2 data. Average time spent sitting for hobbies; weighted by weekday and weekend day. (mins/day)

Real

Av day sed household min

Phase 2 data. Average time spent sitting while doing household tasks; weighted by weekday and weekend day. (mins/day)

Real

Av meals sed time min

Phase 2 data. Weighted average time spent sedentary during meal times. Calculated from and weighted by weekday and weekend sedentary time during meals. (mins/day)

Real

Wkday meals sed time min

Phase 2 data. Weekday time spent sedentary during meal times. (mins/day)

Real

Wkend meals sed time min

Phase 2 data. Weekend day time spent sedentary during meal times. (mins/day)

Real

Av day sed music min

Phase 2 data. Average time spent sitting while listening to music; weighted by weekday and weekend day. (mins/day)

Real

Average napping duration min

Phase 2 data. Weighted average day napping duration calculated from weekday and weekend napping durations. (mins/day)

Real

Av occ sed time min

Phase 2 data. Total occupational sedentary time calculated from sedentary time during occupation 1 and occupation 2. (mins/day)

Real

Av day sed other acts min

Phase 2 data. Average time spent sitting for other activities (activity not previously listed); weighted by weekday and weekend day. (mins/day)

Real

Av day total other sed min

Phase 2 data. Average day total sedentary time of all other activities (e.g. reading; household tasks etc.) Weighted by weekday and weekend day. (mins/day)

Real

Wkend sitting household min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE DOING HOUSEHOLD TASKS (cooking; ironing; ) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while doing household tasks on a weekend day.

Real

Wkend sitting household min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE DOING HOUSEHOLD TASKS (cooking; ironing; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting caring min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE CARING (for children; grandchildren; elderly or disabled relatives; ) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while caring on a weekday.

Real

Wkday sitting caring min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE CARING (for children; grandchildren; elderly or disabled relatives; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday total other sed min

Phase 2 data. Weekday total sedentary time of all other activities (e.g. reading; household tasks etc.) (mins/day)

Real

Wkend day total other sed min

Phase 2 data. Weekend day total sedentary time of all other activities (e.g. reading; household tasks etc.) (mins/day)

Real

Av sed travel part of occ min

Phase 2 data. Total sedentary time travelling as part of occupation. Calculated from sedetary time travelling as part of occupation 1 and occupation 2. (mins/day)

Real

Av day sed reading min

Phase 2 data. Average time spent sitting while reading; weighted by weekday and weekend day. (mins/day)

Real

Av day total sed screen time min

Phase 2 data. Average day total screen time sedentary time (including TV viewing; non-occupational computer use and computer games sedentary time). Weighted by weekday and weekend day. (mins/day)

Real

Wkday sed screen time min

Phase 2 data. Weekday total screen time sedentary time (including TV viewing; non-occupational computer use and computer games sedentary time). (mins/day)

Real

Wkend day sed screen time min

Phase 2 data. Weekend day total screen time sedentary time (including TV viewing; non-occupational computer use and computer games sedentary time). (mins/day)

Real

Av day total sed time min

Phase 2 data. Average day total sedentary time (including sleep; meal time; occupation; screen time etc.) Weighted by weekday and weekend. (mins/day)

Real

Wkend sitting caring min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE CARING (for children; grandchildren; elderly or disabled relatives) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while caring on a weekend day.

Real

Wkend sitting caring min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE CARING (for children; grandchildren; elderly or disabled relatives; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting hobbies min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR HOBBIES (platying piano; cards; doing crosswords; ) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down for hobbies on a weekday.

Real

Wkday sitting hobbies min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR HOBBIES (platying piano; cards; doing crosswords; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Av day total sed time awake min

Phase 2 data. Average day total sedentary time (awake time only but including meal time; occupation; screen time etc.) Weighted by weekday and weekend. (mins/day)

Real

Av sleep dur exc napping min

Phase 2 data. Weighted average day sleep duration (excluding napping) calculated from weekday and weekend day sleep durations. (mins/day)

Real

Av sleep dur inc napping min

Phase 2 data. Average sleep duration including napping calculated from weighted average of sleep and nap durations (mins/day)

Real

Wkday sleep dur inc nap min

Phase 2 data. Weekday sleep duration including napping calculated from reported weekday sleep times and napping durations. (mins/day)

Real

Wkend sleep dur inc nap min

Phase 2 data. Weekend day sleep duration including napping calculated from reported weekend day sleep times and napping durations (mins/day)

Real

Av day sed socialising min

Phase 2 data. Average time spent sitting for socialising; weighted by weekday and weekend day. (mins/day)

Real

Av sed travel to/from occ min

Phase 2 data. Total sedentary time travelling to and from occupation. Calculated from sedetary time travelling to and from occupation 1 and occupation 2. (mins/day)

Real

Av total sed transport min

Phase 2 data. Total transportation sedentary time. Calculated from total occupational sedentary time travelling and total sedentary time travelling apart from occupation. (mins/day)

Real

Wkend sitting hobbies min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR HOBBIES (playing piano; cards; doing crosswords) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down for hobbies on a weekend day.

Real

Wkend sitting hobbies min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR HOBBIES (platying piano; cards; doing crosswords; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting socialising min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR SOCIALISING (visiting friends; pub; cinema; sporting event) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while socialising on a weekday.

Real

Wkday sitting socialising min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR SOCIALISING (visiting friends; pub; cinema; sporting event; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Av sed occ transport min

Phase 2 data. Total occupational sedentary time travelling. Calculated from sedentary time travelling to and from occupation 1 and 2 and sedentary time as part of occupation 1 and 2. (mins/day)

Real

Av sed time watching TV min

Phase 2 data. Weighted average sedentary time while watching TV; calculated from weekday and weekend day TV viewing sedentary time (dE17_1_dur_tv_wd_c and dE17_2_dur_tv_wndd_c). (mins/day)

Real

Wkday sed time watching TV hr/d

Phase 2 data. Weekday TV viewing sedentary time. (hrs/day)

Real

Wkend sed time watching TV hr/d

Phase 2 data. Weekend day TV viewing sedentary time. (hrs/day)

Real

None

Phase 2 data. Wyman Dillon batch number for 7DSB data entry batch

Text

Wkday sleep duration decimal

Phase 2 data. Sleep duration on a weekday calculated from go sleep and get up times (decimal)

Real

Wkend sleep duration decimal

Phase 2 data. Sleep duration on a weekend day calculated from go sleep and get up times (decimal)

Real

OLINK assay SKAP1

Phase 1 OLINK assay data for target SKAP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cln variable: Skiing hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Skiing or snowboarding. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Wkend sitting socialising min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR SOCIALISING (visiting friends; pub; cinema; sporting event; ) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while socialising on a weekend day.

Real

Wkend sitting socialising min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR SOCIALISING (visiting friends; pub; cinema; sporting event; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting music min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE LISTENING TO MUSIC (radio; CD; MP3; iPOD; ) on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while listening to music on a weekday.

Real

Wkday sitting music min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE LISTENING TO MUSIC (radio; CD; MP3; iPOD; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Skiing or snowboarding hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Skiing Or snowboarding. -1 = left blank. DO NOT USE THIS VARIABLE. Use SkiHr_CLEAN_P2 instead.

Real

Cln variable: Skiing min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Skiing or snowboarding. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Skiing or snowboarding min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Skiing Or Snowboarding. -1 = left blank. DO NOT USE THIS VARIABLE. Use SkiMin_CLEAN_P2 instead.

Real

Cln variable: Skiing

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Skiing or snowboarding. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

Skiing or snowboarding

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Skiing or snowboarding. DO NOT USE THIS VARIABLE. Use Ski_CLEAN_P2 instead.

Real

Skiing or snowboarding

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Skiing or snowboarding. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Wkend sitting music min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE LISTENING TO MUSIC (radio; CD; MP3; iPOD; ) on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down while listening to music on a weekend day.

Real

Wkend sitting music min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING WHILE LISTENING TO MUSIC (radio; CD; MP3; iPOD; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Name of other sitting activity

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR OTHER ACTIVITIES write below? Name of other activitiy that is not previously listed. -1 = left blank.

Text

Name of other sitting activity

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR OTHER ACTIVITIES write below (radio; CD; MP3; iPOD; ). on a WEEKDAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkday sitting other act min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read:?This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR OTHER ACTIVITIES on a WEEKDAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down for other activities (activity not previously listed) on a weekday.

Real

OLINK assay SKR3

Phase 1 OLINK assay data for target SKR3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SLAMF1

Phase 1 OLINK assay data for target SLAMF1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SLAMF7

Phase 1 OLINK assay data for target SLAMF7 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SLAMF8

Phase 1 OLINK assay data for target SLAMF8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

SLEEP

SLEEP. Derived Intermediate not for general release. Data can be provided if necessary.

Integer

Sleep Heart Rate

Sleeping Heart Rate during AH (Actiheart) free living. [The SHR is set as the average ofthe highest value of the thirty lowest minute-by-minute HR readings during each 24 hr day when the monitor was worn.]

Integer

Wkday sitting other act min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR OTHER ACTIVITIES write below (radio; CD; MP3; iPOD; ). on a WEEKEND DAY. 1 = None; 2 = 1-15 min; 3 = 15-30 min; 4 = 30 min - 1 hour; 5 = 1 -2 hours; 6 = 2-3 hours; 7 = 3-4 hours; 8 =4-5 hours; 9 = 5-6 hours; 10 = 6-7 hours; 11 = more than 7 hours; -1 = left blank; -5 = more than 1 selected; -10 = does not fit any other instructions; -51 = both crosses and ticks used and tick is weighted as the correct one (-51) 1 AND 4 - 4 where the dominant (ticked) value is repeated at the end;

Categorical

Wkend sitting other act min

Phase 2 data. OTHER ACTIVITIES. Questionnaire read -This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR OTHER ACTIVITIES write below (radio; CD; MP3; iPOD). on a WEEKEND DAY? Questionnaire values were reported in categories of time E.g. 1-15mins. Values cleaned and standardised to minutes (mid point of category used) to produce minutes per day sitting or lying down for other activities (activity not previously listed) on a weekend day.

Real

Wkend sitting other act min

Phase 2 data. OTHER ACTIVITIES. This last section refers to the time you spent sitting or lying down during other activities in the last 7 days. Remember each period of sitting down should only be entered once. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. Please remember that each period of sitting down should only be entered once. Please; do not include time already reported in the Meals section. 19. In the last 7 days on average how long did you spend sitting or lying down in the following activities per day? SITTING FOR OTHER ACTIVITIES write below. Name. -1 = left blank;

Real

Sitting-lying last 7 days

Phase 2 data. Questionnaire read-These questions are about the amount of time that you spent sitting or lying down in the last 7 days. This questionnaire is organised into five sections; each asking about sitting or lying down in different settings. Compare your amount of sitting time over the last 7 days with a typical week for you. Each period of sitting down should only be entered once on this questionnaire. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. If there is a big difference between different weekdays or between different weekend days for some answers then tick the box which is nearest to the average for those weekdays or weekend days in the last 7 days. The focus of this questionnaire is sitting and lying while doing the activities specified below. If some of these activities also involved standing or walking around please try to only include the time spent sitting and lying during these activities. If you tick the wrong box please put a large cross through it and then tick the correct box. In the last 7 days my amount of sitting was? 1 = Much less than normal; 2 = A little less than normal; 3 = About the same; 4 = A little more than normal; 5 = A lot more than normal; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction. Cleaned

Categorical

Sleep HR during AH free living

Phase 2 data. Sleeping Heart Rate during AH (Actiheart) free living. The SHR is set as the average ofthe highest value of the thirty lowest minute-by-minute HR readings during each 24 hr day when the monitor was worn.

Real

Weighted avg daily sleep duration

Phase 2 data. Weighted average daily sleep duration (hours) from cleaned GenQ sleep times

Real

Assigned Sleep duration (hours)

Phase 2 data. Derived with method 2. Assigned Sleep duration (hours)

Real

None

Agilent slide barcode

Real

Agilent slide barcode

Phase 2 data. Agilent slide barcode

Text

OLINK assay SLITRK2

Phase 1 OLINK assay data for target SLITRK2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SLITRK6

Phase 1 OLINK assay data for target SLITRK6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Sitting time in the last 7 days

Phase 2 data. These questions are about the amount of time that you spent sitting or lying down in the last 7 days. This questionnaire is organised into five sections; each asking about sitting or lying down in different settings. Compare your amount of sitting time over the last 7 days with a typical week for you. Each period of sitting down should only be entered once on this questionnaire. For example if you spent one hour sitting on the sofa reading a book while you were listening to music count this time as one hour reading if this was your main focus. Do not also count this as one hour listening to music. If there is a big difference between different weekdays or between different weekend days for some answers then tick the box which is nearest to the average for those weekdays or weekend days in the last 7 days. The focus of this questionnaire is sitting and lying while doing the activities specified below. If some of these activities also involved standing or walking around please try to only include the time spent sitting and lying during these activities. If you tick the wrong box please put a large cross through it and then tick the correct box. In the last 7 days my amount of sitting was? 1 = Much less than normal; 2 = A little less than normal; 3 = About the same; 4 = A little more than normal; 5 = A lot more than normal; -1 = left blank; -5 = more than one selected; -10 = does not fit with any other instruction;

Categorical

OLINK assay SMAD1

Phase 1 OLINK assay data for target SMAD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

SMC160_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC160_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.03. 2nd and final QC step on this var created new and final var BIOR_129.

Real

SMC161_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC161_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_130.

Real

SMC180_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC180_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.07. 2nd and final QC step on this var created new and final var BIOR_131.

Real

SMC181_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC181_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_132.

Real

SMC202_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC202_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.005. 2nd and final QC step on this var created new and final var BIOR_133.

Real

SMC240_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC240_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.13. 2nd and final QC step on this var created new and final var BIOR_134.

Real

SMC241_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMC241_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.; valid=0 LoD=0.035. 2nd and final QC step on this var created new and final var BIOR_135.

Real

OLINK assay SMOC1

Phase 1 OLINK assay data for target SMOC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SMOC2

Phase 1 OLINK assay data for target SMOC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

SMOHC141_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMOHC141_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD.;. 2nd and final QC step on this var created new and final var BIOR_136.

Real

SMOHC161_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMOHC161_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.012. 2nd and final QC step on this var created new and final var BIOR_137.

Real

SMOHC221_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMOHC221_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.015. 2nd and final QC step on this var created new and final var BIOR_138.

Real

SMOHC222_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable SMOHC222_raw. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit). Unit = uM. The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. valid=0 LoD=0.01. 2nd and final QC step on this var created new and final var BIOR_139.

Real

Smoking History / Status

Current Smoking Consumption History / Status as requested by Ruth Loos. Derived from GenQ Qs by DM team JAVA script. Pls request G_SMOKE variable as well. 0 = never smoked;

Categorical

Smoking History

Phase 2 data. Current Smoking Consumption History / Status. Derived from GenQ Qs by DM team JAVA script. Pls request G_SMOKE variable as well. 0 = never smoked; 1 = ex smoker; 2 = current; 9 = not known;

Categorical

SmokingStatus

Whether volunteer smokes has previously quit smoking (and year) or never smoked. Free text data item which can provide additional information to SmokingStatusCode.

Text

SmokingStatusCode

New in R7. Smoking status as deduced by study team based on Gen Q entry by participant. Used for feedback to GP along with blood test results. This should not be used for data analysis but could be used for cross-checking.

Categorical

Smoking Status Code

Phase 2 data. Smoking status as deduced by study team based on Gen Q entry by participant. Used for feedback to GP along with blood test results. This should not be used for data analysis but could be used for cross-checking. Use main set of smoking variables derived from General quetionnaire for anlysis. 1 = ex smoker; 2 = current smoker; 0 = never smoked;

Categorical

Smoking Status

Phase 2 data. Whether volunteer smokes has previously quit smoking (and year) or never smoked. Free text data item which can provide additional information to SmokingStatusCode. Used for participant and GP feedback only. Not for analysis

Text

OLINK assay SMPD1

Phase 1 OLINK assay data for target SMPD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

None

Lipid profile obtained by negative mode ionisation high resolution mass spectrometry.

Real

Snack Given

Phase 2 data. Details of Snack Given prior to exercise. Related to Hemocue results. Free text

Text

OLINK assay SNAP23

Phase 1 OLINK assay data for target SNAP23 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SNAP29

Phase 1 OLINK assay data for target SNAP29 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SNCG

Phase 1 OLINK assay data for target SNCG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Snooker Billiards Or Darts

Please indicate the average length of time (in hours) you spent doing the activity per episode. Snooker Billiards Or Darts.

Integer

Hours of Snooker Billiards Or Darts CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Snooker Billiards Or Darts. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Snooker Billiards hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Snooker Billiards Or Darts. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Snooker billiards or darts hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Snooker Billiards Or Darts. -1 = left blank. DO NOT USE THIS VARIABLE. Use snookerBillardsDartsHr_CLEAN_P2 instead.

Real

Minutes of Snooker Billiards Or Darts

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Snooker Billiards Or Darts.

Integer

Minutes of Snooker Billiards Or Darts CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Snooker Billiards Or Darts. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Snooker Billiards min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Snooker Billiards Or Darts. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Snooker billiards or darts min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Snooker Billiards Or Darts. -1 = left blank. DO NOT USE THIS VARIABLE. Use snookerBillardsDartsMin_CLEAN_P2 instead.

Real

Frequency of Snooker Billiards Or Darts CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker Billiards Or Darts. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

snookerBillardsDarts_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Snooker Billiards Or Darts

Real

Cln variable: Snooker Billiards

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker Billiards Or Darts. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

snookerBillardsDarts_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker Billiards Or Darts. Data normalised to DE template 1 data.

Categorical

Snooker billiards or darts

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker billiards or darts. DO NOT USE THIS VARIABLE. Use snookerBillardsDarts_CLEAN_P2 instead.

Real

Snooker Billiards or Darts

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker Billiards Or Darts. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Snooker Billiards Or Darts DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker Billiards Or Darts. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in snookerBillardsDarts_T2. Instead use snookerBillardsDarts_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Snooker Billiards Or Darts DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Snooker Billiards Or Darts. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in snookerBillardsDarts_T1. Instead use snookerBillardsDarts_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay SOD1

Phase 1 OLINK assay data for target SOD1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SOD2

Phase 1 OLINK assay data for target SOD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SORCS2

Phase 1 OLINK assay data for target SORCS2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SORT1

Phase 1 OLINK assay data for target SORT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SOST

Phase 1 OLINK assay data for target SOST in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Vegetable Soups (bowl) ERROR CODES CLEANED

Average use last year of Vegetable Soups (bowl) After cleaning this variable is renamed as VEGETABLE_SOUP which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Meat Soups (bowl) ERROR CODES CLEANED

Average use last year of Meat Soups (bowl) After cleaning this variable is renamed as MEAT_SOUP which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sauces eg white sauce(tablespoon) ERROR CODES CLEANED

Average use last year of Sauces eg white sauce cheese sauce gravy (tablespoon) After cleaning this variable is renamed as SAUCES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Tomato Ketchup (tablespoon) ERROR CODES CLEANED

Average use last year of Tomato Ketchup (tablespoon) After cleaning this variable is renamed as KETCHUP which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Pickles chutney (tablespoon) ERROR CODES CLEANED

Average use last year of Pickles chutney (tablespoon) After cleaning this variable is renamed as PICKLES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Marmite Bovril (teaspoon) ERROR CODES CLEANED

Average use last year of Marmite Bovril (teaspoon) After cleaning this variable is renamed as MARMITE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Jam Marmalade honey (teaspoon) ERROR CODES CLEANED

Average use last year of Jam Marmalade honey (teaspoon) After cleaning this variable is renamed as JAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Peanut Butter (teaspoon) ERROR CODES CLEANED

Average use last year of Peanut butter (teaspoon) After cleaning this variable is renamed as PEANUT_BUTTER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Vegetable Soups bowl

Average use last year of Vegetable Soups (bowl). After cleaning this variable is renamed as VEGETABLE_SOUP which is then used by the FETA program for analysis.

Categorical

Vegetable Soups bowl

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Meat Soups bowl

Average use last year of Meat Soups (bowl). After cleaning this variable is renamed as MEAT_SOUP which is then used by the FETA program for analysis.

Categorical

Meat Soups bowl

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sauces eg white sauce cheese sauce gravy tablespoon

Average use last year of Sauces eg. white sauce cheese sauce gravy (tablespoon). After cleaning this variable is renamed as SAUCES which is then used by the FETA program for analysis.

Categorical

Sauces eg white sauce cheese sauce

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Tomato Ketchup tablespoon

Average use last year of Tomato Ketchup (tablespoon). After cleaning this variable is renamed as KETCHUP which is then used by the FETA program for analysis.

Categorical

Tomato Ketchup tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Pickles chutney tablespoon

Average use last year of Pickles chutney (tablespoon). After cleaning this variable is renamed as PICKLES which is then used by the FETA program for analysis.

Categorical

Pickles chutney tablespoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Marmite Bovril teaspoon

Average use last year of Marmite Bovril (teaspoon). After cleaning this variable is renamed as MARMITE which is then used by the FETA program for analysis.

Categorical

Marmite Bovril teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Jam Marmalade honey teaspoon

Average use last year of Jam Marmalade honey (teaspoon). After cleaning this variable is renamed as JAM which is then used by the FETA program for analysis.

Categorical

Jam Marmalade honey teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Peanut Butter teaspoon

Average use last year of Peanut butter (teaspoon). After cleaning this variable is renamed as PEANUT_BUTTER which is then used by the FETA program for analysis.

Categorical

Peanut Butter teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay SPARCL1

Phase 1 OLINK assay data for target SPARCL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPARC

Phase 1 OLINK assay data for target SPARC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

MET_QCd_Special_Wells

New in R8. Coded number for data which does not belong to Fenland participant

Text

Spermidine_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Spermidine_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_033.

Real

OLINK assay SPINK1

Phase 1 OLINK assay data for target SPINK1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPINK5

Phase 1 OLINK assay data for target SPINK5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPINT1

Phase 1 OLINK assay data for target SPINT1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPINT2

Phase 1 OLINK assay data for target SPINT2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

SplpitP13233

Heparin biomarker 32-33 Split proinsulin measurement in pmol/l. Raw data; cleaned data provided in variable G_SplitPI3233 with x_Threshold and x_Com variables provided for clarification. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

OLINK assay SPOCK1

Phase 1 OLINK assay data for target SPOCK1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPON1

Phase 1 OLINK assay data for target SPON1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPON2

Phase 1 OLINK assay data for target SPON2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SPRY2

Phase 1 OLINK assay data for target SPRY2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Squash

Please indicate the average length of time (in hours) you spent doing the activity per episode. Squash.

Integer

Hours of Squash CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Squash. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Squash hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Squash. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Squash hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Squash. -1 = left blank. DO NOT USE THIS VARIABLE. Use squashHr_CLEAN_P2 instead.

Real

Minutes of Squash

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Squash.

Integer

Minutes of Squash CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Squash. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Squash min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Squash. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Squash min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Squash. -1 = left blank. DO NOT USE THIS VARIABLE. Use squashMin_CLEAN_P2 instead.

Real

Frequency of Squash CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

squash_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Squash.

Real

Cln variable: Squash

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

squash_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. Data normalised to DE template 1 data.

Categorical

Squash

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. DO NOT USE THIS VARIABLE. Use squash_CLEAN_P2 instead.

Real

Squash

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Squash DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in squash_T2. Instead use squash_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Squash DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Squash. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in squash_T1. Instead use squash_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay SRC

Phase 1 OLINK assay data for target SRC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SRP14

Phase 1 OLINK assay data for target SRP14 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SRPK2

Phase 1 OLINK assay data for target SRPK2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SSC4D

Phase 1 OLINK assay data for target SSC4D in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ST1A1

Phase 1 OLINK assay data for target ST1A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ST2

Phase 1 OLINK assay data for target ST2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ST3GAL1

Phase 1 OLINK assay data for target ST3GAL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ST6GAL1

Phase 1 OLINK assay data for target ST6GAL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

STAIRadj

STAIRadj. Derived Intermediate not for general release. Data can be provided if necessary.

STAIRFLIGHT1

STAIRFLIGHT1. Derived Intermediate not for general release. Data can be provided if necessary.

STAIRFLIGHT2

STAIRFLIGHT2. Derived Intermediate not for general release. Data can be provided if necessary.

Stairs climbed weekday

Number of times you climbed up a flight of stairs (approx 10 steps) each day at home on a weekday. Average over the last 4 weeks.

Categorical

Stairs climbed weekday CLEANED

Number of times you climbed up a flight of stairs (approx 10 steps) each day at home on a weekday. Average over the last 4 weeks.Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Categorical

No times stairs climbed home wkday

Phase 2 data. Questionnaire reads D4. Stair climbing at home. Number of times you climbed up a flight of stairs (approx 10 steps) each day at home on a weekday. Average over the last 4 weeks. 1 = none; 2 = 1 to 5 times a day; 3 = 6 to 10 times a day; 4 = 11 to 15 times a day; 5 = 16 to 20 times a day; 6 = more than 20 times a day; -1 = left blank; -5 = more than one selected;

Categorical

Stairs climbed weekend

Number of times you climbed up a flight of stairs (approx 10 steps) each day at home on a weekend day. Average over the last 4 weeks.

Categorical

Stairs climbed weekend CLEANED

Number of times you climbed up a flight of stairs (approx 10 steps) each day at home on a weekend day. Average over the last 4 weeks.Error codes cleaned by DM team with this rule: RELATIVE. And then -10 errors cleaned by PA team.

Categorical

No times stairs climbed home wknday

Phase 2 data. Questionnaire reads D4. Stair climbing at home. Number of times you climbed up a flight of stairs (approx 10 steps) each day at home on a weekend day. Average over the last 4 weeks. 1 = none; 2 = 1 to 5 times a day; 3 = 6 to 10 times a day; 4 = 11 to 15 times a day; 5 = 16 to 20 times a day; 6 = more than 20 times a day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay STAMBP

Phase 1 OLINK assay data for target STAMBP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay STC1

Phase 1 OLINK assay data for target STC1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay STIP1

Phase 1 OLINK assay data for target STIP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay STK4

Phase 1 OLINK assay data for target STK4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Study Support comments

Anthro team Study Support Comments on tests performed data quality or samples missing. No data available for participants not included in R6 or earlier.

Text

Anthro team Study Support Comments

Phase 2 data. Anthro team Study Support Comments on tests performed data quality or samples missing. No data available for participants not included in R6 or earlier.

Text

OLINK assay STX16

Phase 1 OLINK assay data for target STX16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay STX6

Phase 1 OLINK assay data for target STX6 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay STX8

Phase 1 OLINK assay data for target STX8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay STXBP3

Phase 1 OLINK assay data for target STXBP3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SULT2A1

Phase 1 OLINK assay data for target SULT2A1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay SUMF2

Phase 1 OLINK assay data for target SUMF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Sweet biscuits chocolate eg digestive (one) ERROR CODES CLEANED

Average use last year (medium serving) of Sweet biscuits chocolate eg digestive (one) After cleaning this variable is renamed as CHOCOLATE_BISCUIT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sweet biscuits plain eg Nice ginger (one) ERROR CODES CLEANED

Average use last year (medium serving) of Sweet biscuits plain eg Nice ginger (one) After cleaning this variable is renamed as PLAIN_BISCUIT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cakes eg fruit sponge home baked ERROR CODES CLEANED

Average use last year (medium serving) of Cakes eg fruit sponge home baked After cleaning this variable is renamed as HOMEBAKED_CAKE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cakes eg fruit sponge ready made ERROR CODES CLEANED

Average use last year (medium serving) of Cakes eg fruit sponge ready made After cleaning this variable is renamed as READYMADE_CAKE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Buns pastries eg scones flapjacks home baked ERROR CODES CLEANED

Average use last year (medium serving) of Buns pastries eg scones flapjacks home baked After cleaning this variable is renamed as HOMEBAKED_BUNS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Buns pastries eg scones flapjacks ready made ERROR CODES CLEANED

Average use last year (medium serving) of Buns pastries eg scones flapjacks ready made After cleaning this variable is renamed as READYMADE_BUNS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fruit pies tarts crumbles home baked ERROR CODES CLEANED

Average use last year (medium serving) of Fruit pies tarts crumbles home baked After cleaning this variable is renamed as HOMEBAKED_FRUIT_PIES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Fruit pies tarts crumbles ready made ERROR CODES CLEANED

Average use last year (medium serving) of Fruit pies tarts crumbles ready made After cleaning this variable is renamed as READYMADE_FRUIT_PIES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sponge puddings home baked ERROR CODES CLEANED

Average use last year (medium serving) of Sponge puddings home baked After cleaning this variable is renamed as HOMEBAKED_SPONGE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sponge puddings ready made

Average use last year (medium serving) of Sponge puddings ready made. After cleaning this variable is renamed as READYMADE_SPONGE which is then used by the FETA program for analysis.

Categorical

Sponge puddings ready made ERROR CODES CLEANED

Average use last year (medium serving) of Sponge puddings ready made After cleaning this variable is renamed as READYMADE_SPONGE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sponge puddings ready made

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Milk puddings eg rice custard trifle

Average use last year (medium serving) of Milk puddings eg. rice custard trifle. After cleaning this variable is renamed as MILK_PUDDINGS which is then used by the FETA program for analysis.

Categorical

Milk puddings eg rice custard trifle ERROR CODES CLEANED

Average use last year (medium serving) of Milk puddings eg rice custard trifle After cleaning this variable is renamed as MILK_PUDDINGS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Milk puddings

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Ice cream choc ices

Average use last year (medium serving) of Ice cream choc ices. After cleaning this variable is renamed as ICE_CREAM which is then used by the FETA program for analysis.

Categorical

Ice cream choc ices ERROR CODES CLEANED

Average use last year (medium serving) of Ice cream choc ices After cleaning this variable is renamed as ICE_CREAM which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Ice cream choc ices

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Chocolates single or squares

Average use last year (medium serving) of Chocolates single or squares. After cleaning this variable is renamed as CHOCOLATES which is then used by the FETA program for analysis.

Categorical

Chocolates single or squares ERROR CODES CLEANED

Average use last year (medium serving) of Chocolates single or squares After cleaning this variable is renamed as CHOCOLATES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Chocolates single or squares

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Chocolate snack bars eg Mars Crunchie

Average use last year (medium serving) of Chocolate snack bars eg. Mars Crunchie. After cleaning this variable is renamed as CHOCOLATE_BARS which is then used by the FETA program for analysis.

Categorical

Chocolate snack bars eg Mars Crunchie ERROR CODES CLEANED

Average use last year (medium serving) of Chocolate snack bars eg Mars Crunchie After cleaning this variable is renamed as CHOCOLATE_BARS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Chocolate snack bars 

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sweets toffees mints

Average use last year (medium serving) of Sweets toffees mints. After cleaning this variable is renamed as SWEETS which is then used by the FETA program for analysis.

Categorical

Sweets toffees mints ERROR CODES CLEANED

Average use last year (medium serving) of Sweets toffees mints After cleaning this variable is renamed as SWEETS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sweets toffees mints

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sugar added to tea coffee cereal teaspoon

Average use last year (medium serving) of Sugar added to tea coffee cereal (teaspoon). After cleaning this variable is renamed as SUGAR which is then used by the FETA program for analysis.

Categorical

Sugar added to tea coffee cereal (teaspoon) ERROR CODES CLEANED

Average use last year (medium serving) of Sugar added to tea coffee cereal (teaspoon) After cleaning this variable is renamed as SUGAR which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sugar added to tea coffee cereal teaspoon

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Crisps or other packet snacks eg Wotsits

Average use last year (medium serving) of Crisps or other packet snacks eg Wotsits. After cleaning this variable is renamed as CRISPS which is then used by the FETA program for analysis.

Categorical

Crisps or other packet snacks eg Wotsits ERROR CODES CLEANED

Average use last year (medium serving) of Crisps or other packet snacks eg Wotsits After cleaning this variable is renamed as CRISPS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Crisps or other packet snacks

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Peanuts or other nuts

Average use last year (medium serving) of Peanuts or other nuts. After cleaning this variable is renamed as NUTS which is then used by the FETA program for analysis.

Categorical

Peanuts or other nuts ERROR CODES CLEANED

Average use last year (medium serving) of Peanuts or other nuts After cleaning this variable is renamed as NUTS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Peanuts or other nuts

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sweet biscuits; chocolate ; eg digestive one

Average use last year (medium serving) of Sweet biscuits chocolate eg. digestive (one). After cleaning this variable is renamed as CHOCOLATE_BISCUIT which is then used by the FETA program for analysis.

Categorical

Sweet biscuits chocolate

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sweet biscuits; plain; eg Nice; ginger one

Average use last year (medium serving) of Sweet biscuits plain eg. Nice ginger (one). After cleaning this variable is renamed as PLAIN_BISCUIT which is then used by the FETA program for analysis.

Categorical

Sweet biscuits plain

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cakes eg fruit; sponge; home baked

Average use last year (medium serving) of Cakes eg. fruit sponge home baked. After cleaning this variable is renamed as HOMEBAKED_CAKE which is then used by the FETA program for analysis.

Categorical

Cakes: fruit; sponge; home baked

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cakes eg fruit; sponge; ready made

Average use last year (medium serving) of Cakes eg. fruit sponge ready made. After cleaning this variable is renamed as READYMADE_CAKE which is then used by the FETA program for analysis.

Categorical

Cakes: fruit; sponge; ready made

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Buns pastries eg scones flapjacks home baked

.Average use last year (medium serving) of Buns pastries eg. scones flapjacks home baked. After cleaning this variable is renamed as HOMEBAKED_BUNS which is then used by the FETA program for analysis.

Categorical

Buns pastries scones flapjacks home baked

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Buns pastries eg scones flapjacks ready made

Average use last year (medium serving) of Buns pastries eg. scones flapjacks ready made. After cleaning this variable is renamed as READYMADE_BUNS which is then used by the FETA program for analysis.

Categorical

Buns pastries scones flapjacks ready made

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fruit pies tarts crumbles home baked

Average use last year (medium serving) of Fruit pies tarts crumbles home baked. After cleaning this variable is renamed as HOMEBAKED_FRUIT_PIES which is then used by the FETA program for analysis.

Categorical

Fruit pies tarts crumbles home baked

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Fruit pies tarts crumbles ready made

Average use last year (medium serving) of Fruit pies tarts crumbles ready made. After cleaning this variable is renamed as READYMADE_FRUIT_PIES which is then used by the FETA program for analysis.

Categorical

Fruit pies tarts crumbles ready made

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sponge puddings home baked

Average use last year (medium serving) of Sponge puddings home baked. After cleaning this variable is renamed as HOMEBAKED_SPONGE which is then used by the FETA program for analysis.

Categorical

Sponge puddings home baked

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Hours of Swimming - Competitive

Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - Competitive.

Integer

Hours of Swimming - Competitive CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - Competitive. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Swimming - Compt hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - Competitive. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Swimming competitive hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - Competitive. -1 = left blank. DO NOT USE THIS VARIABLE. Use swimCompHr_CLEAN_P2 instead.

Real

Minutes of Swimming - Competitive

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - Competitive.

Integer

Minutes of Swimming - Competitive CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - Competitive. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Swimming - Compt min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - Competitive. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Swimming competitive min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - Competitive. -1 = left blank. DO NOT USE THIS VARIABLE. Use swimCompMin_CLEAN_P2 instead.

Real

Frequency of Swimming - Competitive CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - Competitive . Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

swimComp_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Swimming - Competitive

Real

Cln variable: Swimming - Compt

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - Competitive . Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

swimComp_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - Competitive . Data normalised to DE template 1 data.

Categorical

Swimming competitive

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - Competitive. DO NOT USE THIS VARIABLE. Use swimComp_CLEAN_P2 instead.

Real

Swimming - Competitive

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - Competitive . Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Swimming - Competitive DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - Competitive . Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in swimComp_T2. Instead use swimComp_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Swimming - Competitive DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - Competitive . Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in swimComp_T1. Instead use swimComp_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Hours of Swimming - leisure

Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - leisure.

Integer

Hours of Swimming - leisure CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - leisure. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Swimming-leisure hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - leisure. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Swimming leisure hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - leisure. -1 = left blank. DO NOT USE THIS VARIABLE. Use swimLeisHr_CLEAN_P2 instead.

Real

Minutes of Swimming - leisure

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - leisure.

Integer

Minutes of Swimming - leisure CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - leisure. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Swimming-leisure min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - leisure. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Swimming leisure min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Swimming - leisure. -1 = left blank. DO NOT USE THIS VARIABLE. Use swimLeisMin_CLEAN_P2 instead.

Real

Frequency of Swimming - leisure CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - leisure. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

swimLeis_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Swimming - leisure

Real

Cln variable: Swimming - leisure

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - leisure. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

swimLeis_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - leisure. Data normalised to DE template 1 data.

Categorical

Swimming leisure

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Swimming - leisure. DO NOT USE THIS VARIABLE. Use swimLeis_CLEAN_P2 instead.

Real

Swimming - leisure

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - leisure. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Swimming - leisure DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - leisure. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in swimLeis_T2. Instead use swimLeis_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Swimming - leisure DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Swimming - leisure. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in swimLeis_T1. Instead use swimLeis_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay SYND1

Phase 1 OLINK assay data for target SYND1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

t4OHPro_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable t4OHPro_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_030.

Real

Hours of Table Tennis

Please indicate the average length of time (in hours) you spent doing the activity per episode. Table Tennis.

Integer

Hours of Table Tennis CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Table Tennis. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Table Tennis hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Table Tennis. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Table tennis hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Table Tennis. -1 = left blank. DO NOT USE THIS VARIABLE. Use tableTennisHr_CLEAN_P2 instead.

Real

Minutes of Table Tennis

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Table Tennis.

Integer

Minutes of Table Tennis CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Table Tennis. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Table Tennis min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Table Tennis. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Table tennis min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Table Tennis. -1 = left blank. DO NOT USE THIS VARIABLE. Use tableTennisMin_CLEAN_P2 instead.

Real

Frequency of Table Tennis CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table Tennis. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

tableTennis_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Table Tennis

Real

Cln variable: Table Tennis

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table Tennis. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

tableTennis_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table Tennis. Data normalised to DE template 1 data.

Categorical

Table tennis

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table tennis. DO NOT USE THIS VARIABLE. Use tableTennis_CLEAN_P2 instead.

Real

Table Tennis

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table Tennis. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Table Tennis DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table Tennis. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in tableTennis_T2. Instead use tableTennis_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Table Tennis DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Table Tennis. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in tableTennis_T1. Instead use tableTennis_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

OLINK assay TACC3

Phase 1 OLINK assay data for target TACC3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TACSTD2

Phase 1 OLINK assay data for target TACSTD2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TANK

Phase 1 OLINK assay data for target TANK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Target capture gene ID

Text

None

Target capture stable variant id: chromosome; position and alleles using GRCh38 coordinates.

Text

None

Sequencing pool number

Real

None

Change to protein: amino acid change

Text

Taurine_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Taurine_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_034.

Real

OLINK assay TBCB

Phase 1 OLINK assay data for target TBCB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TCL1A

Phase 1 OLINK assay data for target TCL1A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TCL1B

Phase 1 OLINK assay data for target TCL1B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TCN2

Phase 1 OLINK assay data for target TCN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TDGF1

Phase 1 OLINK assay data for target TDGF1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TDRKH

Phase 1 OLINK assay data for target TDRKH in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

TEE

Average Daily Total Energy Expenditure during AH free living (TEE). Calculated in commercial software (REE+AEE+DIT). Average kcal/day. For purpose of volunteer feedback only.

Real

Avg Daily TEE during AH free living

Phase 2 data. Average Daily Total Energy Expenditure during AH free living (TEE). Calculated in commercial software (REE+AEE+DIT). Average kcal/day. For purpose of volunteer feedback only.

Real

None

Phase 2 data. Derived with method 2. Template number used for processing (1 is standard)

Text

Hours of Tennis Or Badminton

Please indicate the average length of time (in hours) you spent doing the activity per episode. Tennis Or Badminton.

Integer

Hours of Tennis Or Badminton CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Tennis Or Badminton. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Tennis badminton hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Tennis Or Badminton. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Tennis or badminton hrs

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in hours) you spent doing the activity per episode. Tennis Or Badminton. -1 = left blank. -1 = left blank. DO NOT USE THIS VARIABLE. Use tennisBadmintonHr_CLEAN_P2 instead.

Real

Minutes of Tennis Or Badminton

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Tennis Or Badminton.

Integer

Minutes of Tennis Or Badminton CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Tennis Or Badminton. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Tennis badminton min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Tennis Or Badminton. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Tennis or badminton min

Phase 2 data. Questionnaire reads D14. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Tennis Or Badminton. -1 = left blank. DO NOT USE THIS VARIABLE. Use tennisBadmintonMin_CLEAN_P2 instead.

Real

Frequency of Tennis or badminton CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Tennis or badminton. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

tennisBadminton_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Tennis Or Badminton

Real

Cln variable: Tennis or badminton

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Tennis or badminton. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

tennisBadminton_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Tennis or badminton. Data normalised to DE template 1 data.

Categorical

Tennis or badminton

Phase 2 data. Questionnaire reads D14. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks.Tennis or badminton. DO NOT USE THIS VARIABLE. Use tennisBadminton_CLEAN_P2 instead.

Real

Tennis or badminton

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Tennis or badminton. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Tennis or badminton DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Tennis or badminton. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in tennisBadminton_T2. Instead use tennisBadminton_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Tennis or badminton DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Tennis or badminton. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in tennisBadminton_T1. Instead use tennisBadminton_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

None

To be used for clustering particpants in age groups of 10 year blocks. Useful when data of birth can not be released.

Ten Year Age Group

Phase 2 data. Age group the volunteer belonged to at the time of their phase 2 clinical appointment where age groups have been split up into groups of 10 years. Derived by data management team based on AgeAtTest_DM_Attended_P2. Can be used where precise age cannot be released or in not required.

Text

TestDate

Date volunteer was tested at site.

Date

Test length

Test length in Minutes (Un-cleaned) For purpose of volunteer feedback only. The data is as it was used for feedback to the participant and will not have been changed if after feedback the data was found to contain an error.

Real

Treadmill Test length in Minutes

Phase 2 data. Treadmill Test length in Minutes (Un-cleaned) For purpose of volunteer feedback only. The data is as it was used for feedback to the participant and will not have been changed if after feedback the data was found to contain an error.

Integer

Test length in seconds

Phase 2 data. Test length in seconds (Un-cleaned) For purpose of volunteer feedback only. The data is as it was used for feedback to the participant and will not have been changed if after feedback the data was found to contain an error. Use cleaned variables from main Actiheart dataset instead.

Integer

TestSite

Location of the test site at which the participant initially registered for the Fenland study. This can be different from the site the participant currently attends if he/she has relocated. Cambridge Ely or Wisbech.

Text

Test start

Time of start of test in Hrs:Mins:Secs

Time

Time of start of treadmill test

Phase 2 data. Time of start of treadmill test in Hrs:Mins:Secs

Time

TestStoppedPreHR

Data as entered on Study database. Was the treadmill test stopped Pre HR criteria? Yes-tick or no-left blank

Categorical

Treadmill test stop Pre HR criteria

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. Was the treadmill test stopped Pre HR criteria? 0 = no; 1 = yes;

Categorical

TestStoppedReason

Data as entered on Study database. If the treadmill test stopped Pre HR criteria please tell us why.

Categorical

Reason test stop Pre HR criteria

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. If the treadmill test stopped Pre HR criteria please tell us why. 1 = Limited-medication; 2 = Limited ECG/Med review; 3 = joint pain/injury; 4 = Volunteer requested to stop; 5 = Inappropriate footwear/clothing; 6 = Loss of polar signal; 7 = Unwell; 8 = Time constraints; 9 = Volunteer unsteady on treadmill; 10 = Other-please note in comments; 11 = RER > 1.1;

Categorical

OLINK assay TFF2

Phase 1 OLINK assay data for target TFF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TFF3

Phase 1 OLINK assay data for target TFF3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TFPI-2

Phase 1 OLINK assay data for target TFPI-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TFPI

Phase 1 OLINK assay data for target TFPI in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Thyroid function test analaysis on T120 blood sample. Fenland phase 1. Thyroid function test analysis. Any comments provided by lab on sample quality or test results.

Text

None

Thyroid function test analaysis on T120 blood sample. Fenland phase 1. Date TFT analytes were measured.

Date

OLINK assay TF

Phase 1 OLINK assay data for target TF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TGFBI

Phase 1 OLINK assay data for target TGFBI in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TGFBR3

Phase 1 OLINK assay data for target TGFBR3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TGFR-2

Phase 1 OLINK assay data for target TGFR-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TGF-alpha

Phase 1 OLINK assay data for target TGF-alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TGF-alpha

Phase 1 OLINK assay data for target TGF-alpha in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TGM2

Phase 1 OLINK assay data for target TGM2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay THBS2

Phase 1 OLINK assay data for target THBS2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay THBS4

Phase 1 OLINK assay data for target THBS4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay THOP1

Phase 1 OLINK assay data for target THOP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay THPO

Phase 1 OLINK assay data for target THPO in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Additional comments on Three-Factor Eating Questionnaire

Additional comments on Three-Factor Eating Questionnaire

Categorical

Thr_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Thr_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_019.

Real

OLINK assay THY 1

Phase 1 OLINK assay data for target THY 1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum TIBC RAW

Serum biomarker TIBC (Total Iron Binding Capacity) measured in umol/L. Raw data; cleaned data provided in variable G_TIBC with x_Threshold and x_Com variables provided for clarification. TIBC measures the blood's capacity to bind iron with transferrin and is measured by drawing blood and measuring the maximum amount of iron that it can carry which indirectly measures transferrin as transferrin is the most dynamic iron carrier. Data provided by an external lab and was measured on the Siemens Dimension RXL autoanalyser using reagents purchased from Siemens. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

OLINK assay TIE1

Phase 1 OLINK assay data for target TIE1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TIE2

Phase 1 OLINK assay data for target TIE2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TIGAR

Phase 1 OLINK assay data for target TIGAR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TIMD4

Phase 1 OLINK assay data for target TIMD4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Time of ApoE

Data produced by UCL from blood samples.

Time

Time of factor H

Data produced by UCL from blood samples.

Time

Time120BloodSample

Exact time 120 min blood sample was taken

Text

Time 120 min blood sample taken

Phase 2 data. Exact time 120 min blood sample was taken. For QC and filed team use. Not for analysis

Time

OLINK assay TIMP1

Phase 1 OLINK assay data for target TIMP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TIMP4

Phase 1 OLINK assay data for target TIMP4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TINAGL1

Phase 1 OLINK assay data for target TINAGL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TLR3

Phase 1 OLINK assay data for target TLR3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TLT-2

Phase 1 OLINK assay data for target TLT-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TMPRSS15

Phase 1 OLINK assay data for target TMPRSS15 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TMPRSS5

Phase 1 OLINK assay data for target TMPRSS5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TMSB10

Phase 1 OLINK assay data for target TMSB10 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TM

Phase 1 OLINK assay data for target TM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNC

Phase 1 OLINK assay data for target TNC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFB

Phase 1 OLINK assay data for target TNFB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF10A

Phase 1 OLINK assay data for target TNFRSF10A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF10A

Phase 1 OLINK assay data for target TNFRSF10A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF10C

Phase 1 OLINK assay data for target TNFRSF10C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF11A

Phase 1 OLINK assay data for target TNFRSF11A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF12A

Phase 1 OLINK assay data for target TNFRSF12A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF13B

Phase 1 OLINK assay data for target TNFRSF13B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF13C

Phase 1 OLINK assay data for target TNFRSF13C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF14

Phase 1 OLINK assay data for target TNFRSF14 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF19

Phase 1 OLINK assay data for target TNFRSF19 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF21

Phase 1 OLINK assay data for target TNFRSF21 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF4

Phase 1 OLINK assay data for target TNFRSF4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF6B

Phase 1 OLINK assay data for target TNFRSF6B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFRSF9

Phase 1 OLINK assay data for target TNFRSF9 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFSF13B

Phase 1 OLINK assay data for target TNFSF13B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFSF13

Phase 1 OLINK assay data for target TNFSF13 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNFSF14

Phase 1 OLINK assay data for target TNFSF14 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNF

Phase 1 OLINK assay data for target TNF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNF-R1

Phase 1 OLINK assay data for target TNF-R1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNF-R2

Phase 1 OLINK assay data for target TNF-R2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNNI3

Phase 1 OLINK assay data for target TNNI3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TNXB

Phase 1 OLINK assay data for target TNXB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TN-R

Phase 1 OLINK assay data for target TN-R in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TOP2B

Phase 1 OLINK assay data for target TOP2B in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

TOTALtime

Total reported duration (hours) of activity + assumed sleep [hrs/d]. Created by PA team to facilitate data cleaning. Data can be provided if needed.

TOTALTRAVMILES_DER

Derived Intermediate not for general release. Data can be provided if necessary.

No. of correct targets in food

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets across all food pictures in the Rapid Serial Visualisation Task.

Integer

No. of correct targets in neutral

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. Number of correctly identified targets across all trials with only neutral pictures in the Rapid Serial Visualisation Task.

Integer

TOTDUR_aerobicsHigh

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_aerobicsHigha

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_aerobicsOther

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_aerobicsOthera

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_backPackMountainClimb

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_backPackMountainClimba

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_bowling

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_bowlinga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_combatsSports

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_combatsSportsa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_compRun

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_compRuna

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_conditionExercise

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_conditionExercisea

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_cricket

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_cricketa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_cyclePleasure

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_cyclePleasurea

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_cyclingRacingRough

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_cyclingRacingRougha

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_dancing

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_dancinga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_dIY

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_dIYa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_exerciseWeights

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_exerciseWeightsa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_floorExercise

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_floorExercisea

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_footballRugbyHockey

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_footballRugbyHockeya

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_golf

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_golfa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_heavyGardening

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_heavyGardeninga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_horseBased

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_horseBaseda

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_huntingShootingFish

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_huntingShootingFisha

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_iceSkating

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_iceSkatinga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_jog

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_joga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_mowing

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_mowinga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_musicalInstrumentSing

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_musicalInstrumentSinga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_netVolleyBasketBall

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_netVolleyBasketBalla

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_rowing

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_rowinga

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_sailingWindsurfBoat

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_sailingWindsurfBoata

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_snookerBillardsDarts

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_snookerBillardsDartsa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_squash

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_squasha

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_swimComp

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_swimCompa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_swimLeis

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_swimLeisa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_tableTennis

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_tableTennisa

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_tennisBadminton

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_tennisBadmintona

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_walkPleasure

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_walkPleasurea

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_waterLawn

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_waterLawna

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_weedPrune

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTDUR_weedPrunea

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOTMETHRS

Total reported duration (hours) of activity times intensity (MET) [METhrs/d]. Created by PA team to facilitate data cleaning. Data can be provided if needed.

Total MET hours

Phase 2 data. Derived with method 2. Total reported duration (hours) of activity times intensity (MET) METhrs/d

Real

TOTMETHRS_w_UNACCtime

Created by PA team to facilitate data cleaning. Data can be provided if needed.

Total MET hrs plus unaccounted hrs

Phase 2 data. Derived with method 2. Total reported (plus unaccounted) duration (hours) of activity times intensity (MET) METhrs/d

Real

TOTtime

Total reported duration (hours) of activity [hrs/d]. Created by PA team to facilitate data cleaning. Data can be provided if needed.

Total reported hrs of activity

Phase 2 data. Derived with method 2. Total reported duration (hours) of activity hrs/d

Real

TOT_aerobicsHighHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_aerobicsOtherHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_backPackMountainClimbHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_bowlingHr

TOT_bowlingHr. Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_combatsSportsHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_compRunHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_conditionExerciseHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_cricketHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_cyclePleasureHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_cyclingRacingRoughHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_dancingHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_dIYHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_exerciseWeightsHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_floorExerciseHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_footballRugbyHockeyHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_golfHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_heavyGardeningHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_horseBasedHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_huntingShootingFishHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_iceSkatingHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_jogHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_mowingHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_musicalInstrumentSingHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_netVolleyBasketBallHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_rowingHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_sailingWindsurfBoatHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_snookerBillardsDartsHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_squashHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_swimCompHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_swimLeisHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_tableTennisHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_tennisBadmintonHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_walkPleasureHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_waterLawnHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

TOT_weedPruneHr

Derived Intermediate not for general release. Data can be provided if necessary.

Real

OLINK assay TP53

Phase 1 OLINK assay data for target TP53 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TPP1

Phase 1 OLINK assay data for target TPP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TPPP3

Phase 1 OLINK assay data for target TPPP3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TPSAB1

Phase 1 OLINK assay data for target TPSAB1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TRAF2

Phase 1 OLINK assay data for target TRAF2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TRAIL

Phase 1 OLINK assay data for target TRAIL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TRAIL

Phase 1 OLINK assay data for target TRAIL in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TRAIL-R2

Phase 1 OLINK assay data for target TRAIL-R2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TRANCE

Phase 1 OLINK assay data for target TRANCE in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Serum Transferrin RAW

Serum biomarker transferrin measured in g/L. Raw data; cleaned data provided in variable G_Transferrin with x_Threshold and x_Com variables provided for clarification. Data provided by an external lab and it was measured on the Siemens Dimension RXL autoanalyser using reagents purchased from Siemens. Only measured on 10000+ Fenland volunteers so far as it is not part of the routine set of measurements.

Real

TreadMill1_Hr

Data as entered on Study database. Treadmill test time point 1 - hours

TreadMill1_Mins

Data as entered on Study database. Treadmill test time point 1 - minutes

TreadMill2_Hr

Data as entered on Study database. Treadmill test time point 2 - hours

TreadMill2_Mins

Data as entered on Study database. Treadmill test time point 2 - minutes

TreadMill3_Hr

Data as entered on Study database. Treadmill test time point 3 - hours

TreadMill3_Mins

Data as entered on Study database. Treadmill test time point 3 - minutes

OLINK assay TREM1

Phase 1 OLINK assay data for target TREM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Triglyceride 0 minutes

Serum Triglyceride measurement taken at 0 minutes in mmol/l

Real

Triglyceride 0 minutes

Phase 2 data. Serum Triglyceride measurement taken at 0 minutes in mmol/l

Real

OLINK assay TRIM21

Phase 1 OLINK assay data for target TRIM21 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TRIM5

Phase 1 OLINK assay data for target TRIM5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Trp_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Trp_raw. All values below detection limit set to 0. -7 = Internal standard undetectable (Concentration unreliable). The _i in the name indicates that missingness was between 0 and 5% and the missing values have been replaced by a random imputed value between 0 and the plate-specific LOD. 2nd and final QC step on this var created new and final var BIOA_020.

Real

OLINK assay TR-AP

Phase 1 OLINK assay data for target TR-AP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TR

Phase 1 OLINK assay data for target TR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

None

Thyroid Function Test (TFT) analaysis on T120 blood sample. Fenland phase 1. Thyroid Stimulating Hormone (TSH). Sample used is T120 plasma Heparin sample as that was being shipped off for Insulin_T120 measurement already.

Real

OLINK assay TSHB

Phase 1 OLINK assay data for target TSHB in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TSLP

Phase 1 OLINK assay data for target TSLP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

TVadj

Derived Intermediate not for general release. Data can be provided if necessary.

TVDUR1

TVDUR1. Derived Intermediate not for general release. Data can be provided if necessary.

TVDUR2

TVDUR2. Derived Intermediate not for general release. Data can be provided if necessary.

TVDUR3

TVDUR3. Derived Intermediate not for general release. Data can be provided if necessary.

TVDUR4

TVDUR4. Derived Intermediate not for general release. Data can be provided if necessary.

OLINK assay TWEAK

Phase 1 OLINK assay data for target TWEAK in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TXLNA

Phase 1 OLINK assay data for target TXLNA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TXNDC5

Phase 1 OLINK assay data for target TXNDC5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay TYMP

Phase 1 OLINK assay data for target TYMP in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Tyr_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Tyr_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_021.

Real

OLINK assay TYRO3

Phase 1 OLINK assay data for target TYRO3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay t-PA

Phase 1 OLINK assay data for target t-PA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay UBE2F

Phase 1 OLINK assay data for target UBE2F in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

UCL date

produced by UCL for blood samples. No longer in use replaced by UCLDate.

Date

None

UCLDate rounded to 0.1 years.

Real

OLINK assay UMOD

Phase 1 OLINK assay data for target UMOD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

UNACCOUNTED

Derived Intermediate not for general release. Data can be provided if necessary.

OLINK assay UNC5C

Phase 1 OLINK assay data for target UNC5C in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay uPA

Phase 1 OLINK assay data for target uPA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay uPA

Phase 1 OLINK assay data for target uPA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Urine ACR

Urine ACR (Albumin/Creatinine Ratio) measurement in mg/mmol/L

Real

Urine ACR

Phase 2 data. Urine ACR (Albumin/Creatinine Ratio) measurement in mg/mmol/L

Real

Urine Albumin

Urine Albumin measurement in mg/l. Prior to (date?) the lab was queried for all results of the value 2.5 to ask if in fact the measuremt fell below 2.5. If so a minus sign was added to the value of 2.5 so a value of -2.5 is present. After that date the lab was no longer queried for values of 2.5 and therefore 2.5 can either represent a true value of 2.5 or any value below 2.5. Raw data; Cleaned data provide in variable G_Uralbumin with x_Threshold and x_Com variables provided for clarification.

Real

Urine Albumin

Phase 2 data. Urine Albumin measurement in mg/l. Raw data; Cleaned data provide in variable G_Uralbumin with x_Threshold and x_Com variables provided for clarification.

Real

Urine Creatinine

Phase 2 data. Urine Creatinine measurement in mmol/l. Raw data. Cleaned data provide in variable G_UrCreatinine with x_Threshold and x_Com variables provided for clarification.

Real

Urea 0 minutes

Serum Urea measurement taken at 0 minutes in mmol/l

Real

Urea 0 minutes

Phase 2 data. Serum Urea measurement taken at 0 minutes in mmol/l

Real

UrineFasted

Data as entered on Study database. Did participant fast prior to taking of urine sample. Fasted - not fasted - unknown

Pt fasted prior taking urine sample

Phase 2 data. Data as entered on Study database. Did participant fast prior to taking of urine sample. Fasted - not fasted - unknown

Text

US Abdominal Completed by

Phase 2 data. Initials/ID of staff member who completed the abdominal Ultrsound

Text

UltrasoundEntered

Ultrasound entered

Categorical

Ultrasound Entered

Phase 2 data. Ultrasound entered? 0 = no; 1 = yes;

Categorical

US Liver Completed by

Phase 2 data. Initials/ID of staff member who completed the liver Ultrsound

Text

OLINK assay USP8

Phase 1 OLINK assay data for target USP8 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay U-PAR

Phase 1 OLINK assay data for target U-PAR in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Val_QCstep1

New in R8. 1st step QCd metabolomics data variable for raw variable Val_raw. 0% missingness was found so data is identical to the raw variable data. All values below detection limit set to 0. Invalid flag: missing peak; internal standard too low; signal exceeds quantification limit. Unit = uM. 2nd and final QC step on this var created new and final var BIOA_022.

Real

measurement comments

Measurement is either OK; or OutOfRange; or Invalid; or InvalidOutOfRange

Results Validation Status

Phase 2 data. Measurement is either OK; or OutOfRange; or Invalid; or InvalidOutOfRange. This status is based on any one of the results fields being inavlid or out of range

Text

Total points in Prob. Learning Task

This variable was derived from data collected as part of the Cognitive and Behavioural Measurement Sub Study. 482 participants from the Fenland Cohort took part on this sub study. The accumulated points across all test blocks in the Probabilistic Reversal Learning Task. Variable generated by Inquisit as part of the plt2_summary file for the Probabilistic Reversal Learning Task task.

Integer

OLINK assay VAMP5

Phase 1 OLINK assay data for target VAMP5 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

VariousWorkLocation

VariousWorkLocation. Created by PA team to facilitate data cleaning. Data can be provided if needed. Yes = participant works at various locations

Text

OLINK assay VASH1

Phase 1 OLINK assay data for target VASH1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VASN

Phase 1 OLINK assay data for target VASN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VCAM1

Phase 1 OLINK assay data for target VCAM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VCAN

Phase 1 OLINK assay data for target VCAN in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Carrots ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Carrots After cleaning this variable is renamed as CARROTS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Spinach ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Spinach After cleaning this variable is renamed as SPINACH which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Broccoli spring greens kale ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Broccoli spring greens kale After cleaning this variable is renamed as BROCCOLI which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Brussels sprouts ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Brussels sprouts After cleaning this variable is renamed as SPROUTS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cabbage ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Cabbage After cleaning this variable is renamed as CABBAGE which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Peas ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Peas After cleaning this variable is renamed as PEAS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Green beans broad beans runner beans ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Green beans broad beans runner beans After cleaning this variable is renamed as GREEN_BEANS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Marrow courgettes ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Marrow courgettes After cleaning this variable is renamed as MARROW which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Cauliflower ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Cauliflower After cleaning this variable is renamed as CAULIFLOWER which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Parsnips turnips Swedes

Average use last year of medium serving of fresh frozen or tinned Parsnips turnips Swedes. After cleaning this variable is renamed as PARSNIPS which is then used by the FETA program for analysis.

Categorical

Parsnips turnips Swedes ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Parsnips turnips Swedes After cleaning this variable is renamed as PARSNIPS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Parsnips

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Leeks

Average use last year of medium serving of fresh frozen or tinned Leeks. After cleaning this variable is renamed as LEEKS which is then used by the FETA program for analysis.

Categorical

Leeks ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Leeks After cleaning this variable is renamed as LEEKS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Leeks

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Onions

Average use last year of medium serving of fresh frozen or tinned Onions. After cleaning this variable is renamed as ONIONS which is then used by the FETA program for analysis.

Categorical

Onions ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Onions After cleaning this variable is renamed as ONIONS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Onions

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Garlic

Average use last year of medium serving of fresh frozen or tinned Garlic. After cleaning this variable is renamed as GARLIC which is then used by the FETA program for analysis.

Categorical

Garlic ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Garlic After cleaning this variable is renamed as GARLIC which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Garlic

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Mushrooms

Average use last year of medium serving of fresh frozen or tinned Mushrooms. After cleaning this variable is renamed as MUSHROOMS which is then used by the FETA program for analysis.

Categorical

Mushrooms ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Mushrooms After cleaning this variable is renamed as MUSHROOMS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Mushrooms

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sweet peppers

Average use last year of medium serving of fresh frozen or tinned Sweet peppers. After cleaning this variable is renamed as PEPPERS which is then used by the FETA program for analysis.

Categorical

Sweet peppers ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Sweet peppers After cleaning this variable is renamed as PEPPERS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

SweetPeppers

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Beansprouts

Average use last year of medium serving of fresh frozen or tinned Beansprouts. After cleaning this variable is renamed as BEANSPROUTS which is then used by the FETA program for analysis.

Categorical

Beansprouts ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Beansprouts After cleaning this variable is renamed as BEANSPROUTS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Beansprouts

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Green salad lettuce cucumber celery

Average use last year of medium serving of fresh frozen or tinned Green salad lettuce cucumber celery. After cleaning this variable is renamed as GREEN_SALAD which is then used by the FETA program for analysis.

Categorical

Green salad lettuce cucumber celery ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Green salad lettuce cucumber celery After cleaning this variable is renamed as GREEN_SALAD which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

GreenSalad

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Watercress

Average use last year of medium serving of fresh frozen or tinned Watercress. After cleaning this variable is renamed as WATERCRESS which is then used by the FETA program for analysis.

Categorical

Watercress ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Watercress After cleaning this variable is renamed as WATERCRESS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Watercress

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Tomatoes

Average use last year of medium serving of fresh frozen or tinned Tomatoes. After cleaning this variable is renamed as TOMATOES which is then used by the FETA program for analysis.

Categorical

Tomatoes ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Tomatoes After cleaning this variable is renamed as TOMATOES which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Tomatoes

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Carrots

Average use last year of medium serving of fresh frozen or tinned Carrots. After cleaning this variable is renamed as CARROTS which is then used by the FETA program for analysis.

Categorical

Carrots

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Sweetcorn

Average use last year of medium serving of fresh frozen or tinned Sweetcorn. After cleaning this variable is renamed as SWEETCORN which is then used by the FETA program for analysis.

Categorical

Sweetcorn ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Sweetcorn After cleaning this variable is renamed as SWEETCORN which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Sweetcorn

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Beetroot

Average use last year of medium serving of fresh frozen or tinned Beetroot. After cleaning this variable is renamed as BEETROOT which is then used by the FETA program for analysis.

Categorical

Beetroot ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Beetroot After cleaning this variable is renamed as BEETROOT which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Beetroot

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Coleslaw

Average use last year of medium serving of fresh frozen or tinned Coleslaw. After cleaning this variable is renamed as COLESLAW which is then used by the FETA program for analysis.

Categorical

Coleslaw ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Coleslaw After cleaning this variable is renamed as COLESLAW which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Coleslaw

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Avocado

Average use last year of medium serving of fresh frozen or tinned Avocado. After cleaning this variable is renamed as AVOCADO which is then used by the FETA program for analysis.

Categorical

Avocado ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Avocado After cleaning this variable is renamed as AVOCADO which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Avocado

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Baked beans

Average use last year of medium serving of fresh frozen or tinned Baked beans. After cleaning this variable is renamed as BEANS which is then used by the FETA program for analysis.

Categorical

Baked beans ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Baked beans After cleaning this variable is renamed as BEANS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

BakedBeans

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Dried lentils beans peas ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Dried lentils beans peas After cleaning this variable is renamed as LENTILS which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

DriedLentils

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Tofu soya meat TVP Vegeburger

Average use last year of medium serving of fresh frozen or tinned Tofu soya meat TVP Vegeburger. After cleaning this variable is renamed as TOFU which is then used by the FETA program for analysis.

Categorical

Tofu; soya meat; TVP; Vegeburger ERROR CODES CLEANED

Average use last year of medium serving of fresh frozen or tinned Tofu soya meat TVP Vegeburger After cleaning this variable is renamed as TOFU which is then used by the FETA program for analysis. All raw data with error codes (> 1 answer) cleaned by averaging all answers ticked and rounding up to next whole number.

Categorical

Tofu

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Spinach

Average use last year of medium serving of fresh frozen or tinned Spinach. After cleaning this variable is renamed as SPINACH which is then used by the FETA program for analysis.

Categorical

Spinach

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Broccoli; spring greens; kale

Average use last year of medium serving of fresh frozen or tinned Broccoli spring greens kale. After cleaning this variable is renamed as BROCCOLI which is then used by the FETA program for analysis.

Categorical

Broccoli

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Brussels sprouts

Average use last year of medium serving of fresh frozen or tinned Brussels sprouts. After cleaning this variable is renamed as SPROUTS which is then used by the FETA program for analysis.

Categorical

BrusselsSprouts

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cabbage

Average use last year of medium serving of fresh frozen or tinned Cabbage. After cleaning this variable is renamed as CABBAGE which is then used by the FETA program for analysis.

Categorical

Cabbage

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Peas

Average use last year of medium serving of fresh frozen or tinned Peas. After cleaning this variable is renamed as PEAS which is then used by the FETA program for analysis.

Categorical

Peas

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Green beans; broad beans; runner beans

Average use last year of medium serving of fresh frozen or tinned Green beans broad beans runner beans. After cleaning this variable is renamed as GREEN_BEANS which is then used by the FETA program for analysis.

Categorical

Beans

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Marrow courgettes

Average use last year of medium serving of fresh frozen or tinned Marrow courgettes. After cleaning this variable is renamed as MARROW which is then used by the FETA program for analysis.

Categorical

Marrow

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

Cauliflower

Average use last year of medium serving of fresh frozen or tinned Cauliflower. After cleaning this variable is renamed as CAULIFLOWER which is then used by the FETA program for analysis.

Categorical

Cauliflower

Phase 2 data. FFQ questionnaire ELY-PQ-3-204 reads Please estimate your average food use as best you can and please answer every question - do not leave ANY lines blank. Foods and Amounts; Average use last year. 1 = Never or less than once a month; 2 = 1-3 per month; 3 = Once a week; 4 = 2-4 per week; 5 = 5-6 per week; 6 = Once a day; 7 = 2-3 per day; 8 = 4-5 per day; 9 = 6+ per day; -1 = left blank; -5 = more than one selected;

Categorical

OLINK assay VEGFA

Phase 1 OLINK assay data for target VEGFA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VEGFA

Phase 1 OLINK assay data for target VEGFA in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VEGFC

Phase 1 OLINK assay data for target VEGFC in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VEGFD

Phase 1 OLINK assay data for target VEGFD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VEGFD

Phase 1 OLINK assay data for target VEGFD in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VEGFR-2

Phase 1 OLINK assay data for target VEGFR-2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VEGFR-3

Phase 1 OLINK assay data for target VEGFR-3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Cln variable: Qnr version no

Phase 2 data. Derived with method 2. Questionnaire version number

Text

VIGOROUStime

Time spent at vigorous intensity activity [hrs/d]. Created by PA team to facilitate data cleaning. Data can be provided if needed.

Real

Time spent at vigorous intensity activity work not inc

Phase 2 data. Derived with method 2. Time spent at vigorous intensity activity; No work and no other acts hrs/d

Real

Time spent at vigorous intensity activity work inc

Phase 2 data. Derived with method 2. Time spent at vigorous intensity activity; Work inc but no other acts hrs/d

Real

VIGOROUS_INTENSITY

Vigorous intensity energy expenditure [METhrs/d]. Created by PA team to facilitate data cleaning. Data can be provided if needed.

Real

OLINK assay VIM

Phase 1 OLINK assay data for target VIM in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

VisitComplete_Phase1

New in R8. Partially completed variable. Use this to explain why no data is available for a volunteer.

Categorical

Vitamin C Results

Data produced by UCL from blood samples in umol/l. Raw data; cleaned data provided in variable G_VitaminCResult with x_Threshold and x_Com variables provided for clarification.

Real

Vitamin C Results

Data produced by UCL from blood samples in umol/l. Raw data; cleaned data provided in variable G_VitaminCResult with x_Threshold and x_Com variables provided for clarification.

Real

QCd Vitamin C result

Phase 2 data. QCd Vitamin C result in umol/l. Where VitaminCResult_P2_Raw data is questionable it has been removed by the DM team and a comment has been provided in VitaminC_P2_DMcomment

Real

Raw Vitamin C result

Phase 2 data. raw Vitamin C result as received from lab in umol/l

Real

DM comment on raw VitC data

Phase 2 data. Data management comment on raw VitC data in table to clarify data QC

Text

Vit C Comment

Comment for Vitamin C data.

Text

Lab Vitamin C analysis comment

Phase 2 data. Laboratory analysis comment for phase 2 Vitamin C analysis.

Text

VO2 max

Prediction of volunteers VO2max based on treadmill performance (VO2 max). Calculated based on a few HR observations during treadmill test and age-predicted max HR. Uses non-individual VO2 and VO2 responses to treadmill test (non-jaeger). For purpose of volunteer feedback only.

Real

VO2Max_New

Data as entered on Study database. New variable to calculate VO2max using a different algorithm.

VO2max calculation

Phase 2 data. Data as entered on Study database. New variable to calculate VO2max using a different algorithm. Values used for participant feedback only. Not for analysis. Use fitness variables in main actiheart dataset instead

Real

None

Has the VO2 letter been sent off?

OLINK assay VSIG2

Phase 1 OLINK assay data for target VSIG2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VSIG4

Phase 1 OLINK assay data for target VSIG4 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VSTM1

Phase 1 OLINK assay data for target VSTM1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay VWC2

Phase 1 OLINK assay data for target VWC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay vWF

Phase 1 OLINK assay data for target vWF in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

WALKadj

Derived Intermediate not for general release. Data can be provided if necessary.

Walk Test Walking Aid Type

Phase 2 data. Walk Test Walking Aid Type. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Text

Walk Test walking aid used

Phase 2 data. Walk Test walking aid used. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead. 0 = no; 1 = yes;

Categorical

WALKMILES

Derived Intermediate not for general release. Data can be provided if necessary.

Hours of Walking for pleasure

Please indicate the average length of time (in hours) you spent doing the activity per episode. Walking for pleasure (not as a means of transport).

Integer

Hours of Walking for pleasure CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Walking pleasure hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Walking for pleasure hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). -1 = left blank. DO NOT USE THIS VARIABLE. Use walkPleasureHr_CLEAN_P2 instead.

Real

Minutes of Walking for pleasure

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Walking for pleasure (not as a means of transport).

Integer

Minutes of Walking for pleasure CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Walking pleasure min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Walking for pleasure min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). -1 = left blank. DO NOT USE THIS VARIABLE. Use walkPleasureMin_CLEAN_P2 instead.

Real

Frequency of Walking for pleasure CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Walking for pleasure (not as a means of transport). Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

walkPleasure_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Walking for pleasure

Real

Cln variable: Walking pleasure

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Walking for pleasure (not as a means of transport). Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

walkPleasure_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Walking for pleasure (not as a means of transport). Data normalised to DE template 1 data.

Categorical

Walking for pleasure

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Walking for pleasure (not as a means of transport). DO NOT USE THIS VARIABLE. Use walkPleasure_CLEAN_P2 instead.

Real

Walking for pleasure

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Walking for pleasure (not as a means of transport). Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Walking for pleasure DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Walking for pleasure (not as a means of transport). Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in walkPleasure_T2. Instead use walkPleasure_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Walking for pleasure DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Walking for pleasure (not as a means of transport). Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in walkPleasure_T1. Instead use walkPleasure_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Walk Test Comments

Phase 2 data. Walk Test Comments. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Text

Walk Test Distance

Phase 2 data. Walk Test Distance. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Integer

Walk Test Entered

Phase 2 data. Walk test data entered? 0 = no; 1 = yes;

Categorical

Walk Test number of laps

Phase 2 data. Walk Test number of laps. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Integer

Walk length minutes

Phase 2 data. Walk length minutes. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Real

Walk Test length Seconds

Phase 2 data. Walk Test length Seconds. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Integer

Walk Test Standing HR

Phase 2 data. Walk Test Standing HR. Data as entered on Study database. For participant feedback only. Use cleaned Walk test variables from main Actiheart dataset instead.

Integer

Walk Test Start time

Phase 2 data. Walk Test Start time. Data as entered on Study database. For study coordination purposes and QC only. Use cleaned Walk test variables from main Actiheart dataset instead.

Time

OLINK assay WASF1

Phase 1 OLINK assay data for target WASF1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay WASF3

Phase 1 OLINK assay data for target WASF3 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay WAS

Phase 1 OLINK assay data for target WAS in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of Watering the lawn or garden

Please indicate the average length of time (in hours) you spent doing the activity per episode. Watering the lawn or garden.

Integer

Hours of Watering the lawn or garden CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Watering the lawn or garden. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Watering the lawn hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Watering the lawn or garden. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Watering the lawn or garden hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Watering the lawn or garden. -1 = left blank. DO NOT USE THIS VARIABLE. Use waterLawnHr_CLEAN_P2 instead.

Real

Minutes of Watering the lawn or garden

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Watering the lawn or garden.

Integer

Minutes of Watering the lawn or garden CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Watering the lawn or garden. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: Watering the lawn min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Watering the lawn or garden. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Watering the lawn or garden min

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Watering the lawn or garden. -1 = left blank. DO NOT USE THIS VARIABLE. Use waterLawnMin_CLEAN_P2 instead.

Real

Frequency of Watering the lawn or garden CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Watering the lawn or garden. Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

waterLawn_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Watering the lawn or garden

Real

Cln variable: Watering the lawn

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Watering the lawn or garden. Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

waterLawn_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Watering the lawn or garden. Data normalised to DE template 1 data.

Categorical

Watering the lawn or garden

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Watering the lawn or garden. DO NOT USE THIS VARIABLE. Use waterLawn_CLEAN_P2 instead.

Real

Watering the lawn or garden

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Watering the lawn or garden. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Watering the lawn or garden DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Watering the lawn or garden. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in waterLawn_T2. Instead use waterLawn_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Watering the lawn or garden DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Watering the lawn or garden. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in waterLawn_T1. Instead use waterLawn_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Hours of Weeding or Pruning

Please indicate the average length of time (in hours) you spent doing the activity per episode. Weeding or Pruning.

Integer

Hours of Weeding or Pruning CLEANED

Please indicate the average length of time (in hours) you spent doing the activity per episode. Weeding or Pruning. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: WeedingorPruning hrs

Phase 2 data. Please indicate the average length of time (in hours) you spent doing the activity per episode. Weeding or Pruning. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Weeding or Pruning hrs

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Weeding or Pruning. -1 = left blank. DO NOT USE THIS VARIABLE. Use weedPruneHr_CLEAN_P2 instead.

Real

Minutes of Weeding or Pruning

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Weeding or Pruning.

Integer

Minutes of Weeding or Pruning CLEANED

Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Weeding or Pruning. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Integer

Cln variable: WeedingorPruning min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Weeding or Pruning. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team. -1 = left blank.

Real

Weeding or Pruning min

Phase 2 data. Please indicate the average length of time (in additional minutes) you spent doing the activity per episode. Weeding or Pruning. -1 = left blank. DO NOT USE THIS VARIABLE. Use weedPruneMin_CLEAN_P2 instead.

Real

Frequency of Weeding or Pruning CLEANED

Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Weeding or Pruning.Error codes cleaned by DM team. And then -10 errors cleaned by PA team.

Categorical

weedPrune_CLEAN_FRQ

New in R8. Cleaned translated frequency (per week) for Weeding or Pruning

Real

Cln variable: Weeding or Pruning

Phase 2 data. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Weeding or Pruning.Error codes cleaned by DM team. And then -10 errors cleaned by PA team. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -9 = not completed; -10 = any text as written;

Categorical

weedPrune_NORM

New in R7. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Weeding or Pruning. Data normalised to DE template 1 data.

Categorical

Weeding or Pruning

Phase 2 data. Questionnaire reads D13. Please indicate the average length of time (in hours) you spent doing the activity per episode. Weeding or Pruning. DO NOT USE THIS VARIABLE. Use weedPrune_CLEAN_P2 instead.

Real

Weeding or Pruning

Phase 2 data. Data sources are varname_T1 and varname_T2 where the raw uncleaned data was normalised to the same data entry codes and then pooled into this new variable. Do not use. Use _CLEAN variable instead. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Weeding or Pruning. Data normalised to DE template 1 data. 1 = None; 2 = once in last 4 wks; 3 = 2-3 times in last 4 wks; 4 = once a week; 5 = 2-3 times a week; 6 = 4-5 times a week; 7 = every day; -1 = left blank; -5 = more than one selected; -10 = any text as written;

Categorical

Freq of Weeding or Pruning DE temp1

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Weeding or Pruning. Data entered using data entry template with 1-2-3-4-5-6-7 codes. This data cannot be compared with data in weedPrune_T2. Instead use weedPrune_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Freq of Weeding or Pruning DE temp2

New in R7. Please indicate how often (total number of times) you did the activity on average over the last 4 weeks. Weeding or Pruning. Data entered using data entry template with 1-3-4-5-6-7-8 codes. This data cannot be compared with data in weedPrune_T1. Instead use weedPrune_Norm which contains combined raw uncleaned data from varname_T1 and varname_T2 normalised to the same data entry codes.

Categorical

Cln variable: Wkday go to bed time

Phase 2 data. Weekday go to bed time (from General Q) - cleaned 24hr format

Time

No Wk days worked in a typical wk

Phase 2 data. Questionnaire reads Think about a typical week in the last 4 weeks. Enter how many days a week you worked on a week and a weekend day. Number of WEEK days worked In a typical week. ELECTRONIC F0RM ONLY additional instructions: please enter 0 if not worked.

Real

Cln variable: Wkday wake time

Phase 2 data. Weekday wake time (from General Q) - cleaned 24hr format

Time

Weekday daily sleep duration

Phase 2 data. Weekday daily sleep duration (hours) from cleaned GenQ sleep times

Real

Cln variable: Wknd day bed time

Phase 2 data. Weekend day go to bed time (from General Q) - cleaned 24hr format

Time

No Wkn days worked in a typical wk

Phase 2 data. Questionnaire reads Think about a typical week in the last 4 weeks. Enter how many days a week you worked on a week and a weekend day. Number of WEEKEND days worked In a typical week. ELECTRONIC F0RM ONLY additional instructions: please enter 0 if not worked.

Real

Cln variable: Wknd day wake time

Phase 2 data. Weekend day wake time (from General Q) - cleaned 24hr format

Time

Wknd day daily sleep duration

Phase 2 data. Weekend day daily sleep duration (hours) from cleaned GenQ sleep times

Time

OLINK assay WFDC2

Phase 1 OLINK assay data for target WFDC2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Wfh

Works from home status of Fenland phase 1 participants according to postcode data (-9 = missing; 1 = works from home; 2= works outside of home)

Categorical

Work from home status

Phase 2 data. Work from home status of Fenland phase 2 participants according to self-report and postcode information (-9 = missing; 0 = works from home as home postcode equal to work postcode; 1 = self-reported works from home; 2= works outside of home)

Categorical

OLINK assay WFIKKN1

Phase 1 OLINK assay data for target WFIKKN1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay WFIKKN2

Phase 1 OLINK assay data for target WFIKKN2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

White Blood Cell Count

A full blood count (FBC) test includes a white blood cell (WBC) count; which measures the number of white blood cells in a sample of blood. The normal range for WBC count is typically 4.5 to 11.0 x 10^9/L . WBCs; also known as leukocytes; are crucial for the immune system; helping the body fight infections and diseases.

Real

OLINK assay WIF-1

Phase 1 OLINK assay data for target WIF-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay WISP-1

Phase 1 OLINK assay data for target WISP-1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay WNT9A

Phase 1 OLINK assay data for target WNT9A in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

Hours of worked/wk 1 wks ago

Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 1 week ago.

Real

Hrs worked excluding travel 1 wk

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 1 week ago. -1 = left blank

Real

Extra min worked excluding travel

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many extra minutes work did you do per week (excluding travel)? 1 week ago. -1 = left blank

Real

Reason hrs not worked 1 week ago

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours work did you do per week? If 0 hours were worked 1 week ago record reason why. Merged data from PAPER and ELECTRONIC FORMS. 1 = Holiday; 3 = Other;

Categorical

Work1wkago_CLEAN

During the last 4 weeks how many hours work did you do per week? 1 week agoError codes cleaned by DM team with this rule: . And then -10 errors cleaned by PA team.

Real

Reason 0 wrkhrs 1wkago

Created by PA team to track reason for working zero hours that week.

Categorical

Work hrs excluding travel 1 week

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours did you work per week? Work hours (excluding travel) 1 week ago. Free text variable only collected on paper Questionnaire. Answer should be in total number of hours that week. Added -9 to electronic records to indicate data not collected

Real

Hours of worked/wk 2 wks ago

Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 2 weeks ago.

Real

Hrs worked excluding travel 2 wks

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 2 weeks ago. -1 = left blank

Real

Extra min worked excluding travel

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many extra minutes work did you do per week (excluding travel)? 2 weeks ago. -1 = left blank

Real

Reason hrs not worked 2 week ago

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours work did you do per week? If 0 hours were worked 2 week ago record reason why. Merged data from PAPER and ELECTRONIC FORMS. 1 = Holiday; 3 = Other;

Categorical

Hours of worked/wk 2 wks ago CLEANED

During the last 4 weeks how many hours work did you do per week? 2 weeks ago. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Real

Reason 0 wrkhrs 2wkago

Created by PA team to track reason for working zero hours that week.

Categorical

Work hrs excluding travel 2 weeks

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours did you work per week? Work hours (excluding travel) 2 weeks ago. Free text variable only collected on paper Questionnaire. Answer should be in total number of hours that week. Added -9 to electronic records to indicate data not collected

Real

Hours of worked/wk 3 wks ago

Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 3 weeks ago.

Real

Hrs worked excluding travel 3 wks

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 3 weeks ago. -1 = left blank

Real

Extra min worked excluding travel

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many extra minutes work did you do per week (excluding travel)? 3 weeks ago. -1 = left blank

Real

Reason hrs not worked 3 week ago

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours work did you do per week? If 0 hours were worked 3 week ago record reason why. Merged data from PAPER and ELECTRONIC FORMS. 1 = Holiday; 3 = Other;

Categorical

Hours of worked/wk 3 wks ago CLEANED

During the last 4 weeks how many hours work did you do per week? 3 weeks ago. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Real

Reason 0 wrkhrs 3wkago

Created by PA team to track reason for working zero hours that week.

Categorical

Work hrs excluding travel 3 weeks

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours did you work per week? Work hours (excluding travel) 3 weeks ago. Free text variable only collected on paper Questionnaire. Answer should be in total number of hours that week. Added -9 to electronic records to indicate data not collected

Real

Hours of worked/wk 4 wks ago

Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 4 weeks ago.

Real

Hrs worked excluding travel 4 wks

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many hours work did you do per week (excluding travel)? 4 weeks ago. -1 = left blank

Real

Extra min worked excluding travel

Phase 2 data. ELECTRONIC FORM ONLY: Please answer this section only if you have been in paid employment at any time during the last 4 weeks or you have done regular organised voluntary work. During the last 4 weeks how many extra minutes work did you do per week (excluding travel)? 4 weeks ago. -1 = left blank

Real

Reason hrs not worked 4 week ago

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours work did you do per week? If 0 hours were worked 4 week ago record reason why. Merged data from PAPER and ELECTRONIC FORMS. 1 = Holiday; 3 = Other;

Categorical

Hours of worked/wk 4 wks ago CLEANED

During the last 4 weeks how many hours work did you do per week? 4 weeks ago. Error codes cleaned by DM team with this rule: AVG_TEXT (average returned as text with no rounding). And then -10 errors cleaned by PA team.

Real

Reason 0 wrkhrs 4wkago

Created by PA team to track reason for working zero hours that week.

Categorical

Work hrs excluding travel 4 weeks

Phase 2 data. Questionnaire reads D6. During the last 4 weeks how many hours did you work per week? Work hours (excluding travel) 4 weeks ago. Free text variable only collected on paper Questionnaire. Answer should be in total number of hours that week. Added -9 to electronic records to indicate data not collected

Real

Work address

If work postcode not known please give your work address. Data as entered by participant.

Text

Work address DERIVED

Work address derived by PA team from work postcode data provided by participant using google.

Text

Work address

Phase 2 data. Questionnaire reads D11. If work postcode not known please give your work address. Data as entered by participant. -1 = left blank

Text

Work postcode

What is the postcode for your main place of work during the last 4 weeks? Data as entered by participant.

Text

Work postcode CLEANED

What is the postcode for your main place of work during the last 4 weeks? Data derived by PA team from other data entered. Data cleaned.

Text

Work postcode DERIVED

What is the postcode for your main place of work during the last 4 weeks? Data derived by PA team from work address data provided by participant using google.

Text

Work Postcode

Phase 2 data. Questionnaire reads D11. What is the postcode for your main place of work during the last 4 weeks? Data as entered by participant. -1 = left blank

Text

WORKtime

WORKtime. Derived Intermediate not for general release. Data can be provided if necessary.

Work type

We would like to know the type and amount of physical activity involved in your work. Please tick the one option that best corresponds with your occupation(s) in the last 4 weeks. SEDENTARY: you spend most of your time sitting such as in an office. STANDING occupation: You spend most of your time standing or walking however your work does not require intense physical effort eg shop assistant hairdresser guard. MANUAL work: This involves some physical effort including handling of heavy objects and use of tools eg plumber electrician carpenter. HEAVY MANUAL work: This implies very vigorous activity including handling of very heavy objects eg dock worker miner bricklayer construction worker.

Categorical

Work type CLEANED

We would like to know the type and amount of physical activity involved in your work. Please tick the one option that best corresponds with your occupation(s) in the last 4 weeks.Error codes cleaned by DM team with this rule: AVG#RDOWN_TEXT. And then -10

Categorical

Cln variable: Type and amount of PA

Phase 2 data. We would like to know the type and amount of physical activity involved in your work. Please tick the one option that best corresponds with your occupation(s) in the last 4 weeks.Error codes cleaned by DM team with this rule: AVG#RDOWN_TEXT. And then -10

Real

Type and amount of PA in work

Phase 2 data. Questionnaire reads D7. We would like to know the type and amount of physical activity involved in your work. Please tick the one option that best corresponds with your occupation(s) in the last 4 weeks. SEDENTARY: you spend most of your time sitting such as in an office. STANDING occupation: You spend most of your time standing or walking however your work does not require intense physical effort eg shop assistant hairdresser guard. MANUAL work: This involves some physical effort including handling of heavy objects and use of tools eg plumber electrician carpenter. HEAVY MANUAL work: This implies very vigorous activity including handling of very heavy objects eg dock worker miner bricklayer construction worker. 1 = sedentary; 2 = standing; 3 = manual work; 4 = heavy manual work; DO NOT USE THIS VARIABLE. Use Worktype_CLEAN_P2 instead.

Categorical

WORK_ACTMETS

Work domain activity energy expenditure [net METhrs/d]

Real

Work domain AEE

Phase 2 data. Derived with method 2. Work domain activity energy expenditure net METhrs/d

Real

Work location changed btwn phases

Phase 2 data. Work location changed between phases 1 and 2 including those that started working from home during study period (-9 = missing; 1 = no job address change 2 = job address change)

Categorical

WORK_METS

Work domain energy expenditure [METhrs/d]

Real

Work domain energy expenditure

Phase 2 data. Derived with method 2. Work domain energy expenditure METhrs/d

Real

WORK_PAEE

Work domain activity energy expenditure [kJ/kg/d]

Real

Work domain PAEE

Phase 2 data. Derived with method 2. Work domain activity energy expenditure kJ/kg/d

Real

Work_pc

Description of work postcode missings of Fenland phase 1 participants according to postcode data (-9 = outside of study area;-99 = no work information; -999 = invalid postcode unit; 1 = valid postcode data)

Categorical

Description work postcode missing

Phase 2 data. Description of work postcode missings of Fenland phase 2 participants according to postcode data (-9 = outside of study area;-99 = no work information; -999 = invalid work address data/more than one workplace; -9999 = retired; 1 = valid postcode data)

Categorical

Cln variable: Work postcode

Phase 2 data. Cleaned Phase 2 Work Postcode based on data entered into the contact database transcribed from the phase 2 measrurment questionnaire. -1 = Unknown left blank unspecific postcode unit or multiple postcode unit options;-2 = Retired

Categorical

Cmnt missing values Work postcode

Phase 2 data. Comment related to missing values in Work_postcode_cleaned_P2

Text

Work_Supermarket

Count of supermarkets within a 1 mile Eucladian distance of participants work Fenland phase 1 (-9 = missing)

Integer

Cnt of supermarkets 1 mile Pts work

Phase 2 data. Count of supermarkets within a 1 mile Eucladian distance of participants' work Fenland phase 2 (-9 = missing)

Integer

Work_Takeaway

Count of takeaways within a 1 mile Eucladian distance of participants work Fenland phase 1 (-9 = missing)

Integer

Cnt of takeaways 1 mile Pts work

Phase 2 data. Count of takeaways within a 1 mile Eucladian distance of participants' work Fenland phase 2 (-9 = missing)

Integer

WristAcc_Arm

Data as entered on Study database. If wrist accelerometer has been issued to particpant which arm has it been fastened to left or right.

WristAcc_Issued

Data as entered on Study database. Has wrist accelerometer been issued to particpant? yes-tick or no-left blank

Wrist acc issued to pt

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. Has wrist accelerometer been issued to particpant? 0 = no; 1 = yes;

Categorical

Wrist worn acc used treadmil test

Phase 2 data. Data as entered on Study database. For study coordination purposes and QC only. Wrist worn accelerometer used for treadmil test? 0 = no; 1 = yes;

Categorical

Travel to work by bicycle

Travel to and from work in the last 4 weeks. How did you normally travel to work? Bicycle?

Categorical

Travel to work by bicycle CLEANED

Travel to and from work in the last 4 weeks. How did you normally travel to work? Bicycle. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Cln variable: Travel wrk by bicycle

Phase 2 data. Travel to and from work in the last 4 weeks. How did you normally travel to work? Bicycle. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Travel to work by bicycle

Phase 2 data. Questionnaire reads D10. Travel to and from work in the last 4 weeks. How did you normally travel to work? By Bicycle; 1 = always; 2 = usually; 3 = occasionally; 4 = never or rarely; DO NOT USE THIS VARIABLE. Use Wrkbybicycle_CLEAN_P2 instead.

Categorical

Travel to work by car

Travel to and from work in the last 4 weeks. How did you normally travel to work? Car?

Categorical

Travel to work by car CLEANED

Travel to and from work in the last 4 weeks. How did you normally travel to work? Car. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Cln variable: Travel wrk by car

Phase 2 data. Travel to and from work in the last 4 weeks. How did you normally travel to work? Car. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Travel to work by car

Phase 2 data. Questionnaire reads D10. Travel to and from work in the last 4 weeks. How did you normally travel to work? By Car; 1 = always; 2 = usually; 3 = occasionally; 4 = never or rarely; DO NOT USE THIS VARIABLE. Use Wrkbycar_CLEAN_P2 instead.

Categorical

Walk to work

Travel to and from work in the last 4 weeks. How did you normally travel to work? Walking?

Categorical

Walk to work CLEANED

Travel to and from work in the last 4 weeks. How did you normally travel to work? Walking. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Cln variable: Travel wrk walking

Phase 2 data. Travel to and from work in the last 4 weeks. How did you normally travel to work? Walking. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Travel to work walking

Phase 2 data. Questionnaire reads D10. Travel to and from work in the last 4 weeks. How did you normally travel to work? Walking; 1 = always; 2 = usually; 3 = occasionally; 4 = never or rarely; DO NOT USE THIS VARIABLE. Use Wrkbyfoot_CLEAN_P2 instead.

Categorical

Travel to work by public transport

Travel to and from work in the last 4 weeks. How did you normally travel to work? Public transport?

Categorical

Travel to work by public transport CLEANED

Travel to and from work in the last 4 weeks. How did you normally travel to work? Public transport. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Cln variable: Travel wrk pub trans

Phase 2 data. Travel to and from work in the last 4 weeks. How did you normally travel to work? Public transport. Error codes cleaned by DM team with this rule: AVG#RUP_AVG#RUP_TEXT. And then -10 errors cleaned by PA team.

Real

Travel to work by public transport

Phase 2 data. Questionnaire reads D10. Travel to and from work in the last 4 weeks. How did you normally travel to work? By works or Public transport; 1 = always; 2 = usually; 3 = occasionally; 4 = never or rarely; DO NOT USE THIS VARIABLE. Use Wrkbypubtran_CLEAN_P2 instead.

Categorical

Work from home

Phase 2 data. Travel to and from work in the last 4 weeks. What is the approximate distance from your home to your work? COLLECTED ON PAPER Q ONLY: If work from home tick here and enter 0 for distance. 1 = ticked; -1 = left blank;

Real

Distance Home-work kilometres

Travel to and from work in the last 4 weeks. What is the approximate distance from your home to your work? In kilometres. Data as entered by participant.

Integer

Distance Home-work in kilometres CLEANED

Distance Home-work in kilometres. Data derived from other data entered.Error codes cleaned by DM team with this rule: AVG_TEXT. And then -10 errors cleaned by PA team.

Integer

Cln variable: Dist Home-work in kms

Phase 2 data. RPAQ data. Distance Home-work in kilometres. Data derived from other data entered.Error codes cleaned by DM team with this rule: AVG_TEXT. And then -10 errors cleaned by PA team.

Real

Distance Home-work in kilometres DERIVED

Distance Home-work in kilometres. Data derived from other data provided by participant. Where multiple routes are available shortest route is used. A 0 has been added where home postcode and work postcode match AND the distance column reads -1 unless participant already provided distance.

Integer

Approx distance home to work kms

Phase 2 data. Questionnaire reads D8. Travel to and from work in the last 4 weeks. What is the approximate distance from your home to your work? In kilometres. Data as entered by participant. -1 = left blank. DO NOT USE THIS VARIABLE. Use Wrkkms_CLEAN_P2 instead.

Real

Distance Home-work miles

Travel to and from work in the last 4 weeks. What is the approximate distance from your home to your work? In miles. Data as entered by participant.

Integer

Distance Home-work miles CLEANED

Distance Home-work in miles. Data derived from other data entered. Data cleaned.

Integer

Cln variable: Dist Home-work miles

Phase 2 data. Distance Home-work in miles. Data derived from other data entered. Data cleaned.

Real

Distance Home-work miles DERIVED

Distance Home-work in miles. Data derived from other data provided by participant. Where multiple routes are available shortest route is used. A 0 has been added where home postcode and work postcode match AND the distance column reads -1 unless participant already provided distance.

Integer

Approx distance home to work miles

Phase 2 data. Questionnaire reads D8. Travel to and from work in the last 4 weeks. What is the approximate distance from your home to your work? In miles. Data as entered by participant. -1 = left blank. DO NOT USE THIS VARIABLE. Use Wrkmiles_CLEAN_P2 instead.

Real

Work from multiple locations

Phase 2 data. Derived by using data from WrkMultipleLocations_p_P2; WrkMultipleLocations_e_P2 and WrkFromHome_P2. Refer to Wrkmiles_P2 and Wrkkms_P2 if needed. 1 = works from home; 2 = works from multiple location; -1 = not answered left blank; -10 = estimated average distance from home to work (unit unknown);

Categorical

Journeys from home to work

Travel to and from work in the last 4 weeks. How many times per week did you travel from home to your main place of work? Count outward journeys only.

Categorical

Journeys from home to work CLEANED

Travel to and from work in the last 4 weeks. How many times per week did you travel from home to your main place of work? Count outward journeys only.Error codes cleaned by DM team with this rule: AVG_AVG_TEXT. And then -10 errors cleaned by PA team.

Categorical

Cln variable: Travel wrk per wk

Phase 2 data. Travel to and from work in the last 4 weeks. How many times per week did you travel from home to your main place of work? Count outward journeys only.Error codes cleaned by DM team with this rule: AVG_AVG_TEXT. And then -10 errors cleaned by PA team.

Real

Times per wk travel home to work

Phase 2 data. Questionnaire reads D9. Travel to and from work in the last 4 weeks. How many times per week did you travel from home to your main place of work? Count outward journeys only. -1 = left blank. DO NOT USE THIS VARIABLE. Use Wrktimesperweek_CLEAN_P2 instead.

Real

OLINK assay WWP2

Phase 1 OLINK assay data for target WWP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay XCL1

Phase 1 OLINK assay data for target XCL1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay XG

Phase 1 OLINK assay data for target XG in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay XPNPEP2

Phase 1 OLINK assay data for target XPNPEP2 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay YES1

Phase 1 OLINK assay data for target YES1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ZBTB16

Phase 1 OLINK assay data for target ZBTB16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ZBTB16

Phase 1 OLINK assay data for target ZBTB16 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay ZBTB17

Phase 1 OLINK assay data for target ZBTB17 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay 4E-BP1

Phase 1 OLINK assay data for target 4E-BP1 in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real

OLINK assay 5'-NT

Phase 1 OLINK assay data for target 5'-NT in NPX format. See https://olink.com/faq/what-is-npx/ for explanation of units and how to use.

Real